PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Aschebrook-Kilfoy, B; Argos, M; Pierce, BL; Tong, L; Jasmine, F; Roy, S; Parvez, F; Ahmed, A; Islam, T; Kibriya, MG; Ahsan, H				Aschebrook-Kilfoy, Briseis; Argos, Maria; Pierce, Brandon L.; Tong, Lin; Jasmine, Farzana; Roy, Shantanu; Parvez, Faruque; Ahmed, Alauddin; Islam, Tariqul; Kibriya, Muhammad G.; Ahsan, Habibul			Genome-Wide Association Study of Parity in Bangladeshi Women	PLOS ONE			English	Article							FUNCTIONAL GENETIC POLYMORPHISMS; FEMALE REPRODUCTIVE DISORDERS; HERITABILITY; INFERTILITY; FERTILITY; TRAITS	Human fertility is a complex trait determined by gene-environment interactions in which genetic factors represent a significant component. To better understand inter-individual variability in fertility, we performed one of the first genome-wide association studies (GWAS) of common fertility phenotypes, lifetime number of pregnancies and number of children in a developing country population. The fertility phenotype data and DNA samples were obtained at baseline recruitment from individuals participating in a large prospective cohort study in Bangladesh. GWAS analyses of fertility phenotypes were conducted among 1,686 married women. One SNP on chromosome 4 was non-significantly associated with number of children at P <10(-7) and number of pregnancies at P <10(-6). This SNP is located in a region without a gene within 1 Mb. One SNP on chromosome 6 was non-significantly associated with extreme number of children at P <10(-6). The closest gene to this SNP is HDGFL1, a hepatoma-derived growth factor. When we excluded hormonal contraceptive users, a SNP on chromosome 5 was non-significantly associated at P <10(-5) for number of children and number of pregnancies. This SNP is located near C5orf64, an open reading frame, and ZSWIM6, a zinc ion binding gene. We also estimated the heritability of these phenotypes from our genotype data using GCTA (Genome-wide Complex Trait Analysis) for number of children (h(g)(2) = 0.149, SE = 0.24, p-value = 0.265) and number of pregnancies (h(g)(2) = 0.007, SE = 0.22, p-value = 0.487). Our genome-wide association study and heritability estimates of number of pregnancies and number of children in Bangladesh did not confer strong evidence of common variants for parity variation. However, our results suggest that future studies may want to consider the role of 3 notable SNPs in their analysis.	[Aschebrook-Kilfoy, Briseis; Argos, Maria; Pierce, Brandon L.; Tong, Lin; Jasmine, Farzana; Roy, Shantanu; Kibriya, Muhammad G.; Ahsan, Habibul] Univ Chicago, Dept Hlth Studies, Chicago, IL 60637 USA; [Pierce, Brandon L.; Ahsan, Habibul] Univ Chicago, Ctr Comprehens Canc, Chicago, IL 60637 USA; [Ahmed, Alauddin; Islam, Tariqul] UChicago Res Bangladesh Ltd, Dhaka, Bangladesh; [Parvez, Faruque] Columbia Univ, Mailman Sch Publ Hlth, Dept Environm Hlth Sci, New York, NY USA; [Ahsan, Habibul] Univ Chicago, Dept Med, Chicago, IL 60637 USA; [Ahsan, Habibul] Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA	University of Chicago; Robert H. Lurie Comprehensive Cancer Center; University of Chicago; Columbia University; University of Chicago; University of Chicago	Ahsan, H (corresponding author), Univ Chicago, Dept Hlth Studies, Chicago, IL 60637 USA.	habib@uchicago.edu		Pierce, Brandon/0000-0002-7829-952X	National Institutes of Health [P42 ES10349]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000430] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES009089, P42ES010349] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by National Institutes of Health grant ## P42 ES10349. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahsan H, 2006, J EXPO SCI ENV EPID, V16, P191, DOI 10.1038/sj.jea.7500449; Ansermet F, 2010, J CHILD SEX ABUS, V19, P337, DOI 10.1080/10538711003788991; Bangladesh Bank, 2015, FOR DIR INV FDI BANG; Berry DP, 2012, ANIMAL, V6, P1206, DOI 10.1017/S1751731112000067; Chen WM, 2007, AM J HUM GENET, V81, P913, DOI 10.1086/521580; Choi J, 2007, INT J UROL, V14, P431, DOI 10.1111/j.1442-2042.2007.01741.x; Fidler AT, 1999, PUBLIC HEALTH REP, V114, P494, DOI 10.1093/phr/114.6.494; Golub MS, 1998, J TOXICOL ENV HEAL B, V1, P199, DOI 10.1080/10937409809524552; Hoggart CJ, 2008, GENET EPIDEMIOL, V32, P179, DOI 10.1002/gepi.20292; International Centre for Diarrhoeal Disease Research Bangladesh (ICDDRB), 2002, HLTH DEM SURV SYST M, V33; Kang HM, 2010, NAT GENET, V42, P348, DOI 10.1038/ng.548; Kohler HP, 2006, INT J ANDROL, V29, P46, DOI 10.1111/j.1365-2605.2005.00606.x; Kosova G, 2010, P NATL ACAD SCI USA, V107, P1772, DOI 10.1073/pnas.0906196106; Krausz C, 2007, ARCH ANDROLOGY, V53, P125, DOI 10.1080/01485010701271786; Layman LC, 2003, ENDOCRIN METAB CLIN, V32, P549, DOI 10.1016/S0889-8529(03)00040-9; Matzuk MM, 2008, NAT MED, V14, P1197, DOI 10.1038/nm.f.1895; MITRA S, 1997, BANGLADESH DEMOGRAPH; MITRA SNA, 1994, BANGLADESH DEMOGRAPH; National Institute of population Research and training (NIPORT), 2009, BANGL DEM HLTH SURV; NIPORT Mitra and Associates ORC Macro, 2005, BANGL DEM HLTH SURV; O'Brien KLO, 2010, FERTIL STERIL, V93, P1, DOI 10.1016/j.fertnstert.2009.10.045; Penagaricano F, 2012, ANIM GENET, V43, P65, DOI 10.1111/j.1365-2052.2012.02350.x; Pierce BL, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002522; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Simoni M, 2008, HUM REPROD UPDATE, V14, P459, DOI 10.1093/humupd/dmn024; Tempfer CB, 2009, HUM REPROD UPDATE, V15, P97, DOI 10.1093/humupd/dmn040; Yang JA, 2010, NAT GENET, V42, P565, DOI 10.1038/ng.608; Yoon SH, 2010, HUM REPROD, V25, P283, DOI 10.1093/humrep/dep375	28	7	7	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2015	10	3							e0118488	10.1371/journal.pone.0118488	http://dx.doi.org/10.1371/journal.pone.0118488			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9KG	25742292	Green Published, Green Submitted, gold			2022-12-27	WOS:000350688100020
J	Eom, SY; Yim, DH; Lee, CH; Choe, KH; An, JY; Lee, KY; Kim, YD; Kim, H				Eom, Sang-Yong; Yim, Dong-Hyuk; Lee, Chul-Ho; Choe, Kang-Hyeon; An, Jin Young; Lee, Kye Young; Kim, Yong-Dae; Kim, Heon			Interactions between Paraoxonase 1 Genetic Polymorphisms and Smoking and Their Effects on Oxidative Stress and Lung Cancer Risk in a Korean Population	PLOS ONE			English	Article							1 PON1 GENE; SERUM PARAOXONASE; PLASMA PARAOXONASE; ARYLESTERASE ACTIVITIES; DNA-DAMAGE; SUSCEPTIBILITY; ASSOCIATION; TOBACCO; MYELOPEROXIDASE; DETERMINANTS	Background Few studies in epidemiology have evaluated the effects of gene-environment interaction on oxidative stress, even though this interaction is an important etiologic factor in lung carcinogenesis. We investigated the effects of the genetic polymorphisms of paraoxonase 1 (PON1), smoking, and the interaction between the two on lung cancer risk and oxidative stress. Methods This study's subjects consisted of 416 newly diagnosed lung cancer patients and an equal number of matched controls. The GoldenGate assay was used for genotypic analyses of the PON1 gene. Urinary 8-hydroxydeoxyguanosine (8-OHdG) and thiobarbituric acid reactive substances levels were measured as indicators of oxidative stress. Results The PON1 rs662 AA genotype showed a significantly lower risk of lung cancer than the GG genotype (OR = 0.60, 95% CI: 0.36-0.99). The protective effect of the PON1 rs662 AA genotype on lung cancer risk was limited to non-smokers. Lung cancer patients who had the rs662 A allele showed a dose-dependent association between smoking status and oxidative stress markers. Among non-smoking lung cancer patients, urinary 8-OHdG levels were significantly lower in individuals with the rs662 GA and AA genotypes than in those with the GG genotype. Furthermore, we found a significant interaction effect between PON1 rs662 and smoking status on urinary 8-OHdG levels in lung cancer patients. Conclusions Our results suggest that the protective effect of PON1 rs662 SNP against lung carcinogenesis and the induction of oxidative stress might be modulated by the interaction between PON1 genetic polymorphisms and tobacco smoking.	[Eom, Sang-Yong; Yim, Dong-Hyuk; Kim, Yong-Dae; Kim, Heon] Chungbuk Natl Univ, Coll Med, Dept Prevent Med, Cheongju, South Korea; [Eom, Sang-Yong; Yim, Dong-Hyuk; Choe, Kang-Hyeon; An, Jin Young; Kim, Yong-Dae; Kim, Heon] Chungbuk Natl Univ, Coll Med, Med Res Inst, Cheongju, South Korea; [Eom, Sang-Yong; Yim, Dong-Hyuk; Kim, Yong-Dae; Kim, Heon] Chungbuk Natl Univ, Ctr Farmers Safety & Hlth, Cheongju, South Korea; [Lee, Chul-Ho] Korea Environm Corp, Asbestos Damage Relief Ctr, Inchon, South Korea; [Lee, Kye Young; Kim, Yong-Dae] Chungbuk Natl Univ, Coll Med, Dept Internal Med, Cheongju, South Korea; [Lee, Kye Young] Konkuk Univ, Coll Med, Dept Internal Med, Seoul, South Korea	Chungbuk National University; Chungbuk National University; Chungbuk National University; Chungbuk National University; Konkuk University; Konkuk University Medical Center	Kim, H (corresponding author), Chungbuk Natl Univ, Coll Med, Dept Prevent Med, Cheongju, South Korea.	kimheon@cbu.ac.kr	Eom, Sang-Yong/B-5705-2016	Eom, Sang-Yong/0000-0002-4559-8152; Kim, Heon/0000-0003-0329-5249	National R&D Program for Cancer Control, Ministry of Health & Welfare, Republic of Korea [1120330]	National R&D Program for Cancer Control, Ministry of Health & Welfare, Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea)	This study was supported by a grant from the National R&D Program for Cancer Control, Ministry of Health & Welfare, Republic of Korea (1120330).	Agarwal R, 2002, J CHROMATOGR B, V775, P121, DOI 10.1016/S1570-0232(02)00273-8; Ahsan H, 2004, JAMA-J AM MED ASSOC, V292, P3026, DOI 10.1001/jama.292.24.3026; Aksoy-Sagirli P, 2011, ANTICANCER RES, V31, P2225; Alberg AJ, 2013, CHEST, V143, pE1, DOI 10.1378/chest.12-2345; Antognelli C, 2005, PROSTATE, V63, P240, DOI 10.1002/pros.20184; Aydin O, 2013, CLIN LAB, V59, P1231, DOI 10.7754/Clin.Lab.2012.120914; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bhattacharyya T, 2008, JAMA-J AM MED ASSOC, V299, P1265, DOI 10.1001/jama.299.11.1265; Conesa-Zamora P, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-228; Costa LG, 2005, BIOCHEM PHARMACOL, V69, P541, DOI 10.1016/j.bcp.2004.08.027; Costa LG, 2003, BIOMARKERS, V8, P1, DOI 10.1080/13547500210148315; Crawford A, 2012, GENE, V501, P89, DOI 10.1016/j.gene.2012.04.011; Elkiran ET, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-48; Eom SY, 2011, J KOREAN MED SCI, V26, P720, DOI 10.3346/jkms.2011.26.6.720; Fang DH, 2012, MOL BIOL REP, V39, P6801, DOI 10.1007/s11033-012-1505-3; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Gaidukov L, 2006, J LIPID RES, V47, P2492, DOI 10.1194/jlr.M600297-JLR200; Halliwell B., 2007, FREE RADICALS BIOL M; Harik-Khan RI, 1998, AM J RESP CRIT CARE, V158, P1459, DOI 10.1164/ajrccm.158.5.9712006; Hecht SS, 1999, JNCI-J NATL CANCER I, V91, P1194, DOI 10.1093/jnci/91.14.1194; Huang Y, 2013, J CLIN INVEST, V123, P3815, DOI 10.1172/JCI67478; In KH, 2009, LUNG CANCER, V64, P232, DOI 10.1016/j.lungcan.2008.08.005; Ji GX, 2012, FREE RADICAL BIO MED, V52, P775, DOI 10.1016/j.freeradbiomed.2011.11.032; Jung KW, 2013, CANCER RES TREAT, V45, P15, DOI 10.4143/crt.2013.45.1.15; Kang HJ, 2005, NUCLEIC ACIDS RES, V33, pD518; Karaman E, 2010, J CRANIOFAC SURG, V21, P1745, DOI 10.1097/SCS.0b013e3181f4040a; Kurtul N, 2014, INHAL TOXICOL, V26, P235, DOI 10.3109/08958378.2013.878007; Lee Chul-Ho, 2005, J Prev Med Public Health, V38, P345; Loke WM, 2012, FREE RADICAL RES, V46, P1230, DOI 10.3109/10715762.2012.701291; Lurie G, 2008, CANCER EPIDEM BIOMAR, V17, P2070, DOI 10.1158/1055-9965.EPI-08-0145; Mackness B, 1998, FEBS LETT, V423, P57, DOI 10.1016/S0014-5793(98)00064-7; Mackness B, 2010, IUBMB LIFE, V62, P480, DOI 10.1002/iub.347; Min J, 2006, REPROD TOXICOL, V22, P418, DOI 10.1016/j.reprotox.2006.01.003; Nishio E, 1997, BIOCHEM BIOPH RES CO, V236, P289, DOI 10.1006/bbrc.1997.6961; Ozturk O, 2009, ANTICANCER RES, V29, P4041; Parry H, 1997, AM J CLIN PATHOL, V107, P64; Purcell S, 2003, BIOINFORMATICS, V19, P149, DOI 10.1093/bioinformatics/19.1.149; Rainwater DL, 2009, HEREDITY, V102, P147, DOI 10.1038/hdy.2008.110; Rodrigo L, 2001, CHEM-BIOL INTERACT, V137, P123, DOI 10.1016/S0009-2797(01)00225-3; Rozenberg O, 2003, FREE RADICAL BIO MED, V34, P774, DOI 10.1016/S0891-5849(02)01429-6; Saadat M, 2012, CANCER EPIDEMIOL, V36, pE101, DOI 10.1016/j.canep.2011.10.015; Seo T, 2008, ANN EPIDEMIOL, V18, P330, DOI 10.1016/j.annepidem.2007.10.002; Sole X, 2006, BIOINFORMATICS, V22, P1928, DOI 10.1093/bioinformatics/btl268; Valko M, 2006, CHEM-BIOL INTERACT, V160, P1, DOI 10.1016/j.cbi.2005.12.009; Wang H, 2012, J INVEST MED, V60, P592, DOI 10.2310/JIM.0b013e318245d557; Zengi O, 2012, CLIN CHEM LAB MED, V50, P529, DOI 10.1515/CCLM.2011.792	47	21	22	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2015	10	3							e0119100	10.1371/journal.pone.0119100	http://dx.doi.org/10.1371/journal.pone.0119100			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9KG	25741997	Green Submitted, gold, Green Published			2022-12-27	WOS:000350688100081
J	Li, J; Chanrion, M; Sawey, E; Wang, T; Chow, E; Tward, A; Su, Y; Xue, W; Lucito, R; Zender, L; Lowe, SW; Bishop, JM; Powers, S				Li, Jinyu; Chanrion, Maia; Sawey, Eric; Wang, Tim; Chow, Edward; Tward, Aaron; Su, Yi; Xue, Wen; Lucito, Robert; Zender, Lars; Lowe, Scott W.; Bishop, J. Michael; Powers, Scott			Reciprocal Interaction of Wnt and RXR-alpha Pathways in Hepatocyte Development and Hepatocellular Carcinoma	PLOS ONE			English	Article							BETA-CATENIN; SOMATIC MUTATIONS; LIVER-CANCER; GENE; IDENTIFICATION; CLASSIFICATION; ACTIVATION; SURVIVAL; RECEPTOR	Genomic analysis of human hepatocellular carcinoma (HCC) is potentially confounded by the differentiation state of the hepatic cell-of-origin. Here we integrated genomic analysis of mouse HCC (with defined cell-of-origin) along with normal development. We found a major shift in expression of Wnt and RXR-alpha pathway genes (up and down, respectively) coincident with the transition from hepatoblasts to hepatocytes. A combined Wnt and RXR-alpha gene signature categorized HCCs into two subtypes (high Wnt, low RXR-alpha and low Wnt, high RXR-alpha), which matched cell-of-origin in mouse models and the differentiation state of human HCC. Suppression of RXR-alpha levels in hepatocytes increased Wnt signaling and enhanced tumorigenicity, whereas ligand activation of RXR-alpha achieved the opposite. These results corroborate that there are two main HCC subtypes that correspond to the degree of hepatocyte differentation and that RXR-alpha, in part via Wnt signaling, plays a key functional role in the hepatocyte-like subtype and potentially could serve as a selective therapeutic target.	[Li, Jinyu; Chanrion, Maia; Sawey, Eric; Wang, Tim; Su, Yi; Lucito, Robert; Powers, Scott] Cold Spring Harbor Lab, Canc Genome Ctr, Woodbury, NY 11740 USA; [Chow, Edward] Natl Univ Singapore, Canc Sci Inst Singapore, Singapore 117599, Singapore; [Tward, Aaron; Bishop, J. Michael] Univ Calif San Francisco, GW Hooper Fdn, San Francisco, CA 94143 USA; [Tward, Aaron; Bishop, J. Michael] Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA; [Xue, Wen; Zender, Lars; Lowe, Scott W.; Powers, Scott] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA	Cold Spring Harbor Laboratory; National University of Singapore; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Cold Spring Harbor Laboratory	Powers, S (corresponding author), Cold Spring Harbor Lab, Canc Genome Ctr, Woodbury, NY 11740 USA.	rscottpowers@gmail.com	Lucito, Robert/AID-7159-2022	Chow, Edward/0000-0002-3075-1898; Wang, Timothy/0000-0001-5730-3019; Powers, Scott/0000-0003-2769-1932	National Cancer Institute [R01CA124648]; NATIONAL CANCER INSTITUTE [U01CA168409, P01CA013106, R01CA124648, P30CA008748] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Funding by R01CA124648 National Cancer Institute (SP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen JB, 2010, HEPATOLOGY, V51, P1401, DOI 10.1002/hep.23488; Boyault S, 2007, HEPATOLOGY, V45, P42, DOI 10.1002/hep.21467; Cha SM, 2012, J HAND SURG-AM, V37A, P2481, DOI 10.1016/j.jhsa.2012.07.031; Chiang DY, 2008, CANCER RES, V68, P6779, DOI 10.1158/0008-5472.CAN-08-0742; Choi JI, 2012, J KOREAN MED SCI, V27, P1265, DOI 10.3346/jkms.2012.27.10.1265; Cleary SP, 2013, HEPATOLOGY; Croft D, 2014, NUCLEIC ACIDS RES, V42, pD472, DOI 10.1093/nar/gkt1102; Fujimoto A, 2012, NAT GENET, V44, P760, DOI 10.1038/ng.2291; Goyal L, 2013, CLIN CANCER RES, V19, P2310, DOI 10.1158/1078-0432.CCR-12-2791; Gu DQ, 2002, TRANSPLANTATION, V73, P1818, DOI 10.1097/00007890-200206150-00020; Guichard C, 2012, NAT GENET, V44, P694, DOI 10.1038/ng.2256; Hoshida Y, 2009, CANCER RES, V69, P7385, DOI 10.1158/0008-5472.CAN-09-1089; Kim SM, 2012, HEPATOLOGY, V55, P1443, DOI 10.1002/hep.24813; Lee SY, 2014, FISH SHELLFISH IMMUN, V37, P11, DOI 10.1016/j.fsi.2014.01.006; Lee S, 2013, J GERIATR ONCOL, V4, P382, DOI 10.1016/j.jgo.2013.03.001; Mark Manuel, 2009, Nucl Recept Signal, V7, pe002, DOI 10.1621/nrs.07002; Miyoshi Y, 1998, CANCER RES, V58, P2524; Otu HH, 2007, J BIOL CHEM, V282, P11197, DOI 10.1074/jbc.M608441200; Ovejero C, 2004, HEPATOLOGY, V40, P167, DOI 10.1002/hep.20286; Sawey ET, 2011, CANCER CELL, V19, P347, DOI 10.1016/j.ccr.2011.01.040; Sell S, 2002, SEMIN CELL DEV BIOL, V13, P419, DOI 10.1016/S1084952102001295; Shachaf CM, 2004, NATURE, V431, P1112, DOI 10.1038/nature03043; Spiegelman VS, 2000, MOL CELL, V5, P877, DOI 10.1016/S1097-2765(00)80327-5; SUCOV HM, 1994, GENE DEV, V8, P1007, DOI 10.1101/gad.8.9.1007; Tan XP, 2008, HEPATOLOGY, V47, P1667, DOI 10.1002/hep.22225; Thorgeirsson SS, 2011, J HEPATOL; Tward AD, 2007, P NATL ACAD SCI USA, V104, P14771, DOI 10.1073/pnas.0706578104; Villanueva A, 2011, J HEPATOL; Villanueva A, 2010, ANNU REV MED, V61, P317, DOI 10.1146/annurev.med.080608.100623; Wang R, 2001, J CELL BIOL, V153, P1023, DOI 10.1083/jcb.153.5.1023; Wurmbach E, 2007, HEPATOLOGY, V45, P938, DOI 10.1002/hep.21622; Xiao JH, 2003, J BIOL CHEM, V278, P29954, DOI 10.1074/jbc.M304761200; Xue W, 2008, GENE DEV, V22, P1439, DOI 10.1101/gad.1672608; Yao H, 2011, Blood Cancer J, V1, pe43, DOI 10.1038/bcj.2011.41; Yoo NJ, 2012, HISTOPATHOLOGY, V60, P943, DOI 10.1111/j.1365-2559.2012.04178.x; Zender L, 2006, CELL, V125, P1253, DOI 10.1016/j.cell.2006.05.030	36	6	7	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2015	10	3							e0118480	10.1371/journal.pone.0118480	http://dx.doi.org/10.1371/journal.pone.0118480			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9JM	25738607	Green Submitted, Green Accepted, Green Published, gold			2022-12-27	WOS:000350685900040
J	Vandegehuchte, ML; Raschein, U; Schutz, M; Gwiazdowicz, DJ; Risch, AC				Vandegehuchte, Martijn L.; Raschein, Ursina; Schuetz, Martin; Gwiazdowicz, Dariusz J.; Risch, Anita C.			Indirect Short- and Long-Term Effects of Aboveground Invertebrate and Vertebrate Herbivores on Soil Microarthropod Communities	PLOS ONE			English	Article							STABLE-ISOTOPE RATIOS; SUB-ALPINE GRASSLANDS; SPECIES-DIVERSITY; PLANT DIVERSITY; DECOMPOSITION PROCESSES; LITTER DECOMPOSITION; GROUND COMMUNITIES; NUTRIENT DYNAMICS; FEEDING GUILDS; RED DEER	Recognition is growing that besides ungulates, small vertebrate and invertebrate herbivores are important drivers of grassland functioning. Even though soil microarthropods play key roles in several soil processes, effects of herbivores-especially those of smaller body size-on their communities are not well understood. Therefore, we progressively excluded large, medium and small vertebrate and invertebrate herbivores for three growing seasons using size-selective fences in two vegetation types in subalpine grasslands; short-grass and tall-grass vegetation generated by high and low historical levels of ungulate grazing. Herbivore exclusions generally had few effects on microarthropod communities, but exclusion of all herbivore groups resulted in decreased total springtail and Poduromorpha richness compared with exclusion of only ungulates and medium-sized mammals, regardless of vegetation type. The tall-grass vegetation had a higher total springtail richness and mesostigmatid mite abundance than the short-grass vegetation and a different oribatid mite community composition. Although several biotic and abiotic variables differed between the exclusion treatments and vegetation types, effects on soil microarthropods were best explained by differences in nutrient and fibre content of the previous year's vegetation, a proxy for litter quality, and to a lesser extent soil temperature. After three growing seasons, smaller herbivores had a stronger impact on these functionally important soil microarthropod communities than large herbivores. Over longer time-scales, however, large grazers created two different vegetation types and thereby influenced microarthropod communities bottomup, e.g. by altering resource quality. Hence, both short-and long-term consequences of herbivory affected the structure of the soil microarthropod community.	[Vandegehuchte, Martijn L.; Raschein, Ursina; Schuetz, Martin; Risch, Anita C.] Swiss Fed Inst Forest Snow & Landscape Res, Res Unit Community Ecol, Birmensdorf, Switzerland; [Raschein, Ursina] Univ Zurich, Inst Evolutionary Biol & Environm Studies, Zurich, Switzerland; [Gwiazdowicz, Dariusz J.] Poznan Univ Life Sci, Fac Forestry, Poznan, Poland	Swiss Federal Institutes of Technology Domain; Swiss Federal Institute for Forest, Snow & Landscape Research; University of Zurich; Poznan University of Life Sciences	Vandegehuchte, ML (corresponding author), Swiss Fed Inst Forest Snow & Landscape Res, Res Unit Community Ecol, Birmensdorf, Switzerland.	martijn.vandegehuchte@wsl.ch	Risch, Anita C./A-9836-2012	Risch, Anita C./0000-0003-0531-8336; Vandegehuchte, Martijn L./0000-0003-1283-4654; Gwiazdowicz, Dariusz/0000-0002-0064-2316	Swiss National Science Foundation, SNF [31003A_122009/1, 31003A_140939/1]	Swiss National Science Foundation, SNF(Swiss National Science Foundation (SNSF))	This study was funded by the Swiss National Science Foundation, SNF grant-no 31003A_122009/1 and SNF grant-no 31003A_140939/1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allan E, 2011, ECOL LETT, V14, P1246, DOI 10.1111/j.1461-0248.2011.01694.x; ANDERSON JPE, 1978, SOIL BIOL BIOCHEM, V10, P215, DOI 10.1016/0038-0717(78)90099-8; Anderson M.J., 2008, PERMANOVA PRIMER GUI; Bakker ES, 2006, ECOL LETT, V9, P780, DOI 10.1111/j.1461-0248.2006.00925.x; Bakker ES, 2004, OECOLOGIA, V138, P91, DOI 10.1007/s00442-003-1402-5; Ball BA, 2014, SOIL BIOL BIOCHEM, V69, P71, DOI 10.1016/j.soilbio.2013.10.048; Bardgett RD, 1999, SOIL BIOL BIOCHEM, V31, P1007, DOI 10.1016/S0038-0717(99)00014-0; Bardgett RD, 2003, ECOLOGY, V84, P2258, DOI 10.1890/02-0274; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Berg MP, 2004, PEDOBIOLOGIA, V48, P589, DOI 10.1016/j.pedobi.2004.07.006; Blankinship JC, 2011, OECOLOGIA, V165, P553, DOI 10.1007/s00442-011-1909-0; Bradford MA, 2008, SOIL BIOL BIOCHEM, V40, P1253, DOI 10.1016/j.soilbio.2007.12.001; Carrillo Y, 2011, SOIL BIOL BIOCHEM, V43, P1440, DOI 10.1016/j.soilbio.2011.03.011; Chahartaghi M, 2005, SOIL BIOL BIOCHEM, V37, P1718, DOI 10.1016/j.soilbio.2005.02.006; Clapperton MJ, 2002, PEDOBIOLOGIA, V46, P496, DOI 10.1078/0031-4056-00155; Clarke KR, 2006, J EXP MAR BIOL ECOL, V330, P55, DOI 10.1016/j.jembe.2005.12.017; Cole L, 2008, SOIL BIOL BIOCHEM, V40, P505, DOI 10.1016/j.soilbio.2007.09.018; Cole L, 2005, SOIL BIOL BIOCHEM, V37, P1707, DOI 10.1016/j.soilbio.2005.02.005; Cousineau D, 2005, TUTOR QUANT METHODS, V1, P42, DOI 10.20982/tqmp.01.1.p042; Crawley MJ, 1989, RELATIVE IMPORTANCE, P45; CROSSLEY DA, 1991, AGR ECOSYST ENVIRON, V34, P187, DOI 10.1016/0167-8809(91)90104-6; Davidson AD, 2012, FRONT ECOL ENVIRON, V10, P477, DOI 10.1890/110054; Dombos M, 2001, SOIL BIOL BIOCHEM, V33, P2037, DOI 10.1016/S0038-0717(01)00125-0; Eisenhauer N, 2011, SOIL BIOL BIOCHEM, V43, P1697, DOI 10.1016/j.soilbio.2011.04.015; FRANK DA, 1990, OIKOS, V57, P57, DOI 10.2307/3565736; Grayston SJ, 2005, SOIL BIOL BIOCHEM, V37, P1157, DOI 10.1016/j.soilbio.2004.11.014; Haase J, 2008, ECOLOGY, V89, P3072, DOI 10.1890/07-1983.1; Haynes AG, 2014, PLANT SOIL, V374, P579, DOI 10.1007/s11104-013-1905-8; Hedlund K, 2003, OIKOS, V103, P45, DOI 10.1034/j.1600-0706.2003.12511.x; Hobbs NT, 1996, J WILDLIFE MANAGE, V60, P695, DOI 10.2307/3802368; Howe HF, 2006, ECOLOGY, V87, P3007, DOI 10.1890/0012-9658(2006)87[3007:MADEOM]2.0.CO;2; Hunter MD, 2001, AGR FOREST ENTOMOL, V3, P77, DOI 10.1046/j.1461-9563.2001.00100.x; Ilieva-Makulec K, 2006, EUR J SOIL BIOL, V42, pS244, DOI 10.1016/j.ejsobi.2006.07.030; Joern A, 2013, ANNU REV ENTOMOL, V58, P19, DOI 10.1146/annurev-ento-120811-153540; Lessard JP, 2012, BASIC APPL ECOL, V13, P59, DOI 10.1016/j.baae.2011.11.001; MILCHUNAS DG, 1993, ECOL MONOGR, V63, P327, DOI 10.2307/2937150; Morey RD, 2008, TUTOR QUANT METHODS, V4, P61, DOI 10.20982/tqmp.04.2.p061; NEELY CL, 1991, SOIL BIOL BIOCHEM, V23, P947, DOI 10.1016/0038-0717(91)90175-J; Olofsson J, 2008, OECOLOGIA, V156, P825, DOI 10.1007/s00442-008-1038-6; Petersen H, 2004, PEDOBIOLOGIA, V48, P559, DOI 10.1016/j.pedobi.2004.06.003; Risch AC, 2013, ECOSYSTEMS, V16, P1192, DOI 10.1007/s10021-013-9676-x; Sabais ACW, 2011, ACTA OECOL, V37, P195, DOI 10.1016/j.actao.2011.02.002; Salamon JA, 2006, SOIL BIOL BIOCHEM, V38, P209, DOI 10.1016/j.soilbio.2005.04.033; Salamon JA, 2004, OIKOS, V106, P51, DOI 10.1111/j.0030-1299.2004.12905.x; Schadler M, 2003, OIKOS, V100, P203, DOI 10.1034/j.1600-0706.2003.11821.x; Schneider K, 2004, SOIL BIOL BIOCHEM, V36, P1769, DOI 10.1016/j.soilbio.2004.04.033; Schneider K., 2004, PHYTOPHAGA-PALERMO, VXIV, P247; Schneider K, 2009, SOIL BIOL BIOCHEM, V41, P170, DOI 10.1016/j.soilbio.2008.10.013; Schneider T, 2012, ISME J, V6, P1749, DOI 10.1038/ismej.2012.11; Schon NL, 2012, APPL SOIL ECOL, V53, P98, DOI 10.1016/j.apsoil.2011.11.003; Schutz M, 2006, ECOSYSTEMS, V9, P624, DOI 10.1007/s10021-006-0091-4; Schutz M, 2003, FOREST ECOL MANAG, V181, P177, DOI 10.1016/S0378-1127(03)00131-2; Schweitzer JA, 2005, OIKOS, V110, P133, DOI 10.1111/j.0030-1299.2005.13650.x; SEASTEDT TR, 1984, ANNU REV ENTOMOL, V29, P25, DOI 10.1146/annurev.en.29.010184.000325; Sinka M, 2007, APPL SOIL ECOL, V36, P92, DOI 10.1016/j.apsoil.2006.12.004; Sinka M, 2009, ECOL ENTOMOL, V34, P588, DOI 10.1111/j.1365-2311.2009.01106.x; Szanser M, 2011, SOIL BIOL BIOCHEM, V43, P9, DOI 10.1016/j.soilbio.2010.08.031; Tom N, 2006, NEW ZEAL J AGR RES, V49, P261, DOI 10.1080/00288233.2006.9513717; Ukabi S, 2009, J ARID ENVIRON, V73, P907, DOI 10.1016/j.jaridenv.2009.04.001; van der Wal A, 2013, FEMS MICROBIOL REV, V37, P477, DOI 10.1111/1574-6976.12001; Wickings K, 2013, PEDOBIOLOGIA, V56, P105, DOI 10.1016/j.pedobi.2013.01.001	61	17	17	6	67	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2015	10	3							e0118679	10.1371/journal.pone.0118679	http://dx.doi.org/10.1371/journal.pone.0118679			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9JM	25738942	gold, Green Published			2022-12-27	WOS:000350685900061
J	von Hippel, T; von Hippel, C				von Hippel, Ted; von Hippel, Courtney			To Apply or Not to Apply: A Survey Analysis of Grant Writing Costs and Benefits	PLOS ONE			English	Article							IMPACT	We surveyed 113 astronomers and 82 psychologists active in applying for federally funded research on their grant-writing history between January, 2009 and November, 2012. We collected demographic data, effort levels, success rates, and perceived non-financial benefits from writing grant proposals. We find that the average proposal takes 116 PI hours and 55 CI hours to write; although time spent writing was not related to whether the grant was funded. Effort did translate into success, however, as academics who wrote more grants received more funding. Participants indicated modest non-monetary benefits from grant writing, with psychologists reporting a somewhat greater benefit overall than astronomers. These perceptions of non-financial benefits were unrelated to how many grants investigators applied for, the number of grants they received, or the amount of time they devoted to writing their proposals. We also explored the number of years an investigator can afford to apply unsuccessfully for research grants and our analyses suggest that funding rates below approximately 20%, commensurate with current NIH and NSF funding, are likely to drive at least half of the active researchers away from federally funded research. We conclude with recommendations and suggestions for individual investigators and for department heads.	[von Hippel, Ted] Embry Riddle Aeronaut Univ, Daytona Beach, FL 32114 USA; [von Hippel, Courtney] Univ Queensland, St Lucia, Qld 4069, Australia	Embry-Riddle Aeronautical University; University of Queensland	von Hippel, T (corresponding author), Embry Riddle Aeronaut Univ, Daytona Beach, FL 32114 USA.	ted.vonhippel@erau.edu	von Hippel, Courtney/C-1294-2014	von Hippel, Courtney/0000-0003-1224-0194	College of Arts and Sciences at Embry-Riddle Aeronautical University	College of Arts and Sciences at Embry-Riddle Aeronautical University	Research reported in this publication was partially supported by the College of Arts and Sciences at Embry-Riddle Aeronautical University, which provided the first author two weeks of salary support to write up the results. The authors otherwise received no specific funding for this work. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Academy of Arts and Sciences, 2008, ADV RES SCI ENG INV; American Society for Biochemistry and Molecular Biology, 2013, UNL POT VAN OPP NOND; Augustine NR, 2010, RISING GATHERING STO, V5; Ballou J, 2002, MATH POLICY RES; Barrett L, 2011, HIGH EDUC, V61, P141, DOI 10.1007/s10734-010-9329-3; Carulli AJ, 2013, AM J PHYSIOL-GASTR L, V305, pG761, DOI 10.1152/ajpgi.00297.2013; Danthi N, 2014, CIRC RES, V114, P600, DOI 10.1161/CIRCRESAHA.114.302656; Hurtado S., 2012, UNDERGRADUATE TEACHI; Marsh HW, 2008, AM PSYCHOL, V63, P160, DOI 10.1037/0003-066X.63.3.160; Martin MR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013526; MERTON RK, 1968, SCIENCE, V159, P56, DOI 10.1126/science.159.3810.56; National Science Board, 2013, REP NAT SCI BOARD NA; Pflumm M, 2011, NAT MED, V17, P637, DOI 10.1038/nm0611-637b; Sheltzer JM, 2014, PNAS, V111, P28	14	24	24	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2015	10	3							e0118494	10.1371/journal.pone.0118494	http://dx.doi.org/10.1371/journal.pone.0118494			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9JM	25738742	Green Submitted, Green Published, gold			2022-12-27	WOS:000350685900041
J	Warren-Myers, F; Dempster, T; Fjelldal, PG; Hansen, T; Swearer, SE				Warren-Myers, Fletcher; Dempster, Tim; Fjelldal, Per Gunnar; Hansen, Tom; Swearer, Stephen E.			An Industry-Scale Mass Marking Technique for Tracing Farmed Fish Escapees	PLOS ONE			English	Article							SALMON SALMO-SALAR; ENRICHED STABLE-ISOTOPES; INDUCED ABDOMINAL LESIONS; PERCH MACQUARIA-AMBIGUA; ATLANTIC SALMON; TRANSGENERATIONAL MARKING; BATCH MARKING; WILD SALMON; OTOLITHS; L.	Farmed fish escape and enter the environment with subsequent effects on wild populations. Reducing escapes requires the ability to trace individuals back to the point of escape, so that escape causes can be identified and technical standards improved. Here, we tested if stable isotope otolith fingerprint marks delivered during routine vaccination could be an accurate, feasible and cost effective marking method, suitable for industrial-scale application. We tested seven stable isotopes, Ba-134, Ba-135, Ba-136, Ba-137, Sr-86, Sr-87 and Mg-26, on farmed Atlantic salmon reared in freshwater, in experimental conditions designed to reflect commercial practice. Marking was 100% successful with individual Ba isotopes at concentrations as low as 0.001 mu g.g(-1) fish and for Sr isotopes at 1 mu g. g(-1) fish. Our results suggest that 63 unique fingerprint marks can be made at low cost using Ba (0.0002-0.02 $US per mark) and Sr (0.46-0.82 $US per mark) isotopes. Stable isotope fingerprinting during vaccination is feasible for commercial application if applied at a company level within the world's largest salmon producing nations. Introducing a mass marking scheme would enable tracing of escapees back to point of origin, which could drive greater compliance, better farm design and improved management practices to reduce escapes.	[Warren-Myers, Fletcher; Dempster, Tim; Swearer, Stephen E.] Univ Melbourne, Sch BioSci, Parkville, Vic 3052, Australia; [Fjelldal, Per Gunnar; Hansen, Tom] Inst Marine Res, Matre Aquaculture Res Stn, Matredal, Norway	University of Melbourne; Institute of Marine Research - Norway	Warren-Myers, F (corresponding author), Univ Melbourne, Sch BioSci, Parkville, Vic 3052, Australia.	fwwm@student.unimelb.edu.au	SWEARER, STEPHEN/AAC-1527-2020; Swearer, Stephen/X-4882-2018; Dempster, Tim/E-9630-2011	SWEARER, STEPHEN/0000-0001-6381-9943; Swearer, Stephen/0000-0001-6381-9943; Dempster, Tim/0000-0001-8041-426X	Norwegian Fisheries and Aquaculture Research Fund [900710]	Norwegian Fisheries and Aquaculture Research Fund	Funding was provided by the Norwegian Fisheries and Aquaculture Research Fund ( project #900710), http://www.fao.org/docrep/008/a0012e/a0012e09.htm. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aunsmo A, 2008, J FISH DIS, V31, P515, DOI 10.1111/j.1365-2761.2007.00899.x; Bjornsson BT, 2000, GEN COMP ENDOCR, V119, P17, DOI 10.1006/gcen.2000.7439; Brudeseth BE, 2013, FISH SHELLFISH IMMUN, V35, P1759, DOI 10.1016/j.fsi.2013.05.029; Crook DA, 2009, N AM J FISH MANAGE, V29, P279, DOI 10.1577/M07-224.1; Crozier WW, 2000, FISHERIES MANAG ECOL, V7, P437, DOI 10.1046/j.1365-2400.2000.00219.x; de Braux E, 2014, ICES J MAR SCI, V71, P2530, DOI 10.1093/icesjms/fsu091; de Vries MC, 2005, GEOCHIM COSMOCHIM AC, V69, P4061, DOI 10.1016/j.gca.2005.03.052; Fiske P, 2006, ICES J MAR SCI, V63, P1182, DOI 10.1016/j.icesjms.2006.04.006; Fleming IA, 2000, P ROY SOC B-BIOL SCI, V267, P1517, DOI 10.1098/rspb.2000.1173; Garcia de Leaniz C, 2007, BIOL REV, V82, P173, DOI 10.1111/j.1469-185X.2006.00004.x; Glover KA, 2013, BMC GENET, V14, P1, DOI [10.1186/1471-2156-14-1, DOI 10.1186/1471-2156-14-1]; Glover KA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043129; Glover KA, 2010, AQUACULT ENV INTERAC, V1, P1, DOI 10.3354/aei00002; Glover KA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060924; Grini A, 2011, J FISH DIS, V34, P531, DOI 10.1111/j.1365-2761.2011.01265.x; Hansen LP, 2006, ICES J MAR SCI, V63, P1211, DOI 10.1016/j.icesjms.2006.04.022; Hindar K, 2006, ICES J MAR SCI, V63, P1234, DOI 10.1016/j.icesjms.2006.04.025; Hutchings JA, 2008, MOL ECOL, V17, P294, DOI 10.1111/j.1365-294X.2007.03485.x; Jensen O, 2010, AQUACULT ENV INTERAC, V1, P71, DOI 10.3354/aei00008; Maguire ME, 2002, BIOMETALS, V15, P203, DOI 10.1023/A:1016058229972; Martinez I, 2009, FOOD CHEM, V116, P766, DOI 10.1016/j.foodchem.2009.03.026; MCCORMICK SD, 1987, CAN J FISH AQUAT SCI, V44, P1462, DOI 10.1139/f87-175; McGinnity P, 1997, ICES J MAR SCI, V54, P998, DOI 10.1016/S1054-3139(97)80004-5; McGinnity P, 2003, P ROY SOC B-BIOL SCI, V270, P2443, DOI 10.1098/rspb.2003.2520; Munro AR, 2009, J FISH BIOL, V75, P668, DOI 10.1111/j.1095-8649.2009.02352.x; RICKER W E, 1975, P382; SHEARER KD, 1992, FISH PHYSIOL BIOCHEM, V9, P387, DOI 10.1007/BF02274219; Skaala O, 2012, CAN J FISH AQUAT SCI, V69, P1994, DOI 10.1139/f2012-118; Skilbrei OT, 2010, AQUACULT ENV INTERAC, V1, P147, DOI 10.3354/aei00017; Skilbrei OT, 2010, AQUACULT ENV INTERAC, V1, P117, DOI 10.3354/aei00013; Sorum U, 2004, AQUACULTURE, V232, P333, DOI 10.1016/S0044-8486(03)00529-5; Toledo-Guedes K, 2001, MAR ECOL, V31, P26; Vander Haegen GE, 2005, N AM J FISH MANAGE, V25, P1161, DOI 10.1577/M04-011.1; Volk EC, 1999, FISH RES, V43, P205, DOI 10.1016/S0165-7836(99)00073-9; Warren-Myers F, 2014, AQUACULT ENV INTERAC, V5, P143, DOI 10.3354/aei00103; Williamson DH, 2009, J FISH BIOL, V74, P891, DOI 10.1111/j.1095-8649.2008.02176.x; Woodcock SH, 2011, ECOL FRESHW FISH, V20, P157, DOI 10.1111/j.1600-0633.2010.00475.x; Woodcock SH, 2011, N AM J FISH MANAGE, V31, P843, DOI 10.1080/02755947.2011.623760	38	11	11	2	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2015	10	3							e0118594	10.1371/journal.pone.0118594	http://dx.doi.org/10.1371/journal.pone.0118594			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9JM	25738955	Green Accepted, Green Published, gold			2022-12-27	WOS:000350685900052
J	Zhou, MJ; Daubresse, M; Stafford, RS; Alexander, GC				Zhou, Meijia; Daubresse, Matthew; Stafford, Randall S.; Alexander, G. Caleb			National Trends in the Ambulatory Treatment of Hypertension in the United States, 1997-2012	PLOS ONE			English	Article							ANTIHYPERTENSIVE MEDICATION USE; PLACEBO-LIKE TOLERABILITY; BLOOD-PRESSURE CONTROL; ORAL RENIN INHIBITOR; CLINICAL-PRACTICE; REAL-LIFE; ALISKIREN; MANAGEMENT; ADULTS; EFFICACY	Importance Hypertension is common and costly. Over the past decade, new antihypertensive therapies have been developed, several have lost patent protection and additional evidence regarding the safety and effectiveness of these agents has accrued. Objective To examine trends in the use of antihypertensive therapies in the United States between 1997 and 2012. Design, Setting and Participants We used nationally representative audit data from the IMS Health National Disease and Therapeutic Index to examine the ambulatory pharmacologic treatment of hypertension. Outcome Measures Our primary unit of analysis was a visit where hypertension was a reported diagnosis and treated with a pharmacotherapy (treatment visit). We restricted analyses to the use of six therapeutic classes of antihypertensive medications among individuals 18 years or older. Results Annual hypertension treatment visits increased from 56.9 million treatment visits (95% confidence intervals [CI], 53.9-59.8) in 1997 to 83.3 million visits (CI 79.2-87.3) in 2008, then declined steadily to 70.9 million visits (CI 66.7-75.0) by 2012. Angiotensin receptor blocker utilization increased substantially from 3% of treatment visits in 1997 to 18% by 2012, whereas calcium channel blocker use decreased from 27% to 18% of visits. Rates of diuretic and beta-blocker use remained stable and represented 24%-30% and 14-16% of visits, respectively. Use of direct renin inhibitor accounted for fewer than 2% of annual visits. The proportion of visits treated using fixed-dose combination therapies increased from 28% to 37% of visits. Conclusions Several important changes have occurred in the landscape of antihypertensive treatment in the United States during the past decade. Despite their novel mechanism of action, the adoption rate of direct renin inhibitors remains low.	[Zhou, Meijia; Daubresse, Matthew; Alexander, G. Caleb] Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD 21205 USA; [Zhou, Meijia; Daubresse, Matthew; Alexander, G. Caleb] Johns Hopkins Bloomberg Sch Publ Hlth, Ctr Drug Safety & Effectiveness, Baltimore, MD USA; [Stafford, Randall S.] Stanford Univ, Sch Med, Stanford Prevent Res Ctr, Program Prevent Outcomes & Practices, Stanford, CA 94305 USA; [Alexander, G. Caleb] Johns Hopkins Med, Div Gen Internal Med, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Stanford University; Johns Hopkins University; Johns Hopkins Medicine	Alexander, GC (corresponding author), Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD 21205 USA.	galexand@jhsph.edu	Stafford, Randall/F-3974-2017	Stafford, Randall/0000-0003-1805-1271	Agency for Healthcare Research and Quality [RO1 HS0189960]	Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)	Dr. Alexander is supported by the Agency for Healthcare Research and Quality (RO1 HS0189960). The funding sources had no role in the design and conduct of the study, analysis, or interpretation of the data; and preparation or final approval of the manuscript prior to publication.	Cabana MD, 1999, JAMA-J AM MED ASSOC, V282, P1458, DOI 10.1001/jama.282.15.1458; Chauhan D, 2008, J CLIN PHARM THER, V33, P339, DOI 10.1111/j.1365-2710.2008.00925.x; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Fung V, 2007, CLIN THER, V29, P972, DOI 10.1016/j.clinthera.2007.05.010; Go AS, 2014, CIRCULATION, V129, pE28, DOI 10.1161/01.cir.0000441139.02102.80; Gradman AH, 2005, CIRCULATION, V111, P1012, DOI 10.1161/01.CIR.0000156466.02908.ED; Grimm RH, 2011, J CLIN HYPERTENS, V13, P654, DOI 10.1111/j.1751-7176.2011.00510.x; Gu QP, 2012, CIRCULATION, V126, P2105, DOI 10.1161/CIRCULATIONAHA.112.096156; Gu QP, 2006, CIRCULATION, V113, P213, DOI 10.1161/CIRCULATIONAHA.105.542290; Gupta H, 2010, J PHARM BIOALLIED SC, V2, P2, DOI 10.4103/0975-7406.62694; Heidenreich PA, 2011, CIRCULATION, V123, P933, DOI 10.1161/CIR.0b013e31820a55f5; Higashi A, 2011, J GEN INTERN MED, V26, P1465, DOI 10.1007/s11606-011-1796-4; Hoyert DL, 2011, NATL VITAL STAT REP, V61, P1; James PA, 2014, JAMA-J AM MED ASSOC, V311, P507, DOI 10.1001/jama.2013.284427; Kushiro T, 2006, HYPERTENS RES, V29, P997, DOI 10.1291/hypres.29.997; Ma J, 2006, HYPERTENSION, V48, P846, DOI 10.1161/01.HYP.0000240931.90917.0c; Parving HH, 2012, NEW ENGL J MED, V367, P2204, DOI 10.1056/NEJMoa1208799; Psaty BM, 2002, ARCH INTERN MED, V162, P2325, DOI 10.1001/archinte.162.20.2325; Rabbani A, 2008, AM J HYPERTENS, V21, P509, DOI 10.1038/ajh.2008.31; Sica DA, 2002, DRUGS, V62, P443, DOI 10.2165/00003495-200262030-00003; Sosner P, 2013, J HYPERTENS, V31, P1491, DOI 10.1097/HJH.0b013e328360f716; Stafford RS, 2003, J AM COLL CARDIOL, V41, P56, DOI 10.1016/S0735-1097(02)02670-0; Stanton A, 2003, HYPERTENSION, V42, P1137, DOI 10.1161/01.HYP.0000101688.17370.87; Tocci G, 2012, HIGH BLOOD PRESS CAR, V19, P73, DOI 10.2165/11632170-000000000-00000; Verpooten GA, 2011, INT J CLIN PRACT, V65, P54, DOI 10.1111/j.1742-1241.2010.02562.x; Volpe M, 2012, J HYPERTENS, V30, P194, DOI 10.1097/HJH.0b013e32834e1c66; Zell ER, P SURV RES METH SECT	27	14	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2015	10	3							e0119292	10.1371/journal.pone.0119292	http://dx.doi.org/10.1371/journal.pone.0119292			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9JM	25738503	gold, Green Published, Green Submitted			2022-12-27	WOS:000350685900101
J	Leifeld, J; Meyer, S; Budge, K; Sebastia, MT; Zimmermann, M; Fuhrer, J				Leifeld, Jens; Meyer, Stefanie; Budge, Karen; Sebastia, Maria Teresa; Zimmermann, Michael; Fuhrer, Juerg			Turnover of Grassland Roots in Mountain Ecosystems Revealed by Their Radiocarbon Signature: Role of Temperature and Management	PLOS ONE			English	Article							BELOW-GROUND BIOMASS; ORGANIC-MATTER; CARBON; SOIL; PRODUCTIVITY; DYNAMICS; PATTERNS; AGE; TERRESTRIAL; LONGEVITY	Root turnover is an important carbon flux component in grassland ecosystems because it replenishes substantial parts of carbon lost from soil via heterotrophic respiration and leaching. Among the various methods to estimate root turnover, the root's radiocarbon signature has rarely been applied to grassland soils previously, although the value of this approach is known from studies in forest soils. In this paper, we utilize the root's radiocarbon signatures, at 25 plots, in mountain grasslands of the montane to alpine zone of Europe. We place the results in context of a global data base on root turnover and discuss driving factors. Root turnover rates were similar to those of a subsample of the global data, comprising a similar temperature range, but measured with different approaches, indicating that the radiocarbon method gives reliable, plausible and comparable results. Root turnover rates (0.06-1.0 y(-1)) scaled significantly and exponentially with mean annual temperatures. Root turnover rates indicated no trend with soil depth. The temperature sensitivity was significantly higher in mountain grassland, compared to the global data set, suggesting additional factors influencing root turnover. Information on management intensity from the 25 plots reveals that root turnover may be accelerated under intensive and moderate management compared to low intensity or semi-natural conditions. Because management intensity, in the studied ecosystems, co-varied with temperature, estimates on root turnover, based on mean annual temperature alone, may be biased. A greater recognition of management as a driver for root dynamics is warranted when effects of climatic change on belowground carbon dynamics are studied in mountain grasslands.	[Leifeld, Jens; Fuhrer, Juerg] Climate Air Pollut Grp, Agroscope, Zurich, Switzerland; [Meyer, Stefanie] Univ Jena, Inst Geog, Jena, Germany; [Sebastia, Maria Teresa] Forest Sci Ctr Catalonia, Lleida, Spain; [Sebastia, Maria Teresa] Univ Lleida, Dept HBJ, ETSEA, Lleida, Spain; [Zimmermann, Michael] Univ Nat Resources & Life Sci Vienna, Dept Forest & Soil Sci, Vienna, Austria	Swiss Federal Research Station Agroscope; Friedrich Schiller University of Jena; Centre Tecnologic Forestal de Catalunya (CTFC); Universitat de Lleida; University of Natural Resources & Life Sciences, Vienna	Leifeld, J (corresponding author), Climate Air Pollut Grp, Agroscope, Zurich, Switzerland.	jens.leifeld@agroscope.admin.ch	Zimmermann, Michael/F-7547-2010; Leifeld, Jens/GYR-0349-2022; Leifeld, Jens/A-3298-2014; Sebastia, M. Teresa/B-5479-2013	Zimmermann, Michael/0000-0002-5162-2008; Leifeld, Jens/0000-0002-7245-9852; Leifeld, Jens/0000-0002-7245-9852; Sebastia, M. Teresa/0000-0002-9017-3575	Swiss National Science Foundation [200021-115891]; Swiss State Secretariat for Education and Research [C07.0031]; Spanish Ministry of Science and Innovation, (project CAPAS) [CGL2010-22378-C03-01]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Swiss State Secretariat for Education and Research; Spanish Ministry of Science and Innovation, (project CAPAS)(Ministry of Science and Innovation, Spain (MICINN))	KB received support from the Swiss National Science Foundation, project 200021-115891 (www.snf.ch). SM received support from the Swiss State Secretariat for Education and Research, project C07.0031 (www.sbfi.admin.ch). MTS received support from the Spanish Ministry of Science and Innovation, (project CAPAS, CGL2010-22378-C03-01) (www.idi.mineco.gob.es). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bolinder MA, 2007, AGR ECOSYST ENVIRON, V118, P29, DOI 10.1016/j.agee.2006.05.013; Budge K, 2011, BIOGEOSCIENCES, V8, P1911, DOI 10.5194/bg-8-1911-2011; Budge K, 2011, THESIS U ZURICH; Crawford MC, 1998, ADV SOIL S, P381; Crow SE, 2009, GLOBAL CHANGE BIOL, V15, P2003, DOI 10.1111/j.1365-2486.2009.01850.x; Dietl W., 1986, SCHWEIZERISCHE LANDW, V64, P241; European Commission, AGR ENV; Fitter AH, 1998, OECOLOGIA, V114, P20, DOI 10.1007/s004420050415; Garcia-Pausas J, 2011, PLANT SOIL, V340, P315, DOI 10.1007/s11104-010-0601-1; Gaudinski JB, 2001, OECOLOGIA, V129, P420, DOI 10.1007/s004420100746; Gaul D, 2009, FUNCT PLANT BIOL, V36, P11, DOI 10.1071/FP08195; Gill RA, 2000, NEW PHYTOL, V147, P13, DOI 10.1046/j.1469-8137.2000.00681.x; Gill RA, 2002, GLOBAL ECOL BIOGEOGR, V11, P79, DOI 10.1046/j.1466-822X.2001.00267.x; HARKNESS DD, 1986, RADIOCARBON, V28, P328, DOI 10.1017/S0033822200007426; Klumpp K, 2009, J ECOL, V97, P876, DOI 10.1111/j.1365-2745.2009.01549.x; Kucharik CJ, 2006, GLOBAL CHANGE BIOL, V12, P122, DOI 10.1111/j.1365-2486.2005.01053.x; Leifeld J, 2013, BIOGEOCHEMISTRY, V112, P59, DOI 10.1007/s10533-011-9689-5; Leifeld J, 2009, GLOBAL CHANGE BIOL, V15, P668, DOI 10.1111/j.1365-2486.2008.01782.x; Levin I, 2004, RADIOCARBON, V46, P1261, DOI 10.1017/S0033822200033130; Levin I, 2013, TELLUS B, V65, DOI 10.3402/tellusb.v65i0.20092; Luo YQ, 2003, GLOBAL CHANGE BIOL, V9, P1118, DOI 10.1046/j.1365-2486.2003.00642.x; Meyer S, 2012, BIOGEOSCIENCES, V9, P853, DOI 10.5194/bg-9-853-2012; Meyer S, 2012, THESIS U ZURICH; Milchunas DG, 2009, ECOSYSTEMS, V12, P1381, DOI 10.1007/s10021-009-9295-8; Pfimlin A, 2003, GRASSLAND SCI EUROPE, V8, P1; Pucheta E, 2004, AUSTRAL ECOL, V29, P201, DOI 10.1111/j.1442-9993.2004.01337.x; Rasse DP, 2005, PLANT SOIL, V269, P341, DOI 10.1007/s11104-004-0907-y; Riedo M, 1998, ECOL MODEL, V105, P141, DOI 10.1016/S0304-3800(97)00110-5; Scott JT, 2012, NEW ZEAL J AGR RES, V55, P147, DOI 10.1080/00288233.2012.662896; Solly E, 2013, BIOGEOSCIENCES, V10, P4833, DOI 10.5194/bg-10-4833-2013; Soussana JF, 2012, ECOL MODEL, V231, P134, DOI 10.1016/j.ecolmodel.2012.02.002; Stuiver M, 1998, RADIOCARBON, V40, P1127, DOI 10.1017/S0033822200019172; STUIVER M, 1977, RADIOCARBON, V19, P355, DOI 10.1017/S0033822200003672; Synal HA, 2007, NUCL INSTRUM METH B, V259, P7, DOI 10.1016/j.nimb.2007.01.138; Trumbore S, 2006, GLOBAL CHANGE BIOL, V12, P217, DOI 10.1111/j.1365-2486.2005.001063.x; von Haden AC, 2014, AGR ECOSYST ENVIRON, V185, P188, DOI 10.1016/j.agee.2013.12.027	36	24	25	1	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2015	10	3							e0119184	10.1371/journal.pone.0119184	http://dx.doi.org/10.1371/journal.pone.0119184			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4HV	25734640	Green Published, gold, Green Submitted			2022-12-27	WOS:000350314700057
J	Lemmens, RJM; Janssen-Potten, YJM; Timmermans, AAA; Smeets, RJEM; Seelen, HAM				Lemmens, Ryanne J. M.; Janssen-Potten, Yvonne J. M.; Timmermans, Annick A. A.; Smeets, Rob J. E. M.; Seelen, Henk A. M.			Recognizing Complex Upper Extremity Activities Using Body Worn Sensors	PLOS ONE			English	Article							PHYSICAL-ACTIVITY; WEARABLE SENSORS; STROKE; ARM; CLASSIFICATION; CHILDREN; LIFE	To evaluate arm-hand therapies for neurological patients it is important to be able to assess actual arm-hand performance objectively. Because instruments that measure the actual quality and quantity of specific activities in daily life are lacking, a new measure needs to be developed. The aims of this study are to a) elucidate the techniques used to identify upper extremity activities, b) provide a proof-of-principle of this method using a set of activities tested in a healthy adult and in a stroke patient, and c) provide an example of the method's applicability in daily life based on readings taken from a healthy adult. Multiple devices, each of which contains a tri-axial accelerometer, a tri-axial gyroscope and a tri-axial magnetometer were attached to the dominant hand, wrist, upper arm and chest of 30 healthy participants and one stroke patient, who all performed the tasks 'drinking', 'eating' and 'brushing hair' in a standardized environment. To establish proof-of-principle, a prolonged daily life recording of 1 participant was used to identify the task 'drinking'. The activities were identified using multi-array signal feature extraction and pattern recognition algorithms and 2D-convolution. The activities 'drinking', 'eating' and 'brushing hair' were unambiguously recognized in a sequence of recordings of multiple standardized daily activities in a healthy participant and in a stroke patient. It was also possible to identify a specific activity in a daily life recording. The long term aim is to use this method to a) identify arm-hand activities that someone performs during daily life, b) determine the quantity of activity execution, i.e. amount of use, and c) determine the quality of arm-hand skill performance.	[Lemmens, Ryanne J. M.; Janssen-Potten, Yvonne J. M.; Smeets, Rob J. E. M.; Seelen, Henk A. M.] Maastricht Univ, Res Sch CAPHRI, Dept Rehabil Med, NL-6200 MD Maastricht, Netherlands; [Lemmens, Ryanne J. M.; Janssen-Potten, Yvonne J. M.; Smeets, Rob J. E. M.; Seelen, Henk A. M.] Adelante, Ctr Expertise Rehabil & Audiol, Hoensbroek, Netherlands; [Timmermans, Annick A. A.] Hasselt Univ, BIOMED Biomed Res Inst, Diepenbeek, Belgium; [Smeets, Rob J. E. M.] Maastricht Univ, Med Ctr, Dept Rehabil Med, NL-6200 MD Maastricht, Netherlands	Maastricht University; Hasselt University; Maastricht University	Lemmens, RJM (corresponding author), Maastricht Univ, Res Sch CAPHRI, Dept Rehabil Med, NL-6200 MD Maastricht, Netherlands.	r.lemmens@adelante-zorggroep.nl	Smeets, Rob JEM/D-1522-2011	Smeets, Rob JEM/0000-0002-9503-366X; Timmermans, Annick/0000-0002-5461-947X	Adelante; Centre of Expertise in Rehabilitation and Audiology; Hoensbroek; Netherlands	Adelante; Centre of Expertise in Rehabilitation and Audiology; Hoensbroek; Netherlands(Netherlands Government)	This paper was funded by Adelante, Centre of Expertise in Rehabilitation and Audiology, Hoensbroek, the Netherlands. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arner M, 2008, J HAND SURG-AM, V33A, P1337, DOI 10.1016/j.jhsa.2008.02.032; Bai J, 2011, ELECTRON J STAT, V6, P559; Broeks JG, 1999, DISABIL REHABIL, V21, P357; CHEN JJJ, 1992, IEEE T BIO-MED ENG, V39, P9, DOI 10.1109/10.108122; Ermes M, 2008, IEEE T INF TECHNOL B, V12, P20, DOI 10.1109/TITB.2007.899496; Gebruers N, 2010, ARCH PHYS MED REHAB, V91, P288, DOI 10.1016/j.apmr.2009.10.025; Gyllensten IC, 2011, IEEE T BIO-MED ENG, V58, P2656, DOI 10.1109/TBME.2011.2160723; Jain AK, 2000, IEEE T PATTERN ANAL, V22, P4, DOI 10.1109/34.824819; Janssen L, 2011, RES DEV DISABIL, V32, P963, DOI 10.1016/j.ridd.2011.02.002; Lemmens RJM, PLOS ONE IN PRESS; Lemmens RJM, 2014, BMC NEUROLOGY, P14; Lemmens RJM, 2012, BMC NEUROL, V12, DOI 10.1186/1471-2377-12-21; Leutheuser H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075196; Lyden K, 2014, MED SCI SPORT EXER, V46, P386, DOI 10.1249/MSS.0b013e3182a42a2d; Magill RA, 2007, MOTOR LEARNING CONTR, P2; Min CH, 2008, IEEE ENG MED BIO, P5192, DOI 10.1109/IEMBS.2008.4650384; Nichols-Larsen DS, 2005, STROKE, V36, P1480, DOI 10.1161/01.STR.0000170706.13595.4f; Patel S, 2012, J NEUROENG REHABIL, V9, DOI 10.1186/1743-0003-9-21; Preece SJ, 2009, PHYSIOL MEAS, V30, pR1, DOI 10.1088/0967-3334/30/4/R01; Sokal B, 2013, ARCH PHYS MED REHABI; Strohrmann C, 2013, J NEUROENG REHABIL, V10, DOI 10.1186/1743-0003-10-83; Timmermans Annick A. A., 2009, 2009 IEEE International Conference on Rehabilitation Robotics: Reaching Users & the Community (ICORR), P98, DOI 10.1109/ICORR.2009.5209558; Timmermans AAA, 2009, DISABIL REHABIL, V31, P1344, DOI 10.1080/09638280902823664; Uswatte G, 2009, REHABIL PSYCHOL, V54, P398, DOI 10.1037/a0017501; VANSANT AF, 1988, PHYS THER, V68, P1330, DOI 10.1093/ptj/68.9.1330; Wagner JF, 2006, COGNITION INSTRUCT, V24, P1, DOI 10.1207/s1532690xci2401_1; Wolfe CDA, 2000, BRIT MED BULL, V56, P275, DOI 10.1258/0007142001903120	27	25	27	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2015	10	3							e0118642	10.1371/journal.pone.0118642	http://dx.doi.org/10.1371/journal.pone.0118642			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4HV	25734641	Green Submitted, Green Published, gold			2022-12-27	WOS:000350314700043
J	Levine, SL; Tan, JG; Mueller, GM; Bachman, PM; Jensen, PD; Uffman, JP				Levine, Steven L.; Tan, Jianguo; Mueller, Geoffrey M.; Bachman, Pamela M.; Jensen, Peter D.; Uffman, Joshua P.			Independent Action between DvSnf7 RNA and Cry3Bb1 Protein in Southern Corn Rootworm, Diabrotica undecimpunctata howardi and Colorado Potato Beetle, Leptinotarsa decemlineata	PLOS ONE			English	Article							INSECTICIDAL ACTIVITY; BT-MAIZE; TOXICITY; HYBRIDS; POTENTIATION; COLEOPTERA; CRY1A.105; SYNERGISM; EFFICACY; CRY2AB2	In recent years, corn rootworm (CRW)-resistant maize events producing two or more CRW-active Bt proteins have been commercialized to enhance efficacy against the target pest(s) by providing multiple modes of action (MoA). The maize hybrid MON 87411 has been developed that produces the CRW-active Cry3Bb1 Bt protein (hereafter Cry3Bb1) and expresses a RNAi-mediated MoA that also targets CRW. As part of an environmental risk assessment for MON 87411, the potential for an interaction between the CRW-active DvSnf7 RNA (hereafter DvSnf7) and Cry3Bb1 was assessed in 12-day diet incorporation bioassays with the southern corn rootworm (SCR, Diabrotica undecimpunctata howardi). The potential for an interaction between DvSnf7 and Cry3Bb1 was evaluated with two established experimental approaches. The first approach evaluated each substance alone and in combination over three different response levels. For all three response levels, observed responses were shown to be additive and not significantly different from predicted responses under the assumption of independent action. The second approach evaluated the potential for a fixed sub-lethal concentration of Cry3Bb1 to decrease the median lethal concentration (LC50) of DvSnf7 and vice-versa. With this approach, the LC50 value of DvSnf7 was not altered by a sub-lethal concentration of Cry3Bb1 and vice-versa. In addition, the potential for an interaction between the Cry3Bb1 and DvSnf7 was tested with Colorado potato beetle (CPB, Leptinotarsa decemlineata), which is sensitive to Cry3Bb1 but not DvSnf7. CPB assays also demonstrated that DvSnf7 does not alter the activity of Cry3Bb1. The results from this study provide multiple lines of evidence that DvSnf7 and Cry3Bb1 produced in MON 87411 have independent action.	[Levine, Steven L.; Tan, Jianguo; Mueller, Geoffrey M.; Bachman, Pamela M.; Jensen, Peter D.; Uffman, Joshua P.] Monsanto Co, Regulatory Sci, St Louis, MO 63167 USA	Monsanto	Levine, SL (corresponding author), Monsanto Co, Regulatory Sci, St Louis, MO 63167 USA.	steven.l.levine@monsanto.com; jianguo.tan@monsanto.com			Monsanto Company	Monsanto Company	Monsanto Company funded this study. The funder provided support in the form of salaries for all authors, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Andersson HC, 2010, EFSA J, V8, DOI 10.2903/j.efsa.2010.1879; [Anonymous], 2009, FIFRA SCI ADV PAN M; [Anonymous], 2003, US EPA NEW CORN PEST; Bachman PM, 2013, TRANSGENIC RES, V22, P1207, DOI 10.1007/s11248-013-9716-5; Baum JA, 2007, NAT BIOTECHNOL, V25, P1322, DOI 10.1038/nbt1359; Belden JB, 2006, ENVIRON TOXICOL CHEM, V25, P623, DOI 10.1897/05-370R.1; BERENBAUM MC, 1989, PHARMACOL REV, V41, P93; Bliss CI, 1939, ANN APPL BIOL, V26, P585, DOI 10.1111/j.1744-7348.1939.tb06990.x; Bolognesi R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047534; Bravo A, 2007, TOXICON, V49, P423, DOI 10.1016/j.toxicon.2006.11.022; Bravo A, 2011, INSECT BIOCHEM MOLEC, V41, P423, DOI 10.1016/j.ibmb.2011.02.006; Center for Environmental Risk Assessment ( CERA), 2013, GM CROP DAT; DELECLUSE A, 1988, MOL GEN GENET, V214, P42, DOI 10.1007/BF00340177; Desneux N, 2007, ANNU REV ENTOMOL, V52, P81, DOI 10.1146/annurev.ento.52.110405.091440; Devos Y, 2013, TRANSGENIC RES, V22, P269, DOI 10.1007/s11248-012-9657-4; Devos Y, 2012, TRANSGENIC RES, V21, P1, DOI 10.1007/s11248-011-9515-9; DONOVAN WP, 1992, APPL ENVIRON MICROB, V58, P3921, DOI 10.1128/AEM.58.12.3921-3927.1992; Fabrick J, 2009, J BIOL CHEM, V284, P18401, DOI 10.1074/jbc.M109.001651; Faust M, 2000, J ENVIRON QUAL, V29, P1063, DOI 10.2134/jeq2000.00472425002900040005x; Faust M, 2003, AQUAT TOXICOL, V63, P43, DOI 10.1016/S0166-445X(02)00133-9; Finney DJ, 1942, ANN APPL BIOL, V29, P82, DOI 10.1111/j.1744-7348.1942.tb06923.x; Head G, 2014, CROP PROT, V57, P38, DOI 10.1016/j.cropro.2013.11.025; Koci J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0083985; Kodell Ralph L., 1991, STAT TOXICOLOGY, P559; Konemann WH, 1996, FOOD CHEM TOXICOL, V34, P1025, DOI 10.1016/S0278-6915(97)00070-7; MACINTOSH SC, 1990, J AGR FOOD CHEM, V38, P1145, DOI 10.1021/jf00094a051; Marra M. C., 2012, AgBioForum, V15, P217; MARRONE PG, 1985, J ECON ENTOMOL, V78, P290, DOI 10.1093/jee/78.1.290; Meissle M, 2009, ENTOMOL EXP APPL, V131, P308, DOI 10.1111/j.1570-7458.2009.00859.x; OECD, 2007, ORGAN EC COOPERATION, P1, DOI DOI 10.1787/16812328; Pardo-Lopez L, 2013, FEMS MICROBIOL REV, V37, P3, DOI 10.1111/j.1574-6976.2012.00341.x; Poch G, 1995, CAN J PHYSIOL PHARM, V73, P1574; Ramaseshadri P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054270; Rule DM, 2014, J ECON ENTOMOL, V107, P403, DOI 10.1603/EC12448; Siebert MW, 2012, J ECON ENTOMOL, V105, P1825, DOI 10.1603/EC12155; Soberon M, 2009, CELL MOL LIFE SCI, V66, P1, DOI [10.1007/s00018-008-8483-6, DOI 10.1007/S00018-008-8483-6]; TABASHNIK BE, 1992, APPL ENVIRON MICROB, V58, P3343, DOI 10.1128/AEM.58.10.3343-3346.1992; Vaughn T, 2005, CROP SCI, V45, P931, DOI 10.2135/cropsci2004.0304; WU D, 1985, FEBS LETT, V190, P232, DOI 10.1016/0014-5793(85)81290-4; YU YM, 1987, J GEN APPL MICROBIOL, V33, P459, DOI 10.2323/jgam.33.459; Zhang XB, 2006, P NATL ACAD SCI USA, V103, P9897, DOI 10.1073/pnas.0604017103	41	33	36	2	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2015	10	3							e0118622	10.1371/journal.pone.0118622	http://dx.doi.org/10.1371/journal.pone.0118622			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4HV	25734482	Green Published, gold, Green Submitted			2022-12-27	WOS:000350314700041
J	Walter, BA; Likhitpanichkul, M; Illien-Junger, S; Roughley, PJ; Hecht, AC; Iatridis, JC				Walter, Benjamin A.; Likhitpanichkul, Morakot; Illien-Junger, Svenja; Roughley, Peter J.; Hecht, Andrew C.; Iatridis, James C.			TNF alpha Transport Induced by Dynamic Loading Alters Biomechanics of Intact Intervertebral Discs	PLOS ONE			English	Article							EARLY DEGENERATIVE CHANGES; NECROSIS-FACTOR-ALPHA; ORGAN-CULTURE SYSTEM; FACET JOINT INJURY; GENE-EXPRESSION; AGGRECAN DEGRADATION; SPINAL-CORD; MODEL; COMPRESSION; CATABOLISM	Objective Intervertebral disc (IVD) degeneration is an important contributor to the development of back pain, and a key factor relating pain and degeneration are the presence of pro-inflammatory cytokines and IVD motion. There is surprisingly limited understanding of how mechanics and inflammation interact in the IVD. This study investigated interactions between mechanical loading and pro-inflammatory cytokines in a large animal organ culture model to address fundamental questions regarding (i.) how inflammatory mediators arise within the IVD, (ii.) how long inflammatory mediators persist, and (iii.) how inflammatory mediators influence IVD biomechanics. Methods Bovine caudal IVDs were cultured for 6 or 20-days under static & amp; dynamic loading with or without exogenous TNF alpha in the culture medium, simulating a consequence of inflammation of the surrounding spinal tissues. TNF alpha transport within the IVD was assessed via immunohistochemistry. Changes in IVD structural integrity (dimensions, histology & amp; aggrecan degradation), biomechanical behavior (Creep, Recovery & amp; Dynamic stiffness) and pro-inflammatory cytokines in the culture medium (ELISA) were assessed. Results TNF alpha was able to penetrate intact IVDs when subjected to dynamic loading but not static loading. Once transported within the IVD, pro-inflammatory mediators persisted for 4-8 days after TNF alpha removal. TNF alpha exposure induced changes in IVD biomechanics (reduced diurnal displacements & amp; increased dynamic stiffness). Discussion This study demonstrated that exposure to TNF alpha, as might occur from injured surrounding tissues, can penetrate healthy intact IVDs, induce expression of additional pro-inflammatory cytokines and alter IVD mechanical behavior. We conclude that exposure to pro-inflammatory cytokine may be an initiating event in the progression of IVD degeneration in addition to being a consequence of disease.				james.iatridis@mssm.edu	Walter, Ben A/E-9220-2015; Illien-Junger, Svenja/B-9105-2018; Illien-Junger, Svenja/AAV-1853-2020	Illien-Junger, Svenja/0000-0001-9895-0693; Illien-Junger, Svenja/0000-0001-9895-0693; Iatridis, James/0000-0002-2186-0590	National Institute of Arthritis and Musculoskeletal and Skin Diseases of the National Institutes of Health [R01AR057397, R01AR064157]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR064157, R01AR057397] Funding Source: NIH RePORTER	National Institute of Arthritis and Musculoskeletal and Skin Diseases of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	Research reported in this publication was supported by the National Institute of Arthritis and Musculoskeletal and Skin Diseases of the National Institutes of Health under Award Number R01AR057397 and R01AR064157. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams MA, 2006, SPINE, V31, P2151, DOI 10.1097/01.brs.0000231761.73859.2c; Adams MA, 2012, J ANAT, V221, P497, DOI 10.1111/j.1469-7580.2012.01551.x; Albert HB, 2011, EUR SPINE J, V20, P1355, DOI 10.1007/s00586-011-1794-6; Albro MB, 2010, J BIOMECH, V43, P2267, DOI 10.1016/j.jbiomech.2010.04.041; Alipui DO, 2014, T ORS P 2014; Bachmeier BE, 2007, ANN NY ACAD SCI, V1096, P44, DOI 10.1196/annals.1397.069; Chan SCW, 2011, EUR SPINE J, V20, P1796, DOI 10.1007/s00586-011-1827-1; Cortes DH, 2014, J BIOMECHANICS; Demers CN, 2004, SPINE, V29, P2793, DOI 10.1097/01.brs.0000147744.74215.b0; Ferguson SJ, 2004, J BIOMECH, V37, P213, DOI 10.1016/S0021-9290(03)00250-1; Gantenbein B, 2006, SPINE, V31, P2665, DOI 10.1097/01.brs.0000244620.15386.df; Hiyama A, 2013, ARTHRITIS RES THER, V15, DOI 10.1186/ar4379; Hiyama A, 2010, ARTHRITIS RHEUM-US, V62, P3036, DOI 10.1002/art.27599; Hoyland JA, 2008, RHEUMATOLOGY, V47, P809, DOI 10.1093/rheumatology/ken056; Huang CY, 2008, J BIOMECH, V41, P1184, DOI 10.1016/j.jbiomech.2008.02.002; Korecki CL, 2008, SPINE, V33, P1403, DOI 10.1097/BRS.0b013e318175cae7; Kras JV, 2014, SPINE, V39, P207, DOI 10.1097/BRS.0000000000000107; Kras JV, 2013, J NEUROSCI RES, V91, P1312, DOI 10.1002/jnr.23254; Kras JV, 2013, SPINE, V38, P217, DOI 10.1097/BRS.0b013e3182685ba1; LAI WM, 1991, J BIOMECH ENG-T ASME, V113, P245, DOI 10.1115/1.2894880; Laudier D, 2007, J ORTHOP RES, V25, P390, DOI 10.1002/jor.20304; Le Maitre CL, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2275; MacLean JJ, 2003, SPINE, V28, P973, DOI 10.1097/00007632-200305150-00004; Markova DZ, 2013, ARTHRITIS RES THER, V15, DOI 10.1186/ar4301; Millward-Sadler SJ, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2693; OSHIMA H, 1993, J ORTHOP RES, V11, P332, DOI 10.1002/jor.1100110304; Ponnappan RK, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3494; Purmessur D, 2013, BIOCHEM BIOPH RES CO, V433, P151, DOI 10.1016/j.bbrc.2013.02.034; Risbud MV, 2014, NAT REV RHEUMATOL, V10, P44, DOI 10.1038/nrrheum.2013.160; Seguin CA, 2005, SPINE, V30, P1940, DOI 10.1097/01.brs.0000176188.40263.f9; Seguin CA, 2006, MATRIX BIOL, V25, P409, DOI 10.1016/j.matbio.2006.07.002; Stevens AL, 2009, MOL CELL PROTEOMICS, V8, P1475, DOI 10.1074/mcp.M800181-MCP200; Stokes IAF, 2004, SPINE, V29, P2724, DOI 10.1097/01.brs.0000146049.52152.da; Sztrolovics R, 1997, BIOCHEM J, V326, P235, DOI 10.1042/bj3260235; Ulrich JA, 2007, SPINE, V32, P2812, DOI 10.1097/BRS.0b013e31815b9850; Walter BA, 2011, OSTEOARTHR CARTILAGE, V19, P1011, DOI 10.1016/j.joca.2011.04.005; Walter BA, 2014, J BIOMECHANICS; Wang JR, 2011, J BIOL CHEM, V286, P39738, DOI 10.1074/jbc.M111.264549; Wang XM, 2009, PAIN, V142, P275, DOI 10.1016/j.pain.2009.02.001; Weiler C, 2005, SPINE, V30, P44, DOI 10.1097/01.brs.0000149186.63457.20; Wuertz K, 2013, GLOB SPINE J, V3, P175, DOI 10.1055/s-0033-1347299; Wuertz K, 2009, BIOCHEM BIOPH RES CO, V379, P824, DOI 10.1016/j.bbrc.2008.12.145	42	22	24	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2015	10	3							e0118358	10.1371/journal.pone.0118358	http://dx.doi.org/10.1371/journal.pone.0118358			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4HV	25734788	Green Published, gold			2022-12-27	WOS:000350314700023
J	Chen, ZG; Zhu, JY; Huang, CY; Lian, F; Wu, GB; Zhao, YN				Chen, Zhigang; Zhu, Jiye; Huang, Chaoyuan; Lian, Fang; Wu, Guobin; Zhao, Yinnong			The Association between Three Cyclooxygenase-2 Polymorphisms and Hepatocellular Carcinoma Risk: A Meta-Analysis	PLOS ONE			English	Article							SINGLE-NUCLEOTIDE POLYMORPHISMS; PROMOTER POLYMORPHISM; FUNCTIONAL POLYMORPHISMS; GENETIC-VARIANTS; COX-2 GENE; CANCER; GROWTH; -765-G-GREATER-THAN-C; PTGS2	Background A quantity of case-control studies have been performed to address the association between three cyclooxygenase-2(COX-2) polymorphisms (-1195G/A, -765G/C and + 8473T/C) and the risk of hepatocellular carcinoma (HCC). However, previous research results are inconsistent. We conducted this meta-analysis to clarify the correlation between these COX-2 polymorphisms and HCC risk. Methods The authors searched in PubMed, EMBASE, Google Scholar, CNKI and WanFang database for relevant articles up to April 28, 2014. The data were extracted by two independent reviewers. Odds ratios (ORs) and 95% confidence intervals were calculated. Results A total of 8 studies consisting of 2182 cases and 3324 controls were included in this meta-analysis. For COX-2 polymorphism -1195G/A, an association with increased risk was observed under the heterogeneous, homozygous, dominant model. However, COX-2 polymorphisms (-765G/C and + 8473T/C) were not related to HCC risk in this study. We also found a similar result in the subgroup analysis of Chinese population that -1195G/A polymorphism, instead of -765G/C or + 8473T/C polymorphism, was correlated with the risk of HCC. Conclusions Polymorphism -1195G/A of COX-2 might be associated with susceptibility to HCC, but no similar correlations were observed between polymorphisms (-765G/C and + 8473T/C) and HCC risk. Further large and well-designed studies are required to validate this association.	[Chen, Zhigang; Zhu, Jiye; Huang, Chaoyuan; Wu, Guobin; Zhao, Yinnong] Guangxi Med Univ, Tumor Hosp, Hepatobiliary Surg Dept, Nanning, Peoples R China; [Lian, Fang] Guangxi Med Univ, Dept Physiol, Nanning, Peoples R China	Guangxi Medical University; Guangxi Medical University	Wu, GB (corresponding author), Guangxi Med Univ, Tumor Hosp, Hepatobiliary Surg Dept, Nanning, Peoples R China.	gb.wu@139.com; mike106210mh@126.com	zhu, ji/HDM-1538-2022; Lian, Fang/X-5381-2018		National Natural Science Foundation of China [81360315/H1603-]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Natural Science Foundation of China (81360315/H1603-) and the funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. URL: http://www.nsfc.gov.cn/	Akkiz H, 2011, MOL CELL BIOCHEM, V347, P201, DOI 10.1007/s11010-010-0629-9; [Anonymous], [No title captured]; [Anonymous], [No title captured]; Aubin F, 2010, J INVEST DERMATOL, V130, P2134, DOI 10.1038/jid.2010.116; Ben Nasr H, 2009, MOL BIOL REP, V36, P193, DOI 10.1007/s11033-007-9166-3; Bu XM, 2013, TUMOR BIOL, V34, P1479, DOI 10.1007/s13277-013-0672-8; Chang WS, 2012, CHINESE J PHYSIOL, V55, P1, DOI 10.4077/CJP.2012.AMM056; Cui W, 2005, CLIN CANCER RES, V11, P8213, DOI 10.1158/1078-0432.CCR-05-1044; Dong J, 2010, J GASTROEN HEPATOL, V25, P1042, DOI 10.1111/j.1440-1746.2010.06293.x; Duval S, 2000, BIOMETRICS, V56, P455, DOI 10.1111/j.0006-341X.2000.00455.x; Fattovich G, 2004, GASTROENTEROLOGY, V127, pS35, DOI 10.1053/j.gastro.2004.09.014; Forner A, 2012, LANCET, V379, P1245, DOI 10.1016/S0140-6736(11)61347-0; Gharib AF, 2014, GENE, V543, P234, DOI 10.1016/j.gene.2014.04.014; He JH, 2012, MOL BIOL REP, V39, P4163, DOI 10.1007/s11033-011-1199-y; Kim WH, 2012, GENE, V504, P92, DOI 10.1016/j.gene.2012.05.014; Langsenlehner U, 2006, CLIN CANCER RES, V12, P1392, DOI 10.1158/1078-0432.CCR-05-2055; Lin JS, 2010, CHIN J GASTROENTEROL, V19, P333; Mohamed FZ, 2014, MOL BIOL REP, V41, P1461, DOI 10.1007/s11033-013-2991-7; Pan F, 2011, ASIAN PAC J CANCER P, V12, P1941; Pazhang Y, 2012, TUMOR BIOL, V33, P207, DOI 10.1007/s13277-011-0263-5; Rouzer CA, 2011, CHEM REV, V111, P5899, DOI 10.1021/cr2002799; Santovito D, 2009, CURR OPIN LIPIDOL, V20, P402, DOI 10.1097/MOL.0b013e32832fa22c; Sitarz R, 2008, MODERN PATHOL, V21, P685, DOI 10.1038/modpathol.2008.36; Song X, 2011, PRACTICAL J CANC, P255; Srivastava K, 2010, J HUM GENET, V55, P495, DOI 10.1038/jhg.2010.54; Upadhyay R, 2009, MUTAT RES-FUND MOL M, V663, P52, DOI 10.1016/j.mrfmmm.2009.01.007; Wang XF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073213; Xie HH, 2009, MOL CARCINOGEN, V48, P56, DOI 10.1002/mc.20455; Yin JB, 2010, ONCOL RES, V19, P131, DOI 10.3727/096504011X12935427587803; Yu MC, 2004, GASTROENTEROLOGY, V127, pS72, DOI 10.1016/j.gastro.2004.09.018; Zhang XM, 2005, GASTROENTEROLOGY, V129, P565, DOI 10.1053/j.gastro.2005.05.003; Zhu W, 2010, MOL BIOL REP, V37, P277, DOI 10.1007/s11033-009-9685-1	32	5	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2015	10	3							e0118251	10.1371/journal.pone.0118251	http://dx.doi.org/10.1371/journal.pone.0118251			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9JF	25730260	gold, Green Published, Green Submitted			2022-12-27	WOS:000350684900021
J	Tripathi, MK; Singh, R; Pati, AK				Tripathi, Manish Kumar; Singh, Ramesh; Pati, Atanu Kumar			Daily and Seasonal Rhythms in Immune Responses of Splenocytes in the Freshwater Snake, Natrix piscator	PLOS ONE			English	Article							MOUSE PERITONEAL-MACROPHAGES; TURTLE MAUREMYS-CASPICA; PHAGOCYTIC-ACTIVITY; PERIPHERAL-BLOOD; BONE-MARROW; CIRCADIAN VARIATIONS; BIOLOGICAL RHYTHM; DIURNAL-VARIATION; CELL; SYSTEM	Present study was designed to examine daily and seasonal variability in the innate immune responses of splenocytes in the fresh water snake, Natrix piscator. Animals were mildly anesthetized and spleen was aseptically isolated and processed for macrophage phagocytosis, NBT reduction, nitrite production, splenocyte proliferation and serum lysozyme activity. Samples were collected at seven time points, viz., 0000, 0400, 0800, 1200, 1600, 2000 and 0000 h during three different seasons, namely summer, winter and spring. Cosinor analysis revealed that percent phagocytosis had a significant 24-h rhythm during summer and spring seasons. The peaks of rhythms in NBT reduction and nitrite release occurred in the morning hours at 10.88 h and 8.31 h, respectively, in winter. A significant 24-h rhythm was also observed in lysozyme concentration and splenocyte proliferation (both Basal and Concanavalin A stimulated) in all three seasons. A significant phase shift in splenocyte proliferation was obtained with a trend of delayed phase shift from winter to spring and from spring to summer. Of the nine variables, significant annual (seasonal) rhythms were detected in almost all variables, excluding phagocytic and splenosomatic indices. All rhythmic variables, except spleen cellularity, exhibited tightly synchronized peaks coinciding with the progressive and recrudescence phases of annual reproductive cycle. It is concluded that the snake synchronizes its daily and seasonal immune activity with the corresponding external time cues. The enhancement of immune function coinciding with one of its crucial reproductive phases might be helping it to cope with the seasonal stressors, including abundance of pathogens, which would otherwise jeopardize the successful reproduction and eventual survival of the species.	[Tripathi, Manish Kumar; Singh, Ramesh] Udai Pratap Autonomous Coll, Dept Zool, Varanasi 221002, Uttar Pradesh, India; [Pati, Atanu Kumar] Pt Ravishankar Shukla Univ, Sch Life Sci, Raipur 492010, Madhya Pradesh, India	Udai Pratap College, Varanasi; Pt. Ravishankar Shukla University	Singh, R (corresponding author), Udai Pratap Autonomous Coll, Dept Zool, Varanasi 221002, Uttar Pradesh, India.	upcrsingh@yahoo.com	Pati, Atanu/AAQ-5611-2020	Pati, Atanu/0000-0002-4618-017X	Department of Science and Technology, New Delhi, Govt. of India [SR/SO/AS-15/2005]	Department of Science and Technology, New Delhi, Govt. of India(Department of Science & Technology (India))	Financial Grant (SR/SO/AS-15/2005) from Department of Science and Technology, New Delhi, Govt. of India to Ramesh Singh.	AARDAL NP, 1983, EXP HEMATOL, V11, P792; ABO T, 1981, J IMMUNOL, V126, P1360; BACIU I, 1988, INT J NEUROSCI, V41, P143, DOI 10.3109/00207458808985750; Berger J, 2004, J APPL BIOMED, V2, P179; Berger J., 2003, COMP CLIN PATHOL, V12, P84, DOI [10.1007/s00580-003-0478-y, DOI 10.1007/S00580-003-0478-Y]; Berridge MV, 2005, BIOTECHNOL ANN REV, V11, P127, DOI 10.1016/S1387-2656(05)11004-7; BONGRAND P, 1988, CHRONOBIOL INT, V5, P81, DOI 10.3109/07420528809078554; Brigagao MRPL, 1998, BIOL RHYTHM RES, V29, P598, DOI 10.1076/brhm.29.5.598.4818; Bureau JP, 1996, PATHOL BIOL, V44, P610; CLARK RH, 1969, SCIENCE, V166, P236, DOI 10.1126/science.166.3902.236; CORY AH, 1991, CANCER COMMUN, V3, P207, DOI 10.3727/095535491820873191; Cove-Smith JR, 1979, CHRONOPHARMACOLOGY, P369; Demers NE, 1997, DEV COMP IMMUNOL, V21, P363, DOI 10.1016/S0145-305X(97)00009-8; DING AH, 1988, J IMMUNOL, V141, P2407; ESKOLA J, 1976, CLIN EXP IMMUNOL, V26, P253; Esteban MA, 2006, J PINEAL RES, V41, P261, DOI 10.1111/j.1600-079X.2006.00362.x; FERNANDES G, 1976, J IMMUNOL, V117, P962; Fernandes G, 1980, RECENT ADV CHRONOBIO, P289; Fernandes G, 1992, BIOL RHYTHMS CLIN LA, P493; Fernandes G, 1977, CHRONOBIOLOGY ALLERG, P233; GIENI RS, 1995, J IMMUNOL METHODS, V187, P85, DOI 10.1016/0022-1759(95)00170-F; HALDAR C, 1989, GEN COMP ENDOCR, V76, P214, DOI 10.1016/0016-6480(89)90152-4; HAUS E, 1983, AM J ANAT, V168, P467, DOI 10.1002/aja.1001680406; Haus E, 1999, CHRONOBIOL INT, V16, P581, DOI 10.3109/07420529908998730; Hayashi M, 2007, BIOL PHARM BULL, V30, P621, DOI 10.1248/bpb.30.621; Hriscu M, 1998, Rom J Physiol, V35, P319; Hriscu M.L., 2004, J APPL BIOMED, V2, P199; Hriscu ML, 2005, ANN NY ACAD SCI, V1057, P403, DOI 10.1196/annals.1356.032; Hriscu Monica, 2002, Rom J Physiol, V39-40, P17; HUSSEIN MF, 1978, DEV COMP IMMUNOL, V2, P297, DOI 10.1016/S0145-305X(78)80072-X; JORENS PG, 1995, MEDIAT INFLAMM, V4, P75, DOI 10.1155/S0962935195000135; Keller JM, 2005, VET IMMUNOL IMMUNOP, V103, P269, DOI 10.1016/j.vetimm.2004.09.029; KNYSZYNSKI A, 1981, J IMMUNOL, V127, P2508; LEE P, 1977, Q J MED, V46, P1; LEVI F, 1992, ADV DRUG DELIVER REV, V9, P85, DOI 10.1016/0169-409X(92)90035-O; LEVI FA, 1985, J IMMUNOL, V134, P217; MAUER AM, 1965, BLOOD-J HEMATOL, V26, P1; MELCHART D, 1992, CHRONOBIOL INT, V9, P35, DOI 10.3109/07420529209064514; Mondal S, 1999, GEN COMP ENDOCR, V116, P291, DOI 10.1006/gcen.1999.7370; Mondal S., 1999, 3 INT S AS OC SOC CO, P482; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Munoz FJ, 2000, VET IMMUNOL IMMUNOP, V77, P27, DOI 10.1016/S0165-2427(00)00228-2; Munoz FJ, 2001, J COMP PHYSIOL B, V171, P195; NELSON W, 1979, CHRONOBIOLOGIA, V6, P305; PATI AK, 1987, CELL IMMUNOL, V108, P227, DOI 10.1016/0008-8749(87)90207-3; Pati AK., 1992, J PARASITOL APPL ANI, V1, P151; Pati AK, 1987, BIOME, V2, P58; Pati AK, 1989, J RAVISHANKAR U B, V2B, P18; Pati AK, 1984, CHRONOBIOLOGY 1982 8, P25; Ralph MR, 2013, CHRONOBIOL INT, V30, P540, DOI 10.3109/07420528.2012.754449; Rodriguez AB, 1999, J PINEAL RES, V26, P35, DOI 10.1111/j.1600-079X.1999.tb00564.x; Roy B, 2008, J ENDOCRINOL, V199, P471, DOI 10.1677/JOE-08-0270; Scheving EL, 1968, AM J PHYSIOL, V215, P1097; SHERIF M, 1992, IMMUNOBIOLOGY, V184, P348, DOI 10.1016/S0171-2985(11)80592-9; Singh Tumul, 2012, Bioscan, V7, P211; SZABO I, 1978, CHRONOBIOLOGIA, V5, P137; vanWerven T, 1996, VET IMMUNOL IMMUNOP, V55, P83, DOI 10.1016/S0165-2427(96)05723-6	57	10	10	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2015	10	2							e0116588	10.1371/journal.pone.0116588	http://dx.doi.org/10.1371/journal.pone.0116588			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC3LS	25723391	Green Submitted, Green Published, gold			2022-12-27	WOS:000350251200016
J	de Paiva, HN; Paiva, PCP; Silva, CJD; Lamounier, JA; Ferreira, EFE; Ferreira, RC; Kawachi, I; Zarzar, PM				de Paiva, Haroldo Neves; Pelli Paiva, Paula Cristina; de Paula Silva, Carlos Jose; Lamounier, Joel Alves; Ferreira e Ferreira, Efigenia; Ferreira, Raquel Conceicao; Kawachi, Ichiro; Zarzar, Patricia Maria			Is There an Association between Traumatic Dental Injury and Social Capital, Binge Drinking and Socioeconomic Indicators among Schoolchildren?	PLOS ONE			English	Article							PERMANENT INCISORS; SCHOOL-CHILDREN; ALCOHOL-USE; PREVALENCE; HEALTH; EPIDEMIOLOGY; CONSTRUCT; SEVERITY; ETIOLOGY; VALIDITY	Objectives Traumatic dental injury is defined as trauma caused by forces on a tooth with variable extent and severity. The aim of the present study was to investigate the prevalence of traumatic dental injury and its association with overjet, lip protection, sex, socioeconomic status, social capital and binge drinking among 12-year-old students. Research Design and Method A cross-sectional study was conducted with a sample of 633 12-year-old students. Data were collected through a clinical exam and self-administered questionnaires. Socioeconomic status was determined based on mother's schooling and household income. The Social Capital Questionnaire for Adolescent Students and Alcohol Use Disorders Identification Test (AUDIT-C) were used to measure social capital and binge drinking, respectively. Results The prevalence of traumatic dental injury was 29.9% (176/588). Traumatic dental injury was more prevalent among male adolescents (p = 0.010), those with overjet greater than 5 mm (p < 0.001) and those with inadequate lip protection (p < 0.001). In the multiple logistic regression analysis, overjet [OR = 3.80 (95% CI: 2.235-6.466), p < 0.0001], inadequate lip protection [OR = 5.585 (95% CI: 3.654-8.535), p < 0.0001] and binge drinking [OR = 1.93 (95% CI: 1.21-3.06), p = 0.005] remained significantly associated with traumatic dental injury. Conclusions The present findings suggest that a high level of total social capital and trust are not associated with TDI in adolescents, unlike binge drinking. The effects of social and behavioral factors on TDI are not well elucidated. Therefore, further research involving other populations and a longitudinal design is recommended.	[de Paiva, Haroldo Neves] Fed Univ Jequitinhonha & Mucuri Valleys, Dept Dent, BR-39100000 Diamantina, Brazil; [Pelli Paiva, Paula Cristina; Lamounier, Joel Alves] Univ Fed Minas Gerais, Dept Child & Adolescent Hlth, BR-30130100 Belo Horizonte, MG, Brazil; [de Paula Silva, Carlos Jose] Fed Univ Jequitinhonha & Mucuri Valleys, Dept Dent, BR-39100000 Diamantina, Brazil; [Ferreira e Ferreira, Efigenia; Ferreira, Raquel Conceicao] Univ Fed Minas Gerais, Sch Dent, Dept Publ Oral Hlth, BR-31270901 Belo Horizonte, MG, Brazil; [Kawachi, Ichiro] Harvard Univ, Sch Publ Hlth, Dept Social & Behav Sci, Boston, MA 02115 USA; [Kawachi, Ichiro] Harvard Univ, Sch Med, Dept Social & Behav Sci, Boston, MA USA; [Zarzar, Patricia Maria] Univ Fed Minas Gerais, Sch Dent, BR-31270901 Belo Horizonte, MG, Brazil	Universidade Federal dos Vales do Jequitinhonha e Mucuri (UFVJM); Universidade Federal de Minas Gerais; Universidade Federal dos Vales do Jequitinhonha e Mucuri (UFVJM); Universidade Federal de Minas Gerais; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard Medical School; Universidade Federal de Minas Gerais	Paiva, PCP (corresponding author), Univ Fed Minas Gerais, Dept Child & Adolescent Hlth, BR-30130100 Belo Horizonte, MG, Brazil.	paulacpp@ig.com.br	de Araújo Zarzar, Patricia Maria Pereira/H-9534-2012; Ferreira, Raquel Conceição/L-5589-2013; de araujo zarzar, patricia maria pereira/F-4237-2018; Ferreira, Efigenia/AAF-5226-2021; Ferreira, Raquel Conceição/J-5236-2015	de Araújo Zarzar, Patricia Maria Pereira/0000-0002-6952-5767; Ferreira, Raquel Conceição/0000-0001-8897-9345; Ferreira, Efigenia/0000-0002-0665-211X; Ferreira, Raquel Conceição/0000-0001-8897-9345	Brazilian fostering agencies Coordenacao de aperfeicoamento de Pessoal de Nivel Superior (CAPES); FAPEMIG	Brazilian fostering agencies Coordenacao de aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); FAPEMIG(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG))	This study was supported by the Brazilian fostering agencies Coordenacao de aperfeicoamento de Pessoal de Nivel Superior (CAPES) and FAPEMIG. The funders had no role in the study design, data collection and analysis, decision to publish or preparation of the manuscript.	Adekoya-Sofowora CA, 2009, DENT TRAUMATOL, V25, P314, DOI 10.1111/j.1600-9657.2008.00704.x; Adsett L, 2013, N Z Dent J, V109, P142; Al-Khateeb S, 2005, DENT TRAUMATOL, V21, P26, DOI 10.1111/j.1600-9657.2004.00269.x; Aminzadeh K, 2013, SOC SCI MED, V84, P13, DOI 10.1016/j.socscimed.2013.02.012; Anderasen JO, 2007, TXB COLOR ATLAS TRAU; Andersson L, 2013, PEDIATR DENT, V35, P102; ANDREASEN JO, 1990, ENDOD DENT TRAUMATOL, V6, P78; Batista AM, 2012, BRAZ ORAL RES, V26, P132, DOI 10.1590/S1806-83242012000200008; Bauss O, 2008, J OROFAC ORTHOP, V69, P402, DOI 10.1007/s00056-008-8805-1; Bendo CB, 2009, DENT TRAUMATOL, V25, P420, DOI 10.1111/j.1600-9657.2009.00803.x; Chrcanovic BR, 2012, ORAL MAXILLOFAC SURG, V16, P3, DOI 10.1007/s10006-011-0280-y; Dame-Teixeira N, 2013, DENT TRAUMATOL, V29, P52, DOI 10.1111/j.1600-9657.2012.01124.x; David J, 2009, DENT TRAUMATOL, V25, P500, DOI 10.1111/j.1600-9657.2009.00807.x; Dua R, 2012, CONTEMP CLIN DENT, V3, P38, DOI 10.4103/0976-237X.94544; Faus-Damia M, 2011, MED ORAL PATOL ORAL, V16, pE292, DOI 10.4317/medoral.16.e292; Feldens CA, 2013, DENT TRAUMATOL, V29, P248, DOI 10.1111/edt.12018; Fujiwara T, 2012, ACTA MED OKAYAMA, V66, P343; Furuta M, 2012, COMMUNITY DENT ORAL, V40, P97, DOI 10.1111/j.1600-0528.2011.00642.x; Glendor U, 2008, DENT TRAUMATOL, V24, P603, DOI 10.1111/j.1600-9657.2008.00696.x; Glendor U, 2009, DENT TRAUMATOL, V25, P19, DOI 10.1111/j.1600-9657.2008.00694.x; IBGE-Instituto Brasileiro de Geografia e Estatistica, DAD DISTR MG; Jayaraj R, 2012, BMC HLTH SER RES, V12, P1472; Jorge KO, 2012, DENT TRAUMATOL, V28, P136, DOI 10.1111/j.1600-9657.2011.01056.x; Kaljee LM, 2011, ADOLESC HEALTH MED T, V2, P113, DOI 10.2147/AHMT.S26560; Kim D, 2011, SOC SCI MED, V73, P1689, DOI 10.1016/j.socscimed.2011.09.019; Kirana PS, 2009, INT J CLIN PRACT, V63, P1435, DOI 10.1111/j.1742-1241.2009.02183.x; Kumar A, 2011, ORAL HLTH PREV DENT, V9, P301; Lima CT, 2005, ALCOHOL ALCOHOLISM, V40, P584, DOI 10.1093/alcalc/agh202; Magnabosco Molise de Bem, 2007, Rev. bras. epidemiol., V10, P637, DOI 10.1590/S1415-790X2007000400021; Marcenes W, 2001, DENT TRAUMATOL, V17, P222; McCambridge J, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000413; Meneses-Gaya C, 2010, ALCOHOL CLIN EXP RES, V34, P1417, DOI 10.1111/j.1530-0277.2010.01225.x; Morgan A, 2009, HEALTH PROMOT INT, V24, P363, DOI 10.1093/heapro/dap028; Moyses SJ, 2006, HEALTH PLACE, V12, P48, DOI 10.1016/j.healthplace.2004.10.001; Murayama H, 2012, J EPIDEMIOL, V22, P179, DOI 10.2188/jea.JE20110128; Murphy DA, 2010, ORAL MAXIL SURG CLIN, V22, P231, DOI 10.1016/j.coms.2010.01.005; O'Mullane D M, 1972, J Ir Dent Assoc, V18, P160; Oliveira PM, 2013, DENT TRAUMATOL, V29, P372, DOI 10.1111/edt.12015; Oliveira PM, 2013, DENT TRAUMATOL, V30, P122; Paiva PCP, 2015, INT J PAEDIATR DENT, V25, P239, DOI 10.1111/ipd.12135; Pattussi MP, 2006, AM J PUBLIC HEALTH, V96, P1462, DOI 10.2105/AJPH.2005.066159; Paiva PCP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103785; Piovesan C, 2011, BRAZ ORAL RES, V25, P69, DOI 10.1590/S1806-83242011000100012; Putnam R.D., 1994, MAKING DEMOCRACY WOR, DOI DOI 10.2307/206637; Ramos-Jorge ML, 2013, DENT TRAUMATOL, V29, P266, DOI 10.1111/edt.12005; Ramos-Jorge ML, 2011, DENT TRAUMATOL, V27, P442, DOI 10.1111/j.1600-9657.2011.01027.x; Reinert DF, 2007, ALCOHOL CLIN EXP RES, V31, P185, DOI 10.1111/j.1530-0277.2006.00295.x; Salentijn EG, 2013, J CRANIO MAXILL SURG, V41, P630, DOI 10.1016/j.jcms.2012.11.043; Santiago BM, 2013, BMC ORAL HEALTH, V13, P1, DOI [10.1186/1472-6831-13-1, DOI 10.1186/1472-6831-13-1]; Santos SE, 2010, J ORAL MAXIL SURG, V68, P1826, DOI 10.1016/j.joms.2009.10.006; Soriano EP, 2007, DENT TRAUMATOL, V23, P232, DOI 10.1111/j.1600-9657.2005.00426.x; Taiwo OO, 2011, DENT TRAUMATOL, V27, P230, DOI 10.1111/j.1600-9657.2011.00997.x; Takeuchi K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061741; Teevale T, 2012, NEW ZEAL MED J, V125, P60; Traebert J, 2006, DENT TRAUMATOL, V22, P173, DOI 10.1111/j.1600-9657.2006.00359.x; Traebert J, 2010, CIENC SAUDE COLETIVA, V15, P1849, DOI 10.1590/S1413-81232010000700098; Veenstra G, 2005, SOC SCI MED, V60, P2799, DOI 10.1016/j.socscimed.2004.11.013; Wechsler H, 2001, PSYCHOL ADDICT BEHAV, V15, P287, DOI 10.1037/0893-164X.15.4.287; Zarzar PM, 2012, BRAZ ORAL RES, V26, P388, DOI 10.1590/S1806-83242012000500002	59	16	16	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2015	10	2							e0118484	10.1371/journal.pone.0118484	http://dx.doi.org/10.1371/journal.pone.0118484			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CC2ZH	25719561	gold, Green Submitted, Green Published			2022-12-27	WOS:000350213200056
J	Fitzgerald, TL; Powell, JJ; Stiller, J; Weese, TL; Abe, T; Zhao, GY; Jia, J; McIntyre, CL; Li, ZY; Manners, JM; Kazan, K				Fitzgerald, Timothy L.; Powell, Jonathan J.; Stiller, Jiri; Weese, Terri L.; Abe, Tomoko; Zhao, Guangyao; Jia, Jizeng; McIntyre, C. Lynne; Li, Zhongyi; Manners, John M.; Kazan, Kemal			An Assessment of Heavy Ion Irradiation Mutagenesis for Reverse Genetics in Wheat (Triticum aestivum L.)	PLOS ONE			English	Article							DISEASE RESISTANCE; DEFENSE RESPONSES; INDUCED MUTATIONS; DRAFT GENOME; ARABIDOPSIS; RICE; BRACHYPODIUM; IMPROVEMENT; REVEALS	Reverse genetic techniques harnessing mutational approaches are powerful tools that can provide substantial insight into gene function in plants. However, as compared to diploid species, reverse genetic analyses in polyploid plants such as bread wheat can present substantial challenges associated with high levels of sequence and functional similarity amongst homoeologous loci. We previously developed a high-throughput method to identify deletions of genes within a physically mutagenized wheat population. Here we describe our efforts to combine multiple homoeologous deletions of three candidate disease susceptibility genes (TaWRKY11, TaPFT1 and TaPLD beta 1). We were able to produce lines featuring homozygous deletions at two of the three homoeoloci for all genes, but this was dependent on the individual mutants used in crossing. Intriguingly, despite extensive efforts, viable lines possessing homozygous deletions at all three homoeoloci could not be produced for any of the candidate genes. To investigate deletion size as a possible reason for this phenomenon, we developed an amplicon sequencing approach based on synteny to Brachypodium distachyon to assess the size of the deletions removing one candidate gene (TaPFT1) in our mutants. These analyses revealed that genomic deletions removing the locus are relatively large, resulting in the loss of multiple additional genes. The implications of this work for the use of heavy ion mutagenesis for reverse genetic analyses in wheat are discussed.	[Fitzgerald, Timothy L.; Powell, Jonathan J.; Stiller, Jiri; Weese, Terri L.; McIntyre, C. Lynne; Kazan, Kemal] Commonwealth Sci & Ind Res Org, Agr Flagship, Queensland Biosci Precinct, St Lucia, Qld 4067, Australia; [Powell, Jonathan J.; Kazan, Kemal] Univ Queensland, Queensland Alliance Agr & Food Innovat, St Lucia, Qld 4072, Australia; [Abe, Tomoko] RIKEN Nishina Ctr Accelerator Based Sci, Wako, Saitama 3510198, Japan; [Zhao, Guangyao; Jia, Jizeng] Chinese Acad Agr Sci, Inst Crop Sci, Natl Key Facil Crop Resources & Genet Improvement, Beijing 100081, Peoples R China; [Li, Zhongyi; Manners, John M.] Commonwealth Sci & Ind Res Org, Black Mt Labs, Agr Flagship, Acton, ACT 2601, Australia	Commonwealth Scientific & Industrial Research Organisation (CSIRO); University of Queensland; RIKEN; Chinese Academy of Agricultural Sciences; Institute of Crop Sciences, CAAS; Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Fitzgerald, TL (corresponding author), Commonwealth Sci & Ind Res Org, Agr Flagship, Queensland Biosci Precinct, 306 Carmody Rd, St Lucia, Qld 4067, Australia.	timothy.l.fitzgerald@gmail.com; kemal.kazan@csiro.au	Li, Zhongyi/A-2932-2010; Manners, John M/A-4922-2008; McIntyre, Cathrine/AAT-9596-2021; Kazan, Kemal/B-8032-2008; McIntyre, Cathrine L/F-5782-2011	Li, Zhongyi/0000-0002-7334-8935; McIntyre, Cathrine/0000-0002-1991-1299; Kazan, Kemal/0000-0002-5169-8934; McIntyre, Cathrine L/0000-0002-1991-1299; Powell, Jonathan/0000-0002-6222-8030	Grains Research and Development Corporation [CSP00155]	Grains Research and Development Corporation(Grains R&D Corp)	Funding from Grains Research and Development Corporation (http://www.grdc.com.au/); Project CSP00155. The funders had no role in the design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahloowalia BS, 2001, EUPHYTICA, V118, P167, DOI 10.1023/A:1004162323428; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Bartos J, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-155; Bossolini E, 2007, PLANT J, V49, P704, DOI 10.1111/j.1365-313X.2006.02991.x; Brenchley R, 2012, NATURE, V491, P705, DOI 10.1038/nature11650; Cao J, 2011, NAT GENET, V43, P956, DOI 10.1038/ng.911; Choulet F, 2010, PLANT CELL, V22, P1686, DOI 10.1105/tpc.110.074187; Comai L, 2006, PLANT J, V45, P684, DOI 10.1111/j.1365-313X.2006.02670.x; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Endo TR, 1996, J HERED, V87, P295, DOI 10.1093/oxfordjournals.jhered.a023003; Feuillet C, 2002, ANN BOT-LONDON, V89, P3, DOI 10.1093/aob/mcf008; Fitzgerald TL, 2012, CRIT REV PLANT SCI, V31, P181, DOI 10.1080/07352689.2011.635538; Fitzgerald TL, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-264; Greene EA, 2003, GENETICS, V164, P731; Huang XH, 2013, TRENDS GENET, V29, P225, DOI 10.1016/j.tig.2012.12.001; Huo NX, 2009, PLANT MOL BIOL, V70, P47, DOI 10.1007/s11103-009-9456-3; Jia JZ, 2013, NATURE, V496, P91, DOI 10.1038/nature12028; Journot-Catalino N, 2006, PLANT CELL, V18, P3289, DOI 10.1105/tpc.106.044149; Kazama Y, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-161; Kidd BN, 2009, PLANT CELL, V21, P2237, DOI 10.1105/tpc.109.066910; Knoll JE, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-81; Lai KT, 2012, PLANT BIOTECHNOL J, V10, P743, DOI 10.1111/j.1467-7652.2012.00718.x; Li DH, 2014, METHODS MOL BIOL, V1062, P65, DOI 10.1007/978-1-62703-580-4_4; Ling HQ, 2013, NATURE, V496, P87, DOI 10.1038/nature11997; Lloyd J, 2012, PLANT PHYSIOL, V158, P1115, DOI 10.1104/pp.111.192393; Magori S., 2010, HDB PLANT MUTATION S, P1, DOI [10.1002/ 9783527629398.ch1, DOI 10.1002/9783527629398.CH1]; MANTEL N, 1963, J AM STAT ASSOC, V58, P690; Mayer KFX, 2014, SCIENCE, V345, DOI 10.1126/science.1251788; Mayer KFX, 2012, NATURE, V491, P711, DOI 10.1038/nature11543; McCourt P, 2010, PLANT J, V61, P905, DOI 10.1111/j.1365-313X.2010.04176.x; Mittal A, 2014, J EXP BOT IN PRESS, DOI [10.1093/jxb/eru472, DOI 10.1093/JXB/ERU472]; Naito K, 2005, GENETICS, V169, P881, DOI 10.1534/genetics.104.033654; Panoli AP, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-24; Safar J, 2010, CYTOGENET GENOME RES, V129, P211, DOI 10.1159/000313072; Schneeberger K, 2011, TRENDS PLANT SCI, V16, P282, DOI 10.1016/j.tplants.2011.02.006; Sears E. R., 1966, Chromosome manipulations and plant genetics., P29; Shaw LM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079459; Shikazono N, 2005, J EXP BOT, V56, P587, DOI 10.1093/jxb/eri047; Slade AJ, 2005, NAT BIOTECHNOL, V23, P75, DOI 10.1038/nbt1043; Spielmeyer W, 2008, THEOR APPL GENET, V116, P481, DOI 10.1007/s00122-007-0684-0; Uauy C, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-115; Wang TL, 2012, PLANT BIOTECHNOL J, V10, P761, DOI 10.1111/j.1467-7652.2012.00708.x; Wanjugi H, 2009, GENOME, V52, P576, DOI [10.1139/G09-033, 10.1139/g09-033]; Yamaguchi T, 2009, PLANT PHYSIOL, V150, P308, DOI 10.1104/pp.108.131979; Zhao J, 2013, NEW PHYTOL, V199, P228, DOI 10.1111/nph.12256	45	17	19	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2015	10	2							e0117369	10.1371/journal.pone.0117369	http://dx.doi.org/10.1371/journal.pone.0117369			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC2ZH	25719507	gold, Green Published, Green Submitted			2022-12-27	WOS:000350213200021
J	Dutilleul, M; Goussen, B; Bonzom, JM; Galas, S; Reale, D				Dutilleul, Morgan; Goussen, Benoit; Bonzom, Jean-Marc; Galas, Simon; Reale, Denis			Pollution Breaks Down the Genetic Architecture of Life History Traits in Caenorhabditis elegans	PLOS ONE			English	Article							QUANTITATIVE GENETICS; PHENOTYPIC PLASTICITY; PESTICIDE RESISTANCE; ISOFEMALE LINES; BODY-SIZE; EVOLUTION; DROSOPHILA; ENVIRONMENT; ADAPTATION; COVARIANCE	When pollution occurs in an environment, populations present suffer numerous negative and immediate effects on their life history traits. Their evolutionary potential to live in a highly stressful environment will depend on the selection pressure strengths and on the genetic structure, the trait heritability, and the genetic correlations between them. If expression of this structure changes in a stressful environment, it becomes necessary to quantify these changes to estimate the evolutionary potential of the population in this new environment. We studied the genetic structure for survival, fecundity, and early and late growth in isogenic lines of a Caenorhabditis elegans population subject to three different environments: a control environment, an environment polluted with uranium, and a high salt concentration environment. We found a heritability decrease in the polluted environments for fecundity and early growth, two traits that were the most heritable in the control environment. The genetic structure of the traits was particularly affected in the uranium polluted environment, probably due to generally low heritability in this environment. This could prevent selection from acting on traits despite the strong selection pressures exerted on them. Moreover, phenotypic traits were more strongly affected in the salt than in the uranium environment and the heritabilities were also lower in the latter environment. Consequently the decrease in heritability was not proportional to the population fitness reduction in the polluted environments. Our results suggest that pollution can alter the genetic structure of a C. elegans population, and thus modify its evolutionary potential.	[Dutilleul, Morgan; Reale, Denis] Univ Quebec, Dept Sci Biol, Montreal, PQ H3C 3P8, Canada; [Dutilleul, Morgan; Goussen, Benoit; Bonzom, Jean-Marc] Cadarache, PRP ENV SERIS LECO, IRSN, F-13115 St Paul Les Durance, France; [Dutilleul, Morgan; Galas, Simon] Univ Montpellier I, Fac Pharm, Lab Toxicol, Montpellier 5, France; [Goussen, Benoit] INERIS Parc ALATA, Unit Models Ecotoxicol & Toxicol METO, Verneuil En Halatte, France	University of Quebec; University of Quebec Montreal; CEA; Universite de Montpellier; Institut National de l'Environnement Industriel et des Risques (INERIS); Universite de Reims Champagne-Ardenne	Dutilleul, M (corresponding author), Univ Quebec, Dept Sci Biol, CP 8888, Montreal, PQ H3C 3P8, Canada.	morgan.dutilleul@hotmail.fr	GOUSSEN, Benoit/E-7687-2012; REALE, Denis/AAG-1571-2020; Galas, Simon/X-1312-2019	GOUSSEN, Benoit/0000-0001-7204-7981; REALE, Denis/0000-0002-0419-7125; Galas, Simon/0000-0002-1717-1266	French Institute for Radioprotection and Nuclear Safety (Institut de Radioprotection et de Surete Nuclaire, IRSN)	French Institute for Radioprotection and Nuclear Safety (Institut de Radioprotection et de Surete Nuclaire, IRSN)	This work was part of the Envirhom-Eco research program supported by the French Institute for Radioprotection and Nuclear Safety (Institut de Radioprotection et de Surete Nuclaire, IRSN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antebi Adam, 1997, Cold Spring Harbor Monograph Series, V33, P583; Arnold SJ, 2008, EVOLUTION, V62, P2451, DOI 10.1111/j.1558-5646.2008.00472.x; Aschner M., 2011, J TOXICOL-US, DOI [10.1155/ 2011/ 280304, DOI 10.1155/2011/280304, 10.1155/2F2011/2F895236, DOI 10.1155/2F2011/2F895236]; Astles PA, 2006, J EVOLUTION BIOL, V19, P114, DOI 10.1111/j.1420-9101.2005.00997.x; Barata C, 2002, ENVIRON TOXICOL CHEM, V21, P1058, DOI [10.1897/1551-5028(2002)021<1058:AAWPVI>2.0.CO;2, 10.1897/1551-5028(2002)021&lt;1058:AAWPVI&gt;2.0.CO;2]; Begin M, 2004, J EVOLUTION BIOL, V17, P1255, DOI 10.1111/j.1420-9101.2004.00772.x; Blows MW, 2005, ECOLOGY, V86, P1371, DOI 10.1890/04-1209; Braendle C, 2008, CURR TOP DEV BIOL, V80, P171, DOI 10.1016/S0070-2153(07)80005-6; Bubliy OA, 2001, HEREDITY, V86, P363, DOI 10.1046/j.1365-2540.2001.00837.x; BYERLY L, 1976, DEV BIOL, V51, P23, DOI 10.1016/0012-1606(76)90119-6; Charmantier A, 2005, P ROY SOC B-BIOL SCI, V272, P1415, DOI 10.1098/rspb.2005.3117; CHEVERUD JM, 1984, J THEOR BIOL, V110, P155, DOI 10.1016/S0022-5193(84)80050-8; Coutellec MA, 2011, ECOTOXICOLOGY, V20, P493, DOI 10.1007/s10646-011-0637-x; David JR, 2005, HEREDITY, V94, P3, DOI 10.1038/sj.hdy.6800562; DEJONG G, 1992, AM NAT, V139, P749, DOI 10.1086/285356; DEJONG G, 1995, AM NAT, V145, P493, DOI 10.1086/285752; Dolgin ES, 2007, EVOLUTION, V61, P1339, DOI 10.1111/j.1558-5646.2007.00118.x; Doroszuk A, 2008, AM NAT, V171, P291, DOI 10.1086/527478; Dutilleul M, 2013, ECOTOXICOLOGY, V22, P862, DOI 10.1007/s10646-013-1090-9; Falconer D. S., 1996, Introduction to quantitative genetics.; Fuller RC, 2005, INTEGR COMP BIOL, V45, P391, DOI 10.1093/icb/45.3.391; Garant D, 2008, MOL ECOL, V17, P179, DOI 10.1111/j.1365-294X.2007.03436.x; GEBHARDTHENRICH SG, 1991, J EVOLUTION BIOL, V4, P341, DOI 10.1046/j.1420-9101.1991.4030341.x; Gelman A, 2008, STAT MED, V27, P2865, DOI 10.1002/sim.3107; Gibert P, 1998, GENET SEL EVOL, V30, P181, DOI 10.1051/gse:19980207; Giovanetti A, 2010, J ENVIRON RADIOACTIV, V101, P509, DOI 10.1016/j.jenvrad.2010.03.003; Goranson NC, 2005, EVOL ECOL RES, V7, P325; Gutteling EW, 2007, HEREDITY, V98, P206, DOI 10.1038/sj.hdy.6800929; Hadfield JD, 2007, J EVOLUTION BIOL, V20, P549, DOI 10.1111/j.1420-9101.2006.01262.x; Hadfield JD, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i02; Hart AC, 2006, BEHAVIOUR, P1, DOI DOI 10.1895/W0RMB00K.1.87.1; Harvey SC, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-15; HEDRICK PW, 1980, GENETICS, V94, P791; Hendrickx F, 2008, J EVOLUTION BIOL, V21, P183, DOI 10.1111/j.1420-9101.2007.01452.x; HODGKIN J, 1991, P ROY SOC B-BIOL SCI, V246, P19, DOI 10.1098/rspb.1991.0119; Hoffmann A.A., 1991, EVOLUTIONARY GENETIC; Hoffmann AA, 1999, TRENDS ECOL EVOL, V14, P96, DOI 10.1016/S0169-5347(99)01595-5; HOLLOWAY GJ, 1990, HEREDITY, V64, P323, DOI 10.1038/hdy.1990.40; Honnay O, 2007, CONSERV GENET, V8, P293, DOI 10.1007/s10592-006-9169-y; Jansen M, 2011, EVOLUTION, V65, P2681, DOI 10.1111/j.1558-5646.2011.01331.x; Jiang GCT, 2009, TOXICOL SCI, V111, P345, DOI 10.1093/toxsci/kfp161; Kause A, 2001, EVOLUTION, V55, P1992, DOI 10.1111/j.0014-3820.2001.tb01316.x; Klerks PL, 2002, HUM ECOL RISK ASSESS, V8, P971, DOI 10.1080/1080-700291905774; Knight CG, 2001, EVOLUTION, V55, P1795, DOI 10.1111/j.0014-3820.2001.tb00828.x; Kristensen TN, 2003, CONSERV GENET, V4, P453, DOI 10.1023/A:1024763013798; Kruuk LEB, 2004, PHILOS T R SOC B, V359, P873, DOI 10.1098/rstb.2003.1437; Kuhne WW, 2002, ENVIRON TOXICOL CHEM, V21, P2198, DOI [10.1897/1551-5028(2002)021<2198:EODUOT>2.0.CO;2, 10.1897/1551-5028(2002)021&lt;2198:EODUOT&gt;2.0.CO;2]; Lamitina ST, 2005, AM J PHYSIOL-CELL PH, V288, pC467, DOI 10.1152/ajpcell.00451.2004; Lamitina ST, 2004, AM J PHYSIOL-CELL PH, V286, pC785, DOI 10.1152/ajpcell.00381.2003; Lamitina T, 2006, P NATL ACAD SCI USA, V103, P12173, DOI 10.1073/pnas.0602987103; LANDE R, 1983, EVOLUTION, V37, P1210, DOI 10.1111/j.1558-5646.1983.tb00236.x; LANDE R, 1979, EVOLUTION, V33, P234, DOI [10.2307/2407380, 10.1111/j.1558-5646.1979.tb04678.x]; Lopes PC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003741; MacArthur R.H., 1967, THEORY ISLAND BIOGEO, DOI DOI 10.1080/00379271.2014.984955; McGuigan K, 2006, MOL ECOL, V15, P883, DOI 10.1111/j.1365-294X.2006.02809.x; Medina MH, 2007, CHEMOSPHERE, V67, P2105, DOI 10.1016/j.chemosphere.2006.12.024; Messiaen M, 2012, Ecotoxicology, V21, P1899, DOI 10.1007/s10646-012-0923-2; Morgan AJ, 2007, ENVIRON SCI TECHNOL, V41, P1085, DOI 10.1021/es061992x; POSTHUMA L, 1993, COMP BIOCHEM PHYS C, V106, P11, DOI 10.1016/0742-8413(93)90251-F; Prahlad V, 2003, SCIENCE, V302, P1046, DOI 10.1126/science.1087946; R Development Core Team, 2012, R LANG ENV STAT COMP, DOI [10.1002/jcc.22917, DOI 10.1002/JCC.22917]; Rasband W., 2006, IMAGEJ; Reed DH, 2003, CONSERV BIOL, V17, P230, DOI 10.1046/j.1523-1739.2003.01236.x; Roff Derek, 2002, pi; Sgro CM, 2004, HEREDITY, V93, P241, DOI 10.1038/sj.hdy.6800532; Sgro CM, 2004, GENETICS, V167, P1281, DOI 10.1534/genetics.103.026120; Shirley MDF, 1999, EVOLUTION, V53, P826, DOI 10.1111/j.1558-5646.1999.tb05376.x; Steppan SJ, 2002, TRENDS ECOL EVOL, V17, P320, DOI 10.1016/S0169-5347(02)02505-3; SULSTON JE, 1980, DEV BIOL, V78, P542, DOI 10.1016/0012-1606(80)90352-8; Teotonio H, 2006, EVOLUTION, V60, P1300, DOI 10.1111/j.0014-3820.2006.tb01207.x; Teotonio H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035811; WARD S, 1979, DEV BIOL, V73, P304, DOI 10.1016/0012-1606(79)90069-1; Ward TJ, 2005, ENVIRON TOXICOL CHEM, V24, P2341, DOI 10.1897/04-429R.1; WILLIS JH, 1991, EVOLUTION, V45, P441, DOI 10.1111/j.1558-5646.1991.tb04418.x; Wilson AJ, 2006, PLOS BIOL, V4, P1270, DOI 10.1371/journal.pbio.0040216	75	6	6	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2015	10	2							e0116214	10.1371/journal.pone.0116214	http://dx.doi.org/10.1371/journal.pone.0116214			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC2IM	25714492	Green Published, Green Submitted, gold			2022-12-27	WOS:000350168700011
J	Kotb, A; Cameron, C; Hsieh, S; Wells, G				Kotb, Ahmed; Cameron, Chris; Hsieh, Shuching; Wells, George			Comparative Effectiveness of Different Forms of Telemedicine for Individuals with Heart Failure (HF): A Systematic Review and Network Meta-Analysis	PLOS ONE			English	Article							STRUCTURED TELEPHONE SUPPORT; RANDOMIZED CONTROLLED-TRIAL; DISEASE MANAGEMENT PROGRAM; QUALITY-OF-LIFE; CARE MANAGEMENT; HOME; IMPACT; COST; MORTALITY; HOSPITALIZATION	Background Previous studies on telemedicine have either focused on its role in the management of chronic diseases in general or examined its effectiveness in comparison to standard postdischarge care. Little has been done to determine the comparative impact of different telemedicine options for a specific population such as individuals with heart failure (HF). Methods and Findings Systematic reviews (SR) of randomized controlled trials (RCTs) that examined telephone support, telemonitoring, video monitoring or electrocardiographic monitoring for HF patients were identified using a comprehensive search of the following databases: MEDLINE, EMBASE, CINAHL and The Cochrane Library. Studies were included if they reported the primary outcome of mortality or any of the following secondary outcomes: all- cause hospitalization and heart failure hospitalization. Thirty RCTs (N = 10,193 patients) were included. Compared to usual care, structured telephone support was found to reduce the odds of mortality( Odds Ratio 0.80; 95% Credible Intervals [0.66 to 0.96]) and hospitalizations due to heart failure (0.69; [0.56 to 0.85]). Telemonitoring was also found to reduce the odds of mortality(0.53; [0.36 to 0.80]) and reduce hospitalizations related to heart failure (0.64; [0.39 to 0.95]) compared to usual post- discharge care. Interventions that involved ECG monitoring also reduced the odds of hospitalization due to heart failure (0.71; [0.52 to 0.98]). Limitations Much of the evidence currently available has focused on the comparing either telephone support or telemonitoring with usual care. This has therefore limited our current understanding of how some of the less common forms of telemedicine compare to one another. Conclusions Compared to usual care, structured telephone support and telemonitoring significantly reduced the odds of deaths and hospitalization due to heart failure. Despite being the most widely studied forms of telemedicine, little has been done to directly compare these two interventions against one another. Further research into their comparative cost-effectiveness is also warranted. Conclusions Compared to usual care, structured telephone support and telemonitoring significantly reduced the odds of deaths and hospitalization due to heart failure. Despite being the most widely studied forms of telemedicine, little has been done to directly compare these two interventions against one another. Further research into their comparative cost-effectiveness is also warranted.	[Kotb, Ahmed; Hsieh, Shuching; Wells, George] Univ Ottawa, Inst Heart, Ottawa, ON, Canada; [Cameron, Chris; Wells, George] Univ Ottawa, Dept Community Med & Epidemiol, Ottawa, ON, Canada; [Cameron, Chris] Univ Ottawa, Ottawa Hosp Res Inst, Ottawa, ON, Canada	University of Ottawa; University of Ottawa Heart Institute; University of Ottawa; University of Ottawa; Ottawa Hospital Research Institute	Kotb, A (corresponding author), Univ Ottawa, Inst Heart, Ottawa, ON, Canada.	akotb@ottawaheart.ca		Kotb, Ahmed/0000-0001-5066-2836	Ontario Graduate Scholarship; Canadian Institutes of Health Research (CIHR); Canadian Network and Centre for Trials Internationally (CANNeCTIN)	Ontario Graduate Scholarship(Ontario Graduate Scholarship); Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Canadian Network and Centre for Trials Internationally (CANNeCTIN)	Ahmed Kotb is the recipient of the Ontario Graduate Scholarship. Chris Cameron is the recipient of a Vanier Canada Graduate Scholarship from the Canadian Institutes of Health Research (CIHR). Ahmed Kotb and Chris Cameron have received funding from the Canadian Network and Centre for Trials Internationally (CANNeCTIN).	Ades AE, 2006, PHARMACOECONOMICS, V24, P1, DOI 10.2165/00019053-200624010-00001; Angermann CE, 2007, CIRCULATION, V116, P601; Balk AH, 2008, EUR J HEART FAIL, V10, P1136, DOI 10.1016/j.ejheart.2008.08.003; Blum K, 2007, J CARD FAIL, V13, pS164, DOI DOI 10.1016/J.CARDFAIL.2007.06.581; Brooks SP, 1998, J COMPUT GRAPH STAT, V7, P434, DOI 10.2307/1390675; Capomolla S, 2004, EUR HEART J SUPPL, V6, pF91, DOI 10.1016/j.ehjsup.2004.09.011; Chaudhry SI, 2007, J CARD FAIL, V13, P56, DOI 10.1016/j.cardfail.2006.09.001; Clark RA, 2010, EUR HEART J, V31, P944; Clark RA, 2007, BMJ-BRIT MED J, V334, P942, DOI 10.1136/bmj.39156.536968.55; Clark RA, 2011, J CARD FAIL, V17, pS100, DOI 10.1016/j.cardfail.2011.06.335; Clarke M, 2011, J TELEMED TELECARE, V17, P7, DOI 10.1258/jtt.2010.100113; Cleland JGF, 2005, J AM COLL CARDIOL, V45, P1654, DOI 10.1016/j.jacc.2005.01.050; Dang S, 2009, TELEMED J E-HEALTH, V15, P783, DOI 10.1089/tmj.2009.0028; de Lusignan S, 2001, EUR J HEART FAIL, V3, P723, DOI 10.1016/S1388-9842(01)00190-8; DeBusk RF, 2004, ANN INTERN MED, V141, P606, DOI 10.7326/0003-4819-141-8-200410190-00008; Dendale P, 2012, EUR J HEART FAIL, V14, P333, DOI 10.1093/eurjhf/hfr144; DeWalt DA, 2006, BMC HEALTH SERV RES, V6, DOI 10.1186/1472-6963-6-30; Dias S, 2011, 2 NICE DSU; Doval HC, 2005, BMJ-BRIT MED J, V331, P425, DOI 10.1136/bmj.38516.398067.E0; Ekman I, 1998, EUR HEART J, V19, P1254, DOI 10.1053/euhj.1998.1095; Galbreath AD, 2004, CIRCULATION, V110, P3518, DOI 10.1161/01.CIR.0000148957.62328.89; Giamouzis G, 2012, CARDIOL RES PRACT, V2012, DOI 10.1155/2012/410820; Giordano A, 2009, INT J CARDIOL, V131, P192, DOI 10.1016/j.ijcard.2007.10.027; Goldberg LR, 2003, AM HEART J, V146, P705, DOI 10.1016/S0002-8703(03)00393-4; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Holland R, 2005, HEART, V91, P899, DOI 10.1136/hrt.2004.048389; Inglis SC, 2010, EUR HEART J, V31, P878; Inglis SC, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007228.pub3; Inglis SC, 2011, J CARD FAIL, V17, pS90, DOI 10.1016/j.cardfail.2011.06.302; Inglis SC, 2011, EUR J HEART FAIL, V13, P1028, DOI 10.1093/eurjhf/hfr039; Inglis SC, 2010, EUROPEAN JOURNAL OF, V9, pS179; Kielblock B, 2007, DEUT MED WOCHENSCHR, V132, P417, DOI 10.1055/s-2007-970350; Klersy C, 2011, EUR J HEART FAIL, V13, P450, DOI 10.1093/eurjhf/hfq232; Koehler F, 2011, CIRCULATION, V123, P1873, DOI 10.1161/CIRCULATIONAHA.111.018473; Krumholz HM, 2002, J AM COLL CARDIOL, V39, P83, DOI 10.1016/S0735-1097(01)01699-0; Laramee AS, 2003, ARCH INTERN MED, V163, P809, DOI 10.1001/archinte.163.7.809; Lu G, 2004, STAT MED, V23, P3105, DOI 10.1002/sim.1875; Lunn DJ, 2000, STAT COMPUT, V10, P325, DOI 10.1023/A:1008929526011; Mortara A, 2009, EUR J HEART FAIL, V11, P312, DOI 10.1093/eurjhf/hfp022; Pandor A, 2013, HEART, V99, P1717, DOI 10.1136/heartjnl-2013-303811; Polisena J, 2010, J TELEMED TELECARE, V16, P68, DOI 10.1258/jtt.2009.090406; Ramachandran K, 2007, NATL MED J INDIA, V20, P67; Riegel B, 2006, J CARD FAIL, V12, P211, DOI 10.1016/j.cardfail.2006.01.005; Riegel B, 2002, ARCH INTERN MED, V162, P705, DOI 10.1001/archinte.162.6.705; Salanti G, 2008, STAT METHODS MED RES, V17, P279, DOI 10.1177/0962280207080643; Schwarz Karen A, 2008, Prog Cardiovasc Nurs, V23, P18, DOI 10.1111/j.1751-7117.2008.tb00527.x; Scottish Intercollegiate Guidelines Network (SIGN) 50, GUID DEV HDB; Seto E, 2008, TELEMED J E-HEALTH, V14, P679, DOI 10.1089/tmj.2007.0114; Shea BJ, 2007, BMC MED RES METHODOL, V7, DOI 10.1186/1471-2288-7-10; Sisk JE, 2006, ANN INTERN MED, V145, P273, DOI 10.7326/0003-4819-145-4-200608150-00007; Smith M., 2010, NODEXL FREE OPEN NET; Song F, 2008, J CLIN EPIDEMIOL, V61, P455, DOI 10.1016/j.jclinepi.2007.06.006; Spiegelhalter DJ, 2002, J R STAT SOC B, V64, P583, DOI 10.1111/1467-9868.00353; Tonkin A, 2009, HEART LUNG CIRCULA S, V18S, pS105, DOI DOI 10.1016/J.HLC.2009.05.239; Villani A, 2007, G ITAL CARDIOL, V8, P107, DOI 10.1714/677.7890; Wade MJ, 2011, AM J MANAG CARE, V17, pE71; Wakefield BJ, 2008, TELEMED J E-HEALTH, V14, P753, DOI 10.1089/tmj.2007.0131; Woodend AK, 2008, HEART LUNG, V37, P36, DOI 10.1016/j.hrtlng.2007.04.004; Xiang R, 2013, J TELEMED TELECARE, V19, P249, DOI 10.1177/1357633X13495490; Zugck C, 2005, Herzschrittmacherther Elektrophysiol, V16, P176, DOI 10.1007/s00399-005-0476-7	60	79	79	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2015	10	2							e0118681	10.1371/journal.pone.0118681	http://dx.doi.org/10.1371/journal.pone.0118681			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC2IM	25714962	Green Submitted, gold, Green Published			2022-12-27	WOS:000350168700096
J	Wang, Q; Lin, H; Shen, Q; Fan, XP; Bai, NL; Zhao, YH				Wang, Qun; Lin, Hui; Shen, Qi; Fan, Xiaoping; Bai, Naling; Zhao, Yuhua			Characterization of Cellulase Secretion and Cre1-Mediated Carbon Source Repression in the Potential Lignocellulose-Degrading Strain Trichoderma asperellum T-1	PLOS ONE			English	Article							ASPERGILLUS-NIDULANS; CREA GENE; EXPRESSION; MUTANT; ENZYMES	Trichoderma asperellum, a traditional bio-control species, was demonstrated to be an excellent candidate for lignocellulose degradation in this work. Comparing to the representatively industrial strain of Trichoderma reeseiQM6a, T. asperellum T-1 showed more robust growth, stronger spore production, faster secretion of lignocellulose-decomposing enzymes and better pH tolerance. The reducing sugar released by strain T-1 on the second day of fermentation was 87% higher than that of strain QM6a, although the maximum reducing sugar yield and the cellulase production persistence of the strain T-1 were lower. Our experiment found that the cellulase secretion was strongly inhibited by glucose, suggesting the existence of carbon source repression pathway in T. asperellum T-1. The inhibiting effect was enhanced with an increase in glucose concentration and was closely related to mycelium growth. SDS-PAGE and secondary mass-spectrum identification confirmed that the expression of endo-1,4-beta-xylanase I in T. asperellum T-1 was down-regulated when glucose was added. The factor Cre1, which plays an important role in the down-regulation of the endo-1,4-beta-xylanase I gene, was investigated by bioinformatics methods. The protein structure of Cre1, analyzed using multiple protein sequence alignment, indicates the existence of the Zn-fingers domain. Then, the binding sites of Cre1 on the endo-1,4-beta-xylanase I gene promoter were further elucidated. This study is the first report about Cre1-mediated carbon repression in the bio-control strain T. asperellum T-1. All of the above results provided good references for better understanding T. asperellum T-1 and improving its application for lignocellulose degradation.	[Wang, Qun; Shen, Qi; Fan, Xiaoping; Bai, Naling; Zhao, Yuhua] Zhejiang Univ, Coll Life Sci, Inst Microbiol, Hangzhou 310003, Zhejiang, Peoples R China; [Lin, Hui] Zhejiang Acad Agr Sci, Inst Environm Resource & Soil Fertilizer, Hangzhou, Zhejiang, Peoples R China	Zhejiang University; Zhejiang Academy of Agricultural Sciences	Zhao, YH (corresponding author), Zhejiang Univ, Coll Life Sci, Inst Microbiol, Hangzhou 310003, Zhejiang, Peoples R China.	yhzhao225@zju.edu.cn	LIN, HUI/AEA-6702-2022; Fan, Xiaoping/N-7412-2019	LIN, HUI/0000-0002-5446-8069; Fan, Xiaoping/0000-0003-0172-4070				Abu Bakar NK, 2012, BIORESOURCES, V7, P3627; Akira ST, 1996, BIOSCI BIOTECH BIOCH, V60, P173; [Anonymous], 2001, ELECT J BIOTECHN; Aro N, 2003, APPL ENVIRON MICROB, V69, P56, DOI 10.1128/AEM.69.1.56-65.2003; Chandra M, 2009, BIORESOURCE TECHNOL, V100, P1659, DOI 10.1016/j.biortech.2008.09.011; Cherry JR, 2003, CURR OPIN BIOTECH, V14, P438, DOI 10.1016/S0958-1669(03)00099-5; Couturier M, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-57; Ding SY, 2012, SCIENCE, V338, P1055, DOI 10.1126/science.1227491; DOWZER CEA, 1991, MOL CELL BIOL, V11, P5701, DOI 10.1128/MCB.11.11.5701; ELGOGARY S, 1989, P NATL ACAD SCI USA, V86, P6138, DOI 10.1073/pnas.86.16.6138; Gurr S. J., 1987, SPECIAL PUBLICATIONS, P93; Himmel ME, 2007, SCIENCE, V315, P804, DOI 10.1126/science.1137016; Ibrahim MF, 2013, APPL BIOCHEM BIOTECH, V170, P1320, DOI 10.1007/s12010-013-0275-2; Ilmen M, 1996, MOL GEN GENET, V251, P451, DOI 10.1007/s004380050189; Jonkers W, 2009, MOL MICROBIOL, V74, P1100, DOI 10.1111/j.1365-2958.2009.06922.x; Kannan Neethu, 2012, Advances in Bioscience and Biotechnology, V3, P1160, DOI 10.4236/abb.2012.38142; Lin H, 2011, BIORESOURCE TECHNOL, V102, P10569, DOI 10.1016/j.biortech.2011.08.095; Marcello CM, 2010, MICROBIOL RES, V165, P75, DOI 10.1016/j.micres.2008.08.002; Marx IJ, 2013, BIOTECHNOL BIOFUELS, V6, DOI 10.1186/1754-6834-6-172; MILLER GL, 1959, ANAL CHEM, V31, P426, DOI 10.1021/ac60147a030; Orejas M, 2001, J BACTERIOL, V183, P1517, DOI 10.1128/JB.183.5.1517-1523.2001; Raghuwanshi S, 2014, FUEL, V124, P183, DOI 10.1016/j.fuel.2014.01.107; Roy P, 2008, FUNGAL GENET BIOL, V45, P657, DOI 10.1016/j.fgb.2007.10.016; Rubeena M., 2013, Advances in Bioscience and Biotechnology, V4, P214, DOI 10.4236/abb.2013.42030; SAKAI A, 1990, MOL CELL BIOL, V10, P4130, DOI 10.1128/MCB.10.8.4130; Sarrocco S, 2009, J PLANT PATHOL, V91, P331; Sriram S, 2013, CURR SCI INDIA, V104, P1332; STRAUSS J, 1995, FEBS LETT, V376, P103, DOI 10.1016/0014-5793(95)01255-5; Sunil SA, 2012, MOL CELL PROTEOMICS, V11; Takashima S, 1998, BIOSCI BIOTECH BIOCH, V62, P2364, DOI 10.1271/bbb.62.2364; Vautard G, 1999, FEBS LETT, V453, P54, DOI 10.1016/S0014-5793(99)00691-2; Wang YaJing, 2010, Scientia Agricultura Sinica, V43, P1852	32	6	8	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2015	10	3							e0119237	10.1371/journal.pone.0119237	http://dx.doi.org/10.1371/journal.pone.0119237			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9KG	25741694	gold, Green Published, Green Submitted			2022-12-27	WOS:000350688100094
J	Koeppen, AH; Ramirez, RL; Becker, AB; Bjork, ST; Levi, S; Santambrogio, P; Parsons, PJ; Kruger, PC; Yang, KX; Feustel, PJ; Mazurkiewicz, JE				Koeppen, Arnulf H.; Ramirez, R. Liane; Becker, Alyssa B.; Bjork, Sarah T.; Levi, Sonia; Santambrogio, Paolo; Parsons, Patrick J.; Kruger, Pamela C.; Yang, Karl X.; Feustel, Paul J.; Mazurkiewicz, Joseph E.			The Pathogenesis of Cardiomyopathy in Friedreich Ataxia	PLOS ONE			English	Article							ATHEROSCLEROTIC PLAQUE; MITOCHONDRIAL FERRITIN; IRON; HEPCIDIN; DISEASE; INFLAMMATION; HYPERTROPHY; HEARTS; LIVER; LIFE	Friedreich ataxia (FA) is an autosomal recessive disease with a complex neurological phenotype, but the most common cause of death is heart failure. This study presents a systematic analysis of 15 fixed and 13 frozen archival autopsy tissues of FA hearts and 10 normal controls (8 frozen) by measurement of cardiomyocyte hypertrophy; tissue frataxin assay; Xray fluorescence (XRF) of iron (Fe) and zinc (Zn) in polyethylene glycol-embedded samples of left and right ventricular walls (LVW, RVW) and ventricular septum (VS); metal quantification in bulk digests by inductively-coupled plasma optical emission spectrometry (ICP-OES); Fe histochemistry; and immunohistochemistry and immunofluorescence of cytosolic and mitochondrial ferritins and of the inflammatory markers CD68 and hepcidin. FA cardiomyocytes were significantly larger than normal and surrounded by fibrotic endomysium. Frataxin in LVW was reduced to less than 15 ng/g wet weight (normal 235.4 +/- 75.1 ng/g). All sections displayed characteristic Fe-reactive inclusions in cardiomyocytes, and XRF confirmed significant regional Fe accumulation in LVW and VS. In contrast, ICP-OES analysis of bulk extracts revealed normal total Fe levels in LVW, RVW, and VS. Cardiac Zn remained normal by XRF and assay of bulk digests. Cytosolic and mitochondrial ferritins exhibited extensive co-localization in cardiomyocytes, representing translational and transcriptional responses to Fe, respectively. Fe accumulation progressed from a few small granules to coarse aggregates in phagocytized cardiomyocytes. All cases met the "Dallas criteria" of myocarditis. Inflammatory cells contained CD68 and cytosolic ferritin, and most also expressed the Fe-regulatory hormone hepcidin. Inflammation is an important factor in the pathogenesis of FA cardiomyopathy but may be more evident in advanced stages of the disease. Hepcidin-induced failure of Fe export from macrophages is a likely contributory cause of damage to the heart in FA. Frataxin replacement and anti-inflammatory agents are potential therapies in FA cardiomyopathy.	[Koeppen, Arnulf H.] Vet Affairs Med Ctr, Res Neurol & Pathol Serv, Albany, NY 12208 USA; [Koeppen, Arnulf H.] Albany Med Coll, Dept Neurol & Pathol, Albany, NY 12208 USA; [Ramirez, R. Liane; Becker, Alyssa B.; Bjork, Sarah T.] Vet Affairs Med Ctr, Res Serv, Albany, NY USA; [Levi, Sonia; Santambrogio, Paolo] Ist Sci San Raffaele, I-20132 Milan, Italy; [Levi, Sonia] Univ Vita Salute San Raffaele, Milan, Italy; [Parsons, Patrick J.; Kruger, Pamela C.; Yang, Karl X.] New York State Dept Hlth, Div Environm Hlth Sci, Wadsworth Ctr, Albany, NY USA; [Parsons, Patrick J.; Yang, Karl X.] SUNY Albany, Dept Environm Hlth Sci, Albany, NY 12222 USA; [Feustel, Paul J.; Mazurkiewicz, Joseph E.] Albany Med Coll, Ctr Neuropharmacol & Neurosci, Albany, NY 12208 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Albany Medical College; US Department of Veterans Affairs; Veterans Health Administration (VHA); Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Vita-Salute San Raffaele University; State University of New York (SUNY) System; Wadsworth Center; State University of New York (SUNY) System; State University of New York (SUNY) Albany; Albany Medical College	Koeppen, AH (corresponding author), Vet Affairs Med Ctr, Res Neurol & Pathol Serv, Albany, NY 12208 USA.	arnulf.koeppen@med.va.gov	levi, sonia/A-3161-2015; Santambrogio, Paolo/AAN-3837-2020; Parsons, Patrick/ABE-2655-2020; Feustel, Paul/AAW-5157-2021; Parsons, Patrick J/I-2985-2015	levi, sonia/0000-0002-5092-0847; Santambrogio, Paolo/0000-0002-5481-2130; Parsons, Patrick/0000-0001-9133-875X; Feustel, Paul/0000-0002-6963-4349; Parsons, Patrick J/0000-0001-9133-875X	National Institutes of Health [R01 NS069454, 2 U42 OD011158]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS069454] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [U42OD011158] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Friedreich's Ataxia Research Alliance (FARA) supported all aspects of this work including staff salaries and purchases of supplies and services. FARA also supported the tissue donation program. National Ataxia Foundation supported the tissue donation program. National Institutes of Health supported the tissue donation program and pertinent laboratory work (grant number R01 NS069454). NDRI receives financial support from the National Institutes of Health (grant number 2 U42 OD011158). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aretz T, 1986, AM J CARDIOVASC PATH, V1, P3; Condo I, 2006, J BIOL CHEM, V281, P16750, DOI 10.1074/jbc.M511960200; d'Estaintot BL, 2004, J MOL BIOL, V340, P277, DOI 10.1016/j.jmb.2004.04.036; de la Grandmaison GL, 2001, FORENSIC SCI INT, V119, P149, DOI 10.1016/S0379-0738(00)00401-1; DEMICHELE G, 1989, J NEUROL NEUROSUR PS, V52, P1398, DOI 10.1136/jnnp.52.12.1398; Drysdale J, 2002, BLOOD CELL MOL DIS, V29, P376, DOI 10.1006/bcmd.2002.0577; Friedreich N, 1863, VIRCHOWS ARCH PATHOL, V26, P391, DOI 10.1515/9783112391280-017; Hunter JJ, 1999, NEW ENGL J MED, V341, P1276, DOI 10.1056/NEJM199910213411706; Jones SA, 2011, J CLIN INVEST, V121, P3375, DOI 10.1172/JCI57158; KITZMAN DW, 1988, MAYO CLIN PROC, V63, P137, DOI 10.1016/S0025-6196(12)64946-5; Koeppen AH, 2012, CEREBELLUM, V11, P845, DOI 10.1007/s12311-012-0383-5; Koeppen AH, 2011, J NEUROL SCI, V303, P1, DOI 10.1016/j.jns.2011.01.010; Kruger PC, 2010, ACCREDIT QUAL ASSUR, V15, P451, DOI 10.1007/s00769-010-0660-2; LAMARCHE JB, 1980, CAN J NEUROL SCI, V7, P389, DOI 10.1017/S0317167100022927; Lane DJR, 2013, BIOCHEM J, V453, P321, DOI 10.1042/BJ20130079; Li JJ, 2012, ARTERIOSCL THROM VAS, V32, P1158, DOI 10.1161/ATVBAHA.112.246108; LUZZAGO A, 1986, BIOCHIM BIOPHYS ACTA, V872, P61, DOI 10.1016/0167-4838(86)90147-0; Merle U, 2007, ENDOCRINOLOGY, V148, P2663, DOI 10.1210/en.2006-1331; Michael S, 2006, CEREBELLUM, V5, P257, DOI 10.1080/14734220600913246; Nemeth E, 2004, SCIENCE, V306, P2090, DOI 10.1126/science.1104742; Nemeth E, 2004, J CLIN INVEST, V113, P1271, DOI 10.1172/JCI200420945; OLSON LJ, 1987, J AM COLL CARDIOL, V10, P1239, DOI 10.1016/S0735-1097(87)80124-9; Perdomini M, 2014, NAT MED, V20, P546, DOI 10.1038/nm.3510; Ramirez RL, 2012, AM J CARDIOL, V110, P1820, DOI 10.1016/j.amjcard.2012.08.018; Rodriguez R, 2014, INFECT IMMUN, V82, P745, DOI 10.1128/IAI.00983-13; Russell DS, 1946, J PATHOL BACTERIOL, V63, P739; Schrag M, 2010, BIOMETALS, V23, P1123, DOI 10.1007/s10534-010-9359-4; Singal PK, 2003, CARDIAC REMODELING F; Sugden PH, 1999, CIRC RES, V84, P633, DOI 10.1161/01.RES.84.6.633; Sullivan JL, 2007, EXP BIOL MED, V232, P1014, DOI 10.3181/0703-MR-54; Szibor M, 2014, CELL MOL LIFE SCI, V71, P1907, DOI 10.1007/s00018-013-1535-6; Zhang XL, 2010, BBA-GEN SUBJECTS, V1800, P1262, DOI 10.1016/j.bbagen.2010.08.005	32	77	81	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2015	10	3							e0116396	10.1371/journal.pone.0116396	http://dx.doi.org/10.1371/journal.pone.0116396			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9JM	25738292	gold, Green Published, Green Submitted			2022-12-27	WOS:000350685900010
J	Li, D; Xie, XJ; Wang, J; Bian, YJ; Li, QZ; Gao, XJ; Wang, CM				Li, Dan; Xie, Xuejiao; Wang, Jie; Bian, Yanjie; Li, Qingzhang; Gao, Xuejun; Wang, Chunmei			MiR-486 Regulates Lactation and Targets the PTEN Gene in Cow Mammary Glands	PLOS ONE			English	Article							TUMOR-SUPPRESSOR PTEN; MICRORNA; DIFFERENTIATION; EXPRESSION; PROTEIN; INVOLVEMENT; NETWORKS; BREAST; GROWTH	Mammary gland development is controlled by several genes. Although miRNAs have been implicated in mammary gland function, the mechanism by which miR-486 regulates mammary gland development and lactation remains unclear. We investigated miR-486 expression in cow mammary gland using qRT-PCR and ISH and show that miR-486 expression was higher during the high-quality lactation period. We found that miR-486 targets phosphoinositide signaling in the cow mammary gland by directly downregulating PTEN gene expression and by altering the expression of downstream genes that are important for the function of the mammary gland, such as AKT, mTOR. We analyzed the effect of beta-casein, lactose and triglyceride secretion in bovine mammary gland epithelial cells (BMECs) transfected by an inhibitor and by mimics of miR-486. Our results identify miR-486 as a downstream regulator of PTEN that is required for the development of the cow mammary gland.	[Li, Dan; Xie, Xuejiao; Wang, Jie; Bian, Yanjie; Li, Qingzhang; Gao, Xuejun; Wang, Chunmei] Northeast Agr Univ, Educ Minist, Key Lab Dairy Sci, Harbin 150030, Heilongjiang, Peoples R China	Northeast Agricultural University - China	Wang, CM (corresponding author), Northeast Agr Univ, Educ Minist, Key Lab Dairy Sci, Harbin 150030, Heilongjiang, Peoples R China.	wangcm-1@163.com			Major State Basic Research Development Program of China (973 Program) [2011CB100804]; Heilongjiang Department of Education Project Program [1154z1004]	Major State Basic Research Development Program of China (973 Program)(National Basic Research Program of China); Heilongjiang Department of Education Project Program	This study was supported by Major State Basic Research Development Program of China (973 Program, No. 2011CB100804); Heilongjiang Department of Education Project Program, No. 1154z1004. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker SJ, 2007, CELL, V128, P25, DOI 10.1016/j.cell.2006.12.023; BLACKBURN DE, 1982, NUCLEIC ACIDS RES, V10, P2295, DOI 10.1093/nar/10.7.2295; Boutinaud M, 2004, REPROD NUTR DEV, V44, P499, DOI 10.1051/rnd:2004054; Cho WCS, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-60; Chow LML, 2006, CANCER LETT, V241, P184, DOI 10.1016/j.canlet.2005.11.042; Cui W, 2011, MOL CELL BIOCHEM, V355, P17, DOI 10.1007/s11010-011-0834-1; Dey BK, 2011, MOL CELL BIOL, V31, P203, DOI 10.1128/MCB.01009-10; Drakaki A, 2009, CURR GENOMICS, V10, P35, DOI 10.2174/138920209787581299; Dupont J, 2002, J CLIN INVEST, V110, P815, DOI [10.1172/JCI200213829, 10.1172/JCI0213829]; Gil A, 2007, CELL DEATH DIFFER, V14, P395, DOI 10.1038/sj.cdd.4402073; Gimm O, 2000, CANCER RES, V60, P6822; Hennighausen L, 2005, NAT REV MOL CELL BIO, V6, P715, DOI 10.1038/nrm1714; Kim YJ, 2012, STEM CELLS DEV, V21, P1749, DOI 10.1089/scd.2011.0429; Lachyankar MB, 2000, J NEUROSCI, V20, P1404; Li HM, 2012, MOLECULES, V17, P12037, DOI 10.3390/molecules171012037; Li J, 1997, SCIENCE, V275, P1943, DOI 10.1126/science.275.5308.1943; Li Y, 2001, BMC Mol Biol, V2, P2, DOI 10.1186/1471-2199-2-2; Liu JD, 2008, CURR OPIN CELL BIOL, V20, P214, DOI 10.1016/j.ceb.2008.01.006; Mees ST, 2009, ANN SURG ONCOL, V16, P2339, DOI 10.1245/s10434-009-0531-4; Piao HL, 2012, J MAMMARY GLAND BIOL, V17, P33, DOI 10.1007/s10911-012-9245-5; Rijnkels M, 2010, J MAMMARY GLAND BIOL, V15, P85, DOI 10.1007/s10911-010-9170-4; Scaria V, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-68; Silveri L, 2006, REPROD NUTR DEV, V46, P549, DOI 10.1051/rnd:2006026; Small EM, 2010, P NATL ACAD SCI USA, V107, P4218, DOI 10.1073/pnas.1000300107; Tanaka T, 2009, DIFFERENTIATION, V77, P181, DOI 10.1016/j.diff.2008.10.001; Torres J, 2001, EUR J CANCER, V37, P114, DOI 10.1016/S0959-8049(00)00366-X; Tsuchiya S, 2006, J PHARMACOL SCI, V101, P267, DOI 10.1254/jphs.CPJ06013X; Tzur G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007511; Ucar A, 2010, NAT GENET, V42, P1101, DOI 10.1038/ng.709; Wang J, 2014, COMP BIOCHEM PHYS D, V11, P1, DOI 10.1016/j.cbd.2014.05.001; Wang M, 2012, J DAIRY SCI, V95, P6529, DOI 10.3168/jds.2012-5748; Wang ZR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102118; Watson CJ, 2008, DEVELOPMENT, V135, P995, DOI 10.1242/dev.005439; Yamada KM, 2001, J CELL SCI, V114, P2375	34	41	44	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2015	10	3							e0118284	10.1371/journal.pone.0118284	http://dx.doi.org/10.1371/journal.pone.0118284			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9JM	25738494	gold, Green Submitted, Green Published			2022-12-27	WOS:000350685900029
J	Lohr, M; Folkmann, JK; Sheykhzade, M; Jensen, LJ; Kermanizadeh, A; Loft, S; Moller, P				Lohr, Mille; Folkmann, Janne K.; Sheykhzade, Majid; Jensen, Lars J.; Kermanizadeh, Ali; Loft, Steffen; Moller, Peter			Hepatic Oxidative Stress, Genotoxicity and Vascular Dysfunction in Lean or Obese Zucker Rats	PLOS ONE			English	Article							FATTY LIVER-DISEASE; DIESEL EXHAUST PARTICLES; DNA-DAMAGE; 8-OXO-7,8-DIHYDRO-2'-DEOXYGUANOSINE EXCRETION; NONALCOHOLIC STEATOHEPATITIS; ENDOTHELIAL DYSFUNCTION; INSULIN-RESISTANCE; METABOLIC SYNDROME; GLYCEMIC CONTROL; GENE-EXPRESSION	Metabolic syndrome is associated with increased risk of cardiovascular disease, which could be related to oxidative stress. Here, we investigated the associations between hepatic oxidative stress and vascular function in pressurized mesenteric arteries from lean and obese Zucker rats at 14, 24 and 37 weeks of age. Obese Zucker rats had more hepatic fat accumulation than their lean counterparts. Nevertheless, the obese rats had unaltered age-related level of hepatic oxidatively damaged DNA in terms of formamidopyrimidine DNA glycosylase (FPG) or human oxoguanine DNA glycosylase (hOGG1) sensitive sites as measured by the comet assay. There were decreasing levels of oxidatively damaged DNA with age in the liver of lean rats, which occurred concurrently with increased expression of Ogg1. The 37 week old lean rats also had higher expression level of Hmox1 and elevated levels of DNA strand breaks in the liver. Still, both strain of rats had increased protein level of HMOX1 in the liver at 37 weeks. The external and lumen diameters of mesenteric arteries increased with age in obese Zucker rats with no change in media cross-sectional area, indicating outward re-modelling without hypertrophy of the vascular wall. There was increased maximal response to acetylcholine-mediated endothelium-dependent vasodilatation in both strains of rats. Collectively, the results indicate that obese Zucker rats only displayed a modest mesenteric vascular dysfunction, with no increase in hepatic oxidative stress-generated DNA damage despite substantial hepatic steatosis.	[Lohr, Mille; Folkmann, Janne K.; Kermanizadeh, Ali; Loft, Steffen; Moller, Peter] Univ Copenhagen, Environm Hlth Sect, Dept Publ Hlth, DK-1014 Copenhagen K, Denmark; [Sheykhzade, Majid] Univ Copenhagen, Fac Hlth & Med Sci, Dept Drug Design & Pharmacol, DK-2100 Copenhagen O, Denmark; [Jensen, Lars J.] Fac Hlth & Med Sci, Dept Vet Clin & Anim Sci, DK-1870 Frederiksberg C, Denmark	University of Copenhagen; University of Copenhagen	Moller, P (corresponding author), Univ Copenhagen, Environm Hlth Sect, Dept Publ Hlth, Oster Farimagsgade 5A, DK-1014 Copenhagen K, Denmark.	pemo@sund.ku.dk	Kermanizadeh, Ali/AAD-6281-2019; Jensen, Lars Jørn/A-9340-2008	Kermanizadeh, Ali/0000-0002-2989-9078; Jensen, Lars Jørn/0000-0003-4559-7456; Sheykhzade, Majid/0000-0002-4561-0326; Loft, Steffen/0000-0001-9552-8518	Danish Research Councils	Danish Research Councils(Det Frie Forskningsrad (DFF))	Funding provided by Danish Research Councils. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	de Artinano AA, 2009, BRIT J NUTR, V102, P1246, DOI 10.1017/S0007114509990729; Barregard L, 2013, ANTIOXID REDOX SIGN, V18, P2377, DOI 10.1089/ars.2012.4714; Bhatia LS, 2012, EUR HEART J, V33, P1190, DOI 10.1093/eurheartj/ehr453; Bouvet C, 2007, HYPERTENSION, V50, P248, DOI 10.1161/HYPERTENSIONAHA.107.088716; Carmiel-Haggai M, 2004, FASEB J, V18, P136, DOI 10.1096/fj.04-2291fje; Collins AR, 2012, ARTERIOSCL THROM VAS, V32, P2839, DOI 10.1161/ATVBAHA.112.300345; Danielsen PH, 2010, TOXICOL SCI, V118, P574, DOI 10.1093/toxsci/kfq290; Dybdahl M, 2003, CARCINOGENESIS, V24, P1759, DOI 10.1093/carcin/bgg147; Eckel RH, 2005, LANCET, V365, P1415, DOI 10.1016/S0140-6736(05)66378-7; Ersson C, 2013, MUTAGENESIS, V28, P279, DOI 10.1093/mutage/get001; Folkmann JK, 2007, MUTAGENESIS, V22, P105, DOI 10.1093/mutage/gel059; Folkmann JK, 2012, TOXICOL SCI, V129, P98, DOI 10.1093/toxsci/kfs180; Forchhammer L, 2012, MUTAGENESIS, V27, P665, DOI 10.1093/mutage/ges032; Forchhammer L, 2010, MUTAGENESIS, V25, P113, DOI 10.1093/mutage/gep048; Francque S, 2012, LAB INVEST, V92, P1428, DOI 10.1038/labinvest.2012.103; Gozzelino R, 2010, ANNU REV PHARMACOL, V50, P323, DOI 10.1146/annurev.pharmtox.010909.105600; Gupte AA, 2010, HEPATOLOGY, V52, P2001, DOI 10.1002/hep.23941; Gupte RS, 2009, FREE RADICAL BIO MED, V47, P219, DOI 10.1016/j.freeradbiomed.2009.01.028; Imrie H, 2010, BBA-MOL CELL BIOL L, V1801, P320, DOI 10.1016/j.bbalip.2009.09.025; Johansson C, 2010, MUTAGENESIS, V25, P125, DOI 10.1093/mutage/gep055; Kitade M, 2006, HEPATOLOGY, V44, P983, DOI 10.1002/hep.21338; Laurant P, 2004, CAN J PHYSIOL PHARM, V82, P269, DOI 10.1139/Y04-026; Loft S, 2006, CARCINOGENESIS, V27, P1245, DOI 10.1093/carcin/bgi313; Loft S, 2013, CANCER EPIDEM BIOMAR, V22, P1289, DOI 10.1158/1055-9965.EPI-13-0229; Loft S, 2012, FREE RADICAL BIO MED, V52, P167, DOI 10.1016/j.freeradbiomed.2011.10.439; Ma Q, 2013, ANNU REV PHARMACOL, V53, P401, DOI 10.1146/annurev-pharmtox-011112-140320; Mendez-Gonzalez J, 2011, BBA-MOL CELL BIOL L, V1811, P1186, DOI 10.1016/j.bbalip.2011.07.019; Mikkelsen L, 2009, FREE RADICAL BIO MED, V47, P608, DOI 10.1016/j.freeradbiomed.2009.05.030; Mingorance C, 2009, BRIT J NUTR, V102, P1145, DOI 10.1017/S0007114509389230; Moller P, 2010, FREE RADICAL BIO MED, V48, P1275, DOI 10.1016/j.freeradbiomed.2010.02.003; Mozaffari MS, 2009, NUTR METAB, V6, DOI 10.1186/1743-7075-6-51; Okada K, 2013, J GASTROENTEROL, V48, P620, DOI 10.1007/s00535-012-0659-z; Oltman CL, 2006, AM J PHYSIOL-HEART C, V291, pH1780, DOI 10.1152/ajpheart.01297.2005; Panchal SK, 2012, J NUTR, V142, P1026, DOI 10.3945/jn.111.157263; Risom L, 2003, ARCH TOXICOL, V77, P651, DOI 10.1007/s00204-003-0502-7; Risom L, 2003, CARCINOGENESIS, V24, P1847, DOI 10.1093/carcin/bgg144; Risom L, 2003, FREE RADICAL RES, V37, P957, DOI 10.1080/1071576031000150788; Risom L, 2007, FREE RADICAL RES, V41, P172, DOI 10.1080/10715760601024122; Rolo AP, 2012, FREE RADICAL BIO MED, V52, P59, DOI 10.1016/j.freeradbiomed.2011.10.003; Romanko OP, 2005, AM J PHYSIOL-HEART C, V289, pH2097, DOI 10.1152/ajpheart.00213.2005; Salcedo A, 2007, HEPATOL RES, V37, P811, DOI 10.1111/j.1872-034X.2007.00135.x; Shin S, 2009, EUR J PHARMACOL, V620, P138, DOI 10.1016/j.ejphar.2009.08.022; Stoll P, 2011, WORLD J GASTROENTERO, V17, P4184, DOI 10.3748/wjg.v17.i37.4184; Su K, 2012, J BIOL CHEM, V287, P28564, DOI 10.1074/jbc.M112.360081; Subramanian R, 2003, EUR J PHARMACOL, V477, P143, DOI 10.1016/j.ejphar.2003.08.003; Tenorio NM, 2013, CLINICS, V68, P385, DOI 10.6061/clinics/2013(03)OA16; Vesterdal LK, 2014, TOXICOL APPL PHARM, V274, P350, DOI 10.1016/j.taap.2013.10.001; Ward MR, 2000, CIRCULATION, V102, P1186, DOI 10.1161/01.CIR.102.10.1186; Winczura A, 2012, FREE RADICAL RES, V46, P442, DOI 10.3109/10715762.2012.658516; Xu JL, 2012, DIABETES, V61, P3208, DOI 10.2337/db11-1716; Young EJ, 2008, DIABETOLOGIA, V51, P872, DOI 10.1007/s00125-008-0934-y; Zhang YKJ, 2012, TOXICOL APPL PHARM, V264, P305, DOI 10.1016/j.taap.2012.09.014; Zhao L, 2011, J GASTROEN HEPATOL, V26, P875, DOI 10.1111/j.1440-1746.2010.06560.x	53	10	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2015	10	3							e0118773	10.1371/journal.pone.0118773	http://dx.doi.org/10.1371/journal.pone.0118773			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9JM	25738756	Green Published, Green Submitted, gold			2022-12-27	WOS:000350685900068
J	Tyler, E; Jones, S; Black, N; Carter, LA; Barrowclough, C				Tyler, Elizabeth; Jones, Steven; Black, Nancy; Carter, Lesley-Anne; Barrowclough, Christine			The Relationship between Bipolar Disorder and Cannabis Use in Daily Life: An Experience Sampling Study	PLOS ONE			English	Article							SUBSTANCE USE DISORDERS; JOB-SATISFACTION; RATING-SCALE; MOOD; COMORBIDITY; PSYCHOSIS; ABUSE; STRESS; PSYCHOPATHOLOGY; COOCCURRENCE	Objectives Although cannabis use is common in bipolar disorder and may contribute to worse clinical outcomes, little is understood about the relationship between this drug and bipolar disorder over the course of daily life. The aim of study was to examine the effect of cannabis on affect and bipolar symptoms in a group of individuals with bipolar disorder. Methods Twenty-four participants with bipolar disorder type I or type II completed diaries for 6 days using Experience Sampling Methodology to investigate the temporal associations between cannabis, affect and bipolar disorder symptoms. Results The results indicated that higher levels of positive affect increase the odds of using cannabis (OR: 1.25, CI: 1.06-1.47, P=0.008). However, neither negative affect, manic nor depressive symptoms predicted the use of cannabis. Cannabis use was associated with subsequent increases in positive affect (beta=0.35, CI: 0.20-0.51, P=0.000), manic symptoms (beta=0.20, CI: 0.05-0.34, P=0.009) and depressive symptoms (beta=0.17, CI: 0.04-0.29, P=0.008). Conclusion The findings indicate that cannabis use is associated with a number of subsequent psychological effects. However there was no evidence that individuals with BD were using cannabis to self-medicate minor fluctuations in negative affect or bipolar disorder symptoms over the course of daily life. The findings in relation to existing literature and clinical implications are discussed.	[Tyler, Elizabeth; Jones, Steven] Univ Lancaster, Div Hlth Res, Spectrum Ctr Mental Hlth Res, Lancaster, Lancs, England; [Black, Nancy; Barrowclough, Christine] Univ Manchester, Sch Psychol Sci, Manchester, Lancs, England; [Carter, Lesley-Anne] Univ Manchester, Sch Community Based Med, Hlth Methodol Res Grp, Manchester, Lancs, England	Lancaster University; University of Manchester; University of Manchester	Tyler, E (corresponding author), Univ Lancaster, Div Hlth Res, Spectrum Ctr Mental Hlth Res, Lancaster, Lancs, England.	e.tyler@lancaster.ac.uk		Carter, Lesley-Anne/0000-0002-1193-8681; Jones, Steven/0000-0002-8801-5113; Tyler, Elizabeth/0000-0001-5955-5607	PARADES programme grant - National Institute for Health Research (NIHR), UK [RP-PG-0407-10389]; University of Manchester, UK Doctorate of Clinical Psychology training course; National Institute for Health Research [RP-PG-0407-10389] Funding Source: researchfish	PARADES programme grant - National Institute for Health Research (NIHR), UK; University of Manchester, UK Doctorate of Clinical Psychology training course; National Institute for Health Research(National Institute for Health Research (NIHR))	The study was funded by the PARADES programme grant (RP-PG-0407-10389) led by Professor Steven Jones which was funded by National Institute for Health Research (NIHR), UK and the University of Manchester, UK Doctorate of Clinical Psychology training course. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angst J, 1996, BRIT J PSYCHIAT, V168, P31, DOI 10.1192/S0007125000298383; Ashton CH, 2005, J PSYCHOPHARMACOL, V19, P293, DOI 10.1177/0269881105051541; Ashton CH, 1999, BRIT J ANAESTH, V83, P637, DOI 10.1093/bja/83.4.637; ASHTON H, 1981, BRIT J CLIN PHARMACO, V12, P705, DOI 10.1111/j.1365-2125.1981.tb01294.x; ASHTON H, 1999, CME B PALLIAT MED, V1, P73; Barkus E, 2008, PSYCHOL MED, V38, P1267, DOI 10.1017/S0033291707002619; BECH P, 1978, NEUROPHARMACOLOGY, V17, P430, DOI 10.1016/0028-3908(78)90022-9; Bolger N, 2003, ANNU REV PSYCHOL, V54, P579, DOI 10.1146/annurev.psych.54.101601.145030; Brown ES, 2001, J AFFECT DISORDERS, V65, P105, DOI 10.1016/S0165-0327(00)00169-5; Cassidy F, 2001, BIPOLAR DISORD, V3, P181, DOI 10.1034/j.1399-5618.2001.30403.x; De Vries M, 1992, EXPERIENCE PSYCHOPAT; Delespaul P.A.E.G., 1995, ASSESSING SCHIZOPHRE; First M. B., 1997, STRUCTURED CLIN INTE; Pinto AG, 2010, PHARMACOPSYCHIATRY, V43, P263, DOI 10.1055/s-0030-1263169; Gregg L, 2007, CLIN PSYCHOL REV, V27, P494, DOI 10.1016/j.cpr.2006.09.004; Grinspoon L, 1998, J PSYCHOACTIVE DRUGS, V30, P171; Gruber A J, 1996, Depression, V4, P77, DOI 10.1002/(SICI)1522-7162(1996)4:2<77::AID-DEPR7>3.3.CO;2-T; HAMILTON M, 1960, J NEUROL NEUROSUR PS, V23, P56, DOI 10.1136/jnnp.23.1.56; Hardwick S, 2008, HOME OFFICE CANNABIS; Harrison LD, 1996, CANNABISBELEID DUITS, P198; Havermans R, 2007, J NERV MENT DIS, V195, P745, DOI 10.1097/NMD.0b013e318142cbf0; Healey C, 2009, J AFFECT DISORDERS, V113, P118, DOI 10.1016/j.jad.2008.05.010; Heishman SJ, 1997, PHARMACOL BIOCHEM BE, V58, P93, DOI 10.1016/S0091-3057(96)00456-X; Henquet C, 2009, ACTA PSYCHIAT SCAND, V119, P156, DOI 10.1111/j.1600-0447.2008.01265.x; Henquet C, 2006, J AFFECT DISORDERS, V95, P103, DOI 10.1016/j.jad.2006.05.002; Henquet C, 2010, BRIT J PSYCHIAT, V196, P447, DOI 10.1192/bjp.bp.109.072249; Ilies R, 2002, ORGAN BEHAV HUM DEC, V89, P1119, DOI 10.1016/S0749-5978(02)00018-3; Johns A, 2001, BRIT J PSYCHIAT, V178, P116, DOI 10.1192/bjp.178.2.116; Kessler RC, 1997, ARCH GEN PSYCHIAT, V54, P313; Kintz P, 1996, THER DRUG MONIT, V18, P450, DOI 10.1097/00007691-199608000-00024; Knowles R, 2007, BIPOLAR DISORD, V9, P490, DOI 10.1111/j.1399-5618.2007.00457.x; Lev-Ran S, 2013, PSYCHIAT RES, V209, P459, DOI 10.1016/j.psychres.2012.12.014; Merikangas KR, 2008, ARCH GEN PSYCHIAT, V65, P47, DOI 10.1001/archgenpsychiatry.2007.18; Murray RM, 2007, NAT REV NEUROSCI, V8, P885, DOI 10.1038/nrn2253; Myin-Germeys I, 2001, ARCH GEN PSYCHIAT, V58, P1137, DOI 10.1001/archpsyc.58.12.1137; Myin-Germeys I, 2002, AM J PSYCHIAT, V159, P443, DOI 10.1176/appi.ajp.159.3.443; Myin-Germeys I, 2005, PSYCHOL MED, V35, P733, DOI 10.1017/S0033291704004179; Myin-Germeys I, 2009, PSYCHOL MED, V39, P1533, DOI 10.1017/S0033291708004947; Palmier-Claus JE, 2011, ACTA PSYCHIAT SCAND, V123, P12, DOI 10.1111/j.1600-0447.2010.01596.x; Potter DJ, 2008, J FORENSIC SCI, V53, P90, DOI 10.1111/j.1556-4029.2007.00603.x; REGIER DA, 1990, JAMA-J AM MED ASSOC, V264, P2511; Ringen PA, 2010, PSYCHOL MED, V40, P1337, DOI 10.1017/S0033291709991620; Schmitz JM, 2002, ADDICTIVE DISORDERS, V1, P17, DOI DOI 10.1097/01.ADT.0000013364.29088.59; Schuckit MA, 1995, AM DRUG SCENE; StataCorp, 2009, STAT STAT SOFTW REL; Strakowski SM, 2000, BIOL PSYCHIAT, V48, P477, DOI 10.1016/S0006-3223(00)00900-8; Strakowski SM, 2000, CLIN PSYCHOL REV, V20, P191, DOI 10.1016/S0272-7358(99)00025-2; Tijssen MJA, 2010, ACTA PSYCHIAT SCAND, V122, P255, DOI 10.1111/j.1600-0447.2010.01539.x; van Laar M, 2007, ADDICTION, V102, P1251, DOI 10.1111/j.1360-0443.2007.01875.x; van Rossum I, 2009, J NERV MENT DIS, V197, P35, DOI 10.1097/NMD.0b013e31819292a6; VARMA VK, 1988, DRUG ALCOHOL DEPEN, V21, P147, DOI 10.1016/0376-8716(88)90061-0; Weaver T, 2003, BRIT J PSYCHIAT, V183, P304, DOI 10.1192/bjp.183.4.304; Weiss HM, 1999, ORGAN BEHAV HUM DEC, V78, P1, DOI 10.1006/obhd.1999.2824; Weiss RD, 2000, J CLIN PSYCHIAT, V61, P361, DOI 10.4088/JCP.v61n0507; Weiss RD, 2007, AM J PSYCHIAT, V164, P100, DOI 10.1176/appi.ajp.164.1.100; Weiss RD, 2009, DRUG ALCOHOL DEPEN, V104, P212, DOI 10.1016/j.drugalcdep.2009.04.018	56	17	17	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2015	10	3							e0118916	10.1371/journal.pone.0118916	http://dx.doi.org/10.1371/journal.pone.0118916			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CC9JM	25738578	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000350685900084
J	Hayakawa, S; Takaku, Y; Hwang, JS; Horiguchi, T; Suga, H; Gehring, W; Ikeo, K; Gojobori, T				Hayakawa, Shiho; Takaku, Yasuharu; Hwang, Jung Shan; Horiguchi, Takeo; Suga, Hiroshi; Gehring, Walter; Ikeo, Kazuho; Gojobori, Takashi			Function and Evolutionary Origin of Unicellular Camera-Type Eye Structure	PLOS ONE			English	Article							ACTIN-FILAMENTS; LIGHT; DINOFLAGELLATE; MICROTUBULES; PHOTORECEPTOR; ADAPTATION; MOVEMENT; PROTEINS; EYESPOT; RETINA	The ocelloid is an extraordinary eyespot organelle found only in the dinoflagellate family Warnowiaceae. It contains retina- and lens-like structures called the retinal body and the hyalosome. The ocelloid has been an evolutionary enigma because of its remarkable resemblance to the multicellular camera-type eye. To determine if the ocelloid is functionally photoreceptive, we investigated the warnowiid dinoflagellate Erythropsidinium. Here, we show that the morphology of the retinal body changed depending on different illumination conditions and the hyalosome manifests the refractile nature. Identifying a rhodopsin gene fragment in Erythropsidinium ESTs that is expressed in the retinal body by in situ hybridization, we also show that ocelloids are actually light sensitive photoreceptors. The rhodopsin gene identified is most closely related to bacterial rhodopsins. Taken together, we suggest that the ocelloid is an intracellular camera-type eye, which might be originated from endosymbiotic origin.				takashi.gojobori@kaust.edu.sa	Horiguchi, Takeo/D-7612-2012; Hwang, Jung Shan/AAJ-3014-2020	Horiguchi, Takeo/0000-0002-6118-8460; Hwang, Jung Shan/0000-0002-0908-2036	Grants-in-Aid for Scientific Research [26891021] Funding Source: KAKEN	Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))		Arendt D, 2009, PHILOS T R SOC B, V364, P2809, DOI 10.1098/rstb.2009.0104; BURNSIDE B, 1976, J SUPRAMOL STR CELL, V5, P257, DOI 10.1002/jss.400050302; CALMAN BG, 1992, VISUAL NEUROSCI, V9, P365, DOI 10.1017/S0952523800010774; CARTER SB, 1967, NATURE, V213, P261, DOI 10.1038/213261a0; Danne JC, 2012, PROTIST, V163, P76, DOI 10.1016/j.protis.2011.03.002; Darwin C, 1870, ORIGIN SPECIES MEANS; Fishman RS, 2008, ARCH OPHTHALMOL-CHIC, V126, P1586, DOI 10.1001/archopht.126.11.1586; FRANCIS D, 1967, J EXP BIOL, V47, P495; Gehring WJ, 2014, WIRES DEV BIOL, V3, P1, DOI 10.1002/wdev.96; Gomez F, 2008, EUR J PROTISTOL, V44, P291, DOI 10.1016/j.ejop.2008.03.002; Goode BL, 2000, CURR OPIN CELL BIOL, V12, P63, DOI 10.1016/S0955-0674(99)00058-7; Greuet C., 1987, Botanical Monographs (Oxford), V21, P119; GREUET C, 1978, CYTOBIOLOGIE, V17, P114; Greuet C, 1968, PROTISTOLOGICA, P209; Greuet C, 1977, PROTISTOLOGICA, P127; HAUPT W, 1982, ANNU REV PLANT PHYS, V33, P205, DOI 10.1146/annurev.pp.33.060182.001225; Hehenberger E, 2014, GENOME BIOL EVOL, V6, P2321, DOI 10.1093/gbe/evu182; HEVERS W, 1995, TISSUE CELL, V27, P405, DOI 10.1016/S0040-8166(95)80061-1; Hoppenrath M, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-116; Horiguchi Takeo, 1999, Phycological Research, V47, P101, DOI 10.1111/j.1440-1835.1999.tb00290.x; Jekely G, 2009, PHILOS T R SOC B, V364, P2795, DOI 10.1098/rstb.2009.0072; Jonasova K, 2008, SEMIN CELL DEV BIOL, V19, P71, DOI 10.1016/j.semcdb.2007.10.005; Kagawa T, 2001, SCIENCE, V291, P2138, DOI 10.1126/science.291.5511.2138; Kofoid C. A., 1921, MEMOIRS U CALIFORNIA, DOI [10.5962/bhl.title.24995, DOI 10.5962/BHL.TITLE.24995]; Kosloff M, 2003, EMBO J, V22, P459, DOI 10.1093/emboj/cdg054; Kreimer G, 1999, PROTIST, V150, P311, DOI 10.1016/S1434-4610(99)70032-5; Meyer-Rochow VB, 2001, ZOOL SCI, V18, P1175, DOI 10.2108/zsj.18.1175; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Okamoto OK, 2003, J PHYCOL, V39, P519, DOI 10.1046/j.1529-8817.2003.02170.x; Rogers SL, 2000, CURR OPIN CELL BIOL, V12, P57, DOI 10.1016/S0955-0674(99)00057-5; Rozanowska M, 2005, PHOTOCHEM PHOTOBIOL, V81, P1305, DOI 10.1562/2004-11-13-IR-371; Sato Y, 2001, J CELL SCI, V114, P269; Slamovits CH, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1188; Spudich JL, 2000, ANNU REV CELL DEV BI, V16, P365, DOI 10.1146/annurev.cellbio.16.1.365; Spudich JL, 2006, TRENDS MICROBIOL, V14, P480, DOI 10.1016/j.tim.2006.09.005; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tanaka G, 2006, ZOOL J LINN SOC-LOND, V147, P97, DOI 10.1111/j.1096-3642.2006.00216.x; Taylor F. J. R., 1987, BIOL DINOFLAGELLATES; Terakita A, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-3-213; Torres SC, 1997, CELL TISSUE RES, V290, P167, DOI 10.1007/s004410050918	40	22	22	0	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2015	10	3							e0118415	10.1371/journal.pone.0118415	http://dx.doi.org/10.1371/journal.pone.0118415			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4HV	25734540	Green Published, gold, Green Submitted			2022-12-27	WOS:000350314700028
J	Zhang, C; Xie, H; Cheng, X; Wang, DW; Li, Y; Xu, CL; Huang, X				Zhang, Chao; Xie, Hui; Cheng, Xi; Wang, Dong-Wei; Li, Yu; Xu, Chun-Ling; Huang, Xin			Molecular Identification and Functional Characterization of the Fatty Acid- and Retinoid-Binding Protein Gene Rs-far-1 in the Burrowing Nematode Radopholus similis (Tylenchida: Pratylenchidae)	PLOS ONE			English	Article							CAENORHABDITIS-ELEGANS; PARASITIC NEMATODES; EXPRESSION; RNA; INTERFERENCE	Fatty acid-and retinoid-binding protein (FAR) is a nematode-specific protein expressed in the nematode hypodermis. It is involved in nematode development, reproduction, and infection and can disrupt the plant defense reaction. In this study, we obtained the full-length sequence of the far gene from Radopholus similis (Rs-far-1), which is 828 bp long and includes a 558 bp ORF encoding 186 amino acids. A protein homology analysis revealed that Rs-FAR-1 is 75% similar to Mj-FAR-1 from Meloidogyne javanica. A neighbor-joining phylogenetic tree was inferred and showed that Rs-FAR-1 is most similar to Pv-FAR-1 from Pratylenchus vulnus. A fluorescence-based ligand-binding analysis confirmed that Rs-FAR-1 can combine with fatty acids and retinol. qPCR was used to assess Rs-far-1 expression levels at different developmental stages in different R. similis populations, and its expression was 2.5 times greater in the highly pathogenic Rs-C population than in the less pathogenic Rs-P population. The highest expression was found in females, followed by eggs, juveniles and males. When R. similis was treated with Rs-far-1 dsRNA for 36 h, the reproduction and pathogenicity decreased significantly. In situ hybridization revealed Rs-far-1 transcripts in the R. similis hypodermis. Additionally, R. similis treated with Rs-far-1 dsRNA or water were inoculated into Arabidopsis thaliana. Allene oxide synthase (AOS) expression in A. thaliana was upregulated during early infection in both treatments and then returned to the expression levels of the control plant. Compared with the control plant, AOS expression significantly decreased in A. thaliana inoculated with water-treated R. similis but significantly increased in A. thaliana inoculated with Rs-far-1 dsRNA-treated R. similis. This finding indicates that Rs-far-1 regulates AOS expression in A. thaliana. Rs-FAR-1 plays a critical role in R. similis development, reproduction, and infection and can disturb the plant defense reaction. Therefore, Rs-far-1 is an important target gene to control R. similis.				xiehui@scau.edu.cn	Wang, Dongwei/M-7768-2017	Wang, Dongwei/0000-0001-5226-4241	National Natural Science Foundation of China [31371920]; Special Fund for Agro-Scientific Research in the Public Interest [200903040]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Special Fund for Agro-Scientific Research in the Public Interest	This work was funded by National Natural Science Foundation of China (No. 31371920) and Special Fund for Agro-Scientific Research in the Public Interest (No. 200903040). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amsing JJ, 2002, NEMATOLOGY, V4, P421, DOI 10.1163/156854102760199259; ARAGAKI M, 1984, PLANT DIS, V68, P509, DOI 10.1094/PD-69-509; Bae H, 2009, PLANT CELL TISS ORG, V98, P311, DOI 10.1007/s11240-009-9565-3; Bakhetia M, 2005, TRENDS PLANT SCI, V10, P362, DOI 10.1016/j.tplants.2005.06.007; Basavaraju S, 2003, MOL BIOCHEM PARASIT, V126, P63, DOI 10.1016/S0166-6851(02)00253-0; Bath JL, 2009, J NEMATOL, V41, P228; Block A, 2005, MOL PLANT PATHOL, V6, P79, DOI 10.1111/j.1364-3703.2004.00265.x; Cheng X, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066011; Clermont-Dauphin C, 2004, SOIL USE MANAGE, V20, P105, DOI 10.1079/SUM2003231; Cotten J., 1993, P593; Davis EL, 2000, ANNU REV PHYTOPATHOL, V38, P365, DOI 10.1146/annurev.phyto.38.1.365; de Boer JM, 1998, J NEMATOL, V30, P309; De Waele D., 2002, P175, DOI 10.1079/9780851994666.0175; Fairbairn DJ, 2007, PLANTA, V226, P1525, DOI 10.1007/s00425-007-0588-x; FALLAS GA, 1994, NEMATROPICA, V24, P175; Fogain R, 2000, NEMATOLOGY, V2, P129, DOI 10.1163/156854100509015; Garofalo A, 2003, MED MICROBIOL IMMUN, V192, P47, DOI 10.1007/s00430-002-0158-6; Garofalo A, 2003, J BIOL CHEM, V278, P8065, DOI 10.1074/jbc.M206278200; Haegeman A, 2010, MOL PLANT PATHOL, V11, P315, DOI [10.1111/J.1364-3703.2010.00614.X, 10.1111/j.1364-3703.2010.00614.x]; Iberkleid I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064586; Jacob J, 2007, GENE, V402, P9, DOI 10.1016/j.gene.2007.07.015; Jones JT, 2013, MOL PLANT PATHOL, V14, P946, DOI 10.1111/mpp.12057; Kimber MJ, 2007, FASEB J, V21, P1233, DOI 10.1096/fj.06-7343com; Lee D. L., 2002, BIOL NEMATODES; Maier TR, 2013, MOL PLANT MICROBE IN, V26, P31, DOI 10.1094/MPMI-05-12-0121-FI; OBANNON JH, 1977, J NEMATOL, V9, P16; Prior A, 2001, BIOCHEM J, V356, P387, DOI 10.1042/0264-6021:3560387; SARAH JL, 1989, NEMATROPICA, V19, P199; Sarah JL, 1913, BURROWING NEMATODE B; Sindhu AS, 2009, J EXP BOT, V60, P315, DOI 10.1093/jxb/ern289; Smant G, 1997, PHYTOPATHOLOGY, V87, P839, DOI 10.1094/PHYTO.1997.87.8.839; Smith IM, 1998, DISTRIBUTION MAPS QU; Tsang MMC, 2004, ANN APPL BIOL, V145, P309, DOI 10.1111/j.1744-7348.2004.tb00388.x; Tsang MMC, 2003, CROP PROT, V22, P589, DOI 10.1016/S0261-2194(02)00235-1; VIGLIERCHIO DR, 1983, J NEMATOL, V15, P438; Zhang C, 2012, EUR J PLANT PATHOL, V133, P899, DOI 10.1007/s10658-012-0015-4	36	15	16	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2015	10	3							e0118414	10.1371/journal.pone.0118414	http://dx.doi.org/10.1371/journal.pone.0118414			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4HV	25734501	Green Submitted, gold, Green Published			2022-12-27	WOS:000350314700027
J	Samar, D; Kieler, JB; Klutts, JS				Samar, Danial; Kieler, Joshua B.; Klutts, J. Stacey			Identification and Deletion of Tft1, a Predicted Glycosyltransferase Necessary for Cell Wall beta-1,3; 1,4-Glucan Synthesis in Aspergillus fumigatus	PLOS ONE			English	Article							BIOSYNTHESIS; ORGANIZATION; VIRULENCE; MARKER; HOST	Aspergillus fumigatus is an environmental mold that causes severe, often fatal invasive infections in immunocompromised patients. The search for new antifungal drug targets is critical, and the synthesis of the cell wall represents a potential area to find such a target. Embedded within the main beta-1,3-glucan core of the A. fumigatus cell wall is a mixed linkage, beta-D-(1,3; 1,4)-glucan. The role of this molecule or how it is synthesized is unknown, though it comprises 10% of the glucans within the wall. While this is not a well-studied molecule in fungi, it has been studied in plants. Using the sequences of two plant mixed linkage glucan synthases, a single ortholog was identified in A. fumigatus (Tft1). A strain lacking this enzyme (tft1 Delta) was generated along with revertant strains containing the native gene under the control of either the native or a strongly expressing promoter. Immunofluorescence staining with an antibody against beta-(1,3; 1,4)-glucan and biochemical quantification of this polysaccharide in the tft1 Delta strain demonstrated complete loss of this molecule. Reintroduction of the gene into the knockout strain yielded reappearance in amounts that correlated with expected expression of the gene. The loss of Tft1 and mixed linkage glucan yielded no in vitro growth phenotype. However, there was a modest increase in virulence for the tft1 Delta strain in a wax worm model. While the precise roles for beta-(1,3; 1,4)-glucan within A. fumigatus cell wall are still uncertain, it is clear that Tft1 plays a pivotal role in the biosynthesis of this cell wall polysaccharide.	[Samar, Danial; Kieler, Joshua B.; Klutts, J. Stacey] Univ Iowa, Dept Pathol, Carver Coll Med, Iowa City, IA 52242 USA; [Klutts, J. Stacey] Iowa City VA Hlth Syst, Pathol & Lab Med, Iowa City, IA 52246 USA	University of Iowa; US Department of Veterans Affairs; Veterans Health Administration (VHA); Iowa City VA Health Care System	Klutts, JS (corresponding author), Univ Iowa, Dept Pathol, Carver Coll Med, 200 Hawkins Dr, Iowa City, IA 52242 USA.	stacey-klutts@uiowa.edu		Klutts, James/0000-0003-3788-1940	Department of Pathology, University of Iowa Carver College of Medicine	Department of Pathology, University of Iowa Carver College of Medicine	We would like to thank June Kwon Chung and Janyce Sugui for reagents and advice and Don Sheppard and Scott Filler for the acum Delta strain. We would also like to thank Scott Moye-Rowley and members of his laboratory for helpful advice. These studies were funded by internal monies from the Department of Pathology, University of Iowa Carver College of Medicine. We would like to thank the Department for support.	Aimanianda V, 2009, NATURE, V460, P1117, DOI 10.1038/nature08264; Baddley JW, 2011, MED MYCOL, V49, pS7, DOI 10.3109/13693786.2010.505204; Bernard M, 2001, MED MYCOL, V39, P9, DOI 10.1080/mmy.39.1.9.17; Brown RC, 1997, PLANTA, V202, P414, DOI 10.1007/s004250050145; Burton RA, 2006, SCIENCE, V311, P1940, DOI 10.1126/science.1122975; Clinical and Laboratory Standards Institute, 2008, M38A2 CLSI; Dichtl K, 2010, MOL MICROBIOL, V76, P1191, DOI 10.1111/j.1365-2958.2010.07170.x; Doblin MS, 2009, P NATL ACAD SCI USA, V106, P5996, DOI 10.1073/pnas.0902019106; Fontaine T, 2000, J BIOL CHEM, V275, P27594; Fuchs BB, 2010, VIRULENCE, V1, P475, DOI 10.4161/viru.1.6.12985; Gravelat FN, 2010, CELL MICROBIOL, V12, P473, DOI 10.1111/j.1462-5822.2009.01408.x; Hartmann T, 2010, APPL ENVIRON MICROB, V76, P6313, DOI 10.1128/AEM.00882-10; Kieler JB, 2013, J MICROBIOL METH, V95, P373, DOI 10.1016/j.mimet.2013.09.021; Klutts JS, 2006, FEMS YEAST RES, V6, P499, DOI 10.1111/j.1567-1364.2006.00054.x; Kontoyiannis DP, 2010, CLIN INFECT DIS, V50, P1091, DOI 10.1086/651263; Latge JP, 2005, MED MYCOL, V43, pS15, DOI 10.1080/13693780400029155; Liu H, 2010, MOL MICROBIOL, V78, P1038, DOI 10.1111/j.1365-2958.2010.07389.x; McCleary BV, METHODS ENZYMOL, V160, P511; MEIKLE PJ, 1994, PLANT J, V5, P1, DOI 10.1046/j.1365-313X.1994.5010001.x; Mouyna I, 2005, MOL MICROBIOL, V56, P1675, DOI 10.1111/j.1365-2958.2005.04654.x; Paul S, 2012, EUKARYOT CELL, V11, P1167, DOI 10.1128/EC.00174-12; Ram AFJ, 2006, NAT PROTOC, V1, P2253, DOI 10.1038/nprot.2006.397; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Sugui JA, 2005, APPL ENVIRON MICROB, V71, P1798, DOI 10.1128/AEM.71.4.1798-1802.2005	24	19	19	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2015	10	2							e0117336	10.1371/journal.pone.0117336	http://dx.doi.org/10.1371/journal.pone.0117336			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC3LS	25723175	Green Published, gold			2022-12-27	WOS:000350251200029
J	Huang, XX; Gao, CY; Zhao, QJ; Li, CL				Huang, Xian-xian; Gao, Chun-yu; Zhao, Qing-jun; Li, Chun-li			Antimicrobial Characterization of Site-Directed Mutagenesis of Porcine Beta Defensin 2	PLOS ONE			English	Article							MOLECULAR-CLONING; PEPTIDES; EXPRESSION; PROTEIN; INNATE	Porcine beta defensin 2 (pBD2) is a small, cationic and amphiphilic antimicrobial peptide. It has broad antimicrobial activities against bacteria and plays an important role in host defense. In order to enhance its antimicrobial activity and better understand the effect of positively charged residues on its activity, we substituted eight amino acid residues with arginine or lysine respectively. All mutants were cloned and expressed in BL21 (DE3) plysS and the mutant proteins were then purified. These mutant versions had higher positive charges but similar structural configurations compared to the wild-type pBD2. Moreover, these mutant proteins showed different antimicrobial activities against E. coli and S. aureus. The mutant I4R of pBD2 had the highest antimicrobial activity. In addition, all the mutants showed low hemolytic activities. Our results indicated that the positively charged residues were not the only factor that influenced antimicrobial activity, but other factors such as distribution of these residues on the surface of defensins might also contribute to their antimicrobial potency.	[Huang, Xian-xian; Gao, Chun-yu; Zhao, Qing-jun; Li, Chun-li] Henan Agr Univ, Dept Anim & Vet Sci, Zhengzhou, Henan Province, Peoples R China	Henan Agricultural University	Li, CL (corresponding author), Henan Agr Univ, Dept Anim & Vet Sci, Zhengzhou, Henan Province, Peoples R China.	hnclli@126.com			National Natural Science Foundation of China [31072015, 31101694]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The study is supported by National Natural Science Foundation of China (No. 31072015 and No. 31101694). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn HS, 2006, PEPTIDES, V27, P640, DOI 10.1016/j.peptides.2005.08.016; Andra J, 2008, BIOCHEM J, V410, P113, DOI 10.1042/BJ20071051; Antcheva N, 2004, ANTIMICROB AGENTS CH, V48, P685, DOI 10.1128/AAC.48.2.685-688.2004; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Auvynet C, 2009, FEBS J, V276, P6497, DOI 10.1111/j.1742-4658.2009.07360.x; Bai Y, 2009, BIOCHEMISTRY-US, V48, P7229, DOI 10.1021/bi900670d; Campopiano DJ, 2004, J BIOL CHEM, V279, P48671, DOI 10.1074/jbc.M404690200; Chandrababu KB, 2009, BIOCHEMISTRY-US, V48, P6052, DOI 10.1021/bi900154f; Chapnik N, 2012, APPL BIOCHEM BIOTECH, V166, P1703, DOI 10.1007/s12010-012-9571-5; Circo R, 2002, BIOCHEM BIOPH RES CO, V293, P586, DOI 10.1016/S0006-291X(02)00267-X; Hancock RD, 2001, COORDIN CHEM REV, V212, P1, DOI 10.1016/S0010-8545(00)00418-5; Harder J, 2001, J BIOL CHEM, V276, P5707, DOI 10.1074/jbc.M008557200; Hoover DM, 2001, J BIOL CHEM, V276, P39021, DOI 10.1074/jbc.M103830200; Hoover DM, 2003, ANTIMICROB AGENTS CH, V47, P2804, DOI 10.1128/AAC.47.9.2804-2809.2003; Huang L, 2009, APPL MICROBIOL BIOT, V84, P301, DOI 10.1007/s00253-009-1982-z; Jung S, 2011, ANTIMICROB AGENTS CH, V55, P954, DOI 10.1128/AAC.00872-10; Kluver E, 2005, BIOCHEMISTRY-US, V44, P9804, DOI 10.1021/bi050272k; Lehrer RI, 2002, CURR OPIN IMMUNOL, V14, P96, DOI 10.1016/S0952-7915(01)00303-X; Li CL, 2013, PROTEIN PEPTIDE LETT, V20, P715, DOI 10.2174/0929866511320060010; Li CL, 2013, PROTEIN EXPRES PURIF, V88, P47, DOI 10.1016/j.pep.2012.11.015; Pazgier M, 2006, CELL MOL LIFE SCI, V63, P1294, DOI 10.1007/s00018-005-5540-2; Pazgier M, 2007, J BIOL CHEM, V282, P1819, DOI 10.1074/jbc.M607210200; Peschel A, 2006, NAT REV MICROBIOL, V4, P529, DOI 10.1038/nrmicro1441; Sang YM, 2006, MAMM GENOME, V17, P332, DOI 10.1007/s00335-005-0158-0; Sang YM, 2009, VIRAL IMMUNOL, V22, P235, DOI 10.1089/vim.2009.0005; Sang YM, 2009, DEV COMP IMMUNOL, V33, P334, DOI 10.1016/j.dci.2008.05.006; Selsted ME, 2005, NAT IMMUNOL, V6, P551, DOI 10.1038/ni1206; Taylor K, 2008, BIOPOLYMERS, V90, P1, DOI 10.1002/bip.20900; Veldhuizen EJA, 2008, MOL IMMUNOL, V45, P386, DOI 10.1016/j.molimm.2007.06.001; Won HS, 2011, MOL CELLS, V31, P49, DOI 10.1007/s10059-011-0005-y; Wu ZB, 2003, P NATL ACAD SCI USA, V100, P8880, DOI 10.1073/pnas.1533186100; Yang D, 2007, CURR PHARM DESIGN, V13, P3131, DOI 10.2174/138161207782110453; Zhang GL, 1999, J BIOL CHEM, V274, P24031, DOI 10.1074/jbc.274.34.24031; Zhang GL, 1998, FEBS LETT, V424, P37, DOI 10.1016/S0014-5793(98)00134-3; Zhang GL, 2000, VET RES, V31, P277, DOI 10.1051/vetres:2000121; Zou G, 2007, J BIOL CHEM, V27	36	8	10	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2015	10	2							e0118170	10.1371/journal.pone.0118170	http://dx.doi.org/10.1371/journal.pone.0118170			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC2ZH	25719446	Green Published, Green Submitted, gold			2022-12-27	WOS:000350213200041
J	Casalino, R; Tarasoutchi, F; Spina, G; Katz, M; Bacelar, A; Sampaio, R; Ranzani, OT; Pomerantzeff, PM; Grinberg, M				Casalino, Ricardo; Tarasoutchi, Flavio; Spina, Guilherme; Katz, Marcelo; Bacelar, Antonio; Sampaio, Roney; Ranzani, Otavio T.; Pomerantzeff, Pablo M.; Grinberg, Max			EuroSCORE Models in a Cohort of Patients with Valvular Heart Disease and a High Prevalence of Rheumatic Fever Submitted to Surgical Procedures	PLOS ONE			English	Article							RISK-EVALUATION EUROSCORE; CARDIAC-SURGERY; EUROPEAN SYSTEM; MORTALITY; VALVE; VALIDATION; STRATIFICATION; REGURGITATION; COSTS	Objectives Epidemiological differences can be found between Brazilian and European valvular heart disease patients. The prevalence of heart valve diseases due to rheumatic disease is significantly higher in the Brazilian compared with the European population. Therefore, they could have different risks during and after cardiac surgery. The aim of this study was to evaluate the applicability of the additive and logistic EuroSCORE and EuroSCORE II in a cohort of high-risk patients with valvular heart disease of predominantly rheumatic aetiology submitted to surgery. Methods Between 1 February and 30 December 2009, 540 consecutive patients scheduled for valvular heart surgery were included in this study. In this set of patients, we examined the performance of the additive, logistic, and EuroSCORE II models for predicting in-hospital mortality. Calibration of each model was assessed by comparing predicted and observed in-hospital mortality and by the goodness of fit of the Hosmer-Lemeshow chi-square test. Discrimination performance of the model was evaluated with the receiver operating characteristic (ROC) curve analysis. Results The mean age was 56 +/- 16 years, 50.6% were female, and the mortality rate was 16.0% (6.0% in elective surgery and 34.0% in emergency/urgency surgery). Mortality rates were estimated according to the additive and logistic EuroSCORE and EuroSCORE II at 6.1%, 8.7%, and 4.3%, respectively. The AUC was 0.76 (95% confidence interval [95% CI] 0.70-0.81) for the additive EuroSCORE, 0.76 (95% CI 0.70-0.81) for the logistic EuroSCORE and 0.81 (95% CI 0.76-0.86) for EuroSCORE II. Hosmer-Lemeshow goodness-of-fit statistics were P = 0.52, P = 0.07, and P = 0.12 for additive, logistic EuroSCORE, and EuroSCORE II. Conclusions In this cohort of Brazilian patients with valvular heart disease submitted to surgical procedure, the EuroSCORE models had a good discriminatory capacity; however, the calibration was compromised because of an underestimation of the mortality rate.	[Casalino, Ricardo; Tarasoutchi, Flavio; Spina, Guilherme; Sampaio, Roney; Ranzani, Otavio T.; Pomerantzeff, Pablo M.; Grinberg, Max] Univ Sao Paulo, Sch Med, Inst Heart, Sao Paulo, Brazil; [Katz, Marcelo; Bacelar, Antonio] Hosp Israelita Albert Einstein, Sao Paulo, Brazil	Universidade de Sao Paulo; Hospital Israelita Albert Einstein	Casalino, R (corresponding author), Univ Sao Paulo, Sch Med, Inst Heart, Sao Paulo, Brazil.	ricardocasalino@gmail.com	Tarasoutchi, F/I-2458-2013; Pomerantzeff, Pablo M A/L-5525-2016; Ranzani, Otavio T./K-1196-2012; SAMPAIO, RONEY O/L-1643-2016	Tarasoutchi, F/0000-0002-9964-3289; Pomerantzeff, Pablo M A/0000-0003-0566-1038; Ranzani, Otavio T./0000-0002-4677-6862; SAMPAIO, RONEY O/0000-0001-6524-9614; Katz, Marcelo/0000-0003-1909-6607				Barbieri A, 2011, EUR HEART J, V32, P751, DOI 10.1093/eurheartj/ehq294; Brandao CMD, 2002, EUR J CARDIO-THORAC, V22, P922; Breda L, 2013, RHEUMATOLOGY, V52, P953, DOI 10.1093/rheumatology/ket016; Cosgrove D M, 1990, J Card Surg, V5, P227; Doenst T, 2006, ANN THORAC SURG, V81, P1632, DOI 10.1016/j.athoracsur.2005.11.052; Geissler HJ, 2000, EUR J CARDIO-THORAC, V17, P400, DOI 10.1016/S1010-7940(00)00385-7; Andrade ING, 2010, REV BRAS CIR CARDIOV, V25, P11, DOI 10.1590/S0102-76382010000100007; HANLEY JA, 1983, RADIOLOGY, V148, P839, DOI 10.1148/radiology.148.3.6878708; HOSMER DW, 1989, APPL LOGISTIC REGRES; Kawachi Y, 2001, EUR J CARDIO-THORAC, V20, P961, DOI 10.1016/S1010-7940(01)00960-5; Meja OAV, 2013, ARQ BRAS CARDIOL, V100, P246, DOI 10.5935/abc.20130043; Michel P, 2003, EUR J CARDIO-THORAC, V23, P684, DOI 10.1016/S1010-7940(03)00074-5; Nashef SA, 2004, EUR J CARDIO-THORAC, V4, P734; Nashef SAM, 1999, EUR J CARDIO-THORAC, V16, P9, DOI 10.1016/S1010-7940(99)00134-7; Nashef SAM, 2002, EUR J CARDIO-THORAC, V22, P101, DOI 10.1016/S1010-7940(02)00208-7; Nilsson J, 2004, ANN THORAC SURG, V78, P1528, DOI 10.1016/j.athoracsur.2004.04.060; Nilsson J, 2004, ANN THORAC SURG, V77, P1235, DOI 10.1016/j.athoracsur.2003.08.034; PIEHLER JM, 1995, J THORAC CARDIOV SUR, V109, P30, DOI 10.1016/S0022-5223(95)70418-3; Pintor PP, 2003, EUR J CARDIO-THORAC, V23, P595, DOI 10.1016/S1010-7940(02)00868-0; Revilla A, 2007, EUR HEART J, V28, P65, DOI 10.1093/eurheratj/ehl315; Roques F, 1999, EUR J CARDIO-THORAC, V15, P816, DOI 10.1016/S1010-7940(99)00106-2; Roques F, 2003, EUR HEART J, V24, P881, DOI 10.1016/S0195-668X(02)00799-6; Tarasoutchi F, 2003, J AM COLL CARDIOL, V41, P1316, DOI 10.1016/S0735-1097(03)00129-3; Tarasoutchi F, 2011, ARQ BRAS CARDIOL, V7; Toumpoulis IK, 2005, ANN THORAC SURG, V79, P1902, DOI 10.1016/j.athoracsur.2004.12.025; Yap CH, 2006, EUR J CARDIO-THORAC, V29, P441, DOI 10.1016/j.ejcts.2005.12.046; Yap CH, 2005, ANZ J SURG, V75, P508, DOI 10.1111/j.1445-2197.2005.03440.x	27	9	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2015	10	2							e0118357	10.1371/journal.pone.0118357	http://dx.doi.org/10.1371/journal.pone.0118357			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC2IM	25714474	Green Published, Green Submitted, gold			2022-12-27	WOS:000350168700066
J	Ghose, K; McCallum, J; Sweeney-Nixon, M; Fofana, B				Ghose, Kaushik; McCallum, Jason; Sweeney-Nixon, Marva; Fofana, Bourlaye			Histidine 352 (His(352)) and Tryptophan 355 (Trp(355)) Are Essential for Flax UGT74S1 Glucosylation Activity toward Secoisolariciresinol	PLOS ONE			English	Article							SITE-SPECIFIC MUTAGENESIS; SUGAR DONOR SPECIFICITY; SINGLE AMINO-ACID; FUNCTIONAL-CHARACTERIZATION; UDP-GLUCOSE; CRYSTAL-STRUCTURES; GLYCOSYLTRANSFERASE; LIGNANS; GLUCOSYLTRANSFERASE; METABOLISM	Flax secoisolariciresinol diglucoside (SDG) lignan is a natural phytoestrogen for which a positive role in metabolic diseases is emerging. Until recently however, much less was known about SDG and its monoglucoside (SMG) biosynthesis. Lately, flax UGT74S1 was identified and characterized as an enzyme sequentially glucosylating secoisolariciresinol (SECO) into SMG and SDG when expressed in yeast. However, the amino acids critical for UGT74S1 glucosyltransferase activity were unknown. A 3D structural modeling and docking, site-directed mutagenesis of five amino acids in the plant secondary product glycosyltransferase (PSPG) motif, and enzyme assays were conducted. UGT74S1 appeared to be structurally similar to the Arabidopsis thaliana UGT72B1 model. The ligand docking predicted Ser(357) and Trp(355) as binding to the phosphate and hydroxyl groups of UDP-glucose, whereas Cys(335), Gln(337) and Trp(355) were predicted to bind the 7-OH, 2-OCH3 and 17-OCH3 of SECO. Site-directed mutagenesis of Cys(335), Gln(337), His(352), Trp355 and Ser(357), and enzyme assays revealed an alteration of these binding sites and a significant reduction of UGT74S1 glucosyltransferase catalytic activity towards SECO and UDP-glucose in all mutants. A complete abolition of UGT74S1 activity was observed when Trp(355) was substituted to Ala(355) and Gly(355) or when changing His(352) to Asp(352), and an altered metabolite profile was observed in Cys335Ala, Gln337Ala, and Ser357Ala mutants. This study provided for the first time evidence that Trp(355) and His(352) are critical for UGT74S1's glucosylation activity toward SECO and suggested the possibility for SMG production in vitro.	[Ghose, Kaushik; McCallum, Jason; Fofana, Bourlaye] Agr & Agri Food Canada, Crops & Livestock Res Ctr, Charlottetown, PE C1A 4N6, Canada; [Ghose, Kaushik; McCallum, Jason; Sweeney-Nixon, Marva; Fofana, Bourlaye] Univ Prince Edward Isl, Charlottetown, PE C1A 4P3, Canada	Agriculture & Agri Food Canada; University of Prince Edward Island	Fofana, B (corresponding author), Agr & Agri Food Canada, Crops & Livestock Res Ctr, 440 Univ Ave, Charlottetown, PE C1A 4N6, Canada.	bourlaye.fofana@agr.gc.ca	Fofana, Bourlaye/W-4694-2019	Fofana, Bourlaye/0000-0002-5257-6576	Genome Canada/Genome Prairie; Flax Council of Canada	Genome Canada/Genome Prairie(Genome Canada); Flax Council of Canada	This research is part of the Total Utilization Flax Genomics (TUFGEN) project funded by Genome Canada/Genome Prairie with financial contribution of Flax Council of Canada to BF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adolphe JL, 2010, BRIT J NUTR, V103, P929, DOI 10.1017/S0007114509992753; Arroo RRJ, 2009, PHYTOCHEM REV, V8, P375, DOI 10.1007/s11101-009-9128-6; Barvkar VT, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-175; Berim A, 2008, PHYTOCHEMISTRY, V69, P374, DOI 10.1016/j.phytochem.2007.07.030; Bhat WW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073804; Bowles D, 2005, CURR OPIN PLANT BIOL, V8, P254, DOI 10.1016/j.pbi.2005.03.007; Bowles D, 2010, ENCY LIFE SCI ELS, DOI 101002/9780470015902a0021537; Brazier-Hicks M, 2007, P NATL ACAD SCI USA, V104, P20238, DOI 10.1073/pnas.0706421104; Buck K, 2011, BRIT J CANCER, V105, P1151, DOI 10.1038/bjc.2011.374; Cai JH, 2006, PROTEIN SCI, V15, P2071, DOI 10.1110/ps.062238406; Caputi L, 2012, PLANT J, V69, P1030, DOI 10.1111/j.1365-313X.2011.04853.x; Cartwright AM, 2008, J BIOL CHEM, V283, P15724, DOI 10.1074/jbc.M801983200; Dixon RA, 2004, ANNU REV PLANT BIOL, V55, P225, DOI 10.1146/annurev.arplant.55.031903.141729; During A, 2012, J NUTR, V142, P1798, DOI 10.3945/jn.112.162453; Gachon CMM, 2005, TRENDS PLANT SCI, V10, P542, DOI 10.1016/j.tplants.2005.09.007; Geisler-Lee J, 2006, PLANT PHYSIOL, V140, P946, DOI 10.1104/pp.105.072652; Ghose K, 2014, BMC PLANT BIOL, V14, DOI 10.1186/1471-2229-14-82; Grosdidier A, 2007, PROTEINS, V67, P1010, DOI 10.1002/prot.21367; Grosdidier A, 2011, NUCLEIC ACIDS RES, V39, pW270, DOI 10.1093/nar/gkr366; He XZ, 2006, J BIOL CHEM, V281, P34441, DOI 10.1074/jbc.M605767200; Hiromoto T, 2013, J SYNCHROTRON RADIAT, V20, P894, DOI 10.1107/S0909049513020712; Imberty Anne, 2006, V347, P145; Irwin JJ, 2005, J CHEM INF MODEL, V45, P177, DOI 10.1021/ci049714+; Jhala A.J., 2010, AUST J BASIC APPL SC, V4, P4304; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Li LN, 2007, J MOL BIOL, V370, P951, DOI 10.1016/j.jmb.2007.05.036; Looger LL, 2003, NATURE, V423, P185, DOI 10.1038/nature01556; Masada S, 2007, FEBS LETT, V581, P2605, DOI 10.1016/j.febslet.2007.05.002; Modolo LV, 2009, FEBS LETT, V583, P2131, DOI 10.1016/j.febslet.2009.05.046; Noguchi A, 2008, PLANT J, V54, P415, DOI 10.1111/j.1365-313X.2008.03428.x; Noguchi A, 2007, J BIOL CHEM, V282, P23581, DOI 10.1074/jbc.M702651200; Offen W, 2006, EMBO J, V25, P1396, DOI 10.1038/sj.emboj.7600970; Ono E, 2010, PLANT BIOTECHNOL-NAR, V27, P317, DOI 10.5511/plantbiotechnology.27.317; Osmani SA, 2008, PLANT PHYSIOL, V148, P1295, DOI 10.1104/pp.108.128256; Osmani SA, 2009, PHYTOCHEMISTRY, V70, P325, DOI 10.1016/j.phytochem.2008.12.009; Pan JY, 2009, NAT PROD REP, V26, P1251, DOI 10.1039/b910940d; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Prakash D, 2011, PHARMACOLOGYONLINE, V1, P510; Rabetafika HN, 2011, INT J FOOD SCI TECH, V46, P221, DOI 10.1111/j.1365-2621.2010.02477.x; Ross J, 2001, GENOME BIOL, V2, DOI 10.1186/gb-2001-2-2-reviews3004; Rothlisberger D, 2008, NATURE, V453, P190, DOI 10.1038/nature06879; Shao H, 2005, PLANT CELL, V17, P3141, DOI 10.1105/tpc.105.035055; Thompson LU, 2006, NUTR CANCER, V54, P184, DOI 10.1207/s15327914nc5402_5; Thorsoe KS, 2005, PLANT PHYSIOL, V139, P664, DOI 10.1104/pp.105.063842; Toure A, 2010, COMPR REV FOOD SCI F, V9, P261, DOI 10.1111/j.1541-4337.2009.00105.x; Wang J., 2009, FRONT BIOL, V4, P39, DOI [10.1007/s11515-008-0111-1, DOI 10.1007/S11515-008-0111-1]; Wang ZW, 2012, PLANT J, V72, P461, DOI 10.1111/j.1365-313X.2012.05093.x; Webb AL, 2005, NUTR CANCER, V51, P117, DOI 10.1207/s15327914nc5102_1; Witte S, 2009, PLANTA, V229, P1135, DOI 10.1007/s00425-009-0902-x; Witz S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091343; Yonekura-Sakakibara K, 2011, PLANT J, V66, P182, DOI 10.1111/j.1365-313X.2011.04493.x; Yousefzadi M, 2010, ENG LIFE SCI, V10, P281, DOI 10.1002/elsc.201000027	52	7	7	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2015	10	2							e116248	10.1371/journal.pone.0116248	http://dx.doi.org/10.1371/journal.pone.0116248			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC2IM	25714779	Green Submitted, Green Published, gold			2022-12-27	WOS:000350168700013
J	Gu, L; Uhelski, ML; Anand, S; Romero-Ortega, M; Kim, YT; Fuchs, PN; Mohanty, SK				Gu, Ling; Uhelski, Megan L.; Anand, Sanjay; Romero-Ortega, Mario; Kim, Young-tae; Fuchs, Perry N.; Mohanty, Samarendra K.			Pain Inhibition by Optogenetic Activation of Specific Anterior Cingulate Cortical Neurons	PLOS ONE			English	Article							OPTICAL CONTROL; NERVE INJURY; CORTEX; RESPONSES; CHANNELRHODOPSIN-2; STIMULATION; BEHAVIOR; HEAT; FMRI	Cumulative evidence from both humans and animals suggests that the anterior cingulate cortex (ACC) is important for pain-related perception, and thus a likely target for pain relief therapy. However, use of existing electrode based ACC stimulation has not significantly reduced pain, at least in part due to the lack of specificity and likely co-activation of both excitatory and inhibitory neurons. Herein, we report a dramatic reduction of pain behavior in transgenic mice by optogenetic stimulation of the inhibitory neural circuitry of the ACC expressing channelrhodopsin-2. Electrophysiological measurements confirmed that stimulation of ACC inhibitory neurons is associated with decreased neural activity in the ACC. Further, a distinct optogenetic stimulation intensity and frequency-dependent inhibition of spiking activity in the ACC was observed. Moreover, we confirmed specific electrophysiological responses from different neuronal units in the thalamus, in response to particular types of painful stimuli (i,e., formalin injection, pinch), which we found to be modulated by optogenetic control of the ACC inhibitory neurons. These results underscore the inhibition of the ACC as a clinical alternative in inhibiting chronic pain, and leads to a better understanding of the pain processing circuitry of the cingulate cortex.	[Gu, Ling; Mohanty, Samarendra K.] Univ Texas Arlington, Dept Phys, Biophys & Physiol Grp, Arlington, TX 76019 USA; [Uhelski, Megan L.; Fuchs, Perry N.] Univ Texas Arlington, Dept Psychol, Arlington, TX 76019 USA; [Anand, Sanjay; Romero-Ortega, Mario; Kim, Young-tae] Univ Texas Arlington, Dept Bioengn, Arlington, TX 76019 USA; [Fuchs, Perry N.] Univ Texas Arlington, Dept Biol, Arlington, TX 76019 USA	University of Texas System; University of Texas Arlington; University of Texas System; University of Texas Arlington; University of Texas System; University of Texas Arlington; University of Texas System; University of Texas Arlington	Mohanty, SK (corresponding author), Univ Texas Arlington, Dept Phys, Biophys & Physiol Grp, Arlington, TX 76019 USA.	smohanty@uta.edu	Uhelski, Megan/AAR-4432-2021; Romero-Ortega, Mario I/T-2520-2018; Romero-Ortega, Mario/K-6097-2019; Uhelski, Megan/GXG-7515-2022	Uhelski, Megan/0000-0003-3587-3103; Romero-Ortega, Mario I/0000-0003-2576-2629; Romero-Ortega, Mario/0000-0003-2576-2629; Fuchs, Perry/0000-0001-5364-4334	office of Provost; University of Texas at Arlington	office of Provost; University of Texas at Arlington	SKM would like to thank the office of Provost and president of The University of Texas at Arlington for supporting the research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arrenberg AB, 2009, P NATL ACAD SCI USA, V106, P17968, DOI 10.1073/pnas.0906252106; Blom SM, 2014, J NEUROSCI, V34, P5754, DOI 10.1523/JNEUROSCI.3667-13.2014; Boas DA, 2002, OPT EXPRESS, V10, P159, DOI 10.1364/OE.10.000159; Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525; Cao H, 2013, IEEE T BIO-MED ENG, V60, P225, DOI 10.1109/TBME.2012.2217395; COBB SR, 1995, NATURE, V378, P75, DOI 10.1038/378075a0; Davey CG, 2012, PSYCHOL MED, V42, P2071, DOI 10.1017/S0033291712000323; Dhakal KR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111488; Eisenberger NI, 2003, SCIENCE, V302, P290, DOI 10.1126/science.1089134; Eisenberger NI, 2004, TRENDS COGN SCI, V8, P294, DOI 10.1016/j.tics.2004.05.010; Eto K, 2011, J NEUROSCI, V31, P7631, DOI 10.1523/JNEUROSCI.0946-11.2011; Fenno L, 2011, ANNU REV NEUROSCI, V34, P389, DOI 10.1146/annurev-neuro-061010-113817; Foerster BR, 2012, ARTHRITIS RHEUM-US, V64, P579, DOI 10.1002/art.33339; Gatchel RJ, 2007, PSYCHOL BULL, V133, P581, DOI 10.1037/0033-2909.133.4.581; GONCHAR YA, 1995, BRAIN RES, V697, P27, DOI 10.1016/0006-8993(95)00746-D; Gu L, 2012, NAT PRECEDINGS; HUNSKAAR S, 1987, PAIN, V30, P103, DOI 10.1016/0304-3959(87)90088-1; Ivanova E, 2010, MOL VIS, V16, P1059; Johannes CB, 2010, J PAIN, V11, P1230, DOI 10.1016/j.jpain.2010.07.002; Johansen JP, 2010, P NATL ACAD SCI USA, V107, P12692, DOI 10.1073/pnas.1002418107; Johansen JP, 2001, P NATL ACAD SCI USA, V98, P8077, DOI 10.1073/pnas.141218998; Johansson JD, 2010, J BIOMED OPT, V15, DOI 10.1117/1.3495719; Kim TI, 2013, SCIENCE, V340, P211, DOI 10.1126/science.1232437; Koyama T, 2000, NEUROSCI LETT, V283, P17, DOI 10.1016/S0304-3940(00)00894-6; Kuo CC, 2005, J NEUROPHYSIOL, V94, P1825, DOI 10.1152/jn.00294.2005; Kwan CL, 2000, PAIN, V85, P359, DOI 10.1016/S0304-3959(99)00287-0; LaBuda CJ, 2005, NEUROSCIENCE, V136, P311, DOI 10.1016/j.neuroscience.2005.07.010; Lagali PS, 2008, NAT NEUROSCI, V11, P667, DOI 10.1038/nn.2117; LaGraize SC, 2004, EXP NEUROL, V188, P139, DOI 10.1016/j.expneurol.2004.04.003; Lefaucheur JP, 2006, NEUROPHYSIOL CLIN, V36, P117, DOI 10.1016/j.neucli.2006.08.002; Llewellyn ME, 2010, NAT MED, V16, P1161, DOI 10.1038/nm.2228; Lobo MK, 2010, SCIENCE, V330, P385, DOI 10.1126/science.1188472; Ma JH, 2011, EUR J PAIN, V15, P895, DOI 10.1016/j.ejpain.2011.04.003; MCDONALD CT, 1993, J NEUROSCI, V13, P768; Millan MJ, 2002, PROG NEUROBIOL, V66, P355, DOI 10.1016/S0301-0082(02)00009-6; Nagel G, 2003, P NATL ACAD SCI USA, V100, P13940, DOI 10.1073/pnas.1936192100; Pastrana E, 2011, NAT METHODS, V8, P24, DOI 10.1038/NMETH.F.323; Rainville P, 2005, PAIN, V118, P306, DOI 10.1016/j.pain.2005.08.022; Rainville P, 2002, CURR OPIN NEUROBIOL, V12, P195, DOI 10.1016/S0959-4388(02)00313-6; Senapati AK, 2005, J NEUROPHYSIOL, V94, P845, DOI 10.1152/jn.00040.2005; Stuber GD, 2010, NEUROPSYCHOPHARMACOL, V35, P341, DOI 10.1038/npp.2009.102; TALBOT JD, 1991, SCIENCE, V251, P1355, DOI 10.1126/science.2003220; Tomita H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007679; Tonnesen J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017560; Vogt BA, 1999, PROGR BRAIN RES, P223; WANG LH, 1995, COMPUT METH PROG BIO, V47, P131, DOI 10.1016/0169-2607(95)01640-F; Wang LH, 1997, COMPUT METH PROG BIO, V54, P141, DOI 10.1016/S0169-2607(97)00021-7; Yamamura H, 1996, BRAIN RES, V735, P83; Yizhar O, 2011, NATURE, V477, P171, DOI 10.1038/nature10360; Zhang F, 2006, NAT METHODS, V3, P785, DOI 10.1038/nmeth936; Zhang LJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053206; Zhuo M, 2005, CAN J NEUROL SCI, V32, P27, DOI 10.1017/S031716710001684X; Zhuo M, 2006, J NEUROSCI RES, V84, P927, DOI 10.1002/jnr.21003; Ziemann U, 1996, ANN NEUROL, V40, P367, DOI 10.1002/ana.410400306	54	64	66	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2015	10	2							e0117746	10.1371/journal.pone.0117746	http://dx.doi.org/10.1371/journal.pone.0117746			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC2IM	25714399	gold, Green Submitted, Green Published			2022-12-27	WOS:000350168700037
J	Blake, SJP; Ching, ALH; Kenna, TJ; Galea, R; Large, J; Yagita, H; Steptoe, RJ				Blake, Stephen J. P.; Ching, Alan L. H.; Kenna, Tony J.; Galea, Ryan; Large, Justin; Yagita, Hideo; Steptoe, Raymond J.			Blockade of PD-1/PD-L1 Promotes Adoptive T-Cell Immunotherapy in a Tolerogenic Environment	PLOS ONE			English	Article							RESTING DENDRITIC CELLS; EFFECTOR FUNCTION; PERIPHERAL TOLERANCE; ANTI-PD-1 ANTIBODY; ANTITUMOR IMMUNITY; REGULATORY T; PD-1; PATHWAY; LIGAND; COMBINATION	Adoptive cellular immunotherapy using in vitro expanded CD8(+) T cells shows promise for tumour immunotherapy but is limited by eventual loss of function of the transferred T cells through factors that likely include inactivation by tolerogenic dendritic cells (DC). The co-inhibitory receptor programmed death-1 (PD-1), in addition to controlling T-cell responsiveness at effector sites in malignancies and chronic viral diseases is an important modulator of dendritic cell-induced tolerance in naive T cell populations. The most potent therapeutic capacity amongst CD8(+) T cells appears to lie within Tcm or Tcm-like cells but memory T cells express elevated levels of PD-1. Based on established trafficking patterns for Tcm it is likely Tcm-like cells interact with lymphoid-tissue DC that present tumour-derived antigens and may be inherently tolerogenic to develop therapeutic effector function. As little is understood of the effect of PD-1/PD-L1 blockade on Tcm-like CD8(+) T cells, particularly in relation to inactivation by DC, we explored the effects of PD-1/PD-L1 blockade in a mouse model where resting DC tolerise effector and memory CD8(+) T cells. Blockade of PD-1/PDL-1 promoted effector differentiation of adoptively-transferred Tcm-phenotype cells interacting with tolerising DC. In tumour-bearing mice with tolerising DC, effector activity was increased in both lymphoid tissues and the tumour-site and anti-tumour activity was promoted. Our findings suggest PD-1/PD-L1 blockade may be a useful adjunct for adoptive immunotherapy by promoting effector differentiation in the host of transferred Tcm-like cells.	[Blake, Stephen J. P.; Ching, Alan L. H.; Kenna, Tony J.; Galea, Ryan; Large, Justin; Steptoe, Raymond J.] Univ Queensland, UQ Diamantina Inst, Brisbane, Qld, Australia; [Yagita, Hideo] Juntendo Univ, Sch Med, Dept Immunol, Tokyo 113, Japan	University of Queensland; Juntendo University	Steptoe, RJ (corresponding author), Univ Queensland, UQ Diamantina Inst, Brisbane, Qld, Australia.	r.steptoe@uq.edu.au	Steptoe, Raymond/B-3843-2011; Kenna, Tony/A-6035-2011	Steptoe, Raymond/0000-0002-6513-6406; Kenna, Tony/0000-0001-6844-3463	National Health and Medical Research Council [631402, GNT1013066]; Australian Research Council [FT110100372]	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council(Australian Research Council)	Funding was provided by the National Health and Medical Research Council (http://www.nhmrc.gov.au/) Project Grants (631402, GNT1013066) and an Australian Research Council (http://www.arc.gov.au/) ARC Future Fellowship (FT110100372). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agata Y, 1996, INT IMMUNOL, V8, P765, DOI 10.1093/intimm/8.5.765; Ansari MJI, 2003, J EXP MED, V198, P63, DOI 10.1084/jem.20022125; Barber DL, 2006, NATURE, V439, P682, DOI 10.1038/nature04444; Benedict CA, 2008, J IMMUNOL, V180, P4836, DOI 10.4049/jimmunol.180.7.4836; Berrien-Elliott MM, 2013, CANCER RES, V73, P605, DOI 10.1158/0008-5472.CAN-12-2179; Blackburn SD, 2009, NAT IMMUNOL, V10, P29, DOI 10.1038/ni.1679; Blank C, 2004, CANCER RES, V64, P1140, DOI 10.1158/0008-5472.CAN-03-3259; Brahmer JR, 2012, NEW ENGL J MED, V366, P2455, DOI 10.1056/NEJMoa1200694; Butte MJ, 2007, IMMUNITY, V27, P111, DOI 10.1016/j.immuni.2007.05.016; Curran MA, 2010, P NATL ACAD SCI USA, V107, P4275, DOI 10.1073/pnas.0915174107; Currie AJ, 2009, J IMMUNOL, V183, P7898, DOI 10.4049/jimmunol.0901060; Deng LF, 2014, J CLIN INVEST, V124, P687, DOI 10.1172/JCI67313; Dudley ME, 2005, J CLIN ONCOL, V23, P2346, DOI 10.1200/JCO.2005.00.240; Fiorenza S, 2012, J IMMUNOL, V189, P5622, DOI 10.4049/jimmunol.1200709; Goldberg MV, 2007, BLOOD, V110, P186, DOI 10.1182/blood-2006-12-062422; Hernandez J, 2001, J EXP MED, V194, P707, DOI 10.1084/jem.194.6.707; Hodi FS, 2010, NEW ENGL J MED, V363, P711, DOI 10.1056/NEJMoa1003466; HOGQUIST KA, 1994, CELL, V76, P17, DOI 10.1016/0092-8674(94)90169-4; Huang CT, 2003, J IMMUNOL, V170, P3945, DOI 10.4049/jimmunol.170.8.3945; Huang XP, 2004, EUR J IMMUNOL, V34, P1351, DOI 10.1002/eji.200324734; John LB, 2013, CLIN CANCER RES, V19, P5636, DOI 10.1158/1078-0432.CCR-13-0458; Keir ME, 2008, ANNU REV IMMUNOL, V26, P677, DOI 10.1146/annurev.immunol.26.021607.090331; Kenna TJ, 2008, BLOOD, V111, P2091, DOI 10.1182/blood-2007-07-103200; Kenna TJ, 2010, J IMMUNOL, V184, P598, DOI 10.4049/jimmunol.0900032; Klebanoff CA, 2005, P NATL ACAD SCI USA, V102, P9571, DOI 10.1073/pnas.0503726102; Klebanoff CA, 2012, J IMMUNOTHER, V35, P651, DOI 10.1097/CJI.0b013e31827806e6; Kuipers H, 2006, EUR J IMMUNOL, V36, P2472, DOI 10.1002/eji.200635978; Latchman YE, 2004, P NATL ACAD SCI USA, V101, P10691, DOI 10.1073/pnas.0307252101; Lee SJ, 2006, FEBS LETT, V580, P755, DOI 10.1016/j.febslet.2005.12.093; McDonnell AM, 2010, CLIN DEV IMMUNOL, DOI 10.1155/2010/539519; Muhlbauer M, 2006, J HEPATOL, V45, P520, DOI 10.1016/j.jhep.2006.05.007; Mueller SN, 2007, P NATL ACAD SCI USA, V104, P15430, DOI 10.1073/pnas.0702579104; Okazaki T, 2013, NAT IMMUNOL, V14, P1212, DOI 10.1038/ni.2762; Pardoll DM, 2012, NAT REV CANCER, V12, P252, DOI 10.1038/nrc3239; Park JJ, 2010, BLOOD, V116, P1291, DOI 10.1182/blood-2010-01-265975; Paterson AM, 2011, J IMMUNOL, V187, P1097, DOI 10.4049/jimmunol.1003496; Peng WY, 2012, CANCER RES, V72, P5209, DOI 10.1158/0008-5472.CAN-12-1187; Pilon-Thomas S, 2010, J IMMUNOL, V184, P3442, DOI 10.4049/jimmunol.0904114; Probst HC, 2005, NAT IMMUNOL, V6, P280, DOI 10.1038/ni1165; Probst HC, 2003, IMMUNITY, V18, P713, DOI 10.1016/S1074-7613(03)00120-1; Restifo NP, 2012, NAT REV IMMUNOL, V12, P269, DOI 10.1038/nri3191; Reynoso ED, 2009, J IMMUNOL, V182, P2102, DOI 10.4049/jimmunol.0802769; Rodig N, 2003, EUR J IMMUNOL, V33, P3117, DOI 10.1002/eji.200324270; Sakuishi K, 2010, J EXP MED, V207, P2187, DOI 10.1084/jem.20100643; Sallusto F, 1999, NATURE, V401, P708, DOI 10.1038/44385; Sharpe AH, 2007, NAT IMMUNOL, V8, P239, DOI 10.1038/ni1443; Sierro SR, 2011, EUR J IMMUNOL, V41, P2217, DOI 10.1002/eji.201041235; Steptoe RJ, 2007, J IMMUNOL, V178, P2094, DOI 10.4049/jimmunol.178.4.2094; Takamura S, 2010, J IMMUNOL, V184, P4696, DOI 10.4049/jimmunol.0903478; Topalian SL, 2012, NEW ENGL J MED, V366, P2443, DOI 10.1056/NEJMoa1200690; Tsushima F, 2007, BLOOD, V110, P180, DOI 10.1182/blood-2006-11-060087; Wang AR, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004306; Weninger W, 2001, J EXP MED, V194, P953, DOI 10.1084/jem.194.7.953; Wolint P, 2004, J EXP MED, V199, P925, DOI 10.1084/jem.20031799; Xu DQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056539; Yang CJ, 2011, CLIN DEV IMMUNOL, DOI 10.1155/2011/842849; Yang SC, 2011, CANCER IMMUNOL IMMUN, V60, P739, DOI 10.1007/s00262-011-0977-7; Zhou QF, 2010, J IMMUNOL, V185, P5082, DOI 10.4049/jimmunol.1001821; Zhou Q, 2010, BLOOD, V116, P2484, DOI 10.1182/blood-2010-03-275446; Zippelius A, 2004, CANCER RES, V64, P2865, DOI 10.1158/0008-5472.CAN-03-3066; Zou WP, 2005, NAT REV CANCER, V5, P263, DOI 10.1038/nrc1586	61	28	32	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2015	10	3							e0119483	10.1371/journal.pone.0119483	http://dx.doi.org/10.1371/journal.pone.0119483			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9KG	25741704	Green Published, gold, Green Submitted			2022-12-27	WOS:000350688100115
J	Eppenga, WL; Kramers, C; Derijks, HJ; Wensing, M; Wetzels, JFM; De Smet, PAGM				Eppenga, Willemijn L.; Kramers, Cornelis; Derijks, Hieronymus J.; Wensing, Michel; Wetzels, Jack F. M.; De Smet, Peter A. G. M.			Individualizing Pharmacotherapy in Patients with Renal Impairment: The Validity of the Modification of Diet in Renal Disease Formula in Specific Patient Populations with a Glomerular Filtration Rate below 60 Ml/Min. A Systematic Review	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; SERUM CYSTATIN-C; EPIDEMIOLOGY COLLABORATION EQUATION; CREATININE-BASED EQUATIONS; CRITICALLY-ILL PATIENTS; HIV-INFECTED PATIENTS; CHRONIC HEART-FAILURE; COCKCROFT-GAULT; PREDICTION EQUATIONS; LIVER-DISEASE	Background The Modification of Diet in Renal Disease (MDRD) formula is widely used in clinical practice to assess the correct drug dose. This formula is based on serum creatinine levels which might be influenced by chronic diseases itself or the effects of the chronic diseases. We conducted a systematic review to determine the validity of the MDRD formula in specific patient populations with renal impairment: elderly, hospitalized and obese patients, patients with cardiovascular disease, cancer, chronic respiratory diseases, diabetes mellitus, liver cirrhosis and human immunodeficiency virus. Methods and Findings We searched for articles in Pubmed published from January 1999 through January 2014. Selection criteria were (1) patients with a glomerular filtration rate (GFR) < 60 ml/min (/1.73m(2)), (2) MDRD formula compared with a gold standard and (3) statistical analysis focused on bias, precision and/or accuracy. Data extraction was done by the first author and checked by a second author. A bias of 20% or less, a precision of 30% or less and an accuracy expressed as P-30% of 80% or higher were indicators of the validity of the MDRD formula. In total we included 27 studies. The number of patients included ranged from 8 to 1831. The gold standard and measurement method used varied across the studies. For none of the specific patient populations the studies provided sufficient evidence of validity of the MDRD formula regarding the three parameters. For patients with diabetes mellitus and liver cirrhosis, hospitalized patients and elderly with moderate to severe renal impairment we concluded that the MDRD formula is not valid. Limitations of the review are the lack of considering the method of measuring serum creatinine levels and the type of gold standard used. Conclusion In several specific patient populations with renal impairment the use of the MDRD formula is not valid or has uncertain validity.	[Eppenga, Willemijn L.; Wensing, Michel; De Smet, Peter A. G. M.] Radboud Univ Nijmegen, Med Ctr, Radboud Inst Hlth Sci, IQ Healthcare, NL-6525 ED Nijmegen, Netherlands; [Kramers, Cornelis] Radboud Univ Nijmegen, Med Ctr, Dept Pharmacol & Toxicol, NL-6525 ED Nijmegen, Netherlands; [Kramers, Cornelis] Canisius Wilhelmina Hosp, Dept Clin Pharm, Nijmegen, Netherlands; [Derijks, Hieronymus J.] Hosp Pharm ZANOB, S Hertogenbosch, Shertogenbosch, Netherlands; [Derijks, Hieronymus J.] Univ Utrecht, Utrecht Inst Pharmaceut Sci, Div Pharmacoepidemiol & Pharmacotherapy, Utrecht, Netherlands; [Wetzels, Jack F. M.] Radboud Univ Nijmegen, Med Ctr, Dept Nephrol, NL-6525 ED Nijmegen, Netherlands; [De Smet, Peter A. G. M.] Radboud Univ Nijmegen, Med Ctr, Dept Pharm, NL-6525 ED Nijmegen, Netherlands	Radboud University Nijmegen; Radboud University Nijmegen; Canisius-Wilhelmina Hospital; Utrecht University; Radboud University Nijmegen; Radboud University Nijmegen	Eppenga, WL (corresponding author), Radboud Univ Nijmegen, Med Ctr, Radboud Inst Hlth Sci, IQ Healthcare, NL-6525 ED Nijmegen, Netherlands.	Willemijn.Eppenga@radboudumc.nl	Kramers, C./L-4458-2015; Wetzels, Jack F.M./A-1720-2014; Wensing, Michel/H-8113-2014; Smet, P.A.G.M./L-4654-2015	Wetzels, Jack F.M./0000-0002-0650-6921; Wensing, Michel/0000-0001-6569-8137; 				Aapro M, 2012, CANCER TREAT REV, V38, P235, DOI 10.1016/j.ctrv.2011.05.001; Abdo AS, 2011, AM J MED, V124, P26, DOI 10.1016/j.amjmed.2010.05.030; Agarwal R, 2003, AM J KIDNEY DIS, V41, P752, DOI 10.1016/S0272-6386(03)00022-2; Ahmed SB, 2009, HYPERTENS PREGNANCY, V28, P243, DOI 10.1080/10641950801986720; Ainsworth NL, 2012, ANN ONCOL, V23, P1845, DOI 10.1093/annonc/mdr539; Al-Aloul M, 2007, J CYST FIBROS, V6, P41, DOI 10.1016/j.jcf.2006.05.004; Andreev E, 1999, J INTERN MED, V246, P247, DOI 10.1046/j.1365-2796.1999.00515.x; Beddhu S, 2003, J AM SOC NEPHROL, V14, P1000, DOI 10.1097/01.ASN.0000057856.88335.DD; Beringer PM, 2010, PHARMACOTHERAPY, V30, P1004, DOI 10.1592/phco.30.10.1004; Bevc S, 2011, THER APHER DIAL, V15, P261, DOI 10.1111/j.1744-9987.2011.00948.x; BJORNSSON TD, 1979, CLIN PHARMACOKINET, V4, P200, DOI 10.2165/00003088-197904030-00003; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Bolke E, 2011, STRAHLENTHER ONKOL, V187, P191, DOI 10.1007/s00066-010-2203-5; Bonjoch A, 2010, ANTIVIR RES, V88, P347, DOI 10.1016/j.antiviral.2010.09.015; Botev R, 2009, CLIN J AM SOC NEPHRO, V4, P899, DOI 10.2215/CJN.05371008; Bouchard J, 2010, NEPHROL DIAL TRANSPL, V25, P102, DOI 10.1093/ndt/gfp392; Bouquegneau A, 2013, NEPHROL DIAL TRANSPL, V28, P122, DOI 10.1093/ndt/gft329; Chertow GM, 2005, J AM SOC NEPHROL, V16, P3365, DOI 10.1681/ASN.2004090740; Cholongitas E, 2007, ALIMENT PHARM THER, V26, P969, DOI 10.1111/j.1365-2036.2007.03443.x; Chudleigh RA, 2009, DIABETOLOGIA, V52, P1274, DOI 10.1007/s00125-009-1379-7; COCCHETTO DM, 1983, THER DRUG MONIT, V5, P161, DOI 10.1097/00007691-198306000-00002; COCKCROFT DW, 1976, NEPHRON, V16, P31, DOI 10.1159/000180580; Coresh J, 2008, SCAND J CLIN LAB INV, V68, P30, DOI 10.1080/00365510802141140; Coresh J, 2006, CURR OPIN NEPHROL HY, V15, P276, DOI 10.1097/01.mnh.0000222695.84464.61; Craig AJ, 2012, BRIT J CANCER, V107, P1310, DOI 10.1038/bjc.2012.393; de Boer IH, 2009, AM J KIDNEY DIS, V54, P1043, DOI 10.1053/j.ajkd.2009.07.018; de Lemos ML, 2006, GYNECOL ONCOL, V103, P1063, DOI 10.1016/j.ygyno.2006.06.024; Del Fabbro P, 2010, BMC NEPHROL, V11, DOI 10.1186/1471-2369-11-27; Delanaye P, 2013, NEPHROL DIAL TRANSPL, V28, P1396, DOI 10.1093/ndt/gft006; Drenth-van Maanen AC, 2013, BRIT J CLIN PHARMACO, V76, P616, DOI 10.1111/bcp.12199; DUCHARME MP, 1993, ANN PHARMACOTHER, V27, P622; Earley A, 2012, ANN INTERN MED, V156, P785, DOI 10.7326/0003-4819-156-11-201203200-00391; Eppenga WL, 2014, J NEPHROL, V27, P11, DOI 10.1007/s40620-013-0012-5; Evans M, 2013, NEPHROL DIAL TRANSPL, V28, P2518, DOI 10.1093/ndt/gft226; Faluyi OO, 2011, MED ONCOL; Fawaz A, 2006, CURR OPIN NEPHROL HY, V15, P643; Fehrman-Ekholm I, 2009, SCAND J CLIN LAB INV, V69, P606, DOI 10.1080/00365510903015771; Fliser D, 2008, CURR OPIN NEPHROL HY, V17, P604, DOI 10.1097/MNH.0b013e32830f454e; Fontsere N, 2008, DIABETES CARE, V31, P2265, DOI 10.2337/dc08-0958; Fontsere N, 2006, NEPHRON CLIN PRACT, V104, P160, DOI 10.1159/000095476; FOSSATI P, 1994, CLIN CHEM, V40, P130; Francoz C, 2010, LIVER TRANSPLANT, V16, P1169, DOI 10.1002/lt.22128; Frank M, 2012, SWISS MED WKLY, V142, DOI 10.4414/smw.2012.13708; Froissart M, 2005, J AM SOC NEPHROL, V16, P763, DOI 10.1681/ASN.2004070549; Gagneux-Brunon A, 2013, AIDS, V27, P1573, DOI 10.1097/QAD.0b013e32835fac30; Geerts AFJ, 2009, DRUG SAFETY, V32, P1189, DOI 10.2165/11316700-000000000-00000; Gerhardt T, 2011, EUR J GASTROEN HEPAT, V23, P969, DOI 10.1097/MEG.0b013e32834991f1; Gjerde B, 2012, RESP MED, V106, P361, DOI 10.1016/j.rmed.2011.10.004; Gupta SK, 2005, CLIN INFECT DIS, V40, P1559, DOI 10.1086/430257; Hallan S, 2004, AM J KIDNEY DIS, V44, P84, DOI 10.1053/j.ajkd.2004.03.027; Hanley MJ, 2010, CLIN PHARMACOKINET, V49, P71, DOI 10.2165/11318100-000000000-00000; Hanneman SK, 2008, AACN ADV CRIT CARE, V19, P223, DOI 10.1097/01.AACN.0000318125.41512.a3; Hellden A, 2009, DRUG AGING, V26, P595, DOI 10.2165/11315790-000000000-00000; Helou R, 2010, NEPHRON CLIN PRACT, V116, pC172, DOI 10.1159/000317197; Hoffman C, 1996, JAMA-J AM MED ASSOC, V276, P1473, DOI 10.1001/jama.276.18.1473; Horio M, 2010, CLIN EXP NEPHROL, V14, P427, DOI 10.1007/s10157-010-0325-9; Hoste EAJ, 2005, NEPHROL DIAL TRANSPL, V20, P747, DOI 10.1093/ndt/gfh707; Hudson JQ, 2011, CURR OPIN NEPHROL HY, V20, P482, DOI 10.1097/MNH.0b013e328348c11f; Iliadis F, 2011, DIABETOLOGIA, V54, P2987, DOI 10.1007/s00125-011-2307-1; Incalzi RA, 2010, CHEST, V137, P831, DOI 10.1378/chest.09-1710; Inker Lesley A, 2012, J Acquir Immune Defic Syndr, V61, P302, DOI 10.1097/QAI.0b013e31826a6c4f; Inker LA, 2012, NEW ENGL J MED, V367, P20, DOI 10.1056/NEJMoa1114248; Izzedine H, 2004, CURR PHARM DESIGN, V10, P4071, DOI 10.2174/1381612043382431; Janus N, 2010, BRIT J CANCER, V103, P1815, DOI 10.1038/sj.bjc.6605979; Janus N, 2010, ANN ONCOL, V21, P1395, DOI 10.1093/annonc/mdp598; Jones CY, 2008, AM J KIDNEY DIS, V51, P914, DOI 10.1053/j.ajkd.2008.01.027; Joosten H, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2012-002068; Kabat-Koperska J, 2004, ACTA MED AUST, V31, P51; Karstila K, 2008, NEPHRON CLIN PRACT, V108, pC284, DOI 10.1159/000127362; Kemperman FAW, 1999, NEPHROL DIAL TRANSPL, V14, P1247, DOI 10.1093/ndt/14.5.1247; Kilbride HS, 2012, AM J KIDNEY DIS; Koppe L, 2013, J NEPHROL, V26, P716, DOI 10.5301/jn.5000297; Lamb EJ, 2007, AGE AGEING, V36, P689, DOI 10.1093/ageing/afm121; Lamb EJ, 2003, J AM GERIATR SOC, V51, P1012, DOI 10.1046/j.1365-2389.2003.51330.x; Launay-Vacher V, 2007, CANCER-AM CANCER SOC, V110, P1376, DOI 10.1002/cncr.22904; Lee CS, 2010, J KOREAN MED SCI, V25, P1616, DOI 10.3346/jkms.2010.25.11.1616; Leendertse AJ, 2012, ANN PHARMACOTHER, V46, P625, DOI 10.1345/aph.1Q633; Levey AS, 2007, CLIN CHEM, V53, P766, DOI 10.1373/clinchem.2006.077180; Levey AS, 2006, ANN INTERN MED, V145, P247, DOI 10.7326/0003-4819-145-4-200608150-00004; Levey AS, 2006, CLIN CHEM, V52, P2188, DOI 10.1373/clinchem.2006.078733; Levey AS, 2014, AM J KIDNEY DIS, V63, P820, DOI 10.1053/j.ajkd.2013.12.006; Levey Andrew S., 2000, Journal of the American Society of Nephrology, V11, p155A; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; LEVEY AS, 1993, AM J KIDNEY DIS, V22, P207, DOI 10.1016/S0272-6386(12)70188-9; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; Lipcsey M, 2011, UPSALA J MED SCI, V116, P39, DOI 10.3109/03009734.2010.526724; Lopes MB, 2013, BMC NEPHROL, V14, DOI 10.1186/1471-2369-14-265; Luciani R, 2010, J CARDIOVASC MED, V11, P271, DOI 10.2459/JCM.0b013e328336b558; Ma YC, 2006, J AM SOC NEPHROL, V17, P2937, DOI 10.1681/ASN.2006040368; MacAulay J, 2006, CAN J GASTROENTEROL, V20, P521, DOI 10.1155/2006/858053; Macunluoglu B, 2011, INT UROL NEPHROL, V43, P257, DOI 10.1007/s11255-010-9846-0; Martin JH, 2010, INTERN MED J; Marx GM, 2004, ANN ONCOL, V15, P291, DOI 10.1093/annonc/mdh079; Mathew TH, 2007, MED J AUSTRALIA, V187, P459, DOI 10.5694/j.1326-5377.2007.tb01357.x; Matsuo S, 2009, AM J KIDNEY DIS, V53, P982, DOI 10.1053/j.ajkd.2008.12.034; Matsushita K, 2010, AM J KIDNEY DIS, V55, P648, DOI 10.1053/j.ajkd.2009.12.016; Mauss S, 2008, ANTIVIR THER, V13, P1091; Miller WG, 2005, ARCH PATHOL LAB MED, V129, P297; Mindikoglu AL, 2014, HEPATOLOGY, V59, P1532, DOI 10.1002/hep.26556; Mocroft A, 2010, AIDS, V24, P1667, DOI 10.1097/QAD.0b013e328339fe53; MURPHY JL, 1989, CRIT CARE MED, V17, P889, DOI 10.1097/00003246-198909000-00009; Myers GL, 2006, CLIN CHEM, V52, P5, DOI 10.1373/clinchem.2005.0525144; MYRE SA, 1987, THER DRUG MONIT, V9, P161, DOI 10.1097/00007691-198706000-00006; Nygaard HA, 2004, SCAND J PRIM HEALTH, V22, P152, DOI 10.1080/02813430410006468-1; O'Meara E, 2006, EUR J HEART FAIL, V8, P63, DOI 10.1016/j.ejheart.2005.04.013; Odden MC, 2007, ARCH INTERN MED, V167, P2213, DOI 10.1001/archinte.167.20.2213; Pai MP., 2010, ADV CHRONIC KIDNEY D, V17, pe53, DOI DOI 10.1053/J.ACKD.2010.05.010; Peake Michael, 2006, Clin Biochem Rev, V27, P173; Pedone C, 2006, AGE AGEING, V35, P121, DOI 10.1093/ageing/afj041; PERRONE RD, 1992, CLIN CHEM, V38, P1933; Perticone F, 2008, AM J KIDNEY DIS, V52, P74, DOI 10.1053/j.ajkd.2008.02.302; Poggio ED, 2005, AM J KIDNEY DIS, V46, P242, DOI 10.1053/j.ajkd.2005.04.023; Praditpornsilpa K, 2012, AIDS, V26, P1781, DOI 10.1097/QAD.0b013e328356480d; Prigent A, 2008, SEMIN NUCL MED, V38, P32, DOI 10.1053/j.semnuclmed.2007.09.003; Quartarolo JM, 2007, J HOSP MED, V2, P74, DOI 10.1002/jhm.172; Quon H, 2010, PHOTODIAGN PHOTODYN, V7, P268, DOI 10.1016/j.pdpdt.2010.07.008; Ravasi G, 2009, HIV MED, V10, P219, DOI 10.1111/j.1468-1293.2008.00673.x; Rigalleau V, 2005, DIABETES CARE, V28, P838, DOI 10.2337/diacare.28.4.838; Rigalleau V, 2011, DIABETES METAB, V37, P359, DOI 10.1016/j.diabet.2011.05.002; Rigalleau V, 2007, DIABETES CARE, V30, P2034, DOI 10.2337/dc07-0140; Roberts GW, 2009, AGE AGEING, V38, P698, DOI 10.1093/ageing/afp168; Rognant N, 2011, DIABETES CARE, V34, P1320, DOI 10.2337/dc11-0203; Rognant N, 2010, NEPHROL DIAL TRANSPL, V25, P3569, DOI 10.1093/ndt/gfq248; Ruilope LM, 2007, J HYPERTENS, V25, P1473, DOI 10.1097/HJH.0b013e328133246c; Schuck O, 2005, KIDNEY BLOOD PRESS R, V28, P63, DOI 10.1159/000083238; SHEMESH O, 1985, KIDNEY INT, V28, P830, DOI 10.1038/ki.1985.205; Sherman DS, 2003, AM J KIDNEY DIS, V41, P269, DOI 10.1053/ajkd.2003.50035; Smilde TDJ, 2006, CIRCULATION, V114, P1572, DOI 10.1161/CIRCULATIONAHA.105.610642; Spruill WJ, 2009, CLIN PHARMACOL THER, V86, P468, DOI 10.1038/clpt.2009.187; Stevens LA, 2009, CLIN PHARMACOL THER, V86, P465, DOI 10.1038/clpt.2009.124; Stevens LA, 2005, MED CLIN N AM, V89, P457, DOI 10.1016/j.mcna.2004.11.009; Stevens LA, 2007, J AM SOC NEPHROL, V18, P2749, DOI 10.1681/ASN.2007020199; Stevens LA, 2006, NEW ENGL J MED, V354, P2473, DOI 10.1056/NEJMra054415; Stevens LA, 2009, J AM SOC NEPHROL, V20, P2305, DOI 10.1681/ASN.2009020171; Stevens LA, 2009, AM J KIDNEY DIS, V54, P33, DOI 10.1053/j.ajkd.2009.03.008; Stevens LA, 2008, J NEPHROL, V21, P797; SWAIN RR, 1977, CLIN CHEM, V23, P1340; Valente MAE, 2014, EUR J HEART FAIL, V16, P86, DOI 10.1093/eurjhf/hft128; Van Den Noortgate NJ, 2002, J AM GERIATR SOC, V50, P1278, DOI 10.1046/j.1532-5415.2002.50317.x; van Deventer HE, 2011, NEPHROL DIAL TRANSPL, V26, P1553, DOI 10.1093/ndt/gfq621; Van Pottelbergh G, 2010, AGE AGEING, V39, P542, DOI 10.1093/ageing/afq091; Verhave J C, 2007, Ned Tijdschr Geneeskd, V151, P1002; Verhave JC, 2005, AM J KIDNEY DIS, V46, P233, DOI 10.1053/j.ajkd.2005.05.011; Vivier PH, 2011, RADIOLOGY, V259, P462, DOI 10.1148/radiol.11101338; Vrouenraets SME, 2012, CLIN NEPHROL, V77, P311, DOI 10.5414/CN107214; Waldum B, 2010, J CARD FAIL, V16, P374, DOI 10.1016/j.cardfail.2010.01.001; Wolf G, 2002, AM J KIDNEY DIS, V39, P1, DOI 10.1053/ajkd.2002.29865; Zhang L, 2012, J CLIN PHARMACOL, V52, p79S, DOI 10.1177/0091270011415410	148	10	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2015	10	3							e0116403	10.1371/journal.pone.0116403	http://dx.doi.org/10.1371/journal.pone.0116403			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9KG	25741695	Green Published, gold, Green Submitted			2022-12-27	WOS:000350688100003
J	Reed, C; Chaves, SS; Kirley, PD; Emerson, R; Aragon, D; Hancock, EB; Butler, L; Baumbach, J; Hollick, G; Bennett, NM; Laidler, MR; Thomas, A; Meltzer, MI; Finelli, L				Reed, Carrie; Chaves, Sandra S.; Kirley, Pam Daily; Emerson, Ruth; Aragon, Deborah; Hancock, Emily B.; Butler, Lisa; Baumbach, Joan; Hollick, Gary; Bennett, Nancy M.; Laidler, Matthew R.; Thomas, Ann; Meltzer, Martin I.; Finelli, Lyn			Estimating Influenza Disease Burden from Population-Based Surveillance Data in the United States	PLOS ONE			English	Article							SEASONAL INFLUENZA; HOSPITALIZATIONS; VIRUS; CHILDREN; VACCINE; INFECTION; DEATHS	Annual estimates of the influenza disease burden provide information to evaluate programs and allocate resources. We used a multiplier method with routine population-based surveillance data on influenza hospitalization in the United States to correct for under-reporting and estimate the burden of influenza for seasons after the 2009 pandemic. Five sites of the Influenza Hospitalization Surveillance Network (FluSurv-NET) collected data on the frequency and sensitivity of influenza testing during two seasons to estimate under-detection. Population-based rates of influenza-associated hospitalization and Intensive Care Unit admission from 2010-2013 were extrapolated to the U. S. population from FluSurv-NET and corrected for under-detection. Influenza deaths were calculated using a ratio of deaths to hospitalizations. We estimated that influenza-related hospitalizations were under-detected during 2010-11 by a factor of 2.1 (95% CI 1.7-2.9) for age < 18 years, 3.1 (2.4-4.5) for ages 18-64 years, and 5.2 (95% CI 3.8-8.3) for age 65+. Results were similar in 2011-12. Extrapolated estimates for 3 seasons from 2010-2013 included: 114,192-624,435 hospitalizations, 18,491-95,390 ICU admissions, and 4,915-27,174 deaths per year; 54-70% of hospitalizations and 71-85% of deaths occurred among adults aged 65+. Influenza causes a substantial disease burden in the U. S. that varies by age and season. Periodic estimation of multipliers across multiple sites and age groups improves our understanding of influenza detection in sentinel surveillance systems. Adjusting surveillance data using a multiplier method is a relatively simple means to estimate the impact of influenza and the subsequent value of interventions to prevent influenza.	[Reed, Carrie; Chaves, Sandra S.; Finelli, Lyn] Ctr Dis Control & Prevent, Influenza Div, Atlanta, GA 30333 USA; [Kirley, Pam Daily; Emerson, Ruth] Calif Emerging Infect Program, Oakland, CA USA; [Aragon, Deborah] Colorado Dept Publ Hlth & Environm, Colorado Emerging Infect Program, Denver, CO USA; [Hancock, Emily B.; Butler, Lisa; Baumbach, Joan] New Mexico Emerging Infect Program, Santa Fe, NM USA; [Hollick, Gary; Bennett, Nancy M.] Univ Rochester, Sch Med & Dent, New York Emerging Infect Program, Rochester, NY USA; [Laidler, Matthew R.; Thomas, Ann] Oregon Publ Hlth Div, Portland, OR USA; [Meltzer, Martin I.] Ctr Dis Control & Prevent, Div Preparedness & Emerging Infect, Atlanta, GA USA	Centers for Disease Control & Prevention - USA; California Emerging Infections Program; Colorado Department of Public Health & Environment; University of Rochester; Centers for Disease Control & Prevention - USA	Reed, C (corresponding author), Ctr Dis Control & Prevent, Influenza Div, Atlanta, GA 30333 USA.	creed1@cdc.gov	Finelli, Lyn/AAK-2360-2020; Meltzer, Martin/AAT-3235-2021	Meltzer, Martin/0000-0002-7250-0472				Biggerstaff M, 2013, CLIN INFECT DIS, V57, pS12, DOI 10.1093/cid/cit273; Brammer L, 2013, MMWR-MORBID MORTAL W, V62, P473; Bresee J, 2013, MMWR-MORBID MORTAL W, V62, P997; Chartrand C, 2012, ANN INTERN MED, V156, P500, DOI 10.7326/0003-4819-156-7-201204030-00403; Ganatra Rahul, 2012, Morbidity and Mortality Weekly Report, V61, P414; Grijalva CG, 2007, EPIDEMIOL INFECT, V135, P951, DOI 10.1017/S095026880600762X; Grijalva CG, 2006, EMERG INFECT DIS, V12, P103; Kniss Krista, 2011, Morbidity and Mortality Weekly Report, V60, P705; Kostova D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066312; McDonald SA, 2014, INFLUENZA OTHER RESP, V8, P33, DOI 10.1111/irv.12201; Molinari NAM, 2007, VACCINE, V25, P5086, DOI 10.1016/j.vaccine.2007.03.046; Poehling KA, 2006, NEW ENGL J MED, V355, P31, DOI 10.1056/NEJMoa054869; Presanis AM, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000207; Reed C, 2009, EMERG INFECT DIS, V15, P2004, DOI 10.3201/eid1512.091413; Shrestha SS, 2011, CLIN INFECT DIS, V52, pS75, DOI 10.1093/cid/ciq012; Steininger C, 2002, J CLIN MICROBIOL, V40, P2051, DOI 10.1128/JCM.40.6.2051-2056.2002; Talbot HK, 2010, INFECT CONT HOSP EP, V31, P683, DOI 10.1086/653202; Thompson M. G., 2010, Morbidity and Mortality Weekly Report, V59, P1057; Thompson WW, 2009, AM J PUBLIC HEALTH, V99, pS225, DOI 10.2105/AJPH.2008.151944; Thompson WW, 2003, JAMA-J AM MED ASSOC, V289, P179, DOI 10.1001/jama.289.2.179; Thompson WW, 2004, JAMA-J AM MED ASSOC, V292, P1333, DOI 10.1001/jama.292.11.1333; Wakeling I, 2014, SAS MACRO FITTING BE; Young-Xu YN, 2008, BMC MED RES METHODOL, V8, DOI 10.1186/1471-2288-8-58; Yu HJ, 2013, LANCET, V382, P138, DOI 10.1016/S0140-6736(13)61207-6	24	228	232	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2015	10	3							e0118369	10.1371/journal.pone.0118369	http://dx.doi.org/10.1371/journal.pone.0118369			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9JM	25738736	Green Submitted, gold, Green Published			2022-12-27	WOS:000350685900032
J	Menezes, RST; Brady, SG; Carvalho, AF; Del Lama, MA; Costa, MA				Telles Menezes, Rodolpho Santos; Brady, Sean Gary; Carvalho, Antonio Freire; Del Lama, Marco Antonio; Costa, Marco Antonio			Molecular Phylogeny and Historical Biogeography of the Neotropical Swarm-Founding Social Wasp Genus Synoeca (Hymenoptera: Vespidae)	PLOS ONE			English	Article							CYANEA HYMENOPTERA; GENETIC DIVERSITY; ATLANTIC FOREST; BIODIVERSITY; INFERENCE; SAUSSURE; BRAZIL	The Neotropical Region harbors high biodiversity and many studies on mammals, reptiles, amphibians and avifauna have investigated the causes for this pattern. However, there is a paucity of such studies that focus on Neotropical insect groups. Synoeca de Saussure, 1852 is a Neotropical swarm-founding social wasp genus with five described species that is broadly and conspicuously distributed throughout the Neotropics. Here, we infer the phylogenetic relationships, diversification times, and historical biogeography of Synoeca species. We also investigate samples of the disjoint populations of S. septentrionalis that occur in both northwestern parts of South America through Central American and the Brazilian Atlantic rainforests. Our results showed that the interspecific relationships for Synoeca could be described as follows: (S. chalibea+S. virginea) + (S. cyanea + (S. septentrionalis/S. surinama)). Notably, samples of S. septentrionalis and S. surinama collected in the Atlantic Forest were interrelated and may be the result of incomplete lineage sorting and/or mitochondrial introgression among them. Our Bayesian divergence dating analysis revealed recent Plio-Pleistocene diversification in Synoeca. Moreover, our biogeographical analysis suggested an Amazonian origin of Synoeca, with three main dispersal events subsequently occurring during the Plio-Pleistocene.	[Telles Menezes, Rodolpho Santos; Costa, Marco Antonio] Univ Estadual Santa Cruz, Dept Ciencias Biol, Ilheus, Bahia, Brazil; [Telles Menezes, Rodolpho Santos; Brady, Sean Gary] Smithsonian Inst, Natl Museum Nat Hist, Dept Entomol, Washington, DC 20560 USA; [Carvalho, Antonio Freire; Del Lama, Marco Antonio] Univ Fed Sao Carlos, Dept Genet & Evolucao, BR-13560 Sao Carlos, SP, Brazil	Universidade Estadual de Santa Cruz; Smithsonian Institution; Smithsonian National Museum of Natural History; Universidade Federal de Sao Carlos	Menezes, RST (corresponding author), Univ Estadual Santa Cruz, Dept Ciencias Biol, Ilheus, Bahia, Brazil.	rodolphostm1@hotmail.com	Menezes, Rodolpho Santos Telles/B-2952-2014; Costa, Marco A/H-8035-2015; Carvalho, Antônio F./D-1954-2016	Menezes, Rodolpho Santos Telles/0000-0002-6612-3543; Carvalho, Antônio F./0000-0002-4270-4554	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico [CNPq - 485276/2012-7]; Universidade Estadual de Santa Cruz [PROPP UESC - 00220.1100.395]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior "CAPES"; Brazilian Ministry of Education [BEX-12106/13-5]; Fundacao de Amparo a Pesquisa do Estado da Bahia (FAPESB) [BOL0494/2011]	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Universidade Estadual de Santa Cruz; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior "CAPES"; Brazilian Ministry of Education(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Fundacao de Amparo a Pesquisa do Estado da Bahia (FAPESB)(Fundacao de Amparo a Pesquisa do Estado da Bahia (FAPESB))	The authors are grateful for financial support from Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq - 485276/2012-7) and Universidade Estadual de Santa Cruz (PROPP UESC - 00220.1100.395). RSTM is thankful to Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior "CAPES"; Brazilian Ministry of Education) for the scholarship BEX-12106/13-5 and to Fundacao de Amparo a Pesquisa do Estado da Bahia (FAPESB) (BOL0494/2011). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andena SR, 2009, ENTOMOL AM-NY, V115, P81, DOI 10.1664/07-RA-002R.1; Auler AS, 2004, J QUATERNARY SCI, V19, P693, DOI 10.1002/jqs.876; Ayres DL, 2012, SYST BIOL, V61, P170, DOI [10.1093/sysbio/syr100, 10.1093/sysbio/sys029]; Batalha H, 2013, J ORNITHOL, V154, P41, DOI 10.1007/s10336-012-0866-7; Behling H, 2000, QUATERNARY SCI REV, V19, P981, DOI 10.1016/S0277-3791(99)00046-3; Bermudes EGC, 1982, ACTA AMAZONICA, V12, P665; Bermudes EGC, 1981, REV BRAS BIOL, V26, P71; Bermudez EGC, 1981, ACTA AMAZONICA, V11, P377; BROWER AVZ, 1994, P NATL ACAD SCI USA, V91, P6491, DOI 10.1073/pnas.91.14.6491; Carnaval AC, 2009, SCIENCE, V323, P785, DOI 10.1126/science.1166955; Carpenter JM, 2013, ZOOTAXA, V3682, P421, DOI 10.11646/zootaxa.3682.3.3; Carpenter JM, 1997, AM MUS NOVIT, P3203; Carvalho AF, 2014, GENET MOL RES, V13, P89, DOI 10.4238/2014.January.8.7; CASTELLON E G, 1980, Acta Amazonica, V10, P883; CASTELLON E G, 1980, Acta Amazonica, V10, P679; Cely CC, 2011, ZOOTAXA, P43, DOI 10.11646/zootaxa.2899.1.2; COATES AG, 1992, GEOL SOC AM BULL, V104, P814, DOI 10.1130/0016-7606(1992)104<0814:COTIOP>2.3.CO;2; Costa LP, 2003, J BIOGEOGR, V30, P71, DOI 10.1046/j.1365-2699.2003.00792.x; De Oliveira PE, 1999, PALAEOGEOGR PALAEOCL, V152, P319, DOI 10.1016/S0031-0182(99)00061-9; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Elisei T, 2005, SOCIOBIOLOGY, V46, P317; Han HY, 1997, MOL PHYLOGENET EVOL, V7, P17, DOI 10.1006/mpev.1996.0370; He X.-J., 2014, RASP RECONSTRUCT ANC; Heled J, 2010, MOL BIOL EVOL, V27, P570, DOI 10.1093/molbev/msp274; Hoorn C, 2010, AMAZONIA: LANDSCAPE AND SPECIES EVOLUTION: A LOOK INTO THE PAST, P1; Hoorn C, 2010, SCIENCE, V330, P927, DOI 10.1126/science.1194585; Knowles LL, 2010, ESTIMATING SPECIES T; Lanfear R, 2012, MOL BIOL EVOL, V29, P1695, DOI 10.1093/molbev/mss020; Maddison WP, 2006, SYST BIOL, V55, P21, DOI 10.1080/10635150500354928; Menezes RST, 2011, ZOOKEYS, P75, DOI 10.3897/zookeys.151.1882; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Noda SCM, 2003, SOCIOBIOLOGY, V41, P547; Noll Fernando B., 2004, American Museum Novitates, V3467, P1, DOI 10.1206/0003-0082(2004)467<0001:EOCINW>2.0.CO;2; Rambaut A., 2009, FIGTREE TREE FIGURE; Rambaut A, 2009, TRACER V 1 5; Richards O.W., 1978, SOCIAL WASPS AM EXCL; Rull V, 2008, MOL ECOL, V17, P2722, DOI 10.1111/j.1365-294X.2008.03789.x; Rull V, 2011, TRENDS ECOL EVOL, V26, P508, DOI 10.1016/j.tree.2011.05.011; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; VANZOLINI P E, 1974, Papeis Avulsos de Zoologia (Sao Paulo), V28, P61; Wenzel John W., 1998, American Museum Novitates, V3224, P1; Zwickl D. J, 2006, GENETIC ALGORITHM AP	44	18	18	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2015	10	3							e0119151	10.1371/journal.pone.0119151	http://dx.doi.org/10.1371/journal.pone.0119151			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9JM	25738705	Green Submitted, Green Published, gold			2022-12-27	WOS:000350685900094
J	Vanderelst, D; Peremans, H; Razak, NA; Verstraelen, E; Dimitriadis, G				Vanderelst, Dieter; Peremans, Herbert; Razak, Norizham Abdul; Verstraelen, Edouard; Dimitriadis, Greg			The Aerodynamic Cost of Head Morphology in Bats: Maybe Not as Bad as It Seems	PLOS ONE			English	Article							BIG BROWN BAT; EPTESICUS-FUSCUS; PHYLLOSTOMUS-DISCOLOR; ECHOLOCATION BEHAVIOR; SPECTRAL CUES; EXTERNAL EAR; DIRECTIONALITY; FURROWS; STYLE	At first sight, echolocating bats face a difficult trade-off. As flying animals, they would benefit from a streamlined geometric shape to reduce aerodynamic drag and increase flight efficiency. However, as echolocating animals, their pinnae generate the acoustic cues necessary for navigation and foraging. Moreover, species emitting sound through their nostrils often feature elaborate noseleaves that help in focussing the emitted echolocation pulses. Both pinnae and noseleaves reduce the streamlined character of a bat's morphology. It is generally assumed that by compromising the streamlined charactered of the geometry, the head morphology generates substantial drag, thereby reducing flight efficiency. In contrast, it has also been suggested that the pinnae of bats generate lift forces counteracting the detrimental effect of the increased drag. However, very little data exist on the aerodynamic properties of bat pinnae and noseleaves. In this work, the aerodynamic forces generated by the heads of seven species of bats, including noseleaved bats, are measured by testing detailed 3D models in a wind tunnel. Models of Myotis daubentonii, Macrophyllum macrophyllum, Micronycteris microtis, Eptesicus fuscus, Rhinolophus formosae, Rhinolophus rouxi and Phyllostomus discolor are tested. The results confirm that non-streamlined facial morphologies yield considerable drag forces but also generate substantial lift. The net effect is a slight increase in the lift-to-drag ratio. Therefore, there is no evidence of high aerodynamic costs associated with the morphology of bat heads.	[Vanderelst, Dieter] Univ Bristol, Sch Biol Sci, Bristol, Avon, England; [Vanderelst, Dieter; Peremans, Herbert] Univ Antwerp, Dept Engn Management, Act Percept Lab, B-2020 Antwerp, Belgium; [Razak, Norizham Abdul; Verstraelen, Edouard; Dimitriadis, Greg] Univ Sains Malaysia, Sch Aerosp Engn, Perai 14300, Pulau Pinang, Malaysia	University of Bristol; University of Antwerp; Universiti Sains Malaysia	Vanderelst, D (corresponding author), Univ Bristol, Sch Biol Sci, Bristol, Avon, England.	dieter.vanderelst@bristol.ac.uk	Razak, Norizham A Abdul/S-5964-2018	Razak, Norizham A Abdul/0000-0001-8249-3272; Dimitriadis, Grigorios/0000-0003-1684-7372	FWO [1.5.152.11N]; IEF	FWO(FWO); IEF	This study was funded by FWO grant 1.5.152.11N awarded to Herbert Peremans. Dieter Vanderelst was funded in part by an FWO postdoctoral fellowship and an IEF Marie Curie Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson D., 2009, UNDERSTANDING FLIGHT; Barlow J.B., 1999, LOW SPEED WIND TUNNE; Bullen R, 2001, AUST J ZOOL, V49, P235, DOI 10.1071/ZO00037; Chiu C, 2007, ROLE EXTERNAL EAR VE; De Mey F, 2008, J ACOUST SOC AM, V124, P2123, DOI 10.1121/1.2968703; Eger J.L., 2003, Mammalian Species, V731, P1, DOI 10.1644/731; Eisenberg JF, 2000, MAMMALS NEOTROPICS, V3; FENTON MB, 1972, CAN J ZOOLOG, V50, P287, DOI 10.1139/z72-039; Firzlaff U, 2004, HEARING RES, V197, P74, DOI 10.1016/j.heares.2004.06.009; Firzlaff U, 2003, HEARING RES, V181, P27, DOI 10.1016/S0378-5955(03)00164-3; Garcia D, 2011, EXP FLUIDS, V50, P1247, DOI 10.1007/s00348-010-0985-y; Garcia D, 2010, COMPUT STAT DATA AN, V54, P1167, DOI 10.1016/j.csda.2009.09.020; Gardiner JD, 2011, CAN J ZOOL, V89, P90, DOI 10.1139/Z10-096; Gardiner JD, 2008, ACTA CHIROPTEROL, V10, P313, DOI 10.3161/150811008X414881; Geipel I, 2013, PERCEPTION SILENT MO; Giannini NP, 2004, OIKOS, V105, P209, DOI 10.1111/j.0030-1299.2004.12690.x; Hartley D. J., 1987, J ACOUST SOC AM, V82, P1987, DOI DOI 10.1121/1.395684; HOLDERIED MW, 2001, THESIS F ALEXANDER U; Jakobsen L, 2013, NATURE, V493, P93, DOI 10.1038/nature11664; Kunz TH, 1988, ECOLOGICAL BEHAV MET; Kurta A., 1990, MAMM SPECIES, V356, P1, DOI DOI 10.2307/3504258; Kwiecinski Gary G., 2006, Mammalian Species, P1, DOI 10.1644/801.1; Mogdans J, 1988, ROLE PINNA MOVEMENT; Muijres FT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037335; Norberg U., 1990, VERTEBRATE FLIGHT ME; NORBERG U M, 1987, Philosophical Transactions of the Royal Society of London B Biological Sciences, V316, P335, DOI 10.1098/rstb.1987.0030; Nowak RM, 1994, WALKERS BATS WORLD; OBRIST MK, 1993, J EXP BIOL, V180, P119; Schnitzler HU, 2011, J COMP PHYSIOL A, V197, P541, DOI 10.1007/s00359-010-0569-6; SCHNITZLER HU, 1985, J COMP PHYSIOL A, V157, P39, DOI 10.1007/BF00611093; Schnyder HA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112178; Seibert AM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060752; Siemers BM, 2001, J EXP BIOL, V204, P3843; SIMMONS JA, 1969, J ACOUST SOC AM, V46, P1054, DOI 10.1121/1.1911804; Smith P, 2008, MAMMALS OF PARAGUAY; Surlykke A, 2000, J ACOUST SOC AM, V108, P2419, DOI 10.1121/1.1315295; Surlykke A, 2009, J EXP BIOL, V212, P1011, DOI 10.1242/jeb.024620; Tennekes H., 2009, SIMPLE SCI FLIGHT; Vanderelst D, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00191; Vanderelst D, 2012, J R SOC INTERFACE, V9, P1100, DOI 10.1098/rsif.2011.0812; Vanderelst D, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002268; Vanderelst D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020627; Vanderelst D, 2010, LECT NOTES ARTIF INT, V6226, P136, DOI 10.1007/978-3-642-15193-4_13; Vanderelst D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011893; Vaughan TA., 1959, FUNCTIONAL MORPHOLOG; Weinbeer M, 2007, BEHAV ECOL SOCIOBIOL, V61, P1337, DOI 10.1007/s00265-007-0364-8; Wotton JM, 1997, J ACOUST SOC AM, V101, P1723, DOI 10.1121/1.418271; WOTTON JM, 1995, J ACOUST SOC AM, V98, P1423, DOI 10.1121/1.413410; Wotton JM, 2000, J ACOUST SOC AM, V107, P1034, DOI 10.1121/1.428283; Zhuang Q, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.218701	50	4	4	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2015	10	3							e0118545	10.1371/journal.pone.0118545	http://dx.doi.org/10.1371/journal.pone.0118545			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9JM	25739038	Green Published, Green Submitted, gold			2022-12-27	WOS:000350685900045
J	Wu, YC; Lo, HY; Yang, SL; Chu, DC; Chou, P				Wu, Yi-Chun; Lo, Hsiu-Yun; Yang, Shiang-Lin; Chu, Da-Chen; Chou, Pesus			Comparing the Factors Correlated with Tuberculosis-Specific and Non-Tuberculosis-Specific Deaths in Different Age Groups among Tuberculosis-Related Deaths in Taiwan	PLOS ONE			English	Article							MORTALITY; RISK; INFECTION	Background Nearly 20% of tuberculosis (TB) patients die within one year, and TB-related mortality rates remain high in Taiwan. The study aimed to identify factors correlated with TB-specific deaths versus non-TB-specific deaths in different age groups among TB-related mortalities. Methods A retrospective cohort study was conducted from 2006-2008 with newly registered TB patients receiving follow-up for 1 year. The national TB database from the Taiwan-CDC was linked with the National Vital Registry System and the National Health Insurance database. A chi-squared test and logistic regression were used to analyse the correlated factors related to TB-specific and non-TB-specific deaths in different age groups. Results Elderly age (odds ratio [OR] 2.68-8.09), Eastern residence (OR 2.01), positive sputum bacteriology (OR 2.54), abnormal chest X-ray (OR 2.28), and comorbidity with chronic kidney disease (OR 2.35), stroke (OR 1.74) or chronic liver disease (OR 1.29) were most likely to be the cause of TB-specific deaths, whereas cancer (OR 0.79) was less likely to be implicated. For non-TB-specific deaths in patients younger than 65 years of age, male sex (OR 2.04) and comorbidity with HIV (OR 5.92), chronic kidney disease (OR 8.02), stroke (OR 3.75), cancer (OR 9.79), chronic liver disease (OR 2.71) or diabetes mellitus (OR 1.38) were risk factors. Conclusions Different factors correlated with TB-specific deaths compared with non-TB-specific deaths, and the impact of comorbidities gradually decreased as age increased. To reduce TB-specific mortality, special consideration for TB patients with old age, Eastern residence, positive sputum bacteriology and comorbidity with chronic kidney disease or stroke is crucial. In particular, Eastern residence increased the risk of TB-specific death in all age groups. In terms of TB deaths among patients younger than 65 years of age, patients with HIV, chronic kidney disease or cancer had a 6-10 times increased risk of non-TB-specific deaths.	[Wu, Yi-Chun; Lo, Hsiu-Yun; Yang, Shiang-Lin] Minist Hlth & Welf, Ctr Dis Control, Taipei, Taiwan; [Wu, Yi-Chun; Chu, Da-Chen; Chou, Pesus] Natl Yang Ming Univ, Community Med Res Ctr, Taipei 112, Taiwan; [Wu, Yi-Chun; Chu, Da-Chen; Chou, Pesus] Natl Yang Ming Univ, Inst Publ Hlth, Taipei 112, Taiwan; [Chu, Da-Chen] Taipei City Hosp, Dept Emergency Med, Taipei, Taiwan	Centers For Disease Control - Taiwan; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; Taipei City Hospital	Chou, P (corresponding author), Natl Yang Ming Univ, Community Med Res Ctr, Taipei 112, Taiwan.	pschou@ym.edu.tw			Centers for Disease Control, Department of Health, Taiwan [DOH102-DC-2304]	Centers for Disease Control, Department of Health, Taiwan	The Grant No. DOH102-DC-2304 was supported by Centers for Disease Control, Department of Health, Taiwan and the author (YCW) recieved the funding in 2013. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arcavi L, 2004, ARCH INTERN MED, V164, P2206, DOI 10.1001/archinte.164.20.2206; Barnes H L, 1928, Trans Am Climatol Clin Assoc, V44, P39; Chien JY, 2010, INT J TUBERC LUNG D, V14, P616; Dooley KE, 2009, AM J TROP MED HYG, V80, P634, DOI 10.4269/ajtmh.2009.80.634; Inghammar M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010138; Khan FA, 2010, CLIN INFECT DIS, V50, P1288, DOI 10.1086/651686; Lee C Y, 2014, TAIWAN EPIDEMIOL B, V30, P105; Libshitz HI, 1997, J THORAC IMAG, V12, P41, DOI 10.1097/00005382-199701000-00006; Lin HP, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-55; Lo HY, 2015, ASIA-PAC J PUBLIC HE, V27, pNP758, DOI 10.1177/1010539511429591; Low S, 2009, INT J TUBERC LUNG D, V13, P328; Lui SL, 2001, AM J KIDNEY DIS, V38, P1055, DOI 10.1053/ajkd.2001.28599; Shen X, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-95; Sterling TR, 2006, INT J TUBERC LUNG D, V10, P542; Vasankari T, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-291; World Health Organization, 2013, WHO TUB 10 FACTS TUB; World Health Organization, 2011, WHO GLOB PLAN STOP T; World Health Organization, 2009, WHOHTMTB2009420; World Health Organization (WHO), 2020, GLOB TUB REP; Wu YC, 2008, J FORMOS MED ASSOC, V107, P30, DOI 10.1016/S0929-6646(08)60005-4; Yu MC, 2004, J FORMOS MED ASSOC, V103, P817; Yung-Ming Chang, 2006, Southeast Asian J Trop Med Public Health, V37 Suppl 3, P161	22	15	17	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2015	10	3							e0118929	10.1371/journal.pone.0118929	http://dx.doi.org/10.1371/journal.pone.0118929			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4HV	25734444	Green Published, Green Submitted, gold			2022-12-27	WOS:000350314700047
J	Roland, WSU; Sanders, MPA; van Buren, L; Gouka, RJ; Gruppen, H; Vincken, JP; Ritschel, T				Roland, Wibke S. U.; Sanders, Marijn P. A.; van Buren, Leo; Gouka, Robin J.; Gruppen, Harry; Vincken, Jean-Paul; Ritschel, Tina			Snooker Structure-Based Pharmacophore Model Explains Differences in Agonist and Blocker Binding to Bitter Receptor hTAS2R39	PLOS ONE			English	Article							ACTIVATE; IDENTIFICATION; REQUIREMENTS; ASSAY; T2R1; PTC	The human bitter taste receptor hTAS2R39 can be activated by many dietary (iso)flavonoids. Furthermore, hTAS2R39 activity can be blocked by 6-methoxyflavanones, 4'-fluoro-6-methoxyflavanone in particular. A structure-based pharmacophore model of the hTAS2R39 binding pocket was built using Snooker software, which has been used successfully before for drug design of GPCRs of the rhodopsin subfamily. For the validation of the model, two sets of compounds, both of which contained actives and inactives, were used: (i) an (iso) flavonoid-dedicated set, and (ii) a more generic, structurally diverse set. Agonists were characterized by their linear binding geometry and the fact that they bound deeply in the hTAS2R39 pocket, mapping the hydrogen donor feature based on T5.45 and N3.36, analogues of which have been proposed to play a key role in activation of GPCRs. Blockers lack hydrogen-bond donors enabling contact to the receptor. Furthermore, they had a crooked geometry, which could sterically hinder movement of the TM domains upon receptor activation. Our results reveal characteristics of hTAS2R39 agonist and bitter blocker binding, which might facilitate the development of blockers suitable to counter the bitterness of dietary hTAS2R39 agonists in food applications.	[Sanders, Marijn P. A.; Ritschel, Tina] Radboud Univ Nijmegen, Med Ctr, CMBI, Computat Discovery & Design Grp CDD, NL-6500 HB Nijmegen, Netherlands; [van Buren, Leo; Gouka, Robin J.] Unilever R&D, NL-3133 AT Vlaardingen, Netherlands	Radboud University Nijmegen; Unilever	Ritschel, T (corresponding author), Radboud Univ Nijmegen, Med Ctr, CMBI, Computat Discovery & Design Grp CDD, NL-6500 HB Nijmegen, Netherlands.	tina.ritschel@radboudumc.nl		Vincken, Jean-Paul/0000-0001-8540-4327				Adler E, 2000, CELL, V100, P693, DOI 10.1016/S0092-8674(00)80705-9; Behrens M, 2013, CHEM SENSES, V38, P475, DOI 10.1093/chemse/bjt016; Behrens M, 2013, SEMIN CELL DEV BIOL, V24, P215, DOI 10.1016/j.semcdb.2012.08.006; Biarnes X, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012394; Bohin MC, 2013, J AGR FOOD CHEM, V61, P10010, DOI 10.1021/jf4030823; Born S, 2013, J NEUROSCI, V33, P201, DOI 10.1523/JNEUROSCI.3248-12.2013; Brockhoff A, 2011, J NEUROSCI, V31, P14775, DOI 10.1523/JNEUROSCI.2923-11.2011; Brockhoff A, 2010, P NATL ACAD SCI USA, V107, P11110, DOI 10.1073/pnas.0913862107; Dai WM, 2011, J RECEPT SIG TRANSD, V31, P229, DOI 10.3109/10799893.2011.578141; Fletcher JN, 2011, J AGR FOOD CHEM, V59, P13117, DOI 10.1021/jf204359q; Floriano WB, 2006, J MOL MODEL, V12, P931, DOI 10.1007/s00894-006-0102-6; Greene TA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020123; Hellfritsch C, 2012, J AGR FOOD CHEM, V60, P6782, DOI 10.1021/jf301297n; Kohl S, 2013, J AGR FOOD CHEM, V61, P53, DOI 10.1021/jf303146h; Lebon G, 2011, NATURE, V474, P521, DOI 10.1038/nature10136; Levit Anat, 2012, Methods Mol Biol, V914, P179, DOI 10.1007/978-1-62703-023-6_11; Ley JP, 2012, J AGR FOOD CHEM, V60, P6303, DOI 10.1021/jf301335z; Li J, 2004, J MOL BIOL, V343, P1409, DOI 10.1016/j.jmb.2004.08.090; Marchiori A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064675; Meyerhof W, 2010, CHEM SENSES, V35, P157, DOI 10.1093/chemse/bjp092; Miguet L, 2006, J RECEPT SIG TRANSD, V26, P611, DOI 10.1080/10799890600928210; Molecular Operating Environment (MOE), 2011, MOL OP ENV MOE 2011; Narukawa M, 2011, BIOCHEM BIOPH RES CO, V405, P620, DOI 10.1016/j.bbrc.2011.01.079; Renner S, 2004, J MED CHEM, V47, P4653, DOI 10.1021/jm031139y; Roland WSU, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094451; Roland WSU, 2013, J AGR FOOD CHEM, V61, P10454, DOI 10.1021/jf403387p; Roland WSU, 2011, J AGR FOOD CHEM, V59, P11764, DOI 10.1021/jf202816u; Sakurai T, 2010, J BIOL CHEM, V285, P28373, DOI 10.1074/jbc.M110.144444; Sanders MPA, 2011, J CHEM INF MODEL, V51, P2277, DOI 10.1021/ci200088d; Sanders MPA, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-332; Singh N, 2011, J BIOL CHEM, V286, P36032, DOI 10.1074/jbc.M111.246983; Slack JP, 2010, CURR BIOL, V20, P1104, DOI 10.1016/j.cub.2010.04.043; Soares S, 2013, J AGR FOOD CHEM, V61, P1525, DOI 10.1021/jf304198k; Tan J, 2012, J CHEM INF MODEL, V52, P1875, DOI 10.1021/ci300133a; Thalmann S, 2013, BIOCHEM BIOPH RES CO, V435, P267, DOI 10.1016/j.bbrc.2013.04.066; Ueno Y, 2011, BIOSCI BIOTECH BIOCH, V75, P1188, DOI 10.1271/bbb.100893; Upadhyaya J, 2010, BIOCHEM BIOPH RES CO, V398, P331, DOI 10.1016/j.bbrc.2010.06.097; Vroling B, 2011, NUCLEIC ACIDS RES, V39, pD309, DOI 10.1093/nar/gkq1009	38	12	12	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2015	10	3							e0118200	10.1371/journal.pone.0118200	http://dx.doi.org/10.1371/journal.pone.0118200			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9JF	25729848	Green Published, Green Submitted, gold			2022-12-27	WOS:000350684900018
J	Natali, A; Croce, R				Natali, Alberto; Croce, Roberta			Characterization of the Major Light-Harvesting Complexes (LHCBM) of the Green Alga Chlamydomonas reinhardtii	PLOS ONE			English	Article							PHOTOSYSTEM-II ANTENNA; A/B-BINDING PROTEIN; SUPRAMOLECULAR ORGANIZATION; STATE TRANSITIONS; ENERGY-TRANSFER; SINGLET OXYGEN; LHCII COMPLEX; HIGHER-PLANTS; PHOTOSYNTHESIS; ACCLIMATION	Nine genes (LHCBM1-9) encode the major light-harvesting system of Chlamydomonas reinhardtii. Transcriptomic and proteomic analyses have shown that those genes are all expressed albeit in different amounts and some of them only in certain conditions. However, little is known about the properties and specific functions of the individual gene products because they have never been isolated. Here we have purified several complexes from native membranes and/or we have reconstituted them in vitro with pigments extracted from C. reinhardtii. It is shown that LHCBM1 and -M2/7 represent more than half of the LHCBM population in the membrane. LHCBM2/7 forms homotrimers while LHCBM1 seems to be present in heterotrimers. Trimers containing only type I LHCBM (M3/4/6/8/9) were also observed. Despite their different roles, all complexes have very similar properties in terms of pigment content, organization, stability, absorption, fluorescence and excited-state lifetimes. Thus the involvement of LHCBM1 in non-photochemical quenching is suggested to be due to specific interactions with other components of the membrane and not to the inherent quenching properties of the complex. Similarly, the overexpression of LHCBM9 during sulfur deprivation can be explained by its low sulfur content as compared with the other LHCBMs. Considering the highly conserved biochemical and spectroscopic properties, the major difference between the complexes may be in their capacity to interact with other components of the thylakoid membrane.	[Natali, Alberto; Croce, Roberta] Vrije Univ Amsterdam, Fac Sci, Dept Phys & Astron, NL-1081 HV Amsterdam, Netherlands	Vrije Universiteit Amsterdam	Croce, R (corresponding author), Vrije Univ Amsterdam, Fac Sci, Dept Phys & Astron, De Boelelaan 1081, NL-1081 HV Amsterdam, Netherlands.	r.croce@vu.nl	Croce, Roberta/HGU-9554-2022; Croce, Roberta/N-4067-2014; Croce, Roberta/ABG-3595-2021	Croce, Roberta/0000-0003-3469-834X; Croce, Roberta/0000-0003-3469-834X; Croce, Roberta/0000-0003-3469-834X	European Research Council - ERC [281341]	European Research Council - ERC(European Research Council (ERC))	European Research Council - ERC consolidator grant 281341 (ASAP) to RC http://erc.europa.eu/consolidator-grants/polish. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ballottari M, 2007, J BIOL CHEM, V282, P8947, DOI 10.1074/jbc.M606417200; Blaby IK, 2014, TRENDS PLANT SCI; Busch A, 2011, BBA-BIOENERGETICS, V1807, P864, DOI 10.1016/j.bbabio.2010.09.009; Caffarri S, 2001, J BIOL CHEM, V276, P35924, DOI 10.1074/jbc.M105199200; Caffarri S, 2007, FEBS LETT, V581, P4704, DOI 10.1016/j.febslet.2007.08.066; Croce R, 2002, BIOCHEMISTRY-US, V41, P7334, DOI 10.1021/bi0257437; Croce R, 2014, NAT CHEM BIOL, V10, P492, DOI [10.1038/NCHEMBIO.1555, 10.1038/nchembio.1555]; DAINESE P, 1990, PHOTOCHEM PHOTOBIOL, V51, P693, DOI 10.1111/php.1990.51.6.693; Dekker JP, 2005, BBA-BIOENERGETICS, V1706, P12, DOI 10.1016/j.bbabio.2004.09.009; Drop B, 2014, PLANT J, V78, P181, DOI 10.1111/tpj.12459; Drop B, 2014, BBA-BIOENERGETICS, V1837, P63, DOI 10.1016/j.bbabio.2013.07.012; Drop B, 2011, J BIOL CHEM, V286, P44878, DOI 10.1074/jbc.M111.301101; Elrad D, 2002, PLANT CELL, V14, P1801, DOI 10.1105/tpc.002154; Esquivel MG, 2011, TRENDS BIOTECHNOL, V29, P595, DOI 10.1016/j.tibtech.2011.06.008; Ferrante P, 2012, J BIOL CHEM, V287, P16276, DOI 10.1074/jbc.M111.316729; Fischer BB, 2013, ANTIOXID REDOX SIGN, V18, P2145, DOI 10.1089/ars.2012.5124; Fischer N, 1997, BIOCHEMISTRY-US, V36, P93, DOI 10.1021/bi962244v; Garab G, 2009, PHOTOSYNTH RES, V101, P135, DOI 10.1007/s11120-009-9424-4; Georgakopoulou S, 2007, BIOCHEMISTRY-US, V46, P4745, DOI 10.1021/bi062031y; Grewe S, 2014, PLANT CELL, P1, DOI [10.1105/tpc.114.123026, DOI 10.1105/TPC.114.123026]; HOBE S, 1995, BIOCHEMISTRY-US, V34, P10224, DOI 10.1021/bi00032a016; Jansson S, 1999, TRENDS PLANT SCI, V4, P236, DOI 10.1016/S1360-1385(99)01419-3; Kouril R, 2013, BBA-BIOENERGETICS, V1827, P411, DOI 10.1016/j.bbabio.2012.12.003; Krieger-Liszkay A, 2005, J EXP BOT, V56, P337, DOI 10.1093/jxb/erh237; Liguori N, 2013, J AM CHEM SOC, V135, P18339, DOI 10.1021/ja4107463; Liu ZF, 2004, NATURE, V428, P287, DOI 10.1038/nature02373; Minagawa J, 2004, PHOTOSYNTH RES, V82, P241, DOI 10.1007/s11120-004-2079-2; Minagawa J, 2011, BBA-BIOENERGETICS, V1807, P897, DOI 10.1016/j.bbabio.2010.11.005; Moya I, 2001, BIOCHEMISTRY-US, V40, P12552, DOI 10.1021/bi010342x; Mozzo M, 2008, BBA-BIOENERGETICS, V1777, P1263, DOI 10.1016/j.bbabio.2008.04.036; Natali A, 2014, JOVE-J VIS EXP, DOI 10.3791/51852; Nguyen AV, 2008, EUKARYOT CELL, V7, P1965, DOI 10.1128/EC.00418-07; Niyogi KK, 2013, CURR OPIN PLANT BIOL, V16, P307, DOI 10.1016/j.pbi.2013.03.011; Novoderezhkin VI, 2005, J PHYS CHEM B, V109, P10493, DOI 10.1021/jp044082f; Passarini F, 2014, BIOCH BIOPHYS ACTA; Passarini F, 2010, BBA-BIOENERGETICS, V1797, P501, DOI 10.1016/j.bbabio.2010.01.015; PAULSEN H, 1990, PLANTA, V181, P204, DOI 10.1007/BF02411539; Peers G, 2009, NATURE, V462, P518, DOI 10.1038/nature08587; PLUMLEY FG, 1987, P NATL ACAD SCI USA, V84, P146, DOI 10.1073/pnas.84.1.146; Remelli R, 1999, J BIOL CHEM, V274, P33510, DOI 10.1074/jbc.274.47.33510; Rochaix JD, 2002, FEBS LETT, V529, P34, DOI 10.1016/S0014-5793(02)03181-2; Rochaix JD, 2014, ANNU REV PLANT BIOL, V65, P287, DOI 10.1146/annurev-arplant-050213-040226; Ruban AV, 2012, BBA-BIOENERGETICS, V1817, P167, DOI 10.1016/j.bbabio.2011.04.007; Schagger H, 2006, NAT PROTOC, V1, P16, DOI 10.1038/nprot.2006.4; Stauber EJ, 2003, EUKARYOT CELL, V2, P978, DOI 10.1128/EC.2.5.978-994.2003; Takahashi H, 2006, P NATL ACAD SCI USA, V103, P477, DOI 10.1073/pnas.0509952103; Takahashi H, 2014, PLANT CELL PHYSL; van Amerongen H, 2001, J PHYS CHEM B, V105, P604, DOI 10.1021/jp0028406; van Oort B, 2008, BIOPHYS J, V95, P5851, DOI 10.1529/biophysj.108.140467; Wientjes E, 2013, BBA-BIOENERGETICS, V1827, P420, DOI 10.1016/j.bbabio.2012.12.009; Wientjes E, 2011, BIOCHEM J, V433, P477, DOI 10.1042/BJ20101538	51	44	44	1	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2015	10	2							e0119211	10.1371/journal.pone.0119211	http://dx.doi.org/10.1371/journal.pone.0119211			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC3LS	25723534	Green Published, Green Submitted, gold			2022-12-27	WOS:000350251200069
J	Qu, DF; Johnson, J; Chandrakesan, P; Weygant, N; May, R; Aiello, N; Rhim, A; Zhao, LC; Zheng, W; Lightfoot, S; Pant, S; Irvan, J; Postier, R; Hocker, J; Hanas, JS; Ali, N; Sureban, SM; An, GY; Schlosser, MJ; Stanger, B; Houchen, CW				Qu, Dongfeng; Johnson, Jeremy; Chandrakesan, Parthasarathy; Weygant, Nathaniel; May, Randal; Aiello, Nicole; Rhim, Andrew; Zhao, Lichao; Zheng, Wei; Lightfoot, Stanley; Pant, Shubham; Irvan, Jeremy; Postier, Russell; Hocker, James; Hanas, Jay S.; Ali, Naushad; Sureban, Sripathi M.; An, Guangyu; Schlosser, Michael J.; Stanger, Ben; Houchen, Courtney W.			Doublecortin-Like Kinase 1 Is Elevated Serologically in Pancreatic Ductal Adenocarcinoma and Widely Expressed on Circulating Tumor Cells	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; CANCER STEM-CELLS; IDENTIFICATION; MARKER; REGENERATION; MECHANISMS; DISEASE; GROWTH	Doublecortin-like kinase 1 (DCLK1) is a putative pancreatic stem cell marker and is upregulated in pancreatic cancer, colorectal cancer, and many other solid tumors. It marks tumor stem cells in mouse models of intestinal neoplasia. Here we sought to determine whether DCLK1 protein can be detected in the bloodstream and if its levels in archived serum samples could be quantitatively assessed in pancreatic cancer patients. DCLK1 specific ELISA, western blotting, and immunohistochemical analyses were used to determine expression levels in the serum and staining intensity in archived tumor tissues of pancreatic ductal adenocarcinoma (PDAC) patients and in pancreatic cancer mouse models. DCLK1 levels in the serum were elevated in early stages of PDAC (stages I and II) compared to healthy volunteers (normal controls). No differences were observed between stages III/IV and normal controls. In resected surgical tissues, DCLK1 expression intensity in the stromal cells was significantly higher than that observed in tumor epithelial cells. Circulating tumor cells were isolated from KPCY mice and approximately 52% of these cells were positive for Dclk1 staining. Dclk1 levels in the serum of KPC mice were also elevated. We have previously demonstrated that DCLK1 plays a potential role in regulating epithelial mesenchymal transition (EMT). Given the increasingly recognized role of EMT derived stem cells in cancer progression and metastasis, we hypothesize that DCLK1 may contribute to the metastatic process. Taken together, our results suggest that DCLK1 serum levels and DCLK1 positive circulating tumor cells should be further assessed for their potential diagnostic and prognostic significance.	[Qu, Dongfeng; Chandrakesan, Parthasarathy; Weygant, Nathaniel; May, Randal; Pant, Shubham; Ali, Naushad; Sureban, Sripathi M.; Houchen, Courtney W.] Univ Oklahoma, Hlth Sci Ctr, Dept Internal Med, Oklahoma City, OK 73106 USA; [Johnson, Jeremy; Irvan, Jeremy; Postier, Russell] Univ Oklahoma, Hlth Sci Ctr, Dept Surg, Oklahoma City, OK USA; [Zhao, Lichao; Zheng, Wei; Lightfoot, Stanley] Univ Oklahoma, Hlth Sci Ctr, Dept Pathol, Oklahoma City, OK USA; [Hocker, James; Hanas, Jay S.] Univ Oklahoma, Hlth Sci Ctr, Dept Biochem & Mol Biol, Oklahoma City, OK USA; [Qu, Dongfeng; May, Randal; Sureban, Sripathi M.; Houchen, Courtney W.] Dept Vet Affairs Med Ctr, Oklahoma City, OK USA; [Qu, Dongfeng; Chandrakesan, Parthasarathy; Ali, Naushad; Sureban, Sripathi M.; Houchen, Courtney W.] Peggy & Charles Stephenson Oklahoma Canc Ctr, Oklahoma City, OK USA; [Schlosser, Michael J.; Houchen, Courtney W.] COARE Biotechnol Inc, Oklahoma City, OK USA; [Aiello, Nicole; Stanger, Ben] Univ Penn, Dept Med, Philadelphia, PA 19104 USA; [Rhim, Andrew] Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA; [An, Guangyu] Capital Med Univ, Dept Oncol, Beijing Chaoyang Hosp, Beijing, Peoples R China	University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Pennsylvania; University of Michigan System; University of Michigan; Capital Medical University	Houchen, CW (corresponding author), Univ Oklahoma, Hlth Sci Ctr, Dept Internal Med, Oklahoma City, OK 73106 USA.	Courtney-houchen@ouhsc.edu	Hocker, James Randolph Sanders/AAV-4893-2020; Chandrakesan, Parthasarathy/AAB-9136-2020; Sureban, Sripathi/Q-8232-2019; Hocker, James R.S./G-7217-2018	Hocker, James Randolph Sanders/0000-0002-7111-9119; Hocker, James R.S./0000-0002-7111-9119; Sureban, Sripathi/0000-0001-5476-9593; Zheng, Wei/0000-0003-3193-2655; Chandrakesan, Parthasarathy/0000-0002-7587-9553; Aiello, Nicole/0000-0003-1616-5785; Hanas, Jay/0000-0003-1922-5333; Weygant, Nathaniel/0000-0001-7861-6532; Ali, Naushad/0000-0002-0058-7396	NIH [1R21CA137482-01A1]; Oklahoma Center for Adult Stem Cell Research Grant (OCASCR); DoD-CDMRP-Discovery award [W81XWH-12-1-0503]; NATIONAL CANCER INSTITUTE [R21CA137482] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Oklahoma Center for Adult Stem Cell Research Grant (OCASCR); DoD-CDMRP-Discovery award; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was supported by NIH 1R21CA137482-01A1, Oklahoma Center for Adult Stem Cell Research Grant (OCASCR) to CWH, and DoD-CDMRP-Discovery award (W81XWH-12-1-0503). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguirre AJ, 2003, GENE DEV, V17, P3112, DOI 10.1101/gad.1158703; Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Bailey JM, 2014, GASTROENTEROLOGY, V146, P245, DOI 10.1053/j.gastro.2013.09.050; Balagurunathan Y, 2008, MOL CANCER THER, V7, P3071, DOI 10.1158/1535-7163.MCT-08-0402; Bao B, 2011, J CELL BIOCHEM, V112, P2296, DOI 10.1002/jcb.23150; Barton JG, 2009, J GASTROINTEST SURG, V13, P2050, DOI 10.1007/s11605-009-0849-z; Bonnet D, 1997, NAT MED, V3, P730, DOI 10.1038/nm0797-730; Chandrakesan P, 2014, ONCOGENE, V33, P2639, DOI 10.1038/onc.2013.210; Clarke Michael F, 2006, Cancer Res, V66, P9339, DOI 10.1158/0008-5472.CAN-06-3126; DelGiorno KE, 2014, GASTROENTEROLOGY, V146, P233, DOI 10.1053/j.gastro.2013.08.053; Diehn M, 2006, J NATL CANCER I, V98, P1755, DOI 10.1093/jnci/djj505; Gerbe F, 2011, J CELL BIOL, V192, P767, DOI 10.1083/jcb.201010127; Goonetilleke KS, 2007, EJSO-EUR J SURG ONC, V33, P266, DOI 10.1016/j.ejso.2006.10.004; Hermann PC, 2007, CELL STEM CELL, V1, P313, DOI 10.1016/j.stem.2007.06.002; Howard T J, 1996, Curr Probl Cancer, V20, P281, DOI 10.1016/S0147-0272(96)80001-8; Hu G, 2012, INT J ONCOL, V40, P798, DOI 10.3892/ijo.2011.1254; Jimeno A, 2009, MOL CANCER THER, V8, P310, DOI 10.1158/1535-7163.MCT-08-0924; Jordan CT, 2006, NEW ENGL J MED, V355, P1253, DOI 10.1056/NEJMra061808; Khan S, 2013, CANCER RES, V73, P6541, DOI 10.1158/0008-5472.CAN-13-1288; King JB, 2012, AM J PHYSIOL-GASTR L, V303, pG443, DOI 10.1152/ajpgi.00087.2012; Li CW, 2007, CANCER RES, V67, P1030, DOI 10.1158/0008-5472.CAN-06-2030; May R, 2008, STEM CELLS, V26, P630, DOI 10.1634/stemcells.2007-0621; May R, 2010, AM J PHYSIOL-GASTR L, V299, pG303, DOI 10.1152/ajpgi.00146.2010; Nakanishi Y, 2013, NAT GENET, V45, P98, DOI 10.1038/ng.2481; POSTE G, 1982, Invasion and Metastasis, V2, P137; Reichert M, 2013, GENE DEV, V27, P288, DOI 10.1101/gad.204453.112; Reichert M, 2011, J CLIN INVEST, V121, P4572, DOI 10.1172/JCI57131; Rhim AD, 2012, CELL, V148, P349, DOI 10.1016/j.cell.2011.11.025; Shah AN, 2007, ANN SURG ONCOL, V14, P3629, DOI 10.1245/s10434-007-9583-5; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Strobel O, 2007, GASTROENTEROLOGY, V133, P1999, DOI 10.1053/j.gastro.2007.09.009; Sultana A, 2007, J CLIN ONCOL, V25, P2607, DOI 10.1200/JCO.2006.09.2551; Sureban SM, 2014, CANCER LETT, V351, P151, DOI 10.1016/j.canlet.2014.05.011; Sureban SM, 2011, CANCER RES, V71, P2328, DOI 10.1158/0008-5472.CAN-10-2738; Turley EA, 2008, NAT CLIN PRACT ONCOL, V5, P280, DOI 10.1038/ncponc1089; Weygant N, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-103; Wu Q, 2012, PANCREATIC CANC, V2	37	36	37	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2015	10	2							e0118933	10.1371/journal.pone.0118933	http://dx.doi.org/10.1371/journal.pone.0118933			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC3LS	25723399	Green Published, gold, Green Submitted			2022-12-27	WOS:000350251200065
J	Richardson, AK; Currie, MJ; Robinson, BA; Morrin, H; Phung, Y; Pearson, JF; Anderson, TP; Potter, JD; Walker, LC				Richardson, Ann K.; Currie, Margaret J.; Robinson, Bridget A.; Morrin, Helen; Phung, Yen; Pearson, John F.; Anderson, Trevor P.; Potter, John D.; Walker, Logan C.			Cytomegalovirus and Epstein-Barr Virus in Breast Cancer	PLOS ONE			English	Article							MEDULLARY CARCINOMA; VIRAL FACTORS; ASSOCIATION; INFECTION; DNA; RISK; EBV; LOCALIZATION; FIBROADENOMA; EXPRESSION	Findings of polymerase chain reaction (PCR) studies of cytomegalovirus (CMV) and Epstein-Barr virus (EBV) and breast cancer vary, making it difficult to determine whether either, both, or neither virus is causally associated with breast cancer. We investigated CMV and EBV in paired samples of breast cancer and normal breast tissue from 70 women using quantitative PCR. A serum sample from each woman was tested for CMV and EBV IgG. To place our results in context, we reviewed the existing literature and performed a meta-analysis of our results together with previous PCR studies of EBV, CMV, and breast cancer. Of the serology samples, 67 of 70 (96%) were EBV IgG positive and 49 of 70 (70%) were CMV IgG positive. QPCR detected EBV in 24 (34%) of the tumour and 9 (13%) of the paired normal specimens and CMV in 0 (0%) of the tumour and 2 (3%) of the paired normal specimens. Our findings, together with earlier results summarised in the meta-analysis, suggest several possibilities: variable findings may be due to limitations of molecular analyses; 'hit and run' oncogenesis may lead to inconsistent results; one or both viruses has a role at a later stage in breast cancer development; infection with multiple viruses increases breast cancer risk; or neither virus has a role. Future studies should focus on ways to investigate these possibilities, and should include comparisons of breast cancer tissue samples with appropriate normal tissue samples.	[Richardson, Ann K.; Potter, John D.] Univ Canterbury, Sch Hlth Sci, Wayne Francis Canc Epidemiol Res Grp, Christchurch 1, New Zealand; [Currie, Margaret J.; Robinson, Bridget A.; Morrin, Helen; Phung, Yen; Walker, Logan C.] Univ Otago, Mackenzie Canc Res Grp, Christchurch, New Zealand; [Pearson, John F.] Univ Otago, Biostat & Computat Biol Unit, Christchurch, New Zealand; [Anderson, Trevor P.] Canterbury Hlth Labs, Christchurch, New Zealand; [Potter, John D.] Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, Seattle, WA 98104 USA; [Potter, John D.] Massey Univ, Ctr Publ Hlth Res, Wellington, New Zealand	University of Otago; University of Otago; Canterbury Health Laboratories; Fred Hutchinson Cancer Center; Massey University	Richardson, AK (corresponding author), Univ Canterbury, Sch Hlth Sci, Wayne Francis Canc Epidemiol Res Grp, Christchurch 1, New Zealand.	ann.richardson@canterbury.ac.nz	Pearson, John F/D-7428-2012; Currie, Margaret J/I-6223-2015; robinson, bridget/K-7619-2019	Pearson, John F/0000-0001-5607-4517; Currie, Margaret J/0000-0002-9788-8098; Walker, Logan/0000-0003-0018-3719; Robinson, Bridget/0000-0001-9483-9146	Canterbury Medical Research Foundation [12/08]	Canterbury Medical Research Foundation	This work was supported by Canterbury Medical Research Foundation (http://www.cmrf.org.nz/) Grant number 12/08 to LCW, AKR, BAR, HM, and JDP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alibek K, 2013, INFECT AGENTS CANCER, V8, DOI 10.1186/1750-9378-8-32; Antonsson A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039842; Arbach H, 2006, J VIROL, V80, P845, DOI 10.1128/JVI.80.2.845-853.2006; Baltzell K, 2012, BREAST CANCER RES TR, V132, P267, DOI 10.1007/s10549-011-1841-3; Baryawno N, 2011, J CLIN INVESTIGATION; Bonnet M, 1999, J NATL CANCER I, V91, P1376, DOI 10.1093/jnci/91.16.1376; Brink AATP, 2000, J NATL CANCER I, V92, P655, DOI 10.1093/jnci/92.8.655; Chu PGG, 2001, AM J PATHOL, V159, P571, DOI 10.1016/S0002-9440(10)61728-2; Cox B, 2010, BRIT J CANCER, V102, P1665, DOI 10.1038/sj.bjc.6605675; Eghbali M, 2012, INT J MOL CLIN MICRO, V2, P175; El-Shinawi M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055755; Fawzy S, 2008, CLIN BIOCHEM, V41, P486, DOI 10.1016/j.clinbiochem.2007.12.017; Fina F, 2001, BRIT J CANCER, V84, P783, DOI 10.1054/bjoc.2000.1672; GAFFEY MJ, 1993, MODERN PATHOL, V6, P721; GAFFEY MJ, 1993, HUM PATHOL, V24, P657, DOI 10.1016/0046-8177(93)90247-E; Glaser SL, 2004, CANCER EPIDEM BIOMAR, V13, P688; Glenn WK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048788; Grinstein S, 2002, CANCER RES, V62, P4876; Griscelli F, 2001, J CLIN MICROBIOL, V39, P4362, DOI 10.1128/JCM.39.12.4362-4369.2001; Hachana M, 2011, PATHOL RES PRACT, V207, P695, DOI 10.1016/j.prp.2011.09.007; Harkins Lualhati E, 2010, Herpesviridae, V1, P8, DOI 10.1186/2042-4280-1-8; He JR, 2011, CANCER LETT, V309, P128, DOI 10.1016/j.canlet.2011.05.012; Hennighausen L, 2000, BREAST CANCER RES, V2, P2, DOI 10.1186/bcr20; Herrmann K, 2003, BREAST CANCER RES, V5, DOI 10.1186/bcr561; Hippocrate A, 2011, CANCER LETT, V305, P144, DOI 10.1016/j.canlet.2010.11.007; Hjalgrim H, 2000, J NATL CANCER I, V92, P1522, DOI 10.1093/jnci/92.18.1522; HORIUCHI K, 1994, J CLIN PATHOL, V47, P538, DOI 10.1136/jcp.47.6.538; Huang J, 2003, J VIROL, V77, P13267, DOI 10.1128/JVI.77.24.13267-13274.2003; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Joshi D, 2012, BREAST CANCER RES TR, V135, P1, DOI 10.1007/s10549-011-1921-4; Kadivar M, 2011, PATHOL ONCOL RES, V17, P489, DOI 10.1007/s12253-010-9325-z; Kalkan A, 2005, MED PRIN PRACT, V14, P268, DOI 10.1159/000085748; Kamranvar SA, 2011, LEUKEMIA, V25, P1017, DOI 10.1038/leu.2011.35; Khan G, 2011, EXP MOL PATHOL, V91, P466, DOI 10.1016/j.yexmp.2011.04.018; Kleer CG, 2002, MODERN PATHOL, V15, P759, DOI 10.1038/modpathol.3880602; LABRECQUE LG, 1995, CANCER RES, V55, P39; LESPAGNARD L, 1995, AM J CLIN PATHOL, V103, P449; Liao HC, 2007, APPL MATH COMPUT, V188, P989, DOI 10.1016/j.amc.2006.10.069; LUQMANI YA, 1995, INT J ONCOL, V6, P899; Magrath I, 1999, JNCI-J NATL CANCER I, V91, P1349, DOI 10.1093/jnci/91.16.1349; Malouli D, 2014, J CLIN INVEST, V124, P1928, DOI 10.1172/JCI67420; Mazouni C, 2011, BRIT J CANCER, V104, P332, DOI 10.1038/sj.bjc.6606048; McCall SA, 2001, JNCI-J NATL CANCER I, V93, P148, DOI 10.1093/jnci/93.2.148; Michaelis M, 2009, NEOPLASIA, V11, P1, DOI 10.1593/neo.81178; Morales-Sanchez A, 2013, SCI REP-UK, V3, DOI 10.1038/srep02970; Morrin Helen, 2005, N Z Med J, V118, pU1735; Murray PG, 2003, CANCER RES, V63, P2338; Paulus C, 2009, VIRUSES-BASEL, V1, P760, DOI 10.3390/v1030760; Perkins RS, 2006, BREAST CANCER RES, V8, DOI 10.1186/BCR1627; Perrigoue JG, 2005, CANCER EPIDEM BIOMAR, V14, P809, DOI 10.1158/1055-9965.EPI-04-0763; POTTER JD, 1995, CANCER EPIDEM BIOMAR, V4, P319; Preciado MV, 2005, ARCH PATHOL LAB MED, V129, P377; Richardson A, 1997, MED HYPOTHESES, V48, P491, DOI 10.1016/S0306-9877(97)90118-3; Richardson AK, 2004, BRIT J CANCER, V90, P2149, DOI 10.1038/sj.bjc.6601822; Savu A, 2008, INT J CANCER, V123, P1094, DOI 10.1002/ijc.23595; Soderberg-Naucler C, 2008, J CLIN VIROL, V41, P218, DOI 10.1016/j.jcv.2007.11.009; Soroceanu L, 2011, VIRUS RES, V157, P193, DOI 10.1016/j.virusres.2010.10.026; Stewart B. W., 2003, World Cancer Report; STEWART T, 1995, LANCET, V346, P796, DOI 10.1016/S0140-6736(95)91618-0; Straat K, 2009, JNCI-J NATL CANCER I, V101, P488, DOI 10.1093/jnci/djp031; Taher C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056795; Thorne LB, 2005, DIAGN MOL PATHOL, V14, P29, DOI 10.1097/01.pas.0000144448.23464.ab; Tsai JH, 2005, J MED VIROL, V75, P276, DOI 10.1002/jmv.20267; Tsai JH, 2007, J CANCER RES CLIN, V133, P13, DOI 10.1007/s00432-006-0141-5; Utrera-Barillas D, 2013, INFECT AGENTS CANCER, V8, DOI 10.1186/1750-9378-8-12; Viechtbauer W, 2010, J STAT SOFTW, V36, P1, DOI 10.18637/jss.v036.i03; Xue SA, 2003, BRIT J CANCER, V89, P113, DOI 10.1038/sj.bjc.6601027; Yasui Y, 2001, CANCER EPIDEM BIOMAR, V10, P9; Zekri ARN, 2012, J EGYPT NATL CANCER, V24, P123, DOI 10.1016/j.jnci.2012.06.001	69	53	56	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2015	10	2							e0118989	10.1371/journal.pone.0118989	http://dx.doi.org/10.1371/journal.pone.0118989			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC3LS	25723522	Green Submitted, Green Published, gold			2022-12-27	WOS:000350251200068
J	Bejanyan, K; Marshall, TC; Ferenczi, N				Bejanyan, Kathrine; Marshall, Tara C.; Ferenczi, Nelli			Associations of Collectivism with Relationship Commitment, Passion, and Mate Preferences: Opposing Roles of Parental Influence and Family Allocentrism	PLOS ONE			English	Article							ARRANGED MARRIAGES; OFFSPRING CONFLICT; VALUE TRANSMISSION; CULTURAL VARIATION; SEX-DIFFERENCES; ROMANTIC LOVE; SATISFACTION; AMERICAN; INTIMACY; INDIVIDUALISM	In collectivist cultures, families tend to be characterized by respect for parental authority and strong, interdependent ties. Do these aspects of collectivism exert countervailing pressures on mate choices and relationship quality? In the present research, we found that collectivism was associated with greater acceptance of parental influence over mate choice, thereby driving relationship commitment down (Studies 1 and 2), but collectivism was also associated with stronger family ties (referred to as family allocentrism), which drove commitment up (Study 2). Along similar lines, Study 1 found that collectivists' greater acceptance of parental influence on mate choice contributed to their reduced relationship passion, whereas Study 2 found that their greater family allocentrism may have enhanced their passion. Study 2 also revealed that collectivists may have reported a smaller discrepancy between their own preferences for mates high in warmth and trustworthiness and their perception of their parents' preferences for these qualities because of their stronger family allocentrism. However, their higher tolerance of parental influence may have also contributed to a smaller discrepancy in their mate preferences versus their perceptions of their parents' preferences for qualities signifying status and resources. Implications for the roles of collectivism, parental influence, and family allocentrism in relationship quality and mate selection will be discussed.	[Bejanyan, Kathrine; Marshall, Tara C.; Ferenczi, Nelli] Brunel Univ, Dept Psychol, London, England	Brunel University	Bejanyan, K (corresponding author), Brunel Univ, Dept Psychol, London, England.	kathrine.bejanyan@brunel.ac.uk		Ferenczi, Nelli/0000-0002-3757-6244; Marshall, Tara/0000-0002-1379-5290	Brunel University	Brunel University	The first author received small funding from Brunel University departmental research allowance to pay participants for taking part in the study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackerman JM, 2011, J PERS SOC PSYCHOL, V100, P1079, DOI 10.1037/a0022412; Apostolou M, 2008, EVOL PSYCHOL, V6, P456; Barni D, 2011, J MORAL EDUC, V40, P105, DOI 10.1080/03057240.2011.553797; Berry JW, 2005, INT J INTERCULT REL, V29, P697, DOI 10.1016/j.ijintrel.2005.07.013; Bowman JL, 2013, J COMP FAM STUD, V44, P207; Bullis C, 1993, INTERPERSONAL COMMUN, P213; Bullough VL, 1990, ANN REV SEX RES, V1, P75; Buss, 2005, HDB EVOLUTIONARY PSY, P419, DOI 10.1002/9780470939376.ch14; BUSS DM, 1990, J CROSS CULT PSYCHOL, V21, P5, DOI 10.1177/0022022190211001; Buunk AP, 2008, REV GEN PSYCHOL, V12, P47, DOI 10.1037/1089-2680.12.1.47; Buunk AP, 2010, CROSS-CULT RES, V44, P23, DOI 10.1177/1069397109337711; Dasgupta S, 1998, SEX ROLES, V38, P953, DOI 10.1023/A:1018822525427; DERNE S, 1994, SOCIOL PERSPECT, V37, P203, DOI 10.2307/1389320; Derne Steve, 1995, CULTURE ACTION FAMIL; Dubbs SL, 2010, J SOC PERS RELAT, V27, P1051, DOI 10.1177/0265407510378666; Dubbs SL, 2010, EVOL PSYCHOL-US, V8, P586, DOI 10.1177/147470491000800405; Dugsin R, 2001, FAM PROCESS, V40, P233, DOI 10.1111/j.1545-5300.2001.4020100233.x; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Fisher HE, 2006, PHILOS T R SOC B, V361, P2173, DOI 10.1098/rstb.2006.1938; Fletcher GJO, 1999, J PERS SOC PSYCHOL, V76, P72, DOI 10.1037/0022-3514.76.1.72; FURMAN W, 1992, CHILD DEV, V63, P103, DOI 10.2307/1130905; Gala J, 2014, PSYCHOL DEV SOC, V26, P115, DOI 10.1177/0971333613516233; Gangestad SW, 2006, PSYCHOL INQ, V17, P75, DOI 10.1207/s15327965pli1702_1; Gao G, 2001, INT J INTERCULT REL, V25, P329, DOI 10.1016/S0147-1767(01)00007-4; Goodwin R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036106; GRUSEC JE, 1994, DEV PSYCHOL, V30, P4, DOI 10.1037/0012-1649.30.1.4; Hamid S, 2011, CULT HEALTH SEX, V13, P841, DOI 10.1080/13691058.2011.579165; Hamon R. R., 2003, MATE SELECTION CULTU; Hart K, 2007, J ROY ANTHROPOL INST, V13, P345, DOI 10.1111/j.1467-9655.2007.00438.x; Hatfield E, 2006, CLOSE RELATIONSHIPS, P227; Hatfield E., 2002, STABILITY CHANGE REL, P306, DOI [10.1017/CBO9780511499876, DOI 10.1017/CB09780511499876.017]; Hofstede G., 1980, CULTURES CONSEQUENCE; HORTACSU N, 1994, J SOC PSYCHOL, V134, P229, DOI 10.1080/00224545.1994.9711386; Hynie Michaela, 2006, Cultur Divers Ethnic Minor Psychol, V12, P230, DOI 10.1037/1099-9809.12.2.230; Khandelwal M, 2009, SIGNS, V34, P583, DOI 10.1086/593341; Kin Ng T, 2010, J PSYCHOL CHINESE SO, V11, P123; Knafo A, 2003, CHILD DEV, V74, P595, DOI 10.1111/1467-8624.7402018; Knafo A, 2001, J CROSS CULT PSYCHOL, V32, P213, DOI 10.1177/0022022101032002008; Kousha M, 1997, SOC INDIC RES, V40, P329, DOI 10.1023/A:1006894525035; Lalonde RN, 2004, J CROSS CULT PSYCHOL, V35, P503, DOI 10.1177/0022022104268386; Lau M, 2009, J ADOLESCENT RES, V24, P91, DOI 10.1177/0743558408328439; Lay C, 1998, J CROSS CULT PSYCHOL, V29, P434, DOI 10.1177/0022022198293004; Le Espiritu Y, 2001, SIGNS, V26, P415, DOI 10.1086/495599; LEVINE R, 1995, J CROSS CULT PSYCHOL, V26, P554, DOI 10.1177/0022022195265007; LIN YHW, 1995, J SOC PERS RELAT, V12, P7, DOI 10.1177/0265407595121002; Luo BZ, 2008, J SOC PERS RELAT, V25, P867, DOI 10.1177/0265407508096699; MacDonald G, 2012, CROSS-CULT RES, V46, P366, DOI 10.1177/1069397112450854; MacKinnon D P, 2000, Prev Sci, V1, P173, DOI 10.1023/A:1026595011371; MacKinnon DP, 2007, ANNU REV PSYCHOL, V58, P593, DOI 10.1146/annurev.psych.58.110405.085542; Madathil J, 2008, FAM J, V16, P222, DOI 10.1177/1066480708317504; Manohar N, 2008, J COMP FAM STUD, V39, P571, DOI 10.3138/jcfs.39.4.571; MARKUS HR, 1991, PSYCHOL REV, V98, P224, DOI 10.1037/0033-295X.98.2.224; Marshall TC, 2008, J SOC PERS RELAT, V25, P143, DOI 10.1177/0265407507086810; Marshall TC, 2010, PERS RELATIONSHIP, V17, P391, DOI 10.1111/j.1475-6811.2010.01280.x; Medora NP, 2002, J COMP FAM STUD, V33, P155, DOI 10.3138/jcfs.33.2.155; Morgan EM, 2010, DEV PSYCHOL, V46, P139, DOI 10.1037/a0016931; Myers JE, 2005, J COUNS DEV, V83, P183, DOI 10.1002/j.1556-6678.2005.tb00595.x; Nesteruk O, 2012, MARRIAGE FAM REV, V48, P40, DOI 10.1080/01494929.2011.620732; Neto F, 2000, J CROSS CULT PSYCHOL, V31, P626, DOI 10.1177/0022022100031005005; Netting NS, 2010, J FAM ISSUES, V31, P707, DOI 10.1177/0192513X09357555; Netting NS, 2006, J COMP FAM STUD, V37, P129, DOI 10.3138/jcfs.37.1.129; Okagaki L, 1999, J GENET PSYCHOL, V160, P303, DOI 10.1080/00221329909595401; Preacher KJ, 2008, BEHAV RES METHODS, V40, P879, DOI 10.3758/BRM.40.3.879; Punja S, 1992, DIVINE ECSTASY STORY; Puri J, 1997, GENDER SOC, V11, P434, DOI 10.1177/089124397011004004; Regan PC, 2004, SOC BEHAV PERSONAL, V32, P667, DOI 10.2224/sbp.2004.32.7.667; Roland A., 1988, SEARCH SELF INDIA JA; Roy M, 1975, BENGALI WOMEN; Ruan Fang Fu, 1991, SEX CHINA STUDIES SE; Rusbult CE, 1998, PERS RELATIONSHIP, V5, P357, DOI 10.1111/j.1475-6811.1998.tb00177.x; Sandhya S, 2009, J MARITAL FAM THER, V35, P74, DOI 10.1111/j.1752-0606.2008.00103.x; Sato, 2007, INDIVIDUAL DIFFERENC, V5, P194; Sheela J, 2003, J COMP FAM STUD, V34, P497, DOI 10.3138/jcfs.34.4.497; Sherif-Trask B, 2003, MATE SELECTION CULTU, P121; Sinha JBP, 2001, ASIAN J SOC PSYCHOL, V4, P133, DOI 10.1111/j.1467-839X.2001.00081.x; Sivadas E, 2008, J BUS RES, V61, P201, DOI 10.1016/j.jbusres.2007.06.016; SMITH TE, 1982, J MARRIAGE FAM, V44, P661, DOI 10.2307/351587; Sternberg RJ, 1997, EUR J SOC PSYCHOL, V27, P313, DOI 10.1002/(SICI)1099-0992(199705)27:3<313::AID-EJSP824>3.3.CO;2-W; Uskul AK, 2011, J CROSS CULT PSYCHOL, V42, P1165, DOI 10.1177/0022022110383311; WHITBECK LB, 1988, J MARRIAGE FAM, V50, P829, DOI 10.2307/352651; Zaidi AU, 2002, J COMP FAM STUD, V33, P495, DOI 10.3138/jcfs.33.4.495	81	29	29	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2015	10	2							e0117374	10.1371/journal.pone.0117374	http://dx.doi.org/10.1371/journal.pone.0117374			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CC2ZH	25719563	Green Published, Green Accepted, gold			2022-12-27	WOS:000350213200022
J	Moureau, G; Cook, S; Lemey, P; Nougairede, A; Forrester, NL; Khasnatinov, M; Charrel, RN; Firth, AE; Gould, EA; de Lamballerie, X				Moureau, Gregory; Cook, Shelley; Lemey, Philippe; Nougairede, Antoine; Forrester, Naomi L.; Khasnatinov, Maxim; Charrel, Remi N.; Firth, Andrew E.; Gould, Ernest A.; de lamballerie, Xavier			New Insights into Flavivirus Evolution, Taxonomy and Biogeographic History, Extended by Analysis of Canonical and Alternative Coding Sequences	PLOS ONE			English	Article							WEST-NILE-VIRUS; INSECT-SPECIFIC FLAVIVIRUSES; NATURAL MOSQUITO POPULATION; TICK-BORNE FLAVIVIRUSES; FUSING AGENT VIRUS; ENCEPHALITIS-VIRUS; GENUS FLAVIVIRUS; NORTH-AMERICA; DENGUE VIRUS; BAGAZA VIRUS	To generate the most diverse phylogenetic dataset for the flaviviruses to date, we determined the genomic sequences and phylogenetic relationships of 14 flaviviruses, of which 10 are primarily associated with Culex spp. mosquitoes. We analyze these data, in conjunction with a comprehensive collection of flavivirus genomes, to characterize flavivirus evolutionary and biogeographic history in unprecedented detail and breadth. Based on the presumed introduction of yellow fever virus into the Americas via the transatlantic slave trade, we extrapolated a timescale for a relevant subset of flaviviruses whose evolutionary history, shows that different Culex-spp. associated flaviviruses have been introduced from the Old World to the New World on at least five separate occasions, with 2 different sets of factors likely to have contributed to the dispersal of the different viruses. We also discuss the significance of programmed ribosomal frameshifting in a central region of the polyprotein open reading frame in some mosquito-associated flaviviruses.	[Moureau, Gregory; Nougairede, Antoine; Charrel, Remi N.; Gould, Ernest A.; de lamballerie, Xavier] Aix Marseille Univ, IRD French Inst Res Dev, EHESP French Sch Publ Hlth, EPV UMR D Emergence Pathol Virales 190, Marseille, France; [Cook, Shelley] Nat Hist Museum, Dept Life Sci, London SW7 5BD, England; [Lemey, Philippe] Katholieke Univ Leuven, Rega Inst, Dept Microbiol & Immunol, B-3000 Leuven, Belgium; [Forrester, Naomi L.] Univ Texas Med Branch, Inst Human Infect & Immun, Galveston, TX 77555 USA; [Forrester, Naomi L.] Univ Texas Med Branch, Dept Pathol, Galveston, TX 77555 USA; [Khasnatinov, Maxim] Ctr Ecol & Hydrol, Wallingford OX10, Oxon, England; [Firth, Andrew E.] Univ Cambridge, Dept Pathol, Div Virol, Cambridge CB2 1QP, England	Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Aix-Marseille Universite; Natural History Museum London; KU Leuven; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; UK Centre for Ecology & Hydrology (UKCEH); University of Cambridge	Moureau, G (corresponding author), Aix Marseille Univ, IRD French Inst Res Dev, EHESP French Sch Publ Hlth, EPV UMR D Emergence Pathol Virales 190, Marseille, France.	gregory.moureau@univ-amu.fr	Khasnatinov, Maxim/S-7266-2016; Khasnatinov, Maxim/F-2153-2011; Lemey, Philippe/C-3755-2018	Khasnatinov, Maxim/0000-0002-8441-3640; Lemey, Philippe/0000-0003-2826-5353; Firth, Andrew/0000-0002-7986-9520; Charrel, Remi/0000-0002-7675-8251	Wellcome Trust [088789]; Aix-Marseille University; IRD; EHESP; European Virus Archive (under EU grant [228292]; European Union [260644, 278433]; EU [FP7-261504 EDENext]; Natural Environment Research Council [ceh010010] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); Aix-Marseille University; IRD; EHESP; European Virus Archive (under EU grant; European Union(European Commission); EU(European Commission); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	AEF is supported by Wellcome Trust grant 088789. This work was supported by Aix-Marseille University, IRD, EHESP, the project European Virus Archive (under EU grant agreement no 228292), the European Union Seventh Framework Programme projects SILVER and PREDEMICS, under grant agreements 260644 and 278433 respectively. This study was also partially funded by EU grant FP7-261504 EDENext and is catalogued by the EDENext Steering Committee as EDENext299 (http://www.edenext.eu). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abascal F, 2005, BIOINFORMATICS, V21, P2104, DOI 10.1093/bioinformatics/bti263; Aguero M, 2011, EMERG INFECT DIS, V17, P1498, DOI 10.3201/eid1708.110077; Allicock OM, 2012, MOL BIOL EVOL, V29, P1533, DOI 10.1093/molbev/msr320; Bakonyi T, 2004, VIROLOGY, V328, P301, DOI 10.1016/j.virol.2004.08.005; Batista WC, 2011, REV SOC BRAS MED TRO, V44, P528, DOI 10.1590/S0037-86822011000400028; Bhatt S, 2013, NATURE, DOI [10.1038/nature12879, DOI 10.1038/NATURE12879]; Billoir F, 2000, J GEN VIROL, V81, P781, DOI 10.1099/0022-1317-81-3-781; Bloom K. J., 1993, MISSISSIPPI VALLEYS, P1, DOI [10.1111/gwat.12306, DOI 10.1111/GWAT.12306]; Bondre VP, 2007, J GEN VIROL, V88, P875, DOI 10.1099/vir.0.82403-0; Bondre VP, 2009, J GEN VIROL, V90, P2644, DOI 10.1099/vir.0.012336-0; BOUGHTON CR, 1986, MED J AUSTRALIA, V145, P90, DOI 10.5694/j.1326-5377.1986.tb101087.x; Briese T, 1999, LANCET, V354, P1261, DOI 10.1016/S0140-6736(99)04576-6; Bryant JE, 2007, PLOS PATHOG, V3, P668, DOI 10.1371/journal.ppat.0030075; Calisher CH, 2003, ADV VIRUS RES, V59, P1, DOI 10.1016/S0065-3527(03)59001-7; Charrel RN, 2005, EMERG INFECT DIS, V11, P683, DOI 10.3201/eid1105.041298; Charrel RN, 2001, VIROLOGY, V283, P161, DOI 10.1006/viro.2001.0874; Chhilar JS, 2011, 1 REPORT BITING MIDG; CHU F. I., 1959, ACTA ENT SINICA, V9, P161; Clyde K, 2006, J VIROL, V80, P2170, DOI 10.1128/JVI.80.5.2170-2182.2006; Clyde K, 2008, VIROLOGY, V379, P314, DOI 10.1016/j.virol.2008.06.034; Cook S, 2006, J GEN VIROL, V87, P735, DOI 10.1099/vir.0.81475-0; Cook S, 2005, ARCH VIROL; Cook S, 2012, J GEN VIROL, V93, P223, DOI 10.1099/vir.0.036525-0; Cook S, 2009, J GEN VIROL, V90, P2669, DOI 10.1099/vir.0.014183-0; Crochu S, 2004, J GEN VIROL, V85, P1971, DOI 10.1099/vir.0.79850-0; de Lamballerie X, 2002, J GEN VIROL, V83, P2443, DOI 10.1099/0022-1317-83-10-2443; Dilcher M, 2013, VIRUS GENES, V46, P162, DOI 10.1007/s11262-012-0825-7; Domier LL, 2002, J GEN VIROL, V83, P1791, DOI 10.1099/0022-1317-83-7-1791; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Drummond AJ, 2012, MOL BIOL EVOL, V29, P1969, DOI 10.1093/molbev/mss075; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Edwards F. W., 1922, Bulletin of Entomological Research London, V13, P161, DOI 10.1017/S0007485300028030; Emonet S, 2006, BIOCHEM BIOPH RES CO, V344, P1080, DOI 10.1016/j.bbrc.2006.04.015; Emonet SF, 2007, NAT PROTOC, V2, P340, DOI 10.1038/nprot.2006.453; Engel SR, 1998, MOL BIOL EVOL, V15, P35, DOI 10.1093/oxfordjournals.molbev.a025845; Evangelista J, 2013, J GEN VIROL, V94, P1266, DOI 10.1099/vir.0.050575-0; Fang Y, 2012, P NATL ACAD SCI USA, V109, pE2920, DOI 10.1073/pnas.1211145109; Fernandez-Pinero J, 2014, J GEN VIROL, DOI [10.1099/vir.0.000037, DOI 10.1099/VIR.0.000037]; Firth AE, 2012, J GEN VIROL, V93, P1385, DOI 10.1099/vir.0.042499-0; Firth AE, 2011, NUCLEIC ACIDS RES, V39, P6679, DOI 10.1093/nar/gkr224; Firth AE, 2010, VIROLOGY, V399, P153, DOI 10.1016/j.virol.2009.12.033; Firth AE, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-14; Gamino V, 2012, VET RES, V43, DOI 10.1186/1297-9716-43-65; Gao XY, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002459; Gaunt MW, 2005, J VIROL METHODS, V128, P113, DOI 10.1016/j.jviromet.2005.04.006; Gaunt MW, 2001, J GEN VIROL, V82, P1867, DOI 10.1099/0022-1317-82-8-1867; Gill MS, 2013, MOL BIOL EVOL, V30, P713, DOI 10.1093/molbev/mss265; Gould E., 2011, VIRUS TAXONOMY, P1003, DOI DOI 10.1016/J.BJID.2014.12.003; Gould EA, 2008, LANCET, V371, P500, DOI 10.1016/S0140-6736(08)60238-X; Gould EA, 2004, ARCH VIROL, P65; Gould EA, 2003, ADV VIRUS RES, V59, P277, DOI 10.1016/S0065-3527(03)59008-X; Gould EA, 2001, ADV VIRUS RES, V57, P71, DOI 10.1016/S0065-3527(01)57001-3; Gould EA, 2009, ANTIVIR RES, DOI [10.1016/j.antiviral.2009.12.007, DOI 10.1016/J.ANTIVIRAL.2009.12.007]; Grard G, 2007, VIROLOGY, V361, P80, DOI 10.1016/j.virol.2006.09.015; Grard G, 2006, J GEN VIROL, V87, P3273, DOI 10.1099/vir.0.82071-0; Grard G, 2010, J GEN VIROL, V91, P87, DOI 10.1099/vir.0.014506-0; Groat-Carmona AM, 2012, VIROLOGY, V432, P511, DOI 10.1016/j.virol.2012.06.028; Gubler D J, 1987, P R Health Sci J, V6, P107; Gubler DJ, 1997, FACTORS IN THE EMERGENCE OF ARBOVIRUS DISEASES, P83; Harbach RE, 1998, SYST ENTOMOL, V23, P327, DOI 10.1046/j.1365-3113.1998.00072.x; Heinze DM, 2012, J VIROL, V86, P8663, DOI 10.1128/JVI.01013-12; Hobson-Peters J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056534; Hubalek Z, 1999, EMERG INFECT DIS, V5, P594, DOI 10.3201/eid0504.990430; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Hughes AL, 2000, MOL BIOL EVOL, V17, P1558, DOI 10.1093/oxfordjournals.molbev.a026254; Huhtamo E, 2014, VIROLOGY IN PRESS; Huhtamo E, 2012, VIROLOGY, V433, P471, DOI 10.1016/j.virol.2012.08.038; Huhtamo E, 2009, J VIROL, V83, P9532, DOI 10.1128/JVI.00529-09; Junglen S, 2009, J VIROL, V83, P4462, DOI 10.1128/JVI.00014-09; Karabatsos N., 1985, INT CATALOGUE ARBOVI; Khromykh AA, 2001, J VIROL, V75, P6719, DOI 10.1128/JVI.75.14.6719-6728.2001; Kim DY, 2009, VIROLOGY, V386, P154, DOI 10.1016/j.virol.2008.12.034; Kolodziejek J, 2013, J GEN VIROL, DOI [10.1099/vir.0.060822-0, DOI 10.1099/VIR.0.060822-0]; Kono Y, 2000, AM J TROP MED HYG, V63, P94, DOI 10.4269/ajtmh.2000.63.94; Kramer LD, 2001, ARCH VIROL, V146, P2341, DOI 10.1007/s007050170007; Kuno G, 2007, J MED ENTOMOL, V44, P93, DOI 10.1603/0022-2585(2007)44[93:HRSOFC]2.0.CO;2; Kuno G, 2005, CLIN MICROBIOL REV, V18, P608, DOI 10.1128/CMR.18.4.608-637.2005; LAIRD M., 1946, Transactions roy. Soc. N.Z., V76, P158; Lanciotti RS, 1999, SCIENCE, V286, P2333, DOI 10.1126/science.286.5448.2333; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; LaSala PR, 2010, CLIN LAB MED, V30, P221, DOI 10.1016/j.cll.2010.01.002; Lee JS, 2013, VIROLOGY, V435, P220, DOI 10.1016/j.virol.2012.10.020; Lemey P, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000520; Leonova GN, 2009, ARCH VIROL, V154, P811, DOI 10.1007/s00705-009-0376-y; Liu PP, 2012, J GEN VIROL, V93, P2158, DOI 10.1099/vir.0.043554-0; Liu Y, 2009, BBA-GENE REGUL MECH, V1789, P495, DOI 10.1016/j.bbagrm.2009.09.007; Loughran G, 2011, P NATL ACAD SCI USA, V108, pE1111, DOI 10.1073/pnas.1102932108; Lvov DK, 2004, ARCH VIROL, P85; LVOV DK, 1973, ARCH GES VIRUSFORSCH, V41, P170, DOI 10.1007/BF01252762; Mann BR, 2013, INT J ENV RES PUB HE, V10, P5111, DOI 10.3390/ijerph10105111; Maruyama SR, 2014, MEM I OSWALDO CRUZ, V109, P38, DOI 10.1590/0074-0276130166; MATTINGLY P. F., 1960, TRANS ROY SOC TROP MED AND HYG, V54, P97, DOI 10.1016/0035-9203(60)90046-8; May FJ, 2013, J GEN VIROL, V94, P1462, DOI 10.1099/vir.0.049940-0; May FJ, 2011, J VIROL, V85, P2964, DOI 10.1128/JVI.01963-10; May FJ, 2006, J GEN VIROL, V87, P329, DOI 10.1099/vir.0.81252-0; McGuire K, 1998, J GEN VIROL, V79, P981, DOI 10.1099/0022-1317-79-5-981; Melian EB, 2010, J VIROL, V84, P1641, DOI 10.1128/JVI.01979-09; Morales-Betoulle ME, 2008, J MED ENTOMOL, V45, P1187, DOI 10.1603/0022-2585(2008)45[1187:CFIFMI]2.0.CO;2; Moureau G, 2007, VECTOR-BORNE ZOONOT, V7, P467, DOI 10.1089/vbz.2007.0206; Nisbet DJ, 2005, J GEN VIROL, V86, P121, DOI 10.1099/vir.0.80381-0; Pandey Basu Dev, 1999, Southeast Asian Journal of Tropical Medicine and Public Health, V30, P161; Pettersson JH, 2014, J GEN VIROL, DOI [10.1099/vir.0.000037, DOI 10.1099/VIR.0.000037]; Ramsden C, 2009, MOL BIOL EVOL, V26, P143, DOI 10.1093/molbev/msn234; Ramsden C, 2008, MOL BIOL EVOL, V25, P1488, DOI 10.1093/molbev/msn093; Reddy CVS, 2011, STUDIES CERTAIN ASPE; Reeder J, 2007, NUCLEIC ACIDS RES, V35, pW320, DOI 10.1093/nar/gkm258; Reisen WK, 2013, VIRUSES-BASEL, V5, P2079, DOI 10.3390/v5092079; Roehrig JT, 2002, CURR TOP MICROBIOL, V267, P223; Roiz D, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-93; Rothberg JM, 2011, NATURE, V475, P348, DOI 10.1038/nature10242; Sanchez-Seco MP, 2010, VECTOR-BORNE ZOONOT, V10, P203, DOI 10.1089/vbz.2008.0188; Sang RC, 2003, ARCH VIROL, V148, P1085, DOI 10.1007/s00705-003-0018-8; STOLLAR V, 1975, VIROLOGY, V64, P367, DOI 10.1016/0042-6822(75)90113-0; Strode GK, 1951, YELLOW FEVER; Su JL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018106; Sun J, 2012, MICROBES INFECT, V14, P930, DOI 10.1016/j.micinf.2012.03.007; TABACHNICK W J, 1991, American Entomologist, V37, P14; Talavera G, 2007, SYST BIOL, V56, P564, DOI 10.1080/10635150701472164; Telford SR, 1997, EMERG INFECT DIS, V3, P165, DOI 10.3201/eid0302.970209; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tuplin A, 2011, NUCLEIC ACIDS RES, V39, P7034, DOI 10.1093/nar/gkr237; VARELASWESLEY I, 1982, AM J TROP MED HYG, V31, P1273, DOI 10.4269/ajtmh.1982.31.1273; Vazquez A, 2011, VECTOR-BORNE ZOONOT, DOI [10.1089/vbz.2011.0736, DOI 10.1089/VBZ.2011.0736]; Wang HY, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-73; Williams RAJ, 2012, AFR J MICROBIOL RES, V6, P1966, DOI 10.5897/AJMR11.479; Worobey M, 2010, SCIENCE, V329, P1487, DOI 10.1126/science.1193550; Ye Q, 2012, J GEN VIROL, V93, P1959, DOI 10.1099/vir.0.043844-0; ZANOTTO PMD, 1995, VIROLOGY, V210, P152, DOI 10.1006/viro.1995.1326; Zanotto PMD, 1996, P NATL ACAD SCI USA, V93, P548, DOI 10.1073/pnas.93.2.548	130	103	104	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2015	10	2							e0117849	10.1371/journal.pone.0117849	http://dx.doi.org/10.1371/journal.pone.0117849			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC2ZH	25719412	Green Published, gold, Green Accepted			2022-12-27	WOS:000350213200033
J	Rozemeijer, W; Fink, P; Rojas, E; Jones, CH; Pavliakova, D; Giardina, P; Murphy, E; Liberator, P; Jiang, Q; Girgenti, D; Peters, RPH; Savelkoul, PHM; Jansen, KU; Anderson, AS; Kluytmans, J				Rozemeijer, Wouter; Fink, Pamela; Rojas, Eduardo; Jones, C. Hal; Pavliakova, Danka; Giardina, Peter; Murphy, Ellen; Liberator, Paul; Jiang, Qin; Girgenti, Douglas; Peters, Remco P. H.; Savelkoul, Paul H. M.; Jansen, Kathrin U.; Anderson, Annaliesa S.; Kluytmans, Jan			Evaluation of Approaches to Monitor Staphylococcus aureus Virulence Factor Expression during Human Disease	PLOS ONE			English	Article							NASAL CARRIAGE; CLUMPING FACTOR; MOLECULAR CHARACTERIZATION; METHICILLIN-RESISTANT; PROTEIN; VACCINE; INFECTIONS; MECHANISMS; ANTIBODIES; CARRIERS	Staphylococcus aureus is a versatile pathogen of medical significance, using multiple virulence factors to cause disease. A prophylactic S. aureus 4-antigen (SA4Ag) vaccine comprising capsular polysaccharide (types 5 and 8) conjugates, clumping factor A (ClfA) and manganese transporter C (MntC) is under development. This study was designed to characterize S. aureus isolates recovered from infected patients and also to investigate approaches for examining expression of S. aureus vaccine candidates and the host response during human infection. Confirmation of antigen expression in different disease states is important to support the inclusion of these antigens in a prophylactic vaccine. Hospitalized patients with diagnosed S. aureus wound (27) or bloodstream (24) infections were enrolled. Invasive and nasal carriage S. aureus isolates were recovered and characterized for genotypic diversity. S. aureus antigen expression was evaluated directly by real-time, quantitative, reverse-transcriptase PCR (qRT-PCR) analysis and indirectly by serology using a competitive Luminex immunoassay. Study isolates were genotypically diverse and all had the genes encoding the antigens present in the SA4Ag vaccine. S. aureus nasal carriage was detected in 55% of patients, and in those subjects 64% of the carriage isolates matched the invasive strain. In swab samples with detectable S. aureus triosephosphate isomerase housekeeping gene expression, RNA transcripts encoding the S. aureus virulence factors ClfA, MntC, and capsule polysaccharide were detected by qRT-PCR. Antigen expression was indirectly confirmed by increases in antibody titer during the course of infection from acute to convalescent phase. Demonstration of bacterial transcript expression together with immunological response to the SA4Ag antigens in a clinically relevant patient population provides support for inclusion of these antigens in a prophylactic vaccine.	[Rozemeijer, Wouter; Peters, Remco P. H.; Savelkoul, Paul H. M.; Kluytmans, Jan] Vrije Univ Amsterdam Med Ctr, Amsterdam, Netherlands; [Fink, Pamela; Rojas, Eduardo; Jones, C. Hal; Pavliakova, Danka; Giardina, Peter; Murphy, Ellen; Liberator, Paul; Jiang, Qin; Girgenti, Douglas; Jansen, Kathrin U.; Anderson, Annaliesa S.] Pfizer Vaccine Res & Dev, Pearl River, NY 10965 USA	Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Pfizer	Anderson, AS (corresponding author), Pfizer Vaccine Res & Dev, Pearl River, NY 10965 USA.	annaliesa.anderson@pfizer.com		Peters, Remco Petrus Hendricus/0000-0003-2124-7275	Pfizer	Pfizer(Pfizer)	This work was funded by Wyeth (now Pfizer). The authors PL, PF, ER, CHJ, EM, QJ, DG, KJ, ASA, DP and PG were all employed by Pfizer and received salary and stock to fund this study. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson AS, 2012, J INFECT DIS, V205, P1688, DOI 10.1093/infdis/jis272; Blomfeldt A, 2013, J CLIN MICROBIOL, V51, P345, DOI 10.1128/JCM.02571-12; Bode LGM, 2010, NEW ENGL J MED, V362, P9, DOI 10.1056/NEJMoa0808939; Burian M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010040; Date SV, 2014, J INFECT DIS, V209, P1542, DOI 10.1093/infdis/jit668; den Reijer PM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053391; Enright MC, 2000, J CLIN MICROBIOL, V38, P1008, DOI 10.1128/JCM.38.3.1008-1015.2000; Handke LD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077874; Harris SR, 2013, LANCET INFECT DIS, V13, P130, DOI 10.1016/S1473-3099(12)70268-2; Hawkins J, 2012, CLIN VACCINE IMMUNOL, V19, P1641, DOI 10.1128/CVI.00354-12; Katoh K, 2008, BRIEF BIOINFORM, V9, P286, DOI 10.1093/bib/bbn013; Kluytmans J, 1997, CLIN MICROBIOL REV, V10, P505, DOI 10.1128/CMR.10.3.505; KLUYTMANS JAJW, 1995, J INFECT DIS, V171, P216, DOI 10.1093/infdis/171.1.216; Kolata J, 2011, PROTEOMICS, V11, P3914, DOI 10.1002/pmic.201000760; Koreen L, 2004, J CLIN MICROBIOL, V42, P792, DOI 10.1128/JCM.42.2.792-799.2004; Kuklin NA, 2006, INFECT IMMUN, V74, P2215, DOI 10.1128/IAI.74.4.2215-2223.2006; Mathema Barun, 2008, V431, P285; Murphy E, 2011, HUM VACCINES, V7, P51, DOI 10.4161/hv.7.0.14562; Nanra JS, 2013, HUM VACC IMMUNOTHER, V9, P480, DOI 10.4161/hv.23223; Nanra JS, 2009, VACCINE, V27, P3276, DOI 10.1016/j.vaccine.2009.01.062; Nathwani D, 2009, J INFECTION, V59, pS40, DOI 10.1016/S0163-4453(09)60007-4; Nulens E, 2008, J CLIN MICROBIOL, V46, P2438, DOI 10.1128/JCM.00808-08; O'Gara JP, 2007, FEMS MICROBIOL LETT, V270, P179, DOI 10.1111/j.1574-6968.2007.00688.x; Rasmussen G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077477; Richmond P, 2011, ECCMID MIL IT; Siboo IR, 2001, INFECT IMMUN, V69, P3120, DOI 10.1128/IAI.69.5.3120-3127.2001; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; van Cleef BAGL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042787; Verkaik NJ, 2010, CLIN MICROBIOL INFEC, V16, P1312, DOI 10.1111/j.1469-0691.2009.03073.x; Verkaik NJ, 2010, EUR J CLIN MICROBIOL, V29, P509, DOI 10.1007/s10096-010-0888-0; Verkaik NJ, 2010, CLIN INFECT DIS, V50, P61, DOI 10.1086/648673; von Eiff C, 2001, NEW ENGL J MED, V344, P11, DOI 10.1056/NEJM200101043440102; Wertheim HFL, 2005, LANCET INFECT DIS, V5, P751, DOI 10.1016/S1473-3099(05)70295-4; Zorman JK, 2013, HUM VACC IMMUNOTHER, V9, P1857, DOI 10.4161/hv.25253	34	34	37	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2015	10	2							e0116945	10.1371/journal.pone.0116945	http://dx.doi.org/10.1371/journal.pone.0116945			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC2ZH	25719409	Green Submitted, Green Published, gold			2022-12-27	WOS:000350213200012
J	Fan, WZ; Zhang, YQ; Wang, Y; Yao, XH; Yang, JY; Li, JP				Fan, Wenzhe; Zhang, Yingqiang; Wang, Yu; Yao, Xuehua; Yang, Jianyong; Li, Jiaping			Neutrophil-to-Lymphocyte and Platelet-to-Lymphocyte Ratios as Predictors of Survival and Metastasis for Recurrent Hepatocellular Carcinoma after Transarterial Chemoembolization	PLOS ONE			English	Article							PROGNOSTIC VALUE; RESECTION; LIVER; SCORE	Purpose To evaluate whether neutrophil-to-lymphocyte ratio (NLR) and platelet-to-lymphocyte ratio (PLR) predict survival and metastasis in patients after transarterial chemoembolization (TACE) for recurrent hepatocellular carcinoma (RHCC). Materials and Methods Clinical and laboratory data from 132 RHCC patients treated with TACE from January 2003 to December 2012 were retrospectively reviewed. Prognostic factors were assessed by multivariate analysis, and the predictive values of NLR and PLR for overall survival (OS) and extrahepatic metastases were compared. Results Pretreatment mean NLR and PLR were 3.1 and 137, respectively. The 0.5-, 1-, and 2-year OS rates were 93.7%, 67.1%, and 10.1% in the low NLR group and 81.1%, 18.9%, and 3.8% in the high NLR group, respectively (P = 0.017). The corresponding OS rates in the low and high PLR groups were 92.5%, 58.1%, and 9.7% and 84.6%, 23.1%, and 2.6%, respectively (P = 0.030). The discriminatory performance predicting 1-year survival probability was significantly poorer for NLR (area under the curve [AUC] = 0.685, 95% confidence interval [CI] 0.598-0.763) than for PLR (AUC = 0.792, 95% CI 0.712-0.857; P = 0.0295), but was good for both ratios for predicting post-TACE extrahepatic metastasis. Multivariate analysis indicated that high PLR (hazard ratio [HR] = 0.373, 95% CI = 0.216-0.644, P < 0.001, vascular invasion (HR = 0.507, 95% CI = 0.310-0.832, P = 0.007), and multiple tumors (HR= 0.553, 95% CI = 0.333-0.919, P = 0.022) were independent prognostic factors for OS. Conclusions High NLR and PLR were both associated with poor prognosis and metastasis in RHCC patients treated with TACE, but high PLR was a better predictor of 1-year OS. High PLR, vascular invasion, and multiple tumors were independent, unfavorable prognostic factors.	[Fan, Wenzhe; Zhang, Yingqiang; Wang, Yu; Yao, Xuehua; Li, Jiaping] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Intervent Oncol, Guangzhou 510275, Guangdong, Peoples R China; [Yang, Jianyong] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Med Imaging, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University	Li, JP (corresponding author), Sun Yat Sen Univ, Affiliated Hosp 1, Dept Intervent Oncol, Guangzhou 510275, Guangdong, Peoples R China.	lijiaping_2011@126.com			Specialized Research Fund for the Doctoral Program of Higher Education [20130171120083]	Specialized Research Fund for the Doctoral Program of Higher Education(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP))	This study was supported by a grant from the Specialized Research Fund for the Doctoral Program of Higher Education (No.20130171120083) (http://www.cutech.edu.cn/cn/kyjj/gdxxbsdkyjj/A010301index_1.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angermayr B, 2003, GUT, V52, P879, DOI 10.1136/gut.52.6.879; Asher V, 2011, CLIN TRANSL ONCOL, V13, P499, DOI 10.1007/s12094-011-0687-9; Bhatti I, 2010, AM J SURG, V200, P197, DOI 10.1016/j.amjsurg.2009.08.041; Chen TM, 2012, J GASTROEN HEPATOL, V27, P553, DOI 10.1111/j.1440-1746.2011.06910.x; Gomez D, 2008, WORLD J SURG, V32, P1757, DOI 10.1007/s00268-008-9552-6; Huang ZL, 2011, J VASC INTERV RADIOL, V22, P702, DOI 10.1016/j.jvir.2010.12.041; KASUGAI H, 1989, GASTROENTEROLOGY, V97, P965, DOI 10.1016/0016-5085(89)91505-9; Kinoshita A, 2012, BRIT J CANCER, V107, P988, DOI 10.1038/bjc.2012.354; Kishi Y, 2009, ANN SURG ONCOL, V16, P614, DOI 10.1245/s10434-008-0267-6; Lai Q, 2014, TRANSPL INT, V27, P32, DOI 10.1111/tri.12191; Lee S, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-350; Llovet JM, 2003, LANCET, V362, P1907, DOI 10.1016/S0140-6736(03)14964-1; Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205; Meng MB, 2009, RADIOTHER ONCOL, V92, P184, DOI 10.1016/j.radonc.2008.11.002; Neagoe PE, 2009, GROWTH FACTORS, V27, P335, DOI 10.3109/08977190903155043; OKAZAKI M, 1993, HEPATO-GASTROENTEROL, V40, P320; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Poon RTP, 2000, J SURG ONCOL, V73, P109, DOI 10.1002/(SICI)1096-9098(200002)73:2<109::AID-JSO10>3.3.CO;2-A; Ray-Coquard I, 2009, CANCER RES, V69, P5383, DOI 10.1158/0008-5472.CAN-08-3845; Rougier P, 2007, SEMIN ONCOL, V34, pS12, DOI 10.1053/j.seminoncol.2007.01.007; Sarraf KM, 2009, J THORAC CARDIOV SUR, V137, P425, DOI 10.1016/j.jtcvs.2008.05.046; Shi M, 2010, WORLD J GASTROENTERO, V16, P264, DOI 10.3748/wjg.v16.i2.264; Shuto T, 1996, HEPATO-GASTROENTEROL, V43, P932; Smith RA, 2008, J GASTROINTEST SURG, V12, P1422, DOI 10.1007/s11605-008-0554-3; Sugimachi K, 2001, J Hepatobiliary Pancreat Surg, V8, P410, DOI 10.1007/s005340100002; Tuszynski GP, 1996, BIOESSAYS, V18, P71, DOI 10.1002/bies.950180113; Wada Y, 1998, HEPATOLOGY, V27, P407, DOI 10.1002/hep.510270214; Wang DS, 2012, TUMOR BIOL, V33, P749, DOI 10.1007/s13277-011-0285-z; Wang GY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025295; Yamanaka T, 2007, ONCOLOGY-BASEL, V73, P215, DOI 10.1159/000127412; Yau T, 2008, CANCER, V113, P2742, DOI 10.1002/cncr.23878; Zerbini A, 2010, GASTROENTEROLOGY, V138, P1931, DOI 10.1053/j.gastro.2009.12.051	32	60	64	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2015	10	3							e0119312	10.1371/journal.pone.0119312	http://dx.doi.org/10.1371/journal.pone.0119312			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9KG	25742141	Green Published, gold, Green Submitted			2022-12-27	WOS:000350688100103
J	Shan, L; Lian, F; Guo, L; Qiu, T; Ling, Y; Ying, JM; Lin, DM				Shan, Ling; Lian, Fang; Guo, Lei; Qiu, Tian; Ling, Yun; Ying, Jianming; Lin, Dongmei			Detection of ROS1 Gene Rearrangement in Lung Adenocarcinoma: Comparison of IHC, FISH and Real-Time RT-PCR	PLOS ONE			English	Article							EML4-ALK FUSION GENE; TARGETING ROS1; IDENTIFICATION; CANCER; RET	Aims To compare fluorescence in situ hybridization (FISH), immunohistochemistry (IHC) and quantitative real-time reverse transcription-PCR (qRT-PCR) assays for detection of ROS1 fusion in a large number of ROS1-positive lung adenocatcinoma (ADC) patients. Methods Using IHC analysis, sixty lung ADCs including 16 cases with ROS1 protein expression and 44 cases without ROS1 expression were selected for this study. The ROS1 fusion status was examined by FISH and qRT-PCR assay. Results Among 60 cases, 16 (26.7%), 13 (21.7%) and 20 (33.3%) cases were ROS1 positive revealed by IHC, FISH and qRT-PCR, respectively. Using FISH as a standard method for ROS1 fusion detection, the sensitivity and specificity of IHC were 100% and 93.6%, respectively. Three IHC-positive cases, which showed FISH negative, were demonstrated with ROS1 fusion by qRT-PCR analysis. The sensitivity and specificity of qRT-PCR for detection for ROS1 fusion were 100% and 85.1%, respectively. The total concordance rate between IHC and qRT-PCR were 93.3%. Conclusion IHC is a reliable and rapid screening tool in routine pathologic laboratories for the identification of suitable candidates for ROS1-targeted therapy. Some ROS1 IHC-positive but FISH-negative cases did harbor the translocation events and may benefit from crizotinib.	[Shan, Ling; Lian, Fang; Guo, Lei; Qiu, Tian; Ling, Yun; Ying, Jianming; Lin, Dongmei] Chinese Acad Med Sci, Canc Inst & Hosp, Peking Union Med Coll, Dept Pathol, Beijing 100730, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Cancer Institute & Hospital - CAMS; Peking Union Medical College	Ying, JM (corresponding author), Chinese Acad Med Sci, Canc Inst & Hosp, Peking Union Med Coll, Dept Pathol, Beijing 100730, Peoples R China.	jmying@cicams.ac.cn; lindm3@163.com	Lian, Fang/X-5381-2018; Guo, Lei/AEU-0178-2022		Capital Medical Development Foundation [2011-4002-01]	Capital Medical Development Foundation	This work was supported by the Capital Medical Development Foundation (No. 2011-4002-01). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bergethon K, 2012, J CLIN ONCOL, V30, P863, DOI 10.1200/JCO.2011.35.6345; Cai W, 2013, ANN ONCOL, V24, P1822, DOI 10.1093/annonc/mdt071; Chin LP, 2012, J THORAC ONCOL, V7, P1625, DOI 10.1097/JTO.0b013e31826baf83; Davies KD, 2012, CLIN CANCER RES, V18, P4570, DOI 10.1158/1078-0432.CCR-12-0550; Gainor JF, 2013, ONCOLOGIST, V18, P865, DOI 10.1634/theoncologist.2013-0095; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Koivunen JP, 2008, CLIN CANCER RES, V14, P4275, DOI 10.1158/1078-0432.CCR-08-0168; Kwak EL, 2010, NEW ENGL J MED, V363, P1693, DOI 10.1056/NEJMoa1006448; Mescam-Mancini L, 2014, LUNG CANCER, V83, P168, DOI 10.1016/j.lungcan.2013.11.019; Otterson GA, 2012, J CLIN ONCOL, V30; Rikova K, 2007, CELL, V131, P1190, DOI 10.1016/j.cell.2007.11.025; Rimkunas VM, 2012, CLIN CANCER RES, V18, P4449, DOI 10.1158/1078-0432.CCR-11-3351; Schiller JH, 2002, NEW ENGL J MED, V346, P92, DOI 10.1056/NEJMoa011954; Shaw AT, 2009, J CLIN ONCOL, V27, P4247, DOI 10.1200/JCO.2009.22.6993; Sholl LM, 2013, AM J SURG PATHOL, V37, P1441, DOI 10.1097/PAS.0b013e3182960fa7; Soda M, 2007, NATURE, V448, P561, DOI 10.1038/nature05945; Suehara Y, 2012, CLIN CANCER RES, V18, P6599, DOI 10.1158/1078-0432.CCR-12-0838; Takeuchi K, 2012, NAT MED, V18, P378, DOI 10.1038/nm.2658; Ying J, 2013, ANN ONCOL, V24, P2589, DOI 10.1093/annonc/mdt295; Yoshida A, 2014, MODERN PATHOL, V27, P711, DOI 10.1038/modpathol.2013.192	20	68	69	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2015	10	3							e0120422	10.1371/journal.pone.0120422	http://dx.doi.org/10.1371/journal.pone.0120422			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9KG	25742289	Green Published, Green Submitted, gold			2022-12-27	WOS:000350688100132
J	Alsina, L; Basteiro, MG; de Paz, HD; Inigo, M; de Sevilla, MF; Trivino, M; Juan, M; Munoz-Almagro, C				Alsina, Laia; Basteiro, Maria G.; de Paz, Hector D.; Inigo, Melania; de Sevilla, Mariona F.; Trivino, Miriam; Juan, Manel; Munoz-Almagro, Carmen			Recurrent Invasive Pneumococcal Disease in Children: Underlying Clinical Conditions, and Immunological and Microbiological Characteristics	PLOS ONE			English	Article							PYOGENIC BACTERIAL-INFECTIONS; STREPTOCOCCUS-PNEUMONIAE; IMMUNODEFICIENCY; IRAK-4; MYD88; IDENTIFICATION; PREVALENCE; DEFICIENCY; BACTEREMIA; NATIONWIDE	Purpose Clinical, immunological and microbiological characteristics of recurrent invasive pneumococcal disease (IPD) in children were evaluated, differentiating relapse from reinfection, in order to identify specific risk factors for both conditions. Methods All patients < 18 years-old with recurrent IPD admitted to a tertiary-care pediatric center from January 2004 to December 2011 were evaluated. An episode of IPD was defined as the presence of clinical findings of infection together with isolation and/or pneumococcal DNA detection by Real-Time PCR in any sterile body fluid. Recurrent IPD was defined as 2 or more episodes in the same individual at least 1 month apart. Among recurrent IPD, we differentiated relapse (same pneumococcal isolate) from reinfection. Results 593 patients were diagnosed with IPD and 10 patients died. Among survivors, 23 episodes of recurrent IPD were identified in 10 patients (1.7%). Meningitis was the most frequent form of recurrent IPD (10 episodes/4 children) followed by recurrent empyema (8 episodes/4 children). Three patients with recurrent empyema caused by the same pneumococcal clone ST306 were considered relapses and showed high bacterial load in their first episode. In contrast, all other episodes of recurrent IPD were considered reinfections. Overall, the rate of relapse of IPD was 0.5% and the rate of reinfection 1.2%. Five out of 7 patients with reinfection had an underlying risk factor: cerebrospinal fluid leak (n = 3), chemotherapy treatment (n = 1) and a homozygous mutation in MyD88 gene (n = 1). No predisposing risk factors were found in the remainder. Conclusions recurrent IPD in children is a rare condition associated with an identifiable risk factor in case of reinfection in almost 80% of cases. In contrast, recurrent IPD with pleuropneumonia is usually a relapse of infection.	[Alsina, Laia] Univ Barcelona, Hosp St Joan Deu, Allergy & Clin Immunol Dept, Barcelona, Spain; [Basteiro, Maria G.; de Sevilla, Mariona F.; Trivino, Miriam] Univ Barcelona, Hosp St Joan Deu, Dept Pediat, Barcelona, Spain; [de Paz, Hector D.; Inigo, Melania; Munoz-Almagro, Carmen] Univ Barcelona, Hosp St Joan Deu, Dept Mol Microbiol, Barcelona, Spain; [Juan, Manel] Hosp Clin Barcelona, Serv Immunol, Barcelona, Spain; [Juan, Manel] Inst Invest Biomed August Pi & Sunyer IDIBAPS, Barcelona, Spain; [Alsina, Laia; Juan, Manel] Hosp St Joan Deu, Funct Unit Immunol, Barcelona, Spain; [Alsina, Laia; Juan, Manel] Hosp Clin Barcelona, Barcelona, Spain	University of Barcelona; University of Barcelona; University of Barcelona; University of Barcelona; Hospital Clinic de Barcelona; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; University of Barcelona; University of Barcelona; Hospital Clinic de Barcelona	Munoz-Almagro, C (corresponding author), Univ Barcelona, Hosp St Joan Deu, Dept Mol Microbiol, Barcelona, Spain.	cma@hsjdbcn.org	MARIGOMEZ, Ionan/C-3909-2017; Muñoz-Almagro, Carmen/N-7248-2015; Juan, Manel/Q-2931-2019; Alsina, Laia/AID-4372-2022; Munoz-Almagro, Carmen/B-4308-2015; Alsina, Laia/GQI-3516-2022	MARIGOMEZ, Ionan/0000-0001-6274-541X; Muñoz-Almagro, Carmen/0000-0001-5586-404X; Munoz-Almagro, Carmen/0000-0001-5586-404X; Juan, Manel/0000-0002-3064-1648; de Paz Fernandez, Hector David/0000-0002-4190-5063; de Sevilla, Mariona F/0000-0003-3104-675X; Alsina, Laia/0000-0002-3559-0018	Fondo de Investigacion Sanitaria (FIS) [PI10/02058, PI13/01729, PI10/01404]; Agencia de Gestio d'Ajuts Universitaris i de Recerca (AGAUR) [GRC/2014 SGR 505]; Godia Foundation; Sant Joan de Deu Foundation	Fondo de Investigacion Sanitaria (FIS)(Instituto de Salud Carlos III); Agencia de Gestio d'Ajuts Universitaris i de Recerca (AGAUR)(Agencia de Gestio D'Ajuts Universitaris de Recerca Agaur (AGAUR)); Godia Foundation; Sant Joan de Deu Foundation	This work was supported by Fondo de Investigacion Sanitaria (FIS, project number PI10/02058 and PI13/01729 to CMA and PI10/01404 to MJ [http://www.isciii.es/ISCIII/es]), Agencia de Gestio d'Ajuts Universitaris i de Recerca (AGAUR, Project number GRC/2014 SGR 505 to CMA[http://www10.gencat.cat/agaur_web/AppJava/catala/index.jsp]), Godia Foundation and Sant Joan de Deu Foundation (to MI, HdP and CMA[http://www.fundacionfgodia.org/; http://www.fsjd.org/es]). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balmer P, 2003, CLIN EXP IMMUNOL, V133, P364, DOI 10.1046/j.1365-2249.2003.02232.x; Beutler BA, 2009, BLOOD, V113, P1399, DOI 10.1182/blood-2008-07-019307; Bogaert D, 2004, LANCET INFECT DIS, V4, P144, DOI 10.1016/S1473-3099(04)00938-7; Brueggemann AB, 2003, J INFECT DIS, V187, P1424, DOI 10.1086/374624; CDC, 2010, MMWR RECOMM REP, V59; Coccia MR, 1998, CLIN INFECT DIS, V26, P982, DOI 10.1086/513924; Currie AJ, 2004, J PEDIATR-US, V144, P512, DOI 10.1016/j.jpeds.2003.10.034; de Sevilla MF, 2012, PEDIATR INFECT DIS J, V31, P124, DOI 10.1097/INF.0b013e318241d09e; Einarsdottir HM, 2005, CLIN MICROBIOL INFEC, V11, P744, DOI 10.1111/j.1469-0691.2005.01221.x; Enright MC, 1998, MICROBIOL-UK, V144, P3049, DOI 10.1099/00221287-144-11-3049; Esteva C, 2011, CLIN MICROBIOL INFEC, V17, P1441, DOI 10.1111/j.1469-0691.2011.03526.x; Gaschignard J, 2014, CLIN INFECT DIS, V59, P244, DOI 10.1093/cid/ciu274; Grant CC, 2003, ARCH DIS CHILD, V88, P712, DOI 10.1136/adc.88.8.712; Ingels H, 2014, SCAND J INFECT DIS, V46, P265, DOI 10.3109/00365548.2013.877156; Jeurissen A, 2007, CLIN CHEM, V53, P505, DOI 10.1373/clinchem.2006.080051; Ku CL, 2007, J MED GENET, V44, P16, DOI 10.1136/jmg.2006.044446; Ku CL, 2005, IMMUNOL REV, V203, P10, DOI 10.1111/j.0105-2896.2005.00235.x; Mahlaoui N, 2011, J PEDIATR-US, V158, P142, DOI 10.1016/j.jpeds.2010.07.027; Mason EO, 2007, PEDIATR INFECT DIS J, V26, P480, DOI 10.1097/INF.0b013e31805ce277; McEllistrem MC, 2002, J INFECT DIS, V185, P1364, DOI 10.1086/339882; Mu-oz-Almagro C, 2011, J INFECTION, V63, P151, DOI DOI 10.1016/J.JINF.2011.06.002; Mufson MA, 2012, AM J MED SCI, V343, P303, DOI 10.1097/MAJ.0b013e31822d9860; Munoz-Almagro C, 2014, CLIN MICROBIOL INFEC, V20, pO745, DOI 10.1111/1469-0691.12615; Munoz-Almagro C, 2011, EUR J CLIN MICROBIOL, V30, P327, DOI 10.1007/s10096-010-1086-9; Obaro S, 2002, J MED MICROBIOL, V51, P98, DOI 10.1099/0022-1317-51-2-98; Picard C, 2003, SCIENCE, V299, P2076, DOI 10.1126/science.1081902; Picard C, 2003, CURR OPIN ALLERGY CL, V3, P451, DOI 10.1097/01.all.0000104457.09202.c0; Picard C, 2011, CLIN MICROBIOL REV, V24, P490, DOI 10.1128/CMR.00001-11; Picard C, 2010, MEDICINE, V89, P403, DOI 10.1097/MD.0b013e3181fd8ec3; RodriguezCreixems M, 1996, ARCH INTERN MED, V156, P1429, DOI 10.1001/archinte.156.13.1429; Tarrago D, 2008, CLIN MICROBIOL INFEC, V14, P828, DOI 10.1111/j.1469-0691.2008.02028.x; Turvey SE, 2007, PEDIATR INFECT DIS J, V26, P1074, DOI 10.1097/INF.0b013e318156fb93; von Bernuth H, 2008, SCIENCE, V321, P691, DOI 10.1126/science.1158298; von Bernuth H, 2006, PEDIATRICS, V118, P2498, DOI 10.1542/peds.2006-1845	34	12	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2015	10	3							e0118848	10.1371/journal.pone.0118848	http://dx.doi.org/10.1371/journal.pone.0118848			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9JM	25738983	Green Published, gold, Green Submitted			2022-12-27	WOS:000350685900080
J	Bornsen, L; Christensen, JR; Ratzer, R; Hedegaard, C; Sondergaard, HB; Krakauer, M; Hesse, D; Nielsen, CH; Sorensen, PS; Sellebjerg, F				Boernsen, Lars; Christensen, Jeppe Romme; Ratzer, Rikke; Hedegaard, Chris; Sondergaard, Helle B.; Krakauer, Martin; Hesse, Dan; Nielsen, Claus H.; Sorensen, Per S.; Sellebjerg, Finn			Endogenous Interferon-beta-Inducible Gene Expression and Interferon-beta-Treatment Are Associated with Reduced T Cell Responses to Myelin Basic Protein in Multiple Sclerosis	PLOS ONE			English	Article							EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; MESSENGER-RNA EXPRESSION; IFN-BETA; IN-VIVO; INTERLEUKIN-10 PRODUCTION; MONONUCLEAR-CELLS; THERAPY; DISEASE; CYTOKINES; ACTIVATION	Autoreactive CD4(+) T-cells are considered to play a major role in the pathogenesis of multiple sclerosis. In experimental autoimmune encephalomyelitis, an animal model of multiple sclerosis, exogenous and endogenous type I interferons restrict disease severity. Recombinant interferon-beta is used for treatment of multiple sclerosis, and some untreated multiple sclerosis patients have increased expression levels of type I interferon-inducible genes in immune cells. The role of endogenous type I interferons in multiple sclerosis is controversial: some studies found an association of high expression levels of interferon-beta-inducible genes with an increased expression of interleukin-10 and a milder disease course in untreated multiple sclerosis patients, whereas other studies reported an association with a poor response to treatment with interferon-beta. In the present study, we found that untreated multiple sclerosis patients with an increased expression of interferon-beta-inducible genes in peripheral blood mononuclear cells and interferon-beta-treated multiple sclerosis patients had decreased CD4(+) T-cell reactivity to the autoantigen myelin basic protein ex vivo. Interferon-beta-treated multiple sclerosis patients had increased IL10 and IL27 gene expression levels in monocytes in vivo. In vitro, neutralization of interleukin-10 and monocyte depletion increased CD4(+) T-cell reactivity to myelin basic protein while interleukin-10, in the presence or absence of monocytes, inhibited CD4(+) T-cell reactivity to myelin basic protein. Our findings suggest that spontaneous expression of interferon-beta-inducible genes in peripheral blood mononuclear cells from untreated multiple sclerosis patients and treatment with interferon-beta are associated with reduced myelin basic protein-induced T-cell responses. Reduced myelin basic protein-induced CD4(+) T-cell autoreactivity in interferon-beta-treated multiple sclerosis patients may be mediated by monocyte-derived interleukin-10.	[Boernsen, Lars; Christensen, Jeppe Romme; Ratzer, Rikke; Sondergaard, Helle B.; Krakauer, Martin; Hesse, Dan; Sorensen, Per S.; Sellebjerg, Finn] Univ Copenhagen, Rigshosp, Danish Multiple Sclerosis Ctr, Dept Neurol, DK-2100 Copenhagen, Denmark; [Hedegaard, Chris; Nielsen, Claus H.] Univ Copenhagen, Rigshosp, Dept Rheumatol, Inst Inflammat Res, DK-2100 Copenhagen, Denmark	Rigshospitalet; University of Copenhagen; Rigshospitalet; University of Copenhagen	Bornsen, L (corresponding author), Univ Copenhagen, Rigshosp, Danish Multiple Sclerosis Ctr, Dept Neurol, DK-2100 Copenhagen, Denmark.	boernsen@gmail.com	Krakauer, Martin/M-4657-2019	Krakauer, Martin/0000-0002-2191-1861; Sondergaard, Helle Bach/0000-0001-9435-0658; Nielsen, Claus Henrik/0000-0001-7543-9016; Sorensen, Per Soelberg/0000-0002-2818-3780; Hedegaard, Chris Juul/0000-0003-1333-8687; Romme Christensen, Jeppe/0000-0002-7727-3467; Sellebjerg, Finn/0000-0002-1333-9623; Hesse, Dan/0000-0002-9670-6037	Danish Multiple Sclerosis Society; Warwara Larsen Foundation; Johnsen Foundation; Danish Council for Independent Research [271-06-0246]; Danish Council for Strategic Research [2142-08-0039]	Danish Multiple Sclerosis Society; Warwara Larsen Foundation; Johnsen Foundation; Danish Council for Independent Research(Det Frie Forskningsrad (DFF)); Danish Council for Strategic Research(Danske Strategiske Forskningsrad (DSF))	This study was supported by grants from the Danish Multiple Sclerosis Society, the Warwara Larsen Foundation, the Johnsen Foundation, the Danish Council for Independent Research [grant 271-06-0246] and the Danish Council for Strategic Research [grant 2142-08-0039]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Axtell RC, 2011, TRENDS IMMUNOL, V32, P272, DOI 10.1016/j.it.2011.03.008; Babaloo Z, 2013, IRAN J IMMUNOL, V10, P47, DOI IJIv10i1A6; Bushnell SE, 2012, NEUROLOGY, V79, P531, DOI 10.1212/WNL.0b013e318259e123; Byrnes AA, 2002, ANN NEUROL, V51, P165, DOI 10.1002/ana.10084; Calabresi PA, 1998, J NEUROIMMUNOL, V89, P198, DOI 10.1016/S0165-5728(98)00139-8; Calabresi PA, 1997, NEUROLOGY, V48, P1446, DOI 10.1212/WNL.48.5.1446; Carrieri PB, 1998, IMMUNOPHARM IMMUNOT, V20, P373, DOI 10.3109/08923979809034820; Chen X, 2011, FEBS LETT, V585, P3611, DOI 10.1016/j.febslet.2011.04.025; Comabella M, 2009, BRAIN, V132, P3353, DOI 10.1093/brain/awp228; de Waal MR, 1991, J EXP MED, V174, P915, DOI DOI 10.1084/JEM.174.4.915; Galligan CL, 2010, MULT SCLER J, V16, P1458, DOI 10.1177/1352458510381259; Graber JJ, 2007, J NEUROIMMUNOL, V185, P168, DOI 10.1016/j.jneuroim.2007.01.011; Guarda G, 2011, IMMUNITY, V34, P213, DOI 10.1016/j.immuni.2011.02.006; Guo BC, 2008, J CLIN INVEST, V118, P1680, DOI 10.1172/JCI33342; Hallal-Longo DEM, 2007, J INTERF CYTOK RES, V27, P865, DOI 10.1089/jir.2007.0018; Hedegaard CJ, 2008, CLIN IMMUNOL, V129, P80, DOI 10.1016/j.clim.2008.06.007; Hedegaard CJ, 2008, IMMUNOLOGY, V125, P161, DOI 10.1111/j.1365-2567.2008.02837.x; Hesse D, 2011, EUR J NEUROL, V18, P266, DOI 10.1111/j.1468-1331.2010.03116.x; Hesse D, 2010, NEUROLOGY, V74, P1455, DOI 10.1212/WNL.0b013e3181dc1a94; Jacobs LD, 1996, ANN NEUROL, V39, P285, DOI 10.1002/ana.410390304; Kieseier BC, 2011, CNS DRUGS, V25, P491, DOI 10.2165/11591110-000000000-00000; Korneck B, 2003, BRAIN RES BULL, V61, P321, DOI 10.1016/S0361-9230(03)00095-9; Krakauer M, 2008, MULT SCLER J, V14, P622, DOI 10.1177/1352458507087136; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lovett-Racke AE, 2011, BBA-MOL BASIS DIS, V1812, P246, DOI 10.1016/j.bbadis.2010.05.012; Martin-Saavedra FM, 2007, MOL IMMUNOL, V44, P3597, DOI 10.1016/j.molimm.2007.03.002; NAVIKAS V, 1995, SCAND J IMMUNOL, V41, P171, DOI 10.1111/j.1365-3083.1995.tb03550.x; Nielsen CH, 2010, IMMUNOLOGY, V129, P291, DOI 10.1111/j.1365-2567.2009.03183.x; Ouyang WJ, 2011, ANNU REV IMMUNOL, V29, P71, DOI 10.1146/annurev-immunol-031210-101312; PORRINI AM, 1995, J NEUROIMMUNOL, V61, P27, DOI 10.1016/0165-5728(95)00070-I; Prinz M, 2008, IMMUNITY, V28, P675, DOI 10.1016/j.immuni.2008.03.011; Quah BJC, 2007, NAT PROTOC, V2, P2049, DOI 10.1038/nprot.2007.296; Ramgolam VS, 2009, J IMMUNOL, V183, P5418, DOI 10.4049/jimmunol.0803227; RIECKMANN P, 1994, NEUROLOGY, V44, P1523, DOI 10.1212/WNL.44.8.1523; Rudick RA, 1998, NEUROLOGY, V50, P1294, DOI 10.1212/WNL.50.5.1294; Rudick RA, 1996, ANN NEUROL, V40, P618, DOI 10.1002/ana.410400412; Sabat R, 2010, CYTOKINE GROWTH F R, V21, P331, DOI 10.1016/j.cytogfr.2010.09.002; Said EA, 2010, NAT MED, V16, P452, DOI 10.1038/nm.2106; Schulz EG, 2009, IMMUNITY, V30, P673, DOI 10.1016/j.immuni.2009.03.013; Sellebjerg F, 2009, EUR J NEUROL, V16, P1291, DOI 10.1111/j.1468-1331.2009.02716.x; Sospedra M, 2005, ANNU REV IMMUNOL, V23, P683, DOI 10.1146/annurev.immunol.23.021704.115707; Sweeney CM, 2011, BRAIN BEHAV IMMUN, V25, P1170, DOI 10.1016/j.bbi.2011.03.007; Taniguchi T, 2001, NAT REV MOL CELL BIO, V2, P378, DOI 10.1038/35073080; Taylor A, 2006, IMMUNOLOGY, V117, P433, DOI 10.1111/j.1365-2567.2006.02321.x; Teige I, 2003, J IMMUNOL, V170, P4776, DOI 10.4049/jimmunol.170.9.4776; Theofilopoulos AN, 2005, ANNU REV IMMUNOL, V23, P307, DOI 10.1146/annurev.immunol.23.021704.115843; van Baarsen LGM, 2006, GENES IMMUN, V7, P522, DOI 10.1038/sj.gene.6364324; van der Voort LF, 2010, NEUROLOGY, V75, P1228, DOI 10.1212/WNL.0b013e3181f6c556; van der Voort LF, 2010, ARCH NEUROL-CHICAGO, V67, P402, DOI 10.1001/archneurol.2010.21; Verreck FAW, 2004, P NATL ACAD SCI USA, V101, P4560, DOI 10.1073/pnas.0400983101; Weaver CT, 2007, ANNU REV IMMUNOL, V25, P821, DOI 10.1146/annurev.immunol.25.022106.141557; Weiner HL, 2009, ANN NEUROL, V65, P239, DOI 10.1002/ana.21640; Yamaguchi KD, 2008, J NEUROIMMUNOL, V195, P116, DOI 10.1016/j.jneuroim.2007.12.007; Zafranskaya M, 2007, IMMUNOLOGY, V121, P29, DOI 10.1111/j.1365-2567.2006.02518.x	54	15	15	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2015	10	3							e0118830	10.1371/journal.pone.0118830	http://dx.doi.org/10.1371/journal.pone.0118830			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9JM	25738751	Green Submitted, gold, Green Published			2022-12-27	WOS:000350685900077
J	Claycomb, MA; Wang, L; Sharp, C; Ractliffe, KC; Elhai, JD				Claycomb, Meredith A.; Wang, Li; Sharp, Carla; Ractliffe, Kendra C.; Elhai, Jon D.			Assessing Relations between PTSD's Dysphoria and Reexperiencing Factors and Dimensions of Rumination	PLOS ONE			English	Article							POSTTRAUMATIC-STRESS-DISORDER; SYMPTOMS; DEPRESSION; DURATION; MEMORIES	The purpose of the present study was to investigate the relations between posttraumatic stress disorder's (PTSD) dysphoria and reexperiencing factors and underlying dimensions of rumination. 304 trauma-exposed primary care patients were administered the Stressful Life Events Screening Questionnaire, PTSD Symptom Scale based on their worst traumatic event, and Ruminative Thought Style Questionnaire (RTSQ). Confirmatory factor analyses (CFAs) were conducted to determine the dysphoria and reexperiencing factors' relationships with the four factors of rumination. Results revealed that both the dysphoria and reexperiencing factors related more to problem-focused thinking and anticipatory thoughts than counterfactual thinking. Additionally, the reexperiencing factor related more to anticipatory thinking than repetitive thinking. Clinical and theoretical implications are discussed.	[Claycomb, Meredith A.; Elhai, Jon D.] Univ Toledo, Dept Psychol, Toledo, OH 43606 USA; [Wang, Li] Chinese Acad Sci, Inst Psychol, Key Lab Mental Hlth, Beijing 100101, Peoples R China; [Sharp, Carla] Univ Houston, Dept Psychol, Baylor Coll Med, Menninger Clin, Houston, TX USA; [Ractliffe, Kendra C.] San Francisco VA Med Ctr, San Francisco, CA USA; [Elhai, Jon D.] Univ Toledo, Dept Psychiat, Toledo, OH 43606 USA	University System of Ohio; University of Toledo; Chinese Academy of Sciences; Institute of Psychology, CAS; Baylor College of Medicine; University of Houston System; University of Houston; US Department of Veterans Affairs; Veterans Health Administration (VHA); San Francisco VA Medical Center; University System of Ohio; University of Toledo	Elhai, JD (corresponding author), Univ Toledo, Dept Psychol, Toledo, OH 43606 USA.	contact@jon-elhai.com	Elhai, Jon D/U-1901-2017	Elhai, Jon D/0000-0001-5205-9010; wang, li/0000-0002-1459-3412				American psychiatric association, 2013, DIAGNOSTIC STAT MANU, DOI 10.1176/appi.books.9780890425596; Barlow DH, 2008, CLIN HDB PSYCHOL DIS, DOI [10.1007/s10597-009-9223, DOI 10.1007/S10597-009-9223-6]; Brewin CR, 2003, CLIN PSYCHOL REV, V23, P339, DOI 10.1016/S0272-7358(03)00033-3; Brinker JK, 2009, J CLIN PSYCHOL, V65, P1, DOI 10.1002/jclp.20542; Clohessy S, 1999, BRIT J CLIN PSYCHOL, V38, P251, DOI 10.1348/014466599162836; Conway M, 2000, J PERS ASSESS, V75, P404, DOI 10.1207/S15327752JPA7503_04; Ehlers A, 2000, BEHAV RES THER, V38, P319, DOI 10.1016/S0005-7967(99)00123-0; Ehlers A, 1998, J ABNORM PSYCHOL, V107, P508, DOI 10.1037/0021-843X.107.3.508; Ehlers A, 1995, Behav Cogn Psychother, V23, P217, DOI 10.1017/S135246580001585X; Ehring T, 2008, COGNITIVE THER RES, V32, P488, DOI 10.1007/s10608-006-9089-7; Elhai J. D., 2005, PSYCHOL SERV, V2, P3, DOI [10.1037/1541-1559.2.1.3, DOI 10.1037/1541-1559.2.1.3]; Elhai JD, 2011, J TRAUMA STRESS, V24, P435, DOI 10.1002/jts.20653; Elhai JD, 2011, J ANXIETY DISORD, V25, P849, DOI 10.1016/j.janxdis.2011.04.007; Elhai JD, 2011, J ANXIETY DISORD, V25, P340, DOI 10.1016/j.janxdis.2010.10.007; Elwood LS, 2009, CLIN PSYCHOL REV, V29, P87, DOI 10.1016/j.cpr.2008.10.002; Flora DB, 2004, PSYCHOL METHODS, V9, P466, DOI 10.1037/1082-989X.9.4.466; FOA EB, 1993, J TRAUMA STRESS, V6, P459, DOI 10.1007/BF00974317; Forbes D, 2010, J AFFECT DISORDERS, V127, P147, DOI 10.1016/j.jad.2010.05.005; Goodman LA, 1998, J TRAUMA STRESS, V11, P521, DOI 10.1023/A:1024456713321; Gros DF, 2010, J NERV MENT DIS, V198, P885, DOI 10.1097/NMD.0b013e3181fe7410; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; KESSLER RC, 1995, ARCH GEN PSYCHIAT, V52, P1048, DOI 10.1001/archpsyc.1995.03950240066012; King DW, 1998, PSYCHOL ASSESSMENT, V10, P90, DOI 10.1037/1040-3590.10.2.90; Kline R.B., 2011, PRINCIPLES PRACTICE; Michael T, 2005, BEHAV RES THER, V43, P613, DOI 10.1016/j.brat.2004.04.006; Michael T, 2007, DEPRESS ANXIETY, V24, P307, DOI 10.1002/da.20228; Muthen B.O., 2010, MPLUS VERSION 6; NOLENHOEKSEMA S, 1993, J ABNORM PSYCHOL, V102, P20, DOI 10.1037/0021-843X.102.1.20; NOLENHOEKSEMA S, 1991, J ABNORM PSYCHOL, V100, P569, DOI 10.1037/0021-843X.100.4.569; Pacella ML, 2013, J ANXIETY DISORD, V27, P33, DOI 10.1016/j.janxdis.2012.08.004; Simms LJ, 2002, J ABNORM PSYCHOL, V111, P637, DOI 10.1037//0021-843X.111.4.637; Smith JM, 2009, CLIN PSYCHOL REV, V29, P116, DOI 10.1016/j.cpr.2008.10.003; Tanner A, 2013, COGNITIVE THER RES, V37, P633, DOI 10.1007/s10608-012-9492-1; Wirth RJ, 2007, PSYCHOL METHODS, V12, P58, DOI 10.1037/1082-989X.12.1.58; Yufik T, 2010, J ABNORM PSYCHOL, V119, P764, DOI 10.1037/a0020981	35	16	17	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2015	10	3							e0118435	10.1371/journal.pone.0118435	http://dx.doi.org/10.1371/journal.pone.0118435			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CC9JM	25738868	Green Published, Green Submitted, gold			2022-12-27	WOS:000350685900034
J	Eom, YH; Aragon, P; Laniado, D; Kaltenbrunner, A; Vigna, S; Shepelyansky, DL				Eom, Young-Ho; Aragon, Pablo; Laniado, David; Kaltenbrunner, Andreas; Vigna, Sebastiano; Shepelyansky, Dima L.			Interactions of Cultures and Top People of Wikipedia from Ranking of 24 Language Editions	PLOS ONE			English	Article								Wikipedia is a huge global repository of human knowledge that can be leveraged to investigate interwinements between cultures. With this aim, we apply methods of Markov chains and Google matrix for the analysis of the hyperlink networks of 24 Wikipedia language editions, and rank all their articles by PageRank, 2DRank and CheiRank algorithms. Using automatic extraction of people names, we obtain the top 100 historical figures, for each edition and for each algorithm. We investigate their spatial, temporal, and gender distributions in dependence of their cultural origins. Our study demonstrates not only the existence of skewness with local figures, mainly recognized only in their own cultures, but also the existence of global historical figures appearing in a large number of editions. By determining the birth time and place of these persons, we perform an analysis of the evolution of such figures through 35 centuries of human history for each language, thus recovering interactions and entanglement of cultures over time. We also obtain the distributions of historical figures over world countries, highlighting geographical aspects of cross-cultural links. Considering historical figures who appear in multiple editions as interactions between cultures, we construct a network of cultures and identify the most influential cultures according to this network.	[Eom, Young-Ho; Shepelyansky, Dima L.] Univ Toulouse, CNRS, Phys Theor Lab, IRSAMC,UPS, F-31062 Toulouse, France; [Aragon, Pablo; Laniado, David; Kaltenbrunner, Andreas] Barcelona Media Fdn, Barcelona, Spain; [Vigna, Sebastiano] Univ Milan, Dipartimento Informat, Milan, Italy	Centre National de la Recherche Scientifique (CNRS); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; University of Milan	Shepelyansky, DL (corresponding author), Univ Toulouse, CNRS, Phys Theor Lab, IRSAMC,UPS, F-31062 Toulouse, France.	dima@irsamc.ups-tlse.fr	Vigna, Sebastiano/R-5285-2017; Laniado, David/G-7552-2016; Kaltenbrunner, Andreas/A-7301-2016; Shepelyansky, Dima L/G-6050-2016	Vigna, Sebastiano/0000-0002-3257-651X; Laniado, David/0000-0003-4574-0881; Kaltenbrunner, Andreas/0000-0002-2271-3066; Shepelyansky, Dima L/0000-0002-2752-0765; Eom, Young-Ho/0000-0002-4828-7333; Aragon, Pablo/0000-0002-6017-4577	EC FET Open project "New tools and algorithms for directed network analysis" (NADINE) [288956]	EC FET Open project "New tools and algorithms for directed network analysis" (NADINE)	This research is supported in part by the EC FET Open project "New tools and algorithms for directed network analysis" (NADINE number 288956). No additional external or internal funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aragon P, 2012, P 8 INT S WIK OP COL; Brin S, 1998, COMPUT NETWORKS ISDN, V30, P107, DOI 10.1016/S0169-7552(98)00110-X; Callahan ES, 2011, J AM SOC INF SCI TEC, V62, P1899, DOI 10.1002/asi.21577; Carr Edward Hallett, 1961, WHAT IS HIST; Chen P, 2007, J INFORMETR, V1, P8, DOI 10.1016/j.joi.2006.06.001; Chepelianskii A.D., 2010, ARXIV10035455CSSE; Darren Gergle, 2009, P 4 INT C COMM TECHN, P11, DOI DOI 10.1145/1556460.1556463; Eom YH, 2013, EUR PHYS J B, V86, DOI 10.1140/epjb/e2013-40432-5; Eom YH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074554; Ermann L, 2012, J PHYS A-MATH THEOR, V45, DOI 10.1088/1751-8113/45/27/275101; Ermann L, 2011, ACTA PHYS POL A, V120, pA158; Ermann L, 2013, EUR PHYS J B, V86, DOI 10.1140/epjb/e2013-31090-8; Giles J, 2005, NATURE, V438, P900, DOI 10.1038/438900a; Hale Scott A., 2014, P 6 ANN ACM WEB SCI; Hart MH, 1992, 100 RANKING MOST INF; Hecht B, 2010, CHI2010: PROCEEDINGS OF THE 28TH ANNUAL CHI CONFERENCE ON HUMAN FACTORS IN COMPUTING SYSTEMS, VOLS 1-4, P291; Kandiah V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061519; Kittur A, 2009, P SIGCHI C HUM FACT; Kwak H., 2010, PROC 19 INT C WORLD, P591, DOI 10.1145/1772690.1772751; Lam S.K., 2011, WIKISYM 2011 C P 7 A, P1, DOI [DOI 10.1145/2038558.2038560, 10.1145/2038558.2038560]; Langville A., 2006, GOOGLES PAGERANK SCI; Laniado D., 2011, P ICWSM, P177; Lavsa SM, 2011, CURR PHARM TEACH LEA, V3, P154, DOI 10.1016/j.cptl.2011.01.007; Lu LY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021202; Massa P., 2012, P 8 INT S WIK OP COL; Nemoto K, 2011, PROCD SOC BEHV, V26, DOI 10.1016/j.sbspro.2011.10.574; Pfeil U, 2006, J COMPUT-MEDIAT COMM, V12, P88, DOI 10.1111/j.1083-6101.2006.00316.x; Priedhorsky R, 2007, P INT C SUPP GROUP W, P295; Rosenzweig R, 2006, J AM HIST, V93, P117, DOI 10.2307/4486062; Samoilenko A, 2014, EPJ DATA SCI, V3, DOI 10.1140/epjds20; Skiena S, 2014, WHO'S BIGGER?: WHERE HISTORICAL FIGURES REALLY RANK; Warncke-Wang M, 2012, P 8 INT S WIK OP COL; Wikipedia, LIST LANG NUMB NAT S; Wikipedia, NEUTR POINT VIEW; Yasseri T, 2013, ARXIV13055566PHYSICS; Yasseri T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038869; Zhirov AO, 2010, EUR PHYS J B, V77, P523, DOI 10.1140/epjb/e2010-10500-7	37	34	34	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2015	10	3							e0114825	10.1371/journal.pone.0114825	http://dx.doi.org/10.1371/journal.pone.0114825			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9JM	25738291	gold, Green Published, Green Submitted, Green Accepted			2022-12-27	WOS:000350685900001
J	Kannan, VC; Andriamalala, CN; Reynolds, TA				Kannan, Vijay C.; Andriamalala, Clara N.; Reynolds, Teri A.			The Burden of Acute Disease in Mahajanga, Madagascar - A 21 Month Study	PLOS ONE			English	Article							EMERGENCY-MEDICINE; TANZANIA	Background Efforts to develop effective and regionally-appropriate emergency care systems in sub-Saharan Africa are hindered by a lack of data on both the burden of disease in the region and on the state of existing care delivery mechanisms. This study describes the burden of acute disease presenting to an emergency unit in Mahajanga, Madagascar. Methods and Findings Handwritten patient registries on all emergency department patients presenting between 1 January 2011 and 30 September 2012 were reviewed and data entered into a database. Data included age, sex, diagnosis, and disposition. We classified diagnoses into Clinical Classifications Software (CCS) multi-level categories. The population was 53.5% male, with a median age of 31 years. The five most common presenting conditions were 1) Superficial injury; contusion, 2) Open wounds of head; neck; and trunk, 3) Open wounds of extremities, 4) Intracranial injury, and 5) Unspecified injury and poisoning. Trauma accounted for 48%, Infectious Disease for 15%, Mental Health 6.1%, Noncommunicable 29%, and Neoplasms 1.2%. The acuity seen was high, with an admission rate of 43%. Trauma was the most common reason for admission, representing 19% of admitted patients. Conclusions This study describes the burden of acute disease at a large referral center in northern Madagascar. The Centre Hopitalier Universitaire de Mahajanga sees a high volume of acutely ill and injured patients. Similar to other reports from the region, trauma is the most common pathology observed, though infectious disease was responsible for the majority of adult mortality. Typhoid fever other intestinal infections were the most lethal CCS-coded pathologies. By utilizing a widely understood classification system, we are able to highlight contrasts between Mahajanga's acute and overall disease burden as well as make comparisons between this region and the rest of the globe. We hope this study will serve to guide the development of context-appropriate emergency medicine systems in the region.	[Kannan, Vijay C.] Univ Texas Southwestern, Div Emergency Med, Dallas, TX USA; [Kannan, Vijay C.] Maricopa Cty Gen Hosp, Dept Emergency Med, Phoenix, AZ 85008 USA; Univ Mahajanga, Ctr Hosp, Mahajanga, Madagascar; [Reynolds, Teri A.] Muhimbili Natl Hosp, Dept Emergency Med, Dar Es Salaam, Tanzania; [Reynolds, Teri A.] Univ Calif San Francisco, Emergency Med & Global Hlth Sci, San Francisco, CA 94143 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; Maricopa County General Hospital; University of California System; University of California San Francisco	Kannan, VC (corresponding author), Maricopa Cty Gen Hosp, Dept Emergency Med, Phoenix, AZ 85008 USA.	vijay.c.kannan@gmail.com		Kannan, Vijay/0000-0002-5413-3832	School of Medicine, University of Texas Southwestern; Department of Emergency Medicine and Global Health Sciences, University of California San Francisco	School of Medicine, University of Texas Southwestern; Department of Emergency Medicine and Global Health Sciences, University of California San Francisco	VK was supported by School of Medicine, University of Texas Southwestern, funding. TR was supported by Department of Emergency Medicine and Global Health Sciences, University of California San Francisco, funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bombana JA, 1997, J PSYCHOSOM RES, V43, P489, DOI 10.1016/S0022-3999(97)00138-4; Cox M, 2007, EMERG MED AUSTRALAS, V19, P470, DOI 10.1111/j.1742-6723.2007.01012.x; House DR, 2014, AFR J EMERG MED, V4, P20, DOI 10.1016/j.afjem.2013.08.069; Kobusingye OC, 2006, DISEASE CONTROL PRIORITIES IN DEVELOPING COUNTRIES, 2ND EDITION, P1261; Little RM, 2013, AFR J EMERG MED, V3, P164, DOI 10.1016/j.afjem.2013.03.004; LIU Y, 1994, AM J EMERG MED, V12, P247, DOI 10.1016/0735-6757(94)90252-6; Matoussi Nadia, 2007, Tunis Med, V85, P843; Periyanayagam U, 2012, AFR J EMERG MED, V2, P151, DOI 10.1016/j.afjem.2012.09.002; Ramalanjaona G, 1998, ANN EMERG MED, V31, P766, DOI 10.1016/S0196-0644(98)70237-9; Reynolds T, 2012, ANN EMERG MED, V60, pS39, DOI 10.1016/j.annemergmed.2012.06.084; Reynolds TA, 2013, AFR J EMERG MED, V3, P1, DOI 10.1016/j.afjem.2013.01.003; Wachira B, 2011, AFR J EMERG MED, V1, P160, DOI 10.1016/j.afjem.2011.10.008; WHO, WHO GLOB BURD DIS GB; WHO, WHO REG EST 2000 201; WHO, WHO MAD COUNTR PROF; World Health Organization, GLOB STAT REP NONC D	16	4	4	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2015	10	3							e0119029	10.1371/journal.pone.0119029	http://dx.doi.org/10.1371/journal.pone.0119029			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9JM	25738300	Green Published, gold, Green Submitted			2022-12-27	WOS:000350685900091
J	Ahmadi, A; Leipsic, J; Feuchtner, G; Gransar, H; Kalra, D; Heo, R; Achenbach, S; Andreini, D; Al-Mallah, M; Berman, DS; Budoff, M; Cademartiri, F; Callister, TQ; Chang, HJ; Chinnaiyan, K; Chow, B; Cury, RC; Delago, A; Gomez, MJ; Hadamitzky, M; Hausleiter, J; Hindoyan, N; Kaufmann, PA; Kim, YJ; Lin, F; Maffei, E; Pontone, G; Raff, GL; Shaw, LJ; Villines, TC; Dunning, A; Min, JK				Ahmadi, Amir; Leipsic, Jonathon; Feuchtner, Gudrun; Gransar, Heidi; Kalra, Dan; Heo, Ran; Achenbach, Stephan; Andreini, Daniele; Al-Mallah, Mouaz; Berman, Daniel S.; Budoff, Matthew; Cademartiri, Filippo; Callister, Tracy Q.; Chang, Hyuk-Jae; Chinnaiyan, Kavitha; Chow, Benjamin; Cury, Ricardo C.; Delago, Augustin; Gomez, Millie J.; Hadamitzky, Martin; Hausleiter, Joerg; Hindoyan, Niree; Kaufmann, Philipp A.; Kim, Yong-Jin; Lin, Fay; Maffei, Erica; Pontone, Gianluca; Raff, Gilbert L.; Shaw, Leslee J.; Villines, Todd C.; Dunning, Allison; Min, James K.			Is Metabolic Syndrome Predictive of Prevalence, Extent, and Risk of Coronary Artery Disease beyond Its Components? Results from the Multinational Coronary CT Angiography Evaluation for Clinical Outcome: An International Multicenter Registry (CONFIRM)	PLOS ONE			English	Article							ELEVATION MYOCARDIAL-INFARCTION; RESISTANCE SYNDROME PREDICTS; ASSOCIATION TASK-FORCE; ALL-CAUSE MORTALITY; COMPUTED-TOMOGRAPHY; INSULIN-RESISTANCE; HEART-DISEASE; CARDIOVASCULAR-DISEASE; AMERICAN-COLLEGE; DEFINITION	Although metabolic syndrome is associated with increased risk of cardiovascular disease and events, its added prognostic value beyond its components remains unknown. This study compared the prevalence, severity of coronary artery disease (CAD), and prognosis of patients with metabolic syndrome to those with individual metabolic syndrome components. The study cohort consisted of 27125 consecutive individuals who underwent >= 64-detector row coronary CT angiography (CCTA) at 12 centers from 2003 to 2009. Metabolic syndrome was defined as per NCEP/ATP III criteria. Metabolic syndrome patients (n=690) were matched 1:1:1 to those with 1 component (n=690) and 2 components (n=690) of metabolic syndrome for age, sex, smoking status, and family history of premature CAD using propensity scoring. Major adverse cardiac events (MACE) were defined by a composite of myocardial infarction (MI), acute coronary syndrome, mortality and late target vessel revascularization. Patients with 1 component of metabolic syndrome manifested lower rates of obstructive 1-, 2-, and 3-vessel/left main disease compared to metabolic syndrome patients (9.4% vs 13.8%, 2.6% vs 4.5%, and 1.0% vs 2.3%, respectively; p<0.05), while those with 2 components did not (10.5% vs 13.8%, 2.8% vs 4.5% and 1.3% vs 2.3%, respectively; p>0.05). At 2.5 years, metabolic syndrome patients experienced a higher rate of MACE compared to patients with 1 component (4.4% vs 1.6%; p=0.002), while no difference observed compared to individuals with 2 components (4.4% vs 3.2% p=0.25) of metabolic syndrome. In conclusion, Metabolic syndrome patients have significantly greater prevalence, severity, and prognosis of CAD compared to patients with 1 but not 2 components of metabolic syndrome.	[Ahmadi, Amir; Leipsic, Jonathon] Univ British Columbia, Dept Med, Vancouver, BC, Canada; [Leipsic, Jonathon] Univ British Columbia, Dept Radiol, Vancouver, BC, Canada; [Feuchtner, Gudrun] Med Univ Innsbruck, Dept Radiol, A-6020 Innsbruck, Austria; [Gransar, Heidi; Berman, Daniel S.] Cedars Sinai Med Ctr, Dept Imaging, Los Angeles, CA 90048 USA; [Kalra, Dan; Heo, Ran; Gomez, Millie J.; Hindoyan, Niree; Lin, Fay; Min, James K.] NewYork Presbyterian Hosp, Dept Radiol, New York, NY 10032 USA; [Kalra, Dan; Heo, Ran; Gomez, Millie J.; Hindoyan, Niree; Lin, Fay; Min, James K.] Weill Cornell Med Coll, New York, NY USA; [Achenbach, Stephan] Univ Erlangen Nurnberg, Dept Med, D-91054 Erlangen, Germany; [Andreini, Daniele; Pontone, Gianluca] IRCCS, Ctr Cardiol Monzino, Milan, Italy; [Al-Mallah, Mouaz] King Abdul Aziz Med City, King Abdulaziz Cardiac Ctr, Riyadh, Saudi Arabia; [Budoff, Matthew] Harbor UCLA Med Ctr, Dept Med, Los Angeles, CA USA; [Cademartiri, Filippo] Giovanni XXIII Hosp, Dept Radiol, Treviso, Italy; [Callister, Tracy Q.] Tennessee Heart & Vasc Inst, Hendersonville, TN USA; [Chang, Hyuk-Jae] Yonsei Univ Hlth Syst, Div Cardiol, Severance Cardiovasc Hosp, Seoul, South Korea; [Chang, Hyuk-Jae] Yonsei Univ Hlth Syst, Yonsei Univ, Coll Med, Severance Biomed Sci Inst, Seoul, South Korea; [Chinnaiyan, Kavitha; Raff, Gilbert L.] William Beaumont Hosp, Royal Oak, MI USA; [Chow, Benjamin] Univ Ottawa, Dept Med, Ottawa, ON, Canada; [Cury, Ricardo C.] Baptist Cardiac & Vasc Inst, Miami, FL USA; [Delago, Augustin] Capitol Cardiol Associates, Albany, NY USA; [Hadamitzky, Martin] Deutsch Herzzentrum Munich, Div Cardiol, Munich, Germany; [Hausleiter, Joerg] Univ Munich, Med Klin 1, Munich, Germany; [Kaufmann, Philipp A.] Univ Zurich Hosp, CH-8091 Zurich, Switzerland; [Kim, Yong-Jin] Seoul Natl Univ Hosp, Seoul 110744, South Korea; [Maffei, Erica] Erasmus MC, Dept Radiol, Rotterdam, Netherlands; [Shaw, Leslee J.] Emory Univ, Sch Med, Dept Med, Atlanta, GA USA; [Villines, Todd C.] Walter Reed Natl Mil Med Ctr, Dept Med, Bethesda, MD USA; [Dunning, Allison] Duke Clin Res Inst, Durham, NC USA	University of British Columbia; University of British Columbia; Medical University of Innsbruck; Cedars Sinai Medical Center; NewYork-Presbyterian Hospital; Cornell University; University of Erlangen Nuremberg; IRCCS Centro Cardiologico Monzino; King Abdulaziz Medical City; King Saud Bin Abdulaziz University for Health Sciences; King Abdulaziz Cardiac Center (KACC); King Abdulaziz Medical City - Riyadh; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; Tennessee Heart & Vascular; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Beaumont Health; University of Ottawa; Baptist Cardiac & Vascular Institute; German Heart Centre Munich; University of Munich; University of Zurich; University Zurich Hospital; Seoul National University (SNU); Seoul National University Hospital; Erasmus University Rotterdam; Erasmus MC; Emory University; Walter Reed National Military Medical Center; Duke University	Min, JK (corresponding author), NewYork Presbyterian Hosp, Dept Radiol, New York, NY 10032 USA.	jkm2001@med.cornell.edu	Budoff, Matthew/ABD-5175-2021; Maffei, Erica/J-2370-2016; Andreini, Daniele/ABG-9647-2020; Kalra, D/H-6661-2019; Cademartiri, Filippo/H-7336-2015; Lin, Fay/AAJ-9453-2021; Leipsic, Jonathon/ABE-6194-2020; Hausleiter, Jörg/V-4206-2019; Heo, Ran/AAJ-8471-2021; Villines, Todd/AAJ-3744-2021	Budoff, Matthew/0000-0002-9616-1946; Maffei, Erica/0000-0002-0388-4433; Kalra, D/0000-0001-5254-4067; Cademartiri, Filippo/0000-0002-0579-3279; Heo, Ran/0000-0002-2675-3612; Kaufmann, Philipp/0000-0002-9451-5210; Ahmadi, Amir/0000-0002-5747-7112; Chang, Hyuk-Jae/0000-0002-6139-7545; Al-Mallah, Mouaz/0000-0003-2348-0484; Pontone, Gianluca/0000-0002-1339-6679; Chow, Benjamin/0000-0001-8631-0234	National Heart, Lung, and Blood Institute of the National Institutes of Health [R01HL115150]; National Research Foundation of Korea (NRF) - Ministry of Science, ICT & Future Planning (MSIP) [2012027176]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000457, UL1TR002384] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL115150] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Research Foundation of Korea (NRF) - Ministry of Science, ICT & Future Planning (MSIP)(National Research Foundation of KoreaMinistry of Science, ICT & Future Planning, Republic of Korea); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Research reported in this publication was supported by the National Heart, Lung, and Blood Institute of the National Institutes of Health (Bethesda, Maryland) under Award number R01HL115150 and by Leading Foreign Research Institute Recruitment Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT & Future Planning (MSIP) (2012027176). This study was also funded in part, by a generous gift from the Dalio Institute of Cardiovascular Imaging (New York, NY) and the Michael Wolk Foundation (New York, NY). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Austen W G, 1975, Circulation, V51, P5; Bayturan O, 2010, ARCH INTERN MED, V170, P478, DOI 10.1001/archinternmed.2009.551; Braunwald E, 2000, CIRCULATION, V102, P1193, DOI 10.1161/01.CIR.102.10.1193; Budoff MJ, 2008, J AM COLL CARDIOL, V52, P1724, DOI 10.1016/j.jacc.2008.07.031; Chow BJW, 2011, CIRC-CARDIOVASC IMAG, V4, P463, DOI 10.1161/CIRCIMAGING.111.964155; Ferrannini E, 2007, J CLIN ENDOCR METAB, V92, P396, DOI 10.1210/jc.2006-0944; Ford ES, 2005, DIABETES CARE, V28, P1769, DOI 10.2337/diacare.28.7.1769; Galassi A, 2006, AM J MED, V119, P812, DOI 10.1016/j.amjmed.2006.02.031; Gami AS, 2007, J AM COLL CARDIOL, V49, P403, DOI 10.1016/j.jacc.2006.09.032; Girman CJ, 2004, AM J CARDIOL, V93, P136, DOI 10.1016/j.amjcard.2003.09.028; Grundy SM, 2004, CIRCULATION, V109, P433, DOI 10.1161/01.CIR.0000111245.75752.C6; Imbens GW, 2000, BIOMETRIKA, V87, P706, DOI 10.1093/biomet/87.3.706; Kahn R, 2005, DIABETES CARE, V28, P2289, DOI 10.2337/diacare.28.9.2289; Lawlor DA, 2006, DIABETOLOGIA, V49, P41, DOI 10.1007/s00125-005-0040-3; Lempiainen P, 1999, CIRCULATION, V100, P123, DOI 10.1161/01.CIR.100.2.123; Lin F, 2008, ATHEROSCLEROSIS, V197, P700, DOI 10.1016/j.atherosclerosis.2007.07.002; McNeill AM, 2005, DIABETES CARE, V28, P385, DOI 10.2337/diacare.28.2.385; Meijboom WB, 2008, J AM COLL CARDIOL, V52, P2135, DOI 10.1016/j.jacc.2008.08.058; Min JK, 2011, J AM COLL CARDIOL, V58, P849, DOI 10.1016/j.jacc.2011.02.074; Min JK, 2011, J CARDIOVASC COMPUT, V5, P84, DOI 10.1016/j.jcct.2011.01.007; O'Gara PT, 2013, J AM COLL CARDIOL, V61, pE78, DOI [10.1016/j.jacc.2012.11.019, 10.1161/CIR.0b013e3182742cf6]; Pyorala M, 2000, ARTERIOSCL THROM VAS, V20, P538, DOI 10.1161/01.ATV.20.2.538; REAVEN GM, 1988, DIABETES, V37, P1595, DOI 10.2337/diabetes.37.12.1595; Sattar N, 2003, CIRCULATION, V108, P414, DOI 10.1161/01.CIR.0000080897.52664.94; Sokka T, 2008, CLIN EXP RHEUMATOL, V26, pS35, DOI 10.1161/CIRCULATIONAHA.109.192644; Stedman T., 2000, STEDMANS MED DICT, P1746; Stern SE, 2005, DIABETES, V54, P333, DOI 10.2337/diabetes.54.2.333; Sundstrom J, 2006, DIABETES CARE, V29, P1673, DOI 10.2337/dc06-0664; Thygesen K, 2012, J AM COLL CARDIOL, V60, P1581, DOI 10.1016/j.jacc.2012.08.001; Wannamethee SG, 2005, ARCH INTERN MED, V165, P2644, DOI 10.1001/archinte.165.22.2644	30	22	23	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2015	10	3							e0118998	10.1371/journal.pone.0118998	http://dx.doi.org/10.1371/journal.pone.0118998			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4HV	25734639	gold, Green Published, Green Submitted			2022-12-27	WOS:000350314700050
J	Lewandowska, MK; Bakkum, DJ; Rompani, SB; Hierlemann, A				Lewandowska, Marta K.; Bakkum, Douglas J.; Rompani, Santiago B.; Hierlemann, Andreas			Recording Large Extracellular Spikes in Microchannels along Many Axonal Sites from Individual Neurons	PLOS ONE			English	Article							ACTION-POTENTIAL PROPAGATION; MICROFLUIDIC CULTURE PLATFORM; DENSITY MICROELECTRODE ARRAY; DIFFERENTIAL CONDUCTION; DENDRITIC INTEGRATION; MAMMALIAN NEURONS; STIMULATION; LONG; RECONSTRUCTION; FABRICATION	The numerous connections between neuronal cell bodies, made by their dendrites and axons, are vital for information processing in the brain. While dendrites and synapses have been extensively studied, axons have remained elusive to a large extent. We present a novel platform to study axonal physiology and information processing based on combining an 11,011-electrode high-density complementary metal-oxide semiconductor microelectrode array with a poly(dimethylsiloxane) channel device, which isolates axons from somas and, importantly, significantly amplifies recorded axonal signals. The combination of the microelectrode array with recording and stimulation capability with the microfluidic isolation channels permitted us to study axonal signal behavior at great detail. The device, featuring two culture chambers with over 30 channels spanning in between, enabled long-term recording of single spikes from isolated axons with signal amplitudes of 100 mu V up to 2 mV. Propagating signals along axons could be recorded with 10 to 50 electrodes per channel. We (i) describe the performance and capabilities of our device for axonal electrophysiology, and (ii) present novel data on axonal signals facilitated by the device. Spontaneous action potentials with characteristic shapes propagated from somas along axons between the two compartments, and these unique shapes could be used to identify individual axons within channels that contained many axonal branches. Stimulation through the electrode array facilitated the identification of somas and their respective axons, enabling interfacing with different compartments of a single cell. Complex spike shapes observed in channels were traced back to single cells, and we show that more complicated spike shapes originate from a linear superposition of multiple axonal signals rather than signal distortion by the channels.	[Lewandowska, Marta K.; Bakkum, Douglas J.; Hierlemann, Andreas] Swiss Fed Inst Technol, Bio Engn Labs, Dept Biosyst Sci & Engn, Basel, Switzerland; [Rompani, Santiago B.] Friedrich Miescher Inst, Neural Circuits Lab, CH-4002 Basel, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich; Friedrich Miescher Institute for Biomedical Research	Lewandowska, MK (corresponding author), Swiss Fed Inst Technol, Bio Engn Labs, Dept Biosyst Sci & Engn, Basel, Switzerland.	martal@bsse.ethz.ch	Hierlemann, Andreas/A-7046-2008	Hierlemann, Andreas/0000-0002-3838-2468; Rompani, Santiago/0000-0002-3994-3052	European Community through the European Research Council [267351]; Swiss National Science Foundation [PZ00P3_132245, 205321_157092/1]	European Community through the European Research Council; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This work was supported by FP7 of the European Community through the European Research Council Advanced Grant 267351 "NeuroCMOS" (DB, AH) as well as the Swiss National Science Foundation Ambizione Grant PZ00P3_132245 (DB) and additionally through the Swiss National Science Foundation through Grant 205321_157092/1 (AH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alle H, 2008, CURR OPIN NEUROBIOL, V18, P314, DOI 10.1016/j.conb.2008.08.006; Bakkum DJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002088; Bakkum DJ, 2014, FRONT COMPUT NEUROSC, V7, DOI 10.3389/fncom.2013.00193; Bakkum DJ, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3181; Barron DH, 1935, J PHYSIOL-LONDON, V85, P73, DOI 10.1113/jphysiol.1935.sp003303; Bhattacharjee N, 2010, INTEGR BIOL-UK, V2, P669, DOI 10.1039/c0ib00038h; Brewer GJ, 2013, FRONT NEURAL CIRCUIT, V7, DOI 10.3389/fncir.2013.00165; Bucher D, 2011, PROG NEUROBIOL, V94, P307, DOI 10.1016/j.pneurobio.2011.06.001; CLARK J, 1968, BIOPHYS J, V8, P842, DOI 10.1016/S0006-3495(68)86524-5; Claverol-Tinture E, 2007, IEEE T BIO-MED ENG, V54, P331, DOI 10.1109/TBME.2006.880903; Claverol-Tinture E, 2005, J NEURAL ENG, V2, pL1, DOI 10.1088/1741-2560/2/2/L01; Debanne D, 2004, NAT REV NEUROSCI, V5, P304, DOI 10.1038/nrn1397; Debanne D, 1997, NATURE, V389, P286, DOI 10.1038/38502; Debanne D, 2011, PHYSIOL REV, V91, P555, DOI 10.1152/physrev.00048.2009; Dworak BJ, 2009, LAB CHIP, V9, P404, DOI 10.1039/b806689b; Fiscella M, 2012, J NEUROSCI METH, V211, P103, DOI 10.1016/j.jneumeth.2012.08.017; FitzGerald JJ, 2008, IEEE T BIO-MED ENG, V55, P1136, DOI 10.1109/TBME.2007.909533; FitzGerald JJ, 2009, IEEE T BIO-MED ENG, V56, P1524, DOI 10.1109/TBME.2009.2013960; Frey U, 2009, BIOSENS BIOELECTRON, V24, P2191, DOI 10.1016/j.bios.2008.11.028; Frey U, 2010, IEEE J SOLID-ST CIRC, V45, P467, DOI 10.1109/JSSC.2009.2035196; Gomez N, 2007, ADV FUNCT MATER, V17, P1645, DOI 10.1002/adfm.200600669; Griscom L, 2002, SENSOR ACTUAT B-CHEM, V83, P15, DOI 10.1016/S0925-4005(01)01022-X; GROSSMAN Y, 1979, J PHYSIOL-LONDON, V295, P283, DOI 10.1113/jphysiol.1979.sp012969; GROSSMAN Y, 1979, J PHYSIOL-LONDON, V295, P307, DOI 10.1113/jphysiol.1979.sp012970; Hausser M, 2000, SCIENCE, V290, P739, DOI 10.1126/science.290.5492.739; HODGKIN AL, 1952, J PHYSIOL-LONDON, V117, P500, DOI 10.1113/jphysiol.1952.sp004764; Hosmane S, 2011, LAB CHIP, V11, P3888, DOI 10.1039/c1lc20549h; Kanagasabapathi TT, 2012, J NEURAL ENG, V9, DOI 10.1088/1741-2560/9/3/036010; Kole MHP, 2007, NEURON, V55, P633, DOI 10.1016/j.neuron.2007.07.031; LOEB GE, 1977, MED BIOL ENG COMPUT, V15, P195, DOI 10.1007/BF02442964; London M, 2005, ANNU REV NEUROSCI, V28, P503, DOI 10.1146/annurev.neuro.28.061604.135703; Magee JC, 2000, NAT REV NEUROSCI, V1, P181, DOI 10.1038/35044552; Millet LJ, 2010, LAB CHIP, V10, P1525, DOI 10.1039/c001552k; Moorjani S, 2012, P MICROTAS, P401; Muller J, 2013, FRONT NEURAL CIRCUIT, V6, DOI 10.3389/fncir.2012.00121; Nevill JT, 2011, SOFT MATTER, V7, P343, DOI 10.1039/c0sm00869a; OFFNER FF, 1954, ELECTROEN CLIN NEURO, V6, P507, DOI 10.1016/0013-4694(54)90069-3; Pan L, 2013, IEEE T NEUR SYS REH, V22, P453, DOI [10.1109/TNSRE.2013.2289911, DOI 10.1109/TNSRE.2013.2289911]; Pan LB, 2011, J NEURAL ENG, V8, DOI 10.1088/1741-2560/8/4/046031; Park JW, 2006, NAT PROTOC, V1, P2128, DOI 10.1038/nprot.2006.316; Peyrin JM, 2011, LAB CHIP, V11, P3663, DOI 10.1039/c1lc20014c; Potter SM, 2001, J NEUROSCI METH, V110, P17, DOI 10.1016/S0165-0270(01)00412-5; Ravenscroft MS, 1998, J AM CHEM SOC, V120, P12169, DOI 10.1021/ja973669n; Rutten WLC, 2002, ANNU REV BIOMED ENG, V4, P407, DOI 10.1146/annurev.bioeng.4.020702.153427; Shu YS, 2006, NATURE, V441, P761, DOI 10.1038/nature04720; Stenger DA, 1998, J NEUROSCI METH, V82, P167, DOI 10.1016/S0165-0270(98)00047-8; SWADLOW HA, 1980, ANNU REV BIOPHYS BIO, V9, P143, DOI 10.1146/annurev.bb.09.060180.001043; SWADLOW HA, 1985, J NEUROPHYSIOL, V54, P1346, DOI 10.1152/jn.1985.54.5.1346; Taylor AM, 2005, NAT METHODS, V2, P599, DOI 10.1038/NMETH777; Taylor AM, 2003, LANGMUIR, V19, P1551, DOI 10.1021/la026417v; Taylor AM, 2010, NEURON, V66, P57, DOI 10.1016/j.neuron.2010.03.022; Thevenaz P, 2007, MICROSC RES TECHNIQ, V70, P135, DOI 10.1002/jemt.20393; Wagenaar DA, 2004, J NEUROSCI METH, V138, P27, DOI 10.1016/j.jneumeth.2004.03.005; Wang L, 2012, J NEURAL ENG, V9, DOI 10.1088/1741-2560/9/2/026010; Wieringa PA, 2010, J NEURAL ENG, V7, DOI 10.1088/1741-2560/7/1/016001; Yuste R, 1996, NEURON, V16, P701, DOI 10.1016/S0896-6273(00)80091-4; Zhu XY, 2005, NAT MATER, V4, P403, DOI 10.1038/nmat1365	57	47	46	3	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2015	10	3							e0118514	10.1371/journal.pone.0118514	http://dx.doi.org/10.1371/journal.pone.0118514			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4HV	25734567	Green Published, gold, Green Submitted			2022-12-27	WOS:000350314700035
J	Gothwal, VK; Bharani, S; Reddy, SP				Gothwal, Vijaya K.; Bharani, Seelam; Reddy, Shailaja P.			Measuring Coping in Parents of Children with Disabilities: A Rasch Model Approach	PLOS ONE			English	Article							QUALITY-OF-LIFE; DAILY VISION SCALE; VISUAL FUNCTION; IMPAIRMENT QUESTIONNAIRE; HEALTH; VALIDITY; DEPRESSION; OUTCOMES; MOTHERS; IMPACT	Background Parents of a child with disability must cope with greater demands than those living with a healthy child. Coping refers to a person's cognitive or behavioral efforts to manage the demands of a stressful situation. The Coping Health Inventory for Parents (CHIP) is a well-recognized measure of coping among parents of chronically ill children and assesses different coping patterns using its three subscales. The purpose of this study was to provide further insights into the psychometric properties of the CHIP subscales in a sample of parents of children with disabilities. Methods In this cross-sectional study, 220 parents (mean age, 33.4 years; 85% mothers) caring for a child with disability enrolled in special schools as well as in mainstream schools completed the 45-item CHIP. Rasch analysis was applied to the CHIP data and the psychometric performance of each of the three subscales was tested. Subscale revision was performed in the context of Rasch analysis statistics. Results Response categories were not used as intended, necessitating combining categories, thereby reducing the number from 4 to 3. The subscale-'maintaining social support' satisfied all the Rasch model expectations. Four item misfit the Rasch model in the subscale maintaining family integration', but their deletion resulted in a 15-item scale with items that fit the Rasch model well. The remaining subscale-'understanding the healthcare situation' lacked adequate measurement precision (< 2.0 logits). Conclusions The current Rasch analyses add to the evidence of measurement properties of the CHIP and show that the two of its subscales (one original and the other revised) have good psychometric properties and work well to measure coping patterns in parents of children with disabilities. However the third subscale is limited by its inadequate measurement precision and requires more items.	[Gothwal, Vijaya K.; Bharani, Seelam] LV Prasad Eye Inst, Meera & LB Deshpande Ctr Sight Enhancement, Hyderabad, Andhra Pradesh, India; [Reddy, Shailaja P.] LV Prasad Eye Inst, Bausch & Lomb Sch Optometry, Hyderabad, Andhra Pradesh, India	L. V. Prasad Eye Institute; Bausch Health; Bausch + Lomb; L. V. Prasad Eye Institute	Gothwal, VK (corresponding author), LV Prasad Eye Inst, Meera & LB Deshpande Ctr Sight Enhancement, Hyderabad, Andhra Pradesh, India.	vijayagothwal@gmail.com	Gothwal, Vijaya/AAY-4526-2020		Hyderabad Eye Research Foundation, Hyderabad, India	Hyderabad Eye Research Foundation, Hyderabad, India	This study was supported by the Hyderabad Eye Research Foundation, Hyderabad, India. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbeduto L, 2004, AM J MENT RETARD, V109, P237, DOI 10.1352/0895-8017(2004)109<237:PWACIM>2.0.CO;2; ANDRICH D, 1978, PSYCHOMETRIKA, V43, P561, DOI 10.1007/BF02293814; Bond T., 2001, APPL RASCH MODEL FUN; Cavallo S, 2009, CHILD CARE HLTH DEV, V35, P33, DOI 10.1111/j.1365-2214.2008.00884.x; Cavallo S, 2009, PEDIATR RHEUMATOL, V7, DOI 10.1186/1546-0096-7-7; Ceylan R, 2007, SOC BEHAV PERSONAL, V35, P903, DOI 10.2224/sbp.2007.35.7.903; Crocker L, 1986, INTRO CLASSICAL MODE; Desai P, 1999, BRIT J OPHTHALMOL, V83, P1336, DOI 10.1136/bjo.83.12.1336; Desai P, 1996, BRIT J OPHTHALMOL, V80, P868, DOI 10.1136/bjo.80.10.868; DeVellis RF, 2006, MED CARE, V44, pS50, DOI 10.1097/01.mlr.0000245426.10853.30; Dorans NJ, 2006, MED CARE, V44, pS107, DOI 10.1097/01.mlr.0000245182.36914.4a; Eakman Aaron M, 2012, Am J Occup Ther, V66, pe20, DOI 10.5014/ajot.2012.001867; Fox RA, 1995, J GENET PSYCHOL, V156, P431, DOI 10.1080/00221325.1995.9914835; Garamendi E, 2006, VISION RES, V46, P1375, DOI 10.1016/j.visres.2005.07.007; Garro Adrienne, 2004, J Pediatr Health Care, V18, P138, DOI 10.1016/S0891-5245(03)00166-4; Garro A, 2011, J PEDIATR HEALTH CAR, V25, P347, DOI 10.1016/j.pedhc.2010.04.005; Glidden LM, 2006, J INTELL DISABIL RES, V50, P949, DOI 10.1111/j.1365-2788.2006.00929.x; Gothwal VK, 2009, BRIT J OPHTHALMOL, V93, P1652, DOI 10.1136/bjo.2009.159806; Gothwal VK, 2012, OPTOMETRY VISION SCI, V89, P1601, DOI 10.1097/OPX.0b013e31826ca291; Gothwal VK, 2010, INVEST OPHTH VIS SCI, V51, P694, DOI 10.1167/iovs.09-3448; Gothwal VK, 2009, J CATARACT REFR SURG, V35, P1509, DOI 10.1016/j.jcrs.2009.03.056; Gothwal VK, 2009, OPTOMETRY VISION SCI, V86, P836, DOI 10.1097/OPX.0b013e3181ae1ec7; GUILLEMIN F, 1993, J CLIN EPIDEMIOL, V46, P1417, DOI 10.1016/0895-4356(93)90142-N; Harris SL, 1994, TOPICS AUTISM SIBLIN; Haveman M, 1997, FAM RELAT, V46, P417, DOI 10.2307/585101; Hays RD, 2000, MED CARE, V38, P28; Lamoureux EL, 2008, OPHTHAL EPIDEMIOL, V15, P224, DOI 10.1080/09286580802256559; Lamoureux EL, 2006, INVEST OPHTH VIS SCI, V47, P4732, DOI 10.1167/iovs.06-0220; Lazarus R.S., 1984, EMOTION ADAPTATION; Linacre JM, 2012, USERS GUIDE WINSTEPS, DOI [10.1007/s12070-012-0514-9, DOI 10.1007/S12070-012-0514-9]; Linacre John M, 2002, J Appl Meas, V3, P85; Mallinson T, 2007, OPTOMETRY VISION SCI, V84, P675, DOI 10.1097/OPX.0b013e3181339f44; Marella M, 2009, OPTOMETRY VISION SCI, V86, P826, DOI 10.1097/OPX.0b013e3181ae1b3f; Massof RW, 2001, SURV OPHTHALMOL, V45, P531, DOI 10.1016/S0039-6257(01)00194-1; MCCUBBIN HI, 1983, J MARRIAGE FAM, V45, P359, DOI 10.2307/351514; McCubbin M.A., 1987, FAMILY STRESS THEORY; Murphy NA, 2007, CHILD CARE HLTH DEV, V33, P180, DOI 10.1111/j.1365-2214.2006.00644.x; Norquist JM, 2004, MED CARE, V42, P25, DOI 10.1097/01.mlr.0000103530.13056.88; Pallant JF, 2007, BRIT J CLIN PSYCHOL, V46, P1, DOI 10.1348/014466506X96931; Pesudovs K, 2004, OPTOMETRY VISION SCI, V81, P769, DOI 10.1097/00006324-200410000-00009; Pesudovs K, 2003, INVEST OPHTH VIS SCI, V44, P2892, DOI 10.1167/iovs.02-1075; Pesudovs K, 2008, J CATARACT REFR SURG, V34, P925, DOI 10.1016/j.jcrs.2007.12.052; Pesudovs K, 2007, OPTOMETRY VISION SCI, V84, P663, DOI 10.1097/OPX.0b013e318141fe75; Pesudovs K, 2010, J CATARACT REFR SURG, V36, P718, DOI 10.1016/j.jcrs.2009.11.019; Rasch G., 1980, PROBABILISTIC MODELS; Roy KM, 2010, AM J COMMUN PSYCHOL, V45, P139, DOI 10.1007/s10464-009-9282-4; Silver EJ, 1998, J PEDIATR PSYCHOL, V23, P5, DOI 10.1093/jpepsy/23.1.5; Streiner D. L., 2003, HLTH MEASUREMENT SCA; Svensson E, 2001, J REHABIL MED, V33, P47, DOI 10.1080/165019701300006542; Tennant A, 2004, VALUE HEALTH, V7, pS22, DOI 10.1111/j.1524-4733.2004.7s106.x; Trout MD, 1990, FAM RELAT, V39, P292; Velozo C A, 2000, J Outcome Meas, V4, P667; Wright BD, 1975, BEST TEST DESIGN SEL; Wright BD, 1976, RASCH ITEM ANAL HAND; Wright BD, 1979, BEST TEST DESIGN RAS	55	14	14	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2015	10	3							e0118189	10.1371/journal.pone.0118189	http://dx.doi.org/10.1371/journal.pone.0118189			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CC9JF	25730331	Green Published, gold, Green Submitted			2022-12-27	WOS:000350684900017
J	Ameri, P; Bruzzone, S; Mannino, E; Sociali, G; Andraghetti, G; Salis, A; Ponta, ML; Briatore, L; Adami, GF; Ferraiolo, A; Venturini, PL; Maggi, D; Cordera, R; Murialdo, G; Zocchi, E				Ameri, Pietro; Bruzzone, Santina; Mannino, Elena; Sociali, Giovanna; Andraghetti, Gabriella; Salis, Annalisa; Ponta, Monica Laura; Briatore, Lucia; Adami, Giovanni F.; Ferraiolo, Antonella; Venturini, Pier Luigi; Maggi, Davide; Cordera, Renzo; Murialdo, Giovanni; Zocchi, Elena			Impaired Increase of Plasma Abscisic Acid in Response to Oral Glucose Load in Type 2 Diabetes and in Gestational Diabetes	PLOS ONE			English	Article							CYCLIC ADP-RIBOSE; PEPTIDE-1 GLP-1 SECRETION; BILIOPANCREATIC DIVERSION	The plant hormone abscisic acid (ABA) is present and active in humans, regulating glucose homeostasis. In normal glucose tolerant (NGT) human subjects, plasma ABA (ABAp) increases 5-fold after an oral glucose load. The aim of this study was to assess the effect of an oral glucose load on ABAp in type 2 diabetes (T2D) subjects. We chose two sub-groups of patients who underwent an oral glucose load for diagnostic purposes: i) 9 treatment-naive T2D subjects, and ii) 9 pregnant women with gestational diabetes (GDM), who underwent the glucose load before and 8-12 weeks after childbirth. Each group was compared with matched NGT controls. The increase of ABAp in response to glucose was found to be abrogated in T2D patients compared to NGT controls. A similar result was observed in the women with GDM compared to pregnant NGT controls; 8-12 weeks after childbirth, however, fasting ABAp and ABAp response to glucose were restored to normal in the GDM subjects, along with glucose tolerance. We also retrospectively compared fasting ABAp before and after bilio-pancreatic diversion (BPD) in obese, but not diabetic subjects, and in obese T2D patients, in which BPD resulted in the resolution of diabetes. Compared to pre-BPD values, basal ABAp significantly increased 1 month after BPD in T2D as well as in NGT subjects, in parallel with a reduction of fasting plasma glucose. These results indicate an impaired hyperglycemia-induced ABAp increase in T2D and in GDM and suggest a beneficial effect of elevated ABAp on glycemic control.	[Ameri, Pietro; Andraghetti, Gabriella; Ponta, Monica Laura; Briatore, Lucia; Maggi, Davide; Cordera, Renzo; Murialdo, Giovanni] Univ Genoa, Dept Internal Med, I-16132 Genoa, Italy; [Bruzzone, Santina; Mannino, Elena; Sociali, Giovanna; Salis, Annalisa; Zocchi, Elena] Univ Genoa, Biochem Sect, Dept Expt Med, I-16132 Genoa, Italy; [Bruzzone, Santina; Mannino, Elena; Sociali, Giovanna; Salis, Annalisa; Zocchi, Elena] Univ Genoa, CEBR, I-16132 Genoa, Italy; [Adami, Giovanni F.] Univ Genoa, Dept Surg Sci & Integrated Diagnost, I-16132 Genoa, Italy; [Ferraiolo, Antonella; Venturini, Pier Luigi] IRCSS San Martino IST, I-16132 Genoa, Italy; [Venturini, Pier Luigi] Univ Genoa, Dept Neurosci Rehabil Ophthalmol Genet & Mother &, I-16132 Genoa, Italy	University of Genoa; University of Genoa; University of Genoa; University of Genoa; University of Genoa	Zocchi, E (corresponding author), Univ Genoa, Biochem Sect, Dept Expt Med, Viale Benedetto 15-1, I-16132 Genoa, Italy.	ezocchi@unige.it	Ameri, Pietro/K-8556-2016; maggi, davide/AAL-4687-2020; Cordera, Renzo/I-7229-2017; Bruzzone, Santina/A-4264-2015; Ponta, Monica Laura/AFM-9813-2022; Salis, Annalisa/R-9241-2018	Ameri, Pietro/0000-0001-7167-7287; Cordera, Renzo/0000-0002-5280-9691; Bruzzone, Santina/0000-0003-2034-3716; Ponta, Monica Laura/0000-0002-5761-1369; Salis, Annalisa/0000-0002-3082-2908; MAGGI, DAVIDE CARLO/0000-0003-3928-1295	Italian Ministry of Education, University and Scientific Research [2010MCLBCZ]; Fondazione CARIGE; Compagnia di S. Paolo [2012-ID-ROL316]; University of Genova [PRA2011]	Italian Ministry of Education, University and Scientific Research(Ministry of Education, Universities and Research (MIUR)); Fondazione CARIGE(Fondazione Carige); Compagnia di S. Paolo(Compagnia di San Paolo); University of Genova	This work was supported in part by the Italian Ministry of Education, University and Scientific Research (www.miur.it/; grant #2010MCLBCZ), by the Fondazione CARIGE (www.fondazionecarige.it/) and by the Compagnia di S. Paolo (www.compagniadisanpaolo.it/; grant #2012-ID-ROL316) to EZ; and by the University of Genova (www.unige.it/; PRA2011) to SB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amer Diabet Assoc, 2013, DIABETES CARE, V36, pS11, DOI 10.2337/dc13-S011; Briatore L, 2008, OBESITY, V16, P77, DOI 10.1038/oby.2007.9; Briatore L, 2010, OBESITY, V18, P932, DOI 10.1038/oby.2010.28; Bruzzone S, 2008, J BIOL CHEM, V283, P32188, DOI 10.1074/jbc.M802603200; Bruzzone S, 2007, P NATL ACAD SCI USA, V104, P5759, DOI 10.1073/pnas.0609379104; Bruzzone S, 2012, FASEB J, V26, P1251, DOI 10.1096/fj.11-190140; Buchwald H, 2004, JAMA-J AM MED ASSOC, V292, P1724, DOI 10.1001/jama.292.14.1724; Castagneto M, 2012, CURR ATHEROSCLER REP, V14, P624, DOI 10.1007/s11883-012-0284-6; Guri AJ, 2007, CLIN NUTR, V26, P107, DOI 10.1016/j.clnu.2006.07.008; Hey SJ, 2010, ANN BOT-LONDON, V105, P197, DOI 10.1093/aob/mcp285; Lugari R, 2004, HORM METAB RES, V36, P111, DOI 10.1055/s-2004-814222; Magnone M, 2012, FASEB J, V26, P1261, DOI 10.1096/fj.11-187351; Puce S, 2004, J BIOL CHEM, V279, P39783, DOI 10.1074/jbc.M405348200; Scopinaro N, 2005, DIABETES CARE, V28, P2406, DOI 10.2337/diacare.28.10.2406; Valverde I, 2005, OBES SURG, V15, P387, DOI 10.1381/0960892053576613; Zocchi E, 2001, P NATL ACAD SCI USA, V98, P14859, DOI 10.1073/pnas.261448698	16	28	28	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2015	10	2							e0115992	10.1371/journal.pone.0115992	http://dx.doi.org/10.1371/journal.pone.0115992			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC3LS	25723556	Green Published, gold, Green Submitted			2022-12-27	WOS:000350251200012
J	Chmiel, C; Reich, O; Signorell, A; Tandjung, R; Rosemann, T; Senn, O				Chmiel, Corinne; Reich, Oliver; Signorell, Andri; Tandjung, Ryan; Rosemann, Thomas; Senn, Oliver			Appropriateness of Diagnostic Coronary Angiography as a Measure of Cardiac Ischemia Testing in Non-Emergency Patients - A Retrospective Cross-Sectional Analysis	PLOS ONE			English	Article							CARDIOVASCULAR ANGIOGRAPHY; VASCULAR COMPLICATIONS; AMERICAN ASSOCIATION; THORACIC SURGEONS; HEART-ASSOCIATION; TASK-FORCE; INTERVENTIONS; ANGIOPLASTY; MANAGEMENT; COLLEGE	Background Adequate application of guidelines concerning non-invasive ischemia testing (NIIT) could avoid inappropriate invasive testing in non-emergency situations. Hardly any data exists regarding frequency and appropriateness of diagnostic coronary angiography (CA). The aim of this study was to evaluate the proportion and predictors of patients without NIIT prior to elective purely diagnostic CA without therapeutic intervention. Methods Retrospective cross-sectional analysis of insurance claims data from 2012 and 2013. Patients < 18 years, acute cardiac ischemia and emergency procedures and patients insured in a managed care model were excluded from analysis. The proportion of patients with NIIT procedures (stress-ECG, transthoracic echocardiography, stress echocardiography, scintigraphy, computer tomography, heart MRI) undertaken within two months before diagnostic CA was assessed. Multiple logistic regression analysis was applied to investigate independent determinants for receiving NIIT. Findings 2714 patients were included for analysis. 37.5%(1018) did not receive any NIIT before CA. When high risk patients (patients having received therapeutic cardiac intervention within one month after or 18 months prior to diagnostic CA, n = 766) were excluded 34.3%(669) did not receive NIIT before CA. High risk status as well as > 6 chronic comorbidities were independently associated with a lower proportion of NIIT (p< 0.0001, OR 0.607 and p = 0.0041, OR 0.648), when additionally controlled for age, sex, language area, insurance coverage, inpatient treatment, cardiovascular medication and lower number of chronic comorbidities. Age (p< 0.05, OR 1.009) and intake of oral antiplatelet therapy (p< 0.0001, OR 1.914) were independently associated with a higher proportion of NIIT when controlled for the mentioned cofactors. Conclusions Our data show that despite the existence of guidelines a substantial overuse of a potentially harmful and inappropriate diagnostic intervention is performed suggesting the need for improvement of diagnostic pathways prior to invasive testing.	[Chmiel, Corinne; Tandjung, Ryan; Rosemann, Thomas; Senn, Oliver] Univ Zurich, Inst Primary Care, Zurich, Switzerland; [Reich, Oliver; Signorell, Andri] Helsana Grp, Dept Hlth Sci, Zurich, Switzerland	University of Zurich	Chmiel, C (corresponding author), Univ Zurich, Inst Primary Care, Zurich, Switzerland.	corinne.chmiel@usz.ch		Chmiel, Corinne/0000-0002-5249-6592	Swiss Academy of Medical Sciences (SAMS), Switzerland; Helsana Group	Swiss Academy of Medical Sciences (SAMS), Switzerland; Helsana Group	This work was supported by the Swiss Academy of Medical Sciences (SAMS), Switzerland. Helsana Group provided support in the form of salaries for authors [Oliver Reich and Andri Signorell], The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, CHEST PAIN RECENT ON; CARROZZA JP, 1993, AM J CARDIOL, V72, pE47, DOI 10.1016/0002-9149(93)91038-J; Chow BJW, 2009, CIRC-CARDIOVASC IMAG, V2, P16, DOI 10.1161/CIRCIMAGING.108.792572; Fihn SD, 2012, CIRCULATION, V126, P3097, DOI 10.1161/CIR.0b013e3182776f83; Fisher ES, 2003, ANN INTERN MED, V138, P288, DOI 10.7326/0003-4819-138-4-200302180-00007; Goraya TY, 2000, ANN INTERN MED, V132, P862, DOI 10.7326/0003-4819-132-11-200006060-00003; Herman AO, 2013, NEW ENGLAND J MED; Huber CA, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-1030; Lamers LM, 2004, HEALTH POLICY, V68, P113, DOI 10.1016/j.healthpol.2003.09.001; Lee CH, 2008, ARCH INTERN MED, V168, P291, DOI 10.1001/archinternmed.2007.78; Lin GA, 2008, JAMA-J AM MED ASSOC, V300, P1765, DOI 10.1001/jama.300.15.1765; LITTLE WC, 1990, AM J CARDIOL, V66, pG44, DOI 10.1016/0002-9149(90)90395-H; Montalescot G, 2013, EUR HEART J, V34, P2949, DOI 10.1093/eurheartj/eht296; MULLER DWM, 1992, AM J CARDIOL, V69, P63, DOI 10.1016/0002-9149(92)90677-Q; Myers J, 2002, NEW ENGL J MED, V346, P793, DOI 10.1056/NEJMoa011858; Patel MR, 2010, NEW ENGL J MED, V362, P886, DOI 10.1056/NEJMoa0907272; Patel MR, 2009, CIRCULATION, V119, P1330, DOI 10.1161/CIRCULATIONAHA.108.191768; POPMA JJ, 1993, CIRCULATION, V88, P1569, DOI 10.1161/01.CIR.88.4.1569; Shaw LJ, 1999, J AM COLL CARDIOL, V33, P661, DOI 10.1016/S0735-1097(98)00606-8; Skinner JS, 2010, HEART, V96, P974, DOI 10.1136/hrt.2009.190066; Stone NJ, 2014, J AM COLL CARDIOL, V63, P2889, DOI 10.1016/j.jacc.2013.11.002; TOPOL EJ, 1993, CIRCULATION, V87, P1489, DOI 10.1161/01.CIR.87.5.1489; Yu Meng-yue, 2003, Zhonghua Yi Xue Za Zhi, V83, P91	23	15	15	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2015	10	2							e0117172	10.1371/journal.pone.0117172	http://dx.doi.org/10.1371/journal.pone.0117172			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC2ZH	25719869	Green Published, gold, Green Accepted			2022-12-27	WOS:000350213200016
J	Maibeche, Y; Moali, A; Yahi, N; Menard, N				Maibeche, Yasmina; Moali, Aissa; Yahi, Nassima; Menard, Nelly			Is Diet Flexibility an Adaptive Life Trait for Relictual and Peri-Urban Populations of the Endangered Primate Macaca sylvanus?	PLOS ONE			English	Article							BABOONS PAPIO-URSINUS; BARBARY MACAQUES; NATIONAL-PARK; FOOD RESOURCES; FOREST FRAGMENTATION; ALGERIAN HABITATS; ECOLOGICAL TRAPS; SPATIAL OVERLAP; OLIVE BABOONS; GORILLA DIET	Habitat loss, fragmentation and urban expansion may drive some species to marginal habitats while others succeed in exploiting urban areas. Species that show dietary flexibility are more able to take advantage of human activities to supplement their diet with anthropogenically abundant and accessible resources. The Barbary macaque (Macaca sylvanus) is an endangered species due to the loss of its habitat, and human pressure. The population of Gouraya National Park (Algeria) lives in a relictual habitat that constitutes about 0.6% of the species range. In addition, this population is a unique case where urban expansion favours contact zones between Barbary macaque habitats and a big city (Bejaia). We quantified the dietary composition of Gouraya macaques over an annual cycle with the objective to understand how diet flexibility of this species may help it adapt to a relictual habitat or cope with urban expansion. We recorded the phenology of plant species every month. This study shows that Gouraya macaques, compared to those living in other forest types of the distribution area, are under lower seasonal constraints. They consume a greater amount of fruit and seeds that are available throughout much of the year, and a lesser amount of costly to find and extract subterranean foods. Therefore the Gouraya relictual habitat appears as a favourable environment compared to other major habitats of that species. This study also shows that colonizing peri-urban zones increases the availability and species richness of diet resources for Barbary macaques as they consume more human foods and exotic plants than in farther sites. Adult males eat more human foods than adult females and immatures do. The exploitation of high-energy anthropogenic food could favour macaque population growth and expansion towards the city center associated with human/macaque conflicts. We recommend applying management actions to restore macaques back to their natural habitat.	[Maibeche, Yasmina; Moali, Aissa] Univ Abderahmane Mira, Fac Nat Sci & Life, Lab Ecol & Environm, Bejaia, Algeria; [Yahi, Nassima] Univ Sci & Technol Houari Boumediene, Lab Vegetal Ecol, Fac Biol Sci, Algiers, Algeria; [Menard, Nelly] Univ Rennes 1, CNRS, Lab Ecosyst Biodivers Evolut, Stn Biol Paimpont,UMR 6553, Paimpont, France	Universite de Bejaia; University Science & Technology Houari Boumediene; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Universite de Rennes	Menard, N (corresponding author), Univ Rennes 1, CNRS, Lab Ecosyst Biodivers Evolut, Stn Biol Paimpont,UMR 6553, Paimpont, France.	nelly.menard@univ-rennes1.fr	MENARD, Nelly/L-2214-2018	MENARD, Nelly/0000-0003-4122-9330	CNRS (France)/Ministsore de l'Enseignement Superieur et de la Recherche Scientifique-University of Bejaia (Algeria) [3378]	CNRS (France)/Ministsore de l'Enseignement Superieur et de la Recherche Scientifique-University of Bejaia (Algeria)	This research was funded by the research project: "Programme International de Cooperation Scientifique" CNRS (France)/Ministsore de l'Enseignement Superieur et de la Recherche Scientifique-University of Bejaia (Algeria): PICS No 3378, with N. Menard and A. Moali as French and Algerian scientific leaders, respectively. The funders had no role in study design, data collection or analysis, decision to publish, or preparation of the manuscript.	Abbas F, 2011, OECOLOGIA, V167, P401, DOI 10.1007/s00442-011-1994-0; ALTMANN J, 1974, BEHAVIOUR, V49, P227, DOI 10.1163/156853974X00534; Antonovics J, 2006, AM NAT, V167, P16, DOI 10.1086/498539; Baker PJ, 2007, MAMMAL REV, V37, P297, DOI 10.1111/j.1365-2907.2007.00102.x; Bateman PW, 2012, J ZOOL, V287, P1, DOI 10.1111/j.1469-7998.2011.00887.x; Battin J, 2004, CONSERV BIOL, V18, P1482, DOI 10.1111/j.1523-1739.2004.00417.x; Boal CW, 1999, J WILDLIFE MANAGE, V63, P77, DOI 10.2307/3802488; BUTET A, 2006, LANDSCAPE ECOL, V21, P449; Carpenter Len H., 2000, Human Dimensions of Wildlife, V5, P5; CHAO A, 1987, BIOMETRICS, V43, P783, DOI 10.2307/2531532; Clergeau P, 2011, WILDLIFE BIOL, V17, P248, DOI 10.2981/09-092; Colwell RK, 2013, ESTIMATES STAT ESTIM; Cortes J., 2006, P199; Croci S, 2008, CONDOR, V110, P223, DOI 10.1525/cond.2008.8409; Croci S, 2007, BIODIVERS CONSERV, V16, P511, DOI 10.1007/s10531-006-6732-2; Dela JDS, 2012, INT J PRIMATOL, V33, P40, DOI 10.1007/s10764-011-9538-3; DeStefano S, 2003, FRONT ECOL ENVIRON, V1, P95, DOI 10.1890/1540-9295(2003)001[0095:ETEOSW]2.0.CO;2; Devictor V, 2008, OIKOS, V117, P507, DOI 10.1111/j.2008.0030-1299.16215.x; Dickman AJ, 2010, ANIM CONSERV, V13, P458, DOI 10.1111/j.1469-1795.2010.00368.x; Donati G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019807; Doran DM, 2002, AM J PRIMATOL, V58, P91, DOI 10.1002/ajp.10053; Duarte MHL, 2011, INT J PRIMATOL, V32, P329, DOI 10.1007/s10764-010-9468-5; Estrada A, 2012, AM J PRIMATOL, V74, P696, DOI 10.1002/ajp.22033; FA JE, 1984, INT J PRIMATOL, V5, P273, DOI 10.1007/BF02735762; Fahrig L, 2003, ANNU REV ECOL EVOL S, V34, P487, DOI 10.1146/annurev.ecolsys.34.011802.132419; Fuentes A, 2008, AM J PRIMATOL, V70, P879, DOI 10.1002/ajp.20575; Fuentes A, 2006, AM J PRIMATOL, V68, P880, DOI 10.1002/ajp.20295; Gilroy JJ, 2007, TRENDS ECOL EVOL, V22, P351, DOI 10.1016/j.tree.2007.03.014; Haupt M, 2006, J MAMMAL, V87, P351, DOI 10.1644/05-MAMM-A-193R1.1; Higham JP, 2009, AM J PRIMATOL, V71, P293, DOI 10.1002/ajp.20651; Hill CM, 2010, AM J PRIMATOL, V72, P919, DOI 10.1002/ajp.20845; Hill RA, 2002, EVOL ECOL, V16, P579, DOI 10.1023/A:1021625003597; Hoffman TS, 2012, ECOL SOC, V17, DOI 10.5751/ES-04882-170313; Hoffman TS, 2011, INT J PRIMATOL, V32, P308, DOI 10.1007/s10764-010-9467-6; Hsu MJ, 2009, AM J PRIMATOL, V71, P214, DOI 10.1002/ajp.20638; IUCN, 2013, IUCN RED LIST; Jaman MF, 2013, PRIMATES, V54, P49, DOI 10.1007/s10329-012-0330-6; Jones-Engel L, 2004, AM J PRIMATOL, V62, P71, DOI 10.1002/ajp.20008; Kaplan BS, 2011, INT J PRIMATOL, V32, P1397, DOI 10.1007/s10764-011-9541-8; Kawecki TJ, 2008, ANNU REV ECOL EVOL S, V39, P321, DOI 10.1146/annurev.ecolsys.38.091206.095622; Kristan WB, 2003, OIKOS, V103, P457; Kumara HN, 2010, CURR SCI INDIA, V99, P663; Mangalam M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0085497; McKinney ML, 2006, BIOL CONSERV, V127, P247, DOI 10.1016/j.biocon.2005.09.005; MEHLMAN PT, 1988, J ZOOL, V214, P469, DOI 10.1111/j.1469-7998.1988.tb03754.x; MENARD N, 1986, REV ECOL-TERRE VIE, V41, P173; Menard N., 1996, P106; Menard N, 2014, ANIM CONSERV, V17, P115, DOI 10.1111/acv.12063; MENARD N, 1988, REV ECOL-TERRE VIE, V43, P201; Menard N, 2002, EVOL ANTHROPOL, V11, P95, DOI 10.1002/evan.10067; Menard N, 1997, AM J PRIMATOL, V43, P285; MENARD N, 1985, REV ECOL-TERRE VIE, V40, P351; MENARD N, 1993, AM J PRIMATOL, V30, P101, DOI 10.1002/ajp.1350300203; MENARD N, 1993, INT J PRIMATOL, V14, P479, DOI 10.1007/BF02192778; Menard N, 2014, ORYX, V48, P276, DOI 10.1017/S0030605312000312; Menard N, 2014, AM J PRIMATOL, V76, P679, DOI 10.1002/ajp.22262; Menard N, 2013, PRIMATES, V54, P217, DOI 10.1007/s10329-013-0350-x; Miller JR, 2002, CONSERV BIOL, V16, P330, DOI 10.1046/j.1523-1739.2002.00420.x; Mittermeier R. A., 2009, PRIMATES PERIL WORLD; Newsome TM, 2015, GLOBAL ECOL BIOGEOGR, V24, P1, DOI 10.1111/geb.12236; Nijman V, 2010, INT J PEST MANAGE, V56, P153, DOI 10.1080/09670870903248850; Nijman V, 2012, INT J PRIMATOL, V33, P743, DOI 10.1007/s10764-012-9609-0; OLEARY H, 1993, FOLIA PRIMATOL, V61, P77, DOI 10.1159/000156733; Onderdonk DA, 2000, INT J PRIMATOL, V21, P587, DOI 10.1023/A:1005509119693; Parker L., 2008, Endangered Species Research, V5, P29, DOI 10.3354/esr00107; Quezel P., 1963, NOUVELLE FLORE ALGER; Quezel P, 1962, NOUVELLE FLORE ALGE; R Development Core Team, 2010, LANG ENV STAT COMP R; Radeloff VC, 2005, ECOL APPL, V15, P799, DOI 10.1890/04-1413; Rebbas K, 2011, REV ECOL-TERRE VIE, V66, P267; RICHARD AF, 1989, INT J PRIMATOL, V10, P569, DOI 10.1007/BF02739365; Riley EP, 2007, INT J PRIMATOL, V28, P107, DOI 10.1007/s10764-006-9104-6; Rogers ME, 2004, AM J PRIMATOL, V64, P173, DOI 10.1002/ajp.20071; Romeo C, 2010, ACTA OECOL, V36, P604, DOI 10.1016/j.actao.2010.09.005; Rossi J. P., 2011, Diversity, V3, P112, DOI 10.3390/d3010112; Rutz C, 2008, J ANIM ECOL, V77, P1008, DOI 10.1111/j.1365-2656.2008.01420.x; Sabbatini G, 2008, BRAZ J BIOL, V68, P685, DOI 10.1590/S1519-69842008000400002; SCHOENER TW, 1970, ECOLOGY, V51, P408, DOI 10.2307/1935376; Seltmann A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067285; Sha JCM, 2013, AM J PRIMATOL, V75, P581, DOI 10.1002/ajp.22137; Sha JCM, 2009, BIODIVERS CONSERV, V18, P2909, DOI 10.1007/s10531-009-9616-4; SINGH M, 1990, PRIMATES, V31, P589, DOI 10.1007/BF02382542; TAUB DM, 1977, FOLIA PRIMATOL, V27, P108; Teixeira FZ, 2013, BIOTA NEOTROP, V13, P117, DOI 10.1590/S1676-06032013000100013; van Doorn AC, 2010, AM J PRIMATOL, V72, P104, DOI 10.1002/ajp.20759; WALLACE RK, 1981, T AM FISH SOC, V110, P72, DOI 10.1577/1548-8659(1981)110&lt;72:AAODI&gt;2.0.CO;2; Warren Y, 2011, DEV PRIMATOL-PROG PR, P307, DOI 10.1007/978-1-4419-7403-7_8; Yahi N., 2012, Journal of Threatened Taxa, V4, P2753; Yahi N, 2010, IMPORTANT PLANT AREA, P27	89	23	24	0	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2015	10	2							e0118596	10.1371/journal.pone.0118596	http://dx.doi.org/10.1371/journal.pone.0118596			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC2IM	25714476	Green Published, gold, Green Submitted			2022-12-27	WOS:000350168700091
J	Yao, MT; Werners, SE; Hutjes, RWA; Kabat, P; Huang, HQ				Yao, Mingtian; Werners, Saskia E.; Hutjes, Ronald W. A.; Kabat, Pavel; Huang, Heqing			Sectorial Water Use Trends in the Urbanizing Pearl River Delta, China	PLOS ONE			English	Article							CLIMATE-CHANGE; DEMAND MODEL; DRAINAGE; IMPACTS; GROWTH	Assessing and managing water use is crucial for supporting sustainable river basin management and regional development. The first consistent and comprehensive assessment of sectorial water use in the Pearl River Delta (PRD) is presented by analysing homogenized annual water use data from 2000 to 2010 in relation to socio economic statistics for the same period. An abstraction of water use, using the concept of water use intensity, and based on equations inspired by those used in global water resource models, is developed to explore the driving forces underlying water use changes in domestic, industrial and agricultural sectors. We do this at both the level of the region as a whole, as well as for the nine cities that constitute the PRD separately. We find that, despite strong population and economic growth, the PRD managed to stabilize its absolute water use by significant improvements in industrial water use intensities, and early stabilisation of domestic water use intensities. Results reveal large internal differentiation of sectorial water use among the cities in this region, with industrial water use intensity varying from -80 to + 95% and domestic water use intensity by +/- 30% compared to the PRD average. In general, per capita water use is highest in the cities that industrialised first. Yet, all cities except Guangzhou are expected to approach a saturation value of per capita water use much below what is suggested in recent global studies. Therefore, existing global assessments probably have overestimated future domestic water use in developing countries. Although scarce and uncertain input data and model limitations lead to a high level of uncertainty, the presented conceptualization of water use is useful in exploring the underlying driving forces of water use trends.	[Yao, Mingtian; Hutjes, Ronald W. A.] Wageningen Univ, Earth Syst Sci, NL-6700 AP Wageningen, Netherlands; [Werners, Saskia E.] Univ Wageningen & Res Ctr, Alterra, Wageningen, Netherlands; [Kabat, Pavel] Int Inst Appl Syst Anal, A-2361 Laxenburg, Austria; [Huang, Heqing] Chinese Acad Sci, Inst Geog Sci & Nat Resources Res, Key Lab Water Cycle & Related Land Surface Proc, Beijing, Peoples R China	Wageningen University & Research; Wageningen University & Research; International Institute for Applied Systems Analysis (IIASA); Chinese Academy of Sciences; Institute of Geographic Sciences & Natural Resources Research, CAS	Yao, MT (corresponding author), Wageningen Univ, Earth Syst Sci, NL-6700 AP Wageningen, Netherlands.	mingtian.yao@wur.nl	Kabat, Pavel/AAJ-2245-2020; , Huang/GWN-1843-2022	werners, saskia/0000-0002-1705-4318	"Working with Water: adaptive land use and water management in the Pearl River Delta under climate change and sea level rise" - Joint Scientific Thematic Research Programme of the Royal Netherlands Organization for Scientific Research (NWO) [842.00.002]; Chinese Academy of Sciences (CAS) as the External Cooperation Program of Chinese Academy of Science [GJHZ1019]; ICER [1311121] Funding Source: National Science Foundation	"Working with Water: adaptive land use and water management in the Pearl River Delta under climate change and sea level rise" - Joint Scientific Thematic Research Programme of the Royal Netherlands Organization for Scientific Research (NWO); Chinese Academy of Sciences (CAS) as the External Cooperation Program of Chinese Academy of Science; ICER(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	This work was supported by the project "Working with Water: adaptive land use and water management in the Pearl River Delta under climate change and sea level rise" funded by Joint Scientific Thematic Research Programme of the Royal Netherlands Organization for Scientific Research (NWO) under contract number 842.00.002 and The Chinese Academy of Sciences (CAS) as the External Cooperation Program of Chinese Academy of Science no. GJHZ1019. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcamo J, 2003, HYDROLOG SCI J, V48, P317, DOI 10.1623/hysj.48.3.317.45290; Alcamo J, 2003, HYDROLOG SCI J, V48, P339, DOI 10.1623/hysj.48.3.339.45278; Allen R. G., 1998, FAO Irrigation and Drainage Paper; Arbues F., 2003, J SOC EC, V32, P81, DOI 10.1016/S1053-5357(03)00005-2; Bondeau A, 2007, GLOBAL CHANGE BIOL, V13, P679, DOI 10.1111/j.1365-2486.2006.01305.x; Cai XM, 2002, WATER INT, V27, P159, DOI 10.1080/02508060208686989; Chapagain AK, 2008, WATER INT, V33, P19, DOI 10.1080/02508060801927812; Chen H, 2009, COMMUN NONLINEAR SCI, V14, P2462, DOI 10.1016/j.cnsns.2007.12.013; Chen J, 2007, MODSIM 2007: INTERNATIONAL CONGRESS ON MODELLING AND SIMULATION, P1985; CHEN Q, 2006, CHINA WATER WASTEWAT, V22; Chen YD, 2009, RIVER RES APPL, V25, P1153, DOI 10.1002/rra.1212; Chu JY, 2009, WATER RESOUR MANAG, V23, P3267, DOI 10.1007/s11269-009-9433-2; Clarke GP, 1997, J CHART INST WATER E, V11, P186; Doll P, 2002, WATER INT, V27, P310, DOI 10.1080/02508060208687011; Flu┬rke M., 2004, EEARNC03007 U KASS C; Fthenakis V, 2010, RENEW SUST ENERG REV, V14, P2039, DOI 10.1016/j.rser.2010.03.008; Gleick PH, 1996, WATER INT, V21, P83, DOI 10.1080/02508069608686494; Gottmann J., 1964, MEGALOPOLIS THE URBA; Groffman PM, 2003, FRONT ECOL ENVIRON, V1, P315, DOI 10.2307/3868092; Guneralp B, 2008, GLOBAL ENVIRON CHANG, V18, P720, DOI 10.1016/j.gloenvcha.2008.07.004; Hall P. G., 2006, POLYCENTRIC METROPOL, DOI DOI 10.4324/9781849773911; Hatt BE, 2004, ENVIRON MANAGE, V34, P112, DOI 10.1007/s00267-004-0221-8; He G, 2006, J CHINA HYDROLOGY, V26; Huang ZG, 2004, NAT HAZARDS, V33, P247, DOI 10.1023/B:NHAZ.0000037038.18814.b0; Inhaber H, 2004, ENERG SOURCE, V26, P309, DOI 10.1080/00908310490266698; Jachner S, 2007, MUCH WATER IS USED G; Kaufmann RK, 2007, J CLIMATE, V20, P2299, DOI 10.1175/JCLI4109.1; Lemos D, 2013, J CLEAN PROD, V54, P157, DOI 10.1016/j.jclepro.2013.04.029; Loubet P, 2013, ENVIRON SCI TECHNOL, V47, P14242, DOI 10.1021/es403056x; Mimi Z, 2000, WATER INT, V25, P464, DOI 10.1080/02508060008686854; Paul MJ, 2001, ANNU REV ECOL SYST, V32, P333, DOI 10.1146/annurev.ecolsys.32.081501.114040; Poelmans L, 2010, LAND USE POLICY, V27, P965, DOI 10.1016/j.landusepol.2009.12.010; PRWRC, 2011, PEARL RIV WAT RES B; Seckler D., 1998, Research Report - International Irrigation Management Institute; Semadeni-Davies A, 2008, J HYDROL, V350, P100, DOI 10.1016/j.jhydrol.2007.05.028; Seto KC, 2002, INT J REMOTE SENS, V23, P1985, DOI 10.1080/01431160110075532; Shandas V, 2012, J WATER CLIM CHANGE, V3, P225, DOI 10.2166/wcc.2011.024; Shiklomanov IA, 2000, WATER INT, V25, P11, DOI 10.1080/02508060008686794; Solley W.B., 1998, ESTIMATED USE WATER; Torcellini P. A., 2003, CONSUMPTIVE WATER US; Tu XJ, 2012, STOCH ENV RES RISK A, V26, P823, DOI 10.1007/s00477-011-0516-2; Voss F, 2009, 17 WATCH; Voss F, 2010, SPATIALLY EXPLICIT E, P23; Walsh CJ, 2005, J N AM BENTHOL SOC, V24, P706, DOI 10.1899/04-020.1; Watkins K, 2006, HUM DEV REP 2006 SCA; Weidema B.P., 1996, J CLEAN PROD, V4, P167, DOI [10.1016/S0959-6526(96)00043-1, DOI 10.1016/S0959-6526(96)00043-1]; Xiong Y, 2005, J WATER RESOURCES WA, V16; Zhu Z, 2002, RESOURCES SCI, V24; Zhu ZY, 2004, J AM WATER WORKS ASS, V96, P159; Zhu ZY, 2002, AMBIO, V31, P226, DOI 10.1579/0044-7447-31.3.226	50	8	8	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2015	10	2							e0115039	10.1371/journal.pone.0115039	http://dx.doi.org/10.1371/journal.pone.0115039			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC2IM	25714731	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000350168700003
J	Berghauzen-Maciejewska, K; Wardas, J; Kosmowska, B; Glowacka, U; Kuter, K; Ossowska, K				Berghauzen-Maciejewska, Klemencja; Wardas, Jadwiga; Kosmowska, Barbara; Glowacka, Urszula; Kuter, Katarzyna; Ossowska, Krystyna			Alterations of BDNF and trkB mRNA Expression in the 6-Hydroxydopamine-Induced Model of Preclinical Stages of Parkinson's Disease: An Influence of Chronic Pramipexole in Rats	PLOS ONE			English	Article							NEUROTROPHIC FACTOR BDNF; UNPREDICTABLE MILD STRESS; DEPRESSIVE-LIKE BEHAVIOR; DEEP BRAIN-STIMULATION; DENTATE GYRUS; LATERAL HABENULA; LEARNED HELPLESSNESS; DOPAMINERGIC-NEURONS; CELL-PROLIFERATION; SUBSTANTIA-NIGRA	Our recent study has indicated that a moderate lesion of the mesostriatal and mesolimbic pathways in rats, modelling preclinical stages of Parkinson's disease, induces a depressive-like behaviour which is reversed by chronic treatment with pramipexole. The purpose of the present study was to examine the role of brain derived neurotrophic factor (BDNF) signalling in the aforementioned model of depression. Therefore, we investigated the influence of 6-hydoxydopamine (6-OHDA) administration into the ventral region of the caudate-putamen on mRNA levels of BDNF and tropomyosin-related kinase B (trkB) receptor. The BDNF and trkB mRNA levels were determined in the nigrostriatal and limbic structures by in situ hybridization 2 weeks after the operation. Pramipexole (1 mg/kg sc twice a day) and imipramine (10 mg/kg ip once a day) were injected for 2 weeks. The lesion lowered the BDNF and trkB mRNA levels in the hippocampus [CA1, CA3 and dentate gyrus (DG)] and amygdala (basolateral/lateral) as well as the BDNF mRNA content in the habenula (medial/lateral). The lesion did not influence BDNF and trkB expression in the caudate-putamen, substantia nigra, nucleus accumbens (shell and core) and ventral tegmental area (VTA). Chronic imipramine reversed the lesion-induced decreases in BDNF mRNA in the DG. Chronic pramipexole increased BDNF mRNA, but decreased trkB mRNA in the VTA in lesioned rats. Furthermore, it reduced BDNF and trkB mRNA expression in the shell and core of the nucleus accumbens, BDNF mRNA in the amygdala and trkB mRNA in the caudate-putamen in these animals. The present study indicates that both the 6-OHDA-induced dopaminergic lesion and chronic pramipexole influence BDNF signalling in limbic structures, which may be related to their pro-depressive and antidepressant activity in rats, respectively.	[Berghauzen-Maciejewska, Klemencja; Wardas, Jadwiga; Kosmowska, Barbara; Glowacka, Urszula; Kuter, Katarzyna; Ossowska, Krystyna] Polish Acad Sci, Inst Pharmacol, Dept Neuropsychopharmacol, PL-31343 Krakow, Poland	Polish Academy of Sciences	Berghauzen-Maciejewska, K (corresponding author), Polish Acad Sci, Inst Pharmacol, Dept Neuropsychopharmacol, 12 Smetna St, PL-31343 Krakow, Poland.	klemberg@if-pan.krakow.pl	Kosmowska, Barbara/ADS-2341-2022; Kosmowska, Barbara/R-7972-2016	Wardas, Jadwiga/0000-0002-0208-1946; Berghauzen-Maciejewska, Klemencja/0000-0001-7969-8517; Kuter, Katarzyna/0000-0001-8210-6447; Ossowska, Krystyna/0000-0002-8381-6632; Kosmowska, Barbara/0000-0003-4581-6196; Glowacka, Urszula/0000-0002-1552-3117	project "Depression-Mechanisms-Therapy" [POIG.01.01.02-12-004/09-00]; EU from the European Regional Development Fund as a part of the Operative Programme "Innovative Economy"; KNOW - Ministry of Science and Higher Education, Republic of Poland	project "Depression-Mechanisms-Therapy"; EU from the European Regional Development Fund as a part of the Operative Programme "Innovative Economy"; KNOW - Ministry of Science and Higher Education, Republic of Poland	The study was supported by the project "Depression-Mechanisms-Therapy" (POIG.01.01.02-12-004/09-00) co-financed by the EU from the European Regional Development Fund as a part of the Operative Programme "Innovative Economy 2007-2013". Klemencja Berghauzen-Maciejewska is a holder of scholarship from the KNOW sponsored by Ministry of Science and Higher Education, Republic of Poland. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarsland D, 2012, NAT REV NEUROL, V8, P35, DOI 10.1038/nrneurol.2011.189; Aydemir O, 2005, PROG NEURO-PSYCHOPH, V29, P261, DOI 10.1016/j.pnpbp.2004.11.009; AZMITIA EC, 1978, J COMP NEUROL, V179, P641, DOI 10.1002/cne.901790311; BECKSTEAD RM, 1979, BRAIN RES, V175, P191, DOI 10.1016/0006-8993(79)91001-1; Berghauzen-Maciejewska K, 2014, BEHAV BRAIN RES, V271, P343, DOI 10.1016/j.bbr.2014.06.029; Berton O, 2006, SCIENCE, V311, P864, DOI 10.1126/science.1120972; Bessa JM, 2013, TRANSL PSYCHIAT, V3, DOI 10.1038/tp.2013.39; Bonito-Oliva A, 2014, BIOL PSYCHIAT, V75, P701, DOI 10.1016/j.biopsych.2013.02.015; Byrum CE, 1999, PROG NEURO-PSYCHOPH, V23, P175, DOI 10.1016/S0278-5846(98)00106-7; Castren E, 2007, CURR OPIN PHARMACOL, V7, P18, DOI 10.1016/j.coph.2006.08.009; Castren E, 2010, DEV NEUROBIOL, V70, P289, DOI 10.1002/dneu.20758; Chen B, 2001, BIOL PSYCHIAT, V50, P260, DOI 10.1016/S0006-3223(01)01083-6; Collier TJ, 2005, EXP NEUROL, V191, pS60, DOI 10.1016/j.expneurol.2004.08.018; Conner JM, 1997, J NEUROSCI, V17, P2295; Du F, 2005, EUR J NEUROSCI, V22, P2422, DOI 10.1111/j.1460-9568.2005.04438.x; Duman RS, 2006, BIOL PSYCHIAT, V59, P1116, DOI 10.1016/j.biopsych.2006.02.013; Duman RS, 2005, NEUROBIOL AGING, V26, pS88, DOI 10.1016/j.neurobiolaging.2005.08.018; Duman RS, 1997, ARCH GEN PSYCHIAT, V54, P597; Duman RS, 2004, NEUROMOL MED, V5, P11, DOI 10.1385/NMM:5:1:011; Dwivedi Y, 2003, ARCH GEN PSYCHIAT, V60, P804, DOI 10.1001/archpsyc.60.8.804; Eisch AJ, 2003, BIOL PSYCHIAT, V54, P994, DOI 10.1016/j.biopsych.2003.08.003; Fanous S, 2010, NEUROSCIENCE, V167, P598, DOI 10.1016/j.neuroscience.2010.02.064; Favier M, 2014, MOVEMENT DISORD, V29, P912, DOI 10.1002/mds.25837; Gervasoni N, 2005, NEUROPSYCHOBIOLOGY, V51, P234, DOI 10.1159/000085725; Gonul AS, 2005, EUR ARCH PSY CLIN N, V255, P381, DOI 10.1007/s00406-005-0578-6; Govindarajan A, 2006, P NATL ACAD SCI USA, V103, P13208, DOI 10.1073/pnas.0605180103; Gronli J, 2006, PHARMACOL BIOCHEM BE, V85, P842, DOI 10.1016/j.pbb.2006.11.021; Guilloux JP, 2012, MOL PSYCHIATR, V17, P1130, DOI 10.1038/mp.2011.113; Hoglinger GU, 2004, NAT NEUROSCI, V7, P726, DOI 10.1038/nn1265; Howells DW, 2000, EXP NEUROL, V166, P127, DOI 10.1006/exnr.2000.7483; Hoyer C, 2012, NEUROPSYCHOBIOLOGY, V65, P147, DOI 10.1159/000335243; Karege F, 2005, MOL BRAIN RES, V136, P29, DOI 10.1016/j.molbrainres.2004.12.020; Karege F, 2002, PSYCHIAT RES, V109, P143, DOI 10.1016/S0165-1781(02)00005-7; Knott C, 2002, PARKINSONISM RELAT D, V8, P329, DOI 10.1016/S1353-8020(02)00008-1; Krishnan V, 2007, CELL, V131, P391, DOI 10.1016/j.cell.2007.09.018; Kuter K, 2011, PHARMACOL REP, V63, P1383; Lakshminarasimhan H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030481; Larsen MH, 2008, EUR J PHARMACOL, V578, P114, DOI 10.1016/j.ejphar.2007.08.050; Larsen MH, 2010, J PSYCHIATR RES, V44, P808, DOI 10.1016/j.jpsychires.2010.01.005; Lecca S, 2014, EUR J NEUROSCI, V39, P1170, DOI 10.1111/ejn.12480; LeDoux J, 2007, CURR BIOL, V17, pR868, DOI 10.1016/j.cub.2007.08.005; Li B, 2011, NATURE, V470, P535, DOI 10.1038/nature09742; Liu DX, 2014, BEHAV BRAIN RES, V264, P9, DOI 10.1016/j.bbr.2014.01.039; Lobo MK, 2010, SCIENCE, V330, P385, DOI 10.1126/science.1188472; Luo JX, 2013, BEHAV BRAIN RES, V253, P48, DOI 10.1016/j.bbr.2013.07.014; MANDELL AJ, 1961, CALIF MED, V95, P12; Manji HK, 2003, BIOL PSYCHIAT, V53, P707, DOI 10.1016/S0006-3223(03)00117-3; Mao QQ, 2014, BEHAV BRAIN RES, V261, P140, DOI 10.1016/j.bbr.2013.12.020; Mcchetti I, 2007, NEUROTOX RES, V12, P135, DOI 10.1007/BF03033922; McEwen BS, 2001, ANN NY ACAD SCI, V933, P265, DOI 10.1111/j.1749-6632.2001.tb05830.x; McEwen BS, 2005, METABOLISM, V54, P20, DOI 10.1016/j.metabol.2005.01.008; Mogi M, 1999, NEUROSCI LETT, V270, P45, DOI 10.1016/S0304-3940(99)00463-2; Murakami S, 2005, NEUROSCI RES, V53, P129, DOI 10.1016/j.neures.2005.06.008; Nestler EJ, 2002, NEURON, V34, P13, DOI 10.1016/S0896-6273(02)00653-0; NIBUYA M, 1995, J NEUROSCI, V15, P7539; Numan S, 1997, EUR J NEUROSCI, V9, P489, DOI 10.1111/j.1460-9568.1997.tb01626.x; OADES RD, 1987, BRAIN RES REV, V12, P117, DOI 10.1016/0165-0173(87)90011-7; Parain K, 1999, NEUROREPORT, V10, P557, DOI 10.1097/00001756-199902250-00021; Paxinos G, 2007, RAT BRAIN STEREOTAXI, DOI [10.1093/jxb/erm028, DOI 10.1093/JXB/ERM028]; Pelled G, 2007, J MAGN RESON IMAGING, V26, P863, DOI 10.1002/jmri.21051; Pendolino V, 2014, EXP NEUROL, V261, P377, DOI 10.1016/j.expneurol.2014.07.006; Peyron C, 1996, J COMP NEUROL, V364, P402; Pierucci M, 2009, ANN NY ACAD SCI, V1155, P316, DOI 10.1111/j.1749-6632.2008.03679.x; Prinz A, 2013, EXP NEUROL, V248, P236, DOI 10.1016/j.expneurol.2013.06.015; Rasmusson AM, 2002, NEUROPSYCHOPHARMACOL, V27, P133, DOI 10.1016/S0893-133X(02)00286-5; Reus GZ, 2013, BEHAV BRAIN RES, V242, P40, DOI 10.1016/j.bbr.2012.11.044; Reus GZ, 2011, NEUROCHEM RES, V36, P460, DOI 10.1007/s11064-010-0364-3; Rogoz Z, 2007, J PHYSIOL PHARMACOL, V58, P219; SAKAI K, 1977, BRAIN RES, V137, P11, DOI 10.1016/0006-8993(77)91010-1; Sartorius A, 2007, MED HYPOTHESES, V69, P1305, DOI 10.1016/j.mehy.2007.03.021; Savitz J, 2010, NEUROIMAGE, V49, P2966, DOI 10.1016/j.neuroimage.2009.11.025; Seppi K, 2011, MOVEMENT DISORD, V26, pS42, DOI 10.1002/mds.23884; SEROOGY KB, 1994, J COMP NEUROL, V342, P321, DOI 10.1002/cne.903420302; Shabel SJ, 2012, NEURON, V74, P475, DOI 10.1016/j.neuron.2012.02.037; Shimizu E, 2003, BIOL PSYCHIAT, V54, P70, DOI 10.1016/S0006-3223(03)00181-1; Shirayama Y, 2002, J NEUROSCI, V22, P3251, DOI 10.1523/JNEUROSCI.22-08-03251.2002; Smith JP, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00121; SMITH MA, 1995, J NEUROSCI, V15, P1768, DOI 10.1523/JNEUROSCI.15-03-01768.1995; Song L, 2006, PHARMACOL BIOCHEM BE, V83, P186, DOI 10.1016/j.pbb.2006.01.004; Sourani D, 2012, EUR J NEUROSCI, V36, P2822, DOI 10.1111/j.1460-9568.2012.08200.x; Stott SRW, 2014, EUR J NEUROSCI, V39, P1042, DOI 10.1111/ejn.12459; Sun XP, 2014, NEUROENDOCRINOL LETT, V35, P129; Suzuki K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009260; Vaidya VA, 1999, NEUROSCI LETT, V262, P1, DOI 10.1016/S0304-3940(99)00006-3; Vaidya VA, 1997, J NEUROSCI, V17, P2785; Van Hoomissen JD, 2003, BRAIN RES, V974, P228, DOI 10.1016/S0006-8993(03)02584-8; VENERO JL, 1994, NEUROREPORT, V5, P429, DOI 10.1097/00001756-199401120-00014; Vyas A, 2006, NEUROSCIENCE, V143, P387, DOI 10.1016/j.neuroscience.2006.08.003; Vyas A, 2004, NEUROSCIENCE, V128, P667, DOI 10.1016/j.neuroscience.2004.07.013; Walsh S, 2011, NEUROSCIENCE, V175, P251, DOI 10.1016/j.neuroscience.2010.12.005; Wang S, 2009, NEUROSCIENCE, V159, P850, DOI 10.1016/j.neuroscience.2008.12.051; WATANABE Y, 1992, BRAIN RES, V588, P341, DOI 10.1016/0006-8993(92)91597-8; Zhou JW, 2000, NEUROREPORT, V11, P3289, DOI 10.1097/00001756-200009280-00048	93	24	26	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2015	10	3							e0117698	10.1371/journal.pone.0117698	http://dx.doi.org/10.1371/journal.pone.0117698			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9JM	25739024	gold, Green Published, Green Submitted			2022-12-27	WOS:000350685900017
J	Cortes, V; Amigo, L; Zanlungo, S; Galgani, J; Robledo, F; Arrese, M; Bozinovic, F; Nervi, F				Cortes, Victor; Amigo, Ludwig; Zanlungo, Silvana; Galgani, Jose; Robledo, Fermin; Arrese, Marco; Bozinovic, Francisco; Nervi, Flavio			Metabolic Effects of Cholecystectomy: Gallbladder Ablation Increases Basal Metabolic Rate through G-Protein Coupled Bile Acid Receptor Gpbar1-Dependent Mechanisms in Mice	PLOS ONE			English	Article							BILIARY CHOLESTEROL SECRETION; ORGANIC SOLUTE TRANSPORTER; ALPHA-OST-BETA; ENERGY-METABOLISM; GALLSTONE DISEASE; TGR5; PLASMA; LIVER	Background & Aims Bile acids (BAs) regulate energy expenditure by activating G-protein Coupled Bile Acid Receptor Gpbar1/TGR5 by cAMP-dependent mechanisms. Cholecystectomy (XGB) increases BAs recirculation rates resulting in increased tissue exposure to BAs during the light phase of the diurnal cycle in mice. We aimed to determine: 1) the effects of XGB on basal metabolic rate (BMR) and 2) the roles of TGR5 on XGB-dependent changes in BMR. Methods BMR was determined by indirect calorimetry in wild type and Tgr5 deficient (Tgr5(-/-)) male mice. Bile flow and BAs secretion rates were measured by surgical diversion of biliary duct. Biliary BAs and cholesterol were quantified by enzymatic methods. BAs serum concentration and specific composition was determined by liquid chromatography/tandem mass spectrometry. Gene expression was determined by qPCR analysis. Results XGB increased biliary BAs and cholesterol secretion rates, and elevated serum BAs concentration in wild type and Tgr5(-/-) mice during the light phase of the diurnal cycle. BMR was similar to 25% higher in cholecystectomized wild type mice (p < 0.02), whereas no changes were detected in cholecystectomized Tgr5(-/-) mice compared to wild-type animals. Conclusion XGB increases BMR by TGR5-dependent mechanisms in mice.	[Amigo, Ludwig; Zanlungo, Silvana; Robledo, Fermin; Arrese, Marco; Nervi, Flavio] Pontificia Univ Catolica Chile, Dept Gastroenterol, Santiago, Chile; [Cortes, Victor; Galgani, Jose] Pontificia Univ Catolica Chile, Dept Nutr Diabet & Metab, Santiago, Chile; [Bozinovic, Francisco] Pontificia Univ Catolica Chile, Fac Med, CASEB, Santiago, Chile; [Bozinovic, Francisco] Pontificia Univ Catolica Chile, Fac Ciencias Biol, Dept Ecol, Santiago, Chile	Pontificia Universidad Catolica de Chile; Pontificia Universidad Catolica de Chile; Pontificia Universidad Catolica de Chile; Pontificia Universidad Catolica de Chile	Nervi, F (corresponding author), Pontificia Univ Catolica Chile, Dept Gastroenterol, Alameda 340, Santiago, Chile.	fnervi@med.puc.cl	ARRESE, MARCO/ABB-9061-2021	Zanlungo, Silvana/0000-0001-8383-9829; Cortes, Victor/0000-0002-1658-0965	FONDECYT (Fondo Nacional de Ciencia y Tecnologia) [1130146, 1141134, 1110455]	FONDECYT (Fondo Nacional de Ciencia y Tecnologia)(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT)	This work was supported by FONDECYT (Fondo Nacional de Ciencia y Tecnologia) Grants # 1130146 to FN, 1141134 to VC and 1110455 to MA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alnouti Y, 2008, J CHROMATOGR B, V873, P209, DOI 10.1016/j.jchromb.2008.08.018; Amigo L, 2011, LIVER INT, V31, P52, DOI 10.1111/j.1478-3231.2010.02361.x; Bjursell M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064721; Brufau G, 2010, HEPATOLOGY, V52, P1455, DOI 10.1002/hep.23831; Brufau G, 2010, NUTR METAB, V7, DOI 10.1186/1743-7075-7-73; Bunnett NW, 2014, J PHYSIOL-LONDON, V592, P2943, DOI 10.1113/jphysiol.2014.271155; Chavez-Tapia NC, 2012, ANN HEPATOL, V11, P85, DOI 10.1016/S1665-2681(19)31490-5; Chiang JYL, 2013, COMPR PHYSIOL, V3, P1191, DOI 10.1002/cphy.c120023; Dawson PA, 2014, J LIPID RES, V10; Dikkers A, 2010, WORLD J GASTROENTERO, V16, P5936, DOI 10.3748/wjg.v16.i47.5936; ERLINGER S, 1982, AM J PHYSIOL, V243, pG243, DOI 10.1152/ajpgi.1982.243.4.G243; Hulbert AJ, 2004, PHYSIOL BIOCHEM ZOOL, V77, P869, DOI 10.1086/422768; Hylemon PB, 2009, J LIPID RES, V50, P1509, DOI 10.1194/jlr.R900007-JLR200; Ioannou GN, 2010, AM J GASTROENTEROL, V105, P1364, DOI 10.1038/ajg.2009.737; Keitel V, 2011, DIGEST DIS, V29, P45, DOI 10.1159/000324127; KULLAKUBLICK GA, 1995, HEPATOLOGY, V21, P41, DOI 10.1016/0270-9139(95)90406-9; LEBOEUF RC, 1994, J LIPID RES, V35, P121; Lefebvre P, 2009, PHYSIOL REV, V89, P147, DOI 10.1152/physrev.00010.2008; Li TT, 2011, MOL ENDOCRINOL, V25, P1066, DOI 10.1210/me.2010-0460; Maruyama T, 2006, J ENDOCRINOL, V191, P197, DOI 10.1677/joe.1.06546; McNab BK, 1997, PHYSIOL ZOOL, V70, P718, DOI 10.1086/515881; NERVI F, 1988, J CLIN INVEST, V82, P1818, DOI 10.1172/JCI113797; Nervi F, 2013, AM J GASTROENTEROL, V108, P959, DOI 10.1038/ajg.2013.84; Nespolo Roberto F., 2003, Comparative Biochemistry and Physiology Part A Molecular & Integrative Physiology, V134A, P139, DOI 10.1016/S1095-6433(02)00220-9; PALOU A, 1981, HORM METAB RES, V13, P326, DOI 10.1055/s-2007-1019258; Pols TWH, 2011, J HEPATOL, V54, P1263, DOI 10.1016/j.jhep.2010.12.004; Poole DP, 2010, NEUROGASTROENT MOTIL, V22, DOI 10.1111/j.1365-2982.2010.01487.x; Rao A, 2008, P NATL ACAD SCI USA, V105, P3891, DOI 10.1073/pnas.0712328105; RODA E, 1978, GUT, V19, P640, DOI 10.1136/gut.19.7.640; Rolfe DFS, 1997, PHYSIOL REV, V77, P731, DOI 10.1152/physrev.1997.77.3.731; Ruhl CE, 2013, AM J GASTROENTEROL, V108, P952, DOI 10.1038/ajg.2013.70; Ruhl CE, 2011, GASTROENTEROLOGY, V140, P508, DOI 10.1053/j.gastro.2010.10.060; SHAFFER EA, 1977, J CLIN INVEST, V59, P828, DOI 10.1172/JCI108705; Shen C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088189; Soroka CJ, 2010, SEMIN LIVER DIS, V30, P178, DOI 10.1055/s-0030-1253226; Thomas C, 2009, CELL METAB, V10, P167, DOI 10.1016/j.cmet.2009.08.001; Trauner M, 2010, DIGEST DIS, V28, P220, DOI 10.1159/000282091; Vallim TQD, 2013, CELL METAB, V17, P657, DOI 10.1016/j.cmet.2013.03.013; VEERKAMP JH, 1986, BIOCHEM MED METAB B, V35, P248, DOI 10.1016/0885-4505(86)90080-0; VELOSO C, 1993, ECOLOGY, V74, P2003, DOI 10.2307/1940843; Watanabe M, 2006, NATURE, V439, P484, DOI 10.1038/nature04330; Watanabe M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038286; Watanabe M, 2011, J BIOL CHEM, V286, P26913, DOI 10.1074/jbc.M111.248203; Yu XH, 2014, CLIN CHIM ACTA, V428, P82, DOI 10.1016/j.cca.2013.11.010; Zanlungo S, 2004, CURR OPIN LIPIDOL, V15, P279, DOI 10.1097/00041433-200406000-00007	45	14	17	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2015	10	3							e0118478	10.1371/journal.pone.0118478	http://dx.doi.org/10.1371/journal.pone.0118478			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9JM	25738495	Green Published, gold, Green Submitted			2022-12-27	WOS:000350685900038
J	Kipp, AM; Audet, CM; Earnshaw, VA; Owens, J; McGowan, CC; Wallston, KA				Kipp, Aaron M.; Audet, Carolyn M.; Earnshaw, Valerie A.; Owens, Jared; McGowan, Catherine C.; Wallston, Kenneth A.			Re-Validation of the Van Rie HIV/AIDS-Related Stigma Scale for Use with People Living with HIV in the United States	PLOS ONE			English	Article							PSYCHOMETRIC ASSESSMENT; SOCIAL RELATIONSHIPS; PARALLEL SCALES; HEALTH; TUBERCULOSIS; METAANALYSIS; RELIABILITY; VALIDATION; ADHERENCE; VALIDITY	There is little consensus about which of the many validated human immunodeficiency virus (HIV) stigma scales should be regularly used, with few being re-validated in different contexts or evaluated for how they compare to other, existing HIV stigma scales. The purpose of this exploratory study was to re-validate the Van Rie HIV/AIDS-Related Stigma Scale, originally validated in Thailand and using a third-person wording structure, for use with people living with HIV in the United States. Adult HIV clinic patients completed a survey including the Berger and Van Rie scales, and measures of social support and depression. Eighty-five of 211 (40%) eligible participants provided data for both stigma scales. Exploratory factor analyses identified three factors to the Van Rie scale: Loss of Social Relationships (new subscale), Managing HIV Concealment (new subscale), and Perceived Community Stigma (original subscale). These subscales were moderately inter-related (r = 0.51 to 0.58) with acceptable to excellent reliability (Cronbach's alpha = 0.69 to 0.90). The Van Rie subscales were also moderately inter-correlated with the Berger subscales (r = 0.44 to 0.76), had similar construct validity, and tended to have higher mean stigma scores when compared with Berger subscales that were conceptually most similar. The revised Van Rie HIV-related Stigma Scale demonstrates good validity and internal consistency, offering a valid measure of HIV stigma with a three-factor structure. The third-person wording may be particularly suitable for measuring stigmatizing attitudes during an individual's transition from at-risk and undergoing HIV testing to newly diagnosed, a time when experiences of discrimination and processing issues of disclosure have not yet occurred. The stigma mechanisms for individuals making this transition have not been well explored. These scenarios, combined with the observed non-response to the Berger Enacted Stigma subscale items (a surprise finding), highlight gaps in our understanding of HIV stigma and how best to measure it.	[Kipp, Aaron M.] Vanderbilt Univ, Med Ctr, Div Epidemiol, Nashville, TN 37235 USA; [Kipp, Aaron M.; Audet, Carolyn M.] Vanderbilt Univ, Med Ctr, Vanderbilt Inst Global Hlth, Nashville, TN USA; [Audet, Carolyn M.] Vanderbilt Univ, Med Ctr, Dept Prevent Med, Nashville, TN USA; [Earnshaw, Valerie A.] Yale Univ, Ctr Interdisciplinary Res AIDS, New Haven, CT USA; [Owens, Jared] Middle Tennessee State Univ, Dept Psychol, Murfreesboro, TN 37132 USA; [McGowan, Catherine C.] Vanderbilt Univ, Div Infect Dis, Med Ctr, Nashville, TN USA; [Wallston, Kenneth A.] Vanderbilt Univ, Sch Nursing, Nashville, TN 37240 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; Yale University; Middle Tennessee State University; Vanderbilt University; Vanderbilt University	Kipp, AM (corresponding author), Vanderbilt Univ, Med Ctr, Div Epidemiol, Nashville, TN 37235 USA.	aaron.kipp@vanderbilt.edu	Harding, Richard/G-9729-2012		Vanderbilt Institute for Clinical and Translational Research grant from NCATS/NIH [UL1TR000011]; Vanderbilt Clinical and Translational Science Award from NCRR/NIH [UL1 RR024975]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [ZIATR000011, UL1TR000445] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024975] Funding Source: NIH RePORTER	Vanderbilt Institute for Clinical and Translational Research grant from NCATS/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); Vanderbilt Clinical and Translational Science Award from NCRR/NIH; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	Support for this study was provided in part by the Vanderbilt Institute for Clinical and Translational Research grant (UL1TR000011 from NCATS/NIH) and the Vanderbilt Clinical and Translational Science Award grant (UL1 RR024975 from NCRR/NIH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahams N, 2012, J INT AIDS SOC, V15, DOI 10.7448/IAS.15.2.17330; Audet CM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070326; Berger BE, 2001, RES NURS HEALTH, V24, P518, DOI 10.1002/nur.10011; Bunn JY, 2007, AIDS EDUC PREV, V19, P198, DOI 10.1521/aeap.2007.19.3.198; Earnshaw VA, 2013, AIDS BEHAV, V17, P1785, DOI 10.1007/s10461-013-0437-9; Earnshaw VA, 2013, J BEHAV MED, V36, P270, DOI 10.1007/s10865-012-9422-4; Earnshaw VA, 2009, AIDS BEHAV, V13, P1160, DOI 10.1007/s10461-009-9593-3; Ebrahimi-Kalan M, 2013, HEALTH PROMOT PERSPE, V3, P194, DOI 10.5681/hpp.2013.023; Fife BL, 2000, J HEALTH SOC BEHAV, V41, P50, DOI 10.2307/2676360; Franke MF, 2010, AIDS BEHAV, V14, P189, DOI 10.1007/s10461-008-9474-1; Genberg BL, 2008, AIDS BEHAV, V12, P772, DOI 10.1007/s10461-007-9340-6; Holzemer WL, 2007, AIDS CARE, V19, P1002, DOI 10.1080/09540120701245999; Kaai S, 2010, SAHARA J-J SOC ASP H, V7, P62, DOI 10.1080/17290376.2010.9724958; Kalichman SC, 2009, AIDS CARE, V21, P87, DOI 10.1080/09540120802032627; Katz IT, 2013, J INT AIDS SOC, V16, DOI 10.7448/IAS.16.3.18640; Kipp AM, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-675; Logie C, 2009, AIDS CARE, V21, P742, DOI 10.1080/09540120802511877; MacPherson P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026814; Mak WWS, 2006, SOC SCI MED, V63, P1912, DOI 10.1016/j.socscimed.2006.04.016; McGowan CC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018462; Neufeld SAS, 2012, AIDS BEHAV, V16, P1063, DOI 10.1007/s10461-011-0086-9; Nyblade L, 2013, J INT AIDS SOC, V16, DOI 10.7448/IAS.16.3.18718; Nyblade Laura C, 2006, Psychol Health Med, V11, P335, DOI 10.1080/13548500600595178; OBRIEN K, 1993, SOC SCI MED, V36, P1161, DOI 10.1016/0277-9536(93)90236-W; Pearson CR, 2009, AIDS BEHAV, V13, P1189, DOI 10.1007/s10461-009-9596-0; Qian HZ, 2011, J SUBST ABUSE TREAT, V41, P14, DOI 10.1016/j.jsat.2011.01.007; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Sayles JN, 2008, AIDS BEHAV, V12, P748, DOI 10.1007/s10461-008-9375-3; Shafer AB, 2006, J CLIN PSYCHOL, V62, P123, DOI 10.1002/jclp.20213; Smith EA, 2014, HEALTH EDUC BEHAV, V41, P387, DOI 10.1177/1090198113515245; Stangl AL, 2013, J INT AIDS SOC, V16, DOI 10.7448/IAS.16.3.18734; Steward WT, 2008, SOC SCI MED, V67, P1225, DOI 10.1016/j.socscimed.2008.05.032; STRAHAN R, 1972, J CLIN PSYCHOL, V28, P191, DOI 10.1002/1097-4679(197204)28:2<191::AID-JCLP2270280220>3.0.CO;2-G; Tsai AC, 2013, AIDS BEHAV, V17, P427, DOI 10.1007/s10461-012-0281-3; Van Brakel Wim H, 2006, Psychol Health Med, V11, P307, DOI 10.1080/13548500600595160; Van Rie A, 2008, TROP MED INT HEALTH, V13, P21, DOI 10.1111/j.1365-3156.2007.01971.x; Visser MJ, 2008, AIDS BEHAV, V12, P759, DOI 10.1007/s10461-008-9363-7; Ware NC, 2006, AIDS CARE, V18, P904, DOI 10.1080/09540120500330554; Wolitski RJ, 2009, AIDS BEHAV, V13, P1222, DOI 10.1007/s10461-008-9455-4; Zelaya CE, 2012, AIDS CARE, V24, P846, DOI 10.1080/09540121.2011.647674	40	18	19	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2015	10	3							e0118836	10.1371/journal.pone.0118836	http://dx.doi.org/10.1371/journal.pone.0118836			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CC9JM	25738884	Green Submitted, gold, Green Published			2022-12-27	WOS:000350685900079
J	Lacle, MM; van Diest, PJ; Goldschmeding, R; van der Wall, E; Nguyen, TQ				Lacle, Miangela M.; van Diest, Paul J.; Goldschmeding, Roel; van der Wall, Elsken; Nguyen, Tri Q.			Expression of Connective Tissue Growth Factor in Male Breast Cancer: Clinicopathologic Correlations and Prognostic Value	PLOS ONE			English	Article							DEPENDENT PROBE AMPLIFICATION; HEPATOCELLULAR-CARCINOMA; IMMUNOHISTOCHEMISTRY; TUMORS; CELLS	Connective tissue growth factor (CTGF/CCN2) is a member of the CCN family of secreted proteins that are believed to play an important role in the development of neoplasia. In particular, CTGF has been reported to play an important role in mammary tumorigenesis and to have prognostic value in female breast cancer (FBC). The aim of the present study was to investigate clinicopathologic correlations and prognostic value of CTGF in male breast cancer (MBC) and to compare these findings with FBC. For this, we studied CTGF protein expression by immunohistochemistry in 109 MBC cases and 75 FBC cases. In MBC, stromal CTGF expression was seen in the majority of the cases 78% (85/109) with high expression in 31/109 cases (28.4%), but expression in tumor cells was only seen in 9.2% (10/109) of cases. High stromal CTGF expression correlated with high grade and high proliferation index (> 15%) assessed by MIB-1 immunohistochemical staining. CTGF expression in tumor epithelial cells did not correlate with any of the clinicopathologic features. In FBC, stromal CTGF expression positively correlated with mitotic count and tumor CTGF expression was associated with triple negative status of the tumor (p = 0.002). Neither stromal nor tumor epithelial cell CTGF expression had prognostic value in MBC and FBC. In conclusion, stromal CTGF expression was seen in a high percentage of MBC and was correlated with high grade and high proliferation index. In view of the important role of the microenvironment in cancer progression, this might suggest that stromal CTGF could be an interesting target for novel therapies and molecular imaging. However, the lack of association with prognosis warrants caution. The potential role of CTGF as a therapeutic target for triple negative FBC deserves to be further studied.	[Lacle, Miangela M.; van Diest, Paul J.; Goldschmeding, Roel; Nguyen, Tri Q.] Univ Med Ctr Utrecht, Dept Pathol, Utrecht, Netherlands; [van der Wall, Elsken] Univ Med Ctr Utrecht, Div Internal Med & Dermatol, Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center	van Diest, PJ (corresponding author), Univ Med Ctr Utrecht, Dept Pathol, Utrecht, Netherlands.	p.j.vandiest@umcutrecht.nl	Nguyen, Tri/A-9508-2009; Nguyen, Tri Q/AAN-9673-2021	Nguyen, Tri/0000-0001-6475-0706; Nguyen, Tri Q/0000-0001-6475-0706; Lacle, Miangela/0000-0003-3466-3569				Bocker W, 2002, VERH DEUT G, V86, P116; Boersema M, 2012, AM J TRANSPLANT, V12, P1429, DOI 10.1111/j.1600-6143.2012.04001.x; BORK P, 1993, FEBS LETT, V327, P125, DOI 10.1016/0014-5793(93)80155-N; Capparelli C, 2012, CELL CYCLE, V11, P2272, DOI 10.4161/cc.20717; Chien WW, 2011, INT J ONCOL, V38, P1741, DOI 10.3892/ijo.2011.985; Frazier KS, 1997, INT J BIOCHEM CELL B, V29, P153, DOI 10.1016/S1357-2725(96)00127-6; Jia XQ, 2011, CHINESE MED J-PEKING, V124, P3794, DOI 10.3760/cma.j.issn.0366-6999.2011.22.034; Johansson I, BREAST CANC RES, V14, pR31; Kornegoor R, 2012, MOD PATHOL; Kornegoor R, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3220; Kornegoor R, 2012, BREAST CANCER RES TR, V135, P49, DOI 10.1007/s10549-012-2051-3; Kornegoor R, 2012, MODERN PATHOL, V25, P398, DOI 10.1038/modpathol.2011.174; Lacle MM, 2013, MODERN PATHOL, V26, P1461, DOI 10.1038/modpathol.2013.94; Lacle MM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060138; Perbal B, 2013, J CELL COMMUN SIGNAL, V7, P169, DOI 10.1007/s12079-013-0193-7; Shaaban AM, 2012, BREAST CANCER RES TR, V133, P949, DOI 10.1007/s10549-011-1856-9; van Diest PJ, 2002, BMJ-BRIT MED J, V325, P648, DOI 10.1136/bmj.325.7365.648; WeberChappuis K, 1996, EUR J CANCER, V32A, P1686, DOI 10.1016/0959-8049(96)00154-2; Xie D, 2001, CANCER RES, V61, P8917; Xiu M, 2012, WORLD J GASTROENTERO, V18, P7070, DOI 10.3748/wjg.v18.i47.7070; Yeger H, 2007, J CELL COMMUN SIGNAL, V1, P159, DOI 10.1007/s12079-008-0022-6	21	10	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2015	10	3							e0118957	10.1371/journal.pone.0118957	http://dx.doi.org/10.1371/journal.pone.0118957			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9JM	25738829	Green Submitted, Green Published, gold			2022-12-27	WOS:000350685900087
J	Stephan, Y; Sutin, AR; Terracciano, A				Stephan, Yannick; Sutin, Angelina R.; Terracciano, Antonio			How Old Do You Feel? The Role of Age Discrimination and Biological Aging in Subjective Age	PLOS ONE			English	Article							PEAK EXPIRATORY FLOW; SELF-RATED HEALTH; PERCEIVED DISCRIMINATION; TELOMERE LENGTH; PHYSICAL-ACTIVITY; WAIST CIRCUMFERENCE; COGNITIVE FUNCTION; MORTALITY; RISK; LIFE	Subjective age, or how young or old individuals experience themselves to be relative to their chronological age, is a crucial construct in gerontology. Subjective age is a significant predictor of important health outcomes, but little is known about the criteria by which individuals' subjectively evaluate their age. To identify psychosocial and biomedical factors linked to the subjective evaluation of age, this study examined whether perceived age discrimination and markers of biological aging are associated with subjective age. Participants were 4776 adults (M-age = 68) from the 2008 and 2010 waves of the Health and Retirement Study (HRS) who completed measures of subjective age, age discrimination, demographic variables, self-rated health and depression, and had physical health measures, including peak expiratory flow, grip strength, waist circumference, systolic and diastolic blood pressure. Telomere length was available for a subset of participants in the 2008 wave (n = 2214). Regression analysis indicated that perceived age discrimination, lower peak expiratory flow, lower grip strength, and higher waist circumference were associated with an older subjective age, controlling for sociodemographic factors, self-rated health, and depression. In contrast, blood pressure and telomere length were not related to subjective age. These findings are consistent with the hypothesis that how old a person feels depends in part on psychosocial and biomedical factors, including the experiences of ageism and perceptible indices of fitness and biological age.	[Stephan, Yannick] Univ Montpellier, F-34059 Montpellier, France; [Sutin, Angelina R.; Terracciano, Antonio] Florida State Univ, Coll Med, Tallahassee, FL 32306 USA	Universite de Montpellier; State University System of Florida; Florida State University	Stephan, Y (corresponding author), Univ Montpellier, F-34059 Montpellier, France.	yannick.stephan@univ-montp1.fr; antonio.terracciano@med.fsu.edu	Terracciano, Antonio/H-7403-2019	Terracciano, Antonio/0000-0001-5799-8885				Barnes LL, 2012, J INT NEUROPSYCH SOC, V18, P856, DOI 10.1017/S1355617712000628; Barnes LL, 2008, AM J PUBLIC HEALTH, V98, P1241, DOI 10.2105/AJPH.2007.114397; Barnes LL, 2011, J GERONTOL B-PSYCHOL, V66, P354, DOI 10.1093/geronb/gbr016; Barrett AE, 2003, J GERONTOL B-PSYCHOL, V58, pS101, DOI 10.1093/geronb/58.2.S101; Bergland A, 2014, AGING MENT HEALTH, V18, P653, DOI 10.1080/13607863.2013.869545; Cawthon RM, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.10.e47; Center for Disease Control and Prevention, 2010, BLOOD PRESS SIGNS SY; Chen W, 2011, J GERONTOL A-BIOL, V66, P312, DOI 10.1093/gerona/glq223; Craig AD, 2009, NAT REV NEUROSCI, V10, P59, DOI 10.1038/nrn2555; Craig AD, 2003, CURR OPIN NEUROBIOL, V13, P500, DOI 10.1016/S0959-4388(03)00090-4; Dodds R, 2013, AGE AGEING, V42, P794, DOI 10.1093/ageing/aft124; Dore GA, 2008, ANN BEHAV MED, V35, P341, DOI 10.1007/s12160-008-9038-7; Eibach RP, 2010, J EXP SOC PSYCHOL, V46, P643, DOI 10.1016/j.jesp.2010.03.002; Fisher G. G., 2000, DOCUMENTATION AFFECT; Fragoso CAV, 2008, J AM GERIATR SOC, V56, P1014, DOI 10.1111/j.1532-5415.2008.01687.x; Gana K, 2004, AGING MENT HEALTH, V8, P58, DOI 10.1081/13607860310001613347; Herd P, 2012, J GERONTOL B-PSYCHOL, V67, P503, DOI 10.1093/geronb/gbs048; Houston DK, 2005, INT J OBESITY, V29, P1457, DOI 10.1038/sj.ijo.0803043; Infurna FJ, 2010, PSYCHOL AGING, V25, P470, DOI 10.1037/a0017979; Jacobs EJ, 2010, ARCH INTERN MED, V170, P1293, DOI 10.1001/archinternmed.2010.201; Jylha M, 2006, J CLIN EPIDEMIOL, V59, P465, DOI 10.1016/j.jclinepi.2005.12.004; Jylha M, 2009, SOC SCI MED, V69, P307, DOI 10.1016/j.socscimed.2009.05.013; Karasik D, 2005, J GERONTOL A-BIOL, V60, P574, DOI 10.1093/gerona/60.5.574; Kessler RC, 1999, J HEALTH SOC BEHAV, V40, P208, DOI 10.2307/2676349; Klein BEK, 2001, DIABETES CARE, V24, P1967, DOI 10.2337/diacare.24.11.1967; Kleinspehn-Ammerlahn A, 2008, J GERONTOL B-PSYCHOL, V63, pP377, DOI 10.1093/geronb/63.6.P377; Koh-Banerjee P, 2003, AM J CLIN NUTR, V78, P719, DOI 10.1093/ajcn/78.4.719; Koher-Gruhn D, 2012, J GERONTOL B-PSYCHOL, V67, P563, DOI 10.1093/geronb/gbr153; Kotter-Gruhn D, 2009, PSYCHOL AGING, V24, P654, DOI 10.1037/a0016510; Levy B, 2009, CURR DIR PSYCHOL SCI, V18, P332, DOI 10.1111/j.1467-8721.2009.01662.x; Mather KA, 2011, J GERONTOL A-BIOL, V66, P202, DOI 10.1093/gerona/glq180; Newman AB, 2006, J GERONTOL A-BIOL, V61, P72, DOI 10.1093/gerona/61.1.72; Pascoe EA, 2009, PSYCHOL BULL, V135, P531, DOI 10.1037/a0016059; Pelkonen M, 2003, AM J RESP CRIT CARE, V168, P494, DOI 10.1164/rccm.200208-954OC; Rubin DC, 2006, PSYCHON B REV, V13, P776, DOI 10.3758/BF03193996; Saum KU, 2014, EXP GERONTOL, V58, P250, DOI 10.1016/j.exger.2014.08.009; Stephan Y, 2014, AM J GERIAT PSYCHIAT, V22, P1180, DOI 10.1016/j.jagp.2013.03.007; Stephan Y, 2012, PSYCHOL AGING, V27, P875, DOI 10.1037/a0028301; Stephan Y, 2013, J GERONTOL B-PSYCHOL, V68, P1, DOI 10.1093/geronb/gbs037; Stephan Y, 2011, AGING MENT HEALTH, V15, P428, DOI 10.1080/13607863.2010.536138; Sutin AR, 2015, AM J GERIAT PSYCHIAT, V23, P171, DOI 10.1016/j.jagp.2014.03.007; Taekema DG, 2010, AGE AGEING, V39, P331, DOI 10.1093/ageing/afq022; Uotinen V, 2005, AGE AGEING, V34, P368, DOI 10.1093/ageing/afi091; Weiss D, 2013, PSYCHOL AGING, V28, P1140, DOI 10.1037/a0033811; Weiss D, 2012, PSYCHOL AGING, V27, P153, DOI 10.1037/a0024887; Wiens S, 2005, CURR OPIN NEUROL, V18, P442, DOI 10.1097/01.wco.0000168079.92106.99; Willeit P, 2010, JAMA-J AM MED ASSOC, V304, P69, DOI 10.1001/jama.2010.897; Williams D R, 1997, J Health Psychol, V2, P335, DOI 10.1177/135910539700200305	48	96	97	2	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2015	10	3							e0119293	10.1371/journal.pone.0119293	http://dx.doi.org/10.1371/journal.pone.0119293			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CC9JM	25738579	Green Submitted, Green Published, gold			2022-12-27	WOS:000350685900102
J	Wu, X; Yamamoto, H; Nakanishi, H; Yamamoto, Y; Inoue, A; Tei, M; Hirose, H; Uemura, M; Nishimura, J; Hata, T; Takemasa, I; Mizushima, T; Hossain, S; Akaike, T; Matsuura, N; Doki, Y; Mori, M				Wu, Xin; Yamamoto, Hirofumi; Nakanishi, Hiroyuki; Yamamoto, Yuki; Inoue, Akira; Tei, Mitsuyoshi; Hirose, Hajime; Uemura, Mamoru; Nishimura, Junichi; Hata, Taishi; Takemasa, Ichiro; Mizushima, Tsunekazu; Hossain, Sharif; Akaike, Toshihiro; Matsuura, Nariaki; Doki, Yuichiro; Mori, Masaki			Innovative Delivery of siRNA to Solid Tumors by Super Carbonate Apatite	PLOS ONE			English	Article							RNA NANOPARTICLES; SYSTEMIC DELIVERY; POLYMERIC MICELLES; INTERFERING RNA; IN-VIVO; CANCER; THERAPEUTICS; ATELOCOLLAGEN; DNA; ACCUMULATION	RNA interference (RNAi) technology is currently being tested in clinical trials for a limited number of diseases. However, systemic delivery of small interfering RNA (siRNA) to solid tumors has not yet been achieved in clinics. Here, we introduce an in vivo pH-sensitive delivery system for siRNA using super carbonate apatite (sCA) nanoparticles, which is the smallest class of nanocarrier. These carriers consist simply of inorganic ions and accumulate specifically in tumors, yet they cause no serious adverse events in mice and monkeys. Intravenously administered sCA-siRNA abundantly accumulated in the cytoplasm of tumor cells at 4 h, indicating quick achievement of endosomal escape. sCA-survivin-siRNA induced apoptosis in HT29 tumors and significantly inhibited in vivo tumor growth of HCT116, to a greater extent than two other in vivo delivery reagents. With innovative in vivo delivery efficiency, sCA could be a useful nanoparticle for the therapy of solid tumors.	[Wu, Xin; Yamamoto, Hirofumi; Inoue, Akira; Tei, Mitsuyoshi; Hirose, Hajime; Uemura, Mamoru; Nishimura, Junichi; Hata, Taishi; Takemasa, Ichiro; Mizushima, Tsunekazu; Doki, Yuichiro; Mori, Masaki] Osaka Univ, Grad Sch Med, Dept Surg, Gastroenterol Surg, Suita, Osaka, Japan; [Wu, Xin] Japan Soc Promot Sci, Tokyo, Japan; [Nakanishi, Hiroyuki; Yamamoto, Yuki] Nakanishi Gastroenterol Res Inst, Sakai, Osaka, Japan; [Hossain, Sharif; Akaike, Toshihiro] Tokyo Inst Technol, Dept Biomol Engn, Grad Sch Biosci & Biotechnol, Yokohama, Kanagawa 227, Japan; [Hossain, Sharif; Akaike, Toshihiro] Fdn Adv Int Sci, Biomat Ctr Regenerat Med Engn, Tsukuba, Ibaraki, Japan; [Matsuura, Nariaki] Osaka Med Ctr Canc & Cardiovasc Dis, Osaka, Japan	Osaka University; Japan Society for the Promotion of Science; Tokyo Institute of Technology; Osaka Medical Center for Cancer & Cardiovascular Diseases	Yamamoto, H (corresponding author), Osaka Univ, Grad Sch Med, Dept Surg, Gastroenterol Surg, Suita, Osaka, Japan.	hyamamoto@gesurg.med.osaka-u.ac.jp	Nakanishi, Hiroyuki/AAD-9324-2020; Nishimura, Junichi/K-8390-2015	Nakanishi, Hiroyuki/0000-0003-3982-3314; Nishimura, Junichi/0000-0001-8220-3423	KAKENHI [21390360, 30322184, 24390315]; Grants-in-Aid for Scientific Research [23220014] Funding Source: KAKEN	KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by a Grant-in-Aid for Scientific Research (KAKENHI) to H.Y. (No. 21390360, 30322184, 24390315). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelmawla S, 2011, MOL THER, V19, P1312, DOI 10.1038/mt.2011.35; Bian S, 2012, CRYST GROWTH DES, V12, P3481, DOI 10.1021/cg2016885; Bumcrot D, 2006, NAT CHEM BIOL, V2, P711, DOI 10.1038/nchembio839; Burg KJL, 2000, BIOMATERIALS, V21, P2347, DOI 10.1016/S0142-9612(00)00102-2; Burnett JC, 2011, BIOTECHNOL J, V6, P1130, DOI 10.1002/biot.201100054; Cabral H, 2011, NAT NANOTECHNOL, V6, P815, DOI [10.1038/nnano.2011.166, 10.1038/NNANO.2011.166]; Castanotto D, 2009, NATURE, V457, P426, DOI 10.1038/nature07758; Cho ST, 2013, INT J UROL, V20, P208, DOI 10.1111/j.1442-2042.2012.03131.x; Choi HS, 2007, NAT BIOTECHNOL, V25, P1165, DOI 10.1038/nbt1340; Chowdhury EH, 2006, GENE, V376, P87, DOI 10.1016/j.gene.2006.02.028; Christie RJ, 2012, ACS NANO, V6, P5174, DOI 10.1021/nn300942b; Davis ME, 2010, NATURE, V464, P1067, DOI 10.1038/nature08956; Dominska M, 2010, J CELL SCI, V123, P1183, DOI 10.1242/jcs.066399; Friend DS, 1996, BBA-BIOMEMBRANES, V1278, P41, DOI 10.1016/0005-2736(95)00219-7; Fukuda S, 2006, MOL CANCER THER, V5, P1087, DOI 10.1158/1535-7163.MCT-05-0375; Gnessin E, 2011, J ENDOUROL, V25, P1519, DOI 10.1089/end.2010.0698; Grimm D, 2006, NATURE, V441, P537, DOI 10.1038/nature04791; Guo PX, 2012, NUCLEIC ACID THER, V22, P226, DOI 10.1089/nat.2012.0350; Guo PX, 2010, NAT NANOTECHNOL, V5, P833, DOI [10.1038/nnano.2010.231, 10.1038/NNANO.2010.231]; Guo S, 2006, GENE THER, V13, P814, DOI 10.1038/sj.gt.3302716; Haque F, 2012, NANO TODAY, V7, P245, DOI 10.1016/j.nantod.2012.06.010; Hossain S, 2010, J CONTROL RELEASE, V147, P101, DOI 10.1016/j.jconrel.2010.06.024; Imai K, 2006, NAT REV CANCER, V6, P714, DOI 10.1038/nrc1913; Judge AD, 2005, NAT BIOTECHNOL, V23, P457, DOI 10.1038/nbt1081; Khaled A, 2005, NANO LETT, V5, P1797, DOI 10.1021/nl051264s; Kim SH, 2008, J CONTROL RELEASE, V129, P107, DOI 10.1016/j.jconrel.2008.03.008; MATSUMURA Y, 1986, CANCER RES, V46, P6387; Matsumura Y, 2009, CANCER SCI, V100, P572, DOI 10.1111/j.1349-7006.2009.01103.x; MORIKAWA K, 1988, CANCER RES, V48, P6863; Mu P, 2009, INT J CANCER, V125, P2978, DOI 10.1002/ijc.24382; Nag K., 2013, J NANOMEDICINE NANOT, V4, P174, DOI [10.4172/2157-7439.1000174, DOI 10.4172/2157-7439.1000174]; Ochiya T, 1999, NAT MED, V5, P707, DOI 10.1038/9560; OONISHI H, 1991, BIOMATERIALS, V12, P171, DOI 10.1016/0142-9612(91)90196-H; Pecot CV, 2011, NAT REV CANCER, V11, P59, DOI 10.1038/nrc2966; Perrault SD, 2009, NANO LETT, V9, P1909, DOI 10.1021/nl900031y; Piskounova E, 2011, CELL, V147, P1066, DOI 10.1016/j.cell.2011.10.039; Pittella F, 2012, J CONTROL RELEASE, V161, P868, DOI 10.1016/j.jconrel.2012.05.005; Prabha S, 2002, INT J PHARM, V244, P105, DOI 10.1016/S0378-5173(02)00315-0; Rahman MA, 2012, J CONTROL RELEASE, V159, P384, DOI 10.1016/j.jconrel.2012.01.045; Sano A, 2003, ADV DRUG DELIVER REV, V55, P1651, DOI 10.1016/j.addr.2003.08.005; Science Council of Japan, 2006, GUID PROP COND AN EX; Shu D, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gkt885; Shu D, 2011, NAT NANOTECHNOL, V6, P658, DOI [10.1038/nnano.2011.105, 10.1038/NNANO.2011.105]; Shu Y, 2014, ADV DRUG DELIVER REV, V66, P74, DOI 10.1016/j.addr.2013.11.006; Shu Y, 2013, RNA, V19, P767, DOI 10.1261/rna.037002.112; Takeshita F, 2005, P NATL ACAD SCI USA, V102, P12177, DOI 10.1073/pnas.0501753102; Tamura A, 2010, NANOMEDICINE-UK, V5, P1089, DOI [10.2217/nnm.10.76, 10.2217/NNM.10.76]; Yagi N, 2009, CANCER RES, V69, P6531, DOI 10.1158/0008-5472.CAN-08-3945; Yamamoto H, 2008, CANCER SCI, V99, P1709, DOI 10.1111/j.1349-7006.2008.00870.x; Zhang JM, 2009, NAT REV CANCER, V9, P28, DOI 10.1038/nrc2559; Zhang SY, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000678; Zhou JH, 2013, PHARMACEUTICALS, V6, P85, DOI 10.3390/ph6010085; Zuckerman JE, 2012, P NATL ACAD SCI USA, V109, P3137, DOI 10.1073/pnas.1200718109	53	24	26	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2015	10	3							e0116022	10.1371/journal.pone.0116022	http://dx.doi.org/10.1371/journal.pone.0116022			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9JM	25738937	Green Published, Green Submitted, gold			2022-12-27	WOS:000350685900007
J	Ellwardt, L; van Tilburg, T; Aartsen, M; Wittek, R; Steverink, N				Ellwardt, Lea; van Tilburg, Theo; Aartsen, Marja; Wittek, Rafael; Steverink, Nardi			Personal Networks and Mortality Risk in Older Adults: A Twenty-Year Longitudinal Study	PLOS ONE			English	Article							ALL-CAUSE MORTALITY; SOCIAL NETWORKS; LIFE-STYLE; LONELINESS; SUPPORT; HEALTH; AGE; METAANALYSIS; TIES	Background Research on aging has consistently demonstrated an increased chance of survival for older adults who are integrated into rich networks of social relationships. Theoretical explanations state that personal networks offer indirect psychosocial and direct physiological pathways. We investigate whether effects on and pathways to mortality risk differ between functional and structural characteristics of the personal network. The objective is to inquire which personal network characteristics are the best predictors of mortality risk after adjustment for mental, cognitive and physical health. Methods and Findings Empirical tests were carried out by combining official register information on mortality with data from the Longitudinal Aging Study Amsterdam (LASA). The sample included 2,911 Dutch respondents aged 54 to 85 at baseline in 1992 and six follow-ups covering a time span of twenty years. Four functional characteristics (emotional and social loneliness, emotional and instrumental support) and four structural characteristics (living arrangement, contact frequency, number of contacts, number of social roles) of the personal network as well as mental, cognitive and physical health were assessed at all LASA follow-ups. Statistical analyses comprised of Cox proportional hazard regression models. Findings suggest differential effects of personal network characteristics on survival, with only small gender differences. Mortality risk was initially reduced by functional characteristics, but disappeared after full adjustment for the various health variables. Mortality risk was lowest for older adults embedded in large (HR = 0.986, 95% CI 0.979-0.994) and diverse networks (HR = 0.948, 95% CI 0.917-0.981), and this effect continued to show in the fully adjusted models. Conclusions Functional characteristics (i.e. emotional and social loneliness) are indirectly associated with a reduction in mortality risk, while structural characteristics (i.e. number of contacts and number of social roles) have direct protective effects. More research is needed to understand the causal mechanisms underlying these relations.	[Ellwardt, Lea] Univ Cologne, Cologne Grad Sch Management Econ & Social Sci CGS, D-50931 Cologne, Germany; [van Tilburg, Theo; Aartsen, Marja] Vrije Univ Amsterdam, Dept Sociol, Amsterdam, Netherlands; [Wittek, Rafael; Steverink, Nardi] Univ Groningen, Dept Sociol, Groningen, Netherlands; [Wittek, Rafael; Steverink, Nardi] Univ Groningen, Interuniv Ctr Social Sci Theory & Methodol ICS, Groningen, Netherlands; [Steverink, Nardi] Univ Groningen, Univ Med Ctr Groningen, Dept Hlth Psychol, Groningen, Netherlands	University of Cologne; Vrije Universiteit Amsterdam; University of Groningen; University of Groningen; University of Groningen	Ellwardt, L (corresponding author), Univ Cologne, Cologne Grad Sch Management Econ & Social Sci CGS, D-50931 Cologne, Germany.	ellwardt@wiso.uni-koeln.de	Steverink, Nardi/F-1936-2013; Ellwardt, Lea/ABE-5867-2021; Aartsen, Marja/U-2676-2019; van Tilburg, Theo/F-1269-2010; Wittek, Rafael/E-5560-2012	Ellwardt, Lea/0000-0001-9292-2392; Aartsen, Marja/0000-0003-4246-7621; van Tilburg, Theo/0000-0002-1005-6732; Wittek, Rafael/0000-0002-8473-6984	Healthy Aging, Population and Society (HAPS), an investment of the University of Groningen strategic research focus Healthy Aging; Netherlands Ministry of Health Welfare and Sports, Directorate of Long-Term Care	Healthy Aging, Population and Society (HAPS), an investment of the University of Groningen strategic research focus Healthy Aging; Netherlands Ministry of Health Welfare and Sports, Directorate of Long-Term Care	This research is financed by Healthy Aging, Population and Society (HAPS), an investment of the University of Groningen strategic research focus Healthy Aging. The Longitudinal Aging Study Amsterdam is largely supported by a grant from the Netherlands Ministry of Health Welfare and Sports, Directorate of Long-Term Care. No funding bodies had any role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aartsen MJ, 2004, J SOC PERS RELAT, V21, P249, DOI 10.1177/0265407504041386; Barefoot JC, 2005, AM J EPIDEMIOL, V161, P960, DOI 10.1093/aje/kwi128; BERKMAN LF, 1979, AM J EPIDEMIOL, V109, P186, DOI 10.1093/oxfordjournals.aje.a112674; Berkman LF, 2000, SOC SCI MED, V51, P843, DOI 10.1016/S0277-9536(00)00065-4; Cacioppo JT, 2003, PERSPECT BIOL MED, V46, pS39, DOI 10.1353/pbm.2003.0049; CARSTENSEN LL, 1993, NEBR SYM MOTIV, V40, P209; Christakis NA, 2007, NEW ENGL J MED, V357, P370, DOI 10.1056/NEJMsa066082; COHEN S, 1985, PSYCHOL BULL, V98, P310, DOI 10.1037/0033-2909.98.2.310; Cohen S, 1997, JAMA-J AM MED ASSOC, V277, P1940; DEJONGGIERVELD J, 1985, APPL PSYCH MEAS, V9, P289, DOI 10.1177/014662168500900307; Ellwardt L, 2015, SOC SCI MED, V125, P107, DOI 10.1016/j.socscimed.2014.05.007; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Fratiglioni L, 2004, LANCET NEUROL, V3, P343, DOI 10.1016/S1474-4422(04)00767-7; Holt-Lunstad J, 2003, HEALTH PSYCHOL, V22, P388, DOI 10.1037/0278-6133.22.4.388; Holt-Lunstad J, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000316; HOUSE JS, 1988, SCIENCE, V241, P540, DOI 10.1037/0003-066X.59.8.676; Iecovich E, 2011, INT J AGING HUM DEV, V72, P243, DOI 10.2190/AG.72.3.e; KATZ S, 1963, JAMA-J AM MED ASSOC, V185, P914, DOI 10.1001/jama.1963.03060120024016; Kroenke CH, 2012, BREAST CANCER RES TR, V133, P375, DOI 10.1007/s10549-012-1962-3; Litwin H, 2006, GERONTOLOGIST, V46, P735, DOI 10.1093/geront/46.6.735; Luo Y, 2012, SOC SCI MED, V74, P907, DOI 10.1016/j.socscimed.2011.11.028; Nyqvist F, 2014, SOC INDIC RES, V116, P545, DOI 10.1007/s11205-013-0288-9; Pinquart M, 2010, CRIT REV ONCOL HEMAT, V75, P122, DOI 10.1016/j.critrevonc.2009.06.003; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Rizzuto D, 2012, BRIT MED J, V345, DOI 10.1136/bmj.e5568; Shor E, 2013, SOC NETWORKS, V35, P626, DOI 10.1016/j.socnet.2013.08.004; Steptoe A, 2013, P NATL ACAD SCI USA, V110, P5797, DOI 10.1073/pnas.1219686110; van Groenou MB, 2013, J AGING HEALTH, V25, P274, DOI 10.1177/0898264312468033; van Tilburg T, 1998, J GERONTOL B-PSYCHOL, V53, pS313, DOI 10.1093/geronb/53B.6.S313; Wrzus C, 2013, PSYCHOL BULL, V139, P53, DOI 10.1037/a0028601; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	31	60	62	2	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2015	10	3							e0116731	10.1371/journal.pone.0116731	http://dx.doi.org/10.1371/journal.pone.0116731			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CC4HV	25734570	Green Published, gold			2022-12-27	WOS:000350314700007
J	Wada, T; Iwamoto, T; Tamaru, A; Seto, J; Ahiko, T; Yamamoto, K; Hase, A; Maeda, S; Yamamoto, T				Wada, Takayuki; Iwamoto, Tomotada; Tamaru, Aki; Seto, Junji; Ahiko, Tadayuki; Yamamoto, Kaori; Hase, Atushi; Maeda, Shinji; Yamamoto, Taro			Clonality and Micro-Diversity of a Nationwide Spreading Genotype of Mycobacterium tuberculosis in Japan	PLOS ONE			English	Article							BEIJING FAMILY STRAINS; MOLECULAR EPIDEMIOLOGY; TRANSMISSION; PHYLOGENY; OUTBREAKS; BACTERIA; LOCI	Mycobacterium tuberculosis transmission routes can be estimated from genotypic analysis of clinical isolates from patients. In Japan, still a middle-incidence country of TB, a unique genotype strain designated as 'M-strain' has been isolated nationwide recently. To ascertain the history of the wide spread of the strain, 10 clinical isolates from different areas were subjected to genome-wide analysis based on deep sequencers. Results show that all isolates possessed common mutations to those of referential strains. The greatest number of accumulated single nucleotide variants (SNVs) from the oldest coalescence was 13 nucleotides, indicating high clonality of these isolates. When an SNV common to the isolates was used as a surrogate marker of the clone, authentic clonal isolates with variation in a reliable subset of variable number of tandem repeat (VNTR) genotyping method can be selected successfully from clinical isolates populations of M. tuberculosis. When the authentic clones can also be assigned to sub-clonal groups by SNVs derived from the genomic comparison, they are classifiable into three sub-clonal groups with a bias of geographical origins. Feedback from genomic analysis of clinical isolates of M. tuberculosis to genotypic markers will be an efficient strategy for the big data in various settings for public health actions against TB.	[Wada, Takayuki; Yamamoto, Taro] Nagasaki Univ, Dept Int Hlth, Inst Trop Med, Nagasaki 852, Japan; [Iwamoto, Tomotada] Kobe Inst Hlth, Dept Microbiol, Kobe, Hyogo, Japan; [Tamaru, Aki] Osaka Prefectural Inst Publ Hlth, Dept Microbiol, Osaka 537, Japan; [Seto, Junji; Ahiko, Tadayuki] Yamagata Prefectural Inst Publ Hlth, Dept Microbiol, Yamagata 9900031, Japan; [Yamamoto, Kaori; Hase, Atushi] Osaka City Inst Publ Hlth & Environm Sci, Dept Microbiol, Osaka 543, Japan; [Maeda, Shinji] Res Inst TB, Dept Mycobacterium Reference & Res, Tokyo, Japan	Nagasaki University; Osaka Prefectural Institute of Public Health	Wada, T (corresponding author), Nagasaki Univ, Dept Int Hlth, Inst Trop Med, Nagasaki 852, Japan.	twada@nagasaki-u.ac.jp	Iwamoto, Tomotada/I-8944-2019	Iwamoto, Tomotada/0000-0002-2650-0308; Seto, Junji/0000-0003-2227-5315	Ministry of Health, Labour and Welfare (Research on Emerging and Re-emerging Infectious Diseases, Health Sciences Research Grants); JSPS [24689034, 22790585]	Ministry of Health, Labour and Welfare (Research on Emerging and Re-emerging Infectious Diseases, Health Sciences Research Grants); JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by a grant from the Ministry of Health, Labour and Welfare (Research on Emerging and Re-emerging Infectious Diseases, Health Sciences Research Grants). This work was also supported in part by Grant-in-Aid for Young Scientists (A) (24689034) and (B) (22790585) from JSPS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allix-Beguec C, 2008, J CLIN MICROBIOL, V46, P1398, DOI 10.1128/JCM.02089-07; Asante-Poku A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092675; Bryant JM, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-110; Cole EC, 1998, AM J INFECT CONTROL, V26, P453, DOI 10.1016/S0196-6553(98)70046-X; Comas I, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007815; Dou HY, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-170; Filliol I, 2006, J BACTERIOL, V188, P759, DOI 10.1128/JB.188.2.759-772.2006; Galagan JE, 2010, TUBERCULOSIS, V90, P225, DOI 10.1016/j.tube.2010.03.010; Gardy JL, 2011, NEW ENGL J MED, V364, P730, DOI 10.1056/NEJMoa1003176; Iwamoto T, 2007, FEMS MICROBIOL LETT, V270, P67, DOI 10.1111/j.1574-6968.2007.00658.x; Iwamoto T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049651; Kenyon TA, 1996, NEW ENGL J MED, V334, P933, DOI 10.1056/NEJM199604113341501; Kohl TA, 2014, J CLIN MICROBIOL, V52, P2479, DOI 10.1128/JCM.00567-14; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Luo T, 2014, TUBERCULOSIS, V94, P434, DOI 10.1016/j.tube.2014.04.005; Luo T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089726; Maeda S, 2010, INT J TUBERC LUNG D, V14, P1201; Mathema B, 2006, CLIN MICROBIOL REV, V19, P658, DOI 10.1128/CMR.00061-05; Molhuizen HOF, 1998, METH MOL B, V101, P381, DOI 10.1385/0-89603-471-2:381; Murase Y, 2008, J MED MICROBIOL, V57, P873, DOI 10.1099/jmm.0.47564-0; Nakajima C, 2013, J CLIN MICROBIOL, V51, P2025, DOI 10.1128/JCM.03404-12; Nakanishi N, 2013, INFECT GENET EVOL, V16, P174, DOI 10.1016/j.meegid.2013.02.007; Ohkado A, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-138; Ojo OO, 2010, INFECT GENET EVOL, V10, P1110, DOI 10.1016/j.meegid.2010.07.008; Parish T, 1998, METHOD MOL BIOL, P31; Perez-Lago L, 2014, J INFECT DIS, V209, P98, DOI 10.1093/infdis/jit439; Reddy TBK, 2009, NUCLEIC ACIDS RES, V37, pD499, DOI 10.1093/nar/gkn652; Roetzer A, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001387; Sails AD, 2011, THORAX, V66, P709, DOI 10.1136/thx.2011.158881; Supply P, 2006, J CLIN MICROBIOL, V44, P4498, DOI 10.1128/JCM.01392-06; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; The Research Institute of Tuberculosis, JATA STAT TUB 2012 S; The Research Institute of Tuberculosis, JATA TRENDS NOT RAT; van Soolingen D, 1999, J INFECT DIS, V180, P726, DOI 10.1086/314930; van Soolingen D, 2001, J INTERN MED, V249, P1, DOI 10.1046/j.1365-2796.2001.00772.x; Vassiloyanakopoulos A, 1999, Euro Surveill, V4, P96; Wada Takayuki, 2013, Kekkaku, V88, P393; Wada T, 2012, INFECT GENET EVOL, V12, P1392, DOI 10.1016/j.meegid.2012.04.029; Wada Takayuki, 2010, Kekkaku, V85, P845; Wada T, 2009, TUBERCULOSIS, V89, P252, DOI 10.1016/j.tube.2009.05.007; Walker TM, 2013, CLIN MICROBIOL INFEC, V19, P796, DOI 10.1111/1469-0691.12183; Walker TM, 2013, LANCET INFECT DIS, V13, P137, DOI 10.1016/S1473-3099(12)70277-3; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1	43	9	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2015	10	3							e0118495	10.1371/journal.pone.0118495	http://dx.doi.org/10.1371/journal.pone.0118495			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4HV	25734518	gold, Green Submitted, Green Published			2022-12-27	WOS:000350314700034
J	Camargo, LM; Zhang, XD; Loerch, P; Caceres, RM; Marine, SD; Uva, P; Ferrer, M; de Rinaldis, E; Stone, DJ; Majercak, J; Ray, WJ; Chen, YA; Shearman, MS; Mizuguchi, K				Camargo, Luiz Miguel; Zhang, Xiaohua Douglas; Loerch, Patrick; Caceres, Ramon Miguel; Marine, Shane D.; Uva, Paolo; Ferrer, Marc; de Rinaldis, Emanuele; Stone, David J.; Majercak, John; Ray, William J.; Chen Yi-An; Shearman, Mark S.; Mizuguchi, Kenji			Pathway-Based Analysis of Genome-Wide siRNA Screens Reveals the Regulatory Landscape of App Processing	PLOS ONE			English	Article							AMYLOID-PRECURSOR PROTEIN; ALZHEIMERS-DISEASE; GAMMA-SECRETASE; ARGININE METABOLISM; IDENTIFIES VARIANTS; GENE; BETA; ASSOCIATION; EXPRESSION; DIFFERENTIATION	The progressive aggregation of Amyloid-beta (A beta) in the brain is a major trait of Alzheimer's Disease (AD). A beta is produced as a result of proteolytic processing of the beta-amyloid precursor protein (APP). Processing of APP is mediated by multiple enzymes, resulting in the production of distinct peptide products: the non-amyloidogenic peptide sAPP alpha and the amyloidogenic peptides sAPP beta, A beta 40, and A beta 42. Using a pathway-based approach, we analyzed a large-scale siRNA screen that measured the production of different APP proteolytic products. Our analysis identified many of the biological processes/pathways that are known to regulate APP processing and have been implicated in AD pathogenesis, as well as revealing novel regulatory mechanisms. Furthermore, we also demonstrate that some of these processes differentially regulate APP processing, with some mechanisms favouring production of certain peptide species over others. For example, synaptic transmission having a bias towards regulating A beta 40 production over A beta 42 as well as processes involved in insulin and pancreatic biology having a bias for sAPP beta production over sAPP alpha. In addition, some of the pathways identified as regulators of APP processing contain genes (CLU, BIN1, CR1, PICALM, TREM2, SORL1, MEF2C, DSG2, EPH1A) recently implicated with AD through genome wide association studies (GWAS) and associated meta-analysis. In addition, we provide supporting evidence and a deeper mechanistic understanding of the role of diabetes in AD. The identification of these processes/pathways, their differential impact on APP processing, and their relationships to each other, provide a comprehensive systems biology view of the "regulatory landscape" of APP.	[Camargo, Luiz Miguel; Loerch, Patrick; Caceres, Ramon Miguel; Shearman, Mark S.] Merck & Co Inc, Merck Res Labs, Boston, MA USA; [Zhang, Xiaohua Douglas] Merck & Co Inc, Merck Res Labs, Beijing, Peoples R China; [Marine, Shane D.; Ferrer, Marc] Merck & Co Inc, Merck Res Labs, N Wales, PA USA; [Uva, Paolo; de Rinaldis, Emanuele] Merck Res Labs, Inst Recerca Biol Mol, Pomezia, Italy; [Stone, David J.; Majercak, John; Ray, William J.] Merck & Co Inc, Merck Res Labs, West Point, PA USA; [Chen Yi-An; Mizuguchi, Kenji] Natl Inst Biomed Innovat, Osaka, Japan	Merck & Company; Merck & Company; Merck & Company; Merck & Company; National Institute of Health Sciences - Japan	Camargo, LM (corresponding author), Novartis Inst Biomed Res, Cambridge, England.	miguelcamargo@novartis.com	Uva, Paolo/A-2877-2011; Ray, William J/E-9834-2016; Mizuguchi, Kenji/GVS-5857-2022	Uva, Paolo/0000-0002-9524-8492; Mizuguchi, Kenji/0000-0003-3021-7078; Zhang, Xiaohua Douglas/0000-0002-2486-7931; Ray, William/0000-0002-4491-167X	Merck Co; Novartis; CRS4 Bioinformatica; Merck Serono; Boehringer Ingelheim; Takeda Pharmaceuticals	Merck Co(Merck & Company); Novartis(Novartis); CRS4 Bioinformatica; Merck Serono(Merck & Company); Boehringer Ingelheim(Boehringer Ingelheim); Takeda Pharmaceuticals(Takeda Pharmaceutical Company Ltd)	Merck & Co funded the work presented in this manuscript. All authors, with the exception of Kenji Mizuguchi (KM) and Chen Yi-An (CYA), were employed by Merck & Co during the time the research was conducted. The funder, Merck & Co provided support in the form of salaries for authors LMC, XDZ, PL, MC, SDM, PU, MF, EDR, DJS, JM, WJR and MSS during the course of the study, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section. Novartis, CRS4 Bioinformatica, Merck Serono, Boehringer Ingelheim, and Takeda Pharmaceuticals provided support in the form of salaries for authors LMC, PU, MS, JM, and WJR, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Barabasi AL, 2011, NAT REV GENET, V12, P56, DOI 10.1038/nrg2918; Barber AJ, 2001, J BIOL CHEM, V276, P32814, DOI 10.1074/jbc.M104738200; Beher D, 2005, EXPERT OPIN INV DRUG, V14, P1385, DOI 10.1517/13543784.14.11.1385; Best JD, 2007, J PHARMACOL EXP THER, V320, P552, DOI 10.1124/jpet.106.114330; Buehler E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051942; Buehler E, 2012, SCI REP-UK, V2, DOI 10.1038/srep00428; Bushman FD, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000437; Cerami EG, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-497; Chen FS, 2006, NATURE, V440, P1208, DOI 10.1038/nature04667; Chen YT, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0017876, 10.1371/journal.pone.0021428, 10.1371/journal.pone.0017844, 10.1371/journal.pone.0024144, 10.1371/journal.pone.0027163, 10.1371/journal.pone.0027333]; Chung NJ, 2008, J BIOMOL SCREEN, V13, P149, DOI 10.1177/1087057107312035; Cirrito JR, 2005, NEURON, V48, P913, DOI 10.1016/j.neuron.2005.10.028; Cissell MA, 2003, J BIOL CHEM, V278, P751, DOI 10.1074/jbc.M205905200; Currais A, 2012, AGING CELL; Denner LA, 2012, J NEUROSCI, V32, P16725, DOI 10.1523/JNEUROSCI.2153-12.2012; Djogo N, 2013, NEUROBIOL DIS, V56, P104, DOI 10.1016/j.nbd.2013.04.014; Frisardi V, 2010, AGEING RES REV, V9, P399, DOI 10.1016/j.arr.2010.04.007; Gandhi S, 2010, NAT NEUROSCI, V13, P789, DOI 10.1038/nn.2584; Gasparini L, 2001, J NEUROSCI, V21, P2561, DOI 10.1523/JNEUROSCI.21-08-02561.2001; Gervais FG, 1999, CELL, V97, P395, DOI 10.1016/S0092-8674(00)80748-5; Gravitz L, 2011, NATURE, V475, pS9, DOI 10.1038/475S9a; Guerreiro R., 2012, N ENGL J MED; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Harold D, 2009, NAT GENET, V41, P1088, DOI 10.1038/ng.440; Herrup K, 2010, J NEUROSCI, V30, P16755, DOI 10.1523/JNEUROSCI.4521-10.2010; Hokama M, 2014, CEREB CORTEX, V24, P2476, DOI 10.1093/cercor/bht101; Huang HP, 2000, J BIOMED SCI, V7, P27, DOI 10.1159/000025426; Jackson AL, 2003, NAT BIOTECHNOL, V21, P635, DOI 10.1038/nbt831; Jonsson T, 2012, NATURE, V488, P96, DOI 10.1038/nature11283; Kanehisa M, 2002, NOVART FDN SYMP, V247, P91; Kang MJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104617; Kaplow IM, 2009, NAT METHODS, V6, P476, DOI 10.1038/nmeth0709-476; Killick R, 2012, MOL PSYCHIAT; Konig R, 2007, NAT METHODS, V4, P847, DOI 10.1038/NMETH1089; Kwak YD, 2014, BIOCHEM BIOPH RES CO, V447, P394, DOI 10.1016/j.bbrc.2014.03.139; Lambert JC, 2013, NAT GENET, V45, P1452, DOI 10.1038/ng.2802; Lambert JC, 2009, NAT GENET, V41, P1094, DOI 10.1038/ng.439; Levine DM, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r93; Liu P, 2014, NEUROBIOL AGING, V35, P1992, DOI 10.1016/j.neurobiolaging.2014.03.013; Liu P, 2011, NEUROSCIENCE, V193, P269, DOI 10.1016/j.neuroscience.2011.07.054; Luo B, 2008, P NATL ACAD SCI USA, V105, P20380, DOI 10.1073/pnas.0810485105; Majercak J, 2006, P NATL ACAD SCI USA, V103, P17967, DOI 10.1073/pnas.0605461103; Marine S, 2012, J BIOMOL SCREEN, V17, P370, DOI 10.1177/1087057111427348; Matschinsky FM, 2009, NAT REV DRUG DISCOV, V8, P399, DOI 10.1038/nrd2850; Mattson MP, 2006, NAT REV NEUROSCI, V7, P278, DOI 10.1038/nrn1886; Mattson MP, 2004, NATURE, V430, P631, DOI 10.1038/nature02621; Mi HY, 2005, NUCLEIC ACIDS RES, V33, pD284, DOI 10.1093/nar/gki078; Morgan K, 2011, NEUROPATH APPL NEURO, V37, P353, DOI 10.1111/j.1365-2990.2011.01181.x; Nalivaeva NN, 2008, CURR ALZHEIMER RES, V5, P212, DOI 10.2174/156720508783954785; National Diabetes Information Clearinghouse (NDIC) (National Institute of Diabetes and Digestive and Kidney Diseases N, 2007, MON FORMS DIAB NEON; Odom DT, 2004, SCIENCE, V303, P1378, DOI 10.1126/science.1089769; Ong WY, 2013, J ALZHEIMERS DIS, V35, P643, DOI 10.3233/JAD-121990; Parks AL, 2007, TRENDS GENET, V23, P140, DOI 10.1016/j.tig.2007.01.008; Pavlidis Paul, 2002, Pac Symp Biocomput, P474; Ravasz E, 2002, SCIENCE, V297, P1551, DOI 10.1126/science.1073374; Rivkin A, 2010, BIOORG MED CHEM LETT, V20, P2279, DOI 10.1016/j.bmcl.2010.02.008; Schaefer CF, 2009, NUCLEIC ACIDS RES, V37, pD674, DOI 10.1093/nar/gkn653; Sigoillot FD, 2012, NAT METHODS, V9, P363, DOI [10.1038/NMETH.1898, 10.1038/nmeth.1898]; Sigoillot FD, 2011, ACS CHEM BIOL, V6, P47, DOI 10.1021/cb100358f; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sussel L, 1998, DEVELOPMENT, V125, P2213; Tesco G, 2007, NEURON, V54, P721, DOI 10.1016/j.neuron.2007.05.012; Thinakaran G, 2008, J BIOL CHEM, V283, P29615, DOI 10.1074/jbc.R800019200; Town T, 2008, NAT MED, V14, P681, DOI 10.1038/nm1781; Vastrik I, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-3-r39; Wakabayashi T, 2009, NAT CELL BIOL, V11, P1340, DOI 10.1038/ncb1978; Watson GS, 2003, CNS DRUGS, V17, P27, DOI 10.2165/00023210-200317010-00003; Wiesinger H, 2001, PROG NEUROBIOL, V64, P365, DOI 10.1016/S0301-0082(00)00056-3; Wolfe MS, 2002, NAT REV DRUG DISCOV, V1, P859, DOI 10.1038/nrd938; Young-Pearse TL, 2008, NEURAL DEV, V3, DOI 10.1186/1749-8104-3-15; Zhang XD, 2011, BIOINFORMATICS, V27, P2775, DOI 10.1093/bioinformatics/btr474; Zhou LG, 2011, BEHAV BRAIN RES, V222, P274, DOI 10.1016/j.bbr.2011.03.043; Zhou SX, 2007, BIOCHEMISTRY-US, V46, P2553, DOI 10.1021/bi602509c	74	15	15	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2015	10	2							e0115369	10.1371/journal.pone.0115369	http://dx.doi.org/10.1371/journal.pone.0115369			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC3LS	25723573	Green Published, gold			2022-12-27	WOS:000350251200006
J	Burkart-Waco, D; Ngo, K; Lieberman, M; Comai, L				Burkart-Waco, Diana; Ngo, Kathie; Lieberman, Meric; Comai, Luca			Perturbation of Parentally Biased Gene Expression during Interspecific Hybridization	PLOS ONE			English	Article							SEED DEVELOPMENT; DNA METHYLATION; ARABIDOPSIS; ACTIVATION; EVOLUTION; PHERES1; GENOME	Interspecific hybridization often induces epigenetic remodeling that leads to transposon activation, gene expression changes, and loss of imprinting. These genomic changes can be deleterious and contribute to postzygotic hybrid incompatibility. In Arabidopsis, loss of genomic imprinting of PHERES1 and presumed failure of Polycomb Repressive Complex contributes to seed inviability observed in A. thaliana X A. arenosa interspecific hybrids. We used this species pair to further analyze the relationship between parentally biased gene expression and postzygotic hybrid incompatibility using two A. thaliana accessions, Col-0 and C24, with differential seed survival. We found that parentally biased expression was perturbed to a similar degree in both A. thaliana hybrids for PHERES1, HDG3, and six other normally paternally expressed genes. We propose that early genome remodeling and loss of imprinting of seed development genes induces lethality in both compatible and incompatible hybrids.	[Comai, Luca] Univ Calif Davis, Genome Ctr, Davis, CA 95616 USA; Univ Calif Davis, Plant Biol Sect, Davis, CA 95616 USA	University of California System; University of California Davis; University of California System; University of California Davis	Comai, L (corresponding author), Univ Calif Davis, Genome Ctr, Davis, CA 95616 USA.	lcomai@ucdavis.edu	Comai, Luca/F-4279-2010	Comai, Luca/0000-0003-2642-6619	National Institutes of Health [R01 GM076103-01A1]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM076103] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded by National Institutes of Health (www.nih.gov/) R01 GM076103-01A1 (Dosage dependent regulation in hybridization) to LC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams S, 2000, DEVELOPMENT, V127, P2493; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Autran D, 2011, CELL, V145, P707, DOI 10.1016/j.cell.2011.04.014; Barlow DP, 2011, ANNU REV GENET, V45, P379, DOI 10.1146/annurev-genet-110410-132459; Beaudet AL, 2002, AM J HUM GENET, V70, P1389, DOI 10.1086/340969; Belmonte MF, 2013, P NATL ACAD SCI USA, V110, pE435, DOI 10.1073/pnas.1222061110; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Berger F, 2009, TRENDS PLANT SCI, V14, P550, DOI 10.1016/j.tplants.2009.08.003; Burkart-Waco D, 2011, PLANT PHYSL; Burkart-Waco D, 2013, PLANT CELL, V25, P2037, DOI 10.1105/tpc.112.108258; Christodoulou D. C., 2011, CURR PROTOC MOL BIOL, V94, P4121, DOI DOI 10.1002/0471142727.MB0412S94; Clauss MJ, 2006, TRENDS PLANT SCI, V11, P449, DOI 10.1016/j.tplants.2006.07.005; Comai L, 2000, PLANT CELL, V12, P1551, DOI 10.1105/tpc.12.9.1551; Del Toro-De Leon G, 2014, NATURE, V514, P624, DOI 10.1038/nature13620; Dilkes BP, 2004, PLANT CELL, V16, P3174, DOI 10.1105/tpc.104.161230; Gehring M, 2006, CELL, V124, P495, DOI 10.1016/j.cell.2005.12.034; Gehring M, 2004, PLANT CELL, V16, pS203, DOI 10.1105/tpc.017988; Gehring M, 2013, ANNU REV GENET, V47, P187, DOI 10.1146/annurev-genet-110711-155527; Gehring M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023687; Gehring M, 2009, SCIENCE, V324, P1447, DOI 10.1126/science.1171609; Gerald JNF, 2009, DEVELOPMENT, V136, P3399, DOI 10.1242/dev.036921; HAIG D, 1989, AM NAT, V134, P147, DOI 10.1086/284971; Hsieh TF, 2011, P NATL ACAD SCI USA, V108, P1755, DOI 10.1073/pnas.1019273108; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Hurst LD, 1998, CURR OPIN GENET DEV, V8, P701, DOI 10.1016/S0959-437X(98)80040-3; Jahnke S, 2009, CURR BIOL, V19, P1677, DOI 10.1016/j.cub.2009.08.053; Josefsson C, 2006, CURR BIOL, V16, P1322, DOI 10.1016/j.cub.2006.05.045; Jullien PE, 2006, PLANT CELL, V18, P1360, DOI 10.1105/tpc.106.041178; Kinoshita T, 2004, SCIENCE, V303, P521, DOI 10.1126/science.1089835; Kohler C, 2010, HEREDITY, V105, P57, DOI 10.1038/hdy.2009.176; Kohler C, 2006, EMBO REP, V7, P1223, DOI 10.1038/sj.embor.7400854; Kohler C, 2005, NAT GENET, V37, P28, DOI 10.1038/ng1495; Kradolfer D, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003163; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Luo M, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002125; Makarevich G, 2008, J CELL SCI, V121, P906, DOI 10.1242/jcs.023077; Nodine MD, 2012, NATURE, V482, P94, DOI 10.1038/nature10756; PAUL W, 1992, PLANT MOL BIOL, V19, P611, DOI 10.1007/BF00026787; Pignatta D, 2014, ELIFE, V3, DOI 10.7554/eLife.03198; Sharma DR, 1996, EUPHYTICA, V89, P325; Shirzadi R, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001303; Spencer HG, 2014, HEREDITY, V113, P112, DOI 10.1038/hdy.2013.129; Spillane C, 2007, NATURE, V448, P349, DOI 10.1038/nature05984; Thorvaldsdottir H, 2013, BRIEF BIOINFORM, V14, P178, DOI 10.1093/bib/bbs017; Vielle-Calzada JP, 2000, NATURE, V404, P91, DOI 10.1038/35003595; Waters AJ, 2013, P NATL ACAD SCI USA, V110, P19639, DOI 10.1073/pnas.1309182110; Wolff P, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002126; Zilberman D, 2007, NAT GENET, V39, P61, DOI 10.1038/ng1929	48	22	23	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2015	10	2							e0117293	10.1371/journal.pone.0117293	http://dx.doi.org/10.1371/journal.pone.0117293			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC2ZH	25719202	Green Submitted, Green Published, gold			2022-12-27	WOS:000350213200017
J	Dupre, A; Melodelima, D; Perol, D; Chen, Y; Vincenot, J; Chapelon, JY; Rivoire, M				Dupre, Aurelien; Melodelima, David; Perol, David; Chen, Yao; Vincenot, Jeremy; Chapelon, Jean-Yves; Rivoire, Michel			First Clinical Experience of Intra-Operative High Intensity Focused Ultrasound in Patients with Colorectal Liver Metastases: A Phase I-IIa Study	PLOS ONE			English	Article							RADIOFREQUENCY ABLATION; PROSTATE-CANCER; HEPATOCELLULAR-CARCINOMA; HEPATIC RESECTION; HIFU; THERAPY; TUMOR; SURGERY; DEVICE; TRIAL	Background Surgery is the only curative treatment in patients with colorectal liver metastases (CLM), but only 10-20% of patients are eligible. High Intensity Focused Ultrasound (HIFU) technology is of proven value in several indications, notably prostate cancer. Its intra-operative use in patients with CLM has not previously been studied. Preclinical work suggested the safety and feasibility of a new HIFU device capable of ablating volumes of up to 2cm x 2cm in a few seconds. Methods We conducted a prospective, single-centre phase I-IIa trial. HIFU was delivered immediately before scheduled hepatectomy. To demonstrate the safety and efficacy of rapidly ablating liver parenchyma, ablations were performed on healthy tissue within the areas scheduled for resection. Results In total, 30 ablations were carried out in 15 patients. These ablations were all generated within 40 seconds and on average measured 27.5mm x 21.0mm. The phase I study (n = 6) showed that use of the HIFU device was feasible and safe and did not damage neighbouring tissue. The phase IIa study (n = 9) showed both that the area of ablation could be precisely targeted on a previously implanted metallic mark (used to represent a major anatomical structure) and that ablations could be undertaken deliberately to avoid such a mark. Ablations were achieved with a precision of 1-2mm. Conclusion HIFU was feasible, safe and effective in ablating areas of liver scheduled for resection. The next stage is a phase IIb study which will attempt ablation of small metastases with a 5 mm margin, again prior to planned resection.	[Dupre, Aurelien; Chen, Yao; Rivoire, Michel] Ctr Leon Berard, Dept Surg Oncol, F-69373 Lyon, France; [Dupre, Aurelien; Melodelima, David; Vincenot, Jeremy; Chapelon, Jean-Yves; Rivoire, Michel] Univ Lyon, INSERM, U1032, LabTau, Lyon, France; [Perol, David] Ctr Leon Berard, Biostat & Treatment Evaluat Unit, F-69373 Lyon, France	UNICANCER; Centre Leon Berard; Institut National de la Sante et de la Recherche Medicale (Inserm); UNICANCER; Centre Leon Berard	Rivoire, M (corresponding author), Ctr Leon Berard, Dept Surg Oncol, F-69373 Lyon, France.	Michel.rivoire@lyon.unicancer.fr	Melodelima, David/N-4670-2017; dupré, aurélien/J-4027-2019; d, p/GWC-4283-2022; Melodelima, David/AAR-7183-2020	dupré, aurélien/0000-0002-5216-538X; Melodelima, David/0000-0003-3913-1270	Autism Speaks and Molecular Biosciences Training Grant (National Institutes of Health) [T32 GM007215, R01 GM044783 (NIH)]	Autism Speaks and Molecular Biosciences Training Grant (National Institutes of Health)	This work was supported by Dennis Weatherstone Predoctoral Fellowship from Autism Speaks and Molecular Biosciences Training Grant T32 GM007215 (National Institutes of Health) to SBJ, and Grant R01 GM044783 (NIH) to RTR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam R, 2000, ANN SURG, V232, P777, DOI 10.1097/00000658-200012000-00006; Bickenbach KA, 2013, ANN SURG ONCOL, V20, P2029, DOI 10.1245/s10434-012-2813-5; Crouzet S, 2014, EUR UROL, V65, P907, DOI 10.1016/j.eururo.2013.04.039; D'Hondt M, 2011, HPB, V13, P665, DOI 10.1111/j.1477-2574.2011.00349.x; Des Jarlais DC, 2004, AM J PUBLIC HEALTH, V94, P361, DOI 10.2105/AJPH.94.3.361; Evrard S, 2012, BRIT J SURG, V99, P558, DOI [10.1002/bjs.8665, 10.1002/bjs.8724]; Folprecht G, 2005, ANN ONCOL, V16, P1311, DOI 10.1093/annonc/mdi246; Illing RO, 2005, BRIT J CANCER, V93, P890, DOI 10.1038/sj.bjc.6602803; Jung SE, 2011, ABDOM IMAGING, V36, P185, DOI 10.1007/s00261-010-9628-2; LEE YJ, 1981, SEMIN ONCOL, V8, P403; Leyendecker JR, 2002, AM J ROENTGENOL, V178, P1147, DOI 10.2214/ajr.178.5.1781147; McCulloch P, 2009, LANCET, V374, P1105, DOI 10.1016/S0140-6736(09)61116-8; Melodelima D, 2009, PHYS MED BIOL, V54, P6353, DOI 10.1088/0031-9155/54/20/021; Melodelima D, 2009, ULTRASOUND MED BIOL, V35, P425, DOI 10.1016/j.ultrasmedbio.2008.09.020; Melodelima D, 2007, APPL PHYS LETT, V91, DOI 10.1063/1.2805113; N'Djin WA, 2011, MED PHYS, V38, P1769, DOI 10.1118/1.3551985; N'Djin WA, 2008, ULTRASOUND MED BIOL, V34, P1934, DOI 10.1016/j.ultrasmedbio.2008.04.012; Nordlinger B, 2013, LANCET ONCOL, V14, P1208, DOI 10.1016/S1470-2045(13)70447-9; Parmentier H, 2009, ANN SURG, V249, P129, DOI 10.1097/SLA.0b013e31818c70b6; Pawlik TM, 2008, ONCOLOGIST, V13, P51, DOI 10.1634/theoncologist.2007-0142; Poissonnier L, 2007, EUR UROL, V51, P381, DOI 10.1016/j.eururo.2006.04.012; Rosenthal R, 2013, ANN SURG, V257, P1007, DOI 10.1097/SLA.0b013e318283cf7f; Ruers T, 2012, ANN ONCOL, V23, P2619, DOI 10.1093/annonc/mds053; Skinner MG, 1998, PHYS MED BIOL, V43, P3535, DOI 10.1088/0031-9155/43/12/011; Tanter M, 2007, INT J HYPERTHER, V23, P141, DOI 10.1080/02656730701209996; Ter Haar G, 2007, INT J HYPERTHER, V23, P89, DOI 10.1080/02656730601186138; Uchida T, 2012, INT J UROL, V19, P187, DOI 10.1111/j.1442-2042.2011.02936.x; Wu F, 2005, RADIOLOGY, V235, P659, DOI 10.1148/radiol.2352030916; Wu YZ, 2011, WORLD J GASTROENTERO, V17, P4143, DOI 10.3748/wjg.v17.i36.4143; Zhu H, 2009, EUR J RADIOL, V72, P160, DOI 10.1016/j.ejrad.2008.07.003	30	29	30	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2015	10	2							e0118212	10.1371/journal.pone.0118212	http://dx.doi.org/10.1371/journal.pone.0118212			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC2ZH	25719540	Green Published, Green Submitted, gold			2022-12-27	WOS:000350213200042
J	Farooqui, A; Khan, A; Borghetto, I; Kazmi, SU; Rubino, S; Paglietti, B				Farooqui, Amber; Khan, Adnan; Borghetto, Ilaria; Kazmi, Shahana U.; Rubino, Salvatore; Paglietti, Bianca			Synergistic Antimicrobial Activity of Camellia sinensis and Juglans regia against Multidrug-Resistant Bacteria	PLOS ONE			English	Article							INTENSIVE-CARE UNITS; IN-VITRO ACTIVITIES; STAPHYLOCOCCUS-AUREUS; ACINETOBACTER-BAUMANNII; ANTIBACTERIAL ACTIVITY; DRUG-RESISTANCE; COMBINATION; AGENTS; MRSA; CHECKERBOARD	Synergistic combinations of antimicrobial agents with different mechanisms of action have been introduced as more successful strategies to combat infections involving multidrug resistant (MDR) bacteria. In this study, we investigated synergistic antimicrobial activity of Camellia sinensis and Juglans regia which are commonly used plants with different antimicrobial agents. Antimicrobial susceptibility of 350 Gram-positive and Gram-negative strains belonging to 10 different bacterial species, was tested against Camellia sinensis and Juglans regia extracts. Minimum inhibitory concentrations (MICs) were determined by agar dilution and microbroth dilution assays. Plant extracts were tested for synergistic antimicrobial activity with different antimicrobial agents by checkerboard titration, Etest/agar incorporation assays, and time kill kinetics. Extract treated and untreated bacteria were subjected to transmission electron microscopy to see the effect on bacterial cell morphology. Camellia sinensis extract showed higher antibacterial activity against MDR S. Typhi, alone and in combination with nalidixic acid, than to susceptible isolates." We further explore anti-staphylococcal activity of Juglans regia that lead to the changes in bacterial cell morphology indicating the cell wall of Gram-positive bacteria as possible target of action. The synergistic combination of Juglans regia and oxacillin reverted oxacillin resistance of methicillin resistant Staphylococcus aureus (MRSA) strains in vitro. This study provides novel information about antimicrobial and synergistic activity of Camellia sinensis and Juglans regia against MDR pathogens	[Farooqui, Amber; Khan, Adnan; Kazmi, Shahana U.] Univ Karachi, Dept Microbiol, Immunol & Infect Dis Res Lab, Karachi, Pakistan; [Farooqui, Amber; Khan, Adnan; Borghetto, Ilaria; Rubino, Salvatore; Paglietti, Bianca] Univ Sassari, Dept Biomed Sci, I-07100 Sassari, Italy; [Farooqui, Amber] Shantou Univ, Coll Med, Int Inst Infect & Immun, Div Immunol, Shantou, Guangdong, Peoples R China; [Rubino, Salvatore] King Faisal Specialist Hosp & Res Ctr, Dept Infect & Immun, Riyadh 11211, Saudi Arabia	University of Karachi; University of Sassari; Shantou University; King Faisal Specialist Hospital & Research Center	Farooqui, A (corresponding author), Univ Karachi, Dept Microbiol, Immunol & Infect Dis Res Lab, Karachi, Pakistan.	amberfarooqui@hotmail.com	Barac, Aleksandra/W-9785-2019; Rubino, Salvatore/AAC-5848-2022	Farooqui, Amber/0000-0002-6031-9561; PAGLIETTI, Bianca/0000-0002-2568-0642	Higher Education Commission of Pakistan; Sardinian Region [LR7-2008 - CRP1_381]	Higher Education Commission of Pakistan(Higher Education Commission of Pakistan); Sardinian Region(Regione Sardegna)	The study was supported by the grants of Higher Education Commission of Pakistan (http://hec.gov.pk) which were awarded to Amber Farooqui and Adnan Khan for PhD in Science and Technology. Partial support was also provided by the grant of Sardinian Region (grant number LR7-2008 - CRP1_381) awarded to Salvatore Rubino and Bianca Paglietti. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abreu AC, 2012, NAT PROD REP, V29, P1007, DOI 10.1039/c2np20035j; Ahmad A, 2014, MOLECULES, V19, P2896, DOI 10.3390/molecules19032896; Akram Farhana, 2014, ISRN Microbiol, V2014, P469758, DOI 10.1155/2014/469758; Ali NH, 2007, PAK J PHARM SCI, V20, P140; Ali NH, 2010, J INFECT DEV COUNTR, V4, P382, DOI 10.3855/jidc.599; Allegranzi B, 2011, LANCET, V377, P228, DOI 10.1016/S0140-6736(10)61458-4; BECK WD, 1986, J BACTERIOL, V165, P373, DOI 10.1128/jb.165.2.373-378.1986; Begum S, 2012, NAT PROD RES, V26, P2084, DOI 10.1080/14786419.2011.625502; Cetin ES, 2013, JPN J INFECT DIS, V66, P463, DOI 10.7883/yoken.66.463; Chan EWC, 2011, PHARMACOGN RES, V3, P266, DOI 10.4103/0974-8490.89748; Coates ARM, 2011, BRIT J PHARMACOL, V163, P184, DOI 10.1111/j.1476-5381.2011.01250.x; Cockerill FR, 2013, PERFORMANCE STANDARD; Cowan MM, 1999, CLIN MICROBIOL REV, V12, P564, DOI 10.1128/CMR.12.4.564; Ghosh S, 2012, BIOTECHNOL ADV, V30, P1425, DOI 10.1016/j.biotechadv.2012.03.001; Gordon NC, 2010, INT J ANTIMICROB AG, V36, P129, DOI 10.1016/j.ijantimicag.2010.03.025; Grubb WB, 1998, REV MED MICROBIOL, V9, P153; Hamilton-Miller JMT, 2000, J ANTIMICROB CHEMOTH, V46, P852, DOI 10.1093/jac/46.5.852; HAMILTONMILLER JMT, 1995, ANTIMICROB AGENTS CH, V39, P2375, DOI 10.1128/AAC.39.11.2375; Hartmann M, 2010, ANTIMICROB AGENTS CH, V54, P3132, DOI 10.1128/AAC.00124-10; Iyer A, 2014, J INFECT DEV COUNTR, V8, P372, DOI 10.3855/jidc.3589; Jain S, 2013, J INFECT DEV COUNTR, V7, P788, DOI 10.3855/jidc.3030; Klancnik A, 2010, J MICROBIOL METH, V81, P121, DOI 10.1016/j.mimet.2010.02.004; Klitgaard JK, 2008, J ANTIMICROB CHEMOTH, V62, P1215, DOI 10.1093/jac/dkn417; Kristiansen JE, 2007, J ANTIMICROB CHEMOTH, V59, P1271, DOI 10.1093/jac/dkm071; Moellering RC, 2012, J ANTIMICROB CHEMOTH, V67, P4, DOI 10.1093/jac/dkr437; Nariman F, 2004, HELICOBACTER, V9, P146, DOI 10.1111/j.1083-4389.2004.00211.x; Noumi E, 2010, EUR J CLIN MICROBIOL, V29, P81, DOI 10.1007/s10096-009-0824-3; Oliveira I, 2008, FOOD CHEM TOXICOL, V46, P2326, DOI 10.1016/j.fct.2008.03.017; Pereira JA, 2007, FOOD CHEM TOXICOL, V45, P2287, DOI 10.1016/j.fct.2007.06.004; Petersen PJ, 2006, J ANTIMICROB CHEMOTH, V57, P573, DOI 10.1093/jac/dki477; Pinho MG, 2001, J BACTERIOL, V183, P6525, DOI 10.1128/JB.183.22.6525-6531.2001; Rojas Jhon J, 2006, BMC Complement Altern Med, V6, P2, DOI 10.1186/1472-6882-6-2; Shetty Mamatha, 1994, Journal of Communicable Diseases, V26, P147; Sopirala MM, 2010, ANTIMICROB AGENTS CH, V54, P4678, DOI 10.1128/AAC.00497-10; Taguri T, 2004, BIOL PHARM BULL, V27, P1965, DOI 10.1248/bpb.27.1965; Timurkaynak F, 2006, INT J ANTIMICROB AG, V27, P224, DOI 10.1016/j.ijantimicag.2005.10.012; Vernet G, 2014, EMERG INFECT DIS, V20, P434, DOI [10.3201/eid2003.121157, 10.3201/EID2003.121157]; Vincent JL, 2009, JAMA-J AM MED ASSOC, V302, P2323, DOI 10.1001/jama.2009.1754; Yam TS, 1997, FEMS MICROBIOL LETT, V152, P169, DOI 10.1016/S0378-1097(97)00197-3; Zhao WH, 2001, ANTIMICROB AGENTS CH, V45, P1737, DOI 10.1128/AAC.45.6.1737-1742.2001	40	49	52	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2015	10	2							e0118431	10.1371/journal.pone.0118431	http://dx.doi.org/10.1371/journal.pone.0118431			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC2ZH	25719410	gold, Green Published, Green Submitted			2022-12-27	WOS:000350213200054
J	Hashimoto, O; Ohtsuki, H; Kakizaki, T; Amou, K; Sato, R; Doi, S; Kobayashi, S; Matsuda, A; Sugiyama, M; Funaba, M; Matsuishi, T; Terasawa, F; Shindo, J; Endo, H				Hashimoto, Osamu; Ohtsuki, Hirofumi; Kakizaki, Takehiko; Amou, Kento; Sato, Ryo; Doi, Satoru; Kobayashi, Sara; Matsuda, Ayaka; Sugiyama, Makoto; Funaba, Masayuki; Matsuishi, Takashi; Terasawa, Fumio; Shindo, Junji; Endo, Hideki			Brown Adipose Tissue in Cetacean Blubber	PLOS ONE			English	Article							PHOCOENA-PHOCOENA; ADULT HUMANS; ADIPOCYTES; EXPRESSION; DISTINCT; MUSCLE; PRDM16; BEIGE; FAT	Brown adipose tissue (BAT) plays an important role in thermoregulation in species living in cold environments, given heat can be generated from its chemical energy reserves. Here we investigate the existence of BAT in blubber in four species of delphinoid cetacean, the Pacific white-sided and bottlenose dolphins, Lagenorhynchus obliquidens and Tursiops truncates, and Dall's and harbour porpoises, Phocoenoides dalli and Phocoena phocoena. Histology revealed adipocytes with small unilocular fat droplets and a large eosinophilic cytoplasm intermingled with connective tissue in the innermost layers of blubber. Chemistry revealed a brown adipocyte-specific mitochondrial protein, uncoupling protein 1 (UCP1), within these same adipocytes, but not those distributed elsewhere throughout the blubber. Western blot analysis of extracts from the inner blubber layer confirmed that the immunohistochemical positive reaction was specific to UCP1 and that this adipose tissue was BAT. To better understand the distribution of BAT throughout the entire cetacean body, cadavers were subjected to computed tomography (CT) scanning. Resulting imagery, coupled with histological corroboration of fine tissue structure, revealed adipocytes intermingled with connective tissue in the lowest layer of blubber were distributed within a thin, highly dense layer that extended the length of the body, with the exception of the rostrum, fin and fluke regions. As such, we describe BAT effectively enveloping the cetacean body. Our results suggest that delphinoid blubber could serve a role additional to those frequently attributed to it: simple insulation blanket, energy storage, hydrodynamic streamlining or contributor to positive buoyancy. We believe delphinoid BAT might also function like an electric blanket, enabling animals to frequent waters cooler than blubber as an insulator alone might otherwise allow an animal to withstand, or allow animals to maintain body temperature in cool waters during sustained periods of physical inactivity.	[Hashimoto, Osamu; Ohtsuki, Hirofumi; Kakizaki, Takehiko; Amou, Kento; Sato, Ryo; Doi, Satoru; Sugiyama, Makoto; Shindo, Junji] Kitasato Univ Sch Vet Med, Towada, Aomori 0348628, Japan; [Kobayashi, Sara; Endo, Hideki] Univ Tokyo, Univ Museum, Bunkyo Ku, Tokyo 1130033, Japan; [Matsuda, Ayaka; Matsuishi, Takashi] Hokkaido Univ, Grad Sch Fisheries Sci, Fac Fisheries Sci, Hakodate, Hokkaido 0418611, Japan; [Funaba, Masayuki] Kyoto Univ Grad Sch Agr, Div Appl Biosci, Kyoto 6068502, Japan; [Terasawa, Fumio] Enoshima Aquarium, Fujisawa, Kanagawa 2510035, Japan	University of Tokyo; Hokkaido University; Kyoto University	Hashimoto, O (corresponding author), Kitasato Univ Sch Vet Med, Towada, Aomori 0348628, Japan.	ohashim@vmas.kitasato-u.ac.jp	Funaba, Masayuki/E-4676-2018; Matsuishi, Takashi Fritz/C-7005-2012; SUGIYAMA, Makoto/AAD-5585-2020	Funaba, Masayuki/0000-0002-4303-6682; Matsuishi, Takashi Fritz/0000-0003-0884-3523; SUGIYAMA, Makoto/0000-0001-9340-6015; Kakizaki, Takehiko/0000-0001-7694-0064	Enoshima Aquarium; Grants-in-Aid for Scientific Research [25304005] Funding Source: KAKEN	Enoshima Aquarium; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	The authors received no specific funding for this work. Co-author Fumio Terasawa is employed by Enoshima Aquarium. Enoshima Aquarium provided support in the form of salary for author FT, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.	AGUILAR A, 1991, MAR ENVIRON RES, V31, P275, DOI 10.1016/0141-1136(91)90017-3; Asano H, 2013, GEN COMP ENDOCR, V184, P87, DOI 10.1016/j.ygcen.2013.01.006; Cannon B, 2004, PHYSIOL REV, V84, P277, DOI 10.1152/physrev.00015.2003; Castellini M, 2009, ENCYCLOPEDIA OF MARINE MAMMALS, 2ND EDITION, P1166; Cypess AM, 2013, NAT MED, V19, P635, DOI 10.1038/nm.3112; Cypess AM, 2009, NEW ENGL J MED, V360, P1509, DOI 10.1056/NEJMoa0810780; DAVYDOV AF, 1965, FED PROC, V24, pT563; Dearolf JL, 2000, J MORPHOL, V244, P203, DOI 10.1002/(SICI)1097-4687(200006)244:3<203::AID-JMOR5>3.0.CO;2-V; Doidge D.W., 1990, Canadian Bulletin of Fisheries and Aquatic Sciences, V224, P129; Fruhbeck G, 2009, TRENDS CELL BIOL, V19, P141, DOI 10.1016/j.tcb.2009.01.007; Gessner K., LIB I DE QUADRIPEDIB, V1551, P842; Gesta S, 2007, CELL, V131, P242, DOI 10.1016/j.cell.2007.10.004; GRAV HJ, 1974, ACTA PHYSIOL SCAND, V92, P427; Hamilton JL, 2004, J MORPHOL, V261, P105, DOI 10.1002/jmor.10232; Hashimoto O, 2006, BIOCHEM BIOPH RES CO, V341, P416, DOI 10.1016/j.bbrc.2005.12.205; Ishibashi J, 2010, SCIENCE, V328, P1113, DOI 10.1126/science.1190816; Kipps EK, 2002, MAR MAMMAL SCI, V18, P765, DOI 10.1111/j.1748-7692.2002.tb01072.x; Koopman HN, 1998, J MAMMAL, V79, P260, DOI 10.2307/1382862; Koopman HN, 1996, J COMP PHYSIOL B, V165, P628, DOI 10.1007/BF00301131; Lee P, 2013, ENDOCR REV, V34, P413, DOI 10.1210/er.2012-1081; Lichtenbelt WDV, 2009, NEW ENGL J MED, V360, P1500, DOI 10.1056/NEJMoa0808718; Lilly J. C., 1964, HDB PHYSL ENV, P741; McLellan WA, 2002, J ZOOL, V257, P457, DOI 10.1017/S0952836902001061; Nakamura K, 2007, AM J PHYSIOL-REG I, V292, pR127, DOI 10.1152/ajpregu.00427.2006; PARRY DA, 1949, Q J MICROSC SCI, V90, P13; Pearson LE, 2014, J THERM BIOL, V44, P93, DOI 10.1016/j.jtherbio.2014.02.001; Petrovic N, 2010, J BIOL CHEM, V285, P7153, DOI 10.1074/jbc.M109.053942; Saito M, 2009, DIABETES, V58, P1526, DOI 10.2337/db09-0530; Seale P, 2008, NATURE, V454, P961, DOI 10.1038/nature07182; Sekiguchi Y, 2003, PHYSIOL BEHAV, V79, P643, DOI 10.1016/S0031-9384(03)00119-7; Suzuki M, 2012, GEN COMP ENDOCR, V177, P76, DOI 10.1016/j.ygcen.2012.02.010; Virtanen KA, 2009, NEW ENGL J MED, V360, P1518, DOI 10.1056/NEJMoa0808949; WORTHY GAJ, 1990, PHYSIOL ZOOL, V63, P432, DOI 10.1086/physzool.63.2.30158506; Wu J, 2012, CELL, V150, P366, DOI 10.1016/j.cell.2012.05.016	34	22	23	2	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2015	10	2							e0116734	10.1371/journal.pone.0116734	http://dx.doi.org/10.1371/journal.pone.0116734			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC2ZH	25719384	gold, Green Published, Green Submitted			2022-12-27	WOS:000350213200011
J	Hong, S; Yi, SW; Sull, JW; Hong, JS; Jee, SH; Ohrr, H				Hong, Seri; Yi, Sang-Wook; Sull, Jae Woong; Hong, Jae-Seok; Jee, Sun Ha; Ohrr, Heechoul			Body Mass Index and Mortality among Korean Elderly in Rural Communities: Kangwha Cohort Study	PLOS ONE			English	Article							OBESITY; OVERWEIGHT; RISK; MEN; BMI; ASSOCIATION; PREVALENCE; ADULTS	Background The relationship between body mass index (BMI) and mortality may differ by ethnicity, but its exact nature remains unclear among Koreans. The study aim was to prospectively examine the association between BMI and mortality in Korean. Methods 6166 residents (2636 men; 3530 women) of rural communities (Kangwha County, Republic of Korea) aged 55 and above were followed up for deaths from 1985-2008. The multivariable-adjusted hazard ratios were calculated using the Cox proportional hazards model. Results During the 23.8 years of follow-up (an average of 12.5 years in men and 15.7 years in women), 2174 men and 2372 women died. Men with BMI of 21.0-27.4 and women with BMI of 20.0-27.4 had a minimal risk for all-cause mortality. A lower BMI as well as a higher BMI increased the hazard ratio of death. For example, multivariable-adjusted hazard ratios associated with BMI below 16, and with BMI of 27.5 and above, were 2.4 (95% CI = 1.6-3.5) and 1.5 (95% CI = 1.1-1.9) respectively, in men, compared to those with BMI of 23.0-24.9. This reverse J-curve association was maintained among never smokers, and among people with no known chronic diseases. Higher BMI increased vascular mortality, while lower BMI increased deaths from vascular diseases, cancers, and, especially, respiratory diseases. Except for cancers, these associations were generally weaker in women than in men. Conclusions A reverse J-curve association between BMI and all-cause mortality may exist. BMI of 21-27.4 (rather than the range suggested by WHO of 18.5-23 for Asians) may be considered a normal range with acceptable risk in Koreans aged 55 and above, and may be used as cut points for interventions. More concern should be given to people with BMI above and below a BMI range with acceptable risk. Further studies are needed to determine ethnicity-specific associations.	[Hong, Seri] Yonsei Univ, Dept Prevent Med, Grad Sch Publ Hlth, Seoul 120749, South Korea; [Hong, Seri] Yonsei Univ Grad Sch, Dept Publ Hlth, Seoul, South Korea; [Yi, Sang-Wook] Catholic Kwandong Univ Coll Med, Dept Prevent Med & Publ Hlth, Kangnung, South Korea; [Sull, Jae Woong] Eulji Univ Coll Hlth Sci, Dept Biomed Lab Sci, Sungnam, South Korea; [Hong, Jae-Seok] Hlth Insurance Review & Assessment Serv, Seoul, South Korea; [Jee, Sun Ha] Yonsei Univ, Dept Epidemiol & Hlth Promot, Grad Sch Publ Hlth, Seoul 120749, South Korea; [Jee, Sun Ha; Ohrr, Heechoul] Yonsei Univ, Grad Sch Publ Hlth, Inst Hlth Promot, Seoul 120749, South Korea; [Ohrr, Heechoul] Yonsei Univ Coll Med, Dept Prevent Med, Seoul, South Korea	Yonsei University; Yonsei University Health System; Catholic Kwandong University; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System	Yi, SW (corresponding author), Catholic Kwandong Univ Coll Med, Dept Prevent Med & Publ Hlth, Kangnung, South Korea.	flyhigh@cku.ac.kr		Yi, Sang-Wook/0000-0002-6656-6205	Korea Science and Engineering Foundation - Ministry of Science and Technology of Korea [KOSEF: R-01-1993-000-00073-0]	Korea Science and Engineering Foundation - Ministry of Science and Technology of Korea	Original survey was supported by a Korea Science and Engineering Foundation grant (KOSEF: R-01-1993-000-00073-0) funded by the Ministry of Science and Technology of Korea. The authors received no specific funding for the analysis of data in this study. The funder had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bei-Fan Z, 2002, ASIA PAC J CLIN NUTR, V11, pS685, DOI 10.1046/j.1440-6047.11.s8.9.x; BRAMER G R, 1988, World Health Statistics Quarterly, V41, P32; Chen Y, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f5446; Chiolero A, 2007, OBES REV, V8, P373, DOI 10.1111/j.1467-789X.2007.00375.x; Flegal KM, 2013, OBESITY, V21, P1744, DOI 10.1002/oby.20588; Flegal KM, 2013, JAMA-J AM MED ASSOC, V309, P71, DOI 10.1001/jama.2012.113905; Flegal KM, 2011, AM J EPIDEMIOL, V173, P1, DOI 10.1093/aje/kwq341; Flegal KM, 2005, JAMA-J AM MED ASSOC, V293, P1861, DOI 10.1001/jama.293.15.1861; Goh VHH, 2004, J LIPID RES, V45, P1892, DOI 10.1194/jlr.M400159-JLR200; Hong JS, 2007, ANN EPIDEMIOL, V17, P622, DOI 10.1016/j.annepidem.2007.03.004; Jackson CL, 2014, OBESITY, V22, P842, DOI 10.1002/oby.20471; Janssen I, 2007, OBES REV, V8, P41, DOI 10.1111/j.1467-789X.2006.00248.x; Jee SH, 2006, NEW ENGL J MED, V355, P779, DOI 10.1056/NEJMoa054017; Kim DM, 2005, OBES REV, V6, P117, DOI 10.1111/j.1467-789X.2005.00173.x; Kvamme JM, 2012, J EPIDEMIOL COMMUN H, V66, P611, DOI 10.1136/jech.2010.123232; Lopez-Jimenez F, 2009, LANCET, V373, P1055, DOI 10.1016/S0140-6736(09)60628-0; Mathus-Vliegen EMH, 2012, OBESITY FACTS, V5, P460, DOI 10.1159/000341193; Shiwaku K, 2004, INT J OBESITY, V28, P152, DOI 10.1038/sj.ijo.0802486; Song YM, 2001, EPIDEMIOLOGY, V12, P173, DOI 10.1097/00001648-200103000-00008; Thorogood M, 2003, J EPIDEMIOL COMMUN H, V57, P130, DOI 10.1136/jech.57.2.130; von Elm E, 2007, EPIDEMIOLOGY, V18, P800, DOI 10.1097/EDE.0b013e3181577654; WANG J, 1994, AM J CLIN NUTR, V60, P23, DOI 10.1093/ajcn/60.1.23; Whitlock G, 2009, LANCET, V373, P1083, DOI 10.1016/S0140-6736(09)60318-4; WHO, 2004, LANCET, V363, P902; World Health Organization, 2000, AS PAC PERSP RED OB; Yi SW, 2010, J EPIDEMIOL, V20, P204, DOI 10.2188/jea.JE20090077; Yi SW, 2009, STROKE, V40, P3428, DOI 10.1161/STROKEAHA.109.555144; Zheng W, 2011, NEW ENGL J MED, V364, P719, DOI 10.1056/NEJMoa1010679	28	14	16	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2015	10	2							e0117731	10.1371/journal.pone.0117731	http://dx.doi.org/10.1371/journal.pone.0117731			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC2ZH	25719567	Green Published, gold, Green Submitted			2022-12-27	WOS:000350213200029
J	Lopes, JLS; Beltramini, LM; Wallace, BA; Araujo, APU				Lopes, Jose L. S.; Beltramini, Leila M.; Wallace, Bonnie A.; Araujo, Ana P. U.			Deconstructing the DGAT1 Enzyme: Membrane Interactions at Substrate Binding Sites	PLOS ONE			English	Article							ACYLTRANSFERASE 1 DGAT1; COA-DIACYLGLYCEROL ACYLTRANSFERASE; N-TERMINAL FRAGMENT; HEPATIC STEATOSIS; MILK-YIELD; INHIBITORS; GENE; IDENTIFICATION	Diacylglycerol acyltransferase 1 (DGAT1) is a key enzyme in the triacylglyceride synthesis pathway. Bovine DGAT1 is an endoplasmic reticulum membrane-bound protein associated with the regulation of fat content in milk and meat. The aim of this study was to evaluate the interaction of DGAT1 peptides corresponding to putative substrate binding sites with different types of model membranes. Whilst these peptides are predicted to be located in an extramembranous loop of the membrane-bound protein, their hydrophobic substrates are membrane-bound molecules. In this study, peptides corresponding to the binding sites of the two substrates involved in the reaction were examined in the presence of model membranes in order to probe potential interactions between them that might influence the subsequent binding of the substrates. Whilst the conformation of one of the peptides changed upon binding several types of micelles regardless of their surface charge, suggesting binding to hydrophobic domains, the other peptide bound strongly to negatively-charged model membranes. This binding was accompanied by a change in conformation, and produced leakage of the liposome-entrapped dye calcein. The different hydrophobic and electrostatic interactions observed suggest the peptides may be involved in the interactions of the enzyme with membrane surfaces, facilitating access of the catalytic histidine to the triacylglycerol substrates.	[Lopes, Jose L. S.; Beltramini, Leila M.; Araujo, Ana P. U.] Univ Sao Paulo, Inst Fis Sao Carlos, Sao Carlos, SP, Brazil; [Wallace, Bonnie A.] Univ London, Birkbeck Coll, Inst Struct & Mol Biol, London, England	Universidade de Sao Paulo; University of London; Birkbeck University London	Wallace, BA (corresponding author), Univ London, Birkbeck Coll, Inst Struct & Mol Biol, London, England.	b.wallace@mail.cryst.bbk.ac.uk; anapaula@ifsc.usp.br	Lopes, Jose Luiz S/AAC-2917-2021; Araujo, Ana Paula U/I-6664-2012; Lopes, Jose L S/D-3213-2012; Beltramini, Leila M/I-5523-2012; Wallace, B A/C-3753-2008	Araujo, Ana Paula U/0000-0001-5455-084X; Lopes, Jose L S/0000-0003-1281-0521; Beltramini, Leila M/0000-0001-5741-8238; Wallace, B A/0000-0001-9649-5092	Sao Paulo Research Foundation (FAPESP) [2009/17698-5, 2010/13036-5]; UK Biotechnology and Biological Sciences Research Council (BBSRC) [H023852, J019135]; BBSRC [J019747]; Brazil National Council of Technological and Scientific Development (CNPq) [553056/2011-5, 407337/2013-0]; BBSRC [BB/H023852/1, BB/J019747/1, BB/J019135/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/H023852/1, BB/J019135/1, BB/J019747/1, BBS/B/02959] Funding Source: researchfish	Sao Paulo Research Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); UK Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Brazil National Council of Technological and Scientific Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by a fellowship from Sao Paulo Research Foundation (FAPESP) to JLSL, grants 2009/17698-5 and 2010/13036-5; and grants H023852 and J019135 from the UK Biotechnology and Biological Sciences Research Council (BBSRC) (to BAW); and paired UK-Brazil partnering grants from the BBSRC (to BAW grant J019747) and Brazil National Council of Technological and Scientific Development (CNPq) to APUA, grants 553056/2011-5 and 407337/2013-0. Access to the Synchrotron Radiation Circular Dichroism (SRCD) beamlines at ISA (Aarhus, Denmark) and ANKA (Karlsruhe, Germany) was enabled by beamtime grants (to BAW and JLSL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAPTISTA MD, 1992, J PHYS CHEM-US, V96, P6442, DOI 10.1021/j100194a063; Birch AM, 2010, CURR OPIN DRUG DISC, V13, P489; Buszczak M, 2002, GENETICS, V160, P1511; Cao JS, 2011, J BIOL CHEM, V286, P41838, DOI 10.1074/jbc.M111.245456; Cases S, 1998, P NATL ACAD SCI USA, V95, P13018, DOI 10.1073/pnas.95.22.13018; Chen HC, 2000, TRENDS CARDIOVAS MED, V10, P188, DOI 10.1016/S1050-1738(00)00066-9; Cheng D, 2001, BIOCHEM J, V359, P707, DOI 10.1042/0264-6021:3590707; Coleman RA, 2000, ANNU REV NUTR, V20, P77, DOI 10.1146/annurev.nutr.20.1.77; Colon-Gonzalez F, 2006, BBA-MOL CELL BIOL L, V1761, P827, DOI 10.1016/j.bbalip.2006.05.001; DAVISON SC, 1974, BIOCHEMISTRY-US, V140, P461, DOI 10.1042/bj1400461; DeVita RJ, 2013, J MED CHEM, V56, P9820, DOI 10.1021/jm4007033; Dickey A, 2008, BIOPHYS J, V95, P2636, DOI 10.1529/biophysj.107.128074; Fasman G.D., 1996, CIRCULAR DICHROISM C; Grisart B, 2004, P NATL ACAD SCI USA, V101, P2398, DOI 10.1073/pnas.0308518100; Grisart B, 2002, GENOME RES, V12, P222, DOI 10.1101/gr.224202; Kelly SM, 2005, BBA-PROTEINS PROTEOM, V1751, P119, DOI 10.1016/j.bbapap.2005.06.005; Lakowicz J. R., 2002, PROTEIN FLUORESCENCE; Lees JG, 2004, ANAL BIOCHEM, V332, P285, DOI 10.1016/j.ab.2004.06.002; Lopes JLS, 2014, BBA-BIOMEMBRANES, V1838, P3145, DOI 10.1016/j.bbamem.2014.08.017; Matsuda D, 2007, CURR OPIN INVEST DR, V8, P836; MCCLARE CWF, 1971, ANAL BIOCHEM, V39, P527, DOI 10.1016/0003-2697(71)90443-X; McFie PJ, 2010, J BIOL CHEM, V285, P37377, DOI 10.1074/jbc.M110.163691; Monetti M, 2007, CELL METAB, V6, P69, DOI 10.1016/j.cmet.2007.05.005; Moreira LM, 2008, COLLOID SURFACE B, V61, P153, DOI 10.1016/j.colsurfb.2007.07.010; Schibli DJ, 1999, BIOCHEMISTRY-US, V38, P16749, DOI 10.1021/bi990701c; Siloto RMP, 2008, BIOCHEM BIOPH RES CO, V373, P350, DOI 10.1016/j.bbrc.2008.06.031; Subauste Angela, 2003, Current Drug Targets - Immune Endocrine and Metabolic Disorders, V3, P263, DOI 10.2174/1568008033340081; Talhari DT, 2009, BBA-BIOMEMBRANES, V1788, P2320, DOI 10.1016/j.bbamem.2009.07.023; van Meer G, 2008, NAT REV MOL CELL BIO, V9, P112, DOI 10.1038/nrm2330; Villanueva CJ, 2009, HEPATOLOGY, V50, P434, DOI 10.1002/hep.22980; Weselake Randall J., 2006, BMC Biochemistry, V7, DOI 10.1186/1471-2091-7-24; Yen CLE, 2008, J LIPID RES, V49, P2283, DOI 10.1194/jlr.R800018-JLR200; Zhang FY, 2005, PLANT SCI, V169, P689, DOI 10.1016/j.plantsci.2005.05.019; Zhou G, 2014, ACS MED CHEM LETT, V5, P544, DOI 10.1021/ml400527n	34	10	10	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2015	10	2							e0118407	10.1371/journal.pone.0118407	http://dx.doi.org/10.1371/journal.pone.0118407			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC2ZH	25719207	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000350213200052
J	Saxena, R; Vashist, P; Tandon, R; Pandey, RM; Bhardawaj, A; Menon, V; Mani, K				Saxena, Rohit; Vashist, Praveen; Tandon, Radhika; Pandey, R. M.; Bhardawaj, Amit; Menon, Vimala; Mani, Kalaivani			Prevalence of Myopia and Its Risk Factors in Urban School Children in Delhi: The North India Myopia Study (NIM Study)	PLOS ONE			English	Article							REFRACTIVE ERROR; VISUAL IMPAIRMENT; SCHOOLCHILDREN; POPULATION; STUDENTS; DISTRICT	Purpose Assess prevalence of myopia and identify associated risk factors in urban school children. Methods This was a cross-sectional study screening children for sub-normal vision and refractive errors in Delhi. Vision was tested by trained health workers using ETDRS charts. Risk factor questionnaire was filled for children with vision < 6/9.5, wearing spectacles and for a subset (10%) of randomly selected children with normal vision. All children with vision < 6/9.5 underwent cycloplegic refraction. The prevalence of myopia <-0.5 diopters was assessed. Association of risk factors and prevalence of myopia was analyzed for children with myopia and randomly selected non myopic children and adjusted odds ratio values for all risk factors were estimated. Results A total number of 9884 children were screened with mean age of 11.6 + 2.2 years and 66.8% boys. Prevalence of myopia was 13.1% with only 320 children (24.7%) wearing appropriate spectacles. Mean myopic spherical error was -1.86 + 1.4 diopters. Prevalence of myopia was higher in private schools compared to government schools (p< 0.001), in girls vs. boys (p = 0.004) and among older (> 11 years) children (p< 0.001). There was a positive association of myopia with studying in private schools vs. government schools (p< 0.001), positive family history (p< 0.001) and higher socio-economic status (p = 0.037). Positive association of presence of myopia was observed with children studying/reading > 5 hours per day (p < 0.001), watching television > 2 hours/day (p < 0.001) and with playing computer/video/mobile games (p < 0.001). An inverse association with outdoor activities/playing was observed with children playing > 2 hours in a day. Conclusion Myopia is a major health problem in Indian school children. It is important to identify modifiable risk factors associated with its development and try to develop cost effective intervention strategies.	[Saxena, Rohit; Tandon, Radhika; Menon, Vimala] All India Inst Med Sci, Dr Rajendra Prasad Ctr Ophthalm Sci, Dept Ophthalmol, New Delhi 110029, India; [Vashist, Praveen; Bhardawaj, Amit] All India Inst Med Sci, Dr Rajendra Prasad Ctr Ophthalm Sci, Dept Community Ophthalmol, New Delhi 110029, India; [Pandey, R. M.; Mani, Kalaivani] All India Inst Med Sci, Dept Biostat, New Delhi, India	All India Institute of Medical Sciences (AIIMS) New Delhi; Dr. Rajendra Prasad Centre for Ophthalmic Sciences; All India Institute of Medical Sciences (AIIMS) New Delhi; Dr. Rajendra Prasad Centre for Ophthalmic Sciences; All India Institute of Medical Sciences (AIIMS) New Delhi	Saxena, R (corresponding author), All India Inst Med Sci, Dr Rajendra Prasad Ctr Ophthalm Sci, Dept Ophthalmol, New Delhi 110029, India.	rohitsaxena80@yahoo.com	GARG, RAKESH/H-4591-2011	GARG, RAKESH/0000-0001-5842-8024	Department of Science and Technology, Government of India	Department of Science and Technology, Government of India(Department of Science & Technology (India))	The Department of Science and Technology, Government of India provided funds for the study. The funds were for school visits, data collection and analysis. None of the authors are employed by the funding agency (www.dst.gov.in). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashby R, 2009, INVEST OPHTH VIS SCI, V50, P5348, DOI 10.1167/iovs.09-3419; Dandona R, 2002, INVEST OPHTH VIS SCI, V43, P615; Fan DSP, 2004, INVEST OPHTH VIS SCI, V45, P1071, DOI 10.1167/iovs.03-1151; Ghosh Sambuddha, 2012, Indian J Public Health, V56, P163, DOI 10.4103/0019-557X.99919; Gogate P, 2013, INDIAN J OPHTHALMOL, V61, P8, DOI 10.4103/0301-4738.99996; Goh PP, 2005, OPHTHALMOLOGY, V112, P678, DOI 10.1016/j.ophtha.2004.10.048; He MG, 2004, INVEST OPHTH VIS SCI, V45, P793, DOI 10.1167/iovs.03-1051; Jones LA, 2007, INVEST OPHTH VIS SCI, V48, P3524, DOI 10.1167/iovs.06-1118; Lam CSY, 2012, OPHTHAL PHYSL OPT, V32, P17, DOI 10.1111/j.1475-1313.2011.00886.x; Lim HT, 2012, JPN J OPHTHALMOL, V56, P76, DOI 10.1007/s10384-011-0090-7; Lin LLK, 2004, ANN ACAD MED SINGAP, V33, P27; Lin LLK, 2001, J FORMOS MED ASSOC, V100, P684; Matsumura H, 1999, SURV OPHTHALMOL, V44, pS109, DOI 10.1016/S0039-6257(99)00094-6; Morgan IG, 2013, OPHTHAL PHYSL OPT, V33, P329, DOI 10.1111/opo.12040; Morgan IG, 2012, LANCET, V379, P1739, DOI 10.1016/S0140-6736(12)60272-4; Murthy GVS, 2002, INVEST OPHTH VIS SCI, V43, P623; Pan CW, 2013, INVEST OPHTH VIS SCI, V54, P2590, DOI 10.1167/iovs.13-11725; Pan CW, 2012, OPHTHAL PHYSL OPT, V32, P3, DOI 10.1111/j.1475-1313.2011.00884.x; Pokharel GP, 2000, AM J OPHTHALMOL, V129, P436, DOI 10.1016/S0002-9394(99)00453-5; Qian YS, 2009, INVEST OPHTH VIS SCI, V50, P1598, DOI 10.1167/iovs.07-1362; Quek TPL, 2004, OPHTHAL PHYSL OPT, V24, P47, DOI 10.1046/j.1475-1313.2003.00166.x; Resnikoff S, 2008, B WORLD HEALTH ORGAN, V86, P63, DOI 10.2471/BLT.07.041210; Rose KA, 2008, OPHTHALMOLOGY, V115, P1279, DOI 10.1016/j.ophtha.2007.12.019; Rustagi N, 2012, INDIAN J OPHTHALMOL, V60, P203, DOI 10.4103/0301-4738.95872; Saw SM, 2007, OPHTHAL PHYSL OPT, V27, P126, DOI 10.1111/j.1475-1313.2006.00455.x; Saw SM, 2005, OPHTHAL PHYSL OPT, V25, P381, DOI 10.1111/j.1475-1313.2005.00298.x; Saw SM, 2002, ARCH OPHTHALMOL-CHIC, V120, P620, DOI 10.1001/archopht.120.5.620; Vitale S, 2009, ARCH OPHTHALMOL-CHIC, V127, P1632, DOI 10.1001/archophthalmol.2009.303; Wu JB, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0082763, 10.1371/journal.pone.0081986, 10.1371/journal.pone.0081982]; Yoon Kyung-Chul, 2011, Korean J Ophthalmol, V25, P421, DOI 10.3341/kjo.2011.25.6.421; You QS, 2014, ACTA OPHTHALMOL, V92, pE398, DOI 10.1111/aos.12299; Zhao JL, 2000, AM J OPHTHALMOL, V129, P427, DOI 10.1016/S0002-9394(99)00452-3	32	91	97	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2015	10	2							e0117349	10.1371/journal.pone.0117349	http://dx.doi.org/10.1371/journal.pone.0117349			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC2ZH	25719391	gold, Green Published, Green Submitted			2022-12-27	WOS:000350213200019
J	Catano, LB; Gunn, BK; Kelley, MC; Burkepile, DE				Catano, Laura B.; Gunn, Bridgette K.; Kelley, Megan C.; Burkepile, Deron E.			Predation Risk, Resource Quality, and Reef Structural Complexity Shape Territoriality in a Coral Reef Herbivore	PLOS ONE			English	Article							REGION-WIDE DECLINES; SPARISOMA-VIRIDE; HAREM SIZE; REPRODUCTIVE-BEHAVIOR; STOPLIGHT-PARROTFISH; MATING SUCCESS; FISH; SELECTION; FLORIDA; COMPETITION	For many species securing territories is important for feeding and reproduction. Factors such as competition, habitat availability, and male characteristics can influence an individual's ability to establish and maintain a territory. The risk of predation can have an important influence on feeding and reproduction; however, few have studied its effect on territoriality. We investigated territoriality in a haremic, polygynous species of coral reef herbivore, Sparisoma aurofrenatum (redband parrotfish), across eight reefs in the Florida Keys National Marine Sanctuary that were either protected or unprotected from fishing of piscivorous fishes. We examined how territory size and quality varied with reef protection status, competition, predation risk, and male size. We then determined how territory size and quality influenced harem size and female size to understand the effect of territoriality on reproductive potential. We found that protected reefs trended towards having more large predatory fishes and that territories there were smaller but had greater algal nutritional quality relative to unprotected reefs. Our data suggest that even though males in protected sites have smaller territories, which support fewer females, they may improve their reproductive potential by choosing nutritionally rich areas, which support larger females. Thus, reef protection appears to shape the trade-off that herbivorous fishes make between territory size and quality. Furthermore, we provide evidence that males in unprotected sites, which are generally less complex than protected sites, choose territories with higher structural complexity, suggesting the importance of this type of habitat for feeding and reproduction in S. aurofrenatum. Our work argues that the loss of corals and the resulting decline in structural complexity, as well as management efforts to protect reefs, could alter the territory dynamics and reproductive potential of important herbivorous fish species.	[Catano, Laura B.; Gunn, Bridgette K.; Kelley, Megan C.; Burkepile, Deron E.] Florida Int Univ, Dept Biol Sci, Marine Sci Program, North Miami, FL 33027 USA	State University System of Florida; Florida International University	Catano, LB (corresponding author), Florida Int Univ, Dept Biol Sci, Marine Sci Program, North Miami, FL 33027 USA.	lbhatti@fiu.edu			National Science Foundation; Biological Oceanography Program [OCE-1130786]; NOAA Coral Reef Conservation Program; College of Arts and Sciences at Florida International University; Directorate For Geosciences [1130786] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Biological Oceanography Program; NOAA Coral Reef Conservation Program(National Oceanic Atmospheric Admin (NOAA) - USA); College of Arts and Sciences at Florida International University; Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	This work was supported in part by a grant from the National Science Foundation (nsf.gov), Biological Oceanography Program (OCE-1130786) to DEB and R. Vega Thurber, a grant from the NOAA Coral Reef Conservation Program (coralreef.noaa.gov) to DEB and B. I. Ruttenberg, and by the College of Arts and Sciences at Florida International University (cas.fiu.edu). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramsky Z, 2002, ECOLOGY, V83, P1330, DOI 10.2307/3071947; Adams ES, 2001, ANNU REV ECOL SYST, V32, P277, DOI 10.1146/annurev.ecolsys.32.081501.114034; Alvarez-Filip L, 2009, P ROY SOC B-BIOL SCI, V276, P3019, DOI 10.1098/rspb.2009.0339; Ault JS, 2005, B MAR SCI, V76, P595; BARLOW GW, 1975, MAR BIOL, V33, P281, DOI 10.1007/BF00390566; BERGLUND A, 1993, ANIM BEHAV, V46, P169, DOI 10.1006/anbe.1993.1172; BEST LB, 1977, CONDOR, V79, P192, DOI 10.2307/1367162; Bohne J., 2009, PROG REP FLORIDA KEY, P1; BOHNSACK JA, 1994, B MAR SCI, V54, P982; Bohnsack JA, 1988, NOAA TECH MEMO NMFS; Both C, 2000, J ANIM ECOL, V69, P1021, DOI 10.1046/j.1365-2656.2000.00458.x; Brock JC, 2006, REMOTE SENS ENVIRON, V104, P31, DOI 10.1016/j.rse.2006.04.017; Brooker RM, 2013, CORAL REEFS, V32, P613, DOI 10.1007/s00338-013-1057-6; Brown J. L., 1964, Wilson Bulletin, V76, P160; BRUGGEMANN JH, 1994, MAR ECOL PROG SER, V106, P41, DOI 10.3354/meps106041; Burkepile DE, 2013, SCI REP-UK, V3, DOI 10.1038/srep01493; Candolin U, 2001, OIKOS, V95, P225, DOI 10.1034/j.1600-0706.2001.950204.x; Catano LB, 2014, MAR ECOL PROG SER, V511, P193, DOI 10.3354/meps10921; Chapman MR, 2000, ENVIRON BIOL FISH, V57, P11, DOI 10.1023/A:1004545724503; CHIVERS DP, 1995, ETHOLOGY, V99, P278; Clavijo IE, 1982, THESIS; CLIFTON KE, 1993, NATURE, V366, P520, DOI 10.1038/366520b0; de la Moriniere EC, 2003, MAR ECOL PROG SER, V246, P279; Dubin RE, 1981, THESIS; ENDLER JA, 1987, ANIM BEHAV, V35, P1376, DOI 10.1016/S0003-3472(87)80010-6; Feary DA, 2011, CONSERV BIOL, V25, P341, DOI 10.1111/j.1523-1739.2010.01613.x; FESTABIANCHET M, 1988, OECOLOGIA, V75, P580, DOI 10.1007/BF00776423; FORSGREN E, 1992, AM NAT, V140, P1041, DOI 10.1086/285455; FRICKE HW, 1980, ANIM BEHAV, V28, P561, DOI 10.1016/S0003-3472(80)80065-0; Fuller R, 1996, BEHAV ECOL, V7, P69, DOI 10.1093/beheco/7.1.69; Gardner TA, 2003, SCIENCE, V301, P958, DOI 10.1126/science.1086050; GILLIAM JF, 1987, ECOLOGY, V68, P1856, DOI 10.2307/1939877; Gladstone W, 2007, MAR ECOL PROG SER, V351, P235, DOI 10.3354/meps07108; Graham NAJ, 2013, CORAL REEFS, V32, P315, DOI 10.1007/s00338-012-0984-y; HARRIGAN P, 1989, B MAR SCI, V44, P65; Hata H, 2004, J EXP MAR BIOL ECOL, V313, P285, DOI 10.1016/j.jembe.2004.08.009; Hay M.E., 1991, P96; Heithaus MR, 2002, ECOLOGY, V83, P480, DOI 10.1890/0012-9658(2002)083[0480:FAATSP]2.0.CO;2; HIXON MA, 1980, AM NAT, V115, P510, DOI 10.1086/283577; HIXON MA, 1993, ECOL MONOGR, V63, P77, DOI 10.2307/2937124; Hughes TP, 2003, SCIENCE, V301, P929, DOI 10.1126/science.1085046; JOHANNES R E, 1978, Environmental Biology of Fishes, V3, P65, DOI 10.1007/BF00006309; KAUFMANN JH, 1983, BIOL REV, V58, P1, DOI 10.1111/j.1469-185X.1983.tb00379.x; Keeley ER, 2000, ANIM BEHAV, V59, P477, DOI 10.1006/anbe.1999.1288; KELLER BD, 2006, 2002 03 SANCTUARY SC; Kohler KE, 2006, COMPUT GEOSCI-UK, V32, P1259, DOI 10.1016/j.cageo.2005.11.009; Krause ET, 2012, BEHAVIOUR, V149, P1, DOI 10.1163/156853912X623748; Kuffner IB, 2007, ENVIRON BIOL FISH, V78, P71, DOI 10.1007/s10641-006-9078-4; LaManna JR, 2007, BEHAVIOUR, V144, P985, DOI 10.1163/156853907781871824; LEWIS SM, 1985, J EXP MAR BIOL ECOL, V87, P215, DOI 10.1016/0022-0981(85)90206-0; Lima SL, 1998, ADV STUD BEHAV, V27, P215; LIMA SL, 1990, CAN J ZOOL, V68, P619, DOI 10.1139/z90-092; Lindholm J, 2005, MARINE SANCTUARIES C, P17; Lopez-Sepulcre A, 2005, AM NAT, V166, P317, DOI 10.1086/432560; Madin EMP, 2010, ECOLOGY, V91, P3563, DOI 10.1890/09-2174.1; MAGNHAGEN C, 1991, TRENDS ECOL EVOL, V6, P183, DOI 10.1016/0169-5347(91)90210-O; Martel G, 1996, CAN J FISH AQUAT SCI, V53, P660, DOI 10.1139/cjfas-53-3-660; McArthur C, 2012, FUNCT ECOL, V26, P74, DOI 10.1111/j.1365-2435.2011.01930.x; Mumby PJ, 2002, ENVIRON BIOL FISH, V63, P265, DOI 10.1023/A:1014359403167; Munoz RC, 2000, COPEIA, P674; Munoz RC, 2010, B MAR SCI, V86, P93; Nanami A, 2008, MAR BIOL, V153, P1103, DOI 10.1007/s00227-007-0882-y; Pauly D, 1998, SCIENCE, V279, P860, DOI 10.1126/science.279.5352.860; Pays O, 2012, OECOLOGIA, V169, P419, DOI 10.1007/s00442-011-2218-3; Petersen CW, 1995, B MAR SCI, V57, P690; Randall J. E, 1967, STUD TROP OCEANOGR U, V5, P665; REINBOTH R, 1973, HELGOLAND WISS MEER, V24, P174, DOI 10.1007/BF01609510; ROBERTS CM, 1992, ENVIRON BIOL FISH, V34, P79, DOI 10.1007/BF00004786; Robertson DR, 1978, SMITHSON CONTRIB TO, V255, P1; Sancho G, 2000, MAR ECOL PROG SER, V206, P193, DOI 10.3354/meps206193; Schmitz OJ, 1997, ECOLOGY, V78, P1388, DOI 10.1890/0012-9658(1997)078[1388:BMTCEO]2.0.CO;2; SIH A, 1994, J FISH BIOL, V45, P111, DOI 10.1111/j.1095-8649.1994.tb01087.x; Smith SG, 2011, FISH RES, V109, P25, DOI 10.1016/j.fishres.2011.01.012; Taylor RJ, 1988, EVOL ECOL, V2, P95, DOI 10.1007/BF02067270; Vanpe C, 2009, J ANIM ECOL, V78, P42, DOI 10.1111/j.1365-2656.2008.01467.x; vanRooij JM, 1996, ENVIRON BIOL FISH, V47, P65, DOI 10.1007/BF00002380; vanRooij JM, 1996, ENVIRON BIOL FISH, V47, P81, DOI 10.1007/BF00002381; vanRooij JM, 1996, ENVIRON BIOL FISH, V47, P353, DOI 10.1007/BF00005050; Wade MJ, 2004, AM NAT, V164, pE83, DOI 10.1086/424531; Ward-Paige C, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0011722, 10.1371/journal.pone.0011968]; WARNER RR, 1980, EVOLUTION, V34, P508, DOI 10.1111/j.1558-5646.1980.tb04840.x; WARNER RR, 1984, AM SCI, V72, P128; WARNER RR, 1980, ECOLOGY, V61, P772, DOI 10.2307/1936747; WEATHERHEAD PJ, 1977, CAN J ZOOL, V55, P1261, DOI 10.1139/z77-165; Wedding LM, 2008, REMOTE SENS ENVIRON, V112, P4159, DOI 10.1016/j.rse.2008.01.025	85	22	22	1	67	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2015	10	2							e0118764	10.1371/journal.pone.0118764	http://dx.doi.org/10.1371/journal.pone.0118764			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC2IM	25714431	Green Published, Green Submitted, gold			2022-12-27	WOS:000350168700099
J	Doherty, KE; Evans, JS; Walker, J; Devries, JH; Howerter, DW				Doherty, Kevin E.; Evans, Jeffrey S.; Walker, Johann; Devries, James H.; Howerter, David W.			Building the Foundation for International Conservation Planning for Breeding Ducks across the US and Canadian Border	PLOS ONE			English	Article							PRAIRIE POTHOLE REGION; NORTH-DAKOTA; HABITAT SELECTION; GRASSLAND BIRDS; WATERFOWL NESTS; LAND-USE; DENSITY; POPULATIONS; SURVIVAL; WETLAND	We used publically available data on duck breeding distribution and recently compiled geospatial data on upland habitat and environmental conditions to develop a spatially explicit model of breeding duck populations across the entire Prairie Pothole Region (PPR). Our spatial population models were able to identify key areas for duck conservation across the PPR and predict between 62.1 - 79.1% (68.4% avg.) of the variation in duck counts by year from 2002 - 2010. The median difference in observed vs. predicted duck counts at a transect segment level was 4.6 ducks. Our models are the first seamless spatially explicit models of waterfowl abundance across the entire PPR and represent an initial step toward joint conservation planning between Prairie Pothole and Prairie Habitat Joint Ventures. Our work demonstrates that when spatial and temporal variation for highly mobile birds is incorporated into conservation planning it will likely increase the habitat area required to support defined population goals. A major goal of the current North American Waterfowl Management Plan and subsequent action plan is the linking of harvest and habitat management. We contend incorporation of spatial aspects will increase the likelihood of coherent joint harvest and habitat management decisions. Our results show at a minimum, it is possible to produce spatially explicit waterfowl abundance models that when summed across survey strata will produce similar strata level population estimates as the design-based Waterfowl Breeding Pair and Habitat Survey (r(2) = 0.977). This is important because these design-based population estimates are currently used to set duck harvest regulations and to set duck population and habitat goals for the North American Waterfowl Management Plan. We hope this effort generates discussion on the important linkages between spatial and temporal variation in population size, and distribution relative to habitat quantity and quality when linking habitat and population goals across this important region.	[Doherty, Kevin E.] US Fish & Wildlife Serv, Lakewood, CO 80228 USA; [Evans, Jeffrey S.] Nature Conservancy, Ft Collins, CO 80524 USA; [Evans, Jeffrey S.] Univ Wyoming, Dept Zool & Physiol, Laramie, WY 82071 USA; [Walker, Johann] Ducks Unlimited Canada, Great Plains Reg, Bismarck, ND USA; [Devries, James H.; Howerter, David W.] Ducks Unlimited Canada, Inst Wetland & Waterfowl Res, Stonewall, MB, Canada	United States Department of the Interior; US Fish & Wildlife Service; Nature Conservancy; University of Wyoming	Doherty, KE (corresponding author), US Fish & Wildlife Serv, 134 Union Blvd, Lakewood, CO 80228 USA.	kevin_doherty@fws.gov		Evans, Jeffrey/0000-0002-5533-7044	United States Fish & Wildlife Service; Ducks Unlimited; Ducks Unlimited Canada	United States Fish & Wildlife Service(US Fish & Wildlife Service); Ducks Unlimited; Ducks Unlimited Canada	Funding for this research came from the United States Fish & Wildlife Service, Ducks Unlimited, and Ducks Unlimited Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackerman JT, 2004, OIKOS, V107, P128; Anderson MG, 2007, REPORT JOINT TASK GR; Baldassarre G.A., 2006, WATERFOWL ECOLOGY MA; Ball IJ, 1995, WILDLIFE SOC B, V23, P767; Baruch-Mordo S, 2013, BIOL CONSERV, V167, P233, DOI 10.1016/j.biocon.2013.08.017; Batt B.D.J., 1989, P204; BETHKE RW, 1995, ECOL APPL, V5, P588, DOI 10.2307/1941969; Beyersbergen G. W., 2004, NO PRAIRIE PARKLAND; Bivand R, 2013, RGDAL BINDINGS GEOSP; Bivand RS, 2008, USE R, P1; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Brennan LA, 2005, J WILDLIFE MANAGE, V69, P1, DOI 10.2193/0022-541X(2005)069&lt;0001:NAGBAU&gt;2.0.CO;2; Burnham KP, 1980, WILDLIFE MONOGRAPHS, P3; Coe PK, 2011, J WILDLIFE MANAGE, V75, P159, DOI 10.1002/jwmg.10; Cressie N, 1991, STAT SPATIAL DATA; Cutler DR, 2007, ECOLOGY, V88, P2783, DOI 10.1890/07-0539.1; Dai AG, 2011, J GEOPHYS RES-ATMOS, V116, DOI 10.1029/2010JD015541; DeCesare NJ, 2012, ECOL APPL, V22, P1068, DOI 10.1890/11-1610.1; Doherty KE, 2013, WILDLIFE SOC B, V37, P546, DOI 10.1002/wsb.284; DUNNING JB, 1995, ECOL APPL, V5, P3, DOI 10.2307/1942045; Euliss NH, 1999, INVERTEBRATES IN FRESHWATER WETLANDS OF NORTH AMERICA, P471; Evans J.S., 2011, LANDSCAPE ECOLOGY CO; Farr TG, 2007, REV GEOPHYS, V45, DOI 10.1029/2005RG000183; Fieberg J, 2010, PHILOS T R SOC B, V365, P2233, DOI 10.1098/rstb.2010.0079; Fritzell E.K., 1989, P268; Gao BC, 1996, REMOTE SENS ENVIRON, V58, P257, DOI 10.1016/S0034-4257(96)00067-3; Greenwood R. J., 1995, WILDLIFE MONOGR, V128, P3; Hastie T., 2009, ELEMENTS STAT LEARNI, V2nd ed.; HESTBECK JB, 1995, J WILDLIFE MANAGE, V59, P9, DOI 10.2307/3809109; Hijmans RJ, 2013, R PACKAGE VERSION; Hoekstra JM, 2005, ECOL LETT, V8, P23, DOI 10.1111/j.1461-0248.2004.00686.x; JOHNSON DH, 1988, WILDLIFE MONOGR, P1; JOHNSON DH, 1980, ECOLOGY, V61, P65, DOI 10.2307/1937156; Johnson DH, 2002, J WILDLIFE MANAGE, V66, P919, DOI 10.2307/3802926; Kahara SN, 2009, WETLANDS, V29, P678, DOI 10.1672/07-09.1; Kantrud HA, 1989, 58728 US FISH WILDL; KLETT AT, 1988, J WILDLIFE MANAGE, V52, P431, DOI 10.2307/3801586; KRAPU GL, 1983, AUK, V100, P689, DOI 10.1093/auk/100.3.689; Krapu GL, 2000, J WILDLIFE MANAGE, V64, P553, DOI 10.2307/3803253; Lariviere S, 1998, OIKOS, V83, P12, DOI 10.2307/3546541; Lehtinen RM, 1999, WETLANDS, V19, P1, DOI 10.1007/BF03161728; Mattsson BJ, 2012, ECOL MODEL, V225, P146, DOI 10.1016/j.ecolmodel.2011.10.028; Meyer CB, 2006, DIVERS DISTRIB, V12, P288, DOI 10.1111/j.1366-9516.2006.00241.x; Miller JR, 2004, BIOSCIENCE, V54, P310, DOI 10.1641/0006-3568(2004)054[0310:SETSOP]2.0.CO;2; Millett B, 2009, CLIMATIC CHANGE, V93, P243, DOI 10.1007/s10584-008-9543-5; Murkin HR, 2000, PRAIRIE WETLAND ECOLOGY, P99; Murphy MA, 2010, ECOLOGY, V91, P252, DOI 10.1890/08-0879.1; Natural_Resources_Canada, 2008, CANVEC 3 0; NAWMP, 2012, N AM WAT MAN PLAN; Niemuth ND, 2003, WATERBIRDS, V26, P233, DOI 10.1675/1524-4695(2003)026[0233:ROWTNO]2.0.CO;2; Niemuth ND, 2008, CONDOR, V110, P211, DOI 10.1525/cond.2008.8514; Niemuth ND, 2010, WETLANDS, V30, P1053, DOI 10.1007/s13157-010-0111-1; Olden JD, 2008, Q REV BIOL, V83, P171, DOI 10.1086/587826; Peterjohn BG, 1997, COLON WATERBIRD, V20, P566, DOI 10.2307/1521612; Peterka J, 1989, FISHES N PRAIRIE WET, P302; PrairieHabitatJointVenture, 2008, PRAIR HAB JOINT VENT; PULLIAM HR, 1988, AM NAT, V132, P652, DOI 10.1086/284880; R Core Team, 2021, R LANGUAGE ENV STAT; Rashford BS, 2011, CAN J AGR ECON, V59, P185, DOI 10.1111/j.1744-7976.2010.01212.x; Rashford BS, 2011, CONSERV BIOL, V25, P276, DOI 10.1111/j.1523-1739.2010.01618.x; Rehfeldt GE, 2006, INT J PLANT SCI, V167, P1123, DOI 10.1086/507711; REYNOLDS RE, 1991, J WILDLIFE MANAGE, V55, P483, DOI 10.2307/3808979; Reynolds RE, 2001, J WILDLIFE MANAGE, V65, P765, DOI 10.2307/3803027; Reynolds RE, 2006, WILDLIFE SOC B, V34, P963, DOI 10.2193/0091-7648(2006)34[963:TFBADP]2.0.CO;2; Ringelman J., 2005, PRAIRIE POTHOLE JOIN; Ringelman KM, 2012, OECOLOGIA, V169, P695, DOI 10.1007/s00442-011-2228-1; Running SW, 2004, BIOSCIENCE, V54, P547, DOI 10.1641/0006-3568(2004)054[0547:ACSMOG]2.0.CO;2; Ryba A, 2012, BUILDING FDN INT CON; SAMSON F, 1994, BIOSCIENCE, V44, P418, DOI 10.2307/1312365; Sawyer H, 2006, J WILDLIFE MANAGE, V70, P396, DOI 10.2193/0022-541X(2006)70[396:WHSOMD]2.0.CO;2; Smith G. W., 1995, CRITICAL REV AERIAL; SMITH RI, 1970, J WILDLIFE MANAGE, V34, P943, DOI 10.2307/3799166; Soil Landscapes of Canada Working Group, 2007, SLC 3 1 1; Stephens SE, 2005, ECOL APPL, V15, P2137, DOI 10.1890/04-1162; USDI-FWS, 2011, NAT WETL INV; USFWS-DOI, 2013, WAT BREED POP HAB SU; Verboom J, 2010, LANDSCAPE ECOL, V25, P1289, DOI 10.1007/s10980-010-9497-7; Walker J, 2013, ECOL APPL, V23, P1061, DOI 10.1890/12-1755.1; Watmough M., 2007, ENV CANADAS PRAIRIE; WELLER MW, 1979, J WILDLIFE MANAGE, V43, P367, DOI 10.2307/3800345; Wickham JD, 2010, REMOTE SENS ENVIRON, V114, P1286, DOI 10.1016/j.rse.2010.01.018; Williams BK, 1996, J WILDLIFE MANAGE, V60, P223, DOI 10.2307/3802220; Wright CK, 2013, P NATL ACAD SCI; Zimpfer NL, 2013, TRENDS DUCK BREEDING	84	13	13	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2015	10	2							e0116735	10.1371/journal.pone.0116735	http://dx.doi.org/10.1371/journal.pone.0116735			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC2IM	25714747	gold, Green Published, Green Submitted			2022-12-27	WOS:000350168700022
J	McGuire, AL; Bennett, SC; Lansley, SM; Popowicz, ND; della Vergiliana, JFV; Wong, D; Lee, YCG; Chakera, A				McGuire, Amanda L.; Bennett, Sophia C.; Lansley, Sally M.; Popowicz, Natalia D.; della Vergiliana, Julius F. Varano; Wong, Daniel; Lee, Y. C. Gary; Chakera, Aron			Preclinical Assessment of Adjunctive tPA and DNase for Peritoneal Dialysis Associated Peritonitis	PLOS ONE			English	Article							TISSUE-PLASMINOGEN ACTIVATOR; INTRAPERITONEAL UROKINASE; PSEUDOMONAS-AERUGINOSA; STAPHYLOCOCCUS-AUREUS; EXTRACELLULAR DNA; BIOFILM FORMATION; OUTCOMES; PATIENT; SURFACE; INFECTIONS	A major complication of peritoneal dialysis is the development of peritonitis, which is associated with reduced technique and patient survival. The inflammatory response elicited by infection results in a fibrin and debris-rich environment within the peritoneal cavity, which may reduce the effectiveness of antimicrobial agents and predispose to recurrence or relapse of infection. Strategies to enhance responses to antimicrobial agents therefore have the potential to improve patient outcomes. This study presents pre-clinical data describing the compatibility of tPA and DNase in combination with antimicrobial agents used for the treatment of PD peritonitis. tPA and DNase were stable in standard dialysate solution and in the presence of antimicrobial agents, and were safe when given intraperitoneally in a mouse model with no evidence of local or systemic toxicity. Adjunctive tPA and DNase may have a role in the management of patients presenting with PD peritonitis.	[McGuire, Amanda L.; Bennett, Sophia C.; Chakera, Aron] Harry Perkins Inst Med Res, Translat Renal Res Grp, Perth, WA, Australia; [McGuire, Amanda L.; Bennett, Sophia C.; Chakera, Aron] Univ Western Australia, Sch Med & Pharmacol, Perth, WA 6009, Australia; [Lansley, Sally M.; Popowicz, Natalia D.; della Vergiliana, Julius F. Varano; Lee, Y. C. Gary] Sch Med & Pharmacol, Ctr Asthma Allergy Resp Res, Lung Inst Western Australia, Pleural Dis Unit, Perth, WA, Australia; [Wong, Daniel] QEII Med Ctr, PathWest Lab Med WA, Dept Anat Pathol, Perth, WA, Australia; [Lee, Y. C. Gary] Sir Charles Gairdner Hosp, Resp Dept, Perth, WA, Australia; [Chakera, Aron] Sir Charles Gairdner Hosp, Renal Dept, Perth, WA, Australia	Harry Perkins Institute of Medical Research; University of Western Australia; University of Western Australia	Chakera, A (corresponding author), Harry Perkins Inst Med Res, Translat Renal Res Grp, Perth, WA, Australia.	aron.chakera@uwa.edu.au	Lee, Y C Gary/H-5264-2014; Popowicz, Natalia/M-7505-2018	Popowicz, Natalia/0000-0003-0200-1819; Lee, Yun Chor Gary/0000-0002-0036-511X; McGuire, Amanda/0000-0002-1261-9236				AHRENHOLZ DH, 1980, SURGERY, V88, P41; Boateng EA, 2011, J RENAL CARE, V37, P190, DOI 10.1111/j.1755-6686.2011.00244.x; Boudville N, 2012, J AM SOC NEPHROL, V23, P1398, DOI 10.1681/ASN.2011121135; Brown F, 2007, PERITON DIALYSIS INT, V27, P565; DASGUPTA MK, 1991, ADV PERIT D, V7, P165; Davies SJ, 2013, NAT REV NEPHROL, V9, P399, DOI 10.1038/nrneph.2013.100; de Boer AW, 1999, PEDIATR NEPHROL, V13, P284, DOI 10.1007/s004670050609; Duch JM, 2001, AM J KIDNEY DIS, V37, P149, DOI 10.1016/S0272-6386(01)80069-X; Eckardt KU, 2013, LANCET, V382, P158, DOI 10.1016/S0140-6736(13)60439-0; Eckhart L, 2007, BRIT J DERMATOL, V156, P1342, DOI 10.1111/j.1365-2133.2007.07886.x; Gadallah M F, 2000, Adv Perit Dial, V16, P233; Ghaffari A, 2013, PD 1 PERITONEAL DIAL; Ghali JR, 2011, PERITON DIALYSIS INT, V31, P651, DOI 10.3747/pdi.2010.00131; Hall-Stoodley L, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-173; Hanlon GW, 2004, J PHARM PHARMACOL, V56, P847, DOI 10.1211/0022357023817; Hurst K, 2012, ANZDATA REGISTRY REP, pXXIII; Ince A, 2002, AM J SURG, V183, P67, DOI 10.1016/S0002-9610(01)00850-9; INNES A, 1994, NEPHROL DIAL TRANSPL, V9, P797; Izano EA, 2008, APPL ENVIRON MICROB, V74, P470, DOI 10.1128/AEM.02073-07; Jager KJ, 2004, AM J KIDNEY DIS, V43, P891, DOI 10.1053/j.ajkd.2003.12.051; Johnson D, 2006, ANZDATA REGISTRY REP, P88; Kim GC, 2000, AM J KIDNEY DIS, V36, P1000, DOI 10.1053/ajkd.2000.19102; Kumar VA, 2013, PERIT DIAL INT; Lamping DL, 2000, LANCET, V356, P1543, DOI 10.1016/S0140-6736(00)03123-8; Li PKT, 2010, PERITON DIALYSIS INT, V30, P393, DOI 10.3747/pdi.2010.00049; Marcus RJ, 2008, EXPERT OPIN BIOL TH, V8, P1159, DOI 10.1517/14712598.8.8.1159 ; Mastrosimone S, 2002, PERITON DIALYSIS INT, V22, P91; MCINTOSH ME, 1985, EUR J CLIN PHARMACOL, V28, P187, DOI 10.1007/BF00609690; Miles R, 2009, KIDNEY INT, V76, P622, DOI 10.1038/ki.2009.202; de Bustillo EM, 2011, NEFROLOGIA, V31, P723, DOI 10.3265/Nefrologia.pre2011.Oct.10987; MURPHY G, 1991, INT J ARTIF ORGANS, V14, P87, DOI 10.1177/039139889101400206; Nemoto K, 2003, CHEMOTHERAPY, V49, P121, DOI 10.1159/000070617; Piccolo F, 2014, ANN AM THORACIC SOC; Pihl M, 2013, PERITON DIALYSIS INT, V33, P51, DOI 10.3747/pdi.2011.00320; Rahman NM, 2011, NEW ENGL J MED, V365, P518, DOI 10.1056/NEJMoa1012740; READ RR, 1989, KIDNEY INT, V35, P614, DOI 10.1038/ki.1989.30; Sepandj F, 2003, PERITON DIALYSIS INT, V23, P77; SHAK S, 1990, P NATL ACAD SCI USA, V87, P9188, DOI 10.1073/pnas.87.23.9188; Shea M, 2001, Adv Perit Dial, V17, P249; Thomas VC, 2008, J BACTERIOL, V190, P5690, DOI 10.1128/JB.00314-08; Tong MKH, 2005, J NEPHROL, V18, P204; VASSALLI JD, 1991, J CLIN INVEST, V88, P1067, DOI 10.1172/JCI115405; Walker A, 2013, NEPHROLOGY CARLTON; Wiggins KJ, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005284.pub2; Worland MA, 1998, ANN PHARMACOTHER, V32, P1216, DOI 10.1345/aph.16153; Zorzanello Mary M, 2004, Nephrol Nurs J, V31, P534; Zorzanello MM, 2004, J AM NEPHROLOGY NURS, V31, P534	47	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2015	10	3							e0119238	10.1371/journal.pone.0119238	http://dx.doi.org/10.1371/journal.pone.0119238			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9KG	25742006	gold, Green Submitted, Green Published			2022-12-27	WOS:000350688100095
J	Hashizume, O; Yamanashi, H; Taketo, MM; Nakada, K; Hayashi, JI				Hashizume, Osamu; Yamanashi, Haruka; Taketo, Makoto M.; Nakada, Kazuto; Hayashi, Jun-Ichi			A Specific Nuclear DNA Background Is Required for High Frequency Lymphoma Development in Transmitochondrial Mice with G13997A mtDNA	PLOS ONE			English	Article							MUTATIONS; TUMORS; GENE; GENERATION; DISEASES; MODELS	We previously found that mouse mitochondrial DNA (mtDNA) with a G13997A mutation (G13997A mtDNA) controls not only the transformation of cultured lung carcinoma cells from poorly metastatic into highly metastatic cells, but also the transformation of lymphocytes into lymphomas in living C57BL/6 (B6) mice. Because the nuclear genetic background of the B6 strain makes the strain prone to develop lymphomas, here we examined whether G13997A mtDNA independently induces lymphoma development even in mice with the nuclear genetic background of the A/J strain, which is not prone to develop lymphomas. Our results showed that the B6 nuclear genetic background is required for frequent lymphoma development in mice with G13997A mtDNA. Moreover, G13997A mtDNA in mice did not enhance the malignant transformation of lung adenomas into adenocarcinomas or that of hepatocellular carcinomas from poorly metastatic into highly metastatic carcinomas. Therefore, G13997A mtDNA enhances the frequency of lymphoma development under the abnormalities in the B6 nuclear genome, and does not independently control tumor development and tumor progression.	[Hashizume, Osamu; Nakada, Kazuto; Hayashi, Jun-Ichi] Univ Tsukuba, Fac Life & Environm Sci, Tsukuba, Ibaraki, Japan; [Yamanashi, Haruka] Univ Tsukuba, Grad Sch Life & Environm Sci, Tsukuba, Ibaraki, Japan; [Taketo, Makoto M.] Kyoto Univ, Grad Sch Med, Dept Pharmacol, Sakyou Ku, Kyoto, Japan; [Nakada, Kazuto; Hayashi, Jun-Ichi] Univ Tsukuba, Int Inst Integrat Sleep Med WPI IIIS, Tsukuba, Ibaraki, Japan; [Hayashi, Jun-Ichi] Univ Tsukuba, TARA Ctr, Tsukuba, Ibaraki, Japan	University of Tsukuba; University of Tsukuba; Kyoto University; University of Tsukuba; University of Tsukuba	Hayashi, JI (corresponding author), Univ Tsukuba, Fac Life & Environm Sci, 1-1-1 Tennodai, Tsukuba, Ibaraki, Japan.	jih45@biol.tsukuba.ac.jp			Japan Society for the Promotion of Science [25250011, 23240058, 24117503]; World Premier International Research Center Initiative; Ministry of Education, Culture, Sports, Science and Technology-Japan; Grants-in-Aid for Scientific Research [23240058] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); World Premier International Research Center Initiative(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Education, Culture, Sports, Science and Technology-Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grants-in-Aid for Scientific Research A 25250011 (to JH), Scientific Research A 23240058 (to KN), and Scientific Research on Innovative Areas 24117503 (to JH) from the Japan Society for the Promotion of Science. This work was supported also by the World Premier International Research Center Initiative; Ministry of Education, Culture, Sports, Science and Technology-Japan (to KN and J-IH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akimoto M, 2005, BIOCHEM BIOPH RES CO, V327, P1028, DOI 10.1016/j.bbrc.2004.12.105; Balmain A, 1998, TRENDS GENET, V14, P139, DOI 10.1016/S0168-9525(98)01422-X; Baysal BE, 2000, SCIENCE, V287, P848, DOI 10.1126/science.287.5454.848; Chouchani ET, 2014, NATURE, V515, P431, DOI 10.1038/nature13909; Fliss MS, 2000, SCIENCE, V287, P2017, DOI 10.1126/science.287.5460.2017; Freeman D, 2006, CANCER RES, V66, P6492, DOI 10.1158/0008-5472.CAN-05-4143; Gottlieb E, 2005, NAT REV CANCER, V5, P857, DOI 10.1038/nrc1737; HARVEY M, 1993, FASEB J, V7, P938, DOI 10.1096/fasebj.7.10.8344491; Hashizume O, 2012, P NATL ACAD SCI USA, V109, P10528, DOI 10.1073/pnas.1202367109; He YP, 2010, NATURE, V464, P610, DOI 10.1038/nature08802; Ishikawa K, 2008, FEBS LETT, V582, P3525, DOI 10.1016/j.febslet.2008.09.024; Ishikawa K, 2008, SCIENCE, V320, P661, DOI 10.1126/science.1156906; Kasahara A, 2006, HUM MOL GENET, V15, P871, DOI 10.1093/hmg/ddl005; Koppenol WH, 2011, NAT REV CANCER, V11, P325, DOI 10.1038/nrc3038; Krupke DM, 2008, NAT REV CANCER, V8, P459, DOI 10.1038/nrc2390; Manenti G, 2002, INT J CANCER, V99, P555, DOI 10.1002/ijc.10386; Miller YE, 2003, CANCER LETT, V198, P139, DOI 10.1016/S0304-3835(03)00309-4; Miyoshi H, 2002, CANCER RES, V62, P2261; Nakau M, 2002, CANCER RES, V62, P4549; Niemann S, 2000, NAT GENET, V26, P268, DOI 10.1038/81551; Polyak K, 1998, NAT GENET, V20, P291, DOI 10.1038/3108; Shimizu A, 2014, P NATL ACAD SCI USA, V111, P3104, DOI 10.1073/pnas.1318109111; Taylor RW, 2005, NAT REV GENET, V6, P389, DOI 10.1038/nrg1606; Wallace DC, 1999, SCIENCE, V283, P1482, DOI 10.1126/science.283.5407.1482; Yokota M, 2010, FEBS LETT, V584, P3943, DOI 10.1016/j.febslet.2010.07.048	25	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2015	10	3							e0118561	10.1371/journal.pone.0118561	http://dx.doi.org/10.1371/journal.pone.0118561			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9JM	25738506	Green Published, Green Submitted, gold			2022-12-27	WOS:000350685900047
J	Monedero, J; Lyons, EJ; O'Gorman, DJ				Monedero, Javier; Lyons, Elizabeth J.; O'Gorman, Donal J.			Interactive Video Game Cycling Leads to Higher Energy Expenditure and Is More Enjoyable than Conventional Exercise in Adults	PLOS ONE			English	Article							ACTIVITY ENJOYMENT SCALE; PHYSICAL-ACTIVITY; WII FIT; PERFORMANCE; INTENSITY; PARTICIPATION; DISTRACTION; ADHERENCE; RESPONSES; CHILDREN	Background Despite the widely accepted health benefits of regular physical activity, only a small percentage of the population meets the current recommendations. The reasons include a wide use of technology and a lack of enjoyment while exercising. The purpose of this study was to compare the physiological, perceptual and enjoyment responses between a single bout of (I) conventional cycling and (II) interactive cycling video game at a matched workload. Methods A cross-sectional study in 34 healthy participants was performed. Initially, participants completed an incremental maximal cycling test to measure peak oxygen uptake and to determine ventilatory threshold. In random order, participants carried out a 30 min interactive cycling trial and a 30 min conventional cycling trial at 55% of peak power output. During the trials, oxygen uptake and energy expenditure were measured by open-circuit spirometry and heart rate was measured by radiotelemetry. RPE and enjoyment were measured every 10 minutes with Borg scale and a modified PACES scale. Results Interactive cycling resulted in a significantly greater %(V) over dotO(2)Reserve (68.2% +/- 9.2% vs 64.7% +/- 8.1%), rate of energy expenditure (505.8 +/- 75.2 vs 487.4 +/- 81.2 j.kg(-1).min(-1)), and enjoyment (63.4% +/- 17 vs 42% +/- 13.6), P < 0.05. Participants were working at a higher intensity in relation to the individual's ventilatory threshold during the interactive cycling video game trial (M = 11.86, SE = 3.08) than during the Conventional cycling trial (M = 7.55, SE = 3.16, t(33) = -2.69, P < 0.05, r = .42). No significant differences were found for heart rate reserve (72.5 +/- 10.4 vs 71.4 +/- 10.1%) and RPE (13.1 +/- 1.8 vs 13.2 +/- 1.7). Conclusion Interactive cycling games can be a valid alternative to conventional exercise as they result in a higher exercise intensity than conventional cycling and a distraction from aversive cognitive and physiological states at and above the ventilatory threshold.	[Monedero, Javier; O'Gorman, Donal J.] Dublin City Univ, Sch Hlth & Human Performance, Dublin 9, Ireland; [Lyons, Elizabeth J.] Univ Texas Med Branch, Inst Translat Sci, Galveston, TX 77555 USA; [O'Gorman, Donal J.] Dublin City Univ, Ctr Prevent Med, Dublin 9, Ireland	Dublin City University; University of Texas System; University of Texas Medical Branch Galveston; Dublin City University	O'Gorman, DJ (corresponding author), Dublin City Univ, Sch Hlth & Human Performance, Dublin 9, Ireland.	donal.ogorman@dcu.ie	O'Gorman, Donal J./J-7182-2015; Monedero, Javier/L-5011-2019	O'Gorman, Donal J./0000-0002-8228-1488; Monedero, Javier/0000-0003-4509-1658; Lyons, Elizabeth/0000-0003-1695-2236				Allender S, 2006, HEALTH EDUC RES, V21, P826, DOI 10.1093/her/cyl063; Annesi JJ, 2001, CAN J BEHAV SCI, V33, P193, DOI 10.1037/h0087141; Barkley J. E., 2009, J EXERC PHYSL ONLINE, V21, P12; Bauman AE, 2012, LANCET, V380, P258, DOI 10.1016/S0140-6736(12)60735-1; BEAVER WL, 1986, J APPL PHYSIOL, V60, P2020, DOI 10.1152/jappl.1986.60.6.2020; BECKER N, 1994, PERCEPT MOTOR SKILL, V79, P1043, DOI 10.2466/pms.1994.79.2.1043; Bharani A, 2004, INT J CARDIOL, V97, P305, DOI 10.1016/j.ijcard.2003.05.048; Booth FW, 2002, J APPL PHYSIOL, V93, P3, DOI 10.1152/japplphysiol.00073.2002; Booth ML, 2000, PREV MED, V31, P15, DOI 10.1006/pmed.2000.0661; Carraro A, 2008, SOC BEHAV PERSONAL, V36, P911, DOI 10.2224/sbp.2008.36.7.911; Consolazio CF., 1963, HDB PHYSL, P313; Cowley B., 2008, COMPUT ENTERTAIN, V6, P20, DOI [10.1145/1371216.1371223, DOI 10.1145/1371216.1371223]; Csikszentmihalyi M., 1990, FLOW THE PSYCHOLOGY; Dishman RK, 1996, MED SCI SPORT EXER, V28, P706, DOI 10.1097/00005768-199606000-00010; Ekkekakis P., 2009, INT REV SPORT EXER P, V2, P139, DOI [DOI 10.1080/17509840902829323, 10.1080/17509840902829323]; Ekkekakis P, 2008, ANN BEHAV MED, V35, P136, DOI 10.1007/s12160-008-9025-z; Ekkekakis P, 2009, SPORTS MED, V39, P857, DOI 10.2165/11315210-000000000-00000; Graves LEF, 2010, J PHYS ACT HEALTH, V7, P393, DOI 10.1123/jpah.7.3.393; Guderian B, 2010, J SPORT MED PHYS FIT, V50, P436; Guy S, 2011, INT J HYPERTENS, V2011, DOI 10.4061/2011/179124; Haddock Bryan L, 2009, Open Sports Sci J, V2, P42; Hagberg LA, 2009, SCAND J MED SCI SPOR, V19, P740, DOI 10.1111/j.1600-0838.2008.00844.x; Hallal PC, 2012, LANCET, V380, P247, DOI 10.1016/S0140-6736(12)60646-1; KARVONEN MJ, 1957, ANN MED EXP BIOL FEN, V35, P307; Keats MR, 2011, HLTH FITNESS J CAN, V4, P20; KENDZIERSKI D, 1991, J SPORT EXERCISE PSY, V13, P50, DOI 10.1123/jsep.13.1.50; Kraft JA, 2011, J STRENGTH COND RES, V25, P1736, DOI 10.1519/JSC.0b013e3181e06f13; Kruk J, 2007, ASIAN PAC J CANCER P, V8, P325; KUIPERS H, 1985, INT J SPORTS MED, V6, P197, DOI 10.1055/s-2008-1025839; Lakdawalla D., 2002, NBER WORKING PAPERS, V8946; Leslie E, 1999, PREV MED, V28, P20, DOI 10.1006/pmed.1998.0375; Lyons EJ, 2011, MED SCI SPORT EXER, V43, P1987, DOI 10.1249/MSS.0b013e318216ebf3; MALONE TW, 1981, COGNITIVE SCI, V5, P333, DOI 10.1016/S0364-0213(81)80017-1; Monedero J, 2014, GAMES HEALTH J, V3, P234, DOI 10.1089/g4h.2013.0096; Motl RW, 2001, AM J PREV MED, V21, P110, DOI 10.1016/S0749-3797(01)00326-9; NOBLE BJ, 1983, MED SCI SPORT EXER, V15, P523; Peng W, 2013, HEALTH EDUC BEHAV, V40, P171, DOI 10.1177/1090198112444956; Rhodes RE, 2009, ANN BEHAV MED, V38, P180, DOI 10.1007/s12160-009-9147-y; Rhodes RE, 2009, PSYCHOL HEALTH MED, V14, P631, DOI 10.1080/13548500903281088; Salmon J, 2003, HEALTH PSYCHOL, V22, P178, DOI 10.1037/0278-6133.22.2.178; Sherry JL, 2004, COMMUN THEOR, V14, P328, DOI 10.1093/ct/14.4.328; Sorensen L, 2005, OCCUP MED-OXFORD, V55, P136, DOI 10.1093/occmed/kqi036; Trost SG, 2002, MED SCI SPORT EXER, V34, P350, DOI 10.1097/00005768-200202000-00025; Warburton DER, 2007, APPL PHYSIOL NUTR ME, V32, P655, DOI 10.1139/H07-038; Warburton DER, 2009, MED SCI SPORT EXER, V41, P920, DOI 10.1249/MSS.0b013e31819012bd; Willems HL, 2009, MED SPORTIVA, V13, P95, DOI DOI 10.2478/V10036-009-0015-4; Wilmot EG, 2012, DIABETOLOGIA, V55, P2895, DOI 10.1007/s00125-012-2677-z	47	36	37	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2015	10	3							e0118470	10.1371/journal.pone.0118470	http://dx.doi.org/10.1371/journal.pone.0118470			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CC9JM	25738290	Green Published, Green Submitted, gold			2022-12-27	WOS:000350685900037
J	Tadesse, G; Yakob, B				Tadesse, Gojjam; Yakob, Bereket			Risky Sexual Behaviors among Female Youth in Tiss Abay, a Semi-Urban Area of the Amhara Region, Ethiopia	PLOS ONE			English	Article							SUB-SAHARAN AFRICA; CONDOM USE; TRANSMITTED INFECTIONS; SUBSTANCE USE; YOUNG-PEOPLE; ALCOHOL-USE; HIV; ADOLESCENT; SCHOOL; INTERCOURSE	Background Little is known about sexual risks and associated factors about female youths in semi-urban areas of Ethiopia. This study aimed to describe the nature and magnitude of risky sexual behaviors, and the socio-demographic and behavioral determinants among female youths in Tiss Abay, a semi-urban area on the outskirts of Bahir Dar City of the Amhara Region in northern Ethiopia. Methods A cross-sectional census type study was conducted among female youths who were unmarried and aged 15-29 years in September 2011. Results 711 female youths participated in the study, with the mean age of initiation of sex of 78.6% being16.73 +/- 2.53 years. Only 52(9.3%) used condom during the first sex. Within the last 12 months, 509(71.6%) had sexual intercourse and 278(54.6%) had two or more sex partners, and 316(62.1%) did not use condom during their last sex. Sex under the influence of substances was reported by 350(68.8%), and a third of the recent sexes were against the will of participants. One or more risky sexual practices were reported by 503(70.3%) participants, including: multiple sexual partnerships, inconsistently using or not using condoms, sex under the influence of alcohol and/or sex immediately after watching pornography. Age group, current marital status, drinking homemade alcohol, chewing 'khat', watching pornography and using any form of stimulant substances were the predictors of risky sexual behavior. Watching pornography before sex and sex for transaction were the predicators of not using condom during most recent sex. Conclusions Risky sexual behaviors were very common among the female youths in Tiss Abay. Initiation of context-based interventions, such as raising awareness about the risks, safer sex practices, condom promotion and integration of gender issues in the programs are recommended.	[Tadesse, Gojjam] Addis Continental Inst Publ Hlth, Bahir Dar, Ethiopia; [Yakob, Bereket] Univ KwaZulu Natal, Sch Nursing & Publ Hlth, Howard Coll, Durban, South Africa; [Yakob, Bereket] Univ KwaZulu Natal, Hlth Econ & AIDS Res Div HEARD, Durban, South Africa	Addis Continental Institute of Public Health; University of Kwazulu Natal; University of Kwazulu Natal	Yakob, B (corresponding author), Univ KwaZulu Natal, Sch Nursing & Publ Hlth, Howard Coll, Durban, South Africa.	berekbot@yahoo.com	Yakob, Bereket/X-5487-2019	Yakob, Bereket/0000-0002-8383-6449				Alemu H, 2007, J HEALTH POPUL NUTR, V25, P344; Amaro H, 2000, SEX ROLES, V42, P723, DOI 10.1023/A:1007059708789; [Anonymous], 2000, AIDS PREVENT MENT H; Bachanas PJ, 2002, J PEDIATR PSYCHOL, V27, P373, DOI 10.1093/jpepsy/27.4.373; Bauman LJ, 2005, AIDS BEHAV, V9, P211, DOI 10.1007/s10461-005-3902-2; Beckerleg S, 2010, J ETHNOPHARMACOL, V132, P600, DOI 10.1016/j.jep.2010.08.057; Belaineh Girma, 2004, Ethiopian Journal of Health Development, V18, P25; BIGLAN A, 1990, J BEHAV MED, V13, P245, DOI 10.1007/BF00846833; Birech J., 2013, International Journal of Humanities and Social Science, V3, P97; Boyer CB, 2006, J INFECT DIS, V194, P307, DOI 10.1086/506328; Cherie A., 2012, WORLD J AIDS, V02, P159, DOI DOI 10.4236/wja.2012.23021; Dryfoos JG., 1990, ADOLESCENTS RISK PRE; EDHS, 2011, ETH DEM HLTH SURV; Fako T.T., 2010, EUROPEAN J SOCIAL SC, V15, P115; Feyissa AM, 2008, PROG NEURO-PSYCHOPH, V32, P1147, DOI 10.1016/j.pnpbp.2007.12.033; Fury DB, 2006, ASSESSMENT PREMARITA; Gage AJ, 2013, SOC SCI MED, V97, P124, DOI 10.1016/j.socscimed.2013.08.017; Jain S, 2007, NEW INSIGHTS PREVENT; Kabiru CW, 2009, J ADOLESCENCE, V32, P1023, DOI 10.1016/j.adolescence.2008.08.001; Kaestle CE, 2005, AM J EPIDEMIOL, V161, P774, DOI 10.1093/aje/kwi095; Kalichman SC, 2007, PREV SCI, V8, P141, DOI 10.1007/s11121-006-0061-2; Kebede D, 2005, BMC PUBLIC HEALTH, V5, DOI 10.1186/1471-2458-5-109; Koenig MA, 2004, INT FAM PLAN PERSPEC, V30, P156, DOI 10.1363/3015604; Lagarde E, 2001, AIDS, V15, P877, DOI 10.1097/00002030-200105040-00008; Luster T, 1996, J MARRIAGE FAM, P622; Machel JZ, 2001, REPROD HEALTH MATTER, V9, P82, DOI 10.1016/S0968-8080(01)90011-4; MacPhail C, 2001, SOC SCI MED, V52, P1613, DOI 10.1016/S0277-9536(00)00272-0; Madise Nyovani, 2007, Afr J Reprod Health, V11, P83, DOI 10.2307/25549733; MAH TL, 2008, AIDS BEHAV; Malaju MT, 2013, BMC INT HEALTH HUM R, V13, DOI 10.1186/1472-698X-13-10; Mavedzenge SN, 2011, J ADOLESCENT HEALTH, V49, P559, DOI 10.1016/j.jadohealth.2011.02.012; Mazengia F, 2009, ETHIOP J HEALTH DEV, V23, P154; MGLSD, 2001, NAT YOUTH POL KAMP; Molla M, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-9; Montgomery CM, 2008, AIDS CARE, V20, P733, DOI 10.1080/09540120701693974; Mwenda J M, 2003, East Afr Med J, V80, P318; MYSC, 2014, YOUTH POLICY; Samuel L, 2012, INT J PHARM SCI RES, V3, P1080, DOI 10.13040/IJPSR.0975-8232.3(4).1080-86; Santelli JS, 2004, J ADOLESCENT HEALTH, V34, P200, DOI 10.1016/j.jadohealth.2003.06.004; Sionean C, 2002, J ADOLESCENT HEALTH, V30, P55, DOI 10.1016/S1054-139X(01)00318-4; Smith M. K., 2002, Gender and Development, V10, P63, DOI 10.1080/13552070215914; Taffa N., 2002, Ethiopian Journal of Health Development, V16, P139; Tanser F, 2011, LANCET, V378, P247, DOI 10.1016/S0140-6736(11)60779-4; Underwood C, 2011, SOC SCI MED, V73, P343, DOI 10.1016/j.socscimed.2011.05.044; UNESCO, 2013, WHAT DO WE MEAN YOUT; Urassa W, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-159; VanDevanter N, 2011, AIDS PATIENT CARE ST, V25, P113, DOI 10.1089/apc.2010.0100; Visser M., 2003, S AFR J ED, V23, P58; WALTER HJ, 1992, AM J PUBLIC HEALTH, V82, P528, DOI 10.2105/AJPH.82.4.528; Wellings K, 2006, LANCET SEXUAL REPROD; Whiteside A, 2002, THIRD WORLD Q, V23, P313, DOI 10.1080/01436590220126667; Woolf SE, 2008, SEX ROLES, V58, P689, DOI 10.1007/s11199-007-9381-3	52	21	23	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2015	10	3							e0119050	10.1371/journal.pone.0119050	http://dx.doi.org/10.1371/journal.pone.0119050			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CC9JM	25738508	Green Published, Green Submitted, gold			2022-12-27	WOS:000350685900092
J	Tan, C; Liu, S; Tan, SK; Zeng, XY; Yu, HP; Li, AH; Bei, CH; Qiu, XQ				Tan, Chao; Liu, Shun; Tan, Shengkui; Zeng, Xiaoyun; Yu, Hongping; Li, Anhua; Bei, Chunhua; Qiu, Xiaoqiang			Polymorphisms in MicroRNA Target Sites of Forkhead Box O Genes Are Associated with Hepatocellular Carcinoma	PLOS ONE			English	Article							FOXO TRANSCRIPTION FACTORS; CANCER CELLS; EXPRESSION; RESOURCE; DIFFERENTIATION; PROLIFERATION; APOPTOSIS; DISEASE; ARREST	The forkhead box O (FOXO) transcription factors play important roles in various cancer development including Hepatocellular Carcinoma (HCC). In this study we conducted a hospital-based case control study including 1049 cases (HCC patients) and 1052 controls (nontumor patients) to examine whether single nucleotide polymorphisms (SNPs) within microRNA (miRNA) target sites of FOXO genes confer HCC susceptibility. A total of three miRNA target site SNPs in the 3' untranslated regions (UTR) of FOXO1 (rs17592236), FOXO3 (rs4946936) and FOXO4 (rs4503258) were analyzed. No statistically significant differences were found in genotype distribution for rs17592236, rs4946936, and rs4503258 between the HCC patient group and the tumor-free control group using single factor chi-square analysis (P> 0.05). However, multivariate logistic regression analysis showed that the CT/TT genotype in rs17592236 was significantly associated with decreased risk of HCC development (P = 0.010, OR = 0.699, 95% CI: 0.526-0.927) as compared to the CC genotype in rs17592236. Additionally, a genetic interaction was found between rs17592236 and rs4503258 (P = 0.003, OR = 0.755, 95% CI: 0.628-0.908). Functional dual luciferase reporter assays verified that the rs17592236 SNP was a target site of human miRNA miR-137. Together, these results indicate that the rs17592236 polymorphism is associated with decreasing of HCC hereditary susceptibility likely through modulating the binding affinity of miR-137 to the 3' UTR in FOXO1 messenger RNA (mRNA). Further knowledge obtained from this study may provide important evidence for the prevention and targeted therapy of HCC.	[Tan, Chao; Liu, Shun; Zeng, Xiaoyun; Li, Anhua; Qiu, Xiaoqiang] Guangxi Med Univ, Sch Publ Hlth, Dept Epidemiol, Nanning, Guangxi, Peoples R China; [Tan, Shengkui; Yu, Hongping; Bei, Chunhua] Guilin Med Univ, Sch Publ Hlth, Dept Epidemiol, Guilin, Guangxi, Peoples R China	Guangxi Medical University; Guilin Medical University	Qiu, XQ (corresponding author), Guangxi Med Univ, Sch Publ Hlth, Dept Epidemiol, Nanning, Guangxi, Peoples R China.	xqqiu9999@sina.com		Bei, chunhua/0000-0001-7515-3464	National Natural Science Foundation of China [81241100]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The work was financially supported by grant from the National Natural Science Foundation of China (grant No. 81241100). XQ is the recipient of the grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Accili D, 2004, CELL, V117, P421, DOI 10.1016/S0092-8674(04)00452-0; Alikhani M, 2005, J BIOL CHEM, V280, P12096, DOI 10.1074/jbc.M412171200; Arden KC, 2007, CELL, V128, P235, DOI 10.1016/j.cell.2007.01.009; Bemis LT, 2008, CANCER RES, V68, P1362, DOI 10.1158/0008-5472.CAN-07-2912; Betel D, 2008, NUCLEIC ACIDS RES, V36, pD149, DOI 10.1093/nar/gkm995; Calnan DR, 2008, ONCOGENE, V27, P2276, DOI 10.1038/onc.2008.21; Chen CJ, 2002, HEPATOLOGY, V36, P1046, DOI 10.1053/jhep.2002.37084; Chun HB, 2011, CHINESE J PUBLIC HLT, V27, P309; Farazi PA, 2006, NAT REV CANCER, V6, P674, DOI 10.1038/nrc1934; Fei M, 2009, MED ONCOL, V26, P178, DOI 10.1007/s12032-008-9105-8; Fendler A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080807; Fu Z, 2008, ONCOGENE, V27, P2312, DOI 10.1038/onc.2008.24; Furukawa-Hibi Y, 2005, ANTIOXID REDOX SIGN, V7, P752, DOI 10.1089/ars.2005.7.752; Greer EL, 2008, ACTA PHYSIOL, V192, P19, DOI 10.1111/j.1748-1716.2007.01780.x; Guttilla IK, 2009, J BIOL CHEM, V284, P23204, DOI 10.1074/jbc.M109.031427; Horie Y, 2004, J CLIN INVEST, V113, P1774, DOI 10.1172/JCI200420513; Hou T, 2014, BRIT J CANCER, V110, P1260, DOI 10.1038/bjc.2013.829; Huang CY, 2013, J NUTR BIOCHEM, V24, P1596, DOI 10.1016/j.jnutbio.2013.01.010; Jones SM, 2000, ONCOGENE, V19, P5558, DOI 10.1038/sj.onc.1203858; Langevin SM, 2011, CANCER-AM CANCER SOC, V117, P1454, DOI 10.1002/cncr.25689; Lee SY, 2013, CELL CYCLE, V12, P67, DOI 10.4161/cc.22962; Liang L, 2013, GASTROENTEROLOGY, V144, P624, DOI 10.1053/j.gastro.2012.11.033; Lu MD, 2009, PATHOL ONCOL RES, V15, P679, DOI 10.1007/s12253-009-9171-z; Luo J, 2003, CANCER CELL, V4, P257, DOI 10.1016/S1535-6108(03)00248-4; Maiese K, 2009, MED RES REV, V29, P395, DOI 10.1002/med.20139; Nakae J, 2003, DEV CELL, V4, P119, DOI 10.1016/S1534-5807(02)00401-X; Niedan S, 2014, ONCOGENE, V33, P3927, DOI 10.1038/onc.2013.361; Packer BR, 2006, NUCLEIC ACIDS RES, V34, pD617, DOI 10.1093/nar/gkj151; Paik JH, 2007, CELL, V128, P309, DOI 10.1016/j.cell.2006.12.029; Park JM, 2013, BIORESOURCE TECHNOL, V135, P1, DOI 10.1016/j.biortech.2013.03.132; Pezzoli K, 2007, ENVIRON HEALTH PERSP, V115, P564, DOI 10.1289/ehp.9817; Sethupathy P, 2008, TRENDS GENET, V24, P489, DOI 10.1016/j.tig.2008.07.004; Tomasetti M, 2014, ANTIOXID REDOX SIGN, V21, P2109, DOI 10.1089/ars.2013.5215; Trotman LC, 2006, NATURE, V441, P523, DOI 10.1038/nature04809; Ward EC, 2008, ENDOCRINOLOGY, V149, P1942, DOI 10.1210/en.2007-0756; Wu LH, 2012, FEBS LETT, V586, P1038, DOI 10.1016/j.febslet.2012.02.050; Yang J, 2008, MUTAT RES-FUND MOL M, V638, P205, DOI 10.1016/j.mrfmmm.2007.08.007; Yu MW, 1999, HEPATOLOGY, V29, P697, DOI 10.1002/hep.510290330; Yu ZB, 2007, NUCLEIC ACIDS RES, V35, P4535, DOI 10.1093/nar/gkm480; Zeng XY, 2009, CHINESE J CANC PREVE, V16, P1629; Zhang YQ, 2011, CANCER BIOL THER, V12, P253, DOI 10.4161/cbt.12.4.15954	41	23	24	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2015	10	3							e0119210	10.1371/journal.pone.0119210	http://dx.doi.org/10.1371/journal.pone.0119210			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9JM	25739100	gold, Green Submitted, Green Published			2022-12-27	WOS:000350685900099
J	Varga, S; Laaksonen, E; Siikamaki, P; Kytoviita, MM				Varga, Sandra; Laaksonen, Ester; Siikamaki, Pirkko; Kytoviita, Minna-Maarit			Absence of Sex Differential Plasticity to Light Availability during Seed Maturation in Geranium sylvaticum	PLOS ONE			English	Article							REPRODUCTIVE OUTPUT; HERMAPHRODITES; POLLINATION; ALLOCATION; FEMALES; POLLEN; RATIO; MACULATUM; EVOLUTION; SYMBIOSIS	Sex-differential plasticity (SDP) hypothesis suggests that since hermaphrodites gain fitness through both pollen and seed production they may have evolved a higher degree of plasticity in their reproductive strategy compared to females which achieve fitness only through seed production. SDP may explain the difference in seed production observed between sexes in gynodioecious species in response to resource (nutrients or water) availability. In harsh environments, hermaphrodites decrease seed production whereas females keep it relatively similar regardless of the environmental conditions. Light availability can be also a limiting resource and thus could theoretically affect differently female and hermaphrodite seed output even though this ecological factor has been largely overlooked. We tested whether the two sexes in the gynodioecious species Geranium sylvaticum differ in their tolerance to light limitation during seed maturation in the field. We used a fully factorial block experiment exposing female and hermaphrodite plants to two different light environments (control and shade) after their peak flowering period. Specifically, we measured fruit and seed production in response to decreased light availability and compared it between the sexes. Shading reduced the number of fruits and seeds produced, but the decrease was similar between the sexes. Furthermore, shading delayed seed production by three days in both sexes, but did not affect seed mass, seed P content, or the probability of re-flowering the following year. Our results give no evidence for reproductive SDP in response to light during seed maturation.	[Varga, Sandra; Kytoviita, Minna-Maarit] Univ Jyvaskyla, Dept Biol & Environm Sci, Jyvaskyla 40014, Finland; [Laaksonen, Ester] Univ Oulu, Dept Biol, Oulu 90014, Finland; [Siikamaki, Pirkko] Metsahallitus, Kuusamo 93601, Finland	University of Jyvaskyla; University of Oulu	Varga, S (corresponding author), Univ Jyvaskyla, Dept Biol & Environm Sci, POB 35, Jyvaskyla 40014, Finland.	Sandra.varga@jyu.fi	Varga, Sandra/AAO-7881-2021	Varga, Sandra/0000-0001-9799-714X; Kytoviita, Minna-Maarit/0000-0002-8928-6951	Academy of Finland; Societas Biologica Fennica Vanamo; Oulanka Foundation	Academy of Finland(Academy of Finland); Societas Biologica Fennica Vanamo; Oulanka Foundation	This study was funded by the Academy of Finland (SV) and Societas Biologica Fennica Vanamo and Oulanka Foundation grants (EL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGREN J, 1994, OIKOS, V70, P35, DOI 10.2307/3545696; Alonso C, 2008, ECOSCIENCE, V15, P358, DOI 10.2980/15-3-3115; Ashman T. L., 2006, ECOLOGY EVOLUTION FL, P204; ASHMAN TL, 1994, AM J BOT, V81, P433, DOI 10.2307/2445492; Asikainen E, 2005, AM J BOT, V92, P487, DOI 10.3732/ajb.92.3.487; Asikainen E, 2005, ANN BOT-LONDON, V95, P879, DOI 10.1093/aob/mci094; Asikainen E, 2003, AM J BOT, V90, P226, DOI 10.3732/ajb.90.2.226; Asikainen E., 2004, THESIS TURKU U; Barr CM, 2004, P ROY SOC B-BIOL SCI, V271, P1935, DOI 10.1098/rspb.2004.2820; BERTIN RI, 1993, AM MIDL NAT, V129, P52, DOI 10.2307/2426435; Case Andrea L., 2005, P126; CHARLESWORTH B, 1978, AM NAT, V112, P975, DOI 10.1086/283342; CHARLESWORTH D, 1989, J THEOR BIOL, V139, P327, DOI 10.1016/S0022-5193(89)80212-7; Delph LF, 2005, NEW PHYTOL, V166, P119, DOI 10.1111/j.1469-8137.2005.01339.x; Delph LF, 2003, EVOL DEV, V5, P34, DOI 10.1046/j.1525-142X.2003.03006.x; DELPH LF, 1990, EVOLUTION, V44, P134, DOI 10.1111/j.1558-5646.1990.tb04284.x; Delph LF, 1999, AM J BOT, V86, P140, DOI 10.2307/2656963; Dorken ME, 2008, EVOLUTION, V62, P971, DOI 10.1111/j.1558-5646.2008.00336.x; Dufay M, 2012, ANN BOT-LONDON, V109, P505, DOI 10.1093/aob/mcr062; Gutterman Y., 2000, Seeds: the ecology of regeneration in plant communities, P59, DOI 10.1079/9780851994321.0059; HERRERA CM, 1995, ECOLOGY, V76, P1516, DOI 10.2307/1938153; Hulten E., 1986, ATLAS N EUROPEAN VAS, V1-3; Jacobs MS, 2003, AM NAT, V161, P837, DOI 10.1086/375174; Jacquemyn H, 2010, J ECOL, V98, P1204, DOI 10.1111/j.1365-2745.2010.01697.x; JOHN MK, 1970, SOIL SCI, V109, P214, DOI 10.1097/00010694-197004000-00002; Jurgens A, 2002, SEX PLANT REPROD, V14, P279, DOI 10.1007/s00497-001-0124-2; Korhonen J, 2004, CAN J BOT, V82, P89, DOI [10.1139/B03-142, 10.1139/b03-142]; LEWIS D., 1941, NEW PHYTOT, V40, P56, DOI 10.1111/j.1469-8137.1941.tb07028.x; LLOYD DG, 1976, THEOR POPUL BIOL, V9, P299, DOI 10.1016/0040-5809(76)90050-2; LLOYD DG, 1974, HEREDITY, V32, P11, DOI 10.1038/hdy.1974.2; McCauley DE, 2009, ANN BOT-LONDON, V104, P611, DOI 10.1093/aob/mcp141; Spigler RB, 2011, NEW PHYTOL, V190, P1058, DOI 10.1111/j.1469-8137.2011.03657.x; Spigler RB, 2013, ANN BOT, V109, P531; STEARNS SC, 1989, FUNCT ECOL, V3, P259, DOI 10.2307/2389364; STEARNS SC, 1976, Q REV BIOL, V51, P3, DOI 10.1086/409052; Toivonen E, 2012, ANN BOT-LONDON, V109, P1159, DOI 10.1093/aob/mcs037; Vaarama A., 1967, ANN ACAD SCI FENNI A, V108, P1; Van Etten ML, 2008, INT J PLANT SCI, V169, P271, DOI 10.1086/524109; Van Etten ML, 2009, NEW PHYTOL, V183, P649, DOI 10.1111/j.1469-8137.2009.02940.x; Varga S, 2014, PLANT BIOLOGY, V16, P306, DOI 10.1111/plb.12050; Varga S, 2010, FUNCT ECOL, V24, P750, DOI 10.1111/j.1365-2435.2010.01708.x; Varga S, 2009, PLANT ECOL, V202, P325, DOI 10.1007/s11258-008-9492-0; Yampolsky C., 1922, BIBLIOTHECA GENETICA, V3, P1	43	8	8	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2015	10	3							e0118981	10.1371/journal.pone.0118981	http://dx.doi.org/10.1371/journal.pone.0118981			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9JM	25738943	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000350685900088
J	Zhan, C; Yan, L; Wang, L; Ma, J; Jiang, W; Zhang, YX; Shi, Y; Wang, Q				Zhan, Cheng; Yan, Li; Wang, Lin; Ma, Jun; Jiang, Wei; Zhang, Yongxing; Shi, Yu; Wang, Qun			Isoform Switch of Pyruvate Kinase M1 Indeed Occurs but Not to Pyruvate Kinase M2 in Human Tumorigenesis	PLOS ONE			English	Article							NUCLEAR TRANSLOCATION; POOR-PROGNOSIS; PKM2 EXPRESSION; HIF-1-ALPHA; HEXOKINASE; CARCINOMA; CANCER; OVEREXPRESSION; IDENTIFICATION; PROLIFERATION	Muscle type of pyruvate kinase (PKM) is one of the key mediators of the Warburg effect and tumor metabolism. Due to alternative splicing, there are at least 12 known isoforms of the PKM gene, of which PKM1 and PKM2 are two major isoforms with only a 23 amino acid sequenced difference but quite different characteristics and functions. It was previously thought the isoform switch from PKM1 to PKM2 resulted in high PKM2 expression in tumors, providing a great advantage to tumor cells. However, this traditional view was challenged by two recent studies; one study claimed that this isoform switch does not occur during the Warburg effect; the other study asserted that the isoform switch is tissue-specific. Here, we reanalyzed the RNA sequencing data of 25 types of human tumors from The Cancer Genome Atlas Data Portal, and confirmed that PKM2 was the major isoform in the tumors and was highly elevated in addition to the entire PKM gene. We further demonstrated that the expression level of PKM1 significantly declined even though there was substantially increased expression of the entire PKM gene. The proportion of PKM1 in total transcript variants also significantly declined in tumors but the proportion of PKM2 did not change accordingly. Therefore, we conclude that the isoform switch of PKM1 does indeed occur, but it switches to other isoforms rather than PKM2. Considering the change in the expression levels of PKM1, PKM2 and the entire PKM gene, we propose that the upregulation of PKM2 is primarily due to elevated transcriptional levels of the entire PKM gene, instead of the isoform switch.	[Zhan, Cheng; Wang, Lin; Ma, Jun; Jiang, Wei; Zhang, Yongxing; Shi, Yu; Wang, Qun] Fudan Univ, Dept Thorac Surg, Zhongshan Hosp, Shanghai 200433, Peoples R China; [Yan, Li] Fudan Univ, Dept Radiat Oncol, Eye & ENT Hosp, Shanghai 200433, Peoples R China	Fudan University; Fudan University	Shi, Y (corresponding author), Fudan Univ, Dept Thorac Surg, Zhongshan Hosp, Shanghai 200433, Peoples R China.	shi.yu@zs-hospital.sh.cn; wang.qun@zs-hospital.sh.cn	Zhan, Cheng/F-3265-2014; wang, lin/HHM-2225-2022; Yan, Li/ABC-8451-2020; wang, lina/HGC-1592-2022	Zhan, Cheng/0000-0001-8745-9276; Yan, Li/0000-0002-0697-7838; Jiang, Wei/0000-0003-0904-3990	National Natural Science Foundation of China [81401875, 81472225]; Natural Science Foundation of Shanghai, China [14ZR1406000]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Shanghai, China(Natural Science Foundation of Shanghai)	This study was supported by the National Natural Science Foundation of China (Grant Nos. 81401875, 81472225) (http://www.nsfc.gov.cn/) and Natural Science Foundation of Shanghai, China (Grant No. 14ZR1406000) (http://www.stcsm.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bluemlein K, 2011, ONCOTARGET, V2, P393; Chen J, 2014, J CANCER RES CLIN, V140, P1205, DOI 10.1007/s00432-014-1644-0; Chen J, 2014, TUMOR BIOL, V35, P3743, DOI 10.1007/s13277-013-1496-2; Christofk HR, 2008, NATURE, V452, P230, DOI 10.1038/nature06734; Dando I, 2013, BBA-MOL CELL RES, V1833, P672, DOI 10.1016/j.bbamcr.2012.10.028; Dang CV, 2008, ERNST SCHERING FOUND, V4, P35, DOI 10.1007/2789_2008_088; Dennison JB, 2013, CLIN CANCER RES, V19, P3703, DOI 10.1158/1078-0432.CCR-13-0623; Desai S, 2013, ONCOTARGET; Diaz-Jullien C, 2011, BBA-PROTEINS PROTEOM, V1814, P355, DOI 10.1016/j.bbapap.2010.10.004; Falkenius J, 2013, MELANOMA RES, V23, P452, DOI 10.1097/CMR.0000000000000027; Gao XL, 2012, MOL CELL, V45, P598, DOI 10.1016/j.molcel.2012.01.001; Girgis H, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-101; Guo Y, 2014, INT J MOL SCI, V15, P7974, DOI 10.3390/ijms15057974; He GD, 2014, ASIA PAC J CLIN NUTR, V23, P174, DOI 10.6133/apjcn.2014.23.1.14; Hoshino A, 2007, J BIOL CHEM, V282, P17706, DOI 10.1074/jbc.M700094200; Hur H, 2013, INT J ONCOL, V42, P44, DOI 10.3892/ijo.2012.1687; Ignacak J, 2003, COMP BIOCHEM PHYS B, V134, P425, DOI 10.1016/S1096-4959(02)00283-X; Kress S, 1998, J CANCER RES CLIN, V124, P315, DOI 10.1007/s004320050175; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Li J, 2014, CLIN TRANSL ONCOL, V16, P200, DOI 10.1007/s12094-013-1063-8; Lim JY, 2012, WORLD J GASTROENTERO, V18, P4037, DOI 10.3748/wjg.v18.i30.4037; Lu HQ, 2013, MOL CANCER THER, V12, P2187, DOI 10.1158/1535-7163.MCT-12-1245; Luo WB, 2011, CELL, V145, P732, DOI 10.1016/j.cell.2011.03.054; Mamczur P, 2013, BBA-MOL CELL RES, V1833, P2812, DOI 10.1016/j.bbamcr.2013.07.013; Mazurek S, 2005, SEMIN CANCER BIOL, V15, P300, DOI 10.1016/j.semcancer.2005.04.009; Mazurek S, 2011, INT J BIOCHEM CELL B, V43, P969, DOI 10.1016/j.biocel.2010.02.005; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Peng SY, 2008, ONCOL REP, V19, P1045; Pernemalm M, 2013, J PROTEOME RES, V12, P3934, DOI 10.1021/pr4002096; Puzone R, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-97; Saman DM, 2014, DM-DIS MON, V60, P150, DOI 10.1016/j.disamonth.2014.02.003; Sato-Tadano A, 2013, CANCER SCI, V104, P1380, DOI 10.1111/cas.12238; Semenza GL, 2007, J BIOENERG BIOMEMBR, V39, P231, DOI 10.1007/s10863-007-9081-2; Song Y, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-65; Spoden GA, 2009, EXP CELL RES, V315, P2765, DOI 10.1016/j.yexcr.2009.06.024; Stetak A, 2007, CANCER RES, V67, P1602, DOI 10.1158/0008-5472.CAN-06-2870; Tang ZJ, 2012, J BIOENERG BIOMEMBR, V44, P117, DOI 10.1007/s10863-012-9420-9; Teng YC, 2013, J OBSTET GYNAECOL RE, V39, P317, DOI 10.1111/j.1447-0756.2012.01970.x; Wang DR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061262; Wang HJ, 2014, P NATL ACAD SCI USA, V111, P279, DOI 10.1073/pnas.1311249111; Wilhelm M, 2014, NATURE, V509, P582, DOI 10.1038/nature13319; Yang F, 2014, MOL CELL, V53, P88, DOI 10.1016/j.molcel.2013.11.004; Yang WW, 2012, NAT CELL BIOL, V14, P1295, DOI 10.1038/ncb2629; Yang WW, 2011, NATURE, V480, P118, DOI 10.1038/nature10598; Yao Y, 2014, TUMOUR BIOL; Yuan C, 2014, HISTOPATHOLOGY; Zhan C, 2013, DIS ESOPHAGUS, V26, P746, DOI 10.1111/dote.12023; Zhan C, 2014, ACTA BIOCH BIOPH SIN, V46, P330, DOI 10.1093/abbs/gmt153; Zhang XL, 2013, PATHOL RES PRACT, V209, P510, DOI 10.1016/j.prp.2013.06.005	49	24	25	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2015	10	3							e0118663	10.1371/journal.pone.0118663	http://dx.doi.org/10.1371/journal.pone.0118663			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9JM	25738776	Green Submitted, Green Published, gold			2022-12-27	WOS:000350685900059
J	Pedraz, M; Martin-Velasco, AI; Garcia-Marchena, N; Araos, P; Serrano, A; Romero-Sanchiz, P; Suarez, J; Castilla-Ortega, E; Barrios, V; Campos-Cloute, R; Ruiz, JJ; Torrens, M; Chowen, JA; Argente, J; de la Torre, R; Santin, LJ; Villanua, MA; de Fonseca, FR; Pavon, FJ				Pedraz, Maria; Isabel Martin-Velasco, Ana; Garcia-Marchena, Nuria; Araos, Pedro; Serrano, Antonia; Romero-Sanchiz, Pablo; Suarez, Juan; Castilla-Ortega, Estela; Barrios, Vicente; Campos-Cloute, Rafael; Jesus Ruiz, Juan; Torrens, Marta; Ann Chowen, Julie; Argente, Jesus; de la Torre, Rafael; Javier Santin, Luis; Angeles Villanua, Maria; Rodriguez de Fonseca, Fernando; Javier Pavon, Francisco			Plasma Concentrations of BDNF and IGF-1 in Abstinent Cocaine Users with High Prevalence of Substance Use Disorders: Relationship to Psychiatric Comorbidity	PLOS ONE			English	Article							GROWTH-FACTOR-I; NEUROTROPHIC FACTOR; RESEARCH INTERVIEW; MENTAL-DISORDERS; DSM-5 CRITERIA; BRAIN; INSULIN; DEPRESSION; ALCOHOL; NEUROPLASTICITY	Recent studies have identified biomarkers related to the severity and pathogenesis of cocaine addiction and common comorbid psychiatric disorders. Monitoring these plasma mediators may improve the stratification of cocaine users seeking treatment. Because the neurotrophic factors are involved in neural plasticity, neurogenesis and neuronal survival, we have determined plasma concentrations of brain-derived neurotrophic factor (BDNF), insulin-like growth factor 1 (IGF-1) and IGF-1 binding protein 3 (IGFBP-3) in a cross-sectional study with abstinent cocaine users who sought outpatient treatment for cocaine (n = 100) and age/body mass matched controls (n = 85). Participants were assessed with the diagnostic interview 'Psychiatric Research Interview for Substance and Mental Disorders'. Plasma concentrations of these peptides were not different in cocaine users and controls. They were not associated with length of abstinence, duration of cocaine use or cocaine symptom severity. The pathological use of cocaine did not influence the association of IGF-1 with age observed in healthy subjects, but the correlation between IGF-1 and IGFBP-3 was not significantly detected. Correlation analyses were performed between these peptides and other molecules sensitive to addiction: BDNF concentrations were not associated with inflammatory mediators, lipid derivatives or IGF-1 in cocaine users, but correlated with chemokines (fractalkine/CX3CL1 and SDF-1/CXCL12) and N-acyl-ethanolamines (N-palmitoyl-, N-oleoyl-, N-arachidonoyl-, N-linoleoyl- and N-dihomo-y-linolenoyl-ethanolamine) in controls; IGF-1 concentrations only showed association with IGFBP-3 concentrations in controls; and IGFBP-3 was only correlated with N-stearoyl-ethanolamine concentrations in cocaine users. Multiple substance use disorders and life-time comorbid psychopathologies were common in abstinent cocaine users. Interestingly, plasma BDNF concentrations were exclusively found to be decreased in users diagnosed with both primary and cocaine-induced disorders for mood and anxiety disorders. In summary, BDNF, IGF-1 and IGFBP-3 were not affected by a history of pathological use of cocaine supported by the absence of associations with other molecules sensitive to cocaine addiction. However, BDNF was affected by comorbid mood disorders. Further research is necessary to elucidate the role of BDNF and IGF-1 in the transition to cocaine addiction and associated psychiatric comorbidity.	[Pedraz, Maria; Garcia-Marchena, Nuria; Araos, Pedro; Serrano, Antonia; Romero-Sanchiz, Pablo; Suarez, Juan; Castilla-Ortega, Estela; Rodriguez de Fonseca, Fernando; Javier Pavon, Francisco] Univ Malaga, Hosp Reg Univ Malaga, Unidad Gest Clin Salud Mental, Inst Invest Biomed Malaga IBIMA, E-29071 Malaga, Spain; [Isabel Martin-Velasco, Ana; Angeles Villanua, Maria] Univ Complutense Madrid, Fac Med, Dept Physiol, Madrid, Spain; [Barrios, Vicente; Ann Chowen, Julie; Argente, Jesus] Hosp Infantil Univ Nino Jesus, Inst Invest La Princesa, Dept Pediat & Pediat Endocrinol, Madrid, Spain; [Barrios, Vicente; Ann Chowen, Julie; Argente, Jesus] Univ Autonoma Madrid, Dept Pediat, Madrid, Spain; [Barrios, Vicente; Ann Chowen, Julie; Argente, Jesus; de la Torre, Rafael; Rodriguez de Fonseca, Fernando] Inst Salud Carlos III, Ctr Invest Biomed Red Fisiopatol Obesidad & Nutr, Madrid, Spain; [Campos-Cloute, Rafael] Ctr Tratamiento Ambulatorio Mijas Costa Diputac M, Mijas, Spain; [Jesus Ruiz, Juan] Ctr Prov Drogodependencia Diputac Malaga, Malaga, Spain; [Torrens, Marta; de la Torre, Rafael] Inst Hosp Mar Invest Med IMIM, Neurosci Program, Barcelona, Spain; [Torrens, Marta] Inst Neuropsiquiatria & Addicc INAD Parc Salut MA, Barcelona, Spain; [Torrens, Marta] Univ Autonoma Barcelona UAB, Dept Psychiat, Barcelona, Spain; [de la Torre, Rafael] Univ Pompeu Fabra CEXS UPF, Fac Ciencies Salut & Vida, Barcelona, Spain; [Javier Santin, Luis] Univ Malaga, Fac Psicol, Dept Psicobiol & Metodol Ciencias Comportamiento, E-29071 Malaga, Spain	Universidad de Malaga; Complutense University of Madrid; Autonomous University of Madrid; CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN; Instituto de Salud Carlos III; Institut Hospital del Mar d'Investigacions Mediques (IMIM); Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Pompeu Fabra University; Universidad de Malaga	de Fonseca, FR (corresponding author), Univ Malaga, Hosp Reg Univ Malaga, Unidad Gest Clin Salud Mental, Inst Invest Biomed Malaga IBIMA, E-29071 Malaga, Spain.	fernando.rodriguez@ibima.eu; javier.pavon@ibima.eu	Castilla-Ortega, Estela/K-2811-2015; Santin, Luis Javier LJ/G-4364-2011; Argente, Jesús/M-5226-2019; Chowen, Julie/C-8979-2011; Pavón Morón, Francisco Javier/AAG-9721-2020; de la Torre, Rafael/D-3561-2018; Suarez, Juan/I-5188-2015; Sabador, Vicente Barrios/N-6982-2016; Romero-Sanchiz, Pablo/B-8454-2011; Martín, Ana Isabel/K-5301-2014; GÓMEZ, PEDRO FERNANDO ARAOS/AAX-1715-2021; Santin, Luis Javier/G-4364-2011	Castilla-Ortega, Estela/0000-0002-4496-1167; Santin, Luis Javier LJ/0000-0003-0894-8536; Argente, Jesús/0000-0001-5826-0276; Chowen, Julie/0000-0002-4770-2291; Pavón Morón, Francisco Javier/0000-0002-5256-8904; de la Torre, Rafael/0000-0002-6765-1866; Suarez, Juan/0000-0001-5254-9802; Sabador, Vicente Barrios/0000-0002-5507-7545; Romero-Sanchiz, Pablo/0000-0002-3683-3835; Martín, Ana Isabel/0000-0002-4445-590X; GÓMEZ, PEDRO FERNANDO ARAOS/0000-0001-5172-8796; Pedraz, Maria/0000-0002-1923-6692; Santin, Luis Javier/0000-0003-1755-6497; Serrano, Antonia/0000-0002-8017-9754; RODRIGUEZ DE FONSECA, FERNANDO/0000-0002-4516-5795	Institut de Salud Carlos III (ISC-III); Red de Trastornos Adictivos UE-FEDER [RD12/0028]; Ministerio de Economia y Competitividad [PI13/02261]; Plan Nacional sobre Drogas [049/2009, 049/2013]; Consejeria de Economia, Innovacion y Ciencia, Junta de Andalucia UE-FEDER [CTS-433]; Consejeria de Salud y Bienestar Social, Junta Andalucia [PI0228-2013, PI0823-2012]; Departament d'Innovacio, Universitats i Empresa, Generalitat de Catalunya [2014-SGR-680]; ISC-III [CP12/03109, CP14/00173, CP14/00212]	Institut de Salud Carlos III (ISC-III)(Instituto de Salud Carlos III); Red de Trastornos Adictivos UE-FEDER; Ministerio de Economia y Competitividad(Spanish Government); Plan Nacional sobre Drogas; Consejeria de Economia, Innovacion y Ciencia, Junta de Andalucia UE-FEDER; Consejeria de Salud y Bienestar Social, Junta Andalucia; Departament d'Innovacio, Universitats i Empresa, Generalitat de Catalunya(Generalitat de Catalunya); ISC-III(Instituto de Salud Carlos III)	The present study has been supported by Institut de Salud Carlos III (ISC-III), Red de Trastornos Adictivos UE-FEDER 2012 (RD12/0028); Ministerio de Economia y Competitividad (PI13/02261); Plan Nacional sobre Drogas 049/2009 and 049/2013; Consejeria de Economia, Innovacion y Ciencia, Junta de Andalucia UE-FEDER (CTS-433); Consejeria de Salud y Bienestar Social, Junta Andalucia (PI0228-2013 and PI0823-2012); Departament d'Innovacio, Universitats i Empresa, Generalitat de Catalunya (2014-SGR-680). JS, AS and FJP hold a "Miguel Servet" research contract from ISC-III (CP12/03109, CP14/00173 and CP14/ 00212, respectively). PR-S holds a "Rio Hortega" research contract from ISC-III (CM13/0115). EC-O holds a "Sara Borrell" research contract from ISC-III (CD 12/00455). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aleman A, 2009, PROG NEUROBIOL, V89, P256, DOI 10.1016/j.pneurobio.2009.07.008; Araos P, 2015, ADDICT BIOL, V20, P756, DOI 10.1111/adb.12156; Araos P, 2014, ADICCIONES, V26, P15, DOI 10.20882/adicciones.124; Bao Q, 2014, MOL CELL ENDOCRINOL, V394, P115, DOI 10.1016/j.mce.2014.07.005; BEITNERJOHNSON D, 1993, ANN NY ACAD SCI, V692, P246; Bocchio-Chiavetto L, 2010, WORLD J BIOL PSYCHIA, V11, P763, DOI 10.3109/15622971003611319; Brunoni AR, 2008, INT J NEUROPSYCHOPH, V11, P1169, DOI 10.1017/S1461145708009309; Castren E, 2004, MOL NEUROBIOL, V29, P289, DOI 10.1385/MN:29:3:289; Corominas-Roso M, 2013, NEUROPSYCHOBIOLOGY, V68, P146, DOI 10.1159/000353259; Corominas-Roso M, 2013, EUR NEUROPSYCHOPHARM, V23, P1078, DOI 10.1016/j.euroneuro.2012.08.016; Corominas-Roso M, 2013, INT J NEUROPSYCHOPH, V16, P1267, DOI 10.1017/S1461145712001629; D'Sa C, 2011, BIOL PSYCHIAT, V70, P706, DOI 10.1016/j.biopsych.2011.05.013; Deuschle M, 1997, PSYCHONEUROENDOCRINO, V22, P493, DOI 10.1016/S0306-4530(97)00046-2; Domenici E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009166; Domenici Enrico, 2007, Expert Opin Med Diagn, V1, P235, DOI 10.1517/17530059.1.2.235; Garcia-Valdecasas-Campelo E, 2007, ALCOHOL ALCOHOLISM, V42, P533, DOI 10.1093/alcalc/agm065; Guevara-Aguirre J, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001845; Haile CN, 2012, PHARMACOL THERAPEUT, V134, P260, DOI 10.1016/j.pharmthera.2012.01.010; Hall K., 1999, Journal of Endocrinological Investigation, V22, P48; Han C, 2014, ALCOHOL ALCOHOL S1, V49, pi49; Hashiguchi Y, 1996, BRAIN RES BULL, V40, P99, DOI 10.1016/0361-9230(96)00045-7; Hasin D, 2006, AM J PSYCHIAT, V163, P689, DOI 10.1176/appi.ajp.163.4.689; Hasin DS, 2013, AM J PSYCHIAT, V170, P834, DOI 10.1176/appi.ajp.2013.12060782; Hasin DS, 2012, DRUG ALCOHOL DEPEN, V122, P28, DOI 10.1016/j.drugalcdep.2011.09.005; Hasin DS, 1996, AM J PSYCHIAT, V153, P1195; Herrero MJ, 2008, ADDICTION, V103, P284, DOI 10.1111/j.1360-0443.2007.02076.x; Pavon FJ, 2013, ADDICT BIOL, V18, P955, DOI 10.1111/adb.12107; Junnila RK, 2013, NAT REV ENDOCRINOL, V9, P366, DOI 10.1038/nrendo.2013.67; Kenna HA, 2014, J AFFECT DISORDERS, V156, P214, DOI 10.1016/j.jad.2013.01.054; Kim YK, 2007, PROG NEURO-PSYCHOPH, V31, P78, DOI 10.1016/j.pnpbp.2006.06.024; Leggio L, 2008, ALCOHOL CLIN EXP RES, V32, P450, DOI 10.1111/j.1530-0277.2007.00589.x; Lin F, 2014, PSYCHONEUROENDOCRINO, V42, P118, DOI 10.1016/j.psyneuen.2014.01.006; Liu XZ, 2014, ADV MATER INTERFACES, V1, DOI 10.1002/admi.201300053; Malberg JE, 2007, NEUROPSYCHOPHARMACOL, V32, P2360, DOI 10.1038/sj.npp.1301358; Martinowich K, 2007, NAT NEUROSCI, V10, P1089, DOI 10.1038/nn1971; Molle RD, 2012, TRANSL PSYCHIAT, V2, DOI 10.1038/tp.2012.126; Morgello S, 2006, INT J METH PSYCH RES, V15, P131, DOI 10.1002/mpr.189; Muller AP, 2012, MOL CELL NEUROSCI, V49, P9, DOI 10.1016/j.mcn.2011.07.008; O'Kusky J, 2012, FRONT NEUROENDOCRIN, V33, P230, DOI 10.1016/j.yfrne.2012.06.002; Pawlikowska L, 2009, AGING CELL, V8, P460, DOI 10.1111/j.1474-9726.2009.00493.x; Piccinni A, 2008, J AFFECT DISORDERS, V105, P279, DOI 10.1016/j.jad.2007.05.005; Reece AS, 2013, NEUROENDOCRINOL LETT, V34, P18; Rivera P, 2013, EUR J NEUROSCI, V37, P105, DOI 10.1111/ejn.12012; ROBINS LN, 1988, ARCH GEN PSYCHIAT, V45, P1069; Robinson TE, 2004, NEUROPHARMACOLOGY, V47, P33, DOI 10.1016/j.neuropharm.2004.06.025; Rosa A R, 2014, Psychol Med, V44, P2409, DOI 10.1017/S0033291714000014; Sinha R, 2011, CURR PSYCHIAT REP, V13, P398, DOI 10.1007/s11920-011-0224-0; Sordi AO, 2014, PSYCHOPHARMACOLOGY, V231, P4031, DOI 10.1007/s00213-014-3542-1; Stouthart PJHM, 2003, PSYCHONEUROENDOCRINO, V28, P612, DOI 10.1016/S0306-4530(02)00045-8; Suliman S, 2013, FRONT INTEGR NEUROSC, V7, DOI 10.3389/fnint.2013.00055; Thomas MJ, 2008, BRIT J PHARMACOL, V154, P327, DOI 10.1038/bjp.2008.77; Torrens M, 2004, AM J PSYCHIAT, V161, P1231, DOI 10.1176/appi.ajp.161.7.1231; Torrens M, 2006, NEUROTOX RES, V10, P253, DOI 10.1007/BF03033361; Torres-Aleman I, 2010, DEV NEUROBIOL, V70, P384, DOI 10.1002/dneu.20778; Trueba-Saiz A, 2013, TRANSL PSYCHIAT, V3, DOI 10.1038/tp.2013.102; van Heemst D, 2005, AGING CELL, V4, P79, DOI 10.1111/j.1474-9728.2005.00148.x; Viola TW, 2014, J PSYCHIATR NEUROSCI, V39, P206, DOI 10.1503/jpn.130027; von Diemen L, 2014, INT J NEUROPSYCHOPH, V17, P33, DOI 10.1017/S146114571300103X	58	22	22	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2015	10	3							e0118610	10.1371/journal.pone.0118610	http://dx.doi.org/10.1371/journal.pone.0118610			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4HV	25734326	Green Published, gold, Green Submitted			2022-12-27	WOS:000350314700039
J	Hazaymeh, K; Hassan, QK				Hazaymeh, Khaled; Hassan, Quazi K.			Fusion of MODIS and Landsat-8 Surface Temperature Images: A New Approach	PLOS ONE			English	Article							REFLECTANCE; RESOLUTION; MODEL; PRODUCTS	Here, our objective was to develop a spatio-temporal image fusion model (STI-FM) for enhancing temporal resolution of Landsat-8 land surface temperature (LST) images by fusing LST images acquired by the Moderate Resolution Imaging Spectroradiometer (MODIS); and implement the developed algorithm over a heterogeneous semi-arid study area in Jordan, Middle East. The STI-FM technique consisted of two major components: (i) establishing a linear relationship between two consecutive MODIS 8-day composite LST images acquired at time 1 and time 2; and (ii) utilizing the above mentioned relationship as a function of a Landsat-8 LST image acquired at time 1 in order to predict a synthetic Landsat-8 LST image at time 2. It revealed that strong linear relationships (i.e., r(2), slopes, and intercepts were in the range 0.93-0.94, 0.94-0.99; and 2.97-20.07) existed between the two consecutive MODIS LST images. We evaluated the synthetic LST images qualitatively and found high visual agreements with the actual Landsat-8 LST images. In addition, we conducted quantitative evaluations of these synthetic images; and found strong agreements with the actual Landsat-8 LST images. For example, r(2), root mean square error (RMSE), and absolute average difference (AAD)-values were in the ranges 084-0.90, 0.061-0.080, and 0.003-0.004, respectively.	[Hazaymeh, Khaled; Hassan, Quazi K.] Univ Calgary, Schulich Sch Engn, Dept Geomat Engn, Calgary, AB, Canada	University of Calgary	Hassan, QK (corresponding author), Univ Calgary, Schulich Sch Engn, Dept Geomat Engn, 2500 Univ Dr NW, Calgary, AB, Canada.	qhassan@ucalgary.ca		Hazaymeh, Khaled/0000-0002-2162-7385; Hassan, Quazi K./0000-0002-7034-359X	Yarmouk University - Jordan; National Sciences and Engineering Research Council (NSERC) - Canada	Yarmouk University - Jordan; National Sciences and Engineering Research Council (NSERC) - Canada(Natural Sciences and Engineering Research Council of Canada (NSERC))	The funders or sources of support include Yarmouk University - Jordan, and the National Sciences and Engineering Research Council (NSERC) - Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akther MS, 2011, BOREAL ENVIRON RES, V16, P407; Anderson MC, 2011, HYDROL EARTH SYST SC, V15, P223, DOI 10.5194/hess-15-223-2011; Anyamba A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092538; Cammalleri C, 2013, WATER RESOUR RES, V49, P4672, DOI 10.1002/wrcr.20349; Chowdhury EH, 2013, NAT HAZARDS, V67, P321, DOI 10.1007/s11069-013-0564-7; Chuang TW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046882; Feng M, 2013, REMOTE SENS ENVIRON, V134, P276, DOI 10.1016/j.rse.2013.02.031; Feng M, 2012, COMPUT GEOSCI-UK, V38, P9, DOI 10.1016/j.cageo.2011.04.011; Fu DJ, 2013, REMOTE SENS-BASEL, V5, P6346, DOI 10.3390/rs5126346; Gao F, 2006, IEEE T GEOSCI REMOTE, V44, P2207, DOI 10.1109/TGRS.2006.872081; Hassan QK, 2007, J APPL REMOTE SENS, V1, DOI 10.1117/1.2740040; Hassan QK, 2013, J PLANT ECOL, V6, P84, DOI 10.1093/jpe/rts010; Huang B, 2013, IEEE GEOSCI REMOTE S, V10, P1011, DOI 10.1109/LGRS.2012.2227930; JME (Jordan Ministry of Environment), 2006, NAT STRAT ACT PLAN C; Kerr YH, 2004, THERMAL REMOTE SENSING IN LAND SURFACE PROCESSES, P33; Kim J, 2012, J APPL REMOTE SENS, V6, DOI 10.1117/1.JRS.6.063569; Li YY, 2012, INT J APPL EARTH OBS, V19, P127, DOI 10.1016/j.jag.2012.05.001; Li ZL, 2013, REMOTE SENS ENVIRON, V131, P14, DOI 10.1016/j.rse.2012.12.008; Liu H, 2012, REMOTE SENS ENVIRON, V117, P57, DOI 10.1016/j.rse.2011.06.023; Mildrexler DJ, 2011, J GEOPHYS RES-BIOGEO, V116, DOI 10.1029/2010JG001486; Moran MS, 2004, THERMAL REMOTE SENSING IN LAND SURFACE PROCESSES, P257; Oguro Y., 2011, Applied and Environmental Soil Science, V2011, P948135, DOI 10.1155/2011/948135; Roy DP, 2008, REMOTE SENS ENVIRON, V112, P3112, DOI 10.1016/j.rse.2008.03.009; Shen HF, 2013, INT J REMOTE SENS, V34, P4367, DOI 10.1080/01431161.2013.777488; Tang RL, 2010, REMOTE SENS ENVIRON, V114, P540, DOI 10.1016/j.rse.2009.10.012; USGS, 2013, US USGS LANDS 8 PROD; USGS (U.S. Geological Survey), 2014, LANDS 8 L8 OP LAND I; Vermote E.F., 2011, MODIS SURFACE REFLEC; Walker JJ, 2012, REMOTE SENS ENVIRON, V117, P381, DOI 10.1016/j.rse.2011.10.014; Wan Z, 2004, INT J REMOTE SENS, V25, P261, DOI 10.1080/0143116031000116417; Wan Z., 2013, MODIS LAND SURFACE T; Weng QH, 2014, REMOTE SENS ENVIRON, V145, P55, DOI 10.1016/j.rse.2014.02.003; Wu PH, 2013, INT J DIGIT EARTH, V6, P113, DOI 10.1080/17538947.2013.783131; Yu Y, 2008, IEEE T GEOSCI REMOTE, V46, P179, DOI 10.1109/TGRS.2007.909097; Zhang W, 2013, REMOTE SENS-BASEL, V5, P5346, DOI 10.3390/rs5105346; Zhao SH, 2009, J EARTH SYST SCI, V118, P345, DOI 10.1007/s12040-009-0027-4; Zhu XL, 2010, REMOTE SENS ENVIRON, V114, P2610, DOI 10.1016/j.rse.2010.05.032	37	25	25	4	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2015	10	3							e0117755	10.1371/journal.pone.0117755	http://dx.doi.org/10.1371/journal.pone.0117755			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9JF	25730279	Green Published, Green Submitted, gold			2022-12-27	WOS:000350684900014
J	Lu, QH; Adler, PN				Lu, Qiuheng; Adler, Paul N.			The diaphanous Gene of Drosophila Interacts Antagonistically with multiple wing hairs and Plays a Key Role in Wing Hair Morphogenesis	PLOS ONE			English	Article							PLANAR CELL POLARITY; ORGAN PRECURSOR CELL; TISSUE POLARITY; F-ACTIN; DUSKY-LIKE; PROTEIN; FORMIN; FAT; BRISTLES; ENCODES	The Drosophila wing is covered by an array of distally pointing hairs that has served as a key model system for studying planar cell polarity (PCP). The adult cuticular hairs are formed in the pupae from cell extensions that contain extensive actin filaments and microtubules. The importance of the actin cytoskeleton for hair growth and morphogenesis is clear from the wide range of phenotypes seen in mutations in well-known actin regulators. Formin proteins promote the formation of long actin filaments of the sort thought to be important for hair growth. We report here that the formin encoding diaphanous (dia) gene plays a key role in hair morphogenesis. Both loss of function mutations and the expression of a constitutively active Dia led to cells forming both morphologically abnormal hairs and multiple hairs. The conserved frizzled (fz)/starry night (stan) PCP pathway functions to restrict hair initiation and activation of the cytoskeleton to the distal most part of wing cells. It also ensures the formation of a single hair per cell. Our data suggest that the localized inhibition of Dia activity may be part of this mechanism. We found the expression of constitutively active Dia greatly expands the region for activation of the cytoskeleton and that dia functions antagonistically with multiple wing hairs (mwh), the most downstream member of the fz/stan pathway. Further we established that purified fragments of Dia and Mwh could be co-immunoprecipitated suggesting the genetic interaction could reflect a direct physical interaction.	[Lu, Qiuheng; Adler, Paul N.] Univ Virginia, Dept Biol, Charlottesville, VA 22904 USA; [Adler, Paul N.] Univ Virginia, Dept Cell Biol, Charlottesville, VA USA	University of Virginia; University of Virginia	Adler, PN (corresponding author), Univ Virginia, Dept Biol, Charlottesville, VA 22904 USA.	pna@virginia.edu			National Institutes of Health [GM037163]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM037163] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	National Institutes of Health, GM037163 to PNA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler PN, 2013, DEV BIOL, V379, P76, DOI 10.1016/j.ydbio.2013.04.012; Adler PN, 2012, CURR TOP DEV BIOL, V101, P1, DOI 10.1016/B978-0-12-394592-1.00001-6; Adler PN, 2002, DEV CELL, V2, P525, DOI 10.1016/S1534-5807(02)00176-4; ADLER PN, 1992, BIOESSAYS, V14, P735, DOI 10.1002/bies.950141103; Adler PN, 1998, DEVELOPMENT, V125, P959; Adler PN, 2000, GENESIS, V28, P82, DOI 10.1002/1526-968X(200010)28:2<82::AID-GENE60>3.0.CO;2-Z; Alberts AS, 2001, J BIOL CHEM, V276, P2824, DOI 10.1074/jbc.M006205200; Axelrod JD, 2001, GENE DEV, V15, P1182; Bitan A, 2012, DEVELOPMENT, V139, P1987, DOI 10.1242/dev.076893; Blair A, 2006, DEVELOPMENT, V133, P1789, DOI 10.1242/dev.02320; BRAND AH, 1993, DEVELOPMENT, V118, P401; BRYANT PJ, 1988, DEV BIOL, V128, P386, DOI 10.1016/0012-1606(88)90300-4; CANT K, 1994, J CELL BIOL, V125, P369, DOI 10.1083/jcb.125.2.369; CASTRILLON DH, 1994, DEVELOPMENT, V120, P3367; Chesarone MA, 2010, NAT REV MOL CELL BIO, V11, P62, DOI 10.1038/nrm2816; Dickinson WJ, 1997, CELL MOTIL CYTOSKEL, V38, P9; Dietzl G, 2007, NATURE, V448, P151, DOI 10.1038/nature05954; Eaton S, 1996, J CELL BIOL, V135, P1277, DOI 10.1083/jcb.135.5.1277; Fei XY, 2002, J CELL SCI, V115, P3797, DOI 10.1242/jcs.00065; Franke JD, 2010, DEV BIOL, V345, P117, DOI 10.1016/j.ydbio.2010.06.028; FRISTROM D, 1993, DEVELOPMENT, V117, P509; Gho M, 1998, NATURE, V393, P178, DOI 10.1038/30265; Giansanti MG, 2004, MOL BIOL CELL, V15, P2509, DOI 10.1091/mbc.E03-08-0603; Gomes JE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004485; Goode BL, 2007, ANNU REV BIOCHEM, V76, P593, DOI 10.1146/annurev.biochem.75.103004.142647; Guild GM, 2005, MOL BIOL CELL, V16, P3620, DOI 10.1091/mbc.E05-03-0185; Habas R, 2001, CELL, V107, P843, DOI 10.1016/S0092-8674(01)00614-6; Harris ES, 2006, J BIOL CHEM, V281, P14383, DOI 10.1074/jbc.M510923200; Harumoto T, 2010, DEV CELL, V19, P389, DOI 10.1016/j.devcel.2010.08.004; He B, 2001, MECH DEVELOP, V104, P69, DOI 10.1016/S0925-4773(01)00368-9; Homem CCF, 2009, MOL BIOL CELL, V20, P5138, DOI 10.1091/mbc.E09-02-0144; Johnston CA, 2013, J CELL SCI, V126, P4436, DOI 10.1242/jcs.129544; Kiehart DP, 2004, GENETICS, V168, P1337, DOI 10.1534/genetics.104.026369; Kiehart DP, 1989, EMBO J, V8; Kitayama C, 2003, J CELL SCI, V116, P711, DOI 10.1242/jcs.00265; KRASNOW RE, 1994, DEVELOPMENT, V120, P1883; Kuhn S, 2014, SMALL GTPASES, P5; Lawrence PA, 2008, NAT CELL BIOL, V10, P1379, DOI 10.1038/ncb1208-1379; Li F, 2005, J BIOL CHEM, V280, P6986, DOI 10.1074/jbc.M411605200; Ma D, 2003, NATURE, V421, P543, DOI 10.1038/nature01366; Maiti S, 2012, CYTOSKELETON, V69, P393, DOI 10.1002/cm.21033; Matis M, 2014, ELIFE, V3, DOI 10.7554/eLife.02893; Matis M, 2013, GENE DEV, V27, P2207, DOI 10.1101/gad.228098.113; Matusek T, 2006, DEVELOPMENT, V133, P957, DOI 10.1242/dev.02266; McGuire Sean E, 2004, Sci STKE, V2004, ppl6, DOI 10.1126/stke.2202004pl6; Moseley JB, 2004, MOL BIOL CELL, V15, P896, DOI 10.1091/mbc.E03-08-0621; Nagaraj R, 2012, DEVELOPMENT, V139, P906, DOI 10.1242/dev.074252; Niwa R, 2002, CELL, V108, P233, DOI 10.1016/S0092-8674(01)00638-9; PARKHURST SM, 1985, CELL, V41, P429, DOI 10.1016/S0092-8674(85)80016-7; Petersen J, 1998, J CELL BIOL, V141, P1217, DOI 10.1083/jcb.141.5.1217; PETERSEN NS, 1994, GENETICS, V136, P173; POSAKONY JW, 1994, CELL, V76, P415, DOI 10.1016/0092-8674(94)90105-8; Price MH, 2006, J CELL SCI, V119, P403, DOI 10.1242/jcs.02761; Ren N, 2006, GENETICS, V172, P1643, DOI 10.1534/genetics.105.051433; Ren N, 2005, GENETICS, V171, P625, DOI 10.1534/genetics.105.043687; Ren N, 2007, GENETICS, V176, P2223, DOI 10.1534/genetics.107.072959; Rottner K, 2010, TRENDS CELL BIOL, V20, P650, DOI 10.1016/j.tcb.2010.08.014; Rotty JD, 2013, NAT REV MOL CELL BIO, V14, P7, DOI 10.1038/nrm3492; Sharma P, 2013, PROG MOL BIOL TRANSL, V116, P215, DOI 10.1016/B978-0-12-394311-8.00010-8; Shimada Y, 2006, DEV CELL, V10, P209, DOI 10.1016/j.devcel.2005.11.016; Strutt D, 2008, DEVELOPMENT, V135, P3103, DOI 10.1242/dev.025205; Thomas C, 2012, DEV DYNAM, V241, P27, DOI 10.1002/dvdy.22736; Tilney LG, 2005, P NATL ACAD SCI USA, V102, P18785, DOI 10.1073/pnas.0509437102; TILNEY LG, 1995, J CELL BIOL, V130, P629, DOI 10.1083/jcb.130.3.629; Turner CM, 1998, MECH DEVELOP, V70, P181, DOI 10.1016/S0925-4773(97)00194-9; Wang YS, 2007, DEVELOPMENT, V134, P647, DOI 10.1242/dev.02772; WILLIAMS JA, 1988, EMBO J, V7, P1355, DOI 10.1002/j.1460-2075.1988.tb02951.x; Winter CG, 2001, CELL, V105, P81, DOI 10.1016/S0092-8674(01)00298-7; WONG LL, 1993, J CELL BIOL, V123, P209, DOI 10.1083/jcb.123.1.209; Xu YW, 2004, CELL, V116, P711, DOI 10.1016/S0092-8674(04)00210-7; Yan J, 2008, GENETICS, V180, P219, DOI 10.1534/genetics.108.091314; Yan J, 2009, DEV BIOL, V333, P186, DOI 10.1016/j.ydbio.2009.06.027; Yang CH, 2002, CELL, V108, P675, DOI 10.1016/S0092-8674(02)00658-X	73	8	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2015	10	3							e0115623	10.1371/journal.pone.0115623	http://dx.doi.org/10.1371/journal.pone.0115623			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9JF	25730111	gold, Green Published, Green Submitted			2022-12-27	WOS:000350684900006
J	Dong, TY; Liu, SY; Xia, JJ; Fan, J; Zhang, L				Dong, Tianyang; Liu, Siyuan; Xia, Jiajia; Fan, Jing; Zhang, Ling			A Time-Critical Adaptive Approach for Visualizing Natural Scenes on Different Devices	PLOS ONE			English	Article							3-D OBJECT RETRIEVAL; REAL-TIME; RECOGNITION	To automatically adapt to various hardware and software environments on different devices, this paper presents a time-critical adaptive approach for visualizing natural scenes. In this method, a simplified expression of a tree model is used for different devices. The best rendering scheme is intelligently selected to generate a particular scene by estimating the rendering time of trees based on their visual importance. Therefore, this approach can ensure the reality of natural scenes while maintaining a constant frame rate for their interactive display. To verify its effectiveness and flexibility, this method is applied in different devices, such as a desktop computer, laptop, iPad and smart phone. Applications show that the method proposed in this paper can not only adapt to devices with different computing abilities and system resources very well but can also achieve rather good visual realism and a constant frame rate for natural scenes.	[Dong, Tianyang; Liu, Siyuan; Xia, Jiajia; Fan, Jing] Zhejiang Univ Technol, Sch Comp Sci & Technol, Hangzhou, Zhejiang, Peoples R China; [Dong, Tianyang; Liu, Siyuan; Zhang, Ling] Key Lab Visual Media Intelligent Proc Technol Zhe, Hangzhou, Zhejiang, Peoples R China	Zhejiang University of Technology	Fan, J (corresponding author), Zhejiang Univ Technol, Sch Comp Sci & Technol, Hangzhou, Zhejiang, Peoples R China.	fanjing@zjut.edu.cn			National Natural Science Foundation of China [61173097, 61202202]; Zhejiang Natural Science Foundation of China [Z1090459]; Tsinghua-Tencent Joint Laboratory for Internet Innovation Technology	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Zhejiang Natural Science Foundation of China; Tsinghua-Tencent Joint Laboratory for Internet Innovation Technology	This work is supported by National Natural Science Foundation of China (No. 61173097, 61202202), Zhejiang Natural Science Foundation of China (No. Z1090459) and Tsinghua-Tencent Joint Laboratory for Internet Innovation Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2012, INT J COMPUT VISION, DOI DOI 10.1007/s11263-011-0472-9; [Anonymous], [No title captured], DOI DOI 10.1145/585740.585742; Bao GB, 2012, COMPUT GRAPH-UK, V36, P140, DOI 10.1016/j.cag.2012.01.005; Cook RL, 2007, ACM T GRAPHIC, V26, DOI [10.1145/1276377.1276476, 10.1145/1239451.1239530]; Deng QQ, 2010, COMPUT ANIMAT VIRT W, V21, P1, DOI 10.1002/cav.283; [董天阳 Dong Tianyang], 2013, [中国图象图形学报, Journal of Image and Graphics], V18, P1486; Fan J, 2013, SCI CHINA INFORM SCI, V56, DOI 10.1007/s11432-013-4990-7; Funkhouser T. A., 1993, Computer Graphics Proceedings, P247, DOI 10.1145/166117.166149; Gao Y, 2014, IEEE T IND ELECTRON, V61, P2088, DOI 10.1109/TIE.2013.2262760; Gao Y, 2012, IEEE T IMAGE PROCESS, V21, P4290, DOI 10.1109/TIP.2012.2199502; Guan T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098806; Guan T, 2014, IEEE MULTIMEDIA, V21, P32, DOI 10.1109/MMUL.2013.31; Guan T, 2013, IEEE T MULTIMEDIA, V15, P1688, DOI 10.1109/TMM.2013.2265674; Guan T, 2011, IEEE COMPUT GRAPH, V31, P56, DOI 10.1109/MCG.2010.23; Guanbo Bao, 2011, 2011 IEEE International Symposium on VR Innovation (ISVRI), P217, DOI 10.1109/ISVRI.2011.5759637; Gumbau J, 2011, COMPUT GRAPH-UK, V35, P364, DOI 10.1016/j.cag.2010.11.014; Ji R., 2011, ACM T MULTIM COMPUT, V7, P1, DOI DOI 10.1145/2037676.2037688; Ji RR, 2013, IEEE T MULTIMEDIA, V15, P153, DOI 10.1109/TMM.2012.2225035; Ji RR, 2012, IEEE T IMAGE PROCESS, V21, P2282, DOI 10.1109/TIP.2011.2176950; Li LJ, 2006, LECT NOTES COMPUT SC, V4270, P328; Liu F. F., 2011, THESIS; Liu XD, 2012, VISUAL COMPUT, V28, P613, DOI 10.1007/s00371-012-0709-9; [刘晓茜 LIU Xiao-qian], 2010, [中国图象图形学报, Journal of Image and Graphics], V15, P136; Martin LM, 2002, IEEE INTERNATIONAL CONFERENCE ON MULTIMEDIA AND EXPO, VOL I AND II, PROCEEDINGS, P373, DOI 10.1109/ICME.2002.1035796; Park T, 2013, INFORMATION AN INTER, V16, P393; Remolar I, 2002, P EUR 02 SAARBR GERM, V2, P397; Scherzer D, 2012, COMPUT GRAPH FORUM, V31, P2378, DOI 10.1111/j.1467-8659.2012.03075.x; Shen HC, 2011, COMPUT AIDED DESIGN, V30, P149; Tu C, 2011, COMPUTER TECHNOLOGY, V19, P206; Wang Y., 2012, THESIS; Wei BC, 2014, IEEE MULTIMEDIA, V21, P41, DOI 10.1109/MMUL.2013.65; Wimmer M, 1998, LOAD BALANCING FOR S; Wloka M, 1993, DISSERTATION PROPOSA; Xuefeng Cao, 2010, 2010 Second International Conference on Computer Modeling and Simulation (ICCMS 2010), P327, DOI 10.1109/ICCMS.2010.438; Zhang L., 2008, THESIS; Zhang X., 2006, P ACM SIGGRAPH INT C, P331; Zhang YT, 2008, TIME CRITICAL ADAPTI; Zhu XY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076393	38	2	3	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2015	10	2							e0117586	10.1371/journal.pone.0117586	http://dx.doi.org/10.1371/journal.pone.0117586			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC3LS	25723177	Green Published, Green Submitted, gold			2022-12-27	WOS:000350251200036
J	Fernandez, CA; Christ, SL; LeBlanc, WG; Arheart, KL; Dietz, NA; McCollister, KE; Fleming, LE; Muntaner, C; Muennig, P; Lee, DJ				Fernandez, Cristina A.; Christ, Sharon L.; LeBlanc, William G.; Arheart, Kristopher L.; Dietz, Noella A.; McCollister, Kathyrn E.; Fleming, Lora E.; Muntaner, Carles; Muennig, Peter; Lee, David J.			Effect of Childhood Victimization on Occupational Prestige and Income Trajectories	PLOS ONE			English	Article							GENDER-DIFFERENCES; ADOLESCENT VICTIMIZATION; UNITED-STATES; RISK-FACTORS; VIOLENCE; ABUSE; MALTREATMENT; EXPOSURE; EDUCATION; CHILDREN	Background Violence toward children (childhood victimization) is a major public health problem, with long-term consequences on economic well-being. The purpose of this study was to determine whether childhood victimization affects occupational prestige and income in young adulthood. We hypothesized that young adults who experienced more childhood victimizations would have less prestigious jobs and lower incomes relative to those with no victimization history. We also explored the pathways in which childhood victimization mediates the relationships between background variables, such as parent's educational impact on the socioeconomic transition into adulthood. Methods A nationally representative sample of 8,901 young adults aged 18-28 surveyed between 1999-2009 from the National Longitudinal Survey of Youth 1997 (NLSY) were analyzed. Covariate-adjusted multivariate linear regression and path models were used to estimate the effects of victimization and covariates on income and prestige levels and on income and prestige trajectories. After each participant turned 18, their annual 2002 Census job code was assigned a yearly prestige score based on the 1989 General Social Survey, and their annual income was calculated via self-reports. Occupational prestige and annual income are time-varying variables measured from 1999-2009. Victimization effects were tested for moderation by sex, race, and ethnicity in the multivariate models. Results Approximately half of our sample reported at least one instance of childhood victimization before the age of 18. Major findings include 1) childhood victimization resulted in slower income and prestige growth over time, and 2) mediation analyses suggested that this slower prestige and earnings arose because victims did not get the same amount of education as non-victims. Conclusions Results indicated that the consequences of victimization negatively affected economic success throughout young adulthood, primarily by slowing the growth in prosperity due to lower education levels.	[Fernandez, Cristina A.; LeBlanc, William G.; Dietz, Noella A.; McCollister, Kathyrn E.; Fleming, Lora E.; Lee, David J.] Univ Miami, Miller Sch Med, Dept Publ Hlth Sci, Miami, FL 33136 USA; [Christ, Sharon L.] Purdue Univ, Dept Human Dev & Family Studies, W Lafayette, IN 47907 USA; [Christ, Sharon L.] Purdue Univ, Dept Stat, W Lafayette, IN 47907 USA; [Arheart, Kristopher L.] Univ Miami, Miller Sch Med, Div Biostat, Dept Epidemiol & Publ Hlth, Miami, FL 33136 USA; [Fleming, Lora E.] Univ Exeter, European Ctr Environm & Human Hlth, Sch Med, Exeter EX4 4QJ, Devon, England; [Fleming, Lora E.] Royal Cornwall Hosp, Knowledge Spa, Truro, Cornwall, England; [Muntaner, Carles] Univ Toronto, Bloomberg Fac Nursing, Toronto, ON, Canada; [Muntaner, Carles] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada; [Muntaner, Carles] Univ Toronto, Dept Psychiat, Toronto, ON, Canada; [Muntaner, Carles] Korea Univ, Dept Hlth Care Management, Seoul, South Korea; [Muennig, Peter] Columbia Univ, Mailman Sch Publ Hlth, Dept Hlth Policy & Management, New York, NY USA	University of Miami; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus; University of Miami; University of Exeter; Royal Cornwall Hospital; University of Toronto; University of Toronto; University of Toronto; Korea University; Columbia University	Fernandez, CA (corresponding author), Univ Miami, Miller Sch Med, Dept Publ Hlth Sci, Miami, FL 33136 USA.	CFernandez5@med.miami.edu	Fleming, Lora E/ABH-1310-2021; Fernandez, Cristina/M-4311-2016	Fleming, Lora E/0000-0003-1076-9967; Muennig, Peter/0000-0002-4234-0498; Fernandez, Cristina/0000-0001-7360-9229	National Institute for Occupational Safety and Health [R01 OH03915]; European Regional Development Fund (ERDF) Programme; European Social Fund (ESF) Convergence Programme for Cornwall; Isles of Scilly (University of Exeter Medical School); NATIONAL INSTITUTE FOR OCCUPATIONAL SAFETY AND HEALTH [R01OH003915] Funding Source: NIH RePORTER	National Institute for Occupational Safety and Health(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USANational Institute for Occupational Safety & Health (NIOSH)); European Regional Development Fund (ERDF) Programme; European Social Fund (ESF) Convergence Programme for Cornwall; Isles of Scilly (University of Exeter Medical School); NATIONAL INSTITUTE FOR OCCUPATIONAL SAFETY AND HEALTH(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USANational Institute for Occupational Safety & Health (NIOSH))	This work was partially funded by grants from the National Institute for Occupational Safety and Health R01 OH03915, and the European Regional Development Fund (ERDF) Programme 2007 to 2013 and European Social Fund (ESF) Convergence Programme for Cornwall and the Isles of Scilly (University of Exeter Medical School).	Adler NE, 2008, ANN REV PUBLIC HLTH, V29; Arbuckle JL., 1996, ADV STRUCTURAL EQUAT, P243, DOI DOI 10.4324/9781315827414; Belknap J., 2006, FEM CRIMINOL, V1, P48, DOI DOI 10.1177/1557085105282897; Boden JM, 2007, CHILD ABUSE NEGLECT, V31, P1101, DOI 10.1016/j.chiabu.2007.03.022; Boynton-Jarrett R, 2008, PEDIATRICS, V122, P961, DOI 10.1542/peds.2007-3063; Breslau N, 1999, AM J PSYCHIAT, V156, P902, DOI 10.1176/ajp.156.6.902; Bureau of Labor Statstics, NLSY97 SUMM; Christ SL, 2012, SOCIOLOGY HLTH ILLNE; Corso R, 2007, FIREFIGHTERS SCI TEA, P77; Currie J, 2010, CHILD MALTREATMENT, V15, P111, DOI 10.1177/1077559509355316; Day J.C., 2002, SPECIAL STUDIES CURR; Dembo R, 1992, Violence Vict, V7, P245; Desai Sujata, 2002, Violence Vict, V17, P639, DOI 10.1891/vivi.17.6.639.33725; Duncan OD., 1961, CLASS CRIT CONCEPTS, V1, P388; ELDER GH, 1992, CONTEMP SOCIOL, V21, P632, DOI 10.2307/2075543; Eysenck H. J., 1983, STRESS RES, P121; Fang XM, 2012, CHILD ABUSE NEGLECT, V36, P156, DOI 10.1016/j.chiabu.2011.10.006; Fosse GK, 2004, J NERV MENT DIS, V192, P385, DOI 10.1097/01.nmd.0000126734.38673.41; Frederick C., 2010, CROSSWALK USING PRE; Gorman-Smith D, 1998, DEV PSYCHOPATHOL, V10, P101, DOI 10.1017/S0954579498001539; Hauser R. M., 1996, SOCIOECONOMIC INDEXE; Hyman B, 2004, J MARRIAGE FAM, V62, P199; Jonson-Reid M, 2004, CHILD MALTREATMENT, V9, P382, DOI 10.1177/1077559504269192; Krieger N, 1997, ANNU REV PUBL HEALTH, V18, P341, DOI 10.1146/annurev.publhealth.18.1.341; Lansford JE, 2002, ARCH PEDIAT ADOL MED, V156, P824, DOI 10.1001/archpedi.156.8.824; Macmillan R, 2004, J RES ADOLESCENCE, V14, P127, DOI 10.1111/j.1532-7795.2004.01402001.x; Macmillan R, 2000, CRIMINOLOGY, V38, P553, DOI 10.1111/j.1745-9125.2000.tb00899.x; McCabe KM, 2002, J AM ACAD CHILD PSY, V41, DOI 10.1097/00004583-200207000-00020; Mulvihill D, 2005, Compr Child Adoles N, V28, P115, DOI 10.1080/01460860590950890; Murray J, 2010, CAN J PSYCHIAT, V55, P633, DOI 10.1177/070674371005501003; Muthen, M MPLUS VERSION 7 0; Nakao K, 1992, GSS METHODOLOGICAL R, V74; Nakao K, 1992, 1989 SOCIOECONOMIC I; Nakao K, 1992, 1989 SOCIOECONOMIC I; North Carolina Institute of Medicine, SOC DET HLTH; Paxson C, 2002, J LABOR ECON, V20, P435, DOI 10.1086/339609; PEREZ CM, 1994, CHILD ABUSE NEGLECT, V18, P617, DOI 10.1016/0145-2134(94)90012-4; RESICK PA, 1981, J CONSULT CLIN PSYCH, V49, P705, DOI 10.1037/0022-006X.49.5.705; SAS, 2003, SAS VERS 9 3; Stein MB, 2000, BEHAV RES THER, V38, P619, DOI 10.1016/S0005-7967(99)00098-4; Sugaya L, 2012, J TRAUMATIC STRESS; Tolman RM, 2005, AM J COMMUN PSYCHOL, V36, P147, DOI 10.1007/s10464-005-6239-0; TRICKETT PK, 1991, DEV PSYCHOL, V27, P148, DOI 10.1037/0012-1649.27.1.148; Ullman SE, 2005, CHILD ABUSE NEGLECT, V29, P767, DOI 10.1016/j.chiabu.2005.01.005; United States Department of Labor-Beureau of Labor Statistics, SUMM VAR AV EACH ROU; United States Department of Labor-Bureau of Labor Statistics, NAT LONG SURV NLSY97; US Bureau of Labor Statistics, NAT LONG SURV YOUTH; Wegman HL, 2009, PSYCHOSOM MED, V71, P805, DOI 10.1097/PSY.0b013e3181bb2b46; WIDOM CS, 1995, J STUD ALCOHOL, V56, P207, DOI 10.15288/jsa.1995.56.207; WIDOM CS, 2000, NATL I JUSTICE J; WILLIAMS DR, 1995, ANNU REV SOCIOL, V21, P349, DOI 10.1146/annurev.so.21.080195.002025	51	8	8	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2015	10	2							e0115519	10.1371/journal.pone.0115519	http://dx.doi.org/10.1371/journal.pone.0115519			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CC3LS	25723670	Green Published, Green Submitted, gold			2022-12-27	WOS:000350251200007
J	Ali, A; Hasan, Z; McNerney, R; Mallard, K; Hill-Cawthorne, G; Coll, F; Nair, M; Pain, A; Clark, TG; Hasan, R				Ali, Asho; Hasan, Zahra; McNerney, Ruth; Mallard, Kim; Hill-Cawthorne, Grant; Coll, Francesc; Nair, Mridul; Pain, Arnab; Clark, Taane G.; Hasan, Rumina			Whole Genome Sequencing Based Characterization of Extensively Drug-Resistant Mycobacterium tuberculosis Isolates from Pakistan	PLOS ONE			English	Article							STREPTOMYCIN RESISTANCE; ANTIBIOTIC-RESISTANCE; ETHAMBUTOL RESISTANCE; PAIRED-END; MUTATIONS; STRAINS; SUSCEPTIBILITY; EXPRESSION; COST; RPOB	Improved molecular diagnostic methods for detection drug resistance in Mycobacterium tuberculosis (MTB) strains are required. Resistance to first-and second-line anti-tuberculous drugs has been associated with single nucleotide polymorphisms (SNPs) in particular genes. However, these SNPs can vary between MTB lineages therefore local data is required to describe different strain populations. We used whole genome sequencing (WGS) to characterize 37 extensively drug-resistant (XDR) MTB isolates from Pakistan and investigated 40 genes associated with drug resistance. Rifampicin resistance was attributable to SNPs in the rpoB hot-spot region. Isoniazid resistance was most commonly associated with the katG codon 315 (92%) mutation followed by inhA S94A (8%) however, one strain did not have SNPs in katG, inhA or oxyR-ahpC. All strains were pyrazimamide resistant but only 43% had pncA SNPs. Ethambutol resistant strains predominantly had embB codon 306 (62%) mutations, but additional SNPs at embB codons 406, 378 and 328 were also present. Fluoroquinolone resistance was associated with gyrA 91-94 codons in 81% of strains; four strains had only gyrB mutations, while others did not have SNPs in either gyrA or gyrB. Streptomycin resistant strains had mutations in ribosomal RNA genes; rpsL codon 43 (42%); rrs 500 region (16%), and gidB (34%) while six strains did not have mutations in any of these genes. Amikacin/kanamycin/capreomycin resistance was associated with SNPs in rrs at nt1401 (78%) and nt1484 (3%), except in seven (19%) strains. We estimate that if only the common hot-spot region targets of current commercial assays were used, the concordance between phenotypic and genotypic testing for these XDR strains would vary between rifampicin (100%), isoniazid (92%), flouroquinolones (81%), aminoglycoside (78%) and ethambutol (62%); while pncA sequencing would provide genotypic resistance in less than half the isolates. This work highlights the importance of expanded targets for drug resistance detection in MTB isolates.	[Ali, Asho; Hasan, Zahra; Hasan, Rumina] Aga Khan Univ Hosp, Dept Pathol & Microbiol, Karachi, Pakistan; [Ali, Asho] Aga Khan Univ Hosp, Sch Nursing & Midwifery, Karachi, Pakistan; [McNerney, Ruth; Mallard, Kim; Coll, Francesc; Clark, Taane G.] London Sch Hyg & Trop Med, Fac Infect & Trop Dis, London WC1, England; [Hill-Cawthorne, Grant; Nair, Mridul; Pain, Arnab] KAUST, Pathogen Genom Lab, Thuwal, Saudi Arabia; [Hill-Cawthorne, Grant] Univ Sydney, Sydney Emerging Infect & Biosecur Inst, Sydney Med Sch, Sydney, NSW 2006, Australia; [Hill-Cawthorne, Grant] Univ Sydney, Sch Publ Hlth, Sydney Med Sch, Sydney, NSW 2006, Australia	Aga Khan University; Aga Khan University; University of London; London School of Hygiene & Tropical Medicine; King Abdullah University of Science & Technology; University of Sydney; University of Sydney	Hasan, Z (corresponding author), Aga Khan Univ Hosp, Dept Pathol & Microbiol, Karachi, Pakistan.	zahra.hasan@aku.edu	Clark, Taane G./AAM-2570-2020; Hill-Cawthorne, Grant A/B-8039-2009; Hasan, Zahra/F-5111-2015; Hasan, Zahra/AAF-2191-2020; Coll, Francesc/V-1980-2019; Pain, Arnab/L-5766-2015	Clark, Taane G./0000-0001-8985-9265; Hill-Cawthorne, Grant A/0000-0002-3828-5473; Hasan, Zahra/0000-0001-7580-372X; Coll, Francesc/0000-0002-7882-2325; Pain, Arnab/0000-0002-1755-2819				Ajbani K, 2011, J CLIN MICROBIOL, V49, P1588, DOI 10.1128/JCM.00113-11; Ali A, 2011, ANTIMICROB AGENTS CH, V55, P5654, DOI 10.1128/AAC.05101-11; Ali A, 2009, SCAND J INFECT DIS, V41, P37, DOI 10.1080/00365540802570519; Andersson DI, 2010, NAT REV MICROBIOL, V8, P260, DOI 10.1038/nrmicro2319; Arjomandzadegan M, 2012, TUBERK TORAK, V60, P153, DOI 10.5578/tt.3520; Ayaz A, 2012, INT J INFECT DIS, V16, pE303, DOI 10.1016/j.ijid.2011.12.015; Borrell S, 2011, CLIN MICROBIOL INFEC, V17, P815, DOI 10.1111/j.1469-0691.2011.03556.x; Borrell S, 2009, J CLIN MICROBIOL, V47, P198, DOI 10.1128/JCM.00507-08; Brandis G, 2013, J ANTIMICROB CHEMOTH, V68, P2493, DOI 10.1093/jac/dkt224; Campbell PJ, 2011, ANTIMICROB AGENTS CH, V55, P2032, DOI 10.1128/AAC.01550-10; Casali N, 2012, GENOME RES, V22, P735, DOI 10.1101/gr.128678.111; Chan RCY, 2007, J ANTIMICROB CHEMOTH, V59, P866, DOI 10.1093/jac/dkm054; Chen K, 2009, NAT METHODS, V6, P677, DOI [10.1038/NMETH.1363, 10.1038/nmeth.1363]; Coll F, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5812; Coll F, 2014, TUBERCULOSIS, V94, P346, DOI 10.1016/j.tube.2014.02.005; Coll F, 2012, BIOINFORMATICS, V28, P2991, DOI 10.1093/bioinformatics/bts544; Comas I, 2012, NAT GENET, V44, P106, DOI 10.1038/ng.1038; Dalla Costa ER, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-39; de Steenwinkel JEM, 2012, EMERG INFECT DIS, V18, P660, DOI 10.3201/eid1804.110912; de Vos M, 2013, ANTIMICROB AGENTS CH, V57, P827, DOI 10.1128/AAC.01541-12; El Garch F, 2010, J ANTIMICROB CHEMOTH, V65, P2076, DOI 10.1093/jac/dkq287; Ford C, 2012, TUBERCULOSIS, V92, P194, DOI 10.1016/j.tube.2011.11.003; Gagneux S, 2009, CLIN MICROBIOL INFEC, V15, P66, DOI 10.1111/j.1469-0691.2008.02685.x; Gagneux S, 2006, P NATL ACAD SCI USA, V103, P2869, DOI 10.1073/pnas.0511240103; Gagneux S, 2006, SCIENCE, V312, P1944, DOI 10.1126/science.1124410; Hasan R, 2010, EMERG INFECT DIS, V16, P1473, DOI 10.3201/eid1609.100280; Hillemann D, 2009, J CLIN MICROBIOL, V47, P1767, DOI 10.1128/JCM.00081-09; Hirsh AE, 2004, P NATL ACAD SCI USA, V101, P4871, DOI 10.1073/pnas.0305627101; Honore-Bouakline S, 2003, J CLIN MICROBIOL, V41, P2323, DOI 10.1128/JCM.41.6.2323-2329.2003; Huson DH, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-460; Huson DH, 2012, SYST BIOL, V61, P1061, DOI 10.1093/sysbio/sys062; Ioerger TR, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-670; Jagielski T, 2014, J ANTIMICROB CHEMOTH, V69, P2369, DOI 10.1093/jac/dku161; Jnawali HN, 2013, WORLD J MICROBIOL BI; Kamerbeek J, 1997, J CLIN MICROBIOL, V35, P907, DOI 10.1128/JCM.35.4.907-914.1997; Koneman EW AS, 1983, COLOR ATLAS TXB DIAG; Liu CH, 2012, J INFECT; Mariam DH, 2004, ANTIMICROB AGENTS CH, V48, P1289, DOI 10.1128/AAC.48.4.1289-1294.2004; Maus CE, 2005, ANTIMICROB AGENTS CH, V49, P571, DOI 10.1128/AAC.49.2.571-577.2005; MEIER A, 1994, ANTIMICROB AGENTS CH, V38, P228, DOI 10.1128/AAC.38.2.228; Okamoto S, 2007, MOL MICROBIOL, V63, P1096, DOI 10.1111/j.1365-2958.2006.05585.x; Rausch T, 2012, BIOINFORMATICS, V28, pI333, DOI 10.1093/bioinformatics/bts378; Sandgren A, 2009, PLOS MED, V6, P132, DOI 10.1371/journal.pmed.1000002; Shang SB, 2011, TUBERCULOSIS, V91, P378, DOI 10.1016/j.tube.2011.06.001; Sheen P, 2013, TUBERCULOSIS, V93, P515, DOI 10.1016/j.tube.2013.03.005; Sirgel FA, 2012, CHEMOTHERAPY, V58, P358, DOI 10.1159/000343474; Sirgel FA, 2012, J ANTIMICROB CHEMOTH, V67, P1088, DOI 10.1093/jac/dks033; Sirgel FA, 2012, MICROB DRUG RESIST, V18, P193, DOI 10.1089/mdr.2011.0063; Spies FS, 2013, TUBERCULOSIS, V93, P150, DOI 10.1016/j.tube.2012.11.004; Sreevatsan S, 1997, P NATL ACAD SCI USA, V94, P9869, DOI 10.1073/pnas.94.18.9869; Srivastava S, 2006, CURR MICROBIOL, V53, P401, DOI 10.1007/s00284-006-0135-1; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Steingart KR, 2014, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD009593.pub2, 10.1002/14651858.CD009593.pub3]; Stoffels K, 2012, ANTIMICROB AGENTS CH, V56, P5186, DOI 10.1128/AAC.05385-11; Supply P, 2003, MOL MICROBIOL, V47, P529, DOI 10.1046/j.1365-2958.2003.03315.x; Tan YJ, 2014, J CLIN MICROBIOL, V52, P291, DOI 10.1128/JCM.01903-13; Tanveer M, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-171; Valvatne H, 2009, J ANTIMICROB CHEMOTH, V64, P694, DOI 10.1093/jac/dkp292; Verma JS, 2014, J ANTIMICROB CHEMOTH, V69, P2935, DOI 10.1093/jac/dku273; Vilcheze C, 2006, NAT MED, V12, P1027, DOI 10.1038/nm1466; Walker TM, 2013, LANCET INFECT DIS, V13, P137, DOI 10.1016/S1473-3099(12)70277-3; Wang JM, 2011, NAT METHODS, V8, P652, DOI [10.1038/nmeth.1628, 10.1038/NMETH.1628]; Wang K, 2013, CURR MICROBIOL, V66, P222, DOI 10.1007/s00284-012-0215-3; WHO, 2014, GLOB TUB REP, DOI [10.1016/j.jpba.2014.12.039, DOI 10.1016/J.JPBA.2014.12.039]; Woods GL., 2003, M24A NCCLS, V23; Ye K, 2009, BIOINFORMATICS, V25, P2865, DOI 10.1093/bioinformatics/btp394; Yin XM, 2010, J INFECTION, V61, P150, DOI 10.1016/j.jinf.2010.05.001; Zhang Y, 2003, J ANTIMICROB CHEMOTH, V52, P790, DOI 10.1093/jac/dkg446	68	45	48	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2015	10	2							e0117771	10.1371/journal.pone.0117771	http://dx.doi.org/10.1371/journal.pone.0117771			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC2ZH	25719196	Green Submitted, Green Published, gold, Green Accepted			2022-12-27	WOS:000350213200031
J	Dussex, N; Rawlence, NJ; Robertson, BC				Dussex, Nicolas; Rawlence, Nicolas J.; Robertson, Bruce C.			Ancient and Contemporary DNA Reveal a Pre-Human Decline but No Population Bottleneck Associated with Recent Human Persecution in the Kea (Nestor notabilis)	PLOS ONE			English	Article							QUATERNARY FOSSIL FAUNAS; NEW-ZEALAND; SOUTH-ISLAND; MICROSATELLITE LOCI; LANDSCAPE TRANSFORMATION; GENETIC BOTTLENECK; NORTH CANTERBURY; SIZE; EXTINCTION; EXPANSION	The impact of population bottlenecks is an important factor to consider when assessing species survival. Population declines can considerably limit the evolutionary potential of species and make them more susceptible to stochastic events. New Zealand has a well documented history of decline of endemic avifauna related to human colonization. Here, we investigate the genetic effects of a recent population decline in the endangered kea (Nestor notabilis). Kea have undergone a long-lasting persecution between the late 1800s to 1970s where an estimated 150,000 kea were culled under a governmental bounty scheme. Kea now number 1,000-5,000 individuals in the wild and it is likely that the recent population decline may have reduced the genetic diversity of the species. Comparison of contemporary (n = 410), historical (n = 15) and fossil samples (n = 4) showed a loss of mitochondrial diversity since the end of the last glaciation (Otiran Glacial) but no loss of overall genetic diversity associated with the cull. Microsatellite data indicated a recent bottleneck for only one population and a range-wide decline in N-e dating back some 300 - 6,000 years ago, a period predating European arrival in NZ. These results suggest that despite a recent human persecution, kea might have experienced a large population decline before stabilizing in numbers prior to human settlement of New Zealand in response to Holocene changes in habitat distribution. Our study therefore highlights the need to understand the respective effects of climate change and human activities on endangered species dynamics when proposing conservation guidelines.	[Dussex, Nicolas; Rawlence, Nicolas J.; Robertson, Bruce C.] Univ Otago, Dept Zool, Allan Wilson Ctr Mol Ecol & Evolut, Dunedin 9054, New Zealand	University of Otago	Dussex, N (corresponding author), Univ Otago, Dept Zool, Allan Wilson Ctr Mol Ecol & Evolut, POB 56, Dunedin 9054, New Zealand.	nicolas.dussex@gmail.com	Dussex, Nicolas/Q-9947-2017	Dussex, Nicolas/0000-0002-9179-8593	University of Otago	University of Otago	This study was supported by University of Otago funding to Bruce C. Robertson. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allentoft ME, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016670; Allentoft ME, 2010, QUATERNARY SCI REV, V29, P753, DOI 10.1016/j.quascirev.2009.11.022; Allentoft ME, 2014, P NATL ACAD SCI USA, V111, P4922, DOI 10.1073/pnas.1314972111; Alloway BV, 2007, J QUATERNARY SCI, V22, P9, DOI 10.1002/jqs.1079; Alter SE, 2007, P NATL ACAD SCI USA, V104, P15162, DOI 10.1073/pnas.0706056104; Anderson R., 1986, Forest & Bird (Wellington), V17, P2; Anmarkrud JA, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-138; Beattie J.H., 1994, TRADITIONAL LIFEWAYS; Beaumont MA, 1999, GENETICS, V153, P2013; Beaumont MA, 2002, GENETICS, V162, P2025; Benham WB, 1907, T NZ I, V39, P71; Best E., 1977, FOREST LORE MAORI; Boessenkool S, 2009, P ROY SOC B-BIOL SCI, V276, P815, DOI 10.1098/rspb.2008.1246; Bond Alan B., 1992, Notornis, V39, P151; Broquet T, 2010, CONSERV BIOL, V24, P1596, DOI 10.1111/j.1523-1739.2010.01556.x; Brotherton P, 2007, NUCLEIC ACIDS RES, V35, P5717, DOI 10.1093/nar/gkm588; Brouwer K., 2000, International Zoo Yearbook, V37, P299, DOI 10.1111/j.1748-1090.2000.tb00735.x; Brown JW, 2007, MOL ECOL, V16, P327, DOI 10.1111/j.1365-294X.2007.03151.x; Buller WL., 1888, HIST BIRDS NZ, V2; BURROWS CJ, 1989, NEW ZEAL J ECOL, V12, P51; Busch JD, 2007, MOL ECOL, V16, P2450, DOI 10.1111/j.1365-294X.2007.03283.x; Campos PF, 2010, P NATL ACAD SCI USA, V107, P5675, DOI 10.1073/pnas.0907189107; Chan CH, 2005, CONSERV GENET, V6, P651, DOI 10.1007/s10592-005-9021-9; Chikhi L, 2010, GENETICS, V186, P983, DOI 10.1534/genetics.110.118661; Clarke C. M. H., 1970, Notornis, V17, P105; Collins CJ, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.0097; Conner J. K., 2004, PRIMER ECOLOGICAL GE; Cooper A, 2000, SCIENCE, V289, P1139; Cornuet JM, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-401; Cornuet JM, 2008, BIOINFORMATICS, V24, P2713, DOI 10.1093/bioinformatics/btn514; Cornuet JM, 1996, GENETICS, V144, P2001; Cunningham JM., 1948, B ORNITHOLOGICAL SOC, V2, P154; De Oliveira LR, 2009, J MAR BIOL ASSOC UK, V89, P1717, DOI 10.1017/S0025315409000162; DIAMOND J, 1991, ETHOLOGY, V88, P128; Diamond J., 1999, KEA BIRD PARADOX EVO, P230; DIRIENZO A, 1994, P NATL ACAD SCI USA, V91, P3166, DOI 10.1073/pnas.91.8.3166; Duncan RP, 2004, GLOBAL ECOL BIOGEOGR, V13, P509, DOI 10.1111/j.1466-822X.2004.00132.x; Dussex N, 2014, MOL ECOL, V23, P2193, DOI 10.1111/mec.12729; Dussex N, 2013, CONSERV GENET RESOUR, V5, P1063, DOI 10.1007/s12686-013-9975-8; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Ellegren H, 2004, NAT REV GENET, V5, P435, DOI 10.1038/nrg1348; Elliott G, 1999, CONSERVATION ECOLOGY, V49; Elliott Graeme, 2004, DOC Science Internal Series, V181, P1; ElMousadik A, 1996, THEOR APPL GENET, V92, P832, DOI 10.1007/BF00221895; Estoup A, 2002, MOL ECOL, V11, P1591, DOI 10.1046/j.1365-294X.2002.01576.x; Excoffier L, 2005, GENETICS, V169, P1727, DOI 10.1534/genetics.104.036236; Fagundes NJR, 2007, P NATL ACAD SCI USA, V104, P17614, DOI 10.1073/pnas.0708280104; Falla R.A., 1979, P1; Falush D, 2003, GENETICS, V164, P1567; Frankham R, 2005, BIOL CONSERV, V126, P131, DOI 10.1016/j.biocon.2005.05.002; Frankham R, 2010, INTRODUCTION TO CONS, V617; Gajdon GK, 2004, LEARN BEHAV, V32, P62; Garza JC, 2001, MOL ECOL, V10, P305, DOI 10.1046/j.1365-294x.2001.01190.x; Gibbs GW., 2006, GHOSTS GONDWANA; Girod C, 2011, GENETICS, V188, P165, DOI 10.1534/genetics.110.121764; Goossens B, 2006, PLOS BIOL, V4, P285, DOI 10.1371/journal.pbio.0040025; GUO SW, 1992, BIOMETRICS, V48, P361, DOI 10.2307/2532296; Hailer F, 2006, BIOL LETTERS, V2, P316, DOI 10.1098/rsbl.2006.0453; Hedrick PW, 2000, ANNU REV ECOL SYST, V31, P139, DOI 10.1146/annurev.ecolsys.31.1.139; Henry P, 2009, MOL ECOL, V18, P3173, DOI 10.1111/j.1365-294X.2009.04266.x; Hoffman JI, 2011, MOL ECOL, V20, P3989, DOI 10.1111/j.1365-294X.2011.05248.x; Holdaway Richard N., 1999, P189; Holdaway Richard N., 1993, Notornis, V40, P95; HOLDAWAY RN, 1989, NEW ZEAL J ECOL, V12, P11; Holdaway RN, 1997, NEW ZEAL J ZOOL, V24, P69, DOI 10.1080/03014223.1997.9518107; Holdaway RN, 2000, SCIENCE, V287, P2250, DOI 10.1126/science.287.5461.2250; Holdaway RN, 2001, NEW ZEAL J ZOOL, V28, P119, DOI 10.1080/03014223.2001.9518262; Hu Y, 2011, MOL ECOL, V20, P2662, DOI 10.1111/j.1365-294X.2011.05126.x; Huber L, 2006, ANIM COGN, V9, P295, DOI 10.1007/s10071-006-0033-8; Hundertmark KJ, 2010, CONSERV GENET, V11, P139, DOI 10.1007/s10592-009-0013-z; Innes J, 2010, NEW ZEAL J ECOL, V34, P86; JACKSON J. R., 1960, NOTORNIS, V9, P39; Jakobsson M, 2007, BIOINFORMATICS, V23, P1801, DOI 10.1093/bioinformatics/btm233; Jeffreys H., 1948, INT SERIES MONOGRAPH, V2a; KASS RE, 1995, J AM STAT ASSOC, V90, P773, DOI 10.1080/01621459.1995.10476572; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Keller LF, 2001, P ROY SOC B-BIOL SCI, V268, P1387, DOI 10.1098/rspb.2001.1607; Keller LF, 2002, TRENDS ECOL EVOL, V17, P230, DOI 10.1016/S0169-5347(02)02489-8; Keuling O, 2008, EUR J WILDLIFE RES, V54, P729, DOI 10.1007/s10344-008-0204-9; King C., 1984, IMMIGRANT KILLERS IN; Kirk T, 1895, T NZ I, V28, P1; Knapp M, 2012, ANN ANAT, V194, P3, DOI 10.1016/j.aanat.2011.03.008; Lacy RC, 1997, J MAMMAL, V78, P320, DOI 10.2307/1382885; Larsson JK, 2008, MOL ECOL, V17, P1897, DOI 10.1111/j.1365-294X.2008.03717.x; Li YC, 2002, MOL ECOL, V11, P2453, DOI 10.1046/j.1365-294X.2002.01643.x; Loader C., 2007, LOCFIT LOCAL REGRESS; Luikart G, 1998, CONSERV BIOL, V12, P228, DOI 10.1046/j.1523-1739.1998.96388.x; MacDonald GM, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1881; Macken AC, 2012, J QUATERNARY SCI, V27, P415, DOI 10.1002/jqs.1563; Marriner GR, 1908, KEA NZ PROBLEM INCLU; McGlone MS, 2010, TERRA AUSTRALIS, V32, P49; McGlone MS, 1995, QUATERNARY SCI REV, V14, P867, DOI 10.1016/0277-3791(95)00068-2; McWethy DB, 2010, P NATL ACAD SCI USA, V107, P21343, DOI 10.1073/pnas.1011801107; McWethy DB, 2009, HOLOCENE, V19, P883, DOI 10.1177/0959683609336563; Menzies MLC, 1878, T NZ I, V11, P376; Myers JG, 1924, NZ J AGR, V29, P25; Nei M., 1987, MOL EVOLUTIONARY GEN; Nei M., 2000, MOL EVOLUTION PHYLOG; O'Conner K. F., 1978, Proceedings of the First International Rangeland Congress, Denver, Colorado, USA, August 14-18, 1978, P104; O'Donnell CF, 1986, TECHNICAL REPORT; OCONNOR KF, 1982, NEW ZEAL J ECOL, V5, P97; Okello JBA, 2008, MOL ECOL, V17, P3788, DOI 10.1111/j.1365-294X.2008.03871.x; Peery MZ, 2012, MOL ECOL, V21, P3403, DOI 10.1111/j.1365-294X.2012.05635.x; Perry GLW, 2012, GLOBAL CHANGE BIOL, V18, P1609, DOI 10.1111/j.1365-2486.2011.02631.x; Phillips J, 2004, CULT GEOGR, V11, P342, DOI 10.1191/1474474004eu310xx; Piry S, 1999, J HERED, V90, P502, DOI 10.1093/jhered/90.4.502; Prideaux GJ, 2007, GEOLOGY, V35, P33, DOI 10.1130/G23070A.1; Pritchard JK, 2000, GENETICS, V155, P945; Prost S, 2011, METHODS ECOL EVOL, V2, P663, DOI 10.1111/j.2041-210X.2011.00129.x; *R DEV TEAM, 2005, R LANG ENV STAT COMP; Rawlence NJ, 2011, J ROY SOC NEW ZEAL, V41, P217, DOI 10.1080/03036758.2011.559663; Rawlence NJ, 2012, QUATERNARY SCI REV, V50, P141, DOI 10.1016/j.quascirev.2012.07.004; Reed DH, 2003, CONSERV BIOL, V17, P230, DOI 10.1046/j.1523-1739.2003.01236.x; RICE WR, 1989, EVOLUTION, V43, P223, DOI 10.1111/j.1558-5646.1989.tb04220.x; Robertson BC, 2009, MOL ECOL RESOUR, V9, P664, DOI 10.1111/j.1755-0998.2008.02506.x; Rohland N, 2010, MOL ECOL RESOUR, V10, P677, DOI 10.1111/j.1755-0998.2009.02824.x; Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Salmona J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043524; Sandom C, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.3254; Schwartz MK, 2007, J WILDLIFE MANAGE, V71, P2170, DOI 10.2193/2007-026; Schwing Raoul, 2010, Notornis, V57, P98; Smith I, 2010, 6 U OT ANTHR DEP; Smith I, 2010, 7 U OT ANTHR DEP OT; Spear SF, 2006, CONSERV GENET, V7, P605, DOI 10.1007/s10592-005-9095-4; Storz JF, 2002, MOL BIOL EVOL, V19, P1981, DOI 10.1093/oxfordjournals.molbev.a004022; Storz JF, 2002, EVOLUTION, V56, P154; Temple P, 1996, BOOK OF THE KEA; Tennyson AJD, 2014, NOTORNIS, V61, P174; Tennyson AJD, 2010, NEW ZEAL J ECOL, V34, P6; TOWNS DR, 1994, NEW ZEAL J ZOOL, V21, P325, DOI 10.1080/03014223.1994.9518003; USFWS, 2010, TECHNICAL REPORT REG; USFWS, 2010, US FISH AND WILDLIFE; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; Wallis GP, 2009, MOL ECOL, V18, P3548, DOI 10.1111/j.1365-294X.2009.04294.x; Wandeler P, 2007, TRENDS ECOL EVOL, V22, P634, DOI 10.1016/j.tree.2007.08.017; WARDLE P., 1963, NEW ZEALAND JOUR BOT, V1, P3; WEBER JL, 1993, HUM MOL GENET, V2, P1123, DOI 10.1093/hmg/2.8.1123; Welch AJ, 2012, MOL BIOL EVOL, V29, P3729, DOI 10.1093/molbev/mss185; White NE, 2014, DIVERS DISTRIB, V20, P1208, DOI 10.1111/ddi.12202; White T, 1895, T NZ I, Vxxvii, P273; Williamson-Natesan EG, 2005, CONSERV GENET, V6, P551, DOI 10.1007/s10592-005-9009-5; Wilmshurst JM, 2008, P NATL ACAD SCI USA, V105, P7676, DOI 10.1073/pnas.0801507105; WORTHY TH, 1994, J ROY SOC NEW ZEAL, V24, P297, DOI 10.1080/03014223.1994.9517474; WORTHY TH, 1993, J ROY SOC NEW ZEAL, V23, P147, DOI 10.1080/03036758.1993.10721222; Worthy TH, 2003, J ROY SOC NEW ZEAL, V33, P427, DOI 10.1080/03014223.2003.9517738; WORTHY TH, 1989, NEW ZEAL J GEOL GEOP, V32, P243, DOI 10.1080/00288306.1989.10427586; Worthy TH, 1998, J ROY SOC NEW ZEAL, V28, P421, DOI 10.1080/03014223.1998.9517573; Worthy TH, 1998, J ROY SOC NEW ZEAL, V28, P537, DOI 10.1080/03014223.1998.9517575; Worthy TH, 2006, ALCHERINGA AUSTRALAS, V30, P389, DOI [10.1080/03115510609506874, DOI 10.1080/03115510609506874]; Yao XH, 2007, NEW PHYTOL, V176, P472, DOI 10.1111/j.1469-8137.2007.02175.x	151	21	21	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2015	10	2							e0118522	10.1371/journal.pone.0118522	http://dx.doi.org/10.1371/journal.pone.0118522			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	CC2ZH	25719752	Green Submitted, gold, Green Published			2022-12-27	WOS:000350213200057
J	Grotz, C; Letenneur, L; Bonsang, E; Amieva, H; Meillon, C; Quertemont, E; Salmon, E; Adam, S				Grotz, Catherine; Letenneur, Luc; Bonsang, Eric; Amieva, Helene; Meillon, Celine; Quertemont, Etienne; Salmon, Eric; Adam, Stephane		ICTUS DSA Grp	Retirement Age and the Age of Onset of Alzheimer's Disease: Results from the ICTUS Study	PLOS ONE			English	Article							LATE-LIFE; COGNITIVE FUNCTION; LINGUISTIC ABILITY; SOCIAL NETWORK; RISK; DEMENTIA; COMPLEXITY; WORK	Objectives To test whether deferred retirement is associated with delayed onset of Alzheimer's disease (AD), and, if so, to determine whether retirement age still predicts the age at onset of AD when two potential biases are considered. Methods The study sample was gathered from the Impact of Cholinergic Treatment Use/Data Sharing Alzheimer cohort (ICTUS/DSA), a European study of 1,380 AD patients. Information regarding retirement age, onset of symptoms and covariates was collected at baseline whereas age at diagnosis was gathered from the patient's medical record prior to study entry. Linear mixed models, adjusted for gender, education, occupation, center, country, household income, depression and cardiovascular risk factors were conducted on 815 patients. Results (1) The global analyses (n = 815) revealed that later age at retirement was associated with later age at diagnosis (beta = 0.31, p < 0.0001); (2) once the selection bias was considered (n = 637), results showed that this association was weaker but remained significant (beta = 0.15, p = 0.004); (3) once the bias of the reverse causality (i.e., the possibility that subjects may have left the workforce due to prior cognitive impairment) was considered (n = 447), the effect was no longer significant (beta = 0.06, p = 0.18). Conclusion The present study supports that there is an association between retirement age and age at onset of AD. However, the strength of this association appears to be overestimated due to the selection bias. Moreover, the causality issue remains unresolved. Further prospective investigations are mandatory in order to correctly address this question.	[Grotz, Catherine; Adam, Stephane] Univ Liege, Psychol Aging Unit, Liege, Belgium; [Letenneur, Luc; Amieva, Helene; Meillon, Celine] INSERM, U897, F-33076 Bordeaux, France; [Letenneur, Luc; Amieva, Helene; Meillon, Celine] Univ Bordeaux, F-33076 Bordeaux, France; [Bonsang, Eric] Maastricht Univ, Res Ctr Educ & Labour Force Market ROA, NL-6200 MD Maastricht, Netherlands; [Bonsang, Eric] Int Networks Studies Technol Environm Alternat De, Ctr Etude Populat Pauvrete & Polit Socioecon Int, Esch Sur Alzette, Luxembourg; [Quertemont, Etienne] Univ Liege, Cognit & Behav Neurosci Ctr, Liege, Belgium; [Salmon, Eric; Adam, Stephane] Univ Hosp Liege, Memory Ctr, Liege, Belgium	University of Liege; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; UDICE-French Research Universities; Universite de Bordeaux; Maastricht University; University of Liege; University of Liege	Grotz, C (corresponding author), Univ Liege, Psychol Aging Unit, Liege, Belgium.	cgrotz@ulg.ac.be	Amieva, Helene/T-4170-2019; Salmon, Eric/AAE-4901-2020; Frisoni, Giovanni B./K-1360-2016; Quertemont, Etienne/AGQ-2658-2022; Rikkert, Marcel Olde/D-9773-2012; LETENNEUR, Luc/T-4424-2019; Eriksdotter, Maria/I-5427-2015; Rikkert, M.G.M. Olde/H-8078-2014; Meillon, Céline/T-4487-2019	Amieva, Helene/0000-0002-0119-7242; Salmon, Eric/0000-0003-2520-9241; Frisoni, Giovanni B./0000-0002-6419-1753; LETENNEUR, Luc/0000-0002-3274-937X; Eriksdotter, Maria/0000-0003-2498-4000; Rikkert, M.G.M. Olde/0000-0003-1397-1677; Camus, Vincent/0000-0002-6845-221X; Adam, Stephane/0000-0002-8157-4641; Salva, Antoni/0000-0001-6328-3261	European Commission within the 5th framework program [QLK6-CT-2002-02645]; xeach of Eisai; Jansen; Lundbeck; Novartis pharmaceutical companies; University Hospital Center of Toulouse; "Association Monegasque pour la recherche sur la maladie d'Alzheimer"(AMPA); UMR 1027 Unit INSERM - University of Toulouse III	European Commission within the 5th framework program(European CommissionEuropean Commission Joint Research Centre); xeach of Eisai(Eisai Co Ltd); Jansen; Lundbeck(Lundbeck Corporation); Novartis pharmaceutical companies; University Hospital Center of Toulouse; "Association Monegasque pour la recherche sur la maladie d'Alzheimer"(AMPA); UMR 1027 Unit INSERM - University of Toulouse III	C. Grotz is supported by the Fund for Scientific Research (F. R. S. - FNRS), Belgium (www.frs-fnrs.be). The other authors reported no disclosures. The ICTUS study was partially supported by a grant from the European Commission within the 5th framework program (QLK6-CT-2002-02645) and partially from an unrestricted equal grant xeach of Eisai, Jansen, Lundbeck, and Novartis pharmaceutical companies. The pharmaceutical companies had no role in the study design or conduct of the study, data collection, data analysis, data interpretation; or preparation, review, or approval of the manuscript. Promotion of the ICTUS study was supported by the University Hospital Center of Toulouse. The data sharing activity was supported by the "Association Monegasque pour la recherche sur la maladie d'Alzheimer"(AMPA) and the UMR 1027 Unit INSERM - University of Toulouse III.	Adam S, 2013, CLIN INTERV AGING, V8, P377, DOI 10.2147/CIA.S39921; Akbaraly TN, 2009, NEUROLOGY, V73, P854, DOI 10.1212/WNL.0b013e3181b7849b; Amieva H, 2008, ANN NEUROL, V64, P492, DOI 10.1002/ana.21509; Andel R, 2005, J GERONTOL B-PSYCHOL, V60, pP251, DOI 10.1093/geronb/60.5.P251; ARRIGHI HM, 1994, EPIDEMIOLOGY, V5, P189, DOI 10.1097/00001648-199403000-00009; Barnes LL, 2004, NEUROLOGY, V63, P2322, DOI 10.1212/01.WNL.0000147473.04043.B3; Bonsang E, 2010, PAPER NO 11 2010 069; Bonsang E, 2012, J HEALTH ECON, V31, P490, DOI 10.1016/j.jhealeco.2012.03.005; Craik FIM, 2010, NEUROLOGY, V75, P1726, DOI 10.1212/WNL.0b013e3181fc2a1c; Crooks VC, 2008, AM J PUBLIC HEALTH, V98, P1221, DOI 10.2105/AJPH.2007.115923; Dufouil C, 2014, EUR J EPIDEMIOL, V29, P353, DOI 10.1007/s10654-014-9906-3; Ertel KA, 2008, AM J PUBLIC HEALTH, V98, P1215, DOI 10.2105/AJPH.2007.113654; Finkel D, 2009, PSYCHOL AGING, V24, P563, DOI 10.1037/a0015511; Fratiglioni L, 2004, LANCET NEUROL, V3, P343, DOI 10.1016/S1474-4422(04)00767-7; Fratiglioni L, 2000, LANCET, V355, P1315, DOI 10.1016/S0140-6736(00)02113-9; Kroger E, 2008, AM J EPIDEMIOL, V167, P820, DOI 10.1093/aje/kwm382; Lupton MK, 2010, INT J GERIATR PSYCH, V25, P30, DOI 10.1002/gps.2294; Mazzonna F, 2012, EUR ECON REV, V56, P691, DOI 10.1016/j.euroecorev.2012.03.004; Meng XF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038268; Potter GG, 2008, NEUROLOGY, V70, P1803, DOI 10.1212/01.wnl.0000295506.58497.7e; Reynish E, 2007, NEUROEPIDEMIOLOGY, V29, P29, DOI 10.1159/000108915; Riley KP, 2005, NEUROBIOL AGING, V26, P341, DOI 10.1016/j.neurobiolaging.2004.06.019; Rowe JW, 1997, GERONTOLOGIST, V37, P433, DOI 10.1093/geront/37.4.433; Schooler C, 1999, PSYCHOL AGING, V14, P483, DOI 10.1037/0882-7974.14.3.483; Snowdon DA, 1996, JAMA-J AM MED ASSOC, V275, P528, DOI 10.1001/jama.275.7.528; Wilson RS, 2007, NEUROLOGY, V69, P1911, DOI 10.1212/01.wnl.0000271087.67782.cb; Wilson RS, 2012, NEUROLOGY, V78, P1116, DOI 10.1212/WNL.0b013e31824f7ff2	27	12	12	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2015	10	2							e0115056	10.1371/journal.pone.0115056	http://dx.doi.org/10.1371/journal.pone.0115056			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CC2IM	25714815	Green Published, gold, Green Submitted			2022-12-27	WOS:000350168700004
J	Klimes, P; Fibich, P; Idigel, C; Rimandai, M				Klimes, Petr; Fibich, Pavel; Idigel, Cliffson; Rimandai, Maling			Disentangling the Diversity of Arboreal Ant Communities in Tropical Forest Trees	PLOS ONE			English	Article							RAIN-FOREST; HYMENOPTERA-FORMICIDAE; SPECIES RICHNESS; ANOPLOLEPIS-GRACILIPES; MAINTAIN DIVERSITY; COCOA PLANTATIONS; CANOPY; BIODIVERSITY; ASSEMBLAGES; ABUNDANCE	Tropical canopies are known for their high abundance and diversity of ants. However, the factors which enable coexistence of so many species in trees, and in particular, the role of foragers in determining local diversity, are not well understood. We censused nesting and foraging arboreal ant communities in two 0.32 ha plots of primary and secondary lowland rainforest in New Guinea and explored their species diversity and composition. Null models were used to test if the records of species foraging (but not nesting) in a tree were dependent on the spatial distribution of nests in surrounding trees. In total, 102 ant species from 389 trees occurred in the primary plot compared with only 50 species from 295 trees in the secondary forest plot. However, there was only a small difference in mean ant richness per tree between primary and secondary forest (3.8 and 3.3 sp. respectively) and considerably lower richness per tree was found only when nests were considered (1.5 sp. in both forests). About half of foraging individuals collected in a tree belonged to species which were not nesting in that tree. Null models showed that the ants foraging but not nesting in a tree are more likely to nest in nearby trees than would be expected at random. The effects of both forest stage and tree size traits were similar regardless of whether only foragers, only nests, or both datasets combined were considered. However, relative abundance distributions of species differed between foraging and nesting communities. The primary forest plot was dominated by native ant species, whereas invasive species were common in secondary forest. This study demonstrates the high contribution of foragers to arboreal ant diversity, indicating an important role of connectivity between trees, and also highlights the importance of primary vegetation for the conservation of native ant communities.	[Klimes, Petr] Czech Acad Sci, Ctr Biol, Inst Entomol, Ceske Budejovice, Czech Republic; [Klimes, Petr; Fibich, Pavel] Univ South Bohemia, Fac Sci, Ceske Budejovice, Czech Republic; [Idigel, Cliffson; Rimandai, Maling] New Guinea Binatang Res Ctr, Madang, Papua N Guinea	Czech Academy of Sciences; Biology Centre of the Czech Academy of Sciences; University of South Bohemia Ceske Budejovice	Klimes, P (corresponding author), Czech Acad Sci, Ctr Biol, Inst Entomol, Ceske Budejovice, Czech Republic.	peta.klimes@gmail.com	Klimes, Petr/G-6823-2014; Fibich, Pavel/B-3013-2015	Klimes, Petr/0000-0002-6561-4455; Fibich, Pavel/0000-0001-9066-3753	Czech Science Foundation Postdoctoral Grant [P505/12/P875]; Czech Ministry of Education [LH11008]; project Biodiversity of forest ecosystems [CZ.1.07/2.3.00/20.0064]; European Social Fund; state budget of the Czech Republic; Czech Science Foundation Center for tropical biology [14-36098G]; Darwin Initiative for the Survival of Species [19008]; Christensen Fund	Czech Science Foundation Postdoctoral Grant; Czech Ministry of Education(Ministry of Education, Youth & Sports - Czech Republic); project Biodiversity of forest ecosystems; European Social Fund(European Social Fund (ESF)); state budget of the Czech Republic; Czech Science Foundation Center for tropical biology; Darwin Initiative for the Survival of Species; Christensen Fund	PK was supported by the Czech Science Foundation Postdoctoral Grant(P505/12/P875), the Czech Ministry of Education (LH11008), BC CAS institutional support (RVO:60077344) and by the project Biodiversity of forest ecosystems CZ.1.07/2.3.00/20.0064 co-financed by the European Social Fund and the state budget of the Czech Republic. PF was supported by the Czech Science Foundation Center for tropical biology (14-36098G). CI and MR were supported by Darwin Initiative for the Survival of Species (Ref: 19008) and the Christensen Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott KL, 2007, OIKOS, V116, P1238, DOI 10.1111/j.0030-1299.2007.15629.x; Agosti D, 2000, BIOL DIVERSITY HDB S; [Anonymous], 2014, R LANG ENV STAT COMP; Antwiki, 2014, TAX CHANG 2014 ANTW; BASSET Y, 2003, ARTHROPODS TROPICAL; Basset Y, 2012, SCIENCE, V338, P1481, DOI 10.1126/science.1226727; Bluthgen N, 2007, AUSTRAL ECOL, V32, P93, DOI 10.1111/j.1442-9993.2007.01744.x; Bluthgen N, 2004, OIKOS, V106, P344, DOI 10.1111/j.0030-1299.2004.12687.x; Bolton B., 2006, BOLTONS CATALOGUE AN; Bolton B., 1994, IDENTIFICATION GUIDE; Bolton Barry, 2007, Contributions of the American Entomological Institute, V35, P1; Bos MM, 2008, BIOL INVASIONS, V10, P1399, DOI 10.1007/s10530-008-9215-4; Campos RI, 2006, ECOGRAPHY, V29, P442, DOI 10.1111/j.2006.0906-7590.04520.x; Clay NA, 2010, ECOL ENTOMOL, V35, P417, DOI 10.1111/j.1365-2311.2010.01197.x; COLWELL RK, 2009, ESTIMATESS STAT ESTI; CONDIT R, 1995, TRENDS ECOL EVOL, V10, P18, DOI 10.1016/S0169-5347(00)88955-7; Davidson DW, 2007, BIOTROPICA, V39, P468, DOI 10.1111/j.1744-7429.2007.00304.x; Davidson DW, 2003, SCIENCE, V300, P969, DOI 10.1126/science.1082074; Dejean A, 2000, SOCIOBIOLOGY, V35, P403; Dejean A., 2007, FUNCT ECOSYST COMMUN, V1, P105, DOI DOI 10.1515/CCLM.2008.220; Dejean A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037683; Dejean A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009319; Delabie JHC, 2007, BIODIVERS CONSERV, V16, P2359, DOI 10.1007/s10531-007-9190-6; Dial RJ, 2006, BIOTROPICA, V38, P643, DOI 10.1111/j.1744-7429.2006.00181.x; Drescher J, 2011, BIOTROPICA, V43, P93, DOI 10.1111/j.1744-7429.2010.00662.x; Dunn RR, 2004, CONSERV BIOL, V18, P302, DOI 10.1111/j.1523-1739.2004.00151.x; Ellwood MDF, 2009, ECOL LETT, V12, P277, DOI 10.1111/j.1461-0248.2009.01284.x; Fayle TM, 2013, ECOGRAPHY, V36, P1051, DOI 10.1111/j.1600-0587.2012.00192.x; Fayle TM, 2010, BASIC APPL ECOL, V11, P337, DOI 10.1016/j.baae.2009.12.009; Feener DH, 1998, OECOLOGIA, V116, P191, DOI 10.1007/s004420050579; Floren A, 2000, OECOLOGIA, V123, P129, DOI 10.1007/s004420050998; Floren A, 2005, ECOSYSTEMS, V8, P559, DOI 10.1007/s10021-002-0272-8; Floren A., 1997, P344; Floren A, 2001, ECOGRAPHY, V24, P547, DOI 10.1034/j.1600-0587.2001.d01-210.x; Floren A, 2014, MYRMECOL NEWS, V19, P65; Floren Andreas, 2005, Myrmecologische Nachrichten, V7, P91; Folgarait PJ, 1998, BIODIVERS CONSERV, V7, P1221, DOI 10.1023/A:1008891901953; Fonseca CR, 2003, OIKOS, V102, P407, DOI 10.1034/j.1600-0579.2003.12021.x; Gascon C, 1999, BIOL CONSERV, V91, P223, DOI 10.1016/S0006-3207(99)00080-4; Gibbs HK, 2010, P NATL ACAD SCI USA, V107, P16732, DOI 10.1073/pnas.0910275107; Gotelli N.J., 1996, NULL MODELS ECOLOGY; Gotzenberger L, 2012, BIOL REV, V87, P111, DOI 10.1111/j.1469-185X.2011.00187.x; Gove AD, 2009, BASIC APPL ECOL, V10, P187, DOI 10.1016/j.baae.2008.02.005; Groombridge B., 1992, GLOBAL BIODIVERSITY; GULLAN PJ, 1993, J TROP ECOL, V9, P81, DOI 10.1017/S0266467400006994; Hashimoto Y, 2010, SOCIOBIOLOGY, V56, P435; Holldobler B., 1990, pi; HURLBERT SH, 1984, ECOL MONOGR, V54, P187, DOI 10.2307/1942661; Janda M., 2007, MYRMECOL NEWS, V10, P109; Janda M, 2011, J TROP ECOL, V27, P83, DOI 10.1017/S0266467410000623; Klimes P, 2014, MYRMECOL NEWS, V20, P141; Klimes P, 2012, J ANIM ECOL, V81, P1103, DOI 10.1111/j.1365-2656.2012.02002.x; Klimes P, 2011, ECOL ENTOMOL, V36, P94, DOI 10.1111/j.1365-2311.2010.01250.x; Lach L, 2010, ANT ECOLOGY, P1; Lawton JH, 1998, NATURE, V391, P72, DOI 10.1038/34166; Leponce M, 2014, 51 ANN M ATBC CAIRNS; Leps J, 2003, MULTIVARIATE ANAL EC; Longino JT, 2002, ECOLOGY, V83, P689, DOI 10.1890/0012-9658(2002)083[0689:TAFOAT]2.0.CO;2; Lucky A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084012; Luke SH, 2014, BIODIVERS CONSERV, V23, P2817, DOI 10.1007/s10531-014-0750-2; MAJER JD, 1990, BIOTROPICA, V22, P191, DOI 10.2307/2388412; Majer Jonathan D., 1993, P115; McAlpine J.R., 1983, CLIMATE PAPUA NEW GU; McGlynn TP, 1999, J BIOGEOGR, V26, P535, DOI 10.1046/j.1365-2699.1999.00310.x; NGBRC, 2014, NEW GUIN BIN RES CTR; Novotny V, 2000, OIKOS, V89, P564, DOI 10.1034/j.1600-0706.2000.890316.x; Novotny V, 2010, BIOTROPICA, V42, P546, DOI 10.1111/j.1744-7429.2010.00658.x; Oksanen J, 2013, COMMUNITY ECOLOGY PA, V2, P1; Oksanen L, 2001, OIKOS, V94, P27, DOI 10.1034/j.1600-0706.2001.11311.x; Osborn F, 1999, STUD NEOTROP FAUNA E, V34, P59, DOI 10.1076/snfe.34.1.59.8918; Ozanne CMP, 2003, SCIENCE, V301, P183, DOI 10.1126/science.1084507; Paijmans K., 1976, NEW GUINEA VEGETATIO; Palladini JD, 2007, FOREST ECOL MANAG, V242, P619, DOI 10.1016/j.foreco.2007.01.074; Pfeiffer M, 2008, ECOGRAPHY, V31, P21, DOI 10.1111/j.2007.0906-7590.05172.x; Philpott SM, 2005, ECOL APPL, V15, P1478, DOI 10.1890/04-1496; Powell S, 2011, J ANIM ECOL, V80, P352, DOI 10.1111/j.1365-2656.2010.01779.x; Primack RB, 2005, TROPICAL RAIN FOREST; Ribas CR, 2003, AUSTRAL ECOL, V28, P305, DOI 10.1046/j.1442-9993.2003.01290.x; Riedel J, 2014, MYRMECOL NEWS, V20, P113; ROOM PM, 1975, J APPL ECOL, V12, P47, DOI 10.2307/2401717; Sanders NJ, 2007, BIOTROPICA, V39, P422, DOI 10.1111/j.1744-7429.2007.00263.x; Sarnat E. M., 2008, PIAKEY IDENTIFICATIO; Schonberg LA, 2004, BIOTROPICA, V36, P402, DOI 10.1111/j.1744-7429.2004.tb00333.x; Schulz A, 2002, OECOLOGIA, V133, P224, DOI 10.1007/s00442-002-1010-9; StatSoft, 2010, STATISTICA DAT AN SO; Steffan-Dewenter I, 2007, P NATL ACAD SCI USA, V104, P4973, DOI 10.1073/pnas.0608409104; Stuntz S, 2003, BASIC APPL ECOL, V4, P363, DOI 10.1078/1439-1791-00170; Tanaka HO, 2010, POPUL ECOL, V52, P147, DOI 10.1007/s10144-009-0172-2; Ter Braak C.J.F., 1998, CANOCO RELEASE 4 REF; Tobin JE, 1997, J NEW YORK ENTOMOL S, V105, P105; Wetterer JK, 2009, MYRMECOL NEWS, V12, P23; Wetterer JK, 2005, SOCIOBIOLOGY, V45, P77; Whitfeld TJS, 2012, ECOGRAPHY, V35, P821, DOI 10.1111/j.1600-0587.2011.07181.x; Whitfeld TJS, 2014, BIOTROPICA, V46, P538, DOI 10.1111/btp.12136; Whitfeld TJS, 2012, ECOLOGY, V93, pS211, DOI 10.1890/11-0503.1; Wilkie KTR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013146; Wilkie KTR, 2009, MYRMECOL NEWS, V12, P139; Wills C, 2006, SCIENCE, V311, P527, DOI 10.1126/science.1117715; WILSON EO, 1959, ECOLOGY, V40, P437, DOI 10.2307/1929761; WILSON EO, 1987, BIOTROPICA, V19, P245, DOI 10.2307/2388342; Wittman SE, 2014, MYRMECOL NEWS, V19, P111; Woodcock P, 2011, PHILOS T R SOC B, V366, P3256, DOI 10.1098/rstb.2011.0031; Yanoviak SP, 2015, ECOLOGY OF LIANAS, P345; Yanoviak SP, 2012, J TROP ECOL, V28, P199, DOI 10.1017/S026646741100071X; Yusah KM, 2012, BIOTROPICA, V44, P73, DOI 10.1111/j.1744-7429.2011.00775.x	105	39	40	0	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2015	10	2							e0117853	10.1371/journal.pone.0117853	http://dx.doi.org/10.1371/journal.pone.0117853			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC2IM	25714831	gold, Green Submitted, Green Published			2022-12-27	WOS:000350168700041
J	Faiao-Flores, F; Suarez, JAQ; Fruet, AC; Maria-Engler, SS; Pardi, PC; Maria, DA				Faiao-Flores, Fernanda; Quincoces Suarez, Jose Agustin; Fruet, Andrea Costa; Maria-Engler, Silvya Stuchi; Pardi, Paulo Celso; Maria, Durvanei Augusto			Curcumin Analog DM-1 in Monotherapy or Combinatory Treatment with Dacarbazine as a Strategy to Inhibit In Vivo Melanoma Progression	PLOS ONE			English	Article							RESISTANCE; ANEMIA; DEATH	Malignant melanoma is a highly aggressive form of skin cancer with a high mortality rate if not discovered in early stages. Although a limited number of treatment options for melanoma currently exist, patients with a more aggressive form of this cancer frequently decline treatment. DM-1 is a sodium phenolate and curcumin analog with proven anticancer, anti-proliferative and anti-metastatic properties. In this paper, the DM-1 compound showed in vivo antitumor activity alone or in combination with chemotherapeutic DTIC in B16F10 melanoma-bearing mice. Beneficial effects such as melanoma tumor burden reduction with pyknotic nuclei, decreased nuclei/cytoplasmic ratio and nuclear degradation occurred after DM-1 treatment. No toxicological changes were observed in the liver, kidneys, spleen and lungs after DM-1 monotherapy or DTIC combined therapy. DTIC+DM-1 treatment induced the recovery of anemia arising from melanoma and immunomodulation. Both DM-1 treatment alone and in combination with DTIC induced apoptosis with the cleavage of caspase-3, -8 and -9. Furthermore, melanoma tumors treated with DM-1 showed a preferential apoptotic intrinsic pathway by decreasing Bcl-2/Bax ratio. Considering the chemoresistance exhibited by melanoma towards conventional chemotherapy drugs, DM-1 compound in monotherapy or in combination therapy provides a promising improvement in melanoma treatment with a reduction of side effects.	[Faiao-Flores, Fernanda; Fruet, Andrea Costa; Maria-Engler, Silvya Stuchi] Univ Sao Paulo, Sch Pharmaceut Sci, Dept Clin Chem & Toxicol, Sao Paulo, Brazil; [Quincoces Suarez, Jose Agustin] Anhanguera Univ Sao Paulo, Organ Synth Lab, UNIAN, Sao Paulo, Brazil; [Pardi, Paulo Celso] Anhanguera Univ Sao Paulo, Lab Expt Pathol, UNIAN, Sao Paulo, Brazil; [Maria, Durvanei Augusto] Butantan Inst, Biochem & Biophys Lab, Sao Paulo, Brazil	Universidade de Sao Paulo; Instituto Butantan	Faiao-Flores, F (corresponding author), Univ Sao Paulo, Sch Pharmaceut Sci, Dept Clin Chem & Toxicol, Sao Paulo, Brazil.	fernandafaiao@usp.br; durvanei@usp.br	Maria-Engler, Silvya/ABC-2016-2020; Engler, Silvya Stuchi Maria/K-5936-2016; Faião-Flores, Fernanda/F-7111-2012; Pardi, Paulo Celso/AAW-1540-2020; Pardi, Paulo C/B-8965-2012	Maria-Engler, Silvya/0000-0003-4771-6041; Engler, Silvya Stuchi Maria/0000-0003-4771-6041; Faião-Flores, Fernanda/0000-0003-3449-9930; 	Sao Paulo Research Foundation [Fapesp 2008/56397-8, 2011/50435-8]; National Council for Scientific and Technological Development [CNPq 573663/2008-4]	Sao Paulo Research Foundation(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); National Council for Scientific and Technological Development(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	The authors are grateful to the Sao Paulo Research Foundation (Fapesp 2008/56397-8 and 2011/50435-8) and the National Council for Scientific and Technological Development (CNPq 573663/2008-4) for the financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLEN AC, 1953, CANCER-AM CANCER SOC, V6, P1, DOI 10.1002/1097-0142(195301)6:1<1::AID-CNCR2820060102>3.0.CO;2-C; Brasil. Ministerio da Saude, 2007, MEMENTO TERAPEUTICO; Burgoyne LA, 1999, EXP CELL RES, DOI [10.1038/cddis.2013.237, DOI 10.1038/CDDIS.2013.237]; Chapman PB, 2011, NEW ENGL J MED, V364, P2507, DOI 10.1056/NEJMoa1103782; Coit DG, 2013, J NATL COMPR CANC NE, V11, P395, DOI 10.6004/jnccn.2013.0055; DELEVE LD, 1994, J PHARMACOL EXP THER, V268, P1261; Eberle J, 2008, EXP DERMATOL, V17, P1, DOI 10.1111/j.1600-0625.2007.00655.x; Faiao-Flores F, 2012, TUMOUR BIOL J INT SO, DOI [10.1007/413277-011-0293-z, DOI 10.1007/413277-011-0293-Z]; Faiao-Flores F, 2008, APPL CANC RES, V28, P72; Faiao-Flores F, 2013, TUMOR BIOL, V34, P1119, DOI 10.1007/s13277-013-0653-y; Faiao-Flores F, 2013, TUMOR BIOL, V34, P1235, DOI 10.1007/s13277-013-0666-6; Ferrario E, 2004, CANCER TREAT REV, V30, P563, DOI 10.1016/j.ctrv.2004.04.005; Fischer AH, 2010, J CELL BIOCHEM, V110, P795, DOI 10.1002/jcb.22585; Gajewski TF, 2007, CLIN CANCER RES, V13, P5256, DOI 10.1158/1078-0432.CCR-07-0892; Glaspy JA, 2002, ONCOLOGY-NY, V16, P35; Gonzalez FHD, 2003, INTRO BIOQUIMICA CLI; Grazia G, 2014, INT J ONCOL, DOI [10.3892/942014. 2491, DOI 10.3892/942014.2491]; Guicciardi ME, 2009, FASEB J, V23, P1625, DOI 10.1096/fj.08-111005; Hamdy S, 2008, VACCINE, V26, P5046, DOI 10.1016/j.vaccine.2008.07.035; Hayes AW, 2001, PRINCIPLES METHODS T; Hu-Lieskovan S, 2014, J CLIN ONCOL, V32, P2248, DOI 10.1200/JCO.2013.52.1377; Jilaveanu LB, 2009, CLIN DERMATOL, V27, P614, DOI 10.1016/j.clindermatol.2008.09.020; Kretzer IF, 2012, CELL ONCOL, V35, P451, DOI 10.1007/s13402-012-0104-6; Leiter U, 2014, HAUTARZT, V65, P600, DOI 10.1007/s00105-013-2735-6; Lito P, 2013, NAT MED, V19, P1401, DOI 10.1038/nm.3392; Markovic SN, 2007, MAYO CLIN PROC; Menter DG, 2014, CANCER METAST REV, V33, P231, DOI 10.1007/s10555-014-9498-0; Oberholzer PA, 2012, J CLIN ONCOL, V30, P316, DOI 10.1200/JCO.2011.36.7680; Pasquali S, 2015, HEAD NECK-J SCI SPEC, V37, P1596, DOI 10.1002/hed.23801; Porter AG, 1999, CELL DEATH DIFFER, V6, P99, DOI 10.1038/sj.cdd.4400476; Quincoces Suarez JA, 2009, Patent No. [PCTBR2009/ 000375, 2009000375]; Quincoces Suarez JA, 2007, Patent No. [PCT/ BR2007/ 000175, 2007000175]; Quincoces Suarez JA, 2013, Patent No. [WO 2008/003155, 2008003155]; Quincoces Suarez JA, 2010, Patent No. [WO2010/142007, 2010142007]; Quincoces Suarez JA, 2013, Japan-Patent, Patent No. 5317290; Quincoces Suarez JA, 2010, BIOORGAN MED CHEM, DOI [10.1016/1.bmc. 2010.07.026, DOI 10.1016/1.BMC.2010.07.026]; Quincoces Suarez JA, 2013, Brazilian Patent, Patent No. [PI 0602640-0, 06026400]; Quincoces Suarez JA, 2009, [Pharmaceutical composition and use of the pharmaceutical composition for the treatment, prophylaxis or prevention of neoplastic diseases in human and animals, Brazilian Patent], Patent No. [PI 0902039-0, 09020390]; Ruby AJ, 1995, CANCER LETTER; Siegel R., 2015, CA-CANCER J CLIN, V65, P29, DOI [10.3322/caac.21254, DOI 10.3322/CAAC.21254, DOI 10.3322/caac.21208]; Vikey AK, 2012, ORAL ONCOL, DOI [10.1016/j.oraloncology, DOI 10.1016/J.ORALONCOLOGY]; Yang CH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071130; Zhang G, 2014, ONCOL LETT, V8, P248, DOI 10.3892/ol.2014.2121	43	22	22	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2015	10	3							e0118702	10.1371/journal.pone.0118702	http://dx.doi.org/10.1371/journal.pone.0118702			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9KG	25742310	Green Published, Green Submitted, gold			2022-12-27	WOS:000350688100034
J	Rao, SQ; Lang, JH; Zhu, L; Chen, J				Rao, Shuquan; Lang, Jinghe; Zhu, Lan; Chen, Juan			Exome Sequencing Identifies a Novel Gene, WNK1, for Susceptibility to Pelvic Organ Prolapse (POP)	PLOS ONE			English	Article							WOMEN; FIBROBLASTS; KINASES	Pelvic organ prolapse (POP) is a common gynecological disorder; however, the genetic components remain largely unidentified. Exome sequencing has been widely used to identify pathogenic gene mutations of several diseases because of its high chromosomal coverage and accuracy. In this study, we performed whole exome sequencing (WES), for the first time, on 8 peripheral blood DNA samples from representative POP cases. After filtering the sequencing data from the dbSNP database (build 138) and the 1000 Genomes Project, 2 missense variants in WNK1, c. 2668G > A (p. G890R) and c. 6761C> T (p. P2254L), were identified and further validated via Sanger sequencing. In validation stage, the c. 2668G > A (p. G890R) variant and 8 additional variants were detected in 11 out of 161 POP patients. All these variants were absent in 231 healthy controls. Functional experiments showed that fibroblasts from the utero-sacral ligaments of POP with WNK1 mutations exhibited loose and irregular alignment compared with fibroblasts from healthy controls. In sum, our study identified a novel gene, WNK1, for POP susceptibility, expanded the causal mutation spectrums of POP, and provided evidence for the genetic diagnosis and medical management of POP in the future.	[Rao, Shuquan] Chinese Acad Med Sci, Inst Basic Med Sci, Natl Lab Med Mol Biol, Beijing 100005, Peoples R China; [Rao, Shuquan] Tsinghua Univ, Peking Union Med Coll, Beijing 100005, Peoples R China; [Lang, Jinghe; Zhu, Lan; Chen, Juan] Chinese Acad Med Sci, Peking Union Med Coll Hosp, Dept Obstet & Gynecol, Beijing 100005, Peoples R China; [Lang, Jinghe; Zhu, Lan; Chen, Juan] Peking Union Med Coll, Beijing 100005, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Basic Medical Sciences - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Tsinghua University; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Chen, J (corresponding author), Chinese Acad Med Sci, Peking Union Med Coll Hosp, Dept Obstet & Gynecol, Beijing 100005, Peoples R China.	pumchcj@sina.com			National Natural Science Foundation of China [81070474]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Natural Science Foundation of China (81070474). URL: http://www.nsfc.gov.cn/. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An SW, 2011, CURR BIOL, V21, P1979, DOI 10.1016/j.cub.2011.11.002; Bamshad MJ, 2011, NAT REV GENET, V12, P745, DOI 10.1038/nrg3031; Bentley DR, 2008, NATURE, V456, P53, DOI 10.1038/nature07517; Chiaffarino F, 1999, EUR J OBSTET GYN R B, V82, P63, DOI 10.1016/S0301-2115(98)00175-4; Choi M, 2009, P NATL ACAD SCI USA, V106, P19096, DOI 10.1073/pnas.0910672106; Dai Yu-xin, 2010, Zhonghua Fu Chan Ke Za Zhi, V45, P342; Dietz HP, 2002, INT UROGYNECOL J PEL, V13, P284, DOI 10.1007/s001920200062; Ewies AAA, 2008, MOL HUM REPROD, V14, P127, DOI 10.1093/molehr/gam090; Ferrari MM, 2012, ARCH GYNECOL OBSTET, V285, P1581, DOI 10.1007/s00404-011-2199-9; Hendrix SL, 2002, AM J OBSTET GYNECOL, V186, P1160, DOI 10.1067/mob.2002.123819; Jack GS, 2006, INT UROGYNECOL J, V17, P498, DOI 10.1007/s00192-005-0054-x; Jelovsek JE, 2007, LANCET, V369, P1027, DOI 10.1016/S0140-6736(07)60462-0; Jelovsek JE, 2006, AM J OBSTET GYNECOL, V194, P1455, DOI 10.1016/j.ajog.2006.01.060; Jeon MJ, 2009, J UROLOGY, V181, P1213, DOI 10.1016/j.juro.2008.11.027; Kim JY, 2014, EUR J OBSTET GYN R B, V175, P205, DOI 10.1016/j.ejogrb.2014.01.028; Kong D, 2008, BIOPHYS J, V95, P4034, DOI [10.1529/biophysj.108.131342, 10.1529/biophysj.l08.131342]; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lifton RP, 2001, CELL, V104, P545, DOI 10.1016/S0092-8674(01)00241-0; Luber KM, 2001, AM J OBSTET GYNECOL, V184, P1496, DOI 10.1067/mob.2001.114868; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Newhouse S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005003; Ng SB, 2010, NAT GENET, V42, P30, DOI 10.1038/ng.499; Nikolova G, 2007, HUM GENET, V120, P847, DOI 10.1007/s00439-006-0267-1; Poncet S, 2005, AM J OBSTET GYNECOL, V192, P426, DOI 10.1016/j.ajog.2004.09.018; Potulska-Chromik A, 2012, ACTA BIOCHIM POL, V59, P413; Rortveit G, 2003, NEW ENGL J MED, V348, P900, DOI 10.1056/NEJMoa021788; Ruiz-Zapata AM, 2013, INT UROGYNECOL J, V24, P1567, DOI 10.1007/s00192-013-2069-z; Serysheva E, 2013, EMBO REP, V14, P718, DOI 10.1038/embor.2013.88; Skorupski P, 2013, INT UROGYNECOL J, V24, P1033, DOI 10.1007/s00192-012-1970-1; Soderberg MW, 2007, ACTA OBSTET GYNECOL, V83, P1193; Swift S, 2005, AM J OBSTET GYNECOL, V192, P795, DOI 10.1016/j.ajog.2004.10.602; Syed F, 2012, WOUND REPAIR REGEN, V20, P688, DOI 10.1111/j.1524-475X.2012.00823.x; Verissimo F, 2001, ONCOGENE, V20, P5562, DOI 10.1038/sj.onc.1204726; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Wang Zhen, 2012, Zhonghua Yi Xue Za Zhi, V92, P1669; Weber AM, 2001, INT UROGYNECOL J PEL, V12, P178, DOI 10.1007/PL00004033; Xu BE, 2004, J BIOL CHEM, V279, P7826, DOI 10.1074/jbc.M313465200; Xu BE, 2000, J BIOL CHEM, V275, P16795, DOI 10.1074/jbc.275.22.16795; Yu L, 2014, J MED GENET, V51, P197, DOI 10.1136/jmedgenet-2013-101989; Yu TW, 2013, NEURON, V77, P259, DOI 10.1016/j.neuron.2012.11.002	40	3	8	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2015	10	3							e0119482	10.1371/journal.pone.0119482	http://dx.doi.org/10.1371/journal.pone.0119482			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9JM	25739019	Green Published, Green Submitted, gold			2022-12-27	WOS:000350685900107
J	Hateml, PK; Verhulst, B				Hateml, Peter K.; Verhulst, Brad			Political Attitudes Develop Independently of Personality Traits	PLOS ONE			English	Article							5-FACTOR MODEL; CONSERVATISM; STABILITY; FRAMEWORK; GENETICS; TWIN; SOCIALIZATION; PERSISTENCE; ENVIRONMENT; PROFILES	The primary assumption within the recent personality and political orientations literature is that personality traits cause people to develop political attitudes. In contrast, research relying on traditional psychological and developmental theories suggests the relationship between most personality dimensions and political orientations are either not significant or weak. Research from behavioral genetics suggests the covariance between personality and political preferences is not causal, but due to a common, latent genetic factor that mutually influences both. The contradictory assumptions and findings from these research streams have yet to be resolved. This is in part due to the reliance on cross-sectional data and the lack of longitudinal genetically informative data. Here, using two independent longitudinal genetically informative samples, we examine the joint development of personality traits and attitude dimensions to explore the underlying causal mechanisms that drive the relationship between these features and provide a first step in resolving the causal question. We find change in personality over a ten-year period does not predict change in political attitudes, which does not support a causal relationship between personality traits and political attitudes as is frequently assumed. Rather, political attitudes are often more stable than the key personality traits assumed to be predicting them. Finally, the results from our genetic models find that no additional variance is accounted for by the causal pathway from personality traits to political attitudes. Our findings remain consistent with the original construction of the five-factor model of personality and developmental theories on attitude formation, but challenge recent work in this area.	[Hateml, Peter K.] Univ Sydney, US Studies Ctr, Sydney, NSW 2006, Australia; [Hateml, Peter K.] Penn State Univ, Polit Sci, University Pk, PA 16802 USA; [Verhulst, Brad] Virginia Commonwealth Univ, Virginia Inst Psychiat & Behav Genet, Richmond, VA 23284 USA	University of Sydney; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Virginia Commonwealth University	Hateml, PK (corresponding author), Univ Sydney, US Studies Ctr, Sydney, NSW 2006, Australia.	phatemi@gmail.com		Hatemi, Peter/0000-0001-6514-2614	National Health and Medical Research Council, Australia [941177, 971232, 901061, 950998, 241944]; Australian Research Council [A7960034, A79906588, A79801419]	National Health and Medical Research Council, Australia(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council(Australian Research Council)	Funding was provided by the National Health and Medical Research Council, Australia (941177, 971232, 901061, 950998, 241944) and the Australian Research Council (A7960034, A79906588, A79801419). The funders had no role in study design, data collection, analysis, decision to publish, or preparation of the manuscript.	Abendschon S, 2010, 33 ANN SCI M INT SOC; ACHEN CH, 1975, AM POLIT SCI REV, V69, P1218, DOI 10.2307/1955282; Adorno Theodor W, 1950, AUTHORITARIAN PERSON; ALWIN DF, 1991, AM J SOCIOL, V97, P169, DOI 10.1086/229744; Alwin DF, 1991, POLITICAL ATTITUDES, Vxxviii; Baker LA, 1996, BEHAV GENET, V26, P89, DOI 10.1007/BF02359887; BECK PA, 1991, J POLIT, V53, P742, DOI 10.2307/2131578; Benjamin DJ, 2012, P NATL ACAD SCI USA, V109, P8026, DOI 10.1073/pnas.1120666109; Block J, 2006, J RES PERS, V40, P734, DOI 10.1016/j.jrp.2005.09.005; Boker S. M., 2012, OPENMX 1 2 USER GUID; Bouchard TJ, 2003, PERS INDIV DIFFER, V34, P959, DOI 10.1016/S0191-8869(02)00080-6; BOUCHARD TJ, 1994, SCIENCE, V264, P1700, DOI 10.1126/science.8209250; Campbell A, 1960, AM VOTER, Vviii; Caprara GV, 2006, POLIT PSYCHOL, V27, P1, DOI 10.1111/j.1467-9221.2006.00447.x; Carney DR, 2008, POLIT PSYCHOL, V29, P807, DOI 10.1111/j.1467-9221.2008.00668.x; Caspi A, 2001, PSYCHOL INQ, V12, P49, DOI 10.1207/S15327965PLI1202_01; Cattell R.B., 1957, PERSONALITY MOTIVATI; Clark L. A., 2008, HDB PERSONALITY THEO; Connell R.W., 1971, CHILDS CONSTRUCTION; Converse P.E, 1964, IDEOLOGY DISCONTENT; COOK TE, 1985, AM POLIT SCI REV, V79, P1079, DOI 10.2307/1956249; Costa P., 1997, HDB PERSONALITY PSYC, P269, DOI DOI 10.1016/B978-012134645-4/50012-3; Costa P.T., 1992, PERS INDIVID DIF, V13, P653, DOI [10.1016/0191-8869(92)90236-I, DOI 10.1016/0191-8869(92)90236-I]; Eagly AH, 1993, PSYCHOL ATTITUDES, Vxxii; Eaves L, 1989, GENES CULTURE PERSON; EAVES LJ, 1974, NATURE, V249, P288, DOI 10.1038/249288a0; Eysenck H.J., 1967, BIOL BASIS PERSONALI; Eysenck H.J., 1954, PSYCHOL POLITICS; Eysenck HJ., 1993, MANUAL EYSENCK PERSO, DOI 10.1037/t05461-000; Eysenck HJ, 1985, PERSONALITY INDIVIDU, Vxviii; FENDRICH JM, 1988, AM SOCIOL REV, V53, P780, DOI 10.2307/2095823; Fraley RC, 2005, PSYCHOL REV, V112, P60, DOI 10.1037/0033-295X.112.1.60; Gerber AS, 2010, AM POLIT SCI REV, V104, P111, DOI 10.1017/S0003055410000031; Graziano WG, 2003, J PERS, V71, P893, DOI 10.1111/1467-6494.7106001; Greene J.A., 2010, PERSONAL EPISTEMOLOG, P368; Hatemi PK, 2007, BEHAV GENET, V37, P435, DOI 10.1007/s10519-006-9138-8; Hatemi PK, 2014, BEHAV GENET, V44, P282, DOI 10.1007/s10519-014-9648-8; Hatemi PK, 2011, J POLIT, V73, P271, DOI 10.1017/S0022381610001015; Hatemi PK, 2009, J POLIT, V71, P1141, DOI 10.1017/S0022381609090938; Haug Lena., 2013, GROWING POLITICS CON, P231; Hess R, 1959, AM SOCIOL REV, V24, P502; Hess RD, 1967, DEV POLITICAL ATTITU, Vxviii; Hoyle rh, 2009, HDB INDIVIDUAL DIFFE, P257, DOI DOI 10.1007/S00018-010-0311-0; Jennings M.K., 2014, GENERATIONS POLITICS; John O.P., 1999, HDB PERSONALITY THEO, VVolume 2, P102; John O. P., 2008, HDB PERSONALITY THEO, V3, P114; Jost JT, 2007, PERS SOC PSYCHOL B, V33, P989, DOI 10.1177/0146167207301028; Jost JT, 2003, PSYCHOL BULL, V129, P339, DOI 10.1037/0033-2909.129.3.339; KENNY DA, 1975, PSYCHOL BULL, V82, P887, DOI 10.1037/0033-2909.82.6.887; Lewis M, 2001, PSYCHOL INQ, V12, P67, DOI 10.1207/S15327965PLI1202_02; MARKUS GB, 1986, POLITICAL BEHAV, V0008; MARTIN NG, 1986, P NATL ACAD SCI USA, V83, P4364, DOI 10.1073/pnas.83.12.4364; Martin NG., 1986, HANS EYSENCK CONSENS, P13; MARWELL G, 1987, PUBLIC OPIN QUART, V51, P359, DOI 10.1086/269041; MCCLOSKY H, 1958, AM POLIT SCI REV, V52, P27, DOI 10.2307/1953011; McCrae R.R., 1997, HDB PERSONALITY PSYC, P825, DOI DOI 10.1016/B978-012134645-4/50032-9; McCrae RR, 2005, J PERS SOC PSYCHOL, V89, P407, DOI 10.1037/0022-3514.89.3.407; MCCRAE RR, 1992, J PERS, V60, P175, DOI 10.1111/j.1467-6494.1992.tb00970.x; MCCRAE RR, 1994, CURR DIR PSYCHOL SCI, V3, P173, DOI 10.1111/1467-8721.ep10770693; MCCRAE RR, 1987, J PERS SOC PSYCHOL, V52, P81, DOI 10.1037/0022-3514.52.1.81; MCGUE M, 1993, DEV PSYCHOL, V29, P96, DOI 10.1037/0012-1649.29.1.96; MERELMAN RM, 1969, AM POLIT SCI REV, V63, P750, DOI 10.2307/1954426; MISCHEL W, 1973, PSYCHOL REV, V80, P252, DOI 10.1037/h0035002; Mischel W, 1968, PERS ASSESS, Vxii; Mondak J. J., 2010, PERSONALITY FDN POLI; Mondak JJ, 2008, BRIT J POLIT SCI, V38, P335, DOI 10.1017/S0007123408000173; Mondak JJ, 2010, AM POLIT SCI REV, V104, P85, DOI 10.1017/S0003055409990359; Muthen B., 2010, MPLUS USERS GUIDE; Petty R.E., 1986, ADV EXPT SOCIAL PSYC, V19, P123, DOI [10.1016/S0065-2601(08)60214-2, DOI 10.1016/S0065-2601(08)60214-2, https://doi.org/10.1016/S0065-2601(08)60214-2]; Piaget J, 1970, GENETIC EPISTEMOLOGY, DOI [10.3109/inf.1970.2.issue-3.14, DOI 10.3109/INF.1970.2.ISSUE-3.14]; Reifen Tagar M, 2014, PSYCHOL SCI; RIEMANN R, 1993, PERS INDIV DIFFER, V15, P313, DOI 10.1016/0191-8869(93)90222-O; Roberts B. W., 2003, HDB LIFE COURSE, P579, DOI DOI 10.1007/978-0-306-48247-2_26; Roberts BW, 2000, PSYCHOL BULL, V126, P3, DOI 10.1037/0033-2909.126.1.3; Roberts BW, 2004, J PERS, V72, P89, DOI 10.1111/j.0022-3506.2004.00257.x; Roberts BW, 2008, HDB PERSONALITY THEO; ROGOSA D, 1980, PSYCHOL BULL, V88, P245, DOI 10.1037/0033-2909.88.2.245; Rosenberg SW, 1988, POLITICAL REASONING, Vix; Saucier G, 2000, J PERS SOC PSYCHOL, V78, P366, DOI 10.1037/0022-3514.78.2.366; Saucier G, 1998, J PERS ASSESS, V70, P263, DOI 10.1207/s15327752jpa7002_6; Sears DO, 1999, J POLIT, V61, P1, DOI 10.2307/2647773; Sullivan JL, 2002, THINKING POLITICAL P, P23; Torney-Purta J, 2004, POLIT PSYCHOL, V25, P465, DOI 10.1111/j.1467-9221.2004.00380.x; Torney-Purta J, 2003, PS-POLIT SCI POLIT, V36, P269, DOI 10.1017/S1049096503002208; Torney-Purta J., 2001, CITIZENSHIP ED 28 CO; Torney-Purta Judith, 1999, CIVIC ED COUNTRIES 2; TRUETT KR, 1992, BEHAV GENET, V22, P43, DOI 10.1007/BF01066792; van Deth JW, 2011, POLIT PSYCHOL, V32, P147, DOI 10.1111/j.1467-9221.2010.00798.x; van Hiel A, 2000, PERS INDIV DIFFER, V28, P741, DOI 10.1016/S0191-8869(99)00135-X; Vecchione M, 2011, PERS INDIV DIFFER, V51, P737, DOI 10.1016/j.paid.2011.06.015; Verhulst B, 2012, J THEOR POLIT, V24, P328, DOI 10.1177/0951629812439348; Verhulst B, 2012, POLIT PSYCHOL, V33, P375, DOI 10.1111/j.1467-9221.2012.00882.x; Verhulst B, 2012, AM J POLIT SCI, V56, P34, DOI 10.1111/j.1540-5907.2011.00568.x; Verhulst B, 2010, PERS INDIV DIFFER, V49, P306, DOI 10.1016/j.paid.2009.11.013; Wagner J, 1986, POLITICAL BEHAVIOR, V8, P45; WILSON GD, 1968, BRIT J SOC CLIN PSYC, V7, P264; Wilson GD, 1973, PSYCHOL CONSERVATISM, Vxv; Wright MJ, 2004, AUST J PSYCHOL, V56, P65, DOI 10.1080/00049530410001734865; Wright MJ, 2001, BEHAV GENET, V31, P555, DOI 10.1023/A:1013393327704; Yamagata S, 2006, J PERS SOC PSYCHOL, V90, P987, DOI 10.1037/0022-3514.90.6.987; Zimprich D, 2009, J RES PERS, V43, P444, DOI 10.1016/j.jrp.2009.01.018	101	21	21	1	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2015	10	3							e0118106	10.1371/journal.pone.0118106	http://dx.doi.org/10.1371/journal.pone.0118106			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CC4HV	25734580	Green Published, gold			2022-12-27	WOS:000350314700015
J	Kruglikov, IL				Kruglikov, Ilja L.			Microstructural Inhomogeneity of Electrical Conductivity in Subcutaneous Fat Tissue	PLOS ONE			English	Article							INSULATING SPHERES; ULTRASOUND; MIXTURE	Microscopic peculiarities stemming from a temperature increase in subcutaneous adipose tissue (sWAT) after applying a radio-frequency (RF) current, must be strongly dependent on the type of sWAT. This effect is connected with different electrical conductivities of pathways inside (triglycerides in adipocytes) and outside (extra-cellular matrix) the cells and to the different weighting of these pathways in hypertrophic and hyperplastic types of sWAT. The application of the RF current to hypertrophic sWAT, which normally has a strongly developed extracellular matrix with high concentrations of hyaluronan and collagen in a pericellular space of adipocytes, can produce, micro-structurally, a highly inhomogeneous temperature distribution, characterized by strong temperature gradients between the pericellular sheath of the extra-cellular matrix around the hypertrophic adipocytes and their volumes. In addition to normal temperature effects, which are generally considered in body contouring, these temperature gradients can produce thermo-mechanical stresses on the cells' surfaces. Whereas these stresses are relatively small under normal conditions and cannot cause any direct fracturing or damage of the cell structure, these stresses can, under some supportive conditions, be theoretically increased by several orders of magnitude, causing the thermo-mechanical cell damage. This effect cannot be realized in sWAT of normal or hyperplastic types where the peri-cellular structures are under-developed. It is concluded that the results of RF application in body contouring procedures must be strongly dependent on the morphological structure of sWAT.	Wellcomet GmbH, D-76229 Karlsruhe, Germany		Kruglikov, IL (corresponding author), Wellcomet GmbH, Greschbachstr 2-4, D-76229 Karlsruhe, Germany.	i.kruglikov@welicomet.de	Kruglikov, Ilja L./K-3077-2019					Alkhouli N, 2013, AM J PHYSIOL-ENDOC M, V305, pE1427, DOI 10.1152/ajpendo.00111.2013; Arnoczky S P, 2000, J Am Acad Orthop Surg, V8, P305; Berjano EJ, 2006, BIOMED ENG ONLINE, V5, DOI 10.1186/1475-925X-5-24; Comley K, 2012, INT J IMPACT ENG, V46, P1, DOI 10.1016/j.ijimpeng.2011.12.009; Comley K, 2010, INT J SOLIDS STRUCT, V47, P2982, DOI 10.1016/j.ijsolstr.2010.07.001; Feng Y, 2003, MATER CHEM PHYS, V78, P196, DOI 10.1016/S0254-0584(02)00334-6; Garcia O, 2013, AESTHET SURG J, V33, P117, DOI 10.1177/1090820X12469627; Grimnes S., 2011, BIOIMPEDANCE BIOELEC; Han CY, 2007, DIABETES, V56, P2260, DOI 10.2337/db07-0218; Kang L, 2013, DIABETES, V62, P1888, DOI 10.2337/db12-1502; Khan T, 2009, MOL CELL BIOL, V29, P1575, DOI 10.1128/MCB.01300-08; Kruglikov I.L., 2014, J COSMETICS DERMATOL, V04, P117; Kruglikov IL, 2014, J COSMETICS DERMATOL, V4, P207; Kruglikov IL, 2012, AM J COSMETIC SURG, V29, P196; Kruglikov IL, 2012, AM J COSMETIC SURG, V29, P121; Kruglikov IL, 2013, KOSMETISCHE MED, V34, P166; Lackey DE, 2014, AM J PHYSIOL-ENDOC M, V306, pE233, DOI 10.1152/ajpendo.00476.2013; Lozano JNJ, 2013, LASER SURG MED, V45, P326, DOI 10.1002/lsm.22146; OTTAVI H, 1978, J PHYS C SOLID STATE, V11, P1311, DOI 10.1088/0022-3719/11/7/021; Pavselj N, 2011, INT J HEAT MASS TRAN, V54, P2294, DOI 10.1016/j.ijheatmasstransfer.2011.02.035; TROADEC JP, 1981, J PHYS-PARIS, V42, P113, DOI 10.1051/jphys:01981004201011300; Wells PNT, 2011, J R SOC INTERFACE, V8, P1521, DOI 10.1098/rsif.2011.0054	22	5	5	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2015	10	3							e0117072	10.1371/journal.pone.0117072	http://dx.doi.org/10.1371/journal.pone.0117072			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4HV	25734656	gold, Green Published, Green Submitted			2022-12-27	WOS:000350314700008
J	Nieminen, P; Ryokas, E; Mustonen, AM				Nieminen, Petteri; Ryokas, Esko; Mustonen, Anne-Mari			Experiential Thinking in Creationism-A Textual Analysis	PLOS ONE			English	Article							EVOLUTION; MUSCLES; BELIEF; BIASES	Creationism is a religiously motivated worldview in denial of biological evolution that has been very resistant to change. We performed a textual analysis by examining creationist and pro-evolutionary texts for aspects of "experiential thinking", a cognitive process different from scientific thought. We observed characteristics of experiential thinking as follows: testimonials (present in 100% of sampled creationist texts), such as quotations, were a major form of proof. Confirmation bias (100% of sampled texts) was represented by ignoring or dismissing information that would contradict the creationist hypothesis. Scientifically irrelevant or flawed information was re-interpreted as relevant for the falsification of evolution (75-90% of sampled texts). Evolutionary theory was associated to moral issues by demonizing scientists and linking evolutionary theory to atrocities (63-93% of sampled texts). Pro-evolutionary rebuttals of creationist claims also contained testimonials (93% of sampled texts) and referred to moral implications (80% of sampled texts) but displayed lower prevalences of stereotypical thinking (47% of sampled texts), confirmation bias (27% of sampled texts) and pseudodiagnostics (7% of sampled texts). The aspects of experiential thinking could also be interpreted as argumentative fallacies. Testimonials lead, for instance, to ad hominem and appeals to authorities. Confirmation bias and simplification of data give rise to hasty generalizations and false dilemmas. Moral issues lead to guilt by association and appeals to consequences. Experiential thinking and fallacies can contribute to false beliefs and the persistence of the claims. We propose that science educators would benefit from the systematic analysis of experiential thinking patterns and fallacies in creationist texts and pro-evolutionary rebuttals in order to concentrate on scientific misconceptions instead of the scientifically irrelevant aspects of the creationist-evolutionist debate.				petteri.nieminen@uef.fi						Behe MJ, EDGE EVOLUTION SEARC; Bergman, 1999, CEN TECHNICAL J, V13, P101; Bergman J, 2012, J CREATION, V26, P48; Bergman J, 2005, IMPACT, P383; Bergman J, 2004, IMPACT, P367; Boudry M, 2011, RELIGION, V41, P449, DOI 10.1080/0048721X.2011.600464; Brace RA, 2004, BIBLE EVOLUTOIN I WA; Brace RA, 2006, UTTER FAILURE 19 20; Buchanan S, 2012, GORILLA ORANGUTAN CH; Buchanan S, 2010, ASSESSING LIMITS EVO; Burgess S, 2006, DESIGNER HUMANS; Burgess S, 2007, HUMANS PURPOSELY DES; Burrows AM, 2006, J ANAT, V208, P153, DOI 10.1111/j.1469-7580.2006.00523.x; Carrier R, 2010, CHRISTIAN DELUSION W, P396; Carter RW, 2010, CHIMPANZEE CHROMOSOM; Conway Morris S., 1998, CRUCIBLE CREATION BU; Creation Ministries International, 2014, SJ GOULD RAC; Darwin C, 1859, ORIGIN SPECIES MEANS; Davis P, 1993, PANDAS PEOPLE CENTRA; Dawkins R, 1989, SELFISH GENE; Dawkins R., 1989, NY TIMES; DENESRAJ V, 1994, J PERS SOC PSYCHOL, V66, P819, DOI 10.1037/0022-3514.66.5.819; Diogo R, 2011, J ANAT, V219, P273, DOI 10.1111/j.1469-7580.2011.01403.x; Diogo R, 2009, J ANAT, V215, P300, DOI 10.1111/j.1469-7580.2009.01111.x; Doherty ME, 1981, SCI THINKING, P158; Doyle S, 2007, J CREATION, V21, P11; Eldredge N, 1985, RETHINKING DARWINIAN; Episcopal Church in the United States of America the Committee on Science Technology and Faith of the Executive Council, 2005, CAT CREAT EP UND; EPSTEIN S, 1994, AM PSYCHOL, V49, P709, DOI 10.1037/0003-066X.49.8.709; Evangelical Church in Germany, 2008, EV KIRCH ZIEHT KLAR; Evans EM, 2001, COGNITIVE PSYCHOL, V42, P217, DOI 10.1006/cogp.2001.0749; Evowiki, 2008, EV RAC; Fogelin RJ, 1987, ARGUMENTATION, V1, P255; GOULD S J, 1977, Paleobiology, V3, P115; Gould S. J., 1980, PANDAS THUMB, P179; Gould S. J., 1977, ONTOGENY PHYLOGENY; Gould SJ, 1997, NAT HIST, V106, P16; Grigg R, 2005, CREATION, V28, P18; Gurney RJM, 2010, CREATION, V32, P53; Hafiz Y., 2013, HUFFINGTON POST; Harker BR, 2011, J CREATION, V25, P121; Harris WS, 2003, NATL CATHOLIC BIOETH, P531; Henke KR, 2014, YOUNG EARTH CREATION; Henry H, 2011, EVOLUTION STAMP CO 2; Hodge B, 2007, FINLAND SCH SCHOOTIN; Hughes JF, 2010, NATURE, V463, P536, DOI 10.1038/nature08700; John II Paul, 1996, MESSAGE PONTIFICAL A; Johnson P., 1993, DARWIN TRIAL; Johnson PE, 1995, REASON BALANE CASE N; Kahneman D., 2011, THINKING FAST SLOW; Kaye TG, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002808; Landau M., 1989, CREATION EVOLUTION J, V9, P1; Laudan L., 1983, PHYS PHILOS PSYCHOAN, P111, DOI DOI 10.1007/978-94-009-7055-7_6; Leisola M, 2012, ALUSTA VIIMEISEEN AI, P6; Lindeman M, 1998, SCAND J PSYCHOL, V39, P257, DOI 10.1111/1467-9450.00085; Lindeman M, 2000, J Health Psychol, V5, P195, DOI 10.1177/135910530000500210; Lindeman M, 2011, PSYCHOL HEALTH, V26, P371, DOI 10.1080/08870440903440707; Luskin C., 2008, INTELLIGENT DESIGN 1, P215; MacCoun RJ, 1998, ANNU REV PSYCHOL, V49, P259, DOI 10.1146/annurev.psych.49.1.259; Mackie John L., 1982, MIRACLE THEISM ARGUM; Marsden N, 2005, CREATION, V28, P36; McGrath Alister, 2010, SCI RELIG NEW INTRO; Mitroff Ian I., 1981, SCI THINKING, P170; Morris HM, 1972, REMARKABLE BIRTH PLA; Morris HM, 2001, IMPACT, P332; Morris JD, 2006, ACTS FACTS, P35; Nickerson R.S., 1998, REV GEN PSYCHOL, V2, P175, DOI [10.1037/1089-2680.2.2.175, DOI 10.1037/1089-2680.2.2.175]; Nieminen P, 2014, EVOL EDUC OUTREACH, V7, P11, DOI [10.1186/s12052-014-0011-6, DOI 10.1186/s12052-014-0011-6]; NUMBERS RL, 1982, SCIENCE, V218, P538, DOI 10.1126/science.6750792; Numbers RL, 2011, HIST PHIL LIFE SCI, V33, P129; Pacini R, 1999, J PERS SOC PSYCHOL, V76, P972, DOI 10.1037/0022-3514.76.6.972; Paley W., 1809, NATURAL THEOLOGY, V12th; Panda's Thumb archive, 2010, CREAT Y CHROM; Pannenberg W, 1997, CREATION THEORY EVOL, VXXXV, P21; Pennock RT, 2002, SCI ED, V11, P111; Pigliucci M, 2004, PHILOS NOW, P46; Poole M, 2007, USERS GUIDE SCI BELI; Popper K., 1978, DIALECTICA, V32, P339, DOI [10.1111/j.1746-8361.1978.tb01321.x, DOI 10.1111/J.1746-8361.1978.TB01321.X]; Puolimatka T, 2010, TIEDEKESKUSTELUN AVO; Puolimatka T, 2009, USKO TIEDE EVOLUUTIO; Purves W. K., 2004, LIFE SCI BIOL; Putz R., 2009, SOBOTTA ATLAS HUMAN, V14th; Reinikainen P, 2013, EVOLUUTIO VAI LUOMIN; Reinikainen P, 2003, DINOSAURUSTEN ARVOIT; Reinikainen P, 2013, ENKELEITA ALEMMAKSI; Reinikainen P, 2011, DARWIN VAI ALYKAS SU; Reinikainen P, 1991, UNOHDETTU GENESIS; Sarfati J, 2005, REINFORCING DARWIN H; Scott EC, 1997, ANNU REV ANTHROPOL, V26, P263, DOI 10.1146/annurev.anthro.26.1.263; Sherman S. J., 1984, HDB SOCIAL COGNITION, V1, P189; Stanley S. M., 1979, MACROEVOLUTION PATTE; Stanovich KE, 1997, J EDUC PSYCHOL, V89, P342, DOI 10.1037/0022-0663.89.2.342; Stanovich KE, 2013, CURR DIR PSYCHOL SCI, V22, P259, DOI 10.1177/0963721413480174; Steering Committee on Science and Creationism, 1999, SCI CREAT VIEW NAT A; Swenson K, 2001, RADIO DATING RUBBLE; TalkOrigins archive, 2001, CLAIM CA610; TalkOrigins archive, 2001, CLAIM CA321; TalkOrigins archive, 2003, CLAIM CA012; TalkOrigins archive, 2000, CLAIM CA310; TalkOrigins archive, 2001, CLAIM CA006 1; TalkOrigins archive, 2003, CLAIM CC001; TalkOrigins archive, 2001, CLAIM CA602; TalkOrigins archive, 2001, CLAIM CA005; TalkOrigins archive, 2003, CLAIM CA041 1; Thomas B, 2010, ARE HUMANS CLOSE CHI; van Eemeren Frans H., 1992, ARGUMENTATION COMMUN; Wiens Roger C., 2002, RADIOMETRIC DATING C; Wilkins JS, 2011, SYNTHESE, V178, P207, DOI 10.1007/s11229-009-9544-6; Wolpert Lewis, 1994, UNNATURAL NATURE SCI; Young W, 1985, FALLACIES CREATIONIS	110	7	7	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2015	10	3							e0118314	10.1371/journal.pone.0118314	http://dx.doi.org/10.1371/journal.pone.0118314			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	CC4HV	25734650	Green Submitted, Green Published, gold			2022-12-27	WOS:000350314700022
J	Nolan, VG; Nottage, KA; Cole, EW; Hankins, JS; Gurney, JG				Nolan, Vikki G.; Nottage, Kerri A.; Cole, Elliott W.; Hankins, Jane S.; Gurney, James G.			Prevalence of Vitamin D Deficiency in Sickle Cell Disease: A Systematic Review	PLOS ONE			English	Article							BONE-MINERAL DENSITY; RESTING ENERGY-EXPENDITURE; D-ENDOCRINE SYSTEM; D-BINDING PROTEIN; PARATHYROID-HORMONE; METABOLIC-RATE; SERUM-CALCIUM; YOUNG-ADULTS; CHRONIC PAIN; CHILDREN	Vitamin D deficiency has emerged as a public health focus in recent years and patients with sickle cell disease (SCD) reportedly have a high prevalence of the condition. Our objectives were to summarize definitions of vitamin D deficiency and insufficiency used in the literature, and to determine the prevalence and magnitude of each in patients with SCD through a systematic review conducted according to PRISMA guidelines. From a PubMed search, 34 potential articles were identified and 15 met eligibility criteria for inclusion. Definitions of deficiency and insufficiency varied greatly across studies making direct comparisons difficult. This review provides evidence to suggest that suboptimal vitamin D levels are highly prevalent among those with SCD, far more so than in comparable non-SCD patients or matched control populations. Defining deficiency as vitamin D <20ng/mL, prevalence estimates in SCD populations range from 56.4% to 96.4%. When compared with results from the population-based National Health and Nutrition Examination Survey, however, the general African American population appeared to have a similarly high prevalence of vitamin D deficiency. African American patients with and without SCD were both substantially higher than that of Caucasians. What remains to be determined is whether there are adverse health effects for patients with SCD because of concurrent vitamin D deficiency.	[Nolan, Vikki G.; Cole, Elliott W.; Gurney, James G.] Univ Memphis, Sch Publ Hlth, Dept Hematol, Div Epidemiol Biostat & Environm Hlth, Memphis, TN 38152 USA; [Nottage, Kerri A.; Hankins, Jane S.] Univ Memphis, Sch Publ Hlth, Div Epidemiol Biostat & Environm Hlth, Memphis, TN 38152 USA; [Gurney, James G.] St Jude Childrens Res Hosp, Memphis, TN 38105 USA	University of Memphis; University of Memphis; St Jude Children's Research Hospital	Nolan, VG (corresponding author), Univ Memphis, Sch Publ Hlth, Dept Hematol, Div Epidemiol Biostat & Environm Hlth, Memphis, TN 38152 USA.	vgnolan@memphis.edu	Hankins, Jane/N-3362-2018		Baptist Foundation; American Lebanese Syrian Associated Charities (ALSAC)	Baptist Foundation; American Lebanese Syrian Associated Charities (ALSAC)(American Lebanese Syrian Associated Charities (ALSAC))	Support for the researchers' time provided by the Baptist Foundation. St. Jude investigators are supported by the American Lebanese Syrian Associated Charities (ALSAC). The funders had no role in the study design, data collection and analysis, decision to publish or preparation of the manuscript.	Aloia JF, 2006, AM J CLIN NUTR, V84, P602, DOI 10.1093/ajcn/84.3.602; Arlet JB, 2013, BONE, V52, P206, DOI 10.1016/j.bone.2012.10.005; Ballas SK, 2013, AM J HEMATOL, V88, P927, DOI 10.1002/ajh.23575; Barden EM, 2000, J PEDIATR-US, V136, P73, DOI 10.1016/S0022-3476(00)90053-2; BELL NH, 1985, J CLIN INVEST, V76, P470, DOI 10.1172/JCI111995; BELL NH, 1985, J CLIN INVEST, V76, P370, DOI 10.1172/JCI111971; Bjelakovic G, 2011, COCHRANE LIB; Boyd JH, 2004, PEDIATR PULM, V38, P229, DOI 10.1002/ppul.20066; Brehm John M, 2010, J Allergy Clin Immunol, V126, P52, DOI 10.1016/j.jaci.2010.03.043; Brehm JM, 2009, AM J RESP CRIT CARE, V179, P765, DOI 10.1164/rccm.200808-1361OC; Brinker M R, 1998, Am J Orthop (Belle Mead NJ), V27, P43; Buison AM, 2004, J PEDIATR-US, V145, P622, DOI 10.1016/j.jpeds.2004.06.055; Chapelon E, 2009, EUR J HAEMATOL, V83, P572, DOI 10.1111/j.1600-0609.2009.01333.x; Garrido C, 2012, EUR J PEDIATR, V171, P1793, DOI 10.1007/s00431-012-1817-2; Ginde AA, 2009, ARCH INTERN MED, V169, P626, DOI 10.1001/archinternmed.2008.604; Gladwin MT, 2012, J AM COLL CARDIOL, V59, P1123, DOI 10.1016/j.jacc.2011.10.900; Glover TL, 2012, ARTHRITIS RHEUM-US, V64, P3926, DOI 10.1002/art.37687; Goodman BM, 2010, J NATL MED ASSOC, V102, P332, DOI 10.1016/S0027-9684(15)30605-2; GRAY NT, 1992, AM J PEDIAT HEMATOL, V14, P57; Guasch A, 2006, J AM SOC NEPHROL, V17, P2228, DOI 10.1681/ASN.2002010084; Gupta A, 2011, AM J RESP CRIT CARE, V184, P1342, DOI 10.1164/rccm.201107-1239OC; Gutierrez OM, 2011, OSTEOPOROSIS INT, V22, P1745, DOI 10.1007/s00198-010-1383-2; Heaney RP, 2002, CALCIFIED TISSUE INT, V70, P70, DOI [10.1007/s00223-001-0032-3, 10.1007/S00223-001-0032-3]; Holick MF, 2007, NEW ENGL J MED, V357, P266, DOI 10.1056/NEJMra070553; Ibidapo MO, 2000, CLIN LAB HAEMATOL, V22, P151, DOI 10.1046/j.1365-2257.2000.00292.x; Jackson TC, 2012, PEDIATR HEMAT ONCOL, V29, P261, DOI 10.3109/08880018.2012.661034; Jarvis JK, 2002, J NATL MED ASSOC, V94, P55; Julka RN, 2008, J NATL MED ASSOC, V100, P339, DOI 10.1016/S0027-9684(15)31248-7; Kim TH, 2013, PAIN PHYSICIAN, V16, P165; Kopp-Hoolihan LE, 1999, J AM DIET ASSOC, V99, P195, DOI 10.1016/S0002-8223(99)00047-4; Lal A, 2006, PEDIATR BLOOD CANCER, V47, P901, DOI 10.1002/pbc.20681; Levin A, 2007, KIDNEY INT, V71, P31, DOI 10.1038/sj.ki.5002009; McBeth J, 2010, ANN RHEUM DIS, V69, P1448, DOI 10.1136/ard.2009.116053; Miller RG, 2006, AM J HEMATOL, V81, P236, DOI 10.1002/ajh.20541; Mithal A, 2009, OSTEOPOROSIS INT, V20, P1807, DOI 10.1007/s00198-009-0954-6; MOHAMMED S, 1993, ANN CLIN BIOCHEM, V30, P45, DOI 10.1177/000456329303000108; Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b4037, 10.1371/journal.pmed.1000097]; NHS Antenal and Newborn Screening Programmes, 2007, SICKL CELL DIS CHILD; O'Connor MY, 2013, PROG CARDIOVASC DIS, V56, P261, DOI 10.1016/j.pcad.2013.10.015; ODONKOR PO, 1983, B EUR PHYSIOPATH RES, V19, P357; Osunkwo I, 2011, BR J HAEMATOL, V153; Osunkwo I, 2011, J PEDIAT HEMATOLOGY, V33; Osunkwo I, 2012, BRIT J HAEMATOL, V159, P211, DOI 10.1111/bjh.12019; Osunkwo I, 2011, BRIT J HAEMATOL, V153, P538, DOI 10.1111/j.1365-2141.2010.08458.x; Ozen S, 2013, TURK J HEMATOL, V30, P25, DOI 10.4274/tjh.2012.0001; PHEBUS CK, 1988, AM J HEMATOL, V29, P67, DOI 10.1002/ajh.2830290203; Powe CE, 2014, NEW ENGL J MED, V370, P880, DOI 10.1056/NEJMc1315850; Powe CE, 2013, NEW ENGL J MED, V369, P1991, DOI 10.1056/NEJMoa1306357; Rees DC, 2010, LANCET, V376, P2018, DOI 10.1016/S0140-6736(10)61029-X; Reid M, 2013, CR BIOL, V336, P159, DOI 10.1016/j.crvi.2012.09.007; ROSENSTREICH SJ, 1971, J CLIN INVEST, V50, P679, DOI 10.1172/JCI106538; Rovner AJ, 2008, J AM DIET ASSOC, V108, P1512, DOI 10.1016/j.jada.2008.06.433; Rovner AJ, 2008, ARCH PEDIAT ADOL MED, V162, P513, DOI 10.1001/archpedi.162.6.513; Sadat-Ali M, 2011, AM J HEMATOL, V86, P506, DOI 10.1002/ajh.22010; Salman EK, 1996, PEDIATR RES, V40, P34, DOI 10.1203/00006450-199607000-00007; SEDRANI SH, 1983, AM J CLIN NUTR, V38, P129, DOI 10.1093/ajcn/38.1.129; SINGHAL A, 1993, AM J CLIN NUTR, V57, P32, DOI 10.1093/ajcn/57.1.32; Singhal A, 2002, AM J CLIN NUTR, V75, P1093, DOI 10.1093/ajcn/75.6.1093; SKLAR AH, 1990, INT J ARTIF ORGANS, V13, P231, DOI 10.1177/039139889001300408; Steinberg MH, 1999, NEW ENGL J MED, V340, P1021, DOI 10.1056/NEJM199904013401307; vanderDijs FPL, 1997, ANN CLIN BIOCHEM, V34, P170, DOI 10.1177/000456329703400207; Waldron JL, 2013, J CLIN PATHOL, V66, P620, DOI 10.1136/jclinpath-2012-201301; Wang L, 2012, CIRC-CARDIOVASC QUAL, V5, P819, DOI 10.1161/CIRCOUTCOMES.112.967604; Wang TJ, 2008, CIRCULATION, V117, P503, DOI 10.1161/CIRCULATIONAHA.107.706127; Wortsman J, 2000, AM J CLIN NUTR, V72, P690, DOI 10.1093/ajcn/72.3.690; Wright NC, 2012, OSTEOPOROSIS INT, V23, P2283, DOI 10.1007/s00198-011-1877-6	66	33	34	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2015	10	3							e0119908	10.1371/journal.pone.0119908	http://dx.doi.org/10.1371/journal.pone.0119908			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4HV	25734582	Green Submitted, gold, Green Published			2022-12-27	WOS:000350314700064
J	Riou, J; Lefevre, T; Parizot, I; Lhuissier, A; Chauvin, P				Riou, Julien; Lefevre, Thomas; Parizot, Isabelle; Lhuissier, Anne; Chauvin, Pierre			Is There Still a French Eating Model? A Taxonomy of Eating Behaviors in Adults Living in the Paris Metropolitan Area in 2010	PLOS ONE			English	Article							CLASS DISCOVERY; FAMILY; MEALS; FREQUENCY; PATTERNS; CHILDREN; FRANCE; DIET; FOOD	Background Meal times in France still represent an important moment in everyday life. The model of three rigorously synchronized meals is still followed by a majority of people, while meal frequencies have flattened in other European or North-American countries. We aimed to examine the "French model" of eating behavior by identifying and characterizing distinct meal patterns. Methods Analyses were based on data from the SIRS cohort, a representative survey of the adult population in the Paris area. A clustering algorithm was applied to meal variables (number, time, location, with whom the meal is usually shared and activities associated with meals). Regression models were used to investigate associations between patterns and socio-demographic, social environment and perceived food quality variables. Results Five different patterns were identified among 2994 participants. The first three types (prevalence 33%, 17% and 24%) followed a three-meal pattern, with differences in locations and social interactions mainly related to time constraints and age. More marked differences were observed in the remaining two types. In the fourth type (prevalence 13%), individuals ate one or two meals per day, often with an irregular schedule, at home and in front of the television. They frequently were unemployed and had lower income. Breakfast skipping, increased snacking and a low adherence to dietary guidelines suggested that this behavior might have health consequences. In the fifth type (12%), people also ate two meals or less per day, possibly with the same consequences on food quality. However, meals were often taken outside the home, in social settings, and individuals following this pattern were typically active, integrated, young people, suggesting that this pattern might be an adaptation to a modern urban lifestyle. Conclusions While a majority of the population still follows the three-meal pattern, our analysis distinguished two other eating patterns associated with specific sociological profiles.	[Riou, Julien; Lefevre, Thomas; Chauvin, Pierre] Univ Paris 06, Pierre Louis Inst Epidemiol & Publ Hlth, Dept Epidemiol & Social Med, Sorbonne Univ,Dept Social Epidemiol,UMR S 1136, F-75013 Paris, France; [Riou, Julien; Lefevre, Thomas; Chauvin, Pierre] INSERM, Pierre Louis Inst Epidemiol & Publ Hlth, Dept Social Epidemiol, UMR S 1136, F-75013 Paris, France; [Lefevre, Thomas] Hop Jean Verdier, Dept Forens Med, AP HP, F-93140 Bondy, France; [Parizot, Isabelle] CNRS, Ctr Maurice Halbwachs, UMR 8097, Res Team Social Inequal, F-75014 Paris, France; [Lhuissier, Anne] INRA, ALISS UR1303, F-94205 Ivry, France; [Lhuissier, Anne] Univ Oxford, Dept Sociol, Oxford OX1 3UQ, England	UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Jean-Verdier - APHP; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Humanities & Social Sciences (INSHS); INRAE; UDICE-French Research Universities; Universite Paris Saclay; University of Oxford	Riou, J (corresponding author), Univ Paris 06, Pierre Louis Inst Epidemiol & Publ Hlth, Dept Epidemiol & Social Med, Sorbonne Univ,Dept Social Epidemiol,UMR S 1136, F-75013 Paris, France.	julien.riou.k@gmail.com	Thomas, Lefèvre/AAE-8350-2022; Riou, Julien/AAA-9152-2022; Chauvin, Pierre/S-2981-2019	Chauvin, Pierre/0000-0002-9183-6406; Riou, Julien/0000-0002-3808-2852; Lefevre, Thomas/0000-0003-3038-479X	National Research Agency (ANR) within the framework of the National Food Research Program [ANR-07-PNRA-002-01]; Institute for Public Health Research (IReSP) [2008-87]; French Interministerial Committee for Urban Affairs [2009-273]	National Research Agency (ANR) within the framework of the National Food Research Program(French National Research Agency (ANR)); Institute for Public Health Research (IReSP); French Interministerial Committee for Urban Affairs	This study was supported by the National Research Agency (ANR) within the framework of the National Food Research Program (grant number ANR-07-PNRA-002-01; URL: http://www.agence-nationale-recherche.fr). The SIRS survey was also supported by the Institute for Public Health Research (IReSP) (grant number 2008-87; URL: http://www.iresp.net) and the French Interministerial Committee for Urban Affairs (grant number 2009-273; URL: http://www.ville.gouv.fr/?le-commissariat-general-a-l, 9). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Caillavet F, 2005, ALIMENTATION POPULAT, P44; De Saint Pol T, 2012, INSEE PREMIERE, P1417; De Saint Pol T., 2006, EC STAT, V400, P45; Diaz-Mendez C, 2014, INT J COMP SOCIOL, V55, P24, DOI 10.1177/0020715213519657; Escalon H, 2009, BAROMETRE SANTE NUTR, P424; Eurostat, 2004, EUR SPEND THEIR TIM; FANTASIA R, 1995, THEOR SOC, V24, P201, DOI 10.1007/BF00993397; FISCHLER Claude, 1990, HOMNIVORE GOUT CUISI; Fulkerson JA, 2014, J NUTR EDUC BEHAV, V46, P2, DOI 10.1016/j.jneb.2013.07.012; Grignon C., 1996, Food & Foodways, V6, P205; Hammons AJ, 2011, PEDIATRICS, V127, pE1565, DOI 10.1542/peds.2010-1440; Hebel P, 2013, CONSOMM MODES VIE; HERPIN N, 1988, REV FR SOCIOL, V29, P503, DOI 10.2307/3321627; Kaufman L., 1990, FINDING GROUPS DATA, DOI 10.1002/9780470316801; Leech RM, 2014, INT J BEHAV NUTR PHY, V11, DOI 10.1186/1479-5868-11-4; Lhuissier A, 2014, ANTHR FOOD, pS10; Lhuissier A, 2013, APPETITE, V63, P59, DOI 10.1016/j.appet.2012.12.012; Lund TB, 2014, APPETITE, V82, P143, DOI 10.1016/j.appet.2014.07.004; Makela J, 1999, APPETITE, V32, P73, DOI 10.1006/appe.1998.0198; Martin-Fernandez J, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-486; Mestdag I, 2009, SOCIOL REV, V57, P703, DOI 10.1111/j.1467-954X.2009.01868.x; Monteleone E, 2009, MEALS SCI PRACTICE I, P704; Monti S, 2003, MACH LEARN, V52, P91, DOI 10.1023/A:1023949509487; Pereira M, 2011, J NUTR, V141, P163, DOI 10.3945/jn.109.114405; Poulain JP, 2002, APPETITE, V39, P43, DOI 10.1006/appe.2001.0461; R Core Team, 2021, R LANGUAGE ENV STAT; Simpson TI, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-590; Skafida V, 2013, SOCIOL HEALTH ILL, V35, P906, DOI 10.1111/1467-9566.12007; Sobal J, 2003, APPETITE, V41, P181, DOI 10.1016/S0195-6663(03)00078-3; Sobal J, 2011, PUBLIC HEALTH NUTR, V14, P1555, DOI 10.1017/S1368980011000127; Tavoularis G, 2010, CONSOMM MODES VIE, V232, P1; Todd J.E., 2010, ERR90 USDA; Tovar A, 2013, INT J BEHAV NUTR PHY, V10, DOI 10.1186/1479-5868-10-84; Venables WN., 2002, MODERN APPL STAT S 4; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1	35	19	19	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2015	10	3							e0119161	10.1371/journal.pone.0119161	http://dx.doi.org/10.1371/journal.pone.0119161			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CC4HV	25734543	Green Published, Green Submitted, gold			2022-12-27	WOS:000350314700056
J	Haslam, SA; Reicher, SD; Millard, K				Haslam, S. Alexander; Reicher, Stephen D.; Millard, Kathryn			Shock Treatment: Using Immersive Digital Realism to Restage and Re-Examine Milgram's 'Obedience to Authority' Research	PLOS ONE			English	Article							PSYCHOLOGY; PARADIGM; DISOBEDIENCE	Attempts to revisit Milgram's 'Obedience to Authority' (OtA) paradigm present serious ethical challenges. In recent years new paradigms have been developed to circumvent these challenges but none involve using Milgram's own procedures and asking naive participants to deliver the maximum level of shock. This was achieved in the present research by using Immersive Digital Realism (IDR) to revisit the OtA paradigm. IDR is a dramatic method that involves a director collaborating with professional actors to develop characters, the strategic withholding of contextual information, and immersion in a real-world environment. 14 actors took part in an IDR study in which they were assigned to conditions that restaged Milgrams's New Baseline ('Coronary') condition and four other variants. Post-experimental interviews also assessed participants' identification with Experimenter and Learner. Participants' behaviour closely resembled that observed in Milgram's original research. In particular, this was evidenced by (a) all being willing to administer shocks greater than 150 volts, (b) near-universal refusal to continue after being told by the Experimenter that "you have no other choice, you must continue'' (Milgram's fourth prod and the one most resembling an order), and (c) a strong correlation between the maximum level of shock that participants administered and the mean maximum shock delivered in the corresponding variant in Milgram's own research. Consistent with an engaged follower account, relative identification with the Experimenter (vs. the Learner) was also a good predictor of the maximum shock that participants administered.	[Haslam, S. Alexander] Univ Queensland, Sch Psychol, Brisbane, Qld, Australia; [Reicher, Stephen D.] Univ St Andrews, Sch Psychol & Neurosci, St Andrews, Fife, Scotland; [Millard, Kathryn] Macquarie Univ, Dept Media Mus Commun & Cultural Studies, Sydney, NSW 2109, Australia	University of Queensland; University of St Andrews; Macquarie University	Haslam, SA (corresponding author), Univ Queensland, Sch Psychol, Brisbane, Qld, Australia.	a.haslam@uq.edu.au	Haslam, Alex/AAA-2512-2019	Haslam, Alex/0000-0001-9523-7921; Millard, Kathryn/0000-0002-0748-0516	Australian Research Council [DP1301108, FL110100199]; Economic and Social Research Council [ES/L003104/1]; ESRC [ES/L003104/1] Funding Source: UKRI	Australian Research Council(Australian Research Council); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))	The main work on this paper was supported by a grant from the Australian Research Council to KM and SDR ("Reinterpreting Milgram's Obedience Studies via Documentary Film''; DP1301108). Additional funding was provided by the Australian Research Council to SAH ("An Advanced Social Identity Approach''; FL110100199) and by the Economic and Social Research Council to SDR ("Beyond the Banality of Evil''; ES/L003104/1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1961, NY TIMES, P28; [Anonymous], 2013, BAD SHOW; ARENDT, 2006, EICHMANN JERUSALEM R; BAUMRIND D, 1964, AM PSYCHOL, V19, P421, DOI 10.1037/h0040128; Blass T., 2004, MAN WHO SHOCKED WORL; Brehm J.W., 1966, THEORY PSYCHOL REACT; Burger JM, 2011, SOC PSYCHOL PERS SCI, V2, P460, DOI 10.1177/1948550610397632; Burger JM, 2009, AM PSYCHOL, V64, P1, DOI 10.1037/a0010932; Cesarani David, 2004, EICHMANN HIS LIFE CR; Dambrun M, 2010, EUR J SOC PSYCHOL, V40, P760, DOI 10.1002/ejsp.646; Gamson W. A., 1982, ENCOUNTERS UNJUST AU; Gibson S, 2013, BRIT J SOC PSYCHOL, V52, P290, DOI 10.1111/j.2044-8309.2011.02070.x; Griggs RA, 2014, TEACH PSYCHOL, V41, P195, DOI 10.1177/0098628314537968; Haslam A, 2015, BRIT J SOC PSYCHOL, V54, P55, DOI 10.1111/bjso.12074; Haslam Alexander, 2012, SOCIAL PSYCHOL REVIS; Haslam N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093927; Haslam SA, 2011, NEW PSYCHOLOGY OF LEADERSHIP: IDENTITY, INFLUENCE, AND POWER, P1; Haslam SA, 2007, PERS SOC PSYCHOL B, V33, P615, DOI 10.1177/0146167206298570; Haslam SA, 2014, J SOC ISSUES, V70, P473, DOI 10.1111/josi.12072; Haslam SA, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001426; Haslam SA, 2014, J SOC ISSUES, V70; Jetten J, 2014, J SOC ISSUES, V70, P587, DOI 10.1111/josi.12080; Kershaw I., 1993, CONTEMP EUR HIST, V2, P103, DOI DOI 10.1017/S0960777300000382; Lagouranis D, 2007, FEAR HARSH ARMY INTE, P231; Lozowick Yaacov, 2002, HITLERS BUREAUCRATS; Mandel D. R., 1998, AK, V20, P74, DOI DOI 10.1515/AUK-1998-0105; MANTELL DM, 1976, BRIT J SOC CLIN PSYC, V15, P239, DOI 10.1111/j.2044-8260.1976.tb00030.x; Martens A, 2007, PERS SOC PSYCHOL B, V33, P1251, DOI 10.1177/0146167207303020; Mastroianni GR., 2002, J THEOR PHILOS PSYCH, V22, P158, DOI [10.1037/h0091220, DOI 10.1037/H0091220]; MEEUS WHJ, 1986, EUR J SOC PSYCHOL, V16, P311, DOI 10.1002/ejsp.2420160402; MILGRAM S, 1964, AM PSYCHOL, V19, P848, DOI 10.1037/h0044954; MILGRAM S, 1965, HUM RELAT, V18, P57, DOI 10.1177/001872676501800105; MILGRAM S., 1974, OBEDIENCE AUTHORITY; Milgram S, 1965, OBEDIENCE MOTION PIC; Millard K, 2014, SCREENWRITING IN A DIGITAL ERA, P1, DOI 10.1057/9781137319104; Millard K, 2012, RANDOM 8 MOTION PICT; Millard K, 2014, J SOC ISSUES, V70, P439, DOI 10.1111/josi.12070; Millard K, 2011, PSYCHOLOGIST, V24, P658; Mixon D., 1972, J THEOR SOC BEHAV, V2, P145, DOI DOI 10.1111/J.1468-5914.1972.TB00309.X; Navarick DJ, 2009, PSYCHOL REC, V59, P155, DOI 10.1007/BF03395656; Newman LS, 2001, THESIS SYRACUSE U SY; OLEARY CJ, 1970, SOCIOL QUART, V11, P87, DOI 10.1111/j.1533-8525.1970.tb02077.x; Packer DJ, 2008, PERSPECT PSYCHOL SCI, V3, P301, DOI 10.1111/j.1745-6924.2008.00080.x; Perry G, 2011, SHOCK MACHINE UNTOLD; Reicher S, 2006, BRIT J SOC PSYCHOL, V45, P1, DOI 10.1348/014466605X48998; Reicher S. D., 2011, SCI AM MIND, V22, P30; Reicher S, 2011, BRIT J SOC PSYCHOL, V50, P163, DOI 10.1111/j.2044-8309.2010.02015.x; Reicher SD, 2014, J SOC ISSUES, V70, P393, DOI 10.1111/josi.12067; Reicher SD, 2012, PERSPECT PSYCHOL SCI, V7, P315, DOI 10.1177/1745691612448482; Rochat F, 2014, J SOC ISSUES, V70, P456, DOI 10.1111/josi.12071; Russell N., 2014, SOCIAL SCI, V3, P194, DOI [DOI 10.3390/SOCSCI3020194, 10.3390/socsci3020194]; Russell N, 2010, PSYCHOLOGIST, V23, P780; Russell NJC, 2011, BRIT J SOC PSYCHOL, V50, P140, DOI 10.1348/014466610X492205; Slater M, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000039; Yardley-Matwiejczuk K. M., 1997, ROLE PLAY THEORY PRA; Zeigler-Hill V, 2013, J SOC PSYCHOL, V153, P161, DOI 10.1080/00224545.2012.713041	57	15	15	1	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2015	10	3							e109015	10.1371/journal.pone.0109015	http://dx.doi.org/10.1371/journal.pone.0109015			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9JF	25730318	Green Published, Green Submitted, gold			2022-12-27	WOS:000350684900001
J	Amin, J; Boyd, MA; Kumarasamy, N; Moore, CL; Losso, MH; Nwizu, CA; Mohapi, L; Kerr, SJ; Sohn, AH; Teppler, H; Renjifo, B; Molina, JM; Emery, S; Cooper, DA				Amin, Janaki; Boyd, Mark A.; Kumarasamy, Nagalingeswaran; Moore, Cecilia L.; Losso, Marcello H.; Nwizu, Chidi A.; Mohapi, Lerato; Kerr, Stephen J.; Sohn, Annette H.; Teppler, Hedy; Renjifo, Boris; Molina, Jean-Michel; Emery, Sean; Cooper, David A.			Raltegravir Non-Inferior to Nucleoside Based Regimens in SECOND-LINE Therapy with Lopinavir/Ritonavir over 96 Weeks: A Randomised Open Label Study for the Treatment Of HIV-1 Infection	PLOS ONE			English	Article							ANTIRETROVIRAL THERAPY; PROTEASE INHIBITOR; CLINICAL-TRIALS; EFFICACY; TENOFOVIR/EMTRICITABINE; METAANALYSIS; DISEASE; SAFETY; ADULTS	Objective To determine the durability over 96 weeks of safety and efficacy of lopinavir/ritonavir (LPV/r) and raltegravir (RAL) which was demonstrated to have non-inferior efficacy relative to a regimen of LPV/r with nucleoside/nucleotide reverse transcriptase inhibitors (N(t)RTIs) (Control) in primary analysis at 48 weeks. Design Open label, centrally randomised trial. Setting Recruitment was from 37 primary and secondary care sites from Africa, Asia, Australia, Europe and Latin America. Subjects 541 HIV-1 infected adults virologically failing first-line non-NRTI + 2N(t)RTI, with no previous exposure to protease inhibitors or integrase strand transfer inhibitors were analysed, 425 completed 96 weeks follow up on randomised therapy. Intervention Randomisation was 1:1 to Control or RAL. Main outcome measures Differences between the proportion of participants with plasma HIV-1 RNA (VL) <200 copies/mL by intention to treat were compared with a non-inferiority margin of -12%. Differences in biochemical, haematological and metabolic changes were assessed using T-tests. Results VL <200 copies/mL at 96 weeks was: RAL 80.4%, Control 76.0%(difference: 4.4 [95% CI -2.6, 11.3]) andmet non-inferiority criteria. The RAL arm had a significantly higher mean change (difference Control-RAL; 95% CI) in haemoglobin (-2.9; -5.7, -1.1), total lymphocytes (-0.2; -0.3, -0.0), total cholesterol (-0.5; -0.8, -0.3), HDL cholesterol (-0.1; -0.1, -0.0) and LDL cholesterol (-0.3; -0.5, -0.2). Conclusion At 96 weeks, both RAL and Control maintained efficacy greater than 75% and continued to demonstrate similar safety profiles. These results support the use of a combination LPV/r and RAL regimen as an option following failure of 1st line NNRTI + 2N(t)RTIs.	[Amin, Janaki; Boyd, Mark A.; Moore, Cecilia L.; Emery, Sean; Cooper, David A.] UNSW Australia, Kirby Inst, Sydney, NSW, Australia; [Kumarasamy, Nagalingeswaran] YR Gaitonde Ctr AIDS Res & Educ, Madras, Tamil Nadu, India; [Losso, Marcello H.] Hosp JM Ramos Mejia, Buenos Aires, DF, Argentina; [Nwizu, Chidi A.] Univ Maryland, Sch Med, Inst Human Virol, Baltimore, MD 21201 USA; [Mohapi, Lerato] Univ Witwatersrand, Johannesburg, South Africa; [Mohapi, Lerato] Baragwanath Hosp, ZA-2013 Johannesburg, South Africa; [Kerr, Stephen J.] UNSW Australia, HIV Netherlands Australia Thailand Res Collaborat, Bangkok, Thailand; [Sohn, Annette H.] Fdn AIDS Res, TREAT Asia, AmfAR, Bangkok, Thailand; [Teppler, Hedy] Merck Res Labs, Merck Sharp & Dohme, Whitehouse Stn, NJ USA; [Renjifo, Boris] Abbvie, Global Med Affairs Virol, N Chicago, IL USA; [Molina, Jean-Michel] Hop St Louis, Serv Malad Infect, Assistance Publ Hop Paris, Paris, France	University of New South Wales Sydney; Kirby Institute; Hospital Ramos Mejia; University of Buenos Aires; University System of Maryland; University of Maryland Baltimore; University of Witwatersrand; Merck & Company; AbbVie; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Universite Paris Cite	Amin, J (corresponding author), UNSW Australia, Kirby Inst, Sydney, NSW, Australia.	jamin@kirby.unsw.edu.au	Emery, Sean/J-3825-2017; Emery, Sean/O-9122-2019; Kumarasasmy, Nagalingeswaran/AAB-7348-2021; Kerr, Stephen/J-6126-2012	Emery, Sean/0000-0001-6072-8309; Emery, Sean/0000-0001-6072-8309; Kerr, Stephen/0000-0002-1919-4525; Moore, Cecilia/0000-0002-5438-6143; Boyd, Mark/0000-0002-6848-3307; Amin, Janaki/0000-0003-2161-9366	University of New South Wales; Merck; AbbVie; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI069453, UM1AI069453] Funding Source: NIH RePORTER	University of New South Wales; Merck(Merck & Company); AbbVie(AbbVie); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	University of New South Wales, Merck and AbbVie funded the study. The sponsors participated in the study design, data collection, data analysis, data interpretation, and review and approval of the report and supplied the study drug. Merck provided support in the form of salaries for author HT and AbbVie for BR. The specific roles of these authors are articulated in the 'author contributions' section.	Behrens G, 2012, ANTIVIR THER, V17, P1011, DOI 10.3851/IMP2305; Boyd MA, 2013, LANCET, V381, P2091, DOI 10.1016/S0140-6736(13)61164-2; Campo R, 2013, CLIN INFECT DIS, V56, P1637, DOI 10.1093/cid/cis1203; Chesney MA, 2000, AIDS CARE, V12, P255, DOI 10.1080/09540120050042891; D'Agostino RB, 2001, JAMA-J AM MED ASSOC, V286, P180, DOI 10.1001/jama.286.2.180; Goicoechea M, 2008, J INFECT DIS, V197, P102, DOI 10.1086/524061; Gotuzzo E, 2012, JAIDS-J ACQ IMM DEF, V61, P73, DOI 10.1097/QAI.0b013e318263277e; Humphreys EH, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006517.pub3; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; Lifson AR, 2010, HIV CLIN TRIALS, V11, P205, DOI 10.1310/hct1104-205; Morlat P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066223; Moyle G, 2004, CLIN THER, V26, P92, DOI 10.1016/S0149-2918(04)90009-4; Nishijima T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073639; Paton NI, 2014, NEW ENGL J MED, V371, P234, DOI 10.1056/NEJMoa1311274; Reynes J, 2013, AIDS RES HUM RETROV, V29, P256, DOI [10.1089/aid.2011.0275, 10.1089/AID.2011.0275]; Smith F, 2011, DRUG INF J, V45, P291, DOI 10.1177/009286151104500309; Stone NJ., 2014, J AM COLL CARDIOL, V63, P2889; WHO, 2010, ANT THER HIV INF AD; Wilson PWF, 2005, CIRCULATION, V112, P3066, DOI 10.1161/CIRCULATIONAHA.105.539528	19	20	24	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2015	10	2							e0118228	10.1371/journal.pone.0118228	http://dx.doi.org/10.1371/journal.pone.0118228			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC3LS	25723472	Green Published, gold			2022-12-27	WOS:000350251200052
J	Karschin, J; Lagerpusch, M; Enderle, J; Eggeling, B; Muller, MJ; Bosy-Westphal, A				Karschin, Judith; Lagerpusch, Merit; Enderle, Janna; Eggeling, Ben; Mueller, Manfred J.; Bosy-Westphal, Anja			Endocrine Determinants of Changes in Insulin Sensitivity and Insulin Secretion during a Weight Cycle in Healthy Men	PLOS ONE			English	Article							GLUCOSE-TOLERANCE; GLYCEMIC INDEX; CARBOHYDRATE INTAKE; THYROID-HORMONES; PLASMA GHRELIN; LEPTIN LEVELS; BODY-WEIGHT; RESISTANCE; ADIPONECTIN; METABOLISM	Objective Changes in insulin sensitivity (IS) and insulin secretion occur with perturbations in energy balance and glycemic load (GL) of the diet that may precede the development of insulin resistance and hyperinsulinemia. Determinants of changes in IS and insulin secretion with weight cycling in non-obese healthy subjects remain unclear. Methods In a 6wk controlled 2-stage randomized dietary intervention 32 healthy men (26 +/- 4y, BMI: 24 +/- 2kg/m(2)) followed 1wk of overfeeding (OF), 3wks of caloric restriction (CR) containing either 50% or 65% carbohydrate (CHO) and 2wks of refeeding (RF) with the same amount of CHO but either low or high glycaemic index at +/- 50% energy requirement. Measures of IS (basal: HOMA-index, postprandial: Matsuda-ISI), insulin secretion (early: Stumvoll-index, total: tAUC-insulin/tAUC-glucose) and potential endocrine determinants (ghrelin, leptin, adiponectin, thyroid hormone levels, 24h-urinary catecholamine excretion) were assessed. Results IS improved and insulin secretion decreased due to CR and normalized upon RF. Weight loss-induced improvements in basal and postprandial IS were associated with decreases in leptin and increases in ghrelin levels, respectively (r = 0.36 and r = 0.62, p<0.05). Weight regain-induced decrease in postprandial IS correlated with increases in adiponectin, fT3, TSH, GL of the diet and a decrease in ghrelin levels (r-values between -0.40 and 0.83, p<0.05) whereas increases in early and total insulin secretion were associated with a decrease in leptin/adiponectin-ratio (r = -0.52 and r = -0.46, p<0.05) and a decrease in fT4 (r = -0.38, p<0.05 for total insulin secretion only). After controlling for GL associations between RF-induced decrease in postprandial IS and increases in fT3 and TSH levels were no longer significant. Conclusion Weight cycling induced changes in IS and insulin secretion were associated with changes in all measured hormones, except for catecholamine excretion. While leptin, adiponectin and ghrelin seem to be the major endocrine determinants of IS, leptin/adiponectin-ratio and fT4 levels may impact changes in insulin secretion with weight cycling.	[Karschin, Judith; Bosy-Westphal, Anja] Univ Hohenheim, Inst Nutr Med, Stuttgart, Germany; [Lagerpusch, Merit; Enderle, Janna; Eggeling, Ben; Mueller, Manfred J.; Bosy-Westphal, Anja] Univ Kiel, Inst Human Nutr & Food Sci, Kiel, Germany	University Hohenheim; University of Kiel	Bosy-Westphal, A (corresponding author), Univ Hohenheim, Inst Nutr Med, Stuttgart, Germany.	Anja.Bosy-Westphal@uni-hohenheim.de			Germany Ministry of Education and Research [BMBF 0315681]; German Research Foundation [DFG Bo 3296/1-1]; BMBF Kompetenznetz Adipositas, Core domain "Body composition" (Korperzusammensetzung) [FKZ 01GI1125]	Germany Ministry of Education and Research; German Research Foundation(German Research Foundation (DFG)); BMBF Kompetenznetz Adipositas, Core domain "Body composition" (Korperzusammensetzung)(Federal Ministry of Education & Research (BMBF))	The study was funded by a grant of the Germany Ministry of Education and Research (BMBF 0315681), the German Research Foundation (DFG Bo 3296/1-1) and the BMBF Kompetenznetz Adipositas, Core domain "Body composition" (Korperzusammensetzung; FKZ 01GI1125). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adochio RL, 2009, NUTR METAB, V6, DOI 10.1186/1743-7075-6-37; Albareda M, 2000, DIABETOLOGIA, V43, P1507, DOI 10.1007/s001250051561; Amini P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045657; Arita Y, 2012, BIOCHEM BIOPH RES CO, V425, P560, DOI 10.1016/j.bbrc.2012.08.024; Barclay AW, 2008, AM J CLIN NUTR, V87, P627, DOI 10.1093/ajcn/87.3.627; BERNE C, 1992, DIABETOLOGIA, V35, P873, DOI 10.1007/BF00399935; Brands M, 2013, CLIN ENDOCRINOL OXF; Brenta G, 2011, J THROID RES, V2011, DOI 10.4061/2011/152850; Broglio F, 2004, CLIN ENDOCRINOL, V61, P503, DOI 10.1111/j.1365-2265.2004.02121.x; Broglio F, 2001, J CLIN ENDOCR METAB, V86, P5083, DOI 10.1210/jc.86.10.5083; Brons C, 2009, J PHYSIOL-LONDON, V587, P2387, DOI 10.1113/jphysiol.2009.169078; Canale MP, 2013, INT J ENDOCRINOL, V2013, DOI 10.1155/2013/865965; Chan JL, 2003, J CLIN INVEST, V111, P1409, DOI 10.1172/JCI200317490; Chandra R, 2013, CURR OPIN GASTROEN, V29, P517, DOI 10.1097/MOG.0b013e3283639326; de Moraes CMM, 2005, OBES SURG, V15, P1287; DEFRONZO RA, 1979, AM J PHYSIOL, V237, pE214; Fagerberg B, 2003, METABOLISM, V52, P1460, DOI 10.1016/S0026-0495(03)00274-9; Finucane FM, 2009, DIABETOLOGIA, V52, P2345, DOI 10.1007/s00125-009-1508-3; Folsom AR, 1996, INT J OBESITY, V20, P704; Galofre JC, 2008, ANN NUTR METAB, V53, P188, DOI 10.1159/000172981; GAVIN LA, 1988, ENDOCRINOLOGY, V123, P1075, DOI 10.1210/endo-123-2-1075; HAMM P, 1989, AM J EPIDEMIOL, V129, P312, DOI 10.1093/oxfordjournals.aje.a115135; Hills Andrew P, 2014, Front Nutr, V1, P5, DOI 10.3389/fnut.2014.00005; Hinton PS, 2011, ENDOCRINOL METAB SYN, V01, DOI [10.4172/2161-1017, DOI 10.4172/2161-1017]; Hollenbach E, 1998, LIFE SCI, V63, P737, DOI 10.1016/S0024-3205(98)00329-4; Inoue M, 2006, METABOLISM; Kahlhofer J, 2014, EUR J CLIN NUTR, V68, P1060, DOI 10.1038/ejcn.2014.132; Knudsen SH, 2012, J APPL PHYSIOL, V113, P7, DOI 10.1152/japplphysiol.00189.2011; Kolb H, 2010, DIABETOLOGIA, V53, P10, DOI 10.1007/s00125-009-1573-7; Kotronen A, 2008, GASTROENTEROLOGY, V135, P122, DOI 10.1053/j.gastro.2008.03.021; Lagerpusch M, 2012, INT J OBESITY, V36, P1094, DOI 10.1038/ijo.2011.211; Lagerpusch M, 2013, J NUTR, V143, P1593, DOI 10.3945/jn.113.179390; Lagerpusch M, 2013, BRIT J NUTR, V109, P1606, DOI 10.1017/S000711451200462X; Lam TKT, 2003, AM J PHYSIOL-ENDOC M, V284, pE863, DOI 10.1152/ajpendo.00033.2003; Lambadiari V, 2011, ENDOCRINE, V39, P28, DOI 10.1007/s12020-010-9408-3; Lambert GW, 2010, PHARMACOL THERAPEUT, V126, P159, DOI 10.1016/j.pharmthera.2010.02.002; Liu SM, 2000, AM J CLIN NUTR, V71, P1455; MALAISSE W, 1967, ENDOCRINOLOGY, V80, P975, DOI 10.1210/endo-80-5-975; Fernandez-Real JM, 2009, J CLIN ENDOCR METAB, V94, P237, DOI 10.1210/jc.2008-0270; Matsuda M, 1999, DIABETES CARE, V22, P1462, DOI 10.2337/diacare.22.9.1462; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; MATTHEWS JNS, 1990, BRIT MED J, V300, P230, DOI 10.1136/bmj.300.6719.230; Meloni AR, 2013, DIABETES OBES METAB, V15, P15, DOI 10.1111/j.1463-1326.2012.01663.x; Oda N, 2008, METABOLISM, V57, P268, DOI 10.1016/j.metabol.2007.09.011; Olson MB, 2000, J AM COLL CARDIOL, V36, P1565, DOI 10.1016/S0735-1097(00)00901-3; Onur S, 2005, EUR J ENDOCRINOL, V152, P179, DOI 10.1530/eje.1.01850; Ortega E, 2008, EUR J ENDOCRINOL, V158, P217, DOI 10.1530/EJE-07-0592; Patane G, 2013, ACTA DIABETOL, V50, P851, DOI 10.1007/s00592-013-0458-x; Pitteloud N, 2005, DIABETES CARE, V28, P1636, DOI 10.2337/diacare.28.7.1636; PORTE D, 1969, ARCH INTERN MED, V123, P252, DOI 10.1001/archinte.123.3.252; Poykko SM, 2003, DIABETES, V52, P2546, DOI 10.2337/diabetes.52.10.2546; Radikova Z, 2006, EXP CLIN ENDOCR DIAB, V114, P249, DOI 10.1055/s-2006-924233; Rahmanpour H, 2012, J PEDIATR ADOL GYNEC, V25, P208, DOI 10.1016/j.jpag.2012.02.004; Reinehr T, 2008, HORM RES, V70, P51, DOI 10.1159/000129678; Reinehr T, 2006, J CLIN ENDOCR METAB, V91, P3088, DOI 10.1210/jc.2006-0095; Reinehr T, 2010, MOL CELL ENDOCRINOL, V316, P165, DOI 10.1016/j.mce.2009.06.005; ROBERTSON RP, 1973, DIABETES, V22, P1; Rosenbaum M, 2000, AM J CLIN NUTR, V71, P1421; Seufert J, 1999, J CLIN ENDOCR METAB, V84, P670, DOI 10.1210/jc.84.2.670; Stumvoll M, 2000, DIABETES CARE, V23, P295, DOI 10.2337/diacare.23.3.295; Sun YX, 2007, NEUROENDOCRINOLOGY, V86, P215, DOI 10.1159/000109094; Tong J, 2010, DIABETES, V59, P2145, DOI 10.2337/db10-0504; UEHLINGER DE, 1986, J CARDIOVASC PHARM, V8, P1122, DOI 10.1097/00005344-198611000-00005; Vestergaard ET, 2008, DIABETES, V57, P3205, DOI 10.2337/db08-0025; Wang CH, 2007, J BIOL CHEM, V282, P7991, DOI 10.1074/jbc.M700098200; Wang CX, 2013, J DIABETES RES, V2013, DOI 10.1155/2013/390534; Wang TN, 2013, KAOHSIUNG J MED SCI, V29, P436, DOI 10.1016/j.kjms.2012.08.041; Wang Y, 2010, FEBS LETT, V584, P1503, DOI 10.1016/j.febslet.2010.02.069; Wauters M, 2003, HORM METAB RES, V35, P92, DOI 10.1055/s-2003-39054; WELLE S, 1984, METABOLISM, V33, P837, DOI 10.1016/0026-0495(84)90111-2; Westermann R, 2000, WISSENSCHAFTSTHEORIE, P357; Weyer C, 2013, HYPOADIPONECTINEMIA; Xiang AH, 2014, DIABETOLOGIA, V57, P334, DOI 10.1007/s00125-013-3121-8	73	10	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2015	10	2							e0117865	10.1371/journal.pone.0117865	http://dx.doi.org/10.1371/journal.pone.0117865			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC3LS	25723719	gold, Green Submitted, Green Published			2022-12-27	WOS:000350251200041
J	Li, J; Guo, ZY; Gao, XH; Bian, Q; Jia, M; Lai, XL; Wang, TY; Bian, XL; Wang, HY				Li, Juan; Guo, Zhi Yong; Gao, Xian Hua; Bian, Qi; Jia, Meng; Lai, Xue Li; Wang, Tie Yun; Bian, Xiao Lu; Wang, Hai Yan			Low Molecular Weight Heparin (LMWH) Improves Peritoneal Function and Inhibits Peritoneal Fibrosis Possibly through Suppression of HIF-1 alpha, VEGF and TGF-beta 1	PLOS ONE			English	Article							TGF-BETA; TRANSCRIPTION FACTORS; DIALYSIS SOLUTIONS; EXPRESSION; MODEL; GLYCOSAMINOGLYCANS; ULTRAFILTRATION; TRANSPORT; RAPAMYCIN; RECEPTOR	Background Peritoneal fibrosis is the major cause of ultrafiltration failure, and intraperitoneal administration of Low Molecular Weight Heparin (LMWH) was reported to protect peritoneal function. But the exact mechanism of its influence on peritoneal structure and function is still unknown. Methods A fibrosis model of rat was established by intraperitoneal (IP) administration of PD fluid and Erythromycin Lactobionate. Fifty-two rats were randomly divided into 6 groups: (1) normal control group (CON, n = 6); (2) normal saline group (NS, n = 10); (3) high-glucose group (GLU, n = 10); (4) heparin group (HEP, n = 6); (5) low dose LMWH group (LLMWH, n = 10); (6) high dose LMWH group (HLMWH, n = 10). Two hour peritoneal equilibration test was performed after 28 days of intervention. The peritoneum, mesentery and omentum were harvested, and evaluated by Hematoxylin-Eosin and Masson Trichrome staining. The expressions of HIF-1 alpha, VEGF and TGF-beta 1 in parietal peritoneum were detected by IHC and RT-PCR (Reverse Transcriptase Polymerase Chain Reaction). Results Compared with group CON and NS, ultrafiltration volume and D2/D0 glucose in group GLU decreased significantly, D/Purea (Dialysate-Plasma ratio of urea), D/Palb (Dialysate-Plasma ratio of albumin), peritoneal thickness, neoangiogenesis and inflammatory reaction increased significantly (all P<0.05). Administration of heparin and LMWH markedly alleviated these above pathological changes. The protein and mRNA levels of HIF-1 alpha, VEGF and TGF-beta 1 increased significantly in group GLU, and decreased significantly after administration of LMWH in a dose-dependent manner. Conclusions LMWH ameliorates peritoneal function and inhibits peritoneal fibrosis, possibly through suppression of HIF-1 alpha, VEGF and TGF-beta 1.	[Li, Juan; Guo, Zhi Yong; Bian, Qi; Jia, Meng; Lai, Xue Li; Wang, Tie Yun; Bian, Xiao Lu; Wang, Hai Yan] Second Mil Med Univ, Changhai Hosp, Dept Nephrol, Shanghai 200433, Peoples R China; [Gao, Xian Hua] Second Mil Med Univ, Changhai Hosp, Dept Colorectal Surg, Shanghai 200433, Peoples R China	Naval Medical University; Naval Medical University	Guo, ZY (corresponding author), Second Mil Med Univ, Changhai Hosp, Dept Nephrol, Shanghai 200433, Peoples R China.	zhiyong_guo@126.com	Bian, Qi/GOP-1906-2022	Gao, Xian Hua/0000-0001-8020-6946	National Natural Science Foundation of China [81270773]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the National Natural Science Foundation of China (Grants No. 81270773) (http://www.nsfc.gov.cn/), GZY. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambler DR, 2012, SYST BIOL REPROD MED, V58, P324, DOI 10.3109/19396368.2012.713439; Bazargani F, 2005, PERITON DIALYSIS INT, V25, P394; BAZZATO G, 1995, LANCET, V346, P740; Brimble KS, 2006, J AM SOC NEPHROL, V17, P2591, DOI 10.1681/ASN.2006030194; Diaz-Buxo JA, 2007, PERITON DIALYSIS INT, V27, P16; Fracasso A, 1999, AM J KIDNEY DIS, V33, P105, DOI 10.1016/S0272-6386(99)70264-7; Gozdzikiewicz J, 2009, CLIN APPL THROMB-HEM, V15, P92, DOI 10.1177/1076029607304722; Hao M, 2012, QI LU YI XUE ZA ZHI, V27, P233; Haung Derek, 2009, Biomed Sci Instrum, V45, P340; Lepenies J, 2011, NEPHRON CLIN PRACT, V119, pC97, DOI 10.1159/000324765; Ma FF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035144; Mizuiri S, 2009, AM J NEPHROL, V30, P295, DOI 10.1159/000225929; Qian D, 2004, MOL REPROD DEV, V68, P198, DOI 10.1002/mrd.20061; Saglam F, 2012, RENAL FAILURE, V34, P95, DOI 10.3109/0886022X.2011.623498; Schilte MN, 2009, PERITON DIALYSIS INT, V29, P26; Sekiguchi Y, 2012, J CELL MOL MED, V16, P1934, DOI 10.1111/j.1582-4934.2011.01493.x; Shih SC, 2001, GROWTH FACTORS, V19, P19, DOI 10.3109/08977190109001073; Sjoland JA, 2005, NEPHRON CLIN PRACT, V100, pC105, DOI 10.1159/000085289; Sjoland JA, 2004, NEPHROL DIAL TRANSPL, V19, P1264, DOI 10.1093/ndt/gfh065; Subeq YM, 2011, CYTOKINE, V53, P223, DOI 10.1016/j.cyto.2010.11.004; Tacchini L, 2008, J BIOL CHEM, V283, P20674, DOI 10.1074/jbc.M800365200; Tomino Y, 2012, CLIN EXP NEPHROL, V16, P109, DOI 10.1007/s10157-011-0533-y; TYRRELL DJ, 1995, TRENDS PHARMACOL SCI, V16, P198, DOI 10.1016/S0165-6147(00)89022-7; Ueno M, 2011, AM J PHYSIOL-LUNG C, V300, pL740, DOI 10.1152/ajplung.00146.2010; Xu T, 2012, BLOOD PURIFICAT, V34, P48, DOI 10.1159/000339814; Yao Q, 2008, NEPHRON EXP NEPHROL, V109, pE71, DOI 10.1159/000142529; Zweers MM, 1999, J LAB CLIN MED, V134, P124, DOI 10.1016/S0022-2143(99)90116-6	27	13	14	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2015	10	2							e0118481	10.1371/journal.pone.0118481	http://dx.doi.org/10.1371/journal.pone.0118481			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC3LS	25723475	Green Published, Green Submitted, gold			2022-12-27	WOS:000350251200059
J	Senatore, A; Edirisinghe, N; Katz, PS				Senatore, Adriano; Edirisinghe, Neranjan; Katz, Paul S.			Deep mRNA Sequencing of the Tritonia diomedea Brain Transcriptome Provides Access to Gene Homologues for Neuronal Excitability, Synaptic Transmission and Peptidergic Signalling	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; APLYSIA-CALIFORNICA; ADAPTIVE EVOLUTION; TERRESTRIAL SLUG; SODIUM-CHANNELS; SEQ DATA; LYMNAEA; GABA; PROTEIN; NEUROPEPTIDE	Background The sea slug Tritonia diomedea (Mollusca, Gastropoda, Nudibranchia), has a simple and highly accessible nervous system, making it useful for studying neuronal and synaptic mechanisms underlying behavior. Although many important contributions have been made using Tritonia, until now, a lack of genetic information has impeded exploration at themolecular level. Results We performed Illumina sequencing of central nervous system mRNAs from Tritonia, generating 133.1 million 100 base pair, paired-end reads. De novo reconstruction of the RNA-Seq data yielded a total of 185,546 contigs, which partitioned into 123,154 non-redundant gene clusters (unigenes). BLAST comparison with RefSeq and Swiss-Prot protein databases, as well as mRNA data from other invertebrates (gastropod molluscs: Aplysia californica, Lymnaea stagnalis and Biomphalaria glabrata; cnidarian: Nematostella vectensis) revealed that up to 76,292 unigenes in the Tritonia transcriptome have putative homologues in other databases, 18,246 of which are below a more stringent E-value cut-off of 1x10-6. In silico prediction of secreted proteins from the Tritonia transcriptome shotgun assembly (TSA) produced a database of 579 unique sequences of secreted proteins, which also exhibited markedly higher expression levels compared to other genes in the TSA. Conclusions Our efforts greatly expand the availability of gene sequences available for Tritonia diomedea. We were able to extract full length protein sequences for most queried genes, including those involved in electrical excitability, synaptic vesicle release and neurotransmission, thus confirming that the transcriptome will serve as a useful tool for probing the molecular correlates of behavior in this species. We also generated a neurosecretome database that will serve as a useful tool for probing peptidergic signalling systems in the Tritonia brain.	[Senatore, Adriano; Katz, Paul S.] Georgia State Univ, Inst Neurosci, Atlanta, GA 30303 USA; [Edirisinghe, Neranjan] Georgia State Univ, IS&T, Atlanta, GA 30303 USA	University System of Georgia; Georgia State University; University System of Georgia; Georgia State University	Katz, PS (corresponding author), Georgia State Univ, Inst Neurosci, Atlanta, GA 30303 USA.	pkatz@gsu.edu		Katz, Paul/0000-0003-0786-1287	National Science Foundation [IOS-1120950]; March of Dimes Foundation [6-FY14-441]; Brains and Behavior, Georgia State University; Division Of Integrative Organismal Systems [1120950] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); March of Dimes Foundation(March of Dimes); Brains and Behavior, Georgia State University; Division Of Integrative Organismal Systems(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by National Science Foundation grant no. IOS-1120950 to PSK; March of Dimes Foundation grant no. 6-FY14-441 to PSK; and a Seed grant from Brains and Behavior, Georgia State University to PSK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Bendtsen JD, 2004, PROTEIN ENG DES SEL, V17, P349, DOI 10.1093/protein/gzh037; Bravarenko NI, 2001, EXP BRAIN RES, V141, P340; BUCK LB, 1987, CELL, V51, P127, DOI 10.1016/0092-8674(87)90017-1; CATTERALL WA, 1995, ANNU REV BIOCHEM, V64, P493, DOI 10.1146/annurev.biochem.64.1.493; Clapham DE, 2007, CELL, V131, P1047, DOI 10.1016/j.cell.2007.11.028; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Diaz-Rios M, 2005, J NEUROPHYSIOL, V93, P2142, DOI 10.1152/jn.00003.2004; EAHOLTZ G, 1994, NEURON, V12, P1041, DOI 10.1016/0896-6273(94)90312-3; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Emanuelsson O, 2000, J MOL BIOL, V300, P1005, DOI 10.1006/jmbi.2000.3903; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Fan XM, 1997, J COMP NEUROL, V387, P53, DOI 10.1002/(SICI)1096-9861(19971013)387:1<53::AID-CNE5>3.0.CO;2-M; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Feng ZP, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-451; Fredman D, 2013, NEMATOSTELLA VECTENS; Garg G, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-S7-S8; Gene Ontology Consortium, 2004, NUCLEIC ACIDS RES, V32, pD258, DOI DOI 10.1093/NAR/GKH036; Getting PA, 1989, NEURONAL AND CELLULA; GILLETTE R, 1991, BIOL BULL, V180, P234, DOI 10.2307/1542393; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Gunaratne CA, 2014, J COMP NEUROL, V522, P794, DOI 10.1002/cne.23446; Haas BJ, 2013, NAT PROTOC, V8, P1494, DOI 10.1038/nprot.2013.084; Huang ZX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051279; Ito I, 2004, J NEUROBIOL, V59, P304, DOI 10.1002/neu.10328; JACOB MH, 1984, J NEUROSCI, V4, P1225; Jing J, 2003, J NEUROSCI, V23, P5283; Jorgensen Erik M, 2005, WormBook, P1; Kandel ER, 2001, SCIENCE, V294, P1030, DOI 10.1126/science.1067020; Katz P. S., 2007, SCHOLARPEDIA, V2, P3504; Katz PS., 2009, SCHOLARPEDIA, V4, P3638, DOI [DOI 10.4249/SCHOLARPEDIA.3638, 10.4249/scholarpedia.3638]; KELLETT E, 1994, J NEUROSCI, V14, P6564; Kircher M, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-382; Kiss T, 2011, GEN COMP ENDOCR, V172, P10, DOI 10.1016/j.ygcen.2011.02.016; Kobayashi S, 2008, ACTA BIOL HUNG, V59, P77, DOI 10.1556/ABiol.59.2008.Suppl.12; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; LASEK RJ, 1971, SCIENCE, V172, P278, DOI 10.1126/science.172.3980.278; Lee HO, 2009, GENE DEV, V23, P2461, DOI 10.1101/gad.1829209; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Lillvis JL, 2013, J NEUROSCI, V33, P2709, DOI 10.1523/JNEUROSCI.4196-12.2013; LLOYD PE, 1989, J NEUROSCI, V9, P312; Lloyd PE, 1996, PEPTIDES, V17, P17, DOI 10.1016/0196-9781(95)02093-4; MAHON AC, 1985, P NATL ACAD SCI USA, V82, P3925, DOI 10.1073/pnas.82.11.3925; Marder E, 2001, CURR BIOL, V11, pR986, DOI 10.1016/S0960-9822(01)00581-4; Martin JA, 2011, NAT REV GENET, V12, P671, DOI 10.1038/nrg3068; Martyniuk CJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000894; Matsuo R, 2012, ACTA BIOL HUNG, V63, P171, DOI 10.1556/ABiol.63.2012.Suppl.2.22; Metzker Michael L, 2010, Nat Rev Genet, V11, P31, DOI 10.1038/nrg2626; Moccia F, 2009, INVERTEBR NEUROSCI, V9, P29, DOI 10.1007/s10158-009-0086-x; Moroz LL, 2006, CELL, V127, P1453, DOI 10.1016/j.cell.2006.09.052; NAGLE GT, 1989, PEPTIDES, V10, P849, DOI 10.1016/0196-9781(89)90124-1; NAMBU JR, 1983, CELL, V35, P47, DOI 10.1016/0092-8674(83)90206-4; Norekian TP, 2005, J NEUROPHYSIOL, V93, P305, DOI 10.1152/jn.00722.2004; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Phares GA, 1996, PEPTIDES, V17, P753, DOI 10.1016/0196-9781(96)00081-2; Rizo J, 2008, NAT STRUCT MOL BIOL, V15, P665, DOI 10.1038/nsmb.1450; Romanova EV, 1996, GEN PHARMACOL-VASC S, V27, P1067, DOI 10.1016/0306-3623(95)00122-0; Sadamoto H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042546; SCHAEFER M, 1985, CELL, V41, P457, DOI 10.1016/S0092-8674(85)80019-2; SHYAMALA M, 1986, DNA-J MOLEC CELL BIO, V5, P203, DOI 10.1089/dna.1986.5.203; Simakov O, 2013, NATURE, V493, P526, DOI 10.1038/nature11696; Smit AB, 1996, NEUROSCIENCE, V70, P589, DOI 10.1016/0306-4522(95)00378-9; SMIT AB, 1993, J MOL ENDOCRINOL, V11, P103, DOI 10.1677/jme.0.0110103; SMIT AB, 1993, EUR J BIOCHEM, V215, P397, DOI 10.1111/j.1432-1033.1993.tb18046.x; Smit AB, 2001, NATURE, V411, P261, DOI 10.1038/35077000; Smit AB, 2006, J MOL NEUROSCI, V30, P9, DOI 10.1385/JMN:30:1:9; Soong TW, 2006, TRENDS GENET, V22, P621, DOI 10.1016/j.tig.2006.08.010; Southey BR, 2006, NUCLEIC ACIDS RES, V34, pW267, DOI 10.1093/nar/gkl161; Staras K, 2002, EUR J NEUROSCI, V15, P109, DOI 10.1046/j.0953-816x.2001.01845.x; STRADER CD, 1994, ANNU REV BIOCHEM, V63, P101, DOI 10.1146/annurev.bi.63.070194.000533; Sudhof TC, 2004, ANNU REV NEUROSCI, V27, P509, DOI 10.1146/annurev.neuro.26.041002.131412; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tsang SY, 2007, MOL BIOL EVOL, V24, P599, DOI 10.1093/molbev/msl188; Vijay N, 2013, MOL ECOL, V22, P620, DOI 10.1111/mec.12014; Zakon HH, 2012, P NATL ACAD SCI USA, V109, P10619, DOI 10.1073/pnas.1201884109; Zdobnov EM, 2001, BIOINFORMATICS, V17, P847, DOI 10.1093/bioinformatics/17.9.847; Zhang X, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0040320, 10.1371/journal.pone.0042529]; Zhao QY, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-S14-S2	80	18	18	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2015	10	2							e0118321	10.1371/journal.pone.0118321	http://dx.doi.org/10.1371/journal.pone.0118321			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC2ZH	25719197	Green Published, gold, Green Submitted			2022-12-27	WOS:000350213200045
J	Zhang, YK; Zhu, DF; Zhang, YP; Chen, HZ; Xiang, J; Lin, XQ				Zhang, Yi-Kai; Zhu, De-Feng; Zhang, Yu-Ping; Chen, Hui-Zhe; Xiang, Jing; Lin, Xian-Qing			Low pH-Induced Changes of Antioxidant Enzyme and ATPase Activities in the Roots of Rice (Oryza sativa L.) Seedlings	PLOS ONE			English	Article							MEMBRANE H+-ATPASE; PLASMA-MEMBRANE; HYDROGEN-PEROXIDE; HIGH LIGHT; STRESS; RESPONSES; PLANTS; FERTILIZATION; CHLOROPLASTS; ARABIDOPSIS	Soil acidification is the main problem in the current rice production. Here, the effects of low pH on the root growth, reactive oxygen species metabolism, plasma membrane functions, and the transcript levels of the related genes were investigated in rice seedlings (Oryza sativa L.) in a hydroponic system at pH 3.5, 4.5, and 5.5. There were two hybrid rice cultivars in this trial, including Yongyou 12 (YY12, a japonica hybrid) and Zhongzheyou 1 (ZZY1, an indica hybrid). Higher H+ activity markedly decreased root length, the proportion of fine roots, and dry matter production, but induced a significant accumulation of hydrogen peroxide (H2O2), and led to serious lipid peroxidation in the roots of the two varieties. The transcript levels of copper/zinc superoxide dismutase 1 (Cu/Zn SOD1), copper/zinc superoxide dismutase 2 (Cu/Zn SOD2), catalase A (CATA) and catalase B (CATB) genes in YY12 and ZZY1 roots were significantly down-regulated after low pH exposure for two weeks. Meanwhile, a significant decrease was observed in the expression of the P-type Ca2+-ATPases in roots at pH 3.5. The activities of antioxidant enzymes (SOD, CAT) and plasma membrane (PM) Ca2+-ATPase in the two varieties were dramatically inhibited by strong rhizosphere acidification. However, the expression levels of ascorbate peroxidase 1 (APX1) and PM H+-ATPase isoform 7 were up-regulated under H+ stress compared with the control. Significantly higher activities of APX and PM H+-ATPase could contribute to the adaptation of rice roots to low pH.	[Zhang, Yi-Kai; Zhu, De-Feng; Zhang, Yu-Ping; Chen, Hui-Zhe; Xiang, Jing; Lin, Xian-Qing] China Natl Rice Res Inst, State Key Lab Rice Biol, Hangzhou 310006, Zhejiang, Peoples R China	Chinese Academy of Agricultural Sciences; China National Rice Research Institute, CAAS	Zhu, DF (corresponding author), China Natl Rice Res Inst, State Key Lab Rice Biol, Hangzhou 310006, Zhejiang, Peoples R China.	cnrice@qq.com			Agricultural Scientific and Technological Innovation project of Chinese Academy of Agricultural Sciences [CAAS-ASTIP-2013-CNRRI]; China Agricultural Research System [CARS-01-10B]; Special Fund for Agroscientific Research in the Public Interest [201003016]	Agricultural Scientific and Technological Innovation project of Chinese Academy of Agricultural Sciences; China Agricultural Research System; Special Fund for Agroscientific Research in the Public Interest	This work was supported by Agricultural Scientific and Technological Innovation project of Chinese Academy of Agricultural Sciences (CAAS-ASTIP-2013-CNRRI), China Agricultural Research System (CARS-01-10B) and Special Fund for Agroscientific Research in the Public Interest (201003016). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad P, 2010, CRIT REV BIOTECHNOL, V30, P161, DOI 10.3109/07388550903524243; Ahn SJ, 2004, NEW PHYTOL, V162, P71, DOI 10.1111/j.1469-8137.2004.01009.x; Ahn SJ, 2002, J EXP BOT, V53, P1959, DOI 10.1093/jxb/erf049; Arango M, 2003, PLANTA, V216, P355, DOI 10.1007/s00425-002-0856-8; Asada K, 1999, ANNU REV PLANT PHYS, V50, P601, DOI 10.1146/annurev.arplant.50.1.601; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRISKIN DP, 1987, METHOD ENZYMOL, V148, P542; CAKMAK I, 1992, PLANT PHYSIOL, V98, P1222, DOI 10.1104/pp.98.4.1222; Chen J, 2013, PLANT PHYSIOL BIOCH, V64, P41, DOI 10.1016/j.plaphy.2012.12.012; Chen J, 2013, PLANT SOIL, V362, P301, DOI 10.1007/s11104-012-1275-7; FELLE H, 1988, PHYSIOL PLANTARUM, V74, P583, DOI 10.1111/j.1399-3054.1988.tb02022.x; Foy C.D., 1984, AGRON MON, V12, P57, DOI DOI 10.2134/AGR0NM0N0GR12.2ED.C2; GUERN J, 1991, INT REV CYTOL, V127, P111; Guo JH, 2010, SCIENCE, V327, P1008, DOI 10.1126/science.1182570; He LongFei, 2001, Scientia Agricultura Sinica, V34, P526; HEATH RL, 1968, ARCH BIOCHEM BIOPHYS, V125, P189, DOI 10.1016/0003-9861(68)90654-1; Jagels R, 2002, ATMOS RES, V64, P169, DOI 10.1016/S0169-8095(02)00089-3; KASAMO K, 1986, PLANT CELL PHYSIOL, V27, P49; Kochian LV, 2004, ANNU REV PLANT BIOL, V55, P459, DOI 10.1146/annurev.arplant.55.031903.141655; Koyama H, 2001, J EXP BOT, V52, P361, DOI 10.1093/jexbot/52.355.361; Liu EU, 2011, WATER AIR SOIL POLL, V215, P127, DOI 10.1007/s11270-010-0464-3; Liu TT, 2011, BIOL TRACE ELEM RES, V144, P1186, DOI 10.1007/s12011-011-9053-6; Maeda H, 2008, PLANT CELL, V20, P452, DOI 10.1105/tpc.107.054718; MEAD JF, 1976, FREE RADICALS BIOLOG, V1, P51; MICHELET B, 1995, PLANT PHYSIOL, V108, P1, DOI 10.1104/pp.108.1.1; Mittler R, 2002, TRENDS PLANT SCI, V7, P405, DOI 10.1016/S1360-1385(02)02312-9; Morsomme P, 2000, BBA-BIOMEMBRANES, V1465, P1, DOI 10.1016/S0005-2736(00)00128-0; NAKANO Y, 1981, PLANT CELL PHYSIOL, V22, P867; OHNISHI T, 1975, ANAL BIOCHEM, V69, P261, DOI 10.1016/0003-2697(75)90585-0; Palmgren MG, 1999, J EXP BOT, V50, P883, DOI 10.1093/jexbot/50.suppl_1.883; Pandhair V, 2006, J PLANT BIOCHEM BIOT, V15, P71, DOI 10.1007/BF03321907; PATTERSON BD, 1984, ANAL BIOCHEM, V139, P487, DOI 10.1016/0003-2697(84)90039-3; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Rao KVM, 2000, PLANT SCI, V157, P113, DOI 10.1016/S0168-9452(00)00273-9; Rossel JB, 2006, PLANT CELL ENVIRON, V29, P269, DOI 10.1111/j.1365-3040.2005.01419.x; Russell AE, 2006, SOIL SCI SOC AM J, V70, P249, DOI 10.2136/sssaj2005.0058; SCANDALIOS JG, 1993, PLANT PHYSIOL, V101, P7, DOI 10.1104/pp.101.1.7; SCHUBERT S, 1990, PLANT SOIL, V124, P239, DOI 10.1007/BF00009266; Serrano R., 1990, The plant plasma membrane., P127; Shi QingHua, 2006, Agricultural Sciences in China, V5, P767, DOI 10.1016/S1671-2927(06)60122-3; Veselov AP, 2002, RUSS J PLANT PHYSL+, V49, P344, DOI 10.1023/A:1015540918588; Yan F, 1998, PLANT PHYSIOL, V117, P311, DOI 10.1104/pp.117.1.311; Yoshida S., 1976, LABORATORY MANUAL FO; Zhang HM, 2009, PEDOSPHERE, V19, P199, DOI 10.1016/S1002-0160(09)60109-0; Zhu YY, 2009, PLANT CELL ENVIRON, V32, P1428, DOI 10.1111/j.1365-3040.2009.02009.x	45	32	37	2	68	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2015	10	2							e0116971	10.1371/journal.pone.0116971	http://dx.doi.org/10.1371/journal.pone.0116971			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC2ZH	25719552	Green Published, Green Submitted, gold			2022-12-27	WOS:000350213200014
J	Brooks, FJ; Grigsby, PW				Brooks, Frank J.; Grigsby, Perry W.			Low-Order Non-Spatial Effects Dominate Second-Order Spatial Effects in the Texture Quantifier Analysis of 18F-FDG-PET Images	PLOS ONE			English	Article							TUMOR HETEROGENEITY; FEATURES; CANCER; PET; INFORMATION; VOLUMES	Background There is increasing interest in applying image texture quantifiers to assess the intra-tumor heterogeneity observed in FDG-PET images of various cancers. Use of these quantifiers as prognostic indicators of disease outcome and/or treatment response has yielded inconsistent results. We study the general applicability of some well-established texture quantifiers to the image data unique to FDG-PET. Methods We first created computer-simulated test images with statistical properties consistent with clinical image data for cancers of the uterine cervix. We specifically isolated second-order statistical effects from low-order effects and analyzed the resulting variation in common texture quantifiers in response to contrived image variations. We then analyzed the quantifiers computed for FIGOIIb cervical cancers via receiver operating characteristic (ROC) curves and via contingency table analysis of detrended quantifier values. Results We found that image texture quantifiers depend strongly on low-effects such as tumor volume and SUV distribution. When low-order effects are controlled, the image texture quantifiers tested were not able to discern only the second-order effects. Furthermore, the results of clinical tumor heterogeneity studies might be tunable via choice of patient population analyzed. Conclusion Some image texture quantifiers are strongly affected by factors distinct from the second-order effects researchers ostensibly seek to assess via those quantifiers.	[Brooks, Frank J.; Grigsby, Perry W.] Washington Univ, Sch Med, Dept Radiat Oncol, St Louis, MO 63130 USA; [Grigsby, Perry W.] Washington Univ, Med Ctr, Mallinckrodt Inst Radiol, Div Nucl Med, St Louis, MO 63110 USA; [Grigsby, Perry W.] Washington Univ, Med Ctr, Dept Obstet & Gynecol, St Louis, MO USA; [Grigsby, Perry W.] Washington Univ, Med Ctr, Alvin J Siteman Canc Ctr, St Louis, MO USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Siteman Cancer Center; Washington University (WUSTL)	Brooks, FJ (corresponding author), Washington Univ, Sch Med, Dept Radiat Oncol, St Louis, MO 63130 USA.	fjbrooks@wustl.edu	Brooks, Frank/AAM-3677-2021		National Institutes of Health [1R01-CA136931-01A2]; NATIONAL CANCER INSTITUTE [R01CA136931] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the National Institutes of Health under Grant 1R01-CA136931-01A2, http://www.nih.gov. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMADASUN M, 1989, IEEE T SYST MAN CYB, V19, P1264, DOI 10.1109/21.44046; Bagci U, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057105; Brooks FJ, 2013, RADIAT ONCOL, V8, DOI 10.1186/1748-717X-8-294; Brooks FJ, 2014, J NUCL MED, V55, P37, DOI 10.2967/jnumed.112.116715; Brooks FJ, 2013, EUR J NUCL MED MOL I, V40, P1292, DOI 10.1007/s00259-013-2430-y; Cook GJR, 2013, J NUCL MED, V54, P19, DOI 10.2967/jnumed.112.107375; Dong XZ, 2013, NUCL MED COMMUN, V34, P40, DOI 10.1097/MNM.0b013e32835ae50c; El Naqa I, 2009, PATTERN RECOGN, V42, P1162, DOI 10.1016/j.patcog.2008.08.011; FIDLER IJ, 1978, CANCER RES, V38, P2651; Gonzalez R. C., 2006, PEARSON ED, V3rd, P8; Hanusiak RK, 2012, INT J DOC ANAL RECOG, V15, P213, DOI 10.1007/s10032-011-0166-4; HARALICK RM, 1973, IEEE T SYST MAN CYB, VSMC3, P610, DOI 10.1109/TSMC.1973.4309314; HEPPNER GH, 1984, CANCER RES, V44, P2259; Hernandez B, 2007, COMPUT VIS IMAGE UND, V106, P258, DOI 10.1016/j.cviu.2006.08.012; Lartizien C, 2013, IEEE J BIOMED HEALTH, DOI [10.1109/JBHI.2013.2261819, DOI 10.1109/JBHI.2013.2261819]; Laws K. I., 1980, Proceedings of the Society of Photo-Optical Instrumentation Engineers, V238, P376; LOH HH, 1988, IEEE T IND ELECTRON, V35, P323, DOI 10.1109/41.192665; Marusyk A, 2012, NAT REV CANCER, V12, P323, DOI 10.1038/nrc3261; Miller TR, 2002, INT J RADIAT ONCOL, V53, P353, DOI 10.1016/S0360-3016(02)02705-0; Nielsen B, 2006, CELL ONCOL, V28, P85; Orlhac F, 2014, J NUCL MED, V55, P414, DOI 10.2967/jnumed.113.129858; Robin X, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-77; ROLLAND JP, 1992, J OPT SOC AM A, V9, P649, DOI 10.1364/JOSAA.9.000649; Sonka Milan, 2014, CENGAGE LEARNING, DOI DOI 10.1007/978-1-4899-3216-7; Soussan M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094017; Tan S, 2013, INT J RADIAT ONCOL, V85, P1375, DOI 10.1016/j.ijrobp.2012.10.017; Tang I, 2011, IEEE T INTELL TRANSP, V12, P476, DOI 10.1109/TITS.2010.2095499; Tang XO, 1998, IEEE T IMAGE PROCESS, V7, P1602, DOI 10.1109/83.725367; Thibault G, 2009, PATTERN RECOGNITION; Tixier F, 2012, J NUCL MED, V53, P693, DOI 10.2967/jnumed.111.099127; Tixier F, 2011, J NUCL MED, V52, P369, DOI 10.2967/jnumed.110.082404; Vaidya M, 2012, RADIOTHER ONCOL, V102, P239, DOI 10.1016/j.radonc.2011.10.014; Wang HJ, 2013, NUCL SCI TECH, V24; Yang F, 2013, ENVIRON TECHNOL, V34, P2951, DOI 10.1080/09593330.2013.796008	34	11	11	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2015	10	2							e0116574	10.1371/journal.pone.0116574	http://dx.doi.org/10.1371/journal.pone.0116574			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC2IM	25714472	Green Published, Green Submitted, gold			2022-12-27	WOS:000350168700020
J	Yu, TS; Kim, A; Kernie, SG				Yu, Tzong-Shiue; Kim, Ahleum; Kernie, Steven G.			Donepezil Rescues Spatial Learning and Memory Deficits following Traumatic Brain Injury Independent of Its Effects on Neurogenesis	PLOS ONE			English	Article							ADULT HIPPOCAMPAL NEUROGENESIS; GROWTH-FACTOR-I; PATTERN SEPARATION; MICE; RATS	Traumatic brain injury (TBI) is ubiquitous and effective treatments for it remain supportive largely due to uncertainty over how endogenous repair occurs. Recently, we demonstrated that hippocampal injury-induced neurogenesis is one mechanism underlying endogenous repair following TBI. Donepezil is associated with increased hippocampal neurogenesis and has long been known to improve certain aspects of cognition following many types of brain injury through unknown mechanisms. By coupling donepezil therapy with temporally regulated ablation of injury-induced neurogenesis using nestin-HSV transgenic mice, we investigated whether the pro-cognitive effects of donepezil following injury might occur through increasing neurogenesis. We demonstrate that donepezil itself enhances neurogenesis and improves cognitive function following TBI, even when injury-induced neurogenesis was inhibited. This suggests that the therapeutic effects of donepezil in TBI occur separately from its effects on neurogenesis.	[Kernie, Steven G.] Columbia Univ, Coll Phys & Surg, Dept Pediat, New York, NY 10032 USA; Columbia Univ, Coll Phys & Surg, Dept Pathol & Cell Biol, New York, NY 10032 USA	Columbia University; Columbia University	Kernie, SG (corresponding author), Columbia Univ, Coll Phys & Surg, Dept Pediat, 3959 Broadway,CHN 10-24, New York, NY 10032 USA.	sk3516@columbia.edu	Kernie, Steven/AAT-9912-2020	Kernie, Steven/0000-0003-1371-0549; Yu, Tzong-Shiue/0000-0003-4277-6213	National Institutes of Health [R21 NS083077]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS083077] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	National Institutes of Health R21 NS083077, SK, TY, AK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akers KG, 2014, SCIENCE, V344, P598, DOI 10.1126/science.1248903; Ballesteros J, 2008, J HEAD TRAUMA REHAB, V23, P171, DOI 10.1097/01.HTR.0000319935.99837.96; Blaiss CA, 2011, J NEUROSCI, V31, P4906, DOI 10.1523/JNEUROSCI.5265-10.2011; Bruel-Jungerman E, 2011, BEHAV BRAIN RES, V221, P379, DOI 10.1016/j.bbr.2011.01.021; Creer DJ, 2010, P NATL ACAD SCI USA, V107, P2367, DOI 10.1073/pnas.0911725107; DIXON CE, 1991, J NEUROSCI METH, V39, P253; Dou JT, 2005, LEARN MEMORY, V12, P646, DOI 10.1101/lm.88005; Itou Y, 2011, HIPPOCAMPUS, V21, P446, DOI 10.1002/hipo.20761; Kaneko N, 2006, GENES CELLS, V11, P1145, DOI 10.1111/j.1365-2443.2006.01010.x; Kernie SG, 2001, J NEUROSCI RES, V66, P317, DOI 10.1002/jnr.10013; Kotani S, 2008, CHEM-BIOL INTERACT, V175, P227, DOI 10.1016/j.cbi.2008.04.004; Miles DK, 2008, HIPPOCAMPUS, V18, P793, DOI 10.1002/hipo.20439; Narimatsu N, 2009, J PHARMACOL EXP THER, V330, P2, DOI 10.1124/jpet.108.147280; Olsen AS, 2012, J NEUROTRAUM, V29, P1898, DOI 10.1089/neu.2012.2358; Sahay A, 2011, NATURE, V472, P466, DOI 10.1038/nature09817; Shaw KE, 2013, J NEUROTRAUM, V30, P557, DOI 10.1089/neu.2012.2782; Shelton SB, 2008, J NEUROSCI METH, V168, P431, DOI 10.1016/j.jneumeth.2007.11.003; Sonntag WE, 2005, AGEING RES REV, V4, P195, DOI 10.1016/j.arr.2005.02.001; van Praag H, 2005, J NEUROSCI, V25, P8680, DOI 10.1523/JNEUROSCI.1731-05.2005; Yu SJ, 2009, BRAIN RES, V1287, P157, DOI 10.1016/j.brainres.2009.06.067; Yu TS, 2008, J NEUROSCI, V28, P12901, DOI 10.1523/JNEUROSCI.4629-08.2008	21	22	22	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2015	10	2							e0118793	10.1371/journal.pone.0118793	http://dx.doi.org/10.1371/journal.pone.0118793			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC2IM	25714524	gold, Green Published, Green Submitted			2022-12-27	WOS:000350168700100
J	Kumar, CSC; Loh, WS; Chandraju, S; Win, YF; Tan, WK; Quah, CK; Fun, HK				Kumar, C. S. Chidan; Loh, Wan-Sin; Chandraju, Siddegowda; Win, Yip-Foo; Tan, Weng Kang; Quah, Ching Kheng; Fun, Hoong-Kun			Synthesis, Structural and Antioxidant Studies of Some Novel N-Ethyl Phthalimide Esters	PLOS ONE			English	Article							DERIVATIVES; DESIGN	A series of N-ethyl phthalimide esters 4(a-n) were synthesized and characterized by spectroscopic studies. Further, the molecular structure of majority of compounds were analysed by single crystal X-ray diffraction studies. The X-ray analysis revealed the importance of substituents on the crystal stability and molecular packing. All the synthesized compounds were tested for in vitro antioxidant activity by DPPH radical scavenging, FRAP and CUPRAC methods. Few of them have shown good antioxidant activity.	[Kumar, C. S. Chidan; Loh, Wan-Sin; Quah, Ching Kheng; Fun, Hoong-Kun] Univ Sains Malaysia, Sch Phys, Xray Crystallog Unit, George Town, Malaysia; [Kumar, C. S. Chidan] Alvas Inst Engn & Technol, Dept Chem, Mijar, Karnataka, India; [Chandraju, Siddegowda] Univ Mysore, Sir MV PG Ctr, Dept Sugar Technol & Chem, Tubinakere, Karnataka, India; [Win, Yip-Foo] Univ Tunku Abdul Rahman, Fac Sci, Dept Chem Sci, Bandar Barat, Perak, Malaysia; [Tan, Weng Kang] Klin Kesihatan Batu Kawa, Kuching, Sarawak, Malaysia; [Fun, Hoong-Kun] King Saud Univ, Coll Pharm, Dept Pharmaceut Chem, Riyadh 11451, Saudi Arabia	Universiti Sains Malaysia; University of Mysore; Universiti Tunku Abdul Rahman (UTAR); King Saud University	Kumar, CSC (corresponding author), Univ Sains Malaysia, Sch Phys, Xray Crystallog Unit, George Town, Malaysia.	chidankumar@gmail.com; ckquah@usm.my	Quah, Ching Kheng/A-5525-2009; Loh, Wansin/C-7581-2009; Fun, Hoong-Kun/A-3561-2009	Quah, Ching Kheng/0000-0002-3279-4349; Loh, Wansin/0000-0003-4718-0363; 	Universiti Sains Malaysia (USM); Malaysian Government; USM for Fundamental Research Grant Scheme (FRGS) [203/PFIZIK/6711411]; Deanship of Scientific Research at King Saud University [RGP VPP-207]	Universiti Sains Malaysia (USM)(Universiti Sains Malaysia); Malaysian Government; USM for Fundamental Research Grant Scheme (FRGS); Deanship of Scientific Research at King Saud University(King Saud University)	CSCK thanks Universiti Sains Malaysia (USM) for a postdoctoral research fellowship. WSL thanks Malaysian Government for MyBrain15 (MyPhD) scholarship. CKQ thanks Malaysian Government and USM for Fundamental Research Grant Scheme (FRGS) (203/PFIZIK/6711411). The authors extend their appreciation to The Deanship of Scientific Research at King Saud University for the funding the work through the research group project No. RGP VPP-207. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antunes R, 1998, BIOORG MED CHEM LETT, V8, P3071, DOI 10.1016/S0960-894X(98)00558-7; Apak R, 2008, MICROCHIM ACTA, V160, P413, DOI 10.1007/s00604-007-0777-0; Babu IS, 2013, PHARM CHEM, V5, P198; BAILLEUX V, 1994, CHEM PHARM BULL, V42, P1817; BERNSTEIN J, 1995, ANGEW CHEM INT EDIT, V34, P1555, DOI 10.1002/anie.199515551; Bruker AXS Inc, 2009, SAINT SADABS; Dolomanov OV, 2009, J APPL CRYSTALLOGR, V42, P339, DOI 10.1107/S0021889808042726; Heller E, 2009, TETRAHEDRON LETT, V50, P1321, DOI 10.1016/j.tetlet.2009.01.035; Kumar CSC, 2014, Z KRIST-CRYST MATER, V229, P328, DOI 10.1515/zkri-2013-1709; Lai LS, 2001, J AGR FOOD CHEM, V49, P963, DOI 10.1021/jf001146k; Machado AL, 2005, BIOORG MED CHEM LETT, V15, P1169, DOI 10.1016/j.bmcl.2004.12.012; OYAIZU M, 1986, Japanese Journal of Nutrition, V44, P307; Pavia D.L., 2001, INTRO SPECTROSCOPY, Vthird; Pozharskii F, 1997, HETEROCYCLES LIFE SO, P301, DOI [10.1002/prac.19983400517, DOI 10.1002/PRAC.19983400517]; Salat K, 2013, MINI-REV MED CHEM, V13, P335; Samee W, 2011, AFR J PHARM PHARMACO, V5, P477, DOI 10.5897/AJPP10.156; Sena Vera L. M., 2003, Farmaco (Lausanne), V58, P1283, DOI 10.1016/S0014-827X(03)00185-X; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; Toth G, 2007, CURR PHARM DESIGN, V13, P3476, DOI 10.2174/138161207782794284; Vogel AI, 1998, TXB PRACTICAL ORGANI, P1065; Zamani K, 2005, TURK J CHEM, V29, P171; Zhang QS, 2012, J AM CHEM SOC, V134, P14706, DOI 10.1021/ja306538w	22	11	11	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2015	10	3							e0119440	10.1371/journal.pone.0119440	http://dx.doi.org/10.1371/journal.pone.0119440			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9KG	25742494	Green Submitted, Green Accepted, Green Published, gold			2022-12-27	WOS:000350688100112
J	Nieto-Gonzalez, JL; Holm, MM; Vardya, I; Christensen, T; Wiborg, O; Jensen, K				Nieto-Gonzalez, Jose Luis; Holm, Mai Marie; Vardya, Irina; Christensen, Trine; Wiborg, Ove; Jensen, Kimmo			Presynaptic Plasticity as a Hallmark of Rat Stress Susceptibility and Antidepressant Response	PLOS ONE			English	Article							CHRONIC MILD STRESS; NEUROTRANSMITTER RELEASE; CHROMATIN REGULATION; MODEL; DEPRESSION; HIPPOCAMPUS; RESILIENCE; ESCITALOPRAM; RESISTANCE; DRUG	Two main questions are important for understanding and treating affective disorders: why are certain individuals susceptible or resilient to stress, and what are the features of treatment response and resistance? To address these questions, we used a chronic mild stress (CMS) rat model of depression. When exposed to stress, a fraction of rats develops anhedonic-like behavior, a core symptom of major depression, while another subgroup of rats is resilient to CMS. Furthermore, the anhedonic-like state is reversed in about half the animals in response to chronic escitalopram treatment (responders), while the remaining animals are resistant (non-responder animals). Electrophysiology in hippocampal brain slices was used to identify a synaptic hallmark characterizing these groups of animals. Presynaptic properties were investigated at GABAergic synapses onto single dentate gyrus granule cells. Stress-susceptible rats displayed a reduced probability of GABA release judged by an altered paired-pulse ratio of evoked inhibitory postsynaptic currents (IPSCs) (1.48 +/- 0.25) compared with control (0.81 +/- 0.05) and stress-resilient rats (0.78 +/- 0.03). Spontaneous IPSCs (sIPSCs) occurred less frequently in stress-susceptible rats compared with control and resilient rats. Finally, a subset of stress-susceptible rats responding to selective serotonin reuptake inhibitor (SSRI) treatment showed a normalization of the paired-pulse ratio (0.73 +/- 0.06) whereas non-responder rats showed no normalization (1.2 +/- 0.2). No changes in the number of parvalbumin-positive interneurons were observed. Thus, we provide evidence for a distinct GABAergic synaptopathy which associates closely with stress-susceptibility and treatment-resistance in an animal model of depression.	[Nieto-Gonzalez, Jose Luis; Holm, Mai Marie; Vardya, Irina; Jensen, Kimmo] Aarhus Univ, Dept Biomed, Synapt Physiol Lab, DK-8000 Aarhus C, Denmark; [Christensen, Trine; Wiborg, Ove; Jensen, Kimmo] Aarhus Univ Hosp, Translat Neuropsychiat Unit, DK-8240 Risskov, Denmark; [Jensen, Kimmo] Gothenburg Univ, Sahlgrenska Acad, Inst Neurosci & Physiol, Gothenburg, Sweden	Aarhus University; Aarhus University; University of Gothenburg	Nieto-Gonzalez, JL (corresponding author), Aarhus Univ, Dept Biomed, Synapt Physiol Lab, Bldg 1160, DK-8000 Aarhus C, Denmark.	jlnieto@us.es	Nieto-Gonzalez, Jose L/B-7165-2013	Nieto-Gonzalez, Jose L/0000-0003-1757-4951; Jensen, Kimmo/0000-0001-8895-6194; Holm, Mai/0000-0001-7347-8724	Lundbeck Foundation; Danish MRC; Velux Foundation; Lundbeck Foundation [R67-2010-6537] Funding Source: researchfish	Lundbeck Foundation(Lundbeckfonden); Danish MRC(Danish Medical Research Council); Velux Foundation(Velux Fonden); Lundbeck Foundation(Lundbeckfonden)	The present study was supported by the Lundbeck Foundation, The Danish MRC and the Velux Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bergstrom A, 2007, J MOL NEUROSCI, V33, P201, DOI 10.1007/s12031-007-0065-9; Bergstrom A, 2008, BRAIN RES, V1196, P41, DOI 10.1016/j.brainres.2007.12.025; Bisgaard CF, 2007, J MOL NEUROSCI, V32, P132, DOI 10.1007/s12031-007-0025-4; Brambilla P, 2003, MOL PSYCHIATR, V8, P721, DOI 10.1038/sj.mp.4001362; Cabezas C, 2006, J NEUROPHYSIOL, V95, P3024, DOI 10.1152/jn.00739.2005; Christensen T, 2011, NEUROSCIENCE, V196, P66, DOI 10.1016/j.neuroscience.2011.08.024; Christiansen S, 2012, STRESS, V15, P647, DOI 10.3109/10253890.2011.654370; Czeh B, 2005, NEUROPSYCHOPHARMACOL, V30, P67, DOI 10.1038/sj.npp.1300581; Deng LB, 2011, NEURON, V69, P317, DOI 10.1016/j.neuron.2011.01.005; Drasbek KR, 2006, CEREB CORTEX, V16, P1134, DOI 10.1093/cercor/bhj055; Fanselow MS, 2010, NEURON, V65, P7, DOI 10.1016/j.neuron.2009.11.031; Farrant M, 2005, NAT REV NEUROSCI, V6, P215, DOI 10.1038/nrn1625; Feder A, 2009, NAT REV NEUROSCI, V10, P446, DOI 10.1038/nrn2649; Gao SF, 2011, NEUROSCIENTIST, V17, P124, DOI 10.1177/1073858410361780; Girotti M, 2006, NEUROSCIENCE, V138, P1067, DOI 10.1016/j.neuroscience.2005.12.002; Gorman Jack M, 2006, Gend Med, V3, P93, DOI 10.1016/S1550-8579(06)80199-3; Han YY, 2011, NEURON, V69, P304, DOI 10.1016/j.neuron.2010.12.014; Hasler G, 2007, ARCH GEN PSYCHIAT, V64, P193, DOI 10.1001/archpsyc.64.2.193; Hefft S, 2005, NAT NEUROSCI, V8, P1319, DOI 10.1038/nn1542; Henningsen K, 2009, BEHAV BRAIN RES, V198, P136, DOI 10.1016/j.bbr.2008.10.039; Hoge EA, 2007, DEPRESS ANXIETY, V24, P139, DOI 10.1002/da.20175; Holderbach R, 2007, BIOL PSYCHIAT, V62, P92, DOI 10.1016/j.biopsych.2006.07.007; Holm MM, 2011, HIPPOCAMPUS, V21, P422, DOI 10.1002/hipo.20758; Holm MM, 2009, J NEUROSCI, V29, P12412, DOI 10.1523/JNEUROSCI.2978-09.2009; Hu W, 2010, NEUROPSYCHOPHARMACOL, V35, P1693, DOI 10.1038/npp.2010.31; Huang FS, 2007, EUR J NEUROSCI, V25, P3253, DOI 10.1111/j.1460-9568.2007.05539.x; Jayatissa MN, 2008, NEUROPHARMACOLOGY, V54, P530, DOI 10.1016/j.neuropharm.2007.11.009; Jayatissa MN, 2006, NEUROPSYCHOPHARMACOL, V31, P2395, DOI 10.1038/sj.npp.1301041; Joels M, 2008, EUR J PHARMACOL, V583, P312, DOI 10.1016/j.ejphar.2007.11.064; Kennedy SH, 2006, J PSYCHIATR NEUROSCI, V31, P122; Klausberger T, 2008, SCIENCE, V321, P53, DOI 10.1126/science.1149381; Krishnan V, 2007, CELL, V131, P391, DOI 10.1016/j.cell.2007.09.018; Levinson AJ, 2010, BIOL PSYCHIAT, V67, P458, DOI 10.1016/j.biopsych.2009.09.025; Luscher B, 2011, MOL PSYCHIATR, V16, P383, DOI 10.1038/mp.2010.120; Maguire JL, 2005, NAT NEUROSCI, V8, P797, DOI 10.1038/nn1469; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; Regehr WG, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a005702; Schoch S, 2002, NATURE, V415, P321, DOI 10.1038/415321a; Stetler C, 2011, PSYCHOSOM MED, V73, P114, DOI 10.1097/PSY.0b013e31820ad12b; Tsankova NM, 2006, NAT NEUROSCI, V9, P519, DOI 10.1038/nn1659; Uchida S, 2010, J NEUROSCI, V30, P15007, DOI 10.1523/JNEUROSCI.1436-10.2010; Wiborg O, 2013, CELL TISSUE RES, V354, P155, DOI 10.1007/s00441-013-1664-0; Wilkinson MB, 2009, J NEUROSCI, V29, P7820, DOI 10.1523/JNEUROSCI.0932-09.2009; Williams SR, 1998, J PHYSIOL-LONDON, V510, P477, DOI 10.1111/j.1469-7793.1998.477bk.x; Willner P, 2005, NEUROPSYCHOBIOLOGY, V52, P90, DOI 10.1159/000087097; Wood SK, 2010, ENDOCRINOLOGY, V151, P1795, DOI 10.1210/en.2009-1026; Zucker RS, 2002, ANNU REV PHYSIOL, V64, P355, DOI 10.1146/annurev.physiol.64.092501.114547	47	20	21	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2015	10	3							e0119993	10.1371/journal.pone.0119993	http://dx.doi.org/10.1371/journal.pone.0119993			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9KG	25742132	Green Published, gold, Green Submitted			2022-12-27	WOS:000350688100131
J	Bernhardt, AM; Wilking, C; Gilbert-Diamond, D; Emond, JA; Sargent, JD				Bernhardt, Amy M.; Wilking, Cara; Gilbert-Diamond, Diane; Emond, Jennifer A.; Sargent, James D.			Children's Recall of Fast Food Television Advertising-Testing the Adequacy of Food Marketing Regulation	PLOS ONE			English	Article								Background and Aim In the United States, the fast food companies McDonald's and Burger King participate in marketing self-regulation programs that aim to limit emphasis on premiums and promote emphasis of healthy food choices. We determine what children recall from fast food television advertisements aired by these companies. Methods One hundred children aged 3-7 years were shown McDonald's and Burger King children's (MDC & BKC) and adult (MDA & BKA) meal ads, randomly drawn from ads that aired on national US television from 2010-11. Immediately after seeing the ad, children were asked to recall what they had seen and transcripts evaluated for descriptors of food, healthy food (apples or milk), and premiums/tie-ins. Results Premiums/tie-ins were common in children's but rarely appeared in adult ads, and all children's ads contained images of healthy foods (apples and milk). Participants were significantly less likely to recall any food after viewing the children's vs. the adult ad (MDC 32% [95% confidence interval 23, 41] vs. MDA 68% [59, 77]) p < 0.001; BKC 46% [39, 56] vs. BKA 67% [58, 76] respectively, p = 0.002). For children's ads alone and for both restaurants, recall frequency for all food was not significantly different from premium/tie-ins, and participants were significantly more likely to recall other food items than apples or milk. Moreover, premiums/tie-ins were recalled much more frequently than healthy food (MDC 45% [35, 55] vs. 9% [3, 15] p< 0.001; BKC 54% [44, 64] vs. 2% [0, 5] respectively, p< 0.001). Conclusions Children's net impressions of television fast food advertising indicate that industry self-regulation failed to achieve a de-emphasis on toy premiums and tie-ins and did not adequately communicate healthy menu choices. The methods devised for this study could be used to monitor and better regulate advertising patterns of practice.	[Bernhardt, Amy M.; Gilbert-Diamond, Diane; Emond, Jennifer A.; Sargent, James D.] Norris Cotton Canc Ctr, Geisel Sch Med Dartmouth, Lebanon, NH 03766 USA; [Wilking, Cara] Northeastern Univ, Sch Law, Publ Hlth Advocacy Inst, Boston, MA 02115 USA; [Gilbert-Diamond, Diane; Emond, Jennifer A.; Sargent, James D.] Geisel Sch Med Dartmouth, Dept Community & Family Med, Lebanon, NH USA; [Sargent, James D.] Geisel Sch Med Dartmouth, Dept Pediat, Lebanon, NH USA	Dartmouth College; Norris Cotton Cancer Center; Northeastern University; Dartmouth College; Dartmouth College	Sargent, JD (corresponding author), Norris Cotton Canc Ctr, Geisel Sch Med Dartmouth, Lebanon, NH 03766 USA.	james.d.sargent@dartmouth.edu	Sargent, James D/I-2773-2013		Robert Wood Johnson Foundation Healthy Eating Research Program [69552]; Prouty research program of the Norris Cotton Cancer Center; National Institutes of Health [HD076097]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R21HD076097] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P30CA023108] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM104416] Funding Source: NIH RePORTER	Robert Wood Johnson Foundation Healthy Eating Research Program(Robert Wood Johnson Foundation (RWJF)); Prouty research program of the Norris Cotton Cancer Center; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The study was funded by the Robert Wood Johnson Foundation Healthy Eating Research Program, grant #69552, (PI JDS) and the Prouty research program of the Norris Cotton Cancer Center; Gilbert-Diamond is funded by HD076097 from the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Advertising Self Regulatory Council (ASRC), 2010, CARU REF HAR ADV FTC; Barnes B., 2013, NY TIMES; Bernhardt AM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072479; Botha S., 2012, REV FOOD MARKETING C; Boyland EJ, 2011, PEDIATRICS, V128, pE93, DOI 10.1542/peds.2010-1859; Burger King Corp, 2009, BURG KING CORPS 4 SU; Burger King Corp, 2007, BURG KING CORP PLEDG; Children's Advertising Review Unit, 2009, SELF REG PROGR CHILD; Christakis DA, 2013, PEDIATRICS, V131, P431, DOI 10.1542/peds.2012-1493; Graff S, 2012, HEALTH AFFAIR, V31, P392, DOI 10.1377/hlthaff.2011.0609; Harris JL, 2009, HEALTH PSYCHOL, V28, P404, DOI 10.1037/a0014399; HAYES DS, 1980, DEV PSYCHOL, V16, P410, DOI 10.1037/0012-1649.16.5.410; Maher JK, 2006, J ADVERTISING, V35, P23, DOI 10.2753/JOA0091-3367350102; McDonald's USA, 2010, MCDON US SUPP UPD FE; McDonald's USA, 2007, MCDON US SUPP; Nestle M, 2006, NEW ENGL J MED, V354, P2527, DOI 10.1056/NEJMp068014; R Core Team, 2021, R LANGUAGE ENV STAT; Stitt C, 2008, HEALTH COMMUN, V23, P573, DOI 10.1080/10410230802465258; The Public Health Advocacy Institute, 2013, MCDON REP VIOL CARU; Vader AM, 2009, PREV CHRONIC DIS, V6	20	11	11	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2015	10	3							e0119300	10.1371/journal.pone.0119300	http://dx.doi.org/10.1371/journal.pone.0119300			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CC9JM	25738653	gold, Green Submitted, Green Published			2022-12-27	WOS:000350685900103
J	Saito, T; Rehmsmeier, M				Saito, Takaya; Rehmsmeier, Marc			The Precision-Recall Plot Is More Informative than the ROC Plot When Evaluating Binary Classifiers on Imbalanced Datasets	PLOS ONE			English	Article							MICRORNA PRECURSORS; CLASSIFICATION; PREDICTION; RECOGNITION; ACCURACY; GENOMICS; SEQUENCE; MODEL; AREA	Binary classifiers are routinely evaluated with performance measures such as sensitivity and specificity, and performance is frequently illustrated with Receiver Operating Characteristics (ROC) plots. Alternative measures such as positive predictive value (PPV) and the associated Precision/Recall (PRC) plots are used less frequently. Many bioinformatics studies develop and evaluate classifiers that are to be applied to strongly imbalanced datasets in which the number of negatives outweighs the number of positives significantly. While ROC plots are visually appealing and provide an overview of a classifier's performance across a wide range of specificities, one can ask whether ROC plots could be misleading when applied in imbalanced classification scenarios. We show here that the visual interpretability of ROC plots in the context of imbalanced datasets can be deceptive with respect to conclusions about the reliability of classification performance, owing to an intuitive but wrong interpretation of specificity. PRC plots, on the other hand, can provide the viewer with an accurate prediction of future classification performance due to the fact that they evaluate the fraction of true positives among positive predictions. Our findings have potential implications for the interpretation of a large number of studies that use ROC plots on imbalanced datasets.	[Saito, Takaya; Rehmsmeier, Marc] Univ Bergen, Dept Informat, Computat Biol Unit, N-5020 Bergen, Norway	University of Bergen	Saito, T (corresponding author), Univ Bergen, Dept Informat, Computat Biol Unit, POB 7803, N-5020 Bergen, Norway.	takaya.saito@ii.uib.no; marc.rehmsmeier@ii.uib.no	Rehmsmeier, Marc/A-4982-2013	Saito, Takaya/0000-0002-0154-8452				ALTMAN DG, 1994, BRIT MED J, V308, P1552, DOI 10.1136/bmj.308.6943.1552; Baldi P, 2000, BIOINFORMATICS, V16, P412, DOI 10.1093/bioinformatics/16.5.412; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Ben-Hur A, 2010, METHODS MOL BIOL, V609, P223, DOI 10.1007/978-1-60327-241-4_13; Ben-Hur A, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000173; Berrar D, 2012, BRIEF BIOINFORM, V13, P83, DOI 10.1093/bib/bbr008; Boser B. E., 1992, Proceedings of the Fifth Annual ACM Workshop on Computational Learning Theory, P144, DOI 10.1145/130385.130401; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; Chawla N, 2004, SIGKDD EXPLOR, V6; Chawla NV, 2002, J ARTIF INTELL RES, V16, P321, DOI 10.1613/jair.953; Davis J, 2006, P 23 INT C MACH LEAR, P233, DOI [DOI 10.1145/1143844.1143874, 10.1145/1143844.1143874]; Drummond C., 2000, Proceedings. KDD-2000. Sixth ACM SIGKDD International Conference on Knowledge Discovery and Data Mining, P198, DOI 10.1145/347090.347126; Elkan C, 2001, P 17 INT JOINT C ART, P973, DOI DOI 10.5555/1642194.1642224; Estabrooks A, 2004, COMPUT INTELL-US, V20, P18, DOI 10.1111/j.0824-7935.2004.t01-1-00228.x; Fawcett T, 2006, PATTERN RECOGN LETT, V27, P861, DOI 10.1016/j.patrec.2005.10.010; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gomes Clarissa P. C., 2013, Frontiers in Genetics, V4, P81, DOI 10.3389/fgene.2013.00081; Goutte C, 2005, LECT NOTES COMPUT SC, V3408, P345; Gribskov M, 1996, COMPUT CHEM, V20, P25, DOI 10.1016/S0097-8485(96)80004-0; Gruber AR, 2010, BIOCOMPUT-PAC SYM, P69; Hall M., 2009, SIGKDD EXPLORATIONS, V11, P10, DOI [10.1145/1656274.1656278, DOI 10.1145/1656274.1656278]; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; He HB, 2009, IEEE T KNOWL DATA EN, V21, P1263, DOI 10.1109/TKDE.2008.239; Hertel J, 2006, BIOINFORMATICS, V22, pE197, DOI 10.1093/bioinformatics/btl257; HILDEN J, 1991, MED DECIS MAKING, V11, P95, DOI 10.1177/0272989X9101100204; Hirschhorn JN, 2005, NAT REV GENET, V6, P95, DOI 10.1038/nrg1521; HOFACKER IL, 1994, MONATSH CHEM, V125, P167, DOI 10.1007/BF00818163; Hong X, 2007, IEEE T NEURAL NETWOR, V18, P28, DOI 10.1109/TNN.2006.882812; Huang TH, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-341; Ihaka R., 1996, J COMPUT GRAPH STAT, V5, P299, DOI [DOI 10.1080/10618600.1996.10474713, 10.2307/1390807]; Japkowicz N., 2002, Intelligent Data Analysis, V6, P429; Jiang P, 2007, NUCLEIC ACIDS RES, V35, pW339, DOI 10.1093/nar/gkm368; Kozomara A, 2011, NUCLEIC ACIDS RES, V39, pD152, DOI 10.1093/nar/gkq1027; Krogh A, 2008, NAT BIOTECHNOL, V26, P195, DOI 10.1038/nbt1386; Kubat M, 1998, MACH LEARN, V30, P195, DOI 10.1023/A:1007452223027; Kubat M., 1997, ADDRESSING CURSE IMB, P179, DOI DOI 10.1007/S13398-014-0173-7.2; Ling C. X., 1998, Proceedings Fourth International Conference on Knowledge Discovery and Data Mining, P73; Mac Namee B, 2002, ARTIF INTELL MED, V24, P51, DOI 10.1016/S0933-3657(01)00092-6; Macskassy S, 2004, P 1 WORKSH ROC AN AI, P61; Meyer PE, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-461; Nam JW, 2005, NUCLEIC ACIDS RES, V33, P3570, DOI 10.1093/nar/gki668; Provost F, 2000, AAAI 2000 WORKSH IMB; Rao R.B., 2006, ACM SIGKDD EXPLOR NE, V8, P3, DOI [10.1145/1147234.1147236.1, DOI 10.1145/1147234.1147236.1]; RAUDYS SJ, 1991, IEEE T PATTERN ANAL, V13, P252, DOI 10.1109/34.75512; Sing T, 2005, BIOINFORMATICS, V21, P3940, DOI 10.1093/bioinformatics/bti623; Soreide K, 2009, J CLIN PATHOL, V62, P1, DOI 10.1136/jcp.2008.061010; Sun YM, 2007, PATTERN RECOGN, V40, P3358, DOI 10.1016/j.patcog.2007.04.009; Swamidass SJ, 2010, BIOINFORMATICS, V26, P1348, DOI 10.1093/bioinformatics/btq140; SWETS JA, 1988, SCIENCE, V240, P1285, DOI 10.1126/science.3287615; Tarca AL, 2007, PLOS COMPUT BIOL, V3, P953, DOI 10.1371/journal.pcbi.0030116; Truchon JF, 2007, J CHEM INF MODEL, V47, P488, DOI 10.1021/ci600426e; Van Hulse J., 2007, P 24 INT C MACH LEAR, P935, DOI [10.1145/1273496.1273614, DOI 10.1145/1273496.1273614]; Wu G., 2003, WORKSH LEARN IMB DAT	54	1368	1374	15	82	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2015	10	3							e0118432	10.1371/journal.pone.0118432	http://dx.doi.org/10.1371/journal.pone.0118432			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9JM	25738806	Green Published, Green Submitted, gold			2022-12-27	WOS:000350685900033
J	Song, YB; Wang, F; Wang, B; Tao, SH; Zhang, HP; Liu, S; Ramirez, O; Zeng, QY				Song, Yuanbin; Wang, Fan; Wang, Bin; Tao, Shaohua; Zhang, Huiping; Liu, Sai; Ramirez, Oscar; Zeng, Qiyi			Time Series Analyses of Hand, Foot and Mouth Disease Integrating Weather Variables	PLOS ONE			English	Article							ENTEROVIRUS 71; RISK-FACTORS; CIRCULATION; ASSOCIATION; INFECTION; GUANGZHOU; EPIDEMIC; SHENZHEN; HUMIDITY; CHILDREN	Background The past decade witnessed an increment in the incidence of hand foot mouth disease (HFMD) in the Pacific Asian region; specifically, in Guangzhou China. This emphasized the requirement of an early warning system designed to allow the medical community to better prepare for outbreaks and thus minimize the number of fatalities. Methods Samples from 1,556 inpatients (hospitalized) and 11,004 outpatients (non-admitted) diagnosed with HFMD were collected in this study from January 2009 to October 2013. Seasonal Autoregressive Integrated Moving Average (SARIMA) model was applied to establish high predictive model for inpatients and outpatient as well as three viral serotypes (EV71, Pan-EV and CA16). To integrate climate variables in the data analyses, data from eight climate variables were simultaneously obtained during this period. Significant climate variable identified by correlation analyses was executed to improve time series modeling as external repressors. Results Among inpatients with HFMD, 248 (15.9%) were affected by EV71, 137 (8.8%) were affected by Pan-EV+, and 436 (28.0%) were affected by CA16. Optimal Univariate SARIMA model was identified: (2,0,3)(1,0,0) 52 for inpatients, (0,1,0)(0,0,2) 52 for outpatients as well as three serotypes (EV71, (1,0,1)(0,0,1) 52; CA16, (1,0,1)(0,0,0) 52; Pan-EV, (1,0,1) (0,0,0) 52). Using climate as our independent variable, precipitation (PP) was first identified to be associated with inpatients (r = 0.211, P = 0.001), CA16-serotype (r = 0.171, P = 0.007) and outpatients (r = 0.214, P = 0.01) in partial correlation analyses, and was then shown a significant lag in cross-autocorrelation analyses. However, inclusion of PP [lag -3 week] as external repressor showed a moderate impact on the predictive performance of the SARIMA model described here-in. Conclusion Climate patterns and HFMD incidences have been shown to be strongly correlated. The SARIMA model developed here can be a helpful tool in developing an early warning system for HFMD.	[Song, Yuanbin; Wang, Bin; Tao, Shaohua; Zeng, Qiyi] Southern Med Univ, Pediat Ctr, Zhujiang Hosp, Guangzhou, Guangdong, Peoples R China; [Wang, Fan] Univ Penn, Dept Biostat & Epidemiol, Philadelphia, PA 19104 USA; [Ramirez, Oscar] Yale Univ, Sch Med, Yale Canc Ctr, New Haven, CT 06520 USA; [Zhang, Huiping] Yale Univ, Sch Med, Dept Psychiat, New Haven, CT USA; [Liu, Sai] Yale Univ, Dept Psychol, New Haven, CT 06520 USA	Southern Medical University - China; University of Pennsylvania; Yale University; Yale University; Yale University	Ramirez, O (corresponding author), Yale Univ, Sch Med, Yale Canc Ctr, New Haven, CT 06520 USA.	oscar.ramirez@yale.edu; ZQY_88@163.com	Ibrahim, Essam Hassan/G-1960-2018	Ibrahim, Essam Hassan/0000-0003-0130-2257; Zhang, Huiping/0000-0002-4902-0104; WANG, FAN/0000-0001-9806-5037	Guangzhou medicine technology major projects [201102A211007]; National Natural Science Foundation of China [81272070]; Southern Medical University research projects for young scientist [B1012039]	Guangzhou medicine technology major projects; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Southern Medical University research projects for young scientist	This work was supported by Guangzhou medicine technology major projects (grant 201102A211007), partly by National Natural Science Foundation of China (grant 81272070), and Southern Medical University research projects for young scientist (grant B1012039). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], GUANGZH STAT YB 2013; Bateson TF, 2001, EPIDEMIOLOGY, V12, P654, DOI 10.1097/00001648-200111000-00013; Blomqvist S, 2010, J CLIN VIROL, V48, P49, DOI 10.1016/j.jcv.2010.02.002; Bo YC, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-358; Box G. E., 1970, J AM STAT ASSOC, V65, P1509, DOI [10.1080/01621459.1970.10481180, DOI 10.1080/01621459.1970.10481180]; Chang LY, 1999, LANCET, V354, P1682, DOI 10.1016/S0140-6736(99)04434-7; Chen CJ, 2013, INT CONF BIOMETR; Chen MJ, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0040659, 10.1371/journal.pone.0034651]; Chinese Ministry of Health, HAND FOOT MOUTH DIS; Chua Kaw Bing, 2011, Virologica Sinica, V26, P221, DOI 10.1007/s12250-011-3195-8; Deng T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056943; Fang YR, 2014, SCAND J INFECT DIS, V46, P515, DOI 10.3109/00365548.2014.907929; Feng HF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087916; He YQ, 2013, J CLIN MICROBIOL, V51, P3560, DOI 10.1128/JCM.01231-13; Hii YL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016796; Ho MT, 1999, NEW ENGL J MED, V341, P929, DOI 10.1056/NEJM199909233411301; Huang Y, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-134; Investigators P, 2011, PROP COR DAT PROT; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Lee BY, 2010, VACCINE, V28, P7731, DOI 10.1016/j.vaccine.2010.09.065; Li T, 2014, EPIDEMIOL INFECT, V142, P1741, DOI 10.1017/S0950268813002938; Li W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087603; Li XC, 2013, ATHEROSCLEROSIS, V231, P136, DOI 10.1016/j.atherosclerosis.2013.08.031; Lin HL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065585; Luz PM, 2008, AM J TROP MED HYG, V79, P933, DOI 10.4269/ajtmh.2008.79.933; Nguyen NTB, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-341; Nobre FF, 2001, STAT MED, V20, P3051, DOI 10.1002/sim.963; Onozuka D, 2011, SCI TOTAL ENVIRON, V410, P119, DOI 10.1016/j.scitotenv.2011.09.055; Quenel P, 1998, EUR J EPIDEMIOL, V14, P275, DOI 10.1023/A:1007467814485; Rajendran K, 2011, INDIAN J MED RES, V133, P138; Wang JJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092745; Wang YR, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-539; WHO/WPRO, 2010, COMM DIS SURV RESP R; Xing WJ, 2014, LANCET INFECT DIS, V14, P308, DOI 10.1016/S1473-3099(13)70342-6; Xu W, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-8; Yu LJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098241; Zhang T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067157; Zhao X, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-57; Zhu FC, 2014, NEW ENGL J MED, V370, P818, DOI 10.1056/NEJMoa1304923	39	29	33	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2015	10	3							e0117296	10.1371/journal.pone.0117296	http://dx.doi.org/10.1371/journal.pone.0117296			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9JF	25729897	Green Published, gold, Green Submitted			2022-12-27	WOS:000350684900012
J	Neapolitan, RE; Jiang, X				Neapolitan, Richard E.; Jiang, Xia			Study of Integrated Heterogeneous Data Reveals Prognostic Power of Gene Expression for Breast Cancer Survival	PLOS ONE			English	Article							PREDICTORS; RECURRENCE	Background Studies show that thousands of genes are associated with prognosis of breast cancer. Towards utilizing available genetic data, efforts have been made to predict outcomes using gene expression data, and a number of commercial products have been developed. These products have the following shortcomings: 1) They use the Cox model for prediction. However, the RSF model has been shown to significantly outperform the Cox model. 2) Testing was not done to see if a complete set of clinical predictors could predict as well as the gene expression signatures. Methodology/Findings We address these shortcomings. The METABRIC data set concerns 1981 breast cancer tumors. Features include 21 clinical features, expression levels for 16,384 genes, and survival. We compare the survival prediction performance of the Cox model and the RSF model using the clinical data and the gene expression data to their performance using only the clinical data. We obtain significantly better results when we used both clinical data and gene expression data for 5 year, 10 year, and 15 year survival prediction. When we replace the gene expression data by PAM50 subtype, our results are significant only for 5 year and 15 year prediction. We obtain significantly better results using the RSF model over the Cox model. Finally, our results indicate that gene expression data alone may predict long-term survival. Conclusions/Significance Our results indicate that we can obtain improved survival prediction using clinical data and gene expression data compared to prediction using only clinical data. We further conclude that we can obtain improved survival prediction using the RSF model instead of the Cox model. These results are significant because by incorporating more gene expression data with clinical features and using the RSF model, we could develop decision support systems that better utilize heterogeneous information to improve outcome prediction and decision making.	[Neapolitan, Richard E.] Northwestern Univ, Dept Prevent Med, Feinberg Sch Med, Chicago, IL 60611 USA; [Jiang, Xia] Univ Pittsburgh, Dept Biomed Informat, Pittsburgh, PA 15213 USA	Northwestern University; Feinberg School of Medicine; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Neapolitan, RE (corresponding author), Northwestern Univ, Dept Prevent Med, Feinberg Sch Med, Chicago, IL 60611 USA.	richard.neapolitan@northwestern.edu			National Library of Medicine [R00LM010822, R01LM011663]; NATIONAL LIBRARY OF MEDICINE [R00LM010822, R01LM011663] Funding Source: NIH RePORTER	National Library of Medicine(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	This work was supported by National Library of Medicine grants number R00LM010822 and R01LM011663. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen SSB, 1998, SIAM J SCI COMPUT, V20, P33, DOI 10.1137/S1064827596304010; COX DR, 1972, J R STAT SOC B, V34, P187; Fan C, 2006, NEW ENGL J MED, V355, P560, DOI 10.1056/NEJMoa052933; Filipits M, 2011, CLIN CANCER RES, V17, P6012, DOI 10.1158/1078-0432.CCR-11-0926; Gelman A., 2006, DATA ANAL USING REGR, DOI DOI 10.1017/CBO9780511790942.005; Hu ZY, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-96; Ishwaran H, 2008, ANN APPL STAT, V2, P841, DOI 10.1214/08-AOAS169; Jiang X, 2014, CANCER INFORM, V13, P47, DOI 10.4137/CIN.S13053; Jiang Xia, 2010, AMIA Annu Symp Proc, V2010, P341; Kim HY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104743; Lowsky DJ, 2013, STAT MED, V32, P2062, DOI 10.1002/sim.5673; Musen MA, 2006, BIOMEDICAL INFORM CO, P698, DOI DOI 10.1007/0-387-36278-920; Neve RM, 2006, CANCER CELL, V10, P515, DOI 10.1016/j.ccr.2006.10.008; Paik S, 2004, NEW ENGL J MED, V351, P2817, DOI 10.1056/NEJMoa041588; Parker JS, 2009, J CLIN ONCOL, V27, P1160, DOI 10.1200/JCO.2008.18.1370; Pezza RJ, 2007, GENE DEV, V21, P1758, DOI 10.1101/gad.1562907; Robnik-Sikonja M, 2003, MACH LEARN, V53, P23, DOI 10.1023/A:1025667309714; Ross JS, 2008, ONCOLOGIST, V13, P477, DOI 10.1634/theoncologist.2007-0248; Sorlie T, 2003, P NATL ACAD SCI USA, V100, P8418, DOI 10.1073/pnas.0932692100; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Su YS, 2011, J STAT SOFTW, V45, P1; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a	22	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2015	10	2							e0117658	10.1371/journal.pone.0117658	http://dx.doi.org/10.1371/journal.pone.0117658			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC3LS	25723490	gold, Green Submitted, Green Published, Green Accepted			2022-12-27	WOS:000350251200038
J	Ojima, M; Ito, M; Suzuki, K; Kai, M				Ojima, Mitsuaki; Ito, Maki; Suzuki, Keiji; Kai, Michiaki			Unstable Chromosome Aberrations Do Not Accumulate in Normal Human Fibroblast after Fractionated X-Irradiation	PLOS ONE			English	Article							DOUBLE-STRAND BREAKS; CHINESE-HAMSTER CELLS; DOSE-RATE DEPENDENCE; CRAB-EATING MONKEY; CO-60 GAMMA-RAYS; HUMAN-LYMPHOCYTES; IONIZING-RADIATION; ADAPTIVE RESPONSE; MAMMALIAN-CELLS; IN-VITRO	We determined the frequencies of dicentric chromosomes per cell in non-dividing confluent normal human fibroblasts (MRC-5) irradiated with a single 1 Gy dose or a fractionated 1 Gy dose (10X0.1 Gy, 5X0.2 Gy, and 2X0.5 Gy). The interval between fractions was between 1 min to 1440 min. After the completion of X-irradiation, the cells were incubated for 24 hours before re-plating at a low density. Then, demecolcine was administrated at 6 hours, and the first mitotic cells were collected for 42 hours. Our study demonstrated that frequencies of dicentric chromosomes in cells irradiated with a 1 Gy dose at different fractions were significantly reduced if the fraction interval was increased from 1 min to 5 min (p<0.05, chi(2)-test). Further increasing the fraction interval from 5 up to 1440 min did not significantly affect the frequency of dicentric chromosomes. Since misrejoining of two independent chromosome breaks introduced in close proximity gives rise to dicentric chromosome, our results indicated that such circumstances might be quite infrequent in cells exposed to fractionated X-irradiation with prolonged fraction intervals. Our findings should contribute to improve current estimation of cancer risk from chronic low-dose-rate exposure, or intermittent exposure of low-dose radiation by medical exposure.	[Ojima, Mitsuaki; Ito, Maki; Kai, Michiaki] Oita Univ Nursing & Hlth Sci, Dept Environm Hlth Sci, Oita 8401201, Japan; [Suzuki, Keiji] Nagasaki Univ, Dept Radiat Med Sci, Atom Bomb Dis Inst, Nagasaki 8528523, Japan	Oita University; Nagasaki University	Ojima, M (corresponding author), Oita Univ Nursing & Hlth Sci, Dept Environm Hlth Sci, 2944-9 Megusuno, Oita 8401201, Japan.	ojima@oita-nhs.ac.jp	Ojima, Mitsuaki/ABC-2089-2020	Kai, Michiaki/0000-0001-7812-727X	Oita University of Nursing and Health Sciences; Grants-in-Aid for Scientific Research [26293222] Funding Source: KAKEN	Oita University of Nursing and Health Sciences; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Oita University of Nursing and Health Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAUCHINGER M, 1979, INT J RADIAT BIOL, V35, P229, DOI 10.1080/09553007914550261; BEDFORD JS, 1963, INT J RADIAT BIOL RE, V7, P377, DOI 10.1080/09553006314551311; BENHUR E, 1974, RADIAT RES, V58, P38, DOI 10.2307/3573947; Beyreuther E, 2012, RADIAT ENVIRON BIOPH, V51, P33, DOI 10.1007/s00411-011-0396-3; Beyreuther E, 2009, RADIAT ENVIRON BIOPH, V48, P333, DOI 10.1007/s00411-009-0221-4; Burma S, 2001, J BIOL CHEM, V276, P42462, DOI 10.1074/jbc.C100466200; Chen C, 1999, NAT GENET, V23, P81, DOI 10.1038/12687; Cremer T, 2001, NAT REV GENET, V2, P292, DOI 10.1038/35066075; Dianov GL, 2001, BIOESSAYS, V23, P745, DOI 10.1002/bies.1104; Elmore E, 2006, RADIAT RES, V166, P832, DOI 10.1667/RR0682.1; FABRY L, 1986, ACTA RADIOL ONCOL, V25, P143, DOI 10.3109/02841868609136393; FABRY L, 1985, RADIAT RES, V103, P122, DOI 10.2307/3576677; Forand A, 2004, BIOL REPROD, V71, P643, DOI 10.1095/biolreprod.104.027466; HALL EJ, 1964, RADIAT RES, V22, P305, DOI 10.2307/3571661; HANSMANN I, 1983, INT J RADIAT BIOL, V43, P91, DOI 10.1080/09553008314550081; HELLIN H, 1990, Strahlentherapie und Onkologie, V166, P549; Hoeijmakers JHJ, 2001, NATURE, V411, P366, DOI 10.1038/35077232; IKUSHIMA T, 1987, MUTAT RES, V180, P215, DOI 10.1016/0027-5107(87)90217-X; IKUSHIMA T, 1989, MUTAT RES, V227, P241, DOI 10.1016/0165-7992(89)90104-8; Ishii K, 1996, INT J RADIAT BIOL, V69, P291, DOI 10.1080/095530096145841; Iwasaki T, 2011, RADIAT RES, V175, P208, DOI 10.1667/RR2097.1; Johnson RD, 2000, EMBO J, V19, P3398, DOI 10.1093/emboj/19.13.3398; Kakimoto Ayana, 2008, Radioisotopes, V57, P99, DOI 10.3769/radioisotopes.57.99; Kanda R, 1996, INT J RADIAT BIOL, V69, P701, DOI 10.1080/095530096145445; Karthikeya-Prabhu B, 2003, RADIAT PROT DOSIM, V103, P103, DOI 10.1093/oxfordjournals.rpd.a006120; KONECNA H, 1987, FOLIA BIOL-PRAGUE, V33, P301; Lavin MF, 2005, MUTAT RES-FUND MOL M, V569, P123, DOI 10.1016/j.mrfmmm.2004.04.020; Liang F, 1998, P NATL ACAD SCI USA, V95, P5172, DOI 10.1073/pnas.95.9.5172; LLOYD DC, 1975, INT J RADIAT BIOL, V28, P75, DOI 10.1080/09553007514550781; LLOYD DC, 1984, RADIAT ENVIRON BIOPH, V23, P179, DOI 10.1007/BF01213220; LUCHNIK NV, 1976, MUTAT RES, V36, P363, DOI 10.1016/0027-5107(76)90246-3; Mariotti LG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079541; NAKANO M, 1993, INT J RADIAT BIOL, V64, P565, DOI 10.1080/09553009314551781; NORMAN A, 1966, INT J RADIAT BIOL RE, V11, P321; Ojima M, 2008, RADIAT RES, V170, P365, DOI 10.1667/RR1255.1; Ojima Mitsuaki, 2001, Physiological Chemistry and Physics and Medical NMR, V33, P41; Ojima M, 2011, RADIAT PROT DOSIM, V146, P276, DOI 10.1093/rpd/ncr169; Ojima M, 2011, RADIAT RES, V175, P90, DOI 10.1667/RR2223.1; OLIVIERI G, 1984, SCIENCE, V223, P594, DOI 10.1126/science.6695170; Parada LA, 2002, TRENDS CELL BIOL, V12, P425, DOI 10.1016/S0962-8924(02)02351-6; PURROTT RJ, 1976, MUTAT RES, V35, P437, DOI 10.1016/0027-5107(76)90206-2; Rothkamm K, 2003, P NATL ACAD SCI USA, V100, P5057, DOI 10.1073/pnas.0830918100; SASAKI MS, 1995, INT J RADIAT BIOL, V68, P281, DOI 10.1080/09553009514551211; Schroder H, 2002, MUTAT RES-GEN TOX EN, V517, P167, DOI 10.1016/S1383-5718(02)00067-0; SHADLEY JD, 1989, INT J RADIAT BIOL, V56, P107, DOI 10.1080/09553008914551231; Shiloh Y, 2003, NAT REV CANCER, V3, P155, DOI 10.1038/nrc1011; Stiff T, 2004, CANCER RES, V64, P2390, DOI 10.1158/0008-5472.CAN-03-3207; Suzuki K, 2006, RADIAT RES, V165, P499, DOI 10.1667/RR3542.1; Suzuki K, 1999, J BIOL CHEM, V274, P25571, DOI 10.1074/jbc.274.36.25571; TAKAHASHI E, 1982, MUTAT RES, V94, P115, DOI 10.1016/0027-5107(82)90173-7; TAKAHASHI EI, 1979, MUTAT RES, V60, P357, DOI 10.1016/0027-5107(79)90026-5; Takata M, 1998, EMBO J, V17, P5497, DOI 10.1093/emboj/17.18.5497; Tanaka K, 2009, RADIAT RES, V171, P290, DOI 10.1667/RR1238.1; Thompson LH, 2002, MUTAT RES-FUND MOL M, V509, P49, DOI 10.1016/S0027-5107(02)00224-5; WATANABE M, 1984, RADIAT RES, V98, P274, DOI 10.2307/3576235; WILSON JH, 1982, MOL CELL BIOL, V2, P1258, DOI 10.1128/MCB.2.10.1258	56	3	3	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2015	10	2							e0116645	10.1371/journal.pone.0116645	http://dx.doi.org/10.1371/journal.pone.0116645			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC3LS	25723489	Green Published, Green Submitted, gold			2022-12-27	WOS:000350251200018
J	Tremblay, M; Gallant, F; Lavalliere, M; Chiasson, M; Silvey, D; Behm, D; Albert, WJ; Johnson, MJ				Tremblay, Mathieu; Gallant, Francois; Lavalliere, Martin; Chiasson, Martine; Silvey, Dustin; Behm, David; Albert, Wayne J.; Johnson, Michel J.			Driving Performance on the Descending Limb of Blood Alcohol Concentration (BAC) in Undergraduate Students: A Pilot Study	PLOS ONE			English	Article							FIELD-OF-VIEW; HEART-RATE-VARIABILITY; YOUNG; DRINKING; RELIABILITY; EXPECTANCY; VALIDITY; DRIVERS; CRASHES; TRENDS	Young drivers are overrepresented in collisions resulting in fatalities. It is not uncommon for young drivers to socially binge drink and decide to drive a vehicle a few hours after consumption. To better understand the risks that may be associated with this behaviour, the present study has examined the effects of a social drinking bout followed by a simulated drive in undergraduate students on the descending limb of their BAC (blood alcohol concentration) curve. Two groups of eight undergraduate students (n = 16) took part in this study. Participants in the alcohol group were assessed before drinking, then at moderate and low BAC as well as 24 hours post-acute consumption. This group consumed an average of 5.3 +/- 1.4 (mean +/- SD) drinks in an hour in a social context and were then submitted to a driving and a predicted crash risk assessment. The control group was assessed at the same time points without alcohol intake or social context.; at 8 a.m., noon, 3 p.m. and 8 a.m. the next morning. These multiple time points were used to measure any potential learning effects from the assessment tools (i.e. driving simulator and useful field of view test (UFOV)). Diminished driving performance at moderate BAC was observed with no increases in predicted crash risk. Moderate correlations between driving variables were observed. No association exists between driving variables and UFOV variables. The control group improved measures of selective attention after the third asessement. No learning effect was observed from multiple sessions with the driving simulator. Our results show that a moderate BAC, although legal, increases the risky behaviour. Effects of alcohol expectancy could have been displayed by the experimental group. UFOV measures and predicted crash risk categories were not sentitive enough to predict crash risk for young drivers, even when intoxicated.	[Tremblay, Mathieu; Chiasson, Martine; Albert, Wayne J.] Univ New Brunswick, Fac Kinesiol, Fredericton, NB, Canada; [Gallant, Francois; Johnson, Michel J.] Univ Moncton, Ecole Kinesiol & Loisir, Moncton, NB E1A 3E9, Canada; [Tremblay, Mathieu; Gallant, Francois; Chiasson, Martine; Johnson, Michel J.] Univ Moncton, Hlth Driver Res Grp, Moncton, NB E1A 3E9, Canada; [Lavalliere, Martin] MIT, AgeLab, Cambridge, MA 02139 USA; [Lavalliere, Martin] Univ New England, Transportat Ctr, Cambridge, MA USA; [Silvey, Dustin; Behm, David] Mem Univ Newfoundland, Sch Human Kinet & Recreat, St John, NF, Canada	University of New Brunswick; University of Moncton; University of Moncton; Massachusetts Institute of Technology (MIT); University of New England - Maine; Memorial University Newfoundland	Johnson, MJ (corresponding author), Univ Moncton, Ecole Kinesiol & Loisir, Moncton, NB E1A 3E9, Canada.	michel.johnson@umoncton.ca	Lavalliere, Martin/AFU-5311-2022; Behm, David George/I-6509-2019	Lavalliere, Martin/0000-0003-0247-0308; Behm, David George/0000-0002-9406-6056; Tremblay, Mathieu/0000-0002-9507-9051				Bentley SA, 2012, INVEST OPHTH VIS SCI, V53, P6763, DOI 10.1167/iovs.12-9718; Burian SE, 2003, HUM PSYCHOPHARM CLIN, V18, P175, DOI 10.1002/hup.473; CPHA, 2011, TOO HIGH COST PUBL H, V20; Dry MJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050977; Edwards JD, 2005, J CLIN EXP NEUROPSYC, V27, P529, DOI 10.1080/13803390490515432; Edwards JD, 2006, ARCH CLIN NEUROPSYCH, V21, P275, DOI 10.1016/j.acn.2006.03.001; French MT, 2014, P 6 ANN M EC RISK BE, P20; Hegg-Deloye S, 2010, P 20 CAN MULT ROAD S, P14; Karpyak VM, 2014, ALCOHOL CLIN EXP RES, V38, P9, DOI 10.1111/acer.12270; Kypri K, 2005, ALCOHOL ALCOHOLISM, V40, P447, DOI 10.1093/alcalc/agh178; Lambert-Belanger A, 2012, J SAFETY RES, V43, P333, DOI 10.1016/j.jsr.2012.10.011; MADD Canada, 2014, YOUTH SERV STAT LINK; Martin TL, 2013, J FORENSIC SCI, V58, P1238, DOI 10.1111/1556-4029.12227; McGwin G, 1999, ACCIDENT ANAL PREV, V31, P181; Moskowitz H., 2000, REV LIT EFFECTS LOW; Oei TPS, 2004, ADDICT BEHAV, V29, P159, DOI 10.1016/S0306-4603(03)00076-5; Richards E, 2006, VISION RES, V46, P4217, DOI 10.1016/j.visres.2006.08.011; Romanowicz M, 2011, ALCOHOL CLIN EXP RES, V35, P1092, DOI 10.1111/j.1530-0277.2011.01442.x; Roudsari B, 2009, TRAFFIC INJ PREV, V10, P410, DOI 10.1080/15389580903131506; Sahami S, 2009, TRANSPORT RES REC, P94, DOI 10.3141/2138-13; Schnabel E., 2012, ALCOHOL DRIVING REL; Studer J, 2014, INT J DRUG POLICY, V25, P700, DOI 10.1016/j.drugpo.2014.02.002; Testa M, 2006, ALCOHOL CLIN EXP RES, V30, P339, DOI 10.1111/j.1530-0277.2006.00039.x; Traffic Injury Research Foundation, 2013, ALC CRASH PROBL CAN; Vanlaar W, 2012, ACCIDENT ANAL PREV, V48, P297, DOI 10.1016/j.aap.2012.01.030; WHO, 2009, ALCOHOL AND INJURIES: EMERGENCY DEPARTMENT STUDIES IN AN INTERNATIONAL PERSPECTIVE, P1; Williams AF, 2006, INJURY PREV, V12, P4, DOI 10.1136/ip.2006.011783; Wood JM, 2014, GERONTOLOGY, V60, P315, DOI 10.1159/000356753	28	2	2	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2015	10	2							e0118348	10.1371/journal.pone.0118348	http://dx.doi.org/10.1371/journal.pone.0118348			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC3LS	25723618	Green Accepted, Green Published, gold			2022-12-27	WOS:000350251200056
J	van der Kooij, K; Brenner, E; van Beers, RJ; Smeets, JBJ				van der Kooij, Katinka; Brenner, Eli; van Beers, Robert J.; Smeets, Jeroen B. J.			Visuomotor Adaptation: How Forgetting Keeps Us Conservative	PLOS ONE			English	Article							MOTOR MEMORIES; DECAY; SAVINGS	Even when provided with feedback after every movement, adaptation levels off before biases are completely removed. Incomplete adaptation has recently been attributed to forgetting: the adaptation is already partially forgotten by the time the next movement is made. Here we test whether this idea is correct. If so, the final level of adaptation is determined by a balance between learning and forgetting. Because we learn from perceived errors, scaling these errors by a magnification factor has the same effect as subjects increasing the amount by which they learn from each error. In contrast, there is no reason to expect scaling the errors to affect forgetting. The magnification factor should therefore influence the balance between learning and forgetting, and thereby the final level of adaptation. We found that adaptation was indeed more complete for larger magnification factors. This supports the idea that incomplete adaptation is caused by part of what has been learnt quickly being forgotten.	[van der Kooij, Katinka; Brenner, Eli; van Beers, Robert J.; Smeets, Jeroen B. J.] Vrije Univ Amsterdam, Fac Human Movement Sci, MOVE Res Inst Amsterdam, Amsterdam, Netherlands	Vrije Universiteit Amsterdam	van der Kooij, K (corresponding author), Vrije Univ Amsterdam, Fac Human Movement Sci, MOVE Res Inst Amsterdam, Amsterdam, Netherlands.	k.vander.kooij@vu.nl	van Beers, Robert J/R-7248-2018; Smeets, Jeroen/B-4198-2008	van Beers, Robert J/0000-0003-3847-8918; Smeets, Jeroen/0000-0002-3794-0579; Brenner, Eli/0000-0002-3611-2843; van der Kooij, Katinka/0000-0002-4190-7827	Netherlands Organization for Scientific Research, NWO Vici grant [453-08-004]; Stichting Technologie en Wetenschap (STW), Open Technology Program (OTP) grant [12668]	Netherlands Organization for Scientific Research, NWO Vici grant(Netherlands Organization for Scientific Research (NWO)); Stichting Technologie en Wetenschap (STW), Open Technology Program (OTP) grant	This work was supported by a grant from the Netherlands Organization for Scientific Research (www.nwo.nl), NWO Vici grant 453-08-004 to JBJS and by grant by Stichting Technologie en Wetenschap (STW), Open Technology Program (OTP) grant 12668 to JBJS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baddeley RJ, 2003, J NEUROSCI, V23, P3066; Berniker M, 2008, NAT NEUROSCI, V11, P1454, DOI 10.1038/nn.2229; Burge J, 2008, J VISION, V8, DOI 10.1167/8.4.20; Cheng S, 2007, J NEUROPHYSIOL, V97, P3057, DOI 10.1152/jn.00897.2006; CHOE CS, 1974, J EXP PSYCHOL, V102, P1076, DOI 10.1037/h0036325; Criscimagna-Hemminger SE, 2010, J NEUROPHYSIOL, V103, P2275, DOI 10.1152/jn.00822.2009; Diedrichsen J, 2005, J NEUROSCI, V25, P9919, DOI 10.1523/JNEUROSCI.1874-05.2005; Fernandez-Ruiz J, 2004, COGNITIVE BRAIN RES, V20, P92, DOI 10.1016/j.cogbrainres.2004.01.007; Franklin S, 2012, J NEUROPHYSIOL, V108, P467, DOI 10.1152/jn.01123.2011; Galea JM, 2010, DISSOCIATING THE ROL; Henriques DYP, 2012, J MOTOR BEHAV, V44, P435, DOI 10.1080/00222895.2012.659232; Hinder MR, 2010, EXP BRAIN RES, V201, P191, DOI 10.1007/s00221-009-2025-9; Huang VS, 2011, NEURON, V70, P787, DOI 10.1016/j.neuron.2011.04.012; Ingram JN, 2013, CURR BIOL, V23, P1107, DOI 10.1016/j.cub.2013.04.079; Kitago T, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00307; Krakauer JW, 2011, CURR OPIN NEUROBIOL, V21, P636, DOI 10.1016/j.conb.2011.06.012; Krakauer JW, 2009, ADV EXP MED BIOL, V629, P405, DOI 10.1007/978-0-387-77064-2_21; Lee JY, 2009, J NEUROSCI, V29, P10396, DOI 10.1523/JNEUROSCI.1294-09.2009; Ostry DJ, 2010, J NEUROSCI, V30, P5384, DOI 10.1523/JNEUROSCI.4571-09.2010; Patton JL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0046466; Pekny SE, 2011, J NEUROSCI, V31, P13829, DOI 10.1523/JNEUROSCI.1704-11.2011; Peled A, 2012, J MOTOR BEHAV, V44, P185, DOI 10.1080/00222895.2012.672349; Scheidt RA, 2007, J NEUROPHYSIOL, V98, P3600, DOI 10.1152/jn.00121.2007; Schot WD, 2012, PERCEPTION, V41, P991, DOI 10.1068/p7261; SHADMEHR R, 1994, J NEUROSCI, V14, P3208; Shmuelof L, 2012, J NEUROSCI, V32, P14617, DOI 10.1523/JNEUROSCI.2184-12.2012; Smeets JBJ, 2006, P NATL ACAD SCI USA, V103, P18781, DOI 10.1073/pnas.0607687103; Smith MA, 2006, PLOS BIOL, V4, P1035, DOI 10.1371/journal.pbio.0040179; Sousa R, 2010, VISION RES, V50, P1786, DOI 10.1016/j.visres.2010.05.035; van Beers RJ, 2009, NEURON, V63, P406, DOI 10.1016/j.neuron.2009.06.025; van der Kooij K, 2013, J NEUROPHYSIOL, V109, P1890, DOI 10.1152/jn.00845.2012; Vaswani PA, 2013, J NEUROSCI, V33, P7700, DOI 10.1523/JNEUROSCI.0124-13.2013; Wei KL, 2009, J NEUROPHYSIOL, V101, P655, DOI 10.1152/jn.90545.2008; Welch R. B., 1978, PERCEPTUAL MODIFICAT; Zarahn E, 2008, J NEUROPHYSIOL, V100, P2537, DOI 10.1152/jn.90529.2008	35	59	60	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2015	10	2							e0117901	10.1371/journal.pone.0117901	http://dx.doi.org/10.1371/journal.pone.0117901			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC3LS	25723763	Green Published, gold			2022-12-27	WOS:000350251200042
J	Dezfouli, MP; Daliri, MR				Dezfouli, Mohsen Parto; Daliri, Mohammad Reza			The Effect of Adaptation on the Tuning Curves of Rat Auditory Cortex	PLOS ONE			English	Article							STIMULUS-SPECIFIC ADAPTATION; FREQUENCY-RESPONSE AREAS; MISMATCH NEGATIVITY MMN; INFERIOR COLLICULUS; CORTICAL-NEURONS; CLASSIFICATION; DEVIANCE; THALAMUS; FIELDS	Repeated stimulus causes a specific suppression of neuronal responses, which is so-called as Stimulus-Specific Adaptation (SSA). This effect can be recovered when the stimulus changes. In the auditory system SSA is a well-known phenomenon that appears at different levels of the mammalian auditory pathway. In this study, we explored the effects of adaptation to a particular stimulus on the auditory tuning curves of anesthetized rats. We used two sequences and compared the responses of each tone combination in these two conditions. First sequence consists of different pure tone combinations that were presented randomly. In the second one, the same stimuli of the first sequence were presented in the context of an adapted stimulus (adapter) that occupied 80% of sequence probability. The population results demonstrated that the adaptation factor decreased the frequency response area and made a change in the tuning curve to shift it unevenly toward the higher thresholds of tones. The local field potentials and multi-unit activity responses have indicated that the neural activities strength of the adapted frequency has been suppressed as well as with lower suppression in neighboring frequencies. This aforementioned reduction changed the characteristic frequency of the tuning curve.	[Daliri, Mohammad Reza] Iran Univ Sci & Technol, Fac Elect Engn, Dept Biomed Engn, Tehran 1684613114, Iran; Iran Univ Sci & Technol, Fac Elect Engn, INTC, Tehran 1684613114, Iran	Iran University Science & Technology; Iran University Science & Technology	Daliri, MR (corresponding author), Iran Univ Sci & Technol, Fac Elect Engn, Dept Biomed Engn, Tehran 1684613114, Iran.	daliri@iust.ac.ir	Daliri, Mohammad Reza/AAF-4609-2021; Daliri, Mohammad Reza/S-9308-2018	Daliri, Mohammad Reza/0000-0001-9241-8751; Parto Dezfouli, Mohsen/0000-0002-9064-2212	Iran Neural Technology Center (INTC), Faculty of Electrical Engineering, Iran University of Science and Technology (IUST), Tehran, Iran	Iran Neural Technology Center (INTC), Faculty of Electrical Engineering, Iran University of Science and Technology (IUST), Tehran, Iran	This work was supported by Iran Neural Technology Center (INTC), Faculty of Electrical Engineering, Iran University of Science and Technology (IUST), Tehran, Iran. All the data have been recorded in INTC. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson LA, 2009, J NEUROSCI, V29, P7359, DOI 10.1523/JNEUROSCI.0793-09.2009; Antunes FM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014071; Ayala YA, 2012, FRONT NEURAL CIRCUIT, V6, P1; Bauerle P, 2011, J NEUROSCI, V31, P9708, DOI 10.1523/JNEUROSCI.5814-10.2011; Cornella M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043604; CSEPE V, 1987, ELECTROEN CLIN NEURO, V66, P571, DOI 10.1016/0013-4694(87)90103-9; Haidarliu S, 1996, PHYSIOL BEHAV, V60, P111, DOI 10.1016/0031-9384(95)02257-0; Hara K, 2002, ANESTH ANALG, V94, P313, DOI 10.1097/00000539-200202000-00015; Hernandez O, 2005, NEUROSCIENCE, V132, P203, DOI 10.1016/j.neuroscience.2005.01.001; JAVITT DC, 1994, BRAIN RES, V667, P192, DOI 10.1016/0006-8993(94)91496-6; Jeyabalaratnam J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064294; Katz Y, 2006, J NEUROSCI, V26, P13363, DOI 10.1523/JNEUROSCI.4056-06.2006; Malmierca MS, 2009, J NEUROSCI, V29, P5483, DOI 10.1523/JNEUROSCI.4153-08.2009; MOVSHON JA, 1979, NATURE, V278, P850, DOI 10.1038/278850a0; Muller JR, 1999, SCIENCE, V285, P1405, DOI 10.1126/science.285.5432.1405; Naatanen R, 2007, CLIN NEUROPHYSIOL, V118, P2544, DOI 10.1016/j.clinph.2007.04.026; Nelken I, 2007, J PSYCHOPHYSIOL, V21, P214, DOI 10.1027/0269-8803.21.34.214; Palmer AR, 2013, J PHYSIOL-LONDON, V591, P4003, DOI 10.1113/jphysiol.2013.255943; Paxinos G., 2004, RAT NERVOUS SYSTEM, V3rd; Polley DB, 2007, J NEUROPHYSIOL, V97, P3621, DOI 10.1152/jn.01298.2006; Pouzat C, 2002, J NEUROSCI METH, V122, P43, DOI 10.1016/S0165-0270(02)00276-5; Profant O, 2013, HEARING RES, V296, P51, DOI 10.1016/j.heares.2012.11.021; Sutter ML, 2000, J NEUROPHYSIOL, V84, P1012, DOI 10.1152/jn.2000.84.2.1012; Szymanski FD, 2009, J NEUROPHYSIOL, V102, P1483, DOI 10.1152/jn.00240.2009; Taaseh N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023369; Ulanovsky N, 2004, J NEUROSCI, V24, P10440, DOI 10.1523/JNEUROSCI.1905-04.2004; Ulanovsky N, 2003, NAT NEUROSCI, V6, P391, DOI 10.1038/nn1032; Yaron A, 2012, NEURON, V76, P603, DOI 10.1016/j.neuron.2012.08.025; Zhou ZH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052186	29	11	11	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2015	10	2							e0115621	10.1371/journal.pone.0115621	http://dx.doi.org/10.1371/journal.pone.0115621			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC2ZH	25719404	Green Published, gold, Green Submitted			2022-12-27	WOS:000350213200005
J	Pradhan, GP; Prasad, PVV				Pradhan, Gautam Prasad; Prasad, P. V. Vara			Evaluation of Wheat Chromosome Translocation Lines for High Temperature Stress Tolerance at Grain Filling Stage	PLOS ONE			English	Article							HEAT-STRESS; LIPID-PEROXIDATION; HARVEST INDEX; STRIPE RUST; RESISTANCE; DROUGHT; YIELD; CHLOROPHYLL; SENESCENCE; GROWTH	High temperature (HT, heat) stress is detrimental to wheat (Triticum aestivum L.) production. Wild relatives of bread wheat may offer sources of HT stress tolerance genes because they grow in stressed habitats. Wheat chromosome translocation lines, produced by intro-gressing small segments of chromosome from wild relatives to bread wheat, were evaluated for tolerance to HT stress during the grain filling stage. Sixteen translocation lines and four wheat cultivars were grown at optimum temperature (OT) of 22/14 degrees C (day/night). Ten days after anthesis, half of the plants were exposed to HT stress of 34/26 degrees C for 16 d, and other half remained at OT. Results showed that HT stress decreased grain yield by 43% compared with OT. Decrease in individual grain weight (by 44%) was the main reason for yield decline at HT. High temperature stress had adverse effects on leaf chlorophyll content and Fv/Fm; and a significant decrease in Fv/Fm was associated with a decline in individual grain weight. Based on the heat response (heat susceptibility indices, HSIs) of physiological and yield traits to each other and to yield HSI, TA5594, TA5617, and TA5088 were highly tolerant and TA5637 and TA5640 were highly susceptible to HT stress. Our results suggest that change in Fv/Fm is a highly useful trait in screening genotypes for HT stress tolerance. This study showed that there is genetic variability among wheat chromosome translocation lines for HT stress tolerance at the grain filling stage and we suggest further screening of a larger set of translocation lines.	[Pradhan, Gautam Prasad] N Dakota State Univ, Williston Res Extens Ctr, Williston, ND USA; [Prasad, P. V. Vara] Kansas State Univ, Dept Agron, Manhattan, KS 66506 USA	North Dakota State University Fargo; Kansas State University	Prasad, PVV (corresponding author), Kansas State Univ, Dept Agron, Manhattan, KS 66506 USA.	vara@ksu.edu	Prasad, P.V. Vara/B-3835-2012; Pradhan, Gautam/AAN-6198-2020	Prasad, P.V. Vara/0000-0001-6632-3361; Pradhan, Gautam/0000-0001-5760-9616	Kansas Wheat Commission; Kansas Wheat Alliance; Coordinated Agricultural Project from the USDA National Institute of Food and Agriculture [2011-68002-30029]; Kansas State University Open Access Publishing Fund	Kansas Wheat Commission; Kansas Wheat Alliance; Coordinated Agricultural Project from the USDA National Institute of Food and Agriculture; Kansas State University Open Access Publishing Fund	This research was supported by the Kansas Wheat Commission; Kansas Wheat Alliance; and Coordinated Agricultural Project Grant no. 2011-68002-30029 (Triticeae- CAP) from the USDA National Institute of Food and Agriculture. Publication of this article was funded in part by the Kansas State University Open Access Publishing Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdalla O, 2010, ENHANCEMENT HEAT TOL, P144; ALKHATIB K, 1984, PHYSIOL PLANTARUM, V61, P363, DOI 10.1111/j.1399-3054.1984.tb06341.x; Amani I, 1996, J AGRON CROP SCI, V176, P119, DOI 10.1111/j.1439-037X.1996.tb00454.x; Asseng S, 2011, GLOBAL CHANGE BIOL, V17, P997, DOI 10.1111/j.1365-2486.2010.02262.x; Ayeneh A, 2002, FIELD CROP RES, V79, P173, DOI 10.1016/S0378-4290(02)00138-7; CHAITANYA KSK, 1994, NEW PHYTOL, V126, P623, DOI 10.1111/j.1469-8137.1994.tb02957.x; CHEN PD, 1995, THEOR APPL GENET, V91, P1125, DOI 10.1007/BF00223930; Chen Q, 2002, CAN J PLANT SCI, V82, P451, DOI 10.4141/P01-062; Dias AS, 2009, J AGRON CROP SCI, V195, P137, DOI 10.1111/j.1439-037X.2008.00347.x; Djanaguiraman M, 2011, ENVIRON EXP BOT, V71, P215, DOI 10.1016/j.envexpbot.2010.12.006; FISCHER RA, 1978, AUST J AGR RES, V29, P897, DOI 10.1071/AR9780897; Gibson LR, 1999, CROP SCI, V39, P1841, DOI 10.2135/cropsci1999.3961841x; Gill BS, 2006, ADV AGRON, V89, P73, DOI 10.1016/S0065-2113(05)89002-9; Hays DB, 2007, PLANT SCI, V172, P1113, DOI 10.1016/j.plantsci.2007.03.004; Kansas State University, 2014, GERMPL REL WHEAT GEN; KRAUSE GH, 1984, PHOTOSYNTH RES, V5, P139, DOI 10.1007/BF00028527; Kumar S, 2012, EUPHYTICA, V186, P265, DOI 10.1007/s10681-012-0675-3; Kuraparthy V, 2007, THEOR APPL GENET, V114, P1379, DOI 10.1007/s00122-007-0524-2; Littell RC, 2006, SAS MIXED MODELS, V2nd; Liu C, 2011, GENOME, V54, P836, DOI [10.1139/G11-051, 10.1139/g11-051]; Liu W, 2011, CROP SCI, V51, P2382, DOI 10.2135/cropsci2011.03.0118; Liu XZ, 2000, CROP SCI, V40, P503, DOI 10.2135/cropsci2000.402503x; Lobell DB, 2012, NAT CLIM CHANGE, V2, P186, DOI [10.1038/nclimate1356, 10.1038/NCLIMATE1356]; Lopes MS, 2010, FUNCT PLANT BIOL, V37, P147, DOI 10.1071/FP09121; Lott N, 2011, BILLION DOLLAR US WE; Mahan JR, 2012, IRRIGATION SCI, V30, P127, DOI 10.1007/s00271-011-0269-1; Meehl GA, 2004, SCIENCE, V305, P994, DOI 10.1126/science.1098704; Parry MAJ, 2011, J EXP BOT, V62, P453, DOI 10.1093/jxb/erq304; PAULSEN GM, 1994, PHYSIOLOGY AND DETERMINATION OF CROP YIELD, P365; Pietragalla J., 2012, PHYSIOLOGICAL BREEDI, P10; Pradhan GP, 2012, CROP SCI, V52, P292, DOI 10.2135/cropsci2011.04.0186; Pradhan GP, 2012, FUNCT PLANT BIOL, V39, P190, DOI 10.1071/FP11245; Pradhan GP, 2012, FUNCT PLANT BIOL, V39, P51, DOI 10.1071/FP11171; Prasad PVV, 2006, AGR FOREST METEOROL, V139, P237, DOI 10.1016/j.agrformet.2006.07.003; Prasad PVV, 2006, FIELD CROP RES, V95, P398, DOI 10.1016/j.fcr.2005.04.008; Qi LL, 2008, THEOR APPL GENET, V117, P1155, DOI 10.1007/s00122-008-0853-9; Qi LL, 1996, GENOME, V39, P191, DOI 10.1139/g96-025; REYNOLDS MP, 1994, AUST J PLANT PHYSIOL, V21, P717, DOI 10.1071/PP9940717; Ristic Z, 2007, CROP SCI, V47, P2067, DOI 10.2135/cropsci2006.10.0674; Sekmen AH, 2011, SUPEROXIDE DISMUTASE; Semenov MA, 2011, SCI REP-UK, V1, DOI 10.1038/srep00066; Solomon S, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P1; Tewari AK, 1998, PLANT PHYSIOL, V117, P851, DOI 10.1104/pp.117.3.851; Viswanathan C, 2001, J AGRON CROP SCI, V186, P1, DOI 10.1046/j.1439-037x.2001.00432.x; Wahid A, 2007, ENVIRON EXP BOT, V61, P199, DOI 10.1016/j.envexpbot.2007.05.011; WANJURA DF, 1994, IRRIGATION SCI, V14, P199, DOI 10.1007/BF00190191; WARDLAW IF, 1994, AUST J PLANT PHYSIOL, V21, P695, DOI 10.1071/PP9940695; Wilhelm EP, 1999, CROP SCI, V39, P1733, DOI 10.2135/cropsci1999.3961733x; Yang J, 2002, EUPHYTICA, V126, P185, DOI 10.1023/A:1016365728633; Zhao H, 2007, PLANT GROWTH REGUL, V51, P149, DOI 10.1007/s10725-006-9157-8; ZHONGHU H, 1993, EUPHYTICA, V72, P197	51	29	31	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2015	10	2							e0116620	10.1371/journal.pone.0116620	http://dx.doi.org/10.1371/journal.pone.0116620			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC2ZH	25719199	Green Submitted, Green Published, gold			2022-12-27	WOS:000350213200010
J	Stulp, G; Buunk, AP; Verhulst, S; Pollet, TV				Stulp, Gert; Buunk, Abraham P.; Verhulst, Simon; Pollet, Thomas V.			Human Height Is Positively Related to Interpersonal Dominance in Dyadic Interactions	PLOS ONE			English	Article							BODY-MASS INDEX; SELF-REPRESENTATION; LEADERSHIP; ABILITY; AGGRESSION; AUTHORITY; STRENGTH; SUCCESS; STATURE; GENDER	Across cultures, taller stature is linked to increased social status, but the potential reasons why this should be are unclear. One potential explanation is that taller individuals are more likely to win a dyadic confrontation with a competitor (i.e., they are more dominant), which leads to higher social rank. Although some previous studies have shown that perceptions of status or dominance are related to height, and are therefore consistent with such an explanation, there is surprisingly little research testing whether height actually has any influence on the behavioural outcomes in real-life social interactions. Here, we present three naturalistic observational studies demonstrating that height predicts interpersonal dominance during brief dyadic interactions. Study 1 investigated the likelihood of giving way in a narrow passage (N = 92); Study 2 investigated giving way in a busy shopping street, plus the likelihood of colliding with another individual (N = 1,108); and Study 3 investigated the likelihood of maintaining a linear path while walking, and potentially entering another individual's personal space (N = 1,056). We conclude that human height is positively related to interpersonal dominance, and may well contribute to the widely observed positive association between height and social status.	[Stulp, Gert; Buunk, Abraham P.] Univ Groningen, Dept Psychol, Grote Kruisstr 2-1, NL-9712 TS Groningen, Netherlands; [Stulp, Gert; Verhulst, Simon] Univ Groningen, Groningen Inst Evolutionary Life Sci, Groningen, Netherlands; [Stulp, Gert] London Sch Hyg & Trop Med, Dept Populat Hlth, London WC1, England; [Buunk, Abraham P.] Univ Curacao, Fac Social & Behav Sci, Willemstad, Netherlands; [Pollet, Thomas V.] Vrije Univ Amsterdam, Dept Social & Org Psychol, Amsterdam, Netherlands	University of Groningen; University of Groningen; University of London; London School of Hygiene & Tropical Medicine; Vrije Universiteit Amsterdam	Stulp, G (corresponding author), Univ Groningen, Dept Psychol, Grote Kruisstr 2-1, NL-9712 TS Groningen, Netherlands.	gertstulp@gmail.com	PEIRO, JOSE M./B-3388-2011; Pollet, Thomas/M-6346-2019; Verhulst, Simon/B-1613-2009; Pollet, Thomas V/H-3397-2012; Verhulst, Simon/S-3404-2019	PEIRO, JOSE M./0000-0001-5293-0355; Pollet, Thomas/0000-0002-4210-935X; Verhulst, Simon/0000-0002-1143-6868; Pollet, Thomas V/0000-0002-4210-935X; Verhulst, Simon/0000-0002-1143-6868; Stulp, Gert/0000-0003-0173-5554	Royal Netherlands Academy of Arts and Sciences; NWO (de Nederlandse Organisatie voor Wetenschappelijk Onderzoek) Veni grant [451.10.032]	Royal Netherlands Academy of Arts and Sciences; NWO (de Nederlandse Organisatie voor Wetenschappelijk Onderzoek) Veni grant	This research was supported by a grant to APB from the Royal Netherlands Academy of Arts and Sciences (http://www.knaw.nl), and an NWO (de Nederlandse Organisatie voor Wetenschappelijk Onderzoek; www.nwo.nl) Veni grant to TVP (451.10.032). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson Malte, 1994; Archer J, 1988, BIOL AGGRESSION; Archer J, 2007, PERS INDIV DIFFER, V43, P627, DOI 10.1016/j.paid.2007.01.005; Barton K, 2014, R PACKAGE VERSION; BIELICKI T, 1983, ANN HUM BIOL, V10, P403, DOI 10.1080/03014468300006591; Blaker N.M., 2014, PSYCHOL SOCIAL STATU, P119; Blaker NM, 2013, GROUP PROCESS INTERG, V16, P17, DOI 10.1177/1368430212437211; Buunk AP, 2008, EVOL HUM BEHAV, V29, P133, DOI 10.1016/j.evolhumbehav.2007.11.006; Camperio C.A., 2002, HUM EVOL, V17, P175, DOI [10.1007/BF02436369, DOI 10.1007/BF02436369]; Case A, 2008, J POLIT ECON, V116, P499, DOI 10.1086/589524; Cavelaars AEJM, 2000, ANN HUM BIOL, V27, P407, DOI 10.1080/03014460050044883; CERNERUD L, 1995, SCAND J SOC MED, V23, P28, DOI 10.1177/140349489502300106; Cinnirella F., 2009, 2733 CESIFO; Cohen D, 1996, J PERS SOC PSYCHOL, V70, P945, DOI 10.1037/0022-3514.70.5.945; Courtiol A, 2010, EVOLUTION, V64, P2189, DOI 10.1111/j.1558-5646.2010.00985.x; Darwin C., 1871, P423; DREWS C, 1993, BEHAVIOUR, V125, P283, DOI 10.1163/156853993X00290; Ellis B, 1992, ADAPTED MIND EVOLUTI, P267; Ellis L., 1994, SOCIAL STRATIFICATIO, P93; Fessler DMT, 2014, EVOL HUM BEHAV, V35, P26, DOI 10.1016/j.evolhumbehav.2013.09.003; Fessler DMT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032751; FISHER JD, 1975, J PERS SOC PSYCHOL, V32, P15, DOI 10.1037/h0076837; Gawley T, 2009, SEX ROLES, V60, P208, DOI 10.1007/s11199-008-9520-5; Holbrook C, 2013, COGNITION, V127, P46, DOI 10.1016/j.cognition.2012.12.002; Huang W., 2002, P C HUM FACT COMP SY, P716, DOI DOI 10.1145/506443.506562; Judge TA, 2004, J APPL PSYCHOL, V89, P428, DOI 10.1037/0021-9010.89.3.428; KENNER AN, 1993, PSYCHOL REP, V72, P625, DOI 10.2466/pr0.1993.72.2.625; Krzyzanowska M, 2011, J BIOSOC SCI, V43, P611, DOI 10.1017/S0021932011000137; Magnusson PKE, 2006, INT J EPIDEMIOL, V35, P658, DOI 10.1093/ije/dyl011; Marsh AA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005707; Murray GR, 2011, SOC SCI QUART, V92, P1215, DOI 10.1111/j.1540-6237.2011.00815.x; Nakagawa S, 2013, METHODS ECOL EVOL, V4, P133, DOI 10.1111/j.2041-210x.2012.00261.x; PECK AMN, 1992, J EPIDEMIOL COMMUN H, V46, P71, DOI 10.1136/jech.46.1.71; Pellegrini AD, 2007, J COMP PSYCHOL, V121, P54, DOI 10.1037/0735-7036.121.1.54; Persico N, 2004, NATL BUR EC RES WORK; Puts DA, 2010, EVOL HUM BEHAV, V31, P157, DOI 10.1016/j.evolhumbehav.2010.02.005; R Core Team, 2018, R LANG ENV STAT COMP; Re DE, 2012, PERCEPTION, V41, P1477, DOI 10.1068/p7342; Rhodes MG, 2009, APPL COGNITIVE PSYCH, V23, P1, DOI 10.1002/acp.1442; Scheipl F., 2020, LINEAR MIXED EFFECTS, DOI 10.18637/jss.v067.i01; Schonbeck Y, 2013, PEDIATR RES, V73, P371, DOI 10.1038/pr.2012.189; Sell A, 2009, P R SOC B, V276, P575, DOI 10.1098/rspb.2008.1177; Silventoinen K, 2004, AM J HUM BIOL, V16, P544, DOI 10.1002/ajhb.20060; Silventoinen K, 1999, INT J EPIDEMIOL, V28, P911, DOI 10.1093/ije/28.5.911; Stogdill RM, 1948, J PSYCHOL, V25, P35, DOI 10.1080/00223980.1948.9917362; Stulp G, 2013, ANIM BEHAV, V86, P37, DOI 10.1016/j.anbehav.2013.03.038; Stulp G, 2013, LEADERSHIP QUART, V24, P159, DOI 10.1016/j.leaqua.2012.09.002; Stulp G, 2012, EVOL PSYCHOL-US, V10, P588, DOI 10.1177/147470491201000314; Stulp G, 2012, AM J HUM BIOL, V24, P486, DOI 10.1002/ajhb.22252; Stulp G, 2012, BEHAV ECOL SOCIOBIOL, V66, P375, DOI 10.1007/s00265-011-1283-2; SUNDSTROM E, 1976, HUM ECOL, V4, P47, DOI 10.1007/BF01531456; Thomsen L, 2011, SCIENCE, V331, P477, DOI 10.1126/science.1199198; Van Vugt M, 2008, AM PSYCHOL, V63, P182, DOI 10.1037/0003-066X.63.3.182; von Rueden C, 2008, EVOL HUM BEHAV, V29, P402, DOI 10.1016/j.evolhumbehav.2008.05.001; Voss LD, 2000, BMJ-BRIT MED J, V320, P612, DOI 10.1136/bmj.320.7235.612; WARREN WH, 1987, J EXP PSYCHOL HUMAN, V13, P371, DOI 10.1037/0096-1523.13.3.371; WILSON PR, 1968, J SOC PSYCHOL, V74, P97, DOI 10.1080/00224545.1968.9919806; Yee N, 2007, HUM COMMUN RES, V33, P271, DOI 10.1111/j.1468-2958.2007.00299.x; Yee N, 2009, COMMUN RES, V36, P285, DOI 10.1177/0093650208330254; Young TJ, 1996, PERCEPT MOTOR SKILL, V82, P1002, DOI 10.1177/003151259608200301	60	53	54	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2015	10	2							e0117860	10.1371/journal.pone.0117860	http://dx.doi.org/10.1371/journal.pone.0117860			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CC2ZH	25719490	Green Accepted, Green Submitted, Green Published, gold			2022-12-27	WOS:000350213200034
J	Tyteca, D; Nishino, T; Debaix, H; Van Der Smissen, P; N'Kuli, F; Hoffmann, D; Cnops, Y; Rabolli, V; van Loo, G; Beyaert, R; Huaux, F; Devuyst, O; Courtoy, PJ				Tyteca, Donatienne; Nishino, Tomoya; Debaix, Huguette; Van Der Smissen, Patrick; N'Kuli, Francisca; Hoffmann, Delia; Cnops, Yvette; Rabolli, Virginie; van Loo, Geert; Beyaert, Rudi; Huaux, Francois; Devuyst, Olivier; Courtoy, Pierre J.			Regulation of Macrophage Motility by the Water Channel Aquaporin-1: Crucial Role of M0/M2 Phenotype Switch	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; KIDNEY PROXIMAL TUBULE; CELL-MIGRATION; ALTERNATIVE ACTIVATION; PHOSPHOINOSITIDE 3-KINASE; PERITONEAL-DIALYSIS; J774 MACROPHAGES; PHOSPHOLIPASE-C; LEADING-EDGE; MDCK CELLS	The water channel aquaporin-1 (AQP1) promotes migration of many cell types. Although AQP1 is expressed in macrophages, its potential role in macrophage motility, particularly in relation with phenotype polarization, remains unknown. We here addressed these issues in peritoneal macrophages isolated from AQP1-deficient mice, either undifferentiated (M0) or stimulated with LPS to orientate towards pro-inflammatory phenotype (classical macrophage activation; M1). In non-stimulated macrophages, ablation of AQP1 (like inhibition by HgCl2) increased by 2-3 fold spontaneous migration in a Src/PI3K/Rac-dependent manner. This correlated with cell elongation and formation of lamellipodia/ruffles, resulting in membrane lipid and F4/80 recruitment to the leading edge. This indicated that AQP1 normally suppresses migration of resting macrophages, as opposed to other cell types. Resting Aqp1(-/-) macrophages exhibited CD206 redistribution into ruffles and increased arginase activity like IL4/IL13 (alternative macrophage activation; M2), indicating a M0-M2 shift. In contrast, upon M1 orientation by LPS in vitro or peritoneal inflammation in vivo, migration of Aqp1(-/-)macrophages was reduced. Taken together, these data indicate that AQP1 oppositely regulates macrophage migration, depending on stimulation or not by LPS, and that macrophage phenotypic and migratory changes may be regulated independently of external cues.	[Tyteca, Donatienne; Van Der Smissen, Patrick; N'Kuli, Francisca; Hoffmann, Delia; Courtoy, Pierre J.] Catholic Univ Louvain, Duve Inst DDUV, CELL Unit, B-1200 Brussels, Belgium; [Nishino, Tomoya; Debaix, Huguette; Cnops, Yvette; Devuyst, Olivier] Catholic Univ Louvain, IREC, Pole Nephrol NEFR, B-1200 Brussels, Belgium; [Rabolli, Virginie; Huaux, Francois] Catholic Univ Louvain, Louvain Ctr Toxicol & Appl Pharmacol LTAP, IREC, B-1200 Brussels, Belgium; [Nishino, Tomoya] Nagasaki Univ, Div Nephrol, Nagasaki 852, Japan; [van Loo, Geert; Beyaert, Rudi] Univ Ghent, Dept Biomed Mol Biol, Inflammat Res Ctr, VIB, B-9000 Ghent, Belgium	Universite Catholique Louvain; Universite Catholique Louvain; Universite Catholique Louvain; Nagasaki University; Flanders Institute for Biotechnology (VIB); Ghent University	Tyteca, D (corresponding author), Catholic Univ Louvain, Duve Inst DDUV, CELL Unit, B-1200 Brussels, Belgium.	donatienne.tyteca@uclouvain.be	Hoffmann, Delia/AAB-6799-2019; Beyaert, Rudi/B-2589-2009; , van Loo Geert/AAD-1220-2019; van Loo, Geert/C-1505-2009	Hoffmann, Delia/0000-0001-5574-6123; , van Loo Geert/0000-0002-8427-4775; Devuyst, Olivier/0000-0003-3744-4767; Beyaert, Rudi/0000-0002-5704-582X	UCL; F.R.S.- FNRS; Region wallonne; Region bruxelloise; Loterie nationale; ARC, (Actions de Recherche concertee); IUAP (The InterUniversity Attraction Poles IUAP (all Belgium); Baxter Healthcare (Extramural Grant Program); Sumitomo Life Social Welfare Services Foundation	UCL; F.R.S.- FNRS(Fonds de la Recherche Scientifique - FNRS); Region wallonne; Region bruxelloise(Innoviris); Loterie nationale; ARC, (Actions de Recherche concertee); IUAP (The InterUniversity Attraction Poles IUAP (all Belgium); Baxter Healthcare (Extramural Grant Program); Sumitomo Life Social Welfare Services Foundation	This work was supported by grants from UCL, F.R.S.-FNRS, Region wallonne, Region bruxelloise, Loterie nationale, ARC, (Actions de Recherche concertee), IUAP (The InterUniversity Attraction Poles IUAP (all Belgium), Baxter Healthcare (Extramural Grant Program) and the Sumitomo Life Social Welfare Services Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amyere M, 2000, MOL BIOL CELL, V11, P3453, DOI 10.1091/mbc.11.10.3453; Belge H, 2006, NEPHROL DIAL TRANSPL, V21, P2069, DOI 10.1093/ndt/gfl162; Carlsson O, 1996, AM J PHYSIOL-HEART C, V271, pH2254, DOI 10.1152/ajpheart.1996.271.6.H2254; Carquin M, 2014, J LIPID RES, V55, P1331, DOI 10.1194/jlr.M048538; Chaumont F, 2005, BIOL CELL, V97, P749, DOI 10.1042/BC20040133; Combet S, 1999, J AM SOC NEPHROL, V10, P2185; D'Auria L, 2013, J LIPID RES, V54, P1066, DOI 10.1194/jlr.M034314; D'auria L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017021; de Diesbach MT, 2010, EXP CELL RES, V316, P3239, DOI 10.1016/j.yexcr.2010.09.001; de Souza LF, 2009, MOL IMMUNOL, V46, P937, DOI 10.1016/j.molimm.2008.09.012; DENKER BM, 1988, J BIOL CHEM, V263, P15634; Fischer G, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000130; Friedl P, 2004, CURR OPIN CELL BIOL, V16, P14, DOI 10.1016/j.ceb.2003.11.001; Gordon S, 2003, NAT REV IMMUNOL, V3, P23, DOI 10.1038/nri978; Hara-Chikuma M, 2006, CELL MOL LIFE SCI, V63, P1386, DOI 10.1007/s00018-006-6028-4; Hara-Chikuma M, 2006, J AM SOC NEPHROL, V17, P39, DOI 10.1681/ASN.2005080846; Houk AR, 2012, CELL, V148, P175, DOI 10.1016/j.cell.2011.10.050; Ishibashi K, 2006, BBA-BIOMEMBRANES, V1758, P989, DOI 10.1016/j.bbamem.2006.02.024; Jay SM, 2007, AM J PATHOL, V171, P632, DOI 10.2353/ajpath.2007.061213; Kleveta G, 2012, J CELL BIOCHEM, V113, P80, DOI 10.1002/jcb.23330; Lam J, 2009, BIOPHYS J, V96, P248, DOI 10.1529/biophysj.108.139154; Lawrence T, 2011, NAT REV IMMUNOL, V11, P750, DOI 10.1038/nri3088; Leidi M, 2009, J IMMUNOL, V182, P4415, DOI 10.4049/jimmunol.0713732; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Ma TH, 1998, J BIOL CHEM, V273, P4296, DOI 10.1074/jbc.273.8.4296; Maeda Norikazu, 2009, Handb Exp Pharmacol, P233, DOI 10.1007/978-3-540-79885-9_12; Martinez FO, 2009, ANNU REV IMMUNOL, V27, P451, DOI 10.1146/annurev.immunol.021908.132532; Maurel C, 2007, FEBS LETT, V581, P2227, DOI 10.1016/j.febslet.2007.03.021; McKnight AJ, 1996, J BIOL CHEM, V271, P486, DOI 10.1074/jbc.271.1.486; McWhorter FY, 2013, P NATL ACAD SCI USA, V110, P17253, DOI 10.1073/pnas.1308887110; Mettlen M, 2006, TRAFFIC, V7, P589, DOI 10.1111/j.1600-0854.2006.00412.x; Monzani E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006167; Mulder R, 2014, IMMUNOBIOLOGY, V219, P737, DOI 10.1016/j.imbio.2014.05.005; Munder M, 1998, J IMMUNOL, V160, P5347; Ni J, 2006, KIDNEY INT, V69, P1518, DOI 10.1038/sj.ki.5000285; Ni J, 2003, J AM SOC NEPHROL, V14, P3205, DOI 10.1097/01.ASN.0000099382.18284.57; NIELSEN S, 1993, P NATL ACAD SCI USA, V90, P7275, DOI 10.1073/pnas.90.15.7275; Ozu M, 2013, BIOPHYS J, V104, P85, DOI 10.1016/j.bpj.2012.11.3818; Papadopoulos MC, 2008, PFLUG ARCH EUR J PHY, V456, P693, DOI 10.1007/s00424-007-0357-5; Pelegrin P, 2009, EMBO J, V28, P2114, DOI 10.1038/emboj.2009.163; Petrie RJ, 2012, J CELL SCI, V125, P5917, DOI 10.1242/jcs.093732; Platek A, 2004, J CELL SCI, V117, P4849, DOI 10.1242/jcs.01359; Pontes B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067708; Prabhu KS, 2002, BIOCHEM J, V366, P203, DOI 10.1042/BJ20020256; Rabolli V, 2014, J BIOL CHEM; Rey-Giraud F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042656; Saadoun S, 2005, NATURE, V434, P786, DOI 10.1038/nature03460; Schwab A, 2001, AM J PHYSIOL-RENAL, V280, pF739, DOI 10.1152/ajprenal.2001.280.5.F739; Soveral G, 1997, J MEMBRANE BIOL, V158, P219; Soveral G, 2008, BBA-BIOMEMBRANES, V1778, P2573, DOI 10.1016/j.bbamem.2008.07.018; Steffen A, 2013, J CELL SCI, V126, P4572, DOI 10.1242/jcs.118232; STEIN M, 1992, J EXP MED, V176, P287, DOI 10.1084/jem.176.1.287; Tyteca D, 2002, EXP CELL RES, V281, P86, DOI 10.1006/excr.2002.5613; Tyteca D, 2010, BBA-BIOMEMBRANES, V1798, P909, DOI 10.1016/j.bbamem.2010.01.021; Van Ginderachter JA, 2006, IMMUNOBIOLOGY, V211, P487, DOI 10.1016/j.imbio.2006.06.002; Vereyken EJF, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-58; Vitorino P, 2008, GENE DEV, V22, P3268, DOI 10.1101/gad.1725808; Vogel DYS, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-23; White SR, 2009, AM J PHYSIOL-LUNG C, V297, pL164, DOI 10.1152/ajplung.90453.2008; Williams LM, 2000, J IMMUNOL, V164, P2028, DOI 10.4049/jimmunol.164.4.2028; Yool AJ, 2013, J AM SOC NEPHROL, V24, P1045, DOI 10.1681/ASN.2012080869; Zhu N, 2011, FASEB J, V25, P4233, DOI 10.1096/fj.11-182808	62	22	23	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2015	10	2							e0117398	10.1371/journal.pone.0117398	http://dx.doi.org/10.1371/journal.pone.0117398			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC2ZH	25719758	Green Published, gold, Green Accepted			2022-12-27	WOS:000350213200023
J	Coulon, M; Nowak, R; Peyrat, J; Chandeze, H; Boissy, A; Boivin, X				Coulon, Marjorie; Nowak, Raymond; Peyrat, Julie; Chandeze, Herve; Boissy, Alain; Boivin, Xavier			Do Lambs Perceive Regular Human Stroking as Pleasant? Behavior and Heart Rate Variability Analyses	PLOS ONE			English	Article							MOTHER-YOUNG INTERACTIONS; DIFFERENT BODY REGIONS; HUMAN CONTACT; RESPONSES; EMOTIONS; WELFARE; STRESS; AVOIDANCE; POSTURES; AFFINITY	Stroking by humans is beneficial to the human-animal relationship and improves welfare in many species that express intraspecific allogrooming, but very few studies have looked at species like sheep that do not express such contact except around parturition. This study investigated the way lambs perceive regular human tactile contact using behavioral and physiological responses. Twenty-four lambs were reared and bucket-fed in groups of four. All were stroked daily by their familiar caregiver. At 8 weeks of age, the lambs were individually tested in their home pen but in a 1x1m open-barred pen after a 15h period of habituation to physical separation from peers while remaining in visual and auditory contact. Half of the lambs received stroking by their caregiver for 8min and half were exposed to their caregiver's immobile presence. Heart rate and heart rate variability were recorded and analyzed by 2-min slots over the same interval based on three measures: mean heart rate value (HR), root mean square of successive differences (RMSSD) and standard deviation of all intervals measured between consecutive sinus beats (SDNN). Behavioral responses (ear postures of the lamb and time spent in contact with the familiar caregiver, on the knees of the familiar caregiver, and moving) were recorded throughout the test. Lamb HR decreased continuously while in the presence of their caregiver. Lambs being stroked showed slower HR and higher RMSSD which reflected positive emotional states compared to lambs left unstroked. All behavioral variables were highly correlated with the main component axis of the PCA analyses: the more the animals stayed in contact with their caregiver, the less they moved and the more their ears were hanging. This first component clearly differentiates lambs being stroked or not. Behavioral and physiological observations support the hypothesis that gentle physical contact with the caregiver is perceived positively by lambs.	[Coulon, Marjorie; Peyrat, Julie; Chandeze, Herve; Boissy, Alain; Boivin, Xavier] INRA, Unite Mixte Rech Herbivores 1213, F-63122 St Genes Champanelle, France; [Coulon, Marjorie; Peyrat, Julie; Chandeze, Herve; Boissy, Alain; Boivin, Xavier] Clermont Univ, Unite Mixte Rech Herbivores, VetAgro Sup, F-63000 Clermont Ferrand, France; [Nowak, Raymond] INRA, Unite Mixte Rech Physiol Reprod & Comportement 85, F-37380 Nouzilly, France; [Nowak, Raymond] CNRS, Unite Mixte Rech 7247, F-37380 Nouzilly, France; [Nowak, Raymond] Univ Tours, F-37041 Tours, France; [Nowak, Raymond] Inst Francais Cheval & Equitat, F-37380 Nouzilly, France	INRAE; VetAgro Sup; INRAE; Centre National de la Recherche Scientifique (CNRS); Universite de Tours	Coulon, M (corresponding author), INRA, Unite Mixte Rech Herbivores 1213, Site Theix, F-63122 St Genes Champanelle, France.	marjoriecoulon82@yahoo.fr		Boivin, xavier/0000-0002-4518-5454	Agence Nationale de la Recherche [French National Agency for Research] [NT09 492885, ANR BOND. 007]	Agence Nationale de la Recherche [French National Agency for Research](French National Research Agency (ANR))	RN received funding by the Agence Nationale de la Recherche [French National Agency for Research] under ANR BOND. 007, no. NT09 492885. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bertenshaw C, 2008, APPL ANIM BEHAV SCI, V114, P65, DOI 10.1016/j.applanim.2007.12.002; Boissy A, 2011, ANIM WELFARE, V20, P47; Boissy A, 2007, PHYSIOL BEHAV, V92, P375, DOI 10.1016/j.physbeh.2007.02.003; Boissy A, 2014, GENETICS AND THE BEHAVIOR OF DOMESTIC ANIMALS, 2ND EDITION, P81, DOI 10.1016/B978-0-12-394586-0.00003-2; Boivin X, 2000, J ANIM SCI, V78, P879; Caro TM, 2004, ANIM BEHAV, V67, P205, DOI 10.1016/j.anbehav.2002.12.007; Coulon M, 2014, STRESS, V17, P460, DOI 10.3109/10253890.2014.969238; Coulon M, 2013, PSYCHONEUROENDOCRINO, V38, P499, DOI 10.1016/j.psyneuen.2012.07.008; Despres G., 2003, Journal of Animal and Veterinary Advances, V2, P615; Destrez A, 2013, J ANIM SCI, V91, P5418, DOI 10.2527/jas.2012-5654; Destrez A, 2013, ANIMAL, V7, P476, DOI 10.1017/S1751731112001796; Diego M, 2009, INT J NEUROSCI, V119, P630, DOI 10.1080/00207450802329605; FEH C, 1993, ANIM BEHAV, V46, P1191, DOI 10.1006/anbe.1993.1309; Fisher Andrew, 2001, P211, DOI 10.1079/9780851993973.0211; Forkman B, 2007, PHYSIOL BEHAV, V92, P340, DOI 10.1016/j.physbeh.2007.03.016; Fraser D, 1998, ANIM WELFARE, V7, P383; Hemsworth P. H., 2011, Animal welfare, P246, DOI 10.1079/9781845936594.0246; Henry S, 2006, DEV PSYCHOBIOL, V48, P712, DOI 10.1002/dev.20189; Markowitz TM, 1998, ANIM BEHAV, V55, P573, DOI 10.1006/anbe.1997.0640; MCCRATY R, 1995, AM J CARDIOL, V76, P1089, DOI 10.1016/S0002-9149(99)80309-9; McMillan FD, 1999, J AM VET MED ASSOC, V215, P1592; Nowak R, 2000, REV REPROD, V5, P153, DOI 10.1530/ror.0.0050153; Nowak R, 2014, APPL ANIM B IN PRESS; Odendaal JSJ, 2003, VET J, V165, P296, DOI 10.1016/S1090-0233(02)00237-X; Overmier JB, 2002, INTEGR PHYS BEH SCI, V37, P4, DOI 10.1007/BF02688801; Pishbin T, 2010, WORLD ACAD SCI ENG T, V46, P523; Plush KJ, 2011, APPL ANIM BEHAV SCI, V134, P130, DOI 10.1016/j.applanim.2011.07.009; Probst JK, 2013, APPL ANIM BEHAV SCI, V144, P14, DOI 10.1016/j.applanim.2012.12.007; Probst JK, 2012, APPL ANIM BEHAV SCI, V139, P42, DOI 10.1016/j.applanim.2012.03.002; Rankin CH, 2009, NEUROBIOL LEARN MEM, V92, P135, DOI 10.1016/j.nlm.2008.09.012; Reefmann N, 2009, ANIM BEHAV, V78, P651, DOI 10.1016/j.anbehav.2009.06.015; Reefmann N, 2009, PHYSIOL BEHAV, V98, P235, DOI 10.1016/j.physbeh.2009.05.017; Reefmann N, 2009, APPL ANIM BEHAV SCI, V118, P199, DOI 10.1016/j.applanim.2009.02.013; Rehn T, 2014, PHYSIOL BEHAV, V124, P45, DOI 10.1016/j.physbeh.2013.10.009; Sankey C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015446; Schmied C, 2008, J DAIRY SCI, V91, P596, DOI 10.3168/jds.2007-0360; Schmied C, 2008, APPL ANIM BEHAV SCI, V109, P25, DOI 10.1016/j.applanim.2007.01.013; Schmied C, 2010, INTERACT STUD, V11, P467, DOI 10.1075/is.11.3.08sch; Tallet C, 2005, APPL ANIM BEHAV SCI, V94, P59, DOI 10.1016/j.applanim.2005.02.007; Tallet C, 2009, APPL ANIM BEHAV SCI, V119, P56, DOI 10.1016/j.applanim.2009.03.012; UvnasMoberg K, 1997, ANN NY ACAD SCI, V807, P146, DOI 10.1111/j.1749-6632.1997.tb51917.x; von Borell E, 2007, PHYSIOL BEHAV, V92, P293, DOI 10.1016/j.physbeh.2007.01.007	42	46	47	0	73	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2015	10	2							e0118617	10.1371/journal.pone.0118617	http://dx.doi.org/10.1371/journal.pone.0118617			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC2IM	25714604	Green Published, gold, Green Submitted			2022-12-27	WOS:000350168700092
J	Luo, ZC; Wang, PF; Zhang, A; Zuo, GQ; Zheng, YY; Huang, Y				Luo, Zhenchun; Wang, Pengfei; Zhang, An; Zuo, Guoqing; Zheng, Yuanyi; Huang, Yan			Evaluation of the Microcirculation in a Rabbit Hemorrhagic Shock Model Using Laser Doppler Imaging	PLOS ONE			English	Article							SYSTEMIC-SCLEROSIS; BLOOD-FLOW	The aim of this study is to evaluate the feasibility of Laser Doppler imaging (LDI) for noninvasive and dynamic assessment of hemorrhagic shock in a rabbit model. A rabbit model of hemorrhagic shock was generated and LDI of the microcirculation in the rabbit ears was performed before and at 0, 30, 60, and 90 min after hemorrhage. The CCD (Charge Coupled Device) image of the ears, the mean arterial pressure (MAP) and the heart rate (HR) were monitored. The mean LDI flux was calculated. The HR of rabbits was significantly (p < 0.05) elevated and the MAP was decreased after hemorrhage, compared to the pre-hemorrhage level. Within the initial 30 min after hemorrhage, the perfusion flux lineally dropped down. In contrast, the MAP values did not differ significantly between the time points of 0 and 30 after hemorrhage (p > 0.05). Both the flux numbers and the red-to-blue color changes on LDI imaging showed the reduction of the microcirculation. LDI imaging is a noninvasive and non-contact approach to evaluate the microcirculation and may offer benefits in the diagnosis and treatment of hemorrhage shock. Further studies are needed to confirm its effectiveness in clinical practice.	[Luo, Zhenchun; Wang, Pengfei; Zhang, An] Chongqing Med Univ, Affiliated Hosp 2, Dept Crit Care Med, Chongqing, Peoples R China; [Zheng, Yuanyi] Chongqing Med Univ, Affiliated Hosp 2, Dept Ultrasound, Chongqing, Peoples R China; [Huang, Yan] Chongqing Med Univ, Affiliated Hosp 2, Dept Anesthesiol, Chongqing, Peoples R China; [Zuo, Guoqing] Tradit Chinese Med Hosp Chongqing, Dept Internal Med, Chongqing, Peoples R China	Chongqing Medical University; Chongqing Medical University; Chongqing Medical University	Huang, Y (corresponding author), Chongqing Med Univ, Affiliated Hosp 2, Dept Anesthesiol, Chongqing, Peoples R China.	huangyancum@gmail.com			National Nature Science Foundation of China [81270021, 30900371, 81227801, 81161120548, 81130025, 81271598]; Key Project of Chinese Ministry of Education [2012-76]; Chongqing Funding of China [KJ120328, 2012-1-040, 2010-2159]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Project of Chinese Ministry of Education(Ministry of Education, China); Chongqing Funding of China	This work was supported in part by the National Nature Science Foundation of China (No. 81270021, 30900371, 81227801, 81161120548, 81130025, 81271598), the Key Project of Chinese Ministry of Education (No. 2012-76) and Chongqing Funding of China (KJ120328, 2012-1-040, 2010-2159). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bezemer R, 2012, CRIT CARE, V16, DOI 10.1186/cc11236; Bornmyr S, 2001, CLIN PHYSIOL, V21, P570, DOI 10.1046/j.1365-2281.2001.00364.x; GOODFIELD MJD, 1988, BRIT J DERMATOL, V118, P661, DOI 10.1111/j.1365-2133.1988.tb02567.x; GROH J, 1990, Infusionstherapie, V17, P4; Gundersen Y, 2001, ACTA ANAESTH SCAND, V45, P994, DOI 10.1034/j.1399-6576.2001.450812.x; Holland AJA, 2002, BURNS, V28, P11, DOI 10.1016/S0305-4179(01)00064-X; Kaiser ML, 2011, J TRAUMA, V71, P401, DOI 10.1097/TA.0b013e318225458c; Mill J, 2009, BURNS, V35, P824, DOI 10.1016/j.burns.2008.11.016; Murray AK, 2006, ARTHRITIS RHEUM, V54, P1952, DOI 10.1002/art.21911; Murray AK, 2004, RHEUMATOLOGY, V43, P1210, DOI 10.1093/rheumatology/keh275; Seeley HF, 1987, BR J HOSP MED, V37, p[14, 16]; Sheng C, 2011, J SURG RES, V168, P103, DOI 10.1016/j.jss.2009.09.007; Yao LN, 2009, J SURG RES, V155, P25, DOI 10.1016/j.jss.2008.07.012	14	4	4	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2015	10	2							e0116076	10.1371/journal.pone.0116076	http://dx.doi.org/10.1371/journal.pone.0116076			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC2IM	25714398	Green Published, gold, Green Submitted			2022-12-27	WOS:000350168700010
J	Mbongue, JC; Nicholas, DA; Zhang, KL; Kim, NS; Hamilton, BN; Larios, M; Zhang, GY; Umezawa, K; Firek, AF; Langridge, WHR				Mbongue, Jacques C.; Nicholas, Dequina A.; Zhang, Kangling; Kim, Nan-Sun; Hamilton, Brittany N.; Larios, Marco; Zhang, Guangyu; Umezawa, Kazuo; Firek, Anthony F.; Langridge, William H. R.			Induction of Indoleamine 2, 3-Dioxygenase in Human Dendritic Cells by a Cholera Toxin B Subunit-Proinsulin Vaccine	PLOS ONE			English	Article							REGULATORY T-CELLS; ARYL-HYDROCARBON RECEPTOR; NONOBESE DIABETIC MICE; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; NOD MICE; TRYPTOPHAN CATABOLISM; IMMUNE-RESPONSES; IN-VITRO; 2,3-DIOXYGENASE; INHIBITION	Dendritic cells (DC) interact with naive T cells to regulate the delicate balance between immunity and tolerance required to maintain immunological homeostasis. In this study, immature human dendritic cells (iDC) were inoculated with a chimeric fusion protein vaccine containing the pancreatic beta-cell auto-antigen proinsulin linked to a mucosal adjuvant the cholera toxin B subunit (CTB-INS). Proteomic analysis of vaccine inoculated DCs revealed strong up-regulation of the tryptophan catabolic enzyme indoleamine 2, 3-dioxygenase (IDO1). Increased biosynthesis of the immunosuppressive enzyme was detected in DCs inoculated with the CTB-INS fusion protein but not in DCs inoculated with proinsulin, CTB, or an unlinked combination of the two proteins. Immunoblot and PCR analyses of vaccine treated DCs detected IDO1mRNA by 3 hours and IDO1 protein synthesis by 6 hours after vaccine inoculation. Determination of IDO1 activity in vaccinated DCs by measurement of tryptophan degradation products (kynurenines) showed increased tryptophan cleavage into N-formyl kynurenine. Vaccination did not interfere with monocytes differentiation into DC, suggesting the vaccine can function safely in the human immune system. Treatment of vaccinated DCs with pharmacological NF-kappa B inhibitors ACHP or DHMEQ significantly inhibited IDO1 biosynthesis, suggesting a role for NF-kappa B signaling in vaccine up-regulation of dendritic cell IDO1. Heat map analysis of the proteomic data revealed an overall down-regulation of vaccinated DC functions, suggesting vaccine suppression of DC maturation. Together, our experimental data indicate that CTB-INS vaccine induction of IDO1 biosynthesis in human DCs may result in the inhibition of DC maturation generating a durable state of immunological tolerance. Understanding how CTB-INS modulates IDO1 activity in human DCs will facilitate vaccine efficacy and safety, moving this immunosuppressive strategy closer to clinical applications for prevention of type 1 diabetes autoimmunity.	[Mbongue, Jacques C.; Nicholas, Dequina A.; Kim, Nan-Sun; Hamilton, Brittany N.; Larios, Marco; Langridge, William H. R.] Loma Linda Univ, Sch Med, Dept Basic Sci, Ctr Hlth Dispar & Mol Med, Loma Linda, CA 92350 USA; [Mbongue, Jacques C.] Loma Linda Univ, Sch Med, Dept Basic Sci, Div Physiol, Loma Linda, CA 92350 USA; [Nicholas, Dequina A.; Zhang, Kangling; Kim, Nan-Sun; Zhang, Guangyu; Langridge, William H. R.] Loma Linda Univ, Sch Med, Dept Basic Sci, Dept Biochem,Mass Spectrometer Core Facil, Loma Linda, CA 92350 USA; [Zhang, Kangling] Univ Texas Med Branch, Sch Med, Dept Pharmacol & Toxicol, Galveston, TX 77555 USA; [Hamilton, Brittany N.] Loma Linda Univ, Sch Med, Dept Basic Sci, Div Microbiol & Mol Genet, Loma Linda, CA 92350 USA; [Umezawa, Kazuo] Aichi Med Univ, Sch Med, Dept Mol Target Med Screening, Nagakute, Aichi 48011, Japan; [Firek, Anthony F.] JL Pettis Mem VA Med Ctr, Endocrinol Sect, Loma Linda, CA USA; [Kim, Nan-Sun] Chonbuk Natl Univ, Dept Mol Biol, Jeonju 561756, South Korea	Loma Linda University; Loma Linda University; Loma Linda University; University of Texas System; University of Texas Medical Branch Galveston; Loma Linda University; Aichi Medical University; Jeonbuk National University	Langridge, WHR (corresponding author), Loma Linda Univ, Sch Med, Dept Basic Sci, Ctr Hlth Dispar & Mol Med, Loma Linda, CA 92350 USA.	blangridge@llu.edu	Nicholas, Dequina/AAF-1412-2019	Mbongue, Jacques/0000-0002-7123-3480; Nicholas, Dequina/0000-0003-4996-2190	NIH [DK-99-013, 1S10RR027643, 5P20MD006988]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR027643] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R25GM060507] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [P20MD006988] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This work was funded in part by NIH award DK-99-013 to W.H.R.L, 1S10RR027643 to K.Z. and 5P20MD006988 to the Loma Linda University Center for Health Disparities and Molecular Medicine and to the Loma Linda University Research Fund to A.F.F. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen JS, 2009, DIABETES, V58, P138, DOI 10.2337/db08-0964; Arakawa T, 1998, NAT BIOTECHNOL, V16, P292, DOI 10.1038/4381; Aspord C, 2002, CLIN EXP IMMUNOL, V130, P204, DOI 10.1046/j.1365-2249.2002.01988.x; ATKINSON MA, 1994, NEW ENGL J MED, V331, P1428; Belladonna ML, 2007, TRANSPLANTATION, V84, pS17, DOI 10.1097/01.tp.0000269199.16209.22; Bergerot I, 1997, P NATL ACAD SCI USA, V94, P4610, DOI 10.1073/pnas.94.9.4610; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Carrero JA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059701; Carter JE, 2006, MOL BIOTECHNOL, V32, P1, DOI 10.1385/MB:32:1:001; CAUX C, 1995, IMMUNOL TODAY, V16, P2, DOI 10.1016/0167-5699(95)80061-1; Chang Tammy T, 2002, Curr Dir Autoimmun, V5, P113; Chapuis F, 1997, EUR J IMMUNOL, V27, P431, DOI 10.1002/eji.1830270213; Denes B, 2005, J IMMUNOTHER, V28, P438, DOI 10.1097/01.cji.0000171315.82997.9a; Denes B, 2006, MOL BIOTECHNOL, V34, P317, DOI 10.1385/MB:34:3:317; Denes B, 2013, CLIN DEV IMMUNOL, DOI 10.1155/2013/578786; Dilioglou S, 2003, EXP MOL PATHOL, V75, P217, DOI 10.1016/S0014-4800(03)00072-8; EISENBARTH GS, 1986, NEW ENGL J MED, V314, P1360; Fallarino F, 2006, J IMMUNOL, V176, P6752, DOI 10.4049/jimmunol.176.11.6752; Fallarino I, 2002, CELL DEATH DIFFER, V9, P1069, DOI 10.1038/sj.cdd.4401073; Faure-Andre G, 2008, SCIENCE, V322, P1705, DOI 10.1126/science.1159894; Forbes JM, 2013, PHYSIOL REV, V93, P137, DOI 10.1152/physrev.00045.2011; Frumento G, 2002, J EXP MED, V196, P459, DOI 10.1084/jem.20020121; Ganguly D, 2013, NAT REV IMMUNOL, V13, P566, DOI 10.1038/nri3477; Grohmann U, 2003, J EXP MED, V198, P153, DOI 10.1084/jem.20030633; Han BY, 2005, J CLIN INVEST, V115, P1879, DOI 10.1172/JCI24219; Harden JL, 2012, IMMUNOL INVEST, V41, P738, DOI 10.3109/08820139.2012.676122; Itano AA, 2003, IMMUNITY, V19, P47, DOI 10.1016/S1074-7613(03)00175-4; Koch LK, 2009, BLOOD, V114, P5062, DOI 10.1182/blood-2009-06-227587; Kutter D, 2000, ACTA HAEMATOL-BASEL, V104, P10, DOI 10.1159/000041062; Lanier LL, 1998, NATURE, V391, P703, DOI 10.1038/35642; Matozaki T, 2009, TRENDS CELL BIOL, V19, P72, DOI 10.1016/j.tcb.2008.12.001; Mbongue J, 2014, J IMMUNOL RES, V2014, DOI 10.1155/2014/857143; Melendez-Ramirez LY, 2010, ENDOCRIN METAB CLIN, V39, P625, DOI 10.1016/j.ecl.2010.05.009; Meng QH, 2011, CLIN DEV IMMUNOL, DOI 10.1155/2011/831704; Mezrich JD, 2010, J IMMUNOL, V185, P3190, DOI 10.4049/jimmunol.0903670; Muller AJ, 2005, NAT MED, V11, P312, DOI 10.1038/nm1196; NAJFELD V, 1993, CYTOGENET CELL GENET, V64, P231, DOI 10.1159/000133584; Nguyen NT, 2010, P NATL ACAD SCI USA, V107, P19961, DOI 10.1073/pnas.1014465107; Odumosu O, 2010, TOXINS, V2, P1612, DOI 10.3390/toxins2071612; Odumosu O, 2011, VACCINE, V29, P8451, DOI 10.1016/j.vaccine.2011.07.077; Odumosu O, 2011, IMMUNOBIOLOGY, V216, P447, DOI 10.1016/j.imbio.2010.09.008; Orabona C, 2006, BLOOD, V107, P2846, DOI 10.1182/blood-2005-10-4077; Pallotta MT, 2011, NAT IMMUNOL, V12, P870, DOI 10.1038/ni.2077; Pallotta MT, 2014, J CELL MOL MED, V18, P2082, DOI 10.1111/jcmm.12360; Palucka K, 2010, IMMUNITY, V33, P464, DOI 10.1016/j.immuni.2010.10.007; Phipps PA, 2003, EUR J IMMUNOL, V33, P224, DOI 10.1002/immu.200390025; Ploix C, 1999, DIABETES, V48, P2150, DOI 10.2337/diabetes.48.11.2150; Prado C, 2012, J IMMUNOL, V188, P3062, DOI 10.4049/jimmunol.1103096; Pulendran B, 1999, P NATL ACAD SCI USA, V96, P1036, DOI 10.1073/pnas.96.3.1036; Pulendran B, 2001, J IMMUNOL, V167, P5067, DOI 10.4049/jimmunol.167.9.5067; Relloso M, 2002, J IMMUNOL, V168, P2634, DOI 10.4049/jimmunol.168.6.2634; Ruhlman T, 2007, PLANT BIOTECHNOL J, V5, P495, DOI 10.1111/j.1467-7652.2007.00259.x; Salahshoor Mohammad Reza, 2013, Int J Prev Med, V4, P1402; Sanda T, 2005, CLIN CANCER RES, V11, P1974, DOI 10.1158/1078-0432.CCR-04-1936; Schmidt NW, 2006, J IMMUNOL, V177, P7203, DOI 10.4049/jimmunol.177.10.7203; Sick E, 2012, BRIT J PHARMACOL, V167, P1415, DOI 10.1111/j.1476-5381.2012.02099.x; Slavica L, 2012, SCAND J IMMUNOL, V76, P113, DOI 10.1111/j.1365-3083.2012.02713.x; Stanford M, 2004, CLIN EXP IMMUNOL, V137, P201, DOI 10.1111/j.1365-2249.2004.02520.x; Sun JB, 2012, J IMMUNOL, V188, P1686, DOI 10.4049/jimmunol.1101771; TAKIKAWA O, 1988, J BIOL CHEM, V263, P2041; Tang QZ, 2006, NAT IMMUNOL, V7, P83, DOI 10.1038/ni1289; Tas SW, 2007, BLOOD, V110, P1540, DOI 10.1182/blood-2006-11-056010; Terness P, 2002, J EXP MED, V196, P447, DOI 10.1084/jem.20020052; Tisch R, 1996, CELL, V85, P291, DOI 10.1016/S0092-8674(00)81106-X; Umezawa K, 2006, CANCER SCI, V97, P990, DOI 10.1111/j.1349-7006.2006.00285.x; Van VQ, 2006, EMBO J, V25, P5560, DOI 10.1038/sj.emboj.7601415; Vogel CFA, 2013, IMMUNOL CELL BIOL, V91, P568, DOI 10.1038/icb.2013.43; Woltman AM, 2003, J LEUKOCYTE BIOL, V73, P428, DOI 10.1189/jlb.0902431; Yan YP, 2010, J IMMUNOL, V185, P5953, DOI 10.4049/jimmunol.1001628; Zaher SS, 2011, INVEST OPHTH VIS SCI, V52, P2640, DOI 10.1167/iovs.10-5793; Ziegler-Heitbrock L, 2010, BLOOD, V116, pE74, DOI 10.1182/blood-2010-02-258558	71	20	21	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2015	10	2							e0118562	10.1371/journal.pone.0118562	http://dx.doi.org/10.1371/journal.pone.0118562			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC2IM	25714914	gold, Green Submitted, Green Published			2022-12-27	WOS:000350168700087
J	Harris, AC; LeSage, MG; Shelley, D; Perry, JL; Pentel, PR; Owens, SM				Harris, Andrew C.; LeSage, Mark G.; Shelley, David; Perry, Jennifer L.; Pentel, Paul R.; Owens, S. Michael			The Anti-(+)-Methamphetamine Monoclonal Antibody mAb7F9 Attenuates Acute (+)-Methamphetamine Effects on Intracranial Self-Stimulation in Rats	PLOS ONE			English	Article							BRAIN REWARD FUNCTION; METHAMPHETAMINE ADDICTION; INDIVIDUAL-DIFFERENCES; CHRONIC AMPHETAMINE; NICOTINE; WITHDRAWAL; DECREASES; PHARMACOTHERAPY; ANTAGONISTS; SMOKING	Passive immunization with monoclonal antibodies (mAbs) against (+)-methamphetamine (METH) is being evaluated for the treatment of METH addiction. A human/mouse chimeric form of the murine anti-METH mAb7F9 has entered clinical trials. This study examined the effects of murine mAb7F9 on certain addiction-related behavioral effects of METH in rats as measured using intracranial self-stimulation (ICSS). Initial studies indicated that acute METH (0.1-0.56 mg/kg, s.c.) lowered the minimal (threshold) stimulation intensity that maintained ICSS. METH (0.3 mg/kg, s.c.) also blocked elevations in ICSS thresholds (anhedonia-like behavior) during spontaneous withdrawal from a chronic METH infusion (10 mg/kg/day x 7 days). In studies examining effects of i.v. pretreatment with mAb7F9 (at 30, 100, or 200 mg/kg), 200 mg/kg blocked the ability of an initial injection of METH (0.3 mg/kg, s.c.) to reduce baseline ICSS thresholds, but was less capable of attenuating the effect of subsequent daily injections of METH. MAb7F9 (200 mg/kg) also produced a small but significant reduction in the ability of METH (0.3 mg/kg, s.c.) to reverse METH withdrawal-induced elevations in ICSS thresholds. These studies demonstrate that mAb7F9 can partially attenuate some addiction-related effects of acute METH in an ICSS model, and provide some support for the therapeutic potential of mAb7F9 for the treatment of METH addiction.	[Harris, Andrew C.; LeSage, Mark G.; Shelley, David; Perry, Jennifer L.; Pentel, Paul R.] Minneapolis Med Res Fdn Inc, Minneapolis, MN 55415 USA; [Harris, Andrew C.; LeSage, Mark G.; Pentel, Paul R.] Univ Minnesota, Sch Med, Dept Med, Minneapolis, MN 55455 USA; [Owens, S. Michael] Univ Arkansas Med Sci, Coll Med, Dept Pharmacol & Toxicol, Little Rock, AR 72205 USA	Minneapolis Medical Research Foundation; University of Minnesota System; University of Minnesota Twin Cities; University of Arkansas System; University of Arkansas Medical Sciences	Harris, AC (corresponding author), Minneapolis Med Res Fdn Inc, Minneapolis, MN 55415 USA.	harr0547@umn.edu	LeSage, Mark G./AAS-8628-2020		National Institute on Drug Abuse [U01-DA023900]; Minneapolis Medical Research Translational Addiction Research Program; National Center for Advancing Translational Sciences [UL1TR000039]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000039] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [U01DA023900] Funding Source: NIH RePORTER	National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); Minneapolis Medical Research Translational Addiction Research Program; National Center for Advancing Translational Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	Supported by the National Institute on Drug Abuse (U01-DA023900 awarded to SMO), the Minneapolis Medical Research Translational Addiction Research Program (awarded to ACH), and the National Center for Advancing Translational Sciences (UL1TR000039 awarded to SMO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bauer CT, 2013, BRIT J PHARMACOL, V168, P850, DOI 10.1111/j.1476-5381.2012.02214.x; Byrnes-Blake KA, 2003, EUR J PHARMACOL, V461, P119, DOI 10.1016/S0014-2999(03)01313-X; Caggiula AR, 2009, NEBR SYM MOTIV, V55, P91, DOI 10.1007/978-0-387-78748-0_6; Carroll FI, 2009, J MED CHEM, V52, P7301, DOI 10.1021/jm901134w; Chaudhri N, 2006, PSYCHOPHARMACOLOGY, V184, P353, DOI 10.1007/s00213-005-0178-1; Cryan JF, 2003, BIOL PSYCHIAT, V54, P49, DOI 10.1016/S0006-3223(02)01730-4; Elkashef A, 2008, SUBST ABUS, V29, P31, DOI 10.1080/08897070802218554; Epping-Jordan MP, 1998, NATURE, V393, P76, DOI 10.1038/30001; Gentry WB, 2010, CLIN PHARMACOL THER, V88, P390, DOI 10.1038/clpt.2010.155; Gentry WB, 2009, HUM VACCINES, V5, P206, DOI 10.4161/hv.5.4.7456; Gentry WB, 2006, INT IMMUNOPHARMACOL, V6, P968, DOI 10.1016/j.intimp.2006.01.008; Hambuchen MD, 2014, VACCINE; Harris AC, 2008, EXP CLIN PSYCHOPHARM, V16, P86, DOI 10.1037/1064-1297.16.1.86; Harris AC, 2011, PSYCHOPHARMACOLOGY, V217, P153, DOI 10.1007/s00213-011-2273-9; Harris AC, 2010, PHARMACOL BIOCHEM BE, V96, P217, DOI 10.1016/j.pbb.2010.05.008; Harris AC, 2009, PSYCHOPHARMACOLOGY, V205, P599, DOI 10.1007/s00213-009-1567-7; Harrison AA, 2002, PSYCHOPHARMACOLOGY, V160, P56, DOI 10.1007/s00213-001-0953-6; Higley AE, 2011, J PSYCHOPHARMACOL, V25, P263, DOI 10.1177/0269881109358201; Jang CG, 2013, PSYCHOPHARMACOLOGY, V225, P753, DOI 10.1007/s00213-012-2864-0; KORNETSKY C, 1979, FED PROC, V38, P2473; Laurenzana EM, 2009, VACCINE, V27, P7011, DOI 10.1016/j.vaccine.2009.09.072; Laurenzana EM, 2003, DRUG METAB DISPOS, V31, P1320, DOI 10.1124/dmd.31.11.1320; Laurenzana EM, 2014, HUM VACC IMMUNOTHER, V10; Lin D, 2000, PHARMACOL BIOCHEM BE, V65, P407, DOI 10.1016/S0091-3057(99)00213-0; Lin D, 1999, PSYCHOPHARMACOLOGY, V145, P283, DOI 10.1007/s002130051060; Manbeck KE, 2014, PHARMACOL BIOCHEM BE, V116, P84, DOI 10.1016/j.pbb.2013.11.002; MARKOU A, 1992, PHYSIOL BEHAV, V51, P111, DOI 10.1016/0031-9384(92)90211-J; McMillan DE, 2004, J PHARMACOL EXP THER, V309, P1248, DOI 10.1124/jpet.103.061762; McMillan DE, 2002, BEHAV PHARMACOL, V13, P465; Meredith CW, 2005, HARVARD REV PSYCHIAT, V13, P141, DOI 10.1080/10673220591003605; Miyata H, 2011, CURR NEUROPHARMACOL, V9, P63, DOI 10.2174/157015911795017218; Owens SM, 2011, CNS NEUROL DISORD-DR, V10, P892; Panenka WJ, 2013, DRUG ALCOHOL DEPEN, V129, P167, DOI 10.1016/j.drugalcdep.2012.11.016; Paterson NE, 2000, PSYCHOPHARMACOLOGY, V152, P440, DOI 10.1007/s002130000559; Paterson NE, 2008, NICOTINE TOB RES, V10, P995, DOI 10.1080/14622200802097571; Paterson NE, 2009, BEHAV PHARMACOL, V20, P211, DOI 10.1097/FBP.0b013e32832c7083; Peterson EC, 2014, ADV PHARMACOL, V69, P107, DOI 10.1016/B978-0-12-420118-7.00003-2; Roiko SA, 2009, PHARMACOL BIOCHEM BE, V93, P105, DOI 10.1016/j.pbb.2009.04.011; Rose ME, 2008, ANN CLIN PSYCHIATRY, V20, P145, DOI 10.1080/10401230802177656; Stevens MW, 2014, MABS-AUSTIN, V6, P547, DOI 10.4161/mabs.27620; Thorn DA, 2012, EUR J PHARMACOL, V680, P69, DOI 10.1016/j.ejphar.2012.01.037; Wise RA, 1996, ANNU REV NEUROSCI, V19, P319, DOI 10.1146/annurev.ne.19.030196.001535; Wise RA, 2002, NEURON, V36, P229, DOI 10.1016/S0896-6273(02)00965-0	43	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2015	10	3							e0118787	10.1371/journal.pone.0118787	http://dx.doi.org/10.1371/journal.pone.0118787			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9KG	25742165	Green Submitted, Green Published, gold			2022-12-27	WOS:000350688100047
J	Yang, ML; Wu, Y; Jin, S; Hou, JY; Mao, YJ; Liu, WB; Shen, YC; Wu, LF				Yang, Minglei; Wu, Ying; Jin, Shan; Hou, Jinyan; Mao, Yingji; Liu, Wenbo; Shen, Yangcheng; Wu, Lifang			Flower Bud Transcriptome Analysis of Sapium sebiferum (Linn.) Roxb. and Primary Investigation of Drought Induced Flowering: Pathway Construction and G-Quadruplex Prediction Based on Transcriptome	PLOS ONE			English	Article							ABSCISIC-ACID BIOSYNTHESIS; SIGNALING PATHWAYS; FLORAL INDUCTION; JATROPHA-CURCAS; SALICYLIC-ACID; GENE; ARABIDOPSIS; STRESS; EXPRESSION; FAMILY	Sapium sebiferum (Linn.) Roxb. (Chinese Tallow Tree) is a perennial woody tree and its seeds are rich in oil which hold great potential for biodiesel production. Despite a traditional woody oil plant, our understanding on S. sebiferum genetics and molecular biology remains scant. In this study, the first comprehensive transcriptome of S. sebiferum flower has been generated by sequencing and de novo assembly. A total of 149,342 unigenes were generated from raw reads, of which 24,289 unigenes were successfully matched to public database. A total of 61 MADS box genes and putative pathways involved in S. sebiferum flower development have been identified. Abiotic stress response network was also constructed in this work, where 2,686 unigenes are involved in the pathway. As for lipid biosynthesis, 161 unigenes have been identified in fatty acid (FA) and triacylglycerol (TAG) biosynthesis. Besides, the G-Quadruplexes in RNA of S. sebiferum also have been predicted. An interesting finding is that the stress-induced flowering was observed in S. sebiferum for the first time. According to the results of semi-quantitative PCR, expression tendencies of flowering-related genes, GA1, AP2 and CRY2, accorded with stress-related genes, such as GRX50435 and PRX parallel to 39562. This transcriptome provides functional genomic information for further research of S. sebiferum, especially for the genetic engineering to shorten the juvenile period and improve yield by regulating flower development. It also offers a useful database for the research of other Euphorbiaceae family plants.	[Yang, Minglei; Wu, Ying; Jin, Shan; Hou, Jinyan; Mao, Yingji; Liu, Wenbo; Shen, Yangcheng; Wu, Lifang] Chinese Acad Sci, Key Lab Ion Beam Bioengn, Hefei Inst Phys Sci, Hefei, Anhui, Peoples R China; [Yang, Minglei; Wu, Ying; Jin, Shan; Hou, Jinyan; Mao, Yingji; Liu, Wenbo; Shen, Yangcheng; Wu, Lifang] Chinese Acad Sci, Bioenergy Forest Res Ctr State Forestry Adm, Hefei Inst Phys Sci, Hefei, Anhui, Peoples R China; [Wu, Ying; Mao, Yingji; Liu, Wenbo; Wu, Lifang] Univ Sci & Technol China, Sch Life Sci, Hefei 230026, Anhui, Peoples R China; [Wu, Ying] Henan Univ Sci & Technol, Coll Food & Bioengn, Luoyang, Henan, Peoples R China; [Shen, Yangcheng] Anhui Univ, Sch Life Sci, Hefei 230039, Anhui, Peoples R China	Chinese Academy of Sciences; Hefei Institutes of Physical Science, CAS; Chinese Academy of Sciences; Hefei Institutes of Physical Science, CAS; Chinese Academy of Sciences; University of Science & Technology of China, CAS; Henan University of Science & Technology; Anhui University	Wu, LF (corresponding author), Chinese Acad Sci, Key Lab Ion Beam Bioengn, Hefei Inst Phys Sci, Hefei, Anhui, Peoples R China.	lfwu@ipp.ac.cn	Mao, Yingji/AAW-7766-2020	Mao, Yingji/0000-0001-9737-1526; Jin, Shan/0000-0001-7531-9997	Special Fund for Forest Scientific Research in the Public Welfare [201404110]; National Nature Science Foundation of China [11375232]; Fund of Hefei Center of Physical Science and Technology [2012FXCX006]	Special Fund for Forest Scientific Research in the Public Welfare; National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fund of Hefei Center of Physical Science and Technology	This research was supported by Special Fund for Forest Scientific Research in the Public Welfare (201404110), National Nature Science Foundation of China (11375232), and Fund of Hefei Center of Physical Science and Technology (2012FXCX006). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe M, 2005, SCIENCE, V309, P1052, DOI 10.1126/science.1115983; Aguilar PS, 2001, EMBO J, V20, P1681, DOI 10.1093/emboj/20.7.1681; Aukerman MJ, 2003, PLANT CELL, V15, P2730, DOI 10.1105/tpc.016238; Blazquez MA, 1997, DEVELOPMENT, V124, P3835; Castillejo C, 2008, CURR BIOL, V18, P1338, DOI 10.1016/j.cub.2008.07.075; Danquah A, 2014, BIOTECHNOL ADV, V32, P40, DOI 10.1016/j.biotechadv.2013.09.006; Deng J., 2010, COTTON SCI, V22, P6; Dewalt SJ, 2006, MOL ECOL NOTES, V6, P505, DOI 10.1111/j.1471-8286.2006.01296.x; Di Antonio M, 2012, METHODS, V57, P84, DOI 10.1016/j.ymeth.2012.01.008; Ding YL, 2014, NATURE, V505, P696, DOI 10.1038/nature12756; Divakara BN, 2010, APPL ENERG, V87, P732, DOI 10.1016/j.apenergy.2009.07.013; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Horvath D, 2009, PLANT SCI, V177, P523, DOI 10.1016/j.plantsci.2009.09.002; Jack T, 2001, TRENDS PLANT SCI, V6, P310, DOI 10.1016/S1360-1385(01)01987-2; Jaryan V, 2014, ENVIRON MONIT ASSESS, V186, P4423, DOI 10.1007/s10661-014-3708-7; Jiang K, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1004043; Jung C, 2009, TRENDS PLANT SCI, V14, P563, DOI 10.1016/j.tplants.2009.07.005; Jung JH, 2007, PLANT CELL, V19, P2736, DOI 10.1105/tpc.107.054528; Kasuga M, 1999, NAT BIOTECHNOL, V17, P287, DOI 10.1038/7036; Knight H, 2001, TRENDS PLANT SCI, V6, P262, DOI 10.1016/S1360-1385(01)01946-X; Kumar O, 2007, CELLULAR MOL BIOL, V53, P10; Kumar S, 2004, BRIEF BIOINFORM, V5, P150, DOI 10.1093/bib/5.2.150; Kumari S, 2007, NAT CHEM BIOL, V3, P218, DOI 10.1038/nchembio864; Leseberg CH, 2006, GENE, V378, P84, DOI 10.1016/j.gene.2006.05.022; Liotenberg S, 1999, PLANT PHYSIOL BIOCH, V37, P341, DOI 10.1016/S0981-9428(99)80040-0; Makkar HRS, 2009, EUR J LIPID SCI TECH, V111, P773, DOI 10.1002/ejlt.200800244; Martinez C, 2004, PLANT J, V37, P209, DOI 10.1046/j.1365-313X.2003.01954.x; Mathieu J, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000148; Moon J, 2003, PLANT J, V35, P613, DOI 10.1046/j.1365-313X.2003.01833.x; Mullen MA, 2010, NUCLEIC ACIDS RES, V38, P8149, DOI 10.1093/nar/gkq804; Murata N, 1997, PLANT PHYSIOL, V115, P875, DOI 10.1104/pp.115.3.875; Nagao K, 2005, J BIOSCI BIOENG, V100, P152, DOI 10.1263/jbb.100.152; Nakagawa M, 2012, SCI HORTIC-AMSTERDAM, V139, P108, DOI 10.1016/j.scienta.2012.03.005; Nakashima K, 1997, PLANT J, V12, P851, DOI 10.1046/j.1365-313X.1997.12040851.x; Orvar BL, 2000, PLANT J, V23, P785, DOI 10.1046/j.1365-313x.2000.00845.x; Parenicova L, 2003, PLANT CELL, V15, P1538, DOI 10.1105/tpc.011544; Park J, 1998, J MOL BIOL, V284, P1201, DOI 10.1006/jmbi.1998.2221; Park SY, 2004, MOL GENET GENOMICS, V271, P339, DOI 10.1007/s00438-004-0986-8; Peng X, 2008, CHINESE WILD PLANT R, V27; Qin XQ, 1999, P NATL ACAD SCI USA, V96, P15354, DOI 10.1073/pnas.96.26.15354; Reiser V, 2003, J CELL BIOL, V161, P1035, DOI 10.1083/jcb.200301099; Roychoudhury A, 2013, PLANT CELL REP, V32, P985, DOI 10.1007/s00299-013-1414-5; Schmid M, 2003, DEVELOPMENT, V130, P6001, DOI 10.1242/dev.00842; Seo M, 2000, P NATL ACAD SCI USA, V97, P12908, DOI 10.1073/pnas.220426197; Song YH, 2013, TRENDS PLANT SCI, V18, P575, DOI 10.1016/j.tplants.2013.05.003; Suzuki I, 2000, EMBO J, V19, P1327, DOI 10.1093/emboj/19.6.1327; Takahashi H, 2012, J BIOSCI BIOENG, V114, P570, DOI 10.1016/j.jbiosc.2012.05.017; Thompson AJ, 2000, PLANT J, V23, P363, DOI 10.1046/j.1365-313x.2000.00789.x; Turck F, 2008, ANNU REV PLANT BIOL, V59, P573, DOI 10.1146/annurev.arplant.59.032607.092755; van Nocker S, 2003, BMC GENOMICS, V4, DOI 10.1186/1471-2164-4-50; Wada KC, 2010, PLANT SIGNAL BEHAV, V5, P944, DOI 10.4161/psb.5.8.11826; Wada KC, 2010, J PLANT PHYSIOL, V167, P447, DOI 10.1016/j.jplph.2009.10.006; Wang CX, 2007, PLANT CELL REP, V26, P1357, DOI 10.1007/s00299-007-0336-5; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Wellmer F, 2010, TRENDS GENET, V26, P519, DOI 10.1016/j.tig.2010.09.001; Wigge PA, 2005, SCIENCE, V309, P1056, DOI 10.1126/science.1114358; Xing S, 2006, PLANT BIOLOGY, V8, P547, DOI 10.1055/s-2006-924278; Xing SP, 2005, DEVELOPMENT, V132, P1555, DOI 10.1242/dev.01725; Xiong LM, 2002, PLANT CELL, V14, pS165, DOI 10.1105/tpc.000596; Xiong LM, 2001, PLANT CELL, V13, P2063, DOI 10.1105/tpc.13.9.2063; Yang Z, 2007, HUBEI FORESTRY SCI T, V6, P3	61	24	25	1	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2015	10	3							e0118479	10.1371/journal.pone.0118479	http://dx.doi.org/10.1371/journal.pone.0118479			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9JM	25738565	Green Published, gold, Green Submitted			2022-12-27	WOS:000350685900039
J	Caronni, S; Calabretti, C; Delaria, MA; Bernardi, G; Navone, A; Occhipinti-Ambrogi, A; Panzalis, P; Ceccherelli, G				Caronni, Sarah; Calabretti, Chiara; Delaria, Maria Anna; Bernardi, Giuseppe; Navone, Augusto; Occhipinti-Ambrogi, Anna; Panzalis, Pieraugusto; Ceccherelli, Giulia			Consumer Depletion Alters Seagrass Resistance to an Invasive Macroalga	PLOS ONE			English	Article							SEAWEED CAULERPA-RACEMOSA; BIOTIC RESISTANCE; VAR. CYLINDRACEA; PLANT INVASION; DISTURBANCE; DIVERSITY; HERBIVORY; ECOLOGY; CANOPY; SEA	Few field studies have investigated how changes at one trophic level can affect the invasibility of other trophic levels. We examined the hypothesis that the spread of an introduced alga in disturbed seagrass beds with degraded canopies depends on the depletion of large consumers. We mimicked the degradation of seagrass canopies by clipping shoot density and reducing leaf length, simulating natural and anthropogenic stressors such as fish overgrazing and water quality. Caulerpa racemosa was transplanted into each plot and large consumers were excluded from half of them using cages. Potential cage artifacts were assessed by measuring irradiance, scouring by leaf movement, water flow, and sedimentation. Algal invasion of the seagrass bed differed based on the size of consumers. The alga had higher cover and size under the cages, where the seagrass was characterized by reduced shoot density and canopy height. Furthermore, canopy height had a significant effect depending on canopy density. The alteration of seagrass canopies increased the spread of Caulerpa racemosa only when large consumers were absent. Our results suggest that protecting declining habitats and/or restoring fish populations will limit the expansion of Caulerpa racemosa. Because MPAs also enhance the abundance and size of fish consuming seagrass they can indirectly promote algal invasion. The effects of MPAs on invasive species are context dependent and require balancing opposing forces, such as the conservation of seagrass canopy structure and the protection of fish grazing the seagrass.	[Caronni, Sarah; Calabretti, Chiara; Occhipinti-Ambrogi, Anna] Univ Pavia, Dept Earth & Environm Sci, I-27100 Pavia, Italy; [Delaria, Maria Anna; Ceccherelli, Giulia] Univ Sassari, Dept Sci Nat & Environm Resources, I-07100 Sassari, Italy; [Bernardi, Giuseppe; Navone, Augusto; Panzalis, Pieraugusto] Marine Protected Area Tavolara Punta Coda Cavallo, I-07026 Olbia, OT, Italy	University of Pavia; University of Sassari	Caronni, S (corresponding author), Univ Pavia, Dept Earth & Environm Sci, Via S Epifanio 14, I-27100 Pavia, Italy.	sarah.caronni@unipv.it		OCCHIPINTI, ANNA CARMEN/0000-0002-5737-8317; Ceccherelli, Giulia/0000-0002-9832-9677	MIUR; Tavolara Punta Coda Cavallo MPA; Federparchi	MIUR(Ministry of Education, Universities and Research (MIUR)); Tavolara Punta Coda Cavallo MPA; Federparchi	This study is a contribution within the framework of the PRIN project 2010PBMAXP funded by MIUR. The study was also funded by Tavolara Punta Coda Cavallo MPA and Federparchi.	Airoldi L, 1998, ECOLOGY, V79, P2759, DOI 10.1890/0012-9658(1998)079[2759:RODSSA]2.0.CO;2; Airoldi L, 2007, OCEANOGR MAR BIOL, V45, P345; Altieri AH, 2012, ECOLOGY, V93, P1402, DOI 10.1890/11-1314.1; Barbier EB, 2011, ECOL MONOGR, V81, P169, DOI 10.1890/10-1510.1; Bertness MD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092916; Boudouresque CF, 2009, BOT MAR, V52, P395, DOI 10.1515/BOT.2009.057; Box A, 2009, J EXP MAR BIOL ECOL, V380, P11, DOI 10.1016/j.jembe.2009.08.010; Bulleri F, 2009, OIKOS, V118, P269, DOI 10.1111/j.1600-0706.2008.16955.x; Bulleri F, 2011, MAR ECOL PROG SER, V431, P55, DOI 10.3354/meps09137; Bulleri F, 2010, ECOLOGY, V91, P2205, DOI 10.1890/09-1857.1; Byers JE, 2002, OECOLOGIA, V130, P146, DOI 10.1007/s004420100777; Byers JE, 2003, ECOLOGY, V84, P1428, DOI 10.1890/02-3131; Cadenasso ML, 2001, CONSERV BIOL, V15, P91, DOI 10.1046/j.1523-1739.2001.99309.x; Capiomont A, 2005, BOT MAR, V48, P80, DOI 10.1515/BOT.2005.006; Cebrian E, 2009, ESTUARINE COASTAL SH, V75, P803; Cebrian E, 2011, BIOL INVASIONS, V13, P1397, DOI 10.1007/s10530-010-9898-1; Ceccherelli G, 1999, J EXP MAR BIOL ECOL, V240, P19, DOI 10.1016/S0022-0981(99)00044-1; Ceccherelli G, 2000, J EXP MAR BIOL ECOL, V243, P227, DOI 10.1016/S0022-0981(99)00122-7; Ceccherelli G, 2014, BIOL INVASIONS, V16, P2737, DOI 10.1007/s10530-014-0700-7; Christianen MJA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062413; Chytry M, 2008, J APPL ECOL, V45, P448, DOI 10.1111/j.1365-2664.2007.01398.x; Clark GF, 2011, ECOL LETT, V14, P52, DOI 10.1111/j.1461-0248.2010.01550.x; DANTONIO CM, 1992, ANNU REV ECOL SYST, V23, P63, DOI 10.1146/annurev.es.23.110192.000431; Davis MA, 2000, J ECOL, V88, P528, DOI 10.1046/j.1365-2745.2000.00473.x; Di Franco A, 2009, MAR ECOL PROG SER, V387, P275, DOI 10.3354/meps08051; Dietz H., 2006, ECOL LETT, V87, P1369; Duarte CM, 2002, ENVIRON CONSERV, V29, P192, DOI 10.1017/S0376892902000127; Duffy JE, 2003, ECOL LETT, V6, P637; Elton C. S., 1958, ECOLOGY INVASIONS AN; Eschtruth AK, 2009, ECOL MONOGR, V79, P265, DOI 10.1890/08-0221.1; FONSECA MS, 1986, MAR ECOL PROG SER, V29, P15, DOI 10.3354/meps029015; Fraschetti S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081838; Friedlander AM, 2002, J FISH BIOL, V60, P28, DOI 10.1006/jfbi.2001.1808; Froese R., 2011, FISHBASE WORLD WIDE; GAMBI MC, 1990, MAR ECOL PROG SER, V61, P159, DOI 10.3354/meps061159; Glasby TM, 2013, BIOL INVASIONS, V15, P1017, DOI 10.1007/s10530-012-0347-1; Guidetti P, 2008, BIOL CONSERV, V141, P699, DOI 10.1016/j.biocon.2007.12.013; Guidetti P, 2006, ECOL APPL, V16, P963, DOI 10.1890/1051-0761(2006)016[0963:MRRLPI]2.0.CO;2; Guidetti P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091841; HOBBS RJ, 1992, CONSERV BIOL, V6, P324, DOI 10.1046/j.1523-1739.1992.06030324.x; Hughes TP, 2007, TRENDS ECOL EVOL, V22, P1, DOI 10.1016/j.tree.2006.10.009; Katsanevakis S, 2010, MAR ENVIRON RES, V70, P210, DOI 10.1016/j.marenvres.2010.05.003; KENNELLY SJ, 1989, MAR ECOL PROG SER, V50, P215, DOI 10.3354/meps050215; Kimbro DL, 2013, ECOL LETT, V16, P821, DOI 10.1111/ele.12106; Kiparissis S, 2011, BIOL INVASIONS, V13, P669, DOI 10.1007/s10530-010-9858-9; Levine JM, 2004, ECOL LETT, V7, P975, DOI 10.1111/j.1461-0248.2004.00657.x; Levine JM, 1999, OIKOS, V87, P15, DOI 10.2307/3546992; Lotze HK, 2006, SCIENCE, V312, P1806, DOI 10.1126/science.1128035; Maron JL, 2001, OIKOS, V95, P361, DOI 10.1034/j.1600-0706.2001.950301.x; Martin PH, 2006, J ECOL, V94, P1070, DOI 10.1111/j.1365-2745.2006.01159.x; Micheli F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079889; Montefalcone M, 2009, MAR POLLUT BULL, V58, P515, DOI 10.1016/j.marpolbul.2008.12.001; Morey G, 2003, FISH RES, V62, P89, DOI 10.1016/S0165-7836(02)00250-3; Pages JF, 2012, FUNCT ECOL, V26, P1015, DOI 10.1111/j.1365-2435.2012.02038.x; Piazzi L, 2009, BIOL INVASIONS, V11, P193, DOI 10.1007/s10530-008-9224-3; PICKETT STA, 1995, SCIENCE, V269, P331, DOI 10.1126/science.269.5222.331; Pimentel D, 2005, ECOL ECON, V52, P273, DOI 10.1016/j.ecolecon.2004.10.002; Pinna S, 2013, MAR ECOL PROG SER, V485, P47, DOI 10.3354/meps10326; Prado P, 2008, MAR ECOL PROG SER, V371, P11, DOI 10.3354/meps07662; Ruitton S, 2006, VIE MILIEU, V56, P33; Sala E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032742; Seabloom EW, 2003, P NATL ACAD SCI USA, V100, P13384, DOI 10.1073/pnas.1835728100; Shea K, 2002, TRENDS ECOL EVOL, V17, P170, DOI 10.1016/S0169-5347(02)02495-3; Short FT, 1996, ENVIRON CONSERV, V23, P17, DOI 10.1017/S0376892900038212; Stachowicz JJ, 2002, ECOLOGY, V83, P2575; Tamburello L, 2012, MAR ECOL PROG SER, V457, P29, DOI 10.3354/meps09703; Tamburello L, 2014, J APPL ECOL, V51, P406, DOI 10.1111/1365-2664.12199; Terlizzi A, 2011, AQUAT BIOL, V12, P109, DOI 10.3354/ab00330; Thebaud C, 1996, ECOLOGY, V77, P791, DOI 10.2307/2265502; Theoharides KA, 2007, NEW PHYTOL, V176, P256, DOI 10.1111/j.1469-8137.2007.02207.x; Tomas F, 2005, MAR ECOL PROG SER, V301, P95, DOI 10.3354/meps301095; Tomas F, 2011, ESTUAR COAST SHELF S, V92, P27, DOI 10.1016/j.ecss.2010.12.004; Tomas F, 2011, BIOL INVASIONS, V13, P1559, DOI 10.1007/s10530-010-9913-6; Waycott M, 2009, P NATL ACAD SCI USA, V106, P12377, DOI 10.1073/pnas.0905620106; Werner EE, 2003, ECOLOGY, V84, P1083, DOI 10.1890/0012-9658(2003)084[1083:AROTII]2.0.CO;2; Williams SL, 2001, MARINE COMMUNITY ECOLOGY, P317; Williams SL, 2007, J EXP MAR BIOL ECOL, V350, P89, DOI 10.1016/j.jembe.2007.05.032	77	10	10	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2015	10	2							e0115858	10.1371/journal.pone.0115858	http://dx.doi.org/10.1371/journal.pone.0115858			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC3LS	25723466	Green Published, gold			2022-12-27	WOS:000350251200010
J	Zhao, LQ; Wen, ZJ; Wei, Y; Xu, J; Chen, Z; Qi, BZ; Wang, ZM; Shi, YY; Liu, SW				Zhao, Li-qun; Wen, Zu-jia; Wei, Yong; Xu, Juan; Chen, Zheng; Qi, Bao-zhen; Wang, Zhi-ming; Shi, Yong-yong; Liu, Shao-wen			Polymorphisms of Renin-Angiotensin-Aldosterone System Gene in Chinese Han Patients with Nonfamilial Atrial Fibrillation	PLOS ONE			English	Article							CONVERTING ENZYME; HEART-DISEASE; SYNTHASE GENE; ACE; ASSOCIATION; POPULATION; I/D	Background Atrial fibrillation(AF) is the most common arrhythmia in the adult population. The activated renin-angiotensin-aldosterone system (RAS) has been reported to play an important role in the pathogenesis of atrial fibrillation. The aim of this study was to investigate the association between nonfamilial AF and polymorphisms in RAS gene. Methods A total of 931 patients with nonfamilial AF, 663 non-AF heart disease patients and 727 healthy subjects were selected. 10 tagSNPs (tSNPs) (ACE gene rs8066114, AGT gene rs7539020, rs3789678, rs2478544, rs11568023, rs2478523, rs4762, rs699 and CYP11B2 rs3802230, rs3097) were chosen and genotyped in our study. Single-locus analysis and haplotype analysis were used in this study. Results In single-locus analysis, we found rs11568023 and rs3789678 in AGT gene were associated with nonfamilial AF in Chinese Han population. AF risk was associated with rs3789678 between the AF group and control groups. Under dominant model, the significant AF risk was observed in rs3789678 between the AF group and non AF heart control group; And the protective effect was found in rs11568023, compared with the non-AF heart disease control group. In multilocus haplotype analysis, the association between frequencies of the haplotypes and AF risk was showed in AGT gene (rs7539020-rs3789678), compared 'TT' haplotype with the common 'TC' haplotype, adjusted for age, gender, LVEF, LVEDD, LAD and frequency of hypertension and diabetes. The diplotype with 'TC', carrying rs3789678-C-allele, was associated with reduced risk of AF between the AF group and the healthy control group. The diplotype with 'TT' haplotype in the same block, carrying rs3789678-T-allele, was associated with increased risk of AF. Conclusions Via a large-scale case-control study, we found that rs3789678 site was potential susceptible locus of AF whereas rs11568023 was protective factor.	[Zhao, Li-qun; Wei, Yong; Xu, Juan; Chen, Zheng; Qi, Bao-zhen; Liu, Shao-wen] Shanghai Jiao Tong Univ, Shanghai Peoples Hosp 1, Dept Cardiol, Shanghai 200080, Peoples R China; [Wen, Zu-jia; Shi, Yong-yong] Shanghai Jiao Tong Univ, Bio X Inst, Shanghai 200030, Peoples R China; [Wang, Zhi-ming] Chinese Natl Human Genome Ctr, Dept Genet, Shanghai MOST Key Lab Hlth & Dis Genom, Shanghai 201203, Peoples R China; [Wang, Zhi-ming] SITI, Shanghai 201203, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University	Wang, ZM (corresponding author), Chinese Natl Human Genome Ctr, Dept Genet, Shanghai MOST Key Lab Hlth & Dis Genom, Shanghai 201203, Peoples R China.	wangzhm@chgc.sh.cn; 13764928889@163.com; shaowen.liu@hotmail.com	Liu, Shaowen/AAJ-4121-2020; Shi, Yongyong/GSO-1627-2022	Shi, Yongyong/0000-0003-1710-1505	Science and Technology Commission of Shanghai Municipality [10411954800]	Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM))	This study was supported by grants from the Science and Technology Commission of Shanghai Municipality (No. 10411954800). The funder had a role in study design and decision to publish.	Amir O, 2008, AM J CARDIOL, V102, P326, DOI 10.1016/j.amjcard.2008.03.063; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Brand E, 1998, HYPERTENSION, V32, P198, DOI 10.1161/01.HYP.32.2.198; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Huang MF, 2009, CLIN CHEM LAB MED, V47, P32, DOI 10.1515/CCLM.2009.023; LEWONTIN RC, 1988, GENETICS, V120, P849; Liu T, 2011, EUROPACE, V13, P346, DOI 10.1093/europace/euq407; Perneger TV, 1998, BRIT MED J, V316, P1236, DOI 10.1136/bmj.316.7139.1236; Ravn LS, 2008, PHARMACOGENET GENOM, V18, P525, DOI 10.1097/FPC.0b013e3282fce3bd; Rothermund L, 2002, AM J HYPERTENS, V15, P644, DOI 10.1016/S0895-7061(02)02956-4; Rothman K J, 1990, Epidemiology, V1, P43, DOI 10.1097/00001648-199001000-00010; Schaid DJ, 2002, AM J HUM GENET, V70, P425, DOI 10.1086/338688; Stephens M, 2003, AM J HUM GENET, V73, P1162, DOI 10.1086/379378; Topal NP, 2011, J RENIN-ANGIO-ALDO S, V12, P549, DOI 10.1177/1470320311399605; Tsai CT, 2008, CARDIOLOGY, V111, P1, DOI 10.1159/000113419; Tsai CT, 2004, CIRCULATION, V109, P1640, DOI 10.1161/01.CIR.0000124487.36586.26; VAZIRI SM, 1994, CIRCULATION, V89, P724, DOI 10.1161/01.CIR.89.2.724; Watanabe H, 2009, HEART RHYTHM, V6, P1327, DOI 10.1016/j.hrthm.2009.05.014; WHITE PC, 1994, NEW ENGL J MED, V331, P250; Yamashita T, 1997, JPN HEART J, V38, P637; Zhang XL, 2012, EXP THER MED, V4, P741, DOI 10.3892/etm.2012.650	21	7	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2015	10	2							e0117489	10.1371/journal.pone.0117489	http://dx.doi.org/10.1371/journal.pone.0117489			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC3LS	25723521	gold, Green Published, Green Submitted			2022-12-27	WOS:000350251200033
J	Tenforde, MW; Gupte, N; Dowdy, DW; Asmuth, DM; Balagopal, A; Pollard, RB; Sugandhavesa, P; Lama, JR; Pillay, S; Cardoso, SW; Pawar, J; Santos, B; Riviere, C; Mwelase, N; Kanyama, C; Kumwenda, J; Hakim, JG; Kumarasamy, N; Bollinger, R; Semba, RD; Campbell, TB; Gupta, A				Tenforde, Mark W.; Gupte, Nikhil; Dowdy, David W.; Asmuth, David M.; Balagopal, Ashwin; Pollard, Richard B.; Sugandhavesa, Patcharaphan; Lama, Javier R.; Pillay, Sandy; Cardoso, Sandra W.; Pawar, Jyoti; Santos, Breno; Riviere, Cynthia; Mwelase, Noluthando; Kanyama, Cecilia; Kumwenda, Johnstone; Hakim, James G.; Kumarasamy, Nagalingeswaran; Bollinger, Robert; Semba, Richard D.; Campbell, Thomas B.; Gupta, Amita		ACTG PEARLS NWCS 319 Study Grp	C-Reactive Protein (CRP), Interferon Gamma-Inducible Protein 10 (IP-10), and Lipopolysaccharide (LPS) Are Associated with Risk of Tuberculosis after Initiation of Antiretroviral Therapy in Resource-Limited Settings	PLOS ONE			English	Article							HIV-INFECTED PATIENTS; T-CELL RECONSTITUTION; DISEASE PROGRESSION; MICROBIAL TRANSLOCATION; MORTALITY; COHORT; INFLAMMATION; DIAGNOSIS; HAART	Objective The association between pre-antiretroviral (ART) inflammation and immune activation and risk for incident tuberculosis (TB) after ART initiation among adults is uncertain. Design Nested case-control study (n = 332) within ACTG PEARLS trial of three ART regimens among 1571 HIV-infected, treatment-naive adults in 9 countries. We compared cases (participants with incident TB diagnosed by 96 weeks) to a random sample of controls (participants who did not develop TB, stratified by country and treatment arm). Methods We measured pre-ART C-reactive protein (CRP), EndoCab IgM, ferritin, interferon gamma (IFN-gamma), interleukin 6 (IL-6), interferon gamma-inducible protein 10 (IP-10), lipopolysaccharide (LPS), soluble CD14 (sCD14), tumor necrosis factor alpha (TNF-alpha), and CD4/DR+/38+ and CD8/DR+/38+ T cells. Markers were defined according to established cutoff definitions when available, 75th percentile of measured values when not, and detectable versus unde-tectable for LPS. Using logistic regression, we measured associations between biomarkers and incident TB, adjusting for age, sex, study site, treatment arm, baseline CD4 and log10 viral load. We assessed the discriminatory value of biomarkers using receiver operating characteristic (ROC) analysis. Results Seventy-seven persons (4.9%) developed incident TB during follow-up. Elevated baseline CRP (aOR 3.25, 95% CI: 1.55-6.81) and IP-10 (aOR 1.89, 95% CI: 1.05-3.39), detectable plasma LPS (aOR 2.39, 95% CI: 1.13-5.06), and the established TB risk factors anemia and hypoalbuminemia were independently associated with incident TB. In ROC analysis, CRP, albumin, and LPS improved discrimination only modestly for TB risk when added to baseline routine patient characteristics including CD4 count, body mass index, and prior TB. Conclusion Incident TB occurs commonly after ART initiation. Although associated with higher post-ART TB risk, baseline CRP, IP-10, and LPS add limited value to routine patient characteristics in discriminating who develops active TB. Besides determining ideal cutoffs for these biomarkers, additional biomarkers should be sought that predict TB disease in ART initiators.	[Tenforde, Mark W.; Gupte, Nikhil; Balagopal, Ashwin; Bollinger, Robert; Semba, Richard D.; Gupta, Amita] Johns Hopkins Univ Sch Med, Baltimore, MD 21287 USA; [Dowdy, David W.; Gupta, Amita] Johns Hopkins Univ Bloomberg Sch Publ Hlth, Baltimore, MD USA; [Asmuth, David M.; Pollard, Richard B.] Univ Calif Davis Med Ctr, Sacramento, CA USA; [Sugandhavesa, Patcharaphan] Chiang Mai Univ, Res Inst Hlth Sci, Chiang Mai 50000, Thailand; [Lama, Javier R.] Asociac Civil Impacta Salud & Educ IMPACT Peru Cl, Lima, Peru; [Pillay, Sandy] Univ KwaZulu Natal, Nelson Mandela Sch Med, Durban, South Africa; [Cardoso, Sandra W.] Fundacao Oswaldo Cruz, Inst Pesquisa Clin Evandro Chagas, Rio De Janeiro, Brazil; [Pawar, Jyoti] Natl AIDS Res Inst, Pune, Maharashtra, India; [Santos, Breno] Hosp Nossa Senhora Conceicao, Porto Alegre, RS, Brazil; [Riviere, Cynthia] Ctr Grp Haitien Etud Sarcome Kaposi & Infect Oppu, Port Au Prince, Haiti; [Mwelase, Noluthando] Univ Witwatersrand, Johannesburg, South Africa; [Kanyama, Cecilia] Univ North Carolina Project, Kamuzu Cent Hosp, Lilongwe, Malawi; [Kumwenda, Johnstone] Johns Hopkins Univ Res Project, Malawi Coll Med, Blantyre, Malawi; [Hakim, James G.] Univ Zimbabwe, Harare, Zimbabwe; [Kumarasamy, Nagalingeswaran] YRG CARE, Chennai, Tamil Nadu, India; [Campbell, Thomas B.] Univ Colorado Denver Sch Med, Aurora, CO USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; University of California System; University of California Davis; Chiang Mai University; University of Kwazulu Natal; Fundacao Oswaldo Cruz; Indian Council of Medical Research (ICMR); ICMR - National AIDS Research Institute (NARI); University of Witwatersrand; University of Malawi; University of Zimbabwe; University of Colorado System; University of Colorado Anschutz Medical Campus	Gupta, A (corresponding author), Johns Hopkins Univ Sch Med, Baltimore, MD 21287 USA.	agupta25@jhmi.edu	pawar, jyoti/AAG-3163-2019; Cardoso, Sandra W/D-7965-2015; Kumarasasmy, Nagalingeswaran/AAB-7348-2021	Cardoso, Sandra W/0000-0001-5230-0003; Bollinger, Robert/0000-0002-6798-6834; Tenforde, Mark/0000-0002-8702-8393; Gupta, Amita/0000-0001-7036-2718; Asmuth, David/0000-0003-0916-7950	AIDS Clinical Trials Group; US National Institutes of Health [R01 AI45462]; Boehringer-Ingelheim; Bristol-Myers Squibb; Gilead Sciences; GlaxoSmithKline; US National Institute of Allergy and Infectious Diseases [AI68636, AI069450]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [UM1AI069423, UM1AI069518, U01AI069450, UM1AI068636, U01AI068636, UM1AI069463, R01AI045462, UM1AI069450] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA016078] Funding Source: NIH RePORTER	AIDS Clinical Trials Group; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Boehringer-Ingelheim(Boehringer Ingelheim); Bristol-Myers Squibb(Bristol-Myers Squibb); Gilead Sciences(Gilead Sciences); GlaxoSmithKline(GlaxoSmithKline); US National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by the AIDS Clinical Trials Group and funded by the US National Institute of Allergy and Infectious Diseases (AI68636, AI069450); additional grants from the US National Institutes of Health (R01 AI45462 to Amita Gupta); also in part supported by Boehringer-Ingelheim, Bristol-Myers Squibb, Gilead Sciences, and GlaxoSmithKline. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aabye MG, 2010, EUR RESPIR J, V36, P1488, DOI 10.1183/09031936.00039010; Balagopal A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041258; Bhowmik A, 2012, ASIAN PAC J TROP MED, V5, P986, DOI 10.1016/S1995-7645(12)60187-4; Borgstrom E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043438; Boulware DR, 2011, J INFECT DIS, V203, P1637, DOI 10.1093/infdis/jir134; Brinkhof MWG, 2007, CLIN INFECT DIS, V45, P1518, DOI 10.1086/522986; Campbell TB, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001290; Cao W, 2009, AIDS RES HUM RETROV, V25, P183, DOI 10.1089/aid.2008.0140; Cattamanchi A, 2011, JAIDS-J ACQ IMM DEF, V56, P230, DOI 10.1097/QAI.0b013e31820b07ab; Chegou NN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038501; Choun K, 2013, T ROY SOC TROP MED H, V107, P235, DOI 10.1093/trstmh/trt001; Dembele M, 2010, INT J TUBERC LUNG D, V14, P318; Drain PK, 2007, AIDS, V21, P2067, DOI 10.1097/QAD.0b013e32826fb6c7; Dufour JH, 2002, J IMMUNOL, V168, P3195, DOI 10.4049/jimmunol.168.7.3195; Ferrero E, 2003, IMMUNOLOGY, V108, P365, DOI 10.1046/j.1365-2567.2003.01600.x; Goletti D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012577; Gupta A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028691; Hong JY, 2012, INT J INFECT DIS, V16, pE855, DOI 10.1016/j.ijid.2012.07.013; Isanaka S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037350; Jiao YM, 2012, VIRAL IMMUNOL, V25, P333, DOI 10.1089/vim.2012.0011; Kabeer BSA, 2010, AIDS, V24, P323, DOI 10.1097/QAD.0b013e328334895e; Kassa A, 2012, T ROY SOC TROP MED H, V106, P363, DOI 10.1016/j.trstmh.2012.03.002; Kellar KL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026545; Lau B, 2006, ARCH INTERN MED, V166, P64, DOI 10.1001/archinte.166.1.64; Lawn SD, 2013, INT J TUBERC LUNG D, V17, P636, DOI 10.5588/ijtld.12.0811; Lawn SD, 2005, AIDS, V19, P2109, DOI 10.1097/01.aids.0000194808.20035.c1; Marchetti G, 2008, AIDS, V22, P2035, DOI 10.1097/QAD.0b013e3283112d29; McDermid JM, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-48; McDermid JM, 2009, AM J CLIN NUTR, V90, P225, DOI 10.3945/ajcn.2009.27709; Meintjes G, 2008, LANCET INFECT DIS, V8, P516, DOI 10.1016/S1473-3099(08)70184-1; Merlini E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018580; Mihret A, 2013, J INFECTION, V66, P357, DOI 10.1016/j.jinf.2012.11.005; Nicholas S, 2011, JAIDS-J ACQ IMM DEF, V57, P311, DOI 10.1097/QAI.0b013e318218a713; Nowroozalizadeh S, 2010, J INFECT DIS, V201, P1150, DOI 10.1086/651430; Pai M, 2010, NAT REV MICROBIOL, V8, P242, DOI 10.1038/nrmicro2236-c1; Pokkali S, 2009, HUM IMMUNOL, V70, P110, DOI 10.1016/j.humimm.2008.11.003; Reiberger T, 2008, ANTIVIR THER, V13, P969; Sandler NG, 2011, J INFECT DIS, V203, P780, DOI 10.1093/infdis/jiq118; Sterling TR, 2011, J INFECT DIS, V204, P893, DOI 10.1093/infdis/jir421; Sudfeld CR, 2013, J INFECT DIS, V207, P1370, DOI 10.1093/infdis/jit027; Suthar AB, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001270; Tien PC, 2010, JAIDS-J ACQ IMM DEF, V55, P316, DOI 10.1097/QAI.0b013e3181e66216; Van Rie A, 2011, JAIDS-J ACQ IMM DEF, V56, P349, DOI 10.1097/QAI.0b013e3181f9fb39; Wang XJ, 2012, TUBERCULOSIS, V92, P513, DOI 10.1016/j.tube.2012.06.005; Welsh KJ, 2008, MICROBIOL-SGM, V154, P1813, DOI 10.1099/mic.0.2008/016923-0; WHO, 2011, SER FERR CONC ASS IR; Worodria W, 2011, CLIN DEV IMMUNOL, DOI 10.1155/2011/758350; Yu Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044944	48	21	23	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2015	10	2							e0117424	10.1371/journal.pone.0117424	http://dx.doi.org/10.1371/journal.pone.0117424			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC2ZH	25719208	Green Published, gold, Green Submitted			2022-12-27	WOS:000350213200024
J	Giraudet, L; St-Louis, ME; Scannella, S; Causse, M				Giraudet, Louise; St-Louis, Marie-Eve; Scannella, Sebastien; Causse, Mickael			P300 Event-Related Potential as an Indicator of Inattentional Deafness?	PLOS ONE			English	Article							PERCEPTUAL LOAD; LATE ND; DISTRACTION PARADIGM; SELECTIVE ATTENTION; TARGET DETECTION; PARIETAL CORTEX; OLDER-ADULTS; TIME-COURSE; DUAL-TASK; MEMORY	An analysis of airplane accidents reveals that pilots sometimes purely fail to react to critical auditory alerts. This inability of an auditory stimulus to reach consciousness has been coined under the term of inattentional deafness. Recent data from literature tends to show that tasks involving high cognitive load consume most of the attentional capacities, leaving little or none remaining for processing any unexpected information. In addition, there is a growing body of evidence for a shared attentional capacity between vision and hearing. In this context, the abundant information in modern cockpits is likely to produce inattentional deafness. We investigated this hypothesis by combining electroencephalographic (EEG) measurements with an ecological aviation task performed under contextual variation of the cognitive load (high or low), including an alarm detection task. Two different audio tones were played: standard tones and deviant tones. Participants were instructed to ignore standard tones and to report deviant tones using a response pad. More than 31% of the deviant tones were not detected in the high load condition. Analysis of the EEG measurements showed a drastic diminution of the auditory P300 amplitude concomitant with this behavioral effect, whereas the N100 component was not affected. We suggest that these behavioral and electrophysiological results provide new insights on explaining the trend of pilots' failure to react to critical auditory information. Relevant applications concern prevention of alarms omission, mental workload measurements and enhanced warning designs.	[Giraudet, Louise; Scannella, Sebastien; Causse, Mickael] Univ Toulouse, ISAE, DMIA, F-31055 Toulouse, France; [St-Louis, Marie-Eve] Univ Laval, Ecole Psychol, Quebec City, PQ G1V 0A6, Canada	Universite de Toulouse; Institut Superieur de l'Aeronautique et de l'Espace (ISAE-SUPAERO); Laval University	Giraudet, L (corresponding author), Univ Toulouse, ISAE, DMIA, F-31055 Toulouse, France.	louise.giraudet@isae.fr			Institut Superieur de l'aeronautique et de l'espace (ISAE, France)	Institut Superieur de l'aeronautique et de l'espace (ISAE, France)	This study was supported by the Institut Superieur de l'aeronautique et de l'espace (ISAE, France). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Analyse BE, 1993, A40EK000823A; Armstrong GAB, 2011, EXP BRAIN RES, V213, P35, DOI 10.1007/s00221-011-2774-0; Arnott SR, 2002, PSICOLOGICA, V23, P311; Berti S, 2003, EUR J NEUROSCI, V17, P1119, DOI 10.1046/j.1460-9568.2003.02527.x; Berti S, 2013, FRONT HUM NEUROSCI, V7, DOI [10.3389/fnhum.2013.00940, DOI 10.3389/FNHUM.2013.00940]; Bledowski C, 2004, J NEUROSCI, V24, P9353, DOI 10.1523/JNEUROSCI.1897-04.2004; Bliss JP, 2003, INT J AVIAT PSYCHOL, V13, P249, DOI 10.1207/S15327108IJAP1303_04; Bliss JP, 2000, ERGONOMICS, V43, P1283, DOI 10.1080/001401300421743; Breznitz S., 1984, CRY WOLF PSYCHOL FAL; Brun J.-P., 1984, QUESTIONNAIRE BREF A; Charron S, 2010, SCIENCE, V328, P360, DOI 10.1126/science.1183614; DAVIS H, 1966, J ACOUST SOC AM, V39, P109, DOI 10.1121/1.1909858; Dehais F, 2013, HUMAN FACTORS J HUMA; Dehais F, 2012, MISSING CRITICAL AUD; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; Doll TJ, 1983, AUDITORY INFORM SYST, P1; Donchin E., 1986, PSYCHOPHYSIOLOGY SYS; Dux PE, 2006, NEURON, V52, P1109, DOI 10.1016/j.neuron.2006.11.009; EDWORTHY J, 1991, HUM FACTORS, V33, P205, DOI 10.1177/001872089103300206; FOWLER B, 1994, HUM FACTORS, V36, P670, DOI 10.1177/001872089403600408; Friedman D, 2000, NEUROPSYCHOLOGIA, V38, P542, DOI 10.1016/S0028-3932(99)00122-0; FRIEDMAN D, 1994, COGNITIVE BRAIN RES, V2, P49, DOI 10.1016/0926-6410(94)90020-5; Hansenne M, 2000, NEUROPHYSIOL CLIN, V30, P191, DOI 10.1016/S0987-7053(00)00223-9; Hart S.G., 1990, MANPRINT APPROACH SY, P257; Hughes RW, 2013, J EXP PSYCHOL HUMAN, V39, P539, DOI 10.1037/a0029064; Kok A, 2001, PSYCHOPHYSIOLOGY, V38, P557, DOI 10.1017/S0048577201990559; Kolev V, 1997, NEUROREPORT, V8, P2061, DOI 10.1097/00001756-199705260-00050; Koreimann S, 2009, INATTENTIONAL DEAFNE; KRAMER AF, 1987, HUM FACTORS, V29, P145, DOI 10.1177/001872088702900203; LAVIE N, 1995, J EXP PSYCHOL HUMAN, V21, P451, DOI 10.1037/0096-1523.21.3.451; Leber AB, 2006, PSYCHON B REV, V13, P132, DOI 10.3758/BF03193824; Macdonald JSP, 2011, ATTEN PERCEPT PSYCHO, V73, P1780, DOI 10.3758/s13414-011-0144-4; Mack A., 1998, INATTENTIONAL BLINDN; McCarthy G, 1997, J NEUROPHYSIOL, V77, P1630, DOI 10.1152/jn.1997.77.3.1630; Menon V, 1997, NEUROREPORT, V8, P3029, DOI 10.1097/00001756-199709290-00007; Mulert C, 2004, EUR ARCH PSY CLIN N, V254, P190, DOI 10.1007/s00406-004-0469-2; Mulert C, 2004, NEUROIMAGE, V22, P83, DOI 10.1016/j.neuroimage.2003.10.051; Munka L, 2006, NEUROSCI LETT, V396, P177, DOI 10.1016/j.neulet.2005.11.035; Murphy S, 2013, COGNITION, V129, P345, DOI 10.1016/j.cognition.2013.07.014; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Peryer G, 2005, INT J AVIAT PSYCHOL, V15, P233, DOI 10.1207/s15327108ijap1503_2; PICTON TW, 1974, ELECTROEN CLIN NEURO, V36, P191, DOI 10.1016/0013-4694(74)90156-4; Plack J, 2010, PERCEPTION, V39, P1009; Polich J, 2007, CLIN NEUROPHYSIOL, V118, P2128, DOI 10.1016/j.clinph.2007.04.019; Qu JG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089989; Ramirez J, 2005, BIOL PSYCHOL, V68, P121, DOI 10.1016/j.biopsycho.2004.04.005; SanMiguel I, 2008, J COGNITIVE NEUROSCI, V20, P1131, DOI 10.1162/jocn.2008.20078; Scannella S, 2013, INT J PSYCHOPHYSIOL, V89, P115, DOI 10.1016/j.ijpsycho.2013.06.009; Shapiro N., 1994, NBC DATELINE; Singhal A, 2004, COGNITIVE BRAIN RES, V21, P124, DOI 10.1016/j.cogbrainres.2004.06.003; Singhal A, 2002, PSYCHOPHYSIOLOGY, V39, P236, DOI 10.1017/S0048577201392156; Song L, 2001, DESCRIBING PREDICTIN; SORKIN RD, 1988, J ACOUST SOC AM, V84, P1107, DOI 10.1121/1.397232; Spence C, 2003, PSYCHOL SCI, V14, P251, DOI 10.1111/1467-9280.02439; Spencer KM, 1999, PSYCHOPHYSIOLOGY, V36, P409, DOI 10.1017/S0048577299981180; SQUIRES NK, 1975, ELECTROEN CLIN NEURO, V38, P387, DOI 10.1016/0013-4694(75)90263-1; Tombaugh TN, 2006, ARCH CLIN NEUROPSYCH, V21, P53, DOI 10.1016/j.acn.2005.07.006; Troche S, 2014, EUROPEAN J PAIN, DOI [10.1002/ejp.645, DOI 10.1002/EJP.645]; VERKINDT C, 1995, EVOKED POTENTIAL, V96, P143, DOI 10.1016/0168-5597(94)00242-7; Wester AE, 2008, ACCIDENT ANAL PREV, V40, P1, DOI 10.1016/j.aap.2007.02.014; Wheale J L, 1981, Br J Audiol, V15, P205, DOI 10.3109/03005368109081439; WICKENS CD, 1984, ANN NY ACAD SCI, V425, P295, DOI 10.1111/j.1749-6632.1984.tb23550.x; WOOD NL, 1995, J EXP PSYCHOL GEN, V124, P243, DOI 10.1037/0096-3445.124.3.243; WOODS DL, 1993, COGNITIVE BRAIN RES, V1, P227, DOI 10.1016/0926-6410(93)90007-R	64	41	41	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2015	10	2							e0118556	10.1371/journal.pone.0118556	http://dx.doi.org/10.1371/journal.pone.0118556			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CC2IM	25714746	Green Accepted, Green Published, gold			2022-12-27	WOS:000350168700085
J	Li, F; Ma, JQ; Geng, SS; Wang, JL; Liu, JR; Zhang, J; Sheng, XY				Li, Feng; Ma, Jingqiu; Geng, Shanshan; Wang, Junli; Liu, Jinrong; Zhang, Jie; Sheng, Xiaoyang			Fecal Calprotectin Concentrations in Healthy Children Aged 1-18 Months	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; CROHNS-DISEASE; INTESTINAL PERMEABILITY; PROTEIN CALPROTECTIN; BARRIER FUNCTION; BIRTH-WEIGHT; L1 PROTEIN; MARKER; INFANTS; GRANULOCYTES	Objective Fecal calprotectin (FC) is an established biomarker of gut inflammation. The aim of this study was to evaluate FC concentrations in healthy children between 1 and 18 months of age. Methods Healthy children aged 1-18 months were enrolled in this study at the Department of Children's Health Care in Shanghai, China. Children's stool samples were collected and analyzed, and FC concentration was determined using a commercially available enzyme-linked immunosorbent assay (ELISA). The children's weights and lengths were measured. Parents were asked to complete a brief questionnaire regarding several clinical and sociodemographic factors. Results The FC concentrations were unevenly distributed; the median FC concentration was 174.3 mu g/g (range: 6.0-1097.7 mu g/g) or 2.241 log10 mu g/g (range: 0.775-3.041 log10 mu g/g) for all 288 children. The children were divided into several age groups: 1-3 months, 3-6 months, 6-9 months, 9-12 months and 12-18 months. The median FC concentrations for these age groups were 375.2 mu g/g (2.574 log10 mu g/g), 217.9 mu g/g (2.338 log10 mu g/g), 127.7 mu g/g (2.106 log10 mu g/g), 96.1 mu g/g (1.983 log10 mu g/g) and 104.2 mu g/g (2.016 log10 mu g/g), respectively. A significant correlation between age and FC concentration was found (r=-0.490, p < 0.001). A simple correlation analysis of weight-for-length Z-scores or weight-for-age Z-scores vs. FC concentrations showed that these variables were negatively correlated (Spearman's rho=-0.287, p < 0.001; Spearman's rho=-0.243, p < 0.001, respectively). Conclusions The FC levels of children aged 1-18 months exhibit a downward trend with increasing age and are greater than the normal levels observed in healthy adults. In healthy children aged <6 months, FC levels are high. In children aged 6-18 months, FC concentrations are relatively low but are still higher than those of children aged >4 years.	[Li, Feng; Ma, Jingqiu; Geng, Shanshan; Wang, Junli; Liu, Jinrong; Zhang, Jie; Sheng, Xiaoyang] Shanghai Jiao Tong Univ, Xin Hua Hosp, Sch Med, Dept Children & Adolescents Hlth Care,MOE Shangha, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University	Sheng, XY (corresponding author), Shanghai Jiao Tong Univ, Xin Hua Hosp, Sch Med, Dept Children & Adolescents Hlth Care,MOE Shangha, Shanghai 200030, Peoples R China.	shengxiaoyangcn@aliyun.com			Shanghai Key Laboratory of Pediatric Gastroenterology and Nutrition [11DZ2260500]; National Natural Science Foundation of China [81172686, 81302446]; Shanghai Science and Technology Commission Pujiang Talent Program of China [08PJ14082]	Shanghai Key Laboratory of Pediatric Gastroenterology and Nutrition; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Science and Technology Commission Pujiang Talent Program of China	This study was funded by Shanghai Key Laboratory of Pediatric Gastroenterology and Nutrition (No.11DZ2260500), National Natural Science Foundation of China (No.81172686, No.81302446) and Shanghai Science and Technology Commission Pujiang Talent Program of China (No.08PJ14082). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aydemir O, 2012, J MATERN FETAL NEONA; Baldassarre M. E., 2007, Endocrine Metabolic & Immune Disorders-Drug Targets, V7, P1; BERNTZEN HB, 1990, SCAND J CLIN LAB INV, V50, P769, DOI 10.3109/00365519009091071; BJERKE K, 1993, GUT, V34, P1357, DOI 10.1136/gut.34.10.1357; Boussac M, 2000, ELECTROPHORESIS, V21, P665, DOI 10.1002/(SICI)1522-2683(20000201)21:3<665::AID-ELPS665>3.0.CO;2-U; BRANDTZAEG P, 1987, AM J CLIN PATHOL, V87, P700, DOI 10.1093/ajcp/87.6.700; Bunn SK, 2001, J PEDIATR GASTR NUTR, V33, P14, DOI 10.1097/00005176-200107000-00003; Bunn SK, 2001, J PEDIATR GASTR NUTR, V32, P171, DOI 10.1097/00005176-200102000-00015; Campbell DI, 2003, J NUTR, V133, P1332; Campeotto F, 2004, ARCH DIS CHILD-FETAL, V89, pF353, DOI 10.1136/adc.2002.022368; Campeotto F, 2009, J PEDIATR GASTR NUTR, V48, P507, DOI 10.1097/MPG.0b013e318186c4a6; Canani RB, 2004, DIGEST LIVER DIS, V36, P467, DOI 10.1016/j.dld.2004.02.009; Caplan A, 2005, J PEDIATR GASTR NUTR, V41, P305, DOI 10.1097/01.mpg.0000172749.71726.13; Chen CC, 2012, J PEDIATR GASTR NUTR, V55, P541, DOI 10.1097/MPG.0b013e318262a718; Dorosko SM, 2008, BREASTFEED MED, V3, P117, DOI 10.1089/bfm.2007.0036; Ezri J, 2011, Rev Med Suisse, V7, P69; Fagerberg UL, 2003, J PEDIATR GASTR NUTR, V37, P468, DOI 10.1097/00005176-200310000-00013; Gaya DR, 2005, QJM-INT J MED, V98, P435, DOI 10.1093/qjmed/hci069; Hestvik E, 2011, BMC PEDIATR, V11, DOI 10.1186/1471-2431-11-9; Husebye E, 2001, AM J GASTROENTEROL, V96, P2683; Josefsson S, 2007, J PEDIATR GASTR NUTR, V44, P407, DOI 10.1097/MPG.0b013e3180320643; Kapel N, 2010, J PEDIATR GASTR NUTR, V51, P542, DOI 10.1097/MPG.0b013e3181e2ad72; Kukkonen K, 2010, PEDIAT ALLERG IMM-UK, V21, P67, DOI 10.1111/j.1399-3038.2009.00907.x; Li F, 2014, EARLY HUM DEV, V90, P471, DOI 10.1016/j.earlhumdev.2014.06.005; Liu JR, 2012, BMC PEDIATR, V12, DOI 10.1186/1471-2431-12-129; Manz M, 2012, BMC GASTROENTEROL, V12, DOI 10.1186/1471-230X-12-5; NASH S, 1987, J CLIN INVEST, V80, P1104, DOI 10.1172/JCI113167; Nissen AC, 2004, J PEDIATR GASTR NUTR, V38, P107, DOI 10.1097/00005176-200401000-00025; Olafsdottir E, 2002, ACTA PAEDIATR, V91, P45, DOI 10.1080/080352502753457932; Pang T, 2015, J GASTROEN HEPATOL, V30, P866, DOI 10.1111/jgh.12842; Poullis A, 2003, J GASTROEN HEPATOL, V18, P756, DOI 10.1046/j.1440-1746.2003.03014.x; Rammes A, 1997, J BIOL CHEM, V272, P9496; Roseth AG, 1999, SCAND J GASTROENTERO, V34, P50; Roseth AG, 1997, DIGESTION, V58, P176, DOI 10.1159/000201441; ROSETH AG, 1992, SCAND J GASTROENTERO, V27, P793, DOI 10.3109/00365529209011186; Rouge C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011083; Rugtveit J, 2002, J PEDIATR GASTR NUTR, V34, P323, DOI 10.1097/00005176-200203000-00022; Savino F, 2010, NEONATOLOGY, V97, P299, DOI 10.1159/000255161; Silberer H, 2005, CLIN LAB, V51, P117; Sipponen T, 2008, INFLAMM BOWEL DIS, V14, P1392, DOI 10.1002/ibd.20490; Sipponen T, 2008, INFLAMM BOWEL DIS, V14, P40, DOI 10.1002/ibd.20312; Splichal I, 2005, IMMUNOBIOLOGY, V209, P681, DOI 10.1016/j.imbio.2004.09.009; STEINBAKK M, 1990, LANCET, V336, P763, DOI 10.1016/0140-6736(90)93237-J; Striz I, 2004, PHYSIOL RES, V53, P245; Summerton CB, 2002, EUR J GASTROEN HEPAT, V14, P841, DOI 10.1097/00042737-200208000-00005; Sykora J, 2010, ACTA PAEDIATR, V99, P1389, DOI 10.1111/j.1651-2227.2010.01843.x; Tamboli CP, 2003, GASTROENTEROLOGY, V124, P1972, DOI 10.1016/S0016-5085(03)00552-3; Thuijls G, 2010, ANN SURG, V251, P1174, DOI 10.1097/SLA.0b013e3181d778c4; Tibble J, 2000, GUT, V47, P506, DOI 10.1136/gut.47.4.506; Tomas AB, 2007, REV ESP ENFERM DIG, V99, P689, DOI 10.4321/s1130-01082007001200002; Ton H, 2000, CLIN CHIM ACTA, V292, P41, DOI 10.1016/S0009-8981(99)00206-5; van Elburg RM, 2003, ARCH DIS CHILD-FETAL, V88, P52; Vaos G, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/542363; Vermeire S, 2006, GUT, V55, P426, DOI 10.1136/gut.2005.069476; Voganatsi A, 2001, J LEUKOCYTE BIOL, V70, P130; von Roon AC, 2007, AM J GASTROENTEROL, V102, P803, DOI 10.1111/j.1572-0241.2007.01126.x; WEAVER LT, 1984, ARCH DIS CHILD, V59, P236, DOI 10.1136/adc.59.3.236	57	46	49	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2015	10	3							e0119574	10.1371/journal.pone.0119574	http://dx.doi.org/10.1371/journal.pone.0119574			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9KG	25742018	Green Submitted, Green Published, gold			2022-12-27	WOS:000350688100123
J	Robiou-du-Pont, S; Li, AH; Christie, S; Sohani, ZN; Meyre, D				Robiou-du-Pont, Sebastien; Li, Aihua; Christie, Shanice; Sohani, Zahra N.; Meyre, David			Should We Have Blind Faith in Bioinformatics Software? Illustrations from the SNAP Web-Based Tool	PLOS ONE			English	Article							ASSOCIATION; ANNOTATION; AGREEMENT; HAPMAP	Bioinformatics tools have gained popularity in biology but little is known about their validity. We aimed to assess the early contribution of 415 single nucleotide polymorphisms (SNPs) associated with eight cardio-metabolic traits at the genome-wide significance level in adults in the Family Atherosclerosis Monitoring In earLY Life (FAMILY) birth cohort. We used the popular web-based tool SNAP to assess the availability of the 415 SNPs in the Illumina Cardio-Metabochip genotyped in the FAMILY study participants. We then compared the SNAP output with the Cardio-Metabochip file provided by Illumina using chromosome and chromosomal positions of SNPs from NCBI Human Genome Browser (Genome Reference Consortium Human Build 37). With the HapMap 3 release 2 reference, 201 out of 415 SNPs were reported as missing in the Cardio-Metabochip by the SNAP output. However, the Cardio-Metabochip file revealed that 152 of these 201 SNPs were in fact present in the Cardio-Metabochip array (false negative rate of 36.6%). With the more recent 1000 Genomes Project release, we found a false-negative rate of 17.6% by comparing the outputs of SNAP and the Illumina product file. We did not find any 'false positive' SNPs (SNPs specified as available in the Cardio-Metabochip by SNAP, but not by the Cardio-Metabochip Illumina file). The Cohen's Kappa coefficient, which calculates the percentage of agreement between both methods, indicated that the validity of SNAP was fair to moderate depending on the reference used (the HapMap 3 or 1000 Genomes). In conclusion, we demonstrate that the SNAP outputs for the Cardio-Metabochip are invalid. This study illustrates the importance of systematically assessing the validity of bioinformatics tools in an independent manner. We propose a series of guidelines to improve practices in the fast-moving field of bioinformatics software implementation.	[Robiou-du-Pont, Sebastien; Li, Aihua; Christie, Shanice; Sohani, Zahra N.; Meyre, David] McMaster Univ, Dept Clin Epidemiol & Biostat, Hamilton, ON, Canada; [Sohani, Zahra N.] McMaster Univ, Populat Hlth Res Inst, Hamilton, ON, Canada; [Sohani, Zahra N.] Hamilton Gen Hosp, Hamilton Hlth Sci, Hamilton, ON, Canada	McMaster University; McMaster University; Population Health Research Institute; McMaster University	Meyre, D (corresponding author), McMaster Univ, Dept Clin Epidemiol & Biostat, Hamilton, ON, Canada.	meyred@mcmaster.ca	Meyre, David/D-7315-2011; Robiou-du-Pont, Sébastien/O-1692-2015	Meyre, David/0000-0003-4850-7444; Robiou-du-Pont, Sébastien/0000-0002-4569-0039	Tier 2 Canada Research Chair; Heart and Stroke Foundation of Ontario [NA 7293]; Ontario Graduate Scholarships	Tier 2 Canada Research Chair(Canada Research Chairs); Heart and Stroke Foundation of Ontario(Heart & Stroke Foundation of Ontario); Ontario Graduate Scholarships(Ontario Graduate Scholarship)	DM is supported by a Tier 2 Canada Research Chair. SRP is supported by the Heart and Stroke Foundation of Ontario (grant # NA 7293 "Early genetic origins of cardiovascular risk factors"). AL and ZNS are funded by Ontario Graduate Scholarships. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Beck K., 2001, MANIFESTO AGILE SOFT; Choquet H, 2011, CURR GENOMICS, V12, P154, DOI 10.2174/138920211795677921; COHEN J, 1960, EDUC PSYCHOL MEAS, V20, P37, DOI 10.1177/001316446002000104; Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168; Johnson AD, 2008, BIOINFORMATICS, V24, P2938, DOI 10.1093/bioinformatics/btn564; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Liefeld T, 2005, BIOINFORMATICS, V21, P3681, DOI 10.1093/bioinformatics/bti587; Little J, 2009, PLOS MED, V6, P151, DOI 10.1371/journal.pmed.1000022; McCullough BD, 2006, J MONEY CREDIT BANK, V38, P1093, DOI 10.1353/mcb.2006.0061; Merali Z, 2010, NATURE, V467, P775, DOI 10.1038/467775a; Morrison KM, 2009, AM HEART J, V158, P533, DOI 10.1016/j.ahj.2009.07.005; Ouzounis CA, 2003, BIOINFORMATICS, V19, P2176, DOI 10.1093/bioinformatics/btg309; Rother K, 2012, BRIEF BIOINFORM, V13, P244, DOI 10.1093/bib/bbr035; Sladek R, 2007, NATURE, V445, P881, DOI 10.1038/nature05616; Voight BF, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002793; Wilson GV, 2013, ARXIV12100530	17	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2015	10	3							e0118925	10.1371/journal.pone.0118925	http://dx.doi.org/10.1371/journal.pone.0118925			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9KG	25742008	Green Published, Green Submitted, gold			2022-12-27	WOS:000350688100060
J	Schmeltz, MT; Sembajwe, G; Marcotullio, PJ; Grassman, JA; Himmelstein, DU; Woolhandler, S				Schmeltz, Michael T.; Sembajwe, Grace; Marcotullio, Peter J.; Grassman, Jean A.; Himmelstein, David U.; Woolhandler, Stephanie			Identifying Individual Risk Factors and Documenting the Pattern of Heat-Related Illness through Analyses of Hospitalization and Patterns of Household Cooling	PLOS ONE			English	Article							EMERGENCY-DEPARTMENTS; AMBIENT-TEMPERATURE; CASE-CROSSOVER; PUBLIC-HEALTH; EXTREME HEAT; US CITIES; MORTALITY; WAVE; VULNERABILITY; MORBIDITY	Background As climate change increases the frequency and intensity of extreme heat events researchers and public health officials must work towards understanding the causes and outcomes of heat-related morbidity and mortality. While there have been many studies on both heat-related illness (HRI), there are fewer on heat-related morbidity than on heat-related mortality. Objective To identify individual and environmental risk factors for hospitalizations and document patterns of household cooling. Methods We performed a pooled cross-sectional analysis of secondary U.S. data, the Nationwide Inpatient Sample. Risk ratios were calculated from multivariable models to identify risk factors for hospitalizations. Hierarchical modeling was also employed to identify relationships between individual and hospital level predictors of hospitalizations. Patterns of air conditioning use were analyzed among the vulnerable populations identified. Results Hospitalizations due to HRI increased over the study period compared to all other hospitalizations. Populations at elevated risk for HRI hospitalization were blacks, males and all age groups above the age of 40. Those living in zip-codes in the lowest income quartile and the uninsured were also at an increased risk. Hospitalizations for HRI in rural and small urban clusters were elevated, compared to urban areas. Conclusions Risk factors for HRI include age greater than 40, male gender and hospitalization in rural areas or small urban clusters. Our analysis also revealed an increasing pattern of HRI hospitalizations over time and decreased association between common comorbidities and heat illnesses which may be indicative of underreporting.	[Schmeltz, Michael T.; Sembajwe, Grace; Grassman, Jean A.; Himmelstein, David U.; Woolhandler, Stephanie] CUNY, Sch Publ Hlth, New York, NY 10021 USA; [Sembajwe, Grace; Marcotullio, Peter J.; Himmelstein, David U.; Woolhandler, Stephanie] CUNY, Hunter Coll, New York, NY USA; [Marcotullio, Peter J.] CUNY, Inst Sustainable Cities, New York, NY 10021 USA; [Grassman, Jean A.] CUNY Brooklyn Coll, Hlth & Nutr Sci, Brooklyn, NY 11210 USA	City University of New York (CUNY) System; City University of New York (CUNY) System; Hunter College (CUNY); City University of New York (CUNY) System; City University of New York (CUNY) System; Brooklyn College (CUNY)	Schmeltz, MT (corresponding author), CUNY, Sch Publ Hlth, New York, NY 10021 USA.	mschmeltz@gc.cuny.edu	; Sembajwe, Grace/H-3288-2017	Schmeltz, Michael/0000-0003-4764-9723; Sembajwe, Grace/0000-0002-7163-4743; Marcotullio, Peter/0000-0001-8133-1204	Division Of Behavioral and Cognitive Sci [1229429] Funding Source: National Science Foundation	Division Of Behavioral and Cognitive Sci(National Science Foundation (NSF)NSF - Directorate for Social, Behavioral & Economic Sciences (SBE))		Abrahamson V, 2009, J PUBLIC HEALTH-UK, V31, P119, DOI 10.1093/pubmed/fdn102; Astrom DO, 2011, MATURITAS, V69, P99, DOI 10.1016/j.maturitas.2011.03.008; Barros V, 2014, CLIMATE CHANGE 2014: IMPACTS, ADAPTATION, AND VULNERABILITY, PT A: GLOBAL AND SECTORAL ASPECTS, pIX; Bassil KL, 2008, CAN J PUBLIC HEALTH, V99, P339, DOI 10.1007/BF03403768; Basu R, 2009, ENVIRON HEALTH-GLOB, V8, DOI 10.1186/1476-069X-8-40; Bell ML, 2008, INT J EPIDEMIOL, V37, P796, DOI 10.1093/ije/dyn094; Bouchama A, 2002, NEW ENGL J MED, V346, P1978, DOI 10.1056/NEJMra011089; Chow WTL, 2012, PROF GEOGR, V64, P286, DOI 10.1080/00330124.2011.600225; Conlon KC, 2011, MATURITAS, V69, P197, DOI 10.1016/j.maturitas.2011.04.004; Curriero FC, 2002, AM J EPIDEMIOL, V155, P80, DOI 10.1093/aje/155.1.80; D'lppoliti D, 2010, ENVIRON HEALTH, V9; Deddens JA, 2008, OCCUP ENVIRON MED, V65, P501, DOI 10.1136/oem.2007.034777; Elixhauser A, 1998, MED CARE, V36, P8, DOI 10.1097/00005650-199801000-00004; Fouillet A, 2006, INT ARCH OCC ENV HEA, V80, P16, DOI 10.1007/s00420-006-0089-4; Fowler DR, 2013, MMWR-MORBID MORTAL W, V62, P433; Hansen AL, 2008, INT J EPIDEMIOL, V37, P1359, DOI 10.1093/ije/dyn165; Healthcare Cost and Utilization Project (HCUP), 2013, OVERVIEW OF THE NATI; Hess JJ, 2014, ENVIRON HEALTH PERSP, V122, P1209, DOI 10.1289/ehp.1306796; Houchens R, 2007, HCUP METHODS SERIES; Imhoff ML, 2010, REMOTE SENS ENVIRON, V114, P504, DOI 10.1016/j.rse.2009.10.008; Isaac M, 2009, ENERG POLICY, V37, P507, DOI 10.1016/j.enpol.2008.09.051; Johnson DP, 2014, GEOCARTO INT, V29, P65, DOI 10.1080/10106049.2013.799718; Josseran L, 2009, BMC MED INFORM DECIS, V9, DOI 10.1186/1472-6947-9-14; Kalkstein AJ, 2007, INT J BIOMETEOROL, V52, P43, DOI 10.1007/s00484-006-0073-4; Kenny GP, 2010, CAN MED ASSOC J, V182, P1053, DOI 10.1503/cmaj.081050; Kershaw SE, 2012, ENVIRON MONIT ASSESS, V184, P7329, DOI 10.1007/s10661-011-2502-z; Kestens Y, 2011, INT J HEALTH GEOGR, V10, DOI 10.1186/1476-072X-10-7; Khalaj B, 2010, INT ARCH OCC ENV HEA, V83, P833, DOI 10.1007/s00420-010-0534-2; Kilbourne EM, 2002, AM J PREV MED, V22, P328, DOI 10.1016/S0749-3797(02)00412-9; Knowlton K, 2009, ENVIRON HEALTH PERSP, V117, P61, DOI 10.1289/ehp.11594; Knowlton K, 2007, AM J PUBLIC HEALTH, V97, P2028, DOI 10.2105/AJPH.2006.102947; Kondo M, 2013, ENVIRON HEALTH PREV, V18, P251, DOI 10.1007/s12199-012-0313-7; Kovats R. S., 2003, CLIMATE CHANGE HUMAN, P181; Kovats RS, 2008, ANNU REV PUBL HEALTH, V29, P41, DOI 10.1146/annurev.publhealth.29.020907.090843; Kovats RS, 2004, OCCUP ENVIRON MED, V61, P893, DOI 10.1136/oem.2003.012047; Kravchenko J, 2013, AM J PREV MED, V44, P274, DOI 10.1016/j.amepre.2012.11.015; Li B, 2012, CLIMATIC CHANGE, V110, P959, DOI [10.1007/s10584-011-0120-y, 10.1007/s10584-011-0120-v]; Li TT, 2013, NAT CLIM CHANGE, V3, P717, DOI [10.1038/nclimate1902, 10.1038/NCLIMATE1902]; Lugo-Amador NM, 2004, EMERG MED CLIN N AM, V22, P315, DOI 10.1016/j.emc.2004.01.004; Mastrangelo G, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-200; Medina-Ramon M, 2006, ENVIRON HEALTH PERSP, V114, P1331, DOI 10.1289/ehp.9074; Meehl GA, 2004, SCIENCE, V305, P994, DOI 10.1126/science.1098704; Nunes B, 2011, OCCUP ENVIRON MED, V68, P218, DOI 10.1136/oem.2010.058396; O'Neill MS, 2005, J URBAN HEALTH, V82, P191, DOI 10.1093/jurban/jti043; Ostro B, 2010, AM J EPIDEMIOL, V172, P1053, DOI 10.1093/aje/kwq231; Reid CE, 2012, ENVIRON HEALTH PERSP, V120, P715, DOI 10.1289/ehp.1103766; Reid CE, 2009, ENVIRON HEALTH PERSP, V117, P1730, DOI 10.1289/ehp.0900683; Richard L, 2011, HEALTH EDUC RES, V26, P77, DOI 10.1093/her/cyq072; Schwartz J, 2005, EPIDEMIOLOGY, V16, P67, DOI 10.1097/01.ede.0000147114.25957.71; Semenza JC, 1999, AM J PREV MED, V16, P269, DOI 10.1016/S0749-3797(99)00025-2; Semenza JC, 1996, NEW ENGL J MED, V335, P84, DOI 10.1056/NEJM199607113350203; Stafoggia M, 2006, EPIDEMIOLOGY, V17, P315, DOI 10.1097/01.ede.0000208477.36665.34; Steiner Claudia, 2002, Eff Clin Pract, V5, P143; Stone B, 2010, ENVIRON HEALTH PERSP, V118, P1425, DOI 10.1289/ehp.0901879; Tan JG, 2010, INT J BIOMETEOROL, V54, P75, DOI 10.1007/s00484-009-0256-x; United States Census Bureau, 2013, 2010 CENSUS URBAN AN; United States Energy Information Administration (EIA), 2013, RESIDENTIAL ENERGY C; Vaneckova P, 2008, ENVIRON RES, V108, P361, DOI 10.1016/j.envres.2008.07.015; Vaneckova P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055459; Wheeler K, 2013, MMWR-MORBID MORTAL W, V62, P617; Wilby R., 2003, WEATHER, V58, P251, DOI DOI 10.1256/WEA.183.02; Xu ZW, 2012, ENVIRON RES, V117, P120, DOI 10.1016/j.envres.2012.07.002; Ye XF, 2012, ENVIRON HEALTH PERSP, V120, P19, DOI [10.1289/ehp.1003198, 10.1289/ehp.120-a19]; Yeo Theresa Pluth, 2004, AACN Clin Issues, V15, P280, DOI 10.1097/00044067-200404000-00013; Yun GY, 2011, APPL ENERG, V88, P2191, DOI 10.1016/j.apenergy.2011.01.010; Zhang Y, 2013, SCI TOTAL ENVIRON, V442, P1, DOI 10.1016/j.scitotenv.2012.10.042	66	13	15	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2015	10	3							e0118958	10.1371/journal.pone.0118958	http://dx.doi.org/10.1371/journal.pone.0118958			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CC9KG	25742021	Green Published, gold			2022-12-27	WOS:000350688100067
J	Fernandes, V; Triska, P; Pereira, JB; Alshamali, F; Rito, T; Machado, A; Fajkosova, Z; Cavadas, B; Cerny, V; Soares, P; Richards, MB; Pereira, L				Fernandes, Veronica; Triska, Petr; Pereira, Joana B.; Alshamali, Farida; Rito, Teresa; Machado, Alison; Fajkosova, Zuzana; Cavadas, Bruno; Cerny, Viktor; Soares, Pedro; Richards, Martin B.; Pereira, Luisa			Genetic Stratigraphy of Key Demographic Events in Arabia	PLOS ONE			English	Article							HUMAN MITOCHONDRIAL-DNA; BAYESIAN COALESCENT INFERENCE; GENOME-WIDE PATTERNS; MTDNA VARIATION; PHYLOGENETIC ANALYSIS; POPULATION-STRUCTURE; HUMAN-EVOLUTION; SUB-SAHARAN; AFRICA; HAPLOGROUP	At the crossroads between Africa and Eurasia, Arabia is necessarily a melting pot, its peoples enriched by successive gene flow over the generations. Estimating the timing and impact of these multiplemigrations are important steps in reconstructing the key demographic events in the human history. However, current methods based on genome-wide information identify admixture events inefficiently, tending to estimate only the more recent ages, as here in the case of admixture events across the Red Sea (similar to 8-37 generations for African input into Arabia, and 30-90 generations for "back-to-Africa" migrations). An mtDNA-based founder analysis, corroborated by detailed analysis of the whole-mtDNA genome, affords an alternative means by which to identify, date and quantify multiple migration events at greater time depths, across the full range of modern human history, albeit for the maternal line of descent only. In Arabia, this approach enables us to infer several major pulses of dispersal between the Near East and Arabia, most likely via the Gulf corridor. Although some relict lineages survive in Arabia from the time of the out-of-Africa dispersal, 60 ka, the major episodes in the peopling of the Peninsula took place from north to south in the Late Glacial and, to a lesser extent, the immediate post-glacial/Neolithic. Exchanges across the Red Sea were mainly due to the Arab slave trade and maritime dominance (from similar to 2.5 ka to very recent times), but had already begun by the early Holocene, fuelled by the establishment of maritime networks since similar to 8 ka. Themain "back-to-Africa" migrations, again undetected by genome-wide dating analyses, occurred in the Late Glacial period for introductions into eastern Africa, whilst the Neolithic was more significant for migrations towards North Africa.	[Fernandes, Veronica; Triska, Petr; Pereira, Joana B.; Cavadas, Bruno; Pereira, Luisa] Univ Porto, Inst Invest & Inovacao Saude, P-4100 Oporto, Portugal; [Fernandes, Veronica; Triska, Petr; Pereira, Joana B.; Rito, Teresa; Machado, Alison; Fajkosova, Zuzana; Cavadas, Bruno; Soares, Pedro; Pereira, Luisa] Inst Patol & Imunol Mol Univ Porto IPATIMUP, Oporto, Portugal; [Fernandes, Veronica; Pereira, Joana B.; Richards, Martin B.] Univ Leeds, Sch Biol, Fac Biol Sci, Leeds, W Yorkshire, England; [Triska, Petr] Univ Porto ICBAS, Inst Ciencias Biomed, Oporto, Portugal; [Alshamali, Farida] Dubai Police Gen Headquarters, Gen Dept Forens Sci & Criminol, Dubai, U Arab Emirates; [Fajkosova, Zuzana; Cerny, Viktor] Acad Sci Czech Republ, Inst Archaeol, Archaeogenet Lab, Prague, Czech Republic; [Richards, Martin B.] Univ Huddersfield, Dept Biol Sci, Sch Appl Sci, Huddersfield HD1 3DH, W Yorkshire, England; [Pereira, Luisa] Univ Porto, Fac Med, P-4100 Oporto, Portugal	Universidade do Porto; i3S - Instituto de Investigacao e Inovacao em Saude, Universidade do Porto; University of Leeds; Universidade do Porto; Czech Academy of Sciences; Institute of Archaeology of the Czech Academy of Sciences - Prague; University of Huddersfield; Universidade do Porto	Pereira, L (corresponding author), Univ Porto, Inst Invest & Inovacao Saude, Rua Campo Alegre 823, P-4100 Oporto, Portugal.	lpereira@ipatimup.pt	Fernandes, Vernonica/AAC-6824-2022; Hofmanová, Zuzana/M-6666-2019; Rito, Teresa/AAC-9041-2019; Cerny, Viktor/G-7842-2014; Rito, Teresa/O-7726-2014; Pereira, Joana B./J-6026-2013; Pereira, Luisa/H-3050-2011; Soares, Pedro A/G-9422-2011	Hofmanová, Zuzana/0000-0003-1336-4455; Rito, Teresa/0000-0002-8374-6347; Rito, Teresa/0000-0002-8374-6347; Pereira, Joana B./0000-0002-4409-514X; Pereira, Luisa/0000-0002-4271-1527; Soares, Pedro A/0000-0002-2807-690X; Cavadas, Bruno/0000-0003-4104-5398; fernandes, veronica/0000-0002-3873-2034	FCT, the Portuguese Foundation for Science and Technology [PTDC/CS-ANT/113832/2009, SFRH/BD/61342/2009, SFRH/BD/45657/2008, SFRH/BPD/64233/2009]; People Programme (Marie Curie Actions) of the European Union's Seventh Framework Programme FP7 under REA [317184]; Leverhulme Trust [10 105/D]; DeLaszlo Foundation; FCT; Grant Agency of the Czech Republic [13-37998S-P505]; Fundação para a Ciência e a Tecnologia [PTDC/CS-ANT/113832/2009] Funding Source: FCT	FCT, the Portuguese Foundation for Science and Technology(Portuguese Foundation for Science and Technology); People Programme (Marie Curie Actions) of the European Union's Seventh Framework Programme FP7 under REA; Leverhulme Trust(Leverhulme Trust); DeLaszlo Foundation; FCT(Portuguese Foundation for Science and TechnologyEuropean Commission); Grant Agency of the Czech Republic(Grant Agency of the Czech Republic); Fundação para a Ciência e a Tecnologia	FCT, the Portuguese Foundation for Science and Technology, supported this work through the research project PTDC/CS-ANT/113832/2009 and the personal grants to V.F. (SFRH/BD/61342/2009), J.B.P. (SFRH/BD/45657/2008), and P.S. (SFRH/BPD/64233/2009). P.T. has a PhD grant from the People Programme (Marie Curie Actions) of the European Union's Seventh Framework Programme FP7/2007-2013/ under REA grant agreement no. 317184. The authors also thank the Leverhulme Trust (research project grant 10 105/D) (to M.B.R.) and the DeLaszlo Foundation (to M.B.R./P.S.) for support. The Instituto de Patologia e Imunologia Molecular da Universidade do Porto is an Associate Laboratory of the Portuguese Ministry of Science, Technology, and Higher Education and is partially supported by FCT. VC was supported by the Grant Agency of the Czech Republic (Grant no. 13-37998S-P505). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Amero KK, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-45; Abu-Amero KK, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-32; Al-Abri A, 2012, AM J PHYS ANTHROPOL, V149, P291, DOI 10.1002/ajpa.22131; Alexander DH, 2009, GENOME RES, V19, P1655, DOI 10.1101/gr.094052.109; Alshamali F, 2008, FORENSIC SCI INT-GEN, V2, pE9, DOI 10.1016/j.fsigen.2007.08.005; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Alves M, 2012, ADV INTEL SOFT COMPU, V154, P129; Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779; Arredi B, 2004, AM J HUM GENET, V75, P338, DOI 10.1086/423147; Atkinson QD, 2009, P ROY SOC B-BIOL SCI, V276, P367, DOI 10.1098/rspb.2008.0785; BANDELT HJ, 1995, GENETICS, V141, P743; Behar DM, 2010, NATURE, V466, P238, DOI 10.1038/nature09103; Boivin N, 2009, VERTEBR PALEOBIOL PA, P251, DOI 10.1007/978-90-481-2719-1_18; Bryc K, 2010, P NATL ACAD SCI USA, V107, P786, DOI 10.1073/pnas.0909559107; Busby GBJ, 2012, P ROY SOC B-BIOL SCI, V279, P884, DOI 10.1098/rspb.2011.1044; Cerezo M, 2012, GENOME RES, V22, P821, DOI 10.1101/gr.134452.111; Cerny V, 2008, AM J PHYS ANTHROPOL, V136, P128, DOI 10.1002/ajpa.20784; Cerny V, 2011, MOL BIOL EVOL, V28, P2491, DOI 10.1093/molbev/msr067; Cerny V, 2011, MOL BIOL EVOL, V28, P71, DOI 10.1093/molbev/msq178; Cerny V, 2009, AM J PHYS ANTHROPOL, V138, P439, DOI 10.1002/ajpa.20960; Costa MD, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3543; Drechsler P., 2009, BRIT ARCHAEOLOGICAL, V1969; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Falush D, 2003, GENETICS, V164, P1567; Fedele FG, 2009, VERTEBR PALEOBIOL PA, P215, DOI 10.1007/978-90-481-2719-1_16; Fernandes V, 2012, AM J HUM GENET, V90, P347, DOI 10.1016/j.ajhg.2011.12.010; Forster P, 1996, AM J HUM GENET, V59, P935; Francalacci P, 2013, SCIENCE, V341, P565, DOI 10.1126/science.1237947; Freitag U, 1997, HADHRAMI TRADERS SCH, P392; Fu QM, 2013, CURR BIOL, V23, P553, DOI 10.1016/j.cub.2013.02.044; Groucutt HS, 2012, EVOL ANTHROPOL, V21, P113, DOI 10.1002/evan.21308; Harich N, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-138; Hellenthal G, 2014, SCIENCE, V343, P747, DOI 10.1126/science.1243518; Hodgson JA, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004393; Kitchen A, 2009, P ROY SOC B-BIOL SCI, V276, P2703, DOI 10.1098/rspb.2009.0408; Kivisild T, 2004, AM J HUM GENET, V75, P752, DOI 10.1086/425161; Kloss-Brandstatter A, 2011, HUM MUTAT, V32, P25, DOI 10.1002/humu.21382; Kujanova M, 2009, AM J PHYS ANTHROPOL, V140, P336, DOI 10.1002/ajpa.21078; Li JZ, 2008, SCIENCE, V319, P1100, DOI 10.1126/science.1153717; Lovejoy PE, 1983, TRANSFORMATIONS SLAV, P200; Mellars P, 2013, P NATL ACAD SCI USA, V110, P10699, DOI 10.1073/pnas.1306043110; Mitchell P, 2005, AFRICAN CONNECTIONS, P328; Moorjani P, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001373; Musilova E, 2011, AM J PHYS ANTHROPOL, V145, P592, DOI 10.1002/ajpa.21522; Olivieri A, 2006, SCIENCE, V314, P1767, DOI 10.1126/science.1135566; Parker AG, 2009, VERTEBR PALEOBIOL PA, P39, DOI 10.1007/978-90-481-2719-1_3; Patterson N, 2006, PLOS GENET, V2, P2074, DOI 10.1371/journal.pgen.0020190; Patterson N, 2012, GENETICS, V192, P1065, DOI 10.1534/genetics.112.145037; Pennarun E, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-234; Pereira L, 2000, ANN HUM GENET, V64, P491, DOI 10.1046/j.1469-1809.2000.6460491.x; Pereira L, 2007, MOL BIOL EVOL, V24, P868, DOI 10.1093/molbev/msm004; Pereira L, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-390; Pereira L, 2009, AM J HUM GENET, V84, P628, DOI 10.1016/j.ajhg.2009.04.013; Petraglia MD, 2003, ANTIQUITY, V77, P671, DOI 10.1017/S0003598X00061639; Pool JE, 2009, GENETICS, V181, P711, DOI 10.1534/genetics.108.098095; Poznik GD, 2013, SCIENCE, V341, P562, DOI 10.1126/science.1237619; Pugach I, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-2-r19; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Ray PH, 2003, ARCHAEOLOGY SEAFARIN, P350; Richards M, 2000, AM J HUM GENET, V67, P1251, DOI 10.1016/S0002-9297(07)62954-1; Richards M, 2003, AM J HUM GENET, V72, P1058, DOI 10.1086/374384; Rito T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080031; Rose JI, 2009, VERTEBR PALEOBIOL PA, P1, DOI 10.1007/978-90-481-2719-1_1; Saillard J, 2000, AM J HUM GENET, V67, P718, DOI 10.1086/303038; Scally A, 2012, NAT REV GENET, V13, P745, DOI 10.1038/nrg3295; Segal R, 2002, ISLAMS BLACK SLAVES, P288; Soares P, 2008, MOL BIOL EVOL, V25, P1209, DOI 10.1093/molbev/msn068; Soares P, 2012, MOL BIOL EVOL, V29, P915, DOI 10.1093/molbev/msr245; Soares P, 2009, AM J HUM GENET, V84, P740, DOI 10.1016/j.ajhg.2009.05.001; Uerpmann HP, 2009, VERTEBR PALEOBIOL PA, P205, DOI 10.1007/978-90-481-2719-1_15; van Oven M, 2009, HUM MUTAT, V30, pE386, DOI 10.1002/humu.20921; Wei W, 2013, GENOME RES, V23, P388, DOI 10.1101/gr.143198.112; Yang ZH, 1997, COMPUT APPL BIOSCI, V13, P555	74	37	37	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2015	10	3							e0118625	10.1371/journal.pone.0118625	http://dx.doi.org/10.1371/journal.pone.0118625			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9JM	25738654	gold, Green Published, Green Accepted			2022-12-27	WOS:000350685900058
J	Okuno, T; Ishitani, T; Yokomizo, T				Okuno, Toshiaki; Ishitani, Tohru; Yokomizo, Takehiko			Biochemical Characterization of Three BLT Receptors in Zebrafish	PLOS ONE			English	Article							LEUKOTRIENE B-4 RECEPTOR; PROTEIN-COUPLED RECEPTOR; 12-HYDROXYHEPTADECATRIENOIC ACID; CELL MOVEMENTS; GASTRULATION; MIGRATION; INFLAMMATION; EXPRESSION	The leukotriene B-4 (LTB4) receptor 1 (BLT1) is a high affinity receptor for LTB4, a chemotactic and inflammatory eicosanoid. The LTB4 receptor 2 (BLT2) was originally identified as a low affinity receptor for LTB4, and, more recently, as a high affinity receptor for 12-hydroxy-heptadecatrienoic acid (12-HHT). The zebrafish BLT receptors have not been previously identified and the in vivo functions of these receptors have been unknown. In this paper, we describe one zebrafish BLT1-like receptor, Blt1, and two zebrafish BLT2-like receptors, Blt2a and Blt2b. Cells expressing Blt1 exhibited LTB4-induced intracellular [Ca2+] increases, inhibition of cAMP production, ligand-dependent [S-35]GTP gamma S binding, and transforming growth factor-alpha (TGF alpha) shedding activity in a dose-dependent manner, similar to human BLT1. Cells expressing Blt2a and Blt2b exhibited 12-HHT- and LTB4-induced intracellular [Ca2+] increases, inhibition of cAMP production, [S-35]GTP gamma S binding, and TGF alpha shedding activity, with a dose-dependency similar to human BLT2. Reverse transcription (RT)-PCR analysis and whole-mount in situ hybridization revealed that blt1, blt2a, blt2b, zebrafish LTA(4) hydrolase (lta4h), and zebrafish 5-lipoxiganase (5lo) are expressed in zebrafish embryos. Knockdown of blt1 by morpholino antisense oligonucleotides resulted in delayed epiboly at gastrulation. Consistently, knockdown of lta4h, an enzyme mediating LTB4 production, induced a phenotype similar to knockdown of blt1. These results suggest that the LTB4-BLT1 axis is involved in epiboly in zebrafish development.	[Okuno, Toshiaki; Yokomizo, Takehiko] Juntendo Univ, Sch Med, Dept Biochem, Tokyo 113, Japan; [Okuno, Toshiaki; Yokomizo, Takehiko] Kyushu Univ, Dept Med Biochem, Fukuoka 812, Japan; [Ishitani, Tohru] Kyushu Univ, Div Cell Regulat Syst, Dept Immunobiol & Neurosci, Med Inst Bioregulat, Fukuoka 812, Japan	Juntendo University; Kyushu University; Kyushu University	Okuno, T (corresponding author), Juntendo Univ, Sch Med, Dept Biochem, Tokyo 113, Japan.	tokuno@juntendo.ac.jp	Yokomizo, Takehiko/P-5673-2016; , Tohru/AAH-8979-2020	Yokomizo, Takehiko/0000-0002-5219-1553; , Tohru/0000-0002-6200-7043	Ministry of Education, Culture, Sports, Science, and Technology of Japan [21390083, 22116001, 22116002, 25460374, 24102522]; Naito Foundation; Ono Medical Research Foundation; Uehara Memorial Foundation; Takeda Science Foundation; Inamori Foundation; Grants-in-Aid for Scientific Research [15H05897] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Naito Foundation(Naito Memorial Foundation); Ono Medical Research Foundation; Uehara Memorial Foundation(Uehara Memorial Foundation); Takeda Science Foundation(Takeda Science Foundation (TSF)); Inamori Foundation; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grants-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (nos. 21390083, 22116001, and 22116002 to T.Y.; and nos. 25460374 and 24102522 to T.O.), the Naito Foundation, the Ono Medical Research Foundation, the Uehara Memorial Foundation, the Takeda Science Foundation, and the Inamori Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Back M, 2011, PHARMACOL REV, V63, P539, DOI 10.1124/pr.110.004184; Basu S, 2007, J BIOL CHEM, V282, P10005, DOI 10.1074/jbc.M609552200; Bischel LL, 2013, LAB CHIP, V13, P1732, DOI 10.1039/c3lc50099c; Cha YI, 2006, GENE DEV, V20, P77, DOI 10.1101/gad.1374506; Cha YI, 2005, DEV BIOL, V282, P274, DOI 10.1016/j.ydbio.2005.03.014; Costa MFD, 2010, J LEUKOCYTE BIOL, V87, P323, DOI 10.1189/jlb.0809563; Hikiji H, 2009, P NATL ACAD SCI USA, V106, P21294, DOI 10.1073/pnas.0905209106; Huang WW, 1998, J EXP MED, V188, P1063, DOI 10.1084/jem.188.6.1063; Iizuka Y, 2010, FASEB J, V24, P4678, DOI 10.1096/fj.10-165050; Inoue A, 2012, NAT METHODS, V9, P1021, DOI [10.1038/nmeth.2172, 10.1038/NMETH.2172]; Johansson AS, 2011, PROSTAG LEUKOTR ESS, V84, P109, DOI 10.1016/j.plefa.2010.11.003; Kavelaars A, 2003, J IMMUNOL, V171, P6128, DOI 10.4049/jimmunol.171.11.6128; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Kuniyeda K, 2007, J BIOL CHEM, V282, P3998, DOI 10.1074/jbc.M610540200; Lepage SE, 2010, INT J DEV BIOL, V54, P1213, DOI 10.1387/ijdb.093028sl; Lin F, 2005, J CELL BIOL, V169, P777, DOI 10.1083/jcb.200501104; Lin F, 2009, J CELL BIOL, V184, P909, DOI 10.1083/jcb.200805148; Liu M, 2014, J EXP MED, V211, P1063, DOI 10.1084/jem.20132063; Matsunaga Y, 2013, FASEB J, V27, P3306, DOI 10.1096/fj.12-217000; Matsunobu T, 2013, J LIPID RES, V54, P2979, DOI 10.1194/jlr.M037754; Meijer AH, 2011, CURR DRUG TARGETS, V12, P1000; Miyahara N, 2008, J IMMUNOL, V181, P1170, DOI 10.4049/jimmunol.181.2.1170; Moraes J, 2010, ATHEROSCLEROSIS, V212, P406, DOI 10.1016/j.atherosclerosis.2010.06.009; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; Okuno T, 2005, J BIOL CHEM, V280, P32049, DOI 10.1074/jbc.R500007200; Okuno T, 2003, J BIOL CHEM, V278, P41500, DOI 10.1074/jbc.M307335200; Okuno T, 2008, J EXP MED, V205, P759, DOI 10.1084/jem.20072329; Rohde LA, 2007, INT REV CYTOL, V261, P159, DOI 10.1016/S0074-7696(07)61004-3; SAMUELSSON B, 1987, SCIENCE, V237, P1171, DOI 10.1126/science.2820055; Solnica-Krezel L, 2012, ANNU REV CELL DEV BI, V28, P687, DOI 10.1146/annurev-cellbio-092910-154043; Tager AM, 2003, NAT IMMUNOL, V4, P982, DOI 10.1038/ni970; Tobin DM, 2012, CELL, V148, P434, DOI 10.1016/j.cell.2011.12.023; Tobin DM, 2010, CELL, V140, P717, DOI 10.1016/j.cell.2010.02.013; Toda A, 2010, BIOCHIMIE, V92, P682, DOI 10.1016/j.biochi.2009.12.002; WARGA RM, 1990, DEVELOPMENT, V108, P569; Yasuda D, 2009, FASEB J, V23, P1470, DOI 10.1096/fj.08-125385; Yokomizo T, 2000, J EXP MED, V192, P421, DOI 10.1084/jem.192.3.421; Yokomizo T, 1997, NATURE, V387, P620, DOI 10.1038/42506	38	14	15	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2015	10	3							e0117888	10.1371/journal.pone.0117888	http://dx.doi.org/10.1371/journal.pone.0117888			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9JM	25738285	Green Published, Green Submitted, gold			2022-12-27	WOS:000350685900019
J	Yi, SN; He, WQ; Zhan, L; Qi, ZY; Zhu, CL; Luo, WB; Li, H				Yi, Shengnan; He, Weiqi; Zhan, Lei; Qi, Zhengyang; Zhu, Chuanlin; Luo, Wenbo; Li, Hong			Emotional Noun Processing: An ERP Study with Rapid Serial Visual Presentation	PLOS ONE			English	Article							EVENT-RELATED POTENTIALS; ELECTROPHYSIOLOGICAL EVIDENCE; TEMPORAL DYNAMICS; WORDS; BRAIN; ADJECTIVES; AROUSAL; FACE; LATERALIZATION; SUPPRESSION	Reading is an important part of our daily life, and rapid responses to emotional words have received a great deal of research interest. Our study employed rapid serial visual presentation to detect the time course of emotional noun processing using event-related potentials. We performed a dual-task experiment, where subjects were required to judge whether a given number was odd or even, and the category into which each emotional noun fit. In terms of P1, we found that there was no negativity bias for emotional nouns. However, emotional nouns elicited larger amplitudes in the N170 component in the left hemisphere than did neutral nouns. This finding indicated that in later processing stages, emotional words can be discriminated from neutral words. Furthermore, positive, negative, and neutral words were different from each other in the late positive complex, indicating that in the third stage, even different emotions can be discerned. Thus, our results indicate that in a three-stage model the latter two stages are more stable and universal.	[Yi, Shengnan; He, Weiqi; Zhan, Lei; Qi, Zhengyang; Zhu, Chuanlin; Luo, Wenbo] Liaoning Normal Univ, Sch Psychol, Dalian, Peoples R China; [Luo, Wenbo] Chongqing Univ Arts & Sci, Lab Cognit & Mental Hlth, Chongqing, Peoples R China; [Li, Hong] Shenzhen Univ, Res Ctr Brain Funct & Psychol Sci, Shenzhen, Peoples R China	Liaoning Normal University; Chongqing University of Arts & Sciences; Shenzhen University	Luo, WB (corresponding author), Liaoning Normal Univ, Sch Psychol, Dalian, Peoples R China.	wenbo9390@sina.com			National Natural Science Foundation of China [31371033, 31170984]; Special Public-welfare Project of the Ministry of Health [201002003]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Special Public-welfare Project of the Ministry of Health	The work was supported by the National Natural Science Foundation of China (31371033 and 31170984) the Special Public-welfare Project of the Ministry of Health (201002003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison T, 1999, CEREB CORTEX, V9, P415, DOI 10.1093/cercor/9.5.415; Barbeau EJ, 2008, CEREB CORTEX, V18, P997, DOI 10.1093/cercor/bhm140; Bayer M, 2012, PSYCHOPHYSIOLOGY, V49, P959, DOI 10.1111/j.1469-8986.2012.01381.x; Bayer M, 2010, INT J PSYCHOPHYSIOL, V78, P299, DOI 10.1016/j.ijpsycho.2010.09.004; Bernat E, 2001, INT J PSYCHOPHYSIOL, V42, P11, DOI 10.1016/S0167-8760(01)00133-7; Fischler I, 2006, PROG BRAIN RES, V156, P185, DOI 10.1016/S0079-6123(06)56009-1; Gao X, 2011, INT J PSYCHOPHYSIOL, V82, P133, DOI 10.1016/j.ijpsycho.2011.07.015; Gianotti LRR, 2008, BRAIN TOPOGR, V20, P143, DOI 10.1007/s10548-007-0041-2; Herbert C, 2008, PSYCHOPHYSIOLOGY, V45, P487, DOI 10.1111/j.1469-8986.2007.00638.x; Herbert C, 2006, PSYCHOPHYSIOLOGY, V43, P197, DOI 10.1111/j.1469-8986.2006.00385.x; Hillyard SA, 1998, PHILOS T ROY SOC B, V353, P1257, DOI 10.1098/rstb.1998.0281; Kissler J, 2007, PSYCHOL SCI, V18, P475, DOI 10.1111/j.1467-9280.2007.01924.x; Kissler J, 2009, BIOL PSYCHOL, V80, P75, DOI 10.1016/j.biopsycho.2008.03.004; Lang PJ, 1997, ATTENTION AND ORIENTING: SENSORY AND MOTIVATIONAL PROCESSES, P97; Luo WB, 2013, BIOL PSYCHOL, V92, P395, DOI 10.1016/j.biopsycho.2012.11.019; Luo WB, 2010, NEUROIMAGE, V49, P1857, DOI 10.1016/j.neuroimage.2009.09.018; Mercure E, 2008, J COGNITIVE NEUROSCI, V20, P2070, DOI 10.1162/jocn.2008.20137; NAUMANN E, 1992, J PSYCHOPHYSIOL, V6, P285; Onitsuka T, 2009, BRAIN IMAGING BEHAV, V3, P240, DOI 10.1007/s11682-009-9066-3; Palazova M, 2011, NEUROPSYCHOLOGIA, V49, P2766, DOI 10.1016/j.neuropsychologia.2011.06.005; RAYMOND JE, 1992, J EXP PSYCHOL HUMAN, V18, P849, DOI 10.1037/0096-1523.18.3.849; REISENZEIN R, 1994, J PERS SOC PSYCHOL, V67, P525, DOI 10.1037/0022-3514.67.3.525; Rossion B, 2003, NEUROIMAGE, V20, P1609, DOI 10.1016/j.neuroimage.2003.07.010; RUSSELL JA, 1980, J PERS SOC PSYCHOL, V39, P1161, DOI 10.1037/h0077714; Sass SM, 2010, PSYCHOPHYSIOLOGY, V47, P247, DOI 10.1111/j.1469-8986.2009.00926.x; Schacht A, 2009, BRAIN COGNITION, V69, P538, DOI 10.1016/j.bandc.2008.11.005; Schapkin SA, 2000, ACTA NEUROBIOL EXP, V60, P17; Schupp HT, 2004, EMOTION, V4, P189, DOI 10.1037/1528-3542.4.2.189; Schutter DJLG, 2004, INT J PSYCHOPHYSIOL, V53, P29, DOI 10.1016/j.ijpsycho.2004.01.003; Scott GG, 2009, BIOL PSYCHOL, V80, P95, DOI 10.1016/j.biopsycho.2008.03.010; Sergent C, 2005, NAT NEUROSCI, V8, P1391, DOI 10.1038/nn1549; Simon G, 2007, BEHAV BRAIN FUNCT, V3, DOI 10.1186/1744-9081-3-21; Sprengelmeyer R, 2006, NEUROPSYCHOLOGIA, V44, P2899, DOI 10.1016/j.neuropsychologia.2006.06.020; van Hooff JC, 2008, INT J PSYCHOPHYSIOL, V67, P23, DOI 10.1016/j.ijpsycho.2007.09.002; Vogel EK, 1998, J EXP PSYCHOL HUMAN, V24, P1656, DOI 10.1037/0096-1523.24.6.1656; Williams LM, 2006, NEUROIMAGE, V31, P458, DOI 10.1016/j.neuroimage.2005.12.009; Zhang DD, 2014, SOC COGN AFFECT NEUR, V9, P1897, DOI 10.1093/scan/nst188; Zhang DD, 2013, BRAIN RES, V1512, P78, DOI 10.1016/j.brainres.2013.03.044	38	25	27	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2015	10	3							e0118924	10.1371/journal.pone.0118924	http://dx.doi.org/10.1371/journal.pone.0118924			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CC9JM	25738633	Green Published, Green Submitted, gold			2022-12-27	WOS:000350685900085
J	Bos, SD; Page, CM; Andreassen, BK; Elboudwarej, E; Gustavsen, MW; Briggs, F; Quach, H; Leikfoss, IS; Bjolgerud, A; Berge, T; Harbo, HF; Barcellos, LF				Bos, Steffan D.; Page, Christian M.; Andreassen, Bettina K.; Elboudwarej, Emon; Gustavsen, Mane W.; Briggs, Farren; Quach, Hong; Leikfoss, Ingvild S.; Bjolgerud, Anja; Berge, Tone; Harbo, Hanne F.; Barcellos, Lisa F.			Genome-Wide DNA Methylation Profiles Indicate CD8+T Cell Hypermethylation in Multiple Sclerosis	PLOS ONE			English	Article							EPIGENETICS; TWINS	Objective Determine whether MS-specific DNA methylation profiles can be identified in whole blood or purified immune cells from untreated MS patients. Methods Whole blood, CD4+ and CD8+ T cell DNA from 16 female, treatment naive MS patients and 14 matched controls was profiled using the HumanMethylation450K BeadChip. Genotype data were used to assess genetic homogeneity of our sample and to exclude potential SNP-induced DNA methylation measurement errors. Results As expected, significant differences between CD4+ T cells, CD8+ T cells and whole blood DNA methylation profiles were observed, regardless of disease status. Strong evidence for hypermethylation of CD8+ T cell, but not CD4+ T cell or whole blood DNA in MS patients compared to controls was observed. Genome-wide significant individual CpG-site DNA methylation differences were not identified. Furthermore, significant differences in gene DNA methylation of 148 established MS-associated risk genes were not observed. Conclusion While genome-wide significant DNA methylation differences were not detected for individual CpG-sites, strong evidence for DNA hypermethylation of CD8+ T cells for MS patients was observed, indicating a role for DNA methylation in MS. Further, our results suggest that large DNA methylation differences for CpG-sites tested here do not contribute to MS susceptibility. In particular, large DNA methylation differences for CpG-sites within 148 established MS candidate genes tested in our study cannot explain missing heritability. Larger studies of homogenous MS patients and matched controls are warranted to further elucidate the impact of CD8+ T cell and more subtle DNA methylation changes in MS development and pathogenesis.	[Bos, Steffan D.; Page, Christian M.; Gustavsen, Mane W.; Leikfoss, Ingvild S.; Bjolgerud, Anja; Berge, Tone; Harbo, Hanne F.] Oslo Univ Hosp, Dept Neurol, Oslo, Norway; [Bos, Steffan D.; Page, Christian M.; Gustavsen, Mane W.; Leikfoss, Ingvild S.; Bjolgerud, Anja; Harbo, Hanne F.] Univ Oslo, Inst Clin Med, Oslo, Norway; [Andreassen, Bettina K.] Univ Oslo, Dept Biostat, Oslo Ctr Biostat & Epidemiol, Oslo, Norway; [Andreassen, Bettina K.] Univ Oslo, Akershus Univ Hosp, Inst Clin Med, Epigen, Oslo, Norway; [Elboudwarej, Emon; Briggs, Farren; Quach, Hong; Barcellos, Lisa F.] Univ Calif Berkeley, Sch Publ Hlth, Div Epidemiol, Genet Epidemiol & Genom Lab, Berkeley, CA 94720 USA	University of Oslo; University of Oslo; University of Oslo; University of Oslo; University of California System; University of California Berkeley	Bos, SD (corresponding author), Oslo Univ Hosp, Dept Neurol, Oslo, Norway.	s.d.bos@medisin.uto.no	Bos, Steffan D/L-7896-2016; Briggs, Farren/Q-2164-2019; Page, Christian/J-7129-2019	Bos, Steffan D/0000-0002-2975-7520; Briggs, Farren/0000-0003-0903-1359; Page, Christian/0000-0002-1897-3666	Norwegian Research Council [196776/V50]; National Institutes of Health/National Institute of Environmental Health Sciences [R01 ES017080]; Molecular Life Sciences fund at the University of Oslo	Norwegian Research Council(Research Council of NorwayEuropean Commission); National Institutes of Health/National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Molecular Life Sciences fund at the University of Oslo	Funding for this study was provided through "The Norwegian Research Council" grant ID 196776/V50 (SDB, AB, MWG, HFH), the National Institutes of Health/National Institute of Environmental Health Sciences grant ID R01 ES017080 (LB) and the Molecular Life Sciences fund at the University of Oslo (SDB, CMP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Absher DM, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003678; Altorok N, 2014, ARTHRITIS RHEUMATOL, V66, P731, DOI 10.1002/art.38264; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Baranzini SE, 2013, AM J HUM GENET, V92, P854, DOI 10.1016/j.ajhg.2013.04.019; Baranzini SE, 2010, NATURE, V464, P1351, DOI 10.1038/nature08990; Beecham AH, 2013, NAT GENET, V45, P1353, DOI 10.1038/ng.2770; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bibikova M, 2011, GENOMICS, V98, P288, DOI 10.1016/j.ygeno.2011.07.007; Boks MP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006767; Broux B, 2013, CRIT REV IMMUNOL, V33, P283; Calabrese R, 2012, MULT SCLER J, V18, P299, DOI 10.1177/1352458511421055; Chitnis T, 2007, INT REV NEUROBIOL, V79, P43, DOI 10.1016/S0074-7742(07)79003-7; Compston A, 2008, LANCET, V372, P1502, DOI 10.1016/S0140-6736(08)61620-7; Dayeh T, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004160; Dedeurwaerder S, 2011, EPIGENOMICS-UK, V3, P771, DOI [10.2217/EPI.11.105, 10.2217/epi.11.105]; Feinberg AP, 2007, NATURE, V447, P433, DOI 10.1038/nature05919; Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168; Gourraud PA, 2012, IMMUNOL REV, V248, P87, DOI 10.1111/j.1600-065X.2012.01134.x; Graves MC, 2014, MULT SCLER J, V20, P1033, DOI 10.1177/1352458513516529; Hafler DA, 2007, NEW ENGL J MED, V357, P851, DOI 10.1056/NEJMoa073493; Houseman EA, 2014, BIOINFORMATICS, V30, P1431, DOI 10.1093/bioinformatics/btu029; Howie BN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000529; Huseby ES, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00064; Huynh JL, 2014, NAT NEUROSCI, V17, P121, DOI 10.1038/nn.3588; Jaffe AE, 2012, INT J EPIDEMIOL, V41, P200, DOI 10.1093/ije/dyr238; Kumagai C, 2012, J NEUROIMMUNOL, V246, P51, DOI 10.1016/j.jneuroim.2012.03.003; Maurano MT, 2012, SCIENCE, V337, P1190, DOI 10.1126/science.1222794; Nielsen Helene Myrtue, 2013, Subcell Biochem, V61, P455, DOI 10.1007/978-94-007-4525-4_20; Polman CH, 2011, ANN NEUROL, V69, P292, DOI 10.1002/ana.22366; Price EM, 2013, EPIGENET CHROMATIN, V6, DOI 10.1186/1756-8935-6-4; R Core Team, 2013, LANG ENV STAT COMP, DOI [10.1007/s13197-013-0993-z, DOI 10.1007/S13197-013-0993-Z]; Reinius LE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041361; Szyf M, 2009, ANNU REV PHARMACOL, V49, P243, DOI 10.1146/annurev-pharmtox-061008-103102; Teschendorff AE, 2013, BIOINFORMATICS, V29, P189, DOI 10.1093/bioinformatics/bts680; Whitaker JW, 2013, GENOME MED, V5, DOI 10.1186/gm444; Zeilinger S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063812	36	68	70	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2015	10	3							e0117403	10.1371/journal.pone.0117403	http://dx.doi.org/10.1371/journal.pone.0117403			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4HV	25734800	Green Published, gold			2022-12-27	WOS:000350314700009
J	Li, ZY; Ren, M; Tian, JW; Jiang, SQ; Liu, YJ; Zhang, L; Wang, ZZ; Song, QQ; Liu, C; Wu, T				Li, Ziyao; Ren, Min; Tian, Jiawei; Jiang, Shuangquan; Liu, Yujie; Zhang, Lei; Wang, Zhenzhen; Song, Qianqian; Liu, Chong; Wu, Tong			The Differences in Ultrasound and Clinicopathological Features between Basal-Like and Normal-Like Subtypes of Triple Negative Breast Cancer	PLOS ONE			English	Article							CARCINOMAS; FIBROADENOMA; PROGNOSIS; RECEPTOR; BIOPSY; TUMORS	Purpose The aim of this study was to identify the ultrasound features and clinicopathological characteristics of basal-like subtype of triple negative breast cancers (TNBCs). Materials and Methods This study was approved by the ethical board of the Second Affiliated Hospital of Harbin Medical University. The patients' clinicopathological information was available. The ultrasound features of 62 tumors from 62 TNBC patients were interpreted. The immunohistochemical results of cytokertain5/6 (CK5/6) and Epidermal Growth Factor Receptor (EGFR) were used to classify the tumor into basal-like and normal-like groups. The association of the ultrasound features interpreted by experienced ultrasound doctors with the immunohistochemical classification was studied. Results Of the 62 TNBC cases, 42 (67.7%) exhibited the basal-like phenotype and 20 (32.3%) exhibited the normal-like phenotype based on the immunohistochemical CK5/6 and EGFR markers. Of all the tumors, 90.3% were invasive carcinomas. The basal-like tumors were significantly associated with a maximum diameter on ultrasound of more than 20 mm (36, 85.7%) (P = 0.0014). The normal-like tumors usually exhibited lateral shadows (15, 75%) (P = 0.0115) as well as microlobulated margins (12, 60%) (P = 0.0204) compared to the basal-like subtype. Other ultrasound features showed no significant differences between the two groups. Conclusions Although ultrasound cannot yet be used to differentiate between the basal-like subtype and normal-like subtype of TNBC, ultrasound can be used to provide some useful information to the clinicians.	[Li, Ziyao; Ren, Min; Tian, Jiawei; Jiang, Shuangquan; Liu, Yujie; Zhang, Lei; Wang, Zhenzhen; Liu, Chong; Wu, Tong] Harbin Med Univ, Affiliated Hosp 2, Dept Ultrasound, Harbin, Heilongjiang Pr, Peoples R China; [Song, Qianqian] Harbin Med Univ, Coll Publ Hlth, Dept Biostat, Harbin, Heilongjiang Pr, Peoples R China	Harbin Medical University; Harbin Medical University	Ren, M (corresponding author), Harbin Med Univ, Affiliated Hosp 2, Dept Ultrasound, Harbin, Heilongjiang Pr, Peoples R China.	1455168546@qq.com; juvtian2004@163.com	song, qian/HDL-9868-2022		National Natural Science Foundations of China [81271647, 81071216, 81101103]	National Natural Science Foundations of China(National Natural Science Foundation of China (NSFC))	The project was supported by the National Natural Science Foundations of China (Grant NO. 81271647, NO. 81071216 and NO. 81101103). Jiawei Tian received the previous two and Ying Wang received the last one.	ADLER DD, 1990, ULTRASOUND MED BIOL, V16, P553, DOI 10.1016/0301-5629(90)90020-D; Au-Yong ITH, 2009, EUR RADIOL, V19, P2342, DOI 10.1007/s00330-009-1418-2; Banerjee S, 2006, J CLIN PATHOL, V59, P729, DOI 10.1136/jcp.2005.033043; Billar JAY, 2010, ANN SURG ONCOL, V17, pS384, DOI 10.1245/s10434-010-1260-4; BLOOM HJG, 1957, BRIT J CANCER, V11, P359, DOI 10.1038/bjc.1957.43; Boisserie-Lacroix M, 2013, Diagn Interv Imaging, V94, P1069, DOI 10.1016/j.diii.2013.04.010; Boisserie-Lacroix M, 2013, ONCOLOGIST, V18, P802, DOI 10.1634/theoncologist.2013-0380; Cakir A, 2012, DIAGN PATHOL, V7, DOI 10.1186/1746-1596-7-145; Choccalingam C, 2012, BREAST CANCER-BASIC, V6, P21, DOI 10.4137/BCBCR.S8611; COLEBEUGLET C, 1983, AM J ROENTGENOL, V140, P369, DOI 10.2214/ajr.140.2.369; Dent R, 2007, CLIN CANCER RES, V13, P4429, DOI 10.1158/1078-0432.CCR-06-3045; Dogan BE, 2012, ANN ONCOL, V23, P23, DOI 10.1093/annonc/mds191; FORNAGE BD, 1989, RADIOLOGY, V172, P671, DOI 10.1148/radiology.172.3.2549564; FORNAGE BD, 1990, J ULTRAS MED, V9, P559; Guerra I, 2003, J CLIN PATHOL-MOL PA, V56, P323, DOI 10.1136/mp.56.6.323; Ko ES, 2010, EUR RADIOL, V20, P1111, DOI 10.1007/s00330-009-1656-3; Krizmanich-Conniff KM, 2012, AM J ROENTGENOL, V199, P458, DOI 10.2214/AJR.10.6096; Livasy CA, 2006, MODERN PATHOL, V19, P264, DOI 10.1038/modpathol.3800528; Luparia A, 2013, RADIOL MED, V118, P1119, DOI 10.1007/s11547-013-0941-z; Rakha EA, 2007, J CLIN PATHOL, V60, P1300, DOI 10.1136/jcp.2006.045377; Rakha EA, 2007, CANCER-AM CANCER SOC, V109, P25, DOI 10.1002/cncr.22381; Rakha EA, 2009, PATHOLOGY, V41, P40, DOI 10.1080/00313020802563510; Rao C, 2013, J CLIN DIAGN RES, V7, P1361, DOI 10.7860/JCDR/2013/5823.3129; REINER A, 1990, CANCER RES, V50, P7057; Reis-Filho JS, 2008, HISTOPATHOLOGY, V52, P108, DOI 10.1111/j.1365-2559.2007.02889.x; STAVROS AT, 1995, RADIOLOGY, V196, P123, DOI 10.1148/radiology.196.1.7784555; Taucher S, 2003, CANCER, V98, P2547, DOI 10.1002/cncr.11828; Thike AA, 2010, MODERN PATHOL, V23, P123, DOI 10.1038/modpathol.2009.145; UENO E, 1988, ULTRASOUND MED BIOL, V14, P53, DOI 10.1016/0301-5629(88)90047-6	29	18	20	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2015	10	3							e0114820	10.1371/journal.pone.0114820	http://dx.doi.org/10.1371/journal.pone.0114820			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4HV	25734578	Green Published, gold, Green Submitted			2022-12-27	WOS:000350314700001
J	Yuan, WW; Yuan, Y; Zhang, T; Wu, SY				Yuan, Weiwei; Yuan, Ye; Zhang, Tao; Wu, Shiyong			Role of Bmi-1 in Regulation of Ionizing Irradiation-Induced Epithelial-Mesenchymal Transition and Migration of Breast Cancer Cells	PLOS ONE			English	Article							GROWTH-FACTOR; RADIATION; INVASION; METASTASIS; EXPRESSION; CARCINOMA	Radiotherapy is a widely used treatment for cancer. However, recent studies suggest that ionizing radiation (IR) can promote tumor invasion and metastasis. Bmi-1, a member of the polycomb group protein family, has been observed as a regulator of oxidative stress and promotes metastasis in some tumors. But, its potential role in the metastasis induced by IR of breast cancer has not been explored. In our study, we found that increased levels of Bmi-1 were correlated to EMT of breast cancer cells. Through analyzing the EMT state and metastasis of breast cancer induced by IR, we found the metastatic potential of breast cancer cells can either be inhibited or accelerated by IR following a time-dependent pattern. Silencing Bmi-1 completely abolished the ability of the IR to alter, reduce or increase, the migration of breast cancer cells. Also, when Bmi-1 was knocked down, the effect of inhibition of PI3K/AKT signaling on EMT affected by IR was blocked. These results suggest that Bmi-1 is a key gene in regulation of EMT and migration of breast cancer cells induced by IR through activation of PI3K/AKT signaling; therefore, Bmi-1 could be a new target for inhibiting metastasis caused by IR.	[Yuan, Weiwei; Zhang, Tao] Gen Hosp Chengdu Mil Dist, Dept Oncol, Chengdu, Sichuan, Peoples R China; [Yuan, Weiwei; Yuan, Ye; Wu, Shiyong] Ohio Univ, Dept Chem & Biochem, Athens, OH 45701 USA; [Yuan, Weiwei; Yuan, Ye; Wu, Shiyong] Ohio Univ, Edison Biotechnol Inst, Athens, OH 45701 USA	University System of Ohio; Ohio University; University System of Ohio; Ohio University	Zhang, T (corresponding author), Gen Hosp Chengdu Mil Dist, Dept Oncol, Chengdu, Sichuan, Peoples R China.	zhangtao269@126.com; wus1@ohio.edu			National Institutes of Health [RO1CA086928]; China Scholarship Council; Department of Chemistry and Biochemistry, Ohio University; NATIONAL CANCER INSTITUTE [R01CA086928] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); China Scholarship Council(China Scholarship Council); Department of Chemistry and Biochemistry, Ohio University; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was partially supported by National Institutes of Health RO1CA086928 (S. Wu) and PhD Cooperation Program Fund (to W. Yuan) from China Scholarship Council and graduate assistantship (to Y. Yuan) from the Department of Chemistry and Biochemistry, Ohio University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdouh M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031870; Barcellos-Hoff MH, 2005, NAT REV CANCER, V5, P867, DOI 10.1038/nrc1735; Cao LX, 2011, J CELL BIOCHEM, V112, P2729, DOI 10.1002/jcb.23234; Chatoo W, 2009, J NEUROSCI, V29, P529, DOI 10.1523/JNEUROSCI.5303-08.2009; Cheng HW, 2013, LIFE SCI, V93, P798, DOI 10.1016/j.lfs.2013.09.029; Darzynkiewicz Z, 2012, CRIT REV CL LAB SCI, V49, P199, DOI 10.3109/10408363.2012.738808; Guo BH, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-10; Jung JW, 2007, EUR J CANCER, V43, P1214, DOI 10.1016/j.ejca.2007.01.034; Kavanagh JN, 2013, ANTIOXID REDOX SIGN, V18, P2458, DOI 10.1089/ars.2012.5151; Kim JH, 2011, EVID-BASED COMPL ALT, V2011, P1, DOI 10.1155/2011/718302; Kyjacova L, 2015, CELL DEATH DIFFER, V22, P898, DOI 10.1038/cdd.2014.97; Lee S, 2014, EVID-BASED COMPL ALT, V2014, DOI 10.1155/2014/967462; Li DW, 2010, J CANCER RES CLIN, V136, P997, DOI 10.1007/s00432-009-0745-7; Li XL, 2013, INT J ONCOL, V43, P793, DOI 10.3892/ijo.2013.1992; Lukacs RU, 2010, CELL STEM CELL, V7, P682, DOI 10.1016/j.stem.2010.11.013; Madani I, 2008, B CANCER, V95, P292, DOI 10.1684/bdc.2008.0598; Moncharmont C, 2014, CRIT REV ONCOL HEMAT, V92, P133, DOI 10.1016/j.critrevonc.2014.05.006; Multhoff G, 2012, FRONT ONCOL, V2, P1, DOI 10.3389/fonc.2012.00058; Nakamura S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036209; Siddique HR, 2012, STEM CELLS, V30, P372, DOI 10.1002/stem.1035; Vala IS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011222; VONESSEN CF, 1991, CLIN EXP METASTAS, V9, P77, DOI 10.1007/BF01756381; Xu ZS, 2011, ONCOL REP, V25, P409, DOI 10.3892/or.2010.1078; Zhang XY, 2014, TUMOR BIOL, V35, P739, DOI 10.1007/s13277-013-1100-9; Zhou YC, 2011, INT J RADIAT ONCOL, V81, P1530, DOI 10.1016/j.ijrobp.2011.06.1956	25	29	34	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2015	10	3							e0118799	10.1371/journal.pone.0118799	http://dx.doi.org/10.1371/journal.pone.0118799			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4HV	25734775	Green Submitted, gold, Green Published			2022-12-27	WOS:000350314700044
J	Ramos, T; Dedesko, S; Siegel, JA; Gilbert, JA; Stephens, B				Ramos, Tiffanie; Dedesko, Sandra; Siegel, Jeffrey A.; Gilbert, Jack A.; Stephens, Brent			Spatial and Temporal Variations in Indoor Environmental Conditions, Human Occupancy, and Operational Characteristics in a New Hospital Building	PLOS ONE			English	Article							RESISTANT STAPHYLOCOCCUS-AUREUS; RELATIVE-HUMIDITY; AIRBORNE SURVIVAL; THERMAL COMFORT; AIR-QUALITY; TEMPERATURE; BACTERIA; ACQUISITION; PREVENTION; HEALTH	The dynamics of indoor environmental conditions, human occupancy, and operational characteristics of buildings influence human comfort and indoor environmental quality, including the survival and progression of microbial communities. A suite of continuous, long-term environmental and operational parameters were measured in ten patient rooms and two nurse stations in a new hospital building in Chicago, IL to characterize the indoor environment in which microbial samples were taken for the Hospital Microbiome Project. Measurements included environmental conditions (indoor dry-bulb temperature, relative humidity, humidity ratio, and illuminance) in the patient rooms and nurse stations; differential pressure between the patient rooms and hallways; surrogate measures for human occupancy and activity in the patient rooms using both indoor air CO2 concentrations and infrared doorway beam-break counters; and outdoor air fractions in the heating, ventilating, and air-conditioning systems serving the sampled spaces. Measurements were made at 5-minute intervals over consecutive days for nearly one year, providing a total of similar to 8x10(6) data points. Indoor temperature, illuminance, and human occupancy/ activity were all weakly correlated between rooms, while relative humidity, humidity ratio, and outdoor air fractions showed strong temporal (seasonal) patterns and strong spatial correlations between rooms. Differential pressure measurements confirmed that all patient rooms were operated at neutral pressure. The patient rooms averaged about 100 combined entrances and exits per day, which suggests they were relatively lightly occupied compared to higher traffic environments (e.g., retail buildings) and more similar to lower traffic office environments. There were also clear differences in several environmental parameters before and after the hospital was occupied with patients and staff. Characterizing and understanding factors that influence these building dynamics is vital for hospital environments, where they can impact patient health and the survival and spread of healthcare associated infections.	[Ramos, Tiffanie; Stephens, Brent] IIT, Dept Civil Architectural & Environm Engn, Chicago, IL 60616 USA; [Dedesko, Sandra; Siegel, Jeffrey A.] Univ Toronto, Dept Civil Engn, Toronto, ON, Canada; [Gilbert, Jack A.] Argonne Natl Lab, Inst Genom & Syst Biol, Argonne, IL 60439 USA; [Gilbert, Jack A.] Univ Chicago, Dept Ecol & Evolut, Chicago, IL 60637 USA	Illinois Institute of Technology; University of Toronto; United States Department of Energy (DOE); Argonne National Laboratory; University of Chicago	Stephens, B (corresponding author), IIT, Dept Civil Architectural & Environm Engn, Chicago, IL 60616 USA.	brent@iit.edu	Gilbert, Jack/AAF-3270-2019		Alfred P. Sloan Foundation's program on the Microbiology of the Built Environment [2012-10-04]; Starr-Fieldhouse Research Fellowship	Alfred P. Sloan Foundation's program on the Microbiology of the Built Environment; Starr-Fieldhouse Research Fellowship	This work was funded by a grant from the Alfred P. Sloan Foundation's program on the Microbiology of the Built Environment (Grant No. 2012-10-04): http://www.sloan.org/major-programareas/basic-research/microbiology-of-the-builtenvironment/. Tiffanie Ramos was also supported by a Starr-Fieldhouse Research Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aliabadi Amir A, 2011, Adv Prev Med, V2011, P124064, DOI 10.4061/2011/124064; [Anonymous], 2013, 552013 ASHRAE; ASHRAE, 2013, VENT HLTH CAR FAC; ASHRAE, 2013, ASHRAE HDB FUND; Balaras CA, 2007, ENERG BUILDINGS, V39, P454, DOI 10.1016/j.enbuild.2006.09.004; Baughman AV, 1996, ASHRAE TRAN, V102, P193; Bessonneau V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055535; Carratala A, 2013, INT J FOOD MICROBIOL, V164, P128, DOI 10.1016/j.ijfoodmicro.2013.04.007; Coughenour C, 2011, MICROB DRUG RESIST, V17, P457, DOI 10.1089/mdr.2011.0007; Dascalaki EG, 2008, BUILD ENVIRON, V43, P1945, DOI 10.1016/j.buildenv.2007.11.015; Dascalaki EG, 2009, ENERG BUILDINGS, V41, P551, DOI 10.1016/j.enbuild.2008.11.023; Drees M, 2008, CLIN INFECT DIS, V46, P678, DOI 10.1086/527394; Eames I, 2009, J R SOC INTERFACE, V6, pS697, DOI 10.1098/rsif.2009.0407.focus; Eber MR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025298; Faure O, 2002, J HOSP INFECT, V50, P155, DOI 10.1053/jhin.2001.1148; Glass EM, 2013, ISME J; Gosden PE, 1998, J HOSP INFECT, V39, P173, DOI 10.1016/S0195-6701(98)90255-9; HANDLEY BA, 1993, J APPL BACTERIOL, V75, P35, DOI 10.1111/j.1365-2672.1993.tb03404.x; Hobday RA, 2013, J HOSP INFECT; Hodas N, 2014, AEROSOL SCI TECH, V48, P271, DOI 10.1080/02786826.2013.871500; Hospodsky D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034867; Huang SS, 2006, ARCH INTERN MED, V166, P1945, DOI 10.1001/archinte.166.18.1945; Humphreys H, 2004, J HOSP INFECT, V56, P93, DOI 10.1016/j.jhin.2003.10.011; Hwang RL, 2007, BUILD ENVIRON, V42, P2980, DOI 10.1016/j.buildenv.2006.07.035; Jawad A, 1996, J CLIN MICROBIOL, V34, P2881, DOI 10.1128/JCM.34.12.2881-2887.1996; Jose-Alonso JF, 1999, ENERG BUILDINGS, V29, P179; KARIM YG, 1985, CAN J MICROBIOL, V31, P1058, DOI 10.1139/m85-199; Kembel SW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087093; Kembel SW, 2012, ISME J, V6, P1469, DOI 10.1038/ismej.2011.211; Khodakarami J, 2012, RENEW SUST ENERG REV, V16, P4071, DOI 10.1016/j.rser.2012.03.054; Kramer A, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-130; Lai ACK, 2009, ENERG BUILDINGS, V41, P930, DOI 10.1016/j.enbuild.2009.03.016; Lax S, 2014, SCIENCE, V345, P1048, DOI 10.1126/science.1254529; Makison C, 2006, INDOOR BUILT ENVIRON, V15, P85, DOI 10.1177/1420326X06062582; MBITHI JN, 1991, APPL ENVIRON MICROB, V57, P1394, DOI 10.1128/AEM.57.5.1394-1399.1991; MCELDOWNEY S, 1988, LETT APPL MICROBIOL, V7, P83, DOI 10.1111/j.1472-765X.1988.tb01258.x; Mendell MJ, 2009, INDOOR AIR, V19, P291, DOI 10.1111/j.1600-0668.2009.00592.x; Noti JD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057485; Noyce JO, 2006, J HOSP INFECT, V63, P289, DOI 10.1016/j.jhin.2005.12.008; Persily A., 1997, ASHRAE T, V103, P1; Qian J, 2012, INDOOR AIR, V22, P339, DOI 10.1111/j.1600-0668.2012.00769.x; Ramos T, 2014, BUILD ENVIRON, V81, P243, DOI 10.1016/j.buildenv.2014.07.004; Richardson ET, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096334; Rubinstein F., 2003, ANAL OCCUPANCY PROFI; Rui Z, 2008, BUILD ENVIRON, V43, P793, DOI 10.1016/j.buildenv.2007.01.018; SATTAR SA, 1984, APPL ENVIRON MICROB, V47, P879, DOI 10.1128/AEM.47.4.879-881.1984; Shaman J, 2009, P NATL ACAD SCI USA, V106, P3243, DOI 10.1073/pnas.0806852106; Shaughnessy MK, 2011, INFECT CONT HOSP EP, V32, P201, DOI 10.1086/658669; Skoog J, 2006, INDOOR BUILT ENVIRON, V15, P93, DOI 10.1177/1420326X06062100; Skoog J, 2005, ENERG BUILDINGS, V37, P872, DOI 10.1016/j.enbuild.2004.11.003; SONGER JR, 1967, APPL MICROBIOL, V15, P35, DOI 10.1128/AEM.15.1.35-42.1967; Tang CK, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0060038, 10.1371/journal.pone.0075307, 10.1371/journal.pone.0061093]; Tang JW, 2009, J R SOC INTERFACE, V6, pS737, DOI 10.1098/rsif.2009.0227.focus; Tham KW, 2005, INDOOR AIR, V15, P48, DOI 10.1111/j.1600-0668.2005.00303.x; Wan GH, 2011, AM J INFECT CONTROL, V39, P302, DOI 10.1016/j.ajic.2010.07.006; Wang D, 2005, ENERG BUILDINGS, V37, P121, DOI 10.1016/j.enbuild.2004.06.015	56	45	46	1	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2015	10	3							e0118207	10.1371/journal.pone.0118207	http://dx.doi.org/10.1371/journal.pone.0118207			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9JF	25729898	Green Submitted, Green Published, gold			2022-12-27	WOS:000350684900019
J	Faraut, B; Leger, D; Medkour, T; Dubois, A; Bayon, V; Chennaoui, M; Perrot, S				Faraut, Brice; Leger, Damien; Medkour, Terkia; Dubois, Alexandre; Bayon, Virginie; Chennaoui, Mounir; Perrot, Serge			Napping Reverses Increased Pain Sensitivity Due to Sleep Restriction	PLOS ONE			English	Article							LOW-BACK-PAIN; HEALTHY-SUBJECTS; MUSCULOSKELETAL PAIN; RISK-FACTOR; DEPRIVATION; THRESHOLDS; RECOVERY; INSOMNIA; PERFORMANCE; DISTURBANCE	Study Objective To investigate pain sensitivity after sleep restriction and the restorative effect of napping. Design A strictly controlled randomized crossover study with continuous polysomnography monitoring was performed. Setting Laboratory-based study. Participants 11 healthy male volunteers. Interventions Volunteers attended two three-day sessions: "sleep restriction" alone and "sleep restriction and nap". Each session involved a baseline night of normal sleep, a night of sleep deprivation and a night of free recovery sleep. Participants were allowed to sleep only from 02:00 to 04:00 during the sleep deprivation night. During the "sleep restriction and nap" session, volunteers took two 30-minute naps, one in the morning and one in the afternoon. Measurements and Results Quantitative sensory testing was performed with heat, cold and pressure, at 10: 00 and 16: 00, on three areas: the supraspinatus, lower back and thigh. After sleep restriction, quantitative sensory testing revealed differential changes in pain stimuli thresholds, but not in thermal threshold detection: lower back heat pain threshold decreased, pressure pain threshold increased in the supraspinatus area and no change was observed for the thigh.Napping restored responses to heat pain stimuli in the lower back and to pressure stimuli in the supraspinatus area. Conclusions Sleep restriction induces different types of hypersensitivity to pain stimuli in different body areas, consistent with multilevel mechanisms, these changes being reversed by napping. The napping restorative effect on pain thresholds result principally from effects on pain mechanisms, since it was independent of vigilance status.	[Faraut, Brice; Leger, Damien; Dubois, Alexandre; Bayon, Virginie; Chennaoui, Mounir] Univ Paris 05, Hotel Dieu Paris, AP HP, Sorbonne Paris Cite,Ctr Sommeil & Vigilance,Equip, Paris, France; [Medkour, Terkia; Perrot, Serge] Univ Paris 05, Hotel Dieu Paris, AP HP,Pain Ctr, Sorbonne Paris Cite,Serv Med Interne & Therapeut, Paris, France; [Chennaoui, Mounir] IRBA, Unite Fat Vigilance, Paris, France; [Medkour, Terkia; Perrot, Serge] INSERM, U987, Pain Ctr, Boulogne, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Hotel-Dieu - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Hotel-Dieu - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay	Faraut, B (corresponding author), Univ Paris 05, Hotel Dieu Paris, AP HP, Sorbonne Paris Cite,Ctr Sommeil & Vigilance,Equip, Paris, France.	brice.faraut@htd.aphp.fr		chennaoui, mounir/0000-0002-4409-813X	mutual insurance company REUNICA; Societe Francaise de Recherche et de Medecine du Sommeil	mutual insurance company REUNICA; Societe Francaise de Recherche et de Medecine du Sommeil	This research project was supported from an unrestricted grant from the mutual insurance company REUNICA and from a postdoctoral fellowship from the "Societe Francaise de Recherche et de Medecine du Sommeil" (BF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alsaadi SM, 2014, CLIN J PAIN, V30, P755, DOI 10.1097/AJP.0000000000000055; Arora V, 2006, ANN INTERN MED, V144, P792, DOI 10.7326/0003-4819-144-11-200606060-00005; Artner J, 2013, J PAIN RES, V6, P1, DOI 10.2147/JPR.S36386; Auvinen JP, 2010, EUR SPINE J, V19, P641, DOI 10.1007/s00586-009-1215-2; Basner M, 2013, CURR OPIN NEUROBIOL, V23, P854, DOI 10.1016/j.conb.2013.02.008; Basner M, 2011, SLEEP, V34, P581, DOI 10.1093/sleep/34.5.581; Boudreau P, 2013, SLEEP, V36, P1919, DOI 10.5665/sleep.3230; Bouhassira D, 1999, PAIN, V80, P265, DOI 10.1016/S0304-3959(98)00227-9; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4; Canivet C, 2008, INT J BEHAV MED, V15, P254, DOI 10.1080/10705500802365466; Castro LS, 2013, ANN NEUROL, V74, P537, DOI 10.1002/ana.23945; Cooperman NR, 1934, AM J PHYSIOL, V107, P589, DOI 10.1152/ajplegacy.1934.107.3.589; Edwards RR, 2008, PAIN, V137, P202, DOI 10.1016/j.pain.2008.01.025; Faraut B, 2012, SLEEP MED REV, V16, P137, DOI 10.1016/j.smrv.2011.05.001; Faraut B, 2011, BRAIN BEHAV IMMUN, V25, P16, DOI 10.1016/j.bbi.2010.08.001; FRUHSTORFER H, 1976, J NEUROL NEUROSUR PS, V39, P1071, DOI 10.1136/jnnp.39.11.1071; Haack M, 2007, SLEEP, V30, P1145, DOI 10.1093/sleep/30.9.1145; HICKS RA, 1979, PERCEPT MOTOR SKILL, V48, P687, DOI 10.2466/pms.1979.48.3.687; HODDES E, 1973, PSYCHOPHYSIOLOGY, V10, P431, DOI 10.1111/j.1469-8986.1973.tb00801.x; HORNE J A, 1976, International Journal of Chronobiology, V4, P97; JOHNS MW, 1991, SLEEP, V14, P540, DOI 10.1093/sleep/14.6.540; Kundermann B, 2004, PSYCHOSOM MED, V66, P932, DOI 10.1097/01.psy.0000145912.24553.c0; Leger D, 2011, SLEEP MED, V12, P454, DOI 10.1016/j.sleep.2010.12.012; Lentz MJ, 1999, J RHEUMATOL, V26, P1586; LUBIN A, 1976, PSYCHOPHYSIOLOGY, V13, P334, DOI 10.1111/j.1469-8986.1976.tb03086.x; Mancini F, 2014, ANN NEUROL, V75, P917, DOI 10.1002/ana.24179; Mednick SC, 2008, BEHAV BRAIN RES, V193, P79, DOI 10.1016/j.bbr.2008.04.028; Milner CE, 2009, J SLEEP RES, V18, P272, DOI 10.1111/j.1365-2869.2008.00718.x; MOLDOFSKY H, 1975, PSYCHOSOM MED, V37, P341, DOI 10.1097/00006842-197507000-00008; O'Donoghue GM, 2009, BMC MUSCULOSKEL DIS, V10, DOI 10.1186/1471-2474-10-122; Onen SH, 2001, J SLEEP RES, V10, P35, DOI 10.1046/j.1365-2869.2001.00240.x; Onen SH, 2000, NEUROSCI LETT, V291, P25, DOI 10.1016/S0304-3940(00)01383-5; Roehrs TA, 2012, SLEEP, V35, P1667, DOI 10.5665/sleep.2240; Rolke R, 2006, PAIN, V123, P231, DOI 10.1016/j.pain.2006.01.041; Sauvet F, 2012, EUR J APPL PHYSIOL, V112, P3239, DOI 10.1007/s00421-011-2297-1; Schuh-Hofer S, 2013, PAIN, V154, P1613, DOI 10.1016/j.pain.2013.04.046; Silber MH, 2007, J CLIN SLEEP MED, V3, P121; Smith MT, 2004, SLEEP MED REV, V8, P119, DOI 10.1016/S1087-0792(03)00044-3; Steinmiller CL, 2010, EXP CLIN PSYCHOPHARM, V18, P277, DOI 10.1037/a0018899; Tassi P, 2000, SLEEP MED REV, V4, P341, DOI 10.1053/smrv.2000.0098; Tiede W, 2010, PAIN, V148, P36, DOI 10.1016/j.pain.2009.08.029; Waterhouse J, 2007, J SPORT SCI, V25, P1557, DOI 10.1080/02640410701244983; Weissman-Fogel I, 2012, EXP BRAIN RES, V216, P181, DOI 10.1007/s00221-011-2924-4; WITTIG RM, 1982, J NERV MENT DIS, V170, P429, DOI 10.1097/00005053-198207000-00011; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	45	33	33	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2015	10	2							e0117425	10.1371/journal.pone.0117425	http://dx.doi.org/10.1371/journal.pone.0117425			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CC3LS	25723495	Green Published, gold			2022-12-27	WOS:000350251200032
J	Wodal, W; Schwendinger, MG; Savidis-Dacho, H; Crowe, BA; Hohenadl, C; Fritz, R; Bruhl, P; Portsmouth, D; Karner-Pichl, A; Balta, D; Grillberger, L; Kistner, O; Barrett, PN; Howard, MK				Wodal, Walter; Schwendinger, Michael G.; Savidis-Dacho, Helga; Crowe, Brian A.; Hohenadl, Christine; Fritz, Richard; Bruehl, Peter; Portsmouth, Daniel; Karner-Pichl, Anita; Balta, Dalida; Grillberger, Leopold; Kistner, Otfried; Barrett, P. Noel; Howard, M. Keith			Immunogenicity and Protective Efficacy of a Vero Cell Culture-Derived Whole-Virus H7N9 Vaccine in Mice and Guinea Pigs	PLOS ONE			English	Article							SEASONAL INFLUENZA VACCINE; IMMUNE-RESPONSES; A/ANHUI/1/2013 H7N9; INHIBITING ANTIBODY; RESPIRATORY-TRACT; CROSS-PROTECTION; RECEPTOR-BINDING; HUMAN INFECTION; H1N1 VACCINE; B VIRUSES	Background A novel avian H7N9 virus with a high case fatality rate in humans emerged in China in 2013. We evaluated the immunogenicity and protective efficacy of a candidate Vero cell culture-derived whole-virus H7N9 vaccine in small animal models. Methods Antibody responses induced in immunized DBA/2J mice and guinea pigs were evaluated by hemagglutination inhibition (HI), microneutralization (MN), and neuraminidase inhibition (NAi) assays. T-helper cell responses and IgG subclass responses in mice were analyzed by ELISPOT and ELISA, respectively. Vaccine efficacy against lethal challenge with wildtype H7N9 virus was evaluated in immunized mice. H7N9-specific antibody responses induced in mice and guinea pigs were compared to those induced by a licensed whole-virus pandemic H1N1 (H1N1pdm09) vaccine. Results The whole-virus H7N9 vaccine induced dose-dependent H7N9-specific HI, MN and NAi antibodies in mice and guinea pigs. Evaluation of T-helper cell responses and IgG subclasses indicated the induction of a balanced Th1/Th2 response. Immunized mice were protected against lethal H7N9 challenge in a dose-dependent manner. H7N9 and H1N1pdm09 vaccines were similarly immunogenic. Conclusions The induction of H7N9-specific antibody and T cell responses and protection against lethal challenge suggest that the Vero cell culture-derived whole-virus vaccine would provide an effective intervention against the H7N9 virus.	[Wodal, Walter; Schwendinger, Michael G.; Crowe, Brian A.; Hohenadl, Christine; Fritz, Richard; Bruehl, Peter; Portsmouth, Daniel; Karner-Pichl, Anita; Kistner, Otfried; Barrett, P. Noel; Howard, M. Keith] Baxter BioSci, Vaccine R&D, Orth, Austria; [Savidis-Dacho, Helga] Baxter BioSci, Pharmacol R&D, Orth, Austria; [Balta, Dalida; Grillberger, Leopold] Baxter BioSci, Proc Dev R&D, Orth, Austria		Barrett, PN (corresponding author), Baxter BioSci, Vaccine R&D, Orth, Austria.	noel_barrett@baxter.com			Baxter	Baxter	The study was funded by Baxter. Baxter employees were responsible for study design, data collection and analysis, decision to publish, and preparation of the manuscript.	[Anonymous], 2010, EMA5279852010; Bart SA, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008761; Boon ACM, 2010, J VIROL, V84, P7662, DOI 10.1128/JVI.02444-09; Boon ACM, 2009, J VIROL, V83, P10417, DOI 10.1128/JVI.00514-09; Celvapan, 2012, EPAR SUMM PUBL; Chan MCW, 2013, LANCET RESP MED, V1, P534, DOI 10.1016/S2213-2600(13)70138-3; Chu DH, 2014, VACCINE, V32, P3473, DOI 10.1016/j.vaccine.2014.04.060; Couch RB, 2013, J INFECT DIS, V207, P974, DOI 10.1093/infdis/jis935; De Groot AS, 2013, HUM VACC IMMUNOTHER, V9, P950, DOI 10.4161/hv.24939; de Jong J C, 2003, Dev Biol (Basel), V115, P63; Dengler L, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-212; Doherty PC, 2006, NAT IMMUNOL, V7, P449, DOI 10.1038/ni1343; Ehrlich HJ, 2008, NEW ENGL J MED, V358, P2573, DOI 10.1056/NEJMoa073121; Ehrlich HJ, 2012, VACCINE, V30, P4543, DOI 10.1016/j.vaccine.2012.03.061; Ehrlich HJ, 2009, J INFECT DIS, V200, P1113, DOI 10.1086/605608; Fries LF, 2013, NEW ENGL J MED, V369, P2564, DOI 10.1056/NEJMc1313186; Fritz R, 2012, J INFECT DIS, V205, P28, DOI 10.1093/infdis/jir711; Gao HN, 2013, NEW ENGL J MED, V368, P2277, DOI 10.1056/NEJMoa1305584; Gao RB, 2013, NEW ENGL J MED, V368, P1888, DOI 10.1056/NEJMoa1304459; Geeraedts F, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000138; Geeraedts F, 2008, INFLUENZA OTHER RESP, V2, P41, DOI 10.1111/j.1750-2659.2008.00038.x; Hagenaars N, 2008, VACCINE, V26, P6555, DOI 10.1016/j.vaccine.2008.09.057; HOBSON D, 1972, J HYG-CAMBRIDGE, V70, P767, DOI 10.1017/S0022172400022610; Howard MK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023791; Jia N, 2008, J VIROL METHODS, V153, P43, DOI 10.1016/j.jviromet.2008.06.016; Kistner O, 2007, VACCINE, V25, P6028, DOI 10.1016/j.vaccine.2007.05.013; Kistner O, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009349; Knepper J, 2013, MBIO, V4, DOI 10.1128/mBio.00601-13; Kundi M, 1999, ANTIVIR RES, V41, P145, DOI 10.1016/S0166-3542(99)00008-X; Lam TTY, 2013, NATURE, V502, P241, DOI 10.1038/nature12515; Li Q, 2014, NEW ENGL J MED, V370, P520, DOI 10.1056/NEJMoa1304617; Liu D, 2013, LANCET, V381, P1926, DOI 10.1016/S0140-6736(13)60938-1; Loew-Baselli A, 2012, VACCINE, V30, P5956, DOI 10.1016/j.vaccine.2012.07.039; McKinstry KK, 2011, J INTERN MED, V269, P507, DOI 10.1111/j.1365-2796.2011.02367.x; Meijer A, 2006, J VIROL METHODS, V132, P113, DOI 10.1016/j.jviromet.2005.10.001; Pandemic Influenza Vaccine H5N1 Baxter AG, 2012, PANDEMIC INFLUENZA V; Pica N, 2011, J VIROL, V85, P12825, DOI 10.1128/JVI.05930-11; Qi X, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f4752; Rockman S, 2013, J VIROL, V87, P3053, DOI 10.1128/JVI.02434-12; Shi Y, 2013, SCIENCE, V342, P243, DOI 10.1126/science.1242917; Smith GE, 2013, VACCINE, V31, P4305, DOI 10.1016/j.vaccine.2013.07.043; Solorzano A, 2010, J VIROL, V84, P4587, DOI 10.1128/JVI.00101-10; Srivastava B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004857; Tang LH, 2014, VACCINE, V32, P5375, DOI 10.1016/j.vaccine.2014.07.087; Tharakaraman K, 2013, CELL, V153, P1486, DOI 10.1016/j.cell.2013.05.034; van der Velden MVW, 2014, J INFECT DIS, V209, P12, DOI 10.1093/infdis/jit498; van der Velden MVW, 2012, VACCINE, V30, P6127, DOI 10.1016/j.vaccine.2012.07.077; van Riel D, 2013, AM J PATHOL, V183, P1137, DOI 10.1016/j.ajpath.2013.06.011; Watanabe T, 2013, NATURE, V501, P551, DOI 10.1038/nature12392; Wong SS, 2014, VACCINE, V32, P4571, DOI 10.1016/j.vaccine.2014.06.016; Wu CY, 2014, VACCINE, V32, P4485, DOI 10.1016/j.vaccine.2014.06.043; Zhang QY, 2013, SCIENCE, V341, P410, DOI 10.1126/science.1240532; Zhou JF, 2013, NATURE, V499, P500, DOI 10.1038/nature12379	53	18	21	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2015	10	2							e0113963	10.1371/journal.pone.0113963	http://dx.doi.org/10.1371/journal.pone.0113963			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC2ZH	25719901	gold, Green Submitted, Green Published			2022-12-27	WOS:000350213200002
J	Fecher, B; Friesike, S; Hebing, M				Fecher, Benedikt; Friesike, Sascha; Hebing, Marcel			What Drives Academic Data Sharing?	PLOS ONE			English	Article							BIODIVERSITY DATA; SYSTEMATIC REVIEWS; IMAGE DATA; REQUIREMENTS; SCIENCE; PUBLICATION; ECONOMICS; METADATA; LESSONS; ACCESS	Despite widespread support from policy makers, funding agencies, and scientific journals, academic researchers rarely make their research data available to others. At the same time, data sharing in research is attributed a vast potential for scientific progress. It allows the reproducibility of study results and the reuse of old data for new research questions. Based on a systematic review of 98 scholarly papers and an empirical survey among 603 secondary data users, we develop a conceptual framework that explains the process of data sharing from the primary researcher's point of view. We show that this process can be divided into six descriptive categories: Data donor, research organization, research community, norms, data infrastructure, and data recipients. Drawing from our findings, we discuss theoretical implications regarding knowledge creation and dissemination as well as research policy measures to foster academic collaboration. We conclude that research data cannot be regarded as knowledge commons, but research policies that better incentivise data sharing are needed to improve the quality of research results and foster scientific progress.	[Fecher, Benedikt; Friesike, Sascha] Alexander von Humboldt Inst Internet & Soc, Berlin, Germany; [Fecher, Benedikt; Hebing, Marcel] German Inst Econ Res, Berlin, Germany	DIW Berlin - Deutsches Institut fur Wirtschaftsforschung	Fecher, B (corresponding author), Alexander von Humboldt Inst Internet & Soc, Berlin, Germany.	benedikt.fecher@hiig.de			Deutsche Forschungsgemeinschaft [WA 547/6-1]; Alexander von Humboldt Institute for Internet and Society; German Institute for Economic Research	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Alexander von Humboldt Institute for Internet and Society; German Institute for Economic Research	This study was funded by the Deutsche Forschungsgemeinschaft (PI: Gert G. Wagner, DFG-Grant Number WA 547/6-1) and by the Alexander von Humboldt Institute for Internet and Society and the German Institute for Economic Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acord SK, 2013, NEW MEDIA SOC, V15, P379, DOI 10.1177/1461444812465140; Albert H, 2012, SPRINGER HEALTHC NEW, V1, P1, DOI [10.1007/s40014-012-1434-z, DOI 10.1007/S40014-012-1434-Z]; Alsheikh-Ali AA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024357; Anagnostou P, 2013, FORENSIC SCI INT-GEN, V7, pE117, DOI 10.1016/j.fsigen.2013.07.012; Anderson James R, 2009, IRB, V31, P17; Axelsson AS, 2009, ACTA SOCIOL, V52, P213, DOI 10.1177/0001699309339799; Belmonte MK, 2008, J AUTISM DEV DISORD, V38, P2, DOI 10.1007/s10803-006-0352-2; Benkler Y, 2002, YALE LAW J, V112, P369, DOI 10.2307/1562247; BENKLER Y, 2006, WEALTH NETWORKS; Bezuidenhout L, 2013, SCI ENG ETHICS, V19, P83, DOI 10.1007/s11948-011-9298-7; Booth A, 2016, SYSTEMATIC APPROACHE; Borgman CL, 2012, J AM SOC INF SCI TEC, V63, P1059, DOI 10.1002/asi.22634; Brakewood B, 2013, NEUROIMAGE, V82, P671, DOI 10.1016/j.neuroimage.2013.02.040; Breeze JL, 2012, GIGASCIENCE, V1, DOI 10.1186/2047-217X-1-9; Butler D, 2007, NATURE, V446, P10, DOI 10.1038/446010b; Cahill JM, 2007, NEAR EAST ARCHAEOL, V70, P194, DOI 10.2307/20361332; Campbell EG, 2012, JAMA-J AM MED ASSOC, V287, P473, DOI [10.1007/s00438-012-0693-9, DOI 10.1007/S00438-012-0693-9]; Chandramohan D, 2008, PLOS MED, V5, P169, DOI 10.1371/journal.pmed.0050057; Chokshi DA, 2006, B WHO, V84; Cohn JP, 2012, BIOSCIENCE, V62, P1004, DOI [10.1525/bio.2012.62.11.16, DOI 10.1525/BI0.2012.62.11.16]; Constable H, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000309; Cooper M, 2007, J EMPIR RES HUM RES, V2, P3, DOI 10.1525/jer.2007.2.1.3; Costello MJ, 2009, BIOSCIENCE, V59, P418, DOI 10.1525/bio.2009.59.5.9; Cragin MH, 2010, PHILOS T R SOC A, V368, P4023, DOI 10.1098/rsta.2010.0165; Czarmtzki D, 2014, ACCESS RES INPUTS OP; Dahlander L, 2010, RES POLICY, V39, P699, DOI 10.1016/j.respol.2010.01.013; Dalgleish R, 2012, HUM MUTAT, V33, P1494, DOI 10.1002/humu.22123; Davies P, 2000, OXFORD REV EDUC, V26, P365, DOI 10.1080/713688543; de Wolf Virginia A, 2005, IRB, V27, P12, DOI 10.2307/3563537; de Wolf Virginia A, 2006, IRB, V28, P10; Delson E, 2007, EVOL ANTHROPOL, V16, P161, DOI 10.1002/evan.20141; DEWALD WG, 1986, AM ECON REV, V76, P587; Drew BT, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001636; Edwards PN, 2011, SOC STUD SCI, V41, P667, DOI 10.1177/0306312711413314; Eisenberg RS, 2006, IND CORP CHANGE, V15, P1013, DOI 10.1093/icc/dtl025; Elman C, 2010, PS-POLIT SCI POLIT, V43, P23, DOI 10.1017/S104909651099077X; Enke N, 2012, ECOL INFORM, V11, P25, DOI 10.1016/j.ecoinf.2012.03.004; Eschenfelder K, 2011, P ASIST ANNU MEET, V48, P1, DOI [10.1002/meet.2011.14504801062, DOI 10.1002/MEET.2011.14504801062]; European Commission, 2012, SCI DAT OP ACC RES R; Feinberg SE, 1985, SHARING RES DATA; Feldman L, 2012, LANCET, V379, P1877, DOI 10.1016/S0140-6736(12)60809-5; Fernandez Jose M., 2012, Financial Cryptography and Data Security. FC 2012 Workshops, USEC and WECSR 2012. Revised Selected Papers, P136, DOI 10.1007/978-3-642-34638-5_13; Fisher JB, 2010, INFORM MANAGE-AMSTER, V47, P237, DOI 10.1016/j.im.2010.04.001; Franzoni C, 2014, RES POLICY, V43, P1, DOI 10.1016/j.respol.2013.07.005; Freymann JB, 2012, J DIGIT IMAGING, V25, P14, DOI 10.1007/s10278-011-9422-x; Fulk J, 2004, ORGAN SCI, V15, P569, DOI 10.1287/orsc.1040.0081; Gardner D, 2003, NEUROINFORMATICS, V1, P289, DOI 10.1385/NI:1:3:289; Given L., 2008, SAGE ENCY QUALITATIV, DOI [10.4135/9781412963909, DOI 10.4135/9781412963909]; Haddow G, 2011, J EVAL CLIN PRACT, V17, P1140, DOI 10.1111/j.1365-2753.2010.01488.x; Haendel MA, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001339; Haeussler C, 2011, RES POLICY, V40, P105, DOI 10.1016/j.respol.2010.08.007; Hammersley M, 2001, BRIT EDUC RES J, V27, P543, DOI 10.1080/01411920120095726; Harding A, 2012, ENVIRON HEALTH PERSP, V120, P6, DOI 10.1289/ehp.1103904; Hayman B, 2012, J CLIN NURS, V21, P285, DOI 10.1111/j.1365-2702.2011.04002.x; Hess Charlotte, 2007, UNDERSTANDING KNOWLE, P3; Higging JP., 2008, COCHRANE HDB SYSTEMA; Huang XL, 2013, BIOSCIENCE, V63, P5, DOI 10.1525/bio.2013.63.1.2; Huang XL, 2012, CONSERV LETT, V5, P399, DOI 10.1111/j.1755-263X.2012.00259.x; Jarnevich CS, 2007, BIOL INVASIONS, V9, P597, DOI 10.1007/s10530-006-9042-4; Jiang XQ, 2013, MED CARE, V51, pS58, DOI 10.1097/MLR.0b013e31829b1d10; Jones RB, 2012, CURR ONCOL REP, V14, P486, DOI 10.1007/s11912-012-0271-7; Karami M, 2013, COMPUT GEOSCI-UK, V60, P23, DOI 10.1016/j.cageo.2013.06.007; Kim Y., 2012, J COMPUTATIONAL SCI, V3, P47, DOI DOI 10.22369/ISSN.2153-4136/3/1/6; Kittur A, 2008, CSCW: 2008 ACM CONFERENCE ON COMPUTER SUPPORTED COOPERATIVE WORK, CONFERENCE PROCEEDINGS, P37; Knowledge Exchange, 2013, ANN REPORT; Kowalczyk S, 2011, ANNU REV INFORM SCI, V45, P247, DOI 10.1002/aris.2011.1440450113; L?vy P., 1997, COLLECTIVE INTELLIGE; Levenson D, 2010, AM J MED GENET A, V152A, pVII, DOI 10.1002/ajmg.a.33287; Linkert M, 2010, J CELL BIOL, V189, P777, DOI 10.1083/jcb.201004104; Ludman EJ, 2010, J EMPIR RES HUM RES, V5, P9, DOI 10.1525/jer.2010.5.3.9; Masum H, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003244; MAYRING Philipp, 2000, COMPANION QUALIT RES, V1, P20; McCullough BD, 2009, ECON ANAL POLICY, V39, P117, DOI 10.1016/S0313-5926(09)50047-1; Mennes M, 2013, NEUROIMAGE, V82, P683, DOI 10.1016/j.neuroimage.2012.10.064; Milia N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037552; Molloy JC, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001195; Myneni S, 2010, INT J INFORM MANAGE, V30, P256, DOI 10.1016/j.ijinfomgt.2009.09.005; Nelson B, 2009, NATURE, V461, P160, DOI 10.1038/461160a; Nicholson SW, 2011, PORTAL-LIBR ACAD, V11, P505; Nielsen M., 2012, REINVENTING DISCOVER; NIH, 2002, ANTHR NEWS, V43, P30, DOI [10.1111/an.2002.43.4.30.2, DOI 10.1111/AN.2002.43.4.30.2]; NIH, 2003, ANTHR NEWS, V44, P25, DOI [10.1111/ an. 2003.44.4.25.2, DOI 10.1111/AN.2003.44.4.25.2]; Noor MAF, 2006, PLOS BIOL, V4, P1113, DOI 10.1371/journal.pbio.0040228; Ostell J, 2009, HUM MUTAT, V30, pvii, DOI [10.1002/humu.21013, DOI 10.1002/HUMU.21013]; Overbey MM, 1999, DATA SHARING DILEMMA; Parr CS, 2005, TRENDS ECOL EVOL, V20, P362, DOI 10.1016/j.tree.2005.04.023; Parr CS, 2007, BIOSCIENCE, V57, P309, DOI 10.1641/B570402; Patton MQ., 2002, QUALITATIVE RES EVAL, V3rd; Pearce N, 2011, ENVIRON HEALTH-GLOB, V10, DOI 10.1186/1476-069X-10-107; Perrino T, 2013, PERSPECT PSYCHOL SCI, V8, P433, DOI 10.1177/1745691613491579; Pitt MA, 2013, TOP COGN SCI, V5, P214, DOI 10.1111/tops.12006; Piwowar HA, 2010, WHO SHARES WHO DOESN, P1; Piwowar HA, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000308; Piwowar HA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018657; Piwowar HA, 2010, J INFORMETR, V4, P148, DOI 10.1016/j.joi.2009.11.010; Piwowar HA, 2008, PLOS MED, V5, P1315, DOI 10.1371/journal.pmed.0050183; Rai AK, 2006, BERKELEY TECH LJ, P1187; Reidpath DD, 2001, BIOETHICS, V15, P125, DOI 10.1111/1467-8519.00220; Resnik David B, 2010, IRB, V32, P1; Richter D, 2013, SOEP SCALES MANUAL; Rodgers W, 2006, J EMPIR RES HUM RES, V1, P85, DOI 10.1525/jer.2006.1.3.85; Rohlfing T, 2012, NEUROIMAGE, V59, P4189, DOI 10.1016/j.neuroimage.2011.09.080; Rushby N, 2013, BRIT J EDUC TECHNOL, V44, P675, DOI 10.1111/bjet.12091; Samson K, 2008, ANN NEUROL, V64, pA13, DOI 10.1002/ana.21432; Sansone SA, 2012, GIGASCIENCE, V1, DOI 10.1186/2047-217X-1-10; Savage CJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007078; Sayogo DS, 2013, GOV INFORM Q, V30, pS19, DOI 10.1016/j.giq.2012.06.011; Schreier, 2012, QUALITATIVE CONTENT; Sheather J, 2009, BR MED J, V338; SIEBER JE, 1988, LAW HUMAN BEHAV, V12, P199, DOI 10.1007/BF01073128; STANLEY B, 1988, LAW HUMAN BEHAV, V12, P173, DOI 10.1007/BF01073125; Surowiecki James, 2004, WISDOM CROWDS WHY MA; Teeters JL, 2008, NEUROINFORMATICS, V6, P47, DOI 10.1007/s12021-008-9009-y; Tenopir C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021101; Torgerson CJ, 2006, BRIT J EDUC STUD, V54, P89, DOI 10.1111/j.1467-8527.2006.00332.x; Tucker J, 2009, MOTIVATING SUBJECTS; Van Horn JD, 2013, NEUROIMAGE, V82, P677, DOI 10.1016/j.neuroimage.2012.11.010; von Hippel E, 2003, ORGAN SCI, V14, P209, DOI 10.1287/orsc.14.2.209.14992; Wagner G. G., 2007, SCHMOLLERS JB, V127, P139, DOI DOI 10.2139/SSRN.1028709; Wallis JC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067332; Weber NM, 2013, B AM SOC INF SCI TEC, V39, P23, DOI [10.1002/bult.2013.1720390609, DOI 10.1002/BULT.2013.1720390609]; Whitlock MC, 2011, TRENDS ECOL EVOL, V26, P61, DOI 10.1016/j.tree.2010.11.006; Whitlock MC, 2010, AM NAT, V175, pE45, DOI 10.1086/650340; Wicherts JM, 2006, AM PSYCHOL, V61, P726, DOI 10.1037/0003-066X.61.7.726; Wicherts JM, 2012, INTELLIGENCE, V40, P73, DOI 10.1016/j.intell.2012.01.004; Zimmerman AS, 2008, SCI TECHNOL HUM VAL, V33, P631, DOI 10.1177/0162243907306704	126	159	160	10	138	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2015	10	2							e0118053	10.1371/journal.pone.0118053	http://dx.doi.org/10.1371/journal.pone.0118053			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CC2IM	25714752	Green Submitted, Green Published, gold			2022-12-27	WOS:000350168700049
J	Otsuki, S; Sawada, H; Yodoya, N; Shinohara, T; Kato, T; Ohashi, H; Zhang, EQ; Imanaka-Yoshida, K; Shimpo, H; Maruyama, K; Komada, Y; Mitani, Y				Otsuki, Shoichiro; Sawada, Hirofumi; Yodoya, Noriko; Shinohara, Tsutomu; Kato, Taichi; Ohashi, Hiroyuki; Zhang, Erquan; Imanaka-Yoshida, Kyoko; Shimpo, Hideto; Maruyama, Kazuo; Komada, Yoshihiro; Mitani, Yoshihide			Potential Contribution of Phenotypically Modulated Smooth Muscle Cells and Related Inflammation in the Development of Experimental Obstructive Pulmonary Vasculopathy in Rats	PLOS ONE			English	Article							HEAVY-CHAIN EXPRESSION; ARTERIAL-HYPERTENSION; CORONARY ANGIOPLASTY; VASCULAR DEVELOPMENT; PLEXIFORM LESIONS; CHRONIC HYPOXIA; PATHOLOGY; DISEASE; MICE; ATHEROSCLEROSIS	We tested the hypothesis that phenotypically modulated smooth muscle cells (SMCs) and related inflammation are associated with the progression of experimental occlusive pulmonary vascular disease (PVD). Occlusive PVD was induced by combined exposure to a vascular endothelial growth factor receptor tyrosine kinase inhibitor Sugen 5416 and hypobaric hypoxia for 3 weeks in rats, which were then returned to ambient air. Hemodynamic, morphometric, and immunohistochemical studies, as well as gene expression analyses, were performed at 3, 5, 8, and 13 weeks after the initial treatment (n = 78). Experimental animals developed pulmonary hypertension and right ventricular hypertrophy, and exhibited a progressive increase in indices of PVD, including cellular intimal thickening and intimal fibrosis. Cellular intimal lesions comprised a smooth muscle actin (alpha SMA)+, SM1+, SM2+/-, vimentin+ immature SMCs that were covered by endothelial monolayers, while fibrous intimal lesions typically included alpha SMA+, SM1+, SM2+, vimentin+/- mature SMCs. Plexiform lesions comprised alpha SMA+, vimentin+, SM1-, SM2- myofibroblasts covered by endothelial monolayers. Immature SMC- rich intimal and plexiform lesions were proliferative and were infiltrated by macrophages, while fibrous intimal lesions were characterized by lower proliferative abilities and were infiltrated by few macrophages. Compared with controls, the number of perivascular macrophages was already higher at 3 weeks and progressively increased during the experimental period; gene expression of pulmonary hypertension- related inflammatory molecules, including IL6, MCP1, MMP9, cathepsin- S, and RANTES, was persistently or progressively up-regulated in lungs of experimental animals. We concluded that phenotypically modulated SMCs and related inflammation are potentially associated with the progression of experimental obstructive PVD.	[Otsuki, Shoichiro; Yodoya, Noriko; Shinohara, Tsutomu; Kato, Taichi; Ohashi, Hiroyuki; Komada, Yoshihiro; Mitani, Yoshihide] Mie Univ, Dept Pediat, Grad Sch Med, Tsu, Mie 514, Japan; [Sawada, Hirofumi] Mie Univ, Grad Sch Med, Dept Pediat & Anesthesiol & Crit Care Med, Tsu, Mie 514, Japan; [Shinohara, Tsutomu] Nagoya City Univ, Dept Pediat & Neonatol, Grad Sch Med Sci, Nagoya, Aichi, Japan; [Kato, Taichi] Nagoya Univ, Grad Sch Med, Dept Pediat, Nagoya, Aichi 4648601, Japan; [Zhang, Erquan; Maruyama, Kazuo] Mie Univ, Dept Anesthesiol & Crit Care Med, Grad Sch Med, Tsu, Mie 514, Japan; [Imanaka-Yoshida, Kyoko] Mie Univ, Grad Sch Med, Dept Pathol, Tsu, Mie 514, Japan; [Shimpo, Hideto] Mie Univ, Grad Sch Med, Dept Thorac & Cardiovasc Surg, Tsu, Mie 514, Japan	Mie University; Mie University; Nagoya City University; Nagoya University; Mie University; Mie University; Mie University	Mitani, Y (corresponding author), Mie Univ, Dept Pediat, Grad Sch Med, Tsu, Mie 514, Japan.	ymitani@clin.medic.mie-u.ac.jp		Ohashi, Hiroyuki/0000-0001-6542-7222; Sawada, Hirofumi/0000-0001-8069-5751	Ministry of Education, Culture, Sports, Science, and Technology of Japan [24591574, 23591565, 24791057]	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This study was supported by a grant from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (24591574 for YM, 23591565 for H. Sawada, 24791057 for NY). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe K, 2010, CIRCULATION, V121, P2747, DOI 10.1161/CIRCULATIONAHA.109.927681; Aikawa M, 1997, CIRCULATION, V96, P82; AIKAWA M, 1993, CIRC RES, V73, P1000, DOI 10.1161/01.RES.73.6.1000; Ailawadi G, 2009, J THORAC CARDIOV SUR, V138, P1392, DOI 10.1016/j.jtcvs.2009.07.075; Alexander MR, 2012, ANNU REV PHYSIOL, V74, P13, DOI 10.1146/annurev-physiol-012110-142315; Arciniegas E, 2007, AM J PHYSIOL-LUNG C, V293, pL1, DOI 10.1152/ajplung.00378.2006; Atkinson C, 2002, CIRCULATION, V105, P1672, DOI 10.1161/01.CIR.0000012754.72951.3D; Fishman AP, 2000, PHYSIOL RES, V49, P485; Gomez D, 2012, CARDIOVASC RES, V95, P156, DOI 10.1093/cvr/cvs115; HEATH D, 1987, BRIT HEART J, V58, P204; HEATH D, 1958, CIRCULATION, V18, P533, DOI 10.1161/01.CIR.18.4.533; Jiang BH, 2004, CHEST, V125, P2247, DOI 10.1378/chest.125.6.2247; Kim YM, 2011, AM J PATHOL, V179, P1560, DOI 10.1016/j.ajpath.2011.05.051; Lacolley P, 2012, CARDIOVASC RES, V95, P194, DOI 10.1093/cvr/cvs135; Lagna G, 2007, J BIOL CHEM, V282, P37244, DOI 10.1074/jbc.M708137200; Mitani Y, 1997, CIRCULATION, V96, P689; Mitani Y, 2002, J APPL PHYSIOL, V93, P1770, DOI 10.1152/japplphysiol.00500.2002; Mitani Y, 2001, EUR RESPIR J, V17, P316, DOI 10.1183/09031936.01.17203160; Mitani Y, 2000, FASEB J, V14, P805, DOI 10.1096/fasebj.14.5.805; Oka M, 2007, CIRC RES, V100, P923, DOI 10.1161/01.RES.0000261658.12024.18; Owens GK, 2004, PHYSIOL REV, V84, P767, DOI 10.1152/physrev.00041.2003; Price LC, 2012, CHEST, V141, P210, DOI 10.1378/chest.11-0793; Qiao LN, 2014, CIRCULATION, V129, P692, DOI 10.1161/CIRCULATIONAHA.113.003734; Qin YW, 2012, CARDIOVASC RES, V96, P401, DOI 10.1093/cvr/cvs263; RABINOVITCH M, 1981, AM J PHYSIOL, V240, pH62, DOI 10.1152/ajpheart.1981.240.1.H62; RABINOVITCH M, 1986, LAB INVEST, V55, P632; Rabinovitch M, 2012, J CLIN INVEST, V122, P4306, DOI 10.1172/JCI60658; Ricard N, 2014, CIRCULATION, V129, P1586, DOI 10.1161/CIRCULATIONAHA.113.007469; Sawada H, 2007, CHEST, V132, P1265, DOI 10.1378/chest.06-2243; Sawada H, 2014, J EXP MED, V211, P263, DOI 10.1084/jem.20111741; Shirasawa B, 2000, EUR SURG RES, V32, P30, DOI 10.1159/000008738; SMITH P, 1990, J PATHOL, V160, P111, DOI 10.1002/path.1711600204; Stacher E, 2012, AM J RESP CRIT CARE, V186, P261, DOI 10.1164/rccm.201201-0164OC; Stenmark KR, 2006, PHYSIOLOGY, V21, P134, DOI 10.1152/physiol.00053.2005; Stevens Troy, 2008, Proc Am Thorac Soc, V5, P783, DOI 10.1513/pats.200803-027HR; Suzuki JI, 1996, CIRCULATION, V94, P1118, DOI 10.1161/01.CIR.94.5.1118; Taraseviciene-Stewart L, 2001, FASEB J, V15, P427, DOI 10.1096/fj.00-0343com; Taraseviciene-Stewart L, 2007, AM J RESP CRIT CARE, V175, P1280, DOI 10.1164/rccm.200608-1189OC; Taraseviciene-Stewart L, 2006, AM J PHYSIOL-LUNG C, V291, pL668, DOI 10.1152/ajplung.00491.2005; Toba M, 2014, AM J PHYSIOL-HEART C, V306, pH243, DOI 10.1152/ajpheart.00728.2013; TUDER RM, 1994, AM J PATHOL, V144, P275; UEDA M, 1991, CIRCULATION, V83, P1327, DOI 10.1161/01.CIR.83.4.1327; Yi ES, 2000, AM J RESP CRIT CARE, V162, P1577, DOI 10.1164/ajrccm.162.4.9912131	43	28	28	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2015	10	2							e0118655	10.1371/journal.pone.0118655	http://dx.doi.org/10.1371/journal.pone.0118655			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC2IM	25714834	Green Published, Green Submitted, gold			2022-12-27	WOS:000350168700094
J	Roloff, F; Scheiblich, H; Dewitz, C; Dempewolf, S; Stern, M; Bicker, G				Roloff, Frank; Scheiblich, Hannah; Dewitz, Carola; Dempewolf, Silke; Stern, Michael; Bicker, Gerd			Enhanced Neurite Outgrowth of Human Model (NT2) Neurons by Small-Molecule Inhibitors of Rho/ROCK Signaling	PLOS ONE			English	Article							SPINAL-CORD-INJURY; VENTRAL ROOT AVULSION; RHO-ASSOCIATED KINASE; AXON REGENERATION; FUNCTIONAL RECOVERY; NERVE REGENERATION; ROCK INHIBITORS; ACTIVATED RHOA; MAMMALIAN CNS; GLIAL SCAR	Axonal injury in the adult human central nervous system often results in loss of sensation and motor functions. Promoting regeneration of severed axons requires the inactivation of growth inhibitory influences from the tissue environment and stimulation of the neuron intrinsic growth potential. Especially glial cell derived factors, such as chondroitin sulfate proteoglycans, Nogo-A, myelin-associated glycoprotein, and myelin in general, prevent axon regeneration. Most of the glial growth inhibiting factors converge onto the Rho/ROCK signaling pathway in neurons. Although conditions in the injured nervous system are clearly different from those during neurite outgrowth in vitro, here we use a chemical approach to manipulate Rho/ROCK signalling with small-molecule agents to encourage neurite outgrowth in cell culture. The development of therapeutic treatments requires drug testing not only on neurons of experimental animals, but also on human neurons. Using human NT2 model neurons, we demonstrate that the pain reliever Ibuprofen decreases RhoA (Ras homolog gene family, member A GTPase) activation and promotes neurite growth. Inhibition of the downstream effector Rho kinase by the drug Y-27632 results in a strong increase in neurite outgrowth. Conversely, activation of the Rho pathway by lysophosphatidic acid results in growth cone collapse and eventually to neurite retraction. Finally, we show that blocking of Rho kinase, but not RhoA results in an increase in neurons bearing neurites. Due to its anti-inflammatory and neurite growth promoting action, the use of a pharmacological treatment of damaged neural tissue with Ibuprofen should be explored.	[Roloff, Frank; Scheiblich, Hannah; Dewitz, Carola; Dempewolf, Silke; Stern, Michael; Bicker, Gerd] Univ Vet Med Hannover, Div Cell Biol, D-30173 Hannover, Germany; [Bicker, Gerd] Ctr Syst Neurosci, Hannover, Germany	University of Veterinary Medicine Hannover, Foundation	Bicker, G (corresponding author), Univ Vet Med Hannover, Div Cell Biol, Bischofsholer Damm 15-102, D-30173 Hannover, Germany.	gerd.bicker@tiho-hannover.de	Scheiblich, Hannah/ABC-3883-2021; Stern, Michael/E-7980-2011	Dewitz, Carola/0000-0003-3093-3138; Stern, Michael/0000-0002-5088-5439	German Research Foundation [BI 262/16-2, 1103]	German Research Foundation(German Research Foundation (DFG))	This study was supported by a grant from the German Research Foundation for GB (Research Unit 1103, BI 262/16-2). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGUAYO AJ, 1981, J EXP BIOL, V95, P231; ANDREWS PW, 1984, LAB INVEST, V50, P147; ARCHIBALD SJ, 1995, J NEUROSCI, V15, P4109; Benowitz LI, 2007, DEV NEUROBIOL, V67, P1148, DOI 10.1002/dneu.20515; Bito H, 2000, NEURON, V26, P431, DOI 10.1016/S0896-6273(00)81175-7; Boomkamp SD, 2012, GLIA, V60, P441, DOI 10.1002/glia.22278; Bradbury EJ, 2002, NATURE, V416, P636, DOI 10.1038/416636a; Cheng C, 2008, EXP NEUROL, V212, P358, DOI 10.1016/j.expneurol.2008.04.023; Degasperi A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087293; DeGeer J, 2013, EXP CELL RES, V319, P2384, DOI 10.1016/j.yexcr.2013.06.016; Dergham P, 2002, J NEUROSCI, V22, P6570; Dong JM, 1998, J BIOL CHEM, V273, P22554, DOI 10.1074/jbc.273.35.22554; Ellezam B, 2002, PROG BRAIN RES, V137, P371; Filbin MT, 2003, NAT REV NEUROSCI, V4, P703, DOI 10.1038/nrn1195; Flynn KC, 2013, BIOARCHITECTURE, V3; Fournier AE, 2003, J NEUROSCI, V23, P1416, DOI 10.1523/JNEUROSCI.23-04-01416.2003; Fu Q, 2007, J NEUROSCI, V27, P4154, DOI 10.1523/JNEUROSCI.4353-06.2007; Gallo G, 2004, J NEUROBIOL, V58, P92, DOI 10.1002/neu.10282; Gao XP, 2013, REV NEUROSCIENCE, V24, P443, DOI 10.1515/revneuro-2013-0022; Gu Haigang, 2013, Int J Physiol Pathophysiol Pharmacol, V5, P11; Hirose M, 1998, J CELL BIOL, V141, P1625, DOI 10.1083/jcb.141.7.1625; Hoang TX, 2003, J COMP NEUROL, V467, P477, DOI 10.1002/cne.10928; Hu R, 2010, J NEUROSURG-SPINE, V13, P169, DOI 10.3171/2010.3.SPINE09190; Hu XF, 2013, J BIOMAT SCI-POLYM E, V24, P1869, DOI 10.1080/09205063.2013.808150; KOLIATSOS VE, 1994, J COMP NEUROL, V342, P35, DOI 10.1002/cne.903420105; Kopp MA, 2012, CELL TISSUE RES, V349, P119, DOI 10.1007/s00441-012-1334-7; Kubo T, 2007, CURR PHARM DESIGN, V13, P2493; Lang P, 1996, EMBO J, V15, P510, DOI 10.1002/j.1460-2075.1996.tb00383.x; Lingor P, 2008, BRAIN, V131, P250, DOI 10.1093/brain/awm284; Lingor P, 2007, J NEUROCHEM, V103, P181, DOI 10.1111/j.1471-4159.2007.04756.x; Marianecci C, 2011, J PHARM PHARM SCI, V14, P336, DOI 10.18433/J3160B; Martin LJ, 1999, J NEUROBIOL, V40, P185, DOI 10.1002/(SICI)1097-4695(199908)40:2<185::AID-NEU5>3.3.CO;2-R; Mcdonald D, 2006, NEURON GLIA BIOL, V2, P139, DOI 10.1017/S1740925X05000347; McGee AW, 2003, TRENDS NEUROSCI, V26, P193, DOI 10.1016/S0166-2236(03)00062-6; Natsume A, 2002, J NEUROTRAUM, V19, P61, DOI 10.1089/089771502753460240; Paquet-Durand F, 2007, CURR MOL MED, V7, P541, DOI 10.2174/156652407781695747; Radtke Christine, 2009, Eplasty, V9, pe47; Reyes Onix, 2005, P R Health Sci J, V24, P215; Roloff F, 2013, BMC NEUROSCI, V14, DOI 10.1186/1471-2202-14-141; Schwab ME, 2004, CURR OPIN NEUROBIOL, V14, P118, DOI 10.1016/j.conb.2004.01.004; Sebok A, 1999, J NEUROCHEM, V73, P949, DOI 10.1046/j.1471-4159.1999.0730949.x; Shiraishi M, 2006, J CELL PHYSIOL, V209, P1029, DOI 10.1002/jcp.20814; Silver J, 2004, NAT REV NEUROSCI, V5, P146, DOI 10.1038/nrn1326; Tegenge MA, 2011, CELL MOL NEUROBIOL, V31, P635, DOI 10.1007/s10571-011-9659-4; Tonges L, 2011, FRONT MOL NEUROSCI, V4, DOI 10.3389/fnmol.2011.00039; Wang XX, 2009, J NEUROTRAUM, V26, P81, DOI 10.1089/neu.2007.0464; Watzlawick R, 2014, JAMA NEUROL, V71, P91, DOI 10.1001/jamaneurol.2013.4684; Wu DS, 2009, MOL THER, V17, P2020, DOI 10.1038/mt.2009.168; Yamaguchi Y, 2001, J BIOL CHEM, V276, P18977, DOI 10.1074/jbc.M100254200	49	39	42	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2015	10	2							e0118536	10.1371/journal.pone.0118536	http://dx.doi.org/10.1371/journal.pone.0118536			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC2IM	25714396	gold, Green Submitted, Green Published			2022-12-27	WOS:000350168700082
J	Uono, S; Hietanen, JK				Uono, Shota; Hietanen, Jari K.			Eye Contact Perception in the West and East: A Cross-Cultural Study	PLOS ONE			English	Article							GAZE DIRECTION; EMOTIONAL EXPRESSIONS; LOOKING; ME; SELF; RECOGNITION; JUDGMENTS; DISPLAY; DEPENDS; HUMANS	This study investigated whether eye contact perception differs in people with different cultural backgrounds. Finnish (European) and Japanese (East Asian) participants were asked to determine whether Finnish and Japanese neutral faces with various gaze directions were looking at them. Further, participants rated the face stimuli for emotion and other affect-related dimensions. The results indicated that Finnish viewers had a smaller bias toward judging slightly averted gazes as directed at them when judging Finnish rather than Japanese faces, while the bias of Japanese viewers did not differ between faces from their own and other cultural backgrounds. This may be explained by Westerners experiencing more eye contact in their daily life leading to larger visual experience of gaze perception generally, and to more accurate perception of eye contact with people from their own cultural background particularly. The results also revealed cultural differences in the perception of emotion from neutral faces that could also contribute to the bias in eye contact perception.	[Uono, Shota] Kyoto Univ, Grad Sch Med, Fac Human Hlth Sci, Kyoto, Japan; [Hietanen, Jari K.] Univ Tampere, Sch Social Sci & Humanities, Human Informat Proc Lab, FIN-33101 Tampere, Finland	Kyoto University; Tampere University	Uono, S (corresponding author), Kyoto Univ, Grad Sch Med, Fac Human Hlth Sci, Kyoto, Japan.	uonoshota1982@gmail.com		Uono, Shota/0000-0003-0547-0522	Academy of Finland [131 786]; Japan Society for the Promotion of Science [11J05000]	Academy of Finland(Academy of Finland); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This study was supported by the Academy of Finland [grant number 131 786 to J.K.H.]; the Japan Society for the Promotion of Science [grant number 11J05000 and Institutional Program for Young Researcher Overseas Visits to S.U.]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams RB, 2003, PSYCHOL SCI, V14, P644, DOI 10.1046/j.0956-7976.2003.psci_1479.x; Akechi H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059312; ARGYLE M, 1986, INT J PSYCHOL, V21, P287, DOI 10.1080/00207598608247591; Argyle M., 1976, GAZE MUTUAL GAZE; Baron-Cohen S., 1997, MINDBLINDNESS ESSAY; Blais C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003022; CLINE MG, 1967, AM J PSYCHOL, V80, P41, DOI 10.2307/1420539; Conty L, 2007, NEUROPSYCHOLOGIA, V45, P3024, DOI 10.1016/j.neuropsychologia.2007.05.017; Dadds MR, 2012, BRIT J PSYCHIAT, V200, P191, DOI 10.1192/bjp.bp.110.085720; Dunham Y, 2011, J EXP SOC PSYCHOL, V47, P668, DOI 10.1016/j.jesp.2011.01.003; Ewbank MP, 2009, J VIS, V9, P11, DOI [10.1167/9.13.16, DOI 10.1167/9.13.16]; Farroni T, 2002, P NATL ACAD SCI USA, V99, P9602, DOI 10.1073/pnas.152159999; Gale C, 2000, PERCEPT PSYCHOPHYS, V62, P586, DOI 10.3758/BF03212110; Gamer M, 2007, J EXP PSYCHOL HUMAN, V33, P705, DOI 10.1037/0096-1523.33.3.705; Gamer M, 2011, COGNITION EMOTION, V25, P756, DOI 10.1080/02699931.2010.503117; GIBSON JJ, 1963, AM J PSYCHOL, V76, P386, DOI 10.2307/1419779; Helminen TM, 2011, BIOL PSYCHOL, V88, P124, DOI 10.1016/j.biopsycho.2011.07.002; Hietanen JK, 2008, NEUROPSYCHOLOGIA, V46, P2423, DOI 10.1016/j.neuropsychologia.2008.02.029; Jack RE, 2009, CURR BIOL, V19, P1543, DOI 10.1016/j.cub.2009.07.051; Kanai Y., 2004, JPN J PSYCHOSOM MED, V44, P841, DOI DOI 10.15064/JJPM.44.11_; Kelly DJ, 2007, PSYCHOL SCI, V18, P1084, DOI 10.1111/j.1467-9280.2007.02029.x; Kelly DJ, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00095; KLEINKE CL, 1986, PSYCHOL BULL, V100, P78, DOI 10.1037/0033-2909.100.1.78; Kobayashi H, 1997, NATURE, V387, P767, DOI 10.1038/42842; Kurita H., 2003, JPN J CLIN PSYCHIAT, V32, P1235; Lobmaier JS, 2008, EMOTION, V8, P573, DOI 10.1037/1528-3542.8.4.573; Lobmaier JS, 2011, COGNITION EMOTION, V25, P334, DOI 10.1080/02699931003794557; Mareschal I, 2013, CURR BIOL, V23, P717, DOI 10.1016/j.cub.2013.03.030; MARKUS HR, 1991, PSYCHOL REV, V98, P224, DOI 10.1037/0033-295X.98.2.224; Mason MF, 2004, MEMORY, V12, P637, DOI 10.1080/09658210344000152; Matsumoto D, 2002, COGNITION EMOTION, V16, P721, DOI 10.1080/02699930143000608; Matsumoto D, 1999, COGNITION EMOTION, V13, P201, DOI 10.1080/026999399379339; Matsumoto D., 1998, ASIAN J SOC PSYCHOL, V1, P147, DOI [10.1111/1467-839X.00010, DOI 10.1111/1467-839X.00010]; McCarthy A, 2008, J CROSS CULT PSYCHOL, V39, P716, DOI 10.1177/0022022108323807; McCarthy A, 2006, J CROSS CULT PSYCHOL, V37, P717, DOI 10.1177/0022022106292079; MORSBACH H, 1973, J NERV MENT DIS, V157, P262, DOI 10.1097/00005053-197310000-00006; Oosterhof NN, 2008, P NATL ACAD SCI USA, V105, P11087, DOI 10.1073/pnas.0805664105; Ponkanen LM, 2011, SOC COGN AFFECT NEUR, V6, P486, DOI 10.1093/scan/nsq068; Powers KE, 2014, PSYCHOL SCI, V25, P1943, DOI 10.1177/0956797614547706; Rhodes G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049317; Sacco DF, 2009, EMOTION, V9, P39, DOI 10.1037/a0014081; Said CP, 2009, EMOTION, V9, P260, DOI 10.1037/a0014681; Sangrigoli S, 2005, PSYCHOL SCI, V16, P440; Schulze L, 2013, COGNITION EMOTION, V27, P1305, DOI 10.1080/02699931.2013.773881; Senju A, 2008, CURR BIOL, V18, P668, DOI 10.1016/j.cub.2008.03.059; Senju A, 2009, TRENDS COGN SCI, V13, P127, DOI 10.1016/j.tics.2008.11.009; Symons LA, 2004, J GEN PSYCHOL, V131, P451; vonGrunau M, 1995, PERCEPTION, V24, P1297, DOI 10.1068/p241297; Yuki M, 2007, J EXP SOC PSYCHOL, V43, P303, DOI 10.1016/j.jesp.2006.02.004	49	45	45	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2015	10	2							e0118094	10.1371/journal.pone.0118094	http://dx.doi.org/10.1371/journal.pone.0118094			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CC2IM	25714900	Green Published, Green Submitted, gold			2022-12-27	WOS:000350168700051
J	Cunha, FD; Molle, RD; Portella, AK; Benetti, CD; Noschang, C; Goldani, MZ; Silveira, PP				Cunha, Fabio da Silva; Molle, Roberta Dalle; Portella, Andre Krumel; Benetti, Carla da Silva; Noschang, Cristie; Goldani, Marcelo Zubaran; Silveira, Patricia Pelufo			Both Food Restriction and High-Fat Diet during Gestation Induce Low Birth Weight and Altered Physical Activity in Adult Rat Offspring: The "Similarities in the Inequalities" Model	PLOS ONE			English	Article							SEDENTARY BEHAVIOR; OBESITY; REINFORCEMENT; MICE; MEN; PHENOTYPE; BENEFITS; EXERCISE; FAMINE; HEALTH	We have previously described a theoretical model in humans, called "Similarities in the Inequalities", in which extremely unequal social backgrounds coexist in a complex scenario promoting similar health outcomes in adulthood. Based on the potential applicability of and to further explore the "similarities in the inequalities" phenomenon, this study used a rat model to investigate the effect of different nutritional backgrounds during gestation on the willingness of offspring to engage in physical activity in adulthood. Sprague-Dawley rats were time mated and randomly allocated to one of three dietary groups: Control (Adlib), receiving standard laboratory chow ad libitum; 50% food restricted (FR), receiving 50% of the ad libitum-fed dam's habitual intake; or high-fat diet (HF), receiving a diet containing 23% fat. The diets were provided from day 10 of pregnancy until weaning. Within 24 hours of birth, pups were cross-fostered to other dams, forming the following groups: Adlib_Adlib, FR_Adlib, and HF_Adlib. Maternal chow consumption and weight gain, and offspring birth weight, growth, physical activity (one week of free exercise in running wheels), abdominal adiposity and biochemical data were evaluated. Western blot was performed to assess D2 receptors in the dorsal striatum. The "similarities in the inequalities" effect was observed on birth weight (both FR and HF groups were smaller than the Adlib group at birth) and physical activity (both FR_Adlib and HF_Adlib groups were different from the Adlib_Adlib group, with less active males and more active females). Our findings contribute to the view that health inequalities in fetal life may program the health outcomes manifested in offspring adult life (such as altered physical activity and metabolic parameters), probably through different biological mechanisms.	[Cunha, Fabio da Silva; Molle, Roberta Dalle; Benetti, Carla da Silva; Noschang, Cristie; Goldani, Marcelo Zubaran; Silveira, Patricia Pelufo] Univ Fed Rio Grande do Sul, Hosp Clin Porto Alegre, Fac Med, Dept Pediat,Programa Posgrad Saude Crianca & Adol, Porto Alegre, RS, Brazil; [Portella, Andre Krumel] Univ Fed Ciencias Saude Porto Alegre, Dept Pediat, Porto Alegre, RS, Brazil	Universidade Federal do Rio Grande do Sul; Universidade Federal de Ciencias da Saude de Porto Alegre	Silveira, PP (corresponding author), Univ Fed Rio Grande do Sul, Hosp Clin Porto Alegre, Fac Med, Dept Pediat,Programa Posgrad Saude Crianca & Adol, Porto Alegre, RS, Brazil.	00032386@ufrgs.br	Silveira, Patricia P/F-4897-2014; Portella, Andre Krumel/A-9333-2010; Silveira, Patricia/K-2364-2019; Goldani, Marcelo Zubaran/U-8596-2019	Silveira, Patricia P/0000-0001-8626-2519; Portella, Andre Krumel/0000-0003-3390-0016; Silveira, Patricia/0000-0001-8626-2519; 	PRONEX; FAPERGS/CNPq [10/0018.3]; Projeto IVAPSA-Impacto das Variacoes do Ambiente Perinatal sobre a Saude do Adulto; Fundo de Incentivo a Pesquisa e Eventos do Hospital de Clinicas de Porto Alegre (FIPE/HCPA); Pro-Pesquisa/PROPESQ/UFRGS; Coordination for the Improvement of Higher Education Personnel (CAPES); Capes - Brazil	PRONEX; FAPERGS/CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)Fundacao de Amparo a Ciencia e Tecnologia do Estado do Rio Grande do Sul (FAPERGS)); Projeto IVAPSA-Impacto das Variacoes do Ambiente Perinatal sobre a Saude do Adulto; Fundo de Incentivo a Pesquisa e Eventos do Hospital de Clinicas de Porto Alegre (FIPE/HCPA); Pro-Pesquisa/PROPESQ/UFRGS; Coordination for the Improvement of Higher Education Personnel (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Capes - Brazil(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	Financial support from: PRONEX 2009, FAPERGS/CNPq 10/0018.3, Projeto IVAPSA-Impacto das Variacoes do Ambiente Perinatal sobre a Saude do Adulto; Fundo de Incentivo a Pesquisa e Eventos do Hospital de Clinicas de Porto Alegre (FIPE/HCPA); Pro-Pesquisa/PROPESQ/UFRGS; Coordination for the Improvement of Higher Education Personnel (CAPES). Cunha FS had a MSc supporting grant from Capes - Brazil. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barbieri MA, 2009, PEDIATR RES, V65, P215, DOI 10.1203/PDR.0b013e31818d6850; Barker DJP, 1998, CLIN SCI, V95, P115, DOI 10.1042/CS19980019; Belke TW, 2007, J EXP ANAL BEHAV, V88, P199, DOI 10.1901/jeab.2007.62-06; BELKE TW, 1994, ANIM LEARN BEHAV, V22, P267, DOI 10.3758/BF03209834; Blair SN, 2009, ANN EPIDEMIOL, V19, P253, DOI 10.1016/j.annepidem.2009.01.019; Brene S, 2007, PHYSIOL BEHAV, V92, P136, DOI 10.1016/j.physbeh.2007.05.015; BUE JM, 1989, AM J OBSTET GYNECOL, V161, P234, DOI 10.1016/0002-9378(89)90272-X; Bungum TJ, 1997, AM J PREV MED, V13, P115, DOI 10.1016/S0749-3797(18)30208-3; COLLIER G, 1971, J COMP PHYSIOL PSYCH, V77, P155, DOI 10.1037/h0031588; Crimi E, 2009, NAT REV CARDIOL, V6, P292, DOI 10.1038/nrcardio.2009.8; Darmon N, 2008, AM J CLIN NUTR, V87, P1107, DOI 10.1093/ajcn/87.5.1107; Davies AA, 2004, CIRCULATION, V110, P1258, DOI 10.1161/01.CIR.0000140980.61294.4D; Desai M, 2005, AM J PHYSIOL-REG I, V288, pR91, DOI 10.1152/ajpregu.00340.2004; Deslandes A, 2009, NEUROPSYCHOBIOLOGY, V59, P191, DOI 10.1159/000223730; Dudley KJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021662; Ekkekakis P, 2005, J SPORT SCI, V23, P477, DOI 10.1080/02640410400021492; Fernandes FS, 2010, J DEV ORIG HLTH DIS, V1, P255, DOI 10.1017/S204017441000019X; Ford SP, 2012, REPROD FERT DEVELOP, V24, P105, DOI 10.1071/RD11911; Francis TC, 2015, BIOL PSYCHIAT, V77, P212, DOI 10.1016/j.biopsych.2014.07.021; Grissom NM, 2013, INT J DEV NEUROSCI, V31, P406, DOI 10.1016/j.ijdevneu.2012.11.006; HALES CN, 1992, DIABETOLOGIA, V35, P595, DOI 10.1007/BF00400248; Hallal PC, 2006, BMJ-BRIT MED J, V332, P1002, DOI 10.1136/bmj.38776.434560.7C; Hamer M, 2009, EUR J CARDIOV PREV R, V16, P156, DOI 10.1097/HJR.0b013e32831f1b77; Howie GJ, 2009, J PHYSIOL-LONDON, V587, P905, DOI 10.1113/jphysiol.2008.163477; IVERSEN IH, 1993, J EXP ANAL BEHAV, V60, P219, DOI 10.1901/jeab.1993.60-219; James MH, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00244; KAGAN J, 1954, J COMP PHYSIOL PSYCH, V47, P108, DOI 10.1037/h0058877; Kajantie E, 2010, J PEDIATR-US, V157, P610, DOI 10.1016/j.jpeds.2010.04.002; Kantomaa MT, 2007, PREV MED, V44, P410, DOI 10.1016/j.ypmed.2007.01.008; Kirk SL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005870; Kravitz AV, 2012, PHYSIOLOGY, V27, P167, DOI 10.1152/physiol.00004.2012; Landi F, 2008, PREV MED, V47, P422, DOI 10.1016/j.ypmed.2008.06.020; Lett BT, 2000, APPETITE, V34, P87, DOI 10.1006/appe.1999.0274; LIANG KY, 1986, BIOMETRIKA, V73, P13, DOI 10.1093/biomet/73.1.13; Liu M, 2006, PHARM STAT, V5, P7, DOI 10.1002/pst.189; Ma Y, 2012, REGION ANESTH PAIN M, V37, P99, DOI 10.1097/AAP.0b013e31823ebc74; Marais L, 2009, METAB BRAIN DIS, V24, P587, DOI 10.1007/s11011-009-9157-2; Martinez R, 2009, FOOD NUTR INSECURITY; Matthews PA, 2011, J PHYSIOL-LONDON, V589, P3969, DOI 10.1113/jphysiol.2011.212324; McMinn AM, 2013, EUR J PUBLIC HEALTH, V23, P805, DOI 10.1093/eurpub/cks160; McMullen S, 2012, MED HYPOTHESES, V78, P88, DOI 10.1016/j.mehy.2011.09.047; Miotto PM, 2013, MOLECULES, V18, P15094, DOI 10.3390/molecules181215094; Mo Frank, 2005, Int J Adolesc Med Health, V17, P49; Ong ZY, 2011, FASEB J, V25, P2167, DOI 10.1096/fj.10-178392; Organization WH, 2002, WORLD HLTH REP RED R, DOI [10.2134/jeq2014.02.0058, DOI 10.2134/JEQ2014.02.0058]; Painter RC, 2005, REPROD TOXICOL, V20, P345, DOI 10.1016/j.reprotox.2005.04.005; Paxinos G., 2007, RAT BRAIN STEREOTAXI, V6th ed.; Penedo FJ, 2005, CURR OPIN PSYCHIATR, V18, P189, DOI 10.1097/00001504-200503000-00013; Portella AK, 2012, J DEV ORIG HLTH DIS, V3, P140, DOI 10.1017/S2040174412000062; PREMACK D, 1964, J EXP ANAL BEHAV, V7, P91, DOI 10.1901/jeab.1964.7-91; Rabadan-Diehl C, 2013, J DEV ORIG HLTH DIS, V4, P3, DOI 10.1017/S2040174412000487; Raudsepp L, 2006, ACTA PAEDIATR, V95, P93, DOI 10.1080/08035250500323772; Ravelli ACJ, 1999, AM J CLIN NUTR, V70, P811; Refinetti R, 2006, J COMP PHYSIOL A, V192, P701, DOI 10.1007/s00359-006-0093-x; Ross MG, 2005, AM J PHYSIOL-REG I, V288, pR25, DOI 10.1152/ajpregu.00418.2004; Shaw MA, 1997, J NUTR, V127, P64, DOI 10.1093/jn/127.1.64; Sherwin CM, 1998, ANIM BEHAV, V56, P11, DOI 10.1006/anbe.1998.0836; Sherwin CM, 1996, ANIM BEHAV, V51, P1087, DOI 10.1006/anbe.1996.0110; Silveira PP, 2010, INT J DEV NEUROSCI, V28, P111, DOI 10.1016/j.ijdevneu.2009.08.018; Silveira PP, 2006, BEHAV BRAIN RES, V173, P205, DOI 10.1016/j.bbr.2006.06.031; Silveira PP, 2005, LANCET, V366, P451, DOI 10.1016/S0140-6736(05)67054-7; Stessman J, 2009, ARCH INTERN MED, V169, P1476, DOI 10.1001/archinternmed.2009.248; Tamashiro KLK, 2010, PHYSIOL BEHAV, V100, P560, DOI 10.1016/j.physbeh.2010.04.008; TIMBERLAKE W, 1979, ANIM LEARN BEHAV, V7, P461, DOI 10.3758/BF03209702; Van der Horst K, 2007, MED SCI SPORT EXER, V39, P1241, DOI 10.1249/mss.0b013e318059bf35; Veitch J, 2010, INT J BEHAV NUTR PHY, V7, DOI 10.1186/1479-5868-7-11; Vickers MH, 2003, AM J PHYSIOL-REG I, V285, pR271, DOI 10.1152/ajpregu.00051.2003	67	26	27	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2015	10	3							e0118586	10.1371/journal.pone.0118586	http://dx.doi.org/10.1371/journal.pone.0118586			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9JM	25738800	Green Published, gold, Green Submitted			2022-12-27	WOS:000350685900050
J	Huang, AH; Pan, SH; Chang, WH; Hong, QS; Chen, JJW; Yu, SL				Huang, Ay-Huey; Pan, Szu-Hua; Chang, Wen-Hsin; Hong, Qi-Sheng; Chen, Jeremy J. W.; Yu, Sung-Liang			PARVA Promotes Metastasis by Modulating ILK Signalling Pathway in Lung Adenocarcinoma	PLOS ONE			English	Article							INTEGRIN-LINKED KINASE; AP-1 TRANSCRIPTION FACTOR; MEDIATED UP-REGULATION; ALPHA-PARVIN; EXTRACELLULAR-MATRIX; PROGENITOR CELLS; CANCER; EXPRESSION; INVASION; PHOSPHORYLATION	alpha-parvin (PARVA) is known to be involved in the linkage of integrins, regulation of actin cytoskeleton dynamics and cell survival. However, the role that PARVA plays in cancer progression remains unclear. Here, using a lung cancer invasion cell line model and expression microarrays, we identify PARVA as a potential oncogene. The overexpression of PARVA increased cell invasion, colony-forming ability and endothelial cell tube formation. By contrast, knockdown of PARVA inhibited invasion and tube formation in vitro. Overexpression of PARVA also promoted tumorigenicity, angiogenesis and metastasis in in vivo mouse models. To explore the underlying mechanism, we compared the expression microarray profiles of PARVA-overexpressing cells with those of control cells to identify the PARVA-regulated signalling pathways. Pathway analysis showed that eight of the top 10 pathways are involved in invasion, angiogenesis and cell death. Next, to identify the direct downstream signalling pathway of PARVA, 371 significantly PARVA-altered genes were analysed further using a transcription factor target model. Seven of the top 10 PARVA-altered transcription factors shared a common upstream mediator, ILK. Lastly, we found that PARVA forms a complex with SGK1 and ILK to enhance the phosphorylation of ILK, which led to the phosphorylation of Akt and GSK3 beta. Notably, the inactivation of ILK reversed PARVA-induced invasion. Taken together, our findings imply that PARVA acts as an oncogene by activating ILK, and that this activation is followed by the activation of Akt and inhibition of GSK3 beta. To our knowledge, this is the first study to characterize the role of PARVA in lung cancer progression.	[Huang, Ay-Huey; Chen, Jeremy J. W.] Natl Chung Hsing Univ, Inst Mol Biol, Taichung 40227, Taiwan; [Pan, Szu-Hua] Natl Taiwan Univ, Coll Med, Grad Inst Med Genom & Prote, Taipei 10764, Taiwan; [Chen, Jeremy J. W.] Natl Chung Hsing Univ, Inst Biomed Sci, Taichung 40227, Taiwan; [Chen, Jeremy J. W.] Natl Chung Hsing Univ, Agr Biotechnol Ctr, Taichung 40227, Taiwan; [Chang, Wen-Hsin; Hong, Qi-Sheng; Yu, Sung-Liang] Natl Taiwan Univ, Coll Med, Dept Clin Lab Sci & Med Biotechnol, Taipei 10764, Taiwan; [Yu, Sung-Liang] Natl Taiwan Univ, Ctr Genom Med, Taipei 10764, Taiwan; [Yu, Sung-Liang] Natl Taiwan Univ, Coll Med, Ctr Optoelect Biomed, Taipei 10764, Taiwan; [Yu, Sung-Liang] Natl Taiwan Univ Hosp, Dept Lab Med, Taipei, Taiwan	National Chung Hsing University; National Taiwan University; National Chung Hsing University; National Chung Hsing University; National Taiwan University; National Taiwan University; National Taiwan University; National Taiwan University; National Taiwan University Hospital	Chen, JJW (corresponding author), Natl Chung Hsing Univ, Inst Mol Biol, Taichung 40227, Taiwan.	jwchen@dragon.nchu.edu.tw; slyu@ntu.edu.tw		YU, SUNG-LIANG/0000-0003-4535-9036; Pan, Szu-Hua/0000-0002-0138-0434; Chang, Wen-Hsin/0000-0002-8027-302X; Chen, Jeremy J.W./0000-0003-1049-3825	National Science Council of the Republic of China [NSC98-2314-B-002-120-MY3, NSC98-2314-B-002-022-MY3, NSC102-2911-I-002-303, 102R7557]; Ministry of Education, Taiwan, under the ATU plan	National Science Council of the Republic of China(Ministry of Science and Technology, Taiwan); Ministry of Education, Taiwan, under the ATU plan(Ministry of Education, Taiwan)	This study was supported by the National Science Council of the Republic of China (grants NSC98-2314-B-002-120-MY3, NSC98-2314-B-002-022-MY3, NSC102-2911-I-002-303, 102R7557), as well as in part by the Ministry of Education, Taiwan, under the ATU plan. The authors thank the NCFPB C5 microarray core facility for technique support and the BCRC cell bank for providing the STR profiling data. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acconcia F, 2007, P NATL ACAD SCI USA, V104, P6782, DOI 10.1073/pnas.0701999104; Albasri A, 2011, ONCOGENE, V30, P2997, DOI 10.1038/onc.2011.26; Attwell S, 2003, MOL BIOL CELL, V14, P4813, DOI 10.1091/mbc.E03-05-0308; Barker HE, 2012, NAT REV CANC; Biswas S, 2012, CARCINOGENESIS, V33, P1717, DOI 10.1093/carcin/bgs222; Cattaneo MG, 2008, BRIT J PHARMACOL, V153, P728, DOI 10.1038/sj.bjp.0707609; Chan J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016984; Chen CH, 2012, MOL CANCER RES, V10, P1319, DOI 10.1158/1541-7786.MCR-12-0189; Chen JJW, 2001, CANCER RES, V61, P5223; Cho ML, 2006, IMMUNOL LETT, V103, P159, DOI 10.1016/j.imlet.2005.10.020; Chu YW, 1997, AM J RESP CELL MOL, V17, P353, DOI 10.1165/ajrcmb.17.3.2837; Chun Jaesun, 2005, Integrative Biosciences, V9, P161; Devalliere J, 2012, FASEB J; Fukuda K, 2009, MOL CELL, V36, P819, DOI 10.1016/j.molcel.2009.11.028; Gagne D, 2010, J CELL PHYSIOL, V222, P387, DOI 10.1002/jcp.21963; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hong TM, 2000, AM J RESP CELL MOL, V23, P355, DOI 10.1165/ajrcmb.23.3.4002; Jung KY, 2007, J AM SOC NEPHROL, V18, P66, DOI 10.1681/ASN.2006050421; Kalluri R, 2006, NAT REV CANCER, V6, P392, DOI 10.1038/nrc1877; Koul D, 2005, MOL CANCER THER, V4, P1681, DOI 10.1158/1535-7163.MCT-05-0258; Lee CC, 2006, J BIOMED SCI, V13, P143, DOI 10.1007/s11373-005-9037-7; Lee SL, 2011, J MED CHEM, V54, P6364, DOI 10.1021/jm2007744; Legate KR, 2006, NAT REV MOL CELL BIO, V7, P20, DOI 10.1038/nrm1789; Liang CH, 2012, CANC RES; Loesch M, 2010, J BIOL CHEM, V285, P15149, DOI 10.1074/jbc.M110.105429; Montanez E, 2009, EMBO J, V28, P3132, DOI 10.1038/emboj.2009.295; Oneyama C, 2012, ONCOGENE, V31, P1623, DOI 10.1038/onc.2011.367; Pan SH, 2011, J CLIN INVEST, V121, P3189, DOI 10.1172/JCI42975; Papachristou DJ, 2008, EUR J CANCER, V44, P2518, DOI 10.1016/j.ejca.2008.07.021; Persad S, 2001, J BIOL CHEM, V276, P27462, DOI 10.1074/jbc.M102940200; Pignatelli J, 2012, J BIOL CHEM; Pylayeva-Gupta Y, 2011, NAT REV CANCER, V11, P761, DOI 10.1038/nrc3106; Schroeter MR, 2012, CARDIOVASC RES, V93, P170, DOI 10.1093/cvr/cvr275; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Stanchi F, 2009, J CELL SCI, V122, P1800, DOI 10.1242/jcs.044602; Tan C, 2004, CANCER CELL, V5, P79, DOI 10.1016/S1535-6108(03)00281-2; Troussard AA, 2000, ONCOGENE, V19, P5444, DOI 10.1038/sj.onc.1203928; Troussard AA, 1999, MOL CELL BIOL, V19, P7420; Tsai LN, 2008, MOL CELL BIOL, V28, P4240, DOI 10.1128/MCB.01489-07; Tsai MF, 2006, JNCI-J NATL CANCER I, V98, P825, DOI 10.1093/jnci/djj229; Wang YY, 2011, EUR J CELL BIOL, V90, P642, DOI 10.1016/j.ejcb.2011.03.005; Whiteside TL, 2008, ONCOGENE, V27, P5904, DOI 10.1038/onc.2008.271; Wu CY, 2001, J CELL BIOL, V155, P505, DOI 10.1083/jcb.200108077; Yun SP, 2011, J CELL PHYSIOL, V226, P683, DOI 10.1002/jcp.22383; Zhao MJ, 2013, INT J MED SCI, V10, P995, DOI 10.7150/ijms.5963	45	21	22	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2015	10	3							e0118530	10.1371/journal.pone.0118530	http://dx.doi.org/10.1371/journal.pone.0118530			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9JM	25738875	Green Submitted, Green Published, gold			2022-12-27	WOS:000350685900043
J	Larsen, J; Weile, C; Antvorskov, JC; Engkilde, K; Nielsen, SMB; Josefsen, K; Buschard, K				Larsen, Jesper; Weile, Christian; Antvorskov, Julie Christine; Engkilde, Kare; Nielsen, Signe Marie Borch; Josefsen, Knud; Buschard, Karsten			Effect of Dietary Gluten on Dendritic Cells and Innate Immune Subsets in BALB/c and NOD Mice	PLOS ONE			English	Article							NONOBESE DIABETIC MICE; CELIAC-DISEASE; T-CELLS; GLIADIN FRAGMENTS; WHEAT; AUTOIMMUNITY; INFLAMMATION; SENSITIVITY; ACTIVATION; MATURATION	The innate immune system is known to play an important role in oral tolerance to dietary antigens. This is important in development of celiac disease (CD) but may also be important in type 1 diabetes (T1D), and could potentially explain the reduced incidence of T1D in mice receiving a gluten-free (GF) diet. The direct in vivo effect of gluten on innate cells, and particularly dendritic cells (DC) is not sufficiently clarified. Therefore, we wished to investigate the innate cell populations of spontaneous diabetic NOD mice and healthy BALB/c mice kept on a GF or a standard (STD) gluten containing diet. We studied, by flow cytometry and reverse transcription-quantitative polymerase chain reaction (qRT-PCR), if dietary gluten induces changes in the activation of DCs and distribution of selected innate cells in lymphoid, pancreatic and intestinal tissues in BALB/c and NOD mice. We found that a GF diet increased the percentage of macrophages in BALB/c spleen and of CD11c(+) DCs in BALB/c and NOD spleen. Strictly gluten-free (SGF) diet increased the percentage of CD103(+) DCs in BALB/c mice and decreased percentages of CD11b(+) DCs in mesenteric and pancreatic lymph nodes in BALB/c mice. SGF diet in BALB/c mice also decreased DC expression of CD40, CCR7 and MHC-II in pancreatic lymph nodes. In conclusion, GF diet changes the composition of the innate immune system in BALB/c and NOD mice and increases expression of DC activation markers in NOD mice. These results contribute to the explanation of the low diabetes incidence in GF NOD mice. This mechanism may be important in development of type 1 diabetes, celiac disease and non-celiac gluten sensitivity.	[Larsen, Jesper; Weile, Christian; Antvorskov, Julie Christine; Engkilde, Kare; Nielsen, Signe Marie Borch; Josefsen, Knud; Buschard, Karsten] Rigshosp, Bartholin Inst, DK-2100 Copenhagen, Denmark	Rigshospitalet; University of Copenhagen	Larsen, J (corresponding author), Rigshosp, Bartholin Inst, DK-2100 Copenhagen, Denmark.	jelars@gmail.com		Buschard, Karsten/0000-0002-0126-7423	"Kirsten & Freddy Johansens foundation"	"Kirsten & Freddy Johansens foundation"	The study was funded by "Kirsten & Freddy Johansens foundation", http://www.kf-j.dk. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adlercreutz EH, 2014, CLIN EXP IMMUNOL, V177, P391, DOI 10.1111/cei.12340; Antvorskov JC, 2014, DIABETOLOGIA, V57, P1770, DOI 10.1007/s00125-014-3265-1; Antvorskov JC, 2013, IMMUNOLOGY, V138, P23, DOI 10.1111/imm.12007; Antvorskov JC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033315; Auricchio R, 2004, DIABETES, V53, P1680, DOI 10.2337/diabetes.53.7.1680; Badami E, 2011, DIABETES, V60, P2120, DOI 10.2337/db10-1201; Beitnes ACR, 2011, SCAND J IMMUNOL, V74, P186, DOI 10.1111/j.1365-3083.2011.02549.x; Beitnes ACR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033556; Bosi E, 2006, DIABETOLOGIA, V49, P2824, DOI 10.1007/s00125-006-0465-3; Catassi C, 2013, NUTRIENTS, V5, P3839, DOI 10.3390/nu5103839; Chakir H, 2005, DIABETOLOGIA, V48, P1576, DOI 10.1007/s00125-005-1842-z; Cinova J, 2007, J CLIN IMMUNOL, V27, P201, DOI 10.1007/s10875-006-9061-z; Coombes JL, 2008, NAT REV IMMUNOL, V8, P435, DOI 10.1038/nri2335; Coombes JL, 2007, J EXP MED, V204, P1757, DOI 10.1084/jem.20070590; Creusot RJ, 2014, DIABETES, V63, P20, DOI 10.2337/db13-0886; Diana J, 2013, NAT MED, V19, P65, DOI 10.1038/nm.3042; Diana J, 2011, DISCOV MED, V11, P513; Fasano A, 2011, PHYSIOL REV, V91, P151, DOI 10.1152/physrev.00003.2008; Funda DP, 2008, DIABETES-METAB RES, V24, P59, DOI 10.1002/dmrr.748; Funda DP, 1999, DIABETES-METAB RES, V15, P323; Giordani L, 2014, EXP CELL RES, V321, P248, DOI 10.1016/j.yexcr.2013.11.008; Graham S, 2004, GUT, V53, P1437, DOI 10.1136/gut.2004.042481; Hanninen A, 1996, DIABETES, V45, P1173, DOI 10.2337/diabetes.45.9.1173; Hanninen A, 1998, J IMMUNOL, V160, P6018; Hansen CHF, 2014, DIABETES, V63, P2821, DOI 10.2337/db13-1612; Jabri B, 2009, NAT REV IMMUNOL, V9, P858, DOI 10.1038/nri2670; Junker Y, 2012, J EXP MED, V209, P2395, DOI 10.1084/jem.20102660; Kriegel MA, 2012, P NATL ACAD SCI USA, V109, P3457, DOI 10.1073/pnas.1115308109; Larsen J, 2014, EUR J IMMUNOL, V44, P3056, DOI 10.1002/eji.201344264; LAVO B, 1989, AM J MED, V87, P655, DOI 10.1016/0002-9343(89)90726-2; Maurano F, 2005, DIABETOLOGIA, V48, P931, DOI 10.1007/s00125-005-1718-2; Nikulina M, 2004, J IMMUNOL, V173, P1925, DOI 10.4049/jimmunol.173.3.1925; Norris JM, 2003, JAMA-J AM MED ASSOC, V290, P1713, DOI 10.1001/jama.290.13.1713; Palova-Jelinkova L, 2005, J IMMUNOL, V175, P7038, DOI 10.4049/jimmunol.175.10.7038; Pociot F, 2002, GENES IMMUN, V3, P235, DOI 10.1038/sj.gene.6363875; Raki M, 2006, GASTROENTEROLOGY, V131, P428, DOI 10.1053/j.gastro.2006.06.002; Rescigno M, 2009, J CLIN INVEST, V119, P2441, DOI 10.1172/JCI39134; Roep BO, 2013, DIABETES, V62, P1821, DOI 10.2337/db13-0276; Rozen S, 2000, Methods Mol Biol, V132, P365; Schmid S, 2004, CLIN IMMUNOL, V111, P108, DOI 10.1016/j.clim.2003.09.012; Schulz O, 2009, J EXP MED, V206, P3101, DOI 10.1084/jem.20091925; Scott CL, 2011, TRENDS IMMUNOL, V32, P412, DOI 10.1016/j.it.2011.06.003; Scott FW, 2002, DIABETES, V51, P73, DOI 10.2337/diabetes.51.1.73; Sildorf SM, 2012, BMJ CASE REP; Sollid LM, 2013, NAT REV IMMUNOL, V13, P294, DOI 10.1038/nri3407; Terrazzano G, 2007, J IMMUNOL, V179, P372, DOI 10.4049/jimmunol.179.1.372; Troncone R, 2003, AM J GASTROENTEROL, V98, P590, DOI 10.1111/j.1572-0241.2003.07301.x; Tuckova L, 2002, J LEUKOCYTE BIOL, V71, P625; Verdu EF, 2009, AM J GASTROENTEROL, V104, P1587, DOI 10.1038/ajg.2009.188; Worbs T, 2006, J EXP MED, V203, P519, DOI 10.1084/jem.20052016; Yin N, 2012, J IMMUNOL, V188, P4921, DOI 10.4049/jimmunol.1103725; Ziegler AG, 2003, JAMA-J AM MED ASSOC, V290, P1721, DOI 10.1001/jama.290.13.1721	52	21	23	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2015	10	3							e0118618	10.1371/journal.pone.0118618	http://dx.doi.org/10.1371/journal.pone.0118618			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9JM	25738288	Green Published, Green Submitted, gold			2022-12-27	WOS:000350685900055
J	Zhao, F; Li, MH; Wang, ZH; Fu, Z; Cui, YF; Chen, ZQ; Yu, JM				Zhao, Fen; Li, Minghuan; Wang, Zhiheng; Fu, Zheng; Cui, Yunfeng; Chen, Zhaoqiu; Yu, Jinming			F-18-Fluorothymidine PET-CT for Resected Malignant Gliomas before Radiotherapy: Tumor Extent according to Proliferative Activity Compared with MRI	PLOS ONE			English	Article							POSITRON-EMISSION-TOMOGRAPHY; HIGH-GRADE GLIOMAS; BRAIN-TUMORS; 3'-DEOXY-3'-F-18-FLUOROTHYMIDINE PET; COMPUTED-TOMOGRAPHY; CELL PROLIFERATION; TARGET DELINEATION; RADIATION-THERAPY; GLIAL NEOPLASMS; F-18-FLT PET	Objective To compare the presence of post-operative residual disease by magnetic resonance imaging (MRI) and [F-18] fluorothymidine (FLT)-positron emission tomography (PET)-computer tomography (CT) in patients with malignant glioma and to estimate the impact of F-18-FLT PET on the delineation of post-operative target volumes for radiotherapy (RT) planning. Methods Nineteen patients with post-operative residual malignant gliomas were enrolled in this study. For each patient, F-18-FLT PET-CT and MRI were acquired in the same week, within 4 weeks after surgery but before the initiation of RT. The PET-CT and MRI data were co-registered based on mutual information. The residual tumor volume defined on the F-18-FLT PET (Vol-PET) was compared with that of gadolinium [Gd] enhancement on T1-weighted MRI (Vol-T1) and areas of hyperintensity on T2-weighted MRI (Vol-T2). Results The mean Vol-PET (14.61 cm(3)) and Vol-T1 (13.60 cm(3)) were comparable and smaller than the mean Vol-T2 (32.93 cm(3)). The regions of F-18-FLT uptake exceeded the contrast enhancement and the hyperintense area on the MRI in 14 (73.68%) and 8 patients (42.11%), respectively. In 5 (26.32%) of the 19 patients, Vol-PET extended beyond 25 mm from the margin of Vol-T1; in 2 (10.53%) patients, Vol-PET extended 20 mm from the margin of Vol-T2. Vol-PET was detected up to 35 mm away from the edge of Vol-T1 and 24 mm away from the edge of Vol-T2. In 16 (84.21%) of the 19 patients, the Vol-T1 extended beyond the Vol-PET. In all of the patients, at least some of the Vol-T2 was located outside of the Vol-PET. Conclusions The volumes of post-operative residual tumor in patients with malignant glioma defined by F-18-FLT uptake on PET are not always consistent with the abnormalities shown on post-operative MRI. Incorporation of F-18-FLT-PET in tumor delineation may have the potential to improve the definition of target volume in post-operative radiotherapy.	[Zhao, Fen; Li, Minghuan; Fu, Zheng; Chen, Zhaoqiu; Yu, Jinming] Shandong Acad Med Sci, Shandong Canc Hosp, Dept Radiat Oncol, Jinan, Peoples R China; [Zhao, Fen; Li, Minghuan; Yu, Jinming] Shandong Canc Hosp & Inst, Key Lab Radiat Oncol Shandong Prov, Jinan, Shandong, Peoples R China; [Wang, Zhiheng; Cui, Yunfeng] Duke Univ, Med Ctr, Dept Radiat Oncol, Durham, NC USA; [Fu, Zheng] Shandong Canc Hosp & Inst, Dept Nucl Med, Jinan, Shandong, Peoples R China; [Chen, Zhaoqiu] Shandong Canc Hosp & Inst, Dept Radiol, Jinan, Shandong, Peoples R China	Shandong First Medical University & Shandong Academy of Medical Sciences; University of Jinan; Shandong First Medical University & Shandong Academy of Medical Sciences; Duke University; Shandong First Medical University & Shandong Academy of Medical Sciences; Shandong First Medical University & Shandong Academy of Medical Sciences	Yu, JM (corresponding author), Shandong Acad Med Sci, Shandong Canc Hosp, Dept Radiat Oncol, Jinan, Peoples R China.	chinasdyjm@gmail.com			Shandong Academy of Medical Sciences [2012-23]	Shandong Academy of Medical Sciences	Fen Zhao reports research grants from Shandong Academy of Medical Sciences (2012-23), during the conduct of the study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The other authors have nothing to disclose.	Aydin H, 2001, STRAHLENTHER ONKOL, V177, P424, DOI 10.1007/PL00002424; Barajas RF, 2009, RADIOLOGY, V253, P486, DOI 10.1148/radiol.2532090007; Barwick T, 2009, NUCL MED COMMUN, V30, P908, DOI 10.1097/MNM.0b013e32832ee93b; CHAMBERLAIN MC, 1988, NEUROLOGY, V38, P1371, DOI 10.1212/WNL.38.9.1371; Chang EL, 2007, INT J RADIAT ONCOL, V68, P144, DOI 10.1016/j.ijrobp.2006.12.009; Chen W, 2005, J NUCL MED, V46, P945; Choi SJ, 2005, EUR J NUCL MED MOL I, V32, P653, DOI 10.1007/s00259-004-1742-3; Dowling C, 2001, AM J NEURORADIOL, V22, P604; GARDEN AS, 1991, RADIOTHER ONCOL, V20, P99, DOI 10.1016/0167-8140(91)90143-5; Grosu AL, 2005, INT J RADIAT ONCOL, V63, P64, DOI 10.1016/j.ijrobp.2005.01.045; Grosu AL, 2003, INT J RADIAT ONCOL, V56, P1450, DOI 10.1016/S0360-3016(03)00279-7; Gupta RK, 2000, J NEURO-ONCOL, V50, P215, DOI 10.1023/A:1006431120031; HOCHBERG FH, 1980, NEUROLOGY, V30, P907, DOI 10.1212/WNL.30.9.907; Idema AJS, 2012, J NUCL MED, V53, P1904, DOI 10.2967/jnumed.112.105544; Jacobs AH, 2005, J NUCL MED, V46, P1948; Kaschten B, 1998, J NUCL MED, V39, P778; KELLY PJ, 1987, MAYO CLIN PROC, V62, P450, DOI 10.1016/S0025-6196(12)65470-6; KELLY PJ, 1987, J NEUROSURG, V66, P865, DOI 10.3171/jns.1987.66.6.0865; Kirkby NF, 2007, J THEOR BIOL, V245, P112, DOI 10.1016/j.jtbi.2006.09.007; Lee IH, 2009, INT J RADIAT ONCOL, V73, P479, DOI 10.1016/j.ijrobp.2008.04.050; Majos C, 2002, RADIOLOGY, V225, P556, DOI 10.1148/radiol.2252011592; Mardor Y, 2003, J CLIN ONCOL, V21, P1094, DOI 10.1200/JCO.2003.05.069; Matsuo M, 2012, INT J RADIAT ONCOL, V82, P83, DOI 10.1016/j.ijrobp.2010.09.020; Meral R, 2006, CLIN ONCOL, V18, P93; MOSSKIN M, 1989, ACTA RADIOL, V30, P225; NELSON DF, 1993, INT J RADIAT ONCOL, V25, P193, DOI 10.1016/0360-3016(93)90340-2; OGAWA T, 1993, RADIOLOGY, V186, P45, DOI 10.1148/radiology.186.1.8380108; Pirzkall A, 2001, INT J RADIAT ONCOL, V50, P915, DOI 10.1016/S0360-3016(01)01548-6; Rieken S, 2013, RADIOTHER ONCOL, V109, P487, DOI 10.1016/j.radonc.2013.06.043; Saga T, 2006, CLIN NUCL MED, V31, P774, DOI 10.1097/01.rlu.0000246820.14892.d2; Schwarzenberg J, 2012, J NUCL MED, V53, P29, DOI 10.2967/jnumed.111.092387; Sherriff J, 2013, BRIT J RADIOL, V86, DOI 10.1259/bjr.20120414; Spence AM, 2009, MOL IMAGING BIOL, V11, P343, DOI 10.1007/s11307-009-0215-2; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; THORNTON AF, 1992, INT J RADIAT ONCOL, V24, P767, DOI 10.1016/0360-3016(92)90727-Y; Ullrich R, 2008, CLIN CANCER RES, V14, P2049, DOI 10.1158/1078-0432.CCR-07-1553; Urtasun RC, 1996, INT J RADIAT ONCOL, V36, P1163, DOI 10.1016/S0360-3016(96)00429-4; WATANABE M, 1992, NEURORADIOLOGY, V34, P463, DOI 10.1007/BF00598951; Wen PY, 2010, J CLIN ONCOL, V28, P1963, DOI 10.1200/JCO.2009.26.3541; Yue JB, 2010, J NUCL MED, V51, P528, DOI 10.2967/jnumed.109.072124	40	12	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2015	10	3							e0118769	10.1371/journal.pone.0118769	http://dx.doi.org/10.1371/journal.pone.0118769			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9JM	25738617	Green Submitted, Green Published, gold			2022-12-27	WOS:000350685900067
J	Abass, E; Kang, C; Martinkovic, F; Semiao-Santos, SJ; Sundar, S; Walden, P; Piarroux, R; el Harith, A; Lohoff, M; Steinhoff, U				Abass, Elfadil; Kang, Cholho; Martinkovic, Franjo; Semiao-Santos, Saul J.; Sundar, Shyam; Walden, Peter; Piarroux, Renaud; el Harith, Abdallah; Lohoff, Michael; Steinhoff, Ulrich			Heterogeneity of Leishmania donovani Parasites Complicates Diagnosis of Visceral Leishmaniasis: Comparison of Different Serological Tests in Three Endemic Regions	PLOS ONE			English	Article							DIRECT AGGLUTINATION-TEST; SUDANESE PATIENTS; KALA-AZAR; INFANTUM; ANTIGEN; PREVALENCE; EXPRESSION; ANTIBODIES; DIVERSITY; INFECTION	Diagnostic tests for visceral leishmaniasis that are based on antigens of a single Leishmania strain can have low diagnostic performance in regions where heterologous parasites predominate. The aim of this study was to investigate and compare the performance of five serological tests, based on different Leishmania antigens, in three endemic countries for visceral leishmaniasis. A total number of 231 sera of symptomatic and asymptomatic cases and controls from three endemic regions of visceral leishmaniasis in East Sudan, North India and South France were evaluated by following serological tests: rKLO8-and rK39 ELISA, DAT (ITMA-DAT) and two rapid tests of rK39 (IT LEISH) and rKE16 (Signal-KA). Overall, rKLO8-and rK39 ELISA were most sensitive in immunocompetent patients from all endemic regions (96-100%) and the sensitivity was reduced to 81.8% in HIV co-infected patients from France. Sera of patients from India demonstrated significantly higher antibody responses to rKLO8 and rK39 compared with sera from Sudan (p<0.0001) and France (p<0.0037). Further, some Indian and Sudanese patients reacted better with rKLO8 than rK39. Sensitivity of DAT (ITMA-DAT) was high in Sudan (94%) and India (92.3%) but low in France being 88.5% and 54.5% for VL and VL/HIV patients, respectively. In contrast, rapid tests displayed high sensitivity only in patients from India (96.2%) but not Sudan (64-88%) and France (73.1-88.5% and 63.6-81.8% in VL and VL/HIV patients, respectively). While the sensitivity varied, all tests showed high specificity in Sudan (96.7-100%) and India (96.6%). Heterogeneity of Leishmania parasites which is common in many endemic regions complicates the diagnosis of visceral leishmaniasis. Therefore, tests based on homologous Leishmania antigens are required for particular endemic regions to detect cases which are difficult to be diagnosed with currently available tests.	[Abass, Elfadil; Kang, Cholho; Lohoff, Michael; Steinhoff, Ulrich] Univ Marburg, Inst Med Microbiol & Hyg, D-35043 Marburg, Germany; [Abass, Elfadil; el Harith, Abdallah] Ahfad Univ Women, Biomed Res Lab, Omdurman, Sudan; [Abass, Elfadil] Sudan Int Univ, Fac Med Lab Sci, Khartoum, Sudan; [Martinkovic, Franjo] Univ Zagreb, Fac Vet Med, Dept Parasitol & Parasit Dis Clin, Zagreb 10000, Croatia; [Semiao-Santos, Saul J.] Univ Tiradentes UNIT, Dept Nursing, BR-49032490 Aracaju, Sergipe, Brazil; [Sundar, Shyam] Banaras Hindu Univ, Inst Med Sci, Varanasi 221005, Uttar Pradesh, India; [Walden, Peter] Charite, D-10117 Berlin, Germany; [Piarroux, Renaud] Aix Marseille Univ, UMR MD3, Marseille, France	Philipps University Marburg; University of Zagreb; Universidade Tiradentes; Banaras Hindu University (BHU); Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; UDICE-French Research Universities; Aix-Marseille Universite	Abass, E (corresponding author), Univ Marburg, Inst Med Microbiol & Hyg, D-35043 Marburg, Germany.	elfadil_abass@yahoo.com; ulrich.steinhoff@staff.uni-marburg.de	Abass, Elfadil/AAF-5259-2019	Semeao-Santos, Saul/0000-0001-8791-3408; Steinhoff, Ulrich/0000-0003-2141-7756; piarroux, renaud/0000-0002-4151-4134				Abass E, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002322; Abass EM, 2007, J MED MICROBIOL, V56, P1256, DOI 10.1099/jmm.0.47267-0; Alam MZ, 2009, INFECT GENET EVOL, V9, P24, DOI 10.1016/j.meegid.2008.09.005; Alvar J, 1997, CLIN MICROBIOL REV, V10, P298, DOI 10.1128/CMR.10.2.298; Bhattacharyya T, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002675; Bhattacharyya T, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002057; Boelaert M, 1999, TROP MED INT HEALTH, V4, P31, DOI 10.1046/j.1365-3156.1999.00348.x; CARVALHO EM, 1981, INFECT IMMUN, V33, P498, DOI 10.1128/IAI.33.2.498-500.1981; Chappuis F, 2007, NAT REV MICROBIOL, V5, P873, DOI 10.1038/nrmicro1748; Cunningham J, 2012, CLIN INFECT DIS, V55, P1312, DOI 10.1093/cid/cis716; ELHARITH A, 1995, J CLIN MICROBIOL, V33, P1984, DOI 10.1128/JCM.33.8.1984-1988.1995; Forgber M, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000040; Gelanew T, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000889; Hamad SH, 2010, EXP PARASITOL, V125, P389, DOI 10.1016/j.exppara.2010.03.008; Hamzavi Y, 2012, IRAN J PARASITOL, V7, P49; Jamjoom MB, 2004, PARASITOLOGY, V129, P399, DOI 10.1017/S0031182004005955; Kuhls K, 2007, MICROBES INFECT, V9, P334, DOI 10.1016/j.micinf.2006.12.009; Maia Z, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001484; MARY C, 1992, AM J TROP MED HYG, V47, P764, DOI 10.4269/ajtmh.1992.47.764; Medrano FJ, 1998, AM J TROP MED HYG, V59, P155, DOI 10.4269/ajtmh.1998.59.155; MENGISTU G, 1990, T ROY SOC TROP MED H, V84, P359, DOI 10.1016/0035-9203(90)90317-8; Mueller M, 2007, T ROY SOC TROP MED H, V101, P19, DOI 10.1016/j.trstmh.2006.02.005; Newcombe RG, 1998, STAT MED, V17, P873, DOI 10.1002/(SICI)1097-0258(19980430)17:8<873::AID-SIM779>3.0.CO;2-I; Nuwayri-Salti N, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001782; Oshaghi MA, 2009, EXP PARASITOL, V123, P218, DOI 10.1016/j.exppara.2009.07.004; Ostyn B, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001284; Pattabhi S, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000822; PIARROUX R, 1994, J CLIN MICROBIOL, V32, P746, DOI 10.1128/JCM.32.3.746-749.1994; Picado A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087641; Romero HD, 2009, AM J TROP MED HYG, V81, P27; SHIDDO SA, 1995, T ROY SOC TROP MED H, V89, P21, DOI 10.1016/0035-9203(95)90640-1; Sivakumar R, 2006, PROTEIN EXPRES PURIF, V46, P156, DOI 10.1016/j.pep.2005.07.027; Sivakumar R, 2008, INFECT GENET EVOL, V8, P313, DOI 10.1016/j.meegid.2008.02.004; Thakur CP, 2007, INDIAN J MED RES, V126, P447; Topno RK, 2010, AM J TROP MED HYG, V83, P502, DOI 10.4269/ajtmh.2010.09-0345; van den Bogaart E, 2014, BMC IMMUNOL, V15, DOI 10.1186/1471-2172-15-16; van den Bogaart E, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001617	37	42	44	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2015	10	3							e0116408	10.1371/journal.pone.0116408	http://dx.doi.org/10.1371/journal.pone.0116408			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4HV	25734336	gold, Green Published, Green Submitted			2022-12-27	WOS:000350314700004
J	Enright, J; Kao, RR				Enright, Jessica; Kao, Rowland R.			A Few Bad Apples: A Model of Disease Influenced Agent Behaviour in a Heterogeneous Contact Environment	PLOS ONE			English	Article							BOVINE TUBERCULOSIS; MOUTH-DISEASE; CATTLE; BVD	For diseases that infect humans or livestock, transmission dynamics are at least partially dependent on human activity and therefore human behaviour. However, the impact of human behaviour on disease transmission is relatively understudied, especially in the context of heterogeneous contact structures such as described by a social network. Here, we use a strategic game, coupled with a simple disease model, to investigate how strategic agent choices impact the spread of disease over a contact network. Using beliefs that are based on disease status and that build up over time, agents choose actions that stochastically determine disease spread on the network. An agent's disease status is therefore a function of both his own and his neighbours actions. The effect of disease on agents is modelled by a heterogeneous payoff structure. We find that the combination of network shape and distribution of payoffs has a non-trivial impact on disease prevalence, even if the mean payoff remains the same. An important scenario occurs when a small percentage (called noncooperators) have little incentive to avoid disease. For diseases that are easily acquired when taking a risk, then even when good behavior can lead to disease eradication, a small increase in the percentage of noncooperators (less than 5%) can yield a large (up to 25%) increase in prevalence.				Jessica.Enright@glasgow.ac.uk; Rowland.Kao@glasgow.ac.uk		Enright, Jessica/0000-0002-0266-3292; Kao, Rowland/0000-0003-0919-6401	EPIC (Epidemiology, Population health and Infectious disease Control)	EPIC (Epidemiology, Population health and Infectious disease Control)	This work was supported by EPIC (Epidemiology, Population health and Infectious disease Control), website at: http://epicscotland.org/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bauch CT, 2013, SCIENCE, V342, P47, DOI 10.1126/science.1244492; Bauch CT, 2004, P NATL ACAD SCI USA, V101, P13391, DOI 10.1073/pnas.0403823101; Funk S, 2010, J R SOC INTERFACE, V7, P1247, DOI 10.1098/rsif.2010.0142; Gilbert M, 2005, NATURE, V435, P491, DOI 10.1038/nature03548; Gintis H., 2000, GAME THEORY EVOLVING; Green DM, 2008, P R SOC B, V275, P1001, DOI 10.1098/rspb.2007.1601; Gunn GJ, 2004, VET J, V167, P143, DOI 10.1016/S1090-0233(03)00112-6; Heffernan C, 2008, PREV VET MED, V87, P358, DOI 10.1016/j.prevetmed.2008.05.007; McElreath R., 2007, MATH MODELS SOCIAL E; Moennig Volker, 2005, Animal Health Research Reviews, V6, P63, DOI 10.1079/AHR2005102; Nisan N, 2007, ALGORITHMIC GAME THEORY, P1, DOI 10.1017/CBO9780511800481; Reluga TC, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000793; Rich KM, 2007, AM J AGR ECON, V89, P682, DOI 10.1111/j.1467-8276.2007.01006.x; Rich KM, 2005, REV AGR ECON, V27, P456, DOI 10.1111/j.1467-9353.2005.00244.x; Skuce RA, 2012, VET MED INT, P1, DOI [10.1155/2012/621210, DOI 10.1155/2012/621210]; Stott AW, 2003, PREV VET MED, V59, P51, DOI 10.1016/S0167-5877(03)00062-X; The Scottish Government, VET GUID BVD ER PHAS	17	7	7	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2015	10	3							e0118127	10.1371/journal.pone.0118127	http://dx.doi.org/10.1371/journal.pone.0118127			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4HV	25734661	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000350314700016
J	Santoni, G; Angleman, S; Welmer, AK; Mangialasche, F; Marengoni, A; Fratiglioni, L				Santoni, Gioia; Angleman, Sara; Welmer, Anna-Karin; Mangialasche, Francesca; Marengoni, Alessandra; Fratiglioni, Laura			Age-Related Variation in Health Status after Age 60	PLOS ONE			English	Article							MINI-MENTAL-STATE; PHYSICAL PERFORMANCE; MORTALITY; MULTIMORBIDITY; POPULATIONS; EDUCATION; SURVIVAL; DEMENTIA; SPEED	Background Disability, functionality, and morbidity are often used to describe the health of the elderly. Although particularly important when planning health and social services, knowledge about their distribution and aggregation at different ages is limited. We aim to characterize the variation of health status in a 60+ old population using five indicators of health separately and in combination. Methods 3080 adults 60+ living in Sweden between 2001 and 2004 and participating at the SNAC-K population-based cohort study. Health indicators: number of chronic diseases, gait speed, Mini Mental State Examination (MMSE), disability in instrumental-activities of daily living (I-ADL), and in personal-ADL (P-ADL). Results Probability of multimorbidity and probability of slow gait speed were already above 60% and 20% among sexagenarians. Median MMSE and median I-ADL showed good performance range until age 84; median P-ADL was close to zero up to age 90. Thirty% of sexagenarians and 11% of septuagenarians had no morbidity and no impairment, 92% and 80% of them had no disability. Twenty-eight% of octogenarians had multimorbidity but only 27% had some I-ADL disability. Among nonagenarians, 13% had severe disability and impaired functioning while 12% had multimorbidity and slow gait speed. Conclusions Age 80-85 is a transitional period when major health changes take place. Until age 80, most people do not have functional impairment or disability, despite the presence of chronic disorders. Disability becomes common only after age 90. This implies an increasing need of medical care after age 70, whereas social care, including institutionalization, becomes a necessity only in nonagenarians.	[Santoni, Gioia; Angleman, Sara; Welmer, Anna-Karin; Mangialasche, Francesca; Fratiglioni, Laura] Karolinska Inst, Dept Neurobiol Care Sci & Soc, Aging Res Ctr, Stockholm, Sweden; [Santoni, Gioia; Angleman, Sara; Welmer, Anna-Karin; Mangialasche, Francesca; Fratiglioni, Laura] Stockholm Univ, S-10691 Stockholm, Sweden; [Welmer, Anna-Karin] Karolinska Univ Hosp, Stockholm, Sweden; [Mangialasche, Francesca] Univ Perugia, Dept Med, Sect Gerontol & Geriatr, I-06100 Perugia, Italy; [Marengoni, Alessandra] Univ Brescia, Dept Clin & Expt Sci, Geriatr Unit, Brescia, Italy; [Fratiglioni, Laura] Karolinska Inst, Stockholm Gerontol Res Ctr, Dept Neurobiol Care Sci & Soc, Stockholm, Sweden	Karolinska Institutet; Stockholm University; Karolinska Institutet; Karolinska University Hospital; University of Perugia; University of Brescia; Karolinska Institutet	Santoni, G (corresponding author), Karolinska Inst, Dept Neurobiol Care Sci & Soc, Aging Res Ctr, Stockholm, Sweden.	giola.santoni@ki.se	Welmer, Anna-Karin/AAL-3446-2021	Santoni, Giola/0000-0002-9094-5037; Welmer, Anna-Karin/0000-0001-5819-8724; Angleman, Sara/0000-0002-9520-5716; Mangialasche, Francesca/0000-0002-2686-3926; marengoni, alessandra/0000-0002-4851-1825	Ministry of Health and Social Affairs, Sweden; Ragnhild och Einar Lundstroms Minne foundation [LA2013-0412]; Swedish Research Council	Ministry of Health and Social Affairs, Sweden; Ragnhild och Einar Lundstroms Minne foundation; Swedish Research Council(Swedish Research CouncilEuropean Commission)	The Swedish National study on Aging and Care, SNAC, (www.snac.org) is financially supported by the Ministry of Health and Social Affairs, Sweden; the participating county councils and municipalities; and the Swedish Research Council. In addition, a specific grant (LA2013-0412) was obtained from Ragnhild och Einar Lundstroms Minne foundation (http://www.lindhes.se/stiftelseforvaltning/ansokanom-bidrag). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguero-Torres H, 1998, AM J PUBLIC HEALTH, V88, P1452, DOI 10.2105/AJPH.88.10.1452; Baltes PB, 2003, GERONTOLOGY, V49, P123, DOI 10.1159/000067946; Bottai M, 2010, STAT MED, V29, P309, DOI 10.1002/sim.3781; Christensen K, 2009, LANCET, V374, P1196, DOI 10.1016/S0140-6736(09)61460-4; Collerton J, 2009, BMJ, V339; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; GURALNIK JM, 1994, J GERONTOL, V49, pM85, DOI 10.1093/geronj/49.2.M85; Jacobs JM, 2012, GERONTOLOGY, V58, P313, DOI 10.1159/000335238; Lafortune L, 2009, MED CARE, V47, P286, DOI 10.1097/MLR.0b013e3181894293; Lagergren M, 2004, AGING CLIN EXP RES, V16, P158; Lee SJ, 2008, AM J PUBLIC HEALTH, V98, P1209, DOI 10.2105/AJPH.2007.130955; Lleras-Muney A, 2005, REV ECON STUD, V72, P189, DOI 10.1111/0034-6527.00329; Lowsky DJ, 2013, J GERONTOL A-BIOL; Marengoni Alessandra, 2011, J Comorb, V1, P11; Marengoni A, 2011, AGEING RES REV, V10, P430, DOI 10.1016/j.arr.2011.03.003; Mcdowell I., 2006, MEASURING HLTH GUIDE, V3, P37, DOI [DOI 10.1093/ACPROF:OSO/9780195165678.001.0001, 10.1093/acprof:oso/9780195165678.001.0001]; Menotti A, 2001, J CLIN EPIDEMIOL, V54, P680, DOI 10.1016/S0895-4356(00)00368-1; Mitchell AJ, 2009, J PSYCHIATR RES, V43, P411, DOI 10.1016/j.jpsychires.2008.04.014; NEUGARTEN BL, 1974, ANN AM ACAD POLIT SS, V415, P187, DOI 10.1177/000271627441500114; Njegovan V, 2001, J GERONTOL A-BIOL, V56, pM638, DOI 10.1093/gerona/56.10.M638; Rizzuto D, 2012, BMJ, V345; Schwenk M, 2014, GERONTOLOGY, V60, P79, DOI 10.1159/000354211; Studenski S, 2011, JAMA-J AM MED ASSOC, V305, P50, DOI 10.1001/jama.2010.1923; Van Buuren S, 1999, STAT MED, V18, P681, DOI 10.1002/(SICI)1097-0258(19990330)18:6<681::AID-SIM71>3.0.CO;2-R; von Haehling S, 2012, J CACHEXIA SARCOPENI, V3, P213, DOI 10.1007/s13539-012-0089-z; Welmer AK, 2014, J GERONTOL A-BIOL; Welmer AK, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-641; Welmer AK, 2012, AGING CLIN EXP RES, V24, P480, DOI 10.3275/8584	28	78	78	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2015	10	3							e0120077	10.1371/journal.pone.0120077	http://dx.doi.org/10.1371/journal.pone.0120077			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CC4HV	25734828	gold, Green Published, Green Submitted			2022-12-27	WOS:000350314700066
J	Wang, XQ; Lu, ML; Shi, Y; Ou, Y; Cheng, XD				Wang, Xuequan; Lu, Meiling; Shi, Yang; Ou, Yu; Cheng, Xiaodong			Discovery of Novel New Delhi Metallo-beta-Lactamases-1 Inhibitors by Multistep Virtual Screening	PLOS ONE			English	Article							METALLO-BETA-LACTAMASE; ANTIBIOTIC-RESISTANCE; CRYSTAL-STRUCTURE; KLEBSIELLA-PNEUMONIAE; ESCHERICHIA-COLI; NDM-1; ZINC; DOCKING; DISSEMINATION; RECOGNITION	The emergence of NDM-1 containing multi-antibiotic resistant "Superbugs" necessitates the needs of developing of novel NDM-1inhibitors. In this study, we report the discovery of novel NDM-1 inhibitors by multi-step virtual screening. From a 2,800,000 virtual drug-like compound library selected from the ZINC database, we generated a focused NDM-1 inhibitor library containing 298 compounds of which 44 chemical compounds were purchased and evaluated experimentally for their ability to inhibit NDM-1 in vitro. Three novel NDM-1 inhibitors with micromolar IC50 values were validated. The most potent inhibitor, VNI-41, inhibited NDM-1 with an IC50 of 29.6 +/- 1.3 mu M. Molecular dynamic simulation revealed that VNI-41 interacted extensively with the active site. In particular, the sulfonamide group of VNI-41 interacts directly with the metal ion Zn1 that is critical for the catalysis. These results demonstrate the feasibility of applying virtual screening methodologies in identifying novel inhibitors for NDM-1, a metallo-beta-lactamase with a malleable active site and provide a mechanism base for rational design of NDM-1 inhibitors using sulfonamide as a functional scaffold.				ouyu2008@126.com; xiaodong.cheng@uth.tmc.ectu	Cheng, Xiaodong/O-8176-2019	Cheng, Xiaodong/0000-0002-3479-1694	National Natural Science Foundation of China [81302795, 81328023]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (No: 81302795 and No: 81328023). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMBLER RP, 1980, PHILOS T R SOC B, V289, P321, DOI 10.1098/rstb.1980.0049; Arpin C, 2012, ANTIMICROB AGENTS CH, V56, P3432, DOI 10.1128/AAC.00230-12; Attene-Ramos M.S., 2014, ENCY TOXICOLOGY, V3rd, P916, DOI DOI 10.1016/B978-0-12-386454-3.00209-8; Bradford PA, 2001, CLIN MICROBIOL REV, V14, P933, DOI 10.1128/CMR.14.4.933-951.2001; Brown MC, 2014, METHODS MOL BIOL, V1084, P227, DOI 10.1007/978-1-62703-658-0_12; Bush K, 1998, CLIN INFECT DIS, V27, pS48, DOI 10.1086/514922; Chen J., 2013, AM J BIOMED RES, V1, P120, DOI DOI 10.12691/AJBR-1-4-8; Cole JC, 2005, PROTEINS, V60, P325, DOI 10.1002/prot.20497; DALE JW, 1985, FEBS LETT, V191, P39, DOI 10.1016/0014-5793(85)80989-3; Docquier JD, 2003, J ANTIMICROB CHEMOTH, V51, P257, DOI 10.1093/jac/dkg067; Docquier JD, 2010, ANTIMICROB AGENTS CH, V54, P4343, DOI 10.1128/AAC.00409-10; Dundas J, 2006, NUCLEIC ACIDS RES, V34, pW116, DOI 10.1093/nar/gkl282; Fast W, 2013, BBA-PROTEINS PROTEOM, V1834, P1648, DOI 10.1016/j.bbapap.2013.04.024; Feher M, 2000, J CHEM INF COMP SCI, V40, P495, DOI 10.1021/ci9900682; Fisher JF, 2005, CHEM REV, V105, P395, DOI 10.1021/cr030102i; Galleni M, 2001, ANTIMICROB AGENTS CH, V45, P660, DOI 10.1128/AAC.45.3.660-663.2001; Goto J, 2004, J MED CHEM, V47, P6804, DOI 10.1021/jm0493818; Green VL, 2011, ACTA CRYSTALLOGR F, V67, P1160, DOI 10.1107/S1744309111029654; Guo Y, 2011, PROTEIN CELL, V2, P384, DOI 10.1007/s13238-011-1055-9; Haas Juergen, 2013, Database (Oxford), V2013, pbat031, DOI 10.1093/database/bat031; Halgren TA, 1999, J COMPUT CHEM, V20, P720, DOI 10.1002/(SICI)1096-987X(199905)20:7<720::AID-JCC7>3.0.CO;2-X; Hu X, 2004, J MOL GRAPH MODEL, V22, P293, DOI 10.1016/j.jmgm.2003.11.002; Hu X, 2003, J MOL GRAPH MODEL, V22, P115, DOI 10.1016/S1093-3263(03)00153-0; Irwin JJ, 2005, BIOCHEMISTRY-US, V44, P12316, DOI 10.1021/bi050801k; Irwin JJ, 2005, J CHEM INF MODEL, V45, P177, DOI 10.1021/ci049714+; Isozumi R, 2012, EMERG INFECT DIS, V18, P1383, DOI 10.3201/eid1808.111816; JAURIN B, 1981, P NATL ACAD SCI-BIOL, V78, P4897, DOI 10.1073/pnas.78.8.4897; Karthikeyan K, 2010, J ANTIMICROB CHEMOTH, V65, P2253, DOI 10.1093/jac/dkq273; Kim Young Sook, 2011, Evid Based Complement Alternat Med, V2011, P761859, DOI 10.1093/ecam/nep078; Kim Y, 2013, FASEB J, V27, P1917, DOI 10.1096/fj.12-224014; King D, 2011, PROTEIN SCI, V20, P1484, DOI 10.1002/pro.697; King DT, 2012, J AM CHEM SOC, V134, P11362, DOI 10.1021/ja303579d; Kumarasamy KK, 2010, LANCET INFECT DIS, V10, P597, DOI 10.1016/S1473-3099(10)70143-2; Labute P, 2005, J CHEM INF MODEL, V45, P215, DOI 10.1021/ci049915d; Laxminarayan R, 2013, LANCET INFECT DIS, V13, P1057, DOI 10.1016/S1473-3099(13)70318-9; Li T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061914; Marcou G, 2007, J CHEM INF MODEL, V47, P195, DOI 10.1021/ci600342e; McGovern SL, 2003, J MED CHEM, V46, P4265, DOI 10.1021/jm030266r; Mincione F, 2007, CURR TOP MED CHEM, V7, P849, DOI 10.2174/156802607780636735; Mohamed MS, 2011, EUR J MED CHEM, V46, P6075, DOI 10.1016/j.ejmech.2011.10.030; Morar M, 2010, ANNU REV GENET, V44, P25, DOI 10.1146/annurev-genet-102209-163517; Olsen L, 2004, J COMPUT AID MOL DES, V18, P287, DOI 10.1023/B:JCAM.0000046821.15502.71; Rollinger Judith M., 2008, V65; Selevsek N, 2009, J BIOL CHEM, V284, P16419, DOI 10.1074/jbc.M109.001305; Shahid M, 2011, LANCET INFECT DIS, V11, P334, DOI 10.1016/S1473-3099(11)70074-3; Shen BZ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062955; Stone NRH, 2011, J ANTIMICROB CHEMOTH, V66, P2677, DOI 10.1093/jac/dkr337; Tamilselvi A, 2008, J BIOL INORG CHEM, V13, P1039, DOI 10.1007/s00775-008-0407-2; Thomas PW, 2013, BIOORGAN MED CHEM, V21, P3138, DOI 10.1016/j.bmc.2013.03.031; U.S. Centers for Disease Control and Prevention, ANTIBIOTIC RESISTANC; Wailan AM, 2014, EXPERT REV ANTI-INFE, V12, P91, DOI 10.1586/14787210.2014.856756; Walsh TR, 2011, LANCET INFECT DIS, V11, P355, DOI 10.1016/S1473-3099(11)70059-7; Wildman SA, 2001, J CHEM INF COMP SCI, V41, P446, DOI 10.1021/ci0000880; Yong D, 2009, ANTIMICROB AGENTS CH, V53, P5046, DOI 10.1128/AAC.00774-09; Yuan QH, 2012, ANTIMICROB AGENTS CH, V56, P5157, DOI 10.1128/AAC.05896-11; Zhang HM, 2011, FASEB J, V25, P2574, DOI 10.1096/fj.11-184036	57	20	24	2	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2015	10	3							e0118290	10.1371/journal.pone.0118290	http://dx.doi.org/10.1371/journal.pone.0118290			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4HV	25734558	Green Published, Green Submitted, gold			2022-12-27	WOS:000350314700021
J	Sloan, L; Morgan, J; Burnap, P; Williams, M				Sloan, Luke; Morgan, Jeffrey; Burnap, Pete; Williams, Matthew			Who Tweets? Deriving the Demographic Characteristics of Age, Occupation and Social Class from Twitter User Meta-Data	PLOS ONE			English	Article							BEHAVIOR	This paper specifies, designs and critically evaluates two tools for the automated identification of demographic data (age, occupation and social class) from the profile descriptions of Twitter users in the United Kingdom (UK). Meta-data data routinely collected through the Collaborative Social Media Observatory (COSMOS: http://www.cosmosproject.net/) relating to UK Twitter users is matched with the occupational lookup tables between job and social class provided by the Office for National Statistics (ONS) using SOC2010. Using expert human validation, the validity and reliability of the automated matching process is critically assessed and a prospective class distribution of UK Twitter users is offered with 2011 Census baseline comparisons. The pattern matching rules for identifying age are explained and enacted following a discussion on how to minimise false positives. The age distribution of Twitter users, as identified using the tool, is presented alongside the age distribution of the UK population from the 2011 Census. The automated occupation detection tool reliably identifies certain occupational groups, such as professionals, for which job titles cannot be confused with hobbies or are used in common parlance within alternative contexts. An alternative explanation on the prevalence of hobbies is that the creative sector is overrepresented on Twitter compared to 2011 Census data. The age detection tool illustrates the youthfulness of Twitter users compared to the general UK population as of the 2011 Census according to proportions, but projections demonstrate that there is still potentially a large number of older platform users. It is possible to detect "signatures" of both occupation and age from Twitter meta-data with varying degrees of accuracy (particularly dependent on occupational groups) but further confirmatory work is needed.	[Sloan, Luke; Williams, Matthew] Cardiff Univ, Cardiff Sch Social Sci, Cardiff CF10 3AX, S Glam, Wales; [Morgan, Jeffrey; Burnap, Pete] Cardiff Univ, Cardiff Sch Comp Sci & Informat, Cardiff CF10 3AX, S Glam, Wales	Cardiff University; Cardiff University	Sloan, L (corresponding author), Cardiff Univ, Cardiff Sch Social Sci, Cardiff CF10 3AX, S Glam, Wales.	SloanLS@cardiff.ac.uk	Williams, Matthew/E-9688-2016	Williams, Matthew/0000-0003-2566-6063; Burnap, Pete/0000-0003-0396-633X	Jisc; Economic and Social Research Council [ES/J009903/1, ES/K008013/1, ES/M003329/1]; National Centre Research for Methods; High Performance Computing Wales (Scaling the Computational Analysis of "Big Social Data" & Massive Temporal Social Media Datasets); Economic and Social Research Council [ES/F035098/1] Funding Source: researchfish; ESRC [ES/F035098/1, ES/J009903/1, ES/M003329/1, ES/K008013/1] Funding Source: UKRI	Jisc; Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); National Centre Research for Methods; High Performance Computing Wales (Scaling the Computational Analysis of "Big Social Data" & Massive Temporal Social Media Datasets); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))	The Collaborative Online Social Media Observatory (COSMOS) has received funding for platform development from Jisc (http://www.jisc.ac.uk/whatwedo/programmes/di_research/researchtools/COSMOS.aspx), the Economic and Social Research Council (ES/J009903/1, ES/K008013/1, ES/M003329/1), the National Centre Research for Methods (http://www.ncrm.ac.uk/research/MIP/prediction.php) and High Performance Computing Wales (Scaling the Computational Analysis of "Big Social Data" & Massive Temporal Social Media Datasets). Details of all other awards associated with the project can be found on the COSMOS website (http://www.cosmosproject.net/). However, the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackland R., 2013, WEB SOCIAL SCI CONCE; anetzko D, 2014, NETNOMICS EC RES ELE, P1, DOI DOI 10.1007/S11066-014-9087-Y; ARGAMON S, 2006, TEXT INTERDISCIPLINA, V23, P321; Asur S., 2010, Proceedings 2010 IEEE/ACM International Conference on Web Intelligence-Intelligent Agent Technology (WI-IAT), P492, DOI 10.1109/WI-IAT.2010.63; Bechar-Israeli H., 1995, JCMC127 J COMPUTER M, V1, DOI [10.1111/j.1083-6101.1995.tb00325, DOI 10.1111/J.1083-6101.1995.TB00325]; BIS, 2013, SEIZ DAT OPP STRAT U; Burnap P, 2015, TECHNOL FORECAST SOC, V95, P96, DOI 10.1016/j.techfore.2013.04.013; Burnap P, 2015, INT J PARALLEL EMERG, V30, P80, DOI 10.1080/17445760.2014.902057; Burnap P, 2013, INT J SOC RES METHOD, V16, P215, DOI 10.1080/13645579.2013.774174; Duggan M, 2013, DEMOGRAPHICS SOCIAL; Edwards A, 2013, INT J SOC RES METHOD, V16, P245, DOI 10.1080/13645579.2013.774185; Erikson Robert, 1992, CONSTANT FLUX; Gayo-Avello D., 2012, I WANTED PREDICT ELE; Ginsberg J, 2009, NATURE, V457, P1012, DOI 10.1038/nature07634; Goel S, 2010, P NATL ACAD SCI USA, V107, P17486, DOI 10.1073/pnas.1005962107; Goldthorpe J. H., 1997, CONSTRUCTING CLASSES; Goldthorpe J. H., 2007, SOCIOLOGY, V2, P101; Grasmuck S, 2009, J COMPUT-MEDIAT COMM, V15, P158, DOI 10.1111/j.1083-6101.2009.01498.x; HESA, 2014, UK PERF IND DEF; Housley W, 2014, BIG DATA SOC, V1, DOI 10.1177/2053951714545135; Ipsos MediaCT, 2014, TECH TRACK Q REL Q3; Joinson A. N, 2003, UNDERSTANDING PSYCHO; Markham A. N, 1998, LIFE ONLINE RES REAL; Mestyan M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071226; Moat HS, 2014, BEHAV BRAIN SCI, V37, P92, DOI 10.1017/S0140525X13001817; NatCen, 2014, RES US SOC MED US VI; Noguchi T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095209; ONS, 2014, NAT STAT SOC CLASS N; Papaioannou P, 2013, NETNOMICS, V14, P47, DOI 10.1007/s11066-013-9079-3; Parker M, 2010, WORLD WIDE RES RESHA; Rosenquist J., 2021, P INT AAAI C WEB SOC, V5, P554; Savage M, 2007, SOCIOLOGY, V41, P885, DOI 10.1177/0038038507080443; Savage M, 2013, SOCIOLOGY, V47, P219, DOI 10.1177/0038038513481128; Schwartz HA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073791; Sloan L, 2013, SOCIOL RES ONLINE, V18, DOI 10.5153/sro.3001; SMITH D., 2014, MANY PEOPLE USE TOP; Steinfield C, 2014, J COMPUT-MEDIAT COMM, V19, P1; Tam D., 2012, FACEBOOK PROCESSES M; Turkle S., 1995, LIFE SCREEN IDENTITY; Valenzuela S, 2009, J COMPUT-MEDIAT COMM, V14, P875, DOI 10.1111/j.1083-6101.2009.01474.x; Wang T, 2013, TWEET FORMER VICE PR; Williams M, 2013, COSMOS ETHICS RESOUR; Williams M., 2006, VIRTUALLY CRIMINAL C; Williams ML, 2013, POLIC SOC, V23, P461, DOI 10.1080/10439463.2013.780225	45	187	189	4	64	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2015	10	3							e0115545	10.1371/journal.pone.0115545	http://dx.doi.org/10.1371/journal.pone.0115545			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CC9JF	25729900	gold, Green Submitted, Green Accepted, Green Published			2022-12-27	WOS:000350684900005
J	Woods, DL; Doss, Z; Herron, TJ; Arbogast, T; Younus, M; Ettlinger, M; Yund, EW				Woods, David L.; Doss, Zoe; Herron, Timothy J.; Arbogast, Tanya; Younus, Masood; Ettlinger, Marc; Yund, E. William			Speech Perception in Older Hearing Impaired Listeners: Benefits of Perceptual Training	PLOS ONE			English	Article							STOP-CONSONANT RECOGNITION; WORD-RECOGNITION; NOISE; IDENTIFICATION; PERFORMANCE; DISCRIMINATION; PLASTICITY; ADULTS; ARTICULATION; COMPRESSION	Hearing aids (HAs) only partially restore the ability of older hearing impaired (OHI) listeners to understand speech in noise, due in large part to persistent deficits in consonant identification. Here, we investigated whether adaptive perceptual training would improve consonant-identification in noise in sixteen aided OHI listeners who underwent 40 hours of computer-based training in their homes. Listeners identified 20 onset and 20 coda consonants in 9,600 consonant-vowel-consonant (CVC) syllables containing different vowels (/alpha/, /i/, or /u/) and spoken by four different talkers. Consonants were presented at three consonant-specific signal-to-noise ratios (SNRs) spanning a 12 dB range. Noise levels were adjusted over training sessions based on d' measures. Listeners were tested before and after training to measure (1) changes in consonant-identification thresholds using syllables spoken by familiar and unfamiliar talkers, and (2) sentence reception thresholds (SeRTs) using two different sentence tests. Consonant-identification thresholds improved gradually during training. Laboratory tests of d' thresholds showed an average improvement of 9.1 dB, with 94% of listeners showing statistically significant training benefit. Training normalized consonant confusions and improved the thresholds of some consonants into the normal range. Benefits were equivalent for onset and coda consonants, syllables containing different vowels, and syllables presented at different SNRs. Greater training benefits were found for hard-to-identify consonants and for consonants spoken by familiar than unfamiliar talkers. SeRTs, tested with simple sentences, showed less elevation than consonant-identification thresholds prior to training and failed to show significant training benefit, although SeRT improvements did correlate with improvements in consonant thresholds. We argue that the lack of SeRT improvement reflects the dominant role of top-down semantic processing in processing simple sentences and that greater transfer of benefit would be evident in the comprehension of more unpredictable speech material.	[Woods, David L.; Doss, Zoe; Herron, Timothy J.; Arbogast, Tanya; Younus, Masood; Ettlinger, Marc; Yund, E. William] VANCHCS, Human Cognit Neurophysiol Lab, Martinez, CA 95553 USA; [Woods, David L.] Univ Calif Davis, Dept Neurol, Sacramento, CA 95817 USA; [Woods, David L.] Univ Calif Davis, Ctr Neurosci, Davis, CA 95616 USA; [Woods, David L.] Univ Calif Davis, Ctr Mind & Brain, Davis, CA 95616 USA	University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis	Woods, DL (corresponding author), VANCHCS, Human Cognit Neurophysiol Lab, 150 Muir Rd, Martinez, CA 95553 USA.	dlwoods@ucdavis.edu		Yund, E./0000-0002-6833-0052; Herron, Timothy/0000-0002-4297-014X; Woods, David/0000-0002-8804-3587	VA Research Service grant [1I01CX000583]; Veterans Affairs [I01CX001000] Funding Source: NIH RePORTER	VA Research Service grant; Veterans Affairs(US Department of Veterans Affairs)	This research was supported by VA Research Service grant 1I01CX000583 to DLW. The content is solely the responsibility of the authors and does not necessarily represent the official views of the agencies.	Ahissar M, 2009, PHILOS T R SOC B, V364, P285, DOI 10.1098/rstb.2008.0253; Ahlstrom JB, 2014, EAR HEARING, V35, P72, DOI 10.1097/AUD.0b013e3182a02274; Ahlstrom JB, 2009, EAR HEARING, V30, P203, DOI 10.1097/AUD.0b013e31819769c1; Alexander JM, 2009, J SPEECH LANG HEAR R, V52, P653, DOI 10.1044/1092-4388(2008/08-0038); Benichov J, 2012, EAR HEARING, V33, P262, DOI 10.1097/AUD.0b013e31822f680f; BILGER RC, 1984, J SPEECH HEAR RES, V27, P32, DOI 10.1044/jshr.2701.32; Boothroyd A, 2010, J AM ACAD AUDIOL, V21, P601, DOI 10.3766/jaaa.21.9.6; Bradlow AR, 1999, PERCEPT PSYCHOPHYS, V61, P977, DOI 10.3758/BF03206911; Brennan SE, 1996, J EXP PSYCHOL LEARN, V22, P1482, DOI 10.1037/0278-7393.22.6.1482; Brysbaert M, 2009, BEHAV RES METHODS, V41, P977, DOI 10.3758/BRM.41.4.977; Burk MH, 2008, J SPEECH LANG HEAR R, V51, P759, DOI 10.1044/1092-4388(2008/054); Burk MH, 2007, J SPEECH LANG HEAR R, V50, P25, DOI 10.1044/1092-4388(2007/003); Burk MH, 2006, EAR HEARING, V27, P263, DOI 10.1097/01.aud.0000215980.21158.a2; Coez A, 2010, NEUROPSYCHOLOGIA, V48, P3057, DOI 10.1016/j.neuropsychologia.2010.06.016; Cox R M, 2001, J Am Acad Audiol, V12, P423; DUBNO JR, 1989, J ACOUST SOC AM, V85, P355, DOI 10.1121/1.397687; DUBNO JR, 1989, J ACOUST SOC AM, V85, P347, DOI 10.1121/1.397686; Dubno JR, 2013, AM J AUDIOL, V22, P335, DOI 10.1044/1059-0889(2013/12-0080); Eckman FR, 2003, SECOND LANG RES, V19, P169, DOI 10.1191/0267658303sr2190a; Ferguson MA, 2014, EAR HEARING, V35, pE110, DOI 10.1097/AUD.0000000000000020; Fu QJ, 2005, ACOUST RES LETT ONL, V6, P106, DOI 10.1121/1.1898345; Gold JR, 2014, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00110; Goldstone RL, 1998, ANNU REV PSYCHOL, V49, P585, DOI 10.1146/annurev.psych.49.1.585; GORDONSALANT S, 1987, EAR HEARING, V8, P270, DOI 10.1097/00003446-198710000-00003; GREENHOUSE SW, 1959, PSYCHOMETRIKA, V24, P95, DOI 10.1007/BF02289823; Hedrick MS, 1997, J SPEECH LANG HEAR R, V40, P1445, DOI 10.1044/jslhr.4006.1445; Henshaw H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062836; Humes LE, 2007, J AM ACAD AUDIOL, V18, P590, DOI 10.3766/jaaa.18.7.6; Humes LE, 2014, J ACOUST SOC AM, V136, pEL224, DOI 10.1121/1.4890663; Humes LE, 2009, EAR HEARING, V30, P613, DOI 10.1097/AUD.0b013e3181b00d90; Killion MC, 2004, J ACOUST SOC AM, V116, P2395, DOI 10.1121/1.1784440; Kuchinsky SE, 2014, PSYCHOPHYSIOLOGY; Kuk F, 2010, EAR HEARING, V31, P779, DOI 10.1097/AUD.0b013e3181e97bfb; Marriage JE, 2003, INT J AUDIOL, V42, P418, DOI 10.3109/14992020309080051; Miller James D, 2008, Hear J, V61, P29; Miller James D, 2008, Proc Meet Acoust, V2, P1; Moreno S, 2014, HEARING RES, V308, P84, DOI 10.1016/j.heares.2013.09.012; NILSSON M, 1994, J ACOUST SOC AM, V95, P1085, DOI 10.1121/1.408469; Oba SI, 2011, EAR HEAR; Olson AD, 2013, J AM ACAD AUDIOL, V24, P214, DOI 10.3766/jaaa.24.3.7; Phatak SA, 2009, J ACOUST SOC AM, V126, P2683, DOI 10.1121/1.3238257; Pichora-Fuller MK, 2012, AM J AUDIOL, V21, P351, DOI 10.1044/1059-0889(2012/12-0025); Pisoni David, 1997, TALKER VARIABILITY S, P9; Port RF, 2005, LANGUAGE, V81, P927, DOI 10.1353/lan.2005.0195; RECANZONE GH, 1993, J NEUROSCI, V13, P87; Reed Charlotte M, 2009, Trends Amplif, V13, P4, DOI 10.1177/1084713808325412; REVOILE SG, 1985, J ACOUST SOC AM, V77, P1263, DOI 10.1121/1.392199; Saripella R, 2011, J ACOUST SOC AM, V130, P3028, DOI 10.1121/1.3641407; Saunders GH, 2010, NCRAR SEMINAR SERIES; SCHWARTZ DM, 1979, J SPEECH HEAR DISORD, V44, P61, DOI 10.1044/jshd.4401.61; Stecker GC, 2006, J REHABIL RES DEV, V43, P537, DOI 10.1682/JRRD.2005.11.0171; Stewart R, 2009, J AM ACAD AUDIOL, V20, P147, DOI 10.3766/jaaa.20.2.7; Strelcyk O, 2013, J ACOUST SOC AM, V133, P1598, DOI 10.1121/1.4789894; Sweetow RW, 2006, J AM ACAD AUDIOL, V17, P538, DOI 10.3766/jaaa.17.8.2; Turner Christopher W, 2006, Audiol Neurootol, V11 Suppl 1, P2, DOI 10.1159/000095606; Watson Charles S, 2008, Hear J, V61, P26; Whittaker J., 1990, GRAPHICAL MODELS APP; Whitton JP, 2014, P NATL ACAD SCI USA, V111, pE2606, DOI 10.1073/pnas.1322184111; Wilson RH, 2003, J REHABIL RES DEV, V40, P329, DOI 10.1682/JRRD.2003.07.0329; Woods DL, 2012, J REHABIL RES DEV, V49, P1277, DOI 10.1682/JRRD.2011.08.0150; Woods DL, 2010, J REHABIL RES DEV, V47, P243, DOI 10.1682/JRRD.2009.04.0040; Woods DL, 2010, J ACOUST SOC AM, V127, P1609, DOI 10.1121/1.3293005; Woods DL, 2014, PLOS ONE IN PRESS; Yund EW, 2010, EAR HEARING, V31, P769, DOI 10.1097/AUD.0b013e3181e68e4a	64	13	15	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2015	10	3							e0113965	10.1371/journal.pone.0113965	http://dx.doi.org/10.1371/journal.pone.0113965			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CC9JF	25730330	Green Published, gold, Green Submitted			2022-12-27	WOS:000350684900002
J	Mukherjee, S; Kim, J; Mooren, OL; Shahan, ST; Cohan, M; Cooper, JA				Mukherjee, Suranjana; Kim, Joanna; Mooren, Olivia L.; Shahan, Stefanie T.; Cohan, Megan; Cooper, John A.			Role of Cortactin Homolog HS1 in Transendothelial Migration of Natural Killer Cells	PLOS ONE			English	Article							ARP2/3 COMPLEX; PROTEIN; ADHESION; PHOSPHORYLATION; ACTIVATION; MECHANISMS; INTERACTS; RAC	Natural Killer (NK) cells perform many functions that depend on actin assembly, including adhesion, chemotaxis, lytic synapse assembly and cytolysis. HS1, the hematopoietic homolog of cortactin, binds to Arp2/3 complex and promotes actin assembly by helping to form and stabilize actin filament branches. We investigated the role of HS1 in transendothelial migration (TEM) by NK cells. Depletion of HS1 led to a decrease in the efficiency of TEM by NK cells, as measured by transwell assays with endothelial cell monolayers on porous filters. Transwell assays involve chemotaxis of NK cells across the filter, so to examine TEM more specifically, we imaged live-cell preparations and antibody-stained fixed preparations, with and without the chemoattractant SDF-1 alpha. We found small to moderate effects of HS1 depletion on TEM, including whether the NK cells migrated via the transcellular or paracellular route. Expression of HS1 mutants indicated that phosphorylation of HS1 tyrosines at positions 222, 378 and 397 was required for rescue in the transwell assay, but HS1 mutations affecting interaction with Arp2/3 complex or SH3-domain ligands had no effect. The GEF Vav1, a ligand of HS1 phosphotyrosine, influenced NK cell transendothelial migration. HS1 and Vav1 also affected the speed of NK cells migrating across the surface of the endothelium. We conclude that HS1 has a role in transendothelial migration of NK cells and that HS1 tyrosine phosphorylation may signal through Vav1.	[Mukherjee, Suranjana; Kim, Joanna; Mooren, Olivia L.; Shahan, Stefanie T.; Cohan, Megan; Cooper, John A.] Washington Univ, Sch Med, Dept Cell Biol & Physiol, St Louis, MO 63110 USA	Washington University (WUSTL)	Cooper, JA (corresponding author), Washington Univ, Sch Med, Dept Cell Biol & Physiol, St Louis, MO 63110 USA.	jcooper@wustl.edu	Kim, Joanna/U-5556-2018; Cooper, John/D-4448-2014	Kim, Joanna/0000-0001-7877-9446; Cooper, John/0000-0002-0933-4571	National Institutes of Health [GM38542]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM038542] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health grant GM38542 to JAC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLAVENA P, 1991, J EXP MED, V173, P439, DOI 10.1084/jem.173.2.439; BIANCHI G, 1993, J IMMUNOL, V151, P5135; Brunati AM, 1999, J BIOL CHEM, V274, P7557, DOI 10.1074/jbc.274.11.7557; Burke TA, 2014, CURR BIOL, V24, P579, DOI 10.1016/j.cub.2014.01.072; BUTCHER EC, 1991, CELL, V67, P1033, DOI 10.1016/0092-8674(91)90279-8; Butler B, 2008, NAT IMMUNOL, V9, P887, DOI 10.1038/ni.1630; Butler B, 2009, CURR BIOL, V19, P1886, DOI 10.1016/j.cub.2009.10.029; Cavnar PJ, 2012, J BIOL CHEM, V287, P25466, DOI 10.1074/jbc.M112.364562; Dehring DAK, 2011, J IMMUNOL, V186, P4805, DOI 10.4049/jimmunol.1003102; Engelhardt B, 2004, EUR J IMMUNOL, V34, P2955, DOI 10.1002/eji.200425327; Galletta BJ, 2012, BIOPHYS J, V103, P2145, DOI 10.1016/j.bpj.2012.10.009; Garcia-Bernal D, 2005, MOL BIOL CELL, V16, P3223, DOI 10.1091/mbc.E04-12-1049; Gomez TS, 2006, IMMUNITY, V24, P741, DOI 10.1016/j.immuni.2006.03.022; Helgeson LA, 2013, ELIFE, V2, DOI 10.7554/eLife.00884; Kim HS, 2010, IMMUNITY, V32, P175, DOI 10.1016/j.immuni.2010.02.004; Kinley AW, 2003, CURR BIOL, V13, P384, DOI 10.1016/S0960-9822(03)00107-6; Kos FJ, 1998, IMMUNOL RES, V17, P303, DOI 10.1007/BF02786453; Lettau M, 2015, EUR J IMMUNOL, V45, P551, DOI 10.1002/eji.201444473; Ley K, 2007, NAT REV IMMUNOL, V7, P678, DOI 10.1038/nri2156; Lotze M.T., 2009, NATURAL KILLER CELLS; Martinez-Quiles N, 2013, OA IMMUNOLOGY, V1, P2; Meijering E, 2012, METHOD ENZYMOL, V504, P183, DOI 10.1016/B978-0-12-391857-4.00009-4; Muller WA, 2011, ANNU REV PATHOL-MECH, V6, P323, DOI 10.1146/annurev-pathol-011110-130224; Muller WA, 2009, CIRC RES, V105, P223, DOI 10.1161/CIRCRESAHA.109.200717; Murphy K, 2017, JANEWAY'S IMMUNOBIOLOGY, 9TH EDITION, P37; Onken MD, 2014, CYTOSKELETON; Padrick SB, 2011, P NATL ACAD SCI USA, V108, pE472, DOI 10.1073/pnas.1100236108; Sirotkin V, 2011, CURR BIOL, V21, pR552, DOI 10.1016/j.cub.2011.06.029; Smith BA, 2013, ELIFE, V2, DOI 10.7554/eLife.01008; Smith BA, 2013, P NATL ACAD SCI USA, V110, P1285, DOI 10.1073/pnas.1211164110; Ti SC, 2011, P NATL ACAD SCI USA, V108, pE463, DOI 10.1073/pnas.1100125108; Timonen T, 1997, J LEUKOCYTE BIOL, V62, P693, DOI 10.1002/jlb.62.6.693; Uruno T, 2003, BIOCHEM J, V371, P485, DOI 10.1042/BJ20021791; Weed SA, 2001, ONCOGENE, V20, P6418, DOI 10.1038/sj.onc.1204783; Wittchen ES, 2005, CURR OPIN HEMATOL, V12, P14, DOI 10.1097/01.moh.0000147892.83713.a7; Yamanashi Y, 1997, J EXP MED, V185, P1387, DOI 10.1084/jem.185.7.1387	36	13	14	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2015	10	2							e0118153	10.1371/journal.pone.0118153	http://dx.doi.org/10.1371/journal.pone.0118153			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC3LS	25723543	Green Published, Green Submitted, gold			2022-12-27	WOS:000350251200046
J	Anderson, SJ; Kierepka, EM; Swihart, RK; Latch, EK; Rhodes, OE				Anderson, Sara J.; Kierepka, Elizabeth M.; Swihart, Robert K.; Latch, Emily K.; Rhodes, Olin E., Jr.			Assessing the Permeability of Landscape Features to Animal Movement: Using Genetic Structure to Infer Functional Connectivity	PLOS ONE			English	Article							CHIPMUNKS TAMIAS-STRIATUS; HABITAT FRAGMENTATION; SMALL MAMMALS; FOREST FRAGMENTATION; POPULATION-STRUCTURE; DIVERSITY; DISPERSAL; EVOLUTION; MODELS; CONSERVATION	Human-altered environments often challenge native species with a complex spatial distribution of resources. Hostile landscape features can inhibit animal movement (i.e., genetic exchange), while other landscape attributes facilitate gene flow. The genetic attributes of organisms inhabiting such complex environments can reveal the legacy of their movements through the landscape. Thus, by evaluating landscape attributes within the context of genetic connectivity of organisms within the landscape, we can elucidate how a species has coped with the enhanced complexity of human altered environments. In this research, we utilized genetic data from eastern chipmunks (Tamias striatus) in conjunction with spatially explicit habitat attribute data to evaluate the realized permeability of various landscape elements in a fragmented agricultural ecosystem. To accomplish this we 1) used logistic regression to evaluate whether land cover attributes were most often associated with the matrix between or habitat within genetically identified populations across the landscape, and 2) utilized spatially explicit habitat attribute data to predict genetically-derived Bayesian probabilities of population membership of individual chipmunks in an agricultural ecosystem. Consistency between the results of the two approaches with regard to facilitators and inhibitors of gene flow in the landscape indicate that this is a promising new way to utilize both landscape and genetic data to gain a deeper understanding of human-altered ecosystems.	[Anderson, Sara J.] Minnesota State Univ Moorhead, Biosci Dept, Moorhead, MN 56563 USA; [Anderson, Sara J.; Swihart, Robert K.; Rhodes, Olin E., Jr.] Purdue Univ, Dept Forestry & Nat Resources, W Lafayette, IN 47907 USA; [Kierepka, Elizabeth M.; Latch, Emily K.] Univ Wisconsin, Dept Biol Sci, Behav & Mol Ecol Grp, Milwaukee, WI 53024 USA; [Rhodes, Olin E., Jr.] Savannah River Ecol Lab, Aiken, SC 29802 USA	Minnesota State Colleges & Universities; Minnesota State University Moorhead; Purdue University System; Purdue University; Purdue University West Lafayette Campus; University of Wisconsin System; University of Wisconsin Milwaukee; United States Department of Energy (DOE); Savannah River Ecology Laboratory	Kierepka, EM (corresponding author), Univ Wisconsin, Dept Biol Sci, Behav & Mol Ecol Grp, 3209 N Maryland Ave, Milwaukee, WI 53024 USA.	Liz.Kierepka@gmail.com	Swihart, Robert K/D-2787-2016	Kierepka, Elizabeth/0000-0002-5816-8872	Cooperative State Research Education and Extension Service, U.S. Department of Agriculture [2000-04649]; John S. Wright Fund; Department of Forestry and Natural Resources, Purdue University; U.S. Department of Education Graduate Assistance in Areas of National Need Award [P200A030188]	Cooperative State Research Education and Extension Service, U.S. Department of Agriculture(United States Department of Agriculture (USDA)National Institute of Food and Agriculture); John S. Wright Fund; Department of Forestry and Natural Resources, Purdue University; U.S. Department of Education Graduate Assistance in Areas of National Need Award(US Department of Education)	Financial support for this work was provided by: 1) Cooperative State Research Education and Extension Service, U.S. Department of Agriculture under Agreement no. 2000-04649 (http://www.csrees.usda.gov/Extension/), 2) the John S. Wright Fund (http://www.treefund.org/home), 3) Department of Forestry and Natural Resources, Purdue University (https://ag.purdue.edu/fnr/Pages/default.aspx), and 4) U.S. Department of Education Graduate Assistance in Areas of National Need Award P200A030188 (http://www2.ed.gov/programs/gaann/index.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander SM, 2005, CAN GEOGR-GEOGR CAN, V49, P321, DOI 10.1111/j.0008-3658.2005.00099.x; Anderson SJ, 2007, MOL ECOL NOTES, V7, P513, DOI 10.1111/j.1471-8286.2006.01638.x; Anderson SJ, 2010, THESIS PURDUE U; Andre T, 2008, FOREST ECOL MANAG, V255, P340, DOI 10.1016/j.foreco.2007.09.055; Andreassen HP, 1998, ECOLOGY, V79, P1223, DOI 10.1890/0012-9658(1998)079[1223:SURTHF]2.0.CO;2; ANDREN H, 1994, OIKOS, V71, P355, DOI 10.2307/3545823; Angelone S, 2011, ECOGRAPHY, V34, P714, DOI 10.1111/j.1600-0587.2010.06494.x; Balkenhol N, 2014, ECOGRAPHY, V37, P552, DOI 10.1111/j.1600-0587.2013.00462.x; BENNETT AF, 1994, BIOL CONSERV, V68, P155, DOI 10.1016/0006-3207(94)90347-6; Bissonette JA, 2008, BIOL CONSERV, V141, P482, DOI 10.1016/j.biocon.2007.10.019; Blair C, 2012, MOL ECOL RESOUR, V12, P822, DOI 10.1111/j.1755-0998.2012.03151.x; Bond BT, 2001, J WILDLIFE MANAGE, V65, P1004, DOI 10.2307/3803049; Cosic N, 2013, CONSERV GENET, V14, P345, DOI 10.1007/s10592-013-0466-y; Dijkstra E. W., 1959, NUMERISCHE MATH, V1, P269, DOI [DOI 10.1007/BF01386390, 10.1007/BF01386390]; Dudaniec RY, 2013, MOL ECOL, V22, P3752, DOI 10.1111/mec.12359; Epps CW, 2007, J APPL ECOL, V44, P714, DOI 10.1111/j.1365-2664.2007.01325.x; Epps CW, 2013, MOL ECOL, V22, P1574, DOI 10.1111/mec.12198; Fant JB, 2014, HEREDITY, V112, P519, DOI 10.1038/hdy.2013.134; Ford AT, 2008, J MAMMAL, V89, P895, DOI 10.1644/07-MAMM-A-320.1; FORSYTH DJ, 1973, AM MIDL NAT, V90, P107, DOI 10.2307/2424271; Frantz AC, 2012, MOL ECOL, V21, P3445, DOI 10.1111/j.1365-294X.2012.05623.x; Frantz AC, 2009, J APPL ECOL, V46, P493, DOI 10.1111/j.1365-2664.2008.01606.x; Galpern P, 2012, MOL ECOL, V21, P3996, DOI 10.1111/j.1365-294X.2012.05677.x; Gauffre B, 2008, MOL ECOL, V17, P4619, DOI 10.1111/j.1365-294X.2008.03950.x; GEIER AR, 1980, J WILDLIFE MANAGE, V44, P16, DOI 10.2307/3808346; Gibbs JP, 1998, LANDSCAPE ECOL, V13, P263, DOI 10.1023/A:1008056424692; Goudet J., 2002, FSTAT PROGRAM ESTIMA; Gross J., 2006, NORTEST TESTS NORMAL; Guillot G, 2005, GENETICS, V170, P1261, DOI 10.1534/genetics.104.033803; Guillot G, 2005, MOL ECOL NOTES, V5, P712, DOI 10.1111/j.1471-8286.2005.01031.x; GUO SW, 1992, BIOMETRICS, V48, P361, DOI 10.2307/2532296; Habel JC, 2012, CONSERV GENET, V13, P247, DOI 10.1007/s10592-011-0280-3; HANSKI I, 1997, METAPOPULATION BIOL; Heino M, 2001, AM NAT, V157, P495, DOI 10.1086/319927; Hepenstrick D, 2012, BASIC APPL ECOL, V13, P631, DOI 10.1016/j.baae.2012.08.009; Hill JK, 2006, BIOL LETTERS, V2, P152, DOI 10.1098/rsbl.2005.0401; Keenan K, 2013, METHODS ECOL EVOL, V4, P782, DOI 10.1111/2041-210X.12067; Kutner M., 2005, APPL LINEAR STAT MOD; Latch EK, 2006, CONSERV GENET, V7, P295, DOI 10.1007/s10592-005-9098-1; Latch EK, 2014, MOL ECOL, V23, P3171, DOI 10.1111/mec.12803; Latch EK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027794; Legendre P, 2010, MOL ECOL RESOUR, V10, P831, DOI 10.1111/j.1755-0998.2010.02866.x; Mahan CG, 1996, AM MIDL NAT, V136, P352, DOI 10.2307/2426739; Manel S, 2003, TRENDS ECOL EVOL, V18, P189, DOI 10.1016/S0169-5347(03)00008-9; Marin JC, 2013, MOL ECOL, V22, P463, DOI 10.1111/mec.12111; Marshall TC, 1998, MOL ECOL, V7, P639, DOI 10.1046/j.1365-294x.1998.00374.x; McGregor RL, 2008, J APPL ECOL, V45, P117, DOI 10.1111/j.1365-2664.2007.01403.x; Mcrae BH, 2008, ECOLOGY, V89, P2712, DOI 10.1890/07-1861.1; McRae BH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052604; Moore JE, 2005, J WILDLIFE MANAGE, V69, P933, DOI 10.2193/0022-541X(2005)069[0933:MPOBFR]2.0.CO;2; MORITZ C, 1994, TRENDS ECOL EVOL, V9, P373, DOI 10.1016/0169-5347(94)90057-4; Murphy MA, 2008, ECOGRAPHY, V31, P685, DOI 10.1111/j.1600-0587.2008.05428.x; Oksanen J., 2008, VEGAN COMMUNITY ECOL; Opdam P, 2004, BIOL CONSERV, V117, P285, DOI 10.1016/j.biocon.2003.12.008; OXLEY DJ, 1974, J APPL ECOL, V11, P51, DOI 10.2307/2402004; Pearse DE, 2004, CONSERV GENET, V5, P585, DOI 10.1007/s10592-003-1863-4; Perez-Espona S, 2008, MOL ECOL, V17, P981, DOI 10.1111/j.1365-294X.2007.03629.x; Peterman WE, 2014, BIORXIV, DOI [10.1101/007575, DOI 10.1101/007575]; R Core Team, 2021, R LANGUAGE ENV STAT; Rayfield B, 2010, LANDSCAPE ECOL, V25, P519, DOI 10.1007/s10980-009-9436-7; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Reding DM, 2012, MOL ECOL, V21, P3078, DOI 10.1111/j.1365-294X.2012.05595.x; Rico A, 2009, ACTA THERIOL, V54, P297, DOI 10.4098/j.at.0001-7051.068.2008; Ripley B., 2012, PACKAGE MASS; Rizkalla CE, 2007, BIOL CONSERV, V140, P339, DOI 10.1016/j.biocon.2007.08.019; Rosenberg DK, 1998, CAN J ZOOL, V76, P117, DOI 10.1139/cjz-76-1-117; Row JR, 2010, MOL ECOL, V19, P5157, DOI 10.1111/j.1365-294X.2010.04872.x; Sawyer SC, 2011, J APPL ECOL, V48, P668, DOI 10.1111/j.1365-2664.2011.01970.x; Schumaker NH, 1996, ECOLOGY, V77, P1210, DOI 10.2307/2265590; Schwartz MK, 2007, TRENDS ECOL EVOL, V22, P25, DOI 10.1016/j.tree.2006.08.009; Sharma S, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.1506; Smissen PJ, 2013, J BIOGEOGR, V40, P1729, DOI 10.1111/jbi.12128; Smith W. B., 1994, NC168 US FOR SERV; Storfer A, 2010, MOL ECOL, V19, P3496, DOI 10.1111/j.1365-294X.2010.04691.x; Stronen AV, 2014, BMC ECOL, V14, DOI 10.1186/1472-6785-14-11; Urban NA, 2009, J MAMMAL, V90, P1431, DOI 10.1644/08-MAMM-A-393R.1; Wang IJ, 2009, MOL ECOL, V18, P1365, DOI 10.1111/j.1365-294X.2009.04122.x; Waples RS, 2006, MOL ECOL, V15, P1419, DOI 10.1111/j.1365-294X.2006.02890.x; WEGNER JF, 1979, J APPL ECOL, V16, P349, DOI 10.2307/2402513; WILCOX BA, 1985, AM NAT, V125, P879, DOI 10.1086/284386; WILKINS KT, 1982, SOUTHWEST NAT, V27, P459, DOI 10.2307/3670722; Wright S, 1931, GENETICS, V16, P0097; Zeller KA, 2012, LANDSCAPE ECOL, V27, P777, DOI 10.1007/s10980-012-9737-0; [No title captured]	84	16	17	1	65	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2015	10	2							e0117500	10.1371/journal.pone.0117500	http://dx.doi.org/10.1371/journal.pone.0117500			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC2ZH	25719366	Green Published, gold			2022-12-27	WOS:000350213200025
J	Gao, JP; Wang, D; Cao, LY; Sun, HF				Gao, Jian Ping; Wang, Dong; Cao, Ling Ya; Sun, Hai Feng			Transcriptome Sequencing of Codonopsis pilosula and Identification of Candidate Genes Involved in Polysaccharide Biosynthesis	PLOS ONE			English	Article							EXPRESSION; TOOL; GLYCOSYLTRANSFERASES; CLONING; ROOTS; PCR	Background Codonopsis pilosula (Franch.) Nannf. is one of the most widely used medicinal plants. Although chemical and pharmacological studies have shown that codonopsis polysaccharides (CPPs) are bioactive compounds and that their composition is variable, their biosynthetic pathways remain largely unknown. Next-generation sequencing is an efficient and high-throughput technique that allows the identification of candidate genes involved in secondary metabolism. Principal Findings To identify the components involved in CPP biosynthesis, a transcriptome library, prepared using root and other tissues, was assembled with the help of Illumina sequencing. A total of 9.2 Gb of clean nucleotides was obtained comprising 91,175,044 clean reads, 102,125 contigs, and 45,511 unigenes. After aligning the sequences to the public protein databases, 76.1% of the unigenes were annotated. Among these annotated unigenes, 26,189 were assigned to Gene Ontology categories, 11,415 to Clusters of Orthologous Groups, and 18,848 to Kyoto Encyclopedia of Genes and Genomes pathways. Analysis of abundance of transcripts in the library showed that genes, including those encoding metallothionein, aquaporin, and cysteine protease that are related to stress responses, were in the top list. Among genes involved in the biosynthesis of CPP, those responsible for the synthesis of UDP-L-arabinose and UDP-xylose were highly expressed. Significance To our knowledge, this is the first study to provide a public transcriptome dataset prepared from C. pilosula and an outline of the biosynthetic pathway of polysaccharides in a medicinal plant. Identified candidate genes involved in CPP biosynthesis provide understanding of the biosynthesis and regulation of CPP at the molecular level.	[Gao, Jian Ping; Wang, Dong; Cao, Ling Ya] Shanxi Med Univ, Coll Pharm, Taiyuan, Shanxi, Peoples R China; [Sun, Hai Feng] Shanxi Univ, Coll Chem & Chem Engn, Taiyuan, Shanxi, Peoples R China	Shanxi Medical University; Shanxi University	Gao, JP (corresponding author), Shanxi Med Univ, Coll Pharm, Taiyuan, Shanxi, Peoples R China.	jpgao123@sina.com			National Natural Science Foundation of China [81072987]; National Key Technology Research and Development Program of the Ministry of Science and Technology of China [2011BAI07B07]; Program for the Top Young and Middle-aged Innovative Talents of Higher Learning Institutions of Shanxi Province; Program for the Top Science and Technology Innovation Teams of Higher Learning Institutions of Shanxi Province	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Technology Research and Development Program of the Ministry of Science and Technology of China(National Key Technology R&D Program); Program for the Top Young and Middle-aged Innovative Talents of Higher Learning Institutions of Shanxi Province; Program for the Top Science and Technology Innovation Teams of Higher Learning Institutions of Shanxi Province	This work was funded by the National Natural Science Foundation of China (81072987), the National Key Technology Research and Development Program of the Ministry of Science and Technology of China (2011BAI07B07), the Program for the Top Young and Middle-aged Innovative Talents of Higher Learning Institutions of Shanxi Province and the Program for the Top Science and Technology Innovation Teams of Higher Learning Institutions of Shanxi Province. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Chinese Pharmacopoeia Commission, 2010, PHARMACOPOEIA PEOPLE, VI, P264; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Gachon CMM, 2005, TRENDS PLANT SCI, V10, P542, DOI 10.1016/j.tplants.2005.09.007; Gille S, 2011, PLANTA, V234, P515, DOI 10.1007/s00425-011-1422-z; Gomez-Casati DF, 2013, PROTEIN PEPTIDE LETT, V20, P856; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Hao DC, 2012, SCI CHINA LIFE SCI, V55, P452, DOI 10.1007/s11427-012-4319-6; He K, 2011, J ETHNOPHARMACOL, V137, P1135, DOI 10.1016/j.jep.2011.07.033; He M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042081; Hua WP, 2011, GENOMICS, V98, P272, DOI 10.1016/j.ygeno.2011.03.012; Huang LL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038653; Iseli C, 1999, Proc Int Conf Intell Syst Mol Biol, P138; Kanehisa M, 2004, NUCLEIC ACIDS RES, V32, pD277, DOI 10.1093/nar/gkh063; Lai ZX, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-561; Lee EK, 2010, NAT BIOTECHNOL, V28, P1213, DOI 10.1038/nbt.1693; Li CY, 2009, J CHROMATOGR A, V1216, P2124, DOI 10.1016/j.chroma.2008.10.080; Li CF, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-245; Li XX, 2012, JOURNAL OF SHANXI CO, V13, P29; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Nag A, 2012, DATABASE-OXFORD, DOI 10.1093/database/bas013; Nan HJ, 2008, JOURNAL OF SHANXI ME, V39, P641; Nanjing University of Chinese Medicine, 2006, DICTIONARY OF CHINES; Park JI, 2010, PLANT CELL PHYSIOL, V51, P981, DOI 10.1093/pcp/pcq057; Pauly M, 2013, PLANTA, V238, P627, DOI 10.1007/s00425-013-1921-1; Peng JS, 2000, ACTA BOT SIN, V42, P940; Pertea G, 2003, BIOINFORMATICS, V19, P651, DOI 10.1093/bioinformatics/btg034; Quan Xian-Qing, 2006, Yichuan, V28, P375; Que YX, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106476; Rozen S, 2000, Methods Mol Biol, V132, P365; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Sun YX, 2009, CHEM BIODIVERS, V6, P890, DOI 10.1002/cbdv.200800154; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tang Q, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-343; Tatusov RL, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-41; Tsai KH, 2013, FOOD CHEM, V138, P1856, DOI 10.1016/j.foodchem.2012.11.056; Labate MTV, 2010, GENET MOL BIOL, V33, P686, DOI 10.1590/S1415-47572010005000078; Wang JF, 2009, PLANT PHYSIOL BIOCH, V47, P86, DOI 10.1016/j.plaphy.2008.10.011; Wang XQ, 2009, FEBS LETT, V583, P3303, DOI 10.1016/j.febslet.2009.09.042; Wang Y, 2012, PLANT MOL BIOL, V79, P243, DOI 10.1007/s11103-012-9909-y; Wu XJ, 2000, ACTA U TRADITIONIS M, V14, P53; Xiao M, 2013, J BIOTECHNOL, V166, P122, DOI 10.1016/j.jbiotec.2013.04.004; Xu C, 2012, INT J BIOL MACROMOL, V50, P891, DOI 10.1016/j.ijbiomac.2012.01.013; Yang F. D., 2007, CHINESE J INFORM TRA, V14, P100; Yang FY, 2011, CHINA MEDICAL HERALD, V8, P34; Yang XB, 2008, BIOL PHARM BULL, V31, P1860, DOI 10.1248/bpb.31.1860; Ye Guan, 2005, Zhongguo Zhong Yao Za Zhi, V30, P1338; Ye J, 2006, NUCLEIC ACIDS RES, V34, pW293, DOI 10.1093/nar/gkl031; Yin YB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027995; Zhang QS, 2006, BIOCHEM J, V394, P115, DOI 10.1042/BJ20051329; Zhang XD, 2013, CHINESE ARCHIVES OF, V31, P496; [张晓丹 Zhang Xiaodan], 2003, [中草药, Chinese Traditional and Herbal Drugs], V34, P822; [张晓君 Zhang Xiaojun], 2003, [中药新药与临床药理, Traditional Chinese Drug Research and Clinical Plarmacology], V14, P174; Zhang YJ, 2010, FITOTERAPIA, V81, P157, DOI 10.1016/j.fitote.2009.08.011; [张雅君 Zhang Yajun], 2005, [中国药学杂志, Chinese Pharmaceutical Journal], V40, P1107	56	24	34	4	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2015	10	2							e0117342	10.1371/journal.pone.0117342	http://dx.doi.org/10.1371/journal.pone.0117342			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC2ZH	25719364	Green Submitted, Green Published, gold			2022-12-27	WOS:000350213200018
J	Tan, HB; Kang, X; Lu, SH; Liu, L				Tan Haibo; Kang Xin; Lu ShiHeng; Liu Lin			Comparison of Ahmed Glaucoma Valve Implantation and Trabeculectomy for Glaucoma: A Systematic Review and Meta-Analysis	PLOS ONE			English	Article							MITOMYCIN-C; OUTCOMES; EYES	Objective To compare the efficacy and safety of Ahmed glaucoma valve implantation (AGV) with trabeculectomy in the management of glaucoma patients. Methods A comprehensive literature search (PubMed, Embase, Google, and the Cochrane library) was performed, including a systematic review with meta-analysis of controlled clinical trials comparing AGV versus trabeculectomy. Efficacy estimates were the weighted mean differences (WMDs) for the percentage intraocular pressure reduction (IOPR %) from baseline to end-point, the reduction in glaucoma medications, and the odds ratios (ORs) for complete and qualified success rates. Safety estimates were the relative risks (RRs) for adverse events. All outcomes were reported with a 95% confidence interval (CI). Statistical analysis was performed using the RevMan 5.0 software. Results Six controlled clinical trials were included in this meta-analysis. There was no significant difference between the AGV and trabeculectomy in the IOPR% (WMD = -3.04, 95% CI: -8.36-2.26; P = 0.26). The pooled ORs comparing AGV with trabeculectomy were 0.46 (0.22, 0.99) for the complete success rate (P = 0.05) and 0.97 (0.78-1.20) for the quantified success rate (P = 0.76). No significant difference in the reduction in glaucoma medicines was observed (WMD = 0.24; 95% CI: -0.27-0.76; P = 0.35). AGV was found to be associated with a significantly lower frequency of all adverse events (RR = 0.71; 95% CI: 1.14-0.97; p = 0.001) than trabeculectomy, while the most common complications did not differ significantly (all p > 0.05). Conclusion AGV was equivalent to trabeculectomy in reducing the IOP, the number of glaucoma medications, success rates, and rates of the most common complications. However, AGV was associated with a significantly lower frequency of overall adverse events.	[Tan Haibo; Lu ShiHeng; Liu Lin] Shanghai Jiao Tong Univ, RenJi Hosp Affiliated, Dept Ophthalmol, Sch Med, Shanghai 200030, Peoples R China; [Kang Xin] Second Mil Med Univ, Changhai Hosp Affiliated, Dept Clin Pharmacol, Shanghai, Peoples R China	Shanghai Jiao Tong University; Naval Medical University	Liu, L (corresponding author), Shanghai Jiao Tong Univ, RenJi Hosp Affiliated, Dept Ophthalmol, Sch Med, Shanghai 200030, Peoples R China.	thbbobo@126.com						Anshu A, 2011, MOL VIS, V17, P1891; Budenz DL, 2011, OPHTHALMOLOGY, V118, P443, DOI 10.1016/j.ophtha.2010.07.016; Downs SH, 1998, J EPIDEMIOL COMMUN H, V52, P377, DOI 10.1136/jech.52.6.377; Fea AM, 2014, CLIN OPHTHALMOL, V8, P875, DOI 10.2147/OPTH.S59932; GANDHAM SB, 1993, AM J OPHTHALMOL, V116, P189, DOI 10.1016/S0002-9394(14)71284-X; He M, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0085782, DOI 10.1371/J0URNAL.P0NE.0085782]; Higgins J, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.ED000049; Hill R, 2003, BRIT J OPHTHALMOL, V87, P673, DOI 10.1136/bjo.87.6.673; Hille K, 2004, Klin Oczna, V106, P670; Im YW, 2004, J KOREAN OPHTHALMOL, V45, P1515; Iwao K, 2014, J GLAUCOMA, V23, P88, DOI 10.1097/IJG.0b013e3182685167; Jonas JB, 2014, OPHTHALMOLOGE, V111, P181, DOI 10.1007/s00347-013-3006-8; Liang YB, 2014, J GLAUCOMA, V23, P136, DOI 10.1097/IJG.0b013e31826981c9; Mosaed S, 2010, EXPERT REV MED DEVIC, V7, P661, DOI 10.1586/ERD.10.32; Nakatake S, 2014, BMC OPHTHALMOL, V14, DOI 10.1186/1471-2415-14-55; Nguyen NX, 1999, J GLAUCOMA, V8, P18; NouriMahdavi K, 1995, OPHTHALMOLOGY, V102, P1760, DOI 10.1016/S0161-6420(95)30796-8; Pakravan M, 2007, J GLAUCOMA, V16, P631, DOI 10.1097/IJG.0b013e3180640f58; Quigley HA, 2006, BRIT J OPHTHALMOL, V90, P262, DOI 10.1136/bjo.2005.081224; Shen CC, 2011, CLIN OPHTHALMOL, V5, P281, DOI 10.2147/OPTH.S16976; Tran DH, 2009, BRIT J OPHTHALMOL, V93, P1504, DOI 10.1136/bjo.2008.150870; Wilson MR, 2003, AM J OPHTHALMOL, V136, P464, DOI 10.1016/S0002-9394(03)00239-3; Yamamoto T, 2014, OPHTHALMOLOGY, V121, P1001, DOI 10.1016/j.ophtha.2013.11.025; 이태윤, 2008, [Journal of The Korean Ophthalmological Society, 대한안과학회지], V49, P293	24	16	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2015	10	2							e0118142	10.1371/journal.pone.0118142	http://dx.doi.org/10.1371/journal.pone.0118142			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC2ZH	25719405	Green Submitted, gold, Green Published			2022-12-27	WOS:000350213200040
J	Erdmann, F; Kugler, S; Blaesse, P; Lange, MD; Skryabin, BV; Pape, HC; Jungling, K				Erdmann, Frank; Kuegler, Sebastian; Blaesse, Peter; Lange, Maren D.; Skryabin, Boris V.; Pape, Hans-Christian; Juengling, Kay			Neuronal Expression of the Human Neuropeptide S Receptor NPSR1 Identifies NPS-Induced Calcium Signaling Pathways	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM; ANXIETY DISORDERS; PANIC DISORDER; CRAC CHANNEL; FOOD-INTAKE; GENE; POLYMORPHISM; ACTIVATION; AMYGDALA; STIM1	The neuropeptide S (NPS) system was discovered as a novel neurotransmitter system a decade ago and has since been identified as a key player in the modulation of fear and anxiety. Genetic variations of the human NPS receptor (NPSR1) have been associated with pathologies like panic disorders. However, details on the molecular fundamentals of NPSR1 activity in neurons remained elusive. We expressed NPSR1 in primary hippocampal cultures. Using single-cell calcium imaging we found that NPSR1 stimulation induced calcium mobilization from the endoplasmic reticulum via activation of IP3 and ryanodine receptors. Store-operated calcium channels were activated in a downstream process mediating entry of extracellular calcium. We provide the first detailed analysis of NPSR1 activity and the underlying intracellular pathways with respect to calcium mobilization in neurons.	[Erdmann, Frank; Blaesse, Peter; Lange, Maren D.; Pape, Hans-Christian; Juengling, Kay] Univ Munster, Inst Physiol 1, D-48149 Munster, Germany; [Kuegler, Sebastian] Univ Med Gottingen, Dept Neurol, Ctr Mol Physiol Brain, D-37073 Gottingen, Germany; [Skryabin, Boris V.] Univ Munster, Inst Expt Pathol, ZMBE, D-48149 Munster, Germany; [Skryabin, Boris V.] Univ Munster, Interdisciplinary Clin Res Ctr, D-48149 Munster, Germany	University of Munster; University of Gottingen; University of Munster; University of Munster	Jungling, K (corresponding author), Univ Munster, Inst Physiol 1, Robert Koch Str 27a, D-48149 Munster, Germany.	kay.juengling@gmx.de	Skryabin, Boris/AAL-3100-2020	Skryabin, Boris/0000-0002-4392-185X	Deutsche Forschungsgemeinschaft [SFB-TRR 58 TP A07, SFB-TRR 58 TP A03]; Max-Planck-Research Award; Interdisziplinares Zentrum fur Klinische Forschung der Westfalischen Wilhelms-Universitat Munster (IZKF) [PaHC3/003/10]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Max-Planck-Research Award(Max Planck Society); Interdisziplinares Zentrum fur Klinische Forschung der Westfalischen Wilhelms-Universitat Munster (IZKF)	This work was supported by the Deutsche Forschungsgemeinschaft (SFB-TRR 58 TP A07 to K. J. and SFB-TRR 58 TP A03 to H.-C.P), the Max-Planck-Research Award (to H.-C.P.) and the Interdisziplinares Zentrum fur Klinische Forschung der Westfalischen Wilhelms-Universitat Munster (IZKF, PaHC3/003/10 to H.-C.P. and K.J.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahnaou A, 2012, NEUROPSYCHOBIOLOGY, V65, P195, DOI 10.1159/000336998; Anedda F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029523; Beck B, 2005, BIOCHEM BIOPH RES CO, V332, P859, DOI 10.1016/j.bbrc.2005.05.029; Bernier V, 2006, J BIOL CHEM, V281, P24704, DOI 10.1074/jbc.M603691200; BLEASDALE JE, 1990, J PHARMACOL EXP THER, V255, P756; Castro AA, 2009, PHARMACOL BIOCHEM BE, V91, P636, DOI 10.1016/j.pbb.2008.10.015; Chauveau F, 2012, NEUROPSYCHOPHARMACOL, V37, P1588, DOI 10.1038/npp.2012.3; Clark SD, 2010, PEPTIDES, V31, P130, DOI 10.1016/j.peptides.2009.10.015; D'Amato M, 2007, GASTROENTEROLOGY, V133, P808, DOI 10.1053/j.gastro.2007.06.012; D'Amato M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009315; Domschke K, 2011, MOL PSYCHIATR, V16, P938, DOI 10.1038/mp.2010.81; Donner J, 2010, BIOL PSYCHIAT, V68, P474, DOI 10.1016/j.biopsych.2010.05.039; Gradinaru V, 2010, CELL, V141, P154, DOI 10.1016/j.cell.2010.02.037; Gruszczynska-Biegala J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019285; Hofherr A, 2005, J CELL SCI, V118, P1935, DOI 10.1242/jcs.02322; Jungling K, 2008, NEURON, V59, P298, DOI 10.1016/j.neuron.2008.07.002; Kaech S, 2006, NAT PROTOC, V1, P2406, DOI 10.1038/nprot.2006.356; Kaneko Y, 2014, BRIT J PHARMACOL, V171, P2474, DOI 10.1111/bph.12414; Khirug S, 2010, J NEUROSCI, V30, P12028, DOI 10.1523/JNEUROSCI.3154-10.2010; Kormann MSD, 2005, AM J RESP CRIT CARE, V171, P1358, DOI 10.1164/rccm.200410-1312OC; Kozak JA, 2002, J GEN PHYSIOL, V120, P221, DOI 10.1085/jgp.20028601; Laas K, 2014, INT J NEUROPSYCHOPH, V17, P541, DOI 10.1017/S1461145713001478; Lee KP, 2014, J BIOL CHEM, V289, P6372, DOI 10.1074/jbc.M113.546556; Leonard SK, 2008, PSYCHOPHARMACOLOGY, V197, P601, DOI 10.1007/s00213-008-1080-4; Liou J, 2005, CURR BIOL, V15, P1235, DOI 10.1016/j.cub.2005.05.055; Luik RM, 2008, NATURE, V454, P538, DOI 10.1038/nature07065; Maddalena A, 2013, MOL THER-NUCL ACIDS, V2, DOI 10.1038/mtna.2013.35; Malenka RC, 2004, NEURON, V44, P5, DOI 10.1016/j.neuron.2004.09.012; Malerba G, 2007, CLIN EXP ALLERGY, V37, P83, DOI 10.1111/j.1365-2222.2006.02615.x; Maruyama T, 1997, J BIOCHEM-TOKYO, V122, P498; McConalogue K, 1998, AM J PHYSIOL-GASTR L, V274, pG792, DOI 10.1152/ajpgi.1998.274.5.G792; Meis S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002695; MERRITT JE, 1990, BIOCHEM J, V271, P515, DOI 10.1042/bj2710515; Moller TC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063352; Okamura N, 2008, J PHARMACOL EXP THER, V325, P893, DOI 10.1124/jpet.107.135103; Okamura N, 2007, PROG NEURO-PSYCHOPH, V31, P1444, DOI 10.1016/j.pnpbp.2007.06.026; Paneda C, 2009, J NEUROSCI, V29, P4155, DOI 10.1523/JNEUROSCI.5256-08.2009; Pape HC, 2010, NEUROPHARMACOLOGY, V58, P29, DOI 10.1016/j.neuropharm.2009.06.001; Parekh AB, 2005, PHYSIOL REV, V85, P757, DOI 10.1152/physrev.00057.2003; PlengeTellechea F, 1997, J BIOL CHEM, V272, P2794, DOI 10.1074/jbc.272.5.2794; Raczka KA, 2010, MOL PSYCHIATR, V15, P1067, DOI 10.1038/mp.2010.79; Reinscheid RK, 2005, J PHARMACOL EXP THER, V315, P1338, DOI 10.1124/jpet.105.093427; Rizzi A, 2008, BRIT J PHARMACOL, V154, P471, DOI 10.1038/bjp.2008.96; Roth AL, 2006, J BIOL CHEM, V281, P20809, DOI 10.1074/jbc.M601846200; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Smith KL, 2006, ENDOCRINOLOGY, V147, P3510, DOI 10.1210/en.2005-1280; Smyth JT, 2008, J CELL SCI, V121, P762, DOI 10.1242/jcs.023903; Varnai P, 2009, TRENDS PHARMACOL SCI, V30, P118, DOI 10.1016/j.tips.2008.11.005; Verkhratsky A, 2002, CELL CALCIUM, V32, P393, DOI 10.1016/S0143416002001896; Xu YL, 2007, J COMP NEUROL, V500, P84, DOI 10.1002/cne.21159; Xu YL, 2004, NEURON, V43, P487, DOI 10.1016/j.neuron.2004.08.005; Yeromin AV, 2006, NATURE, V443, P226, DOI 10.1038/nature05108	52	23	24	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2015	10	2							e0117319	10.1371/journal.pone.0117319	http://dx.doi.org/10.1371/journal.pone.0117319			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC2IM	25714705	Green Published, Green Submitted, gold			2022-12-27	WOS:000350168700031
J	Hendesi, H; Barbe, MF; Safadi, FF; Monroy, MA; Popoff, SN				Hendesi, Honey; Barbe, Mary F.; Safadi, Fayez F.; Monroy, M. Alexandra; Popoff, Steven N.			Integrin Mediated Adhesion of Osteoblasts to Connective Tissue Growth Factor (CTGF/CCN2) Induces Cytoskeleton Reorganization and Cell Differentiation	PLOS ONE			English	Article							HEPATIC STELLATE CELLS; TRANSCRIPTION FACTOR; IN-VITRO; EXTRACELLULAR-MATRIX; FACTOR CTGF; OSTEOGENIC DIFFERENTIATION; RGD-GLYCOPROTEINS; PROMOTES ADHESION; DIVALENT-CATIONS; GENE-EXPRESSION	Pre-osteoblast adhesion and interaction with extracellular matrix (ECM) proteins through integrin receptors result in activation of signaling pathways regulating osteoblast differentiation. Connective tissue growth factor (CTGF/CCN2) is a matricellular protein secreted into the ECM. Prior studies in various cell types have shown that cell adhesion to CTGF via integrin receptors results in activation of specific signaling pathways that regulate cell functions, such as differentiation and cytoskeletal reorganization. To date, there are no studies that have examined whether CTGF can serve as an adhesive substrate for osteoblasts. In this study, we used the MC3T3-E1 cell line to demonstrate that CTGF serves as an adhesive matrix for osteoblasts. Anti-integrin blocking experiments and co-immunoprecipitation assays demonstrated that the integrin alpha(v)beta 1 plays a key role in osteoblast adhesion to a CTGF matrix. Immunofluorescence staining of osteoblasts cultured on a CTGF matrix confirmed actin cytoskeletal reorganization, enhanced spreading, formation of focal adhesions, and activation of Rac1. Alkaline phosphatase (ALP) staining and activity assays, as well as Alizarin red staining demonstrated that osteoblast attachment to CTGF matrix enhanced maturation, bone nodule formation and matrix mineralization. To investigate whether the effect of CTGF on osteoblast differentiation involves integrin-mediated activation of specific signaling pathways, we performed Western blot, chromatin immunoprecipitation (ChIP) and qPCR assays. Osteoblasts cultured on a CTGF matrix showed increased total and phosphorylated (activated) forms of focal adhesion kinase (FAK) and extracellular signal-regulated kinase (ERK). Inhibition of ERK blocked osteogenic differentiation in cells cultured on a CTGF matrix. There was an increase in runt-related transcription factor 2 (Runx2) binding to the osteocalcin gene promoter, and in the expression of osteogenic markers regulated by Runx2. Collectively, the results of this study are the first to demonstrate CTGF serves as a suitable matrix protein, enhancing osteoblast adhesion (via alpha(v)beta 1 integrin) and promoting cell spreading via cytoskeletal reorganization and Rac1 activation. Furthermore, integrinmediated activation of ERK signaling resulted in increased osteoblast differentiation accompanied by an increase in Runx2 binding to the osteocalcin promoter and in the expression of osteogenic markers.	[Hendesi, Honey; Barbe, Mary F.; Monroy, M. Alexandra; Popoff, Steven N.] Temple Univ, Dept Anat & Cell Biol, Sch Med, Philadelphia, PA 19122 USA; [Safadi, Fayez F.] Northeast Ohio Med Univ, Dept Anat & Neurobiol, Rootstown, OH USA; [Popoff, Steven N.] Temple Univ, Sch Med, Dept Orthoped Surg, Philadelphia, PA 19122 USA; [Monroy, M. Alexandra] Temple Univ, Sch Med, Dept Surg, Philadelphia, PA 19122 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Northeast Ohio Medical University (NEOMED); Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University	Popoff, SN (corresponding author), Temple Univ, Dept Anat & Cell Biol, Sch Med, Philadelphia, PA 19122 USA.	spopoff@temple.edu	Safadi, Fayez/AAU-8699-2021	Hendesi, Honey/0000-0002-7942-576X; Barbe, Mary/0000-0002-5235-9803	National Institutes of Health [R01 AR47432]; Pennsylvania Department of Health; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR047432] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pennsylvania Department of Health; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This study was supported by grants from the National Institutes of Health (R01 AR47432) and the Pennsylvania Department of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abreu JG, 2002, NAT CELL BIOL, V4, P599, DOI 10.1038/ncb826; Arnaout MA, 2002, IMMUNOL REV, V186, P125, DOI 10.1034/j.1600-065X.2002.18612.x; Arnott JA, 2011, CRIT REV EUKAR GENE, V21, P43, DOI 10.1615/CritRevEukarGeneExpr.v21.i1.40; Ball DK, 2003, J ENDOCRINOL, V176, pR1, DOI 10.1677/joe.0.176R001; Borset M, 2000, BLOOD, V96, P2528; Campbell ID, 2011, COLD SPRING HARB PER, V1, P3, DOI DOI 10.1101/CSHPERSPECT; Carey DJ, 1997, BIOCHEM J, V327, P1; Chen CC, 2001, J BIOL CHEM, V276, P10443, DOI 10.1074/jbc.M008087200; Chen YL, 2004, MOL BIOL CELL, V15, P5635, DOI 10.1091/mbc.E04-06-0490; Cicha I, 2005, ARTERIOSCL THROM VAS, V25, P1008, DOI 10.1161/01.ATV.0000162173.27682.7b; De Winter P, 2008, GROWTH FACTORS, V26, P80, DOI 10.1080/08977190802025602; DeMali KA, 2003, CURR OPIN CELL BIOL, V15, P572, DOI 10.1016/S0955-0674(03)00109-1; Ducy P, 1997, CELL, V89, P747, DOI 10.1016/S0092-8674(00)80257-3; Franceschi RT, 1999, CRIT REV ORAL BIOL M, V10, P40, DOI 10.1177/10454411990100010201; GAILIT J, 1988, J BIOL CHEM, V263, P12927; Gao R, 2006, GUT, V55, P856, DOI 10.1136/gut.2005.079178; Gao RP, 2005, GASTROENTEROLOGY, V129, P1019, DOI 10.1053/j.gastro.2005.06.067; Gao RP, 2004, J BIOL CHEM, V279, P8848, DOI 10.1074/jbc.M313204200; Gao RP, 2003, HEPATOL RES, V27, P214, DOI 10.1016/S1386-6346(03)00241-9; Gao Runping, 2005, Cell Commun Signal, V3, P14; GRZESIK WJ, 1994, J BONE MINER RES, V9, P487, DOI 10.1002/jbmr.5650090408; Guo FK, 2006, J BIOL CHEM, V281, P18652, DOI 10.1074/jbc.M603508200; Hall A, 2005, BIOCHEM SOC T, V33, P891, DOI 10.1042/BST0330891; Harada H, 1999, J BIOL CHEM, V274, P6972, DOI 10.1074/jbc.274.11.6972; Hoshijima M, 2006, FEBS LETT, V580, P1376, DOI 10.1016/j.febslet.2006.01.061; Hotchin NA, 1995, J CELL BIOL, V131, P1857, DOI 10.1083/jcb.131.6.1857; Huang J, 2013, INT J MOL MED, V32, P423, DOI 10.3892/ijmm.2013.1398; Huveneers S, 2009, J CELL SCI, V122, P1059, DOI 10.1242/jcs.039446; HYNES RO, 1992, CELL, V69, P11, DOI 10.1016/0092-8674(92)90115-S; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Ivkovic S, 2003, DEVELOPMENT, V130, P2779, DOI 10.1242/dev.00505; Jimenez MJG, 1999, MOL CELL BIOL, V19, P4431; Jung GY, 2011, J CELL BIOCHEM, V112, P2541, DOI 10.1002/jcb.23178; Kawaki H, 2008, J BONE MINER RES, V23, P1751, DOI 10.1359/JBMR.080615; Kiwanuka E, 2013, EXP CELL RES, V319, P2938, DOI 10.1016/j.yexcr.2013.08.021; Knight CG, 2000, J BIOL CHEM, V275, P35, DOI 10.1074/jbc.275.1.35; Lambi AG, 2012, DEV DYNAM, V241, P1944, DOI 10.1002/dvdy.23888; Leask A, 2006, J CELL SCI, V119, P4803, DOI 10.1242/jcs.03270; MAJESKA RJ, 1993, J BONE MINER RES, V8, P277; MERRIMAN HL, 1995, BIOCHEMISTRY-US, V34, P13125, DOI 10.1021/bi00040a025; Mizuno M, 2000, J CELL PHYSIOL, V184, P207, DOI 10.1002/1097-4652(200008)184:2<207::AID-JCP8>3.3.CO;2-L; Moursi AM, 1997, J CELL SCI, V110, P2187; Moursi AM, 1996, J CELL SCI, V109, P1369; Mundy C, 2014, J CELL PHYSIOL, V229, P672, DOI 10.1002/jcp.24491; Nishida T, 2000, J CELL PHYSIOL, V184, P197, DOI 10.1002/1097-4652(200008)184:2<197::AID-JCP7>3.0.CO;2-R; OLDBERG A, 1988, J BIOL CHEM, V263, P19433; Ono M, 2007, BIOCHEM BIOPH RES CO, V357, P20, DOI 10.1016/j.bbrc.2007.03.052; Petit V, 2000, BIOL CELL, V92, P477, DOI 10.1016/S0248-4900(00)01101-1; Price LS, 1998, MOL BIOL CELL, V9, P1863, DOI 10.1091/mbc.9.7.1863; Roca H, 2008, NUCLEIC ACIDS RES, V36, P1723, DOI 10.1093/nar/gkn022; Ruoslahti E, 1996, ANNU REV CELL DEV BI, V12, P697, DOI 10.1146/annurev.cellbio.12.1.697; Safadi FF, 2003, J CELL PHYSIOL, V196, P51, DOI 10.1002/jcp.10319; SCHNEIDER G, 1994, EXP CELL RES, V214, P264, DOI 10.1006/excr.1994.1257; Schneider GB, 2001, J DENT RES, V80, P1540, DOI 10.1177/00220345010800061201; Schwab EH, 2013, INT J MED SCI, V10, P1846, DOI 10.7150/ijms.6908; Thirunavukkarasu K, 2000, J BIOL CHEM, V275, P25163, DOI 10.1074/jbc.M000322200; Tong ZY, 2006, J ENDOCRINOL, V188, pR1, DOI 10.1677/joe.1.06719; Wilcox-Adelman SA, 2002, J BIOL CHEM, V277, P32970, DOI 10.1074/jbc.M201283200; Xiao GZ, 1998, J BIOL CHEM, V273, P32988, DOI 10.1074/jbc.273.49.32988; Xiao GZ, 2000, J BIOL CHEM, V275, P4453, DOI 10.1074/jbc.275.6.4453; Yang AT, 2013, INT J MOL MED, V32, P35, DOI 10.3892/ijmm.2013.1380; Zhang K, 2012, CELL ADHES MIGR, V6, P20, DOI 10.4161/cam.18702	62	36	38	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2015	10	2							e0115325	10.1371/journal.pone.0115325	http://dx.doi.org/10.1371/journal.pone.0115325			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC2IM	25714841	Green Submitted, Green Published, gold			2022-12-27	WOS:000350168700005
J	Lau, HC; Lee, IK; Ko, PW; Lee, HW; Huh, JS; Cho, WJ; Lim, JO				Lau, Hui-Chong; Lee, In-Kyu; Ko, Pan-Woo; Lee, Ho-Won; Huh, Jeung-Soo; Cho, Won-Ju; Lim, Jeong-Ok			Non-Invasive Screening for Alzheimer's Disease by Sensing Salivary Sugar Using Drosophila Cells Expressing Gustatory Receptor (Gr5a) Immobilized on an Extended Gate Ion-Sensitive Field-Effect Transistor (EG-ISFET) Biosensor	PLOS ONE			English	Article							MILD COGNITIVE IMPAIRMENT; AMYLOID PRECURSOR PROTEIN; PHOSPHORYLATED TAU; BIOMARKERS; IDENTIFICATION; A-BETA-42; DIAGNOSIS; DEMENTIA; BRAIN; FLUID	Body fluids are often used as specimens for medical diagnosis. With the advent of advanced analytical techniques in biotechnology, the diagnostic potential of saliva has been the focus of many studies. We recently reported the presence of excess salivary sugars, in patients with Alzheimer's disease (AD). In the present study, we developed a highly sensitive, cell-based biosensor to detect trehalose levels in patient saliva. The developed biosensor relies on the overexpression of sugar sensitive gustatory receptors (Gr5a) in Drosophila cells to detect the salivary trehalose. The cell-based biosensor was built on the foundation of an improved extended gate ion-sensitive field-effect transistor (EG-ISFET). Using an EG-ISFET, instead of a traditional ion-sensitive field-effect transistor (ISFET), resulted in an increase in the sensitivity and reliability of detection. The biosensor was designed with the gate terminals segregated from the conventional ISFET device. This design allows the construction of an independent reference and sensing region for simultaneous and accurate measurements of samples from controls and patients respectively. To investigate the efficacy of the cell-based biosensor for AD screening, we collected 20 saliva samples from each of the following groups: participants diagnosed with AD, participants diagnosed with Parkinson's disease (PD), and a control group composed of healthy individuals. We then studied the response generated from the interaction of the salivary trehalose of the saliva samples and the Gr5a in the immobilized cells on an EG-ISFET sensor. The cell-based biosensor significantly distinguished salivary sugar, trehalose of the AD group from the PD and control groups. Based on these findings, we propose that salivary trehalose, might be a potential biomarker for AD and could be detected using our cell-based EG-ISFET biosensor. The cell-based EG-ISFET biosensor provides a sensitive and direct approach for salivary sugar detection and may be used in the future as a screening method for AD.	[Lau, Hui-Chong; Lim, Jeong-Ok] Kyungpook Natl Univ, Dept Biomed Sci, Biomed Res Inst, Taegu, South Korea; [Lee, In-Kyu; Cho, Won-Ju] Kwangwoon Univ, Dept Elect Mat Engn, Seoul, South Korea; [Ko, Pan-Woo] Daegu Med Ctr, Taegu, South Korea; [Lee, Ho-Won] Kyungpook Natl Univ Hosp, Med Ctr, Dept Neurol, Chilgok, South Korea; [Huh, Jeung-Soo] Kyungpook Natl Univ, Dept Mat Sci & Met Engn, Taegu, South Korea	Kyungpook National University; Kwangwoon University; Kyungpook National University	Lim, JO (corresponding author), Kyungpook Natl Univ, Dept Biomed Sci, Biomed Res Inst, Taegu, South Korea.	jolim@knu.ac.kr			Converging Research Center Program through the National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology [2013K000364, 2013K000372]	Converging Research Center Program through the National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology	This research was supported by the Converging Research Center Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (2013K000364 and 2013K000372). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abikshyeet P, 2012, DIABETES METAB SYNDR, V5, P149, DOI 10.2147/DMSO.S32112; Bermejo-Pareja F, 2010, BMC NEUROL, V10, DOI 10.1186/1471-2377-10-108; Bian C, 2011, BIOMED MICRODEVICES, V13, P345, DOI 10.1007/s10544-010-9498-y; Blennow K, 2001, MOL NEUROBIOL, V24, P87, DOI 10.1385/MN:24:1-3:087; Blennow K, 2010, NAT REV NEUROL, V6, P131, DOI 10.1038/nrneurol.2010.4; Brosky Mary Elizabeth, 2007, J Support Oncol, V5, P215; Buerger K, 2009, EXP GERONTOL, V44, P579, DOI 10.1016/j.exger.2009.06.003; Cheau-Feng Lin F, 2014, BIOMARKERS, P1, DOI [10.3109/1354750X.2014.985254, DOI 10.3109/1354750X.2014.985254]; Chen CP, 2011, ANAL CHEM, V83, P1938, DOI 10.1021/ac102489y; Chiappin S, 2007, CLIN CHIM ACTA, V383, P30, DOI 10.1016/j.cca.2007.04.011; Conrad C, 2002, P NATL ACAD SCI USA, V99, P7751, DOI 10.1073/pnas.112194599; DeMattos RB, 2002, SCIENCE, V295, P2264, DOI 10.1126/science.1067568; Exalto LG, 2012, EXP GERONTOL, V47, P858, DOI 10.1016/j.exger.2012.07.014; Freeman SH, 2007, J NEUROPATH EXP NEUR, V66, P264, DOI 10.1097/NEN.0b013e31803d3ae4; Goncalves AC, 2013, DIAGN PATHOL, V8, DOI 10.1186/1746-1596-8-46; Han WP, 2010, P NATL ACAD SCI USA, V107, P6557, DOI 10.1073/pnas.1002555107; Hansson O, 2010, NEUROBIOL AGING, V31, P357, DOI 10.1016/j.neurobiolaging.2008.03.027; Herukka SK, 2005, NEUROLOGY, V64, P1294, DOI 10.1212/01.WNL.0000156914.16988.56; Hoffmann J, 2000, EUR J CELL BIOL, V79, P905, DOI 10.1078/0171-9335-00117; Hu S, 2005, PROTEOMICS, V5, P1714, DOI 10.1002/pmic.200401037; Huang CM, 2004, ARCH ORAL BIOL, V49, P951, DOI 10.1016/j.archoralbio.2004.06.003; Jou YJ, 2010, ANAL CHIM ACTA, V681, P41, DOI 10.1016/j.aca.2010.09.030; Kaufman E, 2002, CRIT REV ORAL BIOL M, V13, P197, DOI 10.1177/154411130201300209; Kaufman E, 2000, J CLIN PERIODONTOL, V27, P453, DOI 10.1034/j.1600-051x.2000.027007453.x; Ko SY, 2004, INT J CANCER, V111, P727, DOI 10.1002/ijc.20328; Lau HC, 2013, JPN J APPL PHYS, V52, DOI 10.7567/JJAP.52.04CL02; Lim J, 2013, J KOREAN SENSOR SOC, V22, P281; Matse JH, 2013, CLIN CANCER RES, V19, P3032, DOI 10.1158/1078-0432.CCR-12-3505; Melvin JE, 2005, ANNU REV PHYSIOL, V67, P445, DOI 10.1146/annurev.physiol.67.041703.084745; Naik VV, 2011, INDIAN J PUBLIC HLTH, V2, P103; Nittayananta W, 2013, J ORAL PATHOL MED, V42, P53, DOI 10.1111/j.1600-0714.2012.01183.x; Ott A, 1999, NEUROLOGY, V53, P1937, DOI 10.1212/WNL.53.9.1937; Pesaresi M, 2006, NEUROBIOL AGING, V27, P904, DOI 10.1016/j.neurobiolaging.2006.03.004; Profenno LA, 2010, BIOL PSYCHIAT, V67, P505, DOI 10.1016/j.biopsych.2009.02.013; Satish B N V S, 2014, J Int Oral Health, V6, P114; Shi M, 2011, J ALZHEIMERS DIS, V27, P299, DOI 10.3233/JAD-2011-110731; Sims-Robinson C, 2010, NAT REV NEUROL, V6, P551, DOI 10.1038/nrneurol.2010.130; Spielmann N, 2011, ORAL DIS, V17, P345, DOI 10.1111/j.1601-0825.2010.01773.x; Subramaniam P, 2013, J ORAL PATHOL MED, V42, P705, DOI 10.1111/jop.12061; Wallin AK, 2006, DEMENT GERIATR COGN, V21, P131, DOI 10.1159/000090631; Yang CM, 2013, SENSOR ACTUAT B-CHEM, V187, P274, DOI 10.1016/j.snb.2012.11.023	41	30	30	3	65	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2015	10	2							e0117810	10.1371/journal.pone.0117810	http://dx.doi.org/10.1371/journal.pone.0117810			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC2IM	25714733	gold, Green Published, Green Submitted			2022-12-27	WOS:000350168700040
J	Swamidass, SJ; Matlock, M; Rozenblit, L				Swamidass, S. Joshua; Matlock, Matthew; Rozenblit, Leon			Securely Measuring the Overlap between Private Datasets with Cryptosets	PLOS ONE			English	Article							SET INTERSECTION; HEALTH; COMPUTATION; PROTOCOLS; SECURITY; KERNELS	Many scientific questions are best approached by sharing data-collected by different groups or across large collaborative networks-into a combined analysis. Unfortunately, some of the most interesting and powerful datasets-like health records, genetic data, and drug discovery data-cannot be freely shared because they contain sensitive information. In many situations, knowing if private datasets overlap determines if it is worthwhile to navigate the institutional, ethical, and legal barriers that govern access to sensitive, private data. We report the first method of publicly measuring the overlap between private datasets that is secure under a malicious model without relying on private protocols or message passing. This method uses a publicly shareable summary of a dataset's contents, its cryptoset, to estimate its overlap with other datasets. Cryptosets approach "information-theoretic" security, the strongest type of security possible in cryptography, which is not even crackable with infinite computing power. We empirically and theoretically assess both the accuracy of these estimates and the security of the approach, demonstrating that cryptosets are informative, with a stable accuracy, and secure.	[Swamidass, S. Joshua; Matlock, Matthew] Washington Univ, Sch Med, Dept Pathol, St Louis, MO 63110 USA; [Rozenblit, Leon] Prometheus Res LLC, New Haven, CT USA	Washington University (WUSTL)	Swamidass, SJ (corresponding author), Washington Univ, Sch Med, Dept Pathol, St Louis, MO 63110 USA.	swamidass@wustl.edu	Swamidass, Sanjay Joshua/H-3331-2019	Swamidass, Sanjay Joshua/0000-0003-2191-0778; Matlock, Matthew/0000-0003-3087-4027	Pathology and Immunology Department at the Washington University School of Medicine	Pathology and Immunology Department at the Washington University School of Medicine	This study was funded by the Pathology and Immunology Department at the Washington University School of Medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal CC, 2008, ADV DATABASE SYST, V34, P11; Agrawal R., 2003, P 2003 ACM SIGMOD IN, P86, DOI [DOI 10.1145/872757.872771, 10.1145/872757.872771]; [Anonymous], 2012, ASIACCS; Ateniese G, 2011, LECT NOTES COMPUT SC, V6571, P156, DOI 10.1007/978-3-642-19379-8_10; Bianchi Giuseppe, 2012, Privacy in Statistical Databases. UNESCO Chair in Data Privacy. Proceedings of the International Conference, PSD 2012, P348, DOI 10.1007/978-3-642-33627-0_27; Boneh D., 1999, NOT AM MATH SOC, V46, P203; Broder A., 2004, INTERNET MATH, V1, P485, DOI [DOI 10.1080/15427951.2004.10129096, 10.1080/15427951.2004.10129096]; Dachman-Soled D, 2009, LECT NOTES COMPUT SC, V5536, P125, DOI 10.1007/978-3-642-01957-9_8; De Cristofaro E, 2010, LECT NOTES COMPUT SC, V6477, P213, DOI 10.1007/978-3-642-17373-8_13; Deng F., 2006, P ACM SIGMOD C NEW Y, P25, DOI [DOI 10.1145/1142473.1142477, 10.1145/1142473.1142477]; Diamond CC, 2009, HEALTH AFFAIR, V28, P454, DOI 10.1377/hlthaff.28.2.454; El Emam K, 2008, J AM MED INFORM ASSN, V15, P627, DOI 10.1197/jamia.M2716; Field D, 2009, SCIENCE, V326, P234, DOI 10.1126/science.1180598; Fontaine C, 2007, EURASIP J INF SECUR, DOI 10.1155/2007/13801; Foster MW, 2007, NAT REV GENET, V8, P633, DOI 10.1038/nrg2124; Freedman MJ, 2004, LECT NOTES COMPUT SC, V3027, P1; Greenbaum D, 2008, AM J BIOETHICS, V8, P71, DOI 10.1080/15265160802478560; Guo DK, 2010, IEEE T KNOWL DATA EN, V22, P120, DOI 10.1109/TKDE.2009.57; Gymrek M, 2013, SCIENCE, V339, P321, DOI 10.1126/science.1229566; Hazay C, 2008, LECT NOTES COMPUT SC, V4948, P155, DOI 10.1007/978-3-540-78524-8_10; Huang Y, 2012, NETW DISTR SYST SEC; Huang Y, 2011, LECT NOTES COMPUT SC, V7093, P28, DOI 10.1007/978-3-642-25560-1_2; Jarecki S, 2009, LECT NOTES COMPUT SC, V5444, P577; Johnson SB, 2010, J AM MED INFORM ASSN, V17, P689, DOI 10.1136/jamia.2009.002063; Kamara S, 2013, MSRTR201363; Karakasidis A, 2011, J COMPUT SCI ENG, V5, P101, DOI [10.5626/JCSE.2011.5.3.223, DOI 10.5626/JCSE.2011.5.3.223]; Kaye J, 2011, HUM GENET, V130, P377, DOI 10.1007/s00439-011-1063-0; Kissner L, 2005, LECT NOTES COMPUT SC, V3621, P241; Kissner L, 2004, TECHNICAL REPORT; Koh H.C., 2011, J HEALTHCARE INFORM, V19, P65, DOI [DOI 10.0001/.1.92.3184, https://doi.org/10.0001/.1.92.3184]; KULLBACK S, 1951, ANN MATH STAT, V22, P79, DOI 10.1214/aoms/1177729694; Kuzu M, 2013, J AM MED INFORM ASSN, V20, P285, DOI 10.1136/amiajnl-2012-000917; Kuzu M, 2011, LECT NOTES COMPUT SC, V6794, P226, DOI 10.1007/978-3-642-22263-4_13; Li QL, 2010, DRUG DISCOV TODAY, V15, P1052, DOI 10.1016/j.drudis.2010.10.003; Liang YB, 2008, FOUND TRENDS COMMUN, V5, P355, DOI 10.1561/0100000036; Lin Z, 2004, SCIENCE, V305, P183, DOI 10.1126/science.1095019; Lumley T, 2010, JAMA-J AM MED ASSOC, V303, P659, DOI 10.1001/jama.2010.120; Matlock MK, 2013, BIOINFORMATICS; McGuire AL, 2006, SCIENCE, V312, P370, DOI 10.1126/science.1125339; MENG XL, 1992, PSYCHOL BULL, V111, P172, DOI 10.1037/0033-2909.111.1.172; Mervis J, 2012, SCIENCE, V336, P22, DOI 10.1126/science.336.6077.22; Nojima R, 2009, TRANS DATA PRIV, V2, P131; O'Boyle NM, 2008, CHEM CENT J, V2, DOI 10.1186/1752-153X-2-5; Ralaivola L, 2005, NEURAL NETWORKS, V18, P1093, DOI 10.1016/j.neunet.2005.07.009; Renyi A, 1961, P 4 BERK S MATH STAT, V1; Rodriguez LL, 2013, SCIENCE, V339, P275, DOI 10.1126/science.1234593; Rothstein MA, 2010, AM J BIOETHICS, V10, P3, DOI 10.1080/15265161.2010.494215; Shand M., 1993, Proceedings. 11th Symposium on Computer Arithmetic (Cat. No.93CH3324-1), P252, DOI 10.1109/ARITH.1993.378085; Stern J, 2003, LECT NOTES COMPUT SC, V2656, P449; Stewart BA, 2010, J AM MED INFORM ASSN, V17, P341, DOI 10.1136/jamia.2009.001750; Swamidass SJ, 2007, J CHEM INF MODEL, V47, P952, DOI 10.1021/ci600526a; Swamidass SJ, 2005, BIOINFORMATICS, V21, pI359, DOI 10.1093/bioinformatics/bti1055; Theocharoulis K., 2010, Proceedings 2010 International Conference on Field Programmable Logic and Applications (FPL 2010), P145, DOI 10.1109/FPL.2010.120; Vukmir RB, 2004, AM J DRUG ALCOHOL AB, V30, P551, DOI 10.1081/ADA-200032294; Wagner D, 2003, LECT NOTES COMPUT SC, V2851, P234; Weber GM, 2013, J AM MED INFORM ASSN, V20, pE155, DOI 10.1136/amiajnl-2012-001299; Wilke RA, 2011, CLIN PHARMACOL THER, V89, P379, DOI 10.1038/clpt.2010.260	57	3	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2015	10	2							e0117898	10.1371/journal.pone.0117898	http://dx.doi.org/10.1371/journal.pone.0117898			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC2IM	25714898	Green Published, gold			2022-12-27	WOS:000350168700042
J	Hsu, CY; Liu, PH; Lee, YH; Hsia, CY; Huang, YH; Lin, HC; Chiou, YY; Lee, FY; Huo, TI				Hsu, Chia-Yang; Liu, Po-Hong; Lee, Yun-Hsuan; Hsia, Cheng-Yuan; Huang, Yi-Hsiang; Lin, Han-Chieh; Chiou, Yi-You; Lee, Fa-Yauh; Huo, Teh-Ia			Using Serum alpha-Fetoprotein for Prognostic Prediction in Patients with Hepatocellular Carcinoma: What is the Most Optimal Cutoff?	PLOS ONE			English	Article							GAMMA-CARBOXY PROTHROMBIN; LIVER-TRANSPLANTATION; TRANSARTERIAL CHEMOEMBOLIZATION; PERFORMANCE STATUS; SYSTEM; MANAGEMENT; APOPTOSIS; SELECTION; CRITERIA; IMPACT	Background and Aims The prognostic ability of alpha-fetoprotein (AFP) for patients with hepatocellular carcinoma (HCC) was examined by using different cutoff values. The optimal AFP cutoff level is still unclear. Methods A total of 2579 HCC patients were consecutively enrolled in Taiwan, where hepatitis B is the major etiology of chronic liver disease. Four frequently used AFP cutoff levels, 20, 200, 400, 1000 ng/mL, were investigated. One-to-one matched pairs between patients having AFP higher and lower than the cutoffs were selected by using the propensity model. The adjusted hazard ratios of survival difference were calculated with Cox proportional hazards model. Results Patients with a higher AFP level were associated with more severe cirrhosis, more frequent vascular invasion, higher tumor burden and poorer performance status (all p<0.0001). In the propensity model, 4 groups of paired patients were selected, and there was no difference found in the comparison of baseline characteristics (all p>0.05). Patients with AFP <20 ng/mL had significantly better long-term survival than patients with AFP >= 20 ng/mL (p<0.0001), and patients with AFP <400 ng/mL had significantly better overall outcome than patients with AFP >= 400 ng/mL (p = 0.0186). There was no difference of long-term survival between patients divided by AFP levels of 200 and 1000 ng/mL. The adjusted hazard ratios of AFP >= 20 ng/mL and AFP >= 400 ng/mL were 1.545 and 1.471 (95% confidence interval: 1.3-1.838 and 1.178-1.837), respectively. Conclusions This study shows the independently predictive ability of baseline serum AFP level in HCC patients. AFP levels of 20 and 400 ng/mL are considered feasible cutoffs to predict long-term outcome in unselected HCC patients.	[Hsu, Chia-Yang; Liu, Po-Hong; Lee, Yun-Hsuan; Hsia, Cheng-Yuan; Lin, Han-Chieh; Chiou, Yi-You; Lee, Fa-Yauh; Huo, Teh-Ia] Natl Yang Ming Univ, Fac Med, Sch Med, Taipei 112, Taiwan; [Huang, Yi-Hsiang] Natl Yang Ming Univ, Inst Clin Med, Sch Med, Taipei 112, Taiwan; [Huo, Teh-Ia] Natl Yang Ming Univ, Inst Pharmacol, Sch Med, Taipei 112, Taiwan; [Hsu, Chia-Yang; Liu, Po-Hong; Lee, Yun-Hsuan; Huang, Yi-Hsiang; Lin, Han-Chieh; Lee, Fa-Yauh; Huo, Teh-Ia] Taipei Vet Gen Hosp, Dept Med, Taipei, Taiwan; [Hsia, Cheng-Yuan] Taipei Vet Gen Hosp, Dept Surg, Taipei, Taiwan; [Chiou, Yi-You] Taipei Vet Gen Hosp, Dept Radiol, Taipei, Taiwan; [Hsu, Chia-Yang] Univ Calif Los Angeles, Dept Biostat, Los Angeles, CA USA	National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; Taipei Veterans General Hospital; Taipei Veterans General Hospital; Taipei Veterans General Hospital; University of California System; University of California Los Angeles	Huo, TI (corresponding author), Natl Yang Ming Univ, Fac Med, Sch Med, Taipei 112, Taiwan.	tihuo@vghtpe.gov.tw	Liu, Po-Hong/HGB-9015-2022; Liu, Po-Hong/G-8459-2015	Liu, Po-Hong/0000-0001-6205-3704; Huang, Yi-Hsiang/0000-0001-5241-5425	Taipei Veterans General Hospital, Taiwan [V103C-008]; Ministry of Education, Aiming for the Top University Plan, Taiwan [103AC-P618]	Taipei Veterans General Hospital, Taiwan(Taipei Veterans General Hospital); Ministry of Education, Aiming for the Top University Plan, Taiwan	This study was supported by the grants from Taipei Veterans General Hospital (V103C-008), Taiwan, and from the Ministry of Education, Aiming for the Top University Plan (103AC-P618), Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Austin PC, 2014, STAT MED, V33, P1057, DOI 10.1002/sim.6004; Blank S, 2014, ANN SURG ONCOL, V21, P986, DOI 10.1245/s10434-013-3357-z; Bruix J, 2005, HEPATOLOGY, V42, P1208, DOI 10.1002/hep.20933; Bruix J, 2001, J HEPATOL, V35, P421, DOI 10.1016/S0168-8278(01)00130-1; El-Serag HB, 2008, GASTROENTEROLOGY, V134, P1752, DOI 10.1053/j.gastro.2008.02.090; Fujiki M, 2009, AM J TRANSPLANT, V9, P2362, DOI 10.1111/j.1600-6143.2009.02783.x; Gonwa T, 2004, LIVER TRANSPLANT, V10, P301, DOI 10.1002/lt.20017; Hakeem AR, 2012, ALIMENT PHARM THER, V35, P987, DOI 10.1111/j.1365-2036.2012.05060.x; Hsu CY, 2013, ANN SURG ONCOL, V20, P2035, DOI 10.1245/s10434-012-2847-8; Hsu CY, 2013, HEPATOL INT, V7, P188, DOI 10.1007/s12072-011-9338-z; Hsu CY, 2013, HEPATOLOGY, V57, P112, DOI 10.1002/hep.25950; Hsu CY, 2010, J HEPATOL, V53, P108, DOI 10.1016/j.jhep.2010.01.038; Lee YH, 2013, HEPATOL INT, V7, P645, DOI 10.1007/s12072-012-9375-2; Lee YH, 2012, J GASTROEN HEPATOL, V27, P1581, DOI 10.1111/j.1440-1746.2012.07151.x; Lok AS, 2010, GASTROENTEROLOGY, V138, P493, DOI 10.1053/j.gastro.2009.10.031; Merani S, 2011, J HEPATOL, V55, P814, DOI 10.1016/j.jhep.2010.12.040; Mitsuhashi N, 2008, J GASTROEN HEPATOL, V23, pE189, DOI 10.1111/j.1440-1746.2008.05340.x; Perrone F, 2000, HEPATOLOGY, V31, P840; Ramirez AG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035573; Shim JH, 2012, ANN SURG ONCOL, V19, P3687, DOI 10.1245/s10434-012-2416-1; Sotiropoulos GC, 2007, J AM COLL SURGEONS, V205, P661, DOI 10.1016/j.jamcollsurg.2007.05.023; Tangkijvanich P, 2000, J CLIN GASTROENTEROL, V31, P302, DOI 10.1097/00004836-200012000-00007; Toyoda H, 2008, J HEPATOL, V49, P223, DOI 10.1016/j.jhep.2008.04.013; Wang Y, 2012, ANN SURG ONCOL, V19, P3540, DOI 10.1245/s10434-012-2368-5; Yamashita T, 2009, GASTROENTEROLOGY, V136, P1012, DOI 10.1053/j.gastro.2008.12.004; Yang XJ, 2008, CANCER LETT, V271, P281, DOI 10.1016/j.canlet.2008.06.017	26	33	36	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2015	10	3							e0118825	10.1371/journal.pone.0118825	http://dx.doi.org/10.1371/journal.pone.0118825			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9JM	25738614	gold, Green Published, Green Submitted			2022-12-27	WOS:000350685900076
J	Kunicki, M; Lukaszuk, K; Jakiel, G; Liss, J				Kunicki, Michal; Lukaszuk, Krzysztof; Jakiel, Grzegorz; Liss, Joanna			Serum Dehydroepiandrosterone Sulphate Concentration Is Not a Predictive Factor in IVF Outcomes before the First Cycle of GnRH Agonist Administration in Women with Normal Ovarian Reserve	PLOS ONE			English	Article							ANTI-MULLERIAN HORMONE; IN-VITRO FERTILIZATION; SINGLE-EMBRYO-TRANSFER; LIVE BIRTH; DHEA SUPPLEMENTATION; PREGNANCY RATE; STIMULATION; MODELS; IMPACT	Objective The aim of our study was to determine whether serum dehydroepiandrosterone sulphate (DHEAS) concentration and the models incorporating it could help clinicians to predict IVF outcomes in women with normal ovarian reserve undergoing their first long protocol. Study Design We performed a retrospective analysis of 459 women undergoing cycles of intracytoplasmic sperm injection (ICSI) for the first time in a long GnRH agonist protocol. Results Embryo transfer was performed in 407 women (88.7%). The fertilisation rate was 78.6%. The clinical pregnancy rate was 44.8% per started cycle and 50.6% per embryo transfer. Our univariate model revealed that the best predictors of clinical pregnancy were the number of mature oocytes, the number of embryos transferred and the number of good quality embryos, account for the clinical parameters that reflect ovarian reserve the best being AMH level and AFC. DHEAS did not predict clinical pregnancy (OR 1.001, 95% CI, 0.999-1.004). After adjusting for the number of embryos transferred and class of embryos in a multivariate model, the best predictors were age (OR 0.918, 95% CI, 0.867-0.972) and AFC (OR 1.022, 95% CI, 0.992-1.053). Serum DHEAS levels were positively correlated with AFC (r=0.098, P<0.039) and testosterone levels (r=0.371, P<0.001), as well as the number of mature oocytes (r=0.109, P<0.019); serum DHEAS levels were negatively correlated with age (r=-0.220, P<0.001), follicle-stimulating hormone (FSH), (r=-0.116, P<0.015) and sex hormone-binding globulin (SHBG), (r=-0.193, P<0.001). Conclusions DHEAS concentration (in addition to the known factors of ovarian reserve) does not predict clinical pregnancy in women with normal ovarian reserve who are undergoing ICSI.	[Kunicki, Michal; Jakiel, Grzegorz] INVICTA, Fertil & Reprod Ctr, Warsaw, Poland; [Lukaszuk, Krzysztof] Med Univ Gdansk, Fac Hlth Sci, Dept Obstet & Gynaecol Nursing, Gdansk, Poland; [Lukaszuk, Krzysztof] Univ Varmia & Masuria, Fac Med Sci, Dept Obstet & Gynaecol, Olsztyn, Poland; [Lukaszuk, Krzysztof; Liss, Joanna] NVICTA, Fertil & Reprod Ctr, Gdansk, Poland; [Jakiel, Grzegorz] Med Ctr Postgrad Educ, Dept Obstet & Gynecol, Warsaw, Poland	Fahrenheit Universities; Medical University Gdansk; Centre of Postgraduate Medical Education - Poland	Kunicki, M (corresponding author), INVICTA, Fertil & Reprod Ctr, Warsaw, Poland.	michal.kunicki@invicta.pl	MICHAŁ, kUNICKI/U-9114-2019; Lukaszuk, Krzysztof/ABD-1103-2021	MICHAŁ, kUNICKI/0000-0001-9672-3382; Lukaszuk, Krzysztof/0000-0001-5996-6991; Liss, Joanna/0000-0002-9199-5212; Jakiel, Grzegorz/0000-0002-6094-2273				Alebic MS, 2014, REPROD BIOMED ONLINE, V28, P191, DOI 10.1016/j.rbmo.2013.09.023; Alebic MS, 2013, INT J ENDOCRINOL, V2013, DOI 10.1155/2013/637919; Andersen AN, 2011, HUM REPROD, V26, P3413, DOI 10.1093/humrep/der318; Broekmans FJ, 2006, HUM REPROD UPDATE, V12, P685, DOI 10.1093/humupd/dml034; Broer SL, 2009, FERTIL STERIL, V91, P705, DOI 10.1016/j.fertnstert.2007.12.013; Casson PR, 2000, HUM REPROD, V15, P2129, DOI 10.1093/humrep/15.10.2129; COLAKOGLU M, 1986, Clinical and Experimental Obstetrics and Gynecology, V13, P32; Ferlitsch K, 2004, J ASSIST REPROD GEN, V21, P431, DOI 10.1007/s10815-004-8759-1; Frattarelli JL, 2006, FERTIL STERIL, V86, P51, DOI 10.1016/j.fertnstert.2005.12.028; Gardner DK, 2000, FERTIL STERIL, V73, P1155, DOI 10.1016/S0015-0282(00)00518-5; Gleicher N, 2011, REPROD BIOL ENDOCRIN, V9, DOI 10.1186/1477-7827-9-67; Gnoth C, 2008, HUM REPROD, V23, P1359, DOI 10.1093/humrep/den108; Guo J, 2014, J SUN YAT S IN PRESS; Guo J, 2014, REPROD BIOMED ONLINE, V28, P723, DOI 10.1016/j.rbmo.2014.02.009; Hunault CC, 2002, FERTIL STERIL, V77, P725, DOI 10.1016/S0015-0282(01)03243-5; Kwee J, 2008, FERTIL STERIL, V90, P737, DOI 10.1016/j.fertnstert.2007.07.1293; La Marca A, 2011, REPROD BIOMED ONLINE, V22, P341, DOI 10.1016/j.rbmo.2010.11.005; La Marca A, 2010, HUM REPROD UPDATE, V16, P113, DOI 10.1093/humupd/dmp036; Lee TH, 2009, REPROD BIOL ENDOCRIN, V7, DOI 10.1186/1477-7827-7-100; Lukaszuk K, 2005, FERTIL STERIL, V83, P1372, DOI 10.1016/j.fertnstert.2004.11.055; Nelson SM, 2007, HUM REPROD, V22, P2414, DOI 10.1093/humrep/dem204; Nelson SM, 2009, HUM REPROD, V24, P867, DOI 10.1093/humrep/den480; Ottosen LDM, 2007, J ASSIST REPROD GEN, V24, P29, DOI 10.1007/s10815-006-9082-9; *PRACT COMM, 2004, FERTIL STERIL, V82, P772; Verberg MFG, 2008, FERTIL STERIL, V89, P1159, DOI 10.1016/j.fertnstert.2007.05.020; Verhagen TEM, 2008, HUM REPROD UPDATE, V14, P95, DOI 10.1093/humupd/dmn001; Weghofer A, 2012, HUM REPROD, V27, P3287, DOI 10.1093/humrep/des265; Weghofer A, 2011, HUM REPROD, V26, P1905, DOI 10.1093/humrep/der134; Weissman A, 2011, GYNECOL ENDOCRINOL, V27, P1014, DOI 10.3109/09513590.2011.569611; Younis JS, 2010, FERTIL STERIL, V94, P655, DOI 10.1016/j.fertnstert.2009.03.036	30	3	3	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2015	10	3							e0118570	10.1371/journal.pone.0118570	http://dx.doi.org/10.1371/journal.pone.0118570			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9JM	25738591	Green Published, Green Submitted, gold			2022-12-27	WOS:000350685900048
J	Lin, Q; Li, SJ; Dong, WC; Feng, C; Yin, XR; Xu, CJ; Sun, CD; Chen, KS				Lin, Qiong; Li, Shaojia; Dong, Wencheng; Feng, Chao; Yin, Xueren; Xu, Changjie; Sun, Chongde; Chen, Kunsong			Involvement of CitCHX and CitDIC in Developmental-Related and Postharvest-Hot-Air Driven Citrate Degradation in Citrus Fruits	PLOS ONE			English	Article							ORGANIC-ACID; FUNCTIONAL-CHARACTERIZATION; DICARBOXYLATE TRANSPORTER; EXPRESSION PROFILES; RETICULATA FRUIT; GRAPE BERRIES; RNA-SEQ; ARABIDOPSIS; MALATE; ACCUMULATION	Citrate is the predominant organic acid associated with taste in citrus fruit. Although citrate metabolism has been widely studied in recent years, the potential contributions of transport proteins to citrate content remain unclear. In the present study, high-acid citrus fruit Gaocheng ('GC', Citrus sp.) and low-acid citrus fruit Satsuma mandarin ('SM', Citrus unshiu Marc.) were selected for study, and the degradation of citrate was deduced to be the main cause of the difference in acidity in fully mature fruits. RNA-seq analysis was carried out on 'GC' and 'SM' fruit samples over the same time course, and the results indicated that citrate degradation occurred mainly through the glutamine pathway, catalyzed by CitAco3-CitGS2-CitGDU1, and also two transport-related genes, CitCHX and CitDIC, were shown to be associated with citrate degradation. These results were confirmed by real-time PCR. In postharvest 'GC' fruit, the expressions of these two transport-related genes were induced by 2-fold under hot air treatment, accompanied by a reduction of 7%-9% in total acid degradation. Transient expression of CitCHX and CitDIC in tobacco leaves was performed, and the citrate content was reduced by 62%, 75% and 78% following CitCHX, CitDIC and CitCHX plus CitDIC treatments, respectively, as compared with expression of an empty vector. Overall, these data indicated that two transport proteins, CitCHX and CitDIC, are not only involved in citrate degradation during fruit development, but also involved in postharvest hot air triggered citrate reduction.	[Lin, Qiong; Li, Shaojia; Dong, Wencheng; Feng, Chao; Yin, Xueren; Xu, Changjie; Sun, Chongde; Chen, Kunsong] Zhejiang Univ, Lab Hort Plant Growth Dev & Qual Improvement, Lab Fruit Qual Biol, State Agr Minist, Hangzhou 310058, Zhejiang, Peoples R China	Zhejiang University	Sun, CD (corresponding author), Zhejiang Univ, Lab Hort Plant Growth Dev & Qual Improvement, Lab Fruit Qual Biol, State Agr Minist, Hangzhou 310058, Zhejiang, Peoples R China.	adesun2006@zju.edu.cn	Yin, Xue-ren/B-3893-2008; Xu, Changjie/D-2656-2009	Yin, Xue-ren/0000-0002-1282-4432; 	National Basic Research Program of China (973 program) [2011CB100602]; Program of International Science and Technology Cooperation [2011DFB31580]; National Key Technology Research and Development Program of the Ministry of Science and Technology of China [2012BAD38B03]	National Basic Research Program of China (973 program)(National Basic Research Program of China); Program of International Science and Technology Cooperation; National Key Technology Research and Development Program of the Ministry of Science and Technology of China(National Key Technology R&D Program)	This research was supported by the National Basic Research Program of China (973 program) (2011CB100602), the Program of International Science and Technology Cooperation (2011DFB31580) and the National Key Technology Research and Development Program of the Ministry of Science and Technology of China (2012BAD38B03). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bai Y, 2012, MOL GENET GENOMICS, V287, P663, DOI 10.1007/s00438-012-0707-7; Barragan V, 2012, PLANT CELL, V24, P1127, DOI 10.1105/tpc.111.095273; Canel C, 1996, PLANT MOL BIOL, V31, P143, DOI 10.1007/BF00020613; Cellier F, 2004, PLANT J, V39, P834, DOI 10.1111/j.1365-313X.2004.02177.x; Cercos M, 2006, PLANT MOL BIOL, V62, P513, DOI 10.1007/s11103-006-9037-7; Chanroj S, 2011, J BIOL CHEM, V286, P33931, DOI 10.1074/jbc.M111.252650; Chen M, 2013, PLANT MOL BIOL REP, V31, P1131, DOI 10.1007/s11105-013-0583-2; Chen M, 2012, SCI HORTIC-AMSTERDAM, V147, P118, DOI 10.1016/j.scienta.2012.09.011; Coursol S, 2000, BIOCHEM SOC T, V28, P821, DOI 10.1042/BST0280821; De Angeli A, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2815; Durrett TP, 2007, PLANT PHYSIOL, V144, P197, DOI 10.1104/pp.107.097162; Etienne A, 2013, J EXP BOT, V64, P1451, DOI 10.1093/jxb/ert035; Gmitter FG, 2012, TREE GENET GENOMES, V8, P611, DOI 10.1007/s11295-012-0499-2; Gruber BD, 2010, J EXP BOT, V61, P1455, DOI 10.1093/jxb/erq023; Han DG, 2012, BIOL PLANTARUM, V56, P50, DOI 10.1007/s10535-012-0015-4; HARDY PJ, 1968, PLANT PHYSIOL, V43, P224, DOI 10.1104/pp.43.2.224; Hurth MA, 2005, PLANT PHYSIOL, V137, P901, DOI 10.1104/pp.104.058453; Katz E, 2007, PLANTA, V226, P989, DOI 10.1007/s00425-007-0545-8; Katz E, 2011, J EXP BOT, V62, P5367, DOI 10.1093/jxb/err197; Ligaba A, 2012, PLANT CELL ENVIRON, V35, P1185, DOI 10.1111/j.1365-3040.2011.02479.x; Lin Q, 2015, GENE, V554, P64, DOI 10.1016/j.gene.2014.10.025; LINN TC, 1979, J BIOL CHEM, V254, P1691; Liu JP, 2009, PLANT J, V57, P389, DOI 10.1111/j.1365-313X.2008.03696.x; Liu XF, 2013, PLANT MOL BIOL REP, V31, P1474, DOI 10.1007/s11105-013-0621-0; Maeshima M, 2001, ANNU REV PLANT PHYS, V52, P469, DOI 10.1146/annurev.arplant.52.1.469; Mancusso R, 2012, NATURE, V491, P622, DOI 10.1038/nature11542; Martinelli F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038039; Mei L, 2009, QUALITY EVALUATION W; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; OLESKI N, 1987, PLANT PHYSIOL, V84, P997, DOI 10.1104/pp.84.4.997; Osorio Sonia, 2012, Methods Mol Biol, V860, P101, DOI 10.1007/978-1-61779-594-7_7; Pillitteri LJ, 2004, J AM SOC HORTIC SCI, V129, P846, DOI 10.21273/JASHS.129.6.0846; Pilot G, 2004, PLANT CELL, V16, P1827, DOI 10.1105/tpc.021642; Pratelli R, 2010, PLANT PHYSIOL, V152, P762, DOI 10.1104/pp.109.151746; Regalado A, 2013, PLANTA, V237, P693, DOI 10.1007/s00425-012-1786-8; RENTSCH D, 1991, PLANTA, V184, P532, DOI 10.1007/BF00197903; Rongala J, 2008, IDENTIFICATION LOCAL; Saunt J., 1990, CITRUS VARIETIES WOR; Shan LL, 2008, PLANTA, V227, P1243, DOI 10.1007/s00425-008-0696-2; Shimada T, 2005, PLANT SCI, V168, P1383, DOI 10.1016/j.plantsci.2005.01.013; Taniguchi M, 1997, PLANT PHYSIOL, V114, P285, DOI 10.1104/pp.114.1.285; Terrier N, 1998, PLANT PHYSIOL BIOCH, V36, P367, DOI 10.1016/S0981-9428(98)80078-8; Tovkach A, 2013, PLANT PHYSIOL, V161, P880, DOI 10.1104/pp.112.207142; Wang LK, 2010, BIOINFORMATICS, V26, P136, DOI 10.1093/bioinformatics/btp612; Xu Q, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-540; Yao YX, 2011, PLANT PHYSIOL BIOCH, V49, P1201, DOI 10.1016/j.plaphy.2011.05.012; Yin XR, 2010, PLANT PHYSIOL, V153, P1280, DOI 10.1104/pp.110.157081; Yin YG, 2010, PLANT CELL PHYSIOL, V51, P1300, DOI 10.1093/pcp/pcq090; Yokosho K, 2009, PLANT PHYSIOL, V149, P297, DOI 10.1104/pp.108.128132; Zheng BB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043758	50	15	19	1	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2015	10	3							e0119410	10.1371/journal.pone.0119410	http://dx.doi.org/10.1371/journal.pone.0119410			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9JM	25738939	Green Submitted, gold, Green Published			2022-12-27	WOS:000350685900106
J	Zou, JF; Guo, QM; Shao, H; Li, B; Du, YX; Liu, MF; Liu, FL; Dai, LX; Lin, HJ; Su, SB; Guo, HR; Huang, CC				Zou, Jian-Fang; Guo, Qiming; Shao, Hua; Li, Bin; Du, Yuxiu; Liu, Maofeng; Liu, Fengling; Dai, Lixin; Lin, Hung-Jung; Su, Shih-Bin; Guo, How-Ran; Huang, Chien-Cheng			Lack of Pupil Reflex and Loss of Consciousness Predict 30-Day Neurological Sequelae in Patients with Carbon Monoxide Poisoning	PLOS ONE			English	Article							HYPERBARIC-OXYGEN; BRAIN; MANAGEMENT; TOXICITY; ISSUES	Background Predicting the neurological sequelae of carbon monoxide poisoning (COP) has not been well studied. We investigated the independent predictors of neurological sequelae in patients with COP and combined these predictors to predict the prognosis. Methods This study was conducted at four hospitals in Shandong Province, China. Data were retrospectively collected from 258 patients with COP between November 1990 and October 2011. Thirty-day neurological sequelae were the primary endpoints. Results A lack of pupil reflex and a loss of consciousness appear to be independent predictors for neurological sequelae in patients with COP. The presence of either one had a sensitivity of 77.0% (95% confidence interval [CI]: 69.3-83.2), a specificity of 47.1% (95% CI: 38.3-56.0), positive predictive value (PPV) of 62.9% (95% CI: 55.2-70.1), and a negative predictive value (NPV) of 63.6%(95% CI: 52.6-73.4). With both predictors present, the sensitivity was 11.5%(95% CI: 6.9 to 18.3), the specificity was 99.2 (95% CI: 94.7-100.0), the PPV was 94.1%(95% CI: 69.2-99.7), and the NPV was 49.0%(95% CI: 42.5-55.5). Conclusions The risk for neurological sequelae apparently increased with the number of independent predictors. In patients with both predictors, the risk for neurological sequelae was 94.1%. Almost all (99.2%) patients with neither predictor had no neurological sequelae. This finding may help physicians make decisions about and dispositions for patients with COP. For patients with a higher risk, earlier treatment and more appropriate utilization of health care services, including hyperbaric oxygen, should be considered.	[Zou, Jian-Fang; Guo, Qiming; Shao, Hua] Acad Med Sci, Clin Div Occupat Med, Inst Occupat Hlth & Occupat Med, Jinan, Shandong, Peoples R China; [Li, Bin] Natl Inst Occupat Hlth & Poison Control, Div Toxicol, Beijing, Peoples R China; [Du, Yuxiu] Second Peoples Hosp Dongying, Dept Med, Dongying, Shandong, Peoples R China; [Liu, Maofeng; Liu, Fengling] Qilu Petrochem Corp Hosp, Dept Med, Zibo, Shandong, Peoples R China; [Dai, Lixin] Second Peoples Hosp Kenli, Dept Med, Kenli, Shandong, Peoples R China; [Lin, Hung-Jung] Chi Mei Med Ctr, Dept Emergency Med, Tainan, Taiwan; [Lin, Hung-Jung] Southern Taiwan Univ Sci & Technol, Dept Biotechnol, Tainan, Taiwan; [Su, Shih-Bin] Chi Mei Med Ctr, Dept Occupat Med, Tainan, Taiwan; [Su, Shih-Bin] Southern Taiwan Univ Sci & Technol, Dept Leisure Recreat & Tourism Management, Tainan, Taiwan; [Su, Shih-Bin] Chi Mei Med Ctr, Dept Med Res, Tainan, Taiwan; [Guo, How-Ran; Huang, Chien-Cheng] Natl Cheng Kung Univ, Coll Med, Dept Environm & Occupat Hlth, Tainan 70101, Taiwan; [Guo, How-Ran] Natl Cheng Kung Univ Hosp, Dept Occupat & Environm Med, Tainan 70428, Taiwan; [Huang, Chien-Cheng] Southern Taiwan Univ Sci & Technol, Dept Child Care & Educ, Tainan, Taiwan; [Huang, Chien-Cheng] Kuo Gen Hosp, Dept Emergency Med, Tainan, Taiwan	Chinese Center for Disease Control & Prevention; National Institute of Occupational Health & Poison Control, Chinese Center for Disease Control & Prevention; Chi Mei Hospital; Southern Taiwan University of Science & Technology; Chi Mei Hospital; Southern Taiwan University of Science & Technology; Chi Mei Hospital; National Cheng Kung University; National Cheng Kung University; National Cheng Kung University Hospital; Southern Taiwan University of Science & Technology	Guo, HR (corresponding author), Natl Cheng Kung Univ, Coll Med, Dept Environm & Occupat Hlth, Tainan 70101, Taiwan.	hrguo@mail.ncku.edu.tw; chienchenghuang@yahoo.com.tw	Guo, How-Ran/AAK-9063-2020	Guo, How-Ran/0000-0003-3343-3446				Colman AM, 2001, DICT PSYCHOL OXFORD; Dehaene S, 2001, COGNITION, V79, P1, DOI 10.1016/S0010-0277(00)00123-2; Ernst A, 1998, NEW ENGL J MED, V339, P1603, DOI 10.1056/NEJM199811263392206; Gorman D, 2003, TOXICOLOGY, V187, P25, DOI 10.1016/S0300-483X(03)00005-2; Hampson NB, 2001, UNDERSEA HYPERBAR M, V28, P157; Hampson NB, 2012, AM J RESP CRIT CARE, V186, P1095, DOI 10.1164/rccm.201207-1284CI; Hampson Neil B., 1995, Journal of Emergency Medicine, V13, P227, DOI 10.1016/0736-4679(94)00144-8; Hu HJ, 2011, AM J EMERG MED, V29, P261, DOI 10.1016/j.ajem.2009.09.030; Kao LW, 2004, EMERG MED CLIN N AM, V22, P985, DOI 10.1016/j.emc.2004.05.003; Laureys S, 2004, LANCET NEUROL, V3, P537, DOI 10.1016/S1474-4422(04)00852-X; Lo CP, 2007, AM J ROENTGENOL, V189, pW205, DOI 10.2214/AJR.07.2425; O'Donnell P, 2000, CLIN RADIOL, V55, P273, DOI 10.1053/crad.1999.0369; Omaye ST, 2002, TOXICOLOGY, V180, P139, DOI 10.1016/S0300-483X(02)00387-6; Shprecher D, 2010, NEUROREHABILITATION, V26, P65, DOI 10.3233/NRE-2010-0536; Steriade M., 1997, THALAMUS; Thom SR, 2002, NEW ENGL J MED, V347, P1105, DOI 10.1056/NEJMe020103; Thom SR, 2006, TOXICOL APPL PHARM, V213, P152, DOI 10.1016/j.taap.2005.10.006; Weaver LK, 2007, AM J RESP CRIT CARE, V176, P491, DOI 10.1164/rccm.200701-026OC; Weaver LK, 2002, NEW ENGL J MED, V347, P1057, DOI 10.1056/NEJMoa013121; Wolf SJ, 2008, ANN EMERG MED, V51, P138, DOI 10.1016/j.annemergmed.2007.10.012; Zeman A, 2001, BRAIN, V124, P1263, DOI 10.1093/brain/124.7.1263	21	21	22	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2015	10	3							e0119126	10.1371/journal.pone.0119126	http://dx.doi.org/10.1371/journal.pone.0119126			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9JM	25738593	Green Submitted, gold, Green Published			2022-12-27	WOS:000350685900093
J	Borshchevskiy, V; Round, E; Bertsova, Y; Polovinkin, V; Gushchin, I; Ishchenko, A; Kovalev, K; Mishin, A; Kachalova, G; Popov, A; Bogachev, A; Gordeliy, V				Borshchevskiy, Valentin; Round, Ekaterina; Bertsova, Yulia; Polovinkin, Vitaly; Gushchin, Ivan; Ishchenko, Andrii; Kovalev, Kirill; Mishin, Alexey; Kachalova, Galina; Popov, Alexander; Bogachev, Alexander; Gordeliy, Valentin			Structural and Functional Investigation of Flavin Binding Center of the NqrC Subunit of Sodium-Translocating NADH: Quinone Oxidoreductase from Vibrio harveyi	PLOS ONE			English	Article							UBIQUINONE OXIDOREDUCTASE; THREONINE RESIDUE; PROSTHETIC GROUPS; REDOX PROPERTIES; FMN; REDUCTASE; MECHANISM; DOMAINS; PHENIX	Na+-translocating NADH: quinone oxidoreductase (NQR) is a redox-driven sodium pump operating in the respiratory chain of various bacteria, including pathogenic species. The enzyme has a unique set of redox active prosthetic groups, which includes two covalently bound flavin mononucleotide (FMN) residues attached to threonine residues in subunits NqrB and NqrC. The reason of FMN covalent bonding in the subunits has not been established yet. In the current work, binding of free FMN to the apo-form of NqrC from Vibrio harveyi was studied showing very low affinity of NqrC to FMN in the absence of its covalent bonding. To study structural aspects of flavin binding in NqrC, its holo-form was crystallized and its 3D structure was solved at 1.56A resolution. It was found that the isoalloxazine moiety of the FMN residue is buried in a hydrophobic cavity and that its pyrimidine ring is squeezed between hydrophobic amino acid residues while its benzene ring is extended from the protein surroundings. This structure of the flavin-binding pocket appears to provide flexibility of the benzene ring, which can help the FMN residue to take the bended conformation and thus to stabilize the one-electron reduced form of the prosthetic group. These properties may also lead to relatively weak noncovalent binding of the flavin. This fact along with periplasmic location of the FMN-binding domains in the vast majority of NqrC-like proteins may explain the necessity of the covalent bonding of this prosthetic group to prevent its loss to the external medium.	[Borshchevskiy, Valentin; Polovinkin, Vitaly; Gushchin, Ivan; Kovalev, Kirill; Mishin, Alexey; Gordeliy, Valentin] Moscow Inst Phys & Technol, Dolgoprudnyi, Russia; [Borshchevskiy, Valentin; Round, Ekaterina; Polovinkin, Vitaly; Gushchin, Ivan; Ishchenko, Andrii; Gordeliy, Valentin] Res Ctr Julich GmbH, Inst Complex Syst ICS 6 Struct Biochem, Julich, Germany; [Bertsova, Yulia; Bogachev, Alexander] Moscow MV Lomonosov State Univ, Belozersky Inst Physicochem Biol, Moscow, Russia; [Kachalova, Galina] Russian Acad Sci, AN Bach Inst Biochem, Moscow, Russia; [Popov, Alexander] European Synchrotron Radiat Facil, F-38043 Grenoble, France; [Gordeliy, Valentin] Univ Grenoble Alpes, IBS, Grenoble, France; [Gordeliy, Valentin] CNRS, IBS, Grenoble, France; [Gordeliy, Valentin] CEA Grenoble, IBS, F-38054 Grenoble, France	Moscow Institute of Physics & Technology; Helmholtz Association; Research Center Julich; Lomonosov Moscow State University; Research Center of Biotechnology RAS; Russian Academy of Sciences; European Synchrotron Radiation Facility (ESRF); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS)	Bogachev, A (corresponding author), Moscow MV Lomonosov State Univ, Belozersky Inst Physicochem Biol, Moscow, Russia.	bogachev@belozersky.msu.ru; valentin.gordeliy@ibs.fr	Polovinkin, Vitaly/G-6627-2017; Bertsova, Yulia V./B-5505-2014; Gordeliy, Valentin I/J-3636-2013; Bogachev, Alexander V/E-5844-2012; kachalova, galina/AAD-9742-2019; Gushchin, Ivan/AAO-8829-2020; Kovalev, Kirill/J-6750-2015; Gushchin, Ivan/K-9197-2015; Borshchevskiy, Valentin I./F-2287-2014; Kachalova, Galina S/J-9437-2015; Mishin, Alexey V/F-2960-2014	Polovinkin, Vitaly/0000-0002-3630-5565; Gordeliy, Valentin I/0000-0001-5782-5896; Bogachev, Alexander V/0000-0003-3035-4494; Gushchin, Ivan/0000-0002-5348-6070; Gushchin, Ivan/0000-0002-5348-6070; Borshchevskiy, Valentin I./0000-0003-4398-9712; Kachalova, Galina S/0000-0002-8240-6287; Mishin, Alexey V/0000-0003-3759-380X; Popov, Alexander/0000-0002-3058-8912; Kovalev, Kirill/0000-0002-2229-181X	Russian foundation for basic research [13-04- 91320]; Helmholtz Association of German Research Centres [HRJRG-401]; RSCF [14-14-00128]; BMBF; Russian Federal Target Program "Research and Development" [14.587.21.0004]; GRAL [ANR-10-LABX-4901]; FRISBI [ANR-10-INSB-05-02]; Grenoble Instruct centre (ISBG) [UMS 3518 CNRS-CEA-UJF-EMBL]; Russian Science Foundation [14-14-00128] Funding Source: Russian Science Foundation	Russian foundation for basic research(Russian Foundation for Basic Research (RFBR)); Helmholtz Association of German Research Centres(Helmholtz Association); RSCF(Russian Science Foundation (RSF)); BMBF(Federal Ministry of Education & Research (BMBF)); Russian Federal Target Program "Research and Development"; GRAL; FRISBI; Grenoble Instruct centre (ISBG); Russian Science Foundation(Russian Science Foundation (RSF))	The work was supported by Russian foundation for basic research (research projects 13-04- 91320) and Helmholtz Association of German Research Centres (project ID: HRJRG-401) as well as the Russian state Program 5top100-programme for enhancing the competitiveness of MIPT among the world's leading research and education centers of the Ministry of education and science. NqrC purification and flavinylation as well as studying of FMN binding properties of apoNqrC' were supported by RSCF research project 14-14-00128. Crystallization, X-ray data collection and treatment were supported by RSCF research project 14-1400995. The work was supported by the program "Chaires d'excellence" edition 2008 of ANR France and CEA(IBS) - HGF(FZJ) STC 5.1 specific agreement. Part of this work was supported by BMBF (PhoNa - Photonic Nanomaterials) and Russian Federal Target Program "Research and Development" (No 14.587.21.0004, unique identifier RFMEFI58714X0004). The work used the platforms of the Grenoble Instruct centre (ISBG; UMS 3518 CNRS-CEA-UJF-EMBL) with support from FRISBI (ANR-10-INSB-05-02) and GRAL (ANR-10-LABX-4901) within the Grenoble Partnership for Structural Biology (PSB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Backiel J, 2008, BIOCHEMISTRY-US, V47, P11273, DOI 10.1021/bi800920j; Bertsova YV, 2014, BBA-BIOENERGETICS, V1837, P1122, DOI 10.1016/j.bbabio.2013.12.006; Bertsova YV, 2013, J BIOL CHEM, V288, P14276, DOI 10.1074/jbc.M113.455402; Bogachev AV, 2012, MOL MICROBIOL, V86, P1452, DOI 10.1111/mmi.12067; Bogachev AV, 2009, BIOCHEMISTRY-US, V48, P6291, DOI 10.1021/bi900524m; Bogachev AV, 2009, BIOCHEMISTRY-US, V48, P6299, DOI 10.1021/bi900525v; DiMaio F, 2013, NAT METHODS, V10, P1102, DOI [10.1038/nmeth.2648, 10.1038/NMETH.2648]; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Hase CC, 2001, MICROBIOL MOL BIOL R, V65, P353, DOI 10.1128/MMBR.65.3.353-370.2001; Hayashi M, 2001, FEBS LETT, V488, P5, DOI 10.1016/S0014-5793(00)02404-2; HAYASHI M, 1994, FEBS LETT, V356, P330, DOI 10.1016/0014-5793(94)01274-1; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Joosten RP, 2011, NUCLEIC ACIDS RES, V39, pD411, DOI 10.1093/nar/gkq1105; Juarez O, 2009, J BIOL CHEM, V284, P8963, DOI 10.1074/jbc.M809395200; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Li X, 2006, BIOCHEMISTRY-US, V45, P14781, DOI 10.1021/bi0610956; Macheroux P, 2011, FEBS J, V278, P2625, DOI 10.1111/j.1742-4658.2011.08202.x; Muralidhara BK, 2005, J MOL BIOL, V349, P87, DOI 10.1016/j.jmb.2005.03.054; Nicholas KB., 1997, GENEDOC TOOL EDITING; RICH PR, 1995, FEBS LETT, V375, P5, DOI 10.1016/0014-5793(95)01164-A; Rohr AK, 2010, ANGEW CHEM INT EDIT, V49, P2324, DOI 10.1002/anie.200907143; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; Steuber J, 2014, NATURE, V516, P62, DOI 10.1038/nature14003; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; Verkhovsky MI, 2010, BBA-BIOENERGETICS, V1797, P738, DOI 10.1016/j.bbabio.2009.12.020; Vohl G, 2014, ACTA CRYSTALLOGR F, V70, P987, DOI 10.1107/S2053230X14009881; Wunsch P, 2005, J BACTERIOL, V187, P1992, DOI 10.1128/JB.187.6.1992-2001.2005; Yeats C, 2003, BMC MICROBIOL, V3, DOI 10.1186/1471-2180-3-3; Zhou WD, 1999, BIOCHEMISTRY-US, V38, P16246, DOI 10.1021/bi991664s	30	13	13	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2015	10	3							e0118548	10.1371/journal.pone.0118548	http://dx.doi.org/10.1371/journal.pone.0118548			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4HV	25734798	gold, Green Published			2022-12-27	WOS:000350314700037
J	Wang, M; Xu, X; Zhang, XX; Sun, S; Wu, CX; Hou, WS; Wang, QY; Han, TF				Wang, Miao; Xu, Xin; Zhang, Xinxin; Sun, Shi; Wu, Cunxiang; Hou, Wensheng; Wang, Qingyu; Han, Tianfu			Functional Analysis of GmCPDs and Investigation of Their Roles in Flowering	PLOS ONE			English	Article							GIBBERELLIN 20-OXIDASE; TRANSCRIPT LEVELS; FLORAL-INDUCTION; CIRCADIAN CLOCK; DE-ETIOLATION; CPD GENE; BRASSINOSTEROIDS; ARABIDOPSIS; EXPRESSION; CYTOCHROME-P450	The onset of floral development is a pivotal switch in the life of soybean. Brassinosteroids (BRs), a group of steroidal phytohormones with essential roles in plant growth and development, are associated with flowering induction. Genes involved in BR biosynthesis have been studied to a great extent in Arabidopsis, but the study of these genes has been limited in soybean. In this study, four CPD homologs (GmCPDs) catalyzing BR synthesis were isolated from soybean. Transcripts were mainly confined to cotyledons and leaves and were down-regulated in response to exogenous BR. Bioinformatic analysis showed strong sequence and structure similarity between GmCPDs and AtCPD as well as CPDs of other species. Overexpression of GmCPDs in an Arabidopsis BR-deficient mutant rescued the phenotype by restoring the biosynthesis pathway, revealing the functional roles of each GmCPDs in. Except for the rescue of root development, leaf expansion and plant type architecture, GmCPDs in expression also complemented the late flowering phenotype of Arabidopsis mutants deficient in CPD. Further evidence in soybean plants is that the expression levels of GmCPDs in are under photoperiod control in Zigongdongdou, a photoperiod-sensitive variety, and show a sudden peak upon floral meristem initiation. Together with increased GmCPDs in expression in the leaves and cotyledons of photoperiod- insensitive early-maturity soybean, it is clear that GmCPDs in contribute to flowering development and are essential in the early stages of flowering regulation.	[Wang, Miao; Xu, Xin; Zhang, Xinxin; Sun, Shi; Wu, Cunxiang; Hou, Wensheng; Han, Tianfu] Chinese Acad Agr Sci, Inst Crop Sci, Minist Agr, Key Lab Soybean Biol Beijing, Beijing 100081, Peoples R China; [Wang, Miao; Wang, Qingyu] Jilin Univ, Coll Plant Sci, Changchun 130062, Jilin, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Crop Sciences, CAAS; Ministry of Agriculture & Rural Affairs; Jilin University	Wang, QY (corresponding author), Jilin Univ, Coll Plant Sci, Changchun 130062, Jilin, Peoples R China.	qywang@jlu.edu.cn; hantianfu@caas.cn			China Agriculture Research System [CARS-04]; CAAS Innovation Project	China Agriculture Research System; CAAS Innovation Project	This work was supported by the China Agriculture Research System (CARS-04) and CAAS Innovation Project to T.H. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achard P, 2007, P NATL ACAD SCI USA, V104, P6484, DOI 10.1073/pnas.0610717104; Ait-Ali T, 1999, PLANT PHYSIOL, V121, P783, DOI 10.1104/pp.121.3.783; Alabadi D, 2009, INT J DEV BIOL, V53, P1597, DOI 10.1387/ijdb.072423da; Azpiroz R, 1998, PLANT CELL, V10, P219, DOI 10.1105/tpc.10.2.219; Bajguz A, 2003, PHYTOCHEMISTRY, V62, P1027, DOI 10.1016/S0031-9422(02)00656-8; Bancos S, 2006, PLANT PHYSIOL, V141, P299, DOI 10.1104/pp.106.079145; Bancos S, 2002, PLANT PHYSIOL, V130, P504, DOI 10.1104/pp.005439; BATTEY NH, 1990, BOT REV, V56, P162, DOI 10.1007/BF02858534; CHORY J, 1991, PLANT CELL, V3, P445, DOI 10.1105/tpc.3.5.445; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Clouse SD, 1998, ANNU REV PLANT PHYS, V49, P427, DOI 10.1146/annurev.arplant.49.1.427; Corbesier L, 2007, SCIENCE, V316, P1030, DOI 10.1126/science.1141752; Curtis DF, 2000, CROP SCI, V40, P1624, DOI 10.2135/cropsci2000.4061624x; Divi UK, 2009, NEW BIOTECHNOL, V26, P131, DOI 10.1016/j.nbt.2009.07.006; Domagalska MA, 2007, DEVELOPMENT, V134, P2841, DOI 10.1242/dev.02866; Gai JunYi, 2001, Scientia Agricultura Sinica, V34, P139; Green RM, 1999, P NATL ACAD SCI USA, V96, P4176, DOI 10.1073/pnas.96.7.4176; Han TianFu, 1998, Acta Agronomica Sinica, V24, P168; Hanano S, 2006, GENES CELLS, V11, P1381, DOI 10.1111/j.1365-2443.2006.01026.x; Harmer SL, 2005, PLANT CELL, V17, P1926, DOI 10.1105/tpc.105.033035; Higgins JA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010065; Jackson SD, 2000, PLANT PHYSIOL, V124, P423, DOI 10.1104/pp.124.1.423; Jia Zhen, 2011, Acta Agronomica Sinica, V37, P650, DOI 10.3724/SP.J.1006.2011.00650; Kauschmann A, 1996, PLANT J, V9, P701, DOI 10.1046/j.1365-313X.1996.9050701.x; Kim HB, 2006, PLANT PHYSIOL, V140, P548, DOI 10.1104/pp.105.067918; KOCH BM, 1995, ARCH BIOCHEM BIOPHYS, V323, P177; Kotchoni SO, 2009, PLANT PHYSIOL, V149, P803, DOI 10.1104/pp.108.132324; Krumova S, 2013, J PHOTOCH PHOTOBIO B, V126, P97, DOI 10.1016/j.jphotobiol.2013.07.008; Lee JH, 2007, GENE DEV, V21, P397, DOI 10.1101/gad.1518407; Li JH, 2010, J EXP BOT, V61, P4221, DOI 10.1093/jxb/erq241; Li JM, 1997, CELL, V90, P929, DOI 10.1016/S0092-8674(00)80357-8; Li XiaoMei, 2005, Acta Agronomica Sinica, V31, P1437; Liu SH, 2014, GENE, V543, P145, DOI 10.1016/j.gene.2014.03.026; Mathur J, 1998, PLANT J, V14, P593, DOI 10.1046/j.1365-313X.1998.00158.x; McClung CR, 2006, PLANT CELL, V18, P792, DOI 10.1105/tpc.106.040980; Michaels SD, 2009, CURR OPIN PLANT BIOL, V12, P75, DOI 10.1016/j.pbi.2008.09.005; Montoya T, 2005, PLANT J, V42, P262, DOI 10.1111/j.1365-313X.2005.02376.x; Noguchi T, 2000, PLANT PHYSIOL, V124, P201, DOI 10.1104/pp.124.1.201; Nomura T, 2007, PLANT PHYSIOL, V143, P1680, DOI 10.1104/pp.106.093096; Ohnishi T, 2006, PLANT CELL, V18, P3275, DOI 10.1105/tpc.106.045443; Ohnishi T, 2012, J BIOL CHEM, V287, P31551, DOI 10.1074/jbc.M112.392720; Shimada Y, 2003, PLANT PHYSIOL, V131, P287, DOI 10.1104/pp.013029; Suarez-Lopez P, 2001, NATURE, V410, P1116, DOI 10.1038/35074138; Sun HB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029238; Symons GM, 2006, PLANT PHYSIOL, V140, P150, DOI 10.1104/pp.105.070706; Symons GM, 2004, PLANT PHYSIOL, V135, P2196, DOI 10.1104/pp.104.043034; Symons GM, 2008, J EXP BOT, V59, P17, DOI 10.1093/jxb/erm098; Szekeres M, 1996, CELL, V85, P171, DOI 10.1016/S0092-8674(00)81094-6; Toyomasu T, 1998, PLANT PHYSIOL, V118, P1517, DOI 10.1104/pp.118.4.1517; Tsuda K, 2014, PLANT CELL, V26, P3488, DOI 10.1105/tpc.114.129122; Washburn CF, 2000, AM J BOT, V87, P1425, DOI 10.2307/2656869; Wellmer F, 2010, TRENDS GENET, V26, P519, DOI 10.1016/j.tig.2010.09.001; Wollenberg AC, 2008, PLANT PHYSIOL, V148, P1681, DOI 10.1104/pp.108.125468; Wu CX, 2006, PLANTA, V223, P725, DOI 10.1007/s00425-005-0130-y; Xu Y, 2014, PLANT PHYSL BIOCH; Yamaguchi S, 1998, PLANT CELL, V10, P2115, DOI 10.1105/tpc.10.12.2115; Yang CJ, 2011, MOL PLANT, V4, P588, DOI 10.1093/mp/ssr020; Yanovsky MJ, 2002, NATURE, V419, P308, DOI 10.1038/nature00996; Zhang YY, 2013, PLANT CELL, V25, P2504, DOI 10.1105/tpc.113.110296	59	13	15	1	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2015	10	3							e0118476	10.1371/journal.pone.0118476	http://dx.doi.org/10.1371/journal.pone.0118476			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4HV	25734273	Green Published, Green Submitted, gold			2022-12-27	WOS:000350314700032
J	Chen, YH; Su, C; Tseng, JM; Li, WJ				Chen, YaoHan; Su, ChungHwei; Tseng, JoMing; Li, WunJie			Experimental and Numerical Analysis of the Cooling Performance of Water Spraying Systems during a Fire	PLOS ONE			English	Article							SMOKE; MIST; SUPPRESSION; ENVIRONMENT; SIMULATION; DYNAMICS; STATION	The water spray systems are effective protection systems in the confined or unconfined spaces to avoid the damage to building structures since the high temperature when fires occur. NFPA 15 and 502 have suggested respectively that the factories or vehicle tunnels install water spray systems to protect the machinery and structures. This study discussed the cooling effect of water spray systems in experimental and numerical analyses. The actual combustion of woods were compared with the numerical simulations. The results showed that although the flame continued, the cooling effects by water spraying process within 120 seconds were obvious. The results also indicated that the simulation results of the fifth version Fire Dynamics Simulator (FDS) overestimated the space temperature before water spraying in the case of the same water spray system.	[Chen, YaoHan] WuFeng Univ, Dept Fire Sci, Minxiong Township, Chiayi County, Taiwan; [Su, ChungHwei] Natl Kaohsiung First Univ Sci & Technol, Dept Safety Hlth & Environm Engn, Kaohsiung, Taiwan; [Tseng, JoMing] Cent Taiwan Univ Sci & Technol, Inst Safety & Disaster Prevent Technol, Taichung, Taiwan; [Li, WunJie] WuFeng Univ, Grad Sch Optomechatron & Mat, Minxiong Township, Chiayi County, Taiwan	National Kaohsiung University of Science & Technology; Central Taiwan University Science & Technology	Su, C (corresponding author), Natl Kaohsiung First Univ Sci & Technol, Dept Safety Hlth & Environm Engn, Kaohsiung, Taiwan.	such@nkfust.edu.tw			Ministry of Science and Technology [NSC 102-2221-E-274 -001 -MY3]	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea)	The authors gratefully acknowledge the financial support for this project from the Ministry of Science and Technology under Grant no. NSC 102-2221-E-274 -001 -MY3. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], NIST SPECIAL PUBLICA; [Anonymous], 2004, FDS SIMULATION FIRE; BAUM HR, 1989, FIRE SAFETY SCIENCE - PROCEEDINGS OF THE SECOND INTERNATIONAL SYMPOSIUM, P129; Blanchard E, 2014, FIRE TECHNOL, V50, P565, DOI 10.1007/s10694-013-0323-z; Blocken B, 2011, J BUILD PERFORM SIMU, V4, P157, DOI 10.1080/19401493.2010.513740; Brotons L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062392; Chow WK, 2011, MOD SIMUL ENG, V2011, DOI 10.1155/2011/781252; Chow WK, 2005, BUILD ENVIRON, V40, P897, DOI 10.1016/j.buildenv.2004.09.010; Chow WK, 2004, BUILD ENVIRON, V39, P611, DOI 10.1016/j.buildenv.2003.12.012; Deckers X, 2013, FIRE SAFETY J, V57, P22, DOI 10.1016/j.firesaf.2012.02.005; Gann RG, 2013, FIRE TECHNOL, V49, P679, DOI 10.1007/s10694-012-0288-3; Hu LH, 2007, J HAZARD MATER, V140, P293, DOI 10.1016/j.jhazmat.2006.08.075; Kerber S, 2007, FIRE TECHNOL, V43, P45, DOI 10.1007/s10694-007-0007-7; Ko YJ, 2013, FIRE SAFETY J, V58, P240, DOI 10.1016/j.firesaf.2013.03.001; Kubilay A, 2013, BUILD ENVIRON, V61, P69, DOI 10.1016/j.buildenv.2012.12.005; Lai CM, 2013, FIRE SAFETY J, V58, P1, DOI 10.1016/j.firesaf.2013.01.015; Li SC, 2008, FIRE SAFETY SCI, V9, P861; Luo N, 2014, SAFETY SCI, V70, P202, DOI 10.1016/j.ssci.2014.06.002; Mawhinney JR, 2013, FIRE TECHNOL, V49, P477, DOI 10.1007/s10694-011-0220-2; Meng N, 2012, J FIRE SCI, V30, P138, DOI 10.1177/0734904111428898; Ministere de la sante, 2013, ARR N 2013 551 MS CA, P3; National Fire Protection Association, 2010, NFPA 502 STAND ROAD; National Fire Protection Association, 2011, NFPA 15 STAND WAT SP; Nmira F, 2009, FIRE SAFETY J, V44, P198, DOI 10.1016/j.firesaf.2008.06.002; Rinne T., 2007, VTT WORKING PAPERS, V6; Su CH, 2014, J BUILDING IN PRESS; Su CH, 2011, J APPL FIRE SCI, V21, P111; Wang Y, 2012, FIRE SCI TECHNOLOGY, V12, P007	28	2	2	1	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2015	10	2							e0118306	10.1371/journal.pone.0118306	http://dx.doi.org/10.1371/journal.pone.0118306			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC3LS	25723519	Green Published, gold, Green Submitted			2022-12-27	WOS:000350251200054
J	Polena, V; Huchon, C; Ramos, CV; Rouzier, R; Dumont, A; Fauconnier, A				Polena, Viola; Huchon, Cyrille; Ramos, Catalina Varas; Rouzier, Roman; Dumont, Alexandre; Fauconnier, Arnaud			Non-Invasive Tools for the Diagnosis of Potentially Life-Threatening Gynaecological Emergencies: A Systematic Review	PLOS ONE			English	Article							PELVIC-INFLAMMATORY-DISEASE; ECTOPIC PREGNANCY; ADNEXAL TORSION; RISK-FACTORS; TRANSVAGINAL ULTRASONOGRAPHY; PHYSICAL-EXAMINATION; DOPPLER SONOGRAPHY; OVARIAN TORSION; ULTRASOUND; MANAGEMENT	Objective To identify non- invasive tools for diagnosis of the major potentially life-threatening gynaecological emergencies (G-PLEs) reported in previous studies, and to assess their diagnostic accuracy. Methods MEDLINE; EMBASE; Cochrane Central Register of Controlled Trials (CENTRAL; The Cochrane Library) were searched to identify all eligible studies published in English or French between January 1990 and December 2012. Studies were considered eligible if they were primary diagnostic studies of any designs, with a gold standard and with sufficient information for construction of a 2 x 2 contingency table, concerning at least one of the following G-PLEs: complicated ectopic pregnancy, complicated pelvic inflammatory disease, adnexal torsion and haemoperitoneum of any gynaecological origin. Extraction of data and assessment of study quality were conducted by two independent reviewers. We set the thresholds for the diagnostic value of signs retrieved at Sensibility >= 95% and LR- <= 0.25, or Specificity >= 90% and LR+ >= 4. Results We identified 8288 reports of diagnostic studies for the selected G-PLEs, 45 of which met the inclusion criteria. The methodological quality of the included studies was generally low. The most common diagnostic tools evaluated were transvaginal ultrasound (20/45), followed by medical history (18/45), clinical examination (15/45) and laboratory tests (14/45). Standardised questioning about symptoms, systolic blood pressure < 110 mmHg, shock index>0.85, identification of a mass by abdominal palpation or vaginal examination, haemoglobin concentration < 10 g/dl and six ultrasound and Doppler signs presented high performances for the diagnosis of G-PLEs. Transvaginal ultrasound was the diagnostic tool with the best individual performance for the diagnosis of all G-PLEs. Conclusion This systematic review suggests that blood pressure measurement, haemoglobin tests and transvaginal ultrasound are cornerstone examinations for the diagnosis of G-PLEs that should be available in all gynaecological emergency care services. Standardised questioning about symptoms could be used for triage of patients.	[Polena, Viola; Huchon, Cyrille; Ramos, Catalina Varas; Rouzier, Roman; Dumont, Alexandre; Fauconnier, Arnaud] Versailles St Quentin Univ UVSQ, EA Res Unit 7285, Risk & Safety Clin Med Women & Perinatal Hlth, F-78180 Montigny Le Bretonneux, France; [Huchon, Cyrille; Fauconnier, Arnaud] Intercommunal Hosp Ctr Poissy St Germain En Laye, Dept Gynaecol & Obstet, F-78103 Poissy, France; [Rouzier, Roman] Inst Curie, Dept Surg, F-92210 St Cloud, France; [Dumont, Alexandre] Univ Paris 05, Sorbonne Paris Cite, Inst Rech Dev, UMR 216, Paris, France	UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Universite Paris Cite	Fauconnier, A (corresponding author), Versailles St Quentin Univ UVSQ, EA Res Unit 7285, Risk & Safety Clin Med Women & Perinatal Hlth, F-78180 Montigny Le Bretonneux, France.	afauconnier@chi-poissy-st-germain.fr	Dumont, Alexandre/I-9429-2016; Rouzier, Roman/G-2953-2018	Dumont, Alexandre/0000-0003-3826-0193; Rouzier, Roman/0000-0002-8167-6808	association 'Maternite et Medecine de la Reproduction, Poissy', France	association 'Maternite et Medecine de la Reproduction, Poissy', France	V.P. received PhD funding from the association 'Maternite et Medecine de la Reproduction, Poissy', France. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABBOTT J, 1990, AM J EMERG MED, V8, P515, DOI 10.1016/0735-6757(90)90154-R; Adhikari S, 2007, AM J EMERG MED, V25, P591, DOI 10.1016/j.ajem.2006.11.020; Alouini S, 2012, J GYNECOL OBST BIO R, V41, P48, DOI 10.1016/j.jgyn.2011.08.004; Ankum WM, 1996, FERTIL STERIL, V65, P1093, DOI 10.1016/S0015-0282(16)58320-4; ANKUM WM, 1993, HUM REPROD, V8, P1307, DOI 10.1093/oxfordjournals.humrep.a138247; Antoniou N, 2004, Clin Exp Obstet Gynecol, V31, P235; BARNHART K, 1994, OBSTET GYNECOL, V84, P1010; Barnhart KT, 2006, FERTIL STERIL, V86, P36, DOI 10.1016/j.fertnstert.2005.12.023; Barnhart KT, 2009, NEW ENGL J MED, V361, P379, DOI 10.1056/NEJMcp0810384; BAYER AI, 1994, AM J OBSTET GYNECOL, V171, P1506, DOI 10.1016/0002-9378(94)90393-X; Beigi RH, 2003, OBSTET GYN CLIN N AM, V30, P777, DOI 10.1016/S0889-8545(03)00088-3; Bignardi T, 2010, ULTRASOUND OBST GYN, V35, P344, DOI 10.1002/uog.7523; Bora S, 2007, ULTRASOUND OBST GYN, V30, P467; Bouyer J, 2003, AM J EPIDEMIOL, V157, P185, DOI 10.1093/aje/kwf190; Brown Todd, 2003, CJEM, V5, P120; Bryan Sheila, 2003, Emerg Med (Fremantle), V15, P219, DOI 10.1046/j.1442-2026.2003.00462.x; Buckley RG, 1998, ACAD EMERG MED, V5, P951, DOI 10.1111/j.1553-2712.1998.tb02770.x; Buckley RG, 1999, ANN EMERG MED, V34, P589, DOI 10.1016/S0196-0644(99)70160-5; Capmas P, 2014, FERTIL STERIL, V101, P615, DOI 10.1016/j.fertnstert.2014.01.029; CHAMBERS SE, 1990, BRIT J RADIOL, V63, P246, DOI 10.1259/0007-1285-63-748-246; Chapron C, 1996, HUM REPROD, V11, P998; Chen S, 2006, PORTABLE ULTRASOUND; Condous G, 2005, HUM REPROD, V20, P1404, DOI 10.1093/humrep/deh770; Crochet JR, 2013, JAMA-J AM MED ASSOC, V309, P1722, DOI 10.1001/jama.2013.3914; Cronin AM, 2008, BMC MED RES METHODOL, V8, DOI 10.1186/1471-2288-8-75; Dart RG, 1999, ANN EMERG MED, V33, P283, DOI 10.1016/S0196-0644(99)70364-1; Desai SK, 1994, OBSTET GYNECOL, V84, P669; ESCHENBACH DA, 1984, UROL CLIN N AM, V11, P65; GEORGY FM, 1974, OBSTET GYNECOL, V44, P441; Goehring C, 2004, STAT MED, V23, P125, DOI 10.1002/sim.1591; GRAIF M, 1984, AM J ROENTGENOL, V143, P1331, DOI 10.2214/ajr.143.6.1331; Haider Z, 2006, ULTRASOUND OBST GYN, V28, P207, DOI 10.1002/uog.2801; Harmon JC, 2008, PEDIATR RADIOL, V38, P175, DOI 10.1007/s00247-007-0683-y; HIBBARD LT, 1985, AM J OBSTET GYNECOL, V152, P456, DOI 10.1016/S0002-9378(85)80157-5; Hoey R, 2004, EMERG MED J, V21, P461, DOI 10.1136/emj.2003.012443; Huchon C, 2012, HUM REPROD, V27, P2359, DOI 10.1093/humrep/des186; Huchon C, 2012, ACAD EMERG MED, V19, P24, DOI 10.1111/j.1553-2712.2011.01238.x; Huchon C, 2010, HUM REPROD, V25, P2276, DOI 10.1093/humrep/deq173; Huchon C, 2010, EUR J OBSTET GYN R B, V150, P8, DOI 10.1016/j.ejogrb.2010.02.006; Isoardi K, 2009, EMERG MED AUSTRALAS, V21, P440, DOI 10.1111/j.1742-6723.2009.01227.x; JAESCHKE R, 1994, JAMA-J AM MED ASSOC, V271, P703, DOI 10.1001/jama.271.9.703; KAHN JG, 1991, JAMA-J AM MED ASSOC, V266, P2594, DOI 10.1001/jama.266.18.2594; Kirk E, 2007, HUM REPROD, V22, P2824, DOI 10.1093/humrep/dem283; Kirk E, 2009, BEST PRACT RES CL OB, V23, P501, DOI 10.1016/j.bpobgyn.2008.12.010; Lambert MJ, 2004, EMERG MED CLIN N AM, V22, P683, DOI 10.1016/j.emc.2004.04.016; LEE AR, 1993, AM J ROENTGENOL, V161, P343, DOI 10.2214/ajr.161.2.8333374; Lee EJ, 1998, J ULTRAS MED, V17, P83; MCCORMACK WM, 1994, NEW ENGL J MED, V330, P115, DOI 10.1056/NEJM199401133300207; McRae A, 2009, CAN J EMERG MED, V11, P355; McWilliams GDE, 2008, SURG CLIN N AM, V88, P265, DOI 10.1016/j.suc.2007.12.007; Miller TD, 2002, AM J MED, V112, P290, DOI 10.1016/S0002-9343(01)01111-1; Mol BWJ, 1997, OBSTET GYNECOL, V89, P704, DOI 10.1016/S0029-7844(97)00101-4; Moore C, 2007, ACAD EMERG MED, V14, P755, DOI 10.1197/j.aem.2007.04.010; MOULD TAJ, 1992, ULTRASOUND OBST GYN, V2, P121, DOI 10.1046/j.1469-0705.1992.02020121.x; Nadukhovskaya L, 2001, AM J EMERG MED, V19, P495, DOI 10.1053/ajem.2001.24492; Newman TB, 2009, EVIDENCE-BASED DIAGNOSIS, P10, DOI 10.1017/CBO9780511759512.003; NICHOLS DH, 1985, CLIN OBSTET GYNECOL, V28, P375, DOI 10.1097/00003081-198528020-00015; Oelsner G, 2006, CLIN OBSTET GYNECOL, V49, P459, DOI 10.1097/00003081-200609000-00006; Pena JE, 2000, FERTIL STERIL, V73, P1047, DOI 10.1016/S0015-0282(00)00487-8; PETERSON HB, 1991, JAMA-J AM MED ASSOC, V266, P2605, DOI 10.1001/jama.266.18.2605; Popowski T, 2012, GYNECOL OBSTET FERTI, V40, P182, DOI 10.1016/j.gyobfe.2011.08.028; Ramphal SR, 2006, BEST PRACT RES CL OB, V20, P729, DOI 10.1016/j.bpobgyn.2006.04.001; Read MD, 1994, CURRENT OBSTET GYNAE, V4, p98e103; ROSADO WM, 1992, AM J ROENTGENOL, V159, P1251, DOI 10.2214/ajr.159.6.1442394; SCHWARTZ RO, 1980, OBSTET GYNECOL, V56, P197; Shadinger LL, 2008, J ULTRAS MED, V27, P7, DOI 10.7863/jum.2008.27.1.7; Soper DE, 2010, OBSTET GYNECOL, V116, P419, DOI 10.1097/AOG.0b013e3181e92c54; Stein JC, 2010, ANN EMERG MED, V56, P674, DOI 10.1016/j.annemergmed.2010.06.563; STOVALL TG, 1990, ANN EMERG MED, V19, P1098, DOI 10.1016/S0196-0644(05)81511-2; Toret-Labeeuw F, 2013, WORLD J EMERG SURG, V8, DOI 10.1186/1749-7922-8-16; Valentin L, 2006, BEST PRACT RES CL OB, V20, P881, DOI 10.1016/j.bpobgyn.2006.06.001; van Mello NM, 2012, FERTIL STERIL, V97, P623, DOI 10.1016/j.fertnstert.2011.12.021; VANVOORHIS BJ, 1992, FERTIL STERIL, V58, P215; Walker J W, 1987, Emerg Med Clin North Am, V5, P425; Wang R, 2011, ANN EMERG MED, V58, P12, DOI 10.1016/j.annemergmed.2010.12.023; Whiting PF, 2011, ANN INTERN MED, V155, P529, DOI 10.7326/0003-4819-155-8-201110180-00009	76	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2015	10	2							e0114189	10.1371/journal.pone.0114189	http://dx.doi.org/10.1371/journal.pone.0114189			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC3LS	25723401	Green Published, gold, Green Submitted			2022-12-27	WOS:000350251200002
J	Vivo, M; Matarese, M; Sepe, M; Di Martino, R; Festa, L; Calabro, V; La Mantia, G; Pollice, A				Vivo, Maria; Matarese, Maria; Sepe, Maria; Di Martino, Rosaria; Festa, Luisa; Calabro, Viola; La Mantia, Girolama; Pollice, Alessandra			MDM2-Mediated Degradation of p14ARF: A Novel Mechanism to Control ARF Levels in Cancer Cells	PLOS ONE			English	Article							UBIQUITIN-INDEPENDENT DEGRADATION; TUMOR-SUPPRESSOR; P53; MDM2; P14(ARF); STABILIZATION; NUCLEOLAR; DOMAINS; OVEREXPRESSION; NUCLEAR	We here show a new relationship between the human p14ARF oncosuppressor and the MDM2 oncoprotein. MDM2 overexpression in various cancer cell lines causes p14ARF reduction inducing its degradation through the proteasome. The effect does not require the ubiquitin ligase activity of MDM2 and preferentially occurs in the cytoplasm. Interestingly, treatment with inhibitors of the PKC (Protein Kinase C) pathway and use of p14ARF phosphorylation mutants indicate that ARF phosphorylation could play a role in MDM2 mediated ARF degradation reinforcing our previous observations that ARF phosphorylation influences its stability and biological activity. Our study uncovers a new potentially important mechanism through which ARF and MDM2 can counterbalance each other during the tumorigenic process.	[Vivo, Maria; Matarese, Maria; Sepe, Maria; Di Martino, Rosaria; Festa, Luisa; Calabro, Viola; La Mantia, Girolama; Pollice, Alessandra] Univ Naples Federico II, Dipartimento Biol, Naples, Italy; [Matarese, Maria] CNR, IGB, I-80125 Naples, Italy; [Sepe, Maria] Univ Naples Federico II, Dipartimento Med Mol & Biotecnol Med, Naples, Italy; [Di Martino, Rosaria] CNR, IBP, I-80125 Naples, Italy; [Festa, Luisa] CNR, I-80125 Naples, Italy	University of Naples Federico II; Consiglio Nazionale delle Ricerche (CNR); Istituto di Genetica e Biofisica "Adriano Buzzati-Traverso" (IGB-CNR); University of Naples Federico II; Consiglio Nazionale delle Ricerche (CNR); Istituto di Biochimica delle Proteine (IBP-CNR); Consiglio Nazionale delle Ricerche (CNR)	Pollice, A (corresponding author), Univ Naples Federico II, Dipartimento Biol, Naples, Italy.	apollice@unina.it	Calabro, Viola/H-6156-2013; Vivo, Maria/S-3390-2017	Vivo, Maria/0000-0003-2458-4226; Calabro, Viola/0000-0002-6508-8889	Legge Regionale (Regione Campania) [5/2007]; Progetto "Campania Research in Experimental Medicine" (CREME)	Legge Regionale (Regione Campania); Progetto "Campania Research in Experimental Medicine" (CREME)	This work was supported by grants from Legge Regionale (Regione Campania) no 5/2007 to AP and GLM and Progetto "Campania Research in Experimental Medicine" (CREME). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brady CA, 2010, J CELL SCI, V123, P2527, DOI 10.1242/jcs.064501; Carnero A, 2000, NAT CELL BIOL, V2, P148, DOI 10.1038/35004020; Chen DL, 2010, NATURE, V464, P624, DOI 10.1038/nature08820; Chen XY, 2007, MOL CELL, V26, P843, DOI 10.1016/j.molcel.2007.05.022; Clark PA, 2002, ONCOGENE, V21, P4498, DOI 10.1038/sj.onc.1205558; Colombo E, 2006, CANCER RES, V66, P3044, DOI 10.1158/0008-5472.CAN-05-2378; den Besten W, 2005, CELL CYCLE, V4, P1593; Di Costanzo A, 2012, J BIOL CHEM, V287, P30170, DOI 10.1074/jbc.M112.349951; Eymin B, 2002, ONCOGENE, V21, P2750, DOI 10.1038/sj.onc.1205359; Galli F, 2010, J CELL SCI, V123, P2423, DOI 10.1242/jcs.061010; Inoue R, 2005, BIOCHEM BIOPH RES CO, V330, P1314, DOI 10.1016/j.bbrc.2005.03.117; Jin YT, 2003, EMBO J, V22, P6365, DOI 10.1093/emboj/cdg600; Korgaonkar C, 2002, MOL CELL BIOL, V22, P196, DOI 10.1128/MCB.22.1.196-206.2002; Kulikov R, 2010, P NATL ACAD SCI USA, V107, P10038, DOI 10.1073/pnas.0911716107; Kuo ML, 2004, GENE DEV, V18, P1862, DOI 10.1101/gad.1213904; Llanos S, 2001, NAT CELL BIOL, V3, P445, DOI 10.1038/35074506; Lohrum MAE, 2000, CURR BIOL, V10, P539, DOI 10.1016/S0960-9822(00)00472-3; LUNA RMD, 1995, NATURE, V378, P203; Muniz VP, 2011, MOL CANCER RES, V9, P867, DOI 10.1158/1541-7786.MCR-10-0475; Pimkina J, 2009, AUTOPHAGY, V5, P397, DOI 10.4161/auto.5.3.7782; Pollice A, 2007, ONCOGENE, V26, P5154, DOI 10.1038/sj.onc.1210313; Pollice A, 2004, J BIOL CHEM, V279, P6345, DOI 10.1074/jbc.M310957200; Pollice A, 2008, FEBS LETT, V582, P3257, DOI 10.1016/j.febslet.2008.09.026; Rizos H, 2000, ONCOGENE, V19, P2978, DOI 10.1038/sj.onc.1203629; Rodway H, 2004, ONCOGENE, V23, P6186, DOI 10.1038/sj.onc.1207854; Sdek P, 2005, MOL CELL, V20, P699, DOI 10.1016/j.molcel.2005.10.017; Sepe M, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0022800, DOI 10.1371/J0URNAL.P0NE.0022800]; Sherr CJ, 2006, NAT REV CANCER, V6, P663, DOI 10.1038/nrc1954; Shimizu T, 2010, ONCOGENE, V29, P5687, DOI 10.1038/onc.2010.312; Vivo M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053631; Vivo M, 2009, CELL CYCLE, V8, P3545, DOI 10.4161/cc.8.21.9954; Weber JD, 2000, MOL CELL BIOL, V20, P2517, DOI 10.1128/MCB.20.7.2517-2528.2000; Yu ZK, 2000, ONCOGENE, V19, P5892, DOI 10.1038/sj.onc.1203980; Zhang YP, 2001, CELL GROWTH DIFFER, V12, P175	34	19	20	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2015	10	2							e0117252	10.1371/journal.pone.0117252	http://dx.doi.org/10.1371/journal.pone.0117252			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC3LS	25723571	gold, Green Published, Green Submitted			2022-12-27	WOS:000350251200026
J	Kawaji, K; Foppa, M; Roujol, S; Akcakaya, M; Nezafat, R				Kawaji, Keigo; Foppa, Murilo; Roujol, Sebastien; Akcakaya, Mehmet; Nezafat, Reza			Whole Heart Coronary Imaging with Flexible Acquisition Window and Trigger Delay	PLOS ONE			English	Article							MAGNETIC-RESONANCE ANGIOGRAPHY; STATE FREE PRECESSION; SINGLE BREATH-HOLD; MR-ANGIOGRAPHY; TEMPORAL RESOLUTION; GOLDEN-RATIO; TIME; SSFP; RECONSTRUCTION; VISUALIZATION	Coronary magnetic resonance imaging (MRI) requires a correctly timed trigger delay derived from a scout cine scan to synchronize k-space acquisition with the quiescent period of the cardiac cycle. However, heart rate changes between breath-held cine and free-breathing coronary imaging may result in inaccurate timing errors. Additionally, the determined trigger delay may not reflect the period of minimal motion for both left and right coronary arteries or different segments. In this work, we present a whole-heart coronary imaging approach that allows flexible selection of the trigger delay timings by performing k-space sampling over an enlarged acquisition window. Our approach addresses coronary motion in an interactive manner by allowing the operator to determine the temporal window with minimal cardiac motion for each artery region. An electrocardiogram-gated, k-space segmented 3D radial stack-of-stars sequence that employs a custom rotation angle is developed. An interactive reconstruction and visualization platform is then employed to determine the subset of the enlarged acquisition window for minimal coronary motion. Coronary MRI was acquired on eight healthy subjects (5 male, mean age = 37 +/- 18 years), where an enlarged acquisition window of 166-220 ms was set 50 ms prior to the scout-derived trigger delay. Coronary visualization and sharpness scores were compared between the standard 120 ms window set at the trigger delay, and those reconstructed using a manually adjusted window. The proposed method using manual adjustment was able to recover delineation of five mid and distal right coronary artery regions that were otherwise not visible from the standard window, and the sharpness scores improved in all coronary regions using the proposed method. This paper demonstrates the feasibility of a whole-heart coronary imaging approach that allows interactive selection of any subset of the enlarged acquisition window for a tailored reconstruction for each branch region.	[Nezafat, Reza] Beth Israel Deaconess Med Ctr, Dept Med, Boston, MA 02215 USA; Harvard Univ, Sch Med, Boston, MA 02215 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School	Nezafat, R (corresponding author), Beth Israel Deaconess Med Ctr, Dept Med, Boston, MA 02215 USA.	rnezafat@bidmc.harvard.edu	Kawaji, Keigo/J-5501-2018; Foppa, Murilo/V-4845-2019	Kawaji, Keigo/0000-0002-4813-3414; Foppa, Murilo/0000-0003-2914-4406; Roujol, Sebastien/0000-0002-7146-0552; Akcakaya, Mehmet/0000-0001-6400-7736	Samsung Electronics	Samsung Electronics(Samsung)	This work is supported by a research grant from Samsung Electronics. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal MD, 2013, J MAGN RESON IMAGING, V37, P1129, DOI 10.1002/jmri.23920; Bi XM, 2007, MAGN RESON IMAGING, V25, P1138, DOI 10.1016/j.mri.2007.01.004; Bi XM, 2007, MAGN RESON MED, V58, P1, DOI 10.1002/mrm.21224; Bi XM, 2005, MAGN RESON MED, V54, P470, DOI 10.1002/mrm.20575; Bornert P, 2014, MAGN RESON MED, V71, P156, DOI 10.1002/mrm.24648; DERICHE R, 1990, IEEE T PATTERN ANAL, V12, P78, DOI 10.1109/34.41386; Etienne A, 2002, MAGNET RESON MED, V48, P658, DOI 10.1002/mrm.10253; Feng L, 2013, MAGN RESON MED; Fessler JA, 2007, J MAGN RESON, V188, P191, DOI 10.1016/j.jmr.2007.06.012; Kim YC, 2013, MAGN RESON MED; Kim YC, 2012, J MAGN RESON IMAGING, V35, P943, DOI 10.1002/jmri.23510; Kim YC, 2011, MAGN RESON MED, V65, P1711, DOI 10.1002/mrm.22742; Kim YC, 2011, MAGN RESON MED, V65, P1365, DOI 10.1002/mrm.22714; Kressler B, 2006, MAGN RESON MED, V56, P704, DOI 10.1002/mrm.21004; Lai P, 2008, MAGN RESON MED, V59, P1378, DOI 10.1002/mrm.21617; Lai P, 2010, MAGN RESON MED, V63, P970, DOI 10.1002/mrm.22246; Leupold J, 2006, MAGN RESON MED, V55, P557, DOI 10.1002/mrm.20790; Liu G, 2012, MED PHYS, V39, P3009, DOI 10.1118/1.4711757; Liu J, 2010, MAGN RESON MED, V63, P1230, DOI 10.1002/mrm.22306; Lustig M, 2007, MAGN RESON MED, V58, P1182, DOI 10.1002/mrm.21391; Nam S, 2012, MAGN RESON MED; Nayak KS, 2007, MAGN RESON MED, V58, P931, DOI 10.1002/mrm.21296; Nielsen J, 1999, COMMUN ACM, V42, P65, DOI 10.1145/291469.291470; Park J, 2005, MAGN RESON MED, V54, P833, DOI 10.1002/mrm.20627; Paul J, 2014, MAGN RESON MED; Piccini D, 2014, RADIOLOGY, V270, P378, DOI 10.1148/radiol.13132045; Pruessmann KP, 2001, MAGNET RESON MED, V46, P638, DOI 10.1002/mrm.1241; Roes SD, 2008, J MAGN RESON IMAGING, V27, P1046, DOI 10.1002/jmri.21361; Sakuma H, 2005, RADIOLOGY, V237, P316, DOI 10.1148/radiol.2371040830; Santos JM, 2006, MAGN RESON MED, V55, P371, DOI 10.1002/mrm.20765; Sharif B, 2014, MAGN RESON MED; Shechter G, 2006, IEEE T MED IMAGING, V25, P369, DOI 10.1109/TMI.2005.862752; Song HK, 2013, MAGN RESON MED; Stehning C, 2005, MAGN RESON MED, V53, P719, DOI 10.1002/mrm.20397; Warmuth C, 2007, INVEST RADIOL, V42, P550, DOI 10.1097/RLI.0b013e31803c4a5a; Weber OM, 2003, MAGNET RESON MED, V50, P1223, DOI 10.1002/mrm.10653; Winkelmann S, 2007, IEEE T MED IMAGING, V26, P68, DOI 10.1109/TMI.2006.885337; Wu HH, 2013, MAGN RESON MED, V69, P1083, DOI 10.1002/mrm.24346; Xu B, 2012, MAGN RESON MED; Yonezawa M, 2013, RADIOLOGY; Zhang T, 2013, MAGN RESON MED, V69, P571, DOI 10.1002/mrm.24267; Zhu YH, 2013, IEEE T MED IMAGING, V32, P838, DOI 10.1109/TMI.2012.2230017	43	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2015	10	2							e0112020	10.1371/journal.pone.0112020	http://dx.doi.org/10.1371/journal.pone.0112020			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC2ZH	25719750	gold, Green Published, Green Submitted			2022-12-27	WOS:000350213200001
J	Ligaba, SB; Khurana, A; Graham, G; Krawczyk, E; Jablonski, S; Petricoin, EF; Glazer, RI; Upadhyay, G				Ligaba, Segni B.; Khurana, Anikita; Graham, Garrett; Krawczyk, Ewa; Jablonski, Sandra; Petricoin, Emanuel F.; Glazer, Robert I.; Upadhyay, Geeta			Multifactorial Analysis of Conditional Reprogramming of Human Keratinocytes	PLOS ONE			English	Article							PLURIPOTENT STEM-CELLS; EPITHELIAL-CELLS; ROCK INHIBITOR; TGF-BETA; NOTCH; DIFFERENTIATION; SKIN; ACTIVATION; RADIATION; CULTURE	Co-culture of human primary epithelial cells with irradiated 3T3 fibroblast feeder cells (J2 cells) and the Rho kinase inhibitor Y-27632 (Y) allows for the unrestricted growth of cells of epithelial origin by the process termed conditional reprogramming. To better understand the nature of the signaling processes associated with conditionally reprogrammed cells, the effect of the two critical components of the co-culture conditions, J2 cells and Y, on the growth of human foreskin keratinocytes (HFKs) was evaluated by gene expression profiling, reverse-phase protein arrays and siRNA screening. J2 cells and Y acted cooperatively to down-regulate differentiation, and upregulate proliferation and cell adhesion, including increased pT308Akt and pERK, and reduced TGF-beta pathway signaling. These findings establish a mechanistic basis for the unlimited growth potential of human epithelial cells that will be invaluable to assess the effect of genetic changes in pathologic tissues and their response to therapeutic agents.	[Ligaba, Segni B.; Khurana, Anikita; Krawczyk, Ewa; Upadhyay, Geeta] Georgetown Univ, Dept Pathol, Washington, DC 20007 USA; [Graham, Garrett; Jablonski, Sandra; Glazer, Robert I.; Upadhyay, Geeta] Georgetown Univ, Dept Oncol, Washington, DC 20007 USA; [Jablonski, Sandra; Glazer, Robert I.; Upadhyay, Geeta] Georgetown Univ, Lombardi Comprehens Canc Ctr, Washington, DC 20007 USA; [Petricoin, Emanuel F.] George Mason Univ, Dept Mol & Microbiol, Manassas, VA 20110 USA	Georgetown University; Georgetown University; Georgetown University; George Mason University	Upadhyay, G (corresponding author), Georgetown Univ, Dept Pathol, Washington, DC 20007 USA.	gu6@georgetown.edu	Upadhyay, Geeta/AEB-0203-2022	Graham, Garrett/0000-0002-1097-0962; Jablonski, Sandra/0000-0001-7220-8159	National Cancer Institute [1R21CA175862-01A1, 1P30CA051008]; National Institute of Health [5UL1RR031975-02]; Georgetown-Howard Universities Center for Clinical and Translational Sciences; NIH to the Lombardi Comprehensive Cancer Center; NATIONAL CANCER INSTITUTE [R21CA175862, P30CA051008] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR031975] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Georgetown-Howard Universities Center for Clinical and Translational Sciences; NIH to the Lombardi Comprehensive Cancer Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This research was supported by 1R21CA175862-01A1 from the National Cancer Institute, National Institute of Health www.nih.gov to GU, 5UL1RR031975-02 National Institute of Health, to Georgetown-Howard Universities Center for Clinical and Translational Sciences, subaward AWD4004019 to GU, and 1P30CA051008 from the National Cancer Institute, NIH to the Lombardi Comprehensive Cancer Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal S, 2012, AM J PATHOL, V180, P443, DOI 10.1016/j.ajpath.2011.12.001; BARRANDON Y, 1987, P NATL ACAD SCI USA, V84, P2302, DOI 10.1073/pnas.84.8.2302; Blanpain C, 2006, GENE DEV, V20, P3022, DOI 10.1101/gad.1477606; Chapman S, 2010, J CLIN INVEST, V120, P2619, DOI 10.1172/JCI42297; Einspahr JG, 2012, CANCER PREV RES, V5, P403, DOI 10.1158/1940-6207.CAPR-11-0427; Ezratty EJ, 2011, CELL, V145, P1129, DOI 10.1016/j.cell.2011.05.030; Ishizaki T, 2000, MOL PHARMACOL, V57, P976; James D, 2005, DEVELOPMENT, V132, P1273, DOI 10.1242/dev.01706; Kang JS, 2009, TRENDS CELL BIOL, V19, P385, DOI 10.1016/j.tcb.2009.05.008; Kumar PA, 2011, CELL, V147, P525, DOI 10.1016/j.cell.2011.10.001; Larsson C, 2006, CELL SIGNAL, V18, P276, DOI 10.1016/j.cellsig.2005.07.010; Liu XF, 2012, AM J PATHOL, V180, P599, DOI 10.1016/j.ajpath.2011.10.036; Maherali N, 2009, CURR BIOL, V19, P1718, DOI 10.1016/j.cub.2009.08.025; Massague J, 2008, CELL, V134, P215, DOI 10.1016/j.cell.2008.07.001; Palechor-Ceron N, 2013, AM J PATHOL, V183, P1862, DOI 10.1016/j.ajpath.2013.08.009; Pollock CB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016215; Senoo M, 2007, CELL, V129, P523, DOI 10.1016/j.cell.2007.02.045; Shimizu Y, 2005, J CELL BIOL, V168, P941, DOI 10.1083/jcb.200411179; SKEHAN P, 1990, J NATL CANCER I, V82, P1107, DOI 10.1093/jnci/82.13.1107; Skobowiat C, 2011, AM J PHYSIOL-ENDOC M, V301, pE484, DOI [10.1152/ajpendo.00217.2011, 10.1152/ajpendo.00217.2011.]; Slominski AT, 2012, ADV ANAT EMBRYOL CEL, V212, P1; Subramanyam D, 2011, NAT BIOTECHNOL, V29, P443, DOI 10.1038/nbt.1862; Suprynowicz FA, 2012, P NATL ACAD SCI USA, V109, P20035, DOI 10.1073/pnas.1213241109; Ulloa L, 2001, J BIOL CHEM, V276, P21397, DOI 10.1074/jbc.M010783200; Upadhyay G, 2011, P NATL ACAD SCI USA, V108, P7820, DOI 10.1073/pnas.1103441108; Wang X, 2008, J CELL BIOL, V183, P37, DOI 10.1083/jcb.200804030; Wilson B, 2010, DIS MARKERS, V28, P225, DOI [10.1155/2010/240248, 10.3233/DMA-2010-0705]; Yu M, 2014, SCIENCE, V345, P216, DOI 10.1126/science.1253533; Yuan H, 2012, NEW ENGL J MED, V367, P1220, DOI 10.1056/NEJMoa1203055; Yugaw T, 2013, MOL CELL BIOL, V33, P4434, DOI 10.1128/MCB.00577-13	30	15	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2015	10	2							e0116755	10.1371/journal.pone.0116755	http://dx.doi.org/10.1371/journal.pone.0116755			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC2IM	25714835	Green Published, Green Submitted, gold			2022-12-27	WOS:000350168700023
J	Besic, V; Shi, HJ; Stubbs, RS; Hayes, MT				Besic, Vinko; Shi, Hongjun; Stubbs, Richard S.; Hayes, Mark T.			Aberrant Liver Insulin Receptor Isoform A Expression Normalises with Remission of Type 2 Diabetes after Gastric Bypass Surgery	PLOS ONE			English	Article							GROWTH-FACTOR-II; MESSENGER-RNA; NEONATAL HEPATOCYTES; SPLICE VARIANTS; SKELETAL-MUSCLE; GLUCOSE-UPTAKE; HIGH-AFFINITY; HEPG2 CELLS; RESISTANCE; CANCER	Type 2 diabetes mellitus ( T2DM) results from a combination of progressive insulin resistance and loss of pancreatic beta cell function and/or mass. Insulin signalling occurs through the insulin receptor, (INSR) which is alternatively spliced into two isoforms: INSRA (-exon 11) and INSRB (+exon 11). Because the INSR isoforms have different functional characteristics, their relative expression ratio has been implicated in the pathogenesis of insulin resistance and T2DM. We studied levels of INSR isoform mRNA in liver samples taken from 46 individuals with or without T2DM at Roux-en-Y (RYGB) surgery, and on average 17 (+/- 5.6) months later in 16 of the same individuals (8 diabetic and non-diabetic patients). INSRA or INSRB was also overexpressed in HepG2 cells to ascertain their effect on AKT phosphorylation and PCK1 expression as markers of insulin-mediated metabolic signalling. We found the INSRB:A isoform ratio was reduced in individuals with T2DM in comparison to those with normal glucose tolerance and normalised with remission of diabetes. The INSRB:A ratio increased due to a reduction in the alternatively spliced INSRA isoform following remission of diabetes. Overexpressing INSRA isoform in HepG2 hepatoma cells reduced inhibition of PCK1 transcription and did not increase AKT phosphorylation in response to insulin load compared to the effect of overexpressing the B isoform. Data presented here revitalizes the role of the INSR isoforms in the pathogenesis of T2DM, and suggests that an abrogated INSRB:A ratio that favours the INSRA isoform may negatively impact insulin-mediated metabolic signalling.	[Besic, Vinko; Shi, Hongjun; Stubbs, Richard S.; Hayes, Mark T.] Univ Otago, Wakefield Biomed Res Unit, Dept Pathol & Mol Med, Wellington, New Zealand; [Stubbs, Richard S.] Wakefield Hosp, Wakefield Clin, Wellington, New Zealand; [Hayes, Mark T.] Australian Natl Univ, John Curtin Sch Med Res, Canberra, ACT 2601, Australia	University of Otago; Australian National University; John Curtin School of Medical Research	Besic, V (corresponding author), Univ Otago, Wakefield Biomed Res Unit, Dept Pathol & Mol Med, Wellington, New Zealand.	vinko.besic@otago.ac.nz; mark.hayes@anu.edu.au	Besic, Vinko/K-2955-2015	Besic, Vinko/0000-0002-8137-1019	Wellington Medical Research Foundation; Wakefield Gastroenterology Research Trust; Wakefield Clinic	Wellington Medical Research Foundation; Wakefield Gastroenterology Research Trust; Wakefield Clinic	This work was supported by the Wellington Medical Research Foundation, Wakefield Gastroenterology Research Trust and the Wakefield Clinic who provided contributions to salaries and consumables. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON CM, 1993, J CLIN ENDOCR METAB, V76, P1380, DOI 10.1210/jc.76.5.1380; Belfiore A, 2009, ENDOCR REV, V30, P586, DOI 10.1210/er.2008-0047; BENECKE H, 1992, J CLIN INVEST, V89, P2066, DOI 10.1172/JCI115819; Birkenfeld AL, 2011, J BIOL CHEM, V286, P36163, DOI 10.1074/jbc.M111.228817; Blanquart C, 2008, BIOCHEM PHARMACOL, V76, P873, DOI 10.1016/j.bcp.2008.07.027; Bluher M, 2002, DEV CELL, V3, P25, DOI 10.1016/S1534-5807(02)00199-5; Bock G, 2007, DIABETES, V56, P1703, DOI 10.2337/db06-1776; Braatvedt G, 2006, NZ MED J, P119; Bruning JC, 1998, MOL CELL, V2, P559, DOI 10.1016/S1097-2765(00)80155-0; Buse JB, 2009, DIABETES CARE, V32, P2133, DOI 10.2337/dc09-9036; Campos GM, 2010, J GASTROINTEST SURG, V14, P15, DOI 10.1007/s11605-009-1060-y; CONSOLI A, 1989, DIABETES, V38, P550, DOI 10.2337/diabetes.38.5.550; De Meyts P, 2012, ENDOCRINOLOGY, V153, P2054, DOI 10.1210/en.2012-1234; Denley A, 2003, HORM METAB RES, V35, P778; Di Paola R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019462; EBINA Y, 1985, CELL, V40, P747, DOI 10.1016/0092-8674(85)90334-4; Ehrhardt C., 2006, SIGNAL TRANSDUCT BAN, V6, P179, DOI [10.1002/sita.200500073, DOI 10.1002/SITA.200500073]; Escribano O, 2009, DIABETES, V58, P820, DOI 10.2337/db08-0551; Foo J, 2011, OBES SURG, V21, P1914, DOI 10.1007/s11695-011-0527-6; Frasca F, 1999, MOL CELL BIOL, V19, P3278, DOI 10.1128/mcb.19.5.3278; Fukumoto Y, 2010, CYTOTECHNOLOGY, V62, P73, DOI 10.1007/s10616-010-9259-z; Giovannucci E, 2010, DIABETES CARE, V33, P1674, DOI 10.2337/dc10-0666; Gonzalez-Rodriguez A, 2008, AM J PHYSIOL-GASTR L, V295, pG338, DOI 10.1152/ajpgi.00514.2007; Harrington SC, 2012, GROWTH HORM IGF RES, V22, P108, DOI 10.1016/j.ghir.2012.04.001; Johnson JA, 2012, DIABETOLOGIA, V55, P1607, DOI 10.1007/s00125-012-2525-1; KELLERER M, 1993, DIABETOLOGIA, V36, P628, DOI 10.1007/BF00404072; KELLERER M, 1992, BIOCHEMISTRY-US, V31, P4588, DOI 10.1021/bi00134a008; Kleemann R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008817; KOSAKI A, 1993, J BIOL CHEM, V268, P21990; KOSAKI A, 1995, J BIOL CHEM, V270, P20816, DOI 10.1074/jbc.270.35.20816; Lima MMO, 2010, J CLIN ENDOCR METAB, V95, P3871, DOI 10.1210/jc.2010-0085; Malaguarnera R, 2012, ENDOCRINOLOGY, V153, P2152, DOI 10.1210/en.2011-1843; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; MCCLAIN DA, 1991, MOL ENDOCRINOL, V5, P734, DOI 10.1210/mend-5-5-734; Michael MD, 2000, MOL CELL, V6, P87, DOI 10.1016/S1097-2765(00)00010-1; MOLLER DE, 1989, MOL ENDOCRINOL, V3, P1263, DOI 10.1210/mend-3-8-1263; MOSTHAF L, 1993, P NATL ACAD SCI USA, V90, P2633, DOI 10.1073/pnas.90.7.2633; MOSTHAF L, 1990, EMBO J, V9, P2409, DOI 10.1002/j.1460-2075.1990.tb07416.x; MOSTHAF L, 1991, P NATL ACAD SCI USA, V88, P4728, DOI 10.1073/pnas.88.11.4728; Nevado C, 2006, ENDOCRINOLOGY, V147, P3709, DOI 10.1210/en.2005-1663; NORGREN S, 1994, P NATL ACAD SCI USA, V91, P1465, DOI 10.1073/pnas.91.4.1465; NORGREN S, 1993, DIABETES, V42, P675, DOI 10.2337/diabetes.42.5.675; NORGREN S, 1994, BIOCHEM BIOPH RES CO, V199, P277, DOI 10.1006/bbrc.1994.1225; Pandini G, 2003, J BIOL CHEM, V278, P42178, DOI 10.1074/jbc.M304980200; Renehan AG, 2006, TRENDS ENDOCRIN MET, V17, P328, DOI 10.1016/j.tem.2006.08.006; Savkur RS, 2001, NAT GENET, V29, P40, DOI 10.1038/ng704; SEINO S, 1989, BIOCHEM BIOPH RES CO, V159, P312, DOI 10.1016/0006-291X(89)92439-X; SELL SM, 1994, J BIOL CHEM, V269, P30769; Sen S, 2009, MOL CELL BIOL, V29, P871, DOI 10.1128/MCB.01709-08; SESTI G, 1995, DIABETOLOGIA, V38, P445, DOI 10.1007/BF00410282; ULLRICH A, 1985, NATURE, V313, P756, DOI 10.1038/313756a0; White S, 2005, OBES SURG, V15, P155, DOI 10.1381/0960892053268282; Wickremesekera K, 2005, OBES SURG, V15, P474, DOI 10.1381/0960892053723402; YAMAGUCHI Y, 1993, ENDOCRINOLOGY, V132, P1132, DOI 10.1210/en.132.3.1132	54	18	20	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2015	10	3							e0119270	10.1371/journal.pone.0119270	http://dx.doi.org/10.1371/journal.pone.0119270			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9KG	25742416	Green Published, Green Submitted, gold			2022-12-27	WOS:000350688100098
J	Kim, CH; Kim, SJ; Lee, MJ; Kwon, YE; Kim, YL; Park, KS; Ryu, HJ; Park, JT; Han, SH; Yoo, TH; Kang, SW; Oh, HJ				Kim, Chan Ho; Kim, Seung Jun; Lee, Mi Jung; Kwon, Young Eun; Kim, Yung Ly; Park, Kyoung Sook; Ryu, Han Jak; Park, Jung Tak; Han, Seung Hyeok; Yoo, Tae-Hyun; Kang, Shin-Wook; Oh, Hyung Jung			An Increase in Mean Platelet Volume from Baseline Is Associated with Mortality in Patients with Severe Sepsis or Septic Shock	PLOS ONE			English	Article							PERCUTANEOUS CORONARY INTERVENTION; GOAL-DIRECTED THERAPY; LONG-TERM MORTALITY; RHEUMATOID-ARTHRITIS; DISEASE-ACTIVITY; UNITED-STATES; VALIDATION; DYSFUNCTION; GUIDELINES; INFECTION	Introduction Mean platelet volume (MPV) is suggested as an index of inflammation, disease activity, and anti-inflammatory treatment efficacy in chronic inflammatory disorders; however, the effect of MPV on sepsis mortality remains unclear. Therefore, we investigated whether the change in MPV between hospital admission and 72 hours (Delta MPV72h-adm) predicts 28-day mortality in severe sepsis and/or septic shock. Methods We prospectively enrolled 345 patients admitted to the emergency department (ED) who received standardized resuscitation (early goal-directed therapy) for severe sepsis and/or septic shock between November 2007 and December 2011. Changes in platelet indices, including Delta MPV72h-adm, were compared between survivors and non-survivors by linear mixed model analysis. The prognostic value of Delta MPV72h-adm for 28-day mortality was ascertained by Cox proportional hazards model analysis. Results Thirty-five (10.1%) patients died within 28 days after ED admission. MPV increased significantly during the first 72 hours in non-survivors (P = 0.001) and survivors (P < 0.001); however, the rate of MPV increase was significantly higher in non-survivors (P = 0.003). Nonetheless, the difference in the platelet decline rate over the first 72 hours did not differ significantly between groups (P = 0.360). In multivariate analysis, Delta MPV72h-adm was an independent predictor of 28-day mortality, after adjusting for plausible confounders (hazard ratio, 1.44; 95% confidence interval, 1.01-2.06; P = 0.044). Conclusions An increase in MPV during the first 72 hours of hospitalization is an independent risk factor for adverse clinical outcomes. Therefore, continuous monitoring of MPV may be useful to stratify mortality risk in patients with severe sepsis and/or septic shock.	[Kim, Chan Ho; Kim, Seung Jun] Catholic Kwandong Univ, Int St Marys Hosp, Coll Med, Dept Internal Med, Inchon, South Korea; [Kim, Chan Ho; Kim, Seung Jun] Yonsei Univ, Grad Sch Med, Dept Med, Seoul 120749, South Korea; [Lee, Mi Jung; Kwon, Young Eun; Kim, Yung Ly; Park, Kyoung Sook; Ryu, Han Jak; Park, Jung Tak; Han, Seung Hyeok; Yoo, Tae-Hyun; Kang, Shin-Wook; Oh, Hyung Jung] Yonsei Univ, Coll Med, Dept Internal Med, Seoul 120749, South Korea; [Yoo, Tae-Hyun; Kang, Shin-Wook] Yonsei Univ, Brain Korea PLUS Project Med Sci 21, Seoul 120749, South Korea	Catholic Kwandong University; Yonsei University; Yonsei University; Yonsei University Health System; Yonsei University	Oh, HJ (corresponding author), Yonsei Univ, Coll Med, Dept Internal Med, Seoul 120749, South Korea.	ohjmd@naver.com	; Han, Seung Hyeok/K-4559-2018	Yoo, Tae-Hyun/0000-0002-9183-4507; Park, Jung Tak/0000-0002-2325-8982; Lee, Mi Jung/0000-0001-8888-029X; Kang, Shin-Wook/0000-0002-5677-4756; Han, Seung Hyeok/0000-0001-7923-5635	Brain Korea 21 PLUS Project for Medical Science, Yonsei University College of Medicine; Korea Healthcare Technology R&D Project, Ministry of Health and Welfare, Republic of Korea [HI10C2020]	Brain Korea 21 PLUS Project for Medical Science, Yonsei University College of Medicine; Korea Healthcare Technology R&D Project, Ministry of Health and Welfare, Republic of Korea	This work was supported by the Brain Korea 21 PLUS Project for Medical Science, Yonsei University College of Medicine, and a grant of the Korea Healthcare Technology R&D Project, Ministry of Health and Welfare, Republic of Korea (HI10C2020). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akca S, 2002, CRIT CARE MED, V30, P753, DOI 10.1097/00003246-200204000-00005; Akinosoglou K, 2014, THROMB RES, V133, P131, DOI 10.1016/j.thromres.2013.07.002; Bath P, 2004, STROKE, V35, P622, DOI 10.1161/01.STR.0000116105.26237.EC; Becchi C, 2006, MINERVA ANESTESIOL, V72, P749; BONE RC, 1992, CRIT CARE MED, V20, P864, DOI 10.1097/00003246-199206000-00025; Braekkan SK, 2010, J THROMB HAEMOST, V8, P157, DOI 10.1111/j.1538-7836.2009.03498.x; Briggs C, 2009, INT J LAB HEMATOL, V31, P277, DOI 10.1111/j.1751-553X.2009.01160.x; CHARLSON M, 1994, J CLIN EPIDEMIOL, V47, P1245, DOI 10.1016/0895-4356(94)90129-5; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Colkesen Y, 2012, CLIN CHEM LAB MED, V50, P631, DOI 10.1515/CCLM.2011.806; DASTUGUE N, 1982, NOUV PRESSE MED, V11, P2899; Dellinger RP, 2008, CRIT CARE MED, V36, P296, DOI 10.1097/01.CCM.0000298158.12101.41; Dombrovskiy VY, 2007, CRIT CARE MED, V35, P1244, DOI 10.1097/01.CCM.0000261890.41311.E9; Estevez-Loureiro R, 2009, THROMB RES, V124, P536, DOI 10.1016/j.thromres.2009.03.012; Garraud O, 2013, CRIT CARE, V17, DOI 10.1186/cc12716; Gasparyan AY, 2011, CURR PHARM DESIGN, V17, P47; Gasparyan Armen Yuri, 2010, Inflammation & Allergy Drug Targets, V9, P45; Gawaz M, 1997, INTENS CARE MED, V23, P379, DOI 10.1007/s001340050344; Huczek Z, 2005, J AM COLL CARDIOL, V46, P284, DOI 10.1016/j.jacc.2005.03.065; JACKSON SR, 1993, BLOOD REV, V7, P104, DOI 10.1016/S0268-960X(05)80020-7; Jones AE, 2007, CHEST, V132, P425, DOI 10.1378/chest.07-0234; Ju HY, 2014, PLATELETS, DOI [10.3109/ 095371042014.890179, DOI 10.3109/095371042014.890179]; Kayahan H, 2007, INT J COLORECTAL DIS, V22, P1429, DOI 10.1007/s00384-007-0330-y; Kitazawa T, 2013, INTERNAL MED, V52, P1487, DOI 10.2169/internalmedicine.52.9555; Leader A, 2012, ANN MED, V44, P805, DOI 10.3109/07853890.2011.653391; Linde-Zwirble WT, 2004, CRIT CARE, V8, P222, DOI 10.1186/cc2917; Rivers E, 2001, NEW ENGL J MED, V345, P1368, DOI 10.1056/NEJMoa010307; Shah B, 2013, AM J CARDIOL, V111, P185, DOI 10.1016/j.amjcard.2012.09.014; Shen J, 2009, THROMB RES, V123, P604, DOI 10.1016/j.thromres.2008.04.004; Shyamsundar M, 2013, CRIT CARE, V17, DOI 10.1186/cc12710; TANIGUCHI T, 1990, J SURG RES, V49, P400, DOI 10.1016/0022-4804(90)90187-7; Ucar H, 2014, PLATELETS, V25, P274, DOI 10.3109/09537104.2013.805406; VALTONEN V, 1993, EUR HEART J, V14, P20; VANDERLELIE J, 1983, J CLIN PATHOL, V36, P693, DOI 10.1136/jcp.36.6.693; Vincent JL, 2002, CRIT CARE MED, V30, pS313, DOI 10.1097/00003246-200205001-00022; Wang HE, 2007, CRIT CARE MED, V35, P1928, DOI 10.1097/01.CCM.0000277043.85378.C1; Yaguchi A, 2004, J THROMB HAEMOST, V2, P2096, DOI 10.1111/j.1538-7836.2004.01009.x; Yazici S, 2010, PLATELETS, V21, P122, DOI 10.3109/09537100903474373; Yazici S, 2010, PLATELETS, V21, P126, DOI 10.3109/09537100903470306; Yilmaz Z, 2008, VET CLIN PATH, V37, P159, DOI 10.1111/j.1939-165X.2008.00023.x; Zahar JR, 2011, CRIT CARE MED, V39, P1886, DOI 10.1097/CCM.0b013e31821b827c	41	90	102	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2015	10	3							e0119437	10.1371/journal.pone.0119437	http://dx.doi.org/10.1371/journal.pone.0119437			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9KG	25742300	Green Published, Green Submitted, gold			2022-12-27	WOS:000350688100111
J	Li, ZL; Yang, CW; Jin, BX; Yu, MZ; Liu, K; Sun, M; Zhan, M				Li, Zhenlong; Yang, Chaowei; Jin, Baoxuan; Yu, Manzhu; Liu, Kai; Sun, Min; Zhan, Matthew			Enabling Big Geoscience Data Analytics with a Cloud-Based, MapReduce-Enabled and Service-Oriented Workflow Framework	PLOS ONE			English	Article							CLIMATE-CHANGE; CYBERINFRASTRUCTURE; SYSTEM	Geoscience observations and model simulations are generating vast amounts of multi-dimensional data. Effectively analyzing these data are essential for geoscience studies. However, the tasks are challenging for geoscientists because processing the massive amount of data is both computing and data intensive in that data analytics requires complex procedures and multiple tools. To tackle these challenges, a scientific workflow framework is proposed for big geoscience data analytics. In this framework techniques are proposed by leveraging cloud computing, MapReduce, and Service Oriented Architecture (SOA). Specifically, HBase is adopted for storing and managing big geoscience data across distributed computers. MapReduce-based algorithm framework is developed to support parallel processing of geoscience data. And service-oriented workflow architecture is built for supporting on-demand complex data analytics in the cloud environment. A proof-of-concept prototype tests the performance of the framework. Results show that this innovative framework significantly improves the efficiency of big geoscience data analytics by reducing the data processing time as well as simplifying data analytical procedures for geoscientists.	[Li, Zhenlong; Yang, Chaowei; Jin, Baoxuan; Yu, Manzhu; Liu, Kai; Sun, Min; Zhan, Matthew] George Mason Univ, NSF Spatiotemporal Innovat Ctr, Fairfax, VA 22030 USA; [Jin, Baoxuan] Yunnan Prov Geomat Ctr, Yunnan Bur Surveying Mapping & GeoInformat, Kunming, Yunnan, Peoples R China; [Zhan, Matthew] Univ Texas Austin, Dept Comp Sci, Austin, TX 78712 USA	George Mason University; University of Texas System; University of Texas Austin	Yang, CW (corresponding author), George Mason Univ, NSF Spatiotemporal Innovat Ctr, Fairfax, VA 22030 USA.	cyang3@gmu.edu	Yu, Manzhu/J-6953-2019; Li, Zhenlong/M-1065-2017; Yang, Chaowei/A-9881-2017	Yu, Manzhu/0000-0001-6769-7517; Li, Zhenlong/0000-0002-8938-5466; Yang, Chaowei/0000-0001-7768-4066; , Baoxuan/0000-0001-5079-2083	NSF [PLR-1349259, IIP-1338925, CNS-1117300]; NASA [NNG12PP37I]	NSF(National Science Foundation (NSF)); NASA(National Aeronautics & Space Administration (NASA))	This research is supported by NSF (PLR-1349259, IIP-1338925, CNS-1117300) and NASA (NNG12PP37I). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barga R, 2008, TRIDENT SCI WORKFLOW, P317, DOI [10.1007/s12265-008-9065-6, DOI 10.1007/S12265-008-9065-6]; Bavoil L, 2005, IEEE VISUALIZATION 2005, PROCEEDINGS, P135, DOI 10.1109/visual.2005.1532788; Chang F, 2008, ACM T COMPUT SYST, V26, DOI 10.1145/1365815.1365816; Chen JY, 2013, IEEE INT CONF CON AU, P400; Cinquini L, 2012, EARTH SYSTEM GRID FE, P1; Cugler DC, 2013, GEOJOURNAL IN PRESS; Cui D, 2010, MASSIVE SPATIAL DATA, P347, DOI [10.1002/pst.472, DOI 10.1002/PST.472]; Deelman E, 2006, NSF WORKSH CHALL SCO, P1; Dongarra J., 2011, INT J HIGH PERFORMAN; Duffy D. Q., 2012, PRELIMINARY EVALUATI; Edwards PN, 2010, VAST MACHINE COMPUTE; Fiore S, 2012, FUTURE GENER COMP SY, V28, P1, DOI 10.1016/j.future.2011.05.015; Foster I, 2001, INT J HIGH PERFORM C, V15, P200, DOI 10.1177/109434200101500302; Geist A., 1994, PVM PARALLEL VIRTUAL; Gil Y, 2008, SCI PROGRAMMING, V16, P4; Grassl H, 2011, SURV GEOPHYS, V32, P319, DOI 10.1007/s10712-011-9129-z; Groot R., 2000, GEOSPATIAL DATA INFR; Gropp W., 1999, USING MPI PORTABLE P; Hodgson JA, 2009, J APPL ECOL, V46, P964, DOI 10.1111/j.1365-2664.2009.01695.x; Hoffa Christina, 2008, 2008 IEEE Fourth International Conference on eScience, P640, DOI 10.1109/eScience.2008.167; Huang QY, 2013, COMPUT GEOSCI-UK, V59, P41, DOI 10.1016/j.cageo.2013.05.001; Juve G, 2009, SCI WORKFLOW APPL AM, P59; Juve G., 2011, GRIDS CLOUDS VIRTUAL, P71, DOI DOI 10.1007/978-0-85729-049-6_4; Khetrapal A., 2006, HBASE HYPERTABLE LAR; Lakshman Avinash, 2010, Operating Systems Review, V44, P35, DOI 10.1145/1773912.1773922; Li JY, 2014, COMPUT GEOSCI-UK, V70, P110, DOI 10.1016/j.cageo.2014.05.008; Li ZL, 2017, COMPUT ENVIRON URBAN, V61, P141, DOI 10.1016/j.compenvurbsys.2014.06.004; Li ZL, 2011, INT J GEOGR INF SCI, V25, P595, DOI 10.1080/13658816.2010.484811; Liu Yi, 2009, Application Research of Computers, V26, P3428, DOI 10.3969/j.issn.1001-3695.2009.09.064; Liu YF, 2013, STAT INTERFACE, V6, P1; Ludascher B, 2006, CONCURR COMP-PRACT E, V18, P1039, DOI 10.1002/cpe.994; Majithia S., 2004, TRIANA GRAPHICAL WEB, P514; Mattmann CA, 2011, HANDBOOK OF DATA INTENSIVE COMPUTING, P25, DOI 10.1007/978-1-4614-1415-5_2; Mell P., 2011, NIST DEFINITION CLOU; Minchin S, 2014, BIG DATA DEALING DEL; Murphy JM, 2004, NATURE, V430, P768, DOI 10.1038/nature02771; Oinn T, 2004, BIOINFORMATICS, V20, P3045, DOI 10.1093/bioinformatics/bth361; PORTER JH, 2000, ECOLOGICAL DATA DESI, P48; Rizvandi NB, 2011, MAPREDUCE IMPLEMENTA, P86, DOI [10.1007/s12262-011-0358-7, DOI 10.1007/S12262-011-0358-7]; Schnase JL, 2017, COMPUT ENVIRON URBAN, V61, P198, DOI 10.1016/j.compenvurbsys.2013.12.003; Simmhan Y, 2009, 2009 THIRD INTERNATIONAL CONFERENCE ON ADVANCED ENGINEERING COMPUTING AND APPLICATIONS IN SCIENCES (ADVCOMP 2009), P41, DOI 10.1109/ADVCOMP.2009.14; Stonebraker M, 2010, COMMUN ACM, V53, P10, DOI 10.1145/1721654.1721659; Taylor IJ, 2007, WORKFLOWS E SCI, DOI [10.1093/jxb/erm028, DOI 10.1093/JXB/ERM028]; Wang SW, 2010, ANN ASSOC AM GEOGR, V100, P535, DOI 10.1080/00045601003791243; Williams DN, 2009, B AM METEOROL SOC, V90, P195, DOI 10.1175/2008BAMS2459.1; Wright DJ, 2011, P NATL ACAD SCI USA, V108, P5488, DOI 10.1073/pnas.1103051108; Yang CW, 2011, INT J DIGIT EARTH, V4, P305, DOI 10.1080/17538947.2011.587547; Yang CW, 2011, P NATL ACAD SCI USA, V108, P5498, DOI 10.1073/pnas.0909315108; Yang CW, 2010, COMPUT ENVIRON URBAN, V34, P264, DOI 10.1016/j.compenvurbsys.2010.04.001; Yang CW, 2008, INT J DIGIT EARTH, V1, P259, DOI 10.1080/17538940802037954; Yue P., 2009, 2009 17 INT C GEOINF, P1, DOI 10.1016/j.fas.2009.11.003; Yue P, 2007, COMPUT GEOSCI-UK, V33, P649, DOI 10.1016/j.cageo.2006.09.003; Zhang H, 2007, PHYS EARTH PLANET IN, V163, P2, DOI 10.1016/j.pepi.2007.05.008; Zhao H, 2010, LECT NOTES COMPUT SC, V6318, P425, DOI 10.1007/978-3-642-16515-3_53; Zhenlong Li, 2013, Web and Wireless Geographical Information Systems. 12th International Symposium, W2GIS 2013. Proceedings, P190, DOI 10.1007/978-3-642-37087-8_14	56	28	29	3	77	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2015	10	3							e0116781	10.1371/journal.pone.0116781	http://dx.doi.org/10.1371/journal.pone.0116781			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9KG	25742012	Green Published, gold, Green Submitted			2022-12-27	WOS:000350688100004
J	Sun, W; Meng, XY; Liang, LJ; Jiang, WS; Huang, YF; He, J; Hu, HY; Almqvist, J; Gao, X; Wang, L				Sun, Wei; Meng, Xiangyu; Liang, Lingjie; Jiang, Wangshu; Huang, Yafei; He, Jing; Hu, Haiyan; Almqvist, Jonas; Gao, Xiang; Wang, Li			Molecular and Biochemical Analysis of Chalcone Synthase from Freesia hybrid in Flavonoid Biosynthetic Pathway	PLOS ONE			English	Article							SITE-DIRECTED MUTAGENESIS; ANTHOCYANIN BIOSYNTHESIS; ENZYMATIC FORMATION; CELL-CULTURES; GENE; POLYKETIDE; EXPRESSION; ENZYMES; ACCUMULATION; INSIGHTS	Chalcone synthase (CHS) catalyzes the first committed step in the flavonoid biosynthetic pathway. In this study, the cDNA (FhCHS1) encoding CHS from Freesia hybrida was successfully isolated and analyzed. Multiple sequence alignments showed that both the conserved CHS active site residues and CHS signature sequence were found in the deduced amino acid sequence of FhCHS1. Meanwhile, crystallographic analysis revealed that protein structure of FhCHS1 is highly similar to that of alfalfa CHS2, and the biochemical analysis results indicated that it has an enzymatic role in naringenin biosynthesis. Moreover, quantitative real-time PCR was performed to detect the transcript levels of FhCHS1 in flowers and different tissues, and patterns of FhCHS1 expression in flowers showed significant correlation to the accumulation patterns of anthocyanin during flower development. To further characterize the functionality of FhCHS1, its ectopic expression in Arabidopsis thaliana tt4 mutants and Petunia hybrida was performed. The results showed that overexpression of FhCHS1 in tt4 mutants fully restored the pigmentation phenotype of the seed coats, cotyledons and hypocotyls, while transgenic petunia expressing FhCHS1 showed flower color alteration from white to pink. In summary, these results suggest that FhCHS1 plays an essential role in the biosynthesis of flavonoid in Freesia hybrida and may be used to modify the components of flavonoids in other plants.	[Sun, Wei; Meng, Xiangyu; Liang, Lingjie; He, Jing; Hu, Haiyan; Gao, Xiang; Wang, Li] NE Normal Univ, Inst Cytol & Genet, Changchun, Peoples R China; [Jiang, Wangshu; Huang, Yafei; Almqvist, Jonas] Uppsala Univ, Uppsala Biomed Ctr, Dept Cell & Mol Biol, S-75124 Uppsala, Sweden	Northeast Normal University - China; Uppsala University	Gao, X (corresponding author), NE Normal Univ, Inst Cytol & Genet, Changchun, Peoples R China.	gaoxiang424@163.com; wanglee57@163.com			National Natural Science Foundation of China [31170276, 31300271]; Jilin provincial Government of the People's Republic of China [20130102061JC, 201201074, 20125035]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Jilin provincial Government of the People's Republic of China	This work was supported by the National Natural Science Foundation of China (31170276, 31300271) and Jilin provincial Government of the People's Republic of China (20130102061JC, 201201074, 20125035). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe I, 2002, ORG LETT, V4, P3623, DOI 10.1021/ol0201409; Abe I, 2010, NAT PROD REP, V27, P809, DOI 10.1039/b909988n; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Austin MB, 2003, NAT PROD REP, V20, P79, DOI 10.1039/b100917f; Buer CS, 2010, J INTEGR PLANT BIOL, V52, P98, DOI 10.1111/j.1744-7909.2010.00905.x; Chandler SF, 2011, BIOTECHNOL LETT, V33, P207, DOI 10.1007/s10529-010-0424-4; CHANG C, 1988, P NATL ACAD SCI USA, V85, P6856, DOI 10.1073/pnas.85.18.6856; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Commenges D, 2000, EUR J EPIDEMIOL, V16, P357, DOI 10.1023/A:1007614613771; Dare AP, 2013, PLANT J, V74, P398, DOI 10.1111/tpj.12140; Davis G, 2012, DNA CELL BIOL, V31, P939, DOI 10.1089/dna.2011.1589; Deng XB, 2014, NEW PHYTOL, V201, P1469, DOI 10.1111/nph.12610; Des Marais DL, 2008, NATURE, V454, P762, DOI 10.1038/nature07092; Dong XY, 2001, PLANT PHYSIOL, V127, P46, DOI 10.1104/pp.127.1.46; Ferreyra MLF, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00222; Fanali C, 2011, J SEP SCI, V34, P150, DOI 10.1002/jssc.201000665; Ferrer JL, 2008, PLANT PHYSIOL BIOCH, V46, P356, DOI 10.1016/j.plaphy.2007.12.009; Ferrer JL, 1999, NAT STRUCT BIOL, V6, P775, DOI 10.1038/11553; Forkmann G, 2001, CURR OPIN BIOTECH, V12, P155, DOI 10.1016/S0958-1669(00)00192-0; Grotewold E, 2006, ANNU REV PLANT BIOL, V57, P761, DOI 10.1146/annurev.arplant.57.032905.105248; Helariutta Y, 1996, P NATL ACAD SCI USA, V93, P9033, DOI 10.1073/pnas.93.17.9033; HOLTON TA, 1995, PLANT CELL, V7, P1071, DOI 10.1105/tpc.7.7.1071; Jaakola L, 2013, TRENDS PLANT SCI, V18, P477, DOI 10.1016/j.tplants.2013.06.003; Jiang CG, 2006, PHYTOCHEMISTRY, V67, P2531, DOI 10.1016/j.phytochem.2006.09.030; Jung CS, 2009, THEOR APPL GENET, V120, P45, DOI 10.1007/s00122-009-1158-3; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Knekt P, 2002, AM J CLIN NUTR, V76, P560, DOI 10.1093/ajcn/76.3.560; Koduri PKH, 2010, PLANT MOL BIOL, V72, P247, DOI 10.1007/s11103-009-9565-z; Kovinich N, 2010, PHYTOCHEMISTRY, V71, P1253, DOI 10.1016/j.phytochem.2010.05.009; KREUZALER F, 1972, FEBS LETT, V28, P69, DOI 10.1016/0014-5793(72)80679-3; Kuckuck H, 1936, MOL GENET GENOMICS, V71, P429; LANZ T, 1991, J BIOL CHEM, V266, P9971; Liu BY, 2003, PLANT J, V34, P847, DOI 10.1046/j.1365-313X.2003.01771.x; Ma LQ, 2009, PLANTA, V229, P457, DOI 10.1007/s00425-008-0845-7; Maleka M.F., 2013, PHILOS T GENET, V2, P55; Martens S, 2005, PHYTOCHEMISTRY, V66, P2399, DOI 10.1016/j.phytochem.2005.07.013; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; MEYER P, 1987, NATURE, V330, P677, DOI 10.1038/330677a0; Mol J, 1998, TRENDS PLANT SCI, V3, P212, DOI 10.1016/S1360-1385(98)01242-4; Moore S, 2002, J EXP BOT, V53, P2023, DOI 10.1093/jxb/erf057; Morita H, 2000, BIOCHEM BIOPH RES CO, V279, P190, DOI 10.1006/bbrc.2000.3920; Napoli CA, 1999, PLANT PHYSIOL, V120, P615, DOI 10.1104/pp.120.2.615; Niyogi KK, 2000, CURR OPIN PLANT BIOL, V3, P455, DOI 10.1016/S1369-5266(00)00113-8; Owens DK, 2008, PLANT PHYSIOL, V147, P1046, DOI 10.1104/pp.108.117457; Pang YZ, 2005, PLANT SCI, V168, P1525, DOI 10.1016/j.plantsci.2005.02.003; Pelletier MK, 1999, PLANT MOL BIOL, V40, P45, DOI 10.1023/A:1026414301100; Penninckx IAMA, 1996, PLANT CELL, V8, P2309, DOI 10.1105/tpc.8.12.2309; Peter Goldbiatt JCM, 2008, THE IRIS FAMILY NATU; Petroni K, 2011, PLANT SCI, V181, P219, DOI 10.1016/j.plantsci.2011.05.009; Pourcel L, 2012, REC ADV POLYPHEN RES, V3, P143; Rahman RNZRA, 2012, INT J MOL SCI, V13, P9673, DOI 10.3390/ijms13089673; RYDER TB, 1987, MOL GEN GENET, V210, P219, DOI 10.1007/BF00325687; SHIRLEY BW, 1995, PLANT J, V8, P659, DOI 10.1046/j.1365-313X.1995.08050659.x; SOMMER H, 1986, MOL GEN GENET, V202, P429, DOI 10.1007/BF00333273; STAFFORD HA, 1991, PLANT PHYSIOL, V96, P680, DOI 10.1104/pp.96.3.680; Stracke R, 2009, PLANTA, V229, P427, DOI 10.1007/s00425-008-0841-y; Suh DY, 2000, BIOCHEM BIOPH RES CO, V275, P725, DOI 10.1006/bbrc.2000.3368; Sui X, 2011, PLANT CELL REP, V30, P1209, DOI 10.1007/s00299-011-1029-7; Teixeira S, 2005, FREE RADICAL BIO MED, V39, P1099, DOI 10.1016/j.freeradbiomed.2005.05.028; Trojan V, 2014, J CEREAL SCI, V59, P48, DOI 10.1016/j.jcs.2013.10.008; Wang HX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078484; Winkel-Shirley B, 2001, PLANT PHYSIOL, V127, P1399, DOI 10.1104/pp.127.4.1399; Winkel-Shirley B, 2002, CURR OPIN PLANT BIOL, V5, P218, DOI 10.1016/S1369-5266(02)00256-X; Yoshida K, 2010, J PLANT RES, V123, P801, DOI 10.1007/s10265-010-0325-6; Zhou XW, 2013, J BIOSCIENCES, V38, P593, DOI 10.1007/s12038-013-9339-2	66	77	98	5	90	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2015	10	3							e0119054	10.1371/journal.pone.0119054	http://dx.doi.org/10.1371/journal.pone.0119054			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9KG	25742495	Green Published, gold, Green Submitted			2022-12-27	WOS:000350688100077
J	Zhang, XM; Kong, W; Wanda, SY; Xin, W; Alamuri, P; Curtiss, R				Zhang, Xiangmin; Kong, Wei; Wanda, Soo-Young; Xin, Wei; Alamuri, Praveen; Curtiss, Roy, III			Generation of Influenza Virus from Avian Cells Infected by Salmonella Carrying the Viral Genome	PLOS ONE			English	Article							A VIRUSES; ESCHERICHIA-COLI; PLASMID DNA; YERSINIA-PSEUDOTUBERCULOSIS; INTRACELLULAR BACTERIA; GENETIC REASSORTMENT; PROTECTIVE ANTIGENS; STABLE MAINTENANCE; VACCINE STRAINS; CLONED GENES	Domestic poultry serve as intermediates for transmission of influenza A virus from the wild aquatic bird reservoir to humans, resulting in influenza outbreaks in poultry and potential epidemics/pandemics among human beings. To combat emerging avian influenza virus, an inexpensive, heat-stable, and orally administered influenza vaccine would be useful to vaccinate large commercial poultry flocks and even migratory birds. Our hypothesized vaccine is a recombinant attenuated bacterial strain able to mediate production of attenuated influenza virus in vivo to induce protective immunity against influenza. Here we report the feasibility and technical limitations toward such an ideal vaccine based on our exploratory study. Five 8-unit plasmids carrying a chloramphenicol resistance gene or free of an antibiotic resistance marker were constructed. Influenza virus was successfully generated in avian cells transfected by each of the plasmids. The Salmonella carrier was engineered to allow stable maintenance and conditional release of the 8-unit plasmid into the avian cells for recovery of influenza virus. Influenza A virus up to 10(7) 50% tissue culture infective doses (TCID50)/ml were recovered from 11 out of 26 co-cultures of chicken embryonic fibroblasts (CEF) and Madin-Darby canine kidney (MDCK) cells upon infection by the recombinant Salmonella carrying the 8-unit plasmid. Our data prove that a bacterial carrier can mediate generation of influenza virus by delivering its DNA cargoes into permissive host cells. Although we have made progress in developing this Salmonella influenza virus vaccine delivery system, further improvements are necessary to achieve efficient virus production, especially in vivo.	[Zhang, Xiangmin; Kong, Wei; Wanda, Soo-Young; Xin, Wei; Alamuri, Praveen; Curtiss, Roy, III] Arizona State Univ, Biodesign Inst, Tempe, AZ 85281 USA; [Zhang, Xiangmin] Wayne State Univ, Eugene Applebaum Coll Pharm Hlth Sci, Dept Pharmaceut Sci, Detroit, MI USA; [Curtiss, Roy, III] Arizona State Univ, Sch Life Sci, Tempe, AZ USA	Arizona State University; Arizona State University-Tempe; Wayne State University; Arizona State University; Arizona State University-Tempe	Zhang, XM (corresponding author), Arizona State Univ, Biodesign Inst, Tempe, AZ 85281 USA.	xiangmin.zhang@wayne.edu		Zhang, Xiangmin/0000-0001-9285-1619	National Institutes of Health [AI065779]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI093348, R01AI065779] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by grants from the National Institutes of Health (AI065779). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bakowski MA, 2008, TRAFFIC, V9, P2022, DOI 10.1111/j.1600-0854.2008.00827.x; Beuzon CR, 2000, EMBO J, V19, P3235, DOI 10.1093/emboj/19.13.3235; Brown IH, 1998, J GEN VIROL, V79, P2947, DOI 10.1099/0022-1317-79-12-2947; Brumell JH, 2002, TRAFFIC, V3, P407, DOI 10.1034/j.1600-0854.2002.30604.x; Brune W, 2001, SCIENCE, V291, P303, DOI 10.1126/science.291.5502.303; Campitelli L, 2004, VIROLOGY, V323, P24, DOI 10.1016/j.virol.2004.02.015; Capua I, 2007, VACCINE, V25, P5645, DOI 10.1016/j.vaccine.2006.10.053; Capua I, 2007, VACCINE, V25, P4987, DOI 10.1016/j.vaccine.2007.01.113; CASTRUCCI MR, 1993, VIROLOGY, V193, P503, DOI 10.1006/viro.1993.1155; CHAMBERS TM, 1991, ARCH VIROL, V116, P261, DOI 10.1007/BF01319247; Chen H, 2009, REV SCI TECH OIE, V28, P267, DOI 10.20506/rst.28.1.1860; Chen ZY, 2006, VIROLOGY, V345, P416, DOI 10.1016/j.virol.2005.10.005; Cheung TKW, 2007, ANN NY ACAD SCI, V1102, P1, DOI 10.1196/annals.1408.001; Cicin-Sain L, 2003, J VIROL, V77, P8249, DOI 10.1128/JVI.77.15.8249-8255.2003; Claas ECJ, 1998, LANCET, V351, P472, DOI 10.1016/S0140-6736(97)11212-0; Curtiss R, 2002, J CLIN INVEST, V110, P1061, DOI 10.1172/JCI200216941; CURTISS R, 1989, IMMUNOL INVEST, V18, P583, DOI 10.3109/08820138909112265; Curtiss R, 2005, MUCOSAL IMMUNOLOGY, 3RD EDITION, P1009, DOI 10.1016/B978-012491543-5/50060-7; Curtiss R, 2010, CRIT REV IMMUNOL, V30, P255, DOI 10.1615/CritRevImmunol.v30.i3.30; Curtiss R, 2009, INFECT IMMUN, V77, P1071, DOI 10.1128/IAI.00693-08; Dean DA, 1997, EXP CELL RES, V230, P293, DOI 10.1006/excr.1996.3427; Dean DA, 1999, EXP CELL RES, V253, P713, DOI 10.1006/excr.1999.4716; deJong JC, 1997, NATURE, V389, P554, DOI 10.1038/39218; Droge M, 1998, J BIOTECHNOL, V64, P75, DOI 10.1016/S0168-1656(98)00105-9; FARACI WS, 1988, BIOCHEMISTRY-US, V27, P3267, DOI 10.1021/bi00409a022; Fouchier RAM, 2005, J VIROL, V79, P2814, DOI 10.1128/JVI.79.5.2814-2822.2005; GALAN JE, 1990, GENE, V94, P29, DOI 10.1016/0378-1119(90)90464-3; GENTSCHEV I, 1995, INFECT IMMUN, V63, P4202, DOI 10.1128/IAI.63.10.4202-4205.1995; Grillot-Courvalin C, 2002, CELL MICROBIOL, V4, P177, DOI 10.1046/j.1462-5822.2002.00184.x; Grillot-Courvalin C, 1998, NAT BIOTECHNOL, V16, P862, DOI 10.1038/nbt0998-862; GUO YJ, 1983, J GEN VIROL, V64, P177, DOI 10.1099/0022-1317-64-1-177; Hai R, 2011, J VIROL, V85, P6832, DOI 10.1128/JVI.00609-11; HALVORSON DA, 1985, APPL ENVIRON MICROB, V49, P914, DOI 10.1128/AEM.49.4.914-919.1985; HEITMANN D, 1993, BIOSYSTEMS, V29, P37, DOI 10.1016/0303-2647(93)90080-V; HINSHAW VS, 1981, INFECT IMMUN, V34, P354, DOI 10.1128/IAI.34.2.354-361.1981; Ito T, 1998, J VIROL, V72, P7367, DOI 10.1128/JVI.72.9.7367-7373.1998; Ito T, 2000, VET MICROBIOL, V74, P71, DOI 10.1016/S0378-1135(00)00167-X; Jin H, 2003, VIROLOGY, V306, P18, DOI 10.1016/S0042-6822(02)00035-1; Kang HY, 2002, J BACTERIOL, V184, P307, DOI 10.1128/JB.184.1.307-312.2002; KIDA H, 1980, INFECT IMMUN, V30, P547; Killian Mary Lea, 2008, V436, P47, DOI 10.1007/978-1-59745-279-3_7; Kong QK, 2010, VACCINE, V28, P6094, DOI 10.1016/j.vaccine.2010.06.074; Kong QK, 2009, INFECT IMMUN, V77, P5572, DOI 10.1128/IAI.00831-09; Kong W, 2008, P NATL ACAD SCI USA, V105, P9361, DOI 10.1073/pnas.0803801105; Kong W, 2012, P NATL ACAD SCI USA, V109, P19414, DOI 10.1073/pnas.1217554109; Kotton CN, 2004, INFECT IMMUN, V72, P5535, DOI 10.1128/IAI.72.10.5535-5547.2004; Li YH, 2008, INFECT IMMUN, V76, P5238, DOI 10.1128/IAI.00720-08; LOCKMAN HA, 1990, J INFECT DIS, V162, P1397, DOI 10.1093/infdis/162.6.1397; Loessner H, 2006, FEMS MICROBIOL LETT, V265, P81, DOI 10.1111/j.1574-6968.2006.00470.x; Marriott I, 1999, EUR J IMMUNOL, V29, P1107, DOI 10.1002/(SICI)1521-4141(199904)29:04<1107::AID-IMMU1107>3.0.CO;2-0; Mesika A, 2001, MOL THER, V3, P653, DOI 10.1006/mthe.2001.0312; Miao B, 2012, ONCOGENE, V31, P4317, DOI 10.1038/onc.2011.593; Munster VJ, 2006, VACCINE, V24, P6729, DOI 10.1016/j.vaccine.2006.05.060; NELSON J, 1993, VIRUS RES, V29, P155, DOI 10.1016/0168-1702(93)90056-S; Neumann G, 2005, P NATL ACAD SCI USA, V102, P16825, DOI 10.1073/pnas.0505587102; Neumann G, 1999, P NATL ACAD SCI USA, V96, P9345, DOI 10.1073/pnas.96.16.9345; Osterhaus ADME, 2000, SCIENCE, V288, P1051, DOI 10.1126/science.288.5468.1051; Osterhaus Albert D. M. E., 2008, V27, P1; Park MS, 2006, P NATL ACAD SCI USA, V103, P8203, DOI 10.1073/pnas.0602566103; Rand KN, 1996, TECH TIPS ONLINE, V1, P23; ROGERS SG, 1983, APPL ENVIRON MICROB, V46, P37, DOI 10.1128/AEM.46.1.37-43.1983; Santander J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015944; SCHAFFNER W, 1980, P NATL ACAD SCI-BIOL, V77, P2163, DOI 10.1073/pnas.77.4.2163; SCHULTZ U, 1991, VIROLOGY, V183, P61, DOI 10.1016/0042-6822(91)90118-U; Shi HY, 2013, CLIN VACCINE IMMUNOL, V20, P931, DOI 10.1128/CVI.00003-13; Shinya K, 2006, NATURE, V440, P435, DOI 10.1038/440435a; Sims LD, 2007, DEV BIOLOGICALS, V130, P39; SIZEMORE DR, 1995, SCIENCE, V270, P299, DOI 10.1126/science.270.5234.299; SMALL PLC, 1987, INFECT IMMUN, V55, P1674, DOI 10.1128/IAI.55.7.1674-1679.1987; Steel J, 2009, J VIROL, V83, P1742, DOI 10.1128/JVI.01920-08; Suarez DL, 1998, J VIROL, V72, P6678, DOI 10.1128/JVI.72.8.6678-6688.1998; Subramanian A, 1999, NAT BIOTECHNOL, V17, P873, DOI 10.1038/12860; Sun W, 2008, APPL ENVIRON MICROB, V74, P4241, DOI 10.1128/AEM.00940-08; Sun W, 2014, INFECT IMMUN, V82, P4390, DOI 10.1128/IAI.02173-14; Swayne DE, 2009, COMP IMMUNOL MICROB, V32, P351, DOI 10.1016/j.cimid.2008.01.006; Swayne DE, 2008, IMMUNOL REV, V225, P314, DOI 10.1111/j.1600-065X.2008.00668.x; Thanaketpaisarn O, 2008, J BIOTECHNOL, V133, P36, DOI 10.1016/j.jbiotec.2007.08.047; Tong SX, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003657; Tong SX, 2012, P NATL ACAD SCI USA, V109, P4269, DOI 10.1073/pnas.1116200109; Torres-Escobar A, 2010, INFECT IMMUN, V78, P2529, DOI 10.1128/IAI.00005-10; Villarreal-Chavez C, 2003, AVIAN DIS, V47, P1002, DOI 10.1637/0005-2086-47.s3.1002; Webby RJ, 2001, PHILOS T R SOC B, V356, P1817, DOI 10.1098/rstb.2001.0997; WEBSTER RG, 1978, VIROLOGY, V84, P268, DOI 10.1016/0042-6822(78)90247-7; WEBSTER RG, 1992, MICROBIOL REV, V56, P152, DOI 10.1128/MMBR.56.1.152-179.1992; Xin W, 2012, INFECT IMMUN, V80, P3621, DOI 10.1128/IAI.00620-12; Zanta MA, 1999, P NATL ACAD SCI USA, V96, P91, DOI 10.1073/pnas.96.1.91; Zhang X, 1997, INFECT IMMUN, V65, P5381, DOI 10.1128/IAI.65.12.5381-5387.1997; Zhang XM, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-31; Zhang XM, 2009, J VIROL, V83, P9296, DOI 10.1128/JVI.00781-09	89	4	6	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2015	10	3							e0119041	10.1371/journal.pone.0119041	http://dx.doi.org/10.1371/journal.pone.0119041			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9KG	25742162	Green Submitted, Green Published, gold			2022-12-27	WOS:000350688100075
J	Grove, O; Berglund, AE; Schabath, MB; Aerts, HJWL; Dekker, A; Wang, H; Velazquez, ER; Lambin, P; Gu, YH; Balagurunathan, Y; Eikman, E; Gatenby, RA; Eschrich, S; Gillies, RJ				Grove, Olya; Berglund, Anders E.; Schabath, Matthew B.; Aerts, Hugo J. W. L.; Dekker, Andre; Wang, Hua; Velazquez, Emmanuel Rios; Lambin, Philippe; Gu, Yuhua; Balagurunathan, Yoganand; Eikman, Edward; Gatenby, Robert A.; Eschrich, Steven; Gillies, Robert J.			Quantitative Computed Tomographic Descriptors Associate Tumor Shape Complexity and Intratumor Heterogeneity with Prognosis in Lung Adenocarcinoma	PLOS ONE			English	Article							TEXTURE ANALYSIS; POTENTIAL MARKER; CT IMAGES; CANCER; MUTATIONS	Two CT features were developed to quantitatively describe lung adenocarcinomas by scoring tumor shape complexity (feature 1: convexity) and intratumor density variation (feature 2: entropy ratio) in routinely obtained diagnostic CT scans. The developed quantitative features were analyzed in two independent cohorts (cohort 1: n = 61; cohort 2: n = 47) of patients diagnosed with primary lung adenocarcinoma, retrospectively curated to include imaging and clinical data. Preoperative chest CTs were segmented semi-automatically. Segmented tumor regions were further subdivided into core and boundary sub-regions, to quantify intensity variations across the tumor. Reproducibility of the features was evaluated in an independent test-retest dataset of 32 patients. The proposed metrics showed high degree of reproducibility in a repeated experiment (concordance, CCC >= 0.897; dynamic range, DR >= 0.92). Association with overall survival was evaluated by Cox proportional hazard regression, Kaplan-Meier survival curves, and the log-rank test. Both features were associated with overall survival (convexity: p = 0.008; entropy ratio: p = 0.04) in Cohort 1 but not in Cohort 2 (convexity: p = 0.7; entropy ratio: p = 0.8). In both cohorts, these features were found to be descriptive and demonstrated the link between imaging characteristics and patient survival in lung adenocarcinoma.	[Grove, Olya; Wang, Hua; Gu, Yuhua; Balagurunathan, Yoganand; Gatenby, Robert A.; Gillies, Robert J.] H Lee Moffitt Canc Ctr & Res Inst, Dept Canc Imaging & Metab, Tampa, FL 33612 USA; [Berglund, Anders E.; Eschrich, Steven] H Lee Moffitt Canc Ctr & Res Inst, Dept Biomed Informat, Tampa, FL USA; [Schabath, Matthew B.] H Lee Moffitt Canc Ctr & Res Inst, Dept Canc Epidemiol, Tampa, FL USA; [Eikman, Edward; Gatenby, Robert A.; Gillies, Robert J.] H Lee Moffitt Canc Ctr & Res Inst, Dept Radiol, Tampa, FL USA; [Dekker, Andre; Lambin, Philippe] Maastricht Univ, Res Inst GROW, MAASTRO Clin, Dept Radiat Oncol, NL-6229 ET Maastricht, Netherlands; [Wang, Hua] Tianjin Med Univ, Key Lab Canc Prevent & Therapy, Canc Inst & Hosp, Dept Radiol,Natl Clin Res Ctr Canc, Tianjin, Peoples R China; [Aerts, Hugo J. W. L.; Velazquez, Emmanuel Rios] Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Radiat Oncol,Dana Farber Canc Inst, Boston, MA USA; [Aerts, Hugo J. W. L.] Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Radiol, Boston, MA USA	H Lee Moffitt Cancer Center & Research Institute; H Lee Moffitt Cancer Center & Research Institute; H Lee Moffitt Cancer Center & Research Institute; H Lee Moffitt Cancer Center & Research Institute; Maastricht University; Maastricht University Medical Centre (MUMC); Tianjin Medical University; Harvard University; Brigham & Women's Hospital; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Gillies, RJ (corresponding author), H Lee Moffitt Canc Ctr & Res Inst, Dept Canc Imaging & Metab, Tampa, FL 33612 USA.	Robert.Gillies@Moffitt.org	Balagurunathan, Yoganand/AAH-9139-2021; Aerts, Hugo/ABF-2821-2020; Balagurunathan, Yoganand/AAF-9163-2020; Dekker, Andre/AAE-4830-2019; Aerts, Hugo/P-6350-2015; Schabath, Matthew B./J-3763-2016; Eschrich, Steven/K-6848-2013	Aerts, Hugo/0000-0002-2122-2003; Balagurunathan, Yoganand/0000-0002-5598-4727; Dekker, Andre/0000-0002-0422-7996; Aerts, Hugo/0000-0002-2122-2003; Schabath, Matthew B./0000-0003-3241-3216; Eschrich, Steven/0000-0002-9833-2788; Gillies, Robert/0000-0002-8888-7747; Berglund, Anders/0000-0002-0393-3530; Lambin, Philippe/0000-0001-7961-0191	National Cancer Institute; NIH/NCI, Radiomics of NSCLC [U01CA143062]; NIH/NCI, Radiomics of Lung Cancer Screening [P50CA119997]; Florida Biomedical Research Programs: King Team Science Grant [2KT01]; NATIONAL CANCER INSTITUTE [U01CA196405, U01CA143062, R25CA174664, P50CA119997, P30CA076292] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH/NCI, Radiomics of NSCLC; NIH/NCI, Radiomics of Lung Cancer Screening; Florida Biomedical Research Programs: King Team Science Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Funding provided by National Cancer Institute: http://www.cancer.gov/, 1.NIH/NCI U01CA143062, Radiomics of NSCLC; 2. NIH/NCI P50CA119997, Radiomics of Lung Cancer Screening. Florida Biomedical Research Programs: http://researchtest.magnet.fsu.edu/newsletters/2013/July/documents/2013-2014%20SUMMER%20CALL%20King%20Program.pdf, King Team Science Grant 2KT01. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balagurunathan Y, 2014, TRANSL ONCOL, V7, P72, DOI 10.1593/tlo.13844; Barber CB, 1996, ACM T MATH SOFTWARE, V22, P469, DOI 10.1145/235815.235821; Diehn M, 2008, P NATL ACAD SCI USA, V105, P5213, DOI 10.1073/pnas.0801279105; Ding L, 2008, NATURE, V455, P1069, DOI 10.1038/nature07423; Ganeshan B, 2012, EUR RADIOL, V22, P796, DOI 10.1007/s00330-011-2319-8; Gatenby RA, 2013, RADIOLOGY, V269, P8, DOI 10.1148/radiol.13122697; Gevaert O, 2012, RADIOLOGY, V264, P387, DOI 10.1148/radiol.12111607; Gu YH, 2013, PATTERN RECOGN, V46, P692, DOI 10.1016/j.patcog.2012.10.005; Honda T, 2013, CLIN RADIOL, V68, pE21, DOI 10.1016/j.crad.2012.09.002; Jaffe CC, 2012, RADIOLOGY, V264, P329, DOI 10.1148/radiol.12120871; Kelsey CR, 2009, CANCER-AM CANCER SOC, V115, P5218, DOI 10.1002/cncr.24625; Kratz JR, 2012, LANCET, V379, P823, DOI 10.1016/S0140-6736(11)61941-7; Kuo MD, 2014, RADIOLOGY, V270, P320, DOI 10.1148/radiol.13132195; Lambin P, 2012, EUR J CANCER, V48, P441, DOI 10.1016/j.ejca.2011.11.036; LIN LI, 1989, BIOMETRICS, V45, P255, DOI 10.2307/2532051; Miles KA, 2009, RADIOLOGY, V250, P444, DOI 10.1148/radiol.2502071879; Nair VS, 2010, CHEST, V137, P1150, DOI 10.1378/chest.09-2356; Peifer M, 2012, NAT GENET, V44, P1104, DOI 10.1038/ng.2396; Prokop M, 2001, SPIRAL MULTISLICE CO, P1104; Ravanelli M, 2013, EUR RADIOL, V23, P3450, DOI 10.1007/s00330-013-2965-0; Rees JH, 1996, RADIOGRAPHICS, V16, P1413, DOI 10.1148/radiographics.16.6.8946545; Rose CJ, 2009, MAGN RESON MED, V62, P488, DOI 10.1002/mrm.22003; Rutman AM, 2009, EUR J RADIOL, V70, P232, DOI 10.1016/j.ejrad.2009.01.050; Segal E, 2007, NAT BIOTECHNOL, V25, P675, DOI 10.1038/nbt1306; Shultz DB, 2014, CLIN LUNG CANCER, V15, P294, DOI 10.1016/j.cllc.2013.12.011; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Yang XK, 2011, EURASIP J ADV SIG PR, DOI 10.1155/2011/412647; Zhao BS, 2009, RADIOLOGY, V252, P263, DOI 10.1148/radiol.2522081593	28	155	158	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2015	10	3							e0118261	10.1371/journal.pone.0118261	http://dx.doi.org/10.1371/journal.pone.0118261			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9JM	25739030	Green Published, Green Submitted, gold			2022-12-27	WOS:000350685900026
J	Hochst, B; Mikulec, J; Baccega, T; Metzger, C; Welz, M; Peusquens, J; Tacke, F; Knolle, P; Kurts, C; Diehl, L; Ludwig-Portugall, I				Hoechst, Bastian; Mikulec, Julita; Baccega, Tania; Metzger, Christina; Welz, Meike; Peusquens, Julia; Tacke, Frank; Knolle, Percy; Kurts, Christian; Diehl, Linda; Ludwig-Portugall, Isis			Differential Induction of Ly6G and Ly6C Positive Myeloid Derived Suppressor Cells in Chronic Kidney and Liver Inflammation and Fibrosis	PLOS ONE			English	Article							LIMITS TUMOR PROGRESSION; T-CELL; CYCLOOXYGENASE-2 INHIBITORS; IMMUNE SUPPRESSION; MOUSE MODEL; CANCER; ACCUMULATION; MECHANISM; EXPANSION; MICE	CD11b(+)Gr1(+) myeloid derived suppressor cells (MDSC) are known to be very potent suppressors of T cell immunity and can be further stratified into granulocytic MDSC and monocytic MDSC in mice based on expression of Ly6G or Ly6C, respectively. Here, using these markers and functional assays, we aimed to identify whether MDSC are induced during chronic inflammation leading to fibrosis in both kidney and liver and whether additional markers could more specifically identify these MDSC subsets. In an adenine-induced model of kidney inflammation/fibrosis suppressive Ly6Gpos MDSC were induced. The suppressive function within the Ly6G+MDSC population was exclusively present in IFN gamma R beta expressing cells. In contrast, in chronic inflammation in the liver induced by bile duct ligation, suppressive capacity was exclusively present in the Ly6Cpos MDSC subset. Gene expression analyses confirmed the differential origins and regulation of those MDSC subsets. Additionally, depletion of MDSC in either kidney or liver fibrosis enhanced fibrosis markers, indicating a protective role for MDSC in organ fibrosis. Thus, our data demonstrate that during liver inflammation and kidney fibrosis MDSC with similar function arise bearing a distinct marker profile and arising from different cell populations.	[Hoechst, Bastian; Mikulec, Julita; Metzger, Christina; Welz, Meike; Knolle, Percy; Diehl, Linda] Univ Bonn, Inst Mol Med, Bonn, Germany; [Hoechst, Bastian] Tech Univ Munich, Inst Mol Immunol, D-80290 Munich, Germany; [Baccega, Tania; Kurts, Christian; Ludwig-Portugall, Isis] Univ Bonn, Inst Expt Immunol, Bonn, Germany; [Peusquens, Julia; Tacke, Frank] Univ Hosp Aachen, Dept Med 3, Aachen, Germany; [Diehl, Linda] Univ Med Ctr Hamburg Eppendorf, Inst Expt Immunol & Hepatol, Hamburg, Germany	University of Bonn; Technical University of Munich; University of Bonn; RWTH Aachen University; RWTH Aachen University Hospital; University of Hamburg; University Medical Center Hamburg-Eppendorf	Diehl, L (corresponding author), Univ Bonn, Inst Mol Med, Bonn, Germany.	li.diehl@uke.de; Isis.Ludwig-Portugall@ukb.uni-bonn.de	Höchst, Bastian/ABG-2094-2020; Tacke, Frank/ABF-2212-2020	Höchst, Bastian/0000-0002-5567-1173; Knolle, Percy A./0000-0003-2983-0414	German research council [SFB704]; medical faculty of the university of Bonn; SFB [TRR57]	German research council(German Research Foundation (DFG)); medical faculty of the university of Bonn; SFB(Austrian Science Fund (FWF))	LD was financially supported by a grant of the German research council (SFB704), BH by a BONFOR grant from the medical faculty of the university of Bonn, CK and ILP by SFB TRR57. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bernabei P, 2001, J LEUKOCYTE BIOL, V70, P950; Bunt SK, 2006, J IMMUNOL, V176, P284, DOI 10.4049/jimmunol.176.1.284; Bunt SK, 2007, CANCER RES, V67, P10019, DOI 10.1158/0008-5472.CAN-07-2354; Cheng PY, 2008, J EXP MED, V205, P2235, DOI 10.1084/jem.20080132; Chou HS, 2012, TRANSPLANTATION, V93, P272, DOI 10.1097/TP.0b013e31823ffd39; Chou HS, 2011, HEPATOLOGY, V53, P1007, DOI 10.1002/hep.24162; Dietlin TA, 2007, J LEUKOCYTE BIOL, V81, P1205, DOI 10.1189/jlb.1006640; Foell D, 2007, J LEUKOCYTE BIOL, V81, P28, DOI 10.1189/jlb.0306170; Greifenberg V, 2009, EUR J IMMUNOL, V39, P2865, DOI 10.1002/eji.200939486; Gujral JS, 2004, AM J PHYSIOL-GASTR L, V286, pG499, DOI 10.1152/ajpgi.00318.2003; Haile LA, 2008, GASTROENTEROLOGY, V135, P871, DOI 10.1053/j.gastro.2008.06.032; Hernandez-Gea V, 2013, GASTROENTEROLOGY, V144, P512, DOI 10.1053/j.gastro.2013.01.002; Hoechst B, 2008, GASTROENTEROLOGY, V135, P234, DOI 10.1053/j.gastro.2008.03.020; Huang LR, 2013, NAT IMMUNOL, V14, P574, DOI 10.1038/ni.2573; Kusmartsev S, 2002, CANCER IMMUNOL IMMUN, V51, P293, DOI 10.1007/s00262-002-0280-8; Lauvau G, 2014, CELL IMMUNOL, V291, P32, DOI 10.1016/j.cellimm.2014.07.007; Liu Y, 2008, CLIN IMMUNOL, V129, P471, DOI 10.1016/j.clim.2008.07.030; Luan Y, 2013, AM J TRANSPLANT, V13, P3123, DOI 10.1111/ajt.12461; Mandruzzato S, 2009, J IMMUNOL, V182, P6562, DOI 10.4049/jimmunol.0803831; Mazzoni A, 2002, J IMMUNOL, V168, P689, DOI 10.4049/jimmunol.168.2.689; Movahedi K, 2008, BLOOD, V111, P4233, DOI 10.1182/blood-2007-07-099226; Nefedova Y, 2007, CANCER RES, V67, P11021, DOI 10.1158/0008-5472.CAN-07-2593; Ostrand-Rosenberg S, 2009, J IMMUNOL, V182, P4499, DOI 10.4049/jimmunol.0802740; Pestka Sidney, 1997, Cytokine and Growth Factor Reviews, V8, P189, DOI 10.1016/S1359-6101(97)00009-9; Rodriguez PC, 2009, CANCER RES, V69, P1553, DOI 10.1158/0008-5472.CAN-08-1921; Roth F, 2012, CANCER RES, V72, P1373, DOI 10.1158/0008-5472.CAN-11-2772; Sinha P, 2005, J IMMUNOL, V174, P636, DOI 10.4049/jimmunol.174.2.636; Sinha P, 2007, J IMMUNOL, V179, P977, DOI 10.4049/jimmunol.179.2.977; Sinha P, 2007, CANCER RES, V67, P4507, DOI 10.1158/0008-5472.CAN-06-4174; Soehnlein O, 2010, NAT REV IMMUNOL, V10, P427, DOI 10.1038/nri2779; Song XP, 2005, J IMMUNOL, V175, P8200, DOI 10.4049/jimmunol.175.12.8200; Sunderkotter C, 2004, J IMMUNOL, V172, P4410, DOI 10.4049/jimmunol.172.7.4410; Taketo MM, 1998, JNCI-J NATL CANCER I, V90, P1609, DOI 10.1093/jnci/90.21.1609; Taketo MM, 1998, J NATL CANCER I, V90, P1529, DOI 10.1093/jnci/90.20.1529; Tamura M, 2009, HISTOCHEM CELL BIOL, V131, P483, DOI 10.1007/s00418-009-0557-5; Teteris SA, 2012, NEPHROLOGY, V17, P364, DOI 10.1111/j.1440-1797.2012.01581.x; Voisin MB, 2004, INFECT IMMUN, V72, P5487, DOI 10.1128/IAI.72.9.5487-5492.2004; Youn JI, 2008, J IMMUNOL, V181, P5791, DOI 10.4049/jimmunol.181.8.5791; Zeng QL, 2014, MOL CELLS, V37, P66, DOI 10.14348/molcells.2014.2282; Zhang HY, 2014, J AUTOIMMUN, V53, P55, DOI 10.1016/j.jaut.2014.02.010; Zhao XQ, 2012, J CLIN INVEST, V122, P4094, DOI 10.1172/JCI64115; Zhu B, 2007, J IMMUNOL, V179, P5228, DOI 10.4049/jimmunol.179.8.5228	42	37	38	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2015	10	3							e0119662	10.1371/journal.pone.0119662	http://dx.doi.org/10.1371/journal.pone.0119662			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9JM	25738302	Green Published, Green Submitted, gold			2022-12-27	WOS:000350685900109
J	Kelly, TR; McNeill, JB; Avens, L; Hall, AG; Goshe, LR; Hohn, AA; Godfrey, MH; Mihnovets, AN; Cluse, WM; Harms, CA				Kelly, Terra R.; McNeill, Joanne Braun; Avens, Larisa; Hall, April Goodman; Goshe, Lisa R.; Hohn, Aleta A.; Godfrey, Matthew H.; Mihnovets, A. Nicole; Cluse, Wendy M.; Harms, Craig A.			Clinical Pathology Reference Intervals for an In-Water Population of Juvenile Loggerhead Sea Turtles (Caretta caretta) in Core Sound, North Carolina, USA	PLOS ONE			English	Article							CHELONIA-MYDAS; BLOOD BIOCHEMISTRY; GREEN TURTLES; REFERENCE VALUES; PLASMA; HEMATOLOGY; PARAMETERS; CHEMISTRY; ANALYTES; PAMLICO	The loggerhead sea turtle (Caretta caretta) is found throughout the waters of the Atlantic, Pacific, and Indian Oceans. It is a protected species throughout much of its range due to threats such as habitat loss, fisheries interactions, hatchling predation, and marine debris. Loggerheads that occur in the southeastern U.S. are listed as "threatened" on the U.S. Endangered Species List, and receive state and federal protection. As part of an on-going population assessment conducted by the National Marine Fisheries Service, samples were collected from juvenile loggerhead sea turtles in Core Sound, North Carolina, between 2004 and 2007 to gain insight on the baseline health of the threatened Northwest Atlantic Ocean population. The aims of the current study were to establish hematologic and biochemical reference intervals for this population, and to assess variation of the hematologic and plasma biochemical analytes by season, water temperature, and sex and size of the turtles. Reference intervals for the clinical pathology parameters were estimated following Clinical Laboratory Standards Institute guidelines. Season, water temperature, sex, and size of the turtles were found to be significant factors of variation for parameter values. Seasonal variation could be attributed to physiological effects of decreasing photoperiod, cooler water temperature, and migration during the fall months. Packed cell volume, total protein, and albumin increased with increasing size of the turtles. The size-related differences in analytes documented in the present study are consistent with other reports of variation in clinical pathology parameters by size and age in sea turtles. As a component of a health assessment of juvenile loggerhead sea turtles in North Carolina, this study will serve as a baseline aiding in evaluation of trends for this population and as a diagnostic tool for assessing the health and prognosis for loggerhead sea turtles undergoing rehabilitation.	[Kelly, Terra R.; Harms, Craig A.] N Carolina State Univ, Environm Med Consortium, Raleigh, NC 27607 USA; [Kelly, Terra R.; Harms, Craig A.] N Carolina State Univ, Dept Clin Sci, Raleigh, NC 27607 USA; [McNeill, Joanne Braun; Avens, Larisa; Hall, April Goodman; Goshe, Lisa R.; Hohn, Aleta A.] NOAA, Natl Marine Fisheries Serv, Beaufort Lab, Beaufort, NC 28516 USA; [Godfrey, Matthew H.; Cluse, Wendy M.] North Carolina Wildlife Resources Commiss, Beaufort, NC 28516 USA; [Mihnovets, A. Nicole] Columbia Univ, Dept Ecol Evolut & Environm Biol, New York, NY 10027 USA; [Harms, Craig A.] Ctr Marine Sci & Technol, Morehead City, NC 27606 USA	University of North Carolina; North Carolina State University; University of North Carolina; North Carolina State University; National Oceanic Atmospheric Admin (NOAA) - USA; Columbia University	Harms, CA (corresponding author), N Carolina State Univ, Environm Med Consortium, 1060 William Moore Dr, Raleigh, NC 27607 USA.	craig_harms@ncsu.edu	Hohn, Aleta A/G-2888-2011	Hohn, Aleta A/0000-0002-9992-7062	National Fish and Wildlife Foundation [2004-0012-001]	National Fish and Wildlife Foundation	National Fish and Wildlife Foundation (http://www.nfwf.org/) #2004-0012-001.	Aguirre AA, 2000, COMP HAEMATOL INT, V10, P132, DOI 10.1007/s005800070004; Avens L, 2003, MAR BIOL, V143, P211, DOI 10.1007/s00227-003-1085-9; Basile Filomena, 2012, Comparative Clinical Pathology, V21, P1401, DOI 10.1007/s00580-011-1306-4; BOLTEN AB, 1992, J WILDLIFE DIS, V28, P407, DOI 10.7589/0090-3558-28.3.407; Braun-McNeill J, 2010, NMFSSEFSC605 NOAA; Braun-McNeill J, 2007, HERPETOLOGICA, V63, P275, DOI 10.1655/0018-0831(2007)63[275:SROTRR]2.0.CO;2; Campbell T., 2006, REPTILE MED SURG, P453, DOI 10.1016/B0-72-169327-X/50032-8; Casal AB, 2009, VET CLIN PATH, V38, P213, DOI 10.1111/j.1939-165X.2008.00106.x; CLSI guideline EP28, 2010, DEFINING ESTABLISHIN, V3rd Ed; Deem SL, 2006, J ZOO WILDLIFE MED, V37, P464, DOI 10.1638/05-102.1; Deem SL, 2009, J WILDLIFE DIS, V45, P41, DOI 10.7589/0090-3558-45.1.41; Delgado C, 2011, J WILDLIFE DIS, V47, P523, DOI 10.7589/0090-3558-47.3.523; DIXON WJ, 1953, BIOMETRICS, V9, P74, DOI 10.2307/3001634; Eisenhawer E, 2008, J ZOO WILDLIFE MED, V39, P208, DOI 10.1638/2007-0166R.1; Epperly Sheryan P., 2007, Endangered Species Research, V3, P283, DOI 10.3354/esr00054; EPPERLY SP, 1995, CONSERV BIOL, V9, P384, DOI 10.1046/j.1523-1739.1995.9020384.x; Fazio Esterina, 2012, Comparative Clinical Pathology, V21, P905, DOI 10.1007/s00580-011-1197-4; Flint M, 2010, VET J, V185, P299, DOI 10.1016/j.tvjl.2009.06.011; Flint M, 2010, J WILDLIFE DIS, V46, P731, DOI 10.7589/0090-3558-46.3.731; FRAIR W, 1982, COMP BIOCHEM PHYS A, V73, P337, DOI 10.1016/0300-9629(82)90164-5; Frye F.L., 1991, BIOMEDICAL SURG ASPE; Geffre A, 2009, VET CLIN PATH, V38, P288, DOI 10.1111/j.1939-165X.2009.00179.x; George Robert H., 1997, P363; Hall AG, 2013, ENDANGER SPECIES RES, V22, P235, DOI 10.3354/esr00539; Hamann M, 2003, CRC MAR BIOL SER, P135; Harms CA, 2003, J WILDLIFE DIS, V39, P366, DOI 10.7589/0090-3558-39.2.366; Hasbun CR, 1998, COMP HAEMATOL INT, V8, P174, DOI 10.1007/BF02642510; Higgins BM, 2003, CRC MAR BIOL SER, P411; Innis CJ, 2009, JAVMA-J AM VET MED A, V235, P426, DOI 10.2460/javma.235.4.426; Kakizoe Y, 2007, J ZOO WILDLIFE MED, V38, P77, DOI 10.1638/05-096.1; Keller JM, 2004, ENVIRON HEALTH PERSP, V112, P1074, DOI 10.1289/ehp.6923; Klaphake Eric, 2010, Veterinary Clinics of North America Exotic Animal Practice, V13, P375, DOI 10.1016/j.cvex.2010.05.007; Lahti A, 2004, CLIN CHEM, V50, P891, DOI 10.1373/clinchem.2003.027953; McClellan CM, 2011, MAR POLICY, V35, P241, DOI 10.1016/j.marpol.2010.10.008; National Marine Fisheries and U.S. Fish and Wildlife Service, 2008, REC PLAN NW ATL POP; Prieto-Torres DA, 2013, S AM J HERPETOL, V8, P147, DOI 10.2994/SAJH-D-13-00010.1; Pritchard P. C. H, 1997, BIOL SEA TURTLES, P1; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Rousselet E, 2013, J ZOO WILDLIFE MED, V44, P859, DOI 10.1638/2012-0162R1.1; Sasso CR, 2006, MAR ECOL PROG SER, V324, P287, DOI 10.3354/meps324287; Stamper MA, 2005, J ZOO WILDLIFE MED, V36, P635, DOI 10.1638/04-074.1; Stay NI, 2011, CLIN LAB MED, V31, P87, DOI 10.1016/j.cll.2010.10.006; Stringer Elizabeth M., 2010, Journal of Herpetological Medicine and Surgery, V20, P122, DOI 10.5818/1529-9651-20.4.122; USFWS, 2014, SPEC PROF LOGG SEA T; Wallace BP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024510; Walton RM, 2001, SEMIN AVIAN EXOT PET, V10, P59, DOI 10.1053/saep.2001.22053; WOOD FE, 1984, HERPETOLOGICA, V40, P331; Wyneken J., 2001, ANATOMY SEA TURTLES	48	21	21	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2015	10	3							e0115739	10.1371/journal.pone.0115739	http://dx.doi.org/10.1371/journal.pone.0115739			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9JM	25738772	gold, Green Published			2022-12-27	WOS:000350685900005
J	Lohr, IH; Hulter, N; Bernhoff, E; Johnsen, PJ; Sundsfjord, A; Naseer, U				Lohr, Iren Hoyland; Hulter, Nils; Bernhoff, Eva; Johnsen, Pal Jarle; Sundsfjord, Arnfinn; Naseer, Umaer			Persistence of a pKPN3-Like CTX-M-15-Encoding IncFII(K) Plasmid in a Klebsiella pneumonia ST17 Host during Two Years of Intestinal Colonization	PLOS ONE			English	Article							LACTAMASE-PRODUCING ENTEROBACTERIACEAE; ESCHERICHIA-COLI; BETA-LACTAMASES; RESISTANCE; SEQUENCE; DISSEMINATION; EMERGENCE; OUTBREAK; SPREAD; EPIDEMIOLOGY	Objectives To characterize the CTX-M-15-encoding plasmid in a Klebsiella pneumoniae ST17 strain, responsible for an outbreak at a Norwegian neonatal intensive care unit and subsequent colonization of affected children for up to two years. To identify plasmid-mediated features relevant for the outbreak dynamics, and to investigate the plasmids capability of horizontal transfer, its segregational stability and plasmid-mediated fitness costs. Methods Plasmid profiling was performed by S1-nuclease PFGE, PCR-based replicon typing and Southern blot-hybridization. The complete sequence of the CTX-M-15-encoding plasmid was obtained by 454 sequencing. Plasmid self-transferability was investigated by broth- and filter mating, segregational stability was explored by serial passage, and plasmid-conferred fitness costs were examined in pairwise head-to-head competitions and by growth rate comparisons. Results CTX-M-15 was encoded by a similar to 180 kb IncFII(K) plasmid in K. pneumoniae ST17. S1-nuclease PFGE profiles of the first and the last CTX-M-15-producing K. pneumoniae isolates, recovered from the four children colonized the longest, suggested that the plasmid was stably maintained during intestinal carriage of up to two years. The DNA sequence of the pKPN3-like plasmid, pKp848CTX, uncovered a Tn3-like antibiotic resistance region and multiple heavy metal-and thermoresistance determinants. Plasmid pKp848CTX could not be transferred to Escherichia coli in vitro and we found no evidence to support horizontal plasmid transfer in vivo. Segregational plasmid loss ranging from 0.83% to 17.5% was demonstrated in evolved populations in vitro, but only minor fitness costs were associated with plasmid-carriage. Conclusions Plasmid pKp848CTX encodes phenotypic traits, which may have had an impact on the fitness and survival of the K. pneumoniae ST17 strain in the outbreak setting. The antibiotic resistance plasmid pKp848CTX was stably maintained during two years of intestinal colonization, conferring negligible fitness cost to its host, and thus seem well adapted to its K. pneumoniae host.	[Lohr, Iren Hoyland; Bernhoff, Eva] Stavanger Univ Hosp, Dept Med Microbiol, Stavanger, Norway; [Lohr, Iren Hoyland] Univ Bergen, Dept Clin Med, Bergen, Norway; [Hulter, Nils; Johnsen, Pal Jarle] UiT Arctic Univ Norway, Dept Pharm, Tromso, Norway; [Sundsfjord, Arnfinn; Naseer, Umaer] UiT Arctic Univ Norway, Dept Med Biol, Tromso, Norway; [Sundsfjord, Arnfinn] Univ Hosp North Norway, Dept Microbiol & Infect Control, Tromso, Norway; [Naseer, Umaer] Norwegian Inst Publ Hlth, Dept Food Borne Infect, Oslo, Norway	Stavanger University Hospital; University of Bergen; UiT The Arctic University of Tromso; UiT The Arctic University of Tromso; UiT The Arctic University of Tromso; University Hospital of North Norway; Norwegian Institute of Public Health (NIPH)	Lohr, IH (corresponding author), Stavanger Univ Hosp, Dept Med Microbiol, Stavanger, Norway.	iren.hoyland.lohr@sus.no	Sundsfjord, Arnfinn/F-9668-2018; Johnsen, Pål J/A-5209-2011	Sundsfjord, Arnfinn/0000-0002-3728-2270; Johnsen, Pal Jarle/0000-0002-6455-6433; Hulter, Nils Fredrik/0000-0002-8873-5276	Western Norway Regional Health Authority [911640]	Western Norway Regional Health Authority	This work was supported by grants from The Western Norway Regional Health Authority (grant number 911640 to IHL). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alouache S, 2014, MICROB DRUG RESIST, V20, P30, DOI 10.1089/mdr.2012.0264; BARTON BM, 1995, ANAL BIOCHEM, V226, P235, DOI 10.1006/abio.1995.1220; Bojer MS, 2012, APMIS, V120, P699, DOI 10.1111/j.1600-0463.2012.02885.x; Bojer MS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015467; BOUMA JE, 1988, NATURE, V335, P351, DOI 10.1038/335351a0; Canton R, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00110; Carattoli A, 2005, J MICROBIOL METH, V63, P219, DOI 10.1016/j.mimet.2005.03.018; Carattoli A, 2014, ANTIMICROB AGENTS CH, V58, P3895, DOI 10.1128/AAC.02412-14; Carattoli A, 2011, INT J MED MICROBIOL, V301, P654, DOI 10.1016/j.ijmm.2011.09.003; Carattoli A, 2009, ANTIMICROB AGENTS CH, V53, P2227, DOI 10.1128/AAC.01707-08; Center for Genomic Epidemiology, PMLST V 1 2; Chen L, 2013, ANTIMICROB AGENTS CH, V57, P1542, DOI 10.1128/AAC.02332-12; Coelho A, 2010, INT J ANTIMICROB AG, V36, P73, DOI 10.1016/j.ijantimicag.2010.03.005; Cooper TF, 2007, PLOS BIOL, V5, P1899, DOI 10.1371/journal.pbio.0050225; D'Andrea MM, 2013, INT J MED MICROBIOL, V303, P305, DOI 10.1016/j.ijmm.2013.02.008; Dahlberg C, 2003, GENETICS, V165, P1641; De Gelder L, 2007, MICROBIOL-SGM, V153, P452, DOI 10.1099/mic.0.2006/001784-0; Dolejska M, 2013, ANTIMICROB AGENTS CH, V57, P1073, DOI 10.1128/AAC.01886-12; Dolejska M, 2012, INT J ANTIMICROB AG, V40, P510, DOI 10.1016/j.ijantimicag.2012.07.016; Eckert C, 2004, ANTIMICROB AGENTS CH, V48, P1249, DOI 10.1128/AAC.48.4.1249-1255.2004; Frasson I, 2012, J CLIN MICROBIOL, V50, P3768, DOI 10.1128/JCM.01892-12; Garcia-Fernandez A, 2009, J ANTIMICROB CHEMOTH, V63, P274, DOI 10.1093/jac/dkn470; Garcia-Fernandez A, 2012, ANTIMICROB AGENTS CH, V56, P2143, DOI 10.1128/AAC.05308-11; Hall BG, 2014, MOL BIOL EVOL, V31, P232, DOI 10.1093/molbev/mst187; Johnsen PJ, 2002, MICROB DRUG RESIST, V8, P161, DOI 10.1089/107662902760326869; Leavitt A, 2010, ANTIMICROB AGENTS CH, V54, P4493, DOI 10.1128/AAC.00175-10; LENSKI RE, 1991, AM NAT, V138, P1315, DOI 10.1086/285289; Lohr IH, 2013, J ANTIMICROB CHEMOTH, V68, P1043, DOI 10.1093/jac/dks502; Lytsy B, 2008, APMIS, V116, P302, DOI 10.1111/j.1600-0463.2008.00922.x; Mataseje LF, 2014, J ANTIMICROB CHEMOTH, V69, P637, DOI 10.1093/jac/dkt445; Naseer U, 2007, APMIS, V115, P120, DOI 10.1111/j.1600-0463.2007.apm_547.x; Naseer U, 2011, MICROB DRUG RESIST, V17, P83, DOI 10.1089/mdr.2010.0132; Naseer U, 2009, APMIS, V117, P526, DOI 10.1111/j.1600-0463.2009.02465.x; Nicolas-Chanoine MH, 2008, J ANTIMICROB CHEMOTH, V61, P273, DOI 10.1093/jac/dkm464; Nielsen JB, 2011, EUR J CLIN MICROBIOL, V30, P773, DOI 10.1007/s10096-011-1153-x; Novais A, 2007, ANTIMICROB AGENTS CH, V51, P796, DOI 10.1128/AAC.01070-06; Oteo J, 2009, J ANTIMICROB CHEMOTH, V64, P524, DOI 10.1093/jac/dkp211; Peirano G, 2012, J ANTIMICROB CHEMOTH, V67, P1114, DOI 10.1093/jac/dks026; Pitout JDD, 2008, LANCET INFECT DIS, V8, P159, DOI 10.1016/S1473-3099(08)70041-0; Pitout JDD, 2010, DRUGS, V70, P313, DOI 10.2165/11533040-000000000-00000; Rabel C, 2003, J BACTERIOL, V185, P1045, DOI 10.1128/JB.185.3.1045-1058.2003; Rettedal S, 2012, APMIS, V120, P612, DOI 10.1111/j.1600-0463.2012.02879.x; Rossolini GM, 2008, CLIN MICROBIOL INFEC, V14, P33, DOI 10.1111/j.1469-0691.2007.01867.x; Sandegren L, 2012, J ANTIMICROB CHEMOTH, V67, P74, DOI 10.1093/jac/dkr405; Shin J, 2014, J ANTIMICROB CHEMOTH, V69, P969, DOI 10.1093/jac/dkt464; Starikova I, 2013, J ANTIMICROB CHEMOTH, V68, P2755, DOI 10.1093/jac/dkt270; Starikova I, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003043; Sundsfjord A, 2004, APMIS, V112, P815, DOI 10.1111/j.1600-0463.2004.apm11211-1208.x; Suzuki H, 2010, J BACTERIOL, V192, P6045, DOI 10.1128/JB.00277-10; TENOVER FC, 1995, J CLIN MICROBIOL, V33, P2233, DOI 10.1128/JCM.33.9.2233-2239.1995; Villa L, 2010, J ANTIMICROB CHEMOTH, V65, P2518, DOI 10.1093/jac/dkq347; Woodford N, 2009, ANTIMICROB AGENTS CH, V53, P4472, DOI 10.1128/AAC.00688-09	52	20	20	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2015	10	3							e0116516	10.1371/journal.pone.0116516	http://dx.doi.org/10.1371/journal.pone.0116516			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9JM	25738592	Green Submitted, Green Published, gold			2022-12-27	WOS:000350685900012
J	Liebl, H; Garcia, EG; Holzner, F; Noel, PB; Burgkart, R; Rummeny, EJ; Baum, T; Bauer, JS				Liebl, Hans; Garcia, Eduardo Grande; Holzner, Fabian; Noel, Peter B.; Burgkart, Rainer; Rummeny, Ernst J.; Baum, Thomas; Bauer, Jan S.			In-Vivo Assessment of Femoral Bone Strength Using Finite Element Analysis (FEA) Based on Routine MDCT Imaging: A Preliminary Study on Patients with Vertebral Fractures	PLOS ONE			English	Article							QUANTITATIVE COMPUTED-TOMOGRAPHY; CONTRAST-ENHANCED MDCT; MEASURED FAILURE LOADS; PROXIMAL FEMUR; TRABECULAR BONE; HIP FRACTURE; CLINICAL MDCT; CT; MODELS; OSTEOPOROSIS	Purpose To experimentally validate a non-linear finite element analysis (FEA) modeling approach assessing in-vitro fracture risk at the proximal femur and to transfer the method to standard in-vivo multi-detector computed tomography (MDCT) data of the hip aiming to predict additional hip fracture risk in subjects with and without osteoporosis associated vertebral fractures using bone mineral density (BMD) measurements as gold standard. Methods One fresh-frozen human femur specimen was mechanically tested and fractured simulating stance and clinically relevant fall loading configurations to the hip. After experimental in-vitro validation, the FEA simulation protocol was transferred to standard contrast-enhanced in-vivo MDCT images to calculate individual hip fracture risk each for 4 subjects with and without a history of osteoporotic vertebral fractures matched by age and gender. In addition, FEA based risk factor calculations were compared to manual femoral BMD measurements of all subjects. Results In-vitro simulations showed good correlation with the experimentally measured strains both in stance (R-2 = 0.963) and fall configuration (R-2 = 0.976). The simulated maximum stress overestimated the experimental failure load (4743 N) by 14.7%(5440 N) while the simulated maximum strain overestimated by 4.7% (4968 N). The simulated failed elements coincided precisely with the experimentally determined fracture locations. BMD measurements in subjects with a history of osteoporotic vertebral fractures did not differ significantly from subjects without fragility fractures (femoral head: p = 0.989; femoral neck: p = 0.366), but showed higher FEA based risk factors for additional incident hip fractures (p = 0.028). Conclusion FEA simulations were successfully validated by elastic and destructive in-vitro experiments. In the subsequent in-vivo analyses, MDCT based FEA based risk factor differences for additional hip fractures were not mirrored by according BMD measurements. Our data suggests, that MDCT derived FEA models may assess bone strength more accurately than BMD measurements alone, providing a valuable in-vivo fracture risk assessment tool.	[Liebl, Hans; Garcia, Eduardo Grande; Noel, Peter B.; Rummeny, Ernst J.; Baum, Thomas] Tech Univ Muenchen, Dept Radiol, Klinikum Rechts Isar, Munich, Germany; [Garcia, Eduardo Grande; Holzner, Fabian; Burgkart, Rainer] Tech Univ Muenchen, Dept Orthopaed Surg, Klinikum Rechts Isar, Munich, Germany; [Bauer, Jan S.] Tech Univ Muenchen, Neuroradiol Sect, Klinikum Rechts Isar, Munich, Germany	Technical University of Munich; Technical University of Munich; Technical University of Munich	Liebl, H (corresponding author), Tech Univ Muenchen, Dept Radiol, Klinikum Rechts Isar, Munich, Germany.	lieblhans@gmail.com	Baum, Thomas/M-6522-2014; Kirschke, Jan/E-2550-2012	Baum, Thomas/0000-0002-4574-5212; Kirschke, Jan/0000-0002-7557-0003; Noel, Peter/0000-0002-9671-6171	BMWi [(Foerderkennzeichen) KF2016102AK2]; German Research Foundation (DFG); Technische Universitat Munchen within the funding program Open Access Publishing	BMWi(Federal Ministry for Economic Affairs and Energy (BMWi)); German Research Foundation (DFG)(German Research Foundation (DFG)); Technische Universitat Munchen within the funding program Open Access Publishing	Funding provided by BMWi as a result of a decision by the "Deutsche Bundestag"; support number (Foerderkennzeichen) KF2016102AK2. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This work was supported by the German Research Foundation (DFG) and the Technische Universitat Munchen within the funding program Open Access Publishing.	Bauer JS, 2007, AM J ROENTGENOL, V188, P1294, DOI 10.2214/AJR.06.1006; Bauer JS, 2006, OSTEOPOROSIS INT, V17, P608, DOI 10.1007/s00198-005-0023-8; Baum T, 2013, CURR MED CHEM, V20, P4844, DOI 10.2174/09298673113206660279; Baum T, 2014, J BONE MINER METAB, V32, P56, DOI 10.1007/s00774-013-0465-6; Bauma T, 2011, EUR J RADIOL, V80, pE140, DOI 10.1016/j.ejrad.2010.08.034; Bayraktar HH, 2004, J BIOMECH, V37, P27, DOI 10.1016/S0021-9290(03)00257-4; Bessho M, 2004, J ORTHOP SCI, V9, P545, DOI 10.1007/s00776-004-0824-1; Bessho M, 2007, J BIOMECH, V40, P1745, DOI 10.1016/j.jbiomech.2006.08.003; Bessho M, 2009, BONE, V45, P226, DOI 10.1016/j.bone.2009.04.241; Bjarnason K, 1996, OSTEOPOROSIS INT, V6, P37, DOI 10.1007/BF01626536; Bliuc D, 2009, JAMA-J AM MED ASSOC, V301, P513, DOI 10.1001/jama.2009.50; Blume SW, 2011, OSTEOPOROSIS INT, V22, P1835, DOI 10.1007/s00198-010-1419-7; Bousson V, 2006, OSTEOPOROSIS INT, V17, P855, DOI 10.1007/s00198-006-0074-5; Bouxsein ML, 2007, J BONE MINER RES, V22, P825, DOI 10.1359/JBMR.070309; Chang G, 2012, J BONE MINER METAB, V30, P243, DOI 10.1007/s00774-011-0333-1; Cheung AM, 2013, CURR OSTEOPOROS REP, V11, P136, DOI 10.1007/s11914-013-0140-9; Cody DD, 2000, ANN BIOMED ENG, V28, P408, DOI 10.1114/1.278; Crawford RP, 2003, BONE, V33, P744, DOI 10.1016/S8756-3282(03)00210-2; Crawford RP, 2003, J BIOMECH ENG-T ASME, V125, P434, DOI 10.1115/1.1589772; Dall'Ara E, 2013, BONE, V52, P27, DOI 10.1016/j.bone.2012.09.006; Dall'Ara E, 2012, OSTEOPOROSIS INT, V23, P563, DOI 10.1007/s00198-011-1568-3; Dragomir-Daescu D, 2011, ANN BIOMED ENG, V39, P742, DOI 10.1007/s10439-010-0196-y; Eckstein F, 2002, J BONE MINER RES, V17, P162, DOI 10.1359/jbmr.2002.17.1.162; Eckstein F, 2007, J BONE MINER RES, V22, P817, DOI 10.1359/JBMR.070301; GENANT HK, 1993, J BONE MINER RES, V8, P1137, DOI 10.1002/jbmr.5650080915; Graeff C, 2013, BONE, V52, P568, DOI 10.1016/j.bone.2012.10.036; Graeff C, 2009, J BONE MINER RES, V24, P1672, DOI [10.1359/JBMR.090416, 10.1359/jbmr.090416]; Gralow JR, 2009, J NATL COMPR CANC NE, V7, pS1, DOI 10.6004/jnccn.2009.0076; Grassi L, 2012, J BIOMECH, V45, P394, DOI 10.1016/j.jbiomech.2011.10.019; Greenspan SL, 1996, CALCIFIED TISSUE INT, V58, P409, DOI 10.1007/BF02509439; Gruber M, 2013, EUR RADIOL, V23, P505, DOI 10.1007/s00330-012-2629-5; Guise TA, 2006, ONCOLOGIST, V11, P1121, DOI 10.1634/theoncologist.11-10-1121; Imai K, 2006, SPINE, V31, P1789, DOI 10.1097/01.brs.0000225993.57349.df; Kazakia GJ, 2008, J BONE MINER RES, V23, P463, DOI 10.1359/JBMR.071116; KELLER TS, 1994, J BIOMECH, V27, P1159, DOI 10.1016/0021-9290(94)90056-6; Keyak JH, 2001, MED ENG PHYS, V23, P657, DOI 10.1016/S1350-4533(01)00094-7; Koivumaki JEM, 2012, BONE, V51, P737, DOI 10.1016/j.bone.2012.06.026; Koivumaki JEM, 2012, BONE, V50, P824, DOI 10.1016/j.bone.2012.01.012; Kopperdahl DL, 2014, J BONE MINER RES, V29, P570, DOI 10.1002/jbmr.2069; McCreadie BR, 2000, J BONE MINER RES, V15, P2305, DOI 10.1359/jbmr.2000.15.12.2305; Mulder L, 2012, BONE, V50, P200, DOI 10.1016/j.bone.2011.10.020; Newitt DC, 2002, OSTEOPOROSIS INT, V13, P6; Nielson CM, 2009, J CLIN ENDOCR METAB, V94, P491, DOI 10.1210/jc.2008-1640; Noel PB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081141; Noel PB, 2011, AM J ROENTGENOL, V197, P1404, DOI 10.2214/AJR.11.6907; Roberts BJ, 2010, BONE, V46, P742, DOI 10.1016/j.bone.2009.10.020; Smith MR, 2006, CLIN CANCER RES, V12, p6315S, DOI 10.1158/1078-0432.CCR-06-0846; Taddei F, 2007, MED ENG PHYS, V29, P973, DOI 10.1016/j.medengphy.2006.10.014; Thevenot J, 2014, J BIOMECH, V47, P438, DOI 10.1016/j.jbiomech.2013.11.004; vandenKroonenberg AJ, 1996, J BIOMECH, V29, P807, DOI 10.1016/0021-9290(95)00134-4; Yamamoto DS, 2009, CLIN J ONCOL NURS, V13, P499, DOI 10.1188/09.CJON.E18-E29; Yosibash Z, 2007, J BIOMECH, V40, P3688, DOI 10.1016/j.jbiomech.2007.06.017; Yosibash Z, 2010, PHILOS T R SOC A, V368, P2707, DOI 10.1098/rsta.2010.0074; Zhang N, 2013, MED PHYS, V40, DOI 10.1118/1.4802085; Zysset Philippe K, 2013, Bonekey Rep, V2, P386, DOI 10.1038/bonekey.2013.120	55	20	20	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2015	10	2							e0116907	10.1371/journal.pone.0116907	http://dx.doi.org/10.1371/journal.pone.0116907			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC3LS	25723187	Green Published, gold, Green Submitted			2022-12-27	WOS:000350251200022
J	Stodulkova, E; Cisarova, I; Kolarik, M; Chudickova, M; Novak, P; Man, P; Kuzma, M; Pavlu, B; Cerny, J; Flieger, M				Stodulkova, Eva; Cisarova, Ivana; Kolarik, Miroslav; Chudickova, Milada; Novak, Petr; Man, Petr; Kuzma, Marek; Pavlu, Barbora; Cerny, Jan; Flieger, Miroslav			Biologically Active Metabolites Produced by the Basidiomycete Quambalaria cyanescens	PLOS ONE			English	Article							ENDOPHYTIC FUNGUS; SP NOV.; NAPHTHOQUINONE; HOST; SPOROTHRIX; EXPRESSION; DIVERSITY; AUSTRALIA; APOPTOSIS; SHIKONIN	Four strains of the fungus Quambalaria cyanescens (Basidiomycota: Microstromatales), were used for the determination of secondary metabolites production and their antimicrobial and biological activities. A new naphthoquinone named quambalarine A, (S)-(+)-3-(5-ethyl-tetrahydrofuran-2-yliden)-5,7,8-trihydroxy-2-oxo-1,4-naphthoquinone (1), together with two known naphthoquinones, 3-hexanoyl-2,5,7,8-tetrahydroxy-1,4-naphthoquinone (named here as quambalarine B, 2) and mompain, 2,5,7,8-tetrahydroxy-1,4-naphthoquinone (3) were isolated. Their structures were determined by single-crystal X-ray diffraction crystallography, NMR and MS spectrometry. Quambalarine A (1) had a broad antifungal and antibacterial activity and is able inhibit growth of human pathogenic fungus Aspergillus fumigatus and fungi co-occurring with Q. cyanescens in bark beetle galleries including insect pathogenic species Beauveria bassiana. Quambalarine B (2) was active against several fungi and mompain mainly against bacteria. The biological activity against human-derived cell lines was selective towards mitochondria (2 and 3); after long-term incubation with 2, mitochondria were undetectable using a mitochondrial probe. A similar effect on mitochondria was observed also for environmental competitors of Q. cyanescens from the genus Geosmithia.	[Stodulkova, Eva; Kolarik, Miroslav; Chudickova, Milada; Novak, Petr; Man, Petr; Kuzma, Marek; Flieger, Miroslav] ASCR, Inst Microbiol, Vvi, Prague, Czech Republic; [Cisarova, Ivana] Charles Univ Prague, Dept Inorgan Chem, Fac Sci, CR-12840 Prague, Czech Republic; [Pavlu, Barbora; Cerny, Jan] Charles Univ Prague, Fac Sci, Dept Cell Biol, Prague, Czech Republic	Czech Academy of Sciences; Institute of Microbiology of the Czech Academy of Sciences; Charles University Prague; Charles University Prague	Flieger, M (corresponding author), ASCR, Inst Microbiol, Vvi, Prague, Czech Republic.	flieger@biomed.cas.cz	Cerny, Jan/C-1887-2012; Man, Petr/H-2451-2014; Pavlů, Barbora/L-7292-2017; Kolařík, Miroslav/A-1680-2008; Kuzma, Marek/F-5468-2015; Cisarova, Ivana/B-1385-2017; Novak, Petr/F-9655-2014; Flieger, Miroslav/B-5395-2011	Cerny, Jan/0000-0002-5624-2215; Man, Petr/0000-0002-1485-2197; Pavlů, Barbora/0000-0002-1401-6404; Kolařík, Miroslav/0000-0003-4016-0335; Kuzma, Marek/0000-0001-7415-2734; Cisarova, Ivana/0000-0002-9612-9831; Novak, Petr/0000-0001-8688-529X; 	Czech Science Foundation [13-16565S]; European Regional Development Fund [BIOCEV CZ.1.05/1.1.00/02.0109]; Operational Programme "Prague"-Competitiveness project [CZ.2.16/3.1.00/24023]	Czech Science Foundation(Grant Agency of the Czech Republic); European Regional Development Fund(European Commission); Operational Programme "Prague"-Competitiveness project	This study was supported by the Czech Science Foundation, project No. 13-16565S, www.gacr.cz/, JC MF ES MKo MC BP PN; European Regional Development Fund BIOCEV CZ.1.05/1.1.00/02.0109, www.biocev.eu, JC, MF, MKo, PN, PM; Operational Programme "Prague"-Competitiveness project CZ.2.16/3.1.00/24023, www.prahafondy.eu/cz/oppk.html, PM, PN, MKu. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTOMARE A, 1994, J APPL CRYSTALLOGR, V27, P435, DOI 10.1107/S002188989400021X; Amin R. M., 2010, Mycology - An International Journal on Fungal Biology, V1, P67; BARBIER P, 1982, J MED CHEM, V25, P943, DOI 10.1021/jm00350a011; Bauer R, 1997, CAN J BOT, V75, P1273, DOI 10.1139/b97-842; Bhasin D, 2013, BIOORGAN MED CHEM, V21, P4662, DOI 10.1016/j.bmc.2013.05.017; BOEKHOUT T, 1991, STUD MYCOL, P1; Boekhout T, 2003, INT J SYST EVOL MICR, V53, P1655, DOI 10.1099/ijs.0.02434-0; de Beer ZW, 2006, STUD MYCOL, P289, DOI 10.3114/sim.55.1.289; DEHOOG GS, 1973, A VAN LEEUW J MICROB, V39, P515, DOI 10.1007/BF02578895; FLEGEL TW, 1984, J ANTIBIOT, V37, P325, DOI 10.7164/antibiotics.37.325; Induli M, 2012, PHYTOCHEM LETT, V5, P506, DOI 10.1016/j.phytol.2012.04.014; Kawiak A, 2012, J NAT PROD, V75, P9, DOI 10.1021/np200247g; Kharwar RN, 2009, CURR MICROBIOL, V58, P233, DOI 10.1007/s00284-008-9313-7; Kolarik M, 2005, MYCOL RES, V109, P1323, DOI 10.1017/S0953756205003965; Kolarik Miroslav, 2006, Czech Mycology, V58, P81; Kolarik M, 2013, MICROB ECOL, V66, P682, DOI 10.1007/s00248-013-0228-x; Li DM, 2013, EUR FOOD RES TECHNOL, V237, P331, DOI 10.1007/s00217-013-1996-8; Medentsev AG, 1998, PHYTOCHEMISTRY, V47, P935, DOI 10.1016/S0031-9422(98)80053-8; NATORI S, 1965, CHEM PHARM BULL, V13, P633; Paap T, 2008, MYCOL RES, V112, P57, DOI 10.1016/j.mycres.2007.10.005; Padhi S, 2013, ANN MICROBIOL, V63, P793, DOI 10.1007/s13213-012-0534-4; Papageorgiou VP, 1999, ANGEW CHEM INT EDIT, V38, P270, DOI 10.1002/(SICI)1521-3773(19990201)38:3<270::AID-ANIE270>3.0.CO;2-0; Pazoutova S, 2010, FUNGAL ECOL, V3, P392, DOI 10.1016/j.funeco.2010.07.002; Perez CA, 2008, AUSTRALAS PLANT PATH, V37, P600, DOI 10.1071/AP08063; Schuck DC, 2013, MALARIA J, V12; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; SIGLER L, 1990, J CLIN MICROBIOL, V28, P1009, DOI 10.1128/JCM.28.5.1009-1015.1990; Sigler L, 2003, MANUAL CLIN MICROBIO, P1726; Simpson J. A., 2000, Australasian Mycologist, V19, P57; Stodulkova E, 2008, FOLIA MICROBIOL, V53, P15, DOI 10.1007/s12223-008-0002-5; Thomson R. H, 1997, NATURALLY OCCURRING, VIV; Wang HY, 2013, TOXICOLOGY, V308, P104, DOI 10.1016/j.tox.2013.03.015; Xu HL, 2013, BIOORG MED CHEM LETT, V23, P3631, DOI 10.1016/j.bmcl.2013.04.007; Yasuda Fumitoshi, 2006, Mycoscience, V47, P36, DOI 10.1007/s10267-005-0266-4	34	17	19	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2015	10	2							e0118913	10.1371/journal.pone.0118913	http://dx.doi.org/10.1371/journal.pone.0118913			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC3LS	25723150	Green Submitted, Green Published, gold			2022-12-27	WOS:000350251200064
J	Yang, ZF; Mok, CKP; Liu, XQ; Li, XB; He, JF; Da Guan, W; Xu, YH; Pan, WQ; Chen, LY; Lin, YP; Wu, SG; Pan, SH; Huang, JC; Ding, GY; Zheng, K; Ke, CW; Lin, JY; Zhang, YH; Lee, HHY; Liu, WK; Yang, CG; Zhou, R; Peiris, JSM; Li, YM; Chen, RC; Chen, L; Zhong, NS				Yang, Zi Feng; Mok, Chris Ka Pun; Liu, Xiao Qing; Li, Xiao Bo; He, Jian Feng; Da Guan, Wen; Xu, Yong Hao; Pan, Wei Qi; Chen, Li Yan; Lin, Yong Ping; Wu, Shi Guan; Pan, Si Hua; Huang, Ji Cheng; Ding, Guo Yun; Zheng, Kui; Ke, Chang Wen; Lin, Jin Yan; Zhang, Yong Hui; Lee, Horace Hok Yeung; Liu, Wen Kuan; Yang, Chun Guang; Zhou, Rong; Peiris, Joseph Sriyal Malik; Li, Yi Min; Chen, Rong Chang; Chen, Ling; Zhong, Nan Shan			Clinical, Virological and Immunological Features from Patients Infected with Re-Emergent Avian-Origin Human H7N9 Influenza Disease of Varying Severity in Guangdong Province	PLOS ONE			English	Article							VIRUS; RESPONSES; CYTOKINE; CHINA	Background The second wave of avian influenza H7N9 virus outbreak in humans spread to the Guangdong province of China by August of 2013 and this virus is now endemic in poultry in this region. Methods Five patients with H7N9 virus infection admitted to our hospital during August 2013 to February 2014 were intensively investigated. Viral load in the respiratory tract was determined by quantitative polymerase chain reaction (Q-PCR) and cytokine levels were measured by bead-based flow cytometery. Results Four patients survived and one died. Viral load in different clinical specimens was correlated with cytokine levels in plasma and broncho-alveolar fluid (BALF), therapeutic modalities used and clinical outcome. Intravenous zanamivir appeared to be better than peramivir as salvage therapy in patients who failed to respond to oseltamivir. Higher and more prolonged viral load was found in the sputum or endotracheal aspirates compared to throat swabs. Upregulation of proinflammatory cytokines IP-10, MCP-1, MIG, MIP-1 alpha/beta, IL-1 beta and IL-8 was found in the plasma and BALF samples. The levels of cytokines in the plasma and viral load were correlated with disease severity. Reactivation of herpes simplex virus type 1 (HSV-1) was found in three out of five patients (60%). Conclusion Expectorated sputum or endotracheal aspirate specimens are preferable to throat swabs for detecting and monitoring H7N9 virus. Severity of the disease was correlated to the viral load in the respiratory tract as well as the extents of cytokinemia. Reactivation of HSV-1 may contribute to clinical outcome.	[Yang, Zi Feng; Liu, Xiao Qing; Da Guan, Wen; Xu, Yong Hao; Pan, Wei Qi; Chen, Li Yan; Lin, Yong Ping; Wu, Shi Guan; Pan, Si Hua; Liu, Wen Kuan; Yang, Chun Guang; Zhou, Rong; Li, Yi Min; Chen, Rong Chang; Chen, Ling; Zhong, Nan Shan] Guangzhou Med Univ, State Key Lab Resp Dis, Natl Clin Res Ctr Resp Dis, Affiliated Hosp 1, Guangzhou, Guangdong, Peoples R China; [Li, Xiao Bo; Huang, Ji Cheng; Ding, Guo Yun; Zheng, Kui] Guangdong Inspect & Quarantine Technol Ctr, Hlth Quarantine BSL 3 Lab, Guangzhou, Guangdong, Peoples R China; [He, Jian Feng; Ke, Chang Wen; Lin, Jin Yan; Zhang, Yong Hui] Guangdong Ctr Dis Control & Prevent, Guangzhou, Guangdong, Peoples R China; [Mok, Chris Ka Pun; Lee, Horace Hok Yeung; Peiris, Joseph Sriyal Malik] Univ Hong Kong, HKU Li Ka Shing Fac Med, Influenza Res Ctr, Sch Publ Hlth, Hong Kong, Hong Kong, Peoples R China; [Mok, Chris Ka Pun; Lee, Horace Hok Yeung; Peiris, Joseph Sriyal Malik] Univ Hong Kong, HKU Pasteur Res Pole, Sch Publ Hlth, HKU Li Ka Shing Fac Med, Hong Kong, Hong Kong, Peoples R China	Guangzhou Medical University; State Key Laboratory of Respiratory Disease; University of Hong Kong; University of Hong Kong	Chen, RC (corresponding author), Guangzhou Med Univ, State Key Lab Resp Dis, Natl Clin Res Ctr Resp Dis, Affiliated Hosp 1, Guangzhou, Guangdong, Peoples R China.	malik@hku.hk; dryiminli@vip.163.com; chenrc@vip.163.com	Mok, Chris Ka Pun/ABD-2667-2021; Peiris, Joseph Sriyal Malik/C-4380-2009	Lee, Hok Yeung Horace/0000-0003-4360-9986; Mok, Chris Ka Pun/0000-0002-0525-6772; Peiris, Joseph Sriyal Malik/0000-0001-8217-5995	Municipal Science and Technology Bureau Foundation of Guangzhou [2014Y2-00031]; Emergency Response Project of Ministry of Science and Technology of China [KJYJ-2013-01-05]; National Science and Technology Major Project of the Ministry of Science and Technology of China [2014ZX10004006]; University Grants Committee, Hong Kong [AoE/M-12/06]	Municipal Science and Technology Bureau Foundation of Guangzhou; Emergency Response Project of Ministry of Science and Technology of China; National Science and Technology Major Project of the Ministry of Science and Technology of China; University Grants Committee, Hong Kong	This study was supported by Municipal Science and Technology Bureau Foundation of Guangzhou (Grant no. 2014Y2-00031), Emergency Response Project of Ministry of Science and Technology of China (Grant no. KJYJ-2013-01-05), National Science and Technology Major Project of the Ministry of Science and Technology of China (Grant no. 2014ZX10004006). CKPM and JSMP were supported by funding by grant AoE/M-12/06 from the University Grants Committee, Hong Kong. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2012, JAMA-J AM MED ASSOC, DOI 10.1001/jama.2012.5669; Bradley-Stewart A, 2013, J CLIN VIROL, V58, P100, DOI 10.1016/j.jcv.2013.05.011; Chen Y, 2013, LANCET, V381, P1916, DOI 10.1016/S0140-6736(13)60903-4; Cheng HW, 2014, J PAIN SYMPTOM MANAG, DOI [10.1016/j.jpainsymman.2014.12.002, DOI 10.1016/J.JPAINSYMMAN.2014.12.002]; Chi Y, 2013, J INFECT DIS, V208, P1962, DOI 10.1093/infdis/jit440; de Jong MD, 2006, NAT MED, V12, P1203, DOI 10.1038/nm1477; Dellinger RP, 2013, INTENS CARE MED, V41, P580, DOI [DOI 10.1007/s00134-012-2769-8, 10.1007/s00134-012-2769-8]; Gao HN, 2013, NEW ENGL J MED, V368, P2277, DOI 10.1056/NEJMoa1305584; Gao RB, 2013, NEW ENGL J MED, V368, P1888, DOI 10.1056/NEJMoa1304459; Hung IFN, 2011, CLIN INFECT DIS, V52, P447, DOI 10.1093/cid/ciq106; Liderot K, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/376219; Lu J, 2014, J VIROL; Mandell LA, 2007, CLIN INFECT DIS, V44, pS27, DOI 10.1086/511159; Shi JR, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0054054, 10.1371/journal.pone.0077651]; Wang C, 2014, CLIN INFECT DIS, V58, P1095, DOI 10.1093/cid/ciu053; Wang XF, 2014, CLIN RESPIR J, V8, P410, DOI 10.1111/crj.12087; Wang ZF, 2014, P NATL ACAD SCI USA, V111, P769, DOI 10.1073/pnas.1321748111; Wu CL, 2013, J MED VIROL, V85, P760, DOI 10.1002/jmv.23492; Xiang NJ, 2013, EMERG INFECT DIS, V19, P1784, DOI 10.3201/eid1911.130865; Yu L, 2013, CLIN INFECT DIS, V57, P1449, DOI 10.1093/cid/cit541; Zhang A, 2013, EUROSURVEILLANCE, V18, P38, DOI 10.2807/1560-7917.ES2013.18.50.20657; Zhou JF, 2013, NATURE, V499, P500, DOI 10.1038/nature12379	22	25	28	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2015	10	2							e0117846	10.1371/journal.pone.0117846	http://dx.doi.org/10.1371/journal.pone.0117846			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC3LS	25723593	Green Published, Green Submitted, gold			2022-12-27	WOS:000350251200040
J	Valentim, FL; van Mourik, S; Pose, D; Kim, MC; Schmid, M; van Ham, RCHJ; Busscher, M; Sanchez-Perez, GF; Molenaar, J; Angenent, GC; Immink, RGH; van Dijk, ADJ				Valentim, Felipe Leal; van Mourik, Simon; Pose, David; Kim, Min C.; Schmid, Markus; van Ham, Roeland C. H. J.; Busscher, Marco; Sanchez-Perez, Gabino F.; Molenaar, Jaap; Angenent, Gerco C.; Immink, Richard G. H.; van Dijk, Aalt D. J.			A Quantitative and Dynamic Model of the Arabidopsis Flowering Time Gene Regulatory Network	PLOS ONE			English	Article							FLORAL TRANSITION; FT PROTEIN; EXPRESSION; INDUCTION; TRANSPORT; SOC1; IDENTIFICATION; INFORMATION; INTEGRATION; SUFFICIENT	Various environmental signals integrate into a network of floral regulatory genes leading to the final decision on when to flower. Although a wealth of qualitative knowledge is available on how flowering time genes regulate each other, only a few studies incorporated this knowledge into predictive models. Such models are invaluable as they enable to investigate how various types of inputs are combined to give a quantitative readout. To investigate the effect of gene expression disturbances on flowering time, we developed a dynamic model for the regulation of flowering time in Arabidopsis thaliana. Model parameters were estimated based on expression time-courses for relevant genes, and a consistent set of flowering times for plants of various genetic backgrounds. Validation was performed by predicting changes in expression level in mutant backgrounds and comparing these predictions with independent expression data, and by comparison of predicted and experimental flowering times for several double mutants. Remarkably, the model predicts that a disturbance in a particular gene has not necessarily the largest impact on directly connected genes. For example, the model predicts that SUPPRESSOR OF OVEREXPRESSION OF CONSTANS (SOC1) mutation has a larger impact on APETALA1 (AP1), which is not directly regulated by SOC1, compared to its effect on LEAFY (LFY) which is under direct control of SOC1. This was confirmed by expression data. Another model prediction involves the importance of cooperativity in the regulation of APETALA1 (AP1) by LFY, a prediction supported by experimental evidence. Concluding, our model for flowering time gene regulation enables to address how different quantitative inputs are combined into one quantitative output, flowering time.	[Valentim, Felipe Leal; van Ham, Roeland C. H. J.; Busscher, Marco; Sanchez-Perez, Gabino F.; Angenent, Gerco C.; Immink, Richard G. H.; van Dijk, Aalt D. J.] Wageningen UR, Plant Res Int, Biosci, Wageningen, Netherlands; [van Mourik, Simon; Molenaar, Jaap; van Dijk, Aalt D. J.] Wageningen UR, Biometris, Wageningen, Netherlands; [Pose, David; Kim, Min C.; Schmid, Markus] Max Planck Inst Dev Biol, Mol Biol, Tubingen, Germany; [Angenent, Gerco C.] Wageningen Univ, Mol Biol Lab, NL-6700 AP Wageningen, Netherlands; [van Mourik, Simon; van Dijk, Aalt D. J.] Netherlands Consortium Syst Biol, Amsterdam, Netherlands; [Sanchez-Perez, Gabino F.] Wageningen Univ, Chair Grp Bioinformat, NL-6700 AP Wageningen, Netherlands	Wageningen University & Research; Wageningen University & Research; Max Planck Society; Wageningen University & Research; Wageningen University & Research	van Dijk, ADJ (corresponding author), Wageningen UR, Plant Res Int, Biosci, Wageningen, Netherlands.	aaltjan.vandijk@wur.nl	Schmid, Markus/I-4384-2015; van Mourik, Simon/D-9006-2013; Immink, Richard G.H./A-9825-2011; Posé, David/A-3424-2014; VALENTIM, Felipe LEAL/T-7105-2019	Schmid, Markus/0000-0002-0068-2967; Posé, David/0000-0003-3332-4661; Immink, Richard/0000-0002-0182-4138; van Dijk, Aalt-Jan/0000-0002-8872-5123	Max Planck postdoctoral fellowship; EMBO Long-Term postdoctoral fellowship; Deutsche Forschungsgemeinschaft (DFG) [SCHM1560/7-1]; Max Planck Society, a Netherlands Organisation for Scientific Research (NWO) [863.08.027]; SYSFLO Marie Curie Initial Training Network; Netherlands Consortium for Systems Biology	Max Planck postdoctoral fellowship(Max Planck Society); EMBO Long-Term postdoctoral fellowship(European Molecular Biology Organization (EMBO)); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Max Planck Society, a Netherlands Organisation for Scientific Research (NWO); SYSFLO Marie Curie Initial Training Network; Netherlands Consortium for Systems Biology	This work was supported by a Max Planck postdoctoral fellowship to DP, an EMBO Long-Term postdoctoral fellowship to MCK, a Deutsche Forschungsgemeinschaft (DFG) grant (ERA-PG "BloomNet", SCHM1560/7-1) to MS and the Max Planck Society, a Netherlands Organisation for Scientific Research (NWO) VENI grant (863.08.027) to ADJvD, the SYSFLO Marie Curie Initial Training Network (FLV), and by the Netherlands Consortium for Systems Biology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. RvH is employed by Keygene N. V. Keygene N. V. provided support in the form of salary for author RvH, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.	Abe M, 2005, SCIENCE, V309, P1052, DOI 10.1126/science.1115983; Andres F, 2012, NAT REV GENET, V13, P627, DOI 10.1038/nrg3291; Chew YH, 2014, PLANT CELL, V26, P5, DOI 10.1105/tpc.113.120006; Corbesier L, 2007, SCIENCE, V316, P1030, DOI 10.1126/science.1141752; de Folter S, 2005, PLANT CELL, V17, P1424, DOI 10.1105/tpc.105.031831; Deng WW, 2011, P NATL ACAD SCI USA, V108, P6680, DOI 10.1073/pnas.1103175108; Dong ZS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043450; Espinosa-soto C, 2004, PLANT CELL, V16, P2923, DOI 10.1105/tpc.104.021725; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; Giakountis A, 2008, CURR OPIN PLANT BIOL, V11, P687, DOI 10.1016/j.pbi.2008.10.003; Gould PD, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2013.7; Gregis V, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-6-r56; Grieneisen VA, 2007, NATURE, V449, P1008, DOI 10.1038/nature06215; Hames C, 2008, EMBO J, V27, P2628, DOI 10.1038/emboj.2008.184; Hartmann U, 2000, PLANT J, V21, P351, DOI 10.1046/j.1365-313x.2000.00682.x; Helliwell CA, 2006, PLANT J, V46, P183, DOI 10.1111/j.1365-313X.2006.02686.x; Hempel FD, 1997, DEVELOPMENT, V124, P3845; Hill A.V, 1910, J PHYSL, V40; Immink RGH, 2012, PLANT PHYSIOL, V160, P433, DOI 10.1104/pp.112.202614; Immink RGH, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-2-r24; Jaeger KE, 2013, PLANT CELL, V25, P820, DOI 10.1105/tpc.113.109355; Jang S, 2009, PLANT J, V60, P614, DOI 10.1111/j.1365-313X.2009.03986.x; Jonsson H, 2006, P NATL ACAD SCI USA, V103, P1633, DOI 10.1073/pnas.0509839103; Jung C, 2009, TRENDS PLANT SCI, V14, P563, DOI 10.1016/j.tplants.2009.07.005; Kaufmann K, 2010, SCIENCE, V328, P85, DOI 10.1126/science.1185244; Keily J, 2013, PLANT J, V76, P247, DOI 10.1111/tpj.12303; Lee JH, 2013, SCIENCE, V342, P628, DOI 10.1126/science.1241097; Lee J, 2008, PLANT J, V55, P832, DOI 10.1111/j.1365-313X.2008.03552.x; Li D, 2008, DEV CELL, V15, P110, DOI 10.1016/j.devcel.2008.05.002; Lloyd J, 2012, PLANT PHYSIOL, V158, P1115, DOI 10.1104/pp.111.192393; Mathieu J, 2007, CURR BIOL, V17, P1055, DOI 10.1016/j.cub.2007.05.009; Mathieu J, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000148; Mendoza L, 1998, J THEOR BIOL, V193, P307, DOI 10.1006/jtbi.1998.0701; Michaels SD, 1999, PLANT CELL, V11, P949, DOI 10.1105/tpc.11.5.949; Michaels SD, 2003, PLANT J, V33, P867, DOI 10.1046/j.1365-313X.2003.01671.x; Pajoro A, 2014, J EXP BOT, V65, P4731, DOI 10.1093/jxb/eru233; Peret B, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2013.43; Pokhilko A, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2012.6; Pose D, 2013, NATURE; Pose D, 2012, CURR OPIN PLANT BIOL, V15, P45, DOI 10.1016/j.pbi.2011.09.002; Salazar JD, 2009, CELL, V139, P1170, DOI 10.1016/j.cell.2009.11.029; Sanchez-Corrales YE, 2010, J THEOR BIOL, V264, P971, DOI 10.1016/j.jtbi.2010.03.006; Satake A, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3303; Schmal C, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002986; Schmid M, 2003, DEVELOPMENT, V130, P6001, DOI 10.1242/dev.00842; Song YH, 2012, SCIENCE, V336, P1045, DOI 10.1126/science.1219644; Srikanth A, 2011, CELL MOL LIFE SCI, V68, P2013, DOI 10.1007/s00018-011-0673-y; Tao Z, 2012, PLANT J, V70, P549, DOI 10.1111/j.1365-313X.2012.04919.x; Taoka K, 2011, NATURE, V476, P332, DOI 10.1038/nature10272; Torti S, 2012, PLANT CELL, V24, P444, DOI 10.1105/tpc.111.092791; van Leeuwen W, 2001, J EXP BOT, V52, P949, DOI 10.1093/jexbot/52.358.949; van Mourik S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0028762; van Mourik S, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-101; Wagner D, 1999, SCIENCE, V285, P582, DOI 10.1126/science.285.5427.582; Wang Y, 2010, MOL CELL, V37, P112, DOI 10.1016/j.molcel.2009.12.020; Welch SM, 2003, AGRON J, V95, P71, DOI 10.2134/agronj2003.0071; Wigge PA, 2005, SCIENCE, V309, P1056, DOI 10.1126/science.1114358; Wigge PA, 2013, CURR OPIN PLANT BIOL; Wilczek AM, 2009, SCIENCE, V323, P930, DOI 10.1126/science.1165826; Yoo SK, 2005, PLANT PHYSIOL, V139, P770, DOI 10.1104/pp.105.066928	61	30	33	2	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2015	10	2							e0116973	10.1371/journal.pone.0116973	http://dx.doi.org/10.1371/journal.pone.0116973			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC2ZH	25719734	Green Submitted, gold, Green Published			2022-12-27	WOS:000350213200015
J	Lam, CS; Tipoe, GL; So, KF; Fung, ML				Lam, Chun-Sing; Tipoe, George Lim; So, Kwok-Fai; Fung, Man-Lung			Neuroprotective Mechanism of Lycium barbarum Polysaccharides against Hippocampal-Dependent Spatial Memory Deficits in a Rat Model of Obstructive Sleep Apnea	PLOS ONE			English	Article							RETINAL GANGLION-CELLS; ISCHEMIC BRAIN-INJURY; BCL-2 FAMILY-MEMBERS; INTERMITTENT HYPOXIA; OXIDATIVE STRESS; DNA-DAMAGE; APOPTOSIS; PROTECTS; DEATH; ACTIVATION	Chronic intermittent hypoxia (CIH) is a hallmark of obstructive sleep apnea (OSA), which induces hippocampal injuries mediated by oxidative stress. This study aims to examine the neuroprotective mechanism of Lycium barbarum polysaccharides (LBP) against CIH-induced spatial memory deficits. Adult Sprague-Dawley rats were exposed to hypoxic treatment resembling a severe OSA condition for a week. The animals were orally fed with LBP solution (1mg/kg) daily 2 hours prior to hypoxia or in air for the control. The effect of LBP on the spatial memory and levels of oxidative stress, inflammation, endoplasmic reticulum (ER) stress, apoptosis and neurogenesis in the hippocampus was examined. There was a significant deficit in the spatial memory and an elevated level of malondialdehyde with a decreased expression of antioxidant enzymes (SOD, GPx-1) in the hypoxic group when compared with the normoxic control. In addition, redox-sensitive nuclear factor kappa B (NF kappa B) canonical pathway was activated with a translocation of NF kappa B members (p65, p50) and increased expression levels of NF kappa B-dependent inflammatory cytokines and mediator (TNF alpha, IL-1 beta, COX-2); also, a significantly elevated level of ER stress (GRP78/Bip, PERK, CHOP) and autophagic flux in the hypoxic group, leading to neuronal apoptosis in hippocampal subfields (DG, CA1, CA3). Remarkably, LBP administration normalized the elevated level of oxidative stress, neuroinflammation, ER stress, autophagic flux and apoptosis induced by hypoxia. Moreover, LBP significantly mitigated both the caspase-dependent intrinsic (Bax, Bcl2, cytochrome C, cleaved caspase-3) and extrinsic (FADD, cleaved caspase-8, Bid) signaling apoptotic cascades. Furthermore, LBP administration prevented the spatial memory deficit and enhanced the hippocampal neurogenesis induced by hypoxia. Our results suggest that LBP is neuroprotective against CIH-induced hippocampal-dependent spatial memory deficits by promoting hippocampal neurogenesis and negatively modulating the apoptotic signaling cascades activated by oxidative stress and inflammation.	[Lam, Chun-Sing; Fung, Man-Lung] Univ Hong Kong, Dept Physiol, Hong Kong, Hong Kong, Peoples R China; [Tipoe, George Lim; So, Kwok-Fai] Univ Hong Kong, Dept Anat, Hong Kong, Hong Kong, Peoples R China; [So, Kwok-Fai] Univ Hong Kong, Dept Ophthalmol, Hong Kong, Hong Kong, Peoples R China; [Tipoe, George Lim; So, Kwok-Fai; Fung, Man-Lung] Univ Hong Kong, Li Ka Shing Fac Med, Res Ctr Heart Brain Hormone & Hlth Aging, Hong Kong, Hong Kong, Peoples R China; [So, Kwok-Fai] Univ Hong Kong, Li Ka Shing Fac Med, State Key Lab Brain & Cognit Sci, Hong Kong, Hong Kong, Peoples R China; [So, Kwok-Fai] Jinan Univ, Guangdong HongKong Macau Inst CNS Regenerat, Jinan, Guangdong, Peoples R China; [So, Kwok-Fai] Jinan Univ, Guangdong Key Lab Brain Funct & Dis, Guangzhou 510632, Guangdong, Peoples R China	University of Hong Kong; University of Hong Kong; University of Hong Kong; University of Hong Kong; University of Hong Kong; Jinan University; University of Jinan; Jinan University	Fung, ML (corresponding author), Univ Hong Kong, Dept Physiol, Hong Kong, Hong Kong, Peoples R China.	fungml@hku.hk		George, Tipoe/0000-0002-2603-0625; So, Kwok-Fai/0000-0003-4039-4246	HKU URC grants [SFPBR 201210159040, SFPBR 201311159037]	HKU URC grants	HKU URC grants: SFPBR 201210159040, SFPBR 201311159037. URL: http://www.rss.hku.hk/about-us/urc. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abarikwu SO, 2012, BASIC CLIN PHARMACOL, V110, P441, DOI 10.1111/j.1742-7843.2011.00834.x; Abdel-Wahab BA, 2012, PHYTOMEDICINE, V19, P444, DOI 10.1016/j.phymed.2011.11.011; Amagase H, 2009, NUTR RES, V29, P19, DOI 10.1016/j.nutres.2008.11.005; Bartley J, 2005, BMC NEUROSCI, V6, DOI 10.1186/1471-2202-6-15; Bossenmeyer-Pourie C, 2002, NEUROSCIENCE, V114, P869, DOI 10.1016/S0306-4522(02)00324-X; Burckhardt IC, 2008, AM J RESP CRIT CARE, V177, P1135, DOI 10.1164/rccm.200701-110OC; Cai XH, 2010, ACTA NEUROBIOL EXP, V70, P279; Carpagnano GE, 2002, CHEST, V122, P1162, DOI 10.1378/chest.122.4.1162; Chan HC, 2007, EXP NEUROL, V203, P269, DOI 10.1016/j.expneurol.2006.05.031; Chang LF, 2006, CELL, V124, P601, DOI 10.1016/j.cell.2006.01.021; Chang NC, 2010, EMBO J, V29, P606, DOI 10.1038/emboj.2009.369; Chang RCC, 2008, CELL MOL NEUROBIOL, V28, P643, DOI 10.1007/s10571-007-9181-x; Chen WW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088076; Chipuk JE, 2008, P NATL ACAD SCI USA, V105, P20327, DOI 10.1073/pnas.0808036105; Chiu K, 2010, J CELL BIOCHEM, V110, P311, DOI 10.1002/jcb.22539; Chiu SC, 2012, J BIOMED SCI, V19, DOI 10.1186/1423-0127-19-29; Deng YB, 2003, CELL, V115, P61, DOI 10.1016/S0092-8674(03)00757-8; Galluzzi L, 2012, CELL DEATH DIFFER, V19, P107, DOI 10.1038/cdd.2011.96; Gozal D, 2001, J NEUROSCI, V21, P2442, DOI 10.1523/JNEUROSCI.21-07-02442.2001; He MH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084800; Ho YS, 2010, J ALZHEIMERS DIS, V19, P813, DOI 10.3233/JAD-2010-1280; Ho YS, 2009, CELL MOL NEUROBIOL, V29, P1233, DOI 10.1007/s10571-009-9419-x; Hu XM, 2005, J NEUROCHEM, V93, P26, DOI 10.1111/j.1471-4159.2004.02968.x; Hu XM, 2003, INT J DEV NEUROSCI, V21, P371, DOI 10.1016/S0736-5748(03)00089-3; Hung MW, 2008, J PINEAL RES, V44, P214, DOI 10.1111/j.1600-079X.2007.00514.x; Jin KL, 2001, P NATL ACAD SCI USA, V98, P4710, DOI 10.1073/pnas.081011098; Karmakar S, 2007, APOPTOSIS, V12, P671, DOI 10.1007/s10495-006-0024-x; Kirkland RA, 2010, J NEUROSCI, V30, P16114, DOI 10.1523/JNEUROSCI.2862-10.2010; Kokturk O, 2005, INT HEART J, V46, P801, DOI 10.1536/ihj.46.801; Konig HG, 2007, BMC CELL BIOL, V8, DOI 10.1186/1471-2121-8-7; Lakhani SA, 2006, SCIENCE, V311, P847, DOI 10.1126/science.1115035; Lau BWM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033374; Li HY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068881; Li RC, 2003, AM J RESP CRIT CARE, V168, P469, DOI 10.1164/rccm.200211-1264OC; Li Z, 2004, BRAIN RES, V1021, P8, DOI 10.1016/j.brainres.2004.05.115; Lin NC, 2011, J AGR FOOD CHEM, V59, P10088, DOI 10.1021/jf2021754; Liu DX, 2014, PHARMACOL BIOCHEM BE, V116, P55, DOI 10.1016/j.pbb.2013.11.009; Lu SP, 2010, INT J BIOL MACROMOL, V47, P681, DOI 10.1016/j.ijbiomac.2010.08.016; Luo Q, 2006, LIFE SCI, V79, P613, DOI 10.1016/j.lfs.2006.02.012; Luo Q, 2014, J ETHNOPHARMACOL, V154, P249, DOI 10.1016/j.jep.2014.04.013; Martinou JC, 2011, DEV CELL, V21, P92, DOI 10.1016/j.devcel.2011.06.017; Miles DK, 2008, HIPPOCAMPUS, V18, P793, DOI 10.1002/hipo.20439; Morrell MJ, 2006, ADV EXP MED BIOL, V588, P75; Niu AJ, 2008, INT J BIOL MACROMOL, V42, P447, DOI 10.1016/j.ijbiomac.2008.02.003; Pack AI, 2006, AM J RESP CRIT CARE, V173, P7, DOI 10.1164/rccm.200509-1478OE; Pae EK, 2005, NEUROSCI LETT, V375, P123, DOI 10.1016/j.neulet.2004.10.091; Pei YH, 2007, APOPTOSIS, V12, P1681, DOI 10.1007/s10495-007-0091-7; Punjabi Naresh M, 2008, Proc Am Thorac Soc, V5, P136, DOI 10.1513/pats.200709-155MG; Row BW, 2003, AM J RESP CRIT CARE, V167, P1548, DOI 10.1164/rccm.200209-1050OC; Ryan S, 2006, AM J RESP CRIT CARE, V174, P824, DOI 10.1164/rccm.200601-066OC; Valencia A, 2004, FREE RADICAL BIO MED, V36, P1112, DOI 10.1016/j.freeradbiomed.2004.02.013; Veasey Sigrid C, 2012, Front Neurol, V3, P139, DOI 10.3389/fneur.2012.00139; Wang CC, 2009, FOOD CHEM, V116, P595, DOI 10.1016/j.foodchem.2009.03.015; Wang TF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090780; Aviles-Reyes RX, 2010, J NEUROCHEM, V112, P854, DOI 10.1111/j.1471-4159.2009.06535.x; Xiao J, 2013, NUTR DIABETES, V3, DOI 10.1038/nutd.2013.22; Xiao J, 2012, J ETHNOPHARMACOL, V139, P462, DOI 10.1016/j.jep.2011.11.033; Yamaguchi A, 2001, J BIOL CHEM, V276, P5256, DOI 10.1074/jbc.M008552200; Yang D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033596; Zhan GX, 2005, AM J RESP CRIT CARE, V171, P1414, DOI 10.1164/rccm.200411-1564OC; Zhang LL, 2013, AFR J TRADIT COMPLEM, V10, P494, DOI 10.4314/ajtcam.v10i6.18; Zhu Y, 2008, J NEUROSCI, V28, P2168, DOI 10.1523/JNEUROSCI.5232-07.2008	62	33	36	1	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2015	10	2							e0117990	10.1371/journal.pone.0117990	http://dx.doi.org/10.1371/journal.pone.0117990			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC2IM	25714473	Green Published, Green Submitted, gold			2022-12-27	WOS:000350168700047
J	Popovych, OV; Xenakis, MN; Tass, PA				Popovych, Oleksandr V.; Xenakis, Markos N.; Tass, Peter A.			The Spacing Principle for Unlearning Abnormal Neuronal Synchrony	PLOS ONE			English	Article							DEEP-BRAIN-STIMULATION; COORDINATED RESET NEUROMODULATION; RESPONSIVE CORTICAL STIMULATION; PARKINSONS-DISEASE; EFFECTIVE DESYNCHRONIZATION; DISTRIBUTED PRACTICE; SUBTHALAMIC NUCLEUS; MODEL; CONNECTIVITY; OSCILLATIONS	Desynchronizing stimulation techniques were developed to specifically counteract abnormal neuronal synchronization relevant to several neurological and psychiatric disorders. The goal of our approach is to achieve an anti-kindling, where the affected neural networks unlearn abnormal synaptic connectivity and, hence, abnormal neuronal synchrony, by means of desynchronizing stimulation, in particular, Coordinated Reset (CR) stimulation. As known from neuroscience, psychology and education, learning effects can be enhanced by means of the spacing principle, i.e. by delivering repeated stimuli spaced by pauses as opposed to delivering a massed stimulus (in a single long stimulation session). To illustrate that the spacing principle may boost the anti-kindling effect of CR neuromodulation, in this computational study we carry this approach to extremes. To this end, we deliver spaced CR neuromodulation at particularly weak intensities which render permanently delivered CR neuromodulation ineffective. Intriguingly, spaced CR neuromodulation at these particularly weak intensities effectively induces an anti-kindling. In fact, the spacing principle enables the neuronal population to successively hop from one attractor to another one, finally approaching attractors characterized by down-regulated synaptic connectivity and synchrony. Our computational results might open up novel opportunities to effectively induce sustained desynchronization at particularly weak stimulation intensities, thereby avoiding side effects, e.g., in the case of deep brain stimulation.	[Popovych, Oleksandr V.; Xenakis, Markos N.; Tass, Peter A.] Julich Res Ctr, Inst Neurosci & Med Neuromodulat, Julich, Germany; [Tass, Peter A.] Stanford Univ, Dept Neurosurg, Stanford, CA 94305 USA; [Tass, Peter A.] Univ Cologne, Dept Neuromodulat, D-50931 Cologne, Germany	Helmholtz Association; Research Center Julich; Stanford University; University of Cologne	Popovych, OV (corresponding author), Julich Res Ctr, Inst Neurosci & Med Neuromodulat, Julich, Germany.	o.popovych@fz-juelich.de	Popovych, Oleksandr V/H-8738-2013; Tass, Peter A/H-8756-2013	Popovych, Oleksandr V/0000-0001-9994-1764; Tass, Peter A/0000-0002-5736-7415; Xenakis, Markos N./0000-0001-9536-4015	Helmholtz Society	Helmholtz Society(Helmholtz Association)	The study was funded by the Helmholtz Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamchic I, 2014, MOVEMENT DISORD, V29, P1679, DOI 10.1002/mds.25923; Adamchic I, 2014, HUM BRAIN MAPP, V35, P2099, DOI 10.1002/hbm.22314; Amit DJ, 1997, CEREB CORTEX, V7, P237, DOI 10.1093/cercor/7.3.237; Benabid AL, 2005, ACTA NEUROL BELG, V105, P149; BENABID AL, 1991, LANCET, V337, P403, DOI 10.1016/0140-6736(91)91175-T; Bertau M., 2008, BIOSIMULATION DRUG D; Bi GQ, 1998, J NEUROSCI, V18, P10464, DOI 10.1523/jneurosci.18-24-10464.1998; Braun J, 2010, NEUROIMAGE, V52, P740, DOI 10.1016/j.neuroimage.2009.12.126; Briggman KL, 2008, ANNU REV NEUROSCI, V31, P271, DOI 10.1146/annurev.neuro.31.060407.125552; Bronte-Stewart H, 2009, EXP NEUROL, V215, P20, DOI 10.1016/j.expneurol.2008.09.008; Cepeda NJ, 2006, PSYCHOL BULL, V132, P354, DOI 10.1037/0033-2909.132.3.354; Cepeda NJ, 2009, EXP PSYCHOL, V56, P236, DOI 10.1027/1618-3169.56.4.236; Cloutier M, 2012, IET SYST BIOL, V6, P86, DOI 10.1049/iet-syb.2011.0076; da Silva FL, 2003, EPILEPSIA, V44, P72, DOI 10.1111/j.0013-9580.2003.12005.x; Dash A., 2014, PHARM BASIC PRINCIPL; Deco G, 2011, NEUROSCIENTIST, V17, P107, DOI 10.1177/1073858409354384; Deuschl G, 2006, NEW ENGL J MED, V355, P896, DOI 10.1056/NEJMoa060281; Dolan K, 2005, PHYSICA D, V211, P128, DOI 10.1016/j.physd.2005.08.009; Ebbinghaus H, 1913, ED REPRINTS, V3; Feldman DE, 2000, NEURON, V27, P45, DOI 10.1016/S0896-6273(00)00008-8; Fisher RS, 1999, NEUROLOGY, V53, P666, DOI 10.1212/WNL.53.4.666; Foffani G, 2003, BRAIN, V126, P2153, DOI 10.1093/brain/awg229; Frey U, 1997, NATURE, V385, P533, DOI 10.1038/385533a0; Frohlich F, 2010, J NEUROSCI, V30, P10734, DOI 10.1523/JNEUROSCI.1239-10.2010; Gerstner W, 1996, NATURE, V383, P76, DOI 10.1038/383076a0; Gradinaru V, 2009, SCIENCE, V324, P354, DOI 10.1126/science.1167093; Hairer E., 1993, SPRINGER SERIES COMP; Hauptmann C, 2005, STOCH DYNAM, V5, P307, DOI 10.1142/S0219493705001420; Hauptmann C, 2009, J NEURAL ENG, V6, DOI 10.1088/1741-2560/6/6/066003; Hauptmann C, 2009, J NEURAL ENG, V6, DOI 10.1088/1741-2560/6/1/016004; Hauptmann C, 2007, BIOSYSTEMS, V89, P173, DOI 10.1016/j.biosystems.2006.04.015; ITOH K, 1995, SCIENCE, V270, P1369, DOI 10.1126/science.270.5240.1369; Kelley P, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00589; Krack P, 2003, NEW ENGL J MED, V349, P1925, DOI 10.1056/NEJMoa035275; Kuhn AA, 2008, J NEUROSCI, V28, P6165, DOI 10.1523/JNEUROSCI.0282-08.2008; Little S, 2013, ANN NEUROL, V74, P449, DOI 10.1002/ana.23951; Lysyansky Borys, 2013, Front Neuroeng, V6, P5, DOI 10.3389/fneng.2013.00005; Lysyansky B, 2011, J NEURAL ENG, V8, DOI 10.1088/1741-2560/8/3/036019; Maistrenko YL, 2007, PHYS REV E, V75, DOI 10.1103/PhysRevE.75.066207; Markram H, 1997, SCIENCE, V275, P213, DOI 10.1126/science.275.5297.213; McIntyre CC, 2004, J NEUROPHYSIOL, V91, P1457, DOI 10.1152/jn.00989.2003; Menzel R, 2001, LEARN MEMORY, V8, P198, DOI 10.1101/lm.40001; Morrell MJ, 2011, NEUROLOGY, V77, P1295, DOI 10.1212/WNL.0b013e3182302056; MORRIS C, 1981, BIOPHYS J, V35, P193, DOI 10.1016/S0006-3495(81)84782-0; Naqib F, 2012, NEURAL PLAST, V2012, DOI 10.1155/2012/581291; Pavlik PI, 2008, J EXP PSYCHOL-APPL, V14, P101, DOI 10.1037/1076-898X.14.2.101; Peters S, 2011, PHYSL BASED PHARMACO, DOI [10.1038/psp.2013.29, DOI 10.1038/PSP.2013.29]; Pikovsky A, 1999, PHYS REV E, V59, P1633, DOI 10.1103/PhysRevE.59.1633; Pikovsky A, 2001, SYNCHRONIZATION UNIV; Popovych OV, 2013, SCI REP-UK, V3, DOI 10.1038/srep02926; Popovych OV, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00058; Popovych OV, 2010, PHYS REV E, V82, DOI 10.1103/PhysRevE.82.026204; Popovych OV, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.164102; Pyragas K, 2007, EPL-EUROPHYS LETT, V80, DOI 10.1209/0295-5075/80/40002; RINZEL J, 1990, ANN NY ACAD SCI, V591, P51; Rinzel J., 1989, METHODS NEURONAL MOD, P135; Rowe MB., 1976, RES COLL SCI TEACHIN, V5, P258; Scharf MT, 2002, J NEUROPHYSIOL, V87, P2770, DOI 10.1152/jn.2002.87.6.2770; Silchenko AN, 2013, NEUROIMAGE, V77, P133, DOI 10.1016/j.neuroimage.2013.03.013; Sun FT, 2008, NEUROTHERAPEUTICS, V5, P68, DOI 10.1016/j.nurt.2007.10.069; Symonds RP, 2012, WALTER MILLERS TXB R; Tass P. A., 2006, Nonlinear Phenomena in Complex Systems, V9, P298; Tass PA, 2009, RESTOR NEUROL NEUROS, V27, P589, DOI 10.3233/RNN-2009-0484; Tass PA, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.011902; Tass P.A., 1999, PHASE RESETTING MED; Tass PA, 2006, BIOL CYBERN, V94, P58, DOI 10.1007/s00422-005-0028-6; Tass PA, 2003, PROG THEOR PHYS SUPP, P281, DOI 10.1143/PTPS.150.281; Tass PA, 2003, BIOL CYBERN, V89, P81, DOI [10.1007/s00422-003-0425-7, 10.1007/S00422-003-0425-7]; Tass PA, 2002, BIOL CYBERN, V87, P102, DOI 10.1007/s00422-002-0322-5; Tass PA, 2001, EUROPHYS LETT, V55, P171, DOI 10.1209/epl/i2001-00397-8; Tass PA, 2001, BIOL CYBERN, V85, P343, DOI 10.1007/s004220100268; Tass PA, 2007, INT J PSYCHOPHYSIOL, V64, P53, DOI 10.1016/j.ijpsycho.2006.07.013; Tass PA, 2012, ANN NEUROL, V72, P816, DOI 10.1002/ana.23663; Tass PA, 2012, RESTOR NEUROL NEUROS, V30, P137, DOI 10.3233/RNN-2012-110218; Tass PA, 2012, BIOL CYBERN, V106, P27, DOI 10.1007/s00422-012-0479-5; Temperli P, 2003, NEUROLOGY, V60, P78, DOI 10.1212/WNL.60.1.78; Volkmann J, 2006, MOVEMENT DISORD, V21, pS284, DOI 10.1002/mds.20961; Volkmann J, 2002, MOVEMENT DISORD, V17, pS181, DOI 10.1002/mds.10162; Wang XJ, 2001, TRENDS NEUROSCI, V24, P455, DOI 10.1016/S0166-2236(00)01868-3; Xue G, 2011, J COGNITIVE NEUROSCI, V23, P1624, DOI 10.1162/jocn.2010.21532	81	27	28	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2015	10	2							e0117205	10.1371/journal.pone.0117205	http://dx.doi.org/10.1371/journal.pone.0117205			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC2IM	25714553	Green Submitted, gold, Green Published			2022-12-27	WOS:000350168700030
J	Herget, ME; Hufford, KM; Mummey, DL; Shreading, LN				Herget, Mollie E.; Hufford, Kristina M.; Mummey, Daniel L.; Shreading, Lauren N.			Consequences of Seed Origin and Biological Invasion for Early Establishment in Restoration of a North American Grass Species	PLOS ONE			English	Article							LOCAL ADAPTATION; GENETIC DIFFERENTIATION; CHEATGRASS COMPETITION; GENOTYPIC DIVERSITY; ECOSYSTEM; PLANTS; COMMUNITIES; ECOTYPES; REMNANT	Local, wild-collected seeds of native plants are recommended for use in ecological restoration to maintain patterns of adaptive variation. However, some environments are so drastically altered by exotic, invasive weeds that original environmental conditions may no longer exist. Under these circumstances, cultivated varieties selected for improved germination and vigor may have a competitive advantage at highly disturbed sites. This study investigated differences in early establishment and seedling performance between wild and cultivated seed sources of the native grass, Poa secunda, both with and without competition from the invasive exotic grass, Bromus tectorum. We measured seedling survival and above-ground biomass at two experimental sites in western Montana, and found that the source of seeds selected for restoration can influence establishment at the restoration site. Cultivars had an overall advantage when compared with local genotypes, supporting evidence of greater vigor among cultivated varieties of native species. This advantage, however, declined rapidly in the presence of B. tectorum and most accessions were not significantly different for growth and survival in competition plots. Only one cultivar had a consistent advantage despite a strong decline in its performance when competing with invasive plants. As a result, cultivated varieties did not meet expectations for greater establishment and persistence relative to local genotypes in the presence of invasive, exotic species. We recommend the use of representative local or regional wild seed sources in restoration to minimize commercial selection, and a mix of individual accessions (wild, or cultivated when necessary) in highly invaded settings to capture vigorous genotypes and increase the odds native plants will establish at restoration sites.	[Herget, Mollie E.; Hufford, Kristina M.] Univ Wyoming, Dept Ecosyst Sci & Management, Laramie, WY 82071 USA; [Mummey, Daniel L.; Shreading, Lauren N.] MPG Ranch, Florence, MT USA	University of Wyoming	Herget, ME (corresponding author), Univ Wyoming, Dept Ecosyst Sci & Management, Laramie, WY 82071 USA.	mherget@uwyo.edu			MPG Ranch; University of Wyoming Reclamation and Restoration Center; Nature Conservancy	MPG Ranch; University of Wyoming Reclamation and Restoration Center; Nature Conservancy	This research has been made possible by funding from MPG Ranch (www.mpgranch.com) to MH and KH, the University of Wyoming Reclamation and Restoration Center (www.uwyo.edu/wrrc) to MH, and The Nature Conservancy (www.nature.org) to MH. MPG Ranch had a role in study design through co-authorship. The funder provided support in the form of salaries for authors DM and LS, but did not have any additional role in the data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	AGUIRRE L, 1991, J RANGE MANAGE, V44, P347, DOI 10.2307/4002397; ALLARD RW, 1988, J HERED, V79, P225, DOI 10.1093/oxfordjournals.jhered.a110503; [Anonymous], 2006, SAS MIXED MODELS; Baer SG, 2014, EVOL APPL, V7, P323, DOI 10.1111/eva.12124; Bakker JD, 2003, ECOL APPL, V13, P137, DOI 10.1890/1051-0761(2003)013[0137:COGROY]2.0.CO;2; Banerjee MJ, 2006, RESTOR ECOL, V14, P339, DOI 10.1111/j.1526-100X.2006.00142.x; Bischoff A, 2006, J ECOL, V94, P1130, DOI 10.1111/j.1365-2745.2006.01174.x; Bischoff A, 2010, RESTOR ECOL, V18, P338, DOI 10.1111/j.1526-100X.2008.00454.x; Booth RE, 2003, J ECOL, V91, P721, DOI 10.1046/j.1365-2745.2003.00804.x; Brown CS, 2008, INVAS PLANT SCI MANA, V1, P399, DOI 10.1614/IPSM-08-082.1; Burton PJ., 2002, ECOLOGICAL RESTORATI, V20, P117, DOI [10.3368/er.20.2.117, DOI 10.3368/ER.20.2.117]; Crutsinger GM, 2006, SCIENCE, V313, P966, DOI 10.1126/science.1128326; DANTONIO CM, 1992, ANNU REV ECOL SYST, V23, P63, DOI 10.1146/annurev.es.23.110192.000431; DAUBENMIRE R., 1959, NORTHWEST SCI, V33, P43; Gasch CK, 2013, BIOL FERT SOILS, V49, P919, DOI 10.1007/s00374-013-0790-x; Gibson DJ, 2012, OIKOS, V121, P496, DOI 10.1111/j.1600-0706.2011.19447.x; Griffith AB, 2010, ECOLOGY, V91, P141, DOI 10.1890/08-1446.1; GUPTA SC, 1979, WATER RESOUR RES, V15, P1633, DOI 10.1029/WR015i006p01633; Gustafson D. J., 2005, Native Plants Journal, V6, P25, DOI 10.2979/NPJ.2005.6.1.25; Gustafson DJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091511; Gustafson DJ, 2004, FUNCT ECOL, V18, P451, DOI 10.1111/j.0269-8463.2004.00850.x; Hironaka M, 1972, GROWTH DEV SITANION; Hufford KM, 2003, TRENDS ECOL EVOL, V18, P147, DOI 10.1016/S0169-5347(03)00002-8; Hufford KM, 2008, RESTOR ECOL, V16, P59, DOI 10.1111/j.1526-100X.2007.00262.x; Hughes AR, 2004, P NATL ACAD SCI USA, V101, P8998, DOI 10.1073/pnas.0402642101; Humphrey LD, 2011, J ARID ENVIRON, V58, P405; Johnson RC, 2010, BOTANY, V88, P725, DOI 10.1139/B10-047; Jones TA, 2013, EVOL APPL, V6, P1109, DOI 10.1111/eva.12090; KELLOGG EA, 1985, J ARNOLD ARBORETUM, V66, P201, DOI 10.5962/bhl.part.13182; Klopf RP, 2011, RESTOR ECOL, V19, P112, DOI 10.1111/j.1526-100X.2009.00539.x; Lambert SM, 2011, NOTICE RELEASE MOUNT; Leger EA, 2008, ECOL APPL, V18, P1226, DOI 10.1890/07-1598.1; Leimu R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004010; Lesica P, 1999, RESTOR ECOL, V7, P42, DOI 10.1046/j.1526-100X.1999.07105.x; Linhart YB, 1996, ANNU REV ECOL SYST, V27, P237, DOI 10.1146/annurev.ecolsys.27.1.237; MACK RN, 1981, AGRO-ECOSYSTEMS, V7, P145, DOI 10.1016/0304-3746(81)90027-5; Majerus M., 2009, PLANT GUIDE SANDBERG; McKay JK, 2005, RESTOR ECOL, V13, P432, DOI 10.1111/j.1526-100X.2005.00058.x; Monsen SB, 2004, RESTORING W RANGES W, V2, P295; Peterson JS, 2002, PLANT FACT SHEET SAN; Rafferty DL, 2002, J RANGE MANAGE, V55, P70, DOI 10.2307/4003265; Reusch TBH, 2005, P NATL ACAD SCI USA, V102, P2826, DOI 10.1073/pnas.0500008102; Rice KJ, 2008, RESTOR ECOL, V16, P12, DOI 10.1111/j.1526-100X.2007.00257.x; Schroder R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071066; Sher AA, 2008, RESTOR ECOL, V16, P129, DOI 10.1111/j.1526-100X.2008.00355.x; Smith SL, 2007, RESTOR ECOL, V15, P369, DOI 10.1111/j.1526-100X.2007.00231.x; Stevens JM, 2011, RESTOR ECOL, V19, P399, DOI 10.1111/j.1526-100X.2009.00565.x; Stubbendieck J, 2011, N AM WILDLAND PLANTS; Vander Mijnsbrugge K, 2010, BASIC APPL ECOL, V11, P300, DOI 10.1016/j.baae.2009.09.002; Weisshuhn K, 2011, BASIC APPL ECOL, V12, P21, DOI 10.1016/j.baae.2010.11.005; Wilkinson DM, 2001, J APPL ECOL, V38, P1371, DOI 10.1046/j.0021-8901.2001.00669.x; Zar JH, 1999, BIOSTATISTICAL ANAL	52	14	14	0	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2015	10	3							e0119889	10.1371/journal.pone.0119889	http://dx.doi.org/10.1371/journal.pone.0119889			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9KG	25741702	Green Submitted, Green Published, gold			2022-12-27	WOS:000350688100129
J	Li, JH; Wang, ZH; Zhu, XJ; Deng, ZH; Cai, CX; Qiu, LQ; Chen, W; Lin, YJ				Li, Jiang-Hua; Wang, Zhi-Hui; Zhu, Xiao-Juan; Deng, Zhao-Hui; Cai, Can-Xin; Qiu, Li-Qiang; Chen, Wei; Lin, Ya-Jun			Health Effects from Swimming Training in Chlorinated Pools and the Corresponding Metabolic Stress Pathways	PLOS ONE			English	Article							DISINFECTION BY-PRODUCTS; TAURINE; CHLOROFORM; ASTHMA; PREVALENCE; ATTENDANCE; EXCRETION	Chlorination is the most popular method for disinfecting swimming pool water; however, although pathogens are being killed, many toxic compounds, called disinfection by-products (DBPs), are formed. Numerous epidemiological publications have associated the chlorination of pools with dysfunctions of the respiratory system and with some other diseases. However, the findings concerning these associations are not always consistent and have not been confirmed by toxicological studies. Therefore, the health effects from swimming in chlorinated pools and the corresponding stress reactions in organisms are unclear. In this study, we show that although the growth and behaviors of experimental rats were not affected, their health, training effects and metabolic profiles were significantly affected by a 12-week swimming training program in chlorinated water identical to that of public pools. Interestingly, the eyes and skin are the organs that are more directly affected than the lungs by the irritants in chlorinated water; instead of chlorination, training intensity, training frequency and choking on water may be the primary factors for lung damage induced by swimming. Among the five major organs (the heart, liver, spleen, lungs and kidneys), the liver is the most likely target of DBPs. Through metabolomics analysis, the corresponding metabolic stress pathways and a defensive system focusing on taurine were presented, based on which the corresponding countermeasures can be developed for swimming athletes and for others who spend a lot of time in chlorinated swimming pools.	[Li, Jiang-Hua; Zhu, Xiao-Juan; Deng, Zhao-Hui; Cai, Can-Xin; Qiu, Li-Qiang; Chen, Wei; Lin, Ya-Jun] Jiangxi Normal Univ, Inst Phys Educ, State Sports Gen Adm, Key Lab Training Monitoring & Intervent Sports Wa, Nanchang, Peoples R China; [Li, Jiang-Hua] Jiangxi Normal Univ, Jiangxi Prov Key Lab Chem Biol, Nanchang, Peoples R China; [Wang, Zhi-Hui] Beijing Econ Management Sch, Beijing, Peoples R China	Jiangxi Normal University; Jiangxi Normal University	Li, JH (corresponding author), Jiangxi Normal Univ, Inst Phys Educ, State Sports Gen Adm, Key Lab Training Monitoring & Intervent Sports Wa, Nanchang, Peoples R China.	lijianghua8@sina.com	li, jianghua/GXG-4735-2022		National Science Foundation of China [NSFC 21365013]; Jiangxi Provincial Education Department [GJJ 13240]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Jiangxi Provincial Education Department	This research was supported by the National Science Foundation of China (NSFC 21365013) and by the science project from the Jiangxi Provincial Education Department (GJJ 13240). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bernard A, 2003, OCCUP ENVIRON MED, V60, P385, DOI 10.1136/oem.60.6.385; Bernard A, 2011, AM J RESP CRIT CARE, V183, P570, DOI 10.1164/rccm.201008-1306ED; Bougault V, 2012, J ALLERGY CLIN IMMUN, V129, P351, DOI 10.1016/j.jaci.2011.11.010; Cunningham C, 1998, BIOCHEM J, V330, P939, DOI 10.1042/bj3300939; Das J, 2012, FOOD FUNCT, V3, P1251, DOI 10.1039/c2fo30117b; Das J, 2009, DRUG CHEM TOXICOL, V32, P93, DOI 10.1080/01480540802564171; Dawson C A, 1970, Med Sci Sports, V2, P51; Dzurik R, 2001, KIDNEY INT, V59, pS278; Florentin A, 2011, INT J HYG ENVIR HEAL, V214, P461, DOI 10.1016/j.ijheh.2011.07.012; Font-Ribera L, 2009, EUR RESPIR J, V34, P1304, DOI 10.1183/09031936.00180608; Font-Ribera L, 2011, AM J RESP CRIT CARE, V183, P582, DOI 10.1164/rccm.201005-0761OC; Gemma S, 1996, ENVIRON TOXICOL PHAR, V2, P233, DOI 10.1016/S1382-6689(96)00060-9; Gemma S, 2003, DRUG METAB DISPOS, V31, P266, DOI 10.1124/dmd.31.3.266; Goodman M, 2008, J ASTHMA, V45, P639, DOI 10.1080/02770900802165980; JACOBSEN JG, 1967, NATURE, V214, P1247, DOI 10.1038/2141247a0; Jaeschke H, 2002, TOXICOL SCI, V65, P166, DOI 10.1093/toxsci/65.2.166; Lakind JS, 2010, ENVIRON SCI TECHNOL, V44, P3205, DOI 10.1021/es903241k; Levesque B, 2006, INT ARCH OCC ENV HEA, V80, P32, DOI 10.1007/s00420-006-0100-0; Lord R.S., 2008, LAB EVALUATIONS INTE; Lubick N, 2007, ENVIRON SCI TECHNOL, V41, P6634, DOI 10.1021/es0726198; Manna P, 2009, AMINO ACIDS, V36, P417, DOI 10.1007/s00726-008-0094-x; Mansuy D, 1997, BIOCHEM BIOPH RES CO, V79, P513; Nickmilder M, 2007, OCCUP ENVIRON MED, V64, P37, DOI 10.1136/oem.2005.025452; POHL LR, 1977, BIOCHEM BIOPH RES CO, V79, P684, DOI 10.1016/0006-291X(77)91166-4; REUBER MD, 1979, ENVIRON HEALTH PERSP, V31, P171, DOI 10.2307/3429156; Ripps H, 2012, MOL VIS, V18, P2673; Roy A, 2009, FREE RADICAL RES, V43, P995, DOI 10.1080/10715760903164998; SPUSTOVA V, 1991, PHYSIOL RES, V40, P599; Tian JS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075721; TIMBRELL JA, 1995, GEN PHARMACOL-VASC S, V26, P453, DOI 10.1016/0306-3623(94)00203-Y; TUMASONIS CF, 1985, ECOTOX ENVIRON SAFE, V9, P233, DOI 10.1016/0147-6513(85)90026-0; Villanueva CM, 2004, EPIDEMIOLOGY, V15, P357, DOI 10.1097/01.ede.0000121380.02594.fc; Vittozzi L, 2000, ENVIRON TOXICOL PHAR, V8, P103, DOI 10.1016/S1382-6689(00)00031-4; World Health Organization (WHO), 2006, GUID SAF RECR WAT EN, V2	34	12	12	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2015	10	3							e0119241	10.1371/journal.pone.0119241	http://dx.doi.org/10.1371/journal.pone.0119241			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9KG	25742134	Green Published, Green Submitted, gold			2022-12-27	WOS:000350688100096
J	Rijs, KJ; Van den Kommer, TN; Comijs, HC; Deeg, DJH				Rijs, Kelly J.; Van den Kommer, Tessa N.; Comijs, Hannie C.; Deeg, Dorly J. H.			Prevalence and Incidence of Memory Complaints in Employed Compared to Non-Employed Aged 55-64 Years and the Role of Employment Characteristics	PLOS ONE			English	Article							PSYCHOSOCIAL FACTORS; SUBJECTIVE FORGETFULNESS; PERSONALITY-TRAITS; COGNITIVE DECLINE; RISK-FACTOR; JOB STRAIN; ILL-HEALTH; FOLLOW-UP; OLDER; WORK	Objectives To examine the association of employment status and characteristics with prevalent and incident memory complaints (MC) in 55-64-year-olds. Methods Subjects were participants of the Longitudinal Aging Study Amsterdam (LASA). Respondents with baseline data were selected to examine the association of employment status (n = 1525) and employment characteristics (n = 1071) with prevalent MC (i.e., MC at baseline). Respondents without MC at baseline were selected to examine the association of employment (n = 526) and employment characteristics (n = 379; working hours, job prestige, job level, psychological job demands, iso-strain) with incident MC (i.e., no MC at baseline and MC at three-year follow-up). Associations were adjusted for relevant covariates (demographics, memory performance, physical health, mental health, personality traits). Logistic regression was applied. Data were weighed according to gender and age of the Dutch population. Results At baseline 20.5% reported MC. At three-year follow-up, 15.4% had incident MC. No associations were found between employment status and MC. Adjusted analysis revealed that individuals with high occupational cognitive demands were more likely to have prevalent MC. Conclusions Middle-aged workers are equally as likely to experience MC as non-working age-peers. Among workers, those with cognitively demanding work were more likely to experience MC, independent of memory performance. Memory decline due to ageing may be noticed sooner in 55-64-year-olds performing cognitively demanding work.	[Rijs, Kelly J.; Van den Kommer, Tessa N.; Deeg, Dorly J. H.] Vrije Univ Amsterdam Med Ctr, EMGO Inst Hlth & Care Res, Dept Epidemiol & Biostat, Amsterdam, Netherlands; [Comijs, Hannie C.; Deeg, Dorly J. H.] Vrije Univ Amsterdam, Med Ctr, EMGO Inst Hlth & Care Res, Dept Psychiat, Amsterdam, Netherlands; [Comijs, Hannie C.] Vrije Univ Amsterdam, Med Ctr, GGZ InGeest Partner, Amsterdam, Netherlands	Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam	Rijs, KJ (corresponding author), Vrije Univ Amsterdam Med Ctr, EMGO Inst Hlth & Care Res, Dept Epidemiol & Biostat, Amsterdam, Netherlands.	kellyrijs@gmail.com	Rijs, Kelly/M-2191-2019		Dutch Ministry of Health, Welfare and Sport; Netherlands Organisation for Scientific Research (NWO), as part of the National Initiative Brain and Cognition (NIHC); Economic Structure Enhancing Fund (Fonds Economische Structuurversterking; Dutch acronym: FES)	Dutch Ministry of Health, Welfare and Sport; Netherlands Organisation for Scientific Research (NWO), as part of the National Initiative Brain and Cognition (NIHC)(Netherlands Organization for Scientific Research (NWO)); Economic Structure Enhancing Fund (Fonds Economische Structuurversterking; Dutch acronym: FES)	This study is based on data from the Longitudinal Aging Study Amsterdam, which is funded largely by the Dutch Ministry of Health, Welfare and Sport. Research performed in the current study is additionally supported with a grant from The Netherlands Organisation for Scientific Research (NWO), as part of the National Initiative Brain and Cognition (NIHC) and the Economic Structure Enhancing Fund (Fonds Economische Structuurversterking; Dutch acronym: FES). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarts S, 2011, INT PSYCHOGERIATR, V23, P616, DOI 10.1017/S1041610210002024; Alavinia SM, 2008, INT ARCH OCC ENV HEA, V82, P39, DOI 10.1007/s00420-008-0304-6; Balash Y, 2010, ACTA NEUROL SCAND, V121, P194, DOI 10.1111/j.1600-0404.2009.01159.x; Beekman ATF, 1997, PSYCHOL MED, V27, P231, DOI 10.1017/S0033291796003510; Blekesaune M, 2012, EUR J AGEING, V9, P199, DOI 10.1007/s10433-011-0212-6; Bonde JPE, 2008, OCCUP ENVIRON MED, V65, P438, DOI 10.1136/oem.2007.038430; BONGERS PM, 1993, SCAND J WORK ENV HEA, V19, P297, DOI 10.5271/sjweh.1470; Bosscher RJ, 1998, BEHAV RES THER, V36, P339, DOI 10.1016/S0005-7967(98)00025-4; Brisson C, 2000, J OCCUP ENVIRON MED, V42, P40, DOI 10.1097/00043764-200001000-00011; CBS Statline, DAT MAD AV STAT NETH; Comijs HC, 2002, J AFFECT DISORDERS, V72, P157, DOI 10.1016/S0165-0327(01)00453-0; Derouesne C, 1999, INT J GERIATR PSYCH, V14, P291, DOI 10.1002/(SICI)1099-1166(199904)14:4<291::AID-GPS902>3.3.CO;2-Z; Dik MG, 2001, NEUROLOGY, V57, P2217, DOI 10.1212/WNL.57.12.2217; Dufouil C, 2005, J AM GERIATR SOC, V53, P616, DOI 10.1111/j.1532-5415.2005.53209.x; Geerlings MI, 1999, AM J PSYCHIAT, V156, P531; Gelissen J, 2006, SOC SCI RES, V35, P702, DOI 10.1016/j.ssresearch.2005.06.005; Handel M.J., 2012, OECD SOCIAL EMPLOYME, V143; Huisman M, 2011, INT J EPIDEMIOL, V40, P868, DOI 10.1093/ije/dyq219; Ilmarinen JE, 2001, OCCUP ENVIRON MED, V58, P546, DOI 10.1136/oem.58.8.546; JOHNSON JV, 1988, AM J PUBLIC HEALTH, V78, P1336, DOI 10.2105/AJPH.78.10.1336; Jorm AF, 2004, PSYCHOL MED, V34, P1495, DOI 10.1017/S0033291704003162; Judge TA, 1999, PERS PSYCHOL, V52, P621, DOI 10.1111/j.1744-6570.1999.tb00174.x; Judge TA, 2002, J APPL PSYCHOL, V87, P530, DOI 10.1037//0021-9010.87.3.530; Karasek R, 1990, HLTH WORK STRESS PRO; Kivimaki M, 2012, LANCET, V380, P1491, DOI 10.1016/S0140-6736(12)60994-5; Klein Hesselink DJ, 2012, WAT ZIJN MOGELIJKE O; Kompier M, 2005, SCAND J WORK ENV HEA, V31, P405, DOI 10.5271/sjweh.946; Kriegsman DMW, 1996, J CLIN EPIDEMIOL, V49, P1407, DOI 10.1016/S0895-4356(96)00274-0; Le H, 2011, J APPL PSYCHOL, V96, P113, DOI 10.1037/a0021016; Luteijn F, 1975, HANDELIDING BIJ NPV; Metternich B, 2010, PSYCHOTHER PSYCHOSOM, V79, P6, DOI 10.1159/000254901; Mol MEM, 2009, AGING MENT HEALTH, V13, P699, DOI 10.1080/13607860902845541; Netterstrom B, 2008, EPIDEMIOL REV, V30, P118, DOI 10.1093/epirev/mxn004; Olesen SC, 2012, SOC PSYCH PSYCH EPID, V47, P735, DOI 10.1007/s00127-011-0375-7; Paradise MB, 2011, BMC PSYCHIATRY, V11, DOI 10.1186/1471-244X-11-108; PEARLIN LI, 1978, J HEALTH SOC BEHAV, V19, P2, DOI 10.2307/2136319; Ponds RWHM, 1997, INT J AGING HUM DEV, V45, P207, DOI 10.2190/MVQ1-WB58-875H-Y4X0; Potter Guy G, 2009, Anxiety Stress Coping, V22, P475, DOI 10.1080/10615800802449610; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Rey A, 1964, LEXAMEN CLINIQUE PSY; Rijs KJ, 2014, ANN OCCUP HYG, V58, P152, DOI 10.1093/annhyg/met052; Rijs KJ, 2013, EUR J PUBLIC HEALTH, V23, P1013, DOI 10.1093/eurpub/cks159; SHERER M, 1982, PSYCHOL REP, V51, P663, DOI 10.2466/pr0.1982.51.2.663; Sixma H, 1983, SISWO PUBLICATION, V291, P91; Stenfors CUD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060637; Stenfors CUD, 2014, BMC PSYCHOL, V2, P1; Valset K, 2007, SCAND J PUBLIC HEALT, V35, P157, DOI 10.1080/14034940600984635; Van Dalen H, 2013, WAAROM LEIDINGGEVEN; van den Berg T, 2010, OCCUP ENVIRON MED, V67, P845, DOI 10.1136/oem.2009.051730; Vestergren P, 2011, APPL COGNITIVE PSYCH, V25, P641, DOI 10.1002/acp.1734	50	8	9	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2015	10	3							e0119192	10.1371/journal.pone.0119192	http://dx.doi.org/10.1371/journal.pone.0119192			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CC9KG	25742133	Green Published, gold, Green Submitted			2022-12-27	WOS:000350688100089
J	Zhou, YJ; Shan, G; Sodergren, E; Weinstock, G; Walker, WA; Gregory, KE				Zhou, Yanjiao; Shan, Gururaj; Sodergren, Erica; Weinstock, George; Walker, W. Allan; Gregory, Katherine E.			Longitudinal Analysis of the Premature Infant Intestinal Microbiome Prior to Necrotizing Enterocolitis: A Case-Control Study	PLOS ONE			English	Article							EXTREMELY PRETERM INFANTS; GUT MICROBIOME; COLONIZATION; PATHOGENESIS; INFLAMMATION; OUTCOMES; TIME; DIET	Necrotizing enterocolitis (NEC) is an inflammatory disease of the newborn bowel, primarily affecting premature infants. Early intestinal colonization has been implicated in the pathogenesis of NEC. The objective of this prospective case-control study was to evaluate differences in the intestinal microbiota between infants who developed NEC and unaffected controls prior to disease onset. We conducted longitudinal analysis of the 16S rRNA genes of 312 samples obtained from 12 NEC cases and 26 age-matched controls with a median frequency of 7 samples per subject and median sampling interval of 3 days. We found that the microbiome undergoes dynamic development during the first two months of life with day of life being the major factor contributing to the colonization process. Depending on when the infant was diagnosed with NEC (i.e. early vs. late onset), the pattern of microbial progression was different for cases and controls. The difference in the microbiota was most overt in early onset NEC cases and controls. In proximity to NEC onset, the abundances of Clostridium sensu stricto from Clostridia class were significantly higher in early onset NEC subjects comparing to controls. In late onset NEC, Escherichia/Shigella among Gammaproteobacteria, showed an increasing pattern prior to disease onset, and was significantly higher in cases than controls six days before NEC onset. Cronobacter from Gammaproteobacteria was also significantly higher in late onset NEC cases than controls 1-3 days prior to NEC onset. Thus, the specific infectious agent associated with NEC may vary by the age of infant at disease onset. We found that intravenously administered antibiotics may have an impact on the microbial diversity present in fecal material. Longitudinal analysis at multiple time points was an important strategy utilized in this study, allowing us to appreciate the dynamics of the premature infant intestinal microbiome while approaching NEC at various points.	[Zhou, Yanjiao] Washington Univ, Genome Inst, St Louis, MO USA; [Zhou, Yanjiao] Washington Univ, Sch Med, Dept Pediat, St Louis, MO USA; [Shan, Gururaj] Rowan Univ, Cooper Med Sch, Camden, NJ USA; [Sodergren, Erica; Weinstock, George] Jackson Lab Genom Med, Farmington, CT USA; [Walker, W. Allan] Massachusetts Gen Hosp Children, Mucosal Immunol & Biol Res Ctr, Dept Pediat, Boston, MA USA; [Gregory, Katherine E.] Brigham & Womens Hosp, Dept Newborn Med, Boston, MA 02115 USA; [Gregory, Katherine E.] Brigham & Womens Hosp, Dept Nursing, Boston, MA 02115 USA; [Walker, W. Allan; Gregory, Katherine E.] Harvard Univ, Sch Med, Boston, MA USA	Washington University (WUSTL); Washington University (WUSTL); Rowan University; Cooper Medical School of Rowan University; Jackson Laboratory; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Gregory, KE (corresponding author), Brigham & Womens Hosp, Dept Newborn Med, 75 Francis St, Boston, MA 02115 USA.	kgregory1@partners.org	Weinstock, George M/C-6314-2013	Weinstock, George M/0000-0002-2997-4592; Gregory, Katherine/0000-0002-0610-5386	pilot feasibility grant from the Harvard Catalyst \ The Harvard Clinical and Translational Science Center (National Center for Research Resources); pilot feasibility grant from the Harvard Catalyst \ The Harvard Clinical and Translational Science Center (National Center for Advancing Translational Sciences, National Institutes of Health) [UL1 TR001102]; Harvard University; National Institutes of Health [K23 NR011320, R01 HD012437, P01 DK003506, R01 HD005126, P30 DK040561]; National Institutes of Health Common Fund [U54HG004968]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD012437] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001102] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG004968] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK040561, P01DK033506] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NURSING RESEARCH [K23NR011320] Funding Source: NIH RePORTER	pilot feasibility grant from the Harvard Catalyst \ The Harvard Clinical and Translational Science Center (National Center for Research Resources); pilot feasibility grant from the Harvard Catalyst \ The Harvard Clinical and Translational Science Center (National Center for Advancing Translational Sciences, National Institutes of Health); Harvard University; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health Common Fund(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NURSING RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR))	This work was conducted with support from a pilot feasibility grant from the Harvard Catalyst vertical bar The Harvard Clinical and Translational Science Center (National Center for Research Resources and the National Center for Advancing Translational Sciences, National Institutes of Health Award UL1 TR001102) and financial contributions from Harvard University and its affiliated academic healthcare centers to KEG and WAW; National Institutes of Health K23 NR011320 to KEG; National Institutes of Health Common Fund U54HG004968 to YZ, ES, and GW; National Institutes of Health R01 HD012437, P01 DK003506, R01 HD005126, P30 DK040561 to WAW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ardeshir A, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008791; Bates D, 2012, LME4 LINEAR MIXED EF; Claud EC, 2013, MICROBIOME, V1, DOI 10.1186/2049-2618-1-20; COLLINS MD, 1994, INT J SYST BACTERIOL, V44, P812, DOI 10.1099/00207713-44-4-812; Costello EK, 2013, MBIO, V4, DOI 10.1128/mBio.00782-13; De la Cochetiere MF, 2004, PEDIATR RES, V56, P366, DOI 10.1203/01.PDR.0000134251.45878.D5; Elahi S, 2013, NATURE, V504, P158, DOI 10.1038/nature12675; Perez-Cobas AE, 2013, GUT, V62, P1591, DOI 10.1136/gutjnl-2012-303184; Emami CN, 2012, J SURG RES, V172, P18, DOI 10.1016/j.jss.2011.04.019; Goodrich JK, 2014, CELL, V158, P250, DOI 10.1016/j.cell.2014.06.037; Gordon PV, 2007, J PERINATOL, V27, P661, DOI 10.1038/sj.jp.7211782; Grishin A, 2013, SEMIN PEDIATR SURG, V22, P69, DOI 10.1053/j.sempedsurg.2013.01.002; Haas BJ, 2011, GENOME RES, V21, P494, DOI 10.1101/gr.112730.110; Hallstrom M, 2004, EUR J CLIN MICROBIOL, V23, P463, DOI 10.1007/s10096-004-1146-0; Holman RC, 2006, PAEDIATR PERINAT EP, V20, P498, DOI 10.1111/j.1365-3016.2006.00756.x; Hunter CJ, 2008, J INFECT DIS, V198, P586, DOI 10.1086/590186; Jenke AC, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/150372; La Rosa PS, 2014, P NATL ACAD SCI USA, V111, P12522, DOI 10.1073/pnas.1409497111; Madan JC, 2012, ARCH DIS CHILD-FETAL, V97, pF456, DOI 10.1136/fetalneonatal-2011-301373; Mai V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052876; Mai V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020647; Methe BA, 2012, NATURE, V486, P215, DOI 10.1038/nature11209; Morowitz MJ, 2011, P NATL ACAD SCI USA, V108, P1128, DOI 10.1073/pnas.1010992108; Morrow AL, 2013, MICROBIOME, V1, DOI 10.1186/2049-2618-1-13; Mshvildadze M, 2010, J PEDIATR-US, V156, P20, DOI 10.1016/j.jpeds.2009.06.063; Nanthakumar NN, 2000, P NATL ACAD SCI USA, V97, P6043, DOI 10.1073/pnas.97.11.6043; Neu J, 2011, NEW ENGL J MED, V364, P255, DOI 10.1056/NEJMra1005408; Normann E, 2013, ACTA PAEDIATR, V102, P129, DOI 10.1111/apa.12059; O'Sulliyan A, 2013, J PROTEOME RES, V12, P2833, DOI 10.1021/pr4001702; Oksanen J., 2020, VEGAN COMMUNITY ECOL; Palmer C, 2007, PLOS BIOL, V5, P1556, DOI 10.1371/journal.pbio.0050177; Sharon I, 2013, GENOME RES, V23, P111, DOI 10.1101/gr.142315.112; Stoll BJ, 2010, PEDIATRICS, V126, P443, DOI 10.1542/peds.2009-2959; Sullivan S, 2010, J PEDIATR-US, V156, P562, DOI 10.1016/j.jpeds.2009.10.040; Torrazza RM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083304; Wadhawan R, 2014, J PERINATOL, V34, P64, DOI 10.1038/jp.2013.128; WALSH MC, 1986, PEDIATR CLIN N AM, V33, P179, DOI 10.1016/s0031-3955(16)34975-6; Wang YW, 2009, ISME J, V3, P944, DOI 10.1038/ismej.2009.37; Weng MQ, 2014, AM J PHYSIOL-GASTR L, V306, pG779, DOI 10.1152/ajpgi.00183.2013; White JR, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000352; Yatsunenko T, 2012, NATURE, V486, P222, DOI 10.1038/nature11053; Zhou Y, 2013, J OPTIMIZ THEORY APP, V156, P1, DOI 10.1007/s10957-013-0271-2	42	106	112	2	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2015	10	3							e0118632	10.1371/journal.pone.0118632	http://dx.doi.org/10.1371/journal.pone.0118632			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9KG	25741698	Green Published, Green Submitted, gold			2022-12-27	WOS:000350688100024
J	Dun, XP; Parkinson, DB				Dun, Xin-peng; Parkinson, David B.			Visualizing Peripheral Nerve Regeneration by Whole Mount Staining	PLOS ONE			English	Article							SCHWANN-CELL PROLIFERATION; WALLERIAN DEGENERATION; INJURED NERVES; MOUSE; AXON; REPAIR; MACROPHAGES; REGROWTH; PAIN	Peripheral nerve trauma triggers a well characterised sequence of events both proximal and distal to the site of injury. Axons distal to the injury degenerate, Schwann cells convert to a repair supportive phenotype and macrophages enter the nerve to clear myelin and axonal debris. Following these events, axons must regrow through the distal part of the nerve, re-innervate and finally are re-myelinated by Schwann cells. For nerve crush injuries (axonotmesis), in which the integrity of the nerve is maintained, repair may be relatively effective whereas for nerve transection (neurotmesis) repair will likely be very poor as few axons may be able to cross between the two parts of the severed nerve, across the newly generated nerve bridge, to enter the distal stump and regenerate. Analysing axon growth and the cell-cell interactions that occur following both nerve crush and cut injuries has largely been carried out by staining sections of nerve tissue, but this has the obvious disadvantage that it is not possible to follow the paths of regenerating axons in three dimensions within the nerve trunk or nerve bridge. To try and solve this problem, we describe the development and use of a novel whole mount staining protocol that allows the analysis of axonal regeneration, Schwann cell-axon interaction and re-vascularisation of the repairing nerve following nerve cut and crush injuries.	[Dun, Xin-peng; Parkinson, David B.] Univ Plymouth, Peninsula Sch Med & Dent, Plymouth PL4 8AA, Devon, England; [Dun, Xin-peng] Hubei Univ Sci & Technol, Xian Ning City, Hubei, Peoples R China	University of Plymouth; Hubei University of Science & Technology	Dun, XP (corresponding author), Univ Plymouth, Peninsula Sch Med & Dent, Plymouth PL4 8AA, Devon, England.	xin-peng.dun@plymouth.ac.uk		Dun, Xin-peng/0000-0003-2837-4672	UK Medical Research Council [MR/J012785/1]; National Natural Science Foundation of China [81371353]; MRC [MR/J012785/1] Funding Source: UKRI; Medical Research Council [MR/J012785/1] Funding Source: researchfish	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by the UK Medical Research Council (MR/J012785/1, http://www.mrc.ac.uk) and the National Natural Science Foundation of China (81371353, http://www.nsfc.gov.cn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe N, 2010, J BIOL CHEM, V285, P28034, DOI 10.1074/jbc.M110.125336; Allodi I, 2012, PROG NEUROBIOL, V98, P16, DOI 10.1016/j.pneurobio.2012.05.005; Arthur-Farraj PJ, 2012, NEURON, V75, P633, DOI 10.1016/j.neuron.2012.06.021; Bruck W, 1997, BRAIN PATHOL, V7, P741, DOI 10.1111/j.1750-3639.1997.tb01060.x; BRUSHART TM, 1980, SCIENCE, V208, P603, DOI 10.1126/science.7367884; CHEN S, 1993, J COMP NEUROL, V333, P449, DOI 10.1002/cne.903330310; Chen YY, 2005, J NEUROPATH EXP NEUR, V64, P613, DOI 10.1097/01.jnen.0000171650.94341.46; Erturk A, 2012, NAT PROTOC, V7, P1983, DOI 10.1038/nprot.2012.119; FAWCETT JW, 1990, ANNU REV NEUROSCI, V13, P43, DOI 10.1146/annurev.neuro.13.1.43; Feng GP, 2000, NEURON, V28, P41, DOI 10.1016/S0896-6273(00)00084-2; Hama H, 2011, NAT NEUROSCI, V14, P1481, DOI 10.1038/nn.2928; Hayashi A, 2007, EXP NEUROL, V207, P128, DOI 10.1016/j.expneurol.2007.06.004; Kiguchi N, 2014, J NEUROCHEM, V129, P169, DOI 10.1111/jnc.12614; KLYMKOWSKY MW, 1991, METHOD CELL BIOL, V36, P419; Lau J, 2011, MOL PAIN, V7, DOI 10.1186/1744-8069-7-100; Levy D, 2001, J NEUROPATH EXP NEUR, V60, P411, DOI 10.1093/jnen/60.5.411; Martini R, 2008, GLIA, V56, P1566, DOI 10.1002/glia.20766; Mcdonald D, 2006, NEURON GLIA BIOL, V2, P139, DOI 10.1017/S1740925X05000347; Nguyen QT, 2002, NAT NEUROSCI, V5, P861, DOI 10.1038/nn905; Painter MW, 2014, NEURON, V83, P331, DOI 10.1016/j.neuron.2014.06.016; Parrinello S, 2010, CELL, V143, P145, DOI 10.1016/j.cell.2010.08.039; Rong LL, 2004, FASEB J, V18, P1812, DOI 10.1096/fj.04-1899com; Stoll G, 2002, J PERIPHER NERV SYST, V7, P13, DOI 10.1046/j.1529-8027.2002.02002.x; Triolo D, 2006, J CELL SCI, V119, P3981, DOI 10.1242/jcs.03168; Vargas ME, 2007, ANNU REV NEUROSCI, V30, P153, DOI 10.1146/annurev.neuro.30.051606.094354; Witzel C, 2005, J COMP NEUROL, V485, P183, DOI 10.1002/cne.20436; Yang DP, 2008, MOL CELL NEUROSCI, V38, P80, DOI 10.1016/j.mcn.2008.01.017; Zochodne DW, 2012, J PERIPHER NERV SYST, V17, P1, DOI 10.1111/j.1529-8027.2012.00378.x; Zochodne DW, 1997, J ANAT, V191, P23, DOI 10.1046/j.1469-7580.1997.19110023.x	29	39	42	3	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2015	10	3							e0119168	10.1371/journal.pone.0119168	http://dx.doi.org/10.1371/journal.pone.0119168			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9JM	25738874	Green Submitted, gold, Green Published			2022-12-27	WOS:000350685900096
J	Dupuis-Maurin, V; Brinza, L; Baguet, J; Plantamura, E; Schicklin, S; Chambion, S; Macari, C; Tomkowiak, M; Deniaud, E; Leverrier, Y; Marvel, J; Michallet, MC				Dupuis-Maurin, Valeryane; Brinza, Lilia; Baguet, Joel; Plantamura, Emilie; Schicklin, Stephane; Chambion, Solene; Macari, Claire; Tomkowiak, Martine; Deniaud, Emmanuelle; Leverrier, Yann; Marvel, Jacqueline; Michallet, Marie-Cecile			Overexpression of the Transcription Factor Sp1 Activates the OAS-RNAse L-RIG-I Pathway	PLOS ONE			English	Article							UNFOLDED-PROTEIN RESPONSE; DNA-BINDING; CELL-GROWTH; ER STRESS; SELF-RNA; APOPTOSIS; PHOSPHORYLATION; EXPRESSION; DIFFERENTIATION; RECOGNITION	Deregulated expression of oncogenes or transcription factors such as specificity protein 1 (Sp1) is observed in many human cancers and plays a role in tumor maintenance. Paradoxically in untransformed cells, Sp1 overexpression induces late apoptosis but the early intrinsic response is poorly characterized. In the present work, we studied increased Sp1 level consequences in untransformed cells and showed that it turns on an early innate immune transcriptome. Sp1 overexpression does not activate known cellular stress pathways such as DNA damage response or endoplasmic reticulum stress, but induces the activation of the OAS-RNase L pathway and the generation of small self-RNAs, leading to the upregulation of genes of the antiviral RIG-I pathway at the transcriptional and translational levels. Finally, Sp1-induced intrinsic innate immune response leads to the production of the chemokine CXCL4 and to the recruitment of inflammatory cells in vitro and in vivo. Altogether our results showed that increased Sp1 level in untransformed cells constitutes a novel danger signal sensed by the OAS-RNase L axis leading to the activation of the RIG-I pathway. These results suggested that the OAS-RNase L-RIG-I pathway may be activated in sterile condition in absence of pathogen.	[Dupuis-Maurin, Valeryane; Brinza, Lilia; Baguet, Joel; Plantamura, Emilie; Schicklin, Stephane; Chambion, Solene; Macari, Claire; Tomkowiak, Martine; Deniaud, Emmanuelle; Leverrier, Yann; Marvel, Jacqueline; Michallet, Marie-Cecile] Univ Lyon 1, ENS Lyon, CNRS, Ctr Int Rech Infectiol,INSERM U111,UMR5308, F-69365 Lyon, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Ecole Normale Superieure de Lyon (ENS de LYON); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Claude Bernard Lyon 1	Marvel, J (corresponding author), Univ Lyon 1, ENS Lyon, CNRS, Ctr Int Rech Infectiol,INSERM U111,UMR5308, F-69365 Lyon, France.	jacqueline.marvel@inserm.fr; marie-cecile.michallet@inserm.fr	marvel, jacqueline/H-8638-2014; LEVERRIER, Yann/M-3767-2014	marvel, jacqueline/0000-0001-6241-459X; LEVERRIER, Yann/0000-0002-4227-5446	Institut National de la Sante et de la Recherche Medicale, Universite de Lyon I; Association pour la Recherche contre le Cancer; Ligue Regionale de Lutte contre le Cancer - Departement du Rhone; Fonds Europeen de Developpement Regional; Finovi foundation; association "Pense a Moelle"; association "Moelle Partage et Vie"	Institut National de la Sante et de la Recherche Medicale, Universite de Lyon I; Association pour la Recherche contre le Cancer(Fondation ARC pour la Recherche sur le Cancer); Ligue Regionale de Lutte contre le Cancer - Departement du Rhone; Fonds Europeen de Developpement Regional; Finovi foundation; association "Pense a Moelle"; association "Moelle Partage et Vie"	This work was supported by Institut National de la Sante et de la Recherche Medicale, Universite de Lyon I, Association pour la Recherche contre le Cancer, Ligue Regionale de Lutte contre le Cancer - Departement du Rhone, Fonds Europeen de Developpement Regional, Finovi foundation and associations "Pense a Moelle" and "Moelle Partage et Vie". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta JC, 2008, CELL, V133, P1006, DOI 10.1016/j.cell.2008.03.038; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bertolotti A, 2000, NAT CELL BIOL, V2, P326, DOI 10.1038/35014014; Besch R, 2009, J CLIN INVEST, V119, P2399, DOI 10.1172/JCI37155; Bin LH, 2011, J ALLERGY CLIN IMMUN, V127, P430, DOI 10.1016/j.jaci.2010.11.013; Black AR, 2001, J CELL PHYSIOL, V188, P143, DOI 10.1002/jcp.1111; BRIGGS MR, 1986, SCIENCE, V234, P47, DOI 10.1126/science.3529394; Cawley S, 2004, CELL, V116, P499, DOI 10.1016/S0092-8674(04)00127-8; Chuang JY, 2009, INT J CANCER, V125, P2066, DOI 10.1002/ijc.24563; Deniaud E, 2006, ONCOGENE, V25, P7096, DOI 10.1038/sj.onc.1209696; Deniaud E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007035; Gasser S, 2005, NATURE, V436, P1186, DOI 10.1038/nature03884; Gonzalez-Navajas JM, 2012, NAT REV IMMUNOL, V12, P125, DOI 10.1038/nri3133; Guan K, 2013, MOL CELL BIOL, V33, P3137, DOI 10.1128/MCB.00030-13; He SH, 2005, MOL BIOL CELL, V16, P4073, DOI 10.1091/mbc.e05-05-0388; Hou FJ, 2011, CELL, V146, P448, DOI 10.1016/j.cell.2011.06.041; Hsu TI, 2012, ONCOGENE, V31, P3973, DOI 10.1038/onc.2011.568; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Iwahori S, 2008, CELL SIGNAL, V20, P1795, DOI 10.1016/j.cellsig.2008.06.007; Iwakoshi NN, 2003, NAT IMMUNOL, V4, P321, DOI 10.1038/ni907; Iwasaki A, 2004, NAT IMMUNOL, V5, P987, DOI 10.1038/ni1112; KADONAGA JT, 1987, CELL, V51, P1079, DOI 10.1016/0092-8674(87)90594-0; KADONAGA JT, 1988, SCIENCE, V242, P1566, DOI 10.1126/science.3059495; Kato H, 2006, NATURE, V441, P101, DOI 10.1038/nature04734; Kato H, 2008, J EXP MED, V205, P1601, DOI 10.1084/jem.20080091; Kato H, 2011, IMMUNOL REV, V243, P91, DOI 10.1111/j.1600-065X.2011.01052.x; Kavurma MM, 2001, J BIOL CHEM, V276, P4964, DOI 10.1074/jbc.M009251200; Kristiansen H, 2011, J INTERF CYTOK RES, V31, P41, DOI 10.1089/jir.2010.0107; Kuilman T, 2008, CELL, V133, P1019, DOI 10.1016/j.cell.2008.03.039; Kuo LJ, 2008, IN VIVO, V22, P305; Leverrier Y, 1997, ONCOGENE, V14, P425, DOI 10.1038/sj.onc.1200845; Liu F, 2011, NAT CELL BIOL, V13, P254, DOI 10.1038/ncb2167; Lou Z, 2005, CANCER RES, V65, P1007; Malathi K, 2007, NATURE, V448, P816, DOI 10.1038/nature06042; Marin M, 1997, CELL, V89, P619, DOI 10.1016/S0092-8674(00)80243-3; McCartney SA, 2009, IMMUNOL REV, V227, P87, DOI 10.1111/j.1600-065X.2008.00726.x; Meylan E, 2005, NATURE, V437, P1167, DOI 10.1038/nature04193; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Moustakas A, 1998, P NATL ACAD SCI USA, V95, P6733, DOI 10.1073/pnas.95.12.6733; Nichols AF, 2003, NUCLEIC ACIDS RES, V31, P562, DOI 10.1093/nar/gkg152; Rajcani J, 2004, VIRUS GENES, V28, P293, DOI 10.1023/B:VIRU.0000025777.62826.92; Ramos HJ, 2011, CURR OPIN VIROL, V1, P167, DOI 10.1016/j.coviro.2011.04.004; Reimand J, 2007, NUCLEIC ACIDS RES, V35, pW193, DOI 10.1093/nar/gkm226; Reimand J, 2011, NUCLEIC ACIDS RES, V39, pW307, DOI 10.1093/nar/gkr378; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sui SJH, 2005, NUCLEIC ACIDS RES, V33, P3154, DOI 10.1093/nar/gki624; SUNE C, 1995, J VIROL, V69, P6572; Tan NY, 2009, MOL CELL BIOL, V29, P2483, DOI 10.1128/MCB.01828-08; Thome M, 1998, CURR BIOL, V8, P885, DOI 10.1016/S0960-9822(07)00352-1; Wang LW, 2003, CLIN CANCER RES, V9, P6371; Wang YT, 2008, J MOL BIOL, V380, P869, DOI 10.1016/j.jmb.2008.05.043; Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0; Yu CY, 2010, J VIROL, V84, P2421, DOI 10.1128/JVI.02174-09	54	14	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2015	10	3							e0118551	10.1371/journal.pone.0118551	http://dx.doi.org/10.1371/journal.pone.0118551			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9JM	25738304	Green Published, gold, Green Submitted			2022-12-27	WOS:000350685900046
J	Ji, FT; Zhu, Y				Ji, Feiteng; Zhu, Yan			A Novel Assay Reveals Hygrotactic Behavior in Drosophila	PLOS ONE			English	Article							MUSHROOM BODY; THERMORECEPTIVE SENSILLUM; RECEPTOR NEURONS; MAP; TASTE; REPRESENTATIONS; HYGROSENSATION; IDENTIFICATION; OSMOSENSATION; MECHANISMS	Humidity is one of the most important factors that determines the geographical distribution and survival of terrestrial animals. The ability to detect variation in humidity is conserved across many species. Here, we established a novel behavioral assay that revealed the thirsty Drosophila exhibits strong hygrotactic behavior, and it can locate water by detecting humidity gradient. In addition, exposure to high levels of moisture was sufficient to elicit proboscis extension reflex behavior in thirsty flies. Furthermore, we found that the third antennal segment was necessary for hygrotactic behavior in thirsty flies, while arista was required for the avoidance of moist air in hydrated flies. These results indicated that two types of hygroreceptor cells exist in Drosophila: one located in the third antennal segment that mediates hygrotactic behavior in thirst status, and the other located in arista which is responsible for the aversive behavior toward moist air in hydration status. Using a neural silencing screen, we demonstrated that synaptic output from the mushroom body alpha/beta surface and posterior neurons was required for both hygrotactic behavior and moisture-aversive behavior.	[Ji, Feiteng; Zhu, Yan] Chinese Acad Sci, Inst Biophys, State Key Lab Brain & Cognit Sci, Beijing 100080, Peoples R China; [Ji, Feiteng] Univ Chinese Acad Sci, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Biophysics, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Zhu, Y (corresponding author), Chinese Acad Sci, Inst Biophys, State Key Lab Brain & Cognit Sci, Beijing 100080, Peoples R China.	zhuyan@ibp.ac.cn			National Basic Research Program of China [2012CB825504]; National Natural Sciences Foundation of China [91232720, 31070925]; Bureau of International Cooperation; Chinese Academy of Sciences [GJHZ201302]; 100-Talents Program of the Chinese Academy of Sciences	National Basic Research Program of China(National Basic Research Program of China); National Natural Sciences Foundation of China(National Natural Science Foundation of China (NSFC)); Bureau of International Cooperation; Chinese Academy of Sciences(Chinese Academy of Sciences); 100-Talents Program of the Chinese Academy of Sciences(Chinese Academy of Sciences)	National Basic Research Program of China (2012CB825504), the National Natural Sciences Foundation of China (91232720 and 31070925), Bureau of International Cooperation, the Chinese Academy of Sciences (GJHZ201302), and 100-Talents Program of the Chinese Academy of Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTNER H, 1977, CELL TISSUE RES, V176, P389, DOI 10.1007/BF00221796; Aso Y, 2009, J NEUROGENET, V23, P156, DOI 10.1080/01677060802471718; BARZEEV M, 1967, NATURE, V213, P737, DOI 10.1038/213737b0; Bourque CW, 2008, NAT REV NEUROSCI, V9, P519, DOI 10.1038/nrn2400; BRAND AH, 1993, DEVELOPMENT, V118, P401; Cameron P, 2010, NATURE, V465, P91, DOI 10.1038/nature09011; Chen ZJ, 2010, J NEUROSCI, V30, P6247, DOI 10.1523/JNEUROSCI.0627-10.2010; DAVIS RL, 1993, NEURON, V11, P1, DOI 10.1016/0896-6273(93)90266-T; Davis RL, 1996, CURR BIOL, V6, P146, DOI 10.1016/S0960-9822(02)00447-5; DEBELLE JS, 1995, NEURON, V15, P245; FISCHER JA, 1988, NATURE, V332, P853, DOI 10.1038/332853a0; Inoshita T, 2006, P NATL ACAD SCI USA, V103, P1094, DOI 10.1073/pnas.0502376103; Jefferis GSXE, 2001, NATURE, V414, P204, DOI 10.1038/35102574; Krashes MJ, 2007, NEURON, V53, P103, DOI 10.1016/j.neuron.2006.11.021; Land MF, 1997, ANNU REV ENTOMOL, V42, P147, DOI 10.1146/annurev.ento.42.1.147; Larsson MC, 2004, NEURON, V43, P703, DOI 10.1016/j.neuron.2004.08.019; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; Lin HH, 2007, CELL, V128, P1205, DOI 10.1016/j.cell.2007.03.006; Liu L, 2007, NATURE, V450, P294, DOI 10.1038/nature06223; McGuire SE, 2001, SCIENCE, V293, P1330, DOI 10.1126/science.1062622; Merivee E, 2010, J INSECT PHYSIOL, V56, P1671, DOI 10.1016/j.jinsphys.2010.06.017; Pedersen SF, 2011, J AM SOC NEPHROL, V22, P1587, DOI 10.1681/ASN.2010121284; PERTTUNEN V, 1952, NATURE, V169, P78, DOI 10.1038/169078a0; Piersanti S, 2011, J INSECT PHYSIOL, V57, P1391, DOI 10.1016/j.jinsphys.2011.07.005; Prager-Khoutorsky M, 2010, TRENDS NEUROSCI, V33, P76, DOI 10.1016/j.tins.2009.11.004; Russell J, 2014, P NATL ACAD SCI USA, V111, P8269, DOI 10.1073/pnas.1322512111; Sayeed O, 1996, P NATL ACAD SCI USA, V93, P6079, DOI 10.1073/pnas.93.12.6079; Sharif-Naeini R, 2008, KIDNEY INT, V73, P811, DOI 10.1038/sj.ki.5002788; Stocker RF, 1997, J NEUROBIOL, V32, P443, DOI 10.1002/(SICI)1097-4695(199705)32:5<443::AID-NEU1>3.0.CO;2-5; SWEENEY ST, 1995, NEURON, V14, P341, DOI 10.1016/0896-6273(95)90290-2; Tanaka NK, 2008, J COMP NEUROL, V508, P711, DOI 10.1002/cne.21692; Tichy H, 2010, J NEUROPHYSIOL, V103, P3274, DOI 10.1152/jn.01043.2009; TICHY H, 1979, J COMP PHYSIOL, V132, P149, DOI 10.1007/BF00610718; TOMINAGA Y, 1982, CELL TISSUE RES, V226, P309, DOI 10.1007/BF00218361; Vosshall LB, 2007, ANNU REV NEUROSCI, V30, P505, DOI 10.1146/annurev.neuro.30.051606.094306; Wang JW, 2003, CELL, V112, P271, DOI 10.1016/S0092-8674(03)00004-7; Wang ZR, 2004, CELL, V117, P981, DOI 10.1016/j.cell.2004.06.011; Wong AM, 2002, CELL, V109, P229, DOI 10.1016/S0092-8674(02)00707-9; Yao CA, 2005, J NEUROSCI, V25, P8359, DOI 10.1523/JNEUROSCI.2432-05.2005; YOKOHARI F, 1981, CELL TISSUE RES, V216, P525	40	13	14	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2015	10	3							e0119162	10.1371/journal.pone.0119162	http://dx.doi.org/10.1371/journal.pone.0119162			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9JM	25738801	gold, Green Published			2022-12-27	WOS:000350685900095
J	Korir, G; Prakash, M				Korir, George; Prakash, Manu			Punch Card Programmable Microfluidics	PLOS ONE			English	Article							LARGE-SCALE INTEGRATION; MEAN SHIFT; PAPER; DEVICES; FUTURE; CHIP	Small volume fluid handling in single and multiphase microfluidics provides a promising strategy for efficient bio-chemical assays, low-cost point-of-care diagnostics and new approaches to scientific discoveries. However multiple barriers exist towards low-cost field deployment of programmable microfluidics. Incorporating multiple pumps, mixers and discrete valve based control of nanoliter fluids and droplets in an integrated, programmable manner without additional required external components has remained elusive. Combining the idea of punch card programming with arbitrary fluid control, here we describe a self-contained, hand-crank powered, multiplex and robust programmable microfluidic platform. A paper tape encodes information as a series of punched holes. A mechanical reader/actuator reads these paper tapes and correspondingly executes operations onto a microfluidic chip coupled to the platform in a plug-and-play fashion. Enabled by the complexity of codes that can be represented by a series of holes in punched paper tapes, we demonstrate independent control of 15 on-chip pumps with enhanced mixing, normally-closed valves and a novel on-demand impact-based droplet generator. We demonstrate robustness of operation by encoding a string of characters representing the word "PUNCHCARD MICROFLUIDICS" using the droplet generator. Multiplexing is demonstrated by implementing an example colorimetric water quality assays for pH, ammonia, nitrite and nitrate content in different water samples. With its portable and robust design, low cost and ease-of-use, we envision punch card programmable microfluidics will bring complex control of microfluidic chips into fieldbased applications in low-resource settings and in the hands of children around the world.	[Korir, George; Prakash, Manu] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA	Stanford University	Prakash, M (corresponding author), Stanford Univ, Dept Bioengn, 443 Via Ortega, Stanford, CA 94305 USA.	manup@stanford.edu		Prakash, Manu/0000-0002-8046-8388; Korir, George/0000-0002-5718-6905	C-IDEA grant (National Institutes of Health) [RC4 TW008781-01]; Spectrum Foundation [NIH CTSA UL1 TR000093]; Coulter Foundation; Pew Foundation; Society for Science and the Public (SPARK); Moore Foundation; Howard Hughes Medical Institute International Student Predoctoral Fellowship; Stanford University's Dean's Doctoral Diversity Fellowship; Ric Weiland Fellowship; His-Fong Ho Engineering Graduate Fellowship; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000093] Funding Source: NIH RePORTER	C-IDEA grant (National Institutes of Health); Spectrum Foundation; Coulter Foundation; Pew Foundation; Society for Science and the Public (SPARK); Moore Foundation(Gordon and Betty Moore Foundation); Howard Hughes Medical Institute International Student Predoctoral Fellowship; Stanford University's Dean's Doctoral Diversity Fellowship; Ric Weiland Fellowship; His-Fong Ho Engineering Graduate Fellowship; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	The project was funded by C-IDEA grant (National Institutes of Health grant RC4 TW008781-01). Manu Prakash acknowledges support from Spectrum Foundation (NIH CTSA UL1 TR000093), Coulter Foundation, Pew Foundation, Society for Science and the Public (SPARK) and Moore Foundation. George Korir acknowledges support from Howard Hughes Medical Institute International Student Predoctoral Fellowship, Stanford University's Dean's Doctoral Diversity Fellowship, Ric Weiland Fellowship and the His-Fong Ho Engineering Graduate Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addae-Mensah KA, 2010, LAB CHIP, V10, P1618, DOI 10.1039/c002349c; Araci IE, 2012, LAB CHIP, V12, P2803, DOI 10.1039/c2lc40258k; Berkowski KL, 2005, J CHEM EDUC, V82, P1365, DOI 10.1021/ed082p1365; Bwambok DK, 2014, ANAL CHEM, V86, P7478, DOI 10.1021/ac501206m; Chen DF, 2010, BIOMED MICRODEVICES, V12, P705, DOI 10.1007/s10544-010-9423-4; Cheng CM, 2010, ANGEW CHEM INT EDIT, V49, P4771, DOI 10.1002/anie.201001005; CHENG YZ, 1995, IEEE T PATTERN ANAL, V17, P790, DOI 10.1109/34.400568; Chin CD, 2007, LAB CHIP, V7, P41, DOI 10.1039/b611455e; Comaniciu D, 2002, IEEE T PATTERN ANAL, V24, P603, DOI 10.1109/34.1000236; Cortada JW, 2000, COMPUTER IBM NCR BUR, P44; de Jong J, 2006, PHYS FLUIDS, V18, DOI 10.1063/1.2397015; DeJarnette N. K., 2012, ED J, V133, P77, DOI DOI 10.1007/S10649-005-9002-4; Franke T, 2009, LAB CHIP, V9, P2625, DOI 10.1039/b906819h; FUKUNAGA K, 1975, IEEE T INFORM THEORY, V21, P32, DOI 10.1109/TIT.1975.1055330; Galas JC, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/7/075027; Golberg A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086341; Gu W, 2004, P NATL ACAD SCI USA, V101, P15861, DOI 10.1073/pnas.0404353101; Gunther A, 2006, LAB CHIP, V6, P1487, DOI 10.1039/b609851g; Hemling M, 2014, J CHEM EDUC, V91, P112, DOI 10.1021/ed4003018; Hobsbawm E, 2010, AGE REVOLUTION 1789, P45; Jahanshahi-Anbuhi S, 2014, ANGEW CHEM INT EDIT, V53, P6155, DOI 10.1002/anie.201403222; Li WT, 2012, LAB CHIP, V12, P1587, DOI 10.1039/c2lc40125h; Link DR, 2006, ANGEW CHEM INT EDIT, V45, P2556, DOI 10.1002/anie.200503540; Martinez AW, 2008, ANAL CHEM, V80, P3699, DOI 10.1021/ac800112r; Martinez AW, 2007, ANGEW CHEM INT EDIT, V46, P1318, DOI 10.1002/anie.200603817; Melin J, 2007, ANNU REV BIOPH BIOM, V36, P213, DOI 10.1146/annurev.biophys.36.040306.132646; Park S, 2011, BIOTECHNOL ADV, V29, P830, DOI 10.1016/j.biotechadv.2011.06.017; Pollock NR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075616; Pollock NR, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003981; Shi WW, 2008, LAB CHIP, V8, P1432, DOI 10.1039/b808753a; Sobel R, 2000, T WATSON IBM COMPUTE, P15; Stroock AD, 2002, SCIENCE, V295, P647, DOI 10.1126/science.1066238; SUBRAMANIAN KS, 1995, BIOL TRACE ELEM RES, V49, P187, DOI 10.1007/BF02788968; Thorsen T, 2001, PHYS REV LETT, V86, P4163, DOI 10.1103/PhysRevLett.86.4163; Unger MA, 2000, SCIENCE, V288, P113, DOI 10.1126/science.288.5463.113; Walker GM, 2002, LAB CHIP, V2, P131, DOI 10.1039/b204381e; Whitesides GM, 2006, NATURE, V442, P368, DOI 10.1038/nature05058; Xia YN, 1999, CHEM REV, V99, P1823, DOI 10.1021/cr980002q; Yager P, 2006, NATURE, V442, P412, DOI 10.1038/nature05064; Yetisen AK, 2013, LAB CHIP, V13, P2210, DOI 10.1039/c3lc50169h	40	13	13	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2015	10	3							e0115993	10.1371/journal.pone.0115993	http://dx.doi.org/10.1371/journal.pone.0115993			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9JM	25738834	Green Published, gold, Green Submitted			2022-12-27	WOS:000350685900006
J	Shastri, MD; Stewart, N; Eapen, M; Peterson, GM; Zaidi, STR; Gueven, N; Sohal, SS; Patel, RP				Shastri, Madhur D.; Stewart, Niall; Eapen, Mathew; Peterson, Gregory M.; Zaidi, Syed Tabish R.; Gueven, Nuri; Sohal, Sukhwinder Singh; Patel, Rahul P.			Opposing Effects of Low Molecular Weight Heparins on the Release of Inflammatory Cytokines from Peripheral Blood Mononuclear Cells of Asthmatics	PLOS ONE			English	Article							POTENTIAL THERAPEUTIC APPLICATIONS; INHALED HEPARIN; DOWN-REGULATION; LICHEN-PLANUS; INHIBITION; PROLIFERATION; SEPARATION; ENOXAPARIN; BRONCHOCONSTRICTION; PREVALENCE	Background T-cell-mediated inflammatory cytokines, such as interleukin (IL)-4, IL-5, IL-13 and tumor necrosis factor-alpha (TNF-alpha), play an important role in the initiation and progression of inflammatory airways diseases. Low-molecular-weight heparins (LMWHs), widely used anticoagulants, possess anti-inflammatory properties making them potential treatment options for inflammatory diseases, including asthma. In the current study, we investigated the modulating effects of two LMWHs (enoxaparin and dalteparin) on the release of cytokines from stimulated peripheral blood mononuclear cells (PBMCs) of asthmatic subjects to identify the specific components responsible for the effects. Methods PBMCs from asthmatic subjects (consist of similar to 75% of T-cells) were isolated from blood taken from ten asthmatic subjects. The PBMCs were pre-treated in the presence or absence of different concentrations of LMWHs, and were then stimulated by phytohaemagglutinin for the release of IL-4, IL-5, IL-13 and TNF-alpha. LMWHs were completely or selectively desulfated and their anticoagulant effect, as well as the ability to modulate cytokine release, was determined. LMWHs were chromatographically fractionated and each fraction was tested for molecular weight determination along with an assessment of anticoagulant potency and effect on cytokine release. Results Enoxaparin inhibited cytokine release by more than 48%, whereas dalteparin increased their release by more than 25%. The observed anti-inflammatory effects of enoxaparin were independent of their anticoagulant activities. Smaller fractions, in particular dp4 (four saccharide units), were responsible for the inhibitory effect of enoxaparin. Whereas, the larger fractions, in particular dp22 (twenty two saccharide units), were associated with the stimulatory effect of dalteparin. Conclusion Enoxaparin and dalteparin demonstrated opposing effects on inflammatory markers. These observed effects could be due to the presence of structurally different components in the two LMWHs arising from different methods of depolymerisation. This study provides a platform for further studies investigating the usefulness of enoxaparin in various inflammatory diseases.	[Shastri, Madhur D.; Stewart, Niall; Peterson, Gregory M.; Zaidi, Syed Tabish R.; Gueven, Nuri; Patel, Rahul P.] Univ Tasmania, Fac Hlth, Div Pharm, Sch Med, Hobart, Tas, Australia; [Eapen, Mathew; Peterson, Gregory M.; Sohal, Sukhwinder Singh] Univ Tasmania, Fac Hlth, Sch Med, Breathe Well Ctr Res Excellence Chron Resp Dis &, Hobart, Tas, Australia	University of Tasmania; University of Tasmania	Patel, RP (corresponding author), Univ Tasmania, Fac Hlth, Div Pharm, Sch Med, Hobart, Tas, Australia.	Rahul.Patel@utas.edu.au	Eapen, Mathew/AAB-9444-2021; Zaidi, Syed Tabish R./J-7336-2014	Guven, Nuri/0000-0003-3782-767X; Shastri, Madhur/0000-0002-1012-2779; Zaidi, Syed Tabish R./0000-0002-2031-1055; Patel, Rahul/0000-0001-9344-1013; Sohal, Sukhwinder Singh/0000-0001-9627-6498; Peterson, Gregory/0000-0002-6764-3882; Eapen, Mathew/0000-0003-0570-7059	Starter Grant from Royal Hobart Hospital Research Foundation, Australia [H22074]; Research Enhancement Grant Schemes from University of Tasmania, Australia [105557]	Starter Grant from Royal Hobart Hospital Research Foundation, Australia; Research Enhancement Grant Schemes from University of Tasmania, Australia	Funding provided by a Starter Grant from Royal Hobart Hospital Research Foundation, Australia (Grant Number- H22074) awarded to RP, NS and SS, http://www.rhhresearchfoundation.org/index.php/site/research/ and a Research Enhancement Grant Schemes from University of Tasmania, Australia (Grant Number- 105557) awarded to RP and NG, http://www.utas.edu.au/research-admin/funding/funding-options/internal-funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed T, 1999, AM J RESP CRIT CARE, V160, P576, DOI 10.1164/ajrccm.160.2.9812076; AHMED T, 1993, NEW ENGL J MED, V329, P90, DOI 10.1056/NEJM199307083290204; Altinbas M, 2004, J THROMB HAEMOST, V2, P1266, DOI 10.1111/j.1538-7836.2004.00871.x; Baniyash M, 2004, NAT REV IMMUNOL, V4, P675, DOI 10.1038/nri1434; Baram D, 1997, CLIN EXP IMMUNOL, V110, P485, DOI 10.1046/j.1365-2249.1997.4541471.x; Barblu L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032874; Barnes PJ, 2008, J CLIN INVEST, V118, P3546, DOI 10.1172/JCI36130; Bloemen K, 2007, IMMUNOL LETT, V113, P6, DOI 10.1016/j.imlet.2007.07.010; BOWLER SD, 1993, AM REV RESPIR DIS, V147, P160, DOI 10.1164/ajrccm/147.1.160; Brown RA, 2006, PULM PHARMACOL THER, V19, P419, DOI 10.1016/j.pupt.2006.04.004; Casu B, 2001, ADV CARBOHYD CHEM BI, V57, P159, DOI 10.1016/S0065-2318(01)57017-1; Casu B., 2005, CHEM BIOL HEPARIN HE, P1, DOI DOI 10.1016/B978-008044859-6/50002-2; CEYHAN B, 1995, CHEST, V107, P1009, DOI 10.1378/chest.107.4.1009; Chen JL, 2012, GASTROENT RES PRACT, V2012, DOI 10.1155/2012/752940; Chwae YJ, 2002, J IMMUNOL, V169, P3726, DOI 10.4049/jimmunol.169.7.3726; Diamant Z, 1996, AM J RESP CRIT CARE, V153, P1790, DOI 10.1164/ajrccm.153.6.8665036; Evans RC, 1997, ALIMENT PHARM THERAP, V11, P1037, DOI 10.1046/j.1365-2036.1997.00252.x; FLINT N, 1994, J CELL SCI, V107, P401; Guerrini Marco, 2012, Handb Exp Pharmacol, P127, DOI 10.1007/978-3-642-23056-1_7; HANKE H, 1992, CIRCULATION, V85, P1548, DOI 10.1161/01.CIR.85.4.1548; HIRSH J, 1991, NEW ENGL J MED, V324, P1565; Hochart H, 2006, BRIT J HAEMATOL, V133, P62, DOI 10.1111/j.1365-2141.2006.05959.x; Hodak E, 1998, J AM ACAD DERMATOL, V38, P564, DOI 10.1016/S0190-9622(98)70118-5; Khorana AA, 2003, ARTERIOSCL THROM VAS, V23, P2110, DOI 10.1161/01.ATV.0000090671.56682.D7; Kidd Parris, 2003, Altern Med Rev, V8, P223; LAM LH, 1976, BIOCHEM BIOPH RES CO, V69, P570, DOI 10.1016/0006-291X(76)90558-1; Lever R, 2002, NAT REV DRUG DISCOV, V1, P140, DOI 10.1038/nrd724; Linhardt R. J., 1991, CHEM IND, V2, P45; Linhardt RJ, 1999, SEMIN THROMB HEMOST, V25, P5; Maurice MM, 1997, J IMMUNOL, V159, P2973; MCLEAN J, 1959, CIRCULATION, V19, P75, DOI 10.1161/01.CIR.19.1.75; Olie RA, 2000, CANCER RES, V60, P2805; Pacheco H, 2001, J DERMATOL TREAT, V12, P123; Papa A, 2000, ALIMENT PHARM THER, V14, P1403, DOI 10.1046/j.1365-2036.2000.00860.x; Patel RP, 2008, J PHARMACEUT BIOMED, V46, P30, DOI 10.1016/j.jpba.2007.10.009; Patel RP, 2009, J PHARM SCI-US, V98, P1118, DOI 10.1002/jps.21483; Patel RP, 2009, J PHARM SCI-US, V98, P1700, DOI 10.1002/jps.21556; Peters SP, 2006, RESP MED, V100, P1139, DOI 10.1016/j.rmed.2006.03.031; Rael EL, 2011, WORLD ALLERGY ORGAN, V4, P54, DOI 10.1097/WOX.0b013e31821188e0; Roy S, 2011, GLYCOBIOLOGY, V21, P1194, DOI 10.1093/glycob/cwr053; Ruiz-Calero V, 2001, ANALYST, V126, P169, DOI 10.1039/b007300h; Shastri MD, 2014, EXPERT OPIN INV DRUG, V23, P357, DOI 10.1517/13543784.2014.866092; Spahn JD, 1996, J IMMUNOL, V157, P2654; TAKAFUJI S, 1991, J IMMUNOL, V147, P3855; Teixeira LK, 2005, MEM I OSWALDO CRUZ, V100, P137, DOI 10.1590/S0074-02762005000900024; Thanawiroon C, 2003, J CHROMATOGR A, V1014, P215, DOI 10.1016/S0021-9673(03)00779-9; To T, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-204; Trifilieff A, 2002, BRIT J PHARMACOL, V135, P1655, DOI 10.1038/sj.bjp.0704616; Tyrrell DJ, 1999, ADV PHARMACOL, V46, P151, DOI 10.1016/S1054-3589(08)60471-8; Vignoli A, 2006, HAEMATOL-HEMATOL J, V91, P207; WEIDMANN E, 1995, ANN HEMATOL, V70, P153, DOI 10.1007/s002770050049; Weitz JI, 1997, NEW ENGL J MED, V337, P688, DOI 10.1056/NEJM199709043371007; Young E, 2008, THROMB RES, V122, P743, DOI 10.1016/j.thromres.2006.10.026	53	20	20	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2015	10	3							e0118798	10.1371/journal.pone.0118798	http://dx.doi.org/10.1371/journal.pone.0118798			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9JM	25738575	gold, Green Published, Green Submitted			2022-12-27	WOS:000350685900075
J	Sumi, A; Akiba, J; Ogasawara, S; Nakayama, M; Nomura, Y; Yasumoto, M; Sanada, S; Nakashima, O; Abe, T; Yano, H				Sumi, Akiko; Akiba, Jun; Ogasawara, Sachiko; Nakayama, Masamichi; Nomura, Yoriko; Yasumoto, Makiko; Sanada, Sakiko; Nakashima, Osamu; Abe, Toshi; Yano, Hirohisa			Des-gamma-Carboxyprothrombin (DCP) and NX-DCP Expressions and Their Relationship with Clinicopathological Features in Hepatocellular Carcinoma	PLOS ONE			English	Article							CARBOXY PROTHROMBIN PRODUCTION; VITAMIN-K-ABSENCE; MICROVASCULAR INVASION; ALPHA-FETOPROTEIN; P-16 ANTIBODIES; TUMOR-MARKERS; SURVIVAL; BIOMARKER; PROGNOSIS; CANCER	Aim Des-gamma-carboxyprothrombin (DCP) has been used as a tumor marker for hepatocellular carcinoma (HCC). Recently the DCP/NX-DCP ratio, calculated by dividing DCP by NX-DCP, has been reported useful in detecting HCC. The purpose of this study is to clarify the significance of DCP and NX-DCP expression in HCC tissues. Methods HCC and non-HCC tissue samples were obtained from 157 patients and were immunohistochemically examined for DCP and NX-DCP expression using anti-DCP antibody and anti-NX-DCP antibody. DCP and NX-DCP expression scores were calculated by multiplying staining intensity grade by percentage of stained area. Serum DCP and NX-DCP levels were determined in 89 patients. We evaluated the relationship between tumor expression, serum level, and pathomorphological findings. Results Intrahepatic metastasis (im) was significantly more frequent in cases with high DCP expression than in cases with low DCP expression. High NX-DCP expression was associated with significantly lower histological grade, and less frequent im or portal vein invasion (vp) than low NX-DCP expression. Serum DCP was correlated with DCP expression, but serum NX-DCP was not correlated with NX-DCP expression. DCP-positive (>= 40 mAU/L), NX-DCP-positive (>= 90 mAU/L), and DCP/NX-DCP ratio-positive (>= 1.5) cases were associated with significantly larger tumor size and more frequent vp than negative cases. DCP was rarely expressed, but NX-DCP was frequently expressed in non-cancerous liver tissues. Patients with NX-DCP expression-negative tumors showed a lower survival rate than those with NX-DCP expression-positive tumors (p = 0.04), whereas the survival in serum NX-DCP-positive cases was lower than that of serum negative cases (p = 0.02). Conclusions DCP and NX-DCP were produced in HCC tissues, but differed in expression level and biological properties. DCP expression, serum DCP or NX-DCP level, and DCP/NX-DCP ratio were closely related to malignant properties of HCC.	[Sumi, Akiko; Akiba, Jun; Ogasawara, Sachiko; Nakayama, Masamichi; Nomura, Yoriko; Yasumoto, Makiko; Sanada, Sakiko; Yano, Hirohisa] Kurume Univ, Sch Med, Dept Pathol, Kurume, Fukuoka 830, Japan; [Sumi, Akiko; Abe, Toshi] Kurume Univ, Sch Med, Dept Radiol, Kurume, Fukuoka 830, Japan; [Nakashima, Osamu] Kurume Univ Hosp, Dept Clin Lab Med, Kurume, Fukuoka, Japan	Kurume University; Kurume University; Kurume University	Sumi, A (corresponding author), Kurume Univ, Sch Med, Dept Pathol, Kurume, Fukuoka 830, Japan.	sumi_akiko@kurume-u.ac.jp						Fujioka M, 2001, HEPATOLOGY, V34, P1128, DOI 10.1053/jhep.2001.29202; Gouw ASH, 2011, LIVER TRANSPLANT, V17, pS72, DOI 10.1002/lt.22368; Hui AM, 2000, J HEPATOL, V33, P975, DOI 10.1016/S0168-8278(00)80131-2; Inagaki Y, 2011, J DIGEST DIS, V12, P481, DOI 10.1111/j.1751-2980.2011.00521.x; Inagaki Y, 2011, LIVER INT, V31, P22, DOI 10.1111/j.1478-3231.2010.02348.x; Japan LCSGo, 2010, GEN RUL CLIN PATH ST; Kudo Masatoshi, 2005, Clin Gastroenterol Hepatol, V3, pS144, DOI 10.1016/S1542-3565(05)00712-3; Matsubara M, 2012, J GASTROEN HEPATOL, V27, P1602, DOI 10.1111/j.1440-1746.2012.07173.x; Miyaaki H, 2007, J GASTROENTEROL, V42, P962, DOI 10.1007/s00535-007-2117-x; Miyahara K, 2013, HEPATOL RES, V43, P1064, DOI 10.1111/hepr.12055; Murata K, 2010, INT J ONCOL, V36, P161, DOI 10.3892/ijo_00000487; Murata K, 2009, INT J ONCOL, V35, P1005, DOI 10.3892/ijo_00000415; Nanashima A, 2013, ANTICANCER RES, V33, P2689; Naraki T, 2002, BBA-MOL BASIS DIS, V1586, P287, DOI 10.1016/S0925-4439(01)00107-7; Poon D, 2009, LANCET ONCOL, V10, P1111, DOI 10.1016/S1470-2045(09)70241-4; Rich N, 2014, BEST PRACT RES CL GA, V28, P843, DOI 10.1016/j.bpg.2014.07.018; Sakamoto N, 2013, J GASTROEN HEPATOL, V28, P755, DOI 10.1111/jgh.12138; Shirabe K, 2011, BRIT J SURG, V98, P261, DOI 10.1002/bjs.7311; Sumie S, 2008, ANN SURG ONCOL, V15, P1375, DOI 10.1245/s10434-008-9846-9; Takeji S, 2013, J GASTROEN HEPATOL, V28, P671, DOI 10.1111/jgh.12076; Tameda M, 2013, CANCER SCI, V104, P725, DOI 10.1111/cas.12149; Tanaka T, 2013, J GASTROEN HEPATOL, V28, P1348, DOI 10.1111/jgh.12166; Tang W, 2005, ONCOL REP, V13, P25; Tang W, 2003, INT J ONCOL, V22, P969; Thompson EW, 2011, NAT MED, V17, P1048, DOI 10.1038/nm.2437; Toyoda H, 2006, CLIN GASTROENTEROL H, V4, P111, DOI 10.1016/S1542-3565(05)00855-4; Toyoda H, 2012, CANCER SCI, V103, P921, DOI 10.1111/j.1349-7006.2012.02232.x; Uehara S, 2005, J GASTROEN HEPATOL, V20, P1545, DOI 10.1111/j.1440-1746.2005.03899.x	28	10	10	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2015	10	3							e0118452	10.1371/journal.pone.0118452	http://dx.doi.org/10.1371/journal.pone.0118452			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9JM	25739032	Green Published, Green Submitted, gold			2022-12-27	WOS:000350685900036
J	Woehrling, EK; Parri, HR; Tse, EHY; Hill, EJ; Maidment, ID; Fox, GC; Coleman, MD				Woehrling, Elizabeth K.; Parri, H. Rheinallt; Tse, Erin H. Y.; Hill, Eric J.; Maidment, Ian D.; Fox, G. Christopher; Coleman, Michael D.			A Predictive In Vitro Model of the Impact of Drugs with Anticholinergic Properties on Human Neuronal and Astrocytic Systems	PLOS ONE			English	Article							MUSCARINIC RECEPTOR SUBTYPES; CENTRAL-NERVOUS-SYSTEM; CELL-LINE; ACETYLCHOLINE-RECEPTORS; ALZHEIMERS-DISEASE; STEADY-STATE; OLDER-ADULTS; HUMAN-BRAIN; RISK SCALE; DIFFERENTIATION	The link between off-target anticholinergic effects of medications and acute cognitive impairment in older adults requires urgent investigation. We aimed to determine whether a relevant in vitro model may aid the identification of anticholinergic responses to drugs and the prediction of anticholinergic risk during polypharmacy. In this preliminary study we employed a co-culture of human-derived neurons and astrocytes (NT2.N/A) derived from the NT2 cell line. NT2.N/A cells possess much of the functionality of mature neurons and astrocytes, key cholinergic phenotypic markers and muscarinic acetylcholine receptors (mAChRs). The cholinergic response of NT2 astrocytes to the mAChR agonist oxotremorine was examined using the fluorescent dye fluo-4 to quantitate increases in intracellular calcium [Ca2+]i. Inhibition of this response by drugs classified as severe (dicycloverine, amitriptyline), moderate (cyclobenzaprine) and possible (cimetidine) on the Anticholinergic Cognitive Burden (ACB) scale, was examined after exposure to individual and pairs of compounds. Individually, dicycloverine had the most significant effect regarding inhibition of the astrocytic cholinergic response to oxotremorine, followed by amitriptyline then cyclobenzaprine and cimetidine, in agreement with the ACB scale. In combination, dicycloverine with cyclobenzaprine had the most significant effect, followed by dicycloverine with amitriptyline. The order of potency of the drugs in combination frequently disagreed with predicted ACB scores derived from summation of the individual drug scores, suggesting current scales may underestimate the effect of polypharmacy. Overall, this NT2.N/A model may be appropriate for further investigation of adverse anticholinergic effects of multiple medications, in order to inform clinical choices of suitable drug use in the elderly.	[Woehrling, Elizabeth K.; Parri, H. Rheinallt; Tse, Erin H. Y.; Coleman, Michael D.] Aston Univ, Sch Life & Hlth Sci, Birmingham B4 7ET, W Midlands, England; [Hill, Eric J.; Maidment, Ian D.] Aston Univ, Aston Res Ctr Hlth Ageing, Birmingham B4 7ET, W Midlands, England; [Fox, G. Christopher] Univ E Anglia, Fac Med & Hlth Sci, Norwich Med Sch, Norwich NR4 7TJ, Norfolk, England	Aston University; Aston University; University of East Anglia	Coleman, MD (corresponding author), Aston Univ, Sch Life & Hlth Sci, Birmingham B4 7ET, W Midlands, England.	m.d.coleman@aston.ac.uk	Coleman, Michael Damian/AAD-5503-2019	Coleman, MIchael D/0000-0002-5510-6852; Hill, Eric/0000-0002-9419-1500; Parri, Rheinallt/0000-0002-1412-2688; Tse, Erin Hsueh Ying/0000-0002-1135-1725; Fox, Chris/0000-0001-9480-5704; Maidment, Ian/0000-0003-4152-9704	British Brain Research Fund, United Kingdom (United Kingdom Registered Charity) [1140361]; British Brain Research Fund, United Kingdom [012013]; Biotechnology and Biological Sciences Research Council [BB/H008527/1] Funding Source: researchfish; BBSRC [BB/H008527/1] Funding Source: UKRI	British Brain Research Fund, United Kingdom (United Kingdom Registered Charity); British Brain Research Fund, United Kingdom; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	Funding provided by British Brain Research Fund, United Kingdom (United Kingdom Registered Charity: 1140361), Grant Number: 012013: www.brainresearchfund.org. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aluigi MG, 2010, CHEM-BIOL INTERACT, V187, P299, DOI 10.1016/j.cbi.2010.03.031; Ancelin ML, 2006, BMJ-BRIT MED J, V332, P455, DOI 10.1136/bmj.38740.439664.DE; ANDREWS PW, 1984, DEV BIOL, V103, P285, DOI 10.1016/0012-1606(84)90316-6; Ballon N, 2001, ENCEPHALE, V27, P373; Bani-Yaghoub M, 1999, NEUROREPORT, V10, P3843, DOI 10.1097/00001756-199912160-00022; Bourgeois J, 2012, DRUG AGING, V29, P759, DOI 10.1007/s40266-012-0003-6; Boustani M., 2008, AGING HLTH, V4, P311, DOI [10.2217/1745509x.4.3.311, DOI 10.2217/1745509X.4.3.311, 10.2217/1745509XA3.311, 10.2217/1745509X.4.3.311]; Campbell N, 2009, CLIN INTERV AGING, V4, P225; Chancellor MB, 2012, DRUG AGING, V29, P259, DOI 10.2165/11597530-000000000-00000; Chapman H, 2007, BRAIN RES, V1129, P15, DOI 10.1016/j.brainres.2006.10.060; Chew ML, 2008, J AM GERIATR SOC, V56, P1333, DOI 10.1111/j.1532-5415.2008.01737.x; Corbel V, 2006, NEUROTOXICOLOGY, V27, P508, DOI 10.1016/j.neuro.2006.01.011; CORTES R, 1986, BRAIN RES, V362, P239, DOI 10.1016/0006-8993(86)90449-X; Coyle DE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016174; Darwish M, 2011, CLIN THER, V33, P746, DOI 10.1016/j.clinthera.2011.05.045; Elhusseiny A, 1999, J CEREBR BLOOD F MET, V19, P794, DOI 10.1097/00004647-199907000-00010; Fischer HS, 2000, REGUL PEPTIDES, V96, P59, DOI 10.1016/S0167-0115(00)00201-9; Fox C, 2014, AGE AGEING, V43, P604, DOI 10.1093/ageing/afu096; Fox C, 2011, J AM GERIATR SOC, V59, P1477, DOI 10.1111/j.1532-5415.2011.03491.x; Fu W, 2013, NEUROSCIENCE, V250, P520, DOI 10.1016/j.neuroscience.2013.07.029; Garfinkel D, 2010, ARCH INTERN MED, V170, P1648, DOI 10.1001/archinternmed.2010.355; Gil-Bea FJ, 2005, NEUROSCI LETT, V375, P37, DOI 10.1016/j.neulet.2004.10.062; Guillemain I, 2000, J COMP NEUROL, V422, P380, DOI 10.1002/1096-9861(20000703)422:3<380::AID-CNE5>3.0.CO;2-C; Hajjar Emily R, 2007, Am J Geriatr Pharmacother, V5, P345, DOI 10.1016/j.amjopharm.2007.12.002; Hartley RS, 1999, J COMP NEUROL, V407, P1, DOI 10.1002/(SICI)1096-9861(19990428)407:1<1::AID-CNE1>3.0.CO;2-Z; Hill EJ, 2008, TOXICOLOGY, V249, P243, DOI 10.1016/j.tox.2008.05.014; Hill EJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036098; Hilmer SN, 2009, CLIN PHARMACOL THER, V85, P86, DOI 10.1038/clpt.2008.224; Kashyap M, 2014, J AM GERIATR SOC, V62, P336, DOI 10.1111/jgs.12632; Kersten H, 2014, BASIC CLIN PHARMACOL, V114, P151, DOI 10.1111/bcpt.12140; Levey AI, 1996, P NATL ACAD SCI USA, V93, P13541, DOI 10.1073/pnas.93.24.13541; Lippmann ES, 2014, SCI REP-UK, V4, DOI 10.1038/srep04160; Liu M, 2008, ANESTH ANALG, V107, P525, DOI 10.1213/ane.0b013e31817b4469; Liu XR, 2009, DRUG METAB DISPOS, V37, P787, DOI 10.1124/dmd.108.024125; Mangoni Arduino A, 2011, Expert Rev Clin Pharmacol, V4, P531, DOI 10.1586/ecp.11.44; Narayan SW, 2013, DRUG AGING, V30, P927, DOI 10.1007/s40266-013-0111-y; Navarrete M, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001259; Neelands TR, 2000, J NEUROPHYSIOL, V84, P2933, DOI 10.1152/jn.2000.84.6.2933; Pasina L, 2013, DRUG AGING, V30, P103, DOI 10.1007/s40266-012-0044-x; Patel AP, DICYCLOMINE HYDROCHL; PLEASURE SJ, 1992, J NEUROSCI, V12, P1802; Podrygajlo G, 2010, DEV DYNAM, V239, P496, DOI 10.1002/dvdy.22193; Podrygajlo G, 2009, CELL TISSUE RES, V336, P439, DOI 10.1007/s00441-009-0783-0; Resende RR, 2009, CELL COMMUN SIGNAL, V7, DOI 10.1186/1478-811X-7-20; Rudolph JL, 2008, ARCH INTERN MED, V168, P508, DOI 10.1001/archinternmed.2007.106; Shelton MK, 2000, J NEUROCHEM, V74, P555, DOI 10.1046/j.1471-4159.2000.740555.x; Summerfield SG, 2007, J PHARMACOL EXP THER, V322, P205, DOI 10.1124/jpet.107.121525; Thomas C, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-86; Thullbery MD, 2005, J CELL BIOCHEM, V96, P599, DOI 10.1002/jcb.20530; Tice MAB, 1996, DEV BRAIN RES, V92, P70, DOI 10.1016/0165-3806(95)01515-9; TUNE L, 1980, ARCH GEN PSYCHIAT, V37, P293; Uusvaara J, 2011, DRUG AGING, V28, P131, DOI 10.2165/11585060-000000000-00000; van Assema DME, 2012, MOL IMAGING BIOL, V14, P771, DOI 10.1007/s11307-012-0556-0; Vijayaraghavan S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065936; Weber ML, 2013, NEUROPHARMACOLOGY, V72, P88, DOI 10.1016/j.neuropharm.2013.04.027; Winchell GA, 2002, J CLIN PHARMACOL, V42, P61, DOI 10.1177/0091270002042001007; Woehrling EK, 2011, NEUROTOX RES, V19, P472, DOI 10.1007/s12640-010-9202-2; Woehrling EK, 2010, NEUROTOX RES, V17, P103, DOI 10.1007/s12640-009-9084-3; WOLF BA, 1995, J BIOL CHEM, V270, P4916, DOI 10.1074/jbc.270.9.4916; ZELLER M, 1995, INT J DEV NEUROSCI, V13, P437, DOI 10.1016/0736-5748(95)00025-C	60	5	5	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2015	10	3							e0118786	10.1371/journal.pone.0118786	http://dx.doi.org/10.1371/journal.pone.0118786			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9JM	25738989	Green Published, Green Accepted, gold			2022-12-27	WOS:000350685900071
J	Yadav, D; Dhillon, P				Yadav, Diwakar; Dhillon, Preeti			Assessing the Impact of Family Planning Advice on Unmet Need and Contraceptive Use among Currently Married Women in Uttar Pradesh, India	PLOS ONE			English	Article							FEMALE SEX WORKERS; CHILD HEALTH; MATERNAL HEALTH; ANTENATAL CARE; SERVICE UTILIZATION; PROPENSITY SCORES; DISTRICT; RISK	Background Counseling/advice is one of the key interventions to promote family planning (FP) in developing countries, including India. It helps to improve the quality of care and reduce maternal deaths. This paper investigates the continuity of maternal health (MH) service utilization from antenatal care to post-natal care and the impact this service utilization has on contraceptive use and on meeting the demand for family planning among currently married women in rural Uttar Pradesh, India. Methods and Findings The study assesses the impact of FP advice on unmet need and contraceptive use by adopting the propensity score matching method. It uses data from the District Level Household Survey (DLHS) (2007-08) that covered 76,147 currently married women (CMW) in the age group 15-44 years in Uttar Pradesh. Results show that the utilization of MH services [Antenatal care (ANC), institutional delivery, Postnatal care (PNC)] and FP advice during ANC and PNC has led to increase in current use of contraception by 3.7% (p<.01), 7.3% (p<.01) and 6.8% (p<.01), respectively. However, a greater utilization of these services has not translated into a reduction of unmet need for contraception at a similar manner. Conclusion MH service utilization including FP advice is more effective in increasing current use of spacing methods as compared to limiting methods. Findings support the need for "effective FP advice" interventions to reduce unintended births and unmet need. However, women from Scheduled Caste/Scheduled Tribe communities are less likely to receive MH services. Thus, efforts are required to ensure that currently married women across socio-economic backgrounds have equal opportunity to receive MH services and information on contraceptive use to meet the demand for family planning methods.	[Yadav, Diwakar] Populat Serv Int, 2-105 Vijayant Khand, Lucknow, Uttar Pradesh, India; [Dhillon, Preeti] Save Children, New Delhi, India	Save the Children	Yadav, D (corresponding author), Populat Serv Int, 2-105 Vijayant Khand, Lucknow, Uttar Pradesh, India.	yadavdiwakar7@gmail.com	Dhillon, Preeti/ABC-7955-2020	Dhillon, Preeti/0000-0001-9757-6492				Ahmed S, 2002, DEMOGRAPHY, V39, P75, DOI 10.1353/dem.2002.0001; Ahmed S, 2012, LANCET, V380, P111, DOI 10.1016/S0140-6736(12)60478-4; [Anonymous], 2001, ASIA PAC POPUL J, DOI DOI 10.1136/BMJ.I2851; Anwar A., 2004, BANGLADESH INEQUALIT; Bhattacharjee P, 2013, AIDS CARE, V25, pS46, DOI 10.1080/09540121.2012.736607; Birungi H, 2006, ACCEPTABILITY SUSTAI; Briggs CJ, 2001, COCHRANE DB SYST REV, V4, DOI [10.1002/14651858.CD003318PMID:11687187, DOI 10.1002/14651858.CD003318]; Commission P, 2011, IND HUM DEV REPR; Dhakal Sulochana, 2007, BMC Pregnancy Childbirth, V7, P19, DOI 10.1186/1471-2393-7-19; Dixit P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066175; Do M, 2013, BMC HEALTH SERV RES, V13, DOI 10.1186/1472-6963-13-6; Fagan EB, 2009, SOUTH MED J, V102, P260, DOI 10.1097/SMJ.0b013e318197fae4; Glasier AF, 1996, CONTRACEPTION, V53, P217, DOI 10.1016/0010-7824(96)00040-6; Guha M, 2012, J EPIDEMIOL COMMUN H, V66, pII55, DOI 10.1136/jech-2011-200562; Hotchkiss DR, 2005, POPUL RES POLICY REV, V24, P543, DOI 10.1007/s11113-005-4852-0; Hotchkiss DR, 1999, J BIOSOC SCI, V31, P145, DOI 10.1017/S0021932099001455; Howe LD, 2009, J EPIDEMIOL COMMUN H, V63, P871, DOI 10.1136/jech.2009.088021; HUNTINGTON D, 1994, STUD FAMILY PLANN, V25, P176, DOI 10.2307/2137943; India Go, 2011, 1 OFF REG GEN CENS C, V1; International Institute for Population Sciences (IIPS), 2010, DISTR LEV HOUS FAC S, DOI [10.1371/journal.pone.0071584, DOI 10.1371/JOURNAL.PONE.0071584]; International Institute for Population Sciences (IIPS) and Macro International, 2007, NAT FAM HLTH SURV NF; Jat TR, 2011, INT J EQUITY HEALTH, V10, DOI 10.1186/1475-9276-10-59; Joshi S., 2007, FAMILY PLANNING INVE; Juneja S, 2013, AIDS BEHAV, V17, P1040, DOI 10.1007/s10461-012-0314-y; KOENIG MA, 1992, STUD FAMILY PLANN, V23, P352, DOI 10.2307/1966893; Lechner M, 2002, J R STAT SOC A STAT, V165, P59, DOI 10.1111/1467-985X.0asp2; Lee JK, 2011, J GEN INTERN MED, V26, P731, DOI 10.1007/s11606-011-1647-3; Levitt C, 2004, BIRTH-ISS PERINAT C, V31, P203, DOI 10.1111/j.0730-7659.2004.00306.x; Liu L, 2008, POP STUD-J DEMOG, V62, P191, DOI 10.1080/00324720801897796; Lopez LM, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001863.pub3; Magoma M, 2011, BMC PREGNANCY CHILDB, V11, DOI 10.1186/1471-2393-11-64; Magoma M, 2010, BMC PREGNANCY CHILDB, V10, DOI 10.1186/1471-2393-10-13; Ministry of Health and Family Welfare (MoHFW), 2005, NAT RUR HLTH MISS 20; Mistry R, 2009, SOC SCI MED, V69, P926, DOI 10.1016/j.socscimed.2009.07.008; MoHFW, 1997, REPR CHILD HLTH PROG; *MOHFW, 2000, NAT POP POL 2000; MoHFW, 2002, NAT HLTH POL 2002; Nikiema B, 2009, HEALTH POLICY PLANN, V24, P367, DOI 10.1093/heapol/czp017; Oakes JM, 2006, METHODS SOCIAL EPIDE, V1st; Ozvaris SB, 1997, ADV CONTRACEPTIVE DE, V13, P63; Pallikadavath S, 2004, SOC SCI MED, V59, P1147, DOI 10.1016/j.socscimed.2003.11.045; Pembe AB, 2009, BMC PREGNANCY CHILDB, V9, DOI 10.1186/1471-2393-9-12; Ram F, 2006, J BIOSOC SCI, V38, P433, DOI 10.1017/S0021932005026453; Renkert S, 2001, HEALTH PROMOT INT, V16, P381, DOI 10.1093/heapro/16.4.381; RGI, 2011, SAMPL REG SYST SRS; Ringheim K, 2011, INTEGRATING FAMILY P; Rodriguez-Barocio R., 1980, INT FAM PLAN PERSPEC, V6, P2, DOI [10.2307/2947963, DOI 10.2307/2947963]; ROSENBAUM PR, 1983, BIOMETRIKA, V70, P41, DOI 10.1093/biomet/70.1.41; ROSENBAUM PR, 1985, AM STAT, V39, P33, DOI 10.2307/2683903; Rubin DB, 1996, BIOMETRICS, V52, P249, DOI 10.2307/2533160; Seiber EE, 2005, SOC SCI MED, V61, P279, DOI 10.1016/j.socscimed.2004.11.068; Sines E., 2007, POSTNATAL CARE CRITI; Singh A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044931; Singh A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037037; Singh S, 2009, ADDING IT COSTS BENE; StataCorp, 2009, STAT STAT SOFTW REL; Stuart EA, 2010, STAT SCI, V25, P1, DOI 10.1214/09-STS313; Sugathan KS, 2001, PROMOTING I DELIVRIE; Taylor C. E., 1987, Health Policy and Planning, V2, P150, DOI 10.1093/heapol/2.2.150; Toth C, 2008, RIGHT MESSAGE RIGHT; Vyas S, 2006, HEALTH POLICY PLANN, V21, P459, DOI 10.1093/heapol/czl029; Waddington C, 2008, INTEGRATED HLTH SERV; WHO, 2003, WORKING WITH INDIVID; Williamson E, 2012, STAT METHODS MED RES, V21, P273, DOI 10.1177/0962280210394483; World Health Organization, 2004, REPR HLTH STRAT ACC; Yadav D, 2012, STUDY SYNERGIES MATE; Yadav D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078361; Zerai A, 2001, Afr J Reprod Health, V5, P68, DOI 10.2307/3583432	68	15	15	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2015	10	3							e0118584	10.1371/journal.pone.0118584	http://dx.doi.org/10.1371/journal.pone.0118584			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CC9JM	25738707	Green Published, Green Submitted, gold			2022-12-27	WOS:000350685900049
J	Zanette, RA; Bitencourt, PER; Kontoyiannis, DP; Fighera, RA; Flores, MM; Kommers, GD; Silva, PS; Ludwig, A; Moretto, MB; Alves, SH; Santurio, JM				Zanette, Regis A.; Bitencourt, Paula E. R.; Kontoyiannis, Dimitrios P.; Fighera, Rafael A.; Flores, Mariana M.; Kommers, Glaucia D.; Silva, Priscila S.; Ludwig, Aline; Moretto, Maria B.; Alves, Sydney H.; Santurio, Janio M.			Complex Interaction of Deferasirox and Pythium insidiosum: Iron-Dependent Attenuation of Growth In Vitro and Immunotherapy-Like Enhancement of Immune Responses In Vivo	PLOS ONE			English	Article							PYTHIOSIS; LYMPHOCYTES; MODEL	Pythium insidiosum iron acquisition mechanisms are unknown. We previously showed that the iron chelator deferasirox had weak activity in vitro and in rabbits with experimental pythiosis. Here we show that deferasirox causes damage to P. insidiosum hyphae in vitro, but that activity is diminished in the presence of exogenous iron. The tissue activity of the proinflammatory enzyme adenosine deaminase and the histological pattern observed in pythiosis lesions of rabbits treated with deferasirox were similar to the ones in animals treated with immunotherapy.	[Zanette, Regis A.; Ludwig, Aline; Alves, Sydney H.; Santurio, Janio M.] Fed Univ Santa Maria UFSM, Hlth Sci Ctr, Grad Program Pharmacol, Santa Maria, RS, Brazil; [Bitencourt, Paula E. R.; Silva, Priscila S.; Moretto, Maria B.; Alves, Sydney H.] Univ Fed Santa Maria, Hlth Sci Ctr, Grad Program Pharmaceut Sci, Santa Maria, RS, Brazil; [Kontoyiannis, Dimitrios P.] Univ Texas MD Anderson Canc Ctr, Dept Infect Dis Infect Control & Employee Hlth, Houston, TX 77030 USA; [Fighera, Rafael A.; Flores, Mariana M.; Kommers, Glaucia D.] Univ Fed Santa Maria, Hlth Sci Ctr, Grad Program Vet Med, Santa Maria, RS, Brazil	Universidade Federal de Santa Maria (UFSM); Universidade Federal de Santa Maria (UFSM); University of Texas System; UTMD Anderson Cancer Center; Universidade Federal de Santa Maria (UFSM)	Santurio, JM (corresponding author), Fed Univ Santa Maria UFSM, Hlth Sci Ctr, Grad Program Pharmacol, Santa Maria, RS, Brazil.	janio.santurio@gmail.com	Alves, Severino/L-8963-2013; ludwig, Aline/W-7037-2018; Zanette, RA/C-3139-2014; Santurio, Janio Morais/J-2392-2012; Alves, Sydney H/N-4159-2014	ludwig, Aline/0000-0002-0904-4953; Zanette, RA/0000-0003-4432-2231; Santurio, Janio Morais/0000-0001-6286-9076; Alves, Sydney H/0000-0001-5740-387X; Bitencourt, Paula/0000-0001-7828-518X	National Council for Scientific and Technological Development-CNPq [471114/2010-3]; Fundacao de Amparo a Pesquisa do Estado do Rio Grande do Sul-CAPES/FAPERGS	National Council for Scientific and Technological Development-CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado do Rio Grande do Sul-CAPES/FAPERGS	This work was supported by the National Council for Scientific and Technological Development-CNPq (grant number 471114/2010-3 to SHA) and Fundacao de Amparo a Pesquisa do Estado do Rio Grande do Sul-CAPES/FAPERGS (to RAZ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antonioli L, 2012, CURR DRUG TARGETS, V13, P842, DOI 10.2174/138945012800564095; Azevedo MI, 2012, VET MICROBIOL, V159, P141, DOI 10.1016/j.vetmic.2012.03.030; Bach BC, 2013, CELL BIOCHEM FUNCT, V31, P476, DOI 10.1002/cbf.2921; Belle LP, 2011, CELL BIOCHEM BIOPHYS, V61, P297, DOI 10.1007/s12013-011-9212-6; Ben-Ami R, 2010, ANTIMICROB AGENTS CH, V54, P484, DOI 10.1128/AAC.00956-09; Casanova V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051287; GiustiG HV, 1974, METHODS ENZYMATIC AN, P1092, DOI DOI 10.1016/B978-0-12-091302-2.50108-0; Ibrahim AS, 2007, J CLIN INVEST, V117, P2649, DOI 10.1172/JCI32338; Kontoyiannis DP, 2007, CANCER-AM CANCER SOC, V110, P1303, DOI 10.1002/cncr.22909; Krajaejun T, 2011, FUNGAL BIOL-UK, V115, P683, DOI 10.1016/j.funbio.2011.05.001; Lewis RE, 2011, ANTIMICROB AGENTS CH, V55, P411, DOI 10.1128/AAC.00792-10; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Martins TB, 2012, J COMP PATHOL, V146, P122, DOI 10.1016/j.jcpa.2011.06.006; Minn Y, 1997, MYCOPATHOLOGIA, V138, P29, DOI 10.1023/A:1006889108673; Pan JH, 2014, INT J SURG CASE REP, V5, P677, DOI 10.1016/j.ijscr.2014.05.018; Pereira DIB, 2008, J MYCOL MED, V18, P129, DOI 10.1016/j.mycmed.2008.05.001; Pires L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085431; Schaible ME, 2004, NAT REV MICROBIOL, V2, P946, DOI 10.1038/nrmicro1046; Schloemer N.J., 2013, INFECT DIS CLIN PRAC, V21, pe24, DOI [10.1097/IPC.0b013e318278f3b5, DOI 10.1097/IPC.0B013E318278F3B5]; Sudjaritruk T, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-33; Zanette RA, 2013, J ANTIMICROB CHEMOTH, V68, P1144, DOI 10.1093/jac/dks534	21	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2015	10	3							e0118932	10.1371/journal.pone.0118932	http://dx.doi.org/10.1371/journal.pone.0118932			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9JM	25738758	Green Published, gold, Green Submitted			2022-12-27	WOS:000350685900086
J	de Monteynard, LA; Dray-Spira, R; de Truchis, P; Grabar, S; Launay, O; Meynard, JL; Khuong-Josses, MA; Gilquin, J; Rey, D; Simon, A; Pavie, J; Mahamat, A; Matheron, S; Costagliola, D; Abgrall, S				de Monteynard, Laure-Amelie; Dray-Spira, Rosemary; de Truchis, Pierre; Grabar, Sophie; Launay, Odile; Meynard, Jean-Luc; Khuong-Josses, Marie-Aude; Gilquin, Jacques; Rey, David; Simon, Anne; Pavie, Juliette; Mahamat, Aba; Matheron, Sophie; Costagliola, Dominique; Abgrall, Sophie		French Hosp Database HIV	Later cART Initiation in Migrant Men from Sub-Saharan Africa without Advanced HIV Disease in France	PLOS ONE			English	Article							ANTIRETROVIRAL THERAPY; PEOPLE; GENDER; RISK	Objective To compare the time from entry into care for HIV infection until combination antiretroviral therapy (cART) initiation between migrants and non migrants in France, excluding late access to care. Methods Antiretroviral-naive HIV-1-infected individuals newly enrolled in the FHDH cohort between 2002-2010, with CD4 cell counts > 200/mu L and no previous or current AIDS events were included. In three baseline CD4 cell count strata (200-349, 350-499, >= 500/mu L), we examined the crude time until cART initiation within three years after enrolment according to geographic origin, and multivariable hazard ratios according to geographic origin, gender and HIV-transmission group, with adjustment for baseline age, enrolment period, region of care, plasma viral load, and HBV/HBC coinfection. Results Among 13338 individuals, 9605 (72.1%) were French natives (FRA), 2873 (21.4%) were migrants from sub-Saharan Africa/non-French West Indies (SSA/NFW), and 860 (6.5%) were migrants from other countries. Kaplan-Meier probabilities of cART initiation were significantly lower in SSA/NFW than in FRA individuals throughout the study period, regardless of the baseline CD4 stratum. After adjustment, the likelihood of cART initiation was respectively 15% (95% CI, 1-28) and 20% (95% CI, 2-38) lower in SSA/NFW men than in FRA men who had sex with men (MSM) in the 350-499 and >= 500 CD4 strata, while no difference was observed between other migrant groups and FRA MSM. Conclusion SSA/NFW migrant men living in France with CD4 > 350/mu L at entry into care are more likely to begin cART later than FRA MSM, despite free access to treatment. Administrative delays in obtaining healthcare coverage do not appear to be responsible.	[de Monteynard, Laure-Amelie; Dray-Spira, Rosemary; Costagliola, Dominique; Abgrall, Sophie] Univ Paris 06, Sorbonne Univ, Inst Pierre Louis Epidemiol & Sante Publ, UMR S 1136, Paris, France; [de Monteynard, Laure-Amelie; Dray-Spira, Rosemary; Grabar, Sophie; Costagliola, Dominique; Abgrall, Sophie] INSERM, Inst Pierre Louis Epidemiol & Sante Publ, UMR S 1136, Paris, France; [de Truchis, Pierre] Hop Raymond Poincare, Hop Univ Paris Ile France Ouest, Dept Med Aigue Specialisee, AP HP, Garches, France; [Grabar, Sophie; Launay, Odile] Univ Paris 05, Sorbonne Paris Cite, Paris, France; [Grabar, Sophie] Grp Hosp Cochin Broca Hotel Dieu, Unite Biostat & Epidemiol, AP HP, Paris, France; [Launay, Odile] Hop Cochin, AP HP, F-75674 Paris, France; [Meynard, Jean-Luc] Hop St Antoine, AP HP, Serv Malad Infect & Trop, F-75571 Paris, France; [Khuong-Josses, Marie-Aude] Hop Delafontaine, Ctr Hosp St Denis, Serv Malad Infect & Trop, St Denis, France; [Gilquin, Jacques] Hop Hotel Dieu, Unite Immunoinfectiol, AP HP, F-75181 Paris, France; [Rey, David] Hop Univ Strasbourg, Ctr Soins Infect VIH, Strasbourg, France; [Simon, Anne] Grp Hosp Pitie Salpetriere, AP HP, Dept Med Interne, F-75634 Paris, France; [Pavie, Juliette] Hop Europeen Georges Pompidou, AP HP, Serv Immunol Clin, Paris, France; [Mahamat, Aba] Ctr Hosp Andree Rosemon, Serv Malad Infect & Trop, Cayenne, France; [Matheron, Sophie] Univ Paris Diderot, Sorbonne Paris Cite, Paris, France; [Matheron, Sophie] Hop Bichat Claude Bernard, AP HP, Serv Malad Infect & Trop, F-75877 Paris 18, France; [Abgrall, Sophie] Hop Avicenne, AP HP, Serv Malad Infect & Trop, F-93009 Bobigny, France	UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Raymond-Poincare - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Hopital Universitaire Hotel-Dieu - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Hotel-Dieu - APHP; UDICE-French Research Universities; Universite Paris Cite; CHU Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Avicenne - APHP; Universite Paris 13	de Monteynard, LA (corresponding author), Univ Paris 06, Sorbonne Univ, Inst Pierre Louis Epidemiol & Sante Publ, UMR S 1136, Paris, France.	lmonteynard@ccde.chups.jussieu.fr	Mahamat, Aba/V-7888-2019; Grabar, Sophie/AAM-9857-2020; TISSOT-DUPONT, Hervé/P-5808-2016; Matheron, Sophie/D-7420-2017; Costagliola, Dominique/H-5849-2011	Mahamat, Aba/0000-0001-8755-0424; Matheron, Sophie/0000-0001-7879-6553; Costagliola, Dominique/0000-0003-0765-0869; Cabie, Andre/0000-0003-0117-3061; Dray-Spira, Rosemary/0000-0001-7646-3667	Agence Nationale de Recherche sur le SIDA et les hepatites virales (ANRS); INSERM; French Ministry of Health	Agence Nationale de Recherche sur le SIDA et les hepatites virales (ANRS)(ANRSFrench National Research Agency (ANR)); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); French Ministry of Health	This work was supported by the Agence Nationale de Recherche sur le SIDA et les hepatites virales (ANRS), INSERM, and the French Ministry of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abgrall S, 2010, AIDS, V24, P763, DOI 10.1097/QAD.0b013e3283366747; [Anonymous], REC SANT PUBL DEP IN; [Anonymous], EUR GUID TREATM HIV; Berchet C, IRDES 2012; Bouvier G., 2010, DESCENDANTS IMMIGRES; Breton G, 2007, HIV MED, V8, P164, DOI 10.1111/j.1468-1293.2007.00447.x; Cazein F., 2014, Bulletin Epidemiologique Hebdomadaire, P154; Crawford T, 2012, J IMMIGR MINOR HEALT, V14, P82, DOI 10.1007/s10903-011-9455-8; de Sante Haute Autorite, 2011, LIST ACT PREST ALD 7; Department of STDS, 2013, FRANC AD NEW NAT POL; Dray-Spira R., 2013, Bulletin Epidemiologique Hebdomadaire, P285; EACS, 2011, EUR GUID TREATM HIV; Elford J, 2008, SEX TRANSM INFECT, V84, P176, DOI 10.1136/sti.2007.029249; Fardet L, 2006, HIV MED, V7, P520, DOI 10.1111/j.1468-1293.2006.00414.x; Jarrin I, 2012, CLIN INFECT DIS, V54, P111, DOI 10.1093/cid/cir814; Lert F., 2013, Bulletin Epidemiologique Hebdomadaire, P300; Lot F., 2011, Bulletin Epidemiologique Hebdomadaire, P454; Mary-Krause M, 2014, INT J EPIDEMIOL; McMahon T, 2012, SYST REV, V1, DOI 10.1186/2046-4053-1-56; Mocroft A, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001510; Monge S, 2012, HIV MED, P273; Montlahuc C, 2013, JAIDS-J ACQ IMM DEF, V64, P197, DOI 10.1097/QAI.0b013e31829cfbfa; Morlat P, 2013, RPISE CHARGE MED PER, DOI [10.1056/NEJMoa1404231, DOI 10.1056/NEJMOA1404231]; Supervie V, 2013, 20 C RETR OPP INF AT; Thierry X., 2008, INED POPULAT SOC, V442, P1; Thompson MA, 2010, JAMA-J AM MED ASSOC, V304, P321, DOI 10.1001/jama.2010.1004; Yeni P, 2006, PRISE CHARGE MED PER, DOI [10.1056/NEJMoa1404231, DOI 10.1056/NEJMOA1404231]; Yeni P, 2010, PRISE CHARGE MED PER, DOI [10.1056/NEJMoa1404231, DOI 10.1056/NEJM0A1404231]	28	10	10	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2015	10	3							e0118492	10.1371/journal.pone.0118492	http://dx.doi.org/10.1371/journal.pone.0118492			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4HV	25734445	Green Published, Green Submitted, gold			2022-12-27	WOS:000350314700033
J	Feller, C; Farcot, E; Mazza, C				Feller, Chrystel; Farcot, Etienne; Mazza, Christian			Self-Organization of Plant Vascular Systems: Claims and Counter-Claims about the Flux-Based Auxin Transport Model	PLOS ONE			English	Article							PATTERN-FORMATION; BIOSYNTHESIS; POLARITY	The plant hormone auxin plays a central role in growth and morphogenesis. In shoot apical meristems, auxin flux is polarized through its interplay with PIN proteins. Concentrationbased mathematical models of the flux can explain some aspects of phyllotaxis for the L1 surface layer, where auxin accumulation points act as sinks and develop into primordia. The picture differs in the interior of the meristem, where the primordia act as auxin sources, leading to the initiation of the vascular system. Self-organization of the auxin flux involves large numbers of molecules and is difficult to treat by intuitive reasoning alone; mathematical models are therefore vital to understand these phenomena. We consider a leading computational model based on the so-called flux hypothesis. This model has been criticized and extended in various ways. One of the basic counter-arguments is that simulations yield auxin concentrations inside canals that are lower than those seen experimentally. Contrary to what is claimed in the literature, we show that the model can lead to higher concentrations within canals for significant parameter regimes. We then study the model in the usual case where the response function F defining the model is quadratic and unbounded, and show that the steady state vascular patterns are formed of loopless directed trees. Moreover, we show that PIN concentrations can diverge in finite time, thus explaining why previous simulation studies introduced cut-offs which force the system to have bounded PIN concentrations. Hence, contrary to previous claims, extreme PIN concentrations are not due to numerical problems but are intrinsic to the model. On the other hand, we show that PIN concentrations remain bounded for bounded F, and simulations show that in this case, loops can emerge at steady state.				christian.mazza@unifr.ch						Bayer EM, 2009, GENE DEV, V23, P373, DOI 10.1101/gad.497009; Draelants D, 2013, J MATH BIOL, V67, P1279, DOI 10.1007/s00285-012-0588-8; Farcot E, 2013, SIAM J APPL DYN SYST, V12, P1330, DOI 10.1137/120891538; Feller C, 2014, J MATH BIOL, V68, P879, DOI 10.1007/s00285-013-0655-9; Feugier FG, 2005, J THEOR BIOL, V236, P366, DOI 10.1016/j.jtbi.2005.03.017; Garnett P, 2010, BIOESSAYS, V32, P828, DOI 10.1002/bies.200900185; Heisler MG, 2006, J PLANT GROWTH REGUL, V25, P302, DOI 10.1007/s00344-006-0066-x; Heisler MG, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000516; Heisler MG, 2005, CURR BIOL, V15, P1899, DOI 10.1016/j.cub.2005.09.052; Jonsson H, 2006, P NATL ACAD SCI USA, V103, P1633, DOI 10.1073/pnas.0509839103; Kramer EM, 2004, TRENDS PLANT SCI, V9, P578, DOI 10.1016/j.tplants.2004.10.010; Kramer EM, 2009, TRENDS PLANT SCI, V14, P242, DOI 10.1016/j.tplants.2009.02.005; Mattsson J, 2003, PLANT PHYSIOL, V131, P1327, DOI 10.1104/pp.013623; MITCHISON GJ, 1981, PHILOS T ROY SOC B, V295, P461, DOI 10.1098/rstb.1981.0154; MITCHISON GJ, 1980, PROC R SOC SER B-BIO, V207, P79, DOI 10.1098/rspb.1980.0015; Paciorek T, 2005, NATURE, V435, P1251, DOI 10.1038/nature03633; Reinhardt D, 2000, PLANT CELL, V12, P507, DOI 10.1105/tpc.12.4.507; Rolland-Lagan AG, 2005, PLANT J, V44, P854, DOI 10.1111/j.1365-313X.2005.02581.x; SACHS T, 1969, ANN BOT-LONDON, V33, P263, DOI 10.1093/oxfordjournals.aob.a084281; Sahlin P, 2009, J THEOR BIOL, V258, P60, DOI 10.1016/j.jtbi.2009.01.019; Scarpella E, 2006, GENE DEV, V20, P1015, DOI 10.1101/gad.1402406; Scarpella E, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001511; Smith RS, 2006, P NATL ACAD SCI USA, V103, P1301, DOI 10.1073/pnas.0510457103; Stoma S, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000207; van Berkel K, 2013, DEVELOPMENT, V140, P2253, DOI 10.1242/dev.079111; Walker ML, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054802; Zhao YD, 2008, CURR OPIN PLANT BIOL, V11, P16, DOI 10.1016/j.pbi.2007.10.008; Zhao YD, 2010, ANNU REV PLANT BIOL, V61, P49, DOI 10.1146/annurev-arplant-042809-112308	28	14	14	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2015	10	3							e0118238	10.1371/journal.pone.0118238	http://dx.doi.org/10.1371/journal.pone.0118238			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4HV	25734327	Green Published, Green Submitted, gold			2022-12-27	WOS:000350314700018
J	Hand, ES; Haller, SL; Peng, C; Rothenburg, S; Hersperger, AR				Hand, Erin S.; Haller, Sherry L.; Peng, Chen; Rothenburg, Stefan; Hersperger, Adam R.			Ectopic Expression of Vaccinia Virus E3 and K3 Cannot Rescue Ectromelia Virus Replication in Rabbit RK13 Cells	PLOS ONE			English	Article							HOST-RANGE; POXVIRUS VECTORS; CAUSATIVE AGENT; PROTEIN; PKR; RNA; INHIBITION; RESISTANCE; OUTBREAKS; DOMAINS	As a group, poxviruses have been shown to infect a wide variety of animal species. However, there is individual variability in the range of species able to be productively infected. In this study, we observed that ectromelia virus (ECTV) does not replicate efficiently in cultured rabbit RK13 cells. Conversely, vaccinia virus (VACV) replicates well in these cells. Upon infection of RK13 cells, the replication cycle of ECTV is abortive in nature, resulting in a greatly reduced ability to spread among cells in culture. We observed ample levels of early gene expression but reduced detection of virus factories and severely blunted production of enveloped virus at the cell surface. This work focused on two important host range genes, named E3L and K3L, in VACV. Both VACV and ECTV express a functional protein product from the E3L gene, but only VACV contains an intact K3L gene. To better understand the discrepancy in replication capacity of these viruses, we examined the ability of ECTV to replicate in wild-type RK13 cells compared to cells that constitutively express E3 and K3 from VACV. The role these proteins play in the ability of VACV to replicate in RK13 cells was also analyzed to determine their individual contribution to viral replication and PKR activation. Since E3L and K3L are two relevant host range genes, we hypothesized that expression of one or both of them may have a positive impact on the ability of ECTV to replicate in RK13 cells. Using various methods to assess virus growth, we did not detect any significant differences with respect to the replication of ECTV between wild-type RK13 compared to versions of this cell line that stably expressed VACV E3 alone or in combination with K3. Therefore, there remain unanswered questions related to the factors that limit the host range of ECTV.	[Hand, Erin S.; Hersperger, Adam R.] Albright Coll, Dept Biol, Reading, PA 19612 USA; [Haller, Sherry L.; Peng, Chen; Rothenburg, Stefan] Kansas State Univ, Div Biol, Lab Host Specif Virol, Manhattan, KS 66506 USA	Kansas State University	Hersperger, AR (corresponding author), Albright Coll, Dept Biol, Reading, PA 19612 USA.	ahersperger@albright.edu	Peng, Chen/AAI-6267-2020	Peng, Chen/0000-0001-6141-8775; Haller, Sherry L./0000-0002-4340-721X	Albright Creative Research Experience (ACRE) program; Albright College	Albright Creative Research Experience (ACRE) program; Albright College	This work was supported through the Albright Creative Research Experience (ACRE) program and other internal funding from Albright College. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahao JS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007428; Beattie E, 1996, VIRUS GENES, V12, P89, DOI 10.1007/BF00370005; Bratke KA, 2013, INFECT GENET EVOL, V14, P406, DOI 10.1016/j.meegid.2012.12.002; Breman JG, 2002, NEW ENGL J MED, V346, P1300, DOI 10.1056/NEJMra020025; Brennan G, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004002; BULLER RML, 1986, CURR TOP MICROBIOL, V127, P319; BULLER RML, 1991, MICROBIOL REV, V55, P80, DOI 10.1128/MMBR.55.1.80-122.1991; BURNET FM, 1946, J IMMUNOL, V53, P1; CARROLL K, 1993, J BIOL CHEM, V268, P12837; Chen NH, 2003, VIROLOGY, V317, P165, DOI 10.1016/S0042-6822(03)00520-8; CHEN W, 1992, VIROLOGY, V187, P433, DOI 10.1016/0042-6822(92)90445-U; Condit RC, 2010, EMERG INFECT DIS, V16, P1022, DOI 10.3201/eid1606.100315; Gomez CE, 2012, HUM VACC IMMUNOTHER, V8, P1192, DOI 10.4161/hv.20778; ENGELSTAD M, 1993, VIROLOGY, V194, P627, DOI 10.1006/viro.1993.1302; Esteban DJ, 2005, J GEN VIROL, V86, P2645, DOI 10.1099/vir.0.81090-0; Fang M, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040030; FENNER F, 1947, AUST J EXP BIOL MED, V25, P275, DOI 10.1038/icb.1947.39; FENNER F, 1947, AUST J EXP BIOL MED, V25, P257, DOI 10.1038/icb.1947.38; Gubser C, 2004, J GEN VIROL, V85, P105, DOI 10.1099/vir.0.19565-0; Haller SL, 2014, INFECT GENET EVOL, V21, P15, DOI 10.1016/j.meegid.2013.10.014; Heo J, 2013, NAT MED, V19, P329, DOI 10.1038/nm.3089; Kim YG, 2004, P NATL ACAD SCI USA, V101, P1514, DOI 10.1073/pnas.0308260100; Langland JO, 2006, VIRUS RES, V119, P100, DOI 10.1016/j.virusres.2005.10.014; Langland JO, 2002, VIROLOGY, V299, P133, DOI 10.1006/viro.2002.1479; Lee EH, 2010, FEBS LETT, V584, P4453, DOI 10.1016/j.febslet.2010.10.003; Mastrangelo MJ, 2000, J CLIN INVEST, V105, P1031, DOI 10.1172/JCI9819; McFadden G, 2005, NAT REV MICROBIOL, V3, P201, DOI 10.1038/nrmicro1099; MCMILLAN NAJ, 1995, J BIOL CHEM, V270, P2601, DOI 10.1074/jbc.270.6.2601; Mortimer P, 2006, REV MED VIROL, V16, P353, DOI 10.1002/rmv.506; Novoa RR, 2005, BIOL CELL, V97, P147, DOI 10.1042/BC20040058; Rahman MM, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003465; Reynolds MG, 2012, TRENDS MICROBIOL, V20, P80, DOI 10.1016/j.tim.2011.12.001; Roberts KL, 2008, TRENDS MICROBIOL, V16, P472, DOI 10.1016/j.tim.2008.07.009; Rothenburg S, 2005, P NATL ACAD SCI USA, V102, P1602, DOI 10.1073/pnas.0408714102; Seet BT, 2003, ANNU REV IMMUNOL, V21, P377, DOI 10.1146/annurev.immunol.21.120601.141049; Smith GL, 2002, J GEN VIROL, V83, P2915, DOI 10.1099/0022-1317-83-12-2915; Smith VP, 2002, J VIROL, V76, P1124, DOI 10.1128/JVI.76.3.1124-1134.2002; Tscharke DC, 1999, J GEN VIROL, V80, P2751, DOI 10.1099/0022-1317-80-10-2751; Werden SJ, 2008, ADV VIRUS RES, V71, P135, DOI 10.1016/S0065-3527(08)00003-1	39	6	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2015	10	3							e0119189	10.1371/journal.pone.0119189	http://dx.doi.org/10.1371/journal.pone.0119189			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4HV	25734776	Green Published, Green Submitted, gold			2022-12-27	WOS:000350314700058
J	Hsiao, AY; Okitsu, T; Onoe, H; Kiyosawa, M; Teramae, H; Iwanaga, S; Kazama, T; Matsumoto, T; Takeuchi, S				Hsiao, Amy Y.; Okitsu, Teru; Onoe, Hiroaki; Kiyosawa, Mahiro; Teramae, Hiroki; Iwanaga, Shintaroh; Kazama, Tomohiko; Matsumoto, Taro; Takeuchi, Shoji			Smooth Muscle-Like Tissue Constructs with Circumferentially Oriented Cells Formed by the Cell Fiber Technology	PLOS ONE			English	Article							TRANSPLANTATION; STIFFNESS; ALIGNMENT; FLOW	The proper functioning of many organs and tissues containing smooth muscles greatly depends on the intricate organization of the smooth muscle cells oriented in appropriate directions. Consequently controlling the cellular orientation in three-dimensional (3D) cellular constructs is an important issue in engineering tissues of smooth muscles. However, the ability to precisely control the cellular orientation at the microscale cannot be achieved by various commonly used 3D tissue engineering building blocks such as spheroids. This paper presents the formation of coiled spring-shaped 3D cellular constructs containing circumferentially oriented smooth muscle-like cells differentiated from dedifferentiated fat (DFAT) cells. By using the cell fiber technology, DFAT cells suspended in a mixture of extracellular proteins possessing an optimized stiffness were encapsulated in the core region of alginate shell microfibers and uniformly aligned to the longitudinal direction. Upon differentiation induction to the smooth muscle lineage, DFAT cell fibers self-assembled to coiled spring structures where the cells became circumferentially oriented. By changing the initial core-shell microfiber diameter, we demonstrated that the spring pitch and diameter could be controlled. 21 days after differentiation induction, the cell fibers contained high percentages of ASMA-positive and calponin-positive cells. Our technology to create these smooth muscle-like spring constructs enabled precise control of cellular alignment and orientation in 3D. These constructs can further serve as tissue engineering building blocks for larger organs and cellular implants used in clinical treatments.	[Hsiao, Amy Y.; Okitsu, Teru; Onoe, Hiroaki; Kiyosawa, Mahiro; Iwanaga, Shintaroh; Takeuchi, Shoji] Univ Tokyo, Inst Ind Sci, Tokyo, Japan; [Okitsu, Teru; Onoe, Hiroaki; Kiyosawa, Mahiro; Iwanaga, Shintaroh; Takeuchi, Shoji] Japan Sci & Technol Agcy, ERATO Takeuchi Biohybrid Innovat Project, Tokyo, Japan; [Onoe, Hiroaki] Shumei Univ, Fac Teacher Educ, Chiba, Japan; [Kazama, Tomohiko; Matsumoto, Taro] Nihon Univ, Sch Med, Dept Funct Morphol, Div Cell Regenerat & Transplantat, Tokyo, Japan	University of Tokyo; Japan Science & Technology Agency (JST); Nihon University	Takeuchi, S (corresponding author), Univ Tokyo, Inst Ind Sci, Tokyo, Japan.	takeuchi@iis.u-tokyo.ac.jp	Takeuchi, Shoji/J-5349-2019	Takeuchi, Shoji/0000-0001-6946-0409	Japan Society for the Promotion of Science (JSPS) Postdoctoral Fellowship; Takeuchi Biohybrid Innovation Project, Exploratory Research for Advanced Technology (ERATO), Japan Science and Technology (JST), Japan	Japan Society for the Promotion of Science (JSPS) Postdoctoral Fellowship(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Takeuchi Biohybrid Innovation Project, Exploratory Research for Advanced Technology (ERATO), Japan Science and Technology (JST), Japan	A.Y. Hsiao is supported by Japan Society for the Promotion of Science (JSPS) Postdoctoral Fellowship for Foreign Researchers. This work was supported by the Takeuchi Biohybrid Innovation Project, Exploratory Research for Advanced Technology (ERATO), Japan Science and Technology (JST), Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Choi JS, 2014, BIOMATERIALS, V35, P63, DOI 10.1016/j.biomaterials.2013.09.106; Cleaver O, 2003, NAT MED, V9, P661, DOI 10.1038/nm0603-661; Discher DE, 2005, SCIENCE, V310, P1139, DOI 10.1126/science.1116995; Duong H, 2009, TISSUE ENG PT A, V15, P1865, DOI 10.1089/ten.tea.2008.0319; Gersh KC, 2010, J THROMB HAEMOST, V8, P2826, DOI 10.1111/j.1538-7836.2010.04118.x; Gittenberger-de Groot AC, 1999, ARTERIOSCL THROM VAS, V19, P1589; Guo C, 2007, BIOMATERIALS, V28, P1105, DOI 10.1016/j.biomaterials.2006.10.010; Khademhosseini A, 2006, P NATL ACAD SCI USA, V103, P2480, DOI 10.1073/pnas.0507681102; Kikuta S, 2013, TISSUE ENG PT A, V19, P1792, DOI [10.1089/ten.tea.2012.0380, 10.1089/ten.TEA.2012.0380]; Kuribayashi-Shigetomi K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051085; Landerholm TE, 1999, DEVELOPMENT, V126, P2053; Lee P, 2006, BIOMED MICRODEVICES, V8, P35, DOI 10.1007/s10544-006-6380-z; Lin Ruei-Zhen, 2008, Biotechnology Journal, V3, P1172, DOI 10.1002/biot.200700228; Matsumoto T, 2008, J CELL PHYSIOL, V215, P210, DOI 10.1002/jcp.21304; Mironov V, 2009, BIOMATERIALS, V30, P2164, DOI 10.1016/j.biomaterials.2008.12.084; Morimoto Y, 2013, BIOMATERIALS, V34, P9413, DOI 10.1016/j.biomaterials.2013.08.062; Nemir S, 2010, ANN BIOMED ENG, V38, P2, DOI 10.1007/s10439-009-9811-1; Norotte C, 2009, BIOMATERIALS, V30, P5910, DOI 10.1016/j.biomaterials.2009.06.034; Obinata D, 2011, INT J UROL, V18, P827, DOI 10.1111/j.1442-2042.2011.02865.x; Onoe H, 2013, NAT MATER, V12, P584, DOI [10.1038/NMAT3606, 10.1038/nmat3606]; Pappano A.J., 2010, BERNE LEVY PHYSL, Vsixth editionupdated ed, P370; Rodriguez LV, 2006, P NATL ACAD SCI USA, V103, P12167, DOI 10.1073/pnas.0604850103; Sakuma T, 2009, J UROLOGY, V182, P355, DOI 10.1016/j.juro.2009.02.103; Shen JY, 2006, TISSUE ENG, V12, P2229, DOI 10.1089/ten.2006.12.2229; Thakar RG, 2003, BIOCHEM BIOPH RES CO, V307, P883, DOI 10.1016/S0006-291X(03)01285-3; Webb RC, 2003, ADV PHYSIOL EDUC, V27, P201, DOI 10.1152/advan.00025.2003	26	50	50	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2015	10	3							e0119010	10.1371/journal.pone.0119010	http://dx.doi.org/10.1371/journal.pone.0119010			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4HV	25734774	Green Published, Green Submitted, gold			2022-12-27	WOS:000350314700051
J	Grindstad, T; Andersen, S; Al-Saad, S; Donnem, T; Kiselev, Y; Melbo-Jorgensen, CN; Skjefstad, K; Busund, LT; Bremnes, RM; Richardsen, E				Grindstad, Thea; Andersen, Sigve; Al-Saad, Samer; Donnem, Tom; Kiselev, Yury; Melbo-Jorgensen, Christian Nordahl; Skjefstad, Kaja; Busund, Lill-Tove; Bremnes, Roy M.; Richardsen, Elin			High Progesterone Receptor Expression in Prostate Cancer Is Associated with Clinical Failure	PLOS ONE			English	Article							ANDROGEN RECEPTOR; RADICAL PROSTATECTOMY; CELL-PROLIFERATION; ESTROGEN; PATHWAY; BETA; LOCALIZATION; MIFEPRISTONE; ACTIVATION; CARCINOMA	Background Prostate cancer is a highly heterogeneous disease and one of the leading causes of mortality in developed countries. Specific prognostic and predictive markers for prostate cancer patients are still lacking. A causal relationship between androgens and the development of prostate cancer is generally considered biologically plausible, but androgens are not the sole effector in the complexity of prostate carcinogenesis. The aim of this study was to evaluate the prognostic significance of progesterone receptor in tumor tissue of T1-3N0 prostate cancer patients undergoing prostatectomy. Methods Tissue microarrays from 535 patients with prostate cancer were constructed. Duplicate cores of tumor cells and tumor stromal tissue from each resected specimen were extracted. Immunohistochemistry was used to evaluate the in-situ expression of progesterone receptor. Results In univariate analyses, high tumor cell density (p = 0.006) and high tumor stromal cell density level (p = 0.045) of progesterone receptor were both significantly associated with tumor progression and clinical failure. In multivariate analysis, progesterone receptor expression in tumor cells was an independent negative prognostic factor for clinical failure (HR: 2.5, 95% CI: 1.2-5.2, p = 0.012). Conclusion High progesterone receptor density in tumor cells of the prostate cancer tumor is an independent negative prognostic factor for clinical failure.	[Grindstad, Thea; Al-Saad, Samer; Kiselev, Yury; Melbo-Jorgensen, Christian Nordahl; Skjefstad, Kaja; Busund, Lill-Tove; Bremnes, Roy M.; Richardsen, Elin] UiT, Dept Med Biol, Tromso, Norway; [Andersen, Sigve; Donnem, Tom; Bremnes, Roy M.] UiT, Dept Clin Med, Tromso, Norway; [Andersen, Sigve; Donnem, Tom] Univ Hosp North Norway, Dept Oncol, Tromso, Norway; [Al-Saad, Samer; Busund, Lill-Tove; Richardsen, Elin] Univ Hosp North Norway, Dept Clin Pathol, Tromso, Norway; [Kiselev, Yury] UiT, Dept Pharm, Tromso, Norway	UiT The Arctic University of Tromso; UiT The Arctic University of Tromso; UiT The Arctic University of Tromso; University Hospital of North Norway; UiT The Arctic University of Tromso; University Hospital of North Norway; UiT The Arctic University of Tromso	Grindstad, T (corresponding author), UiT, Dept Med Biol, Tromso, Norway.	theagrindstad@gmail.com		Kiselev, Yury/0000-0002-6753-8572	Norwegian Health Department; Norwegian Cancer Association; UIT - The Arctic University of Norway; Northern Norway Regional Health Authority (Helse Nord RHF) [30125/30012]	Norwegian Health Department; Norwegian Cancer Association; UIT - The Arctic University of Norway; Northern Norway Regional Health Authority (Helse Nord RHF)	This work was supported by the the Norwegian Health Department (http://www.regjeringen.no/en/dep/hod.html?id=421), the Norwegian Cancer Association (https://kreftforeningen.no/en/main-priorities/), UIT - The Arctic University of Norway (http://en.uit.no/startsida), Northern Norway Regional Health Authority (Helse Nord RHF) (http://www.helse-nord.no/?lang=en_US), funding number 30125/30012. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen S, 2014, BMC UROL, V14, DOI 10.1186/1471-2490-14-49; Arora VK, 2013, CELL, V155, P1309, DOI 10.1016/j.cell.2013.11.012; AUFRERE MB, 1976, J PHARM SCI-US, V65, P783, DOI 10.1002/jps.2600650602; Bonkhoff H, 2001, PROSTATE, V48, P285, DOI 10.1002/pros.1108; Boonyaratanakornkit V, 2007, MOL ENDOCRINOL, V21, P359, DOI 10.1210/me.2006-0337; Bremnes RM, 2002, J CLIN ONCOL, V20, P2417, DOI 10.1200/JCO.2002.08.159; BROLIN J, 1992, PROSTATE, V20, P281, DOI 10.1002/pros.2990200404; CASTAGNETTA LA, 1995, ENDOCRINOLOGY, V136, P2309, DOI 10.1210/en.136.5.2309; Chan MD, 2005, UROLOGY, V65, P214; Check JH, 2010, ANTICANCER RES, V30, P4921; Check JH, 2010, ANTICANCER RES, V30, P623; CHODAK GW, 1992, J UROLOGY, V147, P798, DOI 10.1016/S0022-5347(17)37389-5; Denis LJ, 2000, SEMIN SURG ONCOL, V18, P52, DOI 10.1002/(SICI)1098-2388(200001/02)18:1<52::AID-SSU8>3.0.CO;2-6; DEWINTER JAR, 1994, AM J PATHOL, V144, P735; Dohi O, 2008, CANCER SCI, V99, P518, DOI 10.1111/j.1349-7006.2007.00673.x; Draisma G, 2003, LEAD TIMES OVERDETEC; El Etreby MF, 2000, PROSTATE, V42, P99, DOI 10.1002/(SICI)1097-0045(20000201)42:2<99::AID-PROS3>3.0.CO;2-I; Epstein JI, 2010, J UROLOGY, V183, P433, DOI 10.1016/j.juro.2009.10.046; Gao WQ, 2005, CHEM REV, V105, P3352, DOI 10.1021/cr020456u; Hanekamp EE, 2003, CLIN CANCER RES, V9, P4190; Helpap B, 2009, HISTOL HISTOPATHOL, V24, P661, DOI 10.14670/HH-24.661; Helsen C, 2014, ENDOCRINE RELATED CA; Hiramatsu M, 1996, HISTOPATHOLOGY, V28, P163, DOI 10.1046/j.1365-2559.1996.280326.x; Hobisch A, 1997, J PATHOL, V182, P356, DOI 10.1002/(SICI)1096-9896(199707)182:3<356::AID-PATH863>3.0.CO;2-U; Horvath LG, 2001, CANCER RES, V61, P5331; IARC IA for R on CWHO, 2012, GLOBOCAN 2012 EST CA; Klotz L, 2013, CURR OPIN ENDOCRINOL, V20, P204, DOI 10.1097/MED.0b013e328360332a; Kononen J, 1998, NAT MED, V4, P844, DOI 10.1038/nm0798-844; Latil A, 2001, CANCER RES, V61, P1919; Leav I, 2001, AM J PATHOL, V159, P79, DOI 10.1016/S0002-9440(10)61676-8; LIN MF, 1995, PROSTATE, V26, P194, DOI 10.1002/pros.2990260405; Luetjens CM, 2006, J ENDOCRINOL, V189, P529, DOI 10.1677/joe.1.06348; Madalinska JB, 2001, J CLIN ONCOL, V19, P1619, DOI 10.1200/JCO.2001.19.6.1619; Memarzadeh S, 2007, CANCER CELL, V12, P572, DOI 10.1016/j.ccr.2007.11.002; Migliaccio A, 1998, EMBO J, V17, P2008, DOI 10.1093/emboj/17.7.2008; Migliaccio A, 2007, INT J BIOCHEM CELL B, V39, P1343, DOI 10.1016/j.biocel.2006.12.009; Milanes-Yearsley M, MOD PATHOL, V15, P1366; MOBBS BG, 1990, PROSTATE, V16, P245, DOI 10.1002/pros.2990160308; Morriss-Kay G, 1991, J ANAT, V175, P273, DOI [10.1097/00006534-198801000-00024, DOI 10.1097/00006534-198801000-00024]; Skildum A, 2005, MOL ENDOCRINOL, V19, P327, DOI 10.1210/me.2004-0306; Stephenson AJ, 2006, J CLIN ONCOL, V24, P3973, DOI 10.1200/JCO.2005.04.0756; Hernandez-Hernandez OT, 2012, J STEROID BIOCHEM, V132, P127, DOI 10.1016/j.jsbmb.2012.04.005; WERNERT N, 1988, VIRCHOWS ARCH A, V412, P387, DOI 10.1007/BF00750267; Yu Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092714; Yu Y, 2013, J CLIN ENDOCR METAB, V98, P2887, DOI 10.1210/jc.2012-4000; Zhang WH, 2001, P NATL ACAD SCI USA, V98, P6330	46	32	32	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2015	10	2							e0116691	10.1371/journal.pone.0116691	http://dx.doi.org/10.1371/journal.pone.0116691			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC3LS	25723513	Green Submitted, Green Published, gold			2022-12-27	WOS:000350251200019
J	Liechti, R; Ducray, AD; Jensen, P; Di Santo, S; Seiler, S; Jensen, CH; Meyer, M; Widmer, HR				Liechti, Remy; Ducray, Angelique D.; Jensen, Pia; Di Santo, Stefano; Seiler, Stefanie; Jensen, Charlotte H.; Meyer, Morten; Widmer, Hans Rudolf			Characterization of Fetal Antigen 1/Delta-Like 1 Homologue Expressing Cells in the Rat Nigrostriatal System: Effects of a Unilateral 6-Hydroxydopamine Lesion	PLOS ONE			English	Article							CALCIUM-BINDING PROTEINS; SUBSTANTIA-NIGRA; DOPAMINERGIC-NEURONS; PARKINSONS-DISEASE; GABAERGIC NEURONS; NERVOUS-SYSTEM; DIFFERENTIATION; MIDBRAIN; CALRETININ; BRAIN	Fetal antigen 1/delta-like 1 homologue (FA1/dlk1) belongs to the epidermal growth factor superfamily and is considered to be a non-canonical ligand for the Notch receptor. Interactions between Notch and its ligands are crucial for the development of various tissues. Moreover, FA1/dlk1 has been suggested as a potential supplementary marker of dopaminergic neurons. The present study aimed at investigating the distribution of FA1/dlk1-immunoreactive (-ir) cells in the early postnatal and adult midbrain as well as in the nigrostriatal system of 6-hydroxydopamine (6-OHDA)-lesioned hemiparkinsonian adult rats. FA1/dlk1-ir cells were predominantly distributed in the substantia nigra (SN) pars compacta (SNc) and in the ventral tegmental area. Interestingly, the expression of FA1/dlk1 significantly increased in tyrosine hydroxylase (TH)-ir cells during early postnatal development. Co-localization and tracing studies demonstrated that FA1/dlk1-ir cells in the SNc were nigrostriatal dopaminergic neurons, and unilateral 6-OHDA lesions resulted in loss of both FA1/dlk1-ir and TH-ir cells in the SNc. Surprisingly, increased numbers of FA1/dlk1-ir cells (by 70%) were detected in dopamine-depleted striata as compared to unlesioned controls. The higher number of FA1/dlk1-ir cells was likely not due to neurogenesis as colocalization studies for proliferation markers were negative. This suggests that FA1/dlk1 was up-regulated in intrinsic cells in response to the 6-OHDA-mediated loss of FA1/dlk1-expressing SNc dopaminergic neurons and/or due to the stab wound. Our findings hint to a significant role of FA1/dlk1 in the SNc during early postnatal development. The differential expression of FA1/dlk1 in the SNc and the striatum of dopamine-depleted rats could indicate a potential involvement of FA1/dlk1 in the cellular response to the degenerative processes.	[Liechti, Remy; Ducray, Angelique D.; Di Santo, Stefano; Seiler, Stefanie; Widmer, Hans Rudolf] Univ Bern, Inselspital, Neuroctr, Dept Neurosurg, CH-3010 Bern, Switzerland; [Liechti, Remy; Ducray, Angelique D.; Di Santo, Stefano; Seiler, Stefanie; Widmer, Hans Rudolf] Univ Bern, Inselspital, Regenerat Neurosci Cluster, CH-3010 Bern, Switzerland; [Jensen, Pia; Meyer, Morten] Univ Southern Denmark, Dept Neurobiol Res, Inst Mol Med, DK-5000 Odense C, Denmark; [Jensen, Charlotte H.] Odense Univ Hosp, Dept Clin Biochem & Pharmacol, DK-5000 Odense C, Denmark; [Jensen, Charlotte H.] Univ Southern Denmark, Dept Cardiovasc & Renal Res, DK-5000 Odense C, Denmark	University of Bern; University Hospital of Bern; University of Bern; University Hospital of Bern; University of Southern Denmark; University of Southern Denmark; Odense University Hospital; University of Southern Denmark	Widmer, HR (corresponding author), Univ Bern, Inselspital, Neuroctr, Dept Neurosurg, CH-3010 Bern, Switzerland.	hanswi@insel.ch	Jensen, Charlotte Harken/P-4612-2014; Widmer, Hans R./AAC-8948-2022; Di Santo, Stefano/P-2433-2019; Jensen, Charlotte Harken/AAZ-1738-2020; Di Santo, Stefano/K-5739-2014; Widmer, Hans Rudolf/O-5172-2017	Jensen, Charlotte Harken/0000-0001-9683-8761; Di Santo, Stefano/0000-0002-4032-999X; Jensen, Charlotte Harken/0000-0001-9683-8761; Di Santo, Stefano/0000-0002-4032-999X; Widmer, Hans Rudolf/0000-0003-3378-8765	Swiss Parkinson Foundation; HANELA Foundation; Swiss National Science Foundation [3100A0-112529, 31003A_135565]; Danish Parkinson Association; IMK Almene Fond; Kirsten and Freddy Johansens Fond; Horslev Fonden	Swiss Parkinson Foundation; HANELA Foundation; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Danish Parkinson Association; IMK Almene Fond; Kirsten and Freddy Johansens Fond; Horslev Fonden	This research was supported by the Swiss Parkinson Foundation, the HANELA Foundation and the Swiss National Science Foundation (No. 3100A0-112529 and 31003A_135565). Pia Jensen and Morten Meyer were supported by the Danish Parkinson Association, IMK Almene Fond, Kirsten and Freddy Johansens Fond and Horslev Fonden. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABERCROMBIE M, 1946, ANAT REC, V94, P239, DOI 10.1002/ar.1090940210; AlfahelKakunda A, 1997, DEV BRAIN RES, V103, P9, DOI 10.1016/S0165-3806(97)00101-6; ARTAVANISTSAKONAS S, 1995, SCIENCE, V268, P225, DOI 10.1126/science.7716513; Baladron V, 2005, EXP CELL RES, V303, P343, DOI 10.1016/j.yexcr.2004.10.001; Bauer M, 2008, J NEUROCHEM, V104, P1101, DOI 10.1111/j.1471-4159.2007.05037.x; Cannon JR, 2009, NEUROSCI LETT, V464, P14, DOI 10.1016/j.neulet.2009.08.023; CELIO MR, 1990, NEUROSCIENCE, V35, P375, DOI 10.1016/0306-4522(90)90091-H; Chen L, 2011, J BIOL CHEM, V286, P32140, DOI 10.1074/jbc.M111.230110; Christophersen NS, 2007, EXP NEUROL, V204, P791, DOI 10.1016/j.expneurol.2007.01.014; Costaglioli P, 2001, FEBS LETT, V509, P413, DOI 10.1016/S0014-5793(01)03205-7; Floridon C, 2000, DIFFERENTIATION, V66, P49, DOI 10.1046/j.1432-0436.2000.066001049.x; Gerfen CR, 1996, HDB CHEM NEUROANATOM, P371, DOI [10.1016/S0924-8196(96)80004-2, DOI 10.1016/S0924-8196(96)80004-2]; Gonzalez-Hernandez T, 2004, J COMP NEUROL, V479, P198, DOI 10.1002/cne.20323; Gonzalez-Hernandez T, 2000, J COMP NEUROL, V421, P107, DOI 10.1002/(SICI)1096-9861(20000522)421:1<107::AID-CNE7>3.0.CO;2-F; Harkness L, 2009, STEM CELL REV REP, V5, P353, DOI 10.1007/s12015-009-9099-4; Hontanilla B, 1997, SYNAPSE, V25, P359, DOI 10.1002/(SICI)1098-2396(199704)25:4<359::AID-SYN7>3.3.CO;2-G; Huot P, 2007, BRAIN, V130, P222, DOI 10.1093/brain/awl332; Hyman SE, 1996, NEURON, V16, P901, DOI 10.1016/S0896-6273(00)80111-7; Jacobs FMJ, 2009, DEVELOPMENT, V136, P2363, DOI 10.1242/dev.037556; Jankovic J, 2008, J NEUROL NEUROSUR PS, V79, P368, DOI 10.1136/jnnp.2007.131045; Jensen CH, 2001, NEUROREPORT, V12, P3959, DOI 10.1097/00001756-200112210-00021; Jensen P, 2007, J NEUROSCI RES, V85, P1884, DOI 10.1002/jnr.21327; Jensen P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076592; Korotkova TM, 2004, MOL NEUROBIOL, V29, P243, DOI 10.1385/MN:29:3:243; Laborda J, 2000, HISTOL HISTOPATHOL, V15, P119, DOI 10.14670/HH-15.119; Lang AE, 1998, NEW ENGL J MED, V339, P1044, DOI 10.1056/NEJM199810083391506; LAUDER JM, 1974, J COMP NEUROL, V155, P469, DOI 10.1002/cne.901550407; Lopez-Martin E, 1999, J COMP NEUROL, V406, P199, DOI 10.1002/(SICI)1096-9861(19990405)406:2<199::AID-CNE5>3.0.CO;2-Z; MARCHAND R, 1983, NEUROSCIENCE, V9, P373, DOI 10.1016/0306-4522(83)90300-7; McRitchie DA, 1996, J COMP NEUROL, V364, P121, DOI 10.1002/(SICI)1096-9861(19960101)364:1<121::AID-CNE11>3.0.CO;2-1; Meister B, 2013, J NEUROENDOCRINOL, V25, P617, DOI 10.1111/jne.12029; Meyer M, 1998, EXP BRAIN RES, V119, P345, DOI 10.1007/s002210050350; MOUATTPRIGENT A, 1994, BRAIN RES, V668, P62, DOI 10.1016/0006-8993(94)90511-8; Nemoto C, 1999, BRAIN RES, V846, P129, DOI 10.1016/S0006-8993(99)01950-2; OUIMET CC, 1984, J NEUROSCI, V4, P111; Park M, 2000, BRAIN DEV-JPN, V22, pS38; Paxinos G., 1986, RAT STEREOTAXIC COOR; Rajput PS, 2009, NEUROSCI RES, V65, P53, DOI 10.1016/j.neures.2009.05.005; Rodriguez M, 2001, EXP NEUROL, V169, P163, DOI 10.1006/exnr.2000.7624; ROGERS JH, 1992, NEUROSCIENCE, V51, P843, DOI 10.1016/0306-4522(92)90525-7; Samulewicz SJ, 2002, WOUND REPAIR REGEN, V10, P215, DOI 10.1046/j.1524-475X.2002.10404.x; Schaller B, 2005, BRAIN RES, V1036, P163, DOI 10.1016/j.brainres.2004.12.054; SELF DW, 1995, ANNU REV NEUROSCI, V18, P463, DOI 10.1146/annurev.neuro.18.1.463; STROMBERG I, 1993, EXP NEUROL, V124, P401, DOI 10.1006/exnr.1993.1214; Tse YC, 2000, BRAIN RES, V854, P57, DOI 10.1016/S0006-8993(99)02292-1; Villanueva C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036134	46	4	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2015	10	2							e0116088	10.1371/journal.pone.0116088	http://dx.doi.org/10.1371/journal.pone.0116088			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC3LS	25723595	Green Published, Green Submitted, gold			2022-12-27	WOS:000350251200013
J	Nguyen, NPT; Tran, BX; Hwang, LY; Markham, CM; Swartz, MD; Phan, HTT; Nong, VM; Nguyen, CT; Nguyen, AH; Latkin, CA; Vidrine, DJ				Nhung Phuong Thi Nguyen; Tran, Bach Xuan; Hwang, Lu Y.; Markham, Christine M.; Swartz, Michael D.; Huong Thu Thi Phan; Vuong Minh Nong; Cuong Tat Nguyen; Anh Hue Nguyen; Latkin, Carl A.; Vidrine, Damon J.			Prevalence of Cigarette Smoking and Associated Factors in a Large Sample of HIV-Positive Patients Receiving Antiretroviral Therapy in Vietnam	PLOS ONE			English	Article							ALCOHOL-USE DISORDERS; QUALITY-OF-LIFE; TOBACCO USE; INFECTED PATIENTS; CESSATION; HIV/AIDS; INDIVIDUALS; POPULATION; STRATEGIES; HEALTH	Background Cigarette smoking presents a salient risk for HIV-positive populations. This study is among the first to examine smoking prevalence, nicotine dependence, and associated factors in a large sample of HIV-positive patients receiving antiretroviral therapy (ART) in Vietnam. Methods A cross-sectional study of 1133 HIV-positive people was conducted from January to September 2013 at 8 ART clinics in Hanoi (the capital) and Nam Dinh (a rural area). Smoking history and nicotine dependence (Fagerstrom Test of Nicotine Dependence-FTND) were assessed by participant self-report. Logistic regression and Tobit linear regression were performed to identify factors significantly associated with smoking outcomes. Results Prevalence of current, former, and never smokers in the sample was 36.1%, 9.5%, and 54.4%, respectively. The current smoking proportion was higher in males (59.7%) than females (2.6%). The mean FTND score was 3.6 (SD = 2.1). Males were more likely to currently smoke than females (OR = 23.4, 95% CI = 11.6-47.3). Individuals with problem drinking (OR = 1.8, 95% CI = 1.1-2.9) and ever drug use (OR = 3.7, 95% CI = 2.5-5.7) were more likely to be current smokers. Older age and currently feeling pain were associated with lower nicotine dependence. Conversely, receiving care in Nam Dinh, greater alcohol consumption, ever drug use, and a longer smoking duration were associated with greater nicotine dependence. Conclusions Given the high prevalence of smoking among HIV-positive patients, smoking screening and cessation support should be offered at ART clinics in Vietnam. Risk factors (i.e., substance use) linked with smoking behavior should be considered in prevention programs.	[Nhung Phuong Thi Nguyen; Hwang, Lu Y.; Markham, Christine M.; Swartz, Michael D.] Univ Texas Hlth Sci Ctr Houston, Houston, TX 77030 USA; [Nhung Phuong Thi Nguyen; Vidrine, Damon J.] Univ Texas MD Anderson Canc Ctr, Dept Behav Sci, Unit 1330, Houston, TX 77030 USA; [Tran, Bach Xuan; Vuong Minh Nong; Cuong Tat Nguyen; Anh Hue Nguyen] Hanoi Med Univ, Inst Prevent Med & Publ Hlth, Hanoi 100803, Vietnam; [Nhung Phuong Thi Nguyen] Hanoi Univ Pharm, Hanoi, Vietnam; [Huong Thu Thi Phan] Minist Hlth, Author HIV AIDS Control, Hanoi, Vietnam; [Tran, Bach Xuan; Latkin, Carl A.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Hlth Behav & Soc, Baltimore, MD USA	University of Texas System; University of Texas Health Science Center Houston; University of Texas System; UTMD Anderson Cancer Center; Hanoi Medical University; Hanoi University of Pharmacy; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Tran, BX (corresponding author), Hanoi Med Univ, Inst Prevent Med & Publ Hlth, Hanoi 100803, Vietnam.	bach@hmu.edu.vn	Nguyen, Nhung/J-8012-2019; Swartz, Michael/AEX-2820-2022	Nguyen, Nhung/0000-0002-8661-9597; Swartz, Michael/0000-0003-3953-8775				Tran BX, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-27; Tran BX, 2013, B WORLD HEALTH ORGAN, V91, P475, DOI 10.2471/BLT.12.115147; Tran BX, 2012, HEALTH QUAL LIFE OUT, V10, DOI 10.1186/1477-7525-10-132; Tran BX, 2013, DRUG ALCOHOL DEPEN, V127, P39, DOI 10.1016/j.drugalcdep.2012.06.009; Broom Jennifer, 2012, J Int Assoc Physicians AIDS Care (Chic), V11, P109, DOI 10.1177/1545109711418832; Burkhalter JE, 2005, NICOTINE TOB RES, V7, P511, DOI 10.1080/14622200500186064; Bush K, 1998, ARCH INTERN MED, V158, P1789, DOI 10.1001/archinte.158.16.1789; Duval X, 2008, ANTIVIR THER, V13, P389; EQOLG, 2011, EQ 5D 5L US GUID BAS; Feldman JG, 2006, AM J PUBLIC HEALTH, V96, P1060, DOI 10.2105/AJPH.2005.062745; Furber AS, 2007, SEX TRANSM INFECT, V83, P41, DOI 10.1136/sti.2005.019505; Global Adult Tobacco Survey, 2010, GLOB AD TOB SURV VIE; Gritz ER, 2004, NICOTINE TOB RES, V6, P71, DOI 10.1080/14622200310001656885; HEATHERTON TF, 1991, BRIT J ADDICT, V86, P1119; Helleberg M, 2013, CLIN INFECT DIS, V56, P727, DOI 10.1093/cid/cis933; Higashi H, 2012, ADDICTION, V107, P658, DOI 10.1111/j.1360-0443.2011.03632.x; Hosmer DW, 2000, APPL LOGISTIC REGRES, DOI 10.1002/0471722146; Humfleet GL, 2009, AIDS EDUC PREV, V21, P54, DOI 10.1521/aeap.2009.21.3_supp.54; Jaquet A, 2009, INT J TUBERC LUNG D, V13, P1433; Lifson AR, 2010, AM J PUBLIC HEALTH, V100, P1896, DOI 10.2105/AJPH.2009.188664; Luo XF, 2014, DRUG ALCOHOL DEPEN, V134, P144, DOI 10.1016/j.drugalcdep.2013.09.023; Marshall MM, 2009, AIDS EDUC PREV, V21, P28, DOI 10.1521/aeap.2009.21.3_supp.28; Miguez-Burbano MJ, 2003, ADDICT BIOL, V8, P39, DOI 10.1080/1355621031000069864; National Committee for AIDS and Prostitution Prevention and Control, 2012, VIET NAM AIDS RESP P; Niaura R, 2012, CURR HIV-AIDS REP, V9, P375, DOI 10.1007/s11904-012-0138-4; O'Cleirigh C, 2014, AIDS BEHAV; Pacek LR, 2013, AIDS BEHAV; Rahmanian Shiva, 2011, Proc Am Thorac Soc, V8, P313, DOI 10.1513/pats.201009-058WR; Reynolds NR, 2009, AIDS EDUC PREV, V21, P106, DOI 10.1521/aeap.2009.21.3_supp.106; Shirley DK, 2013, AIDS PATIENT CARE ST, V27, P604, DOI 10.1089/apc.2013.0128; Shirley DK, 2013, CLIN INFECT DIS, V57, P275, DOI 10.1093/cid/cit207; Tang AM, 2011, AIDS RES TREAT, V2011, DOI 10.1155/2011/890308; Tesoriero JM, 2010, AIDS BEHAV, V14, P824, DOI 10.1007/s10461-008-9449-2; The Joint United Nations Programme on HIV and AIDS (UNAIDS), 2013, UNAIDS REP GLOB HIV; Twisk J, 2009, J CLIN EPIDEMIOL, V62, P953, DOI 10.1016/j.jclinepi.2008.10.003; Vidrine DJ, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-696; Vidrine DJ, 2012, NICOTINE TOB RES, V14, P106, DOI 10.1093/ntr/ntr121; Vidrine DJ, 2009, AIDS EDUC PREV, V21, P3, DOI 10.1521/aeap.2009.21.3_supp.3; Vietnam Authority of HIV/AIDS Control, 2014, REP CURR SIT HIV INF; Webb MS, 2007, J BEHAV MED, V30, P371, DOI 10.1007/s10865-007-9112-9	40	22	23	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2015	10	2							e0118185	10.1371/journal.pone.0118185	http://dx.doi.org/10.1371/journal.pone.0118185			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CC3LS	25723596	Green Published, gold, Green Submitted			2022-12-27	WOS:000350251200048
J	Piya, G; Mueller, EN; Haas, HK; Ghospurkar, PL; Wilson, TM; Jensen, JL; Colbert, CL; Haring, SJ				Piya, Gunjan; Mueller, Erica N.; Haas, Heather K.; Ghospurkar, Padmaja L.; Wilson, Timothy M.; Jensen, Jaime L.; Colbert, Christopher L.; Haring, Stuart J.			Characterization of the Interaction between Rfa1 and Rad24 in Saccharomyces cerevisiae	PLOS ONE			English	Article							REPLICATION-PROTEIN-A; DNA-DAMAGE CHECKPOINTS; STRUCTURE PREDICTION; RPA PHOSPHORYLATION; STRUCTURAL-ANALYSIS; COILED COILS; HUMAN RAD17; CELL-CYCLE; ACTIVATION; BINDING	Maintaining the integrity of the genome requires the high fidelity duplication of the genome and the ability of the cell to recognize and repair DNA lesions. The heterotrimeric single stranded DNA (ssDNA) binding complex Replication Protein A (RPA) is central to multiple DNA processes, which are coordinated by RPA through its ssDNA binding function and through multiple protein-protein interactions. Many RPA interacting proteins have been reported through large genetic and physical screens; however, the number of interactions that have been further characterized is limited. To gain a better understanding of how RPA functions in DNA replication, repair, and cell cycle regulation and to identify other potential functions of RPA, a yeast two hybrid screen was performed using the yeast 70 kDa subunit, Replication Factor A1 (Rfa1), as a bait protein. Analysis of 136 interaction candidates resulted in the identification of 37 potential interacting partners, including the cell cycle regulatory protein and DNA damage clamp loader Rad24. The Rfa1-Rad24 interaction is not dependent on ssDNA binding. However, this interaction appears affected by DNA damage. The regions of both Rfa1 and Rad24 important for this interaction were identified, and the region of Rad24 identified is distinct from the region reported to be important for its interaction with Rfc2 5. This suggests that Rad24-Rfc2-5 (Rad24-RFC) recruitment to DNA damage substrates by RPA occurs, at least partially, through an interaction between the N terminus of Rfa1 and the C terminus of Rad24. The predicted structure and location of the Rad24 C-terminus is consistent with a model in which RPA interacts with a damage substrate, loads Rad24-RFC at the 5' junction, and then releases the Rad24-RFC complex to allow for proper loading and function of the DNA damage clamp.	[Piya, Gunjan; Mueller, Erica N.; Haas, Heather K.; Ghospurkar, Padmaja L.; Wilson, Timothy M.; Jensen, Jaime L.; Colbert, Christopher L.; Haring, Stuart J.] N Dakota State Univ, Dept Chem & Biochem, Fargo, ND 58108 USA; [Colbert, Christopher L.; Haring, Stuart J.] N Dakota State Univ, Interdisciplinary Program Cellular & Mol Biol, Fargo, ND 58108 USA	North Dakota State University Fargo; North Dakota State University Fargo	Haring, SJ (corresponding author), N Dakota State Univ, Dept Chem & Biochem, Fargo, ND 58108 USA.	stuart.haring@ndsu.edu		Jensen, Jaime/0000-0002-8818-7513	National Science Foundation [NSF-CAREER-1253723]; North Dakota State University; National Institute of Justice [NIJ-2004RGCX-K001]; National Institutes of Health [NIH-P20RR015566]; Div Of Molecular and Cellular Bioscience [1253723] Funding Source: National Science Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR015566] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); North Dakota State University; National Institute of Justice(US National Institute of Justice); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Div Of Molecular and Cellular Bioscience(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported by the National Science Foundation (NSF-CAREER-1253723) and startup funds provided by North Dakota State University, the National Institute of Justice (NIJ-2004RGCX-K001), and the National Institutes of Health (NIH-P20RR015566) to SJH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anantha RW, 2007, J BIOL CHEM, V282, P35910, DOI 10.1074/jbc.M704645200; Ashley AK, 2014, DNA REPAIR, V21, P131, DOI 10.1016/j.dnarep.2014.04.008; Bae KH, 2003, NUCLEIC ACIDS RES, V31, P3006, DOI 10.1093/nar/gkg422; Ball HL, 2005, MOL BIOL CELL, V16, P2372, DOI 10.1091/mbc.e04-11-1006; Banerjee S, 2008, J CELL BIOL, V181, P1083, DOI 10.1083/jcb.200711146; Bao SD, 2001, NATURE, V411, P969, DOI 10.1038/35082110; Binz SK, 2004, DNA REPAIR, V3, P1015, DOI 10.1016/j.dnarep.2004.03.028; Biswas SB, 1997, BIOCHEMISTRY-US, V36, P13270, DOI 10.1021/bi9712910; Bochkareva E, 2002, EMBO J, V21, P1855, DOI 10.1093/emboj/21.7.1855; Bond CS, 2009, ACTA CRYSTALLOGR D, V65, P510, DOI 10.1107/S0907444909007835; Bonilla CY, 2008, MOL CELL, V30, P267, DOI 10.1016/j.molcel.2008.03.023; Bowman GD, 2004, NATURE, V429, P724, DOI 10.1038/nature02585; Buchan DWA, 2013, NUCLEIC ACIDS RES, V41, pW349, DOI 10.1093/nar/gkt381; Chatr-aryamontri A, 2013, NUCLEIC ACIDS RES, V41, pD816, DOI 10.1093/nar/gks1158; Cole C, 2008, NUCLEIC ACIDS RES, V36, pW197, DOI 10.1093/nar/gkn238; Cuff JA, 1998, BIOINFORMATICS, V14, P892, DOI 10.1093/bioinformatics/14.10.892; Fanning E, 2006, NUCLEIC ACIDS RES, V34, P4126, DOI 10.1093/nar/gkl550; Fisher LA, 2011, J MOL BIOL, V413, P337, DOI 10.1016/j.jmb.2011.08.034; Gardner R, 1999, EMBO J, V18, P3173, DOI 10.1093/emboj/18.11.3173; Gasior SL, 1998, GENE DEV, V12, P2208, DOI 10.1101/gad.12.14.2208; Ghospurkar PL, GENETICS SUBMITTED; Glanzer JG, 2011, BIOORGAN MED CHEM, V19, P2589, DOI 10.1016/j.bmc.2011.03.012; GOLEMIS EA, 1992, MOL CELL BIOL, V12, P3006, DOI 10.1128/MCB.12.7.3006; GOMES XV, 1995, J BIOL CHEM, V270, P4534, DOI 10.1074/jbc.270.9.4534; Green CM, 2000, CURR BIOL CB, V10; GUARENTE L, 1983, METHOD ENZYMOL, V101, P181; GYURIS J, 1993, CELL, V75, P791, DOI 10.1016/0092-8674(93)90498-F; Harrison JC, 2006, ANNU REV GENET, V40, P209, DOI 10.1146/annurev.genet.40.051206.105231; Hegnauer AM, 2012, EMBO J, V31, P3768, DOI 10.1038/emboj.2012.195; Holt LJ, 2009, SCIENCE, V325, P1682, DOI 10.1126/science.1172867; Iftode C, 1999, CRIT REV BIOCHEM MOL, V34, P141, DOI 10.1080/10409239991209255; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; Kallberg M, 2012, NAT PROTOC, V7, P1511, DOI 10.1038/nprot.2012.085; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; KESHAV KF, 1995, MOL CELL BIOL, V15, P3119; Kim HS, 2001, MOL CELL BIOL, V21, P3725, DOI 10.1128/MCB.21.11.3725-3737.2001; Kneissl M, 2003, J MOL BIOL, V327, P111, DOI 10.1016/S0022-2836(03)00079-2; Kondo T, 2001, SCIENCE, V294, P867, DOI 10.1126/science.1063827; Li X, 2007, J PROTEOME RES, V6, P1190, DOI 10.1021/pr060559j; Lindsey-Boltz LA, 2012, J BIOL CHEM, V287, P36123, DOI 10.1074/jbc.M112.407825; Liu SQ, 2012, NUCLEIC ACIDS RES, V40, P10780, DOI 10.1093/nar/gks849; LUPAS A, 1991, SCIENCE, V252, P1162, DOI 10.1126/science.252.5009.1162; Lupas A, 1996, TRENDS BIOCHEM SCI, V21, P375, DOI 10.1016/0968-0004(96)10052-9; MA H, 1987, GENE, V58, P201, DOI 10.1016/0378-1119(87)90376-3; Majka J, 2006, J BIOL CHEM, V281, P27855, DOI 10.1074/jbc.M605176200; Maniar HS, 1997, GENETICS, V145, P891; MATSUDA T, 1995, J BIOL CHEM, V270, P4152, DOI 10.1074/jbc.270.8.4152; Naiki T, 2000, MOL CELL BIOL, V20, P5888, DOI 10.1128/MCB.20.16.5888-5896.2000; Nakada D, 2005, MOL BIOL CELL, V16, P5227, DOI 10.1091/mbc.E05-05-0405; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Oakley GG, 2010, FRONT BIOSCI LANDMAR, V15; Oakley GG, 2009, BIOCHEMISTRY-US, V48, P7473, DOI 10.1021/bi900694p; Post S, 2001, P NATL ACAD SCI USA, V98, P13102, DOI 10.1073/pnas.231364598; Robison JG, 2004, J BIOL CHEM, V279, P34802, DOI 10.1074/jbc.M404750200; Sadowski I, 2013, DATABASE-OXFORD, DOI 10.1093/database/bat026; Small VY, 2008, CELL CYCLE, V7, P3428, DOI 10.4161/cc.7.21.6983; Soding J, 2005, NUCLEIC ACIDS RES, V33, pW244, DOI 10.1093/nar/gki408; Stark C, 2006, NUCLEIC ACIDS RES, V34, pD535, DOI 10.1093/nar/gkj109; Stark C, 2010, DATABASE-OXFORD, DOI 10.1093/database/bap026; Wold MS, 1997, ANNU REV BIOCHEM, V66, P61, DOI 10.1146/annurev.biochem.66.1.61; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40; Zou L, 2003, P NATL ACAD SCI USA, V100, P13827, DOI 10.1073/pnas.2336100100; Zou L, 2003, SCIENCE, V300, P1542, DOI 10.1126/science.1083430	63	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2015	10	2							e0116512	10.1371/journal.pone.0116512	http://dx.doi.org/10.1371/journal.pone.0116512			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC2ZH	25719602	gold, Green Published, Green Submitted			2022-12-27	WOS:000350213200008
J	Ansseau, E; Domire, JS; Wallace, LM; Eidahl, JO; Guckes, SM; Giesige, CR; Pyne, NK; Belayew, A; Harper, SQ				Ansseau, Eugenie; Domire, Jacqueline S.; Wallace, Lindsay M.; Eidahl, Jocelyn O.; Guckes, Susan M.; Giesige, Carlee R.; Pyne, Nettie K.; Belayew, Alexandra; Harper, Scott Q.			Aberrant Splicing in Transgenes Containing Introns, Exons, and V5 Epitopes: Lessons from Developing an FSHD Mouse Model Expressing a D4Z4 Repeat with Flanking Genomic Sequences	PLOS ONE			English	Article							FACIOSCAPULOHUMERAL MUSCULAR-DYSTROPHY; DUX4 GENE; PATHOLOGIES; VECTORS; ENCODES; LOCUS	The DUX4 gene, encoded within D4Z4 repeats on human chromosome 4q35, has recently emerged as a key factor in the pathogenic mechanisms underlying Facioscapulohumeral muscular dystrophy (FSHD). This recognition prompted development of animal models expressing the DUX4 open reading frame (ORF) alone or embedded within D4Z4 repeats. In the first published model, we used adeno-associated viral vectors (AAV) and strong viral control elements (CMV promoter, SV40 poly A) to demonstrate that the DUX4 cDNA caused dose-dependent toxicity in mouse muscles. As a follow-up, we designed a second generation of DUX4-expressing AAV vectors to more faithfully genocopy the FSHD-permissive D4Z4 repeat region located at 4q35. This new vector (called AAV. D4Z4.V5.pLAM) contained the D4Z4/DUX4 promoter region, a V5 epitope-tagged DUX4 ORF, and the natural 3' untranslated region (pLAM) harboring two small introns, DUX4 exons 2 and 3, and the non-canonical poly A signal required for stabilizing DUX4 mRNA in FSHD. AAV. D4Z4. V5. pLAM failed to recapitulate the robust pathology of our first generation vectors following delivery to mouse muscle. We found that the DUX4. V5 junction sequence created an unexpected splice donor in the pre-mRNA that was preferentially utilized to remove the V5 coding sequence and DUX4 stop codon, yielding non-functional DUX4 protein with 55 additional residues on its carboxyl-terminus. Importantly, we further found that aberrant splicing could occur in any expression construct containing a functional splice acceptor and sequences resembling minimal splice donors. Our findings represent an interesting case study with respect to AAV. D4Z4. V5. pLAM, but more broadly serve as a note of caution for designing constructs containing V5 epitope tags and/or transgenes with downstream introns and exons.	[Ansseau, Eugenie; Belayew, Alexandra] Univ Mons, Res Inst Hlth Sci & Technol, Mol Biol Lab, B-7000 Mons, Belgium; [Domire, Jacqueline S.; Wallace, Lindsay M.; Eidahl, Jocelyn O.; Guckes, Susan M.; Giesige, Carlee R.; Pyne, Nettie K.; Harper, Scott Q.] Nationwide Childrens Hosp, Res Inst, Ctr Gene Therapy, Columbus, OH 43205 USA; [Giesige, Carlee R.; Harper, Scott Q.] Ohio State Univ, Biomed Sci Grad Program, Columbus, OH 43210 USA; [Harper, Scott Q.] Ohio State Univ, Coll Med, Dept Pediat, Columbus, OH 43210 USA	University of Mons; University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Research Institute at Nationwide Children's Hospital; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Harper, SQ (corresponding author), Nationwide Childrens Hosp, Res Inst, Ctr Gene Therapy, Columbus, OH 43205 USA.	Scott.Harper@nationwidechildrens.org	BELAYEW, Alexandra/D-5205-2013	BELAYEW, Alexandra/0000-0001-5115-2424; Domire, Jacqueline/0000-0003-3387-2465	FSHD Global Foundation; Chris Carrino Foundation; National Institutes of Health [1R01AR062123-01]; Muscular Dystrophy Association [218892]; Facioscapulohumeral Society [FSHS-JJFR-001]; NIH T32 training grant [1T32NS077984-01]; FSH Society; FNRS Belgium; CWBI (Walloon Region); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [TL1TR001069] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR062123] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [T32NS077984] Funding Source: NIH RePORTER	FSHD Global Foundation; Chris Carrino Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Muscular Dystrophy Association(Muscular Dystrophy Association); Facioscapulohumeral Society; NIH T32 training grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); FSH Society; FNRS Belgium(Fonds de la Recherche Scientifique - FNRS); CWBI (Walloon Region); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by grants from: FSHD Global Foundation, The Chris Carrino Foundation, The National Institutes of Health (1R01AR062123-01, to SQH, URL: www.niams.nih.gov), The Muscular Dystrophy Association (218892, to SQH, URL: www.mda.org),The Facioscapulohumeral Society (FSHS-JJFR-001, to SQH, URL: www.fshsociety.org). During the course of this work, LMW was a fellow on an NIH T32 training grant (Muscle Disease and Biology, 1T32NS077984-01, URL: www.osuchildrensmusclegroup.org). During the course of this work, JSD was a fellow on the Ohio State University Systems and Integrative Biology Training Grant (URL: medicine.osu.edu/bsgp/program-overview/program-highlights/pages/index.aspx). EA travel to SH's laboratory was funded by the FSH Society (www.fshsociety.org), the FNRS Belgium (www.frs-fnrs.be) and the CWBI (Walloon Region; cwbi.fsagx.ac.be). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blankinship MJ, 2004, MOL THER, V10, P671, DOI 10.1016/j.ymthe.2004.07.016; Block GJ, 2013, HUM MOL GENET, V22, P4661, DOI 10.1093/hmg/ddt314; Bosnakovski D, 2008, EMBO J, V27, P2766, DOI 10.1038/emboj.2008.201; Boudreau RL, 2011, NEUROMETHODS, V58, P19, DOI 10.1007/978-1-61779-114-7_2; Brizzard B, 2008, BIOTECHNIQUES, V44, P693, DOI 10.2144/000112841; Dandapat A, 2014, CELL REP, V8, P1484, DOI 10.1016/j.celrep.2014.07.056; de Greef JC, 2009, HUM MUTAT, V30, P1449, DOI 10.1002/humu.21091; Desmet FO, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp215; Dixit M, 2007, P NATL ACAD SCI USA, V104, P18157, DOI 10.1073/pnas.0708659104; FLANIGAN KM, 2013, FACIOSCAPULOHUMERAL, P288; Gabriels J, 1999, GENE, V236, P25, DOI 10.1016/S0378-1119(99)00267-X; Geng LN, 2011, HYBRIDOMA, V30, P125, DOI 10.1089/hyb.2010.0094; Harper SQ, 2005, P NATL ACAD SCI USA, V102, P5820, DOI 10.1073/pnas.0501507102; Hartweck LM, 2013, NEUROLOGY, V80, P392, DOI 10.1212/WNL.0b013e31827f075c; Himeda CL, 2014, MOL CELL BIOL, V34, P1942, DOI 10.1128/MCB.00149-14; Huichalaf C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115278; Jacob AG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104444; Jiang GC, 2003, HUM MOL GENET, V12, P2909, DOI 10.1093/hmg/ddg323; Kowaljow V, 2007, NEUROMUSCULAR DISORD, V17, P611, DOI 10.1016/j.nmd.2007.04.002; Krom YD, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003415; Lemmers RJLF, 2007, AM J HUM GENET, V81, P884, DOI 10.1086/521986; Lemmers RJLF, 2012, NAT GENET, V44, P1370, DOI 10.1038/ng.2454; Lemmers RJLF, 2010, SCIENCE, V329, P1650, DOI 10.1126/science.1189044; Lemmers RJFL, 2004, AM J HUM GENET, V75, P1124, DOI 10.1086/426035; PADGETT RA, 1986, ANNU REV BIOCHEM, V55, P1119, DOI 10.1146/annurev.bi.55.070186.005351; Reese MG, 1997, J COMPUT BIOL, V4, P311, DOI 10.1089/cmb.1997.4.311; Snider L, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001181; Snider L, 2009, HUM MOL GENET, V18, P2414, DOI 10.1093/hmg/ddp180; van Overveld PGM, 2005, ANN NEUROL, V58, P569, DOI 10.1002/ana.20625; Vanderplanck C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026820; Wallace LM, 2013, MOL THER-NUCL ACIDS, V2, DOI 10.1038/mtna.2013.16; Wallace LM, 2012, MOL THER, V20, P1417, DOI 10.1038/mt.2012.68; Wallace LM, 2011, ANN NEUROL, V69, P540, DOI 10.1002/ana.22275	33	11	11	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2015	10	3							e0118813	10.1371/journal.pone.0118813	http://dx.doi.org/10.1371/journal.pone.0118813			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9KG	25742305	Green Published, gold, Green Submitted			2022-12-27	WOS:000350688100048
J	Chung, SH; Gillies, M; Sugiyama, Y; Zhu, L; Lee, SR; Shen, WY				Chung, Sook Hyun; Gillies, Mark; Sugiyama, Yuki; Zhu, Ling; Lee, So-Ra; Shen, Weiyong			Profiling of MicroRNAs Involved in Retinal Degeneration Caused by Selective Muller Cell Ablation	PLOS ONE			English	Article							GENE-EXPRESSION; NEUROTRANSMITTER RELEASE; KINASE-II; CYCLIN D2; PROTEIN; ACTIVATION; CALMODULIN; APOPTOSIS; NEUROPROTECTION; PROLIFERATION	Dysfunction of Muller cells has been implicated in the pathogenesis of several retinal diseases. In order to understand the potential contribution of Muller cells to retinal disease better, we have developed a transgenic model in which foci of Muller cell ablation can be selectively induced. MicroRNAs (miRNAs), small non-coding RNAs that are involved in post-transcriptional modulation, have critical functions in various biological processes. The aim of this study was to profile differential expression of miRNAs and to examine changes in their target genes 2 weeks after Muller cell ablation. We identified 20 miRNAs using the miScript HC PCR array. Data analysis using two target gene prediction databases (TargetScan and mirTarBase) revealed 78 overlapping target genes. DAVID and KEGG pathway analysis suggested that the target genes were generally involved in cell apoptosis, p53, neurotrophin, calcium, chemokine and Jak-STAT signalling pathways. Changes in seven target genes including Cyclin D2, Caspase 9, insulin-like growth factor 1, IL-1 receptor-associated kinase (IRAK), calmodulin (CALM) and Janus kinase 2 (Jak2), were validated with qRT-PCR and western blots. The cellular localisation of cleaved-caspase 9, Cyclin D2, Jak2 and CALM was examined by immunofluorescence studies. We found that the transcription of some miRNAs was positively, rather than negatively, correlated with their target genes. After confirming that overexpressed miR-133a-3p was localised to the outer nuclear layer in the damaged retina, we validated the correlation between miR-133a-3p and one of its predicted target genes, cyclin D2, with a luciferase assay in 661 photoreceptor cells. Results revealed by miRNA profiling, target gene analysis and validation were generally consistent with our previous findings that selective Muller cell ablation causes photoreceptor degeneration and neuroinflammation. Our data on alterations of miRNAs and their target gene expression after Muller cell ablation provide further insights into the potential role of Muller cell dysfunction in retinal disease.	[Chung, Sook Hyun; Gillies, Mark; Zhu, Ling; Lee, So-Ra; Shen, Weiyong] Univ Sydney, Save Sight Inst, Macular Res Grp, Clin Ophthalmol & Eye Hlth, Sydney, NSW 2006, Australia; [Sugiyama, Yuki] Univ Sydney, Save Sight Inst, Lens Res Grp, Clin Ophthalmol & Eye Hlth, Sydney, NSW 2006, Australia	University of Sydney; University of Sydney	Chung, SH (corresponding author), Univ Sydney, Save Sight Inst, Macular Res Grp, Clin Ophthalmol & Eye Hlth, Sydney, NSW 2006, Australia.	sook.chung@sydney.edu.au	Sugiyama, Yuki/B-2656-2018	Sugiyama, Yuki/0000-0001-7830-0677	Lowy Medical Research Institute; National Health and Medical Research Council (NHMRC, Australia) [APP1028393]; Ophthalmic Research Institute of Australia; NHMRC	Lowy Medical Research Institute; National Health and Medical Research Council (NHMRC, Australia)(National Health and Medical Research Council (NHMRC) of Australia); Ophthalmic Research Institute of Australia; NHMRC(National Health and Medical Research Council (NHMRC) of Australia)	This study was supported by grants from Lowy Medical Research Institute, National Health and Medical Research Council (NHMRC, Australia; APP1028393) and Ophthalmic Research Institute of Australia. Mark Gillies is a fellow of Sydney Medical School Foundation and supported by a NHMRC Practitioner Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Bai M, 2007, ANTICANCER RES, V27, P2345; Bray I, 2011, CANCER LETT, V303, P56, DOI 10.1016/j.canlet.2011.01.016; Cao ZD, 1996, SCIENCE, V271, P1128, DOI 10.1126/science.271.5252.1128; Chung SH, 2013, INVEST OPHTH VIS SCI, V54, P6578, DOI 10.1167/iovs.13-12311; Cossetti C, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00117; DELORENZO RJ, 1982, FED PROC, V41, P2265; Ding L, 2010, CELL RES, V20, P784, DOI 10.1038/cr.2010.79; Fabian MR, 2010, PROG MOL SUBCELL BIO, V50, P1, DOI 10.1007/978-3-642-03103-8_1; Fabian MR, 2010, ANNU REV BIOCHEM, V79, P351, DOI 10.1146/annurev-biochem-060308-103103; Fan W, 2006, BRAIN RES, V1067, P48, DOI 10.1016/j.brainres.2005.10.030; Fan W, 2005, MOL BRAIN RES, V139, P306, DOI 10.1016/j.molbrainres.2005.06.008; Fan W, 2009, INVEST OPHTH VIS SCI, V50, P917, DOI 10.1167/iovs.08-2555; Feng BA, 2011, DIABETES, V60, P2975, DOI 10.2337/db11-0478; Freilich RW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079416; Fridman JS, 2003, ONCOGENE, V22, P9030, DOI 10.1038/sj.onc.1207116; Goebel DJ, 2009, BRAIN RES, V1256, P190, DOI 10.1016/j.brainres.2008.12.051; Goodall EF, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00178; Hackler L, 2010, INVEST OPHTH VIS SCI, V51, P1823, DOI 10.1167/iovs.09-4657; Hauck SM, 2006, MOL CELL PROTEOMICS, V5, P324, DOI 10.1074/mcp.M500217-MCP200; Hinds HL, 2003, P NATL ACAD SCI USA, V100, P4275, DOI 10.1073/pnas.0530202100; Huntzinger E, 2011, NAT REV GENET, V12, P99, DOI 10.1038/nrg2936; Ishida W, 2011, INVEST OPHTH VIS SCI, V52, P611, DOI 10.1167/iovs.10-6115; Jablonski MM, 2000, GLIA, V32, P192, DOI 10.1002/1098-1136(200011)32:2<192::AID-GLIA80>3.0.CO;2-6; Jang S, 2007, NEUROCHEM RES, V32, P1, DOI 10.1007/s11064-006-9215-7; Jovicic A, 2013, J NEUROSCI, V33, P5127, DOI 10.1523/JNEUROSCI.0600-12.2013; Karali M, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-715; Kovacs B, 2011, INVEST OPHTH VIS SCI, V52, P4402, DOI 10.1167/iovs.10-6879; Kowalczyk A, 2004, J CELL BIOL, V167, P209, DOI 10.1083/jcb.200404181; Krol J, 2010, CELL, V141, P618, DOI 10.1016/j.cell.2010.03.039; Ksiazek-Winiarek DJ, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/172351; Lau P, 2013, EMBO MOL MED, V5, P1613, DOI 10.1002/emmm.201201974; Lee S, 2013, ADV EXP MED BIOL, V768, P97, DOI 10.1007/978-1-4614-5107-5_7; Liu N, 2008, GENE DEV, V22, P3242, DOI 10.1101/gad.1738708; Loscher CJ, 2008, EXP EYE RES, V87, P529, DOI 10.1016/j.exer.2008.08.016; Loscher CJ, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-11-r248; Ma CY, 1998, P NATL ACAD SCI USA, V95, P9938, DOI 10.1073/pnas.95.17.9938; Maes OC, 2009, CURR GENOMICS, V10, P154, DOI 10.2174/138920209788185252; Mamidipudi V, 2002, J BIOL CHEM, V277, P28010, DOI 10.1074/jbc.M109730200; McArthur K, 2011, DIABETES, V60, P1314, DOI 10.2337/db10-1557; Mortensen RD, 2011, P NATL ACAD SCI USA, V108, P8281, DOI 10.1073/pnas.1105401108; Nunez YO, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-725; Nunez-Iglesias J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008898; Omran A, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/291826; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Place RF, 2008, P NATL ACAD SCI USA, V105, P1608, DOI 10.1073/pnas.0707594105; Powner MB, 2010, OPHTHALMOLOGY, V117, P2407, DOI 10.1016/j.ophtha.2010.04.001; Poy MN, 2004, NATURE, V432, P226, DOI 10.1038/nature03076; Rungger-Brandle E, 2000, INVEST OPHTH VIS SCI, V41, P1971; Shen WY, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-137; Shen WY, 2012, J NEUROSCI, V32, P15715, DOI 10.1523/JNEUROSCI.2841-12.2012; Silva VAO, 2011, MOL VIS, V17, P2228; Siomi H, 2010, MOL CELL, V38, P323, DOI 10.1016/j.molcel.2010.03.013; Sundermeier TR, 2012, CELL MOL LIFE SCI, V69, P2739, DOI 10.1007/s00018-012-0976-7; TOUT S, 1993, NEUROSCIENCE, V55, P291, DOI 10.1016/0306-4522(93)90473-S; Ui-Tei K, 2000, APOPTOSIS, V5, P133, DOI 10.1023/A:1009676528805; Urbach A, 2013, BEHAV NEUROSCI, V127, P1, DOI 10.1037/a0031222; Vasudevan S, 2007, SCIENCE, V318, P1931, DOI 10.1126/science.1149460; Vasudevan S, 2012, WIRES RNA, V3, P311, DOI 10.1002/wrna.121; Yu W, 2002, LAB INVEST, V82, P1229	60	30	30	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2015	10	3							e0118949	10.1371/journal.pone.0118949	http://dx.doi.org/10.1371/journal.pone.0118949			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9KG	25741709	Green Published, Green Submitted, gold			2022-12-27	WOS:000350688100066
J	Loureiro, CL; Aguilar, JC; Aguiar, J; Muzio, V; Penton, E; Garcia, D; Guillen, G; Pujol, FH				Loureiro, Carmen L.; Aguilar, Julio C.; Aguiar, Jorge; Muzio, Verena; Penton, Eduardo; Garcia, Daymir; Guillen, Gerardo; Pujol, Flor H.			HBV Genotypic Variability in Cuba	PLOS ONE			English	Article							HEPATITIS-B-VIRUS; GENETIC DIVERSITY; MOLECULAR CHARACTERIZATION; HEPATOCELLULAR-CARCINOMA; LATIN-AMERICA; BLOOD-DONORS; SUBGENOTYPES; INFECTION; EPIDEMIOLOGY; VENEZUELA	The genetic diversity of HBV in human population is often a reflection of its genetic admixture. The aim of this study was to explore the genotypic diversity of HBV in Cuba. The S genomic region of Cuban HBV isolates was sequenced and for selected isolates the complete genome or precore-core sequence was analyzed. The most frequent genotype was A (167/250, 67%), mainly A2 (149, 60%) but also A1 and one A4. A total of 77 isolates were classified as genotype D (31%), with co-circulation of several subgenotypes (56 D4, 2 D1, 5 D2, 7 D3/6 and 7 D7). Three isolates belonged to genotype E, two to H and one to B3. Complete genome sequence analysis of selected isolates confirmed the phylogenetic analysis performed with the S region. Mutations or polymorphisms in precore region were more common among genotype D compared to genotype A isolates. The HBV genotypic distribution in this Caribbean island correlates with the Y lineage genetic background of the population, where a European and African origin prevails. HBV genotypes E, B3 and H isolates might represent more recent introductions.	[Loureiro, Carmen L.; Pujol, Flor H.] Inst Venezolano Invest Cient, Ctr Microbiol & Biol Ceular, Mol Virol Lab, Caracas, Venezuela; [Aguilar, Julio C.; Aguiar, Jorge; Muzio, Verena; Penton, Eduardo; Garcia, Daymir; Guillen, Gerardo] Ctr Ingn Genet & Biotecnol, Havana, Cuba	Venezuelan Institute Science Research; Centro de Ingenieria Genetica y Biotecnologia	Pujol, FH (corresponding author), Inst Venezolano Invest Cient, Ctr Microbiol & Biol Ceular, Mol Virol Lab, Caracas, Venezuela.	fhpujol@gmail.com	Guillen, Gerardo/ABB-2586-2020; Aguilar, Julio Cesar/AAA-6403-2022; Pujol, Flor H/E-5687-2010	Pujol, Flor H/0000-0001-6086-6883; Loureiro Marino, Carmen Luisa/0000-0003-3665-1107	Proyecto de Cooperacion Cientifica Cuba-Venezuela PEI from Venezuela [20122000768]	Proyecto de Cooperacion Cientifica Cuba-Venezuela PEI from Venezuela	Proyecto de Cooperacion Cientifica Cuba-Venezuela PEI 20122000768 from Venezuela provided funding for this project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alegre R, 2007, MOL IMMUNOL, V44, P2426, DOI 10.1016/j.molimm.2006.10.017; Andernach IE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081690; Andernach IE, 2009, EMERG INFECT DIS, V15, P1222, DOI 10.3201/eid1508.081642; Araujo NM, 2008, HEPATOL RES, V38, P1194, DOI 10.1111/j.1872-034X.2008.00392.x; Araujo NM, 2011, INFECT GENET EVOL, V11, P1199, DOI 10.1016/j.meegid.2011.04.017; Arauz-Ruiz P, 2002, J GEN VIROL, V83, P2059, DOI 10.1099/0022-1317-83-8-2059; Bedoya G, 2006, P NATL ACAD SCI USA, V103, P7234, DOI 10.1073/pnas.0508716103; Bekondi C, 2007, J CLIN VIROL, V40, P31, DOI 10.1016/j.jcv.2007.05.009; Blitz L, 1998, J CLIN MICROBIOL, V36, P648, DOI 10.1128/JCM.36.3.648-651.1998; Brichler S, 2013, J GEN VIROL, V94, P2318, DOI 10.1099/vir.0.055459-0; Carvalho-Silva DR, 2001, AM J HUM GENET, V68, P281, DOI 10.1086/316931; de Guerra DC, 2011, HUM BIOL, V83, P345, DOI 10.3378/027.083.0302; Cento V, 2013, J INFECTION, V67, P303, DOI 10.1016/j.jinf.2013.05.008; Devesa M, 2008, J MED VIROL, V80, P20, DOI 10.1002/jmv.21024; Devesa M, 2007, VIRUS RES, V127, P177, DOI 10.1016/j.virusres.2007.01.004; Echevarria JM, 2005, J MED VIROL, V76, P176, DOI 10.1002/jmv.20341; Barros LMF, 2014, INFECT GENET EVOL, V24, P68, DOI 10.1016/j.meegid.2014.03.007; George E, 2006, CASS MIL STUD, P1; Ghany MG, 2015, CLIN GASTROENTEROL H, V13, P183, DOI 10.1016/j.cgh.2014.06.028; Gopalakrishnan D, 2013, WORLD J GASTROENTERO, V19, P9294, DOI 10.3748/wjg.v19.i48.9294; Gutierrez C, 2004, J MED VIROL, V73, P200, DOI 10.1002/jmv.20076; Huy TTT, 2006, ARCH VIROL, V151, P589, DOI 10.1007/s00705-005-0671-1; Jaspe RC, 2014, J MED MICROBIOL, V63, P1099, DOI 10.1099/jmm.0.067496-0; Kim H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054486; Kitab B, 2011, J INFECTION, V63, P66, DOI 10.1016/j.jinf.2011.05.007; Kramvis A, 2005, J MED VIROL, V77, P47, DOI 10.1002/jmv.20412; Kramvis A, 2013, ANTIVIR THER, V18, P513, DOI 10.3851/IMP2657; Lago BV, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105317; Lago BV, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092223; Lazarevic I, 2014, WORLD J GASTROENTERO, V20, P7653, DOI 10.3748/wjg.v20.i24.7653; Lee SA, 2012, J HEPATOL, V56, P63, DOI 10.1016/j.jhep.2011.06.028; Lindh M, 2005, J CLIN VIROL, V34, P315, DOI 10.1016/j.jcv.2005.10.002; Lu XY, 1996, J VIROL, V70, P2277, DOI 10.1128/JVI.70.4.2277-2285.1996; MANGOLD CMT, 1993, J VIROL, V67, P4588, DOI 10.1128/JVI.67.8.4588-4597.1993; Meldal BHM, 2009, J GEN VIROL, V90, P1622, DOI 10.1099/vir.0.009738-0; Mello FCA, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-103; Mendizabal I, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-213; Norder H, 2004, INTERVIROLOGY, V47, P289, DOI 10.1159/000080872; Pujol FH, 2005, J CLIN GASTROENTEROL, V39, P611, DOI 10.1097/01.mcg.0000170770.49394.92; Quintero A, 2002, ARCH VIROL, V147, P1829, DOI 10.1007/s00705-002-0842-2; Rodriguez-Frias F, 2006, J VIRAL HEPATITIS, V13, P343, DOI 10.1111/j.1365-2893.2005.00691.x; Sanchez LV, 2002, J MED VIROL, V68, P24, DOI 10.1002/jmv.10166; Sze KMF, 2013, HEPATOLOGY, V57, P131, DOI 10.1002/hep.25979; Tanaka J, 2000, VACCINE, V18, pS17, DOI 10.1016/S0264-410X(99)00455-7; Telenta PFS, 1997, J CLIN MICROBIOL, V35, P1873, DOI 10.1128/JCM.35.7.1873-1875.1997; Valdivia Irina, 2005, Vaccimonitor, V14, P7; Valente F, 2010, MEM I OSWALDO CRUZ, V105, P970, DOI 10.1590/S0074-02762010000800004; Yousif M, 2013, HEPATOL RES, V43, P355, DOI 10.1111/j.1872-034X.2012.01090.x	48	15	18	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2015	10	3							e0118959	10.1371/journal.pone.0118959	http://dx.doi.org/10.1371/journal.pone.0118959			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9KG	25742179	Green Published, gold, Green Submitted			2022-12-27	WOS:000350688100068
J	Bai, XM; Wen, ZM; An, SS; Li, BC				Bai, Xiaomei; Wen, Zhongming; An, Shaoshan; Li, Bicheng			Evaluating Sustainability of Cropland Use in Yuanzhou County of the Loess Plateau, China Using an Emergy-Based Ecological Footprint	PLOS ONE			English	Article							CARRYING-CAPACITY	Evaluating the sustainability of cropland use is essential for guaranteeing a secure food supply and accomplishing agriculture sustainable development. This study was conducted in the ecologically vulnerable Loess Plateau region of China to evaluate the sustainability of cropland use based on an ecological footprint model that integrates emergy analysis. One modified method proposed in 2005 is known as the emergetic ecological footprint (EEF). We enhanced the method by accounting for both the surface soil energy in the carrying capacity calculation and the net topsoil loss for human consumption in the EF calculation. This paper evaluates whether the cropland of the study area was overloaded or sustainably managed during the period from 1981 to 2009. Toward this end, the final results obtained from EEF were compared to conventional EF and previous methods. The results showed that the cropland of Yuanzhou County has not been used sustainably since 1983, and the conventional EF analysis provided similar results. In contrast, a deficit did not appear during this time period when previous calculation methods of others were used. Additionally, the ecological sustainable index (ESI) from three models indicated that the recently used cropland system is unlikely to be unsustainable.	[Bai, Xiaomei; Wen, Zhongming; An, Shaoshan; Li, Bicheng] Chinese Acad Sci, Res Ctr Soil & Water Conservat & Ecol Environm, Yangling, Shaanxi, Peoples R China; [Bai, Xiaomei; Wen, Zhongming; An, Shaoshan; Li, Bicheng] Minist Educ, Yangling, Shaanxi, Peoples R China; [Wen, Zhongming; An, Shaoshan] Northwest A&F Univ, Inst Soil & Water Conservat, Yangling, Shaanxi, Peoples R China; [Bai, Xiaomei] Chinese Acad Sci, Grad Univ, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Soil & Water Conservation (ISWC), CAS; Chinese Academy of Sciences; Institute of Soil & Water Conservation (ISWC), CAS; Northwest A&F University - China; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Wen, ZM (corresponding author), Chinese Acad Sci, Res Ctr Soil & Water Conservat & Ecol Environm, Yangling, Shaanxi, Peoples R China.	zmwen@ms.iswc.ac.cn	WEN, Zhongming/F-1215-2010		National Natural Sciences Foundation of China [41271297, 41171226]; national key projects of the 11th five-year plan [2006BCA01A07]	National Natural Sciences Foundation of China(National Natural Science Foundation of China (NSFC)); national key projects of the 11th five-year plan(National Key Technology R&D Program)	This work was funded by the National Natural Sciences Foundation of China (41271297, 41171226) and the national key projects of the 11th five-year plan (2006BCA01A07). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brown L.R., 1995, WHO WILL FEED CHINA; Brown MT, 1997, ECOL ENG, V9, P51, DOI 10.1016/S0925-8574(97)00033-5; Brown MT, 2001, POPUL ENVIRON, V22, P471, DOI 10.1023/A:1010756704612; Brown MT, 1996, ECOL ECON, V19, P219, DOI 10.1016/S0921-8009(96)00046-8; Brown MT, 2001, HDB EMERGY EVALUATIO; Chen B, 2007, ECOL ECON, V61, P355, DOI 10.1016/j.ecolecon.2006.03.009; Chen B, 2006, ECOL MODEL, V198, P101, DOI 10.1016/j.ecolmodel.2006.04.022; Chen B, 2004, RESOURCE SCI, V26, P38; Chen LD, 2007, PROG PHYS GEOG, V31, P389, DOI 10.1177/0309133307081290; Comprehensive investigation team of the Guyuan County, 1988, COMPR AGR REG APPL G; Cuadra M, 2007, ECOL INDIC, V7, P133, DOI 10.1016/j.ecolind.2005.11.003; Fischer G, 1998, IR98047 IIASA; Fu BJ, 2002, LOESS HILLY REGION L; Fu BJ, 2011, ECOL COMPLEX, V8, P284, DOI 10.1016/j.ecocom.2011.07.003; Hau JL, 2004, ECOL MODEL, V178, P215, DOI 10.1016/j.ecolmodel.2003.12.016; Holmberg J, 1999, INT J SUST DEV WORLD, V6, P17, DOI 10.1080/13504509.1999.9728469; Lagerberg C., 1999, J CLEAN PROD, V7, P421, DOI [10.1016/S0959-6526(99)00230-9, DOI 10.1016/S0959-6526(99)00230-9]; Liu JY, 2005, REMOTE SENS ENVIRON, V98, P442, DOI 10.1016/j.rse.2005.08.012; Liu QP, 2008, PEDOSPHERE, V18, P154, DOI 10.1016/S1002-0160(08)60003-X; Lu Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030880; Odum H. T., 1996, ENV ACCOUNTING EMERG; Odum H.T., 2000, EMERGY GLOBAL PROCES; Odum HT, 2000, ECOSYSTEMS, V3, P21, DOI 10.1007/s100210000005; Odum HT, 1996, ECOL MODEL, V93, P155, DOI 10.1016/0304-3800(95)00221-9; ODUM HT, 1988, SCIENCE, V242, P1132, DOI 10.1126/science.242.4882.1132; Pereira L, 2012, ECOL INDIC, V16, P113, DOI 10.1016/j.ecolind.2011.06.016; Rees W, 1996, ENVIRON IMPACT ASSES, V16, P223, DOI 10.1016/S0195-9255(96)00022-4; Rees W.E., 1996, OUR ECOLOGICAL FOOTP; Rees W.E, 1992, ENVIRON URBAN, V4, P120, DOI 10.1177/095624789200400212; Rees WE, 1996, POPUL ENVIRON, V17, P195, DOI 10.1007/BF02208489; Rees WE, 2000, ECOL ECON, V32, P371; Siche R, 2010, COMMUN NONLINEAR SCI, V15, P3182, DOI 10.1016/j.cnsns.2009.10.027; Siche R, 2010, ECOL INDIC, V10, P475, DOI 10.1016/j.ecolind.2009.07.018; Tan S, 2003, ECON GEOGR, V23, P371; [谭术魁 TAN Shu-kui], 2010, [中国人口·资源与环境, China Population·Resources and Environment], V20, P153; Venetoulis Jason, 2008, Environment Development and Sustainability, V10, P441, DOI 10.1007/s10668-006-9074-z; Wackernagel M, 1999, ECOL ECON, V29, P375, DOI 10.1016/S0921-8009(98)90063-5; Wiedmann T., 2010, SUSTAINABILITY-BASEL, V2, DOI 10.3390/su2061645; World Wide Fund for Nature, LIV PLAN REP 2002; Xin ZB, 2008, SCI CHINA SER D, V51, P67, DOI 10.1007/s11430-007-0137-2; [赵其国 Zhao Qiguo], 2006, [土壤学报, Acta Pedologica Sinica], V43, P662; Zhao S, 2005, ECOL MODEL, V185, P65, DOI 10.1016/j.ecolmodel.2004.11.016	42	20	24	3	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2015	10	3							e0118282	10.1371/journal.pone.0118282	http://dx.doi.org/10.1371/journal.pone.0118282			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CC9JM	25738289	Green Published, gold, Green Submitted			2022-12-27	WOS:000350685900028
J	Clausen, MR; Zhang, XM; Yde, CC; Ditlev, DB; Lillefosse, HH; Madsen, L; Kristiansen, K; Liaset, B; Bertram, HC				Clausen, Morten Rahr; Zhang, Xumin; Yde, Christian C.; Ditlev, Ditte B.; Lillefosse, Haldis H.; Madsen, Lise; Kristiansen, Karsten; Liaset, Bjorn; Bertram, Hanne C.			Intake of Hydrolyzed Casein is Associated with Reduced Body Fat Accretion and Enhanced Phase II Metabolism in Obesity Prone C57BL/6J Mice	PLOS ONE			English	Article							LOW-CARBOHYDRATE DIET; HIGH-PROTEIN; MILK PROTEIN; HEPATIC LIPOGENESIS; RANDOMIZED-TRIAL; ADIPOSE-TISSUE; ENERGY-INTAKE; AMINO-ACIDS; MASS; GLUTATHIONE	The amount and form of dietary casein have been shown to affect energy metabolism and lipid accumulation in mice, but the underlying mechanisms are not fully understood. We investigated 48 hrs urinary metabolome, hepatic lipid composition and gene expression in male C57BL/6J mice fed Western diets with 16 or 32 energy% protein in the form of extensively hydrolyzed or intact casein. LC-MS based metabolomics revealed a very strong impact of casein form on the urinary metabolome. Evaluation of the discriminatory metabolites using tandem mass spectrometry indicated that intake of extensively hydrolyzed casein modulated Phase II metabolism associated with an elevated urinary excretion of glucuronic acid-and sulphate conjugated molecules, whereas glycine conjugated molecules were more abundant in urine from mice fed the intact casein diets. Despite the differences in the urinary metabolome, we observed no differences in hepatic expression of genes involved in Phase II metabolism, but it was observed that expression of Abcc3 encoding ATP binding cassette c3 (transporter of glucuronic acid conjugates) was increased in livers of mice fed hydrolyzed casein. As glucuronic acid is derived from glucose and sulphate is derived from cysteine, our metabolomic data provided evidence for changes in carbohydrate and amino acid metabolism and we propose that this modulation of metabolism was associated with the reduced glucose and lipid levels observed in mice fed the extensively hydrolyzed casein diets.	[Clausen, Morten Rahr; Zhang, Xumin; Yde, Christian C.; Ditlev, Ditte B.; Bertram, Hanne C.] Aarhus Univ, Dept Food Sci, Aarslev, Denmark; [Zhang, Xumin] Fudan Univ, Sch Life Sci, State Key Lab Genet Engn, Shanghai 200433, Peoples R China; [Lillefosse, Haldis H.; Madsen, Lise; Liaset, Bjorn] Natl Inst Nutr & Seafood Res, Bergen, Norway; [Lillefosse, Haldis H.; Madsen, Lise; Kristiansen, Karsten] Univ Copenhagen, Dept Biol, Copenhagen, Denmark	Aarhus University; Fudan University; University of Copenhagen	Clausen, MR (corresponding author), Aarhus Univ, Dept Food Sci, Aarslev, Denmark.	mortenr.clausen@food.au.dk	Kristiansen, Karsten/J-5148-2014; Bertram, Hanne Christine/I-8439-2019; Madsen, Lise/C-6246-2012	Kristiansen, Karsten/0000-0002-6024-0917; Bertram, Hanne Christine/0000-0002-1882-5321; Madsen, Lise/0000-0003-4468-1947; Liaset, Bjorn/0000-0002-8652-7801	Danish Strategic Research Council (FOSU); Danish Research Council FTP	Danish Strategic Research Council (FOSU); Danish Research Council FTP(Det Frie Forskningsrad (DFF))	The Danish Strategic Research Council (FOSU) is thanked for financial support through the project 'Health-promoting effects of milk-derived components' (http://fivu.dk/forskning-og-innovation/rad-og-udvalg/det-strategiske-forskningsrad), and the Danish Research Council FTP for financial support through the project 'Advances in food quality and nutrition research through implementation of metabolomics technologies' (http://fivu.dk/forskning-og-innovation/rad-og-udvalg/det-frie-forskningsrad). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acheson KJ, 2011, AM J CLIN NUTR, V93, P525, DOI 10.3945/ajcn.110.005850; Aoyama T, 2000, NUTRITION, V16, P349, DOI 10.1016/S0899-9007(00)00230-6; Baer DJ, 2011, J NUTR, V141, P1489, DOI 10.3945/jn.111.139840; Basu NK, 2003, BIOCHEM BIOPH RES CO, V303, P98, DOI 10.1016/S0006-291X(03)00241-9; Bensaad K, 2007, TRENDS CELL BIOL, V17, P286, DOI 10.1016/j.tcb.2007.04.004; Beyoglu D, 2012, BIOCHEM PHARMACOL, V83, P1331, DOI 10.1016/j.bcp.2011.12.031; Blouet C, 2006, J NUTR, V136, P1849, DOI 10.1093/jn/136.7.1849; Boulange CL, 2013, J PROTEOME RES, V12, P1956, DOI 10.1021/pr400051s; Broccali G, 2005, PANMINERVA MED, V47, P123; BUTLER LE, 1988, TOXICOL APPL PHARM, V95, P301, DOI 10.1016/0041-008X(88)90166-4; Calbet JAL, 2004, EUR J NUTR, V43, P127, DOI 10.1007/s00394-004-0448-4; Dooley TP, 2000, BIOCHEM BIOPH RES CO, V277, P236, DOI 10.1006/bbrc.2000.3643; Eriksson L, 2008, J CHEMOMETR, V22, P594, DOI 10.1002/cem.1187; Foster GD, 2003, NEW ENGL J MED, V348, P2082, DOI 10.1056/NEJMoa022207; Geier A, 2007, BBA-MOL CELL RES, V1773, P283, DOI 10.1016/J.BBAMCR.2006.04.014; Ghose R, 2011, LIFE SCI, V89, P57, DOI 10.1016/j.lfs.2011.05.005; Hamre K, 2001, AQUACULT NUTR, V7, P123, DOI 10.1046/j.1365-2095.2001.00162.x; Hao Q, 2012, AM J PHYSIOL-ENDOC M, V302, pE1097, DOI 10.1152/ajpendo.00524.2011; ITOH H, 1973, J NUTR, V103, P1709, DOI 10.1093/jn/103.12.1709; Johnston CS, 2002, J AM COLL NUTR, V21, P55, DOI 10.1080/07315724.2002.10719194; Kay HY, 2011, ANTIOXID REDOX SIGN, V15, P2135, DOI 10.1089/ars.2010.3834; Kim KM, 2004, PHYTOTHER RES, V18, P950, DOI 10.1002/ptr.1582; Klaus S, 2005, J NUTR, V135, P1854, DOI 10.1093/jn/135.8.1854; Kohle C, 2007, BIOCHEM PHARMACOL, V73, P1853, DOI 10.1016/j.bcp.2007.01.009; Kristensen M, 2012, METABOLOMICS, V8, P64, DOI 10.1007/s11306-011-0282-7; Lacroix M, 2004, AM J PHYSIOL-REG I, V287, pR934, DOI 10.1152/ajpregu.00100.2004; Lacroix M, 2006, AM J CLIN NUTR, V84, P1070, DOI 10.1093/ajcn/84.5.1070; Layman DK, 2003, J NUTR, V133, P405, DOI 10.1093/jn/133.2.405; Liaset B, 2003, PROCESS BIOCHEM, V38, P1747, DOI 10.1016/S0032-9592(02)00251-0; Liaset B, 2011, J BIOL CHEM, V286, P28382, DOI 10.1074/jbc.M111.234732; Liaset B, 2009, BBA-MOL CELL BIOL L, V1791, P254, DOI 10.1016/j.bbalip.2009.01.016; Lillefosse HH, 2014, J PROTEOME RES, V13, P2560, DOI 10.1021/pr500039t; Lillefosse HH, 2013, J NUTR, V143, P1367, DOI 10.3945/jn.112.170415; Lu SC, 1999, FASEB J, V13, P1169, DOI 10.1096/fasebj.13.10.1169; Ma T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021647; Madsen L, 2008, J BIOL CHEM, V283, P7196, DOI 10.1074/jbc.M707775200; Motohashi H, 2004, TRENDS MOL MED, V10, P549, DOI 10.1016/j.molmed.2004.09.003; Pichon L, 2006, J NUTR, V136, P1256, DOI 10.1093/jn/136.5.1256; Pluskal T, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-395; Potier M, 2009, CURR OPIN CLIN NUTR, V12, P54, DOI 10.1097/MCO.0b013e32831b9e01; RERAT AA, 1993, P NUTR SOC, V52, P335, DOI 10.1079/PNS19930069; Roux A, 2012, ANAL CHEM, V84, P6429, DOI 10.1021/ac300829f; SCHMEDES A, 1989, J AM OIL CHEM SOC, V66, P813, DOI 10.1007/BF02653674; Shelby MK, 2003, DRUG METAB DISPOS, V31, P326, DOI 10.1124/dmd.31.3.326; Shi J, 2011, INT DAIRY J, V21, P513, DOI 10.1016/j.idairyj.2011.03.006; Skov AR, 1999, INT J OBESITY, V23, P528, DOI 10.1038/sj.ijo.0800867; Smith CA, 2005, THER DRUG MONIT, V27, P747, DOI 10.1097/01.ftd.0000179845.53213.39; Stanstrup J, 2013, METABOLOMICS; Stipanuk MH, 2006, J NUTR, V136, p1652S, DOI 10.1093/jn/136.6.1652S; Stoll B, 1998, J NUTR, V128, P606, DOI 10.1093/jn/128.3.606; Takahira M, 2011, CIRC J, V75, P2235, DOI 10.1253/circj.CJ-10-1013; TATEISHI N, 1977, J NUTR, V107, P51, DOI 10.1093/jn/107.1.51; Tranberg B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071439; Vomhof-DeKrey EE, 2012, J NUTR BIOCHEM, V23, P1201, DOI 10.1016/j.jnutbio.2012.03.005; Wen H, 2013, MOL CELL PROTEOMICS, V12, P575, DOI 10.1074/mcp.M112.021352; Wishart DS, 2013, NUCLEIC ACIDS RES, V41, pD801, DOI 10.1093/nar/gks1065; Wishart DS, 2009, NUCLEIC ACIDS RES, V37, pD603, DOI 10.1093/nar/gkn810; Woodall GM, 1996, MUTAT RES-ENVIR MUTA, V360, P127, DOI 10.1016/0165-1161(96)00006-4; Xu CJ, 2005, ARCH PHARM RES, V28, P249, DOI 10.1007/BF02977789; Yde CC, 2014, METABOLOMICS; Yde CC, 2012, BRIT J NUTR, V107, P1603, DOI 10.1017/S0007114511004909; Yin YL, 2004, ANIM SCI, V79, P283, DOI 10.1017/S1357729800090147; Zamek-Gliszczynski MJ, 2006, EUR J PHARM SCI, V27, P447, DOI 10.1016/j.ejps.2005.12.007; Zhang XM, 2012, ANAL CHEM, V84, P7785, DOI 10.1021/ac3013835	64	10	11	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2015	10	3							e0118895	10.1371/journal.pone.0118895	http://dx.doi.org/10.1371/journal.pone.0118895			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9JM	25738501	Green Published, gold, Green Submitted			2022-12-27	WOS:000350685900083
J	Mas-Marti, E; Romani, AM; Munoz, I				Mas-Marti, Esther; Romani, Anna M.; Munoz, Isabel			Consequences of Warming and Resource Quality on the Stoichiometry and Nutrient Cycling of a Stream Shredder	PLOS ONE			English	Article							PARTICULATE ORGANIC-MATTER; LEAF-LITTER DECOMPOSITION; ECOLOGICAL STOICHIOMETRY; WATER TEMPERATURE; FEEDING ECOLOGY; GAMMARUS-PULEX; GROWTH-RATE; CONSTRAINTS; FOOD; FLOW	As a result of climate change, streams are warming and their runoff has been decreasing in most temperate areas. These changes can affect consumers directly by increasing their metabolic rates and modifying their physiology and indirectly by changing the quality of the resources on which organisms depend. In this study, a common stream detritivore (Echinogammarus berilloni Catta) was reared at two temperatures (15 and 20 degrees C) and fed Populus nigra L. leaves that had been conditioned either in an intermittent or permanent reach to evaluate the effects of resource quality and increased temperatures on detritivore performance, stoichiometry and nutrient cycling. The lower quality (i.e., lower protein, soluble carbohydrates and higher C: P and N:P ratios) of leaves conditioned in pools resulted in compensatory feeding and lower nutrient retention capacity by E. berilloni. This effect was especially marked for phosphorus, which was unexpected based on predictions of ecological stoichiometry. When individuals were fed pool-conditioned leaves at warmer temperatures, their growth rates were higher, but consumers exhibited less efficient assimilation and higher mortality. Furthermore, the shifts to lower C: P ratios and higher lipid concentrations in shredder body tissues suggest that structural molecules such as phospholipids are preserved over other energetic C-rich macromolecules such as carbohydrates. These effects on consumer physiology and metabolism were further translated into feces and excreta nutrient ratios. Overall, our results show that the effects of reduced leaf quality on detritivore nutrient retention were more severe at higher temperatures because the shredders were not able to offset their increased metabolism with increased consumption or more efficient digestion when fed pool-conditioned leaves. Consequently, the synergistic effects of impaired food quality and increased temperatures might not only affect the physiology and survival of detritivores but also extend to other trophic compartments through detritivore-mediated nutrient cycling.	[Mas-Marti, Esther; Munoz, Isabel] Univ Barcelona, Fac Biol, Dept Ecol, E-08028 Barcelona, Catalonia, Spain; [Romani, Anna M.] Univ Girona, Inst Aquat Ecol, Girona 17071, Catalonia, Spain	University of Barcelona; Universitat de Girona	Mas-Marti, E (corresponding author), Univ Barcelona, Fac Biol, Dept Ecol, Diagonal 643, E-08028 Barcelona, Catalonia, Spain.	emasmarti@ub.edu	Romaní, Anna M/L-7572-2014; Muñoz, Isabel/L-9414-2014	Romaní, Anna M/0000-0001-5183-8231; Muñoz, Isabel/0000-0001-8110-9435	Spanish Ministry of Economy and Competitiveness (Scarce) [Consolider-Ingenio CSD2009-00065]; Spanish Ministry of Economy and Competitiveness (CARBONET) [CGL2011-30474-C02-02]; EC 7th Framework Programme [603629-ENV-2013-6.2.1-Globaqua]; Government of Catalonia	Spanish Ministry of Economy and Competitiveness (Scarce); Spanish Ministry of Economy and Competitiveness (CARBONET); EC 7th Framework Programme; Government of Catalonia(Generalitat de Catalunya)	This project was funded by the Spanish Ministry of Economy and Competitiveness (Scarce, Consolider-Ingenio CSD2009-00065 and CARBONET, CGL2011-30474-C02-02) and the EC 7th Framework Programme (grant agreement 603629-ENV-2013-6.2.1-Globaqua). EMM held a doctoral fellowship (FI) from the Government of Catalonia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acuna V, 2010, GLOBAL CHANGE BIOL, V16, P2638, DOI 10.1111/j.1365-2486.2010.02170.x; Acuna V, 2007, J N AM BENTHOL SOC, V26, P54, DOI 10.1899/0887-3593(2007)26[54:MARIOO]2.0.CO;2; AGNEW DJ, 1986, J EXP MAR BIOL ECOL, V103, P203, DOI 10.1016/0022-0981(86)90141-3; Anderson TR, 2005, AM NAT, V165, P1, DOI 10.1086/426598; APHA AWWA WPCF, 1989, STAND METH DET WAT W, P1134; Arnell NW, 1999, GLOBAL ENVIRON CHANG, V9, P5, DOI 10.1016/S0959-3780(98)00015-6; Assmann C, 2011, FRESHWATER BIOL, V56, P839, DOI 10.1111/j.1365-2427.2010.02530.x; Baerlocher MO, 2004, CAN J BOT, V82, P365, DOI [10.1139/B04-008, 10.1139/b04-008]; Baldy V, 1997, CR ACAD SCI III-VIE, V320, P747, DOI 10.1016/S0764-4469(97)84824-X; Barlocher Felix, 2005, P97, DOI 10.1007/1-4020-3466-0_14; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; BOULTON AJ, 1992, HYDROBIOLOGIA, V241, P107, DOI 10.1007/BF00008263; Bowman MF, 2005, FRESHWATER BIOL, V50, P1836, DOI 10.1111/j.1365-2427.2005.01454.x; BRATBAK G, 1984, APPL ENVIRON MICROB, V48, P755, DOI 10.1128/AEM.48.4.755-757.1984; Brown JH, 2004, ECOLOGY, V85, P1771, DOI 10.1890/03-9000; Chergui H, 1997, ACTA OECOL, V18, P531, DOI 10.1016/S1146-609X(97)80039-2; CHERGUI H, 1990, ARCH HYDROBIOL, V120, P1; Connolly NM, 2013, HYDROBIOLOGIA, V718, P85, DOI 10.1007/s10750-013-1605-7; Cross WF, 2005, FRESHWATER BIOL, V50, P1895, DOI 10.1111/j.1365-2427.2005.01458.x; Cross WF, 2007, ECOLOGY, V88, P2563, DOI 10.1890/06-1348.1; CUMMINS KW, 1979, ANNU REV ECOL SYST, V10, P147, DOI 10.1146/annurev.es.10.110179.001051; Danger M, 2013, FUNCT ECOL, V27, P807, DOI 10.1111/1365-2435.12079; Dewson ZS, 2007, J N AM BENTHOL SOC, V26, P401, DOI 10.1899/06-110.1; Villanueva VD, 2011, HYDROBIOLOGIA, V678, P155, DOI 10.1007/s10750-011-0837-7; Dieter D, 2011, AQUAT SCI, V73, P599, DOI 10.1007/s00027-011-0231-6; Dieter D, 2013, FRESHWATER BIOL, V58, P1918, DOI 10.1111/fwb.12180; Doi H, 2010, OIKOS, V119, P752, DOI 10.1111/j.1600-0706.2009.18540.x; Eaton JG, 1996, LIMNOL OCEANOGR, V41, P1109, DOI 10.4319/lo.1996.41.5.1109; Elser JJ, 2003, ECOL LETT, V6, P936, DOI 10.1046/j.1461-0248.2003.00518.x; Evans-White MA, 2005, FRESHWATER BIOL, V50, P1853, DOI 10.1111/j.1365-2427.2005.01452.x; Feio MJ, 2000, HYDROBIOLOGIA, V439, P7, DOI 10.1023/A:1004189316952; Ferreira V, 2011, OECOLOGIA, V167, P279, DOI 10.1007/s00442-011-1976-2; Ferreira V, 2010, GLOBAL CHANGE BIOL, V16, P3284, DOI 10.1111/j.1365-2486.2009.02153.x; Fink P, 2006, OIKOS, V115, P484, DOI 10.1111/j.2006.0030-1299.14951.x; Flores L, 2014, FRESHW SCI, V33, P134, DOI 10.1086/674578; Friberg N, 1999, FRESHWATER BIOL, V42, P625, DOI 10.1046/j.1365-2427.1999.00501.x; Friberg N, 2009, FRESHWATER BIOL, V54, P2051, DOI 10.1111/j.1365-2427.2009.02234.x; Frost PC, 2005, ARCH HYDROBIOL, V163, P463, DOI 10.1127/0003-9136/2005/0163-0463; Frost PC, 2005, OIKOS, V109, P18, DOI 10.1111/j.0030-1299.2005.14049.x; Garcia L, 2012, HYDROBIOLOGIA, V696, P123, DOI 10.1007/s10750-012-1188-8; Garcia-Berthou E, 1993, CAN J FISH AQUAT SCI, V50, P1394, DOI 10.1139/f93-159; Garcia-Berthou E, 2001, J ANIM ECOL, V70, P708, DOI 10.1046/j.1365-2656.2001.00524.x; Geider RJ, 1996, LIMNOL OCEANOGR, V41, P1; GESSNER MO, 1993, APPL ENVIRON MICROB, V59, P502, DOI 10.1128/AEM.59.2.502-507.1993; Gessner MO, 1996, APPL ENVIRON MICROB, V62, P415, DOI 10.1128/AEM.62.2.415-419.1996; Gonzalez AL, 2014, FRESHWATER BIOL, V59, P737, DOI 10.1111/fwb.12300; Graca MAS, 2001, INT REV HYDROBIOL, V86, P383, DOI 10.1002/1522-2632(200107)86:4/5<383::AID-IROH383>3.0.CO;2-D; Hansen HP, 1983, METHODS SEAWATER ANA, P419; Hari RE, 2006, GLOBAL CHANGE BIOL, V12, P10, DOI 10.1111/j.1365-2486.2005.001051.x; Hartmann D., 2013, CLIMATE CHANGE 2013; Headley JV, 2002, J CHROMATOGR A, V958, P149, DOI 10.1016/S0021-9673(02)00326-6; Hervant F, 1999, J EXP BIOL, V202, P3587; Hessen DO, 2013, LIMNOL OCEANOGR, V58, P2219, DOI 10.4319/lo.2013.58.6.2219; Hirabayashi Y, 2008, HYDROLOG SCI J, V53, P754, DOI 10.1623/hysj.53.4.754; Hogg ID, 1996, ECOLOGY, V77, P395, DOI 10.2307/2265617; IPCC (Intergovernmental Panel on Climate Change), 2013, CLIMATE CHANGE 2013; JEFFREY SW, 1975, BIOCHEM PHYSIOL PFL, V167, P191, DOI 10.1016/s0015-3796(17)30778-3; Kendrick MR, 2013, FRESHWATER BIOL, V58, P1820, DOI 10.1111/fwb.12170; KING JM, 1987, HYDROBIOLOGIA, V154, P165, DOI 10.1007/BF00026838; Koop JHE, 2011, AQUAT ECOL, V45, P547, DOI 10.1007/s10452-011-9375-7; Lake PS, 2003, FRESHWATER BIOL, V48, P1161, DOI 10.1046/j.1365-2427.2003.01086.x; Larranaga A., 2008, THESIS U BASQUE COUN, P177; Mansfield Shawn D., 2005, P85, DOI 10.1007/1-4020-3466-0_12; Mayer Gerd, 2012, International Journal of Zoology, V2012, P1; Persson J, 2011, OECOLOGIA, V165, P123, DOI 10.1007/s00442-010-1756-4; Pozo J, 1997, J N AM BENTHOL SOC, V16, P602, DOI 10.2307/1468147; Quinn G.P., 2002, EXPT DESIGN DATA ANA, P537, DOI DOI 10.1017/CBO9780511806384; Romani AM, 2013, HYDROBIOLOGIA, V719, P43, DOI 10.1007/s10750-012-1302-y; ROSSI L, 1978, OIKOS, V30, P109, DOI 10.2307/3543530; Sanpera-Calbet I., 2014, THESIS U BARCELONA, P169; Schlief J, 2007, INT REV HYDROBIOL, V92, P146, DOI 10.1002/iroh.200510950; Sterner RW, 2002, ECOLOGICAL STOICHIOM, P432; Suzuki-Ohno Y, 2012, OIKOS, V121, P569, DOI 10.1111/j.1600-0706.2011.19320.x; Theil-Nielsen J, 1998, ARCH HYDROBIOL, V141, P195; Timoner X, 2012, FRESHWATER BIOL, V57, P1565, DOI 10.1111/j.1365-2427.2012.02818.x; Vanni MJ, 2002, ANNU REV ECOL SYST, V33, P341, DOI 10.1146/annurev.ecolsys.33.010802.150519; VANNOTE RL, 1980, CAN J FISH AQUAT SCI, V37, P130, DOI 10.1139/f80-017; von Schiller D, 2011, AQUAT SCI, V73, P485, DOI 10.1007/s00027-011-0195-6; von Schiller D, 2008, ECOSYSTEMS, V11, P670, DOI 10.1007/s10021-008-9150-3; Vos JH, 2004, ARCH HYDROBIOL, V161, P469, DOI 10.1127/0003-9136/2004/0161-0469; Vrede T, 2004, ECOLOGY, V85, P1217, DOI 10.1890/02-0249; WELTON JS, 1983, OIKOS, V41, P133, DOI 10.2307/3544355; WELTON JS, 1980, J ANIM ECOL, V49, P581, DOI 10.2307/4265; Ylla I, 2011, AQUAT SCI, V73, P523, DOI 10.1007/s00027-011-0211-x; Ylla I, 2010, HYDROBIOLOGIA, V657, P217, DOI 10.1007/s10750-010-0193-z; ZOLLNER N., 1962, ZEIT GES EXPTL MED, V135, P545, DOI 10.1007/BF02045455	86	27	27	2	76	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2015	10	3							e0118520	10.1371/journal.pone.0118520	http://dx.doi.org/10.1371/journal.pone.0118520			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9JM	25738818	Green Published, gold, Green Submitted			2022-12-27	WOS:000350685900042
J	Nowak-Machen, M; Hilberath, JN; Rosenberger, P; Schmid, E; Memtsoudis, SG; Angermair, J; Tuli, JK; Shernan, SK				Nowak-Machen, Martina; Hilberath, Jan N.; Rosenberger, Peter; Schmid, Eckhard; Memtsoudis, Stavros G.; Angermair, Johannes; Tuli, Jayshree K.; Shernan, Stanton K.			Influence of Intraaortic Balloon Pump Counterpulsation on Transesophageal Echocardiography Derived Determinants of Diastolic Function	PLOS ONE			English	Article							LEFT-VENTRICULAR FUNCTION; BYPASS GRAFT-SURGERY; HEART-FAILURE; DOPPLER-ECHOCARDIOGRAPHY; FLOW PROPAGATION; CONSCIOUS DOGS; DYSFUNCTION; RECOMMENDATIONS; STIFFNESS; VELOCITY	Introduction Intraaortic balloon pump counterpulsation (IABP) is often used in patients with acute coronary syndrome for its favourable effects on left ventricular (LV) systolic function and coronary perfusion. However, the effects of IABP on LV diastolic function have not been comprehensively investigated. Acute diastolic dysfunction has been linked to increased morbidity and mortality. The aim of this study was to examine the influence of IABP on LV diastolic dysfunction using standard TEE derived parameters. Methods Intraoperative TEE was performed in 10 patients (mean age 65 +/- 11 yrs) undergoing urgent coronary artery bypass graft surgery (CABG), who had received an IABP preoperatively. TEE derived measures of diastolic dysfunction included early to late transmitral Doppler inflow velocity ratio (E/A), deceleration time (Dt), pulmonary venous systolic to diastolic Doppler velocity ratio (S/D), transmitral propagation velocity (Vp), and the ratio of early to late mitral annular tissue Doppler velocities (e'/a'). Statistical analyses included the Wilcoxon Sign-Rank test, and a p<0.05 was considered significant. Results Transmitral inflow E/A ratios increased significantly from 0.86 to 1.07 (p<0.05), while Dt decreased significantly from 218 to 180 ms (p<0.05) with the use of IABP. Significant increases in Vp (34 cm/s to 43 cm/s; p<0.05), and e'/a' (0.58 to 0.71; p<0.05) suggested a favourable influence of intraaortic counterpulsation on diastolic function. Conclusion The use of perioperative IABP significantly improves TEE derived parameters of diastolic function consistent with a favourable impact on LV relaxation in cardiac surgery patients undergoing CABG.	[Nowak-Machen, Martina; Hilberath, Jan N.; Rosenberger, Peter; Schmid, Eckhard; Angermair, Johannes] Univ Klinikum Tubingen, Klin Anaesthesiol & Intensivmed, Tubingen, Germany; [Hilberath, Jan N.; Shernan, Stanton K.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Anesthesiol Perioperat & Pain Med, Boston, MA 02115 USA; [Memtsoudis, Stavros G.] Hosp Special Surg, Weill Cornell Med Coll, Dept Anesthesiol, New York, NY 10021 USA; [Tuli, Jayshree K.] Univ Toronto, Dept Stat, Toronto, ON, Canada	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Cornell University; University of Toronto	Nowak-Machen, M (corresponding author), Univ Klinikum Tubingen, Klin Anaesthesiol & Intensivmed, Tubingen, Germany.	martina.nowak-machen@med.uni-tuebingen.de		Hilberath, Jan N./0000-0002-0799-2941				Apostolakis EE, 2009, J CARDIOTHORAC SURG, V4, DOI 10.1186/1749-8090-4-67; Bernard F, 2001, ANESTH ANALG, V92, P291, DOI 10.1213/00000539-200102000-00002; Cheung AT, 1996, ANESTHESIOLOGY, V84, P545, DOI 10.1097/00000542-199603000-00009; Djaiani GN, 2002, ANESTH ANALG, V95, P524, DOI 10.1097/00000539-200209000-00004; Ekery DL, 2003, AM HEART J, V145, P896, DOI 10.1016/S0002-8703(02)94786-1; Gill RM, 2006, AM J PHYSIOL-HEART C, V291, pH3154, DOI 10.1152/ajpheart.00052.2006; Groban L, 2005, CHEST, V128, P3652, DOI 10.1378/chest.128.5.3652; Grossman W, 2000, CIRCULATION, V101, P2020, DOI 10.1161/01.CIR.101.17.2020; Hilberath JN, 2010, J AM SOC ECHOCARDIOG, V23, P1115, DOI 10.1016/j.echo.2010.08.013; Kass DA, 2004, CIRC RES, V94, P1533, DOI 10.1161/01.RES.0000129254.25507.d6; Khir AW, 2003, EUR J CARDIO-THORAC, V24, P277, DOI 10.1016/S1010-7940(03)00268-9; KOMAMURA K, 1992, J CLIN INVEST, V89, P1825, DOI 10.1172/JCI115787; Lappas D G, 1999, Semin Thorac Cardiovasc Surg, V11, P125; Mathison M, 2000, ANN THORAC SURG, V70, P1355, DOI 10.1016/S0003-4975(00)01590-3; Matyal R, 2011, ANESTH ANALG, V113, P449, DOI 10.1213/ANE.0b013e31822649ac; MCKENNEY PA, 1994, J AM COLL CARDIOL, V24, P1189, DOI 10.1016/0735-1097(94)90097-3; MOULOPOULOS SD, 1962, AM HEART J, V63, P669, DOI 10.1016/0002-8703(62)90012-1; Nagueh SF, 2004, CIRCULATION, V110, P155, DOI 10.1161/01.CIR.0000135591.37759.AF; Nagueh SF, 2009, J AM SOC ECHOCARDIOG, V22, P107, DOI 10.1016/j.echo.2008.11.023; Oki T, 1999, J AM SOC ECHOCARDIOG, V12, P308, DOI 10.1016/S0894-7317(99)70051-9; Ommen SR, 2000, CIRCULATION, V102, P1788; POWELL WJ, 1970, CIRC RES, V26, P753, DOI 10.1161/01.RES.26.6.753; Shanewise JS, 1999, J AM SOC ECHOCARDIOG, V12, P884, DOI 10.1016/S0894-7317(99)70199-9; SHIMAMOTO H, 1992, AM HEART J, V123, P1229, DOI 10.1016/0002-8703(92)91027-X; Sohn DW, 1997, J AM COLL CARDIOL, V30, P474, DOI 10.1016/S0735-1097(97)88335-0; Stone GW, 2003, J AM COLL CARDIOL, V41, P1940, DOI 10.1016/S0735-1097(03)00400-5; STORK T, 1995, CARDIOVASC DRUG THER, V9, P533, DOI 10.1007/BF00877866; Swaminathan M, 2011, ANN THORAC SURG, V91, P1844, DOI 10.1016/j.athoracsur.2011.02.008; Takatsuji H, 1996, J AM COLL CARDIOL, V27, P365, DOI 10.1016/0735-1097(96)81240-X	29	4	5	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2015	10	3							e0118788	10.1371/journal.pone.0118788	http://dx.doi.org/10.1371/journal.pone.0118788			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9JM	25739068	Green Published, gold, Green Submitted			2022-12-27	WOS:000350685900072
J	Tomita, T; Ieguchi, K; Sawamura, T; Maru, Y				Tomita, Takeshi; Ieguchi, Katsuaki; Sawamura, Tatsuya; Maru, Yoshiro			Human Serum Amyloid A3 (SAA3) Protein, Expressed as a Fusion Protein with SAA2, Binds the Oxidized Low Density Lipoprotein Receptor	PLOS ONE			English	Article							SMOOTH-MUSCLE-CELLS; BREAST-CANCER CELLS; ENDOTHELIAL-CELLS; UP-REGULATION; HUMAN TRANSCRIPTOME; LUNG METASTASIS; GENE FUSIONS; TNF-ALPHA; LOX-1; ACTIVATION	Serum amyloid A3 (SAA3) possesses characteristics distinct from the other serum amyloid A isoforms, SAA1, SAA2, and SAA4. High density lipoprotein contains the latter three isoforms, but not SAA3. The expression of mouse SAA3 (mSAA3) is known to be up-regulated extrahepatically in inflammatory responses, and acts as an endogenous ligand for the toll-like receptor 4/MD-2 complex. We previously reported that mSAA3 plays an important role in facilitating tumor metastasis by attracting circulating tumor cells and enhancing hyperpermeability in the lungs. On the other hand, human SAA3 (hSAA3) has long been regarded as a pseudogene, which is in contrast to the abundant expression levels of the other isoforms. Although the nucleotide sequence of hSAA3 is very similar to that of the other SAAs, a single oligonucleotide insertion in exon 2 causes a frame-shift to generate a unique amino acid sequence. In the present study, we identified that hSAA3 was transcribed in the hSAA2-SAA3 fusion transcripts of several human cell lines. In the fusion transcript, hSAA2 exon 3 was connected to hSAA3 exon 1 or hSAA3 exon 2, located approximately 130kb downstream from hSAA2 exon 3 in the genome, which suggested that it is produced by alternative splicing. Furthermore, we succeeded in detecting and isolating hSAA3 protein for the first time by an immunoprecipitation-enzyme linked immune assay system using monoclonal and polyclonal antibodies that recognize the hSAA3 unique amino acid sequence. We also demonstrated that hSAA3 bound oxidized low density lipoprotein receptor (oxLDL receptor, LOX-1) and elevated the phosphorylation of ERK, the intracellular MAP-kinase signaling protein.	[Tomita, Takeshi; Ieguchi, Katsuaki; Maru, Yoshiro] Tokyo Womens Med Univ, Dept Pharmacol, Tokyo, Japan; [Sawamura, Tatsuya] Natl Cerebral & Cardiovasc Ctr, Dept Vasc Physiol, Suita, Osaka, Japan	Tokyo Women's Medical University; National Cerebral & Cardiovascular Center - Japan	Tomita, T (corresponding author), Tokyo Womens Med Univ, Dept Pharmacol, Tokyo, Japan.	tomitat@research.twmu.ac.jp; ymaru@research.twmu.ac.jp	Sawamura, Tatsuya/E-7103-2010	Tomita, Takeshi/0000-0001-6815-2244	Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan [21117008, 23590347]; Global COE program, Multidisciplinary Education and Research Center for Regenerative Medicine (MERCREM), from MEXT, Japan; Policy-Based Medical Service Foundation, Japan; Foundation for Promotion of Cancer Research in Japan; Sato Memorial Foundation for Cancer Research; Grants-in-Aid for Scientific Research [26440063] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Global COE program, Multidisciplinary Education and Research Center for Regenerative Medicine (MERCREM), from MEXT, Japan; Policy-Based Medical Service Foundation, Japan; Foundation for Promotion of Cancer Research in Japan; Sato Memorial Foundation for Cancer Research; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan; 21117008 (Y.M.) and 23590347 (T.T.); the Global COE program, Multidisciplinary Education and Research Center for Regenerative Medicine (MERCREM), from MEXT, Japan; Policy-Based Medical Service Foundation, Japan; Foundation for Promotion of Cancer Research in Japan; and Sato Memorial Foundation for Cancer Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aramaki Y, 2008, ATHEROSCLEROSIS, V198, P272, DOI 10.1016/j.atherosclerosis.2007.12.017; BAE SN, 1993, BREAST CANCER RES TR, V24, P241, DOI 10.1007/BF01833264; Baranova IN, 2005, J BIOL CHEM, V280, P8031, DOI 10.1074/jbc.M405009200; Baranova IN, 2010, J BIOL CHEM, V285, P8492, DOI 10.1074/jbc.M109.007526; BENDITT EP, 1979, P NATL ACAD SCI USA, V76, P4092, DOI 10.1073/pnas.76.8.4092; BENDITT EP, 1989, J EXP MED, V169, P1841, DOI 10.1084/jem.169.5.1841; Brooks YS, 2009, J BIOL CHEM, V284, P18033, DOI 10.1074/jbc.M109.006999; Cagnol S, 2010, FEBS J, V277, P2, DOI 10.1111/j.1742-4658.2009.07366.x; Chiba T, 2009, J LIPID RES, V50, P1353, DOI 10.1194/jlr.M900089-JLR200; COETZEE GA, 1986, J BIOL CHEM, V261, P9644; Deguchi A, 2013, J IMMUNOL, V191, P1856, DOI 10.4049/jimmunol.1201996; Fujita Y, 2011, CLIN CHEM, V57, P1398, DOI 10.1373/clinchem.2011.168625; Fujita Y, 2009, CLIN CHEM, V55, P285, DOI 10.1373/clinchem.2008.119750; Gardiner GE, 2009, FEMS IMMUNOL MED MIC, V55, P404, DOI 10.1111/j.1574-695X.2009.00539.x; Gilbert WV, 2010, J BIOL CHEM, V285, P29033, DOI 10.1074/jbc.R110.150532; Hiratsuka S, 2008, NAT CELL BIOL, V10, P1349, DOI 10.1038/ncb1794; Hiratsuka S, 2006, NAT CELL BIOL, V8, P1369, DOI 10.1038/ncb1507; Jorgensen JB, 2000, DEV COMP IMMUNOL, V24, P553, DOI 10.1016/S0145-305X(00)00022-7; KLUVEBECKERMAN B, 1991, DNA CELL BIOL, V10, P651, DOI 10.1089/dna.1991.10.651; Kumon Y, 2001, SCAND J IMMUNOL, V53, P7, DOI 10.1046/j.1365-3083.2001.00829.x; Larson MA, 2003, BIOCHEM BIOPH RES CO, V301, P1030, DOI 10.1016/S0006-291X(03)00045-7; Larson MA, 2003, BIOCHEM BIOPH RES CO, V300, P531, DOI 10.1016/S0006-291X(02)02901-7; Liang M, 2007, CANCER LETT, V258, P31, DOI 10.1016/j.canlet.2007.08.003; Lu ZM, 2006, IUBMB LIFE, V58, P621, DOI 10.1080/15216540600957438; Maher CA, 2009, NATURE, V458, P97, DOI 10.1038/nature07638; Martinez-Estrada OM, 2006, BIOCHEM J, V394, P449, DOI 10.1042/BJ20050591; Mattaliano MD, 2009, AM J PHYSIOL-CELL PH, V296, pC1329, DOI 10.1152/ajpcell.00513.2008; Mehta JL, 2007, CIRC RES, V100, P1634, DOI 10.1161/CIRCRESAHA.107.149724; Nacu S, 2011, BMC MED GENOMICS, V4, DOI 10.1186/1755-8794-4-11; PAGES G, 1993, P NATL ACAD SCI USA, V90, P8319, DOI 10.1073/pnas.90.18.8319; Pan Q, 2008, NAT GENET, V40, P1413, DOI 10.1038/ng.259; Rocken C, 2005, ANN RHEUM DIS, V64, P808, DOI 10.1136/ard.2004.030429; Smirnova IV, 2004, AM J PHYSIOL-RENAL, V287, pF25, DOI 10.1152/ajprenal.00449.2003; Sugimoto K, 2009, CARDIOVASC RES, V84, P127, DOI 10.1093/cvr/cvp177; Sultan M, 2008, SCIENCE, V321, P956, DOI 10.1126/science.1160342; Tanigawa H, 2006, ATHEROSCLEROSIS, V188, P245, DOI 10.1016/j.atherosclerosis.2005.10.046; Tomita T, 2011, ONCOGENE, V30, P3429, DOI 10.1038/onc.2011.53; Uhlar CM, 1999, EUR J BIOCHEM, V265, P501, DOI 10.1046/j.1432-1327.1999.00657.x; Wang ET, 2008, NATURE, V456, P470, DOI 10.1038/nature07509	39	13	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2015	10	3							e0118835	10.1371/journal.pone.0118835	http://dx.doi.org/10.1371/journal.pone.0118835			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9JM	25738827	Green Published, gold, Green Submitted			2022-12-27	WOS:000350685900078
J	Wang, Y; Han, YP; Zhao, X; Li, YG; Teng, WL; Li, DM; Zhan, Y; Li, WB				Wang, Yan; Han, Yingpeng; Zhao, Xue; Li, Yongguang; Teng, Weili; Li, Dongmei; Zhan, Yong; Li, Wenbin			Mapping Isoflavone QTL with Main, Epistatic and QTL x Environment Effects in Recombinant Inbred Lines of Soybean	PLOS ONE			English	Article							LINKAGE MAP; ACCUMULATION; GENES; TRAITS; HEALTH; OIL	Soybean (Glycine max (L.) Merr.) isoflavone is important for human health and plant defense system. To identify novel quantitative trait loci (QTL) and epistatic QTL underlying isoflavone content in soybean, F-5:6, F-5:7 and F-5:8 populations of 130 recombinant inbred (RI) lines, derived from the cross of soybean cultivar 'Zhong Dou 27' (high isoflavone) and 'Jiu Nong 20' (low isoflavone), were analyzed with 95 new SSR markers. A new linkage map including 194 SSR markers and covering 2,312 cM with mean distance of about 12 cM between markers was constructed. Thirty four QTL for both individual and total seed isoflavone contents of soybean were identified. Six, seven, ten and eleven QTL were associated with daidzein (DZ), glycitein (GC), genistein (GT) and total isoflavone (TI), respectively. Of them 23 QTL were newly identified. The qTIF_1 between Satt423 and Satt569 shared the same marker Satt569 with qDZF_2, qGTF_1 and qTIF_2. The qGTD2_1 between Satt186 and Satt226 was detected in four environments and explained 3.41%-10.98% of the phenotypic variation. The qGTA2_1, overlapped with qGCA2_1 and detected in four environments, was close to the previously identified major QTL for GT, which were responsible for large a effects. QTL (qDZF_2, qGTF_1 and qTIF_2) between Satt144-Satt569 were either clustered or pleiotropic. The qGCM_1, qGTM_1 and qTIM_1 between Satt540-Sat_244 explained 2.02%-9.12% of the phenotypic variation over six environments. Moreover, the qGCE_1 overlapped with qGTE_1 and qTIE_1, the qTIH_2 overlapped with qGTH_1, qGCI_1 overlapped with qDZI_1, qTIL_1 overlapped with qGTL_1, and qTIO_1 overlapped with qGTO_1. In this study, some of unstable QTL were detected in different environments, which were due to weak expression of QTL, QTL by environment interaction in the opposite direction to a effects, and/or epistasis. The markers identified in multi-environments in this study could be applied in the selection of soybean cultivars for higher isoflavone content and in the map-based gene cloning.	[Wang, Yan; Han, Yingpeng; Zhao, Xue; Li, Yongguang; Teng, Weili; Li, Dongmei; Li, Wenbin] Northeast Agr Univ, Chinese Minist Educ, Key Lab Soybean Biol, Harbin, Heilongjiang Pr, Peoples R China; [Wang, Yan; Han, Yingpeng; Zhao, Xue; Li, Yongguang; Teng, Weili; Li, Dongmei; Li, Wenbin] Northeast Agr Univ, Chinese Agr Minist, Key Lab Soybean Biol & Breeding Genet, Harbin, Heilongjiang Pr, Peoples R China; [Zhan, Yong] Agr Sci Acad, Shi He Zi, Xinjiang Provin, Peoples R China	Northeast Agricultural University - China; Northeast Agricultural University - China	Zhan, Y (corresponding author), Agr Sci Acad, Shi He Zi, Xinjiang Provin, Peoples R China.	shzzhy@163.com; wenbinli@neau.edu.cn	Li, Yongguang/ACM-0755-2022	Li, Yongguang/0000-0002-9171-2729	National Key Project [2014BAD22B01]	National Key Project	This study was financially supported by National Key Project (2014BAD22B01). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akond M., 2013, Journal of Agricultural Science (Toronto), V5, P20; Benhamou N, 1999, PLANT PHYSIOL BIOCH, V37, P703, DOI 10.1016/S0981-9428(00)86684-X; Bolon YT, 2014, PLANT GENOME-US, V7, DOI 10.3835/plantgenome2013.08.0027; Brouns F, 2002, FOOD RES INT, V35, P187, DOI 10.1016/S0963-9969(01)00182-X; Cederroth CR, 2009, MOL CELL ENDOCRINOL, V304, P30, DOI 10.1016/j.mce.2009.02.027; Chen KI, 2012, APPL MICROBIOL BIOT, V96, P9, DOI 10.1007/s00253-012-4330-7; Collard BCY, 2005, EUPHYTICA, V142, P169, DOI 10.1007/s10681-005-1681-5; Dhaubhadel S, 2003, PLANT MOL BIOL, V53, P733, DOI 10.1023/B:PLAN.0000023666.30358.ae; Doyle JJ, 1987, PHYTOCHEM B, V19, P11, DOI 10.1016/j.bse.2009.07.003; Falconer D. S., 1996, Introduction to quantitative genetics.; Gutierrez-Gonzalez JJ, 2011, THEOR APPL GENET, V123, P1375, DOI 10.1007/s00122-011-1673-x; Gutierrez-Gonzalez JJ, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-105; Gutierrez-Gonzalez JJ, 2009, THEOR APPL GENET, V119, P1069, DOI 10.1007/s00122-009-1109-z; Hoeck JA, 2000, CROP SCI, V40, P48, DOI 10.2135/cropsci2000.40148x; Janila P, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00023; Kassem MA, 2006, THEOR APPL GENET, V113, P1015, DOI 10.1007/s00122-006-0361-8; Kassem MA, 2001, J BIOMED BIOTECHNOL, V1, P52; KOSSLAK RM, 1987, P NATL ACAD SCI USA, V84, P7428, DOI 10.1073/pnas.84.21.7428; LANDER E S, 1987, Genomics, V1, P174, DOI 10.1016/0888-7543(87)90010-3; Liang HZ, 2010, AGR SCI CHINA, V9, P1108, DOI 10.1016/S1671-2927(09)60197-8; Liu P, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-132; Lozovaya VV, 2005, CROP SCI, V45, P1934, DOI 10.2135/cropsci2004.0567; Lozovaya VV, 2004, PLANT PHYSIOL BIOCH, V42, P671, DOI 10.1016/j.plaphy.2004.06.007; Mebrahtu T, 2004, PLANT FOOD HUM NUTR, V59, P55, DOI 10.1007/s11130-004-0023-4; Meksem K., 2001, Journal of Biomedicine and Biotechnology, V1, P38, DOI 10.1155/S1110724301000110; Meng FL, 2011, THEOR APPL GENET, V123, P1459, DOI 10.1007/s00122-011-1680-y; Munro IC, 2003, NUTR REV, V61, P1, DOI 10.1301/nr.2003.janr.1-33; Murphy SE, 2009, CROP SCI, V49, P1313, DOI 10.2135/cropsci2008.09.0533; Primomo VS, 2005, CROP SCI, V45, P2454, DOI 10.2135/cropsci2004.0672; Rochfort S, 2007, J AGR FOOD CHEM, V55, P7981, DOI 10.1021/jf071704w; Stafford HA, 1997, BOT REV, V63, P27, DOI 10.1007/BF02857916; Subramanian S, 2005, PLANT PHYSIOL, V137, P1345, DOI 10.1104/pp.104.057257; Subramanian S, 2004, PLANT MOL BIOL, V54, P623, DOI 10.1023/B:PLAN.0000040814.28507.35; Subramanian S, 2007, TRENDS PLANT SCI, V12, P282, DOI 10.1016/j.tplants.2007.06.006; Subramanian S, 2006, PLANT J, V48, P261, DOI 10.1111/j.1365-313X.2006.02874.x; TANKSLEY SD, 1993, ANNU REV GENET, V27, P205, DOI 10.1146/annurev.ge.27.120193.001225; Trigiano R.N., 1998, HORTTECHNOLOGY, V3, P413, DOI [10.21273/HORTTECH.8.3.413, DOI 10.21273/HORTTECH.8.3.413]; TSUKAMOTO C, 1995, J AGR FOOD CHEM, V43, P1184, DOI 10.1021/jf00053a012; Varshney RK, 2005, TRENDS PLANT SCI, V10, P621, DOI 10.1016/j.tplants.2005.10.004; Voorrips RE, 2002, J HERED, V93, P77, DOI 10.1093/jhered/93.1.77; Wang CM, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-174; Wang DL, 1999, THEOR APPL GENET, V99, P1255, DOI 10.1007/s001220051331; Wang Y, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-680; Yan WK, 2001, AGRON J, V93, P1111, DOI 10.2134/agronj2001.9351111x; Yang J, 2008, BIOINFORMATICS, V24, P721, DOI 10.1093/bioinformatics/btm494; Yang K, 2011, GENES GENOM, V33, P685, DOI 10.1007/s13258-011-0043-z; Zeng GL, 2009, THEOR APPL GENET, V118, P1455, DOI 10.1007/s00122-009-0994-5; ZENG ZB, 1993, P NATL ACAD SCI USA, V90, P10972, DOI 10.1073/pnas.90.23.10972; [张晶莹 Zhang Jingying], 2012, [中国农业科学, Scientia Agricultura Sinica], V45, P3909	49	26	27	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2015	10	3							e0118447	10.1371/journal.pone.0118447	http://dx.doi.org/10.1371/journal.pone.0118447			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9JM	25738957	Green Submitted, Green Published, gold			2022-12-27	WOS:000350685900035
J	Arnberg, FK; Michell, PO; Lundin, T				Arnberg, Filip K.; Michell, Per-Olof; Lundin, Tom			Posttraumatic Stress in Survivors 1 Month to 19 Years after an Airliner Emergency Landing	PLOS ONE			English	Article							EVENT SCALE; GENDER-DIFFERENCES; DISORDER; DISASTER; TRAUMA; IMPACT; PTSD; TRAJECTORIES; RESILIENCE; SYMPTOMATOLOGY	Posttraumatic stress (PTS) is common in survivors from life-threatening events. Little is known, however, about the course of PTS after life threat in the absence of collateral stressors (e.g., bereavement, social stigma, property loss) and there is a scarcity of studies about PTS in the long term. This study assessed the short-and long-term course of PTS, and the influence of gender, education and age on the level and course of PTS, in survivors from a non-fatal airliner emergency landing caused by engine failure at an altitude of 1 km. There were 129 persons on board. A survey including the Impact of Event Scale was distributed to 106 subjects after 1 month, 4 months, 14 months, and 25 months, and to 95 subjects after 19 years (response rates 64-83%). There were initially high levels of PTS. The majority of changes in PTS occurred from 1 to 4 months after the event. There were small changes from 4 to 25 months but further decrease in PTS thereafter. Female gender was associated with higher levels of PTS whereas gender was unrelated to the slope of the short- and long-term trajectories. Higher education was related to a quicker recovery although not to initial or long-term PTS. Age was not associated with PTS. The present findings suggest that a life-threatening experience without collateral stressors may produce high levels of acute posttraumatic stress, yet with a benign prognosis. The findings further implicate that gender is unrelated to trajectories of recovery in the context of highly similar exposure and few collateral stressors.	[Arnberg, Filip K.; Michell, Per-Olof; Lundin, Tom] Uppsala Univ, Natl Ctr Disaster Psychiat, Dept Neurosci, S-75105 Uppsala, Sweden; [Arnberg, Filip K.] Stockholm Univ, Stress Res Inst, S-10691 Stockholm, Sweden	Uppsala University; Stockholm University	Arnberg, FK (corresponding author), Uppsala Univ, Natl Ctr Disaster Psychiat, Dept Neurosci, S-75105 Uppsala, Sweden.	filip.amberg@neuro.uu.se	Arnberg, Filip/I-5756-2019	Arnberg, Filip/0000-0002-1317-2093	Swedish National Board of Health and Welfare; Uppsala Akademiska Hospital	Swedish National Board of Health and Welfare; Uppsala Akademiska Hospital	This study was funded by the Swedish National Board of Health and Welfare (www.socialstyrelsen.se) and by the Uppsala Akademiska Hospital (www.akademiska.se). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Arnberg FK, 2012, J TRAUMA STRESS, V25, P721, DOI 10.1002/jts.21758; Arnberg FK, 2011, J TRAUMA STRESS, V24, P183, DOI 10.1002/jts.20629; Balding DJ, 2004, APPL LONGITUDINAL AN; Birmes P, 1999, J NERV MENT DIS, V187, P754, DOI 10.1097/00005053-199912000-00008; Boe HJ, 2011, J NERV MENT DIS, V199, P49, DOI 10.1097/NMD.0b013e31820446a8; Bonanno GA, 2004, AM PSYCHOL, V59, P20, DOI 10.1037/0003-066X.59.1.20; Brewin CR, 2000, J CONSULT CLIN PSYCH, V68, P748, DOI 10.1037/0022-006X.68.5.748; Ehlers A, 1998, J ABNORM PSYCHOL, V107, P508, DOI 10.1037/0021-843X.107.3.508; Favaro A, 2004, J NERV MENT DIS, V192, P227, DOI 10.1097/01.nmd.0000117590.81374.7c; Fullerton CS, 2001, AM J PSYCHIAT, V158, P1486, DOI 10.1176/appi.ajp.158.9.1486; Furukawa TA, 1999, LANCET, V353, P561, DOI 10.1016/S0140-6736(98)05470-1; Galea S, 2005, EPIDEMIOL REV, V27, P78, DOI 10.1093/epirev/mxi003; Galea S, 2008, J TRAUMA STRESS, V21, P357, DOI 10.1002/jts.20355; Goldberg DP, 1997, PSYCHOL MED, V27, P191, DOI 10.1017/S0033291796004242; Goldberg DP, 1972, DETECTION PSYCHIAT I; GREEN BL, 1990, AM J ORTHOPSYCHIAT, V60, P43, DOI 10.1037/h0079168; Green BL, 1985, TRAUMA ITS WAKE, P53; Gregg W, 1995, BRIT J PSYCHIAT, V167, P812, DOI 10.1192/bjp.167.6.812; Hobfoll S.E., 1995, TRAUMATIC STRESS THE, P29, DOI [10.1007/978-1-4899-1076-9_2, DOI 10.1007/978-1-4899-1076-9_2]; HOROWITZ M, 1979, PSYCHOSOM MED, V41, P209, DOI 10.1097/00006842-197905000-00004; Hull AM, 2002, BRIT J PSYCHIAT, V181, P433, DOI 10.1192/bjp.181.5.433; Johannesson KB, 2009, J NERV MENT DIS, V197, P316, DOI 10.1097/NMD.0b013e3181a206f7; JOSEPH S, 1992, BRIT J CLIN PSYCHOL, V31, P63, DOI 10.1111/j.2044-8260.1992.tb00968.x; KESSLER RC, 1995, ARCH GEN PSYCHIAT, V52, P1048, DOI 10.1001/archpsyc.1995.03950240066012; LIANG KY, 1986, BIOMETRIKA, V73, P13, DOI 10.1093/biomet/73.1.13; Lilly MM, 2009, J ANXIETY DISORD, V23, P767, DOI 10.1016/j.janxdis.2009.02.015; Lowe SR, 2014, AM J COMMUN PSYCHOL, V53, P159, DOI 10.1007/s10464-014-9634-6; Lundin T, 1998, NORD J PSYCHIAT, V52, P145; Mayou R, 1997, PSYCHOSOM MED, V59, P578, DOI 10.1097/00006842-199711000-00004; Mayou R, 2002, PSYCHOL MED, V32, P671, DOI 10.1017/S0033291702005470; McFarlane A. C., 2006, METHODS DISAST MENTA, P3; McHugh PR, 2007, J ANXIETY DISORD, V21, P211, DOI 10.1016/j.janxdis.2006.09.003; Norris FH, 2009, SOC SCI MED, V68, P2190, DOI 10.1016/j.socscimed.2009.03.043; Oe Misari, 2008, Kurume Medical Journal, V55, P1, DOI 10.2739/kurumemedj.55.1; Olff M, 2007, PSYCHOL BULL, V133, P183, DOI 10.1037/0033-2909.133.2.183; Pietrzak RH, 2014, PSYCHOL MED, V44, P205, DOI 10.1017/S0033291713000597; Sloan P, 1988, J TRAUMA STRESS, V1, P211, DOI DOI 10.1002/JTS.2490010208; Sundin EC, 2002, BRIT J PSYCHIAT, V180, P205, DOI 10.1192/bjp.180.3.205; Sveen J, 2010, J ANXIETY DISORD, V24, P618, DOI 10.1016/j.janxdis.2010.03.021; Sveen J, 2010, J BURN CARE RES, V31, P310, DOI 10.1097/BCR.0b013e3181d0f523; Tolin DF, 2006, PSYCHOL BULL, V132, P959, DOI 10.1037/0033-2909.132.6.959; Ursano RJ, 1999, AM J PSYCHIAT, V156, P589; Wahlstrom L, 2008, J TRAUMA STRESS, V21, P463, DOI 10.1002/jts.20360; Weiss D. S., 2007, ASSESSING PSYCHOL TR, P219, DOI [10.1007/978-0-387-70990-1_10, DOI 10.1007/978-0-387-70990-1_10]	45	2	3	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2015	10	3							e0119732	10.1371/journal.pone.0119732	http://dx.doi.org/10.1371/journal.pone.0119732			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CC4HV	25734536	Green Published, gold, Green Submitted			2022-12-27	WOS:000350314700063
J	Fleming, PJ; McCleary-Sills, J; Morton, M; Levtov, R; Heilman, B; Barker, G				Fleming, Paul J.; McCleary-Sills, Jennifer; Morton, Matthew; Levtov, Ruti; Heilman, Brian; Barker, Gary			Risk Factors for Men's Lifetime Perpetration of Physical Violence against Intimate Partners: Results from the International Men and Gender Equality Survey (IMAGES) in Eight Countries	PLOS ONE			English	Article							COMMUNITY MOBILIZATION INTERVENTION; RANDOMIZED-CONTROLLED-TRIAL; PREVENT VIOLENCE; SEXUAL VIOLENCE; STEPPING STONES; SOUTH-AFRICA; HIV RISK; WOMEN; HEALTH; IMPACT	This paper examines men's lifetime physical intimate partner violence (IPV) perpetration across eight low- and middle-income countries to better understand key risk factors that interventions can target in order to promote gender equality and reduce IPV. We use data from men (n = 7806) that were collected as part of the International Men and Gender Equality Survey (IMAGES) in Bosnia and Herzegovina, Brazil, Chile, Croatia, Democratic Republic of Congo (DRC), India, Mexico, and Rwanda. Results show that there is wide variation across countries for lifetime self-reported physical violence perpetration (range: 17% in Mexico to 45% in DRC), men's support for equal roles for men and women, and acceptability of violence against women. Across the sample, 31% of men report having perpetrated physical violence against a partner in their lifetime. In multivariate analyses examining risk factors for men ever perpetrating physical violence against a partner, witnessing parental violence was the strongest risk factor, reinforcing previous research suggesting the intergenerational transmission of violence. Additionally, having been involved in fights not specifically with an intimate partner, permissive attitudes towards violence against women, having inequitable gender attitudes, and older age were associated with a higher likelihood of ever perpetrating physical IPV. In separate analyses for each country, we found different patterns of risk factors in countries with high perpetration compared to countries with low perpetration. Findings are interpreted to identify key knowledge gaps and directions for future research, public policies, evaluation, and programming.	[Fleming, Paul J.] Univ N Carolina, Dept Hlth Behav, Gillings Sch Global Publ Hlth, Chapel Hill, NC 27599 USA; [Fleming, Paul J.] Univ N Carolina, Carolina Populat Ctr, Chapel Hill, NC 27599 USA; [McCleary-Sills, Jennifer; Morton, Matthew] World Bank Grp, Washington, DC 20433 USA; [Levtov, Ruti; Barker, Gary] Promundo US, Washington, DC 20036 USA; [Heilman, Brian] Int Ctr Res Women, Washington, DC 20036 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; The World Bank	Fleming, PJ (corresponding author), Univ N Carolina, Dept Hlth Behav, Gillings Sch Global Publ Hlth, 302 Rosenau Hall, Chapel Hill, NC 27599 USA.	pfleming@unc.edu		Fleming, Paul/0000-0001-9150-1254; Barker, Gary/0000-0001-7120-3639	John D. and Catherine T. MacArthur Foundation; Government of Norway (Ministry of Foreign Affairs and Norad); Ford Foundation; World Bank; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R24HD050924, T32HD007168] Funding Source: NIH RePORTER	John D. and Catherine T. MacArthur Foundation; Government of Norway (Ministry of Foreign Affairs and Norad); Ford Foundation; World Bank(The World Bank India); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	The data collection and the data analysis were generously funded by the John D. and Catherine T. MacArthur Foundation (httmllwww. macfound.org/), The Government of Norway (Ministry of Foreign Affairs and Norad), the Ford Foundation (http fordfoundation oral, the Nordic Trust Fund, the World Bank (.worldbank org), and an anonymous donor. Portions of the country-level work were supported by CARE-Norway (Croatia and Bosnia); UNDP (Rwanda and Chile); UNIFEM and UNFPA (Chile), SIDA (DRC). The authors are grateful to the Carolina Population Center for training support (T32 HD007168) and for general support (R24 HD050924). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramsky T, 2014, BMC MED, V12, DOI 10.1186/s12916-014-0122-5; Abramsky T, 2012, TRIALS, V13, DOI 10.1186/1745-6215-13-96; Abramsky T, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-109; Ackerson LK, 2008, AM J PUBLIC HEALTH, V98, P507, DOI 10.2105/AJPH.2007.113738; [Anonymous], MENS LIVES; [Anonymous], 1999, ENDING VIOLENCE WOME; Archer J, 1999, J INTERPERS VIOLENCE, V14, P1263, DOI 10.1177/088626099014012003; Armstrong T. G., 2002, TRAUMA VIOLENCE ABUS, V3, P181, DOI [DOI 10.1177/15248380020033002, 10.1177/15248380020033002]; Ball B, 2012, VIOLENCE AGAINST WOM, V18, P746, DOI 10.1177/1077801212455188; Bandura A, 2001, ANNU REV PSYCHOL, V52, P1, DOI 10.1146/annurev.psych.52.1.1; Bandura Albert, 1977, SOCIAL LEARNING THEO; Barker G, 2010, GLOB PUBLIC HEALTH, V5, P539, DOI 10.1080/17441690902942464; Barker G, 2010, WHAT MEN HAVE DO IT; Barker G., 2011, EVOLVING MEN INITIAL; Brut India, 2021, 4 INDIAN MEN CALL OU; Cohan M, 2009, SEX CULT, V13, P152, DOI 10.1007/s12119-009-9052-3; Connell R., 1987, GENDER POWER SOC PER; Connell RW, 1995, MASCULINITIES; Contreras M., 2012, BRIDGES ADULTHOOD UN; Copenhaver MM, 2000, SEX ROLES, V42, P405, DOI 10.1023/A:1007050305387; Courtenay WH, 2000, SOC SCI MED, V50, P1385, DOI 10.1016/S0277-9536(99)00390-1; Dalal K, 2009, J BIOSOC SCI, V41, P561, DOI 10.1017/S0021932009990046; Dworkin SL, 2013, AIDS BEHAV, V17, P2845, DOI 10.1007/s10461-013-0565-2; Dworkin SL, 2013, MEN MASC, V16, P181, DOI 10.1177/1097184X12469878; Eckart J, 1992, TEACHING ED, V5, P59; Farre L, 2013, ECONOMICA, V80, P219, DOI 10.1111/ecca.12008; Fleming PJ, 2013, ENGAGING MEN BOYS AD; Franchina J. J., 2001, PSYCHOL MEN MASCULIN, V2, P34, DOI [10.1037/1524-9220.2.1.34, DOI 10.1037/1524-9220.2.1.34]; Fulu E., 2013, WHY DO SOME MEN USE; Gamedze L, 2015, ONE MAN CAN GOES BUS; Garcia-Moreno C, 2005, WHO MULTICOUNTRY STU; Gil-Gonzalez D, 2008, J PUBLIC HEALTH-UK, V30, P14, DOI 10.1093/pubmed/fdm071; Heath R, 2014, WORLD DEV, V57, P32, DOI 10.1016/j.worlddev.2013.10.028; Heise L, 2002, VIOLENCE INTIMATE PA; Heise L L, 1998, Violence Against Women, V4, P262, DOI 10.1177/1077801298004003002; HEISE LL, 1994, SOC SCI MED, V39, P1165, DOI 10.1016/0277-9536(94)90349-2; Heise LL, 2012, DETERMINANTS PARTNER; Hilton NZ, 2003, J INTERPERS VIOLENCE, V18, P223, DOI 10.1177/0886260502250065; Hyde A, 2009, AM J MENS HEALTH, V3, P238, DOI 10.1177/1557988308319730; Jakupcak M., 2002, PSYCHOL MEN MASC, V3, P97, DOI [10.1037/1524-9220.3.2.97, DOI 10.1037/1524-9220.3.2.97]; Jewkes R, 2006, TROP MED INT HEALTH, V11, P3, DOI 10.1111/j.1365-3156.2005.01530.x; Jewkes R, 2002, LANCET, V359, P1423, DOI 10.1016/S0140-6736(02)08357-5; Jewkes R., 2009, UNDERSTANDING MENS H; Jewkes R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029590; Jewkes R, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a506; Kaufman Michael, 1987, PATRIARCHY ESSAYS ME, P1; Kiluva-Ndunda M. M., 2001, WOMENS AGENCY ED POL; Kimmel MS, 2003, AM BEHAV SCI, V46, P1439, DOI 10.1177/0002764203046010010; Knight RA, 2003, ANN NY ACAD SCI, V989, P72, DOI 10.1111/j.1749-6632.2003.tb07294.x; Levtov RG, 2014, MEN MASC, V17, P467, DOI 10.1177/1097184X14558234; Lusher D., 2010, J MENS STUD, V18, P22, DOI DOI 10.3149/JMS.1801.22; MALAMUTH NM, 1991, J CONSULT CLIN PSYCH, V59, P670, DOI 10.1037/0022-006X.59.5.670; Moore T. M., 2005, PSYCHOL MEN MASC, V6, P46, DOI [10.1037/1524-9220.6.1.46, DOI 10.1037/1524-9220.6.1.46]; Peterman A, 2011, AM J PUBLIC HEALTH, V101, P1060, DOI 10.2105/AJPH.2010.300070; Pierotti RS, 2013, AM SOCIOL REV, V78, P240, DOI 10.1177/0003122413480363; Pulerwitz J, 2006, PROMOTING MORE GENDE; Pulerwitz J, 2014, AM J PUBLIC HEALTH, V105, P132; Pulerwitz J, 2008, MEN MASC, V10, P322, DOI 10.1177/1097184X06298778; Ricardo Christine, 2012, MEN WHO CARE MULTICO; Santana MC, 2006, J URBAN HEALTH, V83, P575, DOI 10.1007/s11524-006-9061-6; Shattuck D, 2013, MEN MASC, V16, P540, DOI 10.1177/1097184X13502730; Solorzano I, 2000, EVALUACION DE IMPACT, DOI [10.1111/cobi.12122, DOI 10.1111/C0BI.12122]; Stith SM, 2000, J MARRIAGE FAM, V62, P640, DOI 10.1111/j.1741-3737.2000.00640.x; Stith SM, 2004, AGGRESS VIOLENT BEH, V10, P65, DOI 10.1016/j.avb.2003.09.001; Swiss S, 1998, JAMA-J AM MED ASSOC, V279, P625, DOI 10.1001/jama.279.8.625; UN Women, 2014, WOMEN WAR PEACE; United Nations Economic and Social Council, 2012, GEND STAT SECR GEN S; VanderEnde KE, 2012, SOC SCI MED, V75, P1143, DOI 10.1016/j.socscimed.2012.05.027; West C, 1987, GENDER SOC, V1, P125, DOI 10.1177/0891243287001002002; White V, 2003, MEN REPROD HLTH PROG; WHO (World Health Organization), 2010, POL APPR ENG MEN BOY; Wood EJ, 2006, POLIT SOC, V34, P307, DOI 10.1177/0032329206290426; World Bank, 2010, WORLD DEV IND; World Health Organization, 2007, ENG MEN BOYS CHANG G; World Health Organization, 2021, VIOL WOM PREV EST 20; World Health Organization, 2010, PREV INT PARTN SEX V, DOI [10.1136/ip.2010.029629, DOI 10.1136/IP.2010.029629]; Yount KM, 2012, J FAM ISSUES, V33, P1540, DOI 10.1177/0192513X11424255	77	125	128	7	83	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2015	10	3							e0118639	10.1371/journal.pone.0118639	http://dx.doi.org/10.1371/journal.pone.0118639			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CC4HV	25734544	Green Published, gold			2022-12-27	WOS:000350314700042
J	Lv, ZP; Li, Y; Wu, YZ; Qu, Y				Lv, Zhiping; Li, Ying; Wu, Yongzhong; Qu, Yi			Surgical Complications of Primary Rhegmatogenous Retinal Detachment: A Meta-Analysis	PLOS ONE			English	Article							PARS-PLANA VITRECTOMY; SCLERAL BUCKLE SURGERY; SUBRETINAL FLUID; MANAGEMENT; 25-GAUGE; ENDOPHTHALMITIS; 20-GAUGE; OUTCOMES; TEARS	Background To investigate the surgical complications of scleral buckling (SB) and pars plana vitrectomy (PPV) performed on primary rhegmatogenous retinal detachment (RRD) and to discover which surgical procedures bring fewer complications. Methods An electronic literature search using the PubMed database, ISI Web of Knowledge and the Cochrane Central Register of Controlled Trials to identify randomized controlled trials and observational studies comparing SB with PPV on primary RRD. Outcome measures included intra-operative complications and early and late post-operative complications. Results During the operation, significantly less subretinal hemorrhage occurred in the PPV group than in the SB group (OR = 4.71; 95%CI, 1.33-16.64; p = 0.02) and the hypotony incidence was significantly higher in the SB group (OR = 18.24; 95%CI, 2.37-140.44; p = 0.005); however, the occurrence of iatrogenic breaks was significantly lower in the SB group (OR = 0.05; 95%CI, 0.01-0.21; p<0.0001). In the early stage of post-operation, significantly higher incidence of choroidal detachment was identified in the SB group than in the PPV group (OR = 10.19; 95%CI, 2.36-44.09; p = 0.002); patients undergoing SB had significantly higher odds of residual subretinal fluid (OR = 14.71; 95%CI, 1.84-117.32; p = 0.01); the occurrence of high intraocular pressure was significantly lower in the SB group (OR = 0.46; 95%CI, 0.23-0.89; p = 0.02); and no significant difference was shown in the incidence of epithelia defect (p = 0.37) between the two groups. In the late stage of post-operation, the incidence of diplopia/extraocular muscle dysfunction was significantly higher in the SB group (OR = 4.04; 95%CI, 1.30-12.52; p = 0.02); and significantly less cataract was observed in the SB group (OR = 0.20; 95%CI, 0.14-0.30; p<0.00001); no significant difference was found in the incidences of cystoid macular edema (p = 0.65), macular pucker (p = 0.52), post-operative proliferative vitreoretinopathy (p = 0.73) and epiretinal membrane (p = 0.47) in other late post-operative complications. Conclusions This meta-analysis suggests that PPV could be considered as potential surgical management on primary RRD.	[Lv, Zhiping; Li, Ying; Qu, Yi] Shandong Univ, Qilu Hosp, Dept Ophthalmol, Jinan 250012, Peoples R China; [Wu, Yongzhong] Shandong Univ, State Key Lab Crystal Mat, Jinan 250100, Peoples R China	Shandong University; Shandong University	Qu, Y (corresponding author), Shandong Univ, Qilu Hosp, Dept Ophthalmol, 107 Wenhuaxi Rd, Jinan 250012, Peoples R China.	yiqucn@sdu.edu.cn			Natural Science foundation of Shandong Province [ZR2013HZ003]; Scientific & Technologic Project of Jinan [201302025]; Fundamental Research Funds of Shandong University [2014JC015]	Natural Science foundation of Shandong Province(Natural Science Foundation of Shandong Province); Scientific & Technologic Project of Jinan; Fundamental Research Funds of Shandong University	This study was supported partly by Natural Science foundation of Shandong Province (ZR2013HZ003), Scientific & Technologic Project of Jinan (201302025), and The Fundamental Research Funds of Shandong University (2014JC015). The funders had no role in study design, data, collection and analysis, decision to publish, or preparation of the manuscript.	Abou Shousha M, 2010, CURR OPIN OPHTHALMOL, V21, P45, DOI 10.1097/ICU.0b013e32833303bf; Ahmadieh H, 2005, OPHTHALMOLOGY, V112, P1421, DOI 10.1016/j.ophtha.2005.02.018; Ambresin A, 2003, RETINA-J RET VIT DIS, V23, P622, DOI 10.1097/00006982-200310000-00003; [Anonymous], 2010, MINIMIZING INCISION; Arya AV, 2006, OPHTHALMOLOGY, V113, P1724, DOI 10.1016/j.ophtha.2006.05.044; Azad RV, 2007, ACTA OPHTHALMOL SCAN, V85, P540, DOI 10.1111/j.1600-0420.2007.00888.x; BartzSchmidt KU, 1996, BRIT J OPHTHALMOL, V80, P346, DOI 10.1136/bjo.80.4.346; Brazitikos P D, 2000, Semin Ophthalmol, V15, P65; Brazitikos PD, 2005, RETINA-J RET VIT DIS, V25, P957, DOI 10.1097/00006982-200512000-00001; Feltgen N, 2007, GRAEF ARCH CLIN EXP, V245, P803, DOI 10.1007/s00417-006-0399-y; FISON PN, 1987, BRIT J OPHTHALMOL, V71, P521, DOI 10.1136/bjo.71.7.521; Golubovic M, 2013, Pril (Makedon Akad Nauk Umet Odd Med Nauki), V34, P161; HARBOUR JM, 1995, AM J OPHTHALMOL, V120, P302, DOI 10.1016/S0002-9394(14)72159-2; Heimann H, 1996, GRAEF ARCH CLIN EXP, V234, P561, DOI 10.1007/BF00448800; Heimann H, 2007, OPHTHALMOLOGY, V114, P2142, DOI 10.1016/j.ophtha.2007.09.013; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Higgins JPT, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d5928; Ho LY, 2011, RETINA-J RET VIT DIS, V31, P1109, DOI 10.1097/IAE.0b013e31820b5b9b; HO PC, 1984, OPHTHALMOLOGY, V91, P847; Kang SW, 2008, AM J OPHTHALMOL, V146, P205, DOI 10.1016/j.ajo.2008.04.005; Katsimpris J, 2012, ACTA OPHTHALMOLOGICA, V90; Kim SY, 2013, J CLIN EPIDEMIOL, V66, P408, DOI 10.1016/j.jclinepi.2012.09.016; Knobloch K, 2011, J CRANIO MAXILL SURG, V39, P91, DOI 10.1016/j.jcms.2010.11.001; Kobashi H, 2014, CURR EYE RES, V39, P204, DOI 10.3109/02713683.2013.838270; Koriyama M, 2007, JPN J OPHTHALMOL, V51, P360, DOI 10.1007/s10384-007-0463-0; Kunimoto DY, 2007, OPHTHALMOLOGY, V114, P2133, DOI 10.1016/j.ophtha.2007.08.009; Lecleire-Collet A, 2006, AM J OPHTHALMOL, V142, P176, DOI 10.1016/j.ajo.2006.01.080; Lincoff H, 2005, PRIMARY RETINAL DETACHMENT: OPTIONS FOR REPAIR, P161, DOI 10.1007/3-540-26801-4_8; Miki D, 2001, JPN J OPHTHALMOL, V45, P187, DOI 10.1016/S0021-5155(00)00377-4; Mitry D, 2010, RETINA-J RET VIT DIS, V30, P1561, DOI 10.1097/IAE.0b013e3181f669e6; Oshima Y, 1999, JPN J OPHTHALMOL, V43, P120, DOI 10.1016/S0021-5155(98)00075-6; Oshima Y, 2000, JPN J OPHTHALMOL, V44, P538, DOI 10.1016/S0021-5155(00)00205-7; Pastor JC, 2008, BRIT J OPHTHALMOL, V92, P378, DOI 10.1136/bjo.2007.129437; Schutz JS, 2012, AM J OPHTHALMOL, V153, P188, DOI 10.1016/j.ajo.2011.10.011; Scott IU, 2008, RETINA-J RET VIT DIS, V28, P138, DOI 10.1097/IAE.0b013e31815e9313; Sharma YR, 2005, ACTA OPHTHALMOL SCAN, V83, P293, DOI 10.1111/j.1600-0420.2005.00461.x; Soni C, 2013, OPHTHALMOLOGY, V120, P1440, DOI 10.1016/j.ophtha.2012.12.033; Speicher MA, 2000, RETINA-J RET VIT DIS, V20, P459, DOI 10.1097/00006982-200009000-00005; Tsui I, 2012, SURV OPHTHALMOL, V57, P253, DOI 10.1016/j.survophthal.2011.11.001; Wang XY, 2011, CHINESE MED J-PEKING, V124, P4007, DOI 10.3760/cma.j.issn.0366-6999.2011.23.030; YOSHIDA A, 1992, OPHTHALMOLOGY, V99, P460	41	25	26	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2015	10	3							e0116493	10.1371/journal.pone.0116493	http://dx.doi.org/10.1371/journal.pone.0116493			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4HV	25734450	gold, Green Published, Green Submitted			2022-12-27	WOS:000350314700005
J	MacDonald, DA; Friedman, HL; Brewczynski, J; Holland, D; Salagame, KKK; Mohan, KK; Gubrij, ZO; Cheong, HW				MacDonald, Douglas A.; Friedman, Harris L.; Brewczynski, Jacek; Holland, Daniel; Salagame, Kiran Kumar K.; Mohan, K. Krishna; Gubrij, Zuzana Ondriasova; Cheong, Hye Wook			Spirituality as a Scientific Construct: Testing Its Universality across Cultures and Languages	PLOS ONE			English	Article							PSYCHOMETRIC PROPERTIES; TRANSCENDENCE SCALE; HUMAN-EXPERIENCE; 5-FACTOR MODEL; PERSONALITY; RELIGION; HEALTH; GENERALIZABILITY; TEMPERAMENT; ORIENTATION	Using data obtained from 4004 participants across eight countries (Canada, India, Japan, Korea, Poland, Slovakia, Uganda, and the U.S.), the factorial reliability, validity and structural/ measurement invariance of a 30-item version of Expressions of Spirituality Inventory (ESI-R) was evaluated. The ESI-R measures a five factor model of spirituality developed through the conjoint factor analysis of several extant measures of spiritual constructs. Exploratory factor analyses of pooled data provided evidence that the five ESI-R factors are reliable. Confirmatory analyses comparing four and five factor models revealed that the five dimensional model demonstrates superior goodness-of-fit with all cultural samples and suggest that the ESI-R may be viewed as structurally invariant. Measurement invariance, however, was not supported as manifested in significant differences in item and dimension scores and in significantly poorer fit when factor loadings were constrained to equality across all samples. Exploratory analyses with a second adjective measure of spirituality using American, Indian, and Ugandan samples identified three replicable factors which correlated with ESI-R dimensions in a manner supportive of convergent validity. The paper concludes with a discussion of the meaning of the findings and directions needed for future research.	[MacDonald, Douglas A.] Univ Detroit Mercy, Detroit, MI 48221 USA; [Friedman, Harris L.] Univ Florida, Gainesville, FL USA; [Brewczynski, Jacek] Vet Affairs, Salt Lake City, UT USA; [Brewczynski, Jacek] Univ Utah, Salt Lake City, UT USA; [Holland, Daniel] Neurobehav Ctr Minnesota, Edina, MN USA; [Salagame, Kiran Kumar K.] Univ Mysore, Mysore, Karnataka, India; [Salagame, Kiran Kumar K.] Indian Council Social Sci Res, Mysore, Karnataka, India; [Mohan, K. Krishna] Makerere Univ, Kampala, Uganda; [Mohan, K. Krishna] Mahidol Univ, Bangkok 10700, Thailand; [Gubrij, Zuzana Ondriasova] Univ Arkansas Med Sci, Little Rock, AR 72205 USA; [Cheong, Hye Wook] Dongwoo Fine Chem Co Ltd, Mental Hlth Ctr, Pyeong Taek Si, Gyeonggi Do, South Korea	University of Detroit Mercy; State University System of Florida; University of Florida; US Department of Veterans Affairs; Utah System of Higher Education; University of Utah; University of Mysore; Makerere University; Mahidol University; University of Arkansas System; University of Arkansas Medical Sciences	MacDonald, DA (corresponding author), Univ Detroit Mercy, Detroit, MI 48221 USA.	macdonda@udmercy.edu	MacDonald, Douglas A./Y-4796-2019	MacDonald, Douglas A./0000-0002-2100-1526; , Prof. Kotra Krishna Mohan/0000-0003-1642-7327				Affeldt DL, 2010, J TRANSPERSONAL PSYC, V42, P192; Akyalcin E, 2008, J TRANSPERSONAL PSYC, V40, P41; ALLPORT GW, 1967, J PERS SOC PSYCHOL, V5, P432, DOI 10.1037/h0021212; [Anonymous], 2010, PSYCHOSIS SPIRITUALI; [Anonymous], J RELIG GERONTOL, DOI [10.1300/J078v15n04_03, DOI 10.1300/J078V15N04_03]; [Anonymous], 2001, PSYCHOSIS SPIRITUALI; Beauregard Mario., 2007, SPIRITUAL BRAIN NEUR; Benson P. L., 1993, RES SOCIAL SCI STUDY, V5, P1, DOI DOI 10.1111/J.1468-5906.2010.01551.X; Borsa Juliane Callegaro, 2012, Paidéia (Ribeirão Preto), V22, P423; Brett C, 2002, PHILOS PSYCHIAT PSYC, V9, P321, DOI DOI 10.1353/PPP.2003.0053; Brewczynski J., 2006, INT J PSYCHOL RELIG, V16, P63, DOI [10.1207/s15327582ijpr1601_6, DOI 10.1207/S15327582IJPR1601_6]; Brown IT, 2013, PSYCHOL RELIG SPIRIT, V5, P90, DOI 10.1037/a0030137; Byrne B. M., 2001, STRUCTURAL EQUATION; Byrne BM, 2003, J CROSS CULT PSYCHOL, V34, P155, DOI 10.1177/0022022102250225; CLONINGER CR, 1993, ARCH GEN PSYCHIAT, V50, P975, DOI 10.1001/archpsyc.1993.01820240059008; D'Aquili E., 1999, MYSTICAL MIND PROBIN; Dy-Liacco GS, 2009, PSYCHOL RELIG SPIRIT, V1, P35, DOI 10.1037/a0014937; ELKINS DN, 1988, J HUMANIST PSYCHOL, V28, P5, DOI 10.1177/0022167888284002; Fetzer Institute National Institute on Aging Working Group, 1999, MULT MEAS RELIG SPIR; Foot H, 2004, PSYCHOLOGIST, V17, P256; Fukuyama M.A., 2008, COUNSELING CULTURES, V6th ed., P345; George LK, 2000, J SOC CLIN PSYCHOL, V19, P102, DOI 10.1521/jscp.2000.19.1.102; Gignac GE, 2007, PERS INDIV DIFFER, V43, P1051, DOI 10.1016/j.paid.2007.02.024; GILGEN AR, 1979, PSYCHOL REP, V44, P835, DOI 10.2466/pr0.1979.44.3.835; Grof Cristina., 1990, STORMY SEARCH SELF G; Grof S., 1985, BRAIN BIRTH DEATH TR; Grof S., 1988, ADVENTURE SELF DISCO; Gurven M, 2013, J PERS SOC PSYCHOL, V104, P354, DOI 10.1037/a0030841; Hambleton RK, 2005, ADAPTING EDUCATIONAL AND PSYCHOLOGICAL TESTS FOR CROSS- CULTURAL ASSESSMENT, P3; Hanfstingl B, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/949838; Hay D, 2005, ZYGON, V40, P589, DOI 10.1111/j.1467-9744.2005.00691.x; Heintz LM, 2001, PSYCHOL REP, V88, P651, DOI 10.2466/PR0.88.3.651-654; Helminiak D., 2012, HUMANIST PSYCHOL, V40, DOI 10.1080/08873267.2012.672351; Helminiak D.A., 1996, HUMAN CORE SPIRITUAL; Helminiak DA, 1998, RELIG HUMAN SCI APPR; Helminiak DA, 2008, PASTOR PSYCHOL, V57, P161, DOI 10.1007/s11089-008-0163-9; Henrich J, 2010, BEHAV BRAIN SCI, V33, P111, DOI 10.1017/S0140525X10000725; Hg S, 2009, INT J BEHAV MED, V16, P91, DOI [10.1007/s12529-009-9045-5, DOI 10.1007/S12529-009-9045-5]; Hill PC, 2000, J THEOR SOC BEHAV, V30, P51, DOI 10.1111/1468-5914.00119; Ho DYF, 2007, REV GEN PSYCHOL, V11, P62, DOI 10.1037/1089-2680.11.1.62; HOGE DR, 1972, J SCI STUD RELIG, V11, P369; Hopwood CJ, 2010, PERS SOC PSYCHOL REV, V14, P332, DOI 10.1177/1088868310361240; Howden SW, 1992, THESIS TEXAS WOMANS, V9312917; Huber JT, 2012, J HUMANIST PSYCHOL, V52, P206, DOI 10.1177/0022167811399442; Huguelet P, 2010, PSYCHOPATHOLOGY, V43, P230, DOI 10.1159/000313521; Hunt H, 2002, J HUMANIST PSYCHOL, V42, P90, DOI 10.1177/0022167802421005; Johnson CV, 2008, J HUMANIST PSYCHOL, V48, P505, DOI 10.1177/0022167808314174; Kassab VA, 2011, J RELIG HEALTH, V50, P975, DOI 10.1007/s10943-010-9325-z; Kline R.B., 2011, PRINCIPLES PRACTICE; KNOBLAUCH DL, 1986, J TRANSPERSONAL PSY, V18, P73; Koenig HG, 2008, J NERV MENT DIS, V196, P349, DOI 10.1097/NMD.0b013e31816ff796; Koenig HG, 2010, INT J APPL PSYCH STU, V7, P116, DOI 10.1002/aps.239; Lindeman M, 2012, J NERV MENT DIS, V200, P167, DOI 10.1097/NMD.0b013e3182439719; Lun VMC, 2013, PSYCHOL RELIG SPIRIT, V5, P304, DOI 10.1037/a0033641; MacDonald D. A., 2000, EXPRESSIONS SPIRITUA; MacDonald D.A., 2001, BIOFEEDBACK, V29, P19; MacDonald D.A., 2013, J YOGA PHYS THER, V03, DOI [10.4172/2157-7595.1000138, DOI 10.4172/2157-7595.1000138]; MacDonald DA, 2003, J CLIN PSYCHOL, V59, P399, DOI 10.1002/jclp.10047; MacDonald DA, 2002, PSYCHOL REP, V91, P785, DOI 10.2466/PR0.91.7.785-792; MacDonald DA, 2002, PERS INDIV DIFFER, V32, P1113, DOI 10.1016/S0191-8869(01)00114-3; MacDonald DA, 2000, J PERS, V68, P153, DOI 10.1111/1467-6494.t01-1-00094; MacDonald DA, 2002, PERS INDIV DIFFER, V32, P1013, DOI 10.1016/S0191-8869(01)00107-6; MacDonald DA, 2002, J HUMANIST PSYCHOL, V42, P102, DOI 10.1177/002216702237126; MacDonald DA, 1997, SPIRITUALITY ADJECTI; MacDonald DA, 2009, INT J TRANSPERSONAL, V28, P86, DOI DOI 10.24972/ijts.2009.28.1.86; MacDonald DA, 1998, THESIS U WINDSOR ANN, V52412; MacDonald DA, 2011, J MANAG SPIRITUAL RE, V8, P195, DOI 10.1080/14766086.2011.599145; Maselko J, 2006, SOC SCI MED, V62, P2848, DOI 10.1016/j.socscimed.2005.11.008; McEntee ML, 2013, J SPIRITUAL MENT HE, V15, P141, DOI 10.1080/19349637.2013.799410; McMinn MR, 2009, PSYCHOL RELIG SPIRIT, V1, P3, DOI 10.1037/a0014991; Meezenbroek ED, 2012, J RELIG HEALTH, V51, P336, DOI 10.1007/s10943-010-9376-1; Meezenbroek ED, 2012, J PSYCHOSOC ONCOL, V30, P141, DOI 10.1080/07347332.2011.651258; Mendez D.M., 2012, INT J TRANSPERSONAL, V31, P1, DOI [10.24972/ijts.2012.31.1.1, DOI 10.24972/IJTS.2012.31.1.1, 10.1186/1687-9856-2012-31, DOI 10.1186/1687-9856-2012-31]; Migdal L, 2013, J NERV MENT DIS, V201, P274, DOI 10.1097/NMD.0b013e318288e26a; Moberg DO, 2002, J ADULT DEV, V9, P47, DOI 10.1023/A:1013877201375; Mokuau N, 2001, Pac Health Dialog, V8, P407; Moreira-Almeida A, 2006, SOC SCI MED, V63, P843, DOI 10.1016/j.socscimed.2006.03.001; Neff JA, 2006, J SCI STUD RELIG, V45, P449, DOI 10.1111/j.1468-5906.2006.00318.x; Newberg AB, 2005, ZYGON, V40, P469, DOI 10.1111/j.1467-9744.2005.00675.x; NEWBERG AB, 2001, WHY GOD WONT GO AWAY; Newberg AB, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00215; OXMAN TE, 1988, J NERV MENT DIS, V176, P401, DOI 10.1097/00005053-198807000-00002; Pargament KI, 2000, J CLIN PSYCHOL, V56, P519, DOI 10.1002/(SICI)1097-4679(200004)56:4<519::AID-JCLP6>3.0.CO;2-1; Pargament KI, 2007, SPIRITUALLY INTEGRAT; Pena ED, 2007, CHILD DEV, V78, P1255, DOI 10.1111/j.1467-8624.2007.01064.x; Peterman AH, 2002, ANN BEHAV MED, V24, P49, DOI 10.1207/S15324796ABM2401_06; Phillips RE, 2009, J TRANSPERSONAL PSYC, V41, P61; Piedmont R. L., 2005, HDB PSYCHOL RELIG SP, P253; Piedmont RL, 2007, MENT HEALTH RELIG CU, V10, P89, DOI 10.1080/13694670500275494; Piedmont RL, 2009, PSYCHOL RELIG SPIRIT, V1, P162, DOI 10.1037/a0015883; Piedmont RL, 1999, J PERS, V67, P985, DOI 10.1111/1467-6494.00080; Piedmont RL, 2002, AM BEHAV SCI, V45, P1888; Puig A, 2008, COUNSELING SPIRITUAL, V27, P11; Rican P, 2010, STUD PSYCHOL, V52, P243; Rich Y, 2007, J HUMANIST PSYCHOL, V47, P7, DOI 10.1177/0022167806291324; Saucier G, 2006, J PERS, V74, P1257, DOI 10.1111/j.1467-6494.2006.00409.x; Talik EB, 2013, J RELIG HEALTH, V52, P143, DOI 10.1007/s10943-011-9464-x; Thompson B, 2004, EXPLORATORY CONFIRMA; Traphagan J, 2005, RES AGING, V27, P387, DOI 10.1177/0164027505275193; Underwood LG, 2002, ANN BEHAV MED, V24, P22, DOI 10.1207/S15324796ABM2401_04; Wapnick K., 1969, J TRANSPERSONAL PSY, V1, P49; Wink P, 2002, J ADULT DEV, V9, P79, DOI 10.1023/A:1013833419122; Winters Moore T, 2008, J MANAGEMENT MARKETI, V1, P79; Wu M.L, 2010, STRUCTURAL EQUATION; Yanez B, 2009, J CONSULT CLIN PSYCH, V77, P730, DOI 10.1037/a0015820; Zinnbauer BJ, 1997, J SCI STUD RELIG, V36, P549, DOI 10.2307/1387689	106	50	51	0	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2015	10	3							e0117701	10.1371/journal.pone.0117701	http://dx.doi.org/10.1371/journal.pone.0117701			38	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	CC4HV	25734921	Green Published, Green Submitted, gold			2022-12-27	WOS:000350314700010
J	Utheim, O; Islam, R; Lyberg, T; Roald, B; Eidet, JR; de la Paz, MF; Dartt, DA; Raeder, S; Utheim, TP				Utheim, Oeygunn; Islam, Rakibul; Lyberg, Torstein; Roald, Borghild; Eidet, Jon Roger; Fideliz de la Paz, Maria; Dartt, Darlene A.; Raeder, Sten; Utheim, Tor Paaske			Serum-Free and Xenobiotic-Free Preservation of Cultured Human Limbal Epithelial Cells	PLOS ONE			English	Article							DENUDED AMNIOTIC MEMBRANE; EX-VIVO EXPANSION; FETAL CALF SERUM; STEM-CELLS; EXPRESSION; TRANSPLANTATION; PHENOTYPE; INTACT; ULTRASTRUCTURE; PROLIFERATION	Aim/Purpose of the Study To develop a one-week storage method, without serum and xenobiotics, that would maintain cell viability, morphology, and phenotype of cultured human limbal epithelial sheets. Materials and Methods Human limbal explants were cultured on intact human amniotic membranes for two weeks. The sheets were stored in a hermetically sealed container at 23 degrees C in either a serum-free medium with selected animal serum-derived compounds (Quantum 286) or a xenobioticfree medium (Minimal Essential Medium) for 4 and 7 days. Stored and non-stored cultures were analyzed for cell viability, amniotic membrane and epithelial sheet thickness, and a panel of immunohistochemical markers for immature cells (Delta Np63 alpha, p63, Bmi-1, C/EBP partial derivative, ABCG2 and K19), differentiated cells (K3 and Cx43), proliferation (PCNA), and apoptosis (Caspase-3). Results The cell viability of the cultures was 98 +/- 1% and remained high after storage. Mean central thickness of non-stored limbal epithelial sheets was 23 +/- 3 mu m, and no substantial loss of cells was observed after storage. The non-stored epithelial sheets expressed a predominantly immature phenotype with Delta Np63a positivity of more than 3% in 9 of 13 cultures. After storage, the expression of ABCG2 and C/EBP partial derivative was reduced for the 7 day Quantum 286-storage group; (P = 0.04), and Bmi1 was reduced after 4 day Quantum 286-storage; (P = 0.02). No other markers varied significantly. The expression of differentiation markers was unrelated to the thickness of the epithelia and amnioticmembrane, apart from ABCG2, which correlated negatively with thickness of limbal epithelia (R = -0.69, P = 0.01) and Delta Np63 alpha, which correlated negatively with amniotic membrane thickness (R = -0.59, P = 0.03). Conclusion Limbal epithelial cells cultured from explants on amniotic membrane can be stored at 23 degrees C in both serum-free and xenobiotic-free media, with sustained cell viability, ultrastructure, and Delta Np63 alpha-positivity after both 4 and 7 days.	[Utheim, Oeygunn; Islam, Rakibul; Lyberg, Torstein; Eidet, Jon Roger; Utheim, Tor Paaske] Oslo Univ Hosp, Dept Med Biochem, Oslo, Norway; [Utheim, Oeygunn; Utheim, Tor Paaske] Oslo Univ Hosp, Dept Ophthalmol, Oslo, Norway; [Islam, Rakibul; Utheim, Tor Paaske] Univ Oslo, Fac Dent, Dept Oral Biol, Oslo, Norway; [Roald, Borghild] Oslo Univ Hosp, Dept Pathol, Oslo, Norway; [Fideliz de la Paz, Maria] Univ Autonoma Barcelona, Inst Univ Barraquer, E-08193 Barcelona, Spain; [Dartt, Darlene A.] Harvard Univ, Massachusetts Eye & Ear Infirm, Sch Med, Schepens Eye Res Inst,Dept Ophthalmol, Boston, MA USA; [Raeder, Sten] Norwegian Dry Eye Clin, Oslo, Norway	University of Oslo; University of Oslo; University of Oslo; University of Oslo; Autonomous University of Barcelona; Harvard University; Harvard Medical School; Massachusetts Eye & Ear Infirmary; Schepens Eye Research Institute	Utheim, O (corresponding author), Oslo Univ Hosp, Dept Med Biochem, Oslo, Norway.	utheim2@gmail.com		Islam, Rakibul/0000-0002-7174-9225	South-Eastern Norway Regional Health Authority [2010092]; NATIONAL EYE INSTITUTE [R01EY019470] Funding Source: NIH RePORTER	South-Eastern Norway Regional Health Authority; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	The research was funded by the South-Eastern Norway Regional Health Authority, grant number 2010092, project name "Treating blindness using novel tissue storage technology", url http://forskningsprosjekter.ihelse.net/visningprosjektrapport.aspx?reportId=7593 and http://www.helse-sorost.no/omoss_/english. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguzzi A, 1997, B WORLD HEALTH ORGAN, V75, P505; Barbaro V, 2007, J CELL BIOL, V177, P1037, DOI 10.1083/jcb.200703003; BARNES D, 1980, CELL, V22, P649, DOI 10.1016/0092-8674(80)90540-1; Cancelas JA, 2000, BLOOD, V96, P498; Chachques JC, 2004, INT J CARDIOL, V95, pS29, DOI 10.1016/S0167-5273(04)90009-5; Chen CC, 2002, INVEST OPHTH VIS SCI, V43, P2593; Chen Z, 2004, STEM CELLS, V22, P355, DOI 10.1634/stemcells.22-3-355; Crewe JM, 2001, INVEST OPHTH VIS SCI, V42, P1757; DAVANGER M, 1971, NATURE, V229, P560, DOI 10.1038/229560a0; De Luca M, 2006, REGEN MED, V1, P45, DOI 10.2217/17460751.1.1.45; Di Iorio E, 2005, P NATL ACAD SCI USA, V102, P9523, DOI 10.1073/pnas.0503437102; Dua HS, 2005, BRIT J OPHTHALMOL, V89, P529, DOI 10.1136/bjo.2004.049742; Duan WR, 2003, J PATHOL, V199, P221, DOI 10.1002/path.1289; ERICKSON GA, 1991, DEV BIOLOGICALS, V75, P173; Ghoubay-Benallaoua D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081965; GIBBS CJ, 1985, NEW ENGL J MED, V313, P734, DOI 10.1056/NEJM198509193131207; Grueterich M, 2003, INVEST OPHTH VIS SCI, V44, P4230, DOI 10.1167/iovs.02-0943; Grueterich M, 2002, INVEST OPHTH VIS SCI, V43, P63; Grueterich M, 2002, OPHTHALMOLOGY, V109, P1547, DOI 10.1016/S0161-6420(02)01105-3; HALL PA, 1990, J PATHOL, V162, P285, DOI 10.1002/path.1711620403; Halme DG, 2006, NEW ENGL J MED, V355, P1730, DOI 10.1056/NEJMhpr063086; Hayashi R, 2010, TISSUE ENG PART C-ME, V16, P553, DOI [10.1089/ten.tec.2009.0277, 10.1089/ten.TEC.2009.0277]; Jones RR, 2012, STEM CELL RES, V8, P403, DOI 10.1016/j.scr.2012.01.001; Kim HS, 2004, EXP EYE RES, V79, P41, DOI 10.1016/j.exer.2004.02.015; Kim M, 2002, CLIN CANCER RES, V8, P22; Koizumi N, 2002, INVEST OPHTH VIS SCI, V43, P2114; Koizumi N, 2001, OPHTHALMOLOGY, V108, P1569, DOI 10.1016/S0161-6420(01)00694-7; Koizumi N, 2007, GRAEF ARCH CLIN EXP, V245, P123, DOI 10.1007/s00417-005-0095-3; LAUWERYNS B, 1993, INVEST OPHTH VIS SCI, V34, P1991; Lee SH, 1997, AM J OPHTHALMOL, V123, P303, DOI 10.1016/S0002-9394(14)70125-4; LINDSTROM RL, 1976, AM J OPHTHALMOL, V82, P72, DOI 10.1016/0002-9394(76)90667-X; Mannello F, 2007, STEM CELLS, V25, P1603, DOI 10.1634/stemcells.2007-0127; Matic M, 1997, DIFFERENTIATION, V61, P251, DOI 10.1046/j.1432-0436.1997.6140251.x; Meller D, 2002, BRIT J OPHTHALMOL, V86, P463, DOI 10.1136/bjo.86.4.463; Meyer-Blazejewska EA, 2010, INVEST OPHTH VIS SCI, V51, P765, DOI 10.1167/iovs.09-4109; O'Callaghan AR, 2011, STEM CELLS, V29, P1923, DOI 10.1002/stem.756; Pellegrini G, 1997, LANCET, V349, P990, DOI 10.1016/S0140-6736(96)11188-0; Pellegrini G, 2001, P NATL ACAD SCI USA, V98, P3156, DOI 10.1073/pnas.061032098; Pellegrini G, 2010, TRENDS MOL MED, DOI [10.1016/j.molmed.2010.1010.1003, DOI 10.1016/J.M0LMED.2010.1010.1003]; Raeder S, 2007, INVEST OPHTH VIS SCI, V48, P5484, DOI 10.1167/iovs.07-0494; Raeder S, 2007, ACTA OPHTHALMOL SCAN, V85, P377, DOI 10.1111/j.1600-0420.2006.00873.x; Raeder S, 2010, CORNEA, V29, P439, DOI 10.1097/ICO.0b013e3181ba0c94; Rama P, 2010, NEW ENGL J MED, V363, P147, DOI 10.1056/NEJMoa0905955; ROSENDAAL M, 1994, J CELL SCI, V107, P29; Sangwan VS, 2011, BRIT J OPHTHALMOL, V95, P1525, DOI 10.1136/bjophthalmol-2011-300352; SCHERMER A, 1986, J CELL BIOL, V103, P49, DOI 10.1083/jcb.103.1.49; Schlotzer-Schrehardt U, 2005, EXP EYE RES, V81, P247, DOI 10.1016/j.exer.2005.02.016; Schwab I R, 1999, Trans Am Ophthalmol Soc, V97, P891; Schwab IR, 2006, ARCH OPHTHALMOL-CHIC, V124, P1734, DOI 10.1001/archopht.124.12.1734; Selvaggi TA, 1997, BLOOD, V89, P776, DOI 10.1182/blood.V89.3.776; Sudha B, 2008, INDIAN J MED RES, V128, P149; Tseng SCG, 2010, CURR MOL MED, V10, P841; Utheim TP, 2009, BRIT J OPHTHALMOL, V93, P980, DOI 10.1136/bjo.2008.149591; Utheim TP, 2009, INVEST OPHTH VIS SCI, V50, P5165, DOI 10.1167/iovs.08-2884; Utheim TP, 2007, BRIT J OPHTHALMOL, V91, P797, DOI 10.1136/bjo.2006.103218; Utheim Tor Paaske, 2013, Methods Mol Biol, V1014, P3, DOI 10.1007/978-1-62703-432-6_1; VANHORN DL, 1975, ARCH OPHTHALMOL-CHIC, V93, P275, DOI 10.1001/archopht.1975.01010020285007; Zhou S, 2001, NAT MED, V7, P1028, DOI 10.1038/nm0901-1028	58	17	18	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2015	10	3							e0118517	10.1371/journal.pone.0118517	http://dx.doi.org/10.1371/journal.pone.0118517			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4HV	25734654	Green Submitted, gold, Green Published			2022-12-27	WOS:000350314700036
J	Long, H; Chen, CL; Wang, B; Feng, YN				Long, Hong; Chen, Chunli; Wang, Bing; Feng, Yanni			rDNA Genetic Imbalance and Nucleolar Chromatin Restructuring Is Induced by Distant Hybridization between Raphanus sativus and Brassica alboglabra	PLOS ONE			English	Article							DNA METHYLATION; GENOME EVOLUTION; DOMINANCE; EXPRESSION; HETEROCHROMATIN; POLYPLOIDY; L.	The expression of rDNA in hybrids inherited from only one progenitor refers to nucleolar dominance. The molecular basis for choosing which genes to silence remains unclear. We report genetic imbalance induced by distant hybridization correlates with formation of rDNA genes (NORs) in the hybrids between Raphanus sativus L. and Brassica alboglabra Bailey. Moreover, increased CCGG methylation of rDNA in F-1 hybrids is concomitant with Raphanus-derived rDNA gene silencing and rDNA transcriptional inactivity revealed by nucleolar configuration restriction. Newly formed rDNA gene locus occurred through chromosomal in F-1 hybrids via chromosomal imbalance. NORs are gained de novo, lost, and/or transposed in the new genome. Inhibition of methyltransferases leads to changes in nucleolar architecture, implicating a key role of methylation in control of nucleolar dominance and vital nucleolar configuration transition. Our findings suggest that gene imbalance and methylation-related chromatin restructuring is important for rDNA gene silencing that may be crucial for synthesis of specific proteins.	[Long, Hong] Tianjin Agr Univ, Coll Hort & Landscape, Tianjin, Peoples R China; [Chen, Chunli; Wang, Bing; Feng, Yanni] Huazhong Agr Univ, Coll Life Sci & Technol, Wuhan, Hubei, Peoples R China	Tianjin Agricultural University; Huazhong Agricultural University	Long, H (corresponding author), Tianjin Agr Univ, Coll Hort & Landscape, Tianjin, Peoples R China.	longhong@mail.hzau.edu.cn		Chen, Chunli/0000-0002-6464-4580				Adams KL, 2005, CURR OPIN PLANT BIOL, V8, P135, DOI 10.1016/j.pbi.2005.01.001; Bonisch C, 2008, EXPERT REV PROTEOMIC, V5, P105, DOI 10.1586/14789450.5.1.105; Buggs RJA, 2009, HEREDITY, V103, P73, DOI 10.1038/hdy.2009.24; Cervera MT, 2002, MOL GENET GENOMICS, V268, P543, DOI 10.1007/s00438-002-0772-4; Chen ZJ, 1997, GENE DEV, V11, P2124, DOI 10.1101/gad.11.16.2124; DERENZINI M, 1993, J HISTOCHEM CYTOCHEM, V41, P829, DOI 10.1177/41.6.8315275; Earley KW, 2006, PLANT J, V45, P616, DOI 10.1111/j.1365-313X.2005.02617.x; Fransz P, 2003, CHROMOSOME RES, V11, P227, DOI 10.1023/A:1022835825899; Gregory TR, 2007, EVOLUTION GENOME, P404; Hegarty MJ, 2009, HEREDITY, V103, P100, DOI 10.1038/hdy.2009.61; Kidwell Kimberlee K., 1992, P1; Lawrence RJ, 2004, MOL CELL, V13, P599, DOI 10.1016/S1097-2765(04)00064-4; Levin D. A, 2002, OX ECOL EV; Li XL, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-207; Liu B, 2003, MOL PHYLOGENET EVOL, V29, P365, DOI 10.1016/S1055-7903(03)00213-6; Liu Bao, 2002, Current Genomics, V3, P489, DOI 10.2174/1389202023350255; Long H, 2004, CELL BIOL INT, V28, P845, DOI 10.1016/j.cellbi.2004.08.004; MCCLELLAND M, 1994, NUCLEIC ACIDS RES, V22, P3640, DOI 10.1093/nar/22.17.3640; McKeown PC, 2009, CHROMOSOMA, V118, P11, DOI 10.1007/s00412-008-0184-2; McStay B, 2006, GENE DEV, V20, P1207, DOI 10.1101/gad.1436906; NAVASHIN M., 1934, CYTOLOGIA, V5, P169, DOI 10.1508/cytologia.5.169; NEVES N, 1995, THEOR APPL GENET, V91, P529, DOI 10.1007/BF00222984; Osborn TC, 2003, TRENDS GENET, V19, P141, DOI 10.1016/S0168-9525(03)00015-5; Parisod C, 2009, NEW PHYTOL, V184, P1003, DOI 10.1111/j.1469-8137.2009.03029.x; Pikaard CS, 2013, MOL CELL, V49, P1021, DOI 10.1016/j.molcel.2013.03.013; Pontes O, 2004, P NATL ACAD SCI USA, V101, P18240, DOI 10.1073/pnas.0407258102; Pontvianne F, 2013, GENE DEV, V27, P1545, DOI 10.1101/gad.221648.113; Preuss S, 2007, BBA-GENE STRUCT EXPR, V1769, P383, DOI 10.1016/j.bbaexp.2007.02.005; Preuss SB, 2008, MOL CELL, V32, P673, DOI 10.1016/j.molcel.2008.11.009; ReynaLopez GE, 1997, MOL GEN GENET, V253, P703, DOI 10.1007/s004380050374; RISUENO MC, 1982, J CELL SCI, V58, P313; Santoro R, 2002, NAT GENET, V32, P393, DOI 10.1038/ng1010; TESTILLANO PS, 1991, J HISTOCHEM CYTOCHEM, V39, P1427, DOI 10.1177/39.10.1719069; Tucker S, 2010, CURR OPIN CELL BIOL, V22, P351, DOI 10.1016/j.ceb.2010.03.009; Wang JL, 2004, GENETICS, V167, P1961, DOI 10.1534/genetics.104.027896; Wendel JF, 2003, ADV AGRON, V78, P139, DOI 10.1016/S0065-2113(02)78004-8; Wendel JF, 2000, PLANT MOL BIOL, V42, P225, DOI 10.1023/A:1006392424384; Xiong ZY, 2011, P NATL ACAD SCI USA, V108, P7908, DOI 10.1073/pnas.1014138108	38	9	10	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2015	10	2							e0117198	10.1371/journal.pone.0117198	http://dx.doi.org/10.1371/journal.pone.0117198			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC3LS	25723542	gold, Green Published, Green Submitted			2022-12-27	WOS:000350251200025
J	Marasco, CC; Enders, JR; Seale, KT; McLean, JA; Wikswo, JP				Marasco, Christina C.; Enders, Jeffrey R.; Seale, Kevin T.; McLean, John A.; Wikswo, John P.			Real-Time Cellular Exometabolome Analysis with a Microfluidic-Mass Spectrometry Platform	PLOS ONE			English	Article							SYSTEMS BIOLOGY; IN-VIVO; COCAINE; SUBPOPULATIONS; METABOLISM; DEVICES; CELLS; MS	To address the challenges of tracking the multitude of signaling molecules and metabolites that is the basis of biological complexity, we describe a strategy to expand the analytical techniques for dynamic systems biology. Using microfluidics, online desalting, and mass spectrometry technologies, we constructed and validated a platform well suited for sampling the cellular microenvironment with high temporal resolution. Our platform achieves success in: automated cellular stimulation and microenvironment control; reduced non-specific adsorption to polydimethylsiloxane due to surface passivation; real-time online sample collection; near real-time sample preparation for salt removal; and real-time online mass spectrometry. When compared against the benchmark of "in-culture" experiments combined with ultraperformance liquid chromatography-electrospray ionization-ion mobility-mass spectrometry (UPLC-ESI-IM-MS), our platform alleviates the volume challenge issues caused by dilution of autocrine and paracrine signaling and dramatically reduces sample preparation and data collection time, while reducing undesirable external influence from various manual methods of manipulating cells and media (e.g., cell centrifugation). To validate this system biologically, we focused on cellular responses of Jurkat T cells to microenvironmental stimuli. Application of these stimuli, in conjunction with the cell's metabolic processes, results in changes in consumption of nutrients and secretion of biomolecules (collectively, the exometabolome), which enable communication with other cells or tissues and elimination of waste. Naive and experienced T-cell metabolism of cocaine is used as an exemplary system to confirm the platform's capability, highlight its potential for metabolite discovery applications, and explore immunological memory of T-cell drug exposure. Our platform proved capable of detecting metabolomic variations between naive and experienced Jurkat T cells and highlights the dynamics of the exometabolome over time. Upregulation of the cocaine metabolite, benzoylecgonine, was noted in experienced T cells, indicating potential cellular memory of cocaine exposure. These metabolomics distinctions were absent from the analogous, traditional "in-culture" UPLC-ESI-IM-MS experiment, further demonstrating this platform's capabilities.	[Marasco, Christina C.; Enders, Jeffrey R.; Seale, Kevin T.; McLean, John A.; Wikswo, John P.] Vanderbilt Univ, Vanderbilt Inst Integrat Biosyst Res & Educ, Nashville, TN 37235 USA; [Marasco, Christina C.; Seale, Kevin T.; Wikswo, John P.] Vanderbilt Univ, Dept Biomed Engn, Nashville, TN 37235 USA; [Enders, Jeffrey R.; McLean, John A.] Vanderbilt Univ, Dept Chem, Nashville, TN USA; [Enders, Jeffrey R.; McLean, John A.] Vanderbilt Univ, Vanderbilt Inst Chem Biol, Nashville, TN 37235 USA; [Wikswo, John P.] Vanderbilt Univ, Dept Phys & Astron, Nashville, TN 37235 USA; [Wikswo, John P.] Vanderbilt Univ, Sch Med, Dept Mol Physiol & Biophys, Nashville, TN 37212 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University	Wikswo, JP (corresponding author), Vanderbilt Univ, Vanderbilt Inst Integrat Biosyst Res & Educ, 221 Kirkland Hall, Nashville, TN 37235 USA.	john.wikswo@vanderilt.edu	Enders, Jeffrey/P-2574-2019	Marasco, Christina/0000-0003-0324-9314; Enders, Jeffrey/0000-0003-1224-1664	National Institutes of Health National Center for Advancing Translational Sciences under the NIH Common Fund [UH2TR000491]; National Institute on Drug Addiction Award [RC2DA028981]; Defense Threat Reduction Agency [HDTRA1-09-1-00-13]; Defense Advanced Research Projects Agency [W911NF-12-2-0036]; Vanderbilt Institute for Integrative Biosystems Research and Education; Systems Biology and Bioengineering Undergraduate Research Experience (SyBBURE) - Gideon Searle; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UH3TR000491, UH2TR000491] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [RC2DA028981] Funding Source: NIH RePORTER	National Institutes of Health National Center for Advancing Translational Sciences under the NIH Common Fund; National Institute on Drug Addiction Award; Defense Threat Reduction Agency(United States Department of DefenseDefense Threat Reduction Agency); Defense Advanced Research Projects Agency(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); Vanderbilt Institute for Integrative Biosystems Research and Education; Systems Biology and Bioengineering Undergraduate Research Experience (SyBBURE) - Gideon Searle; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	Research reported in this publication was supported in part by The National Institutes of Health (http://www.nih.gov/) National Center for Advancing Translational Sciences Award No. UH2TR000491 under the NIH Common Fund, and the National Institute on Drug Addiction Award No. RC2DA028981 through the American Recovery and Reinvestment Act of 2009; the Defense Threat Reduction Agency (http://www.dtra.mil/) under Grant HDTRA1-09-1-00-13; the Defense Advanced Research Projects Agency (http://www.darpa.mil/) under Grant W911NF-12-2-0036; the Vanderbilt Institute for Integrative Biosystems Research and Education (http://www.vanderbilt.edu/viibre/); and the Systems Biology and Bioengineering Undergraduate Research Experience (SyBBURE), funded by Gideon Searle (http://www.vanderbilt.edu/viibre/teachinginnovation.php). The content is solely the responsibility of the authors and does not necessarily represent the official views of the funding agencies and organizations. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aebersold R, 2003, NATURE, V422, P198, DOI 10.1038/nature01511; Anderson NL, 2002, MOL CELL PROTEOMICS, V1, P845, DOI 10.1074/mcp.R200007-MCP200; BAGASRA O, 1989, CLIN EXP IMMUNOL, V77, P289; Byrd TF, 2014, SCI REP-UK, V4, DOI 10.1038/srep05117; Chan JH, 1999, ANAL CHEM, V71, P4437, DOI 10.1021/ac9906678; Chao C, 2008, DRUG ALCOHOL DEPEN, V94, P165, DOI 10.1016/j.drugalcdep.2007.11.010; Chen QS, 2012, ANAL CHEM, V84, P1695, DOI 10.1021/ac300003k; Darby SG, 2010, LAB CHIP, V10, P3218, DOI 10.1039/c0lc00087f; Duffy DC, 1998, ANAL CHEM, V70, P4974, DOI 10.1021/ac980656z; Enders JR, 2010, IET SYST BIOL, V4, P416, DOI 10.1049/iet-syb.2010.0012; Enders JR, 2012, ANAL CHEM, V84, P8467, DOI 10.1021/ac3021032; Faley S, 2012, INTEGR BIOL-UK, V4, P368, DOI 10.1039/c2ib00086e; Faley SL, 2011, BIOMICROFLUIDICS, V5, DOI 10.1063/1.3587095; Faley SL, 2009, LAB CHIP, V9, P2659, DOI 10.1039/b902083g; Fandino AS, 2002, CHEM RES TOXICOL, V15, P1543, DOI 10.1021/tx0255828; Han XL, 2003, J LIPID RES, V44, P1071, DOI 10.1194/jlr.R300004-JLR200; Hughey JJ, 2007, 2007 IEEE/NIH LIFE SCIENCE SYSTEMS AND APPLICATIONS WORKSHOP, P132, DOI 10.1109/LSSA.2007.4400902; Jiang Y, 2001, ANAL CHEM, V73, P2048, DOI 10.1021/ac001474j; Kell DB, 2005, NAT REV MICROBIOL, V3, P557, DOI 10.1038/nrmicro1177; Kubera M, 2004, EUR J PHARMACOL, V483, P309, DOI 10.1016/j.ejphar.2003.10.021; LeDuc PR, 2011, ANNU REV BIOMED ENG, V13, P369, DOI 10.1146/annurev-bioeng-071910-124651; Pacifici R, 2002, ANN NY ACAD SCI, V965, P421; Pellegrino T, 1998, J NEUROIMMUNOL, V83, P139, DOI 10.1016/S0165-5728(97)00230-0; Roth MD, 2005, J LEUKOCYTE BIOL, V78, P1198, DOI 10.1189/jlb.0405219; Seale KT, 2010, EXP BIOL MED, V235, P777, DOI 10.1258/ebm.2010.009379; Shotwell MS, 2013, BIOMETRICS, V69, P741, DOI 10.1111/biom.12066; Warner A, 2000, THER DRUG MONIT, V22, P266, DOI 10.1097/00007691-200006000-00006; Wikswo JP, 2014, EXP BIOL MED, V239, P1061, DOI 10.1177/1535370214542068; Wikswo JP, 2013, LAB CHIP, V13, P3496, DOI 10.1039/c3lc50243k; Wikswo JP, 2013, IEEE T BIO-MED ENG, V60, P682, DOI 10.1109/TBME.2013.2244891; Wlodkowic D, 2011, METHODS MOL BIOL, V731, P285, DOI 10.1007/978-1-61779-080-5_23; Xia Y, 2000, ANAL CHEM, V72, P764, DOI 10.1021/ac990201p; Yates JR, 2000, TRENDS GENET, V16, P5, DOI 10.1016/S0168-9525(99)01879-X; Zaia J, 2004, MASS SPECTROM REV, V23, P161, DOI 10.1002/mas.10073	34	21	22	2	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2015	10	2							e0117685	10.1371/journal.pone.0117685	http://dx.doi.org/10.1371/journal.pone.0117685			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC3LS	25723555	gold, Green Published, Green Submitted			2022-12-27	WOS:000350251200039
J	Perdue, CL; Cost, AAE; Rubertone, MV; Lindler, LE; Ludwig, SL				Perdue, Christopher L.; Cost, Angelia A. Eick; Rubertone, Mark V.; Lindler, Luther E.; Ludwig, Sharon L.			Description and Utilization of the United States Department of Defense Serum Repository: A Review of Published Studies, 1985-2012	PLOS ONE			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; EPSTEIN-BARR-VIRUS; MILITARY SERVICE MEMBERS; GULF-WAR SYNDROME; US MILITARY; MULTIPLE-SCLEROSIS; 25-HYDROXYVITAMIN D; RHEUMATOID-ARTHRITIS; ENCEPHALITIS VACCINE; SEROLOGICAL EVIDENCE	Specimens in the United States Department of Defense (DoD) Serum Repository have accumulated in frozen storage since 1985 when the DoD began universal screening for human immunodeficiency virus. Use of the stored serum for health research has been carefully controlled, but the resulting publications have never been systematically identified or described. The Armed Forces Health Surveillance Center (AFHSC) information systems and open (online) sites were used as data sources. Through 2012, the repository contained 54,542,658 serum specimens, of which 228,610 (0.42%) have been accessed for any purpose. Between 2001 (the first year that comprehensive, digital records were available) and 2012, 65.2% of all approved requests for serum were for healthcare or public health investigations, but greater than 99% of all shipped samples were for research. Using two different methods - a structure search of PubMed and an exhaustive online search based on records from AFHSC - we identified 76 articles published between October 1988 and March 2013 that covered a multitude of infectious diseases, injuries, environmental exposures and mental health conditions through analysis of antibodies, biological metabolic, signaling and regulatory substances, Vitamin D, organochlorines, dioxin, omega-3-fatty acid, and portions of human deoxyribonucleic acid. Despite its operational and scientific value, it appears that the DoD Serum Repository has been underutilized. Changes to policy and increased capacity for specimen processing could increase use of the repository without risking privacy or the availability of specimens for the healthcare of individual service members in the future.	[Perdue, Christopher L.; Cost, Angelia A. Eick; Rubertone, Mark V.; Lindler, Luther E.; Ludwig, Sharon L.] Armed Forces Hlth Surveillance Ctr, Silver Spring, MD 20910 USA		Perdue, CL (corresponding author), Armed Forces Hlth Surveillance Ctr, Silver Spring, MD 20910 USA.	Christopher.l.perdue@gmail.com						Anderson AD, 2011, ZOONOSES PUBLIC HLTH, V58, P276, DOI 10.1111/j.1863-2378.2010.01347.x; Anderson AD, 2005, EMERG INFECT DIS, V11, P1320, DOI 10.3201/eid1108.050314; Arbuckle MR, 2003, LUPUS, V12, P99, DOI 10.1191/0961203303lu334oa; Arbuckle MR, 2001, SCAND J IMMUNOL, V54, P211, DOI 10.1046/j.1365-3083.2001.00959.x; Arbuckle MR, 2003, NEW ENGL J MED, V349, P1526, DOI 10.1056/NEJMoa021933; Burgi AA, 2011, J BONE MINER RES, V26, P2371, DOI 10.1002/jbmr.451; BURKE DS, 1988, NEW ENGL J MED, V319, P961, DOI 10.1056/NEJM198810133191501; BURKE DS, 1987, NEW ENGL J MED, V317, P131, DOI 10.1056/NEJM198707163170302; Campo JJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021826; Chia VM, 2010, INT J ANDROL, V33, P588, DOI 10.1111/j.1365-2605.2009.00975.x; Craig SC, 1999, AM J TROP MED HYG, V61, P874, DOI 10.4269/ajtmh.1999.61.874; Deane KD, 2010, ARTHRITIS RHEUM-US, V62, P3161, DOI 10.1002/art.27638; DeFraites RF, 2011, REQUESTS INFORM SERU; DeFraites RF, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-S2-S1; Eick A, 2010, J INFECT DIS, V202, P1302, DOI 10.1086/656598; Faix DJ, 2008, CLIN INFECT DIS, V46, pE65, DOI 10.1086/528866; Faix DJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034581; GAMBEL JM, 1995, J INFECT DIS, V171, P1074, DOI 10.1093/infdis/171.4.1074; GARLAND FC, 1989, JAMA-J AM MED ASSOC, V262, P3161, DOI 10.1001/jama.262.22.3161; Gorham ED, 2012, DIABETOLOGIA, V55, P3224, DOI 10.1007/s00125-012-2709-8; Hakre S, 2011, TRANSFUSION, V51, P473, DOI 10.1111/j.1537-2995.2010.02906.x; Heinlen LD, 2010, J MOL MED, V88, P719, DOI 10.1007/s00109-010-0618-1; Heinlen LD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009599; KELLEY PW, 1990, AM J PUBLIC HEALTH, V80, P405, DOI 10.2105/AJPH.80.4.405; Kelley PW, 1994, THESIS J HOPKINS U B, Vxv; Knapik J, 2012, INT J SPORTS MED, V33, P940, DOI 10.1055/s-0032-1311583; Kolfenbach JR, 2010, ARTHRITIS RHEUM-US, V62, P2633, DOI 10.1002/art.27570; LEDUC JW, 1990, J INFECT DIS, V162, P1182, DOI 10.1093/infdis/162.5.1182; Levin LI, 2005, JAMA-J AM MED ASSOC, V293, P2496, DOI 10.1001/jama.293.20.2496; Levin LI, 2012, BLOOD, V120, P3750, DOI 10.1182/blood-2011-12-390823; Levin LI, 2010, ANN NEUROL, V67, P824, DOI 10.1002/ana.21978; Lewis MD, 2011, J CLIN PSYCHIAT, V72, P1585, DOI 10.4088/JCP.11m06879; LIAO SJ, 1954, AM J HYG, V59, P262, DOI 10.1093/oxfordjournals.aje.a119639; Lo SC, 2000, EPIDEMIOL INFECT, V125, P609, DOI 10.1017/S0950268800004891; Ludwig SL, 1998, J INFECT DIS, V178, P1776, DOI 10.1086/314498; MACILWAIN C, 1995, NATURE, V373, P92, DOI 10.1038/373092a0; Massa J, 2009, J NEUROIMMUNOL, V208, P141, DOI 10.1016/j.jneuroim.2009.01.006; McClain MT, 2004, ARTHRITIS RHEUM-US, V50, P1226, DOI 10.1002/art.20120; McGlynn KA, 2008, JNCI-J NATL CANCER I, V100, P663, DOI 10.1093/jnci/djn101; McGlynn KA, 2009, CANCER RES, V69, P1901, DOI 10.1158/0008-5472.CAN-08-3935; MILNER IB, 1994, JAMA-J AM MED ASSOC, V271, P661, DOI 10.1001/jama.1994.03510330039024; Mohr SB, 2013, CANCER CAUSE CONTROL, V24, P495, DOI 10.1007/s10552-012-0140-6; Munger KL, 2011, MULT SCLER J, V17, P1185, DOI 10.1177/1352458511408991; Munger KL, 2006, JAMA-J AM MED ASSOC, V296, P2832, DOI 10.1001/jama.296.23.2832; Nevin RL, 2007, MIL MED, V172, P787, DOI 10.7205/MILMED.172.7.787; Niebuhr DW, 2008, SCHIZOPHRENIA BULL, V34, P1182, DOI 10.1093/schbul/sbm139; Niebuhr DW, 2011, SCHIZOPHR RES, V128, P51, DOI 10.1016/j.schres.2011.02.005; Nielbuhr DW, 2008, AM J PSYCHIAT, V165, P99, DOI 10.1176/appi.ajp.2007.06081254; Page WF, 2012, SEX TRANSM DIS, V39, P241, DOI 10.1097/OLQ.0b013e3182401a17; PAUL JR, 1964, AM J HYG, V80, P286, DOI 10.1093/oxfordjournals.aje.a120477; POLLARD RB, 1975, AM J EPIDEMIOL, V101, P431, DOI 10.1093/oxfordjournals.aje.a112110; Preston DM, 2000, UROLOGY, V56, P812, DOI 10.1016/S0090-4295(00)00764-0; Riddle MS, 2008, EPIDEMIOL INFECT, V136, P665, DOI 10.1017/S0950268807009016; ROBERTS CR, 1992, AM J PUBLIC HEALTH, V82, P70, DOI 10.2105/AJPH.82.1.70; Rubertone MV, 2002, AM J PUBLIC HEALTH, V92, P1900, DOI 10.2105/AJPH.92.12.1900; Rusiecki JA, 2012, EPIGENOMICS-UK, V4, P29, DOI [10.2217/EPI.11.116, 10.2217/epi.11.116]; Sanchez JL, 2001, MIL MED, V166, P470, DOI 10.1093/milmed/166.6.470; Scher AI, 2011, J NEUROTRAUM, V28, P1739, DOI 10.1089/neu.2011.1982; Schwarz E, 2012, WORLD J BIOL PSYCHIA, V13, P627, DOI 10.3109/15622975.2011.599861; Schwarz E, 2010, BIOMARK INSIGHTS, V5, P39; Scott PT, 2012, AIDS RES HUM RETROV, V28, P1308, DOI 10.1089/aid.2011.0363; Scott PT, 2005, J INFECT DIS, V191, P1835, DOI 10.1086/429965; Sherwood JE, 2012, CLIN INFECT DIS, V55, P1727, DOI 10.1093/cid/cis785; Sokolove J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035296; STRETCH RH, 1995, MIL MED, V160, P131, DOI 10.1093/milmed/160.3.131; Sutcliffe S, 2012, BJU INT, V110, P1627, DOI 10.1111/j.1464-410X.2012.11111.x; Tate JE, 2009, J INFECT DIS, V199, P1419, DOI 10.1086/598520; Taylor G, 2008, SCREENING HLTH RISK; Umhau JC, 2012, PLOS ONE, V8; Vendrame E, 2011, J PROTEOME RES, V10, P113, DOI 10.1021/pr100729z; WALLS KW, 1967, AM J EPIDEMIOL, V85, P87, DOI 10.1093/oxfordjournals.aje.a120678; Wang H, 2008, NEUROLOGY, V71, P1142, DOI 10.1212/01.wnl.0000316195.52001.e1; WARNER RD, 1993, VACCINE, V11, P534, DOI 10.1016/0264-410X(93)90225-M	73	27	27	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2015	10	2							e0114857	10.1371/journal.pone.0114857	http://dx.doi.org/10.1371/journal.pone.0114857			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CC3LS	25723497	gold, Green Submitted, Green Published			2022-12-27	WOS:000350251200004
J	Yoshikawa, T; Osada, Y				Yoshikawa, Tetsuro; Osada, Yutaka			Dietary Compositions and Their Seasonal Shifts in Japanese Resident Birds, Estimated from the Analysis of Volunteer Monitoring Data	PLOS ONE			English	Article							CITIZEN-SCIENCE; ECOLOGICAL RESEARCH; FORAGING BEHAVIOR; FEEDING ECOLOGY; FOREST BIRDS; FOOD-WEB; BIOFILM; NETWORK; PROJECT; FINCHES	Determining the composition of a bird's diet and its seasonal shifts are fundamental for understanding the ecology and ecological functions of a species. Various methods have been used to estimate the dietary compositions of birds, which have their own advantages and disadvantages. In this study, we examined the possibility of using long-term volunteer monitoring data as the source of dietary information for 15 resident bird species in Kanagawa Prefecture, Japan. The data were collected from field observations reported by volunteers of regional naturalist groups. Based on these monitoring data, we calculated the monthly dietary composition of each bird species directly, and we also estimated unidentified items within the reported foraging episodes using Bayesian models that contained additional information regarding foraging locations. Next, to examine the validity of the estimated dietary compositions, we compared them with the dietary information for focal birds based on stomach analysis methods, collected from past literatures. The dietary trends estimated from the monitoring data were largely consistent with the general food habits determined from the previous studies of focal birds. Thus, the estimates based on the volunteer monitoring data successfully detected noticeable seasonal shifts in many of the birds from plant materials to animal diets during spring-summer. Comparisons with stomach analysis data supported the qualitative validity of the monitoring-based dietary information and the effectiveness of the Bayesian models for improving the estimates. This comparison suggests that one advantage of using monitoring data is its ability to detect dietary items such as fleshy fruits, flower nectar, and vertebrates. These results emphasize the potential importance of observation data collecting and mining by citizens, especially free descriptive observation data, for use in bird ecology studies.	[Yoshikawa, Tetsuro] Forestry & Forest Prod Res Inst, Dept Forest Vegetat, Tsukuba, Ibaraki 305, Japan; [Osada, Yutaka] Univ Tokyo, Grad Sch Agr & Life Sci, Lab Biodivers Sci, Tokyo, Japan	Forestry & Forest Products Research Institute - Japan; University of Tokyo	Yoshikawa, T (corresponding author), Forestry & Forest Prod Res Inst, Dept Forest Vegetat, Tsukuba, Ibaraki 305, Japan.	yoshikawa.tetsuro@gmail.com		Yoshikawa, Tetsuro/0000-0001-6998-275X	Japan Society for the Promotion of Science [2610007]; Grants-in-Aid for Scientific Research [14J10007] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	TY was supported by Research Fellowships of the Japan Society for the Promotion of Science for Young Scientists (http://www.jsps.go.jp/english), Grant Number 2610007. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bonter DN, 2012, FRONT ECOL ENVIRON, V10, P305, DOI 10.1890/110273; Corlett RT, 2004, BIOL REV, V79, P497, DOI 10.1017/S1464793103006341; Deagle BE, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000831; Dickinson JL, 2012, FRONT ECOL ENVIRON, V10, P291, DOI 10.1890/110236; Dickinson JL, 2010, ANNU REV ECOL EVOL S, V41, P149, DOI 10.1146/annurev-ecolsys-102209-144636; Dunn PO, 1999, P ROY SOC B-BIOL SCI, V266, P2487, DOI 10.1098/rspb.1999.0950; Evans C, 2005, CONSERV BIOL, V19, P589, DOI 10.1111/j.1523-1739.2005.00s01.x; Gill F., 2010, IOC WORLD BIRD NAMES; GILL FB, 2007, ORNITHOLOGY; Gonzalez-Varo JP, 2010, ECOGRAPHY, V33, P185, DOI 10.1111/j.1600-0587.2009.06021.x; Herrera CM, 1998, ECOL MONOGR, V68, P511, DOI 10.1890/0012-9615(1998)068[0511:LTDOMF]2.0.CO;2; Herrera LG, 2003, OECOLOGIA, V136, P439, DOI 10.1007/s00442-003-1293-5; Inger R, 2008, IBIS, V150, P447, DOI 10.1111/j.1474-919X.2008.00839.x; Kanagawa Branch of The Wild Bird Society of Japan, 2007, BIRDS KAN 2001 05 LI; Kiyosu Y., 1966, ENCY WILD BIRDS JAPA; Kuwae T, 2008, ECOLOGY, V89, P599, DOI 10.1890/07-1442.1; Kuwae T, 2012, ECOL LETT, V15, P347, DOI 10.1111/j.1461-0248.2012.01744.x; MARTIN TE, 1987, ANNU REV ECOL SYST, V18, P453, DOI 10.1146/annurev.ecolsys.18.1.453; Morrison ML, 1990, AVIAN FORAGING THEOR; Murakami M, 2000, P ROY SOC B-BIOL SCI, V267, P1597, DOI 10.1098/rspb.2000.1184; NEWTON I, 1967, IBIS, V109, P33, DOI 10.1111/j.1474-919X.1967.tb00005.x; NEWTON I, 1967, J ANIM ECOL, V36, P721, DOI 10.2307/2822; Plummer M, 2012, JAGS JUST ANTOTHER G; Post DM, 2002, ECOLOGY, V83, P703, DOI 10.2307/3071875; PRICE T, 1987, ECOLOGY, V68, P1015, DOI 10.2307/1938373; R Development Core Team, 2013, R: A Language and Environment for Statistical Computing; Redpath SM, 2001, CONDOR, V103, P184, DOI 10.1650/0010-5422(2001)103[0184:ARDCPP]2.0.CO;2; ROBINSON SK, 1982, ECOLOGY, V63, P1918, DOI 10.2307/1940130; Rosenberg K.V., 1990, Studies in Avian Biology, P80; RUNDLE WD, 1982, J FIELD ORNITHOL, V53, P249; Sekercioglu CH, 2006, TRENDS ECOL EVOL, V21, P464, DOI 10.1016/j.tree.2006.05.007; Siriwardena GM, 1998, J APPL ECOL, V35, P24, DOI 10.1046/j.1365-2664.1998.00275.x; Sullivan BL, 2009, BIOL CONSERV, V142, P2282, DOI 10.1016/j.biocon.2009.05.006; Sutherland WJ, 2004, TECH ECOL CONSERVAT, P233; Uchida S, 1931, ORNITHOLOGICAL MAMMA; Uchida S, 1922, 1 BUR AGR COMM; Uchida S, 1931, 5 BUR AGR COMM; Valentini A, 2009, MOL ECOL RESOUR, V9, P51, DOI 10.1111/j.1755-0998.2008.02352.x; Valentini A, 2009, TRENDS ECOL EVOL, V24, P110, DOI 10.1016/j.tree.2008.09.011; WHEELWRIGHT NT, 1986, AUK, V103, P710, DOI 10.1093/auk/103.4.710; Whelan CJ, 2008, ANN NY ACAD SCI, V1134, P25, DOI 10.1196/annals.1439.003; Witmer MC, 1996, AUK, V113, P414, DOI 10.2307/4088908; Yoshikawa T, 2014, J ANIM ECOL, V83, P651, DOI 10.1111/1365-2656.12161; Yoshikawa T, 2012, OIKOS, V121, P1041, DOI 10.1111/j.1600-0706.2011.19888.x	44	12	12	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2015	10	2							e0119324	10.1371/journal.pone.0119324	http://dx.doi.org/10.1371/journal.pone.0119324			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC3LS	25723544	Green Submitted, Green Published, gold			2022-12-27	WOS:000350251200070
J	Ardelt, PU; Ebbing, J; Adams, F; Reiss, C; Arap, W; Pasqualini, R; Bachmann, A; Wetterauer, U; Riedmiller, H; Kneitz, B				Ardelt, Peter U.; Ebbing, Jan; Adams, Fabian; Reiss, Cora; Arap, Wadih; Pasqualini, Renata; Bachmann, Alexander; Wetterauer, Ulrich; Riedmiller, Hubertus; Kneitz, Burkhard			An Anti-Ubiquitin Antibody Response in Transitional Cell Carcinoma of the Urinary Bladder	PLOS ONE			English	Article							BACILLE CALMETTE-GUERIN; CANCER SURVEILLANCE; IMMUNE-RESPONSE; TUMOR-CELLS; UBIQUITIN; IMMUNOTHERAPY; PROTEIN; BIOMARKERS; SYSTEM; BCG	Background To use combinatorial epitope mapping ("fingerprinting") of the antibody response to identify targets of the humoral immune response in patients with transitional cell carcinoma (TCC) of the bladder. Methods A combinatorial random peptide library was screened on the circulating pool of immunoglobulins purified from an index patient with a high risk TCC (pTa high grade plus carcinoma in situ) to identify corresponding target antigens. A patient cohort was investigated for antibody titers against ubiquitin. Results We selected, isolated, and validated an immunogenic peptide motif from ubiquitin as a dominant epitope of the humoral response. Patients with TCC had significantly higher antibody titers against ubiquitin than healthy donors (p<0.007), prostate cancer patients (p<0.0007), and all patients without TCC taken together (p<0.0001). Titers from superficial tumors were not significantly different from muscle invasive tumors (p = 0.0929). For antibody response against ubiquitin, sensitivity for detection of TCC was 0.44, specificity 0.96, positive predictive value 0.96 and negative predictive value 0.41. No significant titer changes were observed during the standard BCG induction immunotherapy. Conclusions This is the first report to demonstrate an anti-ubiquitin antibody response in patients with TCC. Although sensitivity of antibody production was low, a high specificity and positive predictive value make ubiquitin an interesting candidate for further diagnostic and possibly immune modulating studies.	[Ardelt, Peter U.; Ebbing, Jan; Bachmann, Alexander] Univ Basel Hosp, Dept Urol, CH-4031 Basel, Switzerland; [Ardelt, Peter U.; Adams, Fabian; Wetterauer, Ulrich] Univ Freiburg, Sch Med, Dept Urol & Pediat Urol, D-79106 Freiburg, Germany; [Ardelt, Peter U.; Riedmiller, Hubertus; Kneitz, Burkhard] Bavarian Julius Maximilians Univ, Sch Med, Dept Urol, Wurzburg, Germany; [Reiss, Cora] Johannes Gutenberg Univ Mainz, Med Ctr Mainz, Ctr Thrombosis & Hemostasis, D-55122 Mainz, Germany; [Arap, Wadih; Pasqualini, Renata] Univ New Mexico, Sch Med, Div Hematol Oncol, Albuquerque, NM 87131 USA; [Arap, Wadih; Pasqualini, Renata] Univ New Mexico, Sch Med, Div Mol Med, Dept Internal Med, Albuquerque, NM 87131 USA	University of Basel; University of Freiburg; University of Wurzburg; Johannes Gutenberg University of Mainz; University of New Mexico; University of New Mexico	Ardelt, PU (corresponding author), Univ Basel Hosp, Dept Urol, CH-4031 Basel, Switzerland.	Peter.Ardelt@usb.ch			medac, Wedel, Germany	medac, Wedel, Germany	This work was partly funded by a non restricted fund from medac, Wedel, Germany. The funders had no role in study design, data collection and Analysis, decision to publish or preparation of the manuscript. The other funding was internal from our institution.	Ardelt PU, 2010, CANCER-AM CANCER SOC, V116, P600, DOI 10.1002/cncr.24770; Atkins H, 2003, BRIT J CANCER, V89, P2312, DOI 10.1038/sj.bjc.6601474; Babjuk M, 2011, EUR UROL, V59, P997, DOI 10.1016/j.eururo.2011.03.017; BALDWIN RW, 1966, INT J CANCER, V1, P257, DOI 10.1002/ijc.2910010305; Bubenik J, 1973, INT J CANC, P11; Burger M, 2013, EUR UROL, V63, P234, DOI 10.1016/j.eururo.2012.07.033; Chamie K, 2013, CANCER-AM CANCER SOC, V119, P3219, DOI 10.1002/cncr.28147; Chen D, 2010, CURR PROTEIN PEPT SC, V11, P459, DOI 10.2174/138920310791824057; Choi K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067891; Cooksley CD, 2008, UROLOGY, V71, P519, DOI 10.1016/j.urology.2007.10.056; HANSSON Y, 1983, CANCER IMMUNOL IMMUN, V16, P23; Heo CK, 2012, BMB REP, V45, P677, DOI 10.5483/BMBRep.2012.45.12.236; KAELIN WG, 1992, CELL, V70, P351, DOI 10.1016/0092-8674(92)90108-O; Lamm DL, 2000, EUR UROL, V37, P41, DOI 10.1159/000052391; Lisztwan J, 1999, GENE DEV, V13, P1822, DOI 10.1101/gad.13.14.1822; LIVINGSTONE CD, 1993, COMPUT APPL BIOSCI, V9, P745; Luo Y, 2001, CLIN EXP IMMUNOL, V123, P264, DOI 10.1046/j.1365-2249.2001.01428.x; LUTZEYER W, 1982, J UROLOGY, V127, P250, DOI 10.1016/S0022-5347(17)53725-8; Masdehors P, 2000, BLOOD, V96, P269, DOI 10.1182/blood.V96.1.269.013k10_269_274; Mintz PJ, 2003, NAT BIOTECHNOL, V21, P57, DOI 10.1038/nbt774; Pasqualini R, 2000, IN VIVO PHAGE DISPLA, P1; Pisipati S, 2009, BJU INT, V103, P1453, DOI 10.1111/j.1464-410X.2009.08441.x; Sharma P, 2007, SEMIN ONCOL, V34, P165, DOI 10.1053/j.seminoncol.2006.12.004; Smith GD, 2013, DIAGN CYTOPATHOL, V41, P437, DOI 10.1002/dc.22881; STUDER UE, 1985, UROL RES, V13, P123; Tilki D, 2011, EUR UROL, V60, P484, DOI 10.1016/j.eururo.2011.05.053; TROYE M, 1980, INT J CANCER, V25, P45, DOI 10.1002/ijc.2910250106; WANG GP, 1991, BRAIN RES, V566, P146, DOI 10.1016/0006-8993(91)91692-T; Yoder BJ, 2007, AM J CLIN PATHOL, V127, P295, DOI 10.1309/ADJL7E810U1H42BJ; Yossepowitch O, 2007, J UROLOGY, V177, P1277, DOI 10.1016/j.juro.2006.11.066; Zlotta AR, 2000, INT J CANCER, V87, P844, DOI 10.1002/1097-0215(20000915)87:6<844::AID-IJC14>3.0.CO;2-5; Zlotta AR, 1997, CLIN EXP IMMUNOL, V109, P157, DOI 10.1046/j.1365-2249.1997.4141313.x	32	0	0	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2015	10	3							e0118646	10.1371/journal.pone.0118646	http://dx.doi.org/10.1371/journal.pone.0118646			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9KG	25742283	gold, Green Published, Green Submitted			2022-12-27	WOS:000350688100027
J	Balfer, J; Bajorath, J				Balfer, Jenny; Bajorath, Juergen			Systematic Artifacts in Support Vector Regression-Based Compound Potency Prediction Revealed by Statistical and Activity Landscape Analysis	PLOS ONE			English	Article							HEURISTIC METHOD; MACHINE; CHEMOINFORMATICS; REPRESENTATIONS; CLASSIFICATION; MODELS; UREAS	Support vector machines are a popular machine learning method for many classification tasks in biology and chemistry. In addition, the support vector regression (SVR) variant is widely used for numerical property predictions. In chemoinformatics and pharmaceutical research, SVR has become the probably most popular approach for modeling of non-linear structure-activity relationships (SARs) and predicting compound potency values. Herein, we have systematically generated and analyzed SVR prediction models for a variety of compound data sets with different SAR characteristics. Although these SVR models were accurate on the basis of global prediction statistics and not prone to overfitting, they were found to consistently mispredict highly potent compounds. Hence, in regions of local SAR discontinuity, SVR prediction models displayed clear limitations. Compared to observed activity landscapes of compound data sets, landscapes generated on the basis of SVR potency predictions were partly flattened and activity cliff information was lost. Taken together, these findings have implications for practical SVR applications. In particular, prospective SVR-based potency predictions should be considered with caution because artificially low predictions are very likely for highly potent candidate compounds, the most important prediction targets.	[Balfer, Jenny; Bajorath, Juergen] Univ Bonn, Dept Life Sci Informat, B IT, LIMES Program Unit Chem Biol & Med Chem, D-53113 Bonn, Germany	University of Bonn	Bajorath, J (corresponding author), Univ Bonn, Dept Life Sci Informat, B IT, LIMES Program Unit Chem Biol & Med Chem, Dahlmannstr 2, D-53113 Bonn, Germany.	bajorath@bit.uni-bonn.de						[Anonymous], 2011, MACCS STRUCT KEYS; [Anonymous], OECHEM TK VERS 2 0 0; Baell JB, 2010, J MED CHEM, V53, P2719, DOI 10.1021/jm901137j; Balfer J, 2015, 31 CHEMBL DATA SETS; Boser B. E., 1992, Proceedings of the Fifth Annual ACM Workshop on Computational Learning Theory, P144, DOI 10.1145/130385.130401; Byvatov Evgeny, 2003, Appl Bioinformatics, V2, P67; Cherkasov A, 2014, J MED CHEM, V57, P4977, DOI 10.1021/jm4004285; CORTES C, 1995, MACH LEARN, V20, P273, DOI 10.1023/A:1022627411411; Dimova D, 2013, J CHEM INF MODEL, V53, P2275, DOI 10.1021/ci4004078; Drucker H, 1997, ADV NEUR IN, V9, P155; Fatemi MH, 2007, BIOORGAN MED CHEM, V15, P7746, DOI 10.1016/j.bmc.2007.08.057; Gaulton A, 2012, NUCLEIC ACIDS RES, V40, pD1100, DOI 10.1093/nar/gkr777; Gombar VK, 2013, J CHEM INF MODEL, V53, P948, DOI 10.1021/ci400001u; Leong MK, 2007, CHEM RES TOXICOL, V20, P217, DOI 10.1021/tx060230c; Lind P, 2003, J CHEM INF COMP SCI, V43, P1855, DOI 10.1021/ci034107s; Pavlidis P, 2004, BIOINFORMATICS, V20, P586, DOI 10.1093/bioinformatics/btg461; Pedregosa F, 2011, J MACH LEARN RES, V12, P2825; Peltason L, 2007, J MED CHEM, V50, P5571, DOI 10.1021/jm0705713; Peltason L, 2010, J CHEM INF MODEL, V50, P1021, DOI 10.1021/ci100091e; Ralaivola L, 2005, NEURAL NETWORKS, V18, P1093, DOI 10.1016/j.neunet.2005.07.009; Rogers D, 2010, J CHEM INF MODEL, V50, P742, DOI 10.1021/ci100050t; ROGERS DJ, 1960, SCIENCE, V132, P1115, DOI 10.1126/science.132.3434.1115; Smola AJ, 2004, STAT COMPUT, V14, P199, DOI 10.1023/B:STCO.0000035301.49549.88; Song MH, 2006, J CHEM INF MODEL, V46, P392, DOI 10.1021/ci050308f; Stumpfe D, 2014, J MED CHEM, V57, P18, DOI 10.1021/jm401120g; Sun M, 2009, CHEM BIOL DRUG DES, V73, P644, DOI 10.1111/j.1747-0285.2009.00814.x; Vapnik V. N., 2000, NATURE STAT LEARNING, DOI DOI 10.1007/978-1-4757-3264-1_1; Varnek A, 2012, J CHEM INF MODEL, V52, P1413, DOI 10.1021/ci200409x; Vogt M, 2012, BIOORGAN MED CHEM, V20, P5317, DOI 10.1016/j.bmc.2012.03.030; Wassermann AM, 2010, J MED CHEM, V53, P8209, DOI 10.1021/jm100933w; Willett P, 1998, J CHEM INF COMP SCI, V38, P983, DOI 10.1021/ci9800211; Xue CX, 2004, J CHEM INF COMP SCI, V44, P1693, DOI 10.1021/ci049820b; Yuan YN, 2009, EUR J MED CHEM, V44, P25, DOI 10.1016/j.ejmech.2008.03.004	33	13	13	3	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2015	10	3							e0119301	10.1371/journal.pone.0119301	http://dx.doi.org/10.1371/journal.pone.0119301			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9KG	25742011	Green Published, gold, Green Submitted			2022-12-27	WOS:000350688100102
J	Fong, JJ; Cheng, TL; Bataille, A; Pessier, AP; Waldman, B; Vredenburg, VT				Fong, Jonathan J.; Cheng, Tina L.; Bataille, Arnaud; Pessier, Allan P.; Waldman, Bruce; Vredenburg, Vance T.			Early 1900s Detection of Batrachochytrium dendrobatidis in Korean Amphibians	PLOS ONE			English	Article							CHYTRID FUNGUS; MUSEUM SPECIMENS; CHYTRIDIOMYCOSIS; POPULATIONS; PATHOGEN; FROGS; EMERGENCE; LINEAGES; DYNAMICS; SAMPLES	The pathogenic fungus Batrachochytrium dendrobatidis (Bd) is a major conservation concern because of its role in decimating amphibian populations worldwide. We used quantitative PCR to screen 244 museum specimens from the Korean Peninsula, collected between 1911 and 2004, for the presence of Bd to gain insight into its history in Asia. Three specimens of Rugosa emeljanovi (previously Rana or Glandirana rugosa), collected in 1911 from Wonsan, North Korea, tested positive for Bd. Histology of these positive specimens revealed mild hyperkeratosis - a non-specific host response commonly found in Bd-infected frogs - but no Bd zoospores or zoosporangia. Our results indicate that Bd was present in Korea more than 100 years ago, consistent with hypotheses suggesting that Korean amphibians may be infected by endemic Asian Bd strains.	[Fong, Jonathan J.; Bataille, Arnaud; Waldman, Bruce] Seoul Natl Univ, Sch Biol Sci, Seoul, South Korea; [Cheng, Tina L.; Vredenburg, Vance T.] San Francisco State Univ, Dept Biol, San Francisco, CA 94132 USA; [Cheng, Tina L.] Univ Calif Santa Cruz, Dept Ecol & Evolutionary Biol, Santa Cruz, CA 95064 USA; [Pessier, Allan P.] San Diego Zoo Global, Wildlife Dis Labs, Inst Conservat Res, San Diego, CA USA	Seoul National University (SNU); California State University System; San Francisco State University; University of California System; University of California Santa Cruz	Waldman, B (corresponding author), Seoul Natl Univ, Sch Biol Sci, Seoul, South Korea.	waldman@snu.ac.kr	Waldman, Bruce/A-1269-2009	Waldman, Bruce/0000-0003-0006-5333; Bataille, Arnaud/0000-0002-3508-2144; FONG, Jonathan/0000-0002-3648-6730; Vredenburg, Vance/0000-0002-9682-1190	National Research Foundation of Korea (NRF) - government of the Republic of Korea (MSIP) [2010-0002767, 2012R1A1A2044449, 2012K1A2B1A03000496]; Seoul National University; National Science Foundation [1258133]	National Research Foundation of Korea (NRF) - government of the Republic of Korea (MSIP); Seoul National University; National Science Foundation(National Science Foundation (NSF))	The research was supported by the National Research Foundation of Korea (NRF) funded by the government of the Republic of Korea (MSIP) (grants 2010-0002767, 2012R1A1A2044449 and 2012K1A2B1A03000496 to BW), Seoul National University (Brain Fusion Program, Brain Korea 21 Program, and New Faculty Resettlement Fund grants to BW), and the National Science Foundation (grant 1258133 to VTV). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bai CM, 2012, DIVERS DISTRIB, V18, P307, DOI 10.1111/j.1472-4642.2011.00878.x; Bataille A, 2013, MOL ECOL, V22, P4196, DOI 10.1111/mec.12385; Boyle DG, 2004, DIS AQUAT ORGAN, V60, P141, DOI 10.3354/dao060141; Briggs CJ, 2010, P NATL ACAD SCI USA, V107, P9695, DOI 10.1073/pnas.0912886107; Cheng TL, 2011, P NATL ACAD SCI USA, V108, P9502, DOI 10.1073/pnas.1105538108; Dahanukar N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077528; Farrer RA, 2011, P NATL ACAD SCI USA, V108, P18732, DOI 10.1073/pnas.1111915108; Fisher MC, 2009, ANNU REV MICROBIOL, V63, P291, DOI 10.1146/annurev.micro.091208.073435; Garner TWJ, 2006, BIOL LETTERS, V2, P455, DOI 10.1098/rsbl.2006.0494; Goka K, 2009, MOL ECOL, V18, P4757, DOI 10.1111/j.1365-294X.2009.04384.x; Hall LM, 1997, BIOTECHNIQUES, V22, P928; Hyatt AD, 2007, DIS AQUAT ORGAN, V73, P175, DOI 10.3354/dao073175; Jeong A, 2010, J HERPETOL, V2, P9; Kusrini MD, 2008, DIS AQUAT ORGAN, V82, P187, DOI 10.3354/dao01981; Larsen Kirk W., 2006, KOREA CTR DYNAMICS R, P51; Lillie RD, 1976, HISTOPATHOLOGIC TECH, V4th; Lips KR, 2008, PLOS BIOL, V6, P441, DOI 10.1371/journal.pbio.0060072; LUKIN Alexander, 2006, KOREA CTR DYNAMICS R, P15; McLeod DS, 2008, RAFFLES B ZOOL, V56, P199; McMahon TA, 2014, NATURE, V511, P224, DOI 10.1038/nature13491; Mendelson JR, 2014, S AM J HERPETOL, V9, P151, DOI 10.2994/SAJH-D-14-00021.1; Ouellet M, 2005, CONSERV BIOL, V19, P1431, DOI 10.1111/j.1523-1739.2005.00108.x; Pessier AP, 1999, J VET DIAGN INVEST, V11, P194, DOI 10.1177/104063879901100219; Puschendorf R, 2006, J WILDLIFE DIS, V42, P301, DOI 10.7589/0090-3558-42.2.301; Richards-Hrdlicka KL, 2012, METHODS ECOL EVOL, V3, P842, DOI 10.1111/j.2041-210X.2012.00228.x; Rodriguez D, 2014, MOL ECOL, V23, P774, DOI 10.1111/mec.12615; Rosenblum EB, 2013, P NATL ACAD SCI USA, V110, P9385, DOI 10.1073/pnas.1300130110; Savage AE, 2011, ECOHEALTH, V8, P121, DOI 10.1007/s10393-011-0685-y; Soto-Azat C, 2010, DIVERS DISTRIB, V16, P126, DOI 10.1111/j.1472-4642.2009.00618.x; Stuart BL, 2006, SYST BIODIVERS, V4, P133, DOI 10.1017/S1477200005001891; Swei A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023179; Vredenburg VT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063791; Vredenburg VT, 2010, P NATL ACAD SCI USA, V107, P9689, DOI 10.1073/pnas.0914111107; Wandeler P, 2007, TRENDS ECOL EVOL, V22, P634, DOI 10.1016/j.tree.2007.08.017; Weldon C, 2004, EMERG INFECT DIS, V10, P2100, DOI 10.3201/eid1012.030804; Yang H, 2009, DIS AQUAT ORGAN, V86, P9, DOI 10.3354/dao02098; Zeng ZhaoHui, 2011, Journal of Economic Animal, V15, P160; Zhu W, 2014, ECOHEALTH, V11, P241, DOI 10.1007/s10393-013-0894-7; Zimmermann J, 2008, FRONT ZOOL, V5, DOI 10.1186/1742-9994-5-18	39	26	30	2	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2015	10	3							e0115656	10.1371/journal.pone.0115656	http://dx.doi.org/10.1371/journal.pone.0115656			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9JM	25738656	Green Published, gold, Green Submitted			2022-12-27	WOS:000350685900004
J	Huang, WJ; Jeng, YM; Lai, HS; Fong, IU; Sheu, FYB; Lai, PL; Yuan, RH				Huang, Wei-Ju; Jeng, Yung-Ming; Lai, Hong-Shiee; Fong, Iok-U; Sheu, Fang-Yu Bonnie; Lai, Po-Lin; Yuan, Ray-Hwang			Expression of Hypoxic Marker Carbonic Anhydrase IX Predicts Poor Prognosis in Resectable Hepatocellular Carcinoma	PLOS ONE			English	Article							CA-IX; EARLY RECURRENCE; BREAST-CANCER; ALPHA-FETOPROTEIN; OSTEOPONTIN; TUMORS; PROGRESSION; METASTASIS; PROTEIN; STAGE	Carbonic anhydrase IX (CA-IX), a hypoxia marker, correlates with tumor progression in a variety of human cancers. However, the role of CA-IX in hepatocellular carcinomas (HCCs) remains largely unknown. We examined the expression of 277 unifocal, resectable, primary HCC tumors using immunohistochemistry. The CA-IX protein was expressed in 110 of the 227 (48.5%) HCC tumors. The expression of CA-IX correlated with younger age (P = 0.0446), female sex (P = 0.0049), high serum a-fetoprotein levels (P<1x10(-6)), larger tumor size (P = 0.0031), high tumor grade P<1x10(-6)) and high tumor stage (P = 1.5x10(-6)). Patients with HCC tumors that expressed CA-IX were more likely to have lower 5-year disease-free survival (DFS; P = 0.0001) and 5-year overall survival (OS; P< 1x10(-6)). The multivariate analysis indicated that CA-IX expression was an independent predictor for high tumor stage (P = 0.0047) and DFS (P = 0.0456), and a borderline predictor for OS (P = 0.0762). Furthermore, CA-IX expression predicted poor DFS and OS in patients with high tumor stage (P = 0.0004 and P< 1x10(-6), respectively). Interestingly, CA-IX expression might contribute to the worse prognosis of female patients with advanced HCCs. Our study indicates the expression of the CA-IX protein is a crucial predictor of poor prognosis in resectable HCC, and it is also an unfavorable prognostic predictor in HCC patients with high tumor stage.	[Huang, Wei-Ju; Jeng, Yung-Ming; Fong, Iok-U] Natl Taiwan Univ, Coll Med, Grad Inst Pathol, Taipei 10051, Taiwan; [Huang, Wei-Ju] Hsin Sheng Coll Med Care & Management, Dept Nursing, Longtan Township 32544, Taoyuan County, Taiwan; [Jeng, Yung-Ming; Lai, Po-Lin] Natl Taiwan Univ Hosp, Dept Pathol, Taipei 10051, Taiwan; [Jeng, Yung-Ming; Lai, Hong-Shiee; Lai, Po-Lin; Yuan, Ray-Hwang] Natl Taiwan Univ, Coll Med, Taipei 10051, Taiwan; [Lai, Hong-Shiee; Yuan, Ray-Hwang] Natl Taiwan Univ Hosp, Dept Surg, Taipei 10051, Taiwan; [Sheu, Fang-Yu Bonnie] Univ Illinois, Coll Med, Dept Biomed Sci, Rockford, IL 61107 USA; [Yuan, Ray-Hwang] Natl Taiwan Univ Hosp, Dept Integrated Diagnost & Therapeut, Taipei 10051, Taiwan	National Taiwan University; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University; National Taiwan University Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Rockford; National Taiwan University; National Taiwan University Hospital	Yuan, RH (corresponding author), Natl Taiwan Univ Hosp, Dept Surg, 1 Jen Ai Rd,Sect 1, Taipei 10051, Taiwan.	d83409009@ntu.edu.tw		Lai, Hong-Shiee/0000-0002-7958-2183; Yuan, Ray-Hwang/0000-0002-2767-633X; JENG, YUNG-MING/0000-0002-3878-4491				Abaza M, 2013, EXPERT REV ANTICANC, V13, P1229, DOI 10.1586/14737140.2013.843455; Bache M, 2006, INT J RADIAT ONCOL, V66, P1481, DOI 10.1016/j.ijrobp.2006.07.1376; Befeler AS, 2002, GASTROENTEROLOGY, V122, P1609, DOI 10.1053/gast.2002.33411; Brennan DJ, 2006, CLIN CANCER RES, V12, P6421, DOI 10.1158/1078-0432.CCR-06-0480; Cabibbo G, 2010, HEPATOLOGY, V51, P1274, DOI 10.1002/hep.23485; Ditte P, 2011, CANCER RES, V71, P7558, DOI 10.1158/0008-5472.CAN-11-2520; Dong ZZ, 2013, MINI-REV MED CHEM, V13, P1295; Driessen A, 2006, ANN SURG, V243, P334, DOI 10.1097/01.sla.0000201452.09591.f3; Eckert AW, 2010, J ORAL PATHOL MED, V39, P313, DOI 10.1111/j.1600-0714.2009.00829.x; Edge SB, 2010, AJCC CANC STAGING MA; EDMONDSON HA, 1954, CANCER-AM CANCER SOC, V7, P462, DOI 10.1002/1097-0142(195405)7:3<462::AID-CNCR2820070308>3.0.CO;2-E; Farinati F, 2009, EUR J GASTROEN HEPAT, V21, P1212, DOI 10.1097/MEG.0b013e32831a86f8; Fiaschi T, 2013, CELL CYCLE, V12, P1791, DOI 10.4161/cc.24902; Genega EM, 2010, AM J CLIN PATHOL, V134, P873, DOI 10.1309/AJCPPPR57HNJMSLZ; Giannini EG, 2015, HEPATOLOGY, V61, P184, DOI 10.1002/hep.27443; Haapasalo JA, 2006, CLIN CANCER RES, V12, P473, DOI 10.1158/1078-0432.CCR-05-0848; Hoskin PJ, 2003, BRIT J CANCER, V89, P1290, DOI 10.1038/sj.bjc.6601260; Hussain SA, 2007, BRIT J CANCER, V96, P104, DOI 10.1038/sj.bjc.6603530; Kaluz S, 2009, BIOCHIM BIOPHYS ACTA, V1795, P167; Lee-Kong SA, 2012, DIS COLON RECTUM, V55, P990, DOI 10.1097/DCR.0b013e31825bd80c; Li SS, 2011, HEPAT MON, V11, P821, DOI 10.5812/kowsar.1735143X.771; Liao SY, 2010, GYNECOL ONCOL, V116, P452, DOI 10.1016/j.ygyno.2009.10.062; Liu ZR, 2014, HISTOPATHOLOGY, V64, P921, DOI 10.1111/his.12341; Lock FE, 2013, ONCOGENE, V32, P5210, DOI 10.1038/onc.2012.550; Loncaster JA, 2001, CANCER RES, V61, P6394; Luong-Player A, 2014, AM J CLIN PATHOL, V141, P219, DOI 10.1309/AJCPVJDS28KNYZLD; Maseide K, 2004, CLIN CANCER RES, V10, P4464, DOI 10.1158/1078-0432.CCR-03-0541; McDonald PC, 2012, ONCOTARGET, V3, P84, DOI 10.18632/oncotarget.422; Nurwidya F, 2012, ANAT CELL BIOL, V45, P73, DOI 10.5115/acb.2012.45.2.73; Pan HW, 2003, CANCER-AM CANCER SOC, V98, P119, DOI 10.1002/cncr.11487; PASTOREK J, 1994, ONCOGENE, V9, P2877; Peng SY, 2005, INT J ONCOL, V26, P1053; Peng SY, 2004, INT J CANCER, V112, P44, DOI 10.1002/ijc.20279; Poon RTP, 2000, CANCER, V89, P500, DOI 10.1002/1097-0142(20000801)89:3<500::AID-CNCR4>3.3.CO;2-F; Rosmorduc O, 2010, SEMIN LIVER DIS, V30, P258, DOI 10.1055/s-0030-1255355; Schafer DF, 1999, LANCET, V353, P1253, DOI 10.1016/S0140-6736(98)09148-X; Semenza G.L., 2002, TRENDS MOL MED; Sokkar P, 2012, J MOL MODEL, V18, P1691, DOI 10.1007/s00894-011-1150-0; Svastova E, 2012, J BIOL CHEM, V287, P3392, DOI 10.1074/jbc.M111.286062; Swinson DEB, 2003, J CLIN ONCOL, V21, P473, DOI 10.1200/JCO.2003.11.132; Takacova M, 2014, AM J PATHOL, V184, P953, DOI 10.1016/j.ajpath.2014.01.002; Tan EY, 2009, BRIT J CANCER, V100, P405, DOI 10.1038/sj.bjc.6604844; Tanaka M, 2013, MOL MED REP, V7, P365, DOI 10.3892/mmr.2012.1201; Troost EGC, 2005, RADIOTHER ONCOL, V76, P194, DOI 10.1016/j.radonc.2005.06.031; Wykoff CC, 2000, CANCER RES, V60, P7075; Yang MH, 2008, NAT CELL BIOL, V10, P295, DOI 10.1038/ncb1691; Yu SJ, 2011, ACTA PHARMACOL SIN, V32, P912, DOI 10.1038/aps.2011.24; Yuan RH, 2006, J PATHOL, V209, P549, DOI 10.1002/path.2011; Yuan RH, 2014, J GASTROINTEST SURG, V18, P1784, DOI 10.1007/s11605-014-2596-z; Yuan RH, 2005, CLIN CANCER RES, V11, P2568, DOI 10.1158/1078-0432.CCR-04-2039	50	20	22	3	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2015	10	3							e0119181	10.1371/journal.pone.0119181	http://dx.doi.org/10.1371/journal.pone.0119181			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9JM	25738958	Green Published, gold, Green Submitted			2022-12-27	WOS:000350685900097
J	Soffker, M; Trathan, P; Clark, J; Collins, MA; Belchier, M; Scott, R				Soeffker, Marta; Trathan, Phil; Clark, James; Collins, Martin A.; Belchier, Mark; Scott, Robert			The Impact of Predation by Marine Mammals on Patagonian Toothfish Longline Fisheries	PLOS ONE			English	Article							WHALE ORCINUS-ORCA; KILLER WHALES; SPERM-WHALES; SOUTH-GEORGIA; TWEEDIE DISTRIBUTION; DEPREDATION; CATCH; MOVEMENTS; PATTERNS; BYCATCH	Predatory interaction of marine mammals with longline fisheries is observed globally, leading to partial or complete loss of the catch and in some parts of the world to considerable financial loss. Depredation can also create additional unrecorded fishing mortality of a stock and has the potential to introduce bias to stock assessments. Here we aim to characterise depredation in the Patagonian toothfish (Dissostichus eleginoides) fishery around South Georgia focusing on the spatio-temporal component of these interactions. Antarctic fur seals (Arctocephalus gazella), sperm whales (Physeter macrocephalus), and orcas (Orcinus orca) frequently feed on fish hooked on longlines around South Georgia. A third of longlines encounter sperm whales, but loss of catch due to sperm whales is insignificant when compared to that due to orcas, which interact with only 5% of longlines but can take more than half of the catch in some cases. Orca depredation around South Georgia is spatially limited and focused in areas of putative migration routes, and the impact is compounded as a result of the fishery also concentrating in those areas at those times. Understanding the seasonal behaviour of orcas and the spatial and temporal distribution of "depredation hot spots" can reduce marine mammal interactions, will improve assessment and management of the stock and contribute to increased operational efficiency of the fishery. Such information is valuable in the effort to resolve the human-mammal conflict for resources.	[Soeffker, Marta; Scott, Robert] Ctr Environm Fisheries & Aquaculture Sci, Lowestoft, Suffolk, England; [Trathan, Phil; Belchier, Mark] British Antarctic Survey, Cambridge CB3 0ET, England; [Clark, James] Marine Resources Assessment Grp, London, England; [Belchier, Mark] Govt South Georgia & South Sandwich Isl, Stanley, Hong Kong, Peoples R China	Centre for Environment Fisheries & Aquaculture Science; UK Research & Innovation (UKRI); Natural Environment Research Council (NERC); NERC British Antarctic Survey	Soffker, M (corresponding author), Ctr Environm Fisheries & Aquaculture Sci, Pakefield Rd, Lowestoft, Suffolk, England.	marta.soffker@cefas.co.uk	Söffker, M./D-3258-2009; , Martin/ABE-6728-2020; Collins, Martin A/J-8560-2017	Söffker, M./0000-0002-7131-5486; 	Government of South Georgia and the South Sandwich Islands; Cefas Seedcorn funds; NERC [bas0100025] Funding Source: UKRI; Natural Environment Research Council [bas0100025] Funding Source: researchfish	Government of South Georgia and the South Sandwich Islands; Cefas Seedcorn funds; NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	The project was funded by the Government of South Georgia and the South Sandwich Islands (MS, MAC, RS) with additional support from Cefas Seedcorn funds (MS). The funding bodies had no role in the study design, data analysis or decision to publish, but contributed to the preparation of the final manuscript.	Agnew DJ, 2000, CCAMLR SCI, V7, P119; Ainley David G., 2009, Aquatic Mammals, V35, P334, DOI 10.1578/AM.35.3.2009.334; Andrews RD, 2008, POLAR BIOL, V31, P1461, DOI 10.1007/s00300-008-0487-z; Atkinson A, 2001, MAR ECOL PROG SER, V216, P279, DOI 10.3354/meps216279; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Candy SG, 2004, CCAMLR SCI, V11, P59; Clark JM, 2010, CCAMLR SCI, V17, P163; CLARKE M R, 1980, Discovery Reports, V37, P1; Clarke MR, 1996, PHILOS T ROY SOC B, V351, P1053, DOI 10.1098/rstb.1996.0093; Collins MA, 2007, MAR BIOL, V152, P135, DOI 10.1007/s00227-007-0667-3; Collins MA, 2006, ADV MAR BIOL, V50, P191, DOI 10.1016/S0065-2881(05)50003-8; Crawley M.J., 2007, R BOOK; de Bruyn PJN, 2013, BIOL REV, V88, P62, DOI 10.1111/j.1469-185X.2012.00239.x; Dunn P. K., 2013, R PACKAGE VERSION, V2, P7; Durban JW, 2012, BIOL LETTERS, V8, P274, DOI 10.1098/rsbl.2011.0875; Foote AD, 2010, EVOL ECOL, V24, P803, DOI 10.1007/s10682-009-9337-x; Forney KA, 2011, MAR ECOL-EVOL PERSP, V32, P380, DOI 10.1111/j.1439-0485.2011.00454.x; Gilman Eric, 2006, Journal of Cetacean Research and Management, V8, P215; GUINET C., 2011, J AM CET SOC, V40, P33; Hamer DJ, 2012, MAR MAMMAL SCI, V28, pE345, DOI 10.1111/j.1748-7692.2011.00544.x; Hucke-Gaete R, 2004, CCAMLR SCI, V11, P127; Kock KH, 2006, POLAR BIOL, V29, P379, DOI 10.1007/s00300-005-0067-4; Moreno CA, 2008, CCAMLR SCI, V15, P79; Morin PA, 2010, GENOME RES, V20, P908, DOI 10.1101/gr.102954.109; Noren DP, 2011, MAR MAMMAL SCI, V27, P60, DOI 10.1111/j.1748-7692.2010.00386.x; Peterson MJ, 2013, ICES J MAR SCI, V70, P1220, DOI 10.1093/icesjms/fst045; Peterson MJ, 2013, MAR POLICY, V42, P315, DOI 10.1016/j.marpol.2013.04.001; Pitman R., 2011, J AM CETACEAN SOC, V40, P39, DOI 10.1098/rsbl.2011.0875; Pitman Robert L., 2003, Journal of Cetacean Research and Management, V5, P131; Pitman RL, 2011, POLAR BIOL, V34, P303, DOI 10.1007/s00300-010-0871-3; Purves MG, 2004, CCAMLR SCI, V11, P111; R Core Team, 2021, R LANGUAGE ENV STAT; Rabearisoa N, 2012, J EXP MAR BIOL ECOL, V432, P55, DOI 10.1016/j.jembe.2012.07.004; REID K, 1995, ANTARCT SCI, V7, P241, DOI 10.1017/S0954102095000344; Ripley B, 2019, TREE CLASSIFICATION; Roche C, 2007, CCAMLR SCI, V14, P67; Shono H, 2008, FISH RES, V93, P154, DOI 10.1016/j.fishres.2008.03.006; Staniland IJ, 2010, MAR BIOL, V157, P2383, DOI 10.1007/s00227-010-1503-8; Straley JM, 2014, ENDANGER SPECIES RES, V24, P125, DOI 10.3354/esr00595; Tixier P, 2010, CCAMLR SCI, V17, P179; Trathan P., 1998, CCAMLR SCI, V5, P9; Venables WN., 2002, MODERN APPL STAT S, V4; Visser Ingrid N., 2000, Aquatic Mammals, V26, P241	43	26	27	1	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2015	10	3							e0118113	10.1371/journal.pone.0118113	http://dx.doi.org/10.1371/journal.pone.0118113			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9JM	25738698	gold, Green Published, Green Accepted, Green Submitted			2022-12-27	WOS:000350685900022
J	Yang, C; Li, J; Lin, H; Zhao, KQ; Zheng, CQ				Yang, Chen; Li, Jing; Lin, Hai; Zhao, Keqing; Zheng, Chunquan			Nasal Mucosa Derived-Mesenchymal Stem Cells from Mice Reduce Inflammation via Modulating Immune Responses	PLOS ONE			English	Article							VERSUS-HOST-DISEASE; ALLERGIC RHINITIS	Mesenchymal stem cells (MSCs) have arisen the attention to be a new attractive therapeutic tool treating autoimmune diseases such as allergic rhinitis (AR). AR is a chronic reversible allergic inflammation caused by the excessive activation of T-helper 2 (Th2) cells. Recently, MSCs have been proposed as a new therapy of AR as it can suppress some cytokines to control allogeneic Th2 response and functions. However, how MSCs function to reduce inflammation remains unclear. In this study, we aimed to investigate the role of ectomesenchymal stem cells (ECTO-MSCs) derived from nasal mucosa in eosinophilic inflammation and how it affects some immunoglobulins and cytokines. We used ovalbumin (OVA) as a sensitizer to induce nasal inflammation in mice by both injection and inhalation. In order to obtain deeper insights into the influences of ECTO-MSCs on nasal inflammation, the migration of ECTO-MSCs was assessed, the numbers of eosinophils and sneezing were counted, and several immunoglobulins and cytokines were measured. Here we show the ECTO-MSCs are able to migrate to inflammation site via tail vein injection. Eosinophils and sneezing were suppressed by ECTO-MSCs. Interestingly, IgE, interleukin (IL)-4, IL-5 and IL-10 secreted by Th-2 cells were down-regulated by ECTO-MSCs whereas IgG2 and IFN-gamma were up-regulated. In conclusion, we have observed that ECTO-MSCs are associated with enhanced Th-1 immune response to nasal inflammation and reduced Th-2 immune response. Given the contributions of Th-2 cells to AR, the injection of ECTO-MSCs can be a promising therapy of AR through balancing immune response.	[Yang, Chen; Li, Jing; Lin, Hai; Zhao, Keqing; Zheng, Chunquan] Fudan Univ, Dept Otolaryngol Head & Neck Surg, Eye Ear Nose & Throat Hosp, Shanghai 200433, Peoples R China; [Yang, Chen] Shanghai Jiao Tong Univ, Dept Otolaryngol, Ruijin Hosp, Shanghai 200030, Peoples R China	Fudan University; Shanghai Jiao Tong University	Zheng, CQ (corresponding author), Fudan Univ, Dept Otolaryngol Head & Neck Surg, Eye Ear Nose & Throat Hosp, Shanghai 200433, Peoples R China.	chunquanzheng@163.com			National Natural Science Foundation of China (NSFC) [81470672]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC))	This study is funded by the National Natural Science Foundation of China (NSFC, 81470672). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal S, 2005, BLOOD, V105, P1815, DOI 10.1182/blood-2004-04-1559; Baksh D, 2004, J CELL MOL MED, V8, P301, DOI 10.1111/j.1582-4934.2004.tb00320.x; Cho KS, 2009, STEM CELLS, V27, P259, DOI 10.1634/stemcells.2008-0283; Ciprandi G, 2005, OTOLARYNG HEAD NECK, V133, P429, DOI 10.1016/j.otohns.2005.05.049; COLLINS PD, 1995, J EXP MED, V182, P1169, DOI 10.1084/jem.182.4.1169; Delorme B, 2010, STEM CELLS DEV, V19, P853, DOI 10.1089/scd.2009.0267; Ding DC, 2011, CELL TRANSPLANT, V20, P5, DOI 10.3727/096368910X; FRIEDENS.AJ, 1966, J EMBRYOL EXP MORPH, V16, P381; Fu QL, 2012, ALLERGY, V67, P1215, DOI [10.1111/j.1398-9995.2012.02875.x, 10.1111/j.1398-9995.2012.02875.x.]; Huber VC, 2006, CLIN VACCINE IMMUNOL, V13, P981, DOI 10.1128/CVI.00156-06; Kelly JL, 1997, SURGERY, V122, P146, DOI 10.1016/S0039-6060(97)90003-9; Kidd Parris, 2003, Altern Med Rev, V8, P223; Le Blanc K, 2004, LANCET, V363, P1439, DOI 10.1016/S0140-6736(04)16104-7; LeBlanc K, 2008, LANCET, V371, P1579, DOI 10.1016/S0140-6736(08)60690-X; MAGGI E, 1994, ANN NY ACAD SCI, V725, P2, DOI 10.1111/j.1749-6632.1994.tb39784.x; Minguell JJ, 2001, EXP BIOL MED, V226, P507, DOI 10.1177/153537020122600603; Moingeon P, 2006, ALLERGY, V61, P151, DOI 10.1111/j.1398-9995.2006.01002.x; Oreffo ROC, 2005, STEM CELL REV, V1, P169, DOI 10.1385/SCR:1:2:169; Peterson JD, 1998, P NATL ACAD SCI USA, V95, P3071, DOI 10.1073/pnas.95.6.3071; Sun YQ, 2012, STEM CELLS, V30, P2692, DOI 10.1002/stem.1241; Uccelli A, 2008, NAT REV IMMUNOL, V8, P726, DOI 10.1038/nri2395; Wilson DR, 2005, ALLERGY, V60, P4, DOI 10.1111/j.1398-9995.2005.00699.x; Wise AF, 2012, NEPHROLOGY, V17, P1, DOI 10.1111/j.1440-1797.2011.01501.x; Yang LY, 1998, J EXP MED, V188, P1739, DOI 10.1084/jem.188.9.1739	24	20	21	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2015	10	3							e0118849	10.1371/journal.pone.0118849	http://dx.doi.org/10.1371/journal.pone.0118849			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9JM	25739057	Green Published, gold, Green Submitted			2022-12-27	WOS:000350685900081
J	Lee, DH; Ng, J; Kim, SB; Sonn, CH; Lee, KM; Han, SB				Lee, Dae-Hee; Ng, Joanne; Kim, Sang-Beom; Sonn, Chung Hee; Lee, Kyung-Mi; Han, Seung-Beom			Effect of Donor Age on the Proportion of Mesenchymal Stem Cells Derived from Anterior Cruciate Ligaments	PLOS ONE			English	Article							SYNOVIAL-FLUID; STROMAL CELLS; TRABECULAR BONE; KNEE-JOINT; EXPRESSION; CARTILAGE; THROMBOSPONDIN-4; OSTEOARTHRITIS; CHONDROCYTES; INFLAMMATION	The characteristics of anterior cruciate ligament (ACL)-derived mesenchymal stem cells (MSCs), such as proportion and multilineage potential, can be affected by donor age. However, the qualitative and quantitative features of ACL MSCs isolated from younger and older individuals have not yet been compared directly. This study assessed the phenotypic and functional differences in ACL-MSCs isolated from younger and older donors and evaluated the correlation between ACL-MSC proportion and donor age. Torn ACL remnants were harvested from 36 patients undergoing ACL reconstruction (young: 29.67 +/- 10.92 years) and 33 undergoing TKA (old: 67.96 +/- 5.22 years) and the proportion of their MSCs were measured. The mean proportion of MSCs was slightly higher in older ACL samples of the TKA group than of the younger ACL reconstruction group (19.69 +/- 8.57% vs. 15.33 +/- 7.49%, p = 0.024), but the proportions of MSCs at passages 1 and 2 were similar. MSCs from both groups possessed comparable multilineage potentiality, as they could be differentiated into adipocytes, osteocytes, and chondrocytes at similar level. No significant correlations were observed between patient age and MSC proportions at passages 0-2 or between age and MSC proportion in both the ACL reconstruction and TKA groups. Multiple linear regression analysis found no significant predictor of MSC proportion including donor age for each passage. Microarray analysis identified several genes that were differentially regulated in ACLMSCs from old TKA patients compared to young ACL reconstruction patients. Genes of interest encode components of the extracellular matrix (ECM) and may thus play a crucial role in modulating tissue homeostasis, remodeling, and repair in response to damage or disease. In conclusion, the proportion of freshly isolated ACL-MSC was higher in elderly TKA patients than in younger patients with ACL tears, but their phenotypic and multilineage potential were comparable.	[Lee, Dae-Hee] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Orthopaed Surg, Seoul, South Korea; [Ng, Joanne; Sonn, Chung Hee; Lee, Kyung-Mi] Korea Univ, Coll Med, Dept Biochem & Mol Biol, Div Brain,Korea Program Biomed Sci 21, Seoul 136705, South Korea; [Kim, Sang-Beom] Barunmadi Orthopaed, Songnam, Gyeonggi Do, South Korea; [Han, Seung-Beom] Korea Univ, Coll Med, Dept Orthopaed Surg, Seoul 136705, South Korea	Sungkyunkwan University (SKKU); Samsung Medical Center; Korea University; Korea University Medicine (KU Medicine); Korea University; Korea University Medicine (KU Medicine)	Lee, KM (corresponding author), Korea Univ, Coll Med, Dept Biochem & Mol Biol, Div Brain,Korea Program Biomed Sci 21, Seoul 136705, South Korea.	kyunglee@korea.ac.kr; oshan@korea.ac.kr	lee, dae hee/I-9390-2017	Lee, Kyung-Mi/0000-0002-5378-9258	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT & Future Planning [NRF-2013R1A1A2A10010605, NRF-K20703001994-12A0500-03610, NRF-2013M3A9D3045719]; Korea University Grants [K1423281]	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT & Future Planning; Korea University Grants	This work was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT & Future Planning (NRF-2013R1A1A2A10010605, NRF-K20703001994-12A0500-03610, and NRF-2013M3A9D3045719). This work was also supported by Korea University Grants (K1423281). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cheng MT, 2009, CELL PROLIFERAT, V42, P448, DOI 10.1111/j.1365-2184.2009.00611.x; De Bari C, 2001, ARTHRITIS RHEUM-US, V44, P1928, DOI 10.1002/1529-0131(200108)44:8<1928::AID-ART331>3.0.CO;2-P; Elsaid KA, 2008, ARTHRITIS RHEUM-US, V58, P1707, DOI 10.1002/art.23495; Elsaid KA, 2009, ARTHRITIS RHEUM-US, V60, P2997, DOI 10.1002/art.24800; Fehrer C, 2005, EXP GERONTOL, V40, P926, DOI 10.1016/j.exger.2005.07.006; Frolova EG, 2014, MATRIX BIOL J INT SO; Frolova EG, 2010, CIRC RES, V107, P1313, DOI 10.1161/CIRCRESAHA.110.232371; Gimble JM, 2003, CYTOTHERAPY, V5, P362, DOI 10.1080/14653240310003026; Hasegawa A, 2012, ARTHRITIS RHEUM-US, V64, P696, DOI 10.1002/art.33417; HAUSER N, 1995, FEBS LETT, V368, P307, DOI 10.1016/0014-5793(95)00675-Y; Huang TF, 2008, CYTOTHERAPY, V10, P806, DOI 10.1080/14653240802474323; Jeong JA, 2005, STEM CELLS, V23, P584, DOI 10.1634/stemcells.2004-0304; Jones ARC, 2007, EUR CELLS MATER, V13, P40, DOI 10.22203/eCM.v013a04; Jones EA, 2008, ARTHRITIS RHEUM-US, V58, P1731, DOI 10.1002/art.23485; Katz AJ, 2005, STEM CELLS, V23, P412, DOI 10.1634/stemcells.2004-0021; Koga H, 2007, STEM CELLS, V25, P689, DOI 10.1634/stemcells.2006-0281; LAWLER J, 1993, J CELL BIOL, V120, P1059, DOI 10.1083/jcb.120.4.1059; Lee DH, 2011, CONNECT TISSUE RES, V52, P226, DOI 10.3109/03008207.2010.516850; Lee SY, 2008, BIOCHEM BIOPH RES CO, V376, P148, DOI 10.1016/j.bbrc.2008.08.138; Lemburg AK, 2004, VET IMMUNOL IMMUNOP, V97, P231, DOI 10.1016/j.vetimm.2003.09.007; Levy YD, 2013, ANN RHEUM DIS, V72, P271, DOI 10.1136/annrheumdis-2012-201730; Matsumoto T, 2012, STEM CELLS DEV, V21, P859, DOI 10.1089/scd.2010.0528; Miura Y, 2005, P NATL ACAD SCI USA, V102, P14022, DOI 10.1073/pnas.0409397102; Mochizuki T, 2006, ARTHRITIS RHEUM-US, V54, P843, DOI 10.1002/art.21651; Musumeci G, 2011, EXP BIOL MED, V236, P1333, DOI 10.1258/ebm.2011.011183; Noth U, 2002, J ORTHOP RES, V20, P1060, DOI 10.1016/S0736-0266(02)00018-9; Pei M, 2009, OSTEOARTHR CARTILAGE, V17, P714, DOI 10.1016/j.joca.2008.11.017; Pluskota E, 2005, BLOOD, V106, P3970, DOI 10.1182/blood-2005-03-1292; Prockop DJ, 1997, SCIENCE, V276, P71, DOI 10.1126/science.276.5309.71; QUARTO R, 1995, CALCIFIED TISSUE INT, V56, P123, DOI 10.1007/BF00296343; Ruan MZC, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005409; Sakaguchi Y, 2004, BLOOD, V104, P2728, DOI 10.1182/blood-2003-12-4452; Schmidt TA, 2008, OSTEOARTHR CARTILAGE, V16, P90, DOI 10.1016/j.joca.2007.05.009; Segawa Y, 2009, J ORTHOP RES, V27, P435, DOI 10.1002/jor.20786; Sekiya I, 2012, J ORTHOP RES, V30, P943, DOI 10.1002/jor.22029; Stenderup K, 2001, J BONE MINER RES, V16, P1120, DOI 10.1359/jbmr.2001.16.6.1120; Suzuki S, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3869; Tormin A, 2009, CYTOTHERAPY, V11, P114, DOI 10.1080/14653240802716590; Zaim M, 2012, ANN HEMATOL, V91, P1175, DOI 10.1007/s00277-012-1438-x	39	12	13	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2015	10	3							e0117224	10.1371/journal.pone.0117224	http://dx.doi.org/10.1371/journal.pone.0117224			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9JF	25729860	gold, Green Published, Green Submitted			2022-12-27	WOS:000350684900011
J	Ninomiya, S; Kawano, M; Abe, T; Ishikawa, T; Takahashi, M; Tamura, M; Takahashi, Y; Nashimoto, M				Ninomiya, Sho; Kawano, Mitsuoki; Abe, Takashi; Ishikawa, Tatsuya; Takahashi, Masayuki; Tamura, Masato; Takahashi, Yoshiaki; Nashimoto, Masayuki			Potential Small Guide RNAs for tRNase Z(L) from Human Plasma, Peripheral Blood Mononuclear Cells, and Cultured Cell Lines	PLOS ONE			English	Article							HEPTAMER-TYPE SGRNA; Y RNAS; GENE-EXPRESSION; RIBOSOMAL-RNA; CLEAVAGE; ENDORIBONUCLEASE; ESTABLISHMENT; DIRECTION; APOPTOSIS; PROTEINS	Several pieces of evidence suggest that small RNA degradation products together with tRNase Z(L) appear to form another layer of the whole gene regulatory network. The degraded RNAsuch as a 5'-half-tRNA and an rRNA fragment function as small guide RNA (sgRNA) to guide the enzyme to target RNA. We were curious whether there exist RNAs in plasma that can function as sgRNAs for tRNase Z(L), whether these RNAs are working as signaling molecules between cells to fulfill physiological roles, and whether there are any differences in plasma sgRNA species and levels between normal and pathological conditions. Here, we analyzed small plasma RNAs from three healthy persons and three multiple myeloma patients for potential sgRNAs by deep sequencing. We also examined small RNAs from peripheral blood mononuclear cells (PBMC) of three healthy persons and three myeloma patients and from various cultured human cell lines for sgRNAs. We found that read-number distribution patterns of plasma and PBMC RNAs differ between persons in the range of 5-40 nt and that there are many RNA species that exist significantly more or less abundantly in the plasma or PBMC of the myeloma patients than those of the healthy persons. Furthermore, we found that there are many potential sgRNAs in the 5-40-nt RNAs and that, among them, a 31-nt RNA fragment derived from 94-nt Y4-RNA, which can function as a 50-half-tRNA-type sgRNA, is overwhelmingly abundant in the plasma of 2/3 of the examinees. These observations suggest that the gene regulatory network via tRNase Z(L) and sgRNA may be extended intercellularly.	[Ninomiya, Sho; Kawano, Mitsuoki; Ishikawa, Tatsuya; Takahashi, Masayuki; Nashimoto, Masayuki] Niigata Univ Pharm & Appl Life Sci, Dept Appl Life Sci, Niigata, Japan; [Kawano, Mitsuoki; Tamura, Masato] Hokkaido Univ, Grad Sch Dent Med, Dept Biochem & Mol Biol, Sapporo, Hokkaido, Japan; [Abe, Takashi] Niigata Univ, Dept Informat Engn, Niigata, Japan; [Takahashi, Yoshiaki] Niigata Univ, Grad Sch Hlth Sci, Biochem Lab, Niigata, Japan; [Nashimoto, Masayuki] Niigata Univ Pharm & Appl Life Sci, Res Inst Hlth Living, Niigata, Japan	Niigata University; Hokkaido University; Niigata University; Niigata University; Niigata University	Nashimoto, M (corresponding author), Niigata Univ Pharm & Appl Life Sci, Dept Appl Life Sci, Niigata, Japan.	mnashimoto@nupals.ac.jp	tamura, masato/B-7304-2009; Kawano, Mitsuoki/AAT-7600-2020; Kawano, Mitsuoki/GLS-2569-2022	tamura, masato/0000-0003-3700-5203; Kawano, Mitsuoki/0000-0003-1570-0491	Adaptable and Seamless Technology Transfer Program through Target-driven R&D, Japan Science and Technology Agency; Science Research Promotion Fund from the Promotion and Mutual Aid Corporation for Private Schools of Japan; JSPS [23650618, 24659269]	Adaptable and Seamless Technology Transfer Program through Target-driven R&D, Japan Science and Technology Agency; Science Research Promotion Fund from the Promotion and Mutual Aid Corporation for Private Schools of Japan(Promotion and Mutual Aid Corporation for Private Schools of Japan); JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by Adaptable and Seamless Technology Transfer Program through Target-driven R&D, Japan Science and Technology Agency (to MN), the Science Research Promotion Fund from the Promotion and Mutual Aid Corporation for Private Schools of Japan (to MN), and the JSPS KAKENHI Grant Numbers 23650618 (to MN) and 24659269 (to YT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armache JP, 2010, P NATL ACAD SCI USA, V107, P19748, DOI 10.1073/pnas.1009999107; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; Dhahbi JM, 2013, PHYSIOL GENOMICS, V45, P990, DOI 10.1152/physiolgenomics.00129.2013; DICKE RH, 1965, ASTROPHYS J, V142, P414, DOI 10.1086/148306; Elbarbary RA, 2009, FEBS LETT, V583, P3241, DOI 10.1016/j.febslet.2009.09.015; Elbarbary RA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005908; Elbarbary RA, 2009, BIOCHEM BIOPH RES CO, V379, P924, DOI 10.1016/j.bbrc.2008.12.173; GALLAGHER R, 1979, BLOOD, V54, P713; GIARD DJ, 1973, J NATL CANCER I, V51, P1417, DOI 10.1093/jnci/51.5.1417; Girard A, 2006, NATURE, V442, P199, DOI 10.1038/nature04917; GORSKI JL, 1987, J MOL EVOL, V24, P236, DOI 10.1007/BF02111237; GRAHAM FL, 1977, J GEN VIROL, V36, P59, DOI 10.1099/0022-1317-36-1-59; Habu Y, 2005, NUCLEIC ACIDS RES, V33, P235, DOI 10.1093/nar/gki164; Ivanov P, 2011, MOL CELL, V43, P613, DOI 10.1016/j.molcel.2011.06.022; Jackowiak P, 2011, NUCLEIC ACIDS RES, V39, P7361, DOI 10.1093/nar/gkr450; Kawano M, 2010, BIOTECHNIQUES, V49, P751, DOI 10.2144/000113516; KNOWLES BB, 1980, SCIENCE, V209, P497, DOI 10.1126/science.6248960; Kozomara A, 2014, NUCLEIC ACIDS RES, V42, pD68, DOI 10.1093/nar/gkt1181; Lassmann T, 2009, BIOINFORMATICS, V25, P2839, DOI 10.1093/bioinformatics/btp527; LERNER MR, 1981, SCIENCE, V211, P400, DOI 10.1126/science.6164096; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; MATSUOKA Y, 1967, P SOC EXP BIOL MED, V125, P1246; NAKABAYASHI H, 1982, CANCER RES, V42, P3858; Nakashima A, 2007, GENE THER, V14, P78, DOI 10.1038/sj.gt.3302841; NASHIMOTO M, 1991, BIOCHEM BIOPH RES CO, V178, P1247, DOI 10.1016/0006-291X(91)91027-A; NASHIMOTO M, 1995, NUCLEIC ACIDS RES, V23, P3642, DOI 10.1093/nar/23.18.3642; NASHIMOTO M, 1993, NUCLEIC ACIDS RES, V21, P4696, DOI 10.1093/nar/21.20.4696; Nashimoto M, 1996, RNA, V2, P523; NASHIMOTO M, 1992, NUCLEIC ACIDS RES, V20, P3737, DOI 10.1093/nar/20.14.3737; Nashimoto M, 2000, FEBS LETT, V472, P179, DOI 10.1016/S0014-5793(00)01462-9; Nashimoto M, 1998, NUCLEIC ACIDS RES, V26, P2565, DOI 10.1093/nar/26.11.2565; NICHOLS WW, 1977, SCIENCE, V196, P60, DOI 10.1126/science.841339; Nolte-'t Hoen ENM, 2012, NUCLEIC ACIDS RES, V40, P9272, DOI 10.1093/nar/gks658; PENZIAS AA, 1965, ASTROPHYS J, V142, P419, DOI 10.1086/148307; Rutjes SK, 1999, J BIOL CHEM, V274, P24799, DOI 10.1074/jbc.274.35.24799; Sano T, 2011, BIOCHEM BIOPH RES CO, V416, P427, DOI 10.1016/j.bbrc.2011.11.091; SCHERER WF, 1953, J EXP MED, V97, P695, DOI 10.1084/jem.97.5.695; SCHNEIDER U, 1977, INT J CANCER, V19, P621, DOI 10.1002/ijc.2910190505; Shibata HS, 2005, J BIOL CHEM, V280, P22326, DOI 10.1074/jbc.M502048200; Sim S, 2011, WIRES RNA, V2, P686, DOI 10.1002/wrna.85; Takahashi M, 2014, LEUKEMIA RES, V38, P808, DOI 10.1016/j.leukres.2014.03.021; Takahashi M, 2013, CANCER LETT, V328, P362, DOI 10.1016/j.canlet.2012.10.016; Takahashi M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038496; Takaku H, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh092; Takaku H, 2004, NUCLEIC ACIDS RES, V32, P4429, DOI 10.1093/nar/gkh774; Takaku H, 2003, NUCLEIC ACIDS RES, V31, P2272, DOI 10.1093/nar/gkg337; Tamura M, 2003, NUCLEIC ACIDS RES, V31, P4354, DOI 10.1093/nar/gkg641; Thompson DM, 2009, CELL, V138, P215, DOI 10.1016/j.cell.2009.07.001; TOGAWA A, 1982, INT J CANCER, V29, P495, DOI 10.1002/ijc.2910290502; Tuck AC, 2011, TRENDS GENET, V27, P422, DOI 10.1016/j.tig.2011.06.001; Verhagen APM, 2011, BIOESSAYS, V33, P674, DOI 10.1002/bies.201100048; Watanabe N, 2013, LEUKEMIA RES, V37, P580, DOI 10.1016/j.leukres.2013.01.015; Zhang AT, 2011, J CELL SCI, V124, P2058, DOI 10.1242/jcs.086561	53	11	11	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2015	10	3							e0118631	10.1371/journal.pone.0118631	http://dx.doi.org/10.1371/journal.pone.0118631			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9JF	25730316	Green Published, gold, Green Submitted			2022-12-27	WOS:000350684900022
J	de Oliveira, LC; da Silva, VM; Colussi, F; Cabral, AD; Neto, MD; Squina, FM; Garcia, W				de Oliveira, Leandro C.; da Silva, Viviam M.; Colussi, Francieli; Cabral, Aline D.; de Oliveira Neto, Mario; Squina, Fabio M.; Garcia, Wanius			Conformational Changes in a Hyperthermostable Glycoside Hydrolase: Enzymatic Activity Is a Consequence of the Loop Dynamics and Protonation Balance	PLOS ONE			English	Article							RAY SOLUTION SCATTERING; BIOLOGICAL MACROMOLECULES; PROTEINS; PH; MODELS; FLEXIBILITY; PREDICTION; MANNANASES; ENERGY	Endo-beta-1, 4-mannanase from Thermotoga petrophila (TpMan) is a modular hyperthermostable enzyme involved in the degradation of mannan-containing polysaccharides. The degradation of these polysaccharides represents a key step for several industrial applications. Here, as part of a continuing investigation of TpMan, the region corresponding to the GH5 domain (TpManGH5) was characterized as a function of pH and temperature. The results indicated that the enzymatic activity of the TpManGH5 is pH-dependent, with its optimum activity occurring at pH 6. At pH 8, the studies demonstrated that TpManGH5 is a molecule with a nearly spherical tightly packed core displaying negligible flexibility in solution, and with size and shape very similar to crystal structure. However, TpManGH5 experiences an increase in radius of gyration in acidic conditions suggesting expansion of the molecule. Furthermore, at acidic pH values, TpManGH5 showed a less globular shape, probably due to a loop region slightly more expanded and flexible in solution (residues Y88 to A105). In addition, molecular dynamics simulations indicated that conformational changes caused by pH variation did not change the core of the TpManGH5, which means that only the above mentioned loop region presents high degree of fluctuations. The results also suggested that conformational changes of the loop region may facilitate polysaccharide and enzyme interaction. Finally, at pH 6 the results indicated that TpManGH5 is slightly more flexible at 65 degrees C when compared to the same enzyme at 20 degrees C. The biophysical characterization presented here is well correlated with the enzymatic activity and provide new insight into the structural basis for the temperature and pH-dependent activity of the TpManGH5. Also, the data suggest a loop region that provides a starting point for a rational design of biotechnological desired features.	[de Oliveira, Leandro C.] UNESP Univ Estadual Paulista, Dept Fis, Inst Biociencias Letras & Ciencias Exatas, Sao Jose Do Rio Preto, SP, Brazil; [da Silva, Viviam M.; Colussi, Francieli; Cabral, Aline D.; Garcia, Wanius] Univ Fed ABC UFABC, Ctr Ciencias Nat & Humanas, Santo Andre, SP, Brazil; [de Oliveira Neto, Mario] UNESP Univ Estadual Paulista, Inst Biociencias, Dept Fis & Biofis, Botucatu, SP, Brazil; [Squina, Fabio M.] Ctr Nacl Pesquisa Energia & Mat, Lab Nacl Ciencia & Tecnol Bioetanol, Campinas, SP, Brazil	Universidade Estadual Paulista; Universidade Federal do ABC (UFABC); Universidade Estadual Paulista	Garcia, W (corresponding author), Univ Fed ABC UFABC, Ctr Ciencias Nat & Humanas, Santo Andre, SP, Brazil.	wanius.garcia@ufabc.edu.br	Cabral, Aline Diniz/M-5779-2018; Neto, Mario Oliveira/F-2717-2013; Oliveira, Leandro Cristante de/F-8638-2012; Silva, Wanius J. G./L-3948-2016; Squina, Fabio/J-8130-2012; Cabral, Aline Diniz/Q-8650-2019; Colussi, Francieli/J-9166-2016	Cabral, Aline Diniz/0000-0002-9439-4463; Oliveira, Leandro Cristante de/0000-0002-6932-6792; Squina, Fabio/0000-0002-8154-7459; Cabral, Aline Diniz/0000-0002-9439-4463; Oliveira Neto, Mario/0000-0002-6226-7419; Colussi, Francieli/0000-0002-4392-767X	Fundacao de Amparo a pesquisa do Estado de Sao Paulo (FAPESP); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [2011/13242-7, 2012/21054-9, 478900/2012-0, 2008/58037-9];  [2012/03503-0];  [501037/2012-8]	Fundacao de Amparo a pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); ; 	The authors would like to thank Fundacao de Amparo a pesquisa do Estado de Sao Paulo (FAPESP) and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) for the financial support for this work via grants #2011/13242-7, #2012/21054-9, #478900/2012-0, #2008/58037-9 and #2011/13242-7; and fellowships #2012/03503-0 (VMS) and #501037/2012-8 (FC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bu LT, 2013, J BIOL CHEM, V288, P12175, DOI 10.1074/jbc.M113.462465; Chang MCY, 2007, CURR OPIN CHEM BIOL, V11, P677, DOI 10.1016/j.cbpa.2007.08.039; Colussi F, 2012, EUR BIOPHYS J BIOPHY, V41, P89, DOI 10.1007/s00249-011-0762-8; Cota J, 2011, BIOCHEM BIOPH RES CO, V406, P590, DOI 10.1016/j.bbrc.2011.02.098; Dhawan S, 2007, CRIT REV BIOTECHNOL, V27, P197, DOI 10.1080/07388550701775919; Dolinsky TJ, 2004, NUCLEIC ACIDS RES, V32, pW665, DOI 10.1093/nar/gkh381; dos Santos CR, 2011, BIOTECHNOL LETT, V33, P131, DOI 10.1007/s10529-010-0409-3; Durand D, 2010, J STRUCT BIOL, V169, P45, DOI 10.1016/j.jsb.2009.08.009; Gasteiger E, 2003, NUCLEIC ACIDS RES, V31, P3784, DOI 10.1093/nar/gkg563; Girio FM, 2010, BIORESOURCE TECHNOL, V101, P4775, DOI 10.1016/j.biortech.2010.01.088; Hall M, 2011, J BIOTECHNOL, V155, P370, DOI 10.1016/j.jbiotec.2011.07.016; Jachimska B, 2008, LANGMUIR, V24, P6866, DOI 10.1021/la800548p; Jamros MA, 2010, J BIOL CHEM, V285, P36121, DOI 10.1074/jbc.M110.116947; Jenik M, 2012, NUCLEIC ACIDS RES, V40, pW348, DOI 10.1093/nar/gks447; Kozin MB, 2001, J APPL CRYSTALLOGR, V34, P33, DOI 10.1107/S0021889800014126; KUMAR S, 1992, J COMPUT CHEM, V13, P1011, DOI 10.1002/jcc.540130812; Li H, 2005, PROTEINS, V61, P704, DOI 10.1002/prot.20660; Lima MA, 2013, BIOTECHNOL BIOFUELS, V6, DOI 10.1186/1754-6834-6-75; MILLER GL, 1959, ANAL CHEM, V31, P426, DOI 10.1021/ac60147a030; Montiel MD, 2002, APPL MICROBIOL BIOT, V58, P67, DOI 10.1007/s00253-001-0866-7; Moreira LRS, 2008, APPL MICROBIOL BIOT, V79, P165, DOI 10.1007/s00253-008-1423-4; Noel JK, 2012, J PHYS CHEM B, V116, P8692, DOI 10.1021/jp300852d; Noel JK, 2010, NUCLEIC ACIDS RES, V38, pW657, DOI 10.1093/nar/gkq498; Pelikan M, 2009, GEN PHYSIOL BIOPHYS, V28, P174, DOI 10.4149/gpb_2009_02_174; Pingali SV, 2011, J BIOL CHEM, V286, P32801, DOI 10.1074/jbc.M111.263004; Polizeli MLTM, 2005, APPL MICROBIOL BIOT, V67, P577, DOI 10.1007/s00253-005-1904-7; Rambo RP, 2011, BIOPOLYMERS, V95, P559, DOI 10.1002/bip.21638; Rezende CA, 2011, BIOTECHNOL BIOFUELS, V4, P1, DOI 10.1186/1754-6834-4-54; Saha BC, 2003, J IND MICROBIOL BIOT, V30, P279, DOI 10.1007/s10295-003-0049-x; Santiago PS, 2010, LANGMUIR, V26, P9794, DOI 10.1021/la100060p; SANTOS CR, 2012, J STRUCT BIOL, V177, P469, DOI DOI 10.1016/J.JSB.2011.11.021; Silva V.M., 2014, PLOS ONE, V9, DOI DOI 10.1371/JOURNAL.PONE.0092996; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Svergun DI, 2001, BIOPHYS J, V80, P2946, DOI 10.1016/S0006-3495(01)76260-1; Takahata Y, 2001, INT J SYST EVOL MICR, V51, P1901, DOI 10.1099/00207713-51-5-1901; Tenkanen M, 1997, J BIOTECHNOL, V57, P191, DOI 10.1016/S0168-1656(97)00099-0; van Zyl WH, 2010, PROCESS BIOCHEM, V45, P1203, DOI 10.1016/j.procbio.2010.05.011; VansDer Spoel D., 2005, J COMPUT CHEM, V26, P1701; Volkamer A, 2010, J CHEM INF MODEL, V50, P2041, DOI 10.1021/ci100241y; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; Whitford PC, 2009, PROTEINS, V75, P430, DOI 10.1002/prot.22253	42	29	31	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2015	10	2							e0118225	10.1371/journal.pone.0118225	http://dx.doi.org/10.1371/journal.pone.0118225			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC3LS	25723179	Green Published, gold, Green Submitted			2022-12-27	WOS:000350251200050
J	Merves, J; Chandramouleeswaran, PM; Benitez, AJ; Muir, AB; Lee, AJ; Lim, DM; Dods, K; Mehta, I; Ruchelli, ED; Nakagawa, H; Spergel, JM; Wang, ML				Merves, Jamie; Chandramouleeswaran, Prasanna Modayur; Benitez, Alain J.; Muir, Amanda B.; Lee, Anna J.; Lim, Diana M.; Dods, Kara; Mehta, Isha; Ruchelli, Eduardo D.; Nakagawa, Hiroshi; Spergel, Jonathan M.; Wang, Mei-Lun			Altered Esophageal Histamine Receptor Expression in Eosinophilic Esophagitis (EoE): Implications on Disease Pathogenesis	PLOS ONE			English	Article							COLONY-STIMULATING FACTOR; THYMIC STROMAL LYMPHOPOIETIN; PROTEIN-KINASE-C; H-4 RECEPTOR; EPITHELIAL-CELL; AIRWAY INFLAMMATION; H4 RECEPTOR; MAST-CELLS; IN-VITRO; GM-CSF	Eosinophilic Esophagitis (EoE) is a chronic allergic disorder, whose pathobiology is incompletely understood. Histamine-producing cells including mast cells and basophils have been implicated in EoE. However, very little is currently known about the role of histamine and histamine receptor (HR) expression and signaling in the esophageal epithelium. Herein, we characterized HR (H1R, H2R, H3R, and H4R) expression in human esophageal biopsies and investigate the role of histamine signaling in inducible cytokine expression in human esophageal epithelial cells in vitro. HR expression was quantified in esophageal biopsies from non-EoE control (N = 23), inactive EoE (<15 eos/hpf, N = 26) and active EoE (>15 eos/hpf, N = 22) subjects using qRT-PCR and immunofluorescent localization. HR expression and histamine-mediated cytokine secretion were evaluated in human primary and telomerase-immortalized esophageal epithelial cells. H1R, H2R, and H4R expression were increased in active EoE biopsies compared to inactive EoE and controls. H2R was the most abundantly expressed receptor, and H3R expression was negligible in all 3 cohorts. Infiltrating eosinophils expressed H1R, H2R, and H4R, which contributed to the observed increase in HR in active subjects. H1R and H2R, but not H3R or H4R, were constitutively expressed by primary and immortalized cells, and epithelial histamine stimulation induced GM-CSF, TNF alpha, and IL-8, but not TSLP or eotaxin-3 secretion. Epithelial priming with the TLR3 ligand poly (I:C) induced H1R and H2R expression, and enhanced histamine-induced GM-CSF, TNF alpha, and IL-8 secretion. These effects were primarily suppressed by H1R antagonists, but unaffected by H2R antagonism. Histamine directly activates esophageal epithelial cytokine secretion in vitro in an H1R dependent fashion. However, H1R, H2R and H4R are induced in active inflammation in EoE in vivo. While systemic antihistamine (anti-H1R) therapy may not induce clinical remission in EoE, our study suggests that further study of histamine receptor signaling in EoE is warranted and that targeting of additional histamine receptors may lead to novel treatment strategies for this important disease.	[Merves, Jamie; Chandramouleeswaran, Prasanna Modayur; Benitez, Alain J.; Muir, Amanda B.; Lee, Anna J.; Lim, Diana M.; Dods, Kara; Mehta, Isha; Wang, Mei-Lun] Childrens Hosp Philadelphia, Div Gastroenterol Hepatol & Nutr, Philadelphia, PA 19104 USA; [Spergel, Jonathan M.] Childrens Hosp Philadelphia, Div Allergy & Immunol, Philadelphia, PA 19104 USA; [Ruchelli, Eduardo D.] Childrens Hosp Philadelphia, Div Pathol, Philadelphia, PA 19104 USA; [Merves, Jamie; Muir, Amanda B.; Spergel, Jonathan M.; Wang, Mei-Lun] Univ Penn, Dept Pediat, Perelman Sch Med, Philadelphia, PA 19104 USA; [Nakagawa, Hiroshi] Univ Penn, Dept Gastroenterol Hepatol & Nutr, Perelman Sch Med, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine	Wang, ML (corresponding author), Childrens Hosp Philadelphia, Div Gastroenterol Hepatol & Nutr, Philadelphia, PA 19104 USA.	wangm@email.chop.edu		Spergel, Jonathan/0000-0002-4658-5353	National Institutes of Health (NIH) [R01-DK087789, F32-DK100088]; Hope Award, American Partnership for Eosinophilic Disorders (APFED); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [F32DK100088, R01DK087789] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Hope Award, American Partnership for Eosinophilic Disorders (APFED); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The work was supported by the following: R01-DK087789 (to MLW), National Institutes of Health (NIH); Hope Award (to MLW), American Partnership for Eosinophilic Disorders (APFED); and F32-DK100088 (to ABM), National Institutes of Health (NIH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abonia JP, 2010, J ALLERGY CLIN IMMUN, V126, P140, DOI 10.1016/j.jaci.2010.04.009; Aceves SS, 2010, J ALLERGY CLIN IMMUN, V126, P1198, DOI 10.1016/j.jaci.2010.08.050; Alonso N, 2013, MOL PHARMACOL, V83, P1087, DOI 10.1124/mol.112.083394; Amerongen GPV, 1998, CIRC RES, V83, P1115, DOI 10.1161/01.RES.83.11.1115; Amin K, 2012, RESP MED, V106, P9, DOI 10.1016/j.rmed.2011.09.007; BEGLEY CG, 1986, BLOOD, V68, P162; Blanchard C, 2011, J ALLERGY CLIN IMMUN, V127, P208, DOI 10.1016/j.jaci.2010.10.039; Blatman KSH, 2011, J ALLERGY CLIN IMMUN, V127, P1307, DOI 10.1016/j.jaci.2010.12.1118; Bryce PJ, 2006, J CLIN INVEST, V116, P1624, DOI 10.1172/JCI26150; Cheng E, 2013, GUT, V62, P824, DOI 10.1136/gutjnl-2012-302250; Chhabra J, 2007, EUR RESPIR J, V29, P861, DOI 10.1183/09031936.00106306; Ciebiada M, 2014, AM J RHINOL ALLERGY, V28, pE130, DOI 10.2500/ajra.2014.28.4048; Clayton F, 2014, GASTROENTEROLOGY, V147, P602, DOI 10.1053/j.gastro.2014.05.036; Cowden JM, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-86; Dellon ES, 2014, CLIN GASTROENTEROL H, V12, P589, DOI 10.1016/j.cgh.2013.09.008; Dinh QT, 2005, CLIN EXP ALLERGY, V35, P1443, DOI 10.1111/j.1365-2222.2005.02359.x; ERGER RA, 1995, AM J PHYSIOL-LUNG C, V268, pL117, DOI 10.1152/ajplung.1995.268.1.L117; Gavala ML, 2013, CURR ALLERGY ASTHM R, V13, P298, DOI 10.1007/s11882-013-0344-1; Giustizieri ML, 2004, J ALLERGY CLIN IMMUN, V114, P1176, DOI 10.1016/j.jaci.2004.07.054; Grandi D, 2006, EUR J PHARMACOL, V538, P141, DOI 10.1016/j.ejphar.2006.03.049; Gschwandtner M, 2013, ALLERGY, V68, P37, DOI 10.1111/all.12051; Gutzmer R, 2009, J ALLERGY CLIN IMMUN, V123, P619, DOI 10.1016/j.jaci.2008.12.1110; Handley SA, 2006, P NATL ACAD SCI USA, V103, P9268, DOI 10.1073/pnas.0510414103; Jutel M, 2002, CURR OPIN IMMUNOL, V14, P735, DOI 10.1016/S0952-7915(02)00395-3; Jutel M, 2009, CLIN EXP ALLERGY, V39, P1786, DOI 10.1111/j.1365-2222.2009.03374.x; Jyonouchi S, 2011, J ALLERGY CLIN IMMUN, V128, P102, DOI 10.1016/j.jaci.2011.02.026; Kanda N, 2004, J INVEST DERMATOL, V122, P863, DOI 10.1111/j.0022-202X.2004.22432.x; Kim JH, 2013, ANN ALLERG ASTHMA IM, V111, P508, DOI 10.1016/j.anai.2013.08.024; Liacouras C, 2011, J ALLERGY CLIN IMMUN, V128, P3, DOI 10.1016/j.jaci.2011.02.040; Lim DM, 2009, AM J PHYSIOL-GASTR L, V297, pG1172, DOI 10.1152/ajpgi.00065.2009; Ling P, 2004, BRIT J PHARMACOL, V142, P161, DOI 10.1038/sj.bjp.0705729; Loniewski K, 2008, MOL IMMUNOL, V45, P2312, DOI 10.1016/j.molimm.2007.11.012; LOPEZ AF, 1986, J CLIN INVEST, V78, P1220, DOI 10.1172/JCI112705; Matsubara M, 2005, BIOCHEM PHARMACOL, V69, P433, DOI 10.1016/j.bcp.2004.10.006; Merves J, 2014, ANN ALLERG ASTHMA IM, V112, P397, DOI 10.1016/j.anai.2014.01.023; Mirzahosseini A, 2015, CYTOM PART A, V87A, P23, DOI 10.1002/cyto.a.22566; Mishra A, 2009, IMMUNOL ALLERGY CLIN, V29, P29, DOI 10.1016/j.iac.2008.09.010; Muller T, 2006, INT J MOL MED, V18, P925; Muir AB, 2013, EXP CELL RES, V319, P850, DOI 10.1016/j.yexcr.2012.12.002; Mulder DJ, 2012, DIGEST DIS SCI, V57, P630, DOI 10.1007/s10620-011-1907-4; Noti M, 2013, NAT MED, V19, P1005, DOI 10.1038/nm.3281; Ohsawa Y, 2012, ALLERGY, V67, P1014, DOI 10.1111/j.1398-9995.2012.02854.x; Otani IM, 2013, J ALLERGY CLIN IMMUN, V131, P1576, DOI 10.1016/j.jaci.2013.02.042; OWEN WF, 1987, J EXP MED, V166, P129, DOI 10.1084/jem.166.1.129; Plager DA, 2006, J IMMUNOL, V177, P7340, DOI 10.4049/jimmunol.177.10.7340; Raveendran VV, 2011, IMMUNOLOGY, V132, P578, DOI 10.1111/j.1365-2567.2010.03403.x; Rothenberg ME, 2010, NAT GENET, V42, P289, DOI 10.1038/ng.547; Sander LE, 2006, GUT, V55, P498, DOI 10.1136/gut.2004.061762; Seike M, 2010, ALLERGY, V65, P319, DOI 10.1111/j.1398-9995.2009.02240.x; Sherrill JD, 2010, J ALLERGY CLIN IMMUN, V126, P160, DOI 10.1016/j.jaci.2010.04.037; Simons FER, 2011, J ALLERGY CLIN IMMUN, V128, P1139, DOI 10.1016/j.jaci.2011.09.005; Siracusa MC, 2013, J ALLERGY CLIN IMMUN, V132, P789, DOI 10.1016/j.jaci.2013.07.046; Somma T, 2013, BRIT J PHARMACOL, V170, P200, DOI 10.1111/bph.12264; Straumann A, 2001, J ALLERGY CLIN IMMUN, V108, P954, DOI 10.1067/mai.2001.119917; TANIMOTO Y, 1992, CLIN EXP ALLERGY, V22, P1020, DOI 10.1111/j.1365-2222.1992.tb03031.x; Taylor-Clark T, 2005, BRIT J PHARMACOL, V144, P867, DOI 10.1038/sj.bjp.0706118; Terada N, 1999, CLIN EXP ALLERGY, V29, P52; Thurmond RL, 2008, NAT REV DRUG DISCOV, V7, P41, DOI 10.1038/nrd2465; VANNIER E, 1991, J EXP MED, V174, P281, DOI 10.1084/jem.174.1.281; Varga C, 2005, EUR J PHARMACOL, V522, P130, DOI 10.1016/j.ejphar.2005.08.045; Yamaura K, 2009, J TOXICOL SCI, V34, P427, DOI 10.2131/jts.34.427; Yu SY, 2008, LIFE SCI, V82, P324, DOI 10.1016/j.lfs.2007.12.002; Zampeli E, 2009, BRIT J PHARMACOL, V157, P24, DOI 10.1111/j.1476-5381.2009.00151.x	63	19	19	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2015	10	2							e0114831	10.1371/journal.pone.0114831	http://dx.doi.org/10.1371/journal.pone.0114831			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC3LS	25723478	Green Submitted, Green Published, gold			2022-12-27	WOS:000350251200003
J	Shen, W; Zhang, B; Liu, SY; Wu, HL; Gu, X; Qin, LZ; Tian, P; Zeng, Y; Ye, LX; Ni, ZM; Wang, Q				Shen, Wei; Zhang, Bin; Liu, Shuyun; Wu, Hongling; Gu, Xue; Qin, Lingzhi; Tian, Ping; Zeng, Yun; Ye, Linxiang; Ni, Zemin; Wang, Qi			Association of Blood Lead Levels with Methylenetetrahydrofolate Reductase Polymorphisms among Chinese Pregnant Women in Wuhan City	PLOS ONE			English	Article							BONE-MINERAL DENSITY; GENETIC POLYMORPHISMS; HOMOCYSTEINE LEVELS; C677T POLYMORPHISM; POSTMENOPAUSAL WOMEN; CALCIUM HOMEOSTASIS; COMMON MUTATION; MATERNAL BLOOD; PLASMA FOLATE; RISK-FACTOR	Background Pregnancy is an important stimulus of bone lead release. Elevated blood lead levels (BLLs) may cause adverse pregnancy outcomes for mothers and harmful lead effects on fetuses. However, the reports about maternal BLL changes during pregnancy are conflicting to some extent. This article is to explore the variations in BLLs among pregnant women. The relationships of BLLs with methylenetetrahydrofolate reductase (MTHFR) gene C677T, A1298C, and G1793A polymorphisms, which are associated with bone resorption, were also studied. A total of 973 women, including 234, 249, and 248 women in their first, second, and third trimesters, respectively, and 242 non-pregnant women, were recruited at the Wuhan Women and Children Medical Health Center. Methods BLLs were determined using a graphite furnace atomic absorption spectrometer. Single-nucleotide polymorphisms of MTHFR were identified with the TaqMan probe method. Results The geometric mean (geometric standard deviation) of BLLs was 16.2 (1.78) mu g/L for all participants. All the studied MTHFR alleles were in Hardy-Weinberg equilibrium. Multiple-linear regression analysis revealed the following results. Among the pregnant women, those that carried MTHFR 677CC (i.e. wild-genotype homozygote) and 1298CC (i.e. mutant-genotype homozygote) exhibited higher BLLs than those that carried 677CT/TT (standardized beta= 0.074, P = 0.042) and 1298AC/AA (standardized beta= 0.077, P = 0.035) when other covariates (e.g., age, no. of children, education and income, etc.) were adjusted. The BLLs of pregnant women consistently decreased during the pregnancy and these levels positively correlated with BMI (standard beta = 0.086-0.096, P< 0.05). Conclusions The 1298CC mutant-type homozygote in the MTHFR gene is a risk factor for high BLLs among low-level environmental lead-exposed Chinese pregnant women, whose BLLs consistently decreased during gestation.	[Shen, Wei; Liu, Shuyun; Gu, Xue; Zeng, Yun; Ye, Linxiang; Wang, Qi] Huazhong Univ Sci & Technol, Tongji Med Coll, Dept Epidemiol & Biostat, MOE Key Lab Environm & Hlth,Sch Publ Hlth, Wuhan 430030, Peoples R China; [Zhang, Bin; Wu, Hongling; Qin, Lingzhi; Tian, Ping] Wuhan Women & Children Med Care Ctr, Wuhan 430016, Peoples R China; [Ni, Zemin] Women & Children Med Ctr Jiang An Dist, Wuhan 430017, Peoples R China	Huazhong University of Science & Technology	Wang, Q (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll, Dept Epidemiol & Biostat, MOE Key Lab Environm & Hlth,Sch Publ Hlth, Wuhan 430030, Peoples R China.	wangqi_tj@hust.edu.cn			Natural Science Foundation of China [81102185]; Huazhong University of Science and Technology [2011QN202, 2014TS048]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Huazhong University of Science and Technology	The work has been funded by the Natural Science Foundation of China (Grant no. 81102185), and Huazhong University of Science and Technology (Grant nos. 2011QN202 and 2014TS048). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahamsen B, 2003, J BONE MINER RES, V18, P723, DOI 10.1359/jbmr.2003.18.4.723; [Anonymous], 1991, CDC PREV LEAD POIS Y, P1; BARRY PSI, 1970, BRIT J IND MED, V27, P339; Black AJ, 2000, J BONE MINER RES, V15, P557, DOI 10.1359/jbmr.2000.15.3.557; Bottiger AK, 2007, INT J MOL MED, V19, P659; Chia SE, 2007, OCCUP ENVIRON MED, V64, P688, DOI 10.1136/oem.2006.030882; CLEVELAND LM, 2008, AM J NURS, V108, P40, DOI DOI 10.1097/01.NAJ.0000341887.92446.78; Cortese C, 2001, Public Health Nutr, V4, P493; CROSS NA, 1995, AM J CLIN NUTR, V61, P514, DOI 10.1093/ajcn/61.3.514; de Bree A, 2003, AM J CLIN NUTR, V77, P687, DOI 10.1093/ajcn/77.3.687; FROSST P, 1995, NAT GENET, V10, P111, DOI 10.1038/ng0595-111; Golbahar J, 2004, BONE, V35, P760, DOI 10.1016/j.bone.2004.04.018; GOYER RA, 1990, ENVIRON HEALTH PERSP, V89, P101, DOI 10.2307/3430905; Gueant-Rodriguez RM, 2006, AM J CLIN NUTR, V83, P701, DOI 10.1093/ajcn.83.3.701; Guenther BD, 1999, NAT STRUCT BIOL, V6, P359, DOI 10.1038/7594; Gulson BL, 2003, SCI TOTAL ENVIRON, V303, P79, DOI 10.1016/S0048-9697(02)00355-8; GULSON BL, 1995, J LAB CLIN MED, V125, P703; He KM, 2009, SCI TOTAL ENVIRON, V407, P3986, DOI 10.1016/j.scitotenv.2009.03.018; Hertz-Picciotto I, 2000, AM J EPIDEMIOL, V152, P829, DOI 10.1093/aje/152.9.829; Hong XM, 2007, BONE, V40, P737, DOI 10.1016/j.bone.2006.09.031; Huemer M, 2005, EPILEPSIA, V46, P1677, DOI 10.1111/j.1528-1167.2005.00264.x; HYTTEN F, 1985, CLIN HAEMATOL, V14, P601; Isotalo PA, 2000, AM J HUM GENET, V67, P986, DOI 10.1086/303082; Jedrychowski W, 2009, NEUROEPIDEMIOLOGY, V32, P270, DOI 10.1159/000203075; Jedrychowski Wieslaw, 2006, International Journal of Occupational Medicine and Environmental Health, V19, P205, DOI 10.2478/v10001-006-0034-5; Jorgensen HL, 2002, CALCIFIED TISSUE INT, V71, P386, DOI 10.1007/s00223-001-2126-3; Khan M, 2001, BONE, V28, P387, DOI 10.1016/S8756-3282(01)00409-4; Lagerkvist BJ, 1996, AM J PUBLIC HEALTH, V86, P1247, DOI 10.2105/AJPH.86.9.1247; Li M, 2004, BONE, V35, P1369, DOI 10.1016/j.bone.2004.09.008; Li M, 2013, AC ANN C CHIN SOC EN, P6304; Lubec B, 1996, BBA-MOL BASIS DIS, V1315, P159, DOI 10.1016/0925-4439(95)00119-0; Lucas SR, 1996, PEDIATRICS, V97, P74; Manton WI, 2003, ENVIRON RES, V92, P139, DOI 10.1016/S0013-9351(03)00020-3; Markowitz ME, 2001, ENVIRON RES, V85, P83, DOI 10.1006/enrs.2000.4117; MCMICHAEL AJ, 1986, J EPIDEMIOL COMMUN H, V40, P18, DOI 10.1136/jech.40.1.18; Miyao M, 2000, CALCIFIED TISSUE INT, V66, P190, DOI 10.1007/s002230010038; Moura M, 2002, SCI TOTAL ENVIRON, V299, P123, DOI 10.1016/S0048-9697(02)00255-3; Polanska K, 2014, ANN AGR ENV MED, V21, P49; Rady PL, 2002, AM J MED GENET, V107, P162, DOI 10.1002/ajmg.10122; Rosenberg N, 2002, AM J HUM GENET, V70, P758, DOI 10.1086/338932; ROTHENBERG SJ, 1994, ENVIRON HEALTH PERSP, V102, P876, DOI 10.2307/3432121; Rothenberg SJ, 2000, ENVIRON RES, V82, P81, DOI 10.1006/enrs.1999.4007; Schafer JH, 2005, ENVIRON HEALTH PERSP, V113, P31, DOI 10.1289/ehp.7369; Schell LM, 2000, ARCH ENVIRON HEALTH, V55, P134, DOI 10.1080/00039890009603400; Sowers M, 2002, ARCH ENVIRON HEALTH, V57, P489, DOI 10.1080/00039890209601442; Tellez-Rojo MM, 2004, AM J EPIDEMIOL, V160, P668, DOI 10.1093/aje/kwh271; Vacek TP, 2013, CLIN CHEM LAB MED, V51, P579, DOI 10.1515/cclm-2012-0605; van der Put NMJ, 1998, AM J HUM GENET, V62, P1044, DOI 10.1086/301825; van Meurs JBJ, 2004, NEW ENGL J MED, V350, P2033, DOI 10.1056/NEJMoa032546; Weisberg I, 1998, MOL GENET METAB, V64, P169, DOI 10.1006/mgme.1998.2714; Weisberg IS, 2001, ATHEROSCLEROSIS, V156, P409, DOI 10.1016/S0021-9150(00)00671-7; WHITING SJ, 1981, J NUTR, V111, P1721, DOI 10.1093/jn/111.10.1721; Xu WH, 2007, CANCER EPIDEM BIOMAR, V16, P281, DOI 10.1158/1055-9965.EPI-06-0798; Yamada K, 2001, P NATL ACAD SCI USA, V98, P14853, DOI 10.1073/pnas.261469998; Yamaga A, 1996, J CLIN ENDOCR METAB, V81, P752, DOI 10.1210/jc.81.2.752; Yamaga A, 1997, ENDOCR J, V44, P733, DOI 10.1507/endocrj.44.733; Zhou A, 2007, MATERN CHILD HLTH J, V22, P1670, DOI [10.1371/journal.pone.0116796, DOI 10.1371/JOURNAL.PONE.0116796]	57	2	2	3	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2015	10	2							e0117366	10.1371/journal.pone.0117366	http://dx.doi.org/10.1371/journal.pone.0117366			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC3LS	25723397	Green Submitted, Green Published, gold			2022-12-27	WOS:000350251200030
J	Pijanka, JK; Spang, MT; Sorensen, T; Liu, J; Nguyen, TD; Quigley, HA; Boote, C				Pijanka, Jacek K.; Spang, Martin T.; Sorensen, Thomas; Liu, Jun; Nguyen, Thao D.; Quigley, Harry A.; Boote, Craig			Depth-Dependent Changes in Collagen Organization in the Human Peripapillary Sclera	PLOS ONE			English	Article							OPTIC-NERVE HEAD; HUMAN POSTERIOR SCLERA; HUMAN LAMINA-CRIBROSA; HUMAN CORNEA; EXTRACELLULAR-MATRIX; FIBER ORIENTATION; GLAUCOMA; EYES; AGE; BIOMECHANICS	Purpose The collagen structure of the human peripapillary sclera plays a significant role in determining optic nerve head (ONH) biomechanics, and is therefore of interest in the study of glaucoma. The aim of the current work was to map the anisotropic collagen structure of the normal human peripapillary sclera as a function of tissue depth. Methods Wide-angle x-ray scattering was used to quantify collagen fibril orientation at 0.5mm intervals across six 150 mu m -thick serial sections through the peripapillary sclera of eight normal European-derived human eyes. Two structural parameters were measured: 1) the relative number of fibrils preferentially aligned at a given angle within the tissue plane, 2) the degree of collagen alignment (anisotropy). Results The inner-most one-third of the peripapillary scleral stroma (nearest to the choroid) was characterised by collagen fibrils either randomly arranged or preferentially aligned radially with respect to the ONH. In contrast, the outer two-thirds of the tissue was dominated by a circumferential arrangement of collagen encircling the ONH. In all tissue regions the degree of collagen anisotropy peaked in the mid-stroma and progressively decreased towards the tissue surfaces, with the largest depth variations occurring in the inferior-nasal quadrant, and the smallest occurring in the superior-nasal quadrant. Conclusions Significant, region-specific variations in collagen structure are present in the human peripapillary sclera as a function of depth. In normal eyes, the circumferential collagen fibril architecture is most prominent in the outer two-thirds of the stroma, possibly as a mechanical adaption to more effectively support the lamina cribrosa at the level of its insertion into the scleral canal wall.	[Pijanka, Jacek K.; Spang, Martin T.; Boote, Craig] Cardiff Univ, Sch Optometry & Vis Sci, Struct Biophys Grp, Cardiff CF10 3AX, S Glam, Wales; [Sorensen, Thomas] Diamond Light Source, Didcot, Oxon, England; [Liu, Jun] Ohio State Univ, Dept Biomed Engn, Columbus, OH 43210 USA; [Nguyen, Thao D.] Johns Hopkins Univ, Dept Mech Engn, Baltimore, MD 21218 USA; [Quigley, Harry A.] Johns Hopkins Univ, Sch Med, Wilmer Ophthalmol Inst, Glaucoma Ctr Excellence, Baltimore, MD 21205 USA	Cardiff University; Diamond Light Source; University System of Ohio; Ohio State University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins Medicine	Boote, C (corresponding author), Cardiff Univ, Sch Optometry & Vis Sci, Struct Biophys Grp, Cardiff CF10 3AX, S Glam, Wales.	bootec@cardiff.ac.uk	Spang, Martin T/L-3680-2016; Sørensen, Thomas Lykke-Møller/AAA-7052-2020; Nguyen, Thao/A-3391-2010	Spang, Martin T/0000-0002-8155-6240; Sorensen, Thomas Lykke-Moller/0000-0003-3873-3499; Liu, Jun/0000-0001-5984-4169; Nguyen, Thao/0000-0002-0312-1583; Boote, Craig/0000-0003-0348-6547	Fight For Sight [1360]; National Institutes of Health [EY02120, EY01765, EY021500]; Diamond Light Source Ltd; MRC [MR/K000837/1] Funding Source: UKRI; Medical Research Council [MR/K000837/1] Funding Source: researchfish; Fight for Sight [1359/60] Funding Source: researchfish; NATIONAL EYE INSTITUTE [R01EY002120, R01EY021500, P30EY001765, R56EY002120] Funding Source: NIH RePORTER	Fight For Sight; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Diamond Light Source Ltd; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Fight for Sight; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by the Fight For Sight Grant 1360 (to CB), National Institutes of Health Grants EY02120, EY01765 (to HAQ) and EY021500 (to TDN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. One of the authors (Dr. T. Sorensen) is employed by Diamond Light Source Ltd. Diamond Light Source Ltd provided support in the form of salary for author TS, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the	Boote C, 2006, INVEST OPHTH VIS SCI, V47, P901, DOI 10.1167/iovs.05-0893; Boote C, 2005, J STRUCT BIOL, V149, P1, DOI 10.1016/j.jsb.2004.08.009; Coudrillier B, 2013, BIOMECH MODEL MECHAN, V12, P941, DOI 10.1007/s10237-012-0455-y; Coudrillier B, 2012, INVEST OPHTH VIS SCI, V53, P1714, DOI 10.1167/iovs.11-8009; Danford FL, 2013, INVEST OPHTH VIS SCI, V54, P7922, DOI 10.1167/iovs.13-12262; Girard MJA, 2011, INVEST OPHTH VIS SCI, V52, P9684, DOI 10.1167/iovs.11-7894; Girard MJA, 2009, J BIOMECH ENG-T ASME, V131, DOI 10.1115/1.3113682; Grytz R, 2014, J MECH BEHAV BIOMED, V29, P602, DOI 10.1016/j.jmbbm.2013.03.027; Kokott W., 1934, KLIN MONATSBL TTER F, V92, P177; KOMAI Y, 1991, INVEST OPHTH VIS SCI, V32, P2244; Kotecha A, 2006, BRIT J OPHTHALMOL, V90, P1531, DOI 10.1136/bjo.2006.100388; Lanir Y, 2009, J BIOMECH ENG-T ASME, V131, DOI 10.1115/1.3049863; Liu J, 2013, ARVO, V54, P77; McBrien NA, 2009, OPTOMETRY VISION SCI, V86, P23, DOI 10.1097/OPX.0b013e3181940669; Meek KM, 2009, PROG RETIN EYE RES, V28, P369, DOI 10.1016/j.preteyeres.2009.06.005; Morris HJ, 2013, INVEST OPHTH VIS SCI, V54, P7215, DOI 10.1167/iovs.13-12441; MORRISON JC, 1989, ARCH OPHTHALMOL-CHIC, V107, P123, DOI 10.1001/archopht.1989.01070010125040; Pijanka JK, 2012, INVEST OPHTH VIS SCI, V53, P5258, DOI 10.1167/iovs.12-9705; Pijanka JK, 2013, J APPL CRYSTALLOGR, V46, P1481, DOI 10.1107/S0021889813022358; QUIGLEY HA, 1991, CURR EYE RES, V10, P877, DOI 10.3109/02713689109013884; QUIGLEY HA, 1991, BRIT J OPHTHALMOL, V75, P552, DOI 10.1136/bjo.75.9.552; QUIGLEY HA, 1981, ARCH OPHTHALMOL-CHIC, V99, P635, DOI 10.1001/archopht.1981.03930010635009; Rada JAS, 2006, EXP EYE RES, V82, P185, DOI 10.1016/j.exer.2005.08.009; Ren RJ, 2009, INVEST OPHTH VIS SCI, V50, P2175, DOI 10.1167/iovs.07-1429; Sigal IA, 2012, INVEST OPHTH VIS SCI, V53, P6870, DOI 10.1167/iovs.12-9890; Sigal IA, 2010, EXP EYE RES, V90, P70, DOI 10.1016/j.exer.2009.09.013; Tang JH, 2012, J BIOMECH ENG-T ASME, V134, DOI 10.1115/1.4007365; Tektas OY, 2010, INVEST OPHTH VIS SCI, V51, P5083, DOI 10.1167/iovs.09-5101; Wang L, 2012, ARVO, V53, P2814; Watson PG, 2004, EXP EYE RES, V78, P609, DOI 10.1016/S0014-4835(03)00212-4; Winkler M, 2010, BRAIN RES BULL, V81, P339, DOI 10.1016/j.brainresbull.2009.06.001; Wolff E, 1968, ANATOMY EYE ORBIT; Yamamoto S, 2000, ARCH HISTOL CYTOL, V63, P127, DOI 10.1679/aohc.63.127; Yan DM, 2011, INVEST OPHTH VIS SCI, V52, P821, DOI 10.1167/iovs.09-4651	34	24	24	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2015	10	2							e0118648	10.1371/journal.pone.0118648	http://dx.doi.org/10.1371/journal.pone.0118648			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC2IM	25714753	gold, Green Published, Green Accepted, Green Submitted			2022-12-27	WOS:000350168700093
J	Siedlecka, E; Capper, MM; Denson, TF				Siedlecka, Ewa; Capper, Miriam M.; Denson, Thomas F.			Negative Emotional Events that People Ruminate about Feel Closer in Time	PLOS ONE			English	Article							POSTTRAUMATIC-STRESS-DISORDER; ANGER; DISTANCE; SELF; ACTIVATION; IMPACT; WORRY	Rumination is intrusive, perseverative cognition. We suggest that one psychological consequence of ruminating about negative emotional events is that the events feel as though they happened metaphorically "just yesterday". Results from three studies showed that ruminating about real world anger provocations, guilt-inducing events, and sad times in the last year made these past events feel as though they happened more recently. The relationship between rumination and reduced temporal psychological distance persisted even when controlling for when the event occurred and the emotional intensity of the event. Moreover, angry rumination was correlated with enhanced approach motivation, which mediated the rumination-distance relationship. The relationship between guilty rumination and distance was mediated by enhanced vividness. Construal level and taking a 3(rd) person perspective contributed to the sense of distance when participants were prompted to think about less emotionally charged situations. A meta-analysis of the data showed that the relationship between rumination and reduced distance was significant and twice as large as the same relationship for neutral events. These findings have implications for understanding the role of emotional rumination on memory processes in clinical populations and people prone to rumination. This research suggests that rumination may be a critical mechanism that keeps negative events close in the heart, mind, and time.	[Siedlecka, Ewa; Capper, Miriam M.; Denson, Thomas F.] UNSW Australia, Sch Psychol, Sydney, NSW, Australia	University of New South Wales Sydney	Denson, TF (corresponding author), UNSW Australia, Sch Psychol, Sydney, NSW, Australia.	t.denson@unsw.edu.au	Denson, Thomas F./J-7840-2019; Siedlecka, Ewa/ABE-9607-2021	Denson, Thomas F./0000-0002-9620-4280; 	Discovery Early Career Researcher Award [DE120101945]	Discovery Early Career Researcher Award(Australian Research Council)	This research was supported by a Discovery Early Career Researcher Award to TFD (DE120101945) (www. arc. gov. au). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alter AL, 2011, J EXP SOC PSYCHOL, V47, P16, DOI 10.1016/j.jesp.2010.07.018; Ayduk O, 2010, J PERS SOC PSYCHOL, V98, P809, DOI 10.1037/a0019205; BAUMEISTER RF, 1990, J PERS SOC PSYCHOL, V59, P994, DOI 10.1037/0022-3514.59.5.994; Borkovec TD, 1998, COGNITIVE THER RES, V22, P561, DOI 10.1023/A:1018790003416; Brosschot JF, 2006, J PSYCHOSOM RES, V60, P113, DOI 10.1016/j.jpsychores.2005.06.074; Caruso EM, 2013, PSYCHOL SCI, DOI [10.1177/0956797613512509, DOI 10.1177/0956797613512509]; Carver CS, 2009, PSYCHOL BULL, V135, P183, DOI 10.1037/a0013965; Denson TF, 2013, PERS SOC PSYCHOL REV, V17, P103, DOI 10.1177/1088868312467086; Denson TF, 2009, SYD SYM SOC PSYCHOL, P233; Denson TF, 2009, PSYCHOL BULL, V135, P823, DOI 10.1037/a0016909; Ehlers A, 2004, MEMORY, V12, P403, DOI 10.1080/09658210444000025; EKMAN G, 1971, ACTA PSYCHOL, V35, P430, DOI 10.1016/0001-6918(71)90002-3; Eyal T, 2010, PSYCHOL INQ, V21, P213, DOI 10.1080/1047840X.2010.503184; Fabiansson EC, 2012, NEUROIMAGE, V59, P2974, DOI 10.1016/j.neuroimage.2011.09.078; Gosling SD, 2003, J RES PERS, V37, P504, DOI 10.1016/S0092-6566(03)00046-1; Gross JJ, 2003, J PERS SOC PSYCHOL, V85, P348, DOI 10.1037/0022-3514.85.2.348; Harmon-Jones E, 2009, EMOTION, V9, P183, DOI 10.1037/a0014959; Hayes AF., 2017, MEDIATION MODERATION, V2nd edn; HOROWITZ M, 1979, PSYCHOSOM MED, V41, P209, DOI 10.1097/00006842-197905000-00004; Kelley NJ, 2013, PSYCHOL SCI, V24, P475, DOI 10.1177/0956797612457384; Krans J, J EXP PSYCH IN PRESS, DOI [10.5127/jep.019811, DOI 10.5127/JEP.019811]; Kross E, 2005, PSYCHOL SCI, V16, P709, DOI 10.1111/j.1467-9280.2005.01600.x; Kross E, 2014, J PERS SOC PSYCHOL, V106, P304, DOI 10.1037/a0035173; Kross E, 2011, CURR DIR PSYCHOL SCI, V20, P187, DOI 10.1177/0963721411408883; Kross E, 2009, ANN NY ACAD SCI, V1167, P35, DOI 10.1111/j.1749-6632.2009.04545.x; McHugh T, 2012, CLIN PSYCHOL REV, V32, P93, DOI 10.1016/j.cpr.2011.07.013; Michael T, 2007, DEPRESS ANXIETY, V24, P307, DOI 10.1002/da.20228; Nolen-Hoeksema S, 2008, PERSPECT PSYCHOL SCI, V3, P400, DOI 10.1111/j.1745-6924.2008.00088.x; Orth U, 2006, J CONSULT CLIN PSYCH, V74, P698, DOI 10.1037/0022-006X.74.4.698; Papageorgiou C, 2001, COGN BEHAV PRACT, V8, P160, DOI 10.1016/S1077-7229(01)80021-3; Pedersen WC, 2011, BRIT J SOC PSYCHOL, V50, P281, DOI 10.1348/014466610X515696; Peetz J, 2009, SOC COGNITION, V27, P475, DOI 10.1521/soco.2009.27.4.475; Schmader T, 2006, MOTIV EMOTION, V30, P43, DOI 10.1007/s11031-006-9006-0; Simpson C, 2003, COGN BEHAV PRACT, V10, P91, DOI 10.1016/S1077-7229(03)80012-3; Trope Y, 2010, PSYCHOL REV, V117, P440, DOI 10.1037/a0018963; Van Boven L, 2010, J PERS SOC PSYCHOL, V98, P872, DOI 10.1037/a0019262; Watkins E, 2002, BEHAV RES THER, V40, P1179, DOI 10.1016/S0005-7967(01)00098-5; Watkins ER, 2008, PSYCHOL BULL, V134, P163, DOI 10.1037/0033-2909.134.2.163; Williams LE, 2008, PSYCHOL SCI, V19, P302, DOI 10.1111/j.1467-9280.2008.02084.x; Williams LE, 2014, J CONSUM RES, V40, P1123, DOI 10.1086/674212; Williams T, 1988, DIAGNOSIS TREATMENT, P319; Wilson D.B., 2001, PRACTICAL META ANAL; Xiao YJ, 2012, PERS SOC PSYCHOL B, V38, P959, DOI 10.1177/0146167212442228	43	15	15	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2015	10	2							e0117105	10.1371/journal.pone.0117105	http://dx.doi.org/10.1371/journal.pone.0117105			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CC2IM	25714395	Green Published, Green Submitted, gold			2022-12-27	WOS:000350168700028
J	She, TT; Zhao, CK; Feng, JN; Wang, LX; Qu, LK; Fang, K; Cai, SQ; Shou, CC				She, Tiantian; Zhao, Chuanke; Feng, Junnan; Wang, Lixin; Qu, Like; Fang, Ke; Cai, Shaoqing; Shou, Chengchao			Sarsaparilla (Smilax Glabra Rhizome) Extract Inhibits Migration and Invasion of Cancer Cells by Suppressing TGF-beta 1 Pathway	PLOS ONE			English	Article							FOCAL ADHESION KINASE; AQUEOUS EXTRACT; TNF-ALPHA; GROWTH; HYPERSENSITIVITY; ARTHRITIS; TAXIFOLIN; DISTINCT; BETA; ID1	Sarsaparilla, also known as Smilax Glabra Rhizome (SGR), was shown to modulate immunity, protect against liver injury, lower blood glucose and suppress cancer. However, its effects on cancer cell adhesion, migration and invasion were unclear. In the present study, we found that the supernatant of water-soluble extract from SGR (SW) could promote adhesion, inhibit migration and invasion of HepG2, MDA-MB-231 and T24 cells in vitro, as well as suppress metastasis of MDA-MB-231 cells in vivo. Results of F-actin and vinculin dual staining showed the enhanced focal adhesion in SW-treated cells. Microarray analysis indicated a repression of TGF-beta 1 signaling by SW treatment, which was verified by real-time RT-PCR of TGF-beta 1-related genes and immunoblotting of TGFBR1 protein. SW was also shown to antagonize TGF-beta 1-promoted cell migration. Collectively, our study revealed a new antitumor function of Sarsaparilla in counteracting invasiveness of a subset of cancer cells by inhibiting TGF-beta 1 signaling.	[She, Tiantian; Zhao, Chuanke; Feng, Junnan; Wang, Lixin; Qu, Like; Fang, Ke; Shou, Chengchao] Peking Univ, Canc Hosp & Inst, Minist Educ, Key Lab Carcinogenesis & Translat Res, Beijing 100871, Peoples R China; [Cai, Shaoqing] Peking Univ, Sch Pharmaceut Sci, State Key Lab Nat & Biomimet Drugs, Beijing 100871, Peoples R China	Peking University; Peking University	Shou, CC (corresponding author), Peking Univ, Canc Hosp & Inst, Minist Educ, Key Lab Carcinogenesis & Translat Res, Beijing 100871, Peoples R China.	cshou@vip.sina.com			National Basic Research Program of China [2010CB529303, 2013CB910504]	National Basic Research Program of China(National Basic Research Program of China)	Funding was provided by the National Basic Research Program of China (2010CB529303, 2013CB910504), http://www.973.gov.cn/Default_3.aspx. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhurst RJ, 2001, TRENDS CELL BIOL, V11, pS44, DOI 10.1016/S0962-8924(01)82259-5; Bhattacharya R, 2010, J ONCOL, V2010, DOI 10.1155/2010/856105; Cai Y, 2003, J PHARM PHARMACOL, V55, P691, DOI 10.1211/002235703765344612; Casaschi A, 2004, ATHEROSCLEROSIS, V176, P247, DOI 10.1016/j.atherosclerosis.2004.05.020; Chen L, 2007, J PHARMACEUT BIOMED, V43, P1715, DOI 10.1016/j.jpba.2007.01.007; Drumm ML, 2012, ANNU REV PATHOL-MECH, V7, P267, DOI 10.1146/annurev-pathol-011811-120900; Fei MJ, 2005, J ALLERGY CLIN IMMUN, V116, P1350, DOI 10.1016/j.jaci.2005.08.032; Gao YJ, 2011, TOXICOL LETT, V207, P112, DOI 10.1016/j.toxlet.2011.08.024; Gardel ML, 2010, ANNU REV CELL DEV BI, V26, P315, DOI [doi: 10.1146/annu rev. cellbio.011209.122036 PMID: 19575647, DOI 10.1146/ANNU]; Gunn J, 2013, BIOACT FOOD CHRON, P381, DOI 10.1016/B978-0-12-397153-1.00042-1; HASEGAWA K, 1994, J CELL PHYSIOL, V158, P215, DOI 10.1002/jcp.1041580202; Hellemans J, 2004, NAT GENET, V36, P1213, DOI 10.1038/ng1453; Huang JS, 2013, FREE RADICAL BIO MED, V65, P1246, DOI 10.1016/j.freeradbiomed.2013.09.011; Huttenlocher A, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a005074; Iddamaldeniya S S, 2006, J Carcinog, V5, P11, DOI 10.1186/1477-3163-5-11; Jia LB, 2012, CHIN J INTEGR MED, V18, P325, DOI 10.1007/s11655-011-0950-5; Jiang JY, 2003, J ETHNOPHARMACOL, V85, P53, DOI 10.1016/S0378-8741(02)00340-9; Jiang JY, 1997, PHARMACOL RES, V36, P309, DOI 10.1006/phrs.1997.0234; Lange K, 2008, CANCER RES, V68, P6942, DOI 10.1158/0008-5472.CAN-08-0347; Leyton J, 2002, EUR J PHARMACOL, V442, P179, DOI 10.1016/S0014-2999(02)01539-X; Liang H.L.M., 2003, CHIN J INTEG TRADIT, V9, P157; Liang YY, 2009, CELL RES, V19, P140, DOI 10.1038/cr.2008.321; Liu GX, 2013, MOLECULES, V18, P5265, DOI [doi: 10.3390/ molecules18055265 PMID: 23698042, DOI 10.3390/M0LECULES18055265]; Ma F, 2010, WORLD J GASTROENTERO, V16, P5629, DOI 10.3748/wjg.v16.i44.5629; Majumdar A, 2012, NAT REV GASTRO HEPAT, V9, P530, DOI 10.1038/nrgastro.2012.114; Meng YG, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-75; O'Connor JW, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0083188, 10.1371/journal.pone.0080504]; Ren XD, 2000, J CELL SCI, V113, P3673; Sa F, 2008, CHEM-BIOL INTERACT, V171, P1, DOI 10.1016/j.cbi.2007.08.012; Sere K, 2012, IMMUNITY, V37, P905, DOI 10.1016/j.immuni.2012.07.019; Shi L, 2013, J ETHNOPHARMACOL, V150, P1038, DOI 10.1016/j.jep.2013.10.023; Tauber S, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-200; Tewtrakul S, 2006, J ETHNOPHARMACOL, V105, P312, DOI 10.1016/j.jep.2005.11.021; Theriault A, 2000, J LIPID RES, V41, P1969; Tian HQ, 2010, CHIN J INTEGR MED, V16, P102, DOI 10.1007/s11655-010-0102-3; Tse TW, 2003, CLIN EXP DERMATOL, V28, P469, DOI 10.1046/j.1365-2230.2003.01322.x; Tsuchiya T, 2005, CANCER SCI, V96, P784, DOI 10.1111/j.1349-7006.2005.00113.x; Ulbricht C, 2001, NATURAL STANDARD DAT; Wang J, 2004, J PHARM PHARMACOL, V56, P495, DOI 10.1211/0022357023033; Wang XD, 2007, DIFFERENTIATION, V75, P219, DOI 10.1111/j.1432-0436.2006.00135.x; Wilson T, 2001, BIOL REPROD, V64, P1225, DOI 10.1095/biolreprod64.4.1225; Xu Q, 1999, EUR J PHARMACOL, V377, P93, DOI 10.1016/S0014-2999(99)00401-X; Yi HW, 2008, INT IMMUNOPHARMACOL, V8, P1467, DOI 10.1016/j.intimp.2008.06.006; Yu DH, 1998, J BIOL CHEM, V273, P21125, DOI 10.1074/jbc.273.33.21125; Zhang GD, 2014, P NATL ACAD SCI USA, V111, P11127, DOI 10.1073/pnas.1410432111; Zheng ZG, 2013, J PHARMACEUT BIOMED, V77, P44, DOI 10.1016/j.jpba.2013.01.003	46	17	19	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2015	10	3							e0118287	10.1371/journal.pone.0118287	http://dx.doi.org/10.1371/journal.pone.0118287			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9KG	25742000	Green Submitted, gold, Green Published			2022-12-27	WOS:000350688100011
J	Orstavik, O; Manfra, O; Andressen, KW; Andersen, GO; Skomedal, T; Osnes, JB; Levy, FO; Krobert, KA				Orstavik, Oivind; Manfra, Ornella; Andressen, Kjetil Wessel; Andersen, Geir Oystein; Skomedal, Tor; Osnes, Jan-Bjorn; Levy, Finn Olav; Krobert, Kurt Allen			The Inotropic Effect of the Active Metabolite of Levosimendan, OR-1896, Is Mediated through Inhibition of PDE3 in Rat Ventricular Myocardium	PLOS ONE			English	Article							CARDIAC TROPONIN-C; CALCIUM SENSITIZER; PAPILLARY-MUSCLES; CA2+ SENSITIVITY; PHOSPHORYLATION; PROTEIN; CONTRACTILE; TRANSIENTS; INFUSION; CARDIOMYOCYTES	Aims We recently published that the positive inotropic response (PIR) to levosimendan can be fully accounted for by phosphodiesterase (PDE) inhibition in both failing human heart and normal rat heart. To determine if the PIR of the active metabolite OR-1896, an important mediator of the long-term clinical effects of levosimendan, also results from PDE3 inhibition, we compared the effects of OR-1896, a representative Ca2+ sensitizer EMD57033 (EMD), levosimendan and other PDE inhibitors. Methods Contractile force was measured in rat ventricular strips. PDE assay was conducted on rat ventricular homogenate. cAMP was measured using RII_epac FRET-based sensors. Results OR-1896 evoked a maximum PIR of 33 +/- 10% above basal at 1 mu M. This response was amplified in the presence of the PDE4 inhibitor rolipram (89 +/- 14%) and absent in the presence of the PDE3 inhibitors cilostamide (0.5 +/- 5.3%) or milrinone (3.2 +/- 4.4%). The PIR was accompanied by a lusitropic response, and both were reversed by muscarinic receptor stimulation with carbachol and absent in the presence of beta-AR blockade with timolol. OR-1896 inhibited PDE activity and increased cAMP levels at concentrations giving PIRs. OR-1896 did not sensitize the concentration-response relationship to extracellular Ca2+. Levosimendan, OR-1896 and EMD all increased the sensitivity to beta-AR stimulation. The combination of either EMD and levosimendan or EMD and OR-1896 further sensitized the response, indicating at least two different mechanisms responsible for the sensitization. Only EMD sensitized the alpha(1)-AR response. Conclusion The observed PIR to OR-1896 in rat ventricular strips is mediated through PDE3 inhibition, enhancing cAMP-mediated effects. These results further reinforce our previous finding that Ca2+ sensitization does not play a significant role in the inotropic (and lusitropic) effect of levosimendan, nor of its main metabolite OR-1896.	[Orstavik, Oivind; Manfra, Ornella; Andressen, Kjetil Wessel; Skomedal, Tor; Osnes, Jan-Bjorn; Levy, Finn Olav; Krobert, Kurt Allen] Univ Oslo, Fac Med, Dept Pharmacol, Oslo, Norway; [Orstavik, Oivind; Manfra, Ornella; Andressen, Kjetil Wessel; Skomedal, Tor; Osnes, Jan-Bjorn; Levy, Finn Olav; Krobert, Kurt Allen] Oslo Univ Hosp, N-0450 Oslo, Norway; [Orstavik, Oivind; Manfra, Ornella; Andressen, Kjetil Wessel; Skomedal, Tor; Osnes, Jan-Bjorn; Levy, Finn Olav; Krobert, Kurt Allen] Univ Oslo, Fac Med, KG Jebsen Cardiac Res Ctr, Oslo, Norway; [Orstavik, Oivind; Manfra, Ornella; Andressen, Kjetil Wessel; Andersen, Geir Oystein; Skomedal, Tor; Osnes, Jan-Bjorn; Levy, Finn Olav; Krobert, Kurt Allen] Univ Oslo, Fac Med, Ctr Heart Failure Res, Oslo, Norway; [Andersen, Geir Oystein] Oslo Univ Hosp, Dept Cardiol, N-0450 Oslo, Norway	University of Oslo; University of Oslo; University of Oslo; University of Oslo; University of Oslo	Levy, FO (corresponding author), Univ Oslo, Fac Med, Dept Pharmacol, Oslo, Norway.	f.o.levy@medisin.uio.no	Andersen, Geir/AAR-3010-2020; Stefanadis, Christodoulos/ABH-2232-2020	Stefanadis, Christodoulos/0000-0001-5974-6454; Andressen, Kjetil Wessel/0000-0003-1094-1501	Norwegian Council on Cardiovascular Diseases; Research Council of Norway; Stiftelsen Kristian Gerhard Jebsen Foundation; Anders Jahre's Foundation for the Promotion of Science; Family Blix foundation; University of Oslo	Norwegian Council on Cardiovascular Diseases; Research Council of Norway(Research Council of Norway); Stiftelsen Kristian Gerhard Jebsen Foundation; Anders Jahre's Foundation for the Promotion of Science; Family Blix foundation; University of Oslo	This work was supported by The Norwegian Council on Cardiovascular Diseases, The Research Council of Norway, The Stiftelsen Kristian Gerhard Jebsen Foundation, Anders Jahre's Foundation for the Promotion of Science, The Family Blix foundation and grants from the University of Oslo. The cAMP sensor RII_epac was generously provided by Manuela Zaccolo (Oxford, UK). EMD57033 was generously provided by Dr. Norbert Beier of Merck KGaA (Darmstadt, Germany).	Afzal F, 2011, BRIT J PHARMACOL, V162, P54, DOI 10.1111/j.1476-5381.2010.00890.x; Andersen GO, 2004, AM J PHYSIOL-HEART C, V286, pH1354, DOI 10.1152/ajpheart.00549.2003; Antoniades C, 2007, PHARMACOL THERAPEUT, V114, P184, DOI 10.1016/j.pharmthera.2007.01.008; Boknik P, 1997, J PHARMACOL EXP THER, V280, P277; Brixius K, 2002, AM J PHYSIOL-HEART C, V282, pH131, DOI 10.1152/ajpheart.2002.282.1.H131; Di Benedetto G, 2008, CIRC RES, V103, P836, DOI 10.1161/CIRCRESAHA.108.174813; EDES I, 1995, CIRC RES, V77, P107, DOI 10.1161/01.RES.77.1.107; ENGLAND PJ, 1976, BIOCHEM J, V160, P295, DOI 10.1042/bj1600295; GARVEY JL, 1988, BIOCHEM J, V249, P709, DOI 10.1042/bj2490709; HAIKALA H, 1995, J CARDIOVASC PHARM, V25, P794, DOI 10.1097/00005344-199505000-00016; HAIKALA H, 1995, J MOL CELL CARDIOL, V27, P1859, DOI 10.1016/0022-2828(95)90009-8; Haikala H, 1997, CARDIOVASC RES, V34, P536, DOI 10.1016/S0008-6363(97)00057-6; Hasenfuss G, 1998, CIRCULATION, V98, P2141, DOI 10.1161/01.CIR.98.20.2141; Husebye T, 2013, EUR J HEART FAIL, V15, P565, DOI 10.1093/eurjhf/hfs215; Kaheinen P, 2006, BASIC CLIN PHARMACOL, V98, P74, DOI 10.1111/j.1742-7843.2006.pto_231.x; Kilkenny C, 2010, BRIT J PHARMACOL, V160, P1577, DOI [10.1113/expphysiol.2010.053793, 10.1111/j.1476-5381.2010.00872.x, 10.1113/jphysiol.2010.192278]; Kivikko M, 2002, INT J CLIN PHARM TH, V40, P465; Levy FO, 2013, N-S ARCH PHARMACOL, V386, P665, DOI 10.1007/s00210-013-0874-z; Lilleberg J, 2007, EUR J HEART FAIL, V9, P75, DOI 10.1016/j.ejheart.2006.04.012; MARCHMONT RJ, 1980, BIOCHEM J, V187, P381, DOI 10.1042/bj1870381; McGrath JC, 2010, BRIT J PHARMACOL, V160, P1573, DOI 10.1111/j.1476-5381.2010.00873.x; Orstavik O, 2014, BRIT J PHARMACOL, V171, P5169, DOI 10.1111/bph.12647; POLLESELLO P, 1994, J BIOL CHEM, V269, P28584; Qvigstad E, 2005, CARDIOVASC RES, V65, P869, DOI 10.1016/j.cardiores.2004.11.017; Sato S, 1998, J MOL CELL CARDIOL, V30, P1115, DOI 10.1006/jmcc.1998.0677; Segreti JA, 2008, J PHARMACOL EXP THER, V325, P331, DOI 10.1124/jpet.107.132530; SKOMEDAL T, 1987, ACTA PHYSIOL SCAND, V131, P347, DOI 10.1111/j.1748-1716.1987.tb08249.x; Skomedal T, 1997, J PHARMACOL EXP THER, V280, P721; SOLARO RJ, 1993, CIRC RES, V73, P981, DOI 10.1161/01.RES.73.6.981; Sorsa T, 2001, J BIOL CHEM, V276, P9337, DOI 10.1074/jbc.M007484200; Stangherlin A, 2011, CIRC RES, V108, P929, DOI 10.1161/CIRCRESAHA.110.230698; Szilagyi S, 2005, J CARDIOVASC PHARM, V46, P369, DOI 10.1097/01.fjc.0000175454.69116.9; Szilagyi S, 2004, EUR J PHARMACOL, V486, P67, DOI 10.1016/j.ejphar.2003.12.005; Takahashi R, 2000, EUR J PHARMACOL, V400, P103, DOI 10.1016/S0014-2999(00)00385-X; Takahashi R, 2000, J CARDIOVASC PHARM, V36, P118, DOI 10.1097/00005344-200007000-00016; Takahashi R, 2005, BRIT J PHARMACOL, V145, P1143, DOI 10.1038/sj.bjp.0706292; Takahashi R, 2002, N-S ARCH PHARMACOL, V366, P440, DOI 10.1007/s00210-002-0627-x; Teerlink JR, 2009, HEART FAIL REV, V14, P243, DOI 10.1007/s10741-009-9153-y; Yasuda SI, 2007, CIRC RES, V101, P377, DOI 10.1161/CIRCRESAHA.106.145557	39	21	21	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2015	10	3							e0115547	10.1371/journal.pone.0115547	http://dx.doi.org/10.1371/journal.pone.0115547			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9JM	25738589	Green Published, gold			2022-12-27	WOS:000350685900003
J	Qayyum, M; Khan, H; Rahim, MT; Ullah, I				Qayyum, Mubashir; Khan, Hamid; Rahim, M. Tariq; Ullah, Inayat			Modeling and Analysis of Unsteady Axisymmetric Squeezing Fluid Flow through Porous Medium Channel with Slip Boundary	PLOS ONE			English	Article							HOMOTOPY PERTURBATION METHOD	The aim of this article is to model and analyze an unsteady axisymmetric flow of non-conducting, Newtonian fluid squeezed between two circular plates passing through porous medium channel with slip boundary condition. A single fourth order nonlinear ordinary differential equation is obtained using similarity transformation. The resulting boundary value problem is solved using Homotopy Perturbation Method (HPM) and fourth order Explicit Runge Kutta Method (RK4). Convergence of HPM solution is verified by obtaining various order approximate solutions along with absolute residuals. Validity of HPM solution is confirmed by comparing analytical and numerical solutions. Furthermore, the effects of various dimensionless parameters on the longitudinal and normal velocity profiles are studied graphically.	[Qayyum, Mubashir; Khan, Hamid; Rahim, M. Tariq; Ullah, Inayat] Natl Univ Comp & Emerging Sci, Dept Math, Peshawar 25000, Pakistan		Qayyum, M (corresponding author), Natl Univ Comp & Emerging Sci, Dept Math, FAST Peshawar Campus, Peshawar 25000, Pakistan.	mubashir.qayyum@nu.edu.pk	Qayyum, Mubashir/I-8795-2019	Qayyum, Mubashir/0000-0002-6701-5640				Breugem WP, 2007, PHYS FLUIDS, V19, DOI 10.1063/1.2792323; Domairry G, 2009, MATH PROBL ENG, V2009, DOI 10.1155/2009/603916; Elkouh AF, 1986, J TRIBOLOGY, V106, P223, DOI DOI 10.1115/1.3260889; GRIMM RJ, 1976, APPL SCI RES, V32, P149, DOI 10.1007/BF00383711; GUPTA PS, 1977, WEAR, V45, P177, DOI 10.1016/0043-1648(77)90072-2; Hamdan M.H., 2006, INT J PURE APPL MATH, V27, P491; Hamdan MH, 1998, APPL MATH COMPUT, V93, P83, DOI 10.1016/S0096-3003(97)10047-9; HAMZA EA, 1988, J TRIBOL-T ASME, V110, P375, DOI 10.1115/1.3261636; He JH, 2006, PHYS LETT A, V350, P87, DOI 10.1016/j.physleta.2005.10.005; He JH, 2003, APPL MATH COMPUT, V135, P73, DOI 10.1016/S0096-3003(01)00312-5; He JH, 2000, INT J NONLINEAR MECH, V35, P37, DOI 10.1016/S0020-7462(98)00085-7; He JH, 1999, COMPUT METHOD APPL M, V178, P257, DOI 10.1016/S0045-7825(99)00018-3; He JH, 2006, INT J MOD PHYS B, V20, P2561, DOI 10.1142/S0217979206034819; Ishizawa S, 1966, B JSME, V9, P533, DOI [10.1299/jsme1958.9.533, DOI 10.1299/JSME1958.9.533]; Islam S, 2008, J POROUS MEDIA, V11, P669, DOI 10.1615/JPorMedia.v11.i7.50; Islam S, 2007, J POROUS MEDIA, V10, P401, DOI 10.1615/JPorMedia.v10.i4.60; Islam S, 2011, MATH PROBL ENG, V2011, DOI 10.1155/2011/349803; Khan H, 2012, ABSTR APPL AN; Kolyshkin A, 2007, MATH MODEL ANAL, V12, P101, DOI 10.3846/1392-6292.2007.12.101-106; Krylovas A, 2001, MATH MODEL ANAL, V6, P117; KUZMA DC, 1967, APPL SCI RES, V18, P15; Laun HM, 1999, J NON-NEWTON FLUID, V81, P1, DOI 10.1016/S0377-0257(98)00083-4; LEIDER PJ, 1974, IND ENG CHEM FUND, V13, P336, DOI 10.1021/i160052a007; Naduvinamani NB, 2001, TRIBOL INT, V34, P739, DOI 10.1016/S0301-679X(01)00064-0; Navier C, 1823, MEMOIRES LACADEMIE S, V6, P389; Nayfeh A. H., 1981, INTRO PERTURBATION T; Neto C, 2005, REP PROG PHYS, V68, P2859, DOI 10.1088/0034-4885/68/12/R05; Qayyum A, 2012, CHINESE PHYS LETT, V29, DOI 10.1088/0256-307X/29/3/034701; Siddiqui AM, 2006, INT J NONLIN SCI NUM, V7, P7; Siddiqui AM, 2006, INT J NONLIN SCI NUM, V7, P15; SINGH P, 1990, ING ARCH, V60, P274, DOI 10.1007/BF00577864; Stefan M. J., 1874, MATH NATURWISSEN, V69, P713; Tan WC, 2005, INT J NONLIN MECH, V40, P515, DOI 10.1016/j.ijnonlinmec.2004.07.016; Thorpe JF, 1967, DEV THEORETICAL APPL; TICHY JA, 1970, J LUBR TECHNOL, V92, P588, DOI 10.1115/1.3451480; VAFAI K, 1981, INT J HEAT MASS TRAN, V24, P195, DOI 10.1016/0017-9310(81)90027-2; Vafai K.J., 2005, HDB POROUS MEDIA, V2nd ed.; VERMA RL, 1981, WEAR, V72, P89, DOI 10.1016/0043-1648(81)90286-6; Zhou GL, 2014, INT J NUMER METHOD H, V24, P1331, DOI 10.1108/HFF-01-2013-0021	39	15	15	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2015	10	3							e0117368	10.1371/journal.pone.0117368	http://dx.doi.org/10.1371/journal.pone.0117368			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9JM	25738864	gold, Green Published, Green Submitted			2022-12-27	WOS:000350685900015
J	Wang, Y; Yin, Y; Sun, YW; Zhou, Y; Chen, X; Ding, WN; Wang, W; Li, W; Xu, JR; Du, YS				Wang, Yao; Yin, Yan; Sun, Ya-wen; Zhou, Yan; Chen, Xue; Ding, Wei-na; Wang, Wei; Li, Wei; Xu, Jian-rong; Du, Ya-song			Decreased Prefrontal Lobe Interhemispheric Functional Connectivity in Adolescents with Internet Gaming Disorder: A Primary Study Using Resting-State fMRI	PLOS ONE			English	Article							WHITE-MATTER ABNORMALITIES; ORBITOFRONTAL CORTEX; ADDICTION; SCHIZOPHRENIA; COORDINATION; CHILDREN; REWARD	Purposes Recent neuroimaging studies have shown that people with Internet gaming disorder (IGD) have structural and functional abnormalities in specific brain areas and connections. However, little is known about the alterations of the interhemispheric resting-state functional connectivity (rsFC) in participants with IGD. In the present study, we used a newly developed voxel-mirrored homotopic connectivity (VMHC) method to investigate the interhemispheric rsFC of the whole brain in participants with IGD. Methods We compared interhemispheric rsFC between 17 participants with IGD and 24 healthy controls, group-matched on age, gender, and education status. All participants were provided written informed consent. Resting-state functional and structural magnetic resonance images were acquired for all participants. The rsFC between bilateral homotopic voxels was calculated. Regions showing abnormal VMHC in IGD participants were adopted as regions of interest for correlation analyses. Results Compared to healthy controls, IGD participants showed decreased VMHC between the left and right superior frontal gyrus (orbital part), inferior frontal gyrus (orbital part), middle frontal gyrus and superior frontal gyrus. Further analyses showed Chen Internet Addiction Scale (CIAS)-related VMHC in superior frontal gyrus (orbital part) and CIAS (r=-0.55, p=0.02, uncorrected). Conclusions Our findings implicate the important role of altered interhemispheric rsFC in the bilateral prefrontal lobe in the neuropathological mechanism of IGD, and provide further supportive evidence for the reclassification of IGD as a behavioral addiction.	[Wang, Yao; Yin, Yan; Sun, Ya-wen; Zhou, Yan; Chen, Xue; Ding, Wei-na; Xu, Jian-rong] Shanghai Jiao Tong Univ, Sch Med, Dept Radiol, Ren Ji Hosp, Shanghai 200030, Peoples R China; [Du, Ya-song] Shanghai Jiao Tong Univ, Shanghai Mental Hlth Ctr, Dept Child & Adolescent Psychiat, Shanghai 200030, Peoples R China; [Wang, Wei; Li, Wei] Fourth Mil Med Univ, Dept Radiol, Tangdu Hosp, Xian 710032, Shaanxi, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University; Air Force Military Medical University	Zhou, Y (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Dept Radiol, Ren Ji Hosp, Shanghai 200030, Peoples R China.	clare1475@hotmail.com; xujianr@hotmail.com			National Natural Science Foundation of China [81171325, 81371622, 81371532, 81401393]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was supported by the National Natural Science Foundation of China (No. 81171325), National Natural Science Foundation of China (No. 81371622), National Natural Science Foundation of China (Nos. 81371532), and National Natural Science Foundation of China (81401393). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson KJ, 2001, J AM COLL HEALTH, V50, P21, DOI 10.1080/07448480109595707; Beard KW, 2001, CYBERPSYCHOL BEHAV, V4, P377, DOI 10.1089/109493101300210286; Bonson KR, 2002, NEUROPSYCHOPHARMACOL, V26, P376, DOI 10.1016/S0893-133X(01)00371-2; Brand M, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00375; Cao F, 2007, CHILD CARE HLTH DEV, V33, P275, DOI 10.1111/j.1365-2214.2006.00715.x; Chen SH, 2003, CHINESE J PSYCHOL, V45, P279, DOI [DOI 10.1037/T44491-000, 10.1037/t44491-000]; Di Martino A, 2008, CEREB CORTEX, V18, P2735, DOI 10.1093/cercor/bhn041; Ding WN, 2014, BEHAV BRAIN FUNCT, V10, DOI 10.1186/1744-9081-10-20; Ding WN, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0059902, 10.1371/journal.pone.0061533]; Dong GH, 2013, PROG NEURO-PSYCHOPH, V46, P139, DOI 10.1016/j.pnpbp.2013.07.007; Dong GH, 2012, PSYCHIAT RES-NEUROIM, V203, P153, DOI 10.1016/j.pscychresns.2012.02.001; Han DH, 2010, CYBERPSYCH BEH SOC N, V13, P655, DOI 10.1089/cyber.2009.0327; Heitzeg MM, 2014, DRUG ALCOHOL DEPEN, V141, P51, DOI 10.1016/j.drugalcdep.2014.05.002; Hoeft F, 2008, J PSYCHIATR RES, V42, P253, DOI 10.1016/j.jpsychires.2007.11.010; Hong SB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057831; Hong SB, 2013, BEHAV BRAIN FUNCT, V9, DOI 10.1186/1744-9081-9-11; Hoptman MJ, 2012, SCHIZOPHR RES, V141, P1, DOI 10.1016/j.schres.2012.07.027; Huang HY, 2009, CYBERPSYCHOL BEHAV, V12, P675, DOI 10.1089/cpb.2009.0060; Kelly C, 2011, BIOL PSYCHIAT, V69, P684, DOI 10.1016/j.biopsych.2010.11.022; Kringelbach ML, 2005, NAT REV NEUROSCI, V6, P691, DOI 10.1038/nrn1747; Kuss DJ, 2013, PSYCHOL RES BEHAV MA, V6, P125, DOI 10.2147/PRBM.S39476; Kuss DJ, 2012, BRAIN SCI, V2, P347, DOI 10.3390/brainsci2030347; Lam LT, 2009, INJURY PREV, V15, P403, DOI 10.1136/ip.2009.021949; Leung L, 2004, CYBERPSYCHOL BEHAV, V7, P333, DOI 10.1089/1094931041291303; Lin FC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030253; Meng Y., 2014, ADDICTION BIOL; Patton JH, 1995, J CLIN PSYCHOL, V51, P768, DOI 10.1002/1097-4679(199511)51:6<768::AID-JCLP2270510607>3.0.CO;2-1; Rolls ET, 2000, CEREB CORTEX, V10, P284, DOI 10.1093/cercor/10.3.284; Rose JE, 2011, BIOL PSYCHIAT, V70, P794, DOI 10.1016/j.biopsych.2011.05.031; Salvador R, 2005, PHILOS T R SOC B, V360, P937, DOI 10.1098/rstb.2005.1645; Schoenbaum G, 2006, TRENDS NEUROSCI, V29, P116, DOI 10.1016/j.tins.2005.12.006; Schwarzkopf DS, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00200; Sheehan DV, 2010, J CLIN PSYCHIAT, V71, P313, DOI 10.4088/JCP.09m05305whi; Song XW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025031; Stark DE, 2008, J NEUROSCI, V28, P13754, DOI 10.1523/JNEUROSCI.4544-08.2008; Weiss F, 2005, CURR OPIN PHARMACOL, V5, P9, DOI 10.1016/j.coph.2004.11.001; Weng CB, 2013, EUR J RADIOL, V82, P1308, DOI 10.1016/j.ejrad.2013.01.031; White T, 2011, SCHIZOPHRENIA BULL, V37, P222, DOI 10.1093/schbul/sbp088; Wilson SJ, 2004, NAT NEUROSCI, V7, P211, DOI 10.1038/nn1200; Yan CG, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00013; Yuan K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045476; Zhou Y, 2013, AM J NEURORADIOL, V34, P1180, DOI 10.3174/ajnr.A3386; ZUNG WWK, 1971, PSYCHOSOMATICS, V12, P371; ZUNG WWK, 1965, ARCH GEN PSYCHIAT, V12, P63, DOI 10.1001/archpsyc.1965.01720310065008; Zuo XN, 2010, J NEUROSCI, V30, P15034, DOI 10.1523/JNEUROSCI.2612-10.2010	45	18	20	3	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2015	10	3							e0118733	10.1371/journal.pone.0118733	http://dx.doi.org/10.1371/journal.pone.0118733			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9JM	25738502	Green Published, Green Submitted, gold			2022-12-27	WOS:000350685900065
J	Witthoft, N; Winawer, J; Eagleman, DM				Witthoft, Nathan; Winawer, Jonathan; Eagleman, David M.			Prevalence of Learned Grapheme-Color Pairings in a Large Online Sample of Synesthetes	PLOS ONE			English	Article							LARGE-SCALE; SYNAESTHESIA; IMAGERY	In this paper we estimate the minimum prevalence of grapheme-color synesthetes with letter-color matches learned from an external stimulus, by analyzing a large sample of English-speaking grapheme-color synesthetes. We find that at least 6% (400/6588 participants) of the total sample learned many of their matches from a widely available colored letter toy. Among those born in the decade after the toy began to be manufactured, the proportion of synesthetes with learned letter-color pairings approaches 15% for some 5-year periods. Among those born 5 years or more before it was manufactured, none have colors learned from the toy. Analysis of the letter-color matching data suggests the only difference between synesthetes with matches to the toy and those without is exposure to the stimulus. These data indicate learning of letter-color pairings from external contingencies can occur in a substantial fraction of synesthetes, and are consistent with the hypothesis that grapheme-color synesthesia is a kind of conditioned mental imagery.	[Witthoft, Nathan] Stanford Univ, Dept Psychol, Stanford, CA 94305 USA; [Winawer, Jonathan] NYU, Dept Psychol, New York, NY 10003 USA; [Winawer, Jonathan] NYU, Ctr Neural Sci, New York, NY 10003 USA; [Eagleman, David M.] Baylor Coll Med, Dept Neurosci, Houston, TX 77030 USA	Stanford University; New York University; New York University; Baylor College of Medicine	Witthoft, N (corresponding author), Stanford Univ, Dept Psychol, Stanford, CA 94305 USA.	witthoft@stanford.edu	Winawer, Jonathan/AFQ-2476-2022	Winawer, Jonathan/0000-0001-7475-5586	National Institutes of Health [RO1EY019279-01A1, R00EY022116]; Mind Science Foundation; NATIONAL EYE INSTITUTE [R01EY019279, R00EY022116, R01EY022318] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mind Science Foundation; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	NW was supported by the National Institutes of Health (http://grants.nih.gov/grants/oer.htm), RO1EY019279-01A1. JW was supported by the National Institutes of Health, R00EY022116. DME was supported by The Mind Science Foundation (http://www.mindscience.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander JD, 2008, J EXP PSYCHOL HUMAN, V34, P446, DOI 10.1037/0096-1523.34.2.446; Asano M, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00757; Barnett KJ, 2008, CONSCIOUS COGN, V17, P1032, DOI 10.1016/j.concog.2007.05.011; Barnett KJ, 2008, COGNITION, V106, P871, DOI 10.1016/j.cognition.2007.05.003; Beeli G, 2007, PSYCHOL SCI, V18, P788, DOI 10.1111/j.1467-9280.2007.01980.x; Berlin B, 1969, BASIC COLOR TERMS TH, DOI [10.3758/s13414-010-0055-9, DOI 10.3758/S13414-010-0055-9]; Bower G. H., 1972, COGNITION LEARN MEM, P51; Brang D, 2011, NEUROPSYCHOLOGIA, V49, P1355, DOI 10.1016/j.neuropsychologia.2011.01.002; Calkins M., 1893, AM J PSYCHOL, V5, P439, DOI [10.2307/1411912, DOI 10.2307/1411912]; Chabalier E., 1864, J MED LYON, V1, P92; Colizoli O, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039799; Eagleman DM, 2007, J NEUROSCI METH, V159, P139, DOI 10.1016/j.jneumeth.2006.07.012; Galton F., 1880, NATURE, V21, P252, DOI [10.1038/021252a0, DOI 10.1038/021252A0]; Galton F., 1880, FORTNIGHTLY REV, V24, P312; Howells TH, 1944, J EXP PSYCHOL, V34, P87, DOI 10.1037/h0054424; Jewanski J, 2011, J HIST NEUROSCI, V20, P284, DOI 10.1080/0964704X.2010.528240; Kadosh RC, 2007, TRENDS COGN SCI, V11, P177, DOI 10.1016/j.tics.2007.01.003; Leuba C, 1940, J EXP PSYCHOL, V26, P345, DOI 10.1037/h0057631; Marks L. E., 2005, SYNESTHESIA PERSPECT, P214; Martino G, 2001, CURR DIR PSYCHOL SCI, V10, P61, DOI 10.1111/1467-8721.00116; Meier B, 2009, NEUROPSYCHOLOGIA, V47, P1208, DOI 10.1016/j.neuropsychologia.2009.01.009; Mroczko-Wasowicz A., 2013, OXFORD HDB SYNESTHES, P165; Novich S, 2011, J NEUROPSYCHOL, V5, P353, DOI 10.1111/j.1748-6653.2011.02015.x; PAIVIO A, 1969, PSYCHOL REV, V76, P241, DOI 10.1037/h0027272; Pariyadath V, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00328; Rich AN, 2005, COGNITION, V98, P53, DOI 10.1016/j.cognition.2004.11.003; Rothen N, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00109; Simner J., 2005, COGNITIVE NEUROPSYCH, V22, P1; Simner J, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00603; Simner J, 2009, BRAIN, V132, P57, DOI 10.1093/brain/awn292; Spector F, 2009, DEV PSYCHOL, V45, P175, DOI 10.1037/a0014171; Spence C., 2013, MULTISENSORY IMAGERY, P157, DOI [10.1007/978-1-4614-5879-1_9, DOI 10.1007/978-1-4614-5879-1_9]; Tomson SN, 2011, BEHAV BRAIN RES, V223, P48, DOI 10.1016/j.bbr.2011.03.071; Tyler C. W., 2005, SYNESTHESIA PERSPECT, P34; Ward J, 2003, COGNITION, V89, P237, DOI 10.1016/S0010-0277(03)00122-7; Watson MR, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00098; Wheeler ME, 2000, P NATL ACAD SCI USA, V97, P11125, DOI 10.1073/pnas.97.20.11125; Witthoft N, 2006, CORTEX, V42, P175, DOI 10.1016/S0010-9452(08)70342-3; Witthoft N, 2013, PSYCHOL SCI, V24, P258, DOI 10.1177/0956797612452573; Yon D, 2014, FRONT PSYCHOL, V5, DOI [10.3389/fpsyg.2014.00072, DOI 10.3389/FPSYG.2014.00072]	40	32	32	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2015	10	3							e0118996	10.1371/journal.pone.0118996	http://dx.doi.org/10.1371/journal.pone.0118996			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CC9JM	25739095	Green Published, gold, Green Submitted			2022-12-27	WOS:000350685900090
J	Abdellaoul, A; Hottenga, JJ; Willemsen, G; Bartels, M; van Beijsterveldt, T; Ehli, EA; Davies, GE; Brooks, A; Sullivan, PF; Penninx, BWJH; de Geus, EJ; Boomsma, DI				Abdellaoul, Abdel; Hottenga, Jouke-Jan; Willemsen, Gonneke; Bartels, Meike; van Beijsterveldt, Toos; Ehli, Erik A.; Davies, Gareth E.; Brooks, Andrew; Sullivan, Patrick F.; Penninx, Brenda W. J. H.; de Geus, Eco J.; Boomsma, Dorret I.			Educational Attainment Influences Levels of Homozygosity through Migration and Assortative Mating	PLOS ONE			English	Article							NETHERLANDS TWIN REGISTER; MAJOR DEPRESSION; ASSOCIATION; STRATIFICATION; AUTOZYGOSITY; INTELLIGENCE; DISORDERS; SELECTION; GRADUATE; BIOBANK	Individuals with a higher education are more likely to migrate, increasing the chance of meeting a spouse with a different ancestral background. In this context, the presence of strong educational assortment can result in greater ancestry differences within more educated spouse pairs, while less educated individuals are more likely to mate with someone with whom they share more ancestry. We examined the association between educational attainment and F-roh (=the proportion of the genome consisting of runs of homozygosity [ROHs]) in similar to 2,000 subjects of Dutch ancestry. The subjects' own educational attainment showed a nominally significant negative association with F-roh (p = .045), while the contribution of parental education to offspring Froh was highly significant (father: p < 10(-5); mother: p = 9x10(-5)), with more educated parents having offspring with fewer ROHs. This association was significantly and fully mediated by the physical distance between parental birthplaces (paternal education: p(mediation) = 2.4 x 10(-4); maternal education: pmediation = 2.3 x 10(-4)), which itself was also significantly associated with Froh (p = 9 x 10(-5)). Ancestry-informative principal components from the offspring showed a significantly decreasing association with geography as parental education increased, consistent with the significantly higher migration rates among more educated parents. Parental education also showed a high spouse correlation (Spearman's. = .66, p = 3 x 10(-262)). We show that less educated parents are less likely to mate with the more mobile parents with a higher education, creating systematic differences in homozygosity due to ancestry differences not directly captured by ancestry-informative principal components (PCs). Understanding how behaviors influence the genomic structure of a population is highly valuable for studies on the genetic etiology of behavioral, cognitive, and social traits.	[Abdellaoul, Abdel; Hottenga, Jouke-Jan; Willemsen, Gonneke; Bartels, Meike; van Beijsterveldt, Toos; de Geus, Eco J.; Boomsma, Dorret I.] Vrije Univ Amsterdam, Dept Biol Psychol, Amsterdam, Netherlands; [Abdellaoul, Abdel; Bartels, Meike; Penninx, Brenda W. J. H.; de Geus, Eco J.; Boomsma, Dorret I.] Neurosci Campus Amsterdam, Amsterdam, Netherlands; [Willemsen, Gonneke; Bartels, Meike; Penninx, Brenda W. J. H.; de Geus, Eco J.; Boomsma, Dorret I.] EMGO Inst Hlth & Care Res, Amsterdam, Netherlands; [Ehli, Erik A.; Davies, Gareth E.] Avera McKennan Hosp & Univ Hlth Ctr, Avera Inst Human Genet, Sioux Falls, SD USA; [Brooks, Andrew] Rutgers State Univ, Dept Genet, Piscataway, NJ USA; [Sullivan, Patrick F.] Univ N Carolina, Dept Genet, Chapel Hill, NC USA; [Penninx, Brenda W. J. H.] Vrije Univ Amsterdam, Med Ctr, Dept Psychiat, Amsterdam, Netherlands	Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; Rutgers State University New Brunswick; University of North Carolina; University of North Carolina Chapel Hill; Vrije Universiteit Amsterdam	Abdellaoul, A (corresponding author), Vrije Univ Amsterdam, Dept Biol Psychol, Amsterdam, Netherlands.	a.abdellaoui@vu.nl	Penninx, Brenda WJH/S-7627-2017; Boomsma, Dorret I/AAX-4470-2020; de Geus, Eco J.C./M-9318-2015; Bartels, Meike/D-4492-2014	Penninx, Brenda WJH/0000-0001-7779-9672; de Geus, Eco J.C./0000-0001-6022-2666; Bartels, Meike/0000-0002-9667-7555; van Beijsterveldt, Toos/0000-0002-6617-4201; Willemsen, Gonneke/0000-0003-3755-0236	Netherlands Organization for Scientific Research (NWO: MagW/ZonMW)10-000-1002 [904-61-090, 985-10-002, 904-61-193, 480-04-004, 400-05-717, Addiction-31160008 Middelgroot-911-09-032, Spinozapremie 56-464-14192, 10-000-1002]; Center for Medical Systems Biology (CMSB, NWO Genomics); NBIC/BioAssist/RK [2008.024]; Biobanking and Biomolecular Resources Research Infrastructure (BBMRI -NL) [184.021.007]; VU University's Institute for Health and Care Research; Neuroscience Campus Amsterdam; European Science Foundation (ESF) [EU/QLRT-2001-01254]; European Community's Seventh Framework Program (FP7); ENGAGE [HEALTH-F4-2007-201413]; European Science Council (ERC) [230374]; Rutgers University Cell and DNA Repository (NIMH) [U24 MH068457-06]; Avera Institute for Human Genetics, Sioux Falls, South Dakota (USA); National Institutes of Health (NIH) [R01D0042157-01A]; Genetic Association Information Network (GAIN) of the Foundation for the US National Institutes of Health (NIMH) [MH081802]; Grand Opportunity from the NIMH [1RC2MH089951-01, 1RC2 MH089995-01]; CSMB; Netherlands Scientific Organization (NWO) [480-05-003]; Dutch Brain Foundation; department of Psychology and Education of the VU University Amsterdam; NATIONAL INSTITUTE OF MENTAL HEALTH [RC2MH089995, U24MH068457, RC2MH089951, R01MH081802] Funding Source: NIH RePORTER	Netherlands Organization for Scientific Research (NWO: MagW/ZonMW)10-000-1002; Center for Medical Systems Biology (CMSB, NWO Genomics); NBIC/BioAssist/RK; Biobanking and Biomolecular Resources Research Infrastructure (BBMRI -NL); VU University's Institute for Health and Care Research; Neuroscience Campus Amsterdam; European Science Foundation (ESF)(European Science Foundation (ESF)); European Community's Seventh Framework Program (FP7); ENGAGE; European Science Council (ERC)(European Research Council (ERC)); Rutgers University Cell and DNA Repository (NIMH); Avera Institute for Human Genetics, Sioux Falls, South Dakota (USA); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Genetic Association Information Network (GAIN) of the Foundation for the US National Institutes of Health (NIMH); Grand Opportunity from the NIMH; CSMB; Netherlands Scientific Organization (NWO)(Netherlands Organization for Scientific Research (NWO)); Dutch Brain Foundation; department of Psychology and Education of the VU University Amsterdam; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by the Netherlands Organization for Scientific Research (NWO: MagW/ZonMW grants 904-61-090, 985-10-002,904-61-193,480-04-004, 400-05-717, Addiction-31160008 Middelgroot-911-09-032, Spinozapremie 56-464-14192, Geestkracht program grant 10-000-1002), Center for Medical Systems Biology (CMSB, NWO Genomics; http://www.cmsb.nl/), NBIC/BioAssist/RK(2008.024), Biobanking and Biomolecular Resources Research Infrastructure (BBMRI -NL, 184.021.007), the VU University's Institute for Health and Care Research (EMGO+, http://www.emgo.nl) and Neuroscience Campus Amsterdam (NCA, http://www.neurosciencecampusamsterdam.nl), the European Science Foundation (ESF, EU/QLRT-2001-01254), the European Community's Seventh Framework Program (FP7/2007-2013), ENGAGE (HEALTH-F4-2007-201413); the European Science Council (ERC Advanced, 230374), Rutgers University Cell and DNA Repository (NIMH U24 MH068457-06), the Avera Institute for Human Genetics, Sioux Falls, South Dakota (USA) and the National Institutes of Health (NIH, R01D0042157-01A). Part of the genotyping was funded by the Genetic Association Information Network (GAIN) of the Foundation for the US National Institutes of Health (NIMH, MH081802) and by the Grand Opportunity grants 1RC2MH089951-01 and 1RC2 MH089995-01 from the NIMH. AA was supported by CSMB (http://www.cmsb.nl/). Most statistical analyses were carried out on the Genetic Cluster Computer (http://www.geneticcluster.org), which is financially supported by the Netherlands Scientific Organization (NWO 480-05-003), the Dutch Brain Foundation, and the department of Psychology and Education of the VU University Amsterdam. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdellaoui A, 2013, BEHAV GENET, V43, P455, DOI 10.1007/s10519-013-9610-1; Abdellaoui A, 2013, EUR J HUM GENET, V21, P1277, DOI 10.1038/ejhg.2013.48; Blossfeld HP, 2009, ANNU REV SOCIOL, V35, P513, DOI 10.1146/annurev-soc-070308-115913; Boker S, 2011, PSYCHOMETRIKA, V76, P306, DOI 10.1007/s11336-010-9200-6; Boomsma DI, 2008, EUR J HUM GENET, V16, P335, DOI 10.1038/sj.ejhg.5201979; Boomsma DI, 2006, TWIN RES HUM GENET, V9, P849, DOI 10.1375/183242706779462426; Boomsma DI, 2014, EUR J HUM GENET, V22, P221, DOI 10.1038/ejhg.2013.118; BOUCHARD TJ, 1990, SCIENCE, V250, P223, DOI 10.1126/science.2218526; Branigan AR, 2013, VARIATION HERITABILI, P13; Breslau J, 2008, J PSYCHIATR RES, V42, P708, DOI 10.1016/j.jpsychires.2008.01.016; Chen JM, 2009, AM J HUM GENET, V85, P775, DOI 10.1016/j.ajhg.2009.10.016; Deary IJ, 2007, INTELLIGENCE, V35, P13, DOI 10.1016/j.intell.2006.02.001; DeRaad B, 1996, EUR J PERSONALITY, V10, P303, DOI 10.1002/(SICI)1099-0984(199612)10:5<303::AID-PER262>3.0.CO;2-2; Domingue BW, 2014, P NATL ACAD SCI USA; Esteve A, 2012, POPUL DEV REV, V38, P535, DOI 10.1111/j.1728-4457.2012.00515.x; Faggian A, 2006, ANN REGIONAL SCI, V40, P461, DOI 10.1007/s00168-006-0061-y; Faggian A, 2007, URBAN STUD, V44, P2511, DOI 10.1080/00420980701667177; Haworth CMA, 2010, MOL PSYCHIATR, V15, P1112, DOI 10.1038/mp.2009.55; HEATH AC, 1985, NATURE, V314, P734, DOI 10.1038/314734a0; Howrigan DP, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-460; JENSEN AR, 1983, PERS INDIV DIFFER, V4, P71, DOI 10.1016/0191-8869(83)90054-5; Kaufman AS, 2009, ARCH CLIN NEUROPSYCH, V24, P153, DOI 10.1093/arclin/acp015; Keller MC, 2011, GENETICS, V189, P237, DOI 10.1534/genetics.111.130922; KESSLER RC, 1995, AM J PSYCHIAT, V152, P1026; Koenig HG, 2009, CAN J PSYCHIAT, V54, P283, DOI 10.1177/070674370905400502; Mackenbach JP, 2008, NEW ENGL J MED, V358, P2468, DOI 10.1056/NEJMsa0707519; MARE RD, 1991, AM SOCIOL REV, V56, P15, DOI 10.2307/2095670; Martin NW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020128; McEvoy BP, 2009, GENOME RES, V19, P804, DOI 10.1101/gr.083394.108; Meara ER, 2008, HEALTH AFFAIR, V27, P350, DOI 10.1377/hlthaff.27.2.350; Mingroni MA, 2004, INTELLIGENCE, V32, P65, DOI 10.1016/S0160-2896(03)00058-8; MORTON NE, 1978, P NATL ACAD SCI USA, V75, P3906, DOI 10.1073/pnas.75.8.3906; Mulder C, 2004, DEMOS, V20, P78; Najmabadi H, 2011, NATURE, V478, P57, DOI 10.1038/nature10423; Novembre J, 2008, NATURE, V456, P98, DOI 10.1038/nature07331; Penninx BWJH, 2008, INT J METH PSYCH RES, V17, P121, DOI 10.1002/mpr.256; Power RA, 2014, AM J MED GENET B, V165, P157, DOI 10.1002/ajmg.b.32217; Power RA, 2014, EUR J HUM GENET, V22, P386, DOI 10.1038/ejhg.2013.155; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rietveld CA, 2013, SCIENCE, V340, P1467, DOI 10.1126/science.1235488; Schwartz CR, 2013, ANNU REV SOCIOL, V39, P451, DOI 10.1146/annurev-soc-071312-145544; Tyler-Smith C, 2012, EUR J HUM GENET, V20, P129, DOI 10.1038/ejhg.2011.153; VANDENBERG SG, 1972, BEHAV GENET, V2, P127, DOI 10.1007/BF01065686; Willemsen G, 2010, TWIN RES HUM GENET, V13, P231, DOI 10.1375/twin.13.3.231; Winney B, 2012, EUR J HUM GENET, V20, P203, DOI 10.1038/ejhg.2011.127; Woodley MA, 2009, INTELLIGENCE, V37, P268, DOI 10.1016/j.intell.2008.10.007; Yang JA, 2011, AM J HUM GENET, V88, P76, DOI 10.1016/j.ajhg.2010.11.011	48	21	21	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2015	10	3							e0118935	10.1371/journal.pone.0118935	http://dx.doi.org/10.1371/journal.pone.0118935			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CC4HV	25734509	Green Published, Green Submitted, gold			2022-12-27	WOS:000350314700048
J	Lanier, HC; Gunderson, AM; Weksler, M; Fedorov, VB; Olson, LE				Lanier, Hayley C.; Gunderson, Aren M.; Weksler, Marcelo; Fedorov, Vadim B.; Olson, Link E.			Comparative Phylogeography Highlights the Double-Edged Sword of Climate Change Faced by Arctic- and Alpine-Adapted Mammals	PLOS ONE			English	Article							GLACIAL REFUGIA; SPERMOPHILUS-PARRYII; PLEISTOCENE REFUGIA; MOLECULAR PHYLOGENY; STATISTICAL TESTS; LEMMINGS LEMMUS; DNA DIVERSITY; NORTH-AMERICA; MITOCHONDRIAL; POPULATION	Recent studies suggest that alpine and arctic organisms may have distinctly different phylo-geographic histories from temperate or tropical taxa, with recent range contraction into interglacial refugia as opposed to post-glacial expansion out of refugia. We use a combination of phylogeographic inference, demographic reconstructions, and hierarchical Approximate Bayesian Computation to test for phylodemographic concordance among five species of alpine-adapted small mammals in eastern Beringia. These species (Collared Pikas, Hoary Marmots, Brown Lemmings, Arctic Ground Squirrels, and Singing Voles) vary in specificity to alpine and boreal-tundra habitat but share commonalities (e.g., cold tolerance and nunatak survival) that might result in concordant responses to Pleistocene glaciations. All five species contain a similar phylogeographic disjunction separating eastern and Beringian lineages, which we show to be the result of simultaneous divergence. Genetic diversity is similar within each haplogroup for each species, and there is no support for a post-Pleistocene population expansion in eastern lineages relative to those from Beringia. Bayesian skyline plots for four of the five species do not support Pleistocene population contraction. Brown Lemmings show evidence of late Quaternary demographic expansion without subsequent population decline. The Wrangell-St. Elias region of eastern Alaska appears to be an important zone of recent secondary contact for nearctic alpine mammals. Despite differences in natural history and ecology, similar phylogeographic histories are supported for all species, suggesting that these, and likely other, alpine-and arctic-adapted taxa are already experiencing population and/or range declines that are likely to synergistically accelerate in the face of rapid climate change. Climate change may therefore be acting as a double-edged sword that erodes genetic diversity within populations but promotes divergence and the generation of biodiversity.				hlanier@uwyo.edu	Weksler, Marcelo/A-7420-2010	Weksler, Marcelo/0000-0001-8111-4779; Lanier, Hayley/0000-0001-9337-4017; Olson, Link/0000-0002-2481-5701	Alaska Department of Fish and Game State Wildlife Grant [T-1-6]; National Science Foundation Doctoral Dissertation Improvement Grant [DEB-0808619]; Alaska EPSCoR Dissertation Enhancement Grant [NSF EPS0092040, 0346770]; American Society of Mammalogists; Alaska Quaternary Center David and Rachel Hopkins Fellowship	Alaska Department of Fish and Game State Wildlife Grant; National Science Foundation Doctoral Dissertation Improvement Grant(National Science Foundation (NSF)); Alaska EPSCoR Dissertation Enhancement Grant; American Society of Mammalogists; Alaska Quaternary Center David and Rachel Hopkins Fellowship	This work was supported by the following sources of funding: Alaska Department of Fish and Game (http://www.adfg.alaska.gov) State Wildlife Grant (Grant T-1-6) to LEO; National Science Foundation (http://www.nsf.gov) Doctoral Dissertation Improvement Grant (DEB-0808619) to LEO and HCL; Alaska EPSCoR (http://www.alaska.edu/epscor/) Dissertation Enhancement Grant (NSF EPS0092040, 0346770) to HCL; American Society of Mammalogists (http://www.mammalsociety.org) Grant in Aid of Research to HCL; and Alaska Quaternary Center (http://www.uaf.edu/aqc/) David and Rachel Hopkins Fellowship to HCL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alsos IG, 2005, MOL ECOL, V14, P2739, DOI 10.1111/j.1365-294X.2005.02621.x; BATZLI GO, 1995, OIKOS, V72, P88, DOI 10.2307/3546042; Beever EA, 2003, J MAMMAL, V84, P37, DOI 10.1644/1545-1542(2003)084<0037:POAEAI>2.0.CO;2; Burnham K.P., 2002, PRACTICAL INFORM THE, V2nd ed., DOI [DOI 10.1007/B97636, 10.1007/b97636]; Catto N, 1996, QUATERN INT, V32, P21, DOI 10.1016/S1040-6182(96)90012-9; Clark PU, 2009, SCIENCE, V325, P710, DOI 10.1126/science.1172873; Cook JA, SMALL MAMMAL INVENTO, P1; Cook JA, 2010, J MAMMAL, V91, P1401, DOI 10.1644/09-MAMM-A-386.1; Dalen L, 2006, MOL ECOL, V15, P2809, DOI 10.1111/j.1365-294X.2006.02983.x; Danby RK, 2005, ECOL APPL, V15, P405, DOI 10.1890/04-0043; Dirnbock T, 2011, GLOBAL CHANGE BIOL, V17, P990, DOI 10.1111/j.1365-2486.2010.02266.x; Dixon EJ, 2013, QUATERN INT, V285, P57, DOI 10.1016/j.quaint.2011.02.027; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; DUKRODKIN A, 1991, GEOGR PHYS QUATERN, V45, P79, DOI 10.7202/032847ar; Eddingsaas AA, 2004, J MAMMAL, V85, P601, DOI 10.1644/BRB-204; Ehrich D, 2005, J MAMMAL, V86, P380, DOI 10.1644/BER-126.1; Eidesen PB, 2007, J BIOGEOGR, V34, P1559, DOI 10.1111/j.1365-2699.2007.01719.x; Fay JC, 2000, GENETICS, V155, P1405; Fedorov V, 1999, BIOL J LINN SOC, V66, P357, DOI 10.1006/bijl.1998.0271; Fedorov VB, 2003, MOL ECOL, V12, P725, DOI 10.1046/j.1365-294X.2003.01776.x; Fedorov VB, 2002, P ROY SOC B-BIOL SCI, V269, P2071, DOI 10.1098/rspb.2002.2126; Fedorov VB, 1999, P ROY SOC B-BIOL SCI, V266, P621, DOI 10.1098/rspb.1999.0681; FELSENSTEIN J, 1992, GENET RES, V59, P139, DOI 10.1017/S0016672300030354; Fickert T, 2007, ARCT ANTARCT ALP RES, V39, P245, DOI 10.1657/1523-0430(2007)39[245:DDGSAP]2.0.CO;2; Fleming MA, 2002, MOL ECOL, V11, P795, DOI 10.1046/j.1365-294X.2002.01472.x; Fu YX, 1997, GENETICS, V147, P915; Galbreath KE, 2012, P ROY SOC B-BIOL SCI, V279, P371, DOI 10.1098/rspb.2011.0482; Galbreath KE, 2011, EVOLUTION, V65, P1879, DOI 10.1111/j.1558-5646.2011.01287.x; Galbreath KE, 2009, EVOLUTION, V63, P2848, DOI 10.1111/j.1558-5646.2009.00803.x; Gillis EA, 2005, OIKOS, V108, P231, DOI 10.1111/j.0030-1299.2005.13535.x; Griffin SC, 2008, BIOL CONSERV, V141, P1293, DOI 10.1016/j.biocon.2008.03.001; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Gunderson AM, 2012, J MAMMAL, V93, P66, DOI 10.1644/10-MAMM-A-380.1; Gunderson AM, 2009, J MAMMAL, V90, P859, DOI 10.1644/08-MAMM-A-253.1; GUTHRIE RD, 1973, J MAMMAL, V54, P970, DOI 10.2307/1379093; Guthrie RD, 2003, NATURE, V426, P169, DOI 10.1038/nature02098; Guthrie RD, 1973, QUATERNARY RES, V1, P474; Guthrie RD., 1982, PALEOECOLOGY BERINGI, P307, DOI [10.1016/b978-0-12-355860-2.50030-2, DOI 10.1016/B978-0-12-355860-2.50030-2, 10.1016/B978-0-12-355860-2.50030-2]; Hadly EA, 2004, PLOS BIOL, V2, P1600, DOI 10.1371/journal.pbio.0020290; Harington C.R., 2003, ANNOTATED BIBLIO QUA; Hein J., 2005, GENE GENEALOGIES VAR; Herron MD, 2004, MOL PHYLOGENET EVOL, V31, P1015, DOI 10.1016/j.ympev.2003.09.015; Hewitt G, 2000, NATURE, V405, P907, DOI 10.1038/35016000; Hewitt GM, 2004, PHILOS T R SOC B, V359, P183, DOI 10.1098/rstb.2003.1388; Hewitt GM, 2001, MOL ECOL, V10, P537, DOI 10.1046/j.1365-294x.2001.01202.x; Hickerson MJ, 2010, MOL PHYLOGENET EVOL, V54, P291, DOI 10.1016/j.ympev.2009.09.016; Hickerson MJ, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-268; Hickerson MJ, 2006, MOL ECOL, V15, P209, DOI 10.1111/j.1365-294X.2005.02718.x; Holderegger R, 2009, J BIOGEOGR, V36, P476, DOI 10.1111/j.1365-2699.2008.02027.x; Hopkins D. M, 1967, BERING LAND BRIDGE; Hopkins DM, 1982, PALEOECOLOGY BERINGI; Hulten E, 1937, OUTLINE HIST ARCTIC; Humphries EM, 2011, MOL ECOL, V20, P573, DOI 10.1111/j.1365-294X.2010.04965.x; Jaarola M, 2004, MOL PHYLOGENET EVOL, V33, P647, DOI 10.1016/j.ympev.2004.07.015; JOPLING AV, 1981, ARCTIC, V34, P3; Kurten B., 1980, PLEISTOCENE MAMMALS; Lagerholm VK, 2014, MOL ECOL, V23, P2060, DOI 10.1111/mec.12698; Lanier HC, 2013, J BIOGEOGR, V40, P466, DOI 10.1111/jbi.12035; Lanier HC, 2009, MOL PHYLOGENET EVOL, V53, P1, DOI 10.1016/j.ympev.2009.05.035; Lessa EP, 2003, P NATL ACAD SCI USA, V100, P10331, DOI 10.1073/pnas.1730921100; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Lyons SK, 2005, AM NAT, V165, pE168, DOI 10.1086/429699; MACDONALD S O, 1987, Mammalian Species, P1, DOI 10.2307/3503971; MacDonald SO, 2009, RECENT MAMMALS OF ALASKA, P1; MacPherson AH, 1985, SYST ZOOL, V14, P153; Marr KL, 2008, J BIOGEOGR, V35, P1323, DOI 10.1111/j.1365-2699.2007.01879.x; Miller A, 2005, ANCHORAGE ALASKA LAK; MOTRO U, 1982, EVOLUTION, V36, P1059, DOI 10.1111/j.1558-5646.1982.tb05474.x; MURRAY B M, 1969, Canadian Field-Naturalist, V83, P331; Near TJ, 2003, EVOLUTION, V57, P1610; Nei M., 1987, MOL EVOLUTIONARY GEN; PATTERSON B. D., 2007, DIGITAL DISTRIBUTION; Pauls SU, 2013, MOL ECOL, V22, P925, DOI 10.1111/mec.12152; Petit RJ, 2003, SCIENCE, V300, P1563, DOI 10.1126/science.1083264; PIELOU EC, 1991, ICE AGE RETURN LIFE; Posada D, 2004, SYST BIOL, V53, P793, DOI 10.1080/10635150490522304; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Provan J, 2008, TRENDS ECOL EVOL, V23, P564, DOI 10.1016/j.tree.2008.06.010; Repenning C. A., 1964, Arctic, V17, P176; Rull V, 2010, J BIOGEOGR, V37, P1623, DOI 10.1111/j.1365-2699.2010.02340.x; Shafer ABA, 2011, EVOLUTION, V65, P125, DOI 10.1111/j.1558-5646.2010.01109.x; Shafer ABA, 2010, MOL ECOL, V19, P4589, DOI 10.1111/j.1365-294X.2010.04828.x; Sher A, 1999, NATURE, V397, P103, DOI 10.1038/16341; SIMPSON GEORGE GAYLORD, 1940, JOUR WASHINGTON ACAD SCI, V30, P137; Steppan SJ, 1999, SYST BIOL, V48, P715, DOI 10.1080/106351599259988; Stewart JR, 2009, J EVOLUTION BIOL, V22, P2363, DOI 10.1111/j.1420-9101.2009.01859.x; Stewart JR, 2010, P ROY SOC B-BIOL SCI, V277, P661, DOI 10.1098/rspb.2009.1272; Szeicz JM, 2001, QUATERNARY SCI REV, V20, P247, DOI 10.1016/S0277-3791(00)00119-0; Tajima F, 1996, GENETICS, V143, P1457; TAJIMA F, 1989, GENETICS, V123, P585; Topp CM, 2008, AUK, V125, P461, DOI 10.1525/auk.2008.06254; TYSER RW, 1980, AM MIDL NAT, V104, P32, DOI 10.2307/2424955; Waltari E, 2007, J BIOGEOGR, V34, P561, DOI 10.1111/j.1365-2699.2007.01705.x; Weksler M, 2010, J BIOGEOGR, V37, P1414, DOI 10.1111/j.1365-2699.2010.02310.x; Youngman P.M., 1975, Publications Zool natn Mus nat Sci Can, VNo. 10, P1; Zeng K, 2006, GENETICS, V174, P1431, DOI 10.1534/genetics.106.061432; Zwickl D. J, 2006, GENETIC ALGORITHM AP	97	13	13	1	85	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2015	10	3							e0118396	10.1371/journal.pone.0118396	http://dx.doi.org/10.1371/journal.pone.0118396			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4HV	25734275	Green Submitted, Green Published, gold			2022-12-27	WOS:000350314700025
J	Amrine, KCH; Blanco-Ulate, B; Cantu, D				Amrine, Katherine C. H.; Blanco-Ulate, Barbara; Cantu, Dario			Discovery of Core Biotic Stress Responsive Genes in Arabidopsis by Weighted Gene Co-Expression Network Analysis	PLOS ONE			English	Article							WRKY TRANSCRIPTION FACTORS; DNA-BINDING PROTEINS; PLANT DEFENSE; INDUCED EXPRESSION; CONSERVATION; EVOLUTION; KINASE; ACID; PHOTOSYNTHESIS; INTEGRATION	Intricate signal networks and transcriptional regulators translate the recognition of pathogens into defense responses. In this study, we carried out a gene co-expression analysis of all currently publicly available microarray data, which were generated in experiments that studied the interaction of the model plant Arabidopsis thaliana with microbial pathogens. This work was conducted to identify (i) modules of functionally related co-expressed genes that are differentially expressed in response to multiple biotic stresses, and (ii) hub genes that may function as core regulators of disease responses. Using Weighted Gene Co-expression Network Analysis (WGCNA) we constructed an undirected network leveraging a rich curated expression dataset comprising 272 microarrays that involved microbial infections of Arabidopsis plants with a wide array of fungal and bacterial pathogens with biotrophic, hemibiotrophic, and necrotrophic lifestyles. WGCNA produced a network with scale-free and small-world properties composed of 205 distinct clusters of co-expressed genes. Modules of functionally related co-expressed genes that are differentially regulated in response to multiple pathogens were identified by integrating differential gene expression testing with functional enrichment analyses of gene ontology terms, known disease associated genes, transcriptional regulators, and cis-regulatory elements. The significance of functional enrichments was validated by comparisons with randomly generated networks. Network topology was then analyzed to identify intra-and inter-modular gene hubs. Based on high connectivity, and centrality in meta-modules that are clearly enriched in defense responses, we propose a list of 66 target genes for reverse genetic experiments to further dissect the Arabidopsis immune system. Our results show that statistical-based data trimming prior to network analysis allows the integration of expression datasets generated by different groups, under different experimental conditions and biological systems, into a functionally meaningful co-expression network.	[Amrine, Katherine C. H.; Blanco-Ulate, Barbara; Cantu, Dario] Univ Calif Davis, Dept Viticulture & Enol, Davis, CA 95616 USA	University of California System; University of California Davis	Cantu, D (corresponding author), Univ Calif Davis, Dept Viticulture & Enol, Davis, CA 95616 USA.	dacantu@ucdavis.edu	Cantu, Dario/E-7658-2010; Blanco-Ulate, Barbara/K-9437-2017	Cantu, Dario/0000-0002-4858-1508; 	California Department of Food and Agriculture [11-0148-SA]; College of Agricultural and Environmental Sciences (UC Davis)	California Department of Food and Agriculture; College of Agricultural and Environmental Sciences (UC Davis)	This work was partially supported by funding to DC from the California Department of Food and Agriculture (project 11-0148-SA) and from the College of Agricultural and Environmental Sciences (UC Davis). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert R, 2000, NATURE, V406, P378, DOI 10.1038/35019019; Alexa A, 2010, GENE SET ENRICHMENT; Alexa A, 2006, BIOINFORMATICS, V22, P1600, DOI 10.1093/bioinformatics/btl140; Asai T, 2002, NATURE, V415, P977, DOI 10.1038/415977a; Ascencio-Ibanez JT, 2008, PLANT PHYSIOL, V148, P436, DOI 10.1104/pp.108.121038; Assenov Y, 2008, BIOINFORMATICS, V24, P282, DOI 10.1093/bioinformatics/btm554; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; Bari R, 2009, PLANT MOL BIOL, V69, P473, DOI 10.1007/s11103-008-9435-0; Bilgin DD, 2010, PLANT CELL ENVIRON, V33, P1597, DOI 10.1111/j.1365-3040.2010.02167.x; Blais A, 2005, GENE DEV, V19, P1499, DOI 10.1101/gad.1325605; Boddu J, 2006, MOL PLANT MICROBE IN, V19, P407, DOI 10.1094/MPMI-19-0407; Bolton MD, 2009, MOL PLANT MICROBE IN, V22, P487, DOI 10.1094/MPMI-22-5-0487; Cai B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095176; Carlson M. R., 2012, AFFYMETRIX ARABIDOPS; Carlson MRJ, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-40; Chen WQ, 2002, PLANT CELL, V14, P559, DOI 10.1105/tpc.010410; Chen XT, 2013, PLANT CELL REP, V32, P1589, DOI 10.1007/s00299-013-1469-3; Chisholm ST, 2006, CELL, V124, P803, DOI 10.1016/j.cell.2006.02.008; Davuluri RV, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-25; Ding ZH, 2009, J GENET GENOMICS, V36, P17, DOI 10.1016/S1673-8527(09)60003-5; Dodd AN, 2010, ANNU REV PLANT BIOL, V61, P593, DOI 10.1146/annurev-arplant-070109-104628; Dodds PN, 2010, NAT REV GENET, V11, P539, DOI 10.1038/nrg2812; Du LQ, 2000, PLANT J, V24, P837, DOI 10.1046/j.1365-313x.2000.00923.x; Encinas-Villarejo S, 2009, J EXP BOT, V60, P3043, DOI 10.1093/jxb/erp152; Eulgem T, 1999, EMBO J, V18, P4689, DOI 10.1093/emboj/18.17.4689; Eulgem T, 2007, CURR OPIN PLANT BIOL, V10, P366, DOI 10.1016/j.pbi.2007.04.020; Fujimoto SY, 2000, PLANT CELL, V12, P393, DOI 10.1105/tpc.12.3.393; Hass C, 2004, EMBO J, V23, P3290, DOI 10.1038/sj.emboj.7600337; He SP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018750; Howles PA, 2006, PLANT J, V48, P606, DOI 10.1111/j.1365-313X.2006.02902.x; Jeong H, 2001, NATURE, V411, P41, DOI 10.1038/35075138; Jiang ZQ, 2011, NUCLEIC ACIDS RES, V39, pD1123, DOI 10.1093/nar/gkq1066; Jin JP, 2014, NUCLEIC ACIDS RES, V42, pD1182, DOI 10.1093/nar/gkt1016; Jordan IK, 2004, MOL BIOL EVOL, V21, P2058, DOI 10.1093/molbev/msh222; Kangasjarvi S, 2012, J EXP BOT, V63, P1619, DOI 10.1093/jxb/err402; Kauffmann A, 2009, BIOINFORMATICS, V25, P2092, DOI 10.1093/bioinformatics/btp354; Kerchev PI, 2012, PLANT CELL ENVIRON, V35, P441, DOI 10.1111/j.1365-3040.2011.02399.x; Langfelder P, 2007, BMC SYST BIOL, V1, DOI 10.1186/1752-0509-1-54; Langfelder P, 2008, BIOINFORMATICS, V24, P719, DOI 10.1093/bioinformatics/btm563; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; Langfelder P, 2012, J STAT SOFTW, V46, P1; Lee I, 2010, NAT BIOTECHNOL, V28, P149, DOI 10.1038/nbt.1603; Lee JM, 2003, GENOME RES, V13, P875, DOI 10.1101/gr.737703; Lee TI, 2002, SCIENCE, V298, P799, DOI 10.1126/science.1075090; Ma SS, 2007, GENOME RES, V17, P1614, DOI 10.1101/gr.6911207; Ma SS, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003840; Major IT, 2010, PHOTOSYNTH RES, V104, P41, DOI 10.1007/s11120-009-9507-2; Maleck K, 2000, NAT GENET, V26, P403, DOI 10.1038/82521; Michelmore RW, 2013, ANNU REV PHYTOPATHOL, V51, P291, DOI 10.1146/annurev-phyto-082712-102334; Navarro L, 2004, PLANT PHYSIOL, V135, P1113, DOI 10.1104/pp.103.036749; Obayashi T, 2008, NUCLEIC ACIDS RES, V36, pD77, DOI 10.1093/nar/gkm840; Oldham MC, 2006, P NATL ACAD SCI USA, V103, P17973, DOI 10.1073/pnas.0605938103; Pandey SP, 2009, PLANT PHYSIOL, V150, P1648, DOI 10.1104/pp.109.138990; Pieterse CMJ, 2012, ANNU REV CELL DEV BI, V28, P489, DOI 10.1146/annurev-cellbio-092910-154055; Pieterse CMJ, 2009, NAT CHEM BIOL, V5, P308, DOI 10.1038/nchembio.164; Ramirez V, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003445; Rentel MC, 2004, NATURE, V427, P858, DOI 10.1038/nature02353; Reverter A, 2008, BIOINFORMATICS, V24, P2491, DOI 10.1093/bioinformatics/btn482; Roberts MR, 2006, NEW PHYTOL, V170, P677, DOI 10.1111/j.1469-8137.2006.01707.x; Schulz P, 2013, PLANT PHYSIOL, V163, P523, DOI 10.1104/pp.113.222539; SESSA G, 1995, PLANT MOL BIOL, V28, P145, DOI 10.1007/BF00042046; Shinozaki K, 2000, CURR OPIN PLANT BIOL, V3, P217, DOI 10.1016/S1369-5266(00)00067-4; Singh KB, 2002, CURR OPIN PLANT BIOL, V5, P430, DOI 10.1016/S1369-5266(02)00289-3; Smoot ME, 2011, BIOINFORMATICS, V27, P431, DOI 10.1093/bioinformatics/btq675; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Spoel SH, 2008, CELL HOST MICROBE, V3, P348, DOI 10.1016/j.chom.2008.05.009; STINTZI A, 1993, BIOCHIMIE, V75, P687, DOI 10.1016/0300-9084(93)90100-7; Tao Y, 2003, PLANT CELL, V15, P317, DOI 10.1105/tpc.007591; Torres MA, 2006, PLANT PHYSIOL, V141, P373, DOI 10.1104/pp.106.079467; Tully JP, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-421; van Dam S, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-535; van Loon LC, 2006, ANNU REV PHYTOPATHOL, V44, P135, DOI 10.1146/annurev.phyto.44.070505.143425; Vanderbeld B, 2007, PLANT MOL BIOL, V64, P683, DOI 10.1007/s11103-007-9189-0; von Saint Paul V, 2011, PLANT CELL, V23, P4124, DOI 10.1105/tpc.111.088443; Wise RP, 2007, ANNU REV PHYTOPATHOL, V45, P329, DOI 10.1146/annurev.phyto.45.011107.143944; Wu ZJ, 2004, J AM STAT ASSOC, V99, P909, DOI 10.1198/016214504000000683; Yang TB, 2004, J BIOL CHEM, V279, P42552, DOI 10.1074/jbc.M402830200; Yilmaz A, 2011, NUCLEIC ACIDS RES, V39, pD1118, DOI 10.1093/nar/gkq1120; Yu DQ, 2001, PLANT CELL, V13, P1527, DOI 10.1105/tpc.13.7.1527; Zhang B, 2005, STAT APPL GENET MOL, V4, DOI 10.2202/1544-6115.1128	80	60	61	3	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2015	10	3							e0118731	10.1371/journal.pone.0118731	http://dx.doi.org/10.1371/journal.pone.0118731			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9JF	25730421	Green Published, gold, Green Submitted			2022-12-27	WOS:000350684900024
J	Ettwig, JF; Bronkhorst, AW				Ettwig, Janne F.; Bronkhorst, Adelbert W.			Attentional Switches and Dual-Task Interference	PLOS ONE			English	Article							ABRUPT VISUAL ONSETS; STIMULUS; CAPTURE; SEARCH; DISCRIMINATION; VOLUNTARY; CAPACITY; COLOR; COST	In four experiments, we studied the time course of interference between detection of an oddball orientation target (OT) in an 8-item circular search display, and identification of a letter target (LT) in a central stream of distractor letters. Dual-task performance for different temporal lags between targets was compared to single-task performance. When the LT preceded the OT, dual-task performance levels were reduced at short inter-target intervals of 0 and 166 ms; when the OT preceded the LT, the dual-task interference was unexpectedly stronger and lasted for up to 500 ms. Resource competition due to temporally overlapping target processing cannot account for this result, because the feature search task is easier than the letter identification task, and therefore would have generated less interference when presented first. Two alternative explanations were explored. First, by manipulating the spatial inter-target distance, we investigated to what degree there is a penalty associated with directing the attentional window from a large object (the search display) to a smaller object (the central letter stream). Second, by varying the duration of the OT and subsequent mask, we studied whether the interference was caused by the difficulty of disengaging attention from the search display. Results support this second explanation and thus indicate that switching attention to the letter stream is hampered by the continuing presence of (masked) search display items. This result shows that attentional effects may play a major role in dual-task execution and can easily obscure interference due to other factors such as resource competition.	[Ettwig, Janne F.; Bronkhorst, Adelbert W.] Vrije Univ Amsterdam, Amsterdam, Netherlands; [Ettwig, Janne F.; Bronkhorst, Adelbert W.] TNO, Soesterberg, Netherlands	Vrije Universiteit Amsterdam; Netherlands Organization Applied Science Research	Ettwig, JF (corresponding author), Vrije Univ Amsterdam, Amsterdam, Netherlands.	J.F.Ettwig@vu.nl			Netherlands Ministry of Defense	Netherlands Ministry of Defense	This research was supported by funding from the Netherlands Ministry of Defense. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLPORT DA, 1971, PERCEPT PSYCHOPHYS, V10, P104; Arnell KM, 2002, COGNITIVE PSYCHOL, V44, P105, DOI 10.1006/cogp.2001.0762; BRAUN J, 1994, J NEUROSCI, V14, P554; Braun J, 1998, PERCEPT PSYCHOPHYS, V60, P1, DOI 10.3758/BF03211915; BRAUN J, 1991, PERCEPTION, V20, P483, DOI 10.1068/p200483; CHEAL ML, 1991, ACTA PSYCHOL, V76, P201, DOI 10.1016/0001-6918(91)90020-Z; Colombo J, 2001, ANNU REV PSYCHOL, V52, P337, DOI 10.1146/annurev.psych.52.1.337; Csibra G, 1997, NEUROPSYCHOLOGIA, V35, P855, DOI 10.1016/S0028-3932(97)00016-X; Doi H, 2012, PSYCHON B REV, V19, P858, DOI 10.3758/s13423-012-0284-0; Duncan J, 1997, NATURE, V387, P808, DOI 10.1038/42947; Ettwig JF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053093; FISCHER B, 1987, REV PHYSIOL BIOCH P, V106, P1, DOI 10.1007/BFb0027574; Franconeri SL, 2003, PERCEPT PSYCHOPHYS, V65, P999, DOI 10.3758/BF03194829; Gould IC, 2007, J VISION, V7, DOI 10.1167/7.13.4; HAWKINS HL, 1990, J EXP PSYCHOL HUMAN, V16, P802, DOI 10.1037/0096-1523.16.4.802; Ho CE, 1998, P NATL ACAD SCI USA, V95, P400, DOI 10.1073/pnas.95.1.400; JONIDES J, 1988, PERCEPT PSYCHOPHYS, V43, P346, DOI 10.3758/BF03208805; Jonides J., 1981, ATTENTION PERFORM, P187, DOI DOI 10.1037/0096-1523.29.5.835; Joseph JS, 1997, NATURE, V387, P805, DOI 10.1038/42940; Kinsbourne M, 1989, HUMAN SKILLS, P65; Lee DK, 1999, PERCEPT PSYCHOPHYS, V61, P1241, DOI 10.3758/BF03206177; Leonard CJ, 2008, VIS COGN, V16, P1078, DOI 10.1080/13506280701580698; Lin JY, 2008, PSYCHOL SCI, V19, P686, DOI 10.1111/j.1467-9280.2008.02143.x; Mack A., 1998, INATTENTIONAL BLINDN; MILLER J, 1989, PERCEPT PSYCHOPHYS, V45, P567, DOI 10.3758/BF03208064; Moore CM, 1996, PSYCHON B REV, V3, P360, DOI 10.3758/BF03210761; Morgan MJ, 1998, Q J EXP PSYCHOL-A, V51, P347, DOI 10.1080/713755766; MULLER HJ, 1989, J EXP PSYCHOL HUMAN, V15, P315, DOI 10.1037/0096-1523.15.2.315; PASHLER H, 1994, PSYCHOL BULL, V116, P220, DOI 10.1037/0033-2909.116.2.220; Pashler H., 1997, PSYCHOL ATTENTION; POSNER MI, 1980, J EXP PSYCHOL GEN, V109, P160, DOI 10.1037/0096-3445.109.2.160; POSNER MI, 1980, Q J EXP PSYCHOL, V32, P3, DOI 10.1080/00335558008248231; POSNER MI, 1990, ANNU REV NEUROSCI, V13, P25, DOI 10.1146/annurev.ne.13.030190.000325; RAYMOND JE, 1992, J EXP PSYCHOL HUMAN, V18, P849, DOI 10.1037/0096-1523.18.3.849; Rovamo J, 1979, EXPT BRAIN RES, V37; SCHIFF W, 1962, SCIENCE, V136, P982, DOI 10.1126/science.136.3520.982; Skarratt PA, 2014, J EXP PSYCHOL HUMAN, V40, P566, DOI 10.1037/a0034456; Sperling G., 1986, HDB PERCEPTION PERFO, V1, P1; Takeuchi T, 1997, VISION RES, V37, P2083, DOI 10.1016/S0042-6989(96)00225-8; Theeuwes J, 2002, PERCEPT PSYCHOPHYS, V64, P764, DOI 10.3758/BF03194743; THEEUWES J, 1991, PERCEPT PSYCHOPHYS, V49, P83, DOI 10.3758/BF03211619; THEEUWES J, 1994, J EXP PSYCHOL HUMAN, V20, P799, DOI 10.1037/0096-1523.20.4.799; Theeuwes J, 2010, ACTA PSYCHOL, V135, P77, DOI 10.1016/j.actpsy.2010.02.006; Treisman A. M., 1973, ATTENTION PERFORM, P101; TREISMAN AM, 1969, PSYCHOL REV, V76, P282, DOI 10.1037/h0027242; TREISMAN AM, 1980, COGNITIVE PSYCHOL, V12, P97, DOI 10.1016/0010-0285(80)90005-5; Visser TAW, 1999, PSYCHON B REV, V6, P432, DOI 10.3758/BF03210831; Wickens CD, 2008, HUM FACTORS, V50, P397, DOI 10.1518/001872008X288420; YANTIS S, 1994, J EXP PSYCHOL HUMAN, V20, P95, DOI 10.1037/0096-1523.20.1.95; YANTIS S, 1990, J EXP PSYCHOL HUMAN, V16, P121, DOI 10.1037/0096-1523.16.1.121	50	3	3	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2015	10	3							e0118216	10.1371/journal.pone.0118216	http://dx.doi.org/10.1371/journal.pone.0118216			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CC9JF	25730112	gold, Green Published, Green Submitted			2022-12-27	WOS:000350684900020
J	Deng, JT; Wang, XL; Chen, YX; O'Brien, ER; Gui, Y; Walsh, MP				Deng, Jing-Ti; Wang, Xiu-Ling; Chen, Yong-Xiang; O'Brien, Edward R.; Gui, Yu; Walsh, Michael P.			The Effects of Knockdown of Rho-Associated Kinase 1 and Zipper-Interacting Protein Kinase on Gene Expression and Function in Cultured Human Arterial Smooth Muscle Cells	PLOS ONE			English	Article							MYOSIN LIGHT-CHAIN; SERINE/THREONINE KINASE; RHOA/RHO-KINASE; CA2+ SENSITIZATION; INDUCED APOPTOSIS; CANCER CELLS; DAP-KINASE; PHOSPHORYLATION; PHOSPHATASE; DEATH	Rho-associated kinase (ROCK) and zipper-interacting protein kinase (ZIPK) have been implicated in diverse physiological functions. ROCK1 phosphorylates and activates ZIPK suggesting that at least some of these physiological functions may require both enzymes. To test the hypothesis that sequential activation of ROCK1 and ZIPK is commonly involved in regulatory pathways, we utilized siRNA to knock down ROCK1 and ZIPK in cultured human arterial smooth muscle cells (SMC). Microarray analysis using a whole-transcript expression chip identified changes in gene expression induced by ROCK1 and ZIPK knockdown. ROCK1 knockdown affected the expression of 553 genes, while ZIPK knockdown affected the expression of 390 genes. A high incidence of regulation of transcription regulator genes was observed in both knockdowns. Other affected groups included transporters, kinases, peptidases, transmembrane and G protein-coupled receptors, growth factors, phosphatases and ion channels. Only 76 differentially expressed genes were common to ROCK1 and ZIPK knockdown. Ingenuity Pathway Analysis identified five pathways shared between the two knockdowns. We focused on cytokine signaling pathways since ROCK1 knockdown up-regulated 5 and down-regulated 4 cytokine genes, in contrast to ZIPK knockdown, which affected the expression of only two cytokine genes (both down-regulated). IL-6 gene expression and secretion of IL-6 protein were up-regulated by ROCK1 knockdown, whereas ZIPK knockdown reduced IL-6 mRNA expression and IL-6 protein secretion and increased ROCK1 protein expression, suggesting that ROCK1 may inhibit IL-6 secretion. IL-1 beta mRNA and protein levels were increased in response to ROCK1 knockdown. Differences in the effects of ROCK1 and ZIPK knockdown on cell cycle regulatory genes suggested that ROCK1 and ZIPK regulate the cell cycle by different mechanisms. ROCK1, but not ZIPK knockdown reduced the viability and inhibited proliferation of vascular SMC. We conclude that ROCK1 and ZIPK have diverse, but predominantly distinct regulatory functions in vascular SMC and that ROCK1-mediated activation of ZIPK is not involved in most of these functions.	[Deng, Jing-Ti; Walsh, Michael P.] Univ Calgary, Smooth Muscle Res Grp, Calgary, AB T2N 1N4, Canada; [Deng, Jing-Ti; Walsh, Michael P.] Univ Calgary, Dept Biochem & Mol Biol, Calgary, AB T2N 1N4, Canada; [Wang, Xiu-Ling] Univ Calgary, Southern Alberta Canc Res Inst, Microarray & Genom Facil, Calgary, AB T2N 1N4, Canada; [Chen, Yong-Xiang; O'Brien, Edward R.] Univ Calgary, Div Cardiol, Libin Cardiovasc Inst Alberta, Calgary, AB T2N 1N4, Canada; [Gui, Yu] Univ Calgary, Dept Physiol & Pharmacol, Calgary, AB T2N 1N4, Canada; [Walsh, Michael P.] Univ Calgary, Hotchkiss Brain Inst, Calgary, AB T2N 1N4, Canada; [Walsh, Michael P.] Univ Calgary, Libin Cardiovasc Inst Alberta, Calgary, AB T2N 1N4, Canada	University of Calgary; University of Calgary; University of Calgary; Libin Cardiovascular Institute Of Alberta; University of Calgary; University of Calgary; University of Calgary; Libin Cardiovascular Institute Of Alberta; University of Calgary	Walsh, MP (corresponding author), Univ Calgary, Smooth Muscle Res Grp, Calgary, AB T2N 1N4, Canada.	walsh@ucalgary.ca	O'Brien, Edward R/J-6621-2013	O'Brien, Edward R/0000-0003-1039-9425	Canadian Institutes of Health Research [MOP-111262]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by grant MOP-111262 to MPW from The Canadian Institutes of Health Research (http://www.cihr-irsc.gc.ca). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amano M, 1996, J BIOL CHEM, V271, P20246, DOI 10.1074/jbc.271.34.20246; Barman SA, 2009, VASC HEALTH RISK MAN, V5, P663, DOI 10.2147/VHRM.S4711; Bialik S, 2006, ANNU REV BIOCHEM, V75, P189, DOI 10.1146/annurev.biochem.75.103004.142615; Chang YWE, 2009, RECENT PAT ANTI-CANC, V4, P110, DOI 10.2174/157489209788452830; Das M, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-148; Gao BH, 2007, ANDROLOGIA, V39, P146, DOI 10.1111/j.1439-0272.2007.00782.x; Gozuacik D, 2006, AUTOPHAGY, V2, P74, DOI 10.4161/auto.2.2.2459; Graves PR, 2005, J BIOL CHEM, V280, P9363, DOI 10.1074/jbc.M412538200; Hagerty L, 2007, J BIOL CHEM, V282, P4884, DOI 10.1074/jbc.M609990200; Hiroki J, 2004, J MOL CELL CARDIOL, V37, P537, DOI 10.1016/j.yjmcc.2004.05.008; Ihara E, 2007, CAN J PHYSIOL PHARM, V85, P79, DOI 10.1139/Y06-103; Iizuka K, 1999, BRIT J PHARMACOL, V128, P925, DOI 10.1038/sj.bjp.0702864; Inbal B, 2002, J CELL BIOL, V157, P455, DOI 10.1083/jcb.200109094; Inbal B, 2000, MOL CELL BIOL, V20, P1044, DOI 10.1128/MCB.20.3.1044-1054.2000; Ishizaki T, 1996, EMBO J, V15, P1885, DOI 10.1002/j.1460-2075.1996.tb00539.x; Ishizaki T, 2000, MOL PHARMACOL, V57, P976; Kawai T, 1998, MOL CELL BIOL, V18, P1642, DOI 10.1128/MCB.18.3.1642; Khan WI, 2006, CLIN EXP IMMUNOL, V143, P389, DOI 10.1111/j.1365-2249.2005.02979.x; KITAZAWA T, 1991, P NATL ACAD SCI USA, V88, P9307, DOI 10.1073/pnas.88.20.9307; KITAZAWA T, 1989, J BIOL CHEM, V264, P5339; Kogel D, 2001, BRIT J CANCER, V85, P1801, DOI 10.1054/bjoc.2001.2158; Kogel D, 1998, ONCOGENE, V17, P2645, DOI 10.1038/sj.onc.1202204; Komatsu S, 2004, J CELL BIOL, V165, P243, DOI 10.1083/jcb.200309056; Kosako H, 2000, ONCOGENE, V19, P6059, DOI 10.1038/sj.onc.1203987; KUBOTA Y, 1992, AM J PHYSIOL, V262, pC405, DOI 10.1152/ajpcell.1992.262.2.C405; Kureishi Y, 1997, J BIOL CHEM, V272, P12257, DOI 10.1074/jbc.272.19.12257; Leung T, 1996, MOL CELL BIOL, V16, P5313; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; LoGrasso PV, 2009, CURR TOP MED CHEM, V9, P704, DOI 10.2174/156802609789044452; MacDonald JA, 2001, P NATL ACAD SCI USA, V98, P2419, DOI 10.1073/pnas.041331498; MacDonald JA, 2001, FEBS LETT, V493, P91, DOI 10.1016/S0014-5793(01)02277-3; MASUO M, 1994, J GEN PHYSIOL, V104, P265, DOI 10.1085/jgp.104.2.265; Matsui T, 1996, EMBO J, V15, P2208, DOI 10.1002/j.1460-2075.1996.tb00574.x; Moffat LD, 2011, J BIOL CHEM, V286, P36978, DOI 10.1074/jbc.M111.257949; Mukhopadhyay R, 2008, MOL CELL, V32, P371, DOI 10.1016/j.molcel.2008.09.019; Murata-Hori M, 2001, ONCOGENE, V20, P8175, DOI 10.1038/sj.onc.1205055; Murthy KS, 2003, BIOCHEM J, V374, P145, DOI 10.1042/BJ20021274; Nakamura Y, 2006, BIOCHEM BIOPH RES CO, V350, P68, DOI 10.1016/j.bbrc.2006.08.192; Niiro N, 2001, J BIOL CHEM, V276, P29567, DOI 10.1074/jbc.M102753200; Nunes KP, 2010, CELL MOL LIFE SCI, V67, P3823, DOI 10.1007/s00018-010-0460-1; Pawlak G, 2002, MOL BIOL CELL, V13, P336, DOI 10.1091/mbc.01-02-0302; Riento K, 2003, NAT REV MOL CELL BIO, V4, P446, DOI 10.1038/nrm1128; Rikitake Y, 2005, EXPERT REV CARDIOVAS, V3, P441, DOI 10.1586/14779072.3.3.441; Salinthone S, 2004, AM J PHYSIOL-GASTR L, V287, pG627, DOI 10.1152/ajpgi.00462.2003; Sato N, 2006, IMMUNOL LETT, V103, P127, DOI 10.1016/j.imlet.2005.10.015; Sato N, 2005, INT IMMUNOL, V17, P1543, DOI 10.1093/intimm/dxh331; Shani G, 2004, MOL CELL BIOL, V24, P8611, DOI 10.1128/MCB.24.19.8611-8626.2004; Shimokawa H, 2002, J CARDIOVASC PHARM, V39, P319, DOI 10.1097/00005344-200203000-00001; Shohat G, 2002, BBA-PROTEINS PROTEOM, V1600, P45, DOI 10.1016/S1570-9639(02)00443-0; Shojo H, 2010, NEUROSCIENCE, V171, P1273, DOI 10.1016/j.neuroscience.2010.10.018; Singer CA, 2004, BIOESSAYS, V26, P646, DOI 10.1002/bies.20041; Somlyo AP, 2004, J MUSCLE RES CELL M, V25, P613; Sward K, 2000, J PHYSIOL-LONDON, V522, P33, DOI 10.1111/j.1469-7793.2000.0033m.x; Totsukawa G, 2000, J CELL BIOL, V150, P797, DOI 10.1083/jcb.150.4.797; Usui T, 2014, APOPTOSIS, V19, P387, DOI 10.1007/s10495-013-0934-3; Usui T, 2012, HYPERTENSION, V60, P1031, DOI 10.1161/HYPERTENSIONAHA.112.200337; Usui T, 2011, BIOCHEM BIOPH RES CO, V405, P47, DOI 10.1016/j.bbrc.2010.12.120; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Walter M, 2009, ONCOGENE, V28, P2745, DOI 10.1038/onc.2009.130; Zhang SY, 2009, MOL CANCER RES, V7, P570, DOI 10.1158/1541-7786.MCR-08-0248; Zhao Y, 2013, BIOCHEM BIOPH RES CO, V432, P488, DOI 10.1016/j.bbrc.2013.02.009; Zhao ZY, 2003, DEV DYNAM, V226, P24, DOI 10.1002/dvdy.10212	62	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2015	10	2							e0116969	10.1371/journal.pone.0116969	http://dx.doi.org/10.1371/journal.pone.0116969			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC3LS	25723491	Green Published, gold, Green Submitted			2022-12-27	WOS:000350251200024
J	Soufan, O; Kleftogiannis, D; Kalnis, P; Bajic, VB				Soufan, Othman; Kleftogiannis, Dimitrios; Kalnis, Panos; Bajic, Vladimir B.			DWFS: A Wrapper Feature Selection Tool Based on a Parallel Genetic Algorithm	PLOS ONE			English	Article							MUTUAL INFORMATION; CLASSIFICATION; EXPRESSION; CANCER; PREDICTION	Many scientific problems can be formulated as classification tasks. Data that harbor relevant information are usually described by a large number of features. Frequently, many of these features are irrelevant for the class prediction. The efficient implementation of classification models requires identification of suitable combinations of features. The smaller number of features reduces the problem's dimensionality and may result in higher classification performance. We developed DWFS, a web-based tool that allows for efficient selection of features for a variety of problems. DWFS follows the wrapper paradigm and applies a search strategy based on Genetic Algorithms (GAs). A parallel GA implementation examines and evaluates simultaneously large number of candidate collections of features. DWFS also integrates various filtering methods that may be applied as a pre-processing step in the feature selection process. Furthermore, weights and parameters in the fitness function of GA can be adjusted according to the application requirements. Experiments using heterogeneous datasets from different biomedical applications demonstrate that DWFS is fast and leads to a significant reduction of the number of features without sacrificing performance as compared to several widely used existing methods. DWFS can be accessed online at www.cbrc.kaust.edu.sa/dwfs.	[Soufan, Othman; Bajic, Vladimir B.] King Abdullah Univ Sci & Technol, CBRC, CEMSE, Thuwal 239556900, Saudi Arabia; [Kleftogiannis, Dimitrios; Kalnis, Panos] King Abdullah Univ Sci & Technol, CEMSE, Thuwal 239556900, Saudi Arabia	King Abdullah University of Science & Technology; King Abdullah University of Science & Technology	Bajic, VB (corresponding author), King Abdullah Univ Sci & Technol, CBRC, CEMSE, Thuwal 239556900, Saudi Arabia.	vladimir.bajic@kaust.edu.sa	Soufan, Othman/AAB-9324-2020; Kalnis, Panos/H-2826-2014; Soufan, Othman/AAZ-5986-2020; Bajic, Vladimir/D-2810-2009	Soufan, Othman/0000-0002-4410-1853; Kalnis, Panos/0000-0002-5060-1360; Kleftogiannis, Dimitrios/0000-0003-1086-821X; Bajic, Vladimir/0000-0001-5435-4750	KAUST Research Funds via AEA KAUST-Stanford Round 3 Global Collaborative Research Program	KAUST Research Funds via AEA KAUST-Stanford Round 3 Global Collaborative Research Program	This research has been funded by KAUST Research Funds via AEA KAUST-Stanford Round 3 Global Collaborative Research Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akbani R, 2004, LECT NOTES COMPUT SC, V3201, P39, DOI 10.1007/978-3-540-30115-8_7; [Anonymous], INTRO FEATURE SELECT; Bajic V B, 2000, Brief Bioinform, V1, P214, DOI 10.1093/bib/1.3.214; Batuwita R, 2009, BIOINFORMATICS, V25, P989, DOI 10.1093/bioinformatics/btp107; Blake CL, 1998, UCI REPOSITORY MACHI; Bochkanov S, 2010, ALGLIB SOFTWARE LIB; Braga-Neto UM, 2004, BIOINFORMATICS, V20, P374, DOI 10.1093/bioinformatics/btg419; Brown G, 2012, J MACH LEARN RES, V13, P27; Cantu-Paz E., 1998, CALCULATEURS PARALLE, V10, P141; Cawley GC, 2010, J MACH LEARN RES, V11, P2079; Cheng TJ, 2012, BIOINFORMATICS, V28, P2851, DOI 10.1093/bioinformatics/bts528; Duval B, 2010, BRIEF BIOINFORM, V11, P127, DOI 10.1093/bib/bbp035; Fleuret F, 2004, J MACH LEARN RES, V5, P1531; Garbarine E, 2011, COMPUT BIOL CHEM, V35, P199, DOI 10.1016/j.compbiolchem.2011.04.007; Glaab E, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-358; Golub TR, 1999, SCIENCE, V286, P531, DOI 10.1126/science.286.5439.531; Guyon I., 2003, J MACH LEARN RES, V3, P1157, DOI DOI 10.1162/153244303322753616; Hall M., 2009, SIGKDD EXPLORATIONS, V11, P10, DOI [10.1145/1656274.1656278, DOI 10.1145/1656274.1656278]; Hilario M, 2008, BRIEF BIOINFORM, V9, P102, DOI 10.1093/bib/bbn005; Holland J.H., 1975, ADAPTATION NATURAL A; Jakulin A, 2005, MACHINE LEARNING BAS; Kohavi R, 1997, ARTIF INTELL, V97, P273, DOI 10.1016/S0004-3702(97)00043-X; Kohavi R, 1995, STUDY CROSS VALIDATI, V14, P1137; LEVINE D, 1996, USERS GUIDE PGAPACK; Liu H, 2005, IEEE T KNOWL DATA EN, V17, P491, DOI 10.1109/TKDE.2005.66; Lustgarten JL, 2009, MEASURING STABILITY, P406, DOI [10.1111/j.1551-6709.2009.01079.x, DOI 10.1111/J.1551-6709.2009.01079.X]; Magana-Mora A, 2013, BIOINFORMATICS, V29, P117, DOI 10.1093/bioinformatics/bts638; Peng HC, 2005, IEEE T PATTERN ANAL, V27, P1226, DOI 10.1109/TPAMI.2005.159; Rokach L, 2013, WORLD SCI, V328; Saeys Y, 2007, BIOINFORMATICS, V23, P2507, DOI 10.1093/bioinformatics/btm344; Schmeier S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021887; Seo M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040419; SIEDLECKI W, 1989, PATTERN RECOGN LETT, V10, P335, DOI 10.1016/0167-8655(89)90037-8; Singh D, 2002, CANCER CELL, V1, P203, DOI 10.1016/S1535-6108(02)00030-2; Somol P., 2010, Proceedings of the 2010 20th International Conference on Pattern Recognition (ICPR 2010), P4396, DOI 10.1109/ICPR.2010.1068; Spira A, 2007, NAT MED, V13, P361, DOI 10.1038/nm1556; Wang HT, 2012, BIOINFORMATICS, V28, P2834, DOI 10.1093/bioinformatics/bts531; Xia JG, 2009, NUCLEIC ACIDS RES, V37, pW652, DOI 10.1093/nar/gkp356; Yang HH, 1999, DATA VISUALIZATION F, V12, P687, DOI DOI 10.1094/PHYTO.1999.89.8.687; Ye K, 2008, BIOINFORMATICS, V24, P18, DOI 10.1093/bioinformatics/btm537; Zare H, 2011, FEALECT FEATURE SELE	41	50	51	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2015	10	2							e0117988	10.1371/journal.pone.0117988	http://dx.doi.org/10.1371/journal.pone.0117988			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC2ZH	25719748	Green Published, gold, Green Submitted			2022-12-27	WOS:000350213200036
J	Aasheim, ET; Sharp, SJ; Appleby, PN; Shipley, MJ; Lentjes, MAH; Khaw, KT; Brunner, E; Key, TJ; Wareham, NJ				Aasheim, Erlend T.; Sharp, Stephen J.; Appleby, Paul N.; Shipley, Martin J.; Lentjes, Marleen A. H.; Khaw, Kay-Tee; Brunner, Eric; Key, Tim J.; Wareham, Nicholas J.			Tinned Fruit Consumption and Mortality in Three Prospective Cohorts	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; URINARY BISPHENOL-A; FOOD-FREQUENCY QUESTIONNAIRE; DIETARY ASSESSMENT METHODS; VEGETABLE INTAKE; CARDIOVASCULAR-DISEASE; EPIC-NORFOLK; WEIGHED RECORDS; VITAMIN-C; RISK	Dietary recommendations to promote health include fresh, frozen and tinned fruit, but few studies have examined the health benefits of tinned fruit. We therefore studied the association between tinned fruit consumption and mortality. We followed up participants from three prospective cohorts in the United Kingdom: 22,421 participants from the European Prospective Investigation into Cancer and Nutrition (EPIC)-Norfolk cohort (1993-2012), 52,625 participants from the EPIC-Oxford cohort (1993-2012), and 7440 participants from the Whitehall II cohort (1991-2012), all reporting no history of heart attack, stroke, or cancer when entering these studies. We estimated the association between frequency of tinned fruit consumption and all cause mortality (primary outcome measure) using Cox regression models within each cohort, and pooled hazard ratios across cohorts using random-effects meta-analysis. Tinned fruit consumption was assessed with validated food frequency questionnaires including specific questions about tinned fruit. During 1,305,330 person years of follow-up, 8857 deaths occurred. After adjustment for lifestyle factors and risk markers the pooled hazard ratios (95% confidence interval) of all cause mortality compared with the reference group of tinned fruit consumption less often than one serving per month were: 1.05 (0.99, 1.12) for one to three servings per month, 1.10 (1.03, 1.18) for one serving per week, and 1.13 (1.04, 1.23) for two or more servings per week. Analysis of cause-specific mortality showed that tinned fruit consumption was associated with mortality from cardiovascular causes and from non-cardiovascular, non-cancer causes. In a pooled analysis of three prospective cohorts from the United Kingdom self-reported tinned fruit consumption in the 1990s was weakly but positively associated with mortality during long-term follow-up. These findings raise questions about the evidence underlying dietary recommendations to promote tinned fruit consumption as part of a healthy diet.	[Aasheim, Erlend T.; Sharp, Stephen J.; Wareham, Nicholas J.] Univ Cambridge, Med Res Council Epidemiol Unit, Cambridge, England; [Appleby, Paul N.; Key, Tim J.] Univ Oxford, Nuffield Dept Populat Hlth, Canc Epidemiol Unit, Oxford, England; [Shipley, Martin J.; Brunner, Eric] UCL, Dept Epidemiol & Publ Hlth, London, England; [Lentjes, Marleen A. H.; Khaw, Kay-Tee] Univ Cambridge, Dept Publ Hlth & Primary Care, Cambridge, England	UK Research & Innovation (UKRI); Medical Research Council UK (MRC); University of Cambridge; University of Oxford; University of London; University College London; University of Cambridge	Aasheim, ET (corresponding author), Univ Cambridge, Med Res Council Epidemiol Unit, Cambridge, England.	erlend.aasheim@mrc-epid.cam.ac.uk	Brunner, Eric/H-2114-2011; Khaw, Kay-Tee/AAZ-3209-2021	Brunner, Eric/0000-0002-0595-4474; Lentjes, Marleen/0000-0003-4713-907X; Aasheim, Erlend Tuseth/0000-0002-6246-6303	Medical Research Council [G1000143, G0401527, G9502233, G0300128]; Cancer Research UK [C864/A14136, C865/A2883, C570/A11691]; Medical Research Council; British Heart Foundation; British Health and Safety Executive; British Department of Health; National Heart, Lung, and Blood Institute [R01HL036310]; National Institute on Aging at the US National Institutes of Health (NIH); United Kingdom National Institute for Health Research; MRC [G0500300, MC_UU_12015/1, G0300128, MR/K013351/1] Funding Source: UKRI; British Heart Foundation [RG/13/2/30098] Funding Source: researchfish; Cancer Research UK [14136, 16491] Funding Source: researchfish; Medical Research Council [MR/K013351/1, MC_U106179471, UD99999933, MC_UU_12015/1, G0500300] Funding Source: researchfish; National Institute for Health Research [NF-SI-0512-10114] Funding Source: researchfish; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL036310] Funding Source: NIH RePORTER	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation(British Heart Foundation); British Health and Safety Executive; British Department of Health; National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute on Aging at the US National Institutes of Health (NIH); United Kingdom National Institute for Health Research(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation(British Heart Foundation); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	EPIC-Norfolk is supported by the Medical Research Council (grant numbers G1000143, G0401527, G9502233, G0300128) and Cancer Research UK (grant numbers C864/A14136, C865/A2883). EPIC-Oxford is supported by Cancer Research UK (C570/A11691). Whitehall II has been supported by grants from the Medical Research Council; the British Heart Foundation; the British Health and Safety Executive; the British Department of Health; the National Heart, Lung, and Blood Institute (R01HL036310); and the National Institute on Aging at the US National Institutes of Health (NIH). ETA is supported by an academic clinical fellowship awarded by the United Kingdom National Institute for Health Research. EB is funded by the British Heart Foundation. MAHL received grants from Cancer Research UK, and Medical Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aasebo U, 2009, BRIT MED J, V339, DOI 10.1136/bmj.b5038; [Anonymous], 2010, DIET GUID AM, V7th ed.; ARVANITOYANNIS I, 1990, NAHRUNG, V34, P141, DOI 10.1002/food.19900340208; Bazzano LA, 2002, AM J CLIN NUTR, V76, P93; Bingham SA, 1997, INT J EPIDEMIOL, V26, pS137, DOI 10.1093/ije/26.suppl_1.S137; BINGHAM SA, 1994, BRIT J NUTR, V72, P619, DOI 10.1079/BJN19940064; Bingham SA, 2001, PUBLIC HEALTH NUTR, V4, P847, DOI 10.1079/PHN2000102; Boekholdt MS, 2004, AM J MED, V117, P390, DOI 10.1016/j.amjmed.2004.04.010; Brunner E, 2001, BRIT J NUTR, V86, P405, DOI 10.1079/BJN2001414; Brunner EJ, 2008, AM J CLIN NUTR, V87, P1414, DOI 10.1093/ajcn/87.5.1414; Carwile JL, 2011, JAMA-J AM MED ASSOC, V306, P2218, DOI 10.1001/jama.2011.1721; Crowe FL, 2011, EUR HEART J, V32, P1235, DOI 10.1093/eurheartj/ehq465; Dauchet L, 2004, BRIT J NUTR, V92, P963, DOI 10.1079/BJN20041286; Dauchet L, 2006, J NUTR, V136, P2588, DOI 10.1093/jn/136.10.2588; Dauchet L, 2009, NAT REV CARDIOL, V6, P599, DOI 10.1038/nrcardio.2009.131; Davey GK, 2003, PUBLIC HEALTH NUTR, V6, P259, DOI 10.1079/PHN2002430; Day N, 1999, BRIT J CANCER, V80, P95; Hartley L, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009874.pub2; He FJ, 2007, J HUM HYPERTENS, V21, P717, DOI 10.1038/sj.jhh.1002212; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Hu H, 2007, ENVIRON HEALTH PERSP, V115, P455, DOI 10.1289/ehp.9783; Hung HC, 2004, JNCI-J NATL CANCER I, V96, P1577, DOI 10.1093/jnci/djh296; Joshipura KJ, 2001, ANN INTERN MED, V134, P1106, DOI 10.7326/0003-4819-134-12-200106190-00010; Lang IA, 2008, JAMA-J AM MED ASSOC, V300, P1303, DOI 10.1001/jama.300.11.1303; Liu S, 2000, AM J CLIN NUTR, V72, P922; MARMOT MG, 1991, LANCET, V337, P1387, DOI 10.1016/0140-6736(91)93068-K; MEAH MN, 1991, FOOD ADDIT CONTAM, V8, P485, DOI 10.1080/02652039109373999; Mekary RA, 2009, AM J EPIDEMIOL, V170, P519, DOI 10.1093/aje/kwp163; Melzer D, 2012, CIRCULATION, V125, P1482, DOI 10.1161/CIRCULATIONAHA.111.069153; Ministry of Agriculture Fisheres and Food, 1998, ANNUAL REPORT ON FOO; Ministry of Agriculture Fisheries and Food, 2001, NATIONAL FOOD SURVEY; Morland K, 2007, PUBLIC HEALTH NUTR, V10, P1481, DOI 10.1017/S1368980007000079; Muraki I, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f5001; Oude Griep LM, 2011, EUR J CLIN NUTR, V65, P791, DOI 10.1038/ejcn.2011.36; Oyebode O, 2014, J EPIDEMIOL COMMUN H, V68, P856, DOI 10.1136/jech-2013-203500; Pagidipati NJ, 2013, CIRCULATION, V127, P749, DOI 10.1161/CIRCULATIONAHA.112.128413; Rickman JC, 2007, J SCI FOOD AGR, V87, P930, DOI 10.1002/jsfa.2825; Roe LS, 2013, AM J CLIN NUTR, V98, P693, DOI 10.3945/ajcn.113.062901; Sinha S, 2008, BMC MED RES METHODOL, V8, DOI 10.1186/1471-2288-8-74; Spencer EA, 2002, PUBLIC HEALTH NUTR, V5, P561, DOI 10.1079/PHN2001322; Steffen LM, 2007, CIRCULATION, V115, P188, DOI 10.1161/CIRCULATIONAHA.106.641688; Tucker KL, 2005, J NUTR, V135, P556, DOI 10.1093/jn/135.3.556; U.S. Food and Drug Administration Center for Food Safety and Applied Nutrition, 2007, ACIDIFIED AND LOW AC; U.S. Food and Drug Administration Center for Food Safety and Applied Nutrition, 2007, TOTAL DIET STUDY STA, DOI [10.1093/jxb/erm028, DOI 10.1093/JXB/ERM028]; Wareham NJ, 2002, INT J EPIDEMIOL, V31, P168, DOI 10.1093/ije/31.1.168; Weisskopf MG, 2009, CIRCULATION, V120, P1056, DOI 10.1161/CIRCULATIONAHA.108.827121; Welch AA, 2005, J HUM NUTR DIET, V18, P99, DOI 10.1111/j.1365-277X.2005.00593.x; WHO, 2011, JOINT FAO WHO EXPERT; World Health Organization. WHO MONICA Project, 1990, WHO MONICA PROJECT M; Yang QH, 2014, JAMA INTERN MED, V174, P516, DOI 10.1001/jamainternmed.2013.13563	50	14	14	3	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2015	10	2							e0117796	10.1371/journal.pone.0117796	http://dx.doi.org/10.1371/journal.pone.0117796			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC2IM	25714554	gold, Green Published, Green Submitted			2022-12-27	WOS:000350168700039
J	Kumaravel, R; Narayanaswamy, K				Kumaravel, Rasadurai; Narayanaswamy, Kumaratharan			Performance Enhancement of MC-CDMA System through Novel Sensitive Bit Algorithm Aided Turbo Multi User Detection	PLOS ONE			English	Article							MULTICARRIER CDMA; CHANNEL	Multi carrier code division multiple access (MC-CDMA) system is a promising multi carrier modulation (MCM) technique for high data rate wireless communication over frequency selective fading channels. MC-CDMA system is a combination of code division multiple access (CDMA) and orthogonal frequency division multiplexing (OFDM). The OFDM parts reduce multipath fading and inter symbol interference (ISI) and the CDMA part increases spectrum utilization. Advantages of this technique are its robustness in case of multipath propagation and improve security with the minimize ISI. Nevertheless, due to the loss of orthogonality at the receiver in a mobile environment, the multiple access interference (MAI) appears. The MAI is one of the factors that degrade the bit error rate (BER) performance of MC-CDMA system. The multiuser detection (MUD) and turbo coding are the two dominant techniques for enhancing the performance of the MC-CDMA systems in terms of BER as a solution of overcome to MAI effects. In this paper a low complexity iterative soft sensitive bits algorithm (SBA) aided logarithmic-Maximum a-Posteriori algorithm (Log MAP) based turbo MUD is proposed. Simulation results show that the proposed method provides better BER performance with low complexity decoding, by mitigating the detrimental effects of MAI.	[Kumaravel, Rasadurai; Narayanaswamy, Kumaratharan] Sri Venkateswara Coll Engn, Dept Informat Technol, Pennalur 602117, Sriperumbudur, India		Kumaravel, R (corresponding author), Sri Venkateswara Coll Engn, Dept Informat Technol, Pennalur 602117, Sriperumbudur, India.	krasadurai@gmail.com; kumaratharan@hotmail.com	Kumaravel, Rasadurai/I-3971-2019; N, KUMARATHARAN/S-1774-2019	Kumaravel, Rasadurai/0000-0003-4969-1845; N, KUMARATHARAN/0000-0002-0097-3385				Andrews JG, 2004, IEEE T COMMUN, V52, P811, DOI 10.1109/TCOMM.2004.826240; Chang TS, 2013, WIREL COMMUN MOB COM, V13, P63, DOI 10.1002/wcm.1095; Enayati ARAzmiP, 2010, SPRINGER TELECOMMUN, DOI [10.1007/s, DOI 10.1007/S]; Faisal M, 2012, INT J INTERNET DISTR, V2, P120; Ghosh M, 2005, INT CONF ACOUST SPEE, P1025; Hung HL, 2010, WIRELESS PERS COMMUN, V53, P613, DOI 10.1007/s11277-009-9722-3; Li JQ, 2005, IEEE T WIREL COMMUN, V4, P538, DOI 10.1109/TWC.2004.843023; Li JQ, 2004, IEEE T COMMUN, V52, P1909, DOI 10.1109/TCOMM.2004.836565; Li JQ, 2004, IEEE T COMMUN, V52, P289, DOI 10.1109/TCOMM.2003.822756; Li JQ, 2001, P IEEE INT C COMM HE, V4, P1152; Lim LL, 2011, P 7 INT C WIR MOB CO, P211; Perisoara L. A., 2008, INT J COMMUNICATIONS, V2, P65; Salim M, 2010, INT J COMP APPL, V9, P29; Schulze H, 2005, WIDE BAND WIRELESS C; Silva P, 2007, P INT S COMM INF TEC, P1171; Ting PG, 2006, IEEE J SEL AREA COMM, V24, P1221, DOI 10.1109/JSAC.2005.864009; Tu YP, 2012, WIRELESS PERS COMMUN, V67, P811, DOI 10.1007/s11277-011-0412-6; Ullah SE, 2011, INT J HYBRID INFORM, V4, P41; Wong TF, 2000, IEEE T COMMUN, V48, P829, DOI 10.1109/26.843196; Zhang JK, 2012, IEEE T COMMUN, V60, P1621, DOI 10.1109/TCOMM.2012.032312.110400	20	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2015	10	2							e0115710	10.1371/journal.pone.0115710	http://dx.doi.org/10.1371/journal.pone.0115710			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC2IM	25714917	Green Published, Green Submitted, gold			2022-12-27	WOS:000350168700006
J	Martens, S; Wierda, SM; Dun, M; de Vries, M; Smid, HGOM				Martens, Sander; Wierda, Stefan M.; Dun, Mathijs; de Vries, Michal; Smid, Henderikus G. O. M.			Musical Minds: Attentional Blink Reveals Modality-Specific Restrictions	PLOS ONE			English	Article							INDIVIDUAL-DIFFERENCES; TEMPORAL ATTENTION; WORKING-MEMORY; WITHIN-MODALITY; MUSICIANS; TASK; MAGNITUDE; SELECTION; CHILDREN; CAPACITY	Background Formal musical training is known to have positive effects on attentional and executive functioning, processing speed, and working memory. Consequently, one may expect to find differences in the dynamics of temporal attention between musicians and non-musicians. Here we address the question whether that is indeed the case, and whether any beneficial effects of musical training on temporal attention are modality specific or generalize across sensory modalities. Methodology/Principal Findings When two targets are presented in close temporal succession, most people fail to report the second target, a phenomenon known as the attentional blink (AB). We measured and compared AB magnitude for musicians and non-musicians using auditory or visually presented letters and digits. Relative to non-musicians, the auditory AB was both attenuated and delayed in musicians, whereas the visual AB was larger. Non-musicians with a large auditory AB tended to show a large visual AB. However, neither a positive nor negative correlation was found in musicians, suggesting that at least in musicians, attentional restrictions within each modality are completely separate. Conclusion/Significance AB magnitude within one modality can generalize to another modality, but this turns out not to be the case for every individual. Formal musical training seems to have a domain-general, but modality-specific beneficial effect on selective attention. The results fit with the idea that a major source of attentional restriction as reflected in the AB lies in modality-specific, independent sensory systems rather than a central amodal system. The findings demonstrate that individual differences in AB magnitude can provide important information about the modular structure of human cognition.	[Martens, Sander; Wierda, Stefan M.; Dun, Mathijs; de Vries, Michal; Smid, Henderikus G. O. M.] Univ Groningen, Univ Med Ctr Groningen, Neuroimaging Ctr, Groningen, Netherlands; [Martens, Sander; Wierda, Stefan M.] Univ Groningen, Univ Med Ctr Groningen, Dept Neurosci, Groningen, Netherlands; [Wierda, Stefan M.; de Vries, Michal] Univ Groningen, Inst Artificial Intelligence, Groningen, Netherlands	University of Groningen; University of Groningen; University of Groningen	Martens, S (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Neuroimaging Ctr, Groningen, Netherlands.	s.martens@umcg.nl		Martens, Sander/0000-0001-8237-7984	Behavioural and Cognitive Neurosciences (BCN) Research School	Behavioural and Cognitive Neurosciences (BCN) Research School	This research was supported by a grant of the Behavioural and Cognitive Neurosciences (BCN) Research School. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aleman A, 2000, NEUROPSYCHOLOGIA, V38, P1664, DOI 10.1016/S0028-3932(00)00079-8; Anvari SH, 2002, J EXP CHILD PSYCHOL, V83, P111, DOI 10.1016/S0022-0965(02)00124-8; Arend I, 2006, PSYCHON B REV, V13, P600, DOI 10.3758/BF03193969; Arnell KM, 2010, PSYCHOL RES-PSYCH FO, V74, P457, DOI 10.1007/s00426-009-0265-8; Arnell KM, 2010, PSYCHOL RES-PSYCH FO, V74, P1, DOI 10.1007/s00426-008-0200-4; Arnell KM, 2004, PERCEPT PSYCHOPHYS, V66, P1147, DOI 10.3758/BF03196842; Arnell KM, 2002, COGNITIVE PSYCHOL, V44, P105, DOI 10.1006/cogp.2001.0762; Baayen RH, 2008, J MEM LANG, V59, P390, DOI 10.1016/j.jml.2007.12.005; Barr DJ, 2008, J MEM LANG, V59, P457, DOI 10.1016/j.jml.2007.09.002; Bates D., 2008, LME4 LINEAR MIXEDEFF; Choi H, 2012, P NATL ACAD SCI USA, V109, P12242, DOI 10.1073/pnas.1203972109; Colzato L, 2010, COGNITION, V45, P627; Colzato LS, 2007, PSYCHON B REV, V14, P1051, DOI 10.3758/BF03193090; Colzato LS, 2008, J EXP PSYCHOL LEARN, V34, P302, DOI 10.1037/0278-7393.34.2.302; Dale G, 2010, ATTEN PERCEPT PSYCHO, V72, P602, DOI 10.3758/APP.72.3.602; Duncan J, 1997, NATURE, V387, P808, DOI 10.1038/42947; DUNCAN J, 1994, NATURE, V369, P313, DOI 10.1038/369313a0; Dux PE, 2009, ATTEN PERCEPT PSYCHO, V71, P1683, DOI 10.3758/APP.71.8.1683; Dux PE, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003330; Ferlazzo F, 2007, EXP PSYCHOL, V54, P89, DOI 10.1027/1618-3169.54.2.89; Fujioka T, 2005, J COGNITIVE NEUROSCI, V17, P1578, DOI 10.1162/089892905774597263; Fujioka T, 2006, BRAIN, V129, P2593, DOI 10.1093/brain/awl247; Gaser C, 2003, J NEUROSCI, V23, P9240; Gibson C, 2009, BRAIN COGNITION, V69, P162, DOI 10.1016/j.bandc.2008.07.009; Green CS, 2003, NATURE, V423, P534, DOI 10.1038/nature01647; Hannon EE, 2007, TRENDS COGN SCI, V11, P466, DOI 10.1016/j.tics.2007.08.008; Hein G, 2006, PERCEPT PSYCHOPHYS, V68, P54, DOI 10.3758/BF03193655; Jolicoeur P, 1998, COGNITIVE PSYCHOL, V36, P138, DOI 10.1006/cogp.1998.0684; Kliegl R, 2010, VIS COGN, V18, P655, DOI 10.1080/13506280902986058; Koelsch S, 1999, NEUROREPORT, V10, P1309, DOI 10.1097/00001756-199904260-00029; MacLean MH, 2010, PSYCHON B REV, V17, P556, DOI 10.3758/PBR.17.4.556; Martens S, 2005, MEM COGNITION, V33, P234, DOI 10.3758/BF03195312; Martens S, 2009, EXP BRAIN RES, V192, P43, DOI 10.1007/s00221-008-1551-1; Martens S, 2006, J COGNITIVE NEUROSCI, V18, P1423, DOI 10.1162/jocn.2006.18.9.1423; Martens S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015280; Martens S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013562; Martens S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013509; Martens S, 2010, NEUROSCI BIOBEHAV R, V34, P947, DOI 10.1016/j.neubiorev.2009.12.005; Martens S, 2009, EXP PSYCHOL, V56, P33, DOI 10.1027/1618-3169.56.1.33; Martens S, 2009, EXP PSYCHOL, V56, P18, DOI 10.1027/1618-3169.56.1.18; Moreno S, 2006, PSYCHOPHYSIOLOGY, V43, P287, DOI 10.1111/j.1469-8986.2006.00401.x; Nieuwenstein MR, 2005, J EXP PSYCHOL HUMAN, V31, P1463, DOI 10.1037/0096-1523.31.6.1463; Olivers CNL, 2008, PSYCHOL REV, V115, P836, DOI 10.1037/a0013395; Olivers CNL, 2006, J EXP PSYCHOL HUMAN, V32, P364, DOI 10.1037/0096-1523.32.2.364; Olivers CNL, 2005, PSYCHOL SCI, V16, P265, DOI 10.1111/j.0956-7976.2005.01526.x; Pallesen KJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011120; Pantev C, 2001, NEUROREPORT, V12, P169, DOI 10.1097/00001756-200101220-00041; Pantev C, 1998, NATURE, V392, P811, DOI 10.1038/33918; Peretz I, 2003, NAT NEUROSCI, V6, P688, DOI 10.1038/nn1083; Peretz I, 2005, ANNU REV PSYCHOL, V56, P89, DOI 10.1146/annurev.psych.56.091103.070225; Potter MC, 2008, J MEM LANG, V58, P907, DOI 10.1016/j.jml.2007.12.002; Potter MC, 2002, J EXP PSYCHOL HUMAN, V28, P1149, DOI 10.1037//0096-1523.28.5.1149; Schellenberg EG, 2005, CURR DIR PSYCHOL SCI, V14, P317, DOI 10.1111/j.0963-7214.2005.00389.x; Schellenberg EG, 2004, PSYCHOL SCI, V15, P511, DOI 10.1111/j.0956-7976.2004.00711.x; Schneider P, 2005, NAT NEUROSCI, V8, P1241, DOI 10.1038/nn1530; Schneider W, 2001, E PRIME USERS GUIDE, DOI [10.3758/s13428-012-0302-1, DOI 10.3758/S13428-012-0302-1]; Shahin A, 2003, J NEUROSCI, V23, P5545; Shapiro K, 2006, NEUROREPORT, V17, P163, DOI 10.1097/01.wnr.0000195670.37892.1a; Shapiro KL, 1997, TRENDS COGN SCI, V1, P291, DOI 10.1016/S1364-6613(97)01094-2; Slagter HA, 2007, PLOS BIOL, V5, P1228, DOI 10.1371/journal.pbio.0050138; Slagter HA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010556; Soto-Faraco S, 2002, Q J EXP PSYCHOL-A, V55, P23, DOI 10.1080/02724980143000136; Taatgen NA, 2009, COGNITIVE PSYCHOL, V59, P1, DOI 10.1016/j.cogpsych.2008.12.002; Tang MF, 2014, PSYCHON B REV, V21, P406, DOI 10.3758/s13423-013-0491-3; Vachon F, 2008, PERCEPT PSYCHOPHYS, V70, P1000, DOI 10.3758/PP.70.6.1000; Wierda SM, 2012, P NATL ACAD SCI USA, V109, P8456, DOI 10.1073/pnas.1201858109; Wierda SM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015024; Willems C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066185; Wong PCM, 2007, NAT NEUROSCI, V10, P420, DOI 10.1038/nn1872; Zuk J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099868	70	9	9	2	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2015	10	2							e0118294	10.1371/journal.pone.0118294	http://dx.doi.org/10.1371/journal.pone.0118294			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CC2IM	25714836	Green Published, Green Submitted, gold			2022-12-27	WOS:000350168700060
J	Krizbai, IA; Gasparics, A; Nagyoszi, P; Fazakas, C; Molnar, J; Wilhelm, I; Bencs, R; Rosivall, L; Sebe, A				Krizbai, Istvan A.; Gasparics, Akos; Nagyoszi, Peter; Fazakas, Csilla; Molnar, Judit; Wilhelm, Imola; Bencs, Rita; Rosivall, Laszlo; Sebe, Attila			Endothelial-Mesenchymal Transition of Brain Endothelial Cells: Possible Role during Metastatic Extravasation	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; TUMOR-METASTASIS; MELANOMA-CELLS; TRANSENDOTHELIAL MIGRATION; TRANSCRIPTION FACTOR; CANCER METASTASIS; N-CADHERIN; IN-VITRO; ADHESION; EXPRESSION	Cancer progression towards metastasis follows a defined sequence of events described as the metastatic cascade. For extravasation and transendothelial migration metastatic cells interact first with endothelial cells. Yet the role of endothelial cells during the process of metastasis formation and extravasation is still unclear, and the interaction between metastatic and endothelial cells during transendothelial migration is poorly understood. Since tumor cells are well known to express TGF-beta, and the compact endothelial layer undergoes a series of changes during metastatic extravasation (cell contact disruption, cytoskeletal reorganization, enhanced contractility), we hypothesized that an EndMT may be necessary for metastatic extravasation. We demonstrate that primary cultured rat brain endothelial cells (BEC) undergo EndMT upon TGF-beta 1 treatment, characterized by the loss of tight and adherens junction proteins, expression of fibronectin, beta 1-integrin, calponin and a-smooth muscle actin (SMA). B16/F10 cell line conditioned and activated medium (ACM) had similar effects: claudin-5 down-regulation, fibronectin and SMA expression. Inhibition of TGF-beta signaling during B16/F10 ACM stimulation using SB-431542 maintained claudin-5 levels and mitigated fibronectin and SMA expression. B16/F10 ACM stimulation of BECs led to phosphorylation of Smad2 and Smad3. SB-431542 prevented SMA up-regulation upon stimulation of BECs with A2058, MCF-7 and MDA-MB231 ACM as well. Moreover, B16/F10 ACM caused a reduction in trans-endothelial electrical resistance, enhanced the number of melanoma cells adhering to and transmigrating through the endothelial layer, in a TGF-beta-dependent manner. These effects were not confined to BECs: HUVECs showed TGF-beta-dependent SMA expression when stimulated with breast cancer cell line ACM. Our results indicate that an EndMT may be necessary for metastatic transendothelial migration, and this transition may be one of the potential mechanisms occurring during the complex phenomenon known as metastatic extravasation.	[Krizbai, Istvan A.; Nagyoszi, Peter; Fazakas, Csilla; Molnar, Judit; Wilhelm, Imola] Hungarian Acad Sci, Biol Res Ctr, Inst Biophys, H-6726 Szeged, Hungary; [Krizbai, Istvan A.] Vasile Goldis Western Univ Arad, Inst Life Sci, Arad 310414, Romania; [Gasparics, Akos; Bencs, Rita; Rosivall, Laszlo; Sebe, Attila] Semmelweis Univ, Dept Pathophysiol, H-1089 Budapest, Hungary; [Rosivall, Laszlo] Hungarian Acad Sci, Pediat & Nephrol Res Grp, H-1089 Budapest, Hungary; [Rosivall, Laszlo] Semmelweis Univ, H-1089 Budapest, Hungary	Hungarian Academy of Sciences; Hungarian Biological Research Center; Vasile Goldis Western University of Arad; Semmelweis University; Hungarian Academy of Sciences; Semmelweis University	Sebe, A (corresponding author), Semmelweis Univ, Dept Pathophysiol, Nagyvarad Sq 4, H-1089 Budapest, Hungary.	sebe.attila@med.semmelweis-univ.hu	Sebe, Attila/K-2644-2017; Sebe, Attila/GXV-5092-2022	Sebe, Attila/0000-0001-7814-5144; Sebe, Attila/0000-0001-7814-5144; Krizbai, Istvan/0000-0002-0764-1527	Hungarian Research Fund [OTKA PD-100958, K-100807]; National Development Agency (Hungary-Romania Cross-Border Co-operation Programme) [HURO/1101/173/2.2.1, TAMOP-4.2.2.A-11/1/KONV-2012-0052]; Hungarian Kidney Foundation; Janos Bolyai Research Fellowship of the Hungarian Academy of Sciences; European Union; State of Hungary; European Social Fund, 'National Excellence Program' [TAMOP-4.2.4.A/ 2-11/1-2012-0001]	Hungarian Research Fund(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); National Development Agency (Hungary-Romania Cross-Border Co-operation Programme); Hungarian Kidney Foundation; Janos Bolyai Research Fellowship of the Hungarian Academy of Sciences(Hungarian Academy of Sciences); European Union(European Commission); State of Hungary; European Social Fund, 'National Excellence Program'	This work was supported by grants from the Hungarian Research Fund (OTKA PD-100958, K-100807), the National Development Agency (Hungary-Romania Cross-Border Co-operation Programme 2007-2013: HURO/1101/173/2.2.1; and the TAMOP-4.2.2.A-11/1/KONV-2012-0052 project) and the Hungarian Kidney Foundation. I. Wilhelm was supported by the Janos Bolyai Research Fellowship of the Hungarian Academy of Sciences. The research of C. Fazakas was supported by the European Union and the State of Hungary, co-financed by the European Social Fund in the framework of TAMOP-4.2.4.A/ 2-11/1-2012-0001 'National Excellence Program'. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderberg C, 2013, J EXP MED, V210, P563, DOI 10.1084/jem.20120662; Araki K, 2011, BRIT J CANCER, V105, P1885, DOI 10.1038/bjc.2011.452; Auguste P, 2007, AM J PATHOL, V170, P1781, DOI 10.2353/ajpath.2007.060886; Barthel SR, 2013, CANCER RES, V73, P942, DOI 10.1158/0008-5472.CAN-12-3264; Bodor C, 2012, AM J PHYSIOL-CELL PH, V302, pC267, DOI 10.1152/ajpcell.00138.2011; Dasgupta S, 2006, J CELL BIOCHEM, V97, P1036, DOI 10.1002/jcb.20647; DiChiara MR, 2000, J EXP MED, V192, P695, DOI 10.1084/jem.192.5.695; Dudley AC, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006536; EISENBERG LM, 1995, CIRC RES, V77, P1, DOI 10.1161/01.RES.77.1.1; Fan LZ, 2007, MOL BIOL CELL, V18, P1083, DOI 10.1091/mbc.E06-07-0602; Fazakas C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020758; Fidler IJ, 2003, NAT REV CANCER, V3, P453, DOI 10.1038/nrc1098; Fintha A, 2013, AM J PATHOL, V182, P388, DOI 10.1016/j.ajpath.2012.10.009; Fujii M, 2012, NEUROCHEM INT, V60, P327, DOI 10.1016/j.neuint.2011.12.014; Heyder C, 2002, J CANCER RES CLIN, V128, P533, DOI 10.1007/s00432-002-0377-7; Hiratsuka S, 2011, P NATL ACAD SCI USA, V108, P3725, DOI 10.1073/pnas.1100446108; Huang YJ, 2009, CANCER RES, V69, P7529, DOI 10.1158/0008-5472.CAN-08-4382; Kao J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006146; Kopp HG, 2005, PHYSIOLOGY, V20, P349, DOI 10.1152/physiol.00025.2005; Krasagakis K, 1998, BRIT J CANCER, V77, P1492, DOI 10.1038/bjc.1998.245; Lalor PF, 2006, WORLD J GASTROENTERO, V12, P5429, DOI 10.3748/wjg.v12.i34.5429; Li B, 2006, FEBS LETT, V580, P4252, DOI 10.1016/j.febslet.2006.06.056; Luzzi KJ, 1998, AM J PATHOL, V153, P865, DOI 10.1016/S0002-9440(10)65628-3; Maddaluno L, 2013, NATURE, V498, P492, DOI 10.1038/nature12207; Medici D, 2012, SEMIN CANCER BIOL, V22, P379, DOI 10.1016/j.semcancer.2012.04.004; Mihira H, 2012, J BIOCHEM, V151, P145, DOI 10.1093/jb/mvr121; Navarro P, 1998, J CELL BIOL, V140, P1475, DOI 10.1083/jcb.140.6.1475; Padua D, 2008, CELL, V133, P66, DOI 10.1016/j.cell.2008.01.046; Platta CS, 2010, AM J CLIN ONCOL-CANC, V33, P398, DOI 10.1097/COC.0b013e318194f744; Price EA, 1996, BRIT J CANCER, V74, P1762, DOI 10.1038/bjc.1996.627; Qi JF, 2005, MOL BIOL CELL, V16, P4386, DOI 10.1091/mbc.E05-03-0186; Reymond N, 2012, J CELL BIOL, V199, P653, DOI 10.1083/jcb.201205169; Sebe A, 2008, FEBS LETT, V582, P291, DOI 10.1016/j.febslet.2007.12.021; Sebe A, 2010, NEPHRON EXP NEPHROL, V114, pE117, DOI 10.1159/000265550; Steeg PS, 2006, NAT MED, V12, P895, DOI 10.1038/nm1469; Stoletov K, 2010, J CELL SCI, V123, P2332, DOI 10.1242/jcs.069443; Strell Carina, 2008, Cell Commun Signal, V6, P10, DOI 10.1186/1478-811X-6-10; Stroka KM, 2012, J BIOMECH, V45, P1828, DOI 10.1016/j.jbiomech.2012.04.011; Teti A, 1997, INT J CANCER, V72, P1013; Tulley S, 2014, J BIOL CHEM, V289, P15280, DOI 10.1074/jbc.M114.568501; Valastyan S, 2011, CELL, V147, P275, DOI 10.1016/j.cell.2011.09.024; Vonach C, 2011, BRIT J CANCER, V105, P263, DOI 10.1038/bjc.2011.194; Weil RJ, 2005, AM J PATHOL, V167, P913, DOI 10.1016/S0002-9440(10)61180-7; Wen P.Y., 2001, CANC PRINCIPLES PRAC, P2655; Wilhelm I, 2007, PHYS MED BIOL, V52, P6261, DOI 10.1088/0031-9155/52/20/012; Wilhelm I, 2014, PIGM CELL MELANOMA R, V27, DOI 10.1111/pcmr.12169; Wilhelm I, 2013, INT J MOL SCI, V14, P1383, DOI 10.3390/ijms14011383; Zeisberg EM, 2007, CANCER RES, V67, P10123, DOI 10.1158/0008-5472.CAN-07-3127; Zeisberg EM, 2007, NAT MED, V13, P952, DOI 10.1038/nm1613; Zeisberg EM, 2008, J AM SOC NEPHROL, V19, P2282, DOI 10.1681/ASN.2008050513	50	43	43	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2015	10	3							e0119655	10.1371/journal.pone.0119655	http://dx.doi.org/10.1371/journal.pone.0119655			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9KG	25742314	Green Published, gold, Green Submitted			2022-12-27	WOS:000350688100125
J	Maruyama, S; Shoguchi, E; Satoh, N; Minagawa, J				Maruyama, Shinichiro; Shoguchi, Eiichi; Satoh, Nori; Minagawa, Jun			Diversification of the Light-Harvesting Complex Gene Family via Intra- and Intergenic Duplications in the Coral Symbiotic Alga Symbiodinium	PLOS ONE			English	Article							DIATOM THALASSIOSIRA-PSEUDONANA; BINDING-PROTEIN; PHOTOSYSTEM-I; HEAT-STRESS; EVOLUTION; PHOTOPROTECTION; ANTENNA; MECHANISMS; ALIGNMENT; GENOME	The light-harvesting complex (LHC) is an essential component in light energy capture and transduction to facilitate downstream photosynthetic reactions in plant and algal chloroplasts. The unicellular dinoflagellate alga Symbiodinium is an endosymbiont of cnidarian animals, including corals and sea anemones, and provides carbohydrates generated through photosynthesis to host animals. Although Symbiodinium possesses a unique LHC gene family, called chlorophyll a-chlorophyll c(2)-peridinin protein complex (acpPC), its genome-level diversity and evolutionary trajectories have not been investigated. Here, we describe a phylogenetic analysis revealing that many of the LHCs are encoded by highly duplicated genes with multi-subunit polyprotein structures in the nuclear genome of Symbiodinium minutum. This analysis provides an extended list of the LHC gene family in a single organism, including 80 loci encoding polyproteins composed of 145 LHC subunits recovered in the phylogenetic tree. In S. minutum, 5 phylogenetic groups of the Lhcf-type gene family, which is exclusively conserved in algae harboring secondary plastids of red algal origin, were identified. Moreover, 5 groups of the Lhcr-type gene family, of which members are known to be associated with PSI in red algal plastids and secondary plastids of red algal origin, were identified. Notably, members classified within a phylogenetic group of the Lhcf-type (group F1) are highly duplicated, which may explain the presence of an unusually large number of LHC genes in this species. Some gene units were homologous to other units within single loci of the polyprotein genes, whereas intergenic homologies between separate loci were conspicuous in other cases, implying that gene unit 'shuffling' by gene conversion and/or genome rearrangement might have been a driving force for diversification. These results suggest that vigorous intra-and intergenic gene duplication events have resulted in the genomic framework of photosynthesis in coral symbiont dinoflagellate algae.	[Maruyama, Shinichiro; Minagawa, Jun] Natl Inst Basic Biol, Div Environm Photobiol, Okazaki, Aichi 444, Japan; [Shoguchi, Eiichi; Satoh, Nori] Okinawa Inst Sci & Technol Grad Univ, Marine Genom Unit, Onna, Okinawa, Japan; [Minagawa, Jun] Grad Univ Adv Studies, Dept Basic Biol, Sch Life Sci, Okazaki, Aichi, Japan; [Minagawa, Jun] Japan Sci & Technol Agcy JST, Core Res Evolut Sci & Technol, Kawaguchi, Saitama, Japan	National Institutes of Natural Sciences (NINS) - Japan; National Institute for Basic Biology (NIBB); Okinawa Institute of Science & Technology Graduate University; Graduate University for Advanced Studies - Japan; Japan Science & Technology Agency (JST)	Minagawa, J (corresponding author), Natl Inst Basic Biol, Div Environm Photobiol, Okazaki, Aichi 444, Japan.	minagawa@nibb.ac.jp	Satoh, Nori/C-4123-2009; Maruyama, Shinichiro/AAO-4764-2021	Satoh, Nori/0000-0002-4480-3572; Minagawa, Jun/0000-0002-3028-3203	JSPS KAKENHI Grant [26251033, 25891027, 26117731]; National Institute for Basic Biology; New Energy and Industrial Technology Development Organization; Institute for Fermentation, Osaka	JSPS KAKENHI Grant(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); National Institute for Basic Biology(National Institutes of Natural Sciences (NINS) - Japan); New Energy and Industrial Technology Development Organization(New Energy and Industrial Technology Development Organization (NEDO)); Institute for Fermentation, Osaka(Institute for Fermentation (IFO))	This work was supported by JSPS KAKENHI Grant Numbers 26251033 (to JM), 25891027 and 26117731 (to SM) (http://www.jsps.go.jp/english/index.htm), the research fund for environmental adaptation strategy of living organisms from the National Institute for Basic Biology, and a research fund from the New Energy and Industrial Technology Development Organization to JM, funding from the Institute for Fermentation, Osaka, to SM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armbrust EV, 2004, SCIENCE, V306, P79, DOI 10.1126/science.1101156; Bachvaroff TR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002929; Bailleul B, 2010, P NATL ACAD SCI USA, V107, P18214, DOI 10.1073/pnas.1007703107; Barshis DJ, 2014, MOL BIOL EVOL, V31, P1343, DOI 10.1093/molbev/msu107; Boldt L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047456; Busch A, 2010, PLANT J, V62, P886, DOI 10.1111/j.1365-313X.2010.04202.x; Capella-Gutierrez S, 2009, BIOINFORMATICS, V25, P1972, DOI 10.1093/bioinformatics/btp348; Engelken J, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-233; Gerotto C, 2013, PHYSIOL PLANTARUM, V149, P583, DOI 10.1111/ppl.12070; Goss R, 2010, PHOTOSYNTH RES, V106, P103, DOI 10.1007/s11120-010-9536-x; Grouneva I, 2011, J PROTEOME RES, V10, P5338, DOI 10.1021/pr200600f; HILLER RG, 1995, FEBS LETT, V363, P175, DOI 10.1016/0014-5793(95)00297-M; Hoffman GE, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-101; Iwai M, 2008, PLANT CELL, V20, P2177, DOI 10.1105/tpc.108.059352; Jaeckisch N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028012; Jansson S, 1999, TRENDS PLANT SCI, V4, P236, DOI 10.1016/S1360-1385(99)01419-3; Jansson S, 2006, ADV PHOTO RESPIRAT, V21, P145; Jiang J, 2014, BBA-BIOENERGETICS, V1837, P1904, DOI 10.1016/j.bbabio.2014.07.023; Kanazawa A, 2014, BBA-BIOENERGETICS, V1837, P1227, DOI 10.1016/j.bbabio.2014.03.019; Katoh K, 2009, METHODS MOL BIOL, V537, P39, DOI 10.1007/978-1-59745-251-9_3; Koziol AG, 2008, MOL BIOL EVOL, V25, P92, DOI 10.1093/molbev/msm232; Koziol AG, 2007, PLANT PHYSIOL, V143, P1802, DOI 10.1104/pp.092536; LaJeunesse TC, 2003, LIMNOL OCEANOGR, V48, P2046, DOI 10.4319/lo.2003.48.5.2046; Le QH, 1997, MOL GEN GENET, V255, P595, DOI 10.1007/s004380050533; Lee R, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-122; Leggat W, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026687; Lepetit B, 2007, BIOCHEMISTRY-US, V46, P9813, DOI 10.1021/bi7008344; Li XP, 2000, NATURE, V403, P391, DOI 10.1038/35000131; Lukes J, 2009, P NATL ACAD SCI USA, V106, P9963, DOI 10.1073/pnas.0901004106; Makino T, 2009, TRENDS GENET, V25, P152, DOI 10.1016/j.tig.2009.03.001; Marquardt J, 2001, PHOTOSYNTH RES, V68, P121, DOI 10.1023/A:1011865415369; Maruyama S, 2013, MAR FRESHW BOTANY, P21; Maruyama S, 2014, PLANT CELL PHYSIOL, V55, P1304, DOI 10.1093/pcp/pcu068; Maruyama S, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-105; Minagawa J., 2009, CHLAMYDOMONAS SOURCE, V2, P503, DOI DOI 10.1016/B978-0-12-370873-1.00022-8; Minagawa J, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00513; Mungpakdee S, 2014, GENOME BIOL EVOL, V6, P1408, DOI 10.1093/gbe/evu109; Niedzwiedzki DM, 2014, PHOTOSYNTH RES, V120, P125, DOI 10.1007/s11120-013-9794-5; Niyogi KK, 2013, CURR OPIN PLANT BIOL, V16, P307, DOI 10.1016/j.pbi.2013.03.011; Peers G, 2009, NATURE, V462, P518, DOI 10.1038/nature08587; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; Putnam HM, 2013, MAR BIOL, V160, P2157, DOI 10.1007/s00227-012-2129-9; Reynolds JM, 2008, P NATL ACAD SCI USA, V105, P13674, DOI 10.1073/pnas.0805187105; Richard GF, 2008, MICROBIOL MOL BIOL R, V72, P686, DOI 10.1128/MMBR.00011-08; Shinzato C, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00336; Shoguchi E, 2013, CURR BIOL, V23, P1399, DOI 10.1016/j.cub.2013.05.062; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; Sturm S, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-159; Takahashi S, 2008, P NATL ACAD SCI USA, V105, P4203, DOI 10.1073/pnas.0708554105; Tan S, 1997, PHOTOSYNTH RES, V53, P129, DOI 10.1023/A:1005815321295; ten Lohuis MR, 1998, PLANT PHYSIOL, V117, P189, DOI 10.1104/pp.117.1.189; Veith T, 2009, BBA-BIOENERGETICS, V1787, P905, DOI 10.1016/j.bbabio.2009.04.006; Xie G, 2002, GENOME BIOL, V3; Zhu SH, 2010, BBA-BIOENERGETICS, V1797, P1449, DOI 10.1016/j.bbabio.2010.04.003	54	10	10	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2015	10	3							e0119406	10.1371/journal.pone.0119406	http://dx.doi.org/10.1371/journal.pone.0119406			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9KG	25741697	Green Published, gold, Green Submitted			2022-12-27	WOS:000350688100108
J	Hammar, L; Eggertsen, L; Andersson, S; Ehnberg, J; Arvidsson, R; Gullstrom, M; Molander, S				Hammar, Linus; Eggertsen, Linda; Andersson, Sandra; Ehnberg, Jimmy; Arvidsson, Rickard; Gullstrom, Martin; Molander, Sverker			A Probabilistic Model for Hydrokinetic Turbine Collision Risks: Exploring Impacts on Fish	PLOS ONE			English	Article							RENEWABLE ENERGY; BLADE-STRIKE; GENERATING ELECTRICITY; BEHAVIOR; SPEED; POWER; PERFORMANCE; VESSEL; LIGHT	A variety of hydrokinetic turbines are currently under development for power generation in rivers, tidal straits and ocean currents. Because some of these turbines are large, with rapidly moving rotor blades, the risk of collision with aquatic animals has been brought to attention. The behavior and fate of animals that approach such large hydrokinetic turbines have not yet been monitored at any detail. In this paper, we conduct a synthesis of the current knowledge and understanding of hydrokinetic turbine collision risks. The outcome is a generic fault tree based probabilistic model suitable for estimating population-level ecological risks. New video-based data on fish behavior in strong currents are provided and models describing fish avoidance behaviors are presented. The findings indicate low risk for small-sized fish. However, at large turbines (>= 5 m), bigger fish seem to have high probability of collision, mostly because rotor detection and avoidance is difficult in low visibility. Risks can therefore be substantial for vulnerable populations of large-sized fish, which thrive in strong currents. The suggested collision risk model can be applied to different turbine designs and at a variety of locations as basis for case-specific risk assessments. The structure of the model facilitates successive model validation, refinement and application to other organism groups such as marine mammals.	[Hammar, Linus; Ehnberg, Jimmy; Arvidsson, Rickard; Molander, Sverker] Chalmers Univ Technol, Environm & Energy Dept, S-41296 Gothenburg, Sweden; [Eggertsen, Linda; Gullstrom, Martin] Stockholm Univ, Dept Ecol Environm & Plant Sci, S-10691 Stockholm, Sweden; [Andersson, Sandra] Marine Monitoring AB, Lysekil, Sweden	Chalmers University of Technology; Stockholm University	Hammar, L (corresponding author), Chalmers Univ Technol, Environm & Energy Dept, S-41296 Gothenburg, Sweden.	linus.hammar@chalmers.se	Arvidsson, Rickard/AAV-7598-2020; Molander, Sverker/E-1462-2012	Arvidsson, Rickard/0000-0002-9258-0641; Molander, Sverker/0000-0002-9081-8847	Chalmersska Research Foundation [Dnr CS2010/53]; Aforsk foundation; Adlerbertska Research Foundation	Chalmersska Research Foundation; Aforsk foundation; Adlerbertska Research Foundation	The study received financial support from the Chalmersska Research Foundation (Dnr CS2010/53), the Aforsk foundation (http://www.aforsk.se/in-english.php), and the Adlerbertska Research Foundation (http://adlerbertska.se/en/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARNOLD GP, 1994, ICES J MAR SCI, V51, P207, DOI 10.1006/jmsc.1994.1021; Bahaj AS, 2011, RENEW SUST ENERG REV, V15, P3399, DOI 10.1016/j.rser.2011.04.032; Barreiros JP, 2002, CYBIUM, V26, P83; Bedford T., 2001, PROBABILISTIC RISK A; Boehlert GW, 2010, OCEANOGRAPHY, V23, P68, DOI 10.5670/oceanog.2010.46; Broadhurst M, 2011, SHORT TERM TEMPORAL; Burgman M., 2005, RISKS DECISIONS CONS; Busch DS, 2013, CONSERV BIOL, V27, P1190, DOI 10.1111/cobi.12164; Cada G, 2007, FISHERIES, V32, P174, DOI 10.1577/1548-8446(2007)32[174:PIOHAW]2.0.CO;2; Copping A, 2013, ENV EFFECTS MARINE E, DOI [10.1097/ACC.0b013e3182973a4f, DOI 10.1097/ACC.0B013E3182973A4F]; Corwin J, 1981, HEARING SOUND COMMUN, P91; DADSWELL MJ, 1986, FISHERIES, V11, P26, DOI 10.1577/1548-8446(1986)011<0026:PIOLTP>2.0.CO;2; Deng ZQ, 2007, ECOL MODEL, V208, P165, DOI 10.1016/j.ecolmodel.2007.05.019; Deng ZQ, 2011, ENERGIES, V4, P57, DOI 10.3390/en4010057; Domenici P, 1997, J EXP BIOL, V200, P1165; Douglas R.H., 1990, P373; EPRI, 2011, EV FISH INJ MORT ASS; EPRI, 2005, OC TID WAV EN REN EN; Fraenkel PL, 2002, P I MECH ENG A-J POW, V216, P1, DOI 10.1243/095765002760024782; Frid C, 2012, ENVIRON IMPACT ASSES, V32, P133, DOI 10.1016/j.eiar.2011.06.002; Gill AB, 2005, J APPL ECOL, V42, P605, DOI 10.1111/j.1365-2664.2005.01060.x; GLASS CW, 1989, FISH RES, V7, P249, DOI 10.1016/0165-7836(89)90059-3; Halvorsen M.B., 2011, EFFECTS TIDAL TURBIN; Hammar L., 2013, P 10 EUR WAV TID EN; Hammar L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084141; HAMMER C, 1995, COMP BIOCHEM PHYS A, V112, P1, DOI 10.1016/0300-9629(95)00060-K; Handegard NO, 2005, CAN J FISH AQUAT SCI, V62, P2409, DOI 10.1139/F05-131; Harvey E, 1995, MAR TECHNOL SOC J, V29, P10; Hawkins A.D., 1981, HEARING SOUND COMMUN, P109, DOI DOI 10.1007/978-1-4615-7186-5_6; Hazel Julia, 2007, Endangered Species Research, V3, P105, DOI 10.3354/esr003105; Henkel SK, 2014, HUMANIT SEA, P93, DOI 10.1007/978-94-017-8002-5_8; Inger R, 2009, J APPL ECOL, V46, P1145, DOI 10.1111/j.1365-2664.2009.01697.x; Iosilevskii G, 2008, J R SOC INTERFACE, V5, P329, DOI 10.1098/rsif.2007.1073; Johansen JL, 2007, CORAL REEFS, V26, P577, DOI 10.1007/s00338-007-0217-y; Kastelein RA, 2008, MAR ENVIRON RES, V65, P369, DOI 10.1016/j.marenvres.2008.01.001; KENDALL DG, 1949, J R STAT SOC B, V11, P230; Khan J, 2009, OCEAN ENERGY GLOBAL; Khan MJ, 2008, RENEW SUST ENERG REV, V12, P2177, DOI 10.1016/j.rser.2007.04.016; Kibel P., 2008, ARCHIMEDES SCREW TUR; Knight K, 2011, J EXPT BIOL, V214, pi; Langton R, 2011, MAR POLICY, V35, P623, DOI 10.1016/j.marpol.2011.02.002; LEVY DA, 1995, CAN J FISH AQUAT SCI, V52, P1, DOI 10.1139/f95-001; LEWIS SL, 1969, T AM FISH SOC, V98, P14, DOI 10.1577/1548-8659(1969)98[14:PFIFPI]2.0.CO;2; Liao JC, 2007, PHILOS T R SOC B, V362, P1973, DOI 10.1098/rstb.2007.2082; Lloyd T, 2011, PREDICTING TIDAL TUR; Mazur MM, 2003, ENVIRON BIOL FISH, V67, P397, DOI 10.1023/A:1025807711512; McGowin C., 2005, OCEAN TIDAL WAVE ENE; Minesto, 2014, HIGH EFF LOW IMP; Mitson RB, 2003, AQUAT LIVING RESOUR, V16, P255, DOI 10.1016/S0990-7440(03)00021-4; Muntz W.R.A., 1990, P491; Nedwell J, 2007, VALIDATION DBHT MEAS, DOI [10.1093/jxb/erm028, DOI 10.1093/JXB/ERM028]; Normandeau Associates, 2009, EST SURV INJ FISH PA; Pearson J, 2010, COLLISION RISK FISH; Pine MK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051790; Plaut I, 2001, COMP BIOCHEM PHYS A, V131, P41, DOI 10.1016/S1095-6433(01)00462-7; Ren HY, 2012, 2012 OCEANS, DOI 10.1109/OCEANS.2012.6405010; Romero-Gomez P, 2014, RENEW ENERG, V71, P401, DOI 10.1016/j.renene.2014.05.051; Rourke FO, 2010, APPL ENERG, V87, P398, DOI 10.1016/j.apenergy.2009.08.014; Sand O, 1981, HEARING SOUND COMMUN, P459, DOI [10.1007/978-1-4615-7186-5_23, DOI 10.1007/978-1-4615-7186_23]; Schweizer PE, 2011, ESTIMATION RISKS COL, DOI [10.1080/17437199.2011.587961, DOI 10.1080/17437199.2011.587961]; Shields MA, 2011, OCEAN COAST MANAGE, V54, P2, DOI 10.1016/j.ocecoaman.2010.10.036; Smit C.F., 2003, S AFRICAN J STAT, V37, P59; Soule M., 1987, VIABLE POPULATIONS C; Sparling C, 2013, COLLISION RISK MODEL, DOI [10.1097/ACC.0b013e3182973a4f, DOI 10.1097/ACC.0B013E3182973A4F]; THIEL R, 1995, J FISH BIOL, V46, P47, DOI 10.1111/j.1095-8649.1995.tb05946.x; Turnpenny A., 2000, RISK ASSESSMENT FISH; Urick R., 1983, PRINCIPLES UNDERWATE, P99; Van Waerebeek Koen, 2007, Latin American Journal of Aquatic Mammals, V6, P43; Verdant Power, 2010, FIN KIN HYDR PIL LIC; Viehman HA, 2012, THESIS U MAINE ORONO; Von Raben K., 1957, WASSERWIRTSCHAFT, V4, P97; Wardle CS, 1986, BEHAV TELEOST FISHES, P469; WEBB PW, 1994, MECHANICS AND PHYSIOLOGY OF ANIMAL SWIMMING, P45; Wilson B, 2007, COLLISION RISKS MARI, DOI [10.1093/jxb/erm028, DOI 10.1093/JXB/ERM028]; Wilson B., 2013, USE ACOUSTIC DEVICES	76	28	29	0	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2015	10	3							e0117756	10.1371/journal.pone.0117756	http://dx.doi.org/10.1371/journal.pone.0117756			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9JF	25730314	Green Published, gold, Green Submitted			2022-12-27	WOS:000350684900015
J	Cunha, AF; Genzano, GN; Marques, AC				Cunha, Amanda F.; Genzano, Gabriel N.; Marques, Antonio C.			Reassessment of Morphological Diagnostic Characters and Species Boundaries Requires Taxonomical Changes for the Genus Orthopyxis L. Agassiz, 1862 (Campanulariidae, Hydrozoa) and Some Related Campanulariids	PLOS ONE			English	Article							MAR-DEL-PLATA; HYDROIDS CNIDARIA; MOLECULAR EVIDENCE; THECATE HYDROIDS; OBELIA CNIDARIA; LIFE-CYCLE; MITOCHONDRIAL; EVOLUTION; PHYLOGENY; PHYLOGEOGRAPHY	The genus Orthopyxis is widely known for its morphological variability, making species identification particularly difficult. A number of nominal species have been recorded in the southwestern Atlantic, although most of these records are doubtful. The goal of this study was to infer species boundaries in the genus Orthopyxis from the southwestern Atlantic using an integrative approach. Intergeneric limits were also tested using comparisons with specimens of the genus Campanularia. We performed DNA analyses using the mitochondrial genes 16S and COI and the nuclear ITS1 and ITS2 regions. Orthopyxis was monophyletic in maximum likelihood analyses using the combined dataset and in analyses with 16S alone. Four lineages of Orthopyxis were retrieved for all analyses, corresponding morphologically to the species Orthopyxis sargassicola (previously known in the area), Orthopyxis crenata (first recorded for the southwestern Atlantic), Orthopyxis caliculata (= Orthopyxis minuta Vannucci, 1949 and considered a synonym of O. integra by some authors), and Orthopyxis mianzani sp. nov. A re- evaluation of the traditional morphological diagnostic characters, guided by our molecular analyses, revealed that O. integra does not occur in the study area, and O. caliculata is the correct identification of one of the lineages occurring in this region, corroborating the validity of that species. Orthopyxis mianzani sp. nov. resembles O. caliculata with respect to gonothecae morphology and a smooth hydrothecae rim, although it shows significant differences for other characters, such as perisarc thickness, which has traditionally been thought to have wide intraspecific variation. The species O. sargassicola is morphologically similar to O. crenata, although they differ in gonothecae morphology, and these species can only be reliably identified when this structure is present.	[Cunha, Amanda F.; Marques, Antonio C.] Univ Sao Paulo, Inst Biociencias, Dept Zool, Sao Paulo, Brazil; [Genzano, Gabriel N.] Univ Nacl Mar del Plata, CONICET, IIMyC, Estn Costera Nagera,Dept Cs Marinas, Mar Del Plata, Buenos Aires, Argentina; [Marques, Antonio C.] Univ Sao Paulo, Ctr Biol Marinha, Sao Paulo, Brazil	Universidade de Sao Paulo; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of Mar del Plata; Universidade de Sao Paulo	Cunha, AF (corresponding author), Univ Sao Paulo, Inst Biociencias, Dept Zool, Sao Paulo, Brazil.	amanfcunha@gmail.com	Fapesp, Biota/F-8655-2017; Cunha, Amanda F/R-3863-2017; Marques, Antonio Carlos/E-8049-2011	Fapesp, Biota/0000-0002-9887-8449; Cunha, Amanda F/0000-0003-3276-2651; Marques, Antonio Carlos/0000-0002-2884-0541	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior CAPES); CAPES Procad; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [562143/2010-6, 563106/2010-7, 564945/2010-2, 477156/2011-8, 458555/2013-4, 305805/2013-4]; Sao Paulo Research Foudation (FAPESP) [2004/09961-4, 2010/52324-6, 2011/50242-5, 2013/50484-4, 2011/22260-9]; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET) [PIP 0152 CONICET]	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); CAPES Procad(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Sao Paulo Research Foudation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET))	This study was supported by Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior CAPES) (AFC), CAPES Procad (ACM), Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) (grant no. 562143/2010-6; 563106/2010-7; 564945/2010-2; 477156/2011-8; 458555/2013-4; 305805/2013-4) (ACM), Sao Paulo Research Foudation (FAPESP) (grant no. 2004/09961-4; 2010/52324-6; 2011/50242-5; 2013/50484-4 - ACM, 2011/22260-9 - AFC), and Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET) (grant no. PIP 0152 CONICET) (GNG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar C, 2007, B MAR SCI, V81, P335; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Alurralde G, 2013, POLAR BIOL, V36, P957, DOI 10.1007/s00300-013-1319-3; Arai MN, 1980, CAN BULL FISH AQUAT, V204; BALE W. M., 1934, PROC LINNEAN SOC N S WALES, V59, P273; Bale WM, 1914, P ROYAL SOC VICTORIA, V27, P72; Benzoni F, 2010, ZOOL J LINN SOC-LOND, V160, P421, DOI 10.1111/j.1096-3642.2010.00622.x; BLANCO O M, 1984, Revista del Museo de La Plata Seccion Zoologia, V13, P261; Blanco O.M., 1976, Revista del Museo de La Plata Seccion Zoologia, V12, P27; Blanco O. M., 1968, Revista del Museo de La Plata Zoologia, V10, P195; BLANCO O M, 1967, REVISTA DEL MUSEO DE LA PLATA SECCION ZOOLOGIA, V9, P243; Blanco Olga, 1994, Revista del Museo de La Plata Seccion Zoologia, V14, P181; Blanco OM, 1964, REV MUS LA PLATA, V7, P149; Bo M, 2012, ZOOL J LINN SOC-LOND, V166, P1, DOI 10.1111/j.1096-3642.2012.00834.x; Boero F, 2007, MAR ECOL-EVOL PERSP, V28, P178, DOI 10.1111/j.1439-0485.2007.00164.x; Bouillon J., 1985, Indo-Malayan Zoology, V2, P29; Broch H., 1948, Scientific Results of the Norwegian Antarctic Expedition 1927-1928 Oslo, VNo. 28, P1; BROCH H, 1909, FAUNA ARCTICA, V5, P129; Broch H, 1918, DANISH INGOLF EXPED, V5; Budd AF, 2010, INTEGR COMP BIOL, V50, P411, DOI 10.1093/icb/icq062; CALDER DR, 1970, J FISH RES BOARD CAN, V27, P1501, DOI 10.1139/f70-175; Calder DR, 2014, AQUAT INVASIONS IN P, V9; Calder DR, 1991, R ONT MUS LIFE SCI C, V154; Cantero ALP, 2004, J NAT HIST, V38, P2269, DOI 10.1080/00222930310001647361; Cartwright P, 2008, J MAR BIOL ASSOC UK, V88, P1663, DOI 10.1017/S0025315408002257; Chen SH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008116; Clark SF, 1877, P ACAD NAT SCI PHILA, V1876, P209; Collins AG, 2006, SYST BIOL, V55, P97, DOI 10.1080/10635150500433615; Collins AG, 2005, ZOOL SCR, V34, P91, DOI 10.1111/j.1463-6409.2005.00172.x; Collins AG, 2000, SCI MAR, V64, P5, DOI 10.3989/scimar.2000.64s15; Collins AG, 2011, ZOOTAXA, P53; CORNELIUS P F S, 1975, Bulletin of the British Museum (Natural History) Zoology, V28, P249; Cornelius P.F.S., 1982, Bulletin of the British Museum (Natural History) Zoology, V42, P37; Cornelius P.F.S., 1995, SYNOPSES BRIT FAUNA, V50, P1; CORNELIUS PFS, 1990, J NAT HIST, V24, P535, DOI 10.1080/00222939000770381; Cunha AF, 2010, ZOOLOGIA-CURITIBA, V27, P945, DOI 10.1590/S1984-46702010000600016; CUNNINGHAM CW, 1993, BIOCHEM SYST ECOL, V21, P57, DOI 10.1016/0305-1978(93)90009-G; Dawson MN, 2001, BIOL BULL, V200, P92, DOI 10.2307/1543089; Dawson MN, 2005, J BIOGEOGR, V32, P515, DOI 10.1111/j.1365-2699.2004.01193.x; El Beshbeeshy M, 1991, THESIS; El Beshbeeshy Mohamed, 2011, Verhandlungen des Naturwissenschaftlichen Vereins in Hamburg, P19; Meretta PE, 2015, MAR BIOL RES, V11, P294, DOI 10.1080/17451000.2014.923101; Folino-Rorem NC, 2009, BIOL INVASIONS, V11, P1869, DOI 10.1007/s10530-008-9365-4; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Fraser CM, 1944, HYDROIDS OF THE ATLA; Fritz GB, 2009, J LIMNOL, V68, P46, DOI 10.4081/jlimnol.2009.46; Galea HR, 2007, ZOOTAXA, P39; Galea HR, 2012, ZOOTAXA, P19, DOI 10.11646/zootaxa.3296.1.2; Galea HR, 2007, ZOOTAXA, P1; Galea HR, 2009, ZOOTAXA, P1; Genzano G., 1992, Thalassas, V9, P63; Genzano G.N., 1990, Neritica, V5, P35; Genzano G. N., 1995, Miscellania Zoologica (Barcelona), V18, P1; Genzano G. N., 1998, Miscellania Zoologica (Barcelona), V21, P21; Genzano G, 2011, LAT AM J AQUAT RES, V39, P553, DOI [10.4067/S0718-560X2011000300015, 10.3856/vol39-issue3-fulltext-15]; Genzano G, 2008, LAT AM J AQUAT RES, V36, P301, DOI [10.3856/vol36-issue2-fulltext-11, 10.4067/S0718-560X2008000200011]; Genzano Gabriel N., 1994, Iheringia Serie Zoologia, V76, P3; Genzano GN, 2009, MAR ECOL-EVOL PERSP, V30, P33, DOI 10.1111/j.1439-0485.2008.00247.x; Genzano GN, 2002, OCEANOL ACTA, V25, P303, DOI 10.1016/S0399-1784(02)01197-0; Genzano GN, 2002, OPHELIA, V56, P161, DOI 10.1080/00785236.2002.10409496; Genzano GN, 1997, CIENC MAR, V23, P285; GILI J-M, 1989, Scientia Marina, V53, P67; Goloboff P, 2008, CLADISTICS, V24, P91; Govindarajan AF, 2006, MOL PHYLOGENET EVOL, V38, P820, DOI 10.1016/j.ympev.2005.11.012; Govindarajan AF, 2005, INVERTEBR BIOL, V124, P1, DOI 10.1111/j.1744-7410.2005.1241-01.x; Govindarajan AF, 2005, MAR BIOL, V146, P213, DOI 10.1007/s00227-004-1434-3; Grohmann P.A., 1997, P227; Grohmann PA, 2003, ZOOTAXA, V299, P1, DOI DOI 10.11646/ZOOTAXA.299.1.1; Grohmann PA, 2011, BIOTA NEOTROP, V11, P193, DOI 10.1590/S1676-06032011000200020; Haddad MA, 2000, AN 5 S EC BRAS CONS, V2, P101; Harris DJ, 2000, MOL BIOL EVOL, V17, P284, DOI 10.1093/oxfordjournals.molbev.a026308; HARTLAUB C, 1905, ZOOLOGISCHE JB S, V6, P497; HARTLAUB C, 1901, ZOOLOGISCHE JB ABTEI, V14, P349; He J, 2014, J MAR BIOL ASSOC UK, P1; Hincks T., 1853, ANN MAG NAT HIST, V11, P178; Hincks T., 1868, HIST BRIT HYDROID ZO, V1; Hirohito ES, 1995, THE HYDROIDS OF SAGA; Jaderholm E, 1917, REDOGORELSE NORRKOPI, V1916-1917, P1; Jaderholm E., 1905, WISSENSCHAFTLICHE ER, V5, P1; Ji YJ, 2003, MOL ECOL NOTES, V3, P581, DOI 10.1046/j.1471-8286.2003.00519.x; Johnston G., 1847, HIST BRIT ZOOPHYTES, V1; Jolliffe I.T., 2002, SPRINGER SERIES IN S; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Kayal E, 2012, GENOME BIOL EVOL, V4, P1, DOI 10.1093/gbe/evr123; Kelmo F, 2003, REV BIOL TROP, V51, P123; Ki JS, 2008, ICES J MAR SCI, V65, P443, DOI 10.1093/icesjms/fsn018; Kramp P. L., 1935, Danmarks Fauna, V41, P1; Lamouroux JVF., 1824, VOYAGE AUTOUR MONDE, P603; Leclere L, 2009, SYST BIOL, V58, P509, DOI 10.1093/sysbio/syp044; Leloup E., 1935, Mem Mus Hist Nat Belg (2), V2, P1; LELOUP E, 1974, SARSIA, P1; Levinsen G.M.R., 1893, VIDENSKABELIGE MEDDE, V4, P215; Lindner A, 2002, J MAR BIOL ASSOC UK, V82, P541, DOI 10.1017/S0025315402005866; Lindner A, 2011, ZOOTAXA, P23; Gappa JL, 2007, POLAR BIOL, V30, P679, DOI 10.1007/s00300-006-0225-3; MacGillivray J, 1842, ANN MAG NAT HIST, V9, P462, DOI [10.1080/03745484209445365, DOI 10.1080/03745484209445365]; Marques AC, 2004, INVERTEBR BIOL, V123, P23; Marques Antonio C., 2003, Biota Neotrop., V3, P1, DOI 10.1590/S1676-06032003000200007; Marques Antonio Carlos, 1996, Journal of Comparative Biology, V1, P153; Martinez DE, 2010, MOL PHYLOGENET EVOL, V57, P403, DOI 10.1016/j.ympev.2010.06.016; Matejusova I, 2001, INT J PARASITOL, V31, P738, DOI 10.1016/S0020-7519(01)00176-X; Miglietta MP, 2007, J ZOOL SYST EVOL RES, V45, P11, DOI 10.1111/j.1439-0469.2006.00379.x; Miglietta MP, 2009, ZOOL SCR, V38, P403, DOI 10.1111/j.1463-6409.2008.00376.x; Migotto A.E., 1996, Zoologische Verhandelingen (Leiden), V306, P1; Migotto Alvaro E., 2002, Biota Neotrop., V2, P1, DOI 10.1590/S1676-06032002000100010; Millard N.A.H., 1971, P396; Millard NAH, 1975, ANN S AFR MUS, V68, P1; Milstein A., 1976, Dusenia, V9, P77; Miranda LS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010182; Miranda TP, 2011, BIOTA NEOTROP, V11, P331, DOI 10.1590/S1676-06032011000300027; Moura CJ, 2008, ZOOL SCR, V37, P93, DOI 10.1111/j.1463-6409.2007.00312.x; Moura CJ, 2012, ZOOL SCR, V41, P79, DOI 10.1111/j.1463-6409.2011.00503.x; Moura CJ, 2011, ZOOL SCR, V40, P520, DOI 10.1111/j.1463-6409.2011.00489.x; Naumov DV, 1969, HYDROIDS AND HYDROME; Nawrocki AM, 2010, ZOOL SCR, V39, P290, DOI 10.1111/j.1463-6409.2009.00419.x; Nogueira C.C., 1997, P 6 INT C COEL BIOL, V1995, P365; Nutting CC, 1915, AMERICAN HYDROIDS PA; Oliveira OMP, 2003, THESIS; Oliveira Otto M.P., 2007, Check List, V3, P21; Ostman C., 1999, Zoosystematica Rossica Supplement, V1, P17; OSTMAN C, 1982, ZOOL SCR, V11, P227, DOI 10.1111/j.1463-6409.1982.tb00536.x; De Oliveira OMP, 2011, MAR BIOL RES, V7, P786, DOI 10.1080/17451000.2011.578647; Pena Cantero AL, 2002, ZOOLOGISCHE VERHANDE, V337, P1, DOI DOI 10.1007/S00300-004-0654-9; Cantero ALP, 2010, POLAR BIOL, V33, P41, DOI 10.1007/s00300-009-0683-5; RALPH PATRICIA M., 1957, TRANS ROY SOC NEW ZEALAND, V84, P811; Ritchie J., 1907, T ROY SOC EDINBURGH, V45, P519, DOI DOI 10.1017/S0080456800022821; Rosso S, 1997, PROC 6TH INTL CONF C, V1995, P145; Schierwater B, 2000, SCI MAR, V64, P117, DOI 10.3989/scimar.2000.64s1117; Schmidt-Roach S, 2013, CORAL REEFS, V32, P161, DOI 10.1007/s00338-012-0959-z; Schroth W, 2002, BMC EVOL BIOL, V2, DOI 10.1186/1471-2148-2-1; Schuchert P, 2005, MOL PHYLOGENET EVOL, V36, P194, DOI 10.1016/j.ympev.2005.03.021; Schuchert Peter, 2001, Meddelelser om Gronland Bioscience, V53, P1; Schultz J, 2006, NUCLEIC ACIDS RES, V34, pW704, DOI 10.1093/nar/gkl129; Seo M, 2003, THESIS; Silveira M, 2011, BIOTA NEOTROP, V11, P173, DOI 10.1590/S1676-06032011000100017; Stechow E., 1919, Zoologische Jahrbuecher (Systematik), V42; Stechow E., 1924, Zoologischer Anzeiger Leipzig, V59, P57; Stechow E., 1914, ZOOL ANZ, V45, P120; Swofford DL, 2002, PAUP PHYLOGENETIC AN; Van Iten H, 2006, J SYST PALAEONTOL, V4, P109, DOI 10.1017/S1477201905001793; Vannucci M., 1951, Boletim do Instituto Paulista de Oceanografia, V2, P69; Vannucci M., 1949, Boletim da Faculdade de Filosofia Ciencias e Letras Universidade de Sao Paulo Zoologica, V14, P219; Vannucci M., 1951, Boletim do Instituto Paulista de Oceanografia, V2, P105; Vannucci M, 1954, BOLM INST OCEANOGR, V5, P95; Vannucci Mendes M., 1946, ARQUIVOS ZOOLOGIA ES, V4, P535; Vervoort W., 1993, Zoologische Mededelingen (Leiden), V67, P537; Vervoort W., 1946, Fauna van Nederland Leiden, V14, P1; Vervoort W., 1972, Zoologische Verh Leiden, VNo. 120, P1; Vervoort W., 1949, Zoologische Mededeelingen Leiden, V30, P133; VERVOORT W, 2003, NIWA BIODIVERSITY ME, V119; VOGLER AP, 1994, MOL BIOL EVOL, V11, P393; Watson J.E., 2005, MARINE FLORA FAUNA E, P495; Wei NWV, 2006, ZOOL STUD, V45, P404; Zamponi MO, 1998, RUSSIAN J MARINE BIO, V24, P7; Zhou KL, 2013, J MAR BIOL ASSOC UK, V93, P2075, DOI 10.1017/S0025315413000969	155	28	28	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2015	10	2							e0117553	10.1371/journal.pone.0117553	http://dx.doi.org/10.1371/journal.pone.0117553			35	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC3LS	25723572	Green Published, gold, Green Submitted			2022-12-27	WOS:000350251200034
J	Zhang, DK; Wu, S; Rasch, MJ				Zhang, Danke; Wu, Si; Rasch, Malte J.			Circuit Motifs for Contrast-Adaptive Differentiation in Early Sensory Systems: The Role of Presynaptic Inhibition and Short-Term Plasticity	PLOS ONE			English	Article							GAIN-CONTROL; RECURRENT NETWORK; BIPOLAR CELLS; ADAPTATION; STATISTICS; INTEGRATION; EXCITATION; REDUCTION; INTENSITY; PATHWAYS	In natural signals, such as the luminance value across of a visual scene, abrupt changes in intensity value are often more relevant to an organism than intensity values at other positions and times. Thus to reduce redundancy, sensory systems are specialized to detect the times and amplitudes of informative abrupt changes in the input stream rather than coding the intensity values at all times. In theory, a system that responds transiently to fast changes is called a differentiator. In principle, several different neural circuit mechanisms exist that are capable of responding transiently to abrupt input changes. However, it is unclear which circuit would be best suited for early sensory systems, where the dynamic range of the natural input signals can be very wide. We here compare the properties of different simple neural circuit motifs for implementing signal differentiation. We found that a circuit motif based on presynaptic inhibition (PI) is unique in a sense that the vesicle resources in the presynaptic site can be stably maintained over a wide range of stimulus intensities, making PI a biophysically plausible mechanism to implement a differentiator with a very wide dynamical range. Moreover, by additionally considering short-term plasticity (STP), differentiation becomes contrast adaptive in the PI-circuit but not in other potential neural circuit motifs. Numerical simulations show that the behavior of the adaptive PI-circuit is consistent with experimental observations suggesting that adaptive presynaptic inhibition might be a good candidate neural mechanism to achieve differentiation in early sensory systems.	[Zhang, Danke] Hangzhou Dianzi Univ, Dept Biomed Engn, Hangzhou, Zhejiang, Peoples R China; [Zhang, Danke; Wu, Si; Rasch, Malte J.] Beijing Normal Univ, IDG McGovern Inst Brain Res, State Key Lab Cognit Neurosci & Learning, Beijing 100875, Peoples R China	Hangzhou Dianzi University; Beijing Normal University	Rasch, MJ (corresponding author), Beijing Normal Univ, IDG McGovern Inst Brain Res, State Key Lab Cognit Neurosci & Learning, Beijing 100875, Peoples R China.	malte.rasch@bnu.edu.cn		Zhang, Danke/0000-0002-1415-7207	National Basic Research Program of China [2014CB846101]; National Natural Science Foundation of China [31400941, 31371109, 31261160495]; Fundamental Research Funds for the Central Universities [248-105584GK]; Specialized Research Fund for the Doctoral Program of Higher Education [20130003110022]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Specialized Research Fund for the Doctoral Program of Higher Education(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP))	This work was supported by the National Basic Research Program of China (#2014CB846101), the National Natural Science Foundation of China (#31400941 (DZ), #31371109 (MJR), #31261160495 (SW)), the Fundamental Research Funds for the Central Universities (#248-105584GK (SW)), and the Specialized Research Fund for the Doctoral Program of Higher Education (#20130003110022 (SW)). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott LF, 1997, SCIENCE, V275, P220, DOI 10.1126/science.275.5297.221; Amit DJ, 1997, NETWORK-COMP NEURAL, V8, P373, DOI 10.1088/0954-898X/8/4/003; Aticky JJ, 2011, NETWORK-COMP NEURAL, V22, P4, DOI [10.1088/0954-898X/3/2/009, 10.3109/0954898X.2011.638888]; Barak O, 2007, PLOS COMPUT BIOL, V3, P323, DOI 10.1371/journal.pcbi.0030035; BARLOW HB, 1981, PROC R SOC SER B-BIO, V212, P1, DOI 10.1098/rspb.1981.0022; Beaudoin DL, 2007, J NEUROSCI, V27, P2636, DOI 10.1523/JNEUROSCI.4610-06.2007; Beaudoin DL, 2008, J PHYSIOL-LONDON, V586, P5487, DOI 10.1113/jphysiol.2008.156224; Chen CF, 2003, J NEUROSCI, V23, P3130; CLEMENTS JD, 1987, J PHYSIOL-LONDON, V383, P153; Copelli M, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.060901; Dan Y, 1996, J NEUROSCI, V16, P3351; Dehaene S, 2003, TRENDS COGN SCI, V7, P145, DOI 10.1016/S1364-6613(03)00055-X; Demb JB, 2008, J PHYSIOL-LONDON, V586, P4377, DOI 10.1113/jphysiol.2008.156638; DONG DW, 1995, NETWORK-COMP NEURAL, V6, P345, DOI 10.1088/0954-898X/6/3/003; DONNER K, 1995, VISION RES, V35, P2255, DOI 10.1016/0042-6989(94)00319-H; EVANS EF, 1980, EXP BRAIN RES, V40, P115; Gabernet L, 2005, NEURON, V48, P315, DOI 10.1016/j.neuron.2005.09.022; Gerstner W, 2014, NEURONAL DYNAMICS FR; Hansel D, 2013, J NEUROSCI, V33, P133, DOI 10.1523/JNEUROSCI.3455-12.2013; Hecht S, 1924, J GEN PHYSIOL, V7, P235, DOI 10.1085/jgp.7.2.235; Hosoya T, 2005, NATURE, V436, P71, DOI 10.1038/nature03689; HOUTSMA AJM, 1980, J ACOUST SOC AM, V68, P807, DOI 10.1121/1.384819; Kazama H, 2008, NEURON, V58, P401, DOI 10.1016/j.neuron.2008.02.030; Laughlin S., 1981, Z NATURFORSCH, V36, P51; Le Masson G, 2002, NATURE, V417, P854, DOI 10.1038/nature00825; Luz Y, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002334; Lyu S, 2011, NEURAL COMPUT, V23, P2942, DOI 10.1162/NECO_a_00197; MacDermott AB, 1999, ANNU REV NEUROSCI, V22, P443, DOI 10.1146/annurev.neuro.22.1.443; Markram H, 1996, NATURE, V382, P807, DOI 10.1038/382807a0; Mazor O, 2005, NEURON, V48, P661, DOI 10.1016/j.neuron.2005.09.032; Mongillo G, 2008, SCIENCE, V319, P1543, DOI 10.1126/science.1150769; Nagel KI, 2006, NEURON, V51, P845, DOI 10.1016/j.neuron.2006.08.030; Olsen SR, 2008, NATURE, V452, P956, DOI 10.1038/nature06864; Ozuysal Y, 2012, NEURON, V73, P1002, DOI 10.1016/j.neuron.2011.12.029; Pillow JW, 2006, J VISION, V6, P414, DOI 10.1167/6.4.9; Pouille F, 2001, SCIENCE, V293, P1159, DOI 10.1126/science.1060342; Publio R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048517; RUDERMAN DL, 1994, NETWORK-COMP NEURAL, V5, P517, DOI 10.1088/0954-898X/5/4/006; Schwabedal JTC, 2014, PHYS REV E, V90, DOI 10.1103/PhysRevE.90.022715; Schwartz O, 2001, NAT NEUROSCI, V4, P819, DOI 10.1038/90526; Shadlen MN, 1998, J NEUROSCI, V18, P3870; SHAPLEY RM, 1978, J PHYSIOL-LONDON, V285, P275, DOI 10.1113/jphysiol.1978.sp012571; Solomon SG, 2004, NEURON, V42, P155, DOI 10.1016/S0896-6273(04)00178-3; STEVENS CF, 1995, NEURON, V14, P795, DOI 10.1016/0896-6273(95)90223-6; TACHIBANA M, 1988, VISUAL NEUROSCI, V1, P297, DOI 10.1017/S0952523800001954; Theis L, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003356; Tsodyks M, 1998, NEURAL COMPUT, V10, P821, DOI 10.1162/089976698300017502; Urban NN, 2002, J PHYSIOL-LONDON, V542, P355, DOI 10.1113/jphysiol.2001.013491; vanVreeswijk C, 1996, SCIENCE, V274, P1724, DOI 10.1126/science.274.5293.1724; Vogels TP, 2011, SCIENCE, V334, P1569, DOI 10.1126/science.1211095; Wilson RI, 2006, ANNU REV NEUROSCI, V29, P163, DOI 10.1146/annurev.neuro.29.051605.112950; Wilson RI, 2011, CURR OPIN NEUROBIOL, V21, P254, DOI 10.1016/j.conb.2011.03.002; Wong KF, 2006, J NEUROSCI, V26, P1314, DOI 10.1523/JNEUROSCI.3733-05.2006; YAZULLA S, 1987, BRAIN RES, V411, P400, DOI 10.1016/0006-8993(87)91095-X; Zhang D, 2013, FRONTIERS IN COMPUTA, V7, DOI [10.3389/fncom.2013.00056, DOI 10.3389/FNC0M.2013.00056]	56	3	3	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2015	10	2							e0118125	10.1371/journal.pone.0118125	http://dx.doi.org/10.1371/journal.pone.0118125			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC3LS	25723493	Green Submitted, Green Published, gold			2022-12-27	WOS:000350251200045
J	Schrier, RD; Hong, SZ; Crescini, M; Ellis, R; Perez-Santiago, J; Spina, C; Letendre, S				Schrier, Rachel D.; Hong, Suzi; Crescini, Melanie; Ellis, Ronald; Perez-Santiago, Josue; Spina, Celsa; Letendre, Scott		HNRP Grp	Cerebrospinal Fluid (CSF) CD8+T-Cells That Express Interferon-Gamma Contribute to HIV Associated Neurocognitive Disorders (HAND)	PLOS ONE			English	Article							CD8(+) T-CELLS; RECONSTITUTION INFLAMMATORY SYNDROME; IMMUNODEFICIENCY-VIRUS-INFECTION; HIV-1-INFECTED PATIENTS; VIRAL LOAD; ANTIRETROVIRAL THERAPY; IMMUNE RESTORATION; ADHESION MOLECULE; IN-VIVO; CNS	Background HIV associated neurocognitive disorders (HAND) continue to affect cognition and everyday functioning despite anti-retroviral treatment (ART). Previous studies focused on mechanisms related to monocyte/macrophage mediated inflammation. However, in the ART era, there is increasing evidence for the involvement of CD8+ T-cells in CNS pathogenesis. Methods To investigate the relationship between T-cell responses and neurocognitive impairment (NCI), cerebrospinal fluid (CSF) and peripheral blood CD4+ and CD8+ T-cell intracellular cytokine (IFN gamma, IL-2, TNF alpha) and lytic marker (CD107a) expression were assessed in HIV infected subjects who underwent comprehensive neurocognitive (NC) evaluation and either initiated or changed ART. Results Data were collected from 31 participants at 70 visits. The frequency of cytokine expressing T-cells in CSF was significantly higher than in peripheral blood for CD4+ T-cells: TNF alpha, IL-2, IFN gamma and CD8+ T-cells: IL-2 and IFN gamma. Analysis of T-cell activity and NCI as a function of CSF HIV RNA levels suggested a general association between NCI, high CSF CD8+ (but not CD4+ T-cell) cytokine expression and CSF HIV RNA <10(3) copies/ml (p<0.0001). Specifically, CSF CD8+ T-cell IFN gamma expression correlated with severity of NCI (r = 0.57, p = 0.004). Multivariable analyses indicated that CSF CD8+ T-cell IFN gamma and myeloid activation (CD163) contributed equally and independently to cognitive status and a composite variable produced the strongest correlation with NCI (r = 0.83, p = 0.0001). In contrast, CD8+ cytolytic activity (CD107a expression) was negatively correlated with NCI (p = 0.05) but was dependent on CD4 levels >400/mu l and low CSF HIV RNA levels (<10(3) copies/ml). In our longitudinal analysis of 16 subjects, higher CSF CD8+ IFN gamma expression at baseline predicted NC decline at follow-up (p = 0.02). Severity of NCI at follow-up correlated with level of residual HIV RNA in CSF. Conclusions Presence of IFN gamma expressing CD8+ T-cells, absence of cytolytic CD8+ T-cells, high myeloid activation, and failure of ART to suppress HIV replication in CSF contribute to increased risk of HAND.	[Schrier, Rachel D.; Spina, Celsa] Univ Calif San Diego, Dept Pathol, La Jolla, CA 92093 USA; [Hong, Suzi] Univ Calif San Diego, Dept Psychiat, La Jolla, CA 92093 USA; [Crescini, Melanie; Perez-Santiago, Josue; Spina, Celsa; Letendre, Scott] Dept Med, La Jolla, CA USA; [Crescini, Melanie; Perez-Santiago, Josue; Spina, Celsa; Letendre, Scott] Univ Calif San Diego, La Jolla, CA 92093 USA; [Ellis, Ronald] Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego	Schrier, RD (corresponding author), Univ Calif San Diego, Dept Pathol, La Jolla, CA 92093 USA.	rschrier@ucsd.edu	Letendre, Scott L./GLU-6874-2022; Ellis, Ronald/K-3543-2015	Ellis, Ronald/0000-0003-4931-752X	NIH [R21 MH85610, DA26306, R01 MH58076, R01 HL090975]; UCSD [CFAR P30 AI036214, CARE U19 AI096113];  [P30 MH62512]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL090975] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI096113, P30AI036214, T32AI007384] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P30MH062512, R21MH085610, R01MH058076] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [P50DA026306] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UCSD; ; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This study was supported by NIH awards: R21 MH85610 (SL, RS, SH, RE, MC) / DA26306 (MC, RE, SL, RS) / R01 MH58076 (RE MCSL) / R01 HL090975 (SH, RE, SL, RS, MC). Additional funding came from P30 MH62512 (Heaton, Robert PI: RE, SL, RS, MC), UCSD CFAR P30 AI036214 (Richman D PI: RS, CS, JP) and CARE U19 AI096113 (Margolis D PI: RS, CS). The funding agency had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achim CL, 2004, J NEUROIMMUNOL, V157, P126, DOI 10.1016/j.jneuroim.2004.08.041; Ancuta P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002516; Antonelli LRV, 2010, BLOOD, V116, P3818, DOI 10.1182/blood-2010-05-285080; Asensio VC, 2001, J VIROL, V75, P7067, DOI 10.1128/JVI.75.15.7067-7077.2001; Asquith B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003486; Aubert RD, 2011, P NATL ACAD SCI USA, V108, P21182, DOI 10.1073/pnas.1118450109; Autran B, 1997, SCIENCE, V277, P112, DOI 10.1126/science.277.5322.112; Barcia C, 2006, J EXP MED, V203, P2095, DOI 10.1084/jem.20060420; Boasso A, 2009, J INTERN MED, V265, P78, DOI 10.1111/j.1365-2796.2008.02043.x; Borghans JAM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000920; Burdo TH, 2011, J INFECT DIS, V204, P154, DOI 10.1093/infdis/jir214; Carey CL, 2004, J CLIN EXP NEUROPSYC, V26, P307, DOI 10.1080/13803390490510031; Cysique LA, 2011, J CLIN EXP NEUROPSYC, V33, P505, DOI 10.1080/13803395.2010.535504; Cysique LA, 2010, AIDS, V24, P983, DOI 10.1097/QAD.0b013e32833336c8; de Almeida SN, 2005, J NEUROIMMUNOL, V169, P144, DOI 10.1016/j.jneuroim.2005.07.012; Ellis RJ, 2014, CLIN INFECT DIS; Ellis RJ, 2011, AIDS, V25, P1747, DOI 10.1097/QAD.0b013e32834a40cd; Everall IP, 2005, NEUROTOX RES, V8, P51, DOI 10.1007/BF03033819; Fennema-Notestine C, 2013, J NEUROVIROL, V19, P393, DOI 10.1007/s13365-013-0185-7; Fox L, 1997, J NEUROPATH EXP NEUR, V56, P360, DOI 10.1097/00005072-199704000-00004; Gianella S, 2012, J VIROL, V86, P1307, DOI 10.1128/JVI.06077-11; GIORGI JV, 1993, J ACQ IMMUN DEF SYND, V6, P904; Giorgi JV, 1999, J INFECT DIS, V179, P859, DOI 10.1086/314660; Giunti D, 2003, J LEUKOCYTE BIOL, V73, P584, DOI 10.1189/jlb.1202598; Grant I, 1992, JCONSULTCLINPSYCHOL, V58, P22; Gunthard HF, 2000, J INFECT DIS, V181, P522, DOI 10.1086/315260; Hayes PJ, 1999, CLIN EXP IMMUNOL, V117, P331; Heaton RK, 2008, J NEUROVIROL, P1, DOI [10.1080/13550280701802543, DOI 10.1080/13550280701802543]; Hersperger AR, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000917; Heyes MP, 1998, FASEB J, V12, P881, DOI 10.1096/fasebj.12.10.881; Lamoreaux L, 2006, NAT PROTOC, V1, P1507, DOI 10.1038/nprot.2006.268; Langford TD, 2003, BRAIN PATHOL, V13, P195; Lau LT, 2001, J NEUROTRAUM, V18, P351, DOI 10.1089/08977150151071035; Lescure FX, 2013, CLIN INFECT DIS, V57, P101, DOI 10.1093/cid/cit175; Letendre S, 2008, ARCH NEUROL-CHICAGO, V65, P65, DOI 10.1001/archneurol.2007.31; Li W, 2011, J IMMUNOL, V186, P6771, DOI 10.4049/jimmunol.1100099; Little SJ, 1999, J EXP MED, V190, P841, DOI 10.1084/jem.190.6.841; Mahnke YD, 2012, BLOOD, V119, P3105, DOI 10.1182/blood-2011-09-380840; Mailliard RB, 2013, J IMMUNOL, V191, P2570, DOI 10.4049/jimmunol.1300373; Makedonas G, 2011, IMMUNOL REV, V239, P109, DOI 10.1111/j.1600-065X.2010.00968.x; Marcondes MCG, 2010, AM J PATHOL, V177, P355, DOI 10.2353/ajpath.2010.090953; Marcotte TD, 2003, ARCH NEUROL-CHICAGO, V60, P1406, DOI 10.1001/archneur.60.10.1406; Masliah E, 1997, ANN NEUROL, V42, P963, DOI 10.1002/ana.410420618; Masliah E, 1996, CRIT REV NEUROBIOL, V10, P57, DOI 10.1615/CritRevNeurobiol.v10.i1.30; McCombe JA, 2009, NEUROLOGY, V72, P835, DOI 10.1212/01.wnl.0000343854.80344.69; Mehla R, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-239; Miller RF, 2004, ACTA NEUROPATHOL, V108, P17, DOI 10.1007/s00401-004-0852-0; Navis M, 2008, J INFECT DIS, V197, P871, DOI 10.1086/528695; Neuenburg JK, 2005, JAIDS-J ACQ IMM DEF, V39, P16, DOI 10.1097/01.qai.0000155036.03004.a0; Pitcher CJ, 1999, NAT MED, V5, P518, DOI 10.1038/8400; Riedel DJ, 2006, NAT CLIN PRACT NEURO, V2, P557, DOI 10.1038/ncpneuro0303; Robertson J, 2006, CLIN INFECT DIS, V42, P1639, DOI 10.1086/503903; Rodriguez-Porcel F, 2013, FRONT NEUROL, V4, DOI [10.3389/fneur.2013.00183, 10.3389/fneur.2013.00012]; Sadagopal S, 2008, J VIROL, V82, P10418, DOI 10.1128/JVI.01190-08; Schrier R, 2005, RETINA; Schrier RD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032303; Schrier RD, 1996, J CLIN INVEST, V98, P731, DOI 10.1172/JCI118845; Serrano-Villar S, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004078; Shacklett BL, 2004, J INFECT DIS, V189, P2202, DOI 10.1086/421244; Shan L, 2012, IMMUNITY, V36, P491, DOI 10.1016/j.immuni.2012.01.014; Smolders J, 2013, ACTA NEUROPATHOL, V126, P525, DOI 10.1007/s00401-013-1155-0; Soontornniyomkij V, 2012, AIDS, V26, P2327, DOI 10.1097/QAD.0b013e32835a117c; Tatro ET, 2009, J NEUROIMMUNE PHARM, V4, P218, DOI 10.1007/s11481-009-9146-6; Thompson KA, 2011, AM J PATHOL, V179, P1623, DOI 10.1016/j.ajpath.2011.06.039; Trautmann T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086348; Valcour V, 2012, J INFECT DIS, V206, P275, DOI 10.1093/infdis/jis326; Vendrely A, 2005, ACTA NEUROPATHOL, V109, P449, DOI 10.1007/s00401-005-0983-y; Venkataramana A, 2006, NEUROLOGY, V67, P383, DOI 10.1212/01.wnl.0000227922.22293.93; von Geldern G, 2007, AIDS, V21, P250, DOI 10.1097/QAD.0b013e328011ec76; Waldrop SL, 1997, J CLIN INVEST, V99, P1739, DOI 10.1172/JCI119338; Wiesel M, 2012, EUR J IMMUNOL, V42, P1080, DOI 10.1002/eji.201142205; WILEY CA, 1994, ADV NEUROIMMUNOL, V4, P319, DOI 10.1016/S0960-5428(06)80272-X; WILEY CA, 1986, P NATL ACAD SCI USA, V83, P7089, DOI 10.1073/pnas.83.18.7089; Yamamoto T, 2012, J VIROL, V86, P5877, DOI 10.1128/JVI.00315-12; Young KG, 2011, J IMMUNOL, V187, P1192, DOI 10.4049/jimmunol.1100695; Zajac AJ, 1998, J EXP MED, V188, P2205, DOI 10.1084/jem.188.12.2205	76	52	52	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2015	10	2							e0116526	10.1371/journal.pone.0116526	http://dx.doi.org/10.1371/journal.pone.0116526			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC2ZH	25719800	Green Published, Green Submitted, gold			2022-12-27	WOS:000350213200009
J	Axelrod, V; Yovel, G				Axelrod, Vadim; Yovel, Galit			Successful Decoding of Famous Faces in the Fusiform Face Area	PLOS ONE			English	Article							VENTRAL VISUAL-CORTEX; CONGENITAL PROSOPAGNOSIA; PATTERN-ANALYSIS; FACIAL IDENTITY; SELECTIVE REGIONS; UNFAMILIAR FACES; HUMAN BRAIN; HUMAN LOC; FMRI DATA; REPRESENTATIONS	What are the neural mechanisms of face recognition? It is believed that the network of face-selective areas, which spans the occipital, temporal, and frontal cortices, is important in face recognition. A number of previous studies indeed reported that face identity could be discriminated based on patterns of multivoxel activity in the fusiform face area and the anterior temporal lobe. However, given the difficulty in localizing the face-selective area in the anterior temporal lobe, its role in face recognition is still unknown. Furthermore, previous studies limited their analysis to occipito-temporal regions without testing identity decoding in more anterior face-selective regions, such as the amygdala and prefrontal cortex. In the current high-resolution functional Magnetic Resonance Imaging study, we systematically examined the decoding of the identity of famous faces in the temporo-frontal network of face-selective and adjacent non-face-selective regions. A special focus has been put on the face-area in the anterior temporal lobe, which was reliably localized using an optimized scanning protocol. We found that face-identity could be discriminated above chance level only in the fusiform face area. Our results corroborate the role of the fusiform face area in face recognition. Future studies are needed to further explore the role of the more recently discovered anterior face-selective areas in face recognition.	[Axelrod, Vadim; Yovel, Galit] Tel Aviv Univ, Sch Psychol Sci, IL-69978 Tel Aviv, Israel; [Yovel, Galit] Tel Aviv Univ, Sch Neurosci, IL-69978 Tel Aviv, Israel	Tel Aviv University; Tel Aviv University	Axelrod, V (corresponding author), Tel Aviv Univ, Sch Psychol Sci, IL-69978 Tel Aviv, Israel.	vadim.axelrod@gmail.com	Yovel, Galit/GPT-4409-2022	Yovel, Galit/0000-0003-0971-2357	Levie -Edersheim - Gitter Institute	Levie -Edersheim - Gitter Institute	VA was supported by PhD fellowship from the Levie -Edersheim - Gitter Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews TJ, 2010, J NEUROSCI, V30, P3544, DOI 10.1523/JNEUROSCI.4863-09.2010; Anzellotti S, 2014, CEREB CORTEX, V24, P1988, DOI 10.1093/cercor/bht046; Ashburner J, 2005, NEUROIMAGE, V26, P839, DOI 10.1016/j.neuroimage.2005.02.018; Avidan G, 2005, J COGNITIVE NEUROSCI, V17, P1150, DOI 10.1162/0898929054475145; Avidan G, 2014, CEREB CORTEX, V24, P1565, DOI 10.1093/cercor/bht007; Axelrod V, 2015, CEREB CORTEX, V25, P2160, DOI 10.1093/cercor/bhu022; Axelrod V, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.01435; Axelrod V, 2013, NEUROIMAGE, V81, P371, DOI 10.1016/j.neuroimage.2013.05.015; Axelrod V, 2012, J NEUROSCI, V32, P2442, DOI 10.1523/JNEUROSCI.4770-11.2012; Axelrod V, 2010, J NEUROSCI, V30, P8699, DOI 10.1523/JNEUROSCI.1921-10.2010; Axelrod V, 2010, NEUROIMAGE, V52, P720, DOI 10.1016/j.neuroimage.2010.04.027; Axelrod V, 2011, J COGNITIVE NEUROSCI, V23, P746, DOI 10.1162/jocn.2010.21481; Binder JR, 2009, CEREB CORTEX, V19, P2767, DOI 10.1093/cercor/bhp055; Bjornsdotter M, 2011, NEUROIMAGE, V56, P508, DOI 10.1016/j.neuroimage.2010.07.044; Brett M., 2002, NEUROIMAGE, V16, P1140, DOI DOI 10.1016/S1053-8119(02)90013-3; Chan AWY, 2011, FRONT HUM NEUROSCI, V5, DOI 10.3389/fnhum.2011.00051; Chan AWY, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00371; Chao LL, 1999, NEUROREPORT, V10, P2945, DOI 10.1097/00001756-199909290-00013; Cichy RM, 2011, NEUROIMAGE, V54, P2297, DOI 10.1016/j.neuroimage.2010.09.044; Collins JA, 2014, NEUROPSYCHOLOGIA, V61, P65, DOI 10.1016/j.neuropsychologia.2014.06.005; Coutanche MN, 2013, COGN AFFECT BEHAV NE, V13, P667, DOI 10.3758/s13415-013-0186-2; Cukur T, 2013, J NEUROSCI, V33, P16748, DOI 10.1523/JNEUROSCI.1259-13.2013; Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; Davidesco I, 2014, CEREB CORTEX, V24, P1879, DOI 10.1093/cercor/bht038; Devlin JT, 2000, NEUROIMAGE, V11, P589, DOI 10.1006/nimg.2000.0595; Dubois J, 2013, SOCIETY FOR NEUROSCI, V120, P12; Eger E, 2005, NEUROIMAGE, V26, P1128, DOI 10.1016/j.neuroimage.2005.03.010; Eger E, 2008, J COGNITIVE NEUROSCI, V20, P356, DOI 10.1162/jocn.2008.20019; Ewbank MP, 2008, NEUROIMAGE, V40, P1857, DOI 10.1016/j.neuroimage.2008.01.049; Freiwald WA, 2010, SCIENCE, V330, P845, DOI 10.1126/science.1194908; Gauthier I, 2000, NAT NEUROSCI, V3, P191, DOI 10.1038/72140; Gilaie-Dotan S, 2007, CEREB CORTEX, V17, P325, DOI 10.1093/cercor/bhj150; Goesaert E, 2013, J NEUROSCI, V33, P8549, DOI 10.1523/JNEUROSCI.1829-12.2013; Gorno-Tempini ML, 2002, NEUROIMAGE, V15, P136, DOI 10.1006/nimg.2001.0967; Grill-Spector K, 1999, NEURON, V24, P187, DOI 10.1016/S0896-6273(00)80832-6; Grill-Spector K, 2004, NAT NEUROSCI, V7, P555, DOI 10.1038/nn1224; Hanson SJ, 2008, NEURAL COMPUT, V20, P486, DOI 10.1162/neco.2007.09-06-340; Harris RJ, 2014, NEUROPSYCHOLOGIA, V56, P47, DOI 10.1016/j.neuropsychologia.2014.01.005; Haxby JV, 2000, TRENDS COGN SCI, V4, P223, DOI 10.1016/S1364-6613(00)01482-0; Johnston RA, 2009, MEMORY, V17, P577, DOI 10.1080/09658210902976969; Kanwisher N, 1997, J NEUROSCI, V17, P4302; Kanwisher N, 2006, PHILOS T R SOC B, V361, P2109, DOI 10.1098/rstb.2006.1934; Kietzmann TC, 2012, J NEUROSCI, V32, P11763, DOI 10.1523/JNEUROSCI.0126-12.2012; Kriegeskorte N, 2007, P NATL ACAD SCI USA, V104, P20600, DOI 10.1073/pnas.0705654104; Leibe B, 2003, PROC CVPR IEEE, P409; Logothetis NK, 2001, NATURE, V412, P150, DOI 10.1038/35084005; Malach R, 2002, TRENDS COGN SCI, V6, P176, DOI 10.1016/S1364-6613(02)01870-3; Maldjian JA, 2003, NEUROIMAGE, V19, P1233, DOI 10.1016/S1053-8119(03)00169-1; Megreya AM, 2006, MEM COGNITION, V34, P865, DOI 10.3758/BF03193433; Meyer K, 2010, NAT NEUROSCI, V13, P667, DOI 10.1038/nn.2533; Misaki M, 2010, NEUROIMAGE, V53, P103, DOI 10.1016/j.neuroimage.2010.05.051; Mur M, 2010, CEREB CORTEX, V20, P2027, DOI 10.1093/cercor/bhp272; Nasr S, 2012, NEUROIMAGE, V63, P1743, DOI 10.1016/j.neuroimage.2012.08.031; Natu VS, 2010, J COGNITIVE NEUROSCI, V22, P1570, DOI 10.1162/jocn.2009.21312; Nestor A, 2011, P NATL ACAD SCI USA, V108, P9998, DOI 10.1073/pnas.1102433108; Norman KA, 2006, TRENDS COGN SCI, V10, P424, DOI 10.1016/j.tics.2006.07.005; Olson IR, 2007, BRAIN, V130, P1718, DOI 10.1093/brain/awm052; OScalaidhe SP, 1997, SCIENCE, V278, P1135, DOI 10.1126/science.278.5340.1135; OSHIO K, 1991, JMRI-J MAGN RESON IM, V1, P695, DOI 10.1002/jmri.1880010614; Pinsk MA, 2009, J NEUROPHYSIOL, V101, P2581, DOI 10.1152/jn.91198.2008; Pitcher D, 2011, NEUROIMAGE, V56, P2356, DOI 10.1016/j.neuroimage.2011.03.067; Pourtois G, 2005, NEUROIMAGE, V24, P1214, DOI 10.1016/j.neuroimage.2004.10.038; Rajimehra R, 2009, P NATL ACAD SCI USA, V106, P1995, DOI 10.1073/pnas.0807304106; Ramon M, 2010, EUR J NEUROSCI, V32, P1587, DOI 10.1111/j.1460-9568.2010.07405.x; Rossion B, 2012, BRAIN COGNITION, V79, P138, DOI 10.1016/j.bandc.2012.01.001; Rotshtein P, 2005, NAT NEUROSCI, V8, P107, DOI 10.1038/nn1370; Ruxton GD, 2006, BEHAV ECOL, V17, P688, DOI 10.1093/beheco/ark016; Said CP, 2010, J VISION, V10, DOI 10.1167/10.5.11; Schiltz C, 2006, NEUROIMAGE, V32, P1385, DOI 10.1016/j.neuroimage.2006.05.037; Thomas C, 2009, NAT NEUROSCI, V12, P29, DOI 10.1038/nn.2224; Todorov A, 2012, MOTIV EMOTION, V36, P16, DOI 10.1007/s11031-011-9238-5; Tsao DY, 2008, P NATL ACAD SCI USA, V105, P19514, DOI 10.1073/pnas.0809662105; van den Hurk J, 2011, CEREB CORTEX, V21, P2893, DOI 10.1093/cercor/bhr093; Von Der Heide R, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00017; Vuilleumier P, 2002, NAT NEUROSCI, V5, P491, DOI 10.1038/nn839; Walther DB, 2009, J NEUROSCI, V29, P10573, DOI 10.1523/JNEUROSCI.0559-09.2009; Wong C, 2012, BRAIN RES, V1449, P94, DOI 10.1016/j.brainres.2012.02.017; Xu XK, 2009, VISION RES, V49, P2800, DOI 10.1016/j.visres.2009.08.021; Yang H, 2016, CEREB CORTEX, V26, P1096, DOI 10.1093/cercor/bhu289; Yovel G, 2005, CURR BIOL, V15, P2256, DOI 10.1016/j.cub.2005.10.072; Yovel Galit, 2013, F1000Prime Rep, V5, P10, DOI 10.12703/P5-10; Yue XM, 2011, CEREB CORTEX, V21, P35, DOI 10.1093/cercor/bhq050	82	67	68	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2015	10	2							e0117126	10.1371/journal.pone.0117126	http://dx.doi.org/10.1371/journal.pone.0117126			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CC2IM	25714434	Green Published, Green Submitted, gold			2022-12-27	WOS:000350168700029
J	Lex, H; Essig, K; Knoblauch, A; Schack, T				Lex, Heiko; Essig, Kai; Knoblauch, Andreas; Schack, Thomas			Cognitive Representations and Cognitive Processing of Team-Specific Tactics in Soccer	PLOS ONE			English	Article							VISUOMOTOR ADAPTATION PERFORMANCE; DECISION-MAKING; SEARCH; SKILL; PLAYERS; SPORTS; PERCEPTION; EXPERTISE; STRATEGIES; ATTENTION	Two core elements for the coordination of different actions in sport are tactical information and knowledge about tactical situations. The current study describes two experiments to learn about the memory structure and the cognitive processing of tactical information. Experiment 1 investigated the storage and structuring of team-specific tactics in humans' long-term memory with regard to different expertise levels. Experiment 2 investigated tactical decision-making skills and the corresponding gaze behavior, in presenting participants the identical match situations in a reaction time task. The results showed that more experienced soccer players, in contrast to less experienced soccer players, possess a functionally organized cognitive representation of team-specific tactics in soccer. Moreover, the more experienced soccer players reacted faster in tactical decisions, because they needed less fixations of similar duration as compared to less experienced soccer players. Combined, these experiments offer evidence that a functionally organized memory structure leads to a reaction time and a perceptual advantage in tactical decision-making in soccer. The discussion emphasizes theoretical and applied implications of the current results of the study.	[Lex, Heiko; Essig, Kai; Schack, Thomas] Univ Bielefeld, Res Grp Neurocognit & Act Biomech, D-33615 Bielefeld, Germany; [Lex, Heiko; Essig, Kai; Schack, Thomas] Univ Bielefeld, Cognit Interact Technol Ctr Excellence, D-33615 Bielefeld, Germany; [Knoblauch, Andreas] Albstadt Sigmaringen Univ, Fac Engn, Albstadt Ebingen, Germany	University of Bielefeld; University of Bielefeld	Lex, H (corresponding author), Univ Bielefeld, Res Grp Neurocognit & Act Biomech, D-33615 Bielefeld, Germany.	heiko.lex@uni-bielefeld.de	Essig, Kai/AAR-6354-2021; Lex, Heiko/AAE-9166-2021	Lex, Heiko/0000-0002-3386-832X	Honda Research Institute Europe; Deutsche Forschungsgemeinschaft; Open Access Publication Funds of Bielefeld University	Honda Research Institute Europe; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Open Access Publication Funds of Bielefeld University	This work gratefully acknowledges the financial support from Honda Research Institute Europe. In addition, we acknowledge support for the Article Processing Charge by the Deutsche Forschungsgemeinschaft and the Open Access Publication Funds of Bielefeld University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abernethy B, 2005, APPL COGNITIVE PSYCH, V19, P705, DOI 10.1002/acp.1102; Ali A, 2011, SCAND J MED SCI SPOR, V21, P170, DOI 10.1111/j.1600-0838.2010.01256.x; Calvo-Merino B, 2006, CURR BIOL, V16, P1905, DOI 10.1016/j.cub.2006.07.065; Carling C, 2009, PERFORMANCE ASSESSME; Carling C., 2005, HDB SOCCER MATCH ANA; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; Elferink-Gemser MT, 2004, PERCEPT MOTOR SKILL, V99, P883, DOI 10.2466/PMS.99.7.883-895; Essig K, 2009, P 15 EUR C EYE MOV; Essig K, 2006, INT J PARALLEL EMERG, V21, P79, DOI 10.1080/17445760500354440; Flanagan JR, 2003, NATURE, V424, P769, DOI 10.1038/nature01861; Garganta J., 2009, REV PORT 101 NCIAS D, V9, P81, DOI [10.5628/rpcd.09.01.81, DOI 10.5628/RPCD.09.01.81]; Gonzaga AD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101231; GREHAIGNE JF, 1995, QUEST, V47, P490, DOI 10.1080/00336297.1995.10484171; Helsen WF, 1999, APPL COGNITIVE PSYCH, V13, P1; Hodges NJ, 2007, HDB SPORT PSYCHOL; Hughes MD, 2002, J SPORT SCI, V20, P739, DOI 10.1080/026404102320675602; Jones N, 2004, INT J PERF ANAL SPOR, V4, P61, DOI DOI 10.1080/24748668.2004.11868292; Kiesel A, 2009, J EXP PSYCHOL LEARN, V35, P292, DOI 10.1037/a0014499; Koesling H, 2001, P 11 EUR C EYE MOV; Lago-Ballesteros J, 2010, J HUM KINET, V25, P85, DOI 10.2478/v10078-010-0035-0; Land M., 2009, LOOKING ACTING VISIO; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Lex H, 2014, MIND MACH, V24, DOI [10.7748/ns.29.21.26.s31, DOI 10.7748/NS.29.21.26.S31]; Lex H, 2014, J MOTOR BEHAV, V46, P389, DOI 10.1080/00222895.2014.920290; Lex H, 2012, EXP BRAIN RES, V223, P457, DOI 10.1007/s00221-012-3273-7; Lucchesi M, 2008, PRESSING; Lucchesi M, 2008, WIE GEGEN WELCHE TAK; Marzialli F, 2009, MODERNE FUSSBALLTAKT; McGregor SJ, 1999, J SPORT SCI, V17, P895, DOI 10.1080/026404199365452; McPherson SL, 2003, EXPERT PERFORMANCE S, DOI [10.1136/bjsports-2014-094176, DOI 10.1136/BJSPORTS-2014-094176]; MCPHERSON SL, 2004, INT J SPORT EXERCISE, V2, P274, DOI DOI 10.1080/1612197X.2004.9671746; Memmert D., 2006, OPTIMALES TAKTIKTRAI; Memmert D., 2004, KOGNITIONEN SPORTSPI; MERVIS CB, 1981, ANNU REV PSYCHOL, V32, P89, DOI 10.1146/annurev.ps.32.020181.000513; Moura FA, 2012, SPORT BIOMECH, V11, P85, DOI 10.1080/14763141.2011.637123; O'Donoghue P., 2005, INT J PERF ANAL SPOR, V5, P104, DOI DOI 10.1080/24748668.2005.11868319; Raab M, 2007, J EXP PSYCHOL-APPL, V13, P158, DOI 10.1037/1076-898X.13.3.158; Renkewitz F., 2008, FORSCHUNGSMETHODEN S; Roca A, 2011, COGN PROCESS, V12, P301, DOI 10.1007/s10339-011-0392-1; Schack T, 2006, NEUROSCI LETT, V391, P77, DOI 10.1016/j.neulet.2005.10.009; Schack T, 2012, HDB MEASUREMENT SPOR, V1; Schutz-Bosbach S, 2007, TRENDS COGN SCI, V11, P349, DOI 10.1016/j.tics.2007.06.005; SIMON HA, 1973, AM SCI, V61, P394; Stockel T, 2012, PSYCHOL RES-PSYCH FO, V76, P768, DOI 10.1007/s00426-011-0387-7; Vaeyens R, 2007, J MOTOR BEHAV, V39, P395, DOI 10.3200/JMBR.39.5.395-408; Vaeyens R, 2007, J SPORT EXERCISE PSY, V29, P147, DOI 10.1123/jsep.29.2.147; Vestberg T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034731; Vickers JN, 2009, PROG BRAIN RES, V174, P279, DOI 10.1016/S0079-6123(09)01322-3; Vilar L, 2012, SPORTS MED, V42, P1, DOI 10.2165/11596520-000000000-00000; Ward P, 2003, J SPORT EXERCISE PSY, V25, P93, DOI 10.1123/jsep.25.1.93; Weigelt M, 2011, PSYCHOL SPORT EXERC, V12, P231, DOI 10.1016/j.psychsport.2010.11.001; WILLIAMS AM, 1994, RES Q EXERCISE SPORT, V65, P127, DOI 10.1080/02701367.1994.10607607; Williams AM, 2006, PERCEPTION, V35, P317, DOI 10.1068/p5310; Williams AM, 1998, RES Q EXERCISE SPORT, V69, P111, DOI 10.1080/02701367.1998.10607677; Williams AM, 2000, J SPORT SCI, V18, P657, DOI 10.1080/02640410050120041; WILLIAMS M, 1993, PERCEPT MOTOR SKILL, V76, P579, DOI 10.2466/pms.1993.76.2.579; Winnick JJ, 2005, MED SCI SPORT EXER, V37, P306, DOI 10.1249/01.MSS.0000152803.35130.A4	57	38	38	2	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2015	10	2							e0118219	10.1371/journal.pone.0118219	http://dx.doi.org/10.1371/journal.pone.0118219			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CC2IM	25714486	Green Submitted, Green Published, gold			2022-12-27	WOS:000350168700057
J	Newman, EA; Eisen, L; Eisen, RJ; Fedorova, N; Hasty, JM; Vaughn, C; Lane, RS				Newman, Erica A.; Eisen, Lars; Eisen, Rebecca J.; Fedorova, Natalia; Hasty, Jeomhee M.; Vaughn, Charles; Lane, Robert S.			Borrelia burgdorferi Sensu Lato Spirochetes in Wild Birds in Northwestern California: Associations with Ecological Factors, Bird Behavior and Tick Infestation	PLOS ONE			English	Article							IXODES-PACIFICUS ACARI; LYME-DISEASE SPIROCHETE; BLACK-LEGGED TICK; RESERVOIR COMPETENCE; RELATIVE ABUNDANCE; MIGRATORY BIRDS; IXODIDAE NYMPHS; HOSTS; VECTOR; BIODIVERSITY	Although Borrelia burgdorferi sensu lato (s.l.) are found in a great diversity of vertebrates, most studies in North America have focused on the role of mammals as spirochete reservoir hosts. We investigated the roles of birds as hosts for subadult Ixodes pacificus ticks and potential reservoirs of the Lyme disease spirochete B. burgdorferi sensu stricto (s.s.) in northwestern California. Overall, 623 birds representing 53 species yielded 284 I. pacificus larvae and nymphs. We used generalized linearmodels and zero-inflated negative binomial models to determine associations of bird behaviors, taxonomic relationships and infestation by I. pacificus with borrelial infection in the birds. Infection status in birds was best explained by taxonomic order, number of infesting nymphs, sampling year, and log-transformed average body weight. Presence and counts of larvae and nymphs could be predicted by ground-or bark-foraging behavior and contact with dense oak woodland. Molecular analysis yielded the first reported detection of Borrelia bissettii in birds. Moreover, our data suggest that the Golden-crowned Sparrow (Zonotrichia atricapilla), a non-resident species, could be an important reservoir for B. burgdorferi s.s. Of 12 individual birds (9 species) that carried B. burgdorferi s.l.-infected larvae, no birds carried the same genospecies of B. burgdorferi s.l. in their blood as were present in the infected larvae removed from them. Possible reasons for this discrepancy are discussed. Our study is the first to explicitly incorporate both taxonomic relationships and behaviors as predictor variables to identify putative avian reservoirs of B. burgdorferi s.l. Our findings underscore the importance of bird behavior to explain local tick infestation and Borrelia infection in these animals, and suggest the potential for bird-mediated geographic spread of vector ticks and spirochetes in the far-western United States.	[Newman, Erica A.] Univ Calif Berkeley, Energy & Resources Grp, Berkeley, CA 94720 USA; [Newman, Erica A.; Fedorova, Natalia; Lane, Robert S.] Univ Calif Berkeley, Dept Environm Sci Policy & Management, Berkeley, CA 94720 USA; [Eisen, Lars] Colorado State Univ, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA; [Eisen, Lars; Eisen, Rebecca J.] Ctr Dis Control & Prevent, Div Vector Borne Dis, Ft Collins, CO 80522 USA; [Hasty, Jeomhee M.] Hawaii Dept Hlth, Sanitat Branch, Honolulu, HI 96813 USA; [Vaughn, Charles] Univ Calif Hopland, Res & Extens Ctr, Hopland, CA 95449 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; Colorado State University; Centers for Disease Control & Prevention - USA	Newman, EA (corresponding author), Univ Calif Berkeley, Energy & Resources Grp, 310 Barrows Hall, Berkeley, CA 94720 USA.	newmane@berkeley.edu		Newman, Erica/0000-0001-6433-8594	National Institutes of Health [AI22501]; National Science Foundation	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF))	This research was funded in part by a grant from the National Institutes of Health (AI22501) to RSL, and by a Graduate Research Fellowship from the National Science Foundation to EAN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amundson CL, 2014, AUK, V131, P476, DOI 10.1642/AUK-14-11.1; Bairlein F., 1990, P198; Barbour AG, 2009, AM J TROP MED HYG, V81, P1120, DOI 10.4269/ajtmh.2009.09-0208; Biaich PJ, 1997, GUIDE NESTS EGGS NES; Birds of North America online, 2011, BIRDS N AM ONLINE; Blair RB, 1996, ECOL APPL, V6, P506, DOI 10.2307/2269387; Bolger DT, 1997, CONSERV BIOL, V11, P406, DOI 10.1046/j.1523-1739.1997.96307.x; Brinkerhoff RJ, 2011, FRONT ECOL ENVIRON, V9, P103, DOI 10.1890/090062; Brown RN, 1996, AM J TROP MED HYG, V54, P84, DOI 10.4269/ajtmh.1996.54.84; BROWN RN, 1992, SCIENCE, V256, P1439, DOI 10.1126/science.1604318; BURGDORFER W, 1985, AM J TROP MED HYG, V34, P925, DOI 10.4269/ajtmh.1985.34.925; Burnham K. P., 1998, MODEL SELECTION INFE; Butchart SHM, 2010, SCIENCE, V328, P1164, DOI 10.1126/science.1187512; California Department of Fish and Game, 2003, ATL BIOD CAL; Casher L, 2002, EXP APPL ACAROL, V26, P127, DOI 10.1023/A:1020911306291; Castro MB, 2007, J VECTOR ECOL, V32, P140, DOI 10.3376/1081-1710(2007)32[140:VHOIPA]2.0.CO;2; CDC, 2003, REP CAS LYM DIS YEAR; Chesser RT, 2013, AUK, V130, P558, DOI 10.1525/auk.2013.130.3.1; CLOVER JR, 1995, AM J TROP MED HYG, V53, P237, DOI 10.4269/ajtmh.1995.53.237; Collins PW, 1999, BIRDS N AM ONLINE, DOI 10.2173/bna.472; Comstedt P, 2006, EMERG INFECT DIS, V12, P1087; Cornell Lab of Ornithology, 2011, LIF HIST BIRDS; Craine NG, 1997, FOLIA PARASIT, V44, P155; DEGRAAF RM, 1985, ENVIRON MANAGE, V9, P493, DOI 10.1007/BF01867324; Dennis DT, 1998, J MED ENTOMOL, V35, P629, DOI 10.1093/jmedent/35.5.629; Dingler RJ, 2014, TICKS TICK-BORNE DIS, V5, P436, DOI 10.1016/j.ttbdis.2014.02.002; Eisen L, 2004, J VECTOR ECOL, V29, P295; Eisen L, 2004, MED VET ENTOMOL, V18, P38, DOI 10.1111/j.1365-2915.2004.0476.x; Eisen L, 2002, MED VET ENTOMOL, V16, P235, DOI 10.1046/j.1365-2915.2002.00372.x; Eisen L, 2009, J VECTOR ECOL, V34, P81, DOI [10.1111/j.1948-7134.2009.00010.x, 10.3376/038.034.0110]; Eisen RJ, 2003, ENVIRON ENTOMOL, V32, P1010, DOI 10.1603/0046-225X-32.5.1010; Gaston KJ, 2003, P ROY SOC B-BIOL SCI, V270, P1293, DOI 10.1098/rspb.2002.2303; GILL F.B., 2006, ORNITHOLOGY; Ginsberg HS, 2005, J MED ENTOMOL, V42, P445, DOI 10.1603/0022-2585(2005)042[0445:RCONNA]2.0.CO;2; Girard YA, 2011, J CLIN MICROBIOL, V49, P945, DOI 10.1128/JCM.01689-10; Hubalek Z, 1998, J MED MICROBIOL, V47, P929, DOI 10.1099/00222615-47-10-929; Humair PF, 2002, INT J MED MICROBIOL, V291, P70, DOI 10.1016/S1438-4221(02)80015-7; Iknayan KJ, 2014, TRENDS ECOL EVOL, V29, P97, DOI 10.1016/j.tree.2013.10.012; Ishiguro F, 2000, APPL ENVIRON MICROB, V66, P982, DOI 10.1128/AEM.66.3.982-986.2000; Ivanova LB, 2014, ENVIRON MICROBIOL, V16, P1069, DOI 10.1111/1462-2920.12310; Jackman S., 2012, PSCL CLASSES METHODS; Joint Food and Agriculture Organization (FAO), 2007, FAO AN PROD HLTH MAN, P33; Lane RS, 2006, J PARASITOL, V92, P691, DOI 10.1645/GE-738R1.1; Lane RS, 2007, J VECTOR ECOL, V32, P342, DOI 10.3376/1081-1710(2007)32[342:HBOIPA]2.0.CO;2; Lane RS, 2006, J WILDLIFE DIS, V42, P759, DOI 10.7589/0090-3558-42.4.759; LANE RS, 1991, J MED ENTOMOL, V28, P299, DOI 10.1093/jmedent/28.3.299; Lane RS, 2004, J MED ENTOMOL, V41, P239, DOI 10.1603/0022-2585-41.2.239; Lane RS, 1998, J PARASITOL, V84, P29, DOI 10.2307/3284524; LANE RS, 1991, ANNU REV ENTOMOL, V36, P587, DOI 10.1146/annurev.en.36.010191.003103; Lane RS, 1999, J MED ENTOMOL, V36, P329, DOI 10.1093/jmedent/36.3.329; LoGiudice K, 2003, P NATL ACAD SCI USA, V100, P567, DOI 10.1073/pnas.0233733100; MACE GM, 1983, AM NAT, V121, P120, DOI 10.1086/284043; MacKenzie DI, 2002, ECOLOGY, V83, P2248, DOI 10.1890/0012-9658(2002)083[2248:ESORWD]2.0.CO;2; MANWEILER SA, 1990, J MED ENTOMOL, V27, P1011, DOI 10.1093/jmedent/27.6.1011; Margos G, 2011, INFECT GENET EVOL, V11, P1545, DOI 10.1016/j.meegid.2011.07.022; Marsot M, 2012, INT J PARASITOL, V42, P781, DOI 10.1016/j.ijpara.2012.05.010; MATHER TN, 1989, J PARASITOL, V75, P66, DOI 10.2307/3282938; Mazerolle MJ, 2012, AICCMODAVG MODEL SEL; Millan J, 2004, PARASITOL RES, V93, P605, DOI 10.1007/s00346-004-1113-9; Miyamoto K, 1997, ACTA TROP, V65, P43, DOI 10.1016/S0001-706X(97)00651-7; MOller AP, 2010, EFFECTS CLIMATE CHAN; OLSEN B, 1993, NATURE, V362, P340, DOI 10.1038/362340a0; Ostfeld R, 2000, CAN J ZOOL, V78, P2061, DOI 10.1139/cjz-78-12-2061; Piesman J, 2004, PARASITOLOGY, V129, pS191, DOI 10.1017/S0031182003004694; Postic D, 2007, INT J MED MICROBIOL, V297, P263, DOI 10.1016/j.ijmm.2007.01.006; Poupon MA, 2006, APPL ENVIRON MICROB, V72, P976, DOI 10.1128/AEM.72.1.976-979.2006; PRINZINGER R, 1991, COMP BIOCHEM PHYS A, V99, P499, DOI 10.1016/0300-9629(91)90122-S; R Core Team, 2012, R LANG ENV STAT COMP; Reed Kurt D, 2003, Clin Med Res, V1, P5; Remsen JV, 1996, AUK, V113, P381, DOI 10.2307/4088905; Richter D, 2000, EMERG INFECT DIS, V6, P133, DOI 10.3201/eid0602.000205; Root TL, 2003, NATURE, V421, P57, DOI 10.1038/nature01333; Royle JA, 2003, ECOLOGY, V84, P777, DOI 10.1890/0012-9658(2003)084[0777:EAFRPA]2.0.CO;2; Salkeld DJ, 2008, AM J TROP MED HYG, V79, P535, DOI 10.4269/ajtmh.2008.79.535; Scott JD, 2012, J PARASITOL, V98, P49, DOI 10.1645/GE-2874.1; Shultz AJ, 2012, CONDOR, V114, P258, DOI 10.1525/cond.2012.110029; SINSKY RJ, 1989, J CLIN MICROBIOL, V27, P1723, DOI 10.1128/JCM.27.8.1723-1727.1989; Slowik TJ, 2001, J PARASITOL, V87, P755, DOI 10.1645/0022-3395(2001)087[0755:BATTIN]2.0.CO;2; SOULE M E, 1988, Conservation Biology, V2, P75, DOI 10.1111/j.1523-1739.1988.tb00337.x; SOULE ME, 1992, OIKOS, V63, P39, DOI 10.2307/3545514; Stralberg D., 2002, General Technical Report - Pacific Southwest Research Station, USDA Forest Service, P341; Vaughn C., 2007, SEASONAL CHECKLIST H; Wang Y, 2002, CONDOR, V104, P59, DOI 10.1650/0010-5422(2002)104[0059:COMNAP]2.0.CO;2; WEISBROD AR, 1989, APPL ENVIRON MICROB, V55, P1921, DOI 10.1128/AEM.55.8.1921-1924.1989; Whipple AA, 2011, RESTOR ECOL, V19, P88, DOI 10.1111/j.1526-100X.2009.00633.x; Wright SA, 2011, J MED ENTOMOL, V48, P852, DOI 10.1603/ME11001; Wright SA, 2006, J MED ENTOMOL, V43, P368, DOI 10.1603/0022-2585(2006)043[0368:AACTTP]2.0.CO;2; Wright SA, 1998, J MED ENTOMOL, V35, P1044, DOI 10.1093/jmedent/35.6.1044; Wright SA, 2000, J MED ENTOMOL, V37, P909, DOI 10.1603/0022-2585-37.6.909; Zeileis A, 2008, J STAT SOFTW, V27, P1, DOI 10.18637/jss.v027.i08	90	44	46	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2015	10	2							e0118146	10.1371/journal.pone.0118146	http://dx.doi.org/10.1371/journal.pone.0118146			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC2IM	25714376	Green Published, gold			2022-12-27	WOS:000350168700055
J	Sugahara, R; Jouraku, A; Nakakura, T; Kusakabe, T; Yamamoto, T; Shinohara, Y; Miyoshi, H; Shiotsuki, T				Sugahara, Ryohei; Jouraku, Akiya; Nakakura, Takayo; Kusakabe, Takahiro; Yamamoto, Takenori; Shinohara, Yasuo; Miyoshi, Hideto; Shiotsuki, Takahiro			Two Adenine Nucleotide Translocase Paralogues Involved in Cell Proliferation and Spermatogenesis in the Silkworm Bombyx mori	PLOS ONE			English	Article							MITOCHONDRIAL ADP/ATP CARRIER; ADP ATP TRANSLOCATOR; SACCHAROMYCES-CEREVISIAE; SPECIES LACKING; GENE; EXPRESSION; ISOFORM; TRANSCRIPTION; CHROMOSOME; PROTEIN	Mitochondrial adenine nucleotide translocase (ANT) specifically acts in ADP/ATP exchange through the mitochondrial inner membrane. This transporter protein thereby plays a significant role in energy metabolism in eukaryotic cells. Most mammals have four paralogous ANT genes (ANT1-4) and utilize these paralogues in different types of cells. The fourth paralogue of ANT (ANT4) is present only in mammals and reptiles and is exclusively expressed in testicular germ cells where it is required for meiotic progression in the spermatocytes. Here, we report that silkworms harbor two ANT paralogues, the homeostatic paralogue (BmANTI1) and the testis-specific paralogue (BmANTI2). The BmANTI2 protein has an N-terminal extension in which the positions of lysine residues in the amino acid sequence are distributed as in human ANT4. An expression analysis showed that BmANTI2 transcripts were restricted to the testis, suggesting the protein has a role in the progression of spermatogenesis. By contrast, BmANTI1 was expressed in all tissues tested, suggesting it has an important role in homeostasis. We also observed that cultured silkworm cells required BmANTI1 for proliferation. The ANTI1 protein of the lepidopteran Plutella xylostella (PxANTI1), but not those of other insect species (or PxANTI2), restored cell proliferation in BmANTI1-knockdown cells suggesting that ANTI1 has similar energy metabolism functions across the Lepidoptera. Our results suggest that BmANTI2 is evolutionarily divergent from BmANTI1 and has developed a specific role in spermatogenesis similar to that of mammalian ANT4.	[Sugahara, Ryohei; Nakakura, Takayo; Shiotsuki, Takahiro] Natl Inst Agrobiol Sci, Insect Growth Regulat Res Unit, Tsukuba, Ibaraki, Japan; [Jouraku, Akiya] Natl Inst Agrobiol Sci, Insect Genome Res Unit, Tsukuba, Ibaraki, Japan; [Kusakabe, Takahiro] Kyushu Univ, Lab Silkworm Sci, Grad Sch Bioresource & Bioenvironm Sci, Fukuoka 812, Japan; [Yamamoto, Takenori; Shinohara, Yasuo] Univ Tokushima, Inst Genome Res, Tokushima 770, Japan; [Miyoshi, Hideto] Kyoto Univ, Grad Sch Agr, Div Appl Life Sci, Kyoto, Japan	National Institute of Agrobiological Sciences - Japan; National Institute of Agrobiological Sciences - Japan; Kyushu University; Tokushima University; Kyoto University	Shiotsuki, T (corresponding author), Natl Inst Agrobiol Sci, Insect Growth Regulat Res Unit, Tsukuba, Ibaraki, Japan.	shiotsuk@affrc.go.jp		Sugahara, Ryohei/0000-0001-6603-9029; Jouraku, Akiya/0000-0003-3264-8293	Programme for Promotion of Basic and Applied Researches for Innovations in Bio-oriented Industry; science and technology research promotion program for agriculture, forestry, fisheries and food industry [26021A]	Programme for Promotion of Basic and Applied Researches for Innovations in Bio-oriented Industry; science and technology research promotion program for agriculture, forestry, fisheries and food industry	This work was supported by the Programme for Promotion of Basic and Applied Researches for Innovations in Bio-oriented Industry, and science and technology research promotion program for agriculture, forestry, fisheries and food industry, to YS, HM, and TS (Grant 26021A). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arrese EL, 2010, ANNU REV ENTOMOL, V55, P207, DOI 10.1146/annurev-ento-112408-085356; Arunkumar KP, 2009, GENETICS, V182, P493, DOI 10.1534/genetics.108.099994; AUSTIN J, 1983, ARCH BIOCHEM BIOPHYS, V222, P321, DOI 10.1016/0003-9861(83)90529-5; Barath P, 1999, EXP CELL RES, V248, P583, DOI 10.1006/excr.1999.4432; BETINA S, 1995, EUR J BIOCHEM, V229, P651, DOI 10.1111/j.1432-1033.1995.tb20510.x; Brower JV, 2007, J BIOL CHEM, V282, P29658, DOI 10.1074/jbc.M704386200; Brower JV, 2009, REPRODUCTION, V138, P463, DOI 10.1530/REP-09-0201; BRUNI A, 1964, NATURE, V201, P1219, DOI 10.1038/2011219a0; Chevrollier A, 2005, J BIOENERG BIOMEMBR, V37, P307, DOI 10.1007/s10863-005-8642-5; Chevrollier A, 2011, BBA-BIOENERGETICS, V1807, P562, DOI 10.1016/j.bbabio.2010.10.008; Doerner A, 1997, FEBS LETT, V414, P258, DOI 10.1016/S0014-5793(97)01000-4; Dolce V, 2005, FEBS LETT, V579, P633, DOI 10.1016/j.febslet.2004.12.034; Dupont PY, 2011, GENE, V487, P38, DOI 10.1016/j.gene.2011.07.024; Fiore C, 1998, BIOCHIMIE, V80, P137, DOI 10.1016/S0300-9084(98)80020-5; Gavurnikova G, 1996, EUR J BIOCHEM, V239, P759, DOI 10.1111/j.1432-1033.1996.0759u.x; Gotoh T, 2007, EXP APPL ACAROL, V42, P1, DOI 10.1007/s10493-007-9072-3; Hamazaki T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019250; Hashimoto M, 1999, BBA-BIOENERGETICS, V1409, P113, DOI 10.1016/S0005-2728(98)00155-8; Hatanaka T, 2001, BIOL PHARM BULL, V24, P595, DOI 10.1248/bpb.24.595; HOMYK T, 1980, MOL GEN GENET, V177, P553; Kawamura N, 1998, PROTOPLASMA, V202, P223, DOI 10.1007/BF01282550; Kim YH, 2007, DEV BIOL, V302, P463, DOI 10.1016/j.ydbio.2006.10.004; KLINGENBERG M, 1989, ARCH BIOCHEM BIOPHYS, V270, P1, DOI 10.1016/0003-9861(89)90001-5; KOLAROV J, 1990, J BIOL CHEM, V265, P12711; KRAMER R, 1980, BIOCHEMISTRY-US, V19, P556; LI K, 1989, J BIOL CHEM, V264, P13998; Lim CH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023122; Lousa CD, 2002, BIOCHEMISTRY-US, V41, P14412, DOI 10.1021/bi02641490; Mikhaylova LM, 2011, BMC BIOL, V9, DOI 10.1186/1741-7007-9-29; Minakuchi C, 2008, FEBS J, V275, P2919, DOI 10.1111/j.1742-4658.2008.06428.x; Mitsunobu Hitoshi, 2006, Journal of Insect Biotechnology and Sericology, V75, P141; Mon H, 2014, INSECT BIOCHEM MOLEC, V45, P40, DOI 10.1016/j.ibmb.2013.11.007; Mon H, 2012, RNA BIOL, V9, P40, DOI 10.4161/rna.9.1.18084; Nelson DR, 1998, J MOL BIOL, V277, P285, DOI 10.1006/jmbi.1997.1594; Ogura Ichiro, 2001, Journal of Insect Biotechnology and Sericology, V70, P121; Ogura T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008030; OSANAI M, 1993, AMINO ACIDS, V5, P341, DOI 10.1007/BF00806952; OSANAI M, 1987, J MORPHOL, V193, P1, DOI 10.1002/jmor.1051930102; OSANAI M, 1989, INVERTEBR REPROD DEV, V15, P97, DOI 10.1080/07924259.1989.9672029; Pebay-Peyroula E, 2003, NATURE, V426, P39, DOI 10.1038/nature02056; PFAFF E, 1965, BIOCHIM BIOPHYS ACTA, V104, P312, DOI 10.1016/0304-4165(65)90258-8; SABOVA L, 1993, EUR J BIOCHEM, V213, P547, DOI 10.1111/j.1432-1033.1993.tb17793.x; Sado T., 1963, Journal of the Faculty of Agriculture Kyushu University Fukuoka, V12, P359; Shinoda T, 2003, P NATL ACAD SCI USA, V100, P11986, DOI 10.1073/pnas.2134232100; STEPIEN G, 1992, J BIOL CHEM, V267, P14592; Sugahara R, 2014, INSECT MOL BIOL, V23, P185, DOI 10.1111/imb.12072; Sugahara R, 2012, GENE, V501, P180, DOI 10.1016/j.gene.2012.03.071; Tanaka S, 2010, J INSECT PHYSIOL, V56, P911, DOI 10.1016/j.jinsphys.2010.05.013; Tatsuke T, 2009, J FAC AGR KYUSHU U, V54, P397; Terhzaz S, 2010, PHYSIOL GENOMICS, V41, P33, DOI 10.1152/physiolgenomics.00147.2009; Tsubota T, 2010, INSECT BIOCHEM MOLEC, V40, P100, DOI 10.1016/j.ibmb.2009.12.015; Turner JMA, 2007, DEVELOPMENT, V134, P1823, DOI 10.1242/dev.000018; WALKER JE, 1993, J BIOENERG BIOMEMBR, V25, P435, DOI 10.1007/BF01108401; Wang XH, 2014, NAT COMMUN, V5, P1, DOI 10.1038/ncomms3957; Yang ZQ, 2013, OXID MED CELL LONGEV, V2013, DOI [10.1155/2013/146860, 10.1155/2013/329183]; Zhang YQ, 1999, GENETICS, V153, P891	56	12	14	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2015	10	3							e0119429	10.1371/journal.pone.0119429	http://dx.doi.org/10.1371/journal.pone.0119429			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9KG	25742135	gold, Green Submitted, Green Published			2022-12-27	WOS:000350688100110
J	Ahmed, HA; MacLeod, ET; Welburn, SC; Picozzi, K				Ahmed, Heba A.; MacLeod, Ewan T.; Welburn, Susan C.; Picozzi, Kim			Development of Real Time PCR to Study Experimental Mixed Infections of T. congolense Savannah and T. b. brucei in Glossina morsitans morsitans	PLOS ONE			English	Article							RICKETTSIA-LIKE ORGANISMS; TRYPANOSOMA-BRUCEI; TSETSE-FLIES; SUSCEPTIBILITY; TRANSMISSION; BLOOD	Tsetse flies are able to acquire mixed infections naturally or experimentally either simultaneously or sequentially. Traditionally, natural infection rates in tsetse flies are estimated by microscopic examination of different parts of the fly after dissection, together with the isolation of the parasite in vivo. However, until the advent of molecular techniques it was difficult to speciate trypanosomes infections and to quantify trypanosome numbers within tsetse flies. Although more expensive, qPCR allows the quantification of DNA and is less time consuming due to real time visualization and validation of the results. The current study evaluated the application of qPCR to quantify the infection load of tsetse flies with T. b. brucei and T. congolense savannah and to study the possibility of competition between the two species. The results revealed that the two qPCR reactions are of acceptable efficiency (99.1% and 95.6%, respectively), sensitivity and specificity and can be used for quantification of infection load with trypanosomes in experimentally infected Glossina morsitans morsitans. The mixed infection of laboratory Glossina species and quantification of the infection suggests the possibility that a form of competition exists between the isolates of T. b. brucei and T. congolense savannah that we used when they co-exist in the fly midgut.	[Ahmed, Heba A.; MacLeod, Ewan T.; Welburn, Susan C.; Picozzi, Kim] Univ Edinburgh, Div Pathway Med, Sch Biomed Sci, Coll Med & Vet Med, Edinburgh, Midlothian, Scotland; [Ahmed, Heba A.] Zagazig Univ, Fac Vet Med, Zagazig, Ash Sharqiyah, Egypt	University of Edinburgh; Egyptian Knowledge Bank (EKB); Zagazig University	Picozzi, K (corresponding author), Univ Edinburgh, Div Pathway Med, Sch Biomed Sci, Coll Med & Vet Med, Edinburgh, Midlothian, Scotland.	kim.picozzi@ed.ac.uk	Abdallah, Heba ahmed/J-4996-2019; macleod, ewan/AAG-1005-2019	Abdallah, Heba ahmed/0000-0002-3615-9385; macleod, ewan/0000-0002-5517-0619	European Union's Seventh Framework Program (FP7) under ICONZ (Integrated Control of Neglected Zoonoses) [221948]; 'Dynamic Drivers of Disease in Africa Consortium', NERC project [NE-J001570-1]; Ecosystem Services for Poverty Alleviation Programme (ESPA); Department for International Development (DFID); Economic and Social Research Council (ESRC); Natural Environment Research Council (NERC), as part of the UK's Living with Environmental Change Programme (LWEC); BBSRC through CIDLID; Biotechnology and Biological Sciences Research Council [BB/H009213/1] Funding Source: researchfish; BBSRC [BB/H009213/1] Funding Source: UKRI	European Union's Seventh Framework Program (FP7) under ICONZ (Integrated Control of Neglected Zoonoses); 'Dynamic Drivers of Disease in Africa Consortium', NERC project; Ecosystem Services for Poverty Alleviation Programme (ESPA); Department for International Development (DFID); Economic and Social Research Council (ESRC)(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Natural Environment Research Council (NERC), as part of the UK's Living with Environmental Change Programme (LWEC)(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); BBSRC through CIDLID(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	The research leading to these results has received funding from the European Union's Seventh Framework Program (FP7/2007-2013) under grant agreement no 221948, ICONZ (Integrated Control of Neglected Zoonoses). In addition, these findings were produced with support from the 'Dynamic Drivers of Disease in Africa Consortium', NERC project no. NE-J001570-1, funded with support from the Ecosystem Services for Poverty Alleviation Programme (ESPA). The ESPA programme is funded by the Department for International Development (DFID), the Economic and Social Research Council (ESRC) and the Natural Environment Research Council (NERC), as part of the UK's Living with Environmental Change Programme (LWEC). Support from the BBSRC through CIDLID is also acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Becker S, 2004, DIAGN MICR INFEC DIS, V50, P193, DOI 10.1016/j.diagmicrobio.2004.07.001; Boulanger N, 2002, INSECT BIOCHEM MOLEC, V32, P369, DOI 10.1016/S0965-1748(02)00029-2; GIBSON W, 1992, ACTA TROP, V50, P345, DOI 10.1016/0001-706X(92)90070-E; GIBSON WC, 1986, MOL BIOCHEM PARASIT, V18, P127, DOI 10.1016/0166-6851(86)90033-2; Haines LR, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000793; Jamonneau V, 2004, PARASITOLOGY, V129, P693, DOI 10.1017/S0031182004005876; Kubi C, 2005, J MED ENTOMOL, V42, P1035, DOI 10.1603/0022-2585(2005)042[1035:AOTTFD]2.0.CO;2; MacLeod ET, 2007, PARASITOLOGY, V134, P827, DOI 10.1017/S0031182007002247; MacLeod ET, 2008, PARASITE VECTOR, V1, DOI 10.1186/1756-3305-1-5; MASIGA DK, 1992, INT J PARASITOL, V22, P909, DOI 10.1016/0020-7519(92)90047-O; Maudlin I, 1996, MOL BIOL INSECT DIS, P136; MENSAWILMOT K, 1990, MOL CELL BIOL, V10, P720, DOI 10.1128/MCB.10.2.720; MIHOK S, 1993, PARASITOLOGY, V107, P41, DOI 10.1017/S0031182000079385; MOLOO SK, 1988, TROP MED PARASITOL, V39, P211; MOLOO SK, 1982, ACTA TROP, V39, P303; MOSER DR, 1989, PARASITOLOGY, V99, P57, DOI 10.1017/S0031182000061023; MURRAY W, 1993, COMP CONT EDUC PRACT, V15, P1665; Oberle M, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001023; Peacock Lori, 2007, Kinetoplastid Biology and Disease, V6, pUnpaginated, DOI 10.1186/1475-9292-6-4; Picozzi K, 2008, EXP PARASITOL, V118, P41, DOI 10.1016/j.exppara.2007.05.014; Reifenberg JM, 1997, MED VET ENTOMOL, V11, P246, DOI 10.1111/j.1365-2915.1997.tb00402.x; SEED JR, 1978, J PROTOZOOL, V25, P526, DOI 10.1111/j.1550-7408.1978.tb04179.x; Van den Abbeele J, 1999, PARASITOLOGY, V118, P469, DOI 10.1017/S0031182099004217; Van den Bossche P, 2004, VET PARASITOL, V121, P79, DOI 10.1016/j.vetpar.2004.02.011; Van den Bossche P, 2004, VET PARASITOL, V119, P147, DOI 10.1016/j.vetpar.2003.11.008; Welburn SC, 2006, PARASITOLOGY, V132, pS7, DOI 10.1017/S0031182006000825; WELBURN SC, 1991, PARASITOLOGY, V102, P201, DOI 10.1017/S0031182000062491; Welburn SC, 1997, MED VET ENTOMOL, V11, P286, DOI 10.1111/j.1365-2915.1997.tb00408.x; WELBURN SC, 1993, PARASITOLOGY, V107, P141, DOI 10.1017/S003118200006724X; WELBURN SC, 1989, MED VET ENTOMOL, V3, P77, DOI 10.1111/j.1365-2915.1989.tb00477.x; WELBURN SC, 1992, ANN TROP MED PARASIT, V86, P529, DOI 10.1080/00034983.1992.11812703	31	2	2	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2015	10	3							e0117147	10.1371/journal.pone.0117147	http://dx.doi.org/10.1371/journal.pone.0117147			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9JM	25738803	gold, Green Submitted, Green Published			2022-12-27	WOS:000350685900014
J	Cornford, CS; Close, HJ; Bray, R; Beere, D; Mason, JM				Cornford, Charles S.; Close, Helen J.; Bray, Roz; Beere, Deborah; Mason, James M.			Contraceptive Use and Pregnancy Outcomes among Opioid Drug-Using Women: A Retrospective Cohort Study	PLOS ONE			English	Article							SUBSTANCE USE DISORDERS; REPRODUCTIVE HEALTH; BARRIERS; NEEDS; RISK; SEX	Objective The contraceptive needs of illicit opioid users differ from non-drug users but are poorly understood. The aim of this study was to describe contraceptive use and pregnancy outcomes in opioid-using women, and to examine their association with a range of risk factors. Method This retrospective cohort study used UK general practice records, Treatment Outcomes Profile and National Drug Treatment Monitoring System data, and a nested data validation exercise. A cohort of 376 women aged 20-61 years were in active treatment for opioid addiction in October 2010 at two specialised primary care practices in North-East England. Outcomes were age-adjusted prevalence estimates for contraceptive use and pregnancy outcomes in users of illicit opioids. The association between lifestyle-related risk factors and contraception was explored. Results Drug-using women made lower use of planned (non-condom) contraception (24% vs 50%, p<0.001), had more frequent pregnancy terminations (0.46 vs. 0.025, p = 0.004) and higher annual incidence of chlamydia (1.1% vs. 0.33%, p<0.001), when compared with age-matched population data. Specifically, there was low use of oral contraceptives (4% vs. 25%, p<0.001), IUCD (1% vs. 6%, p<0.001), and sterilisation (7% vs. 6%, p = 0.053), but higher rates of injectable contraceptives (6% vs. 3%, p = 0.003). A total of 64% of children aged <16 years born to this group did not live with their mother. No individual risk factor (such as sex-working) significantly explained the lower use or type of non-condom contraception. Conclusions This is the first study to describe planned contraceptive use among drug-users, as well as the association with a range of risk factors and pregnancy outcomes. The low uptake of planned contraception, set against high rates of terminations and sexually transmitted disease demonstrates the urgent clinical need to improve contraceptive services, informed by qualitative work to explore the values and beliefs influencing low contraceptive uptake.	[Cornford, Charles S.] Fulcrum Med Practice, Middlesbrough, Cleveland, England; [Close, Helen J.; Mason, James M.] Univ Durham, Sch Med Pharm & Hlth, Wolfson Res Inst, Stockton On Tees, England; [Bray, Roz] St George Hosp, Clin Blood Sci, London, England; [Beere, Deborah] Northern Reg Gender Dysphoria Serv, Newcastle Upon Tyne, Tyne & Wear, England	Durham University; St Georges University London	Cornford, CS (corresponding author), Fulcrum Med Practice, Acklam Rd, Middlesbrough, Cleveland, England.	charles.cornford@nhs.net	Mason, James M/D-9904-2011	Mason, James M/0000-0001-9210-4082				Advisory Council on the Misuse of Drugs, 2003, HIDD HARM RESP NEEDS; ARMSTRONG KA, 1991, FAM PLANN PERSPECT, V23, P264, DOI 10.2307/2135777; Banwell C, 2003, AUST NZ J PUBL HEAL, V27, P620, DOI 10.1111/j.1467-842X.2003.tb00609.x; Behnke M, 2013, PEDIATRICS, V131, pE1009, DOI 10.1542/peds.2012-3931; Clarke JG, 2006, AM J PUBLIC HEALTH, V96, P834, DOI 10.2105/AJPH.2004.060236; Cornford CS, 2011, BRIT J GEN PRACT, V61, DOI 10.3399/bjgp11X613115; Cotten-Oldenburg NU, 1999, AM J DRUG ALCOHOL AB, V25, P129, DOI 10.1081/ADA-100101850; Crosby R, 2004, AM J PREV MED, V27, P404, DOI 10.1016/j.amepre.2004.07.017; Family Planning Association, 2007, CONTR PATT US; Harding Catherine, 2003, Aust J Rural Health, V11, P2, DOI 10.1046/j.1440-1584.2003.00477.x; HAY G, 2013, NATL REGIONAL ESTIMA; Health and Social Care Information Centre, 2012, CERV SCREEN PROGR EN; Jeal N, 2007, BJOG-INT J OBSTET GY, V114, P875, DOI 10.1111/j.1471-0528.2007.01379.x; Jessup MA, 2005, J ADDICT NURS, V16, P97, DOI 10.1080/10884500500196693; Jurkovic D, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d3397; Kearney MH, 1994, QUALITATIVE HLTH RES, V4, P142, DOI DOI 10.1177/104973239400400202; Kidorf M, 2004, DRUG ALCOHOL DEPEN, V74, P115, DOI 10.1016/j.drugalcdep.2003.11.014; Leppo A, 2012, INT J DRUG POLICY, V23, P365, DOI 10.1016/j.drugpo.2012.01.004; Marsden J, 2008, ADDICTION, V103, P1450, DOI 10.1111/j.1360-0443.2008.02284.x; May T., 2006, SEX WORK NOW; Office for National Statistics, 2009, CONTR SEX HEATH 2008; Office for National Statistics, 2010, CHAR MOTH 2 ENGL WAL; Plugge E, 2004, J MED SCREEN, V11, P48, DOI 10.1258/096914104772950763; Public Health England, 2012, SEX TRANSM INF ANN D; Public Health England, 2014, DRUGS ALC NAT DRUG T; RALPH N, 1986, AM J PUBLIC HEALTH, V76, P1016, DOI 10.2105/AJPH.76.8.1016; Shannon K, 2009, AM J PUBLIC HEALTH, V99, P659, DOI 10.2105/AJPH.2007.129858; Sharpe TT, 2008, J WOMENS HEALTH, V17, P1339, DOI 10.1089/jwh.2008.0828; Sinha C, 2007, J FAM PLAN REPROD H, V33, P31, DOI 10.1783/147118907779399738; United Nations, 2013, POP FACTS TRENDS CON	30	22	23	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2015	10	3							e0116231	10.1371/journal.pone.0116231	http://dx.doi.org/10.1371/journal.pone.0116231			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CC9JM	25739018	gold, Green Submitted, Green Published, Green Accepted			2022-12-27	WOS:000350685900008
J	Martinet, B; Lecocq, T; Smet, J; Rasmont, P				Martinet, Baptiste; Lecocq, Thomas; Smet, Jeremy; Rasmont, Pierre			A Protocol to Assess Insect Resistance to Heat Waves, Applied to Bumblebees (Bombus Latreille, 1802)	PLOS ONE			English	Article							CRITICAL THERMAL LIMITS; TEMPERATURE EXTREMES; CLIMATE-CHANGE; HYMENOPTERA; ENERGETICS; TOLERANCE; RESPONSES; APIDAE	Insect decline results from numerous interacting factors including climate change. One of the major phenomena related to climate change is the increase of the frequency of extreme events such as heat waves. Since heat waves are suspected to dramatically increase insect mortality, there is an urgent need to assess their potential impact. Here, we determined and compared the resistance to heat waves of insects under hyperthermic stress through their time before heat stupor (THS) when they are exposed to an extreme temperature (40 degrees C). For this, we used a new experimental standardised device available in the field or in locations close to the field collecting sites. We applied this approach on different Arctic, Boreo-Alpine and Widespread bumblebee species in order to predict consequences of heat waves. Our results show a heat resistance gradient: the heat stress resistance of species with a centred arctic distribution is weaker than the heat resistance of the Boreo-Alpine species with a larger distribution which is itself lower than the heat stress resistance of the ubiquitous species.	[Martinet, Baptiste; Lecocq, Thomas; Smet, Jeremy; Rasmont, Pierre] Univ Mons, Res Inst Biosci, Zool Lab, B-7000 Mons, Belgium	University of Mons	Martinet, B (corresponding author), Univ Mons, Res Inst Biosci, Zool Lab, Pl Parc 20, B-7000 Mons, Belgium.	Baptiste.martinet@student.umons.ac.be		Lecocq, Thomas/0000-0002-4947-0332	INTERACT FP-7 EU project; FP-7 STEP Collaborative Project [244090]	INTERACT FP-7 EU project; FP-7 STEP Collaborative Project	INTERACT FP-7 EU project and FP-7 STEP Collaborative Project (grant agreement number: 244090) funded the collection of data (travel costs and accomodation) in Scandinavia and France. The funders had no role in study design, data analysis, decision to publish, or preparation of the manuscript.	Albright TP, 2011, REMOTE SENS ENVIRON, V115, P245, DOI 10.1016/j.rse.2010.08.024; [Anonymous], 1847, GOTTINGERSTUDIEN, V1, P595; Bodenheimer F. S., 1930, Zeitschrift fuer Vergleichende Physiologie Berlin, V11, P345; Brett JR, 1944, SOME LETHAL TEMPERAT; Cameron SA, 2007, BIOL J LINN SOC, V91, P161, DOI 10.1111/j.1095-8312.2007.00784.x; Franzen M, 2012, J INSECT CONSERV, V16, P227, DOI 10.1007/s10841-011-9410-y; Franzen M, 2012, BIODIVERS CONSERV, V21, P517, DOI 10.1007/s10531-011-0197-7; FRY F. E. J., 1957, ANNEE BIOL, V33, P205; HEINRICH B, 1975, J COMP PHYSIOL, V96, P155, DOI 10.1007/BF00706595; HEINRICH B, 1972, J COMP PHYSIOL, V77, P49, DOI 10.1007/BF00696519; Heinrich B., 1979, BUMBLEBEE EC; Hines HM, 2008, SYST BIOL, V57, P58, DOI 10.1080/10635150801898912; Huang SP, 2006, J THERM BIOL, V31, P378, DOI 10.1016/j.jtherbio.2005.11.032; HUTCHISON VH, 1979, AM J PHYSIOL, V237, pR367, DOI 10.1152/ajpregu.1979.237.5.R367; Infoclimat, TEMP MAX; Infoclimat, POURC HUM REL; Jacq F, 2012, B CLIMATIQUE JUILLET; Jiguet F, 2006, ECOL LETT, V9, P1321, DOI 10.1111/j.1461-0248.2006.00986.x; Kingsolver JG, 2013, FUNCT ECOL, V27, P1415, DOI 10.1111/1365-2435.12145; Klok CJ, 2003, BIOL J LINN SOC, V78, P401, DOI 10.1046/j.1095-8312.2003.00154.x; Klok CJ, 1997, J INSECT PHYSIOL, V43, P685, DOI 10.1016/S0022-1910(97)00001-2; Lecocq T, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-263; Lutterschmidt WI, 1997, CAN J ZOOL, V75, P1561, DOI 10.1139/z97-783; Martinez-Porchas M, 2010, TROP ZOOL, V23, P139; McFarlane R.W., 1976, S SERIES NATL TECHNI, P10; McKechnie AE, 2010, BIOL LETTERS, V6, P253, DOI 10.1098/rsbl.2009.0702; Meehl GA, 2004, SCIENCE, V305, P994, DOI 10.1126/science.1098704; Morritt D, 2000, J EXP MAR BIOL ECOL, V255, P215, DOI 10.1016/S0022-0981(00)00299-9; MULLER P., 1974, ASPECTS ZOOGEOGRAPHY; Murrell P, 2005, COMPUETR SCI DATA AN; Novacek MJ, 2001, P NATL ACAD SCI USA, V98, P5466, DOI 10.1073/pnas.091093698; Nyamukondiwa C, 2013, J INSECT PHYSIOL, V59, P1199, DOI 10.1016/j.jinsphys.2013.09.004; Pachauri RK, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, pVII; Parmesan C, 2000, B AM METEOROL SOC, V81, P443, DOI 10.1175/1520-0477(2000)081<0443:IOEWAC>2.3.CO;2; Parmesan C, 2006, ANNU REV ECOL EVOL S, V37, P637, DOI 10.1146/annurev.ecolsys.37.091305.110100; Pottier N, 2007, PHYS STATIQUE HORS E; R Core Team, 2021, R LANGUAGE ENV STAT; Rasmont P., 1988, THESIS FAC SCI AGR E; Rasmont P, 2014, TERTIARY ATLAS EUROP; Rasmont P, 2012, ANN SOC ENTOMOL FR, V48, P275, DOI 10.1080/00379271.2012.10697776; Ribeiro PL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032083; Siegel S, 1988, NONP STAT BEH SCI; SVENSSON BG, 1979, J CHEM ECOL, V5, P603, DOI 10.1007/BF00987845; Terblanche JS, 2007, P ROY SOC B-BIOL SCI, V274, P2935, DOI 10.1098/rspb.2007.0985; UVAROV B. P., 1931, TRANS ENT SOC [LONDON], V79, P1; Weatheronline Ltd, CLIM DAT; Welbergen JA, 2008, P ROY SOC B-BIOL SCI, V275, P419, DOI 10.1098/rspb.2007.1385; Williams PH, 2008, APIDOLOGIE, V39, P46, DOI 10.1051/apido:2007052; WILLIAMS PH, 1986, BEE WORLD, V67, P50, DOI 10.1080/0005772X.1986.11098871; Winfree R, 2010, ANN NY ACAD SCI, V1195, P169, DOI 10.1111/j.1749-6632.2010.05449.x	50	43	44	1	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2015	10	3							e0118591	10.1371/journal.pone.0118591	http://dx.doi.org/10.1371/journal.pone.0118591			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9JM	25738862	gold, Green Published			2022-12-27	WOS:000350685900051
J	Selvakumar, N; Kumar, V; Balaji, S; Prabuseenivasan, S; Radhakrishnan, R; Sekar, G; Chandrasekaran, V; Kannan, T; Thomas, A; Arunagiri, S; Dewan, P; Swaminathan, S				Selvakumar, N.; Kumar, Vanaja; Balaji, S.; Prabuseenivasan, S.; Radhakrishnan, R.; Sekar, Gomathi; Chandrasekaran, V.; Kannan, T.; Thomas, Aleyamma; Arunagiri, S.; Dewan, Puneet; Swaminathan, Soumya			High Rates of Ofloxacin Resistance in Mycobacterium tuberculosis among Both New and Previously Treated Patients in Tamil Nadu, South India	PLOS ONE			English	Article							DRUG-RESISTANCE; FLUOROQUINOLONE RESISTANCE; NATIONAL-SURVEY; SURVEILLANCE; PREVALENCE; CHINA; HIV	Periodic drug resistance surveillance provides useful information on trends of drug resistance and effectiveness of tuberculosis (TB) control measures. The present study determines the prevalence of drug resistance among new sputum smear positive (NSP) and previously treated (PT) pulmonary TB patients, diagnosed at public sector designated microscopy centers (DMCs) in the state of Tamil Nadu, India. In this single-stage cluster-sampling prevalence survey, 70 of 700 DMCs were randomly selected using a probability-proportional to size method. A cluster size of 24 for NSP and a varying size of 0 to 99 for PT cases were fixed for each selected DMC. Culture and drug susceptibility testing was done on Lowenstein-Jensen medium using the economic variant of proportion sensitivity test for isoniazid (INH), rifampicin (RMP), ofloxacin (OFX) and kanamycin (KAN). Human Immunodeficiency Virus (HIV) status was collected from patient records. From June 2011 to August 2012, 1524 NSP and 901 PT patients were enrolled. Any RMP resistance and any INH resistance were observed in 2.6% and 15.1%, and in 10.4% and 30% respectively in NSP and PT cases. Among PT patients, multi drug resistant TB (MDR-TB) was highest in the treatment failure (35%) group, followed by relapse (13%) and treatment after default (10%) groups. Extensively drug resistant TB (XDRTB) was seen in 4.3% of MDR-TB cases. Any OFX resistance was seen in 10.4% of NSP, 13.9% of PT and 29% of PT MDR-TB patients. The HIV status of the patient had no impact on drug resistance levels. RMP resistance was present in 2.6% of new and 15.1% of previously treated patients in Tamil Nadu. Rates of OFX resistance were high among NSP and PT patients, especially among those with MDR-TB, a matter of concern for development of new treatment regimens for TB.	[Selvakumar, N.; Kumar, Vanaja; Balaji, S.; Prabuseenivasan, S.; Radhakrishnan, R.; Sekar, Gomathi; Chandrasekaran, V.; Kannan, T.; Thomas, Aleyamma; Swaminathan, Soumya] Indian Council Med Res, Natl Inst Res TB, Chennai, Tamil Nadu, India; [Arunagiri, S.] Govt Tamil Nadu, State TB Cell, Chennai, Tamil Nadu, India; [Dewan, Puneet] WHO India, New Delhi, India	Indian Council of Medical Research (ICMR); ICMR - National Institute for Research in Tuberculosis (NIRT)	Swaminathan, S (corresponding author), Indian Council Med Res, Natl Inst Res TB, Chennai, Tamil Nadu, India.	doctorsoumya@yahoo.com	Thiruvengadam, Kannan/AAQ-8532-2021; Nagamiah, Selvakumar/AHB-2651-2022	Thiruvengadam, Kannan/0000-0002-3758-1094; 	United States Agency for International Development (USAID), through the World Health Organization (WHO), South-East Asia Regional Office (SEARO), New Delhi	United States Agency for International Development (USAID), through the World Health Organization (WHO), South-East Asia Regional Office (SEARO), New Delhi(United States Agency for International Development (USAID))	This study is supported by the United States Agency for International Development (USAID), through the World Health Organization (WHO), South-East Asia Regional Office (SEARO), New Delhi. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2012, GLOBAL TUBERCULOSIS, P1; Assam-Assam JP, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-94; Blondal K, 2013, INT J TUBERC LUNG D, V17, P961, DOI 10.5588/ijtld.12.0946; Bozeman L, 2005, CLIN INFECT DIS, V40, P386, DOI 10.1086/427292; Central TB Division (CTD, 2009, REV NAT TB CONTR PRO; Chandrasekaran S., 1992, Indian Journal of Tuberculosis, V39, P171; CTD, 2011, CENTR TB DIV NAT SCA; CTD, 2005, CENTR TB DIV MOD LAB; Daniel O, 2011, AFRICAN J RES ME MAR, P18; Ginsburg AS, 2003, NEW ENGL J MED, V349, P1977, DOI 10.1056/NEJM200311133492023; GUPTA PR, 1993, INDIAN J MED RES-A, V97, P102; Hu Y, 2008, MICROB DRUG RESIST, V14, P227, DOI 10.1089/mdr.2008.0823; Ioannidis P, 2011, J CLIN MICROBIOL, V49, P3068, DOI 10.1128/JCM.00718-11; Kart Levent, 2002, Ann Clin Microbiol Antimicrob, V1, P6, DOI 10.1186/1476-0711-1-6; Klinkenberg E, 2012, INT J TUBERC LUNG D, V16, P615, DOI 10.5588/ijtld.11.0262; Mahadev B., 2005, Indian Journal of Tuberculosis, V52, P5; Myneedu V P, 2011, Indian J Tuberc, V58, P160; O'Donnell MR, 2011, EMERG INFECT DIS, V17, P1942, DOI 10.3201/eid1710.110105; Paramasivan C. N., 2000, Indian Journal of Tuberculosis, V47, P27; Paramasivan CN, 2004, INDIAN J MED RES, V120, P377; Paramasivan CN, 2002, INT J TUBERC LUNG D, V6, P479; Ramachandran R, 2009, INT J TUBERC LUNG D, V13, P1154; Raviglione M, 2012, LANCET, V379, P1902, DOI 10.1016/S0140-6736(12)60727-2; Swaminathan S, 2005, INT J TUBERC LUNG D, V9, P896; Umubyeyi AN, 2007, J ANTIMICROB CHEMOTH, V59, P1031, DOI 10.1093/jac/dkm038; WHO, 2009, WHOHTMTB2009411; WHO, 2009, WHOHTMTB2009422; *WHO, 2005, WHOHTMTB2005349; *WHO, 2008, WHOHTMTB2008394; World Health Organization, 2001, WHOCDSTB2001288; World Health Organization, 2010, WHOHTMTB20103; Zhao YL, 2012, NEW ENGL J MED, V366, P2161, DOI 10.1056/NEJMoa1108789	32	15	15	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2015	10	3							e0117421	10.1371/journal.pone.0117421	http://dx.doi.org/10.1371/journal.pone.0117421			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9JM	25738956	Green Accepted, Green Published, Green Submitted, gold			2022-12-27	WOS:000350685900016
J	Steer, CD; Bolton, P; Golding, J				Steer, Colin D.; Bolton, Patrick; Golding, Jean			Preconception and Prenatal Environmental Factors Associated with Communication Impairments in 9 Year Old Children Using an Exposome-Wide Approach	PLOS ONE			English	Article							MATERNAL DEPRESSION; LANGUAGE IMPAIRMENT; PREGNANCY; STRESS; LOCUS; PRESCHOOL; EXPOSURE; HEALTH; HERITABILITY; PARENTS	Although speech and language deficits are common in children and strongly associated with poor educational and social outcomes, little attention has been paid to the antecedents. In this study we used the information from the Avon Longitudinal Study of Parents and Children to examine preconception and prenatal environmental risk factors that were related to communication difficulties in children using the Children's Communication Checklist (CCC). We used an exposome-wide approach to identify environmental factors univariably associated with the CCC. Taking account of the False Discovery rate, we used a P value of 0.000157 to identify 621 of 3855 items tested. These were then subjected to a series of stepwise linear regression analyses, firstly within 10 domains: personal characteristics, health, development, education, socio-economic variables, lifestyle, home and social environments, life events and chemical and other exposures; and then with the predictive variables from each domain. The final model consisted of 19 variables independently associated with the communication scale. These variables suggested 6 possible mechanisms: stressors primarily associated with socio-economic disadvantage although other lifestyle choices such as a social network of family or friends can ameliorate these effects; indicators of future parenting skills primarily associated with aspects of parental personality; aspects of the home environment; poor maternal health with a novel finding concerning maternal hearing loss; and maternal education which was partially mediated by the child's IQ. Finally, there may be a mechanism via the maternal diet in pregnancy in particular the consumption of fatty or processed foods. This is the subject of ongoing investigation.	[Steer, Colin D.] Univ Bristol, Sch Social & Community Med, MRC Integrat Epidemiol Unit, Bristol, Avon, England; [Bolton, Patrick] Kings Coll London, Inst Psychiat, London WC2R 2LS, England; [Golding, Jean] Univ Bristol, Sch Social & Community Med, Ctr Child & Adolescent Hlth, Bristol, Avon, England	University of Bristol; University of London; King's College London; University of Bristol	Steer, CD (corresponding author), Univ Bristol, Sch Social & Community Med, MRC Integrat Epidemiol Unit, Bristol, Avon, England.	Colin.Steer@bristol.ac.uk		Golding, Jean/0000-0003-2826-3307	UK Medical Research Council (MRC); Wellcome Trust; University of Bristol; UK MRC [G0800523]; NIHR Biomedical Research Centre in Mental Health at the South London AMP; Maudsley Hospital; Waterloo Foundation; MRC [G1100226, G0400085, G0800523] Funding Source: UKRI; Medical Research Council [G0800523, G1100226, MC_PC_15018, G9817803B, G0400085] Funding Source: researchfish; National Institute for Health Research [NF-SI-0510-10268] Funding Source: researchfish	UK Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); University of Bristol; UK MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NIHR Biomedical Research Centre in Mental Health at the South London AMP; Maudsley Hospital; Waterloo Foundation; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	The UK Medical Research Council (MRC), the Wellcome Trust and the University of Bristol currently provide core support for ALSPAC. This study was funded by the UK MRC-grant G0800523. Patrick Bolton was supported by The NIHR Biomedical Research Centre in Mental Health at the South London & Maudsley Hospital. Version 3.01 of the exposome was partially funded by the Waterloo Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams RJ, 2003, THORAX, V58, P846, DOI 10.1136/thorax.58.10.846; Bandstra ES, 2002, NEUROTOXICOL TERATOL, V24, P297, DOI 10.1016/S0892-0362(02)00192-7; Belsky J, 2007, EUR J PUBLIC HEALTH, V17, P508, DOI 10.1093/eurpub/ckl261; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bert SC, 2009, FAM RELAT, V58, P176, DOI 10.1111/j.1741-3729.2008.00545.x; Beydoun H, 2008, PAEDIATR PERINAT EP, V22, P438, DOI 10.1111/j.1365-3016.2008.00951.x; Bishop DVM, 2008, GENES BRAIN BEHAV, V7, P365, DOI 10.1111/j.1601-183X.2007.00360.x; Bishop D, 2009, ANN NY ACAD SCI, V1156, P1, DOI 10.1111/j.1749-6632.2009.04419.x; Bishop DVM, 2006, BEHAV GENET, V36, P173, DOI 10.1007/s10519-005-9020-0; Bishop DVM, 1998, J CHILD PSYCHOL PSYC, V39, P879, DOI 10.1111/1469-7610.00388; Bishop DVM, 2001, DEV MED CHILD NEUROL, V43, P809, DOI 10.1017/S0012162201001475; BOYCE P, 1989, AUST NZ J PSYCHIAT, V23, P341; Bronfenbrenner U., 1992, 6 THEORY CHILD DEV R, P187, DOI DOI 10.1006/0BHD.1998.2813; Buss C, 2010, PSYCHONEUROENDOCRINO, V35, P141, DOI 10.1016/j.psyneuen.2009.07.010; COX JL, 1987, BRIT J PSYCHIAT, V150, P782, DOI 10.1192/bjp.150.6.782; Crown S, 1979, MANUAL CROWN CRISP E; Deave T, 2008, BJOG-INT J OBSTET GY, V115, P1043, DOI 10.1111/j.1471-0528.2008.01752.x; Eicher JD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063762; Enriquez R, 2007, J ALLERGY CLIN IMMUN, V120, P625, DOI 10.1016/j.jaci.2007.05.044; Fernandez S, 2008, INT J EARLY CHILD, V40, P85, DOI DOI 10.1007/BF03168487; Field T, 2006, INFANT BEHAV DEV, V29, P445, DOI 10.1016/j.infbeh.2006.03.003; Fried PA, 1997, NEUROTOXICOL TERATOL, V19, P171, DOI 10.1016/S0892-0362(97)00015-9; Golding J, 2001, PAEDIATR PERINAT EP, V15, P74; Graves SB, 1986, J INSTR PSYCHOL, V13, P153; Hammer CS, 2001, INT J LANG COMM DIS, V36, P185, DOI 10.1080/13682820010019919; HELM JM, 1990, FAM RELAT, V39, P432, DOI 10.2307/585224; HOUCK GM, 1991, INF MENTAL HLTH J, V12, P347, DOI 10.1002/1097-0355(199124)12:4<347::AID-IMHJ2280120408>3.0.CO;2-9; Institute of Medicine, 2009, WEIGHT GAIN PREGNANC; JOHNSON JH, 1978, J PSYCHOSOM RES, V22, P205, DOI 10.1016/0022-3999(78)90025-9; Kass GV, 1980, J R STAT SOC C-APPL, P119; Kelly L E, 1995, J Pediatr Nurs, V10, P105, DOI 10.1016/S0882-5963(05)80006-5; Kolominsky Y, 1999, J CHILD PSYCHOL PSYC, V40, P299, DOI 10.1111/1469-7610.00444; Kotchick B.A., 2002, J CHILD FAM STUD, V11, P255, DOI [10.1023/A:1016863921662, DOI 10.1023/A:1016863921662]; La Paro KM, 2004, AM J SPEECH-LANG PAT, V13, P291, DOI 10.1044/1058-0360(2004/030); Laplante DP, 2008, J AM ACAD CHILD PSY, V47, P1063, DOI 10.1097/CHI.0b013e31817eec80; Laplante DP, 2004, PEDIATR RES, V56, P400, DOI 10.1203/01.PDR.0000136281.34035.44; Lencova E, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-208; Leonard H, 2006, ANN EPIDEMIOL, V16, P448, DOI 10.1016/j.annepidem.2005.05.002; Lewis BA, 2013, J SPEECH LANG HEAR R, V56, P1662, DOI 10.1044/1092-4388(2013/12-0119); Lovejoy MC, 2000, CLIN PSYCHOL REV, V20, P561, DOI 10.1016/S0272-7358(98)00100-7; MAISTO AA, 1981, J PSYCHOL, V109, P213, DOI 10.1080/00223980.1981.9915308; Manfreda J, 2001, CAN MED ASSOC J, V164, P995; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; Marra JV, 2009, AM J ORTHOPSYCHIAT, V79, P348, DOI 10.1037/a0017241; Marton K, 2003, J SPEECH LANG HEAR R, V46, P1138, DOI 10.1044/1092-4388(2003/089); Milevsky A., 2007, J CHILD FAM STUD, V16, P39, DOI [DOI 10.1007/S10826-006-9066-5, 10.1007/s10826-006-9066-5]; Miller GW, 2014, TOXICOL SCI, V137, P1, DOI 10.1093/toxsci/kft251; Nadebaum C, 2011, NEUROLOGY, V76, P719, DOI 10.1212/WNL.0b013e31820d62c7; Northstone K, 2008, EUR J CLIN NUTR, V62, P471, DOI 10.1038/sj.ejcn.1602741; NOWICKI S, 1974, J PERS ASSESS, V38, P136, DOI 10.1080/00223891.1974.10119950; O'Donnell KJ, 2002, DEV MED CHILD NEUROL, V44, P76, DOI 10.1017/S0012162201001712; OPCS, 1991, STAND OCC CLASS, V3; PARKER G, 1979, BRIT J MED PSYCHOL, V52, P1, DOI 10.1111/j.2044-8341.1979.tb02487.x; Rappaport SM, 2011, J EXPO SCI ENV EPID, V21, P5, DOI 10.1038/jes.2010.50; Ruser TF, 2007, J AUTISM DEV DISORD, V37, P1323, DOI 10.1007/s10803-006-0274-z; Sanchez-Villegas A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016268; Schetter CD, 2011, ANNU REV PSYCHOL, V62, P531, DOI 10.1146/annurev.psych.031809.130727; SCOLNIK D, 1994, JAMA-J AM MED ASSOC, V271, P767, DOI 10.1001/jama.271.10.767; SEXTON M, 1990, INT J EPIDEMIOL, V19, P72, DOI 10.1093/ije/19.1.72; Steer CD, 2006, J EXPO SCI ENV EPID, V16, P251, DOI 10.1038/sj.jea.7500455; Steer CD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012633; Tata LJ, 2007, AM J RESP CRIT CARE, V175, P991, DOI 10.1164/rccm.200611-1641OC; TINSLEY BJ, 1989, J DEV BEHAV PEDIATR, V10, P236; Tomblin JB, 1997, J COMMUN DISORD, V30, P325, DOI 10.1016/S0021-9924(97)00015-4; Van Buuren S, 1999, STAT MED, V18, P681, DOI 10.1002/(SICI)1097-0258(19990330)18:6<681::AID-SIM71>3.0.CO;2-R; Van den Bergh BRH, 2005, NEUROSCI BIOBEHAV R, V29, P237, DOI 10.1016/j.neubiorev.2004.10.007; Wechsler D., 1992, WECHSLER INTELLIGENC; Whitehouse AJO, 2010, EARLY HUM DEV, V86, P487, DOI 10.1016/j.earlhumdev.2010.06.009; Whitehouse AJO, 2010, PSYCHONEUROENDOCRINO, V35, P1259, DOI 10.1016/j.psyneuen.2010.02.007; Wild CP, 2012, INT J EPIDEMIOL, V41, P24, DOI 10.1093/ije/dyr236; Wild CP, 2005, CANCER EPIDEM BIOMAR, V14, P1847, DOI 10.1158/1055-9965.EPI-05-0456; Wolke D, 1999, DEV MED CHILD NEUROL, V41, P94, DOI 10.1017/S0012162299000201; Woolfson L, 2006, CHILD CARE HLTH DEV, V32, P177, DOI 10.1111/j.1365-2214.2006.00603.x; Wu Q, 2006, OBES REV, V7, P201, DOI 10.1111/j.1467-789X.2006.00232.x; Zubrick SR, 2007, J SPEECH LANG HEAR R, V50, P1562, DOI 10.1044/1092-4388(2007/106)	75	11	11	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2015	10	3							e0118701	10.1371/journal.pone.0118701	http://dx.doi.org/10.1371/journal.pone.0118701			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CC9JM	25739097	Green Published, Green Submitted, gold			2022-12-27	WOS:000350685900063
J	Arevalo, RC; Kumar, P; Urbach, JS; Blair, DL				Arevalo, Richard C.; Kumar, Pramukta; Urbach, Jeffrey S.; Blair, Daniel L.			Stress Heterogeneities in Sheared Type-I Collagen Networks Revealed by Boundary Stress Microscopy	PLOS ONE			English	Article							ELASTICITY; DEFORMATION; RHEOLOGY; MATRICES	Disordered fiber networks provide structural support to a wide range of important materials, and the combination of spatial and dynamic complexity may produce large inhomogeneities in mechanical properties, an effect that is largely unexplored experimentally. In this work, we introduce Boundary Stress Microscopy to quantify the non-uniform surface stresses in sheared collagen gels. We find local stresses exceeding average stresses by an order of magnitude, with variations over length scales much larger than the network mesh size. The strain stiffening behavior observed over a wide range of network mesh sizes can be parameterized by a single characteristic strain and associated stress, which describes both the strain stiffening regime and network yielding. The characteristic stress is approximately proportional to network density, but the peak boundary stress at both the characteristic strain and at yielding are remarkably insensitive to concentration.	[Urbach, Jeffrey S.] Georgetown Univ, Dept Phys, Washington, DC 20057 USA; Georgetown Univ, Inst Soft Matter Synth & Metrol, Washington, DC 20057 USA	Georgetown University; Georgetown University	Urbach, JS (corresponding author), Georgetown Univ, Dept Phys, Washington, DC 20057 USA.	urbachj@georgetown.edu; Daniel.Blair@georgetown.edu	Blair, Daniel/C-7911-2017	Urbach, Jeffrey/0000-0002-1593-520X	National Science Foundation [DMR-0804782]; AFOSR [FA9550-07-1-0130]	National Science Foundation(National Science Foundation (NSF)); AFOSR(United States Department of DefenseAir Force Office of Scientific Research (AFOSR))	This work is supported by the National Science Foundation through grant DMR-0804782 and the AFOSR through grant FA9550-07-1-0130. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achilli M, 2010, POLYMERS-BASEL, V2, P664, DOI 10.3390/polym2040664; Arevalo RC, 2011, CHAOS, V21, DOI 10.1063/1.3666225; Arevalo RC, 2010, BIOPHYS J, V99, pL65, DOI 10.1016/j.bpj.2010.08.008; Beningo KA, 2002, METHOD CELL BIOL, V69, P325, DOI 10.1016/S0091-679X(02)69021-1; Broedersz CP, 2014, REV MOD PHYS, V86, P995, DOI 10.1103/RevModPhys.86.995; Broedersz CP, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.078102; Buxton GA, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.238103; Conti E, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.088102; DiDonna BA, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.066619; Dutta S, 2013, REV SCI INS IN PRESS; Erk KA, 2010, BIOMACROMOLECULES, V11, P1358, DOI 10.1021/bm100136y; Forgacs G, 2003, BIOPHYS J, V84, P1272, DOI 10.1016/S0006-3495(03)74942-X; Friedl P, 2000, CELL MOL LIFE SCI, V57, P41, DOI 10.1007/s000180050498; Gardel ML, 2004, SCIENCE, V304, P1301, DOI 10.1126/science.1095087; Hall MS, 2013, EXP CELL RES, V319, P2396, DOI 10.1016/j.yexcr.2013.06.009; Hatami-Marbini H, 2009, ACTA MECH, V205, P77, DOI 10.1007/s00707-009-0170-7; Head DA, 2003, PHYS REV E, V68, DOI 10.1103/PhysRevE.68.061907; Heussinger C, 2007, EUR PHYS J E, V24, P47, DOI 10.1140/epje/i2007-10209-1; Heussinger C, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.105501; Howell D, 1999, PHYS REV LETT, V82, P5241, DOI 10.1103/PhysRevLett.82.5241; Huisman EM, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.208103; Janmey PA, 2007, NAT MATER, V6, P48, DOI 10.1038/nmat1810; Kaufman LJ, 2005, BIOPHYS J, V89, P635, DOI 10.1529/biophysj.105.061994; Kouwer PHJ, 2013, NATURE, V493, P651, DOI 10.1038/nature11839; Kurniawan NA, 2012, BIOMACROMOLECULES, V13, P691, DOI 10.1021/bm2015812; Lo CM, 2000, BIOPHYS J, V79, P144, DOI 10.1016/S0006-3495(00)76279-5; MACKINTOSH FC, 1995, PHYS REV LETT, V75, P4425, DOI 10.1103/PhysRevLett.75.4425; Mickel W, 2008, BIOPHYS J, V95, P6072, DOI 10.1529/biophysj.108.135939; Motte S, 2013, BIOPOLYMERS, V99, P35, DOI 10.1002/bip.22133; Onck PR, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.178102; Picu RC, 2011, SOFT MATTER; Piechocka IK, 2011, BIOMACROMOLECULES, V12, P2797, DOI 10.1021/bm200553x; Stein A, 2010, COMPLEXITY, V00, P1; Storm C, 2005, NATURE, V435, P191, DOI 10.1038/nature03521; Takigawa T, 1996, POLYM GELS NETW, V4, P1, DOI 10.1016/0966-7822(95)00013-5; Vader D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005902; WALTON AG, 1973, BIOPOLYMERS; Xu Y, 2010, P NATL ACAD SCI USA, V107, P14964, DOI 10.1073/pnas.1005537107; Yao NY, 2010, BIOPHYS J, V98, P2147, DOI 10.1016/j.bpj.2010.01.062; Zagar G, 2011, MACROMOLECULES, V44, P7026, DOI 10.1021/ma201257v	40	33	33	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2015	10	3							e0118021	10.1371/journal.pone.0118021	http://dx.doi.org/10.1371/journal.pone.0118021			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4HV	25734484	Green Submitted, Green Published, gold			2022-12-27	WOS:000350314700013
J	Pickering, AJ; Crider, Y; Amin, N; Bauza, V; Unicomb, L; Davis, J; Luby, SP				Pickering, Amy J.; Crider, Yoshika; Amin, Nuhu; Bauza, Valerie; Unicomb, Leanne; Davis, Jennifer; Luby, Stephen P.			Differences in Field Effectiveness and Adoption between a Novel Automated Chlorination System and Household Manual Chlorination of Drinking Water in Dhaka, Bangladesh: A Randomized Controlled Trial	PLOS ONE			English	Article							QUALITY; POINT; STORAGE; INTERMITTENT; EFFICACY; ACCESS	The number of people served by networked systems that supply intermittent and contaminated drinking water is increasing. In these settings, centralized water treatment is ineffective, while household-level water treatment technologies have not been brought to scale. This study compares a novel low-cost technology designed to passively (automatically) dispense chlorine at shared handpumps with a household-level intervention providing water disinfection tablets (Aquatab), safe water storage containers, and behavior promotion. Twenty compounds were enrolled in Dhaka, Bangladesh, and randomly assigned to one of three groups: passive chlorinator, Aquatabs, or control. Over a 10-month intervention period, the mean percentage of households whose stored drinking water had detectable total chlorine was 75% in compounds with access to the passive chlorinator, 72% in compounds receiving Aquatabs, and 6% in control compounds. Both interventions also significantly improved microbial water quality. Aquatabs usage fell by 50% after behavioral promotion visits concluded, suggesting intensive promotion is necessary for sustained uptake. The study findings suggest high potential for an automated decentralized water treatment system to increase consistent access to clean water in low-income urban communities.				amyjanel@stanford.edu	Amin, Nuhu/AAV-4352-2021; Unicomb, Leanne Elizabeth/AAW-4900-2021; Amin, Nuhu/ABF-5931-2020	Amin, Nuhu/0000-0002-7131-6163; Unicomb, Leanne Elizabeth/0000-0002-7757-5641; Amin, Nuhu/0000-0002-7131-6163; Bauza, Valerie/0000-0003-1919-0767; Crider, Yoshika/0000-0003-3812-6517; Luby, Stephen/0000-0001-5385-899X	United States Agency for International Development; United States Environmental Protection Agency P3: People, Prosperity and the Planet program [SU83531301]; Vice Provost for Undergraduate Education at Stanford University	United States Agency for International Development(United States Agency for International Development (USAID)); United States Environmental Protection Agency P3: People, Prosperity and the Planet program; Vice Provost for Undergraduate Education at Stanford University	Funding was provided by a grant to the International Centre for Diarrhoeal Disease Research, Bangladesh from the United States Agency for International Development; the United States Environmental Protection Agency P3: People, Prosperity and the Planet program (EPA agreement SU83531301); and a research grant from the Vice Provost for Undergraduate Education at Stanford University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agency USEP, 2002, EPA821R02024 OFF WAT, VEPA -821-R-02-024; Aisopou A, 2012, WATER RES, V46, P235, DOI 10.1016/j.watres.2011.10.058; Boisson S, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001497; Cutler D, 2005, DEMOGRAPHY, V42, P1, DOI 10.1353/dem.2005.0002; Elala D, 2011, WATER SCI TECH-W SUP, V11, P400, DOI 10.2166/ws.2011.064; Ercumen A, 2013, U CAR N CAR CHAP HIL; JMP, 2000, GLOB WAT SUPPL SAN A, P1; JMP, 2013, PROGR SAN DRINK WAT, P1; Kumpel E, 2013, WATER RES, V47, P5176, DOI 10.1016/j.watres.2013.05.058; Lantagne D., 2012, Waterlines, V31, P30, DOI 10.3362/1756-3488.2012.005; Lantagne DS, 2012, ENVIRON SCI TECHNOL, V46, P11352, DOI 10.1021/es301842u; Levy K, 2008, ENVIRON HEALTH PERSP, V116, P1533, DOI 10.1289/ehp.11296; Levy K, 2014, WATER RES, V54, P69, DOI 10.1016/j.watres.2014.01.037; Luby SP, 2004, AM J TROP MED HYG, V71, P420, DOI 10.4269/ajtmh.2004.71.420; Luby SP, 2008, AM J TROP MED HYG, V78, P382, DOI 10.4269/ajtmh.2008.78.382; Luoto J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026132; Murray A, 2014, J WATER HLTH; Onda K, 2012, INT J ENV RES PUB HE, V9, P880, DOI 10.3390/ijerph9030880; Peletz R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046548; Pickering AJ, 2010, AM J TROP MED HYG, V82, P270, DOI 10.4269/ajtmh.2010.09-0220; Rosa G, 2010, AM J TROP MED HYG, V82, P289, DOI 10.4269/ajtmh.2010.09-0382; Schmidt WP, 2009, ENVIRON SCI TECHNOL, V43, P986, DOI 10.1021/es802232w; Sobsey MD, 2008, ENVIRON SCI TECHNOL, V42, P4261, DOI 10.1021/es702746n; Stockman LJ, 2007, EMERG INFECT DIS, V13, P1077, DOI 10.3201/eid1307.060767	24	23	22	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2015	10	3							e0118397	10.1371/journal.pone.0118397	http://dx.doi.org/10.1371/journal.pone.0118397			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4HV	25734448	Green Published, Green Submitted, gold			2022-12-27	WOS:000350314700026
J	Chen, Y; Shen, ZY; Morano, JP; Khoshnood, K; Wu, ZY; Lan, GH; Zhu, QY; Zhou, YJ; Tang, S; Liu, W; Chen, J; Tang, ZZ				Chen, Yi; Shen, Zhiyong; Morano, Jamie P.; Khoshnood, Kaveh; Wu, Zunyou; Lan, Guanghua; Zhu, Qiuying; Zhou, Yuejiao; Tang, Shuai; Liu, Wei; Chen, Jie; Tang, Zhenzhu			Bridging the Epidemic: A Comprehensive Analysis of Prevalence and Correlates of HIV, Hepatitis C, and Syphilis, and Infection among Female Sex Workers in Guangxi Province, China	PLOS ONE			English	Article							INJECTION-DRUG USERS; SOUTHERN CHINA; CIRCULATING RECOMBINANT; YUNNAN PROVINCE; KAIYUAN CITY; RISK-FACTORS; CONDOM USE; TRANSMISSION; PREDICTORS; PREVENTION	Introduction Female sex workers (FSWs) are at highest risk for contracting HIV and facilitating the current heterosexual HIV epidemic in Guangxi, China, yet little is known of the impact of recent harm reduction campaigns in the province. We analyzed sentinel surveillance data collected between 2010 and 2012 in Guangxi to explore correlations between the prevalence of HIV, hepatitis C (HCV), and syphilis and risk behaviors of different categories of FSWs in Guangxi. Methods The sentinel surveillance data for 5,1790 FSWs in all 14 prefectures and 64 city/county regions of Guangxi, China from 2010 to 2012 were collected. Differences between three categories of FSWs (grouped by venue) and disease trends (HIV, HCV, and syphilis) by year were analyzed using bivariate and multivariate logistic regression analyses as to evaluate risk factors correlated with HIV, HCV, or syphilis infection. Results HIV and HCV prevalence remained constant across the three FSW categories; however, syphilis prevalence showed a significant increase from 5.7% to 7.3% for low-tier FSWs. Most cases with HIV, HCV, syphilis and intravenous drug use were seen in low-tier FSWs. Testing positive for HIV and syphilis were most correlated with being HCV positive (AOR 4.12 and AOR 4.36), only completing elementary school (AOR 3.71 and AOR 2.35), low tier venues (AOR 2.02 and AOR 2.00), and prior STI (AOR 1.40 and AOR 3.56), respectively. HCV infection was correlated with ever injecting drugs (AOR 60.65) and testing positive for syphilis (AOR 4.16) or HIV (AOR 3.74). Conclusions This study highlights that low tier FSWs with lower formal education levels are the most vulnerable population at risk for acquiring and transmitting HIV, HCV, and syphilis in Guangxi, China. Condom distribution with evolution to safer sex practices are the reasons to explain the non-increasing prevalence of HIV, HCV in Guangxi for 2010-2012.	[Chen, Yi; Shen, Zhiyong; Lan, Guanghua; Zhu, Qiuying; Zhou, Yuejiao; Tang, Shuai; Liu, Wei; Tang, Zhenzhu] Guangxi Ctr Dis Control & Prevent, Nanning, Peoples R China; [Morano, Jamie P.] Univ S Florida, Div Infect Dis & Int Med, Morsani Coll Med, Tampa, FL USA; [Morano, Jamie P.] Univ S Florida, Coll Publ Hlth, Tampa, FL USA; [Khoshnood, Kaveh] Yale Univ, Sch Publ Hlth, New Haven, CT USA; [Wu, Zunyou] China Ctr Dis Control & Prevent, Natl Ctr AIDS STD Control & Prevent, Beijing, Peoples R China; [Chen, Jie] Zhuang Autonomous Reg, Hlth & Family Planning Commiss Guangxi, Nanning, Peoples R China	State University System of Florida; University of South Florida; State University System of Florida; University of South Florida; Yale University; Chinese Center for Disease Control & Prevention; National Center for AIDS/STD Control & Prevention, Chinese Center for Disease Control & Prevention	Tang, ZZ (corresponding author), Guangxi Ctr Dis Control & Prevent, Nanning, Peoples R China.	tangzhzh@163.com	Khoshnood, Kaveh/AAX-1402-2020	Khoshnood, Kaveh/0000-0003-2795-0447	Global Fund; Special Grants from Local and Central Chinese Government for HIV/AIDS Prevention Control; NATIONAL INSTITUTE OF MENTAL HEALTH [P30MH062294] Funding Source: NIH RePORTER	Global Fund; Special Grants from Local and Central Chinese Government for HIV/AIDS Prevention Control; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	The work was supported by the Global Fund (http://www.theglobalfund.org/) and Special Grants from Local and Central Chinese Government for HIV/AIDS Prevention & Control. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1998, MMWR Recomm Rep, V47, P1; [Anonymous], 2011, B OF GUANGXI; Tran BX, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086267; Beyrer C, 2000, AIDS, V14, P75, DOI 10.1097/00002030-200001070-00009; Buzdugan R, 2009, TROP MED INT HEALTH, V14, P673, DOI 10.1111/j.1365-3156.2009.02278.x; Chen XS, 2012, SEX TRANSM DIS, V39, P868, DOI 10.1097/OLQ.0b013e318264c3ba; Chen XS, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-84; Chen Yi, 2013, Zhonghua Liu Xing Bing Xue Za Zhi, V34, P1086; China Ministry of Health, 2011, REP EP SIT AIDS CHIN; Choi SYP, 2007, CULT HEALTH SEX, V9, P489, DOI 10.1080/13691050701220446; Chu TX, 2005, CELL RES, V15, P865, DOI 10.1038/sj.cr.7290360; Deniaud F, 2002, PRESSE MED, V31, P387; Ding YP, 2005, JAIDS-J ACQ IMM DEF, V38, P314; Hao C, 2014, CULT HEALTH SEX, V16, P47, DOI 10.1080/13691058.2013.826820; Harcourt C, 2005, SEX TRANSM INFECT, V81, P201, DOI 10.1136/sti.2004.012468; He YX, 2003, CHINESE J AIDS STD, V9, P343; Hu XY, 2010, J PUB HLTH PREV MED, V21, P45; Jie L, 2010, PRACT PREV MED, V17, P227; Li DM, 2014, CHINESE MED J-PEKING, V127, P707, DOI 10.3760/cma.j.issn.0366-6999.20131502; Li J, 2012, SEX TRANSM DIS, V39, P195, DOI 10.1097/OLQ.0b013e31823d2e2a; Li L, 2013, J MED VIROL, V85, P388, DOI 10.1002/jmv.23360; Liu HJ, 2012, AIDS PATIENT CARE ST, V26, P565, DOI 10.1089/apc.2012.0227; Lu F, 2009, SE ASIAN J TROP MED, V40, P263; Ming ZQ, 2002, CHIN J EPIDEMIOL, V23, P1; National Center for AIDS/STD Control Chinese Centers for Diseases Control and Prevention, 2010, NAT AIDS SENT SURV G; National Center for AIDS/STD Control Chinese Centers for Diseases Control and Prevention, 2009, NAT AIDS SENT SURV G; Pinkham S, 2008, REPROD HEALTH MATTER, V16, P168, DOI 10.1016/S0968-8080(08)31345-7; Piyasirisilp S, 2000, J VIROL, V74, P11286, DOI 10.1128/JVI.74.23.11286-11295.2000; Qi HY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068656; Qian ZH, 2005, SEX TRANSM INFECT, V81, P442, DOI 10.1136/sti.2004.014258; Ruan YH, 2006, SEX TRANSM DIS, V33, P719, DOI 10.1097/01.olq.0000218881.01437.99; Shang H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010631; Spornraft-Ragaller P, 2014, J DTSCH DERMATOL GES, V12, P707, DOI 10.1111/ddg.12382; Su L, 2000, J VIROL, V74, P11367, DOI 10.1128/JVI.74.23.11367-11376.2000; Syvertsen JL, 2014, INT J DRUG POLICY, V25, P836, DOI 10.1016/j.drugpo.2014.02.005; Tee KK, 2008, J VIROL, V82, P9206, DOI 10.1128/JVI.00399-08; Wang HB, 2012, SEX TRANSM DIS, V39, P835, DOI 10.1097/OLQ.0b013e318266b241; Wang HB, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-198; Wang HB, 2009, INT J INFECT DIS, V13, P162, DOI 10.1016/j.ijid.2008.05.1229; Wang Lan, 2013, Zhonghua Liu Xing Bing Xue Za Zhi, V34, P543; Wang ND, 2014, AIDS RES HUM RETROV, V30, P484, DOI [10.1089/aid.2013.0230, 10.1089/AID.2013.0230]; WANG Y, 1994, J HEPATOL, V21, P634, DOI 10.1016/S0168-8278(94)80112-6; Wang Y, 2013, S CHINA J PREV MED, V39, P6; Wen XiaoQing, 2013, Modern Preventive Medicine, V40, P2848; Xia GM, 2005, AIDS EDUC PREV, V17, P143, DOI 10.1521/aeap.17.3.143.62904; Yang XB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030198; Yang ZX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082451; Yi HS, 2010, PSYCHOL HEALTH MED, V15, P172, DOI 10.1080/13548501003623914; Yu XF, 1999, J ACQ IMMUN DEF SYND, V22, P180; Yu XF, 1998, LANCET, V351, P1250, DOI 10.1016/S0140-6736(05)79316-8; Zhang L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084950; Zhao K, 2014, AIDS RES HUM RETROV, V30, P1006, DOI [10.1089/AID.2014.0036, 10.1089/aid.2014.0036]; Zhao Shu-Ming, 2008, Zhongguo Shi Yan Xue Ye Xue Za Zhi, V16, P676; Zhu QY, 2013, ZHEJIANG PREV MED, V11, P31; Zou HC, 2012, SEX HEALTH, V9, P27, DOI 10.1071/SH11021; 周月姣, 2013, [中国公共卫生, China Public Health], V29, P579; 马现君, 2007, [中华流行病学杂志, Chinese Journal of Epidemiology], V28, P733	57	23	29	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2015	10	2							e0115311	10.1371/journal.pone.0115311	http://dx.doi.org/10.1371/journal.pone.0115311			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC3LS	25723548	gold, Green Published, Green Submitted			2022-12-27	WOS:000350251200005
J	Kent, M; Welladsen, HM; Mangott, A; Li, Y				Kent, Megan; Welladsen, Heather M.; Mangott, Arnold; Li, Yan			Nutritional Evaluation of Australian Microalgae as Potential Human Health Supplements	PLOS ONE			English	Article							ESSENTIAL FATTY-ACIDS; CARDIOVASCULAR-DISEASE; MARINE; NANNOCHLOROPSIS; PROTEIN; BIOFUELS; RECOVERY	This study investigated the biochemical suitability of Australian native microalgal species Scenedesmus sp., Nannochloropsis sp., Dunaliella sp., and a chlorophytic polyculture as nutritional supplements for human health. The four microalgal cultures were harvested during exponential growth, lyophilized, and analysed for proximate composition (moisture, ash, lipid, carbohydrates, and protein), pigments, and amino acid and fatty acid profiles. The resulting nutritional value, based on biochemical composition, was compared to commercial Spirulina and Chlorella products. The Australian native microalgae exhibited similar, and in several cases superior, organic nutritional properties relative to the assessed commercial products, with biochemical profiles rich in high-quality protein, nutritious polyunsaturated fats (such as a-linolenic acid, arachidonic acid, and eicosapentaenoic acid), and antioxidant pigments. These findings indicate that the microalgae assessed have great potential as multi-nutrient human health supplements.	[Kent, Megan; Welladsen, Heather M.; Mangott, Arnold; Li, Yan] James Cook Univ, Coll Marine & Environm Sci, Townsville, Qld 4811, Australia; [Mangott, Arnold] MBD Energy Ltd, Melbourne, Australia	James Cook University	Li, Y (corresponding author), James Cook Univ, Coll Marine & Environm Sci, Townsville, Qld 4811, Australia.	yan.li3@jcu.edu.au	Li, Yan/A-5532-2008	Li, Yan/0000-0002-9102-0917; Li, Yan/0000-0002-9742-0081	MBD Energy Ltd.	MBD Energy Ltd.	This research was part of the Advanced Manufacturing Cooperative Research Centre federal funding scheme which was co-funded by MBD Energy Ltd. Dr. Arnold Mangott, a co-author of this work, is employed by MBD Energy Ltd., Melbourne, Australia. MBD Energy Ltd. provided support in the form of salary for author AM, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.	Aguilera-Morales M, 2005, J FOOD COMPOS ANAL, V18, P79, DOI 10.1016/j.jfca.2003.12.012; Arts MT, 2001, CAN J FISH AQUAT SCI, V58, P122, DOI 10.1139/cjfas-58-1-122; Becker EW, 2007, BIOTECHNOL ADV, V25, P207, DOI 10.1016/j.biotechadv.2006.11.002; Becker E.W., 1982, BIOTECHNOLOGY EXPLOI; Benemann J, 2013, ENERGIES, V6, P5869, DOI 10.3390/en6115869; Bishop W., 2012, J NUTR FOOD SCI, V2, P1, DOI [10.4172/2155-9600.1000147, DOI 10.4172/2155-9600.1000147]; Bold HC, 1960, EXPLORATORY STUDIES; Borowitzka M., 1988, MICROALGAL BIOTECHNO, P456; BROWN MR, 1991, J EXP MAR BIOL ECOL, V145, P79, DOI 10.1016/0022-0981(91)90007-J; Buono S, 2014, FOOD FUNCT, V5, P1669, DOI [10.1039/C4FO00125G, 10.1039/c4fo00125g]; Carvalho AP, 2005, J AGR FOOD CHEM, V53, P5049, DOI 10.1021/jf048788i; Chen CY, 2013, BIORESOURCE TECHNOL, V147, P160, DOI 10.1016/j.biortech.2013.08.051; Chisti Y., 2004, HDB MICROALGAL CULTU, P57; Corcoran AA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049397; Croft MT, 2006, EUKARYOT CELL, V5, P1175, DOI 10.1128/EC.00097-06; Dahiya A., 2012, SCI ALGAL FUELS CELL, P447; David F, 2002, IMPROVING ANAL FATTY; FABREGAS J, 1988, PLANTA MED, P109, DOI 10.1055/s-2006-962362; FAO, 1991, 51 UN FAO; Gosch BJ, 2012, GCB BIOENERGY, V4, P919, DOI 10.1111/j.1757-1707.2012.01175.x; Greenfield H, 2003, FOOD COMPOSITION DAT; Grima EM, 2003, BIOTECHNOL ADV, V20, P491; Guillard R.R.L., 1975, CULTURE MARINE INVER, P29, DOI [10.1007/978-1-4615-8714-9_3, DOI 10.1007/978-1-4615-8714-9_3]; Habib MAB, 2008, FAO FISH AQUAC CIRC, V1034, P33; Hall MB, 2003, J ANIM SCI, V81, P3226; HEDENSKO.G, 1969, BIOTECHNOL BIOENG, V11, P37, DOI 10.1002/bit.260110104; Ku CS, 2013, J MED FOOD, V16, P103, DOI 10.1089/jmf.2012.2468; Lewis T, 2000, J MICROBIOL METH, V43, P107, DOI 10.1016/S0167-7012(00)00217-7; Li Y, 2012, BIOFUELS-UK, V3, P427, DOI [10.4155/BFS.12.32, 10.4155/bfs.12.32]; Lubian LM, 2000, J APPL PHYCOL, V12, P249, DOI 10.1023/A:1008170915932; MARKOVITS A, 1992, NUTR RES, V12, P1273, DOI 10.1016/S0271-5317(05)80784-5; Merchant RE, 2001, ALTERN THER HEALTH M, V7, P79; MOKADY S, 1989, FOOD CHEM TOXICOL, V27, P221, DOI 10.1016/0278-6915(89)90159-2; Morist A, 2001, PROCESS BIOCHEM, V37, P535, DOI 10.1016/S0032-9592(01)00230-8; Neori A, 2011, J APPL PHYCOL, V23, P143, DOI 10.1007/s10811-010-9531-9; Pangestuti R, 2011, J FUNCT FOODS, V3, P255, DOI 10.1016/j.jff.2011.07.001; Plourde M, 2007, APPL PHYSIOL NUTR ME, V32, P619, DOI 10.1139/H07-034; Rasala BA, 2015, PHOTOSYNTH RES, V123, P227, DOI 10.1007/s11120-014-9994-7; Ruperez P, 2002, FOOD CHEM, V79, P23, DOI 10.1016/S0308-8146(02)00171-1; SaloVaananen PP, 1996, FOOD CHEM, V57, P27, DOI 10.1016/0308-8146(96)00157-4; Sanchez-Machado DI, 2004, FOOD CHEM, V85, P439, DOI 10.1016/j.foodchem.2003.08.001; Simopoulos AP, 2008, EXP BIOL MED, V233, P674, DOI 10.3181/0711-MR-311; Spolaore P, 2006, J BIOSCI BIOENG, V101, P87, DOI 10.1263/jbb.101.87; Tabarsa M, 2012, J SCI FOOD AGR, V92, P2500, DOI 10.1002/jsfa.5659; Tang GuangWen, 2011, Journal of Pharmacy and Nutrition Sciences, V1, P111; TERAO J, 1989, LIPIDS, V24, P659, DOI 10.1007/BF02535085; Van Heukelem L, 2001, J CHROMATOGR A, V910, P31, DOI 10.1016/S0378-4347(00)00603-4; VENKATARAMAN LV, 1977, NUTR REP INT, V15, P145; Weeks DP, 2011, P NATL ACAD SCI USA, V108, P20859, DOI 10.1073/pnas.1118670109; Wijesekara I, 2011, CARBOHYD POLYM, V84, P14, DOI 10.1016/j.carbpol.2010.10.062; Yamaguchi K, 1996, J APPL PHYCOL, V8, P487, DOI 10.1007/BF02186327; Youdim KA, 2000, INT J DEV NEUROSCI, V18, P383, DOI 10.1016/S0736-5748(00)00013-7; Zhang T, 2009, MAR BIOTECHNOL, V11, P280, DOI 10.1007/s10126-008-9144-3	53	139	147	4	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2015	10	2							e0118985	10.1371/journal.pone.0118985	http://dx.doi.org/10.1371/journal.pone.0118985			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC3LS	25723496	Green Submitted, gold, Green Accepted, Green Published			2022-12-27	WOS:000350251200067
J	Ayithan, N; Bradfute, SB; Anthony, SM; Stuthman, KS; Bavari, S; Bray, M; Ozato, K				Ayithan, Natarajan; Bradfute, Steven B.; Anthony, Scott M.; Stuthman, Kelly S.; Bavari, Sina; Bray, Mike; Ozato, Keiko			Virus-Like Particles Activate Type I Interferon Pathways to Facilitate Post-Exposure Protection against Ebola Virus Infection	PLOS ONE			English	Article							NF-KAPPA-B; DENDRITIC CELLS REQUIRES; TOLL-LIKE RECEPTOR; REGULATORY FACTOR-8; FILOVIRUS INFECTION; CYTOKINE EXPRESSION; NEGATIVE REGULATION; MOUSE MODEL; VP35; PROTEINS	Ebola virus (EBOV) causes a severe hemorrhagic disease with high fatality. Virus-like particles (VLPs) are a promising vaccine candidate against EBOV. We recently showed that VLPs protect mice from lethal EBOV infection when given before or after viral infection. To elucidate pathways through which VLPs confer post-exposure protection, we investigated the role of type I interferon (IFN) signaling. We found that VLPs lead to accelerated induction of IFN stimulated genes (ISGs) in liver and spleen of wild type mice, but not in Ifnar(-/-)mice. Accordingly, EBOV infected Ifnar(-/-)mice, unlike wild type mice succumbed to death even after VLP treatment. The ISGs induced in wild type mice included anti-viral proteins and negative feedback factors known to restrict viral replication and excessive inflammatory responses. Importantly, proinflammatory cytokine/chemokine expression was much higher in WT mice without VLPs than mice treated with VLPs. In EBOV infected Ifnar(-/-)mice, however, uninhibited viral replication and elevated proinflammatory factor expression ensued, irrespective of VLP treatment, supporting the view that type I IFN signaling helps to limit viral replication and attenuate inflammatory responses. Further analyses showed that VLP protection requires the transcription factor, IRF8 known to amplify type I IFN signaling in dendritic cells and macrophages, the probable sites of initial EBOV infection. Together, this study indicates that VLPs afford post-exposure protection by promoting expeditious initiation of type I IFN signaling in the host.	[Ayithan, Natarajan; Ozato, Keiko] NICHHD, Program Genom Differentiat, NIH, Bethesda, MD 20892 USA; [Bradfute, Steven B.; Anthony, Scott M.; Stuthman, Kelly S.; Bavari, Sina] US Army, Med Inst Infect Dis, Ft Detrick, MD USA; [Bray, Mike] NIAID, Integrated Res Facil, NIH, Ft Detrick, MD USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Ozato, K (corresponding author), NICHHD, Program Genom Differentiat, NIH, Bethesda, MD 20892 USA.	ozatok@nih.gov	Ayithan, Natarajan/ABH-3392-2020; Bavari, Sina/L-3642-2019	Bavari, Sina/0000-0001-8424-5635; Anthony, Scott/0000-0002-1590-7401	Intramural Program of NICHD; Trans-NIH FDA intramural Bio-defense Program, NIH; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD008815, ZIAHD001310] Funding Source: NIH RePORTER	Intramural Program of NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Trans-NIH FDA intramural Bio-defense Program, NIH; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by the Intramural Program of NICHD and the Trans-NIH FDA intramural Bio-defense Program, NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alter-Koltunoff M, 2008, J BIOL CHEM, V283, P2724, DOI 10.1074/jbc.M707704200; Ayithan N, 2014, J INTERF CYTOK RES, V34, P79, DOI 10.1089/jir.2013.0035; Bafica A, 2007, J IMMUNOL, V179, P5514, DOI 10.4049/jimmunol.179.8.5514; Basler CF, 2000, P NATL ACAD SCI USA, V97, P12289, DOI 10.1073/pnas.220398297; Basler CF, 2009, J INTERF CYTOK RES, V29, P511, DOI 10.1089/jir.2009.0076; Billiau A, 2006, ANTIVIR RES, V71, P108, DOI 10.1016/j.antiviral.2006.03.006; Bradfute SB, 2015, PLOS ONE IN PRESS, DOI [10.1371/journal.pone.0117162, DOI 10.1371/J0URNAL.P0NE.0117162]; Bradfute SB, 2012, VIRUSES-BASEL, V4, P1477, DOI 10.3390/v4091477; Bradfute SB, 2011, VIRUSES-BASEL, V3, P982, DOI 10.3390/v3070982; Bray M, 1999, J INFECT DIS, V179, pS248, DOI 10.1086/514292; Bray M, 2001, J GEN VIROL, V82, P1365, DOI 10.1099/0022-1317-82-6-1365; Bray M, 2007, J INFECT DIS, V196, pS438, DOI 10.1086/520552; Chang TH, 2012, J IMMUNOL, V189, P3548, DOI 10.4049/jimmunol.1201104; Chang TH, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000493; Ebihara H, 2006, PLOS PATHOG, V2, P705, DOI 10.1371/journal.ppat.0020073; Fausther-Bovendo H, 2012, CURR OPIN VIROL, V2, P324, DOI 10.1016/j.coviro.2012.04.003; Feldmann H, 2007, PLOS PATHOG, V3, P54, DOI 10.1371/journal.ppat.0030002; Geisbert TW, 2003, AM J PATHOL, V163, P2371, DOI 10.1016/S0002-9440(10)63592-4; Geiss GK, 2002, P NATL ACAD SCI USA, V99, P10736, DOI 10.1073/pnas.112338099; Guarda G, 2011, IMMUNITY, V34, P213, DOI 10.1016/j.immuni.2011.02.006; Gupta M, 2001, VIROLOGY, V284, P20, DOI 10.1006/viro.2001.0836; Hambleton S, 2011, NEW ENGL J MED, V365, P127, DOI 10.1056/NEJMoa1100066; Hartman AL, 2008, J VIROL, V82, P5348, DOI 10.1128/JVI.00215-08; Hartman AL, 2008, J VIROL, V82, P2699, DOI 10.1128/JVI.02344-07; Hoenen T, 2012, EXPERT OPIN BIOL TH, V12, P859, DOI 10.1517/14712598.2012.685152; Hu Y, 2010, J IMMUNOL, V185, P7699, DOI 10.4049/jimmunol.1001099; Huang IC, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001258; Hutchinson KL, 2007, J INFECT DIS, V196, pS357, DOI 10.1086/520611; Jahrling PB, 1999, J INFECT DIS, V179, pS224, DOI 10.1086/514310; Johnson RF, 2006, VIROL J, V3, DOI 10.1186/1743-422X-3-31; Kawai T, 2007, SEMIN IMMUNOL, V19, P24, DOI 10.1016/j.smim.2006.12.004; Kuhn Jens H, 2008, Arch Virol Suppl, V20, P13; Kurotaki D, 2013, BLOOD, V121, P1839, DOI 10.1182/blood-2012-06-437863; Kushnir N, 2012, VACCINE, V31, P58, DOI 10.1016/j.vaccine.2012.10.083; Lever MS, 2012, J MED MICROBIOL, V61, P8, DOI 10.1099/jmm.0.036210-0; Liew FY, 2005, NAT REV IMMUNOL, V5, P446, DOI 10.1038/nri1630; Mahanty S, 2003, VIROLOGY, V312, P415, DOI 10.1016/S0042-6822(03)00233-2; Malakhova OA, 2006, EMBO J, V25, P2358, DOI 10.1038/sj.emboj.7601149; Martinez O, 2007, VIROLOGY, V364, P342, DOI 10.1016/j.virol.2007.03.020; Mohamadzadeh M, 2007, NAT REV IMMUNOL, V7, P556, DOI 10.1038/nri2098; Noda T, 2002, J VIROL, V76, P4855, DOI 10.1128/JVI.76.10.4855-4865.2002; O'Brien LM, 2014, VIROLOGY, V452, P324, DOI 10.1016/j.virol.2013.03.028; Olejnik J, 2011, VIRUSES-BASEL, V3, P1501, DOI 10.3390/v3081501; Ozato K, 2008, NAT REV IMMUNOL, V8, P849, DOI 10.1038/nri2413; Pinto AK, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004086; Qiu XG, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006605; Raymond J, 2011, J INFECT DIS, V204, pS986, DOI 10.1093/infdis/jir335; Shi M, 2008, NAT IMMUNOL, V9, P369, DOI 10.1038/ni1577; Smith LM, 2013, J INFECT DIS, V208, P310, DOI 10.1093/infdis/jis921; Tailor P, 2007, IMMUNITY, V27, P228, DOI 10.1016/j.immuni.2007.06.009; Tamura T, 2008, ANNU REV IMMUNOL, V26, P535, DOI 10.1146/annurev.immunol.26.021607.090400; Thakar J, 2013, J INTERF CYTOK RES, V33, P700, DOI 10.1089/jir.2012.0113; Warfield KL, 2005, J IMMUNOL, V175, P1184, DOI 10.4049/jimmunol.175.2.1184; Wauquier N, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000837; Yang CL, 2008, EXPERT REV VACCINES, V7, P333, DOI 10.1586/14760584.7.3.333; Yoshimi R, 2009, J IMMUNOL, V182, P7527, DOI 10.4049/jimmunol.0804121; Yoshimura A, 2003, CURR OPIN IMMUNOL, V15, P704, DOI 10.1016/j.coi.2003.09.004; Yoshimura A, 2007, NAT REV IMMUNOL, V7, P454, DOI 10.1038/nri2093	58	14	16	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2015	10	2							e0118345	10.1371/journal.pone.0118345	http://dx.doi.org/10.1371/journal.pone.0118345			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC2ZH	25719445	Green Submitted, Green Published, gold			2022-12-27	WOS:000350213200048
J	Lewandowska, MA; Czubak, K; Klonowska, K; Jozwicki, W; Kowalewski, J; Kozlowski, P				Lewandowska, Marzena Anna; Czubak, Karol; Klonowska, Katarzyna; Jozwicki, Wojciech; Kowalewski, Janusz; Kozlowski, Piotr			The Use of a Two-Tiered Testing Strategy for the Simultaneous Detection of Small EGFR Mutations and EGFR Amplification in Lung Cancer	PLOS ONE			English	Article							DEPENDENT PROBE AMPLIFICATION; OF-AMERICAN-PATHOLOGISTS; CLINICAL-RESPONSE; LARGE SERIES; COPY NUMBER; IDENTIFICATION; RESISTANCE; GUIDELINE; SELECTION; MLPA	Lung cancer is the leading cause of cancer-related death worldwide. Recent progress in lung cancer diagnosis and treatment has been achieved due to a better understanding the molecular mechanisms of the disease and the identification of biomarkers that allow more specific cancer treatments. One of the best known examples of personalized therapy is the use of tyrosine kinase inhibitors, such as gefitinib and erlotinib, for the successful treatment of non-small-cell lung cancer patients selected based on the specific EGFR mutations. Therefore, the reliable detection of mutations is critical for the application of appropriate therapy. In this study, we tested a two-tiered mutation detection strategy using real-time PCR assays as a well-validated high-sensitivity method and multiplex ligation-dependent probe amplification (MLPA)-based EGFRmut+assay as a second-tier standard-sensitivity method. One additional advantage of the applied MLPA method is that it allows the simultaneous detection of EGFR mutations and copy-number alterations (i.e., amplifications) in EGFR, MET and ERBB2. Our analysis showed high concordance between these two methods. With the use of this two-tier strategy, we reliably determined the frequency of EGFR mutations and EGFR, MET and ERBB2 amplifications in over 200 lung cancer samples. Additionally, taking advantage of simultaneous copy number and small mutation analyses, we showed a very strong correlation between EGFR mutations and EGFR amplifications and a mutual exclusiveness of EGFR mutations/amplifications with MET and ERBB2 amplifications. Our results proved the reliability and usefulness of the two-tiered EGFR testing strategy.	[Lewandowska, Marzena Anna] Franciszek Lukaszczyk Oncol Ctr, Dept Tumour Pathol & Pathomorphol, Mol Oncol & Genet Unit, Bydgoszcz, Poland; [Lewandowska, Marzena Anna] Nicolaus Copernicus Univ, Dept Thorac Surg & Tumours, Ludwik Rydygier Coll Med, Bydgoszcz, Poland; [Czubak, Karol; Klonowska, Katarzyna; Kozlowski, Piotr] Polish Acad Sci, Inst Bioorgan Chem, European Ctr Bioinformat & Genom, Poznan, Poland; [Czubak, Karol; Klonowska, Katarzyna; Kozlowski, Piotr] Poznan Univ Tech, PL-60965 Poznan, Poland; [Jozwicki, Wojciech] Nicolaus Copernicus Univ, Dept Tumour Pathol & Pathomorphol, Ludwik Rydygier Coll Med, Franciszek Lukaszczyk Oncol Ctr, Bydgoszcz, Poland; [Kowalewski, Janusz] Nicolaus Copernicus Univ, Dept Thorac Surg & Tumours, Ludwik Rydygier Coll Med, Franciszek Lukaszczyk Oncol Ctr, Bydgoszcz, Poland	Nicolaus Copernicus University; Polish Academy of Sciences; Institute of Bioorganic Chemistry of the Polish Academy of Sciences; Poznan University of Technology; Nicolaus Copernicus University; Nicolaus Copernicus University	Lewandowska, MA (corresponding author), Franciszek Lukaszczyk Oncol Ctr, Dept Tumour Pathol & Pathomorphol, Mol Oncol & Genet Unit, Bydgoszcz, Poland.	lewandowskam@co.bydgoszcz.pl; kozlowp@yahoo.com	Lewandowska, Marzena/F-6757-2015; Kozlowski, Piotr/I-1860-2019; Jozwicki, Wojciech/I-1948-2014	Lewandowska, Marzena/0000-0002-7360-7810; Kozlowski, Piotr/0000-0003-3770-7715; Czubak, Karol/0000-0002-0489-8773; Jozwicki, Wojciech/0000-0001-9311-1604	National Science Centre [2011/01/B/NZ5/02773]	National Science Centre(National Science Centre, Poland)	This work was supported by research grant 2011/01/B/NZ5/02773 from National Science Centre (http://www.ncn.gov.pl/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Dopierala J, 2010, INVEST OPHTH VIS SCI, V51, P4898, DOI 10.1167/iovs.09-5004; Ercan D, 2010, ONCOGENE, V29, P2346, DOI 10.1038/onc.2009.526; Gahr S, 2013, BRIT J CANCER, V109, P1821, DOI 10.1038/bjc.2013.511; Gazdar AF, 2009, ONCOGENE, V28, pS24, DOI 10.1038/onc.2009.198; Gonzalez E, 2005, SCIENCE, V307, P1434, DOI 10.1126/science.1101160; Hwang VJ, 2014, BMC MED GENET, V15, DOI 10.1186/s12881-014-0106-5; Imielinski M, 2012, CELL, V150, P1107, DOI 10.1016/j.cell.2012.08.029; Jeuken J, 2006, J MOL DIAGN, V8, P433, DOI 10.2353/jmoldx.2006.060012; Jeuken JW, 2007, LAB INVEST, V87, P1055, DOI 10.1038/labinvest.3700664; Ji HB, 2007, NATURE, V448, P807, DOI 10.1038/nature06030; Kawahara A, 2012, LUNG CANCER, V78, P39, DOI 10.1016/j.lungcan.2012.07.002; Kobayashi S, 2005, NEW ENGL J MED, V352, P786, DOI 10.1056/NEJMoa044238; Kozlowski P, 2007, HUM GENET, V121, P389, DOI 10.1007/s00439-006-0308-9; Kozlowski P, 2008, ELECTROPHORESIS, V29, P4627, DOI 10.1002/elps.200800126; Lewandowska MA, 2013, ONCOL REP, V30, P1045, DOI 10.3892/or.2013.2579; Lewandowska MA, 2013, MOL DIAGN THER, V17, P193, DOI 10.1007/s40291-013-0025-8; Liang MC, 2010, ONCOGENE, V29, P1588, DOI 10.1038/onc.2009.452; Lindeman NI, 2013, J THORAC ONCOL, V8, P823, DOI 10.1097/JTO.0b013e318290868f; Lindeman NI, 2013, ARCH PATHOL LAB MED, V137, P828, DOI [10.5858/arpa.2012-0720-OA, 10.1097/JTO.0b013e318290868f]; Lindeman NI, 2013, J MOL DIAGN, V15, P415, DOI 10.1016/j.jmoldx.2013.03.001; Marchetti A, 2005, J CLIN ONCOL, V23, P857, DOI 10.1200/JCO.2005.08.043; Marcinkowska M, 2010, THESCIENTIFICWORLDJO, V10, P2003, DOI 10.1100/tsw.2010.195; McDermott GP, 2013, ANAL CHEM, V85, P11619, DOI 10.1021/ac403061n; Miotke L, 2014, ANAL CHEM, V86, P2618, DOI 10.1021/ac403843j; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; Pennycuick A, 2012, INT J CLIN PRACT, V66, P748, DOI 10.1111/j.1742-1241.2012.02961.x; Rosell R, 2009, NEW ENGL J MED, V361, P958, DOI 10.1056/NEJMoa0904554; Schouten JP, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/gnf056; Scott KL, 2009, NATURE, V459, P1085, DOI 10.1038/nature08109; Shigematsu H, 2005, JNCI-J NATL CANCER I, V97, P339, DOI 10.1093/jnci/dji055; Soda M, 2007, NATURE, V448, P561, DOI 10.1038/nature05945; Tuononen K, 2013, GENE CHROMOSOME CANC, V52, P503, DOI 10.1002/gcc.22047; van Dijk MC, 2005, DIAGN MOL PATHOL, V14, P9, DOI 10.1097/01.pas.0000146701.98954.47	33	17	18	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2015	10	2							e0117983	10.1371/journal.pone.0117983	http://dx.doi.org/10.1371/journal.pone.0117983			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC2ZH	25719557	Green Submitted, Green Published, gold			2022-12-27	WOS:000350213200035
J	Martin, J; Benhamou, S; Yoganand, K; Owen-Smith, N				Martin, Jodie; Benhamou, Simon; Yoganand, K.; Owen-Smith, Norman			Coping with Spatial Heterogeneity and Temporal Variability in Resources and Risks: Adaptive Movement Behaviour by a Large Grazing Herbivore	PLOS ONE			English	Article							PARTIAL MIGRATION; ECOLOGY; WILDEBEEST; ECOSYSTEM; DYNAMICS; ANIMALS; DENSITY; QUALITY; SCALES	Movement is a key mean for mobile species to cope with heterogeneous environments. While in herbivorous mammals large-scale migration has been widely investigated, finescale movement responses to local variations in resources and predation risk remain much less studied, especially in savannah environments. We developed a novel approach based on complementary movement metrics (residence time, frequency of visits and regularity of visits) to relate movement patterns of a savannah grazer, the blue wildebeest Connochaetes taurinus, to fine-scale variations in food availability, predation risk and water availability in the Kruger National Park, South Africa. Wildebeests spent more time in grazing lawns where the grass is of higher quality but shorter than in seep zones, where the grass is of lower quality but more abundant. Although the daily distances moved were longer during the wet season compared to the dry season, the daily net displacement was lower, and the residence time higher, indicating a more frequent occurrence of area-concentred searching. In contrast, during the late dry season the foraging sessions were more fragmented and wildebeests moved more frequently between foraging areas. Surprisingly, predation risk appeared to be the second factor, after water availability, influencing movement during the dry season, when resources are limiting and thus expected to influence movement more. Our approach, using complementary analyses of different movement metrics, provided an integrated view of changes in individual movement with varying environmental conditions and predation risk. It makes it possible to highlight the adaptive behavioral decisions made by wildebeest to cope with unpredictable environmental variations and provides insights for population conservation.	[Martin, Jodie; Yoganand, K.; Owen-Smith, Norman] Univ Witwatersrand, Ctr African Ecol, Sch Anim Plant & Environm Sci, Johannesburg, South Africa; [Benhamou, Simon] CNRS, UMR5175, Ctr Ecol Fonct & Evolut, Montpellier, France	University of Witwatersrand; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; PSL Research University Paris; Ecole Pratique des Hautes Etudes (EPHE); Institut Agro; Montpellier SupAgro; CIRAD; Institut de Recherche pour le Developpement (IRD); Universite Paul-Valery; Universite de Montpellier	Martin, J (corresponding author), Univ Witwatersrand, Ctr African Ecol, Sch Anim Plant & Environm Sci, Johannesburg, South Africa.	martin@ase-research.org	K, Yoganand/AAK-7766-2021; k, y/GSJ-3369-2022; Owen-Smith, Norman/ABI-5113-2020	K, Yoganand/0000-0002-6609-4615; Owen-Smith, Norman/0000-0001-8429-1201	South African National Research Foundation; French Embassy of South Africa; Claude Leon Foundation	South African National Research Foundation(National Research Foundation - South Africa); French Embassy of South Africa; Claude Leon Foundation	This research was supported by the South African National Research Foundation (http://www.nrf.ac.za/). Additional financial support was provided by the French Embassy of South Africa (http://www.ambafrance-rsa.org/) for travel and collaborations. JM was granted with a postdoctoral fellowship from the Claude Leon Foundation (http://www.leonfoundation.co.za/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson DP, 2008, J MAMMAL, V89, P105, DOI 10.1644/07-MAMM-A-035.1; Bailey DW, 1996, J RANGE MANAGE, V49, P386, DOI 10.2307/4002919; Ball JP, 2001, WILDLIFE BIOL, V7, P39, DOI 10.2981/wlb.2001.007; Bar-David S, 2009, ECOLOGY, V90, P2467, DOI 10.1890/08-1532.1; Barraquand F, 2008, ECOLOGY, V89, P3336, DOI 10.1890/08-0162.1; BELL RHV, 1971, SCI AM, V225, P86, DOI 10.1038/scientificamerican0771-86; Benhamou S, 2014, ECOL LETT, V17, P261, DOI 10.1111/ele.12225; Benhamou S, 2012, ECOL MODEL, V227, P112, DOI 10.1016/j.ecolmodel.2011.12.015; Bonnet O, 2010, J ECOL, V98, P908, DOI 10.1111/j.1365-2745.2010.01663.x; Burnham K.P., 2002, MODEL SELECTION MULT, V2nd, DOI [10.1007/b97636, DOI 10.1007/B97636]; Cagnacci F, 2011, OIKOS, V120, P1790, DOI 10.1111/j.1600-0706.2011.19441.x; Chamaille-Jammes S, 2007, J APPL ECOL, V44, P625, DOI 10.1111/j.1365-2664.2007.01300.x; CHARNOV EL, 1976, THEOR POPUL BIOL, V9, P129, DOI 10.1016/0040-5809(76)90040-X; ESTES RD, 1966, NATURE, V212, P999, DOI 10.1038/212999a0; FRYXELL JM, 1991, AM NAT, V138, P478, DOI 10.1086/285227; Hopcraft JGC, 2005, J ANIM ECOL, V74, P559, DOI 10.1111/j.1365-2656.2005.00955.x; Johnson JB, 2004, TRENDS ECOL EVOL, V19, P101, DOI 10.1016/j.tree.2003.10.013; KREULEN D, 1975, East African Wildlife Journal, V13, P297; Lyons AJ, 2013, MOV ECOL, V1, DOI 10.1186/2051-3933-1-2; MCNAUGHTON SJ, 1985, ECOL MONOGR, V55, P259, DOI 10.2307/1942578; MCNAUGHTON SJ, 1984, AM NAT, V124, P863, DOI 10.1086/284321; Mysterud A, 2011, OIKOS, V120, P1817, DOI 10.1111/j.1600-0706.2010.19439.x; Owen-Smith N, 2014, J ZOOL, V293, P181, DOI 10.1111/jzo.12132; Owen-Smith N, 2010, PHILOS T R SOC B, V365, P2267, DOI 10.1098/rstb.2010.0095; Owen-Smith RN., 2002, ADAPTIVE HERBIVORE E, VStudent; Pinheiro J, 2001, MIXED EFFECTS MODELS; Singh NJ, 2012, ECOL APPL, V22, P2007, DOI 10.1890/12-0245.1; Stephens D.W., 1986, pi; Valeix M, 2008, AFR J ECOL, V46, P402, DOI 10.1111/j.1365-2028.2007.00874.x; Valeix M, 2011, J TROP ECOL, V27, P163, DOI 10.1017/S0266467410000647; van Moorter B, 2013, J ANIM ECOL, V82, P770, DOI 10.1111/1365-2656.12045; White PJ, 2007, BIOL CONSERV, V135, P502, DOI 10.1016/j.biocon.2006.10.041; Wilmshurst JF, 1999, CAN J ZOOL, V77, P1223, DOI 10.1139/cjz-77-8-1223; Yoganand K, 2014, ECOGRAPHY, V37, P969, DOI 10.1111/ecog.00534	34	33	34	3	65	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2015	10	2							e0118461	10.1371/journal.pone.0118461	http://dx.doi.org/10.1371/journal.pone.0118461			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC2ZH	25719494	Green Published, gold			2022-12-27	WOS:000350213200055
J	Rogozinska, E; Chamillard, M; Hitman, GA; Khan, KS; Thangaratinam, S				Rogozinska, Ewelina; Chamillard, Monica; Hitman, Graham A.; Khan, Khalid S.; Thangaratinam, Shakila			Nutritional Manipulation for the Primary Prevention of Gestational Diabetes Mellitus: A Meta-Analysis of Randomised Studies	PLOS ONE			English	Article							LIFE-STYLE INTERVENTION; EXCESSIVE WEIGHT-GAIN; OBESE PREGNANT-WOMEN; CONTROLLED-TRIAL; DIETARY; MYOINOSITOL; MANAGEMENT; RISK; OUTCOMES; IMPACT	Introduction The rise in gestational diabetes (GDM), defined as first onset or diagnosis of diabetes in pregnancy, is a global problem. GDM is often associated with unhealthy diet and is a major contributor to adverse outcomes maternal and fetal outcomes. Manipulation of nutrition has the potential to prevent GDM. Methods We assessed the effects of nutritional manipulation in pregnancy on GDM and relevant maternal and fetal outcomes by a systematic review of the literature. We searched MEDLINE, EMBASE, and Cochrane Database from inception to March 2014 without any language restrictions. Randomised controlled trials (RCT) of nutritional manipulation to prevent GDM were included. We summarised dichotomous data as relative risk (RR) and continuous data as standardised mean difference (SMD) with 95% confidence interval (CI). Results From 1761 citations, 20 RCTs (6,444 women) met the inclusion criteria. We identified the following interventions: diet-based (n = 6), mixed approach (diet and lifestyle) interventions (n = 13), and nutritional supplements (myo-inositol n = 1, diet with probiotics n = 1). Diet based interventions reduced the risk of GDM by 33% (RR 0.67; 95% CI 0.39, 1.15). Mixed approach interventions based on diet and lifestyle had no effect on GDM (RR 0.95; 95% CI 0.89, 1.22). Nutritional supplements probiotics combined with diet (RR 0.40; 95% CI 0.20, 0.78) and myo-inositol (RR 0.40; 95% CI 0.16, 0.99) were assessed in one trial each and showed a beneficial effect. We observed a significant interaction between the groups based on BMI for diet-based intervention. The risk of GDM was reduced in obese and overweight pregnant women for GDM (RR 0.40, 95% CI 0.18, 0.86). Conclusions Nutritional manipulation in pregnancy based on diet or mixed approach do not appear to reduce the risk of GDM. Nutritional supplements show potential as agents for primary prevention of GDM.	[Rogozinska, Ewelina; Khan, Khalid S.; Thangaratinam, Shakila] Queen Mary Univ London, Barts & London Sch Med & Dent, Ctr Primary Care & Publ Hlth, Womens Hlth Res Unit,Blizard Inst, London, England; [Rogozinska, Ewelina; Khan, Khalid S.; Thangaratinam, Shakila] Barts & London Queen Marys Sch Med & Dent, Multidisciplinary Evidence Synth Hub MEsh, Ctr Primary Care & Publ Hlth, Blizard Inst, London, England; [Chamillard, Monica] Ctr Rosarino Estudios Perinatales, Rosario, Santa Fe, Argentina; [Hitman, Graham A.] Queen Mary Univ London, Barts & London Sch Med & Dent, Ctr Diabet, Blizard Inst, London, England	University of London; Queen Mary University London; University of London; Queen Mary University London; University of London; Queen Mary University London	Rogozinska, E (corresponding author), Queen Mary Univ London, Barts & London Sch Med & Dent, Ctr Primary Care & Publ Hlth, Womens Hlth Res Unit,Blizard Inst, London, England.	e.a.rogozinska@qmul.ac.uk	Khan, Khalid S/AAT-8824-2020; Thangaratinam, Shakila/AAP-3724-2021; Rogozinska, Ewelina/C-1096-2018	Khan, Khalid S/0000-0001-5084-7312; Thangaratinam, Shakila/0000-0002-4254-460X; Rogozinska, Ewelina/0000-0003-3455-0644; Hitman, Graham/0000-0002-6637-9004	European Union [101377, 247613]	European Union(European Commission)	The authors received funding from the European Union made available to the EBM-CONNECT Collaboration through its Seventh Framework Programme, Marie Curie Actions, International Staff Exchange Scheme (proposal no. 101377; grant agreement no. 247613). None of the funding providers played a role in the planning and execution of this work, or in drafting of the article.	Barrett HL, 2012, ACTA DIABETOL, V49, pS1, DOI 10.1007/s00592-012-0444-8; Bogaerts AFL, 2013, INT J OBESITY, V37, P814, DOI 10.1038/ijo.2012.162; Buchanan TA, 2012, NAT REV ENDOCRINOL, V8, P639, DOI 10.1038/nrendo.2012.96; Cogram P, 2002, HUM REPROD, V17, P2451, DOI 10.1093/humrep/17.9.2451; Coustan DR, 2013, DIABETES CARE, V36, P777, DOI 10.2337/dc12-2505; D'Anna R, 2013, DIABETES CARE, V36, P854, DOI 10.2337/dc12-1371; Dodd JM, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g1285; Ferrara A, 2007, DIABETES CARE, V30, pS141, DOI 10.2337/dc07-s206; FRASER RB, 1988, BRIT J OBSTET GYNAEC, V95, P223, DOI 10.1111/j.1471-0528.1988.tb06861.x; Genazzani AD, 2008, GYNECOL ENDOCRINOL, V24, P139, DOI 10.1080/09513590801893232; Gillies CL, 2007, BMJ-BRIT MED J, V334, P299, DOI 10.1136/bmj.39063.689375.55; Guelinckx I, 2010, AM J CLIN NUTR, V91, P373, DOI 10.3945/ajcn.2009.28166; Han SS, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009021.pub2; Harbord RM, 2006, STAT MED, V25, P3443, DOI 10.1002/sim.2380; Harrison CL, 2011, ENDOCR REV, V32, DOI [10.1210/er.2011-0001, DOI 10.1210/ER.2011-0001]; Hex N, 2012, DIABETIC MED, V29, P855, DOI 10.1111/j.1464-5491.2012.03698.x; Higgins JPT, 2011, COCHRANE REV HDB 5 1; Hui A, 2012, BJOG-INT J OBSTET GY, V119, P70, DOI 10.1111/j.1471-0528.2011.03184.x; Jeffries K, 2009, MED J AUSTRALIA, V191, P429, DOI 10.5694/j.1326-5377.2009.tb02877.x; Jovanovic L, 2001, JAMA-J AM MED ASSOC, V286, P2516, DOI 10.1001/jama.286.20.2516; Kalergis Maria, 2013, Front Endocrinol (Lausanne), V4, P90, DOI 10.3389/fendo.2013.00090; Khan K. S., 2001, 4 U YORK NHS CTR REV; Kim C, 2002, DIABETES CARE, V25, P1862, DOI 10.2337/diacare.25.10.1862; Korpi-Hyovalti E, 2012, BRIT J NUTR, V108, P910, DOI 10.1017/S0007114511006118; Liberati A, 2009, PLOS MED, V6, DOI [10.1371/journal.pmed.1000100, 10.1136/bmj.b2700, 10.7326/0003-4819-151-4-200908180-00136]; Luoto R, 2010, BRIT J NUTR, V103, P1792, DOI 10.1017/S0007114509993898; Luoto R, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001036; Oostdam N, 2011, J WOMENS HEALTH, V20, P1551, DOI 10.1089/jwh.2010.2703; Petrella E, 2013, J MATERN FETAL NEONA; Phelan S, 2011, AM J CLIN NUTR, V93, P772, DOI 10.3945/ajcn.110.005306; Pirc Louise K, 2007, BMC Pediatr, V7, P18, DOI 10.1186/1471-2431-7-18; Polley BA, 2002, INT J OBESITY, V26, P1494, DOI 10.1038/sj.ijo.0802130; Poston L, 2013, BMC PREGNANCY CHILDB, V13, DOI 10.1186/1471-2393-13-148; Qiu CF, 2004, OBSTET GYNECOL, V103, P519, DOI 10.1097/01.AOG.0000113621.53602.7a; Quinlivan JA, 2011, AUST NZ J OBSTET GYN, V51, P141, DOI 10.1111/j.1479-828X.2010.01268.x; Renault KM, 2014, AM J OBSTET GYNECOL, V210, DOI 10.1016/j.ajog.2013.09.029; Shang M, 2014, J PERINATOL, V34, P100, DOI 10.1038/jp.2013.143; Thangaratinam S, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e2088; Thornton YS, 2009, J NATL MED ASSOC, V101, P569, DOI 10.1016/S0027-9684(15)30942-1; Tieu J, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006674.pub2; Vesco K, 2013, AM J OBSTET GYNECOL, V208, pS352, DOI 10.1016/j.ajog.2012.12.009; Vinter CA, 2011, DIABETES CARE, V34, P2502, DOI 10.2337/dc11-1150; Walker JD, 2008, DIABETIC MED, V25, P1025, DOI 10.1111/j.1464-5491.2008.02532.x; Walsh JM, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e5605; Weickert MO, 2008, J NUTR, V138, P439, DOI 10.1093/jn/138.3.439; Wolff S, 2008, INT J OBESITY, V32, P495, DOI 10.1038/sj.ijo.0803710; Zhang CL, 2006, DIABETES CARE, V29, P2223, DOI 10.2337/dc06-0266	47	63	71	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2015	10	2							e0115526	10.1371/journal.pone.0115526	http://dx.doi.org/10.1371/journal.pone.0115526			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC2ZH	25719363	Green Submitted, gold, Green Published			2022-12-27	WOS:000350213200004
J	Arkoun, B; Dumont, L; Milazzo, JP; Way, A; Bironneau, A; Wils, J; Mace, B; Rives, N				Arkoun, Brahim; Dumont, Ludovic; Milazzo, Jean-Pierre; Way, Agathe; Bironneau, Amandine; Wils, Julien; Mace, Bertrand; Rives, Nathalie			Retinol Improves In Vitro Differentiation of Pre-Pubertal Mouse Spermatogonial Stem Cells into Sperm during the First Wave of Spermatogenesis	PLOS ONE			English	Article							FOLLICLE-STIMULATING-HORMONE; ACID GENE-8 STRA8; A-DEFICIENT RATS; VITAMIN-A; SEMINIFEROUS EPITHELIUM; SERTOLI; CULTURE; GERM; SYNCHRONIZATION; TRANSPLANTATION	Testicular tissue freezing has been proposed for fertility preservation in pre-pubertal boys. Thawed frozen testicular tissue must undergo a maturation process to restore sperm production. The purpose of the current study was to evaluate the ability of retinol to improve the in vitro differentiation of pre-pubertal mouse spermatogonial stem cells into sperm. Testes from pre-pubertal mice, aged 2.5 and 6.5 days post-partum, were cultured on agarose gel at a gas-liquid interphase for 34, 38 and 60 days (D) and for 16, 30 and 36 D respectively. Assessment of basal medium (BM) supplemented with retinol (RE) alone, FSH/LH alone or a combination of both, was performed. Stereological analyses and tissue lesion scoring were performed at the culture time points indicated above. Sperm production was quantified at D30 and D34 after mechanical dissection of the testicular tissues. FSH/LH significantly increased the percentage of round spermatids at D30 and D38, when compared to BM alone. However, RE significantly increased the percentages of round but also elongated spermatids at D30 and D34. Moreover, RE significantly increased the number of spermatozoa per milligram of tissue at D30 and D34 when compared to BM. Therefore, RE improved the in vitro production of spermatids and spermatozoa from pre-pubertal SSCs during the first wave of spermatogenesis. The use of RE could be a useful tool for in vitro spermatogenesis from pre-pubertal human testicular tissue.	[Arkoun, Brahim; Dumont, Ludovic; Milazzo, Jean-Pierre; Way, Agathe; Bironneau, Amandine; Mace, Bertrand; Rives, Nathalie] Univ Rouen, Rouen Univ Hosp, Inst Biomed Res, Reprod Biol Lab CECOS,EA Gametogenesis & Gamete Q, Rouen, France; [Wils, Julien] Univ Rouen, Rouen Univ Hosp, Inst Biomed Res, Biochem Lab, Rouen, France	CHU de Rouen; Universite de Rouen Normandie; CHU de Rouen; Universite de Rouen Normandie	Rives, N (corresponding author), Univ Rouen, Rouen Univ Hosp, Inst Biomed Res, Reprod Biol Lab CECOS,EA Gametogenesis & Gamete Q, Rouen, France.	nathalie.rives@chu-rouen.fr	Dumont, Ludovic/J-9134-2019; Wils, Julien/AAY-3299-2020	Dumont, Ludovic/0000-0001-6882-6413; Wils, Julien/0000-0002-6651-0527; Wils, Julien/0000-0002-7394-0322	Conseil Regional de Haute-Normandie; La Ligue Nationale Contre Le Cancer; Rouen University; Grants-in-Aid for Scientific Research [26713012] Funding Source: KAKEN	Conseil Regional de Haute-Normandie(Region Normandie); La Ligue Nationale Contre Le Cancer(Ligue nationale contre le cancer); Rouen University; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	Brahim Arkoun's work was supported by a grant from Conseil Regional de Haute-Normandie. "La Ligue Nationale Contre Le Cancer" and Rouen University (www.univ-rouen.fr) has provided funding for reagents and consumables. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abel MH, 2008, ENDOCRINOLOGY, V149, P3279, DOI 10.1210/en.2008-0086; Abu Elhija M, 2012, ASIAN J ANDROL, V14, P285, DOI 10.1038/aja.2011.112; Braun KW, 2000, J BIOL CHEM, V275, P4145, DOI 10.1074/jbc.275.6.4145; Garcia-Gonzalo FR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001384; Gassei K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053976; Gohbara A, 2010, BIOL REPROD, V83, P261, DOI 10.1095/biolreprod.110.083899; Goossens E, 2013, HUM REPROD, V28, P897, DOI 10.1093/humrep/det039; Hogarth CA, 2010, J CLIN INVEST, V120, P956, DOI 10.1172/JCI41303; Kanatsu-Shinohara M, 2003, BIOL REPROD, V68, P167, DOI 10.1095/biolreprod.102.008516; Kanatsu-Shinohara M, 2003, BIOL REPROD, V69, P612, DOI 10.1095/biolreprod.103.017012; Kubota H, 2004, P NATL ACAD SCI USA, V101, P16489, DOI 10.1073/pnas.0407063101; Li H, 2011, BIOL REPROD, V84, P336, DOI 10.1095/biolreprod.110.086157; Livera G, 2000, BIOL REPROD, V62, P1303, DOI 10.1095/biolreprod62.5.1303; Livera G, 2002, REPRODUCTION, V124, P173, DOI 10.1530/rep.0.1240173; McLean DJ, 2003, BIOL REPROD, V69, P2085, DOI 10.1095/biolreprod.103.017020; Milazzo JP, 2008, HUM REPROD, V23, P17, DOI 10.1093/humrep/dem355; Nagano M, 1998, TISSUE CELL, V30, P389, DOI 10.1016/S0040-8166(98)80053-0; O'Shaughnessy PJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035136; O'Shaughnessy PJ, 2002, J CELL SCI, V115, P3491; Raverdeau M, 2012, P NATL ACAD SCI USA, V109, P16582, DOI 10.1073/pnas.1214936109; Sato T, 2011, NATURE, V471, P504, DOI 10.1038/nature09850; Song H. -W., 2012, SPERMATOGENESIS, V2, P238, DOI [10.4161/spmg.22069, DOI 10.4161/SPMG.22069]; Stukenborg JB, 2009, MOL HUM REPROD, V15, P521, DOI 10.1093/molehr/gap052; Travers A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082819; Valli H, 2014, FERTIL STERIL, V101, P3, DOI 10.1016/j.fertnstert.2013.10.052; VANPELT AMM, 1991, ENDOCRINOLOGY, V128, P697, DOI 10.1210/endo-128-2-697; VANPELT AMM, 1990, BIOL REPROD, V43, P363, DOI 10.1095/biolreprod43.3.363; VANPELT AMM, 1990, BIOL REPROD, V42, P677, DOI 10.1095/biolreprod42.4.677; Verhoeven G, 2010, PHILOS T R SOC B, V365, P1537, DOI 10.1098/rstb.2009.0117; Vernet N, 2006, ENDOCRINOLOGY, V147, P96, DOI 10.1210/en.2005-0953; Wyns C, 2011, HUM REPROD, V26, P737, DOI 10.1093/humrep/deq387; Yang QE, 2014, CURR TOP DEV BIOL, V107, P235, DOI 10.1016/B978-0-12-416022-4.00009-3; Zhang SS, 2011, J CELL BIOCHEM, V112, P1009, DOI 10.1002/jcb.23029; Zhou Q, 2008, BIOL REPROD, V79, P35, DOI 10.1095/biolreprod.107.066795; Zhou Q, 2008, BIOL REPROD, V78, P537, DOI 10.1095/biolreprod.107.064337	35	45	45	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2015	10	2							e0116660	10.1371/journal.pone.0116660	http://dx.doi.org/10.1371/journal.pone.0116660			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC2IM	25714609	Green Submitted, Green Published, gold			2022-12-27	WOS:000350168700021
J	Carroll, JE; Irwin, MR; Merkin, SS; Seeman, TE				Carroll, Judith E.; Irwin, Michael R.; Merkin, Sharon Stein; Seeman, Teresa E.			Sleep and Multisystem Biological Risk: A Population-Based Study	PLOS ONE			English	Article							ALL-CAUSE MORTALITY; SCALE CES-D; ALLOSTATIC LOAD; CARDIOVASCULAR-DISEASE; GLUCOSE-METABOLISM; INSULIN-RESISTANCE; BLOOD-PRESSURE; LEPTIN LEVELS; OLDER-ADULTS; LONG-SLEEP	Background Short sleep and poor sleep quality are associated with risk of cardiovascular disease, diabetes, cancer, and mortality. This study examines the contribution of sleep duration and sleep quality on a multisystem biological risk index that is known to be associated with morbidity and mortality. Methods Analyses include a population-based sample from the Midlife Development in the United States survey recruited to the Biomarker substudy. A total of 1,023 participants aged 54.5 years (SD = 11.8), 56% female and 77.6% white, were included in the analyses. A multisystem biological risk index was derived from 22 biomarkers capturing cardiovascular, immune, lipid-metabolic, glucose-metabolic, sympathetic, parasympathetic, and hypothalamic-pituitary-adrenal systems. Self-reported average sleep duration was categorized as short (<5 hrs), below normal (5 to <6.5 hrs), normal (6.5 to <8.5 hrs), and long sleepers (8.5+ hrs). Sleep quality was determined using the Pittsburgh Sleep Quality Index categorized as normal (<= 5) and poor quality (>5) sleep. Findings Linear mixed effect models adjusting for age, gender, race, education, income, BMI, and health status were performed. As compared to normal sleepers, multisystem biological risk in both short (B(SE) = .38(.15), p<.01) and long sleepers (B(SE) = .28(.11), p<.01) were elevated. Poor quality sleep alone was associated with elevated multisystem biological risk (B(SE) = .15(.06), p = .01), but was not significant after adjustment for health status. All short sleepers reported poor sleep quality. However in the long sleepers, only those who reported poor sleep quality exhibited elevated multisystem biological risk (B(SE) = .93(.3), p = .002). Conclusions Self-reported poor sleep quality with either short or long sleep duration is associated with dysregulation in physiological set points across regulatory systems, leading to elevated multisystem biological risk. Physicians should inquire about sleep health in the assessment of lifestyle factors related to disease risk, with evidence that healthy sleep is associated with lower multisystem biological risk.	[Carroll, Judith E.; Irwin, Michael R.] Univ Calif Los Angeles, David Geffen Sch Med, Semel Inst Neurosci & Human Behav, Cousins Ctr Psychoneuroimmunol, Los Angeles, CA 90095 USA; [Merkin, Sharon Stein; Seeman, Teresa E.] Univ Calif Los Angeles, David Geffen Sch Med, Div Geriatr, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Carroll, JE (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Semel Inst Neurosci & Human Behav, Cousins Ctr Psychoneuroimmunol, Los Angeles, CA 90095 USA.	jcarroll@mednet.ucla.edu	Irwin, Michael R./H-4870-2013; Carroll, Judith/I-3331-2013	Irwin, Michael R./0000-0002-1502-8431; Carroll, Judith/0000-0001-5516-0819	John D. and Catherine T. MacArthur Foundation Research Network; National Institute on Aging [P01-AG020166]; General Clinical Research Centers Program [M01-RR023942, M01-RR00865]; Clinical and Translational Science Award (CTSA) program of the National Center for Research Resources, National Institutes of Health [1UL1RR025011]; American Sleep Medicine Foundation Bridge; UCLA CTSI [UL1TR000124]; Cousins Center for Psychoneuroimmunology, UCLA;  [K01-AG044462];  [T32-MH19925];  [R01-AG034588];  [R01-AG026364];  [R01 CA160245-01];  [R01-CA119159];  [R01 HL095799];  [R01 DA032922-01];  [P30-AG028748]; NATIONAL CANCER INSTITUTE [R01CA160245, R01CA119159] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000124] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025011, M01RR000865, M01RR023942] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL095799] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [T32MH019925] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG034588, K01AG044462, R01AG026364, P01AG020166, P30AG028748] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA032922] Funding Source: NIH RePORTER	John D. and Catherine T. MacArthur Foundation Research Network; National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); General Clinical Research Centers Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Clinical and Translational Science Award (CTSA) program of the National Center for Research Resources, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); American Sleep Medicine Foundation Bridge; UCLA CTSI; Cousins Center for Psychoneuroimmunology, UCLA; ; ; ; ; ; ; ; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	The MIDUS I study (Midlife Development in the U.S.) was supported by the John D. and Catherine T. MacArthur Foundation Research Network on Successful Midlife Development (http://midmac.med.harvard.edu/research.html). The MIDUS II research was supported by a grant from the National Institute on Aging (P01-AG020166; www.nia.nih.gov) to conduct a longitudinal follow-up of the MIDUS I investigation. The Biomarker study was further supported by the following grants M01-RR023942 (Georgetown), M01-RR00865 (UCLA) from the General Clinical Research Centers Program and 1UL1RR025011 (UW) from the Clinical and Translational Science Award (CTSA) program of the National Center for Research Resources, National Institutes of Health (www.nih.gov). The manuscript preparation was supported by grant K01-AG044462; T32-MH19925 (www.nimh.nih.gov); the American Sleep Medicine Foundation Bridge to K Award (JEC; http://www.discoversleep.org/). Additional support provided by R01-AG034588; R01-AG026364; R01 CA160245-01; R01-CA119159; R01 HL095799; R01 DA032922-01; P30-AG028748 to MRI (www.drugabuse.gov; www.cancer.gov; www.nhlbi.nih.gov); and UCLA CTSI UL1TR000124 (www.ctsi.ucla.edu/) and the Cousins Center for Psychoneuroimmunology, UCLA for both JEC and MRI (http://www.semel.ucla.edu/cousins). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beekman ATF, 1997, PSYCHOL MED, V27, P231, DOI 10.1017/S0033291796003510; Bin YS, 2013, AM J EPIDEMIOL, V177, P826, DOI 10.1093/aje/kws308; Brim OG, 2004, MAC FDN MEN, P1; Broussard JL, 2012, ANN INTERN MED, V157, P549, DOI 10.7326/0003-4819-157-8-201210160-00005; Buysse DJ, 2014, SLEEP, V37, P9, DOI 10.5665/sleep.3298; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4; Cappuccio FP, 2008, SLEEP, V31, P619, DOI 10.1093/sleep/31.5.619; Cappuccio FP, 2011, EUR HEART J, V32, P1484, DOI 10.1093/eurheartj/ehr007; Cappuccio FP, 2010, SLEEP, V33, P585, DOI 10.1093/sleep/33.5.585; Cappuccio FP, 2010, DIABETES CARE, V33, P414, DOI 10.2337/dc09-1124; Carrington MJ, 2008, SLEEP, V31, P1701, DOI 10.1093/sleep/31.12.1701; Carroll JE, 2013, P NATL ACAD SCI USA, V110, P17149, DOI 10.1073/pnas.1315458110; Center for Disease Control, 2011, CDC DAT STAT FEAT IN, V8; Chen E, 2012, PSYCHOSOM MED, V74, P178, DOI 10.1097/PSY.0b013e31824206fd; Chen XL, 2014, ANN EPIDEMIOL, V24, P612, DOI 10.1016/j.annepidem.2014.05.014; Chung HY, 2009, AGEING RES REV, V8, P18, DOI 10.1016/j.arr.2008.07.002; Clark AJ, 2014, SLEEP MED, V15, P1571, DOI 10.1016/j.sleep.2014.07.013; Colten HR, 2006, SLEEP DISORDERS SLEE; Dokken B.B, 2008, DIABETES SPECTR, V21, P160, DOI [10.2337/diaspect.21.3.160, DOI 10.2337/DIASPECT.21.3.160]; Ekstedt M, 2004, PSYCHOSOM MED, V66, P925, DOI 10.1097/01.psy.0000145821.25453.f7; Franceschi C., 2014, J GERONTOL A BIOL S1, V69, P4, DOI [DOI 10.1093/GER0NA/GLU057, 10.1093/gerona/glu057, DOI 10.1093/GERONA/GLU057]; Gonnissen HKJ, 2013, BRIT J NUTR, V109, P748, DOI 10.1017/S0007114512001894; Gottlieb DJ, 2006, SLEEP, V29, P1009, DOI 10.1093/sleep/29.8.1009; Grandner MA, 2007, SLEEP MED REV, V11, P341, DOI 10.1016/j.smrv.2007.03.010; Gruenewald TL, 2006, P NATL ACAD SCI USA, V103, P14158, DOI 10.1073/pnas.0606215103; Gruenewald TL, 2012, SOC SCI MED, V74, P75, DOI 10.1016/j.socscimed.2011.09.037; Gruenewald TL, 2009, J AM GERIATR SOC, V57, P1525, DOI 10.1111/j.1532-5415.2009.02389.x; Harrell FE, 2001, REGRESSION MODELING; Irwin MR, 2008, BIOL PSYCHIAT, V64, P538, DOI 10.1016/j.biopsych.2008.05.004; Irwin MR, 2006, ARCH INTERN MED, V166, P1756, DOI 10.1001/archinte.166.16.1756; Irwin MR, 2005, HYPERTENSION, V45, P252, DOI 10.1161/01.HYP.0000153517.44295.07; Irwin MR, 2006, HEALTH PSYCHOL, V25, P3, DOI 10.1037/0278-6133.25.1.3; Irwin MR, 2014, ANNU REV PSYCHOL, P1; Ju SY, 2013, NUTR DIABETES, V3, DOI 10.1038/nutd.2013.8; Karlamangla AS, 2006, PSYCHOSOM MED, V68, P500, DOI 10.1097/01.psy.0000221270.93985.82; Knutson KL, 2009, ARCH INTERN MED, V169, P1055, DOI 10.1001/archinternmed.2009.119; Laugsand LE, 2011, CIRCULATION, V124, P2073, DOI 10.1161/CIRCULATIONAHA.111.025858; Lewinsohn PM, 1997, PSYCHOL AGING, V12, P277, DOI 10.1037/0882-7974.12.2.277; Libby P, 2005, CIRCULATION, V111, P3481, DOI 10.1161/CIRCULATIONAHA.105.537878; Love GD, 2010, J AGING HEALTH, V22, P1059, DOI 10.1177/0898264310374355; McEwen BS, 2006, METABOLISM, V55, pS20, DOI 10.1016/j.metabol.2006.07.008; McEwen BS, 1999, ANN NY ACAD SCI, V896, P30, DOI 10.1111/j.1749-6632.1999.tb08103.x; Mezick EJ, 2014, PSYCHOPHYSIOLOGY, V51, P88, DOI 10.1111/psyp.12144; Mezick EJ, 2011, SLEEP MED REV, V15, P51, DOI 10.1016/j.smrv.2010.03.001; Miller M, 2011, CIRCULATION, V123, P2292, DOI 10.1161/CIR.0b013e3182160726; Motivala SJ, 2011, ANN BEHAV MED, V42, P141, DOI 10.1007/s12160-011-9280-2; Muenter NK, 2000, J APPL PHYSIOL, V88, P966, DOI 10.1152/jappl.2000.88.3.966; Mullington JM, 2009, PROG CARDIOVASC DIS, V51, P294, DOI 10.1016/j.pcad.2008.10.003; Nedeltcheva AV, 2009, J CLIN ENDOCR METAB, V94, P3242, DOI 10.1210/jc.2009-0483; Nicholson A, 2006, EUR HEART J, V27, P2763, DOI 10.1093/eurheartj/ehl338; Okun ML, 2009, BRAIN BEHAV IMMUN, V23, P351, DOI 10.1016/j.bbi.2008.10.008; Omisade A, 2010, PHYSIOL BEHAV, V99, P651, DOI 10.1016/j.physbeh.2010.01.028; Palagini L, 2013, CURR PHARM DESIGN, V19, P2409, DOI 10.2174/1381612811319130009; Pejovic S, 2013, AM J PHYSIOL-ENDOC M, V305, pE890, DOI 10.1152/ajpendo.00301.2013; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Redwine L, 2000, J CLIN ENDOCR METAB, V85, P3597, DOI 10.1210/jc.85.10.3597; Reutrakul S, 2014, ANN NY ACAD SCI, V1311, P151, DOI 10.1111/nyas.12355; Robles TF, 2011, SOC PERSONAL PSYCHOL, V5, P518, DOI 10.1111/j.1751-9004.2011.00368.x; Rod NH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091965; Schulkin J, 2012, ALLOSTASIS HOMEOSTAS; Seeman TE, 1997, ARCH INTERN MED, V157, P2259; Seeman T, 2010, AM J HUM BIOL, V22, P463, DOI 10.1002/ajhb.21018; Seshasai SRK, 2011, NEW ENGL J MED, V364, P829, DOI 10.1056/NEJMoa1008862; Spiegel K, 2005, J APPL PHYSIOL, V99, P2008, DOI 10.1152/japplphysiol.00660.2005; Spiegel K, 1999, LANCET, V354, P1435, DOI 10.1016/S0140-6736(99)01376-8; Spiegel K, 2004, J CLIN ENDOCR METAB, V89, P5762, DOI 10.1210/jc.2004-1003; Stamatakis KA, 2010, CHEST, V137, P95, DOI 10.1378/chest.09-0791; Stranges S, 2008, AM J EPIDEMIOL, V168, P1353, DOI 10.1093/aje/kwn337; Suzuki E, 2009, PREV MED, V49, P135, DOI 10.1016/j.ypmed.2009.06.016; Thorsley D, 2012, AM J PHYSIOL-ENDOC M, V303, pE1190, DOI 10.1152/ajpendo.00271.2012; Troxel WM, 2010, SLEEP, V33, P1633, DOI 10.1093/sleep/33.12.1633; Van Cauter E, 2007, HORM RES, V67, P2, DOI 10.1159/000097543; Vgontzas AN, 2013, SLEEP MED CLIN, V8, P309, DOI 10.1016/j.jsmc.2013.04.009; Vgontzas AN, 2010, SLEEP, V33, P1159, DOI 10.1093/sleep/33.9.1159; Vgontzas AN, 2009, DIABETES CARE, V32, P1980, DOI 10.2337/dc09-0284; Vgontzas AN, 2009, SLEEP, V32, P491, DOI 10.1093/sleep/32.4.491; Vgontzas AN, 2004, J CLIN ENDOCR METAB, V89, P2119, DOI 10.1210/jc.2003-031562; vonTreuer K, 1996, J PINEAL RES, V20, P7; Youngstedt SD, 2004, SLEEP MED REV, V8, P159, DOI 10.1016/j.smrv.2003.10.002	79	56	56	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2015	10	2							e0118467	10.1371/journal.pone.0118467	http://dx.doi.org/10.1371/journal.pone.0118467			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC2IM	25714703	gold, Green Submitted, Green Published			2022-12-27	WOS:000350168700076
J	Hsu, WC; Wang, TL; Lin, YJ; Hsieh, LF; Tsai, CM; Huang, KH				Hsu, Wei-Chun; Wang, Tao-Liang; Lin, Yi-Jia; Hsieh, Lin-Fen; Tsai, Chun-Mei; Huang, Kuang-Hui			Addition of Lidocaine Injection Immediately before Physiotherapy for Frozen Shoulder: A Randomized Controlled Trial	PLOS ONE			English	Article							PAINFUL STIFF SHOULDER; ADHESIVE CAPSULITIS; CORTICOSTEROID INJECTION; PHYSICAL-THERAPY; MANIPULATION; QUESTIONNAIRES; INTERVENTIONS; DISTENSION; ANESTHESIA; OUTCOMES	The intraarticular injection of lidocaine immediately before a physiotherapy session may relieve pain during the stretching and mobilization of the affected joint in patients with a frozen shoulder, thus enhancing the treatment effect. To compare the effects of intraarticular injection of lidocaine plus physiotherapy to that of physiotherapy alone in the treatment of a frozen shoulder, a prospective randomized controlled trial was conducted in the rehabilitation department of a private teaching hospital. Patients with a frozen shoulder were randomized into the physiotherapy group or the lidocaine injection plus physiotherapy (INJPT) group. The subjects in the INJPT group underwent injection of 3 ml of 1% lidocaine into the affected shoulder 10 to 20 minutes before each physiotherapy session. In each group, the treatment lasted 3 months. The primary outcome measures were the active and passive range of motion of the affected shoulder. The secondary outcome measures were the results of the Shoulder Disability Questionnaire, the Shoulder Pain and Disability Index, and the 36-item Short-Form Health Survey (SF-36). The outcome measures were evaluated before treatment and 1, 2, 3, 4, and 6 months after the start of treatment. The group comparisons showed significantly greater improvement in the INJPT group, mainly in active and passive shoulder range of motion in flexion and external rotation and improvements in pain and disability (P < 0.05); however, no significant group difference was seen in the SF-36 results. The intraarticular injection of lidocaine immediately before a physiotherapy session might be superior to physiotherapy alone in the treatment of a frozen shoulder.	[Hsu, Wei-Chun; Lin, Yi-Jia] Natl Taiwan Univ Sci & Technol, Grad Inst Biomed Engn, Taipei, Taiwan; [Wang, Tao-Liang] Somategr Clin, Taipei, Taiwan; [Hsieh, Lin-Fen; Tsai, Chun-Mei; Huang, Kuang-Hui] Shin Kong Wu Ho Su Mem Hosp, Dept Phys Med & Rehabil, Taipei, Taiwan; [Hsieh, Lin-Fen] Fu Jen Catholic Univ, Sch Med, New Taipei City, Taiwan; [Hsu, Wei-Chun] Natl Def Med Ctr, Taipei, Taiwan; [Hsu, Wei-Chun; Lin, Yi-Jia] Natl Taipei Univ Technol, Taipei 106, Taiwan	National Taiwan University of Science & Technology; Shin Kong Wu Ho Su Memorial Hospital; Fu Jen Catholic University; National Defense Medical Center; National Taipei University of Technology	Hsieh, LF (corresponding author), Shin Kong Wu Ho Su Mem Hosp, Dept Phys Med & Rehabil, Taipei, Taiwan.	M001026@ms.skh.org.tw			Shin Kong Wu Ho-Su Memorial Hospital	Shin Kong Wu Ho-Su Memorial Hospital	The authors would like to acknowledge the financial support provided by the Shin Kong Wu Ho-Su Memorial Hospital. No commercial party having a direct financial interest in the results of the research supporting this article has or will confer a benefit on the authors or on any organization with which the authors are associated. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arslan S, 2001, RHEUMATOL INT, V21, P20; Bal A, 2008, CLIN REHABIL, V22, P503, DOI 10.1177/0269215508086179; Bertoft ES, 1999, CRIT REV PHYS REHABI, V11, P229; Bot SDM, 2004, ANN RHEUM DIS, V63, P335, DOI 10.1136/ard.2003.007724; Buchbinder R, 2004, ANN RHEUM DIS, V63, P302, DOI 10.1136/ard.2002.004655; Carette S, 2003, ARTHRITIS RHEUM, V48, P829, DOI 10.1002/art.10954; Castellarin G, 2004, ARCH PHYS MED REHAB, V85, P1236, DOI 10.1016/j.apmr.2003.12.032; Celik D, 2010, ACTA ORTHOP TRAUMATO, V44, P285, DOI 10.3944/AOTT.2010.2367; Clement RGE, 2013, ACTA ORTHOP BELG, V79, P368; Dias R, 2005, BMJ-BRIT MED J, V331, P1453, DOI 10.1136/bmj.331.7530.1453; Diercks RL, 2004, J SHOULDER ELB SURG, V13, P499, DOI 10.1016/j.jse.2004.03.002; Diwan DB, 2005, ARTHROSCOPY, V21, P1105, DOI 10.1016/j.arthro.2005.05.014; Dragoo JL, 2012, AM J SPORT MED, V40, P794, DOI 10.1177/0363546511434571; Favejee MM, 2011, BRIT J SPORT MED, V45, P49, DOI 10.1136/bjsm.2010.071431; Green S, 1998, BRIT MED J, V316, P354, DOI 10.1136/bmj.316.7128.354; Griggs SM, 2000, J BONE JOINT SURG AM, V82A, P1398, DOI 10.2106/00004623-200010000-00005; Hannafin JA, 2000, CLIN ORTHOP RELAT R, P95; Hsieh LF, 2013, MED SCI SPORT EXER, V45, P2205, DOI 10.1249/MSS.0b013e31829b183c; Hsieh LF, 2012, ARCH PHYS MED REHAB, V93, P957, DOI 10.1016/j.apmr.2012.01.021; JACOBS LGH, 1991, BRIT MED J, V302, P1498, DOI 10.1136/bmj.302.6791.1498; Kiyimaki J, 2007, J SHOULDER ELB SURG, V16, P722, DOI 10.1016/j.jse.2007.02.125; Matsen FA, 2013, J BONE JOINT SURG AM, V95A, P1126, DOI [10.2106/JBJS.L.01104, 10.2106/JBJS.L.01733]; Moskowitz Roland W, 2005, Am J Orthop (Belle Mead NJ), V34, P10; Neviaser AS, 2010, AM J SPORT MED, V38, P2346, DOI 10.1177/0363546509348048; Ng CY, 2012, SHOULDER ELBOW, V4, P95; PAL B, 1986, BRIT J RHEUMATOL, V25, P147; Paul A, 2004, ANN RHEUM DIS, V63, P1293, DOI 10.1136/ard.2003.012088; RIDDLE DL, 1987, PHYS THER, V67, P668, DOI 10.1093/ptj/67.5.668; RIZK TE, 1991, ARCH PHYS MED REHAB, V72, P20; Saunders S, 2012, INJECTION TECHNIQUES; Sokk J, 2013, ORTHOP TRAUMATOL-SUR, V99, P699, DOI 10.1016/j.otsr.2013.04.008; Tasto JP, 2007, SPORTS MED ARTHROSC, V15, P216, DOI 10.1097/JSA.0b013e3181595c22; van der Windt DAWM, 1998, BRIT MED J, V317, P1292, DOI 10.1136/bmj.317.7168.1292; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; WILEY A M, 1991, Arthroscopy, V7, P138, DOI 10.1016/0749-8063(91)90098-I; Winters JC, 1997, BRIT MED J, V314, P1320, DOI 10.1136/bmj.314.7090.1320	36	8	8	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2015	10	2							e0118217	10.1371/journal.pone.0118217	http://dx.doi.org/10.1371/journal.pone.0118217			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC2IM	25714415	Green Published, gold, Green Submitted			2022-12-27	WOS:000350168700056
J	Braun, FK; Mathur, R; Sehgal, L; Wilkie-Grantham, R; Chandra, J; Berkova, Z; Samaniego, F				Braun, Frank K.; Mathur, Rohit; Sehgal, Lalit; Wilkie-Grantham, Rachel; Chandra, Joya; Berkova, Zuzana; Samaniego, Felipe			Inhibition of Methyltransferases Accelerates Degradation of cFLIP and Sensitizes B-Cell Lymphoma Cells to TRAIL-Induced Apoptosis	PLOS ONE			English	Article							C-FLIP; DEATH RECEPTORS; KAPPA-B; CANCER; METHYLATION; TARGETS; EZH2; REGULATORS; RITUXIMAB; MICRORNAS	Non-Hodgkin lymphomas (NHLs) are characterized by specific abnormalities that alter cell cycle regulation, DNA damage response, and apoptotic signaling. It is believed that cancer cells are particularly sensitive to cell death induced by tumor necrosis factor alpha-related apoptosis-inducing ligand (TRAIL). However, many cancer cells show blocked TRAIL signaling due to up-regulated expression of anti-apoptotic factors, such as cFLIP. This hurdle to TRAIL's tumor cytotoxicity might be overcome by combining TRAIL-based therapy with drugs that reverse blockages of its apoptotic signaling. In this study, we investigated the impact of a pan-methyltransferase inhibitor (3-deazaneplanocin A, or DZNep) on TRAIL-induced apoptosis in aggressive B-cell NHLs: mantle cell, Burkitt, and diffuse large B-cell lymphomas. We characterized TRAIL apoptosis regulation and caspase activation in several NHL-derived cell lines pre-treated with DZNep. We found that DZNep increased cancer cell sensitivity to TRAIL signaling by promoting caspase-8 processing through accelerated cFLIP degradation. No change in cFLIP mRNA level indicated independence of promoter methylation alterations in methyltransferase activity induced by DZNep profoundly affected cFLIP mRNA stability and protein stability. This appears to be in part through increased levels of cFLIP-targeting microRNAs (miR-512-3p and miR-346). However, additional microRNAs and cFLIP-regulating mechanisms appear to be involved in DZNep-mediated enhanced response to extrinsic apoptotic stimuli. The capacity of DZNep to target cFLIP expression on multiple levels underscores DZNep's potential in TRAIL-based therapies for B-cell NHLs.	[Braun, Frank K.; Mathur, Rohit; Sehgal, Lalit; Berkova, Zuzana; Samaniego, Felipe] Univ Texas MD Anderson Canc Ctr, Dept Lymphoma & Myeloma, Houston, TX 77030 USA; [Chandra, Joya] Univ Texas MD Anderson Canc Ctr, Dept Pediat, Houston, TX 77030 USA; [Wilkie-Grantham, Rachel] Sanford Burnham Med Res Inst, La Jolla, CA USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; Sanford Burnham Prebys Medical Discovery Institute	Samaniego, F (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Lymphoma & Myeloma, Houston, TX 77030 USA.	fsamaniego@mdanderson.org	Chandra, Joya/ABC-7869-2021; Berkova, Zuzana/E-9010-2018	Chandra, Joya/0000-0002-2077-9715; Berkova, Zuzana/0000-0001-8196-6517; Mathur, Rohit/0000-0001-5453-3353; Sehgal, lalit/0000-0002-1151-5427	Richard Spencer Lewis Memorial Foundation; NATIONAL CANCER INSTITUTE [P30CA016672] Funding Source: NIH RePORTER	Richard Spencer Lewis Memorial Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Dr. Elsa Flores, MD Anderson Cancer Center, for supplying constructs encoding for shRNA against DICER. This work was supported in part by the Richard Spencer Lewis Memorial Foundation and patients' families.	Al-Yacoub N, 2012, J INVEST DERMATOL, V132, P2263, DOI 10.1038/jid.2012.125; Antonov AV, 2014, ONCOGENE, V33, P1621, DOI 10.1038/onc.2013.119; Antonov AV, 2011, NUCLEIC ACIDS RES, V39, pW323, DOI 10.1093/nar/gkr372; Ashkenazi A, 2008, J CLIN ONCOL, V26, P3621, DOI 10.1200/JCO.2007.15.7198; Ashkenazi A, 2008, J CLIN INVEST, V118, P1979, DOI 10.1172/JCI34359; Basso K, 2005, NAT GENET, V37, P382, DOI 10.1038/ng1532; Bracken AP, 2003, EMBO J, V22, P5323, DOI 10.1093/emboj/cdg542; Cardesa-Salzmann TM, 2011, HAEMATOL-HEMATOL J, V96, P996, DOI 10.3324/haematol.2010.037408; Chase A, 2011, CLIN CANCER RES, V17, P2613, DOI 10.1158/1078-0432.CCR-10-2156; Chen F, 2010, ONCOL REP, V23, P1457, DOI 10.3892/or_00000784; Dawson MA, 2012, CELL, V150, P12, DOI 10.1016/j.cell.2012.06.013; de Wilt LHAM, 2013, CRIT REV ONCOL HEMAT, V85, P363, DOI 10.1016/j.critrevonc.2012.08.001; DiDonato JA, 2012, IMMUNOL REV, V246, P379, DOI 10.1111/j.1600-065X.2012.01099.x; Fiskus W, 2012, CLIN CANCER RES, V18, P6227, DOI 10.1158/1078-0432.CCR-12-0873; Garofalo M, 2010, CELL DEATH DIFFER, V17, P200, DOI 10.1038/cdd.2009.105; Garofalo M, 2014, CURR PHARM DESIGN, V20, P5328, DOI 10.2174/1381612820666140128211346; God JM, 2010, J ONCOL, V2010, P1; Gonzalvez F, 2010, ONCOGENE, V29, P4752, DOI 10.1038/onc.2010.221; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Howlader N, 2014, SEER CANCER STATISTI; Huang J, 2007, NATURE, V449, P105, DOI 10.1038/nature06092; Issa JPJ, 2009, CLIN CANCER RES, V15, P3938, DOI 10.1158/1078-0432.CCR-08-2783; Jakopovic M, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00261; Lavrik IN, 2012, CELL DEATH DIFFER, V19, P36, DOI 10.1038/cdd.2011.155; Lenz G, 2008, NEW ENGL J MED, V359, P2313, DOI 10.1056/NEJMoa0802885; Mair B, 2014, TRENDS PHARMACOL SCI, V35, P136, DOI 10.1016/j.tips.2014.01.001; Margueron R, 2011, NATURE, V469, P343, DOI 10.1038/nature09784; McCabe MT, 2012, NATURE, V492, P108, DOI 10.1038/nature11606; Menon MP, 2012, CANCER J, V18, P411, DOI 10.1097/PPO.0b013e31826aee97; Micheau O, 2013, BRIT J PHARMACOL, V169, P1723, DOI 10.1111/bph.12238; Miranda TB, 2009, MOL CANCER THER, V8, P1579, DOI 10.1158/1535-7163.MCT-09-0013; Morey L, 2010, TRENDS BIOCHEM SCI, V35, P323, DOI 10.1016/j.tibs.2010.02.009; Murphy TM, 2011, PROSTATE, V71, P1, DOI 10.1002/pros.21212; Nilsen TW, 2014, SCIENCE, V343, P1207, DOI 10.1126/science.1249340; Reed JC, 2005, BLOOD, V106, P408, DOI 10.1182/blood-2004-07-2761; Riccardi C, 2006, NAT PROTOC, V1, P1458, DOI 10.1038/nprot.2006.238; Roue G, 2007, J IMMUNOL, V178, P1923, DOI 10.4049/jimmunol.178.3.1923; Ruan J, 2009, ONCOLOGY-NY, V23, P683; Ryan RJH, 2012, SCIENCE, V336, P1513, DOI 10.1126/science.1223730; Safa A. R., 2012, Experimental Oncology, V34, P176; Sehgal L, 2014, LEUKEMIA, V28, P2376, DOI 10.1038/leu.2014.126; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208; Srikantan S, 2012, CURR PROTEIN PEPT SC, V13, P372, DOI 10.2174/138920312801619394; Takawa M, 2011, CANCER SCI, V102, P1298, DOI 10.1111/j.1349-7006.2011.01958.x; Van Rechem C, 2014, BBA-GENE REGUL MECH, V1839, P1463, DOI 10.1016/j.bbagrm.2014.05.014; Vecchio L, 2013, BBA-REV CANCER, V1836, P90, DOI 10.1016/j.bbcan.2013.04.001; Wang J, 2013, INT J ORAL MAX SURG, V42, P949, DOI 10.1016/j.ijom.2013.04.016; Wang X, 2014, NATURE, V505, P117, DOI 10.1038/nature12730; Wee S, 2014, ANN NY ACAD SCI, V1309, P30, DOI 10.1111/nyas.12356; Wermann H, 2010, J PATHOL, V221, P433, DOI 10.1002/path.2725; Wilkie-Grantham RP, 2013, J BIOL CHEM, V288, P12777, DOI 10.1074/jbc.M112.431320; Wilson WH, 2012, HAEMATOL-HEMATOL J, V97, P758, DOI 10.3324/haematol.2011.056531; Xiao YT, 2011, INT J BIOCHEM CELL B, V43, P474, DOI 10.1016/j.biocel.2011.01.005; Yang XD, 2009, EPIGENETICS-US, V4, P429, DOI 10.4161/epi.4.7.9787; Yang XJ, 2010, TRENDS PHARMACOL SCI, V31, P536, DOI 10.1016/j.tips.2010.08.001; Younes A, 2011, NAT REV CLIN ONCOL, V8, P124, DOI 10.1038/nrclinonc.2011.20; Zhang K, 2005, J CELL BIOCHEM, V96, P1137, DOI 10.1002/jcb.20615; Zhang L, 2012, NATURE, V481, P204, DOI 10.1038/nature10690; Zhang X, 2012, ACTA BIOCH BIOPH SIN, V44, P14, DOI 10.1093/abbs/gmr100; Zhou JB, 2011, BLOOD, V118, P2830, DOI 10.1182/blood-2010-07-294827; Zoabi M, 2011, BIOCHEM BIOPH RES CO, V408, P393, DOI 10.1016/j.bbrc.2011.04.025	61	16	19	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2015	10	3							e0117994	10.1371/journal.pone.0117994	http://dx.doi.org/10.1371/journal.pone.0117994			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9JM	25738497	gold, Green Published, Green Submitted			2022-12-27	WOS:000350685900020
J	Li, W; Yu, J; Lian, BF; Sun, H; Li, J; Zhang, MH; Li, L; Li, YX; Liu, Q; Xie, L				Li, Wei; Yu, Jian; Lian, Baofeng; Sun, Han; Li, Jing; Zhang, Menghuan; Li, Ling; Li, Yixue; Liu, Qian; Xie, Lu			Identifying Prognostic Features by Bottom-Up Approach and Correlating to Drug Repositioning	PLOS ONE			English	Article							ACTIVATED RECEPTOR-GAMMA; HEPATOCELLULAR-CARCINOMA; GENE-EXPRESSION; STAGING-SYSTEM; SURVIVAL; METASTASIS; INHIBITION; SIGNATURE; SCORE; HEPATOCARCINOGENESIS	Background Traditionally top-down method was used to identify prognostic features in cancer research. That is to say, differentially expressed genes usually in cancer versus normal were identified to see if they possess survival prediction power. The problem is that prognostic features identified from one set of patient samples can rarely be transferred to other datasets. We apply bottom-up approach in this study: survival correlated or clinical stage correlated genes were selected first and prioritized by their network topology additionally, then a small set of features can be used as a prognostic signature. Methods Gene expression profiles of a cohort of 221 hepatocellular carcinoma (HCC) patients were used as a training set, 'bottom-up' approach was applied to discover gene-expression signatures associated with survival in both tumor and adjacent non-tumor tissues, and compared with 'top-down' approach. The results were validated in a second cohort of 82 patients which was used as a testing set. Results Two sets of gene signatures separately identified in tumor and adjacent non-tumor tissues by bottom-up approach were developed in the training cohort. These two signatures were associated with overall survival times of HCC patients and the robustness of each was validated in the testing set, and each predictive performance was better than gene expression signatures reported previously. Moreover, genes in these two prognosis signature gave some indications for drug-repositioning on HCC. Some approved drugs targeting these markers have the alternative indications on hepatocellular carcinoma. Conclusion Using the bottom-up approach, we have developed two prognostic gene signatures with a limited number of genes that associated with overall survival times of patients with HCC. Furthermore, prognostic markers in these two signatures have the potential to be therapeutic targets.	[Li, Wei; Li, Jing; Liu, Qian] Huazhong Univ Sci & Technol, Coll Life Sci & Technol, Key Lab Biomed Photon, Minist Educ, Wuhan 430074, Peoples R China; [Li, Wei; Yu, Jian; Lian, Baofeng; Sun, Han; Li, Jing; Zhang, Menghuan; Li, Ling; Li, Yixue; Xie, Lu] Shanghai Acad Sci & Technol, Shanghai Inst Biomed, Shanghai Ctr Bioinformat Technol, Shanghai 201203, Peoples R China; [Li, Wei; Li, Jing; Liu, Qian] Huazhong Univ Sci & Technol, Wuhan Natl Lab Optoelect, Britton Chance Ctr Biomed Photon, Wuhan 430074, Peoples R China; [Lian, Baofeng; Zhang, Menghuan; Li, Yixue] Shanghai Jiao Tong Univ, Dept Bioinformat & Biostat, Shanghai 200240, Peoples R China; [Sun, Han; Li, Yixue] Chinese Acad Sci, Key Lab Syst Biol, Shanghai 200031, Peoples R China	Huazhong University of Science & Technology; Chinese Academy of Sciences; Huazhong University of Science & Technology; Shanghai Jiao Tong University; Chinese Academy of Sciences	Liu, Q (corresponding author), Huazhong Univ Sci & Technol, Coll Life Sci & Technol, Key Lab Biomed Photon, Minist Educ, Wuhan 430074, Peoples R China.	qianliu@mail.hust.edu.cn; xielu@scbit.org	liu, qian/HDM-2936-2022; Liu, Qian/D-8184-2011; Qian, Liu/GYU-5886-2022	Liu, Qian/0000-0002-8398-1021; 	Key Infectious Disease Project [2012ZX10002012-014]; National Hi-Tech Program [2012AA020201]; National Key Basic Research Program [2010CB912702]	Key Infectious Disease Project; National Hi-Tech Program; National Key Basic Research Program(National Basic Research Program of China)	his research was supported by the Key Infectious Disease Project (2012ZX10002012-014), http://www.nmp.gov.cn/zxjs/crb/201012/t20101208 2127.htm; National Hi-Tech Program (2012AA020201), http://www.863.gov.cn/0/7/index.htm; National Key Basic Research Program (2010CB912702), http://www.nsfc.gov.cn/nsfc/cen/xmzn/2013xmzn/03/index.html. LX received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armananzas R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062819; Assenov Y, 2008, BIOINFORMATICS, V24, P282, DOI 10.1093/bioinformatics/btm554; Bair E, 2004, PLOS BIOL, V2, P511, DOI 10.1371/journal.pbio.0020108; Bao ZS, 2014, CNS NEUROSCI THER, V20, P112, DOI 10.1111/cns.12171; Barrat A, 2004, P NATL ACAD SCI USA, V101, P3747, DOI 10.1073/pnas.0400087101; Berasain Carmen, 2011, Cancers (Basel), V3, P2444, DOI 10.3390/cancers3022444; Carter SL, 2006, NAT GENET, V38, P1043, DOI 10.1038/ng1861; Cho EJ, 2013, CLIN CANCER RES, V19, P4218, DOI 10.1158/1078-0432.CCR-12-3443; COX DR, 1972, J R STAT SOC B, V34, P187; Dancik GM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085249; Doxsee DW, 2007, PROSTATE, V67, P162, DOI 10.1002/pros.20508; El-Serag HB, 2011, NEW ENGL J MED, V365, P1118, DOI 10.1056/NEJMra1001683; FREEMAN LC, 1977, SOCIOMETRY, V40, P35, DOI 10.2307/3033543; Funao K, 2008, ONCOL REP, V20, P295, DOI 10.3892/or_00000006; Gout PW, 2001, LEUKEMIA, V15, P1633, DOI 10.1038/sj.leu.2402238; Gruden G, 2005, J AM SOC NEPHROL, V16, P688, DOI 10.1681/ASN.2004030251; Hoshida Y, 2008, NEW ENGL J MED, V359, P1995, DOI 10.1056/NEJMoa0804525; Hwang S, 2008, J THEOR BIOL, V252, P722, DOI 10.1016/j.jtbi.2008.02.011; Kim SM, 2012, HEPATOLOGY, V55, P1443, DOI 10.1002/hep.24813; Knox C, 2011, NUCLEIC ACIDS RES, V39, pD1035, DOI 10.1093/nar/gkq1126; Kohavi R., 1995, IJCAI-95. Proceedings of the Fourteenth International Joint Conference on Artificial Intelligence, P1137; Kudo M, 2003, J GASTROENTEROL, V38, P207, DOI 10.1007/s005350300038; Lagarde P, 2012, CLIN CANCER RES, V18, P826, DOI 10.1158/1078-0432.CCR-11-1610; Lee JS, 2004, HEPATOLOGY, V40, P667, DOI 10.1002/hep.20375; Leung TWT, 2002, CANCER, V94, P1760, DOI 10.1002/cncr.10384; Liu H, 2008, CELL MOL IMMUNOL, V5, P373, DOI 10.1038/cmi.2008.46; Llovet JM, 1999, SEMIN LIVER DIS, V19, P329, DOI 10.1055/s-2007-1007122; Llovet JM, 2012, J HEPATOL, V56, P908, DOI 10.1016/j.jhep.2011.12.001; Louafi S, 2007, CANCER-AM CANCER SOC, V109, P1384, DOI 10.1002/cncr.22532; Manghisi G, 1998, HEPATOLOGY, V28, P751; Martinez-Balibrea E, 2010, BRIT J CANCER, V103, P581, DOI 10.1038/sj.bjc.6605776; Mohanty P, 2004, J CLIN ENDOCR METAB, V89, P2728, DOI 10.1210/jc.2003-032103; Nault JC, 2013, GASTROENTEROLOGY, V145, P176, DOI 10.1053/j.gastro.2013.03.051; Okada Y, 2014, NATURE, V506, P376, DOI 10.1038/nature12873; OKUDA K, 1985, CANCER, V56, P918, DOI 10.1002/1097-0142(19850815)56:4<918::AID-CNCR2820560437>3.0.CO;2-E; Pages F, 2010, ONCOGENE, V29, P1093, DOI 10.1038/onc.2009.416; Raman Karthik, 2010, Autom Exp, V2, P2, DOI 10.1186/1759-4499-2-2; Roessler S, 2010, CANCER RES, V70, P10202, DOI 10.1158/0008-5472.CAN-10-2607; Sanseau P, 2012, NAT BIOTECHNOL, V30, P317, DOI 10.1038/nbt.2151; Schaefer KL, 2005, CANCER RES, V65, P2251, DOI 10.1158/0008-5472.CAN-04-3037; Schimanski CC, 2006, BRIT J CANCER, V95, P210, DOI 10.1038/sj.bjc.6603251; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Shao RX, 2005, WORLD J GASTROENTERO, V11, P1995; Toshima T, 2013, J GASTROENTEROL; Tsuchiya M, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-74; Tsuchiya N, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-150; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; WARD JH, 1963, J AM STAT ASSOC, V58, P236, DOI 10.2307/2282967; Wei L, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-S1-S13; Yu J, 2010, HEPATOLOGY, V51, P2008, DOI 10.1002/hep.23550; Yu MC, 2008, J GASTROEN HEPATOL, V23, pS92, DOI 10.1111/j.1440-1746.2007.05293.x; Yuan JM, 2007, HEPATOLOGY, V46, P749, DOI 10.1002/hep.21735; Zeng LY, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-S8-S14; Zhang YN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100854; Zhu F, 2012, NUCLEIC ACIDS RES, V40, pD1128, DOI 10.1093/nar/gkr797	56	9	9	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2015	10	3							e0118672	10.1371/journal.pone.0118672	http://dx.doi.org/10.1371/journal.pone.0118672			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9JM	25738841	gold, Green Submitted, Green Published			2022-12-27	WOS:000350685900060
J	Tilic, E; Lehrke, J; Bartolomaeus, T				Tilic, Ekin; Lehrke, Janina; Bartolomaeus, Thomas			Homology and Evolution of the Chaetae in Echiura (Annelida)	PLOS ONE			English	Article							NERVOUS-SYSTEM; PHYLOGENETIC SIGNIFICANCE; DEVELOPMENTAL STAGES; HOODED HOOKS; ULTRASTRUCTURE; CHAETOGENESIS; POLYCHAETA; SETAE; TREE	Echiura is traditionally regarded as a small phylum of unsegmented spiralian worms. Molecular analyses, however, provide unquestionable evidence that Echiura are derived annelids that lost segmentation. Like annelids, echiurans possess chaetae, a single ventral pair in all species and one or two additional caudal hemi-circles of chaetae in two subgroups, but their evolutionary origin and affiliation to annelid chaetae are unresolved. Since annelids possess segmental pairs of dorsal (notopodial) and ventral (neuropodial) chaetae that are arranged in a row, the ventral chaetae in Echiura either represent a single or a paired neuropodial group of chaetae, while the caudal circle may represent fused rows of chaetae. In annelids, chaetogenesis is generally restricted to the ventral part of the notopodial chaetal sac and to the dorsal part of the neuropodial chaetal sac. We used the exact position of the chaetal formation site in the echiuran species, Thalassema thalassemum (Pallas, 1766) and Echiurus echiurus (Pallas, 1767), to test different hypotheses of the evolution of echiurid chaetae. As in annelids, a single chaetoblast is responsible for chaetogenesis in both species. Each chaeta of the ventral pair arises from its own chaetal sac and possesses a lateral formation site, evidencing that the pair of ventral chaetae in Echiura is homologous to a pair of neuropodia that fused on the ventral side, while the notopodia were reduced. Both caudal hemi-circles of chaetae in Echiurus echiurus are composed of several individual chaetal sacs, each with its own formative site. This finding argues against a homology of these hemi-circles of chaetae and annelids' rows of chaetae and leads to the hypothesis that the caudal chaetal rings evolved once within the Echiura by multiplication of ventral chaetae.	[Tilic, Ekin; Lehrke, Janina; Bartolomaeus, Thomas] Univ Bonn, Inst Evolutionary Biol & Anim Ecol, Bonn, Germany	University of Bonn	Tilic, E (corresponding author), Univ Bonn, Inst Evolutionary Biol & Anim Ecol, Bonn, Germany.	etilic@evolution.uni-bonn.de	Tilic, Ekin/K-6317-2019	Tilic, Ekin/0000-0003-0463-322X				Baltzer F., 1931, P62; Bartolomaeus T, 2005, HYDROBIOLOGIA, V535, P341, DOI 10.1007/s10750-004-1847-5; BARTOLOMAEUS T, 1995, ZOOMORPHOLOGY, V115, P161, DOI 10.1007/BF00403171; Bartolomaeus T, 1997, INVERTEBR BIOL, V116, P227, DOI 10.2307/3226899; Bartolomaeus T, 1998, ZOOLOGY, V100, P348; Biseswar R, 2012, ZOOTAXA, P69; Biseswar R, 2010, ZOOTAXA, P21; Biseswar R, 2009, ZOOTAXA, P17, DOI 10.11646/zootaxa.2222.1.2; Bleidorn C, 2003, J ZOOL SYST EVOL RES, V41, P186, DOI 10.1046/j.1439-0469.2003.00212.x; Bleidorn C, 2003, MOL PHYLOGENET EVOL, V29, P279, DOI 10.1016/S1055-7903(03)00107-6; Blumer MJF, 2002, J NEUROSCI METH, V120, P11, DOI 10.1016/S0165-0270(02)00166-8; Bourlat SJ, 2008, MOL PHYLOGENET EVOL, V49, P23, DOI 10.1016/j.ympev.2008.07.008; Dunn CW, 2008, NATURE, V452, P745, DOI 10.1038/nature06614; Goto R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056809; Grobe P., 2009, MORPH D BASE 2 0 PUB; Hausen H, 2005, HYDROBIOLOGIA, V535, P37, DOI 10.1007/s10750-004-1836-8; Hejnol A, 2009, P ROY SOC B-BIOL SCI, V276, P4261, DOI 10.1098/rspb.2009.0896; Hessling R, 2003, HYDROBIOLOGIA, V496, P225, DOI 10.1023/A:1026153016913; Hessling R, 2002, J MORPHOL, V252, P100, DOI 10.1002/jmor.1093; Hessling R, 2002, ZOOMORPHOLOGY, V121, P221, DOI 10.1007/s00435-002-0059-7; Kato C, 2011, ZOOMORPHOLOGY, V130, P97, DOI 10.1007/s00435-011-0124-1; Korn H, 1982, MORPHOGENESE TIERE D; Kremer JR, 1996, J STRUCT BIOL, V116, P71, DOI 10.1006/jsbi.1996.0013; Lehrke J, 2012, THESIS U BONN; Lehrke J, 2011, ZOOMORPHOLOGY, V130, P39, DOI 10.1007/s00435-011-0121-4; McHugh D, 1999, CLADISTICS, V15, P85, DOI 10.1006/clad.1999.0086; McHugh D, 1997, P NATL ACAD SCI USA, V94, P8006, DOI 10.1073/pnas.94.15.8006; McKenzie JD, 1999, INVERTEBR BIOL, V118, P296, DOI 10.2307/3226999; Meyer K, 1996, CAN J ZOOL, V74, P2143, DOI 10.1139/z96-243; O'Clair R, 1974, CELL TISSUE RES, P157; ORRHAGE L, 1971, Acta Zoologica (Stockholm), V52, P157; Rousset V, 2007, CLADISTICS, V23, P41, DOI 10.1111/j.1096-0031.2006.00128.x; Schweigkofler M, 1998, ZOOMORPHOLOGY, V118, P117, DOI 10.1007/s004350050062; SPECHT A, 1988, ZOOMORPHOLOGY, V107, P371, DOI 10.1007/BF00312220; Spengel JW., 1880, Z WISS ZOOL, V34, P460; Stephen A. C., 1972, PHYLA SIPUNCULA ECHI; Struck TH, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-57; Struck TH, 2011, NATURE, V471, P95, DOI 10.1038/nature09864; Tilic E, 2014, INVERTEBR BIOL, V133, P354, DOI 10.1111/ivb.12066; Weigert A, 2014, MOL BIOL EVOL, V31, P1391, DOI 10.1093/molbev/msu080; Zrzavy J, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-189	41	20	21	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2015	10	3							e0120002	10.1371/journal.pone.0120002	http://dx.doi.org/10.1371/journal.pone.0120002			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4HV	25734664	Green Published, Green Submitted, gold			2022-12-27	WOS:000350314700065
J	Heisig, M; Mattessich, S; Rembisz, A; Acar, A; Shapiro, M; Booth, CJ; Neelakanta, G; Fikrig, E				Heisig, Martin; Mattessich, Sarah; Rembisz, Alison; Acar, Ali; Shapiro, Martin; Booth, Carmen J.; Neelakanta, Girish; Fikrig, Erol			Frostbite Protection in Mice Expressing an Antifreeze Glycoprotein	PLOS ONE			English	Article							SUBZERO PRESERVATION; ICE CRYSTALS; PROTEINS; MANAGEMENT; PROSPECTS; SURVIVAL; AGENTS; FISH	Ectotherms in northern latitudes are seasonally exposed to cold temperatures. To improve survival under cold stress, they use diverse mechanisms to increase temperature resistance and prevent tissue damage. The accumulation of anti-freeze proteins that improve cold hardiness occurs in diverse species including plants, arthropods, fish, and amphibians. We previously identified an Ixodes scapularis anti-freeze glycoprotein, named IAFGP, and demonstrated its cold protective function in the natural tick host and in a transgenic Drosophila model. Here we show, in a transgenic mouse model expressing an anti-freeze glycoprotein, that IAFGP protects mammalian cells and mice from cold shock and frostbite respectively. Transgenic skin samples showed reduced cell death upon cold storage ex vivo and transgenic mice demonstrated increased resistance to frostbite injury in vivo. IAFGP actively protects mammalian tissue from freezing, suggesting its application for the prevention of frostbite, and other diseases associated with cold exposure.	[Heisig, Martin; Mattessich, Sarah; Rembisz, Alison; Acar, Ali; Shapiro, Martin; Neelakanta, Girish; Fikrig, Erol] Yale Univ, Sch Med, Dept Internal Med, Infect Dis Sect, New Haven, CT 06510 USA; [Acar, Ali] Haydarpasa Training Hosp, Gulhane Mil Med Acad, Dept Infect Dis & Clin Microbiol, Istanbul, Turkey; [Booth, Carmen J.] Yale Univ, Sch Med, Comparat Med Sect, New Haven, CT 06510 USA; [Fikrig, Erol] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA	Yale University; Gulhane Military Medical Academy; Istanbul Haydarpasa Numune Training & Research Hospital; Istanbul Haydarpasa Sultan Abdulhamid Training & Research Hospital; Yale University; Howard Hughes Medical Institute	Fikrig, E (corresponding author), Howard Hughes Med Inst, Chevy Chase, MD 20815 USA.	erol.fikrig@yale.edu	Acar, Ali/W-1157-2019	Acar, Ali/0000-0003-2008-5112	National Institutes of Health [AI41440]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI041440, R56AI041440, R21AI041440] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by grant AI41440 from the National Institutes of Health. Erol Fikrig is an Investigator with the Howard Hughes Medical Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amir G, 2005, J HEART LUNG TRANSPL, V24, P1915, DOI 10.1016/j.healun.2004.11.003; Amir G, 2004, ANN THORAC SURG, V77, P1648, DOI 10.1016/j.athoracsur.2003.04.004; Amir G, 2004, CRYOBIOLOGY, V48, P273, DOI 10.1016/j.crybiol.2004.02.009; Bagis H, 2008, MOL REPROD DEV, V75, P608, DOI 10.1002/mrd.20799; Bang JK, 2013, MAR DRUGS, V11, P2013, DOI 10.3390/md11062013; Berendsen TA, 2014, NAT MED; Breton G, 2000, Biotechnol Annu Rev, V6, P59, DOI 10.1016/S1387-2656(00)06019-1; Brockbank KGM, 2011, IN VITRO CELL DEV-AN, V47, P210, DOI 10.1007/s11626-010-9383-2; Carvajal-Rondanelli PA, 2011, J SCI FOOD AGR, V91, P2507, DOI 10.1002/jsfa.4473; Celik Y, 2013, P NATL ACAD SCI USA, V110, P1309, DOI 10.1073/pnas.1213603110; Chen LB, 1997, P NATL ACAD SCI USA, V94, P3817, DOI 10.1073/pnas.94.8.3817; Clark MS, 2008, J COMP PHYSIOL B, V178, P917, DOI 10.1007/s00360-008-0286-4; Daniel A, 2000, ICE CONFECTION CONTA; Davies PL, 1997, CURR OPIN STRUC BIOL, V7, P828, DOI 10.1016/S0959-440X(97)80154-6; DEVRIES AL, 1969, SCIENCE, V163, P1073, DOI 10.1126/science.163.3871.1073; Doucet D, 2009, CELL MOL LIFE SCI, V66, P1404, DOI 10.1007/s00018-009-8320-6; DUMAN JG, 1982, COMP BIOCHEM PHYS A, V73, P545, DOI 10.1016/0300-9629(82)90261-4; Garner J, 2010, CHEMBIOCHEM, V11, P2489, DOI 10.1002/cbic.201000509; Heisig M, 2014, CELL REP, V9, P417, DOI 10.1016/j.celrep.2014.09.034; Imray C, 2009, POSTGRAD MED J, V85, P481, DOI 10.1136/pgmj.2008.068635; Inglis SR, 2006, CURR PROTEIN PEPT SC, V7, P509, DOI 10.2174/138920306779025576; Kaiser J, 2002, SCIENCE, V295, P1015, DOI 10.1126/science.295.5557.1015; Landry GJ, 2013, J VASC SURG, V57, P1710, DOI 10.1016/j.jvs.2013.03.012; Matsumoto S, 2006, CRYOBIOLOGY, V52, P90, DOI 10.1016/j.cryobiol.2005.10.010; McGillion R, 2005, J EMERG NURS, V31, P500, DOI 10.1016/j.jen.2005.07.002; McMahon JA, 2012, CURR SPORT MED REP, V11, P135, DOI 10.1249/JSR.0b013e3182578783; Neelakanta G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033447; Neelakanta G, 2010, J CLIN INVEST, V120, P3179, DOI 10.1172/JCI42868; Patel SN, 2010, BIOCHEM CELL BIOL, V88, P223, DOI [10.1139/o09-183, 10.1139/O09-183]; Peltier R, 2010, CHEM SCI, V1, P538, DOI 10.1039/c0sc00194e; Pertaya N, 2008, BIOPHYS J, V95, P333, DOI 10.1529/biophysj.107.125328; Pertaya N, 2007, BIOPHYS J, V92, P3663, DOI 10.1529/biophysj.106.096297; Regand A, 2006, J DAIRY SCI, V89, P49, DOI 10.3168/jds.S0022-0302(06)72068-9; Roche-Nagle G, 2008, EUR J EMERG MED, V15, P173, DOI 10.1097/MEJ.0b013e3282bf6ed0; Rock KL, 2010, ANNU REV IMMUNOL, V28, P321, DOI 10.1146/annurev-immunol-030409-101311; RUBINSKY B, 1994, BIOCHEM BIOPH RES CO, V200, P732, DOI 10.1006/bbrc.1994.1512; Soltys KA, 2001, J SURG RES, V96, P30, DOI 10.1006/jsre.2000.6053; STOREY KB, 1992, ANNU REV PHYSIOL, V54, P619, DOI 10.1146/annurev.physiol.54.1.619; Storey KB, 2013, COMPR PHYSIOL, V3, P1283, DOI 10.1002/cphy.c130007; Venketesh S, 2008, CRIT REV BIOTECHNOL, V28, P57, DOI [10.1080/07388550801891152, 10.1080/07388550801891152 ]; Zhang Xia, 2008, Curr Protoc Immunol, VChapter 14, DOI 10.1002/0471142735.im1401s83	41	13	14	0	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2015	10	2							e0116562	10.1371/journal.pone.0116562	http://dx.doi.org/10.1371/journal.pone.0116562			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC2IM	25714402	gold, Green Published, Green Submitted			2022-12-27	WOS:000350168700019
J	Guedes-Martins, L; Gaio, R; Saraiva, J; Cerdeira, S; Matos, L; Silva, E; Macedo, F; Almeida, H				Guedes-Martins, Luis; Gaio, Rita; Saraiva, Joaquim; Cerdeira, Sofia; Matos, Liliana; Silva, Elisabete; Macedo, Filipe; Almeida, Henrique			Reference Ranges for Uterine Artery Pulsatility Index during the Menstrual Cycle: A Cross-Sectional Study	PLOS ONE			English	Article							BLOOD-FLOW; OVULATION INDUCTION; DOPPLER ASSESSMENT; MATERNAL AGE; WAVE-FORMS; PREGNANCY; OVARIAN; WOMEN; ENDOMETRIAL; VELOCITY	Background Cyclic endometrial neoangiogenesis contributes to changes in local vascular patterns and is amenable to non-invasive assessment with Doppler sonography. We hypothesize that the uterine artery (UtA) impedance, measured by its pulsatility index (PI), exhibits a regular pattern during the normal menstrual cycle. Therefore, the main study objective was to derive normative new day-cycle-based reference ranges for the UtA-PI during the entire cycle from days 1 to 34 according to the isolated time effect and potential confounders such as age and parity. Methods From January 2009 to December 2012, a cross-sectional study of 1,821 healthy women undergoing routine gynaecological ultrasound was performed. The Doppler flow of the right and left UtA-PI was studied transvaginally by colour and pulsed Doppler imaging. The mean right and left values and the presence or absence of a bilateral protodiastolic notch were recorded. Reference intervals for the PI according to the cycle day were generated by classical linear regression. Results The majority of patients (97.5%) presented unilateral or bilateral UtA notches. The crude 5th, 50th, and 95th reference percentile curves of the UtA-PI at 1-34 days of the normal menstrual cycle were derived. In all curves, a progressive significant decrease occurred during the first 13 days, followed by an increase and recovery in the UtA-PI. The adjusted 5th, 50th, and 95th reference percentile curves for the effects of age and parity were also obtained. These two conditions generated an approximately identical UtA-PI pattern during the cycle, except with small but significant reductions at the temporal extremes. Conclusions The median, 5th, and the 95th percentiles of the UtA-PI decrease during the first third of the menstrual cycle and recover to their initial values during the last two thirds of the cycle. The rates of decrease and recovery depend significantly on age and parity.	[Guedes-Martins, Luis; Saraiva, Joaquim; Matos, Liliana; Silva, Elisabete; Almeida, Henrique] Univ Porto, Fac Med, Dept Expt Biol, P-4200319 Oporto, Portugal; [Guedes-Martins, Luis; Matos, Liliana; Silva, Elisabete; Almeida, Henrique] Inst Biol Mol & Celular, P-4150180 Oporto, Portugal; [Guedes-Martins, Luis; Saraiva, Joaquim] Ctr Hosp Porto EPE, Dept Mulher & Med Reprod, P-4099001 Oporto, Portugal; [Gaio, Rita] Univ Porto, Fac Sci, Dept Math, P-4169007 Oporto, Portugal; [Gaio, Rita] Univ Porto, Ctr Math, CMUP, P-4169007 Oporto, Portugal; [Saraiva, Joaquim] Private Hosp Trofa, Obstet Gynecol, P-4785409 Trofa, Portugal; [Cerdeira, Sofia] Gulbenkian Program Adv Med Educ, P-1067001 Lisbon, Portugal; [Cerdeira, Sofia] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Dept Med, Boston, MA 02215 USA; [Matos, Liliana] Univ Porto, Fac Nutr & Food Sci, P-4200465 Oporto, Portugal; [Macedo, Filipe] Univ Porto, Fac Med, Dept Cardiol, P-4200319 Oporto, Portugal; [Almeida, Henrique] Hosp CUF Porto, Obstet Gynecol, P-4100180 Oporto, Portugal	Universidade do Porto; Universidade do Porto; Universidade do Porto; Universidade do Porto; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Universidade do Porto; Universidade do Porto	Guedes-Martins, L (corresponding author), Univ Porto, Fac Med, Dept Expt Biol, P-4200319 Oporto, Portugal.	luis.guedes.martins@gmail.com	da Silva Moura, Elisabete Ferreira/L-9184-2014; Macedo, Filipe/AAU-5442-2020; Matos, Liliana/H-5515-2013; Macedo, Filipe/AAL-7675-2020; Matos, Liliana/V-2512-2019	da Silva Moura, Elisabete Ferreira/0000-0002-6736-3469; Macedo, Filipe/0000-0003-3829-9426; Matos, Liliana/0000-0003-4188-532X; Almeida, Henrique/0000-0002-3036-3211; Guedes-Martins, Luis/0000-0002-0491-0752; Cerdeira, A. Sofia/0000-0002-7643-3537; Gaio, Rita/0000-0003-3906-0775				ALTMAN DG, 1993, STAT MED, V12, P917, DOI 10.1002/sim.4780121003; Arrowsmith S, 2012, J MUSCLE RES CELL M, V33, P209, DOI 10.1007/s10974-012-9300-2; Bland JM, 2003, ULTRASOUND OBST GYN, V22, P85, DOI 10.1002/uog.122; BOSSMAR T, 1995, BRIT J OBSTET GYNAEC, V102, P907, DOI 10.1111/j.1471-0528.1995.tb10880.x; Brosens JJ, 2009, AM J OBSTET GYNECOL, V200, DOI 10.1016/j.ajog.2008.11.037; Chien LW, 2004, ULTRASOUND OBST GYN, V23, P496, DOI 10.1002/uog.975; Cnossen JS, 2008, CAN MED ASSOC J, V178, P701, DOI 10.1503/cmaj.070430; COLE TJ, 1992, STAT MED, V11, P1305, DOI 10.1002/sim.4780111005; Crawford BS, 1997, OBSTET GYNECOL, V90, P210, DOI 10.1016/S0029-7844(97)00225-1; Dal J, 2005, FERTIL STERIL, V84, P224, DOI 10.1016/j.fertnstert.2004.12.059; Dechaud H, 2008, REPROD BIOMED ONLINE, V16, P368, DOI 10.1016/S1472-6483(10)60598-6; DOWNING SJ, 1981, J PHYSIOL-LONDON, V317, P425, DOI 10.1113/jphysiol.1981.sp013834; Everett TR, 2012, PLACENTA, V33, P893, DOI 10.1016/j.placenta.2012.07.011; Ferreira AM, 2007, INT J GYNECOL OBSTET, V98, P115, DOI 10.1016/j.ijgo.2007.05.006; Gomez O, 2008, ULTRASOUND OBST GYN, V32, P128, DOI 10.1002/uog.5315; Gordan PL, 1997, BIOL REPROD, V57, P597, DOI 10.1095/biolreprod57.3.597; Groutz A, 1997, J ULTRAS MED, V16, P455; Guedes-Martins L, 2014, SCI REP-UK, V4, DOI 10.1038/srep03785; Guedes-Martins L, 2014, PRENATAL DIAG, V34, P719, DOI 10.1002/pd.4325; Haavaldsen C, 2011, BJOG-INT J OBSTET GY, V118, P1470, DOI 10.1111/j.1471-0528.2011.03053.x; Hafner E, 2000, ULTRASOUND OBST GYN, V16, P625, DOI 10.1046/j.1469-0705.2000.00290.x; Harrington K, 1997, ULTRASOUND OBST GYN, V9, P94, DOI 10.1046/j.1469-0705.1997.09020094.x; Hernandez-Andrade E, 2002, ULTRASOUND OBST GYN, V19, P438, DOI 10.1046/j.1469-0705.2002.00665.x; Hynek M, 2010, EUR J BIOMED INFORM, V6, P43; Ivanovski M, 2012, Akush Ginekol (Sofiia), V51, P55; JAFFA AJ, 1995, GYNECOL OBSTET INVES, V40, P80, DOI 10.1159/000292310; Jokubkiene L, 2006, ULTRASOUND OBST GYN, V27, P672, DOI 10.1002/uog.2742; Khong TY, 2003, PLACENTA, V24, P348, DOI 10.1053/plac.2002.0922; Liedman R, 2008, EUR J OBSTET GYN R B, V137, P189, DOI 10.1016/j.ejogrb.2007.10.015; Meyer MC, 1997, AM J PHYSIOL-HEART C, V272, pH2264, DOI 10.1152/ajpheart.1997.272.5.H2264; Oloyede OA, 2013, PAN AFR MED J, V15, DOI 10.11604/pamj.2013.15.87.2321; Papageorghiou AT, 2001, ULTRASOUND OBST GYN, V18, P456, DOI 10.1046/j.0960-7692.2001.00578.x; Park YW, 2000, AM J OBSTET GYNECOL, V182, P1204, DOI 10.1067/mob.2000.104840; Pirhonen J, 2005, J CLIN ULTRASOUND, V33, P14, DOI 10.1002/jcu.20079; Prefumo F, 2004, ULTRASOUND OBST GYN, V23, P46, DOI 10.1002/uog.908; R Core Team, 2018, R LANG ENV STAT COMP; Royston P, 1998, ULTRASOUND OBST GYN, V11, P30, DOI 10.1046/j.1469-0705.1998.11010030.x; SCHULMAN H, 1986, AM J OBSTET GYNECOL, V155, P1031, DOI 10.1016/0002-9378(86)90340-6; SERAFINI P, 1994, FERTIL STERIL, V62, P815; Silverwood RJ, 2007, ULTRASOUND OBST GYN, V29, P6, DOI 10.1002/uog.3911; SLADKEVICIUS P, 1993, ULTRASOUND OBST GYN, V3, P199, DOI 10.1046/j.1469-0705.1993.03030199.x; STEER CV, 1990, HUM REPROD, V5, P391, DOI 10.1093/oxfordjournals.humrep.a137109; STEER CV, 1995, HUM REPROD, V10, P479, DOI 10.1093/oxfordjournals.humrep.a135966; Suzuki S, 2006, J MATERN-FETAL NEO M, V19, P193, DOI 10.1080/14767050600587850; Tan SL, 1996, AM J OBSTET GYNECOL, V175, P625; Turan OM, 2008, ULTRASOUND OBST GYN, V32, P849, DOI 10.1002/uog.5354; Vedernikov YP, 2003, EUR J OBSTET GYN R B, V108, P59, DOI 10.1016/S0301-2115(02)00415-3; Wahab H, 2001, MIDDLE E FERTILITY S, V16, P209; Wakeman S, 2009, FERTIL STERIL, V91, P2726, DOI 10.1016/j.fertnstert.2008.03.069; Walter SD, 1998, STAT MED, V17, P101, DOI 10.1002/(SICI)1097-0258(19980115)17:1<101::AID-SIM727>3.3.CO;2-5; Wang LN, 2010, REPROD BIOL ENDOCRIN, V8, DOI 10.1186/1477-7827-8-122; Yildiz G, 2012, CLIN EXP OBSTET GYN, V39, P326; Ziegler WF, 1999, OBSTET GYNECOL, V94, P695, DOI 10.1016/S0029-7844(99)00397-X	53	11	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2015	10	3							e0119103	10.1371/journal.pone.0119103	http://dx.doi.org/10.1371/journal.pone.0119103			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9KG	25742286	Green Published, Green Submitted, gold			2022-12-27	WOS:000350688100083
J	Hofman, CS; Makai, P; Blom, JW; Boter, H; Buurman, BM; Rikkert, MGMO; Donders, R; Melis, RJF				Hofman, Cynthia S.; Makai, Peter; Blom, Jeanet W.; Boter, Han; Buurman, Bianca M.; Rikkert, Marcel G. M. Olde; Donders, Rogier; Melis, Rene J. F.			Comparing the Health State Preferences of Older Persons, Informal Caregivers and Healthcare Professionals: A Vignette Study	PLOS ONE			English	Article							QUALITY-OF-LIFE	Background The Older Persons and Informal Caregivers Survey-Minimum Dataset (TOPICS-MDS) collects uniform information from research projects funded under the Dutch National Care for the Elderly Programme. To compare the effectiveness of these projects a preference-weighted outcome measure that combined multidimensional TOPICS-MDS outcomes into a composite endpoint (TOPICS-CEP) was developed based on the health state preferences of older persons and informal caregivers. Objectives To derive preference weights for TOPICS-CEP's components based on health state preferences of healthcare professionals and to investigate whether these weights differ between disciplines and differ from those of older persons and informal caregivers. Materials and Methods Vignette studies were conducted. Participants assessed the general wellbeing of older persons described in vignettes on a scale (0-10). Mixed linear analyses were used to obtain and compare the preference weights of the eight TOPICS-CEP components: morbidities, functional limitations, emotional wellbeing, pain experience, cognitive problems, social functioning, self-perceived health, and self-perceived quality of life (QOL). Results Overall, 330 healthcare professionals, 124 older persons and 76 informal caregivers participated. The preference weights were not significantly different between disciplines. However, the professionals' preference weights differed significantly from those of older persons and informal caregivers. Morbidities and functional limitations were given more weight by older persons and informal caregivers than by healthcare professionals [difference between preference weights: 0.12 and 0.07] while the opposite was true for pain experience, social functioning, and self-perceived QOL [difference between preference weights: 0.13, 0.15 and 0.26]. Conclusion It is important to recognize the discrepancies between the health state preferences of various stakeholders to (1) correctly interpret results when studying the effectiveness of interventions in elderly care and (2) establish appropriate healthcare policies. Furthermore, we should strive to include older persons in our decision making process through a shared decision making approach.	[Hofman, Cynthia S.; Makai, Peter; Rikkert, Marcel G. M. Olde; Melis, Rene J. F.] Radboud Univ Nijmegen, Med Ctr, Dept Geriatr Med HP 925, NL-6525 ED Nijmegen, Netherlands; [Hofman, Cynthia S.; Makai, Peter; Donders, Rogier] Radboud Univ Nijmegen, Med Ctr, Dept Hlth Evidence HP133, NL-6525 ED Nijmegen, Netherlands; [Blom, Jeanet W.] Leiden Univ, Med Ctr, Dept Publ Hlth & Primary Care, Leiden, Netherlands; [Boter, Han] Univ Groningen, Univ Med Ctr Groningen, Dept Epidemiol FA41, Groningen, Netherlands; [Buurman, Bianca M.] Univ Amsterdam, Acad Med Ctr, Dept Internal Med, Sect Geriatr Med F4 108, NL-1105 AZ Amsterdam, Netherlands	Radboud University Nijmegen; Radboud University Nijmegen; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Groningen; University of Amsterdam; Academic Medical Center Amsterdam	Hofman, CS (corresponding author), Radboud Univ Nijmegen, Med Ctr, Dept Geriatr Med HP 925, NL-6525 ED Nijmegen, Netherlands.	Cynthia.Hofman@Radboudumc.nl	Rikkert, M.G.M. Olde/H-8078-2014; Donders, A.R.T./L-4277-2015; Melis, René/J-5943-2012; Rikkert, Marcel Olde/D-9773-2012; Makai, Peter/I-5278-2012	Rikkert, M.G.M. Olde/0000-0003-1397-1677; Donders, A.R.T./0000-0002-0484-1419; Melis, René/0000-0002-7863-4738; Makai, Peter/0000-0002-5332-1751	Dutch national Care for the Elderly Program (NCEP); ZonMw, organization for health research and development the Netherlands [60-6190098-302]	Dutch national Care for the Elderly Program (NCEP); ZonMw, organization for health research and development the Netherlands	The work was supported by a grant from the Dutch national Care for the Elderly Program (NCEP), coordinated and sponsored by ZonMw, organization for health research and development the Netherlands (Grant number: 60-6190098-302). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2012, J AM GERIATR SOC, V60, pE1, DOI [10.1111/j.1532-5415.2012.04188.x, DOI 10.1111/J.1532-5415.2012.04188.X]; Crespo M, 2012, GERONTOLOGIST, V52, P56, DOI 10.1093/geront/gnr080; ERICKSON P, 1989, MED CARE, V27, pS66, DOI 10.1097/00005650-198903001-00006; Fried LP, 2004, J GERONTOL A-BIOL, V59, P255; Gomez-Gallego M, 2012, INT PSYCHOGERIATR, V24, P1805, DOI 10.1017/S1041610212001081; Hofman CS, OLDER PERSONS INFORM; Hofman CS, 2014, BMC GERIATR, V14, DOI 10.1186/1471-2318-14-51; Humphreys G, 2012, B WORLD HEALTH ORGAN, V90, P82, DOI 10.2471/BLT.12.020212; Krabbe PFM, 1999, J CLIN EPIDEMIOL, V52, P293, DOI 10.1016/S0895-4356(98)00163-2; Lutomski JE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081673; PATRICK DL, 1989, MED CARE, V27, pS217, DOI 10.1097/00005650-198903001-00018; Programs UoME, GER ACC CAR ALL SCAR; van der Zee KI, 1996, INT J BEHAV MED, V3, P104, DOI 10.1207/s15327558ijbm0302_2; WEINBERGER M, 1992, J AM GERIATR SOC, V40, P585, DOI 10.1111/j.1532-5415.1992.tb02107.x	14	5	5	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2015	10	3							e0119197	10.1371/journal.pone.0119197	http://dx.doi.org/10.1371/journal.pone.0119197			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CC9JM	25739034	gold, Green Published, Green Submitted			2022-12-27	WOS:000350685900098
J	Oh, DY; Barr, IG; Hurt, AC				Oh, Ding Yuan; Barr, Ian G.; Hurt, Aeron C.			A Novel Video Tracking Method to Evaluate the Effect of Influenza Infection and Antiviral Treatment on Ferret Activity	PLOS ONE			English	Article							VIRUS; OSELTAMIVIR; PROTECTION; DISEASE; TRANSMISSION; H1N1; PATHOGENESIS; REGIMENS; EFFICACY	Ferrets are the preferred animal model to assess influenza virus infection, virulence and transmission as they display similar clinical symptoms and pathogenesis to those of humans. Measures of disease severity in the ferret include weight loss, temperature rise, sneezing, viral shedding and reduced activity. To date, the only available method for activity measurement has been the assignment of an arbitrary score by a 'blind' observer based on pre-defined responsiveness scale. This manual scoring method is subjective and can be prone to bias. In this study, we described a novel video-tracking methodology for determining activity changes in a ferret model of influenza infection. This method eliminates the various limitations of manual scoring, which include the need for a sole 'blind' observer and the requirement to recognise the 'normal' activity of ferrets in order to assign relative activity scores. In ferrets infected with an A(H1N1) pdm09 virus, video-tracking was more sensitive than manual scoring in detecting ferret activity changes. Using this video-tracking method, oseltamivir treatment was found to ameliorate the effect of influenza infection on activity in ferret. Oseltamivir treatment of animals was associated with an improvement in clinical symptoms, including reduced inflammatory responses in the upper respiratory tract, lower body weight loss and a smaller rise in body temperature, despite there being no significant reduction in viral shedding. In summary, this novel video-tracking is an easy-to-use, objective and sensitive methodology for measuring ferret activity.	[Oh, Ding Yuan; Barr, Ian G.; Hurt, Aeron C.] Peter Doherty Inst Infect & Immun, WHO Collaborating Ctr Reference & Res Influenza, VIDRL, Melbourne, Vic 3000, Australia; [Oh, Ding Yuan; Barr, Ian G.] Federat Univ, Sch Appl & Biomed Sci, Churchill, Vic 3842, Australia; [Hurt, Aeron C.] Univ Melbourne, Melbourne Sch Populat & Global Hlth, Melbourne, Vic 3010, Australia	Victorian Infectious Diseases Reference Laboratory; World Health Organization; Federation University Australia; University of Melbourne	Oh, DY (corresponding author), Peter Doherty Inst Infect & Immun, WHO Collaborating Ctr Reference & Res Influenza, VIDRL, Melbourne, Vic 3000, Australia.	dingthomas.oh@influenzacentre.org		Barr, Ian/0000-0002-7351-418X; Oh, Ding Yuan/0000-0003-0695-8490; Hurt, Aeron/0000-0003-1826-4314	National Health and Medical Research Council of Australia /A<SUP>star</SUP>STAR grant [1055793]; Australian Government Department of Health	National Health and Medical Research Council of Australia /A<SUP>star</SUP>STAR grant; Australian Government Department of Health(Australian GovernmentDepartment of Health & Ageing)	This work was supported by a combined National Health and Medical Research Council of Australia /A<SUP>star</SUP>STAR grant (1055793). The Melbourne WHO Collaborating Centre for Reference and Research on Influenza is supported by the Australian Government Department of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartal IB, 2014, ELIFE, V3, DOI 10.7554/eLife.01385; Boltz DA, 2008, J INFECT DIS, V197, P1315, DOI 10.1086/586711; Cox NJ, 1999, LANCET, V354, P1277, DOI 10.1016/S0140-6736(99)01241-6; Darnell MER, 2007, J INFECT DIS, V196, P1329, DOI 10.1086/522431; Dimmock NJ, 2012, ANTIVIR RES, V96, P376, DOI 10.1016/j.antiviral.2012.09.017; Duclot F, 2013, J NEUROSCI, V33, P11048, DOI 10.1523/JNEUROSCI.0199-13.2013; Govorkova EA, 2007, ANTIMICROB AGENTS CH, V51, P1414, DOI 10.1128/AAC.01312-06; Govorkova EA, 2011, ANTIVIR RES, V91, P81, DOI 10.1016/j.antiviral.2011.05.008; Guarnaccia T, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003354; Horn CC, 2012, PHYSIOL BEHAV, V106, P562, DOI 10.1016/j.physbeh.2012.03.031; Ilyushina NA, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000933; Itoh Y, 2009, NATURE, V460, P1021, DOI 10.1038/nature08260; Kim HM, 2013, VIROLOGY, V444, P394, DOI 10.1016/j.virol.2013.07.006; Long JP, 2012, SCI REP-UK, V2, DOI 10.1038/srep00972; Maines TR, 2009, SCIENCE, V325, P484, DOI 10.1126/science.1177238; Marriott AC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094090; MONTO AS, 1981, J CLIN MICROBIOL, V13, P54, DOI 10.1128/JCM.13.1.54-57.1981; Munster VJ, 2009, SCIENCE, V325, P481, DOI 10.1126/science.1177127; Oh DY, 2008, J CLIN MICROBIOL, V46, P2189, DOI 10.1128/JCM.00398-08; Oh DY, 2014, J ANTIMICROB CHEMOTH, V69, P2458, DOI 10.1093/jac/dku146; Pallister J, 2011, VACCINE, V29, P5623, DOI 10.1016/j.vaccine.2011.06.015; Pallister JA, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-237; REUMAN PD, 1989, J VIROL METHODS, V24, P27, DOI 10.1016/0166-0934(89)90004-9; Rockman S, 2013, J VIROL, V87, P3053, DOI 10.1128/JVI.02434-12; Stark GV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058337; WHO/GIP, 2014, CUM NUMB CONF HUM CA; WHO/HQ, 2014, WHO HQ PER REP, V18; Wong SS, 2014, VACCINE, V32, P4571, DOI 10.1016/j.vaccine.2014.06.016; Zhang QY, 2013, SCIENCE, V341, P410, DOI 10.1126/science.1240532	29	19	19	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2015	10	3							e0118780	10.1371/journal.pone.0118780	http://dx.doi.org/10.1371/journal.pone.0118780			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9JM	25738900	Green Published, gold			2022-12-27	WOS:000350685900070
J	Wall-Scheffler, CM; Wagnild, J; Wagler, E				Wall-Scheffler, Cara M.; Wagnild, Janelle; Wagler, Emily			Human Footprint Variation while Performing Load Bearing Tasks	PLOS ONE			English	Article							PLEISTOCENE FOSSIL HOMINIDS; AUSTRALOPITHECUS-AFARENSIS; BODY-MASS; HUNTER-GATHERERS; ENERGETIC COST; HUMAN WALKING; NORTHERN TANZANIA; LOCOMOTOR ANATOMY; SEXUAL-DIMORPHISM; OLDER-ADULTS	Human footprint fossils have provided essential evidence about the evolution of human bipedalism as well as the social dynamics of the footprint makers, including estimates of speed, sex and group composition. Generally such estimates are made by comparing footprint evidence with modern controls; however, previous studies have not accounted for the variation in footprint dimensions coming from load bearing activities. It is likely that a portion of the hominins who created these fossil footprints were carrying a significant load, such as offspring or foraging loads, which caused variation in the footprint which could extend to variation in any estimations concerning the footprint's maker. To identify significant variation in footprints due to load-bearing tasks, we had participants (N = 30, 15 males and 15 females) walk at a series of speeds carrying a 20kg pack on their back, side and front. Paint was applied to the bare feet of each participant to create footprints that were compared in terms of foot length, foot width and foot area. Female foot length and width increased during multiple loaded conditions. An appreciation of footprint variability associated with carrying loads adds an additional layer to our understanding of the behavior and morphology of extinct hominin populations.	[Wall-Scheffler, Cara M.] Seattle Pacific Univ, Dept Biol, Seattle, WA 98119 USA; [Wall-Scheffler, Cara M.] Univ Washington, Dept Anthropol, Seattle, WA 98195 USA; [Wagnild, Janelle] Univ Durham, Dept Anthropol, Durham, England; [Wagler, Emily] Arizona Sch Podiatr Med, Glendale, AZ USA	University of Washington; University of Washington Seattle; Durham University	Wall-Scheffler, CM (corresponding author), Seattle Pacific Univ, Dept Biol, Seattle, WA 98119 USA.	cwallsch@spu.edu		Wagnild, Janelle/0000-0003-3933-6380	3M Faculty/Student Collaborative Grant [212607]; National Center for Research Resources (NCRR) [1 ULJRR033183-01]; National Center for Advancing Translational Sciences (NCATS) of the National Institutes of Health (NIH) [8 ULJTR0001 14-02]	3M Faculty/Student Collaborative Grant; National Center for Research Resources (NCRR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Center for Advancing Translational Sciences (NCATS) of the National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	The DEXA data were paid for by a 3M Faculty/Student Collaborative Grant (#212607). Additionally, the DEXA lab was supported by Grant Number 1 ULJRR033183-01 from the National Center for Research Resources (NCRR) and by Grant Number 8 ULJTR0001 14-02 from the National Center for Advancing Translational Sciences (NCATS) of the National Institutes of Health (NIH) to the University of Minnesota Clinical and Translational Science Institute (CTSI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe D, 2004, APPL ERGON, V35, P329, DOI 10.1016/j.apergo.2004.03.008; Abe D, 2008, APPL ERGON, V39, P392, DOI 10.1016/j.apergo.2007.07.001; Aiello L., 2002, INTRO HUMAN EVOLUTIO; Aiello LC, 2002, AM J HUM BIOL, V14, P551, DOI 10.1002/ajhb.10069; Alcantara E, 2002, J APPL BIOMECH, V18, P345, DOI 10.1123/jab.18.4.345; Alemseged Z, 2006, NATURE, V443, P296, DOI 10.1038/nature05047; Auerbach BM, 2004, AM J PHYS ANTHROPOL, V125, P331, DOI 10.1002/ajpa.20032; Bastien GJ, 2005, EUR J APPL PHYSIOL, V94, P76, DOI 10.1007/s00421-004-1286-z; Bennett MR, 2009, SCIENCE, V323, P1197, DOI 10.1126/science.1168132; BENTLEY GR, 1985, HUM ECOL, V13, P79, DOI 10.1007/BF01531090; Berger LR, 2010, SCIENCE, V328, P195, DOI 10.1126/science.1184944; Blurton Jones N. G., 1989, COMP SOCIOECOLOGY BE, P367; Boening D., 1977, PHYS THER, V57; Brightman R, 1996, COMP STUD SOC HIST, V38, P687, DOI 10.1017/S0010417500020508; Brown LA, 2006, GAIT POSTURE, V24, P418, DOI 10.1016/j.gaitpost.2005.09.013; Brown LA, 2006, GAIT POSTURE, V24, P397, DOI 10.1016/j.gaitpost.2005.04.013; CHARTERIS J, 1981, NATURE, V290, P496, DOI 10.1038/290496a0; CHARTERIS J, 1982, AM J PHYS ANTHROPOL, V58, P133, DOI 10.1002/ajpa.1330580205; Chow DHK, 2005, ERGONOMICS, V48, P642, DOI 10.1080/00140130500070921; Chumanov ES, 2008, CLIN BIOMECH, V23, P1260, DOI 10.1016/j.clinbiomech.2008.07.011; CLARKSON BH, 1983, PHYS THER, V63, P345, DOI 10.1093/ptj/63.3.345; D'Aout K, 2009, FOOTWEAR SCI, V1, P81, DOI 10.1080/19424280903386411; DAY MH, 1980, NATURE, V286, P385, DOI 10.1038/286385a0; Demura T, 2010, J PHYSIOL ANTHROPOL, V29, P29, DOI 10.2114/jpa2.29.29; DeSilva JM, 2013, AM J PHYS ANTHROPOL, V151, P495, DOI 10.1002/ajpa.22287; Dingwall HL, 2013, J HUM EVOL, V64, P556, DOI 10.1016/j.jhevol.2013.02.004; FELDESMAN MR, 1988, J HUM EVOL, V17, P583, DOI 10.1016/0047-2484(88)90086-3; FELDESMAN MR, 1990, AM J PHYS ANTHROPOL, V83, P359, DOI 10.1002/ajpa.1330830309; Fessler DMT, 2005, ANN HUM BIOL, V32, P44, DOI 10.1080/03014460400027581; Filler Aaron G, 2007, Neurosurg Focus, V23, pE4; Garciaguirre JS, 2007, CHILD DEV, V78, P664, DOI 10.1111/j.1467-8624.2007.01020.x; GHORI GMU, 1985, EUR J APPL PHYSIOL O, V54, P145, DOI 10.1007/BF02335921; GOODMAN MJ, 1985, SEX ROLES, V12, P1199, DOI 10.1007/BF00287829; Griffin TM, 2003, J APPL PHYSIOL, V95, P172, DOI 10.1152/japplphysiol.00944.2002; GRINE FE, 1995, AM J PHYS ANTHROPOL, V97, P151, DOI 10.1002/ajpa.1330970207; HARRIS JWK, 1978, GEOLOGICAL BACKGROUN, P529; Harris LJ, 2010, LATERALITY, V15, P56, DOI 10.1080/13576500802584371; Hatala KG, 2013, J HUM EVOL, V65, P21, DOI 10.1016/j.jhevol.2013.03.009; Hawkes K, 1997, CURR ANTHROPOL, V38, P551, DOI 10.1086/204646; Hawkes K, 2001, CURR ANTHROPOL, V42, P681, DOI 10.1086/322559; Hay R.L., 1976, GEOLOGY OLDUVAI GORG; Hilton C. E, 1997, THESIS U NEW MEXICO THESIS U NEW MEXICO; Hilton CE, 2004, FROM BIPED TO STRIDER, P163; Hilton CE, 2008, CURR ANTHROPOL, V49, P144, DOI 10.1086/524760; HURTADO AM, 1985, HUM ECOL, V13, P1, DOI 10.1007/BF01531086; Isaac G.L., 1977, OLORGESAILIE; JONES NB, 1994, J ANTHROPOL RES, V50, P217, DOI 10.1086/jar.50.3.3630178; Jungers W.L., 1988, P115; JUNGERS WL, 1982, NATURE, V297, P676, DOI 10.1038/297676a0; JUNGERS WL, 1988, AM J PHYS ANTHROPOL, V76, P227, DOI 10.1002/ajpa.1330760211; Kanchan T, 2008, FORENSIC SCI INT, V179, P241, DOI 10.1016/j.forsciint.2008.04.029; Knapik JJ, 2004, MIL MED, V169, P45, DOI 10.7205/MILMED.169.1.45; Konner M. J., 2005, HUNTER GATHERER CHIL, P19, DOI DOI 10.4324/9780203789445-3; Kramer PA, 1998, AM J PHYS ANTHROPOL, V107, P71; Kramer PA, 1999, J EXP BIOL, V202, P2807; Kramer PA, 2004, FROM BIPED TO STRIDER, P101; Krishan K, 2008, FORENSIC SCI INT, V179, P63, DOI 10.1016/j.forsciint.2008.04.015; LaFiandra M, 2003, J BIOMECH, V36, P87, DOI 10.1016/S0021-9290(02)00243-9; LEAKEY MD, 1979, NATURE, V278, P317, DOI 10.1038/278317a0; LEAKEY MD, 1979, NATL GEOGR, V155, P446; Lee R. B., 1979, KUNG SAN MEN WOMEN W; Leonard WR, 1997, AM J PHYS ANTHROPOL, V102, P265, DOI 10.1002/(SICI)1096-8644(199702)102:2<265::AID-AJPA8>3.0.CO;2-X; Lloyd R, 2010, APPL ERGON, V41, P522, DOI 10.1016/j.apergo.2009.11.001; Lordkipanidze D, 2013, SCIENCE, V342, P326, DOI 10.1126/science.1238484; LOVEJOY CO, 1973, AM J PHYS ANTHROPOL, V38, P757, DOI 10.1002/ajpa.1330380315; Lovejoy CO, 2005, GAIT POSTURE, V21, P95, DOI 10.1016/j.gaitpost.2004.01.001; Lupo KD, 2006, J ARCHAEOL METHOD TH, V13, P19, DOI 10.1007/s10816-006-9000-6; MALOIY GMO, 1986, NATURE, V319, P668, DOI 10.1038/319668a0; McDonough AL, 2001, ARCH PHYS MED REHAB, V82, P419, DOI 10.1053/apmr.2001.19778; MCHENRY HM, 1992, AM J PHYS ANTHROPOL, V87, P407, DOI 10.1002/ajpa.1330870404; MCHENRY HM, 1991, J HUM EVOL, V20, P21, DOI 10.1016/0047-2484(91)90043-U; McVea DA, 2007, INTEGR COMP BIOL, V47, P457, DOI 10.1093/icb/icm053; Meldrum DJ, 2004, FROM BIPED TO STRIDER, P63; Naples Virginia L., 2004, Anatomical Record Part B:The New Anatomist, V279, P9, DOI 10.1002/ar.b.20025; National Geographic Society US,, 1988, BAKA PEOPL FOR; OCONNELL JF, 1988, CURR ANTHROPOL, V29, P356, DOI 10.1086/203648; Ogg HL, 1963, PHYS THER, V43, P717; PANTERBRICK C, 1992, EUR J APPL PHYSIOL O, V64, P477, DOI 10.1007/BF00625071; Pascoe DD, 1997, ERGONOMICS, V40, P631, DOI 10.1080/001401397187928; Pinnington HC, 2005, EUR J APPL PHYSIOL, V94, P242, DOI 10.1007/s00421-005-1323-6; Pontzer H, 2010, J HUM EVOL, V58, P492, DOI 10.1016/j.jhevol.2010.03.006; Potts R., 1988, EARLY HOMINID ACTIVI; PROST JH, 1980, AM J PHYS ANTHROPOL, V52, P175, DOI 10.1002/ajpa.1330520204; Racic V, 2009, J SOUND VIB, V326, P1, DOI 10.1016/j.jsv.2009.04.020; Raichlen DA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009769; Reno PL, 2010, PHILOS T R SOC B, V365, P3355, DOI 10.1098/rstb.2010.0086; REYNOLDS TR, 1987, AM J PHYS ANTHROPOL, V72, P101, DOI 10.1002/ajpa.1330720113; Rosenberg KR, 2004, BEHAV BRAIN SCI, V27, P522, DOI 10.1017/S0140525X04430118; Ross C, 2001, INT J PRIMATOL, V22, P749, DOI 10.1023/A:1012065332758; Ruff CB, 2000, AM J PHYS ANTHROPOL, V113, P507, DOI 10.1002/1096-8644(200012)113:4<507::AID-AJPA5>3.0.CO;2-F; RUFF CB, 1991, AM J PHYS ANTHROPOL, V86, P397, DOI 10.1002/ajpa.1330860306; Schmid P, 2004, FROM BIPED TO STRIDER, P49; SCHMID P, 1986, Vierteljahrsschrift der Naturforschenden Gesellschaft in Zuerich, V131, P145; SCOTT SH, 1993, J BIOMECH, V26, P1091, DOI 10.1016/S0021-9290(05)80008-9; STERN JT, 1983, AM J PHYS ANTHROPOL, V60, P279, DOI 10.1002/ajpa.1330600302; Steudel K, 1996, AM J PHYS ANTHROPOL, V99, P345; Steudel-Numbers KL, 2004, J HUM EVOL, V47, P95, DOI 10.1016/j.jhevol.2004.06.002; SUSMAN RL, 1984, FOLIA PRIMATOL, V43, P113, DOI 10.1159/000156176; Tanaka J., 1980, SAN HUNTER GATHERERS; Taylor AJ, 2004, GAIT POSTURE, V20, P232, DOI 10.1016/j.gaitpost.2003.02.001; Tong J., 2003, FOOT, V13, P83, DOI DOI 10.1016/S0958-2592(02)00149-9; Tuttle R, 2008, ICHNOS, V15, P158, DOI 10.1080/10420940802467892; Wall-Scheffler CM, 2007, AM J PHYS ANTHROPOL, V133, P841, DOI 10.1002/ajpa.20603; Wall-Scheffler CM, 2013, J HUM EVOL, V64, P448, DOI 10.1016/j.jhevol.2013.01.014; Wall-Scheffler CM, 2012, ANNU REV ANTHROPOL, V41, P71, DOI 10.1146/annurev-anthro-092611-145739; Wall-Scheffler CM, 2012, AM J PHYS ANTHROPOL, V147, P296; Wall-Scheffler CM, 2010, AM J PHYS ANTHROPOL, V143, P601, DOI 10.1002/ajpa.21356; Wall-Scheffler CM., 2012, J ANTHR, V2012, P1, DOI DOI 10.1155/2012/340493; Wang WJ, 2004, J ANAT, V204, P417, DOI 10.1111/j.0021-8782.2004.00295.x; Watson J, 2009, FOLIA PRIMATOL, V80, P309, DOI 10.1159/000258646; Watson JC, 2008, J HUM EVOL, V54, P675, DOI 10.1016/j.jhevol.2007.10.004; Webb D, 2011, AM J PHYS ANTHROPOL, V144, P307; Weijers RE, 2003, FOOT, V13, P70; Whitcome KK, 2007, NATURE, V450, P1075, DOI 10.1038/nature06342; WHITE TD, 1987, AM J PHYS ANTHROPOL, V72, P485, DOI 10.1002/ajpa.1330720409; White TD, 2009, SCIENCE, V326, P75, DOI 10.1126/science.1175802; Whiting J.W.M., 1994, CULTURE HUMAN DEV PP, P107; Wickler SJ, 2001, J APPL PHYSIOL, V90, P1548, DOI 10.1152/jappl.2001.90.4.1548; Witana CP, 2006, INT J IND ERGONOM, V36, P789, DOI 10.1016/j.ergon.2006.06.004; Zeanah DW, 2004, J ANTHROPOL ARCHAEOL, V23, P1, DOI 10.1016/S0278-4165(03)00061-8; Zelik KE, 2010, J EXP BIOL, V213, P4257, DOI 10.1242/jeb.044297	121	9	9	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2015	10	3							e0118619	10.1371/journal.pone.0118619	http://dx.doi.org/10.1371/journal.pone.0118619			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9JM	25738496	Green Published, Green Accepted, gold			2022-12-27	WOS:000350685900056
J	Zhang, SP; Tang, FT; Yang, YH; Lu, ML; Luan, AN; Zhang, J; Yang, J; Wang, HX				Zhang, Suping; Tang, Futian; Yang, Yuhong; Lu, Meili; Luan, Aina; Zhang, Jing; Yang, Juan; Wang, Hongxin			Astragaloside IV Protects against Isoproterenol-Induced Cardiac Hypertrophy by Regulating NF-kappa B/PGC-1 alpha Signaling Mediated Energy Biosynthesis	PLOS ONE			English	Article							FACTOR-KAPPA-B; FATTY-ACID OXIDATION; HEART-FAILURE; TRANSCRIPTIONAL CONTROL; MYOCARDIAL HYPERTROPHY; ERR-ALPHA; METABOLISM; PGC-1-ALPHA; RECEPTOR; ACTIVATION	We previously reported that Astragaloside IV (ASIV), a major active constituent of Astragalus membranaceus (Fisch) Bge protects against cardiac hypertrophy in rats induced by isoproterenol (Iso), however the mechanism underlying the protection remains unknown. Dysfunction of cardiac energy biosynthesis contributes to the hypertrophy and Nuclear Factor kappa B (NF-kappa B)/Peroxisome Proliferator-Activated Receptor-gamma Coactivator 1 alpha (PGC-1 alpha) signaling gets involved in the dysfunction. The present study was designed to investigate the mechanism by which ASIV improves the cardiac hypertrophy with focuses on the NF-kappa B/PGC-1 alpha signaling mediated energy biosynthesis. Sprague-Dawley (SD) rats or Neonatal Rat Ventricular Myocytes (NRVMs) were treated with Iso alone or in combination with ASIV. The results showed that combination with ASIV significantly attenuated the pathological changes, reduced the ratios of heart weight/body weight and Left ventricular weight/body weight, improved the cardiac hemodynamics, down-regulated mRNA expression of Atrial Natriuretic Peptide (ANP) and Brain Natriuretic Peptide (BNP), increased the ratio of ATP/AMP, and decreased the content of Free Fat Acid (FFA) in heart tissue of rats compared with Iso alone. In addition, pretreatment with ASIV significantly decreased the surface area and protein content, down-regulated mRNA expression of ANP and BNP, increased the ratio of ATP/AMP, and decreased the content of FFA in NRVMs compared with Iso alone. Furthermore, ASIV increased the protein expression of ATP5D, subunit of ATP synthase and PGC-1 alpha, inhibited translocation of p65, subunit of NF-kappa B into nuclear fraction in both rats and NRVMs compared with Iso alone. Parthenolide (Par), the specific inhibitor of p65, exerted similar effects as ASIV in NRVMs. Knockdown of p65 with siRNA decreased the surface areas and increased PGC-1 alpha expression of NRVMs compared with Iso alone. The results suggested that ASIV protects against Iso-induced cardiac hypertrophy through regulating NF-kappa B/PGC-1 alpha signaling mediated energy biosynthesis.	[Zhang, Suping; Tang, Futian; Yang, Yuhong; Lu, Meili; Luan, Aina; Zhang, Jing; Yang, Juan; Wang, Hongxin] Liaoning Med Univ, Inst Drug Res, Key Lab Cardiovasc & Cerebrovasc Drug Res Liaonin, Jinzhou, Liaoning, Peoples R China	Jinzhou Medical University	Wang, HX (corresponding author), Liaoning Med Univ, Inst Drug Res, Key Lab Cardiovasc & Cerebrovasc Drug Res Liaonin, Jinzhou, Liaoning, Peoples R China.	hongxinwang@lnmu.edu.cn			National Natural Science Foundation of the People's Republic of China [81374008]	National Natural Science Foundation of the People's Republic of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Natural Science Foundation (No. 81374008) of the People's Republic of China.	ALLARD MF, 1994, AM J PHYSIOL, V267, pH742, DOI 10.1152/ajpheart.1994.267.2.H742; Alvarez-Guardia D, 2010, CARDIOVASC RES, V87, P449, DOI 10.1093/cvr/cvq080; Arany Z, 2005, CELL METAB, V1, P259, DOI 10.1016/j.cmet.2005.03.002; Boucher FR, 2010, CARDIOVASC RES, V87, P403, DOI 10.1093/cvr/cvq185; Dufour CR, 2007, CELL METAB, V5, P345, DOI 10.1016/j.cmet.2007.03.007; Gupta S, 2002, J CELL BIOL, V159, P1019, DOI 10.1083/jcb.200207149; Hall G, 2006, J MOL CELL CARDIOL, V41, P580, DOI 10.1016/j.yjmcc.2006.07.006; Huss JM, 2004, CIRC RES, V95, P568, DOI 10.1161/01.RES.0000141774.29937.e3; Huss JM, 2004, MOL CELL BIOL, V24, P9079, DOI 10.1128/MCB.24.20.9079-9091.2004; Ingwall JS, 2009, CARDIOVASC RES, V81, P412, DOI 10.1093/cvr/cvn301; Johnson RF, 2012, TRENDS BIOCHEM SCI, V37, P317, DOI 10.1016/j.tibs.2012.04.002; KAGAYA Y, 1990, CIRCULATION, V81, P1353, DOI 10.1161/01.CIR.81.4.1353; Lehman JJ, 2002, CLIN EXP PHARMACOL P, V29, P339, DOI 10.1046/j.1440-1681.2002.03655.x; Leone TC, 2011, COLD SH Q B, V76, P175, DOI 10.1101/sqb.2011.76.011965; Lu ML, 2014, PLANTA MED, V80, P63, DOI 10.1055/s-0033-1360129; Lu ML, 2012, PHARMAZIE, V67, P182, DOI 10.1691/ph.2011.1622; Nichtova Z, 2012, GEN PHYSIOL BIOPHYS, V31, P141, DOI 10.4149/gpb_2012_015; Palomer X, 2009, CARDIOVASC RES, V81, P703, DOI 10.1093/cvr/cvn327; Planavila A, 2006, MINI-REV MED CHEM, V6, P357, DOI 10.2174/138955706776073457; Planavila A, 2005, J BIOL CHEM, V280, P17464, DOI 10.1074/jbc.M414220200; Planavila A, 2011, CARDIOVASC RES, V90, P276, DOI 10.1093/cvr/cvq376; Rosca MG, 2013, J MOL CELL CARDIOL, V55, P31, DOI 10.1016/j.yjmcc.2012.09.002; SCHULTHEISS HP, 1992, BASIC RES CARDIOL, V87, P311; Taegtmeyer H, 2002, CLIN EXP PHARMACOL P, V29, P346, DOI 10.1046/j.1440-1681.2002.03656.x; Tang D.-X., 2013, EVID-BASED COMPL ALT, V2013, DOI DOI 10.1155/2013/480597; Tu L, 2013, MICROCIRCULATION, V20, P736, DOI 10.1111/micc.12074; UNVERFERTH DV, 1988, AM HEART J, V115, P139, DOI 10.1016/0002-8703(88)90529-7; van Bilsen M, 2004, CARDIOVASC RES, V61, P218, DOI 10.1016/j.cardiores.2003.11.014; van Bilsen M, 1998, PFLUG ARCH EUR J PHY, V437, P2, DOI 10.1007/s004240050739; Wende AR, 2005, MOL CELL BIOL, V25, P10684, DOI 10.1128/MCB.25.24.10684-10694.2005; Yang J, 2013, J ETHNOPHARMACOL, V150, P1062, DOI 10.1016/j.jep.2013.10.017; Yndestad Arne, 2007, Curr Cardiol Rep, V9, P236, DOI 10.1007/BF02938356; Zhang J, 2013, EVID-BASED COMPL ALT, V2013, DOI DOI 10.1155/2013/378298; Zhang WD, 2006, LIFE SCI, V79, P808, DOI 10.1016/j.lfs.2006.02.032; Zuo YM, 2011, PHYTOTHER RES, V25, P732, DOI 10.1002/ptr.3331	35	32	35	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2015	10	3							e0118759	10.1371/journal.pone.0118759	http://dx.doi.org/10.1371/journal.pone.0118759			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9JM	25738576	Green Published, gold, Green Submitted			2022-12-27	WOS:000350685900066
J	Zhuang, GZ; Keeler, B; Grant, J; Bianchi, L; Fu, ES; Zhang, YP; Erasso, DM; Cul, JG; Wiltshire, T; Li, QZ; Hao, SL; Sarantopoulos, KD; Candiotti, K; Wishnek, SM; Smith, SB; Maixner, W; Diatchenko, L; Martin, ER; Levitt, RC				Zhuang, Gerald Z.; Keeler, Benjamin; Grant, Jeff; Bianchi, Laura; Fu, Eugene S.; Zhang, Yan Ping; Erasso, Diana M.; Cul, Jian-Guo; Wiltshire, Tim; Li, Qiongzhen; Hao, Shuanglin; Sarantopoulos, Konstantinos D.; Candiotti, Keith; Wishnek, Sarah M.; Smith, Shad B.; Maixner, William; Diatchenko, Luda; Martin, Eden R.; Levitt, Roy C.			Carbonic Anhydrase-8 Regulates Inflammatory Pain by Inhibiting the ITPR1-Cytosolic Free Calcium Pathway	PLOS ONE			English	Article							INOSITOL 1,4,5-TRISPHOSPHATE RECEPTOR; DEPENDENT-PROTEIN-KINASE; FAMILIAL ALZHEIMERS-DISEASE; CHRONIC CONSTRICTION INJURY; PRIMARY SENSORY NEURONS; LONG-TERM POTENTIATION; SPINAL NERVE LIGATION; TRISPHOSPHATE RECEPTOR; ENDOPLASMIC-RETICULUM; MECHANICAL ALLODYNIA	Calcium dysregulation is causally linked with various forms of neuropathology including seizure disorders, multiple sclerosis, Huntington's disease, Alzheimer's, spinal cerebellar ataxia (SCA) and chronic pain. Carbonic anhydrase-8 (Car8) is an allosteric inhibitor of inositol trisphosphate receptor-1 (ITPR1), which regulates intracellular calcium release fundamental to critical cellular functions including neuronal excitability, neurite outgrowth, neurotransmitter release, mitochondrial energy production and cell fate. In this report we test the hypothesis that Car8 regulation of ITPR1 and cytoplasmic free calcium release is critical to nociception and pain behaviors. We show Car8 null mutant mice (MT) exhibit mechanical allodynia and thermal hyperalgesia. Dorsal root ganglia (DRG) from MT also demonstrate increased steady-state ITPR1 phosphorylation (pITPR1) and cytoplasmic free calcium release. Overexpression of Car8 wildtype protein in MT nociceptors complements Car8 deficiency, down regulates pITPR1 and abolishes thermal and mechanical hypersensitivity. We also show that Car8 nociceptor overexpression alleviates chronic inflammatory pain. Finally, inflammation results in downregulation of DRG Car8 that is associated with increased pITPR1 expression relative to ITPR1, suggesting a possible mechanism of acute hypersensitivity. Our findings indicate Car8 regulates the ITPR1-cytosolic free calcium pathway that is critical to nociception, inflammatory pain and possibly other neuropathological states. Car8 and ITPR1 represent new therapeutic targets for chronic pain.				rlevitt@med.miami.edu	Smith, Shad/AAO-8760-2020		National Institutes of Health, National Institute of Craniofacial and Dental Research [R01DE022903]; NIDA National Institutes of Health, National Institute of Drug Abuse [R031410]; Algynomics Inc.; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE022903] Funding Source: NIH RePORTER	National Institutes of Health, National Institute of Craniofacial and Dental Research; NIDA National Institutes of Health, National Institute of Drug Abuse; Algynomics Inc.; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	Funding provided by R01DE022903, National Institutes of Health, National Institute of Craniofacial and Dental Research (RCL, ERM, WM, LD, SS); NIDA R031410 National Institutes of Health, National Institute of Drug Abuse (SH). Algynomics Inc. provided support in the form of salaries for authors SS, WM, LD, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Andersen PL, 2003, CELL MOL NEUROBIOL, V23, P205, DOI 10.1023/A:1022902006434; Augustine GJ, 2001, CURR OPIN NEUROBIOL, V11, P320, DOI 10.1016/S0959-4388(00)00214-2; Bengtson CP, 2010, BIOPHYS J, V99, P4066, DOI 10.1016/j.bpj.2010.10.044; BERRIDGE MJ, 1993, NATURE, V361, P315, DOI 10.1038/361315a0; Berridge MJ, 1998, NEURON, V21, P13, DOI 10.1016/S0896-6273(00)80510-3; BEZPROZVANNY I, 1993, NEURON, V10, P1175, DOI 10.1016/0896-6273(93)90065-Y; BEZPROZVANNY I, 1991, NATURE, V351, P751, DOI 10.1038/351751a0; Boehmerle W, 2007, P NATL ACAD SCI USA, V104, P11103, DOI 10.1073/pnas.0701546104; Boehning D, 2003, NAT CELL BIOL, V5, P1051, DOI 10.1038/ncb1063; Boehning D, 2005, P NATL ACAD SCI USA, V102, P1466, DOI 10.1073/pnas.0409650102; Bruce JIE, 2002, J BIOL CHEM, V277, P1340, DOI 10.1074/jbc.M106609200; Carrasco MA, 2004, BIOL RES, V37, P701, DOI 10.4067/S0716-97602004000400028; CHAPLAN SR, 1994, J NEUROSCI METH, V53, P55, DOI 10.1016/0165-0270(94)90144-9; DANOFF SK, 1991, P NATL ACAD SCI USA, V88, P2951, DOI 10.1073/pnas.88.7.2951; deSouza N, 2002, J BIOL CHEM, V277, P39397, DOI 10.1074/jbc.M207059200; Diatchenko L, 2006, PAIN, V123, P226, DOI 10.1016/j.pain.2006.04.015; Dolmetsch RE, 2001, SCIENCE, V294, P333, DOI 10.1126/science.1063395; Dolmetsch RE, 1997, NATURE, V386, P855, DOI 10.1038/386855a0; Fairless R, 2014, CELL TISSUE RES, V357, P455, DOI 10.1007/s00441-013-1758-8; Fang L, 2002, J NEUROSCI, V22, P4196, DOI 10.1523/JNEUROSCI.22-10-04196.2002; FERRIS CD, 1991, BIOCHEM BIOPH RES CO, V175, P192, DOI 10.1016/S0006-291X(05)81219-7; FERRIS CD, 1991, P NATL ACAD SCI USA, V88, P2232, DOI 10.1073/pnas.88.6.2232; GHOSH A, 1995, SCIENCE, V268, P239, DOI 10.1126/science.7716515; Giovannucci DR, 2000, J BIOL CHEM, V275, P33704, DOI 10.1074/jbc.M004278200; Gunter TE, 2001, IUBMB LIFE, V52, P197, DOI 10.1080/15216540152846000; Hamamoto DT, 2007, EUR J PHARMACOL, V558, P73, DOI 10.1016/j.ejphar.2006.11.062; Hardingham GE, 2001, NAT NEUROSCI, V4, P261, DOI 10.1038/85109; HARGREAVES K, 1988, PAIN, V32, P77, DOI 10.1016/0304-3959(88)90026-7; Haug LS, 1999, J BIOL CHEM, V274, P7467, DOI 10.1074/jbc.274.11.7467; Hirasawa M, 2007, MOL CELL NEUROSCI, V35, P161, DOI 10.1016/j.mcn.2007.02.013; Hirota J, 2003, BIOCHEM J, V372, P435, DOI 10.1042/BJ20030110; Ikeda H, 2006, SCIENCE, V312, P1659, DOI 10.1126/science.1127233; Inoue T, 1998, J NEUROSCI, V18, P5366, DOI 10.1523/JNEUROSCI.18-14-05366.1998; Jayaraman T, 1996, SCIENCE, V272, P1492, DOI 10.1126/science.272.5267.1492; Ji RR, 2003, TRENDS NEUROSCI, V26, P696, DOI 10.1016/j.tins.2003.09.017; Jiao Y, 2005, GENETICS, V171, P1239, DOI 10.1534/genetics.105.044487; Jones TL, 2007, ANESTH ANALG, V105, P1650, DOI 10.1213/01.ane.0000287644.00420.49; Kawaai K, 2009, J BIOL CHEM, V284, P372, DOI 10.1074/jbc.M805828200; Kim HY, 2011, J NEUROSCI, V31, P12982, DOI 10.1523/JNEUROSCI.3093-11.2011; LAWSON SN, 1991, J PHYSIOL-LONDON, V435, P41, DOI 10.1113/jphysiol.1991.sp018497; Leissring MA, 1999, J BIOL CHEM, V274, P32535, DOI 10.1074/jbc.274.46.32535; LEVYLAHAD E, 1995, SCIENCE, V269, P973, DOI 10.1126/science.7638622; Lim D, 2008, J BIOL CHEM, V283, P5780, DOI 10.1074/jbc.M704704200; LIU XG, 1995, NEUROSCI LETT, V191, P43, DOI 10.1016/0304-3940(95)11553-0; Luo C, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001283; Mak DOD, 1999, J BIOL CHEM, V274, P22231, DOI 10.1074/jbc.274.32.22231; METZGER H, 1981, ARZNEIMITTEL-FORSCH, V31-2, P1248; MIGNERY GA, 1990, EMBO J, V9, P3893, DOI 10.1002/j.1460-2075.1990.tb07609.x; Mikoshiba K, 1997, CURR OPIN NEUROBIOL, V7, P339, DOI 10.1016/S0959-4388(97)80061-X; Miyata M, 2000, NEURON, V28, P233, DOI 10.1016/S0896-6273(00)00099-4; MIYAWAKI A, 1991, P NATL ACAD SCI USA, V88, P4911, DOI 10.1073/pnas.88.11.4911; NAKADE S, 1994, J BIOL CHEM, V269, P6735; Obata K, 2003, PAIN, V101, P65, DOI 10.1016/S0304-3959(02)00296-8; ONEILL C, 2001, BIOCH SOC S, V67, P177, DOI DOI 10.1042/BSS0670177; Petrenko AB, 2003, ANESTH ANALG, V97, P1108, DOI 10.1213/01.ANE.0000081061.12235.55; RANDIC M, 1993, J NEUROSCI, V13, P5228, DOI 10.1523/JNEUROSCI.13-12-05228.1993; RANG HP, 1988, J NEUROSCI, V8, P2606; Rizzuto R, 2001, CURR OPIN NEUROBIOL, V11, P306, DOI 10.1016/S0959-4388(00)00212-9; ROGAEV EI, 1995, NATURE, V376, P775, DOI 10.1038/376775a0; Ruscheweyh R, 2007, J COMP NEUROL, V502, P325, DOI 10.1002/cne.21311; SCHEPELMANN K, 1993, EXP BRAIN RES, V92, P391; Schmitz-Hubsch T, 2010, MOVEMENT DISORD, V25, P587, DOI 10.1002/mds.22740; Simonetti M, 2013, NEURON, V77, P43, DOI 10.1016/j.neuron.2012.10.037; Sjoblom B, 1996, FEBS LETT, V398, P322, DOI 10.1016/S0014-5793(96)01263-X; Storek B, 2008, P NATL ACAD SCI USA, V105, P1055, DOI 10.1073/pnas.0708003105; SUPATTAPONE S, 1988, P NATL ACAD SCI USA, V85, P8747, DOI 10.1073/pnas.85.22.8747; Tang TS, 2003, NEURON, V39, P227, DOI 10.1016/S0896-6273(03)00366-0; Tang TS, 2003, J NEUROSCI, V23, P403, DOI 10.1523/JNEUROSCI.23-02-00403.2003; Tertyshnikova S, 1998, P NATL ACAD SCI USA, V95, P1613, DOI 10.1073/pnas.95.4.1613; Tertyshnikova X, 1998, J PHYSIOL-LONDON, V512, P89, DOI 10.1111/j.1469-7793.1998.089bf.x; Towne C, 2009, MOL PAIN, V5, DOI 10.1186/1744-8069-5-52; Turkmen S, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000487; Vanderheyden V, 2009, BBA-MOL CELL RES, V1793, P959, DOI 10.1016/j.bbamcr.2008.12.003; Verkhratsky A, 2004, BIOL RES, V37, P693; Wojcikiewicz RJH, 1998, J BIOL CHEM, V273, P5670, DOI 10.1074/jbc.273.10.5670; WOOLF CJ, 1983, NATURE, V306, P686, DOI 10.1038/306686a0; Woolf CJ, 2000, SCIENCE, V288, P1765, DOI 10.1126/science.288.5472.1765; WORLEY PF, 1987, NATURE, V325, P159, DOI 10.1038/325159a0; Wu LJ, 2009, NEUROTHERAPEUTICS, V6, P693, DOI 10.1016/j.nurt.2009.07.008; Xu Y, 2003, HUM GENE THER, V14, P897, DOI 10.1089/104303403765701187; YAMADA M, 1995, BIOCHEM J, V308, P83, DOI 10.1042/bj3080083; Yule DI, 2003, BIOCHEM SOC T, V31, P954; Zeitz KP, 2004, NEUROSCIENCE, V128, P889, DOI 10.1016/j.neuroscience.2004.07.029; Zhang C, 2009, NATURE, V460, P632, DOI 10.1038/nature08177; Zhuang ZY, 2010, J NEUROSCI, V30, P16015, DOI 10.1523/JNEUROSCI.0481-10.2010; Zhuang ZY, 2005, PAIN, V114, P149, DOI 10.1016/j.pain.2004.12.022; Zhuang ZY, 2006, J NEUROSCI, V26, P3551, DOI 10.1523/JNEUROSCI.5290-05.2006; Zhuang ZY, 2004, J NEUROSCI, V24, P8300, DOI 10.1523/JNEUROSCI.2893-04.2004; Zhuo M, 2009, MOL BRAIN, V2, DOI 10.1186/1756-6606-2-4	89	24	28	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2015	10	3							e0118273	10.1371/journal.pone.0118273	http://dx.doi.org/10.1371/journal.pone.0118273			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4HV	25734498	Green Published, gold, Green Submitted			2022-12-27	WOS:000350314700020
J	Bisconte, MG; Caldora, M; Musollino, G; Cardiero, G; Flagiello, A; La Porta, G; Lagona, L; Prezioso, R; Qualtieri, G; Gaudiano, C; Medulla, E; Merlino, A; Pucci, P; Lacerra, G				Bisconte, Maria Grazia; Caldora, Mercedes; Musollino, Gennaro; Cardiero, Giovanna; Flagiello, Angela; La Porta, Gaetana; Lagona, Laura; Prezioso, Romeo; Qualtieri, Gabriele; Gaudiano, Carlo; Medulla, Emilia; Merlino, Antonello; Pucci, Piero; Lacerra, Giuseppina			alpha-Thalassemia Associated with Hb Instability: A Tale of Two Features. The Case of Hb Rogliano or alpha 1 Cod 108(G15)Thr -> Asn and Hb Policoro or alpha 2 Cod 124(H7)Ser -> Pro	PLOS ONE			English	Article							HEMOGLOBIN-STABILIZING PROTEIN; AHSP; MUTATIONS; MECHANISM; VARIANTS; MUTANT; BINDING; GENES; MODEL	We identified two new variants in the third exon of the alpha-globin gene in families from southern Italy: the Hb Rogliano, alpha 1 cod108 ACC>AAC or alpha 1[alpha 108(G15)Thr -> Asn] and the Hb Policoro, alpha 2 cod124 TCC>CCC or alpha 2[alpha 124(H7)Ser -> Pro]. The carriers showed mild alpha-thalassemia phenotype and abnormal hemoglobin stability features. These mutations occurred in the G and H helices of the alpha-globin both involved in the specific recognition of AHSP and beta 1 chain. Molecular characterization of mRNA, globin chain analyses and molecular modelling studies were carried out to highlight the mechanisms causing the alpha-thalassemia phenotype. The results demonstrated that the alpha-thalassemia defect associated with the two Hb variants originated by different defects. Hb Rogliano showed an intrinsic instability of the tetramer due to anomalous intra-and inter-chain interactions suggesting that the variant chain is normally synthesized and complexed with AHSP but rapidly degraded because it is unable to form the alpha 1 beta 1 dimers. On the contrary in the case of Hb Policoro two different molecular mechanisms were shown: the reduction of the variant mRNA level by an unclear mechanism and the protein instability due to impairment of AHSP interaction. These data highlighted that multiple approaches, including mRNA quantification, are needed to properly identify the mechanisms leading to the alpha-thalassemia defect. Elucidation of the specific mechanism leads to the definition of a given phenotype providing important guidance for the diagnosis of unstable variants.	[Bisconte, Maria Grazia; La Porta, Gaetana; Qualtieri, Gabriele] OOC Ematol AO, UOS Microciternia & Patol Globulo Rosso, Cosenza, Italy; [Caldora, Mercedes] PO San Giovanni Bosco ASL NA1, Lab Specialist Ematol, Naples, Italy; [Musollino, Gennaro; Cardiero, Giovanna; Prezioso, Romeo; Lacerra, Giuseppina] CNR, Ist Genet & Biofis Adriano Buzzati Traverso, I-80125 Naples, Italy; [Flagiello, Angela; Pucci, Piero] Univ Naples Federico II, Dipartimento Sci Chim & Ceinge Biotecnol Avanzate, Naples, Italy; [Lagona, Laura; Medulla, Emilia] UOD Thalassemia, ARNAS Garibaldi, Catania, Italy; [Gaudiano, Carlo] Osped Civile, Ctr Lotta Contro Microcitemie, Matera, Italy; [Merlino, Antonello] Univ Naples Federico II, Dipartimento Sci Chim, Naples, Italy; [Merlino, Antonello] CNR Napoli, Ist Biostrutture & Bioimmagini, Naples, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto di Genetica e Biofisica "Adriano Buzzati-Traverso" (IGB-CNR); CEINGE Biotecnologie Avanzate; University of Naples Federico II; University of Naples Federico II; Consiglio Nazionale delle Ricerche (CNR); Istituto di Biostrutture e Bioimmagini (IBB-CNR)	Lacerra, G (corresponding author), CNR, Ist Genet & Biofis Adriano Buzzati Traverso, I-80125 Naples, Italy.	giuseppina.lacerra@igb.cnr.it	Merlino, Antonello/AAI-2114-2020; Prezioso, Romeo/AAY-4681-2020; Lacerra, Giuseppina/I-4474-2012	Prezioso, Romeo/0000-0002-3523-9930; Lacerra, Giuseppina/0000-0003-1038-8363; Merlino, Antonello/0000-0002-1045-7720; PUCCI, Pietro/0000-0002-5885-1495	Ministero Istruzione, Universita e Ricerca, (MIUR), Legge 488/92 [C02]	Ministero Istruzione, Universita e Ricerca, (MIUR), Legge 488/92(Ministry of Education, Universities and Research (MIUR))	This research project was supported by a grant from Ministero Istruzione, Universita e Ricerca, (MIUR), Legge 488/92 (Cluster C02, Project 2).	Andersen O, 2014, BMC EVOL BIOL, V14, DOI 10.1186/1471-2148-14-54; BOISSEL JP, 1993, J BIOL CHEM, V268, P15983; Chong SS, 2000, BLOOD, V95, P360; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fasken MB, 2009, RNA BIOL, V6, P237, DOI 10.4161/rna.6.3.8330; Feng L, 2005, NATURE, V435, P697, DOI 10.1038/nature03609; Feng L, 2004, CELL, V119, P629, DOI 10.1016/j.cell.2004.11.025; FERMI G, 1984, J MOL BIOL, V175, P159, DOI 10.1016/0022-2836(84)90472-8; GOOSSENS M, 1982, NATURE, V296, P864, DOI 10.1038/296864a0; Guex N, 2009, ELECTROPHORESIS, V30, pS162, DOI 10.1002/elps.200900140; Harteveld CL, 2006, HEMOGLOBIN, V30, P349, DOI 10.1080/03630260600755351; HIGGS DR, 1984, NUCLEIC ACIDS RES, V12, P6965, DOI 10.1093/nar/12.18.6965; Huisman THJ, 1977, HEMOGLOBINOPATHIES T; Joly P, 2008, HEMOGLOBIN, V32, P411, DOI 10.1080/03630260802173791; Kutlar F, 2007, HEMOGLOBIN, V31, P243, DOI 10.1080/03630260701297071; Lacerra G, 2000, P NATL ACAD SCI USA, V97, P9591, DOI 10.1073/pnas.97.17.9591; Lacerra G, 2004, HUM MUTAT, V24, P338, DOI 10.1002/humu.20088; Lacerra G, 2003, HEMOGLOBIN, V27, P149, DOI 10.1081/HEM-120023378; Lacerra G, 2004, 3 C NAZ SOSTE CASS F, P48; Lacerra G, 2003, 9 INT C THAL HAEM CI; Lacerra G, 2007, HAEMATOLOGICA, V93, P141, DOI 10.3324/haematol.11789; Lacerra G, 2007, HAEMATOLOGICA, V92, P254, DOI 10.3324/haematol.10736; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LEONE L, 1985, J CHROMATOGR, V321, P407, DOI 10.1016/S0021-9673(01)90459-5; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; Musollino G, 2012, ANN HEMATOL, V91, P1695, DOI 10.1007/s00277-012-1526-y; Patrinos GP, 2004, NUCLEIC ACIDS RES, V32, pD537, DOI 10.1093/nar/gkh006; Peixeiro I, 2011, HAEMATOL-HEMATOL J, V96, P905, DOI 10.3324/haematol.2010.039206; Perez-Ortin JE, 2013, J MOL BIOL, V425, P3750, DOI 10.1016/j.jmb.2013.02.029; PIELA L, 1987, BIOPOLYMERS, V26, P1587, DOI 10.1002/bip.360260910; Poyart C, 1996, MOL ASPECTS MED, V17, P129, DOI 10.1016/0098-2997(96)88344-0; Rodgers ND, 2002, RNA, V8, P1526, DOI 10.1017/S1355838202029035; Shyu AB, 2008, EMBO J, V27, P471, DOI 10.1038/sj.emboj.7601977; Tamaddoni A, 2009, HEMOGLOBIN, V33, P115, DOI 10.1080/03630260902817297; Turbpaiboon C, 2006, BRIT J HAEMATOL, V132, P370, DOI 10.1111/j.1365-2141.2005.05865.x; Vasseur C, 2009, CLIN BIOCHEM, V42, P1818, DOI 10.1016/j.clinbiochem.2009.05.011; Vasseur-Godbillon C, 2006, BLOOD CELL MOL DIS, V37, P173, DOI 10.1016/j.bcmd.2006.09.002; Vyas VK, 2012, INDIAN J PHARM SCI, V74, P1, DOI 10.4103/0250-474X.102537; Wajcman H, 2008, HEMOGLOBIN, V32, P327, DOI 10.1080/03630260802173833; Yu X, 2009, BLOOD, V113, P5961, DOI 10.1182/blood-2008-12-196030	40	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2015	10	3							e0115738	10.1371/journal.pone.0115738	http://dx.doi.org/10.1371/journal.pone.0115738			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9JF	25730315	Green Published, Green Submitted, gold			2022-12-27	WOS:000350684900008
J	Grass, I; Brandl, R; Botzat, A; Neuschulz, EL; Farwig, N				Grass, Ingo; Brandl, Roland; Botzat, Alexandra; Neuschulz, Eike Lena; Farwig, Nina			Contrasting Taxonomic and Phylogenetic Diversity Responses to Forest Modifications: Comparisons of Taxa and Successive Plant Life Stages in South African Scarp Forest	PLOS ONE			English	Article							FUNCTIONAL DIVERSITY; COMMUNITY ECOLOGY; BIODIVERSITY; LANDSCAPE; TREE; ASSEMBLAGES; RICHNESS; SERVICES; CONSERVATION; CONVERGENCE	The degradation of natural forests to modified forests threatens subtropical and tropical biodiversity worldwide. Yet, species responses to forest modification vary considerably. Furthermore, effects of forest modification can differ, whether with respect to diversity components (taxonomic or phylogenetic) or to local (alpha-diversity) and regional (beta-diversity) spatial scales. This real-world complexity has so far hampered our understanding of subtropical and tropical biodiversity patterns in human-modified forest landscapes. In a subtropical South African forest landscape, we studied the responses of three successive plant life stages (adult trees, saplings, seedlings) and of birds to five different types of forest modification distinguished by the degree of within-forest disturbance and forest loss. Responses of the two taxa differed markedly. Thus, the taxonomic a-diversity of birds was negatively correlated with the diversity of all plant life stages and, contrary to plant diversity, increased with forest disturbance. Conversely, forest disturbance reduced the phylogenetic a-diversity of all plant life stages but not that of birds. Forest loss neither affected taxonomic nor phylogenetic diversity of any taxon. On the regional scale, taxonomic but not phylogenetic beta-diversity of both taxa was well predicted by variation in forest disturbance and forest loss. In contrast to adult trees, the phylogenetic diversity of saplings and seedlings showed signs of contemporary environmental filtering. In conclusion, forest modification in this subtropical landscape strongly shaped both local and regional biodiversity but with contrasting outcomes. Phylogenetic diversity of plants may be more threatened than that of mobile species such as birds. The reduced phylogenetic diversity of saplings and seedlings suggests losses in biodiversity that are not visible in adult trees, potentially indicating time-lags and contemporary shifts in forest regeneration. The different responses of taxonomic and phylogenetic diversity to forest modifications imply that biodiversity conservation in this subtropical landscape requires the preservation of natural and modified forests.	[Grass, Ingo; Farwig, Nina] Univ Marburg, Fac Biol, Dept Ecol Conservat Ecol, Marburg, Germany; [Brandl, Roland] Univ Marburg, Fac Biol, Dept Ecol Anim Ecol, Marburg, Germany; [Botzat, Alexandra] Tech Univ Berlin, Dept Ecol, Berlin, Germany; [Neuschulz, Eike Lena] Biodivers & Climate Res Ctr BiK F, Frankfurt, Main, Germany; [Neuschulz, Eike Lena] Senckenberg Gesell Nat Forsch, Frankfurt, Main, Germany	Philipps University Marburg; Philipps University Marburg; Technical University of Berlin; Senckenberg Biodiversitat & Klima- Forschungszentrum (BiK-F); Senckenberg Gesellschaft fur Naturforschung (SGN); Senckenberg Gesellschaft fur Naturforschung (SGN)	Grass, I (corresponding author), Univ Gottingen, Dept Crop Sci Agroecol, Grisebachstr 6, D-37073 Gottingen, Germany.	ingo.grass@agr.uni-goettingen.de	Grass, Ingo/H-7609-2019	Grass, Ingo/0000-0001-7788-1940	Robert Bosch Stiftung [32.5.8043.0004.0]	Robert Bosch Stiftung	The study was funded by the Robert Bosch Stiftung (grant number: 32.5.8043.0004.0. / www.bosch-stiftung.de). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albrecht J, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4810; Baldissera R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048099; Barton K., 2013, MUMIN MULTI MODEL IN; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Berens DG, 2014, BIOTROPICA, V46, P350, DOI 10.1111/btp.12104; Blanchet FG, 2008, ECOLOGY, V89, P2623, DOI 10.1890/07-0986.1; Boon R., 2010, POOLEYS TREES E S AF; Borcard D, 2002, ECOL MODEL, V153, P51, DOI 10.1016/S0304-3800(01)00501-4; BORCARD D, 1992, ECOLOGY, V73, P1045, DOI 10.2307/1940179; Botzat A, PLANT ECOL UNPUB; Botzat A, 2013, J TROP ECOL, V29, P111, DOI 10.1017/S0266467413000102; Brown KA, 2004, P NATL ACAD SCI USA, V101, P6045, DOI 10.1073/pnas.0401456101; Burnham K.P., 2002, PRACTICAL INFORM THE, V2nd ed., DOI [DOI 10.1007/B97636, 10.1007/b97636]; Cadotte MW, 2013, P NATL ACAD SCI USA, V110, P8996, DOI 10.1073/pnas.1301685110; Cadotte MW, 2012, ECOLOGY, V93, pS223, DOI 10.1890/11-0426.1; Cardillo M, 2011, PHILOS T R SOC B, V366, P2545, DOI 10.1098/rstb.2011.0021; Cavender-Bares J, 2009, ECOL LETT, V12, P693, DOI 10.1111/j.1461-0248.2009.01314.x; Coates Palgrave M, 2005, KEITH COATES PALGRAV; Cooper KH, 1985, CONSERVATION STATUS; Cornwell WK, 2006, ECOLOGY, V87, P1465, DOI 10.1890/0012-9658(2006)87[1465:ATTFHF]2.0.CO;2; de Bello F, 2010, J VEG SCI, V21, P992, DOI 10.1111/j.1654-1103.2010.01195.x; Devictor V, 2010, ECOL LETT, V13, P1030, DOI 10.1111/j.1461-0248.2010.01493.x; Dirzo R, 2003, ANNU REV ENV RESOUR, V28, P137, DOI 10.1146/annurev.energy.28.050302.105532; Dray, 2011, PACKFOR FORWARD SELE, P46; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Eeley HAC, 2001, BIODIVERS CONSERV, V10, P1221, DOI 10.1023/A:1016677110980; Ewers RM, 2006, BIOL REV, V81, P117, DOI 10.1017/S1464793105006949; Ferraz G, 2003, P NATL ACAD SCI USA, V100, P14069, DOI 10.1073/pnas.2336195100; Foley JA, 2005, SCIENCE, V309, P570, DOI 10.1126/science.1111772; Forest F, 2007, NATURE, V445, P757, DOI 10.1038/nature05587; Gardner TA, 2009, ECOL LETT, V12, P561, DOI 10.1111/j.1461-0248.2009.01294.x; Gastauer M, 2013, ECOL INFORM, V15, P85, DOI 10.1016/j.ecoinf.2013.03.005; Gibson L, 2011, NATURE, V478, P378, DOI 10.1038/nature10425; Rigueira DMG, 2013, BIODIVERS CONSERV, V22, P3141, DOI 10.1007/s10531-013-0575-4; Graham CH, 2008, ECOL LETT, V11, P1265, DOI 10.1111/j.1461-0248.2008.01256.x; Grass I, 2014, OIKOS, V123, P575, DOI 10.1111/j.1600-0706.2013.00920.x; Grime JP, 2006, J VEG SCI, V17, P255, DOI 10.1111/j.1654-1103.2006.tb02444.x; Grueber CE, 2011, J EVOLUTION BIOL, V24, P699, DOI 10.1111/j.1420-9101.2010.02210.x; JACKSON DA, 1993, ECOLOGY, V74, P2204, DOI 10.2307/1939574; Jetz W, 2012, NATURE, V491, P444, DOI 10.1038/nature11631; Jost L, 2007, ECOLOGY, V88, P2427, DOI 10.1890/06-1736.1; Kembel SW, 2010, BIOINFORMATICS, V26, P1463, DOI 10.1093/bioinformatics/btq166; Kotze DJ, 2007, AUSTRAL ECOL, V32, P294, DOI 10.1111/j.1442-9993.2007.01694.x; Kuhn TS, 2011, METHODS ECOL EVOL, V2, P427, DOI 10.1111/j.2041-210X.2011.00103.x; Laurance William F, 2006, Ecology, V87, P469, DOI 10.1890/05-0064; Lawes MJ, 2005, J VEG SCI, V16, P363, DOI 10.1658/1100-9233(2005)016[0363:ABNEOW]2.0.CO;2; LAWES MJ, 1990, J BIOGEOGR, V17, P669, DOI 10.2307/2845148; Luck GW, 2003, ECOL APPL, V13, P235, DOI 10.1890/1051-0761(2003)013[0235:TCBARC]2.0.CO;2; MACARTHUR R, 1967, AM NAT, V101, P377, DOI 10.1086/282505; Menke S, 2012, OIKOS, V121, P1553, DOI 10.1111/j.1600-0706.2011.20210.x; Metzger JP, 2009, BIOL CONSERV, V142, P1166, DOI 10.1016/j.biocon.2009.01.033; Mucina L., 2006, VEGETATION S AFRICA; Mulwa RK, 2012, BIOTROPICA, V44, P801, DOI 10.1111/j.1744-7429.2012.00877.x; Myers N, 1996, P NATL ACAD SCI USA, V93, P2764, DOI 10.1073/pnas.93.7.2764; Neuschulz EL, 2013, ANIM CONSERV, V16, P170, DOI 10.1111/j.1469-1795.2012.00582.x; Neuschulz EL, 2013, AUSTRAL ECOL, V38, P374, DOI 10.1111/j.1442-9993.2012.02417.x; Neuschulz EL, 2011, OIKOS, V120, P1371, DOI 10.1111/j.1600-0706.2011.19097.x; Newbold T, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2131; R Core Team, 2021, R LANGUAGE ENV STAT; Ranganathan J, 2008, P NATL ACAD SCI USA, V105, P17852, DOI 10.1073/pnas.0808874105; RAO CR, 1982, THEOR POPUL BIOL, V21, P24, DOI 10.1016/0040-5809(82)90004-1; Sala OE, 2000, SCIENCE, V287, P1770, DOI 10.1126/science.287.5459.1770; Santos BA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012625; Sekercioglu CH, 2006, TRENDS ECOL EVOL, V21, P464, DOI 10.1016/j.tree.2006.05.007; Sodhi NS, 2008, DIVERS DISTRIB, V14, P1, DOI 10.1111/j.1472-4642.2007.00398.x; Srivastava DS, 2012, ECOL LETT, V15, P637, DOI 10.1111/j.1461-0248.2012.01795.x; Stork NE, 2009, CONSERV BIOL, V23, P1438, DOI 10.1111/j.1523-1739.2009.01335.x; Swenson NG, 2012, ECOLOGY, V93, pS112, DOI 10.1890/11-0402.1; TILMAN D, 1994, NATURE, V371, P65, DOI 10.1038/371065a0; Tscharntke T, 2008, ECOLOGY, V89, P944, DOI 10.1890/07-0455.1; Tucker CM, 2013, DIVERS DISTRIB, V19, P845, DOI 10.1111/ddi.12087; Webb CO, 2005, MOL ECOL NOTES, V5, P181, DOI 10.1111/j.1471-8286.2004.00829.x; Webb CO, 2002, ANNU REV ECOL SYST, V33, P475, DOI 10.1146/annurev.ecolsys.33.010802.150448	73	16	16	6	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2015	10	2							e0118722	10.1371/journal.pone.0118722	http://dx.doi.org/10.1371/journal.pone.0118722			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC2ZH	25719204	Green Published, gold, Green Submitted			2022-12-27	WOS:000350213200059
J	Kassian, A				Kassian, Alexei			Towards a Formal Genealogical Classification of the Lezgian Languages (North Caucasus): Testing Various Phylogenetic Methods on Lexical Data	PLOS ONE			English	Article							INFERENCE	A lexicostatistical classification is proposed for 20 languages and dialects of the Lezgian group of the North Caucasian family, based on meticulously compiled 110-item wordlists, published as part of the Global Lexicostatistical Database project. The lexical data have been subsequently analyzed with the aid of the principal phylogenetic methods, both distance-based and character-based: Starling neighbor joining (StarlingNJ), Neighbor joining (NJ), Unweighted pair group method with arithmetic mean (UPGMA), Bayesian Markov chain Monte Carlo (MCMC), Unweighted maximum parsimony (UMP). Cognation indexes within the input matrix were marked by two different algorithms: traditional etymological approach and phonetic similarity, i.e., the automatic method of consonant classes (Levenshtein distances). Due to certain reasons (first of all, high lexicographic quality of the wordlists and a consensus about the Lezgian phylogeny among Caucasologists), the Lezgian database is a perfect testing area for appraisal of phylogenetic methods. For the etymology-based input matrix, all the phylogenetic methods, with the possible exception of UMP, have yielded trees that are sufficiently compatible with each other to generate a consensus phylogenetic tree of the Lezgian lects. The obtained consensus tree agrees with the traditional expert classification as well as some of the previously proposed formal classifications of this linguistic group. Contrary to theoretical expectations, the UMP method has suggested the least plausible tree of all. In the case of the phonetic similarity-based input matrix, the distance-based methods (StarlingNJ, NJ, UPGMA) have produced the trees that are rather close to the consensus etymology-based tree and the traditional expert classification, whereas the character-based methods (Bayesian MCMC, UMP) have yielded less likely topologies.	[Kassian, Alexei] Russian Acad Sci, Inst Linguist, Dept Anatolian & Celt Languages, Moscow, Russia; [Kassian, Alexei] Russian Presidential Acad Natl Econ & Publ Adm, Sch Adv Studies Humanities, Moscow, Russia	Institute of Linguistics, Russian Academy of Sciences; Russian Academy of Sciences; Russian Presidential Academy of National Economy & Public Administration	Kassian, A (corresponding author), Russian Acad Sci, Inst Linguist, Dept Anatolian & Celt Languages, Moscow, Russia.	a.kassian@gmail.com	Kassian, Alexei S./C-7281-2015	Kassian, Alexei S./0000-0003-1129-2611	Institute of the Middle East (Moscow)	Institute of the Middle East (Moscow)	Financial support was provided by the Institute of the Middle East (Moscow). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alekseev ME, 1984, VOPROSY YAZYKOZNANIY, V5, P88; Alekseev Mikhail E., 1985, VOPROSY SRAVNITELNO; [Anonymous], 2010, J LANGUAGE RELATIONS, V3, P79; Balanovsky O, 2011, MOL BIOL EVOL, V28, P2905, DOI 10.1093/molbev/msr126; Barbancon F, 2013, DIACHRONICA, V30, P143, DOI 10.1075/dia.30.2.01bar; Baxter W. H., 2000, TIME DEPTH HIST LING, V1, P167; BAXTER WH, 1995, J CHINESE LINGUISTIC, V8, P1; Brown CH, 2013, LANGUAGE, V89, P4; Burlak Svetlana, 2005, SRAVNITELNO ISTORICH; Campbell Lyle, 2008, LANGUAGE CLASSIFICAT; Dolgopolsky A. B., 1964, VOPR YAZYKOZNANIYA, V2, P53; Dolgopolsky A. B., 1986, TYPOLOGY RELATIONSHI, P27; Gascuel O, 1997, MOL BIOL EVOL, V14, P685, DOI 10.1093/oxfordjournals.molbev.a025808; Gippert J, 2010, CAUCASIAN ALBANIAN P, V3; Goloboff PA, 2008, CLADISTICS, V24, P774, DOI 10.1111/j.1096-0031.2008.00217.x; Gray RD, 2003, NATURE, V426, P435, DOI 10.1038/nature02029; Haspelmath M., 2013, WORLD ATLAS LANGUAGE; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; Ibragimov GKh, 1990, TSAKHURSKIJ YAZYK; Ibragimov GKh, 1978, RUTULSKIJ YAZYK; Jager G, 2013, LANG DYN CHANG, V3, P245, DOI 10.1163/22105832-13030204; Kassian A, 2011, GLOBAL LEXICOSTATIST; Kassian Alexei., 2010, J LANGUAGE RELATIONS, V4, P46; Kassian Alexei, 2013, C COMP HIST LING 21; Kessler B., 2007, P 9 M ACL SPEC INT G, P6, DOI DOI 10.3115/1626516.1626518; Kibrik Aleksandr E., 1988, SOPOSTAVITELNOE IZUC; Koryakov YuB, 2006, ATLAS CAUCASIAN LANG; Magometov A. A., 1970, AGULSKIJ YAZYK; Makarenkov V, 2006, APPL MYCOL BIOTECH, V6, P61; Militarev Alexander, 2000, SEMITIC ETYMOLOGICAL; Muller A, 2010, ASJP WORLD LANGUAGE; Nakhleh L, 2005, T PHILOL SOC, V103, P171, DOI 10.1111/j.1467-968X.2005.00149.x; Novotna P, 2007, BALTISTICA, V42, P323; Novotna P, 2007, BALTISTICA, V42, P185; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Schulze W, 2005, FUNCTIONAL GRAMMAR U; Schulze W., 1997, TSAKHUR; Schulze W, 1988, THESIS U BONN; Schulze Wolfgang, 2001, UDI GOSPELS ANNOTATE; Schulze-Furhoff Wolfgang, 1994, INDIGENOUS LANGUAGES, V2, P447; Semple C., 2003, PHYLOGENETICS; Sneath P.H.A., 1973, NUMERICAL TAXONOMY P; Starostin G. S., 2011, GLOBAL LEXICOSTATIST; Starostin GS, 2008, SANT FE I AUG 12 200; Starostin S.A., 2007, T YAZYKOZNANIYU, P481; Starostin SA, 1999, HIST LINGUISTICS LEX, P3; Starostin SA, 1994, LEZGIAN ETYMOLOGICAL; Starostin SA, 1980, ISTORICHESKAYA UNPUB; Starostin Sergei, 1994, N CAUCASIAN ETYMOLOG; Starostin Sergei A., 2007, WORKS LINGUISTICS, P407; Suleymanov ND, 1993, SRAVNITELNO ISTORICH; Talibov BB, 1980, SRAVNITELNAYA FONETI; Turchin P., 2010, J LANGUAGE RELATIONS, V3, P117	54	12	14	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2015	10	2							e0116950	10.1371/journal.pone.0116950	http://dx.doi.org/10.1371/journal.pone.0116950			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	CC2ZH	25719456	gold, Green Submitted, Green Published			2022-12-27	WOS:000350213200013
J	Kato, CD; Nanteza, A; Mugasa, C; Edyelu, A; Matovu, E; Alibu, VP				Kato, Charles D.; Nanteza, Ann; Mugasa, Claire; Edyelu, Andrew; Matovu, Enock; Alibu, Vincent P.			Clinical Profiles, Disease Outcome and Co-Morbidities among T-b. rhodesiense Sleeping Sickness Patients in Uganda	PLOS ONE			English	Article							HUMAN AFRICAN TRYPANOSOMIASIS; IMMUNODEFICIENCY-VIRUS-INFECTION; CHRONIC HELMINTH INFECTIONS; BRUCEI-RHODESIENSE; RISK-FACTORS; GAMBIENSE; EPIDEMIOLOGY; MELARSOPROL; DIAGNOSIS; FOCUS	Background The acute form of Human African Trypanosomiasis (HAT, also known as Sleeping sickness) caused by Trypanosoma brucei rhodesiense has been shown to have a wide spectrum of focus specific clinical presentation and severity in East and Southern Africa. Indeed HAT occurs in regions endemic for other tropical diseases, however data on how these comorbidities might complicate the clinical picture and affect disease outcome remains largely scanty. We here describe the clinical presentation, presence of co-infections, and how the latter impact on HAT prognosis. Methods and Findings We carried out a retrospective analysis of clinical data from 258 sleeping sickness patients reporting to Lwala hospital between 2005 and 2012. The mean patient age was 28.6 years with a significant number of cases below 18 years (p<0.0001). About 93.4% of the cases were diagnosed as late stage (p<0.0001). The case fatality rate was 10.5% with post treatment reactive encephalopathys reported in 7.9% of the cases, of whom 36.8% eventually died. Fever was significantly (p = 0.045) higher in patients under 18 years. Of the early stage patients, 26.7% and 6.7% presented with late stage signs of sleep disorder and mental confusion respectively. Among the co-infections, malaria was significantly more prevalent (28.9%; p<0.0001) followed by urinary tract infections (4.2%). Co-infections were present in 14.3% of in-hospital deaths, 38.5% of which were recorded as Malaria. Malaria was significantly more common in patients under 18 years (45.5%; p<0.02), and was reported in 60% of the fatal cases in this age group. Conclusions We show a wide spectrum of sleeping sickness clinical presentation and disease outcome that was apparently not significantly influenced by concurrent infections. It would thus be interesting to determine the host and/or parasite factors that might be responsible for the observed diverse clinical presentation.	[Kato, Charles D.; Nanteza, Ann; Mugasa, Claire; Matovu, Enock] Makerere Univ, Coll Vet Med Anim Resources & Biosecur, Sch Biosecur Biotech & Lab Sci, Kampala, Uganda; [Alibu, Vincent P.] Makerere Univ, Coll Nat Sci, Kampala, Uganda; [Edyelu, Andrew] Lwala Hosp, Kaberamaido, Uganda	Makerere University; Makerere University	Alibu, VP (corresponding author), Makerere Univ, Coll Nat Sci, Kampala, Uganda.	vpalibu@yahoo.com		Matovu, Enock/0000-0003-0714-7032; Kato, Charles Drago/0000-0003-3160-6657	Welcome Trust through the African Research Consortium on Ecosystem and Population Health (Afrique One) [087535/Z/08/A]	Welcome Trust through the African Research Consortium on Ecosystem and Population Health (Afrique One)	This work was supported by the Welcome Trust through the African Research Consortium on Ecosystem and Population Health (Afrique One), grant number 087535/Z/08/A [http://www.afriqueone.net/]. This grant was received by EM and VPA. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blum J, 2006, ACTA TROP, V97, P55, DOI 10.1016/j.actatropica.2005.08.001; Blum JA, 2007, TROP MED INT HEALTH, V12, P1422, DOI 10.1111/j.1365-3156.2007.01948.x; BOA YF, 1988, B SOC PATHOL EXOT, V81, P427; BOATIN BA, 1986, B WORLD HEALTH ORGAN, V64, P389; Boraschi D, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000255; BUYST H, 1977, ANN SOC BELG MED TR, V57, P349; Chappuis F, 2005, CLIN MICROBIOL REV, V18, P133, DOI 10.1128/CMR.18.1.133-146.2005; Cheesebrough M., 2002, MED LAB MANUAL TROPI; COLLINS JM, 1986, J CLIN PHARMACOL, V26, P22; Docampo R, 2003, PARASITOL RES, V90, pS10, DOI 10.1007/s00436-002-0752-y; Elias D, 2007, EXPERT REV ANTI-INFE, V5, P475, DOI 10.1586/14787210.5.3.475; Eperon G, 2007, ACTA TROP, V101, P31, DOI 10.1016/j.actatropica.2006.12.002; Fevre EM, 2001, LANCET, V358, P625, DOI 10.1016/S0140-6736(01)05778-6; Fevre EM, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000333; GELFAND M, 1966, T ROY SOC TROP MED H, V60, P376, DOI 10.1016/0035-9203(66)90304-X; Hutchinson OC, 2003, LANCET INFECT DIS, V3, P42, DOI 10.1016/S1473-3099(03)00488-2; Kagira JM, 2011, J TROP MED-US, V2011, DOI 10.1155/2011/248914; Kaminsky R, 2000, CURR OP ANTIINF INV, V2, P76; Kennedy PGE, 2013, LANCET NEUROL, V12, P186, DOI 10.1016/S1474-4422(12)70296-X; Kennedy PGE, 2004, J CLIN INVEST, V113, P496, DOI 10.1172/JCI200421052; Kuepfer I, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0000968; Legros D, 1999, T ROY SOC TROP MED H, V93, P439, DOI 10.1016/S0035-9203(99)90151-7; Lutumba P, 2007, EMERG INFECT DIS, V13, P248, DOI 10.3201/eid1302.060075; MacLean L, 2007, J INFECT DIS, V196, P1620, DOI 10.1086/522011; MacLean LM, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000906; MacLeod A, 2001, J MOL EVOL, V52, P290, DOI 10.1007/s002390010157; Matovu E, 2001, MICROBES INFECT, V3, P763, DOI 10.1016/S1286-4579(01)01432-0; Meda HA, 1995, T ROY SOC TROP MED H, V89, P639, DOI 10.1016/0035-9203(95)90425-5; Nok AJ, 2003, PARASITOL RES, V90, P71, DOI 10.1007/s00436-002-0799-9; Odiit M, 2004, ANN TROP MED PARASIT, V98, P339, DOI 10.1179/000349804225003389; Odiit M, 1997, E AFR MED J, V74, P792; Pepin J, 2002, T ROY SOC TROP MED H, V96, P421, DOI 10.1016/S0035-9203(02)90380-9; PEPIN J, 1992, AM J TROP MED HYG, V47, P133, DOI 10.4269/ajtmh.1992.47.133; Pepin J, 2001, ADV PARASIT, V49, P71, DOI 10.1016/S0065-308X(01)49038-5; PEPIN J, 1995, T ROY SOC TROP MED H, V89, P92, DOI 10.1016/0035-9203(95)90673-8; Selby R, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-281; Simarro PP, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001859; SONGA EB, 1991, TROP MED PARASITOL, V42, P389; Truc P, 2012, T ROY SOC TROP MED H, V106, P10, DOI 10.1016/j.trstmh.2011.10.002; van Riet E, 2007, IMMUNOBIOLOGY, V212, P475, DOI 10.1016/j.imbio.2007.03.009; Welburn SC, 2001, TRENDS PARASITOL, V17, P19, DOI 10.1016/S1471-4922(00)01839-0; WHO, 2013, WHO TECH REP SER, V984, P1	43	21	21	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2015	10	2							e0118370	10.1371/journal.pone.0118370	http://dx.doi.org/10.1371/journal.pone.0118370			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC2ZH	25719539	Green Published, Green Submitted, gold			2022-12-27	WOS:000350213200049
J	Mwidunda, SA; Carabin, H; Matuja, WBM; Winkler, AS; Ngowi, HA				Mwidunda, Sylvester A.; Carabin, Helene; Matuja, William B. M.; Winkler, Andrea S.; Ngowi, Helena A.			A School Based Cluster Randomised Health Education Intervention Trial for Improving Knowledge and Attitudes Related to Taenia solium Cysticercosis and Taeniasis in Mbulu District, Northern Tanzania	PLOS ONE			English	Article							PORCINE CYSTICERCOSIS; NEUROCYSTICERCOSIS; PREVALENCE	Taenia solium causes significant economic and public health impacts in endemic countries. This study determined effectiveness of a health education intervention at improving school children's knowledge and attitudes related to T. solium cysticercosis and taeniasis in Tanzania. A cluster randomised controlled health education intervention trial was conducted in 60 schools (30 primary, 30 secondary) in Mbulu district. Baseline data were collected using a structured questionnaire in the 60 schools and group discussions in three other schools. The 60 schools stratified by baseline knowledge were randomised to receive the intervention or serve as control. The health education consisted of an address by a trained teacher, a video show and a leaflet given to each pupil. Two post-intervention re-assessments (immediately and 6 months post-intervention) were conducted in all schools and the third (12 months post-intervention) was conducted in 28 secondary schools. Data were analysed using Bayesian hierarchical log-binomial models for individual knowledge and attitude questions and Bayesian hierarchical linear regression models for scores. The overall score (percentage of correct answers) improved by about 10% in all schools after 6 months, but was slightly lower among secondary schools. Monitoring alone was associated with improvement in scores by about 6%. The intervention was linked to improvements in knowledge regarding taeniasis, porcine cysticercosis, human cysticercosis, epilepsy, the attitude of condemning infected meat but it reduced the attitude of contacting a veterinarian if a pig was found to be infected with cysticercosis. Monitoring alone was linked to an improvement in how best to raise pigs. This study demonstrates the potential value of school children as targets for health messages to control T. solium cysticercosis and taeniasis in endemic areas. Studies are needed to assess effectiveness of message transmission from children to parents and the general community and their impacts in improving behaviours facilitating disease transmission.	[Mwidunda, Sylvester A.; Ngowi, Helena A.] Sokoine Univ Agr, Dept Vet Med & Publ Hlth, Morogoro, Tanzania; [Carabin, Helene] Univ Oklahoma, Hlth Sci Ctr, Coll Publ Hlth, Dept Epidemiol & Biostat, Oklahoma City, OK USA; [Matuja, William B. M.] Muhimbili Univ Hlth & Allied Sci, Dept Neurol, Dar Es Salaam, Tanzania; [Winkler, Andrea S.] Tech Univ Munich, Dept Neurol, D-80290 Munich, Germany	Sokoine University of Agriculture; University of Oklahoma System; University of Oklahoma Health Sciences Center; Muhimbili University of Health & Allied Sciences; Technical University of Munich	Ngowi, HA (corresponding author), Sokoine Univ Agr, Dept Vet Med & Publ Hlth, Morogoro, Tanzania.	h_ngowi@yahoo.com	Carabin, Helene/B-7600-2016		Neurocysticercosis in sub-Saharan Project under the Germany Research Foundation (DFG)	Neurocysticercosis in sub-Saharan Project under the Germany Research Foundation (DFG)(German Research Foundation (DFG))	This study was funded by Neurocysticercosis in sub-Saharan Project, under the Germany Research Foundation (DFG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander AM, 2012, INT HEALTH, V4, P164, DOI 10.1016/j.inhe.2012.04.003; Carabin Helene, 2014, Curr Trop Med Rep, V1, P181; De Andrade BB., 2011, REV BRASILEIRA BIOME, V29, P1; Garcia HH, 2006, AM J TROP MED HYG, V74, P850, DOI 10.4269/ajtmh.2006.74.850; Gyorkos Theresa W, 2013, PLoS Negl Trop Dis, V7, pe2397, DOI 10.1371/journal.pntd.0002397; Kraft R, 2007, AM FAM PHYSICIAN, V76, P91; Krueger RA, 1994, FOCUS GROUPS PRACTIC, V2nd; Lansdown R, 2002, HEALTH EDUC RES, V17, P425, DOI 10.1093/her/17.4.425; Lightowlers MW, 2010, INT J PARASITOL, V40, P1183, DOI 10.1016/j.ijpara.2010.05.001; Murrell K.D., 2005, WHO FAO OIE GUIDELIN, P27; NBS (National Bureau of Statistics), 2012, 2012 POP HOUS CENS; NCCPHP (North Carolina Center for Public Health Preparedness), 2 STAG CLUST SAMPL G; Ngowi HA, 2008, PREV VET MED, V85, P52, DOI 10.1016/j.prevetmed.2007.12.014; Ngowi HA, 2004, VET PARASITOL, V120, P275, DOI 10.1016/j.vetpar.2004.01.015; Ngowi HA, 1999, THESIS; O'Neal SE, 2011, J GLOB INFECT DIS, V3, P156, DOI 10.4103/0974-777X.81693; Olsen W., 2004, DEV SOCIOLOGY; Rabiee F, 2004, P NUTR SOC, V63, P655, DOI 10.1079/PNS2004399; Torney A., 2002, NURSING THEORISTS TH; Willingham AL, 2010, ADV PARASIT, V72, P235, DOI 10.1016/S0065-308X(10)72009-1; Winkler AS, 2012, PATHOG GLOB HEALTH, V106, P261, DOI 10.1179/2047773212Y.0000000047; Winkler AS, 2009, EPILEPSIA, V50, P987, DOI 10.1111/j.1528-1167.2008.01867.x	22	26	26	2	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2015	10	2							e0118541	10.1371/journal.pone.0118541	http://dx.doi.org/10.1371/journal.pone.0118541			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC2ZH	25719902	Green Published, gold, Green Submitted			2022-12-27	WOS:000350213200058
J	Yossef, R; Gur, C; Shemesh, A; Guttman, O; Hadad, U; Nedvetzki, S; Miletic, A; Nalbandyan, K; Cerwenka, A; Jonjic, S; Mandelboim, O; Porgador, A				Yossef, Rami; Gur, Chamutal; Shemesh, Avishai; Guttman, Ofer; Hadad, Uzi; Nedvetzki, Shlomo; Miletic, Antonija; Nalbandyan, Karen; Cerwenka, Adelheid; Jonjic, Stipan; Mandelboim, Ofer; Porgador, Angel			Targeting Natural Killer Cell Reactivity by Employing Antibody to NKp46: Implications for Type 1 Diabetes	PLOS ONE			English	Article							CYTOTOXICITY RECEPTOR NKP44; VIRUS-INFECTED CELLS; NK-CELLS; MONOCLONAL-ANTIBODY; BETA-CELLS; RECOGNITION; STREPTOZOTOCIN; MELLITUS; TUMOR; MICE	Natural killer (NK) cells belong to the innate lymphoid cells. Their cytotoxic activity is regulated by the delicate balance between activating and inhibitory signals. NKp46 is a member of the primary activating receptors of NK cells. We previously reported that the NKp46 receptor is involved in the development of type 1 diabetes (T1D). Subsequently, we hypothesized that blocking this receptor could prevent or hinder disease development. To address this goal, we developed monoclonal antibodies for murine NKp46. One mAb, named NCR1.15, recognizes the mouse homologue protein of NKp46, named Ncr1, and was able to downregulate the surface expression of NKp46 on primary murine NK cells following antibody injection in vivo. Additionally, NCR1.15 treatments were able to down-regulate cytotoxic activity mediated by NKp46, but not by other NK receptors. To test our primary assumption, we examined T1D development in two models, non-obese diabetic mice and low-dose streptozotocin. Our results show a significantly lower incidence of diabetic mice in the NCR1.15-treated group compared to control groups. This study directly demonstrates the involvement of NKp46 in T1D development and suggests a novel treatment strategy for early insulitis.	[Yossef, Rami; Shemesh, Avishai; Hadad, Uzi; Porgador, Angel] Ben Gurion Univ Negev, Fac Hlth Sci, Shraga Segal Dept Microbiol Immunol & Genet, Beer Sheva, Israel; [Yossef, Rami; Shemesh, Avishai; Hadad, Uzi; Porgador, Angel] Ben Gurion Univ Negev, Natl Inst Biotechnol Negev, IL-84105 Beer Sheva, Israel; [Gur, Chamutal; Mandelboim, Ofer] Hebrew Univ Jerusalem, Hadassah Med Sch, Inst Med Res Israel Canada, Lautenberg Ctr Gen & Tumor Immunol, IL-91120 Jerusalem, Israel; [Gur, Chamutal] Hadassah Hebrew Univ Hosp, Dept Med, IL-91120 Jerusalem, Israel; [Guttman, Ofer] Ben Gurion Univ Negev, Fac Hlth Sci, Dept Clin Biochem & Pharmacol, IL-84105 Beer Sheva, Israel; [Nedvetzki, Shlomo] BioLineRx Ltd, IL-91450 Jerusalem, Israel; [Miletic, Antonija; Jonjic, Stipan] Univ Rijeka, Sch Med, Ctr Prote, Rijeka 51000, Croatia; [Miletic, Antonija; Jonjic, Stipan] Univ Rijeka, Sch Med, Dept Histol & Embryol, Rijeka 51000, Croatia; [Nalbandyan, Karen] Soroka Med Ctr, Dept Pathol, IL-84101 Beer Sheva, Israel; [Cerwenka, Adelheid] German Canc Res Ctr, Innate Immun Grp, D-69120 Heidelberg, Germany	Ben Gurion University; Ben Gurion University; Hebrew University of Jerusalem; Hebrew University of Jerusalem; Hadassah University Medical Center; Ben Gurion University; University of Rijeka; University of Rijeka; Ben Gurion University; Soroka Medical Center; Helmholtz Association; German Cancer Research Center (DKFZ)	Porgador, A (corresponding author), Ben Gurion Univ Negev, Fac Hlth Sci, Shraga Segal Dept Microbiol Immunol & Genet, Beer Sheva, Israel.	angel@exchange.bgu.ac.il	Yoseph, Rami/L-6823-2019; Yossef, Rami/K-5740-2019; Jonjic, Stipan/C-5657-2016	Mandelboim, Ofer/0000-0002-9354-1855; Porgador, Angel/0000-0003-1540-4449; Cerwenka, Adelheid/0000-0001-6977-3536; Jonjic, Stipan/0000-0001-5003-3108	Israel Science Foundation-Juvenile Diabetes Research Foundation Grant [123/12]; United States-Israel Binational Science Foundation Grant [2011123]; Israel Science Foundation Grant [304/12]; BioLineRx early development grant; Israeli Ministry of Science and Technology/German Cancer Research Center program Grant [CA142]; National Institutes of Health Grant [1R01AI083201-01]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI083201] Funding Source: NIH RePORTER	Israel Science Foundation-Juvenile Diabetes Research Foundation Grant; United States-Israel Binational Science Foundation Grant; Israel Science Foundation Grant(Israel Science Foundation); BioLineRx early development grant; Israeli Ministry of Science and Technology/German Cancer Research Center program Grant; National Institutes of Health Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the Israel Science Foundation-Juvenile Diabetes Research Foundation Grant 123/12 (to A.P. & O.M.), United States-Israel Binational Science Foundation Grant 2011123 (A.P.), the Israel Science Foundation Grant 304/12 (A.P.), BioLineRx early development grant (A.P. & O.M.), the Israeli Ministry of Science and Technology/German Cancer Research Center program Grant CA142 (A.P. and A.C.), and National Institutes of Health Grant 1R01AI083201-01 (S.J.). The funder provided support in the form of salaries for authors [SN], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Akirav E, 2008, DIABETES, V57, P2883, DOI 10.2337/db07-1817; Alba A, 2008, CLIN EXP IMMUNOL, V151, P467, DOI 10.1111/j.1365-2249.2007.03580.x; Arnon TI, 2006, SEMIN CANCER BIOL, V16, P348, DOI 10.1016/j.semcancer.2006.07.005; Arnon TI, 2004, BLOOD, V103, P664, DOI 10.1182/blood-2003-05-1716; Bloushtain N, 2004, J IMMUNOL, V173, P2392, DOI 10.4049/jimmunol.173.4.2392; Cerwenka A, 2000, IMMUNITY, V12, P721, DOI 10.1016/S1074-7613(00)80222-8; Chan AC, 2010, NAT REV IMMUNOL, V10, P301, DOI 10.1038/nri2761; CHANDY KG, 1984, IMMUNOL LETT, V8, P89, DOI 10.1016/0165-2478(84)90056-7; CHATENOUD L, 1982, EUR J IMMUNOL, V12, P979, DOI 10.1002/eji.1830121116; Chatenoud L, 2007, NAT REV IMMUNOL, V7, P622, DOI 10.1038/nri2134; CHRISTIANSON SW, 1993, DIABETES, V42, P44, DOI 10.2337/diabetes.42.1.44; Colonna M, 2010, NAT IMMUNOL, V11, P1079, DOI [10.1038/ni1210-1079, 10.1038/ni0211-107]; Colucci F, 2010, NAT IMMUNOL, V11, P111, DOI 10.1038/ni0210-111; Dotta F, 2007, P NATL ACAD SCI USA, V104, P5115, DOI 10.1073/pnas.0700442104; Ferlazzo G, 2002, J EXP MED, V195, P343, DOI 10.1084/jem.20011149; Garg A, 2006, J IMMUNOL, V177, P6192, DOI 10.4049/jimmunol.177.9.6192; Gazit R, 2006, NAT IMMUNOL, V7, P517, DOI 10.1038/ni1322; Glasner A, 2012, J IMMUNOL, V188, P2509, DOI 10.4049/jimmunol.1102461; Gur C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074033; Gur C, 2011, J IMMUNOL, V187, P3096, DOI 10.4049/jimmunol.1101269; Gur C, 2010, NAT IMMUNOL, V11, P121, DOI 10.1038/ni.1834; Halfteck GG, 2009, J IMMUNOL, V182, P2221, DOI 10.4049/jimmunol.0801878; Hershkovitz O, 2009, J IMMUNOL, V183, P2610, DOI 10.4049/jimmunol.0802806; Ito K, 2012, BIOL PHARM BULL, V35, P594, DOI 10.1248/bpb.35.594; Ito K, 2011, BIOCHEM BIOPH RES CO, V406, P377, DOI 10.1016/j.bbrc.2011.02.050; Jewett A, 2013, J CANCER, V4, P12, DOI 10.7150/jca.5519; KARRE K, 1986, NATURE, V319, P675, DOI 10.1038/319675a0; Koch J, 2013, TRENDS IMMUNOL, V34, P182, DOI 10.1016/j.it.2013.01.003; Kruse PH, 2013, IMMUNOL CELL BIOL; Lam RA, 2013, ANN MED, V45, P384, DOI 10.3109/07853890.2013.792495; Leiter EH, 2001, CURR PROTOC IMMUNOL; LIKE AA, 1976, SCIENCE, V193, P415, DOI 10.1126/science.180605; Long EO, 2008, IMMUNOL REV, V224, P70, DOI 10.1111/j.1600-065X.2008.00660.x; Mandelboim O, 2001, NATURE, V409, P1055, DOI 10.1038/35059110; Moretta A, 2001, ANNU REV IMMUNOL, V19, P197, DOI 10.1146/annurev.immunol.19.1.197; Narni-Mancinelli E, 2013, M S-MED SCI, V29, P389, DOI 10.1051/medsci/2013294012; Nita II, 2014, FASEB J, V28, P3301, DOI 10.1096/fj.13-248161; OBrien BA, 1996, J PATHOL, V178, P176; Ogasawara K, 2004, IMMUNITY, V20, P757, DOI 10.1016/j.immuni.2004.05.008; PAIK SG, 1980, P NATL ACAD SCI-BIOL, V77, P6129, DOI 10.1073/pnas.77.10.6129; Rodacki M, 2006, CLIN DEV IMMUNOL, V13, P101, DOI 10.1080/17402520600877182; Rosental B, 2011, J IMMUNOL, V187, P5693, DOI 10.4049/jimmunol.1102267; SHACHNER MS, 1992, J SURG RES, V52, P601, DOI 10.1016/0022-4804(92)90136-N; Shibuya A, 2003, INT J HEMATOL, V78, P1, DOI 10.1007/BF02983233; Smith JA, 1997, J EXP MED, V185, P1413, DOI 10.1084/jem.185.8.1413; Vivier E, 2008, NAT IMMUNOL, V9, P503, DOI 10.1038/ni1582; Yu JH, 2011, J CLIN INVEST, V121, P1456, DOI 10.1172/JCI43242	47	17	19	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2015	10	2							e0118936	10.1371/journal.pone.0118936	http://dx.doi.org/10.1371/journal.pone.0118936			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC2ZH	25719382	Green Submitted, Green Published, gold			2022-12-27	WOS:000350213200060
J	Gatti, G; Bianchi, CN; Parravicini, V; Rovere, A; Peirano, A; Montefalcone, M; Massa, F; Morri, C				Gatti, Giulia; Bianchi, Carlo Nike; Parravicini, Valeriano; Rovere, Alessio; Peirano, Andrea; Montefalcone, Monica; Massa, Francesco; Morri, Carla			Ecological Change, Sliding Baselines and the Importance of Historical Data: Lessons from Combing Observational and Quantitative Data on a Temperate Reef Over 70 Years	PLOS ONE			English	Article							ALGA CAULERPA-RACEMOSA; MEDITERRANEAN-SEA; LIGURIAN SEA; CORALLIGENOUS ASSEMBLAGES; CLIMATE-CHANGE; VAR. CYLINDRACEA; MASS-MORTALITY; MARINE SYSTEMS; COMMUNITIES; ECOSYSTEMS	Understanding the effects of environmental change on ecosystems requires the identification of baselines that may act as reference conditions. However, the continuous change of these references challenges our ability to define the true natural status of ecosystems. The so-called sliding baseline syndrome can be overcome through the analysis of quantitative time series, which are, however, extremely rare. Here we show how combining historical quantitative data with descriptive ` naturalistic' information arranged in a chronological chain allows highlighting long-term trends and can be used to inform present conservation schemes. We analysed the long-term change of a coralligenous reef, a marine habitat endemic to the Mediterranean Sea. The coralligenous assemblages of Mesco Reef (Ligurian Sea, NW Mediterranean) have been studied, although discontinuously, since 1937 thus making available both detailed descriptive information and scanty quantitative data: while the former was useful to understand the natural history of the ecosystem, the analysis of the latter was of paramount importance to provide a formal measure of change over time. Epibenthic assemblages remained comparatively stable until the 1990s, when species replacement, invasion by alien algae, and biotic homogenisation occurred within few years, leading to a new and completely different ecosystem state. The shift experienced by the coralligenous assemblages of Mesco Reef was probably induced by a combination of seawater warming and local human pressures, the latter mainly resulting in increased water turbidity; in turn, cumulative stress may have favoured the establishment of alien species. This study showed that the combined analysis of quantitative and descriptive historical data represent a precious knowledge to understand ecosystem trends over time and provide help to identify baselines for ecological management.	[Gatti, Giulia; Bianchi, Carlo Nike; Montefalcone, Monica; Massa, Francesco; Morri, Carla] Univ Genoa, DiSTAV Dept Earth Environm & Life Sci, Genoa, Italy; [Parravicini, Valeriano] Univ Perpignan, LABEX CORAIL, USR CNRS EPHE UPVD 3278, CRIOBE, F-66025 Perpignan, France; [Rovere, Alessio] Univ Bremen, MARUM, D-28359 Bremen, Germany; [Rovere, Alessio] ZMT, Leibniz Ctr Trop Marine Ecol, Bremen, Germany; [Rovere, Alessio] Columbia Univ, Lamont Doherty Earth Observ, Palisades, NY USA; [Peirano, Andrea] ENEA, Marine Environm Res Ctr, La Spezia, Italy	University of Genoa; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; PSL Research University Paris; Ecole Pratique des Hautes Etudes (EPHE); Universite Perpignan Via Domitia; University of Bremen; Leibniz Zentrum fur Marine Tropenforschung (ZMT); Columbia University; Italian National Agency New Technical Energy & Sustainable Economics Development	Gatti, G (corresponding author), Univ Genoa, DiSTAV Dept Earth Environm & Life Sci, Corso Europa 26, Genoa, Italy.	gatti.giulia25@gmail.com	Rovere, Alessio/H-4398-2019	Rovere, Alessio/0000-0001-5575-1168; Parravicini, Valeriano/0000-0002-3408-1625; Massa, Francesco/0000-0001-9632-4939; Morri, Carla/0000-0003-4520-2741; Bianchi, Carlo Nike/0000-0003-1071-3285	Institutional Strategy of the University of Bremen - German Excellence Initiative; ZMT; Centre for Tropical Marine Ecology, Bremen	Institutional Strategy of the University of Bremen - German Excellence Initiative; ZMT; Centre for Tropical Marine Ecology, Bremen	AR's research is supported by the Institutional Strategy of the University of Bremen, funded by the German Excellence Initiative and by ZMT, the Centre for Tropical Marine Ecology, Bremen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AIROLDI L, 1995, BOT MAR, V38, P227, DOI 10.1515/botm.1995.38.1-6.227; Al-Abdulrazzak D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043386; Anderson MJ, 2011, ECOL LETT, V14, P19, DOI 10.1111/j.1461-0248.2010.01552.x; Andreoli MG, 1979, ANALISI RICERCA GOLF; Antoniadou C, 2007, J MAR BIOL ASSOC UK, V87, P629, DOI 10.1017/S0025315407048151; Ardizzone G.D., 1988, Bollettino dei Musei e degli Istituti Biologici dell'Universita di Genova, V52, P115; Associazione Subacquea Parmasub Sezione Ricerche, 1976, DOC SCI FOT PUNT MES; ASTRALDI M, 1995, OCEANOL ACTA, V18, P139; Attolini A, 2005, MISURE TRASPARENZA N; Baldacconi R, 2009, MAR ECOL-EVOL PERSP, V30, P337, DOI 10.1111/j.1439-0485.2009.00282.x; Ballesteros E, 2006, OCEANOGR MAR BIOL, V44, P123; Barange M, 2010, MARINE ECOSYSTEMS AND GLOBAL CHANGE, P1, DOI 10.1093/acprof:oso/9780199558025.001.0001; Baskin Y, 1998, BIOSCIENCE, V48, P788, DOI 10.2307/1313390; Bavestrello G, 1997, AQUAT CONSERV, V7, P253, DOI 10.1002/(SICI)1099-0755(199709)7:3<253::AID-AQC243>3.0.CO;2-1; Bavestrello Giorgio, 1995, Marine Life, V4, P15; Bedini R, 2014, MEDITERR MAR SCI, V15, P302, DOI 10.12681/mms.442; Bianchi CN, 2014, MEDITERR MAR SCI, V15, P482, DOI 10.12681/mms.678; Bianchi C.N., 2001, Biologia Marina Mediterranea, V8, P112; Bianchi C.N., 1997, P ITALIAN ASS OCEANO, V12, P3; Bianchi C. N., 2012, LIFE MEDITERRANEAN S, P1; Bianchi C.N., 2001, ARCH OCEANOGR LIMNOL, V22, P83; Bianchi CN, 2000, MAR POLLUT BULL, V40, P367, DOI 10.1016/S0025-326X(00)00027-8; Boero Ferdinando, 2013, F1000Res, V2, P168, DOI 10.12688/f1000research.2-168.v1; Borja A, 2012, ECOL INDIC, V12, P1, DOI 10.1016/j.ecolind.2011.06.018; BOUDOURESQUE CF, 1970, VIE MILIEU B OCEANOG, V21, P103; Brodie J, 2014, ECOL EVOL, V4, P2787, DOI 10.1002/ece3.1105; Bulleri F, 2008, MAR ECOL PROG SER, V364, P77, DOI 10.3354/meps07484; Bussotti S., 1996, Doriana, V6, P1; Cavazza W, 2000, J COASTAL RES, V16, P295; Cebrian E, 2012, BIOL INVASIONS, V14, P2647, DOI 10.1007/s10530-012-0261-6; Cerrano C, 2000, ECOL LETT, V3, P284, DOI 10.1046/j.1461-0248.2000.00152.x; Cocito S, 1998, MAR BIOL, V131, P73, DOI 10.1007/s002270050298; Conversi A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010633; Crain CM, 2008, ECOL LETT, V11, P1304, DOI 10.1111/j.1461-0248.2008.01253.x; Cupido R, 2009, MAR ECOL PROG SER, V394, P195, DOI 10.3354/meps08260; Damiani V, 1989, STUDIO AMBIENTALE FI, P203; Dayton PK, 1998, ECOL APPL, V8, P309, DOI 10.1890/1051-0761(1998)008[0309:SBGARE]2.0.CO;2; Deter J, 2012, J EXP MAR BIOL ECOL, V418, P75, DOI 10.1016/j.jembe.2012.03.006; Ferrario J, 2011, THESIS U PARMA; Fortibuoni T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015502; Francour P., 1992, RAPP COMM INT MER ME, V33, P38; Garrabou J, 2009, GLOBAL CHANGE BIOL, V15, P1090, DOI 10.1111/j.1365-2486.2008.01823.x; Gatti Giulia, 2012, Advances in Oceanography and Limnology, V3, P51, DOI 10.1080/19475721.2012.671190; Giakoumi S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076449; Guidetti P, 2014, VIE MILIEU, V64, P1; Guidetti P, 2008, BIOL CONSERV, V141, P699, DOI 10.1016/j.biocon.2007.12.013; Harley CDG, 2006, ECOL LETT, V9, P228, DOI 10.1111/j.1461-0248.2005.00871.x; Harmelin Jean-Georges, 1995, Marine Life, V4, P5; Harris PT, 2012, ELSEV INSIGHT, P39, DOI 10.1016/B978-0-12-385140-6.00003-7; Hirst CN, 2007, DIVERS DISTRIB, V13, P361, DOI 10.1111/j.1472-4642.2007.00307.x; Hiscock K, 2005, J MAR BIOL ASSOC UK, V85, P1009, DOI 10.1017/S0025315405012038; Hobday AJ, 2011, MAR ECOL-EVOL PERSP, V32, P392, DOI 10.1111/j.1439-0485.2011.00459.x; Hong J.-S., 1983, Bulletin of the Korean Fisheries Society, V16, P273; Kennedy CJ, 2013, J ENVIRON MANAGE, V128, P43, DOI 10.1016/j.jenvman.2013.04.035; Kipson S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027103; Knowlton N, 2008, PLOS BIOL, V6, P215, DOI 10.1371/journal.pbio.0060054; Kruzic P, 2008, CORAL REEFS, V27, P441, DOI 10.1007/s00338-008-0358-7; Lebart L, 1975, VALIDITE RESULTATS A; MacDougall AS, 2005, ECOLOGY, V86, P42, DOI 10.1890/04-0669; Macneil MA, 2013, ENVIRON CONSERV, V40, P297, DOI 10.1017/S0376892913000386; McClenachan L, 2012, CONSERV LETT, V5, P349, DOI 10.1111/j.1755-263X.2012.00253.x; MITASOVA H, 1993, MATH GEOL, V25, P657, DOI 10.1007/BF00893172; Montefalcone M, 2011, TREATISE ON ESTUARINE AND COASTAL SCIENCE, VOL 10: ECOHYDROLOGY AND RESTORATION, P49; Montefalcone M, 2010, AQUAT CONSERV, V20, P507, DOI 10.1002/aqc.1128; Morri C, 2001, MEDITERRANEAN ECOSYSTEMS: STRUCTURES AND PROCESSES, P375; Motta C, 1959, CTR IT RIC SUB B, P100; Muxika I, 2007, MAR POLLUT BULL, V55, P16, DOI 10.1016/j.marpolbul.2006.05.025; Parravicini V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075767; Parravicini V, 2010, J EXP MAR BIOL ECOL, V395, P21, DOI 10.1016/j.jembe.2010.08.005; Parravicini V, 2010, ESTUAR COAST SHELF S, V86, P276, DOI 10.1016/j.ecss.2009.11.004; Peirano A, 1989, NOVA THALASSIA, V10, P543; Peirano A, 2000, PMNHS NEWSLETTER, V5, P9; Peirano A, 1992, OEBALIA, V17, P523; Piazzi L, 2012, MAR POLLUT BULL, V64, P2623, DOI 10.1016/j.marpolbul.2012.07.027; Ponti M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102782; Raitsos DE, 2010, LIMNOL OCEANOGR, V55, P1478, DOI 10.4319/lo.2010.55.4.1478; Relini G., 1988, Bollettino dei Musei e degli Istituti Biologici dell'Universita di Genova, V52, P163; Roghi F., 2010, Biologia Marina Mediterranea, V17, P59; Roghi F, 2009, THESIS U GENOA GENOA; Roghi G., 1963, MONDO SOMMERSO, V5, P110; Roghi G, 1960, MONDO SOMMERSO, V2, P20; ROSSI L, 1961, RAPP PV REUN COMMN I, V16, P517; Rossi L, 1965, B ZOOL, V32, P859, DOI DOI 10.1080/11250006509441032; Rossi L., 1965, ANN MUS CIV STOR NAT, V75, P144; Salvati E, 1997, THESIS U ROMA LA SAP; Sartoretto S, 2012, SCI MAR, V76, P349, DOI 10.3989/scimar.03262.16B; Teixido N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053742; Teixido N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023744; Terranova R, 1994, ATTI ASS ITAL OCEANO, V10, P245; Tortonese E., 1937, NATURA, V28, P51; Tortonese E, 1962, PUBBL STAZ ZOOL NAPO, V32, P99; Tunesi L, 1989, NOVA THALASSIA, V10, P615; Vargas-Yanez M, 2010, J MARINE SYST, V82, P171, DOI 10.1016/j.jmarsys.2010.04.013; Vellend M, 2013, AM J BOT, V100, P1294, DOI 10.3732/ajb.1200503; Zenetos A, 2005, MEDITERR MAR SCI, V6, P63, DOI 10.12681/mms.186	95	66	66	3	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2015	10	2							e0118581	10.1371/journal.pone.0118581	http://dx.doi.org/10.1371/journal.pone.0118581			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC2IM	25714413	Green Published, gold, Green Submitted			2022-12-27	WOS:000350168700090
J	Hofman, CA; Rick, TC; Hawkins, MTR; Funk, WC; Ralls, K; Boser, CL; Collins, PW; Coonan, T; King, JL; Morrison, SA; Newsome, SD; Sillett, TS; Fleischer, RC; Maldonado, JE				Hofman, Courtney A.; Rick, Torben C.; Hawkins, Melissa T. R.; Funk, W. Chris; Ralls, Katherine; Boser, Christina L.; Collins, Paul W.; Coonan, Tim; King, Julie L.; Morrison, Scott A.; Newsome, Seth D.; Sillett, T. Scott; Fleischer, Robert C.; Maldonado, Jesus E.			Mitochondrial Genomes Suggest Rapid Evolution of Dwarf California Channel Islands Foxes (Urocyon littoralis)	PLOS ONE			English	Article							PHYLOGENETIC ANALYSIS; MOLECULAR EVOLUTION; GENETIC DIVERSITY; MAMMALS; DOMESTICATION; PLEISTOCENE; POPULATIONS; SELECTION; HISTORY; ORIGIN	Island endemics are typically differentiated from their mainland progenitors in behavior, morphology, and genetics, often resulting from long-term evolutionary change. To examine mechanisms for the origins of island endemism, we present a phylogeographic analysis of whole mitochondrial genomes from the endangered island fox (Urocyon littoralis), endemic to California's Channel Islands, and mainland gray foxes (U. cinereoargenteus). Previous genetic studies suggested that foxes first appeared on the islands > 16,000 years ago, before human arrival (similar to 13,000 cal BP), while archaeological and paleontological data supported a colonization > 7000 cal BP. Our results are consistent with initial fox colonization of the northern islands probably by rafting or human introduction similar to 9200-7100 years ago, followed quickly by human translocation of foxes from the northern to southern Channel Islands. Mitogenomes indicate that island foxes are monophyletic and most closely related to gray foxes from northern California that likely experienced a Holocene climate-induced range shift. Our data document rapid morphological evolution of island foxes (in similar to 2000 years or less). Despite evidence for bottlenecks, island foxes have generated and maintained multiple mitochondrial haplotypes. This study highlights the intertwined evolutionary history of island foxes and humans, and illustrates a new approach for investigating the evolutionary histories of other island endemics.	[Hofman, Courtney A.] Univ Maryland, Dept Anthropol, College Pk, MD 20742 USA; [Hofman, Courtney A.; Rick, Torben C.] Smithsonian Inst, Natl Museum Nat Hist, Dept Anthropol, Program Human Ecol & Archaeobiol, Washington, DC 20560 USA; [Hofman, Courtney A.; Hawkins, Melissa T. R.; Ralls, Katherine; Fleischer, Robert C.; Maldonado, Jesus E.] Smithsonian Inst, Natl Zool Pk, Smithsonian Conservat Biol Inst, Ctr Conservat & Evolutionary Genet, Washington, DC 20008 USA; [Hawkins, Melissa T. R.; Maldonado, Jesus E.] Smithsonian Inst, Natl Museum Nat Hist, Dept Vertebrate Zool, Washington, DC 20560 USA; [Funk, W. Chris] Colorado State Univ, Dept Biol, Grad Degree Program Ecol, Ft Collins, CO 80523 USA; [Boser, Christina L.; Morrison, Scott A.] Nature Conservancy, San Francisco, CA USA; [Collins, Paul W.] Santa Barbara Museum Nat Hist, Dept Vertebrate Zool, Santa Barbara, CA USA; [Coonan, Tim] Channel Isl Natl Pk, Natl Pk Serv, Ventura, CA USA; [King, Julie L.] Catalina Isl Conservancy, Avalon, CA USA; [Newsome, Seth D.] Univ New Mexico, Dept Biol, Albuquerque, NM 87131 USA; [Sillett, T. Scott] Smithsonian Inst, Natl Zool Pk, Smithsonian Conservat Biol Inst, Migratory Bird Ctr, Washington, DC 20008 USA	University System of Maryland; University of Maryland College Park; Smithsonian Institution; Smithsonian National Museum of Natural History; Smithsonian Institution; Smithsonian National Zoological Park & Conservation Biology Institute; Smithsonian Institution; Smithsonian National Museum of Natural History; Colorado State University; Nature Conservancy; United States Department of the Interior; University of New Mexico; Smithsonian Institution; Smithsonian National Zoological Park & Conservation Biology Institute	Hofman, CA (corresponding author), Univ Maryland, Dept Anthropol, College Pk, MD 20742 USA.	hofmanc@si.edu	Maldonado, Jesus/AIE-8664-2022; Sillett, Scott/N-2240-2017	Maldonado, Jesus/0000-0002-4282-1072; Sillett, Scott/0000-0002-7486-0076; Hofman, Courtney/0000-0002-6808-3370; King, Julie/0000-0001-7900-8109; Funk, W. Chris/0000-0002-6466-3618; Rick, Torben/0000-0002-8254-5885	Smithsonian Grand Challenges Consortia; Cosmos Club Foundation; Amazon Web Services Education Research Grant; National Museum of Natural History; National Science Foundation Dissertation Improvement Grant [BCS-1338773]	Smithsonian Grand Challenges Consortia; Cosmos Club Foundation; Amazon Web Services Education Research Grant; National Museum of Natural History(Smithsonian InstitutionSmithsonian National Museum of Natural History); National Science Foundation Dissertation Improvement Grant(National Science Foundation (NSF))	This research was funded by the Smithsonian Grand Challenges Consortia (CAH, JEM, TCR, RCF, TSS, KR), the Cosmos Club Foundation (CAH), an Amazon Web Services Education Research Grant (CAH), a National Museum of Natural History small grant (CAH, TR, JEM), and the National Science Foundation Dissertation Improvement Grant (CAH) (BCS-1338773). Roche 454 Life Sciences (RCF, JEM, CAH) provided support with lab equipment and reagents that greatly enhanced the initial phase of this research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achilli A, 2012, P NATL ACAD SCI USA, V109, P2449, DOI 10.1073/pnas.1111637109; Aguilar A, 2004, P NATL ACAD SCI USA, V101, P3490, DOI 10.1073/pnas.0306582101; Anderson RS, 2010, J QUATERNARY SCI, V25, P782, DOI 10.1002/jqs.1358; [Anonymous], 2006, THESIS U TEXAS AUSTI; Bazinet AL, 2007, FUTURE GENER COMP SY, V23, P517, DOI 10.1016/j.future.2006.07.009; Booth DB, 2003, THE CORDELLIAN ICE S; Boyko AR, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000451; Bozarth CA, 2011, J MAMMAL, V92, P283, DOI 10.1644/10-MAMM-A-141.1; Campos PF, 2010, MOL ECOL, V19, P4863, DOI 10.1111/j.1365-294X.2010.04826.x; COLLINS P W, 1991, Journal of Ethnobiology, V11, P51; COLLINS P W, 1991, Journal of Ethnobiology, V11, P205; Collins Paul W., 1993, P351; Coonan TJ, 2010, DECLINE AND RECOVERY; Cuaron AD, 2004, BIODIVERS CONSERV, V13, P317, DOI 10.1023/B:BIOC.0000006501.80472.cc; Darwin C, 1859, ON THE ORIGIN OF SPE; Delport W, 2010, BIOINFORMATICS, V26, P2455, DOI 10.1093/bioinformatics/btq429; DIAMOND J M, 1975, Biological Conservation, V7, P129, DOI 10.1016/0006-3207(75)90052-X; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Erlandson JM, 2011, SCIENCE, V331, P1181, DOI 10.1126/science.1201477; FOSTER JB, 1964, NATURE, V202, P234, DOI 10.1038/202234a0; Frankham R, 1998, CONSERV BIOL, V12, P665, DOI 10.1046/j.1523-1739.1998.96456.x; GILBERT DA, 1990, NATURE, V344, P764, DOI 10.1038/344764a0; Gilbert MTP, 2008, P NATL ACAD SCI USA, V105, P8327, DOI 10.1073/pnas.0802315105; Goldstein DB, 1999, GENETICS, V151, P797; Grayson DK, 2001, J WORLD PREHIST, V15, P1, DOI 10.1023/A:1011165119141; Hoelzel AR, 2002, J EVOLUTION BIOL, V15, P567, DOI 10.1046/j.1420-9101.2002.00419.x; JOHNSON DL, 1975, J MAMMAL, V56, P925, DOI 10.2307/1379668; Kennett DJ, 2008, QUATERNARY SCI REV, V27, P2530, DOI 10.1016/j.quascirev.2008.09.006; Kennett D.J., 2005, THE ISLAND CHUMASH B; Kukekova AV, 2008, BEHAV GENET, V38, P185, DOI 10.1007/s10519-007-9180-1; Kukekova AV, 2011, BEHAV GENET, V41, P593, DOI 10.1007/s10519-010-9418-1; LACY R C, 1987, Conservation Biology, V1, P143, DOI 10.1111/j.1523-1739.1987.tb00023.x; Lindberg J, 2005, CURR BIOL, V15, pR915, DOI 10.1016/j.cub.2005.11.009; Lindblad-Toh K, 2005, NATURE, V438, P803, DOI 10.1038/nature04338; Lindqvist C, 2010, PROC NATL ACAD SCI; MAC ARTHUR ROBERT H., 1967; Matisoo-Smith E, 2009, J ISL COAST ARCHAEOL, V4, P151, DOI [DOI 10.1080/15564890903155273, 10.1080/15564890903155273]; McKenna M.C., 1997, CLASSIFICATION MAMMA; Moray C, 2014, GENOME BIOL EVOL, V6, P161, DOI 10.1093/gbe/evu005; Morin PA, 2010, GENOME RES, V20, P908, DOI 10.1101/gr.102954.109; Munshi-South J, 2010, MOL ECOL; OHTA T, 1992, ANNU REV ECOL SYST, V23, P263, DOI 10.1146/annurev.es.23.110192.001403; Raia P, 2006, EVOLUTION, V60, P1731; Rick TC, 2005, J WORLD PREHIST, V19, P169, DOI 10.1007/s10963-006-9004-x; Rick TC, 2012, WORLD ARCHAEOL, V44, P3, DOI 10.1080/00438243.2012.646101; Rick TC, 2009, QUATERNARY RES, V71, P93, DOI 10.1016/j.yqres.2008.12.003; Roemer GW, 2004, BIOLOGY POLICY AND L; Roemer GW, 2005, BIOLOGY POLICY AND L; Storey AA, 2013, J ISL COAST ARCHAEOL, V8, P37, DOI 10.1080/15564894.2012.761299; Tausch RJ, 2006, J RANGE MANAG ARCH, V46, P439; Thalmann O, 2013, SCIENCE, V342, P871, DOI 10.1126/science.1243650; Vellanoweth RL, 1998, J CALIFORNIA GREAT B, V20, P160; Wallace AR, 1855, ANN MAGAZINE NATURAL, V16, P184, DOI DOI 10.1080/037454809495509; WAYNE RK, 1991, EVOLUTION, V45, P1849, DOI 10.1111/j.1558-5646.1991.tb02692.x; Wenner AM, 1980, THE CALIFORNIA ISLAN, P497; West G.J., 2007, CALIFORNIA PREHISTOR, P11; [No title captured]	57	51	52	1	99	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2015	10	2							e0118240	10.1371/journal.pone.0118240	http://dx.doi.org/10.1371/journal.pone.0118240			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC2IM	25714775	Green Published, gold			2022-12-27	WOS:000350168700059
J	Polo-Cavia, N; Vazquez, Z; de Miguel, FJ				Polo-Cavia, Nuria; Vazquez, Zoraida; Javier de Miguel, Francisco			Asymmetry in Food Handling Behavior of a Tree-Dwelling Rodent (Sciurus vulgaris)	PLOS ONE			English	Article							CEREBRAL LATERALIZATION; NONHUMAN-PRIMATES; MANUAL LATERALITY; PREFERENCES; HANDEDNESS; SPECIALIZATION; SELECTION; BRAIN; CHICK; CROWS	Asymmetry in motor patterns is present in a wide variety of animals. Many lateralized behaviors seem to depend on brain asymmetry, as it is the case of different tasks associated to food handling by several bird and mammal species. Here, we analyzed asymmetry in handling behavior of pine cones by red squirrels (Sciurus vulgaris). Red squirrels devote most of their daily activity to feeding, thus this species constitutes an appropriate model for studying asymmetry in food processing. We aimed to explore 1) the potential lateralization in handling of pine cones by squirrels, 2) the dominant pattern for this behavior (left- vs. right-handed), and 3) whether this pattern varies among populations and depending on the pine tree species available. Results revealed that red squirrels handle pine cones in an asymmetrical way, and that direction of asymmetry varies among populations and seems to be determined more by local influences rather than by the pine tree species.	[Polo-Cavia, Nuria; Vazquez, Zoraida; Javier de Miguel, Francisco] Univ Autonoma Madrid, Dept Biol, E-28049 Madrid, Spain; [Polo-Cavia, Nuria] Spanish Natl Museum Nat Hist CSIC, Dept Biodivers & Evolutionary Biol, Madrid 28006, Spain	Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC)	Polo-Cavia, N (corresponding author), Univ Autonoma Madrid, Dept Biol, E-28049 Madrid, Spain.	nuria.polo@uam.es	, Nuria/L-5372-2014		Spanish Ministry of Science and Innovation (MICINN) [CGL2011-25062]	Spanish Ministry of Science and Innovation (MICINN)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	Financial support for the writing of this paper was provided to N. Polo-Cavia by the Spanish Ministry of Science and Innovation (MICINN), Grant CGL2011-25062. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso Y, 1998, BEHAV PROCESS, V43, P257, DOI 10.1016/S0376-6357(98)00015-1; Arrizabalaga Antoni, 2007, Galemys, V19, P189; Bang P, 1999, HUELLAS Y SENALES DE; Bautista LM, 1998, AM NAT, V152, P543, DOI 10.1086/286189; Benkman CW, 1996, EVOL ECOL, V10, P119, DOI 10.1007/BF01239352; Blois-Heulin C, 2006, AM J PRIMATOL, V68, P429, DOI 10.1002/ajp.20239; Bonati B, 2010, BEHAV BRAIN RES, V207, P1, DOI 10.1016/j.bbr.2009.09.002; Brown C, 2011, BIOL LETTERS, V7, P496, DOI 10.1098/rsbl.2010.1121; Cantalupo C, 1995, NEUROPSYCHOLOGIA, V33, P1637, DOI 10.1016/0028-3932(95)00043-7; Castroviejo S, 1986, PLANTAS VASCULARES D, V1; Cox PG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036299; Damerose E., 2002, P306, DOI 10.1017/CBO9780511546372.011; Deng C, 2005, BEHAV BRAIN SCI, V28, P598, DOI 10.1017/S0140525X05310107; Des Roches ADB, 2008, PHYSIOL BEHAV, V94, P487, DOI 10.1016/j.physbeh.2008.03.002; Dharmaretnam A, 2005, BEHAV BRAIN RES, V162, P62, DOI 10.1016/j.bbr.2005.03.012; Facchin L, 1999, BEHAV BRAIN RES, V103, P229, DOI 10.1016/S0166-4328(99)00043-1; FAGOT J, 1991, PSYCHOL BULL, V109, P76, DOI 10.1037/0033-2909.109.1.76; Ferreira AF, 2002, ESTUDO DA DINAMICA P; Franklin WE, 2001, ANIM BEHAV, V62, P879, DOI 10.1006/anbe.2001.1826; Fredeen AL, 2002, CAN J BOT, V80, P166, DOI [10.1139/B02-002, 10.1139/b02-002]; Hopkins WD, 2004, INT J PRIMATOL, V25, P1243, DOI 10.1023/B:IJOP.0000043961.89133.3d; HORI M, 1993, SCIENCE, V260, P216, DOI 10.1126/science.260.5105.216; Hoso M, 2007, BIOL LETTERS, V3, P169, DOI 10.1098/rsbl.2006.0600; Hunt GR, 2001, NATURE, V414, P707, DOI 10.1038/414707a; Johnsgard PA, 1981, THE PLOVERS SANDPIPE; Karenina K, 2013, BEHAV ECOL SOCIOBIOL, V67, P1195, DOI 10.1007/s00265-013-1545-2; Karenina K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013787; Koboroff A, 2008, BRAIN RES BULL, V76, P304, DOI 10.1016/j.brainresbull.2008.02.015; Krebs J.R., 1978, P23; KREBS J. R., 1984, BEHAV ECOLOGY EVOLUT, P91; Lane A, 2004, APPL ANIM BEHAV SCI, V86, P161, DOI 10.1016/j.applanim.2003.11.015; Larose C, 2006, LATERALITY, V11, P355, DOI 10.1080/13576500600624221; MacNeilage PF, 2009, SCI AM, V301, P60, DOI 10.1038/scientificamerican0709-60; Makowska IJ, 2007, ANIM BEHAV, V74, P153, DOI 10.1016/j.anbehav.2006.11.019; McGrew WC, 1999, PRIMATES, V40, P509, DOI 10.1007/BF02557586; McKenzie R, 1998, NEUROPSYCHOLOGIA, V36, P51, DOI 10.1016/S0028-3932(97)00108-5; Mertl-Millhollen AS, 2007, AM J PRIMATOL, V69, P635, DOI 10.1002/ajp.20374; Mizumori T, 2003, J ORAL REHABIL, V30, P995, DOI 10.1046/j.1365-2842.2003.01086.x; Pepper J. W., 1996, THESIS; PYKE GH, 1977, Q REV BIOL, V52, P137, DOI 10.1086/409852; Quaresmini C, 2014, J COMP PSYCHOL, V128, P276, DOI 10.1037/a0036355; Randler C, 2011, LATERALITY, V16, P201, DOI 10.1080/13576500903513188; RICHARDSON H, 1986, ECOLOGY, V67, P1219, DOI 10.2307/1938677; Robins A, 2010, LATERALITY, V15, P514, DOI 10.1080/13576500903049324; Rogers LJ, 2010, APPL ANIM BEHAV SCI, V127, P1, DOI 10.1016/j.applanim.2010.06.008; Rogers LJ, 2005, BEHAV BRAIN RES, V159, P63, DOI 10.1016/j.bbr.2004.10.003; ROGERS LJ, 1993, EXP BRAIN RES, V93, P89; Salva OR, 2012, COMP COGN BEHAV REV, V7, P110, DOI 10.3819/ccbr.2012.70006; Schaafsma SM, 2009, PHILOS T R SOC B, V364, P915, DOI 10.1098/rstb.2008.0244; SCHWARZ IM, 1992, NEUROSCI LETT, V146, P167, DOI 10.1016/0304-3940(92)90069-J; Shigemiya Y, 2003, J ZOOL, V260, P259, DOI 10.1017/S095283690300373X; Sovrano VA, 2004, BEHAV BRAIN RES, V152, P385, DOI 10.1016/j.bbr.2003.10.022; Stancher G, 2006, BEHAV BRAIN RES, V173, P315, DOI 10.1016/j.bbr.2006.06.023; Strachan R, 1995, MAMMAL DETECTIVE; Vallortigara G, 2005, BEHAV BRAIN SCI, V28, P575, DOI 10.1017/S0140525X05000105; Vallortigara G, 2006, DEV PSYCHOBIOL, V48, P418, DOI 10.1002/dev.20166; Weir AAS, 2004, P ROY SOC B-BIOL SCI, V271, pS344, DOI 10.1098/rsbl.2004.0183; Wichman A, 2009, LATERALITY, V14, P381, DOI 10.1080/13576500802440616	58	1	1	12	68	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2015	10	2							e0118233	10.1371/journal.pone.0118233	http://dx.doi.org/10.1371/journal.pone.0118233			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC2IM	25714614	Green Published, Green Submitted, gold			2022-12-27	WOS:000350168700058
J	Snively, E; Fahlke, JM; Welsh, RC				Snively, Eric; Fahlke, Julia M.; Welsh, Robert C.			Bone-Breaking Bite Force of Basilosaurus isis (Mammalia, Cetacea) from the Late Eocene of Egypt Estimated by Finite Element Analysis	PLOS ONE			English	Article							FEEDING BIOMECHANICS; ARCHAEOCETE WHALES; TYRANNOSAURUS-REX; CRANIAL STRENGTH; JAW MECHANICS; EVOLUTION; PERFORMANCE; BEHAVIOR; ORIGIN; ADAPTATIONS	Bite marks suggest that the late Eocence archaeocete whale Basilosaurus isis (Birket Qarun Formation, Egypt) fed upon juveniles of the contemporary basilosaurid Dorudon atrox. Finite element analysis (FEA) of a nearly complete adult cranium of B. isis enables estimates of its bite force and tests the animal's capabilities for crushing bone. Two loadcases reflect different biting scenarios: 1) an intitial closing phase, with all adductors active and a full condylar reaction force; and 2) a shearing phase, with the posterior temporalis active and minimized condylar force. The latter is considered probable when the jaws were nearly closed because the preserved jaws do not articulate as the molariform teeth come into occulusion. Reaction forces with all muscles active indicate that B. isis maintained relatively greater bite force anteriorly than seen in large crocodilians, and exerted a maximum bite force of at least 16,400 N at its upper P-3. Under the shearing scenario with minimized condylar forces, tooth reaction forces could exceed 20,000 N despite lower magnitudes of muscle force. These bite forces at the teeth are consistent with bone indentations on Dorudon crania, reatract-and-shear hypotheses of Basilosaurus bite function, and seizure of prey by anterior teeth as proposed for other archaeocetes. The whale's bite forces match those estimated for pliosaurus when skull lengths are equalized, suggesting similar tradeoffs of bite function and hydrodynamics. Reaction forces in B. isis were lower than maxima estimated for large crocodylians and carnivorous dinosaurs. However, comparison of force estimates from FEA and regression data indicate that B. isis exerted the largest bite forces yet estimated for any mammal, and greater force than expected from its skull width. Cephalic feeding biomechanics of Basilosaurus isis are thus consistent with habitual predation.	[Snively, Eric] Univ Wisconsin, Dept Biol, La Crosse, WI 54601 USA; [Fahlke, Julia M.] Museum Nat Kunde, Leibniz Inst Evolut & Biodiversitatsforsch, D-10115 Berlin, Germany; [Welsh, Robert C.] Univ Michigan, Dept Radiol, Ann Arbor, MI 48109 USA	University of Wisconsin System; Leibniz Institut fur Evolutions und Biodiversitatsforschung; University of Michigan System; University of Michigan	Snively, E (corresponding author), Univ Wisconsin, Dept Biol, 1725 State St, La Crosse, WI 54601 USA.	esnively@uwlax.edu	Welsh, Robert/ABH-3526-2021		Feodor Lynen Fellowship of the Alexander von Humboldt Foundation; Russ College, Ohio University, Athens; College of Science and Health, University of Wisconsin-La Crosse	Feodor Lynen Fellowship of the Alexander von Humboldt Foundation(Alexander von Humboldt Foundation); Russ College, Ohio University, Athens; College of Science and Health, University of Wisconsin-La Crosse	Funding was provided by a Feodor Lynen Fellowship of the Alexander von Humboldt Foundation (JMF), Russ College, Ohio University, Athens (ES), and the College of Science and Health, University of Wisconsin-La Crosse (ES). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson PSL, 2009, PALEOBIOLOGY, V35, P251, DOI 10.1666/08011.1; [Anonymous], 2008, TYRANNOSAURUS REX TY; Bates KT, 2012, BIOL LETTERS, V8, P660, DOI 10.1098/rsbl.2012.0056; Bell PR, 2010, LETHAIA, V43, P278, DOI 10.1111/j.1502-3931.2009.00195.x; Binder WJ, 2000, J ZOOL, V252, P273, DOI 10.1111/j.1469-7998.2000.tb00622.x; Bright JA, 2011, J ANAT, V219, P456, DOI 10.1111/j.1469-7580.2011.01408.x; Bright JA, 2011, ANAT REC, V294, P610, DOI 10.1002/ar.21358; Carpenter K., 1986, Mississippi Geology, V7, P1; Carpenter K, 2000, GAIA, V15, P135; Christiansen P, 2007, ZOOL J LINN SOC-LOND, V151, P423, DOI 10.1111/j.1096-3642.2007.00321.x; Clementz MT, 2006, J VERTEBR PALEONTOL, V26, P355, DOI 10.1671/0272-4634(2006)26[355:IRFEWA]2.0.CO;2; Cunningham JA, 2014, TRENDS ECOL EVOL, V29, P347, DOI 10.1016/j.tree.2014.04.004; Curtis N, 2010, J BIOMECH, V43, P2804, DOI 10.1016/j.jbiomech.2010.05.037; Del Moral Sachetti J. Fernando, 2011, Acta Zoologica Mexicana Nueva Serie, V27, P757; Erickson GM, 1996, NATURE, V382, P706, DOI 10.1038/382706a0; Erickson GM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031781; Fahlke JM, 2010, SVP 2010, p86A; Fahlke JM, 2013, PALAEOGEOGR PALAEOCL, V386, P690, DOI 10.1016/j.palaeo.2013.06.032; Fahlke JM, 2012, PALAEONTOL ELECTRON, V15; Fahlke JM, 2011, P NATL ACAD SCI USA, V108, P14545, DOI 10.1073/pnas.1108927108; Falkingham PL, 2012, PALAEONTOL ELECTRON, V15; Foffa D, 2014, J ANAT, V225, P209, DOI 10.1111/joa.12200; Fordyce Ewan, 2001, P169; FORDYCE RE, 1994, ANNU REV EARTH PL SC, V22, P419, DOI 10.1146/annurev.ea.22.050194.002223; Gingerich P. D., 1971, Postilla, VNo. 152, P1; Gingerich P. D., 2005, PLACENTAL MAMMALS OR, P234; GINGERICH PD, 1990, SCIENCE, V249, P154, DOI 10.1126/science.249.4965.154; GINGERICH PD, 1972, AM J PHYS ANTHROPOL, V36, P359, DOI 10.1002/ajpa.1330360306; Gingerich PD, 2003, PALEOBIOLOGY, V29, P429, DOI 10.1666/0094-8373(2003)029<0429:LTIEWE>2.0.CO;2; Gingerich PD, 2001, SCIENCE, V293, P2239, DOI 10.1126/science.1063902; GINGERICH PD, 1979, AM J PHYS ANTHROPOL, V51, P135, DOI 10.1002/ajpa.1330510116; GINGERICH PD, 1992, U MICHIGAN PAPERS PA, V30, P1; Gingerich PD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004366; Goswami A, 2011, P ROY SOC B-BIOL SCI, V278, P1831, DOI 10.1098/rspb.2010.2031; Herrel A, 2009, ARCH ORAL BIOL, V54, P772, DOI 10.1016/j.archoralbio.2009.05.002; HERRING SW, 1976, ARCH ORAL BIOL, V21, P473, DOI 10.1016/0003-9969(76)90105-9; HERRING SW, 1973, J MORPHOL, V141, P427, DOI 10.1002/jmor.1051410405; Houston D.C., 1979, SERENGETI DYNAMICS E, P263; HOUSTON DC, 1986, CONDOR, V88, P318, DOI 10.2307/1368878; Hughes T.J. R., 2000, FINITE ELEMENT METHO; James MSB, 2010, THESIS U ALBERTA; Jasinoski SC, 2009, ANAT REC, V292, P862, DOI 10.1002/ar.20906; Johnston C, 2011, MAR MAMMAL SCI, V27, P493, DOI 10.1111/j.1748-7692.2010.00420.x; Kallal RJ, 2012, INT J OSTEOARCHAEOL, V22, P253, DOI 10.1002/oa.1199; KELLOGG R, 1936, CARNEGIE I WASHINGTO, V482; KOOLSTRA JH, 1988, J BIOMECH, V21, P563, DOI 10.1016/0021-9290(88)90219-9; Kruuk H., 1972, SPOTTED HYENA STUDY; Lambert O, 2010, NATURE, V466, P105, DOI 10.1038/nature09067; Long DJ, 1996, GREAT WHITE SHARKS, P293, DOI 10.1016/B978-012415031-7/50028-8; Longrich NR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013419; Lucas P., 2004, DENT FUNCTIONAL MORP; Luo Z., 1999, U MICHIGAN PAPERS PA, V31, P1; Mallison H, 2007, THESIS EBERHARD KARL, DOI [10.1002/ar.23046, DOI 10.1002/AR.23046]; Mallison Heinrich, 2014, Journal of Paleontological Techniques, V12, P1; Martin RB, 1998, SKELETAL TISSUE MECH; McHenry CR, 2009, THESIS U NEWCASTLE N, DOI [10.1016/j.cognition.2013.06.010, DOI 10.1016/J.COGNITION.2013.06.010]; Neenan JM, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.2689; Nummela S, 2004, NATURE, V430, P776, DOI 10.1038/nature02720; O'Leary MA, 1999, PALEOBIOLOGY, V25, P534, DOI 10.1017/S0094837300020376; Oldfield CC, 2012, J ZOOL, V286, P163, DOI 10.1111/j.1469-7998.2011.00862.x; Osborn H. F., 1924, American Museum Novitates, Vno. 146, P1; Peters SE, 2009, PALAIOS, V24, P290, DOI 10.2110/palo.2008.p08-080r; Porro LB, 2011, J MORPHOL, V272, P910, DOI 10.1002/jmor.10957; Rayfield EJ, 2005, ZOOL J LINN SOC-LOND, V144, P309, DOI 10.1111/j.1096-3642.2005.00176.x; Rayfield EJ, 2007, J VERTEBR PALEONTOL, V27, P892, DOI 10.1671/0272-4634(2007)27[892:FMOSCD]2.0.CO;2; Rayfield EJ, 2011, SPEC PAP PALAEONTOL, P241, DOI 10.1111/j.1475-4983.2011.01081.x; REILLY DT, 1975, J BIOMECH, V8, P393, DOI 10.1016/0021-9290(75)90075-5; Roe LJ, 1998, ADV VERT PALEOBIOL, P399; Rothschild BM, 2005, NETH J GEOSCI, V84, P335, DOI 10.1017/S0016774600021119; SINCLAIR AG, 1987, J ZOOL, V213, P107, DOI 10.1111/j.1469-7998.1987.tb03681.x; Snively E, 2013, ANAT REC, V296, P204; Snively E, 2006, ACTA PALAEONTOL POL, V51, P435; Snively Eric, 2010, Kirtlandia, V57, P53; Spoor F, 2002, NATURE, V417, P163, DOI 10.1038/417163a; Swift CC., 1996, PALEONTOLOGICAL SOC, V8, P380; Tanner JB, 2008, BIOL J LINN SOC, V95, P246, DOI 10.1111/j.1095-8312.2008.01052.x; Therrien F, 2005, LIFE O PAST, P179; Thewissen JGM, 2011, PALEOBIOLOGY, V37, P655; Thewissen JGM, 2001, NATURE, V413, P277, DOI 10.1038/35095005; THOMASON JJ, 1991, CAN J ZOOL, V69, P2326, DOI 10.1139/z91-327; Tseng ZJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019171; Uhen MD, 2010, ANNU REV EARTH PL SC, V38, P189, DOI 10.1146/annurev-earth-040809-152453; Uhen MD., 2004, U MICHIGAN PAP PALEO, V34, P1; Walmsley CW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053873; WEIJS WA, 1985, ACTA MORPHOL NEER SC, V23, P267; Werth Alexander, 2000, P487, DOI 10.1016/B978-012632590-4/50017-4; Werth AJ, 2007, ANAT REC, V290, P546, DOI 10.1002/ar.20538; Wroe S, 2005, P ROY SOC B-BIOL SCI, V272, P619, DOI 10.1098/rspb.2004.2986; Wroe S, 2008, J ZOOL, V276, P336, DOI 10.1111/j.1469-7998.2008.00494.x	89	20	20	2	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2015	10	2							e0118380	10.1371/journal.pone.0118380	http://dx.doi.org/10.1371/journal.pone.0118380			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC2IM	25714832	Green Submitted, gold, Green Published			2022-12-27	WOS:000350168700069
J	MacRaild, CA; Zachrdla, M; Andrew, D; Krishnarjuna, B; Novacek, J; Zidek, L; Sklenar, V; Richards, JS; Beeson, JG; Anders, RF; Norton, RS				MacRaild, Christopher A.; Zachrdla, Milan; Andrew, Dean; Krishnarjuna, Bankala; Novacek, Jiri; Zidek, Lukas; Sklenar, Vladimir; Richards, Jack S.; Beeson, James G.; Anders, Robin F.; Norton, Raymond S.			Conformational Dynamics and Antigenicity in the Disordered Malaria Antigen Merozoite Surface Protein 2	PLOS ONE			English	Article							PLASMODIUM-FALCIPARUM MALARIA; PAPUA-NEW-GUINEA; CLINICAL MALARIA; HUMORAL RESPONSE; CIRCUMSPOROZOITE PROTEIN; MONOCLONAL-ANTIBODIES; STRUCTURAL DIVERSITY; INTRINSIC DISORDER; LIPID INTERACTIONS; CROSS-REACTIVITY	Merozoite surface protein 2 (MSP2) of Plasmodium falciparum is an abundant, intrinsically disordered protein that is GPI-anchored to the surface of the invasive blood stage of the malaria parasite. Recombinant MSP2 has been trialled as a component of a malaria vaccine, and is one of several disordered proteins that are candidates for inclusion in vaccines for malaria and other diseases. Nonetheless, little is known about the implications of protein disorder for the development of an effective antibody response. We have therefore undertaken a detailed analysis of the conformational dynamics of the two allelic forms of MSP2 (3D7 and FC27) using NMR spectroscopy. Chemical shifts and NMR relaxation data indicate that conformational and dynamic properties of the N- and C-terminal conserved regions in the two forms of MSP2 are essentially identical, but significant variation exists between and within the central variable regions. We observe a strong relationship between the conformational dynamics and the antigenicity of MSP2, as assessed with antisera to recombinant MSP2. Regions of increased conformational order in MSP2, including those in the conserved regions, are more strongly antigenic, while the most flexible regions are minimally antigenic. This suggests that modifications that increase conformational order may offer a means to tune the antigenicity of MSP2 and other disordered antigens, with implications for vaccine design.	[MacRaild, Christopher A.; Krishnarjuna, Bankala; Norton, Raymond S.] Monash Univ, Monash Inst Pharmaceut Sci, Med Chem, Parkville, Vic 3052, Australia; [Zachrdla, Milan; Novacek, Jiri; Zidek, Lukas; Sklenar, Vladimir] Masaryk Univ, Fac Sci, NCBR, Brno 62500, Czech Republic; [Zachrdla, Milan; Novacek, Jiri; Zidek, Lukas; Sklenar, Vladimir] Masaryk Univ, CEITEC, Brno 62500, Czech Republic; [Andrew, Dean; Richards, Jack S.; Beeson, James G.] Burnet Inst, Ctr Biomed Res, Melbourne, Vic 3004, Australia; [Anders, Robin F.] La Trobe Univ, Dept Biochem, Bundoora, Vic 3086, Australia	Monash University; Masaryk University Brno; Masaryk University Brno; Burnet Institute; La Trobe University	MacRaild, CA (corresponding author), Monash Univ, Monash Inst Pharmaceut Sci, Med Chem, 381 Royal Parade, Parkville, Vic 3052, Australia.	chris.macraild@monash.edu	Sklenar, Vladimir/F-9118-2011; Sklenar, Vladimir/R-4602-2019; Novacek, Jiri/D-8551-2012; Zidek, Lukas/D-7112-2012; Krishnarjuna, Bankala/H-4562-2013; Novacek, Jiri/AAQ-4739-2021; Zidek, Lukas/AAB-6109-2020	Sklenar, Vladimir/0000-0001-9988-4093; Novacek, Jiri/0000-0003-4013-3898; Zidek, Lukas/0000-0002-8013-0336; Krishnarjuna, Bankala/0000-0002-4575-0011; Novacek, Jiri/0000-0003-4013-3898; Zidek, Lukas/0000-0002-8013-0336; Anders, Robin/0000-0002-0693-4547; Norton, Raymond/0000-0001-8893-0584; Richards, Jack/0000-0001-5786-6989; MacRaild, Christopher/0000-0002-3694-3989	Australian National Health and Medical Research Council (NHMRC) [1042520]; project "CEITEC - Central European Institute of Technology" from European Regional Development Fund [CZ.1.05/1.1.00/02.0068]; NHMRC; NHMRC Infrastructure for Independent Research Institutes Support Scheme; Victoria State Government Operational Infrastructure Support	Australian National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); project "CEITEC - Central European Institute of Technology" from European Regional Development Fund; NHMRC(National Health and Medical Research Council (NHMRC) of Australia); NHMRC Infrastructure for Independent Research Institutes Support Scheme(National Health and Medical Research Council (NHMRC) of Australia); Victoria State Government Operational Infrastructure Support	This work was supported in part by an Australian National Health and Medical Research Council (NHMRC) project grant (1042520) and by the project "CEITEC - Central European Institute of Technology" (grant CZ.1.05/1.1.00/02.0068) from European Regional Development Fund. JSR, JGB, and RSN acknowledge fellowship support from the NHMRC. The Burnet Institute is supported by funding from the NHMRC Infrastructure for Independent Research Institutes Support Scheme, and Victoria State Government Operational Infrastructure Support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adda CG, 2012, INFECT IMMUN, V80, P4177, DOI 10.1128/IAI.00665-12; Adda CG, 2009, MOL BIOCHEM PARASIT, V166, P159, DOI 10.1016/j.molbiopara.2009.03.012; ALYAMAN F, 1994, AM J TROP MED HYG, V51, P593, DOI 10.4269/ajtmh.1994.51.593; ALYAMAN F, 1995, PARASITE IMMUNOL, V17, P493, DOI 10.1111/j.1365-3024.1995.tb00920.x; ANDERS RF, 1986, PARASITE IMMUNOL, V8, P529, DOI 10.1111/j.1365-3024.1986.tb00867.x; Anders RF, 2010, HUM VACCINES, V6, P39, DOI 10.4161/hv.6.1.10712; Aucan C, 2000, INFECT IMMUN, V68, P1252, DOI 10.1128/IAI.68.3.1252-1258.2000; Boyle MJ, 2014, INFECT IMMUN, V82, P924, DOI 10.1128/IAI.00866-13; BUCK M, 1995, BIOCHEMISTRY-US, V34, P4041, DOI 10.1021/bi00012a023; Chaudhury S, 2014, J IMMUNOL, V193, P2073, DOI 10.4049/jimmunol.1401054; Dunker AK, 2002, BIOCHEMISTRY-US, V41, P6573, DOI 10.1021/bi012159+; Dutta S, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003840; DYSON HJ, 1990, BIOCHEMISTRY-US, V29, P7828, DOI 10.1021/bi00486a008; Ekala MT, 2002, CLIN EXP IMMUNOL, V129, P326, DOI 10.1046/j.1365-2249.2002.01904.x; EPPING RJ, 1988, MOL BIOCHEM PARASIT, V28, P1, DOI 10.1016/0166-6851(88)90173-9; FARROW NA, 1995, J BIOMOL NMR, V6, P153, DOI 10.1007/BF00211779; Feng ZP, 2006, MOL BIOCHEM PARASIT, V150, P256, DOI 10.1016/j.molbiopara.2006.08.011; FENTON B, 1991, MOL CELL BIOL, V11, P963, DOI 10.1128/MCB.11.2.963; Ferrage F, 2009, J AM CHEM SOC, V131, P6048, DOI 10.1021/ja809526q; Fluck C, 2004, INFECT IMMUN, V72, P6300, DOI 10.1128/IAI.72.11.6300-6305.2004; Fluck C, 2007, INFECT GENET EVOL, V7, P44, DOI 10.1016/j.meegid.2006.03.006; Foquet L, 2014, J CLIN INVEST, V124, P140, DOI 10.1172/JCI70349; Foucault M, 2010, PROTEINS, V78, P1441, DOI 10.1002/prot.22661; Genton B, 2002, J INFECT DIS, V185, P820, DOI 10.1086/339342; Jensen MR, 2014, CHEM REV, V114, P6632, DOI 10.1021/cr400688u; Kaderavek P, 2014, J BIOMOL NMR, V58, P193, DOI 10.1007/s10858-014-9816-4; Kazimierczuk K, 2010, J MAGN RESON, V205, P286, DOI 10.1016/j.jmr.2010.05.012; KEMP DJ, 1987, ANNU REV MICROBIOL, V41, P181, DOI 10.1146/annurev.mi.41.100187.001145; KOLASKAR AS, 1990, FEBS LETT, V276, P172, DOI 10.1016/0014-5793(90)80535-Q; Korzhnev DM, 2001, PROG NUCL MAG RES SP, V38, P197, DOI 10.1016/S0079-6565(00)00028-5; Kwong PD, 2002, NATURE, V420, P678, DOI 10.1038/nature01188; Larsen Jens Erik Pontoppidan, 2006, Immunome Res, V2, P2, DOI 10.1186/1745-7580-2-2; Lawrence N, 2000, PARASITE IMMUNOL, V22, P211, DOI 10.1046/j.1365-3024.2000.00293.x; Low A, 2007, BIOPOLYMERS, V87, P12, DOI 10.1002/bip.20764; MacRaild CA, 2012, BBA-BIOMEMBRANES, V1818, P2572, DOI 10.1016/j.bbamem.2012.06.015; McCarthy JS, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0024413, 10.1371/journal.pone.0021914]; Mittermaier AK, 2009, TRENDS BIOCHEM SCI, V34, P601, DOI 10.1016/j.tibs.2009.07.004; Motackova V, 2010, J BIOMOL NMR, V48, P169, DOI 10.1007/s10858-010-9447-3; MUSTER T, 1993, J VIROL, V67, P6642, DOI 10.1128/JVI.67.11.6642-6647.1993; NOVOTNY J, 1986, P NATL ACAD SCI USA, V83, P226, DOI 10.1073/pnas.83.2.226; Ofek G, 2010, P NATL ACAD SCI USA, V107, P17880, DOI 10.1073/pnas.1004728107; Oldfield CJ, 2014, ANNU REV BIOCHEM, V83, P553, DOI 10.1146/annurev-biochem-072711-164947; Olugbile S, 2009, INFECT IMMUN, V77, P5701, DOI 10.1128/IAI.00652-09; Osier FHA, 2010, PARASITE IMMUNOL, V32, P193, DOI 10.1111/j.1365-3024.2009.01178.x; Osier FHA, 2008, INFECT IMMUN, V76, P2240, DOI 10.1128/IAI.01585-07; Osier FHA, 2014, BMC MED, V12, DOI 10.1186/1741-7015-12-108; Palmer AG, 2004, CHEM REV, V104, P3623, DOI 10.1021/cr030413t; Pavlovic MD, 2014, J IMMUNOL METHODS, V407, P90, DOI 10.1016/j.jim.2014.03.027; Pelupessy P, 2003, J MAGN RESON, V161, P258, DOI 10.1016/S1090-7807(02)00190-8; Pelupessy P, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2715583; Penkett CJ, 1998, BIOCHEMISTRY-US, V37, P17054, DOI 10.1021/bi9814080; Putaporntip C, 2008, GENE, V427, P51, DOI 10.1016/j.gene.2008.09.009; Raj DK, 2014, SCIENCE, V344, P871, DOI 10.1126/science.1254417; Richards JS, 2010, CLIN INFECT DIS, V51, pE50, DOI 10.1086/656413; Saul A, 1999, VACCINE, V17, P3145, DOI 10.1016/S0264-410X(99)00175-9; SAUL A, 1989, PARASITE IMMUNOL, V11, P593, DOI 10.1111/j.1365-3024.1989.tb00923.x; Scopel KKG, 2007, AM J TROP MED HYG, V76, P1084, DOI 10.4269/ajtmh.2007.76.1084; Sharma D, 2000, J BIOMOL NMR, V18, P165, DOI 10.1023/A:1008398416292; SMYTHE JA, 1990, MOL BIOCHEM PARASIT, V39, P227, DOI 10.1016/0166-6851(90)90061-P; SMYTHE JA, 1991, P NATL ACAD SCI USA, V88, P1751, DOI 10.1073/pnas.88.5.1751; STAHL HD, 1984, P NATL ACAD SCI-BIOL, V81, P2456, DOI 10.1073/pnas.81.8.2456; Stanisic DI, 2009, INFECT IMMUN, V77, P1165, DOI 10.1128/IAI.01129-08; Stubbs J, 2011, INFECT IMMUN, V79, P1143, DOI 10.1128/IAI.01034-10; Tamiola K, 2010, J AM CHEM SOC, V132, P18000, DOI 10.1021/ja105656t; TAYLOR RR, 1995, INFECT IMMUN, V63, P4382, DOI 10.1128/IAI.63.11.4382-4388.1995; Taylor RR, 1998, AM J TROP MED HYG, V58, P406, DOI 10.4269/ajtmh.1998.58.406; THOMAS AW, 1990, MOL BIOCHEM PARASIT, V43, P211, DOI 10.1016/0166-6851(90)90146-D; Uversky VN, 2005, J MOL RECOGNIT, V18, P343, DOI 10.1002/jmr.747; WESTHOF E, 1984, NATURE, V311, P123, DOI 10.1038/311123a0; Xue B, 2014, CHEM REV, V114, P6880, DOI 10.1021/cr4005692; Yagi M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098460; Yang XD, 2010, BIOCHIMIE, V92, P1287, DOI 10.1016/j.biochi.2010.06.001; Zhang XC, 2008, J MOL BIOL, V379, P105, DOI 10.1016/j.jmb.2008.03.039; Zilversmit MM, 2010, MOL BIOL EVOL, V27, P2198, DOI 10.1093/molbev/msq108	74	22	22	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2015	10	3							e0119899	10.1371/journal.pone.0119899	http://dx.doi.org/10.1371/journal.pone.0119899			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9KG	25742002	Green Published, gold			2022-12-27	WOS:000350688100130
J	Bach, S; Morrow, MM; Zhao, KD; Hughes, RE				Bach, Sarah; Morrow, Melissa M.; Zhao, Kristin D.; Hughes, Richard E.			Sex Distribution of Study Samples Reported in American Society of Biomechanics Annual Meeting Abstracts	PLOS ONE			English	Article								Background Study samples should be appropriately selected to maximize generalizability of results. Excluding one sex from studies of conditions that affect both sexes is problematic and has received attention as a public policy issue in the United States, resulting in legislation and recommendations made by the National Institutes of Health to address this deficiency of study designs. It is unknown to what extent biomechanical studies have inappropriately excluded one sex. The objective of this study was to provide objective data on this question. Methods A retrospective review of random samples of abstracts presented at American Society of Biomechanics annual meetings from 1983 to 2013 was conducted to assess reporting of sex of study samples and whether the study samples were approximately balanced with respect to sex. Findings We did not find a statistically significant increasing trend in the percentage of abstracts reporting sex over time. However, increasing trends were noted in the percentage of abstracts including both sexes (p<0.05) and percentage of abstracts having an "approximately balanced" study sample containing 50 +/- 20% females (p>0.05). In 2013 the percentage of abstracts reporting studies having approximately balanced study samples was only 28%, far from the ideal level of 100%. Interpretation While there has been modest change since 1983, there remains significant room for improvement in the reporting and composition of experimental studies reported at American Society of Biomechanics annual meetings.	[Bach, Sarah; Hughes, Richard E.] Univ Michigan, Dept Ind & Operat Engn, Ann Arbor, MI 48109 USA; [Morrow, Melissa M.] Mayo Clin, Div Orthoped Res, Rochester, MN USA; [Zhao, Kristin D.] Mayo Clin, Rehabil Med Res Ctr, Phys Med & Rehabil, Rochester, MN USA; [Hughes, Richard E.] Univ Michigan, Dept Orthopaed Surg, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; Mayo Clinic; Mayo Clinic; University of Michigan System; University of Michigan	Hughes, RE (corresponding author), Univ Michigan, Dept Ind & Operat Engn, Ann Arbor, MI 48109 USA.	rehughes@umich.edu						Clayton JA, 2014, NATURE, V509, P282, DOI 10.1038/509282a; Geller SE, 2006, J WOMENS HEALTH, V15, P1123, DOI 10.1089/jwh.2006.15.1123; Raz Limor, 2012, Handb Exp Pharmacol, P127, DOI 10.1007/978-3-642-30726-3_7; Resnik DB, 1996, THEOR MED BIOETH, V20, P245	4	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2015	10	3							e0118797	10.1371/journal.pone.0118797	http://dx.doi.org/10.1371/journal.pone.0118797			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9JM	25738500	Green Published, Green Submitted, gold			2022-12-27	WOS:000350685900074
J	Kroll, MH; Bi, CX; Garber, CC; Kaufman, HW; Liu, DG; Caston-Balderrama, A; Zhang, K; Clarke, N; Xie, MG; Reitz, RE; Suffin, SC; Holick, MF				Kroll, Martin H.; Bi, Caixia; Garber, Carl C.; Kaufman, Harvey W.; Liu, Dungang; Caston-Balderrama, Anne; Zhang, Ke; Clarke, Nigel; Xie, Minge; Reitz, Richard E.; Suffin, Stephen C.; Holick, Michael F.			Temporal Relationship between Vitamin D Status and Parathyroid Hormone in the United States	PLOS ONE			English	Article							25-HYDROXYVITAMIN D CONCENTRATIONS; J-SHAPED ASSOCIATION; ALL-CAUSE MORTALITY; SEASONAL-VARIATION; D DEFICIENCY; SERUM CONCENTRATIONS; D METABOLITES; POPULATION	Background Interpretation of parathyroid hormone (iPTH) requires knowledge of vitamin D status that is influenced by season. Objective Characterize the temporal relationship between 25-hydroxyvitamin D-3 levels [25(OH)D-3] and intact iPTH for several seasons, by gender and latitude in the U. S. and relate 25-hydrovitamin D-2 [25(OH)D-2] levels with PTH levels and total 25(OH)D levels. Method We retrospectively determined population weekly-mean concentrations of unpaired [25(OH)D-2 and 25(OH)D-3] and iPTH using 3.8 million laboratory results of adults. The 25(OH)D-3 and iPTH distributions were normalized and the means fit with a sinusoidal function for both gender and latitudes: North >40, Central 32-40 and South <32 degrees. We analyzed PTH and total 25(OH) D separately in samples with detectable 25(OH)D-2 (>= 4 ng/mL). Findings Seasonal variation was observed for all genders and latitudes. 25(OH)D-3 peaks occurred in September and troughs in March. iPTH levels showed an inverted pattern of peaks and troughs relative to 25(OH)D-3, with a delay of 4 weeks. Vitamin D deficiency and insufficiency was common (33% <20 ng/mL; 60% <30 ng/mL) as was elevated iPTH levels (33%>65 pg/mL). The percentage of patients deficient in 25(OH)D-3 seasonally varied from 21% to 48% and the percentage with elevated iPTH reciprocally varied from 28% to 38%. Patients with detectable 25(OH)D-2 had higher PTH levels and 57% of the samples with a total 25(OH)D > 50 ng/mL had detectable 25(OH)D-2. Interpretation 25(OH)D-3 and iPTH levels vary in a sinusoidal pattern throughout the year, even in vitamin D-2 treated patients; 25(OH)D-3, being higher in the summer and lower in the winter months, with iPTH showing the reverse pattern. A large percentage of the tested population showed vitamin D deficiency and secondary hyperparathyroidism. These observations held across three latitudinal regions, both genders, multiple-years, and in the presence or absence of detectable 25(OH)D-2, and thus are applicable for patient care.	[Kroll, Martin H.; Bi, Caixia; Garber, Carl C.; Kaufman, Harvey W.; Suffin, Stephen C.] Quest Diagnost, Giralda Farms 3, Madison, NJ 07940 USA; [Caston-Balderrama, Anne; Zhang, Ke; Clarke, Nigel; Reitz, Richard E.] Quest Diagnost Nichols Inst, San Juan, CA USA; [Xie, Minge] Rutgers State Univ, Dept Stat & Biostat, Off Stat Consulting, Piscataway, NJ USA; [Liu, Dungang] Yale Univ, Sch Publ Hlth, Dept Biostat, New Haven, CT USA; [Holick, Michael F.] Boston Univ, Sch Med, Dept Med Physiol & Biophys, Boston, MA 02118 USA	Nichols Institute; Rutgers State University New Brunswick; Yale University; Boston University	Kroll, MH (corresponding author), Quest Diagnost, Giralda Farms 3, Madison, NJ 07940 USA.	Martin.H.Kroll@questdiagnostics.com; mfholick@bu.edu			Quest Diagnostics	Quest Diagnostics	This work was funded by Quest Diagnostics. All authors received salary support or consulting support from Quest Diagnostics. Quest Diagnostics provided support in the form of salaries for the authors, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of the authors are articulated in the 'author contributions' section.	ADAMS JS, 1982, NEW ENGL J MED, V306, P722, DOI 10.1056/NEJM198203253061206; Amrein K, 2014, J CLIN ENDOCRINOL ME; Armas LAG, 2004, J CLIN ENDOCR METAB, V89, P5387, DOI 10.1210/jc.2004-0360; CHAPUY MC, 1983, J GERONTOL, V38, P19, DOI 10.1093/geronj/38.1.19; Davies PSW, 1999, EUR J CLIN NUTR, V53, P195, DOI 10.1038/sj.ejcn.1600697; DawsonHughes B, 1997, AM J CLIN NUTR, V65, P67, DOI 10.1093/ajcn/65.1.67; Durup D, 2012, J CLIN ENDOCR METAB, V97, P2644, DOI 10.1210/jc.2012-1176; Fraser A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013882; Hagenau T, 2009, OSTEOPOROSIS INT, V20, P133, DOI 10.1007/s00198-008-0626-y; Harris SS, 1998, AM J CLIN NUTR, V67, P1232, DOI 10.1093/ajcn/67.6.1232; HEGARTY V, 1994, AGE AGEING, V23, P478, DOI 10.1093/ageing/23.6.478; Hoenderop JGJ, 2005, PHYSIOL REV, V85, P373, DOI 10.1152/physrev.00003.2004; Holick MF, 2008, NUTR REV, V66, pS182, DOI 10.1111/j.1753-4887.2008.00104.x; Holick MF, 2011, J CLIN ENDOCR METAB, V96, P1911, DOI 10.1210/jc.2011-0385; Itoh H, 2011, IND HEALTH, V49, P475, DOI 10.2486/indhealth.MS1255; JUTTMANN JR, 1981, BRIT MED J, V282, P1349, DOI 10.1136/bmj.282.6273.1349; Kasahara AK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065785; Kimlin MG, 2007, J PHOTOCH PHOTOBIO B, V86, P234, DOI 10.1016/j.jphotobiol.2006.10.004; KRALL EA, 1989, NEW ENGL J MED, V321, P1777, DOI 10.1056/NEJM198912283212602; Levis S, 2005, J CLIN ENDOCR METAB, V90, P1557, DOI 10.1210/jc.2004-0746; LIPS P, 1983, J CLIN ENDOCR METAB, V57, P204, DOI 10.1210/jcem-57-1-204; Looker AC, 2011, NCHS DATA BRIEF, V59, P1; Looker AC, 2008, AM J CLIN NUTR, V88, P1519, DOI 10.3945/ajcn.2008.26182; Melin A, 2001, J AM GERIATR SOC, V49, P1190, DOI 10.1046/j.1532-5415.2001.49236.x; Need AG, 2000, AM J CLIN NUTR, V71, P1577; Pasco JA, 2004, J BONE MINER RES, V19, P752, DOI 10.1359/JBMR.040125; Sachs MC, 2013, AM J CLIN NUTR; Sempos CT, 2013, J CLIN ENDOCR METAB, V98, P3001, DOI 10.1210/jc.2013-1333; Shoben AB, 2011, AM J EPIDEMIOL, V174, P1363, DOI 10.1093/aje/kwr258; STRYD RP, 1979, J CLIN ENDOCR METAB, V48, P771, DOI 10.1210/jcem-48-5-771; Tangpricha V, 2002, AM J MED, V112, P659, DOI 10.1016/S0002-9343(02)01091-4; TJELLESEN L, 1983, SCAND J CLIN LAB INV, V43, P85; WEBB AR, 1988, J CLIN ENDOCR METAB, V67, P373, DOI 10.1210/jcem-67-2-373; Yetley EA, 2008, AM J CLIN NUTR, V88, p558S, DOI 10.1093/ajcn/88.2.558S	34	101	108	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2015	10	3							e0118108	10.1371/journal.pone.0118108	http://dx.doi.org/10.1371/journal.pone.0118108			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9JM	25738588	Green Published, gold, Green Submitted			2022-12-27	WOS:000350685900021
J	Woolfit, M; Algama, M; Keith, JM; McGraw, EA; Popovici, J				Woolfit, Megan; Algama, Manjula; Keith, Jonathan M.; McGraw, Elizabeth A.; Popovici, Jean			Discovery of Putative Small Non-Coding RNAs from the Obligate Intracellular Bacterium Wolbachia pipientis	PLOS ONE			English	Article							DOMAIN-ENCODING GENES; IV SECRETION; BAYESIAN SEGMENTATION; EXPRESSION; DROSOPHILA; GENOME; SEQUENCE; STRAIN; DENGUE; VIRULENCE	Wolbachia pipientis is an endosymbiotic bacterium that induces a wide range of effects in its insect hosts, including manipulation of reproduction and protection against pathogens. Little is known of the molecular mechanisms underlying the insect-Wolbachia interaction, though it is likely to be mediated via the secretion of proteins or other factors. There is an increasing amount of evidence that bacteria regulate many cellular processes, including secretion of virulence factors, using small non-coding RNAs (sRNAs), but sRNAs have not previously been described from Wolbachia. We have used two independent approaches, one based on comparative genomics and the other using RNA-Seq data generated for gene expression studies, to identify candidate sRNAs in Wolbachia. We experimentally characterized the expression of one of these candidates in four Wolbachia strains, and showed that it is differentially regulated in different host tissues and sexes. Given the roles played by sRNAs in other host-associated bacteria, the conservation of the candidate sRNAs between different Wolbachia strains, and the sex-and tissue-specific differential regulation we have identified, we hypothesise that sRNAs may play a significant role in the biology of Wolbachia, and in particular in its interactions with its host.	[Woolfit, Megan; McGraw, Elizabeth A.; Popovici, Jean] Monash Univ, Sch Biol Sci, Clayton, Vic, Australia; [Algama, Manjula; Keith, Jonathan M.] Monash Univ, Sch Math Sci, Clayton, Vic 3800, Australia	Monash University; Monash University	Popovici, J (corresponding author), Inst Pasteur Cambodia, Malaria Mol Epidemiol Unit, Phnom Penh, Cambodia.	jean.o.popovici@gmail.com	McGraw, Elizabeth/GRF-0434-2022; Popovici, Jean/K-7192-2014; McGraw, Elizabeth/A-6658-2012	Popovici, Jean/0000-0002-3135-1175; McGraw, Elizabeth/0000-0001-7973-088X; Keith, Jonathan/0000-0002-9675-3976	National Health and Medical Research Council of Australia; Australian Research Council [DP1095849]	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council(Australian Research Council)	This work was supported by a grant from the National Health and Medical Research Council of Australia and by a grant from the Australian Research Council (DP1095849). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albrecht M, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-10-r98; Algama M, 2014, COMPUT STRUCT BIOTEC, V10, P107, DOI 10.1016/j.csbj.2014.08.003; Bejerano-Sagie M, 2007, CURR OPIN MICROBIOL, V10, P189, DOI 10.1016/j.mib.2007.03.009; Boughammoura A, 2008, J BACTERIOL, V190, P1518, DOI 10.1128/JB.01640-07; Bradley ES, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002126; Brennan LJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002083; Carver T, 2012, BIOINFORMATICS, V28, P464, DOI 10.1093/bioinformatics/btr703; Darby AC, 2014, ISME J, V8, P925, DOI 10.1038/ismej.2013.192; Darby AC, 2012, GENOME RES, V22, P2467, DOI 10.1101/gr.138420.112; Darling ACE, 2004, GENOME RES, V14, P1394, DOI 10.1101/gr.2289704; Degnan PH, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002252; Frentiu FD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013398; FROHMAN MA, 1988, P NATL ACAD SCI USA, V85, P8998, DOI 10.1073/pnas.85.23.8998; Gerhart E, 2008, HDB RNA BIOCH; Gottesman S, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a003798; Grieshaber NA, 2006, MOL MICROBIOL, V59, P541, DOI 10.1111/j.1365-2958.2005.04949.x; Hedges LM, 2008, SCIENCE, V322, P702, DOI 10.1126/science.1162418; Hoffmann AA, 2011, NATURE, V476, P454, DOI 10.1038/nature10356; Hoffmann AA, 1997, INFLUENTIAL PASSENGERS, P42; Hussain M, 2011, P NATL ACAD SCI USA, V108, P9250, DOI 10.1073/pnas.1105469108; Iturbe-Ormaetxe I, 2005, J BACTERIOL, V187, P5136, DOI 10.1128/JB.187.15.5136-5145.2005; Iturbe-Ormaetxe I, 2011, J MICROBIOL METH, V84, P134, DOI 10.1016/j.mimet.2010.10.019; Keith JM, 2004, METHODOL COMPUT APPL, V6, P29, DOI 10.1023/B:MCAP.0000012414.14405.15; Keith JM, 2008, J COMPUT BIOL, V15, P407, DOI 10.1089/cmb.2007.0173; Keith JM, 2006, J COMPUT BIOL, V13, P1369, DOI 10.1089/cmb.2006.13.1369; Keith Jonathan M., 2008, V452, P207, DOI 10.1007/978-1-60327-159-2_11; Klasson L, 2008, MOL BIOL EVOL, V25, P1877, DOI 10.1093/molbev/msn133; Koo JT, 2011, P NATL ACAD SCI USA, V108, pE709, DOI 10.1073/pnas.1101655108; Kremer N, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-S1-S7; Kremer N, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000630; Kumar Nikhil, 2012, BMC Res Notes, V5, P230, DOI 10.1186/1756-0500-5-230; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Li ZR, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0035834, 10.1371/journal.pone.0051597]; Lohse M, 2012, NUCLEIC ACIDS RES, V40, pW622, DOI 10.1093/nar/gks540; Min KT, 1997, P NATL ACAD SCI USA, V94, P10792, DOI 10.1073/pnas.94.20.10792; Moreira LA, 2009, CELL, V139, P1268, DOI 10.1016/j.cell.2009.11.042; Murphy ER, 2007, INFECT IMMUN, V75, P3470, DOI 10.1128/IAI.00112-07; Oldmeadow C, 2011, BIOINFORMATICS, V27, P604, DOI 10.1093/bioinformatics/btq716; Osei-Amo S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050049; Papafotiou G, 2011, RES MICROBIOL, V162, P764, DOI 10.1016/j.resmic.2011.06.012; Paraskevopoulos C, 2006, CURR MICROBIOL, V53, P388, DOI 10.1007/s00284-006-0054-1; Podkaminski D, 2010, MOL MICROBIOL, V78, P1327, DOI 10.1111/j.1365-2958.2010.07428.x; Rances E, 2008, J BACTERIOL, V190, P5020, DOI 10.1128/JB.00377-08; Rikihisa Y, 2010, CELL MICROBIOL, V12, P1213, DOI 10.1111/j.1462-5822.2010.01500.x; Shelby KS, 2007, J INVERTEBR PATHOL, V95, P77, DOI 10.1016/j.jip.2007.01.001; Siozios S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055390; Skippington E, 2012, GENOME BIOL EVOL, V4, P330, DOI 10.1093/gbe/evs001; Smith NA, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002022; Storz G, 2011, MOL CELL, V43, P880, DOI 10.1016/j.molcel.2011.08.022; Sutton ER, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-928; Teixeira L, 2008, PLOS BIOL, V6, P2753, DOI 10.1371/journal.pbio.1000002; Voth DE, 2012, FUTURE MICROBIOL, V7, P241, DOI [10.2217/fmb.11.150, 10.2217/FMB.11.150]; Walker T, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-39; Werren JH, 2008, NAT REV MICROBIOL, V6, P741, DOI 10.1038/nrmicro1969; Woolfit M, 2009, MOL BIOL EVOL, V26, P367, DOI 10.1093/molbev/msn253; Woolfit M, 2013, GENOME BIOL EVOL, V5, P2189, DOI 10.1093/gbe/evt169; Wu M, 2004, PLOS BIOL, V2, P327, DOI 10.1371/journal.pbio.0020069; Yamada R, 2011, INSECT MOL BIOL, V20, P75, DOI 10.1111/j.1365-2583.2010.01042.x; Zhang GM, 2013, P NATL ACAD SCI USA, V110, P10276, DOI 10.1073/pnas.1303603110; Zug R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038544	60	11	11	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2015	10	3							e0118595	10.1371/journal.pone.0118595	http://dx.doi.org/10.1371/journal.pone.0118595			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9JM	25739023	gold, Green Published, Green Submitted			2022-12-27	WOS:000350685900053
J	Chitwood, MC; Lashley, MA; Kilgo, JC; Pollock, KH; Moorman, CE; DePerno, CS				Chitwood, M. Colter; Lashley, Marcus A.; Kilgo, John C.; Pollock, Kenneth H.; Moorman, Christopher E.; DePerno, Christopher S.			Do Biological and Bedsite Characteristics Influence Survival of Neonatal White-Tailed Deer?	PLOS ONE			English	Article							COYOTE PREDATION; FAWNS; MORTALITY; POPULATIONS; NUTRITION; RATES; RISK; AGE	Coyotes recently expanded into the eastern U.S. and potentially have caused localized white-tailed deer population declines. Research has focused on quantifying coyote predation on neonates, but little research has addressed the potential influence of bedsite characteristics on survival. In 2011 and 2012, we radiocollared 65 neonates, monitored them intensively for 16 weeks, and assigned mortality causes. We used Program MARK to estimate survival to 16 weeks and included biological covariates (i.e., sex, sibling status [whether or not it had a sibling], birth weight, and Julian date of birth). Survival to 16 weeks was 0.141 (95% CI = 0.075-0.249) and the top model included only sibling status, which indicated survival was lower for neonates that had a sibling. Predation was the leading cause of mortality (35 of 55; 64%) and coyotes were responsible for the majority of depredations (30 of 35; 86%). Additionally, we relocated neonates for the first 10 days of life and measured distance to firebreak, visual obstruction, and plant diversity at bedsites. Survival of predation to 10 days (0.726; 95% CI = 0.586-0.833) was weakly associated with plant diversity at bedsites but not related to visual obstruction. Our results indicate that neonate survival was low and coyote predation was an important source of mortality, which corroborates several recent studies from the region. Additionally, we detected only weak support for bedsite cover as a covariate to neonate survival, which indicates that mitigating effects of coyote predation on neonates may be more complicated than simply managing for increased hiding cover.	[Chitwood, M. Colter; Lashley, Marcus A.; Moorman, Christopher E.; DePerno, Christopher S.] N Carolina State Univ, Dept Forestry & Environm Resources, Raleigh, NC 27695 USA; [Kilgo, John C.] US Forest Serv, USDA, Southern Res Stn, New Ellenton, SC USA; [Pollock, Kenneth H.] N Carolina State Univ, Dept Appl Ecol, Raleigh, NC 27695 USA	University of North Carolina; North Carolina State University; United States Department of Agriculture (USDA); United States Forest Service; University of North Carolina; North Carolina State University	Chitwood, MC (corresponding author), N Carolina State Univ, Dept Forestry & Environm Resources, Raleigh, NC 27695 USA.	colter_chitwood@ncsu.edu		Chitwood, Colter/0000-0001-7240-7430	United States Department of Defense; Fort Bragg Wildlife Branch	United States Department of Defense(United States Department of Defense); Fort Bragg Wildlife Branch	The authors thank the United States Department of Defense and Fort Bragg Wildlife Branch for financial contributions to this research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ballard WB, 1999, J WILDLIFE MANAGE, V63, P574, DOI 10.2307/3802645; BARTUSH W S, 1981, Proceedings of the Oklahoma Academy of Science, V61, P23; BEALE DM, 1973, J WILDLIFE MANAGE, V37, P343, DOI 10.2307/3800125; Bishop CJ, 2008, J WILDLIFE MANAGE, V72, P1085, DOI 10.2193/2007-423; Bishop CJ, 2009, WILDLIFE MONOGR, P1, DOI 10.2193/2008-107; Bowman JL, 1998, WILDLIFE SOC B, V26, P295; Brinkman TJ, 2004, WILDLIFE SOC B, V32, P726, DOI 10.2193/0091-7648(2004)032[0726:SOWDIA]2.0.CO;2; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Carstensen M, 2003, WILDLIFE SOC B, V31, P634; Chitwood MC, 2014, SOUTHEAST NAT, V13, pN30, DOI 10.1656/058.013.0316; Chitwood MC, 2014, SOUTHEAST NAT, V13, pN6, DOI 10.1656/058.013.0202; Chitwood MC, 2015, J WILDLIFE MANAGE, V79, P211, DOI 10.1002/jwmg.835; COOK RS, 1971, J WILDLIFE MANAGE, V35, P47, DOI 10.2307/3799870; Creel S, 2007, SCIENCE, V315, P960, DOI 10.1126/science.1135918; DeYoung RW, 2011, BIOLOGY AND MANAGEMENT OF WHITE-TAILED DEER, P311; Diefenbach DR, 2003, WILDLIFE SOC B, V31, P756; Epstein M.B., 1983, Proceedings of the Annual Conference Southeastern Association of Fish and Wildlife Agencies, V37, P161; FAIRBANKS WS, 1993, J MAMMAL, V74, P129, DOI 10.2307/1381911; Garner G.W., 1976, Proceedings of the Annual Conference Southeastern Association of Fish and Wildlife Agencies, V30, P493; Gompper ME, 2002, BIOSCIENCE, V52, P185, DOI 10.1641/0006-3568(2002)052[0185:TCITSE]2.0.CO;2; Grovenburg TW, 2011, J WILDLIFE MANAGE, V75, P213, DOI 10.1002/jwmg.20; HARRISON DJ, 1985, J MAMMAL, V66, P712, DOI 10.2307/1380797; HILL EP, 1987, WILDLIFE SOC B, V15, P521; HUEGEL CN, 1985, J WILDLIFE MANAGE, V49, P377, DOI 10.2307/3801536; Jackson AM, 2013, AM MIDL NAT, V170, P184, DOI 10.1674/0003-0031-170.1.184; Johnson WE, 1997, J MOL EVOL, V44, pS98, DOI 10.1007/PL00000060; Kilgo JC, 2014, J WILDLIFE MANAGE, V78, P1261, DOI 10.1002/jwmg.764; Kilgo JC, 2012, J WILDLIFE MANAGE, V76, P1420, DOI 10.1002/jwmg.393; Kilgo JC, 2010, J WILDLIFE MANAGE, V74, P929, DOI 10.2193/2009-263; Labisky RF, 1998, AM MIDL NAT, V139, P275, DOI 10.1674/0003-0031(1998)139[0275:BOBPOW]2.0.CO;2; Langenau E. E. Jr., 1976, Applied Animal Ethology, V2, P207, DOI 10.1016/0304-3762(76)90053-5; Lashley MA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090652; Lashley MA, 2014, ECOL INDIC, V38, P212, DOI 10.1016/j.ecolind.2013.11.006; Long RA, 1998, WILDLIFE BIOL, V4, P237, DOI 10.2981/wlb.1998.021; Miller K. V., 1995, QUALITY WHITETAILS W; Nowak R.M., 1979, University of Kansas Museum of Natural History Monograph, P1; NUDDS T D, 1977, Wildlife Society Bulletin, V5, P113; O'Gara B.W., 1978, Proceedings of the Pronghorn Antelope Workshop, V8, P380; OZOGA JJ, 1988, J WILDLIFE MANAGE, V52, P549, DOI 10.2307/3801608; Parker G.R., 1995, E COYOTE STORY ITS S; Powell MC, 2005, WILDLIFE SOC B, V33, P643, DOI 10.2193/0091-7648(2005)33[643:LROMAI]2.0.CO;2; Burroughs JP, 2006, J WILDLIFE MANAGE, V70, P743, DOI 10.2193/0022-541X(2006)70[743:CMASOW]2.0.CO;2; Rhoads ML, 2009, J DAIRY SCI, V92, P1986, DOI 10.3168/jds.2008-1641; Roberts SB, 2007, THESIS U GEORGIA; Robinson KF, 2014, J WILDLIFE MANAGE, V78, P571, DOI 10.1002/jwmg.693; Rohm JH, 2007, J WILDLIFE MANAGE, V71, P851, DOI 10.2193/2006-027; Rosenberry CS, 2011, WILDLIFE SOC B, V35, P461, DOI 10.1002/wsb.81; Saalfeld ST, 2007, J WILDLIFE MANAGE, V71, P940, DOI 10.2193/2006-116; Sams MG, 1996, WILDLIFE SOC B, V24, P53; Smith BL, 1998, J WILDLIFE MANAGE, V62, P1036, DOI 10.2307/3802556; Vreeland JK, 2004, WILDLIFE SOC B, V32, P542, DOI 10.2193/0091-7648(2004)32[542:SRMCAH]2.0.CO;2; Warren RJ, 1997, WILDLIFE SOC B, V25, P213; White GC, 1999, BIRD STUDY, V46, P120, DOI 10.1080/00063659909477239; WHITE M, 1973, J MAMMAL, V54, P291, DOI 10.2307/1378900	54	44	44	1	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2015	10	3							e0119070	10.1371/journal.pone.0119070	http://dx.doi.org/10.1371/journal.pone.0119070			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4HV	25734333	Green Submitted, gold, Green Published			2022-12-27	WOS:000350314700053
J	He, F; Fu, Y; Chen, Q; Ruan, Z; Hua, XT; Zhou, H; Yu, YS				He, Fang; Fu, Ying; Chen, Qiong; Ruan, Zhi; Hua, Xiaoting; Zhou, Hua; Yu, Yunsong			Tigecycline Susceptibility and the Role of Efflux Pumps in Tigecycline Resistance in KPC-Producing Klebsiella pneumoniae	PLOS ONE			English	Article							ANTIMICROBIAL DRUG SUSCEPTIBILITY; DECREASED SUSCEPTIBILITY; MULTIDRUG-RESISTANCE; RAMA; EXPRESSION; ACRAB; 1-(1-NAPHTHYLMETHYL)-PIPERAZINE; ENTEROBACTERIACEAE; INHIBITOR; REGULATOR	KPC-producing Klebsiella pneumoniae isolates have emerged as important pathogens of nosocomial infections, and tigecycline is one of the antibiotics recommended for severe infections caused by KPC-producing K. pneumoniae. To identify the susceptibility profile of KPC-producing K. pneumoniae to tigecycline and investigate the role of efflux pumps in tigecycline resistance, a total of 215 KPC-producing K. pneumoniae isolates were collected. The minimum inhibitory concentration (MIC) of tigecycline was determined by standard broth microdilution tests. Isolates showing resistance to tigecycline underwent susceptibility test with efflux pump inhibitors. Expression levels of efflux pump genes (acrB and oqxB) and their regulators (ramA, marA, soxS and rarA) were examined by real-time PCR, and the correlation between tigecycline MICs and gene expression levels were analysed. Our results show that the tigecycline resistance rate in these isolates was 11.2%. Exposure of the tigecycline-resistant isolates to the efflux pump inhibitor NMP resulted in an obvious decrease in MICs and restored susceptibility to tigecycline in 91.7% of the isolates. A statistically significant association between acrB expression and tigecycline MICs was observed, and overexpression of ramA was found in three tigecycline-resistant isolates, further analysis confirmed ramRmutations existed in these isolates. Transformation of one mutant with wild-type ramR restored susceptibility to tigecycline and repressed overexpression of ramA and acrB. These data indicate that efflux pump AcrAB, which can be up-regulated by ramR mutations and subsequent ramA activation, contributed to tigecycline resistance in K. pneumoniae clinical isolates.	[He, Fang; Fu, Ying; Chen, Qiong; Ruan, Zhi; Hua, Xiaoting; Yu, Yunsong] Zhejiang Univ, Sch Med, Dept Infect Dis, Sir Run Run Shaw Hosp, Hangzhou 310016, Zhejiang, Peoples R China; [Zhou, Hua] Zhejiang Univ, Dept Resp Dis, Sch Med, Affiliated Hosp 1, Hangzhou 310003, Zhejiang, Peoples R China	Zhejiang University; Zhejiang University	Yu, YS (corresponding author), Zhejiang Univ, Sch Med, Dept Infect Dis, Sir Run Run Shaw Hosp, Hangzhou 310016, Zhejiang, Peoples R China.	yvys119@163.com	Hua, Xiaoting/B-5786-2011; Ruan, Zhi/P-3987-2015	Hua, Xiaoting/0000-0001-8215-916X; Ruan, Zhi/0000-0001-8648-4592; He, Fang/0000-0002-7002-2382	National Natural Science Foundation of China [NSFC81230039, NSFC81000757]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by research grants from the National Natural Science Foundation of China (No. NSFC81230039 and No. NSFC81000757). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bialek-Davenet S, 2011, ANTIMICROB AGENTS CH, V55, P2795, DOI 10.1128/AAC.00156-11; Bratu S, 2009, J ANTIMICROB CHEMOTH, V64, P278, DOI 10.1093/jac/dkp186; De Majumdar S, 2013, ANTIMICROB AGENTS CH, V57, P1603, DOI 10.1128/AAC.01998-12; DiPersio JR, 2007, INT J ANTIMICROB AG, V29, P518, DOI 10.1016/j.ijantimicag.2006.10.019; Doumith M, 2009, J ANTIMICROB CHEMOTH, V63, P659, DOI 10.1093/jac/dkp029; EUCAST (European Committee on Antimicrobial Susceptibility Testing), 2013, BREAKP TABL INT MICS; Vazquez MF, 2008, INT J ANTIMICROB AG, V32, P541, DOI 10.1016/j.ijantimicag.2008.06.024; Hentschke M, 2010, ANTIMICROB AGENTS CH, V54, P2720, DOI 10.1128/AAC.00085-10; Jenner L, 2013, P NATL ACAD SCI USA, V110, P3812, DOI 10.1073/pnas.1216691110; Keeney D, 2008, J ANTIMICROB CHEMOTH, V61, P46, DOI 10.1093/jac/dkm397; Keeney D, 2007, MICROB DRUG RESIST, V13, P1, DOI 10.1089/mdr.2006.9990; Kern WV, 2006, J ANTIMICROB CHEMOTH, V57, P339, DOI 10.1093/jac/dki445; Nigo M, 2013, ANTIMICROB AGENTS CH, V57, P5743, DOI 10.1128/AAC.00827-13; Pankey GA, 2005, J ANTIMICROB CHEMOTH, V56, P470, DOI 10.1093/jac/dki248; Peleg AY, 2010, NEW ENGL J MED, V362, P1804, DOI 10.1056/NEJMra0904124; Qi Y, 2011, J ANTIMICROB CHEMOTH, V66, P307, DOI 10.1093/jac/dkq431; Ricci V, 2014, J ANTIMICROB CHEMOTH, V69, P643, DOI 10.1093/jac/dkt432; Rodriguez-Avial C, 2012, CLIN MICROBIOL INFEC, V18, P61, DOI 10.1111/j.1469-0691.2011.03482.x; Roy S, 2013, J ANTIMICROB CHEMOTH, V68, P1036, DOI 10.1093/jac/dks535; Ruzin A, 2005, ANTIMICROB AGENTS CH, V49, P1017, DOI 10.1128/AAC.49.3.1017-1022.2005; Ruzin A, 2008, ANTIMICROB AGENTS CH, V52, P3430, DOI 10.1128/AAC.00591-08; Schneiders T, 2003, ANTIMICROB AGENTS CH, V47, P2831, DOI 10.1128/AAC.47.9.2831-2837.2003; Schumacher A, 2006, J ANTIMICROB CHEMOTH, V57, P344, DOI 10.1093/jac/dki446; Shen P, 2009, ANTIMICROB AGENTS CH, V53, P4333, DOI 10.1128/AAC.00260-09; Tsai HY, 2012, J INFECTION, V65, P584, DOI 10.1016/j.jinf.2012.09.007; Van Duin D, 2014, CLIN MICROBIOL INFEC; Veleba M, 2012, ANTIMICROB AGENTS CH, V56, P4466, DOI 10.1128/AAC.06224-11	27	61	66	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2015	10	3							e0119064	10.1371/journal.pone.0119064	http://dx.doi.org/10.1371/journal.pone.0119064			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4HV	25734903	Green Submitted, Green Published, gold			2022-12-27	WOS:000350314700052
J	Emsen, B; Hamiduzzaman, MM; Goodwin, PH; Guzman-Novoa, E				Emsen, Berna; Hamiduzzaman, Mollah Md.; Goodwin, Paul H.; Guzman-Novoa, Ernesto			Lower Virus Infections in Varroa destructor-Infested and Uninfested Brood and Adult Honey Bees (Apis mellifera) of a Low Mite Population Growth Colony Compared to a High Mite Population Growth Colony	PLOS ONE			English	Article							DEFORMED-WING VIRUS; PARALYSIS VIRUS; PCR ANALYSIS; RT-PCR; PREVALENCE; L.; EXPRESSION; COLLAPSE; STRAINS; WORKERS	A comparison was made of the prevalence and relative quantification of deformed wing virus (DWV), Israeli acute paralysis virus (IAPV), black queen cell virus (BQCV), Kashmir bee virus (KBV), acute bee paralysis virus (ABPV) and sac brood virus (SBV) in brood and adult honey bees (Apis mellifera) from colonies selected for high (HMP) and low (LMP) Varroa destructor mite population growth. Two viruses, ABPV and SBV, were never detected. For adults without mite infestation, DWV, IAPV, BQCV and KBV were detected in the HMP colony; however, only BQCV was detected in the LMP colony but at similar levels as in the HMP colony. With mite infestation, the four viruses were detected in adults of the HMP colony but all at higher amounts than in the LMP colony. For brood without mite infestation, DWV and IAPV were detected in the HMP colony, but no viruses were detected in the LMP colony. With mite infestation of brood, the four viruses were detected in the HMP colony, but only DWV and IAPV were detected and at lower amounts in the LMP colony. An epidemiological explanation for these results is that pre-experiment differences in virus presence and levels existed between the HMP and LMP colonies. It is also possible that low V. destructor population growth in the LMP colony resulted in the bees being less exposed to the mite and thus less likely to have virus infections. LMP and HMP bees may have also differed in susceptibility to virus infection.	[Emsen, Berna] Ataturk Univ, Dept Anim Sci, TR-25240 Erzurum, Turkey; [Emsen, Berna; Hamiduzzaman, Mollah Md.; Goodwin, Paul H.; Guzman-Novoa, Ernesto] Univ Guelph, Sch Environm Sci, Guelph, ON N1G 2W1, Canada	Ataturk University; University of Guelph	Guzman-Novoa, E (corresponding author), Univ Guelph, Sch Environm Sci, Guelph, ON N1G 2W1, Canada.	eguzman@uoguelph.ca		Guzman-Novoa, Ernesto/0000-0001-5632-0642	Natural Sciences and Engineering Research Council of Canada (NSERC) [400571]	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC))	This study was funded by a Natural Sciences and Engineering Research Council of Canada (NSERC) Discovery Grant (400571) to EGN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ball B.V., 1997, HONEY BEE PESTS PRED, P13; Benjeddou M, 2001, APPL ENVIRON MICROB, V67, P2384, DOI 10.1128/AEM.67.5.2384-2387.2001; Berthoud H, 2010, J APICULT RES, V49, P60, DOI 10.3896/IBRA.1.49.1.08; Carreck NL, 2010, J APICULT RES, V49, P93, DOI 10.3896/IBRA.1.49.1.13; Chen GYJ, 2000, J PHYTOPATHOL, V148, P57, DOI 10.1111/j.1439-0434.2000.tb04625.x; Chen YP, 2005, APPL ENVIRON MICROB, V71, P436, DOI 10.1128/AEM.71.1.436-441.2005; Cox-Foster DL, 2007, SCIENCE, V318, P283, DOI 10.1126/science.1146498; Dainat B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032151; de Miranda JR, 2010, J INVERTEBR PATHOL, V103, pS30, DOI 10.1016/j.jip.2009.06.014; de Miranda JR, 2010, J INVERTEBR PATHOL, V103, pS48, DOI 10.1016/j.jip.2009.06.012; Dean JD, 2002, PLANT MOL BIOL REP, V20, P347, DOI 10.1007/BF02772122; Di Prisco G, 2011, VIRUSES-BASEL, V3, P2425, DOI 10.3390/v3122425; Ellis JD, 2005, BEE WORLD, V86, P88, DOI 10.1080/0005772X.2005.11417323; Emsen B, 2012, J ANIM VET ADV, V11, P4519; Fedorova AA, 2011, ANTIVIR RES, V91, P267, DOI 10.1016/j.antiviral.2011.06.011; Genersch E, 2010, VET RES, V41, DOI 10.1051/vetres/2010027; Guzman-Novoa E, 2012, J APICULT RES, V51, P342, DOI 10.3896/IBRA.1.51.4.08; Guzman-Novoa E, 2012, J INVERTEBR PATHOL, V110, P314, DOI 10.1016/j.jip.2012.03.020; Guzman-Novoa E, 2010, APIDOLOGIE, V41, P443, DOI 10.1051/apido/2009076; Hamiduzzaman MM, 2012, J INVERTEBR PATHOL, V111, P237, DOI 10.1016/j.jip.2012.09.001; Kirrane MJ, 2011, J ECON ENTOMOL, V104, P1146, DOI 10.1603/EC11035; Le Conte Y, 2007, APIDOLOGIE, V38, P566, DOI 10.1051/apido:2007040; Le Conte Y, 2010, APIDOLOGIE, V41, P353, DOI 10.1051/apido/2010017; Locke B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099998; Maori E, 2007, J GEN VIROL, V88, P3428, DOI 10.1099/vir.0.83284-0; Martin SJ, 2012, SCIENCE, V336, P1304, DOI 10.1126/science.1220941; Page RE, 1997, HONEY BEE PESTS PRED, P469; R Development Core Team, 2012, R LANG ENV STAT COMP; Ribiere M, 2007, APPL ENVIRON MICROB, V73, P7711, DOI 10.1128/AEM.01053-07; Richards EH, 2011, PARASITOLOGY, V138, P602, DOI 10.1017/S0031182011000072; Rinderer TE, 2013, AUST J ENTOMOL, V52, P156, DOI 10.1111/aen.12003; Rosenkranz P, 2010, J INVERTEBR PATHOL, V103, pS96, DOI 10.1016/j.jip.2009.07.016; Stoltz D, 1995, J APICULT RES, V34, P153, DOI 10.1080/00218839.1995.11100900; Strauss U, 2013, J INVERTEBR PATHOL, V114, P45, DOI 10.1016/j.jip.2013.05.003; Tentcheva D, 2004, APPL ENVIRON MICROB, V70, P7185, DOI 10.1128/AEM.70.12.7185-7191.2004; Thompson GJ, 2007, J EXP ZOOL PART A, V307A, P600, DOI 10.1002/jez.415; Vanengelsdorp D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004071; Yang XL, 2005, P NATL ACAD SCI USA, V102, P7470, DOI 10.1073/pnas.0501860102; Yue C, 2005, J GEN VIROL, V86, P3419, DOI 10.1099/vir.0.81401-0	39	20	21	1	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2015	10	2							e0118885	10.1371/journal.pone.0118885	http://dx.doi.org/10.1371/journal.pone.0118885			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC3LS	25723540	Green Published, Green Submitted, gold			2022-12-27	WOS:000350251200063
J	Teicher, MH; Parigger, A				Teicher, Martin H.; Parigger, Angelika			The 'Maltreatment and Abuse Chronology of Exposure' (MACE) Scale for the Retrospective Assessment of Abuse and Neglect During Development	PLOS ONE			English	Article							ADVERSE CHILDHOOD EXPERIENCES; ADULT CHRONIC DEPRESSION; CONFLICT-TACTICS-SCALES; HOUSEHOLD DYSFUNCTION; SENSITIVE PERIODS; CECA INSTRUMENT; LIFE-COURSE; RELATIVE IMPORTANCE; SUICIDE ATTEMPTS; HURTFUL WORDS	There is increasing interest in childhood maltreatment as a potent stimulus that may alter trajectories of brain development, induce epigenetic modifications and enhance risk for medical and psychiatric disorders. Although a number of useful scales exist for retrospective assessment of abuse and neglect they have significant limitations. Moreover, they fail to provide detailed information on timing of exposure, which is critical for delineation of sensitive periods. The Maltreatment and Abuse Chronology of Exposure (MACE) scale was developed in a sample of 1051 participants using item response theory to gauge severity of exposure to ten types of maltreatment (emotional neglect, non-verbal emotional abuse, parental physical maltreatment, parental verbal abuse, peer emotional abuse, peer physical bullying, physical neglect, sexual abuse, witnessing interparental violence and witnessing violence to siblings) during each year of childhood. Items included in the subscales had acceptable psychometric properties based on infit and outfit mean square statistics, and each subscale passed Andersen's Likelihood ratio test. The MACE provides an overall severity score and multiplicity score (number of types of maltreatment experienced) with excellent test-retest reliability. Each type of maltreatment showed good reliability as did severity of exposure across each year of childhood. MACE Severity correlated 0.738 with Childhood Trauma Questionnaire (CTQ) score and MACE Multiplicity correlated 0.698 with the Adverse Childhood Experiences scale (ACE). However, MACE accounted for 2.00- and 2.07-fold more of the variance, on average, in psychiatric symptom ratings than CTQ or ACE, respectively, based on variance decomposition. Different types of maltreatment had distinct and often unique developmental patterns. The 52-item MACE, a simpler Maltreatment Abuse and Exposure Scale (MAES) that only assesses overall exposure and the original test instrument (MACE-X) with several additional items plus spreadsheets and R code for scoring are provided to facilitate use and to spur further development.	[Teicher, Martin H.] Harvard Univ, Sch Med, Dept Psychiat, Boston, MA 02115 USA; [Teicher, Martin H.; Parigger, Angelika] McLean Hosp, Dev Biopsychiat Res Program, Belmont, MA 02178 USA; [Parigger, Angelika] Univ Konstanz, Dept Psychol, Constance, Germany	Harvard University; Harvard Medical School; Harvard University; McLean Hospital; University of Konstanz	Teicher, MH (corresponding author), Harvard Univ, Sch Med, Dept Psychiat, Boston, MA 02115 USA.	martin_teicher@hms.harvard.edu	Teicher, Martin H/P-3906-2017	Teicher, Martin H/0000-0002-6036-0177	National Institute of Mental Health [R01 MH-091391]; National Institute on Drug Abuse [R01 DA-017846]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH091391] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA017846] Funding Source: NIH RePORTER	National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by the National Institute of Mental Health, (http://www.nimh.nih.gov/index.shtml, R01 MH-091391, MHT), and by the National Institute on Drug Abuse (http://www.drugabuse.gov/, R01 DA-017846, MHT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anda RF, 2006, EUR ARCH PSY CLIN N, V256, P174, DOI 10.1007/s00406-005-0624-4; Anda RF, 2002, PSYCHIAT SERV, V53, P1001, DOI 10.1176/appi.ps.53.8.1001; Anda RF, 2007, AM J PREV MED, V32, P389, DOI 10.1016/j.amepre.2007.01.005; Anda RF, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-198; ANDERSEN EB, 1973, PSYCHOMETRIKA, V38, P123, DOI 10.1007/BF02291180; Andersen SL, 2008, J NEUROPSYCH CLIN N, V20, P292, DOI 10.1176/appi.neuropsych.20.3.292; Andersen SL, 2008, TRENDS NEUROSCI, V31, P183, DOI 10.1016/j.tins.2008.01.004; Andersen SL, 2009, NEUROSCI BIOBEHAV R, V33, P516, DOI 10.1016/j.neubiorev.2008.09.009; Anderson CM, 2002, PSYCHONEUROENDOCRINO, V27, P231, DOI 10.1016/S0306-4530(01)00047-6; Bernet C Z, 1999, Depress Anxiety, V9, P169, DOI 10.1002/(SICI)1520-6394(1999)9:4<169::AID-DA4>3.3.CO;2-U; Bernstein DP, 1997, J AM ACAD CHILD PSY, V36, P340, DOI 10.1097/00004583-199703000-00012; BERNSTEIN DP, 1994, AM J PSYCHIAT, V151, P1132, DOI 10.1176/ajp.151.8.1132; Bernstein DP, 1998, CHILDHOOD TRAUMA QUE; BERNSTEIN EM, 1986, J NERV MENT DIS, V174, P727, DOI 10.1097/00005053-198612000-00004; Bierer LM, 2003, CNS SPECTRUMS, V8, P737, DOI 10.1017/S1092852900019118; Bifulco A, 2005, BRIT J CLIN PSYCHOL, V44, P563, DOI 10.1348/014466505X35344; BIFULCO A, 1994, J CHILD PSYCHOL PSYC, V35, P1419, DOI 10.1111/j.1469-7610.1994.tb01284.x; Bland JM, 2007, J BIOPHARM STAT, V17, P571, DOI 10.1080/10543400701329422; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Bond T, 2007, APPLYING THE RASCH M, DOI [10.1186/1471-2377-13-78, DOI 10.1186/1471-2377-13-78]; BREWIN CR, 1993, PSYCHOL BULL, V113, P82, DOI 10.1037/0033-2909.113.1.82; BROGDEN HE, 1977, PSYCHOMETRIKA, V42, P631, DOI 10.1007/BF02295985; Brown GW, 2007, J AFFECT DISORDERS, V103, P225, DOI 10.1016/j.jad.2007.06.007; Brown GW, 2007, J AFFECT DISORDERS, V103, P205, DOI 10.1016/j.jad.2007.05.022; Brown GW, 2007, J AFFECT DISORDERS, V103, P217, DOI 10.1016/j.jad.2007.06.003; Carlyle KE, 2007, J SCHOOL HEALTH, V77, P623, DOI 10.1111/j.1746-1561.2007.00242.x; Chapman DP, 2004, J AFFECT DISORDERS, V82, P217, DOI 10.1016/j.jad.2003.12.013; Choi J, 2012, NEUROIMAGE, V59, P1071, DOI 10.1016/j.neuroimage.2011.09.033; Chu JA, 1999, AM J PSYCHIAT, V156, P749; Cohen RA, 2006, BIOL PSYCHIAT, V59, P975, DOI 10.1016/j.biopsych.2005.12.016; Cole JC, 2004, PSYCHOL ASSESSMENT, V16, P360, DOI 10.1037/1040-3590.16.4.360; Crick NR, 1996, DEV PSYCHOPATHOL, V8, P367, DOI 10.1017/S0954579400007148; CRICK NR, 1995, CHILD DEV, V66, P710, DOI 10.1111/j.1467-8624.1995.tb00900.x; Dannlowski U, 2012, HUM BRAIN MAPP, DOI 10.1002/hbm.22112; Dannlowski U, 2012, BIOL PSYCHIAT, V71, P286, DOI 10.1016/j.biopsych.2011.10.021; Dong M, 2003, ARCH INTERN MED, V163, P1949, DOI 10.1001/archinte.163.16.1949; Dong MX, 2004, CIRCULATION, V110, P1761, DOI 10.1161/01.CIR.0000143074.54995.7F; Dube S. R., 2006, Journal of Adolescent Health, V38, DOI 10.1016/j.jadohealth.2005.06.006; Dube SR, 2003, PEDIATRICS, V111, P564, DOI 10.1542/peds.111.3.564; Dube SR, 2001, JAMA-J AM MED ASSOC, V286, P3089, DOI 10.1001/jama.286.24.3089; Edmiston EE, 2011, ARCH PEDIAT ADOL MED, V165, P1069, DOI 10.1001/archpediatrics.2011.565; Etain B, 2010, J TRAUMA STRESS, V23, P376, DOI 10.1002/jts.20532; Felitti VJ, 1998, AM J PREV MED, V14, P245, DOI 10.1016/S0749-3797(98)00017-8; Finkelhor D, 2005, CHILD ABUSE NEGLECT, V29, P1297, DOI 10.1016/j.chiabu.2005.06.005; Finkelhor D, 2005, CHILD ABUSE NEGLECT, V29, P383, DOI 10.1016/j.chiabu.2004.11.001; Fisher HL, 2011, SCHIZOPHRENIA BULL, V37, P546, DOI 10.1093/schbul/sbp103; Gromping U, 2007, AM STAT, V61, P139, DOI 10.1198/000313007X188252; Heim CM, 2013, AM J PSYCHIAT, V170, P616, DOI 10.1176/appi.ajp.2013.12070950; HERMAN JL, 1989, TRAUMATIC ANTECEDENT; Hyman SM, 2008, DRUG ALCOHOL DEPEN, V92, P208, DOI 10.1016/j.drugalcdep.2007.08.006; Hyman SE, 2000, B WORLD HEALTH ORGAN, V78, P455; Isele D, 2014, Z KL PSYCH PSYCHOTH, V43, P121, DOI 10.1026/1616-3443/a000257; Johnson JW, 2004, ORGAN RES METHODS, V7, P238, DOI 10.1177/1094428104266510; KELLNER R, 1987, J CLIN PSYCHIAT, V48, P268; Kim Young Shin, 2008, Int J Adolesc Med Health, V20, P133; Klomek AB, 2007, J AM ACAD CHILD PSY, V46, P40, DOI 10.1097/01.chi.0000242237.84925.18; Klomek AB, 2009, J AM ACAD CHILD PSY, V48, P254, DOI 10.1097/CHI.0b013e318196b91f; Levitan RD, 1998, AM J PSYCHIAT, V155, P1746, DOI 10.1176/ajp.155.12.1746; Linacre J.M., 1994, RASCH MEASUREMENT T, V8, P360; Lindeman RH, 1980, INTRODUCTION TO BIVA; Luukkonen AH, 2009, PSYCHOPATHOLOGY, V42, P131, DOI 10.1159/000204764; Mair P., 2007, PSYCHOL SCI, V49, P26; Michaud Catherine M, 2006, Popul Health Metr, V4, P11, DOI 10.1186/1478-7954-4-11; Morizot J., 2009, HDB RES METHODS PERS, P407; Mpofu Elias, 2006, J Appl Meas, V7, P323; Pechtel P, 2014, NEUROIMAGE, V97, P236, DOI 10.1016/j.neuroimage.2014.04.025; Polcari A, 2014, CHILD ABUSE NEGLECT, V38, P91, DOI 10.1016/j.chiabu.2013.10.003; Rao H, 2010, NEUROIMAGE, V49, P1144, DOI 10.1016/j.neuroimage.2009.07.003; Rasch G, 1960, PROBABILISLIC MODELS; REYNOLDS WM, 1991, J PERS ASSESS, V56, P289, DOI 10.1207/s15327752jpa5602_9; Roy A, 2010, NEUROPSYCHOPHARMACOL, V35, P1674, DOI 10.1038/npp.2009.236; Roy CA, 2004, J NERV MENT DIS, V192, P343, DOI 10.1097/01.nmd.0000126701.23121.fa; Schreier A, 2009, ARCH GEN PSYCHIAT, V66, P527, DOI 10.1001/archgenpsychiatry.2009.23; Shaffer A, 2008, CHILD ABUSE NEGLECT, V32, P682, DOI 10.1016/j.chiabu.2007.09.010; SPIERS PA, 1985, PRINCIPLES BEHAVIORA, P289; Stein MB, 2008, NEUROPSYCHOPHARMACOL, V33, P312, DOI 10.1038/sj.npp.1301422; Straus M A, 1999, Clin Child Fam Psychol Rev, V2, P55, DOI 10.1023/A:1021891529770; Straus MA, 1996, J FAM ISSUES, V17, P283, DOI 10.1177/019251396017003001; Straus MA, 1998, CHILD ABUSE NEGLECT, V22, P249, DOI 10.1016/S0145-2134(97)00174-9; Teicher MH, 2006, ANN NY ACAD SCI, V1071, P313, DOI 10.1196/annals.1364.024; Teicher MH, 2006, AM J PSYCHIAT, V163, P993, DOI 10.1176/appi.ajp.163.6.993; Teicher MH, 2013, AM J PSYCHIAT, V170, P1114, DOI 10.1176/appi.ajp.2013.12070957; Teicher MH, 2012, P NATL ACAD SCI USA, V109, pE563, DOI 10.1073/pnas.1115396109; Teicher MH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028852; Teicher MH, 2010, AM J PSYCHIAT, V167, P1464, DOI 10.1176/appi.ajp.2010.10010030; TEICHER MH, 1993, J NEUROPSYCH CLIN N, V5, P301; Tomoda A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052528; Tomoda A, 2009, BIOL PSYCHIAT, V66, P642, DOI 10.1016/j.biopsych.2009.04.021; TORGERSON WS, 1965, PSYCHOMETRIKA, V30, P379, DOI 10.1007/BF02289530; TORGERSON WS, 1952, PSYCHOMETRIKA, V17, P401; Uhl GR, 2004, ANN NY ACAD SCI, V1025, P1, DOI 10.1196/annals.1316.001; WILLIAMS EJ, 1959, J ROY STAT SOC B, V21, P396; WILLIAMS LM, 1994, J CONSULT CLIN PSYCH, V62, P1167, DOI 10.1037//0022-006X.63.3.343; Wright B., 1999, MEASUREMENT ESSENTIA, V2nd; Wu LT, 2009, J STUD ALCOHOL DRUGS, V70, P414, DOI 10.15288/jsad.2009.70.414	95	144	145	1	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2015	10	2							e0117423	10.1371/journal.pone.0117423	http://dx.doi.org/10.1371/journal.pone.0117423			37	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CC2IM	25714856	Green Submitted, Green Published, gold			2022-12-27	WOS:000350168700033
J	Broadhurst, L				Broadhurst, Linda			Pollen Dispersal in Fragmented Populations of the Dioecious Wind-Pollinated Tree, Allocasuarina verticillata (Drooping Sheoak, Drooping She-Oak; Allocasuarinaceae)	PLOS ONE			English	Article							SPATIAL AUTOCORRELATION ANALYSIS; CHRONIC HABITAT FRAGMENTATION; MEDIATED GENE FLOW; REPRODUCTIVE SUCCESS; INBREEDING DEPRESSION; FOREST FRAGMENTATION; PATERNITY ANALYSIS; COMPUTER-PROGRAM; MATING PATTERNS; SEED DISPERSAL	Vegetation clearing, land modification and agricultural intensification have impacted on many ecological communities around the world. Understanding how species respond to fragmentation and the scales over which functionality is retained, can be critical for managing biodiversity in agricultural landscapes. Allocasuarina verticillata (drooping sheoak, drooping she-oak) is a dioecious, wind-pollinated and -dispersed species with key conservation values across southeastern Australia. But vegetation clearing associated with agricultural expansion has reduced the abundance and spatial distribution of this species in many regions. Spatial genetic structure, relatedness among trees, pollen dispersal and mating patterns were examined in fragmented A. verticillata populations selected to represent the types of remnants that now characterise this species. Short scale spatial genetic structure (5-25 m) and relatedness among trees were observed in most populations. Unexpectedly, the two male trees closest to each female did not have a reproductive advantage accounting for only 4-15% of the seed produced in larger populations. Biparental inbreeding was also generally low (<4%) with limited evidence of seed crop domination by some male trees. More male trees contributed to seed crops in linear remnants (mean 17) compared to those from patch remnants (mean 11.3) which may reflect differences in pollen dispersal within the two remnant types. On average, pollen travels similar to 100 m irrespective of remnant type but was also detected to have dispersed as far as 1 km in open landscapes. Low biparental inbreeding, limited reproductive assurance for near-neighbour and probably related males and variability in the distances over which females sample pollen pools suggest that some mechanism to prevent matings between relatives exists in this species.	CSIRO, Ctr Australian Natl Biodivers Res, Natl Res Collect, Canberra, ACT, Australia	Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Broadhurst, L (corresponding author), CSIRO, Ctr Australian Natl Biodivers Res, Natl Res Collect, Canberra, ACT, Australia.	Linda.Broadhurst@csiro.au	Broadhurst, Linda/J-6907-2012	Broadhurst, Linda/0000-0002-9853-3328	CSIRO; Department of Primary Industries Victoria; Greening Australia Victoria	CSIRO(Commonwealth Scientific & Industrial Research Organisation (CSIRO)); Department of Primary Industries Victoria; Greening Australia Victoria	This project was jointly funded by CSIRO, Department of Primary Industries Victoria and Greening Australia Victoria. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agren J, 1996, ECOLOGY, V77, P1779, DOI 10.2307/2265783; Aguilar R, 2008, MOL ECOL, V17, P5177, DOI 10.1111/j.1365-294X.2008.03971.x; Aguilar R, 2006, ECOL LETT, V9, P968, DOI 10.1111/j.1461-0248.2006.00927.x; Albaladejo RG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049012; Albaladejo RG, 2009, MOL ECOL, V18, P5195, DOI 10.1111/j.1365-294X.2009.04415.x; ANTONOVICS J, 1980, ANNU REV ECOL SYST, V11, P411, DOI 10.1146/annurev.es.11.110180.002211; AVISE JC, 1989, TRENDS ECOL EVOL, V4, P279, DOI 10.1016/0169-5347(89)90203-6; Bacles CFE, 2008, HEREDITY, V101, P368, DOI 10.1038/hdy.2008.66; Bacles CFE, 2011, TRENDS PLANT SCI, V16, P13, DOI 10.1016/j.tplants.2010.10.002; Bacles CFE, 2006, SCIENCE, V311, P628, DOI 10.1126/science.1121543; Bacles CFE, 2005, EVOLUTION, V59, P979, DOI 10.1111/j.0014-3820.2005.tb01037.x; Bittencourt JVM, 2007, HEREDITY, V99, P580, DOI 10.1038/sj.hdy.6801019; Blundell MJ, 2010, J CEREAL SCI, V52, P187, DOI 10.1016/j.jcs.2010.05.002; Bram MR, 2002, J TORREY BOT SOC, V129, P298, DOI 10.2307/3088701; Broadhurst LM, 2006, BIOL CONSERV, V133, P512, DOI 10.1016/j.biocon.2006.08.004; Broadhurst LM, 2013, BIOL CONSERV, V161, P48, DOI 10.1016/j.biocon.2013.02.016; Broadhurst LM, 2011, AUST J BOT, V59, P770, DOI 10.1071/BT11253; BROWN AHD, 1970, GENETICS, V66, P133; Burczyk J, 2004, FOREST ECOL MANAG, V197, P39, DOI 10.1016/j.foreco.2004.05.003; Burczyk J, 1996, HEREDITY, V77, P251, DOI 10.1038/hdy.1996.139; Burczyk JL, 1997, HEREDITY, V79, P638, DOI 10.1038/hdy.1997.210; Buza L, 2000, BIOL CONSERV, V93, P177, DOI 10.1016/S0006-3207(99)00150-0; Collin CL, 2009, AM J BOT, V96, P2279, DOI 10.3732/ajb.0900073; *COR CATCHM MAN AU, 2003, COR REG CATCHM STRAT; Craft KJ, 2010, AM J BOT, V97, P1999, DOI 10.3732/ajb.0900390; Crowley GM, 2001, AUSTRAL ECOL, V26, P116, DOI 10.1046/j.1442-9993.2001.01093.x; Davies SD, 2013, HEREDITY ADV, DOI [10.1038/hdy.2013.95, DOI 10.1038/HDY.2013.95]; De-Lucas AI, 2009, MOL ECOL, V18, P4564, DOI 10.1111/j.1365-294X.2009.04372.x; Dorken ME, 2002, EVOLUTION, V56, P31, DOI 10.1111/j.0014-3820.2002.tb00847.x; Double MC, 2005, EVOLUTION, V59, P625, DOI 10.1111/j.0014-3820.2005.tb01021.x; Dow BD, 1998, J HERED, V89, P62, DOI 10.1093/jhered/89.1.62; Dubreuil M, 2010, AM J BOT, V97, P303, DOI 10.3732/ajb.0900148; Eppley SM, 2009, HEREDITY, V102, P600, DOI 10.1038/hdy.2009.21; Frankham R, 2014, BIOL CONSERV, V170, P56, DOI 10.1016/j.biocon.2013.12.036; Gordon DR, 1998, RESTOR ECOL, V6, P166, DOI 10.1111/j.1526-100X.1998.00627.x; Hamrick JL, 2004, FOREST ECOL MANAG, V197, P323, DOI 10.1016/j.foreco.2004.05.023; Helenurm K, 1998, CONSERV BIOL, V12, P118, DOI 10.1046/j.1523-1739.1998.96316.x; Herrera CM, 2010, ECOLOGY, V91, P422, DOI 10.1890/09-0849.1; Jump AS, 2007, MOL ECOL, V16, P925, DOI 10.1111/j.1365-294X.2006.03203.x; Jump AS, 2006, P NATL ACAD SCI USA, V103, P8096, DOI 10.1073/pnas.0510127103; Kalinowski ST, 2006, MOL ECOL NOTES, V6, P576, DOI 10.1111/j.1471-8286.2006.01256.x; Kalinowski ST, 2007, MOL ECOL, V16, P1099, DOI 10.1111/j.1365-294X.2007.03089.x; Kettle CJ, 2007, MOL ECOL, V16, P3581, DOI 10.1111/j.1365-294X.2007.03419.x; Knapp EE, 2001, OECOLOGIA, V128, P48, DOI 10.1007/s004420000623; Kolb A, 2005, J ECOL, V93, P1226, DOI 10.1111/j.1365-2745.2005.01049.x; Kramer AT, 2008, CONSERV BIOL, V22, P878, DOI 10.1111/j.1523-1739.2008.00944.x; Marcar N, 2004, TREES SALINE LANDSCA; Marchelli P, 2012, TREE GENET GENOMES, V8, P1123, DOI 10.1007/s11295-012-0500-0; Mathiasen P, 2007, CONSERV BIOL, V21, P232, DOI 10.1111/j.1523-1739.2006.00565.x; Mimura M, 2009, MOL ECOL, V18, P4180, DOI 10.1111/j.1365-294X.2009.04350.x; O'Connell LM, 2006, CAN J BOT, V84, P956, DOI 10.1139/B06-051; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Peakall R, 2003, EVOLUTION, V57, P1182, DOI 10.1111/j.0014-3820.2003.tb00327.x; Pepper JW, 2000, AUSTRAL ECOL, V25, P16, DOI 10.1111/j.1442-9993.2000.tb00003.x; Petit RJ, 2002, FOREST ECOL MANAG, V156, P115, DOI 10.1016/S0378-1127(01)00638-7; Provan J, 2008, CONSERV GENET, V9, P1521, DOI 10.1007/s10592-007-9484-y; Raduski AR, 2012, EVOLUTION, V66, P1275, DOI 10.1111/j.1558-5646.2011.01505.x; Reed MS, 2011, LAND DEGRAD DEV, V22, P261, DOI 10.1002/ldr.1087; RITLAND K, 1990, J HERED, V81, P235; RITLAND K, 1989, EVOLUTION, V43, P848, DOI [10.2307/2409312, 10.1111/j.1558-5646.1989.tb05182.x]; Ritland K, 2002, HEREDITY, V88, P221, DOI 10.1038/sj.hdy.6800029; Safriel U., 2005, ECOSYSTEMS HUMAN WEL, P623; Seltmann P, 2007, FLORA, V202, P547, DOI 10.1016/j.flora.2006.12.002; Seltmann P, 2009, PLANT ECOL, V205, P155, DOI 10.1007/s11258-009-9605-4; Shohami D, 2014, MOL ECOL, V23, P70, DOI 10.1111/mec.12506; Smouse PE, 1999, HEREDITY, V82, P561, DOI 10.1038/sj.hdy.6885180; Smouse PE, 2001, EVOLUTION, V55, P260; Sork VL, 2002, MOL ECOL, V11, P1657, DOI 10.1046/j.1365-294X.2002.01574.x; Steven JC, 2007, PLANT ECOL, V190, P131, DOI 10.1007/s11258-006-9196-2; Teixeira S, 2009, HEREDITY, V102, P101, DOI 10.1038/hdy.2008.86; Teixeira S, 2008, OIKOS, V117, P1594, DOI 10.1111/j.0030-1299.2008.16450.x; Ward M, 2005, OIKOS, V108, P253, DOI 10.1111/j.0030-1299.2005.13468.x; Young A, 1996, TRENDS ECOL EVOL, V11, P413, DOI 10.1016/0169-5347(96)10045-8; Young AG, 2000, CONSERV BIOL SER, V4, P335	74	15	17	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2015	10	3							e0119498	10.1371/journal.pone.0119498	http://dx.doi.org/10.1371/journal.pone.0119498			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9KG	25742183	Green Submitted, gold, Green Published			2022-12-27	WOS:000350688100117
J	Hong, JW; Ku, CR; Noh, JH; Ko, KS; Rhee, BD; Kim, DJ				Hong, Jae Won; Ku, Cheol Ryong; Noh, Jung Hyun; Ko, Kyung Soo; Rhee, Byoung Doo; Kim, Dong-Jun			Association between Low-Grade Albuminuria and Cardiovascular Risk in Korean Adults: The 2011-2012 Korea National Health and Nutrition Examination Survey	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; MICROALBUMINURIA; MORTALITY; HYPERTENSION; INDIVIDUALS; PROTEINURIA; EXCRETION; EVENTS; DEATH	Background Recent studies have indicated that low UACR levels (< 30 mu g/mg) previously considered to be in the normal range ('low-grade albuminuria') are associated with cardiovascular morbidity and mortality in the general population. Methods We studied 9,736 participants with albuminuria in the normal range from the 2011-2012 Korea National Health and Nutrition Examination Survey (KNHANES). Results The weighted prevalences of metabolic syndrome (MS) and the 10-year risk for coronary heart disease measured using the Framingham risk score (FRS) >= 20% (high risk) were 22.5 +/- 0.7% and 14.5 +/- 0.7%, respectively, in males and 23.3 +/- 0.8% and 8.5 +/- 0.4%, respectively in females. Weighted comparisons among the tertiles of UACR revealed that the prevalences of MS and high-risk FRS increased with increasing UACR (MS: males, 15.9 +/- 1.1, 20.2 +/- 1.2, 32.4 +/- 1.5%, respectively; P < 0.001; and females, 17.6 +/- 1.0, 22.7 +/- 1.0, 30.2 +/- 1.4%, respectively; P < 0.001. High-risk FRS: males, 9.5 +/- 0.7, 12.3 +/- 0.9, 22.5 +/- 1.2, respectively; P < 0.001; and females, 5.8 +/- 0.6, 7.9 +/- 0.7, 12.0 +/- 0.9%, respectively; P < 0.001). The positive association persisted after adjusting for hypertension and diabetes. The weighted comparisons among the deciles of UACR revealed that the prevalences of MS and high-risk FRS began to increase at the ranges of 3.89-5.15 and 5.16-7.36 mg/g Cr, respectively. Conclusion Low-grade albuminuria was significantly associated with estimated cardiovascular risk and MS in a nationally representative sample of Koreans.	[Hong, Jae Won; Noh, Jung Hyun; Kim, Dong-Jun] Inje Univ, Coll Med, Ilsan Paik Hosp, Dept Internal Med, Koyang, Gyeonggi Do, South Korea; [Ku, Cheol Ryong] Yonsei Univ, Coll Med, Endocrinol, Seoul, South Korea; [Ko, Kyung Soo; Rhee, Byoung Doo] Inje Univ, Cardiovasc & Metab Dis Ctr, Coll Med, Dept Internal Med,Sanggye Paik Hosp, Seoul, South Korea	Inje University; Yonsei University; Yonsei University Health System; Inje University	Kim, DJ (corresponding author), Inje Univ, Coll Med, Ilsan Paik Hosp, Dept Internal Med, Koyang, Gyeonggi Do, South Korea.	djkim@paik.ac.kr	Noh, Junghyun/ABD-9067-2021; Noh, Junghyun/AAU-8113-2020	Noh, Junghyun/0000-0002-7964-0515; Ku, Cheol Ryong/0000-0001-8693-9630				Alberti KGMM, 2005, LANCET, V366, P1059, DOI 10.1016/S0140-6736(05)67402-8; Arnlov J, 2005, CIRCULATION, V112, P969, DOI 10.1161/CIRCULATIONAHA.105.538132; Barba C, 2004, LANCET, V363, P157, DOI 10.1016/S0140-6736(03)15268-3; Baron AD, 1997, CIRCULATION, V96, P725; Danziger J, 2008, MAYO CLIN PROC, V83, P806, DOI 10.4065/83.7.806; DECKERT T, 1989, DIABETOLOGIA, V32, P219, DOI 10.1007/BF00285287; Gerstein HC, 2000, DIABETES CARE, V23, pB35; Gerstein HC, 2001, JAMA-J AM MED ASSOC, V286, P421, DOI 10.1001/jama.286.4.421; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; Hemann Brian A, 2007, Am Heart Hosp J, V5, P91; Hillege HL, 2002, CIRCULATION, V106, P1777, DOI 10.1161/01.CIR.0000031732.78052.81; Huang Y, 2010, J CLIN ENDOCR METAB, V95, P5122, DOI 10.1210/jc.2010-0544; Katz DH, 2014, CIRCULATION, V129, P42, DOI 10.1161/CIRCULATIONAHA.113.003429; KCDC, KOR NAT HLTH NUTR EX; Keane WF, 1999, AM J KIDNEY DIS, V33, P1004, DOI 10.1016/S0272-6386(99)70442-7; Klausen K, 2004, CIRCULATION, V110, P32, DOI 10.1161/01.CIR.0000133312.96477.48; Lalwani AK, 2013, LARYNGOSCOPE, V123, P3178, DOI 10.1002/lary.24244; Lamb EJ, 2005, ANN CLIN BIOCHEM, V42, P321, DOI 10.1258/0004563054889936; Lee YH, 2012, KIDNEY BLOOD PRESS R, V36, P290, DOI 10.1159/000343418; Lieb W, 2006, NEPHROL DIAL TRANSPL, V21, P2780, DOI 10.1093/ndt/gfl364; MOGENSEN CE, 1984, NEW ENGL J MED, V310, P356, DOI 10.1056/NEJM198402093100605; Romundstad S, 2003, AM J KIDNEY DIS, V42, P466, DOI 10.1016/S0272-6386(03)00742-X; Ruggenenti P, 2006, KIDNEY INT, V70, P1214, DOI 10.1038/sj.ki.5001729; Sung KC, 2008, ATHEROSCLEROSIS, V196, P320, DOI 10.1016/j.atherosclerosis.2006.11.004; Wilson PWF, 1998, CIRCULATION, V97, P1837, DOI 10.1161/01.CIR.97.18.1837; Zhang J, 2013, PLOS ONE, V8	26	11	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2015	10	3							e0118866	10.1371/journal.pone.0118866	http://dx.doi.org/10.1371/journal.pone.0118866			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9KG	25742159	Green Published, Green Submitted, gold			2022-12-27	WOS:000350688100054
J	Allen, KL; Cooke, SB; Gonzales, LA; Kay, RF				Allen, Kari L.; Cooke, Siobhan B.; Gonzales, Lauren A.; Kay, Richard F.			Dietary Inference from Upper and Lower Molar Morphology in Platyrrhine Primates	PLOS ONE			English	Article							MONKEYS LAGOTHRIX-LAGOTRICHA; WOOLLY SPIDER MONKEYS; DOLICHOCEBUS-GAIMANENSIS; ENAMEL THICKNESS; FEEDING ECOLOGY; PARTICLE-SIZE; BODY-SIZE; MIOCENE; ADAPTATIONS; EVOLUTION	The correlation between diet and dental topography is of importance to paleontologists seeking to diagnose ecological adaptations in extinct taxa. Although the subject is well represented in the literature, few studies directly compare methods or evaluate dietary signals conveyed by both upper and lower molars. Here, we address this gap in our knowledge by comparing the efficacy of three measures of functional morphology for classifying an ecologically diverse sample of thirteen medium-to large-bodied platyrrhines by diet category (e.g., folivore, frugivore, hard object feeder). We used Shearing Quotient (SQ), an index derived from linear measurements of molar cutting edges and two indices of crown surface topography, Occlusal Relief (OR) and Relief Index (RFI). Using SQ, OR, and RFI, individuals were then classified by dietary category using Discriminate Function Analysis. Both upper and lower molar variables produce high classification rates in assigning individuals to diet categories, but lower molars are consistently more successful. SQs yield the highest classification rates. RFI and OR generally perform above chance. Upper molar RFI has a success rate below the level of chance. Adding molar length enhances the discriminatory power for all variables. We conclude that upper molar SQs are useful for dietary reconstruction, especially when combined with body size information. Additionally, we find that among our sample of platyrrhines, SQ remains the strongest predictor of diet, while RFI is less useful at signaling dietary differences in absence of body size information. The study demonstrates new ways for inferring the diets of extinct platyrrhine primates when both upper and lower molars are available, or, for taxa known only from upper molars. The techniques are useful in reconstructing diet in stem representatives of anthropoid clade, who share key aspects of molar morphology with extant platyrrhines.	[Allen, Kari L.] Washington Univ, Dept Anat & Neurobiol, Sch Med, St Louis, MO 63110 USA; [Cooke, Siobhan B.] NE Illinois Univ, Dept Anthropol, Chicago, IL 60625 USA; [Gonzales, Lauren A.; Kay, Richard F.] Duke Univ, Dept Evolutionary Anthropol, Durham, NC 27708 USA	Washington University (WUSTL); Duke University	Allen, KL (corresponding author), Washington Univ, Dept Anat & Neurobiol, Sch Med, 660 S Euclid Ave,Box 8108, St Louis, MO 63110 USA.	kari.allen@wustl.edu		Gonzales, Lauren/0000-0003-3304-0634; Cooke, Siobhan/0000-0001-8265-6705	NSF [NSF BNS-0851272, NSF EAR 1338694, NSF DDIG 40761-0001]	NSF(National Science Foundation (NSF))	This research was supported by NSF grants NSF BNS-0851272 and NSF EAR 1338694 to RFK and NSF DDIG 40761-0001 to SBC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen KL, 2012, P ROY SOC B-BIOL SCI, V279, P715, DOI 10.1098/rspb.2011.1311; Anthony MRL, 1994, MOLAR WEAR MOLAR FUN; AYRES JM, 1989, J HUM EVOL, V18, P697, DOI 10.1016/0047-2484(89)90101-2; Ayres JM, 1986, UAKARIES AMAZONIAN F; Bajpai S, 2008, P NATL ACAD SCI USA, V105, P11093, DOI 10.1073/pnas.0804159105; Beard KC, 2004, J HUM EVOL, V46, P401, DOI 10.1016/j.jhevol.2004.01.002; Beard KC, 2002, CAM S BIO EVOL ANTHR, V33, P133; Boyer DM, 2015, AM J PHYS ANTHROPOL, V156, P166, DOI 10.1002/ajpa.22619; Boyer DM, 2008, J HUM EVOL, V55, P1118, DOI 10.1016/j.jhevol.2008.08.002; Bunn JM, 2011, AM J PHYS ANTHROPOL, V145, P247, DOI 10.1002/ajpa.21489; Bush EC, 2004, ANAT REC PART A, V281A, P1083, DOI 10.1002/ar.a.20113; BUTLER PM, 1972, EVOLUTION, V26, P474, DOI 10.1111/j.1558-5646.1972.tb01951.x; Cant J.G.H., 1990, Human Evolution, V5, P269, DOI 10.1007/BF02437243; Cartmill M., 1972, FUNCTIONAL EVOLUTION, P97, DOI DOI 10.4324/9781315132129; Cartmill Matt, 1992, Evolutionary Anthropology, V1, P105, DOI 10.1002/evan.1360010308; CHAPMAN C, 1987, FOLIA PRIMATOL, V49, P90, DOI 10.1159/000156311; CONROY GC, 1987, INT J PRIMATOL, V8, P115, DOI 10.1007/BF02735160; Cooke SB, 2011, ANAT REC, V294, P2073, DOI 10.1002/ar.21502; CROMPTON AW, 1969, NATURE, V222, P678, DOI 10.1038/222678b0; de Carvalho S, 2004, PRIMATES, V45, P201, DOI 10.1007/s10329-004-0079-7; Defler TR, 1996, INT J PRIMATOL, V17, P161, DOI 10.1007/BF02735446; DEMMENT MW, 1985, AM NAT, V125, P641, DOI 10.1086/284369; Dew JL, 2005, INT J PRIMATOL, V26, P1107, DOI 10.1007/s10764-005-6461-5; Evans AR, 2007, NATURE, V445, P78, DOI 10.1038/nature05433; FELSENSTEIN J, 1985, AM NAT, V125, P1, DOI 10.1086/284325; FLEAGLE JG, 1989, AM J PHYS ANTHROPOL, V78, P221; GAULIN S J C, 1982, International Journal of Primatology, V3, P1, DOI 10.1007/BF02693488; Harmon L, 2009, GEIGER ANAL EVOLUTIO; HLADICK A, 1969, Terre et la Vie, V116, P25; HLADIK CM, 1971, FOLIA PRIMATOL, V16, P85, DOI 10.1159/000155393; JULLIOT C, 1993, INT J PRIMATOL, V14, P527, DOI 10.1007/BF02215446; Kaiser TM, 2011, MAMMAL REV, V2011, P1; Kay R.F., 1980, International Journal of Primatology, V1, P21, DOI 10.1007/BF02692256; Kay R.F., 1984, P21; Kay R.F., 1978, P309; Kay R.F., 1984, FOOD ACQUISITION PRO, P467, DOI DOI 10.1007/978-1-4757-5244-1_21; KAY RF, 1990, AM J PHYS ANTHROPOL, V81, P248; KAY RF, 1977, NATURE, V268, P628, DOI 10.1038/268628a0; KAY RF, 1975, AM J PHYS ANTHROPOL, V43, P195, DOI 10.1002/ajpa.1330430207; Kay RF, 2001, ADV PRIMATO, P339; KAY RF, 1987, J HUM EVOL, V16, P173, DOI 10.1016/0047-2484(87)90075-3; KAY RF, 1979, AM J PHYS ANTHROPOL, V50, P301, DOI 10.1002/ajpa.1330500303; KAY RF, 1974, AM J PHYS ANTHROPOL, V40, P227, DOI 10.1002/ajpa.1330400210; KAY RF, 1977, AM J PHYS ANTHROPOL, V46, P327, DOI 10.1002/ajpa.1330460213; Kay RFD, 1999, AM J PRIMATOL, V47, P347; Kay RF, 2008, J HUM EVOL, V54, P323, DOI 10.1016/j.jhevol.2007.09.002; Kay RF, 2013, CAM S BIO EVOL ANTHR, V65, P3; Kay RF, 2012, EARLY MIOCENE PALEOBIOLOGY IN PATAGONIA: HIGH-LATITUDE PALEOCOMMUNITIES OF THE SANTA CRUZ FORMATION, P306; Kay Richard F., 2010, P220; KINZEY WG, 1993, INT J PRIMATOL, V14, P207, DOI 10.1007/BF02192632; KINZEY WG, 1992, AM J PHYS ANTHROPOL, V88, P499, DOI 10.1002/ajpa.1330880406; Kirk EC, 2000, J HUM EVOL, V40, P203; Ledogar JA, 2013, AM J PHYS ANTHROPOL, V150, P107, DOI 10.1002/ajpa.22181; Lee-Thorp JA, 2010, PHILOS T R SOC B, V365, P3389, DOI 10.1098/rstb.2010.0059; Lima EM, 2003, FOLIA PRIMATOL, V74, P150, DOI 10.1159/000070648; Lucas P., 2004, DENT FUNCTIONAL MORP; Lucas P, 2008, BIOESSAYS, V30, P374, DOI 10.1002/bies.20729; LUCHTERHAND K, 1986, CR ACAD SCI II, V303, P1753; M'Kirera F, 2003, AM J PRIMATOL, V60, P31, DOI 10.1002/ajp.10077; Martin LB, 2003, J HUM EVOL, V45, P351, DOI 10.1016/j.jhevol.2003.08.005; MILTON K, 1984, INT J PRIMATOL, V5, P491, DOI 10.1007/BF02692271; Milton K., 1980, FORAGING STRATEGIES; Nadjafzadeh MN, 2008, AM J PHYS ANTHROPOL, V135, P56, DOI 10.1002/ajpa.20704; Nunn CL, 2001, EVOL ANTHROPOL, V10, P81, DOI 10.1002/evan.1019; Opazo JC, 2006, MOL PHYLOGENET EVOL, V40, P274, DOI 10.1016/j.ympev.2005.11.015; Orme D, 2010, CAPER COMP ANAL PHYL; Palminteri S., 2013, EVOLUTIONARY BIOL CO; Perelman P, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001342; PERES CA, 1994, INT J PRIMATOL, V15, P333, DOI 10.1007/BF02696098; Ravosa MJ, 1999, FOLIA PRIMATOL, V70, P65, DOI 10.1159/000021678; Ray DA, 2005, MOL PHYLOGENET EVOL, V35, P117, DOI 10.1016/j.ympev.2004.10.023; Remis MJ, 2000, AM J PHYS ANTHROPOL, V112, P171, DOI 10.1002/(SICI)1096-8644(2000)112:2<171::AID-AJPA4>3.0.CO;2-F; Revell LJ, 2012, METHODS ECOL EVOL, V3, P217, DOI 10.1111/j.2041-210X.2011.00169.x; Rezende EL, 2012, COMPR PHYSIOL, V2, P639, DOI 10.1002/cphy.c100079; Rodman P.S., 1984, P1; ROSENBERGER AL, 1976, AM J PHYS ANTHROPOL, V45, P281, DOI 10.1002/ajpa.1330450214; Russo SE, 2005, INT J PRIMATOL, V26, P1017, DOI 10.1007/s10764-005-6456-2; Sears KE, 2008, AM MUS NOVIT, P1, DOI 10.1206/627.1; SHEINE WS, 1982, J MORPHOL, V172, P139, DOI 10.1002/jmor.1051720202; SHEINE WS, 1977, AM J PHYS ANTHROPOL, V47, P15, DOI 10.1002/ajpa.1330470106; Simmen B, 1996, INT J PRIMATOL, V17, P661, DOI 10.1007/BF02735260; Simons EL, 2007, P NATL ACAD SCI USA, V104, P8731, DOI 10.1073/pnas.0703129104; Smith RJ, 1997, J HUM EVOL, V32, P523, DOI 10.1006/jhev.1996.0122; Sokal RR, 1995, BIOMETRY; STEVENSON PR, 1994, AM J PRIMATOL, V32, P123, DOI 10.1002/ajp.1350320205; Strait SG, 2001, J VERTEBR PALEONTOL, V21, P322, DOI 10.1671/0272-4634(2001)021[0322:DROSBO]2.0.CO;2; STRIER KB, 1991, AM J PRIMATOL, V23, P113, DOI 10.1002/ajp.1350230205; SUSSMAN RW, 1991, AM J PRIMATOL, V23, P209, DOI 10.1002/ajp.1350230402; Takai M, 1996, AM J PHYS ANTHROPOL, V99, P301; TAKAI M, 1994, J HUM EVOL, V27, P329, DOI 10.1006/jhev.1994.1049; Teaford MF, 1996, ADAPTIVE RADIATIONS OF NEOTROPICAL PRIMATES, P433; Terborgh J, 1983, 5 NEW WORLD PRIMATES; Ungar P, 1998, EVOLUTIONAR IN PRESS; Ungar Peter, 2000, Palaeontologia Electronica, V3, P1; Ungar PS, 2010, PHILOS T R SOC B, V365, P3345, DOI 10.1098/rstb.2010.0033; VANROOSMALEN MGM, 1988, AM J PRIMATOL, V14, P11, DOI 10.1002/ajp.1350140103; Vogel ER, 2008, J HUM EVOL, V55, P60, DOI 10.1016/j.jhevol.2007.12.005; Williams BA, 2010, P NATL ACAD SCI USA, V107, P4797, DOI 10.1073/pnas.0908320107; Winchester JM, 2014, AM J PHYS ANTHROPOL, V153, P29, DOI 10.1002/ajpa.22398; Wright P., 1981, ECOLOGY BEHAVIOUR NE, P211; Yamashita N, 1998, AM J PHYS ANTHROPOL, V106, P169, DOI 10.1002/(SICI)1096-8644(199806)106:2<169::AID-AJPA5>3.3.CO;2-O; Youlatos D, 2004, AM J PHYS ANTHROPOL, V123, P181, DOI 10.1002/ajpa.10307	102	68	68	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2015	10	3							e0118732	10.1371/journal.pone.0118732	http://dx.doi.org/10.1371/journal.pone.0118732			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9JM	25738266	Green Published, gold, Green Submitted			2022-12-27	WOS:000350685900064
J	Chakr, RMD; Brenol, JCT; Behar, M; Mendonca, JA; Kohem, CL; Monticielo, OA; Brenol, CV; Xavier, RM				da Silva Chakr, Rafael Mendonca; Tavares Brenol, Joao Carlos; Behar, Marina; Mendonca, Jose Alexandre; Kohem, Charles Lubianca; Monticielo, Odirlei Andre; Brenol, Claiton Viegas; Xavier, Ricardo Machado			Is Ultrasound a Better Target than Clinical Disease Activity Scores in Rheumatoid Arthritis with Fibromyalgia? A Case-Control Study	PLOS ONE			English	Article							AMERICAN-COLLEGE; SCORING SYSTEMS; ULTRASONOGRAPHY; RELIABILITY; SYNOVITIS; JOINTS; RECOMMENDATIONS; CRITERIA; TREAT	Objectives Our goal is to study the correlations among gray-scale seven-joint ultrasound score (GS-US7), power Doppler seven-joint ultrasound score (PD-US7), disease activity score-28 joints (DAS28), simplified disease activity index (SDAI) and clinical disease activity index (CDAI) in patients with and without fibromyalgia (FM). Methods A matched case-control study included all patients consecutively seen in the Rheumatoid Arthritis (RA) Clinic. Participants were allocated into one of two groups: RA with FM and RA without FM. Ultrasound (US) and clinical scoring were blinded for the presence of FM. Medians and proportions were compared by Mann-Whitney's test and McNemar's test, respectively. Spearman's rank correlation coefficients (r(s)) were calculated among clinical and US scores and differences were tested by r-to-z transformation test. Results Seventy-two women were included, out of 247 RA patients, mostly white, with median (IQR) age of 57.5 (49.3-66.8) years, with RA symptoms for 13.0 (6.0-19.0) years and FM symptoms for 6.0 (2.0-15.0) years. Disease-modifying antirheumatic drugs, non-steroidal anti-inflammatory drugs and prednisone use was comparable between groups. Objective activity parameters were not different between groups. RA patients with FM had greater DAS28, SDAI and CDAI but similar GS-US7 and PD-US7. GS-US7 correlated with DAS28, SDAI and CDAI in patients with and without FM (r(s)=0.36-0.57), while PD-US7 correlated with clinical scores only in patients without FM (r(s)=0.35-0.38). Conclusion To our knowledge, this is the first study to demonstrate that ultrasound synovitis scores are not affected by FM in RA patients. PD-US7 performed better than GS-US7 in long-standing RA patients with DAS28, SDAI or CDAI allegedly overestimated due to FM. Since sonographic synovitis predicts erosion better than swollen joint count, C-reactive protein and erythrocyte sedimentation rate, US should be considered a promising treatment target in RA patients with FM.	[da Silva Chakr, Rafael Mendonca; Tavares Brenol, Joao Carlos; Behar, Marina; Kohem, Charles Lubianca; Monticielo, Odirlei Andre; Brenol, Claiton Viegas; Xavier, Ricardo Machado] Univ Fed Rio Grande do Sul, Hosp Clin Porto Alegre, Porto Alegre, RS, Brazil; [Mendonca, Jose Alexandre] Pontificia Univ Catolica Campinas, Campinas, SP, Brazil	Universidade Federal do Rio Grande do Sul; Pontificia Universidade Catolica de Campinas	Chakr, RMD (corresponding author), Univ Fed Rio Grande do Sul, Hosp Clin Porto Alegre, Porto Alegre, RS, Brazil.	rafaelchakr@gmail.com	Brenol, Claiton V/D-5235-2009; Brenol, João Carlos Tavares/V-7062-2019; Monticielo, Odirlei/H-3880-2013; Xavier, Ricardo Machado/G-4426-2012; Chakr, Rafael/C-6963-2014; Kohem, Charles/U-4139-2019; Mendonça, José Alexandre/AAL-3443-2020; Mendonça, José Alexandre/AAX-2346-2021	Brenol, Claiton V/0000-0003-0229-7912; Brenol, João Carlos Tavares/0000-0002-8745-566X; Monticielo, Odirlei/0000-0003-0720-2097; Xavier, Ricardo Machado/0000-0001-6570-4533; Chakr, Rafael/0000-0002-8677-2479; Mendonça, José Alexandre/0000-0003-1689-6705	Fundo de Incentivo a Pesquisa e Eventos of Hospital de Clinicas de Porto Alegre	Fundo de Incentivo a Pesquisa e Eventos of Hospital de Clinicas de Porto Alegre	This study was funded by Fundo de Incentivo a Pesquisa e Eventos of Hospital de Clinicas de Porto Alegre. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aletaha D, 2010, ARTHRITIS RHEUM-US, V62, P2569, DOI 10.1002/art.27584; Backhaus M, 2009, ARTHRIT RHEUM-ARTHR, V61, P1194, DOI 10.1002/art.24646; Cheung PP, 2010, ARTHRIT CARE RES, V62, P323, DOI 10.1002/acr.20102; Colebatch AN, 2013, ANN RHEUM DIS, V72, P804, DOI 10.1136/annrheumdis-2012-203158; Chakr RMD, 2013, CLIN RHEUMATOL, V32, P1249, DOI 10.1007/s10067-013-2291-6; Dale J, 2014, ARTHRIT CARE RES, V66, P19, DOI 10.1002/acr.22218; Damjanov N, 2012, RHEUMATOLOGY, V51, P120, DOI 10.1093/rheumatology/ker255; Dougados M, 2010, ANN RHEUM DIS, V69, P828, DOI 10.1136/ard.2009.115493; Hameed S, 2008, RHEUMATOLOGY, V47, P476, DOI 10.1093/rheumatology/kem383; Mandl P, 2011, J RHEUMATOL, V38, P2055, DOI 10.3899/jrheum.110424; Ohrndorf S, 2012, ARTHRIT CARE RES, V64, P1238, DOI 10.1002/acr.21679; Ohrndorf S, 2013, ANN RHEUM DIS, V72, P69, DOI 10.1136/annrheumdis-2012-202197; Pincus T, 2012, CLIN EXP RHEUMATOL, V30, pS10; Ranzolin A, 2009, ARTHRIT RHEUM-ARTHR, V61, P794, DOI 10.1002/art.24430; Scott DL, 2010, LANCET, V376, P1094, DOI 10.1016/S0140-6736(10)60826-4; Smolen JS, 2010, ANN RHEUM DIS, V69, P631, DOI 10.1136/ard.2009.123919; Szkudlarek M, 2003, ARTHRITIS RHEUM, V48, P955, DOI 10.1002/art.10877; Wolfe F, 2010, ARTHRIT CARE RES, V62, P600, DOI 10.1002/acr.20140	18	22	22	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2015	10	3							e0118620	10.1371/journal.pone.0118620	http://dx.doi.org/10.1371/journal.pone.0118620			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9JM	25738587	Green Published, gold, Green Submitted			2022-12-27	WOS:000350685900057
J	Zhou, YY; Kang, L; Liao, SY; Pan, Q; Ge, XH; Li, ZY				Zhou, Yingying; Kang, Lei; Liao, Shiying; Pan, Qi; Ge, Xianhong; Li, Zaiyun			Transcriptomic Analysis Reveals Differential Gene Expressions for Cell Growth and Functional Secondary Metabolites in Induced Autotetraploid of Chinese Woad (Isatis indigotica Fort.)	PLOS ONE			English	Article							BRASSICA-NAPUS; HYBRIDS; POLYPLOIDY; SIZE; EVOLUTION; AUTOPOLYPLOIDY; TETRAPLOIDS; MECHANISMS; GENERATION; INDUCTION	The giant organs and enhanced concentrations of secondary metabolites realized by autopolyploidy are attractive for breeding the respective medicinal and agricultural plants and studying the genetic mechanisms. The traditional medicinal plant Chinese woad (Isatis indigotica Fort., 2n = 2x = 14) is now still largely used for the diseases caused by bacteria and viruses in China. In this study, its autopolyploids (3x, 4x) were produced and characterized together with the 2x donor for their phenotype and transcriptomic alterations by using high-throughput RNA sequencing. With the increase of genome dosage, the giantism in cells and organs was obvious and the photosynthetic rate was higher. The 4x plants showed predominantly the normal meiotic chromosome pairing (bivalents and quadrivalents) and equal segregation and then produced the majority of 4x progeny. The total 70136 All-unigenes were de novo assembled, and 56,482 (80.53%) unigenes were annotated based on BLASTx searches of the public databases. From pair-wise comparisons between transcriptomic data of 2x, 3x, 4x plants, 1856 (2.65%)(2x vs 4x), 693(0.98%)(2x vs 3x), 1045(1.48%)(3x vs 4x) unigenes were detected to differentially expressed genes (DEGs), including both up-and down-regulated ones. These DEGs were mainly involved in cell growth (synthesis of expansin and pectin), cell wall organization, secondary metabolite biosynthesis, response to stress and photosynthetic pathways. The up-regulation of some DEGs for metabolic pathways of functional compounds in the induced autotetraploids substantiates the promising new type of this medicinal plant with the increased biomass and targeted metabolites.	[Zhou, Yingying; Kang, Lei; Liao, Shiying; Pan, Qi; Ge, Xianhong; Li, Zaiyun] Huazhong Agr Univ, Natl Ctr Crop Mol Breeding Technol, Natl Key Lab Crop Genet Improvement, Natl Ctr Oil Crop Improvement Wuhan,Coll Plant Sc, Wuhan, Peoples R China	Huazhong Agricultural University	Li, ZY (corresponding author), Huazhong Agr Univ, Natl Ctr Crop Mol Breeding Technol, Natl Key Lab Crop Genet Improvement, Natl Ctr Oil Crop Improvement Wuhan,Coll Plant Sc, Wuhan, Peoples R China.	lizaiyun@mail.hzau.edu.cn			National Natural Science Foundation of China [31071451]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The work was supported by National Natural Science Foundation of China (http://www.nsfc.gov.cn/) project (No. 31071451). YZ received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams KL, 2004, GENETICS, V168, P2217, DOI 10.1534/genetics.104.033522; Al-Shehbaz IA, 2006, PLANT SYST EVOL, V259, P89, DOI 10.1007/s00606-006-0415-z; Allario T, 2011, J EXP BOT, V62, P2507, DOI 10.1093/jxb/erq467; Banyai W, 2010, PLANT BIOTECHNOL-NAR, V27, P427, DOI 10.5511/plantbiotechnology.10.0726a; Chen JF, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-857; Comai L, 2000, PLANT CELL, V12, P1551, DOI 10.1105/tpc.12.9.1551; Cosgrove DJ, 2000, NATURE, V407, P321, DOI 10.1038/35030000; Cui C, 2012, GENETICS, V191, P725, DOI 10.1534/genetics.112.140780; De Bodt S, 2005, TRENDS ECOL EVOL, V20, P591, DOI 10.1016/j.tree.2005.07.008; Dhawan OP, 1996, EUPHYTICA, V87, P81, DOI 10.1007/BF00021879; FANKHAUSER G, 1952, INT REV CYTOL, V1, P165, DOI 10.1016/S0074-7696(08)60010-8; Ge XH, 2013, PLANT CELL REP, V32, P1661, DOI 10.1007/s00299-013-1475-5; Gu XF, 2005, PLANT CELL REP, V24, P671, DOI 10.1007/s00299-005-0017-1; Haas BJ, 2013, NAT PROTOC, V8, P1494, DOI 10.1038/nprot.2013.084; Hollister JD, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003093; Hongo S, 2012, PLANT CELL, V24, P2624, DOI 10.1105/tpc.112.099325; Iseli C, 1999, Proc Int Conf Intell Syst Mol Biol, P138; Jansson S, 1999, TRENDS PLANT SCI, V4, P236, DOI 10.1016/S1360-1385(99)01419-3; Kang L, 2014, PLANT CELL REP, V33, P1355, DOI 10.1007/s00299-014-1621-8; Kawade K, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-143; Lavania UC, 2012, PLANT J, V71, P539, DOI 10.1111/j.1365-313X.2012.05006.x; Levan A, 1939, HEREDITAS, V25, P109; Li B, 2000, J 2 MIL MED U, V21, P207; Li B, 2000, ACTA PHARM SIN, V35, P508, DOI [10.16438/j.0513-4870.2000.07.008, DOI 10.16438/J.0513-4870.2000.07.008]; [李彬 Li Bin], 2005, [中草药, Chinese Traditional and Herbal Drugs], V36, P326; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Li XD, 2012, PLANTA, V236, P579, DOI 10.1007/s00425-012-1629-7; Liu SY, 2011, SCI HORTIC-AMSTERDAM, V127, P411, DOI 10.1016/j.scienta.2010.10.012; Lu BB, 2006, PLANT MOL BIOL REP, V24, P197, DOI 10.1007/BF02914058; Lysak MA, 2009, MOL BIOL EVOL, V26, P85, DOI 10.1093/molbev/msn223; Meng HB, 2011, AGR SCI CHINA, V10, P363, DOI 10.1016/S1671-2927(11)60015-1; Mohn T, 2009, PHYTOCHEMISTRY, V70, P924, DOI 10.1016/j.phytochem.2009.04.019; MORRISON JW, 1960, NATURE, V187, P528, DOI 10.1038/187528a0; Mu HZ, 2012, INT J MOL SCI, V13, P13012, DOI 10.3390/ijms131013012; Muntzing A., 1936, HEREDITAS, V21, P263, DOI DOI 10.1111/J.1601-5223.1936.TB03204.X; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; National Pharmacopoeia Council, 2010, PHARM CHIN 2010 ED, P191; Ni ZF, 2009, NATURE, V457, P327, DOI 10.1038/nature07523; Osborn TC, 2003, TRENDS GENET, V19, P141, DOI 10.1016/S0168-9525(03)00015-5; Pagliarini MS, 2008, EUPHYTICA, V164, P181, DOI 10.1007/s10681-008-9697-2; Pan XZ, 2008, BIOLOGIA, V63, P535, DOI 10.2478/s11756-008-0094-z; Pertea G, 2003, BIOINFORMATICS, V19, P651, DOI 10.1093/bioinformatics/btg034; Qiao CZ, 1995, CHIN TRADIT HERB DRU, V26, P423; Rieseberg LH, 2001, CURR BIOL, V11, pR925, DOI 10.1016/S0960-9822(01)00556-5; Romeis T, 2001, EMBO J, V20, P5556, DOI 10.1093/emboj/20.20.5556; Roy AT, 2001, PLANT CELL REP, V20, P489, DOI 10.1007/s002990100364; Rudd JJ, 2001, NEW PHYTOL, V151, P7, DOI 10.1046/j.1469-8137.2001.00173.x; Santos JL, 2003, GENETICS, V165, P1533; Siedlecka A, 2008, PLANT PHYSIOL, V146, P554, DOI 10.1104/pp.107.111963; Stupar RM, 2007, GENETICS, V176, P2055, DOI 10.1534/genetics.107.074286; Sugiyama SI, 2005, ANN BOT-LONDON, V96, P931, DOI 10.1093/aob/mci245; Taschetto Onildes Maria, 2004, Acta Botanica Croatica, V63, P17; Tsukaya H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083729; Tsukaya H, 2008, PLOS BIOL, V6, P1373, DOI 10.1371/journal.pbio.0060174; Tu YQ, 2010, GENOME, V53, P146, DOI [10.1139/G09-093, 10.1139/g09-093]; Tu YQ, 2008, PLANT CELL REP, V27, P873, DOI 10.1007/s00299-008-0513-1; WANG QY, 1988, ACTA AGR BOREALI SIN, V3, P92; Wang XW, 2011, NAT GENET, V43, P1035, DOI 10.1038/ng.919; Wang Yin, 2000, Zhongguo Zhongyao Zazhi, V25, P327; WARNER DA, 1993, PHOTOSYNTH RES, V35, P135, DOI 10.1007/BF00014744; WARNER DA, 1989, PLANT PHYSIOL, V91, P1143, DOI 10.1104/pp.91.3.1143; Wendel JF, 2000, PLANT MOL BIOL, V42, P225, DOI 10.1023/A:1006392424384; Xu ZF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094779; Yao H, 2011, PLANT MOL BIOL, V75, P237, DOI 10.1007/s11103-010-9722-4; Ye J, 2006, NUCLEIC ACIDS RES, V34, pW293, DOI 10.1093/nar/gkl031; Yu Z, 2010, P NATL ACAD SCI USA, V107, P17809, DOI 10.1073/pnas.1000852107; Zhang XS, 2014, INT J MOL SCI, V15, P5079, DOI 10.3390/ijms15035079; Zhu GL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103832	68	41	42	2	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2015	10	3							e0116392	10.1371/journal.pone.0116392	http://dx.doi.org/10.1371/journal.pone.0116392			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9JM	25739089	Green Published, Green Submitted, gold			2022-12-27	WOS:000350685900009
J	Hori, Y; Miyabe, K; Yoshida, M; Nakazawa, T; Hayashi, K; Naitoh, I; Shimizu, S; Kondo, H; Nishi, Y; Umemura, S; Kato, A; Ohara, H; Inagaki, H; Joh, T				Hori, Yasuki; Miyabe, Katsuyuki; Yoshida, Michihiro; Nakazawa, Takahiro; Hayashi, Kazuki; Naitoh, Itaru; Shimizu, Shuya; Kondo, Hiromu; Nishi, Yuji; Umemura, Shuichiro; Kato, Akihisa; Ohara, Hirotaka; Inagaki, Hiroshi; Joh, Takashi			Impact of TP53 Codon 72 and MDM2 SNP 309 Polymorphisms in Pancreatic Ductal Adenocarcinoma	PLOS ONE			English	Article							SINGLE NUCLEOTIDE POLYMORPHISM; SQUAMOUS-CELL CARCINOMA; P53 CODON-72; CANCER RISK; LUNG-CANCER; ARG72PRO POLYMORPHISMS; PROMOTER POLYMORPHISM; DISEASE PROGRESSION; GENE POLYMORPHISMS; COLORECTAL-CANCER	Single-nucleotide polymorphisms (SNPs) of TP53 (codon 72, rs1042522) and MDM2 promoter (SNP 309, rs2279744) have been associated with risk for various human cancers. However, studies analyzing these polymorphisms in pancreatic ductal adenocarcinoma (PDAC) are lacking. We investigated TP53 codon 72 and MDM2 SNP 309 polymorphisms in 32 patients with PDAC, 16 patients with chronic pancreatitis (CP), and 32 normal controls, using formalin-fixed paraffin-embedded tissue. We also examined TP53 and MDM2 protein immunohistochemistry (IHC) to assess the involvement of these differences in malignant transformation and disease progression. TP53 Pro/Pro genotype was significantly more frequent in PDAC patients than in controls (65.6 vs. 15.6%, p < 0.001) and no significant difference was found between CP patients (37.5%) and controls. In MDM2 SNP 309, there were no significant differences among the three groups. Based on the Kaplan-Meier analysis, overall survival was significantly shorter in MDM2 G/G genotypes compared with other genotypes (G/T and T/T) (359 vs. 911 days, p = 0.016) whereas no significant differences in TP53 genotypes were observed (638 vs. 752 days, p = 0.471). Although TP53 IHC was frequent in PDAC patients (53.1%), TP53 and MDM2 protein expression was not correlated with polymorphisms. Our study demonstrated TP53 codon 72 polymorphism is potentially a genetic predisposing factor while MDM2 SNP 309 polymorphism might be useful in predicting survival outcome.	[Hori, Yasuki; Miyabe, Katsuyuki; Yoshida, Michihiro; Nakazawa, Takahiro; Hayashi, Kazuki; Naitoh, Itaru; Shimizu, Shuya; Kondo, Hiromu; Nishi, Yuji; Umemura, Shuichiro; Kato, Akihisa; Joh, Takashi] Nagoya City Univ, Dept Gastroenterol & Metab, Grad Sch Med Sci, Nagoya, Aichi, Japan; [Ohara, Hirotaka] Nagoya City Univ, Grad Sch Med Sci, Dept Community Based Med Educ, Nagoya, Aichi, Japan; [Inagaki, Hiroshi] Nagoya City Univ, Grad Sch Med Sci, Dept Pathol & Mol Diagnost, Nagoya, Aichi, Japan	Nagoya City University; Nagoya City University; Nagoya City University	Miyabe, K (corresponding author), Nagoya City Univ, Dept Gastroenterol & Metab, Grad Sch Med Sci, Nagoya, Aichi, Japan.	kmiyabe@med.nagoya-cu.ac.jp	Naitoh, Itaru/AAB-7252-2020	Naitoh, Itaru/0000-0001-8342-886X; Miyabe, Katsuyuki/0000-0002-4915-9835	Aichi Cancer Research Foundation	Aichi Cancer Research Foundation(Aichi Cancer Research Foundation)	This study was supported by a research grant from Aichi Cancer Research Foundation (http:// www.acrf.or.jp/, no grant number) and the internal source of Nagoya City University Graduate School of Medical Sciences. The funders had no rule in study design, data collection and analysis, employment of any individuals, decision to publish, or preparation of the manuscript.	Ammann RW, 1997, PANCREAS, V14, P215, DOI 10.1097/00006676-199704000-00001; Asomaning K, 2008, CLIN CANCER RES, V14, P4010, DOI 10.1158/1078-0432.CCR-07-4187; BARTEK J, 1993, J PATHOL, V169, P27, DOI 10.1002/path.1711690106; Bass AJ, 2014, NATURE, V513, P202, DOI 10.1038/nature13480; Baxter NN, 2007, ANN SURG ONCOL, V14, P1320, DOI 10.1245/s10434-006-9249-8; Bond GL, 2004, CELL, V119, P591, DOI 10.1016/j.cell.2004.11.022; Dong M, 2003, J SURG ONCOL, V82, P111, DOI 10.1002/jso.10186; Dong M, 2005, WORLD J GASTROENTERO, V11, P2162, DOI 10.3748/wjg.v11.i14.2162; Dumont P, 2003, NAT GENET, V33, P357, DOI 10.1038/ng1093; Fan R, 2000, CANCER EPIDEM BIOMAR, V9, P1037; Grochola LF, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001032; Grochola LF, 2010, PANCREAS, V39, P76, DOI 10.1097/MPA.0b013e3181b9f105; Grochola LF, 2011, PANCREAS, V40, P265, DOI 10.1097/MPA.0b013e3181f95104; Hishida A, 2004, LEUKEMIA LYMPHOMA, V45, P957, DOI 10.1080/10428190310001638878; Horikawa Y, 2008, ONCOL REP, V20, P49; Joshi AM, 2011, JPN J CLIN ONCOL, V41, P232, DOI 10.1093/jjco/hyq200; Kalemi TG, 2005, CANCER LETT, V222, P57, DOI 10.1016/j.canlet.2004.11.025; Kiyohara C, 2010, ONCOL REP, V23, P1361, DOI 10.3892/or_00000772; Kuroda Y, 2003, CANCER LETT, V189, P77, DOI 10.1016/S0304-3835(02)00518-9; Kuroda Y, 2007, ORAL ONCOL, V43, P1043, DOI 10.1016/j.oraloncology.2006.12.001; Langerod A, 2002, CANCER EPIDEM BIOMAR, V11, P1684; Lee JM, 2000, INT J CANCER, V89, P458, DOI 10.1002/1097-0215(20000920)89:5<458::AID-IJC10>3.0.CO;2-R; Li DH, 2006, CANCER RES, V66, P3323, DOI 10.1158/0008-5472.CAN-05-3032; Mabuchi F, 2009, MOL VIS, V15, P1045; Mahasneh AA, 2004, SAUDI MED J, V25, P1568; Naccarati A, 2010, CARCINOGENESIS, V31, P666, DOI 10.1093/carcin/bgq032; Nakashima M, 2008, ACTA OTO-LARYNGOL, V128, P808, DOI 10.1080/00016480701724904; Nenutil R, 2005, J PATHOL, V207, P251, DOI 10.1002/path.1838; Ogura T, 2012, GASTROINTEST ENDOSC, V75, P769, DOI 10.1016/j.gie.2011.11.012; Ohmiya N, 2006, J CLIN ONCOL, V24, P4434, DOI 10.1200/JCO.2005.04.1459; Sakiyama T, 2005, INT J CANCER, V114, P730, DOI 10.1002/ijc.20790; SARNER M, 1984, GUT, V25, P756, DOI 10.1136/gut.25.7.756; Shaib Y, 2007, AM J GASTROENTEROL, V102, P1377, DOI 10.1111/j.1572-0241.2007.01202.x; Shen HB, 2002, CANCER LETT, V183, P123, DOI 10.1016/S0304-3835(02)00117-9; Sonoyama T, 2011, MOL MED REP, V4, P489, DOI 10.3892/mmr.2011.449; Soulitzis N, 2002, CANCER LETT, V179, P175, DOI 10.1016/S0304-3835(01)00867-9; Sugano N, 2010, GENE CHROMOSOME CANC, V49, P620, DOI 10.1002/gcc.20774; Takeuchi S, 2005, BRIT J HAEMATOL, V131, P552, DOI 10.1111/j.1365-2141.2005.05798.x; Thomas M, 1999, MOL CELL BIOL, V19, P1092; Tsai MH, 2002, LARYNGOSCOPE, V112, P116, DOI 10.1097/00005537-200201000-00020; WU WJ, 1995, JPN J CANCER RES, V86, P730, DOI 10.1111/j.1349-7006.1995.tb02461.x; Yoneda T, 2013, ONCOL REP, V30, P25, DOI 10.3892/or.2013.2433; Yu MW, 1999, HEPATOLOGY, V29, P697, DOI 10.1002/hep.510290330; Zehbe I, 1999, LANCET, V354, P218, DOI 10.1016/S0140-6736(99)01914-5; Zhang JG, 2002, IEEE CIRCUITS DEVICE, V18, P18	45	15	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2015	10	3							e0118829	10.1371/journal.pone.0118829	http://dx.doi.org/10.1371/journal.pone.0118829			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4HV	25734904	Green Published, gold, Green Submitted			2022-12-27	WOS:000350314700045
J	Misawa, K; Misawa, Y; Kondo, H; Mochizuki, D; Imai, A; Fukushima, H; Uehara, T; Kanazawa, T; Mineta, H				Misawa, Kiyoshi; Misawa, Yuki; Kondo, Haruki; Mochizuki, Daiki; Imai, Atsushi; Fukushima, Hirofumi; Uehara, Takayuki; Kanazawa, Takeharu; Mineta, Hiroyuki			Aberrant Methylation Inactivates Somatostatin and Somatostatin Receptor Type 1 in Head and Neck Squamous Cell Carcinoma	PLOS ONE			English	Article							TUMOR-SUPPRESSOR ACTIVITY; PROMOTER METHYLATION; POTENTIAL BIOMARKER; PROSTATE-CANCER; TACHYKININ-1; GALANIN; HYPERMETHYLATION; EXPRESSION; PATHOGENESIS; ASSOCIATION	Purpose The aim of this study was to define somatostatin (SST) and somatostatin receptor type 1 (SSTR1) methylation profiles for head and neck squamous cell carcinoma (HNSCC) tumors at diagnosis and follow up and to evaluate their prognostic significance and value as a biomarker. Methods Gene expression was measured by quantitative RT-PCR. Promoter methylation status was determined by quantitative methylation-specific PCR (Q-MSP) in HNSCC. Results Methylation was associated with transcription inhibition. SST methylation in 81% of HNSCC tumor specimens significantly correlated with tumor size (P = 0.043), stage (P = 0.008), galanin receptor type 2 (GALR2) methylation (P = 0.041), and tachykinin-1 (TAC1) (P = 0.040). SSTR1 hypermethylation in 64% of cases was correlated with tumor size (P = 0.037), stage (P = 0.037), SST methylation (P < 0.001), and expression of galanin (P = 0.03), GALR2 (P = 0.014), TAC1 (P = 0.023), and tachykinin receptor type 1 (TACR1) (P = 0.003). SST and SSTR1 promoter hypermethylation showed highly discriminating receiver operator characteristic curve profiles, which clearly distinguished HNSCC from adjacent normal mucosal tissues. Concurrent hypermethylation of galanin and SSTR1 promoters correlated with reduced disease-free survival (log-rank test, P = 0.0001). Among patients with oral cavity and oropharynx cancer, methylation of both SST and SSTR1 promoters correlated with reduced disease-free survival (log-rank test, P = 0.028). In multivariate logistic-regression analysis, concomitant methylation of galanin and SSTR1 was associated with an odds ratio for recurrence of 12.53 ( 95% CI, 2.62 to 59.8; P = 0.002). Conclusions CpG hypermethylation is a likely mechanism of SST and SSTR1 gene inactivation, supporting the hypothesis that SST and SSTR1 play a role in the tumorigenesis of HNSCC and that this hypermethylation may serve as an important biomarker.	[Misawa, Kiyoshi; Misawa, Yuki; Kondo, Haruki; Mochizuki, Daiki; Imai, Atsushi; Mineta, Hiroyuki] Hamamatsu Univ Sch Med, Dept Otolaryngol Head & Neck Surg, Shizuoka, Japan; [Fukushima, Hirofumi] Japanese Fdn Canc Res, Canc Inst Hosp, Dept Head & Neck, Tokyo, Japan; [Uehara, Takayuki] Univ Ryukyus, Grad Sch Med, Dept Otorhinolaryngol Head & Neck Surg, Nishihara, Okinawa 90301, Japan; [Kanazawa, Takeharu] Jichi Med Univ, Dept Otolaryngol Head & Neck Surg, Shimotsuke, Japan	Hamamatsu University School of Medicine; Japanese Foundation for Cancer Research; University of the Ryukyus; Jichi Medical University	Misawa, K (corresponding author), Hamamatsu Univ Sch Med, Dept Otolaryngol Head & Neck Surg, Shizuoka, Japan.	kiyoshim@hama-med.ac.jp		MOCHIZUKI, DAIKI/0000-0002-4561-3404	Ministry of Education, Culture, Sports, Science, and Technology of Japan [24592594, 25861485, 26462599, 26462600, 26861367]	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	A Grant-in-Aid for Scientific Research (No. 24592594, 25861485, 26462599, 26462600 and 26861367) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bolden JE, 2006, NAT REV DRUG DISCOV, V5, P769, DOI 10.1038/nrd2133; BRAZEAU P, 1973, SCIENCE, V179, P77, DOI 10.1126/science.179.4068.77; Brenner JC, 2010, HEAD NECK-J SCI SPEC, V32, P417, DOI 10.1002/hed.21198; Brock MV, 2008, NEW ENGL J MED, V358, P1118, DOI 10.1056/NEJMoa0706550; Chen LF, 2010, CLIN CANCER RES, V16, P2489, DOI 10.1158/1078-0432.CCR-09-2318; David S, 2009, BIOCHEM BIOPH RES CO, V378, P605, DOI 10.1016/j.bbrc.2008.11.078; Gu J, 2006, CLIN CANCER RES, V12, P7329, DOI 10.1158/1078-0432.CCR-06-0894; Hama T, 2009, ONCOLOGIST, V14, P900, DOI 10.1634/theoncologist.2009-0058; Jackson K, 2011, DIGEST DIS SCI, V56, P125, DOI 10.1007/s10620-010-1422-z; Jeschke J, 2012, EPIGENETICS-US, V7, P701, DOI 10.4161/epi.20445; Jiang L, 2008, CANCER RES, V68, P9900, DOI 10.1158/0008-5472.CAN-08-1319; Jin Z, 2008, CANCER-AM CANCER SOC, V112, P43, DOI 10.1002/cncr.23135; Jin Z, 2007, CLIN CANCER RES, V13, P6293, DOI 10.1158/1078-0432.CCR-07-0818; Kanazawa T, 2010, EXPERT OPIN THER TAR, V14, P289, DOI 10.1517/14728221003598922; Katz MH., 2011, MULTIVARIABLE ANAL A; Kharmate G, 2011, BBA-MOL CELL RES, V1813, P1172, DOI 10.1016/j.bbamcr.2011.03.006; Lappano R, 2011, NAT REV DRUG DISCOV, V10, P47, DOI 10.1038/nrd3320; Malik N, 2013, COMP BIOCHEM PHYS B, V165, P260, DOI 10.1016/j.cbpb.2013.05.006; Misawa K, 2013, TRANSL ONCOL, V6, P338, DOI 10.1593/tlo.13115; Misawa K, 2013, J CANCER RES CLIN, V139, P879, DOI 10.1007/s00432-013-1393-5; Misawa K, 2008, CLIN CANCER RES, V14, P7604, DOI 10.1158/1078-0432.CCR-07-4673; Misawa Y, 2014, CANCER-AM CANCER SOC, V120, P205, DOI 10.1002/cncr.28411; Mizutani G, 2012, ACTA HISTOCHEM CYTOC, V45, P167, DOI 10.1267/ahc.12006; Mori Y, 2006, GASTROENTEROLOGY, V131, P797, DOI 10.1053/j.gastro.2006.06.006; REUBI JC, 1995, TRENDS PHARMACOL SCI, V16, P110, DOI 10.1016/S0165-6147(00)88992-0; Ricketts CJ, 2012, EPIGENETICS-US, V7, P278, DOI 10.4161/epi.7.3.19103; Schartinger VH, 2012, J LARYNGOL OTOL, V126, P1261, DOI 10.1017/S0022215112002265; Stafford ND, 2003, CLIN OTOLARYNGOL, V28, P314, DOI 10.1046/j.1365-2273.2003.00711.x; Stewart GD, 2013, J UROLOGY, V189, P1110, DOI 10.1016/j.juro.2012.08.219; Toyooka S, 2003, INT J CANCER, V103, P153, DOI 10.1002/ijc.10787; Van Neste L, 2012, PROSTATE, V72, P1248, DOI 10.1002/pros.22459; VOKES EE, 1993, NEW ENGL J MED, V328, P184, DOI 10.1056/NEJM199301213280306; Watt Heather L, 2012, J Signal Transduct, V2012, P282050, DOI 10.1155/2012/282050; Zhao J, 2013, BRIT J CANCER, V108, P2557, DOI 10.1038/bjc.2013.263	34	25	26	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2015	10	3							e0118588	10.1371/journal.pone.0118588	http://dx.doi.org/10.1371/journal.pone.0118588			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4HV	25734919	Green Published, gold, Green Submitted			2022-12-27	WOS:000350314700038
J	Fuentes-Julian, S; Arnalich-Montiel, F; Jaumandreu, L; Leal, M; Casado, A; Garcia-Tunon, I; Hernandez-Jimenez, E; Lopez-Collazo, E; De Miguel, MP				Fuentes-Julian, Sherezade; Arnalich-Montiel, Francisco; Jaumandreu, Laia; Leal, Marina; Casado, Alfonso; Garcia-Tunon, Ignacio; Hernandez-Jimenez, Enrique; Lopez-Collazo, Eduardo; De Miguel, Maria P.			Adipose-Derived Mesenchymal Stem Cell Administration Does Not Improve Corneal Graft Survival Outcome	PLOS ONE			English	Article							HIGH-RISK KERATOPLASTY; VERSUS-HOST-DISEASE; STROMAL CELLS; MYCOPHENOLATE-MOFETIL; ALLOGRAFT-REJECTION; INTERFERON-GAMMA; UP-REGULATION; ISLET GRAFTS; TISSUE; THERAPY	The effect of local and systemic injections of mesenchymal stem cells derived from adipose tissue (AD-MSC) into rabbit models of corneal allograft rejection with either normal-risk or high-risk vascularized corneal beds was investigated. The models we present in this study are more similar to human corneal transplants than previously reported murine models. Our aim was to prevent transplant rejection and increase the length of graft survival. In the normal-risk transplant model, in contrast to our expectations, the injection of AD-MSC into the graft junction during surgery resulted in the induction of increased signs of inflammation such as corneal edema with increased thickness, and a higher level of infiltration of leukocytes. This process led to a lower survival of the graft compared with the sham-treated corneal transplants. In the high-risk transplant model, in which immune ocular privilege was undermined by the induction of neovascularization prior to graft surgery, we found the use of systemic rabbit AD-MSCs prior to surgery, during surgery, and at various time points after surgery resulted in a shorter survival of the graft compared with the non-treated corneal grafts. Based on our results, local or systemic treatment with AD-MSCs to prevent corneal rejection in rabbit corneal models at normal or high risk of rejection does not increase survival but rather can increase inflammation and neovascularization and break the innate ocular immune privilege. This result can be partially explained by the immunomarkers, lack of immunosuppressive ability and immunophenotypical secretion molecules characterization of AD-MSC used in this study. Parameters including the risk of rejection, the inflammatory/vascularization environment, the cell source, the time of injection, the immunosuppression, the number of cells, and the mode of delivery must be established before translating the possible benefits of the use of MSCs in corneal transplants to clinical practice.	[Fuentes-Julian, Sherezade; Garcia-Tunon, Ignacio; De Miguel, Maria P.] Hosp La Paz, Res Inst, IdiPAZ, Cell Engn Lab, Madrid, Spain; [Arnalich-Montiel, Francisco; Jaumandreu, Laia; Leal, Marina; Casado, Alfonso] Ramon y Cajal Hosp Res Inst, Dept Ophthalmol, Madrid, Spain; [Hernandez-Jimenez, Enrique; Lopez-Collazo, Eduardo] IdiPAZ, Tumor Immunol Dept, Madrid, Spain; [Hernandez-Jimenez, Enrique; Lopez-Collazo, Eduardo] IdiPAZ, Innate Immun Grp, Madrid, Spain	Hospital Universitario La Paz	De Miguel, MP (corresponding author), Hosp La Paz, Res Inst, IdiPAZ, Cell Engn Lab, Madrid, Spain.	mariapdemiguel@gmail.com	García-Tuñón Llanio, Ignacio/K-9901-2014; Arnalich, Francisco/K-7723-2014; Casado, Alfonso/AAI-9951-2020; Lopez-Collazo, Eduardo/U-6634-2018	García-Tuñón Llanio, Ignacio/0000-0003-4758-2151; Casado, Alfonso/0000-0002-3402-7311; Hernandez Jimenez, Enrique/0000-0002-8232-8151; Lopez-Collazo, Eduardo/0000-0003-1957-877X; Arnalich-Montiel, Francisco/0000-0002-1229-2018	Ministry of Health and Social Politics, Spain [EC-11]; Ministry of Economy and Competitiveness, Spain [SAF2010-19230]; Ministry of Education, Culture and Sports [AP2010-0659]; BioMedical Foundations Mutua Madrilena and Marato TV3, Spain	Ministry of Health and Social Politics, Spain; Ministry of Economy and Competitiveness, Spain; Ministry of Education, Culture and Sports; BioMedical Foundations Mutua Madrilena and Marato TV3, Spain	This work was supported by grants EC-11 from the Ministry of Health and Social Politics, Spain; SAF2010-19230 from the Ministry of Economy and Competitiveness, Spain; AP2010-0659 fellowship to SF-J from the Ministry of Education, Culture and Sports; and from the BioMedical Foundations Mutua Madrilena and Marato TV3, Spain. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2009, EYE BANK STAT REP; Arnalich-Montiel F, 2008, STEM CELLS, V26, P570, DOI 10.1634/stemcells.2007-0653; Bartholomew A, 2002, EXP HEMATOL, V30, P42, DOI 10.1016/S0301-472X(01)00769-X; Bernardo ME, 2013, CELL STEM CELL, V13, P392, DOI 10.1016/j.stem.2013.09.006; Birnbaum F, 2005, TRANSPLANTATION, V79, P964, DOI 10.1097/01.TP.0000158022.62059.F2; Birnbaum F, 2009, EYE, V23, P2063, DOI 10.1038/eye.2008.402; Casiraghi F, 2008, J IMMUNOL, V181, P3933, DOI 10.4049/jimmunol.181.6.3933; Chan JL, 2006, BLOOD, V107, P4817, DOI 10.1182/blood-2006-01-0057; Chong Eva-Marie, 2008, International Ophthalmology, V28, P209, DOI 10.1007/s10792-007-9099-9; Crop MJ, 2011, CELL TRANSPLANT, V20, P1547, DOI 10.3727/096368910X564076; De Miguel MP, 2012, CURR MOL MED, V12, P574; Ding YC, 2009, DIABETES, V58, P1797, DOI 10.2337/db09-0317; Engela AU, 2013, CELL TRANSPLANT, V22, P41, DOI 10.3727/096368912X636984; Fang BJ, 2007, PEDIATR TRANSPLANT, V11, P814, DOI 10.1111/j.1399-3046.2007.00780.x; Francois M, 2009, BLOOD, V114, P2632, DOI 10.1182/blood-2009-02-207795; Ge W, 2009, AM J TRANSPLANT, V9, P1760, DOI 10.1111/j.1600-6143.2009.02721.x; Ge W, 2010, TRANSPLANTATION, V90, P1312, DOI 10.1097/TP.0b013e3181fed001; HAUNER H, 1987, KLIN WOCHENSCHR, V65, P803, DOI 10.1007/BF01727474; Hemeda H, 2010, STEM CELLS DEV, V19, P693, DOI 10.1089/scd.2009.0365; Im GI, 2005, OSTEOARTHR CARTILAGE, V13, P845, DOI 10.1016/j.joca.2005.05.005; Inoue S, 2006, TRANSPLANTATION, V81, P1589, DOI 10.1097/01.tp.0000209919.90630.7b; Jia Z, 2012, EXP EYE RES, V102, P44, DOI 10.1016/j.exer.2012.06.008; Jiang XX, 2005, BLOOD, V105, P4120, DOI 10.1182/blood-2004-02-0586; Katz AJ, 1999, CLIN PLAST SURG, V26, P587; Kim YH, 2011, MOL MED, V17, P697, DOI 10.2119/molmed.2010.00098; Kuo YR, 2011, PLAST RECONSTR SURG, V128, p661E, DOI 10.1097/PRS.0b013e318230c60b; Le Blanc K, 2003, EXP HEMATOL, V31, P890, DOI 10.1016/S0301-472X(03)00110-3; LeBlanc K, 2008, LANCET, V371, P1579, DOI 10.1016/S0140-6736(08)60690-X; Lee RH, 2014, P NATL ACAD SCI US; Li YP, 2008, J IMMUNOL, V180, P1598, DOI 10.4049/jimmunol.180.3.1598; Lin YF, 2006, MOL CELL BIOCHEM, V285, P69, DOI 10.1007/s11010-005-9056-8; Menard C, 2013, STEM CELLS DEV, V22, P1789, DOI 10.1089/scd.2012.0594; Nauta AJ, 2006, BLOOD, V108, P2114, DOI 10.1182/blood-2005-11-011650; Nie CL, 2011, CELL TRANSPLANT, V20, P205, DOI 10.3727/096368910X520065; Niederkorn JY, 2010, OCUL IMMUNOL INFLAMM, V18, P162, DOI 10.3109/09273948.2010.486100; Oh JY, 2012, MOL THER, V20, P2143, DOI 10.1038/mt.2012.165; Oh JY, 2009, VET OPHTHALMOL, V12, P35, DOI 10.1111/j.1463-5224.2009.00724.x; Ohmura Y, 2010, TRANSPLANTATION, V90, P1366, DOI 10.1097/TP.0b013e3181ffba31; Prasad VK, 2011, BIOL BLOOD MARROW TR, V17, P534, DOI 10.1016/j.bbmt.2010.04.014; Rathmell JC, 2000, MOL CELL, V6, P683, DOI 10.1016/S1097-2765(00)00066-6; Ren GW, 2008, CELL STEM CELL, V2, P141, DOI 10.1016/j.stem.2007.11.014; Ren GW, 2009, STEM CELLS, V27, P1954, DOI 10.1002/stem.118; Rigol M, 2014, EUR J CLIN INVEST, V44, P83, DOI 10.1111/eci.12195; Ringden O, 2006, TRANSPLANTATION, V81, P1390, DOI 10.1097/01.tp.0000214462.63943.14; Seifert M, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00202; Sheng HM, 2008, CELL RES, V18, P846, DOI 10.1038/cr.2008.80; Shi WY, 2006, INVEST OPHTH VIS SCI, V47, P3339, DOI 10.1167/iovs.05-1425; Spaggiari GM, 2009, BLOOD, V113, P6576, DOI 10.1182/blood-2009-02-203943; Stagg J, 2006, BLOOD, V107, P2570, DOI 10.1182/blood-2005-07-2793; Tavandzi U, 2007, TRANSPLANTATION, V83, P1401, DOI 10.1097/01.tp.0000261711.08833.a1; Thompson RW, 2003, OPHTHALMOLOGY, V110, P1396, DOI 10.1016/S0161-6420(03)00463-9; Xu GW, 2009, STEM CELLS, V27, P942, DOI 10.1002/stem.22; Zangi L, 2009, STEM CELLS, V27, P2865, DOI 10.1002/stem.217; Zhang W, 2007, TRANSPL P, V39, P3404, DOI 10.1016/j.transproceed.2007.06.092; Zuk PA, 2001, TISSUE ENG, V7, P211, DOI 10.1089/107632701300062859	55	28	29	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2015	10	3							e0117945	10.1371/journal.pone.0117945	http://dx.doi.org/10.1371/journal.pone.0117945			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9JF	25730319	gold, Green Published, Green Submitted			2022-12-27	WOS:000350684900016
J	Proctor, MJ; McMillan, DC; Horgan, PG; Fletcher, CD; Talwar, D; Morrison, DS				Proctor, Michael J.; McMillan, Donald C.; Horgan, Paul G.; Fletcher, Colin D.; Talwar, Dinesh; Morrison, David S.			Systemic Inflammation Predicts All-Cause Mortality: A Glasgow Inflammation Outcome Study	PLOS ONE			English	Article							C-REACTIVE PROTEIN; PROGNOSTIC SCORE; ISCHEMIC-STROKE; FOLLOW-UP; CANCER; ASSOCIATION; DISEASE; ALBUMIN; COUNTS; TUMOR	Introduction Markers of the systemic inflammatory response, including C-reactive protein and albumin (combined to form the modified Glasgow Prognostic Score), as well as neutrophil, lymphocyte and platelet counts have been shown to be prognostic of survival in patients with cancer. The aim of the present study was to examine the prognostic relationship between these markers of the systemic inflammatory response and all-cause, cancer, cardiovascular and cerebrovascular mortality in a large incidentally sampled cohort. Methods Patients (n = 160 481) who had an incidental blood sample taken between 2000 and 2008 were studied for the prognostic value of C-reactive protein (> 10mg/l, albumin (> 35mg/l), neutrophil (> 7.5x10(9)/l) lymphocyte and platelet counts. Also, patients (n = 52 091) sampled following the introduction of high sensitivity C-reactive protein (> 3mg/l) measurements were studied. A combination of these markers, to make cumulative inflammation-based scores, were investigated. Results In all patients (n = 160 481) C-reactive protein (> 10mg/l) (HR 2.71, p < 0.001), albumin (> 35mg/l) (HR 3.68, p < 0.001) and neutrophil counts (HR 2.18, p < 0.001) were independently predictive of all-cause mortality. These associations were also observed in cancer, cardiovascular and cerebrovascular mortality before and after the introduction of high sensitivity C-reactive protein measurements (> 3mg/l) (n = 52 091). A combination of high sensitivity C-reactive protein (> 3mg/l), albumin and neutrophil count predicted all-cause (HR 7.37, p < 0.001, AUC 0.723), cancer (HR 9.32, p < 0.001, AUC 0.731), cardiovascular (HR 4.03, p < 0.001, AUC 0.650) and cerebrovascular (HR 3.10, p < 0.001, AUC 0.623) mortality. Conclusion The results of the present study showed that an inflammation-based prognostic score, combining high sensitivity C-reactive protein, albumin and neutrophil count is prognostic of all-cause mortality.	[Proctor, Michael J.; McMillan, Donald C.; Horgan, Paul G.] Univ Glasgow, Acad Surg Unit, Sch Med, Glasgow, Lanark, Scotland; [Fletcher, Colin D.; Talwar, Dinesh] Royal Infirm, Dept Clin Biochem, Glasgow G31 2ER, Lanark, Scotland; [Morrison, David S.] Univ Glasgow, West Scotland Canc Surveillance Unit, Glasgow, Lanark, Scotland	University of Glasgow; Royal Infirmary of Edinburgh; University of Glasgow	Proctor, MJ (corresponding author), Univ Glasgow, Acad Surg Unit, Sch Med, Glasgow, Lanark, Scotland.	m.proctor@nhs.net		McMillan, Donald/0000-0003-4260-5334; Morrison, David/0000-0002-0617-3047				Acanfora D, 2001, AM HEART J, V142, P167, DOI 10.1067/mhj.2001.115792; Bishop J, 2004, DEPRIVATION URBAN RU; den Hertog HM, 2009, J NEUROL, V256, P2003, DOI 10.1007/s00415-009-5228-x; Di Napoli M, 2001, STROKE, V32, P917, DOI 10.1161/01.STR.32.4.917; Gakis G, 2011, BJU INT, V108, P1800, DOI 10.1111/j.1464-410X.2011.10234.x; Gay JL, 2013, J IMMIGR MINOR HLTH; Gillum RF, 2005, ANN EPIDEMIOL, V15, P266, DOI 10.1016/j.annepidem.2004.08.009; Goldwasser P, 1997, J CLIN EPIDEMIOL, V50, P693, DOI 10.1016/S0895-4356(97)00015-2; Greenland P, 2010, J AM COLL CARDIOL, V56, pE50, DOI 10.1016/j.jacc.2010.09.001; Grimm G, 2009, EUR J CLIN INVEST, V39, P860, DOI 10.1111/j.1365-2362.2009.02189.x; Guthrie GJK, 2013, CRIT REV ONCOL HEMAT, V88, P218, DOI 10.1016/j.critrevonc.2013.03.010; Inoue Y, 2013, ONCOLOGY-BASEL, V84, P100, DOI 10.1159/000343822; Kaptoge S, 2012, NEW ENGL J MED, V367, P1310, DOI 10.1056/NEJMoa1107477; Ko YJ, 2012, CANCER EPIDEM BIOMAR, V21, P2076, DOI 10.1158/1055-9965.EPI-12-0611; Lamb GWA, 2012, BRIT J CANCER, V106, P279, DOI 10.1038/bjc.2011.556; Lee S, 2011, J EPIDEMIOL, V21, P161, DOI 10.2188/jea.JE20100128; Maestripieri D, 2011, DEV PSYCHOPATHOL, V23, P1187, DOI 10.1017/S0954579411000551; Marsik C, 2008, CLIN CHEM, V54, P343, DOI 10.1373/clinchem.2007.091959; McMillan DC, 2013, BRIT J CANCER, V109, P529, DOI 10.1038/bjc.2013.418; McMillan DC, 2013, CANCER TREAT REV, V39, P534, DOI 10.1016/j.ctrv.2012.08.003; Phillips AC, 2011, QJM-INT J MED, V104, P319, DOI 10.1093/qjmed/hcq199; Pietila KO, 1996, EUR HEART J, V17, P1345; Proctor MJ, 2010, BRIT J CANCER, V103, P870, DOI 10.1038/sj.bjc.6605855; Proctor MJ, 2013, CANCER-AM CANCER SOC, V119, P2325, DOI 10.1002/cncr.28018; Proctor MJ, 2011, EUR J CANCER, V47, P2633, DOI 10.1016/j.ejca.2011.03.028; Ridker PM, 2008, CLIN CHEM, V54, P234, DOI 10.1373/clinchem.2007.099465; Ridker PM, 2003, CIRCULATION, V108, pE81, DOI 10.1161/01.CIR.0000093381.57779.67; Roxburgh CSD, 2014, BRIT J CANCER, V110, P1409, DOI 10.1038/bjc.2014.90; Sokunbi D O, 1994, Adv Perit Dial, V10, P77; Van Hemelrijck M, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-895; Zacho J, 2010, EUR HEART J, V31, P1624, DOI 10.1093/eurheartj/ehq103; Zamani P, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.112.003103	32	85	89	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2015	10	3							e0116206	10.1371/journal.pone.0116206	http://dx.doi.org/10.1371/journal.pone.0116206			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9JF	25730322	Green Submitted, Green Published, gold, Green Accepted			2022-12-27	WOS:000350684900009
J	Woods, DL; Arbogast, T; Doss, Z; Younus, M; Herron, TJ; Yund, EW				Woods, David L.; Arbogast, Tanya; Doss, Zoe; Younus, Masood; Herron, Timothy J.; Yund, E. William			Aided and Unaided Speech Perception by Older Hearing Impaired Listeners	PLOS ONE			English	Article							CONSONANT RECOGNITION; MULTICHANNEL COMPRESSION; COGNITIVE-FACTORS; NOISE; IDENTIFICATION; BENEFIT; AMPLIFICATION; PERFORMANCE; ADULTS; QUIET	The most common complaint of older hearing impaired (OHI) listeners is difficulty understanding speech in the presence of noise. However, tests of consonant-identification and sentence reception threshold (SeRT) provide different perspectives on the magnitude of impairment. Here we quantified speech perception difficulties in 24 OHI listeners in unaided and aided conditions by analyzing (1) consonant-identification thresholds and consonant confusions for 20 onset and 20 coda consonants in consonant-vowel-consonant (CVC) syllables presented at consonant-specific signal-to-noise (SNR) levels, and (2) SeRTs obtained with the Quick Speech in Noise Test (QSIN) and the Hearing in Noise Test (HINT). Compared to older normal hearing (ONH) listeners, nearly all unaided OHI listeners showed abnormal consonant-identification thresholds, abnormal consonant confusions, and reduced psychometric function slopes. Average elevations in consonant-identification thresholds exceeded 35 dB, correlated strongly with impairments in mid-frequency hearing, and were greater for hard-to-identify consonants. Advanced digital hearing aids (HAs) improved average consonant-identification thresholds by more than 17 dB, with significant HA benefit seen in 83% of OHI listeners. HAs partially normalized consonant-identification thresholds, reduced abnormal consonant confusions, and increased the slope of psychometric functions. Unaided OHI listeners showed much smaller elevations in SeRTs (mean 6.9 dB) than in consonant-identification thresholds and SeRTs in unaided listening conditions correlated strongly (r = 0.91) with identification thresholds of easily identified consonants. HAs produced minimal SeRT benefit (2.0 dB), with only 38% of OHI listeners showing significant improvement. HA benefit on SeRTs was accurately predicted (r = 0.86) by HA benefit on easily identified consonants. Consonant-identification tests can accurately predict sentence processing deficits and HA benefit in OHI listeners.	[Woods, David L.; Arbogast, Tanya; Doss, Zoe; Younus, Masood; Herron, Timothy J.; Yund, E. William] VANCHCS, Human Cognit Neurophysiol Lab, Martinez, CA 95553 USA; [Woods, David L.] Univ Calif Davis, Dept Neurol, Sacramento, CA 95817 USA; [Woods, David L.] Univ Calif Davis, Ctr Neurosci, Davis, CA 95616 USA; [Woods, David L.] Univ Calif Davis, Ctr Mind & Brain, Davis, CA 95616 USA	University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis	Woods, DL (corresponding author), VANCHCS, Human Cognit Neurophysiol Lab, 150 Muir Rd, Martinez, CA 95553 USA.	dlwoods@ucdavis.edu		Yund, E./0000-0002-6833-0052; Woods, David/0000-0002-8804-3587; Herron, Timothy/0000-0002-4297-014X	VA Research Service grant [1I01CX000583]; Veterans Affairs [I01CX001000] Funding Source: NIH RePORTER	VA Research Service grant; Veterans Affairs(US Department of Veterans Affairs)	This research was supported by VA Research Service grant 1I01CX000583 to DLW. The content is solely the responsibility of the authors and does not necessarily represent the official views of the agencies. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlstrom JB, 2014, EAR HEARING, V35, P72, DOI 10.1097/AUD.0b013e3182a02274; Ahlstrom JB, 2009, EAR HEARING, V30, P203, DOI 10.1097/AUD.0b013e31819769c1; Benichov J, 2012, EAR HEARING, V33, P262, DOI 10.1097/AUD.0b013e31822f680f; Bernstein JGW, 2006, J ACOUST SOC AM, V120, P3929, DOI 10.1121/1.2372452; BILGER RC, 1984, J SPEECH HEAR RES, V27, P32, DOI 10.1044/jshr.2701.32; BILGER RC, 1976, J SPEECH HEAR RES, V19, P718, DOI 10.1044/jshr.1904.718; Bonatti LL, 2005, PSYCHOL SCI, V16, P451, DOI 10.1111/j.0956-7976.2005.01556.x; Boothroyd A, 2008, EAR HEARING, V29, P479, DOI 10.1097/AUD.0b013e318174f067; Bosman AJ, 1995, AUDIOLOGY, V34, P260; COX RM, 1991, J SPEECH HEAR RES, V34, P904, DOI 10.1044/jshr.3404.904; Dawes P, 2014, EAR HEARING, V35, P203, DOI 10.1097/AUD.0b013e3182a8eda4; DIRKS DD, 1969, J SPEECH HEAR RES, V12, P650, DOI 10.1044/jshr.1203.650; DRESCHLER WA, 1986, AUDIOLOGY, V25, P19; DRESCHLER WA, 1989, AUDIOLOGY, V28, P49; DUBNO JR, 1989, J ACOUST SOC AM, V85, P347, DOI 10.1121/1.397686; DUBNO JR, 1982, J SPEECH HEAR RES, V25, P141, DOI 10.1044/jshr.2501.141; Feng YM, 2010, EAR HEARING, V31, P115, DOI 10.1097/AUD.0b013e3181bb69be; Flynn MC, 1998, J SPEECH LANG HEAR R, V41, P285, DOI 10.1044/jslhr.4102.285; Fogerty D, 2012, J ACOUST SOC AM, V132, P1667, DOI 10.1121/1.4739463; GIVENS G D, 1981, Journal of Auditory Research, V21, P279; Gordon-Salant S, 2010, J ACOUST SOC AM, V128, P3152, DOI 10.1121/1.3495940; GORDONSALANT S, 1987, EAR HEARING, V8, P270, DOI 10.1097/00003446-198710000-00003; GORDONSALANT S, 1984, J SPEECH HEAR RES, V27, P483, DOI 10.1044/jshr.2704.483; GREENHOUSE SW, 1959, PSYCHOMETRIKA, V24, P95, DOI 10.1007/BF02289823; Hafter ER, 2010, J AM ACAD AUDIOL, V21, P594, DOI 10.3766/jaaa.21.9.5; Hedrick MS, 2003, J SPEECH LANG HEAR R, V46, P636, DOI 10.1044/1092-4388(2003/050); Hillock-Dunn A, 2014, EAR HEAR; Hopkins K, 2014, INT J AUDIOL, V53, P219, DOI 10.3109/14992027.2013.873956; Humes LE, 2007, J AM ACAD AUDIOL, V18, P590, DOI 10.3766/jaaa.18.7.6; Humes LE, 2010, HEARING RES, V264, P30, DOI 10.1016/j.heares.2009.09.010; Humes LE, 2009, SCAND J PSYCHOL, V50, P485, DOI 10.1111/j.1467-9450.2009.00740.x; Killion MC, 2004, J ACOUST SOC AM, V116, P2395, DOI 10.1121/1.1784440; Kochkin S., 2010, HEAR J, V63, P19, DOI [10.1097/01.HJ.0000366912.40173.76, DOI 10.1097/01.HJ.0000366912.40173.76]; Kochkin S, 2010, THE HEARING JOURNAL, V63, P30, DOI DOI 10.1097/1001.HJ.0000366912.0000340173.0000366976; Kuk F, 2010, EAR HEARING, V31, P779, DOI 10.1097/AUD.0b013e3181e97bfb; Kuk F, 2009, J AM ACAD AUDIOL, V20, P465, DOI 10.3766/jaaa.20.8.2; Li FP, 2012, J ACOUST SOC AM, V132, P2663, DOI 10.1121/1.4747008; Lunner T, 2003, INT J AUDIOL, V42, pS49; Mackersie Carol L, 2004, J Am Acad Audiol, V15, P498, DOI 10.3766/jaaa.15.7.4; McArdle RA, 2012, J AM ACAD AUDIOL, V23, P171, DOI 10.3766/jaaa.23.3.4; Mendel Lisa Lucks, 2007, Am J Audiol, V16, P118, DOI 10.1044/1059-0889(2007/016); Munro KJ, 2003, J ACOUST SOC AM, V114, P484, DOI 10.1121/1.1577556; NILSSON M, 1994, J ACOUST SOC AM, V95, P1085, DOI 10.1121/1.408469; OCHS MT, 1989, J SPEECH HEAR RES, V32, P133, DOI 10.1044/jshr.3201.133; ORCHIK DJ, 1980, J SPEECH HEAR DISORD, V45, P401, DOI 10.1044/jshd.4503.401; OWENS E, 1977, J SPEECH HEAR RES, V20, P463, DOI 10.1044/jshr.2003.463; OWENS E, 1968, J SPEECH HEAR RES, V11, P648, DOI 10.1044/jshr.1103.648; OWENS E, 1978, J SPEECH HEAR DISORD, V43, P331, DOI 10.1044/jshd.4303.331; Phatak SA, 2009, J ACOUST SOC AM, V126, P2683, DOI 10.1121/1.3238257; PICHORAFULLER MK, 1995, J ACOUST SOC AM, V97, P593, DOI 10.1121/1.412282; Piquado T, 2012, INT J AUDIOL, V51, P576, DOI 10.3109/14992027.2012.684403; PLOMP R, 1978, J ACOUST SOC AM, V63, P533, DOI 10.1121/1.381753; Plyler Patrick N, 2002, J Am Acad Audiol, V13, P154; Ricketts TA, 2005, EAR HEARING, V26, P473, DOI 10.1097/01.aud.0000179691.21547.01; Rudner M, 2011, J AM ACAD AUDIOL, V22, P156, DOI 10.3766/jaaa.22.3.4; Sammeth C A, 1996, J Am Acad Audiol, V7, P240; Saripella R, 2011, J ACOUST SOC AM, V130, P3028, DOI 10.1121/1.3641407; Saunders GH, 2006, EAR HEARING, V27, P229, DOI 10.1097/01.aud.0000215976.64444.e6; Saunders GH, 1997, EAR HEARING, V18, P129, DOI 10.1097/00003446-199704000-00005; Schafer AJ, 2000, J PSYCHOLINGUIST RES, V29, P169, DOI 10.1023/A:1005192911512; SCHWARTZ DM, 1979, AUDIOLOGY, V18, P157; SHER AE, 1974, J SPEECH HEAR RES, V17, P669, DOI 10.1044/jshr.1704.669; SILMAN S, 1993, J REHABIL RES DEV, V30, P326; Stewart R, 2009, J AM ACAD AUDIOL, V20, P147, DOI 10.3766/jaaa.20.2.7; Strelcyk O, 2013, J ACOUST SOC AM, V133, P1598, DOI 10.1121/1.4789894; Tun PA, 2009, PSYCHOL AGING, V24, P761, DOI 10.1037/a0014802; Valente M, 2008, INT J AUDIOL, V47, P329, DOI 10.1080/14992020801894832; VANROOIJ JCGM, 1990, J ACOUST SOC AM, V88, P2611, DOI 10.1121/1.399981; Walden BE, 2001, EAR HEARING, V22, P333, DOI 10.1097/00003446-200108000-00007; WANG MD, 1978, J SPEECH HEAR RES, V21, P5, DOI 10.1044/jshr.2101.05; Whittaker J., 1990, GRAPHICAL MODELS APP; Wilson RH, 2007, J SPEECH LANG HEAR R, V50, P844, DOI 10.1044/1092-4388(2007/059); Woods DL, 2012, J REHABIL RES DEV, V49, P1277, DOI 10.1682/JRRD.2011.08.0150; Woods DL, 2010, J REHABIL RES DEV, V47, P243, DOI 10.1682/JRRD.2009.04.0040; Woods DL, 2010, J ACOUST SOC AM, V127, P1609, DOI 10.1121/1.3293005; Yoon YS, 2012, J SPEECH LANG HEAR R, V55, P460, DOI 10.1044/1092-4388(2011/10-0239); Yund EW, 2006, J REHABIL RES DEV, V43, P517, DOI 10.1682/JRRD.2005.06.0099; YUND EW, 1995, J ACOUST SOC AM, V97, P1224, DOI 10.1121/1.412232; YUND EW, 1995, J ACOUST SOC AM, V97, P1206, DOI 10.1121/1.413093; ZENG FG, 1990, J SPEECH HEAR RES, V33, P440, DOI 10.1044/jshr.3303.440	80	14	15	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2015	10	3							e0114922	10.1371/journal.pone.0114922	http://dx.doi.org/10.1371/journal.pone.0114922			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9JF	25730423	Green Published, gold, Green Submitted			2022-12-27	WOS:000350684900003
J	Zmienko, A; Samelak-Czajka, A; Goralski, M; Sobieszczuk-Nowicka, E; Kozlowski, P; Figlerowicz, M				Zmienko, Agnieszka; Samelak-Czajka, Anna; Goralski, Michal; Sobieszczuk-Nowicka, Ewa; Kozlowski, Piotr; Figlerowicz, Marek			Selection of Reference Genes for qPCR- and ddPCR-Based Analyses of Gene Expression in Senescing Barley Leaves	PLOS ONE			English	Article							REAL-TIME PCR; LEAF SENESCENCE; DIGITAL PCR; HOUSEKEEPING GENES; NORMALIZATION; IDENTIFICATION; RNA; QUANTIFICATION; INAPPROPRIATE; QUANTITATION	Leaf senescence is a tightly regulated developmental or stress-induced process. It is accompanied by dramatic changes in cell metabolism and structure, eventually leading to the disintegration of chloroplasts, the breakdown of leaf proteins, internucleosomal fragmentation of nuclear DNA and ultimately cell death. In light of the global and intense reorganization of the senescing leaf transcriptome, measuring time-course gene expression patterns in this model is challenging due to the evident problems associated with selecting stable reference genes. We have used oligonucleotide microarray data to identify 181 genes with stable expression in the course of dark-induced senescence of barley leaf. From those genes, we selected 5 candidates and confirmed their invariant expression by both reverse transcription quantitative PCR and droplet digital PCR (ddPCR). We used the selected reference genes to normalize the level of the expression of the following senescence-responsive genes in ddPCR assays: SAG12, ICL, AGXT, CS and RbcS. We were thereby able to achieve a substantial reduction in the data variability. Although the use of reference genes is not considered mandatory in ddPCR assays, our results show that it is advisable in special cases, specifically those that involve the following conditions: i) a low number of repeats, ii) the detection of low-fold changes in gene expression or iii) series data comparisons (such as time-course experiments) in which large sample variation greatly affects the overall gene expression profile and biological interpretation of the data.	[Zmienko, Agnieszka; Goralski, Michal; Kozlowski, Piotr; Figlerowicz, Marek] Polish Acad Sci, Inst Bioorgan Chem, Mol & Syst Biol Dept, Poznan, Poland; [Zmienko, Agnieszka; Samelak-Czajka, Anna; Figlerowicz, Marek] Poznan Univ Tech, Inst Comp Sci, Fac Comp, Poznan, Poland; [Sobieszczuk-Nowicka, Ewa] Adam Mickiewicz Univ, Dept Plant Physiol, Fac Biol, Poznan, Poland	Polish Academy of Sciences; Institute of Bioorganic Chemistry of the Polish Academy of Sciences; Poznan University of Technology; Adam Mickiewicz University	Figlerowicz, M (corresponding author), Polish Acad Sci, Inst Bioorgan Chem, Mol & Syst Biol Dept, Poznan, Poland.	marekf@ibch.poznan.pl	Żmieńko, Agnieszka/L-1667-2014; Kozlowski, Piotr/I-1860-2019	Żmieńko, Agnieszka/0000-0002-9128-7996; Kozlowski, Piotr/0000-0003-3770-7715; Figlerowicz, Marek/0000-0002-6392-0192; Samelak-Czajka, Anna/0000-0002-0167-8265; Sobieszczuk-Nowicka, Ewa/0000-0002-6603-0582	National Science Centre, Poland [2012/05/B/ST6/03026, N N303 418236]; KNOW program of the Polish Ministry of Science and Higher Education	National Science Centre, Poland(National Science Centre, Poland); KNOW program of the Polish Ministry of Science and Higher Education	AZ and ESN were supported by the National Science Centre, Poland (http://www.ncn.gov.pl/) grants: 2012/05/B/ST6/03026 (AZ) and N N303 418236 (ESN). Publication costs were covered by KNOW program of the Polish Ministry of Science and Higher Education. The access to QX200 instrument was kindly provided by BioRad Polska. The funders and the instrument provider had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker M, 2012, NAT METHODS, V9, P541, DOI 10.1038/nmeth.2027; Barrett T, 2011, NUCLEIC ACIDS RES, V39, pD1005, DOI 10.1093/nar/gkq1184; Beliakova-Bethell N, 2014, ANTIVIR RES, V107, P42, DOI 10.1016/j.antiviral.2014.04.005; Belzil VV, 2013, ACTA NEUROPATHOL, V126, P895, DOI 10.1007/s00401-013-1199-1; Breeze E, 2011, PLANT CELL, V23, P873, DOI 10.1105/tpc.111.083345; Buchanan-Wollaston V, 2003, PLANT BIOTECHNOL J, V1, P3, DOI 10.1046/j.1467-7652.2003.00004.x; Bustin SA, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-74; Chan PL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099774; Christiansen MW, 2014, J EXP BOT, V65, P4009, DOI 10.1093/jxb/eru046; Coito Joao L, 2012, BMC Res Notes, V5, P220, DOI 10.1186/1756-0500-5-220; Czechowski T, 2005, PLANT PHYSIOL, V139, P5, DOI 10.1104/pp.105.063743; Day E, 2013, METHODS, V59, P101, DOI 10.1016/j.ymeth.2012.08.001; Dheda K, 2004, BIOTECHNIQUES, V37, P112, DOI 10.2144/04371RR03; Dheda K, 2005, ANAL BIOCHEM, V344, P141, DOI 10.1016/j.ab.2005.05.022; Dodd DW, 2013, NUCLEIC ACID THER, V23, P188, DOI 10.1089/nat.2013.0427; Engqvist MKM, 2011, J BIOL CHEM, V286, P11382, DOI 10.1074/jbc.M110.194175; Evans T, 2012, PLANT GROWTH REGUL, V66, P95, DOI 10.1007/s10725-011-9627-5; Fernandez P, 2011, PLANT CELL REP, V30, P63, DOI 10.1007/s00299-010-0944-3; Fukao T, 2012, PLANT PHYSIOL, V160, P1795, DOI 10.1104/pp.112.207738; Gregersen PL, 2008, PLANT BIOLOGY, V10, P37, DOI 10.1111/j.1438-8677.2008.00114.x; Heredia NJ, 2013, METHODS, V59, pS20, DOI 10.1016/j.ymeth.2012.09.012; Hindson CM, 2013, NAT METHODS, V10, P1003, DOI 10.1038/nmeth.2633; Hruz T, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-156; Huggett J, 2005, GENES IMMUN, V6, P279, DOI 10.1038/sj.gene.6364190; Huggett JF, 2013, CLIN CHEM, V59, P1691, DOI 10.1373/clinchem.2013.214742; Iyer CC, 2014, NEUROMUSCULAR DISORD, V24, P436, DOI 10.1016/j.nmd.2014.02.007; Jackowski G, 1996, Z NATURFORSCH C, V51, P464; Kim JI, 2011, J EXP BOT, V62, P3981, DOI 10.1093/jxb/err094; Kulik A, 2012, PLANT PHYSIOL, V160, P868, DOI 10.1104/pp.112.194472; LEGOCKA J, 1981, Z PFLANZENPHYSIOL, V102, P363, DOI 10.1016/S0044-328X(81)80208-5; Li N, 2014, J CANCER RES CLIN, V140, P145, DOI 10.1007/s00432-013-1555-5; McDermott GP, 2013, ANAL CHEM, V85, P11619, DOI 10.1021/ac403061n; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Sobieszczuk-Nowicka E, 2009, ACTA BIOCHIM POL, V56, P255; Thomas H, 2003, J EXP BOT, V54, P1127, DOI 10.1093/jxb/erg133; Tricarico C, 2002, ANAL BIOCHEM, V309, P293, DOI 10.1016/S0003-2697(02)00311-1; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vogelstein B, 1999, P NATL ACAD SCI USA, V96, P9236, DOI 10.1073/pnas.96.16.9236; von Saint Paul V, 2011, PLANT CELL, V23, P4124, DOI 10.1105/tpc.111.088443; Yang SD, 2011, PLANT CELL, V23, P2155, DOI 10.1105/tpc.111.084913; Zelisko A, 2004, J PLANT PHYSIOL, V161, P1157, DOI 10.1016/j.jplph.2004.01.006; Zhao DJ, 2012, FEBS OPEN BIO, V2, P235, DOI 10.1016/j.fob.2012.08.001	42	35	39	0	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2015	10	2							e0118226	10.1371/journal.pone.0118226	http://dx.doi.org/10.1371/journal.pone.0118226			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC3LS	25723393	Green Submitted, Green Published, gold			2022-12-27	WOS:000350251200051
J	Sokolnikov, M; Preston, D; Gilbert, E; Schonfeld, S; Koshurnikova, N				Sokolnikov, Mikhail; Preston, Dale; Gilbert, Ethel; Schonfeld, Sara; Koshurnikova, Nina			Radiation Effects on Mortality from Solid Cancers Other than Lung, Liver, and Bone Cancer in the Mayak Worker Cohort: 1948-2008	PLOS ONE			English	Article							ATOMIC-BOMB SURVIVORS; PLUTONIUM EXCRETION; NUCLEAR-COMPLEX; EXPOSURE; MODEL; RISK; DOSIMETRY; DISEASES; URINE; PA	Radiation effects on mortality from solid cancers other than lung, liver, and bone cancer in the Mayak worker cohort: 1948-2008. The cohort of Mayak Production Association (PA) workers in Russia offers a unique opportunity to study the effects of prolonged low dose rate external gamma exposures and exposure to plutonium in a working age population. We examined radiation effects on the risk of mortality from solid cancers excluding sites of primary plutonium deposition (lung, liver, and bone surface) among 25,757 workers who were first employed in 1948-1982. During the period 1948-2008, there were 1,825 deaths from cancers other than lung, liver and bone. Using colon dose as a representative external dose, a linear dose response model described the data well. The excess relative risk per Gray for external gamma exposure was 0.16 (95% CI: 0.07 - 0.26) when unadjusted for plutonium exposure and 0.12 (95% CI 0.03 - 0.21) when adjusted for plutonium dose and monitoring status. There was no significant effect modification by sex or attained age. Plutonium exposure was not significantly associated with the group of cancers analyzed after adjusting for monitoring status. Site-specific risks were uncertainly estimated but positive for 13 of the 15 sites evaluated with a statistically significant estimate only for esophageal cancer. Comparison with estimates based on the acute exposures in atomic bomb survivors suggests that the excess relative risk per Gray for prolonged external exposure in Mayak workers may be lower than that for acute exposure but, given the uncertainties, the possibility of equal effects cannot be dismissed.	[Sokolnikov, Mikhail; Koshurnikova, Nina] Southern Urals Biophys Inst, Lab Epidemiol, Ozyorsk, Russia; [Preston, Dale] Hirosoft Int, Eureka, CA USA; [Gilbert, Ethel; Schonfeld, Sara] NCI, Radiat Epidemiol Branch, Div Canc Epidemiol & Genet, Bethesda, MD 20892 USA; [Schonfeld, Sara] Int Agcy Res Canc, Sect Environm & Radiat, F-69372 Lyon, France	Southern Urals Biophysics Institute; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); World Health Organization; International Agency for Research on Cancer (IARC)	Sokolnikov, M (corresponding author), Southern Urals Biophys Inst, Lab Epidemiol, Ozyorsk, Russia.	sokolnikov@subi.su		Koshurnikova, Nina/0000-0002-1907-8858; Sokolnikov, Mikhail/0000-0001-9492-4316	US Department of Energy Joint Coordinating Committee for Radiation Effects Research [DE-HS0000091]; US National Cancer Institute [HHSN261200900090C]; Russian Federal Government; NATIONAL CANCER INSTITUTE [ZIACP010133] Funding Source: NIH RePORTER	US Department of Energy Joint Coordinating Committee for Radiation Effects Research; US National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Russian Federal Government; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The study was funded by the following sources: US Department of Energy Joint Coordinating Committee for Radiation Effects Research contract DE-HS0000091, US National Cancer Institute contract No HHSN261200900090C, and Russian Federal Government contract "Radiation Epidemiology." The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2007, ANN ICRP, V37, P1, DOI [10.1016/j.icrp.2007.10.003, DOI 10.1016/J.ICRP.2007.10.003]; [Anonymous], 1977, 9 REV C 1975 AD 29 W; Azizova TV, 2013, RADIAT RES, V180, P610, DOI 10.1667/RR13228.1; Azizova TV, 2010, RADIAT RES, V174, P851, DOI 10.1667/RR1928.1; Azizova TV, 2010, RADIAT RES, V174, P155, DOI 10.1667/RR1789.1; Bess JD, 2007, HEALTH PHYS, V93, P207, DOI 10.1097/01.HP.0000266741.42070.e8; Cardis E, 2007, RADIAT RES, V167, P396, DOI 10.1667/RR0553.1; Cardis E, 2005, BMJ-BRIT MED J, V331, P77, DOI 10.1136/bmj.38499.599861.E0; Cox DR, 1974, THEORETICAL STAT; Gilbert ES, 2013, RADIAT RES, V179, P332, DOI 10.1667/RR3054.1; Gilbert ES, 2004, RADIAT RES, V162, P505, DOI 10.1667/RR3259; Gilbert ES, 2000, RADIAT RES, V154, P246, DOI 10.1667/0033-7587(2000)154[0246:LCIMW]2.0.CO;2; Hunter N, 2013, BRIT J CANCER, V109, P1989, DOI 10.1038/bjc.2013.543; Khokhryakov VF, 2004, HEALTH PHYS, V86, P523, DOI 10.1097/00004032-200405000-00009; KHOKHRYAKOV VF, 1994, RADIAT PROT DOSIM, V53, P235; Khokhryakov VF, 2002, HEALTH PHYS, V82, P425, DOI 10.1097/00004032-200204000-00001; Khokhryakov VF, 1995, HLTH EFFECTS INTERNA, P117; Khokhryakov VV, 2013, HEALTH PHYS, V104, P366, DOI 10.1097/HP.0b013e31827dbf60; Koshurnikova NA, 1999, RADIAT RES, V152, P352, DOI 10.2307/3580220; Labutina EV, 2013, HEALTH PHYS, V105, P165, DOI 10.1097/HP.0b013e31828f57df; Leggett RW, 2005, RADIAT RES, V164, P111, DOI 10.1667/RR3371; Muirhead CR, 2009, BRIT J CANCER, V100, P206, DOI 10.1038/sj.bjc.6604825; National Research Council, 2006, HLTH RISKS EXP LOW L, P141; Ozasa K, 2012, RADIAT RES, V177, P229, DOI 10.1667/RR2629.1; Preston DL, 2007, RADIAT RES, V168, P1, DOI 10.1667/RR0763.1; Preston DL, 2010, RADIAT RES, V174, P816, DOI 10.1667/RR2024.1; PRESTON D. L., 1993, EPICURE USERS GUIDE; Preston DL, 2003, RADIAT RES, V160, P381, DOI 10.1667/RR3049; Romanov SA, 2007, RADIAT PROT DOSIM, V127, P486, DOI 10.1093/rpd/ncm415; Schonfeld SJ, 2013, RADIAT RES, V179, P183, DOI 10.1667/RR2932.1; Shilnikova NS, 2003, RADIAT RES, V159, P787, DOI 10.1667/0033-7587(2003)159[0787:CMRAWA]2.0.CO;2; Sokolnikov ME, 2008, INT J CANCER, V123, P905, DOI 10.1002/ijc.23581; Vasilenko EK, 2007, HEALTH PHYS, V93, P190, DOI 10.1097/01.HP.0000266071.43137.0e; Zablotska LB, 2014, BRIT J CANCER, V110, P214, DOI 10.1038/bjc.2013.592	34	52	65	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2015	10	2							e0117784	10.1371/journal.pone.0117784	http://dx.doi.org/10.1371/journal.pone.0117784			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC2ZH	25719381	Green Published, Green Submitted, gold			2022-12-27	WOS:000350213200032
J	Souza, GV; Simas, AS; Bastos-Pereira, AL; Frois, GRA; Ribas, JLC; Verdan, MH; Kassuya, CAL; Stefanello, ME; Zampronio, AR				Souza, Georgea V.; Simas, Alex S.; Bastos-Pereira, Amanda L.; Frois, Gisele R. A.; Ribas, Joao L. C.; Verdan, Maria H.; Kassuya, Candida A. L.; Stefanello, Maria E.; Zampronio, Aleksander R.			Antinociceptive Activity of the Ethanolic Extract, Fractions, and Aggregatin D Isolated from Sinningia aggregata Tubers	PLOS ONE			English	Article							PROTEIN-KINASE-C; NITRIC-OXIDE; INFLAMMATORY HYPERNOCICEPTION; MECHANICAL HYPERALGESIA; COLORIMETRIC ASSAY; DIRECT ANTAGONISM; BRADYKININ; CYTOKINES; ALPHA; SENSITIZATION	The present study investigated the effects of the ethanolic extract (ESa), fractions, and compounds isolated from Sinningia aggregata in male Swiss mice on carrageenan-induced paw edema, neutrophil migration, mechanical hyperalgesia, formalin-induced nociception, and lipopolysaccharide-induced fever. The ESa did not alter edema, neutrophil migration, or fever at any of the doses tested. However, the ESa reduced phase II of formalin-induced nociception and carrageenan-induced mechanical hyperalgesia. The petroleum ether (PE) and ethyl acetate (EA) fractions and aggregatin D (AgD; isolated from the EA fraction) reduced formalin-induced nociception. Anthraquinones from the PE fraction were ineffective. AgD also inhibited carrageenan-induced mechanical hyperalgesia. Neither the ESa nor AgD altered thermal nociception or motor performance. Local administration of AgD also reduced hyperalgesia induced by carrageenan, bradykinin, tumor necrosis factor-alpha, interleukin-1 beta, cytokine-induced neutrophil chemoattractant, prostaglandin E-2, and dopamine but not hyperalgesia induced by forskolin or dibutyryl cyclic adenosine monophosphate. The positive control dipyrone reduced the response induced by all of the stimuli. Additionally, glibenclamide abolished the analgesic effect of dipyrone but not the one induced by AgD. AgD did not change lipopolysaccharide-induced nitric oxide production by macrophages or the nociception induced by capsaicin, cinnamaldehyde, acidified saline, or menthol. These results suggest that the ESa has important antinociceptive activity, and this activity results at least partially from the presence of AgD. AgD reduced mechanical hyperalgesia induced by several inflammatory mediators through mechanisms that are different from classic analgesic drugs.	[Souza, Georgea V.; Simas, Alex S.; Bastos-Pereira, Amanda L.; Frois, Gisele R. A.; Ribas, Joao L. C.; Kassuya, Candida A. L.; Zampronio, Aleksander R.] Univ Fed Parana, Dept Pharmacol, Ctr Politecn, BR-81531980 Curitiba, Parana, Brazil; [Verdan, Maria H.; Stefanello, Maria E.] Univ Fed Parana, Dept Chem, Ctr Politecn, BR-81530900 Curitiba, Parana, Brazil	Universidade Federal do Parana; Universidade Federal do Parana	Zampronio, AR (corresponding author), Univ Fed Parana, Dept Pharmacol, Ctr Politecn, POB 19031, BR-81531980 Curitiba, Parana, Brazil.	aleksander@ufpr.br	Zampronio, Aleksander R/B-3915-2013; Kassuya, Candida A. L./G-8329-2011; VERDAN, MARIA H/E-2013-2016; Bastos-Pereira, Amanda/AAQ-1375-2020	VERDAN, MARIA H/0000-0002-2460-0372; Bastos-Pereira, Amanda/0000-0001-9416-1208; Kassuya, Candida/0000-0002-8998-9219; Ribas, Joao/0000-0003-0545-5920; Zampronio, Aleksander/0000-0002-8354-7081	Araucaria Foundation of the State of Parana, Brazil [413/09-15118]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, CNPq, Brazil	Araucaria Foundation of the State of Parana, Brazil; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, CNPq, Brazil(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	Araucaria Foundation of the State of Parana, Brazil # 413/09-15118 and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, CNPq, Brazil for the scholarships for GVS, ASS, ALBP, and JLCR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn KY, 2005, BIOCHEM BIOPH RES CO, V336, P93, DOI 10.1016/j.bbrc.2005.08.059; al-Swayeh OA, 2000, BRIT J PHARMACOL, V130, P1453, DOI 10.1038/sj.bjp.0703509; Alves DP, 2002, EUR J PHARMACOL, V444, P47, DOI 10.1016/S0014-2999(02)01412-7; Amir Mohammad, 2007, Acta Pharmaceutica (Zagreb), V57, P31, DOI 10.2478/v10007-007-0003-y; Andrade EL, 2008, NEUROSCIENCE, V152, P511, DOI 10.1016/j.neuroscience.2007.12.039; Aoganghua A, 2011, INT J MOL MED, V28, P937, DOI 10.3892/ijmm.2011.773; Baggio CH, 2012, INT J BIOL MACROMOL, V50, P872, DOI 10.1016/j.ijbiomac.2011.10.023; Barber LA, 1996, J NEUROCHEM, V67, P72; Barbosa FL, 2013, BASIC CLIN PHARM TOX; CHAPLAN SR, 1994, J NEUROSCI METH, V53, P55, DOI 10.1016/0165-0270(94)90144-9; Chautems A, 2010, CANDOLLEA, V65, P241, DOI 10.15553/c2010v652a6; CODERRE TJ, 1984, PAIN, V18, P13, DOI 10.1016/0304-3959(84)90122-2; COELHO MM, 1992, AM J PHYSIOL, V263, pR423, DOI 10.1152/ajpregu.1992.263.2.R423; CUNHA FQ, 1992, BRIT J PHARMACOL, V107, P660, DOI 10.1111/j.1476-5381.1992.tb14503.x; Cunha TM, 2007, EUR J PHARMACOL, V573, P221, DOI 10.1016/j.ejphar.2007.07.007; Cunha TM, 2004, BRAZ J MED BIOL RES, V37, P401, DOI 10.1590/S0100-879X2004000300018; Cunha TM, 2005, P NATL ACAD SCI USA, V102, P1755, DOI 10.1073/pnas.0409225102; de Souza GEP, 2002, INFLAMM RES, V51, P24, DOI 10.1007/PL00000278; Decarie A, 1996, PEPTIDES, V17, P1009; Denadai-Souza A, 2009, EUR J PAIN, V13, P812, DOI 10.1016/j.ejpain.2008.09.012; DEYOUNG LM, 1989, AGENTS ACTIONS, V26, P335; Dina OA, 2005, PAIN, V115, P191, DOI 10.1016/j.pain.2005.02.028; DIXON WJ, 1980, ANNU REV PHARMACOL, V20, P441, DOI 10.1146/annurev.pa.20.040180.002301; DRAY A, 1988, NEUROSCI LETT, V91, P301, DOI 10.1016/0304-3940(88)90697-0; DUARTE IDG, 1988, BRAZ J MED BIOL RES, V21, P341; DUARTE IDG, 1992, EUR J PHARMACOL, V217, P225, DOI 10.1016/0014-2999(92)90881-4; Ferreira S H, 1993, Drugs, V46 Suppl 1, P1; FERREIRA SH, 1972, NATURE-NEW BIOL, V240, P200, DOI 10.1038/newbio240200a0; Ferreira SH, 1997, BRIT J PHARMACOL, V121, P883, DOI 10.1038/sj.bjp.0701211; Fine PG, 2009, PAIN MED, V10, pS79, DOI 10.1111/j.1526-4637.2009.00666.x; Gao Y, 2011, BRAIN RES BULL, V84, P406, DOI 10.1016/j.brainresbull.2011.01.017; GASIC GP, 1992, ANNU REV PHYSIOL, V54, P507, DOI 10.1146/annurev.physiol.54.1.507; GILLIGAN JP, 1994, INFLAMMATION, V18, P285, DOI 10.1007/BF01534269; Fusaro MCGD, 2010, EUR J PHARMACOL, V649, P177, DOI 10.1016/j.ejphar.2010.09.037; GREEN LC, 1982, ANAL BIOCHEM, V126, P131, DOI 10.1016/0003-2697(82)90118-X; GUTOWSKI S, 1991, J BIOL CHEM, V266, P20519; HUNSKAAR S, 1987, PAIN, V30, P103, DOI 10.1016/0304-3959(87)90088-1; Julius D, 2001, NATURE, V413, P203, DOI 10.1038/35093019; Kanashiro A, 2009, AM J PHYSIOL-REG I, V296, pR1631, DOI 10.1152/ajpregu.90527.2008; Khasar SG, 1998, EUR J NEUROSCI, V10, P435, DOI 10.1046/j.1460-9568.1998.00030.x; Kassuya CAL, 2009, J ETHNOPHARMACOL, V124, P369, DOI 10.1016/j.jep.2009.06.003; Levine JD, 2007, BBA-MOL BASIS DIS, V1772, P989, DOI 10.1016/j.bbadis.2007.01.008; LORENZETTI BB, 1985, EUR J PHARMACOL, V114, P375, DOI 10.1016/0014-2999(85)90383-8; Lu Y, 2011, BIOCHEM PHARMACOL, V82, P1700, DOI 10.1016/j.bcp.2011.08.022; Luo P, 2010, J PHARMACOL EXP THER, V335, P735, DOI 10.1124/jpet.110.170852; Mazzon E, 2008, CLIN EXP IMMUNOL, V153, P136, DOI 10.1111/j.1365-2249.2008.03669.x; MEMO M, 1986, J NEURAL TRANSM, P19; Missale C, 1998, PHYSIOL REV, V78, P189, DOI 10.1152/physrev.1998.78.1.189; Moretao MP, 2004, IMMUNOL LETT, V93, P189, DOI 10.1016/j.imlet.2004.03.021; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Narumiya S, 2009, J MOL MED, V87, P1015, DOI 10.1007/s00109-009-0500-1; Otuki MF, 2005, J PHARMACOL EXP THER, V313, P310, DOI 10.1124/jpet.104.071779; PERRETTI M, 1994, PHARMACOL RES, V30, P53, DOI 10.1016/1043-6618(94)80087-1; Petho G, 2012, PHYSIOL REV, V92, P1699, DOI 10.1152/physrev.00048.2010; Quintao NLM, 2005, ANESTH ANALG, V101, P1763, DOI 10.1213/01.ane.0000184182.03203.61; Riva D, 2012, QUIM NOVA, V35, P974, DOI 10.1590/S0100-40422012000500020; Rudaya AY, 2005, AM J PHYSIOL-REG I, V289, pR1244, DOI 10.1152/ajpregu.00370.2005; Song SH, 2009, INT IMMUNOPHARMACOL, V9, P298, DOI 10.1016/j.intimp.2008.12.003; Southall MD, 2001, J BIOL CHEM, V276, P16083, DOI 10.1074/jbc.M011408200; Stefanello M.E.A., 2005, Rev. bras. farmacogn., V15, P331, DOI 10.1590/S0102-695X2005000400013; Swinny EE, 2000, MAGN RESON CHEM, V38, P1031, DOI 10.1002/1097-458X(200012)38:12<1031::AID-MRC780>3.0.CO;2-3; TADA H, 1986, J IMMUNOL METHODS, V93, P157, DOI 10.1016/0022-1759(86)90183-3; TAIWO YO, 1988, BRAIN RES, V458, P402, DOI 10.1016/0006-8993(88)90487-8; THOMAS G, 1980, PROSTAGLANDINS, V19, P39, DOI 10.1016/0090-6980(80)90152-5; Verdan MH, 2010, J NAT PROD, V73, P1434, DOI 10.1021/np1002466; Verdan MH, 2009, BIOCHEM SYST ECOL, V37, P40, DOI 10.1016/j.bse.2008.11.009; Verri WA, 2006, PHARMACOL THERAPEUT, V112, P116, DOI 10.1016/j.pharmthera.2006.04.001; Villarreal CF, 2013, PHARMACOL BIOCHEM BE, V103, P678, DOI 10.1016/j.pbb.2012.11.006; Villasenor IM, 2002, PHYTOTHER RES, V16, P417, DOI 10.1002/ptr.910; Vranken Jan H., 2009, Central Nervous System Agents in Medicinal Chemistry, V9, P71; WERNER U, 1992, AGENTS ACTIONS, pC101; Zakrzewska JM, 2010, EXPERT OPIN PHARMACO, V11, P1239, DOI 10.1517/14656561003767449	72	12	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2015	10	2							e0117501	10.1371/journal.pone.0117501	http://dx.doi.org/10.1371/journal.pone.0117501			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC2ZH	25719394	Green Published, gold, Green Submitted			2022-12-27	WOS:000350213200026
J	Yu, M; Zhou, QB; Zhou, Y; Fu, ZQ; Tan, LP; Ye, X; Zeng, B; Gao, WC; Zhou, JJ; Liu, YM; Li, ZH; Lin, Y; Lin, Q; Chen, RF				Yu, Min; Zhou, Quanbo; Zhou, Yu; Fu, Zhiqiang; Tan, Langping; Ye, Xiao; Zeng, Bing; Gao, Wenchao; Zhou, Jiajia; Liu, Yimin; Li, Zhihua; Lin, Ye; Lin, Qing; Chen, Rufu			Metabolic Phenotypes in Pancreatic Cancer	PLOS ONE			English	Article							TUMOR MICROENVIRONMENT; GLUTAMINE; MITOCHONDRIAL; FIBROBLASTS; GLYCOLYSIS; BIOLOGY; CELLS	Introduction The aim of present study was to profile the glucose-dependent and glutamine-dependent metabolism in pancreatic cancer. Methods We performed Immunohistochemical staining of GLUT1, CAIX, BNIP3, p62, LC3, GLUD1, and GOT1. Based on the expression of metabolism-related proteins, the metabolic phenotypes of tumors were classified into two categories, including glucose-and glutamine-dependent metabolism. There were Warburg type, reverse Warburg type, mixed type, and null type in glucose-dependent metabolism, and canonical type, non-canonical type, mixed type, null type in glutamine-dependent metabolism. Results Longer overall survival was associated with high expression of BNIP3 in tumor (p = 0.010). Shorter overall survival was associated with high expression of GLUT1 in tumor (P = 0.002) and GOT1 in tumor (p = 0.030). Warburg type of glucose-dependent metabolism had a highest percentage of tumors with nerve infiltration (P = 0.0003), UICC stage (P = 0.0004), and activated autophagic status in tumor (P = 0.0167). Mixed type of glucose-dependent metabolism comprised the highest percentage of tumors with positive marginal status (P < 0.0001), lymphatic invasion (P < 0.0001), and activated autophagic status in stroma (P = 0.0002). Mixed type and Warburg type had a significant association with shorter overall survival (P = 0.018). Non-canonical type and mixed type of glutamine-dependent metabolism comprised the highest percentage of tumors with vascular invasion (p = 0.0073), highest percentage of activated autophagy in tumors (P = 0.0034). Moreover, these two types of glutamine-dependent metabolism were significantly associated with shorter overall survival (P < 0.001). Further analysis suggested that most of tumors were dependent on both glucose- and glutamine-dependent metabolism. After dividing the tumors according to the number of metabolism, we found that the increasing numbers of metabolism subtypes inversely associated with survival outcome. Conclusion Warburg type, non-canonical type and mixed types of glucose-and glutamine-dependent metabolism comprised of more metabolically active, biologically aggressive and poor prognostic tumors. Moreover, the increasing subtypes and categories of the metabolism in each tumor significantly associated with poor prognosis.	[Yu, Min; Zhou, Quanbo; Zhou, Yu; Fu, Zhiqiang; Tan, Langping; Ye, Xiao; Zeng, Bing; Gao, Wenchao; Lin, Qing; Chen, Rufu] Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Dept Hepatobiliary Surg, Guangzhou 510275, Guangdong, Peoples R China; [Yu, Min; Lin, Ye] Guangdong Acad Med Sci, Guangdong Gen Hosp, Dept Gen Surg, Guangzhou, Guangdong, Peoples R China; [Li, Zhihua] Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Dept Med Oncol, Guangzhou 510275, Guangdong, Peoples R China; [Zhou, Jiajia] Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Dept Gen Surg, Guangzhou 510275, Guangdong, Peoples R China; [Liu, Yimin] Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Dept Radiotherapy, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University; Guangdong Academy of Medical Sciences & Guangdong General Hospital; Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University	Lin, Q (corresponding author), Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Dept Hepatobiliary Surg, Guangzhou 510275, Guangdong, Peoples R China.	yuminzhongda@163.com; 409597678@qq.com			National Natural Scientific Foundation of China [81000917, 81370059]	National Natural Scientific Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Natural Scientific Foundation of China (no. 81000917 and no. 81370059). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blum R, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.38; Bristow N, 2011, BBA-MOL BASIS DIS, V1812, P302, DOI 10.1016/j.bbadis.2010.11.013; Cai SW, 2011, SURGERY, V149, P576, DOI 10.1016/j.surg.2010.10.009; Choi J, 2013, BREAST CANCER RES, V15, DOI 10.1186/bcr3472; Clausen TH, 2010, AUTOPHAGY, V6, P330, DOI 10.4161/auto.6.3.11226; Dang CV, 2012, GENE DEV, V26, P877, DOI 10.1101/gad.189365.112; Frezza C, 2009, SEMIN CANCER BIOL, V19, P4, DOI 10.1016/j.semcancer.2008.11.008; Galluzzi L, 2013, NAT REV DRUG DISCOV, V12, P829, DOI 10.1038/nrd4145; Ghaneh P, 2007, GUT, V56, P1134, DOI 10.1136/gut.2006.103333; Guillaumond F, 2013, P NATL ACAD SCI USA, V110, P3919, DOI 10.1073/pnas.1219555110; Hamada S, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00331; Hamanaka RB, 2012, J EXP MED, V209, P211, DOI 10.1084/jem.20120162; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hart I, 2011, CELL CYCLE, V10, P2829, DOI 10.4161/cc.10.17.16572; Hensley CT, 2013, J CLIN INVEST, V123, P3678, DOI 10.1172/JCI69600; Hidalgo M, 2012, ANN ONCOL, V23, P135, DOI 10.1093/annonc/mds313; Kim JY, 2002, ARCH BIOCHEM BIOPHYS, V398, P147, DOI 10.1006/abbi.2001.2673; Kim S, 2013, TUMOR BIOL, V34, P1699, DOI 10.1007/s13277-013-0707-1; Knaevelsrud H, 2010, FEBS LETT, V584, P2635, DOI 10.1016/j.febslet.2010.04.041; Lyssiotis CA, 2013, CELL CYCLE, V12, P1987, DOI 10.4161/cc.25307; Martinez-Outschoorn UE, 2011, CELL CYCLE, V10, P2504, DOI 10.4161/cc.10.15.16585; Pannala R, 2009, LANCET ONCOL, V10, P88, DOI 10.1016/S1470-2045(08)70337-1; Pavlides S, 2009, CELL CYCLE, V8, P3984, DOI 10.4161/cc.8.23.10238; Salem AF, 2012, CELL CYCLE, V11, P2545, DOI 10.4161/cc.20920; Son J, 2013, NATURE, V496, P101, DOI 10.1038/nature12040; Vander Heiden MG, 2013, J CLIN INVEST, V123, P3648, DOI 10.1172/JCI72391; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Ward PS, 2012, CANCER CELL, V21, P297, DOI 10.1016/j.ccr.2012.02.014; Winter JM, 2006, J GASTROINTEST SURG, V10, P1199, DOI 10.1016/j.gassur.2006.08.018; Zheng J, 2012, ONCOL LETT, V4, P1151, DOI 10.3892/ol.2012.928; Zhou WD, 2012, J PROTEOME RES, V11, P554, DOI 10.1021/pr2009274; Zu XL, 2004, BIOCHEM BIOPH RES CO, V313, P459, DOI 10.1016/j.bbrc.2003.11.136	32	56	60	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2015	10	2							e0115153	10.1371/journal.pone.0115153	http://dx.doi.org/10.1371/journal.pone.0115153			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC2ZH	25719198	Green Submitted, gold, Green Published			2022-12-27	WOS:000350213200003
J	Banai, K; Amitay, S				Banai, Karen; Amitay, Sygal			The Effects of Stimulus Variability on the Perceptual Learning of Speech and Non-Speech Stimuli	PLOS ONE			English	Article							TEMPORAL-INTERVAL DISCRIMINATION; TRAINING JAPANESE LISTENERS; TALKER VARIABILITY; UNCERTAINTY	Previous studies suggest fundamental differences between the perceptual learning of speech and non-speech stimuli. One major difference is in the way variability in the training set affects learning and its generalization to untrained stimuli: training-set variability appears to facilitate speech learning, while slowing or altogether extinguishing non-speech auditory learning. We asked whether the reason for this apparent difference is a consequence of the very different methodologies used in speech and non-speech studies. We hypothesized that speech and non-speech training would result in a similar pattern of learning if they were trained using the same training regimen. We used a 2 (random vs. blocked pre-and posttesting) x 2 (random vs. blocked training) x 2 (speech vs. non-speech discrimination task) study design, yielding 8 training groups. A further 2 groups acted as untrained controls, tested with either random or blocked stimuli. The speech task required syllable discrimination along 4 minimal-pair continua (e.g., bee-dee), and the non-speech stimuli required duration discrimination around 4 base durations (e.g., 50 ms). Training and testing required listeners to pick the odd-one-out of three stimuli, two of which were the base duration or phoneme continuum endpoint and the third varied adaptively. Training was administered in 9 sessions of 640 trials each, spread over 4-8 weeks. Significant learning was only observed following speech training, with similar learning rates and full generalization regardless of whether training used random or blocked schedules. No learning was observed for duration discrimination with either training regimen. We therefore conclude that the two stimulus classes respond differently to the same training regimen. A reasonable interpretation of the findings is that speech is perceived categorically, enabling learning in either paradigm, while the different base durations are not well-enough differentiated to allow for categorization, resulting in disruption to learning.	[Banai, Karen] Univ Haifa, Dept Commun Sci & Disorders, IL-31999 Haifa, Israel; [Amitay, Sygal] MRC, Inst Hearing Res, Nottingham, England	University of Haifa	Banai, K (corresponding author), Univ Haifa, Dept Commun Sci & Disorders, IL-31999 Haifa, Israel.	kbanai@research.haifa.ac.il; Sygal.Amitay@ihr.mrc.ac.uk	Banai, Karen/J-1448-2019	Banai, Karen/0000-0002-2990-0470; Amitay, Sygal/0000-0001-9482-3435	National Institute for Psychobiology in Israel; Medical Research Council (UK) - Institute of Hearing Research [U135097130]; Marie Curie International Reintegration Grant [224763]; Medical Research Council [MC_U135097130] Funding Source: researchfish; MRC [MC_U135097130] Funding Source: UKRI	National Institute for Psychobiology in Israel; Medical Research Council (UK) - Institute of Hearing Research(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Marie Curie International Reintegration Grant(European Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This study was funded by The National Institute for Psychobiology in Israel - Founded by The Charles E. Smith Family, Medical Research Council (UK) - Institute of Hearing Research core funding (Grant U135097130 to SA), and a Marie Curie International Reintegration Grant (224763 to KB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahissar M, 1996, VISION RES, V36, P3487, DOI 10.1016/0042-6989(96)00036-3; Ahissar M, 2009, PHILOS T R SOC B, V364, P285, DOI 10.1098/rstb.2008.0253; Amitay S, 2005, PERCEPT PSYCHOPHYS, V67, P691, DOI 10.3758/BF03193525; Amitay S, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00508; Banai K, 2010, NEUROSCIENCE, V165, P436, DOI 10.1016/j.neuroscience.2009.10.060; Banai K, 2012, VISION RES, V61, P83, DOI 10.1016/j.visres.2012.01.009; Banai K, 2012, HEARING RES, V284, P59, DOI 10.1016/j.heares.2011.12.002; Bradlow AR, 2008, COGNITION, V106, P707, DOI 10.1016/j.cognition.2007.04.005; Bradlow AR, 1997, J ACOUST SOC AM, V101, P2299, DOI 10.1121/1.418276; Clarke AM, 2014, VISION RES, V99, P88, DOI 10.1016/j.visres.2013.12.010; Clopper CG, 2004, LANG SPEECH, V47, P207, DOI 10.1177/00238309040470030101; Dayan P, 2003, IETE J RES, V49, P171, DOI 10.1080/03772063.2003.11416335; Demany L, 2002, J ACOUST SOC AM, V111, P1377, DOI 10.1121/1.1445791; Garrigan P, 2008, P NATL ACAD SCI USA, V105, P2248, DOI 10.1073/pnas.0711878105; Herzog MH, 2012, VISION RES, V61, P95, DOI 10.1016/j.visres.2011.11.001; Holt LL, 2008, CURR DIR PSYCHOL SCI, V17, P42, DOI 10.1111/j.1467-8721.2008.00545.x; Holt LL, 2010, ATTEN PERCEPT PSYCHO, V72, P1218, DOI 10.3758/APP.72.5.1218; Karmarkar UR, 2003, LEARN MEMORY, V10, P141, DOI 10.1101/lm.55503; KARNI A, 1991, P NATL ACAD SCI USA, V88, P4966, DOI 10.1073/pnas.88.11.4966; Laing EJC, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00203; Lapid E, 2009, PSYCHON B REV, V16, P382, DOI 10.3758/PBR.16.2.382; LEEK MR, 1984, J ACOUST SOC AM, V76, P1037, DOI 10.1121/1.391422; Liu R, 2011, J COGNITIVE NEUROSCI, V23, P683, DOI 10.1162/jocn.2009.21392; LIVELY SE, 1993, J ACOUST SOC AM, V94, P1242, DOI 10.1121/1.408177; MACMILLAN NA, 1977, PSYCHOL REV, V84, P452, DOI 10.1037/0033-295X.84.5.452; Molloy K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036929; Moore DR, 2005, BRAIN LANG, V94, P72, DOI 10.1016/j.bandl.2004.11.009; Nahum M, 2010, VISION RES, V50, P391, DOI 10.1016/j.visres.2009.09.004; Nahum M, 2010, J NEUROSCI, V30, P1128, DOI 10.1523/JNEUROSCI.1781-09.2010; Samuel AG, 2009, ATTEN PERCEPT PSYCHO, V71, P1207, DOI 10.3758/APP.71.6.1207; Song JH, 2012, CEREB CORTEX, V22, P1180, DOI 10.1093/cercor/bhr196; Tartaglia EM, 2009, VISION RES, V49, P1420, DOI 10.1016/j.visres.2009.02.013; WATSON CS, 1980, ANN OTO RHINOL LARYN, V89, P96; Wright BA, 1997, J NEUROSCI, V17, P3956; Wright BA, 2007, EXP BRAIN RES, V180, P727, DOI 10.1007/s00221-007-0898-z; Wright BA, 2009, PHILOS T R SOC B, V364, P301, DOI 10.1098/rstb.2008.0262	36	5	5	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2015	10	2							e0118465	10.1371/journal.pone.0118465	http://dx.doi.org/10.1371/journal.pone.0118465			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CC2IM	25714552	Green Published, gold, Green Submitted			2022-12-27	WOS:000350168700075
J	Hagedorn, M; Farrell, A; Carter, V; Zuchowicz, N; Johnston, E; Padilla-Gamino, J; Gunasekera, S; Paul, V				Hagedorn, Mary; Farrell, Ann; Carter, Virginia; Zuchowicz, Nikolas; Johnston, Erika; Padilla-Gamino, Jacqueline; Gunasekera, Sarath; Paul, Valerie			Effects of Toxic Compounds in Montipora capitata on Exogenous and Endogenous Zooxanthellae Performance and Fertilization Success	PLOS ONE			English	Article							CORAL GONIOPORA-TENUIDENS; CYTOTOXIC DIACETYLENES; SCLERACTINIAN CORALS; CHEMICAL DEFENSES; HAWAIIAN CORALS; CLIMATE-CHANGE; REEF CRISIS; EGGS; SETTLEMENT; DIGITATA	Studies have identified chemicals within the stony coral genus Montipora that have significant biological activities. For example, Montiporic acids A and B and other compounds have been isolated fromthe adult tissue and eggs of Montipora spp. and have displayed antimicrobial activity and cytotoxicity in cultured cells. The ecological role of these toxic compounds is currently unclear. This study examines the role these toxins play in reproduction. Toxins were found in the eggs and larvae of the coral Montipora capitata. Releasing these toxins by crushing both the eggs and larvae resulted in irreversible inhibition of photosynthesis in endogenous and exogenous zooxanthellae within minutes. Moreover, these toxins were stable, as frozen storage of eggs and larvae did not affect toxicity. Photosynthetic competency of Porites compressa zooxanthellae treated with either frozen or fresh, crushed eggs was inhibited similarly (P > 0.05, ANCOVA). Addition of toxic eggs plugs to live P. compressa fragments caused complete tissue necrosis under the exposed area on the fragments within 1 week. Small volumes of M. capitata crushed eggs added to sperm suspensions reduced in vitro fertilization success by killing the sperm. After 30 min, untreated sperm maintained 90 +/- 1.9% SEM motility while those treated with crushed eggs were rendered immotile, 4 +/- 1.4% SEM. Flow cytometry indicated membrane disruption of the immotile sperm. Fertilization success using untreated sperm was 79 +/- 4% SEM, whereas the success rate dropped significantly after exposure to the crushed eggs, 1.3 +/- 0% SEM. Unlike the eggs and the larvae, M. capitata sperm did not reduce the photosynthetic competency of P. compressa zooxanthellae, suggesting the sperm was nontoxic. The identity of the toxins, cellular mechanism of action, advantage of the toxins for M. capitata and their role on the reef are still unknown.	[Hagedorn, Mary; Farrell, Ann; Carter, Virginia; Zuchowicz, Nikolas] Smithsonian Inst, Natl Zool Pk, Smithsonian Conservat Biol Inst, Dept Reprod Sci, Washington, DC 20008 USA; [Hagedorn, Mary; Farrell, Ann; Carter, Virginia; Zuchowicz, Nikolas; Johnston, Erika; Padilla-Gamino, Jacqueline] Univ Hawaii, Hawaii Inst Marine Biol, Kaneohe, HI USA; [Gunasekera, Sarath; Paul, Valerie] Smithsonian Marine Stn, Ft Pierce, FL USA	Smithsonian Institution; Smithsonian National Zoological Park & Conservation Biology Institute; University of Hawaii System; Smithsonian Institution; Smithsonian National Museum of Natural History	Hagedorn, M (corresponding author), Smithsonian Inst, Natl Zool Pk, Smithsonian Conservat Biol Inst, Dept Reprod Sci, Washington, DC 20008 USA.	hagedornm@si.edu		Zuchowicz, Nikolas/0000-0002-3577-0190; Johnston, Erika/0000-0003-0520-9324	Roddenberry Foundation; Anela Kolohe Foundation; Hawaii Community Foundation; Taronga Conservation Society Australia	Roddenberry Foundation; Anela Kolohe Foundation; Hawaii Community Foundation; Taronga Conservation Society Australia	These experiments were funded through grants from the Roddenberry Foundation (http://roddenberryfoundation.org/), the Anela Kolohe Foundation, Hawaii Community Foundation (www.hawaiicommunityfoundation.org) and the Taronga Conservation Society Australia (http://taronga.org.au/conservation). No individuals were employed or contracted by the funders (other than the named authors), played any role in: study design, data collection and analysis, decision to publish, or preparation of the manuscript. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alam N, 2002, CHEM PHARM BULL, V50, P661, DOI 10.1248/cpb.50.661; Alam N, 2001, J NAT PROD, V64, P1059, DOI 10.1021/np010148b; Alam N, 2001, J NAT PROD, V64, P956, DOI 10.1021/np0100892; BABCOCK RC, 1986, CORAL REEFS, V5, P111, DOI 10.1007/BF00298178; Bae BH, 2000, J NAT PROD, V63, P1511, DOI 10.1021/np0002076; Bellwood DR, 2004, NATURE, V429, P827, DOI 10.1038/nature02691; Blainville H. M., 1830, ZOOPHYTES; COLL JC, 1994, MAR BIOL, V118, P177, DOI 10.1007/BF00349783; COX EF, 1994, B MAR SCI, V54, P535; COX EF, 1986, J EXP MAR BIOL ECOL, V101, P161, DOI 10.1016/0022-0981(86)90047-X; Fearon RJ, 1996, TOXICON, V34, P361, DOI 10.1016/0041-0101(95)00137-9; Fusetani N, 1996, J NAT PROD, V59, P796, DOI 10.1021/np9604036; Glynn PW, 1996, GLOBAL CHANGE BIOL, V2, P495, DOI 10.1111/j.1365-2486.1996.tb00063.x; GLYNN PW, 1990, CORAL REEFS, V8, P181, DOI 10.1007/BF00265009; Gochfeld DJ, 2008, MAR ECOL PROG SER, V362, P119, DOI 10.3354/meps07418; Goreau T, 2000, CONSERV BIOL, V14, P5, DOI 10.1046/j.1523-1739.2000.00011.x; GUNTHORPE L, 1990, TOXICON, V28, P1347, DOI 10.1016/0041-0101(90)90099-S; Hagedorn M, 2010, CRYOBIOLOGY, V60, P147, DOI 10.1016/j.cryobiol.2009.10.005; Hagedorn M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033354; Hoegh-Guldberg O, 1999, MAR FRESHWATER RES, V50, P839, DOI 10.1071/MF99078; Hoeksema B.W., 2014, WORLD REGISTER MARIN; Hughes TP, 2003, SCIENCE, V301, P929, DOI 10.1126/science.1085046; Jung V, 2001, TETRAHEDRON, V57, P7169, DOI 10.1016/S0040-4020(01)00692-5; Kelman D, 2006, MAR BIOL, V149, P357, DOI 10.1007/s00227-005-0218-8; Kolinski SP, 2004, SEXUAL REPROD EARLY; Kolinski Steven P., 2003, Pacific Science, V57, P17, DOI 10.1353/psc.2003.0005; MAIDA M, 1995, MAR ECOL PROG SER, V121, P191, DOI 10.3354/meps121191; Marquis CP, 2005, CORAL REEFS, V24, P248, DOI 10.1007/s00338-005-0473-7; Padilla-Gamino JL, 2011, CORAL REEFS, V30, P371, DOI 10.1007/s00338-010-0700-8; Padilla-Gamino JL, 2012, MAR ECOL PROG SER, V449, P145, DOI 10.3354/meps09530; Paul VJ, 2008, NAT PROD REP, V25, P662, DOI 10.1039/b702742g; Paul VJ, 2011, NAT PROD REP, V28, P345, DOI 10.1039/c0np00040j; PAUL VJ, 1992, J EXP MAR BIOL ECOL, V160, P191, DOI 10.1016/0022-0981(92)90237-5; Pawlik JR, 2007, LIMNOL OCEANOGR, V52, P907, DOI 10.4319/lo.2007.52.2.0907; Rasher DB, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.2615; Thoms C, 2008, J CHEM ECOL, V34, P1242, DOI 10.1007/s10886-008-9518-z; Veron JEN, 2009, MAR POLLUT BULL, V58, P1428, DOI 10.1016/j.marpolbul.2009.09.009	37	11	11	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2015	10	2							e0118364	10.1371/journal.pone.0118364	http://dx.doi.org/10.1371/journal.pone.0118364			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC2IM	25714606	Green Published, gold, Green Submitted			2022-12-27	WOS:000350168700067
J	Lemasson, A; Remeuf, K; Trabalon, M; Cuir, F; Hausberger, M				Lemasson, Alban; Remeuf, Kevin; Trabalon, Marie; Cuir, Frederique; Hausberger, Martine			Mares Prefer the Voices of Highly Fertile Stallions	PLOS ONE			English	Article							INDIVIDUAL ACOUSTIC DISTINCTIVENESS; SPERM QUALITY; REPRODUCTIVE SUCCESS; INDICATE LARGER; MENSTRUAL-CYCLE; MATE-CHOICE; HEART-RATE; PERCEPTION; SIZE; FREQUENCIES	We investigated the possibility that stallion whinnies, known to encode caller size, also encoded information about caller arousal and fertility, and the reactions of mares in relation to type of voice. Voice acoustic features are correlated with arousal and reproduction success, the lower-pitched the stallion's voice, the slower his heart beat and the higher his fertility. Females from three study groups preferred playbacks of low-pitched voices. Hence, females are attracted by frequencies encoding for large male size, calmness and high fertility. More work is needed to explore the relative importance of morpho-physiological features. Assortative mating may be involved as large females preferred voices of larger stallions. Our study contributes to basic and applied ongoing research on mammal reproduction, and questions the mechanisms used by females to detect males' fertility.	[Lemasson, Alban; Remeuf, Kevin; Trabalon, Marie] Univ Rennes 1, Lab Ethol Anim & Humaine, UMR CNRS 6552, Paimpont, France; [Lemasson, Alban] Inst Univ France, Paris, France; [Cuir, Frederique] Haras Pin, Le Pin Au Haras, France; [Hausberger, Martine] UMR 6552 Univ Rennes 1, Lab Ethol Anim & Humaine, CNRS, Rennes, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Rennes; Institut Universitaire de France; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB)	Lemasson, A (corresponding author), Univ Rennes 1, Lab Ethol Anim & Humaine, UMR CNRS 6552, Paimpont, France.	alban.lemasson@univ-rennes1.fr			Institut Francais du Cheval et de l'Equitation; French Ministry of Research; Centre National de la Recherche Scientifique; Institut Universitaire de France	Institut Francais du Cheval et de l'Equitation; French Ministry of Research(Ministry of Research, FranceEuropean Commission); Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); Institut Universitaire de France	This study was funded by the 'Institut Francais du Cheval et de l'Equitation', the French Ministry of Research, the 'Centre National de la Recherche Scientifique' and the 'Institut Universitaire de France'. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apicella CL, 2007, BIOL LETTERS, V3, P682, DOI 10.1098/rsbl.2007.0410; Apicella CL, 2009, P ROY SOC B-BIOL SCI, V276, P1077, DOI 10.1098/rspb.2008.1542; Asa C, 2007, ANIM CONSERV, V10, P326, DOI 10.1111/j.1469-1795.2007.00116.x; ASA CS, 1986, VET CLIN N AM-EQUINE, V2, P519, DOI 10.1016/S0749-0739(17)30704-6; Atkinson J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041811; Beerda B, 1998, APPL ANIM BEHAV SCI, V58, P365, DOI 10.1016/S0168-1591(97)00145-7; Bonde JPE, 1998, LANCET, V352, P1172, DOI 10.1016/S0140-6736(97)10514-1; BOYD LE, 1991, APPL ANIM BEHAV SCI, V29, P301, DOI 10.1016/0168-1591(91)90256-W; Bruckert L, 2006, P ROY SOC B-BIOL SCI, V273, P83, DOI 10.1098/rspb.2005.3265; Burger D, 2010, ANIM REPROD SCI, V121, P63, DOI [10.1016/j.anireprosci.2010.04.183, DOI 10.1016/J.ANIREPROSCI.2010.04.183]; Burger D, 2012, J EQUINE VET SCI, V32, P455, DOI 10.1016/j.jevs.2012.05.076; BURLEY N, 1983, ETHOL SOCIOBIOL, V4, P191, DOI 10.1016/0162-3095(83)90009-2; Charlton BD, 2007, ANIM BEHAV, V74, P707, DOI 10.1016/j.anbehav.2006.09.021; Charlton BD, 2012, ANIM BEHAV, V84, P1565, DOI 10.1016/j.anbehav.2012.09.034; Charlton BD, 2012, BEHAV ECOL SOCIOBIOL, V66, P969, DOI 10.1007/s00265-012-1345-0; Charlton BD, 2010, ANIM BEHAV, V79, P1221, DOI 10.1016/j.anbehav.2010.02.018; Charlton BD, 2010, P R SOC B, V277, P1101, DOI 10.1098/rspb.2009.1431; Charlton BD, 2009, ANIM BEHAV, V78, P893, DOI 10.1016/j.anbehav.2009.06.029; Charrier I, 2010, ANIM COGN, V13, P471, DOI 10.1007/s10071-009-0298-9; Craul M, 2004, PRIMATES, V45, P271, DOI 10.1007/s10329-004-0097-5; Evans S, 2008, PHYSIOL BEHAV, V93, P783, DOI 10.1016/j.physbeh.2007.11.033; Farrell ME, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018533; Feh C, 2005, DOMESTIC HORSE: THE ORIGINS, DEVELOPMENT AND MANAGEMENT OF ITS BEHAVIOUR, P83; Feinberg DR, 2006, HORM BEHAV, V49, P215, DOI 10.1016/j.yhbeh.2005.07.004; Feinberg DR, 2005, ANIM BEHAV, V69, P561, DOI 10.1016/j.anbehav.2004.06.012; Fischer J, 2004, BEHAV ECOL SOCIOBIOL, V56, P140, DOI 10.1007/s00265-003-0739-4; Fitch WT, 1997, J ACOUST SOC AM, V102, P1213, DOI 10.1121/1.421048; Fraser FF, 1992, BEHAV HORSE; Geissmann T, 2000, ANIM BEHAV, V60, P805, DOI 10.1006/anbe.2000.1540; Gomendio M, 2007, REPRODUCTION, V134, P19, DOI 10.1530/REP-07-0143; Graham JK, 1996, VET CLIN N AM-EQUINE, V12, P119; Hodges-Simeon CR, 2011, ARCH SEX BEHAV, V40, P551, DOI 10.1007/s10508-010-9625-0; Janson K, 2010, ANIM REPROD SCI, V121, pS123; Klofstad CA, 2012, P ROY SOC B-BIOL SCI, V279, P2698, DOI 10.1098/rspb.2012.0311; Kremers D, 2012, J COMP PSYCHOL, V126, P433, DOI 10.1037/a0028858; Lemasson A, 2008, BEHAV ECOL SOCIOBIOL, V62, P1027, DOI 10.1007/s00265-007-0530-z; Lemasson A, 2005, J COMP PSYCHOL, V119, P220, DOI 10.1037/0735-7036.119.2.220; Lemasson A, 2013, NATURWISSENSCHAFTEN, V100, P275, DOI 10.1007/s00114-013-1022-9; Lemasson A, 2014, J MAMMAL, V95, P128, DOI 10.1644/12-MAMM-A-313.1; Lemasson A, 2009, ANIM COGN, V12, P693, DOI 10.1007/s10071-009-0229-9; Linklater WL, 2009, ANIM BEHAV, V77, P1085, DOI 10.1016/j.anbehav.2009.01.017; Linklater WL, 2000, BIOL REV, V75, P1, DOI 10.1017/S0006323199005411; Mathevon Nicolas, 2010, BMC Ecology, V10, P9, DOI 10.1186/1472-6785-10-9; MCCALL CA, 1991, APPL ANIM BEHAV SCI, V28, P305, DOI 10.1016/0168-1591(91)90162-Q; McDermott JH, 2012, NEUROSCIENCE OF PREFERENCE AND CHOICE: COGNITIVE AND NEURAL MECHANISMS, P227, DOI 10.1016/B978-0-12-381431-9.00020-6; Pack AA, 2012, ANIM BEHAV, V84, P983, DOI 10.1016/j.anbehav.2012.07.024; Palmer E., 1984, Le cheval. Reproduction, selection, alimentation, exploitation., P113; Petrunkina AM, 2007, REPRODUCTION, V134, P3, DOI 10.1530/REP-07-0046; Pfefferle D, 2008, ANIM BEHAV, V75, P1885, DOI 10.1016/j.anbehav.2007.12.003; PICKEREL TM, 1993, APPL ANIM BEHAV SCI, V38, P1, DOI 10.1016/0168-1591(93)90037-P; Pipitone RN, 2012, ETHOLOGY, V118, P281, DOI 10.1111/j.1439-0310.2011.02010.x; Proops L, 2009, P NATL ACAD SCI USA, V106, P947, DOI 10.1073/pnas.0809127105; Puts DA, 2005, EVOL HUM BEHAV, V26, P388, DOI 10.1016/j.evolhumbehav.2005.03.001; Re DE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032719; Reby D, 2003, ANIM BEHAV, V65, P519, DOI 10.1006/anbe.2003.2078; Richard J-P, 1991, BIOACOUSTICS, V3, P45, DOI DOI 10.1080/09524622.1991.9753156; Sankey C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015446; Semple S, 2000, P ROY SOC B-BIOL SCI, V267, P707, DOI 10.1098/rspb.2000.1060; Simmons LW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029271; Taylor AM, 2010, J ZOOL, V280, P221, DOI 10.1111/j.1469-7998.2009.00661.x; Tsakmakidis IA, 2010, J VET SCI, V11, P151, DOI 10.4142/jvs.2010.11.2.151; Vannoni E, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003113; VEECKMAN J, 1978, APPL ANIM ETHOL, V4, P109; Visser EK, 2002, PHYSIOL BEHAV, V76, P289, DOI 10.1016/S0031-9384(02)00698-4; Waring G.H., 2003, HORSE BEHAV, V2; Wyman MT, 2012, ANIM BEHAV, V84, P1381, DOI 10.1016/j.anbehav.2012.08.037	66	9	9	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2015	10	2							e0118468	10.1371/journal.pone.0118468	http://dx.doi.org/10.1371/journal.pone.0118468			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC2IM	25714814	Green Published, Green Submitted, gold			2022-12-27	WOS:000350168700077
J	Liang-Chu, MMY; Yu, MM; Haverty, PM; Koeman, J; Ziegle, J; Lee, M; Bourgon, R; Neve, RM				Liang-Chu, May M. Y.; Yu, Mamie; Haverty, Peter M.; Koeman, Julie; Ziegle, Janet; Lee, Marie; Bourgon, Richard; Neve, Richard M.			Human Biosample Authentication Using the High-Throughput, Cost-Effective SNPtrace(TM) System	PLOS ONE			English	Article							HUMAN CELL-LINES; SINGLE NUCLEOTIDE POLYMORPHISMS; HUMAN IDENTIFICATION; CULTURE PRACTICE; COLON-CANCER; TASK-FORCE; MULTIPLEX; ASSAY; INSTABILITY; VALIDATION	Cell lines are the foundation for much of the fundamental research into the mechanisms underlying normal biologic processes and disease mechanisms. It is estimated that 15%-35% of human cell lines are misidentified or contaminated, resulting in a huge waste of resources and publication of false or misleading data. Here we evaluate a panel of 96 single-nucleotide polymorphism (SNP) assays utilizing Fluidigm microfluidics technology for authentication and sex determination of human cell lines. The SNPtrace Panel was tested on 907 human cell lines. Pairwise comparison of these data show the SNPtrace Panel discriminated among identical, related and unrelated pairs of samples with a high degree of confidence, equivalent to short tandem repeat (STR) profiling. We also compared annotated sex calls with those determined by the SNPtrace Panel, STR and Illumina SNP arrays, revealing a high number of male samples are identified as female due to loss of the Y chromosome. Finally we assessed the sensitivity of the SNPtrace Panel to detect intra-human cross-contamination, resulting in detection of as little as 2% contaminating cell population. In conclusion, this study has generated a database of SNP fingerprints for 907 cell lines used in biomedical research and provides a reliable, fast, and economic alternative to STR profiling which can be applied to any human cell line or tissue sample.	[Liang-Chu, May M. Y.; Yu, Mamie; Neve, Richard M.] Genentech Inc, Dept Discovery Oncol, San Francisco, CA 94080 USA; [Haverty, Peter M.; Bourgon, Richard] Genentech Inc, Dept Bioinformat & Computat Biol, San Francisco, CA 94080 USA; [Ziegle, Janet; Lee, Marie] Fluidigm Corp, San Francisco, CA 94080 USA; [Koeman, Julie] Van Andel Res Inst, Cytogenet, Grand Rapids, MI 49503 USA	Roche Holding; Genentech; Roche Holding; Genentech; Van Andel Institute	Neve, RM (corresponding author), Genentech Inc, Dept Discovery Oncol, 1 DNA Way, San Francisco, CA 94080 USA.	never@gene.com		Bourgon, Richard/0000-0002-5890-4374				[Anonymous], 2013, Nat Methods, V10, P1035, DOI 10.1038/nmeth1013-1035c; Barallon R, 2010, IN VITRO CELL DEV-AN, V46, P727, DOI 10.1007/s11626-010-9333-z; Buehring GC, 2004, IN VITRO CELL DEV-AN, V40, P211; Capes-Davis A, 2010, INT J CANCER, V127, P1, DOI 10.1002/ijc.25242; Castro F, 2013, INT J CANCER, V132, P308, DOI 10.1002/ijc.27675; Chatterjee R, 2007, SCIENCE, V315, P928, DOI 10.1126/science.315.5814.928; Coecke S, 2005, ATLA-ALTERN LAB ANIM, V33, P261, DOI 10.1177/026119290503300313; Demichelis F, 2008, NUCLEIC ACIDS RES, V36, P2446, DOI 10.1093/nar/gkn089; Dixon LA, 2005, FORENSIC SCI INT, V154, P62, DOI 10.1016/j.forsciint.2004.12.011; Drexler HG, 2003, LEUKEMIA, V17, P416, DOI 10.1038/sj.leu.2402799; Gao L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095904; Gill P, 2001, INT J LEGAL MED, V114, P204, DOI 10.1007/s004149900117; Gorringe KL, 2005, CARCINOGENESIS, V26, P923, DOI 10.1093/carcin/bgi032; Greenman CD, 2010, BIOSTATISTICS, V11, P164, DOI 10.1093/biostatistics/kxp045; Hartung T, 2002, ATLA-ALTERN LAB ANIM, V30, P407, DOI 10.1177/026119290203000404; Inagaki S, 2004, FORENSIC SCI INT, V144, P45, DOI 10.1016/j.forsciint.2004.03.005; Johansen P, 2013, FORENSIC SCI INT-GEN, V7, P482, DOI 10.1016/j.fsigen.2013.04.009; KUAN SF, 1987, CANCER RES, V47, P5715; Lacroix M, 2008, INT J CANCER, V122, P1, DOI 10.1002/ijc.23233; Lee HY, 2005, FORENSIC SCI INT, V148, P107, DOI 10.1016/j.forsciint.2004.04.073; Linger RMA, 2012, BLOOD, V120, P1533; Linger RMA, 2009, BLOOD, V114, P2678, DOI 10.1182/blood-2009-03-209247; Lins AM, 1998, J FORENSIC SCI, V43, P1168; Liu JF, 2012, GENOME RES, V22, P2315, DOI 10.1101/gr.140988.112; Lou CG, 2011, ELECTROPHORESIS, V32, P368, DOI 10.1002/elps.201000426; MacArthur D, 2010, SAMPLE SWAPS 23 ME C; Masters JR, 2001, P NATL ACAD SCI USA, V98, P8012, DOI 10.1073/pnas.121616198; Masters JR, 2002, CYTOTECHNOLOGY, V39, P69, DOI 10.1023/A:1022908930937; Miller JK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088163; Much M, 2014, HUM PATHOL, V45, P549, DOI 10.1016/j.humpath.2013.10.022; Nardone RM, 2007, CELL BIOL TOXICOL, V23, P367, DOI 10.1007/s10565-007-9019-9; Nassir R, 2009, BMC GENET, V10, DOI 10.1186/1471-2156-10-39; Pakstis AJ, 2010, HUM GENET, V127, P315, DOI 10.1007/s00439-009-0771-1; Parson W, 2005, FASEB J, V19, P434, DOI 10.1096/fj.04-3062fje; Reid Y, 2004, AUTHENTICATION HUMAN; Sanchez JJ, 2006, ELECTROPHORESIS, V27, P1713, DOI 10.1002/elps.200500671; Santos FR, 1998, NAT GENET, V18, P103, DOI 10.1038/ng0298-103; Seshagiri S, 2012, NATURE, V488, P660, DOI 10.1038/nature11282; Suter CM, 2003, BRIT J CANCER, V88, P413, DOI 10.1038/sj.bjc.6600699; TANABE H, 1999, TISSUE CULT RES COMM, V18, P329, DOI DOI 10.11418/JTCA1981.18.4_329; Thangaraj K, 2002, INT J LEGAL MED, V116, P121, DOI 10.1007/s00414-001-0262-y; TOM BH, 1976, IN VITRO CELL DEV B, V12, P180; VanBrocklin MW, 2009, PIGM CELL MELANOMA R, V22, P454, DOI 10.1111/j.1755-148X.2009.00576.x; Veerappa AM, 2013, FUNCT INTEGR GENOMIC, V13, P285, DOI 10.1007/s10142-013-0323-6; 2010, NATURE REV CANC, V10, P441, DOI DOI 10.1038/NRC2852	45	24	24	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2015	10	2							e0116218	10.1371/journal.pone.0116218	http://dx.doi.org/10.1371/journal.pone.0116218			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC2IM	25714623	Green Published, gold, Green Submitted			2022-12-27	WOS:000350168700012
J	Nord, M; Forslund, P				Nord, Maria; Forslund, Par			Environmental Gradients Explain Species Richness and Community Composition of Coastal Breeding Birds in the Baltic Sea	PLOS ONE			English	Article							BETA-DIVERSITY; BIODIVERSITY; REGRESSION; HABITAT; ALPHA; SCALE; DISSIMILARITY; ARCHIPELAGO; ASSEMBLAGES; MODELS	Scientifically-based systematic conservation planning for reserve design requires knowledge of species richness patterns and how these are related to environmental gradients. In this study, we explore a large inventory of coastal breeding birds, in total 48 species, sampled in 4646 1 km(2) squares which covered a large archipelago in the Baltic Sea on the east coast of Sweden. We analysed how species richness (alpha diversity) and community composition (beta diversity) of two groups of coastal breeding birds (specialists, i.e. obligate coastal breeders; generalists, i.e. facultative coastal breeders) were affected by distance to open sea, land area, shoreline length and archipelago width. The total number of species per square increased with increasing shoreline length, but increasing land area counteracted this effect in specialists. The number of specialist bird species per square increased with decreasing distance to open sea, while the opposite was true for the generalists. Differences in community composition between squares were associated with differences in land area and distance to open sea, both when considering all species pooled and each group separately. Fourteen species were nationally red-listed, and showed similar relationships to the environmental gradients as did all species, specialists and generalists. We suggest that availability of suitable breeding habitats, and probably also proximity to feeding areas, explain much of the observed spatial distributions of coastal birds in this study. Our findings have important implications for systematic conservation planning of coastal breeding birds. In particular, we provide information on where coastal breeding birds occur and which environments they seem to prefer. Small land areas with long shorelines are highly valuable both in general and for red-listed species. Thus, such areas should be prioritized for protection against human disturbance and used by management in reserve selection.	[Nord, Maria; Forslund, Par] Swedish Univ Agr Sci, Dept Ecol, Uppsala, Sweden	Swedish University of Agricultural Sciences	Nord, M (corresponding author), Swedish Univ Agr Sci, Dept Ecol, Uppsala, Sweden.	maria.nord@slu.se			Swedish Research Council Formas [215-2007-1353]	Swedish Research Council Formas(Swedish Research CouncilSwedish Research Council Formas)	The study was supported by a research grant to PF from the Swedish Research Council Formas (grant number 215-2007-1353, http://www.formas.se/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggemyr E, 2012, J BIOGEOGR, V39, P1645, DOI 10.1111/j.1365-2699.2012.02733.x; AHLEN I, 1970, Ornis Scandinavica, V1, P83, DOI 10.2307/3676027; Anderson MJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057918; Anderson MJ, 2011, ECOL LETT, V14, P19, DOI 10.1111/j.1461-0248.2010.01552.x; [Anonymous], 2010, R LANG ENV STAT COMP; Arponen A, 2008, J APPL ECOL, V45, P1436, DOI 10.1111/j.1365-2664.2008.01513.x; Arrhenius O, 1921, J ECOL, V9, P95, DOI 10.2307/2255763; As Stefan, 1997, Ecological Bulletins, V46, P88; Aspenberg P., 2009, METODJAMFORELSE UNDE, DOI [10.1371/journal.pone.0117162, DOI 10.1371/JOURNAL.PONE.0117162]; Bader P, 2006, HACKANDE KUSTFAGLAR, DOI [10.1371/journal.pone.0117162, DOI 10.1371/JOURNAL.PONE.0117162]; Beale CM, 2010, ECOL LETT, V13, P246, DOI 10.1111/j.1461-0248.2009.01422.x; Bolker BM, 2009, TRENDS ECOL EVOL, V24, P127, DOI 10.1016/j.tree.2008.10.008; BROWN JH, 1995, ECOLOGY, V76, P2028, DOI 10.2307/1941678; Butchart SHM, 2010, SCIENCE, V328, P1164, DOI 10.1126/science.1187512; Chase JM, 2011, ECOSPHERE, V2, DOI 10.1890/ES10-00117.1; Croxall JP, 2012, BIRD CONSERV INT, V22, P1, DOI 10.1017/S0959270912000020; Dormann CF, 2013, ECOGRAPHY, V36, P27, DOI 10.1111/j.1600-0587.2012.07348.x; Ferrier S, 2010, DIVERS DISTRIB, V16, P386, DOI 10.1111/j.1472-4642.2010.00657.x; Freestone AL, 2006, ECOLOGY, V87, P2425, DOI 10.1890/0012-9658(2006)87[2425:DLAEHS]2.0.CO;2; Gardenfors U, 2010, RODLISTADE ARTER SVE, DOI [10.1016/j.jpba.2015.01.006, DOI 10.1016/J.JPBA.2015.01.006]; Gleason HA, 1922, ECOLOGY, V3, P158, DOI 10.2307/1929150; Goslee SC, 2007, J STAT SOFTW, V22, P1, DOI 10.18637/jss.v022.i07; Heinanen S, 2009, DIVERS DISTRIB, V15, P266, DOI 10.1111/j.1472-4642.2008.00532.x; Heinanen S, 2008, ECOGRAPHY, V31, P601, DOI 10.1111/j.0906-7590.2008.05410.x; Heinanen S, 2012, LANDSCAPE ECOL, V27, P545, DOI 10.1007/s10980-012-9705-8; HILDEN OLAVL, 1965, ANN ZOOL FEN NICI, V2, P53; Kessler M, 2009, ECOL APPL, V19, P2142, DOI 10.1890/08-1074.1; Kindstrom M, 2006, 26 BALANCE; Kraft NJB, 2011, SCIENCE, V333, P1755, DOI 10.1126/science.1208584; Kukkala AS, 2013, BIOL REV, V88, P443, DOI 10.1111/brv.12008; Loreau M, 2000, OIKOS, V91, P3, DOI 10.1034/j.1600-0706.2000.910101.x; Mac Nally R, 2004, J BIOGEOGR, V31, P917, DOI 10.1111/j.1365-2699.2004.01089.x; Magurran AE, 2011, BIOL DIVERSITY; MANTEL N, 1967, CANCER RES, V27, P209; Margules CR, 2000, NATURE, V405, P243, DOI 10.1038/35012251; Nordstrom M, 2004, J ANIM ECOL, V73, P424, DOI 10.1111/j.0021-8790.2004.00816.x; Olsson L, 2000, HANDLEDNING KUSTFAGE, DOI [10.1073/pnas.1216683110, DOI 10.1073/PNAS.1216683110]; Ottvall Richard, 2009, Ornis Svecica, V19, P117; RAUP DM, 1979, J PALEONTOL, V53, P1213; Reif J, 2008, ACTA ORNITHOL, V43, P197, DOI 10.3161/000164508X395315; Ripley B., 2014, MASS SUPPORT FUNCTIO; Roberts D.W., 2010, LABDSV ORDINATION MU; Ronka M, 2008, BIOL CONSERV, V141, P402, DOI 10.1016/j.biocon.2007.10.010; Rosenstock SS, 2002, AUK, V119, P46, DOI 10.1642/0004-8038(2002)119[0046:LCTCPA]2.0.CO;2; SMOUSE PE, 1986, SYST ZOOL, V35, P627, DOI 10.2307/2413122; Sokal RR, 1995, FREEMAN, V3, P1995, DOI DOI 10.1016/J.JIP.2003.08.007; Suurkuukka H, 2012, DIVERS DISTRIB, V18, P931, DOI 10.1111/j.1472-4642.2012.00889.x; Svensson S, 1999, SVENSK FAGELATLA S31; Swedish Transport Agency, 2010, BATL 2010 UND SVENSK; Tuomisto H, 2010, ECOGRAPHY, V33, P2, DOI 10.1111/j.1600-0587.2009.05880.x; Veech JA, 2007, GLOBAL ECOL BIOGEOGR, V16, P650, DOI 10.1111/j.1466-8238.2007.00315.x; von Numers Mikael, 1995, Acta Zoologica Fennica, V197, P1; Wetlands International, 2012, WAT POP EST	53	8	8	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2015	10	2							e0118455	10.1371/journal.pone.0118455	http://dx.doi.org/10.1371/journal.pone.0118455			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC2IM	25714432	Green Accepted, gold, Green Published			2022-12-27	WOS:000350168700074
J	Richards, ZT; Garcia, RA; Wallace, CC; Rosser, NL; Muir, PR				Richards, Zoe T.; Garcia, Rodrigo A.; Wallace, Carden C.; Rosser, Natalie L.; Muir, Paul R.			A Diverse Assemblage of Reef Corals Thriving in a Dynamic Intertidal Reef Setting (Bonaparte Archipelago, Kimberley, Australia)	PLOS ONE			English	Article							GREAT-BARRIER-REEF; CLIMATE-CHANGE; TAXONOMIC CLASSIFICATION; COMMUNITY STRUCTURE; SPECIES-DIVERSITY; KO PHUKET; BIODIVERSITY; CNIDARIA; PATTERNS; MARINE	The susceptibility of reef-building corals to climatic anomalies is well documented and a cause of great concern for the future of coral reefs. Reef corals are normally considered to tolerate only a narrow range of climatic conditions with only a small number of species considered heat-tolerant. Occasionally however, corals can be seen thriving in unusually harsh reef settings and these are cause for some optimism about the future of coral reefs. Here we document for the first time a diverse assemblage of 225 species of hard corals occurring in the intertidal zone of the Bonaparte Archipelago, north western Australia. We compare the environmental conditions at our study site (tidal regime, SST and level of turbidity) with those experienced at four other more typical tropical reef locations with similar levels of diversity. Physical extremes in the Bonaparte Archipelago include tidal oscillations of up to 8 m, long subaerial exposure times (>3.5 hrs), prolonged exposure to high SST and fluctuating turbidity levels. We conclude the timing of low tide in the coolest parts of the day ameliorates the severity of subaerial exposure, and the combination of strong currents and a naturally high sediment regime helps to offset light and heat stress. The low level of anthropogenic impact and proximity to the Indo-west Pacific centre of diversity are likely to further promote resistance and resilience in this community. This assemblage provides an indication of what corals may have existed in other nearshore locations in the past prior to widespread coastal development, eutrophication, coral predator and disease outbreaks and coral bleaching events. Our results call for a re-evaluation of what conditions are optimal for coral survival, and the Bonaparte intertidal community presents an ideal model system for exploring how species resilience is conferred in the absence of confounding factors such as pollution.	[Richards, Zoe T.] Western Australian Museum, Dept Aquat Zool, Welshpool, WA 6016, Australia; [Garcia, Rodrigo A.] Curtin Univ, Dept Imaging & Appl Phys, Remote Sensing & Satellite Res Grp, Bentley, WA 6102, Australia; [Wallace, Carden C.; Muir, Paul R.] Museum Trop Queensland, Townsville, Qld 4814, Australia; [Rosser, Natalie L.] Univ Western Australia, Sch Anim Biol, Crawley, WA 6009, Australia	Western Australian Museum; Curtin University; University of Western Australia	Richards, ZT (corresponding author), Western Australian Museum, Dept Aquat Zool, Welshpool, WA 6016, Australia.	zoe.richards@museum.wa.gov.au	Rosser, Natalie/N-3392-2016	Rosser, Natalie/0000-0002-8289-3898; Garcia, Rodrigo/0000-0002-6495-3535	Woodside Energy	Woodside Energy	This project was conducted under contract to INPEX as part of environmental monitoring for the Ichthys Gas Field Development Project. ZR was supported in the write-up phase of this project by Woodside Energy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anthony KRN, 2007, LIMNOL OCEANOGR, V52, P716, DOI 10.4319/lo.2007.52.2.0716; Anthony KRN, 2004, LIMNOL OCEANOGR, V49, P2201, DOI 10.4319/lo.2004.49.6.2201; Anthony KRN, 2000, J EXP MAR BIOL ECOL, V252, P221, DOI 10.1016/S0022-0981(00)00237-9; Barshis DJ, 2013, P NATL ACAD SCI USA, V110, P1387, DOI 10.1073/pnas.1210224110; Bellwood DR, 2004, NATURE, V429, P827, DOI 10.1038/nature02691; Benzoni F, 2010, ZOOL J LINN SOC-LOND, V160, P421, DOI 10.1111/j.1096-3642.2010.00622.x; Brown BE, 2002, MAR BIOL, V141, P21, DOI 10.1007/s00227-002-0810-0; BROWN BE, 1994, MAR ECOL PROG SER, V105, P219, DOI 10.3354/meps105219; Brown BE, 2002, MAR ECOL PROG SER, V242, P119, DOI 10.3354/meps242119; Brown O.B., 1999, U MIAMI, V31, P098; Budd AF, 2012, ZOOL J LINN SOC-LOND, V166, P465, DOI 10.1111/j.1096-3642.2012.00855.x; Burke L., 2011, REEFS RISK REVISITED; Burrows MT, 2011, SCIENCE, V334, P652, DOI 10.1126/science.1210288; Cannizzaro JP, 2006, REMOTE SENS ENVIRON, V101, P13, DOI 10.1016/j.rse.2005.12.002; Carpenter KE, 2008, SCIENCE, V321, P560, DOI 10.1126/science.1159196; Castillo KD, 2012, NAT CLIM CHANGE, V2, P756, DOI [10.1038/nclimate1577, 10.1038/NCLIMATE1577]; Chevron-Australia, 2009, G1NTPLNX0000373 CHEV, P255; Clarke K., 2001, PRIMER V5 USER MANUA; Coles SL, 2013, MAR POLLUT BULL, V72, P323, DOI 10.1016/j.marpolbul.2012.09.006; D'Angelo C, 2014, CURR OPIN ENV SUST, V7, P82, DOI 10.1016/j.cosust.2013.11.029; De'ath G, 2012, P NATL ACAD SCI USA, V109, P17995, DOI 10.1073/pnas.1208909109; De'ath G, 2010, ECOL APPL, V20, P840, DOI 10.1890/08-2023.1; Deloitte Access Economics, 2013, EC CONTR GREAT BARR; DeVantier LM, 1998, ECOL APPL, V8, P480, DOI 10.2307/2641088; Devlin MJ, 2008, ESTUAR COAST SHELF S, V79, P429, DOI 10.1016/j.ecss.2008.04.024; Done TJ, 1982, CORAL REEFS, V1, P96; Dunne RP, 2001, CORAL REEFS, V20, P201; Evans RD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051668; Gilmour JP, 2013, SCIENCE, V340, P69, DOI 10.1126/science.1232310; Gittenberger A, 2011, CONTRIB ZOOL, V80, P107, DOI 10.1163/18759866-08002002; GLYNN PW, 1976, ECOL MONOGR, V46, P431, DOI 10.2307/1942565; Halpern BS, 2008, SCIENCE, V319, P948, DOI 10.1126/science.1149345; Hoegh-Guldberg O, 2008, SCIENCE, V321, P345, DOI 10.1126/science.1157897; Hoegh-Guldberg O, 1999, MAR FRESHWATER RES, V50, P839, DOI 10.1071/MF99078; Howells EJ, 2012, NAT CLIM CHANGE, V2, P116, DOI 10.1038/NCLIMATE1330; Huang DW, 2014, ZOOL J LINN SOC-LOND, V171, P277, DOI 10.1111/zoj12140; Hughes TP, 2010, TRENDS ECOL EVOL, V25, P633, DOI 10.1016/j.tree.2010.07.011; Hume B, 2013, MAR POLLUT BULL, V72, P313, DOI 10.1016/j.marpolbul.2012.11.032; HUSTON MA, 1985, ANNU REV ECOL SYST, V16, P149, DOI 10.1146/annurev.es.16.110185.001053; Jokiel PL, 2004, GLOBAL CHANGE BIOL, V10, P1627, DOI 10.1111/j.1365-2486.2004.00836.x; Karlson RH, 2004, NATURE, V429, P867, DOI 10.1038/nature02685; Knowlton N, 2010, CORAL REEF BIODIVERS, P65; Lee Z, 2001, J GEOPHYS RES-OCEANS, V106, P11639, DOI 10.1029/2000JC000554; LeTissier MDA, 1996, MAR ECOL PROG SER, V136, P235, DOI 10.3354/meps136235; LOYA Y, 1972, MAR BIOL, V13, P100, DOI 10.1007/BF00366561; Mascarelli A, 2014, NATURE, V508, P444, DOI 10.1038/508444a; McAlpine KW, 2013, BIOGEOGRAPHY AUSTR N; Mobley C.D.., 1994, LIGHT WATER RAD TRAN; Moore JAY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051807; Mueller J., 2000, SEAWIFS POSTLAUNCH 3, P24; Mumby PJ, 2001, MAR ECOL PROG SER, V222, P209, DOI 10.3354/meps222209; Palumbi SR, 2014, SCIENCE, V344, P895, DOI 10.1126/science.1251336; Reytar K, 2011, REEFS RISK REVISITED, P114; Richards Z, 2009, ASHMORE REEF NATIONA; Richards ZT, 2013, CORAL REEFS, V32, P287, DOI 10.1007/s00338-012-0963-3; Richards ZT, 2011, MAR POLLUT BULL, V62, P1693, DOI 10.1016/j.marpolbul.2011.06.003; Richards ZT, 2014, STATUS HARD CORAL CO, P1; ROGERS CS, 1990, MAR ECOL PROG SER, V62, P185, DOI 10.3354/meps062185; Ryan NM, 2014, RAFFLES B ZOOL, P399; Salih A, 2000, NATURE, V408, P850, DOI 10.1038/35048564; STAFFORDSMITH MG, 1992, AUST J MAR FRESH RES, V43, P683, DOI 10.1071/MF9920683; STEHLI FG, 1971, SYST ZOOL, V20, P115, DOI 10.2307/2412052; Sweatman H, 2011, CORAL REEFS, V30, P521, DOI 10.1007/s00338-010-0715-1; Thackway R., 1998, INTERIM MARINE COAST; Thompson AA, 2010, CORAL REEFS, V29, P637, DOI 10.1007/s00338-009-0562-0; van der Meij SET, 2010, MAR POLLUT BULL, V60, P1442, DOI 10.1016/j.marpolbul.2010.05.011; Veron J. E., 2000, CORALS WORLD, V1; Veron J.E.N., 2009, Galaxea - Tokyo, V11, P91; VERON JEN, 1995, CORALS SPACE TIME BI; Wallace CC, 2005, INDIAN J MAR SCI, V34, P42; Wallace CC, 2012, MEMOIRS QUEENSLAND M; Waterhouse J, 2012, MAR POLLUT BULL, V65, P394, DOI 10.1016/j.marpolbul.2011.09.031; Werdell PJ, 2005, REMOTE SENS ENVIRON, V98, P122, DOI 10.1016/j.rse.2005.07.001; Wilson B, 2013, BIOGEOGRAPHY OF THE AUSTRALIAN NORTH WEST SHELF: ENVIRONMENTAL CHANGE AND LIFE'S RESPONSE, P1; Wolstenholme J., 1997, P 6 INT MARINE BIOLO, P381; Wooldridge SA, 2009, MAR POLLUT BULL, V58, P745, DOI 10.1016/j.marpolbul.2008.12.013	76	52	53	1	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2015	10	2							e0117791	10.1371/journal.pone.0117791	http://dx.doi.org/10.1371/journal.pone.0117791			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC2IM	25714443	Green Published, Green Submitted, gold			2022-12-27	WOS:000350168700038
J	Wang, H; Zhang, P; Lin, CH; Yu, QX; Wu, JT; Wang, L; Cui, YP; Wang, K; Gao, ZL; Li, H				Wang, Hui; Zhang, Peng; Lin, Chunhua; Yu, Qingxia; Wu, Jitao; Wang, Lin; Cui, Yupeng; Wang, Ke; Gao, Zhenli; Li, Hong			Relevance and Therapeutic Possibility of PTEN-Long in Renal Cell Carcinoma	PLOS ONE			English	Article							TUMOR-SUPPRESSOR; PHOSPHATASE; PTEN/MMAC1; SURVIVAL; PATHWAY; ENTERS; GENE	PTEN-Long is a translational variant of PTEN (Phosphatase and Tensin Homolog). Like PTEN, PTEN-Long is able to antagonize the PI3K-Akt pathway and inhibits tumor growth. In this study, we investigated the role PTEN-Long plays in the development and progression of clear cell renal cell carcinoma (ccRCC) and explored the therapeutic possibility using proteinaceous PTEN-Long to treat ccRCC. We found that the protein levels of PTEN-Long were drastically reduced in ccRCC, which was correlated with increased levels of phosphorylated Akt (pAkt). Gain of function experiments showed overexpression of PTEN-Long in the ccRCC cell line 786-0 suppressed PI3K-Akt signaling, inhibited cell proliferation, migration and invasion, and eventually induced cell death. When purified PTEN-Long was added into cultured 786-0 cells, it entered cells, blocked Akt activation, and induced apoptosis involving Caspase 3 cleavage. Furthermore, PTEN-Long inhibited proliferation of 786-0 cells in xenograft mouse model. Our results implicated that understanding the roles of PTEN-Long in renal cell carcinogenesis has therapeutic significance.	[Wang, Hui; Zhang, Peng; Lin, Chunhua; Wu, Jitao; Wang, Lin; Cui, Yupeng; Wang, Ke; Gao, Zhenli] Qingdao Univ, Coll Med, Inst Urol, Affiliated Yantai Yuhuangding Hosp,Dept Urol, Yantai 264000, Shandong, Peoples R China; [Yu, Qingxia] Qingdao Univ, Coll Med, Affiliated Yantai Yuhuangding Hosp, Yantai 264000, Shandong, Peoples R China; [Li, Hong] LiHuiLi Hosp, Ningbo Med Ctr, Ningbo 315040, Zhejiang, Peoples R China	Qingdao University; Qingdao University	Gao, ZL (corresponding author), Qingdao Univ, Coll Med, Inst Urol, Affiliated Yantai Yuhuangding Hosp,Dept Urol, Yantai 264000, Shandong, Peoples R China.	zhenligao14@hotmail.com; lancet2010@aliyun.com	Lin, Chunhua/AAH-8712-2020	Lin, Chunhua/0000-0001-5225-3518	Science and Technology Development Program, Yantai City, Shandong Province [2011211]; Ningbo Social Development Projects [2013c51009]	Science and Technology Development Program, Yantai City, Shandong Province; Ningbo Social Development Projects	This research was supported by the following grants: Science and Technology Development Program, Yantai City, Shandong Province (2011211) (to Z.G.); Ningbo Social Development Projects (2013c51009) (to H.L.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2013, NATURE, V499, P43, DOI [10.1038/nature12222, DOI 10.1038/NATURE12222, DOI 10.1038/nature12222]; Baker SJ, 2007, CELL, V128, P25, DOI 10.1016/j.cell.2006.12.023; Brenner W, 2002, INT J CANCER, V99, P53, DOI 10.1002/ijc.10303; Cantley LC, 2002, SCIENCE, V296, P1655, DOI 10.1126/science.296.5573.1655; Cully M, 2006, NAT REV CANCER, V6, P184, DOI 10.1038/nrc1819; Di Cristofano A, 1998, NAT GENET, V19, P348, DOI 10.1038/1235; Franke TF, 1997, CELL, V88, P435, DOI 10.1016/S0092-8674(00)81883-8; Furnari FB, 1997, P NATL ACAD SCI USA, V94, P12479, DOI 10.1073/pnas.94.23.12479; Guo J, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-136; Hara S, 2005, ANN ONCOL, V16, P928, DOI 10.1093/annonc/mdi182; Hopkins BD, 2013, SCIENCE, V341, P399, DOI 10.1126/science.1234907; Leslie NR, 2004, BIOCHEM J, V382, P1, DOI 10.1042/BJ20040825; Li J, 1997, SCIENCE, V275, P1943, DOI 10.1126/science.275.5308.1943; Li J, 1998, CANCER RES, V58, P5667; Liang H, 2014, CELL METAB, V19, P836, DOI 10.1016/j.cmet.2014.03.023; Maehama T, 1998, J BIOL CHEM, V273, P13375, DOI 10.1074/jbc.273.22.13375; Pantuck AJ, 2007, CANCER-AM CANCER SOC, V109, P2257, DOI 10.1002/cncr.22677; Pantuck AJ, 2006, SEMIN ONCOL, V33, P607, DOI 10.1053/j.seminoncol.2006.06.002; Podsypanina K, 1999, P NATL ACAD SCI USA, V96, P1563, DOI 10.1073/pnas.96.4.1563; Pulido R, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005560; Sano S, 1999, EMBO J, V18, P4657, DOI 10.1093/emboj/18.17.4657; Sarkaria I, 2006, CANCER RES, V66, P9437, DOI 10.1158/0008-5472.CAN-06-2074; Stambolic V, 1998, CELL, V95, P29, DOI 10.1016/S0092-8674(00)81780-8; Steck PA, 1997, NAT GENET, V15, P356, DOI 10.1038/ng0497-356; Sun H, 1999, P NATL ACAD SCI USA, V96, P6199, DOI 10.1073/pnas.96.11.6199; Trimboli AJ, 2009, NATURE, V461, P1084, DOI 10.1038/nature08486; Wang GP, 2012, CANCER EPIDEMIOL, V36, P177, DOI 10.1016/j.canep.2011.09.006; Zaman MS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050203	28	23	23	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2015	10	2							e114250	10.1371/journal.pone.0114250	http://dx.doi.org/10.1371/journal.pone.0114250			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC2IM	25714556	gold, Green Submitted, Green Published			2022-12-27	WOS:000350168700002
J	Yun, M; Bai, HY; Zhang, JX; Rong, J; Weng, HW; Zheng, ZS; Xu, Y; Tong, ZT; Huang, XX; Liao, YJ; Mai, SJ; Ye, S; Xie, D				Yun, Miao; Bai, Hai-Yan; Zhang, Jia-Xing; Rong, Jian; Weng, Hui-Wen; Zheng, Zhou-San; Xu, Yi; Tong, Zhu-Ting; Huang, Xiao-Xia; Liao, Yi-Ji; Mai, Shi-Juan; Ye, Sheng; Xie, Dan			ULK1: A Promising Biomarker in Predicting Poor Prognosis and Therapeutic Response in Human Nasopharygeal Carcinoma	PLOS ONE			English	Article							BECLIN 1 EXPRESSION; GROWTH-FACTOR; CELL-DEATH; AUTOPHAGY; KINASE; PHOSPHORYLATION; CHEMOTHERAPY; RADIOTHERAPY; METAANALYSIS; SURVIVAL	Plenty of studies have established that dysregulation of autophagy plays an essential role in cancer progression. The autophagy-related proteins have been reported to be closely associated with human cancer patients' prognosis. We explored the expression dynamics and prognostic value of autophagy-related protein ULK1 by immunochemistry (IHC) method in two independent cohorts of nasopharygeal carcinoma (NPC) cases. The X-tile program was applied to determine the optimal cut-off value in the training cohort. This derived cutoff value was then subjected to analysis the association of ULK1 expression with patients' clinical characteristics and survival outcome in the validation cohort and overall cases. High ULK1 expression was closely associated with aggressive clinical feature of NPC patients. Furthermore, high expression of ULK1 was observed more frequently in therapeutic resistant group than that in therapeutic effective group. Our univariate and multivariate analysis also showed that higher ULK1 expression predicted inferior disease-specific survival (DSS) (P < 0.05). Consequently, a new clinicopathologic prognostic model with 3 poor prognostic factors (ie, ULK1 expression, overall clinical stage and therapeutic response) could significantly stratify risk (low, intermediate and high) for DSS in NPC patients (P < 0.001). These findings provide evidence that, the examination of ULK1 expression by IHC method, could serve as an effective additional tool for predicting therapeutic response and patients' survival outcome in NPC patients.	[Yun, Miao; Bai, Hai-Yan; Zhang, Jia-Xing; Huang, Xiao-Xia; Liao, Yi-Ji; Mai, Shi-Juan; Xie, Dan] Sun Yat Sen Univ, Ctr Canc, State Key Lab Oncol South China, Guangzhou 510275, Guangdong, Peoples R China; [Yun, Miao; Zhang, Jia-Xing; Weng, Hui-Wen; Zheng, Zhou-San; Xu, Yi; Ye, Sheng] Sun Yat Sen Univ, Dept Oncol, Affiliated Hosp 1, Guangzhou 510275, Guangdong, Peoples R China; [Rong, Jian] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Extracorporeal Circulat, Guangzhou 510275, Guangdong, Peoples R China; [Tong, Zhu-Ting] Anhui Med Univ, Affiliated Hosp 1, Dept Radiotherapy, Hefei, Peoples R China	State Key Lab Oncology South China; Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University; Anhui Medical University	Ye, S (corresponding author), Sun Yat Sen Univ, Dept Oncol, Affiliated Hosp 1, Guangzhou 510275, Guangdong, Peoples R China.	yes20111212@163.com; xied@mail.sysu.edu.cn	mai, sj/HGE-8908-2022; LIAO, YIJI/Z-4902-2019	LIAO, YIJI/0000-0002-0849-4573	Nature Science Foundation of China [81225018]	Nature Science Foundation of China(National Natural Science Foundation of China (NSFC))	The project was supported by Research grants from the Nature Science Foundation of China (No. 81225018). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHMAD A, 1986, J SURG ONCOL, V33, P194, DOI 10.1002/jso.2930330310; Alers S, 2012, MOL CELL BIOL, V32, P2, DOI 10.1128/MCB.06159-11; Baehrecke EH, 2005, NAT REV MOL CELL BIO, V6, P505, DOI 10.1038/nrm1666; Baujat B, 2006, INT J RADIAT ONCOL, V64, P47, DOI 10.1016/j.ijrobp.2005.06.037; Camp RL., 2004, CLIN CANCER RES, V10, P7252, DOI [DOI 10.1158/1078-0432.CCR-04-0713, 10.1158/1078-0432.CCR-04-0713]; Chang ET, 2006, CANCER EPIDEM BIOMAR, V15, P1765, DOI 10.1158/1055-9965.EPI-06-0353; Chen FH, 2009, CLIN CANCER RES, V15, P1721, DOI 10.1158/1078-0432.CCR-08-1471; Chua DTT, 2005, J CLIN ONCOL, V23, P1118, DOI 10.1200/JCO.2005.12.081; Egan DF, 2011, AUTOPHAGY, V7, P645, DOI 10.4161/auto.7.6.15123; Egan DF, 2011, SCIENCE, V331, P456, DOI 10.1126/science.1196371; Farias TP, 2003, ARCH OTOLARYNGOL, V129, P794, DOI 10.1001/archotol.129.7.794; Huang JJ, 2010, AUTOPHAGY, V6, P777, DOI 10.4161/auto.6.6.12784; Hui EP, 2002, CLIN CANCER RES, V8, P2595; Jiang S, 2011, CANCER SCI, V102, P1568, DOI 10.1111/j.1349-7006.2011.01964.x; Jin SK, 2008, AUTOPHAGY, V4, P563, DOI 10.4161/auto.5830; Kim J, 2011, NAT CELL BIOL, V13, P132, DOI 10.1038/ncb2152; Klionsky DJ, 2007, NAT REV MOL CELL BIO, V8, P931, DOI 10.1038/nrm2245; Kondo Y, 2005, NAT REV CANCER, V5, P726, DOI 10.1038/nrc1692; Kraft C, 2012, EMBO J, V31, P3691, DOI 10.1038/emboj.2012.225; Kroemer G, 2005, NAT REV CANCER, V5, P886, DOI 10.1038/nrc1738; Langendijk JA, 2004, J CLIN ONCOL, V22, P4604, DOI 10.1200/JCO.2004.10.074; Levine B, 2007, NATURE, V446, P745, DOI 10.1038/446745a; Lin SY, 2012, SCIENCE, V336, P477, DOI 10.1126/science.1217032; Liu Y, 2005, CELL, V121, P567, DOI 10.1016/j.cell.2005.03.007; Lum JJ, 2005, CELL, V120, P237, DOI 10.1016/j.cell.2004.11.046; Morselli E, 2009, BBA-MOL CELL RES, V1793, P1524, DOI 10.1016/j.bbamcr.2009.01.006; PETROVICH Z, 1982, RADIOLOGY, V144, P905, DOI 10.1148/radiology.144.4.6810406; Pike LRG, 2013, BIOCHEM J, V449, P389, DOI 10.1042/BJ20120972; Shintani T, 2004, SCIENCE, V306, P990, DOI 10.1126/science.1099993; Suzuki K, 2007, FEBS LETT, V581, P2156, DOI 10.1016/j.febslet.2007.01.096; Wan XB, 2010, AUTOPHAGY, V6, P395, DOI 10.4161/auto.6.3.11303; Wei WI, 2005, LANCET, V365, P2041, DOI 10.1016/S0140-6736(05)66698-6; YAMASHITA S, 1985, ACTA ONCOL, V24, P315, DOI 10.3109/02841868509136058; Zhang JX, 2013, INT J CANCER, V132, P2567, DOI 10.1002/ijc.27930; Zhou WH, 2012, AUTOPHAGY, V8, P389, DOI 10.4161/auto.18641; Zhu ZH, 2009, J CLIN ONCOL, V27, P1091, DOI 10.1200/JCO.2008.16.6991	36	30	32	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2015	10	2							e0117375	10.1371/journal.pone.0117375	http://dx.doi.org/10.1371/journal.pone.0117375			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC2IM	25714809	Green Submitted, Green Published, gold			2022-12-27	WOS:000350168700032
J	Andreeva, N; Trilisenko, L; Eldarov, M; Kulakovskaya, T				Andreeva, Nadezhda; Trilisenko, Ludmila; Eldarov, Mikhail; Kulakovskaya, Tatiana			Polyphosphatase PPN1 of Saccharomyces cerevisiae: Switching of Exopolyphosphatase and Endopolyphosphatase Activities	PLOS ONE			English	Article							INORGANIC POLYPHOSPHATE; PURIFICATION; PHOSPHATE; GROWTH; KINASE; OVEREXPRESSION; MINERALIZATION; COMPARTMENTS; CYTOSOL; PPX1	The polyphosphatase PPN1 of Saccharomyces cerevisiae shows an exopolyphosphatase activity splitting phosphate from chain end and an endopolyphosphatase activity fragmenting high molecular inorganic polyphosphates into shorter polymers. We revealed the compounds switching these activities of PPN1. Phosphate release and fragmentation of high molecular polyphosphate prevailed in the presence of Co2+ and Mg2+, respectively. Phosphate release and polyphosphate chain shortening in the presence of Co2+ were inhibited by ADP but not affected by ATP and arginine. The polyphosphate chain shortening in the presence of Mg2+ was activated by ADP and arginine but inhibited by ATP.	[Andreeva, Nadezhda; Trilisenko, Ludmila; Kulakovskaya, Tatiana] Russian Acad Sci, Skryabin Inst Biochem & Physiol Microorganisms, Pushchino 142290, Russia; [Eldarov, Mikhail] Russian Acad Sci, Ctr Bioengn, Moscow 117312, Russia	Russian Academy of Sciences; Pushchino Scientific Center for Biological Research (PSCBI) of the Russian Academy of Sciences; Research Center of Biotechnology RAS; Russian Academy of Sciences	Kulakovskaya, T (corresponding author), Russian Acad Sci, Skryabin Inst Biochem & Physiol Microorganisms, Pr Nauki 5, Pushchino 142290, Russia.	alla@ibpm.pushchino.ru	Kulakovskaya, Tatiana/R-2803-2018	Kulakovskaya, Tatiana/0000-0001-8556-809X	Russian Basic Research Foundation [14-04-00515]	Russian Basic Research Foundation(Russian Foundation for Basic Research (RFBR))	This work was supported by Russian Basic Research Foundation (Grant 14-04-00515).	Abramov AY, 2007, P NATL ACAD SCI USA, V104, P18091, DOI 10.1073/pnas.0708959104; Albi T, 2014, MICROBIOL-SGM, V160, P2067, DOI 10.1099/mic.0.080952-0; Andreeva NA, 2006, BIOCHEMISTRY-MOSCOW+, V71, P975, DOI 10.1134/S0006297906090045; Andreeva NA, 2004, BIOCHEMISTRY-MOSCOW+, V69, P387, DOI 10.1023/B:BIRY.0000026193.44046.29; ANDREEVA NA, 1993, YEAST, V9, P127, DOI 10.1002/yea.320090204; Andreeva NA, 1998, FEBS LETT, V429, P194, DOI 10.1016/S0014-5793(98)00591-2; Andreeva N, 2015, J BIOSCI BIOENG, V119, P52, DOI 10.1016/j.jbiosc.2014.06.006; BENSADOUN A, 1976, ANAL BIOCHEM, V70, P241, DOI 10.1016/S0003-2697(76)80064-4; Boer VM, 2010, MOL BIOL CELL, V21, P198, DOI 10.1091/mbc.E09-07-0597; Castrol CD, 1999, BIOTECHNOL PROGR, V15, P65, DOI 10.1021/bp9800743; Drozd M, 2014, VIRULENCE, V5, P680, DOI 10.4161/viru.34348; Eldarov MA, 2013, BIOCHEMISTRY-MOSCOW+, V78, P946, DOI 10.1134/S0006297913080129; GREENFIELD NJ, 1987, BIOCHIM BIOPHYS ACTA, V926, P205, DOI 10.1016/0304-4165(87)90205-4; Hothorn M, 2009, SCIENCE, V324, P513, DOI 10.1126/science.1168120; HSIEH PC, 1993, PROTEIN EXPRES PURIF, V4, P76, DOI 10.1006/prep.1993.1012; Kulakovskaya T. V., 1997, BIOCHEMISTRY-MOSCOW, V62, P1180; Kuroda A, 2001, SCIENCE, V293, P705, DOI 10.1126/science.1061315; Lichko LP, 2010, BIOCHEMISTRY-MOSCOW+, V75, P1404, DOI 10.1134/S0006297910110131; Lichko L, 2006, BIOSCIENCE REP, V26, P45, DOI 10.1007/s10540-006-9003-2; Lonetti A, 2011, J BIOL CHEM, V286, P31966, DOI 10.1074/jbc.M111.266320; MATILE P, 1978, ANNU REV PLANT PHYS, V29, P193, DOI 10.1146/annurev.pp.29.060178.001205; Morimoto D, 2010, J BONE MINER METAB, V28, P418, DOI 10.1007/s00774-010-0157-4; Motomura K, 2014, APPL ENVIRON MICROB, V80, P2602, DOI 10.1128/AEM.03971-13; NORRIS PR, 1977, J GEN MICROBIOL, V99, P317, DOI 10.1099/00221287-99-2-317; OKOROKOV LA, 1980, J BACTERIOL, V144, P661, DOI 10.1128/JB.144.2.661-665.1980; Omelon S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005634; Rao NN, 1998, J BACTERIOL, V180, P2186, DOI 10.1128/JB.180.8.2186-2193.1998; Rashid MH, 2000, P NATL ACAD SCI USA, V97, P9636, DOI 10.1073/pnas.170283397; Ryuko S, 2012, MOL GENET GENOMICS, V287, P651, DOI 10.1007/s00438-012-0705-9; Sethuraman A, 2001, P NATL ACAD SCI USA, V98, P8542, DOI 10.1073/pnas.151269398; Shi XB, 2005, FEBS LETT, V579, P2014, DOI 10.1016/j.febslet.2005.02.032; Shiba T, 1997, P NATL ACAD SCI USA, V94, P11210, DOI 10.1073/pnas.94.21.11210; Shulman RG, 2005, METABOLOMICS BY IN VIVO NMR, P149, DOI 10.1002/0470011505.ch11; Smith SA, 2014, CURR OPIN HEMATOL, V21, P388, DOI 10.1097/MOH.0000000000000069; Stotz SC, 2014, MOL BRAIN, V7, DOI 10.1186/1756-6606-7-42; Trilisenko LV, 2014, BIOCHEMISTRY-MOSCOW+, V79, P478, DOI 10.1134/S0006297914050125; Vagabov VM, 1998, MICROBIOLOGY+, V67, P153; VAGABOV VM, 1990, DOKL AKAD NAUK SSSR+, V311, P991; Wang XH, 2014, BIOCHEM PHARMACOL, V89, P413, DOI 10.1016/j.bcp.2014.03.020; WILLIAMS SP, 1993, BIOCHEMISTRY-US, V32, P4895, DOI 10.1021/bi00069a026; Ytting CK, 2012, INTEGR BIOL-UK, V4, P99, DOI 10.1039/c1ib00108f	41	19	20	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2015	10	3							e0119594	10.1371/journal.pone.0119594	http://dx.doi.org/10.1371/journal.pone.0119594			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9KG	25742176	Green Published, gold, Green Submitted			2022-12-27	WOS:000350688100124
J	Greenberg, DC; Lophatananon, A; Wright, KA; Muir, KR; Gnanapragasam, VJ				Greenberg, David C.; Lophatananon, Artitaya; Wright, Karen A.; Muir, Kenneth R.; Gnanapragasam, Vincent J.			Trends and Outcome from Radical Therapy for Primary Non-Metastatic Prostate Cancer in a UK Population	PLOS ONE			English	Article							RADIOTHERAPY; RISK; ENGLAND; MEN	Background Increasing proportions of men diagnosed with prostate cancer in the UK are presenting with non-metastatic disease. We investigated how treatment trends in this demographic have changed. Patient and Methods Non-metastatic cancers diagnosed from 2000-2010 in the UK Anglian Cancer network stratified by age and risk group were analysed [n = 10,365]. Radiotherapy [RT] and prostatectomy [RP] cancer specific survival [CSS] were further compared [n = 4755]. Results Over the decade we observed a fall in uptake of primary androgen deprivation therapy but a rise in conservative management [CM] and radical therapy [p<0.0001]. CM in particular has become the primary management for low-risk disease by the decade end [p<0.0001]. In high-risk disease however both RP and RT uptake increased significantly but in an age dependent manner [p<0.0001]. Principally, increased RP in younger men and increased RT in men >= 70y. In multivariate analysis of radically treated men both high-risk disease [HR 8.0 [2.9-22.2], p<0.0001] and use of RT [HR 1.9 [1.0-3.3], p = 0.024] were significant predictors of a poorer CSM. In age-stratified analysis however, the trend to benefit of RP over RT was seen only in younger men [<= 60 years] with high-risk disease [p = 0.07]. The numbers needed to treat by RP instead of RT to save one cancer death was 19 for this group but 67 for the overall cohort. Conclusion This study has identified significant shifts in non-metastatic prostate cancer management over the last decade. Low-risk disease is now primarily managed by CM while high-risk disease is increasingly treated radically. Treatment of high-risk younger men by RP is supported by evidence of better CSM but this benefit is not evident in older men.	[Greenberg, David C.; Wright, Karen A.] Natl Canc Registrat Serv, Eastern Off, Publ Hlth England, Cambridge, England; [Lophatananon, Artitaya; Muir, Kenneth R.] Univ Warwick, Warwick Med Sch, Div Hlth Sci, Warwick, England; [Lophatananon, Artitaya; Muir, Kenneth R.] Univ Manchester, Inst Populat Hlth, Manchester, Lancs, England; [Gnanapragasam, Vincent J.] Univ Cambridge, Dept Surg & Oncol, Acad Urol Grp, Cambridge, England; [Gnanapragasam, Vincent J.] Univ Cambridge, Hutchison MRC Res Ctr, Translat Prostate Canc Grp, Cambridge, England	Public Health England; University of Warwick; University of Manchester; University of Cambridge; University of Cambridge	Gnanapragasam, VJ (corresponding author), Univ Cambridge, Dept Surg & Oncol, Acad Urol Grp, Cambridge, England.	vjg29@cam.ac.uk						Arcangeli G, 2009, INT J RADIAT ONCOL, V75, P975, DOI 10.1016/j.ijrobp.2008.12.045; Bill-Axelson A, 2014, NEW ENGL J MED, V370, P932, DOI 10.1056/NEJMoa1311593; Briganti A, 2013, EUR UROL, V63, P693, DOI 10.1016/j.eururo.2012.08.054; Center MM, 2012, EUR UROL, V61, P1079, DOI 10.1016/j.eururo.2012.02.054; Dall'Era MA, 2012, EUR UROL, V62, P976, DOI 10.1016/j.eururo.2012.05.072; Dinan MA, 2012, INT J RADIAT ONCOL, V82, pE781, DOI 10.1016/j.ijrobp.2011.11.024; Evans SM, 2013, MED J AUSTRALIA, V198, P540, DOI 10.5694/mja12.11241; Fairley L, 2009, BRIT J CANCER, V101, P1839, DOI 10.1038/sj.bjc.6605424; Gnanapragasam VJ, 2012, BJU INT, V109, P648, DOI 10.1111/j.1464-410X.2011.10596.x; Hoskin PJ, 2012, RADIOTHER ONCOL, V103, P217, DOI 10.1016/j.radonc.2012.01.007; Jacobs BL, 2013, JAMA-J AM MED ASSOC, V309, P2587, DOI 10.1001/jama.2013.6882; Lane JA, 2010, EUR J CANCER, V46, P3095, DOI 10.1016/j.ejca.2010.09.016; Moore AL, 2009, BJU INT, V104, P1592, DOI 10.1111/j.1464-410X.2009.08652.x; Oliver SE, 2003, BJU INT, V91, P331, DOI 10.1046/j.1464-410X.2003.04083.x; Petrelli F, 2014, CLIN GENITOURIN CANC, V12, P215, DOI 10.1016/j.clgc.2014.01.010; Resnick MJ, 2013, NEW ENGL J MED, V368, P436, DOI 10.1056/NEJMoa1209978; Sooriakumaran P, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g1502; van Tol-Geerdink JJ, 2013, BRIT J CANCER, V108, P1784, DOI 10.1038/bjc.2013.181; Warde P, 2011, LANCET, V378, P2104, DOI 10.1016/S0140-6736(11)61095-7; Widmark A, 2009, LANCET, V373, P301, DOI 10.1016/S0140-6736(08)61815-2; Wilt TJ, 2012, NEW ENGL J MED, V367, P203, DOI 10.1056/NEJMoa1113162	21	16	16	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2015	10	3							e0119494	10.1371/journal.pone.0119494	http://dx.doi.org/10.1371/journal.pone.0119494			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9KG	25742020	Green Published, Green Submitted, gold			2022-12-27	WOS:000350688100116
J	Mamad, O; Delaville, C; Benjelloun, W; Benazzouz, A				Mamad, Omar; Delaville, Claire; Benjelloun, Wail; Benazzouz, Abdelhamid			Dopaminergic Control of the Globus Pallidus through Activation of D2 Receptors and Its Impact on the Electrical Activity of Subthalamic Nucleus and Substantia Nigra Reticulata Neurons	PLOS ONE			English	Article							SINGLE-UNIT-ACTIVITY; BASAL GANGLIA; FUNCTIONAL-ANATOMY; PARS RETICULATA; INHIBITION; PATTERN; GABA; INNERVATION; DEPLETION; PATHWAYS	The globus pallidus (GP) receives dopaminergic afferents from the pars compacta of substantia nigra and several studies suggested that dopamine exerts its action in the GP through presynaptic D2 receptors (D2Rs). However, the impact of dopamine in GP on the pallido-subthalamic and pallido-nigral neurotransmission is not known. Here, we investigated the role of dopamine, through activation of D2Rs, in the modulation of GP neuronal activity and its impact on the electrical activity of subthalamic nucleus (STN) and substantia nigra reticulata (SNr) neurons. Extracellular recordings combined with local intracerebral microinjection of drugs were done in male Sprague-Dawley rats under urethane anesthesia. We showed that dopamine, when injected locally, increased the firing rate of the majority of neurons in the GP. This increase of the firing rate was mimicked by quinpirole, a D2R agonist, and prevented by sulpiride, a D2R antagonist. In parallel, the injection of dopamine, as well as quinpirole, in the GP reduced the firing rate of majority of STN and SNr neurons. However, neither dopamine nor quinpirole changed the tonic discharge pattern of GP, STN and SNr neurons. Our results are the first to demonstrate that dopamine through activation of D2Rs located in the GP plays an important role in the modulation of GP-STN and GP-SNr neurotransmission and consequently controls STN and SNr neuronal firing. Moreover, we provide evidence that dopamine modulate the firing rate but not the pattern of GP neurons, which in turn control the firing rate, but not the pattern of STN and SNr neurons.	[Mamad, Omar; Delaville, Claire; Benazzouz, Abdelhamid] Univ Bordeaux, Inst Malad Neurodegenerat, UMR 5293, F-33000 Bordeaux, France; [Mamad, Omar; Delaville, Claire; Benazzouz, Abdelhamid] CNRS, Inst Malad Neurodegenerat, UMR 5293, F-33000 Bordeaux, France; [Mamad, Omar; Benjelloun, Wail] Univ Mohamed V Agdal, Fac Sci, Equipe Rythmes Biol Neurosci & Environm, Rabat 10000, Morocco	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite de Bordeaux; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite de Bordeaux; Mohammed V University in Rabat	Benazzouz, A (corresponding author), Univ Bordeaux, Inst Malad Neurodegenerat, UMR 5293, F-33000 Bordeaux, France.	Abdelhamid.Benazzouz@u-bordeaux.fr	Benazzouz, Abdelhamid/E-5050-2016	Mamad, Omar/0000-0002-4517-3381	Universite de Bordeaux; exchange grants of the "Groupement de Recherche International" [GDRI N198]; exchange grants of the "Groupement de Recherche International" (CNRS INSERM France); exchange grants of the "Groupement de Recherche International" (CNRST Morocco); Egide-Volubilis [20565ZM]; CNRS-CNRST Convention Adivmar [22614]; NEUROMED	Universite de Bordeaux; exchange grants of the "Groupement de Recherche International"; exchange grants of the "Groupement de Recherche International" (CNRS INSERM France); exchange grants of the "Groupement de Recherche International" (CNRST Morocco); Egide-Volubilis; CNRS-CNRST Convention Adivmar; NEUROMED	This study was supported by the "Universite de Bordeaux" and exchange grants of the "Groupement de Recherche International" (GDRI N198, CNRS & INSERM France, and CNRST Morocco), Egide-Volubilis No 20565ZM, CNRS-CNRST Convention Adivmar 22614 and NEUROMED. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abedi PM, 2013, NEUROSCIENCE, V236, P289, DOI 10.1016/j.neuroscience.2013.01.043; ALBIN RL, 1989, TRENDS NEUROSCI, V12, P366, DOI 10.1016/0166-2236(89)90074-X; Baufreton J, 2005, J NEUROSCI, V25, P8505, DOI 10.1523/JNEUROSCI.1163-05.2005; Belujon P, 2007, J NEUROSCI, V27, P9595, DOI 10.1523/JNEUROSCI.2583-07.2007; Benazzouz A, 2002, MOVEMENT DISORD, V17, pS145, DOI 10.1002/mds.10156; BERGMAN H, 1994, J NEUROPHYSIOL, V72, P507, DOI 10.1152/jn.1994.72.2.507; BERGSTROM DA, 1984, BRAIN RES, V310, P23, DOI 10.1016/0006-8993(84)90006-4; Bevan MD, 2006, CURR OPIN NEUROBIOL, V16, P621, DOI 10.1016/j.conb.2006.10.003; Bevan MD, 2002, J NEUROPHYSIOL, V87, P1348, DOI 10.1152/jn.00582.2001; Billings LM, 2003, BRAIN RES, V964, P237, DOI 10.1016/S0006-8993(02)04060-X; Bouali-Benazzouz R, 2009, NEUROSCIENCE, V164, P588, DOI 10.1016/j.neuroscience.2009.07.034; Chetrit J, 2013, J NEUROSCI, V33, P14840, DOI 10.1523/JNEUROSCI.0453-13.2013; Chetrit J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006208; Cooper AJ, 2001, NEUROPHARMACOLOGY, V41, P62, DOI 10.1016/S0028-3908(01)00038-7; Delaville C, 2012, NEUROBIOL DIS, V47, P322, DOI 10.1016/j.nbd.2012.05.019; Deniau JM, 2007, PROG BRAIN RES, V160, P151, DOI 10.1016/S0079-6123(06)60009-5; Floran B, 1997, NEUROSCI LETT, V237, P1, DOI 10.1016/S0304-3940(97)00784-2; Hadipour-Niktarash A, 2012, J NEUROPHYSIOL, V107, P1500, DOI 10.1152/jn.00348.2011; Hallworth NE, 2005, J NEUROSCI, V25, P6304, DOI 10.1523/JNEUROSCI.0450-05.2005; Hassani OK, 1996, NEUROSCIENCE, V72, P105, DOI 10.1016/0306-4522(95)00535-8; Hauber W, 1999, BEHAV BRAIN RES, V106, P143, DOI 10.1016/S0166-4328(99)00102-3; Hernandez A, 2006, J NEUROPHYSIOL, V96, P2877, DOI 10.1152/jn.00664.2006; Hutchison WD, 1998, ANN NEUROL, V44, P622, DOI 10.1002/ana.410440407; Kaneoke Y, 1996, J NEUROSCI METH, V68, P211, DOI 10.1016/0165-0270(96)00081-7; KINCAID AE, 1991, BRAIN RES, V553, P18, DOI 10.1016/0006-8993(91)90224-J; LEVEY AI, 1993, P NATL ACAD SCI USA, V90, P8861, DOI 10.1073/pnas.90.19.8861; LINDVALL O, 1979, BRAIN RES, V172, P169, DOI 10.1016/0006-8993(79)90907-7; Loucif KC, 2005, J PHYSIOL-LONDON, V567, P977, DOI 10.1113/jphysiol.2005.093807; Murer MG, 1997, SYNAPSE, V27, P278, DOI 10.1002/(SICI)1098-2396(199712)27:4<278::AID-SYN2>3.3.CO;2-S; Ni ZG, 2001, BRAIN RES, V899, P142, DOI 10.1016/S0006-8993(01)02219-3; Ni ZG, 2000, EUR J NEUROSCI, V12, P4338, DOI 10.1111/j.1460-9568.2000.01346.x; PARENT A, 1995, BRAIN RES REV, V20, P128, DOI 10.1016/0165-0173(94)00008-D; Paxinos G., 1996, RAT BRAIN STEREOTAXI; Plenz D, 1999, NATURE, V400, P677, DOI 10.1038/23281; Querejeta E, 2001, NEUROSCI LETT, V300, P79, DOI 10.1016/S0304-3940(01)01550-6; RICHFIELD EK, 1987, J COMP NEUROL, V262, P446, DOI 10.1002/cne.902620308; Rommelfanger KS, 2010, FRONT NEUROANAT, V4, DOI 10.3389/fnana.2010.00139; Smith Y, 1998, NEUROSCIENCE, V86, P353; Smith Y, 2008, MOVEMENT DISORD, V23, pS534, DOI 10.1002/mds.22027	39	17	17	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2015	10	3							e0119152	10.1371/journal.pone.0119152	http://dx.doi.org/10.1371/journal.pone.0119152			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9KG	25742005	Green Published, Green Submitted, gold			2022-12-27	WOS:000350688100088
J	Colvin, ME; Peterson, JT; Kent, ML; Schreck, CB				Colvin, Michael E.; Peterson, James T.; Kent, Michael L.; Schreck, Carl B.			Occupancy Modeling for Improved Accuracy and Understanding of Pathogen Prevalence and Dynamics	PLOS ONE			English	Article							MYXOBOLUS-CEREBRALIS; WHIRLING DISEASE; COHO SALMON; IMPERFECT; SENSITIVITY; WILD; TRANSLOCATION; SPECIFICITY; INFECTION; FRAMEWORK	Most pathogen detection tests are imperfect, with a sensitivity < 100%, thereby resulting in the potential for a false negative, where a pathogen is present but not detected. False negatives in a sample inflate the number of non-detections, negatively biasing estimates of pathogen prevalence. Histological examination of tissues as a diagnostic test can be advantageous as multiple pathogens can be examined and providing important information on associated pathological changes to the host. However, it is usually less sensitive than molecular or microbiological tests for specific pathogens. Our study objectives were to 1) develop a hierarchical occupancy model to examine pathogen prevalence in spring Chinook salmon Oncorhynchus tshawytscha and their distribution among host tissues 2) use the model to estimate pathogen-specific test sensitivities and infection rates, and 3) illustrate the effect of using replicate within host sampling on sample sizes required to detect a pathogen. We examined histological sections of replicate tissue samples from spring Chinook salmon O. tshawytscha collected after spawning for common pathogens seen in this population: Apophallus/echinostome metacercariae, Parvicapsula minibicornis, Nanophyetus salmincola/metacercariae, and Renibacterium salmoninarum. A hierarchical occupancy model was developed to estimate pathogen and tissue-specific test sensitivities and unbiased estimation of host-and organ-level infection rates. Model estimated sensitivities and host-and organ-level infections rates varied among pathogens and model estimated infection rate was higher than prevalence unadjusted for test sensitivity, confirming that prevalence unadjusted for test sensitivity was negatively biased. The modeling approach provided an analytical approach for using hierarchically structured pathogen detection data from lower sensitivity diagnostic tests, such as histology, to obtain unbiased pathogen prevalence estimates with associated uncertainties. Accounting for test sensitivity using within host replicate samples also required fewer individual fish to be sampled. This approach is useful for evaluating pathogen or microbe community dynamics when test sensitivity is <100%.	[Colvin, Michael E.] Oregon State Univ, Dept Fisheries & Wildlife, Oregon Cooperat Fish & Wildlife Res Unit, Corvallis, OR 97331 USA; [Peterson, James T.; Schreck, Carl B.] Oregon State Univ, Oregon Cooperat Fish & Wildlife Res Unit, US Geol Survey, Dept Fisheries & Wildlife, Corvallis, OR 97331 USA; [Kent, Michael L.] Oregon State Univ, Dept Microbiol, Corvallis, OR 97331 USA	Oregon State University; Oregon State University; United States Department of the Interior; United States Geological Survey; Oregon State University	Colvin, ME (corresponding author), Mississippi State Univ, Dept Wildlife Fisheries & Aquaculture, POB 9690, Mississippi State, MS 39762 USA.	Michael.colvin@msstate.edu		Colvin, Michael/0000-0002-6581-4764	US Army Corps of Engineers, Military Interdepartmental Purchase Request [W66QKZ20836465]; U.S. Geological Survey; U.S. Fish and Wildlife Service; Oregon Department of Fish and Wildlife, Oregon State University; Wildlife Management Institute	US Army Corps of Engineers, Military Interdepartmental Purchase Request; U.S. Geological Survey(United States Geological Survey); U.S. Fish and Wildlife Service(US Fish & Wildlife Service); Oregon Department of Fish and Wildlife, Oregon State University; Wildlife Management Institute	This study was funded by the US Army Corps of Engineers, Military Interdepartmental Purchase Request Number W66QKZ20836465. The Oregon Cooperative Fish and Wildlife Research Unit is jointly sponsored by the U.S. Geological Survey, the U.S. Fish and Wildlife Service, the Oregon Department of Fish and Wildlife, Oregon State University, and the Wildlife Management Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams MJ, 2010, ECOL APPL, V20, P289, DOI 10.1890/08-2319.1; AFS-FHS (American Fisheries Society-Fish Health Section), 2010, AFS FHS BLUE BOOK SU; Allen TJ, 1986, T NE SECT WILDL SOC, V43, P64; [Anonymous], 2010, R LANG ENV STAT COMP; ANTHONY JA, 1990, J WILDLIFE DIS, V26, P170, DOI 10.7589/0090-3558-26.2.170; Blaustein AR, 2005, CONSERV BIOL, V19, P1460, DOI 10.1111/j.1523-1739.2005.00195.x; Chen PC, 2011, J NEMATOL, V43, P16; Cooch Evan G., 2012, Journal of Ornithology, V152, pS485, DOI 10.1007/s10336-010-0636-3; Courcoul A, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0115916, DOI 10.1371/JOURNAL.PONE.0115916]; Cunningham AA, 1996, CONSERV BIOL, V10, P349, DOI 10.1046/j.1523-1739.1996.10020349.x; Ferguson JA, 2011, J PARASITOL, V97, P1085, DOI 10.1645/GE-2757.1; Gelman A, 2007, DATA ANAL USING REGR, DOI [10.1093/jxb/erm028, DOI 10.1093/JXB/ERM028]; Gelman A., 1992, STAT SCI, V7, P457, DOI [10.1214/ss/1177011136, DOI 10.1214/SS/1177011136]; Greiner M, 2000, PREV VET MED, V45, P43, DOI 10.1016/S0167-5877(00)00116-1; Guillera-Arroita G, PLOS ONE IN PRESS, DOI [10.1371/journal.pone.0117679, DOI 10.1371/JOURNAL.PONE.0117679]; Guillera-Arroita G, 2012, METHODS ECOL EVOL, V3, P860, DOI 10.1111/j.2041-210X.2012.00225.x; Guillera-Arroita G, 2011, METHODS ECOL EVOL, V2, P401, DOI 10.1111/j.2041-210X.2011.00089.x; Guillera-Arroita G, 2010, METHODS ECOL EVOL, V1, P131, DOI 10.1111/j.2041-210X.2010.00017.x; Hanna SE, 2005, J FOOD SCI, V70, pR49; Hiner M, 2001, J AQUAT ANIM HEALTH, V13, P124, DOI 10.1577/1548-8667(2001)013&lt;0124:VIIOMC&gt;2.0.CO;2; Jacobson KC, 2008, MAR ECOL PROG SER, V354, P235, DOI 10.3354/meps07232; Kendall WL, 2009, J APPL ECOL, V46, P1182, DOI 10.1111/j.1365-2664.2009.01732.x; Kent ML, 2013, J VET DIAGN INVEST, V25, P341, DOI 10.1177/1040638713482124; Kent ML, 1998, J AQUAT ANIM HEALTH, V10, P211, DOI 10.1577/1548-8667(1998)010&lt;0211:SOSPIO&gt;2.0.CO;2; Kock RA, 2010, REV SCI TECH OIE, V29, P329, DOI 10.20506/rst.29.2.1980; Koponen K, 2001, AMBIO, V30, P122, DOI 10.1639/0044-7447(2001)030[0122:HOFFFA]2.0.CO;2; Lachish S, 2012, METHODS ECOL EVOL, V3, P339, DOI 10.1111/j.2041-210X.2011.00156.x; Leighton FA, 2002, REV SCI TECH OIE, V21, P187; Link WA, 2010, BAYESIAN INFERENCE WITH ECOLOGICAL APPLICATIONS, P1; Luna LG, 1968, MANUAL HISTOLOGIC ST, V3; Lunn DJ, 2000, STAT COMPUT, V10, P325, DOI 10.1023/A:1008929526011; Mackenzie DI, 2005, J APPL ECOL, V42, P1105, DOI 10.1111/j.1365-2664.2005.01098.x; MacKenzie DI, 2002, ECOLOGY, V83, P2248, DOI 10.1890/0012-9658(2002)083[2248:ESORWD]2.0.CO;2; McClintock BT, 2010, ECOL LETT, V13, P659, DOI 10.1111/j.1461-0248.2010.01472.x; Meyer CP, 2005, PLOS BIOL, V3, P2229, DOI 10.1371/journal.pbio.0030422; Miller DAW, 2012, METHODS ECOL EVOL, V3, P850, DOI 10.1111/j.2041-210X.2012.00216.x; National Research Council, 2011, GUIDE CARE USE LAB A; Nehring RB, 1996, FISHERIES, V21, P28; Nichols JD, 2008, J APPL ECOL, V45, P1321, DOI 10.1111/j.1365-2664.2008.01509.x; NMFS (National Marine Fisheries Service), 1999, FED REGISTER, V64, P14308; NRC ( National Research Council), 2008, BRUC GREAT YELL AR; Pascho RJ, 1997, J AQUAT ANIM HEALTH, V9, P99, DOI 10.1577/1548-8667(1997)009&lt;0099:EBELIA&gt;2.3.CO;2; Poulin R, 2013, PARASITOLOGY, V140, P541, DOI 10.1017/S0031182012002053; Rodnick KJ, 2008, T AM FISH SOC, V137, P1571, DOI 10.1577/T07-138.1; Saksida SM, 2012, J FISH DIS, V35, P137, DOI 10.1111/j.1365-2761.2011.01330.x; Schreck CB, 2013, ANN REPORT US ARMY C; Shea CP, 2012, FRESHWATER BIOL, P382, DOI [10.1182/asheducation-2012.1.382, DOI 10.1182/ASHEDUCATION-2012.1.382]; Starliper CE, 2011, FISH DISEASES AND DISORDERS, VOL 3: VIRAL, BACTERIAL AND FUNGAL INFECTIONS, 2ND EDITION, P606, DOI 10.1079/9781845935542.0606; Stentiford GD, 2003, MAR ENVIRON RES, V55, P137, DOI 10.1016/S0141-1136(02)00212-X; Sturtz S, 2005, J STAT SOFTW, V12, P1, DOI 10.18637/jss.v012.i03; Tamhane A, 2008, CLIN INFECT DIS, V46, P474, DOI 10.1086/524893; Thompson KG, 2007, J AQUAT ANIM HEALTH, V19, P8, DOI 10.1577/H06-016.1; Vincent ER, 1996, FISHERIES, V21, P32; WARNER RE, 1968, CONDOR, V70, P101, DOI 10.2307/1365954; Wilcox TM, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0082806, DOI 10.1371/JOURNAL.PONE.0082806]; Williams CJ, 2010, ECOL INFORM, V5, P273, DOI 10.1016/j.ecoinf.2010.04.003; Williams CJ, 2005, J AQUAT ANIM HEALTH, V17, P386, DOI 10.1577/H04-066.1	57	16	16	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2015	10	3							e0116605	10.1371/journal.pone.0116605	http://dx.doi.org/10.1371/journal.pone.0116605			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9JM	25738709	Green Published, gold, Green Submitted			2022-12-27	WOS:000350685900013
J	Jia, R; Ding, SL; Pan, QH; Liu, SL; Qiao, WT; Liang, C				Jia, Rui; Ding, Shilei; Pan, Qinghua; Liu, Shan-Lu; Qiao, Wentao; Liang, Chen			The C-Terminal Sequence of IFITM1 Regulates Its Anti-HIV-1 Activity	PLOS ONE			English	Article							VESICULAR STOMATITIS-VIRUS; WEST NILE VIRUS; INTERFERON; INFLUENZA; PROTEINS; INFECTION; IDENTIFICATION; REPLICATION; INHIBITION; RESTRICTS	The interferon-inducible transmembrane (IFITM) proteins inhibit a wide range of viruses. We previously reported the inhibition of human immunodeficiency virus type 1 (HIV-1) strain BH10 by human IFITM1, 2 and 3. It is unknown whether other HIV-1 strains are similarly inhibited by IFITMs and whether there exists viral countermeasure to overcome IFITM inhibition. We report here that the HIV-1 NL4-3 strain (HIV-1(NL4-3)) is not restricted by IFITM1 and its viral envelope glycoprotein is partly responsible for this insensitivity. However, HIV-1(NL-43) is profoundly inhibited by an IFITM1 mutant, known as Delta(117-125), which is deleted of 9 amino acids at the C-terminus. In contrast to the wild type IFITM1, which does not affect HIV-1 entry, the Delta(117-125) mutant diminishes HIV-1(NL4-3) entry by 3-fold. This inhibition correlates with the predominant localization of Delta(117-125) to the plasma membrane where HIV-1 entry occurs. In spite of strong conservation of IFITM1 among most species, mouse IFITM1 is 19 amino acids shorter at its C-terminus as compared to human IFITM1 and, like the human IFITM1 mutant Delta(117-125), mouse IFITM1 also inhibits HIV-1 entry. This is the first report illustrating the role of viral envelope protein in overcoming IFITM1 restriction. The results also demonstrate the importance of the C-terminal region of IFITM1 in modulating the antiviral function through controlling protein subcellular localization.	[Jia, Rui; Qiao, Wentao] Nankai Univ, Minist Educ, Key Lab Mol Microbiol & Biotechnol, Tianjin 300071, Peoples R China; [Jia, Rui; Qiao, Wentao] Nankai Univ, Key Lab Microbial Funct Genom Tianjin, Coll Life Sci, Tianjin 300071, Peoples R China; [Jia, Rui; Ding, Shilei; Pan, Qinghua; Liang, Chen] McGill Univ, Jewish Gen Hosp, Lady Davis Inst, Montreal, PQ H3T 1E2, Canada; [Ding, Shilei; Liang, Chen] McGill Univ, Dept Med, Montreal, PQ H3A 2B4, Canada; [Liu, Shan-Lu] Univ Missouri, Sch Med, Dept Mol Microbiol & Immunol, Bond Life Sci Ctr, Columbia, MO 65211 USA	Nankai University; Nankai University; Lady Davis Institute; McGill University; McGill University; University of Missouri System; University of Missouri Columbia	Liang, C (corresponding author), McGill Univ, Jewish Gen Hosp, Lady Davis Inst, Montreal, PQ H3T 1E2, Canada.	chen.liang@mcgill.ca	Liu, Shan-Lu/L-5923-2016	Liu, Shan-Lu/0000-0003-1620-3817; Jia, Rui/0000-0002-1797-4069	National Institutes of Health [AI112381, AI105584, AI109464, AI107095]; Canadian Institutes of Health Research [MOP-133479]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI112381, R21AI109464, R21AI105584, R56AI107095] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by funding from National Institutes of Health to SLL (AI112381, AI105584, AI109464, and AI107095) and funding from Canadian Institutes of Health Research to CL (MOP-133479). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alber D, 1996, J INTERF CYTOK RES, V16, P375, DOI 10.1089/jir.1996.16.375; Almen MS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031961; Anafu AA, 2013, J BIOL CHEM, V288, P17261, DOI 10.1074/jbc.M112.438515; Andreu P, 2006, CANCER RES, V66, P1949, DOI 10.1158/0008-5472.CAN-05-2731; Bailey CC, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002909; Blumenthal R, 2012, J BIOL CHEM, V287, P40841, DOI 10.1074/jbc.R112.406272; Brass AL, 2009, CELL, V139, P1243, DOI 10.1016/j.cell.2009.12.017; Cavrois M, 2002, NAT BIOTECHNOL, V20, P1151, DOI 10.1038/nbt745; Chesarino NM, 2014, J BIOL CHEM, V289, P11986, DOI 10.1074/jbc.M114.557694; Diamond MS, 2013, NAT REV IMMUNOL, V13, P46, DOI 10.1038/nri3344; Ding SL, 2014, VIROLOGY, V454, P11, DOI 10.1016/j.virol.2014.01.020; Everitt AR, 2012, NATURE, V484, P519, DOI 10.1038/nature10921; Hickford D, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-155; Huang IC, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001258; Jia R, 2014, CELL MICROBIOL, V16, P1080, DOI 10.1111/cmi.12262; Jia R, 2012, J VIROL, V86, P13697, DOI 10.1128/JVI.01828-12; Jiang D, 2010, J VIROL, V84, P8332, DOI 10.1128/JVI.02199-09; John SP, 2013, J VIROL, V87, P7837, DOI 10.1128/JVI.00481-13; Le Tortorec A, 2009, J VIROL, V83, P11966, DOI 10.1128/JVI.01515-09; LEWIN AR, 1991, EUR J BIOCHEM, V199, P417, DOI 10.1111/j.1432-1033.1991.tb16139.x; Li K, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003124; Lu J, 2011, J VIROL, V85, P2126, DOI 10.1128/JVI.01531-10; Martensen PM, 2004, J INTERF CYTOK RES, V24, P1, DOI 10.1089/107999004772719864; Moffatt P, 2008, J BONE MINER RES, V23, P1497, DOI 10.1359/JBMR.080412; Mudhasani R, 2013, J VIROL, V87, P8451, DOI 10.1128/JVI.03382-12; Perreira JM, 2013, J MOL BIOL, V425, P4937, DOI 10.1016/j.jmb.2013.09.024; Samarajiwa SA, 2009, NUCLEIC ACIDS RES, V37, pD852, DOI 10.1093/nar/gkn732; Sattentau Q, 2008, NAT REV MICROBIOL, V6, P815, DOI 10.1038/nrmicro1972; Schneider WM, 2014, ANNU REV IMMUNOL, V32, P513, DOI 10.1146/annurev-immunol-032713-120231; Siegrist F, 2011, J INTERF CYTOK RES, V31, P183, DOI 10.1089/jir.2010.0112; TANG BL, 1992, J BIOL CHEM, V267, P7072; Vazquez-Calvo A, 2012, VIRUS RES, V167, P125, DOI 10.1016/j.virusres.2012.05.024; Wakim LM, 2013, NAT IMMUNOL, V14, P238, DOI 10.1038/ni.2525; Weidner JM, 2010, J VIROL, V84, P12646, DOI 10.1128/JVI.01328-10; Weston S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104341; Yoder A, 2008, CELL, V134, P782, DOI 10.1016/j.cell.2008.06.036; Yu DY, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000633; Zhang YH, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2433; Zhao XS, 2014, P NATL ACAD SCI USA, V111, P6756, DOI 10.1073/pnas.1320856111; Zhu HZ, 2003, J VIROL, V77, P5493, DOI 10.1128/JVI.77.9.5493-5498.2003	40	24	25	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2015	10	3							e0118794	10.1371/journal.pone.0118794	http://dx.doi.org/10.1371/journal.pone.0118794			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9JM	25738301	Green Published, Green Submitted, gold			2022-12-27	WOS:000350685900073
J	Korda, RJ; Joshy, G; Paige, E; Butler, JRG; Jorm, LR; Liu, B; Bauman, AE; Banks, E				Korda, Rosemary J.; Joshy, Grace; Paige, Ellie; Butler, James R. G.; Jorm, Louisa R.; Liu, Bette; Bauman, Adrian E.; Banks, Emily			The Relationship between Body Mass Index and Hospitalisation Rates, Days in Hospital and Costs: Findings from a Large Prospective Linked Data Study	PLOS ONE			English	Article							HEALTH-CARE COSTS; ECONOMIC BURDEN; OBESITY; OVERWEIGHT; COMORBIDITIES; EXPENDITURE; MORTALITY; WEIGHT; HEIGHT; BMI	Background Internationally there is limited empirical evidence on the impact of overweight and obesity on health service use and costs. We estimate the burden of hospitalisation-admissions, days and costs-associated with above-normal BMI. Methods Population-based prospective cohort study involving 224,254 adults aged >= 45y in Australia (45 and Up Study). Baseline questionnaire data (2006-2009) were linked to hospitalisation and death records (median follow-up 3.42y) and hospital cost data. The relationships between BMI and hospital admissions and days were modelled using zero-inflated negative binomial regression; generalised gamma models were used to model costs. Analyses were stratified by sex and age (45-64, 65-79, >= 80y), and adjusted for age, area of residence, education, income, smoking, alcohol-intake and private health insurance status. Population attributable fractions were also calculated. Results There were 459,346 admissions (0.55/person-year) and 1,483,523 hospital days (1.76/person- year) during follow-up. For ages 45-64y and 65-79y, rates of admissions, days and costs increased progressively with increments of above-normal BMI. Compared to BMI 22.5-<25kg/m(2), rates of admissions and days were 1.64-2.54 times higher for BMI 40-50kg/m(2); costs were 1.14-1.24 times higher for BMI 27.5-<30kg/m(2), rising to 1.77-2.15 times for BMI 40-50kg/m(2). The BMI-hospitalisation relationship was less clear for >= 80y. We estimated that among Australians 45-79y, around 1 in every 8 admissions are attributable to overweight and obesity (2% to overweight, 11% to obesity), as are 1 in every 6 days in hospital (2%, 16%) and 1 in every 6 dollars spent on hospitalisation (3%, 14%). Conclusions The dose-response relationship between BMI and hospital use and costs in mid-age and older Australians in the above-normal BMI range suggests even small downward shifts in BMI among these people could result in considerable reductions in their annual health care costs; whether this would result in long-term savings to the health care system is not known from this study.	[Korda, Rosemary J.; Joshy, Grace; Paige, Ellie; Banks, Emily] Australian Natl Univ, Natl Ctr Epidemiol & Populat Hlth, Canberra, ACT, Australia; [Butler, James R. G.] Australian Natl Univ, Australian Ctr Econ Res Hlth, Canberra, ACT, Australia; [Jorm, Louisa R.] Univ Western Sydney, Ctr Hlth Res, Sydney, NSW, Australia; [Liu, Bette] Univ New S Wales, Sch Publ Hlth & Community Med, Sydney, NSW, Australia; [Liu, Bette; Banks, Emily] Sax Inst, Sydney, NSW, Australia; [Bauman, Adrian E.] Univ Sydney, Sch Publ Hlth, Sydney, NSW 2006, Australia	Australian National University; Australian National University; Western Sydney University; University of New South Wales Sydney; University of Sydney; University of Sydney	Korda, RJ (corresponding author), Australian Natl Univ, Natl Ctr Epidemiol & Populat Hlth, Canberra, ACT, Australia.	Rosemary.Korda@anu.edu.au	Jorm, Louisa/AAN-6874-2020	Jorm, Louisa/0000-0003-0390-661X; Banks, Emily/0000-0002-4617-1302; Joshy, Grace/0000-0002-0718-6368; Korda, Rosemary/0000-0002-9390-2171; Paige, Ellie/0000-0003-0855-9872	Australian National Health and Medical Research Council [585402]	Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by a grant from the Australian National Health and Medical Research Council [Grant No. 585402]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison DB, 1999, AM J PUBLIC HEALTH, V89, P1194, DOI 10.2105/AJPH.89.8.1194; Andreyeva T, 2004, OBES RES, V12, P1936, DOI 10.1038/oby.2004.243; Anis AH, 2010, OBES REV, V11, P31, DOI 10.1111/j.1467-789X.2009.00579.x; [Anonymous], 2008, GROWING COST OBESITY, DOI DOI 10.1097/SAP.0B013-31816FCAC418434822; Australian Bureau of Statistics, 2011, 4338 0 PROF HLTH; Australian Bureau of Statistics, 2012, AUSTR HLTH SURV 1 RE; Australian Government Department of Health and Ageing, ROUND 14 2009 10 NAT; Australian Institute of Health and Welfare, 2004, AUSTR I HLTH WELF RU, V4; Australian Institute of Health and Welfare, 2013, HLTH SERV SER, V50; Australian Institute of Health and Welfare, 2013, HLTH EXO AUSTR 2011, V50; Australian Institute of Health and Welfare, 2013, AUSTR I HLTH WELF HL, V50; Banks E, 2008, INT J EPIDEMIOL, V37, P941, DOI 10.1093/ije/dym184; Bell JF, 2011, OBESITY, V19, P228, DOI 10.1038/oby.2010.104; Birmingham CL, 1999, CAN MED ASSOC J, V160, P483; Borg S, 2005, VALUE HEALTH, V8, P562, DOI 10.1111/j.1524-4733.2005.00048.x; Brown WJ, 2008, AUST NZ J PUBL HEAL, V32, P150, DOI 10.1111/j.1753-6405.2008.00192.x; Colagiuri S, 2010, MED J AUSTRALIA, V192, P260, DOI 10.5694/j.1326-5377.2010.tb03503.x; Darrow LA, 2011, EPIDEMIOLOGY, V22, P53, DOI 10.1097/EDE.0b013e3181fce49b; Dee Anne, 2014, BMC Res Notes, V7, P242, DOI 10.1186/1756-0500-7-242; Detournay B, 2000, INT J OBESITY, V24, P151, DOI 10.1038/sj.ijo.0801099; Fay MP, 1997, STAT MED, V16, P791; Finkelstein EA, 2008, OBESITY, V16, P1843, DOI 10.1038/oby.2008.290; Glick H, 2007, EC EVALUATION CLIN T; Gorber SC, 2007, OBES REV, V8, P307, DOI 10.1111/j.1467-789X.2007.00347.x; Guh DP, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-88; Joshy G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088641; Khaodhiar L, 1999, Clin Cornerstone, V2, P17, DOI 10.1016/S1098-3597(99)90002-9; Knai C, 2007, ECON HUM BIOL, V5, P392, DOI 10.1016/j.ehb.2007.08.002; Korda RJ, 2012, INT J OBES LOND; Kuriyama S, 2002, INT J OBESITY, V26, P1069, DOI 10.1038/sj.ijo.0802021; Lal A, 2012, AUST NZ J PUBL HEAL, V36, P550, DOI 10.1111/j.1753-6405.2012.00931.x; Luchsinger JA, 2003, J AM GERIATR SOC, V51, P1615, DOI 10.1046/j.1532-5415.2003.51513.x; National Casemix and Classification Centre, 2012, IND HOSP PRIC AUTH A; Ng M, 2014, LANCET, V384, P766, DOI 10.1016/S0140-6736(14)60460-8; Ng SP, 2011, AUST NZ J PUBL HEAL, V35, P557, DOI 10.1111/j.1753-6405.2011.00742.x; Organisation for Economic Co-operation and Development, 2010, OB EC PREV FIT NOT F; Ostbye T, 2014, OBESITY, V22, P1179, DOI 10.1002/oby.20669; Pan WH, 2012, ASIA PAC J CLIN NUTR, V21, P577; Pi-Sunyer FX, 1999, MED SCI SPORT EXER, V31, pS602, DOI 10.1097/00005768-199911001-00019; Reeves GK, 2014, BMC MED, V12, DOI 10.1186/1741-7015-12-45; Rothman KJ, 2013, INT J EPIDEMIOL, V42, P1012, DOI 10.1093/ije/dys223; Tarride JE, 2012, CLINICOECONOMIC OUTC, V4, P21, DOI 10.2147/CEOR.S24192; Tsai AG, 2011, OBES REV, V12, P50, DOI 10.1111/j.1467-789X.2009.00708.x; van Baal PHM, 2008, PLOS MED, V5, P242, DOI 10.1371/journal.pmed.0050029; Whitlock G, 2009, LANCET, V373, P1083, DOI 10.1016/S0140-6736(09)60318-4; Withrow D, 2011, OBES REV, V12, P131, DOI 10.1111/j.1467-789X.2009.00712.x; World Health Organization, 2006, WHO GLOB DAT BOD MAS; Zhao W, 2008, OBES REV, V9, P62, DOI 10.1111/j.1467-789X.2007.00440.x	48	26	26	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2015	10	3							e0118599	10.1371/journal.pone.0118599	http://dx.doi.org/10.1371/journal.pone.0118599			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9JM	25739093	gold, Green Submitted, Green Published			2022-12-27	WOS:000350685900054
J	Li, Y; Maki, M				Li, Yue; Maki, Masayuki			Variation in the Frequency and Extent of Hybridization between Leucosceptrum japonicum and L. stellipilum (Lamiaceae) in the Central Japanese Mainland	PLOS ONE			English	Article							POPULATION GENETIC-STRUCTURE; AMPLIFIED POLYMORPHIC DNA; REPRODUCTIVE ISOLATION; HYBRID ZONES; NATURAL HYBRIDIZATION; SILENE-DIOICA; ECOLOGICAL DIFFERENTIATION; PHYLLODOCE-ALEUTICA; QUERCUS-CRASSIFOLIA; POLLEN PERFORMANCE	Variations in the frequency and extent of hybridization among mixed populations located in the same contact zone provide natural laboratories for the study of extrinsic reproductive isolation maintaining species integrity. In this study, we examined the pattern of hybridization between L. japonicum and L. stellipilum among mixed populations in different localities of a contact zone. The genetic structures from three sympatric populations and six mixed populations in the hybrid zone, and five reference populations far from the contact zone, were characterized using 10 neutral nuclear microsatellite markers. Evidence from genetic distance-based clustering analysis, the frequency distribution of admixture proportion values, and the hybrid category assignment approaches indicated that the frequency and extent of hybridization varied considerably among populations in the contact zone between L. japonicum and L. stellipilum. One likely explanation is that variation in exogenous (ecological) selection among populations might contribute to differences in frequency and extent of hybridization. The present study will facilitate future research exploring the evolution of reproductive isolation between L. japonicum and L. stellipilum.	[Li, Yue] Tohoku Univ, Div Plant Evolutionary Biol, Dept Environm Life Sci, Grad Sch Life Sci,Aoba Ku, Sendai, Miyagi 9808578, Japan; [Li, Yue; Maki, Masayuki] Tohoku Univ, Bot Gardens, Aoba Ku, Sendai, Miyagi 9800862, Japan	Tohoku University; Tohoku University	Li, Y (corresponding author), Tohoku Univ, Div Plant Evolutionary Biol, Dept Environm Life Sci, Grad Sch Life Sci,Aoba Ku, Sendai, Miyagi 9808578, Japan.	yueli@life.biology.tohoku.ac.jp			Japan Society for the Promotion of Science [JSPS KAKENHI 21570086]; Tohoku University Global Centre of Excellence (GCOE) Program "Centre for ecosystem management adapting to global change" [J03]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Tohoku University Global Centre of Excellence (GCOE) Program "Centre for ecosystem management adapting to global change"	This study was supported by a Grant-in-Aid to MM from the Japan Society for the Promotion of Science (JSPS KAKENHI 21570086, http://www.jsps.go.jp) and Tohoku University Global Centre of Excellence (GCOE) Program "Centre for ecosystem management adapting to global change" (J03). The stay of YL in Japan was supported by the China Scholarship Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott R, 2013, J EVOLUTION BIOL, V26, P229, DOI 10.1111/j.1420-9101.2012.02599.x; Albaladejo RG, 2007, ANN BOT-LONDON, V100, P735, DOI 10.1093/aob/mcm154; Albaladejo RG, 2004, BOT J LINN SOC, V145, P97, DOI 10.1111/j.1095-8339.2003.00266.x; Aldridge G, 2006, AM J BOT, V93, P903, DOI 10.3732/ajb.93.6.903; Aldridge G, 2005, NEW PHYTOL, V167, P279, DOI 10.1111/j.1469-8137.2005.01413.x; Aldridge G, 2009, HEREDITY, V102, P257, DOI 10.1038/hdy.2008.112; Aldridge G, 2007, EVOLUTION, V61, P99, DOI 10.1111/j.1558-5646.2007.00008.x; ANDERSON E, 1948, EVOLUTION, V2, P1, DOI 10.2307/2405610; Anderson EC, 2002, GENETICS, V160, P1217; Anderson EC, 2008, PHILOS T R SOC B, V363, P2841, DOI 10.1098/rstb.2008.0043; Boecklen WJ, 1997, ECOLOGY, V78, P2611, DOI 10.1890/0012-9658(1997)078[2611:GAOHZN]2.0.CO;2; Burgess KS, 2005, MOL ECOL, V14, P3471, DOI 10.1111/j.1365-294X.2005.02670.x; Chung MY, 2005, MOL ECOL, V14, P4389, DOI 10.1111/j.1365-294X.2005.02738.x; CRUZAN MB, 1993, EVOLUTION, V47, P1432, DOI 10.1111/j.1558-5646.1993.tb02165.x; De Hert K, 2012, ANN BOT-LONDON, V109, P709, DOI 10.1093/aob/mcr305; Delph LF, 1997, ECOLOGY, V78, P1632, DOI 10.1890/0012-9658(1997)078[1632:HEFAPP]2.0.CO;2; Durrett R, 2000, HEREDITY, V84, P9, DOI 10.1046/j.1365-2540.2000.00566.x; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Ellstrand NC, 1996, P NATL ACAD SCI USA, V93, P5090, DOI 10.1073/pnas.93.10.5090; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Ferguson CJ, 1999, PLANT SYST EVOL, V218, P153, DOI 10.1007/BF01087043; Field DL, 2009, CONSERV GENET, V10, P881, DOI 10.1007/s10592-008-9649-3; Garroway CJ, 2010, GLOBAL CHANGE BIOL, V16, P113, DOI 10.1111/j.1365-2486.2009.01948.x; Goulson D, 1997, OIKOS, V79, P115, DOI 10.2307/3546096; Goulson D, 2009, PLANT ECOL, V205, P201, DOI 10.1007/s11258-009-9610-7; HAMRICK JL, 1979, EVOLUTION, V33, P521, DOI 10.1111/j.1558-5646.1979.tb04707.x; Harrison RG, 1997, EVOLUTION, V51, P493, DOI 10.1111/j.1558-5646.1997.tb02437.x; HARRISON RG, 1986, HEREDITY, V56, P337, DOI 10.1038/hdy.1986.55; HARTIGAN JA, 1985, ANN STAT, V13, P70, DOI 10.1214/aos/1176346577; Hewitt GM, 2004, PHILOS T R SOC B, V359, P183, DOI 10.1098/rstb.2003.1388; HEWITT GM, 1988, TRENDS ECOL EVOL, V3, P158, DOI 10.1016/0169-5347(88)90033-X; Jakobsson M, 2007, BIOINFORMATICS, V23, P1801, DOI 10.1093/bioinformatics/btm233; Jiggins CD, 2000, TRENDS ECOL EVOL, V15, P250, DOI 10.1016/S0169-5347(00)01873-5; Johanet A, 2011, HEREDITY, V106, P962, DOI 10.1038/hdy.2010.144; Johnston JA, 2001, AM J BOT, V88, P933, DOI 10.2307/2657046; Kameyama Y, 2008, J EVOLUTION BIOL, V21, P588, DOI 10.1111/j.1420-9101.2007.01476.x; Kameyama Y, 2011, PLANT SPEC BIOL, V26, P93, DOI 10.1111/j.1442-1984.2010.00301.x; Karrenberg S, 2008, EVOLUTION, V62, P763, DOI 10.1111/j.1558-5646.2008.00330.x; Kuehn MM, 1999, MOL ECOL, V8, P1981, DOI 10.1046/j.1365-294x.1999.00792.x; Langella O., 1999, POPULATIONS 1 2 32; Lepais O, 2009, MOL ECOL, V18, P2228, DOI 10.1111/j.1365-294X.2009.04137.x; LEVIN D A, 1971, Taxon, V20, P91, DOI 10.2307/1218538; Lexer C, 2005, MOL ECOL, V14, P1045, DOI 10.1111/j.1365-294X.2005.02469.x; Li Y, 2014, PLANT SYST EVOL, P1; Li Y, 2013, APPL PLANT SCI, V1, DOI 10.3732/apps.1300038; Lo EYY, 2010, J EVOLUTION BIOL, V23, P2249, DOI 10.1111/j.1420-9101.2010.02087.x; Maechler M, 2009, DIPTEST HARTIGANS DI; Maki M, 1999, MOL ECOL, V8, P145, DOI 10.1046/j.1365-294X.1999.00517.x; Mallet J, 2005, TRENDS ECOL EVOL, V20, P229, DOI 10.1016/j.tree.2005.02.010; Marques I, 2007, AM J BOT, V94, P1352, DOI 10.3732/ajb.94.8.1352; Martin NH, 2007, EVOLUTION, V61, P68, DOI 10.1111/j.1558-5646.2007.00006.x; Martinsen GD, 2001, EVOLUTION, V55, P1325, DOI 10.1111/j.0014-3820.2001.tb00655.x; McIntosh EJ, 2014, ANN BOT-LONDON, V113, P861, DOI 10.1093/aob/mct314; Milne RI, 2003, MOL ECOL, V12, P2719, DOI 10.1046/j.1365-294X.2003.01942.x; Mimura M, 2014, BMC EVOL BIOL, V14, DOI 10.1186/s12862-014-0209-9; Minder AM, 2007, MOL ECOL, V16, P2504, DOI 10.1111/j.1365-294X.2007.03292.x; Moccia MD, 2007, MOL ECOL, V16, P2855, DOI 10.1111/j.1365-294X.2007.03240.x; MURATA G., 1993, FLORA JAPAN A, VIIIa, P84; Naisbit RE, 2003, EVOL DEV, V5, P269, DOI 10.1046/j.1525-142X.2003.03034.x; NASON JD, 1992, AM J BOT, V79, P101, DOI 10.2307/2445203; NEI M, 1983, J MOL EVOL, V19, P153, DOI 10.1007/BF02300753; Nielsen EE, 2006, MOL ECOL NOTES, V6, P971, DOI 10.1111/j.1471-8286.2006.01433.x; Nosil P, 2005, EVOLUTION, V59, P705; Nosil P, 2011, TRENDS ECOL EVOL, V26, P160, DOI 10.1016/j.tree.2011.01.001; Oberprieler C, 2011, PLANT SYST EVOL, V293, P177, DOI 10.1007/s00606-011-0431-5; Ohwi J, 1965, FLORA JAPAN; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; Petit RJ, 2002, FOREST ECOL MANAG, V156, P5, DOI 10.1016/S0378-1127(01)00645-4; Presgraves DC, 2010, NAT REV GENET, V11, P175, DOI 10.1038/nrg2718; Pritchard JK, 2000, GENETICS, V155, P945; R Development Core Team, 2012, R LANG ENV STAT COMP, DOI [10.1002/jcc.22917, DOI 10.1002/JCC.22917]; Ramsey J, 2003, EVOLUTION, V57, P1520, DOI 10.1111/j.0014-3820.2003.tb00360.x; Ren GP, 2012, HEREDITY, V108, P552, DOI 10.1038/hdy.2011.123; Rieseberg LH, 1998, NEW PHYTOL, V140, P599, DOI 10.1046/j.1469-8137.1998.00315.x; RIESEBERG LH, 1993, CRIT REV PLANT SCI, V12, P213, DOI 10.1080/713608045; Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; Ruane LG, 2007, AM J BOT, V94, P219, DOI 10.3732/ajb.94.2.219; Silvertown J, 2005, HEREDITY, V95, P198, DOI 10.1038/sj.hdy.6800710; Sun M, 2011, PLOS ONE, V6; SUZUKI K, 1984, BOT MAG TOKYO, V97, P381, DOI 10.1007/BF02488670; Swenson NG, 2008, WEST N AM NATURALIST, V68, P498, DOI 10.3398/1527-0904-68.4.498; Tagane S, 2008, J PLANT RES, V121, P387, DOI 10.1007/s10265-008-0167-7; Thomas DT, 2008, INT J PLANT SCI, V169, P647, DOI 10.1086/533605; Tovar-Sanchez E, 2006, OECOLOGIA, V147, P702, DOI 10.1007/s00442-005-0328-5; Tovar-Sanchez E, 2004, AM J BOT, V91, P1352, DOI 10.3732/ajb.91.9.1352; Travers SE, 1999, ECOLOGY, V80, P2427, DOI 10.1890/0012-9658(1999)080[2427:PPOPIR]2.0.CO;2; Vaha JP, 2006, MOL ECOL, V15, P63, DOI 10.1111/j.1365-294X.2005.02773.x; Van Droogenbroeck B, 2006, ANN BOT-LONDON, V97, P793, DOI 10.1093/aob/mcl038; Watano Y, 2004, AM J BOT, V91, P65, DOI 10.3732/ajb.91.1.65; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; Westberg E, 2010, BIOL J LINN SOC, V101, P526, DOI 10.1111/j.1095-8312.2010.01487.x; Whitney KD, 2010, PERSPECT PLANT ECOL, V12, P175, DOI 10.1016/j.ppees.2010.02.002; Williams JH, 2001, HEREDITY, V87, P680, DOI 10.1046/j.1365-2540.2001.00968.x; Wu CI, 2001, J EVOLUTION BIOL, V14, P851, DOI 10.1046/j.1420-9101.2001.00335.x; Yost JM, 2012, AM J BOT, V99, P890, DOI 10.3732/ajb.1100521; Zeng YF, 2011, MOL ECOL, V20, P4995, DOI 10.1111/j.1365-294X.2011.05354.x; Zha HG, 2010, ANN BOT-LONDON, V105, P89, DOI 10.1093/aob/mcp267	98	4	4	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2015	10	3							e0116411	10.1371/journal.pone.0116411	http://dx.doi.org/10.1371/journal.pone.0116411			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9JM	25738505	Green Published, Green Submitted, gold			2022-12-27	WOS:000350685900011
J	Regan, JF; Kamitaki, N; Legler, T; Cooper, S; Klitgord, N; Karlin-Neumann, G; Wong, C; Hodges, S; Koehler, R; Tzonev, S; McCarroll, SA				Regan, John F.; Kamitaki, Nolan; Legler, Tina; Cooper, Samantha; Klitgord, Niels; Karlin-Neumann, George; Wong, Catherine; Hodges, Shawn; Koehler, Ryan; Tzonev, Svilen; McCarroll, Steven A.			A Rapid Molecular Approach for Chromosomal Phasing	PLOS ONE			English	Article							POLYMERASE-CHAIN-REACTION; CYSTIC-FIBROSIS GENE; NUCLEOTIDE-BINDING FOLD; DE-NOVO MUTATIONS; REGULATORY VARIATION; GENOMIC DNA; COPY NUMBER; DIGITAL PCR; HUMAN-CELLS; STEM-CELLS	Determining the chromosomal phase of pairs of sequence variants - the arrangement of specific alleles as haplotypes - is a routine challenge in molecular genetics. Here we describe Drop-Phase, a molecular method for quickly ascertaining the phase of pairs of DNA sequence variants (separated by 1-200 kb) without cloning or manual single-molecule dilution. In each Drop-Phase reaction, genomic DNA segments are isolated in tens of thousands of nanoliter-sized droplets together with allele-specific fluorescence probes, in a single reaction well. Physically linked alleles partition into the same droplets, revealing their chromosomal phase in the co-distribution of fluorophores across droplets. We demonstrated the accuracy of this method by phasing members of trios (revealing 100% concordance with inheritance information), and demonstrate a common clinical application by phasing CFTR alleles at genomic distances of 11-116 kb in the genomes of cystic fibrosis patients. Drop-Phase is rapid (requiring less than 4 hours), scalable (to hundreds of samples), and effective at long genomic distances (200 kb).	[Regan, John F.; Legler, Tina; Cooper, Samantha; Klitgord, Niels; Karlin-Neumann, George; Hodges, Shawn; Koehler, Ryan; Tzonev, Svilen] Digital Biol Ctr, Biorad Labs, Pleasanton, CA 94588 USA; [Kamitaki, Nolan; Wong, Catherine; McCarroll, Steven A.] Harvard Univ, Sch Med, Dept Genet, Boston, MA USA; [Kamitaki, Nolan; McCarroll, Steven A.] Program Med & Populat Genet, Cambridge, MA USA; [Kamitaki, Nolan; McCarroll, Steven A.] Stanley Ctr Psychiat Res, Cambridge, MA USA	Harvard University; Harvard Medical School	Regan, JF (corresponding author), Digital Biol Ctr, Biorad Labs, Pleasanton, CA 94588 USA.	jack_regan@bio-rad.com; mccarroll@genetics.med.harvard.edu		Kamitaki, Nolan/0000-0003-0614-0189	Broad Institute	Broad Institute	This work was supported by Broad Institute (http://www.broadinstitute.org/). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abyzov A, 2012, NATURE, V492, P438, DOI 10.1038/nature11629; Bauer DE, 2013, SCIENCE, V342, P253, DOI 10.1126/science.1242088; Boettger LM, 2012, NAT GENET, V44, P881, DOI 10.1038/ng.2334; Chen N, 2011, GENET MED, V13, P1025, DOI 10.1097/GIM.0b013e3182272e0b; Cho SW, 2013, NAT BIOTECHNOL, V31, P230, DOI 10.1038/nbt.2507; CHU CS, 1993, NAT GENET, V3, P151, DOI 10.1038/ng0293-151; COLLINS FS, 1987, SCIENCE, V235, P1046, DOI 10.1126/science.2950591; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Conrad DF, 2011, NAT GENET, V43, P712, DOI 10.1038/ng.862; Cowles CR, 2002, NAT GENET, V32, P432, DOI 10.1038/ng992; CUTTING GR, 1990, NATURE, V346, P366, DOI 10.1038/346366a0; DEAN M, 1990, CELL, V61, P863, DOI 10.1016/0092-8674(90)90196-L; DEAR PH, 1993, NUCLEIC ACIDS RES, V21, P13, DOI 10.1093/nar/21.1.13; Ding CM, 2003, P NATL ACAD SCI USA, V100, P7449, DOI 10.1073/pnas.1232475100; ESTIVILL X, 1987, NATURE, V326, P840, DOI 10.1038/326840a0; Fromer M, 2014, NATURE, V506, P179, DOI 10.1038/nature12929; Hindson BJ, 2011, ANAL CHEM, V83, P8604, DOI 10.1021/ac202028g; Kaper F, 2013, P NATL ACAD SCI USA, V110, P5552, DOI 10.1073/pnas.1218696110; KEREM BS, 1989, SCIENCE, V245, P1073, DOI 10.1126/science.2570460; KIESEWETTER S, 1993, NAT GENET, V5, P274, DOI 10.1038/ng1193-274; Kitzman JO, 2011, NAT BIOTECHNOL, V29, P59, DOI 10.1038/nbt.1740; Kong A, 2012, NATURE, V488, P471, DOI 10.1038/nature11396; LOGAN J, 1994, J CLIN INVEST, V94, P228, DOI 10.1172/JCI117311; Londin ER, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013443; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; McDonald OG, 2002, PHARMACOGENETICS, V12, P93, DOI 10.1097/00008571-200203000-00003; OSBORNE L, 1991, AM J HUM GENET, V48, P608; Pastinen T, 2010, NAT REV GENET, V11, P533, DOI 10.1038/nrg2815; Paul P, 2005, BIOTECHNIQUES, V38, P553, DOI 10.2144/05384ST01; Peters BA, 2012, NATURE, V487, P190, DOI 10.1038/nature11236; Pont-Kingdon G, 2004, J MOL DIAGN, V6, P264, DOI 10.1016/S1525-1578(10)60520-X; RIORDAN JR, 1989, SCIENCE, V245, P1066; RUANO G, 1989, NUCLEIC ACIDS RES, V17, P8392, DOI 10.1093/nar/17.20.8392; Shlush LI, 2014, NATURE, V506, P328, DOI 10.1038/nature13038; Sosnay PR, 2013, NAT GENET, V45, P1160, DOI 10.1038/ng.2745; SYKES PJ, 1992, BIOTECHNIQUES, V13, P444; Vogelstein B, 1999, P NATL ACAD SCI USA, V96, P9236, DOI 10.1073/pnas.96.16.9236; ZIELENSKI J, 1991, GENOMICS, V10, P229, DOI 10.1016/0888-7543(91)90504-8	38	39	43	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2015	10	3							e0118270	10.1371/journal.pone.0118270	http://dx.doi.org/10.1371/journal.pone.0118270			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9JM	25739099	gold, Green Submitted, Green Published			2022-12-27	WOS:000350685900027
J	Gao, JW; Zhang, AQ; Pan, W; Yue, CL; Zeng, L; Gu, W; Jiang, JX				Gao, Jun-wei; Zhang, An-qiang; Pan, Wei; Yue, Cai-li; Zeng, Ling; Gu, Wei; Jiang, Jianxin			Association between IL-6-174G/C Polymorphism and the Risk of Sepsis and Mortality: A Systematic Review and Meta-Analysis	PLOS ONE			English	Article							TNF-ALPHA POLYMORPHISMS; C-REACTIVE PROTEIN; GENETIC POLYMORPHISMS; PROMOTER POLYMORPHISM; INTERLEUKIN-6 GENE; UNITED-STATES; IL-6; VARIANTS; SEVERITY; MARKERS	Background Recent studies have reported the association between IL-6-174G/C polymorphism and sepsis. However, the results are inconclusive and conflicting. To better understand the role of IL-6-174G/C polymorphism in sepsis, we conducted a comprehensive meta-analysis. Methodology Literature search was conducted through PubMed, Embase, Web of Knowledge databases until July 29, 2013. The pooled odds ratios (ORs) and 95% confidence intervals (CIs) were calculated using fixed- or random-effect model based on heterogeneity test in total and subgroup analyses. Results Twenty studies on the risk of sepsis and seven studies on sepsis mortality were included. None of the results showed evidence of a significant association between IL-6-174 G/C polymorphism and sepsis risk in overall analysis or subgroup analyses based on sepsis type, ethnicity, source of control and age under any genetic model (the allele comparison, the codominant, the recessive or the dominant model). Although there was a statistically significant association between IL-6-174 G/C polymorphism and sepsis-related mortality under the recessive model, the significance did not exist after Bonferroni's correction. Conclusions Current evidence does not support a direct effect of IL-6-174 G/C polymorphism on the risk of sepsis. In addition, there was no association between IL-6-174 G/C polymorphism and sepsis mortality after Bonferroni's correction. Further analyses of gene-environment interactions and more studies based on larger sample size and homogeneous sepsis patients are required.	[Gao, Jun-wei; Zhang, An-qiang; Pan, Wei; Yue, Cai-li; Zeng, Ling; Gu, Wei; Jiang, Jianxin] Third Mil Med Univ, Daping Hosp, Inst Surg Res, State Key Lab Trauma Burns & Combined Injury, Chongqing 400042, Peoples R China	Army Medical University	Jiang, JX (corresponding author), Third Mil Med Univ, Daping Hosp, Inst Surg Res, State Key Lab Trauma Burns & Combined Injury, Chongqing 400042, Peoples R China.	hellojjx@126.com	Gao, Junwei/GXF-2694-2022		National Key Technology RD Program [2012BAI11B01]; Major State Basic Research Development Program of China [2012CB518104]; National Natural Science Funds for Distinguished Young Scholar [81201462]; Open fund of State Key Laboratory of Trauma, Burns and Combined Injury, Third Military Medical University [SKLZZ201104]	National Key Technology RD Program(National Key Technology R&D Program); Major State Basic Research Development Program of China(National Basic Research Program of China); National Natural Science Funds for Distinguished Young Scholar(National Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars); Open fund of State Key Laboratory of Trauma, Burns and Combined Injury, Third Military Medical University	This work is supported by National Key Technology R&D Program (2012BAI11B01), the Major State Basic Research Development Program of China (2012CB518104), National Natural Science Funds for Distinguished Young Scholar (81201462), and Open fund of State Key Laboratory of Trauma, Burns and Combined Injury, Third Military Medical University (SKLZZ201104). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Hady H, 2009, J PEDIAT INF DIS-GER, V4, P357, DOI 10.3233/JPI-2009-0203; Ahrens P, 2004, PEDIATR RES, V55, P652, DOI 10.1203/01.PDR.0000112100.61253.85; Angus D C, 2001, Crit Care Med, V29, P1303, DOI 10.1097/00003246-200107000-00002; Baier RJ, 2006, BMC MED, V4, DOI 10.1186/1741-7015-4-10; Balding J, 2003, GENES IMMUN, V4, P533, DOI 10.1038/sj.gene.6364020; Barber RC, 2004, J MED GENET, V41, P808, DOI 10.1136/jmg.2004.021600; BONE RC, 1992, CRIT CARE MED, V20, P864, DOI 10.1097/00003246-199206000-00025; BORDEN EC, 1994, J LAB CLIN MED, V123, P824; Carregaro F, 2010, MEM I OSWALDO CRUZ, V105, P649, DOI 10.1590/S0074-02762010000500008; Chauhan M, 2008, ARCH DIS CHILD-FETAL, V93, P1427, DOI 10.1136/adc.2007.134205; Davis SM, 2010, AM J OBSTET GYNECOL, V202, DOI 10.1016/j.ajog.2010.01.006; Deasy A, 2010, CURR OPIN INFECT DIS, V23, P255, DOI 10.1097/QCO.0b013e32833939de; Dombrovskiy VY, 2007, CRIT CARE MED, V35, P1244, DOI 10.1097/01.CCM.0000261890.41311.E9; Fishman D, 1998, J CLIN INVEST, V102, P1369, DOI 10.1172/JCI2629; Gopel W, 2006, GENES IMMUN, V7, P65, DOI 10.1038/sj.gene.6364264; Grealy R, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/164246; Guerreiro CS, 2009, AM J GASTROENTEROL, V104, P2241, DOI 10.1038/ajg.2009.313; Harding D, 2003, PEDIATRICS, V112, P800, DOI 10.1542/peds.112.4.800; Jin YH, 2013, J VIROL; Kilpinen S, 2001, EUR CYTOKINE NETW, V12, P62; Lam HS, 2008, PATHOLOGY, V40, P141, DOI 10.1080/00313020701813735; Martin-Loeches I, 2012, INTENS CARE MED, V38, P256, DOI 10.1007/s00134-011-2406-y; McDaniel DO, 2007, J TRAUMA, V63, P147, DOI 10.1097/TA.0b013e31806bf0ab; Michalek J, 2007, HUM IMMUNOL, V68, P756, DOI 10.1016/j.humimm.2007.06.003; Miguel-Bayarri V, 2012, MED INTENSIVA, V36, P556, DOI 10.1016/j.medin.2012.01.014; Namath A, 2009, CRIT CARE CLIN, V25, P835, DOI 10.1016/j.ccc.2009.06.004; Palmiere C, 2014, CROAT MED J, V55, P103, DOI 10.3325/cmj.2014.55.103; Palumbo AA, 2012, BURNS, V38, P208, DOI 10.1016/j.burns.2011.07.022; Reiman M, 2008, J PEDIATR-US, V153, P19, DOI 10.1016/j.jpeds.2008.02.009; Sabelnikovs Olegs, 2008, Proceedings of the Latvian Academy of Sciences Section B Natural Exact and Applied Sciences, V62, P162, DOI 10.2478/v10046-008-0019-9; Sapru A., 2011, OPEN INFLAMM, V4, P82; Schluter B, 2002, CRIT CARE MED, V30, P32, DOI 10.1097/00003246-200201000-00005; Shalhub S, 2009, J TRAUMA, V66, P115, DOI 10.1097/TA.0b013e3181938d50; Shimada T, 2011, CYTOKINE, V54, P79, DOI 10.1016/j.cyto.2010.12.001; Sipahi T, 2006, CLIN APPL THROMB-HEM, V12, P47, DOI 10.1177/107602960601200108; Sole-Violan J, 2010, RESP MED, V104, P440, DOI 10.1016/j.rmed.2009.10.009; Treszl A, 2003, BIOL NEONATE, V83, P241, DOI 10.1159/000069484; Tschaikowsky K, 2011, J CRIT CARE, V26, P54, DOI 10.1016/j.jcrc.2010.04.011; Uusitalo-Seppala R, 2011, SCAND J INFECT DIS, V43, P883, DOI 10.3109/00365548.2011.600325; Wong HR, 2012, CRIT CARE MED, V40, P1618, DOI 10.1097/CCM.0b013e318246b546	40	33	37	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2015	10	3							e0118843	10.1371/journal.pone.0118843	http://dx.doi.org/10.1371/journal.pone.0118843			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4HV	25734339	Green Submitted, gold, Green Published			2022-12-27	WOS:000350314700046
J	Profant, O; Tintera, J; Balogova, Z; Ibrahim, I; Jilek, M; Syka, J				Profant, Oliver; Tintera, Jaroslav; Balogova, Zuzana; Ibrahim, Ibrahim; Jilek, Milan; Syka, Josef			Functional Changes in the Human Auditory Cortex in Ageing	PLOS ONE			English	Article							AGE-RELATED-CHANGES; HEARING-LOSS; HEMISPHERIC-ASYMMETRY; SPEECH-PERCEPTION; WORKING-MEMORY; PRESBYCUSIS; RECOGNITION; IMPAIRMENT; LATERALIZATION; DISCRIMINATION	Hearing loss, presbycusis, is one of the most common sensory declines in the ageing population. Presbycusis is characterised by a deterioration in the processing of temporal sound features as well as a decline in speech perception, thus indicating a possible central component. With the aim to explore the central component of presbycusis, we studied the function of the auditory cortex by functional MRI in two groups of elderly subjects (>65 years) and compared the results with young subjects (<lt;30 years). The elderly group with expressed presbycusis (EP) differed from the elderly group with mild presbycusis (MP) in hearing thresholds measured by pure tone audiometry, presence and amplitudes of transient oto acoustic emissions (TEOAE) and distortion-product oto-acoustic emissions (DPOAE), as well as in speech-understanding under noisy conditions. Acoustically evoked activity (pink noise centered around 350 Hz, 700 Hz, 1.5 kHz, 3 kHz, 8 kHz), recorded by BOLD fMRI from an area centered on Heschl's gyrus, was used to determine age-related changes at the level of the auditory cortex. The fMRI showed only minimal activation in response to the 8 kHz stimulation, despite the fact that all subjects heard the stimulus. Both elderly groups showed greater activation in response to acoustical stimuli in the temporal lobes in comparison with young subjects. In addition, activation in the right temporal lobe was more expressed than in the left temporal lobe in both elderly groups, whereas in the young control subjects (YC) leftward lateralization was present. No statistically significant differences in activation of the auditory cortex were found between the MP and EP groups. The greater extent of cortical activation in elderly subjects in comparison with young subjects, with an asymmetry towards the right side, may serve as a compensatory mechanism for the impaired processing of auditory information appearing as a consequence of ageing.	[Profant, Oliver; Balogova, Zuzana; Jilek, Milan; Syka, Josef] Acad Sci Czech Republ, Inst Expt Med, Dept Auditory Neurosci, Prague, Czech Republic; [Tintera, Jaroslav; Ibrahim, Ibrahim] Inst Clin & Expt Med, Dept Diagnost & Intervent Radiol, MR Unit, Prague, Czech Republic; [Profant, Oliver; Balogova, Zuzana] Charles Univ Prague, Univ Hosp Motol, Fac Med 1, Dept Otorhinolaryngol Head & Neck Surg, Prague, Czech Republic	Czech Academy of Sciences; Institute of Experimental Medicine of the Czech Academy of Sciences; Institute for Clinical & Experimental Medicine (IKEM); Charles University Prague; Motol University Hospital	Profant, O (corresponding author), Acad Sci Czech Republ, Inst Expt Med, Dept Auditory Neurosci, Prague, Czech Republic.	profant@biomed.cas.cz	Balogova, Zuzana/R-1146-2018	Ibrahim, Ibrahim/0000-0003-3530-5165	GACR (Czech acronym of the Czech Science Foundation) [P304/10/1872]; GACR [P304/12/G069]; PRVOUK (Czech acronym of the Charles University Research Development Schemes) [P27]	GACR (Czech acronym of the Czech Science Foundation); GACR(Grant Agency of the Czech Republic); PRVOUK (Czech acronym of the Charles University Research Development Schemes)	This research was supported by the grant GACR (Czech acronym of the Czech Science Foundation) P304/10/1872, GACR P304/12/G069, PRVOUK (Czech acronym of the Charles University Research Development Schemes) P27 and Institutional Support 00023001IKEM of the Ministry of Health of the Czech Republic. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1988, J ACOUST SOC AM, V83, P859; Baltes PB, 1997, PSYCHOL AGING, V12, P12, DOI 10.1037/0882-7974.12.1.12; Bao SW, 2004, NAT NEUROSCI, V7, P974, DOI 10.1038/nn1293; Bishop NA, 2010, NATURE, V464, P529, DOI 10.1038/nature08983; Burianova J, 2009, EXP GERONTOL, V44, P161, DOI 10.1016/j.exger.2008.09.012; Burkard R F, 2001, Am J Audiol, V10, P53, DOI 10.1044/1059-0889(2001/008); Cabeza R, 2004, CEREB CORTEX, V14, P364, DOI 10.1093/cercor/bhg133; Cabeza R, 2000, J COGNITIVE NEUROSCI, V12, P1, DOI 10.1162/08989290051137585; Cabeza R, 2001, SCAND J PSYCHOL, V42, P277, DOI 10.1111/1467-9450.00237; Canlon B, 2010, SPRINGER HANDB AUDIT, V34, P39, DOI 10.1007/978-1-4419-0993-0_3; Caspary DM, 2005, J NEUROSCI, V25, P10952, DOI 10.1523/JNEUROSCI.2451-05.2005; Caspary DM, 2008, J EXP BIOL, V211, P1781, DOI 10.1242/jeb.013581; DAVIS AC, 1991, ACTA OTO-LARYNGOL, P23; Dlouha O, 2011, OTORINOLARINGOLOGIE, V3, P125; Eckert MA, 2008, JARO-J ASSOC RES OTO, V9, P252, DOI 10.1007/s10162-008-0113-3; Eckert MA, 2012, JARO-J ASSOC RES OTO, V13, P703, DOI 10.1007/s10162-012-0332-5; Foo C, 2007, J AM ACAD AUDIOL, V18, P618, DOI 10.3766/jaaa.18.7.8; Frisina DR, 1997, HEARING RES, V106, P95, DOI 10.1016/S0378-5955(97)00006-3; Gates GA, 2005, LANCET, V366, P1111, DOI 10.1016/S0140-6736(05)67423-5; GATES GA, 1991, ACTA OTO-LARYNGOL, V111, P240, DOI 10.3109/00016489109137382; GORDONSALANT S, 1993, J SPEECH HEAR RES, V36, P1276, DOI 10.1044/jshr.3606.1276; Helzner EP, 2005, J AM GERIATR SOC, V53, P2119, DOI 10.1111/j.1532-5415.2005.00525.x; Humes LE, 2012, J AM ACAD AUDIOL, V23, P635, DOI 10.3766/jaaa.23.8.5; Humes LE, 2010, SPRINGER HANDB AUDIT, V34, P211, DOI 10.1007/978-1-4419-0993-0_8; Humes LE, 1996, J SPEECH HEAR RES, V39, P923, DOI 10.1044/jshr.3905.923; Kidd AR, 2012, GERONTOLOGY, V58, P490, DOI 10.1159/000338588; Knecht S, 2000, BRAIN, V123, P2512, DOI 10.1093/brain/123.12.2512; Laplante-Levesque A, 2010, J AGING HEALTH, V22, P143, DOI 10.1177/0898264309352731; Lin JFL, 2012, CEREB CORTEX, V22, P1851, DOI 10.1093/cercor/bhr263; Lutz J, 2007, ACAD RADIOL, V14, P692, DOI 10.1016/j.acra.2007.02.014; Madden DJ, 2009, NEUROPSYCHOL REV, V19, P415, DOI 10.1007/s11065-009-9113-2; Manly JJ, 2003, J CLIN EXP NEUROPSYC, V25, P680, DOI 10.1076/jcen.25.5.680.14579; Mazelova J, 2003, EXP GERONTOL, V38, P87, DOI 10.1016/S0531-5565(02)00155-9; Milham MP, 2002, BRAIN COGNITION, V49, P277, DOI 10.1006/brcg.2001.1501; Moffat SD, 2006, NEUROBIOL AGING, V27, P965, DOI 10.1016/j.neurobiolaging.2005.05.011; MOORE BCJ, 1988, J ACOUST SOC AM, V83, P1093, DOI 10.1121/1.396054; Mutter SA, 2006, Q J EXP PSYCHOL, V59, P1556, DOI 10.1080/17470210500343546; Nash SD, 2011, ARCH OTOLARYNGOL, V137, P432, DOI 10.1001/archoto.2011.15; Nelson EG, 2006, LARYNGOSCOPE, V116, P1, DOI 10.1097/01.mlg.0000236089.44566.62; Ouda L, 2008, EXP GERONTOL, V43, P782, DOI 10.1016/j.exger.2008.04.001; Persad CC, 2002, J GERONTOL B-PSYCHOL, V57, pP223, DOI 10.1093/geronb/57.3.P223; PETERS CA, 1988, J AM GERIATR SOC, V36, P981, DOI 10.1111/j.1532-5415.1988.tb04363.x; Poeppel D, 2008, PHILOS T R SOC B, V363, P1071, DOI 10.1098/rstb.2007.2160; Profant O, 2014, NEUROSCIENCE, V260, P87, DOI 10.1016/j.neuroscience.2013.12.010; Profant O, 2013, EXP GERONTOL, V48, P795, DOI 10.1016/j.exger.2013.04.012; Raji CA, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2011.08.010; Raz N, 2004, NEUROBIOL AGING, V25, P377, DOI 10.1016/S0197-4580(03)00118-0; Riecker A, 2003, J CEREBR BLOOD F MET, V23, P565, DOI 10.1097/01.WCB.0000056063.25434.04; Rodriguez-Aranda C, 2006, DEV NEUROPSYCHOL, V30, P697, DOI 10.1207/s15326942dn3002_3; Rybalko N, 2006, EUR J NEUROSCI, V23, P1614, DOI 10.1111/j.1460-9568.2006.04688.x; Rybalko N, 2010, BEHAV BRAIN RES, V209, P123, DOI 10.1016/j.bbr.2010.01.028; Salvi RJ, 2002, HEARING RES, V170, P96, DOI 10.1016/S0378-5955(02)00386-6; Schonwiesner M, 2007, CEREB CORTEX, V17, P492, DOI 10.1093/cercor/bhj165; Schonwiesner M, 2005, EUR J NEUROSCI, V22, P1521, DOI 10.1111/j.1460-9568.2005.04315.x; SCHUKNECHT HF, 1993, ANN OTO RHINOL LARYN, V102, P1; Shapleske J, 1999, BRAIN RES REV, V29, P26, DOI 10.1016/S0165-0173(98)00047-2; Sprinzl GM, 2010, GERONTOLOGY, V56, P351, DOI 10.1159/000275062; Syka J, 2010, HEARING RES, V264, P70, DOI 10.1016/j.heares.2009.11.003; Tadros SF, 2005, AUDIOL NEURO-OTOL, V10, P44, DOI 10.1159/000082307; Tervaniemi M, 2003, BRAIN RES REV, V43, P231, DOI 10.1016/j.brainresrev.2003.08.004; Tramo MJ, 2005, ANN NY ACAD SCI, V1060, P148, DOI 10.1196/annals.1360.011; Tucker-Drob EM, 2011, NEUROPSYCHOLOGY, V25, P368, DOI 10.1037/a0022348; Van Eyken E, 2007, AUDIOL NEURO-OTOL, V12, P345, DOI 10.1159/000106478; VANROOIJ JCGM, 1990, J ACOUST SOC AM, V88, P2611, DOI 10.1121/1.399981; Walton JP, 2002, J NEUROPHYSIOL, V88, P565, DOI 10.1152/jn.2002.88.2.565; Wilke M, 2007, J NEUROSCI METH, V163, P128, DOI 10.1016/j.jneumeth.2007.01.026; Wilke M, 2006, NEUROIMAGE, V33, P522, DOI 10.1016/j.neuroimage.2006.07.010; Willott JF, 2001, AUDIOL NEURO-OTOL, V6, P231, DOI 10.1159/000046129; Wingfield A, 2005, CURR DIR PSYCHOL SCI, V14, P144, DOI 10.1111/j.0963-7214.2005.00356.x; Wong PCM, 2008, J SPEECH LANG HEAR R, V51, P1026, DOI 10.1044/1092-4388(2008/075)	70	36	36	1	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2015	10	3							e0116692	10.1371/journal.pone.0116692	http://dx.doi.org/10.1371/journal.pone.0116692			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4HV	25734519	Green Published, Green Submitted, gold			2022-12-27	WOS:000350314700006
J	Feng, LH; Lin, GY; Zhang, WG; Dai, D				Feng, Lihang; Lin, Guoyu; Zhang, Weigong; Dai, Dong			Inertia Coupling Analysis of a Self-Decoupled Wheel Force Transducer under Multi-Axis Acceleration Fields	PLOS ONE			English	Article							SENSOR; DESIGN	Wheel force transducer (WFT), which measures the three-axis forces and three-axis torques applied to the wheel, is an important instrument in the vehicle testing field and has been extremely promoted by researchers with great interests. The transducer, however, is typically mounted on the wheel of a moving vehicle, especially on a high speed car, when abruptly accelerating or braking, the mass/inertia of the transducer/wheel itself will have an extra effect on the sensor response so that the inertia/mass loads will also be detected and coupled into the signal outputs. The effect which is considered to be inertia coupling problem will decrease the sensor accuracy. In this paper, the inertia coupling of a universal WFT under multi-axis accelerations is investigated. According to the self-decoupling approach of the WFT, inertia load distribution is solved based on the principle of equivalent mass and rotary inertia, thus then inertia impact can be identified with the theoretical derivation. The verification is achieved by FEM simulation and experimental tests. Results show that strains in simulation agree well with the theoretical derivation. The relationship between the applied acceleration and inertia load for both wheel force and moment is the approximate linear, respectively. All the relative errors are less than 5% which are within acceptable and the inertia loads have the maximum impact on the signal output about 1.5% in the measurement range.	[Feng, Lihang; Lin, Guoyu; Zhang, Weigong; Dai, Dong] Southeast Univ, Sch Instrument Sci & Engn, Nanjing, Jiangsu, Peoples R China	Southeast University - China	Lin, GY (corresponding author), Southeast Univ, Sch Instrument Sci & Engn, Nanjing, Jiangsu, Peoples R China.	Andrew.Lin@seu.edu.cn; zhangwg@seu.edu.cn	Feng, Lihang/G-3411-2014	Feng, Lihang/0000-0002-5790-0478; zhang, weigong/0000-0002-8626-2233	Natural Science Foundation of China [51305078]; Suzhou Science & Technology Project [SYG201303]; Colleges and Universities in Jiangsu Province plans to graduate research and innovation [KYLX_0107]; Fundamental Research Funds for the Central Universities	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Suzhou Science & Technology Project; Colleges and Universities in Jiangsu Province plans to graduate research and innovation; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	The work is supported by Natural Science Foundation of China (Grant 51305078), Suzhou Science & Technology Project (Grant SYG201303), Colleges and Universities in Jiangsu Province plans to graduate research and innovation (Grant KYLX_0107) and Fundamental Research Funds for the Central Universities. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], SPINN WHEEL INT FORC; [Anonymous], VEH DYN DUR TEST US; Ballo F, 2014, EXP MECH, V54, P571, DOI 10.1007/s11340-013-9824-4; Chen X, 2014, J SENSORS, V2014, DOI 10.1155/2014/145870; Cho W, 2010, IEEE T VEH TECHNOL, V59, P638, DOI 10.1109/TVT.2009.2034268; Corno M, 2012, IEEE T CONTR SYST T, V20, P1223, DOI 10.1109/TCST.2011.2163717; Ewald BFR, 2000, MEAS SCI TECHNOL, V11, pR81, DOI 10.1088/0957-0233/11/6/201; Feng LH, 2014, SCI RES ESSAYS, V9, P591, DOI 10.5897/SRE2014.5956; Herrmann M, 2006, 2006010734 SAE, DOI [10.4271/2006-01-0734, DOI 10.4271/2006-01-0734]; Herrmann M, 2005, 2005010857 SAE, DOI [10.4271/2005-01-0857, DOI 10.4271/2005-01-0857]; Hou YL, 2009, MECHATRONICS, V19, P199, DOI 10.1016/j.mechatronics.2008.08.002; Kim JH, 2003, MEASUREMENT, V33, P213, DOI 10.1016/S0263-2241(02)00044-1; Lin GY, 2013, MATH PROBL ENG, V2013, DOI 10.1155/2013/275060; Lin GY, 2015, IEEE SENS J, V15, P1043, DOI 10.1109/JSEN.2014.2359744; Lin G, 2014, P I MECH ENG D-J AUT, V228, P319, DOI 10.1177/0954407013508278; Liu Qinghua, 2011, Journal of Jiangsu University Natural Science Edition, V32, P389, DOI 10.3969/j.issn.1671-7775.2011.04.004; Liu SA, 2002, SENSOR ACTUAT A-PHYS, V100, P223, DOI 10.1016/S0924-4247(02)00135-8; Liu W, 2011, MECH SYST SIGNAL PR, V25, P331, DOI 10.1016/j.ymssp.2010.09.008; Ma JQ, 2013, J SENSORS, V2013, DOI 10.1155/2013/357396; Modern machine & tool CO. INC, 2010, STRAIN GAG WIND TUNN; Ng CWW, 2001, SOFT SOIL ENGINEERING, P225; Paykovic D, 2009, IEEE INTL CONF CONTR, P588, DOI 10.1109/CCA.2009.5281121; SENSY S. A., MULT SENS PREC ASS A; Shinde V.V., 2013, SAE TECH PAP, DOI [10.4271/2013-26-0156, DOI 10.4271/2013-26-0156]; Song AG, 2007, MEASUREMENT, V40, P883, DOI 10.1016/j.measurement.2006.11.018; Spletzer B, 2000, INFORM PACKAGE SIMPL; Weiblen W, 1999, 1999011037 SAE, DOI [10.4271/1999-01-1037, DOI 10.4271/1999-01-1037]; [吴宝元 WU Baoyuan], 2011, [宇航学报, Journal of Chinese Society of Astronautics], V32, P2080; Yang SL, 2013, IEEE T INSTRUM MEAS, V62, P2596, DOI 10.1109/TIM.2013.2259100; You SS, 2012, 2012010210 SAE, DOI [10.4271/2012-01-0210, DOI 10.4271/2012-01-0210]; Zhang XiaoIong, 2012, Journal of Mechanical Engineering, V48, P121, DOI 10.3901/JME.2012.22.121; Zhang YZ, 2013, IEEE SENS J, V13, P1756, DOI 10.1109/JSEN.2013.2241051; Zhongpan S, CHINESE J SCI INSTRU, V33, P1062	33	1	2	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2015	10	2							e0118249	10.1371/journal.pone.0118249	http://dx.doi.org/10.1371/journal.pone.0118249			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC3LS	25723492	Green Submitted, Green Published, gold			2022-12-27	WOS:000350251200053
J	Lin, CC; Pan, IH; Li, YR; Pan, YG; Lin, MK; Lu, YH; Wu, HC; Chu, CL				Lin, Chi-Chen; Pan, I-Hong; Li, Yi-Rong; Pan, Yi-Gen; Lin, Ming-Kuem; Lu, Yi-Huang; Wu, Hsin-Chieh; Chu, Ching-Liang			The Adjuvant Effects of High-Molecule-Weight Polysaccharides Purified from Antrodia cinnamomea on Dendritic Cell Function and DNA Vaccines	PLOS ONE			English	Article							CAMPHORATA MYCELIA; PROPIONIBACTERIUM-ACNES; IMMUNE-RESPONSES; MOUSE MODEL; MUSHROOM; EXTRACTS; FUCOIDAN; IMMUNOMODULATORS; IMMUNOGLOBULIN; CHROMATOGRAPHY	The biological activity of the edible basidiomycete Antrodia cinnamomea (AC) has been studied extensively. Many effects, such as anti-cancer, anti-inflammatory, and antioxidant activities, have been reported from either crude extracts or compounds isolated from AC. However, research addressing the function of AC in enhancing immunity is rare. The aim of the present study is to investigate the active components and the mechanism involved in the immunostimulatory effect of AC. We found that polysaccharides (PS) in the water extract of AC played a major role in dendritic cell (DC) activation, which is a critical leukocyte in initiating immune responses. We further size purified and identified that the high-molecular weight PS fraction (greater than 100 kDa) exhibited the activating effect. The AC high-molecular weight PSs (AC hmwPSs) promoted pro-inflammatory cytokine production by DCs and the maturation of DCs. In addition, DC-induced antigen-specific T cell activation and Th1 differentiation were increased by AC hmwPSs. In studying the molecular mechanism, we confirmed the activation of the MAPK and NF-kappa B pathways in DCs after AC hmwPSs treatment. Furthermore, we demonstrated that TLR2 and TLR4 are required for the stimulatory activity of AC hmwPSs on DCs. In a mouse tumor model, we demonstrated that AC hmwPSs enhanced the anti-tumor efficacy of the neu DNA vaccine/neu DNA vaccine by facilitating specific Th1 responses. Thus, we conclude that hmwPSs are the major components of AC that stimulate DCs via the TLR2/TLR4 and NF-kappa B/MAPK signaling pathways. The AC hmwPSs have potential to be applied as adjuvants.	[Lin, Chi-Chen; Li, Yi-Rong] Natl Chung Hsing Univ, Inst Biomed Sci, Taichung 40227, Taiwan; [Lin, Chi-Chen] Natl Chung Hsing Univ, Rong Hsing Res Ctr Translat Med, Taichung 40227, Taiwan; [Lin, Chi-Chen] Taichung Vet Gen Hosp, Dept Med Res & Educ, Taichung, Taiwan; [Pan, I-Hong; Lu, Yi-Huang; Wu, Hsin-Chieh] Ind Technol Res Inst, Biomed Technol & Device Res Labs, Hsinchu, Taiwan; [Pan, Yi-Gen; Chu, Ching-Liang] Natl Taiwan Univ, Coll Med, Grad Inst Immunol, Taipei 10764, Taiwan; [Lin, Ming-Kuem] China Med Univ, Dept Chinese Pharmaceut Sci & Chinese Med Resourc, Taichung, Taiwan	National Chung Hsing University; National Chung Hsing University; Taichung Veterans General Hospital; Industrial Technology Research Institute - Taiwan; National Taiwan University; China Medical University Taiwan	Chu, CL (corresponding author), Natl Taiwan Univ, Coll Med, Grad Inst Immunol, Taipei 10764, Taiwan.	clchu01@ntu.edu.tw	Wu, Han-Chung/B-1209-2011	Wu, Han-Chung/0000-0002-5185-1169; Chu, Ching-Liang/0000-0002-8463-526X; Pan, Yi-Gen/0000-0003-2427-2759; Lin, Chi-Chien/0000-0002-1464-0231	NTUCM grant [100R311001, NSC1012320B002023MY3]; STSP grant [CX090717103];  [TCVGH-1037309C]	NTUCM grant; STSP grant; 	This work was supported by TCVGH-1037309C (for C.C.L.); parts of NTUCM grant 100R311001, NSC1012320B002023MY3, and STSP grant CX090717103 (for C.L.C.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akira S, 2011, PHILOS T R SOC B, V366, P2748, DOI 10.1098/rstb.2011.0106; Ale MT, 2011, MAR DRUGS, V9, P2106, DOI 10.3390/md9102106; Chen CC, 2007, J AGR FOOD CHEM, V55, P5007, DOI 10.1021/jf063484c; Chen DY, 2013, CLIN DEV IMMUNOL, DOI 10.1155/2013/125643; Chen L, 2004, INT IMMUNOPHARMACOL, V4, P403, DOI 10.1016/j.intimp.2003.12.015; Chen SC, 2005, FEMS MICROBIOL LETT, V249, P247, DOI 10.1016/j.femsle.2005.06.033; Chen Yu-Fen, 2013, Recent Pat Food Nutr Agric, V5, P62, DOI 10.2174/2212798411305010010; Chen YJ, 2008, INT IMMUNOPHARMACOL, V8, P458, DOI 10.1016/j.intimp.2007.11.008; Cheng JJ, 2011, CARBOHYD POLYM, V83, P545, DOI 10.1016/j.carbpol.2010.08.016; Cheng JJ, 2005, LIFE SCI, V76, P3029, DOI 10.1016/j.lfs.2004.11.023; Cheng PC, 2008, TOXICOL APPL PHARM, V227, P291, DOI 10.1016/j.taap.2007.10.023; Chu CL, 2011, HUM VACCINES, V7, P1161, DOI 10.4161/hv.7.11.17753; Du XG, 2012, INT IMMUNOPHARMACOL, V14, P463, DOI 10.1016/j.intimp.2012.09.006; El Enshasy HA, 2013, TRENDS BIOTECHNOL, V31, P668, DOI 10.1016/j.tibtech.2013.09.003; Feng BS, 2008, J ALLERGY CLIN IMMUN, V122, P55, DOI 10.1016/j.jaci.2008.04.036; Figueiredo RT, 2012, CARBOHYD RES, V356, P260, DOI 10.1016/j.carres.2012.02.028; Freitas-Silva Rafael, 2014, Front Immunol, V5, P78, DOI 10.3389/fimmu.2014.00078; Han HF, 2006, CHEM PHARM BULL, V54, P496, DOI 10.1248/cpb.54.496; HARDY MR, 1988, ANAL BIOCHEM, V170, P54, DOI 10.1016/0003-2697(88)90089-9; Hu DJ, 2013, J SEP SCI, V36, P1, DOI 10.1002/jssc.201200874; Huang CH, 2010, CANCER IMMUNOL IMMUN, V59, P1259, DOI 10.1007/s00262-010-0852-y; Huang RY, 2010, J IMMUNOL, V184, P6815, DOI 10.4049/jimmunol.0903991; Ishijima Y, 2011, INT J IMMUNOPATH PH, V24, P43, DOI 10.1177/039463201102400106; Jang JY, 2014, FOOD CHEM TOXICOL; Jin JO, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099396; Khan Kishwar Hayat, 2013, Germs, V3, P26, DOI 10.11599/germs.2013.1034; Kim MH, 2008, IMMUNOL LETT, V115, P138, DOI 10.1016/j.imlet.2007.10.016; Kuo MC, 2008, J ETHNOPHARMACOL, V120, P196, DOI 10.1016/j.jep.2008.08.011; Lee IH, 2002, FEMS MICROBIOL LETT, V209, P63, DOI 10.1111/j.1574-6968.2002.tb11110.x; Lemmon HR, 2012, J ETHNOPHARMACOL, V142, P1, DOI 10.1016/j.jep.2012.04.004; Lin CC, 2011, CANCER IMMUNOL IMMUN, V60, P1019, DOI 10.1007/s00262-011-1016-4; Lin KI, 2006, J BIOL CHEM, V281, P24111, DOI 10.1074/jbc.M601106200; Lin MK, 2011, IMMUNOBIOLOGY, V216, P1103, DOI 10.1016/j.imbio.2011.05.002; Ling Y, 2011, IMMUNOL INVEST, V40, P1, DOI 10.3109/08820139.2010.504803; Liu JJ, 2004, TOXICOL APPL PHARM, V201, P186, DOI 10.1016/j.taap.2004.05.016; Liu KJ, 2010, IMMUNOLOGY, V129, P351, DOI 10.1111/j.1365-2567.2009.03175.x; Lobner M, 2008, J MED FOOD, V11, P313, DOI 10.1089/jmf.2007.564; Lu MC, 2013, PHARMACOL THERAPEUT, V139, P124, DOI 10.1016/j.pharmthera.2013.04.001; Luther J, 2011, GUT, V60, P1479, DOI 10.1136/gut.2010.220087; Meng LM, 2012, NUTRITION, V28, P942, DOI 10.1016/j.nut.2012.01.006; Merad M, 2013, ANNU REV IMMUNOL, V31, P563, DOI 10.1146/annurev-immunol-020711-074950; Milani A, 2013, ANN ONCOL, V24, P1740, DOI 10.1093/annonc/mdt133; Mizuno M, 2013, J CLIN BIOCHEM NUTR, V52, P202, DOI 10.3164/jcbn.13-3; Mussalem JS, 2006, MICROBIOL IMMUNOL, V50, P253, DOI 10.1111/j.1348-0421.2006.tb03791.x; Palucka K, 2013, IMMUNITY, V39, P38, DOI 10.1016/j.immuni.2013.07.004; Ramberg JE, 2010, NUTR J, V9, DOI 10.1186/1475-2891-9-54; Ren L, 2012, FOOD FUNCT, V3, P1118, DOI 10.1039/c2fo10279j; Shakya AK, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2012.0536; Steinman RM, 2012, ANNU REV IMMUNOL, V30, P1, DOI 10.1146/annurev-immunol-100311-102839; Sun J, 2013, VACCINE, V31, P472, DOI 10.1016/j.vaccine.2012.11.024; Wang JT, 2013, OCEAN ENG, V63, P8, DOI 10.1016/j.oceaneng.2013.01.028; Wu YY, 2007, ACTA PHARMACOL SIN, V28, P258, DOI 10.1111/j.1745-7254.2007.00500.x; Xu ZT, 2011, AM J CHINESE MED, V39, P15, DOI 10.1142/S0192415X11008610; Yang CM, 2009, J ETHNOPHARMACOL, V123, P407, DOI 10.1016/j.jep.2009.03.034; Yang M, 2008, INT IMMUNOPHARMACOL, V8, P1754, DOI 10.1016/j.intimp.2008.08.007; Yu YL, 2009, EUR J IMMUNOL, V39, P2482, DOI 10.1002/eji.200839039; Yue PYK, 2012, INT J MED MUSHROOMS, V14, P241, DOI 10.1615/IntJMedMushr.v14.i3.20	57	24	33	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2015	10	2							e0116191	10.1371/journal.pone.0116191	http://dx.doi.org/10.1371/journal.pone.0116191			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC3LS	25723174	Green Published, Green Submitted, gold			2022-12-27	WOS:000350251200015
J	Kandasamy, M; Rosskopf, M; Wagner, K; Klein, B; Couillard-Despres, S; Reitsamer, HA; Stephan, M; Nguyen, HP; Riess, O; Bogdahn, U; Winkler, J; von Horsten, S; Aigner, L				Kandasamy, Mahesh; Rosskopf, Michael; Wagner, Katrin; Klein, Barbara; Couillard-Despres, Sebastien; Reitsamer, Herbert A.; Stephan, Michael; Nguyen, Huu Phuc; Riess, Olaf; Bogdahn, Ulrich; Winkler, Juergen; von Hoersten, Stephan; Aigner, Ludwig			Reduction in Subventricular Zone-Derived Olfactory Bulb Neurogenesis in a Rat Model of Huntington's Disease Is Accompanied by Striatal Invasion of Neuroblasts	PLOS ONE			English	Article							NEURAL STEM-CELLS; STROKE-INDUCED NEUROGENESIS; PROGENITOR CELLS; ADULT BRAIN; DOUBLECORTIN EXPRESSION; GABAERGIC INTERNEURONS; REPEAT EXPANSION; CAG REPEAT; TGF-BETA; IN-VIVO	Huntington's disease (HD) is an inherited progressive neurodegenerative disorder caused by an expanded CAG repeat in exon 1 of the huntingtin gene (HTT). The primary neuropathology of HD has been attributed to the preferential degeneration of medium spiny neurons (MSN) in the striatum. Reports on striatal neurogenesis have been a subject of debate; nevertheless, it should be considered as an endogenous attempt to repair the brain. The subventricular zone (SVZ) might offer a close-by region to supply the degenerated striatum with new cells. Previously, we have demonstrated that R6/2 mice, a widely used preclinical model representing an early onset HD, showed reduced olfactory bulb (OB) neurogenesis but induced striatal migration of neuroblasts without affecting the proliferation of neural progenitor cell (NPCs) in the SVZ. The present study revisits these findings, using a clinically more relevant transgenic rat model of late onset HD (tgHD rats) carrying the human HTT gene with 51 CAG repeats and mimicking many of the neuropathological features of HD seen in patients. We demonstrate that cell proliferation is reduced in the SVZ and OB of tgHD rats compared to WT rats. In the OB of tgHD rats, although cell survival was reduced, the frequency of neuronal differentiation was not altered in the granule cell layer (GCL) compared to the WT rats. However, an increased frequency of dopamenergic neuronal differentiation was noticed in the glomerular layer (GLOM) of tgHD rats. Besides this, we observed a selective proliferation of neuroblasts in the adjacent striatum of tgHD rats. There was no evidence for neuronal maturation and survival of these striatal neuroblasts. Therefore, the functional role of these invading neuroblasts still needs to be determined, but they might offer an endogenous alternative for stem or neuronal cell transplantation strategies.	[Kandasamy, Mahesh; Wagner, Katrin; Klein, Barbara; Couillard-Despres, Sebastien; Aigner, Ludwig] Paracelsus Med Univ, Inst Mol Regenerat Med, Salzburg, Austria; [Kandasamy, Mahesh; Wagner, Katrin; Klein, Barbara; Couillard-Despres, Sebastien; Aigner, Ludwig] Paracelsus Med Univ, Spinal Cord Injury & Tissue Regenerat Ctr Salzbur, Salzburg, Austria; [Rosskopf, Michael; Bogdahn, Ulrich] Univ Hosp Regensburg, Dept Neurol, Regensburg, Germany; [Couillard-Despres, Sebastien] Paracelsus Med Univ, Inst Expt Neuroregenerat, Salzburg, Austria; [Reitsamer, Herbert A.] Paracelsus Med Univ, Dept Ophthalmol, SALK, Salzburg, Austria; [Stephan, Michael] Hannover Med Sch, Inst Funct & Appl Anat, Hannover, Germany; [Nguyen, Huu Phuc; Riess, Olaf] Univ Tubingen, Dept Med Genet, Tubingen, Germany; [Winkler, Juergen] Univ Erlangen Nurnberg, Div Mol Neurol, D-91054 Erlangen, Germany; [von Hoersten, Stephan] Univ Erlangen Nurnberg, D-91054 Erlangen, Germany	Paracelsus Private Medical University; Paracelsus Private Medical University; University of Regensburg; Paracelsus Private Medical University; Paracelsus Private Medical University; Hannover Medical School; Eberhard Karls University of Tubingen; University of Erlangen Nuremberg; University of Erlangen Nuremberg	von Horsten, S (corresponding author), Univ Erlangen Nurnberg, D-91054 Erlangen, Germany.	stephan.v.hoersten@uk-erlangen.de; ludwig.aigner@pmu.ac.at	von Hörsten, Stephan/G-9005-2015; Kandasamy, Mahesh/O-4978-2014; Nguyen, Huu Phuc/F-5390-2015; Nguyen, Huu Phuc/HDO-3462-2022	von Hörsten, Stephan/0000-0001-6409-0664; Kandasamy, Mahesh/0000-0002-6720-9082; Nguyen, Huu Phuc/0000-0001-6139-788X; Nguyen, Huu Phuc/0000-0001-6139-788X; Couillard-Despres, Sebastien/0000-0002-8486-6412; Winkler, Jurgen/0000-0003-0630-9204; Aigner, Ludwig/0000-0002-1653-8046	Bayerische Forschungsstiftung, Munich, Germany; Deutsche Forschungsgemeinschaft (DFG) [AI 31/3-1]; Bavarian State Ministry of Sciences, Research; Arts (ForNeuroCell grant); State Government of Salzburg (Austria); German Federal Ministry of Education and Research (BMBF) [01GN0978]; foundation Propter Homines (Liechtenstein); European Union [HEALTH-F2-2011-278850, HEALTH-F2-2011-279288]; FWF Special Research Program (SFB)	Bayerische Forschungsstiftung, Munich, Germany; Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Bavarian State Ministry of Sciences, Research; Arts (ForNeuroCell grant); State Government of Salzburg (Austria); German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); foundation Propter Homines (Liechtenstein); European Union(European Commission); FWF Special Research Program (SFB)	This work was supported by Bayerische Forschungsstiftung, Munich, Germany (MK), the Deutsche Forschungsgemeinschaft (DFG) (AI 31/3-1) (LA), by the Bavarian State Ministry of Sciences, Research and the Arts (ForNeuroCell grant) (SCD, UB, LA). Moreover, this work has been made possible through the support from the State Government of Salzburg (Austria), the German Federal Ministry of Education and Research (BMBF grant 01GN0978) and the foundation Propter Homines (Liechtenstein), through funding from the European Union's Seventh Framework Program (FP7/2007-2013) under grant agreements no HEALTH-F2-2011-278850 (INMiND) and no HEALTH-F2-2011-279288 (IDEA) and the FWF Special Research Program (SFB) F44 "Cell Signaling in Chronic CNS Disorders". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aigner L, 2008, CELL TISSUE RES, V331, P225, DOI 10.1007/s00441-007-0466-7; ALTMAN J, 1969, J COMP NEUROL, V137, P433, DOI 10.1002/cne.901370404; Arias-Carrion Oscar, 2007, CNS & Neurological Disorders-Drug Targets, V6, P326, DOI 10.2174/187152707783220875; Arvidsson A, 2002, NAT MED, V8, P963, DOI 10.1038/nm747; Atanasova B, 2008, NEUROSCI BIOBEHAV R, V32, P1315, DOI 10.1016/j.neubiorev.2008.05.003; Benraiss A, 2012, GENE THER, V19, P483, DOI 10.1038/gt.2011.114; Bergmann O, 2012, NEURON, V74, P634, DOI 10.1016/j.neuron.2012.03.030; Betarbet R, 1996, INT J DEV NEUROSCI, V14, P921, DOI 10.1016/S0736-5748(96)00066-4; Bracko O, 2012, J NEUROSCI, V32, P3376, DOI 10.1523/JNEUROSCI.4248-11.2012; Choi YS, 2009, NEUROBIOL DIS, V36, P259, DOI 10.1016/j.nbd.2009.07.014; Cui X, 2009, J NEUROSCI RES, V87, P86, DOI 10.1002/jnr.21836; Curtis MA, 2003, P NATL ACAD SCI USA, V100, P9023, DOI 10.1073/pnas.1532244100; Curtis MA, 2007, NAT REV NEUROSCI, V8, P712, DOI 10.1038/nrn2216; Dayer AG, 2005, J CELL BIOL, V168, P415, DOI 10.1083/jcb.200407053; Deierborg T, 2009, EXP NEUROL, V219, P363, DOI 10.1016/j.expneurol.2009.05.002; Ekdahl CT, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00041; Ernst A, 2014, CELL, V156, P1072, DOI 10.1016/j.cell.2014.01.044; Gritti A, 2002, J NEUROSCI, V22, P437, DOI 10.1523/JNEUROSCI.22-02-00437.2002; GUSELLA JF, 1983, NATURE, V306, P234, DOI 10.1038/306234a0; Hahn CG, 2005, J COMP NEUROL, V483, P154, DOI 10.1002/cne.20424; He YB, 2014, NAT NEUROSCI, V17, P943, DOI 10.1038/nn.3732; Jin KL, 2006, P NATL ACAD SCI USA, V103, P13198, DOI 10.1073/pnas.0603512103; Kandasamy M, 2014, JOURNAL OF CELLULAR, DOI [10.1111/jcmm.12509, DOI 10.1111/JCMM.12509]; Kandasamy M, 2011, NEUROL RES INT, V2011, DOI 10.1155/2011/124256; Kandasamy M, 2010, J NEUROPATH EXP NEUR, V69, P717, DOI 10.1097/NEN.0b013e3181e4f733; Kantor O, 2006, NEUROBIOL DIS, V22, P538, DOI 10.1016/j.nbd.2005.12.014; Kohl Z, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-114; Kokaia Z, 2003, CURR OPIN NEUROBIOL, V13, P127, DOI 10.1016/S0959-4388(03)00017-5; Kokaia Z, 2006, CEREB CORTEX, V16, pI162, DOI 10.1093/cercor/bhj174; Koller H, 2002, J NEUROVIROL, V8, P411, DOI 10.1080/13550280290100842; Kornack DR, 2001, P NATL ACAD SCI USA, V98, P4752, DOI 10.1073/pnas.081074998; Kraus S, 2013, GLIA, V61, P1767, DOI 10.1002/glia.22551; Lacar B, 2010, FRONT NEUROSCI-SWITZ, V4, DOI 10.3389/fnins.2010.00043; Lee JM, 2012, NEUROLOGY, V78, P690, DOI 10.1212/WNL.0b013e318249f683; Liu YWJ, 2008, EUR J NEUROSCI, V28, P2254, DOI 10.1111/j.1460-9568.2008.06518.x; LOIS C, 1994, SCIENCE, V264, P1145, DOI 10.1126/science.8178174; Luo YQ, 2006, NEUROSCI LETT, V398, P291, DOI 10.1016/j.neulet.2006.01.024; Luzzati F, 2006, J NEUROSCI, V26, P609, DOI 10.1523/JNEUROSCI.4371-05.2006; Luzzati F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025088; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; Macklis JD, 2012, NEURON, V74, P595, DOI 10.1016/j.neuron.2012.05.005; Mangiarini L, 1996, CELL, V87, P493, DOI 10.1016/S0092-8674(00)81369-0; Masuda T, 2007, NEUROSCI LETT, V425, P114, DOI 10.1016/j.neulet.2007.08.039; MCLEAN JH, 1988, J NEUROSCI, V8, P3658; Moberg PJ, 1997, INT J NEUROSCI, V89, P133, DOI 10.3109/00207459708988468; Moller T, 2010, J NEURAL TRANSM, V117, P1001, DOI 10.1007/s00702-010-0430-7; Nacher J, 2001, EUR J NEUROSCI, V14, P629, DOI 10.1046/j.0953-816x.2001.01683.x; Nguyen AD, 2010, HARVARD REV PSYCHIAT, V18, P279, DOI 10.3109/10673229.2010.511060; Pagano SF, 2000, STEM CELLS, V18, P295, DOI 10.1634/stemcells.18-4-295; Palazuelos J, 2009, BRAIN, V132, P3152, DOI 10.1093/brain/awp239; Parent JM, 2003, NEUROSCIENTIST, V9, P261, DOI 10.1177/1073858403252680; Parent JM, 2002, ANN NEUROL, V52, P802, DOI 10.1002/ana.10393; Pencea V, 2001, EXP NEUROL, V172, P1, DOI 10.1006/exnr.2001.7768; Petreanu L, 2002, J NEUROSCI, V22, P6106; Phillips W, 2005, J NEUROSCI, V25, P11564, DOI 10.1523/JNEUROSCI.3796-05.2005; Quinones-Hinojosa A, 2006, J COMP NEUROL, V494, P415, DOI 10.1002/cne.20798; Romanko MJ, 2004, PROG NEUROBIOL, V74, P77, DOI 10.1016/j.pneurobio.2004.07.001; Sakamoto M, 2011, P NATL ACAD SCI USA, V108, P8479, DOI 10.1073/pnas.1018782108; Scadden DT, 2006, NATURE, V441, P1075, DOI 10.1038/nature04957; SNELL RG, 1993, NAT GENET, V4, P393, DOI 10.1038/ng0893-393; Sultan S, 2010, FASEB J, V24, P2355, DOI 10.1096/fj.09-151456; Tattersfield AS, 2004, NEUROSCIENCE, V127, P319, DOI 10.1016/j.neuroscience.2004.04.061; Thored P, 2006, STEM CELLS, V24, P739, DOI 10.1634/stemcells.2005-0281; Tonchev AB, 2003, GLIA, V42, P209, DOI 10.1002/glia.10209; Tonchev AB, 2005, J NEUROSCI RES, V81, P776, DOI 10.1002/jnr.20604; von Horsten S, 2003, HUM MOL GENET, V12, P617, DOI 10.1093/hmg/ddg075; VONSATTEL JP, 1985, J NEUROPATH EXP NEUR, V44, P559, DOI 10.1097/00005072-198511000-00003; Wachs FP, 2003, LAB INVEST, V83, P949, DOI 10.1097/01.LAB.0000075556.74231.A5; Wachs FP, 2006, J NEUROPATH EXP NEUR, V65, P358, DOI 10.1097/01.jnen.0000218444.53405.f0; Walker FO, 2007, LANCET, V369, P218, DOI 10.1016/S0140-6736(07)60111-1; Wattendorf E, 2009, J NEUROSCI, V29, P15410, DOI 10.1523/JNEUROSCI.1909-09.2009; Winner B, 2006, EXP NEUROL, V197, P113, DOI 10.1016/j.expneurol.2005.08.028; Winner B, 2008, J NEUROPATH EXP NEUR, V67, P105, DOI 10.1097/nen.0b013e3181630cff; Xu X, 2012, NEUROSCIENCE, V202, P474, DOI 10.1016/j.neuroscience.2011.12.008; Yang SX, 2008, STROKE, V39, P2079, DOI 10.1161/STROKEAHA.107.508911; Zhang JZ, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-158; Zhang RL, 2007, J NEUROSCI, V27, P3157, DOI 10.1523/JNEUROSCI.4969-06.2007	77	30	33	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2015	10	2							e0116069	10.1371/journal.pone.0116069	http://dx.doi.org/10.1371/journal.pone.0116069			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC2ZH	25719447	Green Published, gold, Green Submitted			2022-12-27	WOS:000350213200006
J	Meghdari, M; Gao, N; Abdullahi, A; Stokes, E; Calhoun, DH				Meghdari, Mariam; Gao, Nicholas; Abdullahi, Abass; Stokes, Erin; Calhoun, David H.			Carboxyl-Terminal Truncations Alter the Activity of the Human alpha-Galactosidase A	PLOS ONE			English	Article							ENZYME-REPLACEMENT THERAPY; AGALSIDASE-BETA THERAPY; FABRY-DISEASE; PHARMACOLOGICAL CHAPERONES; HETEROLOGOUS PROTEINS; ENHANCEMENT THERAPIES; GLYCOLIPID STORAGE; ANTIBODY-FORMATION; PICHIA-PASTORIS; GENE-THERAPY	Fabry disease is an X-linked inborn error of glycolipid metabolism caused by deficiency of the human lysosomal enzyme, alpha-galactosidase A (alpha Gal), leading to strokes, myocardial infarctions, and terminal renal failure, often leading to death in the fourth or fifth decade of life. The enzyme is responsible for the hydrolysis of terminal a-galactoside linkages in various glycolipids. Enzyme replacement therapy (ERT) has been approved for the treatment of Fabry disease, but adverse reactions, including immune reactions, make it desirable to generate improved methods for ERT. One approach to circumvent these adverse reactions is the development of derivatives of the enzyme with more activity per mg. It was previously reported that carboxyl-terminal deletions of 2 to 10 amino acids led to increased activity of about 2 to 6-fold. However, this data was qualitative or semi-quantitative and relied on comparison of the amounts of mRNA present in Northern blots with aGal enzyme activity using a transient expression system in COS-1 cells. Here we follow up on this report by constructing and purifying mutant enzymes with deletions of 2, 4, 6, 8, and 10 C-terminal amino acids (Delta 2,Delta 4,Delta 6,Delta 8,Delta 10) for unambiguous quantitative enzyme assays. The results reported here show that the k(cat)/K-m approximately doubles with deletions of 2, 4, 6 and 10 amino acids (0.8 to 1.7-fold effect) while a deletion of 8 amino acids decreases the k(cat)/K-m (7.2-fold effect). These results indicate that the mutated enzymes with increased activity constructed here would be expected to have a greater therapeutic effect on a per mg basis, and could therefore reduce the likelihood of adverse infusion related reactions in Fabry patients receiving ERT treatment. These results also illustrate the principle that in vitro mutagenesis can be used to generate aGal derivatives with improved enzyme activity.	[Meghdari, Mariam; Gao, Nicholas; Stokes, Erin; Calhoun, David H.] CUNY City Coll, Dept Chem, New York, NY 10031 USA; [Abdullahi, Abass] CUNY Bronx Community Coll, Biol & Med Lab Technol, Bronx, NY USA	City University of New York (CUNY) System; City College of New York (CUNY); City University of New York (CUNY) System	Calhoun, DH (corresponding author), CUNY City Coll, Dept Chem, 160 Convent Ave, New York, NY 10031 USA.	dcalhoun@ccny.cuny.edu	Meghdari, Ali F./B-3933-2011	Meghdari, Ali F./0000-0001-6009-3825	ShelbyBioTech LLC [75994-00 01]; University of Medicine and Dentistry Biomedical Research Support [75745-00 01]; City University of New York Professional Staff Congress [68407-01 01]; City University of New York Collaborative Grant [2109012500]; NATIONAL CENTER FOR RESEARCH RESOURCES [G12RR003060] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [G12MD007603] Funding Source: NIH RePORTER	ShelbyBioTech LLC; University of Medicine and Dentistry Biomedical Research Support; City University of New York Professional Staff Congress; City University of New York Collaborative Grant; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This work was supported by grants from ShelbyBioTech LLC (75994-00 01), the University of Medicine and Dentistry Biomedical Research Support (75745-00 01), and the City University of New York Professional Staff Congress (68407-01 01) to DHC; the City University of New York Collaborative Grant (2109012500) to AA; and by an infrastructure award the City College of New York from the National Institutes of Health (NIH) National Center for Research Resources (2G12RR03060-26A1). The funders delegated all academic responsibilities to the authors and the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilera M, 2012, RES MICROBIOL, V163, P14, DOI 10.1016/j.resmic.2011.10.005; ALBERY WJ, 1976, BIOCHEMISTRY-US, V15, P5631, DOI 10.1021/bi00670a032; Alegra T, 2012, GENET MOL BIOL, V35, P947, DOI 10.1590/S1415-47572012000600009; Baehner F, 2003, J INHERIT METAB DIS, V26, P617, DOI 10.1023/B:BOLI.0000005658.14563.77; Banikazemi M, 2007, ANN INTERN MED, V146, P77, DOI 10.7326/0003-4819-146-2-200701160-00148; BARTON NW, 1991, NEW ENGL J MED, V324, P1464, DOI 10.1056/NEJM199105233242104; BARTON NW, 1990, P NATL ACAD SCI USA, V87, P1913, DOI 10.1073/pnas.87.5.1913; Benkovic SJ, 2003, SCIENCE, V301, P1196, DOI 10.1126/science.1085515; BEUTLER E, 1991, NEW ENGL J MED, V325, P1354; BEUTLER E, 1972, J BIOL CHEM, V247, P7195; BEUTLER E, 1991, BLOOD, V78, P1183; BISHOP DF, 1981, J BIOL CHEM, V256, P1307; Boustany RMN, 2013, NAT REV NEUROL, V9, P583, DOI 10.1038/nrneurol.2013.163; Brady R, 2006, FABRY DISEASE PERSPE; Brady RO, 2004, LANCET NEUROL, V3, P752, DOI 10.1016/S1474-4422(04)00938-X; Brumer H, 1999, BIOCHEM J, V339, P43, DOI 10.1042/0264-6021:3390043; CALHOUN DH, 1985, P NATL ACAD SCI USA, V82, P7364, DOI 10.1073/pnas.82.21.7364; Cereghino GPL, 2002, CURR OPIN BIOTECH, V13, P329, DOI 10.1016/S0958-1669(02)00330-0; Chaudhury S, 2010, BIOINFORMATICS, V26, P689, DOI 10.1093/bioinformatics/btq007; Chen YS, 2000, PROTEIN EXPRES PURIF, V20, P228, DOI 10.1006/prep.2000.1284; Chen YS, 2000, PROTEIN EXPRES PURIF, V20, P472, DOI 10.1006/prep.2000.1325; Chiba Y, 2002, GLYCOBIOLOGY, V12, P821, DOI 10.1093/glycob/cwf096; COPPOLA G, 1994, GENE, V144, P197, DOI 10.1016/0378-1119(94)90378-6; Daly R, 2005, J MOL RECOGNIT, V18, P119, DOI 10.1002/jmr.687; DEAN KJ, 1979, J BIOL CHEM, V254, P9994; DEDUVE C, 1964, FED PROC, V23, P1045; Deegan PB, 2012, J INHERIT METAB DIS, V35, P227, DOI 10.1007/s10545-011-9400-y; Desnick RJ, 2012, ANNU REV GENOM HUM G, V13, P307, DOI 10.1146/annurev-genom-090711-163739; Desnick RJ, 2004, J INHERIT METAB DIS, V27, P385, DOI 10.1023/B:BOLI.0000031101.12838.c6; Desnick RJ, 2003, ANN INTERN MED, V138, P338, DOI 10.7326/0003-4819-138-4-200302180-00014; Desnick RJ, 2002, NAT REV GENET, V3, P954, DOI 10.1038/nrg963; DESNICK RJ, 1979, P NATL ACAD SCI USA, V76, P5326, DOI 10.1073/pnas.76.10.5326; Desnick RJ., 1995, METABOLIC MOL BASES, P2741; Eng CM, 2001, NEW ENGL J MED, V345, P9, DOI 10.1056/NEJM200107053450102; Fernandez-Leiro R, 2010, J BIOL CHEM, V285, P28020, DOI 10.1074/jbc.M110.144584; Frustaci A, 2001, NEW ENGL J MED, V345, P25, DOI 10.1056/NEJM200107053450104; Garman SC, 2004, J MOL BIOL, V337, P319, DOI 10.1016/j.jmb.2004.01.035; Germain DP, 2007, J AM SOC NEPHROL, V18, P1547, DOI 10.1681/ASN.2006080816; GOMORI G, 1955, METHOD ENZYMOL, V1, P138, DOI 10.1016/0076-6879(55)01020-3; Grace ME, 2007, HUM MUTAT, V28, P866, DOI 10.1002/humu.20524; Guce AI, 2011, CHEM BIOL, V18, P1521, DOI 10.1016/j.chembiol.2011.10.012; Guce AI, 2010, J BIOL CHEM, V285, P3625, DOI 10.1074/jbc.M109.060145; HANTZOPOULOS PA, 1987, GENE, V57, P159, DOI 10.1016/0378-1119(87)90119-3; Hsu TY, 1996, J GEN VIROL, V77, P1893, DOI 10.1099/0022-1317-77-8-1893; IOANNOU YA, 1992, J CELL BIOL, V119, P1137, DOI 10.1083/jcb.119.5.1137; Ioannou YA, 1998, BIOCHEM J, V332, P789, DOI 10.1042/bj3320789; Ishii S, 2000, ARCH BIOCHEM BIOPHYS, V377, P228, DOI 10.1006/abbi.2000.1743; Ishii S, 2007, BIOCHEM J, V406, P285, DOI 10.1042/BJ20070479; Jindou S, 2002, J BACTERIOL, V184, P600, DOI 10.1128/JB.184.2.600-604.2002; Kampmann C, 2002, J AM COLL CARDIOL, V40, P1668, DOI 10.1016/S0735-1097(02)02380-X; Kase R, 2000, BBA-MOL BASIS DIS, V1501, P227, DOI 10.1016/S0925-4439(00)00024-7; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; KUSIAK JW, 1978, J BIOL CHEM, V253, P184; Lee K, 2003, GLYCOBIOLOGY, V13, P305, DOI 10.1093/glycob/cwg034; Li C, 2002, MOL THER, V5, P745, DOI 10.1006/mthe.2002.0605; Lieberman RL, 2009, BIOCHEMISTRY-US, V48, P4816, DOI 10.1021/bi9002265; Lin HH, 2005, ARCH BIOCHEM BIOPHYS, V442, P206, DOI 10.1016/j.abb.2005.08.010; Linthorst GE, 2004, KIDNEY INT, V66, P1589, DOI 10.1111/j.1523-1755.2004.00924.x; Lodish H., 2000, CHEM FDN MOL CELL BI; Lombard V, 2014, NUCLEIC ACIDS RES, V42, pD490, DOI 10.1093/nar/gkt1178; LORENZEN A, 1993, ANAL BIOCHEM, V214, P346, DOI 10.1006/abio.1993.1504; LUSIS AJ, 1976, BIOCHIM BIOPHYS ACTA, V437, P487, DOI 10.1016/0304-4165(76)90017-9; Macauley-Patrick S, 2005, YEAST, V22, P249, DOI 10.1002/yea.1208; Maranville E, 2000, ARCH BIOCHEM BIOPHYS, V373, P225, DOI 10.1006/abbi.1999.1532; Marchesan D, 2012, J INHERIT METAB DIS, V35, P1107, DOI 10.1007/s10545-012-9472-3; Marshall J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015033; Matsuura F, 1998, GLYCOBIOLOGY, V8, P329, DOI 10.1093/glycob/8.4.329; Mehta A, 2006, FABRY DIS PERSPECTIV; Miyamura N, 1996, J CLIN INVEST, V98, P1809, DOI 10.1172/JCI118981; Mohammed KD, 2011, J VIROL, V85, P4654, DOI 10.1128/JVI.02374-10; Montesino R, 1998, PROTEIN EXPRES PURIF, V14, P197, DOI 10.1006/prep.1998.0933; Motabar Omid, 2010, Curr Chem Genomics, V4, P50, DOI 10.2174/1875397301004010050; Nakao S, 2003, KIDNEY INT, V64, P801, DOI 10.1046/j.1523-1755.2003.00160.x; Ohashi T, 2008, MOL GENET METAB, V94, P313, DOI 10.1016/j.ymgme.2008.03.008; Ohashi T, 2007, MOL GENET METAB, V92, P271, DOI 10.1016/j.ymgme.2007.06.013; Ohshima T, 1997, P NATL ACAD SCI USA, V94, P2540, DOI 10.1073/pnas.94.6.2540; PASSONNEAU JV, 1964, ADV ENZYME REGUL, V2, P265, DOI 10.1016/S0065-2571(64)80018-2; Pintos-Morell G, 2009, EUR J PEDIATR, V168, P1355, DOI 10.1007/s00431-009-0937-9; Post DA, 2005, APPL MICROBIOL BIOT, V67, P91, DOI 10.1007/s00253-004-1764-6; Przybylska M, 2004, J GENE MED, V6, P85, DOI 10.1002/jgm.468; Ries M, 2005, PEDIATRICS, V115, pE344, DOI 10.1542/peds.2004-1678; de Garibay APR, 2013, BIODRUGS, V27, P237, DOI 10.1007/s40259-013-0032-7; Sakuraba H, 2006, J HUM GENET, V51, P341, DOI 10.1007/s10038-006-0369-6; Schiffmann R, 2002, DRUGS, V62, P733, DOI 10.2165/00003495-200262050-00002; Schiffmann R, 2001, JAMA-J AM MED ASSOC, V285, P2743, DOI 10.1001/jama.285.21.2743; Schiffmann R, 2000, P NATL ACAD SCI USA, V97, P365, DOI 10.1073/pnas.97.1.365; Schiffmann R, 2006, NEPHROL DIAL TRANSPL, V21, P345, DOI 10.1093/ndt/gfi152; Schiffmann R, 2010, J PEDIATR-US, V156, P832, DOI 10.1016/j.jpeds.2009.11.007; Schrodinger LLC, 2010, THE PYMOL MOLECULAR; Shin SH, 2007, BIOCHEM BIOPH RES CO, V359, P168, DOI 10.1016/j.bbrc.2007.05.082; Sikorski RS, 2004, J AM CHEM SOC, V126, P4778, DOI 10.1021/ja031683w; Smid BE, 2013, MOL GENET METAB, V108, P132, DOI 10.1016/j.ymgme.2012.12.005; Sola-Penna M, 2010, IUBMB LIFE, V62, P791, DOI 10.1002/iub.393; Soper AS, 2007, J CHROMATOGR A, V1154, P308, DOI 10.1016/j.chroma.2007.03.126; Sugawara K, 2009, MOL GENET METAB, V96, P233, DOI 10.1016/j.ymgme.2008.12.017; Suzuki Y, 2013, BRAIN DEV-JPN, V35, P515, DOI 10.1016/j.braindev.2012.12.002; Taguchi A, 2013, BIOCHEM J, V456, P373, DOI 10.1042/BJ20130825; Tomasic IB, 2010, J BIOL CHEM, V285, P21560, DOI 10.1074/jbc.M110.118588; Tsukimura T, 2011, MOL GENET METAB, V103, P26, DOI 10.1016/j.ymgme.2011.01.013; Vedder AC, 2008, MOL GENET METAB, V94, P319, DOI 10.1016/j.ymgme.2008.03.003; Wang L, 2006, BIOCHEMISTRY-US, V45, P1383, DOI 10.1021/bi0518242; Wang L, 2006, P NATL ACAD SCI USA, V103, P15753, DOI 10.1073/pnas.0606976103; Wang L, 2006, PHILOS T R SOC B, V361, P1307, DOI 10.1098/rstb.2006.1871; Whybra C, 2006, PEDIATR NEPHROL, V21, P1251, DOI 10.1007/s00467-006-0176-5; Wilcox WR, 2004, AM J HUM GENET, V75, P65, DOI 10.1086/422366; Wong C, 2000, BIOTECHNIQUES, V28, P426, DOI 10.2144/00283bm07; Yasuda K, 2004, PROTEIN EXPRES PURIF, V37, P499, DOI 10.1016/j.pep.2004.07.005; Yoshimitsu M, 2007, GENE THER, V14, P256, DOI 10.1038/sj.gt.3302839; Zhang W., 2000, BIOTECHNOL BIOPROC E, V5, P275, DOI DOI 10.1007/BF02942184; Ziegler RJ, 1999, HUM GENE THER, V10, P1667, DOI 10.1089/10430349950017671; Ziegler RJ, 2004, MOL THER, V9, P231, DOI 10.1016/j.ymthe.2003.11.015; Ziegler RJ, 2002, HUM GENE THER, V13, P935, DOI 10.1089/10430340252939041; Ziegler RJ, 2007, MOL THER, V15, P492, DOI 10.1038/sj.mt.6300066	113	3	4	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2015	10	2							e0118341	10.1371/journal.pone.0118341	http://dx.doi.org/10.1371/journal.pone.0118341			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC2ZH	25719393	Green Published, gold			2022-12-27	WOS:000350213200047
J	Brodin, J; Hedskog, C; Heddini, A; Benard, E; Neher, RA; Mild, M; Albert, J				Brodin, Johanna; Hedskog, Charlotte; Heddini, Alexander; Benard, Emmanuel; Neher, Richard A.; Mild, Mattias; Albert, Jan			Challenges with Using Primer IDs to Improve Accuracy of Next Generation Sequencing	PLOS ONE			English	Article							VARIANTS	Next generation sequencing technologies, like ultra-deep pyrosequencing (UDPS), allows detailed investigation of complex populations, like RNA viruses, but its utility is limited by errors introduced during sample preparation and sequencing. By tagging each individual cDNA molecule with barcodes, referred to as Primer IDs, before PCR and sequencing these errors could theoretically be removed. Here we evaluated the Primer ID methodology on 257,846 UDPS reads generated from a HIV-1 SG3 Delta env plasmid clone and plasma samples from three HIV-infected patients. The Primer ID consisted of 11 randomized nucleotides, 4,194,304 combinations, in the primer for cDNA synthesis that introduced a unique sequence tag into each cDNA molecule. Consensus template sequences were constructed for reads with Primer IDs that were observed three or more times. Despite high numbers of input template molecules, the number of consensus template sequences was low. With 10,000 input molecules for the clone as few as 97 consensus template sequences were obtained due to highly skewed frequency of resampling. Furthermore, the number of sequenced templates was overestimated due to PCR errors in the Primer IDs. Finally, some consensus template sequences were erroneous due to hotspots for UDPS errors. The Primer ID methodology has the potential to provide highly accurate deep sequencing. However, it is important to be aware that there are remaining challenges with the methodology. In particular it is important to find ways to obtain a more even frequency of resampling of template molecules as well as to identify and remove artefactual consensus template sequences that have been generated by PCR errors in the Primer IDs.	[Brodin, Johanna; Hedskog, Charlotte; Heddini, Alexander; Mild, Mattias; Albert, Jan] Karolinska Inst, Dept Microbiol Tumor & Cell Biol, Stockholm, Sweden; [Benard, Emmanuel; Neher, Richard A.] Max Planck Inst Dev Biol, Tubingen, Germany; [Mild, Mattias] Swedish Inst Communicable Dis Control, Unit Support, Stockholm, Sweden; [Albert, Jan] Karolinska Univ Hosp, Dept Clin Microbiol, Stockholm, Sweden	Karolinska Institutet; Max Planck Society; Swedish Institute for Infectious Disease Control; Karolinska Institutet; Karolinska University Hospital	Brodin, J (corresponding author), Karolinska Inst, Dept Microbiol Tumor & Cell Biol, Stockholm, Sweden.	johanna.brodin@ki.se	Benard, Emmanuel/ABE-8395-2021	Benard, Emmanuel/0000-0002-7991-6913; Hedskog, Charlotte/0000-0003-0512-7767; Neher, Richard/0000-0003-2525-1407	Swedish Research Council [2007-1131-49460-36]; EU [223131]	Swedish Research Council(Swedish Research CouncilEuropean Commission); EU(European Commission)	The research leading to these results has received funding from the Swedish Research Council (grant no. 2007-1131-49460-36); the EU grant CHAIN (FP7/2007-2013) "Collaborative HIV and Anti-HIV Drug Resistance Network" grant agreement nu 223131. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balzer S, 2011, BIOINFORMATICS, V27, pI304, DOI 10.1093/bioinformatics/btr251; BRINCHMANN JE, 1991, J VIROL, V65, P2019, DOI 10.1128/JVI.65.4.2019-2023.1991; Brodin J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070388; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Faith JJ, 2013, SCIENCE, V341, P44, DOI 10.1126/science.1237439; Hedskog C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011345; Hoffmann C, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm435; Huse SM, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r143; Jabara CB, 2011, P NATL ACAD SCI USA, V108, P20166, DOI 10.1073/pnas.1110064108; Karlsson A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033484; Kivioja T, 2012, NAT METHODS, V9, P72, DOI [10.1038/nmeth.1778, 10.1038/NMETH.1778]; Liang BH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026745; Liang RH, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku355; Mild M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022741; Poon AFY, 2010, MOL BIOL EVOL, V27, P819, DOI 10.1093/molbev/msp289; Quince C, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-38; Shao W, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-18; Shiroguchi K, 2012, P NATL ACAD SCI USA, V109, P1347, DOI 10.1073/pnas.1118018109; Simen BB, 2009, J INFECT DIS, V199, P693, DOI 10.1086/596736; Varghese V, 2009, JAIDS-J ACQ IMM DEF, V52, P309, DOI 10.1097/QAI.0b013e3181bca669; Zagordi O, 2010, NUCLEIC ACIDS RES, V38, P7400, DOI 10.1093/nar/gkq655	21	23	24	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2015	10	3							e0119123	10.1371/journal.pone.0119123	http://dx.doi.org/10.1371/journal.pone.0119123			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9KG	25741706	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000350688100087
J	Gendronneau, G; Sanii, S; Dang, T; Deshayes, F; Delacour, D; Pichard, E; Advedissian, T; Sidhu, SS; Viguier, M; Magnaldo, T; Poirier, F				Gendronneau, Gaelle; Sanii, Sadaf; Dang, Tien; Deshayes, Frederique; Delacour, Delphine; Pichard, Evelyne; Advedissian, Tamara; Sidhu, Sukhvinder S.; Viguier, Mireille; Magnaldo, Thierry; Poirier, Francoise			Overexpression of Galectin-7 in Mouse Epidermis Leads to Loss of Cell Junctions and Defective Skin Repair	PLOS ONE			English	Article							TUMOR PROGRESSION; INCREASED EXPRESSION; LECTINS; CANCER; ADHESION; BINDING; HYPOPHARYNGEAL; KERATINOCYTES; METASTASIS; MODULATORS	Background The proteins of the galectin family are implicated in many cellular processes, including cell interactions, polarity, intracellular trafficking, and signal transduction. In human and mouse, galectin-7 is almost exclusively expressed in stratified epithelia, notably in the epidermis. Galectin-7 expression is also altered in several human tumors of epithelial origin. This study aimed at dissecting the consequences of galectin-7 overexpression on epidermis structure and functions in vivo. Methods We established transgenic mice specifically overexpressing galectin-7 in the basal epidermal keratinocytes and analyzed the consequences on untreated skin and after UVB irradiation or mechanical injury. Results The intercellular cohesion of the epidermis is impaired in transgenic animals, with gaps developing between adjacent keratinocytes, associated with loss of adherens junctions. The epidermal architecture is aberrant with perturbations in the multilayered cellular organisation of the tissue, and structural defects in the basement membrane. These transgenic animals displayed a reduced re-epithelialisation potential following superficial wound, due to a defective collective migration of keratinocytes. Finally, a single mild dose of UVB induced an abnormal apoptotic response in the transgenic epidermis. Conclusion These results indicate that an excess of galectin-7 leads to a destabilisation of adherens junctions associated with defects in epidermal repair. As this phenotype shares similarities with that of galectin-7 null mutant mice, we conclude that a critical level of this protein is required for maintaining proper epidermal homeostasis. This study brings new insight into the mode of action of galectins in normal and pathological situations.	[Gendronneau, Gaelle; Sanii, Sadaf; Dang, Tien; Deshayes, Frederique; Delacour, Delphine; Pichard, Evelyne; Advedissian, Tamara; Sidhu, Sukhvinder S.; Viguier, Mireille; Poirier, Francoise] Paris Diderot Univ, Inst Jacques Monod, UMR CNRS 7592, Paris, France; [Magnaldo, Thierry] CNRS, INSERM, UNS UMR 7284, IRCAN,U 1081, F-06034 Nice, France	UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); CHU Nice; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Cote d'Azur	Poirier, F (corresponding author), Paris Diderot Univ, Inst Jacques Monod, UMR CNRS 7592, Paris, France.	poirier@ijm.univ-paris-diderot.fr		Sidhu, Sukhvinder/0000-0002-2999-4358; Thierry, Magnaldo/0000-0001-9174-8599; Delacour, Delphine/0000-0001-8202-4425	MENRT; ARC; GEFLUC; LNCC; Foundation de l'Avenir	MENRT; ARC(Australian Research Council); GEFLUC; LNCC; Foundation de l'Avenir	This work was supported by MENRT (www.enseignementsup-recherche.gouv.fr), ARC (www.recherche.cancer.net), GEFLUC (wwwgefluc.org/paris-ile-de-france.html), LNCC (www.ligue-cancer.net), and Foundation de l'Avenir (http//www.fondationdelavenir.org/portail/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARONDES SH, 1994, CELL, V76, P597, DOI 10.1016/0092-8674(94)90498-7; BARONDES SH, 1994, J BIOL CHEM, V269, P20807; Bernerd F, 1999, P NATL ACAD SCI USA, V96, P11329, DOI 10.1073/pnas.96.20.11329; Birchler JA, 2012, P NATL ACAD SCI USA, V109, P14746, DOI 10.1073/pnas.1207726109; Boscher C, 2012, J BIOL CHEM, V287, P32940, DOI 10.1074/jbc.M112.353334; Boscher C, 2011, CURR OPIN CELL BIOL, V23, P383, DOI 10.1016/j.ceb.2011.05.001; BOUKAMP P, 1988, J CELL BIOL, V106, P761, DOI 10.1083/jcb.106.3.761; Brewer CF, 2002, BBA-GEN SUBJECTS, V1572, P255, DOI 10.1016/S0304-4165(02)00312-4; Campion CG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072468; Cao ZY, 2002, J BIOL CHEM, V277, P42299, DOI 10.1074/jbc.M200981200; Demers M, 2010, AM J PATHOL, V176, P3023, DOI 10.2353/ajpath.2010.090876; Elola MT, 2007, CELL MOL LIFE SCI, V64, P1679, DOI 10.1007/s00018-007-7044-8; Etienne-Manneville Sandrine, 2012, Subcell Biochem, V60, P225, DOI 10.1007/978-94-007-4186-7_10; Fuchs E, 1995, ANNU REV CELL DEV BI, V11, P123, DOI 10.1146/annurev.cb.11.110195.001011; Gendronneau G, 2008, MOL BIOL CELL, V19, P5541, DOI 10.1091/mbc.E08-02-0166; Hughes RC, 2001, BIOCHIMIE, V83, P667; KERR JFR, 1972, BRIT J CANCER, V26, P239, DOI 10.1038/bjc.1972.33; Kim HJ, 2013, ANTICANCER RES, V33, P1555; Kuwabara I, 2002, J BIOL CHEM, V277, P3487, DOI 10.1074/jbc.M109360200; Leffler H, 2002, GLYCOCONJUGATE J, V19, P433, DOI 10.1023/B:GLYC.0000014072.34840.04; Liu FT, 2005, NAT REV CANCER, V5, P29, DOI 10.1038/nrc1527; MacGrath SM, 2012, J CELL SCI, V125, P1621, DOI 10.1242/jcs.093781; MADSEN P, 1995, J BIOL CHEM, V270, P5823, DOI 10.1074/jbc.270.11.5823; Magnaldo T, 1998, DIFFERENTIATION, V63, P159, DOI 10.1046/j.1432-0436.1998.6330159.x; MAGNALDO T, 1995, DEV BIOL, V168, P259, DOI 10.1006/dbio.1995.1078; Menkhorst EM, 2014, PLACENTA, V35, P195, DOI 10.1016/j.placenta.2014.01.004; Nakahara S, 2008, ANTI-CANCER AGENT ME, V8, P22; Polyak K, 1997, NATURE, V389, P300, DOI 10.1038/38525; Rabinovich GA, 2007, CURR OPIN STRUC BIOL, V17, P513, DOI 10.1016/j.sbi.2007.09.002; SAITOU M, 1995, NATURE, V374, P159, DOI 10.1038/374159a0; Saussez S, 2008, HISTOPATHOLOGY, V52, P483, DOI 10.1111/j.1365-2559.2008.02973.x; Saussez S, 2006, ANN SURG ONCOL, V13, P999, DOI 10.1245/ASO.2006.08.033; Timmons PM, 1999, INT J DEV BIOL, V43, P229; Vasioukhin V, 2001, CELL, V104, P605, DOI 10.1016/S0092-8674(01)00246-X; WATT FM, 1993, J CELL SCI, V106, P175; Young P, 2003, EMBO J, V22, P5723, DOI 10.1093/emboj/cdg560	36	18	18	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2015	10	3							e0119031	10.1371/journal.pone.0119031	http://dx.doi.org/10.1371/journal.pone.0119031			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9KG	25741714	Green Submitted, Green Published, gold			2022-12-27	WOS:000350688100073
J	Hara, T; Kobayashi, E; Ohtsubo, K; Kumada, S; Kanazawa, M; Abe, T; Itoh, RD; Fujiwara, MT				Hara, Takuya; Kobayashi, Emi; Ohtsubo, Kohei; Kumada, Shogo; Kanazawa, Mikako; Abe, Tomoko; Itoh, Ryuuichi D.; Fujiwara, Makoto T.			Organ-Level Analysis of Idioblast Patterning in Egeria densa Planch. Leaves	PLOS ONE			English	Article							MYROSIN CELLS; ARABIDOPSIS; ULTRASTRUCTURE; TANNINS; PATHWAY; ELODEA; PLANTS; FAMA; FATE	Leaf tissues of plants usually contain several types of idioblasts, defined as specialized cells whose shape and contents differ from the surrounding homogeneous cells. The spatial patterning of idioblasts, particularly of trichomes and guard cells, across the leaf epidermis has received considerable attention as it offers a useful biological model for studying the intercellular regulation of cell fate and patterning. Excretory idioblasts in the leaves of the aquatic monocotyledonous plant Egeria densa produced light blue autofluorescence when irradiated with ultraviolet light. The use of epifluorescence microscopy to detect this autofluorescence provided a simple and convenient method for detecting excretory idioblasts and allowed tracking of those cells across the leaf surfaces, enabling quantitative measurement of the clustering and spacing patterns of idioblasts at the whole leaf level. Occurrence of idioblasts was coordinated along the proximal-distal, medial-lateral, and adaxial-abaxial axes, producing a recognizable consensus spatial pattern of idioblast formation among fully expanded leaves. Idioblast clusters, which comprised up to nine cells aligned along the proximal-distal axis, showed no positional bias or regularity in idioblast-forming areas when compared with singlet idioblasts. Up to 75% of idioblasts existed as clusters on every leaf side examined. The idioblast-forming areas varied between leaves, implying phenotypic plasticity. Furthermore, in young expanding leaves, autofluorescence was occasionally detected in a single giant vesicle or else in one or more small vesicles, which eventually grew to occupy a large portion of the idioblast volume as a central vacuole. Differentiation of vacuoles by accumulating the fluorescence substance might be an integral part of idioblast differentiation. Red autofluorescence from chloroplasts was not detected in idioblasts of young expanding leaves, suggesting idioblast differentiation involves an arrest in chloroplast development at a very early stage, rather than transdifferentiation of chloroplastcontaining epidermal cells.	[Hara, Takuya; Kobayashi, Emi; Ohtsubo, Kohei; Kumada, Shogo; Kanazawa, Mikako; Fujiwara, Makoto T.] Sophia Univ, Dept Biol, Chiyoda Ku, Tokyo 1028554, Japan; [Abe, Tomoko; Fujiwara, Makoto T.] RIKEN, Nishina Ctr, Wako, Saitama 3510198, Japan; [Itoh, Ryuuichi D.] Univ Ryukyus, Fac Sci, Dept Chem Biol & Marine Sci, Nishihara, Okinawa 9031213, Japan	Sophia University; RIKEN; University of the Ryukyus	Fujiwara, MT (corresponding author), Sophia Univ, Dept Biol, Chiyoda Ku, Tokyo 1028554, Japan.	mtf1@mac.com	Itoh, Ryuuichi D/B-1167-2008; Fujiwara, Makoto T/A-2122-2008	Itoh, Ryuuichi D/0000-0002-5786-2176; Fujiwara, Makoto T/0000-0002-4668-276X	Ministry of Education, Culture, Sports, Science and Technology of Japan [22780087, 25450136]; Grants-in-Aid for Scientific Research [25450136, 26440152] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grants-in-Aid from the Ministry of Education, Culture, Sports, Science and Technology of Japan (nos. 22780087 and 25450136 to MTF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreasson E, 2001, PLANT PHYSIOL, V127, P1750, DOI 10.1104/pp.010334; Barlow PW, 2008, RUSS J PLANT PHYSL+, V55, P149, DOI 10.1134/S1021443708020015; Brillouet JM, 2013, ANN BOT-LONDON, V112, P1003, DOI 10.1093/aob/mct168; COOK CDK, 1984, AQUAT BOT, V19, P73, DOI 10.1016/0304-3770(84)90009-3; CORDES WC, 1960, STAIN TECHNOL, V35, P191, DOI 10.3109/10520296009114736; CORDES WC, 1959, PHYSIOL PLANTARUM, V12, P62, DOI 10.1111/j.1399-3054.1959.tb07885.x; Csurhes S., 2008, PEST PLANT RISK ASSE; Evert R.F., 2006, ESAUS PLANT ANATOMY, Vthird, P624, DOI [10.1093/aob/mcm015, DOI 10.1093/AOB/MCM015]; FAHN A, 1988, NEW PHYTOL, V108, P229, DOI 10.1111/j.1469-8137.1988.tb04159.x; FOSTER AS, 1956, PROTOPLASMA, V46, P184, DOI 10.1007/BF01248877; FRANCESCHI VR, 1980, BOT REV, V46, P361, DOI 10.1007/BF02860532; HARAMOTO T, 1988, AQUAT BOT, V30, P389, DOI 10.1016/0304-3770(88)90070-8; KUROIWA T, 1991, INT REV CYTOL, V128, P1; Larkin JC, 1997, PLANT CELL, V9, P1109, DOI 10.1105/tpc.9.7.1109; Li M, 2014, PLANT CELL, V26, P4053, DOI 10.1105/tpc.114.129726; Marinho CR, 2011, FLORA, V206, P1052, DOI 10.1016/j.flora.2011.07.011; Martin C, 2007, CURR OPIN PLANT BIOL, V10, P70, DOI 10.1016/j.pbi.2006.11.004; Momose T, 1995, P ANN M BOT SOC JAPA, V59, P315; Pasqua G, 2004, EUR J HISTOCHEM, V48, P321; PLATT KA, 1992, INT J PLANT SCI, V153, P301, DOI 10.1086/297033; Shirakawa M, 2014, PLANT CELL, V26, P4039, DOI 10.1105/tpc.114.129874; Solereder H., 1913, BOT CENTRALBL S, V30, P24; St-Pierre B, 1999, PLANT CELL, V11, P887, DOI 10.1105/tpc.11.5.887; Stadelmann EJ, 1972, METHODS CELL PHYSL, V5, P325, DOI DOI 10.1016/S0091-679X(08)60717-7; TAKADA HIDEO, 1952, JOUR INST POLYTECH [OSAKA CITY UNIV] SER D BIOL, V3, P31; Tomlinson PB., 1982, ANAL MONOCOTYLEDONS, P126; TRACHTENBERG S, 1981, BOT GAZ, V142, P206, DOI 10.1086/337215; Tretyn A, 1996, PROTOPLASMA, V191, P205, DOI 10.1007/BF01281818; Ueda H, 2006, PLANT CELL PHYSIOL, V47, P164, DOI 10.1093/pcp/pci232; WERKER E, 1974, PLANTA, V116, P243, DOI 10.1007/BF00390230; Yarrow M, 2009, REV CHIL HIST NAT, V82, P299, DOI 10.4067/S0716-078X2009000200010; YOSHIDA YOSHIO, 1958, JOUR FAC SCI NIIGATA UNIV SER N BIOL GEOL AND MINERALOGY, V2, P173; Yu F, 2007, PLANT CELL ENVIRON, V30, P350, DOI 10.1111/j.1365-3040.2006.01630.x	33	9	9	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2015	10	3							e0118965	10.1371/journal.pone.0118965	http://dx.doi.org/10.1371/journal.pone.0118965			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9KG	25742311	Green Published, gold, Green Submitted			2022-12-27	WOS:000350688100069
J	Mozhui, K; Smith, AK; Tylavsky, FA				Mozhui, Khyobeni; Smith, Alicia K.; Tylavsky, Frances A.			Ancestry Dependent DNA Methylation and Influence of Maternal Nutrition	PLOS ONE			English	Article							STOCHASTIC GENE-EXPRESSION; VITAMIN-D; AFRICAN-AMERICAN; GLUCOCORTICOID-RECEPTOR; RACIAL-DIFFERENCES; WHITE WOMEN; CANCER; HEALTH; FOLATE; AGE	There is extensive variation in DNA methylation between individuals and ethnic groups. These differences arise from a combination of genetic and non-genetic influences and potential modifiers include nutritional cues, early life experience, and social and physical environments. Here we compare genome-wide DNA methylation in neonatal cord blood from African American (AA; N = 112) and European American (EA; N = 91) participants of the CANDLE Study (Conditions Affecting Neurocognitive Development and Learning in Early Childhood). Our goal is to determine if there are replicable ancestry-specific methylation patterns that may implicate risk factors for diseases that have differential prevalence between populations. To identify the most robust ancestry-specific CpG sites, we replicate our results in lymphoblastoid cell lines from Yoruba African and CEPH European panels of HapMap. We also evaluate the influence of maternal nutrition-specifically, plasma levels of vitamin D and folate during pregnancy-on methylation in newborns. We define stable ancestry-dependent methylation of genes that include tumor suppressors and cell cycle regulators (e.g., APC, BRCA1, MCC). Overall, there is lower global methylation in African ancestral groups. Plasma levels of 25-hydroxy vitamin D are also considerably lower among AA mothers and about 60% of AA and 40% of EA mothers have concentrations below 20 ng/ml. Using a weighted correlation analysis, we define a network of CpG sites that is jointly modulated by ancestry and maternal vitamin D. Our results show that differences in DNA methylation patterns are remarkably stable and maternal micronutrients can exert an influence on the child epigenome.	[Mozhui, Khyobeni; Tylavsky, Frances A.] Univ Tennessee, Ctr Hlth Sci, Dept Prevent Med, Memphis, TN 38163 USA; [Smith, Alicia K.] Emory Univ, Dept Psychiat & Behav Sci, Atlanta, GA 30322 USA	University of Tennessee System; University of Tennessee Health Science Center; Emory University	Mozhui, K (corresponding author), Univ Tennessee, Ctr Hlth Sci, Dept Prevent Med, Memphis, TN 38163 USA.	kmozhui@uthsc.edu	Smith, Alicia/W-6809-2019	Smith, Alicia/0000-0002-8537-5156	US National Institute of Child Health and Human Development [HD055462, HD060713]; US National Institute of the Heart, Lung and Blood [1R01HL109977]; US National Institute on Minority Health and Health Disparities [R01MD009064]; Children's Foundation Research Center of Memphis, University of Tennessee Health Science Center's Clinical Translational Science Institute; Urban Child Institute, Memphis, TN; US National Center for Research [M01-RR00211]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD055462] Funding Source: NIH RePORTER	US National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); US National Institute of the Heart, Lung and Blood; US National Institute on Minority Health and Health Disparities; Children's Foundation Research Center of Memphis, University of Tennessee Health Science Center's Clinical Translational Science Institute; Urban Child Institute, Memphis, TN; US National Center for Research; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	Supported by the Grants HD055462 and HD060713 from the US National Institute of Child Health and Human Development; 1R01HL109977 US National Institute of the Heart, Lung and Blood and R01MD009064 from the US National Institute on Minority Health and Health Disparities; Children's Foundation Research Center of Memphis, University of Tennessee Health Science Center's Clinical Translational Science Institute; by the grant from the Urban Child Institute, Memphis, TN; and by the Grant M01-RR00211 from the US National Center for Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adkins RM, 2012, CHEM BIODIVERS, V9, P888, DOI 10.1002/cbdv.201100395; Adkins RM, 2011, BMC MED GENET, V12, DOI 10.1186/1471-2350-12-47; Adkins RM, 2011, BIRTH DEFECTS RES A, V91, P728, DOI 10.1002/bdra.20770; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Baccarelli A, 2009, AM J RESP CRIT CARE, V179, P572, DOI 10.1164/rccm.200807-1097OC; Barres R, 2013, CELL REP, V3, P1020, DOI 10.1016/j.celrep.2013.03.018; Bell JT, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-1-r10; Bibikova M, 2009, EPIGENOMICS-UK, V1, P177, DOI [10.2217/epi.09.14, 10.2217/EPI.09.14]; Bocklandt S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014821; Boks MP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006767; Bollati V, 2007, CANCER RES, V67, P876, DOI 10.1158/0008-5472.CAN-06-2995; Braveman Paula, 2009, Pediatrics, V124 Suppl 3, pS163, DOI 10.1542/peds.2009-1100D; Choi SW, 2010, ADV NUTR, V1, P8, DOI 10.3945/an.110.1004; DeSantis C, 2013, CA-CANCER J CLIN, V63, P151, DOI 10.3322/caac.21173; Dolinoy DC, 2007, P NATL ACAD SCI USA, V104, P13056, DOI 10.1073/pnas.0703739104; Dominguez-Salas P, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4746; Du P, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-587; Elowitz MB, 2002, SCIENCE, V297, P1183, DOI 10.1126/science.1070919; Fetahu IS, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00164; Fraser HB, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-2-r8; Fryer AA, 2011, EPIGENETICS-US, V6, P86, DOI 10.4161/epi.6.1.13392; Gibbs JR, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000952; Guenard F, 2013, P NATL ACAD SCI USA, V110, P11439, DOI 10.1073/pnas.1216959110; Hoeft B, 2012, INT J VITAM NUTR RES, V82, P316, DOI 10.1024/0300-9831/a000125; Horvath S, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-10-r115; Horvath S, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-10-r97; Houseman EA, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-86; Hoyo C, 2011, EPIGENETICS-US, V6, P928, DOI 10.4161/epi.6.7.16263; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Johnson WE, 2007, BIOSTATISTICS, V8, P118, DOI 10.1093/biostatistics/kxj037; Kitabchi AE, 2013, DIABETES CARE, V36, P1919, DOI 10.2337/dc12-1912; Klengel T, 2013, NAT NEUROSCI, V16, P33, DOI 10.1038/nn.3275; Koestler DC, 2013, EPIGENETICS-US, V8, P816, DOI 10.4161/epi.25430; Krushkal J, 2014, BEHAV GENET, V44, P113, DOI 10.1007/s10519-014-9641-2; Kuzawa CW, 2009, AM J HUM BIOL, V21, P2, DOI 10.1002/ajhb.20822; Lam LL, 2012, P NATL ACAD SCI USA, V109, P17253, DOI 10.1073/pnas.1121249109; Lamprecht SA, 2003, NAT REV CANCER, V3, P601, DOI 10.1038/nrc1144; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; Leek JT, 2012, BIOINFORMATICS, V28, P882, DOI 10.1093/bioinformatics/bts034; Littlejohns TJ, 2014, NEUROLOGY, V83, P920, DOI 10.1212/WNL.0000000000000755; Looker Anne C, 2011, NCHS Data Brief, P1; Lu Michael C, 2003, Matern Child Health J, V7, P13, DOI 10.1023/A:1022537516969; Maloney CA, 2007, BRIT J NUTR, V97, P1090, DOI 10.1017/S0007114507670834; Martin DN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004531; McGowan PO, 2009, NAT NEUROSCI, V12, P342, DOI 10.1038/nn.2270; McGowan PO, 2008, BRAIN RES, V1237, P12, DOI 10.1016/j.brainres.2008.07.074; McKay JA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033290; McKay JA, 2011, GENES NUTR, V6, P189, DOI 10.1007/s12263-010-0199-1; Millen AE, 2008, AM J CLIN NUTR, V87, p1102S, DOI 10.1093/ajcn/87.4.1102S; Nalls MA, 2008, AM J HUM GENET, V82, P81, DOI 10.1016/j.ajhg.2007.09.003; Nesby-O'Dell S, 2002, AM J CLIN NUTR, V76, P187, DOI 10.1093/ajcn/76.1.187; Nestor CE, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004059; Novakovic B, 2012, AM J CLIN NUTR, V96, P188, DOI 10.3945/ajcn.112.035683; Oberlander TF, 2008, EPIGENETICS-US, V3, P97, DOI 10.4161/epi.3.2.6034; Oldham MC, 2008, NAT NEUROSCI, V11, P1271, DOI 10.1038/nn.2207; Palmer FB, 2013, J PEDIATR-US, V163, P1733, DOI 10.1016/j.jpeds.2013.08.030; PIYATHILAKE CJ, 1994, AM J CLIN NUTR, V60, P559, DOI 10.1093/ajcn/60.4.559; Plass C, 2013, NAT REV GENET, V14, P765, DOI 10.1038/nrg3554; Porter PL, 2004, CANCER-AM CANCER SOC, V100, P2533, DOI 10.1002/cncr.20279; Powe CE, 2013, NEW ENGL J MED, V369, P1991, DOI 10.1056/NEJMoa1306357; Raj A, 2008, CELL, V135, P216, DOI 10.1016/j.cell.2008.09.050; Reich D, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000360; Robinson MD, 2010, EPIGENOMICS-UK, V2, P587, DOI 10.2217/EPI.10.36; Ross A. C., 2010, Dietary reference intakes for calcium and vitamin D; Sabounchi S, 2012, CLIN COLORECTAL CANC, V11, P66, DOI 10.1016/j.clcc.2011.03.026; SCOTT JM, 1974, AM J MED TECHNOL, V40, P125; Simon MS, 2011, CANCER EPIDEM BIOMAR, V20, P1368, DOI 10.1158/1055-9965.EPI-11-0027; Sinclair KD, 2007, P NATL ACAD SCI USA, V104, P19351, DOI 10.1073/pnas.0707258104; Singer ZS, 2014, MOL CELL, V55, P319, DOI 10.1016/j.molcel.2014.06.029; Smith AK, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-145; Smith AK, 2012, EPIGENETICS-US, V7, P458, DOI 10.4161/epi.19617; Tapp HS, 2013, AGING CELL, V12, P148, DOI 10.1111/acel.12030; Terry MB, 2008, CANCER EPIDEM BIOMAR, V17, P2306, DOI 10.1158/1055-9965.EPI-08-0312; van Eijk KR, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-636; Waterland RA, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001252; Wiencke JK, 2004, NAT REV CANCER, V4, P79, DOI 10.1038/nrc1257; Yoav Benjamini, 2001, Behavioural Brain Research, V125, P279, DOI 10.1016/S0166-4328(01)00297-2; Zhang B, 2005, STAT APPL GENET MOL, V4, DOI 10.2202/1544-6115.1128; Zhang DD, 2010, AM J HUM GENET, V86, P411, DOI 10.1016/j.ajhg.2010.02.005; Zhu HD, 2013, J PEDIATR-US, V162, P1004, DOI 10.1016/j.jpeds.2012.10.059	80	29	30	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2015	10	3							e0118466	10.1371/journal.pone.0118466	http://dx.doi.org/10.1371/journal.pone.0118466			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9KG	25742137	Green Submitted, Green Published, gold			2022-12-27	WOS:000350688100019
J	Serena, C; Calvo, E; Clares, MP; Diaz, ML; Chicote, JU; Beltran-Debon, R; Fontova, R; Rodriguez, A; Garcia-Espana, E; Garcia-Espana, A				Serena, Carolina; Calvo, Enrique; Paz Clares, Mari; Luisa Diaz, Mara; Chicote, Javier U.; Beltran-Debon, Raul; Fontova, Ramon; Rodriguez, Alejandro; Garcia-Espana, Enrique; Garcia-Espana, Antonio			Significant In Vivo Anti-Inflammatory Activity of Pytren4Q-Mn a Superoxide Dismutase 2 (SOD2) Mimetic Scorpiand-Like Mn (II) Complex	PLOS ONE			English	Article							OXIDATIVE STRESS; BREAST-CANCER; SEPTIC SHOCK; MOUSE MODELS; THP-1 CELLS; INHIBITION; ACTIVATION; MECHANISMS; EXPRESSION; THERAPY	Background The clinical use of purified SOD enzymes has strong limitations due to their large molecular size, high production cost and immunogenicity. These limitations could be compensated by using instead synthetic SOD mimetic compounds of low molecular weight. Background/Methodology We have recently reported that two SOD mimetic compounds, the Mn-II complexes of the polyamines Pytren2Q and Pytren4Q, displayed high antioxidant activity in bacteria and yeast. Since frequently molecules with antioxidant properties or free-radical scavengers also have anti-inflammatory properties we have assessed the anti-inflammatory potential of Pytren2Q and Pytren4Q Mn-II complexes, in cultured macrophages and in a murine model of inflammation, by measuring the degree of protection they could provide against the cellular injury produced by lipopolisacharide, a bacterial endotoxin. Principal Findings In this report we show that the Mn-II complex of Pytren4Q but not that of Pytren2Q effectively protected human cultured THP-1 macrophages and whole mice from the inflammatory effects produced by LPS. These results obtained with two molecules that are isomers highlight the importance of gathering experimental data from animal models of disease in assessing the potential of candidate molecules. Conclusion/Significance The effective anti-inflammatory activity of the Mn-II complex of Pytren4Q in addition to its low toxicity, water solubility and ease of production would suggest it is worth taking into consideration for future pharmacological studies.	[Serena, Carolina; Calvo, Enrique; Chicote, Javier U.; Beltran-Debon, Raul; Garcia-Espana, Antonio] Univ Rovira & Virgili, Inst Invest Sanitaria Pere Virgili, Hosp Joan XXIII, Res Unit, E-43007 Tarragona, Spain; [Paz Clares, Mari; Garcia-Espana, Enrique] Univ Valencia, Dept Quim Inorgan, Inst Ciencia Mol, Valencia, Spain; [Luisa Diaz, Mara] Univ Rovira & Virgili, Inst Invest Sanitaria Pere Virgili, Hosp Joan XXIII, Dept Pathol, E-43007 Tarragona, Spain; [Fontova, Ramon] Univ Rovira & Virgili, Inst Invest Sanitaria Pere Virgili, Hosp Joan XXIII, Dept Rheumatol, E-43007 Tarragona, Spain; [Rodriguez, Alejandro] Univ Rovira & Virgili, Inst Invest Sanitaria Pere Virgili, Hosp Joan XXIII, Crit Care Dept, E-43007 Tarragona, Spain; [Rodriguez, Alejandro] ISC III, CIBER Enfermedades Resp CIBERES, Bunyola, Palma De Mallor, Spain	Universitat Rovira i Virgili; Institut d'Investigacio Sanitaria Pere Virgili (IISPV); University of Valencia; Universitat Rovira i Virgili; Institut d'Investigacio Sanitaria Pere Virgili (IISPV); Universitat Rovira i Virgili; Institut d'Investigacio Sanitaria Pere Virgili (IISPV); Universitat Rovira i Virgili; Institut d'Investigacio Sanitaria Pere Virgili (IISPV); CIBER - Centro de Investigacion Biomedica en Red; CIBERES	Garcia-Espana, A (corresponding author), Univ Rovira & Virgili, Inst Invest Sanitaria Pere Virgili, Hosp Joan XXIII, Res Unit, E-43007 Tarragona, Spain.	uroteli@iispv.cat	Serena, Carolina/J-5687-2014; Serena, Carolina/AAQ-6831-2021; garcia-españa, antonio/I-4756-2015; Calvo, Enrique/K-8680-2014; García-España, Enrique V./F-5473-2016; Beltrán-Debón, Raúl/A-9287-2014; Clares, M Paz/AAG-5694-2019	Serena, Carolina/0000-0003-2251-0856; Serena, Carolina/0000-0003-2251-0856; garcia-españa, antonio/0000-0002-9957-3161; Calvo, Enrique/0000-0002-2468-0931; García-España, Enrique V./0000-0002-4601-6505; Beltrán-Debón, Raúl/0000-0001-9691-1906; Clares, M Paz/0000-0002-9154-8842; Diaz, Maria Luisa/0000-0003-0303-9077; Fontova Garrofe, Ramon/0000-0002-0592-2018; UGARTE CHICOTE, JAVIER/0000-0001-6771-8584	MINECO CONSOLIDER INGENIO [CSD2010-00065]; GENERALITAT VALENCIANA PROMETEO GVA [2011-008]	MINECO CONSOLIDER INGENIO; GENERALITAT VALENCIANA PROMETEO GVA	This work was supported by MINECO CONSOLIDER INGENIO CSD2010-00065 (A.G-E; E.G-E); GENERALITAT VALENCIANA PROMETEO GVA 2011-008 (E.G-E).	Batinic-Haberle I, 2010, ANTIOXID REDOX SIGN, V13, P877, DOI 10.1089/ars.2009.2876; Brown NS, 2001, BREAST CANCER RES, V3, P323, DOI 10.1186/bcr315; CALANDRA T, 1991, AM J MED, V91, P23, DOI 10.1016/0002-9343(91)90069-A; Choi YY, 2013, INHIBITORY EFFECT CO; Cuadrado I, 2012, TOXICOL APPL PHARM, V258, P109, DOI 10.1016/j.taap.2011.10.013; Cuzzocrea S, 2005, ARTHRITIS RHEUM-US, V52, P1929, DOI 10.1002/art.21044; Daigneault M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008668; Figueroa-Romero C, 2008, REV ENDOCR METAB DIS, V9, P301, DOI 10.1007/s11154-008-9104-2; Garcia-Espana A, 2005, CANCER RES, V65, P1150, DOI 10.1158/0008-5472.CAN-04-2074; Garcia-Espana E., 2011, Patent WO, Patent No. [WO2011/033163 A2, 2011033163, 2011/033163 A2]; Guha M, 2002, J BIOL CHEM, V277, P32124, DOI 10.1074/jbc.M203298200; HALLIWELL B, 1985, MOL ASPECTS MED, V8, P89, DOI 10.1016/0098-2997(85)90001-9; Hong TH, 2014, J TRANSL MED, V12, DOI 10.1186/1479-5876-12-146; Inclan M, 2012, J AM CHEM SOC, V134, P9644, DOI 10.1021/ja300538s; Jiang SR, 2013, INT IMMUNOPHARMACOL, V16, P100, DOI 10.1016/j.intimp.2013.03.024; Kanno S, 2006, LIFE SCI, V78, P673, DOI 10.1016/j.lfs.2005.04.051; Lawton JA, 2003, CURR OPIN CHEM BIOL, V7, P446, DOI 10.1016/S1367-5931(03)00077-2; Martinez FO, 2008, FRONT BIOSCI-LANDMRK, V13, P453, DOI 10.2741/2692; Muscoli C, 2003, BRIT J PHARMACOL, V140, P445, DOI 10.1038/sj.bjp.0705430; Opal SM, 2007, CRIT CARE MED, V35, P387, DOI 10.1097/01.CCM.0000253810.08230.83; Clares MP, 2015, J INORG BIOCHEM, V143, P1, DOI 10.1016/j.jinorgbio.2014.11.001; Clares MP, 2011, CHEM COMMUN, V47, P5988, DOI 10.1039/c1cc10526d; PINSKY MR, 1993, CHEST, V103, P565, DOI 10.1378/chest.103.2.565; Qin ZY, 2012, ATHEROSCLEROSIS, V221, P2, DOI 10.1016/j.atherosclerosis.2011.09.003; Rajapakse N, 2008, IMMUNOLOGY, V123, P348, DOI 10.1111/j.1365-2567.2007.02683.x; Raju H, 2011, RECENT PAT ANTI-CANC, V6, P186, DOI 10.2174/157489211795328459; Riley DP, 1999, CHEM REV, V99, P2573, DOI 10.1021/cr980432g; Rull A, 2007, EXP MOL PATHOL, V83, P361, DOI 10.1016/j.yexmp.2007.08.003; Salvemini D, 2002, PULM PHARMACOL THER, V15, P439, DOI 10.1006/pupt.2002.0374; Seok J, 2013, P NATL ACAD SCI USA, V110, P3507, DOI 10.1073/pnas.1222878110; Sharif O, 2007, BMC IMMUNOL, V8, DOI 10.1186/1471-2172-8-1; Toyokuni S, 2008, IUBMB LIFE, V60, P441, DOI 10.1002/iub.61; Warren HS, 2009, J LEUKOCYTE BIOL, V86, P199, DOI 10.1189/jlb.0309210; You R, 2013, J MED CHEM, V56, P1984, DOI 10.1021/jm301652t	34	15	15	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2015	10	3							e0119102	10.1371/journal.pone.0119102	http://dx.doi.org/10.1371/journal.pone.0119102			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9KG	25742129	Green Published, gold, Green Submitted			2022-12-27	WOS:000350688100082
J	Zhang, MM; Kothari, P; Lampson, MA				Zhang, Maomao; Kothari, Priyanka; Lampson, Michael A.			Spindle Assembly Checkpoint Acquisition at the Mid-Blastula Transition	PLOS ONE			English	Article							DNA-DAMAGE CHECKPOINT; ZEBRAFISH MIDBLASTULA TRANSITION; MAJOR DEVELOPMENTAL TRANSITION; EARLY XENOPUS-EMBRYOS; CELL-CYCLE; ACTIVATION; CHK1; PHOSPHORYLATION; TRANSCRIPTION; KINASE	The spindle assembly checkpoint (SAC) maintains the fidelity of chromosome segregation during mitosis. Nonpathogenic cells lacking the SAC are typically only found in cleavage stage metazoan embryos, which do not acquire functional checkpoints until the mid-blastula transition (MBT). It is unclear how proper SAC function is acquired at the MBT, though several models exist. First, SAC acquisition could rely on transcriptional activity, which increases dramatically at the MBT. Embryogenesis prior to the MBT relies primarily on maternally loaded transcripts, and if SAC signaling components are not maternally supplied, the SAC would depend on zygotic transcription at the MBT. Second, checkpoint acquisition could depend on the Chk1 kinase, which is activated at the MBT to elongate cell cycles and is required for the SAC in somatic cells. Third, SAC function could depend on a threshold nuclear to cytoplasmic (N:C) ratio, which increases during pre-MBT cleavage cycles and dictates several MBT events like zygotic transcription and cell cycle remodeling. Finally, the SAC could by regulated by a timer mechanism that coincides with other MBT events but is independent of them. Using zebrafish embryos we show that SAC acquisition at the MBT is independent of zygotic transcription, indicating that the checkpoint program is maternally supplied. Additionally, by precociously lengthening cleavage cycles with exogenous Chk1 activity, we show that cell cycle lengthening and Chk1 activity are not sufficient for SAC acquisition. Furthermore, we find that SAC acquisition can be uncoupled from the N: C ratio. Together, our findings indicate that SAC acquisition is regulated by a maternally programmed developmental timer.	[Zhang, Maomao; Kothari, Priyanka; Lampson, Michael A.] Univ Penn, Dept Biol, Philadelphia, PA 19104 USA; [Zhang, Maomao; Lampson, Michael A.] Univ Penn, Cell & Mol Biol Grad Grp, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania	Lampson, MA (corresponding author), Univ Penn, Dept Biol, Philadelphia, PA 19104 USA.	lampson@sas.upenn.edu		Kothari, Priyanka/0000-0002-1791-5093	National Institutes of Health [T32HD007516, GM083988]; Searle Scholar award; Penn Genome Frontiers Institute; Pennsylvania Department of Health; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD007516] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM083988] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Searle Scholar award; Penn Genome Frontiers Institute; Pennsylvania Department of Health; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Institutes of Health (grants T32HD007516 to M. Z. and GM083988 to M. A. L.), a Searle Scholar award to M. A. L., and the Penn Genome Frontiers Institute and a grant with the Pennsylvania Department of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartek J, 2003, CANCER CELL, V3, P421, DOI 10.1016/S1535-6108(03)00110-7; Carrassa L, 2009, J CELL MOL MED, V13, P1565, DOI [10.1111/j.1582-4934.2008.00362.x, 10.1111/j.1582-4934.2009.00362.x]; CLUTE P, 1992, DEV GROWTH DIFFER, V34, P27; Clute P, 1995, DEV BIOL, P273; Clute P, 1997, DEV BIOL, V13, P1; Collart C, 2013, SCIENCE, V341, P893, DOI 10.1126/science.1241530; Conn CW, 2004, DEV CELL, V7, P275, DOI 10.1016/j.devcel.2004.07.003; EDGAR BA, 1986, CELL, V44, P871, DOI 10.1016/0092-8674(86)90009-7; GERHART J, 1984, J CELL BIOL, V98, P1247, DOI 10.1083/jcb.98.4.1247; HARA K, 1980, P NATL ACAD SCI-BIOL, V77, P462, DOI 10.1073/pnas.77.1.462; HOWE JA, 1995, GENE DEV, V9, P1164, DOI 10.1101/gad.9.10.1164; Howe JA, 1996, P NATL ACAD SCI USA, V93, P2060, DOI 10.1073/pnas.93.5.2060; Ikegami R, 1997, ZYGOTE, V5, P329, DOI 10.1017/S0967199400003919; KANE DA, 1993, DEVELOPMENT, V119, P447; Katsuragi Y, 2004, MOL BIOL CELL, V15, P1680, DOI 10.1091/mbc.E03-12-0874; KIMELMAN D, 1987, CELL, V48, P399, DOI 10.1016/0092-8674(87)90191-7; Kisielewska J, 2005, BIOL CELL, V97, P221; Lara-Gonzalez P, 2012, CURR BIOL, V22, pR966, DOI 10.1016/j.cub.2012.10.006; MEINECKE B, 1993, J REPROD FERTIL, V98, P195; MINSHULL J, 1994, CELL, V79, P475, DOI 10.1016/0092-8674(94)90256-9; NEWPORT J, 1982, CELL, V30, P675, DOI 10.1016/0092-8674(82)90272-0; NEWPORT J, 1982, CELL, V30, P687, DOI 10.1016/0092-8674(82)90273-2; Nogare DED, 2009, DEV BIOL, V326, P131, DOI 10.1016/j.ydbio.2008.11.002; PAULSON JR, 1982, J BIOL CHEM, V257, P6064; Peng A, 2007, MOL CELL BIOL, V27, P6852, DOI 10.1128/MCB.00195-07; Petsalaki E, 2011, J CELL BIOL, V195, P449, DOI 10.1083/jcb.201104023; Pritchard DK, 1996, GENE DEV, V10, P1131, DOI 10.1101/gad.10.9.1131; SHERMOEN AW, 1991, CELL, V67, P303, DOI 10.1016/0092-8674(91)90182-X; Shimuta K, 2002, EMBO J, V21, P3694, DOI 10.1093/emboj/cdf357; Sibon OCM, 1997, NATURE, V388, P93, DOI 10.1038/40439; Tadros W, 2009, DEVELOPMENT, V136, P3033, DOI 10.1242/dev.033183; Tan MH, 2013, GENOME RES, V23, P201, DOI 10.1101/gr.141424.112; Zachos G, 2007, DEV CELL, V12, P247, DOI 10.1016/j.devcel.2007.01.003; Zhang MM, 2014, CELL CYCLE, V13, P3828, DOI 10.4161/15384101.2014.967066	34	21	22	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2015	10	3							e0119285	10.1371/journal.pone.0119285	http://dx.doi.org/10.1371/journal.pone.0119285			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9KG	25741707	gold, Green Published, Green Submitted			2022-12-27	WOS:000350688100101
J	Hamilton, SE; Lovette, J				Hamilton, Stuart E.; Lovette, John			Ecuador's Mangrove Forest Carbon Stocks: A Spatiotemporal Analysis of Living Carbon Holdings and Their Depletion since the Advent of Commercial Aquaculture	PLOS ONE			English	Article							TROPICAL DEFORESTATION; ABOVEGROUND BIOMASS; DIOXIDE EMISSIONS; RIVER ESTUARY; PRODUCTIVITY; DYNAMICS; PATTERNS	In this paper we estimate the living carbon lost from Ecuador's mangrove forests since the advent of export-focused shrimp aquaculture. We use remote sensing techniques to delineate the extent of mangroves and aquaculture at approximately decadal periods since the arrival of aquaculture in each Ecuadorian estuary. We then spatiotemporally calculate the carbon values of the mangrove forests and estimate the amount of carbon lost due to direct displacement by aquaculture. Additionally, we calculate the new carbon stocks generated due to mangrove reforestation or afforestation. This research introduces time and LUCC (land use/land cover change) into the tropical forest carbon literature and examines forest carbon loss at a higher spatiotemporal resolution than in many earlier analyses. We find that 80 percent, or 7,014,517 t of the living carbon lost in Ecuadorian mangrove forests can be attributed to direct displacement of mangrove forests by shrimp aquaculture. We also find that IPCC (Intergovernmental Panel on Climate Change) compliant carbon grids within Ecuador's estuaries overestimate living carbon levels in estuaries where substantial LUCC has occurred. By approaching the mangrove forest carbon loss question from a LUCC perspective, these findings allow for tropical nations and other intervention agents to prioritize and target a limited set of land transitions that likely drive the majority of carbon losses. This singular cause of transition has implications for programs that attempt to offset or limit future forest carbon losses and place value on forest carbon or other forest good and services.	[Hamilton, Stuart E.] Salisbury Univ, Dept Geog & Geosci, Salisbury, MD 21801 USA; [Lovette, John] Univ N Carolina, Dept Geog, Chapel Hill, NC USA	University System of Maryland; Salisbury University; University of North Carolina; University of North Carolina Chapel Hill	Hamilton, SE (corresponding author), Salisbury Univ, Dept Geog & Geosci, Salisbury, MD 21801 USA.	stuartehamilton@gmail.com	Hamilton, Stuart E./A-4297-2013	Hamilton, Stuart E./0000-0001-8114-7247				Alongi DM, 2012, CARBON MANAG, V3, P313, DOI [10.4155/CMT.12.20, 10.4155/cmt.12.20]; [Anonymous], 1974, ANN REV ECOL SYST, DOI DOI 10.1146/ANNUREV.ES.05.110174.000351; [Anonymous], 2008, NEW IPCC TIER 1 GLOB; [Anonymous], 2014, GLOB; [Anonymous], 1997, WORLD MANGROVE ATLAS; Arriaga L, 1999, OCEAN COAST MANAGE, V42, P229, DOI 10.1016/S0964-5691(98)00055-6; Baccini A, 2012, NAT CLIM CHANGE, V2, P182, DOI [10.1038/NCLIMATE1354, 10.1038/nclimate1354]; Chen RH, 1999, ESTUARIES, V22, P955, DOI 10.2307/1353075; Coello S, 1993, SPECIAL AREA MANAGEM; DeFries RS, 2002, P NATL ACAD SCI USA, V99, P14256, DOI 10.1073/pnas.182560099; Donato DC, 2011, NAT GEOSCI, V4, P293, DOI [10.1038/ngeo1123, 10.1038/NGEO1123]; Duke NC, 1998, GLOBAL ECOL BIOGEOGR, V7, P27, DOI 10.2307/2997695; FAO Fisheries and Aquaculture Department, 2014, GLOB AQ STAT UPD 201; FAO Fisheries and Aquaculture Department, 2014, GLOB CAPT PROD STAT; Fisheries FAO and Department Aquaculture, 2010, STAT WORLD FISH AQ; Fromard F, 1998, OECOLOGIA, V115, P39, DOI 10.1007/s004420050489; Geist HJ, 2002, BIOSCIENCE, V52, P143, DOI 10.1641/0006-3568(2002)052[0143:PCAUDF]2.0.CO;2; Hamilton S, 2013, B MAR SCI, V89, P585, DOI 10.5343/bms.2012.1069; Hamilton SE, 2012, J LAND USE SCI, V7, P177, DOI 10.1080/1747423X.2010.550694; Houghton RA, 2003, TELLUS B, V55, P378, DOI 10.1034/j.1600-0889.2003.01450.x; Kauffman J. B, 2012, PROTOCOLS MEASUREMEN; Kauffman JB, 2011, WETLANDS, V31, P343, DOI 10.1007/s13157-011-0148-9; Komiyama A, 2008, AQUAT BOT, V89, P128, DOI 10.1016/j.aquabot.2007.12.006; Ladd B, 2013, GLOBAL ECOL BIOGEOGR, V22, P461, DOI 10.1111/j.1466-8238.2012.00799.x; MADSEN JE, 2001, FLORA PUNA ISLAND PL; Melillo JM, 1996, ANNU REV ENERG ENV, V21, P293, DOI 10.1146/annurev.energy.21.1.293; Naylor RL, 2000, NATURE, V405, P1017, DOI 10.1038/35016500; Naylor RL, 1998, SCIENCE, V282, P883, DOI 10.1126/science.282.5390.883; Naylor R, 2011, FOOD SECUR, V3, P233, DOI 10.1007/s12571-011-0123-6; Pan YD, 2011, SCIENCE, V333, P988, DOI 10.1126/science.1201609; Polidoro BA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010095; POOL DJ, 1977, BIOTROPICA, V9, P195, DOI 10.2307/2387881; Saatchi SS, 2011, P NATL ACAD SCI USA, V108, P9899, DOI 10.1073/pnas.1019576108; SAENGER P, 1993, OECOLOGIA, V96, P293, DOI 10.1007/BF00317496; Sherman RE, 2003, ECOSYSTEMS, V6, P384, DOI 10.1007/s10021-002-0191-8; Siikamaki J, 2012, P NATL ACAD SCI USA, V109, P14369, DOI 10.1073/pnas.1200519109; Snedaker S. C., 1982, Contributions to the ecology of halophytes., P111; Soares MLG, 2005, ESTUAR COAST SHELF S, V65, P1, DOI 10.1016/j.ecss.2005.05.001; Spalding M., 2010, WETLANDS, V31, P1003, DOI 10.1007/s13157-011-0224-1; TWILLEY RR, 1992, WATER AIR SOIL POLL, V64, P265, DOI 10.1007/BF00477106; Watson RT., 2001, CONTRIBUTION WORKING, P1; Zarin DJ, 2012, SCIENCE, V336, P1518, DOI 10.1126/science.1223251	42	23	24	2	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2015	10	3							e0118880	10.1371/journal.pone.0118880	http://dx.doi.org/10.1371/journal.pone.0118880			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9JM	25738286	Green Submitted, gold, Green Published			2022-12-27	WOS:000350685900082
J	Han, JH; Han, JS; Kim, EJ; Doh, FM; Koo, HM; Kim, CH; Lee, MJ; Oh, HJ; Park, JT; Han, SH; Ryu, DR; Yoo, TH; Kang, SW				Han, Jae Hyun; Han, Ji Suk; Kim, Eun Jin; Doh, Fa Mee; Koo, Hyang Mo; Kim, Chan Ho; Lee, Mi Jung; Oh, Hyung Jung; Park, Jung Tak; Han, Seung Hyeok; Ryu, Dong-Ryeol; Yoo, Tae-Hyun; Kang, Shin-Wook			Diastolic Dysfunction Is an Independent Predictor of Cardiovascular Events in Incident Dialysis Patients with Preserved Systolic Function	PLOS ONE			English	Article							LEFT ATRIAL VOLUME; LEFT-VENTRICULAR HYPERTROPHY; STAGE RENAL-DISEASE; HEART-FAILURE; EJECTION FRACTION; EUROPEAN-SOCIETY; PROGNOSTIC VALUE; RAPID DECLINE; FOLLOW-UP; MORTALITY	Background Diastolic heart failure (HF), the prevalence of which is gradually increasing, is associated with cardiovascular (CV) morbidity and mortality in the general population and, more specifically, in patients with end-stage renal disease (ESRD). However, the impact of diastolic dysfunction on CV outcomes has not been studied in incident dialysis patients with preserved systolic function. Methods This prospective observational cohort study investigates the clinical consequence of diastolic dysfunction and the predictive power of diastolic echocardiographic parameters for CV events in 194 incident ESRD patients with normal or near normal systolic function, who started dialysis between July 2008 and August 2012. Results During a mean follow-up duration of 27.2 months, 57 patients (29.4%) experienced CV events. Compared to the CV event-free group, patients with CV events had a significantly higher left ventricular (LV) mass index, ratio of early mitral flow velocity (E) to early mitral annulus velocity (E') (E/E'), LA volume index (LAVI), deceleration time, and right ventricular systolic pressure, and a significantly lower LV ejection fraction and E'. In multivariate Cox proportional hazard analysis, E/E'>15 and LAVI>32 mL/m(2) significantly predicted CV events (E/E'>15: hazard ratio [HR] = 5.40, 95% confidence interval [CI] = 2.73-10.70, P<.001; LAVI>32 mL/m(2): HR = 5.56, 95% CI = 2.28-13.59, P<.001]. Kaplan-Meier analysis revealed that patients with both E/E'>15 and LAVI>32mL/m(2) had the worst CV outcomes. Conclusion An increase in E/E' or LAVI is a significant risk factor for CV events in incident dialysis patients with preserved LV systolic function.	[Han, Jae Hyun; Han, Ji Suk; Kim, Eun Jin; Doh, Fa Mee; Koo, Hyang Mo; Kim, Chan Ho; Lee, Mi Jung; Oh, Hyung Jung; Park, Jung Tak; Han, Seung Hyeok; Yoo, Tae-Hyun; Kang, Shin-Wook] Yonsei Univ, Coll Med, Dept Internal Med, Seoul, South Korea; [Ryu, Dong-Ryeol] Ewha Womans Univ, Sch Med, Dept Internal Med, Seoul, South Korea; [Kang, Shin-Wook] Yonsei Univ, Coll Med, Severance Biomed Sci Inst, Brain Korea PLUS Project Med Sci 21, Seoul, South Korea	Yonsei University; Yonsei University Health System; Ewha Womans University; Yonsei University; Yonsei University Health System	Kang, SW (corresponding author), Yonsei Univ, Coll Med, Dept Internal Med, Seoul, South Korea.	kswkidney@yuhs.ac	; Han, Seung Hyeok/K-4559-2018	Kang, Shin-Wook/0000-0002-5677-4756; Yoo, Tae-Hyun/0000-0002-9183-4507; Lee, Mi Jung/0000-0001-8888-029X; Park, Jung Tak/0000-0002-2325-8982; doh, fa mee/0000-0002-4780-6728; Ryu, Dong-Ryeol/0000-0002-5309-7606; Han, Seung Hyeok/0000-0001-7923-5635	Brain Korea 21 PLUS Project for Medical Science, Yonsei University College of Medicine; Korea Healthcare Technology R&D Project, Ministry of Health and Welfare, Republic of Korea [HI10C2020]	Brain Korea 21 PLUS Project for Medical Science, Yonsei University College of Medicine; Korea Healthcare Technology R&D Project, Ministry of Health and Welfare, Republic of Korea	This work was supported by the Brain Korea 21 PLUS Project for Medical Science, Yonsei University College of Medicine, and a grant of the Korea Healthcare Technology R&D Project, Ministry of Health and Welfare, Republic of Korea (HI10C2020). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Astorri E, 1997, CARDIOLOGY, V88, P152, DOI 10.1159/000177322; Bella JN, 2002, CIRCULATION, V105, P1928, DOI 10.1161/01.CIR.0000015076.37047.D9; Bhatia RS, 2006, NEW ENGL J MED, V355, P260, DOI 10.1056/NEJMoa051530; Bolton K, 2005, AM J KIDNEY DIS, V45, pS7, DOI 10.1053/j.ajkd.2005.01.016; DEVEREUX RB, 1986, AM J CARDIOL, V57, P450, DOI 10.1016/0002-9149(86)90771-X; Dickstein K, 2008, EUR J HEART FAIL, V10, P933, DOI 10.1016/j.ejheart.2008.08.005; FOLEY RN, 1995, KIDNEY INT, V47, P186, DOI 10.1038/ki.1995.22; Glassock RJ, 2009, CLIN J AM SOC NEPHRO, V4, pS79, DOI 10.2215/CJN.04860709; GREAVES SC, 1994, AM J KIDNEY DIS, V24, P768, DOI 10.1016/S0272-6386(12)80670-6; Halley CM, 2011, ARCH INTERN MED, V171, P1082, DOI 10.1001/archinternmed.2011.244; Kim JK, 2012, J AM SOC ECHOCARDIOG, V25, P411, DOI 10.1016/j.echo.2011.11.026; Kim SJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035534; Kim SJ, 2012, J AM SOC ECHOCARDIOG, V25, P421, DOI 10.1016/j.echo.2011.12.005; Kim SJ, 2011, NEPHROL DIAL TRANSPL, V26, P3732, DOI 10.1093/ndt/gfr118; Koo HM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087231; London GM, 2002, NEPHROL DIAL TRANSPL, V17, P29, DOI 10.1093/ndt/17.suppl_1.29; London GM, 2001, J AM SOC NEPHROL, V12, P2759, DOI 10.1681/ASN.V12122759; Lopez B, 2008, KIDNEY INT, V74, pS19, DOI 10.1038/ki.2008.512; Moller JE, 2003, CIRCULATION, V107, P2207, DOI 10.1161/01.CIR.0000066318.21784.43; Nagueh SF, 2009, EUR J ECHOCARDIOGR, V10, P165, DOI 10.1093/ejechocard/jep007; O'Connor CM, 2000, AM J CARDIOL, V86, P863, DOI 10.1016/S0002-9149(00)01107-3; Oh JK, 1997, J AM SOC ECHOCARDIOG, V10, P246, DOI 10.1016/S0894-7317(97)70062-2; Ommen SR, 2000, CIRCULATION, V102, P1788; Owan TE, 2006, NEW ENGL J MED, V355, P251, DOI 10.1056/NEJMoa052256; Paulus WJ, 2007, EUR HEART J, V28, P2539, DOI 10.1093/eurheartj/ehm037; Paulus WJ, 1998, EUR HEART J, V19, P990; Perseghin G, 2005, J AM COLL CARDIOL, V46, P1085, DOI 10.1016/j.jacc.2005.05.075; Pritchett AM, 2005, J AM COLL CARDIOL, V45, P87, DOI 10.1016/j.jacc.2004.09.054; Redfield MM, 2003, JAMA-J AM MED ASSOC, V289, P194, DOI 10.1001/jama.289.2.194; Rudski LG, 2010, J AM SOC ECHOCARDIOG, V23, P685, DOI 10.1016/j.echo.2010.05.010; Sharma R, 2006, J AM SOC ECHOCARDIOG, V19, P266, DOI 10.1016/j.echo.2005.10.006; Simek C L, 1995, J Am Soc Echocardiogr, V8, P37, DOI 10.1016/S0894-7317(05)80356-6; Sweitzer NK, 2008, AM J CARDIOL, V101, P1151, DOI 10.1016/j.amjcard.2007.12.014; Tripepi G, 2007, J AM SOC NEPHROL, V18, P1316, DOI 10.1681/ASN.2006080881; Wang AYM, 2011, AM J KIDNEY DIS, V57, P308, DOI 10.1053/j.ajkd.2010.07.019; Wang AYM, 2004, J AM SOC NEPHROL, V15, P2186, DOI 10.1097/01.ASN.0000135053.98172.D6; Yamada S, 2010, CLIN J AM SOC NEPHRO, V5, P1793, DOI 10.2215/CJN.00050110; Yancy CW, 2006, J AM COLL CARDIOL, V47, P76, DOI 10.1016/j.jacc.2005.09.022; Zoccali C, 2004, J AM SOC NEPHROL, V15, P1029, DOI 10.1097/01.ASN.0000117977.14912.91; Zoccali C, 2004, KIDNEY INT, V65, P1492, DOI 10.1111/j.1523-1755.2004.00530.x	40	33	35	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2015	10	3							e0118694	10.1371/journal.pone.0118694	http://dx.doi.org/10.1371/journal.pone.0118694			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9JM	25739020	gold, Green Published, Green Submitted			2022-12-27	WOS:000350685900062
J	Bolandzadeh, N; Kording, K; Salowitz, N; Davis, JC; Hsu, L; Chan, A; Sharma, D; Blohm, G; Liu-Ambrose, T				Bolandzadeh, Niousha; Kording, Konrad; Salowitz, Nicole; Davis, Jennifer C.; Hsu, Liang; Chan, Alison; Sharma, Devika; Blohm, Gunnar; Liu-Ambrose, Teresa			Predicting Cognitive Function from Clinical Measures of Physical Function and Health Status in Older Adults	PLOS ONE			English	Article							CARDIOVASCULAR RISK-FACTORS; WHITE-MATTER CHANGES; EXECUTIVE FUNCTION; FALLS RISK; WALK TEST; DECLINE; GAIT; PERFORMANCE; SPEED; CIRCUMFERENCE	Introduction Current research suggests that the neuropathology of dementia-including brain changes leading to memory impairment and cognitive decline-is evident years before the onset of this disease. Older adults with cognitive decline have reduced functional independence and quality of life, and are at greater risk for developing dementia. Therefore, identifying biomarkers that can be easily assessed within the clinical setting and predict cognitive decline is important. Early recognition of cognitive decline could promote timely implementation of preventive strategies. Methods We included 89 community-dwelling adults aged 70 years and older in our study, and collected 32 measures of physical function, health status and cognitive function at baseline. We utilized an L1-L2 regularized regression model (elastic net) to identify which of the 32 baseline measures were strongly predictive of cognitive function after one year. We built three linear regression models: 1) based on baseline cognitive function, 2) based on variables consistently selected in every cross-validation loop, and 3) a full model based on all the 32 variables. Each of these models was carefully tested with nested crossvalidation. Results Our model with the six variables consistently selected in every cross-validation loop had a mean squared prediction error of 7.47. This number was smaller than that of the full model (115.33) and the model with baseline cognitive function (7.98). Our model explained 47% of the variance in cognitive function after one year. Discussion We built a parsimonious model based on a selected set of six physical function and health status measures strongly predictive of cognitive function after one year. In addition to reducing the complexity of the model without changing the model significantly, our model with the top variables improved the mean prediction error and R-squared. These six physical function and health status measures can be easily implemented in a clinical setting.	[Bolandzadeh, Niousha; Liu-Ambrose, Teresa] Univ British Columbia, Expt Med Program, Vancouver, BC V5Z 1M9, Canada; [Bolandzadeh, Niousha; Hsu, Liang; Chan, Alison; Sharma, Devika; Liu-Ambrose, Teresa] Univ British Columbia, Djavad Mowafaghian Ctr Brain Hlth, Vancouver, BC V5Z 1M9, Canada; [Bolandzadeh, Niousha; Hsu, Liang; Chan, Alison; Sharma, Devika; Liu-Ambrose, Teresa] Vancouver Coastal Hlth Res Inst, Ctr Hip Hlth & Mobil, Vancouver, BC, Canada; [Bolandzadeh, Niousha; Davis, Jennifer C.; Hsu, Liang; Chan, Alison; Sharma, Devika; Liu-Ambrose, Teresa] Univ British Columbia, Aging Mobil & Cognit Neurosci Lab, Dept Phys Therapy, Vancouver, BC V5Z 1M9, Canada; [Kording, Konrad] Northwestern Univ, Rehabil Inst Chicago, Chicago, IL 60611 USA; [Salowitz, Nicole] Marquette Univ, Dept Biomed Engn, Milwaukee, WI 53233 USA; [Davis, Jennifer C.] Univ British Columbia, Sch Populat & Publ Hlth, Vancouver, BC V5Z 1M9, Canada; [Davis, Jennifer C.] Ctr Clin Epidemiol & Evaluat, Vancouver, BC, Canada; [Blohm, Gunnar] Queens Univ, Dept Biomed & Mol Sci, Kingstone, ON, Canada	University of British Columbia; University of British Columbia; Vancouver Coastal Health Research Institute; University of British Columbia; Northwestern University; Shirley Ryan AbilityLab; Marquette University; University of British Columbia; Queens University - Canada	Liu-Ambrose, T (corresponding author), Univ British Columbia, Expt Med Program, Vancouver, BC V5Z 1M9, Canada.	tlambrose@exchange.ubc.ca	Liu-Ambrose, Teresa/W-2332-2019; Hsu, Chun Liang/AAN-4254-2021; Kording, Konrad/A-1233-2007	Liu-Ambrose, Teresa/0000-0002-8297-5308; Hsu, Chun Liang/0000-0003-2090-1001; Kording, Konrad/0000-0001-8408-4499; Blohm, Gunnar/0000-0002-2297-3271	Canadian Institutes of Health Research [MOB-93373]; Heart and Stroke Foundation of Canada's (HSFC) Henry JM Barnett's Scholarship	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Heart and Stroke Foundation of Canada's (HSFC) Henry JM Barnett's Scholarship	TLA is funded by the Canadian Institutes of Health Research (MOB-93373). TLA is a Canada Research Chair in Physical Activity, Mobility, and Cognitive Neuroscience, a Michael Smith Foundation for Health Research (MSFHR) Scholar, a Canadian Institutes of Health Research (CIHR) New Investigator, and a Heart and Stroke Foundation of Canada's (HSFC) Henry JM Barnett's Scholarship recipient. JCD is a MSFHR and a CIHR Post-Doctoral Fellow. NB is a HSFC Doctoral trainee. CLH is an Alzheimer's Society Research Program Doctoral trainee. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anstey KJ, 2006, J AM GERIATR SOC, V54, P1169, DOI 10.1111/j.1532-5415.2006.00813.x; Atkinson HH, 2007, J GERONTOL A-BIOL, V62, P844, DOI 10.1093/gerona/62.8.844; Babyak MA, 2004, PSYCHOSOM MED, V66, P411, DOI 10.1097/01.psy.0000127692.23278.a9; Ble A, 2005, J AM GERIATR SOC, V53, P410, DOI 10.1111/j.1532-5415.2005.53157.x; Boyle PA, 2009, ARCH NEUROL-CHICAGO, V66, P1339, DOI 10.1001/archneurol.2009.240; Bruce-Keller AJ, 2012, J ALZHEIMERS DIS, V30, P899, DOI 10.3233/JAD-2012-120025; Buchman AS, 2012, NEUROLOGY, V78, P1323, DOI 10.1212/WNL.0b013e3182535d35; Buracchio T, 2010, ARCH NEUROL-CHICAGO, V67, P980, DOI 10.1001/archneurol.2010.159; Camicioli R, 1998, NEUROLOGY, V50, P1496, DOI 10.1212/WNL.50.5.1496; Cesari M, 2009, J AM GERIATR SOC, V57, P251, DOI 10.1111/j.1532-5415.2008.02126.x; COCKRELL JR, 1988, PSYCHOPHARMACOL BULL, V24, P689; Delbaere K, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c4165; Dobbelsteyn CJ, 2001, INT J OBESITY, V25, P652, DOI 10.1038/sj.ijo.0801582; Elmstahl S, 1997, DEMENT GERIATR COGN, V8, P180, DOI 10.1159/000106629; Enright PL, 2003, CHEST, V123, P387, DOI 10.1378/chest.123.2.387; Fillit H, 2008, AM J GERIATR PHARMAC, V6, P100, DOI 10.1016/j.amjopharm.2008.06.004; Groll DL, 2005, J CLIN EPIDEMIOL, V58, P595, DOI 10.1016/j.jclinepi.2004.10.018; GURALNIK JM, 1995, NEW ENGL J MED, V332, P556, DOI 10.1056/NEJM199503023320902; Hamer M, 2009, PSYCHOL MED, V39, P3, DOI 10.1017/S0033291708003681; Hedden T, 2004, NAT REV NEUROSCI, V5, P87, DOI 10.1038/nrn1323; Heitmann BL, 2004, OBES RES, V12, P482, DOI 10.1038/oby.2004.54; Holtzer R, 2006, NEUROPSYCHOLOGY, V20, P215, DOI 10.1037/0894-4105.20.2.215; Inzitari M, 2007, NEUROEPIDEMIOLOGY, V29, P156, DOI 10.1159/000111577; Kervio G, 2003, MED SCI SPORT EXER, V35, P169, DOI 10.1097/00005768-200301000-00025; Kuo HK, 2004, J GERONTOL A-BIOL, V59, P818; LORD SR, 1994, J AM GERIATR SOC, V42, P1110, DOI 10.1111/j.1532-5415.1994.tb06218.x; LORD SR, 1991, AGE AGEING, V20, P175, DOI 10.1093/ageing/20.3.175; Lord SR, 2003, PHYS THER, V83, P237, DOI 10.1093/ptj/83.3.237; LORD SR, 1991, J AM GERIATR SOC, V39, P1194, DOI 10.1111/j.1532-5415.1991.tb03574.x; Lord SR, 2001, J GERONTOL A-BIOL, V56, pM627, DOI 10.1093/gerona/56.10.M627; Lord SR, 2001, J AM GERIATR SOC, V49, P508, DOI 10.1046/j.1532-5415.2001.49107.x; LundinOlsson L, 1997, LANCET, V349, P617, DOI 10.1016/S0140-6736(97)24009-2; Lutz W, 2008, NATURE, V451, P716, DOI 10.1038/nature06516; Malouin F, 2003, HUM BRAIN MAPP, V19, P47, DOI 10.1002/hbm.10103; Mielke MM, 2013, J GERONTOL A-BIOL, V68, P929, DOI 10.1093/gerona/gls256; Mosconi L, 2008, NEUROBIOL AGING, V29, P676, DOI 10.1016/j.neurobiolaging.2006.12.008; Nasreddine ZS, 2005, J AM GERIATR SOC, V53, P695, DOI 10.1111/j.1532-5415.2005.53221.x; ODENHEIMER G, 1994, ARCH NEUROL-CHICAGO, V51, P573, DOI 10.1001/archneur.1994.00540180051013; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Penninx BWJH, 2003, BIOL PSYCHIAT, V54, P566, DOI 10.1016/S0006-3223(02)01811-5; PODSIADLO D, 1991, J AM GERIATR SOC, V39, P142, DOI 10.1111/j.1532-5415.1991.tb01616.x; POWELL LE, 1995, J GERONTOL A-BIOL, V50, pM28, DOI 10.1093/gerona/50A.1.M28; RAPPORT LJ, 1993, ARCH PHYS MED REHAB, V74, P621, DOI 10.1016/0003-9993(93)90160-C; Rapport LJ, 1998, ARCH PHYS MED REHAB, V79, P629, DOI 10.1016/S0003-9993(98)90035-1; Ritchie K, 2002, LANCET, V360, P1759, DOI 10.1016/S0140-6736(02)11667-9; Roe CM, 2013, NEUROLOGY, V80, P1784, DOI 10.1212/WNL.0b013e3182918ca6; Rubin EH, 1998, ARCH NEUROL-CHICAGO, V55, P395, DOI 10.1001/archneur.55.3.395; Sattler C, 2011, J ALZHEIMERS DIS, V26, P709, DOI 10.3233/JAD-2011-110548; Small GW, 2012, ARCH NEUROL-CHICAGO, V69, P215, DOI 10.1001/archneurol.2011.559; Springer S, 2006, MOV DISORD; Tilvis RS, 2004, J GERONTOL A-BIOL, V59, P268; TINETTI ME, 1990, J GERONTOL, V45, pP239, DOI 10.1093/geronj/45.6.P239; van Boxtel MPJ, 1998, J GERONTOL A-BIOL, V53, pM147; Verdelho A, 2010, NEUROLOGY, V75, P160, DOI 10.1212/WNL.0b013e3181e7ca05; Walter S, 2009, EUR J EPIDEMIOL, V24, P733, DOI 10.1007/s10654-009-9411-2; WASHBURN RA, 1993, J CLIN EPIDEMIOL, V46, P153, DOI 10.1016/0895-4356(93)90053-4; Weuve J, 2004, JAMA-J AM MED ASSOC, V292, P1454, DOI 10.1001/jama.292.12.1454; Woodard JL, 2010, J ALZHEIMERS DIS, V21, P871, DOI 10.3233/JAD-2010-091693; World Health Organization Alzheimer's Disease International, 2012, DEM PUBL HLTH AUTH; Yaffe K, 2001, ARCH INTERN MED, V161, P1703, DOI 10.1001/archinte.161.14.1703; YESAVAGE JA, 1983, J PSYCHIATR RES, V17, P37, DOI 10.1016/0022-3956(82)90033-4; Yogev-Seligmann G, 2008, MOVEMENT DISORD, V23, P329, DOI 10.1002/mds.21720	62	20	23	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2015	10	3							e0119075	10.1371/journal.pone.0119075	http://dx.doi.org/10.1371/journal.pone.0119075			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4HV	25734446	Green Submitted, gold, Green Published			2022-12-27	WOS:000350314700054
J	Bos, AC; van Holsbeke, C; de Backer, JW; van Westreenen, M; Janssens, HM; Vos, WG; Tiddens, HAWM				Bos, Aukje C.; van Holsbeke, Cedric; de Backer, Jan W.; van Westreenen, Mireille; Janssens, Hettie M.; Vos, Wim G.; Tiddens, Harm A. W. M.			Patient-Specific Modeling of Regional Antibiotic Concentration Levels in Airways of Patients with Cystic Fibrosis: Are We Dosing High Enough?	PLOS ONE			English	Article							INHALED AZTREONAM LYSINE; COMPUTATIONAL FLUID-DYNAMICS; PSEUDOMONAS-AERUGINOSA INFECTION; COMPUTED-TOMOGRAPHY; PK/PD TERMINOLOGY; REFERENCE RANGES; DEPOSITION; SAFETY; PHARMACOKINETICS; STANDARDIZATION	Background Pseudomonas aeruginosa (Pa) infection is an important contributor to the progression of cystic fibrosis (CF) lung disease. The cornerstone treatment for Pa infection is the use of inhaled antibiotics. However, there is substantial lung disease heterogeneity within and between patients that likely impacts deposition patterns of inhaled antibiotics. Therefore, this may result in airways below the minimal inhibitory concentration of the inhaled agent. Very little is known about antibiotic concentrations in small airways, in particular the effect of structural lung abnormalities. We therefore aimed to develop a patient-specific airway model to predict concentrations of inhaled antibiotics and to study the impact of structural lung changes and breathing profile on local concentrations in airways of patients with CF. Methods In-and expiratory CT-scans of children with CF (5-17 years) were scored (CF-CT score), segmented and reconstructed into 3D airway models. Computational fluid dynamic (CFD) simulations were performed on 40 airway models to predict local Aztreonam lysine for inhalation (AZLI) concentrations. Patient-specific lobar flow distribution and nebulization of 75 mg AZLI through a digital Pari eFlow model with mass median aerodynamic diameter range were used at the inlet of the airway model. AZLI concentrations for central and small airways were computed for different breathing patterns and airway surface liquid thicknesses. Results In most simulated conditions, concentrations in both central and small airways were well above the minimal inhibitory concentration. However, small airways in more diseased lobes were likely to receive suboptimal AZLI. Structural lung disease and increased tidal volumes, respiratory rates and larger particle sizes greatly reduced small airway concentrations. Conclusions CFD modeling showed that concentrations of inhaled antibiotic delivered to the small airways are highly patient specific and vary throughout the bronchial tree. These results suggest that anti-Pa treatment of especially the small airways can be improved.				h.tiddens@erasmusmc.nl	Van Holsbeke, Cedric/I-4308-2013	Van Holsbeke, Cedric/0000-0003-0248-841X; VOS, WIM/0000-0003-0827-421X	Gilead Sciences Inc	Gilead Sciences Inc(Gilead Sciences)	This was an investigator initiated study. FluidDA nv received an unconditional grant from Gilead Sciences Inc. This grant was used for the Fluid dynamic modeling (JdB, CvH, WV). FluidDA NV covered the salary costs of the PhD student (AB) for the length of this study. Author Cedric van Holsbeke and Wim G. Vos are employed by FluidDA nv. J. de Backer and Wim G. Vos are shareholders of FluidDA NV, a company that commercializes some of the techniques used in this manuscript. FluidDA and investigators AB, HT and HJ have jointly developed the study design. AB, HT, MvW and HJ have acted as an independent party for this study. Study CT selection and assessment of lung disease severity was done by AB independently of FluidDA. FluidDA employees CvH and WV and investigators AB, HT and HJ have jointly analyzed the data and have jointly written the manuscript. The specific roles of the author are articulated in the 'author contributions' section. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bakker EM, 2011, EUR RESPIR J, V38, P1328, DOI 10.1183/09031936.00006211; BALTIMORE RS, 1989, AM REV RESPIR DIS, V140, P1650, DOI 10.1164/ajrccm/140.6.1650; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Burgel PR, 2007, THORAX, V62, P153, DOI 10.1136/thx.2006.062190; Cazzola Mario, 2002, Am J Respir Med, V1, P261; Chiu Loretta M, 2002, Am J Respir Med, V1, P201; Chrystyn H, 2001, BRIT J CLIN PHARMACO, V51, P289, DOI 10.1046/j.1365-2125.2001.01304.x; Dalhoff A, 2014, CLIN MICROBIOL REV, V27, P753, DOI 10.1128/CMR.00022-14; Darquenne C, 2012, J AEROSOL MED PULM D, V25, P140, DOI 10.1089/jamp.2011.0916; Davis SD, 2013, NEW ENGL J MED, V368, P2026, DOI 10.1056/NEJMe1303487; De Backer JW, 2008, MED ENG PHYS, V30, P872, DOI 10.1016/j.medengphy.2007.11.002; De Backer JW, 2008, J BIOMECH, V41, P106, DOI 10.1016/j.jbiomech.2007.07.009; De Backer JW, 2010, RADIOLOGY, V257, P854, DOI 10.1148/radiol.10100322; De Backer LA, 2012, EUR RESPIR J, V40, P298, DOI 10.1183/09031936.00072511; Donaldson SH, 2006, NEW ENGL J MED, V354, P241, DOI 10.1056/NEJMoa043891; Elborn JS, 2010, EXPERT OPIN PHARMACO, V11, P1373, DOI 10.1517/14656566.2010.482102; Geller DE, 2008, PEDIATR PULM, V43, pS5, DOI 10.1002/ppul.20860; Gibson RL, 2006, PEDIATR PULM, V41, P656, DOI 10.1002/ppul.20429; Hasan MA, 2007, J AEROSOL MED, V20, P282, DOI 10.1089/jam.2007.0603; Hutchinson D, 2013, EXPERT OPIN PHARMACO, V14, P2115, DOI 10.1517/14656566.2013.831070; King P, 2010, ANTIMICROB AGENTS CH, V54, P143, DOI 10.1128/AAC.00248-09; Lenney W, 2011, J CYST FIBROS, V10, P9, DOI 10.1016/j.jcf.2010.08.019; Loeve M, 2009, THORAX, V64, P876, DOI 10.1136/thx.2008.110908; Loeve M, 2013, EUR RESPIR J, V42, P844, DOI 10.1183/09031936.00051512; Maiz L, 2013, EXPERT OPIN PHARMACO, V14, P1135, DOI 10.1517/14656566.2013.790366; Mccoy KS, 2008, AM J RESP CRIT CARE, V178, P921, DOI 10.1164/rccm.200712-1804OC; Mott LS, 2013, J PEDIATR-US, V163, P243, DOI 10.1016/j.jpeds.2012.12.042; Mouton JW, 2005, J ANTIMICROB CHEMOTH, V55, P601, DOI 10.1093/jac/dki079; Mouton JW, 2002, INT J ANTIMICROB AG, V19, P355, DOI 10.1016/S0924-8579(02)00031-6; Nair CG, 2013, LETT APPL MICROBIOL, V56, P149, DOI 10.1111/lam.12032; Oermann CM, 2010, PEDIATR PULM, V45, P1121, DOI 10.1002/ppul.21301; Phalen RF, 1988, ANN OCCUP HYG     S1, V32, P11; Ratjen F, 2012, J AEROSOL MED PULM D, V25, P261, DOI 10.1089/jamp.2011.0923; Retsch-Bogart GZ, 2009, CHEST, V135, P1223, DOI 10.1378/chest.08-1421; Rodvold KA, 2011, CLIN PHARMACOKINET, V50, P689, DOI 10.2165/11592900-000000000-00000; Stanojevic S, 2008, AM J RESP CRIT CARE, V177, P253, DOI 10.1164/rccm.200708-1248OC; Talma H., 2010, GROEIDIAGRAMMEN 2010; Tarran R, 2006, ANNU REV PHYSIOL, V68, P543, DOI 10.1146/annurev.physiol.68.072304.112754; Tarran R, 2005, J BIOL CHEM, V280, P35751, DOI 10.1074/jbc.M505832200; Thompson RB, 2012, J AEROSOL MED PULM D, V25, P55, DOI 10.1089/jamp.2011.0897; Tiddens HAWM, 2010, PEDIATR PULM, V45, P107, DOI 10.1002/ppul.21154; Tiddens HAWM, 2000, EUR RESPIR J, V15, P735, DOI 10.1034/j.1399-3003.2000.15d18.x; Vinchurkar S, 2012, INHAL TOXICOL, V24, P81, DOI 10.3109/08958378.2011.644351; Vos W, 2013, RESPIRATION, V86, P393, DOI 10.1159/000347120; Wainwright CE, 2011, JAMA-J AM MED ASSOC, V306, P163, DOI 10.1001/jama.2011.954; Wallis LA, 2005, ARCH DIS CHILD, V90, P1117, DOI 10.1136/adc.2004.068718; Wang HZ, 2013, ANTIMICROB AGENTS CH, V57, P196, DOI 10.1128/AAC.01393-12; Worlitzsch D, 2002, J CLIN INVEST, V109, P317, DOI 10.1172/JCI0213870; Yamazaki K, 2003, AM J RESP CRIT CARE, V168, P1304, DOI 10.1164/rccm.200301-111OC; Zapletal A, 1992, Cesk Pediatr, V47, P520	51	37	37	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2015	10	3							e0118454	10.1371/journal.pone.0118454	http://dx.doi.org/10.1371/journal.pone.0118454			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4HV	25734630	Green Published, gold, Green Submitted			2022-12-27	WOS:000350314700029
J	Kaule, S; Minrath, I; Stein, F; Kragi, U; Schmidt, W; Schmitz, KP; Sternberg, K; Petersen, S				Kaule, Sebastian; Minrath, Ingo; Stein, Florian; Kragi, Udo; Schmidt, Wolfram; Schmitz, Klaus-Peter; Sternberg, Katrin; Petersen, Svea			Correlating Coating Characteristics with the Performance of Drug-Coated Balloons - A Comparative In Vitro Investigation of Own Established Hydrogel- and Ionic Liquid-Based Coating Matrices	PLOS ONE			English	Article							ELUTING BALLOON; RESTENOSIS; DELIVERY; ACID	Drug-coated balloons (DCB), which have emerged as a therapeutic alternative to drug-eluting stents in percutaneous cardiovascular intervention, are well described with regard to clinical efficacy and safety within a number of clinical studies. In vitro studies elucidating the correlation between coating additive and DCB performance are however rare but considered important for the understanding of DCB requirements and the improvement of established DCB. In this regard, we examined three different DCB-systems, which were developed in former studies based on the ionic liquid cetylpyridinium salicylate, the body-own hydrogel hyaluronic acid and the pharmaceutically well-established hydrogel polyvinylpyrrolidone, considering coating morphology, coating thickness, drug-loss, drug-transfer to the vessel wall, residual drug-concentration on the balloon surface and entire drug-load during simulated use in an in vitro vessel model. Moreover, we investigated particle release of the different DCB during simulated use and determined the influence of the three coatings on the mechanical behavior of the balloon catheter. We could show that coating characteristics can be indeed correlated with the performance of DCB. For instance, paclitaxel incorporation in the matrix can reduce the drug wash-off and benefit a high drug transfer. Additionally, a thin coating with a smooth surface and high but delayed solubility can reduce drug wash-off and decrease particle burden. As a result, we suggest that it is very important to characterize DCB in terms of mentioned properties in vitro in addition to their clinical efficacy in order to better understand their function and provide more data for the clinicians to improve the tool of DCB in coronary angioplasty.	[Kaule, Sebastian; Minrath, Ingo; Schmidt, Wolfram; Schmitz, Klaus-Peter; Sternberg, Katrin; Petersen, Svea] Univ Rostock, Inst Biomed Engn, D-18119 Rostock, Germany; [Stein, Florian; Kragi, Udo] Univ Rostock, Inst Chem Analyt & Tech Chem, D-18059 Rostock, Germany	University of Rostock; University of Rostock	Petersen, S (corresponding author), Univ Rostock, Inst Biomed Engn, Friedrich Barnewitz Str 4, D-18119 Rostock, Germany.	svea.petersen@uni-rostock.de	Kragl, Udo/A-3691-2015	Kragl, Udo/0000-0002-2507-7472; Schmidt, Wolfram/0000-0002-0113-3265	Bundesministerium fur Bildung und Forschung (BMBF) within REMEDIS "Hohere Lebensqualitat durch neuartige Mikroimplantate" [FKZ: 03IS2081]; TheraNova [FKZ: V-630-S088-2010/268]	Bundesministerium fur Bildung und Forschung (BMBF) within REMEDIS "Hohere Lebensqualitat durch neuartige Mikroimplantate"; TheraNova	The study was funded by the Bundesministerium fur Bildung und Forschung (BMBF) within REMEDIS "Hohere Lebensqualitat durch neuartige Mikroimplantate" (FKZ: 03IS2081) and TheraNova (FKZ: V-630-S088-2010/268).	Baumbach A, 1999, CATHETER CARDIO INTE, V47, P102, DOI 10.1002/(SICI)1522-726X(199905)47:1<102::AID-CCD22>3.0.CO;2-G; Berg MC, 2012, ADV ENG MATER, V14, pB45, DOI 10.1002/adem.201180067; Bica K, 2010, PHYS CHEM CHEM PHYS, V12, P2011, DOI 10.1039/b923855g; CHEN SH, 1994, TETRAHEDRON, V50, P8633, DOI 10.1016/S0040-4020(01)85337-0; Cortese B, 2012, INT J CARDIOL, V161, P4, DOI 10.1016/j.ijcard.2011.08.855; Cremers B, 2010, MINERVA CARDIOANGIOL, V58, P583; De Labriolle A, 2009, CATHETER CARDIO INTE, V73, P643, DOI 10.1002/ccd.21895; Ferraz R, 2011, CHEMMEDCHEM, V6, P975, DOI 10.1002/cmdc.201100082; Hough WL, 2007, B CHEM SOC JPN, V80, P2262, DOI 10.1246/bcsj.80.2262; Joner M, 2011, THROMB HAEMOSTASIS, V105, P864, DOI 10.1160/TH10-11-0698; Kallmes DF, 1997, AM J NEURORADIOL, V18, P1243; Kelsch B, 2011, INVEST RADIOL, V46, P255, DOI 10.1097/RLI.0b013e31820577df; Loh JP, 2012, JACC-CARDIOVASC INTE, V5, P1001, DOI 10.1016/j.jcin.2012.08.005; Madler S, 2009, J MASS SPECTROM, V44, P694, DOI 10.1002/jms.1544; NAGAOKA S, 1990, BIOMATERIALS, V11, P419, DOI 10.1016/0142-9612(90)90098-B; Petersen S, 2013, COATINGS, V3, P253, DOI 10.3390/coatings3040253; Petersen S, 2013, MAT SCI ENG C-MATER, V33, P4244, DOI 10.1016/j.msec.2013.06.021; Petersen S, 2013, J CHEM-NY, V2013, DOI 10.1155/2013/587875; Pitt WG, 2004, J BIOMED MATER RES A, V68A, P95, DOI 10.1002/jbm.a.10170; Rittger H, 2012, J AM COLL CARDIOL, V59, P1377, DOI 10.1016/j.jacc.2012.01.015; Scheller B, 2003, EUR HEART J, V24, P1462, DOI 10.1016/S0195-668X(03)00317-8; Schmidt W, 2002, Biomed Tech (Berl), V47 Suppl 1 Pt 1, P124, DOI 10.1515/bmte.2002.47.s1a.124; Schmidt W, 2009, CATHETER CARDIO INTE, V73, P350, DOI 10.1002/ccd.21832; Schmidt W., 2013, INSTRUMENTATION, P445; Sternberg K, 2013, CURR PHARM BIOTECHNO, V14, P76; Tonnesen HH, 1996, PHOTOSTABILITY DRUGS; Waksman R, 2009, CIRC-CARDIOVASC INTE, V2, P352, DOI 10.1161/CIRCINTERVENTIONS.109.873703	27	24	25	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2015	10	3							e0116080	10.1371/journal.pone.0116080	http://dx.doi.org/10.1371/journal.pone.0116080			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4HV	25734818	Green Submitted, Green Published, gold			2022-12-27	WOS:000350314700003
J	Roberts, T; Barratt, J; Sandaradura, I; Lee, R; Harkness, J; Marriott, D; Ellis, J; Stark, D				Roberts, Tamalee; Barratt, Joel; Sandaradura, Indy; Lee, Rogan; Harkness, John; Marriott, Deborah; Ellis, John; Stark, Damien			Molecular Epidemiology of Imported Cases of Leishmaniasis in Australia from 2008 to 2014	PLOS ONE			English	Article							WORLD CUTANEOUS LEISHMANIASIS; INTERNAL TRANSCRIBED SPACER; POLYMERASE-CHAIN-REACTION; TOXOPLASMA-GONDII; CLINICAL-SAMPLES; RIBOSOMAL DNA; PCR ASSAY; INFECTION; DISCRIMINATION; HETEROGENEITY	Leishmaniasis is a vector borne disease caused by protozoa of the genus Leishmania. Human leishmaniasis is not endemic in Australia though imported cases are regularly encountered. This study aimed to provide an update on the molecular epidemiology of imported leishmaniasis in Australia. Of a total of 206 biopsies and bone marrow specimens submitted to St Vincent's Hospital Sydney for leishmaniasis diagnosis by PCR, 55 were found to be positive for Leishmania DNA. All PCR products were subjected to restriction fragment length polymorphism analysis for identification of the causative species. Five Leishmania species/species complexes were identified with Leishmania tropica being the most common (30/55). Travel or prior residence in a Leishmania endemic region was the most common route of acquisition with similar to 47% of patients having lived in or travelled to Afghanistan. Cutaneous leishmaniasis was the most common manifestation (94%) with only 3 cases of visceral leishmaniasis and no cases of mucocutaneous leishmaniasis encountered. This report indicates that imported leishmaniasis is becoming increasingly common in Australia due to an increase in global travel and immigration. As such, Australian clinicians must be made aware of this trend and consider leishmaniasis in patients with suspicious symptoms and a history of travel in endemic areas. This study also discusses the recent identification of a unique Leishmania species found in native kangaroos and a potential vector host which could create the opportunity for the establishment of a local transmission cycle within humans.	[Roberts, Tamalee; Sandaradura, Indy; Harkness, John; Marriott, Deborah; Stark, Damien] St Vincents Hosp, Dept Microbiol, SydPath, Darlinghurst, NSW, Australia; [Roberts, Tamalee; Barratt, Joel; Ellis, John] Univ Technol Sydney, Sch Med & Mol Sci, Ultimo, NSW, Australia; [Barratt, Joel] Univ Technol Sydney, Inst i3, Ultimo, NSW, Australia; [Lee, Rogan] Westmead Hosp, Ctr Infect Dis & Microbiol Lab Serv, ICPMR, Westmead, NSW 2145, Australia	St Vincents Hospital Sydney; University of Technology Sydney; University of Technology Sydney; University of Sydney	Roberts, T (corresponding author), St Vincents Hosp, Dept Microbiol, SydPath, Victoria St, Darlinghurst, NSW, Australia.	tamalee.roberts@svha.org.au	Ellis, John T/L-6988-2016; Sandaradura, Indy/AAY-5046-2020; Roberts, Tamalee/GOE-6303-2022	Ellis, John T/0000-0001-7328-4831; Sandaradura, Indy/0000-0002-9457-8262; Roberts, Tamalee/0000-0001-8599-737X; Barratt, Joel/0000-0001-8711-2408				Alvar J, 2006, TRENDS PARASITOL, V22, P552, DOI 10.1016/j.pt.2006.09.004; Alvar J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035671; Antinori S, 2005, CLIN MICROBIOL INFEC, V11, P343, DOI 10.1111/j.1469-0691.2004.01046.x; Armed Forces Health Surveillance Center, 2002, MED SURVEILL MON REP, V14, P2; Bailey MS, 2012, J ROY ARMY MED CORPS, V158, P225, DOI 10.1136/jramc-158-03-16; Bailey MS, 2007, CLIN DERMATOL, V25, P203, DOI 10.1016/j.clindermatol.2006.05.008; Barratt JLN, 2010, CLIN MICROBIOL REV, V23, P795, DOI 10.1128/CMR.00001-10; Barratt J, 2008, MOL CELL PROBE, V22, P228, DOI 10.1016/j.mcp.2008.03.001; Bart A, 2013, EUROSURVEILLANCE, V18, P14, DOI 10.2807/1560-7917.ES2013.18.30.20544; Bensoussan E, 2006, J CLIN MICROBIOL, V44, P1435, DOI 10.1128/JCM.44.4.1435-1439.2006; Blonski KM, 2012, APMIS, V120, P591, DOI 10.1111/j.1600-0463.2012.02875.x; BOOTHROYD JC, 1987, NUCLEIC ACIDS RES, V15, P4065, DOI 10.1093/nar/15.10.4065; Centers for Disease Control (CDC), 1992, MMWR Morb Mortal Wkly Rep, V41, P131; Diniz MMCDL, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-139; Dostalova A, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-276; Dougall A, 2009, EPIDEMIOL INFECT, V137, P1516, DOI 10.1017/S0950268809002313; Dougall AM, 2011, INT J PARASITOL, V41, P571, DOI 10.1016/j.ijpara.2010.12.008; El Tai NO, 2000, T ROY SOC TROP MED H, V94, P575, DOI 10.1016/S0035-9203(00)90093-2; Ghatee MA, 2014, EXP PARASITOL, V144, P44, DOI 10.1016/j.exppara.2014.06.003; GUAY JM, 1992, GENE, V114, P165, DOI 10.1016/0378-1119(92)90570-F; Haouas N, 2010, DIAGN MICR INFEC DIS, V68, P152, DOI 10.1016/j.diagmicrobio.2010.06.011; Harms G, 2003, EMERG INFECT DIS, V9, P872; Harms G, 2011, INT J DERMATOL, V50, P1336, DOI 10.1111/j.1365-4632.2011.04987.x; HEPBURN NC, 1993, BRIT J DERMATOL, V128, P63, DOI 10.1111/j.1365-2133.1993.tb00149.x; Herwaldt BL, 1999, LANCET, V354, P1191, DOI 10.1016/S0140-6736(98)10178-2; Homan WL, 1997, PARASITOL RES, V83, P285, DOI 10.1007/s004360050248; Ju O, 2004, MED J AUSTRALIA, V181, P446, DOI 10.5694/j.1326-5377.2004.tb06372.x; Khairnar K, 2013, PARASITOL RES; Konecny P, 2007, MED J AUSTRALIA, V186, P315, DOI 10.5694/j.1326-5377.2007.tb00910.x; Kumar A, 2010, ACTA TROP, V113, P202, DOI 10.1016/j.actatropica.2009.10.006; Lachaud L, 2013, Euro Surveill, V18, P20534, DOI 10.2807/1560-7917.ES2013.18.29.20534; Lawn SD, 2004, QJM-INT J MED, V97, P781, DOI 10.1093/qjmed/hch127; Maguire GP, 1998, PATHOLOGY, V30, P73, DOI 10.1080/00313029800169715; Morizot G, 2013, CLIN INFECT DIS, V57, P370, DOI 10.1093/cid/cit269; Morizot G, 2007, AM J TROP MED HYG, V76, P48; Pita-Pereira D, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-15; Poeppl W, 2013, TRAVEL MED INFECT DI, V11, P90, DOI 10.1016/j.tmaid.2013.03.002; Rose K, 2004, AUST VET J, V82, P440, DOI 10.1111/j.1751-0813.2004.tb11138.x; Rose K, 2004, INT J PARASITOL, V34, P655, DOI 10.1016/j.ijpara.2004.03.001; Scarisbrick J J, 2006, Travel Med Infect Dis, V4, P14, DOI 10.1016/j.tmaid.2004.11.002; Schonian G, 2003, DIAGN MICR INFEC DIS, V47, P349, DOI 10.1016/S0732-8893(03)00093-2; Schwartz E, 2006, LANCET INFECT DIS, V6, P342, DOI 10.1016/S1473-3099(06)70492-3; Scope A, 2003, J AM ACAD DERMATOL, V49, P672, DOI 10.1067/S0190-9622(03)01576-7; Seaton RA, 1999, QJM-MON J ASSOC PHYS, V92, P659, DOI 10.1093/qjmed/92.11.659; Seblova V, 2012, J MED ENTOMOL, V49, P967, DOI 10.1603/ME12053; Seblova V, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-222; Solomon M, 2007, J AM ACAD DERMATOL, V56, P612, DOI 10.1016/j.jaad.2006.06.044; Stark D, 2006, J CLIN MICROBIOL, V44, P1178, DOI 10.1128/JCM.44.3.1178-1180.2006; Stark D, 2008, J TRAVEL MED, V15, P351, DOI 10.1111/j.1708-8305.2008.00223.x; Storer Emma, 2005, Australas J Dermatol, V46, P80, DOI 10.1111/j.1440-0960.2005.00146.x; van Thiel PPAM, 2011, TRAVEL MED INFECT DI, V9, P153, DOI 10.1016/j.tmaid.2011.03.001; Wall EC, 2012, AM J TROP MED HYG, V86, P115, DOI 10.4269/ajtmh.2012.10-0558; Weina PJ, 2004, CLIN INFECT DIS, V39, P1674, DOI 10.1086/425747; Weirather JL, 2011, J CLIN MICROBIOL, V49, P3892, DOI 10.1128/JCM.r00764-11; Zeegelaar JE, 2005, CLIN EXP DERMATOL, V30, P1, DOI 10.1111/j.1365-2230.2004.01677.x	55	18	19	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2015	10	3							e0119212	10.1371/journal.pone.0119212	http://dx.doi.org/10.1371/journal.pone.0119212			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4HV	25734905	Green Published, gold, Green Submitted			2022-12-27	WOS:000350314700059
J	Xie, JX; Feng, Y; Yuan, JM; You, ZD; Lin, HY; Lu, CL; Xu, JJ				Xie, Jia-Xin; Feng, Yu; Yuan, Jian-Min; You, Zhen-Dong; Lin, Hai-Yan; Lu, Chang-Lin; Xu, Jia-Jun			Positive Effects of bFGF Modified Rat Amniotic Epithelial Cells Transplantation on Transected Rat Optic Nerve	PLOS ONE			English	Article							FIBROBLAST GROWTH-FACTORS; RETINAL GANGLION-CELLS; INJURY; REGENERATION; PROTEIN; GAP-43; LESION; DEATH; MODEL; AXONS	Purpose Effective therapy for visual loss caused by optic nerve injury or diseases has not been achieved even though the optic nerve has the regeneration potential after injury. This study was designed to modify amniotic epithelial cells (AECs) with basic fibroblast growth factor (bFGF) gene, preliminarily investigating its effect on transected optic nerve. Methods A human bFGF gene segment was delivered into rat AECs (AECs/hbFGF) by lentiviral vector, and the gene expression was examined by RT-PCR and ELISA. The AECs/hbFGF and untransfected rat AECs were transplanted into the transected site of the rat optic nerve. At 28 days post transplantation, the survival and migration of the transplanted cells was observed by tracking labeled cells; meanwhile retinal ganglion cells (RGCs) were observed and counted by employing biotin dextran amine (BDA) and Nissl staining. Furthermore, the expression of growth associated protein 43 (GAP-43) within the injury site was examined with immunohistochemical staining. Results The AECs/hbFGF was proven to express bFGF gene and secrete bFGF peptide. Both AECs/hbFGF and AECs could survive and migrate after transplantation. RGCs counting implicated that RGCs numbers of the cell transplantation groups were significantly higher than that of the control group, and the AECs/hbFGF group was significantly higher than that of the AECs group. Moreover GAP-43 integral optical density value in the control group was significantly lower than that of the cell transplantation groups, and the value in the AECs/hbFGF group was significantly higher than that of the AECs group. Conclusions AECs modified with bFGF could reduce RGCs loss and promote expression of GAP-43 in the rat optic nerve transected model, facilitating the process of neural restoration following injury.	[Xie, Jia-Xin; Yuan, Jian-Min; Lin, Hai-Yan; Xu, Jia-Jun] Second Mil Med Univ, Dept Anat, Shanghai, Peoples R China; [You, Zhen-Dong; Lu, Chang-Lin] Second Mil Med Univ, Dept Neurobiol, Shanghai, Peoples R China; [Xie, Jia-Xin] Second Mil Med Univ, Dept Orthopaed, Changzheng Hosp, Shanghai, Peoples R China; [Xie, Jia-Xin; Feng, Yu] Kunming Gen Hosp Chengdu Mil Command, Peoples Liberat Army Clin Ctr Spinal Cord Injury, Kunming, Peoples R China	Naval Medical University; Naval Medical University; Naval Medical University; Kunming General Hospital	Xu, JJ (corresponding author), Second Mil Med Univ, Dept Anat, Shanghai, Peoples R China.	xujiajunsmmu@163.com						AIGNER L, 1995, CELL, V83, P269, DOI 10.1016/0092-8674(95)90168-X; Benowitz LI, 1997, TRENDS NEUROSCI, V20, P84, DOI 10.1016/S0166-2236(96)10072-2; BERKELAAR M, 1994, J NEUROSCI, V14, P4368, DOI 10.1523/jneurosci.14-07-04368.1994; Berry M, 2008, RESTOR NEUROL NEUROS, V26, P147; Bien A, 1999, J NEUROTRAUM, V16, P153, DOI 10.1089/neu.1999.16.153; Blanco RE, 2000, J COMP NEUROL, V423, P646; Campbell G, 1999, NEUROREPORT, V10, P3955, DOI 10.1097/00001756-199912160-00042; ECKENSTEIN FP, 1994, J NEUROBIOL, V25, P1467; GENNARELLI TA, 1989, J NEUROSURG, V71, P244, DOI 10.3171/jns.1989.71.2.0244; Hicks D, 1998, SEMIN CELL DEV BIOL, V9, P263, DOI 10.1006/scdb.1998.0230; HILL DJ, 1993, PLACENTA, V14, P1, DOI 10.1016/S0143-4004(05)80244-9; Kaneda M, 2008, NEUROSCI RES, V61, P281, DOI 10.1016/j.neures.2008.03.008; Kaneda M, 2010, ADV EXP MED BIOL, V664, P97, DOI 10.1007/978-1-4419-1399-9_12; Klocker N, 2001, J NEUROSCI METH, V110, P147, DOI 10.1016/S0165-0270(01)00435-6; Koizumi N, 2000, CURR EYE RES, V20, P173, DOI 10.1076/0271-3683(200003)20:3;1-9;FT173; Kreutz MR, 1999, RESTOR NEUROL NEUROS, V14, P127; Meng XT, 2008, CELL BIOL INT, V32, P1546, DOI 10.1016/j.cellbi.2008.09.001; Miki T, 2005, STEM CELLS, V23, P1549, DOI 10.1634/stemcells.2004-0357; Okawa H, 2001, NEUROREPORT, V12, P4003, DOI 10.1097/00001756-200112210-00030; PARK CM, 1989, DEV BIOL, V134, P201, DOI 10.1016/0012-1606(89)90089-4; Reuss B, 2003, CELL TISSUE RES, V313, P139, DOI 10.1007/s00441-003-0756-7; Sadler TW, 2003, LANGMANS MED EMBRYOL, P51; Sankar V, 2003, NEUROSCIENCE, V118, P11, DOI 10.1016/S0306-4522(02)00929-6; Selhorst JB, 2009, SEMIN NEUROL, V29, P29, DOI 10.1055/s-0028-1124020; Selles-Navarro I, 2001, EXP NEUROL, V167, P282, DOI 10.1006/exnr.2000.7573; SO KF, 1985, BRAIN RES, V328, P349, DOI 10.1016/0006-8993(85)91047-9; Solomon AS, 1996, J NEUROSCI METH, V70, P21, DOI 10.1016/S0165-0270(96)00098-2; Uchida S, 2000, J NEUROSCI RES, V62, P585, DOI 10.1002/1097-4547(20001115)62:4<585::AID-JNR13>3.0.CO;2-U	28	12	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2015	10	3							e0119119	10.1371/journal.pone.0119119	http://dx.doi.org/10.1371/journal.pone.0119119			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4HV	25734497	gold, Green Published, Green Submitted			2022-12-27	WOS:000350314700055
J	Eom, BW; Ryu, KW; Nam, BH; Park, YJ; Lee, HJ; Kim, MC; Cho, GS; Kim, CY; Ryu, SW; Shin, DW; Hyung, WJ; Lee, JH				Eom, Bang Wool; Ryu, Keun Won; Nam, Byung-Ho; Park, Yunjin; Lee, Hyuk-Joon; Kim, Min Chan; Cho, Gyu Seok; Kim, Chan Young; Ryu, Seung Wan; Shin, Dong Woo; Hyung, Woo Jin; Lee, Jun Ho			Survival Nomogram for Curatively Resected Korean Gastric Cancer Patients: Multicenter Retrospective Analysis with External Validation	PLOS ONE			English	Article							DISEASE-SPECIFIC SURVIVAL; ADJUVANT CHEMOTHERAPY; D2 GASTRECTOMY; R0 RESECTION; SURGERY; VOLUME; S-1	Background A small number of nomograms have been previously developed to predict the individual survival of patients who undergo curative resection for gastric cancer. However, all were derived from single high-volume centers. The aim of this study was to develop and validate a nomogram for gastric cancer patients using a multicenter database. Methods We reviewed the clinicopathological and survival data of 2012 patients who underwent curative resection for gastric cancer between 2001 and 2006 at eight centers. Among these centers, six institutions were randomly assigned to the development set, and the other two centers were assigned to the validation set. Multivariate analysis using the Cox proportional hazard regression model was performed, and discrimination and calibration were evaluated by external validation. Results Multivariate analyses revealed that age, tumor size, lymphovascular invasion, depth of invasion, and metastatic lymph nodes were significant prognostic factors for overall survival. In the external validation, the concordance index was 0.831 (95% confidence interval, 0.784-0.878), and Hosmer-Lemeshow chi-square statistic was 3.92 (P = 0.917). Conclusions We developed and validated a nomogram to predict 5-year overall survival after curative resection for gastric cancer based on a multicenter database. This nomogram can be broadly applied even in general hospitals and is useful for counseling patients, and scheduling follow-up.	[Eom, Bang Wool; Ryu, Keun Won; Lee, Jun Ho] Natl Canc Ctr, Gastr Canc Branch, Goyang, Gyeonggi Do, South Korea; [Nam, Byung-Ho; Park, Yunjin] Natl Canc Ctr, Biometr Res Branch, Div Canc Epidemiol & Prevent, Goyang, Gyeonggi Do, South Korea; [Lee, Hyuk-Joon] Seoul Natl Univ, Coll Med, Dept Surg, Seoul, South Korea; [Kim, Min Chan] Dong A Univ, Coll Med, Dept Surg, Pusan, South Korea; [Cho, Gyu Seok] Soonchunhyang Univ, Bucheon Hosp, Dept Surg, Puchon, Gyeonggi Do, South Korea; [Kim, Chan Young] Chonbuk Natl Univ, Sch Med, Dept Surg, Jeonju 561756, Jeollabuk Do, South Korea; [Ryu, Seung Wan] Keimyung Univ, Dept Surg, Sch Med, Daegu, South Korea; [Shin, Dong Woo] Bundang Jesaeng Hosp, Dept Surg, Songnam, Gyeonggi Do, South Korea; [Hyung, Woo Jin] Yonsei Univ, Coll Med, Dept Surg, Seoul, South Korea	National Cancer Center - Korea (NCC); National Cancer Center - Korea (NCC); Seoul National University (SNU); Dong A University; Soonchunhyang University; Jeonbuk National University; Keimyung University; Yonsei University; Yonsei University Health System	Ryu, KW (corresponding author), Natl Canc Ctr, Gastr Canc Branch, Goyang, Gyeonggi Do, South Korea.	docryu@korea.com; byunghonam@ncc.re.kr	Eom, Bang Wool/K-4412-2016	Eom, Bang Wool/0000-0002-0332-2051; Hyung, Woo Jin/0000-0002-8593-9214	National Cancer Center, Republic of Korea [1410140]	National Cancer Center, Republic of Korea	This work was supported by the National Cancer Center, Republic of Korea (Grant no.1410140). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn HS, 2011, BRIT J SURG, V98, P255, DOI 10.1002/bjs.7310; Ajani JA, 2013, J NATL COMPR CANC NE, V11, P531, DOI 10.6004/jnccn.2013.0070; Anderson O, 2011, EUR J CANCER, V47, P2408, DOI 10.1016/j.ejca.2011.07.001; Bang YJ, 2012, LANCET, V379, P315, DOI 10.1016/S0140-6736(11)61873-4; Bertuccio P, 2009, INT J CANCER, V125, P666, DOI 10.1002/ijc.24290; Coupland VH, 2013, GUT, V62, P961, DOI 10.1136/gutjnl-2012-303008; D'Agostino RB, 2004, HANDB STAT, V23, P1; Dikken JL, 2012, BRIT J SURG, V99, P954, DOI 10.1002/bjs.8787; Dikken JL, 2013, ANN SURG ONCOL, V20, P381, DOI 10.1245/s10434-012-2574-1; Edge S.B., 2010, AJCC CANC STAGING MA, V7th ed., P143; Han DS, 2012, J CLIN ONCOL, V30, P3834, DOI 10.1200/JCO.2012.41.8343; Hur H, 2010, ANN SURG ONCOL, V17, P54, DOI 10.1245/s10434-009-0676-1; Japanese Gastric Canc Assoc, 2011, GASTRIC CANCER, V14, P113, DOI 10.1007/s10120-011-0042-4; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Jeong O, 2011, J GASTRIC CANCER, V11, P69, DOI 10.5230/jgc.2011.11.2.69; Jung KW, 2012, CANCER RES TREAT, V44, P11, DOI 10.4143/crt.2012.44.1.11; Kattan MW, 2003, J CLIN ONCOL, V21, P3647, DOI 10.1200/JCO.2003.01.240; Kim YW, 2012, J GASTRIC CANCER, V12, P13, DOI 10.5230/jgc.2012.12.1.13; Novotny AR, 2006, ANN SURG, V243, P74, DOI 10.1097/01.sla.0000194088.81126.85; Okines A, 2010, ANN ONCOL, V21, pv50, DOI 10.1093/annonc/mdq164; Peeters KCMJ, 2005, CANCER-AM CANCER SOC, V103, P702, DOI 10.1002/cncr.20783; Sakuramoto S, 2007, NEW ENGL J MED, V357, P1810, DOI 10.1056/NEJMoa072252; Sasako M, 2011, J CLIN ONCOL, V29, P4387, DOI 10.1200/JCO.2011.36.5908; Song KY, 2014, GASTRIC CANCER, V17, P287, DOI 10.1007/s10120-013-0270-x; Strong VE, 2010, ANN SURG, V251, P640, DOI 10.1097/SLA.0b013e3181d3d29b	25	36	37	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2015	10	2							e0119671	10.1371/journal.pone.0119671	http://dx.doi.org/10.1371/journal.pone.0119671			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC3LS	25723182	Green Submitted, Green Published, gold			2022-12-27	WOS:000350251200071
J	Liu, G; Yang, G; Guan, GP; Zhang, YZ; Ren, WK; Yin, J; Aguilar, YM; Luo, W; Fang, J; Yu, XL; Li, TJ; Yin, YL				Liu, Gang; Yang, Guan; Guan, Guiping; Zhang, Yuzhe; Ren, Wenkai; Yin, Jie; Aguilar, Yordan Martinez; Luo, Wei; Fang, Jun; Yu, Xinglong; Li, Tiejun; Yin, Yulong			Effect of Dietary Selenium Yeast Supplementation on Porcine Circovirus Type 2 (PCV2) Infections in Mice	PLOS ONE			English	Article							MULTISYSTEMIC WASTING SYNDROME; EXPERIMENTAL REPRODUCTION; GENETIC-CHARACTERIZATION; SYNDROME PMWS; RISK-FACTORS; IN-VITRO; PIGS; DISEASE; VIRUS; SWINE	The present study was performed to determine the protective role of dietary selenium (Se) yeast supplementation in porcine circovirus type 2 (PCV2) infected mice. Forty-eight Kun Ming female mice were randomly assigned to Se yeast group (0.3% Se +basal diet, n = 24) and control group (basal diet, n = 24). After 3 days of adaptive feeding and 15 days treatment with the experimental feed, mice were challenged by intraperitioneal injection of PCV2 at the dosage of 2000 TCID50 (50% tissue culture infection dose, TCID50). Serum total superoxide dismutase (SOD) activity, malondialdehyde (MDA) level, tumor necrosis factor alpha (TNF-alpha), C-reactive protein (CRP) and interleukin-1 beta (IL-1 beta) levels were measured at 5, 10, 15, 20 days post infection (dpi). The PCV2 virus load in the liver, spleen and lung, and the microscopic lesions in the liver, spleen and lung also were determined on 5, 10, 15, and 20 dpi. Dietary Se yeast supplementation decreased (P mu 0.05) the serum levels of TNF-alpha, but had no significant effect on the activity of SOD and the levels of MDA, CRP and IL-1 beta between experimental and control groups. Dietary Se yeast supplementation had little effect on the PCV2 virus load in the liver, spleen and lung. However, mice in the selenium yeast group showed a significant decrease in microscopic lesion scores in the lung and spleen compared with those in the control group (P mu 0.05). These data indicate Se yeast attenuated the PCV2 infection through altering the systemic inflammation and maintaining the normal organ morphology.	[Liu, Gang; Zhang, Yuzhe; Ren, Wenkai; Yin, Jie; Aguilar, Yordan Martinez; Li, Tiejun; Yin, Yulong] Chinese Acad Sci, Sci Observing & Expt Stn Anim Nutr & Feed Sci Sou, Hunan Prov Engn Res Ctr Hlth Livestock & Poultry, Key Lab Agroecol Proc Subtrop Reg,Minist Agr,Inst, Changsha 410125, Hunan, Peoples R China; [Yang, Guan; Guan, Guiping; Fang, Jun] Hunan Agr Univ, Coll Anim Sci & Technol, Changsha 410128, Hunan, Peoples R China; [Ren, Wenkai; Yin, Jie] Chinese Acad Sci, Grad Univ, Beijing 100039, Peoples R China; [Luo, Wei; Yu, Xinglong] Hunan Agr Univ, Coll Veterinarian, Changsha 410128, Hunan, Peoples R China	Chinese Academy of Sciences; Ministry of Agriculture & Rural Affairs; Hunan Agricultural University; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Hunan Agricultural University	Yin, YL (corresponding author), Chinese Acad Sci, Sci Observing & Expt Stn Anim Nutr & Feed Sci Sou, Hunan Prov Engn Res Ctr Hlth Livestock & Poultry, Key Lab Agroecol Proc Subtrop Reg,Minist Agr,Inst, Changsha 410125, Hunan, Peoples R China.	18988669786@189.cn; yinyulong@isa.ac.cn	YIN, Jie/H-3578-2019; Liu, Gang/G-5283-2017; Martínez, Yordan/ABF-8953-2020	YIN, Jie/0000-0003-1852-1042; Liu, Gang/0000-0002-9475-5134; Martinez Aguilar, Yordan/0000-0003-2167-4904; YANG, Guan/0000-0002-2131-8435	National Natural Science Foundation of China [31330075, 21275022, 21075011, 313111032]; Hunan Provincial Natural Science Foundation of China [13JJ2034]; projects of National Science & Technology Support Program of China [2012BAD31B08, 2012BAC17B0102]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Hunan Provincial Natural Science Foundation of China(Natural Science Foundation of Hunan Province); projects of National Science & Technology Support Program of China	The present work was supported by the National Natural Science Foundation of China (31330075, 21275022, 21075011, 313111032), Hunan Provincial Natural Science Foundation of China (13JJ2034), projects of National Science & Technology Support Program of China (Nos. 2012BAD31B08, 2012BAC17B0102).	Allan GM, 1998, J VET DIAGN INVEST, V10, P3, DOI 10.1177/104063879801000102; Arthur JR, 2003, J NUTR, V133, p1457S, DOI 10.1093/jn/133.5.1457S; Batinic-Haberle I, 2011, ANTI-CANCER AGENT ME, V11, P327, DOI 10.2174/187152011795677508; BEAUCHAM.C, 1971, ANAL BIOCHEM, V44, P276, DOI 10.1016/0003-2697(71)90370-8; Ch'en PFT, 2005, CELL IMMUNOL, V236, P78, DOI 10.1016/j.cellimm.2005.08.010; Chae C, 2005, VET J, V169, P326, DOI 10.1016/j.tvjl.2004.01.012; Chang HW, 2006, VET IMMUNOL IMMUNOP, V110, P207, DOI 10.1016/j.vetimm.2005.09.016; Choi J, 2002, CAN J VET RES, V66, P217; DINARELLO CA, 1984, REV INFECT DIS, V6, P51, DOI 10.1016/S1359-6101(97)00023-3; Dorr PM, 2007, JAVMA-J AM VET MED A, V230, P244, DOI 10.2460/javma.230.2.244; Dreyfuss ML, 2002, AM J CLIN NUTR, V75, P959, DOI 10.1093/ajcn/75.6.959; Ellis J, 1998, CAN VET J, V39, P44; Fenaux M, 2004, J GEN VIROL, V85, P3377, DOI 10.1099/vir.0.80429-0; Fenaux M, 2002, J VIROL, V76, P541, DOI 10.1128/JVI.76.2.541-551.2002; Fenaux M, 2000, J CLIN MICROBIOL, V38, P2494, DOI 10.1128/JCM.38.7.2494-2503.2000; Francesconi KA, 2004, CLIN CHEM, V50, P2240, DOI 10.1373/clinchem.2004.039875; FREEMAN BA, 1981, J BIOL CHEM, V256, P986; Grau-Roma L, 2007, VET MICROBIOL, V119, P144, DOI 10.1016/j.vetmic.2006.09.009; Grau-Roma L, 2011, VET J, V187, P23, DOI 10.1016/j.tvjl.2010.01.018; Harms PA, 2001, VET PATHOL, V38, P528, DOI 10.1354/vp.38-5-528; Hu Y, 2008, CANCER RES, V68, P4936, DOI 10.1158/0008-5472.CAN-07-6042; Hurwitz BE, 2007, ARCH INTERN MED, V167, P148, DOI 10.1001/archinte.167.2.148; Kim J, 2006, VET PATHOL, V43, P718, DOI 10.1354/vp.43-5-718; Kim J, 2004, CAN J VET RES, V68, P218; Kim J, 2003, VET J, V166, P251, DOI 10.1016/S1090-0233(02)00257-5; Knell S, 2005, VET MICROBIOL, V109, P169, DOI 10.1016/j.vetmic.2005.06.004; Krakowka S, 2000, VET PATHOL, V37, P254, DOI 10.1354/vp.37-3-254; Li J, 2009, TOXICOL SCI, V111, P247, DOI 10.1093/toxsci/kfp151; Lopez-Soria S, 2005, PREV VET MED, V69, P97, DOI 10.1016/j.prevetmed.2004.11.015; Ma CM, 2007, J GEN VIROL, V88, P1733, DOI 10.1099/vir.0.82629-0; Mahan DC, 1996, J ANIM SCI, V74, P2711; Muhling J, 2006, AUST VET J, V84, P421, DOI 10.1111/j.1751-0813.2006.00081.x; Oncul O, 2007, J INFECTION, V54, P250, DOI 10.1016/j.jinf.2006.05.004; Opriessnig T, 2004, VET PATHOL, V41, P624, DOI 10.1354/vp.41-6-624; Pan QX, 2008, J TRACE ELEM MED BIO, V22, P143, DOI 10.1016/j.jtemb.2008.02.002; Paton ND, 2002, POULTRY SCI, V81, P1548, DOI 10.1093/ps/81.10.1548; Rayman MP, 2004, BRIT J NUTR, V92, P557, DOI 10.1079/BJN20041251; Ren W, 2011, AMINO ACIDS; Ren WK, 2014, J NUTR, V144, P988, DOI 10.3945/jn.114.192120; Ren WK, 2013, AMINO ACIDS, V45, P947, DOI 10.1007/s00726-013-1551-8; Ren WK, 2013, BRIT J NUTR, V110, P1492, DOI 10.1017/S0007114513000652; Ren WK, 2013, BRIT J NUTR, V110, P1053, DOI 10.1017/S0007114512006101; Ren WK, 2013, AMINO ACIDS, V45, P555, DOI 10.1007/s00726-013-1490-4; Ren WK, 2012, AMINO ACIDS, V42, P2089, DOI 10.1007/s00726-011-0942-y; Rose N, 2003, PREV VET MED, V61, P209, DOI 10.1016/j.prevetmed.2003.07.003; Rose N, 2009, PREV VET MED, V90, P168, DOI 10.1016/j.prevetmed.2009.04.010; Rosell C, 2000, VET REC, V146, P40, DOI 10.1136/vr.146.2.40; Shang HT, 2009, LAB ANIM-UK, V43, P34, DOI 10.1258/la.2008.007098; Smyth MJ, 2000, MICROSC RES TECHNIQ, V50, P196, DOI 10.1002/1097-0029(20000801)50:3<196::AID-JEMT3>3.0.CO;2-9; Stajn A, 1997, COMP BIOCHEM PHYS C, V117, P167, DOI 10.1016/S0742-8413(97)00063-7; Szalai AJ, 2002, VASC PHARMACOL, V39, P105, DOI 10.1016/S1537-1891(02)00294-X; UCHIYAMA M, 1978, ANAL BIOCHEM, V86, P271, DOI 10.1016/0003-2697(78)90342-1; Vieira AT, 2012, BRIT J NUTR, V108, P1829, DOI 10.1017/S0007114512000013; Volanakis JE, 2001, MOL IMMUNOL, V38, P189, DOI 10.1016/S0161-5890(01)00042-6; Wen LB, 2008, SCI CHINA SER C, V51, P453, DOI 10.1007/s11427-008-0053-5; West KH, 1999, J VET DIAGN INVEST, V11, P530, DOI 10.1177/104063879901100608; Yu L, 2011, BIOL TRACE ELEM RES, V141, P254, DOI 10.1007/s12011-010-8726-x	57	27	33	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2015	10	2							e0115833	10.1371/journal.pone.0115833	http://dx.doi.org/10.1371/journal.pone.0115833			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC3LS	25723390	Green Published, Green Submitted, gold			2022-12-27	WOS:000350251200009
J	Papageorgiou, A; Ziogas, DC; Mavragani, CP; Zintzaras, E; Tzioufas, AG; Moutsopoulos, HM; Voulgarelis, M				Papageorgiou, Aristea; Ziogas, Dimitrios C.; Mavragani, Clio P.; Zintzaras, Elias; Tzioufas, Athanasios G.; Moutsopoulos, Haralampos M.; Voulgarelis, Michael			Predicting the Outcome of Sjogren's Syndrome-Associated Non-Hodgkin's Lymphoma Patients	PLOS ONE			English	Article							TISSUE LYMPHOMA; AUTOIMMUNE-DISEASES; MALIGNANT-LYMPHOMA; RESPONSE CRITERIA; RISK; MORTALITY; COHORT; CLASSIFICATION; MORBIDITY; PATTERNS	Background Non-Hodgkin's lymphoma (NHL) development in Sjogren's syndrome (SS) remains a potentially lethal complication and efforts should focus on the identification of predictors that could aid in appropriate therapeutic decisions. Methods In order to identify potential prognostic factors for outcome in SS-associated NHL, we retrospectively analyzed a cohort of 77 patients, diagnosed with NHL according to WHO classification criteria and meeting the American-European Consensus Classification (AECC) criteria for SS and examined the effect of SS-activity (defined as the EULAR SS disease activity index-ESSDAI) in the prognosis of SS-related NHLs, as defined in terms of overall and event-free survivals (OS and EFS). An event was defined as lymphoma relapse, treatment failure, disease progression, histological transformation or death. The effect of NHL clinical and laboratory characteristics was also investigated. Results MALT lymphomas constituted the majority (66.2%) of lymphomas. During the follow-up (median = 57.93 months), the 5-year OS was 90.91% (95% CI: 82.14-95.80%) and the EFS was 77.92% (95% CI: 67.37-85.82%). Patients with high ESSDAI score at lymphoma diagnosis had a greater risk for death (OR = 5.241, 95% CI: 1.034-26.568) or for event (OR = 4.317, 95% CI: 1.146-9.699, p = 0.008). These patients had also significantly worse EFS (HR = 4.541, 95% CI: 1.772-11.637) and OS (HR = 5.946, 95% CI: 1.259-28.077). In addition, post-chemotherapy ESSDAI improvement was significantly lower in patients who had experienced an event (p = 0.005). An unfavorable International prognostic index (IPI) score (high-intermediate/high) was associated with high risk of death and event (OR = 13.867, 95% CI: 2.656-72.387 and OR = 12.589, 95% CI: 3.911-40.526, respectively), worse EFS (log-rank p < 0.001, HR = 8.718, 95% CI: 3.477-21.858), as well as with worse OS (log-rank p < 0.001, HR = 11.414, 95% CI: 2.414-53.974). After adjustment for identified risk factors, IPI score retained a significant prognostic role following by a strong effect of ESSDAI in survival outcomes. Conclusions At the point of NHL diagnosis, IPI and ESSDAI might be proved useful predictive tools in SS-associated lymphoma prognosis, directing to a more patient-tailored approach.	[Papageorgiou, Aristea; Ziogas, Dimitrios C.; Tzioufas, Athanasios G.; Moutsopoulos, Haralampos M.; Voulgarelis, Michael] Univ Athens, Sch Med, Dept Pathophysiol, GR-11527 Athens, Greece; [Mavragani, Clio P.] Univ Athens, Sch Med, Dept Physiol, GR-11527 Athens, Greece; [Zintzaras, Elias] Univ Thessaly, Sch Med, Dept Biomath, Larisa, Greece	Athens Medical School; National & Kapodistrian University of Athens; Athens Medical School; National & Kapodistrian University of Athens; University of Thessaly	Voulgarelis, M (corresponding author), Univ Athens, Sch Med, Dept Pathophysiol, GR-11527 Athens, Greece.	mvoulgar@med.uoa.gr	Mavrogeni, Sophie/AAV-2105-2021; TZIOUFAS, ATHANASIOS G/A-1690-2008	Tzioufas, Athanasios/0000-0001-6666-8642; Ziogas, Dimitrios C./0000-0003-2620-4004				Ambrosetti A, 2004, BRIT J HAEMATOL, V126, P43, DOI 10.1111/j.1365-2141.2004.04993.x; Anderson LA, 2009, INT J CANCER, V125, P398, DOI 10.1002/ijc.24287; Baimpa E, 2009, MEDICINE, V88, P284, DOI 10.1097/MD.0b013e3181b76ab5; Brito-Zeron P, 2007, RHEUMATOLOGY, V46, P1359, DOI 10.1093/rheumatology/kem079; Brkic Z, 2013, ANN RHEUM DIS, V72, P728, DOI 10.1136/annrheumdis-2012-201381; CARBONE PP, 1971, CANCER RES, V31, P1860; Cheson BD, 1999, J CLIN ONCOL, V17, P1244, DOI 10.1200/JCO.1999.17.4.1244; DANIELS TE, 1994, ARTHRITIS RHEUM-US, V37, P869, DOI 10.1002/art.1780370615; Gill H, 2011, ANN HEMATOL, V90, P1399, DOI 10.1007/s00277-011-1226-z; Gottenberg JE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059868; Hernandez JA, 1996, SCAND J RHEUMATOL, V25, P396; Ioannidis JPA, 2002, ARTHRITIS RHEUM, V46, P741, DOI 10.1002/art.10221; Jaffe ES, 2009, HEMATOL-AM SOC HEMAT, V2009, P523, DOI DOI 10.1182/ASHEDUCATI0N-2009.1.523; KASSAN SS, 1978, ANN INTERN MED, V89, P888, DOI 10.7326/0003-4819-89-6-888; Kruize AA, 1996, ARTHRITIS RHEUM-US, V39, P297, DOI 10.1002/art.1780390219; Martens PB, 1999, J RHEUMATOL, V26, P1296; OKEN MM, 1982, AM J CLIN ONCOL-CANC, V5, P649, DOI 10.1097/00000421-198212000-00014; Pollard RPE, 2011, J RHEUMATOL, V38, P2198, DOI 10.3899/jrheum.110077; Ramos-Casals M, 2005, RHEUMATOLOGY, V44, P89, DOI 10.1093/rheumatology/keh407; Ramos-Casals M, 2014, RHEUMATOLOGY, V53, P321, DOI 10.1093/rheumatology/ket349; Risselada AP, 2013, SEMIN ARTHRITIS RHEU, V43, P171, DOI 10.1016/j.semarthrit.2013.03.001; Royer B, 1997, BLOOD, V90, P766, DOI 10.1182/blood.V90.2.766; Seror R, 2010, ANN RHEUM DIS, V69, P1103, DOI 10.1136/ard.2009.110619; SHIPP MA, 1993, NEW ENGL J MED, V329, P987, DOI 10.1056/nejm199309303291402; Skopouli FN, 2000, SEMIN ARTHRITIS RHEU, V29, P296, DOI 10.1016/S0049-0172(00)80016-5; Smedby KE, 2008, BLOOD, V111, P4029, DOI 10.1182/blood-2007-10-119974; Smedby KE, 2006, JNCI-J NATL CANCER I, V98, P51, DOI 10.1093/jnci/djj004; Solans-Laque R, 2011, SEMIN ARTHRITIS RHEU, V41, P415, DOI 10.1016/j.semarthrit.2011.04.006; Sutcliffe N, 1998, SEMIN ARTHRITIS RHEU, V28, P80, DOI 10.1016/S0049-0172(98)80040-1; Theander E, 2004, ARTHRITIS RHEUM-US, V50, P1262, DOI 10.1002/art.20176; Theander E, 2006, ANN RHEUM DIS, V65, P796, DOI 10.1136/ard.2005.041186; Thieblemont C, 2000, BLOOD, V95, P802, DOI 10.1182/blood.V95.3.802.003k19_802_806; Thieblemont Catherine, 2005, Hematology Am Soc Hematol Educ Program, P307, DOI 10.1182/asheducation-2005.1.307; Tobon GJ, 2013, ARTHRITIS RHEUM-US, V65, P3218, DOI 10.1002/art.38129; Troch M, 2010, ANTICANCER RES, V30, P635; Tzioufas AG, 1996, ARTHRITIS RHEUM, V39, P767, DOI 10.1002/art.1780390508; Vitali C, 2002, ANN RHEUM DIS, V61, P554, DOI 10.1136/ard.61.6.554; Voulgarelis M, 1999, ARTHRITIS RHEUM-US, V42, P1765, DOI 10.1002/1529-0131(199908)42:8<1765::AID-ANR28>3.0.CO;2-V; Voulgarelis M, 2012, MEDICINE, V91, P1, DOI 10.1097/MD.0b013e31824125e4; Wohrer S, 2007, LEUKEMIA, V21, P1812, DOI 10.1038/sj.leu.2404782; Zintzaras E, 2005, ARCH INTERN MED, V165, P2337, DOI 10.1001/archinte.165.20.2337; Zinzani PL, 1999, J CLIN ONCOL, V17, P1254, DOI 10.1200/JCO.1999.17.4.1254; Zucca E, 2003, BLOOD, V101, P2489, DOI 10.1182/blood-2002-04-1279; Zufferey P, 1995, SCAND J RHEUMATOL, V24, P342, DOI 10.3109/03009749509095178	45	62	64	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2015	10	2							e0116189	10.1371/journal.pone.0116189	http://dx.doi.org/10.1371/journal.pone.0116189			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC3LS	25723713	Green Published, gold, Green Submitted			2022-12-27	WOS:000350251200014
J	Schmockel, SM; Garcia, AF; Berger, B; Tester, M; Webb, AAR; Roy, SJ				Schmoeckel, Sandra M.; Garcia, Alexandre F.; Berger, Bettina; Tester, Mark; Webb, Alex A. R.; Roy, Stuart J.			Different NaCl-Induced Calcium Signatures in the Arabidopsis thaliana Ecotypes Col-0 and C24	PLOS ONE			English	Article							SALT TOLERANCE; FREE CA2+; CELL; DROUGHT; STRESS; STIMULUS; SIGNALS; ENCODES; INTACT; SOS1	A common feature of stress signalling pathways are alterations in the concentration of cytosolic free calcium ([Ca2+](cyt)), which allow the specific and rapid transmission of stress signals through a plant after exposure to a stress, such as salinity. Here, we used an aequorin based bioluminescence assay to compare the NaCl-induced changes in [Ca2+](cyt) of the Arabidopsis ecotypes Col-0 and C24. We show that C24 lacks the NaCl specific component of the [Ca2+](cyt) signature compared to Col-0. This phenotypic variation could be exploited as a screening methodology for the identification of yet unknown components in the early stages of the salt signalling pathway.	[Schmoeckel, Sandra M.; Garcia, Alexandre F.; Roy, Stuart J.] Australian Ctr Plant Funct Genom, Adelaide, SA, Australia; [Schmoeckel, Sandra M.; Garcia, Alexandre F.; Roy, Stuart J.] Univ Adelaide, Adelaide, SA, Australia; [Schmoeckel, Sandra M.; Tester, Mark] King Abdullah Univ Sci & Technol, Div Biol & Environm Sci & Engn, Ctr Desert Agr, Thuwal, Saudi Arabia; [Garcia, Alexandre F.; Berger, Bettina] Australian Plant Phen Facil, Adelaide, SA, Australia; [Garcia, Alexandre F.; Berger, Bettina] Univ Adelaide, Adelaide, SA, Australia; [Webb, Alex A. R.] Univ Cambridge, Dept Plant Sci, Cambridge, England	University of Adelaide; King Abdullah University of Science & Technology; University of Adelaide; University of Cambridge	Roy, SJ (corresponding author), Australian Ctr Plant Funct Genom, Adelaide, SA, Australia.	stuart.roy@acpfg.com.au	Tester, Mark/J-2368-2017; Berger, Bettina/AAH-1190-2021	Tester, Mark/0000-0002-5085-8801; Berger, Bettina/0000-0003-1195-4478; Webb, Alex/0000-0003-0261-4375; Schmoeckel, Sandra Manuela/0000-0001-5974-5136; Roy, Stuart/0000-0003-0411-9431	Brenda Nettle Travel Award; King Abdullah University for Science and Technology	Brenda Nettle Travel Award; King Abdullah University for Science and Technology	The authors would like to thank the Australian Centre for Plant Functional Genomics, Australian Research Council, The Grains Research and Development Corporation, The Waite Research Institute, the Barr Smith Travel Scholarship in Agriculture, the Brenda Nettle Travel Award and King Abdullah University for Science and Technology for financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen GJ, 2001, NATURE, V411, P1053, DOI 10.1038/35082575; Cao J, 2011, NAT GENET, V43, P956, DOI 10.1038/ng.911; Choi WG, 2014, P NATL ACAD SCI USA, V111, P6497, DOI 10.1073/pnas.1319955111; Dodd AN, 2006, PLANT J, V48, P962, DOI 10.1111/j.1365-313X.2006.02933.x; Dodd AN, 2010, ANNU REV PLANT BIOL, V61, P593, DOI 10.1146/annurev-arplant-070109-104628; FAO, 2008, FAO LAND PLANT NUTR; Halfter U, 2000, P NATL ACAD SCI USA, V97, P3735, DOI 10.1073/pnas.040577697; Jha D, 2010, PLANT CELL ENVIRON, V33, P793, DOI 10.1111/j.1365-3040.2009.02105.x; Kiegle E, 2000, PLANT J, V23, P267, DOI 10.1046/j.1365-313x.2000.00786.x; Kilian J, 2007, PLANT J, V50, P347, DOI 10.1111/j.1365-313X.2007.03052.x; Knight H, 2000, INT REV CYTOL, V195, P269; Knight H, 1996, PLANT CELL, V8, P489, DOI 10.1105/tpc.8.3.489; Knight H, 1997, PLANT J, V12, P1067, DOI 10.1046/j.1365-313X.1997.12051067.x; KNIGHT MR, 1991, NATURE, V352, P524, DOI 10.1038/352524a0; Kudla J, 2010, PLANT CELL, V22, P541, DOI 10.1105/tpc.109.072686; Ma W, 2007, CELL MICROBIOL, V9, P2571, DOI 10.1111/j.1462-5822.2007.01031.x; MAATHUIS FJM, 1993, PLANTA, V191, P302, DOI 10.1007/BF00195686; Marti MC, 2013, PLANT PHYSIOL, V163, P625, DOI 10.1104/pp.113.222901; McAinsh MR, 2009, NEW PHYTOL, V181, P275, DOI 10.1111/j.1469-8137.2008.02682.x; MCAINSH MR, 1995, PLANT CELL, V7, P1207, DOI 10.1105/tpc.7.8.1207; MONTERO M, 1995, EMBO J, V14, P5467, DOI 10.1002/j.1460-2075.1995.tb00233.x; MUNNS R, 1984, AUST J PLANT PHYSIOL, V11, P497, DOI 10.1071/PP9840497; Munns R, 2008, ANNU REV PLANT BIOL, V59, P651, DOI 10.1146/annurev.arplant.59.032607.092911; Ng CKY, 2001, NEW PHYTOL, V151, P109, DOI 10.1046/j.1469-8137.2001.00152.x; Oldroyd GED, 2009, SCIENCE, V324, P753, DOI 10.1126/science.1171644; Quintero FJ, 2002, P NATL ACAD SCI USA, V99, P9061, DOI 10.1073/pnas.132092099; R Core Team, 2021, R LANGUAGE ENV STAT; Roy SJ, 2014, CURR OPIN BIOTECH, V26, P115, DOI 10.1016/j.copbio.2013.12.004; Shi HZ, 2000, P NATL ACAD SCI USA, V97, P6896, DOI 10.1073/pnas.120170197; Shumway RH, 2011, SPRINGER TEXTS STAT, P1, DOI 10.1007/978-1-4419-7865-3; Stoffer D, 2012, ASTSA APPL STAT TIME; Tracy FE, 2008, PLANT CELL ENVIRON, V31, P1063, DOI 10.1111/j.1365-3040.2008.01817.x; Wu SJ, 1996, PLANT CELL, V8, P617, DOI 10.1105/tpc.8.4.617; Zhu JK, 2000, PLANT PHYSIOL, V124, P941, DOI 10.1104/pp.124.3.941; Zhu JK, 2002, ANNU REV PLANT BIOL, V53, P247, DOI 10.1146/annurev.arplant.53.091401.143329; Zhu XH, 2013, MOL PLANT, V6, P444, DOI 10.1093/mp/sst013	36	9	9	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2015	10	2							e0117564	10.1371/journal.pone.0117564	http://dx.doi.org/10.1371/journal.pone.0117564			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC3LS	25723668	Green Published, gold, Green Submitted			2022-12-27	WOS:000350251200035
J	Winston, A; Puls, R; Kerr, SJ; Duncombe, C; Li, P; Gill, JM; Ramautarsing, R; Taylor-Robinson, SD; Emery, S; Cooper, DA				Winston, Alan; Puls, Rebekah; Kerr, Stephen J.; Duncombe, Chris; Li, Patrick; Gill, John M.; Ramautarsing, Reshmie; Taylor-Robinson, Simon D.; Emery, Sean; Cooper, David A.		ALTAIR Study Grp	Differences in the Direction of Change of Cerebral Function Parameters Are Evident over Three Years in HIV-Infected Individuals Electively Commencing Initial cART	PLOS ONE			English	Article							MAGNETIC-RESONANCE-SPECTROSCOPY; COMBINATION ANTIRETROVIRAL THERAPY; HIV-1-INFECTED INDIVIDUALS; NEUROCOGNITIVE IMPAIRMENT; COGNITIVE FUNCTION; TREATMENT-NAIVE; EFAVIRENZ; DEMENTIA; BATTERY; AIDS	Background Changes in cerebral metabolite ratios (CMR) measured on H-1-MRS and changes in cognitive function (CF) are described in subjects commencing combination antiretroviral therapy (cART), although the dynamics of such changes are poorly understood. Methods Neuroasymptomatic, HIV-infected subjects electively commencing cART were eligible. CMR were assessed in three anatomical voxels and CF assessed at baseline, week 48 and week 144. Overall differences in absolute change in CMRs and CF parameters between 0-48 and 48-144 weeks were assessed. Results Twenty-two subjects completed study procedures. Plasma HIV-RNA was < 50 copies/mL in all at week 48 and in all, but two subjects at week 144. In general, between weeks 0-48 a rise in N-acetyl-aspartate(NAA)/Creatine(Cr) ratio and a decline in myo-Inositol(ml)/Cr ratio were observed. Between weeks 48-144, small rises in NAA/Cr ratio were observed in two anatomical voxels, whereas a rise in ml/Cr ratio was observed in all anatomical locations (0.31 (0.66) and -0.27 (1.35) between weeks 0-48 and 0.13 (0.91) and 1.13 (1.71) between weeks 48-144 for absolute changes in NAA/Cr and ml/Cr (SD) in frontal-grey voxel, respectively). Global CF score improved between weeks 0-48 and then declined between weeks 48-144 (0.63 (1.16) and -0.63 (0.1.41) for mean absolute change (SD) between weeks 0-48 and weeks 48-144, respectively). Conclusions The direction of change of cerebral function parameters differs over time in HIV-infected subjects commencing cART, highlighting the need for long-term follow-up in such studies. The changes we have observed between weeks 48-144 may represent the initial development of cerebral toxicities from cART.	[Winston, Alan; Taylor-Robinson, Simon D.] Univ London Imperial Coll Sci Technol & Med, Dept Med, London, England; [Puls, Rebekah; Kerr, Stephen J.; Emery, Sean; Cooper, David A.] Univ New S Wales, Kirby Inst, Sydney, NSW 2052, Australia; [Kerr, Stephen J.; Duncombe, Chris; Ramautarsing, Reshmie] HIV NAT, Bangkok, Thailand; [Li, Patrick] Queen Elizabeth Hosp, Hong Kong, Hong Kong, Peoples R China; [Gill, John M.] Calgary Hlth, Calgary, AB, Canada	Imperial College London; University of New South Wales Sydney; Kirby Institute	Winston, A (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Med, London, England.	a.winston@imperial.ac.uk	Dodsley, Maria/G-7083-2016; Emery, Sean/O-9122-2019; Winston, Alan/AGZ-3015-2022; Kerr, Stephen/J-6126-2012; Emery, Sean/J-3825-2017	Dodsley, Maria/0000-0001-7587-558X; Emery, Sean/0000-0001-6072-8309; Winston, Alan/0000-0002-5847-8416; Kerr, Stephen/0000-0002-1919-4525; Emery, Sean/0000-0001-6072-8309; Walmsley, Sharon/0000-0002-3959-5692; Hung, Chien-Ching/0000-0001-7345-0836; Wolff, Marcelo/0000-0002-9956-8872; Taylor-Robinson, Simon/0000-0002-8811-1834	Gilead Sciences, Foster City, CA, USA; NIHR Biomedical Research Centre funding scheme at Imperial College Healthcare NHS Trust, London, UK; Australian Government Department of Health Ageing; Faculty of Medicine, The University of New South Wales	Gilead Sciences, Foster City, CA, USA(Gilead Sciences); NIHR Biomedical Research Centre funding scheme at Imperial College Healthcare NHS Trust, London, UK; Australian Government Department of Health Ageing(Australian GovernmentDepartment of Health & Ageing); Faculty of Medicine, The University of New South Wales	The ALTAIR study was funded with an unrestricted research grant from Gilead Sciences, Foster City, CA, USA. AW and SDT-R are grateful for support from the NIHR Biomedical Research Centre funding scheme at Imperial College Healthcare NHS Trust, London, UK for infrastructure funding support. The Kirby Institute is funded by the Australian Government Department of Health & Ageing and is affiliated with the Faculty of Medicine, The University of New South Wales. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chang L, 2004, ANTIVIR THER, V9, P431; Chang L, 1999, NEUROLOGY, V53, P782, DOI 10.1212/WNL.53.4.782; Ciccarelli N, 2011, NEUROLOGY, V76, P1403, DOI 10.1212/WNL.0b013e31821670fb; Collie A, 2003, J INT NEUROPSYCH SOC, V9, P419, DOI 10.1017/S1355617703930074; Cysique LA, 2009, NEUROLOGY; Cysique LAJ, 2006, ARCH CLIN NEUROPSYCH, V21, P185, DOI 10.1016/j.acn.2005.07.011; Cysique LA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061738; Ellis RJ, 2011, AIDS, V25, P1747, DOI 10.1097/QAD.0b013e32834a40cd; Garvey LJ, 2009, AIDS RES HUM RETROV, V25, P765, DOI 10.1089/aid.2008.0292; Kanowski M, 2004, MAGNET RESON MED, V51, P904, DOI 10.1002/mrm.20063; Liner Kevin J 2nd, 2008, Curr HIV/AIDS Rep, V5, P64, DOI 10.1007/s11904-008-0011-7; MCCONNELL JR, 1994, AIDS RES HUM RETROV, V10, P977, DOI 10.1089/aid.1994.10.977; Okada T, 2007, PSYCHIAT RES-NEUROIM, V156, P169, DOI 10.1016/j.pscychresns.2007.03.007; Paul RH, 2008, J INT NEUROPSYCH SOC, V14, P725, DOI 10.1017/S1355617708080910; Puls RL, 2010, CLIN INFECT DIS, V51, P855, DOI 10.1086/656363; Robertson K, 2012, J NEUROVIROL, V18, P388, DOI 10.1007/s13365-012-0120-3; Sacktor N, 2011, NEUROLOGY, V77, P1135, DOI 10.1212/WNL.0b013e31822f0412; Sailasuta N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049272; Schweinsburg BC, 2005, J NEUROVIROL, V11, P356, DOI 10.1080/13550280591002342; Tarasow Eugeniusz, 2004, Med Sci Monit, V10 Suppl 3, P101; Wilkinson ID, 1997, J NEUROL NEUROSUR PS, V63, P477, DOI 10.1136/jnnp.63.4.477; Winston A, 2012, HIV MED, V13, P245, DOI 10.1111/j.1468-1293.2011.00962.x; Winston A, 2010, J VIRAL HEPATITIS, V17, P419, DOI 10.1111/j.1365-2893.2009.01198.x; Winston A, 2010, CLIN INFECT DIS, V50, P920, DOI 10.1086/650743	24	12	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2015	10	2							e0118608	10.1371/journal.pone.0118608	http://dx.doi.org/10.1371/journal.pone.0118608			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC3LS	25723494	Green Submitted, gold, Green Published			2022-12-27	WOS:000350251200060
J	Yu, XY; Lu, CH				Yu, Xinyang; Lu, Changhe			Alpine Glacier Change in the Eastern Altun Mountains of Northwest China during 1972-2010	PLOS ONE			English	Article							CLIMATE-CHANGE	Accurately mapping and monitoring glacier changes over decades is important for providing information to support sustainable use of water resource in arid regions of northwest China. Since 1970, glaciers in the Eastern Altun Mountains showed remarkable recession. Further study is indispensable to indicate the extent and amplitude of glacial change at basin and individual glacier scale. In this study, spatiotemporal glacier changes referring to the year 1972, 1990, 2000 and 2010 were studied for the Eastern Altun Mountains using Landsat MSS/TM/ETM+ images and glacier volume-area scaling. The results demonstrated that the total area and volume of glaciers in EAMs decreased significantly by 10.70 +/- 0.57 km(2) (19.56 +/- 10.41%) and 0.61 +/- 0.03 km(3) (23.19 +/- 11.40%) during 1972-2010, respectively. More than half of the total receding area occurred during 1990-2000, primarily due to higher temperature increasing. However, varied response of individual glaciers indicated that glacier change was also affected by glacier dynamics, which was related to local topography. In addition, five glaciers unrecorded in the glacier inventory of China were reported in this study.	[Yu, Xinyang; Lu, Changhe] Chinese Acad Sci, Key Lab Land Surface Pattern & Simulat, Inst Geog Sci & Nat Resources Res, Beijing, Peoples R China; [Yu, Xinyang] Univ Chinese Acad Sci, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Geographic Sciences & Natural Resources Research, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Lu, CH (corresponding author), Chinese Acad Sci, Key Lab Land Surface Pattern & Simulat, Inst Geog Sci & Nat Resources Res, Beijing, Peoples R China.	luch@igsnrr.ac.cn			National Basic Research Program of China [2012CB955304]	National Basic Research Program of China(National Basic Research Program of China)	The authors' work was supported by the National Basic Research Program of China (No. 2012CB955304). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abshire JB, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL024028; Bahr DB, 1997, J GLACIOL, V43, P557, DOI 10.3189/S0022143000035164; Barry RG, 2006, PROG PHYS GEOG, V30, P285, DOI 10.1191/0309133306pp478ra; Bolch T, 2007, GLOBAL PLANET CHANGE, V56, P1, DOI 10.1016/j.gloplacha.2006.07.009; Bolch T, 2008, J GLACIOL, V54, P592, DOI 10.3189/002214308786570782; Chen J., 1990, IAHS PUBLICATION, V193, P127; Farinotti D, 2009, GLOBAL PLANET CHANGE, V68, P225, DOI 10.1016/j.gloplacha.2009.05.004; Howat IM, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL034496; Huang J, 2012, ATMOS CHEM PHYS, V12, P5391, DOI 10.5194/acp-12-5391-2012; Johannes O, 1994, SCIENCE, V264, P243; Kotlyakov VM, 2008, ANN GLACIOL-SER, V48, P125, DOI 10.3189/172756408784700608; Lanzhou Institute of Glaciology and Geocryology, 1981, GLAC INV CHIN, P4; Liu S, 1999, CHINESE GEOGR SCI, V9, P134, DOI [10.1007/bf02791363., DOI 10.1007/BF02791363]; [刘时银 Liu Shiyin], 2002, [冰川冻土, Journal of Glaciology and Geocryology], V24, P227; Lu AiGang, 2009, Arid Land Geography, V32, P506; MEIER MF, 1996, GLACIERS ICE SHEETS, P89; Narama C, 2010, GLOBAL PLANET CHANGE, V71, P42, DOI 10.1016/j.gloplacha.2009.08.002; Qian Y. L., 2010, J METEOROL ENV, V26, P7; Shangguan D, 2009, PROG NAT SCI-MATER, V19, P727, DOI 10.1016/j.pnsc.2008.11.002; Shi YF, 2007, CLIMATIC CHANGE, V80, P379, DOI 10.1007/s10584-006-9121-7; Wang SJ, 2011, J GEOGR SCI, V21, P263, DOI 10.1007/s11442-011-0843-8; Ye ZhaoXia, 2009, Arid Land Geography, V32, P841; Zhang D, 2013, ADV WATER SCI, V24, P17; [张明军 ZHANG Mingjun], 2011, [地理学报, Acta Geographica Sinica], V66, P1155; Zhang Y., 1998, B GLACIER RES, V16, P1, DOI DOI 10.1142/9789812839718_0001; Zhu H, 2012, GEOGRAPHICAL RES, V32, P1430	26	4	7	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2015	10	2							e0117262	10.1371/journal.pone.0117262	http://dx.doi.org/10.1371/journal.pone.0117262			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC3LS	25723669	gold, Green Published, Green Submitted			2022-12-27	WOS:000350251200027
J	Malachowa, N; Kobayashi, SD; Sturdevant, DE; Scott, DP; Deleo, FR				Malachowa, Natalia; Kobayashi, Scott D.; Sturdevant, Daniel E.; Scott, Dana P.; DeLeo, Frank R.			Insights into the Staphylococcus aureus-Host Interface: Global Changes in Host and Pathogen Gene Expression in a Rabbit Skin Infection Model	PLOS ONE			English	Article							SOFT-TISSUE INFECTIONS; PANTON-VALENTINE LEUKOCIDIN; HUMAN ENDOTHELIAL-CELLS; ONCOSTATIN-M; EMERGENCY-DEPARTMENT; VIRULENCE DETERMINANTS; ADHESION MOLECULES; T-CELLS; USA300; KERATINOCYTES	Staphylococcus aureus is an important cause of human skin and soft tissue infections (SSTIs) globally. Notably, 80% of all SSTIs are caused by S. aureus, of which similar to 63% are abscesses and/or cellulitis. Although progress has been made, our knowledge of the host and pathogen factors that contribute to the pathogenesis of SSTIs is incomplete. To provide a more comprehensive view of this process, we monitored changes in the S. aureus transcriptome and selected host proinflammatory molecules during abscess formation and resolution in a rabbit skin infection model. Within the first 24 h, S. aureus transcripts involved in DNA repair, metabolite transport, and metabolism were up-regulated, suggesting an increase in the machinery encoding molecules involved in replication and cell division. There was also increased expression of genes encoding virulence factors, namely secreted toxins and fibronectin and/or fibrinogen-binding proteins. Of the host genes tested, we found that transcripts encoding IL-8, IL1 beta, oncostatin M-like, CCR1, CXCR1 (IL8RA), CCL4 (MIP-1 beta) and CCL3 (MIP1 alpha)-like proteins were among the most highly up-regulated transcripts during S. aureus abscess formation. Our findings provide additional insight into the pathogenesis of S. aureus SSTIs, including a temporal component of the host response. These results serve as a springboard for future studies directed to better understand how/why mild or moderate SSTIs progress to invasive disease.	[Malachowa, Natalia; Kobayashi, Scott D.; DeLeo, Frank R.] NIAID, Lab Human Bacterial Pathogenesis, Rocky Mt Labs, NIH, Hamilton, MT 59840 USA; [Sturdevant, Daniel E.] NIAID, Res Technol Branch, Rocky Mt Labs, NIH, Hamilton, MT USA; [Scott, Dana P.] NIAID, Vet Branch, Rocky Mt Labs, NIH, Hamilton, MT USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Deleo, FR (corresponding author), NIAID, Lab Human Bacterial Pathogenesis, Rocky Mt Labs, NIH, Hamilton, MT 59840 USA.	fdeleo@niaid.nih.gov		Kobayashi, Scott/0000-0002-5705-1381; DeLeo, Frank/0000-0003-3150-2516	US National Institute of Allergy and Infectious Diseases, National Institutes of Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001079] Funding Source: NIH RePORTER	US National Institute of Allergy and Infectious Diseases, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the Intramural Research Program of the US National Institute of Allergy and Infectious Diseases, National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahamian FM, 2008, INFECT DIS CLIN N AM, V22, P89, DOI 10.1016/j.idc.2007.12.001; Bystry RS, 2001, NAT IMMUNOL, V2, P1126, DOI 10.1038/ni735; Cheng QA, 2010, J IMMUNOL, V185, P1238, DOI 10.4049/jimmunol.0904104; Cho JS, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003047; Date SV, 2014, J INFECT DIS, V209, P1542, DOI 10.1093/infdis/jit668; Fritz DK, 2006, J IMMUNOL, V176, P4352, DOI 10.4049/jimmunol.176.7.4352; Graves SF, 2012, J LEUKOCYTE BIOL, V92, P361, DOI 10.1189/jlb.1111575; Kennedy AD, 2010, J INFECT DIS, V202, P1050, DOI 10.1086/656043; Kobayashi SD, 2011, J INFECT DIS, V204, P937, DOI 10.1093/infdis/jir441; Kobayashi SD, 2015, AM J PATHOL IN PRESS; Li M, 2009, P NATL ACAD SCI USA, V106, P5883, DOI 10.1073/pnas.0900743106; Loughman JA, 2009, J INFECT DIS, V199, P294, DOI 10.1086/595982; Luther SA, 2001, NAT IMMUNOL, V2, P102, DOI 10.1038/84205; Malachowa N, 2012, J INFECT DIS, V206, P1185, DOI 10.1093/infdis/jis495; Malachowa N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018617; Mempel M, 2003, J INVEST DERMATOL, V121, P1389, DOI 10.1111/j.1523-1747.2003.12630.x; Mereghetti L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003143; Miossec P, 2009, NEW ENGL J MED, V361, P888, DOI 10.1056/NEJMra0707449; Modur V, 1997, J CLIN INVEST, V100, P158, DOI 10.1172/JCI119508; Moran GJ, 2006, NEW ENGL J MED, V355, P666, DOI 10.1056/NEJMoa055356; Mosley B, 1996, J BIOL CHEM, V271, P32635, DOI 10.1074/jbc.271.51.32635; Ouyang WJ, 2008, IMMUNITY, V28, P454, DOI 10.1016/j.immuni.2008.03.004; Palazzolo-Ballance AM, 2008, J IMMUNOL, V180, P500, DOI 10.4049/jimmunol.180.1.500; Ray GT, 2013, DIAGN MICR INFEC DIS, V76, P24, DOI 10.1016/j.diagmicrobio.2013.02.020; Roth SA, 2014, J INVEST DERMATOL, V134, P374, DOI 10.1038/jid.2013.313; Talan DA, 2011, CLIN INFECT DIS, V53, P144, DOI 10.1093/cid/cir308; Tay SS, 2014, CURR DERMATOL REP, V3, P13, DOI 10.1007/s13671-013-0063-9; Tkaczyk C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075103; Vebo HC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007660; Ventura CL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011634; Voyich JA, 2005, J IMMUNOL, V175, P3907, DOI 10.4049/jimmunol.175.6.3907; Voyich JM, 2006, J INFECT DIS, V194, P1761, DOI 10.1086/509506; Wang F, 2012, J MOL DIAGN, V14, P22, DOI 10.1016/j.jmoldx.2011.08.002; Wang R, 2007, NAT MED, V13, P1510, DOI 10.1038/nm1656; Yao LB, 1996, J EXP MED, V184, P81, DOI 10.1084/jem.184.1.81; Yao LB, 2013, BLOOD, V122, P3832, DOI 10.1182/blood-2012-12-473835; Yoong P, 2010, P NATL ACAD SCI USA, V107, P2241, DOI 10.1073/pnas.0910344107	37	17	17	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2015	10	2							e0117713	10.1371/journal.pone.0117713	http://dx.doi.org/10.1371/journal.pone.0117713			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC2ZH	25719526	Green Submitted, Green Published, gold			2022-12-27	WOS:000350213200028
J	Wu, JK; Kitajewski, C; Reiley, M; Keung, CH; Monteagudo, J; Andrews, JP; Liou, P; Thirumoorthi, A; Wong, A; Kandel, JJ; Shawber, CJ				Wu, June K.; Kitajewski, Christopher; Reiley, Maia; Keung, Connie H.; Monteagudo, Julie; Andrews, John P.; Liou, Peter; Thirumoorthi, Arul; Wong, Alvin; Kandel, Jessica J.; Shawber, Carrie J.			Aberrant Lymphatic Endothelial Progenitors in Lymphatic Malformation Development	PLOS ONE			English	Article							STEM-CELLS; EXPRESSION; CLASSIFICATION; POPULATION; HEMANGIOMA; VEGFR-3; NOTCH1; CD146; NG2	Lymphatic malformations (LMs) are vascular anomalies thought to arise from dysregulated lymphangiogenesis. These lesions impose a significant burden of disease on affected individuals. LM pathobiology is poorly understood, hindering the development of effective treatments. In the present studies, immunostaining of LM tissues revealed that endothelial cells lining aberrant lymphatic vessels and cells in the surrounding stroma expressed the stem cell marker, CD133, and the lymphatic endothelial protein, podoplanin. Isolated patient-derived CD133+ LM cells expressed stem cell genes (NANOG, Oct4), circulating endothelial cell precursor proteins (CD90, CD146, c-Kit, VEGFR-2), and lymphatic endothelial proteins (podoplanin, VEGFR-3). Consistent with a progenitor cell identity, CD133+ LM cells were multipotent and could be differentiated into fat, bone, smooth muscle, and lymphatic endothelial cells in vitro. CD133+ cells were compared to CD133-cells isolated from LM fluids. CD133 -LM cells had lower expression of stem cell genes, but expressed circulating endothelial precursor proteins and high levels of lymphatic endothelial proteins, VE-cadherin, CD31, podoplanin, VEGFR-3 and Prox1. CD133 -LM cells were not multipotent, consistent with a differentiated lymphatic endothelial cell phenotype. In a mouse xenograft model, CD133+ LM cells differentiated into lymphatic endothelial cells that formed irregularly dilated lymphatic channels, phenocopying human LMs. In vivo, CD133+ LM cells acquired expression of differentiated lymphatic endothelial cell proteins, podoplanin, LYVE1, Prox1, and VEGFR-3, comparable to expression found in LM patient tissues. Taken together, these data identify a novel LM progenitor cell population that differentiates to form the abnormal lymphatic structures characteristic of these lesions, recapitulating the human LM phenotype. This LM progenitor cell population may contribute to the clinically refractory behavior of LMs.	[Wu, June K.; Keung, Connie H.; Monteagudo, Julie; Andrews, John P.; Liou, Peter; Thirumoorthi, Arul; Wong, Alvin; Shawber, Carrie J.] Columbia Univ, Coll Phys & Surg, Dept Surg, New York, NY 10027 USA; [Kitajewski, Christopher; Reiley, Maia; Shawber, Carrie J.] Columbia Univ, Coll Phys & Surg, Dept Ob Gyn, New York, NY USA; [Kandel, Jessica J.] Univ Chicago Med, Dept Surg, Chicago, IL USA	Columbia University; Columbia University	Shawber, CJ (corresponding author), Columbia Univ, Coll Phys & Surg, Dept Surg, New York, NY 10027 USA.	cjs2002@cumc.columbia.edu	Wong, Alvin/ABA-9620-2021	Wong, Alvin/0000-0001-8775-1779; Andrews, John/0000-0002-8025-1525	NIH/NCI [R01CA136673]; NIH/NIBIB [R21EB016515]; Pediatric Cancer Foundation; Sorkin Fund; NIH/NHLBI [K08HL102068-01]; NATIONAL CANCER INSTITUTE [R01CA136673] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000430] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL102068] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R21EB016515] Funding Source: NIH RePORTER	NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH/NIBIB(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); Pediatric Cancer Foundation; Sorkin Fund; NIH/NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	Funding was provided by NIH/NCI R01CA136673 (CJS), NIH/NIBIB R21EB016515 (CJS, JJK), the Pediatric Cancer Foundation (pcfweb.org; JJK), the Sorkin Fund (JJK) and NIH/NHLBI K08HL102068-01 (JKW). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adepoju O, 2011, VASC CELL, V3, DOI 10.1186/2045-824X-3-19; Armulik A, 2011, DEV CELL, V21, P193, DOI 10.1016/j.devcel.2011.07.001; Bai Y, 2009, J ORAL MAXIL SURG, V67, P251, DOI 10.1016/j.joms.2008.06.046; Brice G, 2005, J MED GENET, V42, P98, DOI 10.1136/jmg.2004.024802; Burrows PE, 2013, P NATL ACAD SCI USA, V110, P8621, DOI 10.1073/pnas.1222722110; Corselli M, 2010, ARTERIOSCL THROM VAS, V30, P1104, DOI 10.1161/ATVBAHA.109.191643; Crisan M, 2008, CELL STEM CELL, V3, P301, DOI 10.1016/j.stem.2008.07.003; Dellinger MT, 2008, LYMPHOLOGY, V41, P98; Gale NW, 2007, MOL CELL BIOL, V27, P595, DOI 10.1128/MCB.01503-06; Gill M, 2001, CIRC RES, V88, P167; Horner PJ, 2002, J NEUROCYTOL, V31, P469, DOI 10.1023/A:1025739630398; Huang SS, 2006, FEBS LETT, V580, P6259, DOI 10.1016/j.febslet.2006.10.028; Khan ZA, 2008, J CLIN INVEST, V118, P2592, DOI 10.1172/JCI33493; Kozanoglu I, 2009, CYTOTHERAPY, V11, P527, DOI 10.1080/14653240902923153; Lee JY, 2010, CIRCULATION, V122, P1413, DOI 10.1161/CIRCULATIONAHA.110.941468; Lokmic Z, 2014, ANGIOGENESIS, V17, P1, DOI 10.1007/s10456-013-9371-8; Majka M, 2005, ACTA BIOCHIM POL, V52, P353; Maruyama K, 2005, J CLIN INVEST, V115, P2363, DOI 10.1172/JCI23874; Mulliken J B, 2000, Curr Probl Surg, V37, P517, DOI 10.1016/S0011-3840(00)80013-1; MULLIKEN JB, 1982, PLAST RECONSTR SURG, V70, P120; MULLIKEN JB, 1982, PLAST RECONSTR SURG, V69, P412, DOI 10.1097/00006534-198203000-00002; Murtomaki A, 2013, DEVELOPMENT, V140, P2365, DOI 10.1242/dev.083865; Peichev M, 2000, BLOOD, V95, P952, DOI 10.1182/blood.V95.3.952.003k27_952_958; Platonova N, 2013, BLOOD, V121, P1229, DOI 10.1182/blood-2012-08-450502; Raveh E, 1997, ARCH OTOLARYNGOL, V123, P1061; Religa P, 2005, BLOOD, V106, P4184, DOI 10.1182/blood-2005-01-0226; Roberts AE, 2013, LANCET, V381, P333, DOI 10.1016/S0140-6736(12)61023-X; Russell KC, 2013, TISSUE ENG PT A, V19, P2253, DOI [10.1089/ten.tea.2012.0649, 10.1089/ten.TEA.2012.0649]; Salven P, 2003, BLOOD, V101, P168, DOI 10.1182/blood-2002-03-0755; Schulte-Merker S, 2011, J CELL BIOL, V193, P607, DOI 10.1083/jcb.201012094; Schwartz PH, 2003, J NEUROSCI RES, V74, P838, DOI 10.1002/jnr.10854; Shawber CJ, 2003, ANN NY ACAD SCI, V995, P162, DOI 10.1111/j.1749-6632.2003.tb03219.x; Shiels WE, 2008, J PEDIATR SURG, V43, P136, DOI 10.1016/j.jpedsurg.2007.09.049; Tormin A, 2011, BLOOD, V117, P5067, DOI 10.1182/blood-2010-08-304287; Vorontchikhina MA, 2005, GENE EXPR PATTERNS, V5, P701, DOI 10.1016/j.modgep.2005.02.001; Wong A, 2012, PLAST RECONSTR SURG, V130, P1012, DOI 10.1097/PRS.0b013e318267d3db; Zumsteg A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007067	37	14	14	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2015	10	2							e0117352	10.1371/journal.pone.0117352	http://dx.doi.org/10.1371/journal.pone.0117352			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC2ZH	25719418	Green Submitted, Green Published, gold			2022-12-27	WOS:000350213200020
J	Eckdahl, TT; Campbell, AM; Heyer, LJ; Poet, JL; Blauch, DN; Snyder, NL; Atchley, DT; Baker, EJ; Brown, M; Brunner, EC; Callen, SA; Campbell, JS; Carr, CJ; Carr, DR; Chadinha, SA; Chester, GI; Chester, J; Clarkson, BR; Cochran, KE; Doherty, SE; Doyle, C; Dwyer, S; Edlin, LM; Evans, RA; Fluharty, T; Frederick, J; Galeota-Sprung, J; Gammon, BL; Grieshaber, B; Gronniger, J; Gutteridge, K; Henningsen, J; Isom, B; Itell, HL; Keffeler, EC; Lantz, AJ; Lim, JN; McGuire, EP; Moore, AK; Morton, J; Nakano, M; Pearson, SA; Perkins, V; Parrish, P; Pierson, CE; Polpityaarachchige, S; Quaney, MJ; Slattery, A; Smith, KE; Spell, J; Spencer, M; Taye, T; Trueblood, K; Vrana, CJ; Whitesides, ET				Eckdahl, Todd T.; Campbell, A. Malcolm; Heyer, Laurie J.; Poet, Jeffrey L.; Blauch, David N.; Snyder, Nicole L.; Atchley, Dustin T.; Baker, Erich J.; Brown, Micah; Brunner, Elizabeth C.; Callen, Sean A.; Campbell, Jesse S.; Carr, Caleb J.; Carr, David R.; Chadinha, Spencer A.; Chester, Grace I.; Chester, Josh; Clarkson, Ben R.; Cochran, Kelly E.; Doherty, Shannon E.; Doyle, Catherine; Dwyer, Sarah; Edlin, Linnea M.; Evans, Rebecca A.; Fluharty, Taylor; Frederick, Janna; Galeota-Sprung, Jonah; Gammon, Betsy L.; Grieshaber, Brandon; Gronniger, Jessica; Gutteridge, Katelyn; Henningsen, Joel; Isom, Bradley; Itell, Hannah L.; Keffeler, Erica C.; Lantz, Andrew J.; Lim, Jonathan N.; McGuire, Erin P.; Moore, Alexander K.; Morton, Jerrad; Nakano, Meredith; Pearson, Sara A.; Perkins, Virginia; Parrish, Phoebe; Pierson, Claire E.; Polpityaarachchige, Sachith; Quaney, Michael J.; Slattery, Abagael; Smith, Kathryn E.; Spell, Jackson; Spencer, Morgan; Taye, Telavive; Trueblood, Kamay; Vrana, Caroline J.; Whitesides, E. Tucker			Programmed Evolution for Optimization of Orthogonal Metabolic Output in Bacteria	PLOS ONE			English	Article							SYNTHETIC RIBOSWITCH; GENE-EXPRESSION; SMALL MOLECULES; TRANSCRIPTION; RNA; TRANSLATION; SELECTIONS; SCREENS; DEVICES; ENZYME	Current use of microbes for metabolic engineering suffers from loss of metabolic output due to natural selection. Rather than combat the evolution of bacterial populations, we chose to embrace what makes biological engineering unique among engineering fields - evolving materials. We harnessed bacteria to compute solutions to the biological problem of metabolic pathway optimization. Our approach is called Programmed Evolution to capture two concepts. First, a population of cells is programmed with DNA code to enable it to compute solutions to a chosen optimization problem. As analog computers, bacteria process known and unknown inputs and direct the output of their biochemical hardware. Second, the system employs the evolution of bacteria toward an optimal metabolic solution by imposing fitness defined by metabolic output. The current study is a proof-of-concept for Programmed Evolution applied to the optimization of a metabolic pathway for the conversion of caffeine to theophylline in E. coli. Introduced genotype variations included strength of the promoter and ribosome binding site, plasmid copy number, and chaperone proteins. We constructed 24 strains using all combinations of the genetic variables. We used a theophylline riboswitch and a tetracycline resistance gene to link theophylline production to fitness. After subjecting the mixed population to selection, we measured a change in the distribution of genotypes in the population and an increased conversion of caffeine to theophylline among the most fit strains, demonstrating Programmed Evolution. Programmed Evolution inverts the standard paradigm in metabolic engineering by harnessing evolution instead of fighting it. Our modular system enables researchers to program bacteria and use evolution to determine the combination of genetic control elements that optimizes catabolic or anabolic output and to maintain it in a population of cells. Programmed Evolution could be used for applications in energy, pharmaceuticals, chemical commodities, biomining, and bioremediation.	[Eckdahl, Todd T.; Campbell, Jesse S.; Carr, Caleb J.; Carr, David R.; Cochran, Kelly E.; Grieshaber, Brandon; Keffeler, Erica C.; Morton, Jerrad; Pearson, Sara A.; Pierson, Claire E.; Polpityaarachchige, Sachith; Quaney, Michael J.; Trueblood, Kamay] Missouri Western State Univ, Dept Biol, St Joseph, MO 64507 USA; [Campbell, A. Malcolm; Atchley, Dustin T.; Baker, Erich J.; Brunner, Elizabeth C.; Chadinha, Spencer A.; Clarkson, Ben R.; Doherty, Shannon E.; Doyle, Catherine; Dwyer, Sarah; Evans, Rebecca A.; Gammon, Betsy L.; Gronniger, Jessica; Itell, Hannah L.; Lim, Jonathan N.; McGuire, Erin P.; Nakano, Meredith; Parrish, Phoebe; Slattery, Abagael; Smith, Kathryn E.; Taye, Telavive; Vrana, Caroline J.] Davidson Coll, Dept Biol, Davidson, NC 28036 USA; [Heyer, Laurie J.; Brown, Micah; Galeota-Sprung, Jonah; Lantz, Andrew J.; Spell, Jackson; Spencer, Morgan; Whitesides, E. Tucker] Davidson Coll, Dept Math & Comp Sci, Davidson, NC 28036 USA; [Poet, Jeffrey L.; Callen, Sean A.; Chester, Grace I.; Chester, Josh; Edlin, Linnea M.; Fluharty, Taylor; Frederick, Janna; Gutteridge, Katelyn; Henningsen, Joel; Isom, Bradley; Moore, Alexander K.; Perkins, Virginia] Missouri Western State Univ, Dept Comp Sci Math & Phys, St Joseph, MO USA; [Blauch, David N.; Snyder, Nicole L.] Davidson Coll, Dept Chem, Davidson, NC 28036 USA	Davidson College; Davidson College; Davidson College	Eckdahl, TT (corresponding author), Missouri Western State Univ, Dept Biol, St Joseph, MO 64507 USA.	eckdahl@missouriwestern.edu	; Snyder, Nicole/C-9593-2014	Dwyer Holland, Sarah/0000-0002-4509-7198; Itell, Hannah/0000-0001-8296-8645; Wescott, Elizabeth/0000-0003-3340-213X; Snyder, Nicole/0000-0002-2508-4090; Vrana-Diaz, Caroline/0000-0001-9037-2761	National Science Foundation [MCB-1120558, MCB-1329350, MCB-1120578, MCB-1329351]; Howard Hughes Medical Institute [52005120, 52006292]; Davidson Research Initiative and James G. Martin Genomics Program at Davidson College; Missouri Western State University Program of Research, Teaching, and Applied Learning (PORTAL); Direct For Biological Sciences [1329351] Funding Source: National Science Foundation; Div Of Molecular and Cellular Bioscience [1329350] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Davidson Research Initiative and James G. Martin Genomics Program at Davidson College; Missouri Western State University Program of Research, Teaching, and Applied Learning (PORTAL); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); Div Of Molecular and Cellular Bioscience(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	Support is gratefully acknowledged from National Science Foundation (http://www.nsf.gov/) RUI grants MCB-1120558 and MCB-1329350 to Missouri Western State University (https://www.missouriwestern.edu/) and MCB-1120578 and MCB-1329351 to Davidson College, Howard Hughes Medical Institute (http://www.hhmi.org/) grants 52005120 and 52006292 to Davidson College, the Davidson Research Initiative and James G. Martin Genomics Program at Davidson College, and the Missouri Western State University Program of Research, Teaching, and Applied Learning (PORTAL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alper H, 2006, SCIENCE, V314, P1565, DOI 10.1126/science.1131969; Baumgardner Jordan, 2009, J Biol Eng, V3, P11, DOI 10.1186/1754-1611-3-11; Beisel CL, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000363; Boyle PM, 2012, METAB ENG, V14, P223, DOI 10.1016/j.ymben.2011.10.003; Brune KD, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00203; Cambray G, 2013, NUCLEIC ACIDS RES, V41, P5139, DOI 10.1093/nar/gkt163; Campbell AM, 2014, CBE-LIFE SCI EDUC, V13, P285, DOI 10.1187/cbe.13-09-0189; Ceres P, 2013, ACS SYNTH BIOL, V2, P463, DOI 10.1021/sb4000096; CLARK D, 1980, J BACTERIOL, V141, P177, DOI 10.1128/JB.141.1.177-183.1980; Dandekar AA, 2012, SCIENCE, V338, P264, DOI 10.1126/science.1227289; Desai SK, 2004, J AM CHEM SOC, V126, P13247, DOI 10.1021/ja048634j; Dietrich JA, 2013, ACS SYNTH BIOL, V2, P47, DOI 10.1021/sb300091d; Du J, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks549; Haynes Karmella A, 2008, J Biol Eng, V2, P8, DOI 10.1186/1754-1611-2-8; Kahl LJ, 2013, J BIOL ENG, V7, DOI 10.1186/1754-1611-7-13; Keasling JD, 2010, SCIENCE, V330, P1355, DOI 10.1126/science.1193990; Knight T., 2003, IDEMPOTENT VECTOR DE; Li YF, 2013, ACS SYNTH BIOL, V2, P651, DOI 10.1021/sb400051t; Michener JK, 2012, METAB ENG, V14, P306, DOI 10.1016/j.ymben.2012.04.004; MIT, 2013, REG STAND BIOL PARTS; Mitchell LA, 2013, ACS SYNTH BIOL, V2, P473, DOI 10.1021/sb300131w; Mutalik VK, 2013, NAT METHODS, V10, P354, DOI [10.1038/NMETH.2404, 10.1038/nmeth.2404]; Pearson B, 2011, IBC, V3, P10; Pfleger BF, 2006, NAT BIOTECHNOL, V24, P1027, DOI 10.1038/nbt1226; Poet JL., 2010, XRDS, V17, P10, DOI [10.1145/1836543.1836550, DOI 10.1145/1836543.1836550]; R Core Team, 2013, R PACK STAT COMP; Redding-Johanson AM, 2011, METAB ENG, V13, P194, DOI 10.1016/j.ymben.2010.12.005; Rodrigo G, 2013, ACS SYNTH BIOL, V2, P230, DOI 10.1021/sb300084h; Salis HM, 2011, METHOD ENZYMOL, V498, P19, DOI 10.1016/B978-0-12-385120-8.00002-4; Sawyer EM, 2012, INTERDISCIPLINARY BI, V4; Skulj M, 2008, MICROB CELL FACT, V7, DOI 10.1186/1475-2859-7-6; Spangler M, 2013, PHYSICIAN SPORTSMED, V41, P50, DOI 10.3810/psm.2013.09.2024; Spell J, 2013, GGAJET GOLDEN GATE A; Tafelmeyer P, 2004, CHEM BIOL, V11, P681, DOI 10.1016/j.chembiol.2004.02.026; Topp S, 2007, J AM CHEM SOC, V129, P6807, DOI 10.1021/ja0692480; Topp S, 2010, APPL ENVIRON MICROB, V76, P7881, DOI 10.1128/AEM.01537-10; Wachsmuth M, 2013, NUCLEIC ACIDS RES, V41, P2541, DOI 10.1093/nar/gks1330; Wang HH, 2009, NATURE, V460, P894, DOI 10.1038/nature08187; Weber E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019722; Werner S, 2012, BIOENGINEERED, V3, P38, DOI [10.4161/bbug.3.1.18223, 10.1371/journal.pone.0016765]; Wittmann A, 2012, FEBS LETT, V586, P2076, DOI 10.1016/j.febslet.2012.02.038; Yang J, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2404; Youk H, 2014, SCIENCE, V343, P628, DOI 10.1126/science.1242782; Zelcbuch L, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt151; Zhang Xueli, 2009, Sheng Wu Gong Cheng Xue Bao, V25, P1285	45	15	17	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2015	10	2							e0118322	10.1371/journal.pone.0118322	http://dx.doi.org/10.1371/journal.pone.0118322			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC2IM	25714374	Green Submitted, gold, Green Published			2022-12-27	WOS:000350168700064
J	Houssaye, A; Tafforeau, P; De Muizon, C; Gingerich, PD				Houssaye, Alexandra; Tafforeau, Paul; De Muizon, Christian; Gingerich, Philip D.			Transition of Eocene Whales from Land to Sea: Evidence from Bone Microstructure	PLOS ONE			English	Article							MIDDLE EOCENE; LOCOMOTOR EVOLUTION; PROTOCETID WHALE; LIFE-STYLE; CETACEA; ORIGIN; MAMMALIA; MICROANATOMY; ARCHAEOCETE; TERRESTRIAL	Cetacea are secondarily aquatic amniotes that underwent their land-to-sea transition during the Eocene. Primitive forms, called archaeocetes, include five families with distinct degrees of adaptation to an aquatic life, swimming mode and abilities that remain difficult to estimate. The lifestyle of early cetaceans is investigated by analysis of microanatomical features in postcranial elements of archaeocetes. We document the internal structure of long bones, ribs and vertebrae in fifteen specimens belonging to the three more derived archaeocete families-Remingtonocetidae, Protocetidae, and Basilosauridae-using microtomography and virtual thin-sectioning. This enables us to discuss the osseous specializations observed in these taxa and to comment on their possible swimming behavior. All these taxa display bone mass increase (BMI) in their ribs, which lack an open medullary cavity, and in their femora, whereas their vertebrae are essentially spongious. Humeri and femora show opposite trends in microanatomical specialization in the progressive independence of cetaceans from a terrestrial environment. Humeri change from very compact to spongious, which is in accordance with the progressive loss of propulsive role for the forelimbs, which were used instead for steering and stabilizing. Conversely, hind-limbs in basilosaurids became strongly reduced with no involvement in locomotion but display strong osteosclerosis in the femora. Our study confirms that Remingtonocetidae and Protocetidae were almost exclusively aquatic in locomotion for the taxa sampled, which probably were shallow water suspended swimmers. Basilosaurids display osseous specializations similar to those of modern cetaceans and are considered more active open-sea swimmers. This study highlights the strong need for homologous sections in comparative microanatomical studies, and the importance of combining information from several bones of the same taxon for improved functional interpretation.	[Houssaye, Alexandra] UMR 7179 CNRS Museum Natl Hist Nat, Dept Ecol & Gest Biodivers, Paris, France; [Houssaye, Alexandra] Univ Bonn, Steinmann Inst Geol Palaontol & Mineral, Bonn, Germany; [Tafforeau, Paul] European Synchrotron Radiat Facil, F-38043 Grenoble, France; [De Muizon, Christian] Univ Paris 06, Sorbonne Univ, CNRS CR2P, MNHN,Dept Hist Terre, Paris, France; [Gingerich, Philip D.] Univ Michigan, Dept Earth & Environm Sci, Ann Arbor, MI 48109 USA; [Gingerich, Philip D.] Univ Michigan, Museum Paleontol, Ann Arbor, MI 48109 USA	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Museum National d'Histoire Naturelle (MNHN); University of Bonn; European Synchrotron Radiation Facility (ESRF); Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; Sorbonne Universite; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Houssaye, A (corresponding author), UMR 7179 CNRS Museum Natl Hist Nat, Dept Ecol & Gest Biodivers, Paris, France.	houssaye@mnhn.fr	De Muizon, Christian/P-4335-2017; Gingerich, Philip D/A-6903-2008; Houssaye, Alexandra/J-5631-2015; De Muizon, Christian/Q-7986-2019	De Muizon, Christian/0000-0002-1247-8867; Gingerich, Philip D/0000-0002-1550-2674; De Muizon, Christian/0000-0002-1247-8867; Tafforeau, Paul/0000-0002-5962-1683	A. v. Humboldt Foundation; National Geographic Society; U. S. National Science Foundation; Institut Francais d'Etudes Andines (Lima, Peru);  [ANR-13-PDOC-001]	A. v. Humboldt Foundation(Alexander von Humboldt Foundation); National Geographic Society(National Geographic Society); U. S. National Science Foundation(National Science Foundation (NSF)); Institut Francais d'Etudes Andines (Lima, Peru); 	AH acknowledges financial support from the A. v. Humboldt Foundation and from the ANR-13-PDOC-001. Specimens from Pakistan and Egypt were collected with multiple grants from the National Geographic Society and the U. S. National Science Foundation. The holotype of Cynthiacetus peruvianus was collected with funds of the Institut Francais d'Etudes Andines (Lima, Peru). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amson E, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.0192; Andrews CW, 1904, GEOLOGICAL MAGAZINE, V1, P211, DOI DOI 10.1017/S0016756800119624; Andrews CW, 1906, DESCRIPTIVE CATALOGU, P1; Antar MS, 2010, J VERTEBRATE PALE S2, V30, p54A; Bajpai S, 2000, CURR SCI INDIA, V79, P1478; Bajpai S, 2009, J BIOSCIENCES, V34, P673, DOI 10.1007/s12038-009-0060-0; Bebej RM, 2012, J MAMM EVOL, V19, P77, DOI 10.1007/s10914-011-9184-8; Bianucci G, 2011, J VERTEBR PALEONTOL, V31, P1173, DOI 10.1080/02724634.2011.607985; Canoville A, 2010, BIOL J LINN SOC, V100, P384, DOI 10.1111/j.1095-8312.2010.01431.x; Carlson KJ, 2011, SCIENCE, V333, P1402, DOI 10.1126/science.1203922; Chappard D., 2008, Morphologie, V92, P162, DOI 10.1016/j.morpho.2008.10.003; Cooper LN, 2012, HIST BIOL, V24, P279, DOI 10.1080/08912963.2011.624184; Currey JD, 2003, J BIOMECH, V36, P1487, DOI 10.1016/S0021-9290(03)00124-6; de Buffrenil V., 1990, Journal of Vertebrate Paleontology, V10, P455; de Buffrenil V, 2008, J MORPHOL, V269, P533, DOI 10.1002/jmor.10604; de Buffrenil V, 2010, J MAMM EVOL, V17, P101, DOI 10.1007/s10914-010-9130-1; de Muizon C, 2009, CR PALEVOL, V8, P295, DOI 10.1016/j.crpv.2008.07.002; de Ricqles Armand, 2001, P289; Dumont M, 2013, J MORPHOL, V274, P570, DOI 10.1002/jmor.20122; Fordyce R. Ewan, 1998, Mainzer Naturwissenschaftliches Archiv Beiheft, V21, P161; Fraas E., 1904, GEOLOGISCHE PALAEONT, V6, P199; Francillon-Vieillot H., 1990, P471; Geisler JH, 2005, AM MUS NOVIT, P1, DOI 10.1206/0003-0082(2005)480[0001:ANPWCA]2.0.CO;2; GINGERICH PD, 1990, SCIENCE, V249, P154, DOI 10.1126/science.249.4965.154; Gingerich PD, 2003, PALEOBIOLOGY, V29, P429, DOI 10.1666/0094-8373(2003)029<0429:LTIEWE>2.0.CO;2; GINGERICH PD, 1983, SCIENCE, V220, P403, DOI 10.1126/science.220.4595.403; Gingerich PD, 2001, SCIENCE, V293, P2239, DOI 10.1126/science.1063902; GINGERICH PD, 1994, NATURE, V368, P844, DOI 10.1038/368844a0; Gingerich Philip D., 1995, Contributions from the Museum of Paleontology University of Michigan, V29, P291; Gingerich PD, 2014, J PALEONTOL, V88, P109, DOI 10.1666/13-040; Gingerich PD, 2012, P AM PHILOS SOC, V156, P309; Gingerich Philip D., 2010, P873; Gingerich Philip D., 2001, Contributions from the Museum of Paleontology University of Michigan, V30, P269; Gingerich PD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004366; Gol'din P, 2013, J PALEONTOL, V87, P254, DOI 10.1666/12-080R.1; Gray NM, 2007, ANAT REC, V290, P638, DOI 10.1002/ar.20533; Hayashi S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059146; Houssaye A, 2008, P 2 MOSASAUR M FORT, P81; Houssaye A, 2014, BIOL J LINN SOC, V112, P735, DOI 10.1111/bij.12311; Houssaye A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095637; Houssaye A, 2013, BIOL REV, V88, P117, DOI 10.1111/j.1469-185X.2012.00243.x; Houssaye A, 2012, LETHAIA, V45, P200, DOI 10.1111/j.1502-3931.2011.00273.x; Houssaye A, 2011, J VERTEBR PALEONTOL, V31, P2, DOI 10.1080/02724634.2011.539650; Houssaye A, 2009, INTEGR ZOOL, V4, P325, DOI 10.1111/j.1749-4877.2009.00146.x; Hulbert RC, 1998, J PALEONTOL, V72, P907, DOI 10.1017/S0022336000027232; Ibrahim N, 2014, SCIENCE, V345, P1613, DOI 10.1126/science.1258750; Kellogg AR., 1936, CARNEGIE I WASHINGTO, V482, P1; Klein N, CONTRIBUTIO IN PRESS; Klein N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011613; Laurin M, 2011, CR PALEVOL, V10, P381, DOI 10.1016/j.crpv.2011.02.003; Liu XS, 2009, J BIOMECH, V42, P249, DOI 10.1016/j.jbiomech.2008.10.035; Madar SI, 2007, J PALEONTOL, V81, P176, DOI 10.1666/0022-3360(2007)81[176:TPSOEE]2.0.CO;2; Madar SI, 1998, ADV VERT PALEOBIOL, P353; Martinez-Caceres M, 2011, CR PALEVOL, V10, P517, DOI 10.1016/j.crpv.2011.03.006; Nakajima Y, 2014, ACTA PALAEONTOL POL, V59, P343, DOI 10.4202/app.2012.0045; Roe LJ, 1998, ADV VERT PALEOBIOL, P399; Ruimerman R, 2005, ANN BIOMED ENG, V33, P71, DOI 10.1007/s10439-005-8964-9; Ruimerman R, 2005, J BIOMECH, V38, P931, DOI 10.1016/j.jbiomech.2004.03.037; Sahni A., 1975, Monographs of the Palaeontological Society of India, P1; Sanchez S, 2013, NAT PROTOC, V8, P1708, DOI 10.1038/nprot.2013.098; Spoor F, 2002, NATURE, V417, P163, DOI 10.1038/417163a; STEIN BR, 1989, J MAMMAL, V70, P467, DOI 10.2307/1381418; Tafforeau P, 2006, APPL PHYS A-MATER, V83, P195, DOI 10.1007/s00339-006-3507-2; Thewissen JGM, 2007, NATURE, V450, P1190, DOI 10.1038/nature06343; Thewissen J.G.M., 2009, Evolution Education and Outreach, V2, P272; Thewissen JGM, 2009, J PALEONTOL, V83, P635, DOI 10.1666/08-045.1; Thewissen JGM, 1997, PALEOBIOLOGY, V23, P482, DOI 10.1017/S0094837300019850; THEWISSEN JGM, 1994, SCIENCE, V263, P210, DOI 10.1126/science.263.5144.210; Thewissen JGM, 2002, ANNU REV ECOL SYST, V33, P73, DOI 10.1146/annurev.ecolsys.33.020602.095426; Thewissen JGM, 2001, NATURE, V413, P277, DOI 10.1038/35095005; Turner CH, 1998, BONE, V23, P399, DOI 10.1016/S8756-3282(98)00118-5; Uhen MD, 2008, J VERTEBR PALEONTOL, V28, P589, DOI 10.1671/0272-4634(2008)28[589:NPWFAA]2.0.CO;2; Uhen MD, 2014, MAR MAMMAL SCI, V30, P1029, DOI 10.1111/mms.12100; Uhen MD, 2011, J PALEONTOL, V85, P955, DOI 10.1666/10-162.1; Uhen MD, 2010, ANNU REV EARTH PL SC, V38, P189, DOI 10.1146/annurev-earth-040809-152453; Uhen MD., 2004, U MICHIGAN PAP PALEO, V34, P1	76	45	46	2	94	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2015	10	2							e0118409	10.1371/journal.pone.0118409	http://dx.doi.org/10.1371/journal.pone.0118409			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC2IM	25714394	Green Published, Green Submitted, gold			2022-12-27	WOS:000350168700073
J	Sheng, WL; Chen, WY; Yang, XL; Zhong, YM; Weng, SJ				Sheng, Wen-Long; Chen, Wei-Yi; Yang, Xiong-Li; Zhong, Yong-Mei; Weng, Shi-Jun			Co-Expression of Two Subtypes of Melatonin Receptor on Rat M1-Type Intrinsically Photosensitive Retinal Ganglion Cells	PLOS ONE			English	Article							MELANOPSIN MESSENGER-RNA; SUPRACHIASMATIC NUCLEUS; MAMMALIAN RETINA; CIRCADIAN CLOCK; MT2 MELATONIN; DIFFERENTIAL EXPRESSION; MT(1) MELATONIN; EYE DEVELOPMENT; LIGHT RESPONSE; AMACRINE CELLS	Intrinsically photosensitive retinal ganglion cells (ipRGCs) are involved in circadian and other non-image forming visual responses. An open question is whether the activity of these neurons may also be under the regulation mediated by the neurohormone melatonin. In the present work, by double-staining immunohistochemical technique, we studied the expression of MT1 and MT2, two known subtypes of mammalian melatonin receptors, in rat ipRGCs. A single subset of retinal ganglion cells labeled by the specific antibody against melanopsin exhibited the morphology typical of M1-type ipRGCs. Immunoreactivity for both MT1 and MT2 receptors was clearly seen in the cytoplasm of all labeled ipRGCs, indicating that these two receptors were co-expressed in each of these neurons. Furthermore, labeling for both the receptors were found in neonatal M1 cells as early as the day of birth. It is therefore highly plausible that retinal melatonin may directly modulate the activity of ipRGCs, thus regulating non-image forming visual functions.	[Sheng, Wen-Long; Chen, Wei-Yi; Yang, Xiong-Li; Zhong, Yong-Mei; Weng, Shi-Jun] Fudan Univ, Inst Neurobiol, Inst Brain Sci, State Key Lab Med Neurobiol, Shanghai 200433, Peoples R China; [Sheng, Wen-Long; Chen, Wei-Yi; Yang, Xiong-Li; Zhong, Yong-Mei; Weng, Shi-Jun] Fudan Univ, Collaborat Innovat Ctr Brain Sci, Shanghai 200433, Peoples R China	Fudan University; Fudan University	Zhong, YM (corresponding author), Fudan Univ, Inst Neurobiol, Inst Brain Sci, State Key Lab Med Neurobiol, Shanghai 200433, Peoples R China.	ymzhong@fudan.edu.cn; sjweng@fudan.edu.cn			National Program of Basic Research - Ministry of Science and Technology of China [2011CB504602]; National Natural Science Foundation of China [30930034, 31070967, 31171055, 31121061, 31100796]; ARVO/Pfizer Collaborative Research Fellowship(from the ARVO Foundation for Eye Research); National Program of Basic Research - Ministry of Science and Technology of China [2011CB504602]; National Natural Science Foundation of China [30930034, 31070967, 31171055, 31121061, 31100796]; ARVO/Pfizer Collaborative Research Fellowship(from the ARVO Foundation for Eye Research)	National Program of Basic Research - Ministry of Science and Technology of China(Ministry of Science and Technology, ChinaNational Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); ARVO/Pfizer Collaborative Research Fellowship(from the ARVO Foundation for Eye Research); National Program of Basic Research - Ministry of Science and Technology of China(Ministry of Science and Technology, ChinaNational Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); ARVO/Pfizer Collaborative Research Fellowship(from the ARVO Foundation for Eye Research)	This work was supported by grants from the National Program of Basic Research sponsored by the Ministry of Science and Technology of China (2011CB504602; http://www.most.gov.cn/eng/), the National Natural Science Foundation of China (30930034, 31070967, 31171055, 31121061, 31100796; http://www.nsfc.gov.cn/Portal0/default152.htm), and an ARVO/Pfizer Collaborative Research Fellowship to Shi-Jun Weng (from the ARVO Foundation for Eye Research; http://www.arvo.org/foundation/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn SK, 2012, AURIS NASUS LARYNX, V39, P479, DOI 10.1016/j.anl.2011.09.007; Baba K, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004302; Baba K, 2009, P NATL ACAD SCI USA, V106, P15043, DOI 10.1073/pnas.0904400106; Berson DM, 2010, J COMP NEUROL, V518, P2405, DOI 10.1002/cne.22381; Berson DM, 2002, SCIENCE, V295, P1070, DOI 10.1126/science.1067262; Blasic JR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045387; CAHILL GM, 1992, VISUAL NEUROSCI, V8, P487, DOI 10.1017/S0952523800005009; Cosci B, 1997, LIFE SCI, V60, P1885, DOI 10.1016/S0024-3205(97)00150-1; Delwig A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043787; Ecker JL, 2010, NEURON, V67, P49, DOI 10.1016/j.neuron.2010.05.023; Esquiva G, 2013, INVEST OPHTH VIS SCI, V54, P4605, DOI 10.1167/iovs.13-12120; Fischer TW, 2008, J PINEAL RES, V44, P397, DOI 10.1111/j.1600-079X.2007.00542.x; Fujieda H, 1999, NEUROSCIENCE, V93, P793, DOI 10.1016/S0306-4522(99)00111-6; Fujieda H, 2003, NEUROSCIENCE, V120, P301, DOI 10.1016/S0306-4522(03)00298-7; Fujieda H, 2000, VISUAL NEUROSCI, V17, P63, DOI 10.1017/S0952523800171068; Gerdin MJ, 2004, FASEB J, V18, P1646, DOI 10.1096/fj.03-1339com; Goz D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003153; Gonzalez-Menendez I, 2009, FRONT CELL NEUROSCI, V3, DOI 10.3389/neuro.03.003.2009; Gooley JJ, 2001, NAT NEUROSCI, V4, P1165, DOI 10.1038/nn768; Graham DM, 2008, J NEUROPHYSIOL, V99, P2522, DOI 10.1152/jn.01066.2007; Guler AD, 2008, NATURE, V453, P102, DOI 10.1038/nature06829; HAMM HE, 1980, P NATL ACAD SCI-BIOL, V77, P4998, DOI 10.1073/pnas.77.8.4998; Hannibal J, 2004, NEUROREPORT, V15, P2317, DOI 10.1097/00001756-200410250-00003; Hannibal J, 2013, EXP EYE RES, V106, P55, DOI 10.1016/j.exer.2012.11.006; Hannibal L, 2005, J MOL NEUROSCI, V27, P147, DOI 10.1385/JMN:27:02:147; Hatori M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002451; Hattar S, 2002, SCIENCE, V295, P1065, DOI 10.1126/science.1069609; Hattar S, 2006, J COMP NEUROL, V497, P326, DOI 10.1002/cne.20970; Huang H, 2013, PROG RETIN EYE RES, V32, P64, DOI 10.1016/j.preteyeres.2012.07.003; Hughes S, 2012, PROG BRAIN RES, V199, P19, DOI 10.1016/B978-0-444-59427-3.00002-2; Hunt AE, 2001, AM J PHYSIOL-CELL PH, V280, pC110, DOI 10.1152/ajpcell.2001.280.1.C110; Ingham ES, 2009, J COMP NEUROL, V516, P125, DOI 10.1002/cne.22103; Jimenez-Jorge S, 2007, J PINEAL RES, V42, P240, DOI 10.1111/j.1600-079X.2006.00411.x; Johnson J, 2010, P NATL ACAD SCI USA, V107, P17374, DOI 10.1073/pnas.1008533107; Kaur C, 2013, J PINEAL RES, V54, P190, DOI 10.1111/jpi.12016; Kirkby LA, 2013, P NATL ACAD SCI USA, V110, P12090, DOI 10.1073/pnas.1222150110; Klosen P, 2002, J HISTOCHEM CYTOCHEM, V50, P1647, DOI 10.1177/002215540205001209; Li RS, 2006, INVEST OPHTH VIS SCI, V47, P2951, DOI 10.1167/iovs.05-1295; Meyer P, 2002, BRIT J OPHTHALMOL, V86, P1053, DOI 10.1136/bjo.86.9.1053; Morin LP, 2003, J COMP NEUROL, V465, P401, DOI 10.1002/cne.10881; NAOI N, 1989, EXP EYE RES, V49, P573, DOI 10.1016/S0014-4835(89)80056-9; Pandi-Perumal SR, 2008, PROG NEUROBIOL, V85, P335, DOI 10.1016/j.pneurobio.2008.04.001; Peirson S, 2006, NEURON, V49, P331, DOI 10.1016/j.neuron.2006.01.006; Pfeffer M, 1998, NEUROSCI LETT, V248, P163, DOI 10.1016/S0304-3940(98)00356-5; Ping Y, 2008, J PHYSIOL-LONDON, V586, P2683, DOI 10.1113/jphysiol.2008.152959; Pires SS, 2009, J NEUROSCI, V29, P12332, DOI 10.1523/JNEUROSCI.2036-09.2009; Provencio I, 2002, NATURE, V415, P493, DOI 10.1038/415493a; Provencio I, 1998, P NATL ACAD SCI USA, V95, P340, DOI 10.1073/pnas.95.1.340; Rao S, 2013, NATURE, V494, P243, DOI 10.1038/nature11823; Renna JM, 2011, NAT NEUROSCI, V14, P827, DOI 10.1038/nn.2845; REPPERT SM, 1995, P NATL ACAD SCI USA, V92, P8734, DOI 10.1073/pnas.92.19.8734; REPPERT SM, 1994, NEURON, V13, P1177, DOI 10.1016/0896-6273(94)90055-8; Roy D, 2001, ENDOCRINOLOGY, V142, P4711, DOI 10.1210/en.142.11.4711; Sakamoto K, 2005, EUR J NEUROSCI, V22, P3129, DOI 10.1111/j.1460-9568.2005.04512.x; Sakamoto K, 2004, J NEUROSCI, V24, P9693, DOI 10.1523/JNEUROSCI.2556-04.2004; Sakamoto K, 2002, NEUROSCI LETT, V317, P53, DOI 10.1016/S0304-3940(01)02407-7; Sand A, 2012, PROG RETIN EYE RES, V31, P287, DOI 10.1016/j.preteyeres.2012.03.003; Savaskan E, 2002, J HISTOCHEM CYTOCHEM, V50, P519, DOI 10.1177/002215540205000408; Savaskan E, 2007, CURR ALZHEIMER RES, V4, P47, DOI 10.2174/156720507779939823; Scher J, 2003, EXP EYE RES, V77, P375, DOI 10.1016/S0014-4835(03)00123-4; Scher J, 2002, INVEST OPHTH VIS SCI, V43, P889; Sekaran S, 2005, CURR BIOL, V15, P1099, DOI 10.1016/j.cub.2005.05.053; Sengupta A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024483; Tarttelin EE, 2003, EXP EYE RES, V76, P393, DOI 10.1016/S0014-4835(02)00300-7; Tosini G, 1996, SCIENCE, V272, P419, DOI 10.1126/science.272.5260.419; Van den Top M, 2001, NEUROSCIENCE, V107, P99, DOI 10.1016/S0306-4522(01)00346-3; Van Hook MJ, 2012, EUR J NEUROSCI, V35, P507, DOI 10.1111/j.1460-9568.2011.07975.x; Wang Z, 2013, PHARMACOL RES, V76, P84, DOI 10.1016/j.phrs.2013.07.008; Weng SJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066480; Weng SJ, 2009, J BIOL RHYTHM, V24, P391, DOI 10.1177/0748730409343767; WIECHMANN AF, 1993, NEUROSCI LETT, V150, P207, DOI 10.1016/0304-3940(93)90537-U; Wiechmann AF, 2013, INT REV CEL MOL BIO, V300, P211, DOI 10.1016/B978-0-12-405210-9.00006-0; Wong KY, 2007, J PHYSIOL-LONDON, V582, P279, DOI 10.1113/jphysiol.2007.133751; Wu YH, 2006, J COMP NEUROL, V499, P897, DOI 10.1002/cne.21152; Wu YH, 2013, J AFFECT DISORDERS, V148, P357, DOI 10.1016/j.jad.2012.12.025; Xue T, 2011, NATURE, V479, P67, DOI 10.1038/nature10567; Yang XF, 2011, NEUROSCIENCE, V173, P19, DOI 10.1016/j.neuroscience.2010.11.028; Zele AJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017860; Zeman M, 2011, GEN COMP ENDOCR, V172, P23, DOI 10.1016/j.ygcen.2010.12.022; Zhang PP, 2012, NEUROSCIENCE, V220, P62, DOI 10.1016/j.neuroscience.2012.06.032; Zhao WJ, 2010, J PHYSIOL-LONDON, V588, P2605, DOI 10.1113/jphysiol.2010.187641	81	11	11	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2015	10	2							e0117967	10.1371/journal.pone.0117967	http://dx.doi.org/10.1371/journal.pone.0117967			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC2IM	25714375	Green Submitted, Green Published, gold			2022-12-27	WOS:000350168700046
J	Arriaran, S; Agnelli, S; Sabater, D; Remesar, X; Fernandez-Lopez, JA; Alemany, M				Arriaran, Sofia; Agnelli, Silvia; Sabater, David; Remesar, Xavier; Antonio Fernandez-Lopez, Jose; Alemany, Maria			Evidences of Basal Lactate Production in the Main White Adipose Tissue Sites of Rats. Effects of Sex and a Cafeteria Diet	PLOS ONE			English	Article							BLOOD-FLOW; NITRIC-OXIDE; INSULIN-RESISTANCE; METABOLIC SYNDROME; HUMAN ADIPOCYTES; SKELETAL-MUSCLE; GENE-EXPRESSION; CANCER-CELLS; ACID CYCLE; HYPOXIA	Female and male adult Wistar rats were fed standard chow or a simplified cafeteria diet for one month. Then, the rats were killed and the white adipose tissue (WAT) in four sites: perigonadal, retroperitoneal, mesenteric and subcutaneous (inguinal) were sampled and frozen. The complete WAT weight in each site was measured. Gene expression analysis of key lipid and glucose metabolism enzymes were analyzed, as well as tissue and plasma lactate and the activity of lactate dehydrogenase. Lactate gradients between WAT and plasma were estimated. The influence of sex and diet (and indirectly WAT mass) on lactate levels and their relationships with lactate dehydrogenase activity and gene expressions were also measured. A main conclusion is the high production of lactate by WAT, practically irrespective of site, diet or sex. Lactate production is a direct correlate of lactate dehydrogenase activity in the tissue. Furthermore, lactate dehydrogenase activity is again directly correlated with the expression of the genes Ldha and Ldhb for this enzyme. In sum, the ability to produce lactate by WAT is not directly dependent of WAT metabolic state. We postulate that, in WAT, a main function of the lactate dehydrogenase path may be that of converting excess available glucose to 3C fragments, as a way to limit tissue self-utilization as substrate, to help control glycaemia and/or providing short chain substrates for use as energy source elsewhere. More information must be gathered before a conclusive role of WAT in the control of glycaemia, and the full existence of a renewed glucose-lactate-fatty acid cycle is definitely established.	[Arriaran, Sofia; Agnelli, Silvia; Sabater, David; Remesar, Xavier; Antonio Fernandez-Lopez, Jose; Alemany, Maria] Univ Barcelona, Fac Biol, Dept Nutr & Food Sci, Barcelona, Spain; [Remesar, Xavier; Antonio Fernandez-Lopez, Jose; Alemany, Maria] Univ Barcelona, Inst Biomed, Barcelona, Spain; [Sabater, David; Remesar, Xavier; Antonio Fernandez-Lopez, Jose; Alemany, Maria] CIBER Obes & Nutr, Barcelona, Spain	University of Barcelona; University of Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN	Fernandez-Lopez, JA (corresponding author), Univ Barcelona, Fac Biol, Dept Nutr & Food Sci, Barcelona, Spain.	josfernandez@ub.edu	Remesar, Xavier/G-5703-2013; Alemany, Marià/H-5224-2011; López, José Antonio Fernández/C-5467-2017; Remesar, Xavier/L-4555-2019	Remesar, Xavier/0000-0002-9707-7287; Alemany, Marià/0000-0002-9783-8293; López, José Antonio Fernández/0000-0002-2856-7223; Remesar, Xavier/0000-0002-9707-7287; Arriaran, Sofia/0000-0003-2151-1232; Sabater Martinez, David/0000-0001-8113-8594	Plan Nacional de Investigacion en Biomedicina of the Government of Spain [SAF2012-34895]; Plan Nacional de Ciencia y Tecnologia de los Alimentos of the Government of Spain [AGL-2011-23635]; CIBER-OBN (Institute of Health Carlos III); Leonardo da Vinci fellowship; Catalan Government	Plan Nacional de Investigacion en Biomedicina of the Government of Spain(Spanish Government); Plan Nacional de Ciencia y Tecnologia de los Alimentos of the Government of Spain; CIBER-OBN (Institute of Health Carlos III); Leonardo da Vinci fellowship; Catalan Government	This study was done with the partial support of grants of the Plan Nacional de Investigacion en Biomedicina (SAF2012-34895) and the Plan Nacional de Ciencia y Tecnologia de los Alimentos (AGL-2011-23635) of the Government of Spain, as well as of CIBER-OBN (Institute of Health Carlos III). S. Agnelli was the recipient of a Leonardo da Vinci fellowship, and S. Arriaran a predoctoral fellowship of the Catalan Government, in both cases covering part of the time invested in this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alemany M, 2011, J ENDOCRINOL METAB, V1, P155, DOI 10.4021/jem52w; Alemany M, 2012, HORM-INT J ENDOCRINO, V11, P272, DOI 10.14310/horm.2002.1356; Alemany M, 2012, FREE RADICAL BIO MED, V52, P2108, DOI 10.1016/j.freeradbiomed.2012.03.003; Alemany M, 2011, J CLIN ENDOCR METAB, V96, P66, DOI 10.1210/jc.2010-2541; Alemany M, 2006, CURR NUTR FOOD SCI, V2, P141, DOI 10.2174/157340106776818817; Andersson J, 2012, INT J OBESITY, V36, P783, DOI 10.1038/ijo.2011.152; Ardilouze JL, 2004, CIRCULATION, V109, P47, DOI 10.1161/01.CIR.0000105681.70455.73; Bamias G, 2013, INFLAMM BOWEL DIS, V19, P2840, DOI 10.1097/01.MIB.0000435440.22484.e8; Bohr C, 1904, SKAND ARCH PHYSIOL, V16, P402, DOI 10.1111/j.1748-1716.1904.tb01382.x; Bourriaud C, 2005, J APPL MICROBIOL, V99, P201, DOI 10.1111/j.1365-2672.2005.02605.x; Choi CS, 2002, AM J PHYSIOL-ENDOC M, V283, pE233, DOI 10.1152/ajpendo.00557.2001; Cinti S, 2005, PROSTAG LEUKOTR ESS, V73, P9, DOI 10.1016/j.plefa.2005.04.010; Codoner-Franch P, 2011, ATHEROSCLEROSIS, V215, P475, DOI 10.1016/j.atherosclerosis.2010.12.035; Cori C F, 1981, Curr Top Cell Regul, V18, P377; CRANDALL DL, 1983, HORM METAB RES, V15, P326, DOI 10.1055/s-2007-1018710; DAVIDSON MB, 1993, AM J PHYSIOL, V264, pE18, DOI 10.1152/ajpendo.1993.264.1.E18; De Souza CT, 2005, ENDOCRINOLOGY, V146, P4192, DOI 10.1210/en.2004-1520; Romero MD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090995; DIGIROLAMO M, 1992, FASEB J, V6, P2405, DOI 10.1096/fasebj.6.7.1563593; DRINGEN R, 1993, BIOL CHEM H-S, V374, P343, DOI 10.1515/bchm3.1993.374.1-6.343; Ellmerer M, 1998, J CLIN ENDOCR METAB, V83, P4394, DOI 10.1210/jc.83.12.4394; FELIPE A, 1991, BIOCHEM J, V273, P195, DOI 10.1042/bj2730195; Ferrer-Lorente R, 2005, LIFE SCI, V77, P2051, DOI 10.1016/j.lfs.2005.04.008; FREMINET A, 1975, FEBS LETT, V60, P431, DOI 10.1016/0014-5793(75)80765-4; Fujisaka S, 2013, DIABETOLOGIA, V56, P1403, DOI 10.1007/s00125-013-2885-1; Gallagher D, 2005, AM J CLIN NUTR, V81, P903, DOI 10.1093/ajcn/81.4.903; GARDINER SM, 1990, HYPERTENSION, V15, P486, DOI 10.1161/01.HYP.15.5.486; Gibbs RA, 2004, NATURE, V428, P493, DOI 10.1038/nature02426; GRANATA AL, 1976, PFLUG ARCH EUR J PHY, V366, P247, DOI 10.1007/BF00585885; HAGSTROM E, 1990, AM J PHYSIOL, V258, pE888, DOI 10.1152/ajpendo.1990.258.5.E888; Heinonen I, 2014, CIRC J, V78, P1501, DOI 10.1253/circj.CJ-13-1273; Herschap B, 2011, INT J SURG PATHOL, V19, P190, DOI 10.1177/1066896910397611; Hodson L, 2013, DIABETES, V62, P1417, DOI 10.2337/db12-1032; Hosogai N, 2007, DIABETES, V56, P901, DOI 10.2337/db06-0911; LOPASCHUK GD, 1992, CARDIOVASC RES, V26, P1172, DOI 10.1093/cvr/26.12.1172; Lopez-Lazaro M, 2008, ANTI-CANCER AGENT ME, V8, P305, DOI 10.2174/187152008783961932; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MARTIN AD, 1994, INT J OBESITY, V18, P79; Mather KJ, 2004, DIABETES, V53, P2060, DOI 10.2337/diabetes.53.8.2060; Munoz S, 2010, DIABETOLOGIA, V53, P2417, DOI 10.1007/s00125-010-1840-7; NADALGINARD B, 1978, J BIOL CHEM, V253, P170; Nadra K, 2012, J NEUROCHEM, V123, P662, DOI 10.1111/j.1471-4159.2012.07896.x; O'Rourke RW, 2011, DIABETOLOGIA, V54, P1480, DOI 10.1007/s00125-011-2103-y; OHEA EK, 1969, J NUTR, V99, P338, DOI 10.1093/jn/99.3.338; Priego T, 2008, OBESITY, V16, P819, DOI 10.1038/oby.2007.117; RAFECAS I, 1992, INT J OBESITY, V16, P775; RANDLE PJ, 1963, LANCET, V1, P785; RAPOPORT TA, 1976, BIOCHEM J, V154, P449, DOI 10.1042/bj1540449; Ribiere C, 1996, BIOCHEM BIOPH RES CO, V222, P706, DOI 10.1006/bbrc.1996.0824; ROGNSTAD R, 1982, ARCH BIOCHEM BIOPHYS, V217, P498, DOI 10.1016/0003-9861(82)90530-6; Romero MD, 2007, NUTR METAB, V4, DOI 10.1186/1743-7075-4-26; ROSS BD, 1967, BIOCHEM J, V102, P942, DOI 10.1042/bj1020942; Sabater D, 2014, SCI REP-UK, V4, DOI 10.1038/srep03663; Saggerson ED, 1998, BIOCHEM J, V251, P701; SAHLIN K, 1989, J APPL PHYSIOL, V67, P2640, DOI 10.1152/jappl.1989.67.6.2640a; SCLAFANI A, 1976, PHYSIOL BEHAV, V17, P461, DOI 10.1016/0031-9384(76)90109-8; Slade JM, 2012, J DIABETES COMPLICAT, V26, P1, DOI 10.1016/j.jdiacomp.2011.11.001; Slawik M, 2007, GENES NUTR, V2, P41, DOI 10.1007/s12263-007-0014-9; SOLEY M, 1980, J BIOCHEM BIOPH METH, V2, P207, DOI 10.1016/0165-022X(80)90035-4; Stern-Straeter J, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-66; TAEGTMEYER H, 1980, BIOCHEM J, V186, P701, DOI 10.1042/bj1860701; Tamura Y, 2005, J CLIN ENDOCR METAB, V90, P3191, DOI 10.1210/jc.2004-1959; TANAKA K, 1983, EUR J APPL PHYSIOL O, V52, P51, DOI 10.1007/BF00429025; Taylor CT, 2014, BIOCHEM BIOPH RES CO, V447, P660, DOI 10.1016/j.bbrc.2014.04.062; Toda N, 2013, J CLIN PHARMACOL, V53, P1228, DOI 10.1002/jcph.179; Trayhurn P, 2004, BRIT J NUTR, V92, P347, DOI 10.1079/BJN20041213; van den Borst B, 2013, J APPL PHYSIOL, V114, P1619, DOI 10.1152/japplphysiol.00460.2012; Van der Merwe MT, 1998, J CLIN ENDOCR METAB, V83, P4084, DOI 10.1210/jc.83.11.4084; van Hall G, 2010, ACTA PHYSIOL, V199, P499, DOI 10.1111/j.1748-1716.2010.02122.x; Vassault A, 1984, METHODS ENZYM ANAL, V3, P118; VYTASEK R, 1982, ANAL BIOCHEM, V120, P243, DOI 10.1016/0003-2697(82)90342-6; Wang B, 2007, PFLUG ARCH EUR J PHY, V455, P479, DOI 10.1007/s00424-007-0301-8; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Zhang LY, 2010, BBA-MOL CELL BIOL L, V1801, P1, DOI 10.1016/j.bbalip.2009.09.014	74	29	30	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2015	10	3							e0119572	10.1371/journal.pone.0119572	http://dx.doi.org/10.1371/journal.pone.0119572			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9KG	25741703	Green Published, gold, Green Submitted			2022-12-27	WOS:000350688100122
J	Asakawa, S; Kishimoto, Y; Takano, T; Okita, K; Takakuwa, S; Sato, T; Hiratsuka, M; Takeuchi, O; Hirasawa, N				Asakawa, Sanki; Kishimoto, Yu; Takano, Takayuki; Okita, Kiyuki; Takakuwa, Shiho; Sato, Taiki; Hiratsuka, Masahiro; Takeuchi, Osamu; Hirasawa, Noriyasu			Nickel Ions Selectively Inhibit Lipopolysaccharide-Induced Interleukin-6 Production by Decreasing Its mRNA Stability	PLOS ONE			English	Article							INNATE IMMUNITY; KAPPA-B; RECEPTOR; INDUCTION; DIFFERENTIATION; EXPRESSION; PROMOTES; ALLERGY; COBALT; INFLAMMATION	Nickel (Ni) ions easily elute from many alloys and elicit inflammation and allergies. Previous studies have shown that infections due to the implantation of medical devices cause inflammation and enhance the elution of Ni ions (Ni2+). However, cross-talk between infection- and Ni2+-induced signaling pathways has not yet been elucidated in detail. In the present study, we investigated the effects of Ni2+ on the lipopolysaccharide (LPS)-induced production of cytokines in a LPS-induced air pouch-type inflammation model in BALB/c mice and the murine macrophage cell line RAW264. We demonstrated that Ni2+ inhibited the LPS-induced production of interleukin (IL)-6, but not that of tumor necrosis factor (TNF)-alpha both in vivo and in vitro. This inhibitory effect was also observed with cobalt ion (Co2+), but not with chloride ion (Cl-), zinc ion (Zn2+), or palladium ion (Pd2+), and was highly selective to the production of IL-6. Ni2+ did not inhibit the activation of ERK1/2, p38 MAPK, or JNK. Although Ni2+ decreased IL-6 mRNA levels, it failed to inhibit the LPS-induced activation of the IL-6 promoter. An experiment using actinomycin D, a transcription inhibitor, revealed that Ni2+ decreased the stability of IL-6 mRNA. Moreover, Ni2+ inhibited the LPS-induced expression of Arid5a, but not regnase-1. These results demonstrated that Ni2+ may have selectively inhibited the LPS-induced production of IL-6 by decreasing the Arid5a-dependent stabilization of IL-6 mRNA.	[Asakawa, Sanki; Kishimoto, Yu; Takano, Takayuki; Okita, Kiyuki; Takakuwa, Shiho; Sato, Taiki; Hiratsuka, Masahiro; Hirasawa, Noriyasu] Tohoku Univ, Grad Sch Pharmaceut Sci, Lab Pharmacotherapy Life Style Related Dis, Sendai, Miyagi 980, Japan; [Takeuchi, Osamu] Kyoto Univ, Inst Virus Res, Lab Infect & Prevent, Sakyo Ku, Kyoto 606, Japan	Tohoku University; Kyoto University	Hirasawa, N (corresponding author), Tohoku Univ, Grad Sch Pharmaceut Sci, Lab Pharmacotherapy Life Style Related Dis, Sendai, Miyagi 980, Japan.	hirasawa@m.tohoku.ac.jp	Takeuchi, Osamu/AAG-9359-2019; Hiratsuka, Masahiro/AAO-8082-2020	Takeuchi, Osamu/0000-0002-1260-6232; Hiratsuka, Masahiro/0000-0002-3767-7686; Hirasawa, Noriyasu/0000-0002-8062-4838	Frontier Research Institute for Interdisciplinary Science, Tohoku University; Japan Society for the Promotion of Science [25670034]; Japan Science Society [26-431]	Frontier Research Institute for Interdisciplinary Science, Tohoku University; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Japan Science Society	This study was supported in part by a grant from the Frontier Research Institute for Interdisciplinary Science, Tohoku University (http://www.fris.tohoku.ac.jp/fris/english/index.html) and a Grant-in-aid for Challenging Exploratory Research (25670034) from the Japan Society for the Promotion of Science (http://www.jsps.go.jp/j-grantsinaid/index.html). SA was supported by the Sasakawa Scientific Research Grant (26-431) from The Japan Science Society (http://www.jss.or.jp/ikusei/sasakawa/index.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albanesi C, 1999, J IMMUNOL, V162, P494; Antoine F, 2013, INT IMMUNOPHARMACOL, V17, P1101, DOI 10.1016/j.intimp.2013.09.024; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Beutler B, 2004, NATURE, V430, P257, DOI 10.1038/nature02761; Brant KA, 2009, TOXICOL SCI, V107, P227, DOI 10.1093/toxsci/kfn208; Brook M, 2000, FEBS LETT, V483, P57, DOI 10.1016/S0014-5793(00)02084-6; DENDORFER U, 1994, MOL CELL BIOL, V14, P4443, DOI 10.1128/MCB.14.7.4443; Diehl S, 2002, J EXP MED, V196, P39, DOI 10.1084/jem.20020026; Grabbe S, 1998, IMMUNOL TODAY, V19, P37, DOI 10.1016/S0167-5699(97)01186-9; Hallab N, 2001, J BONE JOINT SURG AM, V83A, P428, DOI 10.2106/00004623-200103000-00017; HEINRICH PC, 1990, BIOCHEM J, V265, P621, DOI 10.1042/bj2650621; Heiss K, 2005, PROTEOMICS, V5, P3614, DOI 10.1002/pmic.200401215; HIRANO T, 1985, P NATL ACAD SCI USA, V82, P5490, DOI 10.1073/pnas.82.16.5490; Ho IC, 1998, J EXP MED, V188, P1859, DOI 10.1084/jem.188.10.1859; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Iwasaki H, 2011, NAT IMMUNOL, V12, P1167, DOI 10.1038/ni.2137; Janeway CA, 2002, ANNU REV IMMUNOL, V20, P197, DOI 10.1146/annurev.immunol.20.083001.084359; Jones SA, 2011, J CLIN INVEST, V121, P3375, DOI 10.1172/JCI57158; Kamachi F, 2007, J PHARMACOL EXP THER, V321, P345, DOI 10.1124/jpet.106.116251; Kaplan DH, 2012, NAT REV IMMUNOL, V12, P114, DOI 10.1038/nri3150; Kasprzak KS, 2003, MUTAT RES-FUND MOL M, V533, P67, DOI 10.1016/j.mrfmmm.2003.08.021; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Kimura A, 2009, J EXP MED, V206, P2027, DOI 10.1084/jem.20090560; Kinbara M, 2011, BRIT J DERMATOL, V164, P356, DOI 10.1111/j.1365-2133.2010.10016.x; Klouche M, 1999, J IMMUNOL, V163, P4583; Kuroishi T, 2013, TOXICOL SCI, V135, P119, DOI 10.1093/toxsci/kft142; Larsen JM, 2009, J ALLERGY CLIN IMMUN, V123, P486, DOI 10.1016/j.jaci.2008.09.036; Masuda K, 2013, P NATL ACAD SCI USA, V110, P9409, DOI 10.1073/pnas.1307419110; Matsushita K, 2009, NATURE, V458, P1185, DOI 10.1038/nature07924; Medici S, 2013, MOLECULES, V18, P12396, DOI 10.3390/molecules181012396; Patsialou A, 2005, NUCLEIC ACIDS RES, V33, P66, DOI 10.1093/nar/gki145; Raghavan B, 2012, EMBO REP, V13, P1109, DOI 10.1038/embor.2012.155; Salnikow K, 2004, J BIOL CHEM, V279, P40337, DOI 10.1074/jbc.M403057200; Sato N, 2007, CLIN EXP ALLERGY, V37, P743, DOI 10.1111/j.1365-2222.2007.02705.x; Sauer I, 2006, BLOOD, V107, P4790, DOI 10.1182/blood-2005-07-3058; Schmidt M, 2010, NAT IMMUNOL, V11, P814, DOI 10.1038/ni.1919; Shawish HB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100933; Shionome T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068257; Sun XS, 2013, METALLOMICS, V5, P928, DOI 10.1039/c3mt00126a; Tanaka R, 2011, J DERMATOL SCI, V62, P50, DOI 10.1016/j.jdermsci.2010.12.006; Thierse HJ, 2005, TOXICOLOGY, V209, P101, DOI 10.1016/j.tox.2004.12.015; Thyssen JP, 2010, CONTACT DERMATITIS, V63, P151, DOI 10.1111/j.1600-0536.2010.01767.x; Thyssen JP, 2010, CHEM RES TOXICOL, V23, P309, DOI 10.1021/tx9002726; Van den Broeke LT, 1999, IMMUNOLOGY, V96, P578; Viemann D, 2007, J IMMUNOL, V178, P3198, DOI 10.4049/jimmunol.178.5.3198; Winzen R, 1999, EMBO J, V18, P4969, DOI 10.1093/emboj/18.18.4969; Zhou Huiping, 2007, Atherosclerosis, V195, pe134, DOI 10.1016/j.atherosclerosis.2007.04.008; Zimmerli W, 2004, NEW ENGL J MED, V351, P1645, DOI 10.1056/NEJMra040181	48	8	8	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2015	10	3							e0119428	10.1371/journal.pone.0119428	http://dx.doi.org/10.1371/journal.pone.0119428			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9KG	25742007	Green Published, Green Submitted, gold			2022-12-27	WOS:000350688100109
J	Armstead, AL; Minarchick, VC; Porter, DW; Nurkiewicz, TR; Li, BY				Armstead, Andrea L.; Minarchick, Valerie C.; Porter, Dale W.; Nurkiewicz, Timothy R.; Li, Bingyun			Acute Inflammatory Responses of Nanoparticles in an Intra-Tracheal Instillation Rat Model	PLOS ONE			English	Article							METAL LUNG-DISEASE; CERIUM DIOXIDE NANOPARTICLES; DUST WC-CO; HARD-METAL; IN-VITRO; TUNGSTEN CARBIDE; PARTICLE-SIZE; NITRIC-OXIDE; PULMONARY TOXICITY; INTRATRACHEAL INSTILLATION	Exposure to hard metal tungsten carbide cobalt (WC-Co) "dusts" in enclosed industrial environments is known to contribute to the development of hard metal lung disease and an increased risk for lung cancer. Currently, the influence of local and systemic inflammation on disease progression following WC-Co exposure remains unclear. To better understand the relationship between WC-Co nanoparticle (NP) exposure and its resultant effects, the acute local pulmonary and systemic inflammatory responses caused by WC-Co NPs were explored using an intra-tracheal instillation (IT) model and compared to those of CeO2 (another occupational hazard) NP exposure. Sprague-Dawley rats were given an IT dose (0-500 mu g per rat) of WC-Co or CeO2 NPs. Following 24-hr exposure, broncho-alveolar lavage fluid and whole blood were collected and analyzed. A consistent lack of acute local pulmonary inflammation was observed in terms of the broncho-alveolar lavage fluid parameters examined (i.e. LDH, albumin, and macrophage activation) in animals exposed to WCCo NP; however, significant acute pulmonary inflammation was observed in the CeO2 NP group. The lack of acute inflammation following WC-Co NP exposure contrasts with earlier in vivo reports regarding WC-Co toxicity in rats, illuminating the critical role of NP dose and exposure time and bringing into question the potential role of impurities in particle samples. Further, we demonstrated that WC-Co NP exposure does not induce acute systemic effects since no significant increase in circulating inflammatory cytokines were observed. Taken together, the results of this in vivo study illustrate the distinct differences in acute local pulmonary and systemic inflammatory responses to NPs composed of WC-Co and CeO2; therefore, it is important that the outcomes of pulmonary exposure to one type of NPs may not be implicitly extrapolated to other types of NPs.	[Armstead, Andrea L.; Li, Bingyun] W Virginia Univ, Sch Med, Dept Orthopaed, Biomat Bioengn & Nanotechnol Lab, Morgantown, WV 26506 USA; [Armstead, Andrea L.; Li, Bingyun] W Virginia Univ, Sch Pharm, Pharmaceut & Pharmacol Sci Grad Program, Morgantown, WV 26506 USA; [Minarchick, Valerie C.; Porter, Dale W.; Nurkiewicz, Timothy R.] W Virginia Univ, Sch Med, Dept Physiol & Pharmacol, Morgantown, WV USA; [Minarchick, Valerie C.; Nurkiewicz, Timothy R.] W Virginia Univ, Sch Med, Robert C Byrd Hlth Sci Ctr, Ctr Cardiovasc & Resp Sci, Morgantown, WV 26506 USA; [Porter, Dale W.; Nurkiewicz, Timothy R.; Li, Bingyun] NIOSH, Pathol & Physiol Res Branch, Hlth Effects Lab Div, Morgantown, WV USA; [Li, Bingyun] Mary Babb Randolph Canc Ctr, Morgantown, WV USA	West Virginia University; West Virginia University; West Virginia University; West Virginia University; Centers for Disease Control & Prevention - USA; National Institute for Occupational Safety & Health (NIOSH)	Li, BY (corresponding author), W Virginia Univ, Sch Med, Dept Orthopaed, Biomat Bioengn & Nanotechnol Lab, Morgantown, WV 26506 USA.	bili@hsc.wvu.edu		Li, Bingyun/0000-0002-5766-5666	American Foundation for Pharmaceutical Education (AFPE) Pre-Doctoral Fellowship in Pharmaceutical Sciences; West Virginia NANOSAFE graduate fellowship program [NSF-1003907]; West Virginia Higher Education Policy Commission Division of Science Research PUI Incubator program;  [R01-ES015022];  [DGE-1144676]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES015022] Funding Source: NIH RePORTER	American Foundation for Pharmaceutical Education (AFPE) Pre-Doctoral Fellowship in Pharmaceutical Sciences; West Virginia NANOSAFE graduate fellowship program; West Virginia Higher Education Policy Commission Division of Science Research PUI Incubator program; ; ; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	ALA acknowledges the American Foundation for Pharmaceutical Education (AFPE) Pre-Doctoral Fellowship in Pharmaceutical Sciences for support (2012-14). VCM acknowledges the West Virginia NANOSAFE graduate fellowship program (NSF-1003907) and TRN acknowledges NSF-1003907, R01-ES015022, and DGE-1144676 for financial support. BL acknowledges the support of the West Virginia Higher Education Policy Commission Division of Science Research PUI Incubator program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamis Z, 1997, ANN OCCUP HYG, V41, P515, DOI 10.1016/S0003-4878(97)00014-8; Albanese A, 2012, ANNU REV BIOMED ENG, V14, P1, DOI [10.1146/annurev-bioeng-071811-150124, 10.1146/annurev.bioeng-071811-150124]; ALLEN RC, 1977, INFECT IMMUN, V15, P828, DOI 10.1128/IAI.15.3.828-833.1977; Anard D, 1997, CARCINOGENESIS, V18, P177, DOI 10.1093/carcin/18.1.177; Antonini JM, 2000, IN VITRO MOL TOXICOL, V13, P5; Armstead AL, 2014, TOXICOL APPL PHARM, V278, P1, DOI 10.1016/j.taap.2014.04.008; BALMES JR, 1987, OCCUP MED, V2, P327; Bastian S, 2009, ENVIRON HEALTH PERSP, V117, P530, DOI 10.1289/ehp.0800121; Bernstein DM, 2004, INHAL TOXICOL, V16, P675, DOI 10.1080/08958370490476587; Blum JL, 2014, INHAL TOXICOL, V26, P48, DOI 10.3109/08958378.2013.851746; Borm PJA, 2004, INT J CANCER, V110, P3, DOI 10.1002/ijc.20064; Borm PYA, 2000, INHAL TOXICOL, V12, P1, DOI 10.1080/08958370050029725; Cassee FR, 2002, ARCH TOXICOL, V76, P277, DOI 10.1007/s00204-002-0344-8; Castranova V, 1998, ENVIRON HEALTH PERSP, V106, P1165, DOI 10.2307/3433980; Castranova V, 2011, J OCCUP ENVIRON MED, V53, pS14, DOI 10.1097/JOM.0b013e31821b1e5a; Cattaneo AG, 2010, J APPL TOXICOL, V30, P730, DOI 10.1002/jat.1609; Courbiere B, 2013, INT J MOL SCI, V14, P21613, DOI 10.3390/ijms141121613; CUGELL DW, 1992, CLIN CHEST MED, V13, P269; De Boeck M, 2003, CARCINOGENESIS, V24, P1793, DOI 10.1093/carcin/bgg146; De Boeck M, 2003, MUTAGENESIS, V18, P177, DOI 10.1093/mutage/18.2.177; Donaldson K, 2013, ACCOUNTS CHEM RES, V46, P723, DOI 10.1021/ar300092y; Du ZJ, 2013, CARDIOVASC TOXICOL, V13, P194, DOI 10.1007/s12012-013-9198-y; DULIN AM, 1982, J DAIRY SCI, V65, P1247, DOI 10.3168/jds.S0022-0302(82)82337-0; Dunlop P, 2005, J THORAC IMAG, V20, P301, DOI 10.1097/01.rti.0000181523.87391.a9; EDEL J, 1990, SCI TOTAL ENVIRON, V95, P107, DOI 10.1016/0048-9697(90)90056-Z; Fedan JS, 2001, TOXICOL APPL PHARM, V174, P199, DOI 10.1006/taap.2001.9205; Gaiser BK, 2012, ENVIRON TOXICOL CHEM, V31, P144, DOI 10.1002/etc.703; Gaiser BK, 2009, ENVIRON HEALTH-GLOB, V8, DOI 10.1186/1476-069X-8-S1-S2; Geiser M, 2002, MICROSC RES TECHNIQ, V57, P512, DOI 10.1002/jemt.10105; Geraets L, 2012, TOXICOL SCI, V127, P463, DOI 10.1093/toxsci/kfs113; Guadagnini R, 2013, NANOTOXICOLOGY, DOI [10.3109/17435390.17432013.17829590, DOI 10.3109/17435390.17432013.17829590]; Gustafsson A, 2011, J IMMUNOTOXICOL, V8, P111, DOI 10.3109/1547691X.2010.546382; Haberl N, 2013, BEILSTEIN J NANOTECH, V4, P933, DOI 10.3762/bjnano.4.105; He XA, 2010, NANOTECHNOLOGY, V21, DOI 10.1088/0957-4484/21/28/285103; HENDERSON RF, 1995, FUND APPL TOXICOL, V24, P183, DOI 10.1006/faat.1995.1022; HUAUX F, 1995, TOXICOL APPL PHARM, V132, P53, DOI 10.1006/taap.1995.1086; Hubbs AF, 2011, TOXICOL PATHOL, V39, P301, DOI 10.1177/0192623310390705; Hussain S, 2012, ACS NANO, V6, P5820, DOI 10.1021/nn302235u; KERFOOT EJ, 1975, AM IND HYG ASSOC J, V36, P17, DOI 10.1080/0002889758507202; Kim KP, 2006, HEALTH PHYS, V91, P58, DOI 10.1097/01.HP.0000200261.96014.6c; KITAMURA H, 1980, ACTA PATHOL JAPON, V30, P241; Knaapen AM, 2004, INT J CANCER, V109, P799, DOI 10.1002/ijc.11708; Knuckles TL, 2012, NANOTOXICOLOGY, V6, P724, DOI 10.3109/17435390.2011.606926; Kraus T, 2001, OCCUP ENVIRON MED, V58, P631, DOI 10.1136/oem.58.10.631; LASFARGUES G, 1992, TOXICOL APPL PHARM, V112, P41, DOI 10.1016/0041-008X(92)90277-Y; Lasfargues G, 1995, ENVIRON RES, V69, P108, DOI 10.1006/enrs.1995.1032; LeBlanc AJ, 2010, CARDIOVASC TOXICOL, V10, P27, DOI 10.1007/s12012-009-9060-4; Li JJ, 2010, EXP BIOL MED, V235, P1025, DOI 10.1258/ebm.2010.010021; LISON D, 1992, TOXICOL LETT, V60, P203, DOI 10.1016/0378-4274(92)90275-O; LISON D, 1990, ENVIRON RES, V52, P187, DOI 10.1016/S0013-9351(05)80253-1; LISON D, 1993, ARCH TOXICOL, V67, P347, DOI 10.1007/BF01973706; Lombaert N, 2004, TOXICOL LETT, V154, P23, DOI 10.1016/j.toxlet.2004.06.009; Lombaert N, 2008, TOXICOL APPL PHARM, V227, P299, DOI 10.1016/j.taap.2007.11.002; Ma JY, 2011, NANOTOXICOLOGY, V5, P312, DOI 10.3109/17435390.2010.519835; McKinney W, 2012, INHAL TOXICOL, V24, P447, DOI 10.3109/08958378.2012.685111; Minarchick VC, 2013, CARDIOVASC TOXICOL, V13, P323, DOI 10.1007/s12012-013-9213-3; Miyata R, 2011, TOXICOL APPL PHARM, V257, P209, DOI 10.1016/j.taap.2011.09.007; Moriyama H, 2007, AM J RESP CRIT CARE, V176, P70, DOI 10.1164/rccm.200601-134OC; Muhlfeld C, 2008, AM J PHYSIOL-LUNG C, V294, pL817, DOI 10.1152/ajplung.00442.2007; Naqvi AH, 2008, ARCH ENVIRON OCCUP H, V63, P51, DOI 10.3200/AEOH.63.2.51-70; Nel A, 2006, SCIENCE, V311, P622, DOI 10.1126/science.1114397; Nemery B, 2001, SEMIN RESP CRIT CARE, V22, P435, DOI 10.1055/s-2001-17386; Nemery B, 2007, AM J RESP CRIT CARE, V176, P2, DOI 10.1164/rccm.200704-527ED; Nurkiewicz Timothy R, 2011, Res Rep Health Eff Inst, P3; Nurkiewicz TR, 2009, TOXICOL SCI, V110, P191, DOI 10.1093/toxsci/kfp051; Nurkiewicz TR, 2006, ENVIRON HEALTH PERSP, V114, P412, DOI 10.1289/ehp.8413; Nurkiewicz TR, 2004, ENVIRON HEALTH PERSP, V112, P1299, DOI 10.1289/ehp.7001; Pauluhn J, 2012, J APPL TOXICOL, V32, P488, DOI 10.1002/jat.1668; Pauluhn J, 2011, INHAL TOXICOL, V23, P763, DOI 10.3109/08958378.2011.606431; Porter DW, 2007, TOXICOL PATHOL, V35, P702, DOI 10.1080/01926230701481915; Porter DW, 2010, TOXICOLOGY, V269, P136, DOI 10.1016/j.tox.2009.10.017; Porter DW, 2006, TOXICOL SCI, V90, P188, DOI 10.1093/toxsci/kfj075; Rengasamy A, 1999, TOXICOL APPL PHARM, V157, P178, DOI 10.1006/taap.1999.8668; Renwick LC, 2004, OCCUP ENVIRON MED, V61, P442, DOI 10.1136/oem.2003.008227; Roesems G, 2000, TOXICOL APPL PHARM, V162, P2, DOI 10.1006/taap.1999.8824; Schrand AM, 2012, ADV EXP MED BIOL, V745, P58, DOI 10.1007/978-1-4614-3055-1_5; Seale-Goldsmith MM, 2009, WIRES NANOMED NANOBI, V1, P553, DOI 10.1002/wnan.49; Silva RM, 2013, J TOXICOL ENV HEAL A, V76, P953, DOI 10.1080/15287394.2013.826567; SJOGREN I, 1980, THORAX, V35, P653, DOI 10.1136/thx.35.9.653; Song YG, 2011, TOXICOL PATHOL, V39, P841, DOI 10.1177/0192623311413787; Srimok B, 2011, RADIAT PROT DOSIM, V147, P439, DOI 10.1093/rpd/ncq488; Stapleton PA, 2012, MICROCIRCULATION, V19, P126, DOI 10.1111/j.1549-8719.2011.00137.x; Stefaniak AB, 2007, IND HEALTH, V45, P793, DOI 10.2486/indhealth.45.793; Stefaniak AB, 2009, J EXPO SCI ENV EPID, V19, P475, DOI 10.1038/jes.2008.37; Tada Y, 2012, J TOXICOL PATHOL, V25, P233, DOI 10.1293/tox.25.233; Toya T, 2010, IND HEALTH, V48, P3, DOI 10.2486/indhealth.48.3; Verstraelen S, 2014, TOXICOL LETT, V228, P157, DOI 10.1016/j.toxlet.2014.05.006; Warheit DB, 2010, ANAL BIOANAL CHEM, V398, P607, DOI 10.1007/s00216-010-4000-5; Yao Z., 1998, METAL POWDER REP, V53, P26, DOI [10.1016/S0026-0657(97)89643-9, DOI 10.1016/S0026-0657(97)89643-9]; Zhang XD, 2010, J ENVIRON PATHOL TOX, V29, P31, DOI 10.1615/JEnvironPatholToxicolOncol.v29.i1.60; Zhou XY, 2013, J NANOSCI NANOTECHNO, V13, P204, DOI 10.1166/jnn.2013.6788; Zhu MT, 2009, TOXICOL SCI, V107, P342, DOI 10.1093/toxsci/kfn245	92	15	16	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2015	10	3							e0118778	10.1371/journal.pone.0118778	http://dx.doi.org/10.1371/journal.pone.0118778			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9JM	25738830	Green Published, gold, Green Submitted			2022-12-27	WOS:000350685900069
J	Houkamau, CA; Sibley, CG				Houkamau, Carla A.; Sibley, Chris G.			Looking Maori Predicts Decreased Rates of Home Ownership: Institutional Racism in Housing Based on Perceived Appearance	PLOS ONE			English	Article							MULTIDIMENSIONAL MODEL; NEW-ZEALAND; HEALTH; DEPRIVATION; STEREOTYPICALITY; DISCRIMINATION; ETHNICITY; AMERICAN; IDENTITY; BLACK	This study examined differences in rates of home ownership among Maori (the indigenous peoples of New Zealand). We identified systematic factors that predicted why some Maori were more likely to own their own home (partially or fully) relative to other Maori. Data were drawn from a large national postal sample of 561 self-identified Maori collected as part of the New Zealand Attitudes and Values Study. As predicted, our analyses indicated that self-reported appearance as Maori, or the extent to which people thought they personally displayed features which visibly identified them as Maori to others, significantly predicted decreased rates of home ownership. This association held when adjusting for numerous demographic covariates, such as education, level of deprivation of the immediate area, household income, age, relationship status, region of residence, and so forth. Our analyses suggest there is, or at least has been in the recent past, institutional racism against Maori in New Zealand's home lending industry based on merely appearing more Maori.	[Houkamau, Carla A.; Sibley, Chris G.] Univ Auckland, Auckland 1, New Zealand	University of Auckland	Houkamau, CA (corresponding author), Univ Auckland, Auckland 1, New Zealand.	c.houkamau@auckland.ac.nz	Sibley, Chris G/D-2974-2009	Sibley, Chris G/0000-0002-4064-8800; Houkamau, Carla/0000-0002-3449-3726	Te Whare Kura New Knowledge Acquisition Grant [03903/1550]; Templeton World Charity Foundation Grant [0077]	Te Whare Kura New Knowledge Acquisition Grant; Templeton World Charity Foundation Grant(Templeton World Charity Foundation)	This research was supported by a Te Whare Kura New Knowledge Acquisition Grant (#03903/1550) and a Templeton World Charity Foundation Grant (ID: 0077). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2009, RACE ETHNICITY MULTI, DOI DOI 10.1353/RAC.0.0027; [Anonymous], SOCIAL INEQUALITIES; Bierre S, 2007, SOC POLICY J N Z, P42; Blair IV, 2002, J PERS SOC PSYCHOL, V83, P5, DOI 10.1037/0022-3514.83.1.5; Chapple S, 1998, TIME SERIES ANAL DIS; Crampton P, 2000, HEALTH EDUC BEHAV, V27, P317, DOI 10.1177/109019810002700306; Eberhardt JL, 2006, PSYCHOL SCI, V17, P383, DOI 10.1111/j.1467-9280.2006.01716.x; Eberhardt JL, 2004, J PERS SOC PSYCHOL, V87, P876, DOI 10.1037/0022-3514.87.6.876; Fink JW, 2011, NEW ZEAL MED J, V124, P52; Flynn M, 2010, MAORI HOUSING TRENDS; Harris R, 2006, LANCET, V367, P2005, DOI 10.1016/S0140-6736(06)68890-9; Harris RB, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-844; Health Utilisation Research Alliance (HURA), 2006, J Health Serv Res Policy, V11, P141, DOI 10.1258/135581906777641721; Hebl MR, 2012, J EXP SOC PSYCHOL, V48, P1329, DOI 10.1016/j.jesp.2012.05.019; Houkamau CA, 2014, SOC INDIC R IN PRESS; Houkamau CA, 2010, NEW ZEAL J PSYCHOL, V39, P8; Houkamau CA, 2011, SOC INDIC RES, V103, P379, DOI 10.1007/s11205-010-9705-5; Jackson M, 1989, MAORI CRIMINAL JUSTI; JUDD CM, 1995, J PERS SOC PSYCHOL, V69, P460, DOI 10.1037/0022-3514.69.3.460; MacDonald J, 1986, RACISM RENTAL ACCOMM; Maori Economic Development Panel, 2012, MAOR EC DEV PAN DISC; Mitchell EA, 2000, SOC SCI MED, V51, P147, DOI 10.1016/S0277-9536(99)00415-3; Moewaka-Barnes A, 2013, MAI J, V2, P63; Nana G, 2011, MAOR EC SCI INN POT; Ogletree Charles J., 2006, LYNCH MOBS KILLING S; Salmond C., 2007, NZDEP2006 INDEX DEPR; Salmond CE, 2012, CAN J PUBLIC HEALTH, V103, pS7; Sibley CG, 2013, CULT DIVERS ETHN MIN, V19, P97, DOI 10.1037/a0031113; Sidanius J, 1999, SOCIAL DOMINANCE AN; Statistics New Zealand, 2014, MAJ ETHN GROUPS NZ I; Statistics New Zealand, 2012, DEM TRENDS 2012 GLOS; Statistics New Zealand, 2012, ETHN CROWD DET EX CR; Statistics New Zealand, 2014, 2013 CENS QUICK STAT; Te Puni Kokiri, 2000, PROGR CLOS SOC EC GA; Tonry M, 2010, CRIME JUSTICE, V39, P273, DOI 10.1086/653045; Turner H, 2013, THESIS U AUCKLAND; Waldegrave C, 2006, MAORI HOUSING EXPERI; Walker R., 1990, KA WHAWAHI TONU MATO; Walker R, 1990, LINES RACISM NZ; White P, 2008, ATLAS SOCIOECONOMIC; Workman Kim, 2011, JUST ROUND C U WAIK, P18	41	26	26	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2015	10	3							e0118540	10.1371/journal.pone.0118540	http://dx.doi.org/10.1371/journal.pone.0118540			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CC9JM	25738961	Green Published, Green Submitted, gold			2022-12-27	WOS:000350685900044
J	Kijani, S; Yrlid, U; Heyden, M; Levin, M; Boren, J; Fogelstrand, P				Kijani, Siavash; Yrlid, Ulf; Heyden, Maria; Levin, Malin; Boren, Jan; Fogelstrand, Per			Filter-Dense Multicolor Microscopy	PLOS ONE			English	Article							CELLS; FLUORESCENCE; MACROPHAGES; DISTINCT	Immunofluorescence microscopy is a unique method to reveal the spatial location of proteins in tissues and cells. By combining antibodies that are labeled with different fluorochromes, the location of several proteins can simultaneously be visualized in one sample. However, because of the risk of bleed-through signals between fluorochromes, standard multicolor microscopy is restricted to a maximum of four fluorescence channels, including one for nuclei staining. This is not always enough to address common scientific questions. In particular, the use of a rapidly increasing number of marker proteins to classify functionally distinct cell populations and diseased tissues emphasizes the need for more complex multistainings. Hence, multicolor microscopy should ideally offer more channels to meet the current needs in biomedical science. Here we present an enhanced multi-fluorescence setup, which we call Filter-Dense Multicolor Microscopy (FDMM). FDMM is based on condensed filter sets that are more specific for each fluorochrome and allow a more economic use of the light spectrum. FDMM allows at least six independent fluorescence channels and can be applied to any standard fluorescence microscope without changing any operative procedures for the user. In the present study, we demonstrate an FDMM setup of six channels that includes the most commonly used fluorochromes for histology. We show that the FDMM setup is specific and robust, and we apply the technique on typical biological questions that require more than four fluorescence microscope channels.	[Kijani, Siavash; Heyden, Maria; Levin, Malin; Boren, Jan; Fogelstrand, Per] Univ Gothenburg, Dept Mol & Clin Med, Wallenberg Lab, Gothenburg, Sweden; [Yrlid, Ulf] Univ Gothenburg, Mucosal Immunobiol & Vaccine Ctr MIVAC, Inst Biomed, Dept Microbiol & Immunol, Gothenburg, Sweden	University of Gothenburg; University of Gothenburg	Fogelstrand, P (corresponding author), Univ Gothenburg, Dept Mol & Clin Med, Wallenberg Lab, Gothenburg, Sweden.	perf@wlab.gu.se	yrlid, ulf/AAR-4416-2020	Levin, Malin/0000-0003-1069-5275	Swedish Research Council [A0282301, A0282302]; Swedish Heart and Lung Foundation [20120262]; Sahlgrenska University Hospital ALF research grants [LUA 70270]; Novo Nordisk Fonden [NNF14OC0010799] Funding Source: researchfish	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Heart and Lung Foundation(Swedish Heart-Lung Foundation); Sahlgrenska University Hospital ALF research grants; Novo Nordisk Fonden(Novo Nordisk Foundation)	The work was supported by grants from the Swedish Research Council (A0282301 and A0282302), the Swedish Heart and Lung Foundation (20120262), and the Sahlgrenska University Hospital ALF research grants (LUA 70270). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balluff B, 2011, AM J PATHOL, V179, P2720, DOI 10.1016/j.ajpath.2011.08.032; Chattopadhyay PK, 2012, CYTOM PART A, V81A, P456, DOI 10.1002/cyto.a.22043; Choi JH, 2011, IMMUNITY, V35, P819, DOI 10.1016/j.immuni.2011.09.014; Duffield JS, 2005, J CLIN INVEST, V115, P56, DOI 10.1172/JCI200522675; Fogelstrand P, 2009, J EXP MED, V206, P2397, DOI 10.1084/jem.20082845; Geginat J, 2013, SEMIN IMMUNOL, V25, P252, DOI 10.1016/j.smim.2013.10.012; Hansson GK, 2011, NAT IMMUNOL, V12, P204, DOI 10.1038/ni.2001; Hristov M, 2011, THROMB HAEMOSTASIS, V106, P757, DOI 10.1160/TH11-07-0500; Lichtman JW, 2005, NAT METHODS, V2, P910, DOI 10.1038/NMETH817; Linterman MA, 2011, NAT MED, V17, P975, DOI 10.1038/nm.2425; Liu NQ, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/djt376; Ma B, 2006, ACTA HISTOCHEM, V108, P243, DOI 10.1016/j.acthis.2006.02.002; Mildner A, 2014, IMMUNITY, V40, P642, DOI 10.1016/j.immuni.2014.04.016; Moore KJ, 2013, NAT REV IMMUNOL, V13, P709, DOI 10.1038/nri3520; Natkunam Y, 2007, HEMATOLOGY, V1, P210, DOI DOI 10.1182/ASHEDUCATI0N-2007.1.210; Niki H, 2004, J IMMUNOL METHODS, V293, P143, DOI 10.1016/j.jim.2004.07.009; Panchuk-Voloshina N, 1999, J HISTOCHEM CYTOCHEM, V47, P1179, DOI 10.1177/002215549904700910; Paulson KE, 2010, CIRC RES, V106, P383, DOI 10.1161/CIRCRESAHA.109.210781; Proietto AI, 2008, IMMUNOL CELL BIOL, V86, P700, DOI 10.1038/icb.2008.63; Resch-Genger U, 2008, NAT METHODS, V5, P763, DOI [10.1038/nmeth.1248, 10.1038/NMETH.1248]; Schieker M, 2007, J ANAT, V210, P592, DOI 10.1111/j.1469-7580.2007.00716.x; Tkachuk M, 1998, J EXP MED, V187, P469, DOI 10.1084/jem.187.4.469; Tsurui H, 2000, J HISTOCHEM CYTOCHEM, V48, P653, DOI 10.1177/002215540004800509; Uhl Rainer, 2012, Cold Spring Harb Protoc, V2012, P931, DOI 10.1101/pdb.top071001	24	11	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2015	10	3							e0119499	10.1371/journal.pone.0119499	http://dx.doi.org/10.1371/journal.pone.0119499			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9JM	25739088	Green Published, gold, Green Submitted			2022-12-27	WOS:000350685900108
J	Pinheiro, HT; Mazzei, E; Moura, RL; Amado, GM; Carvalho, A; Braga, AC; Costa, PAS; Ferreira, BP; Ferreira, CEL; Floeter, SR; Francini, RB; Gasparini, JL; Macieira, RM; Martins, AS; Olavo, G; Pimentel, CR; Rocha, LA; Sazima, I; Simon, T; Teixeira, JB; Xavier, LB; Joyeux, JC				Pinheiro, Hudson T.; Mazzei, Eric; Moura, Rodrigo L.; Amado-Filho, Gilberto M.; Carvalho-Filho, Alfredo; Braga, Adriana C.; Costa, Paulo A. S.; Ferreira, Beatrice P.; Ferreira, Carlos Eduardo L.; Floeter, Sergio R.; Francini-Filho, Ronaldo B.; Gasparini, Joao Luiz; Macieira, Raphael M.; Martins, Agnaldo S.; Olavo, George; Pimentel, Caio R.; Rocha, Luiz A.; Sazima, Ivan; Simon, Thiony; Teixeira, Joao Batista; Xavier, Lucas B.; Joyeux, Jean-Christophe			Fish Biodiversity of the Vitoria-Trindade Seamount Chain, Southwestern Atlantic: An Updated Database	PLOS ONE			English	Article							REEF-FISH; SHORE FISHES; DISTRIBUTION PATTERNS; COMMUNITY STRUCTURE; MIDOCEAN RIDGE; SOUTH ATLANTIC; BRAZIL BASIN; ASSEMBLAGES; ISLANDS; OCEAN	Despite a strong increase in research on seamounts and oceanic islands ecology and biogeography, many basic aspects of their biodiversity are still unknown. In the southwestern Atlantic, the Vitoria-Trindade Seamount Chain (VTC) extends ca. 1,200 km offshore the Brazilian continental shelf, from the Vitoria seamount to the oceanic islands of Trindade and Martin Vaz. For a long time, most of the biological information available regarded its islands. Our study presents and analyzes an extensive database on the VTC fish biodiversity, built on data compiled from literature and recent scientific expeditions that assessed both shallow to mesophotic environments. A total of 273 species were recorded, 211 of which occur on seamounts and 173 at the islands. New records for seamounts or islands include 191 reef fish species and 64 depth range extensions. The structure of fish assemblages was similar between islands and seamounts, not differing in species geographic distribution, trophic composition, or spawning strategies. Main differences were related to endemism, higher at the islands, and to the number of endangered species, higher at the seamounts. Since unregulated fishing activities are common in the region, and mining activities are expected to drastically increase in the near future (carbonates on seamount summits and metals on slopes), this unique biodiversity needs urgent attention and management.	[Pinheiro, Hudson T.; Gasparini, Joao Luiz; Martins, Agnaldo S.; Pimentel, Caio R.; Simon, Thiony; Xavier, Lucas B.; Joyeux, Jean-Christophe] Univ Fed Espirito Santo, Dept Oceanog & Ecol, Vitoria, ES, Brazil; [Mazzei, Eric; Teixeira, Joao Batista] Univ Estadual Santa Cruz, Programa Posgrad Ecol & Conservacao Biodiversidad, Ilheus, BA, Brazil; [Moura, Rodrigo L.] Univ Fed Rio de Janeiro, Inst Biol, BR-21941 Rio De Janeiro, RJ, Brazil; [Moura, Rodrigo L.] Univ Fed Rio de Janeiro, SAGE COPPE, BR-21941 Rio De Janeiro, RJ, Brazil; [Amado-Filho, Gilberto M.] Inst Pesquisas Jardim Bot Rio de Janeiro, Rio De Janeiro, RJ, Brazil; [Carvalho-Filho, Alfredo] Fish Bizz Ltda, Sao Paulo, Brazil; [Braga, Adriana C.; Costa, Paulo A. S.] Univ Fed Estado Rio de Janeiro, Dept Ecol & Recursos Marinhos, Rio De Janeiro, RJ, Brazil; [Ferreira, Beatrice P.] Univ Fed Pernambuco, Dept Oceanog, Recife, PE, Brazil; [Ferreira, Carlos Eduardo L.] Univ Fed Fluminense, Dept Biol Marinha, Niteroi, RJ, Brazil; [Floeter, Sergio R.] Univ Fed Santa Catarina, Dept Ecol & Zool, Florianopolis, SC, Brazil; [Francini-Filho, Ronaldo B.] Univ Fed Paraiba, Ctr Ciencias Aplicadas & Educacao, Rio Tinto, PB, Brazil; [Olavo, George] Univ Estadual Feira de Santana, Lab Biol Pesqueira, Feira De Santana, BA, Brazil; [Rocha, Luiz A.] Calif Acad Sci, San Francisco, CA 94118 USA; [Sazima, Ivan] Univ Estadual Campinas, Museu Zool, Campinas, SP, Brazil	Universidade Federal do Espirito Santo; Universidade Estadual de Santa Cruz; Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro; Jardim Botanico do Rio de Janeiro; Universidade Federal do Estado do Rio de Janeiro; Universidade Federal de Pernambuco; Universidade Federal Fluminense; Universidade Federal de Santa Catarina (UFSC); Universidade Federal da Paraiba; Universidade Estadual de Feira de Santana; California Academy of Sciences; Universidade Estadual de Campinas	Pinheiro, HT (corresponding author), Univ Calif Santa Cruz, Dept Ecol & Evolutionary Biol, Santa Cruz, CA 95064 USA.	htpinheiro@gmail.com	Martins, Agnaldo/F-1615-2011; Francini-Filho, Ronaldo/I-5708-2012; Pinheiro, Hudson/A-4065-2019; Teixeira, João Batista/W-6935-2019; Ferreira, Beatrice P/A-5786-2013; de Moura, Rodrigo Leao/AAL-5781-2020; Pimentel, Caio R/B-2808-2014; Macieira, Raphael/G-2808-2011; Rocha, Luiz/T-6326-2019; Floeter, S. R./B-1438-2012	Martins, Agnaldo/0000-0003-2160-1326; Francini-Filho, Ronaldo/0000-0002-7678-6797; Pinheiro, Hudson/0000-0002-3143-1474; de Moura, Rodrigo Leao/0000-0002-5597-6196; Pimentel, Caio R/0000-0003-4110-1249; Macieira, Raphael/0000-0002-8871-8724; Floeter, S. R./0000-0002-3201-6504; Rocha, Luiz/0000-0003-4011-569X; Ferreira, Carlos Eduardo/0000-0002-4311-0491; Costa, Paulo A. S./0000-0002-7939-6428	CNPq [470725/2009-5, 557043/2009-3, 405360/2012-6, 405419/2012-0, GDE 202475/2011-5]; CAPES	CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This work is funded by CNPq (http://www.cnpq.br) through projects "Vitoria-Trindade Chain: testing the theory for stepping-stone connectivity in reef fishes" (grant 470725/2009-5 to JCJ), "Reef fishes of the insular complex Trindade-Martin Vaz, Vitoria, ES: status, recruitment and evolution of assemblages" (grant 557043/2009-3 to JCJ), Vitoria-Trindade Chain mesophotic reefs: characterization of marine communities and reef health evaluation (grant 405360/2012-6 to GAF) and Paleoceanographic reconstruction of the Vitoria-Trindade Chain based in calcareous algae records (grant 405419/2012-0 to AB). HTP (Ciencia sem Fronteiras; GDE 202475/2011-5) and TS are recipients of doctoral fellowships from CNPq and CAPES (http://capes.gov.br), respectively, and EFM of a MSc fellowship from CAPES. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida F.F.M., 2006, TERRAE DID ATICA, V2, P3, DOI [10.1007/BF01915460, DOI 10.20396/TD.V2I1.8637462]; Althaus F, 2009, MAR ECOL PROG SER, V397, P279, DOI 10.3354/meps08248; Andrade ACS, 2003, AN ACAD BRAS CIENC, V75, P357, DOI 10.1590/S0001-37652003000300008; Andrade L, 2004, HYDROBIOLOGIA, V511, P103, DOI 10.1023/B:HYDR.0000014033.81848.48; Andreata Jose V., 1995, Revista Brasileira de Zoologia, V12, P579; [Anonymous], 2010, OCEANOGRAPHY, V23, P210; Bailey DM, 2009, P ROY SOC B-BIOL SCI, V276, P1965, DOI 10.1098/rspb.2009.0098; Bazilevskaya ES, 2011, DOKL EARTH SCI, V439, P1039, DOI 10.1134/S1028334X11080010; Bergstad OA, 2008, DEEP-SEA RES PT II, V55, P185, DOI 10.1016/j.dsr2.2007.09.005; Bergstad OA, 2012, DEEP-SEA RES PT I, V61, P74, DOI 10.1016/j.dsr.2011.12.002; Bouchon-Navaro Y, 2005, J EXP MAR BIOL ECOL, V315, P31, DOI 10.1016/j.jembe.2004.08.028; Braga AC, 2007, BIODIVERSIDADE FAUNA, P63; Braga AD, 2014, LAT AM J AQUAT RES, V42, P245, DOI 10.3856/vol42-issue1-fulltext-20; Brandley MC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011375; Briggs JC, 2012, J BIOGEOGR, V39, P12, DOI 10.1111/j.1365-2699.2011.02613.x; Carvalho, 1950, B I PAULIST OCEANOGR, V1, P97, DOI [10.1590/S0100-42391950000100008, DOI 10.1590/S0100-42391950000100008]; Carvalho-Filho A., 1999, PEIXES COSTA BRASILE; Castro C.B., 2006, BIODIVERSIDADE BENTO, V18, P147; Cavalcanti GS, 2014, ISME J, V8, P52, DOI 10.1038/ismej.2013.133; CGEE, 2007, MAR AMB COST; Clark M, 2000, J NW ATL FISH SCI, V31, P441; Clark MR, 2012, ENVIRON CONSERV, V39, P204, DOI 10.1017/S0376892912000021; Clark MR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029232; Clark MR, 2011, OCEAN COAST MANAGE, V54, P19, DOI 10.1016/j.ocecoaman.2010.10.006; Clark MR, 2010, MAR ECOL-EVOL PERSP, V31, P200, DOI 10.1111/j.1439-0485.2010.00392.x; Clark MR, 2010, ANNU REV MAR SCI, V2, P253, DOI 10.1146/annurev-marine-120308-081109; Clark MR, 2006, SEAMOUNTS DEEP SEA C, DOI [10.1016/S0378-777X(80)80057-6, DOI 10.1016/S0378-777X(80)80057-6]; Dennis GD, 2005, CARIBB J SCI, V41, P716; ERIKSEN CC, 1991, J GEOPHYS RES-OCEANS, V96, P15227, DOI 10.1029/91JC01176; Etnoyer PJ, 2010, OCEANOGRAPHY, V23, P206, DOI 10.5670/oceanog.2010.96; FAINSTEIN R, 1982, MAR GEOL, V46, P199, DOI 10.1016/0025-3227(82)90080-9; Ferreira CEL, 2004, J BIOGEOGR, V31, P1093, DOI 10.1111/j.1365-2699.2004.01044.x; Floeter SR, 2008, J BIOGEOGR, V35, P22, DOI 10.1111/j.1365-2699.2007.01790.x; Fodor RV, 2000, LITHOS, V51, P293, DOI 10.1016/S0024-4937(00)00002-5; Fossen I, 2008, DEEP-SEA RES PT II, V55, P203, DOI 10.1016/j.dsr2.2007.09.004; FREELAND H, 1994, DEEP-SEA RES PT I, V41, P1715, DOI 10.1016/0967-0637(94)90069-8; Gaeta SA, 1999, ARCH FISH MAR RES, V47, P253; Gasparini JL, 2001, J NAT HIST, V35, P1639, DOI 10.1080/002229301317092379; Goncalves JMS, 2004, ARCH FISH MAR RES, V51, P233; Gubbay S., 2003, SEAMOUNTS N E ATLANT; Halfar J, 2007, SCIENCE, V316, P987, DOI 10.1126/science.1138289; Hart PJB, 2011, MAR ECOL PROG SER, V430, P281, DOI 10.3354/meps08948; Hein JR, 2010, OCEANOGRAPHY, V23, P184, DOI 10.5670/oceanog.2010.70; Hobbs JPA, 2012, J BIOGEOGR, V39, P130, DOI 10.1111/j.1365-2699.2011.02576.x; Humann P., 2002, REEF FISH IDENTIFICA; Jacobs CL, 2010, PREPARATION BATHYMET; Koslow JA, 2000, ICES J MAR SCI, V57, P548, DOI 10.1006/jmsc.2000.0722; Koslow JA, 2001, MAR ECOL PROG SER, V213, P111, DOI 10.3354/meps213111; Leao ZMAN, 2003, LATIN AMERICAN CORAL REEFS, P9, DOI 10.1016/B978-044451388-5/50003-5; Luiz O, 2011, BIOL CONSERV, P1; Lundsten L, 2009, MAR ECOL PROG SER, V389, P223, DOI 10.3354/meps08181; Machado ABM, 2008, LIVRO VERMELHO FAUNA; Macieira RM, 2015, ENVIRON BIOL FISH, V98, P385, DOI 10.1007/s10641-014-0269-0; Martins A, 2005, PESCA POTENCIAIS EXP, V128, P109; Martins AS, 2007, BIODIVERSIDADE FAUNA, V61, P45; Maxfield JM, 2012, MOL PHYLOGENET EVOL, V64, P416, DOI 10.1016/j.ympev.2012.04.016; McClain CR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004141; Morato TF, 2004, SEAMOUNTS BIODIVERSI; Motoki A, 2012, REV BRAS GEOMORFOL, V13, P151; Moura RL, 2011, ESTUAR COAST SHELF S, V95, P274, DOI 10.1016/j.ecss.2011.08.010; Murray G, 1902, GEOGR J, V19, P423, DOI 10.2307/1775240; Nelson JS, 2006, FISHES WORLD, DOI DOI 10.1002/9781119174844; Nichols JT, 1913, B AM MUS NAT HIST, V7, P261; Nogueria C, 2009, MEGADIVERS, V5, P43; Nonaka RH, 2000, FISH B-NOAA, V98, P767; Olavo G., 2005, SERIE LIVROS, P167; Olavo G, 2011, AQUAT CONSERV, V21, P199, DOI 10.1002/aqc.1174; Parrish FA, 2004, MAR BIOL, V144, P1065, DOI 10.1007/s00227-003-1288-0; Pellissier L, 2014, SCIENCE, V344, P1016, DOI 10.1126/science.1249853; Pereira GH, 2012, J COASTAL RES, V28, P261, DOI 10.2112/11T-00007.1; Pereira GH, 2011, BRAZ J OCEANOGR, V59, P201, DOI 10.1590/S1679-87592011000300001; PEREZ JAA, 2009, MAR FISH REV, V71, P24; Pinault M, 2013, J FISH BIOL, V82, P1821, DOI 10.1111/jfb.12110; Pinheiro HT, 2014, CORAL REEFS, V33, P1113, DOI 10.1007/s00338-014-1211-9; Pinheiro HT, 2011, J FISH BIOL, V79, P1984, DOI 10.1111/j.1095-8649.2011.03138.x; Pinheiro HT, 2009, ZOOTAXA, P45, DOI 10.11646/zootaxa.2298.1.3; Pinheiro HT, 2010, ZOOTAXA, P59; Pinheiro HT, 2010, BRAZ ARCH BIOL TECHN, V53, P1417, DOI 10.1590/S1516-89132010000600018; RANDALL JOHN E., 1967, STUD TROP OCEANOGR INST MAR SCI UNIV MIAMI, V5, P665; Ribeiro A. de M., 1919, Archivos do Museu Rio de Janeiro, V22; Rocha LA, 2005, P ROY SOC B-BIOL SCI, V272, P573, DOI 10.1098/2004.3005; Rocha LA, 2001, J FISH BIOL, V58, P985, DOI 10.1006/jfbi.2000.1504; Rocha LA, 2010, ZOOTAXA, P22; Rodriguez-Romero J, 2005, B MAR SCI, V77, P33; Schlacher TA, 2010, MAR ECOL-EVOL PERSP, V31, P1, DOI 10.1111/j.1439-0485.2010.00396.x; SCHMID C, 1995, J PHYS OCEANOGR, V25, P2532, DOI 10.1175/1520-0485(1995)025<2532:TVEAIR>2.0.CO;2; Scott SD, 2007, PROCEEDINGS OF THE SEVENTH (2007) ISOPE OCEAN MINING (& GAS HYDRATES) SYMPOSIUM, P6; SERET B, 1992, Cybium, V16, P81; Shank TM, 2010, OCEANOGRAPHY, V23, P108, DOI 10.5670/oceanog.2010.65; Sheppard CRC, 2012, AQUAT CONSERV, V22, P232, DOI 10.1002/aqc.1248; Siebel W, 2000, J S AM EARTH SCI, V13, P79, DOI 10.1016/S0895-9811(00)00015-8; Silveira I.C.A., 2000, REV BRAS OCEANOGR, V48, P171, DOI [10.1590/S1413-77392000000200008, DOI 10.1590/S1413-77392000000200008]; Simon T, 2013, J FISH BIOL, V82, P2113, DOI 10.1111/jfb.12126; Skolotnev SG, 2010, DOKL EARTH SCI, V431, P435, DOI 10.1134/S1028334X10040057; Smith W., 1997, SCIENCE, V2, P209; Stocks K, 2009, P COL OC DAT S, P77; Taranto GH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042950; VASCONCELOS Y., 2012, REV PESQUISA FAPESP, V197, P62; Wessel P, 2010, OCEANOGRAPHY, V23, P24, DOI 10.5670/oceanog.2010.60; Williams JT, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010676; WIRTZ P, 2014, J MAR BIOL ASSOC UK, V2014, P1; Zar JH., 2010, BIOSTAT ANAL, V5th	102	76	79	2	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2015	10	3							e0118180	10.1371/journal.pone.0118180	http://dx.doi.org/10.1371/journal.pone.0118180			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9JM	25738798	gold, Green Submitted, Green Published			2022-12-27	WOS:000350685900023
J	Sutherland, JJ; Daly, TM; Liu, X; Goldstein, K; Johnston, JA; Ryan, TP				Sutherland, Jeffrey J.; Daly, Thomas M.; Liu, Xiong; Goldstein, Keith; Johnston, Joseph A.; Ryan, Timothy P.			Co-Prescription Trends in a Large Cohort of Subjects Predict Substantial Drug-Drug Interactions	PLOS ONE			English	Article							GENERAL-PRACTICE; ANTIDEPRESSANTS; INHIBITOR; EVENTS; ALERTS; ENZYME; CARE	Pharmaceutical prescribing and drug-drug interaction data underlie recommendations on drug combinations that should be avoided or closely monitored by prescribers. Because the number of patients taking multiple medications is increasing, a comprehensive view of prescribing patterns in patients is important to better assess real world pharmaceutical response and evaluate the potential for multi-drug interactions. We obtained self-reported prescription data from NHANES surveys between 1999 and 2010, and confirm the previously reported finding of increasing drug use in the elderly. We studied co-prescription drug trends by focusing on the 2009-2010 survey, which contains prescription data on 690 drugs used by 10,537 subjects. We found that medication profiles were unique for individuals aged 65 years or more, with >= 98 unique drug regimens encountered per 100 subjects taking 3 or more medications. When drugs were viewed by therapeutic class, it was found that the most commonly prescribed drugs were not the most commonly co-prescribed drugs for any of the 16 drug classes investigated. We cross-referenced these medication lists with drug interaction data from Drugs.com to evaluate the potential for drug interactions. The number of drug alerts rose proportionally with the number of co-prescribed medications, rising from 3.3 alerts for individuals prescribed 5 medications to 11.7 alerts for individuals prescribed 10 medications. We found 22% of elderly subjects taking both a substrate and inhibitor of a given cytochrome P450 enzyme, and 4% taking multiple inhibitors of the same enzyme simultaneously. By examining drug pairs prescribed in 0.1% of the population or more, we found low agreement between co-prescription rate and co-discussion in the literature. These data show that prescribing trends in treatment could drive a large extent of individual variability in drug response, and that current pairwise approaches to assessing drug-drug interactions may be inadequate for predicting real world outcomes.	[Sutherland, Jeffrey J.; Liu, Xiong] Eli Lilly & Co, Lilly Res Labs IT, Indianapolis, IN 46285 USA; [Daly, Thomas M.] Cleveland Clin, Pathol & Lab Med Inst, Cleveland, OH 44106 USA; [Goldstein, Keith] Eli Lilly & Co, Drug Disposit & Toxicol, Indianapolis, IN 46285 USA; [Johnston, Joseph A.] Eli Lilly & Co, Global Patient Outcomes & Real World Evidence, Indianapolis, IN 46285 USA; [Ryan, Timothy P.] Sano Informed Prescribing, Brentwood, TN USA	Eli Lilly; Cleveland Clinic Foundation; Eli Lilly; Eli Lilly	Sutherland, JJ (corresponding author), Eli Lilly & Co, Lilly Res Labs IT, Indianapolis, IN 46285 USA.	sutherlandje@lilly.com; tim@thinksano.com	Liu, Xiong/O-3480-2019	Liu, Xiong/0000-0003-4522-7228	Eli Lilly; Sano	Eli Lilly(Eli Lilly); Sano	Eli Lilly and Sano Informed Prescribing provided support in the form of salaries and benefits for authors Jeffrey J. Sutherland, Xiong Liu, Keith Goldstein, Joseph A. Johnston, and Timothy P. Ryan, but did not have any additional role in the study design, decision to publish, data collection and analysis, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section	Bowlin SJ, 2013, MAYO CLIN PROC, V88, P139, DOI 10.1016/j.mayocp.2012.10.020; Duke JD, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002614; ElDesoky Ehab S, 2007, Am J Ther, V14, P488, DOI 10.1097/01.mjt.0000183719.84390.4d; Flockhart DA., 2007, DRUG INTERACTIONS CY; Gokula M, 2012, CLIN GERIATR MED, V28, P323, DOI 10.1016/j.cger.2012.01.011; Gu Qiuping, 2010, NCHS Data Brief, P1; Harpaz R, 2012, CLIN PHARMACOL THER, V91, P1010, DOI 10.1038/clpt.2012.50; Kent DM, 2010, TRIALS, V11, DOI 10.1186/1745-6215-11-85; Kerr KP, 2014, J CLIN PHARM THER, V39, P383, DOI 10.1111/jcpt.12163; Kootstra-Ros JE, 2006, J CLIN PHARMACOL, V46, P1320, DOI 10.1177/0091270006293754; LEAPE LL, 1995, JAMA-J AM MED ASSOC, V274, P35, DOI 10.1001/jama.1995.03530010049034; Moura C, 2009, J PHARM PHARM SCI, V12, P266, DOI 10.18433/J35C7Z; Muscatello MR, 2012, HUM PSYCHOPHARM CLIN, V27, P239, DOI 10.1002/hup.2217; Paterno MD, 2009, J AM MED INFORM ASSN, V16, P40, DOI 10.1197/jamia.M2808; Preskorn Sheldon H, 2007, J Psychiatr Pract, V13, P5, DOI 10.1097/00131746-200701000-00002; Raschetti R, 1999, EUR J CLIN PHARMACOL, V54, P959, DOI 10.1007/s002280050582; Schoen C, 2011, HEALTH AFFAIR, V30, P2437, DOI 10.1377/hlthaff.2011.0923; Shah NR, 2006, J AM MED INFORM ASSN, V13, P5, DOI 10.1197/jamia.M1868; Tamblyn RM, 1996, CAN MED ASSOC J, V154, P1177; Tatonetti NP, 2011, CLIN PHARMACOL THER, V90, P133, DOI 10.1038/clpt.2011.83; Tragni E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078827; van Baal PH, 2011, POPUL HEALTH METR, V9, DOI 10.1186/1478-7954-9-51; Verger P, 2008, CAN J PSYCHIAT, V53, P94, DOI 10.1177/070674370805300204; Zhao S, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006548	24	27	28	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2015	10	3							e0118991	10.1371/journal.pone.0118991	http://dx.doi.org/10.1371/journal.pone.0118991			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9JM	25739022	Green Published, gold, Green Submitted			2022-12-27	WOS:000350685900089
J	Grijalva, CG; Goeyvaerts, N; Verastegui, H; Edwards, KM; Gil, AI; Lanata, CF; Hens, N				Grijalva, Carlos G.; Goeyvaerts, Nele; Verastegui, Hector; Edwards, Kathryn M.; Gil, Ana I.; Lanata, Claudio F.; Hens, Niel		RESPIRA PERU Project	A Household-Based Study of Contact Networks Relevant for the Spread of Infectious Diseases in the Highlands of Peru	PLOS ONE			English	Article							SOCIAL MIXING PATTERNS; TRANSMISSION; PARAMETERS; INFLUENZA; MODELS	Background Few studies have quantified social mixing in remote rural areas of developing countries, where the burden of infectious diseases is usually the highest. Understanding social mixing patterns in those settings is crucial to inform the implementation of strategies for disease prevention and control. We characterized contact and social mixing patterns in rural communities of the Peruvian highlands. Methods and Findings This cross-sectional study was nested in a large prospective household-based study of respiratory infections conducted in the province of San Marcos, Cajamarca-Peru. Members of study households were interviewed using a structured questionnaire of social contacts (conversation or physical interaction) experienced during the last 24 hours. We identified 9015 reported contacts from 588 study household members. The median age of respondents was 17 years (interquartile range [IQR] 4-34 years). The median number of reported contacts was 12 (IQR 8-20) whereas the median number of physical (i.e. skin-to-skin) contacts was 8.5 (IQR 5-14). Study participants had contacts mostly with people of similar age, and with their offspring or parents. The number of reported contacts was mainly determined by the participants' age, household size and occupation. School-aged children had more contacts than other age groups. Within-household reciprocity of contacts reporting declined with household size (range 70%-100%). Ninety percent of household contact networks were complete, and furthermore, household members' contacts with non-household members showed significant overlap (range 33%-86%), indicating a high degree of contact clustering. A two-level mixing epidemic model was simulated to compare within-household mixing based on observed contact networks and within-household random mixing. No differences in the size or duration of the simulated epidemics were revealed. Conclusion This study of rural low-density communities in the highlands of Peru suggests contact patterns are highly assortative. Study findings support the use of within-household homogenous mixing assumptions for epidemic modeling in this setting.				Carlos.grijalva@vanderbilt.edu	Lanata, Claudio F./N-7997-2018; Hens, Niel/M-4445-2017	Lanata, Claudio F./0000-0002-6994-7425; Hens, Niel/0000-0003-1881-0637; Grijalva, Carlos/0000-0002-2329-7797; Goeyvaerts, Nele/0000-0003-0526-5318	National Institutes of Health [UL1 RR024975]; Pfizer [IIR WS1898786(0887X1-4492)]; Thrasher Research Fund [02832-9]; AXA Research Fund; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024975] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pfizer(Pfizer); Thrasher Research Fund; AXA Research Fund(AXA Research Fund); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported by the Vanderbilt University CTSA grant UL1 RR024975 from National Institutes of Health, an investigator initiated research grant from Pfizer (IIR WS1898786(0887X1-4492), (http://www.pfizer.com) and grant 02832-9 from the Thrasher Research Fund (www.thrasherresearch.org/default.aspx). NG is beneficiary of a postdoctoral grant from the AXA Research Fund (http://www.axa-research. org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ball F, 1997, ANN APPL PROBAB, V7, P46; Beutels P, 2006, EPIDEMIOL INFECT, V134, P1158, DOI 10.1017/S0950268806006418; Budge PJ, 2014, PEDIATR INFECT DIS J, V33, P443, DOI 10.1097/INF.0000000000000135; Budge PJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091247; Ferguson NM, 2006, NATURE, V442, P448, DOI 10.1038/nature04795; Fumanelli L, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002673; Goeyvaerts N, 2010, J R STAT SOC C-APPL, V59, P255, DOI 10.1111/j.1467-9876.2009.00693.x; Grijalva CG, 2014, INT J EPIDEMIOL, V43, P1021, DOI 10.1093/ije/dyt065; Grijalva CG, 2014, CLIN INFECT DIS, V58, P1369, DOI 10.1093/cid/ciu148; Halloran ME, 2008, P NATL ACAD SCI USA, V105, P4639, DOI 10.1073/pnas.0706849105; Horby P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016965; Huicho L, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-47; Instituto Nacional de Estadistica e Informatica (INEI), SIST DIF CENS NAC; Johnstone-Robertson SP, 2011, AM J EPIDEMIOL, V174, P1246, DOI 10.1093/aje/kwr251; Kolaczyk ED, 2009, SPRINGER SER STAT, P1, DOI 10.1007/978-0-387-88146-1_1; Mccaw JM, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-166; Melegaro A, 2011, EPIDEMICS-NETH, V3, P143, DOI 10.1016/j.epidem.2011.04.001; Mossong J, 2008, PLOS MED, V5, P381, DOI 10.1371/journal.pmed.0050074; Ogunjimi B, 2009, MATH BIOSCI, V218, P80, DOI 10.1016/j.mbs.2008.12.009; Potter GE, 2013, J R STAT SOC C-APPL, V62, P629, DOI 10.1111/rssc.12011; Read JM, 2012, EPIDEMIOL INFECT, V140, P2117, DOI 10.1017/S0950268812000842; Smieszek T, 2012, EPIDEMIOL INFECT, V140, P744, DOI 10.1017/S0950268811001130; Smieszek T, 2009, THEOR BIOL MED MODEL, V6, DOI 10.1186/1742-4682-6-25; United Nations Development Program-Peru, 2013, INF DES HUM PER 2013; Wallinga J, 2006, AM J EPIDEMIOL, V164, P936, DOI 10.1093/aje/kwj317; Willem L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048695	26	46	47	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2015	10	3							e0118457	10.1371/journal.pone.0118457	http://dx.doi.org/10.1371/journal.pone.0118457			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4HV	25734772	Green Published, gold, Green Submitted			2022-12-27	WOS:000350314700030
J	Eriksen, A; Tillin, T; O'Connor, L; Brage, S; Hughes, A; Mayet, J; McKeigue, P; Whincup, P; Chaturvedi, N; Forouhi, NG				Eriksen, Anne; Tillin, Therese; O'Connor, Laura; Brage, Soren; Hughes, Alun; Mayet, Jamil; McKeigue, Paul; Whincup, Peter; Chaturvedi, Nish; Forouhi, Nita G.			The Impact of Health Behaviours on Incident Cardiovascular Disease in Europeans and South Asians - A Prospective Analysis in the UK SABRE Study	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; LIFE-STYLE FACTORS; RISK-FACTORS; PRIMARY PREVENTION; PHYSICAL-ACTIVITY; MYOCARDIAL-INFARCTION; ALCOHOL-CONSUMPTION; VEGETABLE INTAKE; UNITED-KINGDOM; 52 COUNTRIES	Background There is consistent evidence on the impact of health behaviours on risk of cardiovascular disease (CVD) in European populations. As South Asians in the UK have an excess risk of CVD and coronary heart disease (CHD) compared to Europeans, we investigated whether a similar association between combined health behaviours and risk of CVD and CHD among this high-risk group exists, and estimated the population impact. Methods and Findings In a prospective cohort of 1090 Europeans and 1006 South Asians (40-69 y) without prevalent CVD at baseline (1988-1990), followed up for 21 years to 2011, there were 601 incident CVD events [Europeans n = 255; South Asians n = 346] of which 520 were CHD events [n = 207 and 313 respectively]. Participants scored between 0 to 4 points for a composite score including four baseline healthy behaviours (non-smoker, moderate alcohol intake, physically active, frequent fruit/vegetable intake). Adjusted hazard ratios (95% confidence intervals) for incident CHD in Europeans who had three, two, one, and zero compared to four health behaviours were 1.33 (0.78-2.29), 1.96 (1.15-3.33), 1.36 (0.74-2.48) and 2.45 (1.18-5.10), respectively, p-trend = 0.025. In South Asians, corresponding HRs were 2.88 (1.33-6.24), 2.28 (1.06-4.91), 3.36 (1.53-7.39) and 3.48 (1.38-8.81), p-trend = 0.022. The results were similar for incident CVD; Europeans HR 2.12 (1.14-3.94), p-trend = 0.014; South Asians HR 2.73 (1.20-6.21), p-trend = 0.018. The population attributable fraction in Europeans was 43% for CHD and 28% for CVD. In South Asians it was 63% and 51% respectively. Conclusions Lack of adherence to four combined health behaviours was associated with 2 to 3-fold increased risk of incident CVD in Europeans and South Asians. A substantial population impact in the South Asian group indicates important potential for disease prevention in this high-risk group by adherence to healthy behaviours.	[Eriksen, Anne; O'Connor, Laura; Brage, Soren; Chaturvedi, Nish; Forouhi, Nita G.] Univ Cambridge, Sch Clin Med, Epidemiol Unit, MRC,Inst Metab Sci, Cambridge, England; [Tillin, Therese; Hughes, Alun] UCL, London Inst Cardiovasc Sci, London, England; [Mayet, Jamil] Univ London Imperial Coll Sci Technol & Med, St Marys Hosp, Int Ctr Circulatory Hlth, London, England; [McKeigue, Paul] Univ Edinburgh, Sch Med, Ctr Populat Hlth Sci, Edinburgh, Midlothian, Scotland; [Whincup, Peter] Univ London, Populat Hlth Res Ctr, London, England	University of Cambridge; University of London; University College London; Imperial College London; University of Edinburgh; University of London	Forouhi, NG (corresponding author), Univ Cambridge, Sch Clin Med, Epidemiol Unit, MRC,Inst Metab Sci, Cambridge Biomed Campus, Cambridge, England.	nita.forouhi@mrc-epid.cam.ac.uk	Brage, Soren/C-6415-2013; O'Connor, Laura/ABD-7999-2021; Hughes, Alun David/N-3781-2013	Brage, Soren/0000-0002-1265-7355; O'Connor, Laura/0000-0002-6022-2022; Hughes, Alun David/0000-0001-5432-5271; Forouhi, Nita/0000-0002-5041-248X; Whincup, Peter/0000-0002-5589-4107; Eriksen, Anne Kirstine/0000-0002-4535-3788	Wellcome Trust [082464/Z/07/Z]; British Heart Foundation [SP/07/001/23603]; NIHR Biomedical Research Centre funding scheme; MRC Epidemiology Unit [MC_UU_12015/5]; MRC [MC_UP_A100_1003, MC_UU_12015/5, MC_U106179473, MC_UU_12015/3] Funding Source: UKRI; British Heart Foundation [PG/08/103/26133, CS/13/1/30327] Funding Source: researchfish; Medical Research Council [MC_UP_A100_1003, MC_U106179473, MC_UU_12015/3, MC_UU_12015/5] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); British Heart Foundation(British Heart Foundation); NIHR Biomedical Research Centre funding scheme(National Institute for Health Research (NIHR)); MRC Epidemiology Unit(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The SABRE study was funded by the Wellcome Trust (082464/Z/07/Z) and British Heart Foundation (SP/07/001/23603). Support from NIHR Biomedical Research Centre funding scheme as well as the MRC Epidemiology Unit (MC_UU_12015/5 to NGF) is acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bryan SN, 2006, CAN J PUBLIC HEALTH, V97, P271, DOI 10.1007/BF03405602; Chiuve SE, 2006, CIRCULATION, V114, P160, DOI 10.1161/CIRCULATIONAHA.106.621417; Doll R, 2004, BMJ-BRIT MED J, V328, P1519, DOI 10.1136/bmj.38142.554479.AE; Eguchi E, 2012, EUR HEART J, V33, P467, DOI 10.1093/eurheartj/ehr429; European Heart Network and European Society of Cardiology, 2012, EUROPEAN CARDIOVASCU; Fischbacher CM, 2004, J PUBLIC HEALTH-UK, V26, P250, DOI 10.1093/pubmed/fdh158; Forouhi NG, 2006, DIABETOLOGIA, V49, P2580, DOI 10.1007/s00125-006-0393-2; Gupta R, 2008, HEART, V94, P16, DOI 10.1136/hrt.2007.132951; Harding S, 2008, INT J EPIDEMIOL, V37, P162, DOI 10.1093/ije/dym252; He FJ, 2007, J HUM HYPERTENS, V21, P717, DOI 10.1038/sj.jhh.1002212; Health Survey for England, 1999, HLTH MIN ETHN GROUPS; Joshipura KJ, 1999, JAMA-J AM MED ASSOC, V282, P1233, DOI 10.1001/jama.282.13.1233; Joshipura KJ, 2001, ANN INTERN MED, V134, P1106, DOI 10.7326/0003-4819-134-12-200106190-00010; Khaw KT, 2008, PLOS MED, V5, P39, DOI 10.1371/journal.pmed.0050012; Knoops KTB, 2004, JAMA-J AM MED ASSOC, V292, P1433, DOI 10.1001/jama.292.12.1433; Kurth T, 2006, ARCH INTERN MED, V166, P1403, DOI 10.1001/archinte.166.13.1403; Kvaavik E, 2010, ARCH INTERN MED, V170, P711, DOI 10.1001/archinternmed.2010.76; MCKEIGUE PM, 1993, CIRCULATION, V87, P152, DOI 10.1161/01.CIR.87.1.152; MCKEIGUE PM, 1989, J CLIN EPIDEMIOL, V42, P597, DOI 10.1016/0895-4356(89)90002-4; Mukamal KJ, 2006, ARCH INTERN MED, V166, P2145, DOI 10.1001/archinte.166.19.2145; Myint PK, 2009, BRIT MED J, V338, DOI 10.1136/bmj.b349; National Health Service UK, PHYS ACT GUID AD; Ness AR, 1997, INT J EPIDEMIOL, V26, P1, DOI 10.1093/ije/26.1.1; Nightingale CM, 2011, INT J EPIDEMIOL, V40, P33, DOI 10.1093/ije/dyq180; O'Donnell MJ, 2010, LANCET, V376, P112, DOI 10.1016/S0140-6736(10)60834-3; Office of Population Censuses and Surveys, 1980, CLASS OCC COD IND; PASSMORE R, 1955, PHYSIOL REV, V35, P801, DOI 10.1152/physrev.1955.35.4.801; Rimm EB, 1999, BMJ-BRIT MED J, V319, P1523, DOI 10.1136/bmj.319.7224.1523; Rockhill B, 1998, AM J PUBLIC HEALTH, V88, P15, DOI 10.2105/AJPH.88.1.15; Sesso HD, 1999, AM J EPIDEMIOL, V150, P408; Sofi F, 2008, EUR J CARDIOV PREV R, V15, P247, DOI 10.1097/HJR.0b013e3282f232ac; Sports Council and Health Education Authority, 1990, ALL DUNB NAT FITN SU; Stampfer MJ, 2000, NEW ENGL J MED, V343, P16, DOI 10.1056/NEJM200007063430103; *STAT CAN, 2002, HLTH IND; Teo KK, 2006, LANCET, V368, P647, DOI 10.1016/S0140-6736(06)69249-0; Thun MJ, 1997, NEW ENGL J MED, V337, P1705, DOI 10.1056/NEJM199712113372401; Tillin T, 2013, J AM COLL CARDIOL, V61, P1777, DOI 10.1016/j.jacc.2012.12.046; Tillin T, 2012, INT J EPIDEMIOL, V41, P33, DOI 10.1093/ije/dyq175; van der Linde RM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065290; W.H. Organization, 1999, DEFINITION DIAGNOSIS; Wild S, 1997, BRIT MED J, V314, P705, DOI 10.1136/bmj.314.7082.705; Williams ED, 2011, HEART, V97, P655, DOI 10.1136/hrt.2010.201012; World Health Organization, INT CLASS DIS ICD; World Health Organization, 2010, ATLAS HEART DIS STRO; Yusuf S, 2004, LANCET, V364, P937, DOI 10.1016/S0140-6736(04)17018-9	45	18	18	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2015	10	3							e0117364	10.1371/journal.pone.0117364	http://dx.doi.org/10.1371/journal.pone.0117364			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9JF	25730129	Green Published, gold			2022-12-27	WOS:000350684900013
J	Berulava, T; Rahmann, S; Rademacher, K; Klein-Hitpass, L; Horsthemke, B				Berulava, Tea; Rahmann, Sven; Rademacher, Katrin; Klein-Hitpass, Ludgar; Horsthemke, Bernhard			N6-Adenosine Methylation in MiRNAs	PLOS ONE			English	Article							MESSENGER-RNA METHYLATION; FTO GENE; MICRORNA BIOGENESIS; EXPRESSION; ASSOCIATION; RS9939609; DISEASE; VARIANT; RISK	Methylation of N6-adenosine (m6A) has been observed in many different classes of RNA, but its prevalence in microRNAs (miRNAs) has not yet been studied. Here we show that a knockdown of the m6A demethylase FTO affects the steady-state levels of several miRNAs. Moreover, RNA immunoprecipitation with an anti-m6A-antibody followed by RNA-seq revealed that a significant fraction of miRNAs contains m6A. By motif searches we have discovered consensus sequences discriminating between methylated and unmethylated miRNAs. The epigenetic modification of an epigenetic modifier as described here adds a new layer to the complexity of the posttranscriptional regulation of gene expression.	[Berulava, Tea; Rahmann, Sven; Rademacher, Katrin; Horsthemke, Bernhard] Univ Duisburg Essen, Inst Human Genet, Univ Hosp Essen, Essen, Germany; [Klein-Hitpass, Ludgar] Univ Duisburg Essen, Inst Human Genet, Inst Cell Biol Tumor Res, Essen, Germany	University of Duisburg Essen; University of Duisburg Essen	Horsthemke, B (corresponding author), Univ Duisburg Essen, Inst Human Genet, Univ Hosp Essen, Essen, Germany.	bernhard.horsthemke@uni-due.de			Bundesministerium fur Bildung und Forschung [01KU1216F]	Bundesministerium fur Bildung und Forschung(Federal Ministry of Education & Research (BMBF))	This work was supported by the Bundesministerium fur Bildung und Forschung (grant number 01KU1216F). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Berulava T, 2013, EUR J HUM GENET, V21, P317, DOI 10.1038/ejhg.2012.168; Berulava T, 2010, EUR J HUM GENET, V18, P1054, DOI 10.1038/ejhg.2010.71; BRINGMANN P, 1987, FEBS LETT, V213, P309, DOI 10.1016/0014-5793(87)81512-0; Cantara WA, 2011, NUCLEIC ACIDS RES, V39, pD195, DOI 10.1093/nar/gkq1028; Church C, 2010, NAT GENET, V42, P1086, DOI 10.1038/ng.713; CSEPANY T, 1990, J BIOL CHEM, V265, P20117; Czerwoniec A, 2009, NUCLEIC ACIDS RES, V37, pD118, DOI 10.1093/nar/gkn710; Dominissini D, 2012, NATURE, V485, P201, DOI 10.1038/nature11112; Finnegan EF, 2013, CRIT REV BIOCHEM MOL, V48, P51, DOI 10.3109/10409238.2012.738643; Fischer J, 2009, NATURE, V458, P894, DOI 10.1038/nature07848; Frayling TM, 2007, SCIENCE, V316, P889, DOI 10.1126/science.1141634; Git A, 2010, RNA, V16, P991, DOI 10.1261/rna.1947110; Heo I, 2008, MOL CELL, V32, P276, DOI 10.1016/j.molcel.2008.09.014; Hernandez-Caballero ME, 2014, MOL BIOL REP; Ho AJ, 2010, P NATL ACAD SCI USA, V107, P8404, DOI 10.1073/pnas.0910878107; HOROWITZ S, 1984, P NATL ACAD SCI-BIOL, V81, P5667, DOI 10.1073/pnas.81.18.5667; IWANAMI Y, 1968, ARCH BIOCHEM BIOPHYS, V124, P472, DOI 10.1016/0003-9861(68)90355-X; Kanellopoulou C, 2005, GENE DEV, V19, P489, DOI 10.1101/gad.1248505; Katoh T, 2009, GENE DEV, V23, P433, DOI 10.1101/gad.1761509; Kawahara Y, 2007, EMBO REP, V8, P763, DOI 10.1038/sj.embor.7401011; Keller L, 2011, J ALZHEIMERS DIS, V23, P461, DOI 10.3233/JAD-2010-101068; Knutsen E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075813; Koster J, 2012, BIOINFORMATICS, V28, P2520, DOI 10.1093/bioinformatics/bts480; Kozomara A, 2014, NUCLEIC ACIDS RES, V42, pD68, DOI 10.1093/nar/gkt1181; Lappalainen T, 2011, NUTR METAB CARDIOVAS, V21, P691, DOI 10.1016/j.numecd.2010.01.006; Liu YC, 2012, BIOINFORMATICS, V28, pI318, DOI 10.1093/bioinformatics/bts414; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Marschall T, 2009, BIOINFORMATICS, V25, pI356, DOI 10.1093/bioinformatics/btp188; Martin M., 2011, EMBNET J, V17, P10, DOI 10.14806/ej.17.1.200; Meyer KD, 2012, CELL, V149, P1635, DOI 10.1016/j.cell.2012.05.003; Pfeffer S, 2004, SCIENCE, V304, P734, DOI 10.1126/science.1096781; Piskounova E, 2011, CELL, V147, P1066, DOI 10.1016/j.cell.2011.10.039; Ross SA, 2014, ANNU REV NUTR, V34, P305, DOI 10.1146/annurev-nutr-071813-105729; SANEYOSHI M, 1969, BIOCHIM BIOPHYS ACTA, V190, P264, DOI 10.1016/0005-2787(69)90078-1; Schwartz S, 2014, CELL REP, V8, P284, DOI 10.1016/j.celrep.2014.05.048; Smemo S, 2014, NATURE, V507, P371, DOI 10.1038/nature13138; Sobczyk-Kopciol A, 2011, ADDICTION, V106, P739, DOI 10.1111/j.1360-0443.2010.03248.x; Trajkovski M, 2011, NATURE, V474, P649, DOI 10.1038/nature10112; Wang X, 2014, NATURE, V505, P117, DOI 10.1038/nature12730; Winter J, 2009, NAT CELL BIOL, V11, P228, DOI 10.1038/ncb0309-228; Xhemalce B, 2012, CELL, V151, P278, DOI 10.1016/j.cell.2012.08.041; Yang WD, 2006, NAT STRUCT MOL BIOL, V13, P13, DOI 10.1038/nsmb1041; Yuan S, 2014, MOL CELL BIOL, V34, P3630, DOI 10.1128/MCB.00243-14; Zhao X, 2014, CELL RES	45	94	102	5	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2015	10	2							e0118438	10.1371/journal.pone.0118438	http://dx.doi.org/10.1371/journal.pone.0118438			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC3LS	25723394	Green Submitted, gold, Green Published			2022-12-27	WOS:000350251200058
J	Kuo, WT; Lin, WC; Chang, KC; Huang, JY; Yen, KC; Young, IC; Sun, YJ; Lin, FH				Kuo, Wei-Ting; Lin, Wen-Chun; Chang, Kai-Chun; Huang, Jian-Yuan; Yen, Ko-Chung; Young, In-Chi; Sun, Yu-Jun; Lin, Feng-Huei			Quantitative Analysis of Ligand-EGFR Interactions: A Platform for Screening Targeting Molecules	PLOS ONE			English	Article							SURFACE-PLASMON RESONANCE; ATOMIC-FORCE MICROSCOPY; EQUILIBRIUM BINDING CONSTANTS; GROWTH-FACTOR RECEPTOR; MACROMOLECULAR INTERACTIONS; IN-VITRO; CANCER; ANTIBODY; DELIVERY; AFFINITY	Epidermal growth factor receptor (EGFR) is often constitutively stimulated in many cancers owing to the binding of ligands such as epidermal growth factor (EGF). Therefore, it is necessary to investigate the interaction between EGFR and its targeting biomolecules. The main aim of this study was to estimate the binding affinity and adhesion force of two targeting molecules, anti-EGFR monoclonal antibody (mAb LA1) and the peptide GE11 (YHWY-GYTPQNVI), with respect to EGFR and to compare these values with those obtained for the ligand, EGF. Surface plasmon resonance (SPR) was used to determine the equilibrium dissociation constant (K-D) for evaluating the binding affinity. Atomic force microscopy (AFM) was performed to estimate the adhesion force. In the case of EGFR, the KD of EGF, GE11, and mAb LA1 were 1.77 x 10(-7), 4.59 x 10(-4) and 2.07 x 10(-9), respectively, indicating that the binding affinity of mAb LA1 to EGFR was higher than that of EGF, while the binding affinity of GE11 to EGFR was the lowest among the three molecules. The adhesion force between EGFR and mAb LA1 was 210.99 pN, which is higher than that observed for EGF (209.41 pN), while the adhesion force between GE11 and EGFR was the lowest (59.51 pN). These results suggest that mAb LA1 binds to EGFR with higher binding affinity than EGF and GE11. Moreover, the adhesion force between mAb LA1 and EGFR was greater than that observed for EGF and GE11. The SPR and AFM experiments confirmed the interaction between the receptor and targeting molecules. The results of this study might aid the screening of ligands for receptor targeting and drug delivery.	[Kuo, Wei-Ting; Lin, Wen-Chun; Huang, Jian-Yuan; Yen, Ko-Chung; Young, In-Chi; Sun, Yu-Jun; Lin, Feng-Huei] Natl Taiwan Univ, Inst Biomed Engn, Taipei 10764, Taiwan; [Chang, Kai-Chun] Natl Taiwan Univ, Grad Inst Clin Dent, Taipei 10764, Taiwan; [Lin, Feng-Huei] Natl Hlth Res Inst, Inst Biomed Engn & Nanomed, Miaoli, Taiwan	National Taiwan University; National Taiwan University; National Health Research Institutes - Taiwan	Lin, FH (corresponding author), Natl Taiwan Univ, Inst Biomed Engn, Taipei 10764, Taiwan.	double@ntu.edu.tw						Abourbeh G, 2012, IUBMB LIFE, V64, P324, DOI 10.1002/iub.1002; Allen S, 1997, BIOCHEMISTRY-US, V36, P7457, DOI 10.1021/bi962531z; Capdevila J, 2009, CANCER TREAT REV, V35, P354, DOI 10.1016/j.ctrv.2009.02.001; CLEVELAND JP, 1993, REV SCI INSTRUM, V64, P403, DOI 10.1063/1.1144209; Cooper MA, 2002, NAT REV DRUG DISCOV, V1, P515, DOI 10.1038/nrd838; DeJesus OT, 2012, CURR RADIOPHARM, V5, P15, DOI 10.2174/1874471011205010015; Engel A, 2000, NAT STRUCT BIOL, V7, P715, DOI 10.1038/78929; FAGERSTAM LG, 1992, J CHROMATOGR, V597, P397, DOI 10.1016/0021-9673(92)80137-J; FLORIN EL, 1994, SCIENCE, V264, P415, DOI 10.1126/science.8153628; Grandis JR, 2004, PHARMACOL THERAPEUT, V102, P37, DOI 10.1016/j.pharmthera.2004.01.002; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Lee CK, 2007, MICRON, V38, P446, DOI 10.1016/j.micron.2006.06.014; Li ZH, 2005, FASEB J, V19, P1978, DOI 10.1096/fj.05-4058com; MacKenzie CR, 1996, J BIOL CHEM, V271, P1527, DOI 10.1074/jbc.271.3.1527; Master AM, 2012, NANOMED-NANOTECHNOL, V8, P655, DOI 10.1016/j.nano.2011.09.012; Mendelsohn J, 2000, ONCOGENE, V19, P6550, DOI 10.1038/sj.onc.1204082; Muller DJ, 2008, NAT NANOTECHNOL, V3, P261, DOI 10.1038/nnano.2008.100; Myszka DG, 1998, ANAL BIOCHEM, V265, P326, DOI 10.1006/abio.1998.2937; Nyati MK, 2006, NAT REV CANCER, V6, P876, DOI 10.1038/nrc1953; O'Shannessy D J, 1994, Curr Opin Biotechnol, V5, P65, DOI 10.1016/S0958-1669(05)80072-2; OSHANNESSY DJ, 1993, ANAL BIOCHEM, V212, P457, DOI 10.1006/abio.1993.1355; Piehler J, 2005, CURR OPIN STRUC BIOL, V15, P4, DOI 10.1016/j.sbi.2005.01.008; Tang H, 2014, MOL PHARM; Wilson WD, 2002, SCIENCE, V295, P2103, DOI 10.1126/science.295.5562.2103; Yarden Y, 2001, EUR J CANCER, V37, pS3; Yarden Y, 2001, NAT REV MOL CELL BIO, V2, P127, DOI 10.1038/35052073	27	19	20	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2015	10	2							e0116610	10.1371/journal.pone.0116610	http://dx.doi.org/10.1371/journal.pone.0116610			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC3LS	25723471	Green Submitted, Green Published, gold			2022-12-27	WOS:000350251200017
J	Xie, HW; Yan, DD; Mao, LG; Wang, QX; Li, Y; Ouyang, CB; Guo, MX; Cao, AC				Xie, Hongwei; Yan, Dongdong; Mao, Liangang; Wang, Qiuxia; Li, Yuan; Ouyang, Canbin; Guo, Meixia; Cao, Aocheng			Evaluation of Methyl Bromide Alternatives Efficacy against Soil-Borne Pathogens, Nematodes and Soil Microbial Community	PLOS ONE			English	Article							1,3-DICHLOROPROPENE PLUS CHLOROPICRIN; SULFURYL FLUORIDE; STEAM STERILIZATION; SOILBORNE PATHOGENS; ENZYME-ACTIVITIES; FOREST SOILS; FUMIGATION; DIVERSITY; FUMIGANTS; SODIUM	Methyl bromide (MB) and other alternatives were evaluated for suppression of Fusarium spp., Phytophthora spp., and Meloidogyne spp. and their influence on soil microbial communities. Both Fusarium spp. and Phytophthora spp. were significantly reduced by the MB (30.74 mg kg(-1)), methyl iodide (MI: 45.58 mg kg(-1)), metham sodium (MS: 53.92 mg kg-1) treatments. MS exhibited comparable effectiveness to MB in controlling Meloidogyne spp. and total nematodes, followed by MI at the tested rate. By contrast, sulfuryl fluoride (SF: 33.04 mg kg(-1)) and chloroform (CF: 23.68 mg kg(-1)) showed low efficacy in controlling Fusarium spp., Phytophthora spp., and Meloidogyne spp. MB, MI and MS significantly lowered the abundance of different microbial populations and microbial biomass in soil, whereas SF and CF had limited influence on them compared with the control. Diversity indices in Biolog studies decreased in response to fumigation, but no significant difference was found among treatments in PLFA studies. Principal component and cluster analyses of Biolog and PLFA data sets revealed that MB and MI treatments greatly influenced the soil microbial community functional and structural diversity compared with SF treatment. These results suggest that fumigants with high effectiveness in suppressing soil-borne disease could significantly influence soil microbial community.	[Xie, Hongwei; Yan, Dongdong; Mao, Liangang; Wang, Qiuxia; Li, Yuan; Ouyang, Canbin; Guo, Meixia; Cao, Aocheng] Chinese Acad Agr Sci, Inst Plant Protect, Beijing 100193, Peoples R China; [Yan, Dongdong; Wang, Qiuxia; Li, Yuan; Ouyang, Canbin; Guo, Meixia; Cao, Aocheng] State Key Lab Biol Plant Dis & Insect Pests, Beijing, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Plant Protection, CAAS	Cao, AC (corresponding author), Chinese Acad Agr Sci, Inst Plant Protect, Beijing 100193, Peoples R China.	caoac@vip.sina.com	yan, dongdong/M-4629-2017	Yan, Dongdong/0000-0002-8196-4615	Projects of China Ministry of Agriculture [2110402]; Beijing Team-Innovation, Modern Agricultural and Industrial Technology Innovation System of China; National Natural Science Foundation of China [40871131]	Projects of China Ministry of Agriculture; Beijing Team-Innovation, Modern Agricultural and Industrial Technology Innovation System of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was supported by the Projects of China Ministry of Agriculture (2110402), Beijing Team-Innovation, Modern Agricultural and Industrial Technology Innovation System of China and National Natural Science Foundation of China (40871131). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baath E, 2003, SOIL BIOL BIOCHEM, V35, P955, DOI 10.1016/S0038-0717(03)00154-8; Baltaci D, 2009, J STORED PROD RES, V45, P19, DOI 10.1016/j.jspr.2008.06.006; Becker JO, 1998, PESTIC SCI, V52, P58, DOI 10.1002/(SICI)1096-9063(199801)52:1&lt;58::AID-PS632&gt;3.0.CO;2-Y; Bell CH, 1999, J STORED PROD RES, V35, P233, DOI 10.1016/S0022-474X(99)00008-9; BENYEPHET Y, 1988, CROP PROT, V7, P327, DOI 10.1016/0261-2194(88)90080-4; BENYEPHET Y, 1988, CROP PROT, V7, P25, DOI 10.1016/0261-2194(88)90033-6; Bossio DA, 1998, MICROBIAL ECOL, V35, P265, DOI 10.1007/s002489900082; Cao AC, 2014, PEST MANAG SCI, V70, P219, DOI 10.1002/ps.3535; Dickens HE, 1999, SOIL BIOL BIOCHEM, V31, P2049, DOI 10.1016/S0038-0717(99)00128-5; Dungan RS, 2003, FEMS MICROBIOL ECOL, V43, P75, DOI 10.1111/j.1574-6941.2003.tb01047.x; FROSTEGARD A, 1993, SOIL BIOL BIOCHEM, V25, P723, DOI 10.1016/0038-0717(93)90113-P; Gilreath JP, 2005, CROP PROT, V24, P779, DOI 10.1016/j.cropro.2005.01.002; Gilreath JP, 2004, CROP PROT, V23, P1187, DOI 10.1016/j.cropro.2004.04.006; Gilreath JP, 2004, CROP PROT, V23, P205, DOI 10.1016/j.cropro.2003.08.015; Hanson BD, 2011, CROP PROT, V30, P203, DOI 10.1016/j.cropro.2010.10.011; Hutchinson CM, 2000, PEST MANAG SCI, V56, P413, DOI 10.1002/(SICI)1526-4998(200005)56:5<413::AID-PS140>3.0.CO;2-J; Ibekwe AM, 2010, J ENVIRON SCI HEAL B, V45, P416, DOI 10.1080/03601231003800073; Ibekwe AM, 2011, SCI TOTAL ENVIRON, V409, P3740, DOI 10.1016/j.scitotenv.2011.06.033; JENKINS W. R., 1964, PLANT DIS REP, V48, P692; Klose S, 2007, CROP PROT, V26, P535, DOI 10.1016/j.cropro.2006.05.004; Klose S, 2006, SOIL BIOL BIOCHEM, V38, P1243, DOI 10.1016/j.soilbio.2005.09.025; KOMADA H, 1975, Review of Plant Protection Research, V8, P114; Locascio SJ, 1997, HORTSCIENCE, V32, P1208, DOI 10.21273/HORTSCI.32.7.1208; Margesin SR, 2005, MANUAL SOIL ANAL MON; Martin FN, 2003, ANNU REV PHYTOPATHOL, V41, P325, DOI 10.1146/annurev.phyto.41.052002.095514; MASAGO H, 1977, PHYTOPATHOLOGY, V67, P425, DOI 10.1094/Phyto-67-425; Minuto A, 2006, CROP PROT, V25, P1244, DOI 10.1016/j.cropro.2006.03.017; Noling JW, 1995, USE METHYL IODIDE NE, P4941; Omirou M, 2011, MICROB ECOL, V61, P201, DOI 10.1007/s00248-010-9740-4; Small GJ, 2007, J STORED PROD RES, V43, P410, DOI 10.1016/j.jspr.2006.11.003; Spokas K, 2007, ATMOS ENVIRON, V41, P8150, DOI 10.1016/j.atmosenv.2007.06.028; Staddon WJ, 1997, MICROB ECOL, V34, P125, DOI 10.1007/s002489900042; Stromberger ME, 2005, SOIL SCI SOC AM J, V69, P1987, DOI 10.2136/sssaj2005.0076; Tanaka S, 2003, SOIL SCI PLANT NUTR, V49, P603, DOI 10.1080/00380768.2003.10410050; Vaculin PD, 2003, 2003 ANN INT RES C M, P20; Yamamoto T, 2008, SOIL SCI PLANT NUTR, V54, P886, DOI 10.1111/j.1747-0765.2008.00319.x; Yao SR, 2006, SOIL BIOL BIOCHEM, V38, P587, DOI 10.1016/j.soilbio.2005.06.026; Zhang CP, 2010, CHEMOSPHERE, V81, P800, DOI 10.1016/j.chemosphere.2010.06.079; Zheng W, 2006, ATMOS ENVIRON, V40, P7046, DOI 10.1016/j.atmosenv.2006.06.009; Zogg GP, 1997, SOIL SCI SOC AM J, V61, P475, DOI 10.2136/sssaj1997.03615995006100020015x	40	20	21	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2015	10	2							e0117980	10.1371/journal.pone.0117980	http://dx.doi.org/10.1371/journal.pone.0117980			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC3LS	25723395	Green Published, Green Submitted, gold			2022-12-27	WOS:000350251200044
J	Halievski, K; Mo, KG; Westwood, JT; Monks, DA				Halievski, Katherine; Mo, Kaiguo; Westwood, J. Timothy; Monks, Douglas A.			Transcriptional Profile of Muscle following Acute Induction of Symptoms in a Mouse Model of Kennedy's Disease/Spinobulbar Muscular Atrophy	PLOS ONE			English	Article							MOTOR-NEURON DISEASES; SKELETAL-MUSCLE; ANDROGEN RECEPTOR; RETROGRADE TRANSPORT; GENE-EXPRESSION; MICE; DIFFERENTIATION; CELLS; OVEREXPRESSION; PHENOTYPES	Background Kennedy's disease/Spinobulbar muscular atrophy (KD/SBMA) is a degenerative neuromuscular disease affecting males. This disease is caused by polyglutamine expansion mutations of the androgen receptor (AR) gene. Although KD/SBMA has been traditionally considered a motor neuron disease, emerging evidence points to a central etiological role of muscle. We previously reported a microarray study of genes differentially expressed in muscle of three genetically unique mouse models of KD/SBMA but were unable to detect those which are androgen-dependent or are associated with onset of symptoms. Methodology/Principal Findings In the current study we examined the time course and androgen-dependence of transcriptional changes in the HSA-AR transgenic (Tg) mouse model, in which females have a severe phenotype after acute testosterone treatment. Using microarray analysis we identified differentially expressed genes at the onset and peak of muscle weakness in testosterone-treated Tg females. We found both transient and persistent groups of differentially expressed genes and analysis of gene function indicated functional groups such as mitochondrion, ion and nucleotide binding, muscle development, and sarcomere maintenance. Conclusions/Significance By comparing the current results with those from the three previously reported models we were able to identify KD/SBMA candidate genes that are androgen dependent, and occur early in the disease process, properties which are promising for targeted therapeutics.	[Halievski, Katherine; Mo, Kaiguo; Westwood, J. Timothy; Monks, Douglas A.] Univ Toronto, Dept Psychol, Mississauga, ON L5L 1C6, Canada	University of Toronto; University Toronto Mississauga	Monks, DA (corresponding author), Univ Toronto, Dept Psychol, Mississauga, ON L5L 1C6, Canada.	ashley.monks@utoronto.ca	Halievski, Katherine/AAA-1563-2022	Halievski, Katherine/0000-0003-0365-5953	Canadian Institutes of Health Research (CIHR) [JNM-116637]; Natural Sciences and Engineering Research Council of Canada (NSERC) [RGPIN 312458]	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC))	The work reported in this manuscript received financial support from the Canadian Institutes of Health Research (CIHR www.cihr-irsc.gc.ca) Operating Grant JNM-116637 (DAM) and Natural Sciences and Engineering Research Council of Canada (NSERC - www.nserc-crsng.gc.ca) Discovery Grant RGPIN 312458 (DAM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bello NF, 2009, CELL DEATH DIFFER, V16, P921, DOI 10.1038/cdd.2009.27; Belmonte SL, 2013, AM J PHYSIOL-HEART C, V305, pH875, DOI 10.1152/ajpheart.00342.2013; Boyer JG, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00356; Cervelli M, 2012, AMINO ACIDS, V42, P441, DOI 10.1007/s00726-011-1014-z; Cervelli M, 2009, INT J BIOCHEM CELL B, V41, P934, DOI 10.1016/j.biocel.2008.09.009; Chen MH, 2005, MOL CELL BIOL, V25, P7042, DOI 10.1128/MCB.25.16.7042-7053.2005; Cortes CJ, 2014, NEURON, V82, P295, DOI 10.1016/j.neuron.2014.03.001; Deinhardt K, 2006, NEURON, V52, P293, DOI 10.1016/j.neuron.2006.08.018; DOBSON DE, 1987, J BIOL CHEM, V262, P1804; Dupuis L, 2010, CURR DRUG TARGETS, V11, P1250, DOI 10.2174/1389450111007011250; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Gertler FB, 1996, CELL, V87, P227, DOI 10.1016/S0092-8674(00)81341-0; Ghedini PC, 2008, MUSCLE NERVE, V38, P1585, DOI 10.1002/mus.21183; Johansen JA, 2009, NEUROBIOL DIS, V34, P113, DOI 10.1016/j.nbd.2008.12.009; Johansson M, 2005, MOL BIOL CELL, V16, P5480, DOI 10.1091/mbc.E05-03-0189; Jordan CL, 2008, CURR OPIN PHARMACOL, V8, P752, DOI 10.1016/j.coph.2008.08.006; Katsuno M, 2002, NEURON, V35, P843, DOI 10.1016/S0896-6273(02)00834-6; Kemp MQ, 2011, HUM MOL GENET, V20, P4475, DOI 10.1093/hmg/ddr380; KENNEDY WR, 1968, NEUROLOGY, V18, P671, DOI 10.1212/WNL.18.7.671; Krakora D, 2013, MOL THER, V21, P1602, DOI 10.1038/mt.2013.108; Krause MP, 2013, ACTA PHYSIOL, V208, P180, DOI 10.1111/apha.12099; LASPADA AR, 1991, NATURE, V352, P77, DOI 10.1038/352077a0; Lecker SH, 2004, FASEB J, V18, P39, DOI 10.1096/fj.03-0610com; Li J, 1999, J CELL BIOL, V147, P1391, DOI 10.1083/jcb.147.7.1391; MacLean HE, 2008, FASEB J, V22, P2676, DOI 10.1096/fj.08-105726; Mo KG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012922; Monks DA, 2008, HORM BEHAV, V53, P729, DOI 10.1016/j.yhbeh.2007.12.009; Monks DA, 2007, P NATL ACAD SCI USA, V104, P18259, DOI 10.1073/pnas.0705501104; Neal SJ, 2003, GENOME, V46, P879, DOI 10.1139/G03-056; Oki K, 2013, MUSCLE NERVE, V47, P823, DOI 10.1002/mus.23813; Park JJ, 2006, PHYSIOL GENOMICS, V27, P114, DOI 10.1152/physiolgenomics.00045.2006; Quinlan KGR, 2010, HUM MOL GENET, V19, P1335, DOI 10.1093/hmg/ddq010; Ramakers C, 2003, NEUROSCI LETT, V339, P62, DOI 10.1016/S0304-3940(02)01423-4; Rocchi A, 2013, J MOL NEUROSCI, V50, P514, DOI 10.1007/s12031-013-9978-7; Rocha N, 2009, J CELL BIOL, V185, P1209, DOI 10.1083/jcb.200811005; Sacheck JM, 2007, FASEB J, V21, P140, DOI 10.1096/fj.06-6604com; Sopher BL, 2004, NEURON, V41, P687, DOI 10.1016/S0896-6273(04)00082-0; Strand AD, 2005, HUM MOL GENET, V14, P1863, DOI 10.1093/hmg/ddi192; Vihervaara T, 2011, CELL MOL LIFE SCI, V68, P537, DOI 10.1007/s00018-010-0470-z; Vuocolo T, 2007, PHYSIOL GENOMICS, V28, P253, DOI 10.1152/physiolgenomics.00121.2006; Wolff C, 2003, CURR BIOL, V13, P1169, DOI 10.1016/S0960-9822(03)00461-5; Yu Z, 2006, J CLIN INVEST, V116, P2663, DOI 10.1172/JCI28773	42	5	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2015	10	2							e0118120	10.1371/journal.pone.0118120	http://dx.doi.org/10.1371/journal.pone.0118120			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC2ZH	25719894	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000350213200037
J	Iversen, H; Lindback, T; L'Abee-Lund, TM; Roos, N; Aspholm, M; Arnesen, LS				Iversen, Hildegunn; Lindback, Toril; L'Abee-Lund, Trine M.; Roos, Norbert; Aspholm, Marina; Arnesen, Lotte Stenfors			The Gut Bacterium Bacteroides thetaiotaomicron Influences the Virulence Potential of the Enterohemorrhagic Escherichia coli O103:H25	PLOS ONE			English	Article							NON-O157 SHIGA TOXIN; REAL-TIME PCR; GENE-EXPRESSION; PROTEIN SECRETION; GROWTH; METABOLISM; LOCUS; TRANSLOCATION; COLONIZATION; CHEMOTAXIS	Enterohemorrhagic E. coli (EHEC) is associated with severe gastrointestinal disease. Upon entering the gastrointestinal tract, EHEC is exposed to a fluctuating environment and a myriad of other bacterial species. To establish an infection, EHEC strains have to modulate their gene expression according to the GI tract environment. In order to explore the interspecies interactions between EHEC and an human intestinal commensal, the global gene expression profile was determined of EHEC O103:H25 (EHEC NIPH-11060424) co-cultured with B. thetaiotaomicron (CCUG 10774) or grown in the presence of spent medium from B. thetaiotaomicron. Microarray analysis revealed that approximately 1% of the EHEC NIPH-11060424 genes were significantly up-regulated both in co-culture (30 genes) and in the presence of spent medium (44 genes), and that the affected genes differed between the two conditions. In co-culture, genes encoding structural components of the type three secretion system were among the most affected genes with an almost 4-fold up-regulation, while the most affected genes in spent medium were involved in chemotaxis and were more than 3-fold up-regulated. The operons for type three secretion system (TTSS) are located on the Locus of enterocyte effacement (LEE) pathogenicity island, and qPCR showed that genes of all five operons (LEE1-LEE5) were up-regulated. Moreover, an increased adherence to HeLa cells was observed in EHEC NIPH-11060424 exposed to B. thetaiotaomicron. Expression of stx2 genes, encoding the main virulence factor of EHEC, was down-regulated in both conditions (co-culture/spent medium). These results show that expression of EHEC genes involved in colonization and virulence is modulated in response to direct interspecies contact between cells, or to diffusible factors released from B. thetaiotaomicron. Such interspecies interactions could allow the pathogen to recognize its predilection site and modulate its behaviour accordingly, thus increasing the efficiency of colonization of the colon mucosa, facilitating its persistence and increasing its virulence potential.	[Iversen, Hildegunn; Lindback, Toril; L'Abee-Lund, Trine M.; Aspholm, Marina; Arnesen, Lotte Stenfors] Norwegian Univ Life Sci, Dept Food Safety & Infect Biol, Oslo, Norway; [Roos, Norbert] Univ Oslo, Dept Biosci, Oslo, Norway	Norwegian University of Life Sciences; University of Oslo	Arnesen, LS (corresponding author), Norwegian Univ Life Sci, Dept Food Safety & Infect Biol, Oslo, Norway.	lotte.s.arnesen@nmbu.no	Aspholm, Marina/ABB-5298-2020; Lindbäck, Toril/AAZ-9278-2020	Aspholm, Marina/0000-0003-3175-6022; Lindback, Toril/0000-0002-5245-1087				[Anonymous], 2014, BIOCONDUCTOR OPEN SO; [Anonymous], 2014, NCBI GENE EXPRESSION; Aoki SK, 2005, SCIENCE, V309, P1245, DOI 10.1126/science.1115109; Arumugam M, 2011, NATURE, V473, P174, DOI 10.1038/nature09944; Bansal T, 2007, INFECT IMMUN, V75, P4597, DOI 10.1128/IAI.00630-07; Barba J, 2005, J BACTERIOL, V187, P7918, DOI 10.1128/JB.187.23.7918-7930.2005; Bassler BL, 2006, CELL, V125, P237, DOI 10.1016/j.cell.2006.04.001; Berdichevsky T, 2005, J BACTERIOL, V187, P349, DOI 10.1128/JB.187.1.349-357.2005; Bingle LEH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0080160; Bott M, 1997, ARCH MICROBIOL, V167, P78, DOI 10.1007/s002030050419; Breitbart M, 2003, J BACTERIOL, V185, P6220, DOI 10.1128/JB.185.20.6220-6223.2003; Bren A, 2000, J BACTERIOL, V182, P6865, DOI 10.1128/JB.182.24.6865-6873.2000; Campellone KG, 2004, J CELL BIOL, V164, P407, DOI 10.1083/jcb.200306032; Carey CM, 2008, J MICROBIOL METH, V73, P125, DOI 10.1016/j.mimet.2008.01.014; Caron E, 2006, CURR OPIN MICROBIOL, V9, P40, DOI 10.1016/j.mib.2005.12.008; CATO EP, 1976, INT J SYST BACTERIOL, V26, P230, DOI 10.1099/00207713-26-2-230; Croxen MA, 2010, NAT REV MICROBIOL, V8, P26, DOI 10.1038/nrmicro2265; Cummings JH, 1997, JPEN-PARENTER ENTER, V21, P357, DOI 10.1177/0148607197021006357; de Sablet T, 2009, INFECT IMMUN, V77, P783, DOI 10.1128/IAI.01048-08; Delcenserie V, 2012, J FOOD PROTECT, V75, P748, DOI 10.4315/0362-028X.JFP-11-384; Draghici S, 2006, TRENDS GENET, V22, P101, DOI 10.1016/j.tig.2005.12.005; Eisenbach M, 1996, MOL MICROBIOL, V20, P903, DOI 10.1111/j.1365-2958.1996.tb02531.x; ELEY A, 1985, J MED MICROBIOL, V19, P195, DOI 10.1099/00222615-19-2-195; Elliott SJ, 2000, INFECT IMMUN, V68, P6115, DOI 10.1128/IAI.68.11.6115-6126.2000; Fischbach MA, 2011, CELL HOST MICROBE, V10, P336, DOI 10.1016/j.chom.2011.10.002; Foster DB, 2013, VIRULENCE, V4, P315, DOI 10.4161/viru.24318; Fratamico PM, 2011, J FOOD SCI, V76, pM79, DOI 10.1111/j.1750-3841.2010.01952.x; FREITAG NE, 1995, MOL MICROBIOL, V16, P575, DOI 10.1111/j.1365-2958.1995.tb02420.x; Garg N, 2014, ANTON LEEUW INT J G, V105, P289, DOI 10.1007/s10482-013-0082-3; Garmendia J, 2005, INFECT IMMUN, V73, P2573, DOI 10.1128/IAI.73.5.2573-2585.2005; Genleman R, 2005, BIOINFORMATICS COMPU, P397; Giron JA, 2002, MOL MICROBIOL, V44, P361, DOI 10.1046/j.1365-2958.2002.02899.x; Gordon DM, 2006, MICROBIOL-SGM, V152, P3239, DOI 10.1099/mic.0.28690-0; Hartland EL, 2000, MOL MICROBIOL, V35, P1483, DOI 10.1046/j.1365-2958.2000.01814.x; Hayes CS, 2010, ANNU REV GENET, V44, P71, DOI 10.1146/annurev.genet.42.110807.091449; Herold S, 2005, ANTIMICROB AGENTS CH, V49, P931, DOI 10.1128/AAC.49.3.931-944.2005; Hibbing ME, 2010, NAT REV MICROBIOL, V8, P15, DOI 10.1038/nrmicro2259; Iyoda S, 2006, J BACTERIOL, V188, P5682, DOI 10.1128/JB.00352-06; Jandu N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004889; Johnson KE, 2006, CLIN INFECT DIS, V43, P1587, DOI 10.1086/509573; Johnson WE, 2007, BIOSTATISTICS, V8, P118, DOI 10.1093/biostatistics/kxj037; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kanehisa M, 2014, NUCLEIC ACIDS RES, V42, pD199, DOI 10.1093/nar/gkt1076; Kaper JB, 2004, NAT REV MICROBIOL, V2, P123, DOI 10.1038/nrmicro818; Kaper JB, 1998, CURR OPIN MICROBIOL, V1, P103, DOI 10.1016/S1369-5274(98)80149-5; KARLSSON FH, 2011, MICROB ECOL, V61, P473, DOI DOI 10.1007/s00248-010-9796-1; Keeney KM, 2013, CURR BIOL, V23, pR108, DOI 10.1016/j.cub.2012.12.027; Kenny B, 1997, INFECT IMMUN, V65, P2606, DOI 10.1128/IAI.65.7.2606-2612.1997; L'Abee-Lund TM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031413; Leek JT, 2012, BIOINFORMATICS, V28, P882, DOI 10.1093/bioinformatics/bts034; Little AEF, 2008, ANNU REV MICROBIOL, V62, P375, DOI 10.1146/annurev.micro.030608.101423; Marlovits TC, 2010, CURR OPIN MICROBIOL, V13, P47, DOI 10.1016/j.mib.2009.11.001; Medellin-Pena MJ, 2007, APPL ENVIRON MICROB, V73, P4259, DOI 10.1128/AEM.00159-07; Miranda RL, 2004, INFECT IMMUN, V72, P1666, DOI 10.1128/IAI.72.3.1666-1676.2004; MOLLBY R, 1976, J GEN MICROBIOL, V96, P137, DOI 10.1099/00221287-96-1-137; Morey JS, 2006, BIOL PROCED ONLINE, V8, P175, DOI 10.1251/bpo126; Muniesa M, 2003, INFECT IMMUN, V71, P4554, DOI 10.1128/IAI.71.8.4554-4562.2003; Nataro JP, 1998, CLIN MICROBIOL REV, V11, P403; Njoroge JW, 2012, MBIO, V3, DOI 10.1128/mBio.00280-12; Nouaille S, 2009, APPL ENVIRON MICROB, V75, P4473, DOI 10.1128/AEM.02653-08; Ogura Y, 2009, P NATL ACAD SCI USA, V106, P17939, DOI 10.1073/pnas.0903585106; Pacheco AR, 2012, NATURE, V492, P113, DOI 10.1038/nature11623; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Ruhe ZC, 2013, TRENDS MICROBIOL, V21, P230, DOI 10.1016/j.tim.2013.02.003; Sambrook J., 2001, MOL CLONING LAB MANU; Scallan E, 2012, CLIN INFECT DIS, V54, pS381, DOI 10.1093/cid/cis257; Schimmer B, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-41; Schmidt MA, 2010, CELL MICROBIOL, V12, P1544, DOI 10.1111/j.1462-5822.2010.01518.x; Sekirov I, 2010, PHYSIOL REV, V90, P859, DOI 10.1152/physrev.00045.2009; Shoaie S, 2013, SCI REP-UK, V3, DOI 10.1038/srep02532; Sircili MP, 2004, INFECT IMMUN, V72, P2329, DOI 10.1128/IAI.72.4.2329-2337.2004; Smith JL, 2012, J FOOD PROTECT, V75, P2241, DOI 10.4315/0362-028X.JFP-12-255; Sourjik V, 2012, CURR OPIN CELL BIOL, V24, P262, DOI 10.1016/j.ceb.2011.11.008; Sperandio V, 2003, P NATL ACAD SCI USA, V100, P8951, DOI 10.1073/pnas.1537100100; Sperandio V, 2002, INFECT IMMUN, V70, P3085, DOI 10.1128/IAI.70.6.3085-3093.2002; Sperandio V, 1999, P NATL ACAD SCI USA, V96, P15196, DOI 10.1073/pnas.96.26.15196; Stecher B, 2013, FEMS MICROBIOL REV, V37, P793, DOI 10.1111/1574-6976.12024; Untergasser A, 2007, NUCLEIC ACIDS RES, V35, pW71, DOI 10.1093/nar/gkm306; Vayssier-Taussat M, 2014, FRONT CELL INFECT MI, V4, DOI 10.3389/fcimb.2014.00029; Wadhams GH, 2004, NAT REV MOL CELL BIO, V5, P1024, DOI 10.1038/nrm1524; Wagner PL, 2001, J BACTERIOL, V183, P2081, DOI 10.1128/JB.183.6.2081-2085.2001; Wagner PL, 2001, INFECT IMMUN, V69, P1934, DOI 10.1128/IAI.69.3.1934-1937.2001; Waldor MK, 2005, CURR OPIN MICROBIOL, V8, P459, DOI 10.1016/j.mib.2005.06.001; Wong ARC, 2011, MOL MICROBIOL, V80, P1420, DOI 10.1111/j.1365-2958.2011.07661.x; Wong ML, 2005, BIOTECHNIQUES, V39, P75, DOI 10.2144/05391RV01; Xu J, 2003, SCIENCE, V299, P2074, DOI 10.1126/science.1080029; Yona-Nadler C, 2003, MICROBIOL-SGM, V149, P877, DOI 10.1099/mic.0.25970-0; Zoetendal EG, 2006, MOL MICROBIOL, V59, P1639, DOI 10.1111/j.1365-2958.2006.05056.x	90	13	15	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2015	10	2							e0118140	10.1371/journal.pone.0118140	http://dx.doi.org/10.1371/journal.pone.0118140			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC2ZH	25719195	Green Published, gold			2022-12-27	WOS:000350213200038
J	Ma, QG; Meng, L; Shen, Q				Ma, Qingguo; Meng, Liang; Shen, Qiang			You Have My Word: Reciprocity Expectation Modulates Feedback-Related Negativity in the Trust Game	PLOS ONE			English	Article							REWARD; GAINS; RESPONSES; PROMISES; LOSSES	Promise is one of the most powerful tools producing trust and facilitating cooperation, and sticking to the promise is deemed as a key social norm in social interactions. The present study explored the extent to which promise would influence investors' decision-making in the trust game where promise had no predictive value regarding trustees' reciprocation. In addition, we examined the neural underpinnings of the investors' outcome processing related to the trustees' promise keeping and promise breaking. Consistent with our hypothesis, behavioral results indicated that promise could effectively increase the investment frequency of investors. Electrophysiological results showed that, promise induced larger differentiated-FRN responses to the reward and non-reward discrepancy. Taken together, these results suggested that promise would promote cooperative behavior, while breach of promise would be regarded as a violation of the social norm, corroborating the vital role of non-enforceable commitment in social decision making.	[Ma, Qingguo; Meng, Liang; Shen, Qiang] Zhejiang Univ, Sch Management, Hangzhou 310003, Zhejiang, Peoples R China; [Ma, Qingguo; Meng, Liang; Shen, Qiang] Zhejiang Univ, Neuromanagement Lab, Hangzhou 310003, Zhejiang, Peoples R China; [Shen, Qiang] Beijing Normal Univ, Natl Key Lab Cognit Neurosci & Learning, Beijing 100875, Peoples R China	Zhejiang University; Zhejiang University; Beijing Normal University	Shen, Q (corresponding author), Zhejiang Univ, Sch Management, Hangzhou 310003, Zhejiang, Peoples R China.	johnsonzhj@gmail.com	Meng, Liang/M-9838-2016	Meng, Liang/0000-0002-0470-7818	National Natural Science Foundation of China [71371167]; Philosophy and Social Science Planning Project of Zhejiang Province [14NDJC011Z]; Open Research Fund of the State Key Laboratory of Cognitive Neuroscience and Learning of Beijing Normal University	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Philosophy and Social Science Planning Project of Zhejiang Province; Open Research Fund of the State Key Laboratory of Cognitive Neuroscience and Learning of Beijing Normal University	This work was supported by grant No. 71371167 from the National Natural Science Foundation of China, and Philosophy and Social Science Planning Project of Zhejiang Province (No. 14NDJC011Z). Qiang Shen was funded by Open Research Fund of the State Key Laboratory of Cognitive Neuroscience and Learning of Beijing Normal University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baumgartner T, 2009, NEURON, V64, P756, DOI 10.1016/j.neuron.2009.11.017; BERG J, 1995, GAME ECON BEHAV, V10, P122, DOI 10.1006/game.1995.1027; Boksem MAS, 2010, SOC NEUROSCI-UK, V5, P118, DOI 10.1080/17470910903202666; Charness G, 2006, ECONOMETRICA, V74, P1579, DOI 10.1111/j.1468-0262.2006.00719.x; Charness G, 2010, ECON LETT, V107, P281, DOI 10.1016/j.econlet.2010.02.009; Chen J, 2012, NEUROSCI LETT, V517, P65, DOI 10.1016/j.neulet.2012.02.082; Declerck CH, 2013, BRAIN COGNITION, V81, P95, DOI 10.1016/j.bandc.2012.09.009; Donkers FCL, 2005, J PSYCHOPHYSIOL, V19, P256, DOI 10.1027/0269-8803.19.4.256; Gehring WJ, 2002, SCIENCE, V295, P2279, DOI 10.1126/science.1066893; Hajcak G, 2007, PSYCHOPHYSIOLOGY, V44, P905, DOI 10.1111/j.1469-8986.2007.00567.x; Holroyd CB, 2004, PSYCHOPHYSIOLOGY, V41, P245, DOI 10.1111/j.1469-8986.2004.00152.x; Johnson ND, 2011, J ECON PSYCHOL, V32, P865, DOI 10.1016/j.joep.2011.05.007; Li P, 2010, NEUROIMAGE, V52, P1727, DOI 10.1016/j.neuroimage.2010.04.275; Luo Y, 2014, PSYCHOPHYSIOLOGY, V51, P834, DOI 10.1111/psyp.12235; Ma QG, 2014, BEHAV BRAIN RES, V261, P1, DOI 10.1016/j.bbr.2013.11.045; Ma QG, 2011, NEUROIMAGE, V54, P2472, DOI 10.1016/j.neuroimage.2010.10.045; Martin RS, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00304; Mussel P, 2014, PSYCHOPHYSIOLOGY, V51, P358, DOI 10.1111/psyp.12184; Osinsky R, 2014, SOC COGN AFFECT NEUR, V9, P731, DOI 10.1093/scan/nst051; Rousseau D.M., 1989, EMPL RESPONSIB RIGHT, V2, P121, DOI [https://doi.org/10.1007/BF01384942, DOI 10.1007/BF01384942]; Schniter E, 2013, J ECON BEHAV ORGAN, V94, P242, DOI 10.1016/j.jebo.2012.09.011; Tzieropoulos H, 2013, SOC NEUROSCI-UK, V8, P407, DOI 10.1080/17470919.2013.832375; Wu Y, 2009, BRAIN RES, V1286, P114, DOI 10.1016/j.brainres.2009.06.032; Yeung N, 2005, CEREB CORTEX, V15, P535, DOI 10.1093/cercor/bhh153; Yu RJ, 2006, NEUROREPORT, V17, P1747, DOI 10.1097/01.wnr.0000239960.98813.50; Yu RJ, 2009, J COGNITIVE NEUROSCI, V21, P684, DOI 10.1162/jocn.2009.21034; Zhou ZH, 2010, NEUROPSYCHOLOGIA, V48, P3606, DOI 10.1016/j.neuropsychologia.2010.08.010	27	17	17	3	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2015	10	2							e0119129	10.1371/journal.pone.0119129	http://dx.doi.org/10.1371/journal.pone.0119129			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CC2ZH	25719408	Green Submitted, Green Published, gold			2022-12-27	WOS:000350213200061
J	Carballo, F; Freidin, E; Putrino, N; Shimabukuro, C; Casanave, E; Bentosela, M				Carballo, Fabricio; Freidin, Esteban; Putrino, Natalia; Shimabukuro, Carolina; Casanave, Emma; Bentosela, Mariana			Dog's Discrimination of Human Selfish and Generous Attitudes: The Role of Individual Recognition, Experience, and Experimenters' Gender	PLOS ONE			English	Article							CANIS-FAMILIARIS; DOMESTIC DOGS; COGNITION; FOOD; RESPONSIVENESS; PERFORMANCE; RECIPROCITY; EVOLUTION; STRESS; FACE	Discrimination of and memory for others' generous and selfish behaviors could be adaptive abilities in social animals. Dogs have seemingly expressed such skills in both direct and indirect interactions with humans. However, recent studies suggest that their capacity may rely on cues other than people's individual characteristics, such as the place where the person stands. Thus, the conditions under which dogs recognize individual humans when solving cooperative tasks still remains unclear. With the aim of contributing to this problem, we made dogs interact with two human experimenters, one generous ( pointed towards the food, gave ostensive cues, and allowed the dog to eat it) and the other selfish ( pointed towards the food, but ate it before the dog could have it). Then subjects could choose between them (studies 1-3). In study 1, dogs took several training trials to learn the discrimination between the generous and the selfish experimenters when both were of the same gender. In study 2, the discrimination was learned faster when the experimenters were of different gender as evidenced both by dogs' latencies to approach the bowl in training trials as well as by their choices in preference tests. Nevertheless, dogs did not get confused by gender when the experimenters were changed in between the training and the choice phase in study 3. We conclude that dogs spontaneously used human gender as a cue to discriminate between more and less cooperative experimenters. They also relied on some other personal feature which let them avoid being confused by gender when demonstrators were changed. We discuss these results in terms of dogs' ability to recognize individuals and the potential advantage of this skill for their lives in human environments.	[Carballo, Fabricio; Freidin, Esteban; Putrino, Natalia; Shimabukuro, Carolina; Bentosela, Mariana] CONICET UBA, Med Res Inst IDIM, Canid Behav Res Grp ICOC, Buenos Aires, DF, Argentina; [Carballo, Fabricio; Casanave, Emma] CONICET UNS, Inst Invest Biol & Biomed INBIOSUR, Bahia Blanca, Buenos Aires, Argentina; [Freidin, Esteban] CONICET UNS, IIESS, Bahia Blanca, Buenos Aires, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of the South; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of the South	Bentosela, M (corresponding author), CONICET UBA, Med Res Inst IDIM, Canid Behav Res Grp ICOC, Buenos Aires, DF, Argentina.	marianabentosela@gmail.com	Putrino, Natalia/AAV-7712-2021; Freidin, Esteban/AAE-7426-2020	Casanave, Emma Beatriz/0000-0003-3482-8175	"Aprendizaje y comunicacion entre perros domesticos y personas: comparaciones intra e interespecificas,"Agencia Nacional de Promocion Cientifica y Tecnologica, PICT Bicentenario [0350]	"Aprendizaje y comunicacion entre perros domesticos y personas: comparaciones intra e interespecificas,"Agencia Nacional de Promocion Cientifica y Tecnologica, PICT Bicentenario	Funding was provided by the grant "Aprendizaje y comunicacion entre perros domesticos y personas: comparaciones intra e interespecificas," Agencia Nacional de Promocion Cientifica y Tecnologica, PICT Bicentenario 2010, No 0350 to MB.	Adachi I, 2007, ANIM COGN, V10, P17, DOI 10.1007/s10071-006-0025-8; Brosnan SF, 2010, PHILOS T R SOC B, V365, P2699, DOI 10.1098/rstb.2010.0154; Bshary R, 2006, NATURE, V441, P975, DOI 10.1038/nature04755; Buttelmann D, 2013, ANIM COGN, V16, P137, DOI 10.1007/s10071-012-0560-4; Carter GG, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2573; Cooper JJ, 2003, APPL ANIM BEHAV SCI, V81, P229, DOI 10.1016/S0168-1591(02)00284-8; Custance D, 2012, ANIM COGN, V15, P851, DOI 10.1007/s10071-012-0510-1; Dorey NR, 2010, ANIM BEHAV, V79, P37, DOI 10.1016/j.anbehav.2009.09.032; Druzhkova AS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057754; Elgier AM, 2009, BEHAV PROCESS, V81, P44, DOI 10.1016/j.beproc.2008.12.023; Freidin E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079198; Gacsi M, 2004, ANIM COGN, V7, P144, DOI 10.1007/s10071-003-0205-8; GHEUSI G, 1994, BEHAV PROCESS, V33, P59, DOI 10.1016/0376-6357(94)90060-4; Hare B, 2005, TRENDS COGN SCI, V9, P439, DOI 10.1016/j.tics.2005.07.003; Hare B, 2007, CURR DIR PSYCHOL SCI, V16, P60, DOI 10.1111/j.1467-8721.2007.00476.x; Harris AC, 2002, PSYCHOL REC, V52, P429, DOI 10.1007/BF03395196; Hauser MD, 2003, P ROY SOC B-BIOL SCI, V270, P2363, DOI 10.1098/rspb.2003.2509; Hennessy MB, 1998, APPL ANIM BEHAV SCI, V61, P63, DOI 10.1016/S0168-1591(98)00179-8; Injaian A, 2014, ANIM BEHAV, V87, P91, DOI 10.1016/j.anbehav.2013.10.014; Jaeggi AV, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.1615; Jaeggi AV, 2011, BEHAV ECOL SOCIOBIOL, V65, P2125, DOI 10.1007/s00265-011-1221-3; Krasnow MM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045662; Kundey SMA, 2011, ANIM COGN, V14, P291, DOI 10.1007/s10071-010-0362-5; Lai WS, 2002, PHYSIOL BEHAV, V76, P225, DOI 10.1016/S0031-9384(02)00721-7; Marshall-Pescini S, 2011, ANIM BEHAV, V81, P1177, DOI 10.1016/j.anbehav.2011.02.029; McMahon S, 2010, BEHAV PROCESS, V85, P293, DOI 10.1016/j.beproc.2010.07.014; Miklosi A, 2013, TRENDS COGN SCI, V17, P287, DOI 10.1016/j.tics.2013.04.005; Nitzschner M, 2014, ANIM BEHAV, V90, P263, DOI 10.1016/j.anbehav.2014.01.035; Nowak MA, 2005, NATURE, V437, P1291, DOI 10.1038/nature04131; Patton JQ, 2005, EVOL HUM BEHAV, V26, P137, DOI 10.1016/j.evolhumbehav.2004.08.008; Petter M, 2009, BEHAV PROCESS, V82, P109, DOI 10.1016/j.beproc.2009.07.002; Pettersson H., 2011, Applied Animal Behaviour Science, V133, P235, DOI 10.1016/j.applanim.2011.05.008; Porter RH, 2006, ANIM BEHAV, V72, P707, DOI 10.1016/j.anbehav.2006.01.021; Racca A, 2010, ANIM COGN, V13, P525, DOI 10.1007/s10071-009-0303-3; Ratcliffe VF, 2014, ANIM BEHAV, V91, P127, DOI 10.1016/j.anbehav.2014.03.009; Reid PJ, 2009, BEHAV PROCESS, V80, P325, DOI 10.1016/j.beproc.2008.11.002; Silk JB, 2013, ANIM BEHAV, V85, P941, DOI 10.1016/j.anbehav.2013.02.014; Simons DJ, 1998, PSYCHON B REV, V5, P644, DOI 10.3758/BF03208840; Soproni K, 2002, J COMP PSYCHOL, V116, P27, DOI 10.1037//0735-7036.116.1.27; Soproni K, 2001, J COMP PSYCHOL, V115, P122, DOI 10.1037//0735-7036.115.2.122; Sorge RE, 2014, NAT METHODS, V11, P629, DOI [10.1038/nmeth.2935, 10.1038/NMETH.2935]; Stephens DW, 2006, BEHAV PROCESS, V71, P29, DOI 10.1016/j.beproc.2005.09.003; Stephens DW, 2002, SCIENCE, V298, P2216, DOI 10.1126/science.1078498; Stevens JR, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2010.00235; Stevens JR, 2004, TRENDS COGN SCI, V8, P60, DOI 10.1016/j.tics.2003.12.003; Subiaul F, 2008, ANIM COGN, V11, P611, DOI 10.1007/s10071-008-0151-6; Tibbetts EA, 2007, TRENDS ECOL EVOL, V22, P529, DOI 10.1016/j.tree.2007.09.001; Topal J, 2009, ADV STUD BEHAV, V39, P71, DOI 10.1016/S0065-3454(09)39003-8; Topal J, 2009, SCIENCE, V325, P1269, DOI 10.1126/science.1176960; Udell MAR, 2010, BIOL REV, V85, P327, DOI 10.1111/j.1469-185X.2009.00104.x; Vila C, 1997, SCIENCE, V276, P1687, DOI 10.1126/science.276.5319.1687; Warneken F, 2006, SCIENCE, V311, P1301, DOI 10.1126/science.1121448; Wells DL, 1999, APPL ANIM BEHAV SCI, V61, P341, DOI 10.1016/S0168-1591(98)00202-0	53	21	21	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2015	10	2							e0116314	10.1371/journal.pone.0116314	http://dx.doi.org/10.1371/journal.pone.0116314			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CC2IM	25714915	Green Published, gold, Green Submitted			2022-12-27	WOS:000350168700015
J	Hardwick, KM; Harmon, LJ; Hardwick, SD; Rosenblum, EB				Hardwick, Kayla M.; Harmon, Luke J.; Hardwick, Scott D.; Rosenblum, Erica Bree			When Field Experiments Yield Unexpected Results: Lessons Learned from Measuring Selection in White Sands Lizards	PLOS ONE			English	Article							NATURAL-SELECTION; PHENOTYPIC SELECTION; ECOLOGICAL SPECIATION; DIRECTIONAL SELECTION; DIVERGENT SELECTION; TEMPORAL VARIATION; CHIHUAHUAN DESERT; FLORAL TRAITS; EVOLUTION; DYNAMICS	Determining the adaptive significance of phenotypic traits is key for understanding evolution and diversification in natural populations. However, evolutionary biologists have an incomplete understanding of how specific traits affect fitness in most populations. The White Sands system provides an opportunity to study the adaptive significance of traits in an experimental context. Blanched color evolved recently in three species of lizards inhabiting the gypsum dunes of White Sands and is likely an adaptation to avoid predation. To determine whether there is a relationship between color and susceptibility to predation in White Sands lizards, we conducted enclosure experiments, quantifying survivorship of Holbrookia maculate exhibiting substrate-matched and substrate-mismatched phenotypes. Lizards in our study experienced strong predation. Color did not have a significant effect on survival, but we found several unexpected relationships including variation in predation over small spatial and temporal scales. In addition, we detected a marginally significant interaction between sex and color, suggesting selection for substrate matching may be stronger for males than females. We use our results as a case study to examine six major challenges frequently encountered in field-based studies of natural selection, and suggest that insight into the complexities of selection often results when experiments turn out differently than expected.	[Hardwick, Kayla M.; Harmon, Luke J.; Rosenblum, Erica Bree] Univ Idaho, Dept Biol Sci, Moscow, ID 83843 USA; [Hardwick, Scott D.] Univ Idaho, Dept Mech Engn, Moscow, ID 83843 USA; [Rosenblum, Erica Bree] Univ Calif Berkeley, Dept Environm Sci Policy & Management, Berkeley, CA 94720 USA	Idaho; University of Idaho; Idaho; University of Idaho; University of California System; University of California Berkeley	Hardwick, KM (corresponding author), Univ Idaho, Dept Biol Sci, Moscow, ID 83843 USA.	kaylamhardwick@gmail.com		Harmon, Luke/0000-0002-4985-5750	NSF CAREER grant [DEB-1054062]; NSF BEACON Center for the Study of Evolution in Action [DBI-0939454]; American Museum of Natural History; American Society of Ichthyologists and Herpetologists; University of Idaho Student Grant Program	NSF CAREER grant(National Science Foundation (NSF)NSF - Office of the Director (OD)); NSF BEACON Center for the Study of Evolution in Action; American Museum of Natural History; American Society of Ichthyologists and Herpetologists; University of Idaho Student Grant Program	This study was funded by an NSF CAREER grant (DEB-1054062; nsf.gov) to EBR. We also acknowledge support from the NSF BEACON Center for the Study of Evolution in Action (DBI-0939454; beacon-center.org) to EBR, the American Museum of Natural History to KMH (amnh.org), the American Society of Ichthyologists and Herpetologists to KMH (asih.org), and the University of Idaho Student Grant Program to KMH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARNOLD SJ, 1986, AM NAT, V128, P143, DOI 10.1086/284548; BARBAULT R, 1981, OECOLOGIA, V51, P335, DOI 10.1007/BF00540903; Barrett RDH, 2008, SCIENCE, V322, P255, DOI 10.1126/science.1159978; Barsh GS, 1996, TRENDS GENET, V12, P299, DOI 10.1016/0168-9525(96)10031-7; Bolnick DI, 2004, EVOLUTION, V58, P608, DOI 10.1111/j.0014-3820.2004.tb01683.x; Bugbee R. E., 1942, Transactions of the Kansas Academy of Science, V46, P321; Cade TJ, 1997, CONSERV BIOL, V11, P21, DOI 10.1046/j.1523-1739.1997.95279.x; Calder WA, 1965, AUK, V82, P84; Caruso CM, 2003, AM J BOT, V90, P1333, DOI 10.3732/ajb.90.9.1333; CLARKE B, 1975, GENETICS, V79, P101; Clusella Trullas S, 2007, J THERM BIOL, V32, P235, DOI 10.1016/j.jtherbio.2007.01.013; CONNELL JH, 1980, OIKOS, V35, P131, DOI 10.2307/3544421; CRAIG RB, 1978, AUK, V95, P221; Cuthill IC, 2000, ADV STUD BEHAV, V29, P159, DOI 10.1016/S0065-3454(08)60105-9; Des Roches S, 2011, ECOL EVOL, V1, DOI 10.1002/ece3.50; Diabate A, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-5; DICE LEE R., 1929, OCCASIONAL PAPERS MUS ZOOL UNIV MICHIGAN, V203, P1; Dixon J. R., 1967, LOS ANGELES COUNTY M, V129, P1; DOBZHANSKY T, 1948, GENETICS, V33, P537; Dobzhansky T., 1951, COPEIA; Endler J.A., 1986, Monographs in Population Biology, pviii; ENDLER JA, 1990, BIOL J LINN SOC, V41, P315, DOI 10.1111/j.1095-8312.1990.tb00839.x; Forsman A, 1999, J EVOLUTION BIOL, V12, P391; FORSMAN A, 1995, BIOL J LINN SOC, V55, P273, DOI 10.1111/j.1095-8312.1995.tb01066.x; Funk DJ, 1998, EVOLUTION, V52, P1744, DOI [10.2307/2411347, 10.1111/j.1558-5646.1998.tb02254.x]; Gilbert F, 1996, OECOLOGIA, V108, P479, DOI 10.1007/BF00333724; GOULD SJ, 1979, PROC R SOC SER B-BIO, V205, P581, DOI 10.1098/rspb.1979.0086; GRANT BR, 1993, P ROY SOC B-BIOL SCI, V251, P111, DOI 10.1098/rspb.1993.0016; Gross J, 1998, J EVOLUTION BIOL, V11, P589; Hager SB, 2001, J HERPETOL, V35, P326, DOI 10.2307/1566125; Hager SB., 2000, CONT HERPETOLOGY, V1, P1; Haller BC, 2014, EVOLUTION, V68, P483, DOI 10.1111/evo.12275; Hardwick KM, 2013, CURR ZOOL, V59, P20, DOI 10.1093/czoolo/59.1.20; Hereford J, 2004, EVOLUTION, V58, P2133; Hoekstra HE, 2001, P NATL ACAD SCI USA, V98, P9157, DOI 10.1073/pnas.161281098; KAUFMAN DW, 1973, AUK, V90, P204; KAUFMAN DW, 1974, J MAMMAL, V55, P271, DOI 10.2307/1378997; Kelley SW, 2011, J FIELD ORNITHOL, V82, P165, DOI 10.1111/j.1557-9263.2011.00319.x; Kingsolver JG, 2001, AM NAT, V157, P245, DOI 10.1086/319193; Kocurek G, 2007, SEDIMENT GEOL, V197, P313, DOI 10.1016/j.sedgeo.2006.10.006; LANDE R, 1983, EVOLUTION, V37, P1210, DOI 10.1111/j.1558-5646.1983.tb00236.x; Lotka AJ, 1920, P NATL ACAD SCI USA, V6, P410, DOI 10.1073/pnas.6.7.410; Lowe C. H., 1956, [S u cowlesi subsp nov] Herpetologica, V12, P125; Maad J, 2000, EVOLUTION, V54, P112, DOI 10.1111/j.0014-3820.2000.tb00012.x; MARTINS EP, 1994, LIZARD ECOLOGY, P117; MAYR E, 1947, EVOLUTION, V1, P263, DOI 10.2307/2405327; Novembre J, 2009, NAT REV GENET, V10, P745, DOI 10.1038/nrg2632; Olsson M, 2005, BIOL LETTERS, V1, P378, DOI 10.1098/rsbl.2005.0327; R Development Core Team, 2012, R LANG ENV STAT COMP; RAITT RJ, 1976, CONDOR, V78, P427, DOI 10.2307/1367091; REID WH, 1981, SOUTHWEST NAT, V26, P204, DOI 10.2307/3671120; Reimchen TE, 2002, EVOLUTION, V56, P2472; REZNICK D, 1982, EVOLUTION, V36, P1236, DOI 10.1111/j.1558-5646.1982.tb05493.x; Robertson JM, 2011, BIOL J LINN SOC, V103, P657, DOI 10.1111/j.1095-8312.2011.01644.x; Rosenblum EB, 2006, AM NAT, V167, P1, DOI 10.1086/498397; Rosenblum EB, 2004, EVOLUTION, V58, P1794, DOI 10.1111/j.0014-3820.2004.tb00462.x; Rosenblum EB, 2007, EVOLUTION, V61, P2971, DOI 10.1111/j.1558-5646.2007.00251.x; Rosenblum EB, 2011, EVOLUTION, V65, P946, DOI 10.1111/j.1558-5646.2010.01190.x; Rosenblum EB, 2010, P NATL ACAD SCI USA, V107, P2113, DOI 10.1073/pnas.0911042107; Sauer JR, 1995, P W FDN VERT ZOOL, V11, P21; SCHEMSKE DW, 1989, EVOLUTION, V43, P461, DOI 10.1111/j.1558-5646.1989.tb04240.x; Schluter D, 2001, TRENDS ECOL EVOL, V16, P372, DOI 10.1016/S0169-5347(01)02198-X; Schluter D, 2009, SCIENCE, V323, P737, DOI 10.1126/science.1160006; Siepielski AM, 2009, ECOL LETT, V12, P1261, DOI 10.1111/j.1461-0248.2009.01381.x; Smith H. M., 1943, Zoological Series Field Museum of Natural History, V24, P339; Strohecker H. F., 1947, ANN ENT SOC AMERICA, V40, P241; STROUD CP, 1949, COPEIA, P232; Totland O, 2001, ECOLOGY, V82, P2233, DOI 10.1890/0012-9658(2001)082[2233:EDPLAS]2.0.CO;2; Vamosi SM, 2002, P ROY SOC B-BIOL SCI, V269, P923, DOI 10.1098/rspb.2001.1946; Via S, 2000, EVOLUTION, V54, P1626, DOI 10.1111/j.0014-3820.2000.tb00707.x; Volterra V, 1926, NATURE, V118, P558, DOI 10.1038/118558a0	71	9	9	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2015	10	2							e0118560	10.1371/journal.pone.0118560	http://dx.doi.org/10.1371/journal.pone.0118560			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC2IM	25714838	Green Published, Green Submitted, gold			2022-12-27	WOS:000350168700086
J	Vale, CG; Pimm, SL; Brito, JC				Vale, Candida Gomes; Pimm, Stuart L.; Brito, Jose Carlos			Overlooked Mountain Rock Pools in Deserts Are Critical Local Hotspots of Biodiversity	PLOS ONE			English	Article							CONSERVATION PRIORITIES; FISH FAUNA; WATER; VEGETATION; RESOLUTION; PATTERNS; RECORDS; REFUGIA	Background The world is undergoing exceptional biodiversity loss. Most conservation efforts target biodiversity hotspots at large scales. Such approach overlooks small-sized local hotspots, which may be rich in endemic and highly threatened species. We explore the importance of mountain rock pools (gueltas) as local biodiversity hotspots in the Sahara-Sahel. Specifically, we considered how many vertebrates (total and endemics) use gueltas, what factors predict species richness, and which gueltas are of most priority for conservation. We expected to provide management recommendations, improve local biodiversity conservation, and simultaneously contribute with a framework for future enhancement of local communities' economy. The identification of local hotspots of biodiversity is important for revaluating global conservation priorities. Methodology/Principal Findings We quantified the number of vertebrate species from each taxonomic group and endemics present in 69 gueltas in Mauritania, then compared these with species present in a surrounding area and recorded in the country. We evaluated the predictors of species number's present in each guelta through a multiple regression model. We ranked gueltas by their priority for conservation taking into account the percentage of endemics and threats to each guelta. Within a mere aggregate extent of 43 ha, gueltas hold about 32% and 78% of the total taxa analysed and endemics of Mauritania, respectively. The number of species present in each guelta increased with the primary productivity and area of gueltas and occurrence of permanent water. Droughts and human activities threaten gueltas, while 64% of them are currently unprotected. Conclusion/Significance Gueltas are crucial for local biodiversity conservation and human activities. They require urgent management plans in Mauritania's mountains. They could provide refugia under climate change being important for long-term conservation of Sahara-Sahel biodiversity. Given their disproportional importance in relation to their size, they are local hotspots of biodiversity deserving global attention.	[Vale, Candida Gomes; Brito, Jose Carlos] Univ Porto, Inst Ciencias Agr Vairao, Ctr Invest Biodiversidade & Recursos Genet, CIBIO InBIO, Vairao, Portugal; [Vale, Candida Gomes; Brito, Jose Carlos] Univ Porto, Fac Ciencias, Dept Biol, P-4100 Oporto, Portugal; [Vale, Candida Gomes; Pimm, Stuart L.] Duke Univ, Nicholas Sch Environm, Durham, NC 27708 USA	Universidade do Porto; Universidade do Porto; Duke University	Vale, CG (corresponding author), Univ Porto, Inst Ciencias Agr Vairao, Ctr Invest Biodiversidade & Recursos Genet, CIBIO InBIO, R Padre Armando Quintas, Vairao, Portugal.	cgvale@cibio.up.pt	Vale, Cândida/L-7243-2013; Brito, José C./A-7831-2010; pimm, stuart/ABF-1082-2020; Vale, Candida Gomes/AAD-9655-2019	Vale, Cândida/0000-0003-1764-8607; Brito, José C./0000-0001-5444-8132; 	Mohammed bin Zayed Species Conservation Fund [11052707]; National Geographic Society [8412-08]; Fundacao para a Ciencia e Tecnologia through the EU programme COMPETE [PTDC/BIA-BEC/099934/2008]; Fundacao para a Ciencia e Tecnologia [SFRH/BD/72522/2010, IF/00459/2013]	Mohammed bin Zayed Species Conservation Fund; National Geographic Society(National Geographic Society); Fundacao para a Ciencia e Tecnologia through the EU programme COMPETE; Fundacao para a Ciencia e Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission)	This work was supported in part by the Mohammed bin Zayed Species Conservation Fund (11052707), the National Geographic Society (8412-08), and by the Fundacao para a Ciencia e Tecnologia (PTDC/BIA-BEC/099934/2008) through the EU programme COMPETE. CGV and JCB are supported by Fundacao para a Ciencia e Tecnologia (SFRH/BD/72522/2010 and IF/00459/2013, respectively). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2011, FAO DIS RISK MAN STR; Anthelme F, 2008, J ARID ENVIRON, V72, P2232, DOI 10.1016/j.jaridenv.2008.07.003; Anyamba A, 2005, J ARID ENVIRON, V63, P596, DOI 10.1016/j.jaridenv.2005.03.007; Bailey SA, 2004, ECOGRAPHY, V27, P207, DOI 10.1111/j.0906-7590.2004.03631.x; Brito JC, 2014, BIOL REV, V89, P215, DOI 10.1111/brv.12049; Brito JC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014734; Brooks N, 2004, DROUGHT AFRICAN SAHE, V61; Brooks TM, 2006, SCIENCE, V313, P58, DOI 10.1126/science.1127609; Brooks TM, 2002, CONSERV BIOL, V16, P909, DOI 10.1046/j.1523-1739.2002.00530.x; Burnham K.P., 2002, PRACTICAL INFORM THE, V2nd ed., DOI [DOI 10.1007/B97636, 10.1007/b97636]; Burnham KP, 2004, SOCIOL METHOD RES, V33, P261, DOI 10.1177/0049124104268644; Campos JC, 2012, J HYDROL, V464, P438, DOI 10.1016/j.jhydrol.2012.07.042; Carroll M.L., 2004, 250 M MODIS NORMALIZ; Cornwell WK, 2009, ECOL MONOGR, V79, P109, DOI 10.1890/07-1134.1; Davis J, 2013, GLOBAL CHANGE BIOL, V19, P1970, DOI 10.1111/gcb.12203; Dekeyser PL, 1956, MEMOIRES I FRANCAIS, V44, P9; Durant SM, 2012, SCIENCE, V336, P1379, DOI 10.1126/science.336.6087.1379; FAO, 2013, LOW INC FOOD DEF COU, DOI [10.1007/s12070-013-0687-x, DOI 10.1007/S12070-013-0687-X]; Fensham RJ, 2011, BIOL CONSERV, V144, P2459, DOI 10.1016/j.biocon.2011.06.024; Froufe E, 2013, AMPHIBIA-REPTILIA, V34, P85, DOI 10.1163/15685381-00002873; Hawkins BA, 2003, ECOLOGY, V84, P3105, DOI 10.1890/03-8006; Held IM, 2005, P NATL ACAD SCI USA, V102, P17891, DOI 10.1073/pnas.0509057102; IAEA, 2014, IS HYDR HELPS ENS SU, DOI [10.1016/j.ejogrb.2014.11.002, DOI 10.1016/J.EJOGRB.2014.11.002]; IUCN, 2014, IUCN RED LIST THREAT, DOI [10.1016/j.ejogrb.2014.11.002, DOI 10.1016/J.EJOGRB.2014.11.002]; Kirsch-Jung KP, 2014, CONSERVATION UTILISA; Kremen C, 2008, SCIENCE, V320, P222, DOI 10.1126/science.1155193; McBurnie G, 2014, J ARID ENVIRON, V113, P69; Monod T., 1951, Bull Inst franc Afr noire, V13, P802; Murphy NP, 2013, MOL PHYLOGENET EVOL, V66, P645, DOI 10.1016/j.ympev.2012.10.013; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Olson DM, 2001, BIOSCIENCE, V51, P933, DOI 10.1641/0006-3568(2001)051[0933:TEOTWA]2.0.CO;2; Padial J. M., 2006, Graellsia, V62, P159; Padial JM, 2005, MAMMALIA, V69, P239, DOI 10.1515/mamm.2005.021; Padial JM, 2014, AMPHIBAIN CONSERVA 2, V27; Pimm SL, 2014, SCIENCE, V344, P987, DOI 10.1126/science.1246752; Tear TH, 2014, BIOL CONSERV, V173, P42, DOI 10.1016/j.biocon.2014.01.028; Telleria JL, 2009, BIODIVERSIDAD CONSER; Telleria JL, 2008, ORYX, V42, P292, DOI 10.1017/S0030605308007850; Touray S, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-193; Trape S, 2013, CR BIOL, V336, P582, DOI 10.1016/j.crvi.2013.10.001; Trape S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004400; UNDP, 2010, HUM DEV REP 2010; United Nations, 2014, UN DEC DES FIGHT DES; Vale CG, 2014, DIVERS DISTRIB, V20, P20, DOI 10.1111/ddi.12115; Villiers A., 1953, B IFAN, V2, P631; Wilson JS, 2012, DIVERS DISTRIB, V18, P1139, DOI 10.1111/j.1472-4642.2012.00902.x	46	29	29	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2015	10	2							e0118367	10.1371/journal.pone.0118367	http://dx.doi.org/10.1371/journal.pone.0118367			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC2IM	25714751	Green Published, Green Submitted, gold			2022-12-27	WOS:000350168700068
J	Visweswaran, M; Schiefer, L; Arfuso, F; Dilley, RJ; Newsholme, P; Dharmarajan, A				Visweswaran, Malini; Schiefer, Luca; Arfuso, Frank; Dilley, Rodney J.; Newsholme, Philip; Dharmarajan, Arun			Wnt Antagonist Secreted Frizzled-Related Protein 4 Upregulates Adipogenic Differentiation in Human Adipose Tissue-Derived Mesenchymal Stem Cells	PLOS ONE			English	Article							OBESITY; GENE	With more than 1.4 billion overweight or obese adults worldwide, obesity and progression of the metabolic syndrome are major health and economic challenges. To address mechanisms of obesity, adipose tissue-derived mesenchymal stem cells (ADSCs) are being studied to detail the molecular mechanisms involved in adipogenic differentiation. Activation of the Wnt signalling pathway has inhibited adipogenesis from precursor cells. In our study, we examined this anti-adipogenic effect in further detail stimulating Wnt with lithium chloride (LiCl) and 6-bromo indirubin 3'oxime (BIO). We also examined the effect of Wnt inhibition using secreted frizzled-related protein 4 (sFRP4), which we have previously shown to be pro-apoptotic, anti-angiogenic, and anti-tumorigenic. Wnt stimulation in LiCl and BIO-treated ADSCs resulted in a significant reduction (2.7-fold and 12-fold respectively) in lipid accumulation as measured by Oil red O staining while Wnt inhibition with sFRP4 induced a 1.5-fold increase in lipid accumulation. Furthermore, there was significant 1.2-fold increase in peroxisome proliferator-activated receptor gamma (PPAR gamma) and CCAAT/enhancer binding protein alpha (C/EBP alpha), and 1.3-fold increase in acetyl CoA carboxylase protein levels. In contrast, the expression of adipogenic proteins (PPAR gamma, C/EBP alpha, and acetyl CoA carboxylase) were decreased significantly with LiCl (by 1.6, 2.6, and 1.9-fold respectively) and BIO (by 7, 17, and 5.6-fold respectively) treatments. These investigations demonstrate interplay between Wnt antagonism and Wnt activation during adipogenesis and indicate pathways for therapeutic intervention to control this process.	[Visweswaran, Malini; Schiefer, Luca; Arfuso, Frank; Newsholme, Philip; Dharmarajan, Arun] Curtin Univ, Curtin Hlth Innovat Res Inst, Sch Biomed Sci, Perth, WA 6845, Australia; [Schiefer, Luca] Med Univ Lubeck, D-23538 Lubeck, Germany; [Dilley, Rodney J.] Univ Western Australia, Ear Sci Ctr, Perth, WA 6009, Australia; [Dilley, Rodney J.] Ear Sci Inst Australia, Perth, WA, Australia	Curtin University; University of Lubeck; University of Western Australia; Ear Science Institute Australia	Dharmarajan, A (corresponding author), Curtin Univ, Curtin Hlth Innovat Res Inst, Sch Biomed Sci, Perth, WA 6845, Australia.	a.dharmarajan@curtin.edu.au	Dilley, Rodney/A-9921-2008; Newsholme, Philip/D-4939-2016	Dilley, Rodney/0000-0003-4681-7502; Newsholme, Philip/0000-0002-0500-6984; Visweswaran, Malini/0000-0003-1200-0131; Dharmarajan, Arun/0000-0002-6715-6005	Curtin School of Biomedical Sciences; Faculty of Health Sciences, Ear Science Institute Australia	Curtin School of Biomedical Sciences; Faculty of Health Sciences, Ear Science Institute Australia	We thank the Curtin School of Biomedical Sciences and Faculty of Health Sciences, Ear Science Institute Australia for research support.	Bennett CN, 2002, J BIOL CHEM, V277, P30998, DOI 10.1074/jbc.M204527200; Bray GA, 2004, J CLIN ENDOCR METAB, V89, P2583, DOI 10.1210/jc.2004-0535; Chi Ying, 2014, Zhongguo Shi Yan Xue Ye Xue Za Zhi, V22, P588, DOI 10.7534/j.issn.1009-2137.2014.03.003; Christodoulides C, 2009, TRENDS ENDOCRIN MET, V20, P16, DOI 10.1016/j.tem.2008.09.002; Constantinou Thecla, 2008, J Mol Signal, V3, P10, DOI 10.1186/1750-2187-3-10; Ehrlund A, 2013, J CLIN ENDOCR METAB, V98, P2012; Fock KM, 2013, J GASTROEN HEPATOL, V28, P59, DOI 10.1111/jgh.12407; Ghoorah K, 2014, EUR HEART J ACUTE CA; Kawano Y, 2003, J CELL SCI, V116, P2627, DOI 10.1242/jcs.00623; Kern S, 2006, STEM CELLS, V24, P1294, DOI 10.1634/stemcells.2005-0342; Kirton JP, 2007, CIRC RES, V101, P581, DOI 10.1161/CIRCRESAHA.107.156372; Lee S, 2013, BIOCHEM PHARMACOL, V85, P965, DOI 10.1016/j.bcp.2012.12.023; Mahdi T, 2012, CELL METAB, V16, P625, DOI 10.1016/j.cmet.2012.10.009; Mitchell RJ, 2014, AUST NZ J PUBL HEAL, V38, P13, DOI 10.1111/1753-6405.12152; Muley A, 2010, AM J PATHOL, V176, P1505, DOI 10.2353/ajpath.2010.090465; Nishizuka M, 2008, FEBS LETT, V582, P3201, DOI 10.1016/j.febslet.2008.08.011; Okamura M, 2009, P NATL ACAD SCI USA, V106, P5819, DOI 10.1073/pnas.0901676106; Park JR, 2008, ROLES WNT ANTAGONIST; Ragni E, 2013, INT J BIOCHEM CELL B, V45, P2456, DOI 10.1016/j.biocel.2013.07.024; Ross SE, 2000, SCIENCE, V289, P950, DOI 10.1126/science.289.5481.950; Saran U, 2012, BMC CELL BIOL, V13, DOI 10.1186/1471-2121-13-25; Wolf V, 1997, FEBS LETT, V417, P385, DOI 10.1016/S0014-5793(97)01324-0; Yu G, 2011, METHODS MOL BIOL, V702, P193, DOI 10.1007/978-1-61737-960-4_14; Zaragosi LE, 2008, BMC CELL BIOL, V9, DOI 10.1186/1471-2121-9-11; Zuk PA, 2002, MOL BIOL CELL, V13, P4279, DOI 10.1091/mbc.E02-02-0105; Zuk PA, 2001, TISSUE ENG, V7, P211, DOI 10.1089/107632701300062859	26	20	21	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2015	10	2							e0118005	10.1371/journal.pone.0118005	http://dx.doi.org/10.1371/journal.pone.0118005			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC2IM	25714610	Green Submitted, Green Published, gold			2022-12-27	WOS:000350168700048
J	Cresawn, SG; Pope, WH; Jacobs-Sera, D; Bowman, CA; Russell, DA; Dedrick, RM; Adair, T; Anders, KR; Ball, S; Bollivar, D; Breitenberger, C; Burnett, SH; Butela, K; Byrnes, D; Carzo, S; Cornely, KA; Cross, T; Daniels, RL; Dunbar, D; Findley, AM; Gissendanner, CR; Golebiewska, UP; Hartzog, GA; Hatherill, JR; Hughes, LE; Jalloh, CS; De Los Santos, C; Ekanem, K; Khambule, SL; King, RA; King-Smith, C; Klyczek, K; Krukonis, GP; Laing, C; Lapin, JS; Lopez, AJ; Mkhwanazi, SM; Molloy, SD; Moran, D; Munsamy, V; Pacey, E; Plymale, R; Poxleitner, M; Reyna, N; Schildbach, JF; Stukey, J; Taylor, SE; Ware, VC; Wellmann, AL; Westholm, D; Wodarski, D; Zajko, M; Zikalala, TS; Hendrix, RW; Hatfull, GF				Cresawn, Steven G.; Pope, Welkin H.; Jacobs-Sera, Deborah; Bowman, Charles A.; Russell, Daniel A.; Dedrick, Rebekah M.; Adair, Tamarah; Anders, Kirk R.; Ball, Sarah; Bollivar, David; Breitenberger, Caroline; Burnett, Sandra H.; Butela, Kristen; Byrnes, Deanna; Carzo, Sarah; Cornely, Kathleen A.; Cross, Trevor; Daniels, Richard L.; Dunbar, David; Findley, Ann M.; Gissendanner, Chris R.; Golebiewska, Urszula P.; Hartzog, Grant A.; Hatherill, J. Robert; Hughes, Lee E.; Jalloh, Chernoh S.; De Los Santos, Carla; Ekanem, Kevin; Khambule, Sphindile L.; King, Rodney A.; King-Smith, Christina; Klyczek, Karen; Krukonis, Greg P.; Laing, Christian; Lapin, Jonathan S.; Lopez, A. Javier; Mkhwanazi, Sipho M.; Molloy, Sally D.; Moran, Deborah; Munsamy, Vanisha; Pacey, Eddie; Plymale, Ruth; Poxleitner, Marianne; Reyna, Nathan; Schildbach, Joel F.; Stukey, Joseph; Taylor, Sarah E.; Ware, Vassie C.; Wellmann, Amanda L.; Westholm, Daniel; Wodarski, Donna; Zajko, Michelle; Zikalala, Thabiso S.; Hendrix, Roger W.; Hatfull, Graham F.			Comparative Genomics of Cluster O Mycobacteriophages	PLOS ONE			English	Article							TRANSFER-RNA GENES; REVEALS; PROTEIN; BACTERIOPHAGE; PHAGE; SEQUENCES; HOMOLOGY; PROGRAM; GROWTH; BPS	Mycobacteriophages - viruses of mycobacterial hosts - are genetically diverse but morphologically are all classified in the Caudovirales with double-stranded DNA and tails. We describe here a group of five closely related mycobacteriophages - Corndog, Catdawg, Dylan, Firecracker, and YungJamal - designated as Cluster O with long flexible tails but with unusual prolate capsids. Proteomic analysis of phage Corndog particles, Catdawg particles, and Corndog-infected cells confirms expression of half of the predicted gene products and indicates a non-canonical mechanism for translation of the Corndog tape measure protein. Bioinformatic analysis identifies 8-9 strongly predicted SigA promoters and all five Cluster O genomes contain more than 30 copies of a 17 bp repeat sequence with dyad symmetry located throughout the genomes. Comparison of the Cluster O phages provides insights into phage genome evolution including the processes of gene flux by horizontal genetic exchange.	[Cresawn, Steven G.] James Madison Univ, Dept Biol, Harrisonburg, VA 22807 USA; [Pope, Welkin H.; Jacobs-Sera, Deborah; Bowman, Charles A.; Russell, Daniel A.; Dedrick, Rebekah M.; Lapin, Jonathan S.; Pacey, Eddie; Hendrix, Roger W.; Hatfull, Graham F.] Univ Pittsburgh, Dept Biol Sci, Pittsburgh, PA 15260 USA; [Adair, Tamarah] Baylor Univ, Dept Biol, Waco, TX 76798 USA; [Anders, Kirk R.; Poxleitner, Marianne] Gonzaga Univ, Dept Biol, Spokane, WA 99258 USA; [Ball, Sarah; Breitenberger, Caroline] Ohio State Univ, Ctr Life Sci Educ, Columbus, OH 43210 USA; [Bollivar, David] Illinois Wesleyan Univ, Dept Biol, Bloomington, IL 61701 USA; [Burnett, Sandra H.] Brigham Young Univ, Dept Mol Biol & Microbiol, Provo, UT 84602 USA; [Butela, Kristen] Seton Hill Univ, Dept Biol, Greensburg, PA USA; [Byrnes, Deanna] Carthage Coll, Dept Biol, Kenosha, WI USA; [Cornely, Kathleen A.] Providence Coll, Dept Chem & Biochem, Providence, RI 02918 USA; [Daniels, Richard L.] Coll Idaho, Dept Biol, Caldwell, NJ USA; [Carzo, Sarah; Cross, Trevor; Dunbar, David; Moran, Deborah; Wodarski, Donna; Zajko, Michelle] Cabrini Coll, Dept Biol, Radnor, PA USA; [Findley, Ann M.] Univ Louisiana Monroe, Sch Sci, Monroe, LA USA; [Gissendanner, Chris R.] Univ Louisiana Monroe, Sch Pharm, Monroe, LA USA; [Golebiewska, Urszula P.] CUNY Queensborough Community Coll, Dept Biol Sci & Geol, New York, NY 11364 USA; [Hartzog, Grant A.; De Los Santos, Carla; Ekanem, Kevin] Univ Calif Santa Cruz, Dept Mol Cell & Dev Biol, Dept Mol Cell & Dev Biol, Santa Cruz, CA 95064 USA; [Hatherill, J. Robert] Del Mar Coll, Dept Nat Sci, Corpus Christi, TX 78404 USA; [Hughes, Lee E.] Univ N Texas, Dept Biol Sci, Denton, TX 76203 USA; [Jalloh, Chernoh S.; Khambule, Sphindile L.; Mkhwanazi, Sipho M.; Wellmann, Amanda L.; Zikalala, Thabiso S.] Univ QwaZulu Natal, Sch Life Sci, Durban, South Africa; [King, Rodney A.] Western Kentucky Univ, Dept Biol, Bowling Green, KY 42101 USA; [King-Smith, Christina] St Josephs Univ, Dept Biol, Philadelphia, PA 19131 USA; [Klyczek, Karen] Univ Wisconsin, Dept Biol, River Falls, WI 54022 USA; [Krukonis, Greg P.] Gettysburg Coll, Dept Biol, Gettysburg, PA 17325 USA; [Laing, Christian] Wilkes Univ, Dept Math & Comp Sci, Wilkes Barre, PA 18766 USA; [Lopez, A. Javier] Carnegie Mellon Univ, Dept Biol Sci, Pittsburgh, PA 15213 USA; [Molloy, Sally D.] Univ Maine, Dept Mol & Biomed Sci, Honors Coll, Orono, ME USA; [Munsamy, Vanisha] KwaZulu Natal Res Inst TB & HIV, Durban, South Africa; [Plymale, Ruth; Reyna, Nathan] Ouachita Baptist Univ, Dept Biol Sci, Arkadelphia, AR USA; [Schildbach, Joel F.] Johns Hopkins Univ, Dept Biol, Baltimore, MD 21218 USA; [Stukey, Joseph] Hope Coll, Dept Biol, Holland, MI 49423 USA; [Taylor, Sarah E.] Brown Univ, Dept Biol, Providence, RI 02912 USA; [Ware, Vassie C.] Lehigh Univ, Dept Biol Sci, Bethlehem, PA 18015 USA; [Westholm, Daniel] Coll St Scholast, Dept Biol, Duluth, MN USA	James Madison University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Baylor University; Gonzaga University; University System of Ohio; Ohio State University; Illinois Wesleyan University; Brigham Young University; Providence College; University of Louisiana System; University of Louisiana Monroe; University of Louisiana System; University of Louisiana Monroe; City University of New York (CUNY) System; University of California System; University of California Santa Cruz; University of North Texas System; University of North Texas Denton; Western Kentucky University; Saint Joseph's University; University of Wisconsin System; Gettysburg College; Wilkes University; Carnegie Mellon University; University of Maine System; University of Maine Orono; Johns Hopkins University; Hope College; Brown University; Lehigh University	Hatfull, GF (corresponding author), Univ Pittsburgh, Dept Biol Sci, Pittsburgh, PA 15260 USA.	gfh@pitt.edu	Breitenberger, Caroline/O-6176-2014	Breitenberger, Caroline/0000-0001-6001-156X; Moran, Deborah/0000-0002-9396-4145; Plymale, Ruth/0000-0001-6122-1905; Anders, Kirk/0000-0002-3372-1379; Butela, Kristen/0000-0003-1463-5288; Schildbach, Joel/0000-0002-3038-9745; Daniels, Richard/0000-0003-2477-6025; Bollivar, David/0000-0002-9378-3408; Klyczek, Karen/0000-0001-7882-0429; Dedrick, Rebekah/0000-0002-3666-711X; Adair, Tamarah/0000-0002-4656-6769; Reyna, Nathan/0000-0003-3430-0282	National Institutes of Health [GM51975]; Howard Hughes Medical Institute [54308198]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103408, R01GM051975] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grants from the National Institutes of Health (GM51975) and from the Howard Hughes Medical Institute (54308198). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrescia NGA, 2012, ANNU REV BIOCHEM, V81, P795, DOI 10.1146/annurev-biochem-060910-095130; Ackermann HW, 2007, ARCH VIROL, V152, P227, DOI 10.1007/s00705-006-0849-1; Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335; Baudet M, 2010, MOL CELL PROTEOMICS, V9, P415, DOI 10.1074/mcp.M900359-MCP200; Brown KL, 1997, EMBO J, V16, P5914, DOI 10.1093/emboj/16.19.5914; CLAROS MG, 1994, COMPUT APPL BIOSCI, V10, P685; Cresawn SG, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-395; Czyz A, 2014, MBIO, V5, DOI 10.1128/mBio.00931-14; Dedrick RM, 2013, MOL MICROBIOL, V88, P577, DOI 10.1111/mmi.12210; Duda RL, 2013, J MOL BIOL, V425, P2765, DOI 10.1016/j.jmb.2013.05.002; FORSMAN P, 1993, ARCH VIROL, V132, P321, DOI 10.1007/BF01309542; Gill JJ, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-542; Hatfull GF, 2014, MICROBIOL SPECTR, V2, DOI 10.1128/microbiolspec.MGM2-0032-2013; Hatfull GF, 2012, ADV VIRUS RES, V82, P179, DOI 10.1016/B978-0-12-394621-8.00015-7; Hatfull GF, 2012, J VIROL, V86, P2382, DOI 10.1128/JVI.06870-11; Hatfull GF, 2011, CURR OPIN VIROL, V1, P298, DOI 10.1016/j.coviro.2011.06.009; Hendrix R.W., 2013, FIELDS VIROLOGY; Hendrix RW, 2012, ADV EXP MED BIOL, V726, P351, DOI 10.1007/978-1-4614-0980-9_15; Hendrix RW, 1999, P NATL ACAD SCI USA, V96, P2192, DOI 10.1073/pnas.96.5.2192; Hirokawa T, 1998, BIOINFORMATICS, V14, P378, DOI 10.1093/bioinformatics/14.4.378; HUANG WM, 1988, SCIENCE, V239, P1005, DOI 10.1126/science.2830666; Jacobs-Sera D, 2012, VIROLOGY, V434, P187, DOI 10.1016/j.virol.2012.09.026; Jordan TC, 2014, MBIO, V5, DOI 10.1128/mBio.01051-13; Kala S, 2014, P NATL ACAD SCI USA, V111, P6022, DOI 10.1073/pnas.1320952111; Kim BJ, 2013, GENOME ANNOUNCEMENTS, V1, DOI 10.1128/genomeA.00604-13; Krumsiek J, 2007, BIOINFORMATICS, V23, P1026, DOI 10.1093/bioinformatics/btm039; Laslett D, 2004, NUCLEIC ACIDS RES, V32, P11, DOI 10.1093/nar/gkh152; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Luque A, 2010, BIOPHYS J, V98, P2993, DOI 10.1016/j.bpj.2010.02.051; NESBIT CE, 1995, MOL MICROBIOL, V17, P1045, DOI 10.1111/j.1365-2958.1995.mmi_17061045.x; Oh B, 2014, VIROLOGY, V456, P171, DOI 10.1016/j.virol.2014.03.022; Oldfield LM, 2014, J BACTERIOL, V196, P3589, DOI 10.1128/JB.01801-14; Pedulla ML, 2003, CELL, V113, P171, DOI 10.1016/S0092-8674(03)00233-2; Pitcher RS, 2006, MOL CELL, V23, P743, DOI 10.1016/j.molcel.2006.07.009; POPA MP, 1991, J VIROL, V65, P3227, DOI 10.1128/JVI.65.6.3227-3237.1991; Pope WH, 2014, MBIO, V5, DOI 10.1128/mBio.02145-14; Pope WH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026750; Pope WH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016329; Riipinen KA, 2011, ARCH VIROL, V156, P1217, DOI 10.1007/s00705-011-0980-5; Sampson T, 2009, MICROBIOL-SGM, V155, P2962, DOI 10.1099/mic.0.030486-0; Singh S, 2014, J MOL BIOL, V426, P412, DOI 10.1016/j.jmb.2013.10.002; Soding J, 2005, NUCLEIC ACIDS RES, V33, pW244, DOI 10.1093/nar/gki408; Sonnhammer E L, 1998, Proc Int Conf Intell Syst Mol Biol, V6, P175; STOLT P, 1994, BIOL CHEM H-S, V375, P747, DOI 10.1515/bchm3.1994.375.11.747; Wommack KE, 2000, MICROBIOL MOL BIOL R, V64, P69, DOI 10.1128/MMBR.64.1.69-114.2000	45	17	18	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2015	10	3							e0118725	10.1371/journal.pone.0118725	http://dx.doi.org/10.1371/journal.pone.0118725			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9KG	25742016	Green Published, gold, Green Accepted			2022-12-27	WOS:000350688100039
J	Fujikawa, A; Matsumoto, M; Kuboyama, K; Suzuki, R; Noda, M				Fujikawa, Akihiro; Matsumoto, Masahito; Kuboyama, Kazuya; Suzuki, Ryoko; Noda, Masaharu			Specific Dephosphorylation at Tyr-554 of Git1 by Ptprz Promotes Its Association with Paxillin and Hic-5	PLOS ONE			English	Article							RECEPTOR-TYPE-Z; PROTEIN-TYROSINE PHOSPHATASES; REGULATES PROTRUSIVE ACTIVITY; SUBSTRATE-TRAPPING SYSTEM; GTPASE-ACTIVATING PROTEIN; ZETA RPTP-BETA; SYNAPSE FORMATION; SPINE MORPHOGENESIS; FOCAL ADHESIONS; ZETA/RPTP-BETA	G protein-coupled receptor kinase-interactor 1 (Git1) is involved in cell motility control by serving as an adaptor that links signaling proteins such as Pix and PAK to focal adhesion proteins. We previously demonstrated that Git1 was a multiply tyrosine-phosphorylated protein, its primary phosphorylation site was Tyr-554 in the vicinity of the focal adhesion targeting-homology (FAH) domain, and this site was selectively dephosphorylated by protein tyrosine phosphatase receptor type Z (Ptprz). In the present study, we showed that Tyr-554 phosphorylation reduced the association of Git1 with the FAH-domain-binding proteins, paxillin and Hic-5, based on immunoprecipitation experiments using the Tyr-554 mutants of Git1. The Tyr-554 phosphorylation of Git1 was higher, and its binding to paxillin was consistently lower in the brains of Ptprz-deficient mice than in those of wild-type mice. We then investigated the role of Tyr-554 phosphorylation in cell motility control using three different methods: random cell motility, wound healing, and Boyden chamber assays. The shRNA-mediated knockdown of endogenous Git1 impaired cell motility in A7r5 smooth muscle cells. The motility defect was rescued by the exogenous expression of wild-type Git1 and a Git1 mutant, which only retained Tyr-554 among the multiple potential tyrosine phosphorylation sites, but not by the Tyr-554 phosphorylation-defective or phosphorylation-state mimic Git1 mutant. Our results suggested that cyclic phosphorylation-dephosphorylation at Tyr-554 of Git1 was crucial for dynamic interactions between Git1 and paxillin/Hic-5 in order to ensure coordinated cell motility.	[Fujikawa, Akihiro; Matsumoto, Masahito; Kuboyama, Kazuya; Suzuki, Ryoko; Noda, Masaharu] Natl Inst Basic Biol, Div Mol Neurobiol, Okazaki, Aichi 444, Japan; [Noda, Masaharu] Grad Univ Adv Studies, Sch Life Sci, Okazaki, Aichi, Japan	National Institutes of Natural Sciences (NINS) - Japan; National Institute for Basic Biology (NIBB); Graduate University for Advanced Studies - Japan	Noda, M (corresponding author), Natl Inst Basic Biol, Div Mol Neurobiol, Okazaki, Aichi 444, Japan.	madon@nibb.ac.jp	Fujikawa, Akihiro/K-9805-2015; Noda, Masaharu/D-7146-2016; Matsumoto, Masahito/ABB-3002-2021	Fujikawa, Akihiro/0000-0002-3950-0550; Noda, Masaharu/0000-0002-3796-524X; Kuboyama, Kazuya/0000-0002-9878-1209	Ministry of Education, Science, Sports and Culture of Japan (MEXT); Grants-in-Aid for Scientific Research [26110722] Funding Source: KAKEN	Ministry of Education, Science, Sports and Culture of Japan (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by grants from the Ministry of Education, Science, Sports and Culture of Japan (MEXT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amerongen GPV, 2004, CIRC RES, V94, P1041, DOI 10.1161/01.RES.0000125627.77235.0C; Bagrodia S, 1999, J BIOL CHEM, V274, P22393, DOI 10.1074/jbc.274.32.22393; Carisey A, 2013, CURR BIOL, V23, P271, DOI 10.1016/j.cub.2013.01.009; Chow JPH, 2008, J BIOL CHEM, V283, P30879, DOI 10.1074/jbc.M802976200; Deakin NO, 2008, J CELL SCI, V121, P2435, DOI 10.1242/jcs.018044; Fujikawa A, 2003, NAT GENET, V33, P375, DOI 10.1038/ng1112; Fujikawa A, 2007, J BIOCHEM, V142, P343, DOI 10.1093/jb/mvm140; Fujikawa A, 2011, J BIOL CHEM, V286, P37137, DOI 10.1074/jbc.M111.270140; Fukada M, 2005, METHODS, V35, P54, DOI 10.1016/j.ymeth.2004.07.008; Harroch S, 2002, NAT GENET, V32, P411, DOI 10.1038/ng1004; Kahn RA, 2008, J CELL BIOL, V182, P1039, DOI 10.1083/jcb.200806041; Kawachi H, 2001, P NATL ACAD SCI USA, V98, P6593, DOI 10.1073/pnas.041608698; Kuboyama K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048797; Lafont D, 2009, BEHAV BRAIN RES, V201, P29, DOI 10.1016/j.bbr.2009.01.025; Maeda N, 1998, J CELL BIOL, V142, P203, DOI 10.1083/jcb.142.1.203; Manabe R, 2002, J CELL SCI, V115, P1497; Meng K, 2000, P NATL ACAD SCI USA, V97, P2603, DOI 10.1073/pnas.020487997; Menon P, 2010, BRAIN RES, V1317, P218, DOI 10.1016/j.brainres.2009.11.084; Meyer MZ, 2006, J BIOL CHEM, V281, P7919, DOI 10.1074/jbc.M600081200; Nayal A, 2006, J CELL BIOL, V173, P587, DOI 10.1083/jcb.200509075; Niisato K, 2005, J NEUROSCI, V25, P1081, DOI 10.1523/JNEUROSCI.2565.04.2005; Nishiwaki T, 1998, J BIOCHEM-TOKYO, V123, P458; Pang JJ, 2013, ARTERIOSCL THROM VAS, V33, P999, DOI 10.1161/ATVBAHA.112.300966; Premont RT, 2004, CELL SIGNAL, V16, P1001, DOI 10.1016/j.cellsig.2004.02.002; Premont RT, 1998, P NATL ACAD SCI USA, V95, P14082, DOI 10.1073/pnas.95.24.14082; Qi MS, 2001, J BIOL CHEM, V276, P15868, DOI 10.1074/jbc.M005911200; Schlenker O, 2009, J MOL BIOL, V386, P280, DOI 10.1016/j.jmb.2008.12.050; Schmalzigaug R, 2007, CELL SIGNAL, V19, P1733, DOI 10.1016/j.cellsig.2007.03.010; Schmalzigaug R, 2009, NEUROSCI LETT, V458, P79, DOI 10.1016/j.neulet.2009.04.037; Segura I, 2007, NAT NEUROSCI, V10, P301, DOI 10.1038/nn1858; Shintani T, 1998, NEUROSCI LETT, V247, P135, DOI 10.1016/S0304-3940(98)00295-X; Tamura H, 2006, NEUROSCI LETT, V399, P33, DOI 10.1016/j.neulet.2006.01.045; Thomaidou D, 2001, J NEUROCHEM, V78, P767, DOI 10.1046/j.1471-4159.2001.00454.x; Tonks NK, 2006, NAT REV MOL CELL BIO, V7, P833, DOI 10.1038/nrm2039; Totaro A, 2007, MOL BIOL CELL, V18, P5124, DOI 10.1091/mbc.E07-06-0550; Totaro A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093199; Turner CE, 1999, J CELL BIOL, V145, P851, DOI 10.1083/jcb.145.4.851; Webb DJ, 2006, BIOCHEM BIOPH RES CO, V346, P1284, DOI 10.1016/j.bbrc.2006.06.036; Webb DJ, 2006, J CELL SCI, V119, P2847, DOI 10.1242/jcs03044; Yin GY, 2005, J BIOL CHEM, V280, P27705, DOI 10.1074/jbc.M502271200; Zhang HY, 2003, J CELL BIOL, V161, P131, DOI 10.1083/jcb.200211002; Zhang HY, 2005, J NEUROSCI, V25, P3379, DOI 10.1523/JNEUROSCI.3553-04.2005; Zhang ZWM, 2008, J BIOL CHEM, V283, P18685, DOI 10.1074/jbc.M801274200; Zhao ZS, 2000, MOL CELL BIOL, V20, P6354, DOI 10.1128/MCB.20.17.6354-6363.2000	44	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2015	10	3							e0119361	10.1371/journal.pone.0119361	http://dx.doi.org/10.1371/journal.pone.0119361			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9KG	25742295	Green Published, Green Submitted, gold			2022-12-27	WOS:000350688100104
J	Kang, J; Lee, HJ; Kim, J; Lee, JJ; Maeng, LS				Kang, Jun; Lee, Hee Jin; Kim, Jiyoung; Lee, Jae Jun; Maeng, Lee-so			Dysregulation of X Chromosome Inactivation in High Grade Ovarian Serous Adenocarcinoma	PLOS ONE			English	Article							GENE-EXPRESSION; BARR BODY; XIST RNA; CANCER; BRCA1; BREAST; ABNORMALITIES; IMPACT	Background One of the two copies of the X chromosome is randomly inactivated in females as a means of dosage compensation. Loss of X chromosome inactivation (XCI) is observed in breast and ovarian cancers, and is frequent in basal-like subtype and BRCA1 mutation-associated breast cancers. We investigated the clinical implications of the loss of XCI in ovarian cancer and the association between the loss of XCI and BRCA1 dysfunction. Materials and Methods We used open source data generated by The Cancer Genome Atlas (TCGA) Genome Data Analysis Centers. Ward's hierarchical clustering method was used to classify the methylation status of the X chromosome. Results We grouped 584 high grade serous ovarian adenocarcinomas (HG-SOA) according to methylation status, loss of heterozygosity and deletion or gain of X chromosome into the following five groups: preserved inactivated X chromosome (Xi) group (n = 175), partial reactivation of Xi group (n = 100), p arm deletion of Xi group (n = 35), q arm deletion of Xi group (n = 44), and two copies of active X group (n = 230). We found four genes (XAGE3, ZNF711, MAGEA4, and ZDHHC15) that were up-regulated by loss of XCI. HG-SOA with loss of XCI showed aggressive behavior (overall survival of partial reactivation of Xi group: HR 1.7, 95% CI 1.1-2.5, two copies of active X group: HR 1.4, 95% CI 1.0-1.9). Mutation and hypermethylation of BRCA1 were not frequent in HG-SOA with loss of XCI. Conclusions Loss of XCI is common in HG-SOA and is associated with poor clinical outcome. The role of BRCA1 in loss of XCI might be limited. XCI induced aberrant expression of cancer-testis antigens, which may have a role in tumor aggressiveness.	[Kang, Jun; Kim, Jiyoung; Lee, Jae Jun; Maeng, Lee-so] Catholic Univ Korea, Inchun St Marys Hosp, Coll Med, Dept Hosp Pathol, Inchon, South Korea; [Lee, Hee Jin] Univ Ulsan, Coll Med, Dept Pathol, Asan Med Ctr, Seoul, South Korea	Catholic University of Korea; University of Ulsan	Kang, J (corresponding author), Catholic Univ Korea, Inchun St Marys Hosp, Coll Med, Dept Hosp Pathol, Inchon, South Korea.	jkang.alien@gmail.com						Ahn J., 2008, NAT ED, V1, P24; Bell D, 2011, NATURE, V474, P609, DOI 10.1038/nature10166; Benoit MH, 2007, INT J ONCOL, V30, P5; BORAH V, 1980, J SURG ONCOL, V13, P1, DOI 10.1002/jso.2930130102; Cheng PC, 1996, J NATL CANCER I, V88, P510, DOI 10.1093/jnci/88.8.510; Forghanifard MM, 2011, CANCER BIOL THER, V12, P191, DOI 10.4161/cbt.12.3.15949; Ganesan S, 2005, COLD SH Q B, V70, P93, DOI 10.1101/sqb.2005.70.045; Huang KC, 2002, MOL CANCER THER, V1, P769; Jacobsen A, 2013, CGDSR R BASED API AC; Kurman RJ, 2013, ANN ONCOL, V24, P16, DOI 10.1093/annonc/mdt463; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Li B, 2010, BIOINFORMATICS, V26, P493, DOI 10.1093/bioinformatics/btp692; Lose F, 2008, JNCI-J NATL CANCER I, V100, DOI 10.1093/jnci/djn345; Manoukian S, 2013, EUR J CANCER, V49, P1136, DOI 10.1016/j.ejca.2012.10.013; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Pageau GJ, 2007, NAT REV CANCER, V7, P628, DOI 10.1038/nrc2172; Pageau GJ, 2007, J CELL BIOCHEM, V100, P835, DOI 10.1002/jcb.21188; Richardson AL, 2006, CANCER CELL, V9, P121, DOI 10.1016/j.ccr.2006.01.013; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Silver DP, 2007, CELL, V128, P991, DOI 10.1016/j.cell.2007.02.025; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Suzuki K, 2006, CANCER CELL, V9, P199, DOI 10.1016/j.ccr.2006.02.016; Thorvaldsdottir H, 2013, BRIEF BIOINFORM, V14, P178, DOI 10.1093/bib/bbs017; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq622; Weber M, 2007, NAT GENET, V39, P457, DOI 10.1038/ng1990; Xiao CY, 2007, CELL, V128, P977, DOI 10.1016/j.cell.2007.01.034; Yang D, 2011, JAMA-J AM MED ASSOC, V306, P1557, DOI 10.1001/jama.2011.1456; Yildirim E, 2013, CELL, V152, P727, DOI 10.1016/j.cell.2013.01.034	28	10	11	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2015	10	3							e0118927	10.1371/journal.pone.0118927	http://dx.doi.org/10.1371/journal.pone.0118927			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9KG	25742136	Green Submitted, Green Published, gold			2022-12-27	WOS:000350688100061
J	Prykhozhij, SV; Rajan, V; Gaston, D; Berman, JN				Prykhozhij, Sergey V.; Rajan, Vinothkumar; Gaston, Daniel; Berman, Jason N.			CRISPR MultiTargeter: A Web Tool to Find Common and Unique CRISPR Single Guide RNA Targets in a Set of Similar Sequences	PLOS ONE			English	Article							CONSERVED SYNTENY; ZEBRAFISH GENOME; CAS9; SPECIFICITY; BACTERIA; DEFENSE; SYSTEMS	Genome engineering has been revolutionized by the discovery of clustered regularly interspaced palindromic repeats (CRISPR) and CRISPR-associated system genes (Cas) in bacteria. The type IIB Streptococcus pyogenes CRISPR/Cas9 system functions in many species and additional types of CRISPR/Cas systems are under development. In the type II system, expression of CRISPR single guide RNA (sgRNA) targeting a defined sequence and Cas9 generates a sequence-specific nuclease inducing small deletions or insertions. Moreover, knock-in of large DNA inserts has been shown at the sites targeted by sgRNAs and Cas9. Several tools are available for designing sgRNAs that target unique locations in the genome. However, the ability to find sgRNA targets common to several similar sequences or, by contrast, unique to each of these sequences, would also be advantageous. To provide such a tool for several types of CRISPR/Cas system and many species, we developed the CRISPR MultiTargeter software. Similar DNA sequences in question are duplicated genes and sets of exons of different transcripts of a gene. Thus, we implemented a basic sgRNA target search of input sequences for single-sgRNA and two-sgRNA/Cas9 nickase targeting, as well as common and unique sgRNA target searches in 1) a set of input sequences; 2) a set of similar genes or transcripts; or 3) transcripts a single gene. We demonstrate potential uses of the program by identifying unique isoform-specific sgRNA sites in 71% of zebrafish alternative transcripts and common sgRNA target sites in approximately 40% of zebrafish duplicated gene pairs. The design of unique targets in alternative exons is helpful because it will facilitate functional genomic studies of transcript isoforms. Similarly, its application to duplicated genes may simplify multi-gene mutational targeting experiments. Overall, this program provides a unique interface that will enhance use of CRISPR/Cas technology.	[Prykhozhij, Sergey V.; Berman, Jason N.] Dalhousie Univ, Dept Pediat, Halifax, NS, Canada; [Rajan, Vinothkumar; Berman, Jason N.] Dalhousie Univ, Dept Microbiol & Immunol, Halifax, NS, Canada; [Gaston, Daniel; Berman, Jason N.] Dalhousie Univ, Dept Pathol, Halifax, NS, Canada	Dalhousie University; Dalhousie University; Dalhousie University	Prykhozhij, SV (corresponding author), Dalhousie Univ, Dept Pediat, Halifax, NS, Canada.	s.prykhozhij@gmail.com	Rajan, Vinothkumar/K-4955-2019; Rajan, Vinothkumar/U-9687-2019	Rajan, Vinothkumar/0000-0003-3323-181X	IGNITE (Orphan Diseases: Identifying Genes and Novel Therapeutics to Enhance Treatment) project grant from Genome Atlantic and Canadian Institutes of Health Research operating grant [287512]	IGNITE (Orphan Diseases: Identifying Genes and Novel Therapeutics to Enhance Treatment) project grant from Genome Atlantic and Canadian Institutes of Health Research operating grant	Although this project was not specifically funded by any grant, the authors gratefully acknowledge the grant support by the IGNITE (Orphan Diseases: Identifying Genes and Novel Therapeutics to Enhance Treatment) project grant from Genome Atlantic and Canadian Institutes of Health Research operating grant 287512.	Bae S, 2014, BIOINFORMATICS, V30, P1473, DOI 10.1093/bioinformatics/btu048; Bhaya D, 2011, ANNU REV GENET, V45, P273, DOI 10.1146/annurev-genet-110410-132430; Carroll D, 2014, ANNU REV BIOCHEM, V83, P409, DOI 10.1146/annurev-biochem-060713-035418; Catchen JM, 2009, GENOME RES, V19, P1497, DOI 10.1101/gr.090480.108; Cock PJA, 2009, BIOINFORMATICS, V25, P1422, DOI 10.1093/bioinformatics/btp163; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Doench JG, 2014, NAT BIOTECHNOL; Dumousseau M, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-101; Fu YF, 2014, NAT BIOTECHNOL, V32, P279, DOI 10.1038/nbt.2808; Fu YF, 2013, NAT BIOTECHNOL, V31, P822, DOI 10.1038/nbt.2623; Gratz SJ, 2014, GENETICS, V196, P961, DOI 10.1534/genetics.113.160713; Grissa I, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-172; Heigwer F, 2014, NAT METHODS, V11, P122, DOI 10.1038/nmeth.2812; Hou ZG, 2013, P NATL ACAD SCI USA, V110, P15644, DOI 10.1073/pnas.1313587110; Howe K, 2013, NATURE, V496, P498, DOI 10.1038/nature12111; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; Hwang WY, 2013, NAT BIOTECHNOL, V31, P227, DOI 10.1038/nbt.2501; Jao LE, 2013, P NATL ACAD SCI USA, V110, P13904, DOI 10.1073/pnas.1308335110; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kasahara M, 2007, CURR OPIN IMMUNOL, V19, P547, DOI 10.1016/j.coi.2007.07.009; Kuraku S, 2012, METHODS MOL BIOL, V855, P385, DOI 10.1007/978-1-61779-582-4_14; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Ma YW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089413; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Menke DB, 2013, GENESIS, V51, P605, DOI 10.1002/dvg.22422; Mojica FJM, 2009, MICROBIOL-SGM, V155, P733, DOI 10.1099/mic.0.023960-0; Naito Y, 2014, BIOINFORMATICS, P1, DOI [10.1093/biainformatics/1408743, DOI 10.1093/BIAINF0RMATICS/1408743]; O'Brien A, 2014, BIOINFORMATICS, V30, P2673, DOI 10.1093/bioinformatics/btu354; Panopoulou G, 2005, TRENDS GENET, V21, P559, DOI 10.1016/j.tig.2005.08.004; Postlethwait JH, 2007, J EXP ZOOL PART B, V308B, P563, DOI 10.1002/jez.b.21137; Ran FA, 2013, CELL, V154, P1380, DOI 10.1016/j.cell.2013.08.021; Sakuma T, 2014, SCI REP-UK, V4, DOI 10.1038/srep05400; Shah SA, 2013, RNA BIOL, V10, P891, DOI 10.4161/rna.23764; Sorek R, 2013, ANNU REV BIOCHEM, V82, P237, DOI 10.1146/annurev-biochem-072911-172315; SUGIMOTO N, 1995, BIOCHEMISTRY-US, V34, P11211, DOI 10.1021/bi00035a029; Walsh RM, 2013, P NATL ACAD SCI USA, V110, P15514, DOI 10.1073/pnas.1314697110; Wolfe K, 2000, NAT GENET, V25, P3, DOI 10.1038/75560; Xiao A, 2014, BIOINFORMATICS, V30, P1180, DOI 10.1093/bioinformatics/btt764; Xie SS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100448; Xu K., 2014, CELL MOL LIFE SCI; Zhu LHJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108424	41	82	104	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2015	10	3							e0119372	10.1371/journal.pone.0119372	http://dx.doi.org/10.1371/journal.pone.0119372			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9KG	25742428	Green Published, gold			2022-12-27	WOS:000350688100105
J	Sun, Y; Lee, R; Chen, Y; Collinson, S; Thakor, N; Bezerianos, A; Sim, K				Sun, Yu; Lee, Renick; Chen, Yu; Collinson, Simon; Thakor, Nitish; Bezerianos, Anastasios; Sim, Kang			Progressive Gender Differences of Structural Brain Networks in Healthy Adults: A Longitudinal, Diffusion Tensor Imaging Study	PLOS ONE			English	Article							SEX-DIFFERENCES; GRAY-MATTER; WHITE-MATTER; SMALL-WORLD; CONNECTIVITY PATTERNS; CORTICAL NETWORKS; CEREBRAL-CORTEX; YOUNG-ADULTS; AGE; VOLUMES	Sexual dimorphism in the brain maturation during childhood and adolescence has been repeatedly documented, which may underlie the differences in behaviors and cognitive performance. However, our understanding of how gender modulates the development of structural connectome in healthy adults is still not entirely clear. Here we utilized graph theoretical analysis of longitudinal diffusion tensor imaging data over a five-year period to investigate the progressive gender differences of brain network topology. The brain networks of both genders showed prominent economical "small-world" architecture (high local clustering and short paths between nodes). Additional analysis revealed a more economical "small-world" architecture in females as well as a greater global efficiency in males regardless of scan time point. At the regional level, both increased and decreased efficiency were found across the cerebral cortex for both males and females, indicating a compensation mechanism of cortical network reorganization over time. Furthermore, we found that weighted clustering coefficient exhibited significant gender-time interactions, implying different development trends between males and females. Moreover, several specific brain regions (e.g., insula, superior temporal gyrus, cuneus, putamen, and parahippocampal gyrus) exhibited different development trajectories between males and females. Our findings further prove the presence of sexual dimorphism in brain structures that may underlie gender differences in behavioral and cognitive functioning. The sex-specific progress trajectories in brain connectome revealed in this work provide an important foundation to delineate the gender related pathophysiological mechanisms in various neuropsychiatric disorders, which may potentially guide the development of sex-specific treatments for these devastating brain disorders.	[Sun, Yu; Thakor, Nitish; Bezerianos, Anastasios] Natl Univ Singapore, Ctr Life Sci, Singapore Inst Neurotechnol SINAPSE, Singapore 117548, Singapore; [Lee, Renick] Natl Univ Singapore, Dept Bioengn, Singapore 117548, Singapore; [Chen, Yu] Natl Univ Singapore, Dept Engn Sci, Singapore 117548, Singapore; [Collinson, Simon] Natl Univ Singapore, Dept Psychol, Singapore 117548, Singapore; [Sim, Kang] Inst Mental Hlth, Dept Gen Psychiat, Singapore, Singapore; [Sim, Kang] Inst Mental Hlth, Dept Res, Singapore, Singapore	National University of Singapore; National University of Singapore; National University of Singapore; National University of Singapore	Sun, Y (corresponding author), Natl Univ Singapore, Ctr Life Sci, Singapore Inst Neurotechnol SINAPSE, Singapore 117548, Singapore.	lsisu@nus.edu.sg; kang_sim@imh.com.sg	Thakor, Nitish/G-9110-2015; Collinson, Simon Lowes/HHZ-6965-2022; Thakor, Nitish V/A-5878-2008; Chen, Yu/F-8340-2017; Bezerianos, Tasos/AAC-2499-2022	Thakor, Nitish/0000-0002-9981-9395; Collinson, Simon Lowes/0000-0001-9232-9732; Chen, Yu/0000-0003-0247-3146; Bezerianos, Tasos/0000-0002-8199-6000; Sim, Kang/0000-0003-3209-9626; SUN, Yu/0000-0002-6666-8586	National Healthcare Group [NHG 11003, 12003]; Agency for Science, Technology, Research/Singapore BioImaging Consortium [ASTAR/SBIC 009/2006]; National University of Singapore [R-719-001-102-232]	National Healthcare Group; Agency for Science, Technology, Research/Singapore BioImaging Consortium(Agency for Science Technology & Research (A*STAR)); National University of Singapore(National University of Singapore)	The authors thank the National Healthcare Group (NHG 11003, 12003 awarded to KS) and Agency for Science, Technology, Research/Singapore BioImaging Consortium (ASTAR/SBIC 009/2006 awarded to KS) for funding support and the National University of Singapore for supporting the Cognitive Engineering Group at the Singapore Institute for Neurotechnology (SINAPSE) under grant number R-719-001-102-232. The authors are very grateful to all the participants and to Dr. Chan Yiong Huak for his insightful advice in relation to the statistical aspects of this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achard S, 2006, J NEUROSCI, V26, P63, DOI 10.1523/JNEUROSCI.3874-05.2006; Achard S, 2007, PLOS COMPUT BIOL, V3, P174, DOI 10.1371/journal.pcbi.0030017; Albert M. L, 2011, CLIN NEUROLOGY AGING; Andrews-Hanna JR, 2007, NEURON, V56, P924, DOI 10.1016/j.neuron.2007.10.038; Bai F, 2012, J NEUROSCI, V32, P4307, DOI 10.1523/JNEUROSCI.5061-11.2012; Bao AM, 2010, NEUROSCIENTIST, V16, P550, DOI 10.1177/1073858410377005; Buchanan CR, 2014, NEUROIMAGE, V86, P231, DOI 10.1016/j.neuroimage.2013.09.054; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Cosgrove KP, 2007, BIOL PSYCHIAT, V62, P847, DOI 10.1016/j.biopsych.2007.03.001; Cui ZX, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00042; Damoiseaux JS, 2009, BRAIN STRUCT FUNCT, V213, P525, DOI 10.1007/s00429-009-0208-6; Dennis EL, 2013, NEUROIMAGE, V64, P671, DOI 10.1016/j.neuroimage.2012.09.004; Ellison A, 2004, BRAIN, V127, P2307, DOI 10.1093/brain/awh244; Fornito A, 2013, NEUROIMAGE, V80, P426, DOI 10.1016/j.neuroimage.2013.04.087; Fornito A, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00022; FREEMAN LC, 1977, SOCIOMETRY, V40, P35, DOI 10.2307/3033543; Ge YL, 2002, AM J NEURORADIOL, V23, P1327; Giedd JN, 1999, NAT NEUROSCI, V2, P861, DOI 10.1038/13158; Giedd JN, 1999, PROG NEURO-PSYCHOPH, V23, P571; Goldstein JM, 2001, CEREB CORTEX, V11, P490, DOI 10.1093/cercor/11.6.490; Gong GL, 2011, NEUROSCIENTIST, V17, P575, DOI 10.1177/1073858410386492; Gong GL, 2009, CEREB CORTEX, V19, P524, DOI 10.1093/cercor/bhn102; Gur RC, 1999, J NEUROSCI, V19, P4065; Gur RC, 2002, CEREB CORTEX, V12, P998, DOI 10.1093/cercor/12.9.998; Hagmann P, 2008, PLOS BIOL, V6, P1479, DOI 10.1371/journal.pbio.0060159; Hamilton C., 2008, COGNITION SEX DIFFER; He Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005226; Humphries MD, 2006, P ROY SOC B-BIOL SCI, V273, P503, DOI 10.1098/rspb.2005.3354; Ingalhalikar M, 2014, P NATL ACAD SCI USA, V111, P823, DOI 10.1073/pnas.1316909110; Latora V, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.198701; Lebel C, 2012, NEUROIMAGE, V60, P340, DOI 10.1016/j.neuroimage.2011.11.094; Li WJ, 2014, HUM BRAIN MAPP, V35, P238, DOI 10.1002/hbm.22168; Lo CY, 2010, J NEUROSCI, V30, P16876, DOI 10.1523/JNEUROSCI.4136-10.2010; Luders E, 2005, NEUROIMAGE, V26, P493, DOI 10.1016/j.neuroimage.2005.02.010; Luders E, 2009, J NEUROSCI, V29, P14265, DOI 10.1523/JNEUROSCI.2261-09.2009; Maslov S, 2002, SCIENCE, V296, P910, DOI 10.1126/science.1065103; Mesulam MM, 1998, BRAIN, V121, P1013, DOI 10.1093/brain/121.6.1013; Mori S, 1999, ANN NEUROL, V45, P265, DOI 10.1002/1531-8249(199902)45:2<265::AID-ANA21>3.0.CO;2-3; Mori S, 2002, NMR BIOMED, V15, P468, DOI 10.1002/nbm.781; Park DC, 2009, ANNU REV PSYCHOL, V60, P173, DOI 10.1146/annurev.psych.59.103006.093656; Paus T, 1996, J COMP NEUROL, V376, P664, DOI 10.1002/(SICI)1096-9861(19961223)376:4<664::AID-CNE12>3.0.CO;2-M; Paus T, 1999, SCIENCE, V283, P1908, DOI 10.1126/science.283.5409.1908; Pfefferbaum A, 2013, NEUROIMAGE, V65, P176, DOI 10.1016/j.neuroimage.2012.10.008; Raz N, 2004, NEUROBIOL AGING, V25, P377, DOI 10.1016/S0197-4580(03)00118-0; Raz N, 2011, PSYCHOL BULL, V137, P790, DOI 10.1037/a0024503; Raznahan A, 2011, J NEUROSCI, V31, P7174, DOI 10.1523/JNEUROSCI.0054-11.2011; Raznahan A, 2010, P NATL ACAD SCI USA, V107, P16988, DOI 10.1073/pnas.1006025107; Rubinov M, 2010, NEUROIMAGE, V52, P1059, DOI 10.1016/j.neuroimage.2009.10.003; Salthouse TA, 2011, PSYCHOL BULL, V137, P753, DOI 10.1037/a0023262; Shu N, 2011, CEREB CORTEX, V21, P2565, DOI 10.1093/cercor/bhr039; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Sommer IEC, 2004, BRAIN, V127, P1845, DOI 10.1093/brain/awh207; Sorensen AG, 2007, P INT SOC MAG RESON, V15, P3720, DOI [DOI 10.1128/MCB.25.11.4371, DOI 10.1038/SJ.IJ0.0803354]; Sowell ER, 2007, CEREB CORTEX, V17, P1550, DOI 10.1093/cercor/bhl066; Sporns O, 2011, ANN NY ACAD SCI, V1224, P109, DOI 10.1111/j.1749-6632.2010.05888.x; Sun Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096505; Taki Y, 2013, HUM BRAIN MAPP, V34, P2292, DOI 10.1002/hbm.22067; Taki Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022734; THOMAS JR, 1985, PSYCHOL BULL, V98, P260, DOI 10.1037/0033-2909.98.2.260; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Wu K, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00113; Wu K, 2012, HUM BRAIN MAPP, V33, P552, DOI 10.1002/hbm.21232; Yan CG, 2011, CEREB CORTEX, V21, P449, DOI 10.1093/cercor/bhq111; Zalesky A, 2010, NEUROIMAGE, V50, P970, DOI 10.1016/j.neuroimage.2009.12.027	65	29	29	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2015	10	3							e0118857	10.1371/journal.pone.0118857	http://dx.doi.org/10.1371/journal.pone.0118857			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CC9KG	25742013	Green Published, Green Submitted, gold			2022-12-27	WOS:000350688100053
J	Wu, Z; Matsui, O; Kitao, A; Kozaka, K; Koda, W; Kobayashi, S; Ryu, Y; Minami, T; Sanada, J; Gabata, T				Wu, Zhuo; Matsui, Osamu; Kitao, Azusa; Kozaka, Kazuto; Koda, Wataru; Kobayashi, Satoshi; Ryu, Yasuji; Minami, Tetsuya; Sanada, Junichiro; Gabata, Toshifumi			Hepatitis C Related Chronic Liver Cirrhosis: Feasibility of Texture Analysis of MR Images for Classification of Fibrosis Stage and Necroinflammatory Activity Grade	PLOS ONE			English	Article							MEDICAL IMAGES; SEGMENTATION; DIAGNOSIS; FEATURES; MODELS; VIRUS	Purpose To assess the feasibility of texture analysis for classifying fibrosis stage and necroinflammatory activity grade in patients with chronic hepatitis C on T2-weighted (T2W), T1-weighted (T1W) and Gd-EOB-DTPA-enhanced hepatocyte-phase (EOB-HP) imaging. Materials and methods From April 2008 to June 2012, MR images from 123 patients with pathologically proven chronic hepatitis C were retrospectively analyzed. Texture parameters derived from histogram, gradient, run-length matrix, co-occurrence matrix, autoregressive model and wavelet transform methods were estimated with imaging software. Fisher, probability of classification error and average correlation, and mutual information coefficients were used to extract subsets of optimized texture features. Linear discriminant analysis in combination with 1-nearest neighbor classifier (LDA/1-NN) was used for lesion classification. In compliance with the software requirement, classification was performed based on datasets from all patients, the patient group with necroinflammatory activity grade 1, and that with fibrosis stage 4, respectively. Results Based on all patient dataset, LDA/1-NN produced misclassification rates of 28.46%, 35.77% and 20.33% for fibrosis staging and 34.15%, 25.20% and 28.46% for necroinflammatory activity grading in T2W, T1W and EOB-HP images. In the patient group with necroinflammatory activity grade 1, LDA/1-NN yielded misclassification rates of 5.00%, 0% and 12.50% for fibrosis staging in T2W, T1W and EOB-HP images respectively. In the patient group with fibrosis stage 4, LDA/1-NN yielded misclassification rates of 5.88%, 12.94% and 11.76% for necroinflammatory activity grading in T2W, T1W and EOB-HP images respectively. Conclusion Texture quantitative parameters of MR images facilitate classification of the fibrosis stage as well as necroinflammatory activity grade in chronic hepatitis C, especially after categorizing the input dataset according to the activity or fibrosis degree in order to remove the interference between the fibrosis stage and necroinflammatory activity grade on texture features.	[Wu, Zhuo; Matsui, Osamu; Kitao, Azusa; Kozaka, Kazuto; Koda, Wataru; Kobayashi, Satoshi; Ryu, Yasuji; Minami, Tetsuya; Sanada, Junichiro; Gabata, Toshifumi] Kanazawa Univ, Dept Radiol, Grad Sch Med Sci, 13-1 Takaramachi, Kanazawa, Ishikawa 9208640, Japan; [Wu, Zhuo] Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Dept Radiol, Guangzhou 510120, Guangdong, Peoples R China	Kanazawa University; Sun Yat Sen University	Wu, Z (corresponding author), Kanazawa Univ, Dept Radiol, Grad Sch Med Sci, 13-1 Takaramachi, Kanazawa, Ishikawa 9208640, Japan.	vojoan@hotmail.com	Kobayashi, Satoshi/C-4645-2015	Kobayashi, Satoshi/0000-0001-7759-399X; Kitao, Azusa/0000-0002-5597-9346	Japan China Sasakawa Medical Fellowship	Japan China Sasakawa Medical Fellowship	This study was supported by Japan China Sasakawa Medical Fellowship. The fellowship fund sponsored 1 year of research for Zhuo Wu in Japan, and had the role in study design, data collection and analysis.	Amin A, 2009, FOOD CHEM TOXICOL, V47, P2111, DOI 10.1016/j.fct.2009.05.038; Castellano G, 2004, CLIN RADIOL, V59, P1061, DOI 10.1016/j.crad.2004.07.008; CHEN PC, 1979, COMPUT VISION GRAPH, V10, P172, DOI 10.1016/0146-664X(79)90049-2; Duan JH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078176; Fukunaga K., 1991, INTRO STAT PATTERN R, Vsecond; Ghany MG, 2009, HEPATOLOGY, V49, P1335, DOI 10.1002/hep.22759; Guido M, 2011, DIGEST LIVER DIS, V43, pS331, DOI 10.1016/S1590-8658(11)60589-6; Hajek M., 2006, TEXTURE ANAL MAGNETI; HARALICK RM, 1973, IEEE T SYST MAN CYB, VSMC3, P610, DOI 10.1109/TSMC.1973.4309314; Harrison LCV, 2009, J EXP CLIN CANC RES, V28, DOI 10.1186/1756-9966-28-87; Harrison LC, 2010, ACAD RADIOL, V7, P696, DOI [d oi: 10.1016/f .acra. 2010.01.005 PM ID: 20457414, DOI 10.1016/F]; Herlidou S, 2004, MAGN RESON IMAGING, V22, P237, DOI 10.1016/j.mri.2003.07.007; HU Y, 1994, IEE P-VIS IMAGE SIGN, V141, P413, DOI 10.1049/ip-vis:19941548; Ichida F, 1996, INT HEPATOL COMMUN, V6, P112, DOI 10.1016/S0928-4346(96)00325-8; Jirak D, 2002, J MAGN RESON IMAGING, V15, P68, DOI 10.1002/jmri.10042; KASHYAP RL, 1983, IEEE T INFORM THEORY, V29, P60, DOI 10.1109/TIT.1983.1056610; Kassner A, 2010, AM J NEURORADIOL, V31, P809, DOI 10.3174/ajnr.A2061; Kato H, 2007, AM J ROENTGENOL, V189, P117, DOI 10.2214/AJR.07.2070; LAINE A, 1993, IEEE T PATTERN ANAL, V15, P1186, DOI 10.1109/34.244679; Mahmoud-Ghoneim D, 2006, MAGN RESON IMAGING, V24, P167, DOI 10.1016/j.mri.2005.10.002; MALLAT SG, 1989, IEEE T ACOUST SPEECH, V37, P2091, DOI 10.1109/29.45554; Manning DS, 2008, GASTROENTEROLOGY, V134, P1670, DOI 10.1053/j.gastro.2008.03.001; Marcellin P, 2009, LIVER INT, V29, P242, DOI 10.1111/j.1478-3231.2008.01802.x; Materka A., 2006, MAZDA MANUAL; Mayerhoefer ME, 2010, J MAGN RESON IMAGING, V32, P352, DOI 10.1002/jmri.22268; Perz JF, 2006, J HEPATOL, V45, P529, DOI 10.1016/j.jhep.2006.05.013; Rahn S B, 2001, J Insur Med, V33, P110; Semelka RC, 2001, J MAGN RESON IMAGING, V13, P385, DOI 10.1002/jmri.1055; Strzelecki M, 2013, NUCL INSTRUM METH A, V702, P137, DOI 10.1016/j.nima.2012.09.006; Szczypinski PM, 2007, 2007 INTERNATIONAL SYMPOSIUM ON INFORMATION TECHNOLOGY CONVERGENCE, PROCEEDINGS, P245, DOI 10.1109/ISITC.2007.15; Szczypinski PM, 2009, COMPUT METH PROG BIO, V94, P66, DOI 10.1016/j.cmpb.2008.08.005; Watanabe H, 2011, RADIOLOGY, V259, P142, DOI 10.1148/radiol.10100621; West J, 2010, GASTROENTEROLOGY, V139, P1230, DOI 10.1053/j.gastro.2010.06.015; Wong VS, 1996, J CLIN PATHOL, V49, P465, DOI 10.1136/jcp.49.6.465; Zhang YY, 2012, INT J BIOMED IMAGING, V2012, DOI 10.1155/2012/762804	35	27	32	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2015	10	3							e0118297	10.1371/journal.pone.0118297	http://dx.doi.org/10.1371/journal.pone.0118297			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9KG	25742285	gold, Green Published, Green Submitted			2022-12-27	WOS:000350688100013
J	Fang, Z; Zhou, LN; Jiang, SM; Cao, LH; Yu, L				Fang, Zhou; Zhou, Linuo; Jiang, Songmin; Cao, Lihuan; Yu, Long			UNC50 Prompts G1/S Transition and Proliferation in HCC by Regulation of Epidermal Growth Factor Receptor Trafficking	PLOS ONE			English	Article							HEPATOCELLULAR-CARCINOMA; CAENORHABDITIS-ELEGANS; GENE-EXPRESSION; PROTEIN; CANCER; CELLS; LIVER; FIBROBLASTS; GEFITINIB; ERLOTINIB	Background UNC50 has long been recognized as a Golgi apparatus protein in yeast, and is involved in nicotinic receptor trafficking in Caenorhabditis elegans, but little is known about UNC50 gene function in human biology despite it being conserved from yeast to high eukaryotes. Objectives We investigated the relation between UNC50 and human hepatocellular carcinoma (HCC) and the potential mechanisms underlying HCC development. Methods UNC50 mRNA expression patterns in 12 HCC and adjacent non-cancerous tissues determined using northern blotting were confirmed by real-time PCR in another 44 paired tissues. Microarray experiments were used to screen for global effects of UNC50 knockdown in the Hep3B cell line, and were confirmed by real-time PCR, western blotting, flow cytometry, and tetrazolium assay in both UNC50 overexpression and knockdown Hep3B cells. Results UNC50 expression levels were upregulated in HCC tissues in comparison with the adjacent non-cancerous tissues. UNC50 knockdown reduced mRNA levels of the downstream targets of the epidermal growth factor receptor (EGFR) pathway: cyclin D1 (CCND1), EGF, matrix metalloproteinase-7 (MMP7), aldose reductase-like 1 (AKR1B10), cell surface-associated mucin 1 (MUC1), and gastrin (GAST). Moreover, UNC50 influenced EGF, inducing cell cycle entry by affecting cell surface EGFR amounts. Conclusions UNC50 may plays some roles in HCC progression by affecting the EGFR pathway.	[Fang, Zhou; Jiang, Songmin; Cao, Lihuan; Yu, Long] Fudan Univ, Sch Life Sci, State Key Lab Genet Engn, Shanghai 200433, Peoples R China; [Zhou, Linuo] Fudan Univ, Huashan Hosp, Dept Endocrinol & Metab, Shanghai 200433, Peoples R China; [Yu, Long] Fudan Univ, Inst Biomed Sci, Shanghai 200433, Peoples R China	Fudan University; Fudan University; Fudan University	Cao, LH (corresponding author), Fudan Univ, Sch Life Sci, State Key Lab Genet Engn, Shanghai 200433, Peoples R China.	lihuancao@fudan.edu.cn; longyu@fudan.edu.cn	CAO, LIHUAN/AAA-3557-2020	cao, lihuan/0000-0002-9722-4611; Fang, Zhou/0000-0002-5231-6539	National 863 Project of China [2006AA020501]; National Key Sci-Tech Special Project of China [2008ZX10002-020]; Project of the Shanghai Municipal Science and Technology Commission [03dz14086]; National Natural Science Foundation of China [30024001, 30771188]	National 863 Project of China(National High Technology Research and Development Program of China); National Key Sci-Tech Special Project of China; Project of the Shanghai Municipal Science and Technology Commission; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National 863 Project of China (2006AA020501), the National Key Sci-Tech Special Project of China (2008ZX10002-020), the Project of the Shanghai Municipal Science and Technology Commission (03dz14086) and the National Natural Science Foundation of China (30024001, 30771188). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BRENNER S, 1974, GENETICS, V77, P71; Chantalat S, 2003, MOL BIOL CELL, V14, P2357, DOI 10.1091/mbc.E02-10-0693; Ciardiello F, 2001, CLIN CANCER RES, V7, P2958; Costanzo M, 2010, SCIENCE, V327, P425, DOI 10.1126/science.1180823; Cury PR, 2007, ARCH ORAL BIOL, V52, P585, DOI 10.1016/j.archoralbio.2006.11.006; Desbois-Mouthon C, 2006, INT J CANCER, V119, P2557, DOI 10.1002/ijc.22221; Dharmaraj N, 2013, J CELL BIOCHEM, V114, P2314, DOI 10.1002/jcb.24580; Eimer S, 2007, EMBO J, V26, P4313, DOI 10.1038/sj.emboj.7601858; El-Serag HB, 2007, GASTROENTEROLOGY, V132, P2557, DOI 10.1053/j.gastro.2007.04.061; Fitzgerald J, 2000, BRAIN RES, V877, P110, DOI 10.1016/S0006-8993(00)02692-5; Ford MG, 1997, J CLIN INVEST, V99, P2762, DOI 10.1172/JCI119466; Fuchs BC, 2014, HEPATOLOGY, V59, P1577, DOI 10.1002/hep.26898; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; HERBST JJ, 1994, J BIOL CHEM, V269, P12865; Kim HJ, 2007, CELL TISSUE RES, V327, P25, DOI 10.1007/s00441-006-0304-3; LEWIS JA, 1980, GENETICS, V95, P905; Liu ZW, 2012, BIOCHEM J, V442, P273, DOI 10.1042/BJ20111322; Mendelsohn J, 2003, J CLIN ONCOL, V21, P2787, DOI 10.1200/JCO.2003.01.504; Patil MA, 2005, ONCOGENE, V24, P3737, DOI 10.1038/sj.onc.1208479; Philip PA, 2005, J CLIN ONCOL, V23, P6657, DOI 10.1200/JCO.2005.14.696; Schiffer E, 2005, HEPATOLOGY, V41, P307, DOI 10.1002/hep.20538; STOSCHECK CM, 1984, J CELL PHYSIOL, V120, P296, DOI 10.1002/jcp.1041200306; Surma MA, 2013, MOL CELL, V51, P519, DOI 10.1016/j.molcel.2013.06.014; Thomas MB, 2007, CANCER-AM CANCER SOC, V110, P1059, DOI 10.1002/cncr.22886; Wang YC, 2014, J GASTROEN HEPATOL, V29, P597, DOI 10.1111/jgh.12461; Yang YY, 2014, HEPATOL RES, V44, P542, DOI 10.1111/hepr.12151	26	4	5	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2015	10	3							e0119338	10.1371/journal.pone.0119338	http://dx.doi.org/10.1371/journal.pone.0119338			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9JM	25738771	Green Submitted, Green Published, gold			2022-12-27	WOS:000350685900104
J	Rau, A; Ritschl, LM; Mucke, T; Wolff, KD; Loeffelbein, DJ				Rau, Andrea; Ritschl, Lucas M.; Muecke, Thomas; Wolff, Klaus-Dietrich; Loeffelbein, Denys J.			Nasoalveolar Molding in Cleft Care-Experience in 40 Patients from a Single Centre in Germany	PLOS ONE			English	Article							UNILATERAL CLEFT; NONSURGICAL CORRECTION; NASAL SYMMETRY; LIP; PALATE; NOSE; DEFORMITY; INFANTS; REPAIR	Nasoalveolar molding (NAM) has gained wide acceptance and evidence in cleft therapy. However, standardized treatment protocols and experiences recorded from European centres are lacking. The results of 40 infants with cleft lip and palate treated with presurgical NAM according to the Grayson technique were analyzed. Standardized parameters of cleft width and nasal symmetry were measured in pre-and posttreatment plaster casts and in digitalized 3-dimensional STL models. Statistical analyses were performed by using Student ' s t-test in a per-protocol manner. 27 out of 40 infants completed NAM and were analyzed. In 13 patients NAM was either temporarily interrupted or terminated prematurely due to skin irritations or lack of parental support. These cases were excluded from statistical analysis, resulting in a drop-out rate of 32.5%. Intersegmental alveolar distance (ISAD), intersegmental lip distance (ISLD), nostril height (NH), nostril width (NW) and columella deviation angle (CDA) were significantly changed in unilateral cleft lip and palate (UCLP) (n = 8). In unilateral cleft lip (UCL) (n = 9), only ISLD, NH and CDA were significantly changed. ISAD of the right and left side, ISLD of the right and left side, premaxilla deviation angle, nostril height and columella length were changed significantly in bilateral cleft lip and palate (BCLP) cases (n = 10). NAM is a suitable presurgical treatment modality. A positive effect has been seen in UCLP and BCLP infants, as compared with their birth status.	[Rau, Andrea; Ritschl, Lucas M.; Muecke, Thomas; Wolff, Klaus-Dietrich; Loeffelbein, Denys J.] Tech Univ Munich, Dept Oral & Maxillofacial Surg, D-80290 Munich, Germany	Technical University of Munich	Rau, A (corresponding author), Tech Univ Munich, Dept Oral & Maxillofacial Surg, D-80290 Munich, Germany.	rau@mkg.med.tum.de	Mücke, Thomas/K-7106-2015; Loeffelbein, Denys/AAF-3231-2019	Mücke, Thomas/0000-0003-3561-1277; 	German Research Foundation (DFG); Bavarian Research Foundation (Bayerische Forschungsstiftung); Technische Universitat Munchen within the funding program Open Access Publishing	German Research Foundation (DFG)(German Research Foundation (DFG)); Bavarian Research Foundation (Bayerische Forschungsstiftung); Technische Universitat Munchen within the funding program Open Access Publishing	None of the authors had any financial and personal relationships with other people or organizations that could have inappropriately influenced this work. The concept of integrating NAM into the cleft treatment protocol was financially supported by the German Research Foundation (DFG, Nasoalveolar Molding (NAM) in cleft patients) and the Bavarian Research Foundation (Bayerische Forschungsstiftung, Rehabilitation of pediatric facial deformities) through travelling sponsorships of D.J.L. Furthermore, this work was supported by the German Research Foundation (DFG) and the Technische Universitat Munchen within the funding program Open Access Publishing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott MM, 2012, PLAST RECONSTR SURG, V130, P659, DOI 10.1097/PRS.0b013e31825dc10a; Ahmed Mohammad M, 2012, Pediatr Dent, V34, pe209; Barillas I, 2009, PLAST RECONSTR SURG, V123, P1002, DOI 10.1097/PRS.0b013e318199f46e; Bennun RD, 1999, PLAST RECONSTR SURG, V104, P616, DOI 10.1097/00006534-199909030-00002; Chang CS, 2010, PLAST RECONSTR SURG, V126, P1276, DOI 10.1097/PRS.0b013e3181ec21e4; Figueroa A., 2006, PLAST SURG-CHIR PLAS, Vsecond, P271; Garfinkle JS, 2011, PLAST RECONSTR SURG, V127, P1659, DOI 10.1097/PRS.0b013e31820a64d7; GEORGIADE NG, 1975, PLAST RECONSTR SURG, V56, P52, DOI 10.1097/00006534-197507000-00011; Grayson BH, 1999, CLEFT PALATE-CRAN J, V36, P486, DOI 10.1597/1545-1569_1999_036_0486_pnmiiw_2.3.co_2; GRAYSON BH, 1993, PLAST RECONSTR SURG, V92, P1422; Lee CTH, 2008, PLAST RECONSTR SURG, V122, P1131, DOI 10.1097/PRS.0b013e318184590c; Levy-Bercowski D, 2009, CLEFT PALATE-CRAN J, V46, P521, DOI 10.1597/07-236.1; Liao YF, 2012, PLAST RECONSTR SURG, V130, P1289, DOI 10.1097/PRS.0b013e31826d16f3; Loeffelbein DJ, 2013, BR J ORAL MAXILLOFAC; MATSUO K, 1984, PLAST RECONSTR SURG, V73, P38, DOI 10.1097/00006534-198401000-00009; MATSUO K, 1989, PLAST RECONSTR SURG, V83, P25, DOI 10.1097/00006534-198901000-00006; Mitsuyoshi I, 2004, BRIT J ORAL MAX SURG, V42, P578, DOI 10.1016/j.bjoms.2004.06.002; Oosterkamp BCM, 2005, CLEFT PALATE-CRAN J, V42, P239, DOI 10.1597/03-109.1; Penfold C, 2011, BRIT J ORAL MAX SURG, V49, P165, DOI 10.1016/j.bjoms.2010.01.017; Singh GD, 2007, ORTHOD CRANIOFAC RES, V10, P161, DOI 10.1111/j.1601-6343.2007.00390.x; Singh GD, 2005, CLEFT PALATE-CRAN J, V42, P403, DOI 10.1597/04-063.1; Sischo L, 2012, CLEFT PALATE-CRAN J, V49, P270, DOI 10.1597/11-053; Spengler AL, 2006, CLEFT PALATE-CRAN J, V43, P321; Suri S, 2010, PLAST RECONSTR SURG, V125, p112E, DOI 10.1097/PRS.0b013e3181cb66e0; van der Heijden P, 2013, PLAST RECONSTR SURG, V131, p62E, DOI 10.1097/PRS.0b013e318267d4a5	25	37	38	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2015	10	3							e0118103	10.1371/journal.pone.0118103	http://dx.doi.org/10.1371/journal.pone.0118103			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4HV	25734535	Green Published, gold, Green Submitted			2022-12-27	WOS:000350314700014
J	van Loon, RJDP; van den Assem, MJ; van Dolder, D				van Loon, Rogier J. D. Potter; van den Assem, Martijn J.; van Dolder, Dennie			Beyond Chance? The Persistence of Performance in Online Poker	PLOS ONE			English	Article							MEASURING SKILL; GAMES	A major issue in the widespread controversy about the legality of poker and the appropriate taxation of winnings is whether poker should be considered a game of skill or a game of chance. To inform this debate we present an analysis into the role of skill in the performance of online poker players, using a large database with hundreds of millions of player-hand observations from real money ring games at three different stakes levels. We find that players whose earlier profitability was in the top (bottom) deciles perform better (worse) and are substantially more likely to end up in the top (bottom) performance deciles of the following time period. Regression analyses of performance on historical performance and other skill-related proxies provide further evidence for persistence and predictability. Simulations point out that skill dominates chance when performance is measured over 1,500 or more hands of play.	[van Loon, Rogier J. D. Potter] Erasmus Univ, Erasmus Sch Econ, Rotterdam, Netherlands; [van den Assem, Martijn J.] Vrije Univ Amsterdam, Fac Econ & Business Adm, Amsterdam, Netherlands; [van Dolder, Dennie] Univ Nottingham, Nottingham Sch Econ, Nottingham NG7 2RD, England	Erasmus University Rotterdam; Vrije Universiteit Amsterdam; University of Nottingham	van Loon, RJDP (corresponding author), Erasmus Univ, Erasmus Sch Econ, Rotterdam, Netherlands.	pottervanloon@ese.eur.nl	van Dolder, Dennie/ABF-8086-2021; van Dolder, Dennie/GQI-2793-2022	van Dolder, Dennie/0000-0002-2498-8311; van den Assem, Martijn/0000-0001-5166-1288	Erasmus University Rotterdam; Erasmus Research Institute of Management (ERIM); Tinbergen Institute; Netherlands Organisation for Scientific Research (VICI NWO Grant) [453-06-001]; Economic and Social Research Council via the Network for Integrated Behavioural Sciences [ES/K002201/1]; Economic and Social Research Council [ES/K002201/1] Funding Source: researchfish; ESRC [ES/K002201/1] Funding Source: UKRI	Erasmus University Rotterdam; Erasmus Research Institute of Management (ERIM); Tinbergen Institute; Netherlands Organisation for Scientific Research (VICI NWO Grant)(Netherlands Organization for Scientific Research (NWO)); Economic and Social Research Council via the Network for Integrated Behavioural Sciences; Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))	Financial support for this project was provided by Erasmus University Rotterdam, the Erasmus Research Institute of Management (ERIM), and the Tinbergen Institute. DvD received further support through the Netherlands Organisation for Scientific Research (VICI NWO Grant 453-06-001), and the Economic and Social Research Council via the Network for Integrated Behavioural Sciences (award n. ES/K002201/1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adcock RJ, 1878, ANALYST, V5, P53, DOI DOI 10.2307/2635758; Borm PEM, 2001, TOP, V9, P91; Cabot Anthony, 2005, COOLEY LAW REV, V22, P443; Croson R, 2008, CHANCE, V21, P25; Dedonno MA, 2008, GAMING LAW REV, V12, P31, DOI 10.1089/glr.2008.12105; Dreef M, 2004, MATH METHOD OPER RES, V59, P375, DOI 10.1007/s001860400347; Dreef M, 2003, INT GAME THEORY REV, V5, P83; Dreef M, 2004, MANAGE RIAL DECISIO, V25, P255; Grohman C., 2006, J LEGAL TECHNOLOGY R, V1, P34; Hendrickx RLP, 2008, CENTER DISCUSSION PA, V2008-106; Heubeck S, 2008, GAMING LAW REV, V12, P231, DOI 10.1089/glre.2008.12306; Kelly JM, 2007, GAMING LAW REV, V11, P190, DOI 10.1089/glr.2007.11309; Kummell CH, 1879, ANALYST, V6, P97, DOI DOI 10.2307/2635646; Larkey P, 1997, MANAGE SCI, V43, P596, DOI 10.1287/mnsc.43.5.596; Levitt SD, 2014, J SPORT ECON, V15, P31, DOI 10.1177/1527002512449471; Siler K, 2010, J GAMBL STUD, V26, P401, DOI 10.1007/s10899-009-9168-2; Tselnik MA, 2007, HOFSTRA LAW REV, V35, P1617	18	12	12	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2015	10	3							e0115479	10.1371/journal.pone.0115479	http://dx.doi.org/10.1371/journal.pone.0115479			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9JF	25729862	Green Submitted, Green Accepted, gold, Green Published			2022-12-27	WOS:000350684900004
J	Masuda, K; Chiyoda, T; Sugiyama, N; Segura-Cabrera, A; Kabe, Y; Ueki, A; Banno, K; Suematsu, M; Aoki, D; Ishihama, Y; Saya, H; Kuninaka, S				Masuda, Kenta; Chiyoda, Tatsuyuki; Sugiyama, Naoyuki; Segura-Cabrera, Aldo; Kabe, Yasuaki; Ueki, Arisa; Banno, Koji; Suematsu, Makoto; Aoki, Daisuke; Ishihama, Yasushi; Saya, Hideyuki; Kuninaka, Shinji			LATS1 and LATS2 Phosphorylate CDC26 to Modulate Assembly of the Tetratricopeptide Repeat Subcomplex of APC/C	PLOS ONE			English	Article							ANAPHASE-PROMOTING COMPLEX; MITOTIC EXIT; SACCHAROMYCES-CEREVISIAE; CHECKPOINT FUNCTION; PROTEIN-KINASE; FISSION YEAST; IDENTIFICATION; PROGRESSION; MITOSIS; COMPLEX/CYCLOSOME	In budding yeast, the Mitotic Exit Network (MEN) regulates anaphase promoting complex/cyclosome (APC/C) via the Dbf2-Cdc14 signaling cascade. Dbf2 kinase phosphorylates and activates Cdc14 phosphatase, which removes the inhibitory phosphorylation of the APC/C cofactor Cdh1. Although each component of the MEN was highly conserved during evolution, there is presently no evidence supporting direct phosphorylation of CDC14 by large tumor suppressor kinase 1 (LATS1), the human counterpart of Dbf2; hence, it is unclear how LATS1 regulates APC/C. Here, we demonstrate that LATS1 phosphorylates the Thr7 (T7) residue of the APC/C component CDC26 directly. Nocodazole-induced phosphorylation of T7 was reduced by knockdown of LATS1 and LATS2 in HeLa cells, indicating that both of these kinases contribute to the phosphorylation of CDC26 in vivo. The T7 residue of CDC26 is critical for its interaction with APC6, a tetratricopeptide repeat-containing subunit of APC/C, and mutation of this residue to Asp (T7D) reduced the interaction of CDC26 with APC6. Replacement of endogenous CDC26 in HeLa cells with exogenous phosphor-mimic T7D-mutated CDC26 increased the elution size of APC/C subunits in a gel filtration assay, implying a change in the APC/C assembly upon phosphorylation of CDC26. Furthermore, T7D-mutated CDC26 promoted the ubiquitination of polo-like kinase 1, a well-known substrate of APC/C. Overall, these results suggest that LATS1/2 are novel kinases involved in APC/C phosphorylation and indicate a direct regulatory link between LATS1/2 and APC/C.	[Masuda, Kenta; Chiyoda, Tatsuyuki; Ueki, Arisa; Saya, Hideyuki; Kuninaka, Shinji] Keio Univ, Sch Med, Inst Adv Med Res, Div Gene Regulat, Tokyo, Japan; [Masuda, Kenta; Chiyoda, Tatsuyuki; Ueki, Arisa; Banno, Koji; Aoki, Daisuke] Keio Univ, Sch Med, Dept Obstet & Gynecol, Tokyo 160, Japan; [Kabe, Yasuaki; Suematsu, Makoto] Keio Univ, Sch Med, Dept Biochem, Tokyo, Japan; [Sugiyama, Naoyuki; Ishihama, Yasushi] Kyoto Univ, Grad Sch Pharmaceut Sci, Dept Mol & Cellular BioAnal, Kyoto, Japan; [Segura-Cabrera, Aldo] Cincinnati Childrens Hosp Med Ctr, Div Expt Hematol & Canc Biol, Cincinnati, OH 45229 USA; [Suematsu, Makoto] Japan Sci & Technol Agcy, CREST, Tokyo, Japan	Keio University; Keio University; Keio University; Kyoto University; Cincinnati Children's Hospital Medical Center; Japan Science & Technology Agency (JST)	Saya, H (corresponding author), Keio Univ, Sch Med, Inst Adv Med Res, Div Gene Regulat, Tokyo, Japan.	hsaya@a5.keio.jp; skuninak@a8.keio.jp	Ishihama, Yasushi/B-3101-2016; Chiyoda, Tatsuyuki/Q-1971-2019; Chiyoda, Tatsuyuki/GLR-5573-2022; Saya, Hideyuki/J-4325-2013; Suematsu, Makoto/I-8135-2013; Suematsu, Makoto/O-5762-2018; Aoki, Daisuke/E-6650-2014	Ishihama, Yasushi/0000-0001-7714-203X; Chiyoda, Tatsuyuki/0000-0002-8214-2242; Suematsu, Makoto/0000-0002-7165-6336; Suematsu, Makoto/0000-0002-7165-6336; Saya, Hideyuki/0000-0001-6610-1902; Sugiyama, Naoyuki/0000-0001-7633-8495; Segura-Cabrera, Aldo/0000-0003-3044-8028	Ministry of Education, Culture, Sports, Science, and Technology of Japan [24590360]; Osaka Cancer Research Foundation; Japan Society for the Promotion of Science (JSPS); Keio University; Grants-in-Aid for Scientific Research [26830125] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Osaka Cancer Research Foundation; Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Keio University; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by grants from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (#24590360), Osaka Cancer Research Foundation, Keio University Doctorate Student Grant-in-Aid Program, and by Research Fellowship from Grant-in-Aid for Japan Society for the Promotion of Science (JSPS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARAKI H, 1992, MOL GEN GENET, V231, P329, DOI 10.1007/BF00279807; Bardin AJ, 2001, NAT REV MOL CELL BIO, V2, P815, DOI 10.1038/35099020; Bichsel SJ, 2004, J BIOL CHEM, V279, P35228, DOI 10.1074/jbc.M404542200; Bothos J, 2005, CANCER RES, V65, P6568, DOI 10.1158/0008-5472.CAN-05-0862; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; Chiyoda T, 2012, J CELL BIOL, V197, P625, DOI 10.1083/jcb.201110110; Devroe E, 2004, J BIOL CHEM, V279, P24444, DOI 10.1074/jbc.M401999200; Gieffers C, 2001, MOL CELL, V7, P907, DOI 10.1016/S1097-2765(01)00234-9; Grallert A, 2012, NAT CELL BIOL, V14, P738, DOI 10.1038/ncb2514; Hao YW, 2008, J BIOL CHEM, V283, P5496, DOI 10.1074/jbc.M709037200; Homeyer N, 2006, J MOL MODEL, V12, P281, DOI 10.1007/s00894-005-0028-4; Iida S, 2004, ONCOGENE, V23, P5266, DOI 10.1038/sj.onc.1207623; Imamura H, 2014, J PROTEOME RES, V13, P3410, DOI 10.1021/pr500319y; Izawa D, 2011, NAT CELL BIOL, V13, P223, DOI 10.1038/ncb2165; Jaspersen SL, 1999, CURR BIOL, V9, P227, DOI 10.1016/S0960-9822(99)80111-0; Jorgensen W. L, 1983, J CHEM PHYS, V79, P10; Kotani S, 1998, MOL CELL, V1, P371, DOI 10.1016/S1097-2765(00)80037-4; Kraft C, 2003, EMBO J, V22, P6598, DOI 10.1093/emboj/cdg627; LAHAVBARATZ S, 1995, P NATL ACAD SCI USA, V92, P9303, DOI 10.1073/pnas.92.20.9303; Lindon C, 2004, J CELL BIOL, V164, P233, DOI 10.1083/jcb.200309035; Mah Angie S., 2005, BMC Biochemistry, V6, DOI 10.1186/1471-2091-6-22; Mocciaro A, 2010, J CELL SCI, V123, P2867, DOI 10.1242/jcs.074815; Mohl DA, 2009, J CELL BIOL, V184, P527, DOI 10.1083/jcb.200812022; Nitta M, 2004, ONCOGENE, V23, P6548, DOI 10.1038/sj.onc.1207873; Ohi MD, 2007, MOL CELL, V28, P871, DOI 10.1016/j.molcel.2007.10.003; Pearce LR, 2010, NAT REV MOL CELL BIO, V11, P9, DOI 10.1038/nrm2822; Peters JM, 2006, NAT REV MOL CELL BIO, V7, P644, DOI 10.1038/nrm1988; Queralt E, 2008, CURR OPIN CELL BIOL, V20, P661, DOI 10.1016/j.ceb.2008.09.003; Rudner AD, 2000, J CELL BIOL, V149, P1377, DOI 10.1083/jcb.149.7.1377; Ryckaert J.-P, 1977, J COMPUT PHYS, V23, P15; Sawin KE, 2000, CURR BIOL, V10, pR547, DOI 10.1016/S0960-9822(00)00613-8; Schreiber A, 2011, NATURE, V470, P227, DOI 10.1038/nature09756; Schwartz D, 2005, NAT BIOTECHNOL, V23, P1391, DOI 10.1038/nbt1146; Steen JAJ, 2008, P NATL ACAD SCI USA, V105, P6069, DOI 10.1073/pnas.0709807104; Sugiyama N, 2007, MOL CELL PROTEOMICS, V6, P1103, DOI 10.1074/mcp.T600060-MCP200; Sullivan M, 2007, NAT REV MOL CELL BIO, V8, P894, DOI 10.1038/nrm2276; Thornton BR, 2006, GENE DEV, V20, P3069, DOI 10.1101/gad.1478306; Vodermaier HC, 2003, CURR BIOL, V13, P1459, DOI 10.1016/S0960-9822(03)00581-5; Wang J, 2009, NAT STRUCT MOL BIOL, V16, P987, DOI 10.1038/nsmb.1645; Yamada H, 1997, J CELL SCI, V110, P1793; Yoon HJ, 2006, J BIOL CHEM, V281, P32284, DOI 10.1074/jbc.M603867200; Zachariae W, 1996, SCIENCE, V274, P1201, DOI 10.1126/science.274.5290.1201; Zachariae W, 1998, SCIENCE, V282, P1721, DOI 10.1126/science.282.5394.1721; Zhang ZG, 2010, EMBO J, V29, P3733, DOI 10.1038/emboj.2010.247	44	11	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2015	10	2							e0118662	10.1371/journal.pone.0118662	http://dx.doi.org/10.1371/journal.pone.0118662			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC3LS	25723520	Green Published, gold, Green Submitted			2022-12-27	WOS:000350251200061
J	Wang, WM; Zhao, ZL; Ma, SR; Yu, GT; Liu, B; Zhang, L; Zhang, WF; Kulkarni, AB; Sun, ZJ; Zhao, YF				Wang, Wei-Ming; Zhao, Zhi-Li; Ma, Si-Rui; Yu, Guang-Tao; Liu, Bing; Zhang, Lu; Zhang, Wen-Feng; Kulkarni, Ashok B.; Sun, Zhi-Jun; Zhao, Yi-Fang			Epidermal Growth Factor Receptor Inhibition Reduces Angiogenesis via Hypoxia-Inducible Factor-1 alpha and Notch1 in Head Neck Squamous Cell Carcinoma	PLOS ONE			English	Article							TUMOR ANGIOGENESIS; GAMMA-SECRETASE; CANCER; PATHWAY; CHEMOTHERAPY; ACTIVATION; CETUXIMAB; VEGF; EXPRESSION; RESISTANCE	Angiogenesis, a marker of cancer development, affects response to radiotherapy sensibility. This preclinical study aims to understand the receptor tyrosine kinase-mediated angiogenesis in head neck squamous cell carcinoma (HNSCC). The receptor tyrosine kinase activity in a transgenic mouse model of HNSCC was assessed. The anti-tumorigenetic and anti-angiogenetic effects of cetuximab-induced epidermal growth factor receptor (EGFR) inhibition were investigated in xenograft and transgenic mouse models of HNSCC. The signaling transduction of Notch1 and hypoxia-inducible factor-1 alpha (HIF-1 alpha) was also analyzed. EGFR was overexpressed and activated in the Tgfbr1/ Pten deletion (2cKO) mouse model of HNSCC. Cetuximab significantly delayed tumor onset by reducing tumor angiogenesis. This drug exerted similar effects on heterotopic xenograft tumors. In the human HNSCC tissue array, increased EGFR expression correlated with increased HIF-1 alpha and micro vessel density. Cetuximab inhibited tumor-induced angiogenesis in vitro and in vivo by significantly downregulating HIF-1 alpha and Notch1. EGFR is involved in the tumor angiogenesis of HNSCC via the HIF-1 alpha and Notch1 pathways. Therefore, targeting EGFR by suppressing hypoxiaand Notch-induced angiogenesis may benefit HNSCC therapy.	[Wang, Wei-Ming; Zhao, Zhi-Li; Ma, Si-Rui; Yu, Guang-Tao; Zhang, Lu; Sun, Zhi-Jun; Zhao, Yi-Fang] Wuhan Univ, Minist Educ, State Key Lab Breeding Base Basic Sci Stomatol, Wuhan 430072, Peoples R China; [Wang, Wei-Ming; Zhao, Zhi-Li; Ma, Si-Rui; Yu, Guang-Tao; Zhang, Lu; Sun, Zhi-Jun; Zhao, Yi-Fang] Wuhan Univ, Minist Educ, Key Lab Oral Biomed, Wuhan 430072, Peoples R China; [Wang, Wei-Ming; Zhao, Zhi-Li; Ma, Si-Rui; Liu, Bing; Zhang, Wen-Feng; Sun, Zhi-Jun; Zhao, Yi-Fang] Wuhan Univ, Sch & Hosp Stomatol, Dept Oral & Maxillofacial Head & Neck Oncol, Wuhan 430072, Peoples R China; [Kulkarni, Ashok B.] Natl Inst Dent & Craniofacial Res, Funct Genom Sect, Lab Cell & Dev Biol, NIH, Bethesda, MD USA	Wuhan University; Wuhan University; Wuhan University; National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR)	Sun, ZJ (corresponding author), Wuhan Univ, Minist Educ, State Key Lab Breeding Base Basic Sci Stomatol, Wuhan 430072, Peoples R China.	zhijundejia@163.com; yifang@whu.edu.cn	Sun, Zhi-Jun/AAD-8791-2022; zhao, zhili/F-4137-2016; Yu, Guang-Tao/GLV-5025-2022	Sun, Zhi-Jun/0000-0003-0932-8013; zhao, zhili/0000-0002-9030-1979; Yu, Guang-Tao/0000-0003-1642-3924	National Natural Science Foundation of China [81072203, 81272963, 81371106, 81272946, 81170977, 81472528]; program for new century excellent talents in university, ministry of education of China [NCET-13-0439]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [ZIADE000664] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); program for new century excellent talents in university, ministry of education of China(Program for New Century Excellent Talents in University (NCET)Ministry of Education, China); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was funded by National Natural Science Foundation of China (81072203, 81272963) to Z.-J. Sun, (81371106) to L. Zhang, (81272946) to W.-F. Zhang, and (81170977) to Y.-F. Zhao. Z.-J. Sun is supported by program for new century excellent talents in university (NCET-13-0439), ministry of education of China. Support also came from National Natural Science Foundation of China (81472528) to Z.-J. Sun. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal N, 2011, SCIENCE, V333, P1154, DOI 10.1126/science.1206923; Ang KK, 2002, CANCER RES, V62, P7350; Arteaga CL, 2008, CLIN CANCER RES, V14, P6277, DOI 10.1158/1078-0432.CCR-08-0482; Arumugam TV, 2011, MOL PHARMACOL, V80, P23, DOI 10.1124/mol.111.071076; Bian Y, 2012, ONCOGENE, V31, P3322, DOI 10.1038/onc.2011.494; Bian YS, 2009, CANCER RES, V69, P5918, DOI 10.1158/0008-5472.CAN-08-4623; Boehm AL, 2008, MOL PHARMACOL, V73, P1632, DOI 10.1124/mol.107.044636; Bonner JA, 2010, LANCET ONCOL, V11, P21, DOI 10.1016/S1470-2045(09)70311-0; Carmeliet P, 2000, NATURE, V407, P249, DOI 10.1038/35025220; CHEN MM, 2014, PLOS COMPUT BIOL, V10, P29918, DOI DOI 10.1371/JOURNAL.PONE.0089548; De Souza JA, 2012, CLIN CANCER RES, V18, P2336, DOI 10.1158/1078-0432.CCR-11-2825; Facciabene A, 2012, CANCER RES, V72, P2162, DOI 10.1158/0008-5472.CAN-11-3687; Facciabene A, 2011, NATURE, V475, P226, DOI 10.1038/nature10169; Funahashi Y, 2008, CANCER RES, V68, P4727, DOI 10.1158/0008-5472.CAN-07-6499; Haddad R, 2013, LANCET ONCOL, V14, P257, DOI 10.1016/S1470-2045(13)70011-1; Hayashi H, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002401; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Kalyankrishna S, 2006, J CLIN ONCOL, V24, P2666, DOI 10.1200/JCO.2005.04.8306; Leeman-Neill RJ, 2011, CANCER PREV RES, V4, P230, DOI 10.1158/1940-6207.CAPR-10-0249; Li JL, 2011, CANCER RES, V71, P6073, DOI 10.1158/0008-5472.CAN-11-1704; Li JL, 2009, FRONT BIOSCI-LANDMRK, V14, P3094, DOI 10.2741/3438; Liao YF, 2007, MOL PHARMACOL, V71, P588, DOI 10.1124/mol.106.024299; Lui VWY, 2013, CANCER DISCOV, V3, P761, DOI 10.1158/2159-8290.CD-13-0103; Niu G, 2010, CLIN CANCER RES, V16, P2095, DOI 10.1158/1078-0432.CCR-09-2495; Phng LK, 2009, DEV CELL, V16, P196, DOI 10.1016/j.devcel.2009.01.015; Soares R, 2004, MOL ENDOCRINOL, V18, P2333, DOI 10.1210/me.2003-0362; Stransky N, 2011, SCIENCE, V333, P1157, DOI 10.1126/science.1208130; Sun ZJ, 2012, CLIN CANCER RES, V18, P5304, DOI 10.1158/1078-0432.CCR-12-1371; Sun ZJ, 2010, J PHARMACOL EXP THER, V334, P500, DOI 10.1124/jpet.110.167692; Takubo K, 2010, CELL STEM CELL, V7, P391, DOI 10.1016/j.stem.2010.06.020; Tang Y, 2012, MOL PHARMACOL, V81, P527, DOI 10.1124/mol.111.076851; Troy JD, 2013, HEAD NECK PATHOL, V7, P344, DOI 10.1007/s12105-013-0447-y; Van Cutsem E, 2009, NEW ENGL J MED, V360, P1408, DOI 10.1056/NEJMoa0805019; Vermorken JB, 2008, NEW ENGL J MED, V359, P1116, DOI 10.1056/NEJMoa0802656; Wang XJ, 2013, MOL CELL BIOCHEM, V380, P57, DOI 10.1007/s11010-013-1657-z; Wang ZW, 2006, CANCER RES, V66, P2778, DOI 10.1158/0008-5472.CAN-05-4281; Wu XL, 2013, ONCOTARGET, V4, P1388, DOI 10.18632/oncotarget.1239; Zhang L, 2013, CANCER LETT, V331, P230, DOI 10.1016/j.canlet.2013.01.003; Zini A, 2010, J ORAL PATHOL MED, V39, P299, DOI 10.1111/j.1600-0714.2009.00845.x	39	32	36	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2015	10	2							e0119723	10.1371/journal.pone.0119723	http://dx.doi.org/10.1371/journal.pone.0119723			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC3LS	25723392	Green Published, Green Submitted, gold			2022-12-27	WOS:000350251200072
J	Amancio, DR				Amancio, Diego R.			Probing the Topological Properties of Complex Networks Modeling Short Written Texts	PLOS ONE			English	Article							STATISTICAL KEYWORD DETECTION; LANGUAGE; BRAIN; CLASSIFICATION; CENTRALITY; CLUSTERS; GRAPH	In recent years, graph theory has been widely employed to probe several language properties. More specifically, the so-called word adjacency model has been proven useful for tackling several practical problems, especially those relying on textual stylistic analysis. The most common approach to treat texts as networks has simply considered either large pieces of texts or entire books. This approach has certainly worked well-many informative discoveries have been made this way-but it raises an uncomfortable question: could there be important topological patterns in small pieces of texts? To address this problem, the topological properties of subtexts sampled from entire books was probed. Statistical analyses performed on a dataset comprising 50 novels revealed that most of the traditional topological measurements are stable for short subtexts. When the performance of the authorship recognition task was analyzed, it was found that a proper sampling yields a discriminability similar to the one found with full texts. Surprisingly, the support vector machine classification based on the characterization of short texts outperformed the one performed with entire books. These findings suggest that a local topological analysis of large documents might improve its global characterization. Most importantly, it was verified, as a proof of principle, that short texts can be analyzed with the methods and concepts of complex networks. As a consequence, the techniques described here can be extended in a straightforward fashion to analyze texts as time-varying complex networks.	Univ Sao Paulo, Inst Math & Comp Sci, Sao Paulo, Brazil	Universidade de Sao Paulo	Amancio, DR (corresponding author), Univ Sao Paulo, Inst Math & Comp Sci, Sao Paulo, Brazil.	diego@icmc.usp.br	Amancio, Diego Raphael/I-1071-2012		Sao Paulo Research Foundation (FAPESP) [2014/20830-0, 2015/00329-8]	Sao Paulo Research Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	DRA acknowledges financial support from Sao Paulo Research Foundation (FAPESP) (grant numbers 2014/20830-0 and 2015/00329-8). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbasi A, 2005, IEEE INTELL SYST, V20, P67, DOI 10.1109/MIS.2005.81; Abramov O, 2011, J QUANT LINGUIST, V18, P291, DOI 10.1080/09296174.2011.608602; Amancio DR, 2011, PHYSICA A, V390, P4673, DOI 10.1016/j.physa.2011.06.079; Amancio DR, 2015, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2015/03/P03005; Amancio DR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067310; Amancio DR, 2012, EPL-EUROPHYS LETT, V100, DOI 10.1209/0295-5075/100/58002; Amancio DR, 2012, PHYSICA A, V391, P4406, DOI 10.1016/j.physa.2012.04.011; Amancio DR, 2012, PHYSICA A, V391, P1855, DOI 10.1016/j.physa.2011.10.015; Amancio DR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094137; Amancio DR, 2012, NEW J PHYS, V14, DOI 10.1088/1367-2630/14/4/043029; Amancio DR, 2011, NEW J PHYS, V13, DOI 10.1088/1367-2630/13/12/123024; [Anonymous], 2009, SAC; Antiqueira L. L., 2007, INTELIGENCIA ARTIFIC, V11, P51, DOI DOI 10.4114/IA.V11I36.891; Backes AR, 2009, PATTERN RECOGN, V42, P54, DOI 10.1016/j.patcog.2008.07.006; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; Baronchelli A, 2013, TRENDS COGN SCI, V17, P348, DOI 10.1016/j.tics.2013.04.010; Barttfeld P, 2011, NEUROPSYCHOLOGIA, V49, P254, DOI 10.1016/j.neuropsychologia.2010.11.024; Beckage N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019348; Berger AL, 1996, COMPUT LINGUIST, V22, P39; Betel D, 2004, BIOINFORMATICS, V20, P55, DOI 10.1093/bioinformatics/bth903; Borge-Holthoefer J, 2010, ENTROPY-SWITZ, V12, P1264, DOI 10.3390/e12051264; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Cambria E, 2013, IEEE INTELL SYST, V28, P15, DOI 10.1109/MIS.2013.30; Cancho RFI, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.051915; Cancho RFI, 2001, P ROY SOC B-BIOL SCI, V268, P2261, DOI 10.1098/rspb.2001.1800; Cano P, 2006, CHAOS, V16, DOI 10.1063/1.2137622; Carretero-Campos C, 2013, PHYSICA A, V392, P1481, DOI 10.1016/j.physa.2012.11.052; Cong J, 2014, PHYS LIFE REV, V11, P598, DOI 10.1016/j.plrev.2014.04.004; CORTES C, 1995, MACH LEARN, V20, P273, DOI 10.1023/A:1022627411411; Costa LD, 2006, J STAT PHYS, V125, P845, DOI 10.1007/s10955-006-9130-y; Dangalchev C, 2004, PHYSICA A, V338, P659, DOI 10.1016/j.physa.2004.01.056; Darrell T, 2006, NEAREST NEIGHBOR MET; de Arruda GF, 2014, CLIN NEUROPHYSIOL, V125, P1589, DOI 10.1016/j.clinph.2013.11.036; de Moura APS, 2003, PHYS REV E, V68, DOI 10.1103/PhysRevE.68.017102; Doye JPK, 2005, J CHEM PHYS, V122, DOI 10.1063/1.1850468; Dreher H, 2007, ISSUES INFORM SCI IN, V4, P601, DOI DOI 10.28945/3141; Duda R.O., 2000, PATTERN CLASSIFICATI; Dunning T., 1993, Computational Linguistics, V19, P61; Ebrahimpour M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054998; FREEMAN LC, 1979, SOC NETWORKS, V1, P215, DOI 10.1016/0378-8733(78)90021-7; FREEMAN LC, 1977, SOCIOMETRY, V40, P35, DOI 10.2307/3033543; Girvan M, 2002, P NATL ACAD SCI USA, V99, P7821, DOI 10.1073/pnas.122653799; Golder SA, 2011, SCIENCE, V333, P1878, DOI 10.1126/science.1202775; Grabska-Gradzinska I, 2012, INT J MOD PHYS C, V23, DOI 10.1142/S0129183112500519; Grant T, 2007, INT J SPEECH LANG LA, V14, P1, DOI 10.1558/ijsll.v14i1.1; Hand DJ, 2001, INT STAT REV, V69, P385, DOI 10.1111/j.1751-5823.2001.tb00465.x; Herrera JP, 2008, EUR PHYS J B, V63, P135, DOI 10.1140/epjb/e2008-00206-x; HOLMES DI, 1994, COMPUT HUMANITIES, V28, P87, DOI 10.1007/BF01830689; Karsai M, 2014, SCI REP-UK, V4, DOI 10.1038/srep04001; Kong JS, 2006, COMPUTER, V39, P67, DOI 10.1109/MC.2006.257; Landauer TK, 2004, P NATL ACAD SCI USA, V101, P5214, DOI 10.1073/pnas.0400341101; Lin D, 1998, P 36 ANN M ASS COMP, P768, DOI DOI 10.3115/980432.980696; Liu HT, 2008, PHYSICA A, V387, P3048, DOI 10.1016/j.physa.2008.01.069; Liu HT, 2013, CHINESE SCI BULL, V58, P1139, DOI 10.1007/s11434-013-5711-8; Liu HT, 2010, CHINESE SCI BULL, V55, P3458, DOI 10.1007/s11434-010-4114-3; Liu HT, 2009, CHINESE SCI BULL, V54, P2781, DOI 10.1007/s11434-009-0467-x; Mac Carron P, 2013, EUR PHYS J B, V86, DOI 10.1140/epjb/e2013-40583-3; Manning C.D., 1999, FDN STAT NATURAL LAN; Masucci AP, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.026102; Matveeva I, 2006, PROCEEDINGS OF THE F, P61; Mihalcea R., 2011, GRAPH BASED NATURAL; Mosteller F, 1964, INFERENCE DISPUTED A; Murthy SK, 1998, DATA MIN KNOWL DISC, V2, P345, DOI 10.1023/A:1009744630224; Navigli R, 2009, ACM COMPUT SURV, V41, DOI 10.1145/1459352.1459355; Newman M., 1992, NETWORKS AN INTRODUC; Paczuski M, 2004, PHYSICA A, V342, P158, DOI 10.1016/j.physa.2004.04.073; Masucci AP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017333; Roxas RM, 2010, INT J MOD PHYS C, V21, P503, DOI 10.1142/S0129183110015257; Roxas-Villanueva RM, 2012, INT J MOD PHYS C, V23, DOI 10.1142/S012918311250009X; Rubinov M, 2010, NEUROIMAGE, V52, P1059, DOI 10.1016/j.neuroimage.2009.10.003; Silva TC, 2013, EUR PHYS J B, V86, DOI 10.1140/epjb/e2013-40025-4; Silva TC, 2012, EPL-EUROPHYS LETT, V98, DOI 10.1209/0295-5075/98/58001; Sporns O, 2004, TRENDS COGN SCI, V8, P418, DOI 10.1016/j.tics.2004.07.008; Stam Cornelis J, 2007, Nonlinear Biomed Phys, V1, P3, DOI 10.1186/1753-4631-1-3; Stamatatos E, 2009, J AM SOC INF SCI TEC, V60, P538, DOI 10.1002/asi.21001; Toivonen R, 2009, SOC NETWORKS, V31, P240, DOI 10.1016/j.socnet.2009.06.004; Veronis J, 2004, COMPUT SPEECH LANG, V18, P223, DOI 10.1016/j.csl.2004.05.002; Vitevitch MS, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00369; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Wu XD, 2008, KNOWL INF SYST, V14, P1, DOI 10.1007/s10115-007-0114-2; Zamora-Lopez G, 2011, PHILOS T R SOC A, V369, P3730, DOI 10.1098/rsta.2011.0121; Zhao XH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033540	82	50	50	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2015	10	2							e0118394	10.1371/journal.pone.0118394	http://dx.doi.org/10.1371/journal.pone.0118394			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC2ZH	25719799	gold, Green Published, Green Submitted			2022-12-27	WOS:000350213200051
J	Woldesemayat, EM; Datiko, DG; Lindtjorn, B				Woldesemayat, Endrias M.; Datiko, Daniel G.; Lindtjorn, Bernt			Follow-Up of Chronic Coughers Improves Tuberculosis Case Finding: Results from a Community-Based Cohort Study in Southern Ethiopia	PLOS ONE			English	Article							INDEXES	Background Untreated smear-positive tuberculosis (TB) patients are the primary source of infection; however, a large number of TB cases have not been identified and are untreated in many sub-Saharan African countries, including Ethiopia. This study determined whether or not a community-based follow-up of chronic coughers improves detection of TB cases and the risk factors for death among such cases. Methods We conducted a census in six rural communities in Sidama, southern Ethiopia. Based on interview and sputum investigation, we identified 724 TB smear-negative chronic coughers, and did a cohort study of these chronic coughers and 1448 neighbourhood controls. For both chronic coughers and neighbourhood controls, we conducted a TB screening interview and performed sputum microscopy, as required, at 4, 7 and 10 months. Between September 2011 and June 2012, we followed chronic coughers and neighbourhood controls for 588 and 1,204 person-years of observation, respectively. Results Of the chronic coughers, 23 developed smear-positive TB (incidence rate = 3912/10(5) person-years) compared to three neighbourhood controls who developed smear-positive TB (incidence rate = 249/10(5) person-years). The male-to-female ratio of smear-positive TB was 1:1. We demonstrated that chronic coughers (adjusted hazards ratio [aHR], 13.5; 95% CI, 4.0-45.7) and the poor (aHR, 2.6; 95% CI, 1.1-5.8) were at high-risk for smear-positive TB. Among the study cohort, 15 chronic coughers and two neighbourhood controls died (aHR, 14.0; 95% CI, 3.2-62.4). Conclusion A community-based follow-up of chronic coughers is helpful in improving smear-positive TB case detection, it benefits socioeconomically disadvantaged people in particular; in rural settings, chronic coughers had a higher risk of death.	[Woldesemayat, Endrias M.] Univ Bergen, Ctr Int Hlth, Bergen, Norway; [Woldesemayat, Endrias M.; Lindtjorn, Bernt] Hawassa Univ, Sch Publ & Environm Hlth, Hawassa, Ethiopia; [Datiko, Daniel G.] Univ Liverpool, Liverpool Sch Trop Med, Liverpool L3 5QA, Merseyside, England; [Datiko, Daniel G.] TB REACH Project, Hawassa, Ethiopia	University of Bergen; Hawassa University; Liverpool School of Tropical Medicine; University of Liverpool	Woldesemayat, EM (corresponding author), Univ Bergen, Ctr Int Hlth, Bergen, Norway.	endromark@yahoo.com	Datiko, Daniel G./AAE-6856-2020; Datiko, Daniel/AAE-7019-2020; Lindtjorn, Bernt/K-9465-2018	Datiko, Daniel/0000-0002-8556-3069; Lindtjorn, Bernt/0000-0002-6267-6984	University of Bergen, Centre for International Health	University of Bergen, Centre for International Health	This study was financially supported by the University of Bergen, Centre for International Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cambanis A, 2005, TROP MED INT HEALTH, V10, P330, DOI 10.1111/j.1365-3156.2005.01393.x; Connolly Maire, 1996, World Health Statistics Quarterly, V49, P115; Datiko DG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005443; Demissie M, 2002, BMC PUBLIC HEALTH, V2, DOI 10.1186/1471-2458-2-23; Ethiopian health and nutrition research institute, 2009, GUIDELINES FOR QUALI; Falagas ME, 2008, EXPERT REV ANTI-INFE, V6, P593, DOI 10.1586/14787210.6.5.593; Fantahun M, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-268; Federal Ministry of Health, 2003, HEALTH AND HEALTH RE; Federal Ministry of Health Ethiopia, 2007, HEALTH EXTENSION PRO; Howe LD, 2008, EMERG THEMES EPIDEMI, V5, DOI 10.1186/1742-7622-5-3; Mesfin MM, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-53; Misganaw A, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-634; Negusse Haile, 2007, Hum Resour Health, V5, P21, DOI 10.1186/1478-4491-5-21; Shargie E. B., 2005, Ethiopian Journal of Health Development, V19, P104; Shargie EB, 2006, B WORLD HEALTH ORGAN, V84, P112, DOI 10.2471/BLT.05.024489; Tadesse T, 2013, INT J TUBERC LUNG D, V17, P630, DOI 10.5588/ijtld.12.0449; Tatek Wondimu, 2007, Ethiopian Journal of Health Development, V21, P148; Tiemersma EW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017601; Vyas S, 2006, HEALTH POLICY PLANN, V21, P459, DOI 10.1093/heapol/czl029; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1; World Health Organization, 2005, PRACTICAL APPROACH T; Yassin MA, 2006, INT J TUBERC LUNG D, V10, P1166; Yassin MA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063174; Yimer S, 2005, BMC INFECT DIS, V5, DOI 10.1186/1471-2334-5-112; Yimer S, 2009, INT J TUBERC LUNG D, V13, P1399	25	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2015	10	2							e0116324	10.1371/journal.pone.0116324	http://dx.doi.org/10.1371/journal.pone.0116324			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC2ZH	25719541	Green Published, gold, Green Accepted			2022-12-27	WOS:000350213200007
J	Apinjoh, TO; Anchang-Kimbi, JK; Mugri, RN; Tangoh, DA; Nyingchu, RV; Chi, HF; Tata, RB; Njumkeng, C; Njua-Yafi, C; Achidi, EA				Apinjoh, Tobias O.; Anchang-Kimbi, Judith K.; Mugri, Regina N.; Tangoh, Delphine A.; Nyingchu, Robert V.; Chi, Hanesh F.; Tata, Rolland B.; Njumkeng, Charles; Njua-Yafi, Clarisse; Achidi, Eric A.			The Effect of Insecticide Treated Nets (ITNs) on Plasmodium falciparum Infection in Rural and Semi-Urban Communities in the South West Region of Cameroon	PLOS ONE			English	Article							MALARIA CONTROL; BED NETS; CONTROL INTERVENTIONS; RISK-FACTORS; COVERAGE; CHILDREN; ETHIOPIA; DETERMINANTS; PREVENTION; POSSESSION	Insecticide Treated Nets (ITNs) have been shown to reduce morbidity and mortality, but coverage and proper utilization continues to be moderate in many parts of sub-Saharan Africa. The gains made through a nationwide free distribution were explored as well as the effect on malaria prevalence in semi-urban and rural communities in south western Cameroon. A cross sectional survey was conducted between August and December 2013. Information on net possession, status and use were collected using a structured questionnaire while malaria parasitaemia was determined on Giemsa-stained blood smears by light microscopy. ITN ownership increased from 41.9% to 68.1% following the free distribution campaign, with 58.3% (466/799) reportedly sleeping under the net. ITN ownership was lower in rural settings (adjusted OR = 1.93, 95% CI = 1.36- 2.74, p< 0.001) and at lower altitude (adjusted OR = 1.79, 95% CI = 1.22-2.62, p = 0.003) compared to semi-urban settings and intermediate altitude respectively. Conversely, ITN usage was higher in semi-urban settings (p = 0.002) and at intermediate altitude ( p = 0.002) compared with rural localities and low altitude. Malaria parasitaemia prevalence was higher in rural (adjusted OR = 1.63, 95% CI = 1.07-2.49) compared to semi-urban settings and in those below 15 years compared to those 15 years and above. Overall, participants who did not sleep under ITN were more susceptible to malaria parasitaemia (adjusted OR = 1.70, 95% CI = 1.14-2.54, p = 0.009). Despite the free distribution campaign, ITN ownership and usage, though improved, is still low. As children who reside in rural settings have greater disease burden (parasitemia) than children in semi-urban settings, the potential gains on both reducing inequities in ITN possession as well as disease burden might be substantial if equitable distribution strategies are adopted.	[Apinjoh, Tobias O.; Tangoh, Delphine A.; Nyingchu, Robert V.; Achidi, Eric A.] Univ Buea, Dept Biochem & Mol Biol, Buea, Cameroon; [Anchang-Kimbi, Judith K.] Univ Buea, Dept Zool & Anim Physiol, Buea, Cameroon; [Mugri, Regina N.; Chi, Hanesh F.; Tata, Rolland B.; Njumkeng, Charles] Univ Buea, Dept Microbiol & Parasitol, Buea, Cameroon; [Tangoh, Delphine A.; Nyingchu, Robert V.] Univ Buea, Dept Med Lab Sci, Buea, Cameroon; [Njua-Yafi, Clarisse] Univ Yaounde I, Dept Anim Biol & Physiol, Yaounde, Cameroon	University of Yaounde I	Apinjoh, TO (corresponding author), Univ Buea, Dept Biochem & Mol Biol, Buea, Cameroon.	apinjohtoby@yahoo.co.uk	Anchang-Kimbi, Judith/AAE-9802-2020	Tata, Rolland Bantar/0000-0002-8814-5241; Apinjoh, Tobias/0000-0001-9889-7271	UK Medical Research Council [G0600]; Centre for Genomics and Global Health	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Centre for Genomics and Global Health	This work was funded by the UK Medical Research Council-Grant no. G0600 to TOA through the Centre for Genomics and Global Health (http:// www.cggh.org). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achidi EA, 2008, ANN TROP MED PARASIT, V102, P103, DOI 10.1179/136485908X252287; Ahmed SM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012660; Alaii JA, 2003, AM J TROP MED HYG, V68, P137, DOI 10.4269/ajtmh.2003.68.137; [Anonymous], 2004, COCHRANE DB SYST REV; Astatkie A, 2009, ETHIOP J HEALTH DEV, V23, P206; Atkinson JA, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-119; Barat LM, 2004, AM J TROP MED HYG, V71, P174, DOI 10.4269/ajtmh.2004.71.174; Biadgilign S, 2012, J TROP MED-US, V2012, DOI 10.1155/2012/235015; Bousema T, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001165; Breman JG, 2007, AM J TROP MED HYG S6, V77; Cameroon DHS-MICS, 2011, PR13 COM DHS MICS; Damien GB, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-380; Deribew A, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-121; DRAPER C. C, 1960, TRANS ROY SOC TROP MED AND HYG, V54, P342, DOI 10.1016/0035-9203(60)90115-2; Ghebreyesus TA, 2000, T ROY SOC TROP MED H, V94, P17, DOI 10.1016/S0035-9203(00)90424-3; Greenwood B.M., 1989, Transactions of the Royal Society of Tropical Medicine and Hygiene, V83, P25, DOI 10.1016/0035-9203(89)90599-3; Howard SC, 2000, T ROY SOC TROP MED H, V94, P357, DOI 10.1016/S0035-9203(00)90103-2; Jima D, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-58; Kazembe Lawrence N, 2007, Int J Equity Health, V6, P5, DOI 10.1186/1475-9276-6-5; Keating J, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-313; Kelechi N, 2008, AFR J APPL ZOOL ENV, V10, P40; Kilian A, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-330; Kirby MJ, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-2; Kleinschmidt I, 2007, AM J TROP MED HYG, V76, P1027, DOI 10.4269/ajtmh.2007.76.1027; Korenromp EL, 2003, TROP MED INT HEALTH, V8, P693, DOI 10.1046/j.1365-3156.2003.01084.x; Lwetoijera DW, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-57; Mabaso MLH, 2004, TROP MED INT HEALTH, V9, P846, DOI 10.1111/j.1365-3156.2004.01263.x; Mabunda S, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-74; Macintyre K, 2006, TROP MED INT HEALTH, V11, P824, DOI 10.1111/j.1365-3156.2006.01637.x; Ministry of Public Health Cameroon, 2009, HLTH SECT STRAT 2001; Mushinzimana E, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-13; Ngwa G, 2000, PIMD18751301, P40; Okell LC, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2241; Pluess B, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006657.pub2; Rehman AM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019205; Sena LD, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-406; Skarbinski J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021995; Slutsker L, 2009, LANCET, V373, P11, DOI 10.1016/S0140-6736(08)61597-4; Tchinda VHM, 2012, PAN AFR MED J, V12; Temu EA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031409; VanBortel W, 1996, TROP MED INT HEALTH, V1, P824; von Seidlein L, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-200; Wanji S, 2003, TROP MED INT HEALTH, V8, P643, DOI 10.1046/j.1365-3156.2003.01070.x; Wanji S, 2012, AM J TROP MED HYG, V86, P764, DOI 10.4269/ajtmh.2012.11-0433; Welch K, 2012, J VECTOR DIS, V49, P1; West PA, 2013, PLOS ONE, V7, P8, DOI DOI 10.1371/J0URNAL.P0NE.0065787; West PA, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-273; WHO, 2013, WORLD MALARIA REPORT 2013, P1; WHO, 2011, WORLD MALARIA REPORT 2011, P1; WHO, 2010, WORLD MALARIA REPORT 2010, P1; WHO, 2007, MAL EL FIELD MAN LOW, DOI [10.1093/jxb/erm028, DOI 10.1093/JXB/ERM028]; WHO UNICEF DHS M Evaluation M CDC, 2005, ROLL BACK MAL GUID C; Worrall E, 2005, TROP MED INT HEALTH, V10, P1047, DOI 10.1111/j.1365-3156.2005.01476.x	53	32	32	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2015	10	2							e0116300	10.1371/journal.pone.0116300	http://dx.doi.org/10.1371/journal.pone.0116300			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC2IM	25714837	Green Published, gold, Green Submitted			2022-12-27	WOS:000350168700014
J	Lee, JS; Shukla, S; Kim, JA; Kim, M				Lee, Jong Suk; Shukla, Shruti; Kim, Jung-Ae; Kim, Myunghee			Anti-Angiogenic Effect of Nelumbo nucifera Leaf Extracts in Human Umbilical Vein Endothelial Cells with Antioxidant Potential	PLOS ONE			English	Article							OXIDATIVE STRESS; NITRIC-OXIDE; CONSTITUENTS; INHIBITION; LEAVES; DAMAGE	Nelumbo nucifera Gaertn (Nymphaeaceae) has long been used as a traditional herb in Chinese, Japanese, Indian, and Korean medicinal practices since prehistoric times and flourishes today as the primary form of medicine. This study reports for the first time the potent ability of N. nucifera leaf extracts to inhibit vascular endothelial growth factor (VEGF)-induced angiogenesis in vitro and in vivo, as well as their antioxidant efficacy in various scavenging models and an analysis of their chemical composition. In vivo anti-angiogenic activity was evaluated in a chick chorioallantoic membrane (CAM) model using fertilized chicken eggs, in human umbilical vein endothelial cells (HUVECs) by using cell viability, cell proliferation and tube formation assays, and by determining intracellular reactive oxygen species (ROS) in vitro. The antioxidant efficacy of N. nucifera leaf extracts was determined in various scavenging models, including total phenolic and flavonoid content. The chemical composition of N. nucifera leaf extracts was determined by GC-MS analysis, which revealed the presence of different phytochemicals. The IC50 values for the DPPH radical scavenging activities of water and methanol extracts were found to be 1699.47 and 514.36 mu g ml(-1), and their total phenolic and flavonoid contents were 85.01 +/- 2.32 and 147.63 +/- 2.23 mg GAE g dry mass(-1) and 35.38 +/- 1.32 and 41.86 +/- 1.07 mg QA g dry mass(-1), respectively. N. nucifera leaf extracts (10-100 mu g ml(-1)) exhibited significant dose-dependent inhibition of VEGF-induced angiogenesis, as well as VEGF-induced proliferation and tube formation in HUVECs. In this study, N. nucifera leaf extracts displayed potent antioxidant and inhibitory effects on VEGF-induced angiogenesis. N. nucifera exerted an inhibitory effect on VEGF-induced proliferation and tube formation, as well as CAM angiogenesis in vivo. Moreover, N. nucifera leaf extracts significantly blocked VEGF-induced ROS production in HUVECs, confirming their possible anti-angiogenic mechanism.	[Lee, Jong Suk; Shukla, Shruti; Kim, Myunghee] Yeungnam Univ, Dept Food Sci & Technol, Kyongsan 712749, Gyeongbuk, South Korea; [Kim, Jung-Ae] Yeungnam Univ, Coll Pharm, Kyongsan 712749, Gyeongbuk, South Korea	Yeungnam University; Yeungnam University	Kim, M (corresponding author), Yeungnam Univ, Dept Food Sci & Technol, Kyongsan 712749, Gyeongbuk, South Korea.	foodtech@ynu.ac.kr	Kim, Myunghee/AAP-8425-2020; Kim, Myunghee/AAO-6713-2021; shukla, shruti/M-7538-2016	Kim, Myunghee/0000-0002-1340-435X; Kim, Myunghee/0000-0002-1340-435X; 	Basic Science Research Program of the National Research Foundation of Korea (NRF) - Ministry of Science, ICT & Future Planning [2012R1A1A3011096]; Yeungnam University Research Grant	Basic Science Research Program of the National Research Foundation of Korea (NRF) - Ministry of Science, ICT & Future Planning; Yeungnam University Research Grant	This research was supported by the Basic Science Research Program of the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT & Future Planning (2012R1A1A3011096) and supported by the Yeungnam University Research Grant in 2012. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abul Hasnat M, 2014, J FOOD BIOCHEM, V38, P6, DOI 10.1111/jfbc.12019; Ahn JH, 2013, BIOORG MED CHEM LETT, V23, P3604, DOI 10.1016/j.bmcl.2013.04.013; Banerjee D, 2014, LETT APPL MICROBIOL, V58, P25, DOI 10.1111/lam.12151; Barbosa-Pereira L, 2013, FOOD RES INT, V51, P663, DOI 10.1016/j.foodres.2013.01.042; Beckman JS, 1996, AM J PHYSIOL-CELL PH, V271, pC1424; BLOIS MS, 1958, NATURE, V181, P1199, DOI 10.1038/1811199a0; Bursal E, 2011, FOOD RES INT, V44, P2217, DOI 10.1016/j.foodres.2010.11.001; Carmeliet P, 2000, NATURE, V407, P249, DOI 10.1038/35025220; Chung YC, 2005, FOOD CHEM, V91, P419, DOI 10.1016/j.foodchem.2004.06.022; Colavitti R, 2002, J BIOL CHEM, V277, P3101, DOI 10.1074/jbc.M107711200; Davis JM, 2009, AM J PHYSIOL-REG I, V296, pR1071, DOI 10.1152/ajpregu.90925.2008; Fukuda S, 2006, CELL BIOCHEM BIOPHYS, V44, P43, DOI 10.1385/CBB:44:1:043; Hurst RD, 2010, MOL NUTR FOOD RES, V54, P353, DOI 10.1002/mnfr.200900094; Jaafar H. Z. E., 2013, Australian Journal of Crop Science, V7, P276; Karki R, 2012, EVID-BASED COMPL ALT, V2012, P1; Kitawat BS, 2013, NEW J CHEM, V37, P2541, DOI 10.1039/c3nj00308f; Lee JS, 2012, EUR J PHARMACOL, V677, P22, DOI 10.1016/j.ejphar.2011.12.012; Lee JS, 2008, J MED FOOD, V11, P643, DOI 10.1089/jmf.2007.0629; Lin MC, 2009, J AGR FOOD CHEM, V57, P5925, DOI 10.1021/jf901058a; Ling ZQ, 2005, J AGR FOOD CHEM, V53, P2441, DOI 10.1021/jf040325p; Liu CP, 2004, LIFE SCI, V75, P699, DOI 10.1016/j.lfs.2004.01.019; Manian R, 2008, FOOD CHEM, V107, P1000, DOI 10.1016/j.foodchem.2007.09.008; MARCOCCI L, 1994, BIOCHEM BIOPH RES CO, V201, P748, DOI 10.1006/bbrc.1994.1764; Melnikov MM, 1971, CHEM PESTICIDE, P100; Min JK, 2004, CANCER RES, V64, P644, DOI 10.1158/0008-5472.CAN-03-3250; Mousa AS, 2005, NUTR CANCER, V53, P104, DOI 10.1207/s15327914nc5301_12; Mukherjee PK, 2009, J PHARM PHARMACOL, V61, P407, DOI 10.1211/jpp/61.04.0001; Muslim NS, 2010, INT J PHARMACOL, V6, P591, DOI 10.3923/ijp.2010.591.599; Narasimhan S, 2006, J ETHNOPHARMACOL, V104, P423, DOI 10.1016/j.jep.2005.09.029; Ohkoshi E, 2007, PLANTA MED, V73, P1255, DOI 10.1055/s-2007-990223; Park BC, 2009, J PHARMACOL SCI, V111, P1, DOI 10.1254/jphs.08305FP; Rashid R. B., 2003, Saudi Pharmaceutical Journal, V11, P52; Razali N, 2008, FOOD CHEM, V111, P38, DOI 10.1016/j.foodchem.2008.03.024; Sakanaka S, 2005, FOOD CHEM, V89, P569, DOI 10.1016/j.foodchem.2004.03.013; Selvamangai G., 2012, Asian Pacific Journal of Tropical Biomedicine, V2, pS1329; Singleton VL, 1999, METHOD ENZYMOL, V299, P152; Slaughter JC, 1999, BIOL REV, V74, P259, DOI 10.1017/S0006323199005332; Weber V, 2002, BIOORGAN MED CHEM, V10, P1647, DOI 10.1016/S0968-0896(02)00053-6; Xu X, 2011, MOLECULES, V16, P2551, DOI 10.3390/molecules16032551; Yang ZD, 2012, NAT PROD RES, V26, P387, DOI 10.1080/14786419.2010.487188; Zurbonsen K, 1991, GEN PHARMACOL, V32, P135	41	37	38	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2015	10	2							e0118552	10.1371/journal.pone.0118552	http://dx.doi.org/10.1371/journal.pone.0118552			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC2IM	25714482	gold, Green Published, Green Submitted			2022-12-27	WOS:000350168700083
J	Luo, CQ; Wei, C; Nansen, C				Luo, Changqing; Wei, Cong; Nansen, Christian			How Do "Mute" Cicadas Produce Their Calling Songs?	PLOS ONE			English	Article							ACOUSTIC-SIGNALS; SOUND PRODUCTION; HIGHER CLASSIFICATION; COURTSHIP BEHAVIOR; HOMOPTERA; HEMIPTERA; COMMUNICATION; CICADIDAE; EVOLUTION; IDENTIFICATION	Insects have evolved a variety of structures and mechanisms to produce sounds, which are used for communication both within and between species. Among acoustic insects, cicada males are particularly known for their loud and diverse sounds which function importantly in communication. The main method of sound production in cicadas is the tymbal mechanism, and a relative small number of cicada species possess both tymbal and stridulatory organs. However, cicadas of the genus Karenia do not have any specialized sound-producing structures, so they are referred to as "mute". This denomination is quite misleading, as they indeed produce sounds. Here, we investigate the sound-producing mechanism and acoustic communication of the "mute" cicada, Karenia caelatata, and discover a new sound-production mechanism for cicadas: i.e., K. caelatata produces impact sounds by banging the forewing costa against the operculum. The temporal, frequency and amplitude characteristics of the impact sounds are described. Morphological studies and reflectance-based analyses reveal that the structures involved in sound production of K. caelatata (i.e., forewing, operculum, cruciform elevation, and wing-holding groove on scutellum) are all morphologically modified. Acoustic playback experiments and behavioral observations suggest that the impact sounds of K. caelatata are used in intraspecific communication and function as calling songs. The new sound-production mechanism expands our knowledge on the diversity of acoustic signaling behavior in cicadas and further underscores the need for more bioacoustic studies on cicadas which lack tymbal mechanism.	[Luo, Changqing; Wei, Cong] Northwest A&F Univ, Entomol Museum, Minist Educ, Key Lab Plant Protect Resources & Pest Management, Yangling 712100, Shaanxi, Peoples R China; [Nansen, Christian] Univ Calif Davis, Dept Entomol & Nematol, Davis, CA 95616 USA	Northwest A&F University - China; University of California System; University of California Davis	Wei, C (corresponding author), Northwest A&F Univ, Entomol Museum, Minist Educ, Key Lab Plant Protect Resources & Pest Management, Yangling 712100, Shaanxi, Peoples R China.	congwei@nwsuaf.edu.cn		Luo, Changqing/0000-0002-6776-7519	National Natural Science Foundation of China [31170360, 31093430, 31493021]; Fundamental Research Funds for the Central Universities of China [QN2011053]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities of China(Fundamental Research Funds for the Central Universities)	This research was partially funded by the National Natural Science Foundation of China (Grant No. 31170360, No. 31093430, No. 31493021) and the Fundamental Research Funds for the Central Universities of China (QN2011053) to CW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEXANDER RD, 1967, ANNU REV ENTOMOL, V12, P495, DOI 10.1146/annurev.en.12.010167.002431; Alexander RD, 1957, OHIO J SCI, V57, P101; ALEXANDER RICHARD D., 1958, OHIO JOUR SCI, V58, P107; Garcia-Allende PB, 2008, SENSOR ACTUAT B-CHEM, V129, P977, DOI 10.1016/j.snb.2007.09.036; BENNETCLARK HC, 1992, J EXP BIOL, V173, P123; Boulard M, 2006, CONT T ENT, P331; Chou I., 1997, CICADIDAE CHINA HOMO; CLARIDGE MF, 1985, ANNU REV ENTOMOL, V30, P297, DOI 10.1146/annurev.en.30.010185.001501; Claridge M, 2006, CONT T ENT, P3; Cooley JR, 2001, BEHAVIOUR, V138, P827, DOI 10.1163/156853901753172674; Cooley JR, 2001, ANN ENTOMOL SOC AM, V94, P755, DOI 10.1603/0013-8746(2001)094[0755:LRASPA]2.0.CO;2; Defernez M, 1997, TRAC-TREND ANAL CHEM, V16, P216, DOI 10.1016/S0165-9936(97)00015-0; DOOLAN JM, 1981, BEHAV ECOL SOCIOBIOL, V9, P269, DOI 10.1007/BF00299882; DUFFELS JP, 1993, J NAT HIST, V27, P1223, DOI 10.1080/00222939300770731; DUGDALE JS, 1969, NEW ZEAL J SCI, V12, P929; ElMasry G, 2008, LWT-FOOD SCI TECHNOL, V41, P337, DOI 10.1016/j.lwt.2007.02.022; Ewing AW, 1989, ARTHROPOD BIOACOUSTI; Faber NM, 2007, ANAL CHIM ACTA, V595, P98, DOI 10.1016/j.aca.2007.05.030; Fisher RA, 1936, ANN EUGENIC, V7, P179, DOI 10.1111/j.1469-1809.1936.tb02137.x; FONSECA P J, 1991, Bioacoustics, V3, P173; Fonseca PJ, 1998, J EXP BIOL, V201, P717; FRINGS H, 1958, ANNU REV ENTOMOL, V3, P87, DOI 10.1146/annurev.en.03.010158.000511; Gagliano M, 2013, BEHAV ECOL, V24, P789, DOI 10.1093/beheco/ars206; Gagliano M, 2012, TRENDS PLANT SCI, V17, P323, DOI 10.1016/j.tplants.2012.03.002; Gerhardt HC., 2002, ACOUSTIC COMMUNICATI; Gogala Matija, 2003, Acta Entomologica Slovenica, V11, P5; Gowen AA, 2009, J FOOD ENG, V93, P7, DOI 10.1016/j.jfoodeng.2008.12.021; GWYNNE DT, 1987, ANIM BEHAV, V35, P571, DOI 10.1016/S0003-3472(87)80283-X; Jia FY, 2007, J ECON ENTOMOL, V100, P759, DOI 10.1603/0022-0493(2007)100[759:DTBACE]2.0.CO;2; Kemsley EK, 1996, CHEMOMETR INTELL LAB, V33, P47, DOI 10.1016/0169-7439(95)00090-9; Klarica J, 2011, J CHEM ECOL, V37, P549, DOI 10.1007/s10886-011-9956-x; Koehl MAR, 1996, ANNU REV ECOL SYST, V27, P501, DOI 10.1146/annurev.ecolsys.27.1.501; Mietchen D, 2005, BIOGEOSCIENCES, V2, P133, DOI 10.5194/bg-2-133-2005; Moulds MS, 2005, REC AUST MUS, V57, P375, DOI 10.3853/j.0067-1975.57.2005.1447; MULLER GB, 1991, ANNU REV ECOL SYST, V22, P229, DOI 10.1146/annurev.es.22.110191.001305; Nansen C, 2014, J EXP BIOL, V217, P1187, DOI 10.1242/jeb.095661; Nansen C, 2014, J FOOD ENG, V123, P17, DOI 10.1016/j.jfoodeng.2013.09.001; Nansen C, 2013, APPL SPECTROSC, V67, P1332, DOI 10.1366/12-06933; Nansen C, 2010, APPL SPECTROSC, V64, P637, DOI 10.1366/000370210791414335; Nowicki S, 2004, ANN NY ACAD SCI, V1016, P704, DOI 10.1196/annals.1298.012; Thai PH, 2012, ZOOTAXA, P32; POPOV AV, 1981, J COMP PHYSIOL, V142, P271, DOI 10.1007/BF00605745; Reeves WK, 2010, MED VET ENTOMOL, V24, P32, DOI 10.1111/j.1365-2915.2009.00843.x; Sanborn A. F., 2014, CATALOGUE CICADOIDEA; Sanborn AF, 1999, ANN ENTOMOL SOC AM, V92, P451, DOI 10.1093/aesa/92.3.451; SIMMONS JA, 1971, SCIENCE, V171, P212, DOI 10.1126/science.171.3967.212; Singh CB, 2009, J STORED PROD RES, V45, P151, DOI 10.1016/j.jspr.2008.12.002; Singh CB, 2010, COMPUT ELECTRON AGR, V73, P118, DOI 10.1016/j.compag.2010.06.001; SMITH R L, 1978, Southwestern Naturalist, V23, P187, DOI 10.2307/3669767; Stolting H, 2004, ZOOLOGY, V107, P243, DOI 10.1016/j.zool.2004.07.003; Sueur J, 2004, J ZOOL, V262, P217, DOI 10.1017/S0952836903004680; Sueur J, 2003, J NAT HIST, V37, P2931, DOI 10.1080/0022293021000007534; Sueur J, 2002, CAN J ZOOL, V80, P126, DOI 10.1139/Z01-212; Sueur J, 2008, BIOACOUSTICS, V18, P213, DOI 10.1080/09524622.2008.9753600; TRFfS Computing, 2011, R LANG ENV STAT COMP, DOI [10.1016/j.neuroimage.2011.01.013, DOI 10.1016/J.NEUROIMAGE.2011.01.013]; VILLET M, 1992, J ENTOMOL SOC S AFR, V55, P93; Wei C, 2009, SYST BIODIVERS, V7, P337, DOI 10.1017/S147720000999003X; WILLIAMS KS, 1995, ANNU REV ENTOMOL, V40, P269, DOI 10.1146/annurev.en.40.010195.001413; YOUNG D, 1995, J EXP BIOL, V198, P1001; YOUNG D, 1990, J EXP BIOL, V151, P41	60	12	12	3	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2015	10	2							e0118554	10.1371/journal.pone.0118554	http://dx.doi.org/10.1371/journal.pone.0118554			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC2IM	25714608	Green Published, gold			2022-12-27	WOS:000350168700084
J	Rerucha, S; Bartonicka, T; Jedlicka, P; Cizek, M; Hlousa, O; Lucan, R; Horacek, I				Rerucha, Simon; Bartonicka, Tomas; Jedlicka, Petr; Cizek, Martin; Hlousa, Ondrej; Lucan, Radek; Horacek, Ivan			The BAARA (Biological AutomAted RAdiotracking) System: A New Approach in Ecological Field Studies	PLOS ONE			English	Article							RADIO-TRACKING; BEHAVIOR	Radiotracking is an important and often the only possible method to explore specific habits and the behaviour of animals, but it has proven to be very demanding and time-consuming, especially when frequent positioning of a large group is required. Our aim was to address this issue by making the process partially automated, to mitigate the demands and related costs. This paper presents a novel automated tracking system that consists of a network of automated tracking stations deployed within the target area. Each station reads the signals from telemetry transmitters, estimates the bearing and distance of the tagged animals and records their position. The station is capable of tracking a theoretically unlimited number of transmitters on different frequency channels with the period of 5-15 seconds per single channel. An ordinary transmitter that fits within the supported frequency band might be used with BAARA (Biological AutomAted RAdiotracking); an extra option is the use of a custom-programmable transmitter with configurable operational parameters, such as the precise frequency channel or the transmission parameters. This new approach to a tracking system was tested for its applicability in a series of field and laboratory tests. BAARA has been tested within fieldwork explorations of Rousettus aegyptiacus during field trips to Dakhla oasis in Egypt. The results illustrate the novel perspective which automated radiotracking opens for the study of spatial behaviour, particularly in addressing topics in the domain of population ecology.	[Rerucha, Simon; Jedlicka, Petr; Cizek, Martin; Hlousa, Ondrej] Inst Sci Instruments ASCR, Vvi, CZ-61264 Brno, Czech Republic; [Bartonicka, Tomas] Masaryk Univ, Dept Bot & Zool, CZ-61137 Brno, Czech Republic; [Lucan, Radek] Charles Univ Prague, Dept Zool, CZ-12844 Prague, Czech Republic	Czech Academy of Sciences; Institute of Scientific Instruments of the Czech Academy of Sciences; Masaryk University Brno; Charles University Prague	Bartonicka, T (corresponding author), Masaryk Univ, Dept Bot & Zool, Kotlarska 2, CZ-61137 Brno, Czech Republic.	bartonic@sci.muni.cz	Lucan, Radek/B-7412-2015; Bartonička, Tomáš/J-2756-2014; Horacek, Ivan/V-9741-2017; Rerucha, Simon/D-6924-2012; /I-7839-2012; Jedlicka, Petr/E-2132-2012	Lucan, Radek/0000-0002-9575-3173; Horacek, Ivan/0000-0002-8356-5554; Rerucha, Simon/0000-0002-2026-5159; /0000-0001-6938-3423; 	Ministry of Education, Youth and Sports of the Czech Republic (MEYS CR) [MSM0021622416, LO1212, CZ.1.07/2.3.00/30.0054]; MEYS CR; EC [CZ.1.05/2.1.00/01.0017]; ASCR [IAA601110905, RVO: 68081731]	Ministry of Education, Youth and Sports of the Czech Republic (MEYS CR); MEYS CR; EC(European CommissionEuropean Commission Joint Research Centre); ASCR(Czech Academy of Sciences)	The study was supported by the Ministry of Education, Youth and Sports of the Czech Republic (MEYS CR) No. MSM0021622416 (TB) and LO1212, CZ.1.07/2.3.00/30.0054. The infrastructure was supported by MEYS CR and EC (CZ.1.05/2.1.00/01.0017). Support was received from the Grant Agency of the ASCR no. IAA601110905 (IH) and the research intent of the ASCR no. RVO: 68081731. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1990, 1145 CCIR INT TEL UN, P83; BANKS EM, 1975, J MAMMAL, V56, P888, DOI 10.2307/1379659; BOAG DA, 1972, J WILDLIFE MANAGE, V36, P511, DOI 10.2307/3799082; BRIGHAM RM, 1991, CAN J ZOOL, V69, P117, DOI 10.1139/z91-017; Briner T, 2003, J MAMMAL, V84, P571, DOI 10.1644/1545-1542(2003)084<0571:ANSFAR>2.0.CO;2; Chen HH, 2014, SCI REP-UK, V4, DOI 10.1038/srep03790; CHUTE FS, 1974, CAN J ZOOL, V52, P1481, DOI 10.1139/z74-190; COCHRAN WW, 1965, BIOSCIENCE, V15, P98, DOI 10.2307/1293346; de Berg M., 2008, COMPUTATIONAL GEOMET, V3; FEUERSTEIN MJ, 1994, IEEE T VEH TECHNOL, V43, P487, DOI 10.1109/25.312809; Freeman R. L., 1987, RADIO SYSTEM DESIGN; Garg H. K., 1998, CRC PR COMP ENG SER; Hagen M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019997; Hall MPM, 1996, PROPAGATION RADIOWAV; Holland RA, 2010, J R SOC INTERFACE, V7, P1617, DOI 10.1098/rsif.2010.0159; Hooge P. M., 2000, ANIMAL MOVEMENT EXTE, P2; Kays R, 2011, COMPUT J, V54, P1931, DOI 10.1093/comjnl/bxr072; Kwiecinski Gary G., 1999, Mammalian Species, V611, P1; Lee W.C., 1993, MOBILE COMMUNICATION; Lemnel PA, 1983, P 4 INT C WILDL BIOL, P76; LORD RD, 1962, SCIENCE, V137, P39, DOI 10.1126/science.137.3523.39; Swift, 1992, WILDLIFE TELEMETRY R; Tsoar Asaf, 2011, Proc Natl Acad Sci U S A, V108, pE718, DOI 10.1073/pnas.1107365108; Wikelski M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010738; XIA HH, 1992, VEHICULAR TECHNOLOGY SOCIETY 42ND VTS CONFERENCE - FRONTIERS OF TECHNOLOGY : FROM PIONEERS TO THE 21ST CENTURY, VOLS 1 AND 2, P349, DOI 10.1109/VETEC.1992.245381	25	10	11	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2015	10	2							e0116785	10.1371/journal.pone.0116785	http://dx.doi.org/10.1371/journal.pone.0116785			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC2IM	25714910	Green Published, Green Submitted, gold			2022-12-27	WOS:000350168700024
J	Safaee, M; Fakurnejad, S; Bloch, O; Clark, AJ; Ivan, ME; Sun, MZ; Oh, T; Phillips, JJ; Parsa, AT				Safaee, Michael; Fakurnejad, Shayan; Bloch, Orin; Clark, Aaron J.; Ivan, Michael E.; Sun, Matthew Z.; Oh, Taemin; Phillips, Joanna J.; Parsa, Andrew T.			Proportional Upregulation of CD97 Isoforms in Glioblastoma and Glioblastoma-Derived Brain Tumor Initiating Cells	PLOS ONE			English	Article							CANCER STEM-CELLS; TRANSMEMBRANE RECEPTOR CD97; CODON 132 MUTATION; INVASION IN-VITRO; GROWTH-FACTOR; ENDOTHELIAL-CELLS; ADHERENT CULTURE; IDH1 MUTATIONS; LIGAND CD55; GLIOMA	CD97 is a novel glioma antigen that confers an invasive phenotype and poor survival in patients with glioblastoma (GBM), the most aggressive primary malignant brain tumor. The short isoform of CD97, known as EGF(1,2,5), has been shown to promote invasion and metastasis, but its role in gliomas and GBM-derived brain tumor initiating cells (BTICs) has not been studied. We sought to characterize CD97 expression among gliomas and identify the specific isoforms expressed. The short isoform of CD97 was identified in GBM and GBM-derived BTICs, but not low grade or anaplastic astrocytomas. All samples expressing the EGF(1,2,5) isoform were also found to express the EGF(1,2,3,5) isoform. These isoforms are believed to possess similar ligand binding patterns and interact with chondroitin sulfate, a component of the extracellular matrix, and the integrin alpha 5 beta 1. Using data acquired from the Cancer Genome Atlas (TCGA), we show that CD97 is upregulated among the classical and mesenchymal subtypes of GBM and significantly decreased among IDH1 mutant GBMs. Given its proven roles in tumor invasion, expression among aggressive genetic subtypes of GBM, and association with overall survival, CD97 is an attractive therapeutic target for patients with GBM.	[Safaee, Michael; Clark, Aaron J.; Ivan, Michael E.; Sun, Matthew Z.; Phillips, Joanna J.] Univ Calif San Francisco, Dept Neurol Surg, San Francisco, CA USA; [Fakurnejad, Shayan; Bloch, Orin; Oh, Taemin; Parsa, Andrew T.] Northwestern Univ, Dept Neurol Surg, Feinberg Sch Med, Chicago, IL 60611 USA	University of California System; University of California San Francisco; Northwestern University; Feinberg School of Medicine	Parsa, AT (corresponding author), Northwestern Univ, Dept Neurol Surg, Feinberg Sch Med, Chicago, IL 60611 USA.	aparsa@nmff.org		Ivan, Michael/0000-0002-4798-4989	NCI NIH HHS [P50 CA097257] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P50CA097257] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Aust G, 1997, CANCER RES, V57, P1798; Aust G, 2002, AM J CLIN PATHOL, V118, P699; Balss J, 2008, ACTA NEUROPATHOL, V116, P597, DOI 10.1007/s00401-008-0455-2; Bao SD, 2006, NATURE, V444, P756, DOI 10.1038/nature05236; Bao SD, 2006, CANCER RES, V66, P7843, DOI 10.1158/0008-5472.CAN-06-1010; Beier D, 2007, CANCER RES, V67, P4010, DOI 10.1158/0008-5472.CAN-06-4180; Beroukhim R, 2007, P NATL ACAD SCI USA, V104, P20007, DOI 10.1073/pnas.0710052104; Biddle A, 2011, CANCER RES, V71, P5317, DOI 10.1158/0008-5472.CAN-11-1059; Bleeker FE, 2010, ACTA NEUROPATHOL, V119, P487, DOI 10.1007/s00401-010-0645-6; Brosseau JP, 2010, RNA, V16, P442, DOI 10.1261/rna.1877010; Chen J, 2012, NATURE, V488, P522, DOI 10.1038/nature11287; Cheng L, 2011, BIOCHEM BIOPH RES CO, V406, P643, DOI 10.1016/j.bbrc.2011.02.123; Chidambaram A, 2012, J NEUROSURG, V116, P843, DOI 10.3171/2011.11.JNS111455; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Durrant LG, 2003, CANCER IMMUNOL IMMUN, V52, P638, DOI 10.1007/s00262-003-0402-y; Eichler W, 1997, TISSUE ANTIGENS, V50, P429, DOI 10.1111/j.1399-0039.1997.tb02897.x; Friedlander DR, 1996, CANCER RES, V56, P1939; Galle J, 2006, AM J PATHOL, V169, P1802, DOI 10.2353/ajpath.2006.060006; Galli R, 2004, CANCER RES, V64, P7011, DOI 10.1158/0008-5472.CAN-04-1364; Gilbert MR, 2012, J NEURO-ONCOL, V106, P147, DOI 10.1007/s11060-011-0650-1; Hamann J, 1998, EUR J IMMUNOL, V28, P1701, DOI 10.1002/(SICI)1521-4141(199805)28:05<1701::AID-IMMU1701>3.0.CO;2-2; Hamann J, 1996, J EXP MED, V184, P1185, DOI 10.1084/jem.184.3.1185; Hartmann C, 2009, ACTA NEUROPATHOL, V118, P469, DOI 10.1007/s00401-009-0561-9; HOLTING T, 1995, EUR J ENDOCRINOL, V132, P229, DOI 10.1530/eje.0.1320229; Ichimura K, 2009, NEURO-ONCOLOGY, V11, P341, DOI 10.1215/15228517-2009-025; Laws ER, 2003, J NEUROSURG, V99, P467, DOI 10.3171/jns.2003.99.3.0467; Lee J, 2006, CANCER CELL, V9, P391, DOI 10.1016/j.ccr.2006.03.030; Lin HH, 2001, J BIOL CHEM, V276, P24160, DOI 10.1074/jbc.M101770200; Lin ME, 2010, PROSTAG OTH LIPID M, V91, P130, DOI 10.1016/j.prostaglandins.2009.02.002; Liu D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039989; Liu GT, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-67; Liu Y, 2005, ONCOL REP, V14, P1413; Liu Yong, 2005, J Zhejiang Univ Sci B, V6, P913, DOI 10.1631/jzus.2005.B0913; Nobusawa S, 2009, CLIN CANCER RES, V15, P6002, DOI 10.1158/1078-0432.CCR-09-0715; Parsa AT, 2005, J NEUROSURG, V102, P622, DOI 10.3171/jns.2005.102.4.0622; Phillips HS, 2006, CANCER CELL, V9, P157, DOI 10.1016/j.ccr.2006.02.019; Pollard SM, 2009, CELL STEM CELL, V4, P568, DOI 10.1016/j.stem.2009.03.014; Qian YM, 1999, IMMUNOLOGY, V98, P303; Qiu B, 2012, J CLIN NEUROSCI, V19, P130, DOI 10.1016/j.jocn.2011.06.014; Rooprai HK, 1999, INT J DEV NEUROSCI, V17, P613, DOI 10.1016/S0736-5748(99)00051-9; Safaee M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062765; Sanson M, 2009, J CLIN ONCOL, V27, P4150, DOI 10.1200/JCO.2009.21.9832; Scaringi C, 2012, ANTICANCER RES, V32, P4213; SCHRAPPE M, 1991, CANCER RES, V51, P4986; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Stacey M, 2003, BLOOD, V102, P2916, DOI 10.1182/blood-2002-11-3540; Steinert M, 2002, AM J PATHOL, V161, P1657, DOI 10.1016/S0002-9440(10)64443-4; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Sun Y, 2008, MOL CELL NEUROSCI, V38, P245, DOI 10.1016/j.mcn.2008.02.014; Tamase A, 2009, P NATL ACAD SCI USA, V106, P17163, DOI 10.1073/pnas.0905016106; Tchaicha JH, 2011, CANCER RES, V71, P6371, DOI 10.1158/0008-5472.CAN-11-0991; Tonn JC, 1998, ANTICANCER RES, V18, P2599; Tso CL, 2006, CANCER RES, V66, P159, DOI 10.1158/0008-5472.CAN-05-0077; Verhaak RGW, 2010, CANCER CELL, V17, P98, DOI 10.1016/j.ccr.2009.12.020; Wang T, 2005, BLOOD, V105, P2836, DOI 10.1182/blood-2004-07-2878; Ward Y, 2012, ONCOGENE; Ward Y, 2011, CANCER RES, V71, P7301, DOI 10.1158/0008-5472.CAN-11-2381; Watanabe T, 2009, AM J PATHOL, V174, P1149, DOI 10.2353/ajpath.2009.080958; Wu JS, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/587672; Yan H, 2009, NEW ENGL J MED, V360, P765, DOI 10.1056/NEJMoa0808710; Yona S, 2008, TRENDS BIOCHEM SCI, V33, P491, DOI 10.1016/j.tibs.2008.07.005; Yu SP, 2011, CHINESE MED J-PEKING, V124, P2599, DOI 10.3760/cma.j.issn.0366-6999.2011.17.007	62	15	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2015	10	2							e0111532	10.1371/journal.pone.0111532	http://dx.doi.org/10.1371/journal.pone.0111532			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC2IM	25714433	Green Published, gold, Green Submitted			2022-12-27	WOS:000350168700001
J	Janata, J; Kadlcik, S; Koberska, M; Ulanova, D; Kamenik, Z; Novak, P; Kopecky, J; Novotna, J; Radojevic, B; Plhackova, K; Gazak, R; Najmanova, L				Janata, Jiri; Kadlcik, Stanislav; Koberska, Marketa; Ulanova, Dana; Kamenik, Zdenek; Novak, Petr; Kopecky, Jan; Novotna, Jitka; Radojevic, Bojana; Plhackova, Kamila; Gazak, Radek; Najmanova, Lucie			Lincosamide Synthetase-A Unique Condensation System Combining Elements of Nonribosomal Peptide Synthetase and Mycothiol Metabolism	PLOS ONE			English	Article							BIOSYNTHETIC GENE-CLUSTER; MOLECULAR-WEIGHT THIOL; PHOSPHOPANTETHEINYL TRANSFERASE; ESCHERICHIA-COLI; CRYSTAL-STRUCTURES; SEQUENCE-ANALYSIS; LINCOMYCIN; ENZYME; INTERMEDIATE; SUPERFAMILY	In the biosynthesis of lincosamide antibiotics lincomycin and celesticetin, the amino acid and amino sugar units are linked by an amide bond. The respective condensing enzyme lincosamide synthetase (LS) is expected to be an unusual system combining nonribosomal peptide synthetase (NRPS) components with so far unknown amino sugar related activities. The biosynthetic gene cluster of celesticetin was sequenced and compared to the lincomycin one revealing putative LS coding ORFs shared in both clusters. Based on a bioassay and production profiles of S. lincolnensis strains with individually deleted putative LS coding genes, the proteins LmbC, D, E, F and V were assigned to LS function. Moreover, the newly recognized N-terminal domain of LmbN (LmbN-CP) was also assigned to LS as a NRPS carrier protein (CP). Surprisingly, the homologous CP coding sequence in celesticetin cluster is part of ccbZ gene adjacent to ccbN, the counterpart of lmbN, suggesting the gene rearrangement, evident also from still active internal translation start in lmbN, and indicating the direction of lincosamide biosynthesis evolution. The in vitro test with LmbN-CP, LmbC and the newly identified S. lincolnensis phosphopantetheinyl transferase Slp, confirmed the cooperation of the previously characterized NRPS A-domain LmbC with a holo-LmbN-CP in activation of a 4-propyl-L-proline precursor of lincomycin. This result completed the functional characterization of LS subunits resembling NRPS initiation module. Two of the four remaining putative LS subunits, LmbE/CcbE and LmbV/CcbV, exhibit low but significant homology to enzymes from the metabolism of mycothiol, the NRPS-independent system processing the amino sugar and amino acid units. The functions of particular LS subunits as well as cooperation of both NRPS-based and NRPS-independent LS blocks are discussed. The described condensing enzyme represents a unique hybrid system with overall composition quite dissimilar to any other known enzyme system.	[Janata, Jiri; Kadlcik, Stanislav; Koberska, Marketa; Ulanova, Dana; Kamenik, Zdenek; Novak, Petr; Kopecky, Jan; Novotna, Jitka; Radojevic, Bojana; Plhackova, Kamila; Gazak, Radek; Najmanova, Lucie] Acad Sci Czech Republ, Inst Microbiol, Vvi, Prague, Czech Republic; [Ulanova, Dana] Kochi Univ, Ctr Sci Res, Oceanog Sect, IMT MEXT, Nankoku, Kochi 7838505, Japan	Czech Academy of Sciences; Institute of Microbiology of the Czech Academy of Sciences; Kochi University	Janata, J (corresponding author), Acad Sci Czech Republ, Inst Microbiol, Vvi, Prague, Czech Republic.	janata@biomed.cas.cz	Najmanova, Lucie/H-3663-2014; Janata, Jiri/K-4554-2014; Novak, Petr/F-9655-2014; Kamenik, Zdenek/A-6620-2010; Kadlčík, Stanislav/K-8851-2014; Koběrská, Markéta/AAE-4877-2019; Radojevic, Bojana/K-5245-2014; Novotna, Jitka/G-2891-2017; Gažák, Radek/H-2443-2014; Kopecky, Jan/C-7400-2013	Najmanova, Lucie/0000-0003-0691-7250; Janata, Jiri/0000-0002-4582-2062; Novak, Petr/0000-0001-8688-529X; Kadlčík, Stanislav/0000-0001-8989-7157; Koběrská, Markéta/0000-0002-9787-4227; Novotna, Jitka/0000-0002-5636-0609; Gažák, Radek/0000-0003-3881-0327; Kopecky, Jan/0000-0002-3437-257X	Ministry of Education, Youth and Sports of the Czech Republic [CZ.1.07/2.3.00/20.0055, CZ.1.07/2.3.00/30.0003]; BIOCEV-Biotechnology and Biomedicine Centre of the Academy of Sciences; Charles University from the European Regional Development Fund in the Czech Republic [CZ.1.05/1.1.00/02.0109]	Ministry of Education, Youth and Sports of the Czech Republic(Ministry of Education, Youth & Sports - Czech Republic); BIOCEV-Biotechnology and Biomedicine Centre of the Academy of Sciences; Charles University from the European Regional Development Fund in the Czech Republic	This work was supported by the Ministry of Education, Youth and Sports of the Czech Republic projects CZ.1.07/2.3.00/20.0055 and CZ.1.07/2.3.00/30.0003 and BIOCEV-Biotechnology and Biomedicine Centre of the Academy of Sciences and Charles University No. CZ.1.05/1.1.00/02.0109, from the European Regional Development Fund in the Czech Republic.	Ahlert J, 2002, SCIENCE, V297, P1173, DOI 10.1126/science.1072105; Allali N, 2002, J BACTERIOL, V184, P3224, DOI 10.1128/JB.184.12.3224-3231.2002; Atlas RM., 2004, HDB MICROBIOLOGICAL; Bauer J, 2014, ACTA CRYSTALLOGR D, V70, P943, DOI 10.1107/S139900471303397X; BRAHME NM, 1984, J AM CHEM SOC, V106, P7878, DOI 10.1021/ja00337a039; Bunet R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087607; Chen L, 2011, CHEM BIOENG, V28, P37; CHUNG ST, 1997, BIOTECHNOLOGY IND AN, P165; Copp JN, 2006, APPL ENVIRON MICROB, V72, P2298, DOI 10.1128/AEM.72.4.2298-2305.2006; Ferrer S, 2012, PHYS CHEM CHEM PHYS, V14, P3482, DOI 10.1039/c2cp23149b; Finking R, 2002, J BIOL CHEM, V277, P50293, DOI 10.1074/jbc.M205042200; Gaballa A, 2010, P NATL ACAD SCI USA, V107, P6482, DOI 10.1073/pnas.1000928107; Garneau S, 2005, BIOCHEMISTRY-US, V44, P2770, DOI 10.1021/bi0476329; Gehring AM, 1997, BIOCHEMISTRY-US, V36, P8495, DOI 10.1021/bi970453p; Grammel N, 2002, EUR J BIOCHEM, V269, P347, DOI 10.1046/j.0014-2956.2001.02657.x; Gust B, 2003, P NATL ACAD SCI USA, V100, P1541, DOI 10.1073/pnas.0337542100; Harris AKP, 2004, MICROBIOL-SGM, V150, P3547, DOI 10.1099/mic.0.27222-0; Hofer I, 2011, CHEM BIOL, V18, P381, DOI 10.1016/j.chembiol.2010.12.018; Hong HJ, 2005, J BIOL CHEM, V280, P13055, DOI 10.1074/jbc.M413801200; Hu Y, 2007, CHEM BIOL, V14, P691, DOI 10.1016/j.chembiol.2007.05.009; Ishiyama D, 2004, APPL ENVIRON MICROB, V70, P1297, DOI 10.1128/AEM.70.3.1297-1306.2004; Janata J, 2001, ANTON LEEUW INT J G, V79, P277, DOI 10.1023/A:1012034421088; Jothivasan VK, 2008, NAT PROD REP, V25, P1091, DOI 10.1039/b616489g; Kadlcik S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084902; Kamenik Z, 2009, ANAL BIOANAL CHEM, V393, P1779, DOI 10.1007/s00216-009-2605-3; Kerbarh O, 2005, J BACTERIOL, V187, P5061, DOI 10.1128/JB.187.15.5061-5066.2005; Kieser T., 2000, PRACTICAL STREPTOMYC, V4362; Koberska M, 2008, FOLIA MICROBIOL, V53, P395, DOI 10.1007/s12223-008-0060-8; Ku J, 1997, CHEM BIOL, V4, P203, DOI 10.1016/S1074-5521(97)90289-1; Lambalot RH, 1996, CHEM BIOL, V3, P923, DOI 10.1016/S1074-5521(96)90181-7; Li W, 2009, APPL ENVIRON MICROB, V75, P2958, DOI 10.1128/AEM.02325-08; Li W, 2009, APPL ENVIRON MICROB, V75, P2869, DOI 10.1128/AEM.02326-08; Lin CI, 2014, J AM CHEM SOC, V136, P906, DOI 10.1021/ja412194w; Marahiel MA, 2009, METHOD ENZYMOL, V458, P337, DOI 10.1016/S0076-6879(09)04813-7; Marchler-Bauer A, 2011, NUCLEIC ACIDS RES, V39, pD225, DOI 10.1093/nar/gkq1189; Maruyama C, 2012, NAT CHEM BIOL, V8, P791, DOI [10.1038/NCHEMBIO.1040, 10.1038/nchembio.1040]; Mejean A, 2010, BIOCHEMISTRY-US, V49, P103, DOI 10.1021/bi9018785; Najmanova L, 2014, FOLIA MICROBIOL, V59, P543, DOI 10.1007/s12223-014-0339-x; Najmanova L, 2013, CHEMBIOCHEM, V14, P2259, DOI 10.1002/cbic.201300389; Nakai T, 1999, BIOCHEMISTRY-US, V38, P2413, DOI 10.1021/bi9819881; Newton GL, 2008, MICROBIOL MOL BIOL R, V72, P471, DOI 10.1128/MMBR.00008-08; Newton GL, 2011, BIOCHEMISTRY-US, V50, P10751, DOI 10.1021/bi201460j; Newton GL, 1996, J BACTERIOL, V178, P1990, DOI 10.1128/jb.178.7.1990-1995.1996; Novotna J, 2004, EUR J BIOCHEM, V271, P3678, DOI 10.1111/j.1432-1033.2004.04308.x; Novotna J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079974; Parris KD, 2000, STRUCT FOLD DES, V8, P883, DOI 10.1016/S0969-2126(00)00178-7; PESCHKE U, 1995, MOL MICROBIOL, V16, P1137, DOI 10.1111/j.1365-2958.1995.tb02338.x; Piepersberg W, 1995, Biotechnology, V28, P531; Quadri LEN, 1998, BIOCHEMISTRY-US, V37, P1585, DOI 10.1021/bi9719861; Reuter K, 1999, EMBO J, V18, P6823, DOI 10.1093/emboj/18.23.6823; Rubio MA, 2004, FEBS LETT, V577, P371, DOI 10.1016/j.febslet.2004.09.087; Sanchez C, 2001, CHEM BIOL, V8, P725, DOI 10.1016/S1074-5521(01)00047-3; Sareen D, 2002, BIOCHEMISTRY-US, V41, P6885, DOI 10.1021/bi012212u; Sasaki E, 2012, J AM CHEM SOC, V134, P17432, DOI 10.1021/ja308221z; Stachelhaus T, 1998, J BIOL CHEM, V273, P22773, DOI 10.1074/jbc.273.35.22773; Stanley AE, 2006, CHEM COMMUN, P3981, DOI 10.1039/b609556a; Ulanova D, 2010, ANTIMICROB AGENTS CH, V54, P927, DOI 10.1128/AAC.00918-09; Wang R, 2007, J BIOL CHEM, V282, P16288, DOI 10.1074/jbc.M610347200; Wilkinson B, 2009, METHOD ENZYMOL, V458, P353, DOI 10.1016/S0076-6879(09)04814-9; Zengliang W, 2010, BIOTECHNOLOGY B, V11, P038	60	21	23	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2015	10	3							e0118850	10.1371/journal.pone.0118850	http://dx.doi.org/10.1371/journal.pone.0118850			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9KG	25741696	gold, Green Published, Green Submitted			2022-12-27	WOS:000350688100052
J	Chen, GL; Lu, L; Liu, C; Shan, L; Yuan, D				Chen, Guolin; Lu, Lu; Liu, Chang; Shan, Lei; Yuan, Di			MicroRNA-377 Suppresses Cell Proliferation and Invasion by Inhibiting TIAM1 Expression in Hepatocellular Carcinoma	PLOS ONE			English	Article							GASTRIC-CANCER; TUMOR-SUPPRESSOR; POOR-PROGNOSIS; METASTASIS; OVEREXPRESSION; GROWTH; GENE; OSTEOSARCOMA; INVOLVEMENT; MIGRATION	Increasing evidence has suggested that microRNAs (miRNAs) play an important role in the initiation and progression of hepatocellular carcinoma (HCC). Here, we identified a novel tumor suppressive miRNA, miR-377, and investigated its role in HCC. The expression of miR-377 in HCC tissues and cell lines was detected by real-time reverse-transcription PCR. The effects of miR-377 on HCC cell proliferation and invasion were also investigated. Western blot and luciferase reporter assay were used to identify the direct and functional target of miR-377. The expression ofmiR-377 was markedly downregulated in human HCC tissues and cell lines. MiR-377 can dramatically inhibit cell growth and invasion in HCC cells. Subsequent investigation revealed that T lymphoma invasion and metastasis 1 (TIAM1) was a direct and functional target ofmiR-377 in HCC cells. Overexpression ofmiR-377 impaired TIAM1-induced promotion of proliferation and invasion in HCC cells. Finally, miR-377 is inversely correlated with TIAM1 expression in human HCC tissues. These findings reveal that miR-377 functions as a tumor suppressor and inhibits the proliferation and invasion of HCC cells by targeting TIAM1, which may consequently serve as a therapeutic target for HCC patients.	[Chen, Guolin; Liu, Chang; Shan, Lei] Harbin Med Univ, Clin Hosp 1, Ward Infect Dept 1, Harbin, Heilongjiang, Peoples R China; [Lu, Lu] Harbin Med Univ, Affiliated Hosp 4, Dept Med Oncol, Harbin, Heilongjiang, Peoples R China; [Yuan, Di] Harbin Med Univ, Clin Hosp 1, Clin Lab, Harbin, Heilongjiang, Peoples R China	Harbin Medical University; Harbin Medical University; Harbin Medical University	Yuan, D (corresponding author), Harbin Med Univ, Clin Hosp 1, Clin Lab, Harbin, Heilongjiang, Peoples R China.	jqhg4y@163.com			research project of science and technology of education department in Heilongjiang province [11531186]	research project of science and technology of education department in Heilongjiang province	This work has been supported by the research project of science and technology of education department in Heilongjiang province, project number is 11531186. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam L, 2001, J BIOL CHEM, V276, P28443, DOI 10.1074/jbc.M009769200; Arribas AJ, 2013, MODERN PATHOL, V26, P889, DOI 10.1038/modpathol.2012.220; Beckman JD, 2011, J BIOL CHEM, V286, P3194, DOI 10.1074/jbc.M110.148726; Chen B, 2012, MOL MED REP, V5, P48, DOI 10.3892/mmr.2011.612; Chen H, 2012, CANCER LETT, V320, P40, DOI 10.1016/j.canlet.2012.01.027; Ding Y, 2009, INT J CANCER, V124, P653, DOI 10.1002/ijc.23954; Engers R, 2006, BRIT J CANCER, V95, P1081, DOI 10.1038/sj.bjc.6603385; Formosa A, 2013, ONCOGENE; HABETS GGM, 1994, CELL, V77, P537, DOI 10.1016/0092-8674(94)90216-X; Hatziapostolou M, 2011, CELL, V147, P1233, DOI 10.1016/j.cell.2011.10.043; Huang J, 2009, SCI CHINA SER C, V52, P31, DOI 10.1007/s11427-009-0014-7; Huang J, 2013, INT J CANCER, V132, P90, DOI 10.1002/ijc.27627; Jin Y, 2013, DNA CELL BIOL, V32, P302, DOI 10.1089/dna.2013.1977; Jin Z, 2011, ONCOGENE, V30, P1577, DOI 10.1038/onc.2010.534; Karakatsanis A, 2013, MOL CARCINOGEN, V52, P297, DOI 10.1002/mc.21864; Li D, 2011, CLIN CANCER RES, V17, P1722, DOI 10.1158/1078-0432.CCR-10-1800; Li X, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.290; Liang YJ, 2013, CARCINOGENESIS, V34, P713, DOI 10.1093/carcin/bgs383; Liu L, 2007, CELL BIOL INT, V31, P805, DOI 10.1016/j.cellbi.2007.01.014; Liu SG, 2014, DIAGN PATHOL, V9, DOI 10.1186/1746-1596-9-69; Long XH, 2013, EXP THER MED, V5, P1048, DOI 10.3892/etm.2013.959; Lowery AJ, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2257; Luk JM, 2011, J BIOL CHEM, V286, P30706, DOI 10.1074/jbc.M111.229831; MICHIELS F, 1995, NATURE, V375, P338, DOI 10.1038/375338a0; Minard ME, 2004, BREAST CANCER RES TR, V84, P21, DOI 10.1023/B:BREA.0000018421.31632.e6; Minguez B, 2011, DIS MARKERS, V31, P181, DOI [10.1155/2011/310675, 10.3233/DMA-2011-0841]; Niyazi M, 2011, RADIAT ONCOL, V6, DOI 10.1186/1748-717X-6-153; Sun QM, 2010, CANCER SCI, V101, P2241, DOI 10.1111/j.1349-7006.2010.01667.x; Suzuki H, 2010, CARCINOGENESIS, V31, P2066, DOI 10.1093/carcin/bgq203; Tsukamoto Y, 2010, CANCER RES, V70, P2339, DOI 10.1158/0008-5472.CAN-09-2777; Wang HM, 2012, ASIAN PAC J CANCER P, V13, P613, DOI 10.7314/APJCP.2012.13.2.613; Wang Q, 2008, FASEB J, V22, P4126, DOI 10.1096/fj.08-112326; Xu Y, 2012, ONCOGENE, V31, P1398, DOI 10.1038/onc.2011.340; Yang QY, 2011, CARCINOGENESIS, V32, P713, DOI 10.1093/carcin/bgr035; Yang WY, 2010, JPN J CLIN ONCOL, V40, P1053, DOI 10.1093/jjco/hyq086; Yoon SO, 2011, HUM PATHOL, V42, P1391, DOI 10.1016/j.humpath.2010.12.010; Yu LN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073077; Yuan QG, 2013, HEPATOLOGY, V57, P299, DOI 10.1002/hep.25984; Zhang L, 2008, P NATL ACAD SCI USA, V105, P7004, DOI 10.1073/pnas.0801615105; Zhang R, 2014, NEUROONCOL; Zhang S, 2012, ONCOGENE, V31, P3607, DOI 10.1038/onc.2011.523; Zhao LA, 2011, J CANCER RES CLIN, V137, P393, DOI 10.1007/s00432-010-0895-7; Zheng F, 2012, GUT, V61, P278, DOI 10.1136/gut.2011.239145; Zhu LH, 2010, FEBS J, V277, P3726, DOI 10.1111/j.1742-4658.2010.07773.x	44	43	48	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2015	10	3							e0117714	10.1371/journal.pone.0117714	http://dx.doi.org/10.1371/journal.pone.0117714			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9JM	25739101	Green Published, Green Submitted, gold			2022-12-27	WOS:000350685900018
J	Morales, DM; Holubkov, R; Inder, TE; Ahn, HC; Mercer, D; Rao, R; McAllister, JP; Holtzman, DM; Limbrick , DD				Morales, Diego M.; Holubkov, Richard; Inder, Terri E.; Ahn, Haejun C.; Mercer, Deanna; Rao, Rakesh; McAllister, James P., II; Holtzman, David M.; Limbrick, David D., Jr.			Cerebrospinal Fluid Levels of Amyloid Precursor Protein Are Associated with Ventricular Size in Post-Hemorrhagic Hydrocephalus of Prematurity	PLOS ONE			English	Article							X-LINKED HYDROCEPHALUS; CELL-ADHESION MOLECULES; BIRTH-WEIGHT INFANTS; CLINICAL ARTICLE; NEURONAL MIGRATION; ALZHEIMERS-DISEASE; PRETERM INFANTS; L1 SYNDROME; MECHANISMS; MUTATIONS	Background Neurological outcomes of preterm infants with post-hemorrhagic hydrocephalus (PHH) remain among the worst in infancy, yet there remain few instruments to inform the treatment of PHH. We previously observed PHH-associated elevations in cerebrospinal fluid (CSF) amyloid precursor protein (APP), neural cell adhesion molecule-L1 (L1CAM), neural cell adhesion molecule-1 (NCAM-1), and other protein mediators of neurodevelopment. Objective The objective of this study was to examine the association of CSF APP, L1CAM, and NCAM-1 with ventricular size as an early step toward developing CSF markers of PHH. Methods CSF levels of APP, L1CAM, NCAM-1, and total protein (TP) were measured in 12 preterm infants undergoing PHH treatment. Ventricular size was determined using cranial ultrasounds. The relationships between CSF APP, L1CAM, and NCAM-1, occipitofrontal circumference (OFC), volume of CSF removed, and ventricular size were examined using correlation and regression analyses. Results CSF levels of APP, L1CAM, and NCAM-1 but not TP paralleled treatment-related changes in ventricular size. CSF APP demonstrated the strongest association with ventricular size, estimated by frontal-occipital horn ratio (FOR) (Pearson R = 0.76, p = 0.004), followed by NCAM-1 (R = 0.66, p = 0.02) and L1CAM (R = 0.57, p = 0.055). TP was not correlated with FOR (R = 0.02, p = 0.95). Conclusions Herein, we report the novel observation that CSF APP shows a robust association with ventricular size in preterm infants treated for PHH. The results from this study suggest that CSF APP and related proteins at once hold promise as biomarkers of PHH and provide insight into the neurological consequences of PHH in the preterm infant.	[Morales, Diego M.; Ahn, Haejun C.; Mercer, Deanna; McAllister, James P., II; Limbrick, David D., Jr.] Washington Univ, Dept Neurol Surg, Sch Med, St Louis, MO 63130 USA; [Holubkov, Richard] Univ Utah, Sch Med, Dept Pediat, Salt Lake City, UT USA; [Inder, Terri E.; Limbrick, David D., Jr.] Washington Univ, Dept Pediat, Sch Med, St Louis, MO 63130 USA; [Rao, Rakesh] Washington Univ, Sch Med, Dept Newborn Med, St Louis, MO USA; [Holtzman, David M.] Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63110 USA; [Holtzman, David M.; Limbrick, David D., Jr.] Washington Univ, Sch Med, Hope Ctr Neurol Disorders, St Louis, MO USA	Washington University (WUSTL); Utah System of Higher Education; University of Utah; Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Morales, DM (corresponding author), Washington Univ, Dept Neurol Surg, Sch Med, St Louis, MO 63130 USA.	moralesd@wudosis.wustl.edu	McAllister, James P./N-9657-2019	Holubkov, Richard/0000-0003-0431-3381; Morales, Diego/0000-0001-6672-9046	NIH/NINDS [K23 NS075151]; Washington University Intellectual and Developmental Disabilities Research Center (NIH/NICHD) [P30 HD0627171]; Women's and Infant's Health Specimen Consortium; Children's Surgical Sciences Institute, St. Louis Children's Hospital; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K23NS075151] Funding Source: NIH RePORTER	NIH/NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Washington University Intellectual and Developmental Disabilities Research Center (NIH/NICHD); Women's and Infant's Health Specimen Consortium; Children's Surgical Sciences Institute, St. Louis Children's Hospital; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This project was supported by a career development award to D.D.L. (NIH/NINDS K23 NS075151), the Washington University Intellectual and Developmental Disabilities Research Center (NIH/NICHD P30 HD0627171), the Women's and Infant's Health Specimen Consortium, and a grant from the Children's Surgical Sciences Institute, St. Louis Children's Hospital (D.D.L.). The authors would like to thank the families who generously participated in this study.	Adams-Chapman I, 2008, PEDIATRICS, V121, pE1167, DOI 10.1542/peds.2007-0423; ALLSOP D, 1983, BRAIN RES, V259, P348, DOI 10.1016/0006-8993(83)91273-8; Dallerac G, 2013, NEUROCHEM RES, V38, P1163, DOI 10.1007/s11064-013-1007-2; Dityatev A, 2008, NEURON GLIA BIOL, V4, P197, DOI 10.1017/S1740925X09990111; EDELMAN GM, 1990, COLD SH Q B, V55, P303; EDELMAN GM, 1986, ANNU REV CELL BIOL, V2, P81, DOI 10.1146/annurev.cb.02.110186.000501; FRANSEN E, 1995, EUR J HUM GENET, V3, P273; Fransen E, 1997, HUM MOL GENET, V6, P1625, DOI 10.1093/hmg/6.10.1625; GENTLEMAN SM, 1993, NEUROSCI LETT, V160, P139, DOI 10.1016/0304-3940(93)90398-5; HARDY J, 1991, TRENDS PHARMACOL SCI, V12, P383, DOI 10.1016/0165-6147(91)90609-V; JOUET M, 1995, AM J HUM GENET, V56, P1304; Kamiguchi H, 2003, MOL NEUROBIOL, V28, P219, DOI 10.1385/MN:28:3:219; Kanemura Y, 2006, J NEUROSURG, V105, P403, DOI 10.3171/ped.2006.105.5.403; KANG J, 1987, NATURE, V325, P733, DOI 10.1038/325733a0; LEVENE MI, 1981, ARCH DIS CHILD, V56, P900, DOI 10.1136/adc.56.12.900; Limbrick DD, 2010, J NEUROSURG-PEDIATR, V6, P224, DOI 10.3171/2010.5.PEDS1010; Maness PF, 2007, NAT NEUROSCI, V10, P19, DOI 10.1038/nn1827; Manktelow BN, 2010, ARCH DIS CHILD-FETAL, V95, pF9, DOI 10.1136/adc.2008.148015; Morales DM, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.011973; Murphy BP, 2002, ARCH DIS CHILD-FETAL, V87, pF37, DOI 10.1136/fn.87.1.F37; Nybroe O, 1990, Adv Exp Med Biol, V265, P185; O'Hayon BB, 1998, PEDIATR NEUROSURG, V29, P245, DOI 10.1159/000028730; Panicker AK, 2003, FRONT BIOSCI, V8, pD900, DOI 10.2741/1014; Parry G, 2003, LANCET, V361, P1789, DOI 10.1016/S0140-6736(03)13397-1; Persson EK, 2005, ACTA PAEDIATR, V94, P726, DOI 10.1080/08035250510027336; Priller C, 2006, J NEUROSCI, V26, P7212, DOI 10.1523/JNEUROSCI.1450-06.2006; RONN LCB, 1995, BRAIN RES, V677, P145, DOI 10.1016/0006-8993(95)00147-I; Schafer MKE, 2010, NEUROBIOL DIS, V40, P222, DOI 10.1016/j.nbd.2010.05.029; Schmid RS, 2008, CURR OPIN NEUROBIOL, V18, P245, DOI 10.1016/j.conb.2008.07.015; Sylvie NTT, 2011, ARCH PEDIAT ADOL MED, V165, P216, DOI 10.1001/archpediatrics.2011.9; Turner PR, 2003, PROG NEUROBIOL, V70, P1, DOI 10.1016/S0301-0082(03)00089-3; Volpe J.J., 2008, NEUROLOGY NEWBORN; Volpe JJ, 2009, LANCET NEUROL, V8, P110, DOI 10.1016/S1474-4422(08)70294-1; Weller S, 2001, HUM MUTAT, V18, P1, DOI 10.1002/humu.1144; Wellons JC, 2013, J NEUROSURG-PEDIATR, V11, P12, DOI 10.3171/2012.10.PEDS12329; Wellons JC, 2009, J NEUROSURG-PEDIATR, V4, P50, DOI 10.3171/2009.2.PEDS08400	36	20	19	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2015	10	3							e0115045	10.1371/journal.pone.0115045	http://dx.doi.org/10.1371/journal.pone.0115045			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9JM	25738507	Green Published, Green Submitted, gold			2022-12-27	WOS:000350685900002
J	Vaseghi, B; Zoghi, M; Jaberzadeh, S				Vaseghi, Bita; Zoghi, Maryam; Jaberzadeh, Shapour			How Does Anodal Transcranial Direct Current Stimulation of the Pain Neuromatrix Affect Brain Excitability and Pain Perception? A Randomised, Double-Blind, Sham-Control Study	PLOS ONE			English	Article							MOTOR CORTEX STIMULATION; PRIMARY SENSORY CORTEX; SOMATOSENSORY CORTEX; MAGNETIC STIMULATION; EVOKED-POTENTIALS; CORTICOSPINAL PROJECTIONS; SYNAPTIC PLASTICITY; PARIETAL CORTEX; MODULATION; DC	Background Integration of information between multiple cortical regions of the pain neuromatrix is thought to underpin pain modulation. Although altered processing in the primary motor (M1) and sensory (S1) cortices is implicated in separate studies, the simultaneous changes in and the relationship between these regions are unknown yet. The primary aim was to assess the effects of anodal transcranial direct current stimulation (a-tDCS) over superficial regions of the pain neuromatrix on M1 and S1 excitability. The secondary aim was to investigate how M1 and S1 excitability changes affect sensory (STh) and pain thresholds (PTh). Methods Twelve healthy participants received 20 min a-tDCS under five different conditions including a-tDCS of M1, a-tDCS of S1, a-tDCS of DLPFC, sham a-tDCS, and no-tDCS. Excitability of dominant M1 and S1 were measured before, immediately, and 30 minutes after intervention respectively. Moreover, STh and PTh to peripheral electrical and mechanical stimulation were evaluated. All outcome measures were assessed at three time-points of measurement by a blind rater. Results A-tDCS of M1 and dorsolateral prefrontal cortex (DLPFC) significantly increased brain excitability in M1 (p < 0.05) for at least 30 min. Following application of a-tDCS over the S1, the amplitude of the N20-P25 component of SEPs increased immediately after the stimulation (p < 0.05), whilst M1 stimulation decreased it. Compared to baseline values, significant STh and PTh increase was observed after a-tDCS of all three stimulated areas. Except in M1 stimulation, there was significant PTh difference between a-tDCS and sham tDCS. Conclusion a-tDCS of M1 is the best spots to enhance brain excitability than a-tDCS of S1 and DLPFC. Surprisingly, a-tDCS of M1 and S1 has diverse effects on S1 and M1 excitability. A-tDCS of M1, S1, and DLPFC increased STh and PTh levels. Given the placebo effects of a-tDCS of M1 in pain perception, our results should be interpreted with caution, particularly with respect to the behavioural aspects of pain modulation.	[Vaseghi, Bita; Jaberzadeh, Shapour] Monash Univ, Fac Med Nursing & Hlth Sci, Sch Primary Hlth Care, Dept Physiotherapy, Melbourne, Vic 3004, Australia; [Zoghi, Maryam] Univ Melbourne, Royal Melbourne Hosp, Dept Med, Melbourne, Vic 3050, Australia	Monash University; Royal Melbourne Hospital; University of Melbourne	Vaseghi, B (corresponding author), Monash Univ, Fac Med Nursing & Hlth Sci, Sch Primary Hlth Care, Dept Physiotherapy, Melbourne, Vic 3004, Australia.	bita.vaseghi@monash.edu.au	, Zoghi/AAF-9536-2019	, Zoghi/0000-0002-1819-6895; jaberzadeh, shapour/0000-0003-2957-4510				Antal A, 2008, CLIN J PAIN, V24, P56, DOI 10.1097/AJP.0b013e318157233b; Apkarian AV, 2005, EUR J PAIN, V9, P463, DOI 10.1016/j.ejpain.2004.11.001; ARONIADOU VA, 1995, CEREB CORTEX, V5, P353, DOI 10.1093/cercor/5.4.353; Bachmann CG, 2010, CLIN NEUROPHYSIOL, V121, P2083, DOI 10.1016/j.clinph.2010.05.005; Basmajian J.V., 1985, MUSCLES ALIVE THEIR, V278, P126; Bastani A, 2013, BRAIN STIMUL, V6, P932, DOI 10.1016/j.brs.2013.04.005; Baudewig J, 2001, MAGN RESON MED, V45, P196, DOI 10.1002/1522-2594(200102)45:2<196::AID-MRM1026>3.0.CO;2-1; Boggio PS, 2008, EUR J NEUROL, V15, P1124, DOI 10.1111/j.1468-1331.2008.02270.x; Boggio PS, 2008, NEUROSCI LETT, V447, P101, DOI 10.1016/j.neulet.2008.10.009; Bornhovd K, 2002, BRAIN, V125, P1326, DOI 10.1093/brain/awf137; Bracht T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052238; Brunoni AR, 2011, INT J NEUROPSYCHOPH, V14, P1133, DOI 10.1017/S1461145710001690; Bunge SA, 2001, BRAIN, V124, P2074, DOI 10.1093/brain/124.10.2074; Casey KL, 1996, J NEUROPHYSIOL, V76, P571, DOI 10.1152/jn.1996.76.1.571; Casey KL, 1999, P NATL ACAD SCI USA, V96, P7668, DOI 10.1073/pnas.96.14.7668; CASTROALAMANCOS MA, 1995, J NEUROSCI, V15, P5324; Chaieb L, 2008, VISUAL NEUROSCI, V25, P77, DOI 10.1017/S0952523808080097; Chen JL, 2013, NATURE, V499, P336, DOI 10.1038/nature12236; Chesterton LS, 2002, PAIN, V99, P253, DOI 10.1016/S0304-3959(02)00118-5; COGHILL RC, 1994, J NEUROSCI, V14, P4095; Craig AD, 2000, NAT NEUROSCI, V3, P184, DOI 10.1038/72131; DaSilva AF, 2011, JOVE-J VIS EXP, DOI 10.3791/2744; Diamond ME, 2008, NAT REV NEUROSCI, V9, P601, DOI 10.1038/nrn2411; DUM RP, 1991, J NEUROSCI, V11, P667; Fernandez-de-las-Penas C, 2010, ARTHRIT CARE RES, V62, P1055, DOI 10.1002/acr.20189; FISCHER AA, 1986, ARCH PHYS MED REHAB, V67, P836; FISCHER AA, 1987, PAIN, V30, P115, DOI 10.1016/0304-3959(87)90089-3; Fischer AA, 1987, CLIN J PAIN, V2, P207; Fregni F, 2007, NAT CLIN PRACT NEURO, V3, P383, DOI 10.1038/ncpneuro0530; Fricke K, 2011, J NEUROPHYSIOL, V105, P1141, DOI 10.1152/jn.00608.2009; Fukuda Satoru, 2006, Masui, V55, P280; Garcia-Larrea L, 2007, NEUROIMAGE, V37, pS71, DOI 10.1016/j.neuroimage.2007.05.062; George MS, 2010, NEUROPSYCHOPHARMACOL, V35, P301, DOI 10.1038/npp.2009.87; Giesecke T, 2005, ARTHRITIS RHEUM-US, V52, P1577, DOI 10.1002/art.21008; Gilmore K L, 1983, Aust J Physiother, V29, P3, DOI 10.1016/S0004-9514(14)60659-0; Grundmann L, 2011, BRAIN STIMUL, V4, P253, DOI 10.1016/j.brs.2010.12.002; Hallett M, 1996, ANN NEUROL, V40, P344, DOI 10.1002/ana.410400303; HE SQ, 1993, J NEUROSCI, V13, P952; Hoshi E, 2006, NEUROSCI RES, V54, P73, DOI 10.1016/j.neures.2005.10.013; Iannetti GD, 2010, EXP BRAIN RES, V205, P1, DOI 10.1007/s00221-010-2340-1; JONES AKP, 1991, P ROY SOC B-BIOL SCI, V244, P39, DOI 10.1098/rspb.1991.0048; JONES EG, 1978, J COMP NEUROL, V181, P291, DOI 10.1002/cne.901810206; Kanda M, 2000, BRAIN RES, V853, P282, DOI 10.1016/S0006-8993(99)02274-X; Keeser D, 2011, J NEUROSCI, V31, P15284, DOI 10.1523/JNEUROSCI.0542-11.2011; Kendall FP, 1993, MUSCLES TESTING FUNC; KIRKWOOD A, 1993, SCIENCE, V260, P1518, DOI 10.1126/science.8502997; Knops A, 2006, NEUROPSYCHOLOGIA, V44, P2270, DOI 10.1016/j.neuropsychologia.2006.05.011; Kolb B., 2009, FUNDAMENTALS HUMAN N, V6th Edn; Kulkarni B, 2005, EUR J NEUROSCI, V21, P3133, DOI 10.1111/j.1460-9568.2005.04098.x; Kuo MF, 2008, CEREB CORTEX, V18, P648, DOI 10.1093/cercor/bhm098; Lang N, 2004, EXP BRAIN RES, V156, P439, DOI 10.1007/s00221-003-1800-2; Lang N, 2005, EUR J NEUROSCI, V22, P495, DOI 10.1111/j.1460-9568.2005.04233.x; Laurent B, 2000, REV NEUROL-FRANCE, V156, P341; Le Pera D, 2001, CLIN NEUROPHYSIOL, V112, P1633, DOI 10.1016/S1388-2457(01)00631-9; Lee S, 2013, NAT NEUROSCI, V16, P1662, DOI 10.1038/nn.3544; Lee S, 2010, J NEUROSCI, V30, P16796, DOI 10.1523/JNEUROSCI.1869-10.2010; Lima MC, 2008, NEUROLOGY, V70, P2329, DOI 10.1212/01.wnl.0000314649.38527.93; Luedtke K, 2012, CLIN J PAIN, V28, P452, DOI 10.1097/AJP.0b013e31823853e3; Martin PG, 2008, J PHYSIOL-LONDON, V586, P1277, DOI 10.1113/jphysiol.2007.140426; Matsunaga K, 2004, CLIN NEUROPHYSIOL, V115, P456, DOI 10.1016/S1388-2457(03)00362-6; Medeiros Liciane Fernandes, 2012, Front Psychiatry, V3, P110, DOI 10.3389/fpsyt.2012.00110; MESULAM MM, 1982, J COMP NEUROL, V212, P38, DOI 10.1002/cne.902120104; Meyers L. S., 2006, APPL MULTIVARIATE RE; Miranda PC, 2006, CLIN NEUROPHYSIOL, V117, P1623, DOI 10.1016/j.clinph.2006.04.009; Monte-Silva K, 2013, BRAIN STIMUL, V6, P424, DOI 10.1016/j.brs.2012.04.011; Monte-Silva K, 2010, J PHYSIOL-LONDON, V588, P3415, DOI 10.1113/jphysiol.2010.190181; Mylius V, 2012, EUR J PAIN, V16, P974, DOI 10.1002/j.1532-2149.2011.00105.x; Nitsche MA, 2007, J NEUROPHYSIOL, V97, P3109, DOI 10.1152/jn.01312.2006; Nitsche MA, 2001, NEUROLOGY, V57, P1899, DOI 10.1212/WNL.57.10.1899; Nitsche MA, 2000, J PHYSIOL-LONDON, V527, P633, DOI 10.1111/j.1469-7793.2000.t01-1-00633.x; Nitsche MA, 2003, J PHYSIOL-LONDON, V553, P293, DOI 10.1113/jphysiol.2003.049916; Nitsche MA, 2009, J NEUROSCI, V29, P2648, DOI 10.1523/JNEUROSCI.5366-08.2009; Nitsche MA, 2008, BRAIN STIMUL, V1, P206, DOI 10.1016/j.brs.2008.06.004; O'Connell NE, 2011, EUR J PHYS REHAB MED, V47, P309; O'Connell NE, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008208.pub3; O'Connell NE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047514; Oh S.J., 2003, CLIN ELECTROMYOGRAPH, DOI [10.1046/j.1468-1331.2003.00654.x, DOI 10.1046/J.1468-1331.2003.00654.X]; Ohara S, 2004, J NEUROPHYSIOL, V91, P736, DOI 10.1152/jn.00648.2003; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Ostrowsky K, 2002, CEREB CORTEX, V12, P376, DOI 10.1093/cercor/12.4.376; Parazzini M, 2013, CLIN NEUROPHYSIOL, DOI [10.1016/j.clinph.2013.12.101, DOI 10.1016/J.CLINPH.2013.12.101]; Pellicciari MC, 2013, NEUROIMAGE, V83, P569, DOI 10.1016/j.neuroimage.2013.06.076; Perotto A., 2005, ANATOMICAL GUIDE ELE; Petreanu L, 2012, NATURE, V489, P299, DOI 10.1038/nature11321; Peyron R, 2000, NEUROPHYSIOL CLIN, V30, P263, DOI 10.1016/S0987-7053(00)00227-6; Ploghaus A, 2003, TRENDS COGN SCI, V7, P197, DOI 10.1016/S1364-6613(03)00061-5; Ploner M, 2004, NERVENARZT, V75, P962, DOI 10.1007/s00115-004-1739-y; Poreisz C, 2007, BRAIN RES BULL, V72, P208, DOI 10.1016/j.brainresbull.2007.01.004; Ragert P, 2004, NEUROSCI LETT, V356, P91, DOI 10.1016/j.neulet.2003.11.034; ROSSINI PM, 1994, ELECTROEN CLIN NEURO, V91, P79, DOI 10.1016/0013-4694(94)90029-9; Rudy B, 2011, DEV NEUROBIOL, V71, P45, DOI 10.1002/dneu.20853; Samii A, 1996, NEUROLOGY, V46, P1376, DOI 10.1212/WNL.46.5.1376; Schabrun SM, 2013, NEUROSCIENCE, V235, P159, DOI 10.1016/j.neuroscience.2012.12.072; Schabrun SM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051298; Schabrun SM, 2012, J PAIN, V13, P187, DOI 10.1016/j.jpain.2011.10.013; Schwartz M. S., 2003, BIOFEEDBACK PRACTITI, V3rd; Stagg CJ, 2011, NEUROSCIENTIST, V17, P37, DOI 10.1177/1073858410386614; Stieglitz T, 2005, EXPERT REV MED DEVIC, V2, P149, DOI 10.1586/17434440.2.2.149; Svensson P, 2003, EUR J PAIN-LONDON, V7, P55, DOI 10.1016/S1090-3801(02)00050-2; TALBOT JD, 1991, SCIENCE, V251, P1355, DOI 10.1126/science.2003220; Tang JS, 2009, PROG NEUROBIOL, V89, P383, DOI 10.1016/j.pneurobio.2009.10.002; Tsao H, 2011, NEUROSCIENCE, V181, P127, DOI 10.1016/j.neuroscience.2011.02.033; Uy J, 2003, J NEUROSCI METH, V127, P193, DOI 10.1016/S0165-0270(03)00142-0; Van Ryckeghem DML, 2013, PAIN, V154, P2700, DOI 10.1016/j.pain.2013.07.055; Vaseghi B, 2014, CLIN NEUROPHYSIOL, V125, P1847, DOI 10.1016/j.clinph.2014.01.020; Vaseghi B, 2014, CLIN NEUROPHYSIOL, DOI [10.1016/j.clinph.2014.09.029, DOI 10.1016/J.CLINPH.2014.09.029]; Vogt BA, 2000, PROG BRAIN RES, V122, P223; Wager TD, 2004, SCIENCE, V303, P1162, DOI 10.1126/science.1093065; Wassermann E., 2008, OXFORD HDB TRANSCRAN; Wood L, 2008, BMJ-BRIT MED J, V336, P601, DOI 10.1136/bmj.39465.451748.AD; Xu NL, 2012, NATURE, V492, P247, DOI 10.1038/nature11601	111	50	50	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2015	10	3							e0118340	10.1371/journal.pone.0118340	http://dx.doi.org/10.1371/journal.pone.0118340			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9JM	25738603	Green Published, gold			2022-12-27	WOS:000350685900031
J	Yokoyama, JS; Lee, AKL; Takada, LT; Busovaca, E; Bonham, LW; Chao, SZ; Tse, M; He, J; Schwarz, CG; Carmichael, OT; Matthews, BR; Karydas, A; Weiner, MW; Coppola, G; DeCarli, CS; Miller, BL; Rosen, HJ				Yokoyama, Jennifer S.; Lee, Allen K. L.; Takada, Leonel T.; Busovaca, Edgar; Bonham, Luke W.; Chao, Steven Z.; Tse, Marian; He, Jing; Schwarz, Christopher G.; Carmichael, Owen T.; Matthews, Brandy R.; Karydas, Anna; Weiner, Michael W.; Coppola, Giovanni; DeCarli, Charles S.; Miller, Bruce L.; Rosen, Howard J.			Apolipoprotein epsilon 4 Is Associated with Lower Brain Volume in Cognitively Normal Chinese but Not White Older Adults	PLOS ONE			English	Article							ALZHEIMERS-DISEASE PATIENTS; LATE-ONSET; MEMORY DECLINE; E POLYMORPHISM; TYPE-4 ALLELE; GENETIC RISK; PUERTO-RICAN; DEMENTIA; IMPAIRMENT; AGE	Studying ethnically diverse groups is important for furthering our understanding of biological mechanisms of disease that may vary across human populations. The epsilon 4 allele of apolipoprotein E (APOE epsilon 4) is a well-established risk factor for Alzheimer's disease (AD), and may confer anatomic and functional effects years before clinical signs of cognitive decline are observed. The allele frequency of APOE epsilon 4 varies both across and within populations, and the size of the effect it confers for dementia risk may be affected by other factors. Our objective was to investigate the role APOE epsilon 4 plays in moderating brain volume in cognitively normal Chinese older adults, compared to older white Americans. We hypothesized that carrying APOE epsilon 4 would be associated with reduced brain volume and that the magnitude of this effect would be different between ethnic groups. We performed whole brain analysis of structural MRIs from Chinese living in America (n = 41) and Shanghai (n = 30) and compared them to white Americans (n = 71). We found a significant interaction effect of carrying APOE epsilon 4 and being Chinese. The APOE epsilon 4xChinese interaction was associated with lower volume in bilateral cuneus and left middle frontal gyrus (P-uncorrected<0.001), with suggestive findings in right entorhinal cortex and left hippocampus (P-uncorrected<0.01), all regions that are associated with neurodegeneration in AD. After correction for multiple testing, the left cuneus remained significantly associated with the interaction effect (P-FWE = 0.05). Our study suggests there is a differential effect of APOE epsilon 4 on brain volume in Chinese versus white cognitively normal elderly adults. This represents a novel finding that, if verified in larger studies, has implications for how biological, environmental and/or lifestyle factors may modify APOE epsilon 4 effects on the brain in diverse populations.	[Yokoyama, Jennifer S.; Lee, Allen K. L.; Takada, Leonel T.; Busovaca, Edgar; Bonham, Luke W.; Tse, Marian; Karydas, Anna; Miller, Bruce L.; Rosen, Howard J.] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA; [Takada, Leonel T.] Univ Sao Paulo, Sch Med, Hosp Clin, Sao Paulo, Brazil; [Chao, Steven Z.] Vet Affairs Hlth Care Syst, Dept Neurol, Palo Alto, CA USA; [Chao, Steven Z.] Stanford Univ, Sch Med, Dept Neurol & Neurol Sci, Stanford, CA 94305 USA; [He, Jing; Carmichael, Owen T.; DeCarli, Charles S.] Univ Calif Davis, Dept Neurol, Davis, CA 95616 USA; [Schwarz, Christopher G.] Mayo Clin & Mayo Fdn, Dept Radiol, Rochester, MN USA; [Carmichael, Owen T.] Univ Calif Davis, Dept Comp Sci, Davis, CA 95616 USA; [Matthews, Brandy R.] Indiana Univ Sch Med, Dept Neurol, Indianapolis, IN 46202 USA; [Weiner, Michael W.] Ctr Imaging Neurodegenerat Dis, Dept Vet Affairs Med Ctr, San Francisco, CA USA; [Weiner, Michael W.] Univ Calif San Francisco, Dept Radiol, San Francisco, CA 94143 USA; [Coppola, Giovanni] Univ Calif Los Angeles, Semel Inst Neurosci & Human Behav, Dept Psychiat & Neurol, Los Angeles, CA 90024 USA	University of California System; University of California San Francisco; Universidade de Sao Paulo; US Department of Veterans Affairs; Veterans Health Administration (VHA); Stanford University; University of California System; University of California Davis; Mayo Clinic; University of California System; University of California Davis; Indiana University System; Indiana University Bloomington; University of California System; University of California San Francisco; University of California System; University of California Los Angeles	Yokoyama, JS (corresponding author), Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA.	jyokoyama@memory.ucsf.edu	Schwarz, Christopher G./AAF-2719-2021; DeCarli, Charles/B-5541-2009; Carmichael, Owen/N-1955-2017; Takada, Leonel/H-7124-2013	Schwarz, Christopher G./0000-0002-1466-8357; Takada, Leonel/0000-0002-0121-9253; Carmichael, Owen/0000-0002-0576-0047	National Institute on Aging-National Institutes of Health (NIH) [P50 AG023501-08S1]; Larry L. Hillblom Foundation [2012-A-015-FEL]; NIH [P50 AG023501, R21 AG028182, P30 AG10129, HD042971, AG012435, AG024904, AG10129, AG030514, RC1 AG035610]; Hillblom Aging Network; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR002529, UL1TR001108] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P30AG010129, P01AG019724, K01AG030514, P01AG012435, R21AG028182, RC1AG035610, K24AG045333, P50AG023501, U19AG024904, K01AG049152, U01AG024904, R01AG042292] Funding Source: NIH RePORTER	National Institute on Aging-National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Larry L. Hillblom Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Hillblom Aging Network; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	J. S. Y. is funded by a diversity supplement from the National Institute on Aging-National Institutes of Health (NIH) (P50 AG023501-08S1, PI: Miller, BL) and by the Larry L. Hillblom Foundation (2012-A-015-FEL). Additional support for this study was provided by NIH grants P50 AG023501 (B. L. M.); R21 AG028182 and P30 AG10129 (C. S. D.); HD042971, AG012435, AG024904, AG10129, and AG030514 (O. T. C.); RC1 AG035610 (G. C.); and the Hillblom Aging Network (B. L. M.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BALDERESCHI M, 1994, NEUROLOGY, V44, P239, DOI 10.1212/WNL.44.2.239; Bates E, 2003, NAT NEUROSCI, V6, P448, DOI 10.1038/nn1050; Binder JR, 1997, J NEUROSCI, V17, P353, DOI 10.1523/JNEUROSCI.17-01-00353.1997; Burchard EG, 2004, AM J RESP CRIT CARE, V169, P386, DOI 10.1164/rccm.200309-1293OC; Caroli A, 2007, J NEUROL, V254, P1698, DOI 10.1007/s00415-007-0631-7; Caselli RJ, 2008, ARCH NEUROL-CHICAGO, V65, P1231, DOI 10.1001/archneurol.2008.1; Caselli RJ, 2009, NEW ENGL J MED, V361, P255, DOI 10.1056/NEJMoa0809437; Chao SZ, 2011, GERONTOLOGIST, V51, pS125, DOI 10.1093/geront/gnr033; CHESSON AL, 1983, BRAIN LANG, V19, P306, DOI 10.1016/0093-934X(83)90073-1; Choudhry S, 2005, AM J RESP CRIT CARE, V171, P563, DOI 10.1164/rccm.200409-1286OC; Chuang WL, 2010, J GERIATR PSYCH NEUR, V23, P42, DOI 10.1177/0891988709351804; Corbo RM, 1999, ANN HUM GENET, V63, P301, DOI 10.1046/j.1469-1809.1999.6340301.x; CORDER EH, 1993, SCIENCE, V261, P921, DOI 10.1126/science.8346443; Crean S, 2011, DEMENT GERIATR COGN, V31, P20, DOI 10.1159/000321984; Crinion JT, 2009, HUM BRAIN MAPP, V30, P4108, DOI 10.1002/hbm.20832; Dean DC, 2014, JAMA NEUROL, V71, P11, DOI 10.1001/jamaneurol.2013.4544; Deary IJ, 2002, NATURE, V418, P932, DOI 10.1038/418932a; Fan M, 2010, NEUROSCI LETT, V479, P332, DOI 10.1016/j.neulet.2010.05.092; Farrer LA, 1997, JAMA-J AM MED ASSOC, V278, P1349, DOI 10.1001/jama.1997.03550160069041; Filbey FM, 2006, NEUROREPORT, V17, P1585, DOI 10.1097/01.wnr.0000234745.27571.d1; Filippini N, 2009, J MAGN RESON IMAGING, V29, P1021, DOI 10.1002/jmri.21757; Filippini N, 2009, P NATL ACAD SCI USA, V106, P7209, DOI 10.1073/pnas.0811879106; Ghebremedhin E, 1998, EXP NEUROL, V153, P152, DOI 10.1006/exnr.1998.6860; He J, 2010, ARCH NEUROL-CHICAGO, V67, P1231, DOI 10.1001/archneurol.2010.230; Hong CJ, 1996, NEUROLOGY, V46, P1749, DOI 10.1212/WNL.46.6.1749; HOSTAGE CA, 2013, PLOS ONE, V8; Hou CE, 2006, DEMENT GERIATR COGN, V22, P42, DOI 10.1159/000093217; Jacobson DR, 1997, NEW ENGL J MED, V336, P466, DOI 10.1056/NEJM199702133360703; Kinkingnehum S, 2008, NEUROLOGY, V70, P2201, DOI 10.1212/01.wnl.0000303960.01039.43; Kochunov P, 2003, NEUROREPORT, V14, P961, DOI 10.1097/01.wnr.0000075417.59944.00; Kramer Joel H, 2003, Cogn Behav Neurol, V16, P211, DOI 10.1097/00146965-200312000-00002; Kwon OD, 2010, DEMENT GERIATR COGN, V30, P486, DOI 10.1159/000322368; Lung FW, 2005, ACTA PSYCHIAT SCAND, V111, P38, DOI 10.1111/j.1600-0447.2004.00394.x; Ma F, 2011, NEUROPSYCHOBIOLOGY, V64, P102, DOI 10.1159/000324991; Mondadori CRA, 2007, CEREB CORTEX, V17, P1934, DOI 10.1093/cercor/bhl103; MORRIS JC, 1993, NEUROLOGY, V43, P2412, DOI 10.1212/WNL.43.11.2412-a; MURDOCH BE, 1987, BRAIN LANG, V31, P122, DOI 10.1016/0093-934X(87)90064-2; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; POIRIER J, 1993, LANCET, V342, P697, DOI 10.1016/0140-6736(93)91705-Q; Prince M, 2003, LANCET, V361, P909, DOI 10.1016/S0140-6736(03)12772-9; Reiman EM, 2004, P NATL ACAD SCI USA, V101, P284, DOI 10.1073/pnas.2635903100; Rosen HJ, 2010, NEUROIMAGE, V49, P3358, DOI 10.1016/j.neuroimage.2009.11.041; Salari K, 2005, GENET EPIDEMIOL, V29, P76, DOI 10.1002/gepi.20079; Scarmeas Nikolaos, 2006, Curr Psychiatry Rep, V8, P11, DOI 10.1007/s11920-006-0076-1; Schwarz C, 2009, LECT NOTES COMPUT SC, V5636, P239, DOI 10.1007/978-3-642-02498-6_20; Seshadri S, 2010, JAMA-J AM MED ASSOC, V303, P1832, DOI 10.1001/jama.2010.574; Shaw P, 2007, LANCET NEUROL, V6, P494, DOI 10.1016/S1474-4422(07)70106-0; Sheline YI, 2010, J NEUROSCI, V30, P17035, DOI 10.1523/JNEUROSCI.3987-10.2010; STRITTMATTER WJ, 1993, P NATL ACAD SCI USA, V90, P1977, DOI 10.1073/pnas.90.5.1977; Sturm VE, 2013, P NATL ACAD SCI USA, V110, P9944, DOI 10.1073/pnas.1301119110; Tang MX, 1996, AM J HUM GENET, V58, P574; Venketasubramanian N., 2011, DEMENTIA GERIATRIC C, V30, P492, DOI DOI 10.1159/000321675; Verghese PB, 2011, LANCET NEUROL, V10, P241, DOI 10.1016/S1474-4422(10)70325-2; Wang PN, 2006, NEUROBIOL AGING, V27, P1797, DOI 10.1016/j.neurobiolaging.2005.10.002; Wang PN, 2011, J NEUROL NEUROSUR PS, V82, P165, DOI 10.1136/jnnp.2010.209122; Wilson SM, 2009, BRAIN, V132, P71, DOI 10.1093/brain/awn300; Wisdom NM, 2011, NEUROBIOL AGING, V32, P63, DOI 10.1016/j.neurobiolaging.2009.02.003; Wishart HA, 2006, NEUROLOGY, V67, P1221, DOI 10.1212/01.wnl.0000238079.00472.3a; Xu GF, 2009, BRAIN, V132, P383, DOI 10.1093/brain/awn254; YOSHIZAWA T, 1994, ANN NEUROL, V36, P656, DOI 10.1002/ana.410360416; Zhao SJ, 2011, J CLIN NEUROSCI, V18, P774, DOI 10.1016/j.jocn.2010.07.149	61	8	8	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2015	10	3							e0118338	10.1371/journal.pone.0118338	http://dx.doi.org/10.1371/journal.pone.0118338			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9JM	25738563	Green Published, gold			2022-12-27	WOS:000350685900030
J	Lee, JH; Hwang, I; Kang, YN; Choi, IJ; Kim, DK				Lee, Jae-Ho; Hwang, Ilseon; Kang, Yu-Na; Choi, In-Jang; Kim, Dae-Kwang			Genetic Characteristics of Mitochondrial DNA Was Associated with Colorectal Carcinogenesis and Its Prognosis	PLOS ONE			English	Article							MICROSATELLITE INSTABILITY; COPY NUMBER; D-LOOP; GENOME INSTABILITY; SOMATIC MUTATIONS; SERRATED POLYPS; CANCER; BRAF; PREVALENCE; ADENOMAS	Clinical value of mitochondrial DNA has been described in colorectal cancer (CRC). To clarify its role in colorectal carcinogenesis, mitochondrial microsatellite instability (mtMSI) and other markers were investigated in CRCs and their precancerous lesions, as a multitier genetic study. DNA was isolated from paired normal and tumoral tissues in 78 tubular adenomas (TAs), 34 serrated polyps (SPs), and 100 CRCs. mtMSI, nucleus microsatellite instability (nMSI), KRAS mutation, and BRAF mutation were investigated in these tumors and their statistical analysis was performed. mtMSI was found in 30% of CRCs and 21.4% of precancerous lesions. Mitochondrial copy number was higher in SPs than TAs and it was associated with mtMSI in low grade TAs. KRAS and BRAF mutations were mutually exclusive in TAs and SPs. CRCs with mtMSI showed shorter overall survival times than the patients without mtMSI. In CRCs without nMSI or BRAF mutation, mtMSI was a more accurate marker for predicting prognosis. The genetic change of mitochondrial DNA is an early and independent event in colorectal precancerous lesions and mtMSI and mitochondrial contents are associated with the tubular adenoma-carcinoma sequence, resulting in poor prognosis. This result suggested that the genetic change in mitochondrial DNA appears to be a possible prognosis marker in CRC.	[Lee, Jae-Ho; Choi, In-Jang] Keimyung Univ, Sch Med, Dept Anat, Daegu, South Korea; [Hwang, Ilseon; Kang, Yu-Na] Keimyung Univ, Sch Med, Dept Pathol, Daegu, South Korea; [Kim, Dae-Kwang] Keimyung Univ, Sch Med, Dept Med Genet, Daegu, South Korea; [Kim, Dae-Kwang] City Womens Clin, Hanvit Inst Med Genet, Daegu, South Korea	Keimyung University; Keimyung University; Keimyung University	Kim, DK (corresponding author), Keimyung Univ, Sch Med, Dept Med Genet, Daegu, South Korea.	dkkimmd@kmu.ac.kr	Lee, Jae-Ho/I-1935-2019	Lee, Jae-Ho/0000-0002-5562-0720; Hwang, Ilseon/0000-0002-6122-4417	Keimyung University Medical Research Promoting Grant	Keimyung University Medical Research Promoting Grant	This study was supported by the research promoting grant from the Keimyung University Medical Research Promoting Grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAKER SJ, 1989, SCIENCE, V244, P217, DOI 10.1126/science.2649981; Baldus SE, 2010, CLIN CANCER RES, V16, P790, DOI 10.1158/1078-0432.CCR-09-2446; Bianchi NO, 2001, MUTAT RES-REV MUTAT, V488, P9, DOI 10.1016/S1383-5742(00)00063-6; Boland CR, 1998, CANCER RES, V58, P5248; BOS JL, 1987, NATURE, V327, P293, DOI 10.1038/327293a0; Brennetot C, 2005, INT J CANCER, V113, P446, DOI 10.1002/ijc.20586; BRONNER CE, 1994, NATURE, V368, P258, DOI 10.1038/368258a0; Chang SC, 2009, INT J COLORECTAL DIS, V24, P623, DOI 10.1007/s00384-009-0663-9; Chen T, 2011, BMC MED GENET, V12, DOI 10.1186/1471-2350-12-8; Cunningham JM, 1998, CANCER RES, V58, P3455; FEARON ER, 1990, CELL, V61, P759, DOI 10.1016/0092-8674(90)90186-I; Feng S, 2011, ONCOL LETT, V2, P899, DOI 10.3892/ol.2011.322; FISHEL R, 1993, CELL, V75, P1027, DOI 10.1016/0092-8674(93)90546-3; FORRESTER K, 1987, NATURE, V327, P298, DOI 10.1038/327298a0; Goldstein NS, 2003, AM J CLIN PATHOL, V119, P778, DOI 10.1309/DRFQ0WFUF1G13CTK; GREENBLATT MS, 1994, CANCER RES, V54, P4855; Guo W, 2013, MOL BIOL REP, V40, P13, DOI 10.1007/s11033-012-1939-7; Habano W, 1998, ONCOGENE, V17, P1931, DOI 10.1038/sj.onc.1202112; Hawkins NJ, 2002, PATHOLOGY, V34, P548, DOI 10.1080/0031302021000035965; Howell N, 1996, AM J HUM GENET, V59, P501; Jass JR, 2006, HISTOPATHOLOGY, V49, P121, DOI 10.1111/j.1365-2559.2006.02466.x; Jass JR, 1999, J PATHOL, V187, P499, DOI 10.1002/(SICI)1096-9896(199904)187:5<499::AID-PATH309>3.0.CO;2-B; Jass JR, 2002, GASTROENTEROLOGY, V123, P862, DOI 10.1053/gast.2002.35392; Jeong CW, 2010, CANCER EPIDEMIOL, V34, P323, DOI 10.1016/j.canep.2010.03.015; KERN SE, 1989, JAMA-J AM MED ASSOC, V261, P3099, DOI 10.1001/jama.261.21.3099; Lee HC, 2004, MUTAT RES-FUND MOL M, V547, P71, DOI 10.1016/j.mrfmmm.2003.12.011; Lee HC, 2009, INT J MOL SCI, V10, P674, DOI 10.3390/ijms10020674; Lee JH, 2011, PATHOL ONCOL RES, V17, P201, DOI 10.1007/s12253-010-9297-z; Lievre A, 2005, J CLIN ONCOL, V23, P3517, DOI 10.1200/JCO.2005.07.044; Lim SW, 2012, INT J CANCER, V131, P1332, DOI 10.1002/ijc.27375; NICOLAIDES NC, 1994, NATURE, V371, P75, DOI 10.1038/371075a0; O'Brien MJ, 2006, AM J SURG PATHOL, V30, P1491, DOI 10.1097/01.pas.0000213313.36306.85; Paabo S, 1996, AM J HUM GENET, V59, P493; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; PEINADO MA, 1992, P NATL ACAD SCI USA, V89, P10065, DOI 10.1073/pnas.89.21.10065; Pinheiro M, 2009, CANCER LETT, V280, P38, DOI 10.1016/j.canlet.2009.02.009; Polyak K, 1998, NAT GENET, V20, P291, DOI 10.1038/3108; Popat S, 2005, J CLIN ONCOL, V23, P609, DOI 10.1200/JCO.2005.01.086; POWELL SM, 1992, NATURE, V359, P235, DOI 10.1038/359235a0; Richard SM, 2000, CANCER RES, V60, P4231; Samowitz WS, 2005, CANCER RES, V65, P6063, DOI 10.1158/0008-5472.CAN-05-0404; Shim JI, 2010, CANCER RES TREAT, V42, P191, DOI 10.4143/crt.2010.42.4.191; Soreide K, 2006, BRIT J SURG, V93, P395, DOI 10.1002/bjs.5328; Spring KJ, 2006, GASTROENTEROLOGY, V131, P1400, DOI 10.1053/j.gastro.2006.08.038; Thiagalingam S, 1996, NAT GENET, V13, P343, DOI 10.1038/ng0796-343; Tsai MH, 2009, ANN SURG ONCOL, V16, P2918, DOI 10.1245/s10434-009-0581-7; Tseng LM, 2006, GENE CHROMOSOME CANC, V45, P629, DOI 10.1002/gcc.20326; Walther A, 2009, NAT REV CANCER, V9, P489, DOI 10.1038/nrc2645; Wang Y, 2005, ANN NY ACAD SCI, V1042, P123, DOI 10.1196/annals.1338.012; Wu CW, 2005, GENE CHROMOSOME CANC, V44, P19, DOI 10.1002/gcc.20213; Yin PH, 2004, BRIT J CANCER, V90, P2390, DOI 10.1038/sj.bjc.6601838	51	24	24	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2015	10	3							e0118612	10.1371/journal.pone.0118612	http://dx.doi.org/10.1371/journal.pone.0118612			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4HV	25734426	Green Published, gold, Green Submitted			2022-12-27	WOS:000350314700040
J	Nakano, T; Otsuka, M; Yoshimoto, J; Doya, K				Nakano, Takashi; Otsuka, Makoto; Yoshimoto, Junichiro; Doya, Kenji			A Spiking Neural Network Model of Model-Free Reinforcement Learning with High-Dimensional Sensory Input and Perceptual Ambiguity	PLOS ONE			English	Article							REPRESENTATION; CATEGORIES	A theoretical framework of reinforcement learning plays an important role in understanding action selection in animals. Spiking neural networks provide a theoretically grounded means to test computational hypotheses on neurally plausible algorithms of reinforcement learning through numerical simulation. However, most of these models cannot handle observations which are noisy, or occurred in the past, even though these are inevitable and constraining features of learning in real environments. This class of problem is formally known as partially observable reinforcement learning (PORL) problems. It provides a generalization of reinforcement learning to partially observable domains. In addition, observations in the real world tend to be rich and high-dimensional. In this work, we use a spiking neural network model to approximate the free energy of a restricted Boltzmann machine and apply it to the solution of PORL problems with high-dimensional observations. Our spiking network model solves maze tasks with perceptually ambiguous high-dimensional observations without knowledge of the true environment. An extended model with working memory also solves history-dependent tasks. The way spiking neural networks handle PORL problems may provide a glimpse into the underlying laws of neural information processing which can only be discovered through such a top-down approach.	[Nakano, Takashi] Okinawa Inst Sci & Technol, Neurobiol Res Unit, Kunigami, Okinawa 9040495, Japan; [Otsuka, Makoto; Yoshimoto, Junichiro; Doya, Kenji] Okinawa Inst Sci & Technol, Neural Computat Unit, Kunigami, Okinawa 9040495, Japan	Okinawa Institute of Science & Technology Graduate University; Okinawa Institute of Science & Technology Graduate University	Nakano, T (corresponding author), Okinawa Inst Sci & Technol, Neurobiol Res Unit, 1919-1 Tancha, Kunigami, Okinawa 9040495, Japan.	nakano@oist.jp	Yoshimoto, Junichiro/B-5884-2015; Yoshimoto, Junichiro/ABI-8028-2020; Nakano, Takashi/B-6061-2015; Doya, Kenji/B-5841-2015	Yoshimoto, Junichiro/0000-0001-7995-0321; Yoshimoto, Junichiro/0000-0001-7995-0321; Nakano, Takashi/0000-0003-0707-4486; Doya, Kenji/0000-0002-2446-6820	Okinawa Institute of Science and Technology Graduate University	Okinawa Institute of Science and Technology Graduate University(Okinawa Institute of Science & Technology Graduate University)	This study was supported by Okinawa Institute of Science and Technology Graduate University. A part of this study is the result of "Bioinformatics for Brain Sciences" carried out under the Strategic Research Program for Brain Sciences by the Ministry of Education, Culture, Sports, Science and Technology of Japan (http://brainprogram. mext. go. jp/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belavkin RV, 2011, COGN SYST RES, V12, P93, DOI 10.1016/j.cogsys.2010.08.003; Boerlin M, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001080; Doya K, 2002, NEURAL NETWORKS, V15, P495, DOI 10.1016/S0893-6080(02)00044-8; Elfwing S, 2010, LECT NOTES COMPUT SC, V6443, P215, DOI 10.1007/978-3-642-17537-4_27; Florian RV, 2007, NEURAL COMPUT, V19, P1468, DOI 10.1162/neco.2007.19.6.1468; Freedman DJ, 2006, NATURE, V443, P85, DOI 10.1038/nature05078; Freedman DJ, 2001, SCIENCE, V291, P312, DOI 10.1126/science.291.5502.312; Gerstner W, 2002, SPIKING NEURON MODEL; Hinton GE, 2002, NEURAL COMPUT, V14, P1771, DOI 10.1162/089976602760128018; Hollensen P, 2011, 21 ANN C JAP NEUR NE; Izhikevich EM, 2007, CEREB CORTEX, V17, P2443, DOI 10.1093/cercor/bhl152; Kwee I, 2001, LECT NOTES COMPUT SC, V2130, P865; Matsuda W, 2009, J NEUROSCI, V29, P444, DOI 10.1523/JNEUROSCI.4029-08.2009; Miller EK, 2002, PHILOS T R SOC B, V357, P1123, DOI 10.1098/rstb.2002.1099; Otsuka M., 2010, P EUR S ART NEUR NET, P541; Otsuka M, 2008, LECT NOTES COMPUT SC, V5163, P377, DOI 10.1007/978-3-540-87536-9_39; Potjans W, 2009, NEURAL COMPUT, V21, P301, DOI 10.1162/neco.2008.08-07-593; Reynolds JNJ, 2001, NATURE, V413, P67, DOI 10.1038/35092560; Rezende DJ, 2014, FRONTIERS COMPUTATIO, V8; Roberts PD, 2008, BIOL CYBERN, V99, P517, DOI 10.1007/s00422-008-0265-6; Saeb S, 2009, NEURAL NETWORKS, V22, P586, DOI 10.1016/j.neunet.2009.06.049; Sallans B, 2004, J MACH LEARN RES, V5, P1063; Samejima K, 2005, SCIENCE, V310, P1337, DOI 10.1126/science.1115270; Schmidhuber J., 2014, ABS14047828 CORR; Schultz W, 1997, SCIENCE, V275, P1593, DOI 10.1126/science.275.5306.1593; Sutton R.S., 2015, REINFORCEMENT LEARNI, V2nd ed.; Szatmary B, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000879; WHITEHEAD SD, 1995, ARTIF INTELL, V73, P271, DOI 10.1016/0004-3702(94)00012-P	29	11	12	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2015	10	3							e0115620	10.1371/journal.pone.0115620	http://dx.doi.org/10.1371/journal.pone.0115620			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4HV	25734662	Green Published, Green Submitted, gold			2022-12-27	WOS:000350314700002
J	Nyondo, AL; Choko, AT; Chimwaza, AF; Muula, AS				Nyondo, Alinane Linda; Choko, Augustine Talumba; Chimwaza, Angela Faith; Muula, Adamson Sinjani			Invitation Cards during Pregnancy Enhance Male Partner Involvement in Prevention of Mother to Child Transmission (PMTCT) of Human Immunodeficiency Virus (HIV) in Blantyre, Malawi: A Randomized Controlled Open Label Trial	PLOS ONE			English	Article							SUB-SAHARAN AFRICA; REPRODUCTIVE HEALTH; MATERNAL HEALTH; ANTENATAL ATTENDANCE; EASTERN UGANDA; SERVICES; WOMEN; OPPORTUNITIES; INFECTION; BARRIERS	Introduction Male involvement (MI) is vital for the uptake of Prevention of Mother to Child Transmission (PMTCT) of Human Immunodeficiency Virus (HIV) interventions. Partner notification (PN) is among the strategies identified for MI in PMTCT services. The purpose of this randomized controlled trial was to evaluate the efficacy of an invitation card to the male partners as a strategy for MI in PMTCT services by comparing the proportion of pregnant women that were accompanied by their partners between the intervention and the non-intervention study groups. Methods Pregnant women attending antenatal care without a male partner at South Lunzu and Mpemba health centres in Blantyre, Malawi, were enrolled in the study from June to December 2013. In an intention-to-treat analysis, we compared all participants that were randomized in the invitation card group with the standard of care (SoC) group. Risk ratios (RR) with 95% confidence intervals (CI) were computed to assess the efficacy of the invitation card. Results Of the 462 randomized women, 65/230 (28.26%) of the women in the invitation card group reported to the antenatal care clinic with their partners compared to 44/232 (18.97%) women in the SoC group. In an unadjusted intention-to-treat analysis women in the invitation card group were 50% more likely to be accompanied by their male partners than those in the SoC group RR: 1.49 (95% CI: 1.06-2.09); p = 0.02. Our random effects analysis showed that there was no clustering by site of recruitment with an inter cluster correlation coefficient (ICC) of 1.98 x 10(-3), (95% CI: 1.78 x 10(-7) - 0.96 x 10(-1)); p = 0.403. Conclusion An invitation card significantly increased the proportion of women who were accompanied by their male partners for the PMTCT services. An invitation card is a feasible strategy for MI in PMTCT.	[Nyondo, Alinane Linda; Muula, Adamson Sinjani] Univ Malawi, Coll Med, Sch Publ Hlth & Family Med, Blantyre, Malawi; [Choko, Augustine Talumba] Malawi Liverpool Wellcome Trust Clin Res Programm, Blantyre, Malawi; [Chimwaza, Angela Faith] Univ Malawi, Kamuzu Coll Nursing, Blantyre, Malawi	University of Malawi; University of Malawi; University of Malawi	Nyondo, AL (corresponding author), Univ Malawi, Coll Med, Sch Publ Hlth & Family Med, Blantyre, Malawi.	lindaalinane@gmail.com	Nyondo, Alinane/AFN-8844-2022; Muula, Adamson/AAF-1153-2020	Nyondo, Alinane/0000-0002-3572-3810; 	Consortium for Advanced Research Training in Africa (CARTA); Wellcome Trust (UK) [087547/Z/08/Z]; Department for International Development (DfID) under the Development Partnerships in Higher Education (DelPHE); Carnegie Corporation of New York [B 8606]; Ford Foundation [1100-0399]; Google.org [191994]; Sida [54100029]; Bill and Melinda Gates Foundation [51228]; Malawi Health Research Capacity Strengthening Initiative; DFID; Wellcome Trust [HRCSI/PhD/12/09]	Consortium for Advanced Research Training in Africa (CARTA); Wellcome Trust (UK)(Wellcome Trust); Department for International Development (DfID) under the Development Partnerships in Higher Education (DelPHE); Carnegie Corporation of New York; Ford Foundation; Google.org; Sida; Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Malawi Health Research Capacity Strengthening Initiative; DFID; Wellcome Trust(Wellcome TrustEuropean Commission)	This research was partially funded by a Fellowship award provided by the Consortium for Advanced Research Training in Africa (CARTA). CARTA has been funded by the Wellcome Trust (UK) (Grant No: 087547/Z/08/Z), the Department for International Development (DfID) under the Development Partnerships in Higher Education (DelPHE), the Carnegie Corporation of New York (Grant No: B 8606), the Ford Foundation (Grant No: 1100-0399), Google.org (Grant No: 191994), Sida (Grant No: 54100029), and the Bill and Melinda Gates Foundation (Grant No: 51228). This study was also funded by the Malawi Health Research Capacity Strengthening Initiative, a DFID and Wellcome Trust funded programme grant number HRCSI/PhD/12/09. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alio AP, 2010, MATERN CHILD HLTH J, V14, P931, DOI 10.1007/s10995-009-0531-9; Aluisio A, 2011, JAIDS-J ACQ IMM DEF, V56, P76, DOI 10.1097/QAI.0b013e3181fdb4c4; Angotti N, 2011, HEALTH POLICY PLANN, V26, P307, DOI 10.1093/heapol/czq066; Betancourt TS., 2010, J INT AIDS SOC, V13; Blantyre DHO, 2012, BLANT STAT; Brown LB, 2011, JAIDS-J ACQ IMM DEF, V56, P437, DOI 10.1097/QAI.0b013e318202bf7d; Byamugisha R, 2011, J INT AIDS SOC, V14, DOI 10.1186/1758-2652-14-43; Byamugisha R, 2010, REPROD HEALTH, V7, DOI 10.1186/1742-4755-7-12; Cohen MS, 2016, NEW ENGL J MED, V375, P830, DOI [10.1056/NEJMoa1600693, 10.1056/NEJMoa1105243]; Dudgeon MR, 2004, SOC SCI MED, V59, P1379, DOI 10.1016/j.socscimed.2003.11.035; EGPAF, 2011, MAL INV PMTCT REACH; Farquhar C, 2004, JAIDS-J ACQ IMM DEF, V37, P1620, DOI 10.1097/00126334-200412150-00016; Ferguson L, 2012, TROP MED INT HEALTH, V17, P564, DOI 10.1111/j.1365-3156.2012.02958.x; Gourlay A, 2013, J INT AIDS SOC, V16, DOI 10.7448/IAS.16.1.18588; [Government of Malawi MoH Ministry of Health], 2014, MAL INT HIV PROGR RE; Homsy J, 2007, JAIDS-J ACQ IMM DEF, V44, P366, DOI 10.1097/QAI.0b013e31802f1303; Kalembo FW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066517; Katz DA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007602; Kululanga LI, 2011, REPROD HEALTH, V8, DOI 10.1186/1742-4755-8-36; Low N, 2006, LANCET, V368, P2001, DOI 10.1016/S0140-6736(06)69482-8; Maman S, 2011, J MIDWIFERY WOM HEAL, V56, P325, DOI 10.1111/j.1542-2011.2011.00029.x; Martin LT, 2007, MATERN CHILD HLTH J, V11, P595, DOI 10.1007/s10995-007-0209-0; Mathews C, 2007, COCHRANE DATABASE SY; Mbuyi B, 2004, INVOLVING MALE PARTN; Mlay R, 2008, AIDS CARE, V20, P356, DOI 10.1080/09540120701561304; Mohlala BKF, 2011, AIDS, V25, P1535, DOI 10.1097/QAD.0b013e328348fb85; Morfaw F, 2013, SYST REV, V2, DOI 10.1186/2046-4053-2-5; Moth I A, 2005, SAHARA J, V2, P244; Msuya SE, 2008, AIDS CARE, V20, P700, DOI 10.1080/09540120701687059; Mullany BC, 2006, SOC SCI MED, V62, P2798, DOI 10.1016/j.socscimed.2005.11.013; Mullany BC, 2007, HEALTH EDUC RES, V22, P166, DOI 10.1093/her/cyl060; NSO, 2008, POP HOUS CENS RES, P1; Nyondo AL, 2013, GLOBAL HEALTH ACTION, V6, P1, DOI 10.3402/gha.v6i0.22780; Nyondo AL, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-691; Rosen S, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001056; Semrau K, 2005, AIDS, V19, P603, DOI 10.1097/01.aids.0000163937.07026.a0; Sternberg P, 2004, HEALTH PROMOT INT, V19, P389, DOI 10.1093/heapro/dah312; Theuring S, 2009, AIDS BEHAV, V13, pS92, DOI 10.1007/s10461-009-9543-0; UNAIDS, 2013, UNAIDS GLOB REP AIDS; Wettstein C, 2012, AIDS, V26, P2361, DOI 10.1097/QAD.0b013e328359ab0c; WHO, 2012, US ANT DRUGS TREAT P; WHO, 2010, PMTCT STRAT VIS 2010, DOI [10.1016/S0140-6736(14)60844-8, DOI 10.1016/S0140-6736(14)60844-8]; Wringe A, 2008, TROP MED INT HEALTH, V13, P319, DOI 10.1111/j.1365-3156.2008.02005.x	43	45	45	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2015	10	3							e0119273	10.1371/journal.pone.0119273	http://dx.doi.org/10.1371/journal.pone.0119273			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CC4HV	25734485	Green Published, Green Submitted, gold			2022-12-27	WOS:000350314700062
J	Takemoto, K; Ishihara, S; Mizutai, T; Kawabata, K; Haga, H				Takemoto, Kenji; Ishihara, Seiichiro; Mizutai, Takeomi; Kawabata, Kazushige; Haga, Hisashi			Compressive Stress Induces Dephosphorylation of the Myosin Regulatory Light Chain via RhoA Phosphorylation by the Adenylyl Cyclase/Protein Kinase A Signaling Pathway	PLOS ONE			English	Article							SMOOTH-MUSCLE MYOSIN; ACTIN-FILAMENTS; MEDIATED ENDOCYTOSIS; PROTEIN PHOSPHATASE; CYCLIC-AMP; CYCLASE; SUBUNIT; FORCE; BINDING; PURIFICATION	Mechanical stress that arises due to deformation of the extracellular matrix (ECM) either stretches or compresses cells. The cellular response to stretching has been actively studied. For example, stretching induces phosphorylation of the myosin regulatory light chain (MRLC) via the RhoA/RhoA-associated protein kinase (ROCK) pathway, resulting in increased cellular tension. In contrast, the effects of compressive stress on cellular functions are not fully resolved. The mechanisms for sensing and differentially responding to stretching and compressive stress are not known. To address these questions, we investigated whether phosphorylation levels of MRLC were affected by compressive stress. Contrary to the response in stretching cells, MRLC was dephosphorylated 5 min after cells were subjected to compressive stress. Compressive loading induced activation of myosin phosphatase mediated via the dephosphorylation of myosin phosphatase targeting subunit 1 (Thr853). Because myosin phosphatase targeting subunit 1 (Thr853) is phosphorylated only by ROCK, compressive loading may have induced inactivation of ROCK. However, GTP-bound RhoA (active form) increased in response to compressive stress. The compression- induced activation of RhoA and inactivation of its effector ROCK are contradictory. This inconsistency was due to phosphorylation of RhoA (Ser188) that reduced affinity of RhoA to ROCK. Treatment with the inhibitor of protein kinase A that phosphorylates RhoA (Ser188) induced suppression of compression-stimulated MRLC dephosphorylation. Incidentally, stretching induced phosphorylation of MRLC, but did not affect phosphorylation levels of RhoA (Ser188). Together, our results suggest that RhoA phosphorylation is an important process for MRLC dephosphorylation by compressive loading, and for distinguishing between stretching and compressing cells.	[Takemoto, Kenji; Ishihara, Seiichiro; Mizutai, Takeomi; Kawabata, Kazushige; Haga, Hisashi] Hokkaido Univ, Fac Adv Life Sci, Transdisciplinary Life Sci Course, Sapporo, Hokkaido, Japan; [Ishihara, Seiichiro; Haga, Hisashi] Hokkaido Univ, Grad Sch Med, Res Ctr Cooperat Projects, Sapporo, Hokkaido, Japan	Hokkaido University; Hokkaido University	Haga, H (corresponding author), Hokkaido Univ, Fac Adv Life Sci, Transdisciplinary Life Sci Course, Sapporo, Hokkaido, Japan.	haga@sci.hokudai.ac.jp	Haga, Hisashi/E-6931-2010	Haga, Hisashi/0000-0001-9464-6723	JSPS KAKENHI [26430104, 26106702, 25127701, 24370069, 26106704, 25287106]; Ministry of Education, Culture, Sports, Science and Technology, Japan; Grants-in-Aid for Scientific Research [26430104] Funding Source: KAKEN	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by JSPS KAKENHI Grant Numbers 26430104, 26106702, 25127701, 24370069 to H.H., 26106704 to T.M., 25287106 to K.K. This study was also partly supported by Special Expenditures for "Reverse Translational Research from Advanced Medical Technology to Advanced Life Science" to H.H. granted by Ministry of Education, Culture, Sports, Science and Technology, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aburima A, 2013, BLOOD, V122, P3533, DOI 10.1182/blood-2013-03-487850; ALESSI D, 1992, EUR J BIOCHEM, V210, P1023, DOI 10.1111/j.1432-1033.1992.tb17508.x; Chen CS, 1997, SCIENCE, V276, P1425, DOI 10.1126/science.276.5317.1425; Coste B, 2010, SCIENCE, V330, P55, DOI 10.1126/science.1193270; Davies SP, 2000, BIOCHEM J, V351, P95, DOI 10.1042/0264-6021:3510095; DENNERLL TJ, 1988, J CELL BIOL, V107, P665, DOI 10.1083/jcb.107.2.665; Dubin-Thaler BJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003735; Dupont S, 2011, NATURE, V474, P179, DOI 10.1038/nature10137; Eisenhoffer GT, 2012, NATURE, V484, P546, DOI 10.1038/nature10999; GRUNSPANSWIRSKY A, 1978, IMMUNOPHARMACOLOGY, V1, P71, DOI 10.1016/0162-3109(78)90010-3; Gschwend S, 2003, BRIT J PHARMACOL, V139, P1317, DOI 10.1038/sj.bjp.0705367; Guilluy C, 2011, NAT CELL BIOL, V13, P722, DOI 10.1038/ncb2254; Halls ML, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004143; Hanoune J, 2001, ANNU REV PHARMACOL, V41, P145, DOI 10.1146/annurev.pharmtox.41.1.145; Hara F, 2001, J ORTHOPAED RES, V19, P126, DOI 10.1016/S0736-0266(00)00011-5; Hayakawa K, 2011, J CELL BIOL, V195, P721, DOI 10.1083/jcb.201102039; Hirano K, 1997, J BIOL CHEM, V272, P3683, DOI 10.1074/jbc.272.6.3683; Hobert O, 1996, ONCOGENE, V12, P1577; Hudson CA, 2012, MOL HUM REPROD, V18, P265, DOI 10.1093/molehr/gar078; Ichikawa K, 1996, BIOCHEMISTRY-US, V35, P6313, DOI 10.1021/bi960208q; IKEBE M, 1985, J BIOL CHEM, V260, P27; Iwanicki MP, 2008, J CELL SCI, V121, P895, DOI 10.1242/jcs.020941; Izzard AS, 2003, AM J PHYSIOL-HEART C, V285, pH1489, DOI 10.1152/ajpheart.00352.2003; Kawamoto T, 2008, JPN J APPL PHYS, V47, P6173, DOI 10.1143/JJAP.47.6173; Khromov A, 2009, J BIOL CHEM, V284, P21569, DOI 10.1074/jbc.M109.019729; Kimura K, 1998, J BIOL CHEM, V273, P5542, DOI 10.1074/jbc.273.10.5542; Kiss E, 2002, BIOCHEM J, V365, P79, DOI 10.1042/BJ20011295; Kovar DR, 2006, CELL, V124, P423, DOI 10.1016/j.cell.2005.11.038; KUO L, 1993, CIRC RES, V72, P607, DOI 10.1161/01.RES.72.3.607; Kwon RY, 2010, FASEB J, V24, P2859, DOI 10.1096/fj.09-148007; Lang P, 1996, EMBO J, V15, P510, DOI 10.1002/j.1460-2075.1996.tb00383.x; Le Clainche C, 2007, EMBO J, V26, P1199, DOI 10.1038/sj.emboj.7601576; Lim Y, 2008, J CELL BIOL, V180, P187, DOI 10.1083/jcb.200708194; Liu YF, 2013, STAT INTERFACE, V6, P1; Mabuchi Y, 2010, BIOCHEMISTRY-US, V49, P2903, DOI 10.1021/bi901963e; Machacek M, 2009, NATURE, V461, P99, DOI 10.1038/nature08242; Masumoto A, 2002, CIRCULATION, V105, P1545, DOI 10.1161/hc1002.105938; Mehta D, 1999, J PHYSIOL-LONDON, V519, P829, DOI 10.1111/j.1469-7793.1999.0829n.x; MEINKOTH JL, 1993, MOL CELL BIOCHEM, V128, P179, DOI 10.1007/BF01076769; Merrifield CJ, 2004, EUR J CELL BIOL, V83, P13, DOI 10.1078/0171-9335-00356; MIYAMOTO S, 1995, J CELL BIOL, V131, P791, DOI 10.1083/jcb.131.3.791; Mizutani T, 2004, CELL MOTIL CYTOSKEL, V59, P242, DOI 10.1002/cm.20037; Mizutani T, 2009, CELL MOTIL CYTOSKEL, V66, P389, DOI 10.1002/cm.20378; Moseley JB, 2006, METHOD ENZYMOL, V406, P215, DOI 10.1016/S0076-6879(06)06016-2; Norman LL, 2010, BIOPHYS J, V99, P1726, DOI 10.1016/j.bpj.2010.07.031; Nusser N, 2006, CELL SIGNAL, V18, P704, DOI 10.1016/j.cellsig.2005.06.010; Osol G, 2002, AM J PHYSIOL-HEART C, V283, pH2260, DOI 10.1152/ajpheart.00634.2002; Pinto C, 2008, J PHARMACOL EXP THER, V325, P27, DOI 10.1124/jpet.107.131904; RISER BL, 1992, J CLIN INVEST, V90, P1932, DOI 10.1172/JCI116071; SALISBURY JL, 1980, J CELL BIOL, V87, P132, DOI 10.1083/jcb.87.1.132; SHIRAZI A, 1994, J BIOL CHEM, V269, P31598; Steffen A, 2013, J CELL SCI, V126, P4572, DOI 10.1242/jcs.118232; Takizawa N, 2002, BIOCHEM BIOPH RES CO, V297, P773, DOI 10.1016/S0006-291X(02)02302-1; Tamura K, 2011, ACTA BIOMATER, V7, P3766, DOI 10.1016/j.actbio.2011.06.013; Tian YR, 2001, DIABETES, V50, P2505, DOI 10.2337/diabetes.50.11.2505; Velasco G, 2002, FEBS LETT, V527, P101, DOI 10.1016/S0014-5793(02)03175-7; Yoshigi M, 2005, J CELL BIOL, V171, P209, DOI 10.1083/jcb.200505018; Yoshikawa T, 1997, BIO-MED MATER ENG, V7, P369	58	20	20	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2015	10	3							e0117937	10.1371/journal.pone.0117937	http://dx.doi.org/10.1371/journal.pone.0117937			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4HV	25734240	Green Published, gold, Green Submitted			2022-12-27	WOS:000350314700011
J	Takeuchi, M; Takino, J; Furuno, S; Shirai, H; Kawakami, M; Muramatsu, M; Kobayashi, Y; Yamagishi, S				Takeuchi, Masayoshi; Takino, Jun-ichi; Furuno, Satomi; Shirai, Hikari; Kawakami, Mihoko; Muramatsu, Michiru; Kobayashi, Yuka; Yamagishi, Sho-ichi			Assessment of the Concentrations of Various Advanced Glycation End-Products in Beverages and Foods That Are Commonly Consumed in Japan	PLOS ONE			English	Article							DIABETIC VASCULAR COMPLICATIONS; ENDPRODUCTS AGES; IMMUNOLOGICAL DETECTION; ADVANCED GLYCOSYLATION; LIQUID-CHROMATOGRAPHY; CARBOXYMETHYL-LYSINE; OXIDATIVE STRESS; DIETARY-INTAKE; SERUM; PATHOGENESIS	Dietary consumption has recently been identified as a major environmental source of pro-inflammatory advanced glycation end-products (AGEs) in humans. It is disputed whether dietary AGEs represent a risk to human health. N-epsilon-(carboxymethyl) lysine (CML), a representative AGE compound found in food, has been suggested to make a significant contribution to circulating CML levels. However, recent studies have found that the dietary intake of AGEs is not associated with plasma CML concentrations. We have shown that the serum levels of glyceraldehyde-derived AGEs (Glycer-AGEs), but not hemoglobin A1c, glucose- derived AGEs (Glu-AGEs), or CML, could be used as biomarkers for predicting the progression of atherosclerosis and future cardiovascular events. We also detected the production/accumulation of Glycer-AGEs in normal rats administered Glu-AGE-rich beverages. Therefore, we assessed the concentrations of various AGEs in a total of 1,650 beverages and foods that are commonly consumed in Japan. The concentrations of four kinds of AGEs (Glu-AGEs, fructose-derived AGEs (Fru-AGEs), CML, and Glycer-AGEs) were measured with competitive enzyme-linked immunosorbent assays involving immunoaffinity-purified specific antibodies. The results of the latter assays indicated that Glu-AGEs and Fru-AGEs (especially Glu-AGEs), but not CML or Glycer-AGEs, are present at appreciable levels in beverages and foods that are commonly consumed by Japanese. Glu-AGEs, Fru-AGEs, CML, and Glycer-AGEs exhibited concentrations of >= 85%, 2-12%, <3%, and trace amounts in the examined beverages and >= 82%, 5-15%, <3%, and trace amounts in the tested foods, respectively. The results of the present study indicate that some lactic acid bacteria beverages, carbonated drinks, sugar-sweetened fruit drinks, sports drinks, mixed fruit juices, confectionery (snacks), dried fruits, cakes, cereals, and prepared foods contain markedly higher Glu-AGE levels than other classes of beverages and foods. We provide useful data on the concentrations of various AGEs, especially Glu-AGEs, in commonly consumed beverages and foods.	[Takeuchi, Masayoshi] Kanazawa Med Univ, Med Res Inst, Dept Adv Med, Uchinada, Ishikawa 92002, Japan; [Takino, Jun-ichi] Hiroshima Int Univ, Fac Pharmaceut Sci, Biochem Lab, Kure, Hiroshima, Japan; [Furuno, Satomi; Shirai, Hikari; Kawakami, Mihoko; Muramatsu, Michiru; Kobayashi, Yuka] Hokuriku Univ, Fac Pharmaceut Sci, Dept Pathophysiol Sci, Kanazawa, Ishikawa 92011, Japan; [Yamagishi, Sho-ichi] Kurume Univ, Sch Med, Dept Pathophysiol & Therapeut Diabet Vasc Complic, Kurume, Fukuoka 830, Japan	Kanazawa Medical University; Hokuriku University; Kurume University	Takeuchi, M (corresponding author), Kanazawa Med Univ, Med Res Inst, Dept Adv Med, Uchinada, Ishikawa 92002, Japan.	takeuchi@kanazawa-med.ac.jp			Japan Society for the Promotion of Science (JSPS, KAKENHI) [19300254, 22300264, 25282029]	Japan Society for the Promotion of Science (JSPS, KAKENHI)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by grants from the Japan Society for the Promotion of Science (JSPS, KAKENHI Grant Numbers 19300254, 22300264, & 25282029 for MT). The funders had no role in the study design, data collection or analysis, the decision to publish, or the preparation of the manuscript.	Ahmed N, 2002, BIOCHEM J, V364, P1; Ahmed N, 2005, MOL NUTR FOOD RES, V49, P691, DOI 10.1002/mnfr.200500008; Alamir I, 2013, AMINO ACIDS, V44, P1441, DOI 10.1007/s00726-012-1427-3; Assar SH, 2009, AMINO ACIDS, V36, P317, DOI 10.1007/s00726-008-0071-4; BROWNLEE M, 1995, ANNU REV MED, V46, P223, DOI 10.1146/annurev.med.46.1.223; Bucala R, 1992, Adv Pharmacol, V23, P1; Fukushima Y, 2013, CARDIOVASC DIABETOL, V12, DOI 10.1186/1475-2840-12-5; Goldberg T, 2004, J AM DIET ASSOC, V104, P1287, DOI 10.1016/j.jada.2004.05.214; Henle T, 2005, AMINO ACIDS, V29, P313, DOI 10.1007/s00726-005-0200-2; Kellow NJ, 2013, EUR J CLIN NUTR, V67, P239, DOI 10.1038/ejcn.2012.220; Koschinsky T, 1997, P NATL ACAD SCI USA, V94, P6474, DOI 10.1073/pnas.94.12.6474; MAKITA Z, 1992, J BIOL CHEM, V267, P5133; MONNIER VM, 1981, SCIENCE, V211, P491, DOI 10.1126/science.6779377; Poulsen MW, 2013, FOOD CHEM TOXICOL, V60, P10, DOI 10.1016/j.fct.2013.06.052; Sato T, 2009, EUR J NUTR, V48, P6, DOI 10.1007/s00394-008-0753-4; Schalkwijk CG, 2004, DIABETES-METAB RES, V20, P369, DOI 10.1002/dmrr.488; Sebekova K, 2007, MOL NUTR FOOD RES, V51, P1079, DOI 10.1002/mnfr.200700035; Semba RD, 2012, EUR J CLIN NUTR, V66, P3, DOI 10.1038/ejcn.2011.139; Semba RD, 2014, J NUTR, V144, P1037, DOI 10.3945/jn.113.189480; Tahara N, 2012, DIABETES CARE, V35, P2618, DOI 10.2337/dc12-0087; Tahara N, 2012, CARDIOVASC THER, V30, P42, DOI 10.1111/j.1755-5922.2010.00177.x; Takeuchi M, 1999, MOL MED, V5, P393, DOI 10.1007/BF03402128; Takeuchi M, 2004, MED HYPOTHESES, V63, P449, DOI 10.1016/j.mehy.2004.02.042; Takeuchi M, 2001, MOL MED, V7, P783, DOI 10.1007/BF03401969; Takeuchi M, 2000, MOL MED, V6, P114, DOI 10.1007/BF03401779; Takeuchi Masayoshi, 2001, Current Molecular Medicine (Hilversum), V1, P305, DOI 10.2174/1566524013363735; Takeuchi M, 2010, CURR DRUG TARGETS, V11, P1468, DOI 10.2174/1389450111009011468; Takeuchi M, 2010, LAB INVEST, V90, P1117, DOI 10.1038/labinvest.2010.62; Takeuchi M, 2009, J ALZHEIMERS DIS, V16, P845, DOI 10.3233/JAD-2009-0974; Tsunosue M, 2010, CLIN EXP MED, V10, P139, DOI 10.1007/s10238-009-0074-9; Ueda S, 2006, MOL MED, V12, P180, DOI 10.2119/2005-00034.Ueda; Ueda S, 2012, CARDIOVASC THER, V30, P249, DOI 10.1111/j.1755-5922.2011.00264.x; Uribarri J, 2007, J GERONTOL A-BIOL, V62, P427, DOI 10.1093/gerona/62.4.427; Uribarri J, 2010, J AM DIET ASSOC, V110, P911, DOI 10.1016/j.jada.2010.03.018; VLASSARA H, 1994, LAB INVEST, V70, P138; Vlassara H, 2011, NAT REV ENDOCRINOL, V7, P526, DOI 10.1038/nrendo.2011.74; Yamagishi S, 2002, J BIOL CHEM, V277, P20309, DOI 10.1074/jbc.M202634200; Zhang QB, 2009, J PROTEOME RES, V8, P754, DOI 10.1021/pr800858h	38	45	45	2	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2015	10	3							e0118652	10.1371/journal.pone.0118652	http://dx.doi.org/10.1371/journal.pone.0118652			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9JF	25730321	Green Published, gold, Green Submitted			2022-12-27	WOS:000350684900023
J	Chen, LS; Zhai, LH; Li, YC; Li, N; Zhang, CP; Ping, LY; Chang, L; Wu, JZ; Li, XP; Shi, DS; Xu, P				Chen, Lingsheng; Zhai, Linhui; Li, Yanchang; Li, Ning; Zhang, Chengpu; Ping, Lingyan; Chang, Lei; Wu, Junzhu; Li, Xiangping; Shi, Deshun; Xu, Ping			Development of Gel-Filter Method for High Enrichment of Low-Molecular Weight Proteins from Serum	PLOS ONE			English	Article							QUANTITATIVE PROTEOMICS REVEALS; MASS-SPECTROMETRY; HUMAN PLASMA; IDENTIFICATION; BIOMARKERS; PEPTIDE; ULTRAFILTRATION; DISCOVERY; LEPTIN; FRACTIONATION	The human serum proteome has been extensively screened for biomarkers. However, the large dynamic range of protein concentrations in serum and the presence of highly abundant and large molecular weight proteins, make identification and detection changes in the amount of low-molecular weight proteins (LMW, molecular weight <= 30kDa) difficult. Here, we developed a gel-filter method including four layers of different concentration of tricine SDS-PAGE-based gels to block high-molecular weight proteins and enrich LMW proteins. By utilizing this method, we identified 1,576 proteins (n = 2) from 10 mu L serum. Among them, 559 (n = 2) proteins belonged to LMW proteins. Furthermore, this gel-filter method could identify 67.4% and 39.8% more LMW proteins than that in representative methods of glycine SDS-PAGE and optimized-DS, respectively. By utilizing SILAC-AQUA approach with labeled recombinant protein as internal standard, the recovery rate for GST spiked in serum during the treatment of gel-filter, optimized-DS, and ProteoMiner was 33.1 +/- 0.01%, 18.7 +/- 0.01% and 9.6 +/- 0.03%, respectively. These results demonstrate that the gel-filter method offers a rapid, highly reproducible and efficient approach for screening biomarkers from serum through proteomic analyses.	[Chen, Lingsheng; Zhai, Linhui; Li, Yanchang; Li, Ning; Zhang, Chengpu; Ping, Lingyan; Chang, Lei; Xu, Ping] Beijing Proteome Res Ctr, Beijing Inst Radiat Med, Natl Engn Res Ctr Prot Drugs, Natl Ctr Prot Sci,State Key Lab Prote, Beijing 102206, Peoples R China; [Chen, Lingsheng; Li, Xiangping; Shi, Deshun] Guangxi Univ, State Key Lab Conservat & Utilizat Subtrop Agrobi, Nanning 530005, Peoples R China; [Wu, Junzhu] Wuhan Univ, Sch Med, Dept Biochem, Wuhan 430071, Peoples R China; [Xu, Ping] Wuhan Univ, Key Lab Combinatorial Biosynth & Drug Discovery, Minist Educ, Wuhan 430071, Peoples R China; [Xu, Ping] Wuhan Univ, Sch Pharmaceut Sci, Wuhan 430071, Peoples R China	Academy of Military Medical Sciences - China; Guangxi University; Wuhan University; Wuhan University; Wuhan University	Shi, DS (corresponding author), Guangxi Univ, State Key Lab Conservat & Utilizat Subtrop Agrobi, Nanning 530005, Peoples R China.	adrsshi@gxu.edu.cn; xupingghy@gmail.com			Chinese National Basic Research Programs [2011CB910600, 2013CB911201]; National Natural Science Foundation of China [31070673, 31170780]; National High-Tech Research and Development Program of China [SS2012AA020502, 2011AA02A114]; National Megaprojects for Key Infectious Diseases [2013zx10003002]; Key Projects in the National Science & Technology Pillar Program [2012BAF14B00]; National Natural Science Foundation of Beijing [5112012]; National Natural Science Foundation of Guangxi [2012GXNSFCB53002]	Chinese National Basic Research Programs(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National High-Tech Research and Development Program of China(National High Technology Research and Development Program of China); National Megaprojects for Key Infectious Diseases; Key Projects in the National Science & Technology Pillar Program; National Natural Science Foundation of Beijing(Beijing Natural Science Foundation); National Natural Science Foundation of Guangxi(National Natural Science Foundation of Guangxi Province)	This work was supported by: 1. Chinese National Basic Research Programs, Grant No. 2011CB910600 & 2013CB911201, http://www.973.gov.cn/English/Index.aspx. 2. National Natural Science Foundation of China, Grant No. 31070673 & 31170780, http://www.nsfc.gov.cn/publish/portal1/. 3. National High-Tech Research and Development Program of China, Grant No. SS2012AA020502 & 2011AA02A114, http://www.most.gov.cn/eng/programmes1/200610/t20061009_36225.htm, 4. National Megaprojects for Key Infectious Diseases, Grant No. 2013zx10003002, http://www.most.gov.cn/eng/programmes1/200610/t20061008_36198.htm. 5. Key Projects in the National Science & Technology Pillar Program, Grant No. 2012BAF14B00, http://www.most.gov.cn/eng/programmes1/200610/t20061009_36224.htm. 6. National Natural Science Foundation of Beijing, Grant No. 5112012, http://www.bjnsf.org/. 7. National Natural Science Foundation of Guangxi, Grant No. 2012GXNSFCB53002, http://gxnsf.gxsti.net/stms/login.jsp.	Adkins JN, 2002, MOL CELL PROTEOMICS, V1, P947, DOI 10.1074/mcp.M200066-MCP200; Anderson NL, 2002, MOL CELL PROTEOMICS, V1, P845, DOI 10.1074/mcp.R200007-MCP200; Barash IA, 1996, ENDOCRINOLOGY, V137, P3144, DOI 10.1210/en.137.7.3144; Bjorhall K, 2005, PROTEOMICS, V5, P307, DOI 10.1002/pmic.200400900; Capriotti AL, 2012, ANAL CHIM ACTA; Carrette O, 2003, PROTEOMICS, V3, P1486, DOI 10.1002/pmic.200300470; Castagna A, 2005, J PROTEOME RES, V4, P1917, DOI 10.1021/pr050153r; Chertov O, 2004, PROTEOMICS, V4, P1195, DOI 10.1002/pmic.200300677; De Bock M, 2010, TALANTA, V82, P245, DOI 10.1016/j.talanta.2010.04.029; De Luis DA, 2009, MINERVA MED, V100, P229; Drake RR, 2007, PROTEOM CLIN APPL, V1, P758, DOI 10.1002/prca.200700175; Elias JE, 2007, NAT METHODS, V4, P207, DOI 10.1038/nmeth1019; Farrah T, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.006353; Geiger T, 2011, NAT PROTOC, V6, P147, DOI 10.1038/nprot.2010.192; Georgiou HM, 2001, PROTEOMICS, V1, P1503, DOI 10.1002/1615-9861(200111)1:12<1503::AID-PROT1503>3.0.CO;2-M; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; Guerrier L, 2008, NAT PROTOC, V3, P883, DOI 10.1038/nprot.2008.59; Guerrier L, 2007, J PROTEOME RES, V6, P4290, DOI 10.1021/pr0703371; Harper RG, 2004, ELECTROPHORESIS, V25, P1299, DOI 10.1002/elps.200405864; Hu S, 2006, PROTEOMICS, V6, P6326, DOI 10.1002/pmic.200600284; Kawashima Y, 2010, J PROTEOME RES, V9, P1694, DOI 10.1021/pr9008018; Kay R, 2008, RAPID COMMUN MASS SP, V22, P3255, DOI 10.1002/rcm.3729; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Li DQ, 2005, BIOINFORMATICS, V21, P3049, DOI 10.1093/bioinformatics/bti439; Mantzoros CS, 1999, ANN INTERN MED, V130, P671, DOI 10.7326/0003-4819-130-8-199904200-00014; Meng R, 2011, J PROTEOMICS, V75, P366, DOI 10.1016/j.jprot.2011.07.030; Millioni R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019603; Moran O, 2003, Pediatr Diabetes, V4, P101, DOI 10.1034/j.1399-5448.2003.00017.x; Motoyama A, 2006, ANAL CHEM, V78, P5109, DOI 10.1021/ac060354u; Pedrioli PGA, 2004, NAT BIOTECHNOL, V22, P1459, DOI 10.1038/nbt1031; Peng JM, 2004, J BIOL CHEM, V279, P21003, DOI 10.1074/jbc.M400103200; Petricoin E, 2003, CLIN CHEM, V49, P1276, DOI 10.1373/49.8.1276; Phillips CM, 2011, J PROTEOME RES, V10, P4177, DOI 10.1021/pr200329b; Pieper R, 2003, PROTEOMICS, V3, P1345, DOI 10.1002/pmic.200300449; Ping LY, 2013, J PROTEOME RES, V12, P5978, DOI 10.1021/pr400775w; Rappsilber J, 2007, NAT PROTOC, V2, P1896, DOI 10.1038/nprot.2007.261; Schagger H, 2006, NAT PROTOC, V1, P16, DOI 10.1038/nprot.2006.4; Sennels L, 2007, J PROTEOME RES, V6, P4055, DOI 10.1021/pr070339l; Shevchenko A, 1996, P NATL ACAD SCI USA, V93, P14440, DOI 10.1073/pnas.93.25.14440; Shi TJ, 2012, METHODS, V56, P246, DOI 10.1016/j.ymeth.2011.09.001; Steppan CM, 2001, NATURE, V409, P307, DOI 10.1038/35053000; Terracciano R, 2006, PROTEOMICS, V6, P3243, DOI 10.1002/pmic.200500614; Tirumalai RS, 2003, MOL CELL PROTEOMICS, V2, P1096, DOI 10.1074/mcp.M300031-MCP200; Washburn MP, 2001, NAT BIOTECHNOL, V19, P242, DOI 10.1038/85686; Xu P, 2009, J PROTEOME RES, V8, P3944, DOI 10.1021/pr900251d; Xu P, 2009, CELL, V137, P133, DOI 10.1016/j.cell.2009.01.041; Zhai LH, 2013, PROTEOMICS, V13, P2229, DOI 10.1002/pmic.201200591; Zheng XY, 2006, J CHROMATOGR A, V1120, P173, DOI 10.1016/j.chroma.2006.01.098; Zhou M, 2004, ELECTROPHORESIS, V25, P1289, DOI 10.1002/elps.200405866	49	13	15	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2015	10	2							e0115862	10.1371/journal.pone.0115862	http://dx.doi.org/10.1371/journal.pone.0115862			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC3LS	25723528	gold, Green Submitted, Green Published			2022-12-27	WOS:000350251200011
J	de Groot, JHB; Smeets, MAM; Semin, GR				de Groot, Jasper H. B.; Smeets, Monique A. M.; Semin, Gun R.			Rapid Stress System Drives Chemical Transfer of Fear from Sender to Receiver	PLOS ONE			English	Article							FACIAL EXPRESSIONS; ASPERGER-SYNDROME; ODOR; CHEMOSIGNALS; ANXIETY; COMMUNICATION; RECOGNITION; PERFORMANCE; AMYGDALA; SIGNALS	Humans can register another person's fear not only with their eyes and ears, but also with their nose. Previous research has demonstrated that exposure to body odors from fearful individuals elicited implicit fear in others. The odor of fearful individuals appears to have a distinctive signature that can be produced relatively rapidly, driven by a physiological mechanism that has remained unexplored in earlier research. The apocrine sweat glands in the armpit that are responsible for chemosignal production contain receptors for adrenalin. We therefore expected that the release of adrenalin through activation of the rapid stress response system (i.e., the sympathetic-adrenal medullary system) is what drives the release of fear sweat, as opposed to activation of the slower stress response system (i.e., hypothalamus-pituitary-adrenal axis). To test this assumption, sweat was sampled while eight participants prepared for a speech. Participants had higher heart rates and produced more armpit sweat in the fast stress condition, compared to baseline and the slow stress condition. Importantly, exposure to sweat from participants in the fast stress condition induced in receivers (N = 31) a simulacrum of the state of the sender, evidenced by the emergence of a fearful facial expression (facial electromyography) and vigilant behavior (i.e., faster classification of emotional facial expressions).	[de Groot, Jasper H. B.; Smeets, Monique A. M.; Semin, Gun R.] Univ Utrecht, Dept Social & Org Psychol, Fac Social & Behav Sci, Utrecht, Netherlands; [Semin, Gun R.] Koc Univ, Dept Psychol, Istanbul, Turkey; [Semin, Gun R.] Inst Univ, ISPA, Lisbon, Portugal	Utrecht University; Koc University; Instituto Superior Psicologia Aplicada (ISPA); Instituto Universitario de Lisboa	de Groot, JHB (corresponding author), Univ Utrecht, Dept Social & Org Psychol, Fac Social & Behav Sci, Utrecht, Netherlands.	j.h.b.degroot@uu.nl	Semin, Gun/J-4046-2013	Semin, Gun/0000-0002-5304-5566	Netherlands Organization for Scientific Research award [406-11-078/MaGW]	Netherlands Organization for Scientific Research award(Netherlands Organization for Scientific Research (NWO))	This research was supported by a Research Talent grant (406-11-078/MaGW) from the Netherlands Organization for Scientific Research (http://www.nwo.nl/en) awarded to JHBG, GRS, and MAMS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackerl K, 2002, NEUROENDOCRINOL LETT, V23, P79; Adolph D, 2013, FRONT HUM NEUROSCI, V7, DOI [10.3389/fnhum.2013.00425, 10.3389/fnhum.2013.00283]; Adolphs R, 2005, NATURE, V433, P68, DOI 10.1038/nature03086; Albrecht J, 2011, CHEM SENSES, V36, P19, DOI 10.1093/chemse/bjq087; Bargh J. A., 2000, HDB RES METHODS SOCI, P253; Baron-Cohen S, 2001, J CHILD PSYCHOL PSYC, V42, P241, DOI 10.1017/S0021963001006643; Baron-Cohen S, 2004, J AUTISM DEV DISORD, V34, P163, DOI 10.1023/B:JADD.0000022607.19833.00; Barrett LF, 2009, PERSPECT PSYCHOL SCI, V4, P326, DOI 10.1111/j.1745-6924.2009.01134.x; Barsalou LW, 2009, PHILOS T R SOC B, V364, P1281, DOI 10.1098/rstb.2008.0319; Biehle-Hulette SJ, 2014, INT J COSMETIC SCI, V36, P102, DOI 10.1111/ics.12103; Bushdid C, 2014, SCIENCE, V343, P1370, DOI 10.1126/science.1249168; CACIOPPO JT, 1990, AM PSYCHOL, V45, P16, DOI 10.1037/0003-066X.45.1.16; Cannon W. B., 1932, THE WISDOM OF THE BO; Chen D, 2000, PERCEPT MOTOR SKILL, V91, P771, DOI 10.2466/pms.2000.91.3.771; Chen D, 2006, CHEM SENSES, V31, P415, DOI 10.1093/chemse/bjj046; Cohen J., 1988, STAT POWER ANAL BEHA, p[281, 284, 285]; Dalton P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077144; de Groot JHB, 2014, J EXP PSYCHOL GEN, V143, P1515, DOI 10.1037/a0035950; de Groot JHB, 2014, J EXP PSYCHOL GEN, V143, P825, DOI 10.1037/a0033731; de Groot JHB, 2012, PSYCHOL SCI, V23, P1417, DOI 10.1177/0956797612445317; Delplanque S, 2009, EMOTION, V9, P316, DOI 10.1037/a0015369; Dimberg U, 2000, PSYCHOPHYSIOLOGY, V37, P693, DOI 10.1111/1469-8986.3750693; Dolan RJ, 2001, P NATL ACAD SCI USA, V98, P10006, DOI 10.1073/pnas.171288598; Doty RL, 2010, THE GREAT PHEROMONE, P1; Du SC, 2014, P NATL ACAD SCI USA, V111, pE1454, DOI 10.1073/pnas.1322355111; Ekman P., 2003, EMOTIONS REVEALED, V2; Estes WK, 1997, PSYCHON B REV, V4, P330, DOI 10.3758/BF03210790; Eysenck H. J., 1991, MANUAL OF THE EYSENC; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Field A, 2009, DISCOVERING STAT USI, V153; FRIDLUND AJ, 1986, PSYCHOPHYSIOLOGY, V23, P567, DOI 10.1111/j.1469-8986.1986.tb00676.x; GROSS JJ, 1995, COGNITION EMOTION, V9, P87, DOI 10.1080/02699939508408966; Haegler K, 2010, NEUROPSYCHOLOGIA, V48, P3901, DOI 10.1016/j.neuropsychologia.2010.09.019; Harker M, 2013, SKIN PHARMACOL PHYS, V26, P92, DOI 10.1159/000346930; Hess U, 2013, PERS SOC PSYCHOL REV, V17, P142, DOI 10.1177/1088868312472607; Hummel T, 1997, CHEM SENSES, V22, P39, DOI 10.1093/chemse/22.1.39; Jacob S, 2001, PHYSIOL BEHAV, V74, P15, DOI 10.1016/S0031-9384(01)00537-6; Jones F., 2001, STRESS MYTH THEORY R; KIRSCHBAUM C, 1993, NEUROPSYCHOBIOLOGY, V28, P76, DOI 10.1159/000119004; Kirschbaum C., 2000, ENCY STRESS, V3, P379, DOI DOI 10.1159/000118611; Langner O, 2010, COGNITION EMOTION, V24, P1377, DOI 10.1080/02699930903485076; LeDoux J, 2003, CELL MOL NEUROBIOL, V23, P727, DOI 10.1023/A:1025048802629; Lenochova P, 2009, CHEM SENSES, V34, P127, DOI 10.1093/chemse/bjn067; Leppanen JM, 2003, EMOTION, V3, P315, DOI 10.1037/1528-3542.3.4.315; Leys C, 2013, J EXP SOC PSYCHOL, V49, P764, DOI 10.1016/j.jesp.2013.03.013; Lindquist KA, 2012, BEHAV BRAIN SCI, V35, P121, DOI 10.1017/S0140525X11000446; Lindsay SL, 2008, BRIT J DERMATOL, V159, P653, DOI 10.1111/j.1365-2133.2008.08740.x; LOFTUS GR, 1994, PSYCHON B REV, V1, P476, DOI 10.3758/BF03210951; Lorig TS, 1999, NEUROSCI BIOBEHAV R, V23, P391, DOI 10.1016/S0149-7634(98)00041-4; Martin A, 2011, INT J COSMETIC SCI, V33, P90, DOI 10.1111/j.1468-2494.2010.00596.x; McEwen BS, 2000, BRAIN RES, V886, P172, DOI 10.1016/S0006-8993(00)02950-4; Molina PE, 2006, ENDOCRINE PHYSIOLOGY; Mujica-Parodi LR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006415; Nater UM, 2009, PSYCHONEUROENDOCRINO, V34, P486, DOI 10.1016/j.psyneuen.2009.01.014; Natsch A, 2006, CHEM BIODIVERS, V3, P1, DOI 10.1002/cbdv.200690015; Olsson MJ, 2014, PSYCHOL SCI, V25, P817, DOI 10.1177/0956797613515681; Pause BM, 2012, CHEMOSENS PERCEPT, V5, P55, DOI 10.1007/s12078-011-9108-2; Pause BM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010342; Pause BM, 2009, INT J PSYCHOPHYSIOL, V74, P88, DOI 10.1016/j.ijpsycho.2009.07.008; Pause BM, 2004, CHEM SENSES, V29, P797, DOI 10.1093/chemse/bjh245; Penn DJ, 2007, J R SOC INTERFACE, V4, P331, DOI 10.1098/rsif.2006.0182; Prehn A, 2006, NEUROSCI LETT, V394, P127, DOI 10.1016/j.neulet.2005.10.012; Prehn-Kristensen A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005987; Radulescu AR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068485; Rubin D, 2012, SOC COGN AFFECT NEUR, V7, P208, DOI 10.1093/scan/nsq097; Sander D, 2003, REV NEUROSCIENCE, V14, P303, DOI 10.1515/REVNEURO.2003.14.4.303; Sanderman R, 1995, HET METEN VAN DE PER; Schmidt-Rose T, 2013, INT J COSMETIC SCI, V35, P622, DOI 10.1111/ics.12086; Sela L, 2010, EXP BRAIN RES, V205, P13, DOI 10.1007/s00221-010-2348-6; Semin GR, 2013, TRENDS COGN SCI, V17, P427, DOI 10.1016/j.tics.2013.05.008; Stevenson RJ, 2010, CHEM SENSES, V35, P3, DOI 10.1093/chemse/bjp083; Susskind JM, 2008, NAT NEUROSCI, V11, P843, DOI 10.1038/nn.2138; Ulrich-Lai YM, 2009, NAT REV NEUROSCI, V10, P397, DOI 10.1038/nrn2647; Van Hout D, 2011, J SENS STUD, V26, P311, DOI 10.1111/j.1745-459X.2011.00346.x; Van Strien, 1992, NEDERLANDS TIJDSCHRI, V47, P88; VINING RF, 1987, J STEROID BIOCHEM, V27, P81, DOI 10.1016/0022-4731(87)90297-4; Wilson D.A., 2006, LEARNING SMELL OLFAC; Wilson-Mendenhall CD, 2013, PSYCHOL SCI, V24, P947, DOI 10.1177/0956797612464242; Wintermann GB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074655; Wolfensberger M, 2000, ACTA OTO-LARYNGOL, V120, P303, DOI 10.1080/000164800750001134; Wysocki CJ, 2009, FLAVOUR FRAG J, V24, P209, DOI 10.1002/ffj.1927; Wysocki CJ, 2004, ANAT REC PART A, V281A, P1201, DOI 10.1002/ar.a.20125; ZENG XN, 1992, J CHEM ECOL, V18, P1039, DOI 10.1007/BF00980061; Zernecke R, 2011, J PSYCHOPHYSIOL, V25, P116, DOI 10.1027/0269-8803/a000047; Zhou W, 2011, SOC NEUROSCI-UK, V6, P270, DOI 10.1080/17470919.2010.523537; Zhou W, 2009, PSYCHOL SCI, V20, P177, DOI 10.1111/j.1467-9280.2009.02263.x	86	14	14	2	114	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2015	10	2							e0118211	10.1371/journal.pone.0118211	http://dx.doi.org/10.1371/journal.pone.0118211			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC3LS	25723720	Green Published, gold			2022-12-27	WOS:000350251200049
J	Leiszter, K; Sipos, F; Galamb, O; Krenacs, T; Veres, G; Wichmann, B; Furi, I; Kalmar, A; Patai, AV; Toth, K; Valcz, G; Tulassay, Z; Molnar, B				Leiszter, Katalin; Sipos, Ferenc; Galamb, Orsolya; Krenacs, Tibor; Veres, Gabor; Wichmann, Barna; Fueri, Istvan; Kalmar, Alexandra; Patai, Arpad V.; Toth, Kinga; Valcz, Gabor; Tulassay, Zsolt; Molnar, Bela			Promoter Hypermethylation-Related Reduced Somatostatin Production Promotes Uncontrolled Cell Proliferation in Colorectal Cancer	PLOS ONE			English	Article							COLON-CANCER; NEUROENDOCRINE TUMORS; GENE-EXPRESSION; GASTRIC-CANCER; PHASE-II; RECEPTORS; ANALOG; OCTREOTIDE; DIAGNOSIS; GROWTH	Background Somatostatin (SST) has anti-proliferative and pro-apoptotic effects. Our aims were to analyze and compare the SST expression during normal aging and colorectal carcinogenesis at mRNA and protein levels. Furthermore, we tested the methylation status of SST in biopsy samples, and the cell growth inhibitory effect of the SST analogue octreotide in human colorectal adenocarcinoma cell line. Methods Colonic samples were collected from healthy children (n1 = 6), healthy adults (n2 = 41) and colorectal cancer patients (CRCs) (n(3) = 34) for SST mRNA expression analysis, using HGU133 Plus2.0 microarrays. Results were validated both on original (n(1) = 6; n(2) = 6; n(3) = 6) and independent samples ((n(1) = 6; n(2) = 6; n(3) = 6) by real-time PCR. SST expressing cells were detected by immunohistochemistry on colonic biopsy samples (n(1) = 14; n(2) = 20; n(3) = 23). The effect of octreotide on cell growth was tested on Caco-2 cell line. SST methylation percentage in biopsy samples (n(1) = 5; n(2) = 5; n(3) = 9) was defined using methylation-sensitive restriction enzyme digestion. Results In case of normal aging SST mRNA expression did not alter, but decreased in cancer (p<0.05). The ratio of SST immunoreactive cells was significantly higher in children (0.70%+/- 0.79%) compared to CRC (0%+/- 0%) (p<0.05). Octreotide significantly increased the proportion of apoptotic Caco-2 cells. SST showed significantly higher methylation level in tumor samples (30.2%+/- 11.6%) compared to healthy young individuals (3.5%+/- 1.9%) (p<0.05). Conclusions In cancerous colonic mucosa the reduced SST production may contribute to the uncontrolled cell proliferation. Our observation that in colon cancer cells octreotide significantly enhanced cell death and attenuated cell proliferation suggests that SST may act as a regulator of epithelial cell kinetics. The inhibition of SST expression in CRC can be epigenetically regulated by promoter hypermethylation.	[Leiszter, Katalin; Sipos, Ferenc; Kalmar, Alexandra; Patai, Arpad V.; Toth, Kinga; Tulassay, Zsolt] Semmelweis Univ, Dept Internal Med 2, H-1085 Budapest, Hungary; [Galamb, Orsolya; Wichmann, Barna; Fueri, Istvan; Valcz, Gabor; Tulassay, Zsolt; Molnar, Bela] Hungarian Acad Sci, Mol Med Res Unit, Budapest, Hungary; [Krenacs, Tibor] Semmelweis Univ, Dept Pathol & Expt Canc Res 1, H-1085 Budapest, Hungary; [Veres, Gabor] Semmelweis Univ, Dept Pediat 1, H-1085 Budapest, Hungary	Semmelweis University; Hungarian Academy of Sciences; Semmelweis University; Semmelweis University	Leiszter, K (corresponding author), Semmelweis Univ, Dept Internal Med 2, H-1085 Budapest, Hungary.	leiszterkata@gmail.com	Sipos, Ferenc/GYV-6182-2022					Adelstein BA, 2011, BMC GASTROENTEROL, V11, DOI 10.1186/1471-230X-11-97; Barnett P, 2003, ENDOCRINE, V20, P255, DOI 10.1385/ENDO:20:3:255; Becker G, 2007, HEPATOLOGY, V45, P9, DOI 10.1002/hep.21468; Benali N, 2000, DIGESTION, V62, P27, DOI 10.1159/000051852; Bontenbal M, 1998, BRIT J CANCER, V77, P115, DOI 10.1038/bjc.1998.18; Bousquet C, 2004, DIGEST LIVER DIS, V36, pS2, DOI 10.1016/j.dld.2003.11.007; Brenner H, 2013, LANCET; Buscail L, 1996, CANCER RES, V56, P1823; CASCINU S, 1995, BRIT J CANCER, V71, P97, DOI 10.1038/bjc.1995.19; Cascinu S, 2001, CHEMOTHERAPY, V47, P127, DOI 10.1159/000049165; Cervia D, 2007, PHARMACOL THERAPEUT, V116, P322, DOI 10.1016/j.pharmthera.2007.06.010; Colucci R, 2008, BRIT J PHARMACOL, V155, P198, DOI 10.1038/bjp.2008.268; Dalm VASH, 2008, MOL CELL ENDOCRINOL, V286, P262, DOI 10.1016/j.mce.2007.09.005; Dasgupta P, 2004, PHARMACOL THERAPEUT, V102, P61, DOI 10.1016/j.pharmthera.2004.02.002; den Bosch JV, 2009, REGUL PEPTIDES, V156, P1, DOI 10.1016/j.regpep.2009.04.003; Dimitroulopoulos D, 2002, HEPATO-GASTROENTEROL, V49, P1245; DY DY, 1992, CANCER RES, V52, P917; Ferjoux G, 2000, J PHYSIOLOGY-PARIS, V94, P205, DOI 10.1016/S0928-4257(00)00206-0; Ferone D, 2004, DIGEST LIVER DIS, V36, pS68, DOI 10.1016/j.dld.2003.11.020; FERRI GL, 1983, GASTROENTEROLOGY, V84, P777; Galamb O, 2010, BRIT J CANCER, V102, P765, DOI 10.1038/sj.bjc.6605515; Galamb O, 2008, CANCER EPIDEM BIOMAR, V17, P2835, DOI 10.1158/1055-9965.EPI-08-0231; Galamb O, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048547; Goel A, 2012, GASTROENTEROLOGY, V143, P1442, DOI 10.1053/j.gastro.2012.09.032; GOLDBERG RM, 1995, CANCER, V76, P961, DOI 10.1002/1097-0142(19950915)76:6<961::AID-CNCR2820760608>3.0.CO;2-A; Grimberg A, 2004, CANCER BIOL THER, V3, P731, DOI 10.4161/cbt.3.8.1030; Grozinsky-Glasberg S, 2008, MOL CELL ENDOCRINOL, V286, P238, DOI 10.1016/j.mce.2007.10.006; Guillermet-Guibert J, 2005, BEST PRACT RES CL GA, V19, P535, DOI 10.1016/j.bpg.2005.03.007; Herszenyi L, 2013, ORVOSI HETILAP, V154, P1535, DOI 10.1556/OH.2013.29721; Jackson K, 2011, DIGEST DIS SCI, V56, P125, DOI 10.1007/s10620-010-1422-z; Jin Z, 2008, CANCER-AM CANCER SOC, V112, P43, DOI 10.1002/cncr.23135; Keller G, 2005, INT J CANCER, V114, P831, DOI 10.1002/ijc.20806; KLIJN JGM, 1990, BRIT J CANCER, V62, P627, DOI 10.1038/bjc.1990.343; Kouroumalis E, 1998, GUT, V42, P442, DOI 10.1136/gut.42.3.442; Kwekkeboom DJ, 1998, EUR J NUCL MED, V25, P1284, DOI 10.1007/s002590050297; Lahlou H, 2004, ANN NY ACAD SCI, V1014, P121, DOI 10.1196/annals.1294.012; Lamberts SWJ, 2002, TRENDS ENDOCRIN MET, V13, P451, DOI 10.1016/S1043-2760(02)00667-7; Leiszter K, 2010, MAGYAR BELORVOSI ARC, V63, P19; Leiszter K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074140; Leiszter Katalin, 2010, Orvosi Hetilap, V151, P885, DOI 10.1556/OH.2010.28882; Low MJ, 2004, BEST PRACT RES CL EN, V18, P607, DOI 10.1016/j.beem.2004.08.005; Mercadante Sebastiano, 1993, Palliative Medicine, V7, P295; MILLER GV, 1992, BRIT J CANCER, V66, P391, DOI 10.1038/bjc.1992.275; Moller LN, 2003, BBA-BIOMEMBRANES, V1616, P1, DOI 10.1016/S0005-2736(03)00235-9; Mori Y, 2006, GASTROENTEROLOGY, V131, P797, DOI 10.1053/j.gastro.2006.06.006; Oberg KE, 2012, CLIN ONCOL-UK, V24, P282, DOI 10.1016/j.clon.2011.08.006; PARSONS JA, 1976, J HISTOCHEM CYTOCHEM, V24, P872, DOI 10.1177/24.7.60436; Patai AV, 2012, DIGEST DIS, V30, P310, DOI 10.1159/000337004; Patel YC, 1999, FRONT NEUROENDOCRIN, V20, P157, DOI 10.1006/frne.1999.0183; Pinter E, 2006, PHARMACOL THERAPEUT, V112, P440, DOI 10.1016/j.pharmthera.2006.04.010; Pyronnet S, 2008, MOL CELL ENDOCRINOL, V286, P230, DOI 10.1016/j.mce.2008.02.002; REUBI JC, 1992, INT J CANCER, V50, P895, DOI 10.1002/ijc.2910500613; Reubi JC, 2001, EUR J NUCL MED, V28, P836, DOI 10.1007/s002590100541; ROSENBERG L, 1995, CANCER, V75, P23, DOI 10.1002/1097-0142(19950101)75:1<23::AID-CNCR2820750106>3.0.CO;2-A; SAVAGE A P, 1987, Alimentary Pharmacology and Therapeutics, V1, P133; Scarpignato C, 2001, CHEMOTHERAPY, V47, P1, DOI 10.1159/000049157; Shi XF, 2013, ONCOL LETT, V6, P1794, DOI 10.3892/ol.2013.1614; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Sipos F, 2011, WORLD J GASTROENTERO, V17, P2981, DOI 10.3748/wjg.v17.i25.2981; Theodoropoulou M, 2013, FRONT NEUROENDOCRIN, V34, P228, DOI 10.1016/j.yfrne.2013.07.005; Thomas RP, 2003, ENDOCR REV, V24, P571, DOI 10.1210/er.2002-0028; Vainas G, 1997, J EXP CLIN CANC RES, V16, P119; VANHAGEN PM, 1994, ARTHRITIS RHEUM, V37, P1521, DOI 10.1002/art.1780371017; VANHAGEN PM, 1994, EUR J NUCL MED, V21, P497; Vekemans Marie-Christiane, 1995, Current Opinion in Oncology, V7, P63; WEBER C, 1989, SURGERY, V106, P416; WECKBECKER G, 1993, PHARMACOL THERAPEUT, V60, P245, DOI 10.1016/0163-7258(93)90009-3; WITZIG TE, 1995, J CLIN ONCOL, V13, P2012, DOI 10.1200/JCO.1995.13.8.2012	68	18	18	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2015	10	2							e0118332	10.1371/journal.pone.0118332	http://dx.doi.org/10.1371/journal.pone.0118332			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC3LS	25723531	Green Published, Green Submitted, gold			2022-12-27	WOS:000350251200055
J	Mori, GM; Zucchi, MI; Souza, AP				Mori, Gustavo M.; Zucchi, Maria I.; Souza, Anete P.			Multiple-Geographic-Scale Genetic Structure of Two Mangrove Tree Species: The Roles of Mating System, Hybridization, Limited Dispersal and Extrinsic Factors	PLOS ONE			English	Article							AVICENNIA-MARINA; POPULATION-STRUCTURE; HIBISCUS-TILIACEUS; PANTROPICAL PLANT; BLACK MANGROVE; DIVERSITY; SOFTWARE; PATTERNS; RHIZOPHORACEAE; INFERENCE	Mangrove plants comprise a unique group of organisms that grow within the intertidal zones of tropical and subtropical regions and whose distributions are influenced by both biotic and abiotic factors. To understand how these extrinsic and intrinsic processes influence a more fundamental level of the biological hierarchy of mangroves, we studied the genetic diversity of two Neotropical mangrove trees, Avicenniagerminans and A. schaueriana, using microsatellites markers. As reported for other sea-dispersed species, there was a strong differentiation between A. germinans and A. schaueriana populations sampled north and south of the northeastern extremity of South America, likely due to the influence of marine superficial currents. Moreover, we observed fine-scale genetic structures even when no obvious physical barriers were present, indicating pollen and propagule dispersal limitation, which could be explained by isolation-by-distance coupled with mating system differences. We report the first evidence of ongoing hybridization between Avicennia species and that these hybrids are fertile, although this interspecific crossing has not contributed to an increase in the genetic diversity the populations where A. germinans and A. schaueriana hybridize. These findings highlight the complex interplay between intrinsic and extrinsic factors that shape the distribution of the genetic diversity in these sea-dispersed colonizer species.	[Mori, Gustavo M.; Souza, Anete P.] Univ Estadual Campinas, Ctr Mol Biol & Genet Engn, Sao Paulo, Brazil; [Zucchi, Maria I.] Sao Paulo Agcy Agribusiness Technol, Sao Paulo, Brazil; [Souza, Anete P.] Univ Estadual Campinas, Inst Biol, Dept Plant Biol, Sao Paulo, Brazil	Universidade Estadual de Campinas; Universidade de Sao Paulo; Universidade Estadual de Campinas	Souza, AP (corresponding author), Univ Estadual Campinas, Ctr Mol Biol & Genet Engn, Sao Paulo, Brazil.	anete@unicamp.br	Mori, Gustavo Maruyama/D-5700-2013; Zucchi, Maria Imaculada/AAC-8157-2019; Zucchi, Maria Imaculada/D-2637-2012; DE SOUZA, ANETE PEREIRA/B-8663-2012	Mori, Gustavo Maruyama/0000-0003-2308-2224; Zucchi, Maria Imaculada/0000-0002-4863-1843; Zucchi, Maria Imaculada/0000-0002-4863-1843; DE SOUZA, ANETE PEREIRA/0000-0003-3831-9829	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2008/52045-0, 2010/50178-2, 2007/57021-9, 2010/50033-4]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	The authors gratefully acknowledge the Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) for financial support (2008/52045-0 and 2010/50178-2) and scholarships to GMM (2007/57021-9 and 2010/50033-4) and the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) for research fellowships to APS and MIZ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson EC, 2002, GENETICS, V160, P1217; Arnaud-Haond S, 2006, MOL ECOL, V15, P3515, DOI 10.1111/j.1365-294X.2006.02997.x; BURNS BR, 1985, AUST J ECOL, V10, P125, DOI 10.1111/j.1442-9993.1985.tb00874.x; Ceron-Souza I, 2006, MOL ECOL NOTES, V6, P692, DOI 10.1111/j.1471-8286.2006.01312.x; Ceron-Souza I, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-205; Ceron-Souza I, 2010, AM J BOT, V97, P945, DOI 10.3732/ajb.0900172; Chapuis MP, 2007, MOL BIOL EVOL, V24, P621, DOI 10.1093/molbev/msl191; Chessel D., 2004, R NEWS, V4, P5; Chiang TY, 2001, MOL ECOL, V10, P2697, DOI 10.1046/j.0962-1083.2001.01399.x; Clarke PJ, 2001, J ECOL, V89, P648, DOI 10.1046/j.0022-0477.2001.00584.x; CLARKE PJ, 1991, AUST J BOT, V39, P283, DOI 10.1071/BT9910283; DUKE N C, 1991, Australian Systematic Botany, V4, P299, DOI 10.1071/SB9910299; Duke NC, 1998, EVOLUTION, V52, P1612, DOI [10.1111/j.1558-5646.1998.tb02242.x, 10.2307/2411335]; Duke NC, 1998, GLOBAL ECOL BIOGEOGR, V7, P27, DOI 10.2307/2997695; Duke NC, 2002, TREES-STRUCT FUNCT, V16, P65, DOI 10.1007/s00468-001-0141-7; Ellison AM, 2002, TREES-STRUCT FUNCT, V16, P181, DOI 10.1007/s00468-001-0133-7; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Falush D, 2003, GENETICS, V164, P1567; FYFE JL, 1951, J AGR SCI, V41, P371, DOI 10.1017/S0021859600049558; Gao H, 2007, GENETICS, V176, P1635, DOI 10.1534/genetics.107.072371; Geng QF, 2008, MOL ECOL, V17, P4724, DOI 10.1111/j.1365-294X.2008.03948.x; Giri C, 2011, GLOBAL ECOL BIOGEOGR, V20, P154, DOI 10.1111/j.1466-8238.2010.00584.x; Goodwillie C, 2005, ANNU REV ECOL EVOL S, V36, P47, DOI 10.1146/annurev.ecolsys.36.091704.175539; Goudet J, 1995, J HERED, V86, P485, DOI 10.1093/oxfordjournals.jhered.a111627; Jakobsson M, 2007, BIOINFORMATICS, V23, P1801, DOI 10.1093/bioinformatics/btm233; Jombart T, 2010, BMC GENET, V11, DOI 10.1186/1471-2156-11-94; Jombart T, 2011, BIOINFORMATICS, V27, P3070, DOI 10.1093/bioinformatics/btr521; Jost L, 2008, MOL ECOL, V17, P4015, DOI 10.1111/j.1365-294X.2008.03887.x; KAPLAN NL, 1989, GENETICS, V123, P887; Keenan K, 2013, METHODS ECOL EVOL, V4, P782, DOI 10.1111/2041-210X.12067; Landry CL, 2013, ANN BOT-LONDON, V111, P207, DOI 10.1093/aob/mcs265; Liao PC, 2011, AUST J BOT, V59, P523, DOI 10.1071/BT10290; Lumpkin R, 2013, J GEOPHYS RES-OCEANS, V118, P2992, DOI 10.1002/jgrc.20210; Menezes Moirah Paula Machado de, 2008, Acta Amaz., V38, P403, DOI 10.1590/S0044-59672008000300004; Maguire TL, 2000, MOL ECOL, V9, P1853, DOI 10.1046/j.1365-294x.2000.01089.x; Mori GM, 2010, AM J BOT, V97, pE79, DOI 10.3732/ajb.1000219; Nadia TD, 2013, PLANT SPEC BIOL, V28, P70, DOI 10.1111/j.1442-1984.2011.00361.x; Nascimento WR, 2013, ESTUAR COAST SHELF S, V117, P83, DOI 10.1016/j.ecss.2012.10.005; Nathan R, 2006, SCIENCE, V313, P786, DOI 10.1126/science.1124975; NEI M, 1972, AM NAT, V106, P283, DOI 10.1086/282771; NEI M, 1973, P NATL ACAD SCI USA, V70, P3321, DOI 10.1073/pnas.70.12.3321; Nettel A, 2005, MOL ECOL NOTES, V5, P103, DOI 10.1111/j.1471-8286.2004.00851.x; Nettel A, 2008, MOL ECOL, V17, P2680, DOI 10.1111/j.1365-294X.2008.03766.x; Nettel A, 2007, EVOLUTION, V61, P958, DOI 10.1111/j.1558-5646.2007.00070.x; Nettel-Hernanz A, 2013, BOT SCI, V91, P115; Oksanen J., 2020, VEGAN COMMUNITY ECOL; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; Pil MW, 2011, AM J BOT, V98, P1031, DOI 10.3732/ajb.1000392; Pritchard JK, 2000, GENETICS, V155, P945; RITLAND K, 1981, HEREDITY, V47, P35, DOI 10.1038/hdy.1981.57; Ritland K, 2002, HEREDITY, V88, P221, DOI 10.1038/sj.hdy.6800029; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Sandoval-Castro E, 2012, AQUAT BOT, V99, P20, DOI 10.1016/j.aquabot.2012.01.002; Storfer A, 2010, MOL ECOL, V19, P3496, DOI 10.1111/j.1365-294X.2010.04691.x; Su GH, 2006, AQUAT BOT, V84, P341, DOI 10.1016/j.aquabot.2006.01.001; Sun M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019671; Takayama K, 2013, AM J BOT, V100, P1, DOI [10.3732/ajb.1200591, DOI 10.3732/AJB.1200591]; Takayama K, 2008, MOL ECOL, V17, P2730, DOI 10.1111/j.1365-294X.2008.03799.x; Takayama K, 2006, MOL ECOL, V15, P2871, DOI 10.1111/j.1365-294X.2006.02963.x; Tomlinson PB, 2016, BOTANY OF MANGROVES, 2ND EDITION, P315; Triest L, 2008, AQUAT BOT, V89, P138, DOI 10.1016/j.aquabot.2007.12.013; Vallejo-Marin M, 2004, EVOLUTION, V58, P1924, DOI 10.1111/j.0014-3820.2004.tb00480.x; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; Wee AKS, 2014, J BIOGEOGR, V41, P954, DOI 10.1111/jbi.12263; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; Zhang RS, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-74; Zhou RC, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-149	69	34	36	2	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2015	10	2							e0118710	10.1371/journal.pone.0118710	http://dx.doi.org/10.1371/journal.pone.0118710			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC3LS	25723532	Green Published, Green Submitted, gold			2022-12-27	WOS:000350251200062
J	Spielman, SE; Folch, DC				Spielman, Seth E.; Folch, David C.			Reducing Uncertainty in the American Community Survey through Data-Driven Regionalization	PLOS ONE			English	Article							PATTERNS; CENSUS; AREAS	The American Community Survey (ACS) is the largest survey of US households and is the principal source for neighborhood scale information about the US population and economy. The ACS is used to allocate billions in federal spending and is a critical input to social scientific research in the US. However, estimates from the ACS can be highly unreliable. For example, in over 72% of census tracts, the estimated number of children under 5 in poverty has a margin of error greater than the estimate. Uncertainty of this magnitude complicates the use of social data in policy making, research, and governance. This article presents a heuristic spatial optimization algorithm that is capable of reducing the margins of error in survey data via the creation of new composite geographies, a process called regionalization. Regionalization is a complex combinatorial problem. Here rather than focusing on the technical aspects of regionalization we demonstrate how to use a purpose built open source regionalization algorithm to process survey data in order to reduce the margins of error to a user-specified threshold.	[Spielman, Seth E.] Univ Colorado, Dept Geog, Boulder, CO 80309 USA; [Spielman, Seth E.] Univ Colorado, Inst Behav Sci, Boulder, CO 80309 USA; [Folch, David C.] Florida State Univ, Dept Geog, Tallahassee, FL 32306 USA	University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder; State University System of Florida; Florida State University	Spielman, SE (corresponding author), Univ Colorado, Dept Geog, Boulder, CO 80309 USA.	seth.spielman@colorado.edu	Spielman, Seth/AAZ-2453-2021; Folch, David/AAU-4770-2021	Spielman, Seth/0000-0002-5089-7632; Folch, David/0000-0002-8167-1118	National Science Foundation [113238, CNS-0821794]; University of Colorado Boulder; Direct For Social, Behav & Economic Scie [1132008] Funding Source: National Science Foundation; Directorate For Engineering [1333271, 1333190] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); University of Colorado Boulder; Direct For Social, Behav & Economic Scie(National Science Foundation (NSF)NSF - Directorate for Social, Behavioral & Economic Sciences (SBE)); Directorate For Engineering(National Science Foundation (NSF)NSF - Directorate for Engineering (ENG))	This work was supported by the National Science Foundation (award number 113238). This work utilized the Janus supercomputer, which is supported by the National Science Foundation (award number CNS-0821794) and the University of Colorado Boulder. The Janus supercomputer is a joint effort of the University of Colorado Boulder, the University of Colorado Denver and the National Center for Atmospheric Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albatineh AN, 2010, J STAT PLAN INFER, V140, P2828, DOI 10.1016/j.jspi.2010.03.005; Arbia G., 1989, SPATIAL DATA CONFIGU; Assuncao RM, 2005, DEMOGRAPHY, V42, P537, DOI 10.1353/dem.2005.0022; Citro CF, 2007, USING AM COMMUNITY S; Dietz RD, 2002, SOC SCI RES, V31, P539, DOI 10.1016/S0049-089X(02)00005-4; Duque JC, 2012, J REGIONAL SCI, V52, P397, DOI 10.1111/j.1467-9787.2011.00743.x; Folch D. C., 2014, WORKING PAPER; Folch DC, 2014, INT J GEOGR INF SCI, V28, P164, DOI 10.1080/13658816.2013.848986; Folch DC, 2014, UNCERTAIN U IN PRESS; Form WH, 1954, AM SOCIOL REV, V19, P434, DOI 10.2307/2087463; FOTHERINGHAM AS, 1991, ENVIRON PLANN A, V23, P1025, DOI 10.1068/a231025; GLOVER F, 1990, INTERFACES, V20, P74, DOI 10.1287/inte.20.4.74; Hunter A., 1974, SYMBOLIC COMMUNITIES; Kwan MP, 2012, ANN ASSOC AM GEOGR, V102, P958, DOI 10.1080/00045608.2012.687349; Lee BA, 2008, AM SOCIOL REV, V73, P766, DOI 10.1177/000312240807300504; Martin D, 2001, ENVIRON PLANN A, V33, P1949, DOI 10.1068/a3497; Montello D. R., 2003, FDN GEOGRAPHIC INFOR, P173, DOI DOI 10.1201/9780203009543.CH9; Navarro F, 2012, TECHNICAL REPORT; New York City Department of City Planning, 2014, NEW YORK CIT NEIGHB; Oakes JM, 2004, SOC SCI MED, V58, P1929, DOI 10.1016/j.socscimed.2003.08.004; Openshaw S, 1979, STAT APPL SPATIAL SC, V21, P127; Rey SJ, 2007, REV REG STUD, V37, P5; Rosing KE, 1997, EUR J OPER RES, V97, P75, DOI 10.1016/S0377-2217(96)00100-2; Spielman SE, 2014, APPL GEOGR, V46, P147, DOI 10.1016/j.apgeog.2013.11.002; Spielman SE, 2013, ANN ASSOC AM GEOGR, V103, P67, DOI 10.1080/00045608.2012.685049; Steinley D, 2004, ST CLASS DAT ANAL, P53; Tarpey T, 2007, AM STAT, V61, P34, DOI 10.1198/000313007X171016; U.S. Census Bureau, 2009, COMP UND US AM COMM; US Census Bureau, 2009, DES METH AM COMM SUR; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Williams J, 2013, 75700R41532 C RES SE	31	57	57	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2015	10	2							e0115626	10.1371/journal.pone.0115626	http://dx.doi.org/10.1371/journal.pone.0115626			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CC3LS	25723176	Green Published, Green Submitted, gold			2022-12-27	WOS:000350251200008
J	Navarro, SL; White, E; Kantor, ED; Zhang, YZ; Rho, J; Song, XL; Milne, GL; Lampe, PD; Lampe, JW				Navarro, Sandi L.; White, Emily; Kantor, Elizabeth D.; Zhang, Yuzheng; Rho, Junghyun; Song, Xiaoling; Milne, Ginger L.; Lampe, Paul D.; Lampe, Johanna W.			Randomized Trial of Glucosamine and Chondroitin Supplementation on Inflammation and Oxidative Stress Biomarkers and Plasma Proteomics Profiles in Healthy Humans	PLOS ONE			English	Article							DIETARY-SUPPLEMENTS; KNEE OSTEOARTHRITIS; CANCER; PROTEIN; DNA; RECOMMENDATIONS; MICROTUBULES; ASSOCIATIONS; MECHANISMS; EXPRESSION	Background Glucosamine and chondroitin are popular non-vitamin dietary supplements used for osteoarthritis. Long-term use is associated with lower incidence of colorectal and lung cancers and with lower mortality; however, the mechanism underlying these observations is unknown. In vitro and animal studies show that glucosamine and chondroitin inhibit NF-kB, a central mediator of inflammation, but no definitive trials have been done in healthy humans. Methods We conducted a randomized, double-blind, placebo-controlled, cross-over study to assess the effects of glucosamine hydrochloride (1500 mg/d) plus chondroitin sulfate (1200 mg/d) for 28 days compared to placebo in 18 (9 men, 9 women) healthy, overweight (body mass index 25.0-32.5 kg/m(2)) adults, aged 20-55 y. We examined 4 serum inflammatory biomarkers: C-reactive protein (CRP), interleukin 6, and soluble tumor necrosis factor receptors I and II; a urinary inflammation biomarker: prostaglandin E2-metabolite; and a urinary oxidative stress biomarker: F-2-isoprostane. Plasma proteomics on an antibody array was performed to explore other pathways modulated by glucosamine and chondroitin. Results Serum CRP concentrations were 23% lower after glucosamine and chondroitin compared to placebo (P = 0.048). There were no significant differences in other biomarkers. In the proteomics analyses, several pathways were significantly different between the interventionsafter Bonferroni correction, the most significant being a reduction in the "cytokine activity" pathway (P = 2.6 x 10(-16)), after glucosamine and chondroitin compared to placebo. Conclusion Glucosamine and chondroitin supplementation may lower systemic inflammation and alter other pathways in healthy, overweight individuals. This study adds evidence for potential mechanisms supporting epidemiologic findings that glucosamine and chondroitin are associated with reduced risk of lung and colorectal cancer.	[Navarro, Sandi L.; White, Emily; Zhang, Yuzheng; Rho, Junghyun; Song, Xiaoling; Lampe, Paul D.; Lampe, Johanna W.] Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, Seattle, WA 98104 USA; [Kantor, Elizabeth D.] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Milne, Ginger L.] Vanderbilt Univ, Sch Med, Div Clin Pharmacol, Nashville, TN 37212 USA	Fred Hutchinson Cancer Center; Harvard University; Harvard T.H. Chan School of Public Health; Vanderbilt University	Navarro, SL (corresponding author), Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, 1124 Columbia St, Seattle, WA 98104 USA.	snavarro@fredhutch.org	Milne, Ginger/D-7648-2014; Navarro, Sandi L/V-8943-2019	Milne, Ginger/0000-0003-3890-151X; Navarro, Sandi L/0000-0002-4260-2486; Kantor, Elizabeth/0000-0002-9124-5323	National Institutes of Health/National Cancer Institute [NCI P30 CA015704-38]; National Cancer Institute, National Institutes of Health [T32CA009001]; National Cancer Institute; Office of Dietary Supplements [K05-CA154337];  [T32 CA09168]; NATIONAL CANCER INSTITUTE [T32CA009001, P30CA015704, T32CA009168, K05CA154337] Funding Source: NIH RePORTER	National Institutes of Health/National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Cancer Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Office of Dietary Supplements(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Institutes of Health/National Cancer Institute grant NCI P30 CA015704-38. S. L. Navarro was supported by T32 CA09168; E. D. Kantor was supported by the National Cancer Institute, National Institutes of Health (T32CA009001); E. White was supported by a grant from National Cancer Institute and Office of Dietary Supplements (K05-CA154337). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberti C, 2009, EUR REV MED PHARMACO, V13, P13; Anderson NL, 2004, MOL CELL PROTEOMICS, V3, P311, DOI 10.1074/mcp.M300127-MCP200; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Aziz N, 2003, CLIN DIAGN LAB IMMUN, V10, P652, DOI 10.1128/CDLI.10.4.652-657.2003; Azuma K, 2012, INFLAMMATION, V35, P1462, DOI 10.1007/s10753-012-9459-0; Bak YK, 2014, J GASTROEN HEPATOL, V29, P957, DOI 10.1111/jgh.12485; Bartsch H, 2006, LANGENBECK ARCH SURG, V391, P499, DOI 10.1007/s00423-006-0073-1; Beauchemin N, 2013, CANCER METAST REV, V32, P643, DOI 10.1007/s10555-013-9444-6; Bell GA, 2012, EUR J EPIDEMIOL, V27, P593, DOI 10.1007/s10654-012-9714-6; Cao R, 2004, MOL CELL, V15, P57, DOI 10.1016/j.molcel.2004.06.020; Cerutti A, 2008, IMMUNITY, V28, P740, DOI 10.1016/j.immuni.2008.05.001; Chan PS, 2006, J RHEUMATOL, V33, P1329; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; Fenkci S, 2006, J INVEST MED, V54, P455, DOI 10.2310/6650.2006.06010; Fitzgerald DW, 2012, CANCER PREV RES, V5, P34, DOI 10.1158/1940-6207.CAPR-11-0496; Herder C, 2007, J CLIN ENDOCR METAB, V92, P4569, DOI 10.1210/jc.2007-0955; Jordan KM, 2003, ANN RHEUM DIS, V62, P1145, DOI 10.1136/ard.2003.011742; Jordan MA, 1998, CURR OPIN CELL BIOL, V10, P123, DOI 10.1016/S0955-0674(98)80095-1; Kanehisa M, 2014, NUCLEIC ACIDS RES, V42, pD199, DOI 10.1093/nar/gkt1076; Kantor ED, 2014, J ALTERN COMPLEM MED, V20, P479, DOI 10.1089/acm.2013.0323; Kantor ED, 2013, CANCER EPIDEM BIOMAR, V22, P2312, DOI 10.1158/1055-9965.EPI-13-0470; Kantor ED, 2012, AM J EPIDEMIOL, V176, P1002, DOI 10.1093/aje/kws186; Kroeze WK, 2003, J CELL SCI, V116, P4867, DOI 10.1242/jcs.00902; Largo R, 2003, OSTEOARTHR CARTILAGE, V11, P290, DOI 10.1016/S1063-4584(03)00028-1; Largo R, 2009, AM J PHYSIOL-HEART C, V297, pH268, DOI 10.1152/ajpheart.00142.2009; Li CI, 2012, BREAST CANCER RES TR, V135, P611, DOI 10.1007/s10549-012-2204-4; Loch CM, 2007, MOL ONCOL, V1, P313, DOI 10.1016/j.molonc.2007.08.004; Lovu M, 2008, OSTEOARTHR CARTILAGE, V16, pS14, DOI 10.1016/j.joca.2008.06.008; Milne GL, 2013, FREE RADICAL BIO MED, V59, P36, DOI 10.1016/j.freeradbiomed.2012.09.030; Mukhtar E, 2014, MOL CANCER THER, V13, P275, DOI 10.1158/1535-7163.MCT-13-0791; Muller WA, 2011, ANNU REV PATHOL-MECH, V6, P323, DOI 10.1146/annurev-pathol-011110-130224; Nakamura H, 2002, J RHEUMATISM JOINT S, V21, P175; Nakamura H, 2007, RHEUMATOL INT, V27, P213, DOI 10.1007/s00296-006-0197-1; Navarro SL, 2012, CANCER EPIDEM BIOMAR, V21, P1167, DOI 10.1158/1055-9965.EPI-12-0110; Pahl HL, 1999, ONCOGENE, V18, P6853, DOI 10.1038/sj.onc.1203239; Pasini D, 2004, EMBO J, V23, P4061, DOI 10.1038/sj.emboj.7600402; Pocobelli G, 2010, AM J CLIN NUTR, V91, P1791, DOI 10.3945/ajcn.2009.28639; Qato DM, 2008, JAMA-J AM MED ASSOC, V300, P2867, DOI 10.1001/jama.2008.892; Ramirez AB, 2010, CANCER BIOMARK, V8, P293, DOI 10.3233/CBM-2011-0215; Ramirez AB, 2010, MOL CELL PROTEOMICS, V9, P1449, DOI 10.1074/mcp.M900496-MCP200; Rawlings JS, 2004, J CELL SCI, V117, P1281, DOI 10.1242/jcs.00963; Rho JH, 2013, J PROTEOME RES, V12, P2311, DOI 10.1021/pr4001674; Satia JA, 2009, CANCER EPIDEM BIOMAR, V18, P1419, DOI 10.1158/1055-9965.EPI-09-0038; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Smyth GK, 2003, METHODS, V31, P265, DOI 10.1016/S1046-2023(03)00155-5; Tudek B, 2012, MUTAT RES-FUND MOL M, V736, P82, DOI 10.1016/j.mrfmmm.2012.04.003; Uwe S, 2008, BIOCHEM PHARMACOL, V75, P1567, DOI 10.1016/j.bcp.2007.10.027; Yin HY, 2007, J BIOL CHEM, V282, P329, DOI 10.1074/jbc.M608975200; Yomogida S, 2008, INT J MOL MED, V22, P317, DOI 10.3892/ijmm_00000025; Zhang Q, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-6-r93; Zhang W, 2008, OSTEOARTHR CARTILAGE, V16, P137, DOI 10.1016/j.joca.2007.12.013	51	41	49	2	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2015	10	2							e0117534	10.1371/journal.pone.0117534	http://dx.doi.org/10.1371/journal.pone.0117534			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC2ZH	25719429	Green Submitted, Green Published, gold			2022-12-27	WOS:000350213200027
J	Cairns, JM; Peng, Y; Yee, VC; Lou, ZK; Wang, LW				Cairns, Junmei; Peng, Yi; Yee, Vivien C.; Lou, Zhenkun; Wang, Liewei			Bora Downregulation Results in Radioresistance by Promoting Repair of Double Strand Breaks	PLOS ONE			English	Article							DNA-DAMAGE RESPONSE; HISTONE H2AX; IONIZING-RADIATION; CHECKPOINT CONTROL; MITOTIC ENTRY; KINASE AURORA; RECOGNITION; ACTIVATION; PROTEINS; BRCA1	Following DNA double-strand breaks cells activate several DNA-damage response protein kinases, which then trigger histone H2AX phosphorylation and the accumulation of proteins such as MDC1, p53-binding protein 1, and breast cancer gene 1 at the damage site to promote DNA double-strand breaks repair. We identified a novel biomarker, Bora (previously called C13orf34), that is associated with radiosensitivity. In the current study, we set out to investigate how Bora might be involved in response to irradiation. We found a novel function of Bora in DNA damage repair response. Bora down-regulation increased colony formation in cells exposed to irradiation. This increased resistance to irradiation in Bora-deficient cells is likely due to a faster rate of double-strand breaks repair. After irradiation, Bora-knockdown cells displayed increased G2-M cell cycle arrest and increased Chk2 phosphorylation. Furthermore, Bora specifically interacted with the tandem breast cancer gene 1 C-terminal domain of MDC1 in a phosphorylation dependent manner, and overexpression of Bora could abolish irradiation induced MDC1 foci formation. In summary, Bora may play a significant role in radiosensitivity through the regulation of MDC1 and DNA repair.	[Cairns, Junmei; Wang, Liewei] Mayo Clin, Dept Mol Pharmacol & Expt Therapeut, Rochester, MN 55905 USA; [Peng, Yi; Yee, Vivien C.] Case Western Reserve Univ, Dept Biochem, Cleveland, OH 44106 USA; [Lou, Zhenkun] Mayo Clin, Dept Oncol & Oncol Res, Rochester, MN 55905 USA	Mayo Clinic; Case Western Reserve University; Mayo Clinic	Wang, LW (corresponding author), Mayo Clin, Dept Mol Pharmacol & Expt Therapeut, Rochester, MN 55905 USA.	wang.liewei@mayo.edu		Cairns, Junmei/0000-0002-3941-4564	National Institutes of Health [U19 GM61388, R01 CA138461]; NATIONAL CANCER INSTITUTE [R01CA138461] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U19GM061388] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	LW received funding from National Institutes of Health U19 GM61388 (The Pharmacogenomics Research Network, PGRN) and R01 CA138461. www.nih.gov. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartek J, 2003, CANCER CELL, V3, P421, DOI 10.1016/S1535-6108(03)00110-7; Bekker-Jensen S, 2010, DNA REPAIR, V9, P1219, DOI 10.1016/j.dnarep.2010.09.010; Bunz F, 1998, SCIENCE, V282, P1497, DOI 10.1126/science.282.5393.1497; Burma S, 2001, J BIOL CHEM, V276, P42462, DOI 10.1074/jbc.C100466200; Carmena M, 2003, NAT REV MOL CELL BIO, V4, P842, DOI 10.1038/nrm1245; Celeste A, 2003, NAT CELL BIOL, V5, P675, DOI 10.1038/ncb1004; Ciccia A, 2010, MOL CELL, V40, P179, DOI 10.1016/j.molcel.2010.09.019; Cook PJ, 2009, NATURE, V458, P591, DOI 10.1038/nature07849; Costanzo V, 2000, MOL CELL, V6, P649, DOI 10.1016/S1097-2765(00)00063-0; Doil C, 2009, CELL, V136, P435, DOI 10.1016/j.cell.2008.12.041; Franco S, 2006, MOL CELL, V21, P201, DOI 10.1016/j.molcel.2006.01.005; Harris PS, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-80; Hirao A, 2000, SCIENCE, V287, P1824, DOI 10.1126/science.287.5459.1824; Hu YD, 2011, GENE DEV, V25, P685, DOI 10.1101/gad.2011011; Huen MSY, 2007, CELL, V131, P901, DOI 10.1016/j.cell.2007.09.041; Hutterer A, 2006, DEV CELL, V11, P147, DOI 10.1016/j.devcel.2006.06.002; Iliakis G, 2003, ONCOGENE, V22, P5834, DOI 10.1038/sj.onc.1206682; Ismail IH, 2005, J BIOL CHEM, V280, P4649, DOI 10.1074/jbc.M411588200; Kolas NK, 2007, SCIENCE, V318, P1637, DOI 10.1126/science.1150034; Larochelle S, 2012, NAT STRUCT MOL BIOL, V19, P1108, DOI 10.1038/nsmb.2399; Lee MS, 2005, J BIOL CHEM, V280, P32053, DOI 10.1074/jbc.C500273200; Lee YC, 2013, CELL CYCLE, V12, P953, DOI 10.4161/cc.23945; Liu QH, 2000, GENE DEV, V14, P1448; Lukas C, 2004, EMBO J, V23, P2674, DOI 10.1038/sj.emboj.7600269; Macurek L, 2008, NATURE, V455, P119, DOI 10.1038/nature07185; Mailand N, 2007, CELL, V131, P887, DOI 10.1016/j.cell.2007.09.040; MEYERSON M, 1992, EMBO J, V11, P2909, DOI 10.1002/j.1460-2075.1992.tb05360.x; Moses AM, 2007, P NATL ACAD SCI USA, V104, P17713, DOI 10.1073/pnas.0700997104; Moynahan ME, 2001, MOL CELL, V7, P263, DOI 10.1016/S1097-2765(01)00174-5; Niu NF, 2010, GENOME RES, V20, P1482, DOI 10.1101/gr.107672.110; Pinato S, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-55; Pommier Y, 2006, CLIN CANCER RES, V12, P2657, DOI 10.1158/1078-0432.CCR-06-0743; Qin B, 2013, J BIOL CHEM, V288, P16139, DOI 10.1074/jbc.M113.456780; Rogakou EP, 1999, J CELL BIOL, V146, P905, DOI 10.1083/jcb.146.5.905; Seki A, 2008, SCIENCE, V320, P1655, DOI 10.1126/science.1157425; Stucki M, 2005, CELL, V123, P1213, DOI 10.1016/j.cell.2005.09.038; Wilson KA, 2008, CELL CYCLE, V7, P3584, DOI 10.4161/cc.7.22.7102; Zhou BBS, 2000, NATURE, V408, P433, DOI 10.1038/35044005; Zou JQ, 2013, CELL CYCLE, V12, P2255, DOI 10.4161/cc.25349; Zou L, 2003, SCIENCE, V300, P1542, DOI 10.1126/science.1083430	40	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2015	10	3							e0119208	10.1371/journal.pone.0119208	http://dx.doi.org/10.1371/journal.pone.0119208			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9KG	25742493	Green Published, gold, Green Submitted			2022-12-27	WOS:000350688100091
J	Leeder, WM; Reuss, AJ; Brecht, M; Kratz, K; Wachtveitl, J; Goringer, HU				Leeder, W. -Matthias; Reuss, Andreas J.; Brecht, Michael; Kratz, Katja; Wachtveitl, Josef; Goeringer, H. Ulrich			Charge Reduction and Thermodynamic Stabilization of Substrate RNAs Inhibit RNA Editing	PLOS ONE			English	Article							A-SITE; AMINOGLYCOSIDE BINDING; AFRICAN TRYPANOSOMES; MAJOR GROOVE; CONFORMATIONAL FLEXIBILITY; DISCOVERY; NEOMYCIN; RECOGNITION; LIGASE; DUPLEX	African trypanosomes cause a parasitic disease known as sleeping sickness. Mitochondrial transcript maturation in these organisms requires a RNA editing reaction that is characterized by the insertion and deletion of U-nucleotides into otherwise non-functional mRNAs. Editing represents an ideal target for a parasite-specific therapeutic intervention since the reaction cycle is absent in the infected host. In addition, editing relies on a macromolecular protein complex, the editosome, that only exists in the parasite. Therefore, all attempts to search for editing interfering compounds have been focused on molecules that bind to proteins of the editing machinery. However, in analogy to other RNA-driven biochemical pathways it should be possible to stall the reaction by targeting its substrate RNAs. Here we demonstrate inhibition of editing by specific aminoglycosides. The molecules bind into the major groove of the gRNA/pre-mRNA editing substrates thereby causing a stabilization of the RNA molecules through charge compensation and an increase in stacking. The data shed light on mechanistic details of the editing process and identify critical parameters for the development of new trypanocidal compounds.	[Leeder, W. -Matthias; Brecht, Michael; Kratz, Katja; Goeringer, H. Ulrich] Tech Univ Darmstadt, Mol Genet, Darmstadt, Germany; [Reuss, Andreas J.; Wachtveitl, Josef] Goethe Univ Frankfurt, Inst Phys & Theoret Chem, Frankfurt, Germany	Technical University of Darmstadt; Goethe University Frankfurt	Goringer, HU (corresponding author), Tech Univ Darmstadt, Mol Genet, Darmstadt, Germany.	goringer@bio.tu-darmstadt.de	Wachtveitl, Josef/A-7590-2017	Wachtveitl, Josef/0000-0002-8496-8240; Leeder, Wolf-Matthias/0000-0001-5258-1255	Deutsche Forschungsgemeinschaft [DFG-SFB902]; Illing Foundation for Macromolecular Chemistry	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Illing Foundation for Macromolecular Chemistry	The work was supported by the Deutsche Forschungsgemeinschaft (DFG-SFB902) to HUG and JW and the Illing Foundation for Macromolecular Chemistry to HUG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amaro RE, 2008, P NATL ACAD SCI USA, V105, P17278, DOI 10.1073/pnas.0805820105; Aphasizhev R, 2014, BIOCHIMIE, V100, P125, DOI 10.1016/j.biochi.2014.01.003; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Baral TN, 2006, NAT MED, V12, P580, DOI 10.1038/nm1395; Bernacchi S, 2007, NUCLEIC ACIDS RES, V35, P7128, DOI 10.1093/nar/gkm856; Bohm C, 2012, J BIOL CHEM, V287, P26268, DOI 10.1074/jbc.M112.365916; Bou-Abdallah F, 2005, BIOCHEMISTRY-US, V44, P13837, DOI 10.1021/bi0514212; Brecht M, 2005, MOL CELL, V17, P621, DOI 10.1016/j.molcel.2005.01.018; Carter AP, 2000, NATURE, V407, P340, DOI 10.1038/35030019; Chen Q, 1997, BIOCHEMISTRY-US, V36, P11402, DOI 10.1021/bi970756j; Clark CL, 1997, NUCLEIC ACIDS RES, V25, P4098, DOI 10.1093/nar/25.20.4098; Demir O, 2014, CHEM BIOL DRUG DES, V84, P131, DOI 10.1111/cbdd.12302; Dolinsky TJ, 2004, NUCLEIC ACIDS RES, V32, P522; Durrant JD, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000803; Ennifar E, 2013, ACS CHEM BIOL, V8, P2509, DOI 10.1021/cb400498n; Fourmy D, 1998, J MOL BIOL, V277, P347, DOI 10.1006/jmbi.1997.1552; Fourmy D, 1998, J MOL BIOL, V277, P333, DOI 10.1006/jmbi.1997.1551; Francois B, 2005, NUCLEIC ACIDS RES, V33, P5677, DOI 10.1093/nar/gki862; Freire F, 2007, CHEM COMMUN, P174, DOI 10.1039/b611597g; Goringer HU, 2012, ANNU REV MICROBIOL, V66, P65, DOI 10.1146/annurev-micro-092611-150150; Goringer HU, 2012, TRENDS PARASITOL, V28, P106, DOI 10.1016/j.pt.2011.12.005; Hamilton PL, 2012, NAT PROD REP, V29, P134, DOI 10.1039/c1np00054c; Hermann T, 1999, J MOL BIOL, V294, P829, DOI 10.1006/jmbi.1999.3312; Hermann T, 2002, BIOCHIMIE, V84, P869, DOI 10.1016/S0300-9084(02)01460-8; Hermann T, 2000, ANGEW CHEM INT EDIT, V39, P1891; Homann M, 2001, BIOORGAN MED CHEM, V9, P2571, DOI 10.1016/S0968-0896(01)00032-3; Igo RP, 2000, MOL CELL BIOL, V20, P8447, DOI 10.1128/MCB.20.22.8447-8457.2000; Igo RP, 2002, EUKARYOT CELL, V1, P112, DOI 10.1128/EC.1.1.112-118.2002; Jin E, 2000, J MOL BIOL, V298, P95, DOI 10.1006/jmbi.2000.3639; Katari VS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083796; Kaul M, 2003, J MOL BIOL, V326, P1373, DOI 10.1016/S0022-2836(02)01452-3; Koumoto K, 2008, CHEM LETT, V37, P864, DOI 10.1246/cl.2008.864; Kruse E, 2013, BBA-GENE REGUL MECH, V1829, P835, DOI 10.1016/j.bbagrm.2013.04.003; Le VH, 2013, ANAL BIOCHEM, V434, P233, DOI 10.1016/j.ab.2012.11.030; Li F, 2011, P NATL ACAD SCI USA, V108, P3542, DOI 10.1073/pnas.1014152108; Liang SA, 2010, RNA, V16, P2435, DOI 10.1261/rna.2347310; Lorger M, 2003, EUKARYOT CELL, V2, P84, DOI 10.1128/EC.2.1.84-94.2003; Mikkelsen NE, 1999, P NATL ACAD SCI USA, V96, P6155, DOI 10.1073/pnas.96.11.6155; Missel A, 1997, MOL CELL BIOL, V17, P4895, DOI 10.1128/MCB.17.9.4895; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; Moshiri H, 2011, J BIOL CHEM, V286, P14178, DOI 10.1074/jbc.M110.199646; Niemann M, 2008, NUCLEIC ACIDS RES, V36, P4465, DOI 10.1093/nar/gkn410; Pramanik S, 2011, J PHYS CHEM B, V115, P13862, DOI 10.1021/jp207856p; Ranjan N, 2010, BIOCHEMISTRY-US, V49, P9891, DOI 10.1021/bi101517e; RECORD MT, 1978, Q REV BIOPHYS, V11, P103, DOI 10.1017/S003358350000202X; RECORD MT, 1976, J MOL BIOL, V107, P145, DOI 10.1016/S0022-2836(76)80023-X; Rogers J, 1996, J MOL BIOL, V259, P916, DOI 10.1006/jmbi.1996.0369; Salavati R, 2012, INT J PARASITOL-DRUG, V2, P36, DOI 10.1016/j.ijpddr.2011.10.003; SAVITZKY A, 1964, ANAL CHEM, V36, P1627, DOI 10.1021/ac60214a047; Scheunemann AE, 2010, NUCLEIC ACIDS RES, V38, P3094, DOI 10.1093/nar/gkp1253; Schnaufer A, 2001, SCIENCE, V291, P2159, DOI 10.1126/science.1058655; STAGE TK, 1995, RNA, V1, P95; Stampfl S, 2007, CHEMBIOCHEM, V8, P1137, DOI 10.1002/cbic.200700030; Stelzer AC, 2011, NAT CHEM BIOL, V7, P553, DOI [10.1038/NCHEMBIO.596, 10.1038/nchembio.596]; Steverding D, 2010, PARASITE VECTOR, V3, DOI 10.1186/1756-3305-3-15; Stich A, 2013, LANCET INFECT DIS, V13, P733, DOI 10.1016/S1473-3099(13)70191-9; Stuart K, 2008, J CLIN INVEST, V118, P1301, DOI 10.1172/JCI33945; Tor Y, 2003, CHEMBIOCHEM, V4, P998, DOI 10.1002/cbic.200300680; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Varani L, 2000, NUCLEIC ACIDS RES, V28, P710, DOI 10.1093/nar/28.3.710; VERSPIEREN P, 1987, GENE, V61, P307, DOI 10.1016/0378-1119(87)90194-6; Walter F, 2002, EMBO J, V21, P760, DOI 10.1093/emboj/21.4.760; Westhof E, 1993, WATER BIOL MACROMOLE, P226, DOI DOI 10.1007/978-1-349-12359-9_7; Xi HJ, 2011, BIOCHEMISTRY-US, V50, P9088, DOI 10.1021/bi201077h; Zhao F, 2005, ANGEW CHEM INT EDIT, V44, P5329, DOI 10.1002/anie.200500903	65	4	4	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2015	10	3							e0118940	10.1371/journal.pone.0118940	http://dx.doi.org/10.1371/journal.pone.0118940			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9KG	25742417	Green Published, gold, Green Submitted			2022-12-27	WOS:000350688100063
J	Horner, SM; Wilkins, C; Badil, S; Iskarpatyoti, J; Gale, M				Horner, Stacy M.; Wilkins, Courtney; Badil, Samantha; Iskarpatyoti, Jason; Gale, Michael, Jr.			Proteomic Analysis of Mitochondrial-Associated ER Membranes (MAM) during RNA Virus Infection Reveals Dynamic Changes in Protein and Organelle Trafficking	PLOS ONE			English	Article							ANTIVIRAL SIGNALING PROTEIN; ENDOPLASMIC-RETICULUM; RIG-I; RAT-LIVER; STATISTICAL-MODEL; INNATE IMMUNITY; CONTACT SITES; REPLICATION; ACTIVATION; FRACTION	RIG-I pathway signaling of innate immunity against RNA virus infection is organized between the ER and mitochondria on a subdomain of the ER called the mitochondrial-associated ER membrane (MAM). The RIG-I adaptor protein MAVS transmits downstream signaling of antiviral immunity, with signaling complexes assembling on the MAM in association with mitochondria and peroxisomes. To identify components that regulate MAVS signalosome assembly on the MAM, we characterized the proteome of MAM, ER, and cytosol from cells infected with either chronic (hepatitis C) or acute (Sendai) RNA virus infections, as well as mock-infected cells. Comparative analysis of protein trafficking dynamics during both chronic and acute viral infection reveals differential protein profiles in the MAM during RIG-I pathway activation. We identified proteins and biochemical pathways recruited into and out of the MAM in both chronic and acute RNA viral infections, representing proteins that drive immunity and/or regulate viral replication. In addition, by using this comparative proteomics approach, we identified 3 new MAVS-interacting proteins, RAB1B, VTN, and LONP1, and defined LONP1 as a positive regulator of the RIG-I pathway. Our proteomic analysis also reveals a dynamic cross-talk between subcellular compartments during both acute and chronic RNA virus infection, and demonstrates the importance of the MAM as a central platform that coordinates innate immune signaling to initiate immunity against RNA virus infection.	[Horner, Stacy M.; Wilkins, Courtney; Badil, Samantha; Gale, Michael, Jr.] Univ Washington, Dept Immunol, Seattle, WA 98195 USA; [Iskarpatyoti, Jason] Duke Univ, Med Ctr, Dept Mol Genet & Microbiol, Durham, NC 27708 USA; [Horner, Stacy M.] Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA	University of Washington; University of Washington Seattle; Duke University; Duke University	Horner, SM (corresponding author), Duke Univ, Med Ctr, Dept Mol Genet & Microbiol, Durham, NC 27708 USA.	stacy.horner@duke.edu		Wilkins, Courtney/0000-0003-4001-7686; Horner, Stacy/0000-0002-9351-7409; Gale, Michael/0000-0002-6332-7436	NIH [R01AI060389, U19AI88778, F32AI088856]; Irvington Institute Fellowship Program of the Cancer Research Institute; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI060389, K22AI100935, U19AI083019, F32AI088856, U19AI088778] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Irvington Institute Fellowship Program of the Cancer Research Institute; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was supported by NIH grants R01AI060389 and U19AI88778 (MG), F32AI088856 (CW) and the Irvington Institute Fellowship Program of the Cancer Research Institute, http://www.cancerresearch.org/grants-programs/grants-fellowships/cri-irvington-postdoctoralfellowships. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez C, 2003, SYNTHESE, V134, P1; Anelli T, 2012, ANTIOXID REDOX SIGN, V16, P1077, DOI 10.1089/ars.2011.4004; Area-Gomez E, 2009, AM J PATHOL, V175, P1810, DOI 10.2353/ajpath.2009.090219; Arnaud N, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002289; Baril M, 2009, J VIROL, V83, P1299, DOI 10.1128/JVI.01659-08; Blight KJ, 2000, SCIENCE, V290, P1972, DOI 10.1126/science.290.5498.1972; Bosch M, 2011, TRAFFIC, V12, P1483, DOI 10.1111/j.1600-0854.2011.01259.x; Bota DA, 2005, FREE RADICAL BIO MED, V38, P665, DOI 10.1016/j.freeradbiomed.2004.11.017; Bozidis P, 2010, J VIROL, V84, P7898, DOI 10.1128/JVI.00885-10; Bozidis Petros, 2007, Curr Protoc Cell Biol, VChapter 3, DOI 10.1002/0471143030.cb0327s37; Bozym RA, 2012, CELL HOST MICROBE, V11, P153, DOI 10.1016/j.chom.2012.01.008; Bravo-Sagua R, 2014, INT J BIOCHEM CELL B, V50, P55, DOI 10.1016/j.biocel.2014.01.019; Bruns AM, 2012, CRIT REV BIOCHEM MOL, V47, P194, DOI 10.3109/10409238.2011.630974; Bui M, 2010, J BIOL CHEM, V285, P31590, DOI 10.1074/jbc.M110.101584; Castanier C, 2010, EMBO REP, V11, P133, DOI 10.1038/embor.2009.258; Csordas G, 1999, EMBO J, V18, P96, DOI 10.1093/emboj/18.1.96; CUI Z, 1993, J BIOL CHEM, V268, P16655; de Brito OM, 2008, NATURE, V456, P605, DOI 10.1038/nature07534; de Brito OM, 2010, EMBO J, V29, P2715, DOI 10.1038/emboj.2010.177; Dixit E, 2010, CELL, V141, P668, DOI 10.1016/j.cell.2010.04.018; Foy E, 2005, P NATL ACAD SCI USA, V102, P2986, DOI 10.1073/pnas.0408707102; Foy E, 2003, SCIENCE, V300, P1145, DOI 10.1126/science.1082604; Gilady SY, 2010, CELL STRESS CHAPERON, V15, P619, DOI 10.1007/s12192-010-0174-1; Giorgi C, 2010, SCIENCE, V330, P1247, DOI 10.1126/science.1189157; Hajnoczky G, 2000, J PHYSIOL-LONDON, V529, P69, DOI 10.1111/j.1469-7793.2000.00069.x; Hayashi T, 2007, CELL, V131, P596, DOI 10.1016/j.cell.2007.08.036; Hayashi T, 2009, TRENDS CELL BIOL, V19, P81, DOI 10.1016/j.tcb.2008.12.002; Helle SCJ, 2013, BBA-MOL CELL RES, V1833, P2526, DOI 10.1016/j.bbamcr.2013.01.028; Higo T, 2005, CELL, V120, P85, DOI 10.1016/j.cell.2004.11.048; Horner SM, 2011, P NATL ACAD SCI US; Horner SM, 2014, J MOL BIOL, V426, P1198, DOI 10.1016/j.jmb.2013.10.032; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Ikeda M, 1998, VIRUS RES, V56, P157, DOI 10.1016/S0168-1702(98)00063-X; Jacobs JL, 2014, J BIOL CHEM, V289, P1604, DOI 10.1074/jbc.M113.520254; Keller A, 2002, ANAL CHEM, V74, P5383, DOI 10.1021/ac025747h; Kim SJ, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003285; Klug L, 2013, BIOCHIM BIOPHYS ACTA, V1841, P215; Koppen M, 2007, CRIT REV BIOCHEM MOL, V42, P221, DOI 10.1080/10409230701380452; Kumar H, 2011, INT REV IMMUNOL, V30, P16, DOI 10.3109/08830185.2010.529976; Lavanchy D, 2009, LIVER INT, V29, P74, DOI 10.1111/j.1478-3231.2008.01934.x; Levine T, 2006, CURR OPIN CELL BIOL, V18, P371, DOI 10.1016/j.ceb.2006.06.011; Lewin TM, 2002, ARCH BIOCHEM BIOPHYS, V404, P263, DOI 10.1016/S0003-9861(02)00247-3; Lewin TM, 2001, J BIOL CHEM, V276, P24674, DOI 10.1074/jbc.M102036200; Li XD, 2005, P NATL ACAD SCI USA, V102, P17717, DOI 10.1073/pnas.0508531102; Li Y, 2004, J CELL BIOL, V164, P35, DOI 10.1083/jcb.200307010; Lin RT, 2006, J VIROL, V80, P6072, DOI 10.1128/JVI.02495-05; Liu HM, 2012, CELL HOST MICROBE, V11, P528, DOI 10.1016/j.chom.2012.04.006; Lohmann V, 1999, SCIENCE, V285, P110, DOI 10.1126/science.285.5424.110; Loo YM, 2006, P NATL ACAD SCI USA, V103, P6001, DOI 10.1073/pnas.0601523103; Loo YM, 2011, IMMUNITY, V34, P680, DOI 10.1016/j.immuni.2011.05.003; Lynes EM, 2012, EMBO J, V31, P457, DOI 10.1038/emboj.2011.384; Lynn DJ, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.55; Man WC, 2006, J LIPID RES, V47, P1928, DOI 10.1194/jlr.M600172-JLR200; Mendes CCP, 2005, J BIOL CHEM, V280, P40892, DOI 10.1074/jbc.M506623200; Meylan E, 2005, NATURE, V437, P1167, DOI 10.1038/nature04193; Mukherjee A, 2009, J BIOL CHEM, V284, P6486, DOI 10.1074/jbc.M807547200; Myhill N, 2008, MOL BIOL CELL, V19, P2777, DOI 10.1091/mbc.E07-10-0995; Nesvizhskii AI, 2003, ANAL CHEM, V75, P4646, DOI 10.1021/ac0341261; Poston CN, 2013, J PROTEOMICS; PREISSNER KT, 1991, ANNU REV CELL BIOL, V7, P275, DOI 10.1146/annurev.cellbio.7.1.275; Raturi A, 2012, BIOCH BIOPHYS ACTA; Roderick HL, 2000, J CELL BIOL, V149, P1235, DOI 10.1083/jcb.149.6.1235; Romero-Brey I, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003056; RUSINOL AE, 1994, J BIOL CHEM, V269, P27494; Saito T, 2008, NATURE, V454, P523, DOI 10.1038/nature07106; Saito T, 2007, P NATL ACAD SCI USA, V104, P582, DOI 10.1073/pnas.0606699104; Schon EA, 2012, MOL CELL NEUROSCI; Schwer B, 2004, J VIROL, V78, P7958, DOI 10.1128/JVI.78.15.7958-7968.2004; Seth RB, 2005, CELL, V122, P669, DOI 10.1016/j.cell.2005.08.012; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Simmen T, 2005, EMBO J, V24, P717, DOI 10.1038/sj.emboj.7600559; Simmen T, 2010, BBA-BIOMEMBRANES, V1798, P1465, DOI 10.1016/j.bbamem.2010.04.009; Simpson PB, 1997, J BIOL CHEM, V272, P22654, DOI 10.1074/jbc.272.36.22654; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Smyth GK, 2003, METHODS, V31, P265, DOI 10.1016/S1046-2023(03)00155-5; Stone SJ, 2009, J BIOL CHEM, V284, P5352, DOI 10.1074/jbc.M805768200; Stone SJ, 2000, J BIOL CHEM, V275, P34534, DOI 10.1074/jbc.M002865200; Stumper R, 2005, J VIROL, V79, P2689, DOI 10.1128/JVI.79.5.2689-2699.2005; Sumpter R, 2004, J VIROL, V78, P11591, DOI 10.1128/JVI.78.21.11591-11604.2004; Szabadkai G, 2006, J CELL BIOL, V175, P901, DOI 10.1083/jcb.200608073; Toulmay A, 2011, CURR OPIN CELL BIOL, V23, P458, DOI 10.1016/j.ceb.2011.04.006; Uzri D, 2009, J VIROL, V83, P4174, DOI 10.1128/JVI.02449-08; van Zuylen WJ, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002747; VANCE JE, 1990, J BIOL CHEM, V265, P7248; Wang HJ, 2000, J CELL BIOL, V150, P1489, DOI 10.1083/jcb.150.6.1489; Wolk B, 2000, J VIROL, V74, P2293, DOI 10.1128/JVI.74.5.2293-2304.2000; Zhang AP, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.009936; Zhou RB, 2011, NATURE, V469, P221, DOI 10.1038/nature09663	89	64	64	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2015	10	3							e0117963	10.1371/journal.pone.0117963	http://dx.doi.org/10.1371/journal.pone.0117963			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4HV	25734423	Green Published, gold			2022-12-27	WOS:000350314700012
J	Booth, TC; Boyd-Ellison, JM				Booth, Thomas C.; Boyd-Ellison, Jennifer M.			The Current Impact of Incidental Findings Found during Neuroimaging on Neurologists' Workloads	PLOS ONE			English	Article							GROUNDED THEORY; HEALTHY-VOLUNTEERS; IMAGING RESEARCH; CT; PREVALENCE; LESIONS	Objective Neuroimaging is an important diagnostic tool in the assessment of neurological disease, but often unmasks Incidental Findings (IFs). The negative impacts of IFs, such as 'patient' anxiety, present neurologists with management dilemmas, largely due to the limited knowledge base surrounding the medical significance of these IFs. In particular, the lack of evidence-based clinical trials investigating the efficacy of treatments for subclinical IFs makes management protocols challenging. The objective was to determine the impact IFs may have on neurologists' workloads and healthcare budgets and to examine neurologists' concerns regarding the clinical management of these 'patients'. Methods Qualitative research based on constructivist grounded theory. Data was collected through semi-structured interviews of purposively sampled neurologists, coded, and concurrent comparative analysis performed. A substantive theory of the 'IF impacts' was developed after concept saturation. Results Neurologists managed the escalating workload caused by an increased number of referrals of 'patients' with IFs found during neuroimaging; however it was unclear whether this was sustainable in the future. Neurologists experienced IF management dilemmas and spent more time with 'patients' affected by anxiety. The lack of information provided to those undergoing neuroimaging by the referring clinician regarding the possibility of discovering IFs was highlighted. Conclusion The impact of IFs upon the neurologist, 'patient' and the health institution appeared considerable. Further research determining the natural history of subclinical IFs and the efficacy of intervention will help to alleviate these issues.	[Booth, Thomas C.] Natl Hosp Neurol & Neurosurg, Lysholm Dept Neuroradiol, Queen Sq, London WC1N 3BG, England; [Boyd-Ellison, Jennifer M.] Western Gen Hosp, Dept Clin Neurosci, Edinburgh EH4 2XU, Midlothian, Scotland	University of London; University College London; UCL Medical School; University College London Hospitals NHS Foundation Trust; University of Edinburgh	Booth, TC (corresponding author), Natl Hosp Neurol & Neurosurg, Lysholm Dept Neuroradiol, Queen Sq, London WC1N 3BG, England.	tombooth@doctors.org.uk			British Association of Magnetic Resonance Radiographers	British Association of Magnetic Resonance Radiographers	TCB received no funding for this work. JMBE received funding from the British Association of Magnetic Resonance Radiographers. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alsheikh-Ali AA, 2009, STROKE, V40, P2349, DOI 10.1161/STROKEAHA.109.547828; Beinfeld MT, 2005, RADIOLOGY, V234, P415, DOI 10.1148/radiol.2342032061; Berland LL, 2010, J AM COLL RADIOL, V7, P754, DOI 10.1016/j.jacr.2010.06.013; Boeije H., 2009, ANAL QUALITATIVE RES; Booth TC, 2012, BRIT J RADIOL, V85, P11, DOI 10.1259/bjr/73283917; Booth TC, 2010, BRIT J RADIOL, V83, P456, DOI 10.1259/bjr/15877332; Born CM, 2004, EUR ARCH PSY CLIN N, V254, P295, DOI 10.1007/s00406-004-0496-z; Bowen GA, 2005, QUAL REP, V10, P208; Burt RS, 2005, BROKERAGE CLOSURE IN; Cramer SC, 2011, NEUROIMAGE, V55, P1020, DOI 10.1016/j.neuroimage.2010.11.091; Crouch M, 2006, SOC SCI INFORM, V45, P483, DOI 10.1177/0539018406069584; Ginsberg LE, 2010, RADIOLOGY, V254, P324, DOI 10.1148/radiol.09091736; Good practice in consent implementation guide, 2001, GOOD PRACT CONS IMPL; Grueter BE, 2012, POSTGRAD MED J, V88, P79, DOI 10.1136/postgradmedj-2011-130307; Hall WA, 2001, QUAL HEALTH RES, V11, P257, DOI 10.1177/104973201129119082; Hayward R, 2003, BRIT MED J, V326, P1273, DOI 10.1136/bmj.326.7401.1273; Heath H, 2004, INT J NURS STUD, V41, P141, DOI 10.1016/S0020-7489(03)00113-5; Housri N, 2011, ANN INTERN MED, V155, P260, DOI 10.7326/0003-4819-155-4-201108160-00010; Illes J, 2008, NEUROLOGY, V70, P384, DOI 10.1212/01.wnl.0000280469.17461.94; Information Service Division Scotland, 2012, NAT HLTH SERV NAT SE; Kiroglu Y, 2008, SURG RADIOL ANAT, V30, P249, DOI 10.1007/s00276-008-0314-9; Launer LJ, 2006, NEUROEPIDEMIOLOGY, V26, P23, DOI 10.1159/000089233; MATSUBAYASHI K, 1992, STROKE, V23, P175, DOI 10.1161/01.STR.23.2.175; McGeorge SJ, 2011, J PSYCHIATR MENT HLT, V18, P67, DOI 10.1111/j.1365-2850.2010.01630.x; Mehmetoglu M, 2006, INT J HOSP MANAG, V25, P12, DOI DOI 10.1016/J.IJHM.2004.12.002; Mills J., 2006, INT J QUAL METHODS, V5, P25, DOI [DOI 10.1177/160940690600500103, 10.1177/160940690600500103]; Milstein AC, 2008, J LAW MED ETHICS, V36, P356, DOI 10.1111/j.1748-720X.2008.00280.x; Morris Z, 2009, BMJ-BRIT MED J, V339, pb3016, DOI [10.1136/bmj.b3016, DOI 10.1136/BMJ.B3016]; Morse J. M., 2002, INT J QUAL METHODS, P13, DOI 10.1177/160940690200100202; Orme NM, 2010, ARCH INTERN MED, V170, P1525, DOI 10.1001/archinternmed.2010.317; Pinato DJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049814; Polgar S., 2020, INTRO RES HLTH SCI, V7th; Sandeman EM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071467; Shalowitz DI, 2005, JAMA-J AM MED ASSOC, V294, P737, DOI 10.1001/jama.294.6.737; Shoemaker JM, 2011, NEUROLOGY, V77, P2123, DOI 10.1212/WNL.0b013e31823d7687; Thompson RJ, 2011, EMERG MED INT, V2011, DOI 10.1155/2011/624847; Tsushima Y, 2005, BMC NEUROL, V5, DOI 10.1186/1471-2377-5-18; Walker D, 2006, QUAL HEALTH RES, V16, P547, DOI 10.1177/1049732305285972; Wiebers D, 2003, LANCET, V362, P103, DOI 10.1016/S0140-6736(03)13860-3; Wolf SM, 2008, J LAW MED ETHICS, V36, P219, DOI 10.1111/j.1748-720X.2008.00266.x; Zhu YC, 2011, AM J NEURORADIOL, V32, P709, DOI 10.3174/ajnr.A2366; Zimmer Etan Z., 2007, Archives of Gynecology and Obstetrics, V276, P487, DOI 10.1007/s00404-007-0369-6	42	12	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2015	10	2							e0118155	10.1371/journal.pone.0118155	http://dx.doi.org/10.1371/journal.pone.0118155			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CC3LS	25723558	gold, Green Published, Green Submitted			2022-12-27	WOS:000350251200047
J	Liao, S; Liang, YJ; Zhang, ZW; Li, JL; Wang, J; Wang, XY; Dou, GF; Zhang, ZQ; Liu, KL				Liao, Sha; Liang, Yuanjun; Zhang, Zhiwei; Li, Jinglai; Wang, Juan; Wang, Xiaoying; Dou, Guifang; Zhang, Zhenqing; Liu, Keliang			In Vitro Metabolic Stability of Exendin-4: Pharmacokinetics and Identification of Cleavage Products	PLOS ONE			English	Article							GLUCAGON-LIKE PEPTIDE-1; TYPE-2 DIABETES-MELLITUS; MASS-SPECTROMETRY; BIOLOGICAL-ACTIVITY; BINDING-SITES; EXENATIDE; ANALOG; PATHOGENESIS; ELIMINATION; DEGRADATION	The aim of this study was to investigate the metabolic stability and cleavage sites of exendin-4 in rat tissue homogenates, as well as to identify the types of proteases involved in exendin-4 degradation. The stability of exendin-4 in kidney and liver homogenates from rats was evaluated using liquid chromatography-electrospray ionization mass spectrometry (LC-ESI-MS) with gradient elution. Furthermore, we used a combination of matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF MS) and LC-ESI-MS/MS to identify the structures of the major degradation products of exendin-4, and peptidase inhibitors were used to characterize exendin-4 degradation in rat liver and kidney homogenates and to identify the proteases involved in exendin-4 metabolism. Exendin-4 had a half-life of 7.8 and 100.9 min in the kidney and liver homogenate, respectively. The enzymes most likely to be involved in the degradation of exendin-4 were aminopeptidases, serineproteases, and metalloproteases. Exendin-4(15-39) and exendin-4(16-39) were the predominant direct exendin-4 metabolites in the kidney, and the main product of exendin-4 metabolism in the liver was exendin-4(12-39). Our results indicated that the metabolism of exendin-4 involved an initial endoproteolytic cleavage and subsequent exoproteolytic digestion. The degradation of exendin-4 in the kidney and liver homogenates followed distinct patterns, and the primary cleavage sites of exendin-4 degradation in rat kidney homogenates were located after AA-14, and -15, whereas those in rat liver homogenates were located after AA-11.	[Liao, Sha; Liang, Yuanjun; Zhang, Zhiwei; Li, Jinglai; Wang, Juan; Wang, Xiaoying; Zhang, Zhenqing; Liu, Keliang] Beijing Inst Pharmacol & Toxicol, Beijing 100850, Peoples R China; [Dou, Guifang] Beijing Inst Transfus Med, Beijing 100850, Peoples R China	Academy of Military Medical Sciences - China	Liu, KL (corresponding author), Beijing Inst Pharmacol & Toxicol, 27 Taiping Rd, Beijing 100850, Peoples R China.	zqzhang55@126.com; keliangliu55@126.com			Members of the Tree Protection Cooperative Program (TPCP); THRIP initiative of the Department of Trade and Industry; DST/NRF Centre of Excellence in Tree Health Biotechnology (CTHB); National Research Foundation [65891]	Members of the Tree Protection Cooperative Program (TPCP); THRIP initiative of the Department of Trade and Industry; DST/NRF Centre of Excellence in Tree Health Biotechnology (CTHB)(Department of Science & Technology (India)); National Research Foundation	Members of the Tree Protection Cooperative Program (TPCP), the THRIP initiative of the Department of Trade and Industry and the DST/NRF Centre of Excellence in Tree Health Biotechnology (CTHB) are acknowledged for financial support. Grant 65891, National Research Foundation, http://www.nrf.ac.za/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnes L, 2009, REGUL PEPTIDES, V153, P88, DOI 10.1016/j.regpep.2008.08.005; ATTELLA MJ, 1992, BEHAV NEURAL BIOL, V57, P157, DOI 10.1016/0163-1047(92)90665-Q; BOULANGER L, 1992, PEPTIDES, V13, P681, DOI 10.1016/0196-9781(92)90173-Z; Bullock BP, 1996, ENDOCRINOLOGY, V137, P2968, DOI 10.1210/en.137.7.2968; Butler PC, 2010, DIABETES CARE, V33, P453, DOI 10.2337/dc09-1902; Chen J, 2007, PROTEIN PEPTIDE LETT, V14, P19, DOI 10.2174/092986607779117272; Copley K, 2006, CURR DRUG METAB, V7, P367, DOI 10.2174/138920006776873490; Deacon CF, 1998, DIABETOLOGIA, V41, P271, DOI 10.1007/s001250050903; DeFronzo RA, 2004, MED CLIN N AM, V88, P787, DOI 10.1016/j.mcna.2004.04.013; Edwards CMB, 2001, AM J PHYSIOL-ENDOC M, V281, pE155, DOI 10.1152/ajpendo.2001.281.1.E155; Ekins S, 2000, J PHARMACOL TOX MET, V44, P313, DOI 10.1016/S1056-8719(00)00110-6; Flamini R, 2006, EXPERT REV PROTEOMIC, V3, P321, DOI 10.1586/14789450.3.3.321; Foger F, 2008, AMINO ACIDS, V35, P233, DOI 10.1007/s00726-007-0581-5; Gabrielsson J, 2009, J PHARMACOL EXP THER, V331, P767, DOI 10.1124/jpet.109.157172; Gao W, 2011, J PHARMACOL EXP THER, V336, P881, DOI 10.1124/jpet.110.175752; Gedulin BR, 2008, INT J PHARM, V356, P231, DOI 10.1016/j.ijpharm.2008.01.015; GOKE R, 1995, NEUROENDOCRINOLOGY, V62, P130, DOI 10.1159/000126997; GOKE R, 1995, EUR J NEUROSCI, V7, P2294, DOI 10.1111/j.1460-9568.1995.tb00650.x; Greven H M, 1973, Prog Brain Res, V39, P429; Hargrove DM, 2007, REGUL PEPTIDES, V141, P113, DOI 10.1016/j.regpep.2006.12.021; Knowler WC, 2002, NEW ENGL J MED, V346, P393, DOI 10.1056/NEJMoa012512; Leahy JL, 2005, ARCH MED RES, V36, P197, DOI 10.1016/j.arcmed.2005.01.003; Linnebjerg H, 2007, BRIT J CLIN PHARMACO, V64, P317, DOI 10.1111/j.1365-2125.2007.02890.x; McCormack PL, 2014, DRUGS; Meier JJ, 2004, DIABETES, V53, P654, DOI 10.2337/diabetes.53.3.654; Nannelli F, 2008, LETT APPL MICROBIOL, V47, P594, DOI 10.1111/j.1472-765X.2008.02472.x; Perry T, 2003, TRENDS PHARMACOL SCI, V24, P377, DOI 10.1016/S0165-6147(03)00160-3; POWELL MF, 1992, J PHARM SCI, V81, P731, DOI 10.1002/jps.2600810802; Ritzel U, 1998, J ENDOCRINOL, V159, P93, DOI 10.1677/joe.0.1590093; Simonsen L, 2006, DIABETOLOGIA, V49, P706, DOI 10.1007/s00125-005-0128-9; Tomas R, 2008, J SEP SCI, V31, P1964, DOI 10.1002/jssc.200800113; van den Broek I, 2008, J CHROMATOGR B, V872, P1, DOI 10.1016/j.jchromb.2008.07.021; Vergote V, 2008, PEPTIDES, V29, P1740, DOI 10.1016/j.peptides.2008.05.018; Werle M, 2006, AMINO ACIDS, V30, P351, DOI 10.1007/s00726-005-0289-3; Ybo BK, 2006, ANN PHARMACOTHER, V40, P1777, DOI 10.1345/aph.1H060	35	12	14	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2015	10	2							e0116805	10.1371/journal.pone.0116805	http://dx.doi.org/10.1371/journal.pone.0116805			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC3LS	25723538	Green Submitted, Green Published, gold			2022-12-27	WOS:000350251200021
J	Tan, L; Zheng, B; Chen, JJ; Jiang, XF				Tan, Lei; Zheng, Bo; Chen, Jun-Jie; Jiang, Xiong-Fei			How Volatilities Nonlocal in Time Affect the Price Dynamics in Complex Financial Systems	PLOS ONE			English	Article							AGENT-BASED MODELS; HERD BEHAVIOR; CROSS-CORRELATIONS; HETEROSKEDASTICITY; FLUCTUATIONS; MARKETS; RISK	What is the dominating mechanism of the price dynamics in financial systems is of great interest to scientists. The problem whether and how volatilities affect the price movement draws much attention. Although many efforts have been made, it remains challenging. Physicists usually apply the concepts and methods in statistical physics, such as temporal correlation functions, to study financial dynamics. However, the usual volatility-return correlation function, which is local in time, typically fluctuates around zero. Here we construct dynamic observables nonlocal in time to explore the volatility-return correlation, based on the empirical data of hundreds of individual stocks and 25 stock market indices in different countries. Strikingly, the correlation is discovered to be non-zero, with an amplitude of a few percent and a duration of over two weeks. This result provides compelling evidence that past volatilities nonlocal in time affect future returns. Further, we introduce an agent-based model with a novel mechanism, that is, the asymmetric trading preference in volatile and stable markets, to understand the microscopic origin of the volatility-return correlation nonlocal in time.	[Tan, Lei; Zheng, Bo; Chen, Jun-Jie; Jiang, Xiong-Fei] Zhejiang Univ, Dept Phys, Hangzhou 310027, Zhejiang, Peoples R China; [Tan, Lei; Zheng, Bo; Chen, Jun-Jie] Nanjing Univ, Collaborat Innovat Ctr Adv Microstruct, Nanjing 210093, Jiangsu, Peoples R China	Zhejiang University; Nanjing University	Zheng, B (corresponding author), Zhejiang Univ, Dept Phys, Hangzhou 310027, Zhejiang, Peoples R China.	zhengbo@zju.edu.cn	zheng, bo/E-8351-2011	Zheng, Bo/0000-0001-6080-5503	NNSF of China [11375149, 11075137]; Zhejiang Provincial Natural Science Foundation of China [Z6090130]	NNSF of China(National Natural Science Foundation of China (NSFC)); Zhejiang Provincial Natural Science Foundation of China(Natural Science Foundation of Zhejiang Province)	This work was supported in part by NNSF of China under Grant Nos. 11375149 and 11075137, and Zhejiang Provincial Natural Science Foundation of China under Grant No. Z6090130. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bekaert G, 2000, REV FINANC STUD, V13, P1, DOI 10.1093/rfs/13.1.1; Black F., 1976, P AM STAT ASS BUS EC, P177; BOLLERSLEV T, 1986, J ECONOMETRICS, V31, P307, DOI 10.1016/0304-4076(86)90063-1; Bollerslev T., 2006, J FINANCIAL ECONOMET, V4, P353, DOI DOI 10.1093/JJFINEC/NBJ014; Bonabeau E, 2002, P NATL ACAD SCI USA, V99, P7280, DOI 10.1073/pnas.082080899; Bouchaud JP, 2001, PHYS REV LETT, V87, part. no., DOI 10.1103/PhysRevLett.87.228701; Boudoukh J, 2007, J FINANC, V62, P877, DOI 10.1111/j.1540-6261.2007.01226.x; Campbell JY, 1988, REV FINANC STUD, V1, P195, DOI 10.1093/rfs/1.3.195; CAMPBELL JY, 1992, J FINANC ECON, V31, P281, DOI 10.1016/0304-405X(92)90037-X; Chen JJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079531; Cont R, 2000, MACROECON DYN, V4, P170; COX JC, 1976, J FINANC ECON, V3, P145, DOI 10.1016/0304-405X(76)90023-4; Da Z, 2011, J FINANC, V66, P1461, DOI 10.1111/j.1540-6261.2011.01679.x; Eguiluz VM, 2000, PHYS REV LETT, V85, P5659, DOI 10.1103/PhysRevLett.85.5659; FAMA EF, 1988, J FINANC ECON, V22, P3, DOI 10.1016/0304-405X(88)90020-7; Farmer JD, 2009, NATURE, V460, P685, DOI 10.1038/460685a; Feng L, 2012, P NATL ACAD SCI USA, V109, P8388, DOI 10.1073/pnas.1205013109; FRENCH KR, 1987, J FINANC ECON, V19, P3, DOI 10.1016/0304-405X(87)90026-2; Gabaix X, 2003, NATURE, V423, P267, DOI 10.1038/nature01624; GLOSTEN LR, 1993, J FINANC, V48, P1779, DOI 10.2307/2329067; Gopikrishnan P, 1999, PHYS REV E, V60, P5305, DOI 10.1103/PhysRevE.60.5305; Hommes CH, 2002, P NATL ACAD SCI USA, V99, P7221, DOI 10.1073/pnas.082080399; Jiang XF, 2014, SCI REP-UK, V4, DOI 10.1038/srep05321; Jiang XF, 2012, EPL-EUROPHYS LETT, V97, DOI 10.1209/0295-5075/97/48006; Kenett DY, 2013, SCI REP-UK, V3, DOI 10.1038/srep02110; Kenett DY, 2012, EPL-EUROPHYS LETT, V99, DOI 10.1209/0295-5075/99/38001; Kenett DY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019378; Kenett DY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015032; Kenett DY, 2010, AUCO CZECH EC REV, V4, P330; Krawiecki A, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.158701; Liu YH, 1999, PHYS REV E, V60, P1390, DOI 10.1103/PhysRevE.60.1390; Lux T, 1999, NATURE, V397, P498, DOI 10.1038/17290; Majdandzic A, 2014, NAT PHYS, V10, P34, DOI [10.1038/nphys2819, 10.1038/NPHYS2819]; MANTEGNA RN, 1995, NATURE, V376, P46, DOI 10.1038/376046a0; Moat HS, 2013, SCI REP-UK, V3, DOI 10.1038/srep01801; NELSON DB, 1991, ECONOMETRICA, V59, P347, DOI 10.2307/2938260; Onnela JP, 2003, PHYS REV E, V68, DOI 10.1103/PhysRevE.68.056110; Plerou V, 2003, NATURE, V421, P130, DOI 10.1038/421130a; Plerou V, 1999, PHYS REV LETT, V83, P1471, DOI 10.1103/PhysRevLett.83.1471; Podobnik B, 2009, P NATL ACAD SCI USA, V106, P22079, DOI 10.1073/pnas.0911983106; Preis T, 2013, SCI REP-UK, V3, DOI 10.1038/srep01684; Preis T, 2012, SCI REP-UK, V2, DOI 10.1038/srep00752; Preis T, 2011, P NATL ACAD SCI USA, V108, P7674, DOI 10.1073/pnas.1019484108; Qiu T, 2006, PHYS REV E, V73, DOI 10.1103/PhysRevE.73.065103; Ren F, 2010, NEW J PHYS, V12, DOI 10.1088/1367-2630/12/7/075030; Samanidou E, 2007, REP PROG PHYS, V70, P409, DOI 10.1088/0034-4885/70/3/R03; Shapira Y, 2011, AIP ADV, V1, DOI 10.1063/1.3598412; Shapira Y, 2009, EUR PHYS J B, V72, P657, DOI 10.1140/epjb/e2009-00384-y; Shen J, 2009, EPL-EUROPHYS LETT, V88, DOI 10.1209/0295-5075/88/28003; Shen J, 2009, EPL-EUROPHYS LETT, V86, DOI 10.1209/0295-5075/86/48005; Sornette D, 2003, PHYS REP, V378, P1, DOI 10.1016/S0370-1573(02)00634-8; Sornette D, 2014, REP PROG PHYS, V77, DOI 10.1088/0034-4885/77/6/062001; TURNER CM, 1989, J FINANC ECON, V25, P3, DOI 10.1016/0304-405X(89)90094-9; Valkanov R, 2003, J FINANC ECON, V68, P201, DOI 10.1016/S0304-405X(03)00065-5; Yamasaki K, 2005, P NATL ACAD SCI USA, V102, P9424, DOI 10.1073/pnas.0502613102; Yura Y, 2014, PHYS REV LETT, V112, DOI 10.1103/PhysRevLett.112.098703; Zhao L, 2011, P NATL ACAD SCI USA, V108, P15058, DOI 10.1073/pnas.1105239108	58	8	8	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2015	10	2							e0118399	10.1371/journal.pone.0118399	http://dx.doi.org/10.1371/journal.pone.0118399			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CC3LS	25723154	Green Published, gold, Green Submitted			2022-12-27	WOS:000350251200057
J	Mao, YJ; Xiong, LD; Wang, SY; Zhong, JQ; Zhou, RY; Li, L				Mao, Yujie; Xiong, Lidan; Wang, Siyu; Zhong, Jianqiao; Zhou, Rongying; Li, Li			Comparison of the Transcriptomes of Mouse Skin Derived Precursors (SKPs) and SKP- Derived Fibroblasts (SFBs) by RNA-Seq	PLOS ONE			English	Article							WNT SIGNALING PATHWAY; STEM-CELLS; TGF-BETA; DIFFERENTIATION; GENE; EXPRESSION; ACTIVATION; PROLIFERATION; CONTRIBUTES; REVEALS	Skin-derived precursors (SKPs) from dermis possess the capacities of self-renewal and multipotency. In vitro and in vivo studies demonstrated that they can differentiate into fibroblasts. However, little is known about the molecular mechanism of the differentiation of SKPs into fibroblasts. Here we compare the transcriptomes of mouse SKPs and SKP-derived fibroblasts (SFBs) by RNA-Seq analysis, trying to find differences in gene expression between the two kinds of cells and then elucidate the candidate genes that may play important roles in the differentiation of SKPs into fibroblasts. A total of 1971 differentially expressed genes (DEGs) were identified by RNA-Seq, which provided abundant data for further analysis. Gene Ontology enrichment analysis revealed that genes related to cell differentiation, cell proliferation, protein binding, transporter activity and membrane were significantly enriched. The most significantly up-regulated genes Wnt4, Wisp2 and Tsp-1 and down-regulated genes Slitrk1, Klk6, Agtr2, Ivl, Msx1, IL15, Atp6v0d2, Kcne1l and Thbs4 may play important roles in the differentiation of SKPs into fibroblasts. KEGG analysis showed that DEGs were significantly enriched in the TGF-beta signaling pathway, Wnt signaling pathway and Notch signaling pathway, which have been previously proven to regulate the differentiation and self-renewal of various stem cells. These identified DEGs and pathways could facilitate further investigations of the detailed molecular mechanisms, making it possible to take advantage of the potential therapeutic applications of SKPs in skin regeneration in the future.	[Mao, Yujie; Xiong, Lidan; Wang, Siyu; Zhong, Jianqiao; Zhou, Rongying; Li, Li] Sichuan Univ, West China Hosp, Dept Dermatol, Chengdu 610041, Peoples R China; [Wang, Siyu] Sichuan Acad Med Sci, Dept Dermatol, Chengdu 610041, Peoples R China; [Wang, Siyu] Sichuan Prov Peoples Hosp, Chengdu 610041, Peoples R China; [Zhong, Jianqiao] Luzhou Med Coll, Dept Dermatol, Affiliated Hosp, Luzhou 646000, Peoples R China	Sichuan University; Sichuan Provincial People's Hospital; Sichuan Provincial People's Hospital; Southwest Medical University	Li, L (corresponding author), Sichuan Univ, West China Hosp, Dept Dermatol, Chengdu 610041, Peoples R China.	lili6271@gmail.com		Xiong, Lidan/0000-0001-8534-4408	National Natural Science Foundation of China [81071312]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (81071312), (http://www.nsfc.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Audic S, 1997, GENOME RES, V7, P986, DOI 10.1101/gr.7.10.986; Benjamini Y, 2001, ANN STAT, V29, P1165; Benner EJ, 2013, NATURE, V497, P369, DOI 10.1038/nature12069; Biernaskie J, 2006, INT J DEV NEUROSCI, V24, P514, DOI 10.1016/j.ijdevneu.2006.09.105; Biernaskie J, 2009, CELL STEM CELL, V5, P610, DOI 10.1016/j.stem.2009.10.019; Biernaskie JA, 2006, NAT PROTOC, V1, P2803, DOI 10.1038/nprot.2006.422; Bige N, 2012, KIDNEY INT, V81, P1226, DOI 10.1038/ki.2012.21; Chen BY, 2013, J NEUROSCI RES, V91, P30, DOI 10.1002/jnr.23138; Cloonan N, 2008, NAT METHODS, V5, P613, DOI 10.1038/nmeth.1223; Dyce PW, 2004, BIOCHEM BIOPH RES CO, V316, P651, DOI 10.1016/j.bbrc.2004.02.093; Falk S, 2014, CEREB CORTEX, V24, P2951, DOI 10.1093/cercor/bht149; Feng ZL, 2004, BIOCHEM BIOPH RES CO, V324, P1333, DOI 10.1016/j.bbrc.2004.09.206; Fernandes KJL, 2004, NAT CELL BIOL, V6, P1082, DOI 10.1038/ncb1181; Fu X, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-161; Gomez-Nicola D, 2011, MOL BIOL CELL, V22, P1960, DOI 10.1091/mbc.E11-01-0053; Guttman M, 2010, NAT BIOTECHNOL, V28, P503, DOI 10.1038/nbt.1633; Hammarstedt A, 2013, P NATL ACAD SCI USA, V110, P2563, DOI 10.1073/pnas.1211255110; HEIN L, 1995, NATURE, V377, P744, DOI 10.1038/377744a0; ICHIKI T, 1995, NATURE, V377, P748, DOI 10.1038/377748a0; Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882; Kang HK, 2011, INT J MOL MED, V28, P1001, DOI 10.3892/ijmm.2011.785; Katayama K, 2010, MOL PSYCHIATR, V15, P177, DOI 10.1038/mp.2008.97; Ke ZF, 2013, TISSUE CELL, V45, P95, DOI 10.1016/j.tice.2012.09.008; Kitisin K, 2007, SCI STKE, V2007, pcm1; Lee SH, 2006, NAT MED, V12, P1403, DOI 10.1038/nm1514; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; Liu DD, 2013, J CELL BIOCHEM, V114, P1105, DOI 10.1002/jcb.24451; Liu Y, 2013, EUR REV MED PHARMACO, V17, P1611; Marioni JC, 2008, GENOME RES, V18, P1509, DOI 10.1101/gr.079558.108; Massague J, 2012, FEBS LETT, V586, P1953, DOI 10.1016/j.febslet.2012.03.023; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Murakami K, 2013, NEUROSCIENCE, V236, P1, DOI 10.1016/j.neuroscience.2012.12.073; Osathanon T, 2012, CELL BIOL INT, V36, P1161, DOI 10.1042/CBI20120288; Pallero MA, 2008, FASEB J, V22, P3968, DOI 10.1096/fj.07-104802; Piccini M, 1999, GENOMICS, V60, P251, DOI 10.1006/geno.1999.5904; Plescia CP, 2001, DIFFERENTIATION, V68, P254, DOI 10.1046/j.1432-0436.2001.680413.x; SATOKATA I, 1994, NAT GENET, V6, P348, DOI 10.1038/ng0494-348; Sinha S, 2004, AM J PHYSIOL-CELL PH, V287, pC1560, DOI 10.1152/ajpcell.00221.2004; Toma JG, 2001, NAT CELL BIOL, V3, P778, DOI 10.1038/ncb0901-778; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Wilhelm BT, 2009, METHODS, V48, P249, DOI 10.1016/j.ymeth.2009.03.016; Wolfe A, 2011, J PHARMACOL EXP THER, V338, P12, DOI 10.1124/jpet.111.179390; Yang W, 2008, CANCER RES, V68, P4287, DOI 10.1158/0008-5472.CAN-07-6691; Yang Z, 2009, STEM CELLS DEV, V18, P929, DOI 10.1089/scd.2008.0219; Ye J, 2006, NUCLEIC ACIDS RES, V34, pW293, DOI 10.1093/nar/gkl031; Zhang LL, 2012, BIOCHEM BIOPH RES CO, V420, P875, DOI 10.1016/j.bbrc.2012.03.092; Zhao MT, 2010, CELL REPROGRAM, V12, P161, DOI 10.1089/cell.2009.0060; Zhao MT, 2009, CLONING STEM CELLS, V11, P111, DOI 10.1089/clo.2008.0071	48	11	12	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2015	10	2							e0117739	10.1371/journal.pone.0117739	http://dx.doi.org/10.1371/journal.pone.0117739			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC2ZH	25719759	Green Published, gold, Green Submitted			2022-12-27	WOS:000350213200030
J	Yang, Q; Chen, HG; Li, BZ				Yang, Qin; Chen, Huaguo; Li, Baizhan			Polycyclic Aromatic Hydrocarbons (PAHs) in Indoor Dusts of Guizhou, Southwest of China: Status, Sources and Potential Human Health Risk	PLOS ONE			English	Article							SOURCE APPORTIONMENT; SURFACE SEDIMENTS; DIETARY EXPOSURE; CANCER-RISK; ROAD DUST; URBAN; SOILS; CITY; INDUSTRIAL; EFFICIENCY	Polycyclic aromatic hydrocarbons (PAHs) were analyzed for 136 indoor dust samples collected from Guizhou province, southwest of China. The Sigma 18PAHs concentrations ranged from 2.18 mu g.g-1 to 14.20 mu g.g-1 with the mean value of 6.78 mu g.g-1. The highest S18PAHs concentration was found in dust samples from orefields, followed by city, town and village. Moreover, the mean concentration of Sigma 18PAHs in indoor dust was at least 10% higher than that of outdoors. The 4-6 rings PAHs, contributing more than 70% of Sigma 18PAHs, were the dominant species. PAHs ratios, principal component analysis with multiple linear regression (PCA-MLR) and hierarchical clustering analysis (HCA) were applied to evaluate the possible sources. Two major origins of PAHs in indoor dust were identified as vehicle emissions and coal combustion. The mean incremental lifetime cancer risk (ILCR) due to human exposure to indoor dust PAHs in city, town, village and orefield of Guizhou province, China was 6.14x10(-6), 5.00x10(-6), 3.08x10(-6), 6.02x10(-6) for children and 5.92x10(-6), 4.83x10(-6), 2.97x10(-6), 5.81x10(-6) for adults, respectively.	[Yang, Qin; Li, Baizhan] Chongqing Univ, Coll Urban Construct & Environm Engn, Chongqing 630044, Peoples R China; [Yang, Qin] Guizhou Univ, Coll Civil Engn, Guiyang 550003, Guizhou, Peoples R China; [Chen, Huaguo] Guizhou Normal Univ, Engn Lab Qual Control & Evaluat Technol Med, Guiyang, Guizhou, Peoples R China	Chongqing University; Guizhou University; Guizhou Normal University	Li, BZ (corresponding author), Chongqing Univ, Coll Urban Construct & Environm Engn, Chongqing 630044, Peoples R China.	baizhanli09@gmail.com	li, bing/GWQ-9617-2022; li, bz/GVR-7133-2022	Li, Baizhan/0000-0001-7526-1748	Guizhou province science and technology plan;  [2011-4008];  [ZY-2011-3013];  [KY-2012-005]	Guizhou province science and technology plan; ; ; 	This work was supported by the Guizhou province science and technology plan. Project No. 2011-4008 was used to fund study design and manuscript preparation, project No. ZY-2011-3013 was used for data collection and project No. KY-2012-005 provided funds for sample analysis.	Barro R, 2009, J CHROMATOGR A, V1216, P540, DOI 10.1016/j.chroma.2008.10.117; Chen HY, 2012, SCI TOTAL ENVIRON, V414, P293, DOI 10.1016/j.scitotenv.2011.10.057; Cheng JP, 2009, ENVIRON INT, V35, P619, DOI 10.1016/j.envint.2008.12.006; de Andrade SJ, 2010, ATMOS ENVIRON, V44, P2913, DOI 10.1016/j.atmosenv.2010.04.026; Dong TTT, 2009, CHEMOSPHERE, V74, P1245, DOI 10.1016/j.chemosphere.2008.11.035; Guerriero E, 2008, J AIR WASTE MANAGE, V58, P1401, DOI 10.3155/1047-3289.58.11.1401; Hahladakis JN, 2013, J HAZARD MATER, V250, P256, DOI 10.1016/j.jhazmat.2013.02.005; Han B, 2011, J ENVIRON MONITOR, V13, P2597, DOI 10.1039/c1em10251f; Hanedar A, 2014, SCI TOTAL ENVIRON, V488, P439, DOI 10.1016/j.scitotenv.2013.11.123; Haritash AK, 2009, J HAZARD MATER, V169, P1, DOI 10.1016/j.jhazmat.2009.03.137; Hassanien MA, 2008, J HAZARD MATER, V151, P247, DOI 10.1016/j.jhazmat.2007.05.079; Hien TT, 2007, ATMOS ENVIRON, V41, P1575, DOI 10.1016/j.atmosenv.2006.10.045; Hu J, 2006, B ENVIRON CONTAM TOX, V76, P80, DOI 10.1007/s00128-005-0892-8; Hu J, 2012, ATMOS RES, V118, P271, DOI 10.1016/j.atmosres.2012.07.015; Hu YD, 2007, SCI TOTAL ENVIRON, V382, P240, DOI 10.1016/j.scitotenv.2007.04.038; Barrado AI, 2012, ATMOS ENVIRON, V49, P224, DOI 10.1016/j.atmosenv.2011.11.056; Jamhari AA, 2014, ATMOS ENVIRON, V86, P16, DOI 10.1016/j.atmosenv.2013.12.019; Kamal A, 2014, SCI TOTAL ENVIRON, V493, P562, DOI 10.1016/j.scitotenv.2014.05.140; Kang YA, 2010, ENVIRON INT, V36, P542, DOI 10.1016/j.envint.2010.04.006; Kanzari F, 2014, SCI TOTAL ENVIRON, V478, P141, DOI 10.1016/j.scitotenv.2014.01.065; Kliucininkas L, 2011, J ENVIRON MONITOR, V13, P182, DOI 10.1039/c0em00260g; Lambert TW, 2004, ENVIRON HEALTH PERSP, V112, P35, DOI 10.1289/ehp.6423; Li WH, 2012, ECOTOX ENVIRON SAFE, V75, P198, DOI 10.1016/j.ecoenv.2011.08.021; Li Z, 2010, J ENVIRON MONITOR, V12, P1110, DOI 10.1039/c000689k; Lioy PJ, 2002, ENVIRON HEALTH PERSP, V110, P969, DOI 10.1289/ehp.02110969; Mannino MR, 2008, ATMOS ENVIRON, V42, P1801, DOI 10.1016/j.atmosenv.2007.11.031; Peng H, 2012, ENVIRON GEOCHEM HLTH, V34, P587, DOI 10.1007/s10653-012-9456-0; Petry T, 1996, CHEMOSPHERE, V32, P639, DOI 10.1016/0045-6535(95)00348-7; Ren Y, 2006, B ENVIRON CONTAM TOX, V76, P442, DOI 10.1007/s00128-006-0941-y; Saha M, 2009, MAR POLLUT BULL, V58, P189, DOI 10.1016/j.marpolbul.2008.04.049; Schulte PA, 2012, TOXICOL LETT, V213, P91, DOI 10.1016/j.toxlet.2011.03.027; Shostak S, 2003, SOC SCI MED, V56, P2327, DOI 10.1016/S0277-9536(02)00231-9; Tan JH, 2011, ATMOS RES, V102, P91, DOI 10.1016/j.atmosres.2011.06.012; U.S. EPA, 2001, SUPPL GUID DEV SOIL; US EPA (US Environmental Protection Agency), 1991, RISK ASS GUID SUP B, V1; Van Oostdam J, 1999, SCI TOTAL ENVIRON, V230, P1, DOI 10.1016/S0048-9697(99)00036-4; Wang HS, 2010, ECOTOX ENVIRON SAFE, V73, P900, DOI 10.1016/j.ecoenv.2010.04.010; Wang W, 2011, SCI TOTAL ENVIRON, V409, P4519, DOI 10.1016/j.scitotenv.2011.07.030; Wang XT, 2013, SCI TOTAL ENVIRON, V447, P80, DOI 10.1016/j.scitotenv.2012.12.086; Wei YJ, 2010, CHEMOSPHERE, V81, P1280, DOI 10.1016/j.chemosphere.2010.08.055; WILD SR, 1991, SCI TOTAL ENVIRON, V101, P235, DOI 10.1016/0048-9697(91)90037-F; WILSON SC, 1993, ENVIRON POLLUT, V81, P229, DOI 10.1016/0269-7491(93)90206-4; Wu Y, 2014, SCI TOTAL ENVIRON, V470, P76, DOI 10.1016/j.scitotenv.2013.09.066; Xia ZH, 2010, SCI TOTAL ENVIRON, V408, P5331, DOI 10.1016/j.scitotenv.2010.08.008; Yang JL, 2010, CHINESE MED J-PEKING, V123, P361, DOI 10.3760/cma.j.issn.0366-6999.2010.03.019; Yang W, 2014, CHEMOSPHERE, V112, P289, DOI 10.1016/j.chemosphere.2014.04.074; Yao H, 2011, ENVIRON TOXICOL CHEM, V30, P530, DOI 10.1002/etc.413; Yim UH, 2005, MAR POLLUT BULL, V50, P319, DOI 10.1016/j.marpolbul.2004.11.003; Yuan HM, 2014, MAR POLLUT BULL, V83, P258, DOI 10.1016/j.marpolbul.2014.03.043; Zhang HF, 2012, ATMOS ENVIRON, V51, P94, DOI 10.1016/j.atmosenv.2012.01.042; Zhao ZH, 2014, ECOTOX ENVIRON SAFE, V104, P323, DOI 10.1016/j.ecoenv.2014.01.037	51	54	57	6	86	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2015	10	2							e0118141	10.1371/journal.pone.0118141	http://dx.doi.org/10.1371/journal.pone.0118141			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC2ZH	25719362	Green Submitted, gold, Green Published			2022-12-27	WOS:000350213200039
J	Erlacher, A; Cardinale, M; Grube, M; Berg, G				Erlacher, Armin; Cardinale, Massimiliano; Grube, Martin; Berg, Gabriele			Biotic Stress Shifted Structure and Abundance of Enterobacteriaceae in the Lettuce Microbiome	PLOS ONE			English	Article							16S RIBOSOMAL-RNA; RHIZOSPHERE MICROBIOME; BACTERIAL COMMUNITIES; DIVERSITY; PATHOGENS; INSIGHTS; GENES; GUT	Lettuce cultivars are not only amongst the most popular vegetables eaten raw, they are also involved in severe pathogen outbreaks world-wide. While outbreaks caused by Enterobacteriaceae species are well-studied, less is known about their occurrence in natural environments as well as the impact of biotic stress. Here, we studied the ecology of the human health-relevant bacterial family Enterobacteriaceae and assessed the impact of biotic disturbances by a soil-borne phytopathogenic fungus and Gastropoda on their structure and abundance in mesocosm and pot experiments. Using a polyphasic approach including network analyses of 16S rRNA gene amplicon libraries, quantitative PCR and complementary fluorescence in situ hybridization (FISH) microscopy we found substantial yet divergent Enterobacteriaceae communities. A similar spectrum of 14 genera was identified from rhizo- and phyllospheres but the abundance of Enterobacteriaceae was on average 3fold higher in phyllosphere samples. Both stress factors shifted the bacterial community of the leaf habitat, characterized by increases of species abundance and diversity. For the rhizosphere, we observed significant structural shifts of Enterobacteriaceae communities but also a high degree of resilience. These results could be confirmed by FISH microscopy but it was difficult to visualize phyllosphere communities. Additional inoculation experiments with Escherichia coli as model revealed their presence below the wax layer as well as in the endosphere of leaves. The observed presence influenced by stress factors and the endophytic life style of Enterobacteriaceae on lettuce can be an important aspect in relation to human health.	[Erlacher, Armin; Cardinale, Massimiliano; Berg, Gabriele] Graz Univ Technol, Inst Environm Biotechnol, A-8010 Graz, Austria; [Erlacher, Armin; Cardinale, Massimiliano; Grube, Martin] Graz Univ, Inst Plant Sci, A-8010 Graz, Austria	Graz University of Technology; University of Graz	Berg, G (corresponding author), Graz Univ Technol, Inst Environm Biotechnol, Petersgasse 12, A-8010 Graz, Austria.	gabriele.berg@tugraz.at	Cardinale, Massimiliano/B-8269-2014	Cardinale, Massimiliano/0000-0003-1421-722X; Berg, Gabriele/0000-0001-9423-3101; Grube, Martin/0000-0001-6940-5282	EFRE by the European Union [A3-11.P-33/2011-6]; Land Steiermark [A3-11.P-33/2011-6]	EFRE by the European Union; Land Steiermark	This work was cooperatively funded in the frame of EFRE by the European Union and Land Steiermark, grant number: A3-11.P-33/2011-6. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMANN RI, 1990, APPL ENVIRON MICROB, V56, P1919, DOI 10.1128/AEM.56.6.1919-1925.1990; Berendsen RL, 2012, TRENDS PLANT SCI, V17, P478, DOI 10.1016/j.tplants.2012.04.001; Berg G, 2005, FEMS MICROBIOL ECOL, V51, P215, DOI 10.1016/j.femsec.2004.08.006; Berg G, 2005, ENVIRON MICROBIOL, V7, P1673, DOI 10.1111/j.1462-2920.2005.00891.x; Berg G, 2009, FEMS MICROBIOL ECOL, V68, P1, DOI 10.1111/j.1574-6941.2009.00654.x; Binh CTT, 2010, AGR ISSUES POLICIES, P141; Blaser M, 2013, NAT REV MICROBIOL, V11, P213, DOI 10.1038/nrmicro2973; Bragina A, 2012, ISME J, V6, P802, DOI 10.1038/ismej.2011.151; Brandl MT, 2006, ANNU REV PHYTOPATHOL, V44, P367, DOI 10.1146/annurev.phyto.44.070505.143359; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Cardinale M, 2008, FEMS MICROBIOL ECOL, V66, P63, DOI 10.1111/j.1574-6941.2008.00546.x; Chowdhury SP, 2014, PLOS ONE, V8; Clemente JC, 2012, CELL, V148, P1258, DOI 10.1016/j.cell.2012.01.035; CONNELL JH, 1978, SCIENCE, V199, P1302, DOI 10.1126/science.199.4335.1302; Doreswamy V, 2011, CLIN EXP ALLERGY, V41, P9, DOI 10.1111/j.1365-2222.2010.03628.x; Erlacher A, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00175; Fox JW, 2013, TRENDS ECOL EVOL, V28, P572, DOI 10.1016/j.tree.2013.07.008; Franz E, 2007, FOOD MICROBIOL, V24, P106, DOI 10.1016/j.fm.2006.03.002; Fredricks DN, 1996, CLIN MICROBIOL REV, V9, P18, DOI 10.1128/CMR.9.1.18; Grosch R, 2004, EUR J PLANT PATHOL, V110, P53, DOI 10.1023/B:EJPP.0000010137.69498.10; Handschur M, 2005, FOOD CHEM TOXICOL, V43, P1595, DOI 10.1016/j.fct.2005.05.009; Hanski I, 2012, P NATL ACAD SCI USA, V109, P8334, DOI 10.1073/pnas.1205624109; Heuer H, 1997, APPL ENVIRON MICROB, V63, P3233, DOI 10.1128/AEM.63.8.3233-3241.1997; Hirsch PR, 2012, NAT BIOTECHNOL, V30, P961, DOI 10.1038/nbt.2387; Hou Z, 2013, FOOD MICROBIOL, V35, P136, DOI 10.1016/j.fm.2013.03.002; Hunter PJ, 2010, APPL ENVIRON MICROB, V76, P8117, DOI 10.1128/AEM.01321-10; Leff JW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059310; Lundberg DS, 2012, NATURE, V488, P86, DOI 10.1038/nature11237; Mendes R, 2013, FEMS MICROBIOL REV, V37, P634, DOI 10.1111/1574-6976.12028; Moyne AL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070643; Muhling M, 2008, ISME J, V2, P379, DOI 10.1038/ismej.2007.97; Olaimat AN, 2012, FOOD MICROBIOL, V32, P1, DOI 10.1016/j.fm.2012.04.016; Pagaling E, 2014, ISME J, V8, P19, DOI 10.1038/ismej.2013.150; Raid RN, 1997, COMPENDIUM LETTUCE D, P15; Ramirez-Puebla ST, 2013, APPL ENVIRON MICROB, V79, P2, DOI 10.1128/AEM.02553-12; Rastogi G, 2013, FEMS MICROBIOL LETT, V348, P1, DOI 10.1111/1574-6968.12225; Rastogi G, 2012, ISME J, V6, P1812, DOI 10.1038/ismej.2012.32; Reisberg EE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078613; Rossmann B, 2012, APPL ENVIRON MICROB, V78, P4933, DOI 10.1128/AEM.00772-12; Schwieger F, 1998, APPL ENVIRON MICROB, V64, P4870; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Teplitski M, 2011, TRENDS MICROBIOL, V19, P121, DOI 10.1016/j.tim.2010.11.007; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07	43	26	26	3	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2015	10	2							e0118068	10.1371/journal.pone.0118068	http://dx.doi.org/10.1371/journal.pone.0118068			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC2IM	25714833	Green Submitted, gold, Green Published			2022-12-27	WOS:000350168700050
J	Marshall-Pescini, S; Viranyi, Z; Range, F				Marshall-Pescini, Sarah; Viranyi, Zsofia; Range, Friederike			The Effect of Domestication on Inhibitory Control: Wolves and Dogs Compared	PLOS ONE			English	Article							HUMAN POINTING GESTURES; FREE-RANGING DOGS; CANIS-FAMILIARIS; SOCIAL BRAIN; EVOLUTION; PERFORMANCE; LUPUS; HUMANS	Inhibitory control i.e. blocking an impulsive or prepotent response in favour of a more appropriate alternative, has been suggested to play an important role in cooperative behaviour. Interestingly, while dogs and wolves show a similar social organization, they differ in their intraspecific cooperation tendencies in that wolves rely more heavily on group coordination in regard to hunting and pup-rearing compared to dogs. Hence, based on the 'canine cooperation' hypothesis wolves should show better inhibitory control than dogs. On the other hand, through the domestication process, dogs may have been selected for cooperative tendencies towards humans and/or a less reactive temperament, which may in turn have affected their inhibitory control abilities. Hence, based on the latter hypothesis, we would expect dogs to show a higher performance in tasks requiring inhibitory control. To test the predictive value of these alternative hypotheses, in the current study two tasks; the 'cylinder task' and the 'detour task', which are designed to assess inhibitory control, were used to evaluate the performance of identically raised pack dogs and wolves. Results from the cylinder task showed a significantly poorer performance in wolves than identically-raised pack dogs (and showed that pack-dogs performed similarly to pet dogs with different training experiences), however contrary results emerged in the detour task, with wolves showing a shorter latency to success and less perseverative behaviour at the fence. Results are discussed in relation to previous studies using these paradigms and in terms of the validity of these two methods in assessing inhibitory control.	[Marshall-Pescini, Sarah; Viranyi, Zsofia; Range, Friederike] Univ Vienna, Med Univ Vienna, Univ Vet Med, Messerli Res Inst, Vienna, Austria; [Marshall-Pescini, Sarah; Viranyi, Zsofia; Range, Friederike] Wolf Sci Ctr, Ernstbrunn, Austria	Medical University of Vienna; University of Veterinary Medicine Vienna; University of Vienna	Marshall-Pescini, S (corresponding author), Univ Vienna, Med Univ Vienna, Univ Vet Med, Messerli Res Inst, Vienna, Austria.	sarah.marshall@vetmeduni.ac.at		Marshall-Pescini, Sarah/0000-0002-5944-4701; Range, Friederike/0000-0003-3127-5536	Austrian Science Fund (FWF) [P21244-B17]; European Research Council under the European Union's Seventh Framework Programme (FP)/ERC [311870]; WWTF project [CS11-026]; Royal Canin; Austrian Science Fund (FWF) [P 24840] Funding Source: researchfish	Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); European Research Council under the European Union's Seventh Framework Programme (FP)/ERC(European Research Council (ERC)); WWTF project; Royal Canin; Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	The project is financially supported by Austrian Science Fund (FWF) project P21244-B17. Sarah Marshall-Pescini and Friederike Range were supported by funding from the European Research Council under the European Union's Seventh Framework Programme (FP/2007-2013)/ERC Grant Agreement n. [311870] and from the WWTF project CS11-026. The authors further thank many private sponsors including Royal Canin for financial support and the Game Park Ernstbrunn for hosting the Wolf Science Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amici F, 2008, CURR BIOL, V18, P1415, DOI 10.1016/j.cub.2008.08.020; Amici F, 2009, P ROY SOC B-BIOL SCI, V276, P3311, DOI 10.1098/rspb.2009.0759; Bailey I, 2013, BEHAV ECOL SOCIOBIOL, V67, P1, DOI 10.1007/s00265-012-1423-3; BOITANI L, 1995, ETHOL ECOL EVOL, V7, P49, DOI 10.1080/08927014.1995.9522969; Bonanni R, 2010, ANIM BEHAV, V79, P981, DOI 10.1016/j.anbehav.2010.02.021; Bonanni R, 2010, ANIM BEHAV, V79, P957, DOI 10.1016/j.anbehav.2010.01.016; Bray EE, 2014, ANIM COGN, V17, P15, DOI 10.1007/s10071-013-0633-z; Burkart JM, 2009, EVOL ANTHROPOL, V18, P175, DOI 10.1002/evan.20222; Burkart JM, 2010, ANIM COGN, V13, P1, DOI 10.1007/s10071-009-0263-7; Butler JRA, 2004, BIOL CONSERV, V115, P369, DOI 10.1016/S0006-3207(03)00152-6; Byrne R., 1988, MACHIAVELLIAN INTELL; Byrne RW, 2007, CURR BIOL, V17, pR714, DOI 10.1016/j.cub.2007.05.069; Cafazzo S, 2010, BEHAV ECOL, V21, P443, DOI 10.1093/beheco/arq001; DANIELS TJ, 1989, J MAMMAL, V70, P754, DOI 10.2307/1381709; Dunbar RIM, 2007, SCIENCE, V317, P1344, DOI 10.1126/science.1145463; Dunbar RIM, 2009, ANN HUM BIOL, V36, P562, DOI 10.1080/03014460902960289; Dunbar RIM, 1998, EVOL ANTHROPOL, V6, P178, DOI 10.1002/(SICI)1520-6505(1998)6:5<178::AID-EVAN5>3.0.CO;2-8; FRANK H, 1985, J COMP PSYCHOL, V99, P266, DOI 10.1037/0735-7036.99.3.266; FRANK H, 1989, B PSYCHONOMIC SOC, V27, P455; FRANK H, 1982, ANIM BEHAV, V30, P95, DOI 10.1016/S0003-3472(82)80241-8; Frank H, 1987, MAN WOLF, P275; Gacsi M, 2005, DEV PSYCHOBIOL, V47, P111, DOI 10.1002/dev.20082; Gacsi M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006584; Hare B, 2005, TRENDS COGN SCI, V9, P439, DOI 10.1016/j.tics.2005.07.003; Hare B, 2005, CURR BIOL, V15, P226, DOI 10.1016/j.cub.2005.01.040; Hare B, 2012, ANIM BEHAV, V83, P573, DOI 10.1016/j.anbehav.2011.12.007; MacLean EL, 2014, P NATL ACAD SCI USA, V111, pE2140, DOI 10.1073/pnas.1323533111; Manor R, 2004, BIOL CONSERV, V119, P231, DOI 10.1016/j.biocon.2003.11.005; Mech D, 1970, WOLF ECOLOGY BEHAV E, DOI [10.3109/inf.1970.2.issue-3.14, DOI 10.3109/INF.1970.2]; Mech L. David, 2003, P1; Miklosi A, 2003, CURR BIOL, V13, P763, DOI 10.1016/S0960-9822(03)00263-X; Miller HC, 2010, PSYCHOL SCI, V21, P534, DOI 10.1177/0956797610364968; Pal SK, 2005, APPL ANIM BEHAV SCI, V90, P31, DOI 10.1016/j.applanim.2004.08.002; Pongracz M, 2005, APPL ANIM BEHAV SCI, V90, P309, DOI 10.1016/j.applanim.2004.08.004; Pongracz P, 2003, ANIM BEHAV, V65, P595, DOI 10.1006/anbe.2003.2079; Pongracz P, 2001, ANIM BEHAV, V62, P1109, DOI 10.1006/anbe.2001.1866; Pongracz P, 2008, ANIM COGN, V7, P90; Range F, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00868; Range F, 2012, ANIM COGN, V15, P597, DOI 10.1007/s10071-012-0488-8; Rosati AG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063058; Schmidt PA, 1997, AM NAT, V150, P513, DOI 10.1086/286079; Shultz S, 2007, P ROY SOC B-BIOL SCI, V274, P2429, DOI 10.1098/rspb.2007.0693; Sillero-Zubiri C, 2004, STATUS SURVEY CONSER, V62; Smith BP, 2010, ANIM BEHAV, V80, P155, DOI 10.1016/j.anbehav.2010.04.017; Thierry B, 2007, EVOL ANTHROPOL, V16, P224, DOI 10.1002/evan.20147; van Schaik CP, 2010, MIND THE GAP: TRACING THE ORIGINS OF HUMAN UNIVERSALS, P477, DOI 10.1007/978-3-642-02725-3_22; Viranyi Z, 2014, THE SOCIAL DOG BEHAV; Viranyi Z, 2008, ANIM COGN, V11, P373, DOI 10.1007/s10071-007-0127-y	48	74	75	0	184	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2015	10	2							e0118469	10.1371/journal.pone.0118469	http://dx.doi.org/10.1371/journal.pone.0118469			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC2IM	25714840	Green Published, gold, Green Submitted			2022-12-27	WOS:000350168700078
J	Rovero, F; Mtui, A; Kitegile, A; Jacob, P; Araldi, A; Tenan, S				Rovero, Francesco; Mtui, Arafat; Kitegile, Amani; Jacob, Philipo; Araldi, Alessandro; Tenan, Simone			Primates Decline Rapidly in Unprotected Forests: Evidence from a Monitoring Program with Data Constraints	PLOS ONE			English	Article							KIBALE NATIONAL-PARK; UDZUNGWA RED COLOBUS; LONG-TERM; COMMUNITY DYNAMICS; MOUNTAINS; CONSERVATION; TANZANIA; MODELS; POPULATIONS; ABUNDANCE	Growing threats to primates in tropical forests make robust and long-term population abundance assessments increasingly important for conservation. Concomitantly, monitoring becomes particularly relevant in countries with primate habitat. Yet monitoring schemes in these countries often suffer from logistic constraints and/or poor rigor in data collection, and a lack of consideration of sources of bias in analysis. To address the need for feasible monitoring schemes and flexible analytical tools for robust trend estimates, we analyzed data collected by local technicians on abundance of three species of arboreal monkey in the Udzungwa Mountains of Tanzania (two Colobus species and one Cercopithecus), an area of international importance for primate endemism and conservation. We counted primate social groups along eight line transects in two forest blocks in the area, one protected and one unprotected, over a span of 11 years. We applied a recently proposed open metapopulation model to estimate abundance trends while controlling for confounding effects of observer, site, and season. Primate populations were stable in the protected forest, while the colobines, including the endemic Udzungwa red colobus, declined severely in the unprotected forest. Targeted hunting pressure at this second site is the most plausible explanation for the trend observed. The unexplained variability in detection probability among transects was greater than the variability due to observers, indicating consistency in data collection among observers. There were no significant differences in both primate abundance and detectability between wet and dry seasons, supporting the choice of sampling during the dry season only based on minimizing practical constraints. Results show that simple monitoring routines implemented by trained local technicians can effectively detect changes in primate populations in tropical countries. The hierarchical Bayesian model formulation adopted provides a flexible tool to determine temporal trends with full account for any imbalance in the data set and for imperfect detection.	[Rovero, Francesco; Araldi, Alessandro] MUSE Museo Sci, Trop Biodivers Sect, Trento, Italy; [Rovero, Francesco; Mtui, Arafat; Jacob, Philipo] Udzungwa Mt Natl Pk, Udzungwa Ecol Monitoring Ctr, Mangula, Tanzania; [Mtui, Arafat] Coll African Wildlife Management, Mweka, Tanzania; [Kitegile, Amani] Sokoine Univ Agr, Dept Wildlife Management, Morogoro, Tanzania; [Tenan, Simone] MUSE Museo Sci, Vertebrate Zool Sect, Trento, Italy	Sokoine University of Agriculture	Rovero, F (corresponding author), MUSE Museo Sci, Trop Biodivers Sect, Corso Lavoro & Sci 3, Trento, Italy.	francesco.rovero@muse.it	Tenan, Simone/N-5246-2014; Rovero, Francesco/AAI-3157-2020	Tenan, Simone/0000-0001-5055-9193; Rovero, Francesco/0000-0001-6688-1494	MUSE - Museo delle Scienze through the Udzungwa Ecological Monitoring Centre; Margot Marsh Biodiversity Foundation; Rufford Foundation	MUSE - Museo delle Scienze through the Udzungwa Ecological Monitoring Centre; Margot Marsh Biodiversity Foundation; Rufford Foundation	Most of the funding for this study came from MUSE - Museo delle Scienze through its support to the Udzungwa Ecological Monitoring Centre; co-funding was from the Margot Marsh Biodiversity Foundation and the Rufford Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrianandrasana HT, 2005, BIODIVERS CONSERV, V14, P2757, DOI 10.1007/s10531-005-8413-y; [Anonymous], 1982, ESTIMATION ANIMAL AB; Araldi A, 2014, INT J PRIMATOL, V35, P941, DOI 10.1007/s10764-014-9772-6; Barelli C., 2014, HIGH ALTITUDE PRIMAT, P211, DOI [10.1007/978-1-4614-8175-1_12, DOI 10.1007/978-1-4614-8175-1_12]; Brooks SP, 2003, PHILOS T ROY SOC A, V361, P2681, DOI 10.1098/rsta.2003.1263; Brooks SP, 1998, J COMPUT GRAPH STAT, V7, P434, DOI 10.2307/1390675; Buckland ST, 2010, INT J PRIMATOL, V31, P833, DOI 10.1007/s10764-010-9431-5; Burton AC, 2012, BIODIVERS CONSERV, V21, P3079, DOI 10.1007/s10531-012-0355-6; Chandler RB, 2011, ECOLOGY, V92, P1429, DOI 10.1890/10-2433.1; Chandler RB, 2011, J APPL ECOL, V48, P1038, DOI 10.1111/j.1365-2664.2011.02001.x; Chapman CA, 2000, CONSERV BIOL, V14, P207, DOI 10.1046/j.1523-1739.2000.98592.x; Chapman CA, 2010, ECOL APPL, V20, P179, DOI 10.1890/09-0128.1; Cowlishaw G., 2000, PRIMATE CONSERVATION; Dail D, 2011, BIOMETRICS, V67, P577, DOI 10.1111/j.1541-0420.2010.01465.x; Danielsen F, 2005, BIODIVERS CONSERV, V14, P2507, DOI 10.1007/s10531-005-8375-0; Danielsen F, 2009, CONSERV BIOL, V23, P31, DOI 10.1111/j.1523-1739.2008.01063.x; Davenport TRB, 2014, ORYX, V48, P39, DOI 10.1017/S0030605312001676; de Thoisy B, 2005, ORYX, V39, P149, DOI 10.1017/S0030605305000384; Dinesen L, 2001, BIOL CONSERV, V99, P223, DOI 10.1016/S0006-3207(00)00218-4; Gelman A., 2004, BAYESIAN DATA ANAL; Gimenez O, 2009, ENVIRON ECOL STAT SE, V3, P883, DOI 10.1007/978-0-387-78151-8_41; Harcourt AH, 2005, J APPL ECOL, V42, P630, DOI 10.1111/j.1365-2664.2005.01037.x; Keane A, 2011, J APPL ECOL, V48, P1164, DOI 10.1111/j.1365-2664.2011.02034.x; Langtimm CA, 2011, J WILDLIFE MANAGE, V75, P399, DOI 10.1002/jwmg.41; Le Saout S, 2013, SCIENCE, V342, P803, DOI 10.1126/science.1239268; Linder JM, 2011, BIOL CONSERV, V144, P738, DOI 10.1016/j.biocon.2010.10.023; Lovett JC, 2006, AFR J ECOL, V44, P478, DOI 10.1111/j.1365-2028.2006.00660.x; Lwanga JS, 2011, AM J PRIMATOL, V15, P1; Marshall AR, 2008, AM J PRIMATOL, V70, P452, DOI 10.1002/ajp.20516; Mitani JC, 2000, INT J PRIMATOL, V21, P269, DOI 10.1023/A:1005477504728; N'Goran PK, 2012, CONSERV BIOL, V26, P565, DOI 10.1111/j.1523-1739.2012.01821.x; Oates JF, 1996, AUST J ECOL, V21, P1, DOI 10.1111/j.1442-9993.1996.tb00580.x; Plummer M., 2013, RJAGS BAYESIAN GRAPH; Plummer M., 2003, P 3 INT WORKSH DISTR; Pollock KH, 2002, ENVIRONMETRICS, V13, P105, DOI 10.1002/env.514; R Development Core Team, 2013, R: A Language and Environment for Statistical Computing; Rovero F., 2010, UZUNGWA SCARP FOREST; Rovero F, 2006, INT J PRIMATOL, V27, P675, DOI 10.1007/s10764-006-9037-0; Rovero F, 2014, DIVERS DISTRIB, V20, P1438, DOI 10.1111/ddi.12246; Rovero F, 2012, BIOL CONSERV, V146, P89, DOI 10.1016/j.biocon.2011.09.017; Rovero F, 2009, J ANTHROPOL SCI, V87, P93; Royle J. A., 2008, HIERARCHICAL MODELIN; Royle JA, 2004, BIOMETRICS, V60, P108, DOI 10.1111/j.0006-341X.2004.00142.x; Solymos P, 2010, R J, V2, P29; Struhsaker TT, 2004, INT J PRIMATOL, V25, P615, DOI 10.1023/B:IJOP.0000023578.08343.4e; Tierney L, 2013, NOW SIMPLE NETWORK W; Williams B. K., 2002, ANAL MANAGEMENT ANIM; Yoccoz NG, 2001, TRENDS ECOL EVOL, V16, P446, DOI 10.1016/S0169-5347(01)02205-4	48	29	31	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2015	10	2							e0118330	10.1371/journal.pone.0118330	http://dx.doi.org/10.1371/journal.pone.0118330			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC2IM	25714404	Green Submitted, Green Published, gold			2022-12-27	WOS:000350168700065
J	Li, SM; Kang, MT; Peng, XX; Li, SY; Wang, Y; Li, L; Yu, J; Qiu, LX; Sun, YY; Liu, LR; Li, H; Sun, X; Millodot, M; Wang, NL				Li, Shi-Ming; Kang, Meng-Tian; Peng, Xiao-xia; Li, Si-Yuan; Wang, Yang; Li, Lei; Yu, Jing; Qiu, Li-Xin; Sun, Yun-Yun; Liu, Luo-Ru; Li, He; Sun, Xin; Millodot, Michel; Wang, Ningli			Efficacy of Chinese Eye Exercises on Reducing Accommodative Lag in School-Aged Children: A Randomized Controlled Trial	PLOS ONE			English	Article							BASE-LINE DATA; REFRACTIVE ERROR; MYOPIA PROGRESSION; VISUAL IMPAIRMENT; LENS COMPENSATION; DOUBLE-BLIND; PREVALENCE; VISION; ONSET; POPULATION	Purpose To evaluate the efficacy of Chinese eye exercises on reducing accommodative lag in children by a randomized, double-blinded controlled trial. Methods A total of 190 children aged 10 to 14 years with emmetropia to moderate myopia were included. They were randomly allocated to three groups: standard Chinese eye exercises group (trained for eye exercises by doctors of traditional Chinese medicine); sham point eye exercises group (instructed to massage on non-acupoints); and eyes closed group (asked to close their eyes without massage). Primary outcome was change in accommodative lag immediately after intervention. Secondary outcomes included changes in corrected near and distant visual acuity, and visual discomfort score. Results Children in the standard Chinese eye exercises group had significantly greater alleviation of accommodative lag (-0.10D) than those in sham point eye exercises group (-0.03D) and eyes closed group (0.07D) (P = 0.04). The proportion of children with alleviation of accommodative lag was significantly higher in the standard Chinese eye exercises group (54.0%) than in the sham point eye exercises group (32.8%) and the eyes closed group (34.9%) (P = 0.03). No significant differences were found in secondary outcomes. Conclusion Chinese eye exercises as performed daily in primary and middle schools in China have statistically but probably clinically insignificant effect in reducing accommodative lag of school-aged children in the short-term. Considering the higher amounts of near work load of Chinese children, the efficacy of eye exercises may be insufficient in preventing myopia progression in the long-term.	[Li, Shi-Ming; Kang, Meng-Tian; Li, Si-Yuan; Wang, Yang; Li, Lei; Yu, Jing; Qiu, Li-Xin; Sun, Yun-Yun; Wang, Ningli] Capital Med Univ, Beijing Tongren Hosp, Beijing Tongren Eye Ctr, Beijing, Peoples R China; [Peng, Xiao-xia] Capital Med Univ, Sch Publ Hlth, Beijing, Peoples R China; [Liu, Luo-Ru; Li, He] Anyang Eye Hosp, Anyang, Henan Province, Peoples R China; [Sun, Xin] Sichuan Univ, West China Hosp, Chinese Evidence Based Med Ctr, Chengdu, Peoples R China; [Sun, Xin] Sichuan Univ, West China Hosp, Clin Res & Evaluat Unit, Chengdu, Peoples R China; [Sun, Xin] McMaster Univ, Dept Clin Epidemiol & Biostat, Hamilton, ON, Canada; [Millodot, Michel] Cardiff Univ, Sch Optometry & Vis Sci, Cardiff CF10 3AX, S Glam, Wales	Capital Medical University; Capital Medical University; Sichuan University; Sichuan University; McMaster University; Cardiff University	Wang, NL (corresponding author), Capital Med Univ, Beijing Tongren Hosp, Beijing Tongren Eye Ctr, Beijing, Peoples R China.	wningli@vip.163.com			Major State Basic Research Development Program of China ("973" Program) [2011CB504601]; Beijing Nova Program [Z121107002512055]; National Natural Science Foundation of China [81120108807, 81300797]	Major State Basic Research Development Program of China ("973" Program)(National Basic Research Program of China); Beijing Nova Program(Beijing Municipal Science & Technology Commission); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by: 1. the Major State Basic Research Development Program of China ("973" Program, 2011CB504601); 2. the Major International (Regional) Joint Research Project of the National Natural Science Foundation of China (81120108807); 3. Beijing Nova Program (Z121107002512055); 4. the National Natural Science Foundation of China (81300797). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen PM, 2006, VISION RES, V46, P491, DOI 10.1016/j.visres.2005.05.007; An YS, 2009, J ALTERN COMPLEM MED, V15, P1075, DOI 10.1089/acm.2009.0257; [Anonymous], 2013, OPHTHAL PHYSL OPT, V33, P661; Berntsen DA, 2012, INVEST OPHTH VIS SCI, V53, P640, DOI 10.1167/iovs.11-7769; Berntsen DA, 2011, VISION RES, V51, P1039, DOI 10.1016/j.visres.2011.02.016; Buch H, 2004, OPHTHALMOLOGY, V111, P53, DOI 10.1016/j.ophtha.2003.05.010; Chase C, 2009, OPTOMETRY VISION SCI, V86, P883, DOI 10.1097/OPX.0b013e3181ae1b7c; GOSS DA, 1991, OPTOMETRY VISION SCI, V68, P110, DOI 10.1097/00006324-199102000-00005; Gwiazda J, 2005, OPTOMETRY VISION SCI, V82, P273, DOI 10.1097/01.OPX.0000159363.07082.7D; GWIAZDA J, 1993, INVEST OPHTH VIS SCI, V34, P690; He MG, 2009, OPTOMETRY VISION SCI, V86, P40, DOI 10.1097/OPX.0b013e3181940719; Hsu WM, 2004, OPHTHALMOLOGY, V111, P62, DOI 10.1016/j.ophtha.2003.05.011; Ip JM, 2008, INVEST OPHTH VIS SCI, V49, P2903, DOI 10.1167/iovs.07-0804; Kim TH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036638; Kirkwood BR, 2003, ESSENTIAL MED STAT; Lai XS, 2009, NEUROSCI LETT, V452, P194, DOI 10.1016/j.neulet.2009.01.052; Li G, 2003, NEUROREPORT, V14, P669, DOI 10.1097/00001756-200304150-00002; Li SM, 2013, OPHTHAL EPIDEMIOL, V20, P348, DOI 10.3109/09286586.2013.842596; Li SM, 2013, CLIN EXP OPHTHALMOL, V41, P329, DOI 10.1111/j.1442-9071.2012.02884.x; Li SM, 2011, SURV OPHTHALMOL, V56, P451, DOI 10.1016/j.survophthal.2011.06.002; Liang CK, 2008, COMPLEMENT THER MED, V16, P305, DOI 10.1016/j.ctim.2008.04.007; Liang YB, 2008, OPHTHALMOLOGY, V115, P1965, DOI 10.1016/j.ophtha.2008.05.030; Lin Z, 2013, BMC COMPLEM ALTERN M, V13, DOI 10.1186/1472-6882-13-306; Liu H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049154; MCBRIEN NA, 1986, OPHTHAL PHYSL OPT, V6, P145, DOI 10.1016/0275-5408(86)90005-0; MCBRIEN NA, 1993, INVEST OPHTH VIS SCI, V34, P205; Morgan IG, 2012, LANCET, V379, P1739, DOI 10.1016/S0140-6736(12)60272-4; Mutti DO, 2006, INVEST OPHTH VIS SCI, V47, P837, DOI 10.1167/iovs.05-0888; Nakatsuka C, 2005, JPN J OPHTHALMOL, V49, P189, DOI 10.1007/s10384-004-0175-7; Naruse Shigeta, 2000, Nippon Ganka Gakkai Zasshi, V104, P717; Norton TT, 2006, INVEST OPHTH VIS SCI, V47, P4687, DOI 10.1167/iovs.05-1369; OSTBERG O, 1992, APPL ERGON, V23, P343, DOI 10.1016/0003-6870(92)90296-8; Pan CW, 2012, OPHTHAL PHYSL OPT, V32, P3, DOI 10.1111/j.1475-1313.2011.00884.x; Park JM, 2011, COMPLEMENT THER MED, V19, pS19, DOI 10.1016/j.ctim.2010.09.004; Price H, 2013, OPTOMETRY VISION SCI, V90, P1274, DOI 10.1097/OPX.0000000000000067; Rosenfield M, 2002, OPTOMETRY VISION SCI, V79, P268, DOI 10.1097/00006324-200204000-00014; Seidel D, 2005, OPTOMETRY VISION SCI, V82, P279, DOI 10.1097/01.OPX.0000159369.85285.21; Sheppard AL, 2010, OPHTHAL PHYSL OPT, V30, P143, DOI 10.1111/j.1475-1313.2009.00701.x; Shih Y F, 1995, Chin J Physiol, V38, P35; So DW, 2002, AM J PUBLIC HEALTH, V92, P1662, DOI 10.2105/AJPH.92.10.1662; Subbaram MV, 2002, OPHTHAL PHYSL OPT, V22, P312, DOI 10.1046/j.1475-1313.2002.00037.x; Wei ML, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007842.pub2; World Health Organization, 2008, WHO STD AC POINT LOC; Xie Hong-Li, 2013, Zhonghua Yi Xue Za Zhi, V93, P999; Xiong R, 2001, CHIN J SCH HLTH, V22, P566; Zhao JL, 2000, AM J OPHTHALMOL, V129, P427, DOI 10.1016/S0002-9394(99)00452-3; Zhao R, 2012, CHIN J SCH HLTH, V33, P270; Zhu XY, 2013, EXP EYE RES, V114, P69, DOI 10.1016/j.exer.2013.02.014; Zhu XY, 2005, INVEST OPHTH VIS SCI, V46, P2238, DOI 10.1167/iovs.04-0956; Zhu XY, 2003, INVEST OPHTH VIS SCI, V44, P2818, DOI 10.1167/iovs.02-0606	50	20	26	7	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2015	10	3							e0117552	10.1371/journal.pone.0117552	http://dx.doi.org/10.1371/journal.pone.0117552			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9KG	25742161	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000350688100005
J	Puig, KL; Manocha, GD; Combs, CK				Puig, Kendra L.; Manocha, Gunjan D.; Combs, Colin K.			Amyloid Precursor Protein Mediated Changes in Intestinal Epithelial Phenotype In Vitro	PLOS ONE			English	Article							ENTERIC NERVOUS-SYSTEM; BETA-PROTEIN; ALZHEIMERS-DISEASE; PROINFLAMMATORY CYTOKINE; MOUSE MODELS; WEIGHT-LOSS; CELLS; EXPRESSION; ACTIVATION; RELEASE	Background Although APP and its proteolytic metabolites have been well examined in the central nervous system, there remains limited information of their functions outside of the brain. For example, amyloid precursor protein (APP) and amyloid beta (A beta) immunoreactivity have both been demonstrated in intestinal epithelial cells. Based upon the critical role of these cells in absorption and secretion, we sought to determine whether APP or its metabolite amyloid beta (A beta), had a definable function in these cells. Methodology/Principal Findings The human colonic epithelial cell line, Caco-2 cells, were cultured to examine APP expression and A beta secretion, uptake, and stimulation. Similar to human colonic epithelium stains, Caco-2 cells expressed APP. They also secreted A beta 1-40 and A beta 1-42, with LPS stimulating higher concentrations of A beta 1-40 secretion. The cells also responded to A beta 1-40 stimulation by increasing IL-6 cytokine secretion and decreasing cholesterol uptake. Conversely, stimulation with a sAPP-derived peptide increased cholesterol uptake. APP was associated with CD36 but not FATP4 in co-IP pull down experiments from the Caco-2 cells. Moreover, stimulation of APP with an agonist antibody acutely decreased CD36-mediated cholesterol uptake. Conclusions/Significance APP exists as part of a multi-protein complex with CD36 in human colonic epithelial cells where its proteolytic fragments have complex, reciprocal roles in regulating cholesterol uptake. A biologically active peptide fragment from the N-terminal derived, sAPP, potentiated cholesterol uptake while the beta secretase generated product, A beta 1-40, attenuated it. These data suggest that APP is important in regulating intestinal cholesterol uptake in a fashion dependent upon specific proteolytic pathways. Moreover, this biology may be applicable to cells beyond the gastrointestinal tract.	[Puig, Kendra L.; Manocha, Gunjan D.; Combs, Colin K.] Univ N Dakota, Sch Med & Hlth Sci, Dept Basic Sci, Grand Forks, ND 58201 USA	University of North Dakota Grand Forks	Combs, CK (corresponding author), Univ N Dakota, Sch Med & Hlth Sci, Dept Basic Sci, Grand Forks, ND 58201 USA.	colin.combs@med.und.edu	Manocha, Gunjan/AAF-2471-2020	Manocha, Gunjan/0000-0003-4488-6627	National Institutes of Health [5R01AG042819-03]; NATIONAL INSTITUTE ON AGING [R01AG042819] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by National Institutes of Health 5R01AG042819-03. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ano Y, 2008, MICROBIOL IMMUNOL, V52, P429, DOI 10.1111/j.1348-0421.2008.00054.x; Ano Y, 2009, HISTOL HISTOPATHOL, V24, P283, DOI 10.14670/HH-24.283; ARAI H, 1991, ANN NEUROL, V30, P686, DOI 10.1002/ana.410300509; Ariga T, 2001, J MOL NEUROSCI, V17, P371, DOI 10.1385/JMN:17:3:371; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Burgess BL, 2006, NEUROBIOL DIS, V24, P114, DOI 10.1016/j.nbd.2006.06.007; CABAL A, 1995, BRAIN RES BULL, V38, P417, DOI 10.1016/0361-9230(95)02006-D; Castellano J, 2014, J VASC RES, V51, P58, DOI 10.1159/000356334; Chabot S, 2006, J IMMUNOL, V176, P4275, DOI 10.4049/jimmunol.176.7.4275; Chong YH, 2001, J BIOL CHEM, V276, P23511, DOI 10.1074/jbc.M009466200; Combs CK, 2001, J NEUROSCI, V21, P1179; Ebert EC, 2008, AM J GASTROENTEROL, V103, P776, DOI 10.1111/j.1572-0241.2007.01669.x; Fernandez PL, 2013, J ALZHEIMERS DIS, V33, P297, DOI 10.3233/JAD-2012-121222; Gakis G, 2009, AUTON NEUROSCI-BASIC, V148, P63, DOI 10.1016/j.autneu.2009.03.004; Galloway S, 2007, J NUTR BIOCHEM, V18, P279, DOI 10.1016/j.jnutbio.2006.07.003; Galloway S, 2008, LIPIDS HEALTH DIS, V7, DOI 10.1186/1476-511X-7-15; Galloway S, 2009, LIPIDS HEALTH DIS, V8, DOI 10.1186/1476-511X-8-46; Ge YM, 2000, J INFECT DIS, V182, P873, DOI 10.1086/315784; Hajri T, 2002, ANNU REV NUTR, V22, P383, DOI 10.1146/annurev.nutr.22.020402.130846; Hauser H, 1998, BIOCHEMISTRY-US, V37, P17843, DOI 10.1021/bi982404y; Ibrahimi A, 1996, P NATL ACAD SCI USA, V93, P2646, DOI 10.1073/pnas.93.7.2646; Imaeda H, 2002, HISTOCHEM CELL BIOL, V118, P381, DOI 10.1007/s00418-002-0458-3; Inelmen EM, 2010, AGING CLIN EXP RES, V22, P192, DOI [10.3275/6677, 10.1007/BF03324796]; James AP, 2003, J ALZHEIMERS DIS, V5, P179, DOI 10.3233/JAD-2003-5302; Jijon HB, 2005, EUR J IMMUNOL, V35, P718, DOI 10.1002/eji.200425688; JOACHIM CL, 1989, NATURE, V341, P226, DOI 10.1038/341226a0; JOHANSON JF, 1992, DIGEST DIS SCI, V37, P179, DOI 10.1007/BF01308169; KLEGERIS A, 1994, BIOCHEM BIOPH RES CO, V199, P984, DOI 10.1006/bbrc.1994.1326; Koudinov AR, 1997, CELL BIOL INT, V21, P265, DOI 10.1006/cbir.1996.0126; Koudinova NV, 1996, FEBS LETT, V395, P204, DOI 10.1016/0014-5793(96)01042-3; Lam V, 2011, NEUROSCI LETT, V492, P160, DOI 10.1016/j.neulet.2011.02.001; Lorton D, 1997, MECH AGEING DEV, V94, P199, DOI 10.1016/S0047-6374(96)01847-7; Lorton D, 1996, J NEUROIMMUNOL, V67, P21, DOI 10.1016/S0165-5728(96)00030-6; Martin C, 2011, PHYSIOL BEHAV, V105, P36, DOI 10.1016/j.physbeh.2011.02.029; Naik S, 2001, J PEDIATR GASTR NUTR, V32, P449, DOI 10.1097/00005176-200104000-00011; NINOMIYA H, 1993, J CELL BIOL, V121, P879, DOI 10.1083/jcb.121.4.879; Pallebage-Gamarallage MM, 2009, BRIT J NUTR, V101, P340, DOI 10.1017/S0007114508012269; Puig KL, 2012, J NEUROIMMUNE PHARM, V7, P215, DOI 10.1007/s11481-011-9327-y; Reboul E, 2005, BIOCHEM J, V387, P455, DOI 10.1042/BJ20040554; Rockenstein E, 2001, J NEUROSCI RES, V66, P573, DOI 10.1002/jnr.1247; Santaolalla R, 2011, CURR OPIN GASTROEN, V27, P125, DOI 10.1097/MOG.0b013e3283438dea; Sattianayagam PT, 2009, NAT REV GASTRO HEPAT, V6, P608, DOI 10.1038/nrgastro.2009.147; Semar S, 2013, J ALZHEIMERS DIS, V36, P7, DOI 10.3233/JAD-120511; Sergi G, 2013, P NUTR SOC, V72, P160, DOI 10.1017/S0029665112002753; SHANKLE WR, 1993, MODERN PATHOL, V6, P10; Shifrin DA, 2012, CURR BIOL, V22, P627, DOI 10.1016/j.cub.2012.02.022; Silverstein RL, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.272re3; Sondag CM, 2006, J NEUROCHEM, V97, P449, DOI 10.1111/j.1471-4159.2006.03759.x; Sondag CM, 2004, J BIOL CHEM, V279, P14456, DOI 10.1074/jbc.M313747200; SONNENBERG A, 1994, AM J GASTROENTEROL, V89, P62; SturchlerPierrat C, 1997, P NATL ACAD SCI USA, V94, P13287, DOI 10.1073/pnas.94.24.13287; Su X, 2009, TRENDS ENDOCRIN MET, V20, P72, DOI 10.1016/j.tem.2008.11.001; Takechi R, 2008, ATHEROSCLEROSIS SUPP, V9, P19, DOI 10.1016/j.atherosclerosissup.2008.05.010; Takechi R, 2010, BRIT J NUTR, V103, P652, DOI 10.1017/S0007114509992194; Van Eldik LJ, 2007, INT REV NEUROBIOL, V82, P277, DOI 10.1016/S0074-7742(07)82015-0; Van Vickle GD, 2007, BIOCHEMISTRY-US, V46, P10317, DOI 10.1021/bi700951u; Wiskur Brandt, 2010, Curr Gastroenterol Rep, V12, P507, DOI 10.1007/s11894-010-0139-7; Yagi Seiji, 2002, Fukuoka Igaku Zasshi, V93, P38; Yang JH, 2012, EXP NEUROL, V236, P199, DOI 10.1016/j.expneurol.2012.05.008; Yates SL, 2000, J NEUROCHEM, V74, P1017, DOI 10.1046/j.1471-4159.2000.0741017.x; Zaheer A, 2008, BRAIN RES, V1208, P192, DOI 10.1016/j.brainres.2008.02.093	61	14	14	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2015	10	3							e0119534	10.1371/journal.pone.0119534	http://dx.doi.org/10.1371/journal.pone.0119534			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9KG	25742317	Green Published, gold, Green Submitted			2022-12-27	WOS:000350688100118
J	Wang, LJ; Zhao, CY; Li, J; Liu, ZH; Wang, JH				Wang, Lijuan; Zhao, Chengyi; Li, Jun; Liu, Zhihui; Wang, Jianghong			Root Plasticity of Populus euphratica Seedlings in Response to Different Water Table Depths and Contrasting Sediment Types	PLOS ONE			English	Article							PHENOTYPIC PLASTICITY; TAMARIX-RAMOSISSIMA; GROWTH; PLANT; RIVER; CONSEQUENCES; ADAPTATION; ELONGATION; MANAGEMENT; EVOLUTION	Riparian plants in arid regions face a highly variable water environment controlled by hydrological processes. To understand whether riparian plants adapt to such environments through plastic responses, we compared the root traits, biomass allocation and growth of Populus euphratica Oliv. Seedlings grown in lysimeters filled with clay or clay/river sand sediments under inundation and varying water table conditions. We hypothesized that adaptive phenotypic plasticity is likely to develop or be advantageous in seedlings of this species to allow them to adapt desert floodplain environments. Growth was significantly reduced by inundation. However, rather than following relatively fixed trait and allocation patterns, the seedlings displayed adaptive mechanisms involving the development of adventitious roots to enhance plant stability and obtain oxygen, together with a lower proportion of root biomass. At the whole-plant level, at deeper water table depths, seedlings allocated more biomass to the roots, and total root length increased with decreasing water table depths, regardless of the sediment, consistent with optimal partitioning theory. The sediment type had a significant effect on seedling root traits. P. euphratica displayed very different root traits in different sediment types under the same hydrological conditions, showing a greater first-order root number in clay sediment under shallower water table conditions, whereas rooting depth was greater in clay/river sand sediment under deep water table conditions. In clay sediment, seedlings responded to lower water availability via greater root elongation, while the root surface area was increased through increasing the total root length in clay/river sand sediment, suggesting that seedlings facing deeper water tables are not always likely to increase their root surface area to obtain more water. Our results indicate that P. euphratica seedlings are able to adapt to a range of water table conditions through plastic responses in root traits and biomass allocation.	[Wang, Lijuan; Zhao, Chengyi; Li, Jun] Chinese Acad Sci, Xinjiang Inst Ecol & Geog, State Key Lab Desert & Oasis Ecol, Urumqi, Xinjiang, Peoples R China; [Wang, Lijuan; Liu, Zhihui] Xinjiang Univ, Coll Resource & Environm Sci, Urumqi, Xinjiang, Peoples R China; [Wang, Lijuan] Univ Chinese Acad Sci, Beijing, Peoples R China; [Wang, Jianghong] Bayingol Mongolian Autonomous Prefecture Environm, Korla, Xinjiang, Peoples R China	Chinese Academy of Sciences; Xinjiang Institute of Ecology & Geography, CAS; Xinjiang University; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Zhao, CY (corresponding author), Chinese Acad Sci, Xinjiang Inst Ecol & Geog, State Key Lab Desert & Oasis Ecol, Urumqi, Xinjiang, Peoples R China.	zcy@ms.xjb.ac.cn			National Natural Science Foundation of China [41171095]; National 973 project [2013CB429905-05]; National Science & Technology Pillar Program of China [2013BAC10B01]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National 973 project(National Basic Research Program of China); National Science & Technology Pillar Program of China	This research was funded by the National Natural Science Foundation of China (Grant no. 41171095; CYZ) (http://www.nsfc.gov.cn), the National 973 project (2013CB429905-05; CYZ) (http://www.973.gov.cn/Default_3.aspx) and National Science & Technology Pillar Program (2013BAC10B01: CYZ) (http://kjzc.jhgl.org) of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alpert P, 2002, EVOL ECOL, V16, P285, DOI 10.1023/A:1019684612767; Blom CWPM, 1996, TRENDS ECOL EVOL, V11, P290, DOI 10.1016/0169-5347(96)10034-3; Cao DC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039121; Capon SJ, 2009, ENVIRON EXP BOT, V66, P178, DOI 10.1016/j.envexpbot.2009.02.012; Chen HJ, 2002, ENVIRON EXP BOT, V48, P119, DOI 10.1016/S0098-8472(02)00018-7; Chen X, 2011, NEW PHYTOL, V190, P409, DOI 10.1111/j.1469-8137.2010.03639.x; Cooper DJ, 1999, REGUL RIVER, V15, P419, DOI 10.1002/(SICI)1099-1646(199909/10)15:5&lt;419::AID-RRR555&gt;3.0.CO;2-Y; Debat V, 2001, TRENDS ECOL EVOL, V16, P555, DOI 10.1016/S0169-5347(01)02266-2; DeWitt TJ, 1998, TRENDS ECOL EVOL, V13, P77, DOI 10.1016/S0169-5347(97)01274-3; Fan J, 2005, CHIN AGR SCI B, V21, P184; FENNER M, 1987, NEW PHYTOL, V106, P35, DOI 10.1111/j.1469-8137.1987.tb04681.x; Gedroc JJ, 1996, FUNCT ECOL, V10, P44, DOI 10.2307/2390260; Ghalambor CK, 2007, FUNCT ECOL, V21, P394, DOI 10.1111/j.1365-2435.2007.01283.x; Gindaba J, 2004, FOREST ECOL MANAG, V201, P121, DOI 10.1016/j.foreco.2004.07.009; Gonzalez E, 2010, TREES-STRUCT FUNCT, V24, P151, DOI 10.1007/s00468-009-0388-y; Gries D, 2003, PLANT CELL ENVIRON, V26, P725, DOI 10.1046/j.1365-3040.2003.01009.x; Guevara A, 2010, PLANT SOIL, V330, P447, DOI 10.1007/s11104-009-0218-4; Guilloy H, 2011, WETLANDS, V31, P1249, DOI 10.1007/s13157-011-0238-8; HUANG P, 1986, ACTA PHYTOECOL GEOBO, V10, P302; Hughes FMR, 2000, HYDROL PROCESS, V14, P3075, DOI 10.1002/1099-1085(200011/12)14:16/17&lt;3075::AID-HYP135&gt;3.0.CO;2-L; Hutchings MJ, 2004, ANN BOT-LONDON, V94, P1, DOI 10.1093/aob/mch111; Imada S, 2008, FUNCT ECOL, V22, P1018, DOI 10.1111/j.1365-2435.2008.01454.x; Imada S, 2010, TREES-STRUCT FUNCT, V24, P1163, DOI 10.1007/s00468-010-0492-z; Jackson MB, 2008, ANN BOT-LONDON, V101, P229, DOI 10.1093/aob/mcm237; Li J, 2013, TREE PHYSIOL, V33, P57, DOI 10.1093/treephys/tps120; Lloret F, 1999, AM J BOT, V86, P1655, DOI 10.2307/2656663; Padilla FM, 2007, FUNCT ECOL, V21, P489, DOI 10.1111/j.1365-2435.2007.01267.x; Padilla FM, 2007, PLANT SOIL, V296, P103, DOI 10.1007/s11104-007-9294-5; Pezeshki SR, 2001, ENVIRON EXP BOT, V46, P299, DOI 10.1016/S0098-8472(01)00107-1; Picotte JJ, 2007, OECOLOGIA, V153, P821, DOI 10.1007/s00442-007-0794-z; Pugnaire FI, 2006, J ARID ENVIRON, V65, P591, DOI 10.1016/j.jaridenv.2005.10.002; Quinn GP, 2003, EXPT DESIGN DATA ANA; Ruger N, 2005, ECOL MODEL, V184, P313, DOI 10.1016/j.ecolmodel.2004.10.010; SCHLICHTING CD, 1986, ANNU REV ECOL SYST, V17, P667, DOI 10.1146/annurev.es.17.110186.003315; Sher AA, 2003, AM J BOT, V90, P413, DOI 10.3732/ajb.90.3.413; Shipley B, 2002, FUNCT ECOL, V16, P326, DOI 10.1046/j.1365-2435.2002.00626.x; Stromberg JC, 2001, J ARID ENVIRON, V49, P17, DOI 10.1006/jare.2001.0833; Sultan SE, 2003, EVOL DEV, V5, P25, DOI 10.1046/j.1525-142X.2003.03005.x; Thevs N, 2008, PHYTOCOENOLOGIA, V38, P65, DOI 10.1127/0340-269X/2008/0038-0065; Thevs N, 2008, FORESTRY, V81, P45, DOI 10.1093/forestry/cpm043; Valladares F, 2007, NEW PHYTOL, V176, P749, DOI 10.1111/j.1469-8137.2007.02275.x; Visser EJW, 2000, PLANT CELL ENVIRON, V23, P1237, DOI 10.1046/j.1365-3040.2000.00628.x; Voesenek LACJ, 2006, NEW PHYTOL, V170, P213, DOI 10.1111/j.1469-8137.2006.01692.x; WALKER KF, 1995, REGUL RIVER, V11, P85, DOI 10.1002/rrr.3450110108; Xu L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053021; Zhuang L, 2010, CHINESE SCI BULL, V55, P4097, DOI 10.1007/s11434-010-4252-7	46	8	11	1	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2015	10	3							e0118691	10.1371/journal.pone.0118691	http://dx.doi.org/10.1371/journal.pone.0118691			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9KG	25742175	Green Submitted, Green Published, gold			2022-12-27	WOS:000350688100033
J	Vasiliu, D; Clamons, S; McDonough, M; Rabe, B; Saha, M				Vasiliu, Daniel; Clamons, Samuel; McDonough, Molly; Rabe, Brian; Saha, Margaret			A Regression-Based Differential Expression Detection Algorithm for Microarray Studies with Ultra-Low Sample Size	PLOS ONE			English	Article							PENALIZED LOGISTIC-REGRESSION; FALSE DISCOVERY RATE; CLASSIFICATION; SELECTION; HOMOLOG; TESTS; NOTCH	Global gene expression analysis using microarrays and, more recently, RNA-seq, has allowed investigators to understand biological processes at a system level. However, the identification of differentially expressed genes in experiments with small sample size, high dimensionality, and high variance remains challenging, limiting the usability of these tens of thousands of publicly available, and possibly many more unpublished, gene expression datasets. We propose a novel variable selection algorithm for ultra-low-n microarray studies using generalized linear model-based variable selection with a penalized binomial regression algorithm called penalized Euclidean distance (PED). Our method uses PED to build a classifier on the experimental data to rank genes by importance. In place of cross-validation, which is required by most similar methods but not reliable for experiments with small sample size, we use a simulation-based approach to additively build a list of differentially expressed genes from the rank-ordered list. Our simulation-based approach maintains a low false discovery rate while maximizing the number of differentially expressed genes identified, a feature critical for downstream pathway analysis. We apply our method to microarray data from an experiment perturbing the Notch signaling pathway in Xenopus laevis embryos. This dataset was chosen because it showed very little differential expression according to limma, a powerful and widely-used method for microarray analysis. Our method was able to detect a significant number of differentially expressed genes in this dataset and suggest future directions for investigation. Our method is easily adaptable for analysis of data from RNA-seq and other global expression experiments with low sample size and high dimensionality.	[Vasiliu, Daniel] Coll William & Mary, Dept Math, Williamsburg, VA 23185 USA; [Clamons, Samuel; McDonough, Molly; Rabe, Brian; Saha, Margaret] Coll William & Mary, Dept Biol, Williamsburg, VA 23185 USA	William & Mary; William & Mary	Saha, M (corresponding author), Coll William & Mary, Dept Biol, Williamsburg, VA 23185 USA.	mssaha@wm.edu			National Science Foundation [IOS-1257895]; National Institutes of Health [R15 NS067566-01]; Howard Hughes Medical Institute Undergraduate Science Education Program [52005868]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R15NS067566] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute Undergraduate Science Education Program(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Support was provided by grants from the National Science Foundation IOS-1257895 (www.nsf.gov) and National Institutes of Health R15 NS067566-01 (www.grants.nih.gov) to MSS and by a grant from the Howard Hughes Medical Institute Undergraduate Science Education Program to the College of William and Mary (52005868) (www.hhmi.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bair E, 2013, WILEY INTERDISCIP RE, V5, DOI 10.1002/wics.1260; Benjamini Y, 2001, ANN STAT, V29, P1165; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Binder H, 2011, BIOMETRICAL J, V53, P170, DOI 10.1002/bimj.201000152; Bovelstad HM, 2007, BIOINFORMATICS, V23, P2080, DOI 10.1093/bioinformatics/btm305; Bowes JB, 2010, NUCLEIC ACIDS RES, V38, pD607, DOI 10.1093/nar/gkp953; Braga-Neto UM, 2004, BIOINFORMATICS, V20, P374, DOI 10.1093/bioinformatics/btg419; Breheny P, 2011, ANN APPL STAT, V5, P232, DOI 10.1214/10-AOAS388; CHITNIS A, 1995, NATURE, V375, P761, DOI 10.1038/375761a0; Du DJ, 2014, NEUROCOMPUTING, V133, P446, DOI 10.1016/j.neucom.2013.12.012; Dudoit S, 2003, STAT SCI, V18, P71, DOI 10.1214/ss/1056397487; Dudoit S, 2002, J AM STAT ASSOC, V97, P77, DOI 10.1198/016214502753479248; Fan J, 2014, SIS SURE INDEPENDENC; Fort G, 2005, BIOINFORMATICS, V21, P1104, DOI 10.1093/bioinformatics/bti114; Friedman J, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i01; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gramacy BR, 2014, ESTIMATION MULTIVARI; Han F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097530; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Jeanmougin M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012336; Jeffery IB, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-359; Kaeser GE, 2011, DEV DYNAM, V240, P862, DOI 10.1002/dvdy.22580; Kooperberg C, 2005, STAT MED, V24, P2281, DOI 10.1002/sim.2109; Lewis AS, 2008, NONSMOOTH OPTIMIZATI; Louvi A, 2012, SEMIN CELL DEV BIOL, V23, P473, DOI 10.1016/j.semcdb.2012.02.005; Loven J, 2012, CELL, V151, P476, DOI 10.1016/j.cell.2012.10.012; Ma S, 2008, BRIEF BIOINFORM, V9, P392, DOI 10.1093/bib/bbn027; Mazumdar M, 2010, METHODS MOL BIOL, V620, P563, DOI 10.1007/978-1-60761-580-4_22; Murie C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-45; Neiuwkoop P, 1994, SYSTEMATIC CHRONOLOG; Owzar K, 2011, CTS-CLIN TRANSL SCI, V4, P466, DOI 10.1111/j.1752-8062.2011.00309.x; Papp K, 2012, CELL MOL LIFE SCI, V69, P2717, DOI 10.1007/s00018-012-0947-z; Park MY, 2008, BIOSTATISTICS, V9, P30, DOI 10.1093/biostatistics/kxm010; Shen L, 2005, IEEE ACM T COMPUT BI, V2, P166, DOI 10.1109/TCBB.2005.22; Singhal S, 2003, CANCER BIOL THER, V2, P383, DOI 10.4161/cbt.2.4.431; Sive H, 2000, EARLY DEVELOPMENT OF; Smyth GK, 2005, BIOINFORMATICS, V21, P2067, DOI 10.1093/bioinformatics/bti270; Suarez E, 2009, P R HEALTH SCI J, V28, P89; Tan YD, 2011, BIOINFORMATION, V7, P400; van Houwelingen HC, 2006, STAT MED, V25, P3201, DOI 10.1002/sim.2353; Vasiliu D, 2014, PENALIZED EUCLIDEAN; Wettstein DA, 1997, DEVELOPMENT, V124, P693; Wu D, 2010, BIOINFORMATICS, V26, P2176, DOI 10.1093/bioinformatics/btq401; Zhu J, 2004, BIOSTATISTICS, V5, P427, DOI 10.1093/biostatistics/kxg046	44	4	5	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2015	10	3							e0118198	10.1371/journal.pone.0118198	http://dx.doi.org/10.1371/journal.pone.0118198			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9JM	25738861	gold, Green Published, Green Submitted			2022-12-27	WOS:000350685900024
J	Irshad, K; Mohapatra, SK; Srivastava, C; Garg, H; Mishra, S; Dikshit, B; Sarkar, C; Gupta, D; Chandra, PS; Chattopadhyay, P; Sinha, S; Chosdol, K				Irshad, Khushboo; Mohapatra, Saroj Kant; Srivastava, Chitrangda; Garg, Harshit; Mishra, Seema; Dikshit, Bhawana; Sarkar, Chitra; Gupta, Deepak; Chandra, Poodipedi Sarat; Chattopadhyay, Parthaprasad; Sinha, Subrata; Chosdol, Kunzang			A Combined Gene Signature of Hypoxia and Notch Pathway in Human Glioblastoma and Its Prognostic Relevance	PLOS ONE			English	Article							GLIOMA-CELL-LINES; STEM-CELLS; IN-VITRO; MONOCLONAL-ANTIBODY; EXPRESSION; CANCER; HIF-1-ALPHA; SURVIVAL; ACTIVATION; MIGRATION	Hypoxia is a hallmark of solid tumors including glioblastoma (GBM). Its synergism with Notch signaling promotes progression in different cancers. However, Notch signaling exhibits pleiotropic roles and the existing literature lacks a comprehensive understanding of its perturbations under hypoxia in GBM with respect to all components of the pathway. We identified the key molecular cluster(s) characteristic of the Notch pathway response in hypoxic GBM tumors and gliomaspheres. Expression of Notch and hypoxia genes was evaluated in primary human GBM tissues by q-PCR. Clustering and statistical analyses were applied to identify the combination of hypoxia markers correlated with upregulated Notch pathway components. We found well-segregated tumor-clusters representing high and low HIF-1 alpha/PGK1-expressors which accounted for differential expression of Notch signaling genes. In combination, a five-hypoxia marker set (HIF-1 alpha/PGK1/VEGF/CA9/OPN) was determined as the best predictor for induction of Notch1/DII1/Hes1/Hes6/Hey1/Hey2. Similar Notch-axis genes were activated in gliomaspheres, but not monolayer cultures, under moderate/severe hypoxia (2%/0.2% O-2). Preliminary evidence suggested inverse correlation between patient survival and increased expression of constituents of the hypoxia-Notch gene signature. Together, our findings delineated the Notch-axis maximally associated with hypoxia in resected GBM, which might be prognostically relevant. Its upregulation in hypoxia- exposed gliomaspheres signify them as a better in-vitro model for studying hypoxia-Notch interactions than monolayer cultures.				sub_sinha@hotmail.com; kunzangchosdol@yahoo.com	Irshad, Khushboo/AAT-6842-2020	Irshad, Khushboo/0000-0002-1552-3686; chosdol, kunzang/0000-0002-7065-3395; Srivastava, Chitrangda/0000-0001-5513-9198; Mohapatra, Saroj Kant/0000-0003-4723-5109; GARG, HARSHIT/0000-0002-4762-2523	Department of Biotechnology, India [BT/PR13645/Med/30/290/2010]; Indian Council of Medical Research, India; All India Institute of Medical Sciences, India; Kishore Vaigyanik Protsahan Yojana, Department of Science and Technology, India; Council of Scientific and Industrial Research, India	Department of Biotechnology, India(Department of Biotechnology (DBT) India); Indian Council of Medical Research, India(Indian Council of Medical Research (ICMR)); All India Institute of Medical Sciences, India; Kishore Vaigyanik Protsahan Yojana, Department of Science and Technology, India; Council of Scientific and Industrial Research, India(Council of Scientific & Industrial Research (CSIR) - India)	Support was provided by: grant from Department of Biotechnology, India (BT/PR13645/Med/30/290/2010) to KC and institutional support from National Brain Research Centre, India, to SS; Research fellowships from Indian Council of Medical Research, India to KI; All India Institute of Medical Sciences, India to C. Srivastava; Kishore Vaigyanik Protsahan Yojana, Department of Science and Technology, India to HG; and Council of Scientific and Industrial Research, India to BD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bar EE, 2010, AM J PATHOL, V177, P1491, DOI 10.2353/ajpath.2010.091021; Chen J, 2010, BRIT J CANCER, V102, P351, DOI 10.1038/sj.bjc.6605486; Chigurupati S, 2010, CANCER RES, V70, P418, DOI 10.1158/0008-5472.CAN-09-2654; Choy MK, 2010, J CELL PHYSIOL, V222, P635, DOI 10.1002/jcp.21980; Chung FY, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-241; Colman H, 2010, NEURO-ONCOLOGY, V12, P49, DOI 10.1093/neuonc/nop007; Cornero A, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-S4-S13; Dai Chen-Xin, 2009, BMC Cancer, V9, P418, DOI 10.1186/1471-2407-9-418; Datta K, 2002, INT J BIOCHEM CELL B, V34, P148, DOI 10.1016/S1357-2725(01)00106-6; Diez H, 2007, EXP CELL RES, V313, P1, DOI 10.1016/j.yexcr.2006.09.009; Flynn JR, 2008, CANCER-AM CANCER SOC, V113, P1032, DOI 10.1002/cncr.23678; Gravendeel LAM, 2009, CANCER RES, V69, P9065, DOI 10.1158/0008-5472.CAN-09-2307; Grossman SA, 2010, CLIN CANCER RES, V16, P2443, DOI 10.1158/1078-0432.CCR-09-3106; Gustafsson MV, 2005, DEV CELL, V9, P617, DOI 10.1016/j.devcel.2005.09.010; Hu YY, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-82; Huang XD, 2012, ASIAN PAC J CANCER P, V13, P4793, DOI 10.7314/APJCP.2012.13.9.4793; Iacopino F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105166; Kamat CD, 2007, CANCER LETT, V249, P209, DOI 10.1016/j.canlet.2006.08.017; Kanamori M, 2007, J NEUROSURG, V106, P417, DOI 10.3171/jns.2007.106.3.417; Kesari S, 2011, SEMIN ONCOL, V38, pS2, DOI 10.1053/j.seminoncol.2011.09.005; Koch U, 2007, CELL MOL LIFE SCI, V64, P2746, DOI 10.1007/s00018-007-7164-1; Lee J, 2006, CANCER CELL, V9, P391, DOI 10.1016/j.ccr.2006.03.030; Li AG, 2008, MOL CANCER RES, V6, P21, DOI 10.1158/1541-7786.MCR-07-0280; Li ZQ, 2011, ASIAN PAC J CANCER P, V12, P215; Liang DM, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-201; Lino MM, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-72; Lobry C, 2011, J EXP MED, V208, P1931, DOI 10.1084/jem.20111855; Main H, 2010, EXP CELL RES, V316, P1610, DOI 10.1016/j.yexcr.2009.12.012; Martinez-Gonzalez A, 2012, B MATH BIOL, V74, P2875, DOI 10.1007/s11538-012-9786-1; Mendez O, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-133; Mimeault M, 2013, J CELL MOL MED; Nakajima T, 2012, J THORAC ONCOL, V7, P1661, DOI 10.1097/JTO.0b013e318265b4df; Palanichamy JK, 2010, MOL CANCER THER, V9, P2114, DOI 10.1158/1535-7163.MCT-09-0977; Persano L, 2011, THESCIENTIFICWORLDJO, V11, P1829, DOI 10.1100/2011/736480; Phung YT, 2011, J CANCER, V2, P507, DOI 10.7150/jca.2.507; Pistollato F, 2010, STEM CELLS, V28, P1918, DOI 10.1002/stem.518; Purow BW, 2005, CANCER RES, V65, P2353, DOI 10.1158/0008-5472.CAN-04-1890; Qiang L, 2012, CELL DEATH DIFFER, V19, P284, DOI 10.1038/cdd.2011.95; Rapisarda A, 2012, NAT REV CLIN ONCOL, V9, P378, DOI 10.1038/nrclinonc.2012.64; Ruano Y, 2008, CANCER-AM CANCER SOC, V112, P1575, DOI 10.1002/cncr.23338; Sahlgren C, 2008, P NATL ACAD SCI USA, V105, P6392, DOI 10.1073/pnas.0802047105; Said HM, 2007, RADIOTHER ONCOL, V83, P398, DOI 10.1016/j.radonc.2007.05.003; Seidel S, 2010, BRAIN, V133, P983, DOI 10.1093/brain/awq042; Semenza GL, 2003, NAT REV CANCER, V3, P721, DOI 10.1038/nrc1187; Sermeus A, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.48; Shahi MH, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-614; Sharma A, 2012, MOL CANCER THER, V11, P77, DOI 10.1158/1535-7163.MCT-11-0508; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Wilson WR, 2011, NAT REV CANCER, V11, P393, DOI 10.1038/nrc3064; Wong DJ, 2008, CANCER RES, V68, P369, DOI 10.1158/0008-5472.CAN-07-0382; Wos Jan, 2011, Otolaryngol Pol, V65, P102; Xing F, 2011, ONCOGENE, V30, P4075, DOI 10.1038/onc.2011.122; Zagzag D, 2000, CANCER-AM CANCER SOC, V88, P2606, DOI 10.1002/1097-0142(20000601)88:11<2606::AID-CNCR25>3.0.CO;2-W; Zheng X, 2008, P NATL ACAD SCI USA, V105, P3368, DOI 10.1073/pnas.0711591105; Zheng Y, 2013, ONCOL LETT, V5, P1285, DOI 10.3892/ol.2013.1185; Zhu YH, 2005, ONCOGENE, V24, P6555, DOI 10.1038/sj.onc.1208800	56	38	39	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2015	10	3							e0118201	10.1371/journal.pone.0118201	http://dx.doi.org/10.1371/journal.pone.0118201			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4HV	25734817	Green Submitted, gold, Green Published			2022-12-27	WOS:000350314700017
J	Lin, CC; Lee, IT; Hsu, CH; Hsu, CK; Chi, PL; Hsiao, LD; Yang, CM				Lin, Chih-Chung; Lee, I-Ta; Hsu, Chun-Hao; Hsu, Chih-Kai; Chi, Pei-Ling; Hsiao, Li-Der; Yang, Chuen-Mao			Sphingosine-1-Phosphate Mediates ICAM-1-Dependent Monocyte Adhesion through p38 MAPK and p42/p44 MAPK-Dependent Akt Activation	PLOS ONE			English	Article							KAPPA-B ACTIVATION; SPHINGOSINE 1-PHOSPHATE; ICAM-1 EXPRESSION; MATRIX-METALLOPROTEINASE-9 EXPRESSION; UP-REGULATION; AIRWAY; INFLAMMATION; RECEPTORS; ERK; SRC	Up-regulation of intercellular adhesion molecule-1 (ICAM-1) is frequently implicated in lung inflammation. Sphingosine-1-phosphate (S1P) has been shown to play a key role in inflammation via adhesion molecules induction, and then causes lung injury. However, the mechanisms underlying S1P-induced ICAM-1 expression in human pulmonary alveolar epithelial cells (HPAEpiCs) remain unclear. The effect of S1P on ICAM-1 expression was determined by Western blot and real-time PCR. The involvement of signaling pathways in these responses was investigated by using the selective pharmacological inhibitors and transfection with siRNAs. S1P markedly induced ICAM-1 expression and monocyte adhesion which were attenuated by pretreatment with the inhibitor of S1PR1 (W123), S1PR3 (CAY10444), c-Src (PP1), EGFR (AG1478), PDGFR (AG1296), MEK1/2 (U0126), p38 MAPK (SB202190), JNK1/2 (SP600125), PI3K (LY294002), or AP-1 (Tanshinone IIA) and transfection with siRNA of S1PR1, S1PR3, c-Src, EGFR, PDGFR, p38, p42, JNK1, c-Jun, or c-Fos. We observed that S1P-stimulated p42/p44 MAPK and p38 MAPK activation was mediated via a c-Src/EGFR and PDGFR-dependent pathway. S1P caused the c-Src/EGFR/PDGFR complex formation. On the other hand, we demonstrated that S1P induced p42/p44 MAPK and p38 MAPK-dependent Akt activation. In addition, S1P-stimulated JNK1/2 phosphorylation was attenuated by SP600125 or PP1. Finally, S1P enhanced c-Fos mRNA levels and c-Jun phosphorylation. S1P-induced c-Jun activation was reduced by PP1, AG1478, AG1296, U0126, SP600125, SB202190, or LY294002. These results demonstrated that S1P-induced ICAM-1 expression and monocyte adhesion were mediated through S1PR1/3/c-Src/EGFR, PDGFR/p38 MAPK, p42/p44 MAPK/Akt-dependent AP-1 activation.				chuenmao@mail.cgu.edu.tw		Yang, Chuen-Mao/0000-0002-3208-5438; Chi, Belinda/0000-0003-0332-6682	National Science Council, Taiwan [NSC102-2321-B-182-011, NSC101-2320-B-182-039-MY3, NSC101-2314-B-182-182A-112]; Ministry of Education, Taiwan [EMRPD1D0231, EMRPD1D0241]; Chang Gung Medical Research Foundation, Taiwan [CMRPD1C0102, CMRPD1B0382, CMRPD1C0561, CMRPD1B0331, CMRPG3C1301, CMRPG3B1092]	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan); Ministry of Education, Taiwan(Ministry of Education, Taiwan); Chang Gung Medical Research Foundation, Taiwan	This work was supported by NSC102-2321-B-182-011, NSC101-2320-B-182-039-MY3, and NSC101-2314-B-182-182A-112 from National Science Council, Taiwan; EMRPD1D0231 and EMRPD1D0241 from Ministry of Education, Taiwan; and CMRPD1C0102, CMRPD1B0382, CMRPD1C0561, CMRPD1B0331, CMRPG3C1301, and CMRPG3B1092 from Chang Gung Medical Research Foundation, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarthi JJ, 2011, J DENT RES, V90, P841, DOI 10.1177/0022034510389178; Ammit AJ, 2001, FASEB J, V15, P1212, DOI 10.1096/fj.00-0742fje; Beckham TH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076593; Brinkmann V, 2007, PHARMACOL THERAPEUT, V115, P84, DOI 10.1016/j.pharmthera.2007.04.006; Chang YJ, 2004, MOL PHARMACOL, V65, P589, DOI 10.1124/mol.65.3.589; Costello RW, 2011, INT J MOL SCI, V12, P3237, DOI 10.3390/ijms12053237; Ishii I, 2004, ANNU REV BIOCHEM, V73, P321, DOI 10.1146/annurev.biochem.73.011303.073731; Kim JI, 2003, J BIOL CHEM, V278, P31731, DOI 10.1074/jbc.M300625200; Lee CW, 2007, AM J PHYSIOL-LUNG C, V292, pL799, DOI 10.1152/ajplung.00311.2006; Lee IT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072783; Lee IT, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/791231; Lee IT, 2013, J NUTR BIOCHEM, V24, P124, DOI 10.1016/j.jnutbio.2012.03.009; Lee IT, 2012, BIOCHEM PHARMACOL, V84, P581, DOI 10.1016/j.bcp.2012.05.005; Lee IT, 2009, AM J PATHOL, V175, P519, DOI 10.2353/ajpath.2009.090016; Lin CH, 2013, CELL SIGNAL, V25, P1166, DOI 10.1016/j.cellsig.2013.01.018; Lin CC, 2007, J CELL PHYSIOL, V211, P771, DOI 10.1002/jcp.20987; Matsuzaki E, 2013, BONE, V55, P315, DOI 10.1016/j.bone.2013.04.008; Milara J, 2009, EUR J PHARMACOL, V609, P132, DOI 10.1016/j.ejphar.2009.03.012; Ryan JJ, 2008, DRUG NEWS PERSPECT, V21, P89, DOI 10.1358/dnp.2008.21.2.1188195; Shi YY, 2006, BREAST CANCER RES TR, V100, P33, DOI 10.1007/s10549-006-9232-x; Sun XG, 2013, AM J PHYSIOL-LUNG C, V305, pL467, DOI 10.1152/ajplung.00010.2013; Takahashi M, 2003, HEPATOL RES, V26, P232, DOI 10.1016/S1386-6346(03)00112-8; Thamilselvan V, 2002, IN VITRO CELL DEV-AN, V38, P246; Yang CM, 2013, BIOCHEM PHARMACOL, V85, P1115, DOI 10.1016/j.bcp.2013.01.013; Yang CM, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-12; Yang CM, 2010, J CELL PHYSIOL, V224, P516, DOI 10.1002/jcp.22153; Yu HS, 2013, INT J MOL SCI, V14, P13329, DOI 10.3390/ijms140713329; Zhang WL, 2013, PROSTAG OTH LIPID M, V106, P62, DOI 10.1016/j.prostaglandins.2013.06.001	28	17	20	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2015	10	3							e0118473	10.1371/journal.pone.0118473	http://dx.doi.org/10.1371/journal.pone.0118473			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4HV	25734900	Green Published, gold, Green Submitted			2022-12-27	WOS:000350314700031
J	Pal, D; Sharma, U; Singh, SK; Kakkar, N; Prasad, R				Pal, Deeksha; Sharma, Ujjawal; Singh, Shrawan Kumar; Kakkar, Nandita; Prasad, Rajendra			Over-Expression of Telomere Binding Factors (TRF1 & TRF2) in Renal Cell Carcinoma and Their Inhibition by Using SiRNA Induce Apoptosis, Reduce Cell Proliferation and Migration Invitro	PLOS ONE			English	Article							GENE-EXPRESSION; TIN2; DNA	Telomere binding factors viz. TRF1 and TRF2 are a part of sheltrin complex that are present exclusively at the ends of chromosomes. These factors play an important role in maintaining chromosomal integrity at the ends. However, their status and role are not clear in renal cell carcinoma (RCC). Therefore, the present study was conducted to evaluate TRF1 and TRF2 expressions in RCC tissues. Further, the role of these factors involved in tumorigenesis was elucidated by gene silencing using siRNA in RCC cell line (A498). The present study documented a significant over-expression of TRF1 (P = 0.005) and TRF2 (P = 0.0048) mRNAs by real time PCR in RCC tissues as compared with adjacent normal kidney tissues. Immunohistochemistry studies also revealed higher expression of TRF1 and TRF2 proteins in RCC. Moreover, TRF1 or TRF2 gene silencing using siRNA showed marked reduction in proliferation of RCC cells (P = 0.000). Further, significantly induced cell cycle arrest (P = 0.000) and apoptosis of RCC cells (P = 0.000) was documented upon TRF1 or TRF2 gene silencing. Henceforth, the results deduce that TRF1 or TRF2 inhibitions play an important role in the induction of apoptosis in A498 cells, which may serve as a potential therapeutic target in RCC.	[Pal, Deeksha; Sharma, Ujjawal; Prasad, Rajendra] PGIMER, Dept Biochem, Chandigarh, India; [Singh, Shrawan Kumar] PGIMER, Dept Urol, Chandigarh, India; [Kakkar, Nandita] PGIMER, Dept Histopathol, Chandigarh, India	Post Graduate Institute of Medical Education & Research (PGIMER), Chandigarh; Post Graduate Institute of Medical Education & Research (PGIMER), Chandigarh; Post Graduate Institute of Medical Education & Research (PGIMER), Chandigarh	Prasad, R (corresponding author), PGIMER, Dept Biochem, Chandigarh, India.	fateh1977@yahoo.com	Sharma, Ujjawal/E-7097-2013	Sharma, Ujjawal/0000-0002-2087-080X	Council of Scientific and Industrial Research, New Delhi, India [27/0218/09/EMR-II]; Indian council of medical research, New Delhi, India [3/1/3/JRF-2010/HRD-67 (11065)]	Council of Scientific and Industrial Research, New Delhi, India(Council of Scientific & Industrial Research (CSIR) - India); Indian council of medical research, New Delhi, India(Indian Council of Medical Research (ICMR))	This is a part of a research project funded by Council of Scientific and Industrial Research, New Delhi, India (vide letter no. 27/0218/09/EMR-II). The authors are thankful to Indian council of medical research, New Delhi, India for awarding junior and senior research fellowship (3/1/3/JRF-2010/HRD-67 (11065). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amato RJ, 2000, SEMIN ONCOL, V27, P177; Armanios M, 2012, NAT REV GENET, V13, P693, DOI 10.1038/nrg3246; Bianchi A, 1999, EMBO J, V18, P5735, DOI 10.1093/emboj/18.20.5735; Biroccio A, 2013, NAT CELL BIOL, V15, P818, DOI 10.1038/ncb2774; Dong WJ, 2009, CANCER BIOL THER, V8, P2165, DOI 10.4161/cbt.8.22.9880; FUHRMAN SA, 1982, AM J SURG PATHOL, V6, P655, DOI 10.1097/00000478-198210000-00007; Ganesamoni R, 2012, J UROLOGY, V187, P1172, DOI 10.1016/j.juro.2011.11.105; Griffith JD, 1999, CELL, V97, P503, DOI 10.1016/S0092-8674(00)80760-6; Karlseder J, 1999, SCIENCE, V283, P1321, DOI 10.1126/science.283.5406.1321; Larkin J, 2012, NAT REV UROL, V9, P147, DOI 10.1038/nrurol.2011.236; Lin JG, 2014, NUCLEIC ACIDS RES, V42, P2493, DOI 10.1093/nar/gkt1132; Matsutani N, 2001, INT J ONCOL, V19, P507; Miyachi K, 2002, J EXP CLIN CANC RES, V21, P269; Nakanishi K, 2003, CLIN CANCER RES, V9, P1105; Oh BK, 2005, AM J PATHOL, V166, P73, DOI 10.1016/S0002-9440(10)62233-X; Opresko PL, 2005, NUCLEIC ACIDS RES, V33, P1230, DOI 10.1093/nar/gki273; Reuter VE, 2000, SEMIN ONCOL, V27, P124; Saito K, 2002, JPN J CANCER RES, V93, P253, DOI 10.1111/j.1349-7006.2002.tb02166.x; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Sharma U, 2014, BIOCHIMIE, V104, P27, DOI 10.1016/j.biochi.2014.05.011; Sharma U, 2012, MOL CELL BIOCHEM, V369, P287, DOI 10.1007/s11010-012-1391-y; Smogorzewska A, 2000, MOL CELL BIOL, V20, P1659, DOI 10.1128/MCB.20.5.1659-1668.2000; Sobin L., 1997, UICC TNM CLASSIFICAT, P184; Stansel RM, 2001, EMBO J, V20, P5532; Wu ZQ, 2008, J BIOL CHEM, V283, P25503, DOI 10.1074/jbc.M803304200; Yamada K, 2002, ANTICANCER RES, V22, P1315	26	33	35	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2015	10	3							e0115651	10.1371/journal.pone.0115651	http://dx.doi.org/10.1371/journal.pone.0115651			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9JF	25730259	gold, Green Submitted, Green Published			2022-12-27	WOS:000350684900007
J	Rac, M; Krupka, M; Binder, S; Sedlarova, M; Matuskova, Z; Raska, M; Pospisil, P				Rac, Marek; Krupka, Michal; Binder, Svatopluk; Sedlarova, Michaela; Matuskova, Zuzana; Raska, Milan; Pospisil, Pavel			Oxidative Damage of U937 Human Leukemic Cells Caused by Hydroxyl Radical Results in Singlet Oxygen Formation	PLOS ONE			English	Article							LIPID-PEROXIDATION; DNA-DAMAGE; ACID HYDROPEROXIDE; MOLECULAR-OXYGEN; REACTIVE OXYGEN; STRESS; BIOMARKERS; MECHANISM; DISEASE; LINE	The exposure of human cells to oxidative stress leads to the oxidation of biomolecules such as lipids, proteins and nuclei acids. In this study, the oxidation of lipids, proteins and DNA was studied after the addition of hydrogen peroxide and Fenton reagent to cell suspension containing human leukemic monocyte lymphoma cell line U937. EPR spin-trapping data showed that the addition of hydrogen peroxide to the cell suspension formed hydroxyl radical via Fenton reaction mediated by endogenous metals. The malondialdehyde HPLC analysis showed no lipid peroxidation after the addition of hydrogen peroxide, whereas the Fenton reagent caused significant lipid peroxidation. The formation of protein carbonyls monitored by dot blot immunoassay and the DNA fragmentation measured by comet assay occurred after the addition of both hydrogen peroxide and Fenton reagent. Oxidative damage of biomolecules leads to the formation of singlet oxygen as conformed by EPR spin-trapping spectroscopy and the green fluorescence of singlet oxygen sensor green detected by confocal laser scanning microscopy. It is proposed here that singlet oxygen is formed by the decomposition of high-energy intermediates such as dioxetane or tetroxide formed by oxidative damage of biomolecules.	[Rac, Marek; Pospisil, Pavel] Palacky Univ, Ctr Reg Hana Biotechnol & Agr Res, Dept Biophys, Fac Sci, Olomouc 78371, Czech Republic; [Krupka, Michal; Raska, Milan] Palacky Univ, Dept Immunol, Fac Med & Dent, Olomouc 77515, Czech Republic; [Binder, Svatopluk] Palacky Univ, Fac Med & Dent, Dept Med Biophys, Olomouc 77515, Czech Republic; [Sedlarova, Michaela] Palacky Univ, Dept Bot, Fac Sci, Olomouc 78371, Czech Republic; [Matuskova, Zuzana] Palacky Univ, Fac Med & Dent, Dept Pharmacol, Olomouc 77515, Czech Republic; [Matuskova, Zuzana] Palacky Univ, Fac Med & Dent, Inst Mol & Translat Med, Olomouc 77515, Czech Republic	Palacky University Olomouc; Palacky University Olomouc; Palacky University Olomouc; Palacky University Olomouc; Palacky University Olomouc; Palacky University Olomouc	Pospisil, P (corresponding author), Palacky Univ, Ctr Reg Hana Biotechnol & Agr Res, Dept Biophys, Fac Sci, Slechtitelu 11, Olomouc 78371, Czech Republic.	pavel.pospisil@upol.cz	Raska, Milan/E-9813-2013; POSPÍŠIL, Pavel/AAH-4451-2019; SEDLÁŘOVÁ, Michaela/L-2055-2018	Raska, Milan/0000-0002-8572-7246; POSPÍŠIL, Pavel/0000-0001-9126-2011; SEDLÁŘOVÁ, Michaela/0000-0003-2319-1033; Krupka, Michal/0000-0002-9699-7903; Racova, Zuzana/0000-0001-9478-9513; Rac, Marek/0000-0003-0226-6796	Ministry of Education, Youth and Sports of the Czech Republic [LO1204, CZ.1.07/2.3.00/20.0057, CZ.1.07/2.3.00/30.0041]; Czech Science Foundation [GP13-29294S];  [IGA_LF_2014_020];  [OPVK 2.3 (CZ.1.07/2.3.00/30.0004)];  [NPU I MSMT-7778/2014];  [PrF-2013-003]	Ministry of Education, Youth and Sports of the Czech Republic(Ministry of Education, Youth & Sports - Czech Republic); Czech Science Foundation(Grant Agency of the Czech Republic); ; ; ; 	This work was supported by the Ministry of Education, Youth and Sports of the Czech Republic grants no. LO1204 (National Program of Sustainability I), no. CZ.1.07/2.3.00/20.0057 (Progress and Internationalization of Biophysical Research at the Faculty of Science, Palacky University) and no. CZ.1.07/2.3.00/30.0041 (Support for Building Excellent Research Teams and Intersectoral Mobility at Palacky University), the Czech Science Foundation grant no. GP13-29294S and by the IGA_LF_2014_020, OPVK 2.3 (CZ.1.07/2.3.00/30.0004), NPU I MSMT-7778/2014, and PrF-2013-003. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam W, 1982, CHEM BIOL GENERATION; Ahmad R, 2008, IN VIVO, V22, P525; Apel K, 2004, ANNU REV PLANT BIOL, V55, P373, DOI 10.1146/annurev.arplant.55.031903.141701; Berlett BS, 1997, J BIOL CHEM, V272, P20313, DOI 10.1074/jbc.272.33.20313; BRITIGAN BE, 1988, J EXP MED, V168, P2367, DOI 10.1084/jem.168.6.2367; Cadet J, 2013, COLD SPRING HARBOR P, V5, DOI [10.1101/cshperspect.a019836, DOI 10.1101/CSHPERSPECT.A019836]; COUDRAY C, 1993, BIOL TRACE ELEM RES, V38, P273, DOI 10.1007/BF02785311; Dean RT, 1997, BIOCHEM J, V324, P1; Garry BR, MOL TARGETS PHOTOSEN; GOLDSTEIN S, 1993, FREE RADICAL BIO MED, V15, P435, DOI 10.1016/0891-5849(93)90043-T; Gollmer A, 2011, PHOTOCHEM PHOTOBIOL, V87, P671, DOI 10.1111/j.1751-1097.2011.00900.x; GUTTERIDGE JMC, 1995, CLIN CHEM, V41, P1819; HALLIWELL B, 1993, AM J CLIN NUTR, V57, P715; Halliwell B, 2007, FREE RADICAL BIO MED, DOI [10.1093/jxb/erm028, DOI 10.1093/JXB/ERM028]; Han D, 2001, BIOCHEM J, V353, P411, DOI 10.1042/0264-6021:3530411; Kanofsky JR, 2011, PHOTOCHEM PHOTOBIOL, V87, P14, DOI 10.1111/j.1751-1097.2010.00855.x; Lambert AJ, 2004, BIOCHEM J, V382, P511, DOI 10.1042/BJ20040485; Lloyd DR, 1999, MUTAT RES-FUND MOL M, V424, P23, DOI 10.1016/S0027-5107(99)00005-6; MINISINI MP, 1994, MUTAT RES-DNA REPAIR, V315, P169, DOI 10.1016/0921-8777(94)90016-7; Miyamoto S, 2006, P NATL ACAD SCI USA, V103, P293, DOI 10.1073/pnas.0508170103; Miyamoto S, 2007, IUBMB LIFE, V59, P322, DOI 10.1080/15216540701242508; MOAN J, 1979, NATURE, V279, P450, DOI 10.1038/279450a0; NIU EP, 1991, AUST J CHEM, V44, P695, DOI 10.1071/CH9910695; PIKE MC, 1980, CLIN RES, V28, pA507; Pilz J, 2000, J CHROMATOGR B, V742, P315, DOI 10.1016/S0378-4347(00)00174-2; Pogozelski WK, 1998, CHEM REV, V98, P1089, DOI 10.1021/cr960437i; POU TE, 1984, J ELECTROCHEM SOC, V131, P1243, DOI 10.1149/1.2115795; Prado FM, 2009, FREE RADICAL BIO MED, V47, P401, DOI 10.1016/j.freeradbiomed.2009.05.001; RUSSELL GA, 1957, J AM CHEM SOC, V79, P3871, DOI 10.1021/ja01571a068; SAGRIPANTI JL, 1989, J BIOL CHEM, V264, P1729; SCHLESINGER JJ, 1980, CLIN RES, V28, pA644; Shen Y, 2011, LASER PHYS LETT, V8, P232, DOI 10.1002/lapl.201010113; Sun SN, 2007, BIOCHEMISTRY-US, V46, P6668, DOI 10.1021/bi700178u; Timmins GS, 1997, CHEM RES TOXICOL, V10, P1090, DOI 10.1021/tx970075p; Von Sonntag C, 1987, CHEM BASIS RAD BIOL; Wei SH, 2006, DYES PIGMENTS, V71, P61, DOI 10.1016/j.dyepig.2005.06.016; Winterbourn CC, 1995, TOXICOL LETT, V82-3, P969, DOI 10.1016/0378-4274(95)03532-X; Wiseman H, 1996, BIOCHEM J, V313, P17, DOI 10.1042/bj3130017; Wu TY, 2004, CANCER EPIDEM BIOMAR, V13, P1399	39	19	20	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2015	10	3							e0116958	10.1371/journal.pone.0116958	http://dx.doi.org/10.1371/journal.pone.0116958			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9JF	25730422	Green Published, Green Submitted, gold			2022-12-27	WOS:000350684900010
J	Anton, H; Taha, N; Boutant, E; Richert, L; Khatter, H; Klaholz, B; Ronde, P; Real, E; de Rocquigny, H; Mely, Y				Anton, Halina; Taha, Nedal; Boutant, Emmanuel; Richert, Ludovic; Khatter, Heena; Klaholz, Bruno; Ronde, Philippe; Real, Eleonore; de Rocquigny, Hugues; Mely, Yves			Investigating the Cellular Distribution and Interactions of HIV-1 Nucleocapsid Protein by Quantitative Fluorescence Microscopy	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; ACID-CHAPERONE ACTIVITY; CORRELATION SPECTROSCOPY; REVERSE TRANSCRIPTION; STRAND TRANSFER; PHOTOBLEACHING RECOVERY; ANOMALOUS SUBDIFFUSION; RESOLVED FLUORESCENCE; STRUCTURAL BIOLOGY; RNA DIMERIZATION	The nucleocapsid protein (NCp7) of the Human immunodeficiency virus type 1 (HIV-1) is a small basic protein containing two zinc fingers. About 2000 NCp7 molecules coat the genomic RNA in the HIV-1 virion. After infection of a target cell, the viral core enters into the cytoplasm, where NCp7 chaperones the reverse transcription of the genomic RNA into the proviral DNA. As a consequence of their much lower affinity for double-stranded DNA as compared to single-stranded RNAs, NCp7 molecules are thought to be released in the cytoplasm and the nucleus of infected cells in the late steps of reverse transcription. Yet, little is known on the cellular distribution of the released NCp7 molecules and on their possible interactions with cell components. Hence, the aim of this study was to identify potential cellular partners of NCp7 and to monitor its intracellular distribution and dynamics by means of confocal fluorescence microscopy, fluorescence lifetime imaging microscopy, fluorescence recovery after photobleaching, fluorescence correlation and cross-correlation spectroscopy, and raster imaging correlation spectroscopy. HeLa cells transfected with eGFP-labeled NCp7 were used as a model system. We found that NCp7-eGFP localizes mainly in the cytoplasm and the nucleoli, where it binds to cellular RNAs, and notably to ribosomal RNAs which are the most abundant. The binding of NCp7 to ribosomes was further substantiated by the intracellular co-diffusion of NCp7 with the ribosomal protein 26, a component of the large ribosomal subunit. Finally, gradient centrifugation experiments demonstrate a direct association of NCp7 with purified 80S ribosomes. Thus, our data suggest that NCp7 molecules released in newly infected cells may primarily bind to ribosomes, where they may exert a new potential role in HIV-1 infection.	[Anton, Halina; Taha, Nedal; Boutant, Emmanuel; Richert, Ludovic; Ronde, Philippe; Real, Eleonore; de Rocquigny, Hugues; Mely, Yves] Univ Strasbourg, Fac Pharm, UMR CNRS 7213, Lab Biophoton & Pharmacol, Illkirch Graffenstaden, France; [Khatter, Heena; Klaholz, Bruno] Univ Strasbourg, Inst Genet & Biol Mol & Cellulaire, UMR CNRS 7104, INSERM,U964, Illkirch Graffenstaden, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Mely, Y (corresponding author), Univ Strasbourg, Fac Pharm, UMR CNRS 7213, Lab Biophoton & Pharmacol, Illkirch Graffenstaden, France.	halina.anton@unistra.fr; yves.mely@unistra.fr	Richert, Ludovic/B-5006-2008; Khatter, Heena/U-3668-2017	Richert, Ludovic/0000-0003-4479-5418; Real, Dr Eleonore/0000-0002-5523-4408; Anton, Halina/0000-0003-1304-8671	European Strategy Forum on Research Infrastructures (ESFRI)	European Strategy Forum on Research Infrastructures (ESFRI)	Instruct as part of the European Strategy Forum on Research Infrastructures (ESFRI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arhel N, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-96; AXELROD D, 1976, BIOPHYS J, V16, P1055, DOI 10.1016/S0006-3495(76)85755-4; Azoulay J, 2003, J MOL BIOL, V326, P691, DOI 10.1016/S0022-2836(02)01430-4; Bacia K, 2007, NAT PROTOC, V2, P2842, DOI 10.1038/nprot.2007.410; Bastiaens PIH, 1999, TRENDS CELL BIOL, V9, P48, DOI 10.1016/S0962-8924(98)01410-X; BERKOWITZ RD, 1995, J VIROL, V69, P6445, DOI 10.1128/JVI.69.10.6445-6456.1995; BERLAND KM, 1995, BIOPHYS J, V68, P694, DOI 10.1016/S0006-3495(95)80230-4; BOUCHAUD JP, 1990, PHYS REV A, V41, P1156, DOI 10.1103/PhysRevA.41.1156; Buckman JS, 2003, J VIROL, V77, P1469, DOI 10.1128/JVI.77.2.1469-1480.2003; Carteau S, 1999, J VIROL, V73, P6670, DOI 10.1128/JVI.73.8.6670-6679.1999; Carteau S, 1997, J VIROL, V71, P6225, DOI 10.1128/JVI.71.8.6225-6229.1997; Clamme JP, 2003, BIOPHYS J, V84, P1960, DOI 10.1016/S0006-3495(03)75004-8; Corry B, 2005, BIOPHYS J, V89, P3822, DOI 10.1529/biophysj.105.069351; Cremazy FGE, 2005, EXP CELL RES, V309, P390, DOI 10.1016/j.yexcr.2005.06.007; Cristofari G, 2002, PROG NUCLEIC ACID RE, V72, P223, DOI 10.1016/S0079-6603(02)72071-0; Darlix J L, 2000, Adv Pharmacol, V48, P345; Darlix JL, 2007, ADV PHARMACOL, V55, P299, DOI 10.1016/S1054-3589(07)55009-X; Darlix JL, 2011, J MOL BIOL, V410, P565, DOI 10.1016/j.jmb.2011.03.037; DARLIX JL, 1993, CR ACAD SCI III-VIE, V316, P763; DARLIX JL, 1995, J MOL BIOL, V254, P523, DOI 10.1006/jmbi.1995.0635; DARZYNKIEWICZ Z, 1988, CANCER RES, V48, P1295; DARZYNKIEWICZ Z, 1986, CANCER RES, V46, P5760; Day RN, 2001, METHODS, V25, P4, DOI 10.1006/meth.2001.1211; Didier P, 2009, J FLUORESC, V19, P561, DOI 10.1007/s10895-008-0424-0; Digman MA, 2005, BIOPHYS J, V88, pL33, DOI 10.1529/biophysj.105.061788; Digman MA, 2005, BIOPHYS J, V89, P1317, DOI 10.1529/biophysj.105.062836; Dorsch S, 2009, NAT METHODS, V6, P225, DOI [10.1038/NMETH.1304, 10.1038/nmeth.1304]; Dross N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005041; GALLAY P, 1995, CELL, V83, P569, DOI 10.1016/0092-8674(95)90097-7; Ganser-Pornillos BK, 2008, CURR OPIN STRUC BIOL, V18, P203, DOI 10.1016/j.sbi.2008.02.001; Godet J, 2006, J MOL BIOL, V356, P1180, DOI 10.1016/j.jmb.2005.12.038; Godet J, 2010, RNA BIOL, V7, P687, DOI 10.4161/rna.7.6.13616; GORELICK RJ, 1990, J VIROL, V64, P3207, DOI 10.1128/JVI.64.7.3207-3211.1990; Guo JH, 1997, J VIROL, V71, P5178, DOI 10.1128/JVI.71.7.5178-5188.1997; HERSCHLAG D, 1995, J BIOL CHEM, V270, P20871, DOI 10.1074/jbc.270.36.20871; Jager S, 2012, NATURE, V481, P365, DOI 10.1038/nature10719; Kafaie J, 2008, VIROLOGY, V375, P592, DOI 10.1016/j.virol.2008.02.001; Kalwarczyk T, 2012, BIOINFORMATICS, V28, P2971, DOI 10.1093/bioinformatics/bts537; KHAN R, 1992, J BIOL CHEM, V267, P6689; Khatter H, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gkt1404; Kim SA, 2007, NAT METHODS, V4, P963, DOI 10.1038/NMETH1104; Krieger J, 2013, QUICKFIT 3 0 STATUS; Krishnamoorthy G, 2003, NUCLEIC ACIDS RES, V31, P5425, DOI 10.1093/nar/gkg738; Lee BM, 1998, J MOL BIOL, V279, P633, DOI 10.1006/jmbi.1998.1766; Levin JG, 2005, PROG NUCLEIC ACID RE, V80, P217, DOI 10.1016/S0079-6603(05)80006-6; Levin JG, 2010, RNA BIOL, V7, P754, DOI 10.4161/rna.7.6.14115; Lochmann TL, 2013, VIRUS RES, V171, P304, DOI 10.1016/j.virusres.2012.09.011; Lodish H, 2000, MOL CELL BIOL; LUBYPHELPS K, 1986, J CELL BIOL, V102, P2015, DOI 10.1083/jcb.102.6.2015; LUBYPHELPS K, 1987, P NATL ACAD SCI USA, V84, P4910, DOI 10.1073/pnas.84.14.4910; Lyonnais S, 2013, VIRUS RES, V171, P287, DOI 10.1016/j.virusres.2012.09.008; Mark-Danieli M, 2005, J VIROL, V79, P7756, DOI 10.1128/JVI.79.12.7756-7767.2005; Medina MA, 2002, BIOESSAYS, V24, P758, DOI 10.1002/bies.10118; MELY Y, 1994, BIOCHEMISTRY-US, V33, P12085, DOI 10.1021/bi00206a011; MELY Y, 1995, J BIOL CHEM, V270, P1650, DOI 10.1074/jbc.270.4.1650; Mirambeau G, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000669; Mirambeau G, 2006, J MOL BIOL, V364, P496, DOI 10.1016/j.jmb.2006.08.065; Mirambeau G, 2010, RNA BIOL, V7, P724, DOI 10.4161/rna.7.6.13777; MORELLET N, 1992, EMBO J, V11, P3059, DOI 10.1002/j.1460-2075.1992.tb05377.x; MORELLET N, 1994, J MOL BIOL, V235, P287, DOI 10.1016/S0022-2836(05)80033-6; Muriaux D, 2010, RNA BIOL, V7, P744, DOI 10.4161/rna.7.6.14065; Ohishi M, 2011, NUCLEIC ACIDS RES, V39, P3404, DOI 10.1093/nar/gkq1314; Pereira CF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017016; Piston DW, 2007, TRENDS BIOCHEM SCI, V32, P407, DOI 10.1016/j.tibs.2007.08.003; Poljak L, 2003, J MOL BIOL, V329, P411, DOI 10.1016/S0022-2836(03)00472-8; Rein A, 1998, TRENDS BIOCHEM SCI, V23, P297, DOI 10.1016/S0968-0004(98)01256-0; Rossow MJ, 2010, NAT PROTOC, V5, P1761, DOI 10.1038/nprot.2010.122; Rudner L, 2005, J VIROL, V79, P4055, DOI 10.1128/JVI.79.7.4055-4065.2005; Rulli SJ, 2007, J VIROL, V81, P6623, DOI 10.1128/JVI.02833-06; Saxton MJ, 2008, BIOPHYS J, V94, P760, DOI 10.1529/biophysj.107.114074; Saxton MJ, 2001, BIOPHYS J, V81, P2226, DOI 10.1016/S0006-3495(01)75870-5; Schnell U, 2012, NAT METHODS, V9, P152, DOI [10.1038/nmeth.1855, 10.1038/NMETH.1855]; Schwille P, 1999, BIOPHYS J, V77, P2251, DOI 10.1016/S0006-3495(99)77065-7; Seksek O, 1997, J CELL BIOL, V138, P131, DOI 10.1083/jcb.138.1.131; SEMMEL M, 1967, BIOCHIM BIOPHYS ACTA, V145, P561, DOI 10.1016/0005-2787(67)90116-5; Sprague BL, 2005, TRENDS CELL BIOL, V15, P84, DOI 10.1016/j.tcb.2004.12.001; Thomas JA, 2008, VIRUS RES, V134, P39, DOI 10.1016/j.virusres.2007.12.006; Thomas JA, 2006, VIROLOGY, V354, P261, DOI 10.1016/j.virol.2006.07.011; Thomas JA, 2006, VIROLOGY, V353, P41, DOI 10.1016/j.virol.2006.05.014; Turner BG, 1999, J MOL BIOL, V285, P1, DOI 10.1006/jmbi.1998.2354; Vo MN, 2009, J MOL BIOL, V386, P789, DOI 10.1016/j.jmb.2008.12.070; Voss TC, 2005, BIOTECHNIQUES, V38, P413, DOI 10.2144/05383RV01; Wachsmuth M, 2000, J MOL BIOL, V298, P677, DOI 10.1006/jmbi.2000.3692; Weiss M, 2004, BIOPHYS J, V87, P3518, DOI 10.1529/biophysj.104.044263; Woodson SA, 2010, RNA BIOL, V7, P677, DOI 10.4161/rna.7.6.13615; YOU JC, 1994, J BIOL CHEM, V269, P31491; Zhang JL, 2002, J VIROL, V76, P10444, DOI 10.1128/JVI.76.20.10444-10454.2002	87	16	16	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2015	10	2							e0116921	10.1371/journal.pone.0116921	http://dx.doi.org/10.1371/journal.pone.0116921			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC3LS	25723396	Green Submitted, Green Published, gold			2022-12-27	WOS:000350251200023
J	Fischer, J; Kleidon, A; Dittrich, P				Fischer, Jakob; Kleidon, Axel; Dittrich, Peter			Thermodynamics of Random Reaction Networks	PLOS ONE			English	Article							METABOLIC NETWORKS; SMALL-WORLD; STATES	Reaction networks are useful for analyzing reaction systems occurring in chemistry, systems biology, or Earth system science. Despite the importance of thermodynamic disequilibrium for many of those systems, the general thermodynamic properties of reaction networks are poorly understood. To circumvent the problem of sparse thermodynamic data, we generate artificial reaction networks and investigate their non-equilibrium steady state for various boundary fluxes. We generate linear and nonlinear networks using four different complex network models (Erdos-Renyi, Barabasi-Albert, Watts-Strogatz, Pan-Sinha) and compare their topological properties with real reaction networks. For similar boundary conditions the steady state flow through the linear networks is about one order of magnitude higher than the flow through comparable nonlinear networks. In all networks, the flow decreases with the distance between the inflow and outflow boundary species, with WattsStrogatz networks showing a significantly smaller slope compared to the three other network types. The distribution of entropy production of the individual reactions inside the network follows a power law in the intermediate region with an exponent of circa -1.5 for linear and -1.66 for nonlinear networks. An elevated entropy production rate is found in reactions associated with weakly connected species. This effect is stronger in nonlinear networks than in the linear ones. Increasing the flow through the nonlinear networks also increases the number of cycles and leads to a narrower distribution of chemical potentials. We conclude that the relation between distribution of dissipation, network topology and strength of disequilibrium is nontrivial and can be studied systematically by artificial reaction networks.	[Fischer, Jakob; Dittrich, Peter] Jena Ctr Bioinformat, Inst Comp Sci, Bio Syst Anal Grp, Jena, Germany; [Fischer, Jakob; Dittrich, Peter] Univ Jena, Jena, Germany; [Fischer, Jakob; Kleidon, Axel] Max Planck Inst Biogeochem, D-07745 Jena, Germany; [Fischer, Jakob] Int Max Planck Res Sch Global Biogeochem Cycles, Jena, Germany	Friedrich Schiller University of Jena; Max Planck Society	Fischer, J (corresponding author), Jena Ctr Bioinformat, Inst Comp Sci, Bio Syst Anal Grp, Jena, Germany.	fischer.jakob@uni-jena.de; peter.dittrich@uni-jena.de	Kleidon, Axel/O-7843-2014	Kleidon, Axel/0000-0002-3798-0730	International Max Planck Research School for Global Biogeochemical Cycles	International Max Planck Research School for Global Biogeochemical Cycles	JF is funded by the International Max Planck Research School for Global Biogeochemical Cycles (http://www.imprs-gbgc.de/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert R, 2002, REV MOD PHYS, V74, P47, DOI 10.1103/RevModPhys.74.47; BAGLEY RJ, 1992, SFI S SCI C, V10, P93; Cannon WR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103582; Cantu AG, 2006, J NON-EQUIL THERMODY, V31, P23, DOI 10.1515/JNETDY.2006.003; Chakrabarti A, 2013, BIOTECHNOL J, V8, P1043, DOI 10.1002/biot.201300091; CLARKE BL, 1988, CELL BIOPHYS, V12, P237, DOI 10.1007/BF02918360; De Martino D, 2013, PHYS REV E, V87, DOI 10.1103/PhysRevE.87.052108; Gleiss PM, 2001, ADV COMPLEX SYST, V04, P207, DOI [10.1142/S0219525901000140, DOI 10.1142/S0219525901000140]; Hordijk W, 2012, J SYST CHEM, V3, P5, DOI DOI 10.1186/1759-2208-3-5; Kaiser EW, 2000, J PHYS CHEM A, V104, P8194, DOI 10.1021/jp994074c; KASTING JF, 1985, J GEOPHYS RES-ATMOS, V90, P10497, DOI 10.1029/JD090iD06p10497; Kondepudi D, 1998, MODERN THERMODYNAMIC; Kreyssig P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045772; Kschischo M, 2010, EUR PHYS J-SPEC TOP, V187, P255, DOI 10.1140/epjst/e2010-01290-3; Layton A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051841; Li C, 2010, BMC SYST BIOL, V4, DOI [10.1186/1752-0509-4-39, 10.1186/1752-0509-4-92]; Li Xin, 2011, Database (Oxford), V2011, pbar005, DOI 10.1093/database/bar005; Marinov NM, 1999, INT J CHEM KINET, V31, P183, DOI 10.1002/(SICI)1097-4601(1999)31:3<183::AID-KIN3>3.0.CO;2-X; Martiez VS, 2014, BIOPHYS J, V107, P493, DOI 10.1016/j.bpj.2014.05.029; Newman MEJ, 2005, CONTEMP PHYS, V46, P323, DOI 10.1080/00107510500052444; OSTER G, 1971, NATURE, V234, P393, DOI 10.1038/234393a0; Pan RK, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.045103; Pan RK, 2008, PRAMANA-J PHYS, V71, P331, DOI 10.1007/s12043-008-0166-1; Pascal R, 2013, OPEN BIOL, V3, P130, DOI [10.1098/rsob.130156, DOI 10.1098/RS0B.130156]; Pons P, 2005, LECT NOTES COMPUT SC, V3733, P284; Renyi A., 1959, PUBL MATH-DEBRECEN, V6, P290, DOI DOI 10.2307/1999405; Saunders SM, 2003, ATMOS CHEM PHYS, V3, P161, DOI 10.5194/acp-3-161-2003; SCHUSTER R, 1993, COMPUT APPL BIOSCI, V9, P79; Soh KC, 2012, FEMS YEAST RES, V12, P129, DOI 10.1111/j.1567-1364.2011.00771.x; Soh KC, 2010, CURR OPIN MICROBIOL, V13, P350, DOI 10.1016/j.mib.2010.03.001; Sole RV, 2004, EPL-EUROPHYS LETT, V3, P1; Srienc F, 2010, ENTROPY-SWITZ, V12, P1921, DOI 10.3390/e12081921; Stanford NJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079195; Unrean P, 2011, METAB ENG, V13, P666, DOI 10.1016/j.ymben.2011.08.003; Wagner A, 2001, P ROY SOC B-BIOL SCI, V268, P1803, DOI 10.1098/rspb.2001.1711; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Yung Y. L., 1998, PHOTOCHEMISTRY PLANE; Zhou WD, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-132	38	6	6	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2015	10	2							e0117312	10.1371/journal.pone.0117312	http://dx.doi.org/10.1371/journal.pone.0117312			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC3LS	25723751	Green Published, gold, Green Submitted			2022-12-27	WOS:000350251200028
J	Huang, L; Li, GY; Mo, ZL; Xiao, P; Li, J; Huang, J				Huang, Lin; Li, Guiyang; Mo, Zhaolan; Xiao, Peng; Li, Jie; Huang, Jie			De Novo Assembly of the Japanese Flounder (Paralichthys olivaceus) Spleen Transcriptome to Identify Putative Genes Involved in Immunity	PLOS ONE			English	Article							PROFILING ANALYSIS; RELEVANT GENES; COAGULATION; COMPLEMENT; EXPRESSION; PATHWAY; FAMILY; TOLLIP; FISH; IDENTIFICATION	Background Japanese flounder (Paralichthys olivaceus) is an economically important marine fish in Asia and has suffered from disease outbreaks caused by various pathogens, which requires more information for immune relevant genes on genome background. However, genomic and transcriptomic data for Japanese flounder remain scarce, which limits studies on the immune system of this species. In this study, we characterized the Japanese flounder spleen transcriptome using an Illumina paired-end sequencing platform to identify putative genes involved in immunity. Methodology/Principal Findings A cDNA library from the spleen of P. olivaceus was constructed and randomly sequenced using an Illumina technique. The removal of low quality reads generated 12,196,968 trimmed reads, which assembled into 96,627 unigenes. A total of 21,391 unigenes (22.14%) were annotated in the NCBI Nr database, and only 1.1% of the BLASTx top-hits matched P. olivaceus protein sequences. Approximately 12,503 (58.45%) unigenes were categorized into three Gene Ontology groups, 19,547 (91.38%) were classified into 26 Cluster of Orthologous Groups, and 10,649 (49.78%) were assigned to six Kyoto Encyclopedia of Genes and Genomes pathways. Furthermore, 40,928 putative simple sequence repeats and 47, 362 putative single nucleotide polymorphisms were identified. Importantly, we identified 1,563 putative immune-associated unigenes that mapped to 15 immune signaling pathways. Conclusions/Significance The P. olivaceus transciptome data provides a rich source to discover and identify new genes, and the immune-relevant sequences identified here will facilitate our understanding of the mechanisms involved in the immune response. Furthermore, the plentiful potential SSRs and SNPs found in this study are important resources with respect to future development of a linkage map or marker assisted breeding programs for the flounder.	[Huang, Lin; Xiao, Peng] Chinese Acad Sci, Key Lab Expt Marine Biol, Inst Oceanol, Qingdao, Peoples R China; [Li, Guiyang; Mo, Zhaolan; Li, Jie; Huang, Jie] Chinese Acad Fishery Sci, Yellow Sea Fisheries Res Inst, Key Lab Sustainable Dev Marine Fisheries, Minist Agr, Qingdao, Peoples R China; [Li, Guiyang; Mo, Zhaolan; Li, Jie; Huang, Jie] Natl Lab Marine Sci & Technol, Qingdao, Peoples R China; [Huang, Lin] Univ Chinese Acad Sci, Beijing, Peoples R China; [Huang, Lin] Qingdao Univ, Coll Life Sci, Qingdao 266071, Peoples R China	Chinese Academy of Sciences; Institute of Oceanology, CAS; Chinese Academy of Fishery Sciences; Yellow Sea Fisheries Research Institute, CAFS; Ministry of Agriculture & Rural Affairs; Qingdao National Laboratory for Marine Science & Technology; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Qingdao University	Mo, ZL (corresponding author), Chinese Acad Fishery Sci, Yellow Sea Fisheries Res Inst, Key Lab Sustainable Dev Marine Fisheries, Minist Agr, Qingdao, Peoples R China.	mozl@ysfri.ac.cn	Huang, Jie/GWQ-5005-2022	Huang, Jie/0000-0002-0348-6590	Hi-tech Research and Development Program of China [2012AA092203]; National Natural Sciences Foundation of China [31072245, 31372567]; special foundation under the Construction Programme for 'Taishan Scholarship' of Shandong Province of China; Special Scientific Research Funds for Central Non-profit Institute, Yellow Sea Fisheries Research Institute [20603022013010]	Hi-tech Research and Development Program of China(National High Technology Research and Development Program of China); National Natural Sciences Foundation of China(National Natural Science Foundation of China (NSFC)); special foundation under the Construction Programme for 'Taishan Scholarship' of Shandong Province of China; Special Scientific Research Funds for Central Non-profit Institute, Yellow Sea Fisheries Research Institute	This research was supported by the Hi-tech Research and Development Program of China (Grant No. 2012AA092203), the National Natural Sciences Foundation of China (Grant No. 31072245 and 31372567), the special foundation under the Construction Programme for 'Taishan Scholarship' of Shandong Province of China, and Special Scientific Research Funds for Central Non-profit Institute, Yellow Sea Fisheries Research Institute (20603022013010). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Amara U, 2008, ADV EXP MED BIOL, V632, P71, DOI 10.1007/978-0-387-78952-1_6; Aoki T, 2006, COMP BIOCHEM PHYS D, V1, P115, DOI 10.1016/j.cbd.2005.07.002; Aoki T, 2011, COMP BIOCHEM PHYS D, V6, P39, DOI 10.1016/j.cbd.2010.06.005; Bacon K, 2003, CYTOKINE, V21, P48, DOI 10.1016/S1043-4666(02)00493-3; Brenner S, 2002, P NATL ACAD SCI USA, V99, P2936, DOI 10.1073/pnas.032680599; Brocker Chad, 2010, Human Genomics, V5, P30; Burns K, 2000, NAT CELL BIOL, V2, P346, DOI 10.1038/35014038; Choi G, 2006, SWISS MED WKLY, V136, P139; CLARK SC, 1987, SCIENCE, V236, P1229, DOI 10.1126/science.3296190; GOLDSTEIN DB, 1995, GENETICS, V139, P463; Gottipati S, 2008, CELL SIGNAL, V20, P269, DOI 10.1016/j.cellsig.2007.08.009; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Gui D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072417; Hu GB, 2014, FISH SHELLFISH IMMUN, V39, P138, DOI 10.1016/j.fsi.2014.05.002; Huang R, 2012, FISH SHELLFISH IMMUN, V33, P459, DOI 10.1016/j.fsi.2012.05.025; Isshiki T, 2001, DIS AQUAT ORGAN, V47, P87, DOI 10.3354/dao047087; Katagiri T, 1999, IMMUNOGENETICS, V50, P43, DOI 10.1007/s002510050684; Kurobe T, 2005, DEV COMP IMMUNOL, V29, P515, DOI 10.1016/j.dci.2004.10.005; Kurosaki T, 2010, ANNU REV IMMUNOL, V28, P21, DOI 10.1146/annurev.immunol.021908.132541; Li S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096625; Li Shuo, 2009, Acta Scientiarum Naturalium Universitatis Sunyatseni, V48, P89; Liao XL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062308; Long Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056998; Markiewski MM, 2007, TRENDS IMMUNOL, V28, P184, DOI 10.1016/j.it.2007.02.006; Mo Zhao-lan, 2001, Chinese Journal of Oceanology and Limnology, V19, P319; Moriya Y, 2007, NUCLEIC ACIDS RES, V35, pW182, DOI 10.1093/nar/gkm321; Moustafa EMM, 2010, J VET MED SCI, V72, P1359, DOI 10.1292/jvms.10-0026; Mu YN, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-506; Nam BH, 2003, J IMMUNOL, V170, P3081, DOI 10.4049/jimmunol.170.6.3081; Nikolich-Zugich J, 2004, MICROBES INFECT, V6, P501, DOI 10.1016/j.micinf.2004.01.006; Nomiyama H, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-222; Ohtani M, 2011, DEV COMP IMMUNOL, V35, P554, DOI 10.1016/j.dci.2010.12.013; Orchard J, 2005, LEUKEMIA LYMPHOMA, V46, P1689, DOI 10.1080/09638280500260079; Oshiumi H, 2003, IMMUNOGENETICS, V54, P791, DOI 10.1007/s00251-002-0519-8; Overgard AC, 2010, FISH SHELLFISH IMMUN, V29, P987, DOI 10.1016/j.fsi.2010.08.011; Palti Y, 2011, DEV COMP IMMUNOL, V35, P1263, DOI 10.1016/j.dci.2011.03.006; Pereiro P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035369; Pertea G, 2003, BIOINFORMATICS, V19, P651, DOI 10.1093/bioinformatics/btg034; Rebl A, 2008, FISH SHELLFISH IMMUN, V25, P153, DOI 10.1016/j.fsi.2008.04.002; Rebl A, 2010, VET IMMUNOL IMMUNOP, V134, P139, DOI 10.1016/j.vetimm.2009.09.021; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Seikai T, 2002, REV FISH SCI, V10, P421, DOI 10.1080/20026491051721; Smith-Garvin JE, 2009, ANNU REV IMMUNOL, V27, P591, DOI 10.1146/annurev.immunol.021908.132706; Stajich JE, 2002, GENOME RES, V12, P1611, DOI 10.1101/gr.361602; Tang JF, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-438; Tatusov RL, 2000, NUCLEIC ACIDS RES, V28, P33, DOI 10.1093/nar/28.1.33; Tayal V, 2008, EUR J PHARMACOL, V579, P1, DOI 10.1016/j.ejphar.2007.10.049; Van der Poll T, 2014, THROMB HAEMOSTASIS, V112, P1, DOI [10.1160/TH14-05-0437, DOI 10.1160/TH14-05-0437]; Xiang LX, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-472; Xu TJ, 2010, DEV COMP IMMUNOL, V34, P1042, DOI 10.1016/j.dci.2010.05.008; Yang DH, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-319; Zhang CZ, 2009, BIOCHEM BIOPH RES CO, V383, P298, DOI 10.1016/j.bbrc.2009.03.137; Zhang GY, 2004, CURR OPIN STRUC BIOL, V14, P154, DOI 10.1016/j.sbi.2004.03.003	54	43	45	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2015	10	2							e0117642	10.1371/journal.pone.0117642	http://dx.doi.org/10.1371/journal.pone.0117642			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC3LS	25723398	Green Published, gold, Green Submitted			2022-12-27	WOS:000350251200037
J	Mahboobi, SH; Javanpour, AA; Mofrad, MRK				Mahboobi, Seyed Hanif; Javanpour, Alex A.; Mofrad, Mohammad R. K.			The Interaction of RNA Helicase DDX3 with HIV-1 Rev-CRM1-RanGTP Complex during the HIV Replication Cycle	PLOS ONE			English	Article							MOLECULAR-MECHANICS; CONTINUUM SOLVENT; NUCLEAR EXPORT; CONFORMATIONAL-CHANGES; DOCKING APPROACH; FREE-ENERGIES; LEPTOMYCIN B; PROTEIN; BINDING; PREDICTION	Molecular traffic between the nucleus and the cytoplasm is regulated by the nuclear pore complex (NPC), which acts as a highly selective channel perforating the nuclear envelope in eukaryotic cells. The human immunodeficiency virus (HIV) exploits the nucleocytoplasmic pathway to export its RNA transcripts across the NPC to the cytoplasm. Despite extensive study on the HIV life cycle and the many drugs developed to target this cycle, no current drugs have been successful in targeting the critical process of viral nuclear export, even though HIV's reliance on a single host protein, CRM1, to export its unspliced and partially spliced RNA transcripts makes it a tempting target. Due to recent findings implicating a DEAD-box helicase, DDX3, in HIV replication and a member of the export complex, it has become an appealing target for anti-HIV drug inhibition. In the present research, we have applied a hybrid computational protocol to analyze protein-protein interactions in the HIV mRNA export cycle. This method is based on molecular docking followed by molecular dynamics simulation and accompanied by approximate free energy calculation (MM/GBSA), computational alanine scanning, clustering, and evolutionary analysis. We highlight here some of the most likely binding modes and interfacial residues between DDX3 and CRM1 both in the absence and presence of RanGTP. This work shows that although DDX3 can bind to free CRM1, addition of RanGTP leads to more concentrated distribution of binding modes and stronger binding between CRM1 and RanGTP.	[Mahboobi, Seyed Hanif; Javanpour, Alex A.; Mofrad, Mohammad R. K.] Univ Calif Berkeley, Mol Cell Biomech Lab, Dept Bioengn, Berkeley, CA 94720 USA; [Mahboobi, Seyed Hanif; Javanpour, Alex A.; Mofrad, Mohammad R. K.] Univ Calif Berkeley, Dept Mech Engn, Berkeley, CA 94720 USA; [Mofrad, Mohammad R. K.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Phys Biosci Div, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Mofrad, MRK (corresponding author), Univ Calif Berkeley, Mol Cell Biomech Lab, Dept Bioengn, Berkeley, CA 94720 USA.	mofrad@berkeley.edu	/R-6010-2019	/0000-0001-7004-4859; Mahboobi, Seyed Hanif/0000-0003-1249-6018				Andrusier N, 2007, PROTEINS, V69, P139, DOI 10.1002/prot.21495; Azimi M, 2014, MOL BIOL CELL, V25, P3643, DOI 10.1091/mbc.E14-06-1065; Azimi M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081741; Carter P, 2005, PROTEINS, V60, P281, DOI 10.1002/prot.20571; Castello A, 2009, J CELL SCI, V122, P3799, DOI 10.1242/jcs.055988; Clark RD, 2002, J MOL GRAPH MODEL, V20, P281, DOI 10.1016/S1093-3263(01)00125-5; Comeau SR, 2004, NUCLEIC ACIDS RES, V32, pW96, DOI 10.1093/nar/gkh354; Daugherty MD, 2010, NAT STRUCT MOL BIOL, V17, P1337, DOI 10.1038/nsmb.1902; de Vries SJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017695; DeJong ES, 2003, BIOCHEMISTRY-US, V42, P8035, DOI 10.1021/bi034252z; DiMattia MA, 2010, P NATL ACAD SCI USA, V107, P5810, DOI 10.1073/pnas.0914946107; Dimonte S, 2011, INTERVIROLOGY; Dominguez C, 2003, J AM CHEM SOC, V125, P1731, DOI 10.1021/ja026939x; Emekli U, 2008, PROTEINS, V70, P1219, DOI 10.1002/prot.21613; Feller SE, 2000, J PHYS CHEM B, V104, P7510, DOI 10.1021/jp0007843; Fernandes JD, 2012, RNA BIOL, V9, P6, DOI 10.4161/rna.9.1.18178; Garbelli A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019810; Glaser F, 2003, BIOINFORMATICS, V19, P163, DOI 10.1093/bioinformatics/19.1.163; Guttler T, 2010, NAT STRUCT MOL BIOL, V17, P1367, DOI 10.1038/nsmb.1931; Hou TJ, 2011, J COMPUT CHEM, V32, P866, DOI 10.1002/jcc.21666; Hou TJ, 2011, J CHEM INF MODEL, V51, P69, DOI 10.1021/ci100275a; Houston DR, 2013, J CHEM INF MODEL, V53, P384, DOI 10.1021/ci300399w; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Hutchinson AB, 2006, JAIDS-J ACQ IMM DEF, V43, P451, DOI 10.1097/01.qai.0000243090.32866.4e; Ishaq M, 2008, MOL BIOTECHNOL, V39, P231, DOI 10.1007/s12033-008-9040-0; Jamali T, 2011, INT REV CEL MOL BIO, V287, P233, DOI 10.1016/B978-0-12-386043-9.00006-2; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275; Joyner JC, 2011, J AM CHEM SOC, V133, P9912, DOI 10.1021/ja203057z; Karaca E, 2011, STRUCTURE, V19, P555, DOI 10.1016/j.str.2011.01.014; Kastritis PL, 2010, J PROTEOME RES, V9, P2216, DOI 10.1021/pr9009854; Klauda JB, 2005, J PHYS CHEM B, V109, P5300, DOI 10.1021/jp0468096; Kollman PA, 2000, ACCOUNTS CHEM RES, V33, P889, DOI 10.1021/ar000033j; Kortemme T., 2004, SCI STKE, V2004, ppl2, DOI [10.1126/stke.2192004pl2, DOI 10.1126/STKE.2192004PL2]; Kudo N, 1999, P NATL ACAD SCI USA, V96, P9112, DOI 10.1073/pnas.96.16.9112; Kuhn B, 2000, J MED CHEM, V43, P3786, DOI 10.1021/jm000241h; Lee MR, 2000, PROTEINS, V39, P309, DOI 10.1002/(SICI)1097-0134(20000601)39:4<309::AID-PROT40>3.0.CO;2-S; Lensink MF, 2010, PROTEINS, V78, P3085, DOI 10.1002/prot.22850; Lindstrom A, 2011, J CHEM INF MODEL, V51, P267, DOI [10.1021/ci1003S4x, 10.1021/ci100354x]; Maga G, 2011, CHEMMEDCHEM, V6, P1371, DOI 10.1002/cmdc.201100166; Massova I, 2000, PERSPECT DRUG DISCOV, V18, P113, DOI 10.1023/A:1008763014207; Massova I, 1999, J AM CHEM SOC, V121, P8133, DOI 10.1021/ja990935j; Miller BR, 2000, MOL BIOL CELL, V11, P3381, DOI 10.1091/mbc.11.10.3381; Monecke T, 2013, P NATL ACAD SCI USA, V110, P960, DOI 10.1073/pnas.1215214110; Moussavi-Baygi R, 2011, BIOPHYS J, V100, P1410, DOI 10.1016/j.bpj.2011.01.061; Moussavi-Baygi R, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002049; Naji S, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.015313; Onufriev A, 2004, PROTEINS, V55, P383, DOI 10.1002/prot.20033; Paraskeva E, 1999, J CELL BIOL, V145, P255, DOI 10.1083/jcb.145.2.255; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Porollo A, 2007, PROTEINS, V66, P630, DOI 10.1002/prot.21248; Radi MS, 2012, COMPOUNDS DDX3 INHIB; Rastelli G, 2009, CHEM BIOL DRUG DES, V73, P283, DOI 10.1111/j.1747-0285.2009.00780.x; Schneidman-Duhovny D, 2005, NUCLEIC ACIDS RES, V33, pW363, DOI 10.1093/nar/gki481; Shah S, 1998, J CELL BIOL, V141, P31, DOI 10.1083/jcb.141.1.31; Sharma D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009613; Srinivasakumar N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028462; Srinivasan J, 1998, J AM CHEM SOC, V120, P9401, DOI 10.1021/ja981844+; Suzek BE, 2007, BIOINFORMATICS, V23, P1282, DOI 10.1093/bioinformatics/btm098; Tovchigrechko A, 2006, NUCLEIC ACIDS RES, V34, pW310, DOI 10.1093/nar/gkl206; Wang JM, 2006, CURR COMPUT-AID DRUG, V2, P287, DOI 10.2174/157340906778226454; Wassenaar TA, 2012, J GRID COMPUT, V10, P743, DOI 10.1007/s10723-012-9246-z; Wolff B, 1997, CHEM BIOL, V4, P139, DOI 10.1016/S1074-5521(97)90257-X; Yedavalli VSRK, 2008, J MED CHEM, V51, P5043, DOI 10.1021/jm800332m; Yedavalli VSRK, 2004, CELL, V119, P381, DOI 10.1016/j.cell.2004.09.029; Zhao CL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093709	65	21	22	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2015	10	2							e0112969	10.1371/journal.pone.0112969	http://dx.doi.org/10.1371/journal.pone.0112969			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC3LS	25723178	gold, Green Submitted, Green Published			2022-12-27	WOS:000350251200001
J	Simbulan, RK; Di Santo, M; Liu, XW; Lin, WK; Donjacour, A; Maltepe, E; Shenoy, A; Borini, A; Rinaudo, P				Simbulan, Rhodel K.; Di Santo, Marlea; Liu, Xiaowei; Lin, Wingka; Donjacour, Annemarie; Maltepe, Emin; Shenoy, Archana; Borini, Andrea; Rinaudo, Paolo			Embryonic Stem Cells Derived from In Vivo or In Vitro-Generated Murine Blastocysts Display Similar Transcriptome and Differentiation Potential	PLOS ONE			English	Article							GENE-EXPRESSION; MOUSE EMBRYOS; VASCULAR DYSFUNCTION; FERTILIZATION; CULTURE; FETAL; DERIVATION; OUTCOMES; ORIGINS; PATTERN	The use of assisted reproductive technologies (ART) such as in vitro fertilization (IVF) has resulted in the birth of more than 5 million children. While children conceived by these technologies are generally healthy, there is conflicting evidence suggesting an increase in adult-onset complications like glucose intolerance and high blood pressure in IVF children. Animal models indicate similar potential risks. It remains unclear what molecular mechanisms may be operating during in vitro culture to predispose the embryo to these diseases. One of the limitations faced by investigators is the paucity of the material in the preimplantation embryo to test for molecular analysis. To address this problem, we generated mouse embryonic stem cells (mESC) from blastocysts conceived after natural mating (mESC(FB)) or after IVF, using optimal (KSOM + 5% O-2; mESC(KAA)) and suboptimal (Whitten's Medium, + 20% O-2, mESC(WM)) conditions. All three groups of embryos showed similar behavior during both derivation and differentiation into their respective mESC lines. Unsupervised hierarchical clustering of microarray data showed that blastocyst culture does not affect the transcriptome of derived mESCs. Transcriptomic changes previously observed in the inner cell mass (ICM) of embryos derived in the same conditions were not present in mESCs, regardless of method of conception or culture medium, suggesting that mESC do not fully maintain a memory of the events occurring prior to their derivation. We conclude that the fertilization method or culture media used to generate blastocysts does not affect differentiation potential, morphology and transcriptome of mESCs.	[Simbulan, Rhodel K.; Di Santo, Marlea; Liu, Xiaowei; Lin, Wingka; Donjacour, Annemarie; Rinaudo, Paolo] Univ Calif San Francisco, Dept Obstet Gynecol & Reprod Sci, San Francisco, CA 94143 USA; [Donjacour, Annemarie] Univ Calif San Francisco, Dept Anat, San Francisco, CA 94143 USA; [Maltepe, Emin] Univ Calif San Francisco, Dept Pediat, San Francisco, CA USA; [Shenoy, Archana] Univ Calif San Francisco, Dept Urol, San Francisco, CA USA; [Di Santo, Marlea; Borini, Andrea] Tecnobios Procreaz, Bologna, Italy	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Rinaudo, P (corresponding author), Univ Calif San Francisco, Dept Obstet Gynecol & Reprod Sci, San Francisco, CA 94143 USA.	Paolo.Rinaudo@ucsf.edu	BORINI, ANDREA/AAC-4423-2020	BORINI, ANDREA/0000-0001-9049-0020	National Institute of Child Health and Human Development (NICHD) [RO1:HD 062803-01A1]; California Institute for Regenerative Medicine [TB1-01194]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD062803, R01HD072455] Funding Source: NIH RePORTER	National Institute of Child Health and Human Development (NICHD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); California Institute for Regenerative Medicine(California Institute for Regenerative Medicine); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by a National Institute of Child Health and Human Development (NICHD) grant (RO1:HD 062803-01A1) to PR. RS was partially supported by the California Institute for Regenerative Medicine (TB1-01194. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARKER DJP, 1990, BRIT MED J, V301, P1111, DOI 10.1136/bmj.301.6761.1111; Bermejo-Alvarez P, 2010, P NATL ACAD SCI USA, V107, P3394, DOI 10.1073/pnas.0913843107; Breitling Rainer, 2005, Journal of Bioinformatics and Computational Biology, V3, P1171, DOI 10.1142/S0219720005001442; Bryja V, 2006, NAT PROTOC, V1, P2082, DOI 10.1038/nprot.2006.355; Bryja V, 2006, STEM CELLS, V24, P844, DOI 10.1634/stemcells.2005-0444; Camarano L, 2012, FERTILITY STERILITY; Ceelen M, 2007, FERTIL STERIL; Ceelen M, 2008, J CLIN ENDOCR METAB, V93, P1682, DOI 10.1210/jc.2007-2432; Cervello I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010964; Chambers SM, 2009, NAT BIOTECHNOL, V27, P275, DOI 10.1038/nbt.1529; Conner D A, 2001, Curr Protoc Mol Biol, VChapter 23, DOI 10.1002/0471142727.mb2302s51; Delle Piane L, 2010, HUM REPROD, V25, P2039, DOI 10.1093/humrep/deq165; Doherty AS, 2000, BIOL REPROD, V62, P1526, DOI 10.1095/biolreprod62.6.1526; Donjacour A, 2014, BIOL REPROD, V90, DOI 10.1095/biolreprod.113.113134; Ecker DJ, 2004, P NATL ACAD SCI USA, V101, P1595, DOI 10.1073/pnas.0306846101; Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044; Fernandez-Gonzalez R, 2004, P NATL ACAD SCI USA, V101, P5880, DOI 10.1073/pnas.0308560101; Feuer SK, 2013, MOL HUM REPROD, V19, P189, DOI 10.1093/molehr/gas066; Feuer SK, 2014, ENDOCRINOLOGY; Feuer SK, 2014, ENDOCRINOLOGY, V155, P1956, DOI 10.1210/en.2013-2081; Giritharan G, 2012, REPROD SCI, V19, P243, DOI 10.1177/1933719111428522; Giritharan G, 2010, HUM REPROD, V25, P3012, DOI 10.1093/humrep/deq266; Giritharan G, 2007, REPRODUCTION, V134, P63, DOI 10.1530/REP-06-0247; Hong FX, 2008, BIOINFORMATICS, V24, P374, DOI 10.1093/bioinformatics/btm620; Horii T, 2011, J REPROD DEVELOP, V57, P579, DOI 10.1262/jrd.10-194A; Horii T, 2010, CELL REPROGRAM, V12, P551, DOI 10.1089/cell.2009.0104; Jackson RA, 2004, OBSTET GYNECOL, V103, P551, DOI 10.1097/01.AOG.0000114989.84822.51; Kwong WY, 2000, DEVELOPMENT, V127, P4195; LAWITTS JA, 1993, METHOD ENZYMOL, V225, P153; Loh YH, 2006, NAT GENET, V38, P431, DOI 10.1038/ng1760; Miles HL, 2007, J CLIN ENDOCR METAB, V92, P3441, DOI 10.1210/jc.2006-2465; Paca A, 2012, DEV BIOL, V361, P90, DOI 10.1016/j.ydbio.2011.10.013; Pera RAR, 2009, DIFFERENTIATION, V78, P18, DOI 10.1016/j.diff.2009.03.004; Pfister S, 2007, GENE EXPR PATTERNS, V7, P558, DOI 10.1016/j.modgep.2007.01.005; Rexhaj E, 2013, J CLIN INVEST, V123, P5052, DOI 10.1172/JCI68943; Rinaudo P, 2004, REPRODUCTION, V128, P301, DOI 10.1530/rep.1.00297; Rinaudo P, 2012, ANNU REV PHYSIOL, V74, P107, DOI 10.1146/annurev-physiol-020911-153245; Rinaudo PF, 2006, FERTIL STERIL, V86, P1252, DOI 10.1016/j.fertnstert.2006.05.017; Scherrer U, 2012, CIRCULATION, V125, P1890, DOI 10.1161/CIRCULATIONAHA.111.071183; Sullivan EA, 2013, HUM REPROD, V28, P1375, DOI 10.1093/humrep/det036; Wang YM, 2007, NAT GENET, V39, P380, DOI 10.1038/ng1969; WHITTEN WK, 1968, J REPROD FERTIL, V17, P399, DOI 10.1530/jrf.0.0170399	42	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2015	10	2							e0117422	10.1371/journal.pone.0117422	http://dx.doi.org/10.1371/journal.pone.0117422			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC3LS	25723476	Green Published, Green Submitted, gold			2022-12-27	WOS:000350251200031
J	Stadelmann, K; Latshang, TD; Lo Cascio, CM; Clark, RA; Huber, R; Kohler, M; Achermann, P; Bloch, KE				Stadelmann, Katrin; Latshang, Tsogyal D.; Lo Cascio, Christian M.; Clark, Ross A.; Huber, Reto; Kohler, Malcolm; Achermann, Peter; Bloch, Konrad E.			Impaired Postural Control in Healthy Men at Moderate Altitude (1630 M and 2590 M): Data from a Randomized Trial	PLOS ONE			English	Article							ACUTE MOUNTAIN-SICKNESS; HYPOXIA; RELIABILITY; BALANCE	Objectives Intact postural control is essential for safe performance of mountain sports, operation of machinery at altitude, and for piloting airplanes. We tested whether exposure to hypobaric hypoxia at moderate altitude impairs the static postural control of healthy subjects. Methods In 51 healthy men, median age 24 y (quartiles 20; 28), static control was evaluated on a balance platform in Zurich, 490 m, and during a 4-day sojourn in Swiss mountain villages at 1630 m and 2590 m, 2 days each. The order of altitude exposure was randomized. Total center of pressure path length (COPL) and sway amplitude measured in two directions by a balance platform, and pulse oximetry were recorded. Data were compared between altitudes. Results Median (quartiles) COPL during standing on both legs with eyes open at 490 m and in the evenings on the first and second days at 1630 and 2590 m, respectively were: 50 (45; 57), 55 (48; 62), 56 (49; 61), 53 (47; 59), 54 (48; 60) cm, P<0.001 ANOVA. Corresponding arterial oxygen saturation was 97% (96; 97), 95% (94; 96), 95%(94; 96), 92%(90; 93), 93%(91; 93), P<0.001. Anterior-posterior sway amplitudes were larger at 1630 and 2590 m compared to 490 m, P<0.001. Multiple logistic regression analysis confirmed that higher altitudes (1630 and 2590m) were independently associated with increased COPL when controlled for the order of altitude exposure and age (P=0.001). Conclusions Exposure to 1630 and 2590m was associated with impaired static postural control even when visual references were available.	[Stadelmann, Katrin; Achermann, Peter] Univ Zurich, Inst Pharmacol & Toxicol, Zurich, Switzerland; [Stadelmann, Katrin; Huber, Reto; Kohler, Malcolm; Achermann, Peter; Bloch, Konrad E.] Univ Zurich, Zurich Ctr Integrat Human Physiol, Zurich, Switzerland; [Latshang, Tsogyal D.; Lo Cascio, Christian M.; Kohler, Malcolm; Bloch, Konrad E.] Univ Zurich Hosp, Div Pulm, CH-8091 Zurich, Switzerland; [Huber, Reto] Univ Childrens Hosp Zurich, Zurich, Switzerland; [Clark, Ross A.] Univ Melbourne, Fac Med Dent & Hlth Sci, Dept Physiotherapy, Melbourne, Vic, Australia	University of Zurich; University of Zurich; Zurich Center Integrative Human Physiology (ZIHP); University of Zurich; University Zurich Hospital; University Children's Hospital Zurich; University of Melbourne	Bloch, KE (corresponding author), Univ Zurich, Zurich Ctr Integrat Human Physiol, Zurich, Switzerland.	konrad.bloch@usz.ch	Clark, Ross/K-7613-2019; Achermann, Peter/N-1215-2014; Clark, Ross A/R-5664-2018	Clark, Ross/0000-0002-7291-8553; Achermann, Peter/0000-0002-0208-3511; Clark, Ross A/0000-0002-7291-8553	Zurich Center for Integrative Human Physiology, University of Zurich; Lunge Zurich, Lung Ligue of Zurich, Zurich; Schweizerische Unfallversicherungsgesellschaft, SUVA, Luzern	Zurich Center for Integrative Human Physiology, University of Zurich; Lunge Zurich, Lung Ligue of Zurich, Zurich; Schweizerische Unfallversicherungsgesellschaft, SUVA, Luzern	This study was supported by unconditional grants from the Zurich Center for Integrative Human Physiology, University of Zurich; the Lunge Zurich, Lung Ligue of Zurich, Zurich; and the Schweizerische Unfallversicherungsgesellschaft, SUVA, Luzern. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aerosp Med Assoc, 2008, AVIAT SPACE ENVIR MD, V79, P433, DOI 10.3357/ASEM.2272.2008; Ageberg E, 2003, BMC MUSCULOSKELET DI, V4, DOI 10.1186/1471-2474-4-14; Bauer C, 2008, ARCH PHYS MED REHAB, V89, P1977, DOI 10.1016/j.apmr.2008.02.033; Baumgartner RW, 2002, HIGH ALT MED BIOL, V3, P283, DOI 10.1089/152702902320604269; Binks AP, 2008, J APPL PHYSIOL, V104, P212, DOI 10.1152/japplphysiol.00069.2007; Browne SM, 2003, J THORAC CARDIOV SUR, V126, P1061, DOI 10.1016/S0022-5223(03)00616-0; Clark RA, 2010, GAIT POSTURE, V31, P307, DOI 10.1016/j.gaitpost.2009.11.012; Cymerman A, 2001, HIGH ALT MED BIOL, V2, P509, DOI 10.1089/152702901753397072; FRASER WD, 1987, AVIAT SPACE ENVIR MD, V58, P768; HOLNESS DE, 1982, AVIAT SPACE ENVIR MD, V53, P647; Latshang TD, 2013, SLEEP, V36, P1969, DOI 10.5665/sleep.3242; Muir SW, 2010, J CLIN EPIDEMIOL, V63, P389, DOI 10.1016/j.jclinepi.2009.06.010; Nordahl SHG, 1998, AVIAT SPACE ENVIR MD, V69, P590; Redfern MS, 2001, J ANXIETY DISORD, V15, P81, DOI 10.1016/S0887-6185(00)00043-8; REGARD M, 1991, AVIAT SPACE ENVIR MD, V62, P291; Stadelmann K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076945; Stowhas AC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070081; United Nations Environmental Programme, 2002, MOUNT; Wagner LS, 2011, AVIAT SPACE ENVIR MD, V82, P518, DOI 10.3357/ASEM.2885.2011; West JB, 2013, HIGH ALTITUDE MEDICINE AND PHYSIOLOGY, 5TH EDITION; World Tourism Organization UNTWO, 2014, 8 WORLD C SNOW MOUNT	21	15	15	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2015	10	2							e0116695	10.1371/journal.pone.0116695	http://dx.doi.org/10.1371/journal.pone.0116695			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC3LS	25723529	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000350251200020
J	Zhang, B; Yan, YH; Jin, J; Lin, HY; Li, ZY; Zhang, XY; Liu, J; Xi, C; Lieber, A; Fan, XL; Ran, L				Zhang, Bo; Yan, Yuhua; Jin, Jie; Lin, Hongyu; Li, Zongyi; Zhang, Xiaoyan; Liu, Jin; Xi, Chao; Lieber, Andre; Fan, Xiaolong; Ran, Liang			Two Types of Functionally Distinct Fiber Containing Structural Protein Complexes Are Produced during Infection of Adenovirus Serotype 5	PLOS ONE			English	Article							CELLULAR RECEPTOR; B ADENOVIRUSES; TIGHT JUNCTION; POTENTIAL ROLE; GENE-TRANSFER; CELLS; DODECAHEDRON; COXSACKIEVIRUS; PENTON; CAR	Adenoviruses are common pathogens. The localization of their receptors coxsackievirus and adenovirus receptor, and desmoglein-2 in cell-cell junction complexes between polarized epithelial cells represents a major challenge for adenovirus infection from the apical surface. Structural proteins including hexon, penton base and fiber are excessively produced in serotype 5 adenovirus (Ad5)-infected cells. We have characterized the composition of structural protein complexes released from Ad5 infected cells and their capacity in remodeling cell-cell junction complexes. Using T84 cells as a model for polarized epithelium, we have studied the effect of Ad5 structural protein complexes in remodeling cell-cell junctions in polarized epithelium. The initial Ad5 infection in T84 cell culture was inefficient. However, progressive distortion of cell-cell junction in association with fiber release was evident during progression of Ad5 infection. Incubation of T84 cell cultures with virion-free supernatant from Ad5 infected culture resulted in distortion of cell-cell junctions and decreased infectivity of Ad5-GFP vector. We used gel filtration chromatography to fractionate fiber containing virion-free supernatant from Ad5 infected culture supernatant. Fiber containing fractions were further characterized for their capacity to inhibit the infection of Ad5-GFP vector, their composition in adenovirus structural proteins using western blot and LC-MS/MS and their capacity in remolding cell-cell junctions. Fiber molecules in complexes containing penton base and hexon, or mainly hexon were identified. Only the fiber complexes with relatively high content of penton base, but not the fiber-hexon complexes with low penton base, were able to penetrate into T84 cells and cause distortion of cell-cell junctions. Our findings suggest that these two types of fiber complexes may play different roles in adenoviral infection.	[Zhang, Bo; Yan, Yuhua; Jin, Jie; Lin, Hongyu; Zhang, Xiaoyan; Liu, Jin; Xi, Chao; Fan, Xiaolong; Ran, Liang] Beijing Normal Univ, Coll Life Sci, Beijing Key Lab Gene Resources & Mol Dev, Beijing 100875, Peoples R China; [Li, Zongyi; Lieber, Andre] Univ Washington, Div Med Genet, Seattle, WA 98195 USA	Beijing Normal University; University of Washington; University of Washington Seattle	Fan, XL (corresponding author), Beijing Normal Univ, Coll Life Sci, Beijing Key Lab Gene Resources & Mol Dev, Beijing 100875, Peoples R China.	XFan@bnu.edu.cn; cyanoran@hotmail.com		Lieber, Andre/0000-0001-6742-6266	National Natural Science Foundation of China [81272535]; China Postdoctoral Science Foundation [103-224220]; NIH [R01 CA080192, R01 HLA078836]; NATIONAL CANCER INSTITUTE [R01CA080192] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Natural Science Foundation of China (grant 81272535), China Postdoctoral Science Foundation (grant 103-224220) and NIH grants R01 CA080192 and R01 HLA078836 (AL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bergelson JM, 2009, CELL HOST MICROBE, V5, P517, DOI 10.1016/j.chom.2009.05.009; Bergelson JM, 1997, SCIENCE, V275, P1320, DOI 10.1126/science.275.5304.1320; BOULANGE.PA, 1973, EUR J BIOCHEM, V39, P37, DOI 10.1111/j.1432-1033.1973.tb03100.x; Citi S, 1998, BBA-MOL CELL RES, V1448, P1, DOI 10.1016/S0167-4889(98)00125-6; Cohen CJ, 2001, P NATL ACAD SCI USA, V98, P15191, DOI 10.1073/pnas.261452898; Coyne CB, 2002, MOL BIOL CELL, V13, P3218, DOI 10.1091/mbc.E02-03-0134; Coyne CB, 2005, ADV DRUG DELIVER REV, V57, P869, DOI 10.1016/j.addr.2005.01.007; Excoffon KJDA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009909; Fender P, 1997, NAT BIOTECHNOL, V15, P52, DOI 10.1038/nbt0197-52; Fender P, 2003, J VIROL, V77, P4960, DOI 10.1128/JVI.77.8.4960-4964.2003; Fender P, 2012, J VIROL, V86, P5380, DOI 10.1128/JVI.07127-11; Franqueville L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002894; Fuschiotti P, 2006, J MOL BIOL, V356, P510, DOI 10.1016/j.jmb.2005.11.048; Gaggar A, 2003, NAT MED, V9, P1408, DOI 10.1038/nm952; Ghebremedhin B, 2014, EUR J MICROBIOL IMMU, V4, P26, DOI 10.1556/EuJMI.4.2014.1.2; Hong SS, 2005, J MOL BIOL, V352, P125, DOI 10.1016/j.jmb.2005.06.070; Marttila M, 2005, J VIROL, V79, P14429, DOI 10.1128/JVI.79.22.14429-14436.2005; Nilsson EC, 2011, NAT MED, V17, P105, DOI 10.1038/nm.2267; Nilsson M, 2004, J GENE MED, V6, P631, DOI 10.1002/jgm.543; NORRBY E, 1969, J GEN VIROL, V5, P221, DOI 10.1099/0022-1317-5-2-221; Raschperger E, 2006, EXP CELL RES, V312, P1566, DOI 10.1016/j.yexcr.2006.01.025; Rebetz J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008484; Russell WC, 2009, J GEN VIROL, V90, P1, DOI 10.1099/vir.0.003087-0; Schoehn G, 1996, EMBO J, V15, P6841, DOI 10.1002/j.1460-2075.1996.tb01075.x; Steed E, 2010, TRENDS CELL BIOL, V20, P142, DOI 10.1016/j.tcb.2009.12.002; Szolajska E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046075; Tamanini A, 2006, J VIROL, V80, P11241, DOI 10.1128/JVI.00721-06; Walters RW, 2002, CELL, V110, P789, DOI 10.1016/S0092-8674(02)00912-1; Wang HJ, 2011, NAT MED, V17, P96, DOI 10.1038/nm.2270; Wang Y, 2006, J MOL HISTOL, V37, P153, DOI 10.1007/s10735-006-9055-4; WICKHAM TJ, 1993, CELL, V73, P309, DOI 10.1016/0092-8674(93)90231-E	31	1	1	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2015	10	2							e0117976	10.1371/journal.pone.0117976	http://dx.doi.org/10.1371/journal.pone.0117976			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC3LS	25723153	Green Published, Green Submitted, gold			2022-12-27	WOS:000350251200043
J	Ozdemir, BA; Karthikesalingam, A; Sinha, S; Poloniecki, JD; Hinchliffe, RJ; Thompson, MM; Gower, JD; Boaz, A; Holt, PJE				Ozdemir, Baris A.; Karthikesalingam, Alan; Sinha, Sidhartha; Poloniecki, Jan D.; Hinchliffe, Robert J.; Thompson, Matt M.; Gower, Jonathan D.; Boaz, Annette; Holt, Peter J. E.			Research Activity and the Association with Mortality	PLOS ONE			English	Article							RETROSPECTIVE ANALYSIS; ADMINISTRATIVE DATA; RESEARCH NETWORKS; ENGLAND; RATES; CARE; MORBIDITY; OUTCOMES; IMPACT; CANCER	Introduction The aims of this study were to describe the key features of acute NHS Trusts with different levels of research activity and to investigate associations between research activity and clinical outcomes. Methods National Institute for Health Research (NIHR) Comprehensive Clinical Research Network (CCRN) funding and number of patients recruited to NIHR Clinical Research Network (CRN) portfolio studies for each NHS Trusts were used as markers of research activity. Patient- level data for adult non-elective admissions were extracted from the English Hospital Episode Statistics (2005-10). Risk-adjusted mortality associations between Trust structures, research activity and, clinical outcomes were investigated. Results Low mortality Trusts received greater levels of funding and recruited more patients adjusted for size of Trust (n = 35, 2,349 (sic)/bed [95% CI 1,855-2,843], 5.9 patients/bed [2.7-9.0]) than Trusts with expected (n = 63, 1,110 (sic)/bed, [864-1,357] p<0.0001, 2.6 patients/bed [1.7-3.5] p<0.0169) or, high (n = 42, 930 (sic)/bed [683-1,177] p = 0.0001, 1.8 patients/bed [1.4-2.1] p<0.0005) mortality rates. The most research active Trusts were those with more doctors, nurses, critical care beds, operating theatres and, made greater use of radiology. Multifactorial analysis demonstrated better survival in the top funding and patient recruitment tertiles (lowest vs. highest (odds ratio & 95% CI: funding 1.050 [1.033-1.068] p<0.0001, recruitment 1.069 [1.052-1.086] p<0.0001), middle vs. highest (funding 1.040 [1.024-1.055] p<0.0001, recruitment 1.085 [1.070-1.100] p<0.0001). Conclusions Research active Trusts appear to have key differences in composition than less research active Trusts. Research active Trusts had lower risk- adjusted mortality for acute admissions, which persisted after adjustment for staffing and other structural factors.	[Ozdemir, Baris A.; Karthikesalingam, Alan; Sinha, Sidhartha; Poloniecki, Jan D.; Hinchliffe, Robert J.; Thompson, Matt M.; Holt, Peter J. E.] St Georges Vasc Inst, Dept Outcomes Res, London, England; [Gower, Jonathan D.] NIHR Comprehens Clin Res Network Coordinating Ctr, Leeds, W Yorkshire, England; [Boaz, Annette] St Georges Univ London, Ctr Hlth & Social Care Res, London, England	St Georges University London; St Georges University London	Ozdemir, BA (corresponding author), St Georges Vasc Inst, Dept Outcomes Res, London, England.	drbaozdemir@gmail.com			National Institute for Health Research (NIHR) [NIHR-CS-011-008]; Circulation Foundation Surgeon Scientist Award; National Institute for Health Research [NIHR-CS-011-008] Funding Source: researchfish	National Institute for Health Research (NIHR)(National Institute for Health Research (NIHR)); Circulation Foundation Surgeon Scientist Award; National Institute for Health Research(National Institute for Health Research (NIHR))	Peter Holt is a Clinician Scientist funded with a personal award by the National Institute for Health Research (NIHR) (NIHR-CS-011-008), but has no direct financial involvement with the Comprehensive Clinical Research Network (CCRN). Jonathan Gower is employed as the assistant director of the CCRN but had no influence over the analysis or results. Alan Karthikesalingam is a Clinical Lecturer supported by the Circulation Foundation Surgeon Scientist Award. All other authors have had no support from any organisation for the submitted work; no other relationships or, activities that could appear to have influenced the submitted work. The NIHR had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The views expressed in this publication are those of the authors and not necessarily those of the NIHR, NHS, or Department of Health.	Abraham AJ, 2010, J SUBST ABUSE TREAT, V38, P275, DOI 10.1016/j.jsat.2010.01.003; Armitage JN, 2010, BRIT J SURG, V97, P772, DOI 10.1002/bjs.6930; Aylin P, 2007, BMJ-BRIT MED J, V334, P1044, DOI 10.1136/bmj.39168.496366.55; Bennett WO, 2012, PUBLIC HEALTH, V126, pS40, DOI 10.1016/j.puhe.2012.05.021; Bottle A, 2011, HEALTH SERV RES, V46, P1741, DOI 10.1111/j.1475-6773.2011.01295.x; Carpenter WR, 2011, MED CARE, V49, P172, DOI 10.1097/MLR.0b013e3182028ff2; Christmas Colleen, 2010, J Grad Med Educ, V2, P478, DOI 10.4300/JGME-D-10-00100.1; DeLong E, 2003, AM HEART J, V145, P16, DOI 10.1067/mhj.2003.27; Department of Health website, PERF DAT STAT; Druss BG, 2005, AM J MED, V118, P658, DOI 10.1016/j.amjmed.2005.02.015; Everitt B. H. T., 2009, HDB STAT ANAL USING; Hanney S, 2007, HEALTH TECHNOL ASSES, V11, P1; Hanney S., 2013, HLTH SERV DELIV RES, V1; Haynes Alex B, 2009, N Engl J Med, V360, P491, DOI 10.1056/NEJMsa0810119; Holt PJE, 2007, BRIT J SURG, V94, P441, DOI 10.1002/bjs.5725; Holt PJE, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/1472-6963-14-270; Hosmer DavidW., 2000, APPL LOGISTIC REGRES; Jarman B, 1999, BMJ-BRIT MED J, V318, P1515, DOI 10.1136/bmj.318.7197.1515; Laliberte L, 2005, MED CARE, V43, P471, DOI 10.1097/01.mlr.0000160416.66188.f5; Lindbloom EJ, 2004, MED CARE, V42, P45, DOI 10.1097/01.mlr.0000119397.65643.d4; Moxey PW, 2010, BRIT J SURG, V97, P1348, DOI 10.1002/bjs.7092; Moxey PW, 2012, ANN SURG, V256, P1102, DOI 10.1097/SLA.0b013e31825f01d1; National Institute for Health Research Comprehensive Clinical Research Network, 2012, NIHR CCRN FUND DAT; National Institute for Health Research website, EL CRIT NIHR CRN SUP; NHS England website, STAT WORK AR; Papanikolaou PN, 2006, PLOS MED, V3, P1603, DOI 10.1371/journal.pmed.0030341; Peterson, 2005, ANN FAM MED S1, V3, pS12, DOI [10.1370/afm.303, DOI 10.1370/AFM.303]; Research and Development Directorate, 2006, BEST RES BEST HLTH; Rhyne R, 2011, J AM BOARD FAM MED, V24, P496, DOI 10.3122/jabfm.2011.05.100295; Rochon J, 2011, ANN ONCOL, V22, P16, DOI 10.1093/annonc/mdr421; Siegel RM, 2006, CLIN PEDIATR, V45, P518, DOI 10.1177/0009922806290567; Sinha S, 2014, CIRC-CARDIOVASC QUAL, V7, P131, DOI 10.1161/CIRCOUTCOMES.113.000579; Sinha S, 2013, SURG ENDOSC, V27, P162, DOI 10.1007/s00464-012-2415-0; von Elm E, 2007, LANCET, V370, P1453, DOI 10.1016/S0140-6736(07)61602-X; Ward V, 2009, J HEALTH SERV RES PO, V14, P156, DOI 10.1258/jhsrp.2009.008120; WARNECKE RB, 1995, JOINT COMM J QUAL IM, V21, P336, DOI 10.1016/S1070-3241(16)30158-4; Wright D, 2013, INT J TECHNOL ASSESS, V29, P192, DOI 10.1017/S026646231300010X	37	90	90	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2015	10	2							e0118253	10.1371/journal.pone.0118253	http://dx.doi.org/10.1371/journal.pone.0118253			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC2ZH	25719608	Green Accepted, gold, Green Submitted, Green Published			2022-12-27	WOS:000350213200043
J	Zheng, L; Sun, DC; Fan, WT; Zhang, ZW; Li, QL; Jiang, T				Zheng, Lei; Sun, Dongchen; Fan, Wentao; Zhang, Zhiwei; Li, Quanlin; Jiang, Tao			Diagnostic Value of SFRP1 as a Favorable Predictive and Prognostic Biomarker in Patients with Prostate Cancer	PLOS ONE			English	Article							FRIZZLED-RELATED PROTEIN-1; WNT/BETA-CATENIN PATHWAY; WNT ANTAGONIST SFRP1; ABERRANT EXPRESSION; GENE-EXPRESSION; METHYLATION; CELL; PROLIFERATION; THERAPY; IDENTIFICATION	Growing genetic and molecular biological evidence suggests that the disruption of balance between Secreted Frizzled-Related Protein-1 (SFRP1) and beta-catenin plays an important role in the initiation and development of multiple cancers. The aim of this study was to examine whether the expression of SFRP1 and beta-catenin is associated with the clinical-pathologic features of patients with prostate cancer (PCa), and to evaluate their potential roles as predictive and prognostic biomarkers. In this study, a total of 61 patients with PCa and 10 patients with benign prostatic hyperplasia were included, and we showed that the expression of SFRP1 and beta-catenin was correlated with the Gleason score, survival rate and response for endocrine therapy of PCa. The survival rates of PCa patients with low SFRP1 expression (P = 0.016) or high beta-catenin expression (P = 0.004) were significantly poorer. A negative correlation (r = -0.275, P = 0.032) between SFRP1 and beta-catenin was observed by Chi-square test. Multivariate analysis suggested that SFRP1 (hazard ratio, 0.429; 95% confidence intervals, 0.227-0.812; P = 0.009) may serve as an independent predictive and prognostic factor for PCa. We also showed that the protein and mRNA levels of SFRP1 in androgen-dependent PCa cell line LNCaP were significantly higher than those in androgenindependent PCa cell lines DU145 and PC3. However, the protein level of B-catenin in LNCaP cells was significantly lower than that in DU145 and PC3 cells, and no significant difference of beta-catenin mRNA level was observed in LNCaP, DU145 and PC3 cells. Bisulfite sequencing PCR assay revealed significantly lower methylation level of SFRP1 promoter in LNCaP cells than that in DU145 and PC3 cells. Taken together, these findings suggest that SFRP1, which expression inversely correlates with that of beta-catenin, is a favorable predictive and prognostic biomarker.	[Zheng, Lei; Sun, Dongchen; Fan, Wentao; Zhang, Zhiwei; Li, Quanlin; Jiang, Tao] Dalian Med Univ, Affiliated Hosp 1, Dept Urol, Dalian, Peoples R China; [Zheng, Lei] Fifth Peoples Hosp Dalian, Dept Urol, Dalian, Peoples R China	Dalian Medical University	Jiang, T (corresponding author), Dalian Med Univ, Affiliated Hosp 1, Dept Urol, Dalian, Peoples R China.	dyjiangt69@163.com			National Natural Science Foundation of China [21272032]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants (21272032 to TJ) from National Natural Science Foundation of China ( http://www.nsfc.gov.cn/publish/portal1/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amado NG, 2012, CURR TOP MED CHEM, V12, P2103; Awakura Y, 2008, ONCOL REP, V20, P1257, DOI 10.3892/or_00000138; Basu M, 2013, J BIOL CHEM, V288, P4355, DOI 10.1074/jbc.M112.409102; Beghini A, 2012, NEOPLASIA, V14, P1236, DOI 10.1593/neo.121480; Bu XM, 2008, CHINESE MED J-PEKING, V121, P952, DOI 10.1097/00029330-200805020-00016; Center MM, 2012, EUR UROL, V61, P1079, DOI 10.1016/j.eururo.2012.02.054; Chung MT, 2009, GYNECOL ONCOL, V112, P646, DOI 10.1016/j.ygyno.2008.10.026; Dong L, 2014, ONCOL LETT, V7, P1203, DOI 10.3892/ol.2014.1866; Drewa T., 2010, Experimental Oncology, V32, P228; Durmus T, 2014, AKTUEL UROL, V45, P119, DOI 10.1055/s-0034-1371875; Elzi DJ, 2012, MOL CELL BIOL, V32, P4388, DOI 10.1128/MCB.06023-11; Farooqi AA, 2011, CELL PROLIFERAT, V44, P508, DOI 10.1111/j.1365-2184.2011.00784.x; Florl AL, 2004, BRIT J CANCER, V91, P985, DOI 10.1038/sj.bjc.6602030; Foro P, 2014, INT J RADIAT ONCOL, V88, P1057, DOI 10.1016/j.ijrobp.2014.01.002; Garnier-Amblard EC, 2011, ACS MED CHEM LETT, V2, P438, DOI 10.1021/ml2000164; Gopalsamy A, 2008, J MED CHEM, V51, P7670, DOI 10.1021/jm801069w; Han JI, 2010, VET PATHOL, V47, P285, DOI 10.1177/0300985809359303; Herman TDLF, 2013, J MED PHYS, V38, P165, DOI 10.4103/0971-6203.121193; Hirata H, 2011, CANCER-AM CANCER SOC, V117, P1649, DOI 10.1002/cncr.25666; Inestrosa NC, 2014, J MOL CELL BIOL, V6, P64, DOI 10.1093/jmcb/mjt051; Izard J, 2014, SURGERY, V155, P789, DOI 10.1016/j.surg.2013.12.007; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Jensen M, 2012, CELL, V149, P173, DOI 10.1016/j.cell.2011.12.038; Jeong YJ, 2013, ONCOL REP, V29, P1946, DOI 10.3892/or.2013.2335; Joesting MS, 2008, DEV BIOL, V317, P161, DOI 10.1016/j.ydbio.2008.02.021; Joesting MS, 2005, CANCER RES, V65, P10423, DOI 10.1158/0008-5472.CAN-05-0824; Kang PC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090308; Kawano Y, 2009, BRIT J CANCER, V100, P1165, DOI 10.1038/sj.bjc.6604976; Kohno H, 2010, ONCOL REP, V24, P423, DOI 10.3892/or_00000875; Kongkham PN, 2010, ONCOGENE, V29, P3017, DOI 10.1038/onc.2010.32; Larriba Maria Jesus, 2013, Cancers (Basel), V5, P1242, DOI 10.3390/cancers5041242; Laschak M, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-130; Leal LF, 2011, J CLIN ENDOCR METAB, V96, P3106, DOI 10.1210/jc.2011-0363; Lee CH, 2010, ANN SURG ONCOL, V17, P2237, DOI 10.1245/s10434-010-0961-z; Liu N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093364; Lodygin D, 2005, CANCER RES, V65, P4218, DOI 10.1158/0008-5472.CAN-04-4407; Luga V, 2012, CELL, V151, P1542, DOI 10.1016/j.cell.2012.11.024; Luo HC, 2013, ASIAN PAC J CANCER P, V14, P4711, DOI 10.7314/APJCP.2013.14.8.4711; Matsuda Y, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2317; Mock S, 2013, J UROLOGY, V190, P1805, DOI 10.1016/j.juro.2013.05.010; Ortiz-Matamoros A, 2013, CURR NEUROPHARMACOL, V11, P465, DOI 10.2174/1570159X11311050001; Perry AS, 2013, INT J CANCER, V132, P1771, DOI 10.1002/ijc.27798; Reins J, 2010, LEUKEMIA RES, V34, P1610, DOI 10.1016/j.leukres.2010.04.013; Robinson DR, 2008, CURR DRUG TARGETS, V9, P571; Scholer-Dahirel A, 2011, P NATL ACAD SCI USA, V108, P17135, DOI 10.1073/pnas.1104182108; Siegel RD, 2013, J ONCOL PRACT, V9, P160, DOI 10.1200/JOP.2013.000925; Snoeks LL, 2013, NETH J MED, V71, P290; Spencer BA, 2013, SUPPORT CARE CANCER, V21, P1303, DOI 10.1007/s00520-012-1666-6; Stewart DJ, 2014, PHARMACOGENOMICS J, V14, P509, DOI 10.1038/tpj.2014.21; Stoehr R, 2004, LAB INVEST, V84, P465, DOI 10.1038/labinvest.3700068; Sverrisson EF, 2014, UROLOGY, V83, P376, DOI 10.1016/j.urology.2013.10.018; Thiele S, 2011, J CELL BIOCHEM, V112, P1593, DOI 10.1002/jcb.23070; Ugolini F, 2001, ONCOGENE, V20, P5810, DOI 10.1038/sj.onc.1204706; Vela I, 2014, CLIN EXP METASTAS, V31, P199, DOI 10.1007/s10585-013-9620-7; Wang XB, 2012, ONCOL LETT, V4, P334, DOI 10.3892/ol.2012.713; Ware KE, 2014, ENDOCR-RELAT CANCER, V21, pT87, DOI 10.1530/ERC-13-0470; You JJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066770; Zhang J, 2010, ONCOGENE, V29, P539, DOI 10.1038/onc.2009.339; Zhang YW, 2011, CANCER LETT, V303, P21, DOI 10.1016/j.canlet.2010.12.011; Zhu XP, 2013, CANCER RES, V73, P1142, DOI 10.1158/0008-5472.CAN-12-1040; Zong Y, 2012, P NATL ACAD SCI USA, V109, pE3395, DOI 10.1073/pnas.1217982109	61	36	38	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2015	10	2							e0118276	10.1371/journal.pone.0118276	http://dx.doi.org/10.1371/journal.pone.0118276			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC2ZH	25719802	Green Published, gold, Green Submitted			2022-12-27	WOS:000350213200044
J	Yuan, QL; Guo, TM; Liu, L; Sun, F; Zhang, YG				Yuan, Qi-ling; Guo, Tuan-mao; Liu, Liang; Sun, Fu; Zhang, Yin-gang			Traditional Chinese Medicine for Neck Pain and Low Back Pain: A Systematic Review and Meta-Analysis	PLOS ONE			English	Article							RANDOMIZED CLINICAL-TRIAL; CHRONIC SPINAL PAIN; TERM-FOLLOW-UP; ACUPUNCTURE TREATMENT; COMPARING ACUPUNCTURE; THERAPY; EXERCISE; ACUPRESSURE; EFFICACY; PLACEBO	Background Neck pain (NP) and low back pain (LBP) are common symptoms bothering people in daily life. Traditional Chinese medicine (TCM) has been used to treat various symptoms and diseases in China and has been demonstrated to be effective. The objective of the present study was to review and analyze the existing data about pain and disability in TCM treatments for NP and LBP. Methods Studies were identified by a comprehensive search of databases, such as MEDLINE, EMBASE, and Cochrane Library, up to September 1, 2013. A meta-analysis was performed to evaluate the efficacy and safety of TCM in managing NP and LBP. Results Seventy five randomized controlled trials (n = 11077) were included. Almost all of the studies investigated individuals experiencing chronic NP (CNP) or chronic LBP (CLBP). We found moderate evidence that acupuncture was more effective than sham-acupuncture in reducing pain immediately post-treatment for CNP (visual analogue scale (VAS) 10 cm, mean difference (MD) = -0.58 (-0.94, -0.22), 95% confidence interval, p = 0.01), CLBP (standardized mean difference = -0.47 (-0.77, -0.17), p = 0.003), and acute LBP (VAS 10 cm, MD = -0.99 (-1.24, -0.73), p < 0.001). Cupping could bemore effective than waitlist in VAS (100mm) (MD = -19.10 (-27.61, -10.58), p < 0.001) for CNP or medications (e.g. NSAID) for CLBP (MD = -5.4 (-8.9, -0.19), p = 0.003). No serious or life-threatening adverse effects were found. Conclusions Acupuncture, acupressure, and cupping could be efficacious in treating the pain and disability associated with CNP or CLBP in the immediate term. Gua sha, tai chi, qigong, and Chinese manipulation showed fair effects, but we were unable to draw any definite conclusions, and further research is still needed. The efficacy of tuina and moxibustion is unknown because no direct evidence was obtained. These TCM modalities are relatively safe.	[Yuan, Qi-ling; Liu, Liang; Sun, Fu; Zhang, Yin-gang] Xi An Jiao Tong Univ, Sch Med, Affiliated Hosp 1, Dept Orthopaed, Xian 710061, Peoples R China; [Guo, Tuan-mao] Xianyang Cent Hosp, Dept Orthopaed 2, Xianyang 712000, Shaanxi, Peoples R China; [Sun, Fu] Xian Med Coll, Affiliated Hosp, Dept Orthopaed, Xian 710077, Peoples R China	Xi'an Jiaotong University; Xi'an Medical University	Zhang, YG (corresponding author), Xi An Jiao Tong Univ, Sch Med, Affiliated Hosp 1, Dept Orthopaed, Xian 710061, Peoples R China.	zyingang@mail.xjtu.edu.cn	Yuan, Qiling/AGX-7768-2022	Yuan, Qiling/0000-0002-4822-2513; Guo, Meiting/0000-0002-1497-7053	Natural Scientific Fund of China [81371987, 81171761]	Natural Scientific Fund of China	The authors are grateful for the support of the Natural Scientific Fund of China (no. 81371987, 81171761). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson G, 1997, ADULT SPINE PRINCIPL; Birch S, 1998, CLIN J PAIN, V14, P248, DOI 10.1097/00002508-199809000-00012; Braun M, 2011, PAIN MED, V12, P362, DOI 10.1111/j.1526-4637.2011.01053.x; Brinkhaus B, 2006, ARCH INTERN MED, V166, P450; Chen J, 2009, CHIN J TRADIT MED TR, V17, P32; Cherkin DC, 2009, ARCH INTERN MED, V169, P858, DOI 10.1001/archinternmed.2009.65; Cherkin DC, 2001, ARCH INTERN MED, V161, P1081, DOI 10.1001/archinte.161.8.1081; Cho YJ, 2013, SPINE, V38, P549, DOI 10.1097/BRS.0b013e318275e601; Chou R, 2010, JAMA-J AM MED ASSOC, V303, P1295, DOI 10.1001/jama.2010.344; COAN RM, 1981, AM J CHINESE MED, V9, P326, DOI 10.1142/S0192415X81000433; COAN RM, 1980, AM J CHINESE MED, V8, P181, DOI 10.1142/S0192415X80000141; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; Cote P, 1998, SPINE, V23, P1689, DOI 10.1097/00007632-199808010-00015; Cramer H, 2011, FORSCH KOMPLEMENTMED, V18, P327, DOI 10.1159/000335294; D'Sylva J, 2010, MANUAL THER, V15, P415, DOI 10.1016/j.math.2010.04.003; Farhadi K, 2009, COMPLEMENT THER MED, V17, P9, DOI 10.1016/j.ctim.2008.05.003; Fejer R, 2006, EUR SPINE J, V15, P834, DOI 10.1007/s00586-004-0864-4; Fu LM, 2009, J ALTERN COMPLEM MED, V15, P133, DOI 10.1089/acm.2008.0135; Fu WB, 2009, CHIN J INTEGR MED, V15, P426, DOI 10.1007/s11655-009-0426-z; Furlan AD, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/953139; Furlan AD, 2009, SPINE, V34, P1929, DOI 10.1097/BRS.0b013e3181b1c99f; Gao S, 1993, ZHONG YI YAO DONG TA, V4, P25, DOI 1016/j.math.2010.04.003; Geng M, 1989, ZHEN JIU XUE BAO, V3, P29; Giles LGF, 2003, SPINE, V28, P1490, DOI 10.1097/00007632-200307150-00003; Giles LGF, 1999, J MANIP PHYSIOL THER, V22, P376, DOI 10.1016/S0161-4754(99)70082-5; Grant DJ, 1999, PAIN, V82, P9, DOI 10.1016/S0304-3959(99)00027-5; Gross A, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004249.pub3; Haake M, 2007, ARCH INTERN MED, V167, P1892, DOI 10.1001/archinte.167.17.1892; Hall AM, 2011, ARTHRIT CARE RES, V63, P1576, DOI 10.1002/acr.20594; Hasegawa TM, 2013, ACUPUNCT MED; Hayden J, 2011, COCHRANE DB SYST REV; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; [洪永锋 HONG Yongfeng], 2006, [中国康复医学杂志, Chinese Journal of Rehabilitation Medicine], V21, P340; Hsieh LLC, 2006, BMJ-BRIT MED J, V332, P696, DOI 10.1136/bmj.38744.672616.AE; Hsieh LLC, 2004, PREV MED, V39, P168, DOI 10.1016/j.ypmed.2004.01.036; Hunter RF, 2012, CLIN J PAIN, V28, P259, DOI 10.1097/AJP.0b013e3182274018; Inoue Motohiro, 2006, Acupunct Med, V24, P103; Irnich D, 2001, BMJ-BRIT MED J, V322, P1574, DOI 10.1136/bmj.322.7302.1574; Itoh K, 2007, COMPLEMENT THER MED, V15, P172, DOI 10.1016/j.ctim.2006.05.003; Itoh Kazunori, 2006, Acupunct Med, V24, P5; Itoh Kazunori, 2004, Acupunct Med, V22, P170; Itoh Kazunori, 2009, Complement Ther Clin Pract, V15, P22, DOI 10.1016/j.ctcp.2008.09.003; Jacobs WCH, 2013, EUR SPINE J, V22, P1936, DOI 10.1007/s00586-013-2823-4; Kennedy S, 2008, COMPLEMENT THER MED, V16, P139, DOI 10.1016/j.ctim.2007.03.001; Kim JI, 2011, TRIALS, V12, DOI 10.1186/1745-6215-12-146; Kim TH, 2012, J OCCUP HEALTH, V54, P416, DOI 10.1539/joh.12-0133-OA; Lam M, 2013, SPINE, V38, P2124, DOI 10.1097/01.brs.0000435025.65564.b7; Lansinger B, 2007, SPINE, V32, P2415, DOI 10.1097/BRS.0b013e3181573b4b; Lao L., 2012, INTEGRATIVE PEDIAT O, P125; Lauche R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065378; Lauche R, 2012, AM J CHINESE MED, V40, P905, DOI 10.1142/S0192415X1250067X; Lauche R, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/429718; Lauche R, 2011, BMC COMPLEM ALTERN M, V11, DOI 10.1186/1472-6882-11-63; Lee JH, 2013, CLIN J PAIN, V29, P172, DOI 10.1097/AJP.0b013e31824909f9; Leibing E, 2002, PAIN, V96, P189, DOI 10.1016/S0304-3959(01)00444-4; Li D, 2006, FLORA CHINA, V22, P7; Li JY, 2009, NEI MONGOL J TRADIT, V14, P31; Li Q, 2007, CHIN J CLIN REHABIL, V11, P4531; Liang ZH, 2011, COMPLEMENT THER MED, V19, pS26, DOI 10.1016/j.ctim.2010.11.005; Lin JH, 2013, MANUAL THER, V18, P308, DOI 10.1016/j.math.2012.11.005; Liu BX, 2008, CHINESE J REHABILITA, V14, P572; Macedo LG, 2013, PHYS THER, V93, P1587, DOI 10.2522/ptj.20120464; MAKELA M, 1991, AM J EPIDEMIOL, V134, P1356; Meng CF, 2003, RHEUMATOLOGY, V42, P1508, DOI 10.1093/rheumatology/keg405; Miyazaki S, 2009, CLIN J PAIN, V25, P438, DOI 10.1097/AJP.0b013e318193a6e1; Molsberger AF, 2002, PAIN, V99, P579, DOI 10.1016/S0304-3959(02)00269-5; Moore RA, 1998, PAIN, V78, P209, DOI 10.1016/S0304-3959(98)00140-7; Moreno SG, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2981; Muller R, 2005, J MANIP PHYSIOL THER, V28, P3, DOI 10.1016/j.jmpt.2004.12.004; Nabeta T, 2002, COMPLEMENT THER MED, V10, P217, DOI 10.1016/S0965-2299(02)00082-1; Nuesch E, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c3515; Owens DK, 2010, J CLIN EPIDEMIOL, V63, P513, DOI 10.1016/j.jclinepi.2009.03.009; PETRIE JP, 1986, BRIT J RHEUMATOL, V25, P271; Rendant D, 2011, SPINE, V36, P419, DOI 10.1097/BRS.0b013e3181d51fca; Roelofs PD, 2011, COCHRANE DB SYST REV; Sahin N, 2010, ACUPUNCTURE ELECTRO, V35, P17, DOI 10.3727/036012910803860959; Sator-Katzenschlager SM, 2004, ANESTH ANALG, V98, P1359, DOI 10.1213/01.ANE.0000107941.16173.F7; Shankar Nilima, 2011, Indian J Physiol Pharmacol, V55, P25; Sherwin D C, 1992, Rehabil Nurs, V17, P253; Su Jiang-tao, 2010, Zhongguo Zhen Jiu, V30, P617; Suen Lorna K P, 2007, Complement Ther Clin Pract, V13, P63, DOI 10.1016/j.ctcp.2006.10.005; THOMAS M, 1991, AM J CHINESE MED, V19, P95, DOI 10.1142/S0192415X91000156; Trinh K, 2007, SPINE, V32, P236, DOI 10.1097/01.brs.0000252100.61002.d4; Tsui MLK, 2004, J ALTERN COMPLEM MED, V10, P803; Vas J, 2006, PAIN, V126, P245, DOI 10.1016/j.pain.2006.07.002; Vas J, 2012, PAIN, V153, P1883, DOI 10.1016/j.pain.2012.05.033; Vas Jorge, 2006, BMC Complement Altern Med, V6, P14, DOI 10.1186/1472-6882-6-14; von Trott P, 2009, J PAIN, V10, P501, DOI 10.1016/j.jpain.2008.11.004; Wang B. X., 2004, CHINESE J CLIN REHAB, V8, P3413; Weiss J, 2013, J ALTERN COMPLEMENT; White P, 2004, ANN INTERN MED, V141, P911, DOI 10.7326/0003-4819-141-12-200412210-00007; Witt CM, 2006, AM J EPIDEMIOL, V164, P487, DOI 10.1093/aje/kwj224; Xu M, 2009, LIAONING J TRADITION, V36, P1007; Xu M, 2013, AM J CHINESE MED, V41, P1, DOI 10.1142/S0192415X13500018; Xu Y, 1977, CHI JIAO YI SHENG ZA, V1, P34; Yang BH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035032; Yeh CH, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/196978; Yeung CKN, 2003, J ALTERN COMPLEM MED, V9, P479, DOI 10.1089/107555303322284767; Yip Y B, 2006, Complement Ther Clin Pract, V12, P18, DOI 10.1016/j.ctcp.2005.09.005; Yip YB, 2004, COMPLEMENT THER MED, V12, P28, DOI 10.1016/j.ctim.2003.12.003; Yun MD, 2012, J ALTERN COMPLEM MED, V18, P130, DOI 10.1089/acm.2010.0779; Zaringhalam Jalal, 2010, Chin Med, V5, P15, DOI 10.1186/1749-8546-5-15; [张洪来 Zhang Honglai], 2003, [中国针灸, Chinese Acupuncture and Moxibustion], V23, P637; Zhu LG, 2005, CHIN J ORTHOP TRAUMA, V18, P489; Zhu XM, 2002, AM J CHINESE MED, V30, P13, DOI 10.1142/S0192415X02000028	105	176	193	8	92	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2015	10	2							e0117146	10.1371/journal.pone.0117146	http://dx.doi.org/10.1371/journal.pone.0117146			37	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9IY	25738838	Green Published, gold, Green Submitted			2022-12-27	WOS:000350683900024
J	Matula, R; Svatek, M; Palkova, M; Volarik, D; Vrska, T				Matula, Radim; Svatek, Martin; Palkova, Marcela; Volarik, Daniel; Vrska, Tomas			Mistletoe Infection in an Oak Forest Is Influenced by Competition and Host Size	PLOS ONE			English	Article							LORANTHUS-EUROPAEUS; TROPICAL MISTLETOE; SEED DEPOSITION; DISPERSAL; SPECIFICITY; POPULATION; PARASITISM; EFFICIENCY; VISCACEAE; PATTERNS	Host size and distance from an infected plant have been previously found to affect mistletoe occurrence in woody vegetation but the effect of host plant competition on mistletoe infection has not been empirically tested. For an individual tree, increasing competition from neighbouring trees decreases its resource availability, and resource availability is also known to affect the establishment of mistletoes on host trees. Therefore, competition is likely to affect mistletoe infection but evidence for such a mechanism is lacking. Based on this, we hypothesised that the probability of occurrence as well as the abundance of mistletoes on a tree would increase not only with increasing host size and decreasing distance from an infected tree but also with decreasing competition by neighbouring trees. Our hypothesis was tested using generalized linear models (GLMs) with data on Loranthus europaeus Jacq., one of the two most common mistletoes in Europe, on 1015 potential host stems collected in a large fully mapped plot in the Czech Republic. Because many trees were multistemmed, we ran the analyses for both individual stems and whole trees. We found that the probability of mistletoe occurrence on individual stems was affected mostly by stem size, whereas competition had the most important effects on the probability of mistletoe occurrence on whole trees as well as on mistletoe abundance. Therefore, we confirmed our hypothesis that competition among trees has a negative effect on mistletoe occurrence.	[Matula, Radim; Svatek, Martin; Volarik, Daniel] Mendel Univ Brno, Fac Forestry & Wood Technol, Dept Forest Bot Dendrol & Geobiocoenol, Brno, Czech Republic; [Palkova, Marcela] Mendel Univ Brno, Fac Forestry & Wood Technol, Dept Silviculture, Brno, Czech Republic; [Palkova, Marcela; Vrska, Tomas] Silva Tarouca Res Inst, Dept Forest Ecol, Brno, Czech Republic	Mendel University in Brno; Mendel University in Brno	Matula, R (corresponding author), Mendel Univ Brno, Fac Forestry & Wood Technol, Dept Forest Bot Dendrol & Geobiocoenol, Brno, Czech Republic.	radim.matula@mendelu.cz	Svatek, Martin/C-1890-2014; Volařík, Daniel/AAE-9556-2019; Geršl, Milan/L-2134-2018; Šrámek, Martin/C-1536-2014	Svatek, Martin/0000-0003-2328-4627; Volařík, Daniel/0000-0002-3682-2992; Šrámek, Martin/0000-0003-0259-9902; Matula, Radim/0000-0002-7460-0100; Gersl, Milan/0000-0002-7721-3309	Ministry of Education, Youth and Sports of the Czech Republic [GA526/08/1050, LG12018, CZ.1.07/2.3.00/20.0267]; Faculty of Forestry and Wood Technology of Mendel University in Brno [IGA 11/2010]	Ministry of Education, Youth and Sports of the Czech Republic(Ministry of Education, Youth & Sports - Czech Republic); Faculty of Forestry and Wood Technology of Mendel University in Brno	This study was funded by projects: GA526/08/1050, "Structure and function of the Quercus-Loranthus complex regarding the potential suppression of the important oak crown killer", LG12018 "Involvement of the Czech Republic in the research of European Forest Institute (EFI)" and CZ.1.07/2.3.00/20.0267 "Coppice forests as the production and biological alternative for the future" of the Ministry of Education, Youth and Sports of the Czech Republic (www.msmt.cz); IGA 11/2010 of the Faculty of Forestry and Wood Technology of Mendel University in Brno (www.ldf.mendelu.cz) - "Spatial and age structure analysis of old oak coppices in the Podyji National Park. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams TP, 2007, P ROY SOC B-BIOL SCI, V274, P3039, DOI 10.1098/rspb.2007.0891; [Anonymous], 2014, R LANG ENV STAT COMP; Arruda R, 2006, FLORA, V201, P127, DOI 10.1016/j.flora.2005.07.001; Arruda R, 2012, ACTA BOT BRAS, V26, P264, DOI 10.1590/S0102-33062012000200003; Aukema JE, 2003, FRONT ECOL ENVIRON, V1, P212, DOI 10.1890/1540-9295(2003)001[0212:VVAVMA]2.0.CO;2; Aukema JE, 2004, ECOGRAPHY, V27, P137, DOI 10.1111/j.0906-7590.2004.03640.x; Aukema JE, 2002, ECOLOGY, V83, P3489, DOI 10.1890/0012-9658(2002)083[3489:WDAFEB]2.0.CO;2; Aukema JE, 2002, ECOGRAPHY, V25, P139, DOI 10.1034/j.1600-0587.2002.250202.x; BIGING GS, 1995, FOREST SCI, V41, P360; Bonser SP, 2013, FUNCT ECOL, V27, P876, DOI 10.1111/1365-2435.12064; Burnham K.P., 2002, PRACTICAL INFORM THE, V2nd ed., DOI [DOI 10.1007/B97636, 10.1007/b97636]; Butin HH, 1995, TREE DIS DISORDERS C; Canham CD, 2004, CAN J FOREST RES, V34, P778, DOI [10.1139/x03-232, 10.1139/X03-232]; Carlo TA, 2005, ECOLOGY, V86, P3245, DOI 10.1890/05-0460; Carnegie AJ, 2009, BOTANY, V87, P49, DOI 10.1139/B08-127; Coates KD, 2009, J ECOL, V97, P118, DOI 10.1111/j.1365-2745.2008.01458.x; Coomes DA, 2007, J ECOL, V95, P1084, DOI 10.1111/j.1365-2745.2007.01280.x; Dobbertin M, 2006, FOREST PATHOL, V36, P309, DOI 10.1111/j.1439-0329.2006.00457.x; DONOHUE K, 1995, INT J PLANT SCI, V156, P816, DOI 10.1086/297305; ELIAS P, 1987, EKOL CSFR, V6, P359; Glatzel G, 2009, BOTANY, V87, P10, DOI 10.1139/B08-096; GLATZEL G, 1983, OECOLOGIA, V56, P193, DOI 10.1007/BF00379691; Janik D, 2007, THAYENSIA, V1, P175; Kubat K, 1997, KVETENA CESKE REPUBL, V5, P467; Mathiasen RL, 2008, PLANT DIS, V92, P988, DOI 10.1094/PDIS-92-7-0988; Matula R, 2012, EUR J FOREST RES, V131, P1501, DOI 10.1007/s10342-012-0618-5; MONTEIRO RF, 1992, J TROP ECOL, V8, P307, DOI 10.1017/S026646740000657X; Mourao FA, 2009, ACTA BOT BRAS, V23, P820, DOI 10.1590/S0102-33062009000300023; OVERTON JM, 1994, J ECOL, V82, P711, DOI 10.2307/2261437; Press MC, 2005, NEW PHYTOL, V166, P737, DOI 10.1111/j.1469-8137.2005.01358.x; Reid N, 2009, BOTANY, V87, P1, DOI 10.1139/B08-109; Rist L, 2011, BIOTROPICA, V43, P50, DOI 10.1111/j.1744-7429.2010.00643.x; SARGENT S, 1995, FUNCT ECOL, V9, P197, DOI 10.2307/2390565; Shaw DC, 2004, AUST J BOT, V52, P481, DOI 10.1071/BT03074; Skorka P, 2005, ACTA ORNITHOL, V40, P35, DOI 10.3161/068.040.0109; Skorka Piotr, 2003, Acta Zoologica Cracoviensia, V46, P29; SNOW BK, 1984, IBIS, V126, P39, DOI 10.1111/j.1474-919X.1984.tb03662.x; STERBA H, 1993, FOREST ECOL MANAG, V62, P39, DOI 10.1016/0378-1127(93)90040-T; Teodoro GS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065836; Vrska T, 1998, THAYENSIA, V1, P101; Ward MJ, 2007, AUSTRAL ECOL, V32, P113, DOI 10.1111/j.1442-9993.2006.01668.x; Watson DM, 2009, BOTANY, V87, P16, DOI 10.1139/B08-105; Watson DM, 2001, ANNU REV ECOL SYST, V32, P219, DOI 10.1146/annurev.ecolsys.32.081501.114024; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1	44	28	29	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2015	10	5							e0127055	10.1371/journal.pone.0127055	http://dx.doi.org/10.1371/journal.pone.0127055			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7BG	25992920	gold, Green Submitted, Green Published			2022-12-27	WOS:000354917300079
J	Matula, R; Damborska, L; Necasova, M; Gersl, M; Sramek, M				Matula, Radim; Damborska, Lenka; Necasova, Monika; Gersl, Milan; Sramek, Martin			Measuring Biomass and Carbon Stock in Resprouting Woody Plants	PLOS ONE			English	Article							SPROUT DEVELOPMENT; TROPICAL FOREST; TREE; PLANTATIONS; VARIABILITY; ALLOMETRY; WOODLAND; STUMPS; GROWTH; STANDS	Resprouting multi-stemmed woody plants form an important component of the woody vegetation in many ecosystems, but a clear methodology for reliable measurement of their size and quick, non-destructive estimation of their woody biomass and carbon stock is lacking. Our goal was to find a minimum number of sprouts, i.e., the most easily obtainable, and sprout parameters that should be measured for accurate sprout biomass and carbon stock estimates. Using data for 5 common temperate woody species, we modelled carbon stock and sprout biomass as a function of an increasing number of sprouts in an interaction with different sprout parameters. The mean basal diameter of only two to five of the thickest sprouts and the basal diameter and DBH of the thickest sprouts per stump proved to be accurate estimators for the total sprout biomass of the individual resprouters and the populations of resprouters, respectively. Carbon stock estimates were strongly correlated with biomass estimates, but relative carbon content varied among species. Our study demonstrated that the size of the resprouters can be easily measured, and their biomass and carbon stock estimated; therefore, resprouters can be simply incorporated into studies of woody vegetation.	[Matula, Radim; Damborska, Lenka; Necasova, Monika; Sramek, Martin] Mendel Univ Brno, Fac Forestry & Wood Technol, Dept Forest Bot Dendrol & Geobiocoenol, Brno, Czech Republic; [Gersl, Milan] Mendel Univ Brno, Fac Agron, Dept Agr Food & Environm Engn, Brno, Czech Republic	Mendel University in Brno; Mendel University in Brno	Matula, R (corresponding author), Mendel Univ Brno, Fac Forestry & Wood Technol, Dept Forest Bot Dendrol & Geobiocoenol, Brno, Czech Republic.	radim.matula@mendelu.cz	Svatek, Martin/C-1890-2014; Volařík, Daniel/AAE-9556-2019; Geršl, Milan/L-2134-2018; Šrámek, Martin/C-1536-2014	Svatek, Martin/0000-0003-2328-4627; Volařík, Daniel/0000-0002-3682-2992; Šrámek, Martin/0000-0003-0259-9902; Matula, Radim/0000-0002-7460-0100; Gersl, Milan/0000-0002-7721-3309	Ministry of Education, Youth and Sports [LG12018]	Ministry of Education, Youth and Sports(Ministry of Education, Youth & Sports - Czech Republic)	This study was funded by project LG12018 of the Ministry of Education, Youth and Sports (www.msmt.cz) titled "Involvement of the Czech Republic in the research of European Forest Institute (EFI)". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BASKERVILLE G L, 1972, Canadian Journal of Forest Research, V2, P49, DOI 10.1139/x72-009; Bond WJ, 2001, TRENDS ECOL EVOL, V16, P45, DOI 10.1016/S0169-5347(00)02033-4; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Chave J, 2005, OECOLOGIA, V145, P87, DOI 10.1007/s00442-005-0100-x; Clarke PJ, 2010, NEW PHYTOL, V188, P651, DOI 10.1111/j.1469-8137.2010.03508.x; Crawley MJ, 2013, R BOOK, P557; Dietze MC, 2008, ECOL MONOGR, V78, P331, DOI 10.1890/07-0271.1; Everham EM, 1996, BOT REV, V62, P113, DOI 10.1007/BF02857920; Fang SZ, 2011, BIOMASS BIOENERG, V35, P3104, DOI 10.1016/j.biombioe.2011.04.017; HAASE R, 1995, FOREST ECOL MANAG, V73, P29, DOI 10.1016/0378-1127(94)03509-U; HARRINGTON RA, 1993, FOREST ECOL MANAG, V56, P315, DOI 10.1016/0378-1127(93)90120-C; Hector A, 2011, PHILOS T R SOC B, V366, P3303, DOI 10.1098/rstb.2011.0094; Henry M, 2011, SILVA FENN, V45, P477, DOI 10.14214/sf.38; HYTONEN J, 1987, BIOMASS, V14, P39, DOI 10.1016/0144-4565(87)90021-7; Hytonen J, 1999, BIOMASS BIOENERG, V17, P455, DOI 10.1016/S0961-9534(99)00061-6; Johansson T, 2008, BIOMASS BIOENERG, V32, P944, DOI 10.1016/j.biombioe.2008.01.009; JOHNSON PS, 2002, ECOLOGY SILVICULTURE; Lamlom SH, 2003, BIOMASS BIOENERG, V25, P381, DOI 10.1016/S0961-9534(03)00033-3; Liu ZL, 2011, FOREST ECOL MANAG, V262, P299, DOI 10.1016/j.foreco.2011.03.035; MAGEE L, 1990, AM STAT, V44, P250, DOI 10.2307/2685352; Matula R, 2014, J ARID ENVIRON, V100, P72, DOI 10.1016/j.jaridenv.2013.10.014; Matula R, 2012, EUR J FOREST RES, V131, P1501, DOI 10.1007/s10342-012-0618-5; Mosseler A, 2014, FOREST ECOL MANAG, V320, P190, DOI 10.1016/j.foreco.2014.02.027; NAGELKERKE NJD, 1991, BIOMETRIKA, V78, P691, DOI 10.1093/biomet/78.3.691; Paciorek CJ, 2000, J ECOL, V88, P765, DOI 10.1046/j.1365-2745.2000.00494.x; Paine CET, 2012, METHODS ECOL EVOL, V3, P245, DOI 10.1111/j.2041-210X.2011.00155.x; Pinheiro J., 2014, NLME LINEAR NONLINEA, V3, P1; R Core Team, 2012, R LANG ENV STAT COMP; Robertson KM, 2014, OECOLOGIA, V174, P765, DOI 10.1007/s00442-013-2823-4; Tanentzap AJ, 2012, J ECOL, V100, P171, DOI 10.1111/j.1365-2745.2011.01879.x; Thomas SC, 2007, J ENVIRON MANAGE, V85, P659, DOI 10.1016/j.jenvman.2006.04.022; Verwijst T, 1999, FOREST ECOL MANAG, V121, P137, DOI 10.1016/S0378-1127(98)00562-3; Wright L, 2006, BIOMASS BIOENERG, V30, P706, DOI 10.1016/j.biombioe.2005.08.008; Zewdie M, 2009, BIOMASS BIOENERG, V33, P421, DOI 10.1016/j.biombioe.2008.08.007; Zhang QZ, 2009, FOREST ECOL MANAG, V258, P722, DOI 10.1016/j.foreco.2009.05.009	35	28	29	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2015	10	2							e0118388	10.1371/journal.pone.0118388	http://dx.doi.org/10.1371/journal.pone.0118388			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC2ZH	25992920	Green Submitted, gold, Green Published			2022-12-27	WOS:000350213200050
